PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Zhang, HY; Zhang, L; Gao, B; Fan, H; Jin, JB; Botella, MA; Jiang, LW; Lin, JX				Zhang, Haiyan; Zhang, Liang; Gao, Bin; Fan, Hai; Jin, Jingbo; Botella, Miguel A.; Jiang, Liwen; Lin, Jinxing			Golgi Apparatus-Localized Synaptotagmin 2 Is Required for Unconventional Secretion in Arabidopsis	PLOS ONE			English	Article							ADP-RIBOSYLATION FACTOR-1; HYGROMYCIN-B INHIBITION; DYNAMIN-LIKE PROTEIN; BREFELDIN-A; SELECTABLE MARKER; PLASMA-MEMBRANE; PREVACUOLAR COMPARTMENTS; ACID-PHOSPHATASE; TRAFFICKING; ENDOCYTOSIS	Background: Most secretory proteins contain signal peptides that direct their sorting to the ER and secreted via the conventional ER/Golgi transport pathway, while some signal-peptide-lacking proteins have been shown to export through ER/Golgi independent secretory pathways. Hygromycin B is an aminoglycoside antibiotic produced by Streptomyces hygroscopicus that is active against both prokaryotic and eukaryotic cells. The hygromycin phosphotransferase (HYG(R)) can phosphorylate and inactivate the hygromycin B, and has been widely used as a positive selective marker in the construction of transgenic plants. However, the localization and trafficking of HYG(R) in plant cells remain unknown. Synaptotagmins (SYTs) are involved in controlling vesicle endocytosis and exocytosis as calcium sensors in animal cells, while their functions in plant cells are largely unclear. Methodology/Principal Findings: We found Arabidopsis synaptotagmin SYT2 was localized on the Golgi apparatus by immunofluorescence and immunogold labeling. Surprisingly, co-expression of SYT2 and HYG(R) caused hypersensitivity of the transgenic Arabidopsis plants to hygromycin B. HYG(R), which lacks a signal sequence, was present in the cytoplasm as well as in the extracellular space in HYG(R)-GFP transgenic Arabidopsis plants and its secretion is not sensitive to brefeldin A treatment, suggesting it is not secreted via the conventional secretory pathway. Furthermore, we found that HYG(R)-GFP was truncated at carboxyl terminus of HYG(R) shortly after its synthesis, and the cells deficient SYT2 failed to efficiently truncate HYGR-GFP, resulting in HYG(R)-GFP accumulated in prevacuoles/vacuoles, indicating that SYT2 was involved in HYG(R)-GFP trafficking and secretion. Conclusion/Significance: These findings reveal for the first time that SYT2 is localized on the Golgi apparatus and regulates HYG(R)-GFP secretion via the unconventional protein transport from the cytosol to the extracelluar matrix in plant cells.	[Zhang, Haiyan; Zhang, Liang; Gao, Bin; Jin, Jingbo; Lin, Jinxing] Chinese Acad Sci, Inst Bot, Key Lab Photosynth & Mol Environm Physiol, Beijing, Peoples R China; [Zhang, Liang] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Gao, Bin; Fan, Hai] Shandong Normal Univ, Coll Life Sci, Jinan, Peoples R China; [Botella, Miguel A.] Univ Malaga, Dept Biol Mol Bioquim, E-29071 Malaga, Spain; [Jiang, Liwen] Chinese Univ Hong Kong, Dept Biol, Shatin, Hong Kong, Peoples R China; [Jiang, Liwen] Chinese Univ Hong Kong, Mol Biotechnol Program, Shatin, Hong Kong, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Shandong Normal University; Universidad de Malaga; Chinese University of Hong Kong; Chinese University of Hong Kong	Zhang, HY (corresponding author), Chinese Acad Sci, Inst Bot, Key Lab Photosynth & Mol Environm Physiol, Beijing, Peoples R China.	linjx@ibcas.ac.cn	JIANG, Liwen/S-6046-2018; Botella, Miguel Ángel/S-3676-2019; Botella, Miguel A/B-5734-2012; Zhang, Haitao/L-7612-2015	JIANG, Liwen/0000-0002-7829-1472; Botella, Miguel Ángel/0000-0002-8867-1831; Botella, Miguel A/0000-0002-8867-1831; Lin, Jinxing/0000-0001-9338-1356; Zhang, Haitao/0000-0003-4879-2951	National Natural Science Foundation of China [90817010, 30770123]; El Ministerio de Cienciae Innovacion [BIO2008-1709]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); El Ministerio de Cienciae Innovacion(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	The National Natural Science Foundation of China, (Granted No. 90817010 and 30770123)(http://www.nsfc.gov.cn/Portal0/default124.htm), and El Ministerio de Cienciae Innovacion (Grant BIO2008-1709). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal GK, 2010, PROTEOMICS, V10, P799, DOI 10.1002/pmic.200900514; Bolte S, 2004, J MICROSC-OXFORD, V214, P159, DOI 10.1111/j.0022-2720.2004.01348.x; Borovinskaya MA, 2008, RNA, V14, P1590, DOI 10.1261/rna.1076908; Cabral M, 2010, EUKARYOT CELL, V9, P1009, DOI 10.1128/EC.00337-09; Cheng FY, 2009, PLANTA, V230, P1093, DOI 10.1007/s00425-009-1006-3; Couchy I, 2003, J EXP BOT, V54, P2053, DOI 10.1093/jxb/erg230; Craxton M, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-43; Dettmer J, 2006, PLANT CELL, V18, P715, DOI 10.1105/tpc.105.037978; Dhonukshe P, 2007, CURR BIOL, V17, P520, DOI 10.1016/j.cub.2007.01.052; Fukuda M, 2004, J BIOL CHEM, V279, P52677, DOI 10.1074/jbc.M409241200; Grebe M, 2003, CURR BIOL, V13, P1378, DOI 10.1016/S0960-9822(03)00538-4; Gustavsson N, 2008, P NATL ACAD SCI USA, V105, P3992, DOI 10.1073/pnas.0711700105; Gustavsson N, 2009, BIOSCIENCE REP, V29, P245, DOI 10.1042/BSR20090031; Harlow E., 1988, ANTIBODIES LAB MANUA; Hu ZT, 2008, BIOCHEM BIOPH RES CO, V371, P781, DOI 10.1016/j.bbrc.2008.04.174; Jaillais Y, 2008, PLANT J, V53, P237, DOI 10.1111/j.1365-313X.2007.03338.x; Jin JB, 2001, PLANT CELL, V13, P1511, DOI 10.1105/tpc.13.7.1511; Kaneko TS, 1996, PLANT CELL REP, V15, P409, DOI 10.1007/BF00232065; Kinseth MA, 2007, CELL, V130, P524, DOI 10.1016/j.cell.2007.06.029; Kotzer AM, 2004, J CELL SCI, V117, P6377, DOI 10.1242/jcs.01564; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; Lee MH, 2002, PLANT PHYSIOL, V129, P1507, DOI 10.1104/pp.003624; Lee OR, 2010, PLANT CELL, V22, P1812, DOI 10.1105/tpc.110.074211; Lu Y, 2007, J FOOD SCI, V72, pM228, DOI 10.1111/j.1750-3841.2007.00437.x; Lynch KL, 2008, MOL BIOL CELL, V19, P5093, DOI 10.1091/mbc.E08-03-0235; McGaha SM, 2007, ANTIMICROB AGENTS CH, V51, P591, DOI 10.1128/AAC.01116-06; Miki B, 2004, J BIOTECHNOL, V107, P193, DOI 10.1016/j.jbiotec.2003.10.011; Nebenfuhr A, 2002, PLANT PHYSIOL, V130, P1102, DOI 10.1104/pp.011569; Neumann U, 2003, ANN BOT-LONDON, V92, P167, DOI 10.1093/aob/mcg134; Nickel W, 2003, EUR J BIOCHEM, V270, P2109, DOI 10.1046/j.1432-1033.2003.03577.x; Nickel W, 2005, TRAFFIC, V6, P607, DOI 10.1111/j.1600-0854.2005.00302.x; Nickel W, 2010, CURR OPIN BIOTECH, V21, P621, DOI 10.1016/j.copbio.2010.06.004; Nickel W, 2009, NAT REV MOL CELL BIO, V10, P148, DOI 10.1038/nrm2617; ORCI L, 1991, CELL, V64, P1183; Ortiz JPA, 1996, PLANT CELL REP, V15, P877, DOI 10.1007/BF00231579; PALADE G, 1975, SCIENCE, V189, P347, DOI 10.1126/science.1096303; PARDO JM, 1985, J GEN MICROBIOL, V131, P1289; Park JM, 1997, PLANT PHYSIOL, V115, P763, DOI 10.1104/pp.115.2.763; Peyroche A, 1999, MOL CELL, V3, P275, DOI 10.1016/S1097-2765(00)80455-4; Pfeffer SR, 2010, J CELL BIOL, V188, P451, DOI 10.1083/jcb.201001121; Pfeiffer W, 1996, PHYSIOL PLANTARUM, V98, P773, DOI 10.1111/j.1399-3054.1996.tb06684.x; PITTENGER RC, 1953, ANTIBIOT CHEMOTHER, V3, P1268; Robineau S, 2000, P NATL ACAD SCI USA, V97, P9913, DOI 10.1073/pnas.170290597; Robinson DG, 2008, TRENDS PLANT SCI, V13, P405, DOI 10.1016/j.tplants.2008.05.010; Schapire AL, 2009, TRENDS PLANT SCI, V14, P645, DOI 10.1016/j.tplants.2009.09.004; Schapire AL, 2008, PLANT CELL, V20, P3374, DOI 10.1105/tpc.108.063859; Schatz G, 1996, SCIENCE, V271, P1519, DOI 10.1126/science.271.5255.1519; Schotman H, 2008, DEV CELL, V14, P171, DOI 10.1016/j.devcel.2007.12.006; Short B, 2005, BBA-MOL CELL RES, V1744, P383, DOI 10.1016/j.bbamcr.2005.02.001; Teh OK, 2007, NATURE, V448, P493, DOI 10.1038/nature06023; Tian LN, 2000, PLANT CELL REP, V19, P358, DOI 10.1007/s002990050740; Tse YC, 2004, PLANT CELL, V16, P672, DOI 10.1105/tpc.019703; Ueda T, 2001, EMBO J, V20, P4730, DOI 10.1093/emboj/20.17.4730; Wang JA, 2010, PLANT CELL, V22, P4009, DOI 10.1105/tpc.110.080697; Wang JQ, 2009, J EXP BOT, V60, P3075, DOI 10.1093/jxb/erp136; Wu FH, 2009, PLANT METHODS, V5, DOI 10.1186/1746-4811-5-16; Xu J, 2005, PLANT CELL, V17, P525, DOI 10.1105/tpc.104.028449; Yamazaki T, 2008, PLANT CELL, V20, P3389, DOI 10.1105/tpc.108.062679; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199	59	47	51	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2011	6	11							e26477	10.1371/journal.pone.0026477	http://dx.doi.org/10.1371/journal.pone.0026477			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KW	22140429	Green Submitted, Green Published, gold			2022-12-27	WOS:000298163400001
J	Brites, P; Ferreira, AS; da Silva, TF; Sousa, VF; Malheiro, AR; Duran, M; Waterham, HR; Baes, M; Wanders, RJA				Brites, Pedro; Ferreira, Ana Sofia; da Silva, Tiago Ferreira; Sousa, Vera F.; Malheiro, Ana R.; Duran, Marinus; Waterham, Hans R.; Baes, Myriam; Wanders, Ronald J. A.			Alkyl-Glycerol Rescues Plasmalogen Levels and Pathology of Ether-Phospholipid Deficient Mice	PLOS ONE			English	Article							RHIZOMELIC CHONDRODYSPLASIA PUNCTATA; ACID ALPHA-OXIDATION; PHYTANIC ACID; PEROXISOMAL DISORDERS; ZELLWEGER-SYNDROME; HARDERIAN-GLAND; PTS2 RECEPTOR; FATTY-ACIDS; DIHYDROXYACETONEPHOSPHATE SYNTHASE; BIOLOGICAL-MEMBRANES	A deficiency of plasmalogens, caused by impaired peroxisomal metabolism affects normal development and multiple organs in adulthood. Treatment options aimed at restoring plasmalogen levels may be relevant for the therapy of peroxisomal and non-peroxisomal disorders. In this study we determined the in vivo efficacy of an alkyl glycerol (AG), namely, 1-O-octadecyl-rac-glycerol, as a therapeutic agent for defects in plasmalogen synthesis. To achieve this, Pex7 knockout mice, a mouse model for Rhizomelic Chondrodysplasia Punctata type 1 characterized by the absence of plasmalogens, and WT mice were fed a control diet or a diet containing 2% alkyl-glycerol. Plasmalogen levels were measured in target organs and the biochemical data were correlated with the histological analysis of affected organs. Plasmalogen levels in all peripheral tissues of Pex7 KO mice fed the AG diet for 2 months normalized to the levels of AG fed WT mice. In nervous tissues of Pex7 KO mice fed the AG-diet, plasmalogen levels were significantly increased compared to control fed KO mice. Histological analysis of target organs revealed that the AG-diet was able to stop the progression of the pathology in testis, adipose tissue and the Harderian gland. Interestingly, the latter tissues are characterized by the presence of lipid droplets which were absent or reduced in size and number when ether-phospholipids are lacking, but which can be restored with the AAG treatment. Furthermore, nerve conduction in peripheral nerves was improved. When given prior to the occurrence of major pathological changes, the AG-diet prevented or ameliorated the pathology observed in Pex7 KO mice depending on the degree of plasmalogen restoration. This study provides evidence of the beneficial effects of treating a plasmalogen deficiency with alkyl-glycerol.	[Brites, Pedro; da Silva, Tiago Ferreira; Sousa, Vera F.; Malheiro, Ana R.] IBMC, Nerve Regenerat Grp, Oporto, Portugal; [Brites, Pedro; Ferreira, Ana Sofia; Duran, Marinus; Waterham, Hans R.; Wanders, Ronald J. A.] Univ Amsterdam, Acad Med Ctr, Lab Genet Metab Dis, NL-1105 AZ Amsterdam, Netherlands; [da Silva, Tiago Ferreira; Sousa, Vera F.] Univ Porto, ICBAS, P-4100 Oporto, Portugal; [Baes, Myriam] Katholieke Univ Leuven, Lab Cell Metab, Dept Pharmaceut Sci, Louvain, Belgium	Universidade do Porto; University of Amsterdam; Academic Medical Center Amsterdam; Universidade do Porto; KU Leuven	Brites, P (corresponding author), IBMC, Nerve Regenerat Grp, Oporto, Portugal.	pedro.brites@ibmc.up.pt	Brites, Pedro/K-4231-2013; Silva, Tiago JCF/I-6961-2015; Ferreira, Ana Sofia/F-7899-2014; Malheiro, Ana/L-1174-2014	Brites, Pedro/0000-0003-1754-1543; Silva, Tiago JCF/0000-0002-0732-8741; Malheiro, Ana/0000-0002-9093-5875; Ferreira, Ana Sofia/0000-0003-3805-8278; Sousa Figueiredo, Vera/0000-0001-7945-0116; Baes, Myriam/0000-0002-2525-2269	Association Europeenne contre les Leucodystrophies [ELA 2008-009C4B, 2010-042c5]; FundaCao para a Cioncia e Tecnologia [PTDS/SAU-ORG/112406/2009]	Association Europeenne contre les Leucodystrophies; FundaCao para a Cioncia e Tecnologia	This research was supported by grants from the Association Europeenne contre les Leucodystrophies (ELA 2008-009C4B and 2010-042c5) and by PTDS/SAU-ORG/112406/2009 from FundaCao para a Cioncia e Tecnologia under the programs FEDER and COMPETE. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen NE, 2008, BRIT J NUTR, V99, P653, DOI 10.1017/S000711450782407X; BALFE A, 1990, PEDIATR RES, V27, P304, DOI 10.1203/00006450-199003000-00023; Beams-Mengerink AM, 2006, NEUROLOGY, V66, P798, DOI 10.1212/01.wnl.0000205594.34647.d0; Braverman N, 1997, NAT GENET, V15, P369, DOI 10.1038/ng0497-369; Braverman N, 2002, HUM MUTAT, V20, P284, DOI 10.1002/humu.10124; Braverman N, 2010, MOL GENET METAB, V99, P408, DOI 10.1016/j.ymgme.2009.12.005; Brites P, 2004, BBA-MOL CELL BIOL L, V1636, P219, DOI 10.1016/j.bbalip.2003.12.010; Brites P, 2003, HUM MOL GENET, V12, P2255, DOI 10.1093/hmg/ddg236; Brites P, 2009, BRAIN, V132, P482, DOI 10.1093/brain/awn295; Brookhyser KM, 1999, PRENATAL DIAG, V19, P383, DOI 10.1002/(SICI)1097-0223(199904)19:4<383::AID-PD544>3.0.CO;2-S; Dacremont G, 1995, J INHERIT METAB DIS, V18, P84, DOI 10.1007/BF00711431; DAS AK, 1988, FEBS LETT, V227, P187, DOI 10.1016/0014-5793(88)80895-0; DAS AK, 1992, LIPIDS, V27, P401, DOI 10.1007/BF02536379; de Vet ECJM, 1998, J BIOL CHEM, V273, P10296, DOI 10.1074/jbc.273.17.10296; de Vet ECJM, 2000, CELL BIOCHEM BIOPHYS, V32, P117, DOI 10.1385/CBB:32:1-3:117; Dragonas C, 2009, CLIN CHEM LAB MED, V47, P894, DOI 10.1515/CCLM.2009.205; Ferdinandusse S, 2008, P NATL ACAD SCI USA, V105, P17712, DOI 10.1073/pnas.0806066105; Gaposchkin DP, 1999, J LIPID RES, V40, P495; Goodenowe DB, 2007, J LIPID RES, V48, P2485, DOI 10.1194/jlr.P700023-JLR200; Gorgas K, 2006, BBA-MOL CELL RES, V1763, P1511, DOI 10.1016/j.bbamcr.2006.08.038; Grandl M, 2006, CYTOM PART A, V69A, P189, DOI 10.1002/cyto.a.20232; Gressens P, 2000, ANN NEUROL, V48, P336, DOI 10.1002/1531-8249(200009)48:3<336::AID-ANA8>3.0.CO;2-Q; HEIKOOP JC, 1990, J CLIN INVEST, V86, P126, DOI 10.1172/JCI114674; HOEFLER G, 1988, J PEDIATR-US, V112, P726, DOI 10.1016/S0022-3476(88)80689-9; HOEFLER S, 1988, PRENATAL DIAG, V8, P571, DOI 10.1002/pd.1970080804; HORIE S, 1989, BIOCHEM J, V262, P677, DOI 10.1042/bj2620677; KAUFMAN S, 1990, BIOCHIM BIOPHYS ACTA, V1040, P19, DOI 10.1016/0167-4838(90)90141-2; Khan M, 2008, J NEUROCHEM, V106, P1766, DOI 10.1111/j.1471-4159.2008.05513.x; KREMSER K, 1989, J CLIN CHEM CLIN BIO, V27, P315; Lankalapalli RS, 2009, ORG LETT, V11, P2784, DOI 10.1021/ol9009078; Lee TC, 1998, BBA-LIPID LIPID MET, V1394, P129, DOI 10.1016/S0005-2760(98)00107-6; Lessig J, 2009, CURR MED CHEM, V16, P2021; Motley AM, 1997, NAT GENET, V15, P377, DOI 10.1038/ng0497-377; Motley AM, 2002, AM J HUM GENET, V70, P612, DOI 10.1086/338998; Nagan N, 2001, PROG LIPID RES, V40, P199, DOI 10.1016/S0163-7827(01)00003-0; Ofman R, 1998, HUM MOL GENET, V7, P847, DOI 10.1093/hmg/7.5.847; PALTAUF F, 1994, CHEM PHYS LIPIDS, V74, P101, DOI 10.1016/0009-3084(94)90054-X; PALTAUF F, 1988, FASEB J, V2, pA1740; PAYNE AP, 1994, J ANAT, V185, P1; POULOS A, 1988, J PEDIATR-US, V113, P685, DOI 10.1016/S0022-3476(88)80378-0; Powers JM, 1999, ACTA NEUROPATHOL, V98, P129, DOI 10.1007/s004010051060; Pugliese PT, 1998, J ALTERN COMPLEM MED, V4, P87, DOI 10.1089/acm.1998.4.1-87; Purdue PE, 1999, NEUROCHEM RES, V24, P581, DOI 10.1023/A:1023957110171; Purdue PE, 1997, NAT GENET, V15, P381, DOI 10.1038/ng0497-381; RADOMINSKAPYREK A, 1979, BIOCHIM BIOPHYS ACTA, V574, P248, DOI 10.1016/0005-2760(79)90006-7; Rodemer C, 2003, HUM MOL GENET, V12, P1881, DOI 10.1093/hmg/ddg191; Rosenberger TA, 2002, J LIPID RES, V43, P59; Sakai S, 2008, BRAIN DEV-JPN, V30, P68, DOI 10.1016/j.braindev.2007.06.002; SCHRAKAMP G, 1988, J LIPID RES, V29, P325; SCHUTGENS RBH, 1993, CLIN CHEM, V39, P1632; Snyder F, 1988, Prog Clin Biol Res, V282, P57; STURK A, 1987, BLOOD, V70, P460; Styger R, 2002, BBA-MOL CELL BIOL L, V1585, P39, DOI 10.1016/S1388-1981(02)00320-7; van den Bosch H, 1988, Prog Clin Biol Res, V282, P139; Van Overloop H, 2007, BIOL CHEM, V388, P315, DOI 10.1515/BC.2007.035; VANDENBOSCH H, 1993, BIOCHIMIE, V75, P183, DOI 10.1016/0300-9084(93)90076-5; Verhoeven NM, 2001, PROG LIPID RES, V40, P453, DOI 10.1016/S0163-7827(01)00011-X; Wanders RJA, 2003, BBA-MOL CELL BIOL L, V1631, P119, DOI 10.1016/S1388-1981(03)00003-9; Wanders RJA, 2001, J NEUROPATH EXP NEUR, V60, P1021, DOI 10.1093/jnen/60.11.1021; Wanders RJA, 2006, ANNU REV BIOCHEM, V75, P295, DOI 10.1146/annurev.biochem.74.082803.133329; Wang HJ, 2010, MOL BIOL CELL, V21, P1991, DOI 10.1091/mbc.E09-05-0364; White AL, 2003, AM J MED GENET A, V118A, P332, DOI 10.1002/ajmg.a.20009; Wierzbicki AS, 2007, BIOCHEM SOC T, V35, P881, DOI 10.1042/BST0350881; WILSON GN, 1986, AM J MED GENET, V24, P69, DOI 10.1002/ajmg.1320240109	64	75	75	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2011	6	12							e28539	10.1371/journal.pone.0028539	http://dx.doi.org/10.1371/journal.pone.0028539			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863OC	22163031	Green Published, gold, Green Submitted			2022-12-27	WOS:000298173500031
J	Anadon, JD; D'Agrosa, C; Gondor, A; Gerber, LR				Daniel Anadon, Jose; D'Agrosa, Caterina; Gondor, Anne; Gerber, Leah R.			Quantifying the Spatial Ecology of Wide-Ranging Marine Species in the Gulf of California: Implications for Marine Conservation Planning	PLOS ONE			English	Article							TURTLE CHELONIA-MYDAS; FORAGING AREA; CONNECTIVITY; DISPERSAL; PATTERNS; BIODIVERSITY; INFORMATION; MOVEMENTS; NETWORKS; MODELS	There is growing interest in systematic establishment of marine protected area (MPA) networks and representative conservation sites. This movement toward networks of no-take zones requires that reserves are deliberately and adequately spaced for connectivity. Here, we test the network functionality of an ecoregional assessment configuration of marine conservation areas by evaluating the habitat protection and connectivity offered to wide-ranging fauna in the Gulf of California (GOC, Mexico). We first use expert opinion to identify representative species of wide-ranging fauna of the GOC. These include leopard grouper, hammerhead sharks, California brown pelicans and green sea turtles. Analyzing habitat models with both structural and functional connectivity indexes, our results indicate that the configuration includes large proportions of biologically important habitat for the four species considered (25-40%), particularly, the best quality habitats (46-57%). Our results also show that connectivity levels offered by the conservation area design for these four species may be similar to connectivity levels offered by the entire Gulf of California, thus indicating that connectivity offered by the areas may resemble natural connectivity. The selected focal species comprise different life histories among marine or marine-related vertebrates and are associated with those habitats holding the most biodiversity values (i.e. coastal habitats); our results thus suggest that the proposed configuration may function as a network for connectivity and may adequately represent the marine megafauna in the GOC, including the potential connectivity among habitat patches. This work highlights the range of approaches that can be used to quantify habitat protection and connectivity for wide-ranging marine species in marine reserve networks.	[Daniel Anadon, Jose; D'Agrosa, Caterina; Gerber, Leah R.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85069 USA; [Gondor, Anne] Nature Conservancy, Tempe, AZ USA; [Daniel Anadon, Jose] Estn Biol Donana, Dept Conservat Biol, Seville, Spain	Arizona State University; Arizona State University-Tempe; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD)	Anadon, JD (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85069 USA.	jdanadon@gmail.com	Anadon, Jose/H-6482-2015		Nature Conservancy; RJ Kose granting program; David and Lucile Packard Foundation	Nature Conservancy; RJ Kose granting program; David and Lucile Packard Foundation(The David & Lucile Packard Foundation)	Funding for this project was provided by The Nature Conservancy, RJ Kose granting program and The David and Lucile Packard Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aburto-Oropeza O, 2007, ECOLOGY, V88, P2220, DOI 10.1890/06-0857.1; Allison GW, 1998, ECOL APPL, V8, pS79, DOI 10.1890/1051-0761(1998)8[S79:MRANBN]2.0.CO;2; [Anonymous], 2004, 7 M C PART CONV BIOL; Becker BJ, 2007, P NATL ACAD SCI USA, V104, P3267, DOI 10.1073/pnas.0611651104; Beman JM, 2005, NATURE, V434, P211, DOI 10.1038/nature03370; Bowen WD, 1997, MAR ECOL PROG SER, V158, P267, DOI 10.3354/meps158267; Bradbury IR, 2008, P ROY SOC B-BIOL SCI, V275, P1803, DOI 10.1098/rspb.2008.0216; BRIGGS KT, 1981, CONDOR, V83, P1, DOI 10.2307/1367591; Brooks LB, 2009, MAR ECOL PROG SER, V386, P263, DOI 10.3354/meps08061; Calabrese JM, 2004, FRONT ECOL ENVIRON, V2, P529, DOI 10.1890/1540-9295(2004)002[0529:ACGTCM]2.0.CO;2; Caro TM, 1999, CONSERV BIOL, V13, P805, DOI 10.1046/j.1523-1739.1999.98338.x; Carr MH, 2010, STANDFORD J LAW SCI; Carvajal MA, 2004, DEFYING OCEANS END A, P105; Clevenger AP, 2002, CONSERV BIOL, V16, P503, DOI 10.1046/j.1523-1739.2002.00328.x; Costello C, 2010, P NATL ACAD SCI USA, V107, P18294, DOI 10.1073/pnas.0908057107; Cowen RK, 2006, SCIENCE, V311, P522, DOI 10.1126/science.1122039; Cudney-Bueno R, 2009, OCEAN COAST MANAGE, V52, P207, DOI 10.1016/j.ocecoaman.2008.12.005; Erisman BE, 2007, MAR BIOL, V151, P1849, DOI 10.1007/s00227-007-0623-2; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; FRANKLIN JF, 1993, ECOL APPL, V3, P202, DOI 10.2307/1941820; Gaines SD, 2010, P NATL ACAD SCI USA, V107, P18251, DOI 10.1073/pnas.1002098107; Halpern BS, 2010, P NATL ACAD SCI USA, V107, P18312, DOI 10.1073/pnas.0908503107; Heithaus MR, 2008, TRENDS ECOL EVOL, V23, P202, DOI 10.1016/j.tree.2008.01.003; Hyrenbach KD, 2000, AQUAT CONSERV, V10, P437, DOI 10.1002/1099-0755(200011/12)10:6<437::AID-AQC425>3.3.CO;2-H; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Kaplan DM, 2006, ECOL APPL, V16, P2248, DOI 10.1890/1051-0761(2006)016[2248:DPRAEM]2.0.CO;2; Kaplan DM, 2009, ECOL APPL, V19, P433, DOI 10.1890/07-1705.1; Kinlan BP, 2003, ECOLOGY, V84, P2007, DOI 10.1890/01-0622; Kitchingman A., 2007, SEAMOUNTS ECOLOGY FI, V12, P26, DOI DOI 10.1002/9780470691953.CH2; Klimley A.P., 1993, Ciencias Marinas, V19, P95; KLIMLEY AP, 1988, MAR ECOL PROG SER, V49, P11, DOI 10.3354/meps049011; Lindenmayer DB, 2002, CONSERV BIOL, V16, P338, DOI 10.1046/j.1523-1739.2002.00450.x; Lopez-Mendilaharsu M, 2005, AQUAT CONSERV, V15, P259, DOI 10.1002/aqc.676; MacMillan DC, 2006, ANIM CONSERV, V9, P11, DOI 10.1111/j.1469-1795.2005.00001.x; Marcot B.G., 1986, P145; Marinone SG, 2008, J MARINE SYST, V71, P149, DOI 10.1016/j.jmarsys.2007.06.005; McGarigal K., 2002, FRAGSTATS SPATIAL PA; Moffitt EA, 2011, BIOL CONSERV, V144, P306, DOI 10.1016/j.biocon.2010.09.008; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; NOSS RF, 1990, CONSERV BIOL, V4, P355, DOI 10.1111/j.1523-1739.1990.tb00309.x; Planes S, 2009, P NATL ACAD SCI USA, V106, P5693, DOI 10.1073/pnas.0808007106; Rubin ES, 2009, J WILDLIFE MANAGE, V73, P859, DOI 10.2193/2008-240; Sala E, 2003, B MAR SCI, V72, P103; Sala E, 2002, SCIENCE, V298, P1991, DOI 10.1126/science.1075284; Seminoff JA, 2002, SOUTHWEST NAT, V47, P314, DOI 10.2307/3672922; Seminoff JA, 2002, MAR ECOL PROG SER, V242, P253, DOI 10.3354/meps242253; Senko J, 2010, J EXP MAR BIOL ECOL, V391, P92, DOI 10.1016/j.jembe.2010.06.017; Talley DM., 2006, CONNECTIVITY CONSERV, P97, DOI DOI 10.1017/CBO9780511754821.006; Taylor PD, 2006, CONNECTIVITY CONSERV, P29, DOI DOI 10.1017/CBO9780511754821.003; Thomas WA, 1972, INDICATORS ENV QUALI; Ulloa R, 2006, PLANEACION ECOREGION; UNEP-WCMC, 2008, NAT REG NETW MAR PRO; VERNER J, 1984, ENVIRON MANAGE, V8, P1, DOI 10.1007/BF01867868; Villavicencio-Garayzar C.J., 2000, AREAS CRIANZA TIBURO; White JW, 2010, MAR ECOL PROG SER, V398, P49, DOI 10.3354/meps08327; Wiegand T, 2005, CONSERV BIOL, V19, P108, DOI 10.1111/j.1523-1739.2005.00208.x; Wiens JA., 2006, CONNECTIVITY CONSERV, P23, DOI DOI 10.1017/CBO9780511754821.002; Wood LJ, 2008, ORYX, V42, P340, DOI 10.1017/S003060530800046X	58	8	8	0	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2011	6	12							e28400	10.1371/journal.pone.0028400	http://dx.doi.org/10.1371/journal.pone.0028400			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863OC	22163013	Green Published, gold, Green Submitted			2022-12-27	WOS:000298173500017
J	Du, QS; Meng, JZ; Wang, CH; Long, SY; Huang, RB				Du, Qi-Shi; Meng, Jian-Zong; Wang, Cheng-Hua; Long, Si-Yu; Huang, Ri-Bo			Structural Position Correlation Analysis (SPCA) for Protein Family	PLOS ONE			English	Article							PDZ DOMAIN; CRYSTAL-STRUCTURE; DETERMINANTS; RECOGNITION; ACTIVATION; INFLUENZA; CATALYSIS; PATHWAYS; MODULES; SYSTEM	Background: The proteins in a family, which perform the similar biological functions, may have very different amino acid composition, but they must share the similar 3D structures, and keep a stable central region. In the conservative structure region similar biological functions are performed by two or three catalytic residues with the collaboration of several functional residues at key positions. Communication signals are conducted in a position network, adjusting the biological functions in the protein family. Methodology: A computational approach, namely structural position correlation analysis (SPCA), is developed to analyze the correlation relationship between structural segments (or positions). The basic hypothesis of SPCA is that in a protein family the structural conservation is more important than the sequence conservation, and the local structural changes may contain information of biology functional evolution. A standard protein P((0)) is defined in a protein family, which consists of the most-frequent amino acids and takes the average structure of the protein family. The foundational variables of SPCA is the structural position displacements between the standard protein P((0)) and individual proteins P(i) of the family. The structural positions are organized as segments, which are the stable units in structural displacements of the protein family. The biological function differences of protein members are determined by the position structural displacements of individual protein Pi to the standard protein P((0)). Correlation analysis is used to analyze the communication network among segments. Conclusions: The structural position correlation analysis (SPCA) is able to find the correlation relationship among the structural segments (or positions) in a protein family, which cannot be detected by the amino acid sequence and frequency-based methods. The functional communication network among the structural segments (or positions) in protein family, revealed by SPCA approach, well illustrate the distantly allosteric interactions, and contains valuable information for protein engineering study.	[Du, Qi-Shi; Wang, Cheng-Hua; Long, Si-Yu; Huang, Ri-Bo] Guangxi Acad Sci, State Key Lab Nonfood Biomass Energy & Enzyme Tec, Natl Engn Res Ctr Nonfood Biorefinery, Nanning, Guangxi, Peoples R China; [Du, Qi-Shi; Meng, Jian-Zong; Huang, Ri-Bo] Guangxi Univ, Life Sci & Biotechnol Coll, State Key Lab Conservat & Utilizat Subtrop Agrobi, Nanning, Guangxi, Peoples R China; [Wang, Cheng-Hua; Huang, Ri-Bo] Nanjing Univ Technol, Nanjing, Jiangsu, Peoples R China	Guangxi University; Nanjing Tech University	Du, QS (corresponding author), Guangxi Acad Sci, State Key Lab Nonfood Biomass Energy & Enzyme Tec, Natl Engn Res Ctr Nonfood Biorefinery, Nanning, Guangxi, Peoples R China.	qishi_du@yahoo.com.cn			National Program on Key Basic Research Project (973 Program) of China [2009CB724703]; National Science Foundation of China (NSFC) [30970562]	National Program on Key Basic Research Project (973 Program) of China(National Basic Research Program of China); National Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work is financially supported by the National Program on Key Basic Research Project (973 Program) of China under the project 2009CB724703, and by the National Science Foundation of China (NSFC) under the project 30970562. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benkovic SJ, 2003, SCIENCE, V301, P1196, DOI 10.1126/science.1085515; Boxus M, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-76; Cabral JHM, 1996, NATURE, V382, P649, DOI 10.1038/382649a0; Carmena A, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000066; CHOTHIA C, 1986, EMBO J, V5, P823, DOI 10.1002/j.1460-2075.1986.tb04288.x; Coleman SK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008715; Daniels DL, 1998, NAT STRUCT BIOL, V5, P317, DOI 10.1038/nsb0498-317; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Du QS, 2007, BIOCHEM BIOPH RES CO, V362, P525, DOI 10.1016/j.bbrc.2007.08.025; Du QS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013207; Du QS, 2010, CHEM PHYS LETT, V485, P191, DOI 10.1016/j.cplett.2009.12.037; Dunn CJ, 1999, DRUGS, V58, P761, DOI 10.2165/00003495-199958040-00016; Fodor AA, 2004, J BIOL CHEM, V279, P19046, DOI 10.1074/jbc.M402560200; Hammes-Schiffer S, 2006, ANNU REV BIOCHEM, V75, P519, DOI 10.1146/annurev.biochem.75.103004.142800; Hanson GT, 2004, J BIOL CHEM, V279, P13044, DOI 10.1074/jbc.M312846200; Hatley ME, 2003, P NATL ACAD SCI USA, V100, P14445, DOI 10.1073/pnas.1835919100; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Hung AY, 2002, J BIOL CHEM, V277, P5699, DOI 10.1074/jbc.R100065200; Kaczanowski S, 2010, THEOR CHEM ACC, V125, P643, DOI 10.1007/s00214-009-0656-3; Kidd BA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000484; Kurakin A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000953; Lichtarge O, 1996, J MOL BIOL, V257, P342, DOI 10.1006/jmbi.1996.0167; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Luque I, 2002, ANNU REV BIOPH BIOM, V31, P235, DOI 10.1146/annurev.biophys.31.082901.134215; Mishra P, 2007, CELL, V131, P80, DOI 10.1016/j.cell.2007.07.037; Morrison DK, 2003, ANNU REV CELL DEV BI, V19, P91, DOI 10.1146/annurev.cellbio.19.111401.091942; Moscona A, 2005, NEW ENGL J MED, V353, P2633, DOI 10.1056/NEJMp058291; Ostergaard H, 2004, J CELL BIOL, V166, P337, DOI 10.1083/jcb.200402120; Ozkan E, 2005, P NATL ACAD SCI USA, V102, P18890, DOI 10.1073/pnas.0509418102; Ponting CP, 1997, PROTEIN SCI, V6, P464; Prakash O, 2010, APPL BIOCHEM BIOTECH, V160, P2401, DOI 10.1007/s12010-009-8735-4; Ranganathan R, 1997, CURR BIOL, V7, pR770, DOI 10.1016/S0960-9822(06)00401-5; Shulman AI, 2004, CELL, V116, P417, DOI 10.1016/S0092-8674(04)00119-9; Socolich M, 2005, NATURE, V437, P512, DOI 10.1038/nature03991; Stricker NL, 2003, NEUROPHARMACOLOGY, V45, P837, DOI 10.1016/S0028-3908(03)00275-2; Swain JF, 2006, CURR OPIN STRUC BIOL, V16, P102, DOI 10.1016/j.sbi.2006.01.003; Thomas MC, 2006, ELEMENTS INFORM THEO; Velthuis AJWT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000189; Walsh NP, 2003, CELL, V113, P61, DOI 10.1016/S0092-8674(03)00203-4; Wilken C, 2004, CELL, V117, P483, DOI 10.1016/S0092-8674(04)00454-4	40	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e28206	10.1371/journal.pone.0028206	http://dx.doi.org/10.1371/journal.pone.0028206			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22163002	gold, Green Published, Green Submitted			2022-12-27	WOS:000298172800019
J	Heine, M; Nollau, P; Masslo, C; Nielsen, P; Freund, B; Bruns, OT; Reimer, R; Hohenberg, H; Peldschus, K; Ittrich, H; Schumacher, U				Heine, Markus; Nollau, Peter; Masslo, Christoph; Nielsen, Peter; Freund, Barbara; Bruns, Oliver T.; Reimer, Rudolph; Hohenberg, Heinrich; Peldschus, Kersten; Ittrich, Harald; Schumacher, Udo			Investigations on the Usefulness of CEACAMs as Potential Imaging Targets for Molecular Imaging Purposes	PLOS ONE			English	Article							CELL-ADHESION MOLECULE; CARCINOEMBRYONIC ANTIGEN; MONOCLONAL-ANTIBODIES; PROGNOSTIC INDICATOR; METASTASIS FORMATION; MALIGNANT-MELANOMA; C-CAM; CANCER; EXPRESSION; CARCINOMA	Members of the carcinoembryonic antigen cell adhesion molecules (CEACAMs) family are the prototype of tumour markers. Classically they are used as serum markers, however, CEACAMs could serve as targets for molecular imaging as well. In order to test the anti CEACAM monoclonal antibody T84.1 for imaging purposes, CEACAM expression was analysed using this antibody. Twelve human cancer cell lines from different entities were screened for their CEACAM expression using qPCR, Western Blot and FACS analysis. In addition, CEACAM expression was analyzed in primary tumour xenografts of these cells. Nine of 12 tumour cell lines expressed CEACAM mRNA and protein when grown in vitro. Pancreatic and colon cancer cell lines showed the highest expression levels with good correlation of mRNA and protein level. However, when grown in vivo, the CEACAM expression was generally downregulated except for the melanoma cell lines. As the CEACAM expression showed pronounced expression in FemX-1 primary tumours, this model system was used for further experiments. As the accessibility of the antibody after i.v. application is critical for its use in molecular imaging, the binding of the T84.1 monoclonal antibody was assessed after i.v. injection into SCID mice harbouring a FemX-1 primary tumour. When applied i.v., the CEACAM specific T84.1 antibody bound to tumour cells in the vicinity of blood vessels. This binding pattern was particularly pronounced in the periphery of the tumour xenograft, however, some antibody binding was also observed in the central areas of the tumour around blood vessels. Still, a general penetration of the tumour by i.v. application of the anti CEACAM antibody could not be achieved despite homogenous CEACAM expression of all melanoma cells when analysed in tissue sections. This lack of penetration is probably due to the increased interstitial fluid pressure in tumours caused by the absence of functional lymphatic vessels.	[Heine, Markus; Schumacher, Udo] Univ Hosp Hamburg Eppendorf, Inst Anat & Expt Morphol, Hamburg, Germany; [Nollau, Peter; Masslo, Christoph] Univ Hosp Hamburg Eppendorf, Dept Clin Chem, Ctr Clin Pathol, Hamburg, Germany; [Nielsen, Peter; Freund, Barbara] Univ Hosp Hamburg Eppendorf, Inst Biochem & Mol Biol Mol Cell Biol 2, Hamburg, Germany; [Bruns, Oliver T.; Reimer, Rudolph; Hohenberg, Heinrich] Univ Hamburg, Heinrich Pette Inst Expt Virol & Immunol, D-2000 Hamburg, Germany; [Peldschus, Kersten; Ittrich, Harald] Univ Hosp Hamburg Eppendorf, Dept Diagnost & Intervent Radiol, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Heinrich Pette Institute; University of Hamburg; University of Hamburg; University Medical Center Hamburg-Eppendorf	Heine, M (corresponding author), Univ Hosp Hamburg Eppendorf, Inst Anat & Expt Morphol, Hamburg, Germany.	ma.heine@uke.uni-hamburg.de	Bruns, Oliver T/D-6735-2015	Bruns, Oliver T/0000-0002-5738-0126; Masslo, Christoph/0000-0002-8595-9637	Bundesministerium fur Bildung und Forschung (TOMCAT) [01EZ0824]	Bundesministerium fur Bildung und Forschung (TOMCAT)(Federal Ministry of Education & Research (BMBF))	This work was supported by the Bundesministerium fur Bildung und Forschung (TOMCAT, grant number 01EZ0824). http://www.bmbf.de/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boulton IC, 2002, NAT IMMUNOL, V3, P229, DOI 10.1038/ni769; BURAGGI GL, 1991, NUCL MED BIOL, V18, P45, DOI 10.1016/0883-2897(91)90045-M; CAREY TE, 1976, P NATL ACAD SCI USA, V73, P3278, DOI 10.1073/pnas.73.9.3278; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; EDLUND M, 1993, EUR J BIOCHEM, V213, P1109, DOI 10.1111/j.1432-1033.1993.tb17860.x; Ergun S, 2000, MOL CELL, V5, P311, DOI 10.1016/S1097-2765(00)80426-8; FODSTAD O, 1988, CANCER RES, V48, P4382; Heldin CH, 2004, NAT REV CANCER, V4, P806, DOI 10.1038/nrc1456; HOROSZEWICZ JS, 1983, CANCER RES, V43, P1809; JAIN RK, 1988, CANCER RES, V48, P7022; Jantscheff P, 2003, J CLIN ONCOL, V21, P3638, DOI 10.1200/JCO.2003.55.135; JAQUES G, 1988, CANCER, V62, P125, DOI 10.1002/1097-0142(19880701)62:1<125::AID-CNCR2820620122>3.0.CO;2-X; KAIGHN ME, 1979, INVEST UROL, V17, P16; Kalinina T, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-295; Kirshner J, 2003, P NATL ACAD SCI USA, V100, P521, DOI 10.1073/pnas.232711199; Kohler S, 2010, BRIT J CANCER, V102, P602, DOI 10.1038/sj.bjc.6605492; Kokkonen N, 2007, INT J CANCER, V121, P2443, DOI 10.1002/ijc.22965; KREUZER F, 1982, EXPERIENTIA, V38, P1415, DOI 10.1007/BF01955753; Kuespert K, 2006, CURR OPIN CELL BIOL, V18, P565, DOI 10.1016/j.ceb.2006.08.008; Laack E, 2002, J CLIN ONCOL, V20, P4279, DOI 10.1200/JCO.2002.08.067; Lange A, 2011, LUNG CANCER, V74, P178, DOI 10.1016/j.lungcan.2011.03.017; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Lehmann A, 2002, J MOL BIOL, V317, P401, DOI 10.1006/jmbi.2002.5443; Lucka L, 2005, GLYCOBIOLOGY, V15, P87, DOI 10.1093/glycob/cwh139; Luo WP, 1999, CANCER GENE THER, V6, P313, DOI 10.1038/sj.cgt.7700055; Marcus CD, 2009, CRIT REV ONCOL HEMAT, V72, P217, DOI 10.1016/j.critrevonc.2008.07.012; Marquez RT, 2005, CLIN CANCER RES, V11, P6116, DOI 10.1158/1078-0432.CCR-04-2509; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; PARK JG, 1990, CANCER RES, V50, P2773; Planque C, 2009, MOL CELL PROTEOMICS, V8, P2746, DOI 10.1074/mcp.M900134-MCP200; Riethdorf L, 1997, J HISTOCHEM CYTOCHEM, V45, P957, DOI 10.1177/002215549704500705; Schmitter T, 2004, J EXP MED, V199, P35, DOI 10.1084/jem.20030204; Schumacher U, 1997, HISTOCHEM J, V29, P677, DOI 10.1023/A:1026404832394; Schumacher U, 1990, LECTINS; SHARKEY RM, 1990, CANCER RES, V50, P2823; Singer BB, 2000, CANCER RES, V60, P1236; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; STEWARD AM, 1974, CANCER-AM CANCER SOC, V33, P1246, DOI 10.1002/1097-0142(197405)33:5<1246::AID-CNCR2820330509>3.0.CO;2-O; Thies A, 2002, J CLIN ONCOL, V20, P2530, DOI 10.1200/JCO.2002.05.033; Thies A, 2001, J PATHOL, V195, P537, DOI 10.1002/path.988; Tlsty TD, 2006, ANNU REV PATHOL-MECH, V1, P119, DOI 10.1146/annurev.pathol.1.110304.100224; WANEBO HJ, 1978, NEW ENGL J MED, V299, P448, DOI 10.1056/NEJM197808312990904; Weissleder R, 2002, NAT REV CANCER, V2, P11, DOI 10.1038/nrc701; Workman P, 2010, BRIT J CANCER, V102, P1555, DOI 10.1038/sj.bjc.6605642	44	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e28030	10.1371/journal.pone.0028030	http://dx.doi.org/10.1371/journal.pone.0028030			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22162753	Green Submitted, gold, Green Published			2022-12-27	WOS:000298172800011
J	Ito, K; Chadani, Y; Nakamori, K; Chiba, S; Akiyama, Y; Abo, T				Ito, Koreaki; Chadani, Yuhei; Nakamori, Kenta; Chiba, Shinobu; Akiyama, Yoshinori; Abo, Tatsuhiko			Nascentome Analysis Uncovers Futile Protein Synthesis in Escherichia coli	PLOS ONE			English	Article							PEPTIDYL-TRANSFER-RNA; TRANSFER-MESSENGER RNA; RIBOSOME-RESCUE FACTOR; PROLYL-TRANSFER-RNA; CHEMICAL REACTIVITY; TRANS-TRANSLATION; ESTER BOND; AMINO-ACID; A-SITE; SECM	Although co-translational biological processes attract much attention, no general and easy method has been available to detect cellular nascent polypeptide chains, which we propose to call collectively a "nascentome.'' We developed a method to selectively detect polypeptide portions of cellular polypeptidyl-tRNAs and used it to study the generality of the quality control reactions that rescue dead-end translation complexes. To detect nascent polypeptides, having their growing ends covalently attached to a tRNA, cellular extracts are separated by SDS-PAGE in two dimensions, first with the peptidyl-tRNA ester bonds preserved and subsequently after their in-gel cleavage. Pulse-labeled nascent polypeptides of Escherichia coli form a characteristic line below the main diagonal line, because each of them had contained a tRNA of nearly uniform size in the first-dimension electrophoresis but not in the second-dimension. The detection of nascent polypeptides, separately from any translation-completed polypeptides or degradation products thereof, allows us to follow their fates to gain deeper insights into protein biogenesis and quality control pathways. It was revealed that polypeptidyl-tRNAs were significantly stabilized in E. coli upon dysfunction of the tmRNA-ArfA ribosome-rescuing system, whose function had only been studied previously using model constructs. Our results suggest that E. coli cells are intrinsically producing aberrant translation products, which are normally eliminated by the ribosome-rescuing mechanisms.	[Ito, Koreaki; Nakamori, Kenta; Chiba, Shinobu] Kyoto Sangyo Univ, Fac Life Sci, Kyoto 603, Japan; [Chadani, Yuhei; Abo, Tatsuhiko] Okayama Univ, Grad Sch Nat Sci & Technol, Okayama 7008530, Japan; [Akiyama, Yoshinori] Kyoto Univ, Inst Virus Res, Kyoto 606, Japan	Kyoto Sangyo University; Okayama University; Kyoto University	Ito, K (corresponding author), Kyoto Sangyo Univ, Fac Life Sci, Kyoto 603, Japan.	kito@cc.kyoto-su.ac.jp	ABO, Tatsuhiko/B-1496-2011	Chiba, Shinobu/0000-0003-3485-3477	MEXT (Ministry of Education, Culture, Sports, Science & Technology in Japan) [20247020]; JSPS (Japan Society for the Promotion of Science) [22020035, 22770125]; Grants-in-Aid for Scientific Research [20247020, 22770125] Funding Source: KAKEN	MEXT (Ministry of Education, Culture, Sports, Science & Technology in Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS (Japan Society for the Promotion of Science)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by MEXT (Ministry of Education, Culture, Sports, Science & Technology in Japan) Grant-in-Aid for Scientific Research on Priority Areas (20247020), JSPS (Japan Society for the Promotion of Science) Grant-in-Aids for Scientific Research (A) (22020035) and JSPS Grant-in-Aid for Young Scientists (B) (22770125). Website: http://www.jsps.go.jp/english/e-grants/grants01.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BONAVENTURA C, 1994, ANAL BIOCHEM, V222, P44, DOI 10.1006/abio.1994.1451; BRESLER S, 1968, BIOCHIM BIOPHYS ACTA, V155, P465, DOI 10.1016/0005-2787(68)90192-5; CASADABAN MJ, 1976, J MOL BIOL, V104, P541, DOI 10.1016/0022-2836(76)90119-4; Chadani Y, 2011, GENES GENET SYST, V86, P151; Chadani Y, 2011, MOL MICROBIOL, V80, P772, DOI 10.1111/j.1365-2958.2011.07607.x; Chadani Y, 2010, MOL MICROBIOL, V78, P796, DOI 10.1111/j.1365-2958.2010.07375.x; Chiba S, 2011, P NATL ACAD SCI USA, V108, P6073, DOI 10.1073/pnas.1018343108; Chiba S, 2009, EMBO J, V28, P3461, DOI 10.1038/emboj.2009.280; Clement SL, 2006, NAT STRUCT MOL BIOL, V13, P299, DOI 10.1038/nsmb0406-299; Fu J, 2010, EMBO J, V29, P3819, DOI 10.1038/emboj.2010.255; Garza-Sanchez F, 2006, J BIOL CHEM, V281, P34258, DOI 10.1074/jbc.M608052200; Garza-Sanchez F, 2011, MOL MICROBIOL, V80, P1204, DOI 10.1111/j.1365-2958.2011.07638.x; Ge ZY, 2010, MOL MICROBIOL, V78, P1159, DOI 10.1111/j.1365-2958.2010.07396.x; Gong F, 2002, SCIENCE, V297, P1864, DOI 10.1126/science.1073997; Hachmann JP, 2005, ANAL BIOCHEM, V342, P237, DOI 10.1016/j.ab.2005.04.015; Hayes CS, 2010, FEBS LETT, V584, P413, DOI 10.1016/j.febslet.2009.11.023; HENTZEN D, 1972, BIOCHIM BIOPHYS ACTA, V281, P228, DOI 10.1016/0005-2787(72)90174-8; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Ito K, 2010, BIOCHEM BIOPH RES CO, V393, P1, DOI 10.1016/j.bbrc.2010.01.073; Keiler KC, 1996, SCIENCE, V271, P990, DOI 10.1126/science.271.5251.990; Keiler KC, 2008, ANNU REV MICROBIOL, V62, P133, DOI 10.1146/annurev.micro.62.081307.162948; KOMINE Y, 1994, P NATL ACAD SCI USA, V91, P9223, DOI 10.1073/pnas.91.20.9223; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lu KP, 2007, NAT CHEM BIOL, V3, P619, DOI 10.1038/nchembio.2007.35; MENNINGER JR, 1976, J BIOL CHEM, V251, P3392; MENNINGER JR, 1978, J BIOL CHEM, V253, P6808; Miller J.H., 1972, EXPT MOL GENETICS; Moore SD, 2005, MOL MICROBIOL, V58, P456, DOI 10.1111/j.1365-2958.2005.04832.x; Moore SD, 2007, ANNU REV BIOCHEM, V76, P101, DOI 10.1146/annurev.biochem.75.103004.142733; Murakami A, 2004, P NATL ACAD SCI USA, V101, P12330, DOI 10.1073/pnas.0404907101; Muto H, 2008, BIOCHEM BIOPH RES CO, V366, P1043, DOI 10.1016/j.bbrc.2007.12.072; Muto H, 2006, MOL CELL, V22, P545, DOI 10.1016/j.molcel.2006.03.033; Nakatogawa H, 2002, CELL, V108, P629, DOI 10.1016/S0092-8674(02)00649-9; Nakatogawa H, 2005, GENE DEV, V19, P436, DOI 10.1101/gad.1259505; Nakatogawa H, 2001, MOL CELL, V7, P185, DOI 10.1016/S1097-2765(01)00166-6; Onouchi H, 2005, GENE DEV, V19, P1799, DOI 10.1101/gad.1317105; Pavlov MY, 2009, P NATL ACAD SCI USA, V106, P50, DOI 10.1073/pnas.0809211106; Pradhan P, 2009, J MOL BIOL, V385, P831, DOI 10.1016/j.jmb.2008.11.027; RYCHLIK I, 1970, EUR J BIOCHEM, V16, P136, DOI 10.1111/j.1432-1033.1970.tb01064.x; SCHUBER F, 1974, BIOCHIMIE, V56, P391, DOI 10.1016/S0300-9084(74)80147-1; SCHUBER F, 1974, BIOCHIMIE, V56, P397, DOI 10.1016/S0300-9084(74)80148-3; SCHUBER F, 1974, BIOCHIMIE, V56, P383, DOI 10.1016/S0300-9084(74)80146-X; Seidelt B, 2009, SCIENCE, V326, P1412, DOI 10.1126/science.1177662; Shimizu Y, 2001, NAT BIOTECHNOL, V19, P751, DOI 10.1038/90802; Shoemaker CJ, 2010, SCIENCE, V330, P369, DOI 10.1126/science.1192430; Sievers A, 2004, P NATL ACAD SCI USA, V101, P7897, DOI 10.1073/pnas.0402488101; SORENSEN MA, 1989, J MOL BIOL, V207, P365, DOI 10.1016/0022-2836(89)90260-X; Tenson T, 2002, CELL, V108, P591, DOI 10.1016/S0092-8674(02)00669-4; Vazquez-Laslop N, 2008, MOL CELL, V30, P190, DOI 10.1016/j.molcel.2008.02.026; Weis F, 2010, EMBO J, V29, P3810, DOI 10.1038/emboj.2010.252; Wilson DN, 2011, CURR OPIN STRUC BIOL, V21, P274, DOI 10.1016/j.sbi.2011.01.007; Yanagitani K, 2011, SCIENCE, V331, P586, DOI 10.1126/science.1197142; Zaher HS, 2009, CELL, V136, P746, DOI 10.1016/j.cell.2009.01.036; Zhang G, 2009, NAT STRUCT MOL BIOL, V16, P274, DOI 10.1038/nsmb.1554	54	45	46	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e28413	10.1371/journal.pone.0028413	http://dx.doi.org/10.1371/journal.pone.0028413			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22162769	Green Published, Green Submitted, gold			2022-12-27	WOS:000298172800035
J	Isaakidis, P; Cox, HS; Varghese, B; Montaldo, C; Da Silva, E; Mansoor, H; Ladomirska, J; Sotgiu, G; Migliori, GB; Pontali, E; Saranchuk, P; Rodrigues, C; Reid, T				Isaakidis, Petros; Cox, Helen S.; Varghese, Bhanumati; Montaldo, Chiara; Da Silva, Esdras; Mansoor, Homa; Ladomirska, Joanna; Sotgiu, Giovanni; Migliori, Giovanni B.; Pontali, Emanuele; Saranchuk, Peter; Rodrigues, Camilla; Reid, Tony			Ambulatory Multi-Drug Resistant Tuberculosis Treatment Outcomes in a Cohort of HIV-Infected Patients in a Slum Setting in Mumbai, India	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; COMMUNITY-BASED TREATMENT; MDR-TB TREATMENT; METAANALYSIS; MORTALITY; CAMBODIA; CHILDREN; THERAPY; PROGRAM; AFRICA	Background: India carries one quarter of the global burden of multi-drug resistant TB (MDR-TB) and has an estimated 2.5 million people living with HIV. Despite this reality, provision of treatment for MDR-TB is extremely limited, particularly for HIV-infected individuals. Medecins Sans Frontieres (MSF) has been treating HIV-infected MDR-TB patients in Mumbai since May 2007. This is the first report of treatment outcomes among HIV-infected MDR-TB patients in India. Methods: HIV-infected patients with suspected MDR-TB were referred to the MSF-clinic by public Antiretroviral Therapy (ART) Centers or by a network of community non-governmental organizations. Patients were initiated on either empiric or individualized second-line TB-treatment as per WHO recommendations. MDR-TB treatment was given on an ambulatory basis and under directly observed therapy using a decentralized network of providers. Patients not already receiving ART were started on treatment within two months of initiating MDR-TB treatment. Results: Between May 2007 and May 2011, 71 HIV-infected patients were suspected to have MDR-TB, and 58 were initiated on treatment. MDR-TB was confirmed in 45 (78%), of which 18 (40%) were resistant to ofloxacin. Final treatment outcomes were available for 23 patients; 11 (48%) were successfully treated, 4 (17%) died, 6 (26%) defaulted, and 2 (9%) failed treatment. Overall, among 58 patients on treatment, 13 (22%) were successfully treated, 13 (22%) died, 7 (12%) defaulted, two (3%) failed treatment, and 23 (40%) were alive and still on treatment at the end of the observation period. Twenty-six patients (45%) experienced moderate to severe adverse events, requiring modification of the regimen in 12 (20%). Overall, 20 (28%) of the 71 patients with MDR-TB died, including 7 not initiated on treatment. Conclusions: Despite high fluoroquinolone resistance and extensive prior second-line treatment, encouraging results are being achieved in an ambulatory MDR-T-program in a slum setting in India. Rapid scale-up of both ART and second-line treatment for MDR-TB is needed to ensure survival of co-infected patients and mitigate this growing epidemic.	[Isaakidis, Petros; Varghese, Bhanumati; Montaldo, Chiara; Da Silva, Esdras; Mansoor, Homa; Ladomirska, Joanna] Med San Frontieres, Bombay, Maharashtra, India; [Cox, Helen S.; Saranchuk, Peter] Med San Frontieres, Cape Town, South Africa; [Cox, Helen S.] Monash Univ, Melbourne, Vic 3004, Australia; [Sotgiu, Giovanni] Univ Sassari, Hyg & Prevent Med Inst, I-07100 Sassari, Italy; [Migliori, Giovanni B.] World Hlth Org Collaborating Ctr TB & Lung Dis, S Maugeri Fdn, Tradate, Italy; [Pontali, Emanuele] Galliera Hosp, Dept Infect Dis, Genoa, Italy; [Rodrigues, Camilla] PD Hinduja Natl Hosp & Med Res Ctr Hinduja, Bombay, Maharashtra, India; [Reid, Tony] Med San Frontieres, Operat Res Unit, Brussels, Belgium	Monash University; University of Sassari; Istituti Clinici Scientifici Maugeri IRCCS; World Health Organization; Ente Ospedaliero Ospedali Galliera; University of Genoa	Isaakidis, P (corresponding author), Med San Frontieres, Bombay, Maharashtra, India.	msfocb-asia-epidemio@brussels.msf.org	Sotgiu, Giovanni/N-1032-2017; Migliori, Giovanni Battista/AAB-8589-2020; Montaldo, Chiara/AAE-3265-2020	Sotgiu, Giovanni/0000-0002-1600-4474; Migliori, Giovanni Battista/0000-0002-2597-574X; Isaakidis, Petros/0000-0002-7881-1554; Pontali, Emanuele/0000-0002-1085-0442; Cox, Helen/0000-0002-6538-7192	M�decins Sans Fronti�res [OCG_pilot_00_Montaldo] Funding Source: researchfish	M�decins Sans Fronti�res		Agrawal D, 2009, INT J TUBERC LUNG D, V13, P79; [Anonymous], 2008, GUID PROGR MAN DRUG; [Anonymous], 2010, MULTIDRUG EXTENSIVEL; [Anonymous], 2010, ROADM ROLL OUT XPERT; Bhargava A, 2011, HYPOTHESIS, V9, pe7; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Brust J, 2010, PLOS ONE, V6; Chadha VK, 2005, INT J TUBERC LUNG D, V9, P1072; Cox HS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001126; D'souza DTB, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-211; Deivanayagam C N, 2002, Indian J Chest Dis Allied Sci, V44, P237; Gandhi NR, 2010, AM J RESP CRIT CARE, V181, P80, DOI 10.1164/rccm.200907-0989OC; Heller T, 2010, INT J TUBERC LUNG D, V14, P420; Isaakidis P, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-11; Johnston JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006914; Joseph P, 2011, INDIAN J MED RES, V133, P529; Karim SSA, 2010, NEW ENGL J MED, V362, P697, DOI 10.1056/NEJMoa0905848; Laserson KF, 2005, INT J TUBERC LUNG D, V9, P640; Leimane V, 2005, LANCET, V365, P318, DOI 10.1016/S0140-6736(05)17786-1; Mahadev B, 2004, INDIAN J TUBERC, V52, P5; Mitnick C, 2003, NEW ENGL J MED, V348, P119, DOI 10.1056/NEJMoa022928; Murray J, 1999, AM J RESP CRIT CARE, V159, P733, DOI 10.1164/ajrccm.159.3.9804147; NUNN P, 1992, AM REV RESPIR DIS, V146, P849, DOI 10.1164/ajrccm/146.4.849; Orenstein EW, 2009, LANCET INFECT DIS, V9, P153, DOI 10.1016/S1473-3099(09)70041-6; Paramasivan CN, 2004, INDIAN J MED RES, V120, P377; Raguenaud ME, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-54; Seung KJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007186; Shin S, 2004, SOC SCI MED, V59, P1529, DOI 10.1016/j.socscimed.2004.01.027; Shin SS, 2006, INT J TUBERC LUNG D, V10, P402; Singla R, 2009, INT J TUBERC LUNG D, V13, P976; Tupasi TE, 2006, PLOS MED, V3, P1587, DOI 10.1371/journal.pmed.0030352; Udwadia ZF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012023; Vadwai V, 2011, J CLIN MICROBIOL, V49, P2540, DOI 10.1128/JCM.02319-10; WHO, 2010, ANT THER HIV INF AD; World Health Organization, 2009, MAN MDR TB FIELD GUI	35	62	63	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2011	6	12							e28066	10.1371/journal.pone.0028066	http://dx.doi.org/10.1371/journal.pone.0028066			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MQ	22145022	Green Published, gold, Green Submitted			2022-12-27	WOS:000298168900005
J	Kashima, H; Hayashi, N				Kashima, Hideaki; Hayashi, Naoyuki			Basic Taste Stimuli Elicit Unique Responses in Facial Skin Blood Flow	PLOS ONE			English	Article							NERVOUS-SYSTEM RESPONSES; CAPSAICIN RECEPTOR; INCREASE; HUMANS	Facial expression changes characteristically with the emotions induced by basic tastes in humans. We tested the hypothesis that the five basic tastes also elicit unique responses in facial skin blood flow. Facial skin blood flow was measured using laser speckle flowgraphy in 16 healthy subjects before and during the application of basic taste stimuli in the oral cavity for 20 s. The skin blood flow in the eyelid increased in response to sweet and umami taste stimuli, while that in the nose decreased in response to a bitter stimulus. There was a significant correlation between the subjective hedonic scores accompanying these taste stimuli and the above changes in skin blood flow. These results demonstrate that sweet, umami, and bitter tastes induce unique changes in facial skin blood flow that reflect subjective hedonic scores.	[Kashima, Hideaki; Hayashi, Naoyuki] Kyushu Univ, Grad Sch Human Environm Studies, Fukuoka 812, Japan; [Hayashi, Naoyuki] Kyushu Univ, Inst Hlth Sci, Fukuoka 812, Japan	Kyushu University; Kyushu University	Kashima, H (corresponding author), Kyushu Univ, Grad Sch Human Environm Studies, Fukuoka 812, Japan.	naohayashi@ihs.kyushu-u.ac.jp	Hayashi, Naoyuki/AAK-5097-2021; Hayashi, Naoyuki/C-1457-2015	Hayashi, Naoyuki/0000-0002-9814-3530	Yazuya Co. Ltd.	Yazuya Co. Ltd.	This work was supported by a grant from Yazuya Co. Ltd. to N.H. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai T, 2010, NEUROSCIENCE, V165, P1476, DOI 10.1016/j.neuroscience.2009.11.051; BERGERSEN TK, 1993, ACTA PHYSIOL SCAND, V147, P195, DOI 10.1111/j.1748-1716.1993.tb09489.x; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Darwin C., 1899, EXPRESSION EMOTIONS; Drummond PD, 1997, PSYCHOPHYSIOLOGY, V34, P163, DOI 10.1111/j.1469-8986.1997.tb02127.x; DRUMMOND PD, 1995, J AUTONOM NERV SYST, V52, P117, DOI 10.1016/0165-1838(94)00151-9; EKMAN P, 1983, SCIENCE, V221, P1208, DOI 10.1126/science.6612338; GALEF BG, 1978, J COMP PHYSIOL PSYCH, V92, P907, DOI 10.1037/h0077531; Horio T, 2000, CHEM SENSES, V25, P149, DOI 10.1093/chemse/25.2.149; Jones D, 2007, NATURE, V447, P768, DOI 10.1038/447768a; KARITA K, 1992, J AUTONOM NERV SYST, V39, P229, DOI 10.1016/0165-1838(92)90016-A; Kemppainen P, 2001, PAIN, V91, P331, DOI 10.1016/S0304-3959(00)00462-0; KEMPPAINEN P, 1994, BRAIN RES BULL, V33, P655, DOI 10.1016/0361-9230(94)90229-1; Kuraoka K, 2011, PHYSIOL BEHAV, V102, P347, DOI 10.1016/j.physbeh.2010.11.029; LEE TS, 1954, J PHYSIOL-LONDON, V124, P528, DOI 10.1113/jphysiol.1954.sp005126; Leterme A, 2008, PHYSIOL BEHAV, V93, P994, DOI 10.1016/j.physbeh.2008.01.005; Nakayama K, 2005, PHYSIOL BEHAV, V84, P783, DOI 10.1016/j.physbeh.2005.03.009; Niedenthal PM, 2007, SCIENCE, V316, P1002, DOI 10.1126/science.1136930; Robin O, 2003, PHYSIOL BEHAV, V78, P385, DOI 10.1016/S0031-9384(02)00981-2; Rolls ET, 2009, AM J CLIN NUTR, V90, p804S, DOI 10.3945/ajcn.2009.27462R; Rousmans S, 2000, CHEM SENSES, V25, P709, DOI 10.1093/chemse/25.6.709; Someya N, 2008, AM J PHYSIOL-REG I, V295, pR1921, DOI 10.1152/ajpregu.90493.2008; Steiner JE, 1987, BASIC TASTE, P97; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Voncken MJ, 2009, BIOL PSYCHOL, V81, P86, DOI 10.1016/j.biopsycho.2009.02.004; YAMAGUCHI S, 1984, AGR BIOL CHEM TOKYO, V48, P1077, DOI 10.1080/00021369.1984.10866271	26	25	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2011	6	12							e28236	10.1371/journal.pone.0028236	http://dx.doi.org/10.1371/journal.pone.0028236			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MQ	22145032	Green Published, Green Submitted, gold			2022-12-27	WOS:000298168900015
J	Adelstein, JS; Shehzad, Z; Mennes, M; DeYoung, CG; Zuo, XN; Kelly, C; Margulies, DS; Bloomfield, A; Gray, JR; Castellanos, FX; Milham, MP				Adelstein, Jonathan S.; Shehzad, Zarrar; Mennes, Maarten; DeYoung, Colin G.; Zuo, Xi-Nian; Kelly, Clare; Margulies, Daniel S.; Bloomfield, Aaron; Gray, Jeremy R.; Castellanos, F. Xavier; Milham, Michael P.			Personality Is Reflected in the Brain's Intrinsic Functional Architecture	PLOS ONE			English	Article							TEMPORAL POLE ACTIVITY; RESTING STATE FMRI; ANTERIOR CINGULATE; INDIVIDUAL-DIFFERENCES; NEUROTICISM TRAIT; DECISION-MAKING; WORKING-MEMORY; HUMAN STRIATUM; CORTICAL HUBS; HAPPY FACES	Personality describes persistent human behavioral responses to broad classes of environmental stimuli. Investigating how personality traits are reflected in the brain's functional architecture is challenging, in part due to the difficulty of designing appropriate task probes. Resting-state functional connectivity (RSFC) can detect intrinsic activation patterns without relying on any specific task. Here we use RSFC to investigate the neural correlates of the five-factor personality domains. Based on seed regions placed within two cognitive and affective 'hubs' in the brain-the anterior cingulate and precuneus-each domain of personality predicted RSFC with a unique pattern of brain regions. These patterns corresponded with functional subdivisions responsible for cognitive and affective processing such as motivation, empathy and future-oriented thinking. Neuroticism and Extraversion, the two most widely studied of the five constructs, predicted connectivity between seed regions and the dorsomedial prefrontal cortex and lateral paralimbic regions, respectively. These areas are associated with emotional regulation, self-evaluation and reward, consistent with the trait qualities. Personality traits were mostly associated with functional connections that were inconsistently present across participants. This suggests that although a fundamental, core functional architecture is preserved across individuals, variable connections outside of that core encompass the inter-individual differences in personality that motivate diverse responses.	[Adelstein, Jonathan S.; Mennes, Maarten; Zuo, Xi-Nian; Kelly, Clare; Bloomfield, Aaron; Castellanos, F. Xavier] NYU, Langone Med Ctr, NYU Child Study Ctr, Phyllis Green & Randolph Cowen Inst Pediat Neuros, New York, NY 10012 USA; [Shehzad, Zarrar; Gray, Jeremy R.] Yale Univ, Dept Psychol, New Haven, CT 06520 USA; [DeYoung, Colin G.] Univ Minnesota, Dept Psychol, Minneapolis, MN 55455 USA; [Zuo, Xi-Nian] Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Lab Funct Connectome & Dev, Beijing 100101, Peoples R China; [Margulies, Daniel S.] Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany; [Margulies, Daniel S.] Univ Berlin, Mind & Brain Inst, Berlin, Germany; [Castellanos, F. Xavier; Milham, Michael P.] Nathan S Kline Inst Psychiat Res, Orangeburg, NY USA; [Milham, Michael P.] Child Mind Inst, Ctr Developing Brain, New York, NY USA	New York University; NYU Langone Medical Center; Yale University; University of Minnesota System; University of Minnesota Twin Cities; Chinese Academy of Sciences; Institute of Psychology, CAS; Max Planck Society; Nathan Kline Institute for Psychiatric Research	Adelstein, JS (corresponding author), NYU, Langone Med Ctr, NYU Child Study Ctr, Phyllis Green & Randolph Cowen Inst Pediat Neuros, New York, NY 10012 USA.	michael.milham@childmind.org	Zuo, Xi-Nian/A-7273-2009; Castellanos, Francisco Xavier/K-1892-2014; Gray, Jeremy/A-2635-2013; Milham, Michael P./Y-3160-2019; Milham, Michael P/K-9501-2014; Mennes, Maarten/C-9924-2011; Kelly, Clare/H-4629-2016; Margulies, Daniel/L-4719-2016	Zuo, Xi-Nian/0000-0001-9110-585X; Castellanos, Francisco Xavier/0000-0001-9192-9437; Mennes, Maarten/0000-0002-7279-3439; Kelly, Clare/0000-0001-8253-357X; Margulies, Daniel/0000-0002-8880-9204	Howard Hughes Medical Institute; National Institute of Mental Health [R01MH083246, R01MH081218]; National Institute on Drug Abuse [R03DA024775, R01DA016979]; Autism Speaks; National Science and Engineering Research Council of Canada; Startup Foundation for Distinguished Research Professor of Institute for Psychology; Natural Science Foundation of China [Y0CX492S03, 81171409]; Stavros Niarchos Foundation; Leon Levy Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH081218, R01MH083246] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA024775, R01DA016979] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Autism Speaks; National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Startup Foundation for Distinguished Research Professor of Institute for Psychology; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Stavros Niarchos Foundation; Leon Levy Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants from the Howard Hughes Medical Institute (to J.S.A.), the National Institute of Mental Health (R01MH083246 and R01MH081218 to F. X. C. and M. P. M.), National Institute on Drug Abuse (R03DA024775, to C. K.; R01DA016979, to F. X. C.) and Autism Speaks, a Post-Graduate Fellowship from the National Science and Engineering Research Council of Canada (to Z.S.), the Startup Foundation for Distinguished Research Professor of Institute for Psychology and the Natural Science Foundation of China (Y0CX492S03 and 81171409 to X-N.Z.) as well as gifts to the New York University Child Study Center from the Stavros Niarchos Foundation, Leon Levy Foundation, and an endowment provided by Phyllis Green and Randolph Cowen. Funders had no role in the design of the study, data analyses or interpretation or presentation of results.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Allemand M, 2008, DEV PSYCHOL, V44, P758, DOI 10.1037/0012-1649.44.3.758; Amin Z, 2004, J RES PERS, V38, P15, DOI 10.1016/j.jrp.2003.09.011; Andersson JLR, 2007, TR07JA2 NONLINEAR RE; Andrews-Hanna JR, 2007, NEURON, V56, P924, DOI 10.1016/j.neuron.2007.10.038; Andrews-Hanna JR, 2010, NEURON, V65, P550, DOI 10.1016/j.neuron.2010.02.005; Berquin PC, 1998, NEUROLOGY, V50, P1087, DOI 10.1212/WNL.50.4.1087; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Bouchard TJ, 2003, J NEUROBIOL, V54, P4, DOI 10.1002/neu.10160; Bressler SL, 2010, TRENDS COGN SCI, V14, P277, DOI 10.1016/j.tics.2010.04.004; Brieger P, 2000, J PERS DISORD, V14, P282, DOI 10.1521/pedi.2000.14.3.282; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Bueti D, 2010, NEUROIMAGE, V51, P1168, DOI 10.1016/j.neuroimage.2010.03.023; Canli T, 2004, J PERS, V72, P1105, DOI 10.1111/j.1467-6494.2004.00292.x; Canli T, 2004, BEHAV NEUROSCI, V118, P897, DOI 10.1037/0735-7044.118.5.897; Canli T, 2002, BRAIN COGNITION, V50, P414, DOI 10.1016/S0278-2626(02)00517-1; Canli T, 2001, BEHAV NEUROSCI, V115, P33, DOI 10.1037//0735-7044.115.1.33; Canli T, 2002, SCIENCE, V296, P2191, DOI 10.1126/science.1068749; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Cohen MX, 2009, NAT NEUROSCI, V12, P32, DOI 10.1038/nn.2228; Cohen MX, 2005, COGNITIVE BRAIN RES, V25, P851, DOI 10.1016/j.cogbrainres.2005.09.018; Costa P.T., 2008, SAGE HDB PERSONALITY, P179, DOI [10.4135/9781849200479.n9, DOI 10.4135/9781849200479.N9, 10.4135/9781849200479.N9]; COSTA PT, 1995, J PERS ASSESS, V64, P21, DOI 10.1207/s15327752jpa6401_2; Cox CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012296; Cuijpers P, 2005, PSYCHIAT RES, V133, P229, DOI 10.1016/j.psychres.2004.10.006; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Depue RA, 1999, BEHAV BRAIN SCI, V22, P491; DeYoung CG, 2005, J PERS, V73, P825, DOI 10.1111/j.1467-6494.2005.00330.x; DeYoung CG, 2010, PSYCHOL SCI, V21, P820, DOI 10.1177/0956797610370159; DeYoung CG, 2009, CAMBRIDGE HANDBOOK OF PERSONALITY PSYCHOLOGY, P323; DeYoung CG, 2009, J PERS SOC PSYCHOL, V97, P883, DOI 10.1037/a0016615; Di Martino A, 2008, CEREB CORTEX, V18, P2735, DOI 10.1093/cercor/bhn041; Di Martino A, 2009, AM J PSYCHIAT, V166, P891, DOI 10.1176/appi.ajp.2009.08121894; Digman JM, 1997, J PERS SOC PSYCHOL, V73, P1246, DOI 10.1037/0022-3514.73.6.1246; Dosenbach NUF, 2007, P NATL ACAD SCI USA, V104, P11073, DOI 10.1073/pnas.0704320104; Eisenberger NI, 2005, COGN AFFECT BEHAV NE, V5, P169, DOI 10.3758/CABN.5.2.169; FLETCHER PC, 1995, NEUROIMAGE, V2, P195, DOI 10.1006/nimg.1995.1025; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; Frank S, 2010, BRAIN RES, V1350, P159, DOI 10.1016/j.brainres.2010.04.030; Fransson P, 2008, NEUROIMAGE, V42, P1178, DOI 10.1016/j.neuroimage.2008.05.059; Friedman HS, 2010, J PERS, V78, P179, DOI 10.1111/j.1467-6494.2009.00613.x; Greene JD, 2004, NEURON, V44, P389, DOI 10.1016/j.neuron.2004.09.027; Haas BW, 2007, BEHAV NEUROSCI, V121, P249, DOI 10.1037/0735-7044.121.2.249; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hampson M, 2006, J NEUROSCI, V26, P13338, DOI 10.1523/JNEUROSCI.3408-06.2006; Hoptman MJ, 2009, SCHIZOPHR B, V36, P1020; Hopwood CJ, 2009, J PERS DISORD, V23, P466, DOI 10.1521/pedi.2009.23.5.466; Iacoboni M, 2004, NEUROIMAGE, V21, P1167, DOI 10.1016/j.neuroimage.2003.11.013; Jang KL, 1998, J PERS SOC PSYCHOL, V74, P1556, DOI 10.1037/0022-3514.74.6.1556; Jausovec N, 2007, INT J PSYCHOPHYSIOL, V66, P215, DOI 10.1016/j.ijpsycho.2007.07.005; Jimura K, 2010, BRAIN RES, V1328, P104, DOI 10.1016/j.brainres.2010.03.016; Jimura K, 2009, NEUROSCI LETT, V453, P45, DOI 10.1016/j.neulet.2009.02.012; John O. P., 2008, HDB PERSONALITY THEO, P114, DOI DOI 10.1016/S0191-8869(97)81000-8; Johnson DL, 1999, AM J PSYCHIAT, V156, P252; Jollant F, 2010, NEUROIMAGE, V51, P1275, DOI 10.1016/j.neuroimage.2010.03.027; Jung RE, 2010, HUM BRAIN MAPP, V31, P398, DOI 10.1002/hbm.20874; Kelly AMC, 2008, NEUROIMAGE, V39, P527, DOI 10.1016/j.neuroimage.2007.08.008; Kelly AMC, 2009, CEREB CORTEX, V19, P640, DOI 10.1093/cercor/bhn117; Kim SH, 2008, NEUROREPORT, V19, P883, DOI 10.1097/WNR.0b013e328300080f; Kober H, 2008, NEUROIMAGE, V42, P998, DOI 10.1016/j.neuroimage.2008.03.059; Krain AL, 2006, NEUROIMAGE, V32, P477, DOI 10.1016/j.neuroimage.2006.02.047; Krienen FM, 2009, CEREB CORTEX, V19, P2485, DOI 10.1093/cercor/bhp135; Kristensen AS, 2009, J ANXIETY DISORD, V23, P600, DOI 10.1016/j.janxdis.2009.01.009; Kumari V, 2007, BEHAV NEUROSCI, V121, P643, DOI 10.1037/0735-7044.121.4.643; Kunisato Y, 2011, NEUROSCI LETT, V492, P109, DOI 10.1016/j.neulet.2011.01.067; Margulies DS, 2007, NEUROIMAGE, V37, P579, DOI 10.1016/j.neuroimage.2007.05.019; Margulies DS, 2009, P NATL ACAD SCI USA, V106, P20069, DOI 10.1073/pnas.0905314106; Marien P, 2009, CORTEX, V45, P527, DOI 10.1016/j.cortex.2007.12.010; Mennes M, 2010, NEUROIMAGE, V50, P1690, DOI 10.1016/j.neuroimage.2010.01.002; MIDDLETON FA, 1994, SCIENCE, V266, P458, DOI 10.1126/science.7939688; Mobbs D, 2005, P NATL ACAD SCI USA, V102, P16502, DOI 10.1073/pnas.0408457102; Nigg JT, 2002, J PERS SOC PSYCHOL, V83, P451, DOI [10.1037/0022-3514.83.2.451, 10.1037//0022-3514.83.2.451]; Olson IR, 2007, BRAIN, V130, P1718, DOI 10.1093/brain/awm052; Omura K, 2005, NEUROREPORT, V16, P1905, DOI 10.1097/01.wnr.0000186596.64458.76; Paulus MP, 2003, NEUROIMAGE, V19, P1439, DOI 10.1016/S1053-8119(03)00251-9; Raichle ME, 2010, SCI AM, V302, P44, DOI 10.1038/scientificamerican0310-44; Read SJ, 2010, PSYCHOL REV, V117, P61, DOI 10.1037/a0018131; Roy AK, 2009, NEUROIMAGE, V45, P614, DOI 10.1016/j.neuroimage.2008.11.030; Sabatini E, 2009, BRAIN RES BULL, V79, P258, DOI 10.1016/j.brainresbull.2009.03.001; Saxe R, 2003, NEUROIMAGE, V19, P1835, DOI 10.1016/S1053-8119(03)00230-1; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Shehzad Z, 2009, CEREB CORTEX, V19, P2209, DOI 10.1093/cercor/bhn256; Sheng T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012611; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Sollberger M, 2009, NEUROPSYCHOLOGIA, V47, P2812, DOI 10.1016/j.neuropsychologia.2009.06.006; Spinhoven P, 2009, GEN HOSP PSYCHIAT, V31, P470, DOI 10.1016/j.genhosppsych.2009.05.002; Stoodley CJ, 2010, CORTEX, V46, P831, DOI 10.1016/j.cortex.2009.11.008; Sutin AR, 2009, CEREB CORTEX, V19, P2797, DOI 10.1093/cercor/bhp066; Terracciano A, 2010, MOL PSYCHIATR, V15, P647, DOI 10.1038/mp.2008.113; Tomasi D, 2010, P NATL ACAD SCI USA, V107, P9885, DOI 10.1073/pnas.1001414107; Tran Y, 2006, INT J PSYCHOPHYSIOL, V60, P215, DOI 10.1016/j.ijpsycho.2005.05.008; Trull TJ, 2005, ANNU REV CLIN PSYCHO, V1, P355, DOI 10.1146/annurev.clinpsy.1.102803.144009; Uliaszek AA, 2009, J RES PERS, V43, P785, DOI 10.1016/j.jrp.2009.05.009; Van Dijk KRA, 2010, J NEUROPHYSIOL, V103, P297, DOI 10.1152/jn.00783.2009; Vincent JL, 2008, J NEUROPHYSIOL, V100, P3328, DOI 10.1152/jn.90355.2008; Woollams AM, 2011, J COGNITIVE NEUROSCI, V23, P992, DOI 10.1162/jocn.2010.21502; Wright CI, 2006, CEREB CORTEX, V16, P1809, DOI 10.1093/cercor/bhj118; Ystad M, 2010, NEUROIMAGE, V52, P379, DOI 10.1016/j.neuroimage.2010.03.062; Zuo XN, 2010, NEUROIMAGE, V49, P2163, DOI 10.1016/j.neuroimage.2009.10.080; Zuo XN, 2010, NEUROIMAGE, V49, P1432, DOI 10.1016/j.neuroimage.2009.09.037	102	192	197	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e27633	10.1371/journal.pone.0027633	http://dx.doi.org/10.1371/journal.pone.0027633			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	863MI	22140453	Green Published, gold			2022-12-27	WOS:000298168100014
J	Lee, BK; Ploner, A; Zhang, ZX; Gryfelt, G; Wikman, A; Reilly, M				Lee, Brian K.; Ploner, Alexander; Zhang, Zhongxing; Gryfelt, Gunilla; Wikman, Agneta; Reilly, Marie			Constructing a Population-Based Research Database from Routine Maternal Screening Records: A Resource for Studying Alloimmunization in Pregnant Women	PLOS ONE			English	Article							RED-CELL ANTIBODIES; ANTI-D; HEMOLYTIC-DISEASE; NEWBORN; FREQUENCY; SWEDEN; FETUS	Background: Although screening for maternal red blood cell antibodies during pregnancy is a standard procedure, the prevalence and clinical consequences of non-anti-D immunization are poorly understood. The objective was to create a national database of maternal antibody screening results that can be linked with population health registers to create a research resource for investigating these issues. Study Design and Methods: Each birth in the Swedish Medical Birth Register was uniquely identified and linked to the text stored in routine maternal antibody screening records in the time window from 9 months prior to 2 weeks after the delivery date. These text records were subjected to a computerized search for specific antibodies using regular expressions. To illustrate the research potential of the resulting database, selected antibody prevalence rates are presented as tables and figures, and the complete data (from more than 60 specific antibodies) presented as online moving graphical displays. Results: More than one million (1,191,761) births with valid screening information from 1982-2002 constitute the study population. Computerized coverage of screening increased steadily over time and varied by region as electronic records were adopted. To ensure data quality, we restricted analysis to birth records in areas and years with a sustained coverage of at least 80%, representing 920,903 births from 572,626 mothers in 17 of the 24 counties in Sweden. During the study period, non-anti-D and anti-D antibodies occurred in 76.8/10,000 and 14.1/10,000 pregnancies respectively, with marked differences between specific antibodies over time. Conclusion: This work demonstrates the feasibility of creating a nationally representative research database from the routine maternal antibody screening records from an extended calendar period. By linkage with population registers of maternal and child health, such data are a valuable resource for addressing important clinical questions, such as the etiological significance of non-anti-D antibodies.	[Lee, Brian K.] Drexel Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Ploner, Alexander; Zhang, Zhongxing; Reilly, Marie] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Gryfelt, Gunilla; Wikman, Agneta] Karolinska Inst, Dept Clin Immunol & Transfus Med, Stockholm, Sweden; [Gryfelt, Gunilla; Wikman, Agneta] Karolinska Univ Hosp, Stockholm, Sweden	Drexel University; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Lee, BK (corresponding author), Drexel Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Philadelphia, PA 19104 USA.	Marie.Reilly@ki.se		Ploner, Alexander/0000-0002-5042-8326; Wikman, Agneta/0000-0002-8810-7974; Lee, Brian/0000-0002-3635-8034	Swedish Research Council (VR) [60521601, K2007-54X-20327-01-2]	Swedish Research Council (VR)(Swedish Research Council)	The work performed was supported by a grant from the Swedish Research Council (VR) contract number 60521601, project number K2007-54X-20327-01-2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameen R, 2005, MED PRIN PRACT, V14, P230, DOI 10.1159/000085740; American College of Obstetricians and Gynecologists, 2006, Obstet Gynecol, V108, P457; Barss VA, 2009, SIGNIFICANCE MINOR R; BASKETT TF, 1986, CAN MED ASSOC J, V134, P1259; BOWELL PJ, 1986, BRIT J OBSTET GYNAEC, V93, P1038, DOI 10.1111/j.1471-0528.1986.tb07828.x; BOWMAN JM, 1983, CAN MED ASSOC J, V129, P343; CNATTINGIUS S, 1990, SCAND J SOC MED, V18, P143, DOI 10.1177/140349489001800209; Daniels G., 2002, ALLOIMMUNE DISORDERS, P21, DOI DOI 10.1017/CBO9780511527043.004; de Silva M, 2003, VOX SANG, V85, P328; Edgren G, 2006, VOX SANG, V91, P316, DOI 10.1111/j.1423-0410.2006.00817.x; FILBEY D, 1995, ACTA OBSTET GYN SCAN, V74, P687, DOI 10.3109/00016349509021175; Gottvall T, 2008, ACTA OBSTET GYN SCAN, V87, P843, DOI 10.1080/00016340802268880; Gotvall T, 1993, ACTA OBSTET GYN SCAN, V72, P434; Koelewijn JM, 2008, TRANSFUSION, V48, P941, DOI 10.1111/j.1537-2995.2007.01625.x; KORNSTAD L, 1983, ACTA OBSTET GYN SCAN, V62, P431, DOI 10.3109/00016348309154215; Moise KJ, 2008, SEMIN FETAL NEONAT M, V13, P207, DOI 10.1016/j.siny.2008.02.007; Robertson G, 2008, IEEE T VIS COMPUT GR, V14, P1325, DOI 10.1109/TVCG.2008.125; SOLOLA A, 1983, OBSTET GYNECOL, V61, P25; Turchin A, 2006, J AM MED INFORM ASSN, V13, P691, DOI 10.1197/jamia.M2078; Urbaniak SJ, 2000, BLOOD REV, V14, P44, DOI 10.1054/blre.1999.0123	20	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e27619	10.1371/journal.pone.0027619	http://dx.doi.org/10.1371/journal.pone.0027619			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140452	Green Published, gold, Green Submitted			2022-12-27	WOS:000298168100013
J	Thurber, AR; Jones, WJ; Schnabel, K				Thurber, Andrew R.; Jones, William J.; Schnabel, Kareen			Dancing for Food in the Deep Sea: Bacterial Farming by a New Species of Yeti Crab	PLOS ONE			English	Article							MITOCHONDRIAL GENE REARRANGEMENTS; POLYUNSATURATED FATTY-ACIDS; HYDROTHERMAL VENT SHRIMPS; RIFTIA-PACHYPTILA JONES; RIMICARIS-EXOCULATA; WATER MOTION; TUBE WORM; ATLANTIC; CARBON; CRUSTACEA	Vent and seep animals harness chemosynthetic energy to thrive far from the sun's energy. While symbiont-derived energy fuels many taxa, vent crustaceans have remained an enigma; these shrimps, crabs, and barnacles possess a phylogenetically distinct group of chemosynthetic bacterial epibionts, yet the role of these bacteria has remained unclear. We test whether a new species of Yeti crab, which we describe as Kiwa puravida n. sp, farms the epibiotic bacteria that it grows on its chelipeds (claws), chelipeds that the crab waves in fluid escaping from a deep-sea methane seep. Lipid and isotope analyses provide evidence that epibiotic bacteria are the crab's main food source and K. puravida n. sp. has highly-modified setae (hairs) on its 3(rd) maxilliped (a mouth appendage) which it uses to harvest these bacteria. The epsilon-and gamma-proteobacteria that this methane-seep species farms are closely related to hydrothermal-vent decapod epibionts. We hypothesize that this species waves its arm in reducing fluid to increase the productivity of its epibionts by removing boundary layers which may otherwise limit carbon fixation. The discovery of this new species, only the second within a family described in 2005, stresses how much remains undiscovered on our continental margins.	[Thurber, Andrew R.] Univ Calif San Diego, Scripps Inst Oceanog, Integrat Oceanog Div, La Jolla, CA 92093 USA; [Jones, William J.] Univ S Carolina, Environm Genom Core Facil, Columbia, SC 29208 USA; [Schnabel, Kareen] Natl Inst Water & Atmospher Res, Wellington, New Zealand	University of California System; University of California San Diego; Scripps Institution of Oceanography; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; National Institute of Water & Atmospheric Research (NIWA) - New Zealand	Thurber, AR (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, Integrat Oceanog Div, La Jolla, CA 92093 USA.	athurber@coas.oregonstate.edu		Schnabel, Kareen/0000-0002-9965-9010	National Science Foundation (NSF) [OCE-0242034, OCE-0826254, OCE-0939557]; New Zealand Foundation for Research, Science and Technology [C01X0502]; David & Lucile Packard Foundation; Monterey Bay Aquarium Research Institute; Michael M. Mullin Memorial Fellowship; Sydney E. Frank Foundation; Census of Marine Life - Training Award for New Investigators (TAWNI); Directorate For Geosciences [0826254] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); New Zealand Foundation for Research, Science and Technology(New Zealand Foundation for Research, Science and Technology); David & Lucile Packard Foundation(The David & Lucile Packard Foundation); Monterey Bay Aquarium Research Institute; Michael M. Mullin Memorial Fellowship; Sydney E. Frank Foundation; Census of Marine Life - Training Award for New Investigators (TAWNI); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This research was supported by the National Science Foundation (NSF) OCE-0242034, OCE-0826254 and OCE-0939557, the New Zealand Foundation for Research, Science and Technology (project C01X0502), the David & Lucile Packard Foundation, the Monterey Bay Aquarium Research Institute, the Michael M. Mullin Memorial Fellowship, the Sydney E. Frank Foundation, and Census of Marine Life - Training Award for New Investigators (TAWNI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRODSKY LI, 1995, BIOCHEMISTRY-MOSCOW+, V60, P923; CAVANAUGH CM, 1981, SCIENCE, V213, P340, DOI 10.1126/science.213.4505.340; Cavanaugh CM, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 1, THIRD EDITION, P475, DOI 10.1007/0-387-30741-9_18; CHILDRESS JJ, 1986, SCIENCE, V233, P1306, DOI 10.1126/science.233.4770.1306; Colaco A, 2007, MAR ECOL-EVOL PERSP, V28, P15, DOI 10.1111/j.1439-0485.2006.00123.x; Conway N.M., 1994, P158; Costa FO, 2007, CAN J FISH AQUAT SCI, V64, P272, DOI 10.1139/F07-008; Currie CR, 1999, NATURE, V398, P701, DOI 10.1038/19519; Dallwitz MJ, 1997, 408 CSIRO DIV ENT; Dalsgaard J, 2003, ADV MAR BIOL, V46, P225, DOI 10.1016/S0065-2881(03)46005-7; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; DENNISON WC, 1988, J EXP MAR BIOL ECOL, V115, P67, DOI 10.1016/0022-0981(88)90190-6; Di Meo CA, 2000, APPL ENVIRON MICROB, V66, P651, DOI 10.1128/AEM.66.2.651-658.2000; Duperron S, 2005, APPL ENVIRON MICROB, V71, P1694, DOI 10.1128/AEM.71.4.1694-1700.2005; Durand L, 2010, FEMS MICROBIOL ECOL, V71, P291, DOI 10.1111/j.1574-6941.2009.00806.x; Ehrlich H., 2010, BIOL MAT MARINE ORIG, V2010, P569; FELBECK H, 1981, SCIENCE, V213, P336, DOI 10.1126/science.213.4505.336; GEBRUK AV, 1993, MAR ECOL PROG SER, V98, P247, DOI 10.3354/meps098247; Gebruk AV, 2000, J MAR BIOL ASSOC UK, V80, P485, DOI 10.1017/S0025315400002186; Goffredi SK, 2008, ENVIRON MICROBIOL, V10, P2623, DOI 10.1111/j.1462-2920.2008.01684.x; Goffredi SK, 2010, ENV MICROBIOL REP, V2, P479, DOI 10.1111/j.1758-2229.2010.00136.x; GROSSMANN S, 1991, MAR ECOL PROG SER, V77, P85, DOI 10.3354/meps077085; Halanych KM, 1998, CAH BIOL MAR, V39, P355; Hickerson MJ, 2000, MOL BIOL EVOL, V17, P639, DOI 10.1093/oxfordjournals.molbev.a026342; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; JOKIEL PL, 1978, J EXP MAR BIOL ECOL, V35, P87, DOI 10.1016/0022-0981(78)90092-8; LESSER MP, 1994, J EXP MAR BIOL ECOL, V178, P153, DOI 10.1016/0022-0981(94)90034-5; Lewis T, 2000, J MICROBIOL METH, V43, P107, DOI 10.1016/S0167-7012(00)00217-7; MacAvoy SE, 2002, CHEM GEOL, V185, P1, DOI 10.1016/S0009-2541(01)00394-1; Macpherson E, 2005, ZOOSYSTEMA, V27, P709; MCCAFFREY MA, 1989, ORG GEOCHEM, V14, P61, DOI 10.1016/0146-6380(89)90019-3; McCutchan JH, 2003, OIKOS, V102, P378, DOI 10.1034/j.1600-0706.2003.12098.x; McLaughlin PA, 2007, J CRUSTACEAN BIOL, V27, P97, DOI 10.1651/S-2675.1; Miyake H, 2007, MAR ECOL-EVOL PERSP, V28, P86, DOI 10.1111/j.1439-0485.2006.00115.x; Morrison CL, 2002, P ROY SOC B-BIOL SCI, V269, P345, DOI 10.1098/rspb.2001.1886; Nichols DS, 2003, FEMS MICROBIOL LETT, V219, P1, DOI 10.1016/S0378-1097(02)01200-4; PATTERSON MR, 1991, LIMNOL OCEANOGR, V36, P936, DOI 10.4319/lo.1991.36.5.0936; PAULL CK, 1984, SCIENCE, V226, P965, DOI 10.1126/science.226.4677.965; Petersen JM, 2010, ENVIRON MICROBIOL, V12, P2204, DOI 10.1111/j.1462-2920.2009.02129.x; POLZ MF, 1995, P NATL ACAD SCI USA, V92, P7232, DOI 10.1073/pnas.92.16.7232; Polz MF, 1998, LIMNOL OCEANOGR, V43, P1631, DOI 10.4319/lo.1998.43.7.1631; Pond DW, 1997, MAR ECOL PROG SER, V156, P167, DOI 10.3354/meps156167; Saito H, 2008, J CHROMATOGR A, V1200, P242, DOI 10.1016/j.chroma.2008.05.094; SCHMALJOHANN R, 1990, MAR ECOL PROG SER, V61, P119, DOI 10.3354/meps061119; SEGONZAC M, 1993, CAH BIOL MAR, V34, P535; Southward AJ, 1998, CAH BIOL MAR, V39, P259; Tsuchida S, 2011, J MAR BIOL ASSOC UK, V91, P23, DOI 10.1017/S0025315410001827; Volkman JK, 1998, ORG GEOCHEM, V29, P1163, DOI 10.1016/S0146-6380(98)00062-X; Vrijenhoek RC, 2007, BIOL BULL-US, V212, P180, DOI 10.2307/25066600; Wolff T, 2005, CAH BIOL MAR, V46, P97; Yang JS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-257; Zbinden M, 2003, FEMS MICROBIOL ECOL, V46, P23, DOI 10.1016/S0168-6496(03)00176-4	52	62	65	1	113	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e26243	10.1371/journal.pone.0026243	http://dx.doi.org/10.1371/journal.pone.0026243			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140426	Green Published, Green Submitted, gold			2022-12-27	WOS:000298168100003
J	Milani, L; Ghiselli, F; Maurizii, MG; Passamonti, M				Milani, Liliana; Ghiselli, Fabrizio; Maurizii, Maria Gabriella; Passamonti, Marco			Doubly Uniparental Inheritance of Mitochondria As a Model System for Studying Germ Line Formation	PLOS ONE			English	Article							LARGE RIBOSOMAL-RNA; VASA-LIKE GENE; MUSSEL MYTILUS-GALLOPROVINCIALIS; DROSOPHILA POLAR GRANULES; DEPENDENT SEX-RATIO; SPERM MITOCHONDRIA; CHROMATOID BODY; CAENORHABDITIS-ELEGANS; XENOPUS-LAEVIS; ULTRASTRUCTURAL CHARACTERIZATION	Background: Doubly Uniparental Inheritance (DUI) of mitochondria occurs when both mothers and fathers are capable of transmitting mitochondria to their offspring, in contrast to the typical Strictly Maternal Inheritance (SMI). DUI was found in some bivalve molluscs, in which two mitochondrial genomes are inherited, one through eggs, the other through sperm. During male embryo development, spermatozoon mitochondria aggregate in proximity of the first cleavage furrow and end up in the primordial germ cells, while they are dispersed in female embryos. Methodology/Principal Findings: We used MitoTracker, microtubule staining and transmission electron microscopy to examine the mechanisms of this unusual distribution of sperm mitochondria in the DUI species Ruditapes philippinarum. Our results suggest that in male embryos the midbody deriving from the mitotic spindle of the first division concurs in positioning the aggregate of sperm mitochondria. Furthermore, an immunocytochemical analysis showed that the germ line determinant Vasa segregates close to the first cleavage furrow. Conclusions/Significance: In DUI male embryos, spermatozoon mitochondria aggregate in a stable area on the animal-vegetal axis: in organisms with spiral segmentation this zone is not involved in cleavage, so the aggregation is maintained. Moreover, sperm mitochondria reach the same embryonic area in which also germ plasm is transferred. In 2-blastomere embryos, the segregation of sperm mitochondria in the same region with Vasa suggests their contribution in male germ line formation. In DUI male embryos, M-type mitochondria must be recognized by egg factors to be actively transferred in the germ line, where they become dominant replacing the Balbiani body mitochondria. The typical features of germ line assembly point to a common biological mechanism shared by DUI and SMI organisms. Although the molecular dynamics of the segregation of sperm mitochondria in DUI species are unknown, they could be a variation of the mechanism regulating the mitochondrial bottleneck in all metazoans.	[Milani, Liliana; Ghiselli, Fabrizio; Maurizii, Maria Gabriella; Passamonti, Marco] Univ Bologna, Dept Biol Evoluzionist Sperimentale, Bologna, Italy	University of Bologna	Milani, L (corresponding author), Univ Bologna, Dept Biol Evoluzionist Sperimentale, Bologna, Italy.	liliana.milani@unibo.it	Passamonti, Marco/J-7502-2012; Milani, Liliana/B-7063-2015; Ghiselli, Fabrizio/D-2260-2010	Milani, Liliana/0000-0001-5052-2075; Ghiselli, Fabrizio/0000-0002-1680-8616; Passamonti, Marco/0000-0002-6222-8225	University and Research Italian Ministry (MIUR PRIN07) [2007NSHJL8_002]; University of Bologna, [A.31.CANZELSEW]	University and Research Italian Ministry (MIUR PRIN07)(Ministry of Education, Universities and Research (MIUR)); University of Bologna,	This work was supported by the University and Research Italian Ministry (MIUR PRIN07, grant number 2007NSHJL8_002 to MP) and the "Canziani Bequest'' fund (University of Bologna, grant number A.31.CANZELSEW to MP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amikura R, 2005, MECH DEVELOP, V122, P1087, DOI 10.1016/j.mod.2005.06.003; Amikura R, 2001, P NATL ACAD SCI USA, V98, P9133, DOI 10.1073/pnas.171286998; Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Becalska AN, 2010, DEV BIOL, V340, P528, DOI 10.1016/j.ydbio.2010.02.006; BIELIAVSKY N, 1990, J SUBMICR CYTOL PATH, V22, P445; Boldogh IR, 2006, BBA-MOL CELL RES, V1763, P450, DOI 10.1016/j.bbamcr.2006.02.014; Breton S, 2007, TRENDS GENET, V23, P465, DOI 10.1016/j.tig.2007.05.011; Breton S, 2011, MOL BIOL EVOL, V28, P1645, DOI 10.1093/molbev/msq345; Cai S, 2010, CURR BIOL, V20, P880, DOI 10.1016/j.cub.2010.03.067; Cao LQ, 2007, NAT GENET, V39, P386, DOI 10.1038/ng1970; Cao LQ, 2004, GENETICS, V166, P883, DOI 10.1534/genetics.166.2.883; Castrillon DH, 2000, P NATL ACAD SCI USA, V97, P9585, DOI 10.1073/pnas.160274797; Chuma S, 2009, MOL CELL ENDOCRINOL, V306, P17, DOI 10.1016/j.mce.2008.11.009; Cogswell AT, 2006, GENOME, V49, P799, DOI 10.1139/G06-036; Cox RT, 2003, DEVELOPMENT, V130, P1579, DOI 10.1242/dev.00365; Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63; Davison A, 2006, BIOESSAYS, V28, P642, DOI 10.1002/bies.20424; Devauchelle N, 1990, TAPES PHILIPPINARUM; DING D, 1994, DEV BIOL, V163, P503, DOI 10.1006/dbio.1994.1166; Doucet-Beaupre H, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-50; Ebbert Mercedes Ann, 1993, P150; EDDY EM, 1975, INT REV CYTOL, V43, P229; Eggert US, 2006, ANNU REV BIOCHEM, V75, P543, DOI 10.1146/annurev.biochem.74.082803.133425; Extavour CG, 2003, DEVELOPMENT, V130, P5869, DOI 10.1242/dev.00804; Fabioux C, 2004, BIOCHEM BIOPH RES CO, V320, P592, DOI 10.1016/j.bbrc.2004.06.009; Fabioux C, 2004, BIOCHEM BIOPH RES CO, V315, P897, DOI 10.1016/j.bbrc.2004.01.145; Ghiselli F, 2012, MOL BIOL EVOL, V29, P771, DOI 10.1093/molbev/msr248; Ghiselli F, 2011, MOL BIOL EVOL, V28, P949, DOI 10.1093/molbev/msq271; Glotzer M, 2009, NAT REV MOL CELL BIO, V10, P9, DOI 10.1038/nrm2609; Gonczy P, 2000, NATURE, V408, P331, DOI 10.1038/35042526; Gustafson EA, 2010, BIOESSAYS, V32, P626, DOI 10.1002/bies.201000001; HAY B, 1988, DEVELOPMENT, V103, P625; HAY B, 1988, CELL, V55, P577, DOI 10.1016/0092-8674(88)90216-4; Hejnol A, 2010, INTEGR COMP BIOL, V50, P695, DOI 10.1093/icb/icq103; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Hurst CDD, 1997, INFLUENTIAL PASSENGERS, P125; Iida T, 1998, P NATL ACAD SCI USA, V95, P11274, DOI 10.1073/pnas.95.19.11274; Ikenishi K, 1998, DEV GROWTH DIFFER, V40, P1; ILLMENSEE K, 1976, DEV BIOL, V49, P40, DOI 10.1016/0012-1606(76)90257-8; ISAEVA VV, 2001, RUSS J MAR BIOL, V27, pS8, DOI DOI 10.1023/A:1013842820458; Kakoi S, 2008, ZOOL SCI, V25, P455, DOI 10.2108/zsj.25.455; KANEDA H, 1995, P NATL ACAD SCI USA, V92, P4542, DOI 10.1073/pnas.92.10.4542; Katayama M, 2006, DEV BIOL, V299, P206, DOI 10.1016/j.ydbio.2006.07.022; Kenchington E, 2002, GENETICS, V161, P1579; Kloc M, 2004, CURR TOP DEV BIOL, V59, P1, DOI 10.1016/S0070-2153(04)59001-4; Kloc M, 2005, J CELL SCI, V118, P269, DOI 10.1242/jcs.01637; Kloc M, 2001, INT REV CYTOL, V203, P63; Kloc M, 1998, MECH DEVELOP, V75, P81, DOI 10.1016/S0925-4773(98)00086-0; Knaut H, 2000, J CELL BIOL, V149, P875, DOI 10.1083/jcb.149.4.875; Kobayashi S, 1998, CURR BIOL, V8, P1117, DOI 10.1016/S0960-9822(98)70466-X; KOBAYASHI S, 1993, SCIENCE, V260, P1521, DOI 10.1126/science.7684857; Kobayashi T, 2000, MECH DEVELOP, V99, P139, DOI 10.1016/S0925-4773(00)00464-0; Kogo N, 2011, DEV BIOL, V349, P462, DOI 10.1016/j.ydbio.2010.11.021; KOMIYA T, 1994, DEV BIOL, V162, P354, DOI 10.1006/dbio.1994.1093; Kotaja N, 2006, P NATL ACAD SCI USA, V103, P2647, DOI 10.1073/pnas.0509333103; Kotaja N, 2007, NAT REV MOL CELL BIO, V8, P85, DOI 10.1038/nrm2081; Kranz AM, 2010, J EXP ZOOL PART B, V314, P1; Kuznicki KA, 2000, DEVELOPMENT, V127, P2907; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASKO PF, 1988, NATURE, V335, P611, DOI 10.1038/335611a0; Lerit DA, 2011, CURR BIOL, V21, P439, DOI 10.1016/j.cub.2011.01.073; Maeda I, 2001, CURR BIOL, V11, P171, DOI 10.1016/S0960-9822(01)00052-5; Matova N, 2001, DEV BIOL, V231, P291, DOI 10.1006/dbio.2000.0120; Maurizii MG, 2009, DEV GENES EVOL, V219, P361, DOI 10.1007/s00427-009-0295-7; MIGNOTTE F, 1987, BIOL CELL, V60, P97, DOI 10.1111/j.1768-322X.1987.tb00549.x; Milani L, J EXP ZOO B IN PRESS; Mochizuki K, 2001, DEV GENES EVOL, V211, P299, DOI 10.1007/s004270100156; Nakao H, 1999, DEV GENES EVOL, V209, P312, DOI 10.1007/s004270050257; Negri H, 2009, P ROY SOC B-BIOL SCI, V276, P2485, DOI 10.1098/rspb.2009.0324; Notredame C, 2003, BIOINFORMATICS AND GENOMES: CURRENT PERSPECTIVES, P27; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Obata M, 2005, DEV GROWTH DIFFER, V47, P255; Obata M, 2010, DEV GENES EVOL, V220, P139, DOI 10.1007/s00427-010-0335-3; Ogawa M, 1999, ZOOL SCI, V16, P445, DOI 10.2108/zsj.16.445; Parvinen M, 2005, INT J ANDROL, V28, P189, DOI 10.1111/j.1365-2605.2005.00542.x; Passamonti M, 2009, DNA CELL BIOL, V28, P79, DOI 10.1089/dna.2008.0807; Paweletz N, 2001, NAT REV MOL CELL BIO, V2, P72, DOI 10.1038/35048077; Peruquetti RL, 2011, MICRON, V42, P87, DOI 10.1016/j.micron.2010.07.009; Piano F, 2000, CURR BIOL, V10, P1619, DOI 10.1016/S0960-9822(00)00869-1; Raz E, 2000, GENOME BIOL, V1, P1, DOI [10.1186/gb-2000-1-3-reviews1017, DOI 10.1186/GB-2000-1-3-REVIEWS1017]; Reunov A, 2000, DEV GROWTH DIFFER, V42, P139; Reunov A, 2006, ZYGOTE, V14, P231, DOI 10.1017/S0967199406003789; Rongo C, 1996, TRENDS GENET, V12, P102, DOI 10.1016/0168-9525(96)81421-1; RUSSELL L, 1978, ANAT REC, V190, P79, DOI 10.1002/ar.1091900108; Saavedra C, 1997, GENETICS, V145, P1073; Saffman EE, 1999, CELL MOL LIFE SCI, V55, P1141, DOI 10.1007/s000180050363; Shang P, 2010, J CELL SCI, V123, P331, DOI 10.1242/jcs.059949; Shitara H, 1998, GENETICS, V148, P851; Shoubridge EA, 2007, CURR TOP DEV BIOL, V77, P87, DOI 10.1016/S0070-2153(06)77004-1; Skop AR, 2004, SCIENCE, V305, P61, DOI 10.1126/science.1097931; Smiraglia DJ, 2008, CANCER BIOL THER, V7, P1182, DOI 10.4161/cbt.7.8.6215; SODERSTROM KO, 1976, CELL TISSUE RES, V168, P335, DOI 10.1007/BF00215311; Sutherland B, 1998, GENETICS, V148, P341; Sutovsky P, 2000, BIOL REPROD, V63, P582, DOI 10.1095/biolreprod63.2.582; Sutovsky P, 1996, BIOL REPROD, V55, P1195, DOI 10.1095/biolreprod55.6.1195; Sutovsky P, 1999, NATURE, V402, P371, DOI 10.1038/46466; Swartz SZ, 2008, DEV GENES EVOL, V218, P107, DOI 10.1007/s00427-008-0203-6; Theologidis I, 2008, EVOLUTION, V62, P959, DOI 10.1111/j.1558-5646.2008.00329.x; TOURTE M, 1984, EUR J CELL BIOL, V34, P171; Tsunekawa N, 2000, DEVELOPMENT, V127, P2741; Tyler SEB, 2006, INT J DEV BIOL, V50, P405, DOI 10.1387/ijdb.052007st; Venetis C, 2006, P R SOC B, V273, P2483, DOI 10.1098/rspb.2006.3607; Volodina N, 2003, DEV DYNAM, V226, P654, DOI 10.1002/dvdy.10275; Williamson A, 1996, ANNU REV CELL DEV BI, V12, P365, DOI 10.1146/annurev.cellbio.12.1.365; Woods FH, 1931, J MORPHOL PHYSIOL, V51, P545, DOI 10.1002/jmor.1050510208; Wylie C, 1999, CELL, V96, P165, DOI 10.1016/S0092-8674(00)80557-7; Zhang YZ, 2008, DEV GROWTH DIFFER, V50, P189, DOI [10.1111/j.1440-169x.2008.00988.x, 10.1111/j.1440-169X.2008.00988.x]; Zhou RR, 2010, CURR GENET, V56, P101, DOI 10.1007/s00294-010-0291-5	108	46	46	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2011	6	11							e28194	10.1371/journal.pone.0028194	http://dx.doi.org/10.1371/journal.pone.0028194			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863LT	22140544	Green Published, Green Submitted, gold			2022-12-27	WOS:000298166300037
J	Donaire, L; Pedrola, L; de la Rosa, R; Llave, C				Donaire, Livia; Pedrola, Laia; de la Rosa, Raul; Llave, Cesar			High-Throughput Sequencing of RNA Silencing-Associated Small RNAs in Olive (Olea europaea L.)	PLOS ONE			English	Article							TRANS-ACTING SIRNAS; STRESS-RESPONSIVE MICRORNAS; PLANT MICRORNAS; ARABIDOPSIS-THALIANA; POPULUS-TRICHOCARPA; DNA METHYLATION; JUVENILE PERIOD; LAND PLANTS; MIRNA GENES; TARGETS	Small RNAs (sRNAs) of 20 to 25 nucleotides (nt) in length maintain genome integrity and control gene expression in a multitude of developmental and physiological processes. Despite RNA silencing has been primarily studied in model plants, the advent of high-throughput sequencing technologies has enabled profiling of the sRNA component of more than 40 plant species. Here, we used deep sequencing and molecular methods to report the first inventory of sRNAs in olive (Olea europaea L.). sRNA libraries prepared from juvenile and adult shoots revealed that the 24-nt class dominates the sRNA transcriptome and atypically accumulates to levels never seen in other plant species, suggesting an active role of heterochromatin silencing in the maintenance and integrity of its large genome. A total of 18 known miRNA families were identified in the libraries. Also, 5 other sRNAs derived from potential hairpin-like precursors remain as plausible miRNA candidates. RNA blots confirmed miRNA expression and suggested tissue-and/or developmental-specific expression patterns. Target mRNAs of conserved miRNAs were computationally predicted among the olive cDNA collection and experimentally validated through endonucleolytic cleavage assays. Finally, we use expression data to uncover genetic components of the miR156, miR172 and miR390/TAS3-derived trans-acting small interfering RNA (tasiRNA) regulatory nodes, suggesting that these interactive networks controlling developmental transitions are fully operational in olive.	[Donaire, Livia; Llave, Cesar] Spanish Natl Res Council, Dept Environm Biol, Ctr Invest Biol, Madrid, Spain; [Pedrola, Laia] Parc Cient Univ Valencia, Lifesequencing SL, Valencia, Spain; [de la Rosa, Raul] IFAPA, Ctr Alameda Obispo, Cordoba, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Donaire, L (corresponding author), Spanish Natl Res Council, Dept Environm Biol, Ctr Invest Biol, Madrid, Spain.	cesarllave@cib.csic.es	De la Rosa, Raul/AIB-1463-2022; De la Rosa, Raul/B-5755-2008; Donaire, Livia/W-3541-2017; Llave, Cesar/ABF-5827-2021	De la Rosa, Raul/0000-0002-0752-9607; De la Rosa, Raul/0000-0002-0752-9607; Donaire, Livia/0000-0002-5454-2994; Pedrola, Laia/0000-0002-3031-6124	GENOMA ESPANA (Spain)	GENOMA ESPANA (Spain)	This work is part of the OLEAGEN research project that was funded by GENOMA ESPANA (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adenot X, 2006, CURR BIOL, V16, P927, DOI 10.1016/j.cub.2006.03.035; Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Axtell MJ, 2008, TRENDS PLANT SCI, V13, P343, DOI 10.1016/j.tplants.2008.03.009; Axtell MJ, 2007, PLANT CELL, V19, P1750, DOI 10.1105/tpc.107.051706; Axtell MJ, 2006, CELL, V127, P565, DOI 10.1016/j.cell.2006.09.032; Axtell MJ, 2005, PLANT CELL, V17, P1658, DOI 10.1105/tpc.105.032185; Baldoni L, 2006, ANN BOT-LONDON, V98, P935, DOI 10.1093/aob/mcl178; Barakat Abdelali, 2007, BMC Genomics, V8, P481, DOI 10.1186/1471-2164-8-481; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Borsani O, 2005, CELL, V123, P1279, DOI 10.1016/j.cell.2005.11.035; Brodersen P, 2008, SCIENCE, V320, P1185, DOI 10.1126/science.1159151; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chan SWL, 2004, SCIENCE, V303, P1336, DOI 10.1126/science.1095989; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen XM, 2009, ANNU REV CELL DEV BI, V25, P21, DOI 10.1146/annurev.cellbio.042308.113417; Curaba JL, 2008, J BIOL CHEM, V283, P3059, DOI 10.1074/jbc.M708983200; De la Rosa R, 2006, AUST J AGR RES, V57, P477, DOI 10.1071/AR05219; de la Rosa R, 2003, THEOR APPL GENET, V106, P1273, DOI 10.1007/s00122-002-1189-5; Dolgosheina EV, 2008, RNA, V14, P1508, DOI 10.1261/rna.1052008; Donaire L, 2009, VIROLOGY, V392, P203, DOI 10.1016/j.virol.2009.07.005; Dunoyer P, 2010, EMBO J, V29, P1699, DOI 10.1038/emboj.2010.65; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Fahlgren N, 2006, CURR BIOL, V16, P939, DOI 10.1016/j.cub.2006.03.065; Fahlgren N, 2009, RNA, V15, P992, DOI 10.1261/rna.1473809; Garcia D, 2006, CURR BIOL, V16, P933, DOI 10.1016/j.cub.2006.03.064; Gonzalez-Ibeas D, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-393; Grad Y, 2003, MOL CELL, V11, P1253, DOI 10.1016/S1097-2765(03)00153-9; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Howell MD, 2007, PLANT CELL, V19, P926, DOI 10.1105/tpc.107.050062; Jay F, 2010, METHODS MOL BIOL, V592, P183, DOI 10.1007/978-1-60327-005-2_13; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Kasschau KD, 2007, PLOS BIOL, V5, P479, DOI 10.1371/journal.pbio.0050057; Kawashima CG, 2009, PLANT J, V57, P313, DOI 10.1111/j.1365-313X.2008.03690.x; Lelandais-Briere C, 2009, PLANT CELL, V21, P2780, DOI 10.1105/tpc.109.068130; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Llave C, 2011, METHODS MOL BIOL, V732, P187, DOI 10.1007/978-1-61779-083-6_14; Lu C, 2005, SCIENCE, V309, P1567, DOI 10.1126/science.1114112; Lu C, 2006, GENOME RES, V16, P1276, DOI 10.1101/gr.5530106; Lu SF, 2005, PLANT CELL, V17, P2186, DOI 10.1105/tpc.105.033456; Lu SF, 2008, PLANT J, V55, P131, DOI 10.1111/j.1365-313X.2008.03497.x; MacLean D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009901; Martinez G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019523; Martinez-Priego L, 2008, VIROLOGY, V376, P346, DOI 10.1016/j.virol.2008.03.024; Matzke M, 2007, CURR OPIN PLANT BIOL, V10, P512, DOI 10.1016/j.pbi.2007.06.007; Meinke DW, 1998, SCIENCE, V282, P662, DOI 10.1126/science.282.5389.662; Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034; Mica E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-558; Moazed D, 2009, NATURE, V457, P413, DOI 10.1038/nature07756; Montgomery TA, 2008, CELL, V133, P128, DOI 10.1016/j.cell.2008.02.033; Moreno-Alias I, 2009, TREES-STRUCT FUNCT, V23, P181, DOI 10.1007/s00468-008-0266-z; Morin RD, 2008, GENOME RES, V18, P571, DOI 10.1101/gr.6897308; Moxon S, 2008, GENOME RES, V18, P1602, DOI 10.1101/gr.080127.108; Pantaleo V, 2010, VIROLOGY, V408, P49, DOI 10.1016/j.virol.2010.09.001; Pantaleo V, 2010, PLANT J, V62, P960, DOI [10.1111/j.1365-313X.2010.04208.x, 10.1111/j.0960-7412.2010.04208.x]; Peragine A, 2004, GENE DEV, V18, P2368, DOI 10.1101/gad.1231804; Poethig RS, 2009, CURR OPIN GENET DEV, V19, P374, DOI 10.1016/j.gde.2009.06.001; Qiu DY, 2009, GENE, V436, P37, DOI 10.1016/j.gene.2009.01.006; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Rubio-Somoza I, 2011, TRENDS PLANT SCI, V16, P258, DOI 10.1016/j.tplants.2011.03.001; Rubio-Somoza I, 2009, CURR OPIN PLANT BIOL, V12, P622, DOI 10.1016/j.pbi.2009.07.003; Santos-Antunes F, 2005, HORTSCIENCE, V40, P1213, DOI 10.21273/HORTSCI.40.5.1213; Shen D, 2009, PLANT SYST EVOL, V283, P125, DOI 10.1007/s00606-009-0221-5; Song CN, 2009, PLANTA, V230, P671, DOI 10.1007/s00425-009-0971-x; Subramanian S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-160; Sunkar R, 2005, NUCLEIC ACIDS RES, V33, P4443, DOI 10.1093/nar/gki758; Tang GL, 2003, GENE DEV, V17, P49, DOI 10.1101/gad.1048103; TOUS J, 2005, VARIEDADES OLIVO CUL; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Vaucheret H, 2008, TRENDS PLANT SCI, V13, P350, DOI 10.1016/j.tplants.2008.04.007; Vazquez F, 2004, MOL CELL, V16, P69, DOI 10.1016/j.molcel.2004.09.028; Vazquez F, 2008, NUCLEIC ACIDS RES, V36, P6429, DOI 10.1093/nar/gkn670; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wang JW, 2009, CELL, V138, P738, DOI 10.1016/j.cell.2009.06.014; Wei B, 2009, FUNCT INTEGR GENOMIC, V9, P499, DOI 10.1007/s10142-009-0128-9; Williams L, 2005, P NATL ACAD SCI USA, V102, P9703, DOI 10.1073/pnas.0504029102; Wu G, 2009, CELL, V138, P750, DOI 10.1016/j.cell.2009.06.031; Xie ZX, 2005, PLANT PHYSIOL, V138, P2145, DOI 10.1104/pp.105.062943; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Xu Q, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-246; Yakovlev IA, 2010, NEW PHYTOL, V187, P1154, DOI 10.1111/j.1469-8137.2010.03341.x; Yoshikawa M, 2005, GENE DEV, V19, P2164, DOI 10.1101/gad.1352605; Zhang BH, 2005, CELL RES, V15, P336, DOI 10.1038/sj.cr.7290302; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	84	49	53	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2011	6	11							e27916	10.1371/journal.pone.0027916	http://dx.doi.org/10.1371/journal.pone.0027916			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KW	22140484	Green Submitted, Green Published, gold			2022-12-27	WOS:000298163400022
J	Opina, ACL; Ghaghada, KB; Zhao, PY; Kiefer, G; Annapragada, A; Sherry, AD				Opina, Ana Christina L.; Ghaghada, Ketan B.; Zhao, Piyu; Kiefer, Garry; Annapragada, Ananth; Sherry, A. Dean			TmDOTA-Tetraglycinate Encapsulated Liposomes as pH-Sensitive LipoCEST Agents	PLOS ONE			English	Article							NUCLEAR MAGNETIC-RESONANCE; SATURATION-TRANSFER CEST; CONTRAST AGENTS; LANTHANIDE(III) COMPLEXES; CHOLESTEROL CONTENT; IN-VIVO; EXCHANGE; INVIVO; PERMEABILITY; STABILITY	Lanthanide DOTA-tetraglycinate (LnDOTA-(gly)(4)(-)) complexes contain four magnetically equivalent amide protons that exchange with protons of bulk water. The rate of this base catalyzed exchange process has been measured using chemical exchange saturation transfer (CEST) NMR techniques as a function of solution pH for various paramagnetic LnDOTA-(gly)(4)(-) complexes to evaluate the effects of lanthanide ion size on this process. Complexes with Tb(III), Dy(III), Tm(III) and Yb(III) were chosen because these ions induce large hyperfine shifts in all ligand protons, including the exchanging amide protons. The magnitude of the amide proton CEST exchange signal differed for the four paramagnetic complexes in order, Yb>Tm>Tb>Dy. Although the Dy(III) complex showed the largest hyperfine shift as expected, the combination of favorable chemical shift and amide proton CEST linewidth in the Tm(III) complex was deemed most favorable for future in vivo applications where tissue magnetization effects can interfere. TmDOTA-(gly)(4)(-) at various concentrations was encapsulated in the core interior of liposomes to yield lipoCEST particles for molecular imaging. The resulting nanoparticles showed less than 1% leakage of the agent from the interior over a range of temperatures and pH. The pH versus amide proton CEST curves differed for the free versus encapsulated agents over the acidic pH regions, consistent with a lower proton permeability across the liposomal bilayer for the encapsulated agent. Nevertheless, the resulting lipoCEST nanoparticles amplify the CEST sensitivity by a factor of similar to 10(4) compared to the free, un-encapsulated agent. Such pH sensitive nano-probes could prove useful for pH mapping of liposomes targeted to tumors.	[Opina, Ana Christina L.; Zhao, Piyu; Kiefer, Garry; Sherry, A. Dean] Univ Texas Dallas, Dept Chem, Richardson, TX 75083 USA; [Ghaghada, Ketan B.; Annapragada, Ananth] Univ Texas Hlth Sci Ctr Houston, Sch Biomed Informat, Houston, TX USA; [Sherry, A. Dean] Univ Texas SW Med Ctr Dallas, Adv Imaging Res Ctr, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Southwestern Medical Center Dallas	Opina, ACL (corresponding author), Univ Texas Dallas, Dept Chem, Richardson, TX 75083 USA.	sherry@utdallas.edu	Ghaghada, Ketan/F-6825-2012; Annapragada, Ananth/GOK-1576-2022; Sherry, Dean/P-2348-2018	Sherry, Dean/0000-0001-7150-8301; Annapragada, Ananth/0000-0002-3156-9617	National Institutes of Health [RR-02584, EB-004582, CA-115531]; Robert A. Welch Foundation [AT-584]; NATIONAL CANCER INSTITUTE [U24CA126608, R01CA115531] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR002584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB004582] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	Funding was provided by the National Institutes of Health (RR-02584, EB-004582, and CA-115531) and the Robert A. Welch Foundation (AT-584). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aime S, 2005, ANGEW CHEM INT EDIT, V44, P5513, DOI 10.1002/anie.200501473; Aime S, 1998, ANGEW CHEM INT EDIT, V37, P2673, DOI 10.1002/(SICI)1521-3773(19981016)37:19<2673::AID-ANIE2673>3.0.CO;2-#; Aime S, 2002, ANGEW CHEM INT EDIT, V41, P4334, DOI 10.1002/1521-3773(20021115)41:22<4334::AID-ANIE4334>3.0.CO;2-1; Aime S, 2002, MAGN RESON MED, V47, P639, DOI 10.1002/mrm.10106; ALLEN TM, 1994, TRENDS PHARMACOL SCI, V15, P215, DOI 10.1016/0165-6147(94)90314-X; Ayyagari AL, 2006, MAGN RESON MED, V55, P1023, DOI 10.1002/mrm.20846; Baranyai Z, 2005, HELV CHIM ACTA, V88, P604, DOI 10.1002/hlca.200590042; Baranyai Z, 2007, EUR J INORG CHEM, P3639, DOI 10.1002/ejic.200700178; BLEANEY B, 1972, J MAGN RESON, V8, P91, DOI 10.1016/0022-2364(72)90027-3; DEGIER J, 1968, BIOCHIM BIOPHYS ACTA, V150, P666, DOI 10.1016/0005-2736(68)90056-4; ENG J, 1991, MAGNET RESON MED, V17, P304, DOI 10.1002/mrm.1910170203; Ghaghada KB, 2007, AM J NEURORADIOL, V28, P48; GREGORIADIS G, 1979, BIOCHEM BIOPH RES CO, V89, P1287, DOI 10.1016/0006-291X(79)92148-X; KIRBY C, 1980, BIOCHEM J, V186, P591, DOI 10.1042/bj1860591; KLIBANOV AL, 1990, FEBS LETT, V268, P235, DOI 10.1016/0014-5793(90)81016-H; LAUFFER RB, 1987, CHEM REV, V87, P901, DOI 10.1021/cr00081a003; MASSARI S, 1991, BIOCHIM BIOPHYS ACTA, V1067, P131, DOI 10.1016/0005-2736(91)90034-6; MCCONNELL HM, 1958, J CHEM PHYS, V28, P430, DOI 10.1063/1.1744152; Sherry AD, 2009, J MAGN RESON IMAGING, V30, P1240, DOI 10.1002/jmri.21966; Terreno E, 2004, INVEST RADIOL, V39, P235, DOI 10.1097/01.rli.0000116607.26372.d0; Ward KM, 2000, MAGN RESON MED, V44, P799, DOI 10.1002/1522-2594(200011)44:5<799::AID-MRM18>3.0.CO;2-S; WOESSNER DE, 1961, J CHEM PHYS, V35, P41, DOI 10.1063/1.1731931; WOLFF SD, 1991, RADIOLOGY, V179, P133, DOI 10.1148/radiology.179.1.2006263; WOLFF SD, 1990, J MAGN RESON, V86, P164, DOI 10.1016/0022-2364(90)90220-4; WOLFF SD, 1989, MAGNET RESON MED, V10, P135, DOI 10.1002/mrm.1910100113; Zhang SR, 2001, J AM CHEM SOC, V123, P1517, DOI 10.1021/ja005820q; Zhao JM, 2008, J AM CHEM SOC, V130, P5178, DOI 10.1021/ja710159q; Zheng JZ, 2007, PHARM RES-DORDR, V24, P1193, DOI 10.1007/s11095-006-9220-1	28	21	21	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2011	6	11							e27370	10.1371/journal.pone.0027370	http://dx.doi.org/10.1371/journal.pone.0027370			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KW	22140438	gold, Green Submitted, Green Published			2022-12-27	WOS:000298163400005
J	Walsh, S; Nygren, J; Ponten, A; Jovinge, S				Walsh, Stuart; Nygren, Jens; Ponten, Annica; Jovinge, Stefan			Myogenic Reprogramming of Bone Marrow Derived Cells in a W(41)Dmd(mdx) Deficient Mouse Model	PLOS ONE			English	Article							STEM-CELL; MUSCLE REGENERATION; MDX MICE; IN-VIVO; HEPATOCYTES; SKELETAL; TRANSPLANTATION; EXPRESSION; DEFECTS; FUSION	Lack of expression of dystrophin leads to degeneration of muscle fibers and infiltration of connective and adipose tissue. Cell transplantation therapy has been proposed as a treatment for intractable muscle degenerative disorders. Several reports have demonstrated the ability of bone-marrow derived cells (BMDC) to contribute to non-haematopoietic tissues including epithelium, heart, liver, skeletal muscle and brain following transplantation by means of fusion and reprogramming. A key issue is the extent to which fusion and reprogramming can occur in vivo, particularly under conditions of myogenic deterioration. To investigate the therapeutic potential of bone marrow transplantation in monogenetic myopathy, green fluorescent protein-positive (GFP(+)) bone marrow cells were transplanted into non-irradiated c-kit receptor - deficient (W-41) mdx mice. This model allows BMDC reconstitution in the absence of irradiation induced myeloablation. We provide the first report of BMDC fusion in a W-41/Dmd(mdx) deficient mouse model. In the absence of irradiation induced injury, few GFP(+) cardiomyocytes and muscle fibres were detected 24 weeks post BMT. It was expected that the frequency of fusion in the hearts of W(41)Dmd(mdx) mice would be similar to frequencies observed in infarcted mice [1]. Although, it is clear from this study that individual cardiomyocytes with monogenetic deficiencies can be rescued by fusion, it is as clear that in the absence of irradiation, the formation of stable and reprogrammed fusion hybrids occurs, with the current techniques, at very low levels in non-irradiated recipients.	[Walsh, Stuart; Ponten, Annica; Jovinge, Stefan] Lund Univ, Lund Strateg Res Ctr Stem Cell Biol & Cell Therap, Lund, Sweden; [Nygren, Jens] Lund Univ, Immunol Unit, Expt Med Res Inst, Lund, Sweden; [Nygren, Jens] Halmstad Univ, Ctr Res Welf Hlth & Sport, Halmstad, Sweden; [Jovinge, Stefan] Univ Lund Hosp, Dept Cardiol, S-22185 Lund, Sweden	Lund University; Lund University; Halmstad University; Lund University; Skane University Hospital	Walsh, S (corresponding author), Lund Univ, Lund Strateg Res Ctr Stem Cell Biol & Cell Therap, Lund, Sweden.	stefan.jovinge@med.lu.se		Nygren, Jens M/0000-0002-3576-2393	Swedish Foundation for Strategic Research [A3 02:094]; Swedish Research Council [K2010-65X-21408-01-3]; Swedish heart-Lung Foundation [20080850]; Juvenile Diabetes Research Foundation [529-2005-8327]; European Comission [223372]	Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish heart-Lung Foundation(Swedish Heart-Lung Foundation); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); European Comission(European CommissionEuropean Commission Joint Research Centre)	Funding provided by the Center of Excellence grant from the Swedish Foundation for Strategic Research grant number A3 02:094, The Swedish Research Council grant number K2010-65X-21408-01-3, The Swedish heart-Lung Foundation grant number 20080850, The Juvenile Diabetes Research Foundation grant number 529-2005-8327 and the European Comission FP7 Grant 223372 CardioCell Consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Dolado M, 2003, NATURE, V425, P968, DOI 10.1038/nature02069; Amalfitano A, 1996, MUSCLE NERVE, V19, P1549, DOI 10.1002/(SICI)1097-4598(199612)19:12<1549::AID-MUS4>3.0.CO;2-A; Bittner RE, 1999, ANAT EMBRYOL, V199, P391, DOI 10.1007/s004290050237; Brazelton TR, 2003, DEV BIOL, V262, P64, DOI 10.1016/S0012-1606(03)00357-9; Brazelton TR, 2000, SCIENCE, V290, P1775, DOI 10.1126/science.290.5497.1775; Chamberlain JS, 2007, FASEB J, V21, P2195, DOI 10.1096/fj.06-7353com; Dreyfus PA, 2004, AM J PATHOL, V164, P773, DOI 10.1016/S0002-9440(10)63165-3; Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528; Fukada S, 2002, J CELL SCI, V115, P1285; Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; LaBarge MA, 2002, CELL, V111, P589, DOI 10.1016/S0092-8674(02)01078-4; Lagasse E, 2000, NAT MED, V6, P1229, DOI 10.1038/81326; LAW DJ, 1993, AM J PATHOL, V142, P1513; Mezey E, 2000, SCIENCE, V290, P1779, DOI 10.1126/science.290.5497.1779; Nygren JM, 2008, NAT CELL BIOL, V10, P584, DOI 10.1038/ncb1721; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; REITH AD, 1990, GENE DEV, V4, P390, DOI 10.1101/gad.4.3.390; Theise ND, 2000, HEPATOLOGY, V31, P235, DOI 10.1002/hep.510310135; Wang X, 2002, AM J PATHOL, V161, P565, DOI 10.1016/S0002-9440(10)64212-5	21	8	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2011	6	11							e27500	10.1371/journal.pone.0027500	http://dx.doi.org/10.1371/journal.pone.0027500			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KW	22140444	Green Published, gold			2022-12-27	WOS:000298163400007
J	Kasprick, DS; Kish, PE; Junttila, TL; Ward, LA; Bohnsack, BL; Kahana, A				Kasprick, Daniel S.; Kish, Phillip E.; Junttila, Tyler L.; Ward, Lindsay A.; Bohnsack, Brenda L.; Kahana, Alon			Microanatomy of Adult Zebrafish Extraocular Muscles	PLOS ONE			English	Article							NEUROMUSCULAR-JUNCTIONS; FINE STRUCTURE; THROMBOSPONDIN-4; INNERVATION; GENE; MICE; FORM	Binocular vision requires intricate control of eye movement to align overlapping visual fields for fusion in the visual cortex, and each eye is controlled by 6 extraocular muscles (EOMs). Disorders of EOMs are an important cause of symptomatic vision loss. Importantly, EOMs represent specialized skeletal muscles with distinct gene expression profile and susceptibility to neuromuscular disorders. We aim to investigate and describe the anatomy of adult zebrafish extraocular muscles (EOMs) to enable comparison with human EOM anatomy and facilitate the use of zebrafish as a model for EOM research. Using differential interference contrast (DIC), epifluorescence microscopy, and precise sectioning techniques, we evaluate the anatomy of zebrafish EOM origin, muscle course, and insertion on the eye. Immunofluorescence is used to identify components of tendons, basement membrane and neuromuscular junctions (NMJs), and to analyze myofiber characteristics. We find that adult zebrafish EOM insertions on the globe parallel the organization of human EOMs, including the close proximity of specific EOM insertions to one another. However, analysis of EOM origins reveals important differences between human and zebrafish, such as the common rostral origin of both oblique muscles and the caudal origin of the lateral rectus muscles. Thrombospondin 4 marks the EOM tendons in regions that are highly innervated, and laminin marks the basement membrane, enabling evaluation of myofiber size and distribution. The NMJs appear to include both en plaque and en grappe synapses, while NMJ density is much higher in EOMs than in somatic muscles. In conclusion, zebrafish and human EOM anatomy are generally homologous, supporting the use of zebrafish for studying EOM biology. However, anatomic differences exist, revealing divergent evolutionary pressures.	[Kasprick, Daniel S.; Kish, Phillip E.; Junttila, Tyler L.; Ward, Lindsay A.; Bohnsack, Brenda L.; Kahana, Alon] Univ Michigan, Kellogg Eye Ctr, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Kasprick, DS (corresponding author), Univ Michigan, Kellogg Eye Ctr, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48109 USA.	akahana@med.umich.edu	Kish, Phil E/H-6051-2011	Kish, Phillip/0000-0002-1992-3310; Bohnsack, Brenda/0000-0001-8961-6343; Kahana, Alon/0000-0002-5667-2274	Fight for Sight Student Award; Research to Prevent Blindness; National Eye Institute of the National Institutes of Health [K08 EY018689]; Department of Ophthalmology and Visual Sciences, Kellogg Eye Center, University of Michigan [P30 EY007003]; National Health Institute-National Center for Research resources [P40 RR012546]; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR012546] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [K08EY018689, P30EY007003] Funding Source: NIH RePORTER	Fight for Sight Student Award; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); National Eye Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Department of Ophthalmology and Visual Sciences, Kellogg Eye Center, University of Michigan; National Health Institute-National Center for Research resources; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by a Fight for Sight Student Award (DSK), Research to Prevent Blindness Career Development Award (AK), Alliance for Vision Research (AK), grant K08 EY018689 (AK) from the National Eye Institute of the National Institutes of Health and a Vision Research Core Award P30 EY007003 to the Department of Ophthalmology and Visual Sciences, Kellogg Eye Center, University of Michigan. The Zebrafish International Resource Center is supported by grant P40 RR012546 from the National Health Institute-National Center for Research resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARBER S, 1995, J CELL BIOL, V131, P1083, DOI 10.1083/jcb.131.4.1083; Bohnsack BL, 2011, ARCH OPHTHALMOL; Colognato H, 1999, CURR BIOL, V9, P1327, DOI 10.1016/S0960-9822(00)80056-1; Colognato H, 2000, DEV DYNAM, V218, P213, DOI 10.1002/(SICI)1097-0177(200006)218:2<213::AID-DVDY1>3.0.CO;2-R; Colognato H, 1999, J CELL BIOL, V145, P619, DOI 10.1083/jcb.145.3.619; COULY GF, 1992, DEVELOPMENT, V114, P1; Easter SS, 1996, DEV BIOL, V180, P646; Fujiwara H, 2001, J BIOL CHEM, V276, P17550, DOI 10.1074/jbc.M010155200; Gage PJ, 1999, DEVELOPMENT, V126, P4643; Gullberg G, 1999, CELL MOL LIFE SCI, V56, P442, DOI 10.1007/PL00000616; Harrison AR, 2007, INVEST OPHTH VIS SCI, V48, P3594, DOI 10.1167/iovs.06-1239; Higashijima S, 1997, DEV BIOL, V192, P289, DOI 10.1006/dbio.1997.8779; Jaggi GP, 2005, INVEST OPHTH VIS SCI, V46, P2258, DOI 10.1167/iovs.04-1164; Jelinsky SA, 2010, J ORTHOP RES, V28, P289, DOI 10.1002/jor.20999; Khanna S, 2004, INVEST OPHTH VIS SCI, V45, P3055, DOI 10.1167/iovs.03-1385; Khanna S, 2003, FASEB J, V17, P1370, DOI 10.1096/fj.02-1108fje; Kjellgren D, 2004, INVEST OPHTH VIS SCI, V45, P4233, DOI 10.1167/iovs.04-0456; KUPFER C, 1960, J PHYSIOL-LONDON, V153, P522, DOI 10.1113/jphysiol.1960.sp006552; Lampe PD, 1998, J CELL BIOL, V143, P1735, DOI 10.1083/jcb.143.6.1735; Newton G, 1999, MAMM GENOME, V10, P1010, DOI 10.1007/s003359901149; NOAKES PG, 1995, NATURE, V374, P258, DOI 10.1038/374258a0; Oh SY, 2001, INVEST OPHTH VIS SCI, V42, P17; Porter JD, 2001, P NATL ACAD SCI USA, V98, P12062, DOI 10.1073/pnas.211257298; PORTER JD, 1995, SURV OPHTHALMOL, V39, P451, DOI 10.1016/S0039-6257(05)80055-4; SADEH M, 1984, J NEUROL SCI, V66, P295, DOI 10.1016/0022-510X(84)90018-2; SAKIMOTO T, 1970, INVEST OPHTH VISUAL, V9, P316; Schilling TF, 1996, DEVELOPMENT, V122, P1417; Spencer R F, 1988, Rev Oculomot Res, V2, P33; ZACKS SI, 1962, J NEUROPATH EXP NEUR, V21, P335, DOI 10.1097/00005072-196207000-00001	29	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e27095	10.1371/journal.pone.0027095	http://dx.doi.org/10.1371/journal.pone.0027095			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132088	Green Submitted, gold, Green Published			2022-12-27	WOS:000298162000010
J	Wu, S; Koizumi, K; MacRae-Crerar, A; Gallagher, KL				Wu, Shuang; Koizumi, Koji; MacRae-Crerar, Aurora; Gallagher, Kimberly L.			Assessing the Utility of Photoswitchable Fluorescent Proteins for Tracking Intercellular Protein Movement in the Arabidopsis Root	PLOS ONE			English	Article							EPIDERMAL-CELL DIFFERENTIATION; TRANSCRIPTION FACTOR; GENE-EXPRESSION; MARKER; CAPRICE; PLANTS; EOSFP; LOCALIZATION; ACTIN; SHR	One way in which cells communicate is through the direct transfer of proteins. In plants, many of these proteins are transcription factors, which are made by one cell type and traffic into another. In order to understand how this movement occurs and its role in development, we would like to track this movement in live, intact plants in real-time. Here we examine the utility of the photoconvertible proteins, Dendra2 and (to a lesser extent) EosFP as tags for studying intracellular and intercellular protein movement in the Arabidopsis root. To this end, we made fusions between Dendra2 and six mobile transcription factors. Our results show that Dendra2 is an effective tool for studying protein movement between plant cells. Interestingly, we found that Dendra2 could not simply be swapped into existing constructs that had originally contained GFP. Most of the fusions made in this way failed to produce a fluorescent fusion. In addition we found that the optimal settings for photoconversion of Dendra2 in stably transformed roots were different from what has been published for photoconversion in transient assays in plants or in animal cells. By modifying the confocal setting, we were able to photoconvert Dendra2 in all cell layers in the root. However the efficiency of photoconversion was affected by the position of the cell layer within the root, with more internal tissues requiring more energy. By examining the Dendra2 fusions, we confirmed the mobility of the SHORT-ROOT (SHR) and CAPRICE (CPC) transcription factors between cells and we further discovered that SHR movement in stele and CPC movement in the epidermis are non-directional.	[Wu, Shuang; Koizumi, Koji; MacRae-Crerar, Aurora; Gallagher, Kimberly L.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA	University of Pennsylvania	Wu, S (corresponding author), Univ Penn, Dept Biol, Philadelphia, PA 19104 USA.	gallagkl@sas.upenn.edu	Wu, Shuang/M-1839-2013		University of Pennsylvania Research Foundation (URF); NSF [0920327]	University of Pennsylvania Research Foundation (URF); NSF(National Science Foundation (NSF))	This research was funded by a University of Pennsylvania Research Foundation (URF) grant and an NSF grant 0920327 awarded to K. L. G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed KA, 2011, J CELL MOL MED, V15, P1458, DOI 10.1111/j.1582-4934.2010.01008.x; Ando R, 2002, P NATL ACAD SCI USA, V99, P12651, DOI 10.1073/pnas.202320599; BENFEY PN, 1989, SCIENCE, V244, P174, DOI 10.1126/science.244.4901.174; Bernhardt C, 2005, DEVELOPMENT, V132, P291, DOI 10.1242/dev.01565; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Cui HC, 2007, SCIENCE, V316, P421, DOI 10.1126/science.1139531; Day RN, 2009, CHEM SOC REV, V38, P2887, DOI 10.1039/b901966a; DERRICK PM, 1992, PLANT CELL, V4, P1405, DOI 10.1105/tpc.4.11.1405; Deuschle K, 2006, PLANT CELL, V18, P2314, DOI 10.1105/tpc.106.044073; Gallagher KL, 2009, PLANT J, V57, P785, DOI 10.1111/j.1365-313X.2008.03735.x; Gallagher KL, 2004, CURR BIOL, V14, P1847, DOI 10.1016/j.cub.2004.09.081; Gurskaya NG, 2006, NAT BIOTECHNOL, V24, P461, DOI 10.1038/nbt1191; Jaeger KE, 2007, CURR BIOL, V17, P1050, DOI 10.1016/j.cub.2007.05.008; Kirik V, 2004, DEV BIOL, V268, P506, DOI 10.1016/j.ydbio.2003.12.037; Koizumi K, 2011, CURR BIOL, V21, P1559, DOI 10.1016/j.cub.2011.08.013; Koshino-Kimura Y, 2005, PLANT CELL PHYSIOL, V46, P817, DOI 10.1093/pcp/pci096; Kurata T, 2005, DEVELOPMENT, V132, P5387, DOI 10.1242/dev.02139; Lee JY, 2011, TRENDS PLANT SCI, V16, P201, DOI 10.1016/j.tplants.2011.01.004; Lee JY, 2006, P NATL ACAD SCI USA, V103, P6055, DOI 10.1073/pnas.0510607103; Martin K, 2009, PLANT J, V59, P150, DOI 10.1111/j.1365-313X.2009.03850.x; Mathur J, 2010, PLANT PHYSIOL, V154, P1573, DOI 10.1104/pp.110.165431; Nakajima K, 2001, NATURE, V413, P307, DOI 10.1038/35095061; Nienhaus GU, 2006, PHOTOCHEM PHOTOBIOL, V82, P351, DOI 10.1562/2005-05-19-RA-533; Prochiantz A, 2011, METHODS MOL BIOL, V683, P249, DOI 10.1007/978-1-60761-919-2_18; Rausin G, 2010, PLANT PHYSIOL, V153, P273, DOI 10.1104/pp.110.154740; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Roslan HA, 2001, PLANT J, V28, P225, DOI 10.1046/j.1365-313X.2001.01146.x; Schenkel M, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-21; Tsutsui H, 2005, EMBO REP, V6, P233, DOI 10.1038/sj.embor.7400361; Wada T, 2002, DEVELOPMENT, V129, P5409, DOI 10.1242/dev.00111; Welch D, 2007, GENE DEV, V21, P2196, DOI 10.1101/gad.440307; Wiedenmann J, 2004, P NATL ACAD SCI USA, V101, P15905, DOI 10.1073/pnas.0403668101; Wiedenmann J, 2006, EXPERT REV PROTEOMIC, V3, P361, DOI 10.1586/14789450.3.3.361; Wigge PA, 2005, SCIENCE, V309, P1056, DOI 10.1126/science.1114358; WILSON IA, 1985, P NATL ACAD SCI USA, V82, P5255, DOI 10.1073/pnas.82.16.5255; Wu S, 2011, CURR OPIN PLANT BIOL, V14, P563, DOI 10.1016/j.pbi.2011.06.006	36	21	21	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e27536	10.1371/journal.pone.0027536	http://dx.doi.org/10.1371/journal.pone.0027536			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132108	Green Published, gold, Green Submitted			2022-12-27	WOS:000298162000024
J	Bhat, S; Zhu, X; Patel, RP; Orlando, R; Shimkets, LJ				Bhat, Swapna; Zhu, Xiang; Patel, Ricky P.; Orlando, Ron; Shimkets, Lawrence J.			Identification and Localization of Myxococcus xanthus Porins and Lipoproteins	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEINS; FRUITING BODY MORPHOGENESIS; GRAM-NEGATIVE BACTERIA; ESCHERICHIA-COLI; EXTRACELLULAR-MATRIX; CELL-INTERACTIONS; WEB SERVER; PREDICTION; SEQUENCE; SIGNAL	Myxococcus xanthus DK1622 contains inner (IM) and outer membranes (OM) separated by a peptidoglycan layer. Integral membrane, beta-barrel proteins are found exclusively in the OM where they form pores allowing the passage of nutrients, waste products and signals. One porin, Oar, is required for intercellular communication of the C-signal. An oar mutant produces CsgA but is unable to ripple or stimulate csgA mutants to develop suggesting that it is the channel for C-signaling. Six prediction programs were evaluated for their ability to identify beta-barrel proteins. No program was reliable unless the predicted proteins were first parsed using Signal P, Lipo P and TMHMM, after which TMBETA-SVM and TMBETADISC-RBF identified beta-barrel proteins most accurately. 228 beta-barrel proteins were predicted from among 7331 protein coding regions, representing 3.1% of total genes. Sucrose density gradients were used to separate vegetative cell IM and OM fractions, and LC-MS/MS of OM proteins identified 54 beta-barrel proteins. Another class of membrane proteins, the lipoproteins, are anchored in the membrane via a lipid moiety at the N-terminus. 44 OM proteins identified by LC-MS/MS were predicted lipoproteins. Lipoproteins are distributed between the IM, OM and ECM according to an N-terminal sorting sequence that varies among species. Sequence analysis revealed conservation of alanine at the +7 position of mature ECM lipoproteins, lysine at the +2 position of IM lipoproteins, and no noticable conservation within the OM lipoproteins. Site directed mutagenesis and immuno transmission electron microscopy showed that alanine at the +7 position is essential for sorting of the lipoprotein FibA into the ECM. FibA appears at normal levels in the ECM even when a +2 lysine is added to the signal sequence. These results suggest that ECM proteins have a unique method of secretion. It is now possible to target lipoproteins to specific IM, OM and ECM locations by manipulating the amino acid sequence near the +1 cysteine processing site.	[Bhat, Swapna; Patel, Ricky P.; Shimkets, Lawrence J.] Univ Georgia, Dept Microbiol, Athens, GA 30602 USA; [Zhu, Xiang; Orlando, Ron] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Bhat, S (corresponding author), Univ Georgia, Dept Microbiol, Athens, GA 30602 USA.	shimkets@uga.edu			National Science Foundation [MCB 0742976]	National Science Foundation(National Science Foundation (NSF))	This work was supported by research grant MCB 0742976 from the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avadhani M, 2006, J BACTERIOL, V188, P8543, DOI 10.1128/JB.01047-06; Bagos PG, 2004, NUCLEIC ACIDS RES, V32, pW400, DOI 10.1093/nar/gkh417; BEHMLANDER RM, 1991, J BACTERIOL, V173, P7810, DOI 10.1128/jb.173.24.7810-7820.1991; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Berven FS, 2004, NUCLEIC ACIDS RES, V32, pW394, DOI 10.1093/nar/gkh351; Bos MP, 2007, EMBO REP, V8, P1149, DOI 10.1038/sj.embor.7401092; Bos MP, 2007, ANNU REV MICROBIOL, V61, P191, DOI 10.1146/annurev.micro.61.080706.093245; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Curtis PD, 2007, J BACTERIOL, V189, P7634, DOI 10.1128/JB.01007-07; DOWNARD J, 1993, J BACTERIOL, V175, P7762, DOI 10.1128/JB.175.24.7762-7770.1993; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Garrow AG, 2005, NUCLEIC ACIDS RES, V33, pW188, DOI 10.1093/nar/gki384; Graham RLJ, 2006, J PROTEOME RES, V5, P3145, DOI 10.1021/pr060293g; Gromiha MM, 2005, NUCLEIC ACIDS RES, V33, pW164, DOI 10.1093/nar/gki367; Gumbart J, 2007, BIOPHYS J, V93, P496, DOI 10.1529/biophysj.107.104158; HAGEN DC, 1978, DEV BIOL, V64, P284, DOI 10.1016/0012-1606(78)90079-9; HANCOCK REW, 1978, J BACTERIOL, V136, P381, DOI 10.1128/JB.136.1.381-390.1978; HORTON RM, 1995, MOL BIOTECHNOL, V3, P93, DOI 10.1007/BF02789105; Hutchings MI, 2009, TRENDS MICROBIOL, V17, P13, DOI 10.1016/j.tim.2008.10.001; Johnson JM, 1999, J MOL BIOL, V287, P695, DOI 10.1006/jmbi.1999.2630; Kahnt J, 2010, J PROTEOME RES, V9, P5197, DOI 10.1021/pr1004983; KAISER D, 1979, P NATL ACAD SCI USA, V76, P5952, DOI 10.1073/pnas.76.11.5952; Kearns DB, 2002, J BACTERIOL, V184, P1678, DOI 10.1128/JB.184.6.1678-1684.2002; KIM SK, 1990, SCIENCE, V249, P926, DOI 10.1126/science.2118274; KIM SK, 1990, GENE DEV, V4, P896, DOI 10.1101/gad.4.6.896; KOSKI P, 1990, GENE, V88, P117; Kruse T, 2001, MOL MICROBIOL, V40, P156, DOI 10.1046/j.1365-2958.2001.02365.x; KUNER JM, 1982, J BACTERIOL, V151, P458, DOI 10.1128/JB.151.1.458-461.1982; Letain TE, 1997, MOL MICROBIOL, V24, P271, DOI 10.1046/j.1365-2958.1997.3331703.x; MARTINEZCANAMERO M, 1993, J BACTERIOL, V175, P4756, DOI 10.1128/JB.175.15.4756-4763.1993; Masuda K, 2002, P NATL ACAD SCI USA, V99, P7390, DOI 10.1073/pnas.112085599; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Ou YY, 2008, COMPUT BIOL CHEM, V32, P227, DOI 10.1016/j.compbiolchem.2008.03.002; Park KJ, 2005, BIOINFORMATICS, V21, P4223, DOI 10.1093/bioinformatics/bti697; Pedrioli PGA, 2004, NAT BIOTECHNOL, V22, P1459, DOI 10.1038/nbt1031; POQUET I, 1993, MOL MICROBIOL, V9, P1061, DOI 10.1111/j.1365-2958.1993.tb01235.x; Postle K, 2007, METHOD ENZYMOL, V422, P245, DOI 10.1016/S0076-6879(06)22012-3; PUGSLEY AP, 1993, MICROBIOL REV, V57, P50, DOI 10.1128/MMBR.57.1.50-108.1993; Punta M, 2007, METHODS, V41, P460, DOI 10.1016/j.ymeth.2006.07.026; REIZER J, 1993, CRIT REV BIOCHEM MOL, V28, P235, DOI 10.3109/10409239309086796; Seydel A, 1999, MOL MICROBIOL, V34, P810, DOI 10.1046/j.1365-2958.1999.01647.x; SHIMKETS LJ, 1982, J BACTERIOL, V152, P451; Shimkets LJ, 1999, ANNU REV MICROBIOL, V53, P525, DOI 10.1146/annurev.micro.53.1.525; SHIMKETS LJ, 1983, P NATL ACAD SCI-BIOL, V80, P1406, DOI 10.1073/pnas.80.5.1406; Simunovic V, 2003, J BACTERIOL, V185, P5066, DOI 10.1128/JB.185.17.5066-5075.2003; TANAKA SY, 2007, J BIOL CHEM, V282; TOAL DR, 1995, MOL MICROBIOL, V16, P177, DOI 10.1111/j.1365-2958.1995.tb02291.x; Tokuda H, 2004, BBA-MOL CELL RES, V1693, P5, DOI 10.1016/j.bbamcr.2004.02.005; van den Berg B, 2005, CURR OPIN STRUC BIOL, V15, P401, DOI 10.1016/j.sbi.2005.06.003; Voulhoux R, 2003, SCIENCE, V299, P262, DOI 10.1126/science.1078973; Wimley WC, 2003, CURR OPIN STRUC BIOL, V13, P404, DOI 10.1016/S0959-440X(03)00099-X; Wu SS, 1997, J BACTERIOL, V179, P7748, DOI 10.1128/jb.179.24.7748-7758.1997; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Zhao JY, 2008, APPL ENVIRON MICROB, V74, P1980, DOI 10.1128/AEM.02143-07	56	41	41	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2011	6	11							e27475	10.1371/journal.pone.0027475	http://dx.doi.org/10.1371/journal.pone.0027475			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858JH	22132103	Green Submitted, gold, Green Published			2022-12-27	WOS:000297792400007
J	Pang, RTK; Liu, WM; Leung, CON; Ye, TM; Kwan, PCK; Lee, KF; Yeung, WSB				Pang, Ronald T. K.; Liu, Wei-Min; Leung, Carmen O. N.; Ye, Tian-Min; Kwan, Peter C. K.; Lee, Kai-Fai; Yeung, William S. B.			miR-135A Regulates Preimplantation Embryo Development through Down-Regulation of E3 Ubiquitin Ligase Seven in Absentia Homolog 1A (SIAH1A) Expression	PLOS ONE			English	Article							MICRORNA EXPRESSION; PROTEASOME PATHWAY; CELL-DEATH; OOCYTE; DEGRADATION; PROTEINS; ACTIVATION; INTERACTS; RNAS; IDENTIFICATION	Background: MicroRNAs (miRNAs) are small non-coding RNA molecules capable of regulating transcription and translation. Previously, a cluster of miRNAs that are specifically expressed in mouse zygotes but not in oocytes or other preimplantation stages embryos are identified by multiplex real-time polymerase chain reaction-based miRNA profiling. The functional role of one of these zygote-specific miRNAs, miR-135a, in preimplantation embryo development was investigated. Methodology/Principal Findings: Microinjection of miR-135a inhibitor suppressed first cell cleavage in more than 30% of the zygotes. Bioinformatics analysis identified E3 Ubiquitin Ligase Seven In Absentia Homolog 1A (Siah1a) as a predicted target of miR-135a. Western blotting and 3'UTR luciferase functional assays demonstrated that miR-135a down-regulated the expression of Siah1 in HeLa cells and in mouse zygotes. Siah1a was expressed in preimplantation embryos and its expression pattern negatively correlated with that of miR-135a. Co-injection of Siah1a-specific antibody with miR-135a inhibitor partially nullified the effect of miR-135a inhibition. Proteasome inhibition by MG-132 revealed that miR-135a regulated proteasomal degradation and potentially controlled the expression of chemokinesin DNA binding protein (Kid). Conclusions/Significance: The present study demonstrated for the first time that zygotic specific miRNA modulates the first cell cleavage through regulating expression of Siah1a.	[Pang, Ronald T. K.; Liu, Wei-Min; Leung, Carmen O. N.; Ye, Tian-Min; Kwan, Peter C. K.; Lee, Kai-Fai; Yeung, William S. B.] Univ Hong Kong, Dept Obstet & Gynaecol, Pokfulam, Hong Kong, Peoples R China; [Pang, Ronald T. K.; Liu, Wei-Min; Lee, Kai-Fai; Yeung, William S. B.] Univ Hong Kong, Ctr Reprod Dev & Growth, Pokfulam, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Pang, RTK (corresponding author), Univ Hong Kong, Dept Obstet & Gynaecol, Pokfulam, Hong Kong, Peoples R China.	wsbyeung@hku.hk	Pang, Ronald/B-8039-2013; Lee, Calvin Kai Fai/C-4328-2009	Lee, Calvin Kai Fai/0000-0001-5957-439X	Department of Obstetrics and Gynaecology, The University of Hong Kong	Department of Obstetrics and Gynaecology, The University of Hong Kong(University of Hong Kong)	This work was supported by the general account from the Department of Obstetrics and Gynaecology, The University of Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Amson RB, 1996, P NATL ACAD SCI USA, V93, P3953, DOI 10.1073/pnas.93.9.3953; Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bowerman B, 2006, DEVELOPMENT, V133, P773, DOI 10.1242/dev.02276; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Brooks WS, 2008, J BIOL CHEM, V283, P22304, DOI 10.1074/jbc.M803238200; DELLA NG, 1993, DEVELOPMENT, V117, P1333; DeRenzo C, 2004, TRENDS CELL BIOL, V14, P420, DOI 10.1016/j.tcb.2004.07.005; Dickins RA, 2002, MOL CELL BIOL, V22, P2294, DOI 10.1128/MCB.22.7.2294-2303.2002; Evsikov AV, 2006, GENE DEV, V20, P2713, DOI 10.1101/gad.1471006; Freemont PS, 2000, CURR BIOL, V10, pR84, DOI 10.1016/S0960-9822(00)00287-6; Frew IJ, 2003, MOL CELL BIOL, V23, P9150, DOI 10.1128/MCB.23.24.9150-9161.2003; Frew IJ, 2002, MOL CELL BIOL, V22, P8155, DOI 10.1128/MCB.22.23.8155-8164.2002; Germani A, 2000, ONCOGENE, V19, P5997, DOI 10.1038/sj.onc.1204002; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Hamatani T, 2004, DEV CELL, V6, P117, DOI 10.1016/S1534-5807(03)00373-3; Hardy K, 1997, MOL HUM REPROD, V3, P919, DOI 10.1093/molehr/3.10.919; Hu G, 1997, GENOMICS, V46, P103, DOI 10.1006/geno.1997.4997; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Johnsen SA, 2002, J BIOL CHEM, V277, P30754, DOI 10.1074/jbc.M204812200; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kiriakidou M, 2004, GENE DEV, V18, P1165, DOI 10.1101/gad.1184704; Koscianska E, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-79; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Ma J, 2010, CURR BIOL, V20, P265, DOI 10.1016/j.cub.2009.12.042; Matsuzawa S, 1998, EMBO J, V17, P2736, DOI 10.1093/emboj/17.10.2736; Mendez R, 2002, EMBO J, V21, P1833, DOI 10.1093/emboj/21.7.1833; Mtango NR, 2007, PHYSIOL GENOMICS, V31, P1, DOI 10.1152/physiolgenomics.00040.2007; Ohsugi M, 2008, CELL, V132, P771, DOI 10.1016/j.cell.2008.01.029; Okamura K, 2007, CELL, V130, P89, DOI 10.1016/j.cell.2007.06.028; Pang RTK, 2010, CARCINOGENESIS, V31, P1037, DOI 10.1093/carcin/bgq066; Papandile A, 2004, ZYGOTE, V12, P57, DOI 10.1017/S0967199404002588; Relaix F, 2000, P NATL ACAD SCI USA, V97, P2105, DOI 10.1073/pnas.040378897; Roperch JP, 1999, P NATL ACAD SCI USA, V96, P8070, DOI 10.1073/pnas.96.14.8070; Stitzel ML, 2007, SCIENCE, V316, P407, DOI 10.1126/science.1138236; Suh N, 2010, CURR BIOL, V20, P271, DOI 10.1016/j.cub.2009.12.044; Susini L, 2001, P NATL ACAD SCI USA, V98, P15067, DOI 10.1073/pnas.261571998; Suzumori N, 2003, P NATL ACAD SCI USA, V100, P550, DOI 10.1073/pnas.0234474100; Tadros W, 2005, DEV DYNAM, V232, P593, DOI 10.1002/dvdy.20297; Tang F, 2007, GENE DEV, V21, P644, DOI 10.1101/gad.418707; Tessmar-Raible K, 2007, CELL, V129, P1389, DOI 10.1016/j.cell.2007.04.041; Viswanathan SR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006143; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Wilkinson KD, 2000, SEMIN CELL DEV BIOL, V11, P141, DOI 10.1006/scdb.2000.0164; Winter M, 2008, NAT CELL BIOL, V10, P812, DOI 10.1038/ncb1743; Wu XM, 2003, NAT GENET, V33, P187, DOI 10.1038/ng1079; Xu ZH, 2006, J BIOL CHEM, V281, P303, DOI 10.1074/jbc.M509060200; Yang YH, 2008, DEV DYNAM, V237, P2315, DOI 10.1002/dvdy.21666	56	29	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2011	6	11							e27878	10.1371/journal.pone.0027878	http://dx.doi.org/10.1371/journal.pone.0027878			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858JH	22132158	gold, Green Published			2022-12-27	WOS:000297792400020
J	Liu, K; Linder, CR; Warnow, T				Liu, Kevin; Linder, C. Randal; Warnow, Tandy			RAxML and FastTree: Comparing Two Methods for Large-Scale Maximum Likelihood Phylogeny Estimation	PLOS ONE			English	Article							ALGORITHM; TREES	Statistical methods for phylogeny estimation, especially maximum likelihood (ML), offer high accuracy with excellent theoretical properties. However, RAxML, the current leading method for large-scale ML estimation, can require weeks or longer when used on datasets with thousands of molecular sequences. Faster methods for ML estimation, among them FastTree, have also been developed, but their relative performance to RAxML is not yet fully understood. In this study, we explore the performance with respect to ML score, running time, and topological accuracy, of FastTree and RAxML on thousands of alignments (based on both simulated and biological nucleotide datasets) with up to 27,634 sequences. We find that when RAxML and FastTree are constrained to the same running time, FastTree produces topologically much more accurate trees in almost all cases. We also find that when RAxML is allowed to run to completion, it provides an advantage over FastTree in terms of the ML score, but does not produce substantially more accurate tree topologies. Interestingly, the relative accuracy of trees computed using FastTree and RAxML depends in part on the accuracy of the sequence alignment and dataset size, so that FastTree can be more accurate than RAxML on large datasets with relatively inaccurate alignments. Finally, the running times of RAxML and FastTree are dramatically different, so that when run to completion, RAxML can take several orders of magnitude longer than FastTree to complete. Thus, our study shows that very large phylogenies can be estimated very quickly using FastTree, with little (and in some cases no) degradation in tree accuracy, as compared to RAxML.	[Liu, Kevin; Warnow, Tandy] Univ Texas Austin, Dept Comp Sci, Austin, TX 78712 USA; [Linder, C. Randal] Univ Texas Austin, Sect Integrat Biol, Sch Biol Sci, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Liu, K (corresponding author), Univ Texas Austin, Dept Comp Sci, Austin, TX 78712 USA.	tandy@cs.utexas.edu			Guggenheim Foundation; National Science Foundation NSF [DEB 0733029]	Guggenheim Foundation; National Science Foundation NSF(National Science Foundation (NSF))	This research was funded by the Guggenheim Foundation Fellowship to TW, and the National Science Foundation NSF DEB 0733029. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cannone J. J, 2002, BMC BIOINF, V3; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Katoh K, 2007, BIOINFORMATICS, V23, P372, DOI 10.1093/bioinformatics/btl592; Litzkow M. J., 1987, Proceedings of the Summer 1987 USENIX Conference, P381; LIU K, SYST BIOL; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Liu K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013057; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stoye J, 1998, BIOINFORMATICS, V14, P157, DOI 10.1093/bioinformatics/14.2.157; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; *TREEBASE, DAT PHYL KNOWL; Zwickl DJ., 2006, THESIS	19	123	139	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2011	6	11							e27731	10.1371/journal.pone.0027731	http://dx.doi.org/10.1371/journal.pone.0027731			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IO	22132132	Green Published, gold, Green Submitted			2022-12-27	WOS:000297789900017
J	Logsdon, NJ; Eberhardt, MK; Allen, CE; Barry, PA; Walter, MR				Logsdon, Naomi J.; Eberhardt, Meghan K.; Allen, Christopher E.; Barry, Peter A.; Walter, Mark R.			Design and Analysis of Rhesus Cytomegalovirus IL-10 Mutants as a Model for Novel Vaccines against Human Cytomegalovirus	PLOS ONE			English	Article							CHRONIC VIRAL-INFECTION; CRYSTAL-STRUCTURE; INTERLEUKIN-10 RECEPTOR; ENCODED INTERLEUKIN-10; INTERFERON-GAMMA; SOLUBLE IL-10R1; DENDRITIC CELLS; SALIVARY-GLANDS; T-CELLS; VIRUS	Background: Human cytomegalovirus (HCMV) expresses a viral ortholog (CMVIL-10) of human cellular interleukin-10 (cIL-10). Despite only similar to 26% amino acid sequence identity, CMVIL-10 exhibits comparable immunosuppressive activity with cIL-10, attenuates HCMV antiviral immune responses, and contributes to lifelong persistence within infected hosts. The low sequence identity between CMVIL-10 and cIL-10 suggests vaccination with CMVIL-10 may generate antibodies that specifically neutralize CMVIL-10 biological activity, but not the cellular cytokine, cIL-10. However, immunization with functional CMVIL-10 might be detrimental to the host because of its immunosuppressive properties. Methods and Findings: Structural biology was used to engineer biologically inactive mutants of CMVIL-10 that would, upon vaccination, elicit a potent immune response to the wild-type viral cytokine. To test the designed proteins, the mutations were incorporated into the rhesus cytomegalovirus (RhCMV) ortholog of CMVIL-10 (RhCMVIL-10) and used to vaccinate RhCMV-infected rhesus macaques. Immunization with the inactive RhCMVIL-10 mutants stimulated antibodies against wildtype RhCMVIL-10 that neutralized its biological activity, but did not cross-react with rhesus cellular IL-10. Conclusion: This study demonstrates an immunization strategy to neutralize RhCMVIL-10 biological activity using nonfunctional RhCMVIL-10 antigens. The results provide the methodology for targeting CMVIL-10 in vaccine, and therapeutic strategies, to nullify HCMV's ability to (1) skew innate and adaptive immunity, (2) disseminate from the site of primary mucosal infection, and (3) establish a lifelong persistent infection.	[Logsdon, Naomi J.; Allen, Christopher E.; Walter, Mark R.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Eberhardt, Meghan K.; Barry, Peter A.] Univ Calif Davis, Ctr Comparat Med, Davis, CA 95616 USA	University of Alabama System; University of Alabama Birmingham; University of California System; University of California Davis	Logsdon, NJ (corresponding author), Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA.	walter@uab.edu			National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIH) [R01 AI49342, RO1 AI047300]; National Center for Research Resources (NIH) [RR00169]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000169] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047300, R01AI049342] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Center for Research Resources (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants R01 AI49342 (to PAB) and RO1 AI047300 (to MRW) from the National Institute of Allergy and Infectious Diseases (www.niaid.nih.gov) of the National Institutes of Health (NIH), and by a grant RR00169 from the National Center for Research Resources (NIH) to the California National Primate Research Center (www.cnprc.ucdavis.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel K, 2008, VACCINE, V26, P6013, DOI 10.1016/j.vaccine.2008.07.103; ALTER G, J CLIN INVEST, V120, P1905; Barboza L, 2009, CELL IMMUNOL, V257, P61, DOI 10.1016/j.cellimm.2009.02.008; Biswas PS, 2007, J IMMUNOL, V179, P4520, DOI 10.4049/jimmunol.179.7.4520; BOLPETTI A, BMC IMMUNOL, V11, P27; Brooks DG, 2006, NAT MED, V12, P1301, DOI 10.1038/nm1492; BUENO LL, PLOS ONE, V5, pE9623; Campbell AE, 2008, MED MICROBIOL IMMUN, V197, P205, DOI 10.1007/s00430-008-0077-2; Chang WLW, 2007, J IMMUNOL, V178, P7794, DOI 10.4049/jimmunol.178.12.7794; Chang WL, P NATL ACAD SCI US, V107, P22647; Chang WLW, 2004, J VIROL, V78, P8720, DOI 10.1128/JVI.78.16.8720-8731.2004; Crough T, 2009, CLIN MICROBIOL REV, V22, P76, DOI 10.1128/CMR.00034-08; Cui XH, 2008, VACCINE, V26, P5760, DOI 10.1016/j.vaccine.2008.07.092; CUNNINGHAM C, J GEN VIROL, V91, P605; De La Barrera S, 2004, CLIN EXP IMMUNOL, V138, P128, DOI 10.1111/j.1365-2249.2004.02577.x; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Ejrnaes M, 2007, AUTOIMMUN REV, V6, P267, DOI 10.1016/j.autrev.2006.09.002; Ejrnaes M, 2006, J EXP MED, V203, P2461, DOI 10.1084/jem.20061462; Garrigue I, 2007, J CLIN VIROL, V40, P120, DOI 10.1016/j.jcv.2007.06.015; GRIFFITHS PD, LANCET, V377, P1256; HANSHAW JB, 1971, J INFECT DIS, V123, P555, DOI 10.1093/infdis/123.5.555; Humphreys IR, 2007, J EXP MED, V204, P1217, DOI 10.1084/jem.20062424; Jones BC, 2002, P NATL ACAD SCI USA, V99, P9404, DOI 10.1073/pnas.152147499; JONES M, J IMMUNOL, V185, P3583; Jones M, 2010, J IMMUNOL, V185, P3583, DOI 10.4049/jimmunol.1001535; Josephson K, 2002, STRUCTURE, V10, P981, DOI 10.1016/S0969-2126(02)00791-8; Josephson K, 2001, IMMUNITY, V15, P35, DOI 10.1016/S1074-7613(01)00169-8; Josephson K, 2001, ACTA CRYSTALLOGR D, V57, P1908, DOI 10.1107/S0907444901016249; Kaplan DE, 2008, J HEPATOL, V48, P903, DOI 10.1016/j.jhep.2008.01.030; Kedhar Sanjay R, 2007, Herpes, V14, P66; Kotenko SV, 2000, P NATL ACAD SCI USA, V97, P1695, DOI 10.1073/pnas.97.4.1695; LI J, IMMUNOL CELL BIOL, V88, P834; Liu Y, 1997, J IMMUNOL, V158, P604; Lockridge KM, 2000, VIROLOGY, V268, P272, DOI 10.1006/viro.2000.0195; Loomis-Huff JE, 2001, VACCINE, V19, P4865, DOI 10.1016/S0264-410X(01)00232-8; Macagno A, 2010, J VIROL, V84, P1005, DOI 10.1128/JVI.01809-09; MARKS E, PLOS PATHOG, V6; Mocarski ES, 2002, TRENDS MICROBIOL, V10, P332, DOI 10.1016/S0966-842X(02)02393-4; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; MOREIRA AP, CELL IMMUNOL, V263, P196; Pass RF, 2009, NEW ENGL J MED, V360, P1191, DOI 10.1056/NEJMoa0804749; Perez AB, 2004, J MED VIROL, V73, P230, DOI 10.1002/jmv.20080; Peters N, 2006, IMMUNOL REV, V213, P159, DOI 10.1111/j.1600-065X.2006.00432.x; Plotkin SA, 1999, AM HEART J, V138, pS484, DOI 10.1016/S0002-8703(99)70281-4; Redpath S, 1999, J IMMUNOL, V162, P6701; ROSS SA, J INFECT DIS, V201, P386; SILVERMAN JM, J IMMUNOL, V185, P5011; SONG W, AIDS RES HUM RETROVI, V27, P639; Spencer JV, 2002, J VIROL, V76, P1285, DOI 10.1128/JVI.76.3.1285-1292.2002; Staras SAS, 2006, CLIN INFECT DIS, V43, P1143, DOI 10.1086/508173; Sylwester AW, 2005, J EXP MED, V202, P673, DOI 10.1084/jem.20050882; UBOL S, J INFECT DIS, V201, P923; WALTER MR, 1995, BIOCHEMISTRY-US, V34, P12118, DOI 10.1021/bi00038a004; WELLER TH, 1971, NEW ENGL J MED, V285, P203, DOI 10.1056/NEJM197107222850406; WILSON EB, CURR TOP MICROBIOL I, V350, P39; WINDSOR WT, 1993, BIOCHEMISTRY-US, V32, P8807, DOI 10.1021/bi00085a011; Yamamoto-Tabata T, 2004, J VIROL, V78, P2831, DOI 10.1128/JVI.78.6.2831-2840.2004; Yoon SI, 2005, STRUCTURE, V13, P551, DOI 10.1016/j.str.2005.01.016; YOON SI, STRUCTURE, V18, P638; Yoon SI, 2006, J BIOL CHEM, V281, P35088, DOI 10.1074/jbc.M606791200; YOW MD, 1989, J INFECT DIS, V159, P163, DOI 10.1093/infdis/159.2.163; Yue YJ, 2003, J GEN VIROL, V84, P3371, DOI 10.1099/vir.0.19508-0; Yue YJ, 2008, ADV VIRUS RES, V72, P207, DOI 10.1016/S0065-3527(08)00405-3; ZDANOV A, 1995, STRUCTURE, V3, P591, DOI 10.1016/S0969-2126(01)00193-9	64	18	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2011	6	11							e28127	10.1371/journal.pone.0028127	http://dx.doi.org/10.1371/journal.pone.0028127			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IO	22132227	Green Published, Green Submitted, gold			2022-12-27	WOS:000297789900049
J	Koscianska, E; Starega-Roslan, J; Krzyzosiak, WJ				Koscianska, Edyta; Starega-Roslan, Julia; Krzyzosiak, Wlodzimierz J.			The Role of Dicer Protein Partners in the Processing of MicroRNA Precursors	PLOS ONE			English	Article							POSTTRANSCRIPTIONAL REGULATION; PASSENGER-STRAND; NUCLEAR EXPORT; RNA; EXPRESSION; TRBP; BIOGENESIS; MIRNAS; SIRNA; PACT	One of the cellular functions of the ribonuclease Dicer is to process microRNA precursors (pre-miRNAs) into mature microRNAs (miRNAs). Human Dicer performs this function in cooperation with its protein partners, AGO2, PACT and TRBP. The exact role of these accessory proteins in Dicer activity is still poorly understood. In this study, we used the northern blotting technique to investigate pre-miRNA cleavage efficiency and specificity after depletion of AGO2, PACT and TRBP by RNAi. The results showed that the inhibition of either Dicer protein partner substantially affected not only miRNA levels but also pre-miRNA levels, and it had a rather minor effect on the specificity of Dicer cleavage. The analysis of the Dicer cleavage products generated in vitro revealed the presence of a cleavage intermediate when pre-miRNA was processed by recombinant Dicer alone. This intermediate was not observed during pre-miRNA cleavage by endogenous Dicer. We demonstrate that AGO2, PACT and TRBP were required for the efficient functioning of Dicer in cells, and we suggest that one of the roles of these proteins is to assure better synchronization of cleavages triggered by two RNase III domains of Dicer.	[Koscianska, Edyta; Starega-Roslan, Julia; Krzyzosiak, Wlodzimierz J.] Polish Acad Sci, Inst Bioorgan Chem, Canc Genet Lab, Poznan, Poland	Polish Academy of Sciences; Institute of Bioorganic Chemistry of the Polish Academy of Sciences	Koscianska, E (corresponding author), Polish Acad Sci, Inst Bioorgan Chem, Canc Genet Lab, Poznan, Poland.	wlodkrzy@ibch.poznan.pl		Koscianska, Edyta/0000-0002-1665-2500	European Regional Development Fund within the Innovative Economy Programme [POIG.01.03.01-30-098/08]; Polish Ministry of Science and Higher Education [N N301 523038]	European Regional Development Fund within the Innovative Economy Programme; Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work was supported by the European Regional Development Fund within the Innovative Economy Programme (POIG.01.03.01-30-098/08) and by the Polish Ministry of Science and Higher Education (N N301 523038). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheloufi S, 2010, NATURE, V465, P584, DOI 10.1038/nature09092; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Diederichs S, 2007, CELL, V131, P1097, DOI 10.1016/j.cell.2007.10.032; Flores-Jasso CF, 2009, ACTA PHARMACOL SIN, V30, P1177, DOI 10.1038/aps.2009.108; Fiszer A, 2011, NUCLEIC ACIDS RES, V39, P5578, DOI 10.1093/nar/gkr156; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Haase AD, 2005, EMBO REP, V6, P961, DOI 10.1038/sj.embor.7400509; Kok KH, 2007, J BIOL CHEM, V282, P17649, DOI 10.1074/jbc.M611768200; Koscianska E, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-14; Koscianska E, 2011, THESCIENTIFICWORLDJO, V11, P102, DOI 10.1100/tsw.2011.11; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Landthaler M, 2004, CURR BIOL, V14, P2162, DOI 10.1016/j.cub.2004.11.001; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2006, EMBO J, V25, P522, DOI 10.1038/sj.emboj.7600942; Leuschner PJF, 2007, METHODS, V43, P105, DOI 10.1016/j.ymeth.2007.04.005; Lund E, 2006, COLD SPRING HARB SYM, V71, P59, DOI 10.1101/sqb.2006.71.050; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; MacRae IJ, 2008, P NATL ACAD SCI USA, V105, P512, DOI 10.1073/pnas.0710869105; MacRae IJ, 2007, CURR OPIN STRUC BIOL, V17, P138, DOI 10.1016/j.sbi.2006.12.002; Maniataki E, 2005, GENE DEV, V19, P2979, DOI 10.1101/gad.1384005; Matranga C, 2005, CELL, V123, P607, DOI 10.1016/j.cell.2005.08.044; Melo SA, 2009, NAT GENET, V41, P365, DOI 10.1038/ng.317; Nelson PT, 2007, RNA, V13, P1787, DOI 10.1261/rna.646007; O'Carroll D, 2007, GENE DEV, V21, P1999, DOI 10.1101/gad.1565607; Obernosterer G, 2006, RNA, V12, P1161, DOI 10.1261/rna.2322506; Park JE, 2011, NATURE, V475, P201, DOI 10.1038/nature10198; Rivas FV, 2005, NAT STRUCT MOL BIOL, V12, P340, DOI 10.1038/nsmb918; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Sakurai K, 2011, NUCLEIC ACIDS RES, V39, P1510, DOI 10.1093/nar/gkq846; Shin YW, 2006, ARCH PHARM RES, V29, P685, DOI 10.1007/BF02968253; Starega-Roslan J, 2011, CELL MOL LIFE SCI, V68, P2859, DOI 10.1007/s00018-011-0726-2; Starega-Roslan J, 2011, NUCLEIC ACIDS RES, V39, P257, DOI 10.1093/nar/gkq727; Tahbaz N, 2004, EMBO REP, V5, P189, DOI 10.1038/sj.embor.7400070; Tan GS, 2009, NUCLEIC ACIDS RES, V37, P7533, DOI 10.1093/nar/gkp812; Vermeulen A, 2005, RNA, V11, P674, DOI 10.1261/rna.7272305; Wang BB, 2009, NAT STRUCT MOL BIOL, V16, P1259, DOI 10.1038/nsmb.1712; Yi R, 2006, NAT GENET, V38, P356, DOI 10.1038/ng1744; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Zhang HD, 2004, CELL, V118, P57, DOI 10.1016/j.cell.2004.06.017	40	87	93	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2011	6	12							e28548	10.1371/journal.pone.0028548	http://dx.doi.org/10.1371/journal.pone.0028548			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863OC	22163034	Green Published, Green Submitted, gold			2022-12-27	WOS:000298173500033
J	Helbing, CC; Wagner, MJ; Pettem, K; Johnston, J; Heimeier, RA; Veldhoen, N; Jirik, FR; Shi, YB; Browder, LW				Helbing, Caren C.; Wagner, Mary J.; Pettem, Katherine; Johnston, Jill; Heimeier, Rachel A.; Veldhoen, Nik; Jirik, Frank R.; Shi, Yun-Bo; Browder, Leon W.			Modulation of Thyroid Hormone-Dependent Gene Expression in Xenopus laevis by INhibitor of Growth (ING) Proteins	PLOS ONE			English	Article							PHD FINGER; BREAST-CANCER; PLANT HOMEODOMAIN; TUMOR-SUPPRESSOR; AXIS DISRUPTION; HISTONE H3; METAMORPHOSIS; RECEPTOR; FAMILY; CHROMATIN	Background: INhibitor of Growth (ING) proteins belong to a large family of plant homeodomain finger-containing proteins important in epigenetic regulation and carcinogenesis. We have previously shown that ING1 and ING2 expression is regulated by thyroid hormone (TH) during metamorphosis of the Xenopus laevis tadpole. The present study investigates the possibility that ING proteins modulate TH action. Methodology/Principal Findings: Tadpoles expressing a Xenopus ING2 transgene (Trans(ING2)) were significantly smaller than tadpoles not expressing the transgene (Trans(GFP)). When exposed to 10 nM 3,5,3'-triiodothyronine (T(3)), premetamorphic Trans(ING2) tadpoles exhibited a greater reduction in tail, head, and brain areas, and a protrusion of the lower jaw than T(3)-treated Trans(GFP) tadpoles. Quantitative real time polymerase chain reaction (QPCR) demonstrated elevated TH receptor beta (TR beta) and TH/bZIP transcript levels in Trans(ING2) tadpole tails compared to Trans(GFP) tadpoles while TR alpha mRNAs were unaffected. In contrast, no difference in TR alpha, TR beta or insulin-like growth factor (IGF2) mRNA abundance was observed in the brain between Trans(ING2) and Trans(GFP) tadpoles. All of these transcripts, except for TR alpha mRNA in the brain, were inducible by the hormone in both tissues. Oocyte transcription assays indicated that ING proteins enhanced TR-dependent, T(3)-induced TR beta gene promoter activity. Examination of endogenous T(3)-responsive promoters (TR beta and TH/bZIP) in the tail by chromatin immunoprecipitation assays showed that ING proteins were recruited to TRE-containing regions in T(3)-dependent and independent ways, respectively. Moreover, ING and TR proteins coimmunoprecipitated from tail protein homogenates derived from metamorphic climax animals. Conclusions/Significance: We show for the first time that ING proteins modulate TH-dependent responses, thus revealing a novel role for ING proteins in hormone signaling. This has important implications for understanding hormone influenced disease states and suggests that the induction of ING proteins may facilitate TR function during metamorphosis in a tissue-specific manner.	[Helbing, Caren C.; Wagner, Mary J.; Pettem, Katherine; Veldhoen, Nik] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC, Canada; [Johnston, Jill; Jirik, Frank R.; Browder, Leon W.] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada; [Heimeier, Rachel A.; Shi, Yun-Bo] NICHHD, Sect Mol Morphogenesis, Lab Gene Regulat & Dev, Program Cell Regulat & Metab,NIH, Bethesda, MD 20892 USA; [Jirik, Frank R.] Univ Calgary, McCaig Inst Bone & Joint Hlth, Calgary, AB, Canada	University of Victoria; University of Calgary; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Calgary	Helbing, CC (corresponding author), Univ Victoria, Dept Biochem & Microbiol, Victoria, BC, Canada.	chelbing@uvic.ca		Helbing, Caren/0000-0002-8861-1070; Shi, Yun-Bo/0000-0002-6330-0639	Natural Sciences and Engineering Research Council (NSERC); National Institute of Child Health and Human Development, NIH; NSERC-PGSM; Michael Smith Foundation for Health Research (MSFHR); PGSD; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001901] Funding Source: NIH RePORTER	Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Institute of Child Health and Human Development, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NSERC-PGSM(Natural Sciences and Engineering Research Council of Canada (NSERC)); Michael Smith Foundation for Health Research (MSFHR)(Michael Smith Foundation for Health Research); PGSD; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was funded by Natural Sciences and Engineering Research Council (NSERC) Discovery grants to CCH and LWB, and also in part by the Intramural Research Program of the National Institute of Child Health and Human Development, NIH (YBS). MJW was recipient of NSERC-PGSM and PGSD scholarships and a Michael Smith Foundation for Health Research (MSFHR) trainee award. CCH is a past MSFHR scholar and recipient of a NSERC University Faculty Award; and FRJ held a Canada Tier I Research Chair Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALMOUZNI G, 1990, NUCLEIC ACIDS RES, V18, P5767, DOI 10.1093/nar/18.19.5767; Amaya E, 1999, METH MOL B, V97, P393, DOI 10.1385/1-59259-270-8:393; Bartke T, 2010, CELL, V143, P470, DOI 10.1016/j.cell.2010.10.012; Bienz M, 2006, TRENDS BIOCHEM SCI, V31, P35, DOI 10.1016/j.tibs.2005.11.001; Bilesimo P, 2011, MOL ENDOCRINOL, V25, P225, DOI 10.1210/me.2010-0269; Boland D, 2000, HYBRIDOMA, V19, P161, DOI 10.1089/02724570050031202; Bua DJ, 2009, CURR DRUG TARGETS, V10, P418, DOI 10.2174/138945009788185112; Buchholz DR, 2005, J BIOL CHEM, V280, P41222, DOI 10.1074/jbc.M509593200; Champagne KS, 2009, CURR DRUG TARGETS, V10, P432, DOI 10.2174/138945009788185040; Cordera F, 2006, SEMIN ONCOL, V33, P631, DOI 10.1053/j.seminoncol.2006.08.020; Das B, 2006, DEV BIOL, V291, P342, DOI 10.1016/j.ydbio.2005.12.032; ELICEIRI BP, 1994, J BIOL CHEM, V269, P24459; Ellerhorst JA, 2003, ONCOL REP, V10, P1317; Garske AL, 2010, NAT CHEM BIOL, V6, P283, DOI [10.1038/NCHEMBIO.319, 10.1038/nchembio.319]; Gonzalez-Sancho JM, 2003, CANCER LETT, V192, P121, DOI 10.1016/S0304-3835(02)00614-6; Gunduz M, 2009, CURR DRUG TARGETS, V10, P465, DOI 10.2174/138945009788185086; Havis E, 2003, EMBO REP, V4, P883, DOI 10.1038/sj.embor.embor908; He GHY, 2005, MOL BIOL EVOL, V22, P104, DOI 10.1093/molbev/msh256; Helbing CC, 2007, AQUAT TOXICOL, V82, P227, DOI 10.1016/j.aquatox.2007.02.013; Helbing CC, 2007, AQUAT TOXICOL, V82, P215, DOI 10.1016/j.aquatox.2007.02.014; Helbing CC, 1997, CANCER RES, V57, P1255; Kataoka H, 2003, CANCER RES, V63, P5785; Kichina JV, 2006, ONCOGENE, V25, P857, DOI 10.1038/sj.onc.1209118; LELOUP J, 1977, CR ACAD SCI D NAT, V284, P2261; Maher Stacey K, 2009, Curr Drug Targets, V10, P392; Martin DGE, 2006, MOL CELL BIOL, V26, P7871, DOI 10.1128/MCB.00573-06; Menendez C, 2009, CURR DRUG TARGETS, V10, P406, DOI 10.2174/138945009788185077; Nieuwkoop PD., 1956, DEVELOPMENT, DOI [DOI 10.1242/DEV.200356, 10.1242/dev.200356]; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; Pena PV, 2009, MAGN RESON CHEM, V47, P352, DOI 10.1002/mrc.2390; Rotondi M, J CLIN ENDOCRINOL ME, V96, P344; Russo J, 2006, J STEROID BIOCHEM, V102, P89, DOI 10.1016/j.jsbmb.2006.09.004; Saksouk N, 2009, MOL CELL, V33, P257, DOI 10.1016/j.molcel.2009.01.007; Shah S, 2009, CURR DRUG TARGETS, V10, P385, DOI 10.2174/138945009788185103; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Shi Y.B., 2000, AMPHIBIAN METAMORPHO; Soliman MA, 2007, TRENDS BIOCHEM SCI, V32, P509, DOI 10.1016/j.tibs.2007.08.006; Sparrow D B, 2000, Nucleic Acids Res, V28, pE12, DOI 10.1093/nar/28.4.e12; Tomita A, 2004, MOL CELL BIOL, V24, P3337, DOI 10.1128/MCB.24.8.3337-3346.2004; Toyama T, 2003, J STEROID BIOCHEM, V87, P57, DOI 10.1016/S0960-0760(03)00388-1; Turken O, 2003, BREAST CANCER RES, V5, pR110, DOI 10.1186/bcr609; Unoki M, 2009, CURR DRUG TARGETS, V10, P442, DOI 10.2174/138945009788185059; Unoki M, 2009, CANCER SCI, V100, P1173, DOI 10.1111/j.1349-7006.2009.01183.x; Veldhoen N, 2002, DEV DYNAM, V225, P457, DOI 10.1002/dvdy.10175; Wagner MJ, 2008, BBA-GENE REGUL MECH, V1779, P152, DOI 10.1016/j.bbagrm.2007.12.002; Wagner MJ, 2005, GEN COMP ENDOCR, V144, P38, DOI 10.1016/j.ygcen.2005.04.008; Wagner MJ, 2001, J BIOL CHEM, V276, P47013, DOI 10.1074/jbc.M106965200; Walzak AA, 2008, EXP CELL RES, V314, P273, DOI 10.1016/j.yexcr.2007.07.029; Wang GG, 2009, NATURE, V459, P847, DOI 10.1038/nature08036; WONG JM, 1995, J BIOL CHEM, V270, P18479, DOI 10.1074/jbc.270.31.18479; WONG JM, 1995, GENE DEV, V9, P2696, DOI 10.1101/gad.9.21.2696; Yen PM, 2006, MOL CELL ENDOCRINOL, V246, P121, DOI 10.1016/j.mce.2005.11.030	52	4	4	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e28658	10.1371/journal.pone.0028658	http://dx.doi.org/10.1371/journal.pone.0028658			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22163049	Green Published, Green Submitted, gold			2022-12-27	WOS:000298172800054
J	Kerzel, D; Schonhammer, J; Burra, N; Born, S; Souto, D				Kerzel, Dirk; Schoenhammer, Josef; Burra, Nicolas; Born, Sabine; Souto, David			Saliency Changes Appearance	PLOS ONE			English	Article							VISUAL-SEARCH; ELECTROPHYSIOLOGICAL EVIDENCE; ATTENTIONAL CAPTURE; TOP-DOWN; COLOR; CONTRAST; TARGET; MAP; DIMENSIONS; CONTINGENT	Numerous studies have suggested that the deployment of attention is linked to saliency. In contrast, very little is known about how salient objects are perceived. To probe the perception of salient elements, observers compared two horizontally aligned stimuli in an array of eight elements. One of them was salient because of its orientation or direction of motion. We observed that the perceived luminance contrast or color saturation of the salient element increased: the salient stimulus looked even more salient. We explored the possibility that changes in appearance were caused by attention. We chose an event-related potential indexing attentional selection, the N2pc, to answer this question. The absence of an N2pc to the salient object provides preliminary evidence against involuntary attentional capture by the salient element. We suggest that signals from a master saliency map flow back into individual feature maps. These signals boost the perceived feature contrast of salient objects, even on perceptual dimensions different from the one that initially defined saliency.	[Kerzel, Dirk; Schoenhammer, Josef; Burra, Nicolas; Born, Sabine; Souto, David] Univ Geneva, Fac Psychol & Sci Educ, Psychol Sect, Geneva, Switzerland	University of Geneva	Kerzel, D (corresponding author), Univ Geneva, Fac Psychol & Sci Educ, Psychol Sect, Geneva, Switzerland.	dirk.kerzel@unige.ch	Souto, David/D-2014-2012	Souto, David/0000-0002-2423-9468; Born, Sabine/0000-0002-2017-2147	Swiss National Foundation [PDFM1-129459, 100014-135374]	Swiss National Foundation(Swiss National Science Foundation (SNSF))	Funding was provided by the Swiss National Foundation PDFM1-129459 and 100014-135374 (www.snf.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carrasco M, 2004, NAT NEUROSCI, V7, P308, DOI 10.1038/nn1194; DEVALOIS RL, 1991, VISION RES, V31, P1619, DOI 10.1016/0042-6989(91)90138-U; Donk M, 2008, PSYCHOL SCI, V19, P733, DOI 10.1111/j.1467-9280.2008.02149.x; Eimer M, 1996, ELECTROEN CLIN NEURO, V99, P225, DOI 10.1016/0013-4694(96)95711-9; Eimer M, 2008, J COGNITIVE NEUROSCI, V20, P1423, DOI 10.1162/jocn.2008.20099; Eimer M, 2010, ACTA PSYCHOL, V135, P100, DOI 10.1016/j.actpsy.2010.04.010; Engmann S, 2009, ATTEN PERCEPT PSYCHO, V71, P1337, DOI 10.3758/APP.71.6.1337; Fecteau JH, 2006, TRENDS COGN SCI, V10, P382, DOI 10.1016/j.tics.2006.06.011; FOLK CL, 1992, J EXP PSYCHOL HUMAN, V18, P1030, DOI 10.1037/0096-1523.18.4.1030; Fuller S, 2006, VISION RES, V46, P4032, DOI 10.1016/j.visres.2006.07.014; Gegenfurtner KR, 1997, J NEUROPHYSIOL, V77, P1906, DOI 10.1152/jn.1997.77.4.1906; Gegenfurtner KR, 1996, VISUAL NEUROSCI, V13, P161, DOI 10.1017/S0952523800007203; Hickey C, 2006, J COGNITIVE NEUROSCI, V18, P604, DOI 10.1162/jocn.2006.18.4.604; Hickey C, 2009, J COGNITIVE NEUROSCI, V21, P760, DOI 10.1162/jocn.2009.21039; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; KAPADIA MK, 1995, NEURON, V15, P843, DOI 10.1016/0896-6273(95)90175-2; Kastner S, 1999, VISUAL NEUROSCI, V16, P587, DOI 10.1017/S095252389916317X; KOCH C, 1985, HUM NEUROBIOL, V4, P219; Koene AR, 2007, J VISION, V7, DOI 10.1167/7.7.6; Krummenacher J, 2002, J EXP PSYCHOL HUMAN, V28, P1303, DOI 10.1037//0096-1523.28.6.1303; Lamme VAF, 1998, CURR OPIN NEUROBIOL, V8, P529, DOI 10.1016/S0959-4388(98)80042-1; Li ZP, 2002, TRENDS COGN SCI, V6, P9, DOI 10.1016/S1364-6613(00)01817-9; Lien MC, 2008, J EXP PSYCHOL HUMAN, V34, P509, DOI 10.1037/0096-1523.34.3.509; LIVINGSTONE MS, 1984, J NEUROSCI, V4, P309; LUCK SJ, 1994, J EXP PSYCHOL HUMAN, V20, P1000, DOI 10.1037/0096-1523.20.5.1000; Muller HJ, 2003, J EXP PSYCHOL HUMAN, V29, P1021, DOI 10.1037/0096-1523.29.5.1021; Nothdurft HC, 2000, VISION RES, V40, P1183, DOI 10.1016/S0042-6989(00)00031-6; Poirier FJAM, 2008, J VISION, V8, DOI 10.1167/8.15.14; Reynolds JH, 2004, ANNU REV NEUROSCI, V27, P611, DOI 10.1146/annurev.neuro.26.041002.131039; Sawaki R, 2010, ATTEN PERCEPT PSYCHO, V72, P1455, DOI 10.3758/APP.72.6.1455; Schade U, 2011, VISION RES, V51, P1, DOI 10.1016/j.visres.2010.09.010; Soltani A, 2010, J NEUROSCI, V30, P12831, DOI 10.1523/JNEUROSCI.1517-10.2010; Tatler BW, 2011, J VISION, V11, DOI 10.1167/11.5.5; THEEUWES J, 1991, PERCEPT PSYCHOPHYS, V50, P184, DOI 10.3758/BF03212219; Theeuwes J, 2010, ACTA PSYCHOL, V135, P77, DOI 10.1016/j.actpsy.2010.02.006; Tollner T, 2011, CEREB CORTEX; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; TSO DY, 1988, J NEUROSCI, V8, P1712; TSOTSOS JK, 1995, ARTIF INTELL, V78, P507, DOI 10.1016/0004-3702(95)00025-9; Turatto M, 2004, EXP BRAIN RES, V158, P141, DOI 10.1007/s00221-004-1884-3; WOLFE JM, 1994, PSYCHON B REV, V1, P202, DOI 10.3758/BF03200774; Wykowska A, 2010, J COGNITIVE NEUROSCI, V22, P640, DOI 10.1162/jocn.2009.21222	42	8	8	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e28292	10.1371/journal.pone.0028292	http://dx.doi.org/10.1371/journal.pone.0028292			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	863NX	22162760	Green Published, gold, Green Submitted			2022-12-27	WOS:000298172800022
J	Yang, CY; Zhang, L; Wang, LL; Zhang, HA; Qiu, LM; Siva, VS; Song, LS				Yang, Chuanyan; Zhang, Lei; Wang, Lingling; Zhang, Huan; Qiu, Limei; Siva, Vinu S.; Song, Linsheng			The Gln32Lys Polymorphism in HSP22 of Zhikong Scallop Chlamys farreri Is Associated with Heat Tolerance	PLOS ONE			English	Article							CHAPERONE-LIKE ACTIVITY; SHOCK-PROTEIN HSP22; DROSOPHILA-MELANOGASTER; HEAT-SHOCK-PROTEIN-90 GENE; ARGOPECTEN-IRRADIANS; MOLECULAR CHAPERONES; TERMINAL DOMAIN; STRESS-RESPONSE; EXPRESSION; CELLS	Background: Heat shock protein 22 is a member of small heat shock proteins with molecular chaperone activity. Though their multiple functions have been well characterized, there is no report about the association between the polymorphisms of HSP22 and heat tolerance. Methodology: Three single nucleotide polymorphisms were identified in HSP22 from scallop Chlamys farreri (CfHSP22), and the +94 C-A locus was found to be nonsynonymous. Three genotypes at locus +94, A/A, A/C and C/C, were revealed by using Bi-PASA PCR analysis, and their frequencies were 19.5%, 27.6% and 52.9% in the heat resistant stock, while 9.3%, 17.4% and 73.3% in the heat susceptible stock, respectively. The frequency differences of the three genotypes were significant (P<0.05) between the two stocks. After incubating at 30 degrees C for 84 h, the cumulative mortality of scallops with +94 C/C genotype and +94 A/C genotypes was 95% and 90%, respectively, which was significantly higher (P<0.01) than that of scallops with +94 A/A genotype (70%). The molecular chaperone activity of two His-tagged fusion proteins, rCfHSP22Q with +94 C/C genotype and rCfHSP22K with +94 A/A genotype were analyzed by testing the ability of protecting citrate synthase (CS) against thermal inactivation in vitro. After incubated with rCfHSP22Q or rCfHSP22K at 38 degrees C for 1 h, the activity of CS lost 50% and 45%, and then recovered to 89% and 95% of the original activity following 1 h restoration at 22 degrees C, respectively, indicating that the mutation from Gln to Lys at this site might have an impact on molecular chaperone activities of CfHSP22. Conclusions: These results implied that the polymorphism at locus +94 of CfHSP22 was associated with heat tolerance of scallop, and the +94 A/A genotype could be a potential marker available in future selection of Zhikong scallop with heat tolerance.	[Yang, Chuanyan; Zhang, Lei; Wang, Lingling; Zhang, Huan; Qiu, Limei; Siva, Vinu S.; Song, Linsheng] Chinese 7 Acad Sci, Key Lab Expt Marine Biol, Inst Oceanol, Qingdao, Peoples R China; [Yang, Chuanyan; Zhang, Lei; Siva, Vinu S.] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Yang, CY (corresponding author), Chinese 7 Acad Sci, Key Lab Expt Marine Biol, Inst Oceanol, Qingdao, Peoples R China.	wanglingling@ms.qdio.ac.cn; lshsong@ms.qdio.ac.cn	zhi, zhouzhi/J-8063-2013		National Basic Research Program of China [2010CB126404]; Chinese Academy of Sciences [KZCX2-EW-QN201]; National Science Foundation of China [30925028]	National Basic Research Program of China(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by National Basic Research Program of China (no. 2010CB126404), a grant from the Knowledge Innovation Program of the Chinese Academy of Sciences (No. KZCX2-EW-QN201 to HZ), and a grant (No. 30925028 to LS) from National Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AR, 2003, HEREDITY, V90, P195, DOI 10.1038/sj.hdy.6800220; Benndorf R, 2001, J BIOL CHEM, V276, P26753, DOI 10.1074/jbc.M103001200; Chowdary TK, 2004, BIOCHEM J, V381, P379, DOI 10.1042/BJ20031958; Dahlgaard J, 1998, FUNCT ECOL, V12, P786, DOI 10.1046/j.1365-2435.1998.00246.x; Depre C, 2006, CIRC RES, V98, P280, DOI 10.1161/01.RES.0000201284.45482.e8; Eifert C, 2005, BBA-PROTEINS PROTEOM, V1748, P146, DOI 10.1016/j.bbapap.2004.12.015; Elicker KS, 2007, GENE, V403, P60, DOI 10.1016/j.gene.2007.08.003; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Frydenberg J, 2010, CELL STRESS CHAPERON, V15, P271, DOI 10.1007/s12192-009-0140-y; Gallagher G, 2003, CYTOKINE HDB; Gao Q, 2008, FISH SHELLFISH IMMUN, V24, P379, DOI 10.1016/j.fsi.2007.08.008; Gao Q, 2007, COMP BIOCHEM PHYS B, V147, P704, DOI 10.1016/j.cbpb.2007.04.010; Gober MD, 2003, J BIOL CHEM, V278, P37600, DOI 10.1074/jbc.M303834200; Gottler LM, 2008, BIOCHEMISTRY-US, V47, P9243, DOI 10.1021/bi801045n; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Hong SW, 2003, PLANT PHYSIOL, V132, P757, DOI 10.1104/pp.102.017145; Irobi J, 2004, NAT GENET, V36, P597, DOI 10.1038/ng1328; Jackson TR, 1998, HEREDITY, V80, P143, DOI 10.1046/j.1365-2540.1998.00289.x; Jiao WW, 2005, J MOL BIOL, V347, P871, DOI 10.1016/j.jmb.2005.01.029; Jolly C, 1999, GENE EXPRESSION, V7, P261; Ju TZ, 2005, NATURE, V437, P1252, DOI 10.1038/4371252a; Kim MV, 2006, ARCH BIOCHEM BIOPHYS, V454, P32, DOI 10.1016/j.abb.2006.07.014; LANDRY J, 1989, J CELL BIOL, V109, P7, DOI 10.1083/jcb.109.1.7; Lee GJ, 1995, METHOD CELL BIOL, V50, P325, DOI 10.1016/S0091-679X(08)61040-7; Lee JH, 1996, MOL GEN GENET, V252, P11, DOI 10.1007/BF02173200; Li L, 2009, FISH SHELLFISH IMMUN, V27, P136, DOI 10.1016/j.fsi.2008.12.005; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Liu ZH, 2007, APPL MICROBIOL BIOT, V77, P901, DOI 10.1007/s00253-007-1226-z; Lund AA, 1998, PLANT PHYSIOL, V116, P1097, DOI 10.1104/pp.116.3.1097; Marcos-Carcavilla A, 2010, CELL STRESS CHAPERON, V15, P67, DOI 10.1007/s12192-009-0123-z; McColl G, 1996, GENETICS, V143, P1615; MERCK KB, 1993, MOL BIOL REP, V18, P209, DOI 10.1007/BF01674432; Morrow G, 2000, J BIOL CHEM, V275, P31204, DOI 10.1074/jbc.M002960200; Plater ML, 1996, J BIOL CHEM, V271, P28558, DOI 10.1074/jbc.271.45.28558; Salerno JC, 2003, PROTEIN ENG, V16, P847, DOI 10.1093/protein/gzg102; Shemetov AA, 2008, J NEUROSCI RES, V86, P264, DOI 10.1002/jnr.21441; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Singh R, 2006, CELL STRESS CHAPERON, V11, P208, DOI 10.1379/CSC-184R.1; Smith CC, 2000, J BIOL CHEM, V275, P25690, DOI 10.1074/jbc.M002140200; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Song LS, 2006, FISH SHELLFISH IMMUN, V21, P335, DOI 10.1016/j.fsi.2005.12.011; Stromer T, 2004, J BIOL CHEM, V279, P11222, DOI 10.1074/jbc.M310149200; Sun Y, 2005, FEBS J, V272, P2613, DOI 10.1111/j.1742-4658.2005.04708.x; Sung DY, 2003, PLANT PHYSIOL, V132, P979, DOI 10.1104/pp.102.019398; Tang BS, 2005, HUM GENET, V116, P222, DOI 10.1007/s00439-004-1218-3; Verschuure P, 2003, EUR J CELL BIOL, V82, P523, DOI 10.1078/0171-9335-00337; [吴龙涛 Wu Longtao], 2003, [高技术通讯, High Technology Letters], V13, P75; Yang H. S., 1999, CHINA MAR SCI, V1, P44; Zhang L, 2010, MOL BIOL REP, V37, P1763, DOI 10.1007/s11033-009-9603-6; Zhang L, 2010, AQUAC RES, V41, P257, DOI 10.1111/j.1365-2109.2009.02328.x	50	8	9	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e28564	10.1371/journal.pone.0028564	http://dx.doi.org/10.1371/journal.pone.0028564			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22162777	Green Submitted, gold, Green Published			2022-12-27	WOS:000298172800048
J	Poeppl, W; Herkner, H; Burgmann, H; Pustelnik, T; Mooseder, G; Popow-Kraupp, T; Redlberger-Fritz, M				Poeppl, Wolfgang; Herkner, Harald; Burgmann, Heinz; Pustelnik, Tom; Mooseder, Gerhard; Popow-Kraupp, Theresia; Redlberger-Fritz, Monika			Performance of the QuickVue Influenza A plus B Rapid Test for Pandemic H1N1 (2009) Virus Infection in Adults	PLOS ONE			English	Article							DIAGNOSTIC-TESTS; A/H1N1; SENSITIVITY; OUTBREAK	To investigate the diagnostic accuracy of the QuickVue (R) Influenza A+B rapid test we conducted a prospective observational study in which this rapid test was compared with a real-time reverse transcription polymerase chain reaction (RT-PCR) for pandemic influenza A H1N1 (2009) infection in Austrian adults. The sensitivity, specificity, and positive and negative predictive values of the QuickVue test compared with the RT-PCR were 26% (95% CI 18-35), 98% (95% CI 92-100), 94% (95% CI 80-99) and 50% (95% CI 42-58), respectively. The prevalence of pandemic H1N1 (2009) virus infection among the 209 patients included in the study was 57%. Our data suggest that a positive QuickVue test provides considerable information for the diagnosis of pandemic influenza A H1N1 (2009) virus infection in young adults but that a negative QuickVue test result should, if relevant for patient management or public health measures, be verified using PCR.	[Poeppl, Wolfgang; Burgmann, Heinz] Med Univ Vienna, Dept Infect Dis & Trop Med, Vienna, Austria; [Herkner, Harald] Med Univ Vienna, Dept Emergency Med, Vienna, Austria; [Poeppl, Wolfgang; Pustelnik, Tom; Mooseder, Gerhard] Mil Hosp Vienna, Dept Dermatol & Trop Med, Vienna, Austria; [Popow-Kraupp, Theresia; Redlberger-Fritz, Monika] Med Univ Vienna, Dept Virol, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Poeppl, W (corresponding author), Med Univ Vienna, Dept Infect Dis & Trop Med, Vienna, Austria.	wolfgang.poeppl@meduniwien.ac.at	Burgmann, Heinz/N-2409-2013	Burgmann, Heinz/0000-0002-2114-0999; Redlberger-Fritz, Monika/0000-0001-6265-557X; Herkner, Harald/0000-0003-1329-6149				Balish A., 2009, Morbidity and Mortality Weekly Report, V58, P826; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P1029; Chan KH, 2009, J CLIN VIROL, V45, P205, DOI 10.1016/j.jcv.2009.05.034; Cheng CKY, 2009, DIAGN MICR INFEC DIS, V65, P35, DOI 10.1016/j.diagmicrobio.2009.05.003; Cowling BJ, 2010, NEW ENGL J MED, V362, P2175, DOI 10.1056/NEJMoa0911530; Drexler JF, 2009, EMERG INFECT DIS, V15, P1662, DOI 10.3201/eid1510.091186; Faix DJ, 2009, NEW ENGL J MED, V361, P728, DOI 10.1056/NEJMc0904264; Gallagher EJ, 1998, ANN EMERG MED, V31, P391, DOI 10.1016/S0196-0644(98)70352-X; Ginocchio CC, 2009, J CLIN VIROL, V45, P191, DOI 10.1016/j.jcv.2009.06.005; Gordon A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010364; Gordon SM, 2009, CLEV CLIN J MED, V76, P577, DOI 10.3949/ccjm.76a.05009; Kok J, 2010, J CLIN MICROBIOL, V48, P290, DOI 10.1128/JCM.01465-09; Louie JK, 2010, EMERG INFECT DIS, V16, P824, DOI [10.3201/eid1605.091794, 10.3201/eid1605.091797]; Redlberger-Fritz M, 2009, RUCKBLICK ERSTE WELL; Rothberg MB, 2008, AM J MED, V121, P258, DOI 10.1016/j.amjmed.2007.10.040; Suntarattiwong P, 2010, PEDIATR INFECT DIS J, V29, P366, DOI 10.1097/INF.0b013e3181c6f05c; Suwannakarn K, 2008, J VIROL METHODS, V152, P25, DOI 10.1016/j.jviromet.2008.06.002; Vasoo S, 2009, CLIN INFECT DIS, V49, P1090, DOI 10.1086/644743; Watcharananan S, 2010, J INFECTION, V60, P86, DOI 10.1016/j.jinf.2009.10.049	19	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2011	6	12							e28089	10.1371/journal.pone.0028089	http://dx.doi.org/10.1371/journal.pone.0028089			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MQ	22145023	Green Published, Green Submitted, gold			2022-12-27	WOS:000298168900006
J	Beer, C; Horner, B; Flicker, L; Scherer, S; Lautenschlager, NT; Bretland, N; Flett, P; Schaper, F; Almeida, OP				Beer, Christopher; Horner, Barbara; Flicker, Leon; Scherer, Samuel; Lautenschlager, Nicola T.; Bretland, Nick; Flett, Penelope; Schaper, Frank; Almeida, Osvaldo P.			A Cluster-Randomised Trial of Staff Education to Improve the Quality of Life of People with Dementia Living in Residential Care: The DIRECT Study	PLOS ONE			English	Article							OLDER-PEOPLE; HOME	Background: The Dementia In Residential care: EduCation intervention Trial (DIRECT) was conducted to determine if delivery of education designed to meet the perceived need of GPs and care staff improves the quality of life of participants with dementia living in residential care. Methodology/Principal Findings: This cluster-randomised controlled trial was conducted in 39 residential aged care facilities in the metropolitan area of Perth, Western Australia. 351 care facility residents aged 65 years and older with Mini-Mental State Examination <= 24, their GPs and facility staff participated. Flexible education designed to meet the perceived needs of learners was delivered to GPs and care facility staff in intervention groups. The primary outcome of the study was self-rated quality of life of participants with dementia, measured using the QOL-Alzheimer's Disease Scale (QOL-AD) at 4 weeks and 6 months after the conclusion of the intervention. Analysis accounted for the effect of clustering by using multi-level regression analysis. Education of GPs or care facility staff did not affect the primary outcome at either 4 weeks or 6 months. In a post hoc analysis excluding facilities in which fewer than 50% of staff attended an education session, self-rated QOL-AD scores were 6.14 points (adjusted 95%CI 1.14, 11.15) higher at four-week follow-up among residents in facilities randomly assigned to the education intervention. Conclusion: The education intervention directed at care facilities or GPs did not improve the quality of life ratings of participants with dementia as a group. This may be explained by the poor adherence to the intervention programme, as participants with dementia living in facilities where staff participated at least minimally seemed to benefit.	[Beer, Christopher; Flicker, Leon; Lautenschlager, Nicola T.; Almeida, Osvaldo P.] WA Ctr Hlth & Ageing, Med Res Ctr, Perth, WA, Australia; [Beer, Christopher; Flicker, Leon] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6009, Australia; [Horner, Barbara] Curtin Univ Technol, Ctr Res Ageing, Perth, WA, Australia; [Lautenschlager, Nicola T.; Almeida, Osvaldo P.] Univ Western Australia, Sch Psychiat & Neurosci, Perth, WA 6009, Australia; [Scherer, Samuel] Royal Freemasons, Victoria, Australia; [Scherer, Samuel] Univ Melbourne, Dept Med, Melbourne, Vic, Australia; [Lautenschlager, Nicola T.] Univ Melbourne, Dept Psychiat, Acad Unit Psychiat Old Age, Melbourne, Vic, Australia; [Bretland, Nick] Rowethorpe Med Ctr, Bentley, WA, Australia; [Flett, Penelope] Brightwater Care, Perth, WA, Australia; [Schaper, Frank] Alzheimers Australia WA Ltd, Perth, WA, Australia; [Almeida, Osvaldo P.] Royal Perth Hosp, Dept Psychiat, Perth, WA, Australia	University of Western Australia; Curtin University; University of Western Australia; University of Melbourne; University of Melbourne; Royal Perth Hospital; University of Western Australia	Beer, C (corresponding author), WA Ctr Hlth & Ageing, Med Res Ctr, Perth, WA, Australia.	Christopher.beer@uwa.edu.au	Etherton-Beer, Christopher/B-2714-2014; Almeida, Osvaldo P./A-4925-2008; Flicker, Leon/AAE-1530-2022	Etherton-Beer, Christopher/0000-0001-5148-0188; Almeida, Osvaldo P./0000-0002-8689-6199; Flicker, Leon/0000-0002-3650-0475; Lautenschlager, Nicola/0000-0003-4850-7794; Schaper, Frank/0000-0002-7687-1510	National Health and Medical Research Council [458797]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This study was funded by a National Health and Medical Research Council Dementia Research Grant Program Strategic Award (number 458797). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beer C, 2010, INT PSYCHOGERIATR, P1; Beer C., 2009, BMC GERIATR, V9, P36, DOI DOI 10.1186/1471-2318-9-36; Beer C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015621; Beer C, 2009, AGE AGEING, V38, P343, DOI 10.1093/ageing/afp018; Beer CD, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-63; Chenoweth L, 2009, LANCET NEUROL, V8, P317, DOI 10.1016/S1474-4422(09)70045-6; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; Edelman P, 2005, GERONTOLOGIST, V45, P27, DOI 10.1093/geront/45.suppl_1.27; Gibson S, PRELIMINARY FIELD TE; Henderson EJ, 2008, J AM MED DIR ASSOC, V9, P88, DOI 10.1016/j.jamda.2007.11.010; Hoe J, 2005, AGE AGEING, V34, P130, DOI 10.1093/ageing/afi030; Moyle W, 2010, INT PSYCHOGERIATR, V22, P1097, DOI 10.1017/S1041610210001754; Orrell M, 2007, INT J GERIATR PSYCH, V22, P1127, DOI 10.1002/gps.1801; Proctor R, 1999, LANCET, V354, P26, DOI 10.1016/S0140-6736(98)08237-3; Rabins PV., 1999, J MENTAL HLTH AGING, V5, P33; SENGSTAKEN EA, 1993, J AM GERIATR SOC, V41, P541, DOI 10.1111/j.1532-5415.1993.tb01892.x; Warden Victoria, 2003, J Am Med Dir Assoc, V4, P9, DOI 10.1097/00130535-200301000-00002	17	26	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e28155	10.1371/journal.pone.0028155	http://dx.doi.org/10.1371/journal.pone.0028155			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	863MI	22140531	gold, Green Published			2022-12-27	WOS:000298168100041
J	Bonitz, T; Alva, V; Saleh, O; Lupas, AN; Heide, L				Bonitz, Tobias; Alva, Vikram; Saleh, Orwah; Lupas, Andrei N.; Heide, Lutz			Evolutionary Relationships of Microbial Aromatic Prenyltransferases	PLOS ONE			English	Article							PROTEIN HOMOLOGY DETECTION; ESCHERICHIA-COLI; STRUCTURAL BASIS; BIOSYNTHESIS; GENE; IDENTIFICATION; DATABASE; SUPERFAMILY; PRENYLATION; EXPRESSION	The linkage of isoprenoid and aromatic moieties, catalyzed by aromatic prenyltransferases (PTases), leads to an impressive diversity of primary and secondary metabolites, including important pharmaceuticals and toxins. A few years ago, a hydroxynaphthalene PTase, NphB, featuring a novel ten-stranded beta-barrel fold was identified in Streptomyces sp. strain CL190. This fold, termed the PT-barrel, is formed of five tandem alpha alpha beta beta structural repeats and remained exclusive to the NphB family until its recent discovery in the DMATS family of indole PTases. Members of these two families exist only in fungi and bacteria, and all of them appear to catalyze the prenylation of aromatic substrates involved in secondary metabolism. Sequence comparisons using PSI-BLAST do not yield matches between these two families, suggesting that they may have converged upon the same fold independently. However, we now provide evidence for a common ancestry for the NphB and DMATS families of PTases. We also identify sequence repeats that coincide with the structural repeats in proteins belonging to these two families. Therefore we propose that the PT-barrel arose by amplification of an ancestral alpha alpha beta beta module. In view of their homology and their similarities in structure and function, we propose to group the NphB and DMATS families together into a single superfamily, the PT-barrel superfamily.	[Bonitz, Tobias; Saleh, Orwah; Heide, Lutz] Univ Tubingen, Inst Pharmaceut, Tubingen, Germany; [Alva, Vikram; Lupas, Andrei N.] Max Planck Inst Dev Biol, Dept Prot Evolut, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Max Planck Society	Bonitz, T (corresponding author), Univ Tubingen, Inst Pharmaceut, Tubingen, Germany.	heide@uni-tuebingen.de	Alva, Vikram/D-9378-2010	Alva, Vikram/0000-0003-1188-473X; Heide, Lutz/0000-0001-7809-7453	German Federal Ministry of Education and Research (BMBF GenBioCom)	German Federal Ministry of Education and Research (BMBF GenBioCom)(Federal Ministry of Education & Research (BMBF))	This work was supported by a grant from the German Federal Ministry of Education and Research (BMBF GenBioCom) to LH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 2005, FEBS J, V272, P5101, DOI 10.1111/j.1742-4658.2005.04945.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Alva V, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-17; Alva V, 2010, PROTEIN SCI, V19, P124, DOI 10.1002/pro.297; ASAI K, 1994, BIOCHEM BIOPH RES CO, V202, P340, DOI 10.1006/bbrc.1994.1933; Awakawa T, 2011, CHEMBIOCHEM, V12, P439, DOI 10.1002/cbic.201000628; Balibar CJ, 2007, NAT CHEM BIOL, V3, P584, DOI 10.1038/nchembio.2007.20; Bayer P, 1998, J MOL BIOL, V280, P275, DOI 10.1006/jmbi.1998.1839; Biegert A, 2008, BIOINFORMATICS, V24, P807, DOI 10.1093/bioinformatics/btn039; Biegert A, 2006, NUCLEIC ACIDS RES, V34, pW335, DOI 10.1093/nar/gkl217; Brauer L, 2008, CHEMBIOCHEM, V9, P982, DOI 10.1002/cbic.200700575; Chaudhuri I, 2008, PROTEINS, V71, P795, DOI 10.1002/prot.21764; Cheng H, 2008, NUCLEIC ACIDS RES, V36, pD211, DOI 10.1093/nar/gkm698; Chooi YH, 2010, CHEM BIOL, V17, P483, DOI 10.1016/j.chembiol.2010.03.015; Copley RR, 2000, J MOL BIOL, V303, P627, DOI 10.1006/jmbi.2000.4152; Dairi T, 2005, J ANTIBIOT, V58, P227, DOI 10.1038/ja.2005.27; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Edwards DJ, 2004, J AM CHEM SOC, V126, P11432, DOI 10.1021/ja047876g; Frickey T, 2004, BIOINFORMATICS, V20, P3702, DOI 10.1093/bioinformatics/bth444; Heide L, 2009, CURR OPIN CHEM BIOL, V13, P171, DOI 10.1016/j.cbpa.2009.02.020; Huang HR, 2005, J BIOL CHEM, V280, P24539, DOI 10.1074/jbc.M504068200; Itoh T, 2010, NAT CHEM, V2, P858, DOI [10.1038/NCHEM.764, 10.1038/nchem.764]; Jost M, 2010, J AM CHEM SOC, V132, P17849, DOI 10.1021/ja106817c; Koeduka T, 2011, PLANT BIOLOGY, V13, P411, DOI 10.1111/j.1438-8677.2010.00409.x; KOONIN EV, 1994, J MOL BIOL, V244, P125, DOI 10.1006/jmbi.1994.1711; Kopec KO, 2010, BIOINFORMATICS, V26, P1927, DOI 10.1093/bioinformatics/btq326; Kumano T, 2008, BIOORGAN MED CHEM, V16, P8117, DOI 10.1016/j.bmc.2008.07.052; Kuzuyama T, 2005, NATURE, V435, P983, DOI 10.1038/nature03668; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li SM, 2009, APPL MICROBIOL BIOT, V84, P631, DOI 10.1007/s00253-009-2128-z; Macone A, 2009, BIOORGAN MED CHEM, V17, P6003, DOI 10.1016/j.bmc.2009.06.061; MELZER M, 1994, BBA-LIPID LIPID MET, V1212, P93, DOI 10.1016/0005-2760(94)90193-7; Metzger U, 2010, J MOL BIOL, V404, P611, DOI 10.1016/j.jmb.2010.09.067; Metzger U, 2009, P NATL ACAD SCI USA, V106, P14309, DOI 10.1073/pnas.0904897106; Nagano N, 2002, J MOL BIOL, V321, P741, DOI 10.1016/S0022-2836(02)00649-6; Nowicka B, 2010, BBA-BIOENERGETICS, V1797, P1587, DOI 10.1016/j.bbabio.2010.06.007; Oster U, 1997, J BIOL CHEM, V272, P9671; Ozaki T, 2009, J ANTIBIOT, V62, P385, DOI 10.1038/ja.2009.48; Pojer F, 2003, P NATL ACAD SCI USA, V100, P2316, DOI 10.1073/pnas.0337708100; Poulter C. Dale, 2006, Phytochemistry Reviews, V5, P17, DOI 10.1007/s11101-005-4887-1; Remmert M, 2010, MOL BIOL EVOL, V27, P1348, DOI 10.1093/molbev/msq017; Sadreyev R, 2003, J MOL BIOL, V326, P317, DOI 10.1016/S0022-2836(02)01371-2; SAIKI K, 1992, BIOCHEM BIOPH RES CO, V189, P1491, DOI 10.1016/0006-291X(92)90243-E; Savidge B, 2002, PLANT PHYSIOL, V129, P321, DOI 10.1104/pp.010747; Schultz AW, 2010, J NAT PROD, V73, P373, DOI 10.1021/np9006876; Shindo K, 2011, BIOSCI BIOTECH BIOCH, V75, P505, DOI 10.1271/bbb.100731; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Soding J, 2006, NUCLEIC ACIDS RES, V34, pW137, DOI 10.1093/nar/gkl130; Stec E, 2011, CHEMBIOCHEM, V12, P1724, DOI 10.1002/cbic.201100188; Steffan N, 2009, CURR MED CHEM, V16, P218, DOI 10.2174/092986709787002772; Suvarna K, 1998, J BACTERIOL, V180, P2782, DOI 10.1128/JB.180.10.2782-2787.1998; Takahashi S, 2010, J BACTERIOL, V192, P2839, DOI 10.1128/JB.01557-09; Tello M, 2008, CELL MOL LIFE SCI, V65, P1459, DOI 10.1007/s00018-008-7579-3; Xiao YL, 2009, MOL BIOSYST, V5, P913, DOI 10.1039/b902370d; Yazaki K, 2009, PHYTOCHEMISTRY, V70, P1739, DOI 10.1016/j.phytochem.2009.08.023; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524; Zou HX, 2011, APPL MICROBIOL BIOT, V89, P1443, DOI 10.1007/s00253-010-2956-x	59	62	67	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e27336	10.1371/journal.pone.0027336	http://dx.doi.org/10.1371/journal.pone.0027336			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140437	gold, Green Submitted, Green Published			2022-12-27	WOS:000298168100008
J	Nesbitt, SJ; Ksepka, DT; Clarke, JA				Nesbitt, Sterling J.; Ksepka, Daniel T.; Clarke, Julia A.			Podargiform Affinities of the Enigmatic Fluvioviridavis platyrhamphus and the Early Diversification of Strisores ("Caprimulgiformes" plus Apodiformes)	PLOS ONE			English	Article							GREEN RIVER FORMATION; MIDDLE EOCENE; PHYLOGENETIC ANALYSIS; FOSSIL RECORD; AVES; BIRDS; PALEOGENE; MESSEL; MOUSEBIRD; NIGHTJARS	Background: The early Eocene Green River Formation avifauna preserves exceptional exemplars of the earliest unambiguous stem representatives of many extant avian clades. We identify the basal-most member of Podargiformes (extant and fossil stem lineage frogmouths) based on a new specimen of Fluvioviridavis platyrhamphus, a unique neoavian bird from the Fossil Butte Member of the Green River Formation of Wyoming. Extant frogmouths (Podargidae) comprise approximately 13 nocturnal species with an exclusively Australasian distribution. Methodology/Principal Findings: The new specimen was included in a combined phylogenetic analysis of morphological (osteology and soft tissue) and molecular sequence (cytochrome b, c-myc exon 3, and RAG) data sampling species-level taxa from both extant and extinct members of Steatornithidae, Podargidae, Caprimulgidae, Nyctibiidae, Aegothelidae, and Apodiformes (=Strisores). New data from F. platyrhamphus help resolve phylogenetic relationships within Strisores, supporting placement of F. platyrhamphus and the European fossil form Masillapodargus longipes as basal parts of Podargiformes and also supporting a sister taxon relationship between Podargiformes and Steatornithiformes (oilbirds) within Strisores. This relationship is recovered only when fossil taxa are included, reaffirming the potential impact of stem fossil taxa on inferences of phylogenetic relationships. The well-preserved mandible and palate of the new specimen demonstrate that many of the unique characteristics of the skull that characterize the crown frogmouth clade Podargidae arose early in the evolutionary history of the clade, over 50 million years ago. Comparisons with the new specimen also indicate that Eurofluvioviridavis and Fluvioviridavis are not closely related. Conclusions/Significance: Together with the European fossil frogmouth Masillapodargus, Fluvioviridavis shows that Podargiformes had a much wider geographic distribution in the past, whereas extant species are restricted to Australasia. The Eocene record of Strisores from the Green River Formation and Messel Formation indicates most major subclade divergences had already occurred by the early-middle Eocene.	[Nesbitt, Sterling J.; Clarke, Julia A.] Univ Texas Austin, Jackson Sch Geosci, Dept Geol Sci, Austin, TX 78712 USA; [Ksepka, Daniel T.] N Carolina State Univ, Dept Marine Earth & Atmospher Sci, Raleigh, NC 27695 USA; [Ksepka, Daniel T.] N Carolina Museum Nat Sci, Dept Paleontol, Raleigh, NC USA	University of Texas System; University of Texas Austin; University of North Carolina; North Carolina State University	Nesbitt, SJ (corresponding author), Univ Texas Austin, Jackson Sch Geosci, Dept Geol Sci, Austin, TX 78712 USA.	nesbitt@jsg.utexas.edu	Ksepka, Daniel/A-2007-2009	Nesbitt, Sterling/0000-0002-7017-1652	National Science Foundation Division of Earth Sciences [0938199, 0719943]; Directorate For Geosciences [0938199] Funding Source: National Science Foundation	National Science Foundation Division of Earth Sciences(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This project was supported by the National Science Foundation Division of Earth Sciences (grants 0938199 to JAC and 0719943 to LG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird S. F., 1858, REPORTS EXPLORATIONS; Baumel Julian J., 1993, Publications of the Nuttall Ornithological Club, V23, P45; Blondel J, 1998, TRENDS ECOL EVOL, V13, P488, DOI 10.1016/S0169-5347(98)01461-X; Bonaparte C.L.J.L., 1838, NUOVI ANN SCI NATURE, V2, P105; Braun MJ, 2009, MOL PHYLOGENET EVOL, V53, P948, DOI 10.1016/j.ympev.2009.08.025; BRODKORB P, 1970, Contributions to Geology University of Wyoming, V9, P13; Buchheim HP, 1997, GEOLOGICAL SOC AM AB, V29, pA105; Clarke JA, 2009, ZOOL J LINN SOC-LOND, V157, P586, DOI 10.1111/j.1096-3642.2009.00550.x; Cleere N, 2007, IBIS, V149, P271, DOI 10.1111/j.1474-919X.2006.00626.x; CODDINGTON J, 1994, CLADISTICS, V10, P415; Cracraft J, 2004, ASSEMBLING THE TREE OF LIFE, P468; Cushman RAJ, 1999, NPSNRGRDGRDTR9903, V4, P67; Eastman C. R., 1900, Geological Magazine, V(2), P54; Elzanowski A, 2009, J MORPHOLOGY; Ericson PGP, 2006, BIOL LETTERS, V2, P543, DOI 10.1098/rsbl.2006.0523; Eugster HP, 1998, MODERN ANCIENT LACUS, P1; Fain MG, 2004, EVOLUTION, V58, P2558; Feduccia A., 1976, Smithsonian Contributions to Paleobiology, VNo. 27, P101; Feduccia A., 1999, ORIGIN EVOLUTION BIR, V2; Frakes L. A, 1992, CLIMATE MODES PHANER; Gradstein F.M., 2004, GEOLOGIC TIME SCALE; Grande L, 1984, GEOLOGICAL SURVEY WY, V63, P1, DOI DOI 10.1021/MA0493168); Grande L, 1994, CONTRIBUTIONS GEOLOG, V30, P13; Grande Lance, 1994, Contributions to Geology University of Wyoming, V30, P33; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; HOLYOAK DT, 1999, HDB BIRDS WORLD, V5, P266; Houde P, PAPERS AVIAN PALEONT, P137; Houde PW., 1988, PALEOGNATHOUS BIRDS; James HF, 2005, AUK, V122, P1049, DOI 10.1642/0004-8038(2005)122[1049:PFATRO]2.0.CO;2; Ksepka DT, 2010, ZOOL J LINN SOC-LOND, V160, P685, DOI 10.1111/j.1096-3642.2009.00626.x; Ksepka DT, 2010, J VERTEBR PALEONTOL, V30, P215, DOI 10.1080/02724630903412414; Ksepka DT, 2009, AUK, V126, P245, DOI 10.1525/auk.2009.07178; Ksepka DT, J PALEONTOL IN PRESS; Livezey Bradley C., 2006, Bulletin of Carnegie Museum of Natural History, V37, P1; Livezey BC, 2007, ZOOL J LINN SOC-LOND, V149, P1, DOI 10.1111/j.1096-3642.2006.00293.x; MacGinitie H.D., 1969, U CALIF PUBLS GEOL S, V83, P1; Mathews GM, 1918, BIRDS AUSTR; Mayr G, 2005, BIOL REV, V80, P515, DOI 10.1017/S1464793105006779; Mayr G, 2003, CLADISTICS, V19, P527, DOI [10.1016/j.cladistics.2003.10.003, 10.1111/j.1096-0031.2003.tb00387.x]; Mayr G, 1999, NEUES JAHRB GEOL P M, P312; Mayr G, 2005, CAN J EARTH SCI, V42, P2021, DOI 10.1139/E05-060; Mayr G, 2005, J SYST PALAEONTOL, V3, P359, DOI 10.1017/S1477201905001653; Mayr G, 2004, J VERTEBR PALEONTOL, V24, P366, DOI 10.1671/1970; Mayr G, 2004, J SYST PALAEONTOL, V2, P1; Mayr G, 2004, ACTA PALAEONTOL POL, V49, P211; Mayr G, 2004, SCIENCE, V304, P861, DOI 10.1126/science.1096856; Mayr G, 2003, AUK, V120, P145, DOI 10.1642/0004-8038(2003)120[0145:POETSA]2.0.CO;2; Mayr G, 2002, J ORNITHOL, V143, P82, DOI 10.1007/BF02465461; Mayr G, 1999, J VERTEBR PALEONTOL, V19, P521, DOI 10.1080/02724634.1999.10011162; Mayr G, 2001, ACTA PALAEONTOL POL, V46, P393; Mayr G, 2001, NEUES JAHRB GEOL P-M, P65; Mayr G., 2009, PALEOGENE FOSSIL BIR, DOI DOI 10.1007/978-3-540-89628-9; Mayr Gerald, 1998, Courier Forschungsinstitut Senckenberg, V205, P1; Mayr Gerald, 2000, Mitteilungen aus dem Museum fuer Naturkunde in Berlin Geowissenschaftliche Reihe, V3, P207; Mayr G, 2010, J ZOOL SYST EVOL RES, V48, P126, DOI 10.1111/j.1439-0469.2009.00552.x; McGrew PO, 1975, 3 NAT PARK SERV; Mertz D.F., 2005, COUR FORSCH I SENCKE, V255, P67; Morgan-Richards M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-20; MOURER-CHAUVIRE C., 1989, ACT 19 C INT ORN, P2047; Olson S.L., 1985, Avian Biology, V8, P79; Olson S.L., 1987, Documents des Laboratoires de Geologie de la Faculte des Sciences de Lyon, P57; Olson S.L., 1977, Smithsonian Contr. Paleobiol., VNo. 35, P1; Olson SL, 2005, ZOOTAXA, P1; Olson SL, PAPERS AVIAN PALEONT, P127; PETERS D S, 1985, Senckenbergiana Lethaea, V66, P143; Reed EH, 2009, T ROY SOC SOUTH AUST, V133, P30, DOI 10.1080/03721426.2009.10887108; Schweizer MK, 2007, PALEOBIOLOGY, V33, P590, DOI 10.1666/05079.1; Smith ME, 2008, GEOL SOC AM BULL, V120, P54, DOI 10.1130/B26073.1; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Weidig I, 2006, PALAEONT Z, V80, P230, DOI 10.1007/BF02988439; Weidig I, 2010, REC AUST MUS, V62, P29, DOI 10.3853/j.0067-1975.62.2010.1544; [No title captured]	72	28	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e26350	10.1371/journal.pone.0026350	http://dx.doi.org/10.1371/journal.pone.0026350			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140427	Green Published, gold, Green Submitted			2022-12-27	WOS:000298168100004
J	Batts, TD; Machado, HL; Zhang, YQ; Creighton, CJ; Li, Y; Rosen, JM				Batts, Torey D.; Machado, Heather L.; Zhang, Yiqun; Creighton, Chad J.; Li, Yi; Rosen, Jeffrey M.			Stem Cell Antigen-1 (Sca-1) Regulates Mammary Tumor Development and Cell Migration	PLOS ONE			English	Article							BREAST-CANCER; MOUSE MODEL; GROWTH-FACTOR; TGF-BETA; EXPRESSION; TUMORIGENESIS; GLAND; IDENTIFICATION; VISUALIZATION; PROGRESSION	Background: Stem cell antigen-1 (Sca-1 or Ly6A) is a glycosyl phostidylinositol (GPI)-anchored cell surface protein associated with both stem and progenitor activity, as well as tumor initiating-potential. However, at present the functional role for Sca-1 is poorly defined. Methodology/Principal Findings: To investigate the role of Sca-1 in mammary tumorigenesis, we used a mammary cell line derived from a MMTV-Wnt1 mouse mammary tumor that expresses high levels of endogenous Sca-1. Using shRNA knockdown, we demonstrate that Sca-1 expression controls cell proliferation during early tumor progression in mice. Functional limiting dilution transplantations into recipient mice demonstrate that repression of Sca-1 increases the population of tumor propagating cells. In scratch monolayer assays, Sca-1 enhances cell migration. In addition, knockdown of Sca-1 was shown to affect cell adhesion to a number of different extracellular matrix components. Microarray analysis indicates that repression of Sca-1 leads to changes in expression of genes involved in proliferation, cell migration, immune response and cell organization. Conclusions/Significance: Sca-1 exerts marked effects on cellular activity and tumorgenicity both in vitro and in vivo. A better understanding of Sca-1 function may provide insight into the broader role of GPI-anchored cell surface proteins in cancer.	[Batts, Torey D.] Baylor Coll Med, Interdept Program Cell & Mol Biol, Houston, TX 77030 USA; [Machado, Heather L.; Li, Yi; Rosen, Jeffrey M.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Zhang, Yiqun; Creighton, Chad J.] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Li, Yi] Baylor Coll Med, Lester & Sue Smith Breast Ctr, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Batts, TD (corresponding author), Baylor Coll Med, Interdept Program Cell & Mol Biol, Houston, TX 77030 USA.	jrosen@bcm.edu	Zhang, YiQun/HCI-2427-2022; Li, Yi/A-7635-2009	Li, Yi/0000-0002-9976-518X	National Cancer Institute [CA16303, CA084243-S01]; National Institutes of Health [GM056929]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI067854, U19AI067854] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	These studies were supported by a grant from the National Cancer Institute, CA16303 (JMR), a research supplement to promote diversity in health related research CA084243-S01 (TDB) and National Institutes of Health GM056929 (JMR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	DeNardo DG, 2009, CANCER CELL, V16, P91, DOI 10.1016/j.ccr.2009.06.018; Epting CL, 2008, J CELL PHYSIOL, V217, P250, DOI 10.1002/jcp.21500; Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Holmes C, 2007, STEM CELLS, V25, P1339, DOI 10.1634/stemcells.2006-0644; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Jo M, 2007, ONCOGENE, V26, P2585, DOI 10.1038/sj.onc.1210066; Kafadar KA, 2009, DEV BIOL, V326, P47, DOI 10.1016/j.ydbio.2008.10.036; Kass L, 2007, INT J BIOCHEM CELL B, V39, P1987, DOI 10.1016/j.biocel.2007.06.025; Li Y, 2003, P NATL ACAD SCI USA, V100, P15853, DOI 10.1073/pnas.2136825100; Lin EY, 2001, J EXP MED, V193, P727, DOI 10.1084/jem.193.6.727; Medina D, 1996, J MAMMARY GLAND BIOL, V1, P5, DOI 10.1007/BF02096299; Pond AC, 2010, CANCER RES, V70, P4868, DOI 10.1158/0008-5472.CAN-09-4404; Roarty K, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2244; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schwertfeger KL, 2006, CANCER RES, V66, P5676, DOI 10.1158/0008-5472.CAN-05-3781; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Sleeman KE, 2007, J CELL BIOL, V176, P19, DOI 10.1083/jcb.200604065; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Toma JG, 2001, NAT CELL BIOL, V3, P778, DOI 10.1038/ncb0901-778; Ulisse S, 2009, CURR CANCER DRUG TAR, V9, P32, DOI 10.2174/156800909787314002; Upadhyay G, 2011, P NATL ACAD SCI USA, V108, P7820, DOI 10.1073/pnas.1103441108; Wang YF, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-84; Welm BE, 2002, DEV BIOL, V245, P42, DOI 10.1006/dbio.2002.0625; Witz IP, 2000, J CELL BIOCHEM, P61; Wyckoff JB, 2007, CANCER RES, V67, P2649, DOI 10.1158/0008-5472.CAN-06-1823; Xin L, 2005, P NATL ACAD SCI USA, V102, P6942, DOI 10.1073/pnas.0502320102; Yuan H, 2011, CANC PREV R IN PRESS; Zhang M, 2008, CANCER RES, V68, P4674, DOI 10.1158/0008-5472.CAN-07-6353	29	26	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2011	6	11							e27841	10.1371/journal.pone.0027841	http://dx.doi.org/10.1371/journal.pone.0027841			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863LT	22140470	gold, Green Published, Green Submitted			2022-12-27	WOS:000298166300012
J	Schutz, U; Cakir, B; Dreinhofer, K; Richter, M; Koepp, H				Schuetz, Uwe; Cakir, Balkan; Dreinhoefer, Karsten; Richter, Marcus; Koepp, Holger			Diagnostic Value of Lumbar Facet Joint Injection: A Prospective Triple Cross-Over Study	PLOS ONE			English	Article							LOW-BACK-PAIN; IMMUNOHISTOCHEMICAL DEMONSTRATION; ZYGAPOPHYSIAL JOINTS; CLINICAL-FEATURES; SPINAL-ANESTHESIA; NERVE BLOCK; ARTHROGRAPHY; DISORDERS; CAPSULE; TRIAL	The diagnosis "lumbar facet syndrome" is common and often indicates severe lumbar spine surgery procedures. It is doubtful whether a painful facet joint (FJ) can be identified by a single FJ block. The aim of this study was to clarify the validity of a single and placebo controlled bilateral FJ blocks using local anesthetics. A prospective single blinded triple cross-over study was performed. 60 patients (31 f, 29 m, mean age 53.2 yrs (22-73)) with chronic low back pain (mean pain persistance 31 months, 6 months of conservative treatment without success) admitted to a local orthopaedic department for surgical or conservative therapy of chronic LBP, were included in the study. Effect on pain reduction (10 point rating scale) was measured. The 60 subjects were divided into six groups with three defined sequences of fluoroscopically guided bilateral monosegmental lumbar FJ test injections in "oblique needle" technique: verum-(local anaesthetic-), placebo-(sodium chloride-) and sham-injection. Carry-over and periodic effects were evaluated and a descriptive and statistical analysis regarding the effectiveness, difference and equality of the FJ injections and the different responses was performed. The results show a high rate of non-response, which documents the lack of reliable and valid predictors for a positive response towards FJ blocks. There was a high rate of placebo reactions noted, including subjects who previously or later reacted positively to verum injections. Equivalence was shown among verum vs. placebo and partly vs. sham also. With regard to test validity criteria, a single intraarticular FJ block with local anesthetics is not useful to detect the pain-responsible FJ and therefore is no valid and reliable diagostic tool to specify indication of lumbar spine surgery. Comparative FJ blocks with local anesthetics and placebo-controls have to be interpretated carefully also, because they solely give no proper diagnosis on FJ being main pain generator.	[Schuetz, Uwe] Univ Ulm, Dept Diagnost & Intervent Radiol, Ulm, Germany; [Cakir, Balkan] Univ Ulm, Dept Orthoped, Ulm, Germany; [Dreinhoefer, Karsten] Charite, Inst Muskuloskeletal Rehabil Prevent & Hlth Serv, CSSB, D-13353 Berlin, Germany; [Dreinhoefer, Karsten] CMSC, D-13353 Berlin, Germany; [Richter, Marcus; Koepp, Holger] St Josefs Hosp, Spine Ctr, Wiesbaden, Germany	Ulm University; Ulm University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Schutz, U (corresponding author), Univ Ulm, Dept Diagnost & Intervent Radiol, Ulm, Germany.	uwe.schuetz@rocketmail.com	Dreinhoefer, Karsten/AAO-9680-2021	Dreinhoefer, Karsten/0000-0001-6021-2804				ADAMS MA, 1983, SPINE, V8, P327, DOI 10.1097/00007632-198304000-00017; ADAMS MA, 1986, J ANAT, V147, P121; Agorastides ID, 2001, EUR J RADIOL, V40, P240, DOI 10.1016/S0720-048X(01)00405-3; Alcock E, 2003, PAIN, V103, P209, DOI 10.1016/S0304-3959(02)00326-3; ASHTON IK, 1992, J ORTHOPAED RES, V10, P72, DOI 10.1002/jor.1100100109; BERRIGAN T, 1992, ANAESTHESIA, V47, P905, DOI 10.1111/j.1365-2044.1992.tb03164.x; Boden, 1996, J Am Acad Orthop Surg, V4, P238; Boden S D, 1998, Phys Med Rehabil Clin N Am, V9, P411; Boden SD, 1996, J BONE JOINT SURG AM, V78A, P114, DOI 10.2106/00004623-199601000-00017; Bogduk N., 1991, CLIN ANATOMY LUMBAR; CARETTE S, 1991, NEW ENGL J MED, V325, P1002, DOI 10.1056/NEJM199110033251405; Carragee EJ, 2004, ORTHOP CLIN N AM, V35, P7, DOI 10.1016/S0030-5898(03)00099-3; CARRERA GF, 1984, CRC CR REV DIAGN IM, V21, P85; Cook NJ, 1999, CLIN RHEUMATOL, V18, P52, DOI 10.1007/s100679970001; DESTOUET JM, 1982, RADIOLOGY, V145, P321, DOI 10.1148/radiology.145.2.6215674; DORY MA, 1981, RADIOLOGY, V140, P23, DOI 10.1148/radiology.140.1.6454162; DREYFUSS PH, 1995, SPINE, V20, P2040, DOI 10.1097/00007632-199509150-00019; DUNLOP RB, 1984, J BONE JOINT SURG BR, V66, P706, DOI 10.1302/0301-620X.66B5.6501365; EISENSTEIN SM, 1987, J BONE JOINT SURG BR, V69, P3, DOI 10.1302/0301-620X.69B1.2950102; ELKHOURY GY, 1991, AM J ROENTGENOL, V157, P685, DOI 10.2214/ajr.157.4.1832511; ESSES SI, 1993, SPINE, V18, P185, DOI 10.1097/00007632-199302000-00003; FAIRBANK JCT, 1981, SPINE, V6, P598, DOI 10.1097/00007632-198111000-00011; Fukui S, 1997, CLIN J PAIN, V13, P303, DOI 10.1097/00002508-199712000-00007; Ghormley RK, 1933, J AMER MED ASSOC, V101, P1773, DOI 10.1001/jama.1933.02740480005002; GILES LGF, 1987, BRIT J RHEUMATOL, V26, P362; GLOVER JR, 1977, ORTHOP CLIN N AM, V8, P37; GOLDSTONE JC, 1987, ANAESTHESIA, V42, P754, DOI 10.1111/j.1365-2044.1987.tb05322.x; Goldthwait JE, 1911, BOSTON MED SURG J, V164, P365, DOI 10.1056/NEJM191103161641101; GOTFRIED Y, 1986, SPINE, V11, P944, DOI 10.1097/00007632-198611000-00016; Grogan J, 1997, AM J NEURORADIOL, V18, P1325; GRONBLAD M, 1991, SPINE, V16, P34; Gronemeyer D, 1989, INTERVENTIONELLE COM; HELBIG T, 1988, SPINE, V13, P61, DOI 10.1097/00007632-198801000-00015; Hildebrandt J, 2001, SCHMERZ, V15, P474, DOI 10.1007/PL00009801; Hildebrant J, 2000, SEM SPINE SURG, V12, P67; HIRSCH CARL, 1963, ACTA ORTHOPAED SCAND, V33, P1, DOI 10.3109/17453676308999829; JACKSON RP, 1992, CLIN ORTHOP RELAT R, P110; JACKSON RP, 1988, SPINE, V13, P966, DOI 10.1097/00007632-198809000-00002; JENSEN MC, 1994, NEW ENGL J MED, V331, P69, DOI 10.1056/NEJM199407143310201; Jerosch J, 1998, BIOMED TECH, V43, P249, DOI 10.1515/bmte.1998.43.9.249; Jerosch J, 1994, FACETTENSYNDROM; KONTTINEN YT, 1990, SPINE, V15, P387, DOI 10.1097/00007632-199005000-00009; Leclaire R, 2001, SPINE, V26, P1411, DOI 10.1097/00007632-200107010-00003; LEWINNEK GE, 1986, CLIN ORTHOP RELAT R, P216; LILIUS G, 1989, J BONE JOINT SURG BR, V71, P681, DOI 10.1302/0301-620X.71B4.2527856; LORENZ M, 1983, SPINE, V8, P122, DOI 10.1097/00007632-198303000-00002; LYNCH MC, 1986, J BONE JOINT SURG BR, V68, P138, DOI 10.1302/0301-620X.68B1.2934398; Magee M, 2000, CLIN NUCL MED, V25, P71, DOI 10.1097/00003072-200001000-00024; Maldjian C, 1998, RADIOL CLIN N AM, V36, P497, DOI 10.1016/S0033-8389(05)70039-7; MARKS R, 1988, ANAESTHESIA, V43, P65, DOI 10.1111/j.1365-2044.1988.tb05442.x; MARKS R, 1989, PAIN, V39, P37, DOI 10.1016/0304-3959(89)90173-5; MARKS RC, 1992, PAIN, V49, P325, DOI 10.1016/0304-3959(92)90239-8; MCCALL IW, 1979, SPINE, V4, P441, DOI 10.1097/00007632-197909000-00009; McLain RF, 1998, SPINE, V23, P168, DOI 10.1097/00007632-199801150-00004; Meier G, 2001, REGIONALANASTHESIE K; Mooney V, 1976, Clin Orthop Relat Res, P149; MORAN R, 1988, SPINE, V13, P1407, DOI 10.1097/00007632-198812000-00013; Murtagh R, 2000, NEUROIMAG CLIN N AM, V10, P465; NORTH RB, 1991, J NEUROSURG, V74, P236, DOI 10.3171/jns.1991.74.2.0236; Okazaki K, 2000, Am J Orthop (Belle Mead NJ), V29, P222; Orpen NM, 2003, J SPINAL DISORD TECH, V16, P285, DOI 10.1097/00024720-200306000-00010; Pfirrmann C W, 1999, Praxis (Bern 1994), V88, P315; PURCELLJONES G, 1989, ANESTH ANALG, V68, P32; REVEL ME, 1992, ARCH PHYS MED REHAB, V73, P824; ROY DF, 1988, J CAN ASSOC RADIOL, V39, P118; Saal JS, 2002, SPINE, V27, P2538, DOI 10.1097/00007632-200211150-00027; SCHLEIFER J, 1995, RADIOLOGE, V35, P844; SCHUIRMANN DJ, 1987, J PHARMACOKINET BIOP, V15, P657, DOI 10.1007/BF01068419; SCHWARZER AC, 1994, J SPINAL DISORD, V7, P331; SCHWARZER AC, 1994, PAIN, V58, P195, DOI 10.1016/0304-3959(94)90199-6; SCHWARZER AC, 1994, SPINE, V19, P1132, DOI 10.1097/00007632-199405001-00006; SCHWARZER AC, 1995, SPINE, V20, P907, DOI 10.1097/00007632-199504150-00005; SCHWARZER AC, 1995, ANN RHEUM DIS, V54, P100, DOI 10.1136/ard.54.2.100; van Kleef M, 1999, SPINE, V24, P1937, DOI 10.1097/00007632-199909150-00013; WHITE AH, 1983, ORTHOP CLIN N AM, V14, P553; YANG KH, 1984, SPINE, V9, P557, DOI 10.1097/00007632-198409000-00005; Zennaro H, 1998, AM J NEURORADIOL, V19, P349	77	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2011	6	11							e27991	10.1371/journal.pone.0027991	http://dx.doi.org/10.1371/journal.pone.0027991			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863LT	22140497	Green Submitted, gold, Green Published			2022-12-27	WOS:000298166300020
J	Guil, F; Fernandez-Olalla, M; Moreno-Opo, R; Mosqueda, I; Gomez, ME; Aranda, A; Arredondo, A; Guzman, J; Oria, J; Gonzalez, LM; Margalida, A				Guil, Francisco; Fernandez-Olalla, Mariana; Moreno-Opo, Ruben; Mosqueda, Ignacio; Elena Gomez, Maria; Aranda, Antonio; Arredondo, Angel; Guzman, Jose; Oria, Javier; Mariano Gonzalez, Luis; Margalida, Antoni			Minimising Mortality in Endangered Raptors Due to Power Lines: The Importance of Spatial Aggregation to Optimize the Application of Mitigation Measures	PLOS ONE			English	Article							EAGLE AQUILA-ADALBERTI; MARKED POINT-PROCESSES; OWL BUBO-BUBO; HEMORRHAGIC-DISEASE; RABBIT-POPULATIONS; MOSAIC LANDSCAPE; BONELLIS EAGLE; ELECTROCUTION; SPAIN; AREAS	Electrocution by power lines is one of the main causes of non-natural mortality in birds of prey. In an area in central Spain, we surveyed 6304 pylons from 333 power lines to determine electrocution rates, environmental and design factors that may influence electrocution and the efficacy of mitigation measures used to minimise electrocution cases. A total of 952 electrocuted raptors, representing 14 different species, were observed. Electrocuted raptors were concentrated in certain areas and the environmental factors associated with increased electrocution events were: greater numbers of prey animals; greater vegetation cover; and shorter distance to roads. The structural elements associated with electrocutions were shorter strings of insulators, one or more phases over the crossarm, cross-shaped design and pylon function. Of the 952 carcasses found, 148 were eagles, including golden eagle (Aquila chrysaetos), Spanish imperial eagle (Aquila adalberti) and Bonelli's eagle (Aquila fasciata). Electrocuted eagles were clustered in smaller areas than other electrocuted raptors. The factors associated with increased eagle electrocution events were: pylons function, shorter strings of insulators, higher slopes surrounding the pylon, and more numerous potential prey animals. Pylons with increased string of insulators had lower raptor electrocution rates than unimproved pylons, although this technique was unsuccessful for eagles. Pylons with cable insulation showed higher electrocution rates than unimproved pylons, both for raptors and eagles, despite this is the most widely used and recommended mitigation measure in several countries. To optimize the application of mitigation measures, our results recommend the substitution of pin-type insulators to suspended ones and elongating the strings of insulators.	[Guil, Francisco; Moreno-Opo, Ruben; Arredondo, Angel; Guzman, Jose; Oria, Javier] CBD Habitat Fdn, Madrid, Spain; [Guil, Francisco] Tragsatec, Gerencia Biodiversidad, Madrid, Spain; [Guil, Francisco; Fernandez-Olalla, Mariana] Univ Politecn Madrid, ETS Ingn Montes, Madrid, Spain; [Mosqueda, Ignacio; Elena Gomez, Maria; Aranda, Antonio] Direcc Gen Montes & Espacios Nat, Toledo, Spain; [Mariano Gonzalez, Luis] Spanish Minist Environm & Rural & Marine Affairs, Direcc Gen Medio Nat & Polit Forestal, Serv Especies Amenazadas, Madrid, Spain; [Margalida, Antoni] Bearded Vulture Study & Protect Grp, El Pont De Suert, Lleida, Spain	Universidad Politecnica de Madrid; Fundacion para la Conservacion del Quebranthuesos (FCQ)	Guil, F (corresponding author), CBD Habitat Fdn, Madrid, Spain.	francisco.guilcelada@gmail.com	Margalida, Antoni/AAG-5337-2020; Margalida, Antoni/A-2723-2011; Margalida, Antoni/A-2723-2011	Margalida, Antoni/0000-0002-0576-3993; Margalida, Antoni/0000-0002-7383-671X; Margalida, Antoni/0000-0002-3904-6212	Obra Social Caja Madrid	Obra Social Caja Madrid	This study has been developed within the framework of LIFE+07/NAT/E/000743 "Conservacion de especies prioritarias del monte mediterraneo en Castilla-La Mancha'', coordinated by the Organismo Autonomo Espacios Naturales de Castilla-La Mancha and participated in by the Fundacion CBD-Habitat and LIFE03/NAT/E/00050" Conservacion del Aguila imperial, Buitre negro y Ciguena negra'', developed by the CBD-Habitat Foundation with the cooperation of the Junta de Castilla-La Mancha and the Spanish Ministry of the Environment. This project is part of the regional recovery plan of Castilla-La Mancha and the National Preservation Strategy for the Spanish imperial eagle. Obra Social Caja Madrid also provided financial and technical support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avian Power Line Interaction Committee, 2006, SUGG PRACT AV PROT P; Bautista LM, 2004, CONSERV BIOL, V18, P726, DOI 10.1111/j.1523-1739.2004.00499.x; Beisbart C, 2002, LECT NOTES PHYS, V600, P358; Bevanger K, 1998, BIOL CONSERV, V86, P67, DOI 10.1016/S0006-3207(97)00176-6; BirdLife International, 2004, BIRDS EUR POP EST TR; Burnham K.P., 2002, MODEL SELECTION MULT, V2nd, DOI [10.1007/b97636, DOI 10.1007/B97636]; Cadahia L, 2010, EUR J WILDLIFE RES, V56, P923, DOI 10.1007/s10344-010-0391-z; Crawley M. J., 2007, R BOOK ATRIUM SO GAT; Del Moral J.C., 2018, AGUILA PERDICERA ESP, DOI [10.31170/0066, DOI 10.31170/0066]; Del Moral J.C., 2009, AGUILA REAL ESPANA P; Delibes-Mateos M, 2008, BIODIVERS CONSERV, V17, P559, DOI 10.1007/s10531-007-9272-5; Dwyer JF, 2007, J RAPTOR RES, V41, P259, DOI 10.3356/0892-1016(2007)41[259:PREIAU]2.0.CO;2; Ferguson-Lees J, 2001, RAPTORS WORLD; Fernandez N, 2005, LANDSCAPE ECOL, V20, P897, DOI 10.1007/s10980-004-3976-7; FERRER M, 1991, J FIELD ORNITHOL, V62, P181; Gonzalez LM, 2008, BIRD CONSERV INT, V18, P242, DOI 10.1017/S0959270908000245; Gonzalez LM, 2007, ORYX, V41, P495, DOI 10.1017/S0030605307414119; Gonzalez LM, 2006, BIRD STUDY, V53, P285, DOI 10.1080/00063650609461444; Guzman Jose, 1998, Ardeola, V45, P161; Haas D., 2005, PROTECTING BIRDS POW; Hager SB, 2009, J RAPTOR RES, V43, P210, DOI 10.3356/JRR-08-63.1; Harness RE, 2001, WILDLIFE SOC B, V29, P612; Janss GFE, 1999, WILDLIFE SOC B, V27, P263; Janss GFE, 2000, BIOL CONSERV, V95, P353, DOI 10.1016/S0006-3207(00)00021-5; Janss GFE, 2001, BIRD CONSERV INT, V11, P3, DOI 10.1017/S0959270901001022; Jenness J, 2004, NEAREST FEATURES EXT; Lehman RN, 2007, BIOL CONSERV, V136, P159, DOI 10.1016/j.biocon.2006.09.015; Lehman RN, 2010, J WILDLIFE MANAGE, V74, P459, DOI 10.2193/2008-332; LIFE Unit, 2010, LIFE PROJ DAT; Lopez-Lopez P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017196; Madrono A., 2004, LIBRO ROJO AVES ESPA; Manosa S, 2001, BIODIVERS CONSERV, V10, P1997, DOI 10.1023/A:1013129709701; Marti R., 2003, ATLAS AVES REPRODUCT; MMA, 2001, ESTR NAC CONS AG IMP; Mojica EK, 2009, J RAPTOR RES, V43, P57, DOI 10.3356/JRR-07-60.1; Moleon M, 2007, ARDEOLA, V54, P319; Montes F, 2008, CAN J FOREST RES, V38, P1924, DOI 10.1139/X08-002; NEGRO JJ, 1995, IBIS, V137, P423, DOI 10.1111/j.1474-919X.1995.tb08045.x; Ortega E, 2009, ORYX, V43, P113, DOI 10.1017/S0030605307991048; Palomino D, 2007, BIOL CONSERV, V140, P100, DOI 10.1016/j.biocon.2007.07.029; Palomino D, 2007, LANDSCAPE URBAN PLAN, V83, P268, DOI 10.1016/j.landurbplan.2007.04.011; Penteriani V, 2005, OIKOS, V108, P523, DOI 10.1111/j.0030-1299.2005.13514.x; PENTTINEN A, 1992, FOREST SCI, V38, P806; Ponce C, 2010, ANIM CONSERV, V13, P603, DOI 10.1111/j.1469-1795.2010.00387.x; Real J, 2001, BIRD STUDY, V48, P221, DOI 10.1080/00063650109461221; Rubolini D, 2001, BIRD CONSERV INT, V11, P319, DOI 10.1017/S0959270901000363; Schaub M, 2010, BIOL CONSERV, V143, P1911, DOI 10.1016/j.biocon.2010.04.047; Sergio F, 2004, J APPL ECOL, V41, P836, DOI 10.1111/j.0021-8901.2004.00946.x; Soutullo A, 2008, BIOL CONSERV, V141, P1013, DOI 10.1016/j.biocon.2008.01.011; STOYAN D, 1994, FRACTAL RANDOM SHAPE; Tinto A, 2010, J WILDLIFE MANAGE, V74, P1852, DOI 10.2193/2009-521; Villafuerte R, 1995, MAMMALIA, V59, P651, DOI 10.1515/mamm.1995.59.4.651; Wiegand T, 2004, OIKOS, V104, P209, DOI 10.1111/j.0030-1299.2004.12497.x; Williams RD, 1989, W RAPT MAN S WORKSH, P173	54	53	56	2	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2011	6	11							e28212	10.1371/journal.pone.0028212	http://dx.doi.org/10.1371/journal.pone.0028212			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KW	22140549	Green Submitted, Green Published, gold			2022-12-27	WOS:000298163400038
J	Guo, W; Song, YB; Yu, FH				Guo, Wei; Song, Yao-Bin; Yu, Fei-Hai			Heterogeneous Light Supply Affects Growth and Biomass Allocation of the Understory Fern Diplopterygium glaucum at High Patch Contrast	PLOS ONE			English	Article							DIVISION-OF-LABOR; CLONAL INTEGRATION; PHYSIOLOGICAL INTEGRATION; FRAGARIA-CHILOENSIS; GLECHOMA-HEDERACEA; ENVIRONMENTAL HETEROGENEITY; RAMETS; HERB; PLASTICITY; FOREST	Spatial heterogeneity in resource supply is common and responses to heterogeneous resource supply have been extensively documented in clonal angiosperms but not in pteridophytes. To test the hypotheses that clonal integration can modify responses of pteridophytes to heterogeneous resource supply and the integration effect is larger at higher patch contrast, we conducted a field experiment with three homogeneous and two heterogeneous light treatments on the rhizomatous, understory fern Diplopterygium glaucum in an evergreen broad-leaved forest in East China. In homogeneous treatments, all D. glaucum ramets in 1.5 mx1.5 m units were subjected to 10, 40 and 100% natural light, respectively. In the heterogeneous treatment of low patch contrast, ramets in the central 0.5 mx0.5 m plots of the units were subjected to 40% natural light and their interconnected ramets in the surrounding area of the units to 100%; in the heterogeneous treatment of high patch contrast, ramets in the central plots were subjected to 10% natural light and those in the surrounding area to 100%. In the homogeneous treatments, biomass and number of living ramets in the central plots decreased and number of dead ramets increased with decreasing light supply. At low contrast heterogeneous light supply did not affect performance or biomass allocation of D. glaucum in the central plots, but at high contrast it increased lamina biomass and number of living ramets older than annual and modified biomass allocation to lamina and rhizome. Thus, clonal integration can affect responses of understory ferns to heterogeneous light supply and ramets in low light patches can be supported by those in high light. The results also suggest that effects of clonal integration depend on the degree of patch contrast and a significant integration effect may be found only under a relatively high patch contrast.	[Guo, Wei; Yu, Fei-Hai] Beijing Forestry Univ, Coll Nat Conservat, Beijing, Peoples R China; [Song, Yao-Bin] Chinese Acad Sci, State Key Lab Vegetat & Environm Change, Inst Bot, Beijing, Peoples R China	Beijing Forestry University; Chinese Academy of Sciences; Institute of Botany, CAS	Guo, W (corresponding author), Beijing Forestry Univ, Coll Nat Conservat, Beijing, Peoples R China.	feihaiyu@bjfu.edu.cn	Yu, Fei-Hai/O-9395-2016	Yu, Fei-Hai/0000-0001-5007-1745	Fundamental Research Funds for the Central Universities [JC2011-4]; National Science Foundation of China [31070371]; CAS [KZCX2-YW-430]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); CAS(Chinese Academy of Sciences)	FHY thanks the support from the Fundamental Research Funds for the Central Universities (Grant JC2011-4), the National Science Foundation of China (Grant 31070371), and the Important Directional Item of CAS Knowledge Innovative Project (KZCX2-YW-430). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpert P, 1996, VEGETATIO, V122, P83, DOI 10.1007/BF00052818; Alpert P, 1999, OECOLOGIA, V120, P69, DOI 10.1007/s004420050834; Caldwell M.M., 1994, EXPLOITATION ENV HET; CARACO T, 1991, ECOLOGY, V72, P81, DOI 10.2307/1938904; Chen JS, 2006, PLANT ECOL, V183, P147, DOI 10.1007/s11258-005-9013-3; Chen JS, 2010, ACTA OECOL, V36, P23, DOI 10.1016/j.actao.2009.09.006; de Kroon J.M, 1990, CLONAL GROWTH PLANTS; de la Cretaz AL, 2002, RESTOR ECOL, V10, P416, DOI 10.1046/j.1526-100X.2002.02037.x; Ding B-Y, 2001, J ZHEJIANG U, V27, P370; DONG M, 1995, OECOLOGIA, V101, P282, DOI 10.1007/BF00328813; Dong M, 1999, PLANT ECOL, V141, P53, DOI 10.1023/A:1009875000149; Du JA, 2010, FLORA, V205, P399, DOI 10.1016/j.flora.2009.12.018; FRIEDMAN D, 1991, OECOLOGIA, V86, P76, DOI 10.1007/BF00317392; George LO, 1999, ECOLOGY, V80, P833, DOI 10.1890/0012-9658(1999)080[0833:TFUAAE]2.0.CO;2; HARTNETT DC, 1983, ECOLOGY, V64, P779, DOI 10.2307/1937201; JACKSON RB, 1993, ECOLOGY, V74, P612, DOI 10.2307/1939320; Janecek S, 2008, EVOL ECOL, V22, P325, DOI 10.1007/s10682-007-9203-7; Jonsdottir I.S., 1997, ECOLOGY EVOLUTION CL, P109; KOTLIAR NB, 1990, OIKOS, V59, P253, DOI 10.2307/3545542; LAU RR, 1988, ECOLOGY, V69, P215, DOI 10.2307/1943177; Legendre P, 2009, ECOLOGY, V90, P663, DOI 10.1890/07-1880.1; Li Yuan-Heng, 2008, Zhiwu Shengtai Xuebao, V32, P1166, DOI 10.3773/j.issn.1005-264x.2008.05.021; Liu J, 2008, PHOTOSYNTHETICA, V46, P299, DOI 10.1007/s11099-008-0054-4; Lu S.G., 2007, PTERIDOLOGY; Nilsson J, 2008, EVOL ECOL, V22, P437, DOI 10.1007/s10682-007-9199-z; Qian C-S, 1959, FLORA REPUBLICAE POP; Railing CA, 2000, AM FERN J, V90, P77, DOI 10.2307/1547416; Roiloa SR, 2006, ANN BOT-LONDON, V98, P1043, DOI 10.1093/aob/mcl185; Roiloa SR, 2007, J ECOL, V95, P397, DOI 10.1111/j.1365-2745.2007.01216.x; Saitoh T, 2002, J ECOL, V90, P78, DOI 10.1046/j.0022-0477.2001.00631.x; SLADE AJ, 1987, J ECOL, V75, P1023, DOI 10.2307/2260311; Stuefer JF, 1996, VEGETATIO, V127, P55, DOI 10.1007/BF00054847; STUEFER JF, 1994, J ECOL, V82, P511, DOI 10.2307/2261260; Van Kleunen M, 2000, J EVOLUTION BIOL, V13, P237; Wang ZW, 2004, ACTA OECOL, V26, P255, DOI 10.1016/j.actao.2004.08.007; Wijesinghe DK, 1999, J ECOL, V87, P860, DOI 10.1046/j.1365-2745.1999.00395.x; Wijesinghe DK, 1996, OIKOS, V77, P137, DOI 10.2307/3545593; Zhang LL, 2009, FLORA, V204, P628, DOI 10.1016/j.flora.2008.09.003; Zhang LL, 2009, FLORA, V204, P182, DOI 10.1016/j.flora.2008.02.001; Zhang XQ, 2006, FLORA, V201, P547, DOI 10.1016/j.flora.2005.12.002	40	23	28	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e27998	10.1371/journal.pone.0027998	http://dx.doi.org/10.1371/journal.pone.0027998			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132189	Green Submitted, Green Published, gold			2022-12-27	WOS:000298162000057
J	Pilon-Thomas, S; Nelson, N; Vohra, N; Jerald, M; Pendleton, L; Szekeres, K; Ghansah, T				Pilon-Thomas, Shari; Nelson, Nadine; Vohra, Nasreen; Jerald, Maya; Pendleton, Laura; Szekeres, Karoly; Ghansah, Tomar			Murine Pancreatic Adenocarcinoma Dampens SHIP-1 Expression and Alters MDSC Homeostasis and Function	PLOS ONE			English	Article							MYELOID SUPPRESSOR-CELLS; INOSITOL PHOSPHATASE; REGULATORY CELLS; CANCER; APOPTOSIS; SURVIVAL; GROWTH; BETA; MICE; PHOSPHORYLATION	Background: Pancreatic cancer is one of the most aggressive cancers, with tumor-induced myeloid-derived suppressor cells (MDSC) contributing to its pathogenesis and ineffective therapies. In response to cytokine/chemokine receptor activation, src homology 2 domain-containing inositol 5'-phosphatase-1 (SHIP-1) influences phosphatidylinositol-3-kinase (PI3K) signaling events, which regulate immunohomeostasis. We hypothesize that factors from murine pancreatic cancer cells cause the down-regulation of SHIP-1 expression, which may potentially contribute to MDSC expansion, and the suppression of CD8(+) T cell immune responses. Therefore, we sought to determine the role of SHIP-1 in solid tumor progression, such as murine pancreatic cancer. Methodology and Principal Findings: Immunocompetent C57BL/6 mice were inoculated with either murine Panc02 cells (tumor-bearing [TB] mice) or Phosphate Buffer Saline (PBS) (control mice). Cytometric Bead Array (CBA) analysis of supernatants of cultured Panc02 detected pro-inflammatory cytokines such as IL-6, IL-10 and MCP-1. TB mice showed a significant increase in serum levels of pro-inflammatory factors IL-6 and MCP-1 measured by CBA. qRT-PCR and Western blot analyses revealed the in vivo down-regulation of SHIP-1 expression in splenocytes from TB mice. Western blot analyses also detected reduced SHIP-1 activity, increased AKT-1 and BAD hyper-phosphorylation and up-regulation of BCL-2 expression in splenocytes from TB mice. In vitro, qRT-PCR and Western blot analyses detected reduced SHIP-1 mRNA and protein expression in control splenocytes co-cultured with Panc02 cells. Flow cytometry results showed significant expansion of MDSC in peripheral blood and splenocytes from TB mice. AutoMACS sorted TB MDSC exhibited hyper-phosphorylation of AKT-1 and over-expression of BCL-2 detected by western blot analysis. TB MDSC significantly suppressed antigen-specific CD8(+) T cell immune responses in vitro. Conclusion/Significance: SHIP-1 may regulate immune development that impacts MDSC expansion and function, contributing to pancreatic tumor progression. Thus, SHIP-1 can be a potential therapeutic target to help restore immunohomeostasis and improve therapeutic responses in patients with pancreatic cancer.	[Pilon-Thomas, Shari; Vohra, Nasreen] H Lee Moffitt Comprehens Canc Ctr & Res Inst, Program Immunol, Tampa, FL 33612 USA; [Nelson, Nadine; Jerald, Maya; Pendleton, Laura; Szekeres, Karoly; Ghansah, Tomar] Univ S Florida, Coll Med, Dept Mol Med, Tampa, FL USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Pilon-Thomas, S (corresponding author), H Lee Moffitt Comprehens Canc Ctr & Res Inst, Program Immunol, Tampa, FL 33612 USA.	tghansah@health.usf.edu	Ghansah, Tomar/H-4566-2011; Vohra, Nasreen/AAW-3454-2021	Vohra, Nasreen/0000-0002-6411-3042	American Cancer Society [93-032-13]; NATIONAL CANCER INSTITUTE [P30CA076292, R00CA128825] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Institutional Research Grant # 93-032-13 from the American Cancer Society awarded to TG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alinikula J, 2010, EUR J IMMUNOL, V40, P2599, DOI 10.1002/eji.200940002; Aman MJ, 2000, MOL CELL BIOL, V20, P3576, DOI 10.1128/MCB.20.10.3576-3589.2000; Bae J, 2001, APOPTOSIS, V6, P319, DOI 10.1023/A:1011319901057; Bunt SK, 2007, CANCER RES, V67, P10019, DOI 10.1158/0008-5472.CAN-07-2354; Burris HA, 1997, J CLIN ONCOL, V15, P2403, DOI 10.1200/JCO.1997.15.6.2403; Carnero A, 2010, CURR PHARM DESIGN, V16, P34, DOI 10.2174/138161210789941865; Clark CE, 2007, CANCER RES, V67, P9518, DOI 10.1158/0008-5472.CAN-07-0175; Collazo MM, 2009, BLOOD, V113, P2934, DOI 10.1182/blood-2008-09-181164; CONDE C, 2011, BIOCH PHARM; CORBETT TH, 1984, CANCER RES, V44, P717; Costinean S, 2009, BLOOD, V114, P1374, DOI 10.1182/blood-2009-05-220814; Coultas L, 2003, SEMIN CANCER BIOL, V13, P115, DOI 10.1016/S1044-579X(02)00129-3; Damen JE, 2001, BLOOD, V97, P1343, DOI 10.1182/blood.V97.5.1343; Gabhann JN, 2010, J IMMUNOL, V184, P2314, DOI 10.4049/jimmunol.0902589; Ghansah T, 2004, J IMMUNOL, V173, P7324, DOI 10.4049/jimmunol.173.12.7324; Gloire G, 2007, BIOCHEM SOC T, V35, P277, DOI 10.1042/BST0350277; Hamilton MJ, 2011, EXP HEMATOL, V39, P2, DOI 10.1016/j.exphem.2010.11.002; Helgason CD, 1998, GENE DEV, V12, P1610, DOI 10.1101/gad.12.11.1610; Huang B, 2006, CANCER RES, V66, P1123, DOI 10.1158/0008-5472.CAN-05-1299; Huang B, 2007, CANCER LETT, V252, P86, DOI 10.1016/j.canlet.2006.12.012; Huber M, 1999, PROG BIOPHYS MOL BIO, V71, P423, DOI 10.1016/S0079-6107(98)00049-2; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kerr WG, 2011, ANN NY ACAD SCI, V1217, P1, DOI 10.1111/j.1749-6632.2010.05869.x; Lakhanpal GK, 2010, BLOOD, V116, P428, DOI 10.1182/blood-2009-10-250217; Liu L, 1997, LEUKEMIA, V11, P181, DOI 10.1038/sj.leu.2400559; Liu QR, 1999, GENE DEV, V13, P786, DOI 10.1101/gad.13.7.786; Lo TCT, 2009, LEUKEMIA RES, V33, P1562, DOI 10.1016/j.leukres.2009.04.032; Ma K, 2008, CELL SIGNAL, V20, P684, DOI 10.1016/j.cellsig.2007.12.004; Maeda K, 2005, BLOOD, V106, P879, DOI 10.1182/blood-2005-02-0456; Maeda K, 2010, BLOOD, V115, P4699, DOI 10.1182/blood-2009-07-230631; Morse MA, 2009, EXPERT OPIN BIOL TH, V9, P331, DOI 10.1517/14712590802715756 ; Nakamura K, 2004, J EXP MED, V199, P243, DOI 10.1084/jem.20031193; O'Connell RM, 2008, J EXP MED, V205, P585, DOI 10.1084/jem.20072108; O'Connell RM, 2009, P NATL ACAD SCI USA, V106, P7113, DOI 10.1073/pnas.0902636106; Ostrand-Rosenberg S, 2010, CANCER IMMUNOL IMMUN, V59, P1593, DOI 10.1007/s00262-010-0855-8; Ostrand-Rosenberg S, 2009, J IMMUNOL, V182, P4499, DOI 10.4049/jimmunol.0802740; Paraiso KHT, 2007, J IMMUNOL, V178, P2893, DOI 10.4049/jimmunol.178.5.2893; Parsons CM, 2010, ANTICANCER RES, V30, P3279; Pedersen IM, 2009, EMBO MOL MED, V1, P288, DOI 10.1002/emmm.200900028; Phee H, 2000, J BIOL CHEM, V275, P19090, DOI 10.1074/jbc.M001093200; Pilon-Thomas S, 2010, J IMMUNOL, V184, P3442, DOI 10.4049/jimmunol.0904114; Prasad NK, 2008, CARCINOGENESIS, V29, P25, DOI 10.1093/carcin/bgm213; Prasad NK, 2008, TUMOR BIOL, V29, P330, DOI 10.1159/000172970; Roongapinun S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014174; Sakaguchi S, 2011, METHODS MOL BIOL, V707, P3, DOI 10.1007/978-1-61737-979-6_1; Sly LM, 2003, EXP HEMATOL, V31, P1170, DOI 10.1016/j.exphem.2003.09.011; Valderrama-Carvajal H, 2002, NAT CELL BIOL, V4, P963, DOI 10.1038/ncb885; Wang JL, 2000, CANCER RES, V60, P1498; Whiteside TL, 2010, J ALLERGY CLIN IMMUN, V125, pS272, DOI 10.1016/j.jaci.2009.09.045	49	38	38	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2011	6	11							e27729	10.1371/journal.pone.0027729	http://dx.doi.org/10.1371/journal.pone.0027729			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858JH	22132131	Green Submitted, Green Published, gold			2022-12-27	WOS:000297792400013
J	Katyal, S; Glubrecht, DD; Li, L; Gao, ZH; Godbout, R				Katyal, Sachin; Glubrecht, Darryl D.; Li, Lei; Gao, Zhihua; Godbout, Roseline			Disabled-1 Alternative Splicing in Human Fetal Retina and Neural Tumors	PLOS ONE			English	Article							AII AMACRINE CELLS; APOE RECEPTOR 2; TYROSINE PHOSPHORYLATION; BRAIN-DEVELOPMENT; REELIN PATHWAY; RETINOBLASTOMA CELLS; NEURONAL MIGRATION; VLDL RECEPTOR; CHICK RETINA; MOUSE	Background: The Reelin-Dab1 signaling pathway plays a critical role in the positioning of migrating neurons, dendrite formation and lamination in the developing central nervous system. We have previously identified two alternatively spliced forms of Dab1 in the developing chick retina: an early form, Dab1-E, expressed in retinal progenitor cells, and a late form, Dab1 or Dab1-L, expressed in amacrine and ganglion cells. Compared to Dab1-L, Dab1-E lacks two exons that encode two Src family kinase (SFK) phosphorylation sites. Principal Findings: Both Dab1-L and Dab1-E-like transcripts were identified in human fetal retina. Expression of human Dab1-L in primary chick retinal cultures resulted in Reelin-mediated induction of SFK phosphorylation and formation of neurite-like processes. In contrast, human Dab1-E-expressing cells retained an undifferentiated morphology. The human Dab1 gene is located within a common fragile site, and it has been postulated that it may function as a tumor suppressor. Analysis of Dab1 splice forms in retinoblastoma and neuroblastoma tumor cells revealed relative enrichment of Dab1-L-like (includes exons 7 and 8) and Dab1-E-like (excludes exons 7 and 8) transcripts in retinoblastoma and neuroblastoma, respectively. Treatment of retinoblastoma cell line RB522A with Reelin resulted in increased tyrosine phosphorylation of Dab1. As Nova2 has previously been implicated in the exclusion of exons 9B and 9C in Dab1, we examined the expression of this splicing factor in neuroblastoma and retinoblastoma cell lines. Nova2 was only detected in neuroblastoma cells, suggesting a correlation between Nova2 expression and increased levels of Dab1-E-like splice forms in neuroblastoma. Conclusions: These results indicate that alternative splicing of Dab1 is conserved in avian and mammalian species, with Dab1-L driving SFK phosphorylation in both species. Dab1-E-and Dab-L-like isoforms are also expressed in childhood neural tumors, with preferential enrichment of Dab1-L-like and Dab1-E-like isoforms in retinoblastoma and neuroblastoma, respectively.	[Katyal, Sachin; Glubrecht, Darryl D.; Li, Lei; Gao, Zhihua; Godbout, Roseline] Univ Alberta, Dept Oncol, Cross Canc Inst, Edmonton, AB, Canada	University of Alberta	Katyal, S (corresponding author), Univ Alberta, Dept Oncol, Cross Canc Inst, Edmonton, AB, Canada.	rgodbout@ualberta.ca	Godbout, Roseline/I-4639-2016	Godbout, Roseline/0000-0002-4779-9265; Katyal, Sachin/0000-0002-7790-4054	Canadian Institutes of Health Research; Alberta Cancer Foundation; Alberta Heritage Foundation for Medical Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Cancer Foundation; Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric)	This work was supported by the Canadian Institutes of Health Research. S.K. was supported by the Dr. Cyril Kay Graduate Studentship Award from the Alberta Cancer Foundation. Z.G. was supported by a studentship from the Alberta Heritage Foundation for Medical Research. L.L. was supported by a fellowship from the Alberta Cancer Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnaud L, 2003, CURR BIOL, V13, P9, DOI 10.1016/S0960-9822(02)01397-0; Ballif BA, 2003, MOL BRAIN RES, V117, P152, DOI 10.1016/S0169-328X(03)00295-X; Bar I, 2003, J BIOL CHEM, V278, P5802, DOI 10.1074/jbc.M207178200; Beffert U, 2002, J BIOL CHEM, V277, P49958, DOI 10.1074/jbc.M209205200; Bock HH, 2003, CURR BIOL, V13, P18, DOI 10.1016/S0960-9822(02)01403-3; BOGENMANN E, 1983, J NATL CANCER I, V70, P95; Buckanovich RJ, 1997, MOL CELL BIOL, V17, P3194, DOI 10.1128/MCB.17.6.3194; Chen D, 2004, CANCER CELL, V5, P539, DOI 10.1016/j.ccr.2004.05.025; Costagli A, 2006, DEV GENES EVOL, V216, P291, DOI 10.1007/s00427-005-0052-5; D'Arcangelo G, 1999, NEURON, V24, P471, DOI 10.1016/S0896-6273(00)80860-0; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; DArcangelo G, 1997, J NEUROSCI, V17, P23, DOI 10.1523/JNEUROSCI.17-01-00023.1997; Dredge BK, 2005, EMBO J, V24, P1608, DOI 10.1038/sj.emboj.7600630; GALLIE BL, 1982, CANCER RES, V42, P301; Gallie BL, 1999, CANCER RES, V59, p1731S; Gao ZH, 2011, CELL SIGNAL, V23, P555, DOI 10.1016/j.cellsig.2010.11.007; Gao ZH, 2010, MOL CELL BIOL, V30, P4339, DOI 10.1128/MCB.00545-10; Glubrecht DD, 2009, J NEUROCHEM, V111, P250, DOI 10.1111/j.1471-4159.2009.06322.x; Hiesberger T, 1999, NEURON, V24, P481, DOI 10.1016/S0896-6273(00)80861-2; Howell BW, 1999, GENE DEV, V13, P643, DOI 10.1101/gad.13.6.643; Howell BW, 2000, CURR BIOL, V10, P877, DOI 10.1016/S0960-9822(00)00608-4; Howell BW, 1997, EMBO J, V16, P121, DOI 10.1093/emboj/16.1.121; Jensen KB, 2000, P NATL ACAD SCI USA, V97, P5740, DOI 10.1073/pnas.090553997; Jiang Z, 1997, ONCOGENE, V14, P1789, DOI 10.1038/sj.onc.1201014; Jossin Y, 2007, J NEUROSCI, V27, P4243, DOI 10.1523/JNEUROSCI.0023-07.2007; Kam R, 2004, NEUROPATH APPL NEURO, V30, P225, DOI 10.1046/j.0305-1846.2004.00526.x; Katyal S, 2004, EMBO J, V23, P1878, DOI 10.1038/sj.emboj.7600185; Katyal S, 2007, J MOL BIOL, V368, P349, DOI 10.1016/j.jmb.2007.01.068; Keshvara L, 2001, J BIOL CHEM, V276, P16008, DOI 10.1074/jbc.M101422200; Lee EJ, 2004, J COMP NEUROL, V470, P372, DOI 10.1002/cne.20010; Li XD, 2010, GENE CHROMOSOME CANC, V49, P819, DOI 10.1002/gcc.20790; Long HA, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-17; McAvoy S, 2008, GENE CHROMOSOME CANC, V47, P165, DOI 10.1002/gcc.20519; OGAWA M, 1995, NEURON, V14, P899, DOI 10.1016/0896-6273(95)90329-1; Rice DS, 2000, J COMP NEUROL, V424, P327, DOI 10.1002/1096-9861(20000821)424:2<327::AID-CNE10>3.0.CO;2-6; Rice DS, 2001, NEURON, V31, P929, DOI 10.1016/S0896-6273(01)00436-6; Robanus-Maandag E, 1998, GENE DEV, V12, P1599, DOI 10.1101/gad.12.11.1599; Sheldon M, 1997, NATURE, V389, P730, DOI 10.1038/39601; Smith DI, 2006, CANCER LETT, V232, P48, DOI 10.1016/j.canlet.2005.06.049; SQUIRE JA, 1995, ONCOGENE, V10, P1417; Tissir F, 2003, NAT REV NEUROSCI, V4, P496, DOI 10.1038/nrn1113; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Ule J, 2003, SCIENCE, V302, P1212, DOI 10.1126/science.1090095; Ule J, 2006, NATURE, V444, P580, DOI 10.1038/nature05304; Ware ML, 1997, NEURON, V19, P239, DOI 10.1016/S0896-6273(00)80936-8; Westermann F, 2002, CANCER LETT, V184, P127, DOI 10.1016/S0304-3835(02)00199-4; Yano M, 2010, NEURON, V66, P848, DOI 10.1016/j.neuron.2010.05.007; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	48	13	13	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2011	6	12							e28579	10.1371/journal.pone.0028579	http://dx.doi.org/10.1371/journal.pone.0028579			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863OC	22163036	Green Published, gold			2022-12-27	WOS:000298173500035
J	Mankus, C; Rich, C; Minns, M; Trinkaus-Randall, V				Mankus, Courtney; Rich, Celeste; Minns, Martin; Trinkaus-Randall, Vickery			Corneal Epithelium Expresses a Variant of P2X(7) Receptor in Health and Disease	PLOS ONE			English	Article							P2X7 RECEPTOR; PORE FORMATION; CELL-DEATH; CASPASE-1 ACTIVATION; P2Y RECEPTORS; CANCER-CELLS; C-TERMINUS; ATP; CHANNEL; APOPTOSIS	Improper wound repair of the corneal epithelium can alter refraction of light resulting in impaired vision. We have shown that ATP is released after injury, activates purinergic receptor signaling pathways and plays a major role in wound closure. In many cells or tissues, ATP activates P2X(7) receptors leading to cation fluxes and cytotoxicity. The corneal epithelium is an excellent model to study the expression of both the full-length P2X(7) form (defined as the canonical receptor) and its truncated forms. When Ca2+ mobilization is induced by BzATP, a P2X(7) agonist, it is attenuated in the presence of extracellular Mg2+ or Zn2+, negligible in the absence of extracellular Ca2+, and inhibited by the competitive P2X7 receptor inhibitor, A438079. BzATP enhanced phosphorylation of ERK. Together these responses indicate the presence of a canonical or full-length P2X(7) receptor. In addition BzATP enhanced epithelial cell migration, and transfection with siRNA to the P2X(7) receptor reduced cell migration. Furthermore, sustained activation did not induce dye uptake indicating the presence of truncated or variant forms that lack the ability to form large pores. Reverse transcription-polymerase chain reaction and Northern blot analysis revealed a P2X(7) splice variant. Western blots identified a full-length and truncated form, and the expression pattern changed as cultures progressed from monolayer to stratified. Cross-linking gels demonstrated the presence of homo- and heterotrimers. We examined epithelium from age matched diabetic and non-diabetic corneas patients and detected a 4-fold increase in P2X(7) mRNA from diabetic corneal epithelium compared to non-diabetic controls and an increased trend in expression of P2X(7)variant mRNA. Taken together, these data indicate that corneal epithelial cells express full-length and truncated forms of P2X(7), which ultimately allows P2X(7) to function as a multifaceted receptor that can mediate cell proliferation and migration or cell death.	[Mankus, Courtney; Rich, Celeste; Minns, Martin; Trinkaus-Randall, Vickery] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Trinkaus-Randall, Vickery] Boston Univ, Sch Med, Dept Ophthalmol, Boston, MA 02118 USA; [Mankus, Courtney] ECI Biotech Worcester, Worcester, MA USA	Boston University; Boston University	Mankus, C (corresponding author), Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA.	vickery@bu.edu		Trinkaus-Randall, Vickery/0000-0002-8573-9108; Minns, Martin/0000-0002-9793-5819	National Institutes of Health [EY06000, EY013431]; Massachusetts Lions Eye Research; New England Corneal Transplant Fund; NATIONAL EYE INSTITUTE [R01EY013431, R01EY006000] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Massachusetts Lions Eye Research; New England Corneal Transplant Fund; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health EY06000, EY013431, Massachusetts Lions Eye Research, and New England Corneal Transplant Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbracchio MP, 1998, JPN J PHARMACOL, V78, P113, DOI 10.1254/jjp.78.113; Adinolfi Elena, 2005, Purinergic Signal, V1, P219, DOI 10.1007/s11302-005-6322-x; Adriouch S, 2002, J IMMUNOL, V169, P4108, DOI 10.4049/jimmunol.169.8.4108; Amstrup J, 2003, BIOCHEM J, V374, P51, DOI 10.1042/BJ20030585; Auger R, 2005, J BIOL CHEM, V280, P28142, DOI 10.1074/jbc.M501290200; Baricordi OR, 1996, BLOOD, V87, P682, DOI 10.1182/blood.V87.2.682.bloodjournal872682; Becker D, 2008, J BIOL CHEM, V283, P25725, DOI 10.1074/jbc.M803855200; Beldi G, 2008, HEPATOLOGY, V48, P841, DOI 10.1002/hep.22401; Boucher I, 2011, AM J PATHOL, V178, P1092, DOI 10.1016/j.ajpath.2010.11.060; Boucher I, 2010, AM J PHYSIOL-CELL PH, V299, pC411, DOI 10.1152/ajpcell.00100.2009; Cabrini G, 2005, J IMMUNOL, V175, P82, DOI 10.4049/jimmunol.175.1.82; Cheewatrakoolpong B, 2005, BIOCHEM BIOPH RES CO, V332, P17, DOI 10.1016/j.bbrc.2005.04.087; Chen QM, 2000, BIOCHEM J, V347, P543, DOI 10.1042/0264-6021:3470543; Chen YG, 2011, J IMMUNOL, V186, P4278, DOI 10.4049/jimmunol.1003733; Chessell IP, 2005, PAIN, V114, P386, DOI 10.1016/j.pain.2005.01.002; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CORNELLBELL AH, 1990, SCIENCE, V247, P470, DOI 10.1126/science.1967852; DIVIRGILIO F, 1995, IMMUNOL TODAY, V16, P524, DOI 10.1016/0167-5699(95)80045-X; Donnelly-Roberts DL, 2007, BRIT J PHARMACOL, V151, P571, DOI 10.1038/sj.bjp.0707265; Feng YH, 2006, NUCLEOS NUCLEOT NUCL, V25, P1271, DOI 10.1080/15257770600890921; Feng YH, 2006, J BIOL CHEM, V281, P17228, DOI 10.1074/jbc.M602999200; Ferrari D, 1999, FEBS LETT, V447, P71, DOI 10.1016/S0014-5793(99)00270-7; Ferrari D, 2006, J IMMUNOL, V176, P3877, DOI 10.4049/jimmunol.176.7.3877; Georgiou JG, 2005, J INVEST DERMATOL, V125, P482, DOI 10.1111/j.0022-202X.2005.23835.x; Gipson IK, 2003, INVEST OPHTH VIS SCI, V44, P2496, DOI 10.1167/iovs.02-0851; Hayashi T, 2003, RECENT PROG HORM RES, V58, P131, DOI 10.1210/rp.58.1.131; Kahlenberg JM, 2005, J IMMUNOL, V175, P7611, DOI 10.4049/jimmunol.175.11.7611; Kahlenberg JM, 2004, AM J PHYSIOL-CELL PH, V286, pC1100, DOI 10.1152/ajpcell.00494.2003; Klepeis VE, 2004, J CELL BIOCHEM, V93, P1115, DOI 10.1002/jcb.20258; Klepeis VE, 2001, J CELL SCI, V114, P4185; Mackenzie AB, 2005, J BIOL CHEM, V280, P33968, DOI 10.1074/jbc.M502705200; Mayo C, 2008, INVEST OPHTH VIS SCI, V49, P4384, DOI 10.1167/iovs.08-1688; Morelli A, 2003, MOL BIOL CELL, V14, P2655, DOI 10.1091/mbc.02-04-0061; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Pfeiffer ZA, 2004, J LEUKOCYTE BIOL, V75, P1173, DOI 10.1189/jlb.1203648; Qiu F, 2009, AM J PHYSIOL-CELL PH, V296, pC250, DOI 10.1152/ajpcell.00433.2008; Raffaghello L, 2006, CANCER RES, V66, P907, DOI 10.1158/0008-5472.CAN-05-3185; Ralevic V, 1998, PHARMACOL REV, V50, P413; Riedel T, 2007, BIOPHYS J, V93, P846, DOI 10.1529/biophysj.106.103614; Saghizadeh M, 2010, INVEST OPHTH VIS SCI, V51, P1970, DOI 10.1167/iovs.09-4569; Solini A, 1999, J CELL SCI, V112, P297; Sperlagh B, 2006, PROG NEUROBIOL, V78, P327, DOI 10.1016/j.pneurobio.2006.03.007; Sugiyama T, 2005, AM J PHYSIOL-CELL PH, V288, pC568, DOI 10.1152/ajpcell.00380.2004; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; Virginio C, 1997, NEUROPHARMACOLOGY, V36, P1285, DOI 10.1016/S0028-3908(97)00141-X; Wang CM, 2003, CELL SIGNAL, V15, P1129, DOI 10.1016/S0898-6568(03)00112-8; Wang QF, 2004, AM J PHYSIOL-CELL PH, V287, pC1349, DOI 10.1152/ajpcell.00256.2004; Weinger Ilene, 2005, Purinergic Signal, V1, P281, DOI 10.1007/s11302-005-8132-6; Wiley JS, 1998, AM J PHYSIOL-CELL PH, V275, pC1224, DOI 10.1152/ajpcell.1998.275.5.C1224; Wilson HL, 2002, J BIOL CHEM, V277, P34017, DOI 10.1074/jbc.M205120200; Yang LL, 2004, J CELL BIOCHEM, V91, P938, DOI 10.1002/jcb.10774; Zhang XL, 2005, INVEST OPHTH VIS SCI, V46, P2183, DOI 10.1167/iovs.05-0052; ZIESKE JD, 1989, J CELL BIOL, V109, P571, DOI 10.1083/jcb.109.2.571	53	26	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2011	6	12							e28541	10.1371/journal.pone.0028541	http://dx.doi.org/10.1371/journal.pone.0028541			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863OC	22163032	Green Published, gold			2022-12-27	WOS:000298173500032
J	Lu, HL; Tanguy, S; Rispe, C; Gauthier, JP; Walsh, T; Gordon, K; Edwards, O; Tagu, D; Chang, CC; Jaubert-Possamai, S				Lu, Hsiao-ling; Tanguy, Sylvie; Rispe, Claude; Gauthier, Jean-Pierre; Walsh, Tom; Gordon, Karl; Edwards, Owain; Tagu, Denis; Chang, Chun-che; Jaubert-Possamai, Stephanie			Expansion of Genes Encoding piRNA-Associated Argonaute Proteins in the Pea Aphid: Diversification of Expression Profiles in Different Plastic Morphs	PLOS ONE			English	Article							ACYRTHOSIPHON-PISUM HEMIPTERA; PIWI; RNA; CELL; PATHWAY; RECOGNITION; BIOGENESIS; SEQUENCE; MEIOSIS	Piwi-interacting RNAs (piRNAs) are known to regulate transposon activity in germ cells of several animal models that propagate sexually. However, the role of piRNAs during asexual reproduction remains almost unknown. Aphids that can alternate sexual and asexual reproduction cycles in response to seasonal changes of photoperiod provide a unique opportunity to study piRNAs and the piRNA pathway in both reproductive modes. Taking advantage of the recently sequenced genome of the pea aphid Acyrthosiphon pisum, we found an unusually large lineage-specific expansion of genes encoding the Piwi sub-clade of Argonaute proteins. In situ hybridisation showed differential expressions between the duplicated piwi copies: while Api-piwi2 and Api-piwi6 are "specialised" in germ cells their most closely related copy, respectively Api-piwi5 and Api-piwi3, are expressed in the somatic cells. The differential expression was also identified in duplicated ago3: Api-ago3a in germ cells and Api-ago3b in somatic cells. Moreover, analyses of expression profiles of the expanded piwi and ago3 genes by semi-quantitative RT-PCR showed that expressions varied according to the reproductive types. These specific expression patterns suggest that expanded aphid piwi and ago3 genes have distinct roles in asexual and sexual reproduction.	[Lu, Hsiao-ling; Chang, Chun-che] Natl Taiwan Univ, Dept Entomol, Inst Biotechnol, Coll Bioresources & Agr, Taipei 10764, Taiwan; [Tanguy, Sylvie; Rispe, Claude; Gauthier, Jean-Pierre; Tagu, Denis; Jaubert-Possamai, Stephanie] Univ Rennes 1, INRA, UMR Unite Mixte Rech Biol Organismes & Populat Ap, Le Rheu, France; [Walsh, Tom; Gordon, Karl] CSIRO Commonwealth Sci & Ind Res Org Ecosyst Sci, Canberra, ACT, Australia; [Edwards, Owain] CSIRO Ecosyst Sci, Wembley, WA, Australia; [Lu, Hsiao-ling; Chang, Chun-che] Natl Taiwan Univ, Res Ctr Dev Biol & Regenerat Med, Taipei 10764, Taiwan; [Chang, Chun-che] Natl Taiwan Univ, Genome & Syst Biol Degree Program, Taipei 10764, Taiwan	National Taiwan University; INRAE; Universite de Rennes; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO); National Taiwan University; National Taiwan University	Lu, HL (corresponding author), Natl Taiwan Univ, Dept Entomol, Inst Biotechnol, Coll Bioresources & Agr, Taipei 10764, Taiwan.	chunche@ntu.edu.tw; Stephanie.Jaubert@rennes.inra.fr	Walsh, Thomas K/C-1263-2009; Edwards, Owain Rhys/B-9707-2008; Gordon, Karl H J/A-1976-2008	Walsh, Thomas K/0000-0001-8425-0135; Edwards, Owain Rhys/0000-0003-3861-7906; Gordon, Karl H J/0000-0002-4371-0454; Chang, Chun-che/0000-0002-3586-1607; Rispe, Claude/0000-0002-9489-5719; Tagu, Denis/0000-0002-6320-8648	National Science Council [97-2313-B-002-035-MY3]; Bureau of Animal and Plant Health Inspection and Quarantine (BAPHIQ) of the Agricultural Council [97-1.1.1-B1(6), 98-1.1.1-B1(2), 100-9.2.1-B1(6)]	National Science Council(Ministry of Science and Technology, Taiwan); Bureau of Animal and Plant Health Inspection and Quarantine (BAPHIQ) of the Agricultural Council	This work was supported by the National Science Council (97-2313-B-002-035-MY3, web site: http://web1.nsc.gov.tw/mp.aspx?mp = 7) and the Bureau of Animal and Plant Health Inspection and Quarantine (BAPHIQ) of the Agricultural Council (97-1.1.1-B1(6); 98-1.1.1-B1(2); 100-9.2.1-B1(6)), web site: http://www.baphiq.gov.tw/mp.asp?mp = 2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravin AA, 2008, MOL CELL, V31, P785, DOI 10.1016/j.molcel.2008.09.003; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bouhouche K, 2011, NUCLEIC ACIDS RES, V39, P4249, DOI 10.1093/nar/gkq1283; Brennecke J, 2008, SCIENCE, V322, P1387, DOI 10.1126/science.1165171; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; BUNING J, 1985, J MORPHOL, V186, P209, DOI 10.1002/jmor.1051860206; Campbell CL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-425; Chang CC, 2008, ARCH INSECT BIOCHEM, V68, P186, DOI 10.1002/arch.20243; Chang CC, 2007, DEV GENES EVOL, V217, P275, DOI 10.1007/s00427-007-0142-7; Couvillion MT, 2010, GENE DEV, V24, P2742, DOI 10.1101/gad.1996210; Couvillion MT, 2009, GENE DEV, V23, P2016, DOI 10.1101/gad.1821209; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; Cox DN, 2000, DEVELOPMENT, V127, P503; Czech B, 2011, NAT REV GENET, V12, P19, DOI 10.1038/nrg2916; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Houwing S, 2008, EMBO J, V27, P2702, DOI 10.1038/emboj.2008.204; Houwing S, 2007, CELL, V129, P69, DOI 10.1016/j.cell.2007.03.026; Huang TY, 2010, INSECT MOL BIOL, V19, P75, DOI 10.1111/j.1365-2583.2009.00940.x; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Jaubert-Possamai S, 2010, MOL BIOL EVOL, V27, P979, DOI 10.1093/molbev/msp256; Lau NC, 2009, GENOME RES, V19, P1776, DOI 10.1101/gr.094896.109; Le Trionnaire G, 2007, INSECT BIOCHEM MOLEC, V37, P1094, DOI 10.1016/j.ibmb.2007.06.008; Le Trionnaire G, 2008, BIOL CELL, V100, P441, DOI 10.1042/BC20070135; Ma JB, 2005, NATURE, V434, P666, DOI 10.1038/nature03514; Mallory A, 2010, PLANT CELL, V22, P3879, DOI 10.1105/tpc.110.080671; Malone CD, 2009, CELL, V137, P522, DOI 10.1016/j.cell.2009.03.040; Megosh HB, 2006, CURR BIOL, V16, P1884, DOI 10.1016/j.cub.2006.08.051; Miura T, 2003, J EXP ZOOL PART B, V295B, P59, DOI 10.1002/jez.b.00003; Nakabachi A, 2005, P NATL ACAD SCI USA, V102, P5477, DOI 10.1073/pnas.0409034102; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Nowotny M, 2009, CURR OPIN STRUC BIOL, V19, P286, DOI 10.1016/j.sbi.2009.04.006; Olivieri D, 2010, EMBO J, V29, P3301, DOI 10.1038/emboj.2010.212; Parker JS, 2009, MOL CELL, V33, P204, DOI 10.1016/j.molcel.2008.12.012; Rouget C, 2010, NATURE, V467, P1128, DOI 10.1038/nature09465; Saito K, 2009, NATURE, V461, P1296, DOI 10.1038/nature08501; Schurko AM, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-78; Senti KA, 2010, TRENDS GENET, V26, P499, DOI 10.1016/j.tig.2010.08.007; Sigova A, 2004, GENE DEV, V18, P2359, DOI 10.1101/gad.1218004; Simon JC, 2011, J HERED, DOI [10.1093/jhered/esr1020, DOI 10.1093/JHERED/ESR1020]; Sun M, 2010, J NEUROSCI, V30, P6025, DOI 10.1523/JNEUROSCI.0789-10.2010; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; The International Aphid Genomics Consortium, 2010, PLoS Biology, V8, P1, DOI 10.1371/journal.pbio.1000313; Wilczynska A, 2009, RNA, V15, P337, DOI 10.1261/rna.1422509; Williams RW, 2002, P NATL ACAD SCI USA, V99, P6889, DOI 10.1073/pnas.072190799; Yan Z, 2011, NUCLEIC ACIDS RES, V39, P6596, DOI 10.1093/nar/gkr298; Yigit E, 2006, CELL, V127, P747, DOI 10.1016/j.cell.2006.09.033; Zhao J, 2010, TOHOKU J EXP MED, V222, P63, DOI 10.1620/tjem.222.63	47	30	31	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e28051	10.1371/journal.pone.0028051	http://dx.doi.org/10.1371/journal.pone.0028051			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22162754	Green Published, Green Submitted, gold			2022-12-27	WOS:000298172800012
J	Valentin-Domelier, AS; Girard, M; Bertrand, X; Violette, J; Francois, P; Donnio, PY; Talon, D; Quentin, R; Schrenzel, J; van der Mee-Marquet, N				Valentin-Domelier, Anne-Sophie; Girard, Myriam; Bertrand, Xavier; Violette, Jeremie; Francois, Patrice; Donnio, Pierre-Yves; Talon, Daniel; Quentin, Roland; Schrenzel, Jacques; van der Mee-Marquet, Nathalie		RHC	Methicillin-Susceptible ST398 Staphylococcus aureus Responsible for Bloodstream Infections: An Emerging Human-Adapted Subclone?	PLOS ONE			English	Article							RESISTANT; DIVERSITY; EMERGENCE; LINEAGES; STRAINS; CLONES	In the course of an annual 3-month bloodstream infections (BSI) survey conducted during a four-year period in 31 healthcare institutions located in three noncontiguous French regions, we report 18 ST398 Staphylococcus aureus BSI. ST398 BSI incidence showed a seven-fold increase during the study period (0.002 per 1,000 patient days in 2007 vs. 0.014 in 2010). ST398 BSI isolates differed from the pig-borne multiresistant clone: 17/18 BSI isolates were methicillin susceptible and none was of t011, t034 or t108 pig-borne spa-types. ST398 BSI isolates had homogenous resistance patterns (15/18 with only Ery(r)) and prophagic content (all harboured the hlb-converting Sau3int phage). The clustering of BSI and pig-borne isolates by spa-typing and MLVA, the occurrence of Sau3int phage in BSI isolates and the lack of this phage in pig-borne isolates suggest that the emergence of BSI isolates could have arisen from horizontal transfer, at least of the Sau3int phage, in genetically diverse MSSA ST398 isolates. The acquisition of the phage likely plays a role in the increasing ability of the lysogenic ST398 isolates to colonize human. The mode of acquisition of the non pig-borne ST398 isolates by our 18 patients remains unclear. ST398 BSI were diagnosed in patients lacking livestock exposure and were significantly associated with digestive portals of entry (3/18 [16.7%] for ST398 vs. 19/767 [2.5%] for non ST398 BSI; p = .012). This raises the question of possible foodborne human infections. We suggest the need for active surveillance to study and control the spread of this human-adapted subclone increasingly isolated in the hospital setting.	[Valentin-Domelier, Anne-Sophie; Quentin, Roland; van der Mee-Marquet, Nathalie] CHU Tours, Serv Bacteriol & Hyg, Hop Trousseau, Tours, France; [Girard, Myriam; Francois, Patrice] Univ Hosp Geneva, Genom Res Lab, Geneva, Switzerland; [Bertrand, Xavier; Talon, Daniel] Univ Franche Comte, UMR Chronoenvironm 6249, F-25030 Besancon, France; [Bertrand, Xavier; Talon, Daniel] Univ Franche Comte, CHU Besancon, Serv Hyg, F-25030 Besancon, France; [Violette, Jeremie; Donnio, Pierre-Yves] Univ Rennes 1, Serv Bacteriol & Hyg Hosp, Ctr Hosp Univ, Rennes, France; [Violette, Jeremie; Donnio, Pierre-Yves] Univ Rennes 1, Microbiol Risques Infect EA1254, Rennes, France; [Schrenzel, Jacques] Univ Hosp Geneva, Clin Microbiol Lab, Geneva, Switzerland; [van der Mee-Marquet, Nathalie] CHU Tours, Reseau Hyg Ctr, Tours, France	CHU Tours; University of Geneva; Universite de Franche-Comte; Universite de Franche-Comte; CHU Besancon; CHU Rennes; Universite de Rennes; Universite de Rennes; University of Geneva; CHU Tours	Valentin-Domelier, AS (corresponding author), CHU Tours, Serv Bacteriol & Hyg, Hop Trousseau, Tours, France.	n.vandermee@chu-tours.fr	Bertrand, Xavier/AAK-3270-2021; Bertrand, Xavier/AAL-3809-2021; Schrenzel, Jacques/P-8525-2017; Schrenzel, Jacques/AAC-5685-2021; francois, patrice/AAL-5583-2020; DONNIO, Pierre-Yves/L-6840-2015	Bertrand, Xavier/0000-0002-8028-1396; Schrenzel, Jacques/0000-0001-5464-7764; Schrenzel, Jacques/0000-0001-5464-7764; Valentin, Anne-Sophie/0000-0001-8662-097X; francois, patrice/0000-0002-0540-750X	Centre de Coordination de la Lutte contre les Infections Nosocomiales de l'Ouest de la France (CCLIN Ouest); Agence Regionale de Sante du Centre; Centre Universitaire de Tours, France; Besancon University hospital, France; Centre Universitaire de Rennes, France	Centre de Coordination de la Lutte contre les Infections Nosocomiales de l'Ouest de la France (CCLIN Ouest); Agence Regionale de Sante du Centre; Centre Universitaire de Tours, France; Besancon University hospital, France; Centre Universitaire de Rennes, France	This work was supported by the Centre de Coordination de la Lutte contre les Infections Nosocomiales de l'Ouest de la France (CCLIN Ouest), the Agence Regionale de Sante du Centre, the Centre Universitaire de Tours, France, Besancon University hospital, France, and the Centre Universitaire de Rennes, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, COMITE ANTIBIOGRAMME; Chen HB, 2010, ANTIMICROB AGENTS CH, V54, P1842, DOI 10.1128/AAC.01563-09; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Francois P, 2005, J CLIN MICROBIOL, V43, P3346, DOI 10.1128/JCM.43.7.3346-3355.2005; Goerke C, 2009, J BACTERIOL, V191, P3462, DOI 10.1128/JB.01804-08; Graveland H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016830; Jarraud S, 2002, INFECT IMMUN, V70, P631, DOI 10.1128/IAI.70.2.631-641.2002; Kadlec K, 2009, J ANTIMICROB CHEMOTH, V64, P1156, DOI 10.1093/jac/dkp350; Lowder BV, 2009, P NATL ACAD SCI USA, V106, P19545, DOI 10.1073/pnas.0909285106; MacCarthy AJ, 2011, GENOME BIOL EVO 0913, DOI [10.1093/gbe/evr092, DOI 10.1093/GBE/EVR092]; Moritz ED, 2011, EMERG INFECT DIS, V17, P742, DOI 10.3201/eid1704.101852; PITTET D, 1995, ARCH INTERN MED, V155, P1177, DOI 10.1001/archinte.155.11.1177; Rasigade JP, 2010, EMERG INFECT DIS, V16, P1330, DOI 10.3201/eid1608.100317; Robinson DA, 2004, J BACTERIOL, V186, P1060, DOI 10.1128/JB.186.4.1060-1064.2004; Shopsin B, 1999, J CLIN MICROBIOL, V37, P3556, DOI 10.1128/JCM.37.11.3556-3563.1999; Soavi L, 2010, EMERG INFECT DIS, V16, P346, DOI 10.3201/eid1602.091478; Stegger M, 2010, CLIN MICROBIOL INFEC, V16, P1018, DOI 10.1111/j.1469-0691.2009.03003.x; Stegger M, 2011, J CLIN MICROBIOL, V49, P732, DOI 10.1128/JCM.01970-10; van Belkum A, 1998, J CLIN MICROBIOL, V36, P1653, DOI 10.1128/JCM.36.6.1653-1659.1998; van Cleef BAGL, 2011, J CLIN MICROBIOL, V49, P1030, DOI 10.1128/JCM.00493-10; van der Mee-Marquet N, 2007, J CLIN MICROBIOL, V45, P851, DOI 10.1128/JCM.02178-06; van der Mee-Marquet N, 2011, CLIN INFECT DIS, V52, P152, DOI 10.1093/cid/ciq053; van Loo I, 2007, EMERG INFECT DIS, V13, P1834, DOI 10.3201/eid1312.070384; Vandendriessche S, 2011, J ANTIMICROB CHEMOTH, V66, P2455, DOI 10.1093/jac/dkr348; Waldron DE, 2006, J BACTERIOL, V188, P5578, DOI 10.1128/JB.00418-06	25	72	74	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e28369	10.1371/journal.pone.0028369	http://dx.doi.org/10.1371/journal.pone.0028369			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22163008	Green Published, Green Submitted, gold			2022-12-27	WOS:000298172800030
J	Auger, C; Lemire, J; Cecchini, D; Bignucolo, A; Appanna, VD				Auger, Christopher; Lemire, Joseph; Cecchini, Dominic; Bignucolo, Adam; Appanna, Vasu D.			The Metabolic Reprogramming Evoked by Nitrosative Stress Triggers the Anaerobic Utilization of Citrate in Pseudomonas fluorescens	PLOS ONE			English	Article							NITRIC-OXIDE; OXIDATIVE STRESS; ISOCITRATE DEHYDROGENASE; GENE-CLUSTER; TCA CYCLE; TOXICITY; PEROXYNITRITE; ALUMINUM; PYRUVATE; HEPATOCYTES	Nitrosative stress is an ongoing challenge that most organisms have to contend with. When nitric oxide (NO) that may be generated either exogenously or endogenously encounters reactive oxygen species (ROS), it produces a set of toxic moieties referred to as reactive nitrogen species (RNS). As these RNS can severely damage essential biomolecules, numerous organisms have evolved elaborate detoxification strategies to nullify RNS. However, the contribution of cellular metabolism in fending off nitrosative stress is poorly understood. Using a variety of functional proteomic and metabolomic analyses, we have identified how the soil microbe Pseudomonas fluorescens reprogrammed its metabolic networks to survive in an environment enriched by sodium nitroprusside (SNP), a generator of nitrosative stress. To combat the RNS-induced ineffective aconitase (ACN) and tricarboxylic acid (TCA) cycle, the microbe invoked the participation of citrate lyase (CL), phosphoenolpyruvate carboxylase (PEPC) and pyruvate phosphate dikinase (PPDK) to convert citrate, the sole source of carbon into pyruvate and ATP. These enzymes were not evident in the control conditions. This metabolic shift was coupled to the concomitant increase in the activities of such classical RNS detoxifiers as nitrate reductase (NR), nitrite reductase (NIR) and S-nitrosoglutathione reductase (GSNOR). Hence, metabolism may hold the clues to the survival of organisms subjected to nitrosative stress and may provide therapeutic cues against RNS-resistant microbes.	[Auger, Christopher; Lemire, Joseph; Cecchini, Dominic; Bignucolo, Adam; Appanna, Vasu D.] Laurentian Univ, Dept Chem & Biochem, Sudbury, ON P3E 2C6, Canada	Laurentian University	Auger, C (corresponding author), Laurentian Univ, Dept Chem & Biochem, Sudbury, ON P3E 2C6, Canada.	vappanna@laurentian.ca	Auger, Christopher/AAF-5757-2019	Appanna, Vasu/0000-0002-0138-5665	Laurentian University; Ontario graduate scholarship; Alexander Graham Bell Canada doctoral fellowship	Laurentian University; Ontario graduate scholarship(Ontario Graduate Scholarship); Alexander Graham Bell Canada doctoral fellowship	This work was funded by Laurentian University. C. Auger is supported by a doctoral Ontario graduate scholarship and J. Lemire is a recipient of the Alexander Graham Bell Canada doctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benhar M, 2009, NAT REV MOL CELL BIO, V10, P721, DOI 10.1038/nrm2764; Blancato VS, 2008, J BACTERIOL, V190, P7419, DOI 10.1128/JB.01704-07; Borisov VB, 2009, J INORG BIOCHEM, V103, P1185, DOI 10.1016/j.jinorgbio.2009.06.002; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buch A, 2010, BIORESOURCE TECHNOL, V101, P679, DOI 10.1016/j.biortech.2009.08.075; Chenier D, 2008, APPL ENVIRON MICROB, V74, P3977, DOI 10.1128/AEM.02702-07; Das UN, 2006, NUTRITION, V22, P965, DOI 10.1016/j.nut.2006.05.009; Denayer S, 2006, FEMS MICROBIOL LETT, V264, P59, DOI 10.1111/j.1574-6968.2006.00435.x; Durzan DJ, 2002, BIOTECHNOL GENET ENG, V19, P293, DOI 10.1080/02648725.2002.10648032; Emre Y, 2010, FEBS LETT, V584, P1437, DOI 10.1016/j.febslet.2010.03.014; Frenzel J, 2005, GLIA, V52, P276, DOI 10.1002/glia.20244; Gebicka L, 2009, J INORG BIOCHEM, V103, P1375, DOI 10.1016/j.jinorgbio.2009.07.011; GIBSON A, 1992, BRIT J PHARMACOL, V107, P715, DOI 10.1111/j.1476-5381.1992.tb14512.x; Heinzelmann S, 2010, BIOL CHEM, V391, P675, DOI 10.1515/BC.2010.068; Kanao T, 2001, EUR J BIOCHEM, V268, P1670, DOI 10.1046/j.1432-1033.2001.02034.x; Lee JH, 2003, J BIOL CHEM, V278, P51360, DOI 10.1074/jbc.M302332200; Lemire J, 2008, J APPL TOXICOL, V28, P175, DOI 10.1002/jat.1263; Mailloux RJ, 2007, TOXICOL IN VITRO, V21, P16, DOI 10.1016/j.tiv.2006.07.013; Mailloux RJ, 2006, J BIOCHEM MOL TOXIC, V20, P198, DOI 10.1002/jbt.20137; Mailloux RJ, 2009, J BACTERIOL, V191, P3804, DOI 10.1128/JB.00046-09; Mailloux RJ, 2009, BIOCHIMIE, V91, P408, DOI 10.1016/j.biochi.2008.10.014; McLean S, 2010, J BIOL CHEM, V285, P20724, DOI 10.1074/jbc.M109.085506; Middaugh J, 2005, J BIOL CHEM, V280, P3159, DOI 10.1074/jbc.M411979200; Miranda KM, 2001, NITRIC OXIDE-BIOL CH, V5, P62, DOI 10.1006/niox.2000.0319; Pelletier AM, 2010, AM J PHYSIOL-GASTR L, V298, pG896, DOI 10.1152/ajpgi.00259.2009; Poole RK, 2005, BIOCHEM SOC T, V33, P176, DOI 10.1042/BST0330176; Pun PBL, 2010, MITOCHONDRION, V10, P83, DOI 10.1016/j.mito.2009.12.142; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Schneider K, 2002, J BACTERIOL, V184, P2439, DOI 10.1128/JB.184.9.2439-2446.2002; Singh R, 2005, J BIOCHEM BIOPH METH, V64, P189, DOI 10.1016/j.jbbm.2005.07.005; Singh R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002682; Tortora V, 2007, FREE RADICAL BIO MED, V42, P1075, DOI 10.1016/j.freeradbiomed.2007.01.007; van Wonderen JH, 2008, J BIOL CHEM, V283, P9587, DOI 10.1074/jbc.M709090200; Varela-Gomez M, 2004, J BIOL CHEM, V279, P54124, DOI 10.1074/jbc.M401697200; Varma SD, 2007, MOL CELL BIOCHEM, V298, P199, DOI 10.1007/s11010-006-9352-y	35	36	36	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2011	6	12							e28469	10.1371/journal.pone.0028469	http://dx.doi.org/10.1371/journal.pone.0028469			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MQ	22145048	Green Published, gold			2022-12-27	WOS:000298168900031
J	Denison, FC; Smith, LB; Muckett, PJ; O'Hara, L; Carling, D; Woods, A				Denison, Fiona C.; Smith, Lee B.; Muckett, Phillip J.; O'Hara, Laura; Carling, David; Woods, Angela			LKB1 Is an Essential Regulator of Spermatozoa Release during Spermiation in the Mammalian Testis	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; PEUTZ-JEGHERS-SYNDROME; TUMOR-SUPPRESSOR LKB1; ECTOPLASMIC SPECIALIZATION; SEMINIFEROUS EPITHELIUM; JUNCTION DYNAMICS; SPLICE VARIANT; MALE-FERTILITY; SPERMATOGENESIS; SUBSTRATE	LKB1 acts as a master upstream protein kinase regulating a number of kinases involved in diverse cellular functions. Recent studies have suggested a role for LKB1 in male fertility. Male mice with reduced total LKB1 expression, including the complete absence of the major splice variant in testis (LKB1(S)), are completely infertile. We sought to further characterise these mice and determine the mechanism underlying this infertility. This involved expression studies of LKB1 in developing germ cells, morphological analysis of mature spermatozoa and histological studies of both the testis and epididymis using light microscopy and transmission electron microscopy. We conclude that a defect in the release of mature spermatids from the seminiferous epithelium (spermiation) during spermatozoan development is a major cause of the infertility phenotype. We also present evidence that this is due, at least in part, to defects in the breakdown of the junctions, known as ectoplasmic specialisations, between the sertoli cells of the testis epithelium and the heads of the maturing spermatids. Overall this study uncovers a critical role for LKB1 in spermiation, a highly regulated, but poorly understood process vital for male fertility.	[Denison, Fiona C.; Muckett, Phillip J.; Carling, David; Woods, Angela] Univ London Imperial Coll Sci Technol & Med, MRC, Ctr Clin Sci, London, England; [Smith, Lee B.; O'Hara, Laura] Univ Edinburgh, MRC, Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland	Imperial College London; University of Edinburgh	Denison, FC (corresponding author), Univ London Imperial Coll Sci Technol & Med, MRC, Ctr Clin Sci, London, England.	angela.woods@csc.mrc.ac.uk	Carling, David/F-1943-2014; Smith, Lee B/J-4861-2013	Carling, David/0000-0002-2316-1830; O'Hara, Laura/0000-0001-7790-9261; Smith, Lee/0000-0002-4103-3074	UK Medical Research Council; BBSRC-CASE; Unilever Discover; Medical Research Council [G1100354, MC_U120027537, G1002033] Funding Source: researchfish; MRC [G1002033, G1100354] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC-CASE(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Unilever Discover(Unilever); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was funded by the UK Medical Research Council. FCD was the recipient of a BBSRC-CASE PhD studentship with Unilever Discover. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Haila A, 2000, ARCH BIOCHEM BIOPHYS, V379, P173, DOI 10.1006/abbi.2000.1880; Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; Amin N, 2009, P NATL ACAD SCI USA, V106, P8941, DOI 10.1073/pnas.0812469106; Baas AF, 2003, EMBO J, V22, P3062, DOI 10.1093/emboj/cdg292; Beardsley A, 2003, BIOL REPROD, V68, P1299, DOI 10.1095/biolreprod.102.009811; Borg CL, 2010, HUM REPROD UPDATE, V16, P205, DOI 10.1093/humupd/dmp032; Boudeau J, 2003, EMBO J, V22, P5102, DOI 10.1093/emboj/cdg490; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bright NJ, 2009, ACTA PHYSIOL, V196, P15, DOI 10.1111/j.1748-1716.2009.01971.x; Cheung PCF, 2000, BIOCHEM J, V346, P659, DOI 10.1042/0264-6021:3460659; DALE S, 1995, FEBS LETT, V361, P191, DOI 10.1016/0014-5793(95)00172-6; Denison FC, 2009, J BIOL CHEM, V284, P67, DOI 10.1074/jbc.M806153200; Drewes G, 1997, CELL, V89, P297, DOI 10.1016/S0092-8674(00)80208-1; Fogarty S, 2009, J BIOL CHEM, V284, P77, DOI 10.1074/jbc.M806152200; Galardo MN, 2007, J MOL ENDOCRINOL, V39, P279, DOI 10.1677/JME-07-0054; Guttman JA, 2000, J CELL SCI, V113, P2167; Guttman JA, 2004, BIOL REPROD, V71, P548, DOI 10.1095/biolreprod.104.028803; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hemminki A, 1998, NATURE, V391, P184, DOI 10.1038/34432; Hemminki A, 1997, NAT GENET, V15, P87, DOI 10.1038/ng0197-87; Hezel AF, 2008, MOL CELL BIOL, V28, P2414, DOI 10.1128/MCB.01621-07; Jaleel M, 2005, FEBS LETT, V579, P1417, DOI 10.1016/j.febslet.2005.01.042; Jenne DE, 1998, NAT GENET, V18, P38, DOI 10.1038/ng0198-38; Kojima Y, 2007, J BIOL CHEM, V282, P23532, DOI 10.1074/jbc.M700590200; Lefebvre DL, 2005, BBA-GEN SUBJECTS, V1724, P71, DOI 10.1016/j.bbagen.2005.03.015; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Martianov I, 2005, P NATL ACAD SCI USA, V102, P2808, DOI 10.1073/pnas.0406060102; MOORE HDM, 1987, GAMETE RES, V17, P245, DOI 10.1002/mrd.1120170308; O'Bryan MK, 2008, DEV BIOL, V316, P359, DOI 10.1016/j.ydbio.2008.01.042; O'Donnell Liza, 2011, Spermatogenesis, V1, P14; O'Hara L, 2011, ENDOCRINOLOGY, V152, P718, DOI 10.1210/en.2010-0928; Rainey MA, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-37; Riera MF, 2009, AM J PHYSIOL-ENDOC M, V297, pE907, DOI 10.1152/ajpendo.00235.2009; Russell L. D., 1990, HISTOLOGICAL HISTOPA; RUSSELL LD, 1993, SERTOLI CELL, P269; Sakamoto K, 2005, EMBO J, V24, P1810, DOI 10.1038/sj.emboj.7600667; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Siu MKY, 2003, ENDOCRINOLOGY, V144, P2141, DOI 10.1210/en.2002-221035; Smith DP, 1999, HUM MOL GENET, V8, P1479, DOI 10.1093/hmg/8.8.1479; Towler MC, 2008, BIOCHEM J, V416, P1, DOI 10.1042/BJ20081447; Welsh M, 2009, FASEB J, V23, P4218, DOI 10.1096/fj.09-138347; Wong CH, 2005, ENDOCRINOLOGY, V146, P1192, DOI 10.1210/en.2004-1275; Wong EWP, 2008, P NATL ACAD SCI USA, V105, P9657, DOI 10.1073/pnas.0801527105; Wong EWP, 2008, BBA-BIOMEMBRANES, V1778, P692, DOI 10.1016/j.bbamem.2007.11.006; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Woods A, 1996, FEBS LETT, V397, P347, DOI 10.1016/S0014-5793(96)01209-4; Woods A, 2011, BIOCHEM J, V434, P49, DOI 10.1042/BJ20101721; Yan HHN, 2007, BIOESSAYS, V29, P36, DOI 10.1002/bies.20513; Ylikorkala A, 2001, SCIENCE, V293, P1323, DOI 10.1126/science.1062074; Zhang JY, 2005, ENDOCRINOLOGY, V146, P1268, DOI 10.1210/en.2004-1194; Zheng B, 2007, P NATL ACAD SCI USA, V104, P819, DOI 10.1073/pnas.0610157104	51	23	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2011	6	12							e28306	10.1371/journal.pone.0028306	http://dx.doi.org/10.1371/journal.pone.0028306			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MQ	22145035	Green Published, gold, Green Submitted			2022-12-27	WOS:000298168900018
J	McFarlane, R; Becker, N; Field, H				McFarlane, Rosemary; Becker, Niels; Field, Hume			Investigation of the Climatic and Environmental Context of Hendra Virus Spillover Events 1994-2010	PLOS ONE			English	Article							SUSCEPTIBILITY; SEASONALITY; INFECTION; LANDSCAPE; DYNAMICS; DRIVEN; BATS	Hendra virus is a recently emerged bat-borne zoonotic agent with high lethality in horses and humans in Australia. This is a rare disease and the determinants of bat to horse transmission, including the factors that bring these hosts together at critical times, are poorly understood. In this cross-disciplinary study climatic and vegetation primary productivity variables are compared for the dispersed and heterogenic 1994-2010 outbreak sites. The significant occurrence of spillover events within the dry season (p = 0.013, 95% CI (0.57-0.98)) suggests seasonal forcing of transmission across species, or seasonal forcing of virus excretion by the reservoir host. We explore the evidence for both. Preliminary investigations of the spatial determinants of Hendra disease locations are also presented. We find that postal areas in the Australian state of Queensland in which pteropid fruit bat (flying fox) roosts occur are approximately forty times more likely (OR = 40.5, (95% CI (5.16, 317.52)) to be the location of Hendra spillover events. This appears to be independent of density of horses at these locations. We consider issues of scale of host resource use, land use change and limitations of existing data that challenge analysis and limit further conclusive outcomes. This investigation of a broad range of potential climatic and environmental influences provides a good base for future investigations. Further understanding of cross-species Hendra virus transmission requires better understanding of flying fox resource use in the urban-rural landscape.	[McFarlane, Rosemary; Becker, Niels] Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia; [Field, Hume] Biosecur Queensland DEEDI, Queensland Ctr Emerging Infect Dis, Brisbane, Qld, Australia	Australian National University	McFarlane, R (corresponding author), Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia.	romcfarlane@gmail.com		McFarlane, Rosemary/0000-0001-8859-3776	Australian Biosecurity Cooperative Research Centre for Emerging Infectious Diseases	Australian Biosecurity Cooperative Research Centre for Emerging Infectious Diseases(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	This study was funded by the Australian Biosecurity Cooperative Research Centre for Emerging Infectious Diseases (http://www.abcrc.org.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altizer S, 2006, ECOL LETT, V9, P467, DOI 10.1111/j.1461-0248.2005.00879.x; Berry S, 2010, GREEN CARBON: THE ROLE OF NATURAL FORESTS IN CARBON STORAGE, PT 2: BIOMASS CARBON STOCKS IN THE GREAT WESTERN WOODLANDS, P1; BiosecurityQueensland, 2011, GUID VET HANDL POT H; Daszak P, 2006, DIS ECOLOGY COMMUNIT; *DEP ENV WAT RES, 2007, AUSTR NAT VEG SUMM A; Donohue RJ, 2008, REMOTE SENS ENVIRON, V112, P2938, DOI 10.1016/j.rse.2008.02.008; Dowell SF, 2001, EMERG INFECT DIS, V7, P369; Field H., 2005, ECOLOGY HENDRA VIRUS; Field HE, 2007, AUST VET J, V85, P268, DOI 10.1111/j.1751-0813.2007.00170.x; Fisman DN, 2007, ANNU REV PUBL HEALTH, V28, P127, DOI 10.1146/annurev.publhealth.28.021406.144128; Fogarty R, 2008, VIRUS RES, V132, P140, DOI 10.1016/j.virusres.2007.11.010; Gilbert M, 2007, AGR ECOSYST ENVIRON, V119, P409, DOI 10.1016/j.agee.2006.09.001; Grassly NC, 2006, P ROY SOC B-BIOL SCI, V273, P2541, DOI 10.1098/rspb.2006.3604; Hall L.S., 2000, FLYING FOXES FRUIT B; Halpin K., 1996, Communicable Diseases Intelligence, V20, P476; Halpin K, 2000, J GEN VIROL, V81, P1927, DOI 10.1099/0022-1317-81-8-1927; Kausrud KL, 2007, P ROY SOC B-BIOL SCI, V274, P1963, DOI 10.1098/rspb.2007.0568; Klein SL, 2000, BEHAV PROCESS, V51, P149, DOI 10.1016/S0376-6357(00)00125-X; Langlois JP, 2001, LANDSCAPE ECOL, V16, P255, DOI 10.1023/A:1011148316537; Lee PF, 2004, J BIOGEOGR, V31, P307, DOI 10.1046/j.0305-0270.2003.00988.x; Linthicum KJ, 1999, SCIENCE, V285, P397, DOI 10.1126/science.285.5426.397; Markus N, 2004, WILDLIFE RES, V31, P345, DOI 10.1071/WR01117; Patz JA, 2000, INT J PARASITOL, V30, P1395, DOI 10.1016/S0020-7519(00)00141-7; Peterson AT, 2004, EMERG INFECT DIS, V10, P40, DOI 10.3201/eid1001.030125; Pinzon JE, 2004, AM J TROP MED HYG, V71, P664, DOI 10.4269/ajtmh.2004.71.664; Plowright R, 2008, FRONT ECOL ENV, V6; Plowright RK, 2008, P ROY SOC B-BIOL SCI, V275, P861, DOI 10.1098/rspb.2007.1260; Plowright RK, 2011, P ROY SOC B-BIOL SCI, V278, P3703, DOI 10.1098/rspb.2011.0522; Relman DA, 2008, CLIMATE ECOLOGY INFE, P104; Sergeant E.S.G., 2018, EPITOOLS EPIDEMIOLOG; Stenseth NC, 2006, P NATL ACAD SCI USA, V103, P13110, DOI 10.1073/pnas.0602447103; Tucker C, 2002, EBOLA OUTBREAKS PHOT, V68; Wacharapluesadee S, 2010, VECTOR-BORNE ZOONOT, V10, P183, DOI 10.1089/vbz.2008.0105; Williamson MM, 1998, AUST VET J, V76, P813, DOI 10.1111/j.1751-0813.1998.tb12335.x; Williamson MM, 2000, J COMP PATHOL, V122, P201, DOI 10.1053/jcpa.1999.0364	35	32	33	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2011	6	12							e28374	10.1371/journal.pone.0028374	http://dx.doi.org/10.1371/journal.pone.0028374			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MQ	22145039	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000298168900022
J	Pilotte, J; Dupont-Versteegden, EE; Vanderklish, PW				Pilotte, Julie; Dupont-Versteegden, Esther E.; Vanderklish, Peter W.			Widespread Regulation of miRNA Biogenesis at the Dicer Step by the Cold-Inducible RNA-Binding Protein, RBM3	PLOS ONE			English	Article							SPINAL-CORD-INJURY; MICRORNA BIOGENESIS; LET-7 MICRORNA; POSTTRANSCRIPTIONAL REGULATION; THERAPEUTIC HYPOTHERMIA; MESSENGER-RNA; HNRNP A1; EXPRESSION; GENES; CELLS	MicroRNAs (miRNAs) play critical roles in diverse cellular events through their effects on translation. Emerging data suggest that modulation of miRNA biogenesis at post-transcriptional steps by RNA-binding proteins is a key point of regulatory control over the expression of some miRNAs and the cellular processes they influence. However, the extent and conditions under which the miRNA pathway is amenable to regulation at posttranscriptional steps are poorly understood. Here we show that RBM3, a cold-inducible, developmentally regulated RNA-binding protein and putative protooncogene, is an essential regulator of miRNA biogenesis. Utilizing miRNA array, Northern blot, and PCR methods, we observed that over 60% of miRNAs detectable in a neuronal cell line were significantly downregulated by knockdown of RBM3. Conversely, for select miRNAs assayed by Northern blot, induction of RBM3 by overexpression or mild hypothermia increased their levels. Changes in miRNA expression were accompanied by changes in the levels of their similar to 70 nt precursors, whereas primary transcript levels were unaffected. Mechanistic studies revealed that knockdown of RBM3 does not reduce Dicer activity or impede transport of pre-miRNAs into the cytoplasm. Rather, we find that RBM3 binds directly to similar to 70 nt pre-miRNA intermediates and promotes / de-represses their ability as larger ribonucleoproteins (pre-miRNPs) to associate with active Dicer complexes. Our findings suggest that the processing of a majority of pre-miRNPs by Dicer is subject to an intrinsic inhibitory influence that is overcome by RBM3 expression. RBM3 may thus orchestrate changes in miRNA expression during hypothermia and other cellular stresses, and in the euthermic contexts of early development, differentiation, and oncogenesis where RBM3 expression is highly elevated. Additionally, our data suggest that temperature-dependent changes in miRNA expression mediated by RBM3 may contribute to the therapeutic effects of hypothermia, and are an important variable to consider in in vitro studies of translation-dependent cellular events.	[Pilotte, Julie; Vanderklish, Peter W.] Scripps Res Inst, Dept Neurobiol, La Jolla, CA 92037 USA; [Dupont-Versteegden, Esther E.] Univ Kentucky, Dept Rehabil Sci, Coll Hlth Sci, Lexington, KY USA	Scripps Research Institute; University of Kentucky	Pilotte, J (corresponding author), Scripps Res Inst, Dept Neurobiol, La Jolla, CA 92037 USA.	pvanderk@scripps.edu			NINDS [R01NS066053]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS066053] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a grant from NINDS (R01NS066053) to P. W. V. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Cheng HYM, 2007, NEURON, V54, P813, DOI 10.1016/j.neuron.2007.05.017; Chip S, 2011, NEUROBIOL DIS, V43, P388, DOI 10.1016/j.nbd.2011.04.010; Danno S, 1997, BIOCHEM BIOPH RES CO, V236, P804, DOI 10.1006/bbrc.1997.7059; Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; Dietrich WD, 2009, J NEUROTRAUM, V26, P301, DOI 10.1089/neu.2008.0806; Dietrich WD, 2009, CRIT CARE MED, V37, pS238, DOI 10.1097/CCM.0b013e3181aa5d85; Dresios J, 2005, P NATL ACAD SCI USA, V102, P1865, DOI 10.1073/pnas.0409764102; Ferry AL, 2011, J CELL PHYS IN PRESS, DOI 0.1152/ajpcell.00098.2011; Filipowicz W, 2005, CURR OPIN STRUC BIOL, V15, P331, DOI 10.1016/j.sbi.2005.05.006; Forman JJ, 2008, P NATL ACAD SCI USA, V105, P14879, DOI 10.1073/pnas.0803230105; Gao FB, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-25; Gao J, 2010, NATURE, V466, P1105, DOI 10.1038/nature09271; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Guil S, 2007, NAT STRUCT MOL BIOL, V14, P591, DOI 10.1038/nsmb1250; Haase AD, 2005, EMBO REP, V6, P961, DOI 10.1038/sj.embor.7400509; Hagan JP, 2009, NAT STRUCT MOL BIOL, V16, P1021, DOI 10.1038/nsmb.1676; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Heo I, 2009, CELL, V138, P696, DOI 10.1016/j.cell.2009.08.002; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kedde M, 2007, CELL, V131, P1273, DOI 10.1016/j.cell.2007.11.034; Kita H, 2002, HUM MOL GENET, V11, P2279, DOI 10.1093/hmg/11.19.2279; Kole AJ, 2011, GENE DEV, V25, P125, DOI 10.1101/gad.1975411; Lampe JW, 2011, ANNU REV MED, V62, P79, DOI 10.1146/annurev-med-052009-150512; Leuschner PJF, 2007, METHODS, V43, P105, DOI 10.1016/j.ymeth.2007.04.005; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Michlewski G, 2010, NAT STRUCT MOL BIOL, V17, P1011, DOI 10.1038/nsmb.1874; Nodin B, 2011, TRANSL ONCOL, V4, P212; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; Okamura K, 2007, CELL, V130, P89, DOI 10.1016/j.cell.2007.06.028; Pilotte J, 2009, BRAIN RES, V1258, P12, DOI 10.1016/j.brainres.2008.12.050; Politz JCR, 2006, P NATL ACAD SCI USA, V103, P18957, DOI 10.1073/pnas.0609466103; Politz JCR, 2009, RNA, V15, P1705, DOI 10.1261/rna.1470409; Ruby JG, 2007, NATURE, V448, P83, DOI 10.1038/nature05983; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; SCHUBERT D, 1974, NATURE, V249, P224, DOI 10.1038/249224a0; Shibata M, 2011, J NEUROSCI, V31, P3407, DOI 10.1523/JNEUROSCI.5085-10.2011; Siomi H, 2010, MOL CELL, V38, P323, DOI 10.1016/j.molcel.2010.03.013; Smart F, 2007, J NEUROCHEM, V101, P1367, DOI 10.1111/j.1471-4159.2007.04521.x; Smyth GK, 2003, METHODS SELECTING CA, P265; Sureban SM, 2008, ONCOGENE, V27, P4544, DOI 10.1038/onc.2008.97; Trabucchi M, 2009, NATURE, V459, P1010, DOI 10.1038/nature08025; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Wellmann S, 2004, J CELL SCI, V117, P1785, DOI 10.1242/jcs.01026; Williams DR, 2005, PHYSIOL GENOMICS, V24, P13, DOI 10.1152/physiolgenomics.00301.2004; Wulczyn FG, 2007, FASEB J, V21, P415, DOI 10.1096/fj.06-6130com; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Yang YH, 2001, PROC SPIE, V4266, P141, DOI 10.1117/12.427982; Zeng Y, 2009, J CELL BIOCHEM, V107, P179, DOI 10.1002/jcb.22114	53	60	66	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2011	6	12							e28446	10.1371/journal.pone.0028446	http://dx.doi.org/10.1371/journal.pone.0028446			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MQ	22145045	Green Published, Green Submitted, gold			2022-12-27	WOS:000298168900028
J	Chowda-Reddy, RV; Sun, HY; Hill, JH; Poysa, V; Wang, AM				Chowda-Reddy, R. V.; Sun, Haiyue; Hill, John H.; Poysa, Vaino; Wang, Aiming			Simultaneous Mutations in Multi-Viral Proteins Are Required for Soybean mosaic virus to Gain Virulence on Soybean Genotypes Carrying Different R Genes	PLOS ONE			English	Article							SILENCING SUPPRESSION ACTIVITY; HELPER COMPONENT PROTEINASE; LONG-DISTANCE MOVEMENT; RESISTANCE GENE; P3 PROTEIN; ELICITOR FUNCTION; CI PROTEIN; CELL-DEATH; POTYVIRUS; GENOME	Background: Genetic resistance is the most effective and sustainable approach to the control of plant pathogens that are a major constraint to agriculture worldwide. In soybean, three dominant R genes, i.e., Rsv1, Rsv3 and Rsv4, have been identified and deployed against Soybean mosaic virus (SMV) with strain-specificities. Molecular identification of virulent determinants of SMV on these resistance genes will provide essential information for the proper utilization of these resistance genes to protect soybean against SMV, and advance knowledge of virus-host interactions in general. Methodology/Principal Findings: To study the gain and loss of SMV virulence on all the three resistance loci, SMV strains G7 and two G2 isolates L and LRB were used as parental viruses. SMV chimeras and mutants were created by partial genome swapping and point mutagenesis and then assessed for virulence on soybean cultivars PI96983 (Rsv1), L-29 (Rsv3), V94-5152 (Rsv4) and Williams 82 (rsv). It was found that P3 played an essential role in virulence determination on all three resistance loci and CI was required for virulence on Rsv1- and Rsv3-genotype soybeans. In addition, essential mutations in HC-Pro were also required for the gain of virulence on Rsv1-genotype soybean. To our best knowledge, this is the first report that CI and P3 are involved in virulence on Rsv1- and Rsv3-mediated resistance, respectively. Conclusions/Significance: Multiple viral proteins, i.e., HC-Pro, P3 and CI, are involved in virulence on the three resistance loci and simultaneous mutations at essential positions of different viral proteins are required for an avirulent SMV strain to gain virulence on all three resistance loci. The likelihood of such mutations occurring naturally and concurrently on multiple viral proteins is low. Thus, incorporation of all three resistance genes in a soybean cultivar through gene pyramiding may provide durable resistance to SMV.	[Chowda-Reddy, R. V.; Sun, Haiyue; Wang, Aiming] Agr & Agri Food Canada, So Crop Protect & Food Res Ctr, London, ON, Canada; [Chowda-Reddy, R. V.] Univ Western Ontario, Dept Biol, London, ON, Canada; [Hill, John H.] Iowa State Univ, Dept Plant Pathol, Ames, IA USA; [Poysa, Vaino] Agr & Agri Food Canada, Greenhouse & Proc Crops Res Ctr, Harrow, ON, Canada	Agriculture & Agri Food Canada; Western University (University of Western Ontario); Iowa State University; Agriculture & Agri Food Canada	Chowda-Reddy, RV (corresponding author), Agr & Agri Food Canada, So Crop Protect & Food Res Ctr, London, ON, Canada.	Aiming.Wang@AGR.GC.CA			AAFC Canadian Crop Genomics Initiative; Grain Farmers of Ontario; Natural Sciences and Engineering Research Council of Canada	AAFC Canadian Crop Genomics Initiative(Agriculture & Agri Food Canada); Grain Farmers of Ontario; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by AAFC Canadian Crop Genomics Initiative, a research grant from Grain Farmers of Ontario, and a discover grant from the Natural Sciences and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Razzak A, 2009, MOL PLANT PATHOL, V10, P109, DOI 10.1111/j.1364-3703.2008.00513.x; Agudelo-Romero P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002397; Ala-Poikela M, 2011, J VIROL, V85, P6784, DOI 10.1128/JVI.00485-11; Bendahmane A, 1999, PLANT CELL, V11, P781, DOI 10.1105/tpc.11.5.781; Blanc S, 1997, VIROLOGY, V231, P141, DOI 10.1006/viro.1997.8521; Bonas U, 2002, CURR OPIN MICROBIOL, V5, P44, DOI 10.1016/S1369-5274(02)00284-9; BUSS GR, 1999, P WORLD SOYB RES C C; Carrington JC, 1998, PLANT J, V14, P393, DOI 10.1046/j.1365-313X.1998.00120.x; CHO EK, 1979, PHYTOPATHOLOGY, V69, P467, DOI 10.1094/Phyto-69-467; Choi BK, 2005, VIRUS RES, V112, P42, DOI 10.1016/j.virusres.2005.03.020; Chowda-Reddy RV, 2011, MOL PLANT MICROBE IN, V24, P37, DOI 10.1094/MPMI-07-10-0158; Chu MH, 1997, MOL PLANT MICROBE IN, V10, P472, DOI 10.1094/MPMI.1997.10.4.472; Chung BYW, 2008, P NATL ACAD SCI USA, V105, P5897, DOI 10.1073/pnas.0800468105; Cui XY, 2011, SOYBEAN - MOLECULAR ASPECTS OF BREEDING, P335; Cui XY, 2010, VIROLOGY, V397, P56, DOI 10.1016/j.virol.2009.11.015; CULVER JN, 1991, ANNU REV PHYTOPATHOL, V29, P193, DOI 10.1146/annurev.py.29.090191.001205; Dinesh-Kumar SP, 2000, P NATL ACAD SCI USA, V97, P14789, DOI 10.1073/pnas.97.26.14789; Dodds PN, 2010, SCIENCE, V330, P1486, DOI 10.1126/science.1200245; Drake JW, 1999, P NATL ACAD SCI USA, V96, P13910, DOI 10.1073/pnas.96.24.13910; Eggenberger AL, 2008, MOL PLANT MICROBE IN, V21, P931, DOI 10.1094/MPMI-21-7-0931; GACIAARENAL F, 2003, INT MICROBIOL, V6, P225; Gagarinova AG, 2008, VIRUS RES, V138, P50, DOI 10.1016/j.virusres.2008.08.010; Gore MA, 2002, GENOME, V45, P592, DOI 10.1139/G02-009; Gunduz I, 2004, PHYTOPATHOLOGY, V94, P687, DOI 10.1094/PHYTO.2004.94.7.687; Gunduz I, 2002, CROP SCI, V42, P90, DOI 10.2135/cropsci2002.0090; Hajimorad MR, 2008, MOL PLANT MICROBE IN, V21, P937, DOI 10.1094/MPMI-21-7-0937; Hajimorad MR, 2011, J VIROL, V85, P2557, DOI 10.1128/JVI.01935-10; Hajimorad MR, 2006, VIROLOGY, V345, P156, DOI 10.1016/j.virol.2005.09.055; Hajimorad MR, 2005, J VIROL, V79, P1215, DOI 10.1128/JVI.79.2.1215-1222.2005; Hajimorad MR, 2003, VIROLOGY, V314, P497, DOI 10.1016/S0042-6822(03)00456-2; Hajimorad MR, 2001, MOL PLANT MICROBE IN, V14, P587, DOI 10.1094/MPMI.2001.14.5.587; Hayes AJ, 2000, CROP SCI, V40, P1434, DOI 10.2135/cropsci2000.4051434x; Hjulsager CK, 2006, VIROLOGY, V355, P52, DOI 10.1016/j.virol.2006.07.016; Janzac B, 2009, MOL PLANT PATHOL, V10, P599, DOI [10.1111/j.1364-3703.2009.00554.x, 10.1111/J.1364-3703.2009.00554.X]; Jenner CE, 2003, MOL PLANT MICROBE IN, V16, P777, DOI 10.1094/MPMI.2003.16.9.777; Jenner CE, 2002, VIROLOGY, V300, P50, DOI 10.1006/viro.2002.1519; Jenner CE, 2000, MOL PLANT MICROBE IN, V13, P1102, DOI 10.1094/MPMI.2000.13.10.1102; Jeong SC, 2002, CROP SCI, V42, P265, DOI 10.2135/cropsci2002.0265; Kang BC, 2005, ANNU REV PHYTOPATHOL, V43, P581, DOI 10.1146/annurev.phyto.43.011205.141140; Kasschau KD, 2001, VIROLOGY, V285, P71, DOI 10.1006/viro.2001.0901; Kasschau KD, 1998, CELL, V95, P461, DOI 10.1016/S0092-8674(00)81614-1; Kekarainen T, 2002, GENOME RES, V12, P584, DOI 10.1101/gr.220702; Kim BM, 2010, MOL PLANT MICROBE IN, V23, P144, DOI 10.1094/MPMI-23-2-0144; Kim YH, 2003, PLANT DIS, V87, P1372, DOI 10.1094/PDIS.2003.87.11.1372; KLEIN PG, 1994, VIROLOGY, V204, P759, DOI 10.1006/viro.1994.1591; Liao L, 2002, J HERED, V93, P447, DOI 10.1093/jhered/93.6.447; Malpica JM, 2002, GENETICS, V162, P1505; Maroof MAS, 2010, PLANT GENOME-US, V3, P14, DOI 10.3835/plantgenome2009.07.0020; Merits A, 1999, VIROLOGY, V263, P15, DOI 10.1006/viro.1999.9926; Montarry J, 2011, MOL PLANT PATHOL, V12, P911, DOI [10.1111/J.1364-3703.2011.00724.X, 10.1111/j.1364-3703.2011.00724.x]; Moury B, 2011, MOL PLANT MICROBE IN, V24, P787, DOI 10.1094/MPMI-10-10-0246; Saenz P, 2002, J VIROL, V76, P1922, DOI 10.1128/JVI.76.4.1922-1931.2002; Seo JK, 2011, ARCH VIROL, V156, P135, DOI 10.1007/s00705-010-0829-3; Seo JK, 2009, VIROLOGY, V393, P91, DOI 10.1016/j.virol.2009.07.007; Seo JK, 2009, MOL PLANT MICROBE IN, V22, P1151, DOI 10.1094/MPMI-22-9-1151; Shiboleth YM, 2007, J VIROL, V81, P13135, DOI 10.1128/JVI.01031-07; Soosaar JLM, 2005, NAT REV MICROBIOL, V3, P789, DOI 10.1038/nrmicro1239; Torres-Barcelo C, 2008, GENETICS, V180, P1039, DOI 10.1534/genetics.108.091363; Tromas N, 2010, GENETICS, V185, P983, DOI 10.1534/genetics.110.115915; Urcuqui-Inchima S, 2001, VIRUS RES, V74, P157, DOI 10.1016/S0168-1702(01)00220-9; Wei TY, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000962; Wen RH, 2011, MOL PLANT PATHOL, V12, P799, DOI [10.1111/J.1364-3703.2011.00714.X, 10.1111/j.1364-3703.2011.00714.x]; Yambao MLM, 2008, ARCH VIROL, V153, P105, DOI 10.1007/s00705-007-1073-3; Zhang CQ, 2009, VIROLOGY, V391, P240, DOI 10.1016/j.virol.2009.06.020; Zheng C, 2005, CROP SCI, V45, P2503, DOI 10.2135/cropsci2005.0114	65	25	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e28342	10.1371/journal.pone.0028342	http://dx.doi.org/10.1371/journal.pone.0028342			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140577	Green Published, gold, Green Submitted			2022-12-27	WOS:000298168100065
J	Diotel, N; Servili, A; Gueguen, MM; Mironov, S; Pellegrini, E; Vaillant, C; Zhu, Y; Kah, O; Anglade, I				Diotel, Nicolas; Servili, Arianna; Gueguen, Marie-Madeleine; Mironov, Svetlana; Pellegrini, Elisabeth; Vaillant, Colette; Zhu, Yong; Kah, Olivier; Anglade, Isabelle			Nuclear Progesterone Receptors Are Up-Regulated by Estrogens in Neurons and Radial Glial Progenitors in the Brain of Zebrafish	PLOS ONE			English	Article							STEROID-HORMONE RECEPTORS; DEVELOPING PURKINJE-CELL; SYNTHESIZED DE-NOVO; NEURAL STEM-CELLS; ADULT MALE-MICE; CEREBRAL-CORTEX; VENTRICULAR ZONE; NEWBORN NEURONS; NERVOUS-SYSTEM; MESSENGER-RNA	In rodents, there is increasing evidence that nuclear progesterone receptors are transiently expressed in many regions of the developing brain, notably outside the hypothalamus. This suggests that progesterone and/or its metabolites could be involved in functions not related to reproduction, particularly in neurodevelopment. In this context, the adult fish brain is of particular interest, as it exhibits constant growth and high neurogenic activity that is supported by radial glia progenitors. However, although synthesis of neuroprogestagens has been documented recently in the brain of zebrafish, information on the presence of progesterone receptors is very limited. In zebrafish, a single nuclear progesterone receptor (pgr) has been cloned and characterized. Here, we demonstrate that this pgr is widely distributed in all regions of the zebrafish brain. Interestingly, we show that Pgr is strongly expressed in radial glial cells and more weakly in neurons. Finally, we present evidence, based on quantitative PCR and immunohistochemistry, that nuclear progesterone receptor mRNA and proteins are upregulated by estrogens in the brain of adult zebrafish. These data document for the first time the finding that radial glial cells are preferential targets for peripheral progestagens and/or neuroprogestagens. Given the crucial roles of radial glial cells in adult neurogenesis, the potential effects of progestagens on their activity and the fate of daughter cells require thorough investigation.	[Diotel, Nicolas; Servili, Arianna; Gueguen, Marie-Madeleine; Mironov, Svetlana; Pellegrini, Elisabeth; Vaillant, Colette; Kah, Olivier; Anglade, Isabelle] Univ Rennes 1, CNRS, UMR 6026, IFR140, Rennes, France; [Zhu, Yong] E Carolina Univ, Dept Biol, Greenville, NC USA	Centre National de la Recherche Scientifique (CNRS); Universite de Rennes; University of North Carolina; East Carolina University	Diotel, N (corresponding author), Univ Rennes 1, CNRS, UMR 6026, IFR140, Rennes, France.	olivier.kah@univ-rennes1.fr	GUEGUEN, marie madeleine/K-1731-2015; Vaillant-Capitaine, Colette CVC/K-1734-2015; Pellegrini, Elisabeth/K-1705-2015; Diotel, Nicolas/Y-1126-2019; kah, olivier/K-7624-2012	Pellegrini, Elisabeth/0000-0003-4821-0966; Diotel, Nicolas/0000-0003-2032-518X; Zhu, Yong/0000-0003-0374-485X; Servili, Arianna/0000-0002-6813-7500	ANR [CES 2008-011]; Post-Grenelle de l'Environnement NEMO;  [222719]	ANR(French National Research Agency (ANR)); Post-Grenelle de l'Environnement NEMO; 	The study was funded by the European project no 222719 (LIFECYCLE to OK), the ANR NEED (CES 2008-011), the Post-Grenelle de l'Environnement NEMO to OK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolf B, 2006, DEV BIOL, V295, P278, DOI 10.1016/j.ydbio.2006.03.023; BARHA CK, 2011, EXP NEUROL; Baulieu EE, 2000, STEROIDS, V65, P605, DOI 10.1016/S0039-128X(00)00173-2; Baulieu EE, 1997, RECENT PROG HORM RES, V52, P1; Bentivoglio M, 1999, BRAIN RES BULL, V49, P305, DOI 10.1016/S0361-9230(99)00065-9; Boonyaratanakornkit V, 2007, MOL ENDOCRINOL, V21, P359, DOI 10.1210/me.2006-0337; Brinton RD, 2008, FRONT NEUROENDOCRIN, V29, P313, DOI 10.1016/j.yfrne.2008.02.001; CAMERON RS, 1991, GLIA, V4, P124, DOI 10.1002/glia.440040204; Campbell K, 2002, TRENDS NEUROSCI, V25, P235, DOI 10.1016/S0166-2236(02)02156-2; Chapouton P, 2007, BIOESSAYS, V29, P745, DOI 10.1002/bies.20615; Chen SX, 2010, BIOL REPROD, V82, P171, DOI 10.1095/biolreprod.109.077644; Compagnone NA, 2000, FRONT NEUROENDOCRIN, V21, P1, DOI 10.1006/frne.1999.0188; Costa MR, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00026; Costa MR, 2010, BRAIN RES REV, V63, P47, DOI 10.1016/j.brainresrev.2010.01.002; DIOTEL N, 2011, EUR J NEUROSCI; Diotel N, 2010, J COMP NEUROL, V518, P4855, DOI 10.1002/cne.22492; Diotel N, 2010, FRONT NEUROENDOCRIN, V31, P172, DOI 10.1016/j.yfrne.2010.01.003; Do Rego JL, 2009, FRONT NEUROENDOCRIN, V30, P259, DOI 10.1016/j.yfrne.2009.05.006; DULKA JG, 1993, BRAIN BEHAV EVOLUT, V42, P265, DOI 10.1159/000114166; Forlano PM, 2001, J NEUROSCI, V21, P8943, DOI 10.1523/JNEUROSCI.21-22-08943.2001; Goodman YD, 1996, J NEUROCHEM, V66, P1836; Grandel H, 2006, DEV BIOL, V295, P263, DOI 10.1016/j.ydbio.2006.03.040; GRONEMEYER H, 1987, EMBO J, V6, P3985, DOI 10.1002/j.1460-2075.1987.tb02741.x; Hanna RN, 2010, BIOL REPROD, V82, P112, DOI 10.1095/biolreprod.109.078527; Hawkins MB, 2005, P ROY SOC B-BIOL SCI, V272, P633, DOI 10.1098/rspb.2004.3008; JIANG R, 2011, J NEUROTRAUMA; Jung-Testas I, 1998, J STEROID BIOCHEM, V65, P243, DOI 10.1016/S0960-0760(97)00191-X; Jung-Testas I, 1999, J STEROID BIOCHEM, V69, P97, DOI 10.1016/S0960-0760(98)00149-6; JUNGTESTAS I, 1992, J STEROID BIOCHEM, V41, P621, DOI 10.1016/0960-0760(92)90394-X; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Kudwa AE, 2009, PHYSIOL BEHAV, V97, P146, DOI 10.1016/j.physbeh.2009.02.023; Kudwa AE, 2004, ENDOCRINOLOGY, V145, P4500, DOI 10.1210/en.2003-1708; Kuo J, 2010, J NEUROSCI, V30, P12950, DOI 10.1523/JNEUROSCI.1158-10.2010; Labombarda F, 2010, NEUROSCIENCE, V166, P94, DOI 10.1016/j.neuroscience.2009.12.012; Lam CS, 2009, DEV DYNAM, V238, P475, DOI 10.1002/dvdy.21853; Le Page Y, 2010, EUR J NEUROSCI, V32, P2105, DOI 10.1111/j.1460-9568.2010.07519.x; Liu LF, 2010, ENDOCRINOLOGY, V151, P5782, DOI 10.1210/en.2010-0005; Lonstein JS, 2004, J NEUROENDOCRINOL, V16, P534, DOI 10.1111/j.1365-2826.2004.01198.x; Lopez V, 2009, J COMP NEUROL, V512, P124, DOI 10.1002/cne.21883; Marz M, 2010, GLIA, V58, P870, DOI 10.1002/glia.20971; McCarthy MM, 2009, NEUROSCIENTIST, V15, P599, DOI 10.1177/1073858409340924; Mellon SH, 2001, BRAIN RES REV, V37, P3, DOI 10.1016/S0165-0173(01)00109-6; Menuet A, 2005, J COMP NEUROL, V485, P304, DOI 10.1002/cne.20497; Menuet A, 2003, J COMP NEUROL, V462, P180, DOI 10.1002/cne.10726; Menuet A, 2002, BIOL REPROD, V66, P1881, DOI 10.1095/biolreprod66.6.1881; Micevych P, 2008, MOL CELL ENDOCRINOL, V290, P44, DOI 10.1016/j.mce.2008.04.016; Micevych P, 2010, NEUROENDOCRINOLOGY, V91, P211, DOI 10.1159/000289568; Micevych PE, 2007, ENDOCRINOLOGY, V148, P782, DOI 10.1210/en.2006-0774; MISSON JP, 1991, GLIA, V4, P138, DOI 10.1002/glia.440040205; Mitterling KL, 2010, J COMP NEUROL, V518, P2729, DOI 10.1002/cne.22361; Mouriec K, 2008, BRAIN RES BULL, V75, P274, DOI 10.1016/j.brainresbull.2007.10.030; Munchrath LA, 2010, J COMP NEUROL, V518, P3302, DOI 10.1002/cne.22401; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Noctor SC, 2002, J NEUROSCI, V22, P3161, DOI 10.1523/JNEUROSCI.22-08-03161.2002; Pellegrini E, 2007, J COMP NEUROL, V501, P150, DOI 10.1002/cne.21222; Pinto L, 2007, PROG NEUROBIOL, V83, P2, DOI 10.1016/j.pneurobio.2007.02.010; Pluchino N, 2009, MATURITAS, V62, P349, DOI 10.1016/j.maturitas.2008.11.023; Quadros PS, 2007, J COMP NEUROL, V504, P42, DOI 10.1002/cne.21427; RAKIC P, 1978, POSTGRAD MED J, V54, P25; ROTHENAIGNER I, 2011, DEVELOPMENT; Rowitch DH, 2010, NATURE, V468, P214, DOI 10.1038/nature09611; Sakamoto H, 2002, NEUROSCI LETT, V322, P111, DOI 10.1016/S0304-3940(02)00077-0; Sakamoto H, 2001, J COMP NEUROL, V439, P291, DOI 10.1002/cne.1351; Sakamoto H, 2001, J NEUROSCI, V21, P6221, DOI 10.1523/JNEUROSCI.21-16-06221.2001; SCHMECHEL DE, 1979, ANAT EMBRYOL, V156, P115, DOI 10.1007/BF00300010; SCHMECHEL DE, 1979, NATURE, V277, P303, DOI 10.1038/277303a0; Schumacher M, 2007, PHARMACOL THERAPEUT, V116, P77, DOI 10.1016/j.pharmthera.2007.06.001; STACEY NE, 1989, GEN COMP ENDOCR, V75, P62, DOI 10.1016/0016-6480(89)90008-7; Thomas P, 2008, FRONT NEUROENDOCRIN, V29, P292, DOI 10.1016/j.yfrne.2008.01.001; Tong SK, 2009, GENESIS, V47, P67, DOI 10.1002/dvg.20459; Tsutsui K, 1999, INT J MOL MED, V4, P49; Tsutsui K, 1999, COMP BIOCHEM PHYS C, V124, P121, DOI 10.1016/S0742-8413(99)00065-1; Vicent GP, 2008, J STEROID BIOCHEM, V109, P344, DOI 10.1016/j.jsbmb.2008.03.015; Vicent GP, 2006, ANN NY ACAD SCI, V1089, P59, DOI 10.1196/annals.1386.025; Wagner CK, 2001, J NEUROBIOL, V47, P176, DOI 10.1002/neu.1025; Wullimann MF, 1996, NEUROANATOMY ZEBRAFI, DOI 10.1007/978-3-0348-8979-7_6; Zhang Z, 2010, NEUROPHARMACOLOGY, V58, P930, DOI 10.1016/j.neuropharm.2010.01.002; Zhang Z, 2010, HIPPOCAMPUS, V20, P402, DOI 10.1002/hipo.20642; Zwain IH, 1999, ENDOCRINOLOGY, V140, P3843, DOI 10.1210/en.140.8.3843	79	33	35	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e28375	10.1371/journal.pone.0028375	http://dx.doi.org/10.1371/journal.pone.0028375			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140581	Green Published, Green Submitted, gold			2022-12-27	WOS:000298168100067
J	Rodas, C; Klena, JD; Nicklasson, M; Iniguez, V; Sjoling, A				Rodas, Claudia; Klena, John D.; Nicklasson, Matilda; Iniguez, Volga; Sjoling, Asa			Clonal Relatedness of Enterotoxigenic Escherichia coli (ETEC) Strains Expressing LT and CS17 Isolated from Children with Diarrhoea in La Paz, Bolivia	PLOS ONE			English	Article							COLONIZATION FACTORS; DEVELOPING-COUNTRIES; VIRULENCE FACTORS; EVOLUTIONARY; TOXINS; IDENTIFICATION; GENES	Background: Enterotoxigenic Escherichia coli (ETEC) is a major cause of traveller's and infantile diarrhoea in the developing world. ETEC produces two toxins, a heat-stable toxin (known as ST) and a heat-labile toxin (LT) and colonization factors that help the bacteria to attach to epithelial cells. Methodology/Principal Findings: In this study, we characterized a subset of ETEC clinical isolates recovered from Bolivian children under 5 years of age using a combination of multilocus sequence typing (MLST) analysis, virulence typing, serotyping and antimicrobial resistance test patterns in order to determine the genetic background of ETEC strains circulating in Bolivia. We found that strains expressing the heat-labile (LT) enterotoxin and colonization factor CS17 were common and belonged to several MLST sequence types but mainly to sequence type-423 and sequence type-443 (Achtman scheme). To further study the LT/CS17 strains we analysed the nucleotide sequence of the CS17 operon and compared the structure to LT/CS17 ETEC isolates from Bangladesh. Sequence analysis confirmed that all sequence type-423 strains from Bolivia had a single nucleotide polymorphism; SNPbol in the CS17 operon that was also found in some other MLST sequence types from Bolivia but not in strains recovered from Bangladeshi children. The dominant ETEC clone in Bolivia (sequence type-423/SNPbol) was found to persist over multiple years and was associated with severe diarrhoea but these strains were variable with respect to antimicrobial resistance patterns. Conclusion/Significance: The results showed that although the LT/CS17 phenotype is common among ETEC strains in Bolivia, multiple clones, as determined by unique MLST sequence types, populate this phenotype. Our data also appear to suggest that acquisition and loss of antimicrobial resistance in LT-expressing CS17 ETEC clones is more dynamic than acquisition or loss of virulence factors.	[Rodas, Claudia; Nicklasson, Matilda; Sjoling, Asa] Univ Gothenburg, WHO Collaborating Ctr Res Enterotoxigen Escherich, Gothenburg, Sweden; [Rodas, Claudia; Nicklasson, Matilda; Sjoling, Asa] Univ Gothenburg, Dept Microbiol & Immunol, Inst Biomed, Gothenburg, Sweden; [Klena, John D.] US Naval Med Res Unit 3, Clin Trials & Mil Studies Program, Cairo, Egypt; [Rodas, Claudia; Iniguez, Volga] Univ Mayor San Andres, Inst Biol Mol & Biotecnol, Fac Ciencias Puras & Nat, La Paz, Bolivia	University of Gothenburg; University of Gothenburg; Naval Medical Research Center (NMRC); Naval Medical Research Unit - No. 3 (NAMRU-3); Universidad Mayor de San Andres	Rodas, C (corresponding author), Univ Gothenburg, WHO Collaborating Ctr Res Enterotoxigen Escherich, Gothenburg, Sweden.	asa.sjoling@microbio.gu.se		Sjoling, Asa/0000-0003-1529-1720	Swedish Agency for Research Economic Cooperation (SIDA); Swedish Foundation of International Cooperation in Research and Higher Education (STINT) [YR2009-7022]; Ministerio de Ciencia e Innovacion (Instituto de Salud Carlos III, Fondo de Investigacion Sanitaria) [REIPI-RD06/0008-1018, S09/01273]; Xunta de Galicia [07MRU036261PR, 09TAL007261PR, 2007/000044-0]; Swedish Institute	Swedish Agency for Research Economic Cooperation (SIDA); Swedish Foundation of International Cooperation in Research and Higher Education (STINT); Ministerio de Ciencia e Innovacion (Instituto de Salud Carlos III, Fondo de Investigacion Sanitaria)(Instituto de Salud Carlos IIIMinistry of Science and Innovation, Spain (MICINN)Spanish Government); Xunta de Galicia(Xunta de GaliciaEuropean Commission); Swedish Institute	This study was supported by the Swedish Agency for Research Economic Cooperation (SIDA) (the UMSA-IBMB "Diarrhoeal Disease Project"). Support was also obtained from The Swedish Foundation of International Cooperation in Research and Higher Education (STINT) Institutional Grants for Younger Researchers YR2009-7022, Ministerio de Ciencia e Innovacion (Instituto de Salud Carlos III, Fondo de Investigacion Sanitaria, REIPI-RD06/0008-1018 and PS09/01273) and Xunta de Galicia (07MRU036261PR, 09TAL007261PR, 2007/000044-0). Claudia Rodas acknowledges the financial support from the Swedish Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanensen DM, 2005, NUCLEIC ACIDS RES, V1, P33; Anantha RP, 2004, INFECT IMMUN, V72, P7190, DOI 10.1128/IAI.72.12.7190-7201.2004; Armstrong GL, 1996, EPIDEMIOL REV, V18, P29, DOI 10.1093/oxfordjournals.epirev.a017914; Beutin L, 2005, J CLIN MICROBIOL, V43, P1552, DOI 10.1128/JCM.43.4.1552-1563.2005; BLACK RE, 1990, REV INFECT DIS, V12, pS73; Bolin I, 2006, J CLIN MICROBIOL, V44, P3872, DOI 10.1128/JCM.00790-06; CLSI (Clinical and Laboratory Standards Institute), 2008, M27A3 CLSI, V28, P25; Escobar-Paramo P, 2004, MOL BIOL EVOL, V21, P1085, DOI 10.1093/molbev/msh118; Gaastra W, 1996, TRENDS MICROBIOL, V4, P444, DOI 10.1016/0966-842X(96)10068-8; Guinee P. A. M., 1981, Laboratory diagnosis in neonatal calf and pig diarrhoea, P126; GYLES CL, 1977, SCIENCE, V198, P198, DOI 10.1126/science.333581; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Nicklasson M, 2008, MICROB PATHOGENESIS, V44, P246, DOI 10.1016/j.micpath.2007.06.009; Nicklasson M, 2010, EMERG INFECT DIS, V16, P143, DOI 10.3201/eid1601.090979; Olesen B, 2009, J CLIN MICROBIOL, V47, P1857, DOI 10.1128/JCM.00230-09; ORSKOV F, 1976, MED MICROBIOL IMMUN, V162, P73, DOI 10.1007/BF02121318; Pacheco ABF, 1998, J CLIN MICROBIOL, V36, P2099, DOI 10.1128/JCM.36.7.2099-2102.1998; Pacheco ABF, 1997, J CLIN MICROBIOL, V35, P1521, DOI 10.1128/JCM.35.6.1521-1525.1997; Perna NT, 1998, INFECT IMMUN, V98, P23; Qadri F, 2000, J CLIN MICROBIOL, V38, P27; Qadri F, 2005, CLIN MICROBIOL REV, V18, P465, DOI 10.1128/CMR.18.3.465-483.2005; RAO MC, 1985, CIBA F SYMP, V112, P74; Rodas C, 2011, BRAZ J INFECT DIS, V15, P132, DOI [10.1016/S1413-8670(11)70158-1, 10.1590/S1413-86702011000200007]; Rodas C, 2009, J CLIN MICROBIOL, V47, P1218, DOI 10.1128/JCM.00316-09; Rodrigues J, 1996, INFECT IMMUN, V64, P2680, DOI 10.1128/IAI.64.7.2680-2686.1996; SACK RB, 1980, J INFECT DIS, V142, P279, DOI 10.1093/infdis/142.2.279; Sjoling A, 2007, J CLIN MICROBIOL, V45, P3295, DOI 10.1128/JCM.00471-07; Steinsland H, 2004, J CLIN MICROBIOL, V42, P3100, DOI 10.1128/JCM.42.7.3100-3107.2004; Steinsland H, 2010, J CLIN MICROBIOL, V48, P2916, DOI 10.1128/JCM.02432-09; Svennerholm AM, 2008, EXPERT REV VACCINES, V7, P795, DOI 10.1586/14760584.7.6.795; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Turner KME, 2007, INT J ANTIMICROB AG, V29, P129, DOI 10.1016/j.ijantimicag.2006.11.002; Walker RI, 2007, VACCINE, V25, P2545, DOI 10.1016/j.vaccine.2006.12.028; WHO, 2002, RED RISKS PROM HLTH; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Wolf MK, 1997, CLIN MICROBIOL REV, V10, P569, DOI 10.1128/CMR.10.4.569	36	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2011	6	11							e18313	10.1371/journal.pone.0018313	http://dx.doi.org/10.1371/journal.pone.0018313			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863LT	22140423	Green Published, Green Submitted, gold			2022-12-27	WOS:000298166300001
J	Schwerk, N; Brinkmann, F; Soudah, B; Kabesch, M; Hansen, G				Schwerk, Nicolaus; Brinkmann, Folke; Soudah, Bisharah; Kabesch, Michael; Hansen, Gesine			Wheeze in Preschool Age Is Associated with Pulmonary Bacterial Infection and Resolves after Antibiotic Therapy	PLOS ONE			English	Article							BRONCHOALVEOLAR LAVAGE; CHILDHOOD ASTHMA; YOUNG-CHILDREN; BIRTH COHORT; AIRWAY; LIFE; CT	Background: Neonates with airways colonized by Haemophilus influenzae, Streptococcus pneumoniae or Moraxella catarrhalis are at increased risk for recurrent wheeze which may resemble asthma early in life. It is not clear whether chronic colonization by these pathogens is causative for severe persistent wheeze in some preschool children and whether these children might benefit from antibiotic treatment. We assessed the relevance of bacterial colonization and chronic airway infection in preschool children with severe persistent wheezing and evaluated the outcome of long-time antibiotic treatment on the clinical course in such children. Methodology/Principal Findings: Preschool children (n = 42) with severe persistent wheeze but no symptoms of acute pulmonary infection were investigated by bronchoscopy and bronchoalveolar lavage (BAL). Differential cell counts and microbiological and virological analyses were performed on BAL samples. Patients diagnosed with bacterial infection were treated with antibiotics for 2-16 weeks (n = 29). A modified ISAAC questionnaire was used for follow-up assessment of children at least 6 months after bronchoscopy. Of the 42 children with severe wheezing, 34 (81%) showed a neutrophilic inflammation and 20 (59%) of this subgroup had elevated bacterial counts (>= 10(4) colony forming units per milliliter) suggesting infection. Haemophilus influenzae, Streptococcus pneumoniae and Moraxella catarrhalis were the most frequently isolated species. After treatment with appropriate antibiotics 92% of patients showed a marked improvement of symptoms upon follow-up examination. Conclusions/Significance: Chronic bacterial infections are relevant in a subgroup of preschool children with persistent wheezing and such children benefit significantly from antibiotic therapy.	[Schwerk, Nicolaus; Brinkmann, Folke; Kabesch, Michael; Hansen, Gesine] Univ Childrens Hosp, Hanover Med Sch, Dept Pneumol Allergy & Neonatol, Hannover, Germany; [Soudah, Bisharah] Hannover Med Sch, Inst Pathol, Hannover, Germany	Hannover Medical School; University of Hamburg; University Medical Center Hamburg-Eppendorf; Hannover Medical School	Schwerk, N (corresponding author), Univ Childrens Hosp, Hanover Med Sch, Dept Pneumol Allergy & Neonatol, Hannover, Germany.	kabesch.michael@mh-hannover.de	schwerk, nicolaus/AAU-5676-2020; Kabesch, Michael/GZM-1583-2022; Brinkmann, Folke/GQA-9081-2022; Kabesch, Michael/AAB-5701-2020	Brinkmann, Folke/0000-0002-4307-4232; 				Aysola RS, 2008, CHEST, V134, P1183, DOI 10.1378/chest.07-2779; Bacharier LB, 2008, ALLERGY, V63, P5, DOI 10.1111/j.1398-9995.2007.01586.x; Beasley R, 1998, LANCET, V351, P1225, DOI 10.1016/S0140-6736(97)07302-9; Biscardi S, 2004, CLIN INFECT DIS, V38, P1341, DOI 10.1086/392498; Bisgaard H, 2007, NEW ENGL J MED, V357, P1487, DOI 10.1056/NEJMoa052632; Bisgaard H, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4978; Blasi F, 2007, INT J ANTIMICROB AG, V29, P485, DOI 10.1016/j.ijantimicag.2006.11.029; Brand PLP, 2008, EUR RESPIR J, V32, P1096, DOI 10.1183/09031936.00002108; Chan EY, 2005, PEDIATR PULM, V39, P558, DOI 10.1002/ppul.20227; Costabel U, 1997, ATLAS BAL; de Blic J, 2000, EUR RESPIR J, V15, P217; Donnelly D, 2007, THORAX, V62, P80, DOI 10.1136/thx.2006.058933; Gibson PG, 2010, MED J AUSTRALIA, V192, P265, DOI 10.5694/j.1326-5377.2010.tb03504.x; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Illi S, 2006, LANCET, V368, P763, DOI 10.1016/S0140-6736(06)69286-6; Lau S, 2003, EUR RESPIR J, V21, P834, DOI 10.1183/09031936.03.00037203; Le Bourgeois M, 2002, CHEST, V122, P791, DOI 10.1378/chest.122.3.791; Marchac V, 2002, AM J ROENTGENOL, V179, P1245, DOI 10.2214/ajr.179.5.1791245; Marchant JM, 2005, COCHRANE DATABASE SY, V19; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; Muhlebach MS, 1999, AM J RESP CRIT CARE, V160, P186, DOI 10.1164/ajrccm.160.1.9808096; Najafi N, 2003, PEDIATR PULM, V35, P302, DOI 10.1002/ppul.10266; Saglani S, 2006, EUR RESPIR J, V27, P29, DOI 10.1183/09031936.06.00030605; Tsai SL, 2002, PEDIATR RADIOL, V32, P498, DOI 10.1007/s00247-001-0654-7	24	38	40	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2011	6	11							e27913	10.1371/journal.pone.0027913	http://dx.doi.org/10.1371/journal.pone.0027913			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863LT	22140482	Green Published, Green Submitted, gold			2022-12-27	WOS:000298166300017
J	Hernandez, JG; Sunden, F; Connolly, J; Svanborg, C; Wullt, B				Hernandez, Jenny Gronberg; Sunden, Fredrik; Connolly, John; Svanborg, Catharina; Wullt, Bjorn			Genetic Control of the Variable Innate Immune Response to Asymptomatic Bacteriuria	PLOS ONE			English	Article							URINARY-TRACT-INFECTION; GRAM-NEGATIVE INFECTION; ACUTE PYELONEPHRITIS; ESCHERICHIA-COLI; INTERLEUKIN-6 RESPONSE; CHILDREN; SUSCEPTIBILITY; CYSTITIS; CHILDHOOD; RECEPTORS	The severity of urinary tract infection (UTI) reflects the quality and magnitude of the host response. While strong local and systemic innate immune activation occurs in patients with acute pyelonephritis, the response to asymptomatic bacteriuria (ABU) is low. The immune response repertoire in ABU has not been characterized, due to the inherent problem to distinguish bacterial differences from host-determined variation. In this study, we investigated the host response to ABU and genetic variants affecting innate immune signaling and UTI susceptibility. Patients were subjected to therapeutic urinary tract inoculation with E. coli 83972 to ensure that they were exposed to the same E. coli strain. The innate immune response repertoire was characterized in urine samples, collected from each patient before and after inoculation with bacteria or PBS, if during the placebo arm of the study. Long-term E. coli 83972 ABU was established in 23 participants, who were followed for up to twelve months and the innate immune response was quantified in 233 urine samples. Neutrophil numbers increased in all but two patients and in an extended urine cytokine/chemokine analysis (31 proteins), the chemoattractants IL-8 and GRO-alpha, RANTES, Eotaxin-1 and MCP-1, the T cell chemoattractant and antibacterial peptide IP-10, inflammatory regulators IL-1-alpha and sIL-1RA and the T lymphocyte/dendritic cell product sIL-2R alpha were detected and variably increased, compared to sterile samples. IL-6, which is associated with symptomatic UTI, remained low and numerous specific immune mediators were not detected. The patients were also genotyped for UTI-associated IRF3 and TLR4 promoter polymorphisms. Patients with ABU associated TLR4 polymorphisms had low neutrophil numbers, IL-6, IP-10, MCP-1 and sIL-2R alpha concentrations. Patients with the ABU-associated IRF3 genotype had lower neutrophils, IL-6 and MCP-1 responses than the remaining group. The results suggest that the host-specific, low immune response to ABU mainly includes innate immune mediators and that host genetics directly influence the magnitude of this response.	[Hernandez, Jenny Gronberg; Svanborg, Catharina; Wullt, Bjorn] Lund Univ, Inst Lab Med, Dept Microbiol Immunol & Glycobiol, Lund, Sweden; [Sunden, Fredrik] Skane Univ Hosp, Dept Urol, Malmo, Sweden; [Connolly, John] ASTAR, Inst Biomed Sci, Singapore Immunol Network SIgN, Singapore, Singapore	Lund University; Lund University; Skane University Hospital; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN)	Hernandez, JG (corresponding author), Lund Univ, Inst Lab Med, Dept Microbiol Immunol & Glycobiol, Lund, Sweden.	catharina.svanborg@med.lu.se			Swedish Medical Research Council [2010 3070]; Crafoord Foundation; Wallenberg Foundation; Lundberg Foundation; Osterlund Foundation; Royal Physiographic Society; Foundation of Gosta Jonsson; Foundation of Hillevi Fries; Foundation of Per-Olof Strom; Foundation of Greta Ekholm, Lund, Sweden; Coloplast, Copenhagen, Denmark; Riksforbundet for Trafik och Polioskadade; Swedish Strategic Programme Against Antibiotic Resistance (STRAMA); Region Skane's FoU	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Crafoord Foundation; Wallenberg Foundation(European Commission); Lundberg Foundation(European Commission); Osterlund Foundation; Royal Physiographic Society; Foundation of Gosta Jonsson; Foundation of Hillevi Fries; Foundation of Per-Olof Strom; Foundation of Greta Ekholm, Lund, Sweden; Coloplast, Copenhagen, Denmark; Riksforbundet for Trafik och Polioskadade; Swedish Strategic Programme Against Antibiotic Resistance (STRAMA); Region Skane's FoU	The studies were supported by grants from the Swedish Medical Research Council (2010 3070), the Crafoord, Wallenberg and Lundberg Foundations, the Osterlund Foundation and the Royal Physiographic Society. Furthermore, the inoculation study was supported by the Foundations of Gosta Jonsson, Hillevi Fries, Per-Olof Strom and Greta Ekholm, Lund, Sweden; Coloplast, Copenhagen, Denmark; Riksforbundet for Trafik och Polioskadade; the Swedish Strategic Programme Against Antibiotic Resistance (STRAMA) and by Region Skane's FoU grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGACE WW, 1993, J CLIN INVEST, V92, P780, DOI 10.1172/JCI116650; Akahoshi M, 2008, LUPUS, V17, P568, DOI 10.1177/0961203308089340; Benson M, 1996, J INFECT DIS, V174, P1080, DOI 10.1093/infdis/174.5.1080; BENSON M, 1994, PEDIATR INFECT DIS J, V13, P612, DOI 10.1097/00006454-199407000-00006; Candela JV, 1998, UROL RES, V26, P175, DOI 10.1007/s002400050043; Chromek M, 2006, NAT MED, V12, P636, DOI 10.1038/nm1407; Ciszek M, 2006, TRANSPLANTATION, V81, P1653, DOI 10.1097/01.tp.0000226072.20185.f8; Cole AM, 2001, J IMMUNOL, V167, P623, DOI 10.4049/jimmunol.167.2.623; Davidoff R, 1997, J UROLOGY, V157, P1980, DOI 10.1016/S0022-5347(01)64914-0; DEMAN P, 1991, J INFECT DIS, V163, P331, DOI 10.1093/infdis/163.2.331; DINARELLO CA, 1994, EUR CYTOKINE NETW, V5, P517; EDEN CS, 1976, LANCET, V2, P490; Fischer H, 2006, EUR J IMMUNOL, V36, P267, DOI 10.1002/eji.200535149; Fischer H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001109; Godaly G, 2000, J IMMUNOL, V165, P5287, DOI 10.4049/jimmunol.165.9.5287; HAGBERG L, 1984, INFECT IMMUN, V46, P839, DOI 10.1128/IAI.46.3.839-844.1984; Hansson S, 1997, INFECT DIS CLIN N AM, V11, P499, DOI 10.1016/S0891-5520(05)70370-6; HANSSON S, 1990, J UROLOGY, V143, P330, DOI 10.1016/S0022-5347(17)39950-0; Hawn TR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008300; HEDGES S, 1992, J INFECT DIS, V166, P653, DOI 10.1093/infdis/166.3.653; HEDGES S, 1991, INFECT IMMUN, V59, P421, DOI 10.1128/IAI.59.1.421-427.1991; HOPP TP, 1986, IMMUNOL RES, V5, P271, DOI 10.1007/BF02935500; Jennette JC, 2007, HEPTINSTALLS PATHOLO; Klemm P, 2006, INFECT IMMUN, V74, P781, DOI 10.1128/IAI.74.1.781-785.2006; KO YC, 1993, INFECT IMMUN, V61, P1307, DOI 10.1128/IAI.61.4.1307-1314.1993; Kunin CM, 1997, URINARY TRACT INFECT; LINDBERG U, 1975, ACTA PAEDIATR SCAND, V64, P425, DOI 10.1111/j.1651-2227.1975.tb03859.x; Lundstedt AC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000825; Nanda N, 2009, BIOMARK INSIGHTS, V4, P111; Olszyna DP, 2000, J INFECT DIS, V182, P1731, DOI 10.1086/317603; Otto G, 2005, KIDNEY INT, V68, P62, DOI 10.1111/j.1523-1755.2005.00381.x; Otto G, 1999, J INFECT DIS, V179, P172, DOI 10.1086/314534; PLOS K, 1995, J INFECT DIS, V171, P625, DOI 10.1093/infdis/171.3.625; Ragnarsdottir B, 2008, EUR J CLIN INVEST, V38, P12, DOI 10.1111/j.1365-2362.2008.02004.x; Ragnarsdottir B, 2007, J INFECT DIS, V196, P475, DOI 10.1086/518893; Ragnarsdottir B, 2011, NAT REV UROL, V8, P449, DOI 10.1038/nrurol.2011.100; Ragnarsdottir B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010734; Rodhe N, 2009, SCAND J PRIM HEALTH, V27, P74, DOI 10.1080/02813430902757634; Rozsai B, 2006, PEDIATR DIABETES, V7, P153, DOI 10.1111/j.1399-543X.2006.00161.x; RUBIN LA, 1985, J IMMUNOL, V135, P3172; SHAHIN RD, 1987, J IMMUNOL, V138, P3475; Silver SA, 2009, CAN J INFECT DIS MED, V20, P107, DOI 10.1155/2009/702545; Sunden F, 2010, J UROLOGY, V184, P179, DOI 10.1016/j.juro.2010.03.024; Svanborg C, 1999, CURR OPIN MICROBIOL, V2, P99, DOI 10.1016/S1369-5274(99)80017-4; Tullus K, 1996, ACTA PAEDIATR, V85, P158, DOI 10.1111/j.1651-2227.1996.tb13984.x; Zdziarski J, 2008, INFECT IMMUN, V76, P695, DOI 10.1128/IAI.01215-07	46	37	39	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2011	6	11							e28289	10.1371/journal.pone.0028289	http://dx.doi.org/10.1371/journal.pone.0028289			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KW	22140570	Green Published, Green Submitted, gold			2022-12-27	WOS:000298163400042
J	Hoeks, J; de Wilde, J; Hulshof, MFM; van den Berg, SAA; Schaart, G; van Dijk, KW; Smit, E; Mariman, ECM				Hoeks, Joris; de Wilde, Janneke; Hulshof, Martijn F. M.; van den Berg, Sjoerd A. A.; Schaart, Gert; van Dijk, Ko Willems; Smit, Egbert; Mariman, Edwin C. M.			High Fat Diet-Induced Changes in Mouse Muscle Mitochondrial Phospholipids Do Not Impair Mitochondrial Respiration Despite Insulin Resistance	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; ACID-COMPOSITION; OXIDATIVE-PHOSPHORYLATION; MEMBRANE PHOSPHOLIPIDS; C57BL/6J MICE; DYSFUNCTION; METABOLISM; GENES; SENSITIVITY; INCREASES	Background: Type 2 diabetes mellitus and muscle insulin resistance have been associated with reduced capacity of skeletal muscle mitochondria, possibly as a result of increased intake of dietary fat. Here, we examined the hypothesis that a prolonged high-fat diet consumption (HFD) increases the saturation of muscle mitochondrial membrane phospholipids causing impaired mitochondrial oxidative capacity and possibly insulin resistance. Methodology: C57BL/6J mice were fed an 8-week or 20-week low fat diet (10 kcal%; LFD) or HFD (45 kcal%). Skeletal muscle mitochondria were isolated and fatty acid (FA) composition of skeletal muscle mitochondrial phospholipids was analyzed by thin-layer chromatography followed by GC. High-resolution respirometry was used to assess oxidation of pyruvate and fatty acids by mitochondria. Insulin sensitivity was estimated by HOMA-IR. Principal Findings: At 8 weeks, mono-unsaturated FA (16:1n7, 18:1n7 and 18:1n9) were decreased (-4.0%, p<0.001), whereas saturated FA (16:0) were increased (+3.2%, p<0.001) in phospholipids of HFD vs. LFD mitochondria. Interestingly, 20 weeks of HFD descreased mono-unsaturated FA while n-6 poly-unsaturated FA (18:2n6, 20:4n6, 22:5n6) showed a pronounced increase (+4.0%, p<0.001). Despite increased saturation of muscle mitochondrial phospholipids after the 8-week HFD, mitochondrial oxidation of both pyruvate and fatty acids were similar between LFD and HFD mice. After 20 weeks of HFD, the increase in n-6 poly-unsaturated FA was accompanied by enhanced maximal capacity of the electron transport chain (+49%, p=0.002) and a tendency for increased ADP-stimulated respiration, but only when fuelled by a lipid-derived substrate. Insulin sensitivity in HFD mice was reduced at both 8 and 20 weeks. Conclusions/Interpretation: Our findings do not support the concept that prolonged HF feeding leads to increased saturation of skeletal muscle mitochondrial phospholipids resulting in a decrease in mitochondrial fat oxidative capacity and (muscle) insulin resistance.	[Hoeks, Joris; de Wilde, Janneke; Hulshof, Martijn F. M.; van Dijk, Ko Willems; Smit, Egbert; Mariman, Edwin C. M.] Maastricht Univ, Dept Human Biol, NUTRIM Sch Nutr Toxicol & Metab, Med Ctr, Maastricht, Netherlands; [de Wilde, Janneke; Hulshof, Martijn F. M.; van den Berg, Sjoerd A. A.; Smit, Egbert; Mariman, Edwin C. M.] Nutrigen Consortium, Top Inst Food & Nutr, Wageningen, Netherlands; [van den Berg, Sjoerd A. A.; van Dijk, Ko Willems] Univ Med Ctr Leiden, Dept Human Genet, Leiden, Netherlands; [Schaart, Gert] Maastricht Univ, Dept Human Movement Sci, NUTRIM Sch Nutr Toxicol & Metab, Med Ctr, Maastricht, Netherlands; [van Dijk, Ko Willems] Univ Med Ctr Leiden, Dept Internal Med, Leiden, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC); Top Institute Food & Nutrition; Leiden University; Leiden University Medical Center (LUMC); Maastricht University; Maastricht University Medical Centre (MUMC); Leiden University; Leiden University Medical Center (LUMC)	Hoeks, J (corresponding author), Maastricht Univ, Dept Human Biol, NUTRIM Sch Nutr Toxicol & Metab, Med Ctr, Maastricht, Netherlands.	j.dewilde@maastrichtuniversity.nl	van den Berg, Sjoerd AA/B-1994-2009; van den Berg, Sjoerd A/R-9541-2018; van Dijk, Ko Willems/A-1798-2008; van Dijk, Ko Willems/AAT-4681-2021	van Dijk, Ko Willems/0000-0002-2172-7394; van Dijk, Ko Willems/0000-0002-2172-7394; van den Berg, Sjoerd/0000-0001-5937-7505; van den Berg, Sjoerd/0000-0001-8967-376X; Hoeks, Joris/0000-0002-0265-0870	Top Institute Food and Nutrition; Dutch government; Netherlands Organization for Health Research and Development (ZonMw) [9120.6050]; Netherlands Consortium for System Biology	Top Institute Food and Nutrition; Dutch government; Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Netherlands Consortium for System Biology	This study was funded by the Top Institute Food and Nutrition, with financial support by the Dutch government. Joris Hoeks was supported by a grant from The Netherlands Organization for Health Research and Development (ZonMw) (Grant No. 9120.6050). Sjoerd van den Berg was supported by the Netherlands Consortium for System Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaynick WA, 2007, CELL METAB, V6, P13, DOI 10.1016/j.cmet.2007.06.007; Bonnard C, 2008, J CLIN INVEST, V118, P789, DOI 10.1172/JCI32601; BORKMAN M, 1993, NEW ENGL J MED, V328, P238, DOI 10.1056/NEJM199301283280404; Boushel R, 2007, DIABETOLOGIA, V50, P790, DOI 10.1007/s00125-007-0594-3; Brehm A, 2006, DIABETES, V55, P136, DOI 10.2337/diabetes.55.1.136; de Wilde J, 2008, PHYSIOL GENOMICS, V32, P360, DOI 10.1152/physiolgenomics.00219.2007; de Wit NJW, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-14; den Hoed M, 2008, J APPL PHYSIOL, V105, P561, DOI 10.1152/japplphysiol.00091.2008; Goyens PLL, 2005, J LIPID RES, V46, P1474, DOI 10.1194/jlr.M400514-JLR200; Gual P, 2005, BIOCHIMIE, V87, P99, DOI 10.1016/j.biochi.2004.10.019; Haag M, 2005, MED SCI MONITOR, V11, pRA359; Hancock CR, 2008, P NATL ACAD SCI USA, V105, P7815, DOI 10.1073/pnas.0802057105; Haugaard SB, 2006, CLIN ENDOCRINOL, V64, P169, DOI 10.1111/j.1365-2265.2006.02444.x; Hoeks J, 2006, DIABETOLOGIA, V49, P2419, DOI 10.1007/s00125-006-0369-2; Hoeks J, 2008, FEBS LETT, V582, P510, DOI 10.1016/j.febslet.2008.01.013; Hoeks J, 2010, DIABETES, V59, P2117, DOI 10.2337/db10-0519; Holloszy JO, 2009, AM J CLIN NUTR, V89, p463S, DOI 10.3945/ajcn.2008.26717C; Hulbert AJ, 2005, BIOL REV, V80, P155, DOI 10.1017/S1464793104006578; Iossa S, 2002, INT J OBESITY, V26, P65, DOI 10.1038/sj.ijo.0801844; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; Koves TR, 2005, AM J PHYSIOL-CELL PH, V288, pC1074, DOI 10.1152/ajpcell.00391.2004; Lemieux H, 2008, COMP BIOCHEM PHYS A, V149, P20, DOI 10.1016/j.cbpa.2007.09.015; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nabben M, BIOCH BIOPH IN PRESS; PAN DA, 1994, J NUTR, V124, P1555, DOI 10.1093/jn/124.9.1555; Pan DA, 1995, J CLIN INVEST, V96, P2802, DOI 10.1172/JCI118350; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314; Phielix E, 2008, DIABETES, V57, P2943, DOI 10.2337/db08-0391; Richardson DK, 2005, J BIOL CHEM, V280, P10290, DOI 10.1074/jbc.M408985200; Savage DB, 2007, PHYSIOL REV, V87, P507, DOI 10.1152/physrev.00024.2006; Schrauwen P, 2010, BBA-MOL CELL BIOL L, V1801, P266, DOI 10.1016/j.bbalip.2009.09.011; Schrauwen-Hinderling VB, 2007, DIABETOLOGIA, V50, P113, DOI 10.1007/s00125-006-0475-1; Shabalina IG, 2010, BBA-BIOENERGETICS, V1797, P968, DOI 10.1016/j.bbabio.2010.02.033; Silva JP, 2005, EMBO J, V24, P4061, DOI 10.1038/sj.emboj.7600866; Sparks LM, 2005, DIABETES, V54, P1926, DOI 10.2337/diabetes.54.7.1926; Turner N, 2007, DIABETES, V56, P2085, DOI 10.2337/db07-0093; UDENFRIEND S, 1972, SCIENCE, V178, P871, DOI 10.1126/science.178.4063.871; Vazquez-Memije ME, 2005, EXP GERONTOL, V40, P482, DOI 10.1016/j.exger.2005.03.006; VESSBY B, 1994, DIABETOLOGIA, V37, P1044, DOI 10.1007/s001250050215	41	25	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2011	6	11							e27274	10.1371/journal.pone.0027274	http://dx.doi.org/10.1371/journal.pone.0027274			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KW	22140436	Green Submitted, gold, Green Published			2022-12-27	WOS:000298163400004
J	Rahman, MM; Kundu, JK; Shin, JW; Na, HK; Surh, YJ				Rahman, Md Mostafizur; Kundu, Joydeb Kumar; Shin, Jun-Wan; Na, Hye-Kyung; Surh, Young-Joon			Docosahexaenoic Acid Inhibits UVB-Induced Activation of NF-kappa B and Expression of COX-2 and NOX-4 in HR-1 Hairless Mouse Skin by Blocking MSK1 Signaling	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; INDUCED OXIDATIVE STRESS; NADPH OXIDASE; CYCLOOXYGENASE-2 EXPRESSION; PROTEIN-KINASE; HUMAN KERATINOCYTES; ROS PRODUCTION; P38 MAPK; IN-VITRO; INFLAMMATION	Exposure to ultraviolet-B (UVB) radiation induces inflammation and photocarcinogenesis in mammalian skin. Docosahexaenoic acid (DHA), a representative omega-3 polyunsaturated fatty acid, has been reported to possess anti-inflammatory and chemopreventive properties. In the present study, we investigated the molecular mechanisms underlying the inhibitory effects of DHA on UVB-induced inflammation in mouse skin. Our study revealed that topical application of DHA prior to UVB irradiation attenuated the expression of cyclooxygenase-2 (COX-2) and NAD(P) H: oxidase-4 (NOX-4) in hairless mouse skin. DHA pretreatment also attenuated UVB-induced DNA binding of nuclear factor-kappaB (NF-kappa B) through the inhibition of phosphorylation of I kappa B kinase-alpha/beta, phosphorylation and degradation of I kappa B alpha and nuclear translocation of p50 and p65. In addition, UVB-induced phosphorylation of p65 at the serine 276 residue was significantly inhibited by topical application of DHA. Irradiation with UVB induced phosphorylation of mitogen and stress-activated kinase-1 (MSK1), extracellular signal-regulated kinase (ERK) and p38 mitogen-activated protein (MAP) kinase, and all these events were attenuated by pretreatment with DHA. Blocking ERK and p38 MAP kinase signaling by U0126 and SB203580, respectively, diminished MSK1 phosphorylation in UVB-irradiated mouse skin. Pretreatment with H-89, a pharmacological inhibitor of MSK1, abrogated UVB-induced activation of NF-kappa B and the expression of COX-2 and NOX-4 in mouse skin. In conclusion, topically applied DHA inhibits the UVB-induced activation of NF-kappa B and the expression of COX-2 and NOX-4 by blocking the phosphorylation of MSK1, a kinase downstream of ERK and p38 MAP kinase, in hairless mouse skin.	[Rahman, Md Mostafizur; Kundu, Joydeb Kumar; Shin, Jun-Wan; Surh, Young-Joon] Seoul Natl Univ, Coll Pharm, Tumor Microenvironm Res Ctr, Seoul, South Korea; [Na, Hye-Kyung] Sungsin Womens Univ, Dept Food & Nutr, Seoul, South Korea; [Surh, Young-Joon] Seoul Natl Univ, Grad Sch Convergence Sci & Technol, WCU Dept Mol Med & Biopharmaceut Sci, Seoul, South Korea; [Surh, Young-Joon] Seoul Natl Univ, Canc Res Inst, Seoul, South Korea	Seoul National University (SNU); Sungshin Women's University; Seoul National University (SNU); Seoul National University (SNU)	Rahman, MM (corresponding author), Seoul Natl Univ, Coll Pharm, Tumor Microenvironm Res Ctr, Seoul, South Korea.	surh@plaza.snu.ac.kr			World Class University [R31-008-000-10103-0]	World Class University	This work was supported by the World Class University grant (R31-008-000-10103-0) from the National Research Foundation of Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An KP, 2002, PHOTOCHEM PHOTOBIOL, V76, P73, DOI 10.1562/0031-8655(2002)076<0073:CEIMAH>2.0.CO;2; An WS, 2009, AM J PHYSIOL-RENAL, V297, pF895, DOI 10.1152/ajprenal.00217.2009; Bachelor MA, 2005, MOL CANCER RES, V3, P90, DOI 10.1158/1541-7786.MCR-04-0065; Beak SM, 2004, BIOCHIMIE, V86, P425, DOI 10.1016/j.biochi.2004.06.010; Chamulitrat W, 2004, J INVEST DERMATOL, V122, P1000, DOI 10.1111/j.0022-202X.2004.22410.x; Chang EJ, 2011, MOL CARCINOGEN, V50, P310, DOI 10.1002/mc.20646; Chun KS, 2004, BIOCHEM PHARMACOL, V68, P1089, DOI 10.1016/j.bcp.2004.05.031; Cucoranu I, 2005, CIRC RES, V97, P900, DOI 10.1161/01.RES.0000187457.24338.3D; de Gruijl FR, 2002, SKIN PHARMACOL APPL, V15, P316, DOI 10.1159/000064535; Dickinson SE, 2011, MOL CARCINOGEN, V50, P469, DOI 10.1002/mc.20734; Diebold I, 2010, MOL BIOL CELL, V21, P2087, DOI 10.1091/mbc.E09-12-1003; Djordjevic T, 2005, ARTERIOSCL THROM VAS, V25, P519, DOI 10.1161/01.ATV.0000154279.98244.eb; Graham KA, 2010, CANCER BIOL THER, V10, DOI 10.4161/cbt.10.3.12207; Groeger AL, 2010, NAT CHEM BIOL, V6, P433, DOI 10.1038/nchembio.367; Halliday GA, 2005, MUTAT RES-FUND MOL M, V571, P107, DOI 10.1016/j.mrfmmm.2004.09.013; Jho David H, 2004, Integr Cancer Ther, V3, P98, DOI 10.1177/1534735404264736; Jiang F, 2011, PHARMACOL REV, V63, P218, DOI 10.1124/pr.110.002980; Karin M, 1999, ONCOGENE, V18, P6867, DOI 10.1038/sj.onc.1203219; Kaur G, 2011, PROG LIPID RES, V50, P28, DOI 10.1016/j.plipres.2010.07.004; Kefaloyianni E, 2006, CELL SIGNAL, V18, P2238, DOI 10.1016/j.cellsig.2006.05.004; Kim AL, 2005, J INVEST DERMATOL, V124, P1318, DOI 10.1111/j.0022-202X.2005.23747.x; Kim JK, 2007, FREE RADICAL RES, V41, P603, DOI 10.1080/10715760701209896; Kundu JK, 2008, MUTAT RES-REV MUTAT, V659, P15, DOI 10.1016/j.mrrev.2008.03.002; Kundu JK, 2009, J FUNCT FOODS, V1, P98, DOI 10.1016/j.jff.2008.09.016; Lee CF, 2010, CIRC RES, V106, P1489, DOI 10.1161/CIRCRESAHA.109.215392; Lewis DA, 2008, J INVEST DERMATOL, V128, P1022, DOI 10.1038/sj.jid.5701127; Lo HW, 2010, MOL CANCER RES, V8, P232, DOI 10.1158/1541-7786.MCR-09-0391; Machida T, 2005, J PHARMACOL SCI, V99, P113, DOI 10.1254/jphs.SC0050099; Manea A, 2010, BIOCHEM BIOPH RES CO, V396, P901, DOI 10.1016/j.bbrc.2010.05.019; Manea A, 2010, ARTERIOSCL THROM VAS, V30, P105, DOI 10.1161/ATVBAHA.109.193896; McCoy CE, 2005, BIOCHEM J, V387, P507, DOI 10.1042/BJ20041501; Moe KT, 2006, J CELL MOL MED, V10, P231, DOI 10.1111/j.1582-4934.2006.tb00304.x; Mullen A, 2010, J NUTR BIOCHEM, V21, P444, DOI 10.1016/j.jnutbio.2009.02.008; Muller-Decker K, 2002, P NATL ACAD SCI USA, V99, P12483, DOI 10.1073/pnas.192323799; Murakami A, 2007, INT J CANCER, V121, P2357, DOI 10.1002/ijc.23161; Nauseef WM, 2008, J BIOL CHEM, V283, P16961, DOI 10.1074/jbc.R700045200; Otkjaer K, 2007, J INVEST DERMATOL, V127, P1326, DOI 10.1038/sj.jid.5700713; Park HS, 2004, J IMMUNOL, V173, P3589, DOI 10.4049/jimmunol.173.6.3589; Park S, 2010, J MOL MED, V88, P807, DOI 10.1007/s00109-010-0622-5; Pentland AP, 1999, CARCINOGENESIS, V20, P1939, DOI 10.1093/carcin/20.10.1939; Reber L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004393; Richard D, 2009, BIOCHEM BIOPH RES CO, V389, P516, DOI 10.1016/j.bbrc.2009.09.013; Sedeek M, 2010, AM J PHYSIOL-RENAL, V299, pF1348, DOI 10.1152/ajprenal.00028.2010; SERINI S, 2010, J NUTR BIOCH; Sharma SD, 2007, MOL CANCER THER, V6, P995, DOI 10.1158/1535-7163.MCT-06-0661; Shono T, 2008, INT J CANCER, V123, P787, DOI 10.1002/ijc.23569; Sol VVD, 2005, J IMMUNOL, V174, P2825, DOI 10.4049/jimmunol.174.5.2825; Sun YY, 2007, WAVE RANDOM COMPLEX, V17, P1, DOI 10.1080/17455030600791694; Surh YJ, 2005, ARCH PHARM RES, V28, P1, DOI 10.1007/BF02975128; Tiano HF, 2002, CANCER RES, V62, P3395; Tobar N, 2010, BRIT J CANCER, V103, P1040, DOI 10.1038/sj.bjc.6605847; Vermeulen L, 2003, EMBO J, V22, P1313, DOI 10.1093/emboj/cdg139; Wang R, 2011, INT J CANCER, V128, P2581, DOI 10.1002/ijc.25610; Wang TM, 2011, J NUTR BIOCHEM, V22, P187, DOI 10.1016/j.jnutbio.2010.01.007; Wingler M, 2001, FREE RADICAL BIO MED, V31, P1456, DOI 10.1016/S0891-5849(01)00727-4; Yamaura M, 2009, CANCER RES, V69, P2647, DOI 10.1158/0008-5472.CAN-08-3745; Yan Y, 2006, PHOTOCHEM PHOTOBIOL, V82, P665, DOI 10.1562/2005-08-17-RA-652; Zhao YF, 2006, CARCINOGENESIS, V27, P1692, DOI 10.1093/carcin/bgl037	58	43	45	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2011	6	11							e28065	10.1371/journal.pone.0028065	http://dx.doi.org/10.1371/journal.pone.0028065			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KW	22140508	Green Published, Green Submitted, gold			2022-12-27	WOS:000298163400030
J	Kijima, M; Gardiol, N; Held, W				Kijima, Mika; Gardiol, Noemie; Held, Werner			Natural Killer Cell Mediated Missing-Self Recognition Can Protect Mice from Primary Chronic Myeloid Leukemia In Vivo	PLOS ONE			English	Article							MHC CLASS-I; CHRONIC MYELOGENOUS LEUKEMIA; BONE-MARROW ALLOGRAFTS; VERSUS-HOST-DISEASE; NK CELLS; HEMATOPOIETIC TRANSPLANTS; INHIBITORY RECEPTORS; KIR LIGANDS; T-CELLS; HLA-C	Background: Natural Killer (NK) cells are thought to protect from residual leukemic cells in patients receiving stem cell transplantation. However, multiple retrospective analyses of patient data have yielded conflicting conclusions regarding a putative role of NK cells and the essential NK cell recognition events mediating a protective effect against leukemia. Further, a NK cell mediated protective effect against primary leukemia in vivo has not been shown directly. Methodology/Principal Findings: Here we addressed whether NK cells have the potential to control chronic myeloid leukemia (CML) arising based on the transplantation of BCR-ABL1 oncogene expressing primary bone marrow precursor cells into lethally irradiated recipient mice. These analyses identified missing-self recognition as the only NK cell-mediated recognition strategy, which is able to significantly protect from the development of CML disease in vivo. Conclusion: Our data provide a proof of principle that NK cells can control primary leukemic cells in vivo. Since the presence of NK cells reduced the abundance of leukemia propagating cancer stem cells, the data raise the possibility that NK cell recognition has the potential to cure CML, which may be difficult using small molecule BCR-ABL1 inhibitors. Finally, our findings validate approaches to treat leukemia using antibody-based blockade of self-specific inhibitory MHC class I receptors.	[Kijima, Mika; Gardiol, Noemie; Held, Werner] Univ Lausanne, Ludwig Ctr Canc Res, CH-1066 Epalinges, Switzerland	University of Lausanne	Kijima, M (corresponding author), Max Planck Inst Immunobiol & Epigenet, Freiburg, Germany.	Werner.Held@unil.ch			Swiss Cancer League	Swiss Cancer League	This work was supported in part by a grant from the Swiss Cancer League to W.H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Anfossi N, 2006, IMMUNITY, V25, P331, DOI 10.1016/j.immuni.2006.06.013; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Benjamin JE, 2010, CURR OPIN ONCOL, V22, P130, DOI 10.1097/CCO.0b013e328335a559; Brodin P, 2009, BLOOD, V113, P2434, DOI 10.1182/blood-2008-05-156836; Brunstein CG, 2009, BLOOD, V113, P5628, DOI 10.1182/blood-2008-12-197467; Chalifour A, 2009, IMMUNITY, V30, P337, DOI 10.1016/j.immuni.2008.12.019; COLONNA M, 1995, SCIENCE, V268, P405, DOI 10.1126/science.7716543; Cooley S, 2009, BLOOD, V113, P726, DOI 10.1182/blood-2008-07-171926; Cooper MA, 2009, P NATL ACAD SCI USA, V106, P1915, DOI 10.1073/pnas.0813192106; DALEY GQ, 1990, SCIENCE, V247, P824, DOI 10.1126/science.2406902; Davies SM, 2002, BLOOD, V100, P3825, DOI 10.1182/blood-2002-04-1197; Dong ZJ, 2009, NAT IMMUNOL, V10, P973, DOI 10.1038/ni.1763; Fernandez NC, 2005, BLOOD, V105, P4416, DOI 10.1182/blood-2004-08-3156; Gratwohl A, 2009, BEST PRACT RES CL HA, V22, P431, DOI 10.1016/j.beha.2009.05.002; Guerra N, 2008, IMMUNITY, V28, P571, DOI 10.1016/j.immuni.2008.02.016; Hanke T, 1999, IMMUNITY, V11, P67, DOI 10.1016/S1074-7613(00)80082-5; Hill GR, 1997, BLOOD, V90, P3204, DOI 10.1182/blood.V90.8.3204; Hsu KC, 2006, BIOL BLOOD MARROW TR, V12, P828, DOI 10.1016/j.bbmt.2006.04.008; Hu YG, 2004, NAT GENET, V36, P453, DOI 10.1038/ng1343; Hu YG, 2006, P NATL ACAD SCI USA, V103, P16870, DOI 10.1073/pnas.0606509103; Ioannidis V, 2001, J IMMUNOL, V167, P6256, DOI 10.4049/jimmunol.167.11.6256; Joncker NT, 2010, J EXP MED, V207, P2065, DOI 10.1084/jem.20100570; KARLHOFER FM, 1992, NATURE, V358, P66, DOI 10.1038/358066a0; Kim S, 2005, NATURE, V436, P709, DOI 10.1038/nature03847; Leung W, 2004, J IMMUNOL, V172, P644, DOI 10.4049/jimmunol.172.1.644; LJUNGGREN HG, 1990, IMMUNOL TODAY, V11, P237, DOI 10.1016/0167-5699(90)90097-S; Mahon FX, 2010, LANCET ONCOL, V11, P1029, DOI 10.1016/S1470-2045(10)70233-3; Miller JS, 2007, BLOOD, V109, P5058, DOI 10.1182/blood-2007-01-065383; Miller JS, 2005, BLOOD, V105, P3051, DOI 10.1182/blood-2004-07-2974; MORETTA A, 1995, J EXP MED, V182, P875, DOI 10.1084/jem.182.3.875; MURPHY WJ, 1987, J EXP MED, V166, P1499, DOI 10.1084/jem.166.5.1499; Nakamura MC, 1999, J EXP MED, V189, P493, DOI 10.1084/jem.189.3.493; Ogasawara K, 2005, NAT IMMUNOL; OHLEN C, 1989, SCIENCE, V246, P666, DOI 10.1126/science.2814488; Olson JA, 2009, J IMMUNOL, V183, P3219, DOI 10.4049/jimmunol.0804268; Orr MT, 2010, NAT IMMUNOL, V11, P321, DOI 10.1038/ni.1849; Pear WS, 1998, BLOOD, V92, P3780, DOI 10.1182/blood.V92.10.3780.422k15_3780_3792; Pegram HJ, 2011, LEUKEMIA RES, V35, P14, DOI 10.1016/j.leukres.2010.07.030; Pende D, 2009, BLOOD, V113, P3119, DOI 10.1182/blood-2008-06-164103; Prlic M, 2007, BLOOD, V110, P2024, DOI 10.1182/blood-2007-04-086108; Raziuddin A, 1998, J IMMUNOL, V160, P87; Ruggeri L, 2002, SCIENCE, V295, P2097, DOI 10.1126/science.1068440; Ruggeri L, 1999, BLOOD, V94, P333, DOI 10.1182/blood.V94.1.333.413a31_333_339; Ruggeri L, 2007, CURR OPIN ONCOL, V19, P142, DOI 10.1097/CCO.0b013e3280148a1a; Shami PJ, 2012, LEUKEMIA, V26, P214, DOI 10.1038/leu.2011.217; Sola C, 2009, P NATL ACAD SCI USA, V106, P12879, DOI 10.1073/pnas.0901653106; Sun JC, 2009, NATURE, V457, P557, DOI 10.1038/nature07665; Vahlne G, 2010, EUR J IMMUNOL, V40, P813, DOI 10.1002/eji.200939755	48	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e27639	10.1371/journal.pone.0027639	http://dx.doi.org/10.1371/journal.pone.0027639			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132120	Green Published, gold, Green Submitted			2022-12-27	WOS:000298162000031
J	Schouten, LJ; van Dijk, BAC; Lumey, LH; Goldbohm, RA; van den Brandt, PA				Schouten, Leo J.; van Dijk, Boukje A. C.; Lumey, L. H.; Goldbohm, R. Alexandra; van den Brandt, Piet A.			Energy Restriction during Childhood and Early Adulthood and Ovarian Cancer Risk	PLOS ONE			English	Article							1944-1945 DUTCH FAMINE; NETHERLANDS COHORT; COLORECTAL-CANCER; BREAST-CANCER; CALORIC RESTRICTION; EARLY-LIFE; DIET; AGE; SUBSEQUENT; HEIGHT	Dietary energy restriction may protect against cancer. In parts of the Netherlands, mostly in larger cities, periods of chronically impaired nutrition and even severe famine (Hunger Winter 1944-1945) existed during the 1930s and World War II (1940-1945). We studied the association between energy restriction during childhood and early adulthood on the risk of ovarian cancer later in life. In 1986, the Netherlands Cohort Study was initiated. A self-administered questionnaire on dietary habits and other cancer risk factors was completed by 62,573 women aged 55-69 years at baseline. Follow-up for cancer was established by record linkage to the Netherlands Cancer Registry. After 16.3 years of follow-up, 364 invasive epithelial ovarian cancer cases and 2220 subcohort members (sampled from the total cohort directly after baseline) with complete information confounders were available for case-cohort analyses. In multivariable analysis, ovarian cancer risk was lower for participants with an unemployed father during the 1930s (Hazard Ratio (HR), 0.70; 95% Confidence Interval (CI), 0.47-1.06) compared to participants with an employed father as well as for participants living in a city during World War II (HR, 0.69; 95% CI, 0.54-0.90) compared to participants living in the country-side. Residence in a Western City during the famine (Hunger Winter) was not associated with a decreased risk. Our results show a relation between proxy variables for modest energy restriction over a longer period of time during childhood or early adulthood and a reduced ovarian cancer risk.	[Schouten, Leo J.; van den Brandt, Piet A.] Maastricht Univ, Dept Epidemiol, GROW Sch Oncol & Dev Biol, Maastricht, Netherlands; [van Dijk, Boukje A. C.] Comprehens Canc Ctr Netherlands, Groningen, Netherlands; [Lumey, L. H.] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA; [Goldbohm, R. Alexandra] TNO, Dept Life Style, Leiden, Netherlands	Maastricht University; Columbia University; Netherlands Organization Applied Science Research	Schouten, LJ (corresponding author), Maastricht Univ, Dept Epidemiol, GROW Sch Oncol & Dev Biol, Maastricht, Netherlands.	Lj.Schouten@epid.unimaas.nl	Schouten, Leo J/AAB-2275-2019; Schouten, Leo J/G-3713-2012	Schouten, Leo J/0000-0003-3361-7560; van den Brandt, Piet/0000-0001-8781-8099	World Cancer Research Fund-United Kingdom [2003-30]; Netherlands Cancer Society	World Cancer Research Fund-United Kingdom; Netherlands Cancer Society(KWF Kankerbestrijding)	This study has received funding from the World Cancer Research Fund-United Kingdom (grant no. 2003-30) and from the Netherlands Cancer Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baer HJ, 2008, BRIT J CANCER, V99, P1916, DOI 10.1038/sj.bjc.6604742; BARLOW WE, 1994, BIOMETRICS, V50, P1064, DOI 10.2307/2533444; Braem MGM, 2010, AM J EPIDEMIOL, V172, P1181, DOI 10.1093/aje/kwq264; Breunis J, 1946, ANN AM ACAD POLIT SS, V245, P87, DOI 10.1177/000271624624500113; BURGER GCE, 1945, LANCET, V2, P282; Carver DK, 2011, CANCER PREV RES, V4, P562, DOI 10.1158/1940-6207.CAPR-10-0294; COX DR, 1972, J R STAT SOC B, V34, P187; CRAMER DW, 1983, JNCI-J NATL CANCER I, V71, P717; DENHARTOG AP, 1983, VOEDING, V44, P92; Dirx MJM, 2003, CANCER-AM CANCER SOC, V97, P46, DOI 10.1002/cncr.11052; Dirx MJM, 1999, CANCER CAUSE CONTROL, V10, P189, DOI 10.1023/A:1008821524297; DOLS M. J. L., 1946, Voeding, V6, P193; Elias SG, 2004, J NATL CANCER I, V96, P539, DOI 10.1093/jnci/djh087; Elias SG, 2005, CANCER EPIDEM BIOMAR, V14, P1981, DOI 10.1158/1055-9965.EPI-04-0839; FATHALLA MF, 1971, LANCET, V2, P163; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Goldbohm RA, 1994, TIJDSCHR SOC GEZONDH, V72, P80; Hankinson SE, 2006, CANC EPIDEMIOLOGY PR, P1013, DOI DOI 10.1093/ACPROF:OSO/9780195149616.003.0052; Hughes LAE, 2010, INT J EPIDEMIOL, V39, P1333, DOI 10.1093/ije/dyq062; KASTEIN GW, 1935, NED TIJDSCHR GENEES, V79, P5583; KRITCHEVSKY D, 1995, EUR J CANCER PREV, V4, P445, DOI 10.1097/00008469-199512000-00002; LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085; Loucks AB, 2006, J CLIN ENDOCR METAB, V91, P3158, DOI 10.1210/jc.2006-0570; Mellemkjaer L, 2001, CANCER CAUSE CONTROL, V12, P173, DOI 10.1023/A:1008974414116; Michels KB, 2004, JAMA-J AM MED ASSOC, V291, P1226, DOI 10.1001/jama.291.10.1226; Prentice RL, 2007, JNCI-J NATL CANCER I, V99, P1534, DOI 10.1093/jnci/djm159; SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.1093/biomet/69.1.239; Schouten LJ, 2008, CANCER EPIDEM BIOMAR, V17, P902, DOI 10.1158/1055-9965.EPI-07-2524; Schouten LJ, 2003, AM J EPIDEMIOL, V157, P424, DOI 10.1093/aje/kwf224; Stein Z., 1975, FAMINE HUM DEV DUTCH; Svensson E, 2005, CANCER CAUSE CONTROL, V16, P215, DOI 10.1007/s10552-004-3073-x; Svensson E, 2002, EUR J CANCER PREV, V11, P489, DOI 10.1097/00008469-200210000-00012; Trienekens G, 2000, FOOD SCI POLICY REGU; TROMP MH, 1934, NED TIJDSCHR GENEES, V78, P5388; VANDENBRANDT PA, 1990, INT J EPIDEMIOL, V19, P553; VANDENBRANDT PA, 1990, J CLIN EPIDEMIOL, V43, P285, DOI 10.1016/0895-4356(90)90009-E; VANDERSPUY ZM, 1985, CLIN OBSTET GYNAECOL, V12, P579	37	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e27960	10.1371/journal.pone.0027960	http://dx.doi.org/10.1371/journal.pone.0027960			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132180	Green Published, Green Submitted, gold			2022-12-27	WOS:000298162000052
J	Czarny, MJ; Arthurs, E; Coffie, DF; Smith, C; Steele, RJ; Ziegelstein, RC; Thombs, BD				Czarny, Matthew J.; Arthurs, Erin; Coffie, Diana-Frances; Smith, Cheri; Steele, Russell J.; Ziegelstein, Roy C.; Thombs, Brett D.			Prevalence of Antidepressant Prescription or Use in Patients with Acute Coronary Syndrome: A Systematic Review	PLOS ONE			English	Review							ACUTE MYOCARDIAL-INFARCTION; SEROTONIN REUPTAKE INHIBITORS; HEART-RATE-VARIABILITY; DEPRESSIVE SYMPTOMS; ARTERY-DISEASE; MAJOR DEPRESSION; MEDICATION USE; UNSTABLE ANGINA; CARDIAC EVENTS; YOUNGER WOMEN	Background and Objectives: Depression is common among acute coronary syndrome (ACS) patients and is associated with poor prognosis. Cardiac side effects of older antidepressants were well-known, but newer antidepressants are generally thought of as safe to use in patients with heart disease. The objective was to assess rates of antidepressant use or prescription to patients within a year of an ACS. Methods: PubMed, PsycINFO, and CINAHL databases searched through May 29, 2009; manual searching of 33 journals from May 2009 to September 2010. Articles in any language were included if they reported point or period prevalence of antidepressant use or prescription in the 12 months prior or subsequent to an ACS for >= 100 patients. Two investigators independently selected studies for inclusion/exclusion and extracted methodological characteristics and outcomes from included studies (study setting, inclusion/exclusion criteria, sample size, prevalence of antidepressant prescription/use, method of assessing antidepressant prescription/use, time period of assessment). Results: A total of 24 articles were included. The majority were from North America and Europe, and most utilized chart review or self-report to assess antidepressant use or prescription. Although there was substantial heterogeneity in results, overall, rates of antidepressant use or prescription increased from less than 5% prior to 1995 to 10-15% after 2000. In general, studies from North America reported substantially higher rates than studies from Europe, approximately 5% higher among studies that used chart or self-report data. Conclusions: Antidepressant use or prescription has increased considerably, and by 2005 approximately 10% to 15% of ACS patients were prescribed or using one of these drugs.	[Czarny, Matthew J.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Czarny, Matthew J.] Harvard Univ, Sch Med, Boston, MA USA; [Arthurs, Erin; Steele, Russell J.; Thombs, Brett D.] McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada; [Coffie, Diana-Frances] Rhode Isl Hosp, Dept Med, Providence, RI 02903 USA; [Coffie, Diana-Frances] Brown Alpert Med Sch, Providence, RI USA; [Smith, Cheri] Johns Hopkins Bayview Med Ctr, Harold E Harrison Med Lib, Baltimore, MD USA; [Steele, Russell J.] McGill Univ, Dept Math & Stat, Montreal, PQ, Canada; [Thombs, Brett D.] McGill Univ, Dept Psychiat, Montreal, PQ, Canada; [Thombs, Brett D.] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Thombs, Brett D.] McGill Univ, Dept Med, Montreal, PQ, Canada; [Thombs, Brett D.] McGill Univ, Sch Nursing, Montreal, PQ, Canada; [Ziegelstein, Roy C.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Lady Davis Institute; McGill University; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Johns Hopkins University; Johns Hopkins Medicine; McGill University; McGill University; McGill University; McGill University; McGill University; Johns Hopkins University	Czarny, MJ (corresponding author), Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA.	brett.thombs@mcgill.ca	Steele, Russell J/G-6926-2017	Thombs, Brett D./0000-0002-5644-8432	National Center for Complementary & Alternative Medicine [R24AT004641]; Miller Family Scholar Program; Canadian Institutes of Health Research; Fonds de la Recherche en Sante Quebec; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R24AT004641] Funding Source: NIH RePORTER	National Center for Complementary & Alternative Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); Miller Family Scholar Program; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche en Sante Quebec(Fonds de la Recherche en Sante du Quebec); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	Dr. Ziegelstein was supported by grant number R24AT004641 from the National Center for Complementary & Alternative Medicine and by the Miller Family Scholar Program. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center for Complementary & Alternative Medicine or the National Institutes of Health. Dr. Thombs was supported by a New Investigator Award from the Canadian Institutes of Health Research and an Etablissement de Jeunes Chercheurs award from the Fonds de la Recherche en Sante Quebec. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso J, 2004, ACTA PSYCHIAT SCAND, V109, P55; Andrade C, 2010, J CLIN PSYCHIAT, V71, P1565, DOI 10.4088/JCP.09r05786blu; Benazon NR, 2005, PSYCHOSOM MED, V67, P916, DOI 10.1097/01.psy.0000188399.80167.aa; Bhattacharyya MR, 2007, EUR HEART J, V28, P160, DOI 10.1093/eurheartj/ehl440; BLACKWELL B, 1967, BRIT J PSYCHIAT, V113, P349, DOI 10.1192/bjp.113.497.349; Boudreau DM, 2004, AM J EPIDEMIOL, V159, P308, DOI 10.1093/aje/kwh038; Corser William, 2006, JOURNAL OF PHARMACY TECHNOLOGY, V22, P319; DELISLE VC, J PSYCHOPHARMACOL; Dias Carla Costa, 2005, Rev Port Cardiol, V24, P507; Dickens C, 2007, J AM COLL CARDIOL, V49, P1834, DOI 10.1016/j.jacc.2007.01.075; Dowlati Y, 2010, CAN J PSYCHIAT, V55, P91, DOI 10.1177/070674371005500205; Fosbol EL, 2009, CIRC-HEART FAIL, V2, P582, DOI 10.1161/CIRCHEARTFAILURE.109.851246; Frasure-Smith N, 2008, ARCH GEN PSYCHIAT, V65, P62, DOI 10.1001/archgenpsychiatry.2007.4; Gill JM, 2010, J AM BOARD FAM MED, V23, P499, DOI 10.3122/jabfm.2010.04.090299; GLASSMAN AH, 1993, JAMA-J AM MED ASSOC, V269, P2673, DOI 10.1001/jama.269.20.2673; Glassman AH, 2002, JAMA-J AM MED ASSOC, V288, P701, DOI 10.1001/jama.288.6.701; Grace SL, 2008, PSYCHOSOMATICS, V49, P199, DOI 10.1176/appi.psy.49.3.199; Grace SL, 2005, PSYCHOSOM MED, V67, P52, DOI 10.1097/01.psy.0000151486.28349.70; Grunau GL, 2006, CAN J CARDIOL, V22, P473, DOI 10.1016/S0828-282X(06)70263-X; Haapea M, 2010, INT J METH PSYCH RES, V19, P88, DOI 10.1002/mpr.304; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Huffman JC, 2006, HEART, V92, P1656, DOI 10.1136/hrt.2005.087213; Jureidini J, 2006, CNS DRUGS, V20, P623, DOI 10.2165/00023210-200620080-00002; Kaptein KI, 2006, PSYCHOSOM MED, V68, P662, DOI 10.1097/01.psy.0000233237.79085.57; Krantz DS, 2009, HEART, V95, P1901, DOI 10.1136/hrt.2009.176040; Kwon A, 2003, MED CARE, V41, P368, DOI 10.1097/00005650-200303000-00005; Lauzon C, 2003, CAN MED ASSOC J, V168, P547; Lesperance F, 2000, ARCH INTERN MED, V160, P1354, DOI 10.1001/archinte.160.9.1354; Lesperance F, 2007, JAMA-J AM MED ASSOC, V297, P367, DOI 10.1001/jama.297.4.367; Licht CMM, 2008, ARCH GEN PSYCHIAT, V65, P1358, DOI 10.1001/archpsyc.65.12.1358; Lichtman JH, 2008, CIRCULATION, V118, P1768, DOI 10.1161/CIRCULATIONAHA.108.190769; Mallik S, 2006, ARCH INTERN MED, V166, P876, DOI 10.1001/archinte.166.8.876; Mazza M, 2010, J PSYCHOPHARMACOL, V24, P1785, DOI 10.1177/0269881109348176; Mojtabai R, 2011, HEALTH AFFAIR, V30, P1434, DOI 10.1377/hlthaff.2010.1024; Monster TBM, 2004, AM J MED, V117, P732, DOI 10.1016/j.amjmed.2004.06.027; Murray JB, 2000, J PSYCHOL, V134, P162, DOI 10.1080/00223980009600859; Nakatani D, 2005, AM HEART J, V150, P652, DOI 10.1016/j.ahj.2005.03.062; O'Connor CM, 2010, J AM COLL CARDIOL, V56, P692, DOI 10.1016/j.jacc.2010.03.068; Olfson M, 2009, ARCH GEN PSYCHIAT, V66, P848, DOI 10.1001/archgenpsychiatry.2009.81; Pacher P, 2004, CURR PHARM DESIGN, V10, P2463, DOI 10.2174/1381612043383872; Parakh K, 2008, AM J CARDIOL, V101, P602, DOI 10.1016/j.amjcard.2007.10.021; Parker GB, 2008, BIOL PSYCHIAT, V64, P660, DOI 10.1016/j.biopsych.2008.05.021; Pitzalis MV, 2001, AM HEART J, V141, P765, DOI 10.1067/mhj.2001.114806; Pizzi C, 2009, CLIN PHARMACOL THER, V86, P527, DOI 10.1038/clpt.2009.121; R Development Core Team, 2011, R LAND ENV STAT COMP; Rudisch B, 2003, BIOL PSYCHIAT, V54, P227, DOI 10.1016/S0006-3223(03)00587-0; Rumsfeld JS, 2005, CIRCULATION, V111, P250, DOI 10.1161/01.CIR.0000154573.62822.89; Rumsfeld JS, 2003, AM HEART J, V145, P493, DOI 10.1067/mhj.2003.177; Sauer WH, 2001, CIRCULATION, V104, P1894, DOI 10.1161/hc4101.097519; Smoller JW, 2009, ARCH INTERN MED, V169, P2128, DOI 10.1001/archinternmed.2009.436; Sorensen C, 2005, ACTA PSYCHIAT SCAND, V111, P116, DOI 10.1111/j.1600-0447.2004.00430.x; Spina E, 2008, CLIN THER, V30, P1206, DOI 10.1016/S0149-2918(08)80047-1; Stahl SM, 2005, CNS SPECTRUMS, V10, P732, DOI 10.1017/S1092852900019726; Strik JTMH, 2000, PSYCHOSOM MED, V62, P783, DOI 10.1097/00006842-200011000-00007; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Taylor CB, 2005, ARCH GEN PSYCHIAT, V62, P792, DOI 10.1001/archpsyc.62.7.792; Taylor D, 2008, ACTA PSYCHIAT SCAND, V118, P434, DOI 10.1111/j.1600-0447.2008.01260.x; Thombs BD, 2006, J GEN INTERN MED, V21, P30, DOI 10.1111/j.1525-1497.2005.00269.x; Thombs BD, 2008, JAMA-J AM MED ASSOC, V300, P2161, DOI 10.1001/jama.2008.667; Tibold A, 2007, AM J CARDIOL, V99, P1025, DOI 10.1016/j.amjcard.2006.11.030; U.S. Food and Drug Administration, CEL CIT HYDR DRUG SA; US Preventive Serv Task Force, 2009, ANN INTERN MED, V151, P784, DOI 10.7326/0003-4819-151-11-200912010-00006; van Melle JP, 2004, PSYCHOSOM MED, V66, P814, DOI 10.1097/01.psy.0000146294.82810.9c; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Whang W, 2009, J AM COLL CARDIOL, V53, P950, DOI 10.1016/j.jacc.2008.10.060; Wong CK, 2008, QJM-INT J MED, V101, P137, DOI 10.1093/qjmed/hcm153; Xiong GL, 2006, AM J CARDIOL, V98, P42, DOI 10.1016/j.amjcard.2006.01.051; Ziegelstein RC, 2007, AM J MED, V120, P525, DOI 10.1016/j.amjmed.2006.10.026; Zimmermann-Viehoff F, 2010, EUR J CARDIOV PREV R, V17, P509, DOI 10.1097/HJR.0b013e328337b57b	69	22	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2011	6	11							e27671	10.1371/journal.pone.0027671	http://dx.doi.org/10.1371/journal.pone.0027671			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	858JH	22132126	gold, Green Published, Green Submitted			2022-12-27	WOS:000297792400012
J	Dutra, RC; Leite, DFP; Bento, AF; Manjavachi, MN; Patricio, ES; Figueiredo, CP; Pesquero, JB; Calixto, JB				Dutra, Rafael C.; Leite, Daniela F. P.; Bento, Allisson F.; Manjavachi, Marianne N.; Patricio, Eliziane S.; Figueiredo, Claudia P.; Pesquero, Joao B.; Calixto, Joao B.			The Role of Kinin Receptors in Preventing Neuroinflammation and Its Clinical Severity during Experimental Autoimmune Encephalomyelitis in Mice	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; TUMOR BARRIER PERMEABILITY; BLOOD-BRAIN-BARRIER; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; MULTIPLE-SCLEROSIS; T-CELLS; ALZHEIMERS-DISEASE; DENDRITIC CELLS; T(H)17 CELLS; EXPRESSION	Background: Multiple sclerosis (MS) is a demyelinating and neuroinflammatory disease of the human central nervous system (CNS). The expression of kinins is increased in MS patients, but the underlying mechanisms by which the kinin receptor regulates MS development have not been elucidated. Methodology/Principal Findings: Experimental autoimmune encephalomyelitis (EAE) was induced in female C57BL/6 mice by immunization with MOG(35-55) peptide emulsified in complete Freund's adjuvant and injected with pertussis toxin on day 0 and day 2. Here, we report that blockade of the B1R in the induction phase of EAE markedly suppressed its progression by interfering with the onset of the immune response. Furthermore, B1R antagonist suppressed the production/expression of antigen-specific T(H)1 and T(H)17 cytokines and transcription factors, both in the periphery and in the CNS. In the chronic phase of EAE, the blockade of B1R consistently impaired the clinical progression of EAE. Conversely, administration of the B1R agonist in the acute phase of EAE suppressed disease progression and inhibited the increase in permeability of the blood-brain barrier (BBB) and any further CNS inflammation. Of note, blockade of the B2R only showed a moderate impact on all of the studied parameters of EAE progression. Conclusions/Significance: Our results strongly suggest that kinin receptors, mainly the B1R subtype, play a dual role in EAE progression depending on the phase of treatment through the lymphocytes and glial cell-dependent pathways.	[Dutra, Rafael C.; Leite, Daniela F. P.; Bento, Allisson F.; Manjavachi, Marianne N.; Patricio, Eliziane S.; Figueiredo, Claudia P.; Calixto, Joao B.] Univ Fed Santa Catarina, Dept Pharmacol, Ctr Biol Sci, Florianopolis, SC, Brazil; [Pesquero, Joao B.] Univ Fed Sao Paulo, Dept Biophys, Sao Paulo, Brazil	Universidade Federal de Santa Catarina (UFSC); Universidade Federal de Sao Paulo (UNIFESP)	Dutra, RC (corresponding author), Univ Fed Santa Catarina, Dept Pharmacol, Ctr Biol Sci, Florianopolis, SC, Brazil.	calixto@farmaco.ufsc.br	Bento, Allisson/F-5603-2013; Pesquero, Joao/C-1470-2012; Figueiredo, Claudia P/F-8424-2012; Dutra, Rafael C/F-8452-2012	Pesquero, Joao/0000-0002-4507-632X; Dutra, Rafael C/0000-0002-6938-2161; Figueiredo, Claudia/0000-0001-9467-9891; calixto, joao Batista/0000-0003-4041-7153	Conselho Nacional de Desenvolvimento Cientifico eTecnologico (CNPq), Brazil; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Brazil; Programa de Apoio aos Nucleos de Excelencia (PRONEX), Brazil; Fundacaode Apoio a Pesquisa Cientifica Tecnologica do Estado de Santa Catarina (FAPESC), Brazil; CNPq; CAPES	Conselho Nacional de Desenvolvimento Cientifico eTecnologico (CNPq), Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Programa de Apoio aos Nucleos de Excelencia (PRONEX), Brazil; Fundacaode Apoio a Pesquisa Cientifica Tecnologica do Estado de Santa Catarina (FAPESC), Brazil; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by grants from the Conselho Nacional de Desenvolvimento Cientifico eTecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Programa de Apoio aos Nucleos de Excelencia (PRONEX) and the Fundacaode Apoio a Pesquisa Cientifica Tecnologica do Estado de Santa Catarina (FAPESC), all of Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. R. C. D., A. F. B., and M.M.N. are Ph.D. students in pharmacology receiving grants from CNPq and CAPES, respectively.	Aliberti J, 2003, J IMMUNOL, V170, P5349, DOI 10.4049/jimmunol.170.11.5349; Alvarez JI, 2011, BBA-MOL BASIS DIS, V1812, P252, DOI 10.1016/j.bbadis.2010.06.017; Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; Bjartmar C, 2003, J NEUROL SCI, V206, P165, DOI 10.1016/S0022-510X(02)00069-2; BORKOWSKI JA, 1995, J BIOL CHEM, V270, P13706, DOI 10.1074/jbc.270.23.13706; Calixto JB, 2004, BRIT J PHARMACOL, V143, P803, DOI 10.1038/sj.bjp.0706012; Campos MM, 2006, TRENDS PHARMACOL SCI, V27, P646, DOI 10.1016/j.tips.2006.10.007; Carola V, 2010, GENES BRAIN BEHAV, V9, P379, DOI 10.1111/j.1601-183X.2010.00572.x; COSTA R, 2011, BR J PHARM; Crusio WE, 2009, GENES BRAIN BEHAV, V8, P1, DOI 10.1111/j.1601-183X.2008.00438.x; Crusio WE, 2004, BIOL PSYCHIAT, V56, P381, DOI 10.1016/j.biopsych.2003.12.026; Danielisova V, 2009, CELL MOL NEUROBIOL, V29, P871, DOI 10.1007/s10571-009-9369-3; Dos Santos AC, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-49; Dutra RC, 2011, BRIT J PHARMACOL, V163, P358, DOI 10.1111/j.1476-5381.2011.01226.x; Ellestad KK, 2009, J IMMUNOL, V183, P298, DOI 10.4049/jimmunol.0803576; Elliott PJ, 1996, EXP NEUROL, V141, P214, DOI 10.1006/exnr.1996.0156; Emerich DF, 2000, PHARMACEUT RES, V17, P1212, DOI 10.1023/A:1026462629438; Frohman EM, 2006, NEW ENGL J MED, V354, P942, DOI 10.1056/NEJMra052130; Gerlai R, 2001, BEHAV BRAIN RES, V125, P13, DOI 10.1016/S0166-4328(01)00282-0; GERMAIN L, 1988, J NEUROL SCI, V83, P211, DOI 10.1016/0022-510X(88)90069-X; Gobin SJP, 2001, GLIA, V36, P68, DOI 10.1002/glia.1096; Gobel K, 2011, J AUTOIMMUN, V36, P106, DOI 10.1016/j.jaut.2010.11.004; Goverman J, 2009, NAT REV IMMUNOL; Gresack JE, 2010, BEHAV BRAIN RES, V209, P80, DOI 10.1016/j.bbr.2010.01.018; Hafler DA, 2004, J CLIN INVEST, V113, P788, DOI 10.1172/JCI200421357; Juan QL, 2009, NEUROSCI LETT, V450, P172, DOI 10.1016/j.neulet.2008.10.080; Kawakami N, 2005, J IMMUNOL, V175, P69, DOI 10.4049/jimmunol.175.1.69; Khan TK, 2009, NEUROBIOL DIS, V34, P332, DOI 10.1016/j.nbd.2009.02.003; Kim H, 2007, BRAIN RES, V1162, P113, DOI 10.1016/j.brainres.2007.05.072; Kiselycznyk C, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00010; Kivisakk P, 2009, ANN NEUROL, V65, P457, DOI 10.1002/ana.21379; Liu LB, 2008, J NEUROSCI RES, V86, P1153, DOI 10.1002/jnr.21558; Liu YH, 2001, NEUROL RES, V23, P379, DOI 10.1179/016164101101198596; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marceau F, 1998, CLIN REV ALLERG IMMU, V16, P385, DOI 10.1007/BF02737658; McFarland HF, 2007, NAT IMMUNOL, V8, P913, DOI 10.1038/ni1507; Moldovan IR, 2003, J NEUROIMMUNOL, V141, P132, DOI 10.1016/S0165-5728(03)00221-2; Mycko MA, 2008, EUR J IMMUNOL, V38, P1999, DOI 10.1002/eji.200737661; Pesquero JB, 2000, P NATL ACAD SCI USA, V97, P8140, DOI 10.1073/pnas.120035997; Prat A, 2000, J NEUROPATH EXP NEUR, V59, P896, DOI 10.1093/jnen/59.10.896; Prat A, 2005, ARCH NEUROL-CHICAGO, V62, P795, DOI 10.1001/archneur.62.5.795; Prediger RDS, 2008, NEUROSCIENCE, V151, P631, DOI 10.1016/j.neuroscience.2007.11.009; Schulze-Topphoff U, 2009, NAT MED, V15, P788, DOI 10.1038/nm.1980; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Stromnes IM, 2008, NAT MED, V14, P337, DOI 10.1038/nm1715; Stromnes IM, 2006, NAT PROTOC, V1, P1810, DOI 10.1038/nprot.2006.285; Terenyi N, 2009, MOL IMMUNOL, V47, P57, DOI 10.1016/j.molimm.2008.12.026; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Tzartos JS, 2008, AM J PATHOL, V172, P146, DOI 10.2353/ajpath.2008.070690; WALKER K, 1995, NEUROCHEM INT, V26, P1, DOI 10.1016/0197-0186(94)00114-A; Walther T, 1998, J BIOL CHEM, V273, P11867, DOI 10.1074/jbc.273.19.11867; Weiss N, 2009, BBA-BIOMEMBRANES, V1788, P842, DOI 10.1016/j.bbamem.2008.10.022; Yao CC, 2009, NAT MED, V15, P633, DOI 10.1038/nm.1968; Zhang H, 2007, BRAIN RES, V1144, P33, DOI 10.1016/j.brainres.2007.01.133; Zhang M, 2010, NEUROSCIENCE, V171, P852, DOI 10.1016/j.neuroscience.2010.09.029	55	24	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2011	6	11							e27875	10.1371/journal.pone.0027875	http://dx.doi.org/10.1371/journal.pone.0027875			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858JH	22132157	Green Submitted, Green Published, gold			2022-12-27	WOS:000297792400019
J	Ren, G; Blum, G; Verdoes, M; Liu, HG; Syed, S; Edgington, LE; Gheysens, O; Miao, Z; Jiang, H; Gambhir, SS; Bogyo, M; Cheng, Z				Ren, Gang; Blum, Galia; Verdoes, Martijn; Liu, Hongguang; Syed, Salahuddin; Edgington, Laura E.; Gheysens, Olivier; Miao, Zheng; Jiang, Han; Gambhir, Sanjiv Sam; Bogyo, Matthew; Cheng, Zhen			Non-Invasive Imaging of Cysteine Cathepsin Activity in Solid Tumors Using a Cu-64-Labeled Activity-Based Probe	PLOS ONE			English	Article							CELL-PENETRATING PEPTIDES; PROTEASE ACTIVITY; CANCER; EXPRESSION; MICROENVIRONMENT; PROTEOLYSIS; ACTIVATION; INVASION; TARGET	The papain family of cysteine cathepsins are actively involved in multiple stages of tumorigenesis. Because elevated cathepsin activity can be found in many types of human cancers, they are promising biomarkers that can be used to target radiological contrast agents for tumor detection. However, currently there are no radiological imaging agents available for these important molecular targets. We report here the development of positron emission tomography (PET) radionuclide-labeled probes that target the cysteine cathepsins by formation of an enzyme activity-dependent bond with the active site cysteine. These probes contain an acyloxymethyl ketone (AOMK) functional group that irreversibly labels the active site cysteine of papain family proteases attached to a 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA) tag for labeling with Cu-64 for PET imaging studies. We performed biodistribution and microPET imaging studies in nude mice bearing subcutaneous tumors expressing various levels of cysteine cathepsin activity and found that the extent of probe uptake by tumors correlated with overall protease activity as measured by biochemical methods. Furthermore, probe signals could be reduced by pre-treatment with a general cathepsin inhibitor. We also found that inclusion of a Cy5 tag on the probe increased tumor uptake relative to probes lacking this fluorogenic dye. Overall, these results demonstrate that small molecule activity-based probes carrying radio-tracers can be used to image protease activity in living subjects.	[Ren, Gang; Liu, Hongguang; Gheysens, Olivier; Miao, Zheng; Jiang, Han; Gambhir, Sanjiv Sam; Bogyo, Matthew; Cheng, Zhen] Stanford Univ, MIPS, Stanford, CA 94305 USA; [Ren, Gang; Liu, Hongguang; Gheysens, Olivier; Miao, Zheng; Jiang, Han; Gambhir, Sanjiv Sam; Cheng, Zhen] Stanford Univ, Dept Radiol, Stanford, CA 94305 USA; [Gambhir, Sanjiv Sam] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Blum, Galia; Verdoes, Martijn; Syed, Salahuddin; Edgington, Laura E.; Bogyo, Matthew] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Bogyo, Matthew] Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Ren, Gang; Liu, Hongguang; Gheysens, Olivier; Miao, Zheng; Jiang, Han; Gambhir, Sanjiv Sam; Bogyo, Matthew; Cheng, Zhen] Stanford Univ, Bio X Program, Stanford, CA 94305 USA; [Blum, Galia] Hebrew Univ Jerusalem, Inst Drug Res, Jerusalem, Israel	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Hebrew University of Jerusalem	Ren, G (corresponding author), Stanford Univ, MIPS, Stanford, CA 94305 USA.	sgambhir@stanford.edu; mbogyo@stanford.edu; zcheng@stanford.edu	Verdoes, Martijn/A-4911-2015; Verdoes, Martijn/AAD-5239-2022; Cheng, Zhen/K-2843-2012; miao, zheng/A-8851-2012	Verdoes, Martijn/0000-0001-8753-3528; Verdoes, Martijn/0000-0001-8753-3528; Cheng, Zhen/0000-0001-8177-9463; , Han/0000-0001-7455-3810; Bogyo, Matthew/0000-0003-3753-4412; SYED, SALAHUDDIN/0000-0002-9696-6437; Edgington-Mitchell, Laura/0000-0002-6810-6149	National Institutes of Health (NIH) National Technology Centers for Networks and Pathways [U54 RR020843]; NIH [R01 EB005011]; Susan G. Komen for the Cure [PDF0504576]; National Cancer Institute (NCI) [R24 CA93862]; NCI In Vivo Cellular Molecular Imaging Center (ICMIC) [P50 CA114747]; NATIONAL CANCER INSTITUTE [T32CA009302, P50CA114747] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020843] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB005011] Funding Source: NIH RePORTER	National Institutes of Health (NIH) National Technology Centers for Networks and Pathways(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI In Vivo Cellular Molecular Imaging Center (ICMIC); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported, in part, by National Institutes of Health (NIH) National Technology Centers for Networks and Pathways grant U54 RR020843 (MB), NIH grant R01 EB005011 (MB), Susan G. Komen for the Cure grant PDF0504576 (GB), National Cancer Institute (NCI) Small Animal Imaging Resource Program (SAIRP) grant R24 CA93862, and NCI In Vivo Cellular Molecular Imaging Center (ICMIC) grant P50 CA114747 (SSG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CJ, 2001, J NUCL MED, V42, P213; Baruch A, 2004, TRENDS CELL BIOL, V14, P29, DOI 10.1016/j.tcb.2003.11.002; Berger Alicia B, 2004, Am J Pharmacogenomics, V4, P371, DOI 10.2165/00129785-200404060-00004; Blum G, 2005, NAT CHEM BIOL, V1, P203, DOI 10.1038/nchembio728; Blum G, 2007, NAT CHEM BIOL, V3, P668, DOI 10.1038/nchembio.2007.26; Bogdanov AA, 2002, NEOPLASIA, V4, P228, DOI 10.1038/sj.neo.7900238; Boswell CA, 2004, J MED CHEM, V47, P1465, DOI 10.1021/jm030383m; Bremer C, 2002, RADIOLOGY, V222, P814, DOI 10.1148/radiol.2223010812; CAMPO E, 1994, AM J PATHOL, V145, P301; Cavallo-Medved D, 2003, CURR TOP DEV BIOL, V54, P313, DOI 10.1016/S0070-2153(03)54013-3; Cheng Z, 2007, BIOCONJUGATE CHEM, V18, P765, DOI 10.1021/bc060306g; D'Orazi G, 2000, J GENE MED, V2, P11; Edgington LE, 2009, NAT MED, V15, P967, DOI 10.1038/nm.1938; Eijan AM, 2003, CANCER, V98, P262, DOI 10.1002/cncr.11493; Figueiredo JL, 2006, INT J CANCER, V118, P2672, DOI 10.1002/ijc.21713; Gambhir SS, 2002, NAT REV CANCER, V2, P683, DOI 10.1038/nrc882; Jedeszko C, 2004, BIOL CHEM, V385, P1017, DOI 10.1515/BC.2004.132; Jiang T, 2004, P NATL ACAD SCI USA, V101, P17867, DOI 10.1073/pnas.0408191101; Joyce JA, 2004, CELL CYCLE, V3, P1516, DOI 10.4161/cc.3.12.1289; Joyce JA, 2004, CANCER CELL, V5, P443, DOI 10.1016/S1535-6108(04)00111-4; Kato D, 2005, NAT CHEM BIOL, V1, P33, DOI 10.1038/nchembio707; Koblinski JE, 2000, CLIN CHIM ACTA, V291, P113, DOI 10.1016/S0009-8981(99)00224-7; Lee M, 2004, CHEM SOC REV, V33, P401, DOI 10.1039/b209224g; Lim IT, 2004, J AM CHEM SOC, V126, P10271, DOI 10.1021/ja0489240; Mahmood U, 1999, RADIOLOGY, V213, P866, DOI 10.1148/radiology.213.3.r99dc14866; Mohamed MM, 2006, NAT REV CANCER, V6, P764, DOI 10.1038/nrc1949; Olson ES, 2010, P NATL ACAD SCI USA, V107, P4311, DOI 10.1073/pnas.0910283107; Olson ES, 2009, INTEGR BIOL-UK, V1, P382, DOI 10.1039/b904890a; Sloane BF, 2006, ANNU REV PHARMACOL, V46, P301, DOI 10.1146/annurev.pharmtox.45.120403.095853; Sloane BF, 2005, SEMIN CANCER BIOL, V15, P149, DOI 10.1016/j.semcancer.2004.08.001; Sun XK, 2004, NUCL MED BIOL, V31, P1051, DOI 10.1016/j.nucmedbio.2004.08.011	31	39	39	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2011	6	11							e28029	10.1371/journal.pone.0028029	http://dx.doi.org/10.1371/journal.pone.0028029			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IO	22132198	Green Published, Green Submitted, gold			2022-12-27	WOS:000297789900039
J	Sanford, MR; Demirci, B; Marsden, CD; Lee, Y; Cornel, AJ; Lanzaro, GC				Sanford, Michelle R.; Demirci, Berna; Marsden, Clare D.; Lee, Yoosook; Cornel, Anthony J.; Lanzaro, Gregory C.			Morphological Differentiation May Mediate Mate-Choice between Incipient Species of Anopheles gambiae s.s.	PLOS ONE			English	Article							MOLECULAR-FORMS; REPRODUCTIVE ISOLATION; CHROMOSOMAL FORMS; WEST-AFRICA; WING LENGTH; GENE FLOW; POPULATIONS; COMPLEX; DIPTERA; DIVERGENCE	The M and S molecular forms of Anopheles gambiae s.s. have been considered incipient species for more than ten years, yet the mechanism underlying assortative mating of these incipient species has remained elusive. The discovery of the importance of harmonic convergence of wing beat frequency in mosquito mating and its relation to wing size have laid the foundation for exploring phenotypic divergence in wing size of wild populations of the two forms. In this study, wings from field collected mosquitoes were measured for wing length and wing width from two parts of the sympatric distribution, which differ with respect to the strength of assortative mating. In Mali, where assortative mating is strong, as evidenced by low rates of hybridization, mean wing lengths and wing widths were significantly larger than those from Guinea-Bissau. In addition, mean wing widths in Mali were significantly different between molecular forms. In Guinea-Bissau, assortative mating appears comparatively reduced and wing lengths and widths did not differ significantly between molecular forms. The data presented in this study support the hypothesis that wing beat frequency may mediate assortative mating in the incipient species of A. gambiae and represent the first documentation of a morphological difference between the M and S molecular forms.	[Sanford, Michelle R.; Marsden, Clare D.; Lee, Yoosook; Lanzaro, Gregory C.] Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA; [Demirci, Berna] Hacettepe Univ, Fac Sci, Ankara, Turkey; [Cornel, Anthony J.] Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA	University of California System; University of California Davis; Hacettepe University; University of California System; University of California Davis	Sanford, MR (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA.	uranotaenia@gmail.com	Sanford, Michelle/C-9575-2011	Sanford, Michelle/0000-0001-6212-4023; Lee, Yoosook/0000-0002-1392-7177	National Institutes of Health [AI062929, AI078183, AI074550]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI074550, R21AI062929, R01AI078183] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by National Institutes of Health grants AI062929, AI078183 and AI074550 awarded to GCL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DC, 2004, ITAL J ZOOL, V71, P5, DOI 10.1080/11250000409356545; Bottecchia M, 2004, J MOL EVOL, V58, P754, DOI 10.1007/s00239-004-2586-y; Caputo B, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-182; Caputo B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016415; Cator LJ, 2010, BEHAV ECOL, V21, P1033, DOI 10.1093/beheco/arq087; Cator LJ, 2009, SCIENCE, V323, P1077, DOI 10.1126/science.1166541; Coetzee M, 2000, PARASITOL TODAY, V16, P74, DOI 10.1016/S0169-4758(99)01563-X; Costantini Carlo, 2009, BMC Ecology, V9, P16, DOI 10.1186/1472-6785-9-16; della Torre A, 2001, INSECT MOL BIOL, V10, P9, DOI 10.1046/j.1365-2583.2001.00235.x; Diabate A, 2006, J MED ENTOMOL, V43, P480, DOI 10.1603/0022-2585(2006)43[480:MSOTMM]2.0.CO;2; Diabate A, 2007, J MED ENTOMOL, V44, P60, DOI 10.1603/0022-2585(2007)44[60:ETEOPI]2.0.CO;2; Diabate A, 2009, P ROY SOC B-BIOL SCI, V276, P4215, DOI 10.1098/rspb.2009.1167; Fanello C, 2002, MED VET ENTOMOL, V16, P461, DOI 10.1046/j.1365-2915.2002.00393.x; Favia G, 2001, INSECT MOL BIOL, V10, P19, DOI 10.1046/j.1365-2583.2001.00236.x; Favia G, 1997, INSECT MOL BIOL, V6, P377, DOI 10.1046/j.1365-2583.1997.00189.x; Gibson G, 2010, JARO-J ASSOC RES OTO, V11, P527, DOI 10.1007/s10162-010-0243-2; Gimonneau G, 2012, MED VET ENTOMOL, V26, P9, DOI 10.1111/j.1365-2915.2011.00957.x; Gleason JM, 1998, EVOLUTION, V52, P1493, DOI [10.2307/2411319, 10.1111/j.1558-5646.1998.tb02031.x]; Koella JC, 1996, J MED ENTOMOL, V33, P261, DOI 10.1093/jmedent/33.2.261; Lanzaro GC, 1998, P NATL ACAD SCI USA, V95, P14260, DOI 10.1073/pnas.95.24.14260; Lawniczak MKN, 2010, SCIENCE, V330, P512, DOI 10.1126/science.1195755; LEE Y, 2009, MALARIA J, V8, DOI DOI 10.1186/1475-2875-1188-1175; Lee Y, 2009, J MED ENTOMOL, V46, P316, DOI 10.1603/033.046.0216; Lehmann T, 2008, INFECT GENET EVOL, V8, P737, DOI 10.1016/j.meegid.2008.06.003; LYIMO EO, 1992, ENTOMOL EXP APPL, V63, P265, DOI 10.1007/BF00192775; MARSDEN CM, 2011, MOL ECOL IN PRESS; NASCI RS, 1990, J MED ENTOMOL, V27, P716, DOI 10.1093/jmedent/27.4.716; Oliveira E, 2008, J MED ENTOMOL, V45, P1057, DOI 10.1603/0022-2585(2008)45[1057:HLOHBM]2.0.CO;2; Peixato AA, 2001, INT J PARASITOL, V31, P635, DOI 10.1016/S0020-7519(01)00149-7; Pennetier C, 2010, CURR BIOL, V20, P131, DOI 10.1016/j.cub.2009.11.040; Slotman MA, 2006, GENETICS, V174, P2081, DOI 10.1534/genetics.106.059949; Souza NA, 2004, J MED ENTOMOL, V41, P906, DOI 10.1603/0022-2585-41.5.906; Taylor C, 2001, GENETICS, V157, P743; Tripet F, 2004, J MED ENTOMOL, V41, P375, DOI 10.1603/0022-2585-41.3.375; Tripet F, 2001, MOL ECOL, V10, P1725, DOI 10.1046/j.0962-1083.2001.01301.x; Tripet F, 2007, AM J TROP MED HYG, V76, P81; Tuno N, 2010, J MED ENTOMOL, V47, P28, DOI 10.1603/033.047.0104; Turner TL, 2005, PLOS BIOL, V3, P1572, DOI 10.1371/journal.pbio.0030285; White BJ, 2010, MOL ECOL, V19, P925, DOI 10.1111/j.1365-294X.2010.04531.x; Wondji C, 2005, J MED ENTOMOL, V42, P998, DOI 10.1603/0022-2585(2005)042[0998:SAPOTA]2.0.CO;2	40	22	22	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2011	6	11							e27920	10.1371/journal.pone.0027920	http://dx.doi.org/10.1371/journal.pone.0027920			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IO	22132169	Green Submitted, Green Published, gold			2022-12-27	WOS:000297789900033
J	Ravindran, RD; Vashist, P; Gupta, SK; Young, IS; Maraini, G; Camparini, M; Jayanthi, R; John, N; Fitzpatrick, KE; Chakravarthy, U; Ravilla, TD; Fletcher, AE				Ravindran, Ravilla D.; Vashist, Praveen; Gupta, Sanjeev K.; Young, Ian S.; Maraini, Giovanni; Camparini, Monica; Jayanthi, R.; John, Neena; Fitzpatrick, Kathryn E.; Chakravarthy, Usha; Ravilla, Thulasiraj D.; Fletcher, Astrid E.			Prevalence and Risk Factors for Vitamin C Deficiency in North and South India: A Two Centre Population Based Study in People Aged 60 Years and Over	PLOS ONE			English	Article							ASCORBIC-ACID; CIRCULATING CONCENTRATIONS; DEHYDROASCORBIC ACID; NUTRITIONAL-STATUS; STABILITY; HEALTH; HAPTOGLOBIN; BLOOD; WOMEN; ANTIOXIDANT	Background: Studies from the UK and North America have reported vitamin C deficiency in around 1 in 5 men and 1 in 9 women in low income groups. There are few data on vitamin C deficiency in resource poor countries. Objectives: To investigate the prevalence of vitamin C deficiency in India. Design: We carried out a population-based cross-sectional survey in two areas of north and south India. Randomly sampled clusters were enumerated to identify people aged 60 and over. Participants (75% response rate) were interviewed for tobacco, alcohol, cooking fuel use, 24 hour diet recall and underwent anthropometry and blood collection. Vitamin C was measured using an enzyme-based assay in plasma stabilized with metaphosphoric acid. We categorised vitamin C status as deficient (<11 mu mol/L), sub-optimal (11-28 mu mol/L) and adequate (>28 mu mol/L). We investigated factors associated with vitamin C deficiency using multivariable Poisson regression. Results: The age, sex and season standardized prevalence of vitamin C deficiency was 73.9% (95% confidence Interval, CI 70.4,77.5) in 2668 people in north India and 45.7% (95% CI 42.5,48.9) in 2970 from south India. Only 10.8% in the north and 25.9% in the south met the criteria for adequate levels. Vitamin C deficiency varied by season, and was more prevalent in men, with increasing age, users of tobacco and biomass fuels, in those with anthropometric indicators of poor nutrition and with lower intakes of dietary vitamin C. Conclusions: In poor communities, such as in our study, consideration needs to be given to measures to improve the consumption of vitamin C rich foods and to discourage the use of tobacco.	[Ravindran, Ravilla D.; Jayanthi, R.] Aravind Eye Hosp Pondicherry, Pondicherry, India; [Vashist, Praveen; Gupta, Sanjeev K.; John, Neena] All India Inst Med Sci, Dr Rajendra Prasad Ctr Ophthalm Sci, New Delhi 110029, India; [Young, Ian S.] Queens Univ Belfast, Sch Med Dent & Biomed Sci, Ctr Publ Hlth, Belfast, Antrim, North Ireland; [Maraini, Giovanni; Camparini, Monica] Univ Parma, Dipartimento Sci Otorino Odonto Oftalmologich & C, Sez Oftalmol, I-43100 Parma, Italy; [Fitzpatrick, Kathryn E.; Fletcher, Astrid E.] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1, England; [Chakravarthy, Usha] Queens Univ Belfast, Sch Med Dent & Biomed Sci, Ctr Vision & Vasc Sci, Belfast, Antrim, North Ireland; [Ravilla, Thulasiraj D.] Lions Aravind Inst Community Ophthalmol, Madurai, Tamil Nadu, India	All India Institute of Medical Sciences (AIIMS) New Delhi; Dr. Rajendra Prasad Centre for Ophthalmic Sciences; Queens University Belfast; University of Parma; University of London; London School of Hygiene & Tropical Medicine; Queens University Belfast	Ravindran, RD (corresponding author), Aravind Eye Hosp Pondicherry, Pondicherry, India.	astrid.fletcher@lshtm.ac.uk		Young, Ian/0000-0003-3890-3152; Gupta, Sanjeev/0000-0002-2014-5333; Chakravarthy, Usha/0000-0002-2606-3734	Wellcome Trust UK [073300]	Wellcome Trust UK(Wellcome Trust)	The study was funded by the Wellcome Trust UK, Grant 073300 (www.wellcome.ac.uk). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberg AJ, 2002, TOXICOLOGY, V180, P121, DOI 10.1016/S0300-483X(02)00386-4; Arlappa N., 2005, Journal of Nutrition for the Elderly, V25, P23, DOI 10.1300/J052v25n02_03; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Bates CJ, 1999, BRIT J NUTR, V82, P7, DOI 10.1017/S0007114599001063; Cahill LE, 2010, AM J CLIN NUTR; Cahill L, 2009, AM J EPIDEMIOL, V170, P464, DOI 10.1093/aje/kwp156; Cahill LE, 2009, AM J CLIN NUTR, V90, P1411, DOI 10.3945/ajcn.2009.28327; Carter K, 2007, INT J LAB HEMATOL, V29, P92, DOI 10.1111/j.1751-553X.2007.00898.x; Ching SYL, 2002, ANN CLIN BIOCHEM, V39, P518, DOI 10.1258/000456302320314566; Chiplonkar SA, 2002, EUR J CLIN NUTR, V56, P96, DOI 10.1038/sj.ejcn.1601291; Chung WY, 2001, CLIN BIOCHEM, V34, P623, DOI 10.1016/S0009-9120(01)00270-3; Dehghan M, 2007, NUTR J, V6, DOI 10.1186/1475-2891-6-41; Delanghe JR, 2002, CLIN CHEM LAB MED, V40, P212, DOI 10.1515/CCLM.2002.035; Dherani M, 2008, INVEST OPHTH VIS SCI, V49, P3328, DOI 10.1167/iovs.07-1202; Donin AS, 2010, BRIT J NUTR, V104, P276, DOI 10.1017/S000711451000070X; Gopalan C, 1971, NUTR VALUE INDIAN FO, p[ii, 204, 202]; Gupta S, 2006, FOOD NUTR BULL, V27, P306, DOI 10.1177/156482650602700404; Hampl JS, 2004, AM J PUBLIC HEALTH, V94, P870, DOI 10.2105/AJPH.94.5.870; Hillbruner C, 2008, FOOD NUTR BULL, V29, P221, DOI 10.1177/156482650802900308; Hughes K., 1998, Annals Academy of Medicine Singapore, V27, P149; Institute of Medicine (US) Panel on Dietary Antioxidants and Related Compounds, 2000, DIET REF INT VIT C V; Ismail S, 1999, BETTER NUTR OLDER PE; Karlsen A, 2007, EUR J CLIN NUTR, V61, P1233, DOI 10.1038/sj.ejcn.1602655; Langlois MR, 1997, AM J CLIN NUTR, V66, P606, DOI 10.1093/ajcn/66.3.606; Leskova E, 2006, J FOOD COMPOS ANAL, V19, P252, DOI 10.1016/j.jfca.2005.04.014; Levine M, 1999, METHOD ENZYMOL, V299, P65; Levine M, 1999, JAMA-J AM MED ASSOC, V281, P1415, DOI 10.1001/jama.281.15.1415; Lykkesfeldt J, 2007, CANCER EPIDEM BIOMAR, V16, P2513, DOI 10.1158/1055-9965.EPI-07-0639; Mosdol A, 2008, J PUBLIC HEALTH-UK, V30, P456, DOI 10.1093/pubmed/fdn076; Ness AR, 1999, INT J EPIDEMIOL, V28, P450, DOI 10.1093/ije/28.3.450; Padayatty SJ, 2003, J AM COLL NUTR, V22, P18, DOI 10.1080/07315724.2003.10719272; PASRICHA S, 1967, INDIAN J MED RES, V55, P779; Patel V, 2011, LANCET, V377, P413, DOI 10.1016/S0140-6736(10)61188-9; Perez-Padilla R, 2010, INT J TUBERC LUNG D, V14, P1079; Schleicher RL, 2009, AM J CLIN NUTR, V90, P1252, DOI 10.3945/ajcn.2008.27016; Somannavar S, 2009, DIABETES CARE, V32, P641, DOI 10.2337/dc08-0403; Subramanian SV, 2004, BMJ-BRIT MED J, V328, P801, DOI 10.1136/bmj.328.7443.801; Timpson NJ, 2010, AM J CLIN NUTR, V92, P375, DOI 10.3945/ajcn.2010.29438; Torheim LE, 2010, J NUTR, V140, p2051S, DOI 10.3945/jn.110.123463; Vashist P, 2011, OPHTHALMOLOGY, V118, P272, DOI 10.1016/j.ophtha.2010.05.020; Vedantam A, 2010, PUBLIC HEALTH NUTR, V13, P1328, DOI 10.1017/S1368980009991674; Villalpando S, 2003, SALUD PUBLICA MEXICO, V45, pS508; VUILLEUMIER JP, 1989, J MICRONUTR ANAL, V5, P25; Willett WC, 1997, AM J CLIN NUTR, V65, P1220, DOI 10.1093/ajcn/65.4.1220S; Wrieden WL, 2000, J EPIDEMIOL COMMUN H, V54, P355, DOI 10.1136/jech.54.5.355	45	37	38	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2011	6	12							e28588	10.1371/journal.pone.0028588	http://dx.doi.org/10.1371/journal.pone.0028588			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863OC	22163038	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000298173500037
J	McTaggart, JS; Lee, S; Iberl, M; Church, C; Cox, RD; Ashcroft, FM				McTaggart, James S.; Lee, Sheena; Iberl, Michaela; Church, Chris; Cox, Roger D.; Ashcroft, Frances M.			FTO Is Expressed in Neurones throughout the Brain and Its Expression Is Unaltered by Fasting	PLOS ONE			English	Article							ENERGY-INTAKE; FOOD-INTAKE; OBESITY GENE; CHILDHOOD; VARIANT; MICE; NEUN	Single-nucleotide polymorphisms in the first intron of the ubiquitously expressed FTO gene are associated with obesity. Although the physiological functions of FTO remain unclear, food intake is often altered when Fto expression levels are manipulated. Furthermore, deletion of FTO from neurones alone has a similar effect on food intake to deletion of FTO in all tissues. These results indicate that FTO expression in the brain is particularly important. Considerable focus has been placed on the dynamic regulation of Fto mRNA expression in the hypothalamus after short-term (16-48 hour) fasting, but results have been controversial. There are no studies that quantify FTO protein levels across the brain, and assess its alteration following short-term fasting. Using immunohistochemistry, we found that FTO protein is widely expressed in mouse brain, and present in the majority of neurones. Using quantitative Western blotting and RT-qPCR we show that FTO protein and mRNA levels in the hypothalamus, cerebellum and rostral brain are relatively uniform, and levels in the brain are higher than in skeletal muscles of the lower limbs. Fasting for 18 hours does not alter the expression pattern, or levels, of FTO protein and mRNA. We further show that the majority of POMC neurones, which are critically involved in food intake regulation, also express FTO, but that the percentage of FTO-positive POMC neurones is not altered by fasting. In summary, we find no evidence that Fto/FTO expression is regulated by short-term (18-hour) fasting. Thus, it is unlikely that the hunger and increased post-fasting food intake caused by such food deprivation is driven by alterations in Fto/FTO expression. The widespread expression of FTO in neurones also suggests that physiological studies of this protein should not be limited to the hypothalamus.	[McTaggart, James S.; Lee, Sheena; Iberl, Michaela; Ashcroft, Frances M.] Henry Wellcome Ctr Gene Funct, OXION Ctr Ion Channel Studies, Dept Physiol Anat & Genet, Oxford, England; [Church, Chris; Cox, Roger D.] MRC Harwell, Harwell, Berks, England	University of Oxford; MRC Harwell	McTaggart, JS (corresponding author), Henry Wellcome Ctr Gene Funct, OXION Ctr Ion Channel Studies, Dept Physiol Anat & Genet, Oxford, England.	frances.ashcroft@dpag.ox.ac.uk		Cox, Roger/0000-0001-7170-5014	Medical Research Council; Wellcome Trust; Royal Society; Medical Research Council [MC_U142661184] Funding Source: researchfish; MRC [MC_U142661184] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thank the Medical Research Council (JSM and CC held Medical Research Council studentships), Wellcome Trust (OXION support for SL and MI), and the Royal Society (Research Professorship to FMA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Agouni A, 2010, BIOCHEM BIOPH RES CO, V401, P104, DOI 10.1016/j.bbrc.2010.09.018; Aponte Y, 2011, NAT NEUROSCI, V14, P351, DOI 10.1038/nn.2739; Balthasar N, 2004, NEURON, V42, P983, DOI 10.1016/j.neuron.2004.06.004; Cecil JE, 2008, NEW ENGL J MED, V359, P2558, DOI 10.1056/NEJMoa0803839; Church C, 2010, NAT GENET, V42, P1086, DOI 10.1038/ng.713; Church C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000599; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Fischer J, 2009, NATURE, V458, P894, DOI 10.1038/nature07848; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Fredriksson R, 2008, ENDOCRINOLOGY, V149, P2062, DOI 10.1210/en.2007-1457; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Guan HP, 2009, J BIOL CHEM, V284, P24644, DOI 10.1074/jbc.M109.034397; HEIZMANN CW, 1982, P NATL ACAD SCI-BIOL, V79, P7243, DOI 10.1073/pnas.79.23.7243; Hodge HC, 1941, J BIOL CHEM, V139, P897; Irimia JM, 2010, J BIOL CHEM, V285, P12851, DOI 10.1074/jbc.M110.106534; Jia G, NAT CHEM BIOL; Jikumaru M, 2007, PHYSIOL CHEM PHYS ME, V39, P247; Kelly T, 2008, INT J OBESITY, V32, P1431, DOI 10.1038/ijo.2008.102; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; MENAHAN LA, 1983, COMP BIOCHEM PHYS B, V74, P859, DOI 10.1016/0305-0491(83)90157-8; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Olszewski PK, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-129; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Speakman JR, 2008, OBESITY, V16, P1961, DOI 10.1038/oby.2008.318; Stratigopoulos G, 2008, AM J PHYSIOL-REG I, V294, pR1185, DOI 10.1152/ajpregu.00839.2007; Tanofsky-Kraff M, 2009, AM J CLIN NUTR, V90, P1483, DOI 10.3945/ajcn.2009.28439; Timpson NJ, 2008, AM J CLIN NUTR, V88, P971, DOI 10.1093/ajcn/88.4.971; Tung YCL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008771; Wang P, 2011, MOL MED, V17, P523, DOI [10.2119/molmed.2010.000134, 10.2119/molmed.2010.00134]; Wang YX, 2004, PLOS BIOL, V2, P1532, DOI 10.1371/journal.pbio.0020294; Wardle J, 2008, INT J OBESITY; Wolf HK, 1996, J HISTOCHEM CYTOCHEM, V44, P1167, DOI 10.1177/44.10.8813082; Wu Q, 2010, BIOCHEM BIOPH RES CO, V401, P390, DOI 10.1016/j.bbrc.2010.09.064	36	62	64	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e27968	10.1371/journal.pone.0027968	http://dx.doi.org/10.1371/journal.pone.0027968			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140494	gold, Green Submitted, Green Published			2022-12-27	WOS:000298168100028
J	Zeyrek, FY; Palacpac, N; Yuksel, F; Yagi, M; Honjo, K; Fujita, Y; Arisue, N; Takeo, S; Tanabe, K; Horii, T; Tsuboi, T; Ishii, KJ; Coban, C				Zeyrek, Fadile Yildiz; Palacpac, Nirianne; Yuksel, Fehmi; Yagi, Masanori; Honjo, Kaori; Fujita, Yukiko; Arisue, Nobuko; Takeo, Satoru; Tanabe, Kazuyuki; Horii, Toshihiro; Tsuboi, Takafumi; Ishii, Ken J.; Coban, Cevayir			Serologic Markers in Relation to Parasite Exposure History Help to Estimate Transmission Dynamics of Plasmodium vivax	PLOS ONE			English	Article							MEROZOITE SURFACE PROTEIN-1; C-TERMINAL REGION; ACQUIRED ANTIBODY-RESPONSES; NEW-GUINEAN CHILDREN; MALARIA TRANSMISSION; IMMUNE-RESPONSES; WHEAT-GERM; FALCIPARUM; INFECTION; TURKEY	Plasmodium vivax infection has been gaining attention because of its re-emergence in several parts of the world. Southeastern Turkey is one of the places in which persistent focal malaria caused exclusively by P. vivax parasites occurs. Although control and elimination studies have been underway for many years, no detailed study has been conducted to understand the mechanisms underlying the ineffective control of malaria in this region. Here, for the first time, using serologic markers we try to extract as much information as possible in this region to get a glimpse of P. vivax transmission. We conducted a sero-immunological study, evaluating antibody responses of individuals living in Sanliurfa to four different P. vivax antigens; three blood-stage antigens (PvMSP1(19), PvAMA1-ecto, and PvSERA4) and one pre-erythrocytic stage antigen (PvCSP). The results suggest that a prior history of malaria infection and age can be determining factors for the levels and sustainability of naturally acquired antibodies. Significantly higher antibody responses to all the studied antigens were observed in blood smear-negative individuals with a prior history of malaria infection. Moreover, these individuals were significantly older than blood smear-negative individuals with no prior history of infection. These data from an area of sole P. vivax-endemic region may have important implications for the global malaria control/elimination programs and vaccine design.	[Zeyrek, Fadile Yildiz; Fujita, Yukiko; Coban, Cevayir] Osaka Univ, Immunol Frontier Res Ctr, Lab Malaria Immunol, Osaka, Japan; [Zeyrek, Fadile Yildiz; Yuksel, Fehmi] Harran Univ Sch Med, Dept Microbiol, Sanliurfa, Turkey; [Palacpac, Nirianne; Yagi, Masanori; Arisue, Nobuko; Horii, Toshihiro] Osaka Univ, Microbial Dis Res Inst, Dept Mol Protozool, Osaka, Japan; [Honjo, Kaori] Osaka Univ, Global Collaborat Ctr, Osaka, Japan; [Takeo, Satoru; Tsuboi, Takafumi] Ehime Univ, Cell Free Sci & Technol Res Ctr, Matsuyama, Ehime 790, Japan; [Tanabe, Kazuyuki] Osaka Univ, Microbial Dis Res Inst, Int Res Ctr Infect Dis, Lab Malariol, Osaka, Japan; [Ishii, Ken J.] Osaka Univ, Lab Vaccine Sci, Immunol Frontier Res Ctr, Osaka, Japan	Osaka University; Harran University; Osaka University; Osaka University; Ehime University; Osaka University; Osaka University	Zeyrek, FY (corresponding author), Osaka Univ, Immunol Frontier Res Ctr, Lab Malaria Immunol, Osaka, Japan.	ccoban@biken.osaka-u.ac.jp	Coban, Cevayir/B-2129-2012; Tsuboi, Takafumi/AAK-6145-2021; ZEYREK, FADİLE YILDIZ/AAA-5368-2021; Ishii, Ken J/B-1685-2012; COBAN, Cevayir/P-1928-2019	Ishii, Ken J/0000-0002-6728-3872; COBAN, Cevayir/0000-0002-4467-7799; Tsuboi, Takafumi/0000-0002-7415-1325; Horii, Toshihiro/0000-0002-3000-2045; Palacpac, Nirianne Marie/0000-0003-4098-3972	Ministry of Education, Culture, Sports, Science and Technology (MEXT); MEXT; Japan Society for the Promotion of Science (JSPS)	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was partly supported by grants from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) and Grants-in-Aid for Scientific Research on Priority Areas from MEXT (http://www.mext.go.jp/english/) (to KT, TH, TT, KJI and CC). FYZ and CC were supported by the Japan Society for the Promotion of Science (JSPS) fellowship program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird JK, 2009, CLIN MICROBIOL REV, V22, P508, DOI 10.1128/CMR.00008-09; Chuangchaiya S, 2010, CLIN EXP IMMUNOL, V160, P233, DOI 10.1111/j.1365-2249.2009.04075.x; Coban C, 2004, INFECT IMMUN, V72, P253, DOI 10.1128/IAI.72.1.253-259.2004; Cook J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-169; Corran P, 2007, TRENDS PARASITOL, V23, P575, DOI 10.1016/j.pt.2007.08.023; Crompton PD, 2010, P NATL ACAD SCI USA, V107, P6958, DOI 10.1073/pnas.1001323107; Culleton R, 2009, J INFECT DIS, V200, P1465, DOI 10.1086/644510; Douglas NM, 2011, CLIN INFECT DIS, V52, P612, DOI 10.1093/cid/ciq249; Drakeley CJ, 2005, P NATL ACAD SCI USA, V102, P5108, DOI 10.1073/pnas.0408725102; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Fernandez-Becerra C, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-29; Galinski MR, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S9; Guerra CA, 2006, TRENDS PARASITOL, V22, P353, DOI 10.1016/j.pt.2006.06.006; Horii T, 2010, PARASITOL INT, V59, P380, DOI 10.1016/j.parint.2010.05.002; Imwong M, 2007, J INFECT DIS, V195, P927, DOI 10.1086/512241; John CC, 2005, AM J TROP MED HYG, V73, P222, DOI 10.4269/ajtmh.2005.73.222; Kirchgatter K, 1998, J INFECT DIS, V177, P511, DOI 10.1086/517389; Kochar DK, 2010, AM J TROP MED HYG, V83, P981, DOI 10.4269/ajtmh.2010.09-0633; KRATZ FW, 1956, PUBLIC HEALTH REP, V71, P409, DOI 10.2307/4589425; Lim KJ, 2004, PARASITOL RES, V92, P384, DOI 10.1007/s00436-003-1009-0; Lin E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009047; Lin JT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018716; Luxemburger C, 1999, LANCET, V354, P162, DOI 10.1016/S0140-6736(05)75295-8; Mendis K, 2001, AM J TROP MED HYG, V64, P97, DOI 10.4269/ajtmh.2001.64.97; Michon P, 2007, AM J TROP MED HYG, V76, P997, DOI 10.4269/ajtmh.2007.76.997; Mueller I, 2009, VACCINE, V27, P5633, DOI [10.1016/j.vaccine.2009.07.018, 10.1016/j.vaccine.2009.08.112]; Mueller I, 2009, LANCET INFECT DIS, V9, P555, DOI 10.1016/S1473-3099(09)70177-X; Mufalo BC, 2008, MICROBES INFECT, V10, P1266, DOI 10.1016/j.micinf.2008.07.023; Okech RN, 2006, AM J TROP MED HYG, V74, P191, DOI 10.4269/ajtmh.2006.74.191; Palacpac NMQ, 2006, MOL BIOCHEM PARASIT, V150, P353, DOI 10.1016/j.molbiopara.2006.07.006; Palacpac NMQ, 2011, VACCINE, V29, P5837, DOI 10.1016/j.vaccine.2011.06.052; Rodrigues MHC, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-39; Rui E, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-192; Snounou G, 2004, TRENDS PARASITOL, V20, P333, DOI 10.1016/j.pt.2004.05.004; Soares IS, 1997, INFECT IMMUN, V65, P1606, DOI 10.1128/IAI.65.5.1606-1614.1997; Tsuboi T, 2008, INFECT IMMUN, V76, P1702, DOI 10.1128/IAI.01539-07; Van den Eede P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016257; Wells TNC, 2010, TRENDS PARASITOL, V26, P145, DOI 10.1016/j.pt.2009.12.005; Wickramarachchi T, 2007, INT J PARASITOL, V37, P199, DOI 10.1016/j.ijpara.2006.09.002; Zeyrek FY, 2008, AM J TROP MED HYG, V78, P729, DOI 10.4269/ajtmh.2008.78.729; Zeyrek FY, 2010, AM J TROP MED HYG, V83, P1230, DOI 10.4269/ajtmh.2010.10-0353; Zeyrek FY, 2006, PARASITE IMMUNOL, V28, P201, DOI 10.1111/j.1365-3024.2006.00822.x	42	24	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2011	6	11							e28126	10.1371/journal.pone.0028126	http://dx.doi.org/10.1371/journal.pone.0028126			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863LT	22140521	Green Published, Green Submitted, gold			2022-12-27	WOS:000298166300027
J	Lim, JH; Kim, SY; Park, SY; Lee, SY; Kim, MJ; Han, YJ; Lee, SW; Chung, JH; Kim, MY; Yang, JH; Ryu, HM				Lim, Ji Hyae; Kim, Shin Young; Park, So Yeon; Lee, Shin Yeong; Kim, Mi Jin; Han, You Jung; Lee, Si Won; Chung, Jin Hoon; Kim, Moon Young; Yang, Jae Hyug; Ryu, Hyun Mee			Non-Invasive Epigenetic Detection of Fetal Trisomy 21 in First Trimester Maternal Plasma	PLOS ONE			English	Article							DNA-METHYLATION; PRENATAL-DIAGNOSIS; DOWN-SYNDROME; 1ST-TRIMESTER; PHOSPHODIESTERASE; IDENTIFICATION; AMNIOCENTESIS; EXTRACTION; WORKSHOP; PDE9A	Background: Down syndrome (DS) is the most common known aneuploidy, caused by an extra copy of all or part of chromosome 21. Fetal-specific epigenetic markers have been investigated for non-invasive prenatal detection of fetal DS. The phosphodiesterases gene, PDE9A, located on chromosome 21q22.3, is completely methylated in blood (M-PDE9A) and unmethylated in the placenta (U-PDE9A). Therefore, we estimated the accuracy of non-invasive fetal DS detection during the first trimester of pregnancy using this tissue-specific epigenetic characteristic of PDE9A. Methodology/Principal Findings: A nested, case-control study was conducted using maternal plasma samples collected from 108 pregnant women carrying 18 DS and 90 normal fetuses (each case was matched with 5 controls according to gestational weeks at blood sampling). All pregnancies were singletons at or before 12 weeks of gestation between October 2008 and May 2009. The maternal plasma levels of M-PDE9A and U-PDE9A were measured by quantitative methylation-specific polymerase chain reaction. M-PDE9A and U-PDE9A levels were obtained in all samples and did not differ between male and female fetuses. M-PDE9A levels did not differ between the DS cases and controls (1854.3 vs 2004.5 copies/mL; P = 0.928). U-PDE9A levels were significantly elevated in women with DS fetuses compared with controls (356.8 vs 194.7 copies/mL, P<0.001). The sensitivities of U-PDE9A level and the unmethylation index of PDE9A for non-invasive fetal DS detection were 77.8% and 83.3%, respectively, with a 5% false-positive rate. In the risk assessment for fetal DS, the adjusted odds ratios of U-PDE9A level and UI were 46.2 [95% confidence interval: 7.8-151.6] and 63.7 [95% confidence interval: 23.2-206.7], respectively. Conclusions: Our findings suggest that U-PDE9A level and the unmethylation index of PDE9A may be useful biomarkers for non-invasive fetal DS detection during the first trimester of pregnancy, regardless of fetal gender.	[Lim, Ji Hyae; Kim, Shin Young; Park, So Yeon; Lee, Shin Yeong; Kim, Mi Jin; Ryu, Hyun Mee] Cheil Gen Hosp, Med Res Inst, Med Genet Lab, Seoul, South Korea; [Han, You Jung; Lee, Si Won; Chung, Jin Hoon; Kim, Moon Young; Yang, Jae Hyug; Ryu, Hyun Mee] KwanDong Univ, Coll Med, Womens Healthcare Ctr, Seoul, South Korea; [Han, You Jung; Lee, Si Won; Chung, Jin Hoon; Kim, Moon Young; Yang, Jae Hyug; Ryu, Hyun Mee] Cheil Gen Hosp, Dept Obstet & Gynecol, Seoul, South Korea	Catholic Kwandong University	Lim, JH (corresponding author), Cheil Gen Hosp, Med Res Inst, Med Genet Lab, Seoul, South Korea.	hmryu@yahoo.com	Han, You Jung/W-3659-2019; Kim, Mi Jin/GXH-9639-2022; Lim, Ji Hyae/N-4634-2013	Han, You Jung/0000-0003-4087-9198; CHUNG, JIN HOON/0000-0002-5137-0680; Lim, Ji Hyae/0000-0002-1105-7235	Life Insurance Philanthropy Foundation	Life Insurance Philanthropy Foundation	This study was supported by a research grant from the Life Insurance Philanthropy Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chan KCA, 2004, CLIN CHEM, V50, P88, DOI 10.1373/clinchem.2003.024893; Chim SSC, 2005, P NATL ACAD SCI USA, V102, P14753, DOI 10.1073/pnas.0503335102; Chim SSC, 2008, CLIN CHEM, V54, P500, DOI 10.1373/clinchem.2007.098731; Clausen FB, 2007, PRENATAL DIAG, V27, P6, DOI 10.1002/pd.1605; Driscoll DA, 2009, NEW ENGL J MED, V360, P2556, DOI 10.1056/NEJMcp0900134; Farina A, 2003, CLIN CHEM, V49, P239, DOI 10.1373/49.2.239; Fisher DA, 1998, J BIOL CHEM, V273, P15559, DOI 10.1074/jbc.273.25.15559; Guipponi M, 1998, HUM GENET, V103, P386, DOI 10.1007/s004390050838; HOOK EB, 1983, JAMA-J AM MED ASSOC, V249, P2034, DOI 10.1001/jama.249.15.2034; Legler TJ, 2007, PRENATAL DIAG, V27, P824, DOI 10.1002/pd.1783; Li Y, 2004, CLIN CHEM, V50, P1002, DOI 10.1373/clinchem.2003.029835; Lim JH, 2008, OBSTET GYNECOL, V111, P1403, DOI 10.1097/AOG.0b013e3181719b7a; Lim JH, 2012, FASEB J, V26, P250, DOI 10.1096/fj.11-191429; Lo YMD, 1998, AM J HUM GENET, V62, P768, DOI 10.1086/301800; Malone FD, 2005, NEW ENGL J MED, V353, P2001, DOI 10.1056/NEJMoa043693; Mujezinovic F, 2007, OBSTET GYNECOL, V110, P687, DOI 10.1097/01.AOG.0000278820.54029.e3; Papageorgiou EA, 2011, NAT MED, V17, P510, DOI 10.1038/nm.2312; Poon LLM, 2002, CLIN CHEM, V48, P35; Rakyan VK, 2008, GENOME RES, V18, P1518, DOI 10.1101/gr.077479.108; Reddy UM, 2006, OBSTET GYNECOL, V107, P167, DOI 10.1097/01.AOG.0000194186.34664.a9; Soderling SH, 2000, CURR OPIN CELL BIOL, V12, P174, DOI 10.1016/S0955-0674(99)00073-3; Tong YK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015244; Wapner R, 2003, NEW ENGL J MED, V349, P1405, DOI 10.1056/NEJMoa025273	23	16	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e27709	10.1371/journal.pone.0027709	http://dx.doi.org/10.1371/journal.pone.0027709			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132128	Green Submitted, gold, Green Published			2022-12-27	WOS:000298162000036
J	Xu, ZH; Zhong, SH; Li, XH; Li, WX; Rothstein, SJ; Zhang, SH; Bi, YM; Xie, CX				Xu, Zhenhua; Zhong, Sihui; Li, Xinhai; Li, Wenxue; Rothstein, Steven J.; Zhang, Shihuang; Bi, Yongmei; Xie, Chuanxiao			Genome-Wide Identification of MicroRNAs in Response to Low Nitrate Availability in Maize Leaves and Roots	PLOS ONE			English	Article							GENE-EXPRESSION; UBIQUITIN LIGASE; NITROGEN STRESS; ARABIDOPSIS; REVEALS; PROTEIN; TRANSCRIPTOME; BIOGENESIS; PATTERNS; NETWORK	Background: Nitrate is the major source of nitrogen available for many crop plants and is often the limiting factor for plant growth and agricultural productivity especially for maize. Many studies have been done identifying the transcriptome changes under low nitrate conditions. However, the microRNAs (miRNAs) varied under nitrate limiting conditions in maize has not been reported. MiRNAs play important roles in abiotic stress responses and nutrient deprivation. Methodology/ Principal Findings: In this study, we used the SmartArray (TM) and GeneChip (R) microarray systems to perform a genome-wide search to detect miRNAs responding to the chronic and transient nitrate limiting conditions in maize. Nine miRNA families (miR164, miR169, miR172, miR397, miR398, miR399, miR408, miR528, and miR827) were identified in leaves, and nine miRNA families (miR160, miR167, miR168, miR169, miR319, miR395, miR399, miR408, and miR528) identified in roots. They were verified by real time stem loop RT-PCR, and some with additional time points of nitrate limitation. The miRNAs identified showed overlapping or unique responses to chronic and transient nitrate limitation, as well as tissue specificity. The potential target genes of these miRNAs in maize were identified. The expression of some of these was examined by qRT-PCR. The potential function of these miRNAs in responding to nitrate limitation is described. Conclusions/Significance: Genome-wide miRNAs responding to nitrate limiting conditions in maize leaves and roots were identified. This provides an insight into the timing and tissue specificity of the transcriptional regulation to low nitrate availability in maize. The knowledge gained will help understand the important roles miRNAs play in maize responding to a nitrogen limiting environment and eventually develop strategies for the improvement of maize genetics.	[Xu, Zhenhua; Li, Xinhai; Li, Wenxue; Zhang, Shihuang; Xie, Chuanxiao] Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100193, Peoples R China; [Zhong, Sihui; Rothstein, Steven J.; Bi, Yongmei] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; University of Guelph	Xu, ZH (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100193, Peoples R China.	cxxie@caas.net.cn	Rothstein, Steven J/A-4947-2013	Rothstein, Steven J/0000-0003-0737-1878	China Ministry of Science and Technology [2009CB118404]; National Science Foundation of China [30871535]; Natural Sciences and Engineering Research Council of Canada	China Ministry of Science and Technology(Ministry of Science and Technology, China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This study was supported by a Chinese National "973" program from the China Ministry of Science and Technology (Subprogram of Grant # 2009CB118404), by the National Science Foundation of China (Grant # 30871535) to CXX and by funding from the Natural Sciences and Engineering Research Council of Canada to SJR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JF, 2008, PHOTOSYNTHESIS ENERG, P1355; Bari R, 2006, PLANT PHYSIOL, V141, P988, DOI 10.1104/pp.106.079707; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bi YM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-281; Bi YM, 2009, PLANT CELL ENVIRON, V32, P1749, DOI 10.1111/j.1365-3040.2009.02032.x; Cai XN, 2006, J EXP BOT, V57, P2563, DOI 10.1093/jxb/erl022; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chiou TJ, 2006, PLANT CELL, V18, P412, DOI 10.1105/tpc.105.038943; Chiou TJ, 2007, PLANT CELL ENVIRON, V30, P323, DOI 10.1111/j.1365-3040.2007.01643.x; Chuck G, 2007, NAT GENET, V39, P1517, DOI 10.1038/ng.2007.20; Chuck G, 2009, CURR OPIN PLANT BIOL, V12, P81, DOI 10.1016/j.pbi.2008.09.008; Ding D, 2009, ANN BOT-LONDON, V103, P29, DOI 10.1093/aob/mcn205; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fujii H, 2005, CURR BIOL, V15, P2038, DOI 10.1016/j.cub.2005.10.016; Gifford ML, 2008, P NATL ACAD SCI USA, V105, P803, DOI 10.1073/pnas.0709559105; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Guo JH, 2010, SCIENCE, V327, P1008, DOI 10.1126/science.1182570; Gutierez RA, 2008, P NATL ACAD SCI USA, V105, P4939, DOI 10.1073/pnas.0800211105; Gutierrez RA, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r7; Hsieh LC, 2009, PLANT PHYSIOL, V151, P2120, DOI 10.1104/pp.109.147280; Jian XY, 2010, GENOMICS, V95, P47, DOI 10.1016/j.ygeno.2009.08.017; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Ju XT, 2009, P NATL ACAD SCI USA, V106, P3041, DOI 10.1073/pnas.0813417106; Kantar M, 2011, PLANTA, DOI [10.1007/s00425-00010-01309-00424, DOI 10.1007/S00425-00010-01309-00424]; Koyama T, 2007, PLANT CELL; Law CJ, 2008, ANNU REV MICROBIOL, V62, P289, DOI 10.1146/annurev.micro.61.080706.093329; Lian XM, 2006, PLANT MOL BIOL, V60, P617, DOI 10.1007/s11103-005-5441-7; Lin SI, 2010, PLANT CELL PHYSIOL, V51, P2119, DOI 10.1093/pcp/pcq170; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mallory AC, 2005, PLANT CELL, V17, P1360, DOI 10.1105/tpc.105.031716; Palenchar PM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r91; Pant BD, 2009, PLANT PHYSIOL, V150, P1541, DOI 10.1104/pp.109.139139; Peng MS, 2007, PLANT MOL BIOL, V65, P775, DOI 10.1007/s11103-007-9241-0; Peng MS, 2007, PLANT J, V50, P320, DOI 10.1111/j.1365-313X.2007.03050.x; Price J, 2004, PLANT CELL, V16, P2128, DOI 10.1105/tpc.104.022616; Salvi S, 2007, P NATL ACAD SCI USA, V104, P11376, DOI 10.1073/pnas.0704145104; Scheible WR, 2004, PLANT PHYSIOL, V136, P2483, DOI 10.1104/pp.104.047019; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Schommer C, 2008, PLOS BIOL, V6, P1991, DOI 10.1371/journal.pbio.0060230; Sunkar R, 2005, PLANT CELL, V17, P1397, DOI 10.1105/tpc.105.031682; Sunkar R, 2007, TRENDS PLANT SCI, V12, P301, DOI 10.1016/j.tplants.2007.05.001; Sunkar R, 2006, PLANT CELL, V18, P2051, DOI 10.1105/tpc.106.041673; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; Trindade I, 2010, PLANTA, V231, P705, DOI 10.1007/s00425-009-1078-0; Uauy C, 2006, SCIENCE, V314, P1298, DOI 10.1126/science.1133649; Vazquez F, 2004, CURR BIOL, V14, P346, DOI 10.1016/j.cub.2004.01.035; Vidal EA, 2010, P NATL ACAD SCI USA, V107, P4477, DOI 10.1073/pnas.0909571107; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wang JW, 2005, PLANT CELL, V17, P2204, DOI 10.1105/tpc.105.033076; Wang RC, 2000, PLANT CELL, V12, P1491, DOI 10.1105/tpc.12.8.1491; Wang RC, 2003, PLANT PHYSIOL, V132, P556, DOI 10.1104/pp.103.021253; Wang RC, 2007, PLANT PHYSIOL, V145, P1735, DOI 10.1104/pp.107.108944; Wang YH, 2001, PLANT PHYSIOL, V127, P345, DOI 10.1104/pp.127.1.345; Wu L, 2009, PLANT CELL, V21, P3421, DOI 10.1105/tpc.109.070938; Zhang LF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000716; Zhang ZX, 2008, ANN BOT-LONDON, V102, P509, DOI 10.1093/aob/mcn129; Zimmermann R, 2005, PLANT MOL BIOL, V58, P669, DOI 10.1007/s11103-005-7702-x	58	109	121	4	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e28009	10.1371/journal.pone.0028009	http://dx.doi.org/10.1371/journal.pone.0028009			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132192	Green Published, Green Submitted, gold			2022-12-27	WOS:000298162000058
J	Adam, T; Ahmad, S; Bigdeli, M; Ghaffar, A; Rottingen, JA				Adam, Taghreed; Ahmad, Saad; Bigdeli, Maryam; Ghaffar, Abdul; Rottingen, John-Arne			Trends in Health Policy and Systems Research over the Past Decade: Still Too Little Capacity in Low-Income Countries	PLOS ONE			English	Article								Background: The past decade has seen several high-level events and documents committing to strengthening the field of health policy and systems research (HPSR) as a critical input to strengthening health systems. Specifically, they called for increased production, capacity to undertake and funding for HPSR. The objective of this paper is to assess the extent to which progress has been achieved, an important feedback for stakeholders in this field. Methods and Finding: Two sources of data have been used. The first is a bibliometric analysis to assess growth in production of HPSR between 2003 and 2009. The six building blocks of the health system were used to define the scope of this search. The second is a survey of 96 research institutions undertaken in 2010 to assess the capacity and funding availability to undertake HPSR, compared with findings from the same survey undertaken in 2000 and 2008. Both analyses focus on HPSR relevant to low-income and middle-income countries (LMICs). Overall, we found an increasing trend of publications on HPSR in LMICs, although only 4% were led by authors from low-income countries (LICs). This is consistent with findings from the institutional survey, where despite improvements in infrastructure of research institutions, a minimal change has been seen in the level of experience of researchers within LIC institutions. Funding availability in LICs has increased notably to institutions in Sub-Saharan Africa; nonetheless, the overall increase has been modest in all regions. Conclusion: Although progress has been made in both the production and funding availability for HPSR, capacity to undertake the research locally has grown at a much slower pace, particularly in LICs where there is most need for this research. A firm commitment to dedicate a proportion of all future funding for research to building capacity may be the only solution to turn the tide.	[Adam, Taghreed; Ahmad, Saad; Bigdeli, Maryam; Ghaffar, Abdul] World Hlth Org, Geneva, Switzerland; [Rottingen, John-Arne] Harvard Univ, Kennedy Sch, Cambridge, MA 02138 USA; [Rottingen, John-Arne] Univ Oslo, Inst Hlth & Soc, Oslo, Norway	World Health Organization; Harvard University; University of Oslo	Adam, T (corresponding author), World Hlth Org, Geneva, Switzerland.	adamt@who.int						Alliance for Health Policy and Systems Research, 2007, WHAT IS HLTH POL SYS; Balabanova D, 2010, HEALTH RES POLICY SY, V8, DOI 10.1186/1478-4505-8-22; Bennett S., 2010, BACKGR PAP GLOB S HL; Bennett S, 2008, LANCET, V372, P1571, DOI 10.1016/S0140-6736(08)61658-X; Bennett S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001081; Commission on Health Research for Development, 1990, HLTH RES; European Commission, 2010, EU ROL GLOB HLTH COM; *GLOB FOR HLTH RES, 2004, MIN SUMM HLTH RES ME; *GLOB FOR HLTH RES, 1999, 1090 GLOB FOR HLTH R; Global Forum for Health Research. Global Ministerial Forum on Research for Health, 2008, GLOB MIN FOR RES HLT; Gonzalez-Block M, 2003, HLTH RES POLICY SYST, V1; Green A, SOUND CHOICES ENHANC; Kolars JC, 2011, BMC INT HEALTH HUM R, V11, DOI 10.1186/1472-698X-11-S1-S1; LAVIS J, 2007, SYSTEMATIC REV INFOR; Okui O, 2011, BMC INT HEALTH HUM R, V11, DOI 10.1186/1472-698X-11-S1-S14; Ranson MK, 2010, B WORLD HEALTH ORGAN, V88, P435, DOI 10.2471/BLT.09.066290; Ritz Lindsay Sarah, 2010, South Med Rev, V3, P2; *STAT CORP, 2005, STAT STAT SOFTW REL; *TASK FORC GLOB AC, 2009, GLOB ACT HLTH SYST S; *TASK FORC INN FIN, 2009, CONSTR SCAL; Task Force Hlth Syst Res, 2004, LANCET, V364, P1756; *THOMS CORP, 2010, REF MANAGER V10; UK Department for International Development. UK Department for International Development, 2008, DFID RES STRAT 2008; WHO, 2005, REP MIN SUMM HLTH RE; *WHO, 2010, WORLD HLTH ASS RES W; *WHO, 2010, WORLD HLTH RES WHA63; *WHO, 2009, EX BOARD 124 SESS WH; WHO, 2007, EV BUS STRENGTH HLTH; *WHO PARTN, 2011, 1 GLOB S HLTH SYST R; World Bank, 2010, WORLD DEV IND 2010; World Health Organization, 2005, WORLD HLTH ASS RES W; World Health Organization, 2004, WORLD REP KNOWL BETT; World Health Organization, 2009, SCAL RES LEARN HLTH; World Health Organization, ALL HLTH POL SYST RE; World Health Organization (WHO), 2008, NEGL HLTH SYST RES	35	50	53	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2011	6	11							e27263	10.1371/journal.pone.0027263	http://dx.doi.org/10.1371/journal.pone.0027263			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858JH	22132094	Green Published, Green Submitted, gold			2022-12-27	WOS:000297792400005
J	Schleit, J; Wall, VZ; Simko, M; Kaeberlein, M				Schleit, Jennifer; Wall, Valerie Z.; Simko, Marissa; Kaeberlein, Matt			The MDT-15 Subunit of Mediator Interacts with Dietary Restriction to Modulate Longevity and Fluoranthene Toxicity in Caenorhabditis elegans	PLOS ONE			English	Article							LIFE-SPAN EXTENSION; DNA ADDUCT FORMATION; CALORIC RESTRICTION; METABOLIC-ACTIVATION; BACTERIAL DEPRIVATION; AROMATIC-HYDROCARBONS; STRESS RESISTANCE; GENETIC PATHWAYS; PROTEIN; SIR2	Dietary restriction (DR), the limitation of calorie intake while maintaining proper nutrition, has been found to extend life span and delay the onset of age-associated disease in a wide range of species. Previous studies have suggested that DR can reduce the lethality of environmental toxins. To further examine the role of DR in toxin response, we measured life spans of the nematode Caenorhabditis elegans treated with the mutagenic polyaromatic hydrocarbon, fluoranthene (FLA). FLA is a direct byproduct of combustion, and is one of U. S. Environmental Protection Agency's sixteen priority environmental toxins. Treatment with 5 mu g/ml FLA shortened the life spans of ad libitum fed nematodes, and DR resulted in increased sensitivity to FLA. To determine the role of detoxifying enzymes in the toxicity of FLA, we tested nematodes with mutations in the gene encoding the MDT-15 subunit of mediator, a transcriptional coactivator that regulates genes involved in fatty acid metabolism and detoxification. Mutation of mdt-15 increased the life span of FLA treated animals compared to wild-type animals with no difference observed between DR and ad libitum fed mdt-15 animals. We also examined mutants with altered insulin-IGF-1-like signaling (IIS), which is known to modulate life span and stress resistance in C. elegans independently of DR. Mutation of the genes coding for the insulin-like receptor DAF-2 or the FOXO-family transcription factor DAF16 did not alter the animals' susceptibility to FLA compared to wild type. Taken together, our results suggest that certain compounds have increased toxicity when combined with a DR regimen through increased metabolic activation. This increased metabolic activation appears to be mediated through the MDT-15 transcription factor and is independent of the IIS pathway.	[Schleit, Jennifer; Wall, Valerie Z.; Simko, Marissa; Kaeberlein, Matt] Univ Washington, Dept Pathol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Schleit, J (corresponding author), Univ Washington, Dept Pathol, Seattle, WA 98195 USA.	kaeber@uw.edu		Kaeberlein, Matt/0000-0002-1311-3421	NIH [R01AG031108, ES007032]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG031108] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by NIH Grant R01AG031108 to MK. JS was supported by the Environmental Pathology/Toxicology Training Grant (NIH Grant ES007032). MK is an Ellison Medical Foundation New Scholar in Aging. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aidoo A, 1999, MUTAT RES-FUND MOL M, V430, P155, DOI 10.1016/S0027-5107(99)00197-9; BERG TF, 1994, FOOD CHEM TOXICOL, V32, P45, DOI 10.1016/0278-6915(84)90035-8; Boily G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001759; Boube M, 2002, CELL, V110, P143, DOI 10.1016/S0092-8674(02)00830-9; Bruce-Keller AJ, 1999, ANN NEUROL, V45, P8, DOI 10.1002/1531-8249(199901)45:1<8::AID-ART4>3.0.CO;2-V; Chen D, 2007, TRENDS MOL MED, V13, P64, DOI 10.1016/j.molmed.2006.12.004; Chen W, 1996, DRUG CHEM TOXICOL, V19, P21, DOI 10.3109/01480549609002194; Chou MW, 1997, TOXICOL LETT, V92, P21, DOI 10.1016/S0378-4274(97)00029-5; Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635; DELANEY JR, 2011, AGING CELL; Essumang DK, 2011, B ENVIRON CONTAM TOX, V86, P438, DOI 10.1007/s00128-011-0232-0; Gems D, 2005, MECH AGEING DEV, V126, P381, DOI 10.1016/j.mad.2004.09.001; GRAM TE, 1970, J PHARMACOL EXP THER, V175, P12; Greer EL, 2007, CURR BIOL, V17, P1646, DOI 10.1016/j.cub.2007.08.047; Greer EL, 2009, ANN NY ACAD SCI, V1170, P688, DOI 10.1111/j.1749-6632.2009.04019.x; Greer EL, 2009, AGING CELL, V8, P113, DOI 10.1111/j.1474-9726.2009.00459.x; Guarente L, 2005, CELL, V120, P473, DOI 10.1016/j.cell.2005.01.029; Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700; HANSON SK, 1978, TOXICOL LETT, V1, P301, DOI 10.1016/0378-4274(78)90011-5; Harper JM, 2006, AGING CELL, V5, P441, DOI 10.1111/j.1474-9726.2006.00236.x; Harper JM, 2006, MECH AGEING DEV, V127, P687, DOI 10.1016/j.mad.2006.04.002; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Holloszy JO, 2007, EXP GERONTOL, V42, P709, DOI 10.1016/j.exger.2007.03.009; Ingram DK, 2006, AGING CELL, V5, P97, DOI 10.1111/j.1474-9726.2006.00202.x; Ingram DK, 2004, ANN NY ACAD SCI, V1019, P412, DOI 10.1196/annals.1297.074; Kaeberlein M, 2004, PLOS BIOL, V2, P1381, DOI 10.1371/journal.pbio.0020296; Kaeberlein M, 2007, AGEING RES REV, V6, P128, DOI 10.1016/j.arr.2007.04.001; Kaeberlein M, 2010, BIOESSAYS, V32, P96, DOI 10.1002/bies.200900171; Kaeberlein TL, 2006, AGING CELL, V5, P487, DOI 10.1111/j.1474-9726.2006.00238.x; Kapahi P, 2010, CELL METAB, V11, P453, DOI 10.1016/j.cmet.2010.05.001; Kennedy BK, 2007, CELL MOL LIFE SCI, V64, P1323, DOI 10.1007/s00018-007-6470-y; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; Lee GD, 2006, AGING CELL, V5, P515, DOI 10.1111/j.1474-9726.2006.00241.x; Leiser SF, 2011, AGING CELL, V10, P318, DOI 10.1111/j.1474-9726.2011.00672.x; Liao CY, 2010, AGING CELL, V9, P92, DOI 10.1111/j.1474-9726.2009.00533.x; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Mair W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004535; Masoro EJ, 2005, MECH AGEING DEV, V126, P913, DOI 10.1016/j.mad.2005.03.012; McCay CM, 1935, J NUTR, V10, P63, DOI 10.1093/jn/10.1.63; McElwee J, 2003, AGING CELL, V2, P111, DOI 10.1046/j.1474-9728.2003.00043.x; McElwee JJ, 2004, J BIOL CHEM, V279, P44533, DOI 10.1074/jbc.M406207200; Mehta R, 2009, SCIENCE, V324, P1196, DOI 10.1126/science.1173507; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Panowski SH, 2007, NATURE, V447, P550, DOI 10.1038/nature05837; PEGRAM RA, 1989, MECH AGEING DEV, V48, P167, DOI 10.1016/0047-6374(89)90048-1; PESSAYRE D, 1980, BIOCHEM PHARMACOL, V29, P2219, DOI 10.1016/0006-2952(80)90201-4; Platt KL, 2008, MUTAT RES-GEN TOX EN, V650, P96, DOI 10.1016/j.mrgentox.2007.09.011; Raffaghello L, 2008, P NATL ACAD SCI USA, V105, P8215, DOI 10.1073/pnas.0708100105; Ramaiah SK, 2001, DRUG METAB DISPOS, V29, P1088; Ramaiah SK, 1998, TOXICOL SCI, V45, P233, DOI 10.1006/toxs.1998.2511; Rogers AN, 2011, CELL METAB, V14, P55, DOI 10.1016/j.cmet.2011.05.010; Roth GS, 2001, ANN NY ACAD SCI, V928, P305; Seng JE, 1996, ARCH BIOCHEM BIOPHYS, V335, P42, DOI 10.1006/abbi.1996.0480; Shaikh ZA, 1999, TOXICOLOGY, V133, P93, DOI 10.1016/S0300-483X(99)00012-8; Shimada T, 2006, DRUG METAB PHARMACOK, V21, P257, DOI 10.2133/dmpk.21.257; Smith ED, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-49; Stanfel MN, 2009, BBA-GEN SUBJECTS, V1790, P1067, DOI 10.1016/j.bbagen.2009.06.007; Steinkraus KA, 2008, AGING CELL, V7, P394, DOI 10.1111/j.1474-9726.2008.00385.x; STRUBELT O, 1981, TOXICOL APPL PHARM, V60, P66, DOI 10.1016/0041-008X(81)90136-8; Sutphin GL, 2008, EXP GERONTOL, V43, P130, DOI 10.1016/j.exger.2007.10.019; SUTPHIN GL, 2009, J VIS EXP; Taubert S, 2006, GENE DEV, V20, P1137, DOI 10.1101/gad.1395406; Taubert S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000021; THOMPSON CM, 1993, CELL, V73, P1361, DOI 10.1016/0092-8674(93)90362-T; WALKER RM, 1982, CAN J PHYSIOL PHARM, V60, P399, DOI 10.1139/y82-058; WARSHAWSKI D, 1992, ENV HLTH PERSPECT, V107, P317; Weindruch R., 1988, RETARDATION AGING DI; Xue WL, 2005, TOXICOL APPL PHARM, V206, P73, DOI 10.1016/j.taap.2004.11.006	70	7	9	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2011	6	11							e28036	10.1371/journal.pone.0028036	http://dx.doi.org/10.1371/journal.pone.0028036			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IO	22132200	Green Published, Green Submitted, gold			2022-12-27	WOS:000297789900041
J	Myers, EF; Parrott, JS; Cummins, DS; Splett, P				Myers, Esther F.; Parrott, J. Scott; Cummins, Deborah S.; Splett, Patricia			Funding Source and Research Report Quality in Nutrition Practice-Related Research	PLOS ONE			English	Article							CONFLICTS-OF-INTEREST; RANDOMIZED CONTROLLED-TRIALS; INDUSTRY SPONSORSHIP; FINANCIAL CONFLICTS; BIAS; HEALTH; PUBLICATION; ASSOCIATION; SCIENCE; TREND	Background: The source of funding is one of many possible causes of bias in scientific research. One method of detecting potential for bias is to evaluate the quality of research reports. Research exploring the relationship between funding source and nutrition-related research report quality is limited and in other disciplines the findings are mixed. Objective: The purpose of this study is to determine whether types of funding sources of nutrition research are associated with differences in research report quality. Design: A retrospective study of research reporting quality, research design and funding source was conducted on 2539 peer reviewed research articles from the American Dietetic Association's Evidence Analysis Library (R) database. Results: Quality rating frequency distributions indicate 43.3% of research reports were rated as positive, 50.1% neutral, and 6.6% as negative. Multinomial logistic regression results showed that while both funding source and type of research design are significant predictors of quality ratings (chi(2) = 118.99, p <= 0.001), the model's usefulness in predicting overall research report quality is little better than chance. Compared to research reports with government funding, those not acknowledging any funding sources, followed by studies with University/hospital funding were more likely to receive neutral vs positive quality ratings, OR = 1.85, P <0.001 and OR = 1.54, P<0.001, respectively and those that did not report funding were more likely to receive negative quality ratings (OR = 4.97, P<0.001). After controlling for research design, industry funded research reports were no more likely to receive a neutral or negative quality rating than those funded by government sources. Conclusion: Research report quality cannot be accurately predicted from the funding source after controlling for research design. Continued vigilance to evaluate the quality of all research regardless of the funding source and to further understand other factors that affect quality ratings are warranted.	[Myers, Esther F.; Cummins, Deborah S.] Amer Dietet Assoc, Chicago, IL USA; [Parrott, J. Scott] Univ Med & Dent New Jersey, Dept Nutr Sci, Newark, NJ 07103 USA; [Splett, Patricia] Splett & Associates, Stanchfield, MN USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Myers, EF (corresponding author), Amer Dietet Assoc, Chicago, IL USA.	emyers@eatright.org	Parrott, James/AAI-8862-2020	Parrott, James/0000-0002-2712-4359; Parrott, James Scott/0000-0003-3486-9567	North American Branch of the International Life Sciences Institute; ILSI North America; ILSI North America industry membership	North American Branch of the International Life Sciences Institute; ILSI North America; ILSI North America industry membership	This research was supported by the North American Branch of the International Life Sciences Institute (www.ilsi.org/NorthAmerica). ILSI North America is a public, nonprofit scientific foundation that provides a forum to advance the understanding of scientific issues related to the nutritional quality and safety of the food supply. ILSI North America carries out its mission by sponsoring relevant research programs, professional education programs and workshops, seminars, and publications, as well as by providing a neutral forum for government, academic, and industry scientists to discuss and resolve scientific issues of common concern for the well-being of the general public. The programs of ILSI North America are supported primarily by the ILSI North America industry membership. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez F, 2009, BRIT J DERMATOL, V161, P1159, DOI 10.1111/j.1365-2133.2009.09382.x; American Dietetic Association, 2010, ADA EV AN MAN; [Anonymous], STROB STAT STRENGTH; [Anonymous], PRISM TRANSP REP SYS, P12; Armstrong R, 2008, J PUBLIC HEALTH-UK, V30, P103, DOI 10.1093/pubmed/fdm082; Barbui C, 2007, ARCH GEN PSYCHIAT, V64, P868, DOI 10.1001/archpsyc.64.7.868-a; Barden J, 2006, PAIN, V121, P207, DOI 10.1016/j.pain.2005.12.011; Bekelman JE, 2003, JAMA-J AM MED ASSOC, V289, P454, DOI 10.1001/jama.289.4.454; Bhandari M, 2004, CAN MED ASSOC J, V170, P477; Brand RA, 2009, CLIN ORTHOP RELAT R, V467, P1393, DOI 10.1007/s11999-009-0786-x; Brent R, 2008, SCRUTINIZING IND FUN; Chung M, 2009, AM J CLIN NUTR, V89, P1099, DOI 10.3945/ajcn.2008.26821; Clifford TJ, 2002, BMC HEALTH SERV RES, V2, DOI 10.1186/1472-6963-2-18; Cook DM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001266; Cope MB, 2010, INT J OBESITY, V34, P84, DOI 10.1038/ijo.2009.239; Coughlin SS, 1997, CASE STUDIES PUBLIC; Davis JM, 2008, NEUROPSYCHOPHARMACOL, V33, P971, DOI 10.1038/sj.npp.1301493; Des Jarlais DC, 2004, AM J PUBLIC HEALTH, V94, P361, DOI 10.2105/AJPH.94.3.361; Elliott C, 2005, LANCET, V366, P422, DOI 10.1016/S0140-6736(05)66794-3; Fontanarosa PB, 2005, JAMA-J AM MED ASSOC, V294, P110, DOI 10.1001/jama.294.1.110; Gluud LL, 2006, PAIN, V121, P175, DOI 10.1016/j.pain.2006.01.001; HUMPHREY GF, 1994, MED SCI LAW, V34, P299, DOI 10.1177/002580249403400405; Katan MB, 2007, PLOS MED, V4, P3, DOI 10.1371/journal.pmed.0040006; Katrak Persis, 2004, BMC Med Res Methodol, V4, P22, DOI 10.1186/1471-2288-4-22; Kleinbaum D. G., 2002, LOGISTIC REGRESSION; Lesser LI, 2007, PLOS MED, V4, P41, DOI 10.1371/journal.pmed.0040005; Lesser LI, 2009, AM J CLIN NUTR, V90, P699, DOI 10.3945/ajcn.2009.28093; Levine J, 2003, AM J PUBLIC HEALTH, V93; Lexchin J, 2003, BMJ-BRIT MED J, V326, P1167, DOI 10.1136/bmj.326.7400.1167; Livingston EH, 2009, ARCH SURG-CHICAGO, V144, P706, DOI 10.1001/archsurg.2009.150; Lohr KN, 2004, INT J QUAL HEALTH C, V16, P9, DOI 10.1093/intqhc/mzh005; Martinson BC, 2009, ACAD MED, V84, P1491, DOI 10.1097/ACM.0b013e3181bb2ca6; Miller FG, 2005, ACAD MED, V80, P899, DOI 10.1097/00001888-200510000-00005; Moher D, 2005, EXPLORE-NY, V1, P40, DOI 10.1016/j.explore.2004.11.001; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Nkansah N, 2009, PUBLIC HEALTH NUTR, V12, P1931, DOI 10.1017/S136898000900487X; Okike K, 2007, J BONE JOINT SURG AM, V89A, P608, DOI 10.2106/JBJS.F.00994; Public Library of Science, 2009, PLOS MED; Resnik DB, 2008, AM J BIOETHICS, V8, P60, DOI 10.1080/15265160802318105; Rowe S, 2009, AM J CLIN NUTR, V89, P1285, DOI 10.3945/ajcn.2009.27604; Sanderson S, 2007, INT J EPIDEMIOL, V36, P666, DOI 10.1093/ije/dym018; Schulz KF, 2010, J CLIN EPIDEMIOL, V63, P834, DOI [10.1016/j.jclinepi.2010.02.005, 10.1186/1741-7015-8-18, 10.1016/j.ijsu.2011.09.004, 10.4103/0976-500X.72352]; Schwartz RS, 2008, NEW ENGL J MED, V358, P1850, DOI 10.1056/NEJMe0802618; Sharp RR, 2008, AM J BIOETHICS, V8, P54, DOI 10.1080/15265160802317982; Shea BJ, 2009, J CLIN EPIDEMIOL, V62, P1013, DOI 10.1016/j.jclinepi.2008.10.009; Sox HC, 2006, ANN INTERN MED, V144, P609, DOI 10.7326/0003-4819-144-8-200604180-00123; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Tabachnick BG., 2013, USING MULTIVARIATE S, V6th; The National Academies, 2003, POL PROC COMM COMP B; Thomas O, 2008, INT J OBESITY, V32, P1531, DOI 10.1038/ijo.2008.137; U. S. Food and Drug Administration, 2009, GUID IND EV BAS REV; Vandenbroucke JP, 2007, PLOS MED, V4, P1628, DOI 10.1371/journal.pmed.0040297; Vandenbrouke JP, 2009, J CLIN EPIDEMIOL, V62, P594, DOI 10.1016/j.jclinepi.2008.12.003; Vartanian LR, 2007, AM J PUBLIC HEALTH, V97, P667, DOI 10.2105/AJPH.2005.083782; Verbeek J, 2008, SCAND J WORK ENV HEA, V34, P165, DOI 10.5271/sjweh.1239; von Elm E, 2007, ANN INTERN MED, V147, P573, DOI 10.7326/0003-4819-147-8-200710160-00010; WHITELY WP, 1994, JAMA-J AM MED ASSOC, V272, P170, DOI 10.1001/jama.272.2.170; Yao F, 2007, OTOLARYNG HEAD NECK, V137, P539, DOI 10.1016/j.otohns.2007.07.018	58	19	19	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2011	6	12							e28437	10.1371/journal.pone.0028437	http://dx.doi.org/10.1371/journal.pone.0028437			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	863OC	22163017	Green Published, gold, Green Submitted			2022-12-27	WOS:000298173500021
J	Humphries, AT; La Peyre, MK; Decossas, GA				Humphries, Austin T.; La Peyre, Megan K.; Decossas, Gary A.			The Effect of Structural Complexity, Prey Density, and "Predator-Free Space" on Prey Survivorship at Created Oyster Reef Mesocosms	PLOS ONE			English	Article							DRUM SCIAENOPS-OCELLATUS; HABITAT COMPLEXITY; GALVESTON BAY; FISH; SIZE; FOOD; FRAGMENTATION; COLONIZATION; COMPETITION; VEGETATION	Interactions between predators and their prey are influenced by the habitat they occupy. Using created oyster (Crassostrea virginica) reef mesocosms, we conducted a series of laboratory experiments that created structure and manipulated complexity as well as prey density and "predator-free space" to examine the relationship between structural complexity and prey survivorship. Specifically, volume and spatial arrangement of oysters as well as prey density were manipulated, and the survivorship of prey (grass shrimp, Palaemonetes pugio) in the presence of a predator (wild red drum, Sciaenops ocellatus) was quantified. We found that the presence of structure increased prey survivorship, and that increasing complexity of this structure further increased survivorship, but only to a point. This agrees with the theory that structural complexity may influence predator-prey dynamics, but that a threshold exists with diminishing returns. These results held true even when prey density was scaled to structural complexity, or the amount of "predator-free space" was manipulated within our created reef mesocosms. The presence of structure and its complexity (oyster shell volume) were more important in facilitating prey survivorship than perceived refugia or density-dependent prey effects. A more accurate indicator of refugia might require "predator-free space" measures that also account for the available area within the structure itself (i.e., volume) and not just on the surface of a structure. Creating experiments that better mimic natural conditions and test a wider range of "predator-free space" are suggested to better understand the role of structural complexity in oyster reefs and other complex habitats.	[Humphries, Austin T.; La Peyre, Megan K.] Louisiana State Univ, US Geol Survey, Louisiana Fish & Wildlife Cooperat Res Unit, Sch Renewable Nat Resources,AgCtr, Baton Rouge, LA 70803 USA; [Humphries, Austin T.] Rhodes Univ, Dept Zool & Entomol, ZA-6140 Grahamstown, South Africa	Louisiana State University System; Louisiana State University; United States Department of the Interior; United States Geological Survey; Rhodes University	Humphries, AT (corresponding author), Louisiana State Univ, US Geol Survey, Louisiana Fish & Wildlife Cooperat Res Unit, Sch Renewable Nat Resources,AgCtr, Baton Rouge, LA 70803 USA.	austin.humphries@gmail.com			Louisiana Department of Wildlife and Fisheries; Louisiana Sea Grant	Louisiana Department of Wildlife and Fisheries; Louisiana Sea Grant	The authors thank the Louisiana Department of Wildlife and Fisheries (http://www.wlf.louisiana.gov) for financial support, and Louisiana Sea Grant for funding through a grant to GD under the Undergraduate Research Opportunities Program (http://www.laseagrant.org/urop/index.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartholomew A, 2000, MAR ECOL PROG SER, V206, P45, DOI 10.3354/meps206045; Bartholomew A, 2002, ESTUARIES, V25, P1045, DOI 10.1007/BF02691351; Beck MW, 1998, MAR ECOL PROG SER, V169, P165, DOI 10.3354/meps169165; Bell S, 1991, HABITAT STRUCTURE PH, P3; Beukers JS, 1998, OECOLOGIA, V114, P50, DOI 10.1007/s004420050419; BOOTHBY RN, 1971, T AM FISH SOC, V100, P290, DOI 10.1577/1548-8659(1971)100<290:FHLRAC>2.0.CO;2; Breitburg D, 1999, OYSTER REEF HABITAT, P238; Canion CR, 2009, MAR ECOL PROG SER, V393, P37, DOI 10.3354/meps08272; COEN LD, 1981, ECOLOGY, V62, P1484, DOI 10.2307/1941505; Coen LD, 2000, ECOL ENG, V15, P323, DOI 10.1016/S0925-8574(00)00084-7; Coen LD, 2007, MAR ECOL PROG SER, V341, P303, DOI 10.3354/meps341303; Dibble ED, 1996, J FRESHWATER ECOL, V11, P311, DOI 10.1080/02705060.1996.9664453; Downes BJ, 1998, ECOL MONOGR, V68, P237, DOI 10.1890/0012-9615(1998)068[0237:HSAROL]2.0.CO;2; Eggleston DB, 1999, J EXP MAR BIOL ECOL, V236, P107, DOI 10.1016/S0022-0981(98)00192-0; Finke DL, 2002, ECOLOGY, V83, P643, DOI 10.1890/0012-9658(2002)083[0643:IPDICS]2.0.CO;2; Grabowski JH, 2004, MAR ECOL PROG SER, V277, P291, DOI 10.3354/meps277291; Grabowski JH, 2004, ECOLOGY, V85, P995, DOI 10.1890/03-0067; Grabowski JH, 2008, ECOLOGY, V89, P3413, DOI 10.1890/07-1057.1; Graham S, 1998, BIOL BULL, V195, P241, DOI 10.2307/1542860; Halley JM, 2004, ECOL LETT, V7, P254, DOI 10.1111/j.1461-0248.2004.00568.x; Harding JM, 2001, J SHELLFISH RES, V20, P951; Harding JM, 1999, B MAR SCI, V65, P289; HARMON ME, 1986, ADV ECOL RES, V15, P133, DOI 10.1016/S0065-2504(08)60121-X; HECK KL, 1981, J EXP MAR BIOL ECOL, V53, P125, DOI 10.1016/0022-0981(81)90014-9; Holbrook SJ, 2002, ECOLOGY, V83, P2855, DOI 10.2307/3072021; Hovel KA, 2001, ECOLOGY, V82, P1814; HUFFAKER C. B., 1958, HILGARDIA, V27, P343; Humphries AT, J EXPT MARI IN PRESS; KOTLER BP, 1991, ECOLOGY, V72, P2249, DOI 10.2307/1941575; Leight AK, 2005, INTEGR COMP BIOL, V45, P143, DOI 10.1093/icb/45.1.143; Liao IC, 2003, FISHERIES SCI, V69, P317, DOI 10.1046/j.1444-2906.2003.00623.x; Manatunge J, 2000, ENVIRON BIOL FISH, V58, P425, DOI 10.1023/A:1007691425268; Mattila J, 2008, MAR ECOL PROG SER, V361, P15, DOI 10.3354/meps07392; McCoy E.D., 1991, P3; Minello TJ, 1998, AM FISH S S, V22, P43; NELSON WG, 1979, J EXP MAR BIOL ECOL, V38, P225, DOI 10.1016/0022-0981(79)90069-8; ORTH RJ, 1984, ESTUARIES, V7, P339, DOI 10.2307/1351618; PAINE RT, 1966, AM NAT, V100, P65, DOI 10.1086/282400; Pattillo ME, 1997, DISTRIBUTION ABUNDAN, VII; PERSSON L, 1995, ECOLOGY, V76, P70, DOI 10.2307/1940632; Riginos C, 2008, ECOLOGY, V89, P2228, DOI 10.1890/07-1250.1; Rilov G, 2007, MAR ECOL PROG SER, V329, P225, DOI 10.3354/meps329225; ROZAS LP, 1988, OECOLOGIA, V77, P101, DOI 10.1007/BF00380932; RUSSO AR, 1987, MAR ECOL PROG SER, V36, P101, DOI 10.3354/meps036101; Scharf FS, 2000, ESTUARIES, V23, P128, DOI 10.2307/1353230; Schmid PE, 2000, ADV ECOL RES, V30, P339; SOLUK DA, 1988, OIKOS, V52, P94, DOI 10.2307/3565987; STONER AW, 1985, J EXP MAR BIOL ECOL, V94, P19, DOI 10.1016/0022-0981(85)90048-6; Stunz GW, 2010, MAR ECOL PROG SER, V406, P147, DOI 10.3354/meps08556; Stunz GW, 2001, J EXP MAR BIOL ECOL, V260, P13, DOI 10.1016/S0022-0981(01)00248-9; UNDERWOOD R, 1982, BEHAVIOUR, V79, P81, DOI 10.1163/156853982X00193; vandeKoppel J, 1996, ECOLOGY, V77, P736, DOI 10.2307/2265498; Warfe DM, 2008, OIKOS, V117, P1764, DOI 10.1111/j.1600-0706.2008.16836.x; Warfe DM, 2004, OECOLOGIA, V141, P171, DOI 10.1007/s00442-004-1644-x; WILCOVE DS, 1985, ECOLOGY, V66, P1211, DOI 10.2307/1939174; Zimmerman R. J, 1989, OYSTER REEF HABITAT	56	50	50	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2011	6	12							e28339	10.1371/journal.pone.0028339	http://dx.doi.org/10.1371/journal.pone.0028339			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MQ	22145037	gold, Green Submitted, Green Published			2022-12-27	WOS:000298168900020
J	Gertow, K; Cedervall, J; Jamil, S; Ali, R; Imreh, MP; Gulyas, M; Sandstedt, B; Ahrlund-Richter, L				Gertow, Karin; Cedervall, Jessica; Jamil, Seema; Ali, Rouknuddin; Imreh, Marta P.; Gulyas, Miklos; Sandstedt, Bengt; Ahrlund-Richter, Lars			Early Events in Xenograft Development from the Human Embryonic Stem Cell Line HS181-Resemblance with an Initial Multiple Epiblast Formation	PLOS ONE			English	Article							HUMAN BLASTOCYSTS; ES CELLS; DIFFERENTIATION; TERATOMAS; MICE; CULTURE; SYSTEM; GROWTH; PLURIPOTENCY; IMPLANTATION	Xenografting is widely used for assessing in vivo pluripotency of human stem cell populations. Here, we report on early to late events in the development of mature experimental teratoma from a well-characterized human embryonic stem cell (HESC) line, HS181. The results show an embryonic process, increasingly chaotic. Active proliferation of the stem cell derived cellular progeny was detected already at day 5, and characterized by the appearance of multiple sites of engraftment, with structures of single or pseudostratified columnar epithelium surrounding small cavities. The striking histological resemblance to developing embryonic ectoderm, and the formation of epiblast-like structures was supported by the expression of the markers OCT4, NANOG, SSEA-4 and KLF4, but a lack of REX1. The early neural marker NESTIN was uniformly expressed, while markers linked to gastrulation, such as BMP-4, NODAL or BRACHYURY were not detected. Thus, observations on day 5 indicated differentiation comparable to the most early transient cell populations in human post implantation development. Confirming and expanding on previous findings from HS181 xenografts, these early events were followed by an increasingly chaotic development, incorporated in the formation of a benign teratoma with complex embryonic components. In the mature HS181 teratomas not all types of organs/tissues were detected, indicating a restricted differentiation, and a lack of adequate spatial developmental cues during the further teratoma formation. Uniquely, a kinetic alignment of rare complex structures was made to human embryos at diagnosed gestation stages, showing minor kinetic deviations between HS181 teratoma and the human counterpart.	[Gertow, Karin; Cedervall, Jessica; Jamil, Seema; Imreh, Marta P.; Sandstedt, Bengt; Ahrlund-Richter, Lars] Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Ali, Rouknuddin] Karolinska Inst, Dept Clin Sci Intervent & Technol, Stockholm, Sweden; [Gulyas, Miklos] Uppsala Univ, Dept Genet & Pathol, Uppsala, Sweden	Karolinska Institutet; Karolinska Institutet; Uppsala University	Gertow, K (corresponding author), Ludwig Inst Canc Res Ltd, Stockholm, Sweden.	ahrlund@gmail.com	Ahrlund-Richter, Lars/C-6226-2012	Gulyas, Miklos/0000-0003-4988-6933; Jamil, Seema/0000-0003-4264-7163	Swedish Research Council [K2008-55X-2034-01-3]; Petrus and Augusta Hedlund's stiftelse; Cancer Society in Stockholm [091551]; King Gustaf V Jubilee Fund [094271]; Karolinska Institutet; Higher Education Commission of Pakistan	Swedish Research Council(Swedish Research CouncilEuropean Commission); Petrus and Augusta Hedlund's stiftelse; Cancer Society in Stockholm; King Gustaf V Jubilee Fund; Karolinska Institutet(Karolinska Institutet); Higher Education Commission of Pakistan(Higher Education Commission of Pakistan)	This work was supported by the Swedish Research Council (K2008-55X-2034-01-3), Petrus and Augusta Hedlund's stiftelse, The Cancer Society in Stockholm (091551), the King Gustaf V Jubilee Fund (094271) and Karolinska Institutet. SJ and RA were supported by stipends from the Higher Education Commission of Pakistan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Blum B, 2008, ADV CANCER RES, V100, P133, DOI 10.1016/S0065-230X(08)00005-5; Blum B, 2007, STEM CELLS, V25, P1924, DOI 10.1634/stemcells.2007-0073; Brivanlou AH, 2003, SCIENCE, V300, P913, DOI 10.1126/science.1082940; BRONNERFRASER M, 1991, DEV BIOL, V143, P213, DOI 10.1016/0012-1606(91)90071-A; Cedervall J, 2012, HUMAN STEM IN PRESS; Cooke MJ, 2006, STEM CELLS DEV, V15, P254, DOI 10.1089/scd.2006.15.254; CROY BA, 1990, J REPROD FERTIL, V88, P231, DOI 10.1530/jrf.0.0880231; FREE MJ, 1976, BIOL REPROD, V14, P481, DOI 10.1095/biolreprod14.4.481; Gardner DK, 1998, FERTIL STERIL, V69, P84, DOI 10.1016/S0015-0282(97)00438-X; Gerecht-Nir S, 2004, BIOL REPROD, V71, P2029, DOI 10.1095/biolreprod.104.031930; Gertow K, 2004, STEM CELLS DEV, V13, P421, DOI 10.1089/scd.2004.13.421; Gertow K, 2007, CURR PROTOC STEM CEL; Gertow K, 2007, J CELL BIOCHEM, V100, P1518, DOI 10.1002/jcb.21144; HAUB O, 1991, DEVELOPMENT, V112, P397; HEBERT JM, 1991, DEVELOPMENT, V112, P407; Heins N, 2004, STEM CELLS, V22, P367, DOI 10.1634/stemcells.22-3-367; Hill MA, 2007, CLIN OBSTET GYNECOL, V50, P2, DOI 10.1097/GRF.0b013e31802f119d; Hovatta O, 2003, HUM REPROD, V18, P1404, DOI 10.1093/humrep/deg290; Imreh MP, 2004, STEM CELLS DEV, V13, P337, DOI 10.1089/1547328041797534; James D, 2005, DEVELOPMENT, V132, P1273, DOI 10.1242/dev.01706; KANNAGI R, 1983, EMBO J, V2, P2355, DOI 10.1002/j.1460-2075.1983.tb01746.x; KEYNES RJ, 1984, NATURE, V310, P786, DOI 10.1038/310786a0; Kruger A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r229; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Lensch MW, 2007, NAT BIOTECHNOL, V25, P1211, DOI 10.1038/nbt1107-1211a; Lensch MW, 2007, CELL STEM CELL, V1, P253, DOI 10.1016/j.stem.2007.07.019; MACDOUGALL JR, 1990, CELL IMMUNOL, V130, P106, DOI 10.1016/0008-8749(90)90165-N; Mikkola M, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-40; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Odorico JS, 2001, STEM CELLS, V19, P193, DOI 10.1634/stemcells.19-3-193; Prokhorova TA, 2009, STEM CELLS DEV, V18, P47, DOI 10.1089/scd.2007.0266; Przyborski SA, 2005, STEM CELLS, V23, P1242, DOI 10.1634/stemcells.2005-0014; Rathjen J, 1999, J CELL SCI, V112, P601; Schier AF, 2000, NATURE, V403, P385, DOI 10.1038/35000126; SETCHELL BP, 1964, J PHYSIOL-LONDON, V171, P411, DOI 10.1113/jphysiol.1964.sp007387; Smith JR, 2008, DEV BIOL, V313, P107, DOI 10.1016/j.ydbio.2007.10.003; TARARA R, 1987, ANAT EMBRYOL, V176, P267, DOI 10.1007/BF00310182; TEILLET MA, 1987, DEV BIOL, V120, P329, DOI 10.1016/0012-1606(87)90236-3; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Vallier L, 2004, DEV BIOL, V275, P403, DOI 10.1016/j.ydbio.2004.08.031; Vallier L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006082; Whitman M, 2001, DEV CELL, V1, P605, DOI 10.1016/S1534-5807(01)00076-4; WIDELITZ RB, 1993, J CELL PHYSIOL, V156, P399, DOI 10.1002/jcp.1041560224; Wobus AM, 2005, PHYSIOL REV, V85, P635, DOI 10.1152/physrev.00054.2003	45	9	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e27741	10.1371/journal.pone.0027741	http://dx.doi.org/10.1371/journal.pone.0027741			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140465	Green Published, gold, Green Submitted			2022-12-27	WOS:000298168100016
J	Sun, HF; Lin, CH; Smith, ME				Sun, Huifang; Lin, Chia-Hui; Smith, Michael E.			Growth Hormone Promotes Hair Cell Regeneration in the Zebrafish (Danio rerio) Inner Ear following Acoustic Trauma	PLOS ONE			English	Article							LATERAL-LINE; NEURAL RETINA; HEARING; GH; PROLIFERATION; MECHANISMS; MACROPHAGE; SURVIVAL; COCHLEA; REPLACEMENT	Background: Previous microarray analysis showed that growth hormone (GH) was significantly upregulated following acoustic trauma in the zebrafish (Danio rerio) ear suggesting that GH may play an important role in the process of auditory hair cell regeneration. Our objective was to examine the effects of exogenous and endogenous GH on zebrafish inner ear epithelia following acoustic trauma. Methodology/Principal Findings: We induced auditory hair cell damage by exposing zebrafish to acoustic overstimulation. Fish were then injected intraperitoneally with either carp GH or buffer, and placed in a recovery tank for either one or two days. Phalloidin-, bromodeoxyuridine (BrdU)-, and TUNEL-labeling were used to examine hair cell densities, cell proliferation, and apoptosis, respectively. Two days post-trauma, saccular hair cell densities in GH-treated fish were similar to that of baseline controls, whereas buffer-injected fish showed significantly reduced densities of hair cell bundles. Cell proliferation was greater and apoptosis reduced in the saccules, lagenae, and utricles of GH-treated fish one day following trauma compared to controls. Fluorescent in situ hybridization (FISH) was used to examine the localization of GH mRNA in the zebrafish ear. At one day post-trauma, GH mRNA expression appeared to be localized perinuclearly around erythrocytes in the blood vessels of the inner ear epithelia. In order to examine the effects of endogenous GH on the process of cell proliferation in the ear, a GH antagonist was injected into zebrafish immediately following acoustic trauma, resulting in significantly decreased cell proliferation one day post-trauma in all three zebrafish inner ear end organs. Conclusions/Significance: Our results show that exogenous GH promotes post-trauma auditory hair cell regeneration in the zebrafish ear through stimulating proliferation and suppressing apoptosis, and that endogenous GH signals are present in the zebrafish ear during the process of auditory hair cell regeneration.	[Sun, Huifang; Lin, Chia-Hui; Smith, Michael E.] Western Kentucky Univ, Dept Biol & Biotechnol Ctr, Bowling Green, KY 42101 USA	Western Kentucky University	Sun, HF (corresponding author), Western Kentucky Univ, Dept Biol & Biotechnol Ctr, Bowling Green, KY 42101 USA.	michael.smith1@wku.edu	Smith, Michael/AAM-8542-2020	Smith, Michael/0000-0002-2174-9825	National Institutes of Health [P20RR16481]; WKU; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016481] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); WKU; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This research was supported by National Institutes of Health grant P20RR16481 and a WKU faculty summer scholarship to MES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali O, 2011, CURR OPIN ENDOCRINOL, V18, P3, DOI 10.1097/MED.0b013e328341f873; Avallone B, 2003, HEARING RES, V178, P79, DOI 10.1016/S0378-5955(03)00040-6; Beisel K, 2008, CELL TISSUE RES, V333, P373, DOI 10.1007/s00441-008-0639-z; Bhave SA, 1998, J COMP NEUROL, V398, P241, DOI 10.1002/(SICI)1096-9861(19980824)398:2<241::AID-CNE6>3.0.CO;2-0; Bidlingmaier Martin, 2010, Handb Exp Pharmacol, P187, DOI 10.1007/978-3-540-79088-4_8; Bravo J, 2000, EMBO J, V19, P2399, DOI 10.1093/emboj/19.11.2399; Brignull HR, 2009, BRAIN RES, V1277, P12, DOI 10.1016/j.brainres.2009.02.028; Brunet-Dunand SE, 2009, ENDOCRINOLOGY, V150, P1341, DOI 10.1210/en.2008-0608; Cacciafesta V, 2001, EUR J ORTHODONT, V23, P733, DOI 10.1093/ejo/23.6.733; CalduchGiner JA, 1997, CELL TISSUE RES, V287, P535, DOI 10.1007/s004410050777; CASANUEVA FF, 1992, ENDOCRIN METAB CLIN, V21, P483, DOI 10.1016/S0889-8529(18)30199-3; CHARDIN S, 1995, SCIENCE, V267, P707, DOI 10.1126/science.7839151; CORWIN JT, 1988, SCIENCE, V240, P1772, DOI 10.1126/science.3381100; DAVIDSON MB, 1987, ENDOCR REV, V8, P115, DOI 10.1210/edrv-8-2-115; DRIEVER W, 1994, TRENDS GENET, V10, P152, DOI 10.1016/0168-9525(94)90091-4; ELLIS AE, 1977, J FISH BIOL, V11, P453, DOI 10.1111/j.1095-8649.1977.tb04140.x; Fettiplace R, 2006, SPR HDB AUD, V27, P154; GILPIN DA, 1994, ANN SURG, V220, P19, DOI 10.1097/00000658-199407000-00004; GOLDE DW, 1977, SCIENCE, V196, P1112, DOI 10.1126/science.870971; Gubbels SP, 2008, NATURE, V455, P537, DOI 10.1038/nature07265; Haddon C, 1996, J COMP NEUROL, V365, P113, DOI 10.1002/(SICI)1096-9861(19960129)365:1<113::AID-CNE9>3.0.CO;2-6; Harris JA, 2003, JARO-J ASSOC RES OTO, V4, P219, DOI 10.1007/s10162-002-3022-x; Harvey S, 2010, ENDOCRINE, V38, P335, DOI 10.1007/s12020-010-9403-8; Harvey S, 2006, NEUROREPORT, V17, P1715, DOI 10.1097/01.wnr.0000239952.22578.90; HERDON DN, 1996, HORM RES S1, V45, P29; Hernandez PP, 2007, DEV NEUROBIOL, V67, P637, DOI 10.1002/dneu.20386; HUDSPETH AJ, 1985, SCIENCE, V230, P745, DOI 10.1126/science.2414845; Hudspeth AJ, 2000, P NATL ACAD SCI USA, V97, P11765, DOI 10.1073/pnas.97.22.11765; ISAKSSON OGP, 1982, SCIENCE, V216, P1237, DOI 10.1126/science.7079756; Izumikawa M, 2005, NAT MED, V11, P271, DOI 10.1038/nm1193; Jones JE, 1996, J NEUROSCI, V16, P649; JONES JE, 1993, J NEUROSCI, V13, P1022; Jongkamonwiwat N, 2010, CURR DRUG TARGETS, V11, P888, DOI 10.2174/138945010791320836; Jung GW, 1998, J UROLOGY, V160, P1899, DOI 10.1016/S0022-5347(01)62440-6; KANJE M, 1988, BRAIN RES, V475, P254, DOI 10.1016/0006-8993(88)90613-0; Kaulsay KK, 2001, ENDOCRINOLOGY, V142, P767, DOI 10.1210/en.142.2.767; Lefebvre PP, 2000, ACTA OTO-LARYNGOL, V120, P142; LOMBARTE A, 1993, HEARING RES, V64, P166, DOI 10.1016/0378-5955(93)90002-I; LOWENSTEIN O, 1971, P253; Ma EY, 2008, J NEUROSCI, V28, P2261, DOI 10.1523/JNEUROSCI.4372-07.2008; Matsuda T, 1998, JPEN-PARENTER ENTER, V22, P368, DOI 10.1177/0148607198022006368; Matsui JI, 2005, J REHABIL RES DEV, V42, P187, DOI 10.1682/JRRD.2005.01.0008; McCullar JS, 2010, J NEUROSCI, V30, P478, DOI 10.1523/JNEUROSCI.5154-09.2010; O'Halloran EK, 2004, J COMP NEUROL, V475, P340, DOI 10.1002/cne.20162; Okada S, 2001, TRENDS MOL MED, V7, P126, DOI 10.1016/S1471-4914(01)01933-5; Oshima K, 2010, CELL, V141, P704, DOI 10.1016/j.cell.2010.03.035; Pandey V, 2008, ENDOCRINOLOGY, V149, P3909, DOI 10.1210/en.2008-0286; Pennisi PA, 2004, ENDOCRINOLOGY, V145, P4748, DOI 10.1210/en.2004-0655; PLATT C, 1993, HEARING RES, V65, P133, DOI 10.1016/0378-5955(93)90208-I; Pyati UJ, 2007, SEMIN CANCER BIOL, V17, P154, DOI 10.1016/j.semcancer.2006.11.007; RENDER CL, 1995, J ENDOCRINOL, V147, P413, DOI 10.1677/joe.0.1470413; Rivolta MN, 2010, DRUG DISCOV TODAY, V15, P283, DOI 10.1016/j.drudis.2010.02.006; ROBERSON DW, 1994, AM J OTOL, V15, P28; Rotwein P, 2010, PEDIATR NEPHROL, V25, P651, DOI 10.1007/s00467-009-1258-y; RYALS BM, 1988, SCIENCE, V240, P1774, DOI 10.1126/science.3381101; Sage C, 2006, P NATL ACAD SCI USA, V103, P7345, DOI 10.1073/pnas.0510631103; Sanders EJ, 2008, GEN COMP ENDOCR, V156, P613, DOI 10.1016/j.ygcen.2008.02.005; Sanders EJ, 2006, EXP EYE RES, V83, P1205, DOI 10.1016/j.exer.2006.06.009; Sanders EJ, 2009, GEN COMP ENDOCR, V163, P63, DOI 10.1016/j.ygcen.2009.01.005; Scheepens A, 2005, HORM RES, V64, P66, DOI 10.1159/000089320; Schuck JB, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-88; Schuck JB, 2009, HEARING RES, V253, P67, DOI 10.1016/j.heares.2009.03.008; SMITH CG, 1952, PROG FISH CULT, V14, P169; Smith ME, 2004, J EXP BIOL, V207, P427, DOI 10.1242/jeb.00755; Smith ME, 2006, J EXP BIOL, V209, P4193, DOI 10.1242/jeb.02490; Smith ME, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-19; TANNER JM, 1972, NATURE, V237, P433, DOI 10.1038/237433a0; Taylor RR, 2005, J COMP NEUROL, V484, P105, DOI 10.1002/cne.20450; Tresguerres JAF, 1999, J ENDOCRINOL, V160, P217, DOI 10.1677/joe.0.1600217; ULLMAN M, 1989, ACTA PHYSIOL SCAND, V135, P537, DOI 10.1111/j.1748-1716.1989.tb08613.x; van den Eijnden MJ, 2007, MOL ENDOCRINOL, V21, P2832, DOI 10.1210/me.2007-0092; Warchol ME, 1997, J NEUROBIOL, V33, P724, DOI 10.1002/(SICI)1097-4695(19971120)33:6<724::AID-NEU2>3.0.CO;2-B; WEIGENT DA, 1988, FASEB J, V2, P2812, DOI 10.1096/fasebj.2.12.3044906; Zheng JL, 2000, NAT NEUROSCI, V3, P580, DOI 10.1038/75753	75	32	32	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e28372	10.1371/journal.pone.0028372	http://dx.doi.org/10.1371/journal.pone.0028372			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140580	gold, Green Published, Green Submitted			2022-12-27	WOS:000298168100066
J	Wilson, AJ; de Boer, M; Arnott, G; Grimmer, A				Wilson, Alastair J.; de Boer, Marloes; Arnott, Gareth; Grimmer, Andrew			Integrating Personality Research and Animal Contest Theory: Aggressiveness in the Green Swordtail Xiphophorus helleri	PLOS ONE			English	Article							BEHAVIORAL SYNDROMES; FIGHTING ABILITY; FISH; EVOLUTION; DOMINANCE; COMPETITION; ECOLOGY; WINNER; COMBAT; RANK	Aggression occurs when individuals compete over limiting resources. While theoretical studies have long placed a strong emphasis on context-specificity of aggression, there is increasing recognition that consistent behavioural differences exist among individuals, and that aggressiveness may be an important component of individual personality. Though empirical studies tend to focus on one aspect or the other, we suggest there is merit in modelling both within-and among-individual variation in agonistic behaviour simultaneously. Here, we demonstrate how this can be achieved using multivariate linear mixed effect models. Using data from repeated mirror trials and dyadic interactions of male green swordtails, Xiphophorus helleri, we show repeatable components of (co)variation in a suite of agonistic behaviour that is broadly consistent with a major axis of variation in aggressiveness. We also show that observed focal behaviour is dependent on opponent effects, which can themselves be repeatable but were more generally found to be context specific. In particular, our models show that within-individual variation in agonistic behaviour is explained, at least in part, by the relative size of a live opponent as predicted by contest theory. Finally, we suggest several additional applications of the multivariate models demonstrated here. These include testing the recently queried functional equivalence of alternative experimental approaches, (e. g., mirror trials, dyadic interaction tests) for assaying individual aggressiveness.	[Wilson, Alastair J.; de Boer, Marloes; Grimmer, Andrew] Univ Edinburgh, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland; [Arnott, Gareth] Univ Glasgow, Inst Biodivers, Glasgow, Lanark, Scotland	University of Edinburgh; University of Glasgow	Wilson, AJ (corresponding author), Univ Edinburgh, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland.	alastair.wilson@ed.ac.uk	Wilson, Alastair/F-3118-2010	Wilson, Alastair/0000-0002-5045-2051	Biology and Biotechnology Research Council	Biology and Biotechnology Research Council	This work was funded by a Biology and Biotechnology Research Council David Phillips fellowship awarded to AJW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnott G, 2011, BIOL LETTERS, V7, P683, DOI 10.1098/rsbl.2011.0328; Arnott G, 2010, BEHAV PROCESS, V84, P750, DOI 10.1016/j.beproc.2010.05.001; Arnott G, 2009, BIOL LETTERS, V5, P762, DOI 10.1098/rsbl.2009.0526; Arnott G, 2009, ANIM BEHAV, V77, P991, DOI 10.1016/j.anbehav.2009.02.010; AUSTAD SN, 1983, ANIM BEHAV, V31, P59, DOI 10.1016/S0003-3472(83)80173-0; BEAUGRAND J, 1991, ANIM BEHAV, V41, P417, DOI 10.1016/S0003-3472(05)80842-5; BEAUGRAND JP, 1985, BEHAV PROCESS, V10, P1, DOI 10.1016/0376-6357(85)90116-0; Bell AM, 2009, ANIM BEHAV, V77, P771, DOI 10.1016/j.anbehav.2008.12.022; Benson KE, 2006, ANIM BEHAV, V71, P129, DOI 10.1016/j.anbehav.2005.05.004; BRADLEY RA, 1952, BIOMETRIKA, V39, P324, DOI 10.1093/biomet/39.3-4.324; Briffa M, 2009, ANIM BEHAV, V77, P759, DOI 10.1016/j.anbehav.2008.11.010; Desjardins JK, 2010, BIOL LETTERS, V6, P744, DOI 10.1098/rsbl.2010.0247; Dochtermann NA, 2010, BEHAV ECOL, V21, P437, DOI 10.1093/beheco/arq021; Dugatkin LA, 1997, BEHAV ECOL, V8, P583, DOI 10.1093/beheco/8.6.583; Dzieweczynski TL, 2010, BEHAV PROCESS, V85, P83, DOI 10.1016/j.beproc.2010.06.011; Earley RL, 2006, BEHAV PROCESS, V73, P290, DOI 10.1016/j.beproc.2006.07.001; Earley RL, 2002, P ROY SOC B-BIOL SCI, V269, P943, DOI 10.1098/rspb.2002.1973; Earley RL, 2000, ETHOLOGY, V106, P743, DOI 10.1046/j.1439-0310.2000.00586.x; Earley RL, 2006, ZEBRAFISH, V3, P287, DOI 10.1089/zeb.2006.3.287; ENQUIST M, 1990, ANIM BEHAV, V40, P1, DOI 10.1016/S0003-3472(05)80660-8; ENQUIST M, 1983, J THEOR BIOL, V102, P387, DOI 10.1016/0022-5193(83)90376-4; Fawcett TW, 2010, P ROY SOC B-BIOL SCI, V277, P1427, DOI 10.1098/rspb.2009.2088; Galwey N.W., 2006, INTRO MIXED MODELLIN; Gibbons JM, 2009, APPL ANIM BEHAV SCI, V121, P1, DOI 10.1016/j.applanim.2009.08.002; Gosling SD, 2001, PSYCHOL BULL, V127, P45, DOI 10.1037//0033-2909.127.1.45; Goulet C, 2001, RELATION DOMIN UNPUB; Hardling R, 2004, AM NAT, V163, P240, DOI 10.1086/381043; Hedeker D., 2006, LONGITUDINAL DATA AN; Higham NJ, 2002, IMA J NUMER ANAL, V22, P329, DOI 10.1093/imanum/22.3.329; Hodge SJ, 2009, BEHAV ECOL, V20, P930, DOI 10.1093/beheco/arp071; Huntingford F.A., 1987, ANIMAL CONFLICT; Johnstone RA, 2001, P NATL ACAD SCI USA, V98, P9177, DOI 10.1073/pnas.161058798; Magellan K, 2010, J ETHOL, V28, P239, DOI 10.1007/s10164-009-0175-7; McGhee KE, 2010, ANIM BEHAV, V79, P497, DOI 10.1016/j.anbehav.2009.11.037; Meyer K, 2008, GENETICS, V180, P1153, DOI 10.1534/genetics.108.090159; Moore AJ, 1997, EVOLUTION, V51, P1352, DOI 10.1111/j.1558-5646.1997.tb01458.x; Moretz J, 2005, BEHAV ECOL SOCIOBIOL, V59, P51, DOI 10.1007/s00265-005-0008-9; MORRIS MR, 1995, BEHAV ECOL SOCIOBIOL, V37, P303, DOI 10.1007/BF00174134; Nakagawa S, 2010, BIOL REV, V85, P935, DOI 10.1111/j.1469-185X.2010.00141.x; Nussey DH, 2007, J EVOLUTION BIOL, V20, P831, DOI 10.1111/j.1420-9101.2007.01300.x; PARKER GA, 1974, J THEOR BIOL, V47, P223, DOI 10.1016/0022-5193(74)90111-8; Payne RJH, 1998, ANIM BEHAV, V56, P651, DOI 10.1006/anbe.1998.0835; Peake TM, 2004, LEARN BEHAV, V32, P114; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Prenter J, 2008, ANIMAL BEHAV; Reale D, 2007, BIOL REV, V82, P291, DOI 10.1111/j.1469-185X.2007.00010.x; Renison D, 2002, BEHAV ECOL, V13, P462, DOI 10.1093/beheco/13.4.462; Robinson MR, 2007, BIOL LETTERS, V3, P651, DOI 10.1098/rsbl.2007.0278; Sih A, 2004, TRENDS ECOL EVOL, V19, P372, DOI 10.1016/j.tree.2004.04.009; SMITH JM, 1973, NATURE, V246, P15, DOI 10.1038/246015a0; Sontirat S., 1984, Kasetsart Journal Natural Sciences, V18, P99; Taylor PW, 2003, ANIM BEHAV, V65, P1195, DOI 10.1006/anbe.2003.2169; Tinbergen, 1951, STUDY INSTINCT; Visscher PM, 2006, TWIN RES HUM GENET, V9, P490, DOI 10.1375/183242706778024928; WARD PI, 1983, BEHAV ECOL SOCIOBIOL, V14, P69, DOI 10.1007/BF00366658; While GM, 2010, HORM BEHAV, V58, P208, DOI 10.1016/j.yhbeh.2010.03.016; Wilson AJ, 2008, J EVOLUTION BIOL, V21, P647, DOI 10.1111/j.1420-9101.2008.01500.x; Wilson AJ, 2011, J EVOLUTION BIOL, V24, P772, DOI 10.1111/j.1420-9101.2010.02212.x; Wilson AJ, 2009, P ROY SOC B-BIOL SCI, V276, P533, DOI 10.1098/rspb.2008.1193	59	51	51	1	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e28024	10.1371/journal.pone.0028024	http://dx.doi.org/10.1371/journal.pone.0028024			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140502	gold, Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000298168100031
J	Bertrand, JT; Njeuhmeli, E; Forsythe, S; Mattison, SK; Mahler, H; Hankins, CA				Bertrand, Jane T.; Njeuhmeli, Emmanuel; Forsythe, Steven; Mattison, Sarah K.; Mahler, Hally; Hankins, Catherine A.			Voluntary Medical Male Circumcision: A Qualitative Study Exploring the Challenges of Costing Demand Creation in Eastern and Southern Africa	PLOS ONE			English	Article							ADULT MALE CIRCUMCISION; SUB-SAHARAN AFRICA; HIV PREVENTION; ACCEPTABILITY; MEN; INTERVENTION; INFECTION	Background: This paper proposes an approach to estimating the costs of demand creation for voluntary medical male circumcision (VMMC) scale-up in 13 countries of eastern and southern Africa. It addresses two key questions: (1) what are the elements of a standardized package for demand creation? And (2) what challenges exist and must be taken into account in estimating the costs of demand creation? Methods and Findings: We conducted a key informant study on VMMC demand creation using purposive sampling to recruit seven people who provide technical assistance to government programs and manage budgets for VMMC demand creation. Key informants provided their views on the important elements of VMMC demand creation and the most effective funding allocations across different types of communication approaches (e. g., mass media, small media, outreach/mobilization). The key finding was the wide range of views, suggesting that a standard package of core demand creation elements would not be universally applicable. This underscored the importance of tailoring demand creation strategies and estimates to specific country contexts before estimating costs. The key informant interviews, supplemented by the researchers' field experience, identified these issues to be addressed in future costing exercises: variations in the cost of VMMC demand creation activities by country and program, decisions about the quality and comprehensiveness of programming, and lack of data on critical elements needed to "trigger the decision" among eligible men. Conclusions: Based on this study's findings, we propose a seven-step methodological approach to estimate the cost of VMMC scale-up in a priority country, based on our key assumptions. However, further work is needed to better understand core components of a demand creation package and how to cost them. Notwithstanding the methodological challenges, estimating the cost of demand creation remains an essential element in deriving estimates of the total costs for VMMC scale-up in eastern and southern Africa.	[Bertrand, Jane T.; Mattison, Sarah K.] Tulane Sch Publ Hlth & Trop Med, New Orleans, LA 70112 USA; [Njeuhmeli, Emmanuel] US Agcy Int Dev, Washington, DE USA; [Forsythe, Steven] Futures Inst, Glastonbury, CT USA; [Mahler, Hally] Jhpiego, Dar Es Salaam, Tanzania; [Hankins, Catherine A.] Joint United Nations Programme HIV AIDS, Geneva, Switzerland	Tulane University; United States Agency for International Development (USAID); Jhpiego	Bertrand, JT (corresponding author), Tulane Sch Publ Hlth & Trop Med, New Orleans, LA 70112 USA.	bertrand@tulane.edu	Forsythe, Steven/AAL-7558-2020	Forsythe, Steven/0000-0002-4409-5991; Hankins, Catherine/0000-0002-1642-8592	United States Agency for International Development (USAID) [GHH-I-00-07-00032-00]; UNAIDS	United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR); UNAIDS	This work was funded by the President's Emergency Plan for AIDS Relief (PEPFAR) through the United States Agency for International Development (USAID) and UNAIDS. Technical staff from USAID and UNAIDS was involved in study design, decision to publish, and preparation of the manuscript.; The work undertaken for this article was supported by the Research to Prevention project, funded by USAID, Project SEARCH, Task Order No. 2, under Contract No. GHH-I-00-07-00032-00, beginning September 30, 2008, and by the President's Emergency Plan for AIDS Relief. Research to Prevention is led by the Johns Hopkins Center for Global Health and managed by the Johns Hopkins Bloomberg School of Public Health Center for Communication Programs. Tulane University School of Public Health and Tropical Medicine serves as a subcontractor on Research to Prevention. We acknowledge Sekai Chideya for her contribution to the data analysis, writing, and review of this paper.	Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Auvert B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002679; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Fieno JV, 2008, AIDS CARE, V20, P515, DOI 10.1080/09540120701867149; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Hankins C, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000109; Hutchinson P, 2006, J HEALTH COMMUN, V11, P7, DOI 10.1080/10810730600973862; Kebaabetswe P, 2003, SEX TRANSM INFECT, V79, P214, DOI 10.1136/sti.79.3.214; Kenya Ministry of Public Health and Sanitation, 2010, VOL MED MAL CIRC VMM; Lagarde E, 2003, AIDS, V17, P89, DOI 10.1097/00002030-200301030-00012; Mattson CL, 2005, AIDS CARE, V17, P182, DOI 10.1080/09540120512331325671; Njeuhmeli E, 2010, 18 INT AIDS C VIENN; Njeuhmeli E, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001132; Salem RM, 2008, POPULATION REPORTS S; Scott BE, 2005, AIDS CARE, V17, P304, DOI 10.1080/09540120412331299744; Snyder LB, 2007, J NUTR EDUC BEHAV, V39, pS32, DOI 10.1016/j.jneb.2006.09.004; Tanzania Commission for AIDS (TACAIDS) Zanzibar AIDS Commission (ZAC) National Bureau of Statistics (NBS) Office of the Chief Government Statistician (OCGS) Macro International Inc., 2008, TANZ HIV AIDS MAL IN; UNAIDS/WHO, 2007, NEW DAT MAL CIRC HIV; United States Agency for International Development Health Policy Initiative, 2009, POT COST IMP EXP MAL; Uthman OA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009628; Westercamp M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015552; Westercamp N, 2007, AIDS BEHAV, V11, P341, DOI 10.1007/s10461-006-9169-4	22	22	22	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2011	6	11							e27562	10.1371/journal.pone.0027562	http://dx.doi.org/10.1371/journal.pone.0027562			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	863LT	22140450	gold, Green Submitted, Green Published			2022-12-27	WOS:000298166300007
J	Johansson, D; Shannon, O; Rasmussen, M				Johansson, Daniel; Shannon, Oonagh; Rasmussen, Magnus			Platelet and Neutrophil Responses to Gram Positive Pathogens in Patients with Bacteremic Infection	PLOS ONE			English	Article							IMMUNOGLOBULIN-G; CELL FILTRATION; IGG BINDING; P-SELECTIN; ACTIVATION; FIBRINOGEN; AGGREGATION; ROLES; COMPLEMENT; MECHANISMS	Background: Many Gram-positive pathogens aggregate and activate platelets in vitro and this has been proposed to contribute to virulence. Platelets can also form complexes with neutrophils but little is however known about platelet and platelet-neutrophil responses in bacterial infection. Methodology/Principal Findings: We added isolates of Gram-positive bacteria from 38 patients with a bacteremic infection to blood drawn from the same patient. Aggregometry and flow cytometry were used to assess platelet aggregation and to quantify activation of platelets, neutrophils, and platelet-neutrophils complexes (PNCs) induced by the bacteria. Fifteen healthy persons served as controls. Most isolates of Staphylococcus aureus, beta hemolytic streptococci, and Enterococcus faecalis induced aggregation of platelets from their respective hosts, whereas pneumococci failed to do so. S. aureus isolates induced platelet aggregation more rapidly in patients than in controls, whereas platelet activation by S. aureus was lower in patients than in controls. PNCs were more abundant in baseline samples from patients than in healthy controls and most bacterial isolates induced additional PNC formation and neutrophil activation. Conclusion/Significance: We have demonstrated for the first time that bacteria isolated from patients with Gram-positive bacteremia can induce platelet activation and aggregation, PNC formation, and neutrophil activation in the same infected host. This underlines the significance of these interactions during infection, which could be a target for future therapies in sepsis.	[Johansson, Daniel; Shannon, Oonagh; Rasmussen, Magnus] Lund Univ, Div Infect Med, Dept Clin Sci, Lund, Sweden	Lund University	Johansson, D (corresponding author), Lund Univ, Div Infect Med, Dept Clin Sci, Lund, Sweden.	Magnus.Rasmussen@med.lu.se		Shannon, Oonagh/0000-0001-8291-8189; Rasmussen, Magnus/0000-0003-1588-5473	Swedish Society of Medicine; Swedish Government; Swedish Research Council [21112, 7480]; Royal Physiographic Society in Lund; Foundations of Osterlund and Crafoord	Swedish Society of Medicine; Swedish Government; Swedish Research Council(Swedish Research CouncilEuropean Commission); Royal Physiographic Society in Lund; Foundations of Osterlund and Crafoord	This study was financed by the Swedish Society of Medicine, the Swedish Government Fund for Clinical Research (ALF), the Swedish Research Council (Project 21112 and 7480), the Royal Physiographic Society in Lund, and the Foundations of Osterlund and Crafoord. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKESSON P, 1990, MOL IMMUNOL, V27, P523, DOI 10.1016/0161-5890(90)90071-7; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Annane D, 2005, LANCET, V365, P63, DOI 10.1016/S0140-6736(04)17667-8; BAYER AS, 1995, INFECT IMMUN, V63, P3634, DOI 10.1128/IAI.63.9.3634-3641.1995; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Brandt CM, 2009, CLIN INFECT DIS, V49, P766, DOI 10.1086/605085; Brown KK, 1998, AM J RESP CELL MOL, V18, P100, DOI 10.1165/ajrcmb.18.1.2314; Clark SR, 2007, NAT MED, V13, P463, DOI 10.1038/nm1565; Evangelista Virgilio, 1996, Blood, V88, P4183; Fitzgerald JR, 2006, NAT REV MICROBIOL, V4, P445, DOI 10.1038/nrmicro1425; Fitzgerald JR, 2006, MOL MICROBIOL, V59, P212, DOI 10.1111/j.1365-2958.2005.04922.x; Gafter-Gvili A, 2011, MAYO CLIN PROC, V86, P389, DOI 10.4065/mcp.2010.0705; GAWAZ M, 1995, EUR J CLIN INVEST, V25, P843, DOI 10.1111/j.1365-2362.1995.tb01694.x; Gawaz M, 1997, INTENS CARE MED, V23, P379, DOI 10.1007/s001340050344; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Keane C, 2010, J THROMB HAEMOST, V8, P2757, DOI 10.1111/j.1538-7836.2010.04093.x; Kerrigan SW, 2010, CELL MOL LIFE SCI, V67, P513, DOI 10.1007/s00018-009-0207-z; Kirschenbaum LA, 2002, SHOCK, V17, P508, DOI 10.1097/00024382-200206000-00012; Kirschenbaum LA, 2000, AM J RESP CRIT CARE, V161, P1602, DOI 10.1164/ajrccm.161.5.9902105; KURPIEWSKI GE, 1983, INFECT IMMUN, V39, P704, DOI 10.1128/IAI.39.2.704-708.1983; Loughman A, 2005, MOL MICROBIOL, V57, P804, DOI 10.1111/j.1365-2958.2005.04731.x; Mavrommatis AC, 2000, CRIT CARE MED, V28, P451, DOI 10.1097/00003246-200002000-00027; McNicol A, 2006, THROMB HAEMOSTASIS, V95, P288, DOI 10.1160/TH05-07-0491; Miajlovic H, 2007, INFECT IMMUN, V75, P3335, DOI 10.1128/IAI.01993-06; Papapanagiotou D, 2009, ATHEROSCLEROSIS, V202, P605, DOI 10.1016/j.atherosclerosis.2008.05.035; Peters MJ, 2003, J LEUKOCYTE BIOL, V73, P722, DOI 10.1189/jlb.1002509; Pietrocola G, 2005, BLOOD, V105, P1052, DOI 10.1182/blood-2004-06-2149; Rasmussen M, 2010, MICROBES INFECT, V12, P295, DOI 10.1016/j.micinf.2010.01.005; Rindi S, 2006, EUR J CLIN INVEST, V36, P536, DOI 10.1111/j.1365-2362.2006.01675.x; Russell JA, 2006, NEW ENGL J MED, V355, P1699, DOI 10.1056/NEJMra043632; Semple JW, 2010, CELL MOL LIFE SCI, V67, P499, DOI 10.1007/s00018-009-0205-1; Sjobring U, 2002, BLOOD, V100, P4470, DOI 10.1182/blood-2002-01-0069; Solovjov DA, 2005, J BIOL CHEM, V280, P1336, DOI 10.1074/jbc.M406968200; SULLAM PM, 1988, INFECT IMMUN, V56, P2907, DOI 10.1128/IAI.56.11.2907-2911.1988; ZIMMERMAN TS, 1975, J CLIN INVEST, V56, P828, DOI 10.1172/JCI108161	35	50	51	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2011	6	11							e26928	10.1371/journal.pone.0026928	http://dx.doi.org/10.1371/journal.pone.0026928			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863LT	22140434	Green Published, Green Submitted, gold			2022-12-27	WOS:000298166300003
J	Li, T; Li, YM; Ahn, K; Price, DL; Sisodia, SS; Wong, PC				Li, Tong; Li, Yue-Ming; Ahn, Kwangwook; Price, Donald L.; Sisodia, Sangram S.; Wong, Philip C.			Increased Expression of PS1 Is Sufficient to Elevate the Level and Activity of gamma-Secretase In Vivo	PLOS ONE			English	Article							FAMILIAL ALZHEIMERS-DISEASE; AMYLOID PRECURSOR PROTEIN; GENOME-WIDE ASSOCIATION; A-BETA LEVELS; IDENTIFIES VARIANTS; MISSENSE MUTATIONS; APOLIPOPROTEIN-E; PRESENILIN-1; NICASTRIN; COMPLEX	Increase in the generation and deposition of amyloid-beta (Ab) plays a central role in the development of Alzheimer's Disease (AD). Elevation of the activity of c-secretase, a key enzyme required for the generation for A beta, can thus be a potential risk factor in AD. However, it is not known whether gamma-secretase can be upregulated in vivo. While in vitro studies showed that expression of all four components of gamma-secretase (Nicastrin, Presenilin, Pen-2 and Aph-1) are required for upregulation of gamma-secretase, it remains to be established as to whether this is true in vivo. To investigate whether overexpressing a single component of the gamma-secretase complex is sufficient to elevate its level and activity in the brain, we analyzed transgenic mice expressing either wild type or familial AD (fAD) associated mutant PS1. In contrast to cell culture studies, overexpression of either wild type or mutant PS1 is sufficient to increase levels of Nicastrin and Pen-2, and elevate the level of active gamma-secretase complex, enzymatic activity of gamma-secretase and the deposition of A beta in brains of mice. Importantly, gamma-secretase comprised of mutant PS1 is less active than that of wild type PS1-containing gamma-secretase; however, gamma-secretase comprised of mutant PS1 cleaves at the A beta 42 site of APP-CTFs more efficiently than at the A beta 40 site, resulting in greater accumulation of A beta deposits in the brain. Our data suggest that whereas fAD-linked PS1 mutants cause early onset disease, upregulation of PS1/gamma-secretase activity may be a risk factor for late onset sporadic AD.	[Li, Tong; Price, Donald L.; Wong, Philip C.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Price, Donald L.; Wong, Philip C.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Price, Donald L.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Li, Yue-Ming; Ahn, Kwangwook] Mem Sloan Kettering Canc Ctr, Mol Pharmacol & Chem Program, New York, NY 10021 USA; [Sisodia, Sangram S.] Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Memorial Sloan Kettering Cancer Center; University of Chicago	Li, T (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA.	tli1@jhmi.edu	LI, Yue/GRS-8071-2022		National Institute of Neurological Disorders and Stroke (NINDS) [R01 NS45150, P01 NS047308]; National Institute on Aging (NIA) [P50 AG05146]; MetLife Foundation; Frederic J. Pelda Alzheimer's Research Fund; Adler Foundation; Ellison Medical Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS047308, R01NS045150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005146] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); MetLife Foundation; Frederic J. Pelda Alzheimer's Research Fund; Adler Foundation; Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from National Institute of Neurological Disorders and Stroke (NINDS) (R01 NS45150, and P01 NS047308 to PCW), the National Institute on Aging (NIA) (P50 AG05146 to DLP), MetLife Foundation (to PCW), Frederic J. Pelda Alzheimer's Research Fund (to Division of Neuropathology at Johns Hopkins) (to TL), Adler Foundation (to TL) and Ellison Medical Foundation (to TL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn K, 2010, P NATL ACAD SCI USA, V107, P21435, DOI 10.1073/pnas.1013246107; Bertram L, 2005, NEW ENGL J MED, V352, P884, DOI 10.1056/NEJMoa042765; Bertram L, 2010, NEURON, V68, P270, DOI 10.1016/j.neuron.2010.10.013; Borchelt DR, 1997, NEURON, V19, P939, DOI 10.1016/S0896-6273(00)80974-5; Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; Bu GJ, 2009, NAT REV NEUROSCI, V10, P333, DOI 10.1038/nrn2620; Cai HB, 2001, NAT NEUROSCI, V4, P233, DOI 10.1038/85064; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; DeMattos RB, 2004, NEURON, V41, P193, DOI 10.1016/S0896-6273(03)00850-X; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Farmery MR, 2003, J BIOL CHEM, V278, P24277, DOI 10.1074/jbc.M211992200; GHOSH A, 1995, NEURON, V15, P89, DOI 10.1016/0896-6273(95)90067-5; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Golde TE, 2011, NEURON, V69, P203, DOI 10.1016/j.neuron.2011.01.002; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Hebert SS, 2008, P NATL ACAD SCI USA, V105, P6415, DOI 10.1073/pnas.0710263105; Kim J, 2009, NEURON, V63, P287, DOI 10.1016/j.neuron.2009.06.026; Kim SH, 2003, J BIOL CHEM, V278, P33992, DOI 10.1074/jbc.M305834200; Kimberly WT, 2003, P NATL ACAD SCI USA, V100, P6382, DOI 10.1073/pnas.1037392100; Kumar VB, J EXP BIOL, V212, P494; Lai MT, 2003, J BIOL CHEM, V278, P22475, DOI 10.1074/jbc.M300974200; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Lee MK, 1997, NAT MED, V3, P756, DOI 10.1038/nm0797-756; LEVYLAHAD E, 1995, SCIENCE, V269, P970, DOI 10.1126/science.7638621; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; Li R, 2004, P NATL ACAD SCI USA, V101, P3632, DOI 10.1073/pnas.0205689101; Li T, 2003, J NEUROSCI, V23, P3272; Li T, 2007, J BIOL CHEM, V282, P32264, DOI 10.1074/jbc.M703649200; Li T, 2007, J NEUROSCI, V27, P10849, DOI 10.1523/JNEUROSCI.2152-07.2007; Li YM, 2000, P NATL ACAD SCI USA, V97, P6138, DOI 10.1073/pnas.110126897; Luo WJ, 2003, J BIOL CHEM, V278, P7850, DOI 10.1074/jbc.C200648200; Ma GJ, 2005, J NEUROSCI, V25, P192, DOI 10.1523/JNEUROSCI.3814-04.2005; Meckler X, 2010, J NEUROSCI, V30, P16160, DOI 10.1523/JNEUROSCI.4436-10.2010; MURRELL J, 1991, SCIENCE, V254, P97, DOI 10.1126/science.1925564; NARUSE S, 1991, LANCET, V337, P978, DOI 10.1016/0140-6736(91)91612-X; Placanica L, 2009, J BIOL CHEM, V284, P2967, DOI 10.1074/jbc.M807269200; Prokop S, 2004, J BIOL CHEM, V279, P23255, DOI 10.1074/jbc.M401789200; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; Rogaeva E, 2007, NAT GENET, V39, P168, DOI 10.1038/ng1943; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; Savonenko A, 2005, NEUROBIOL DIS, V18, P602, DOI 10.1016/j.nbd.2004.10.022; Selkoe D, 2003, ANNU REV NEUROSCI, V26, P565, DOI 10.1146/annurev.neuro.26.041002.131334; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Shirotani K, 2004, J NEUROCHEM, V89, P1520, DOI 10.1111/j.1471-4159.2004.02447.x; Steiner H, 2002, J BIOL CHEM, V277, P39062, DOI 10.1074/jbc.C200469200; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Vehmas AK, 2001, DNA CELL BIOL, V20, P713, DOI 10.1089/10445490152717578; Wong PC, 2006, BASIC NEUROCHEMISTRY, P781; Xu GL, 2002, ALZ DIS ASSOC DIS, V16, P191, DOI 10.1097/00002093-200207000-00010	51	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2011	6	11							e28179	10.1371/journal.pone.0028179	http://dx.doi.org/10.1371/journal.pone.0028179			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863LT	22140537	Green Published, Green Submitted, gold			2022-12-27	WOS:000298166300036
J	Kawelke, N; Vasel, M; Sens, C; von Au, A; Dooley, S; Nakchbandi, IA				Kawelke, Nina; Vasel, Matthaeus; Sens, Carla; von Au, Anja; Dooley, Steven; Nakchbandi, Inaam A.			Fibronectin Protects from Excessive Liver Fibrosis by Modulating the Availability of and Responsiveness of Stellate Cells to Active TGF-beta	PLOS ONE			English	Article							SPLICED EDA SEGMENT; HEPATIC FIBROGENESIS; EXTRACELLULAR-MATRIX; EIIIA SEGMENT; GROWTH; EXPRESSION; PLASMA; POLYMERIZATION; ACTIVATION; STABILITY	Fibrotic tissue in the liver is mainly composed of collagen. Fibronectin, which is also present in fibrotic matrices, is required for collagen matrix assembly in vitro. It also modulates the amount of growth factors and their release from the matrix. We therefore examined the effects of the absence of fibronectin on the development of fibrosis in mice. Conditional deletion of fibronectin in the liver using the Mx promoter to drive cre expression resulted in increased collagen production and hence a more pronounced fibrosis in response to dimethylnitrosamine in mice. Exclusive deletion of fibronectin in hepatocytes or normalization of circulating fibronectin in Mx-cKO mice did not affect the development of fibrosis suggesting a role for fibronectin production by other liver cell types. The boosted fibrosis in fibronectin-deficient mice was associated with enhanced stellate cell activation and proliferation, elevated concentrations of active TGF-beta, and increased TGF-beta-mediated signaling. In vitro experiments revealed that collagen-type-I production by fibronectin-deficient hepatic stellate cells stimulated with TGF-beta was more pronounced, and was associated with augmented Smad3-mediated signaling. Interfering with TGF-beta signaling using SB431542 normalized collagen-type-I production in fibronectin-deficient hepatic stellate cells. Furthermore, precoating culture plates with fibronectin, but not collagen, or providing fibronectin fibrils unable to interact with RGD binding integrins via the RGD domain significantly diminished the amount of active TGF-beta in fibronectin-deficient stellate cells and normalized collagen-type-I production in response to TGF-beta stimulation. Thus, excessive stellate cell activation and production of collagen results from increased active TGF-beta and TGF-beta signaling in the absence of fibronectin. In conclusion, our data indicate that fibronectin controls the availability of active TGF-beta in the injured liver, which impacts the severity of the resulting fibrosis. We therefore propose a novel role for locally produced fibronectin in protecting the liver from an excessive TGF-beta-mediated response.	[Kawelke, Nina; Vasel, Matthaeus; Sens, Carla; von Au, Anja; Nakchbandi, Inaam A.] Max Planck Inst Biochem, D-82152 Martinsried, Germany; [Kawelke, Nina; Vasel, Matthaeus; Sens, Carla; von Au, Anja; Nakchbandi, Inaam A.] Univ Heidelberg, Inst Immunol, D-6900 Heidelberg, Germany; [Dooley, Steven] Univ Heidelberg, Dept Med 2, D-6800 Mannheim, Germany	Max Planck Society; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Kawelke, N (corresponding author), Max Planck Inst Biochem, Klopferspitz 18A, D-82152 Martinsried, Germany.	inaam.nakchbandi@urz.uni-heidelberg.de	Dooley, Steven/T-6491-2018	Dooley, Steven/0000-0002-4840-6240	Max-Planck Society; University of Heidelberg	Max-Planck Society(Max Planck Society); University of Heidelberg	This work was funded by the Max-Planck Society and the University of Heidelberg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE M, 1994, ANAL BIOCHEM, V216, P276, DOI 10.1006/abio.1994.1042; Akiyama SK., 2001, CURR PROTOC CELL BIO; Bentmann A, 2010, J BONE MINER RES, V25, P706, DOI 10.1359/jbmr.091011; BERG RA, 1982, METHOD ENZYMOL, V82, P372; Constandinou C, 2005, METH MOLEC MED, V117, P237; Dallas SL, 2005, J BIOL CHEM, V280, P18871, DOI 10.1074/jbc.M410762200; Fontana L, 2005, FASEB J, V19, P1798, DOI 10.1096/fj.05-4134com; Fukuda T, 2002, CANCER RES, V62, P5603; Geerts A, 1998, HEPATOLOGY, V27, P590, DOI 10.1002/hep.510270238; Hackl N, 2009, CIRCULATING FI UNPUB; Hackl NJ, 2010, SCAND J GASTROENTERO, V45, P349, DOI 10.3109/00365520903490606; Inagaki Y, 2007, GUT, V56, P284, DOI 10.1136/gut.2005.088690; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; JARNAGIN WR, 1994, J CELL BIOL, V127, P2037, DOI 10.1083/jcb.127.6.2037; Kawelke N, 2008, J BONE MINER RES, V23, P1278, DOI 10.1359/JBMR.080313; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Liao YF, 2002, J BIOL CHEM, V277, P14467, DOI 10.1074/jbc.M201100200; Liu W, 2011, PROTEOMICS, V11, P3556, DOI 10.1002/pmic.201100157; Manabe R, 1997, J CELL BIOL, V139, P295, DOI 10.1083/jcb.139.1.295; Manabe R, 1999, J BIOL CHEM, V274, P5919, DOI 10.1074/jbc.274.9.5919; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Matsui S, 1997, J HEPATOL, V27, P843, DOI 10.1016/S0168-8278(97)80322-4; MATSUURA H, 1985, P NATL ACAD SCI USA, V82, P6517, DOI 10.1073/pnas.82.19.6517; Moreira RK, 2007, ARCH PATHOL LAB MED, V131, P1728; Moretti FA, 2007, J BIOL CHEM, V282, P28057, DOI 10.1074/jbc.M611315200; Moriya K, 2011, GASTROENTEROLOGY, V140, P1653, DOI 10.1053/j.gastro.2011.02.005; Ni HY, 2003, P NATL ACAD SCI USA, V100, P2415, DOI 10.1073/pnas.2628067100; Niki T, 1996, HEPATOLOGY, V23, P1538, DOI 10.1053/jhep.1996.v23.pm0008675175; Parsons CJ, 2007, J GASTROEN HEPATOL, V22, pS79, DOI 10.1111/j.1440-1746.2006.04659.x; PRITCHARD DJ, 1989, J PATHOL, V158, P253, DOI 10.1002/path.1711580314; PUCHTLER H, 1973, BEITR PATHOL, V150, P174, DOI 10.1016/S0005-8165(73)80016-2; Sakai T, 2001, NAT MED, V7, P324, DOI 10.1038/85471; Serini G, 1998, J CELL BIOL, V142, P873, DOI 10.1083/jcb.142.3.873; Sottile J, 2002, MOL BIOL CELL, V13, P3546, DOI 10.1091/mbc.E02-01-0048; STEGEMANN H, 1958, H-S Z PHYSIOL CHEM, V311, P41, DOI 10.1515/bchm2.1958.311.1.41; Takahashi S, 2007, J CELL BIOL, V178, P167, DOI 10.1083/jcb.200703021; ten Dijke P, 2004, TRENDS BIOCHEM SCI, V29, P265, DOI 10.1016/j.tibs.2004.03.008; Theret N, 1999, HEPATOLOGY, V30, P462, DOI 10.1002/hep.510300236; Velling T, 2002, J BIOL CHEM, V277, P37377, DOI 10.1074/jbc.M206286200; Wu J, 2000, J GASTROENTEROL, V35, P665, DOI 10.1007/s005350070045; Xu GX, 1997, J PATHOL, V183, P90, DOI 10.1002/(SICI)1096-9896(199709)183:1<90::AID-PATH1105>3.0.CO;2-J; YAMAOKA K, 1993, DIGEST DIS SCI, V38, P1473, DOI 10.1007/BF01308606; Yoshida T, 2004, J EXP MED, V199, P1701, DOI 10.1084/jem.20031675; ZHANG ZH, 1995, P NATL ACAD SCI USA, V92, P6161, DOI 10.1073/pnas.92.13.6161	44	60	61	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2011	6	11							e28181	10.1371/journal.pone.0028181	http://dx.doi.org/10.1371/journal.pone.0028181			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KW	22140539	Green Published, gold, Green Submitted			2022-12-27	WOS:000298163400036
J	van Westen, GJP; Wegner, JK; Geluykens, P; Kwanten, L; Vereycken, I; Peeters, A; IJzerman, AP; van Vlijmen, HWT; Bender, A				van Westen, Gerard J. P.; Wegner, Jorg K.; Geluykens, Peggy; Kwanten, Leen; Vereycken, Inge; Peeters, Anik; IJzerman, Adriaan P.; van Vlijmen, Herman W. T.; Bender, Andreas			Which Compound to Select in Lead Optimization? Prospectively Validated Proteochemometric Models Guide Preclinical Development	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; REVERSE-TRANSCRIPTASE INHIBITOR; HIV-1 DRUG-RESISTANCE; DRUGGABLE GENOME; ANTIRETROVIRAL THERAPY; MULTIPLE LIGANDS; ACTIVITY-CLIFFS; BINDING-SITE; SIMILARITY; MUTATIONS	In quite a few diseases, drug resistance due to target variability poses a serious problem in pharmacotherapy. This is certainly true for HIV, and hence, it is often unknown which drug is best to use or to develop against an individual HIV strain. In this work we applied 'proteochemometric' modeling of HIV Non-Nucleoside Reverse Transcriptase (NNRTI) inhibitors to support preclinical development by predicting compound performance on multiple mutants in the lead selection stage. Proteochemometric models are based on both small molecule and target properties and can thus capture multi-target activity relationships simultaneously, the targets in this case being a set of 14 HIV Reverse Transcriptase (RT) mutants. We validated our model by experimentally confirming model predictions for 317 untested compound -mutant pairs, with a prediction error comparable with assay variability (RMSE 0.62). Furthermore, dependent on the similarity of a new mutant to the training set, we could predict with high accuracy which compound will be most effective on a sequence with a previously unknown genotype. Hence, our models allow the evaluation of compound performance on untested sequences and the selection of the most promising leads for further preclinical research. The modeling concept is likely to be applicable also to other target families with genetic variability like other viruses or bacteria, or with similar orthologs like GPCRs.	[van Westen, Gerard J. P.; IJzerman, Adriaan P.; van Vlijmen, Herman W. T.; Bender, Andreas] Leiden Amsterdam Ctr Drug Res, Div Med Chem, Leiden, Netherlands; [Wegner, Jorg K.; Geluykens, Peggy; Kwanten, Leen; Vereycken, Inge; Peeters, Anik; van Vlijmen, Herman W. T.] Tibotec BVBA, Beerse, Belgium; [Bender, Andreas] Univ Cambridge, Unilever Ctr Mol Sci Informat, Cambridge, England	Leiden University; Leiden University - Excl LUMC; Johnson & Johnson; University of Cambridge	van Westen, GJP (corresponding author), Leiden Amsterdam Ctr Drug Res, Div Med Chem, Leiden, Netherlands.	ab454@cam.ac.uk	van Westen, Gerard/HHZ-3762-2022; Bender, Andreas/C-6942-2009; van Westen, Gerard JP/D-7432-2011; IJzerman, Ad/ABG-1353-2020; Wegner, Jörg K/C-6598-2009	Bender, Andreas/0000-0002-6683-7546; van Westen, Gerard JP/0000-0003-0717-1817; IJzerman, Ad/0000-0002-1182-2259; Wegner, Jörg K/0000-0002-1852-9434	Tibotec; Dutch Top Institute Pharma (TI Pharma) [D1-105]; Tibotec BVBA; JKW; PG; LK; IV; AP; HWTvV	Tibotec; Dutch Top Institute Pharma (TI Pharma); Tibotec BVBA; JKW; PG(Procter & Gamble); LK; IV; AP; HWTvV	GJPvW is a PhD student funded by Tibotec whose role involved contributing to the experimental data, validation of the results, and providing scientific input into the design of the study (such as the improvement of modeling methods). The performing of the data analysis, and the decision to publish was not influenced in any way by the funders. The authors' collaborators from Tibotec helped in the preparation of the manuscript, however, no situation occurred where the academic partners of the team were not able to publish what was desired. AB and API received funding from Dutch Top Institute Pharma (TI Pharma), project number D1-105, who had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: The Non-Nucleoside Reverse Transcriptase Inhibitiros Etravirine and Rilpivirine are marketed drugs developed by Tibotec, one of the funders of the current study. GJPvW was funded by Tibotec BVBA and JKW, PG, LK, IV, AP and HWTvV are employees of this company. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Ahmed SNS, 2000, HEPATOLOGY, V32, P1078, DOI 10.1053/jhep.2000.19619; Altmann A, 2009, ANTIVIR THER, V14, P273; Altmann A, 2009, J INFECT DIS, V199, P999, DOI 10.1086/597305; Andries K, 2004, ANTIMICROB AGENTS CH, V48, P4680, DOI 10.1128/AAC.48.12.4680-4686.2004; [Anonymous], 1998, NUMBERING POSITIONS; Beerenwinkel N, 2002, P NATL ACAD SCI USA, V99, P8271, DOI 10.1073/pnas.112177799; Beerenwinkel N, 2003, BIOINFORMATICS, V19, pI16, DOI 10.1093/bioinformatics/btg1001; Bender A, 2004, J CHEM INF COMP SCI, V44, P1708, DOI 10.1021/ci0498719; Bender A, 2004, ORG BIOMOL CHEM, V2, P3204, DOI 10.1039/b409813g; Bender A, 2009, J CHEM INF MODEL, V49, P108, DOI 10.1021/ci800249s; Das K, 2008, P NATL ACAD SCI USA, V105, P1466, DOI 10.1073/pnas.0711209105; de Jong MD, 2005, NEW ENGL J MED, V353, P2667, DOI 10.1056/NEJMoa054512; Dimitriadou E, 2006, MISC FUNCTION DEP ST; Eriksson L, 2003, ENVIRON HEALTH PERSP, V111, P1361, DOI 10.1289/ehp.5758; Faulon JL, 2010, CH CRC MATH COMP BIO, P1, DOI 10.1201/9781420082999; Frazer KA, 2009, NAT REV GENET, V10, P241, DOI 10.1038/nrg2554; Garland SL, 2011, CURR TOP MED CHEM, V11, P1870; Glen RC, 2006, IDRUGS, V9, P199; Guha R, 2008, J CHEM INF MODEL, V48, P646, DOI 10.1021/ci7004093; Guillemont J.E.G., 2008, Preparation of HIV inhibiting 5,6-substituted pyrimidines, Patent No. [WO2008080965, 2008080965]; Guillemont JEG, 2007, HIV INHIBITING 5 HYD; Guillemont JEG, 2008, HIV INHIBITING 6 SUB; Guillemont JEG, 2007, HIV INHIBITING 5 AMI; Hambly K, 2006, MOL DIVERS, V10, P273, DOI 10.1007/s11030-006-9035-3; Havlir DV, 1996, J VIROL, V70, P7894, DOI 10.1128/JVI.70.11.7894-7899.1996; Hertogs K, 1998, ANTIMICROB AGENTS CH, V42, P269, DOI 10.1093/jac/42.2.269; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Horvath D, 2009, J CHEM INF MODEL, V49, P1762, DOI 10.1021/ci9000579; Jacoby E, 2006, CHEMOGENEOMICS: KNOWLEDGE-BASED APPROACHES TO DRUG DISCOVERY, P1, DOI 10.1142/9781860948114; Jensen BF, 2007, J MED CHEM, V50, P501, DOI 10.1021/jm060333s; Johnson M. A., 1990, CONCEPTS APPL MOL SI; Johnson Victoria A, 2010, Top HIV Med, V18, P156; Kawashima S, 1999, NUCLEIC ACIDS RES, V27, P368, DOI 10.1093/nar/27.1.368; Lapins M, 2009, J CHEM INF MODEL, V49, P1202, DOI 10.1021/ci800453k; Lapinsh M, 2001, BBA-GEN SUBJECTS, V1525, P180, DOI 10.1016/S0304-4165(00)00187-2; Mancinelli L, 2002, AAPS J, V2, P29; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Medina-Franco JL, 2009, J CHEM INF MODEL, V49, P477, DOI 10.1021/ci800379q; MERLUZZI VJ, 1990, SCIENCE, V250, P1411, DOI 10.1126/science.1701568; Meslamani J, 2011, J CHEM INF MODEL, V51, P1593, DOI 10.1021/ci200166t; Morphy R, 2005, J MED CHEM, V48, P6523, DOI 10.1021/jm058225d; Morphy R, 2007, DRUG DISCOV TODAY, V12, P156, DOI 10.1016/j.drudis.2006.12.006; Moscona A, 2009, NEW ENGL J MED, V360, P953, DOI 10.1056/NEJMp0900648; Patterson DE, 1996, J MED CHEM, V39, P3049, DOI 10.1021/jm960290n; Pawlotsky JM, 1998, J VIROL, V72, P2795, DOI 10.1128/JVI.72.4.2795-2805.1998; REN JS, 1995, NAT STRUCT BIOL, V2, P293, DOI 10.1038/nsb0495-293; RICHMAN DD, 1994, J VIROL, V68, P1660, DOI 10.1128/JVI.68.3.1660-1666.1994; Rogers D, 2010, J CHEM INF MODEL, V50, P742, DOI 10.1021/ci100050t; Russ AP, 2005, DRUG DISCOV TODAY, V10, P1607, DOI 10.1016/S1359-6446(05)03666-4; Scitegic Accelrys Software Inc, 2007, PIP PILOT STUD EDIT; Sisay MT, 2009, J CHEM INF MODEL, V49, P2179, DOI 10.1021/ci900243a; Tropsha A, 2003, QSAR COMB SCI, V22, P69, DOI 10.1002/qsar.200390007; van Westen GJP, 2011, MEDCHEMCOMM, V2, P16, DOI 10.1039/c0md00165a; Vapnik V., 2013, NATURE STAT LAERNING; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Vermeiren H, 2007, J VIROL METHODS, V145, P47, DOI 10.1016/j.jviromet.2007.05.009; Wang CL, 2007, GENOME RES, V17, P1195, DOI 10.1101/gr.6468307; Woodcock J, 2007, CLIN PHARMACOL THER, V81, P164, DOI 10.1038/sj.clpt.6100063; WU JC, 1991, BIOCHEMISTRY-US, V30, P2022, DOI 10.1021/bi00222a003; YOUNG SD, 1995, ANTIMICROB AGENTS CH, V39, P2602, DOI 10.1128/AAC.39.12.2602	60	42	44	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e27518	10.1371/journal.pone.0027518	http://dx.doi.org/10.1371/journal.pone.0027518			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132107	Green Published, gold, Green Submitted			2022-12-27	WOS:000298162000023
J	Westereng, B; Ishida, T; Vaaje-Kolstad, G; Wu, M; Eijsink, VGH; Igarashi, K; Samejima, M; Stahlberg, J; Horn, SJ; Sandgren, M				Westereng, Bjorge; Ishida, Takuya; Vaaje-Kolstad, Gustav; Wu, Miao; Eijsink, Vincent G. H.; Igarashi, Kiyohiko; Samejima, Masahiro; Stahlberg, Jerry; Horn, Svein J.; Sandgren, Mats			The Putative Endoglucanase PcGH61D from Phanerochaete chrysosporium Is a Metal-Dependent Oxidative Enzyme that Cleaves Cellulose	PLOS ONE			English	Article							GLYCOSIDE HYDROLASE FAMILY; CELLOBIOSE DEHYDROGENASE	Many fungi growing on plant biomass produce proteins currently classified as glycoside hydrolase family 61 (GH61), some of which are known to act synergistically with cellulases. In this study we show that PcGH61D, the gene product of an open reading frame in the genome of Phanerochaete chrysosporium, is an enzyme that cleaves cellulose using a metal-dependent oxidative mechanism that leads to generation of aldonic acids. The activity of this enzyme and its beneficial effect on the efficiency of classical cellulases are stimulated by the presence of electron donors. Experiments with reduced cellulose confirmed the oxidative nature of the reaction catalyzed by PcGH61D and indicated that the enzyme may be capable of penetrating into the substrate. Considering the abundance of GH61-encoding genes in fungi and genes encoding their functional bacterial homologues currently classified as carbohydrate binding modules family 33 (CBM33), this enzyme activity is likely to turn out as a major determinant of microbial biomass-degrading efficiency.	[Westereng, Bjorge; Vaaje-Kolstad, Gustav; Eijsink, Vincent G. H.; Horn, Svein J.] Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, As, Norway; [Ishida, Takuya; Igarashi, Kiyohiko; Samejima, Masahiro] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biomat Sci, Tokyo, Japan; [Ishida, Takuya; Wu, Miao; Stahlberg, Jerry; Sandgren, Mats] Swedish Univ Agr Sci, Dept Mol Biol, Uppsala, Sweden	Norwegian University of Life Sciences; University of Tokyo; Swedish University of Agricultural Sciences	Westereng, B (corresponding author), Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, As, Norway.	svein.horn@umb.no; mats.sandgren@slu.se	Igarashi, Kiyohiko/E-6799-2016; Horn, Svein Jarle/C-6258-2008; Westereng, Bjørge/A-1688-2013; Stahlberg, Jerry/D-4163-2013	Igarashi, Kiyohiko/0000-0001-5152-7177; Horn, Svein Jarle/0000-0002-1590-9001; Westereng, Bjørge/0000-0002-5141-7231; Stahlberg, Jerry/0000-0003-4059-8580; Sandgren, Mats/0000-0002-2358-4534; Vaaje-Kolstad, Gustav/0000-0002-3077-8003	internal university and faculty money; Norwegian Research Council [186946, 190965, 193817, 196885]	internal university and faculty money; Norwegian Research Council(Research Council of NorwayEuropean Commission)	The majority of the research work described in the paper was funded by internal university and faculty money granted to the participating research groups. This work was also partly supported by the Norwegian Research Council, grants 186946, 190965, 193817 and 196885. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armougom F, 2006, NUCLEIC ACIDS RES, V34, pW604, DOI 10.1093/nar/gkl092; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; DOMON B, 1988, BIOCHEMISTRY-US, V27, P1534, DOI 10.1021/bi00405a021; Eastwood DC, 2011, SCIENCE, V333, P762, DOI 10.1126/science.1205411; Eijsink VGH, 2008, TRENDS BIOTECHNOL, V26, P228, DOI 10.1016/j.tibtech.2008.02.004; Foreman PK, 2003, J BIOL CHEM, V278, P31988, DOI 10.1074/jbc.M304750200; Forsberg Z, 2011, PROTEIN SCI, V20, P1479, DOI 10.1002/pro.689; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Harris PV, 2010, BIOCHEMISTRY-US, V49, P3305, DOI 10.1021/bi100009p; Herpoel-Gimbert I, 2008, BIOTECHNOL BIOFUELS, V1, DOI 10.1186/1754-6834-1-18; Hori C, 2011, FEMS MICROBIOL LETT, V321, P14, DOI 10.1111/j.1574-6968.2011.02307.x; Igarashi K, 2005, FEBS J, V272, P2869, DOI 10.1111/j.1742-4658.2005.04707.x; Igarashi K, 2008, APPL ENVIRON MICROB, V74, P5628, DOI 10.1128/AEM.00812-08; JOHNSRUD SC, 1985, APPL MICROBIOL BIOT, V21, P320; Karkehabadi S, 2008, J MOL BIOL, V383, P144, DOI 10.1016/j.jmb.2008.08.016; Karlsson J, 2001, EUR J BIOCHEM, V268, P6498, DOI 10.1046/j.0014-2956.2001.02605.x; Kawai R, 2003, BIOSCI BIOTECH BIOCH, V67, P1, DOI 10.1271/bbb.67.1; KREMER SM, 1992, EUR J BIOCHEM, V208, P807, DOI 10.1111/j.1432-1033.1992.tb17251.x; Langston JA, 2011, APPL ENVIRON MICROB, V77, P7007, DOI 10.1128/AEM.05815-11; Merino ST, 2007, ADV BIOCHEM ENG BIOT, V108, P95, DOI 10.1007/10_2007_066; Quinlan RJ, 2011, P NATL ACAD SCI USA, V108, P15079, DOI 10.1073/pnas.1105776108; RAGUZ S, 1992, GENE, V119, P183, DOI 10.1016/0378-1119(92)90270-Y; REESE ET, 1950, J BACTERIOL, V59, P485, DOI 10.1128/JB.59.4.485-497.1950; Vaaje-Kolstad G, 2005, J BIOL CHEM, V280, P28492, DOI 10.1074/jbc.M504468200; Vaaje-Kolstad G, 2010, SCIENCE, V330, P219, DOI 10.1126/science.1192231; Vanden Wymelenberg A, 2005, J BIOTECHNOL, V118, P17, DOI 10.1016/j.jbiotec.2005.03.010; Vanden Wymelenberg A, 2002, APPL ENVIRON MICROB, V68, P5765, DOI 10.1128/AEM.68.11.5765-5768.2002; Vanden Wymelenberg A, 2006, FUNGAL GENET BIOL, V43, P343, DOI 10.1016/j.fgb.2006.01.003; Vanden Wymelenberg A, 2009, APPL ENVIRON MICROB, V75, P4058, DOI 10.1128/AEM.00314-09; WOOD TM, 1988, METHOD ENZYMOL, V160, P19; Yoshida M, 2002, FEMS MICROBIOL LETT, V217, P225, DOI 10.1111/j.1574-6968.2002.tb11479.x; Zhang YHP, 2005, BIOMACROMOLECULES, V6, P1510, DOI 10.1021/bm049235j; Zoia L, 2011, J AGR FOOD CHEM, V59, P829, DOI 10.1021/jf103615e	35	196	206	0	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e27807	10.1371/journal.pone.0027807	http://dx.doi.org/10.1371/journal.pone.0027807			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132148	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000298162000045
J	Miller, JP; Krueger, S; Heys, JJ; Gedeon, T				Miller, John P.; Krueger, Susan; Heys, Jeffrey J.; Gedeon, Tomas			Quantitative Characterization of the Filiform Mechanosensory Hair Array on the Cricket Cercus	PLOS ONE			English	Article							INFORMATION-THEORETIC ANALYSIS; GIANT INTERNEURON SYSTEM; WIND-RECEPTOR HAIRS; SENSORY SYSTEM; RANGE FRACTIONATION; RESPONSE PROPERTIES; ACHETA-DOMESTICUS; MORPHOLOGY; PHYSIOLOGY; MECHANORECEPTORS	Background: Crickets and other orthopteran insects sense air currents with a pair of abdominal appendages resembling antennae, called cerci. Each cercus in the common house cricket Acheta domesticus is approximately 1 cm long, and is covered with 500 to 750 filiform mechanosensory hairs. The distribution of the hairs on the cerci, as well as the global patterns of their movement vectors, have been characterized semi-quantitatively in studies over the last 40 years, and have been shown to be very stereotypical across different animals in this species. Although the cercal sensory system has been the focus of many studies in the areas of neuroethology, development, biomechanics, sensory function and neural coding, there has not yet been a quantitative study of the functional morphology of the receptor array of this important model system. Methodology/Principal Findings: We present a quantitative characterization of the structural characteristics and functional morphology of the cercal filiform hair array. We demonstrate that the excitatory direction along each hair's movement plane can be identified by features of its socket that are visible at the light-microscopic level, and that the length of the hair associated with each socket can also be estimated accurately from a structural parameter of the socket. We characterize the length and directionality of all hairs on the basal half of a sample of three cerci, and present statistical analyses of the distributions. Conclusions/Significance: The inter-animal variation of several global organizational features is low, consistent with constraints imposed by functional effectiveness and/or developmental processes. Contrary to previous reports, however, we show that the filiform hairs are not re-identifiable in the strict sense.	[Miller, John P.; Krueger, Susan; Heys, Jeffrey J.; Gedeon, Tomas] Montana State Univ, Ctr Computat Biol, Bozeman, MT 59717 USA; [Gedeon, Tomas] Montana State Univ, Dept Math, Bozeman, MT 59717 USA	Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman	Miller, JP (corresponding author), Montana State Univ, Ctr Computat Biol, Bozeman, MT 59717 USA.	jpmillerusa@gmail.com	Miller, John J/GZG-5663-2022		National Science Foundation (NSF) [CMMI-0849433]; National Institutes of Health (NIH) [R01 MH-064416-06]; Direct For Mathematical & Physical Scien [0818785] Funding Source: National Science Foundation; Directorate For Engineering [0849433] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064416] Funding Source: NIH RePORTER	National Science Foundation (NSF)(National Science Foundation (NSF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The study was financially supported by National Science Foundation (NSF) grant CMMI-0849433 and National Institutes of Health (NIH) grant R01 MH-064416-06. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BACON JP, 1984, J PHYSIOL-LONDON, V352, P601, DOI 10.1113/jphysiol.1984.sp015312; BISCHOF HJ, 1975, J COMP PHYSIOL, V98, P277, DOI 10.1007/BF00656974; Casas J, 2010, ANNU REV ENTOMOL, V55, P505, DOI 10.1146/annurev-ento-112408-085342; CHIBA A, 1992, J EXP BIOL, V164, P205; CUMMINS B, 2011, FRONTIERS S IN PRESS; Cummins B, 2007, J THEOR BIOL, V247, P266, DOI 10.1016/j.jtbi.2007.02.003; Dangles O, 2006, J EXP BIOL, V209, P4363, DOI 10.1242/jeb.02485; Dangles O, 2006, J EXP BIOL, V209, P393, DOI 10.1242/jeb.02000; Dangles O, 2005, J EXP BIOL, V208, P461, DOI 10.1242/jeb.01369; Dangles O, 2008, J COMP PHYSIOL A, V194, P653, DOI 10.1007/s00359-008-0339-x; DUMPERT K, 1977, J COMP PHYSIOL, V122, P9, DOI 10.1007/BF00611245; EDWARDS JS, 1974, PROC R SOC SER B-BIO, V185, P83, DOI 10.1098/rspb.1974.0007; GNATZY W, 1980, CELL TISSUE RES, V213, P441; GNATZY W, 1978, CELL TISSUE RES, V187, P1; GODDE J, 1983, THESIS WESTFALISCHEW; HEILIGENBERG W, 1987, J COMP PHYSIOL A, V161, P621, DOI 10.1007/BF00603665; Heys JJ, 2008, J BIOMECH, V41, P977, DOI 10.1016/j.jbiomech.2007.12.015; HUMPHREY JAC, 1993, PHILOS T R SOC B, V340, P423, DOI 10.1098/rstb.1993.0083; Jacobs GA, 2008, J EXP BIOL, V211, P1819, DOI 10.1242/jeb.016402; KAMPER G, 1990, J COMP PHYSIOL A, V167, P193, DOI 10.1007/BF00188111; Keil T.A., 1984, P477; Keil TA, 1997, MICROSC RES TECHNIQ, V39, P506, DOI 10.1002/(SICI)1097-0029(19971215)39:6<506::AID-JEMT5>3.0.CO;2-B; Kumagai T, 1998, J COMP PHYSIOL A, V183, P187, DOI 10.1007/s003590050246; LANDOLFA MA, 1995, J COMP PHYSIOL A, V177, P749; LANDOLFA MA, 1995, J COMP PHYSIOL A, V177, P759; Magal C, 2006, J THEOR BIOL, V241, P459, DOI 10.1016/j.jtbi.2005.12.009; Mulder-Rosi J, 2010, J NEUROPHYSIOL, V103, P1823, DOI 10.1152/jn.00875.2009; MURPHEY RK, 1980, J COMP NEUROL, V191, P53, DOI 10.1002/cne.901910103; MURPHEY RK, 1981, DEV BIOL, V88, P236, DOI 10.1016/0012-1606(81)90167-6; PALKA J, 1977, J COMP PHYSIOL, V119, P267, DOI 10.1007/BF00656638; PALKA J, 1977, J COMP PHYSIOL, V119, P301, DOI 10.1007/BF00656640; Rasband W.S., 1997, IMAGEJ; Roddey JC, 1996, J NEUROPHYSIOL, V75, P1365, DOI 10.1152/jn.1996.75.4.1365; SAKAGUCHI DS, 1983, J COMP PHYSIOL, V150, P141, DOI 10.1007/BF00606364; Shimozawa T, 1998, J COMP PHYSIOL A, V183, P171, DOI 10.1007/s003590050245; SHIMOZAWA T, 1984, J COMP PHYSIOL, V155, P485, DOI 10.1007/BF00611913; SHIMOZAWA T, 1984, J COMP PHYSIOL, V155, P495, DOI 10.1007/BF00611914; Steinmann T, 2006, J EXP BIOL, V209, P4398, DOI 10.1242/jeb.02506; STERN C, 1954, AM SCI, V42, P212; Theunissen F, 1996, J NEUROPHYSIOL, V75, P1345, DOI 10.1152/jn.1996.75.4.1345; THEUNISSEN FE, 1991, J NEUROPHYSIOL, V66, P1690, DOI 10.1152/jn.1991.66.5.1690; THURM U, 1983, J SUBMICR CYTOL PATH, V15, P151; TOBIAS M, 1979, J COMP PHYSIOL, V129, P51, DOI 10.1007/BF00679911; WALTHALL WW, 1986, DEV BIOL, V113, P182, DOI 10.1016/0012-1606(86)90121-1	44	28	28	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2011	6	11							e27873	10.1371/journal.pone.0027873	http://dx.doi.org/10.1371/journal.pone.0027873			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IO	22132155	gold, Green Published, Green Submitted			2022-12-27	WOS:000297789900026
J	Pujades-Rodriguez, M; Dantony, E; Pinoges, L; Ecochard, R; Etard, JF; Carrillo-Casas, E; Szumilin, E				Pujades-Rodriguez, Mar; Dantony, Emmanuelle; Pinoges, Loretxu; Ecochard, Rene; Etard, Jean-Francois; Carrillo-Casas, Esther; Szumilin, Elisabeth		AIDS Working Grp Med Sans	Toxicity Associated with Stavudine Dose Reduction from 40 to 30 mg in First-Line Antiretroviral Therapy	PLOS ONE			English	Article							DISTAL SENSORY POLYNEUROPATHY; BODY-COMPOSITION; HIV-INFECTION; RISK-FACTORS; NEUROPATHY; LIPODYSTROPHY; TENOFOVIR; REGIMENS; COHORT; TRIAL	Background: To compare the incidence and timing of toxicity associated with the use of a reduced dose of stavudine from 40 to 30 mg in first-line antiretroviral therapy (ART) for HIV treatment and to investigate associated risk factors. Methods: Multicohort study including 23 HIV programs in resource-limited countries. Adults enrolled between January 2005 and December 2009. Four-year rates of all-cause and stavudine-specific toxicity were estimated. Multilevel mixed-effect Poisson and accelerated failure models were used to investigate factors associated with toxicity and timing of diagnosis. Findings: A total of 48,785 patients contributed 62,505 person-years of follow-up. Rate of all-cause toxicity was 7.80 (95%CI 7.59-8.03) per 100 person-years, but varied greatly across sites (range 0.41-21.76). Patients treated with stavudine 40 mg had higher rates of toxicity (adjusted rate ratio [aRR] 1.18, 95%CI 1.06-1.30 during the first year of ART; and 1.51, 95%CI 1.32-1.71 during the second year). Women, older age, initial advanced clinical stage, and low CD4 count were associated with increased toxicity rate ratios. Timing of lipodystrophy and peripheral neuropathy diagnosis were 12% and 13% shorter, respectively, in patients treated with stavudine 40 mg than in those receiving 30 mg stavudine dose (P = 0.03 and 0.07, respectively). Insterpretation: Higher rates of drug-related toxicity were reported in patients receiving stavudine 40 mg compared with 30 mg, and the time to toxicity diagnosis was shorter in patients treated with the higher dose. Higher rates of toxicity were observed during the first two years of ART.	[Pujades-Rodriguez, Mar; Pinoges, Loretxu; Etard, Jean-Francois] Epictr, Dept Clin Res, Paris, France; [Dantony, Emmanuelle; Ecochard, Rene] Hosp Civils Lyon, Serv Biostat, Lyon, France; [Dantony, Emmanuelle; Ecochard, Rene] Ctr Natl Rech Sci, Unite Mixte Rech 5558, Villeurbanne, France; [Dantony, Emmanuelle; Ecochard, Rene] Univ Lyon, Serv Biostat, Lyon, France; [Etard, Jean-Francois] Inst Rech Dev, Unite Mixte Int 233, Montpellier, France; [Carrillo-Casas, Esther] MSF AIDS Working Grp, Dept Med, Amsterdam, Netherlands; [Szumilin, Elisabeth] MSF AIDS Working Grp, Dept Med, Paris, France	CHU Lyon; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); VetAgro Sup; Institut de Recherche pour le Developpement (IRD); Doctors Without Borders; Doctors Without Borders; Sanofi-Aventis; Sanofi France	Pujades-Rodriguez, M (corresponding author), Epictr, Dept Clin Res, Paris, France.	mar.pujades@epicentre.msf.org	Pujades-Rodriguez, Mar/G-4388-2014; Pujades-Rodriguez, Mar/T-1129-2018; Etard, Jean François/A-9630-2008; Etard, Jean-Francois/V-4865-2019	Pujades-Rodriguez, Mar/0000-0002-7778-3520; Pujades-Rodriguez, Mar/0000-0002-1375-1028; Etard, Jean François/0000-0002-4873-0788; Etard, Jean-Francois/0000-0002-4873-0788; Dantony, Emmanuelle/0000-0001-5143-0666	World Health Organization through the Gates Foundation pharmacovigilance initiative; Medecins Sans Frontieres (MSF); MSF AIDS Working Group	World Health Organization through the Gates Foundation pharmacovigilance initiative; Medecins Sans Frontieres (MSF); MSF AIDS Working Group	Funding to perform this work was given by the World Health Organization through the Gates Foundation pharmacovigilance initiative, and Medecins Sans Frontieres (MSF). The World Health Organization and the Gates Foundation had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. MSF staff participated in data collection (through their work in routine projects in collaboration with the Ministry of Health) and preparation of the manuscript (ECC and ES are members of the medical department of MSF). The other authors work for Epicentre, which is a non-profit organisation created by MSF to conduct operational research/evaluations in MSF-supported projects to improve the quality of care provided and evaluate activities/strategies.; The authors thank Micheline Diepart, Chris Duncombe and Marco Vitoria from the World Health Organization for their support to this work; the ministries of health of the countries and the MSF field teams for their daily work and effort to provide care to the patients and for data collection; the members of the MSF AIDS Working Group for their advice and support; and the Epicentre FUCHIA team for their support in data collection and data quality maintenance. We also thank Oliver Yun for his editorial work.	Ait-Mohand H, 2008, HIV MED, V9, P738, DOI 10.1111/j.1468-1293.2008.00616.x; ANDERSON RE, 1995, J INFECT DIS, V171, pS118, DOI 10.1093/infdis/171.Supplement_2.S118; Boulassel MR, 2006, J MED VIROL, V78, P1158, DOI 10.1002/jmv.20676; BROWNE MJ, 1993, J INFECT DIS, V167, P21, DOI 10.1093/infdis/167.1.21; Childs EA, 1999, NEUROLOGY, V52, P607, DOI 10.1212/WNL.52.3.607; Evans SR, 2011, AIDS, V25, P919, DOI 10.1097/QAD.0b013e328345889d; HANVANICH M, 2003, ANTIVIR THER, V8; Hill A, 2007, EXPERT OPIN PHARMACO, V8, P679, DOI 10.1517/14656566.8.5.679; Keswani SC, 2002, AIDS, V16, P2105, DOI 10.1097/00002030-200211080-00002; Lichtenstein KA, 2005, CLIN INFECT DIS, V40, P148, DOI 10.1086/426076; Lopez OL, 2004, EUR J NEUROL, V11, P97, DOI 10.1046/j.1351-5101.2003.00713.x; McComsey GA, 2008, CLIN INFECT DIS, V46, P1290, DOI 10.1086/529384; Mercier S, 2009, JAIDS-J ACQ IMM DEF, V51, P224, DOI 10.1097/QAI.0b013e31819c16f4; Milinkovic A, 2007, ANTIVIR THER, V12, P407; Nolan D, 2003, AIDS, V17, P1329, DOI 10.1097/00002030-200306130-00007; PETERSEN EA, 1995, J INFECT DIS, V171, pS131, DOI 10.1093/infdis/171.Supplement_2.S131; Pujades-Rodriguez M, 2010, JAMA-J AM MED ASSOC, V304, P303, DOI 10.1001/jama.2010.980; Pujari SN, 2005, JAIDS-J ACQ IMM DEF, V39, P199; RIBERA E, 2011, RANDOMIZED STUDY COM; Robinson-Papp J, 2010, PAIN, V151, P732, DOI 10.1016/j.pain.2010.08.045; Rosen S, 2008, JAIDS-J ACQ IMM DEF, V48, P334, DOI 10.1097/QAI.0b013e31817ae5ef; Rossignol R, 1999, J BIOL CHEM, V274, P33426, DOI 10.1074/jbc.274.47.33426; Sanchez-Conde M, 2005, HIV CLIN TRIALS, V6, P197, DOI 10.1310/ED57-EU48-RK6A-E5U0; Schifitto G, 2002, NEUROLOGY, V58, P1764, DOI 10.1212/WNL.58.12.1764; Simpson DM, 2006, NEUROLOGY, V66, P1679, DOI 10.1212/01.wnl.0000218303.48113.5d; Simpson DM, 1998, AIDS, V12, P2425, DOI 10.1097/00002030-199818000-00011; Skopelitis EE, 2006, INT J STD AIDS, V17, P467, DOI 10.1258/095646206777689062; Tagliati M, 1999, ARCH NEUROL-CHICAGO, V56, P84, DOI 10.1001/archneur.56.1.84; Vivithanaporn P, 2010, NEUROLOGY, V75, P1150, DOI 10.1212/WNL.0b013e3181f4d5bb; [WHO UNAIDS UNICEF], 2009, UN ACC SCAL PRIOR HI; *WHO, ADD 2006 WHO GUID AN; WOLF E, 2004, LOW DOSE STAVUDINE L	32	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2011	6	11							e28112	10.1371/journal.pone.0028112	http://dx.doi.org/10.1371/journal.pone.0028112			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IO	22132226	Green Published, gold, Green Submitted			2022-12-27	WOS:000297789900048
J	Herder, C; Peeters, W; Illig, T; Baumert, J; de Kleijn, DPV; Moll, FL; Poschen, U; Klopp, N; Muller-Nurasyid, M; Roden, M; Preuss, M; Karakas, M; Meisinger, C; Thorand, B; Pasterkamp, G; Koenig, W				Herder, Christian; Peeters, Wouter; Illig, Thomas; Baumert, Jens; de Kleijn, Dominique P. V.; Moll, Frans L.; Poschen, Ulrike; Klopp, Norman; Mueller-Nurasyid, Martina; Roden, Michael; Preuss, Michael; Karakas, Mahir; Meisinger, Christa; Thorand, Barbara; Pasterkamp, Gerard; Koenig, Wolfgang		CARDioGRAM Consortium	RANTES/CCL5 and Risk for Coronary Events: Results from the MONICA/KORA Augsburg Case-Cohort, Athero-Express and CARDIoGRAM Studies	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; INHIBITORY FACTOR MIF; HEART-DISEASE; ATHEROSCLEROTIC PLAQUES; ARTERY-DISEASE; ADIPOSE-TISSUE; SERUM CONCENTRATIONS; GENE POLYMORPHISMS; CARDIAC MORTALITY; EUROPEAN-SOCIETY	Background: The chemokine RANTES (regulated on activation, normal T-cell expressed and secreted)/CCL5 is involved in the pathogenesis of cardiovascular disease in mice, whereas less is known in humans. We hypothesised that its relevance for atherosclerosis should be reflected by associations between CCL5 gene variants, RANTES serum concentrations and protein levels in atherosclerotic plaques and risk for coronary events. Methods and Findings: We conducted a case-cohort study within the population-based MONICA/KORA Augsburg studies. Baseline RANTES serum levels were measured in 363 individuals with incident coronary events and 1,908 non-cases (mean follow-up: 10.2 +/- 4.8 years). Cox proportional hazard models adjusting for age, sex, body mass index, metabolic factors and lifestyle factors revealed no significant association between RANTES and incident coronary events (HR [95% CI] for increasing RANTES tertiles 1.0, 1.03 [0.75-1.42] and 1.11 [0.81-1.54]). None of six CCL5 single nucleotide polymorphisms and no common haplotype showed significant associations with coronary events. Also in the CARDIoGRAM study (>22,000 cases, >60,000 controls), none of these CCL5 SNPs was significantly associated with coronary artery disease. In the prospective Athero-Express biobank study, RANTES plaque levels were measured in 606 atherosclerotic lesions from patients who underwent carotid endarterectomy. RANTES content in atherosclerotic plaques was positively associated with macrophage infiltration and inversely associated with plaque calcification. However, there was no significant association between RANTES content in plaques and risk for coronary events (mean follow-up 2.8 +/- 0.8 years). Conclusions: High RANTES plaque levels were associated with an unstable plaque phenotype. However, the absence of associations between (i) RANTES serum levels, (ii) CCL5 genotypes and (iii) RANTES content in carotid plaques and either coronary artery disease or incident coronary events in our cohorts suggests that RANTES may not be a novel coronary risk biomarker. However, the potential relevance of RANTES levels in platelet-poor plasma needs to be investigated in further studies.	[Herder, Christian; Poschen, Ulrike; Roden, Michael] Univ Dusseldorf, Leibniz Ctr Diabet Res, German Diabet Ctr, Inst Clin Diabetol, D-40225 Dusseldorf, Germany; [Peeters, Wouter; Moll, Frans L.] Univ Med Ctr Utrecht, Dept Vasc Surg, Utrecht, Netherlands; [Illig, Thomas; Klopp, Norman] German Res Ctr Environm Hlth, Res Unit Mol Epidemiol, Helmholtz Zentrum Munchen, Neuherberg, Germany; [Baumert, Jens; Meisinger, Christa; Thorand, Barbara] German Res Ctr Environm Hlth, Inst Epidemiol 2, Helmholtz Zentrum Munchen, Neuherberg, Germany; [de Kleijn, Dominique P. V.; Pasterkamp, Gerard] Univ Med Ctr Utrecht, Expt Cardiol Lab, Utrecht, Netherlands; [de Kleijn, Dominique P. V.] Interuniv Cardiol Inst Netherlands, Utrecht, Netherlands; [Mueller-Nurasyid, Martina] Univ Munich, Dept Med 1, Univ Hosp Grosshadern, Munich, Germany; [Mueller-Nurasyid, Martina] Univ Munich, Inst Med Informat Biometry & Epidemiol, Munich, Germany; [Mueller-Nurasyid, Martina] German Res Ctr Environm Hlth, Inst Genet Epidemiol, Helmholtz Zentrum Munchen, Neuherberg, Germany; [Roden, Michael] Univ Dusseldorf, Dept Metab Dis, D-40225 Dusseldorf, Germany; [Preuss, Michael] Univ Lubeck, Inst Med Biometr & Stat, Lubeck, Germany; [Koenig, Wolfgang] Univ Ulm, Med Ctr, Dept Internal Med Cardiol 2, Ulm, Germany	Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; Utrecht University; Utrecht University Medical Center; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Utrecht University; Utrecht University Medical Center; Interuniversity Cardiology Institute of the Netherlands; Utrecht University; University of Munich; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Heinrich Heine University Dusseldorf; University of Lubeck; Ulm University	Herder, C (corresponding author), Univ Dusseldorf, Leibniz Ctr Diabet Res, German Diabet Ctr, Inst Clin Diabetol, D-40225 Dusseldorf, Germany.	thorand@helmholtz-muenchen.de	Peters, Annette/A-6117-2011; Müller-Nurasyid, Martina/I-8735-2018; Roden, Michael/AAD-3843-2019; Meisinger, Christine/B-5358-2014; Thorand, Barbara/B-5349-2014; Willenborg, Christina/D-2668-2012; Meitinger, Thomas/O-1318-2015; Gudnason, Vilmundur/K-6885-2015; Schnabel, Renate B/F-6527-2014; König, Inke R/A-4544-2009; Erdmann, Jeanette/P-7513-2014; Erdmann, Jeanette/A-4417-2009; Dehghan, Abbas/B-9896-2008; Ziegler, Andreas/G-4246-2012; Smith, Albert Vernon/K-5150-2015	Peters, Annette/0000-0001-6645-0985; Müller-Nurasyid, Martina/0000-0003-3793-5910; Thorand, Barbara/0000-0002-8416-6440; Willenborg, Christina/0000-0001-5217-6882; Gudnason, Vilmundur/0000-0001-5696-0084; König, Inke R/0000-0003-0504-6465; Erdmann, Jeanette/0000-0002-4486-6231; Dehghan, Abbas/0000-0001-6403-016X; Aherrahrou, Zouhair/0000-0002-1241-8733; Ramachandran, Vasan/0000-0001-7357-5970; ELOSUA, ROBERTO/0000-0001-8235-0095; Koenig, Wolfgang/0000-0002-2064-9603; Wild, Philipp/0000-0003-4413-9752; Melander, Olle/0000-0002-2581-484X; Voight, Benjamin/0000-0002-6205-9994; Ziegler, Andreas/0000-0002-8386-5397; Zeller, Tanja/0000-0003-3379-2641; Stewart, Alexandre/0000-0003-2673-9164; Glazer, Nicole/0000-0002-6397-609X; Smith, Albert Vernon/0000-0003-1942-5845; Preuss, Michael/0000-0001-5266-8465; Van Duijn, Cornelia/0000-0002-2374-9204; Meitinger, Thomas/0000-0002-8838-8403; Pilz, Stefan/0000-0002-7959-1311; Reilly, Muredach/0000-0002-3035-9386; Hall, Alistair/0000-0003-0306-7887; Meisinger, Christa/0000-0002-9026-6544; Kleber, Marcus/0000-0003-0663-7275	German Research Foundation [TH-784/2-1, TH-784/2-2]; German Diabetes Center (Dusseldorf, Germany); Federal Ministry of Health (Berlin, Germany); Federal Ministry of Education, Science, Research and Technology (National Genome Research Net-2, cardiovascular, Berlin, Germany) [01GS0423]; Ministry of Innovation, Science, Research and Technology of the state North Rhine-Westphalia (Dusseldorf, Germany); Helmholtz Zentrum Munchen, German Research Center for Environmental Health, Neuherberg, Germany; German Federal Ministry of Education, Science, Research and Technology; State of Bavaria; University of Ulm; Helmholtz Zentrum Munchen; Federal Ministry of Education and Research, Berlin, Germany; University Medical Center Utrecht; CARDIoGRAM Consortium; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087647] Funding Source: NIH RePORTER	German Research Foundation(German Research Foundation (DFG)); German Diabetes Center (Dusseldorf, Germany); Federal Ministry of Health (Berlin, Germany); Federal Ministry of Education, Science, Research and Technology (National Genome Research Net-2, cardiovascular, Berlin, Germany); Ministry of Innovation, Science, Research and Technology of the state North Rhine-Westphalia (Dusseldorf, Germany); Helmholtz Zentrum Munchen, German Research Center for Environmental Health, Neuherberg, Germany(Helmholtz Association); German Federal Ministry of Education, Science, Research and Technology; State of Bavaria; University of Ulm; Helmholtz Zentrum Munchen(Helmholtz Association); Federal Ministry of Education and Research, Berlin, Germany(Federal Ministry of Education & Research (BMBF)); University Medical Center Utrecht; CARDIoGRAM Consortium; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The MONICA/KORA Augsburg case-cohort study was supported by research grants from the German Research Foundation (TH-784/2-1, TH-784/2-2) and by additional funds provided by the German Diabetes Center (Dusseldorf, Germany); the Federal Ministry of Health (Berlin, Germany); the Federal Ministry of Education, Science, Research and Technology (National Genome Research Net-2, cardiovascular, 01GS0423; Berlin, Germany); the Ministry of Innovation, Science, Research and Technology of the state North Rhine-Westphalia (Dusseldorf, Germany); Helmholtz Zentrum Munchen, German Research Center for Environmental Health, Neuherberg, Germany (formerly GSF National Research Center for Environment and Health; funded by the German Federal Ministry of Education, Science, Research and Technology and by the State of Bavaria); and the University of Ulm. The MONICA/KORA Augsburg cohort study was financed by the Helmholtz Zentrum Munchen and supported by grants from the Federal Ministry of Education and Research, Berlin, Germany. The Athero-Express study was partially funded by the University Medical Center Utrecht. For the complete list of funders of the CARDIoGRAM Consortium and their support information, please refer to our supplementary file entitled "Text S2. Funding information and competing interests of the CARDIoGRAM Consortium". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALAM R, 1993, J IMMUNOL, V150, P3442; Alpert JS, 2000, J AM COLL CARDIOL, V36, P959, DOI 10.1016/S0735-1097(00)00804-4; Appay V, 1999, J BIOL CHEM, V274, P27505, DOI 10.1074/jbc.274.39.27505; Appay V, 2001, TRENDS IMMUNOL, V22, P83, DOI 10.1016/S1471-4906(00)01812-3; Aukrust P, 2008, ARTERIOSCL THROM VAS, V28, P1909, DOI 10.1161/ATVBAHA.107.161240; Aukrust P, 2007, THROMB HAEMOSTASIS, V97, P748, DOI 10.1160/TH07-01-0029; BARLOW WE, 1994, BIOMETRICS, V50, P1064, DOI 10.2307/2533444; Berg KK, 2009, SCAND J IMMUNOL, V69, P36, DOI 10.1111/j.1365-3083.2008.02187.x; Boger CA, 2005, ATHEROSCLEROSIS, V183, P121, DOI 10.1016/j.atherosclerosis.2005.03.006; Braunersreuther V, 2008, ARTERIOSCL THROM VAS, V28, P1090, DOI 10.1161/ATVBAHA.108.165423; Braunersreuther V, 2007, THROMB HAEMOSTASIS, V97, P714, DOI 10.1160/TH07-01-0036; Braunersreuther V, 2007, ARTERIOSCL THROM VAS, V27, P373, DOI 10.1161/01.ATV.0000253886.44609.ae; Braunersreuther V, 2010, J MOL CELL CARDIOL, V48, P789, DOI 10.1016/j.yjmcc.2009.07.029; Breland UM, 2010, CARDIOVASC RES, V86, P265, DOI 10.1093/cvr/cvq044; Cavusoglu E, 2007, ARTERIOSCL THROM VAS, V27, P929, DOI 10.1161/01.ATV.0000258789.21585.76; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Correia LCL, 2010, CLIN CHIM ACTA, V411, P540, DOI 10.1016/j.cca.2010.01.011; de Kleijn DPV, 2010, ARTERIOSCL THROM VAS, V30, P612, DOI 10.1161/ATVBAHA.109.194944; Ding ZQ, 2000, J LEUKOCYTE BIOL, V67, P825, DOI 10.1002/jlb.67.6.825; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; Hellings WE, 2007, J VASC SURG, V46, P1147, DOI 10.1016/j.jvs.2007.08.018; Hellings WE, 2010, CIRCULATION, V121, P1941, DOI 10.1161/CIRCULATIONAHA.109.887497; Herder C, 2008, DIABETOLOGIA, V51, P276, DOI 10.1007/s00125-007-0800-3; Herder C, 2005, DIABETES, V54, pS11, DOI 10.2337/diabetes.54.suppl_2.S11; Herder C, 2008, ATHEROSCLEROSIS, V200, P380, DOI 10.1016/j.atherosclerosis.2007.12.025; Herder C, 2008, EUR J ENDOCRINOL, V158, pR1, DOI 10.1530/EJE-07-0686; Herder C, 2006, ARTERIOSCL THROM VAS, V26, P2147, DOI 10.1161/01.ATV.0000235691.84430.86; Huber J, 2008, J CLIN ENDOCR METAB, V93, P3215, DOI 10.1210/jc.2007-2630; Jones KL, 2011, BRIT J PHARMACOL, V162, P1453, DOI 10.1111/j.1476-5381.2010.01147.x; KAMEYOSHI Y, 1992, J EXP MED, V176, P587, DOI 10.1084/jem.176.2.587; Koenig W, 2006, ARTERIOSCL THROM VAS, V26, P2745, DOI 10.1161/01.ATV.0000248096.62495.73; Kraaijeveld AO, 2007, CIRCULATION, V116, P1931, DOI 10.1161/CIRCULATIONAHA.107.706986; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Luepker RV, 2003, CIRCULATION, V108, P2543, DOI 10.1161/01.CIR.0000100560.46946.EA; Maury E, 2007, AM J PHYSIOL-ENDOC M, V293, pE656, DOI 10.1152/ajpendo.00127.2007; Montecucco F, 2010, STROKE, V41, P1394, DOI 10.1161/STROKEAHA.110.578369; Oran PE, 2010, CLIN CHEM, V56, P1432, DOI 10.1373/clinchem.2010.147884; Peden JF, 2011, NAT GENET, V43, P339, DOI 10.1038/ng.782; Peeters W, 2009, ARTERIOSCL THROM VAS, V29, P128, DOI 10.1161/ATVBAHA.108.173658; Peeters W, 2011, EUR HEART J, V32, P2314, DOI 10.1093/eurheartj/ehq517; Peeters W, 2011, EUR HEART J, V32, P1758, DOI 10.1093/eurheartj/ehq387; Preuss M, 2010, CIRC-CARDIOVASC GENE, V3, P475, DOI 10.1161/CIRCGENETICS.109.899443; Reilly MP, 2011, LANCET, V377, P383, DOI 10.1016/S0140-6736(10)61996-4; Rothenbacher D, 2006, ARTERIOSCL THROM VAS, V26, P194, DOI 10.1161/01.ATV.0000191633.52585.14; SCHALL TJ, 1991, CYTOKINE, V3, P165, DOI 10.1016/1043-4666(91)90013-4; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Simeoni E, 2004, EUR HEART J, V25, P1438, DOI 10.1016/j.ehj.2004.05.005; Skurk T, 2009, HORM METAB RES, V41, P183, DOI 10.1055/s-0028-1093345; Szalai C, 2001, ATHEROSCLEROSIS, V158, P233, DOI 10.1016/S0021-9150(01)00423-3; Thorand B, 2006, ARTERIOSCL THROM VAS, V26, P398, DOI 10.1161/01.ATV.0000198392.05307.aa; Veillard NR, 2004, CIRC RES, V94, P253, DOI 10.1161/01.RES.0000109793.17591.4E; Verhoeven BAN, 2004, EUR J EPIDEMIOL, V19, P1127, DOI 10.1007/s10564-004-2304-6; Virani SS, 2011, EUR HEART J, V32, P459, DOI 10.1093/eurheartj/ehq367; Vogiatzi K, 2009, THROMB RES, V124, P84, DOI 10.1016/j.thromres.2008.12.043; von Hundelshausen P, 2001, CIRCULATION, V103, P1772, DOI 10.1161/01.CIR.103.13.1772; Wang F, 2011, NAT GENET, V43, P345, DOI 10.1038/ng.783; Wu HZ, 2007, CIRCULATION, V115, P1029, DOI 10.1161/CIRCULATIONAHA.106.638379; Zernecke A, 2008, ARTERIOSCL THROM VAS, V28, P1897, DOI 10.1161/ATVBAHA.107.161174	58	35	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2011	6	12							e25734	10.1371/journal.pone.0025734	http://dx.doi.org/10.1371/journal.pone.0025734			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863OC	22162987	Green Published, gold, Green Submitted			2022-12-27	WOS:000298173500001
J	Schiffers, K; Teal, LR; Travis, JMJ; Solan, M				Schiffers, Katja; Teal, Lorna Rachel; Travis, Justin Mark John; Solan, Martin			An Open Source Simulation Model for Soil and Sediment Bioturbation	PLOS ONE			English	Article							LATTICE-AUTOMATON MODEL; PARTICLE-TRANSPORT; ECOSYSTEM PROCESSES; TRACER DYNAMICS; REWORKING; QUANTIFICATION; BIODIVERSITY; RATES; MASSACHUSETTS; IRRIGATION	Bioturbation is one of the most widespread forms of ecological engineering and has significant implications for the structure and functioning of ecosystems, yet our understanding of the processes involved in biotic mixing remains incomplete. One reason is that, despite their value and utility, most mathematical models currently applied to bioturbation data tend to neglect aspects of the natural complexity of bioturbation in favour of mathematical simplicity. At the same time, the abstract nature of these approaches limits the application of such models to a limited range of users. Here, we contend that a movement towards process-based modelling can improve both the representation of the mechanistic basis of bioturbation and the intuitiveness of modelling approaches. In support of this initiative, we present an open source modelling framework that explicitly simulates particle displacement and a worked example to facilitate application and further development. The framework combines the advantages of rule-based lattice models with the application of parameterisable probability density functions to generate mixing on the lattice. Model parameters can be fitted by experimental data and describe particle displacement at the spatial and temporal scales at which bioturbation data is routinely collected. By using the same model structure across species, but generating species-specific parameters, a generic understanding of species-specific bioturbation behaviour can be achieved. An application to a case study and comparison with a commonly used model attest the predictive power of the approach.	[Schiffers, Katja; Travis, Justin Mark John] Univ Aberdeen, Sch Biol Sci, Aberdeen, Scotland; [Teal, Lorna Rachel; Solan, Martin] Univ Aberdeen, Oceanlab, Newburgh, Aberdeen, Scotland	University of Aberdeen; University of Aberdeen	Schiffers, K (corresponding author), Univ Grenoble 1, CNRS, LECA Lab Ecol Alpine, Unites Mixtes Rech,UMR 5553, Grenoble, France.	katja.schiffers@gmail.com	Teal, Lorna R/C-8972-2009; Solan, Martin/E-9338-2012; Travis, Justin/B-8571-2014	Solan, Martin/0000-0001-9924-5574; Travis, Justin/0000-0002-5785-4272	University of Aberdeen; CEFAS (Centre for Environment, Fisheries and Aquaculture Science); Lowestoft [DP204]; German Academic Exchange Service (DAAD)	University of Aberdeen; CEFAS (Centre for Environment, Fisheries and Aquaculture Science); Lowestoft; German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	This work was supported by University of Aberdeen 6th century scholarship (awarded to LRT), CEFAS (Centre for Environment, Fisheries and Aquaculture Science), Lowestoft (DP204) and the German Academic Exchange Service (DAAD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behzadi B, 2005, CHEM ENG SCI, V60, P6607, DOI 10.1016/j.ces.2005.05.041; BELISLE CJP, 1992, J APPL PROBAB, V29, P885, DOI 10.2307/3214721; Benton TG, 2007, TRENDS ECOL EVOL, V22, P516, DOI 10.1016/j.tree.2007.08.003; Berg P, 2001, AQUAT MICROB ECOL, V26, P81, DOI 10.3354/ame026081; Berner R.A., 1980, EARLY DIAGENESIS THE; Bertics VJ, 2010, ENVIRON MICROBIOL, V12, P3022, DOI 10.1111/j.1462-2920.2010.02279.x; Blair NE, 1996, LIMNOL OCEANOGR, V41, P1208, DOI 10.4319/lo.1996.41.6.1208; BOUDREAU BP, 1987, AM J SCI, V287, P693, DOI 10.2475/ajs.287.7.693; BOUDREAU BP, 1986, AM J SCI, V286, P161, DOI 10.2475/ajs.286.3.161; Boudreau BP, 2001, J MAR RES, V59, P749, DOI 10.1357/002224001762674926; BOUDREAU BP, 1989, GEOCHIM COSMOCHIM AC, V53, P1857, DOI 10.1016/0016-7037(89)90306-2; Broyden C.G., 1970, IMA J APPL MATH, V6, P222, DOI [10.1093/imamat/6.3.222, DOI 10.1093/IMAMAT/6.3.222]; Bulling M, 2008, OECOLOGIA, V158, P511, DOI 10.1007/s00442-008-1160-5; Burnham K. P., 1998, MODEL SELECTION INFE; Choi J, 2002, COMPUT GEOSCI-UK, V28, P213, DOI 10.1016/S0098-3004(01)00064-4; Crank J, 1975, MATH DIFFUSION, P424; Darwin C, 1881, FORMATION VEGETABLE, DOI DOI 10.1017/CBO9780511703850; Dyson KE, 2007, P ROY SOC B-BIOL SCI, V274, P2547, DOI 10.1098/rspb.2007.0922; Fernandes S, 2006, MAR CHEM, V102, P148, DOI 10.1016/j.marchem.2005.12.002; FLETCHER R, 1970, COMPUT J, V13, P317, DOI 10.1093/comjnl/13.3.317; Fornes WL, 1999, J MAR RES, V57, P335, DOI 10.1357/002224099321618245; Forster S, 2003, J MAR RES, V61, P335, DOI 10.1357/002224003322201223; Francois F, 2002, MAR ECOL PROG SER, V229, P127, DOI 10.3354/meps229127; Francois F, 1997, ACTA BIOTHEOR, V45, P295, DOI 10.1023/A:1000636109604; Gerino M, 1998, ESTUAR COAST SHELF S, V46, P531, DOI 10.1006/ecss.1997.0298; GERINO M, 1994, OCEANOL ACTA, V17, P547; Gilbert F, 2003, J EXP MAR BIOL ECOL, V285, P251, DOI 10.1016/S0022-0981(02)00531-2; Godbold JA, 2011, P ROY SOC B-BIOL SCI, V278, P2510, DOI 10.1098/rspb.2010.2414; GOLDBERG ED, 1962, GEOCHIM COSMOCHIM AC, V26, P417, DOI 10.1016/0016-7037(62)90112-6; GOLDFARB D, 1970, MATH COMPUT, V24, P23, DOI 10.2307/2004873; Green MA, 2002, DEEP-SEA RES PT II, V49, P4627, DOI 10.1016/S0967-0645(02)00132-7; GUINASSO NL, 1975, J GEOPHYS RES-OC ATM, V80, P3032, DOI 10.1029/JC080i021p03032; Hilborn Ray, 1997, V28; Hollertz K, 2001, MAR BIOL, V139, P951; Jamieson AJ, 2011, MAR BIOL, V158, P2695, DOI 10.1007/s00227-011-1767-7; MAHAUT ML, 1987, OCEANOL ACTA, V10, P323; Maire O, 2008, AQUAT BIOL, V2, P219, DOI 10.3354/ab00053; Maire O, 2006, MAR ECOL PROG SER, V319, P135, DOI 10.3354/meps319135; McCraith BJ, 2003, J MAR RES, V61, P359, DOI 10.1357/002224003322201232; McDonald CP, 2010, ECOL MODEL, V221, P428, DOI 10.1016/j.ecolmodel.2009.10.021; Mermillod-Blondin F, 2005, J EXP MAR BIOL ECOL, V315, P187, DOI 10.1016/j.jembe.2004.09.013; Mermillod-Blondin F, 2003, J EXP MAR BIOL ECOL, V287, P193, DOI 10.1016/S0022-0981(02)00548-8; Meysman FJR, 2008, GEOCHIM COSMOCHIM AC, V72, P3460, DOI 10.1016/j.gca.2008.04.023; Meysman FJR, 2006, TRENDS ECOL EVOL, V21, P688, DOI 10.1016/j.tree.2006.08.002; Meysman FJR, 2010, J MAR RES, V68, P881, DOI 10.1357/002224010796673885; Meysman FJR, 2003, J MAR RES, V61, P391, DOI 10.1357/002224003322201241; Mugnai C, 2003, HYDROBIOLOGIA, V494, P245, DOI 10.1023/A:1025430719520; Palomar NE, 2005, J ETHOL, V23, P173, DOI 10.1007/s10164-005-0149-3; R Core Team, 2018, R LANG ENV STAT COMP; Raffaelli D, 2005, MAR ECOL PROG SER, V304, P283; Rands SA, 2006, BEHAV ECOL SOCIOBIOL, V60, P572, DOI 10.1007/s00265-006-0202-4; Reed DC, 2007, J MAR RES, V65, P813, DOI 10.1357/002224007784219039; Reed DC, 2006, GEOCHIM COSMOCHIM AC, V70, P5855, DOI 10.1016/j.gca.2006.03.026; RHOADS DC, 1971, MAR BIOL, V11, P255, DOI 10.1007/BF00401273; Rosenberg R, 2008, MAR ECOL PROG SER, V363, P171, DOI 10.3354/meps07463; Sandnes J, 2000, MAR ECOL PROG SER, V197, P169, DOI 10.3354/meps197169; SHANNO DF, 1970, MATH COMPUT, V24, P647, DOI 10.2307/2004840; Shull DH, 2001, J MAR RES, V59, P453, DOI 10.1357/002224001762842271; Soetaert K, 1996, J MAR RES, V54, P1207, DOI 10.1357/0022240963213808; Solan M, 2004, MAR ECOL PROG SER, V271, P1, DOI 10.3354/meps271001; Solan M, 2002, MAR ECOL PROG SER, V228, P179, DOI 10.3354/meps228179; Solan M, 2008, AQUAT BIOL, V2, P289, DOI 10.3354/ab00058; Srivastava DS, 2005, ANNU REV ECOL EVOL S, V36, P267, DOI 10.1146/annurev.ecolsys.36.102003.152636; Teal LR, 2008, AQUAT BIOL, V2, P207, DOI 10.3354/ab00052; Vabo R, 2008, ECOL MODEL, V214, P125, DOI 10.1016/j.ecolmodel.2008.01.026; Vikebo F, 2007, MAR ECOL PROG SER, V347, P207, DOI 10.3354/meps06979; WHEATCROFT RA, 1994, J MAR RES, V52, P1129, DOI 10.1357/0022240943076803; WHEATCROFT RA, 1990, J MAR RES, V48, P177, DOI 10.1357/002224090784984560; Wilkinson MT, 2009, EARTH-SCI REV, V97, P257, DOI 10.1016/j.earscirev.2009.09.005	69	38	38	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e28028	10.1371/journal.pone.0028028	http://dx.doi.org/10.1371/journal.pone.0028028			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22162997	Green Published, Green Accepted, gold			2022-12-27	WOS:000298172800010
J	Azarias, G; Chatton, JY				Azarias, Guillaume; Chatton, Jean-Yves			Selective Ion Changes during Spontaneous Mitochondrial Transients in Intact Astrocytes	PLOS ONE			English	Article							CA2+; OSCILLATIONS; DYSFUNCTION; SUPEROXIDE; TRANSPORT; PH	The bioenergetic status of cells is tightly regulated by the activity of cytosolic enzymes and mitochondrial ATP production. To adapt their metabolism to cellular energy needs, mitochondria have been shown to exhibit changes in their ionic composition as the result of changes in cytosolic ion concentrations. Individual mitochondria also exhibit spontaneous changes in their electrical potential without altering those of neighboring mitochondria. We recently reported that individual mitochondria of intact astrocytes exhibit spontaneous transient increases in their Na+ concentration. Here, we investigated whether the concentration of other ionic species were involved during mitochondrial transients. By combining fluorescence imaging methods, we performed a multiparameter study of spontaneous mitochondrial transients in intact resting astrocytes. We show that mitochondria exhibit coincident changes in their Na+ concentration, electrical potential, matrix pH and mitochondrial reactive oxygen species production during a mitochondrial transient without involving detectable changes in their Ca2+ concentration. Using widefield and total internal reflection fluorescence imaging, we found evidence for localized transient decreases in the free Mg2+ concentration accompanying mitochondrial Na+ spikes that could indicate an associated local and transient enrichment in the ATP concentration. Therefore, we propose a sequential model for mitochondrial transients involving a localized ATP microdomain that triggers a Na+-mediated mitochondrial depolarization, transiently enhancing the activity of the mitochondrial respiratory chain. Our work provides a model describing ionic changes that could support a bidirectional cytosol-to-mitochondria ionic communication.	[Azarias, Guillaume; Chatton, Jean-Yves] Univ Lausanne, Dept Cell Biol & Morphol, Lausanne, Switzerland; [Chatton, Jean-Yves] Univ Lausanne, Cellular Imaging Facil, Lausanne, Switzerland	University of Lausanne; University of Lausanne	Azarias, G (corresponding author), Karolinska Inst, Astrid Lindgren Childrens Hosp, Stockholm, Sweden.	jean-yves.chatton@unil.ch	Azarias, Guillaume/A-6877-2008	Azarias, Guillaume/0000-0001-5627-7349; Chatton, Jean-Yves/0000-0002-8911-0315	Swiss National Science Foundation [3100A0-119827, 31003A-135720]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by grants #3100A0-119827 and 31003A-135720 from the Swiss National Science Foundation to JY Chatton. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azarias G, 2008, GLIA, V56, P342, DOI 10.1002/glia.20619; Azarias G, 2011, J NEUROSCI, V31, P3550, DOI 10.1523/JNEUROSCI.4378-10.2011; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Belousov VV, 2006, NAT METHODS, V3, P281, DOI 10.1038/NMETH866; Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; Bernardinelli Y, 2006, GLIA, V54, P460, DOI 10.1002/glia.20387; Buckman JF, 2001, J NEUROSCI, V21, P5054, DOI 10.1523/JNEUROSCI.21-14-05054.2001; Chalmers S, 2008, J CELL SCI, V121, P75, DOI 10.1242/jcs.014522; Chatton JY, 2000, EUR J NEUROSCI, V12, P3843, DOI 10.1046/j.1460-9568.2000.00269.x; Collins TJ, 2002, EMBO J, V21, P1616, DOI 10.1093/emboj/21.7.1616; De Giorgi F, 2000, CELL CALCIUM, V28, P365, DOI 10.1054/ceca.2000.0177; Demaurex N, 2003, SCIENCE, V300, P65, DOI 10.1126/science.1083628; HAJNOCZKY G, 1995, CELL, V82, P415, DOI 10.1016/0092-8674(95)90430-1; Hattori T, 2005, BIOPHYS J, V88, P2340, DOI 10.1529/biophysj.104.041483; Inoue M, 2002, J PHYSIOL-LONDON, V539, P145, DOI 10.1113/jphysiol.2001.012936; Jacobson J, 2002, J CELL SCI, V115, P1175; Jeninga EH, 2010, ONCOGENE, V29, P4617, DOI 10.1038/onc.2010.206; Kennedy HJ, 1999, J BIOL CHEM, V274, P13281, DOI 10.1074/jbc.274.19.13281; Leyssens A, 1996, J PHYSIOL-LONDON, V496, P111, DOI 10.1113/jphysiol.1996.sp021669; MacAskill AF, 2010, TRENDS CELL BIOL, V20, P102, DOI 10.1016/j.tcb.2009.11.002; Magistretti PJ, 2005, J NEURAL TRANSM, V112, P77, DOI 10.1007/s00702-004-0171-6; Marchaland J, 2008, J NEUROSCI, V28, P9122, DOI 10.1523/JNEUROSCI.0040-08.2008; Muller FL, 2009, FREE RADICAL BIO MED, V47, P1779, DOI 10.1016/j.freeradbiomed.2009.09.019; Nicholls DG, 2000, PHYSIOL REV, V80, P315, DOI 10.1152/physrev.2000.80.1.315; Ouyang YB, 2007, J NEUROSCI, V27, P4253, DOI 10.1523/JNEUROSCI.0211-07.2007; Poburko D, 2011, J BIOL CHEM, V286, P11672, DOI 10.1074/jbc.M110.159962; Pouvreau S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013035; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; Schwarzlander M, 2011, BIOCHEM J, V437, P381, DOI 10.1042/BJ20110883; SORG O, 1992, J NEUROSCI, V12, P4923; Wang W, 2008, CELL, V134, P279, DOI 10.1016/j.cell.2008.06.017; Yaniv Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021985	32	35	36	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2011	6	12							e28505	10.1371/journal.pone.0028505	http://dx.doi.org/10.1371/journal.pone.0028505			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MQ	22145050	Green Published, gold, Green Submitted			2022-12-27	WOS:000298168900033
J	Glyakina, AV; Bogatyreva, NS; Galzitskaya, OV				Glyakina, Anna V.; Bogatyreva, Natalya S.; Galzitskaya, Oxana V.			Accessible Surfaces of Beta Proteins Increase with Increasing Protein Molecular Mass More Rapidly than Those of Other Proteins	PLOS ONE			English	Article							GLOBULAR-PROTEINS; DIMENSIONS; INTERIOR; AREA	Here we present a systematic analysis of accessible surface areas and hydrogen bonds of 2554 globular proteins from four structural classes (all-alpha, all-beta, alpha/beta and alpha+beta proteins) that is aimed to learn in which structural class the accessible surface area increases with increasing protein molecular mass more rapidly than in other classes, and what structural peculiarities are responsible for this effect. The beta structural class of proteins was found to be the leader, with the following possible explanations of this fact. First, in beta structural proteins, the fraction of residues not included in the regular secondary structure is the largest, and second, the accessible surface area of packaged elements of the beta-structure increases more rapidly with increasing molecular mass in comparison with the alpha-structure. Moreover, in the beta structure, the probability of formation of backbone hydrogen bonds is higher than that in the alpha helix for all residues of alpha+beta proteins (the average probability is 0.73 +/- 0.01 for the beta-structure and 0.60 +/- 0.01 for the alpha-structure without proline) and alpha/beta proteins, except for asparagine, aspartic acid, glycine, threonine, and serine (0.70 +/- 0.01 for the beta-structure and 0.60 +/- 0.01 for the alpha-structure without the proline residue). There is a linear relationship between the number of hydrogen bonds and the number of amino acid residues in the protein (Number of hydrogen bonds=0.678: number of residues=3.350).	[Glyakina, Anna V.; Bogatyreva, Natalya S.; Galzitskaya, Oxana V.] Russian Acad Sci, Inst Prot Res, Pushchino 142292, Moscow Region, Russia; [Glyakina, Anna V.] Russian Acad Sci, Inst Math Problems Biol, Pushchino 142292, Moscow Region, Russia	Russian Academy of Sciences; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences	Glyakina, AV (corresponding author), Russian Acad Sci, Inst Prot Res, Pushchino 142292, Moscow Region, Russia.	ogalzit@vega.protres.ru	Glyakina, Anna/O-2759-2013; GALZITSKAYA, OXANA V/L-2664-2015; Bogatyreva, Natalya S/B-9598-2017	Glyakina, Anna/0000-0002-6352-2880; Bogatyreva, Natalya/0000-0002-1719-1136	Russian Foundation for Basic Research [01200959110, 11-04-00763]; Russian Science Support Foundation; Federal Agency for Science and Innovation [02.740.11.0295]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Science Support Foundation(Russian Science Foundation (RSF)); Federal Agency for Science and Innovation(Federal Agency for Science & Innovations (FASI))	This work was supported by the programs "Molecular and Cellular Biology" (01200959110) and "Fundamental Sciences to Medicine", by the Russian Foundation for Basic Research (11-04-00763), by the Russian Science Support Foundation, and by a grant from the Federal Agency for Science and Innovation (#02.740.11.0295). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerji A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007361; Bogatyreva N S, 2008, Mol Biol (Mosk), V42, P1048; CHOTHIA C, 1974, NATURE, V248, P338, DOI 10.1038/248338a0; FEDOROV BA, 1993, J CHEM PHYS, V99, P4076, DOI 10.1063/1.466104; FUSHMAN D, 1990, J BIOMOL STRUCT DYN, V7, P1333, DOI 10.1080/07391102.1990.10508569; Ivankov DN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006476; Joosten RP, 2009, J APPL CRYSTALLOGR, V42, P376, DOI 10.1107/S0021889809008784; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; MILLER S, 1987, NATURE, V328, P834, DOI 10.1038/328834a0; MILLER S, 1987, J MOL BIOL, V196, P641, DOI 10.1016/0022-2836(87)90038-6; Morita H, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.020901; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; PFEIFER P, 1983, J CHEM PHYS, V79, P3558, DOI 10.1063/1.446210; Pfeifer P., 1989, FRACTAL APPROACH HET; Raschke TM, 2001, P NATL ACAD SCI USA, V98, P5965, DOI 10.1073/pnas.111158498; Serdyuk LN, 1997, BIOFIZIKA+, V42, P1197; STICKLE DF, 1992, J MOL BIOL, V226, P1143, DOI 10.1016/0022-2836(92)91058-W; Tejera E, 2009, PHYSICA A, V388, P4600, DOI 10.1016/j.physa.2009.07.015; Timchenko AA, 1997, PROTEINS, V28, P194	20	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2011	6	12							e28464	10.1371/journal.pone.0028464	http://dx.doi.org/10.1371/journal.pone.0028464			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MQ	22145047	Green Published, gold, Green Submitted			2022-12-27	WOS:000298168900030
J	Boudjeltia, KZ; Faraut, B; Esposito, MJ; Stenuit, P; Dyzma, M; Van Antwerpen, P; Brohee, D; Vanhamme, L; Moguilevsky, N; Vanhaeverbeek, M; Kerkhofs, M				Boudjeltia, Karim Zouaoui; Faraut, Brice; Esposito, Maria Jose; Stenuit, Patricia; Dyzma, Michal; Van Antwerpen, Pierre; Brohee, Dany; Vanhamme, Luc; Moguilevsky, Nicole; Vanhaeverbeek, Michel; Kerkhofs, Myriam			Temporal Dissociation between Myeloperoxidase (MPO)-Modified LDL and MPO Elevations during Chronic Sleep Restriction and Recovery in Healthy Young Men	PLOS ONE			English	Article							C-REACTIVE PROTEIN; GROWTH-FACTOR-I; INFLAMMATORY MARKERS; CARDIOVASCULAR RISK; DURATION; CATECHOLAMINE; DEPRIVATION; INCREASES; DISEASE; IMPACT	Objectives: Many studies have evaluated the ways in which sleep disturbances may influence inflammation and the possible links of this effect to cardiovascular risk. Our objective was to investigate the effects of chronic sleep restriction and recovery on several blood cardiovascular biomarkers. Methods and Results: Nine healthy male non-smokers, aged 22-29 years, were admitted to the Sleep Laboratory for 11 days and nights under continuous electroencephalogram polysomnography. The study consisted of three baseline nights of 8 hours sleep (from 11 pm to 7 am), five sleep-restricted nights, during which sleep was allowed only between 1 am and 6 am, and three recovery nights of 8 hours sleep (11 pm to 7 am). Myeloperoxidase-modified low-density lipoprotein levels increased during the sleep-restricted period indicating an oxidative stress. A significant increase in the quantity of slow-wave sleep was measured during the first recovery night. After this first recovery night, insulin-like growth factor-1 levels increased and myeloperoxidase concentration peaked. Conclusions: We observed for the first time that sleep restriction and the recovery process are associated with differential changes in blood biomarkers of cardiovascular disease.	[Boudjeltia, Karim Zouaoui; Faraut, Brice; Esposito, Maria Jose; Dyzma, Michal; Brohee, Dany; Vanhaeverbeek, Michel; Kerkhofs, Myriam] Univ Libre Brussels, Expt Med Lab, Ctr Hosp,Univ Charleroi, Andre Vesale Hosp, Montignies le Tilleul, Belgium; [Faraut, Brice; Esposito, Maria Jose; Stenuit, Patricia; Dyzma, Michal; Kerkhofs, Myriam] Univ Libre Brussels, Sleep Lab, Ctr Hosp,Univ Charleroi, Andre Vesale Hosp, Montignies le Tilleul, Belgium; [Van Antwerpen, Pierre] Univ Libre Brussels, Lab Pharmaceut Chem, Brussels, Belgium; [Vanhamme, Luc] Univ Libre Brussels, Mol Parasitol Lab, Inst Mol Biol & Med, Gosselies, Belgium; [Moguilevsky, Nicole] Univ Namur, Namur, Belgium	Universite Libre de Bruxelles; University of Namur	Boudjeltia, KZ (corresponding author), Univ Libre Brussels, Expt Med Lab, Ctr Hosp,Univ Charleroi, Andre Vesale Hosp, Montignies le Tilleul, Belgium.	mykerkho@ulb.ac.be		Van Antwerpen, Pierre/0000-0002-4934-8863	European Union [MCRTN-CT-2004-512362]; ISPPC-CHU de Charleroi; Institut de Pathologie et de Genetique (Gosselies) Belgium	European Union(European Commission); ISPPC-CHU de Charleroi; Institut de Pathologie et de Genetique (Gosselies) Belgium	This work was supported by European Union Grant MCRTN-CT-2004-512362, Scientific Research Fund of the ISPPC-CHU de Charleroi and Institut de Pathologie et de Genetique (Gosselies) Belgium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldus S, 2004, FREE RADICAL BIO MED, V37, P902, DOI 10.1016/j.freeradbiomed.2004.06.003; BJERKNES R, 1995, J CLIN ENDOCR METAB, V80, P1948, DOI 10.1210/jc.80.6.1948; Bleeke T, 2004, CIRC RES, V94, P37, DOI 10.1161/01.RES.0000109412.80157.7D; Boudjeltia KZ, 2008, VASC HEALTH RISK MAN, V4, P1467; Boudjeltia KZ, 2004, BIOCHEM BIOPH RES CO, V325, P434, DOI 10.1016/j.bbrc.2004.10.049; Calay D, 2010, ANTIOXID REDOX SIGN, V13, P1491, DOI 10.1089/ars.2009.2971; Eiserich JP, 2002, SCIENCE, V296, P2391, DOI 10.1126/science.1106830; Faraut B, 2011, SLEEP MED REV   0809; Faraut B, 2011, BRAIN BEHAV IMMUN, V25, P16, DOI 10.1016/j.bbi.2010.08.001; Frey DJ, 2007, BRAIN BEHAV IMMUN, V21, P1050, DOI 10.1016/j.bbi.2007.04.003; Gallicchio L, 2009, J SLEEP RES, V18, P148, DOI 10.1111/j.1365-2869.2008.00732.x; Haack M, 2002, PSYCHONEUROENDOCRINO, V27, P921, DOI 10.1016/S0306-4530(02)00006-9; Haack M, 2007, SLEEP, V30, P1145, DOI 10.1093/sleep/30.9.1145; Heemskerk VH, 1999, CYTOKINE GROWTH F R, V10, P5, DOI 10.1016/S1359-6101(98)00022-7; Heslop Pauline, 2002, Sleep Med, V3, P305, DOI 10.1016/S1389-9457(02)00016-3; Horne BD, 2005, J AM COLL CARDIOL, V45, P1638, DOI 10.1016/j.jacc.2005.02.054; Inoue T, 2008, INT J CARDIOL, V124, P319, DOI 10.1016/j.ijcard.2007.02.012; Irwin M, 1999, J CLIN ENDOCR METAB, V84, P1979, DOI 10.1210/jc.84.6.1979; Irwin MR, 2010, BRAIN BEHAV IMMUN, V24, P54, DOI 10.1016/j.bbi.2009.06.001; Ishigaki Y, 2008, CIRCULATION, V118, P75, DOI 10.1161/CIRCULATIONAHA.107.745174; Kerkhofs M, 2007, MATURITAS, V56, P212, DOI 10.1016/j.maturitas.2006.07.007; King CR, 2008, JAMA-J AM MED ASSOC, V300, P2859, DOI 10.1001/jama.2008.867; Lange T, 2011, BRAIN BEHAV IMMUN, V25, P14, DOI 10.1016/j.bbi.2010.08.008; Larsson A, 2008, CLIN BIOCHEM, V41, P859, DOI 10.1016/j.clinbiochem.2008.02.018; Meier-Ewert HK, 2004, J AM COLL CARDIOL, V43, P678, DOI 10.1016/j.jacc.2003.07.050; Meier-Ewert HK, 2001, CLIN CHEM, V47, P426; Miller MA, 2009, SLEEP, V32, P857; Moguilevsky N, 2004, BIOCHEM BIOPH RES CO, V323, P1223, DOI 10.1016/j.bbrc.2004.08.220; National Sleep Foundation, 2009, 2009 SLEEP AM POLL; OLIVARES R, 1993, AM J EPIDEMIOL, V137, P49, DOI 10.1093/oxfordjournals.aje.a116601; OSCARSSON J, 1995, CLIN ENDOCRINOL, V42, P673, DOI 10.1111/j.1365-2265.1995.tb02699.x; Rechtschaffen A., 1968, BRAIN INFORM SERVICE; Spiegel K, 2000, AM J PHYSIOL-REG I, V279, pR8746; Tsimikas S, 2006, J AM COLL CARDIOL, V47, pC19, DOI 10.1016/j.jacc.2005.10.066; Tsimikas S, 2008, AM J CARDIOL, V101, p34D, DOI 10.1016/j.amjcard.2008.02.006; Van Antwerpen P, 2010, J BIOL CHEM, V285, P16351, DOI 10.1074/jbc.M109.089748; van Leeuwen WMA, 2010, INT J ENDOCRINOL, V2010, DOI 10.1155/2010/108641; van Leeuwen WMA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004589; Veldhuis JD, 1996, SLEEP, V19, pS221, DOI 10.1093/sleep/19.suppl_10.S221; ZALOKAR JB, 1981, NEW ENGL J MED, V304, P465, DOI 10.1056/NEJM198102193040806	40	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e28230	10.1371/journal.pone.0028230	http://dx.doi.org/10.1371/journal.pone.0028230			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140557	Green Submitted, gold, Green Published			2022-12-27	WOS:000298168100055
J	Yang, JR; Huang, YP; Chang, FY; Hsu, LC; Lin, YC; Su, CH; Chen, PJ; Wu, HS; Liu, MT				Yang, Ji-Rong; Huang, Yuan-Pin; Chang, Feng-Yee; Hsu, Li-Ching; Lin, Yu-Cheng; Su, Chun-Hui; Chen, Pei-Jer; Wu, Ho-Sheng; Liu, Ming-Tsan			New Variants and Age Shift to High Fatality Groups Contribute to Severe Successive Waves in the 2009 Influenza Pandemic in Taiwan	PLOS ONE			English	Article							H1N1 VIRUS-INFECTION; A H1N1; HOSPITALIZED-PATIENTS; UNITED-STATES; VIRULENCE	Past influenza pandemics have been characterized by the signature feature of multiple waves. However, the reasons for multiple waves in a pandemic are not understood. Successive waves in the 2009 influenza pandemic, with a sharp increase in hospitalized and fatal cases, occurred in Taiwan during the winter of 2010. In this study, we sought to discover possible contributors to the multiple waves in this influenza pandemic. We conducted a large-scale analysis of 4703 isolates in an unbiased manner to monitor the emergence, dominance and replacement of various variants. Based on the data from influenza surveillance and epidemic curves of each variant clade, we defined virologically and temporally distinct waves of the 2009 pandemic in Taiwan from May 2009 to April 2011 as waves 1 and 2, an interwave period and wave 3. Except for wave 3, each wave was dominated by one distinct variant. In wave 3, three variants emerged and co-circulated, and formed distinct phylogenetic clades, based on the hemagglutinin (HA) genes and other segments. The severity of influenza was represented as the case fatality ratio (CFR) in the hospitalized cases. The CFRs in waves 1 and 2, the interwave period and wave 3 were 6.4%, 5.1%, 15.2% and 9.8%, respectively. The results highlight the association of virus evolution and variable influenza severity. Further analysis revealed that the major affected groups were shifted in the waves to older individuals, who had higher age-specific CFRs. The successive pandemic waves create challenges for the strategic preparedness of health authorities and make the pandemic uncertain and variable. Our findings indicate that the emergence of new variants and age shift to high fatality groups might contribute potentially to the occurrence of successive severe pandemic waves and offer insights into the adjustment of national responses to mitigate influenza pandemics.	[Yang, Ji-Rong; Huang, Yuan-Pin; Chang, Feng-Yee; Hsu, Li-Ching; Lin, Yu-Cheng; Su, Chun-Hui; Wu, Ho-Sheng; Liu, Ming-Tsan] Ctr Dis Control, Taipei, Taiwan; [Chen, Pei-Jer] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Wu, Ho-Sheng] Taipei Med Univ, Sch Med Lab Sci & Biotechnol, Taipei, Taiwan	Centers For Disease Control - Taiwan; National Taiwan University; Taipei Medical University	Yang, JR (corresponding author), Ctr Dis Control, Taipei, Taiwan.	wuhs@cdc.gov.tw; mtliu@cdc.gov.tw		Chen, Pei-Jer/0000-0001-8316-3785	National Science Council [98-0324-01-F-20, 99-0324-01-F-12]; Centers for Disease Control, Department of Health, Taiwan [DOH99-DC-2027, DOH100-DC-2019, DOH100-DC-2022]	National Science Council(Ministry of Science and Technology, Taiwan); Centers for Disease Control, Department of Health, Taiwan	This study was supported by grants from the National Science Council (National Research Program for Genome Medicine 98-0324-01-F-20 and 99-0324-01-F-12) and the Centers for Disease Control, Department of Health, Taiwan (DOH99-DC-2027, DOH100-DC-2019 and DOH100-DC-2022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANDARANAYAKE D, 2011, EURO SURVEILL, V16; Barr IG, 2010, EUROSURVEILLANCE, V15, P6; Brandsaeter BJ, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-75; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P467; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P521; Christman MC, 2011, INFECT GENET EVOL, V11, P803, DOI 10.1016/j.meegid.2011.02.021; Chutinimitkul S, 2010, J VIROL, V84, P11802, DOI 10.1128/JVI.01136-10; de Vries RP, 2011, J BIOL CHEM, V286, P5868, DOI 10.1074/jbc.M110.193557; Ellis J, 2011, EURO SURVEILL, V16, P19760; Falagas ME, 2011, EPIDEMIOL INFECT, V139, P27, DOI 10.1017/S0950268810002037; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Huang WT, 2010, VACCINE, V28, P7161, DOI 10.1016/j.vaccine.2010.08.069; Igarashi M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008553; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Jayaraman A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017616; Keramarou M, 2011, EURO SURVEILL, V16; Kilander A, 2010, EURO SURVEILL, V15; Louie JK, 2009, JAMA-J AM MED ASSOC, V302, P1896, DOI 10.1001/jama.2009.1583; Lowen AC, 2007, PLOS PATHOG, V3, P1470, DOI 10.1371/journal.ppat.0030151; Mak G, 2011, EURO SURVEILL, V16; Miller MA, 2009, NEW ENGL J MED, V360, P2595, DOI 10.1056/NEJMp0903906; Nelson M, 2009, PLOS CURR INFLUENZA, P1; Nelson MI, 2011, J VIROL, V85, P828, DOI 10.1128/JVI.01762-10; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Nishiura H, 2010, LANCET INFECT DIS, V10, P443, DOI 10.1016/S1473-3099(10)70120-1; POEPPL W, 2011, INFECTION; Presanis AM, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000207; Schrauwen EJA, 2011, EMERG INFECT DIS, V17, P200, DOI 10.3201/eid1702.101268; Shih SR, 2005, J CLIN MICROBIOL, V43, P1651, DOI 10.1128/JCM.43.4.1651-1661.2005; Shrestha SS, 2011, CLIN INFECT DIS, V52, pS75, DOI 10.1093/cid/ciq012; Skarbinski J, 2011, CLIN INFECT DIS, V52, pS50, DOI 10.1093/cid/ciq021; Song MS, 2011, J VIROL, V85, P6275, DOI 10.1128/JVI.02125-10; Stevens J, 2006, J MOL BIOL, V355, P1143, DOI 10.1016/j.jmb.2005.11.002; Truelove SA, 2011, J INFECT DIS, V203, P828, DOI 10.1093/infdis/jiq117; Webb SAR, 2009, NEW ENGL J MED, V361, P1925, DOI 10.1056/NEJMoa0908481; WILKING H, 2010, EURO SURVEILL, V15; Yang JR, 2010, ANTIVIR RES, V88, P256, DOI 10.1016/j.antiviral.2010.09.014; Yang JR, 2009, J CLIN MICROBIOL, V47, P3714, DOI 10.1128/JCM.01646-09	38	22	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e28288	10.1371/journal.pone.0028288	http://dx.doi.org/10.1371/journal.pone.0028288			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140569	Green Submitted, Green Published, gold			2022-12-27	WOS:000298168100061
J	Kim, DK; Lillehoj, H; Min, W; Kim, CH; Park, MS; Hong, YH; Lillehoj, EP				Kim, Duk Kyung; Lillehoj, Hyun; Min, Wongi; Kim, Chul Hong; Park, Myeong Seon; Hong, Yeong Ho; Lillehoj, Erik P.			Comparative Microarray Analysis of Intestinal Lymphocytes following Eimeria acervulina, E. maxima, or E. tenella Infection in the Chicken	PLOS ONE			English	Article							GENE-EXPRESSION; MOLECULAR-CLONING; LIPOPOLYSACCHARIDE; COCCIDIOSIS	Relative expression levels of immune-and non-immune-related mRNAs in chicken intestinal intraepithelial lymphocytes experimentally infected with Eimeria acervulina, E. maxima, or E. tenella were measured using a 10K cDNA microarray. Based on a cutoff of >2.0-fold differential expression compared with uninfected controls, relatively equal numbers of transcripts were altered by the three Eimeria infections at 1, 2, and 3 days post-primary infection. By contrast, E. tenella elicited the greatest number of altered transcripts at 4, 5, and 6 days post-primary infection, and at all time points following secondary infection. When analyzed on the basis of up-or down-regulated transcript levels over the entire 6 day infection periods, approximately equal numbers of up-regulated transcripts were detected following E. tenella primary (1,469) and secondary (1,459) infections, with a greater number of down-regulated mRNAs following secondary (1,063) vs. primary (890) infection. On the contrary, relatively few mRNA were modulated following primary infection with E. acervulina (35 up, 160 down) or E. maxima (65 up, 148 down) compared with secondary infection (E. acervulina, 1,142 up, 1,289 down; E. maxima, 368 up, 1,349 down). With all three coccidia, biological pathway analysis identified the altered transcripts as belonging to the categories of "Disease and Disorder" and "Physiological System Development and Function". Sixteen intracellular signaling pathways were identified from the differentially expressed transcripts following Eimeria infection, with the greatest significance observed following E. acervulina infection. Taken together, this new information will expand our understanding of host-pathogen interactions in avian coccidiosis and contribute to the development of novel disease control strategies.	[Kim, Duk Kyung; Lillehoj, Hyun; Kim, Chul Hong; Park, Myeong Seon] ARS, Anim Parasit Dis Lab, Anim & Nat Resources Inst, Beltsville Agr Res Ctr,USDA, Beltsville, MD USA; [Min, Wongi] Gyeongsang Natl Univ, Coll Vet Med, Jinju, South Korea; [Min, Wongi] Gyeongsang Natl Univ, Life Sci Res Inst, Jinju, South Korea; [Hong, Yeong Ho] Chung Ang Univ, Dept Anim Sci & Technol, Anseong, South Korea; [Lillehoj, Erik P.] Univ Maryland, Sch Med, Dept Pediat, Baltimore, MD 21201 USA	United States Department of Agriculture (USDA); Gyeongsang National University; Gyeongsang National University; Chung Ang University; University System of Maryland; University of Maryland Baltimore	Kim, DK (corresponding author), ARS, Anim Parasit Dis Lab, Anim & Nat Resources Inst, Beltsville Agr Res Ctr,USDA, Beltsville, MD USA.	Hyun.Lillehoj@ars.usda.gov		Lillehoj, Erik/0000-0002-2710-1704; Min, Wongi/0000-0003-2437-7366; Hong, Yeong Ho/0000-0002-4510-7851	ARS in-house CRIS [1265-32000-086]; WCU through the National Research Foundation of Korea [R33-10013]; Ministry of Education, Science and Technology, Republic of Korea; Rural Development Administration, Republic of Korea [PJ008084]	ARS in-house CRIS; WCU through the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology, Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	This project was supported, in part, by an ARS in-house CRIS project 1265-32000-086, the WCU Program (R33-10013) through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology, Republic of Korea and a grant from the Next-Generation BioGreen 21 Program (No. PJ008084), Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Conway DP, 2007, POULTRY COCCIDIOSIS, P32; Hedegaard Jakob, 2009, BMC Proc, V3 Suppl 4, pS5; Hong YH, 2006, VET IMMUNOL IMMUNOP, V114, P259, DOI 10.1016/j.vetimm.2006.08.006; Hong YH, 2006, VET IMMUNOL IMMUNOP, V114, P209, DOI 10.1016/j.vetimm.2006.07.007; Hong YH, 2006, DEV COMP IMMUNOL, V30, P919, DOI 10.1016/j.dci.2005.12.007; Hong YH, 2006, VET IMMUNOL IMMUNOP, V110, P339, DOI 10.1016/j.vetimm.2005.11.002; Jimenez-Marin Angeles, 2009, BMC Proc, V3 Suppl 4, pS6, DOI 10.1186/1753-6561-3-S4-S6; Kim CH, 2008, VET IMMUNOL IMMUNOP, V124, P341, DOI 10.1016/j.vetimm.2008.04.013; Kim CH, 2010, DEV COMP IMMUNOL, V34, P344, DOI 10.1016/j.dci.2009.11.006; Kim DK, 2009, POULTRY SCI, V88, P1565, DOI 10.3382/ps.2009-00012; Lee PD, 2002, GENOME RES, V12, P292, DOI 10.1101/gr.217802; Lillehoj HS, 2007, POULTRY SCI, V86, P1491, DOI 10.1093/ps/86.7.1491; Lillehoj HS, 2004, AVIAN DIS, V48, P244, DOI 10.1637/7054; McDougald LR, 2001, AVIAN DIS, V45, P307, DOI 10.2307/1592969; McShane LM, 2003, J MAMMARY GLAND BIOL, V8, P359, DOI 10.1023/B:JOMG.0000010035.57912.5a; Min W, 2003, APPL MICROBIOL BIOT, V62, P392, DOI 10.1007/s00253-003-1303-x; Min WG, 2005, MOL BIOTECHNOL, V30, P143, DOI 10.1385/MB:30:2:143; Morris GM, 2006, BIOTECHNOL ADV, V24, P590, DOI 10.1016/j.biotechadv.2006.06.001; MOTHA MXJ, 1984, VET MICROBIOL, V9, P121, DOI 10.1016/0378-1135(84)90027-0; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; Neerincx Pieter Bt, 2009, BMC Proc, V3 Suppl 4, pS1, DOI 10.1186/1753-6561-3-S4-S1; Nie Haisheng, 2009, BMC Proc, V3 Suppl 4, pS9, DOI 10.1186/1753-6561-3-S4-S9; Prickett Dennis, 2009, BMC Proc, V3 Suppl 4, pS2, DOI 10.1186/1753-6561-3-S4-S2; Shirley MW, 2007, VACCINE, V25, P5540, DOI 10.1016/j.vaccine.2006.12.030; Trout JM, 1996, VET IMMUNOL IMMUNOP, V53, P163, DOI 10.1016/0165-2427(95)05544-4; Williams RB, 1998, INT J PARASITOL, V28, P1089, DOI 10.1016/S0020-7519(98)00066-6	26	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2011	6	11							e27712	10.1371/journal.pone.0027712	http://dx.doi.org/10.1371/journal.pone.0027712			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KW	22140460	gold, Green Published, Green Submitted			2022-12-27	WOS:000298163400013
J	Tanaka, Y; Kawahashi, K; Katagiri, ZI; Nakayama, Y; Mahajan, M; Kioussis, D				Tanaka, Yujiro; Kawahashi, Koji; Katagiri, Zen-Ichiro; Nakayama, Yasuhiro; Mahajan, Milind; Kioussis, Dimitris			Dual Function of Histone H3 Lysine 36 Methyltransferase ASH1 in Regulation of Hox Gene Expression	PLOS ONE			English	Article							RNA-POLYMERASE-II; TRITHORAX-GROUP PROTEIN; SET DOMAIN; DROSOPHILA-MELANOGASTER; PHOSPHATASE 2A; PHD FINGER; STEM-CELLS; MLL; LEUKEMIA; IDENTIFICATION	Hox genes play important roles in haematopoietic development in mammals. ASH1 is a member of the trithorax group (trxG) that is required for proper expression of Hox genes and is preferentially expressed in haematopoietic stem cells. We have recently reported that ASH1 methylates histone H3 at lysine 36 (K36) but its biological function has remained elusive. Here we show that ASH1 regulates Hox gene expression positively and negatively in a leukemic cell line K562 and is required for myelomonocytic differentiation of murine haematopoietic stem cells. ASH1 binds to endogenous Hox loci in K562 cells and its knockdown causes reduced expression of Hox genes. In addition, ASH1 and MLL1 induce more than 100-fold activation of Hox promoters in HeLa cells if expressed simultaneously but not individually. Notably, ASH1 harbouring a point mutation that kills methyltransferase activity is more efficient than wild type ASH1 in Hox gene activation, indicating that K36 methylation is not a prerequisite for Hox gene expression. Moreover, tethering wild type or catalytically inactive methyltransferase domain of ASH1 to a heterologous promoter causes downregulation or upregulation, respectively, of transcription, supporting a hypothesis that K36 methylation imparts repression. Knockdown of ASH1 in K562 cells in vitro causes increased expression of e-globin gene and reduced expression of myelomonocytic markers GPIIb and GPIIIa, whereas knockdown of ASH1 in murine haematopoietic stem cells in vivo results in decreased number of macrophages and granulocytes, a phenotype similar to that induced by loss of mll1 function. Taken together, our data suggest that ASH1 and MLL1 synergize in activation of Hox genes and thereby regulate development of myelomonocytic lineages from haematopoietic stem cells.	[Tanaka, Yujiro; Kawahashi, Koji; Katagiri, Zen-Ichiro] Tokyo Med & Dent Univ, Med Res Inst, Sch Biomed Sci & Biochem Genet, Tokyo, Japan; [Nakayama, Yasuhiro] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Mahajan, Milind] Yale Univ, Yale Ctr Genome Anal, Orange, CT USA; [Tanaka, Yujiro; Kioussis, Dimitris] Natl Inst Med Res, London NW7 1AA, England	Tokyo Medical & Dental University (TMDU); Yale University; Yale University; MRC National Institute for Medical Research	Tanaka, Y (corresponding author), Tokyo Med & Dent Univ, Med Res Inst, Sch Biomed Sci & Biochem Genet, Tokyo, Japan.	ytanaka.bgen@mri.tmd.ac.jp			Japanese Ministry of Culture and Science [20510183, 22116504]	Japanese Ministry of Culture and Science	This study was supported by a Grant-in-Aid to YT from the Japanese Ministry of Culture and Science (grant nos. 20510183 and 22116504). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler HT, 1997, J BIOL CHEM, V272, P28407, DOI 10.1074/jbc.272.45.28407; Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Ammosova T, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-47; An S, 2011, J BIOL CHEM, V286, P8369, DOI 10.1074/jbc.M110.203380; ANDERSSON LC, 1979, INT J CANCER, V23, P143, DOI 10.1002/ijc.2910230202; Baumli S, 2008, EMBO J, V27, P1907, DOI 10.1038/emboj.2008.121; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Brown MA, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-26; Byrd KN, 2003, P NATL ACAD SCI USA, V100, P11535, DOI 10.1073/pnas.1933593100; Chen W, 2008, CANCER CELL, V13, P432, DOI 10.1016/j.ccr.2008.03.005; DiMartino JF, 1999, BRIT J HAEMATOL, V106, P614, DOI 10.1046/j.1365-2141.1999.01439.x; Ernst P, 2004, DEV CELL, V6, P437, DOI 10.1016/S1534-5807(04)00061-9; Hess JL, 2004, TRENDS MOL MED, V10, P500, DOI 10.1016/j.molmed.2004.08.005; Hess JL, 1997, BLOOD, V90, P1799, DOI 10.1182/blood.V90.5.1799; Ingham PW, 1998, INT J DEV BIOL, V42, P423; Joshi AA, 2005, MOL CELL, V20, P971, DOI 10.1016/j.molcel.2005.11.021; Jude CD, 2007, CELL STEM CELL, V1, P324, DOI 10.1016/j.stem.2007.05.019; Katsani KR, 2001, GENE DEV, V15, P2197, DOI 10.1101/gad.201901; Kharchenko PV, 2011, NATURE, V471, P480, DOI 10.1038/nature09725; Klymenko T, 2004, EMBO REP, V5, P373, DOI 10.1038/sj.embor.7400111; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Lagarou A, 2008, GENE DEV, V22, P2799, DOI 10.1101/gad.484208; LAJEUNESSE D, 1995, MECH DEVELOP, V53, P123, DOI 10.1016/0925-4773(95)00430-0; Lan F, 2007, NATURE, V449, P689, DOI 10.1038/nature06192; Levine M, 2011, CELL, V145, P502, DOI 10.1016/j.cell.2011.04.021; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; LOZZIO CB, 1975, BLOOD, V45, P321, DOI 10.1182/blood.V45.3.321.321; Magli MC, 1997, J CELL PHYSIOL, V173, P168, DOI 10.1002/(SICI)1097-4652(199711)173:2<168::AID-JCP16>3.0.CO;2-C; McMahon KA, 2007, CELL STEM CELL, V1, P338, DOI 10.1016/j.stem.2007.07.002; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Minakuchi M, 2001, EUR J BIOCHEM, V268, P1340, DOI 10.1046/j.1432-1327.2001.02000.x; Nakamura T, 2000, P NATL ACAD SCI USA, V97, P7284, DOI 10.1073/pnas.97.13.7284; Nakamura T, 2002, MOL CELL, V10, P1119, DOI 10.1016/S1097-2765(02)00740-2; Papp B, 2006, GENE DEV, V20, P2041, DOI 10.1101/gad.388706; Pirrotta V, 1998, CELL, V93, P333, DOI 10.1016/S0092-8674(00)81162-9; REEVES R, 1985, NUCLEIC ACIDS RES, V13, P3599, DOI 10.1093/nar/13.10.3599; RUTHERFORD TR, 1979, NATURE, V280, P164, DOI 10.1038/280164a0; Schmitges FW, 2011, MOL CELL, V42, P330, DOI 10.1016/j.molcel.2011.03.025; Schwartz YB, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000805; Shashikant CS, 1995, DEVELOPMENT, V121, P4339; SHEARN A, 1978, GENETICS, V89, P341; Smith E, 2011, GENE DEV, V25, P661, DOI 10.1101/gad.2015411; Sung LY, 2006, NAT GENET, V38, P1323, DOI 10.1038/ng1895; Tanaka Y, 2008, BIOCHEM BIOPH RES CO, V365, P589, DOI 10.1016/j.bbrc.2007.10.159; Tanaka Y, 2007, GENE, V397, P161, DOI 10.1016/j.gene.2007.04.027; Tripoulas N, 1996, GENETICS, V143, P913; TRIPOULAS NA, 1994, GENETICS, V137, P1027; Wada T, 1998, GENE DEV, V12, P343, DOI 10.1101/gad.12.3.343; Yamaguchi Y, 1999, CELL, V97, P41, DOI 10.1016/S0092-8674(00)80713-8; YU BD, 1995, NATURE, V378, P505, DOI 10.1038/378505a0; Yuan W, 2011, J BIOL CHEM, V286, P7983, DOI 10.1074/jbc.M110.194027; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	52	32	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2011	6	11							e28171	10.1371/journal.pone.0028171	http://dx.doi.org/10.1371/journal.pone.0028171			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KW	22140534	gold, Green Published, Green Submitted			2022-12-27	WOS:000298163400035
J	Carvalho, A; Osorio, NS; Saraiva, M; Cunha, C; Almeida, AJ; Teixeira-Coelho, M; Ludovico, P; Pedrosa, J; Pitzurra, L; Aversa, F; Romani, L; Castro, AG; Rodrigues, F				Carvalho, Agostinho; Osorio, Nuno S.; Saraiva, Margarida; Cunha, Cristina; Almeida, Agostinho J.; Teixeira-Coelho, Maria; Ludovico, Paula; Pedrosa, Jorge; Pitzurra, Lucia; Aversa, Franco; Romani, Luigina; Castro, Antonio G.; Rodrigues, Fernando			The C Allele of rs5743836 Polymorphism in the Human TLR9 Promoter Links IL-6 and TLR9 Up-Regulation and Confers Increased B-Cell Proliferation	PLOS ONE			English	Article							RECEPTOR GENES; SELF-DNA; DISEASE; SUSCEPTIBILITY; ASSOCIATION; HAPLOTYPES; LYMPHOMA; BINDING	In humans, allelic variants in Toll-like receptors (TLRs) associate with several pathologies. However, the underlying cellular and molecular mechanisms of this association remain largely unknown. Analysis of the human TLR9 promoter revealed that the C allele of the rs5743836 polymorphism generates several regulatory sites, including an IL-6-responding element. Here, we show that, in mononuclear cells carrying the TC genotype of rs5743836, IL-6 up-regulates TLR9 expression, leading to exacerbated cellular responses to CpG, including IL-6 production and B-cell proliferation. Our study uncovers a role for the rs5743836 polymorphism in B-cell biology with implications on TLR9-mediated diseases and on the therapeutic usage of TLR9 agonists/antagonists.	[Carvalho, Agostinho; Osorio, Nuno S.; Saraiva, Margarida; Cunha, Cristina; Almeida, Agostinho J.; Teixeira-Coelho, Maria; Ludovico, Paula; Pedrosa, Jorge; Castro, Antonio G.; Rodrigues, Fernando] Univ Minho, Life & Hlth Sci Res Inst ICVS, Sch Hlth Sci, Braga, Portugal; [Carvalho, Agostinho; Osorio, Nuno S.; Saraiva, Margarida; Cunha, Cristina; Almeida, Agostinho J.; Teixeira-Coelho, Maria; Ludovico, Paula; Pedrosa, Jorge; Castro, Antonio G.; Rodrigues, Fernando] ICVS 3Bs PT Govt Associate Lab, Braga, Portugal; [Carvalho, Agostinho; Cunha, Cristina; Pitzurra, Lucia; Romani, Luigina] Univ Perugia, Dept Expt Med & Biochem Sci, Microbiol Sect, I-06100 Perugia, Italy; [Aversa, Franco] Univ Perugia, Div Hematol & Clin Immunol, Dept Clin & Expt Med, I-06100 Perugia, Italy	Universidade do Minho; University of Perugia; University of Perugia	Carvalho, A (corresponding author), Univ Minho, Life & Hlth Sci Res Inst ICVS, Sch Hlth Sci, Braga, Portugal.	frodrigues@ecsaude.uminho.pt	Rodrigues, Fernando/T-5299-2018; Osório, Nuno S./D-4773-2013; Cunha, Cristina/AAH-9951-2021; Castro, Gil/T-7584-2018; Osório, Nuno S./AAF-4307-2020; Romani, Luigina/O-9987-2018; Rodrigues, Fernando/A-3123-2011; Pedrosa, Jorge/H-4877-2011; Carvalho, Agostinho/D-2667-2009; Ludovico, Paula/B-4338-2011; Cunha, Cristina/D-2687-2009; Saraiva, Margarida/E-8781-2011	Rodrigues, Fernando/0000-0001-8436-9398; Osório, Nuno S./0000-0003-0949-5399; Cunha, Cristina/0000-0002-6002-5782; Castro, Gil/0000-0002-4684-4183; Osório, Nuno S./0000-0003-0949-5399; Pedrosa, Jorge/0000-0002-8204-4888; Carvalho, Agostinho/0000-0001-8935-8030; Ludovico, Paula/0000-0003-4130-7167; Cunha, Cristina/0000-0002-6002-5782; Saraiva, Margarida/0000-0002-8180-1293; Pitzurra, Lucia/0000-0002-6866-7982; Romani, Luigina/0000-0002-1356-525X; Ramalho Almeida, Agostinho Joao/0000-0002-3367-0540; Aversa, Franco/0000-0002-8871-6817; Teixeira-Coelho, Maria/0000-0003-1435-9332	FCT [PIC/IC/83313/2007]	FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	A. Carvalho, N.S. Osorio, M. Teixeira-Coelho, A.J. Almeida, M. Saraiva and C. Cunha were financially supported by Fundacao para a Ciencia e Tecnologia (FCT), Portugal. This study was supported by FCT - Grant Number PIC/IC/83313/2007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berrington WR, 2007, IMMUNOL REV, V219, P167, DOI 10.1111/j.1600-065X.2007.00545.x; Bourke E, 2003, BLOOD, V102, P956, DOI 10.1182/blood-2002-11-3355; Carvalho A, 2008, J INFECT DIS, V197, P618, DOI 10.1086/526500; Carvalho A, 2012, GENES IMMUN, V13, P197, DOI 10.1038/gene.2011.59; Carvalho A, 2009, EXP HEMATOL, V37, P1022, DOI 10.1016/j.exphem.2009.06.004; Deane JA, 2006, J IMMUNOL, V177, P6573, DOI 10.4049/jimmunol.177.10.6573; Duan HO, 2003, J BIOL CHEM, V278, P41270, DOI 10.1074/jbc.M304210200; Gilliet M, 2008, CURR OPIN IMMUNOL, V20, P401, DOI 10.1016/j.coi.2008.06.008; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Jahrsdorfer B, 2005, CLIN CANCER RES, V11, P1490, DOI 10.1158/1078-0432.CCR-04-1890; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Krieg AM, 2006, NAT REV DRUG DISCOV, V5, P471, DOI 10.1038/nrd2059; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; Lazarus R, 2003, GENOMICS, V81, P85, DOI 10.1016/S0888-7543(02)00022-8; Mollaki V, 2009, J HUM GENET, V54, P655, DOI 10.1038/jhg.2009.90; Ng MTH, 2010, INFECT IMMUN, V78, P1345, DOI 10.1128/IAI.01226-09; Pine SO, 2009, AIDS, V23, P2387, DOI 10.1097/QAD.0b013e328330b489; Takeshita F, 2004, J IMMUNOL, V173, P2552, DOI 10.4049/jimmunol.173.4.2552; Torok HP, 2004, GASTROENTEROLOGY, V127, P365, DOI 10.1053/j.gastro.2004.05.051	19	29	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e28256	10.1371/journal.pone.0028256	http://dx.doi.org/10.1371/journal.pone.0028256			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132241	Green Published, gold, Green Submitted			2022-12-27	WOS:000298162000088
J	Tian, Y; Jia, ZC; Wang, J; Huang, ZM; Tang, J; Zheng, YH; Tang, Y; Wang, QH; Tian, ZQ; Yang, D; Zhang, Y; Fu, XL; Song, JX; Liu, SL; van Velkinburgh, JC; Wu, YZ; Ni, B				Tian, Yi; Jia, Zhengcai; Wang, Jun; Huang, Zemin; Tang, Jun; Zheng, Yanhua; Tang, Yan; Wang, Qinghong; Tian, Zhiqiang; Yang, Di; Zhang, Yi; Fu, Xiaolan; Song, Jianxun; Liu, Shunli; van Velkinburgh, Jennifer C.; Wu, Yuzhang; Ni, Bing			Global Mapping of H3K4me1 and H3K4me3 Reveals the Chromatin State-Based Cell Type-Specific Gene Regulation in Human Treg Cells	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; T-CELLS; GENOME-WIDE; HISTONE MODIFICATIONS; FOXP3 EXPRESSION; DNA METHYLATION; SACCHAROMYCES-CEREVISIAE; ACETYLATION; PROMOTERS; LINEAGE	Regulatory T cells (Treg) contribute to the crucial immunological processes of self-tolerance and immune homeostasis. Genomic mechanisms that regulate cell fate decisions leading to Treg or conventional T cells (Tconv) lineages and those underlying Treg function remain to be fully elucidated, especially at the histone modification level. We generated high-resolution genome-wide distribution maps of monomethylated histone H3 lysine 4 (H3K4me1) and trimethylated H3K4 (H3K4me3) in human CD4(+)CD25(+)FOXP3(+) Tregs and CD4(+)CD25(+)FOXP3(-) activated (a) Tconv cells by DNA sequencing-by-synthesis. 2115 H3K4me3 regions corresponded to proximal promoters; in Tregs, the genes associated with these regions included the master regulator FOXP3 and the chemokine (C-C motif) receptor 7 (CCR7). 41024 Treg-specific H3K4me1 regions were identified. The majority of the H3K4me1 regions differing between Treg and aTconv cells were located at promoter-distal sites, and in vitro reporter gene assays were used to evaluate and identify novel enhancer activity. We provide for the first time a comprehensive genome-wide dataset of lineage-specific H3K4me1 and H3K4me3 patterns in Treg and aTconv cells, which may control cell type-specific gene regulation. This basic principle is likely not restricted to the two closely-related T cell populations, but may apply generally to somatic cell lineages in adult organisms.	[Tian, Yi; Jia, Zhengcai; Huang, Zemin; Tang, Jun; Zheng, Yanhua; Tang, Yan; Wang, Qinghong; Tian, Zhiqiang; Yang, Di; Zhang, Yi; Fu, Xiaolan; Liu, Shunli; Wu, Yuzhang; Ni, Bing] Third Mil Med Univ, PLA, Inst Immunol, Chongqing, Peoples R China; [Wang, Jun] Beijing Genom Inst Branch Shenzhen, Shenzhen, Peoples R China; [Song, Jianxun] Penn State Univ, Coll Med, Dept Microbiol & Immunol, Hershey, PA USA; [van Velkinburgh, Jennifer C.] Initiat Collaboratory BioMed Res, Santa Fe, NM USA	Army Medical University; Beijing Genomics Institute (BGI); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Tian, Y (corresponding author), Third Mil Med Univ, PLA, Inst Immunol, Chongqing, Peoples R China.	wuyuzhang@yahoo.com; nibingxi@yahoo.com	Wang, Jun/A-7261-2013; wang, qinghong/M-7969-2017; yang, zheng/HGC-7753-2022; Wang, Jun/B-9503-2016; Wang, Jun/C-8434-2016; van Velkinburgh, Jennifer/D-7205-2015	Ni, Bing/0000-0002-4297-5346; Wu, Yuzhang/0000-0002-4049-0214; Wang, Jun/0000-0002-2113-5874; Wang, Jun/0000-0002-8540-8931; van Velkinburgh, Jennifer/0000-0002-4592-2397	Major State Basic Research Development Program of China (973 Program) [2007CB512805, 2007CB512401]; National Natural Science Foundation of China [30771950, 31070798]; Chongqing Science and Technology Committee [2008BB5033]	Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chongqing Science and Technology Committee	This work was supported by grants from the Major State Basic Research Development Program of China (973 Program) (Nos. 2007CB512805 and 2007CB512401), http://www.most.gov.cn/index.htm, the General Program of National Natural Science Foundation of China (No. 30771950, and 31070798), http://www.nsfc.gov.cn/ and the Chongqing Science and Technology Committee (2008BB5033), http://www.ctin.ac.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antov A, 2003, J IMMUNOL, V171, P3435, DOI 10.4049/jimmunol.171.7.3435; Araki Y, 2008, J IMMUNOL, V180, P8102, DOI 10.4049/jimmunol.180.12.8102; Arya M, 2005, EXPERT REV MOL DIAGN, V5, P209, DOI 10.1586/14737159.5.2.209; Aschenbrenner K, 2007, NAT IMMUNOL, V8, P351, DOI 10.1038/ni1444; Baron U, 2007, EUR J IMMUNOL, V37, P2378, DOI 10.1002/eji.200737594; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2002, P NATL ACAD SCI USA, V99, P8695, DOI 10.1073/pnas.082249499; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Chong MMW, 2008, J EXP MED, V205, P2449, DOI [10.1084/jem.20071219090508c, 10.1084/jem.20081219]; Floess S, 2007, PLOS BIOL, V5, P169, DOI 10.1371/journal.pbio.0050038; Fontenot JD, 2005, J EXP MED, V202, P901, DOI 10.1084/jem.20050784; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hoffmann P, 2006, BLOOD, V108, P4260, DOI 10.1182/blood-2006-06-027409; Hon G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000566; HOU JZ, 1995, IMMUNITY, V2, P321, DOI 10.1016/1074-7613(95)90140-X; Huehn J, 2009, NAT REV IMMUNOL, V9, P83, DOI 10.1038/nri2474; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim HP, 2007, J EXP MED, V204, P1543, DOI 10.1084/jem.20070109; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lee CK, 2004, NAT GENET, V36, P900, DOI 10.1038/ng1400; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Liston A, 2008, J EXP MED, V205, P1993, DOI 10.1084/jem.20081062; Liston A, 2008, P NATL ACAD SCI USA, V105, P11903, DOI 10.1073/pnas.0801506105; Liu CL, 2005, PLOS BIOL, V3, P1753, DOI 10.1371/journal.pbio.0030328; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Millar CB, 2006, NAT REV MOL CELL BIO, V7, P657, DOI 10.1038/nrm1986; Millar CB, 2006, GENE DEV, V20, P711, DOI 10.1101/gad.1395506; Nocentini G, 1997, P NATL ACAD SCI USA, V94, P6216, DOI 10.1073/pnas.94.12.6216; Ozsolak F, 2007, NAT BIOTECHNOL, V25, P244, DOI 10.1038/nbt1279; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Polansky JK, 2008, EUR J IMMUNOL, V38, P1654, DOI 10.1002/eji.200838105; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; ROBB RJ, 1981, J EXP MED, V154, P1455, DOI 10.1084/jem.154.5.1455; Roh TY, 2006, P NATL ACAD SCI USA, V103, P15782, DOI 10.1073/pnas.0607617103; Roh TY, 2005, GENE DEV, V19, P542, DOI 10.1101/gad.1272505; Schmidl C, 2009, GENOME RES, V19, P1165, DOI 10.1101/gr.091470.109; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; WALUNAS TL, 1994, IMMUNITY, V1, P405, DOI 10.1016/1074-7613(94)90071-X; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Yamazaki S, 2003, J EXP MED, V198, P235, DOI 10.1084/jem.20030422; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; Zhang HY, 2005, CELL, V123, P219, DOI 10.1016/j.cell.2005.08.036; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao XD, 2007, CELL STEM CELL, V1, P286, DOI 10.1016/j.stem.2007.08.004; Zhou XY, 2008, J EXP MED, V205, P1983, DOI 10.1084/jem.20080707; Zorn E, 2006, BLOOD, V108, P1571, DOI 10.1182/blood-2006-02-004747	54	32	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e27770	10.1371/journal.pone.0027770	http://dx.doi.org/10.1371/journal.pone.0027770			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132139	Green Published, Green Submitted, gold			2022-12-27	WOS:000298162000041
J	Xu, XB; Steere, RR; Fedorchuk, CA; Pang, JJ; Lee, JY; Lim, JH; Xu, HD; Pan, ZXK; Maggirwar, SB; Li, JD				Xu, Xiangbin; Steere, Rachel R.; Fedorchuk, Christine A.; Pang, Jinjiang; Lee, Ji-Yun; Lim, Jae Hyang; Xu, Haidong; Pan, Zhixing K.; Maggirwar, Sanjay B.; Li, Jian-Dong			Activation of Epidermal Growth Factor Receptor Is Required for NTHi-Induced NF-kappa B-Dependent Inflammation	PLOS ONE			English	Article							NONTYPABLE HAEMOPHILUS-INFLUENZAE; BRONCHIAL EPITHELIAL-CELLS; SIGNALING CASCADE; AIRWAY EPITHELIUM; MUCIN PRODUCTION; OTITIS-MEDIA; EGFR; P38; INTERLEUKIN-8; EXPRESSION	Background: Inflammation is a hallmark of many serious human diseases. Nontypeable Haemophilus influenzae (NTHi) is an important human pathogen causing respiratory tract infections in both adults and children. NTHi infections are characterized by inflammation, which is mainly mediated by nuclear transcription factor-kappa B (NF-kappa B)-dependent production of proinflammatory mediators. Epidermal growth factor receptor (EGFR) has been shown to play important roles in regulating diverse biological processes, including cell growth, differentiation, apoptosis, adhesion, and migration. Its role in regulating NF-kappa B activation and inflammation, however, remains largely unknown. Methodology/Principal Findings: In the present study, we demonstrate that EGFR plays a vital role in NTHi-induced NF-kappa B activation and the subsequent induction of proinflammatory mediators in human middle ear epithelial cells and other cell types. Importantly, we found that AG1478, a specific tyrosine kinase inhibitor of EGFR potently inhibited NTHi-induced inflammatory responses in the middle ears and lungs of mice in vivo. Moreover, we found that MKK3/6-p38 and PI3K/Akt signaling pathways are required for mediating EGFR-dependent NF-kappa B activation and inflammatory responses by NTHi. Conclusions/Significance: Here, we provide direct evidence that EGFR plays a critical role in mediating NTHi-induced NF-kappa B activation and inflammation in vitro and in vivo. Given that EGFR inhibitors have been approved in clinical use for the treatment of cancers, current studies will not only provide novel insights into the molecular mechanisms underlying the regulation of inflammation, but may also lead to the development of novel therapeutic strategies for the treatment of respiratory inflammatory diseases and other inflammatory diseases.	[Xu, Xiangbin; Steere, Rachel R.; Fedorchuk, Christine A.; Lee, Ji-Yun; Lim, Jae Hyang; Xu, Haidong; Maggirwar, Sanjay B.; Li, Jian-Dong] Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA; [Pang, Jinjiang] Univ Rochester, Med Ctr, Aab Cardiovasc Res Inst, Rochester, NY 14642 USA; [Lee, Ji-Yun; Lim, Jae Hyang; Xu, Haidong; Li, Jian-Dong] Georgia State Univ, Dept Biol, Ctr Inflammat Immun & Infect, Atlanta, GA USA; [Pan, Zhixing K.] Univ Toledo, Dept Med Microbiol & Immunol, Med Ctr, Toledo, OH 43606 USA	University of Rochester; University of Rochester; University System of Georgia; Georgia State University; University System of Ohio; University of Toledo	Xu, XB (corresponding author), Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA.	Xiangbin_Xu@urmc.rochester.edu; jdli@gsu.edu		Lim, Jae Hyang/0000-0003-0972-9271; Li, Jian-Dong/0000-0002-5593-050X	National Institutes of Health [DC010048, DC005843, DC004562, AI073374, NS054578, NS066801, AHA 10SDG2630077]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073374] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054578, R01NS066801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC010048, R01DC004562, R01DC005843] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by grants from National Institutes of Health DC010048 (to X. X.), DC005843, DC004562 and AI073374 (to J.D.L), NS054578, NS066801 (to S.B.M) and AHA 10SDG2630077 (to J.H.L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amishima M, 1998, AM J RESP CRIT CARE, V157, P1907, DOI 10.1164/ajrccm.157.6.9609040; Blanchet S, 2004, AM J RESP CELL MOL, V30, P421, DOI 10.1165/rcmb.2003-0281RC; BLUESTONE CD, 1982, NEW ENGL J MED, V306, P1399, DOI 10.1056/NEJM198206103062305; Bonner JC, 2002, AM J PHYSIOL-LUNG C, V283, pL528, DOI 10.1152/ajplung.00126.2002; Burgel PR, 2004, THORAX, V59, P992, DOI 10.1136/thx.2003.018879; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; Chun YM, 2002, ANN OTO RHINOL LARYN, V111, P507, DOI 10.1177/000348940211100606; Echchannaoui H, 2002, J INFECT DIS, V186, P798, DOI 10.1086/342845; Foxwell AR, 1998, MICROBIOL MOL BIOL R, V62, P294, DOI 10.1128/MMBR.62.2.294-308.1998; Frey MR, 2006, EMBO J, V25, P5683, DOI 10.1038/sj.emboj.7601457; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Huang SM, 1999, INVEST NEW DRUG, V17, P259, DOI 10.1023/A:1006384521198; Hur GY, 2007, EXP MOL MED, V39, P367, DOI 10.1038/emm.2007.41; Jeon KI, 2010, P NATL ACAD SCI USA, V107, P9795, DOI 10.1073/pnas.0914414107; Koff JL, 2008, AM J PHYSIOL-LUNG C, V294, pL1068, DOI 10.1152/ajplung.00025.2008; KUKLINSKA D, 1984, EUR J CLIN MICROBIOL, V3, P249, DOI 10.1007/BF02014895; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Le Page C, 2005, PROSTATE, V65, P306, DOI 10.1002/pros.20291; Mikami F, 2005, J BIOL CHEM, V280, P36185, DOI 10.1074/jbc.M503941200; MURPHY TF, 1992, AM REV RESPIR DIS, V146, P1067, DOI 10.1164/ajrccm/146.4.1067; MURPHY TF, 1987, REV INFECT DIS, V9, P1; Murphy TF, 2000, PEDIATR INFECT DIS J, V19, pS9, DOI 10.1097/00006454-200005001-00003; Nakanaga T, 2007, AM J PHYSIOL-LUNG C, V292, pL1289, DOI 10.1152/ajplung.00356.2006; Ogus AC, 2004, EUR RESPIR J, V23, P219, DOI 10.1183/09031936.03.00061703; Puddicombe SM, 2000, FASEB J, V14, P1362, DOI 10.1096/fj.14.10.1362; Richard KL, 2008, J NEUROSCI, V28, P5784, DOI 10.1523/JNEUROSCI.1146-08.2008; Richter A, 2002, AM J RESP CELL MOL, V27, P85, DOI 10.1165/ajrcmb.27.1.4789; Rothwarf D M, 1999, Sci STKE, V1999, pRE1, DOI 10.1126/stke.1999.5.re1; Shuto T, 2001, P NATL ACAD SCI USA, V98, P8774, DOI 10.1073/pnas.151236098; Takeuchi O, 2000, J IMMUNOL, V165, P5392, DOI 10.4049/jimmunol.165.10.5392; Takeyama K, 1999, P NATL ACAD SCI USA, V96, P3081, DOI 10.1073/pnas.96.6.3081; Tetley Teresa D., 2005, Current Drug Targets - Inflammation and Allergy, V4, P607, DOI 10.2174/156801005774912824; Tjabringa GS, 2003, J IMMUNOL, V171, P6690, DOI 10.4049/jimmunol.171.12.6690; Vargaftig BB, 2003, AM J PHYSIOL-LUNG C, V285, pL808, DOI 10.1152/ajplung.00377.2002; Wang BN, 2003, INFECT IMMUN, V71, P5523, DOI 10.1128/IAI.71.10.5523-5530.2003; Wang X, 2003, NATURE, V424, P456, DOI 10.1038/nature01818; Watanabe T, 2004, P NATL ACAD SCI USA, V101, P3563, DOI 10.1073/pnas.0400557101; Wong WSF, 2005, CURR OPIN PHARMACOL, V5, P264, DOI 10.1016/j.coph.2005.01.009; Xu KM, 2007, CANCER RES, V67, P6121, DOI 10.1158/0008-5472.CAN-07-0141; Yim JJ, 2006, GENES IMMUN, V7, P150, DOI 10.1038/sj.gene.6364274	40	23	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e28216	10.1371/journal.pone.0028216	http://dx.doi.org/10.1371/journal.pone.0028216			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132240	gold, Green Submitted, Green Published			2022-12-27	WOS:000298162000087
J	Milano, I; Babbucci, M; Panitz, F; Ogden, R; Nielsen, RO; Taylor, MI; Helyar, SJ; Carvalho, GR; Espineira, M; Atanassova, M; Tinti, F; Maes, GE; Patarnello, T; Bargelloni, L				Milano, Ilaria; Babbucci, Massimiliano; Panitz, Frank; Ogden, Rob; Nielsen, Rasmus O.; Taylor, Martin I.; Helyar, Sarah J.; Carvalho, Gary R.; Espineira, Montserrat; Atanassova, Miroslava; Tinti, Fausto; Maes, Gregory E.; Patarnello, Tomaso; Bargelloni, Luca		FishPopTrace Consortium	Novel Tools for Conservation Genomics: Comparing Two High-Throughput Approaches for SNP Discovery in the Transcriptome of the European Hake	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; MERLUCCIUS-MERLUCCIUS; POPULATION GENOMICS; GENETIC-STRUCTURE; GENERATION; FISHERIES; ECOLOGY; STOCKS; FLOW; BAY	The growing accessibility to genomic resources using next-generation sequencing (NGS) technologies has revolutionized the application of molecular genetic tools to ecology and evolutionary studies in non-model organisms. Here we present the case study of the European hake (Merluccius merluccius), one of the most important demersal resources of European fisheries. Two sequencing platforms, the Roche 454 FLX (454) and the Illumina Genome Analyzer (GAII), were used for Single Nucleotide Polymorphisms (SNPs) discovery in the hake muscle transcriptome. De novo transcriptome assembly into unique contigs, annotation, and in silico SNP detection were carried out in parallel for 454 and GAII sequence data. High-throughput genotyping using the Illumina GoldenGate assay was performed for validating 1,536 putative SNPs. Validation results were analysed to compare the performances of 454 and GAII methods and to evaluate the role of several variables (e.g. sequencing depth, intron-exon structure, sequence quality and annotation). Despite well-known differences in sequence length and throughput, the two approaches showed similar assay conversion rates (approximately 43%) and percentages of polymorphic loci (67.5% and 63.3% for GAII and 454, respectively). Both NGS platforms therefore demonstrated to be suitable for large scale identification of SNPs in transcribed regions of non-model species, although the lack of a reference genome profoundly affects the genotyping success rate. The overall efficiency, however, can be improved using strict quality and filtering criteria for SNP selection (sequence quality, intron-exon structure, target region score).	[Milano, Ilaria; Tinti, Fausto] Univ Bologna, Dept Expt & Evolutionary Biol, Bologna, Italy; [Babbucci, Massimiliano; Patarnello, Tomaso; Bargelloni, Luca] Univ Padua, Dept Publ Hlth Comparat Pathol & Vet Hyg, Legnaro, Italy; [Panitz, Frank; Nielsen, Rasmus O.] Aarhus Univ, Dept Mol Biol & Genet, Fac Sci & Technol, Tjele, Denmark; [Ogden, Rob] Royal Zool Soc Scotland, TRACE Wildlife Forens Network, Edinburgh, Midlothian, Scotland; [Taylor, Martin I.; Helyar, Sarah J.; Carvalho, Gary R.] Univ Bangor, Mol Ecol & Fisheries Genet Lab MEFGL, Sch Biol Sci, Environm Ctr Wales, Bangor, Gwynedd, Wales; [Espineira, Montserrat; Atanassova, Miroslava] ANFACO CECOPECSA, Vigo, Spain; [Maes, Gregory E.] Katholieke Univ Leuven, Lab Anim Divers & Systemat, Louvain, Belgium	University of Bologna; University of Padua; Aarhus University; Bangor University; KU Leuven	Milano, I (corresponding author), Univ Bologna, Dept Expt & Evolutionary Biol, Bologna, Italy.	ilaria.milano2@unibo.it	Taylor, Martin I/B-4298-2013; Tinti, Fausto/D-4847-2012; Panitz, Frank/A-3281-2017; Atanassova, Miroslava/AAE-4547-2020; Maes, Gregory/N-4983-2019; Maes, Gregory/C-5450-2008; Helyar, Sarah/C-4988-2013	Tinti, Fausto/0000-0002-8649-5387; Panitz, Frank/0000-0002-6909-5162; Atanassova, Miroslava/0000-0001-7636-3084; Maes, Gregory/0000-0002-1531-7321; Maes, Gregory/0000-0002-1531-7321; PATARNELLO, Tomaso/0000-0003-1794-5791; Helyar, Sarah/0000-0002-1600-997X; BABBUCCI, MASSIMILIANO/0000-0002-4060-4728	European Community [FP7/2007-2013, KBBE-212399]; MerSnip project; Joint Research Council (JRC)	European Community(European Commission); MerSnip project; Joint Research Council (JRC)	The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no KBBE-212399 (FishPopTrace). Financial support for GAII sequencing and SNP discovery was provided by the MerSnip project funded by the Joint Research Council (JRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbazuk WB, 2007, PLANT J, V51, P910, DOI 10.1111/j.1365-313X.2007.03193.x; Beaumont MA, 2004, MOL ECOL, V13, P969, DOI 10.1111/j.1365-294X.2004.02125.x; Binladen J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000197; Birol I, 2009, BIOINFORMATICS, V25, P2872, DOI 10.1093/bioinformatics/btp367; Bluthgen Nils, 2005, Genome Inform, V16, P106; Bonin A, 2008, MOL ECOL, V17, P3583, DOI 10.1111/j.1365-294X.2008.03854.x; CASEY J, 1994, HAKE BIOL FISHERIES, P125; Castillo AGF, 2004, MAR BIOTECHNOL, V6, P299, DOI 10.1007/s10126-004-3027-z; Cimmaruta R, 2005, MOL ECOL, V14, P2577, DOI 10.1111/j.1365-294X.2005.02595.x; Everett MV, 2011, MOL ECOL RESOUR, V11, P93, DOI 10.1111/j.1755-0998.2010.02969.x; Fan JB, 2003, COLD SPRING HARB SYM, V68, P69, DOI 10.1101/sqb.2003.68.69; *FAO, 2010, FAO YB FISH AQU STAT; *FAO, 2010, 12 SESS SCI ADV COMM; FERGUSON A, 1994, REV FISH BIOL FISHER, V4, P379, DOI 10.1007/BF00042911; Ferraresso S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-354; Freamo H, 2011, MOL ECOL RESOUR, V11, P254, DOI 10.1111/j.1755-0998.2010.02952.x; Galindo J, 2010, J EVOLUTION BIOL, V23, P2004, DOI 10.1111/j.1420-9101.2010.02071.x; Garvin MR, 2010, MOL ECOL RESOUR, V10, P915, DOI 10.1111/j.1755-0998.2010.02891.x; Glenn TC, 2011, MOL ECOL RESOUR, V11, P759, DOI 10.1111/j.1755-0998.2011.03024.x; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Hale MC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-203; Hauser L, 2008, FISH FISH, V9, P333, DOI 10.1111/j.1467-2979.2008.00299.x; Hauser L, 2008, FISH FISH, V9, P473, DOI 10.1111/j.1467-2979.2008.00306.x; Helyar SJ, 2011, MOL ECOL RESOUR, V11, P123, DOI 10.1111/j.1755-0998.2010.02943.x; Hemmer-Hansen J, 2011, MOL ECOL RESOUR, V11, P71, DOI 10.1111/j.1755-0998.2010.02940.x; Huang WC, 2008, GENOME RES, V18, P1538, DOI 10.1101/gr.076067.108; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Hubert S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-191; Hudson ME, 2008, MOL ECOL RESOUR, V8, P3, DOI 10.1111/j.1471-8286.2007.02019.x; Kerstens HHD, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-4; Kircher M, 2010, BIOESSAYS, V32, P524, DOI 10.1002/bies.200900181; Kraus RHS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-150; Lepoittevin C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011034; Liu SK, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-53; Luikart G, 2003, NAT REV GENET, V4, P981, DOI 10.1038/nrg1226; Lundy CJ, 2000, MOL ECOL, V9, P2067, DOI 10.1046/j.1365-294X.2000.01120.x; Lundy CJ, 1999, MOL ECOL, V8, P1889, DOI 10.1046/j.1365-294x.1999.00789.x; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Marth GT, 1999, NAT GENET, V23, P452, DOI 10.1038/70570; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Morin PA, 2004, TRENDS ECOL EVOL, V19, P208, DOI 10.1016/j.tree.2004.01.009; MURUA H, 2010, BIOL FISHERIES EUROP, P97; Nielsen EE, 2009, MOL ECOL, V18, P3128, DOI 10.1111/j.1365-294X.2009.04272.x; Novaes E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-312; OLIVER P, 1994, HAKE BIOL FISHERIES, P181; Panitz F, 2007, BIOINFORMATICS, V23, pI387, DOI 10.1093/bioinformatics/btm192; Paszkiewicz K, 2010, BRIEF BIOINFORM, V11, P457, DOI 10.1093/bib/bbq020; Pita A, 2010, THALASSAS, V26, P129; Pita A, 2011, CONT SHELF RES, V31, P376, DOI 10.1016/j.csr.2010.09.010; Reiss H, 2009, FISH FISH, V10, P361, DOI 10.1111/j.1467-2979.2008.00324.x; Renaut S, 2010, MOL ECOL, V19, P115, DOI 10.1111/j.1365-294X.2009.04477.x; Roldan MI, 1998, HEREDITY, V81, P327, DOI 10.1046/j.1365-2540.1998.00383.x; Sanchez CC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-559; Seeb JE, 2011, MOL ECOL RESOUR, V11, P1, DOI 10.1111/j.1755-0998.2010.02979.x; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Vera M, 2011, AQUACULTURE, V313, P31, DOI 10.1016/j.aquaculture.2011.01.038; Wall PK, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-347; Wang SL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-450; Weber APM, 2007, PLANT PHYSIOL, V144, P32, DOI 10.1104/pp.107.096677; Wenne R, 2007, AQUAT LIVING RESOUR, V20, P241, DOI 10.1051/alr:2007037; Wheat CW, 2010, GENETICA, V138, P433, DOI 10.1007/s10709-008-9326-y; Zhang LQ, 2004, MOL BIOL EVOL, V21, P236, DOI 10.1093/molbev/msh010	64	49	49	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2011	6	11							e28008	10.1371/journal.pone.0028008	http://dx.doi.org/10.1371/journal.pone.0028008			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858JH	22132191	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000297792400031
J	Wiklund, ED; Gao, S; Hulf, T; Sibbritt, T; Nair, S; Costea, DE; Villadsen, SB; Bakholdt, V; Bramsen, JB; Sorensen, JA; Krogdahl, A; Clark, SJ; Kjems, J				Wiklund, Erik D.; Gao, Shan; Hulf, Toby; Sibbritt, Tennille; Nair, Shalima; Costea, Daniela Elena; Villadsen, Sune B.; Bakholdt, Vivi; Bramsen, Jesper B.; Sorensen, Jens A.; Krogdahl, Annelise; Clark, Susan J.; Kjems, Jorgen			MicroRNA Alterations and Associated Aberrant DNA Methylation Patterns across Multiple Sample Types in Oral Squamous Cell Carcinoma	PLOS ONE			English	Article							E-CADHERIN; PROMOTER METHYLATION; CPG METHYLATION; DOWN-REGULATION; MIR-200 FAMILY; FEEDBACK LOOP; CANCER-CELLS; EXPRESSION; HEAD; GENE	Background: MicroRNA (miRNA) expression is broadly altered in cancer, but few studies have investigated miRNA deregulation in oral squamous cell carcinoma (OSCC). Epigenetic mechanisms are involved in the regulation of >30 miRNA genes in a range of tissues, and we aimed to investigate this further in OSCC. Methods: TaqMan (R) qRT-PCR arrays and individual assays were used to profile miRNA expression in a panel of 25 tumors with matched adjacent tissues from patients with OSCC, and 8 control paired oral stroma and epithelium from healthy volunteers. Associated DNA methylation changes of candidate epigenetically deregulated miRNA genes were measured in the same samples using the MassArray (R) mass spectrometry platform. MiRNA expression and DNA methylation changes were also investigated in FACS sorted CD44(high) oral cancer stem cells from primary tumor samples (CSCs), and in oral rinse and saliva from 15 OSCC patients and 7 healthy volunteers. Results: MiRNA expression patterns were consistent in healthy oral epithelium and stroma, but broadly altered in both tumor and adjacent tissue from OSCC patients. MiR-375 is repressed and miR-127 activated in OSCC, and we confirm previous reports of miR-137 hypermethylation in oral cancer. The miR-200 s/miR-205 were epigenetically activated in tumors vs normal tissues, but repressed in the absence of DNA hypermethylation specifically in CD44(high) oral CSCs. Aberrant miR-375 and miR-200a expression and miR-200c-141 methylation could be detected in and distinguish OSCC patient oral rinse and saliva from healthy volunteers, suggesting a potential clinical application for OSCC specific miRNA signatures in oral fluids. Conclusions: MiRNA expression and DNA methylation changes are a common event in OSCC, and we suggest miR-375, miR-127, miR-137, the miR-200 family and miR-205 as promising candidates for future investigations. Although overall activated in OSCC, miR-200/miR-205 suppression in oral CSCs indicate that cell specific silencing of these miRNAs may drive tumor expansion and progression.	[Wiklund, Erik D.; Gao, Shan; Villadsen, Sune B.; Bramsen, Jesper B.; Kjems, Jorgen] Aarhus Univ, Dept Mol Biol & Genet, Aarhus, Denmark; [Wiklund, Erik D.; Hulf, Toby; Sibbritt, Tennille; Nair, Shalima; Clark, Susan J.] St Vincents Hosp, Garvan Inst Med Res, Canc Program, Epigenet Grp, Darlinghurst, NSW 2010, Australia; [Costea, Daniela Elena] Univ Bergen, Gade Inst, Sect Pathol, Bergen, Norway; [Bakholdt, Vivi; Sorensen, Jens A.] Odense Univ Hosp, Dept Plast Surg, DK-5000 Odense, Denmark; [Krogdahl, Annelise] Odense Univ Hosp, Dept Pathol, DK-5000 Odense, Denmark	Aarhus University; Garvan Institute of Medical Research; St Vincents Hospital Sydney; University of Bergen; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital	Wiklund, ED (corresponding author), Aarhus Univ, Dept Mol Biol & Genet, Aarhus, Denmark.	shg@mb.au.dk	Costea, Daniela Elena/AAB-9705-2020; Clark, Susan J/U-7365-2019; Kjems, Jorgen/I-3490-2016; Clark, Susan J/B-2272-2008; sørensen, jens ahm/D-6279-2014	Clark, Susan J/0000-0001-5925-5030; Kjems, Jorgen/0000-0003-4128-9317; Clark, Susan J/0000-0001-5925-5030; Costea, Daniela-Elena/0000-0001-7673-0358; Sorensen, Jens Ahm/0000-0003-4903-0094	EU; Danish Medical Research Council [09065615]; Novo Nordisk Foundation; Cure Cancer Australia; New South Wales Cancer Institute; NHMRC	EU(European Commission); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Cure Cancer Australia; New South Wales Cancer Institute; NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work was partially supported by EU-FP6 Integrated project: Silencing RNAs: Organisers and coordinators of complexity in eukaryotic organisms (SIROCCO) (to EDW, JBB, SBV and JK), the Danish Medical Research Council (No. 09065615) (to SG and JK), The Novo Nordisk Foundation (to JK), Cure Cancer Australia and New South Wales Cancer Institute Fellowships (to TH), and NH&MRC project grants (to SJC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altekruse SF, 2010, SEER CANC STAT REV 1; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Boldrup L, 2007, J PATHOL, V213, P384, DOI 10.1002/path.2237; BRABLETZ S, 2011, EMBO J; Brabletz S, 2010, EMBO REP, V11, P670, DOI 10.1038/embor.2010.117; Cervigne NK, 2009, HUM MOL GENET, V18, P4818, DOI 10.1093/hmg/ddp446; Childs G, 2009, AM J PATHOL, V174, P736, DOI 10.2353/ajpath.2009.080731; Clark SJ, 2006, NAT PROTOC, V1, P2353, DOI 10.1038/nprot.2006.324; Coolen MW, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm662; Ding L, 2010, CELL RES, V20, P784, DOI 10.1038/cr.2010.79; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Esteller M, 2001, CANCER RES, V61, P3225; Ferracin M, 2010, EXPERT REV MOL DIAGN, V10, P297, DOI 10.1586/ERM.10.11; Gao S, 2005, J ORAL PATHOL MED, V34, P116, DOI 10.1111/j.1600-0714.2004.00275.x; Gao S, 2004, INT J CANCER, V109, P230, DOI 10.1002/ijc.11592; Gomes CC, 2008, ORAL ONCOL, V44, P910, DOI 10.1016/j.oraloncology.2008.01.002; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Hasegawa M, 2002, ONCOGENE, V21, P4231, DOI 10.1038/sj.onc.1205528; Henson BJ, 2009, GENE CHROMOSOME CANC, V48, P569, DOI 10.1002/gcc.20666; Hinshelwood RA, 2007, CANCER RES, V67, P11517, DOI 10.1158/0008-5472.CAN-07-1284; Hulf T, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-54; Korpal M, 2011, NAT MED, V17, P1101, DOI 10.1038/nm.2401; Kozaki KI, 2008, CANCER RES, V68, P2094, DOI 10.1158/0008-5472.CAN-07-5194; Landis SH, 1999, CA-CANCER J CLIN, V49, P8, DOI 10.3322/canjclin.49.1.8; Langevin SM, 2010, CARCINOGENESIS, V31, P864, DOI 10.1093/carcin/bgq051; LANGEVIN SM, 2010, MICRORNA 137 PROMOTE; Liu AM, 2010, BIOCHEM BIOPH RES CO, V394, P623, DOI 10.1016/j.bbrc.2010.03.036; LO WL, 2010, J PATHOL; Lujambio A, 2007, CANCER RES, V67, P1424, DOI 10.1158/0008-5472.CAN-06-4218; MACKENZIE IC, 1979, SCAND J DENT RES, V87, P234; Nakayama S, 2001, INT J CANCER, V93, P667, DOI 10.1002/ijc.1386; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Peter ME, 2009, CELL CYCLE, V8, P843, DOI 10.4161/cc.8.6.7907; PISANI P, 1993, INT J CANCER, V55, P891, DOI 10.1002/ijc.2910550604; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rosas SLB, 2001, CANCER RES, V61, P939; Ross JP, 2010, EPIGENOMICS-UK, V2, P245, DOI 10.2217/EPI.10.2; Saito Y, 2006, CANCER CELL, V9, P435, DOI 10.1016/j.ccr.2006.04.020; Sharma S, 2010, CARCINOGENESIS, V31, P27, DOI 10.1093/carcin/bgp220; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Silber J, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-14; Simonini PDR, 2010, CANCER RES, V70, P9175, DOI 10.1158/0008-5472.CAN-10-1318; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Szulwach KE, 2010, J CELL BIOL, V189, P127, DOI 10.1083/jcb.200908151; Tarantino C, 2010, FASEB J, V24, P3255, DOI 10.1096/fj.09-152207; Tran N, 2007, BIOCHEM BIOPH RES CO, V358, P12, DOI 10.1016/j.bbrc.2007.03.201; Tsukamoto Y, 2010, CANCER RES, V70, P2339, DOI 10.1158/0008-5472.CAN-09-2777; Vrba L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008697; Weber B, 2007, CELL CYCLE, V6, P1001, DOI 10.4161/cc.6.9.4209; Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; WIKLUND ED, 2010, INT J CANC; Williams HK, 2000, J CLIN PATHOL-MOL PA, V53, P165, DOI 10.1136/mp.53.4.165; Wotschofsky Z, 2011, ANAL BIOCHEM, V417, P233, DOI 10.1016/j.ab.2011.06.009	55	116	120	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2011	6	11							e27840	10.1371/journal.pone.0027840	http://dx.doi.org/10.1371/journal.pone.0027840			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858JH	22132151	gold, Green Published			2022-12-27	WOS:000297792400017
J	Murillo-Maldonado, JM; Zeineddine, FB; Stock, R; Thackeray, J; Riesgo-Escovar, JR				Murillo-Maldonado, Juan M.; Zeineddine, Fouad Bou; Stock, Rachel; Thackeray, Justin; Riesgo-Escovar, Juan R.			Insulin Receptor-Mediated Signaling via Phospholipase C-gamma Regulates Growth and Differentiation in Drosophila	PLOS ONE			English	Article							PROTEIN-KINASE-C; EGF RECEPTOR; PLC-GAMMA; CELL; EYE; ACTIVATION; C-GAMMA-1; SEVENLESS; IDENTIFICATION; PROLIFERATION	Coordination between growth and patterning/differentiation is critical if appropriate final organ structure and size is to be achieved. Understanding how these two processes are regulated is therefore a fundamental and as yet incompletely answered question. Here we show through genetic analysis that the phospholipase C-gamma ( PLC-gamma) encoded by small wing (sl) acts as such a link between growth and patterning/differentiation by modulating some MAPK outputs once activated by the insulin pathway; particularly, sl promotes growth and suppresses ectopic differentiation in the developing eye and wing, allowing cells to attain a normal size and differentiate properly. sl mutants have previously been shown to have a combination of both growth and patterning/differentiation phenotypes: small wings, ectopic wing veins, and extra R7 photoreceptor cells. We show here that PLC-gamma activated by the insulin pathway participates broadly and positively during cell growth modulating EGF pathway activity, whereas in cell differentiation PLC-gamma activated by the insulin receptor negatively regulates the EGF pathway. These roles require different SH2 domains of PLC-gamma, and act via classic PLC-gamma signaling and EGF ligand processing. By means of PLC-gamma, the insulin receptor therefore modulates differentiation as well as growth. Overall, our results provide evidence that PLC-gamma acts during development at a time when growth ends and differentiation begins, and is important for proper coordination of these two processes.	[Murillo-Maldonado, Juan M.; Riesgo-Escovar, Juan R.] Univ Nacl Autonoma Mexico, Inst Neurobiol, Dept Neurobiol Desarrollo & Neurofisiol, Queretaro, Mexico; [Zeineddine, Fouad Bou; Stock, Rachel; Thackeray, Justin] Clark Univ, Dept Biol, Worcester, MA 01610 USA	Universidad Nacional Autonoma de Mexico; Clark University	Murillo-Maldonado, JM (corresponding author), Univ Nacl Autonoma Mexico, Inst Neurobiol, Dept Neurobiol Desarrollo & Neurofisiol, Campus Juriquilla, Queretaro, Mexico.	juanriesgo@prodigy.net.mx	Zeineddine, Fouad Bou/AAK-3791-2020	Zeineddine, Fouad Bou/0000-0002-5386-0579; Murillo-Maldonado, Juan Manuel/0000-0003-2019-7106	Consejo Nacional de Ciencia y Tecnologia (CONACYT) [81864, 46133]; Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT) de la Universidad Nacional Autonoma de Mexico (UNAM) [IN201707]; National Institutes of Heath (NIH)	Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT) de la Universidad Nacional Autonoma de Mexico (UNAM)(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico); National Institutes of Heath (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by Consejo Nacional de Ciencia y Tecnologia (CONACYT) (grants # 81864 and 46133), Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT) de la Universidad Nacional Autonoma de Mexico (UNAM) to JRR.-E(IN201707) and by the National Institutes of Heath (NIH) awarded to J.T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAINBRIDGE SP, 1981, J EMBRYOL EXP MORPH, V66, P57; Betson M, 2007, GENETICS, V176, P2201, DOI 10.1534/genetics.107.072967; Blair SS, 2007, ANNU REV CELL DEV BI, V23, P293, DOI 10.1146/annurev.cellbio.23.090506.123606; Bohni R, 1999, CELL, V97, P865, DOI 10.1016/S0092-8674(00)80799-0; Buckley CT, 2004, J BIOL CHEM, V279, P41807, DOI 10.1074/jbc.M407851200; Chattopadhyay A, 1999, J BIOL CHEM, V274, P26091, DOI 10.1074/jbc.274.37.26091; Chen P, 1996, MOL BIOL CELL, V7, P871, DOI 10.1091/mbc.7.6.871; CHOE CU, 2006, SCI STKE, pRE15; Choi JH, 2007, ADV ENZYME REGUL, V47, P104, DOI 10.1016/j.advenzreg.2006.12.010; Crozatier M, 2004, TRENDS GENET, V20, P498, DOI 10.1016/j.tig.2004.07.013; Day SJ, 2000, DEVELOPMENT, V127, P2977; de Celis JF, 2003, BIOESSAYS, V25, P443, DOI 10.1002/bies.10258; DIAZBENJUMEA FJ, 1994, DEVELOPMENT, V120, P569; EMORI Y, 1994, J BIOL CHEM, V269, P19474; Falasca M, 1998, EMBO J, V17, P414, DOI 10.1093/emboj/17.2.414; Garofalo RS, 2002, TRENDS ENDOCRIN MET, V13, P156, DOI 10.1016/S1043-2760(01)00548-3; Hietakangas V, 2009, ANNU REV GENET, V43, P389, DOI 10.1146/annurev-genet-102108-134815; Kayali AG, 1998, J BIOL CHEM, V273, P13808, DOI 10.1074/jbc.273.22.13808; KOLODKIN AL, 1994, DEVELOPMENT, V120, P1731; Lee JR, 2001, CELL, V107, P161, DOI 10.1016/S0092-8674(01)00526-8; Mankidy R, 2003, GENETICS, V164, P553; Marenda DR, 2006, DEVELOPMENT, V133, P43, DOI 10.1242/dev.02168; MARENGERE LEM, 1992, J BIOL CHEM, V267, P22779; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; McCahill A, 2002, MOL PHARMACOL, V62, P1261, DOI 10.1124/mol.62.6.1261; McNeill H, 2008, GENETICS, V179, P843, DOI 10.1534/genetics.107.083097; Mollereau B, 2005, DEV DYNAM, V232, P585, DOI 10.1002/dvdy.20271; Patterson RL, 2005, TRENDS BIOCHEM SCI, V30, P688, DOI 10.1016/j.tibs.2005.10.005; Poulin B, 2005, P NATL ACAD SCI USA, V102, P4276, DOI 10.1073/pnas.0409590102; Raabe T, 1996, CELL, V85, P911, DOI 10.1016/S0092-8674(00)81274-X; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; RiesgoEscovar JR, 1996, GENE DEV, V10, P2759, DOI 10.1101/gad.10.21.2759; Schlesinger A, 2004, DEV CELL, V7, P535, DOI 10.1016/j.devcel.2004.09.001; SEEDORF K, 1995, J BIOL CHEM, V270, P18953, DOI 10.1074/jbc.270.32.18953; SMITH MR, 1994, P NATL ACAD SCI USA, V91, P6554, DOI 10.1073/pnas.91.14.6554; Suh PG, 2008, BMB REP, V41, P415, DOI 10.5483/BMBRep.2008.41.6.415; Thackeray JR, 1998, DEVELOPMENT, V125, P5033; The I, 1997, SCIENCE, V276, P791, DOI 10.1126/science.276.5313.791; Tweedie S, 2009, NUCLEIC ACIDS RES, V37, pD555, DOI 10.1093/nar/gkn788; Voas MG, 2004, DEV DYNAM, V229, P162, DOI 10.1002/dvdy.10449; Walker JA, 2006, GENE DEV, V20, P3311, DOI 10.1101/gad.1466806; Werz C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000596; Wolff T, 2000, DROSOPHILA PROTOCOLS, P229; XU T, 1993, DEVELOPMENT, V117, P1223; Ye KQ, 2002, NATURE, V415, P541, DOI 10.1038/415541a; Zhu L, 2001, CURR OPIN GENET DEV, V11, P91, DOI 10.1016/S0959-437X(00)00162-3	46	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2011	6	11							e28067	10.1371/journal.pone.0028067	http://dx.doi.org/10.1371/journal.pone.0028067			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IO	22132213	Green Published, Green Submitted, gold			2022-12-27	WOS:000297789900045
J	Roshandel, D; Thomson, W; Pye, SR; Boonen, S; Borghs, H; Vanderschueren, D; Huhtaniemi, IT; Adams, JE; Ward, KA; Bartfai, G; Casanueva, FF; Finn, JD; Forti, G; Giwercman, A; Han, TS; Kula, K; Lean, ME; Pendleton, N; Punab, M; Wu, FC; Holliday, KL; O'Neill, TW				Roshandel, Delnaz; Thomson, Wendy; Pye, Stephen R.; Boonen, Steven; Borghs, Herman; Vanderschueren, Dirk; Huhtaniemi, Ilpo T.; Adams, Judith E.; Ward, Kate A.; Bartfai, Gyorgy; Casanueva, Felipe F.; Finn, Joseph D.; Forti, Gianni; Giwercman, Aleksander; Han, Thang S.; Kula, Krzysztof; Lean, Michael E.; Pendleton, Neil; Punab, Margus; Wu, Frederick C.; Holliday, Kate L.; O'Neill, Terence W.		EMAS Study Grp	Polymorphisms in Genes Involved in the NF-kappa B Signalling Pathway Are Associated with Bone Mineral Density, Geometry and Turnover in Men	PLOS ONE			English	Article							OSTEOPOROTIC FRACTURES; RISK; BMD; DETERMINANTS; WOMEN; TWIN; HIP	Introduction: In this study, we aimed to investigate the association between single nucleotide polymorphisms (SNPs) within two genes involved in the NF-kappa B cascade (GPR177 and MAP3K14) and bone mineral density (BMD) assessed at different skeletal sites, radial geometric parameters and bone turnover. Methods: Ten GPR177 SNPs previously associated with BMD with genome-wide significance and twelve tag SNPs (r(2) >= 0.8) within MAP3K14 (+/-10 kb) were genotyped in 2359 men aged 40-79 years recruited from 8 centres for participation in the European Male Aging Study (EMAS). Measurement of bone turnover markers (PINP and CTX-I) in the serum and quantitative ultrasound (QUS) at the calcaneus were performed in all centres. Dual energy X-ray absorptiometry (DXA), at the lumbar spine and hip, and peripheral quantitative computed tomography (pQCT), at the distal and midshaft radius, were performed in a subsample (2 centres). Linear regression was used to test for association between the SNPs and bone measures under an additive genetic model adjusting for study centre. Results: We validated the associations between SNPs in GPR177 and BMD(a) previously reported and also observed evidence of pleiotrophic effects on density and geometry. Rs2772300 in GPR177 was associated with increased total hip and LS BMD(a), increased total and cortical vBMD at the radius and increased cortical area, thickness and stress strain index. We also found evidence of association with BMD(a), vBMD, geometric parameters and CTX-I for SNPs in MAP3K14. None of the GPR177 and MAP3K14 SNPs were associated with calcaneal estimated BMD measured by QUS. Conclusion: Our findings suggest that SNPs in GPR177 and MAP3K14 involved in the NF-kappa B signalling pathway influence bone mineral density, geometry and turnover in a population-based cohort of middle aged and elderly men. This adds to the understanding of the role of genetic variation in this pathway in determining bone health.	[Roshandel, Delnaz; Thomson, Wendy; Pye, Stephen R.; Finn, Joseph D.; Holliday, Kate L.; O'Neill, Terence W.] Univ Manchester, Arthrit Res UK Epidemiol Unit, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Boonen, Steven; Borghs, Herman] Katholieke Univ Leuven, Leuven Univ, Div Geriatr Med, Louvain, Belgium; [Vanderschueren, Dirk] Katholieke Univ Leuven, Dept Androl & Endocrinol, Louvain, Belgium; [Huhtaniemi, Ilpo T.] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, London, England; [Ward, Kate A.] Elsie Widdowson Lab, MRC Human Nutr Res, Cambridge, England; [Bartfai, Gyorgy] Albert Szent Gyorgyi Med Univ, Dept Obstet Gynaecol & Androl, H-6701 Szeged, Hungary; [Casanueva, Felipe F.] Univ Santiago de Compostela, CIBER Fisiopatol Obesidad & Nutr CB06 03, Inst Salud Carlos III, Dept Med,CHUS, Santiago De Compostela, Spain; [Forti, Gianni] Univ Florence, Androl Unit, Dept Clin Physiopathol, Florence, Italy; [Giwercman, Aleksander] Lund Univ, Scanian Androl Ctr, Dept Urol, Malmo Univ Hosp, Lund, Sweden; [Han, Thang S.] Royal Free Hosp, Royal Free & Univ Coll Hosp Med Sch, Dept Endocrinol, London, England; [Kula, Krzysztof] Med Univ Lodz, Dept Androl & Reprod Endocrinol, Lodz, Poland; [Lean, Michael E.] Univ Glasgow, Dept Human Nutr, Glasgow, Lanark, Scotland; [Pendleton, Neil] Univ Manchester, Hope Hosp, Manchester Acad Hlth Sci Ctr, Salford M6 8HD, Lancs, England; [Punab, Margus] Tartu Univ Clin, Androl Unit, United Labs, Tartu, Estonia; [Wu, Frederick C.] Univ Manchester, Manchester Royal Infirm, Dept Endocrinol, Manchester Acad Hlth Sci Ctr, Manchester M13 9WL, Lancs, England	University of Manchester; KU Leuven; KU Leuven; Imperial College London; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research; Szeged University; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Complexo Hospitalario Universitario de Santiago de Compostela; Instituto de Salud Carlos III; Universidade de Santiago de Compostela; University of Florence; Lund University; Skane University Hospital; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; Medical University Lodz; University of Glasgow; University of Manchester; University of Tartu; University of Manchester	Roshandel, D (corresponding author), Univ Manchester, Arthrit Res UK Epidemiol Unit, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England.	Kate.Holliday@manchester.ac.uk	Pye, Stephen R/D-9236-2011; Pendleton, Neil/F-2333-2015	Pye, Stephen R/0000-0002-7263-2897; Pendleton, Neil/0000-0003-0794-2386; Roshandel, Delnaz/0000-0002-4902-8587; Punab, Margus/0000-0001-9601-6311; vanderschueren, dirk/0000-0003-1395-0104; Thomson, Wendy/0000-0002-9022-5179; Ward, Kate/0000-0001-7034-6750; Han, Thang/0000-0003-2570-0938; O'Neill, Terence/0000-0002-8896-4677	Commission of the European Communities [QLK6-CT-2001-00258]; Arthritis Research UK; University Hospitals Leuven, Belgium	Commission of the European Communities(European Commission); Arthritis Research UK(Versus Arthritis); University Hospitals Leuven, Belgium	The European Male Ageing Study (EMAS) is funded by the Commission of the European Communities Fifth Framework Programme "Quality of Life and Management of Living Resources'' Grant QLK6-CT-2001-00258 and supported by funding from the Arthritis Research UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The EMAS principal investigator is Professor Frederick Wu, MD, Dept of Endocrinology, Manchester Royal Infirmary, UK. The authors wish to thank the men who participated in the eight countries, the research/nursing staff in the eight centres: C Pott, Manchester, E Wouters, Leuven, M Nilsson, Malmo, M del Mar Fernandez, Santiago de Compostela, M Jedrzejowska, Lodz, H-M Tabo, Tartu, A Heredi, Szeged for their data collection and C Moseley, Manchester for data entry and project coordination. Dr. Vanderschueren is a senior clinical investigator supported by the Clinical Research Fund of the University Hospitals Leuven, Belgium. Dr. Boonen is a senior clinical investigator of the Fund for Scientific Research-Flanders, Belgium (F.W.O.-Vlaanderen). Dr. Boonen is holder of the Leuven University Chair in Metabolic Bone Diseases.	Banziger C, 2006, CELL, V125, P509, DOI 10.1016/j.cell.2006.02.049; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Consensus Development Conference, 1993, AM J MED, V94, P646; Cummings SR, 2006, J BONE MINER RES, V21, P1550, DOI 10.1359/JBMR.060708; Dargent-Molina P, 1999, OSTEOPOROSIS INT, V9, P188, DOI 10.1007/s001980050134; FLICKER L, 1995, J BONE MINER RES, V10, P1607; Hadjidakis DJ, 2006, ANN NY ACAD SCI, V1092, P385, DOI 10.1196/annals.1365.035; Kraft P, 2007, HUM HERED, V63, P111, DOI 10.1159/000099183; KRALL EA, 1993, J BONE MINER RES, V8, P1; Lee DM, 2009, INT J ANDROL, V32, P11, DOI 10.1111/j.1365-2605.2008.00879.x; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Matsuda A, 2003, ONCOGENE, V22, P3307, DOI 10.1038/sj.onc.1206406; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reid DM, 2006, OSTEOPOROSIS INT, V17, P125, DOI 10.1007/s00198-005-1936-y; Richards JB, 2008, LANCET, V371, P1505, DOI 10.1016/S0140-6736(08)60599-1; Rivadeneira F, 2009, NAT GENET, V41, P1199, DOI 10.1038/ng.446; Roshandel D, 2010, J BONE MINER RES, V25, P1830, DOI 10.1002/jbmr.78; Soysa NS, 2009, BIOCHEM BIOPH RES CO, V378, P1, DOI 10.1016/j.bbrc.2008.10.146; Stone KL, 2003, J BONE MINER RES, V18, P1947, DOI 10.1359/jbmr.2003.18.11.1947; Styrkarsdottir U, 2008, NEW ENGL J MED, V358, P2355, DOI 10.1056/NEJMoa0801197; Styrkarsdottir U, 2009, NAT GENET, V41, P15, DOI 10.1038/ng.284; Videman T, 2007, J BONE MINER RES, V22, P1455, DOI 10.1359/JBMR.070606; Ward KA, 2005, CALCIFIED TISSUE INT, V77, P275, DOI 10.1007/s00223-005-0031-x; Ward KA, 2005, BONE, V36, P1012, DOI 10.1016/j.bone.2005.03.001	25	14	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2011	6	11							e28031	10.1371/journal.pone.0028031	http://dx.doi.org/10.1371/journal.pone.0028031			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IO	22132199	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000297789900040
J	Thomas, B; Suhadev, M; Mani, J; Ganapathy, BG; Armugam, A; Faizunnisha, F; Chelliah, M; Wares, F				Thomas, Beena; Suhadev, Mohanarani; Mani, Jamuna; Ganapathy, B. Gopala; Armugam, Asaithambi; Faizunnisha, F.; Chelliah, Mohanasundari; Wares, Fraser			Feasibility of an Alcohol Intervention Programme for TB Patients with Alcohol Use Disorder (AUD) - A Qualitative Study from Chennai, South India	PLOS ONE			English	Article							RISK-FACTORS; TUBERCULOSIS PATIENTS; FAILURE; DEFAULT; HEALTH; DEATH	Background: The negative influences of alcohol on TB management with regard to delays in seeking care as well as non compliance for treatment has been well documented. This study is part of a larger study on the prevalence of AUD (Alcohol Use Disorder) among TB patients which revealed that almost a quarter of TB patients who consumed alcohol could be classified as those who had AUD. However there is dearth of any effective alcohol intervention programme for TB patients with Alcohol Use Disorder (AUD). Methodology: This qualitative study using the ecological system model was done to gain insights into the perceived effect of alcohol use on TB treatment and perceived necessity of an intervention programme for TB patients with AUD. We used purposive sampling to select 44 men from 73 TB patients with an AUDIT score >8. Focus group discussions (FGDs) and interviews were conducted with TB patients with AUD, their family members and health providers. Results: TB patients with AUD report excessive alcohol intake as one of the reasons for their vulnerability for TB. Peer pressure has been reported by many as the main reason for alcohol consumption. The influences of alcohol use on TB treatment has been elaborated especially with regard to the fears around the adverse effects of alcohol on TB drugs and the fear of being reprimanded by health providers. The need for alcohol intervention programs was expressed by the TB patients, their families and health providers. Suggestions for the intervention programmes included individual and group sessions, involvement of family members, audiovisual aids and the importance of sensitization by health staff. Conclusions: The findings call for urgent need based interventions which need to be pilot tested with a randomized control trial to bring out a model intervention programme for TB patients with AUD.	[Thomas, Beena; Suhadev, Mohanarani; Mani, Jamuna; Ganapathy, B. Gopala; Armugam, Asaithambi; Faizunnisha, F.; Chelliah, Mohanasundari] TB Res Ctr, Madras, Tamil Nadu, India; [Wares, Fraser] Off WHO Representat India, New Delhi, India	Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT); World Health Organization	Thomas, B (corresponding author), TB Res Ctr, Madras, Tamil Nadu, India.	beenaelli09@gmail.com			World Health Organisation; United States agency for International development	World Health Organisation(World Health Organization); United States agency for International development(United States Agency for International Development (USAID))	The study was supported in part by World Health Organisation with financial assistance provided by the United States agency for International development under Model DOTS project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babor TF., 2001, AUDIT ALCOHOL USE DI; Das SK, 2006, NATL MED J INDIA, V19, P94; Flynn JL, 1996, ANN NY ACAD SCI, V795, P137, DOI 10.1111/j.1749-6632.1996.tb52662.x; Ganapathy Sudha, 2008, Indian J Tuberc, V55, P9; Happel Kyle I, 2005, Proc Am Thorac Soc, V2, P428, DOI 10.1513/pats.200507-065JS; Israel BA, 1998, ANNU REV PUBL HEALTH, V19, P173, DOI 10.1146/annurev.publhealth.19.1.173; Jacobson JM, 1992, ALCOHOL HEALTH RES W, V16, P39; Jaggarajamma K, 2008, Indian J Tuberc, V55, P179; Jaggarajamma K, 2007, Indian J Tuberc, V54, P130; Jakubowiak WM, 2007, INT J TUBERC LUNG D, V11, P46; Kolappan C, 2007, INT J TUBERC LUNG D, V11, P999; Lonnroth K, 2008, SEMIN RESP CRIT CARE, V29, P481, DOI 10.1055/s-0028-1085700; Long NH, 1999, SOC SCI MED, V49, P815, DOI 10.1016/S0277-9536(99)00171-9; Lonnroth K, 2009, SOC SCI MED, V68, P2240, DOI 10.1016/j.socscimed.2009.03.041; MUNIYANDI M, 2009, 1 INT C ALC HIV IND; de Albuquerque MDPM, 2007, CAD SAUDE PUBLICA, V23, P1573, DOI 10.1590/S0102-311X2007000700008; Rajeswari R, 2005, SOC SCI MED, V60, P1845, DOI 10.1016/j.socscimed.2004.08.024; Reddy KS, 2002, AM J HEALTH BEHAV, V26, P173, DOI 10.5993/AJHB.26.3.2; REHM J, 2009, SYSTEMATIC REVIEWBMC, V9, P450; Santha T, 2002, INT J TUBERC LUNG D, V6, P780; SAXENA S, 1999, ALCOHOL PUBLIC HLTH, P37; SIVARAM S, 2007, J URBAN HEALTH, V84, P4; *STOP TB PARTN SEC, 2001, HUM RIGHTS APPR TUB; Storla DG, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-15; Suhadev M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019485; Szabo G, 1997, ALCOHOL HEALTH RES W, V21, P39; Szabo G, 1997, ALCOHOL HEALTH RES W, V21, P30; TRINI AM, 2009, EUR J PUBLIC HEALTH, V19, P16; Zhang P, 2002, FRONT BIOSCI-LANDMRK, V7, pD1314	29	12	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2011	6	11							e27752	10.1371/journal.pone.0027752	http://dx.doi.org/10.1371/journal.pone.0027752			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	858IO	22132134	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000297789900018
J	Wang, QD; Zhang, M; Ning, G; Gu, WQ; Su, TW; Xu, M; Li, B; Wang, WQ				Wang, Qidi; Zhang, Min; Ning, Guang; Gu, Weiqiong; Su, Tingwei; Xu, Min; Li, Biao; Wang, Weiqing			Brown Adipose Tissue in Humans Is Activated by Elevated Plasma Catecholamines Levels and Is Inversely Related to Central Obesity	PLOS ONE			English	Article							F-18-FDG PET/CT; ADULT HUMANS; PHEOCHROMOCYTOMA; FAT; ADIPOCYTES; MICE; HYPERLIPIDEMIA; THERMOGENESIS; LIPOLYSIS; PATIENT	Background: Recent studies have shown that adult human possess active brown adipose tissue (BAT), which might be important in controlling obesity. It is known that beta-adrenoceptor-UCP1 system regulates BAT in rodent, but its influence in adult humans remains to be shown. The present study is to determine whether BAT activity can be independently stimulated by elevated catecholamines levels in adult human, and whether it is associated with their adiposity. Methodology/Principal Findings: We studied 14 patients with pheochromocytoma and 14 normal subjects who had performed both (18)F-fluorodeoxyglucose positron emission tomography/computed tomography ((18)F-FDG PET/CT) and plasma total metanephrine (TMN) measurements during 2007-2010. The BAT detection rate and the mean BAT activity were significantly higher in patients with elevated TMN levels (Group A: 6/8 and 6.7 +/- 2.1 SUVmean.g/ml) than patients with normal TMN concentrations (Group B:0/6 and 0.4 +/- 0.04 SUVmean.g/ml) and normal subjects (Group C:0/14 and 0.4 +/- 0.03 SUVmean.g/ml). BAT activities were positively correlated with TMN levels (R = 0.83, p < 0.0001) and were inversely related to body mass index (R = -0.47, p = 0.010), visceral fat areas (R = -0.39, p = 0.044), visceral/total fat areas (R = -0.52, p = 0.0043) and waist circumferences (R = -0.43, p = 0.019). Robust regression revealed that TMN (R = 0.81, p < 0.0001) and waist circumferences (R = -0.009, p = 0.009) were the two independent predictors of BAT activities. Conclusions/Significance: Brown adipose tissue activity in adult human can be activated by elevated plasma TMN levels, such as in the case of patients with pheochromocytoma, and is negatively associated with central adiposity.	[Wang, Qidi; Ning, Guang; Gu, Weiqiong; Su, Tingwei; Xu, Min; Wang, Weiqing] Shanghai Jiao Tong Univ, Sch Med, Shanghai Key Lab Endocrine Tumors, Chinese Hlth Minist,Rui Jin Hosp, Shanghai 200030, Peoples R China; [Wang, Qidi; Ning, Guang; Gu, Weiqiong; Su, Tingwei; Xu, Min; Wang, Weiqing] Shanghai Jiao Tong Univ, Sch Med, Key Lab Endocrine & Metab Dis, Chinese Hlth Minist,Rui Jin Hosp, Shanghai 200030, Peoples R China; [Wang, Qidi; Ning, Guang; Gu, Weiqiong; Su, Tingwei; Xu, Min; Wang, Weiqing] Shanghai Jiao Tong Univ, Sch Med, Shanghai Clin Ctr Endocrine & Metab Dis, E Inst Shanghai Univ,Rui Jin Hosp, Shanghai 200030, Peoples R China; [Wang, Qidi; Ning, Guang; Gu, Weiqiong; Su, Tingwei; Xu, Min; Wang, Weiqing] Shanghai Jiao Tong Univ, Sch Med, Div Endocrinol & Metab, E Inst Shanghai Univ,Rui Jin Hosp, Shanghai 200030, Peoples R China; [Zhang, Min; Li, Biao] Shanghai Jiao Tong Univ, Sch Med, Dept Nucl Med, Rui Jin Hosp, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Wang, QD (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Key Lab Endocrine Tumors, Chinese Hlth Minist,Rui Jin Hosp, Shanghai 200030, Peoples R China.	wqingw@hotmail.com		Wang, Qinhu/0000-0003-1251-073X; Shan, Weixing/0000-0001-7286-4041	National Key Technologies Research and Development Program [2008ZX09312-0191200]; Chinese National Natural Science Foundation [30725037, 81030011]; Key Project of Shanghai Science and Technology [09DZ1950200]; National Natural Science Foundation of China [81070616]; Shanghai Pujiang Program [10PJ1407400]	National Key Technologies Research and Development Program(National Key Technology R&D Program); Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Key Project of Shanghai Science and Technology; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Pujiang Program(Shanghai Pujiang Program)	This study was supported by the grants from the National Key Technologies Research and Development Program (2008ZX09312-0191200), the Chinese National Natural Science Foundation (30725037 and 81030011), the Key Project of Shanghai Science and Technology (09DZ1950200), the National Natural Science Foundation of China (No. 81070616), and Shanghai Pujiang Program (10PJ1407400). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen R., 2008, SAGE U PAPER SERIES; Arch JRS, 1996, INT J OBESITY, V20, P191; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cinti S, 2005, PROSTAG LEUKOTR ESS, V73, P9, DOI 10.1016/j.plefa.2005.04.010; COPPACK SW, 1994, J LIPID RES, V35, P177; COUSIN B, 1992, J CELL SCI, V103, P931; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Daniels SR, 2000, AM J EPIDEMIOL, V152, P1179, DOI 10.1093/aje/152.12.1179; DULLOO AG, 1984, CAN J PHYSIOL PHARM, V62, P235, DOI 10.1139/y84-035; Fruhbeck G, 2009, TRENDS PHARMACOL SCI, V30, P387, DOI 10.1016/j.tips.2009.05.003; Ghorbani M, 1997, INT J OBESITY, V21, P465, DOI 10.1038/sj.ijo.0800432; Guerra C, 1998, J CLIN INVEST, V102, P412, DOI 10.1172/JCI3155; Hadi M, 2007, J NUCL MED, V48, P1077, DOI 10.2967/jnumed.106.035915; Hamann A, 1996, ENDOCRINOLOGY, V137, P21, DOI 10.1210/en.137.1.21; Inokuma K, 2006, AM J PHYSIOL-ENDOC M, V290, pE1014, DOI 10.1152/ajpendo.00105.2005; Yamaga LYI, 2008, EUR J NUCL MED MOL I, V35, P446, DOI 10.1007/s00259-007-0538-7; KAJIMURA S, CELL METAB, V11, P257; Kuji I, 2008, ANN NUCL MED, V22, P231, DOI 10.1007/s12149-007-0096-x; Large V, 1998, DIABETES METAB, V24, P409; LEAN MEJ, 1986, INT J OBESITY, V10, P219; LENDERS JWM, 1993, CLIN CHEM, V39, P97; Lenders JWM, 2002, JAMA-J AM MED ASSOC, V287, P1427, DOI 10.1001/jama.287.11.1427; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lofgren P, 2005, DIABETOLOGIA, V48, P2334, DOI 10.1007/s00125-005-1961-6; LONCAR D, 1991, CELL TISSUE RES, V266, P149, DOI 10.1007/BF00678721; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Lowell BB, 2003, J BIOL CHEM, V278, P29385, DOI 10.1074/jbc.R300011200; LOWELL BB, 1993, NATURE, V366, P740, DOI 10.1038/366740a0; Menke A, 2007, OBESITY, V15, P785, DOI 10.1038/oby.2007.593; Omachi A, 2008, RES VET SCI, V85, P214, DOI 10.1016/j.rvsc.2007.11.003; RICQUIER D, 1982, J CLIN ENDOCR METAB, V54, P803; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Yoshizumi T, 1999, RADIOLOGY, V211, P283, DOI 10.1148/radiology.211.1.r99ap15283; 2005, GE MED SYSTEMS VOLUM, P399	35	97	101	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2011	6	6							e21006	10.1371/journal.pone.0021006	http://dx.doi.org/10.1371/journal.pone.0021006			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782BY	22140518	Green Published, Green Submitted, gold			2022-12-27	WOS:000291983800017
J	Garzon, J; Rodriguez-Munoz, M; Vicente-Sanchez, A; Garcia-Lopez, MA; Martinez-Murillo, R; Fischer, T; Sanchez-Blazquez, P				Garzon, Javier; Rodriguez-Munoz, Maria; Vicente-Sanchez, Ana; Angeles Garcia-Lopez, Maria; Martinez-Murillo, Ricardo; Fischer, Thierry; Sanchez-Blazquez, Pilar			SUMO-SIM Interactions Regulate the Activity of RGSZ2 Proteins	PLOS ONE			English	Article							GTPASE-ACTIVATING PROTEIN; MU-OPIOID-RECEPTORS; ESCHERICHIA-COLI; C-TERMINUS; SUMOYLATION; ASSOCIATION; DOMAIN; PHOSPHORYLATION; NUCLEAR; COMPLEX	The RGSZ2 gene, a regulator of G protein signaling, has been implicated in cognition, Alzheimer's disease, panic disorder, schizophrenia and several human cancers. This 210 amino acid protein is a GTPase accelerating protein (GAP) on G alpha i/o/z subunits, binds to the N terminal of neural nitric oxide synthase (nNOS) negatively regulating the production of nitric oxide, and binds to the histidine triad nucleotide-binding protein 1 at the C terminus of different G protein-coupled receptors (GPCRs). We now describe a novel regulatory mechanism of RGS GAP function through the covalent incorporation of Small Ubiquitin-like MOdifiers (SUMO) into RGSZ2 RGS box (RH) and the SUMO non covalent binding with SUMO-interacting motifs (SIM): one upstream of the RH and a second within this region. The covalent attachment of SUMO does not affect RGSZ2 binding to GPCR-activated G alpha GTP subunits but abolishes its GAP activity. By contrast, non-covalent binding of SUMO with RH SIM impedes RGSZ2 from interacting with G alpha GTP subunits. Binding of SUMO to the RGSZ2 SIM that lies outside the RH does not affect G alpha GTP binding or GAP activity, but it could lead to regulatory interactions with sumoylated proteins. Thus, sumoylation and SUMO-SIM interactions constitute a new regulatory mechanism of RGS GAP function and therefore of GPCR cell signaling as well.	[Garzon, Javier; Vicente-Sanchez, Ana; Martinez-Murillo, Ricardo; Sanchez-Blazquez, Pilar] CSIC, Inst Cajal, E-28002 Madrid, Spain; [Garzon, Javier; Rodriguez-Munoz, Maria; Vicente-Sanchez, Ana; Sanchez-Blazquez, Pilar] ISCIII, CIBER Mental Hlth, Madrid, Spain; [Angeles Garcia-Lopez, Maria; Fischer, Thierry] CSIC, Natl Biotechnol Ctr, Dept Immunol & Oncol, E-28002 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC); CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Instituto de Salud Carlos III; Consejo Superior de Investigaciones Cientificas (CSIC)	Garzon, J (corresponding author), CSIC, Inst Cajal, E-28002 Madrid, Spain.	psb@cajal.csic.es	Martinez-Murillo, Ricardo/K-7596-2014; García-López, Maria Angeles/AAB-5755-2019	Martinez-Murillo, Ricardo/0000-0003-3657-3890; García-López, Maria Angeles/0000-0002-1417-9385; Sanchez Blazquez, Pilar/0000-0002-7211-4504; Fischer, Thierry/0000-0002-9542-322X; Rodriguez-Munoz, Maria/0000-0001-6611-8050; Garzon, Javier/0000-0002-0053-258X	Fondo Investigacion Sanitaria [PS090332, PI080417, MIRG-CT-2006-026702]	Fondo Investigacion Sanitaria(Instituto de Salud Carlos III)	This work was supported by the following grants: Fondo Investigacion Sanitaria PS090332 (JG), Fondo Investigacion Sanitaria PI080417 (PSB), MIRG-CT-2006-026702 (TF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajit SK, 2007, CELL SIGNAL, V19, P723, DOI 10.1016/j.cellsig.2006.09.008; Bailey D, 2002, J GEN VIROL, V83, P2951, DOI 10.1099/0022-1317-83-12-2951; Benzing T, 2000, J BIOL CHEM, V275, P28167; Benzing T, 2002, J BIOL CHEM, V277, P32954, DOI 10.1074/jbc.M200859200; Berman DM, 1996, J BIOL CHEM, V271, P27209, DOI 10.1074/jbc.271.44.27209; Carman CV, 1999, J BIOL CHEM, V274, P34483, DOI 10.1074/jbc.274.48.34483; Davis OSP, 2010, BEHAV GENET, V40, P759, DOI 10.1007/s10519-010-9350-4; DeVries L, 1996, P NATL ACAD SCI USA, V93, P15203, DOI 10.1073/pnas.93.26.15203; DEVRIES L, 1995, P NATL ACAD SCI USA, V92, P11916, DOI 10.1073/pnas.92.25.11916; Drag M, 2008, IUBMB LIFE, V60, P734, DOI 10.1002/iub.113; Fischer T, 2003, P NATL ACAD SCI USA, V100, P8270, DOI 10.1073/pnas.1432965100; Garzon J, 1997, EUR J NEUROSCI, V9, P1194, DOI 10.1111/j.1460-9568.1997.tb01474.x; Garzon J, 2005, NEUROPSYCHOPHARMACOL, V30, P1632, DOI 10.1038/sj.npp.1300726; Garzon J, 2005, NEUROPHARMACOLOGY, V48, P853, DOI 10.1016/j.neuropharm.2005.01.004; Garzon J, 2000, METHOD ENZYMOL, V314, P3; Garzon J, 2011, ANTIOXID REDOX SIGN, V15, P873, DOI 10.1089/ars.2010.3767; Glick JL, 1998, J BIOL CHEM, V273, P26008, DOI 10.1074/jbc.273.40.26008; Guey LT, 2010, EUR UROL, V57, P283, DOI 10.1016/j.eururo.2009.08.001; Hecker CM, 2006, J BIOL CHEM, V281, P16117, DOI 10.1074/jbc.M512757200; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661; Hunt TW, 1996, NATURE, V383, P175, DOI 10.1038/383175a0; James MA, 2009, CANCER RES, V69, P2108, DOI 10.1158/0008-5472.CAN-08-3495; Jordan JD, 1999, J BIOL CHEM, V274, P21507, DOI 10.1074/jbc.274.31.21507; Kerscher O, 2007, EMBO REP, V8, P550, DOI 10.1038/sj.embor.7400980; Kim MJ, 2008, FASEB J, V22, P3785, DOI 10.1096/fj.08-113910; Klenk C, 2006, J BIOL CHEM, V281, P8357, DOI 10.1074/jbc.M513703200; Krumins AM, 2002, METHOD ENZYMOL, V344, P673; LINDER ME, 1990, J BIOL CHEM, V265, P8243; Lindholm E, 2001, AM J HUM GENET, V69, P96, DOI 10.1086/321288; Mao H, 2004, J BIOL CHEM, V279, P26314, DOI 10.1074/jbc.M401800200; Martemyanov KA, 2004, METHOD ENZYMOL, V390, P196; Martin S, 2007, NAT REV NEUROSCI, V8, P948, DOI 10.1038/nrn2276; MARTINEZMURILLO R, 1989, NEUROSCI LETT, V96, P121, DOI 10.1016/0304-3940(89)90044-X; Matunis MJ, 2006, DEV CELL, V11, P596, DOI 10.1016/j.devcel.2006.10.011; Melchior F, 2003, TRENDS BIOCHEM SCI, V28, P612, DOI 10.1016/j.tibs.2003.09.002; Mencia M, 2004, PROTEIN EXPRES PURIF, V37, P409, DOI 10.1016/j.pep.2004.07.001; Meulmeester E, 2008, NATURE, V452, P709, DOI 10.1038/452709a; Minty A, 2000, J BIOL CHEM, V275, P36316, DOI 10.1074/jbc.M004293200; Nishida T, 2001, J BIOL CHEM, V276, P39060, DOI 10.1074/jbc.M103955200; Nixon AB, 2002, J BIOL CHEM, V277, P18127, DOI 10.1074/jbc.M201065200; Perry JJP, 2008, TRENDS BIOCHEM SCI, V33, P201, DOI 10.1016/j.tibs.2008.02.001; Rodriguez-Munoz M, 2008, CELL SIGNAL, V20, P1855, DOI 10.1016/j.cellsig.2008.06.015; Rodriguez-Munoz M, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-19; Rodriguez-Munoz M, 2007, NEUROPSYCHOPHARMACOL, V32, P842, DOI 10.1038/sj.npp.1301184; Rodriguez-Munoz M, 2011, ANTIOXID REDOX SIGN, V14, P2413, DOI 10.1089/ars.2010.3511; Rodriguez-Munoz M, 2011, CELL MOL LIFE SCI, V68, P2933, DOI 10.1007/s00018-010-0598-x; Scheschonka A, 2007, TRENDS NEUROSCI, V30, P85, DOI 10.1016/j.tins.2007.01.003; Shen TH, 2006, MOL CELL, V24, P331, DOI 10.1016/j.molcel.2006.09.013; Song J, 2004, P NATL ACAD SCI USA, V101, P14373, DOI 10.1073/pnas.0403498101; Stemmle LN, 2006, MOL PHARMACOL, V70, P1461, DOI 10.1124/mol.106.023705; Sun YH, 2010, BIOCHEM BIOPH RES CO, V396, P501, DOI 10.1016/j.bbrc.2010.04.127; Takahashi Y, 2008, CELL CYCLE, V7, P1738, DOI 10.4161/cc.7.12.6156; Tang W, 2006, J NEURAL TRANSM, V113, P1537, DOI 10.1007/s00702-005-0419-9; Tatham MH, 2001, J BIOL CHEM, V276, P35368, DOI 10.1074/jbc.M104214200; Tesmer JJG, 2009, PROG MOL BIOL TRANSL, V86, P75, DOI 10.1016/S1877-1173(09)86004-3; Tu YP, 1999, J BIOL CHEM, V274, P38260, DOI 10.1074/jbc.274.53.38260; Tu YP, 2003, J BIOL CHEM, V278, P52273, DOI 10.1074/jbc.M309626200; Wang J, 1997, J BIOL CHEM, V272, P5732, DOI 10.1074/jbc.272.9.5732; Wang J, 1998, J BIOL CHEM, V273, P26014, DOI 10.1074/jbc.273.40.26014; Willars GB, 2006, SEMIN CELL DEV BIOL, V17, P363, DOI 10.1016/j.semcdb.2006.03.005; You M, 2009, CLIN CANCER RES, V15, P2666, DOI 10.1158/1078-0432.CCR-08-2335	61	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2011	6	12							e28557	10.1371/journal.pone.0028557	http://dx.doi.org/10.1371/journal.pone.0028557			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863OC	22163035	gold, Green Published			2022-12-27	WOS:000298173500034
J	Nestor, CE; Monckton, DG				Nestor, Colm E.; Monckton, Darren G.			Correlation of Inter-Locus Polyglutamine Toxicity with CAG center dot CTG Triplet Repeat Expandability and Flanking Genomic DNA GC Content	PLOS ONE			English	Article							SPINOCEREBELLAR ATAXIA TYPE-17; SECONDARY STRUCTURE ASSIGNMENT; DOMINANT CEREBELLAR-ATAXIA; MYOTONIC-DYSTROPHY; TRANSGENIC MICE; HUNTINGTONS-DISEASE; TRINUCLEOTIDE REPEAT; SOMATIC INSTABILITY; LATE-ONSET; GENETIC INSTABILITY	Dynamic expansions of toxic polyglutamine (polyQ)-encoding CAG repeats in ubiquitously expressed, but otherwise unrelated, genes cause a number of late-onset progressive neurodegenerative disorders, including Huntington disease and the spinocerebellar ataxias. As polyQ toxicity in these disorders increases with repeat length, the intergenerational expansion of unstable CAG repeats leads to anticipation, an earlier age-at-onset in successive generations. Crucially, disease associated alleles are also somatically unstable and continue to expand throughout the lifetime of the individual. Interestingly, the inherited polyQ length mediating a specific age-at-onset of symptoms varies markedly between disorders. It is widely assumed that these inter-locus differences in polyQ toxicity are mediated by protein context effects. Previously, we demonstrated that the tendency of expanded CAG center dot CTG repeats to undergo further intergenerational expansion (their 'expandability') also differs between disorders and these effects are strongly correlated with the GC content of the genomic flanking DNA. Here we show that the inter-locus toxicity of the expanded polyQ tracts of these disorders also correlates with both the expandability of the underlying CAG repeat and the GC content of the genomic DNA flanking sequences. Inter-locus polyQ toxicity does not correlate with properties of the mRNA or protein sequences, with polyQ location within the gene or protein, or steady state transcript levels in the brain. These data suggest that the observed inter-locus differences in polyQ toxicity are not mediated solely by protein context effects, but that genomic context is also important, an effect that may be mediated by modifying the rate at which somatic expansion of the DNA delivers proteins to their cytotoxic state.	[Nestor, Colm E.; Monckton, Darren G.] Univ Glasgow, Inst Mol Cell & Syst Biol, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland; [Nestor, Colm E.] Univ Edinburgh, Breakthrough Breast Canc Res Unit, Edinburgh, Midlothian, Scotland; [Nestor, Colm E.] Univ Edinburgh, Inst Genet & Mol Med, Edinburgh, Midlothian, Scotland	University of Glasgow; University of Edinburgh; University of Edinburgh	Nestor, CE (corresponding author), Univ Glasgow, Inst Mol Cell & Syst Biol, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland.	cnestor@hgu.mrc.ac.uk			Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was carried out as a PhD and was funded by the Wellcome Trust (http://www.wellcome.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ramahi I, 2006, J BIOL CHEM; ANVRET M, 1993, HUM MOL GENET, V2, P1397, DOI 10.1093/hmg/2.9.1397; ASHIZAWA T, 1993, NEUROLOGY, V43, P2674, DOI 10.1212/WNL.43.12.2674; Benton CS, 1998, NEUROLOGY, V51, P1081, DOI 10.1212/WNL.51.4.1081; Brock GJR, 1999, HUM MOL GENET, V8, P1061, DOI 10.1093/hmg/8.6.1061; Chai YH, 2004, J BIOL CHEM, V279, P3605, DOI 10.1074/jbc.M310939200; Charles P, 2007, NEUROLOGY, V69, P1970, DOI 10.1212/01.wnl.0000269323.21969.db; CHUNG MY, 1993, NAT GENET, V5, P254, DOI 10.1038/ng1193-254; Cleary JD, 2003, CYTOGENET GENOME RES, V100, P25, DOI 10.1159/000072837; Cummings CJ, 2000, HUM MOL GENET, V9, P909, DOI 10.1093/hmg/9.6.909; David G, 1998, HUM MOL GENET, V7, P165, DOI 10.1093/hmg/7.2.165; de Chiara C, 2005, J MOL BIOL, V354, P883, DOI 10.1016/j.jmb.2005.09.083; Dion V, 2008, HUM MOL GENET, V17, P1306, DOI 10.1093/hmg/ddn019; Duennwald ML, 2006, P NATL ACAD SCI USA, V103, P11045, DOI 10.1073/pnas.0604547103; Duvick L, 2010, NEURON, V67, P929, DOI 10.1016/j.neuron.2010.08.022; Edelmann W, 2000, CANCER RES, V60, P803; Ellegren H, 2000, NAT GENET, V24, P400, DOI 10.1038/74249; Emamian ES, 2003, NEURON, V38, P375, DOI 10.1016/S0896-6273(03)00258-7; Foiry L, 2006, HUM GENET, V119, P520, DOI 10.1007/s00439-006-0164-7; Fortune MT, 2000, HUM MOL GENET, V9, P439, DOI 10.1093/hmg/9.3.439; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Frontali M, 2001, BRAIN RES BULL, V56, P227, DOI 10.1016/S0361-9230(01)00574-3; Frontali M, 1999, PHILOS T ROY SOC B, V354, P1089, DOI 10.1098/rstb.1999.0464; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; Gao R, 2008, EUR J HUM GENET, V16, P215, DOI 10.1038/sj.ejhg.5201954; Gatchel JR, 2005, NAT REV GENET, V6, P743, DOI 10.1038/nrg1691; Geschwind DH, 1997, AM J HUM GENET, V60, P842; Gomes-Pereira M, 2004, HUM MOL GENET, V13, P1815, DOI 10.1093/hmg/ddh186; Gomes-Pereira M, 2006, MUTAT RES-FUND MOL M, V598, P15, DOI 10.1016/j.mrfmmm.2006.01.011; Gouw LG, 1998, HUM MOL GENET, V7, P525, DOI 10.1093/hmg/7.3.525; Gray M, 2008, J NEUROSCI, V28, P6182, DOI 10.1523/JNEUROSCI.0857-08.2008; Gusella JF, 2000, NAT REV NEUROSCI, V1, P109, DOI 10.1038/35039051; Heinig M, 2004, NUCLEIC ACIDS RES, V32, pW500, DOI 10.1093/nar/gkh429; Hubert Jr L, 2011, HUMAN MOL GENETICS; Ishiguro T, 2010, ACTA NEUROPATHOL, V119, P447, DOI 10.1007/s00401-009-0630-0; Jayaraman M, 2009, PROTEIN ENG DES SEL, V22, P469, DOI 10.1093/protein/gzp023; Kaplan S, 2007, PLOS COMPUT BIOL, V3, P2291, DOI 10.1371/journal.pcbi.0030235; Karchin R, 2003, PROTEINS, V51, P504, DOI 10.1002/prot.10369; Kartsaki E, 2006, INT J MOL MED, V17, P335; Kennedy L, 2003, HUM MOL GENET, V12, P3359, DOI 10.1093/hmg/ddg352; Kovtun IV, 2007, NATURE, V447, P447, DOI 10.1038/nature05778; Kovtun IV, 2001, NAT GENET, V27, P407, DOI 10.1038/86906; Kratter IH, 2010, NEURON, V67, P897, DOI 10.1016/j.neuron.2010.09.012; La Spada AR, 2003, NEURON, V38, P681, DOI 10.1016/S0896-6273(03)00328-3; LAVEDAN C, 1993, AM J HUM GENET, V52, P875; Lee JM, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-29; LEEFLANG EP, 1995, HUM MOL GENET, V4, P1519; Libby RT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000257; Libby RT, 2003, HUM MOL GENET, V12, P41, DOI 10.1093/hmg/ddg006; Lin YF, 2010, P NATL ACAD SCI USA, V107, P692, DOI 10.1073/pnas.0909740107; Maciel P, 1997, AM J HUM GENET, V60, P993; Maltecca F, 2003, NEUROLOGY, V61, P1441, DOI 10.1212/01.WNL.0000094123.09098.A0; Mangiarini L, 1997, NAT GENET, V15, P197, DOI 10.1038/ng0297-197; Manley K, 1999, NAT GENET, V23, P471, DOI 10.1038/70598; Marsh JL, 2000, HUM MOL GENET, V9, P13, DOI 10.1093/hmg/9.1.13; Matsuyama Z, 1999, J MED GENET, V36, P546; Menon RP, 2006, CELL MOL LIFE SCI; Monckton DG, 1999, HUM MOL GENET, V8, P2473, DOI 10.1093/hmg/8.13.2473; Monckton DG, 1997, NAT GENET, V15, P193, DOI 10.1038/ng0297-193; Oz G, 2011, CEREBELLUM, V10, P208, DOI 10.1007/s12311-010-0213-6; Ordway JM, 1997, CELL, V91, P753, DOI 10.1016/S0092-8674(00)80464-X; Pearson CE, 1996, BIOCHEMISTRY-US, V35, P5041, DOI 10.1021/bi9601013; QUAN F, 1995, HUM MOL GENET, V4, P2411, DOI 10.1093/hmg/4.12.2411; Ramskold D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000598; Rasmussen A, 2007, ANN NEUROL, V61, P607, DOI 10.1002/ana.21139; REITMAIR AH, 1995, NAT GENET, V11, P64, DOI 10.1038/ng0995-64; RICHARDS RI, 1992, NAT GENET, V1, P7, DOI 10.1038/ng0492-7; Riley BE, 2006, GENE DEV, V20, P2183, DOI 10.1101/gad.1436506; Robertson AL, 2010, CURR MED CHEM; Seznec H, 2000, HUM MOL GENET, V9, P1185, DOI 10.1093/hmg/9.8.1185; Squitieri F, 2006, MECH AGEING DEV, V127, P208, DOI 10.1016/j.mad.2005.09.012; Swami M, 2009, HUM MOL GENET, V18, P3039, DOI 10.1093/hmg/ddp242; THORNTON CA, 1994, ANN NEUROL, V35, P104, DOI 10.1002/ana.410350116; Tome S, 2011, HUM MOL GENET, V20, P2131, DOI 10.1093/hmg/ddr099; Tomiuk J, 2007, EUR J HUM GENET, V15, P81, DOI 10.1038/sj.ejhg.5201721; TZAGOURNISSAKIS M, 1995, HUM MOL GENET, V4, P2239, DOI 10.1093/hmg/4.12.2239; van den Broek WJAA, 2002, HUM MOL GENET, V11, P191, DOI 10.1093/hmg/11.2.191; Veitch NJ, 2007, DNA REPAIR, V6, P789, DOI 10.1016/j.dnarep.2007.01.002; Wexler NS, 2004, P NATL ACAD SCI USA, V101, P3498, DOI 10.1073/pnas.0308479101; Wheeler VC, 2003, HUM MOL GENET, V12, P273, DOI 10.1093/hmg/ddg056; WONG LJC, 1995, AM J HUM GENET, V56, P114; Zuhlke C, 2005, BMC MED GENET, V6, DOI 10.1186/1471-2350-6-27	82	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2011	6	12							e28260	10.1371/journal.pone.0028260	http://dx.doi.org/10.1371/journal.pone.0028260			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863OC	22163004	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000298173500013
J	O'Mahony, E; Buckley, JF; Bolton, D; Whyte, P; Fanning, S				O'Mahony, Emer; Buckley, James F.; Bolton, Declan; Whyte, Paul; Fanning, Seamus			Molecular Epidemiology of Campylobacter Isolates from Poultry Production Units in Southern Ireland	PLOS ONE			English	Article							MATERNAL ANTIBODIES; BROILER HOUSES; JEJUNI; SPP.; FLOCKS; DIFFERENTIATION; IDENTIFICATION; CONTAMINATION; COLONIZATION; TRANSMISSION	This study aimed to identify the sources and routes of transmission of Campylobacter in intensively reared poultry farms in the Republic of Ireland. Breeder flocks and their corresponding broilers housed in three growing facilities were screened for the presence of Campylobacter species from November 2006 through September 2007. All breeder flocks tested positive for Campylobacter species (with C. jejuni and C. coli being identified). Similarly, all broiler flocks also tested positive for Campylobacter by the end of the rearing period. Faecal and environmental samples were analyzed at regular intervals throughout the rearing period of each broiler flock. Campylobacter was not detected in the disinfected house, or in one-day old broiler chicks. Campylobacter jejuni was isolated from environmental samples including air, water puddles, adjacent broiler flocks and soil. A representative subset of isolates from each farm was selected for further characterization using flaA-SVR sub-typing and multi-locus sequence typing (MLST) to determine if same-species isolates from different sources were indistinguishable or not. Results obtained suggest that no evidence of vertical transmission existed and that adequate cleaning/disinfection of broiler houses contributed to the prevention of carryover and cross-contamination. Nonetheless, the environment appears to be a potential source of Campylobacter. The population structure of Campylobacter isolates from broiler farms in Southern Ireland was diverse and weakly clonal.	[O'Mahony, Emer; Whyte, Paul; Fanning, Seamus] Univ Coll Dublin, UCD Ctr Food Safety, Sch Publ Hlth Physiotherapy & Populat Sci, UCD Vet Sci Ctr, Dublin 2, Ireland; [O'Mahony, Emer; Buckley, James F.] Cork Cty Council, Vet Food Safety Lab, Inniscarra, County Cork, Ireland; [Bolton, Declan] Teagasc Food Res Ctr, Food Safety Dept, Dublin, Ireland	University College Dublin; Teagasc	O'Mahony, E (corresponding author), Univ Coll Dublin, UCD Ctr Food Safety, Sch Publ Hlth Physiotherapy & Populat Sci, UCD Vet Sci Ctr, Dublin 2, Ireland.	sfanning@ucd.ie	Bolton, Declan/ABE-6797-2020	Fanning, Seamus/0000-0002-1922-8836	Safefood [04-RESR-04]	Safefood	This work was funded by Safefood (04-RESR-04). www.safefood.eu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACMSF, 2005, 2 ACMSF; Allen VM, 2008, J FOOD PROTECT, V71, P264, DOI 10.4315/0362-028X-71.2.264; [Anonymous], 2010, EFSA J, V8, P1437, DOI DOI 10.2903/J.EFSA.2010.1437; Buhr RJ, 2005, AVIAN DIS, V49, P577, DOI 10.1637/7337-020205R.1; Buhr RJ, 2002, AVIAN DIS, V46, P919, DOI 10.1637/0005-2086(2002)046[0919:ROCFSO]2.0.CO;2; Bull SA, 2006, APPL ENVIRON MICROB, V72, P645, DOI 10.1128/AEM.72.1.645-652.2006; Cawthraw SA, 2010, AVIAN DIS, V54, P86, DOI 10.1637/9004-072709-Reg.1; Cogan TA, 2006, GUT; Cox NA, 2002, AVIAN DIS, V46, P717, DOI 10.1637/0005-2086(2002)046[0717:IOCSFS]2.0.CO;2; Cox NA, 2002, AVIAN DIS, V46, P535, DOI 10.1637/0005-2086(2002)046[0535:IOANSO]2.0.CO;2; Dingle KE, 2001, J CLIN MICROBIOL, V39, P14, DOI 10.1128/JCM.39.1.14-23.2001; European Food Safety Authority, 2010, EFSA J, V8, DOI 10.2903/j.efsa.2010.1503; European Food Safety Authority, 2011, EFSA Journal, V9, P2090; Hald B, 2001, LETT APPL MICROBIOL, V32, P253, DOI 10.1046/j.1472-765X.2001.00896.x; Hansson I, 2007, J FOOD PROTECT, V70, P2008, DOI 10.4315/0362-028X-70.9.2008; Hofshagen M, 2005, J FOOD PROTECT, V68, P2220, DOI 10.4315/0362-028X-68.10.2220; HPSC, 2010, INF DIS NOT IR 2004; Hue O, 2010, FOOD MICROBIOL, V27, P992, DOI 10.1016/j.fm.2010.06.004; JacobsReitsma WF, 1997, VET QUART, V19, P113, DOI 10.1080/01652176.1997.9694753; JACOBSREITSMA WF, 1995, AVIAN DIS, V39, P355, DOI 10.2307/1591879; Lynch OA, 2010, J MICROBIOL METHODS; Meinersmann RJ, 2005, APPL ENVIRON MICROB, V71, P6368, DOI 10.1128/AEM.71.10.6368-6374.2005; Meinersmann RJ, 1997, J CLIN MICROBIOL, V35, P2810, DOI 10.1128/JCM.35.11.2810-2814.1997; Nesbit EG, 2001, AM J VET RES, V62, P190, DOI 10.2460/ajvr.2001.62.190; Newell DG, 2003, APPL ENVIRON MICROB, V69, P4343, DOI 10.1128/AEM.69.8.4343-4351.2003; Patriarchi A, 2011, FOODBORNE PATHOG DIS, V8, P99, DOI 10.1089/fpd.2010.0637; Pearson AD, 1996, APPL ENVIRON MICROB, V62, P4614, DOI 10.1128/AEM.62.12.4614-4620.1996; Petersen L, 2001, APPL ENVIRON MICROB, V67, P2739, DOI 10.1128/AEM.67.6.2739-2745.2001; Petersen L, 2001, APPL ENVIRON MICROB, V67, P3115, DOI 10.1128/AEM.67.7.3115-3121.2001; Rosethorn H, 2009, EMPLOYER BRAND: KEEPING FAITH WITH THE DEAL, P1; Sahin O, 2003, J APPL MICROBIOL, V95, P1070, DOI 10.1046/j.1365-2672.2003.02083.x; Sahin O, 2003, APPL ENVIRON MICROB, V69, P5372, DOI 10.1128/AEM.69.9.5372-5379.2003; Sears A, 2011, EMERG INFECT DIS JUN; Stern NJ, 2003, EPIDEMIOL INFECT, V130, P23, DOI 10.1017/S0950268802007914; Stern NJ, 2001, J FOOD PROTECT, V64, P1705, DOI 10.4315/0362-028X-64.11.1705; Wang GH, 2002, J CLIN MICROBIOL, V40, P4744, DOI 10.1128/JCM.40.12.4744-4747.2002	36	31	31	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2011	6	12							e28490	10.1371/journal.pone.0028490	http://dx.doi.org/10.1371/journal.pone.0028490			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863OC	22163024	gold, Green Submitted, Green Published			2022-12-27	WOS:000298173500026
J	Galuska, D; Pirkmajer, S; Barres, R; Ekberg, K; Wahren, J; Chibalin, AV				Galuska, Dana; Pirkmajer, Sergej; Barres, Romain; Ekberg, Karin; Wahren, John; Chibalin, Alexander V.			C-Peptide Increases Na,K-ATPase Expression via PKC- and MAP Kinase-Dependent Activation of Transcription Factor ZEB in Human Renal Tubular Cells	PLOS ONE			English	Article							NA+-K+-ATPASE; DIABETIC-RATS; INSULIN; MUSCLE; NERVE; ALPHA; ISOFORM; GLUCOSE; PHOSPHORYLATION; AMELIORATION	Background: Replacement of proinsulin C-peptide in type 1 diabetes ameliorates nerve and kidney dysfunction, conditions which are associated with a decrease in Na,K-ATPase activity. We determined the molecular mechanism by which long term exposure to C-peptide stimulates Na,K-ATPase expression and activity in primary human renal tubular cells (HRTC) in control and hyperglycemic conditions. Methodology/Principal Findings: HRTC were cultured from the outer cortex obtained from patients undergoing elective nephrectomy. Ouabain-sensitive rubidium (Rb-86(+)) uptake and Na,K-ATPase activity were determined. Abundance of Na,K-ATPase was determined by Western blotting in intact cells or isolated basolateral membranes (BLM). DNA binding activity was determined by electrical mobility shift assay (EMSA). Culturing of HRTCs for 5 days with 1 nM, but not 10 nM of human C-peptide leads to increase in Na,K-ATPase alpha(1)-subunit protein expression, accompanied with increase in Rb-86(+) uptake, both in normal- and hyperglycemic conditions. Na,K-ATPase alpha(1)-subunit expression and Na,K-ATPase activity were reduced in BLM isolated from cells cultured in presence of high glucose. Exposure to 1 nM, but not 10 nM of C-peptide increased PKC epsilon phosphorylation as well as phosphorylation and abundance of nuclear ERK1/2 regardless of glucose concentration. Exposure to 1 nM of C-peptide increased DNA binding activity of transcription factor ZEB (AREB6), concomitant with Na,K-ATPase a1-subunit mRNA expression. Effects of 1 nM C-peptide on Na,K-ATPase alpha(1)-subunit expression and/or ZEB DNA binding activity in HRTC were abolished by incubation with PKC or MEK1/2 inhibitors and ZEB siRNA silencing. Conclusions/Significance: Despite activation of ERK1/2 and PKC by hyperglycemia, a distinct pool of PKCs and ERK1/2 is involved in regulation of Na,K-ATPase expression and activity by C-peptide. Most likely C-peptide stimulates sodium pump expression via activation of ZEB, a transcription factor that has not been previously implicated in C-peptide-mediated signaling. Importantly, only physiological concentrations of C-peptide elicit this effect.	[Galuska, Dana] Karolinska Inst, Dept Physiol & Pharmacol, Sect Integrat Physiol, Stockholm, Sweden; [Pirkmajer, Sergej; Barres, Romain; Ekberg, Karin; Wahren, John; Chibalin, Alexander V.] Karolinska Inst, Dept Mol Med & Surg, Sect Integrat Physiol, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Galuska, D (corresponding author), Karolinska Inst, Dept Physiol & Pharmacol, Sect Integrat Physiol, Stockholm, Sweden.	Alexander.Chibalin@ki.se	BARRES, Romain/N-2501-2016	BARRES, Romain/0000-0002-0158-519X; Chibalin, Alexander/0000-0002-6339-6271; Pirkmajer, Sergej/0000-0003-1459-6936	Swedish Research Council [K2010-55X-14191-3]; Novo-Nordisk Foundation; Swedish Society of Medicine	Swedish Research Council(Swedish Research CouncilEuropean Commission); Novo-Nordisk Foundation(Novo Nordisk Foundation); Swedish Society of Medicine	This work was supported by grants from the Swedish Research Council (www.vr.se; contract # K2010-55X-14191-3), the Novo-Nordisk Foundation, and the Swedish Society of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Khalili L, 2004, AM J PHYSIOL-CELL PH, V286, pC1410, DOI 10.1152/ajpcell.00444.2003; Chibalin Alexander V, 2007, Pathophysiology, V14, P153; Chibalin AV, 1998, J BIOL CHEM, V273, P8814, DOI 10.1074/jbc.273.15.8814; Chibalin AV, 2001, ENDOCRINOLOGY, V142, P3474, DOI 10.1210/en.142.8.3474; CRAVEN PA, 1989, J CLIN INVEST, V83, P1667, DOI 10.1172/JCI114066; Crider JY, 1997, J OCUL PHARMACOL TH, V13, P337, DOI 10.1089/jop.1997.13.337; Ekberg K, 2003, DIABETES, V52, P536, DOI 10.2337/diabetes.52.2.536; Ekberg K, 2007, DIABETES CARE, V30, P71, DOI 10.2337/dc06-1274; Feraille E, 2001, PHYSIOL REV, V81, P345, DOI 10.1152/physrev.2001.81.1.345; FINK DJ, 1994, J NEUROCHEM, V63, P1782; Galuska D, 2009, AM J PHYSIOL-ENDOC M, V297, pE38, DOI 10.1152/ajpendo.90990.2008; GREENE DA, 1984, AM J PHYSIOL, V247, pE534, DOI 10.1152/ajpendo.1984.247.4.E534; Grunberger G, 2001, DIABETOLOGIA, V44, P1247, DOI 10.1007/s001250100632; IKEDA K, 1995, EUR J BIOCHEM, V233, P73, DOI 10.1111/j.1432-1033.1995.073_1.x; INOGUCHI T, 1992, P NATL ACAD SCI USA, V89, P11059, DOI 10.1073/pnas.89.22.11059; Ishii H, 1996, SCIENCE, V272, P728, DOI 10.1126/science.272.5262.728; Johansson BL, 2000, DIABETIC MED, V17, P181, DOI 10.1046/j.1464-5491.2000.00274.x; KJELDSEN K, 1987, DIABETES, V36, P842, DOI 10.2337/diabetes.36.7.842; Kowluru RA, 1998, DIABETES, V47, P464, DOI 10.2337/diabetes.47.3.464; Li ZG, 2003, DIABETES-METAB RES, V19, P375, DOI 10.1002/dmrr.389; Li Zhen-guo, 2002, Int J Exp Diabetes Res, V3, P241, DOI 10.1080/15604280214936; LINGREL JB, 1994, J BIOL CHEM, V269, P19659; Nordquist L, 2010, DIABETES-METAB RES, V26, P193, DOI 10.1002/dmrr.1071; Ohtomo Y, 1996, DIABETOLOGIA, V39, P199, DOI 10.1007/BF00403963; PEREZ GO, 1977, ARCH INTERN MED, V137, P1018, DOI 10.1001/archinte.137.8.1018; Rigler R, 1999, P NATL ACAD SCI USA, V96, P13318, DOI 10.1073/pnas.96.23.13318; Samnegard B, 2001, KIDNEY INT, V60, P1258, DOI 10.1046/j.1523-1755.2001.00964.x; SCHMIDT TA, 1994, J APPL PHYSIOL, V76, P2140, DOI 10.1152/jappl.1994.76.5.2140; SHIBA T, 1993, AM J PHYSIOL, V265, pE783, DOI 10.1152/ajpendo.1993.265.5.E783; Sima AAF, 2001, DIABETOLOGIA, V44, P889, DOI 10.1007/s001250100570; Sugimoto K, 2000, DIABETES-METAB RES, V16, P408; Thompson CB, 1996, J BIOL CHEM, V271, P32653, DOI 10.1074/jbc.271.51.32653; Tsimaratos M, 2003, DIABETOLOGIA, V46, P124, DOI 10.1007/s00125-002-0996-1; Upadhyay D, 2003, FEBS LETT, V545, P173, DOI 10.1016/S0014-5793(03)00527-1; WATANABE Y, 1993, J BIOCHEM-TOKYO, V114, P849, DOI 10.1093/oxfordjournals.jbchem.a124267; Zhong Z, 2005, DIABETOLOGIA, V48, P187, DOI 10.1007/s00125-004-1602-5; Zhong Z, 2004, CELL MOL LIFE SCI, V61, P2782, DOI 10.1007/s00018-004-4258-x	37	27	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e28294	10.1371/journal.pone.0028294	http://dx.doi.org/10.1371/journal.pone.0028294			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22162761	Green Submitted, Green Published, gold			2022-12-27	WOS:000298172800023
J	Bang, G; Prieur, E; Roussilhon, C; Druilhe, P				Bang, Gilles; Prieur, Eric; Roussilhon, Christian; Druilhe, Pierre			Pre-Clinical Assessment of Novel Multivalent MSP3 Malaria Vaccine Constructs	PLOS ONE			English	Article							MEROZOITE SURFACE PROTEIN-3; BLOOD-STAGE ANTIGENS; PLASMODIUM-FALCIPARUM; INTERFERON-GAMMA; SEASONAL MALARIA; BURKINA-FASO; B-CELL; ANTIBODIES; IDENTIFICATION; TRANSMISSION	Background: MSP3 has been shown to induce protection against malaria in African children. The characterization of a family of Plasmodium falciparum merozoite surface protein 3 (MSP3) antigens sharing a similar structural organization, simultaneously expressed on the merozoite surface and targeted by a cross-reactive network of protective antibodies, is intriguing and offers new perspectives for the development of subunit vaccines against malaria. Methods: Eight recombinant polyproteins containing carefully selected regions of this family covalently linked in different combinations were all efficiently produced in Escherichia coli. The polyproteins consisted of one monovalent, one bivalent, one trivalent, two tetravalents, one hexavalent construct, and two tetravalents incorporating coiled-coil repeats regions from LSA3 and p27 vaccine candidates. Results: All eight polyproteins induced a strong and homogeneous antibody response in mice of three distinct genotypes, with a dominance of cytophilic IgG subclasses, lasting up to six months after the last immunization. Vaccine-induced antibodies exerted a strong monocyte-mediated in vitro inhibition of P. falciparum growth. Naturally acquired antibodies from individuals living in an endemic area of Senegal recognized the polyproteins with a reactivity mainly constituted of cytophilic IgG subclasses. Conclusions: Combination of genetically conserved and antigenically related MSP3 proteins provides promising subunit vaccine constructs, with improved features as compared to the first generation construct employed in clinical trials (MSP3-LSP). These multivalent MSP3 vaccine constructs expand the epitope display of MSP3 family proteins, and lead to the efficient induction of a wider range of antibody subclasses, even in genetically different mice. These findings are promising for future immunization of genetically diverse human populations.	[Bang, Gilles] Inst Pasteur, Malaria Vaccine Dev Lab, Paris, France; Vac4all Initiat, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Bang, G (corresponding author), Inst Pasteur, Malaria Vaccine Dev Lab, Paris, France.	druilhe@vac4all.org			Ministry of Research	Ministry of Research(Ministry of Research and Technology of the Republic of Indonesia (RISTEK))	This study received support from the VIH-PAL+ program from the Ministry of Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audran R, 2005, INFECT IMMUN, V73, P8017, DOI 10.1128/IAI.73.12.8017-8026.2005; BOUHAROUNTAYOUN H, 1995, J EXP MED, V182, P409, DOI 10.1084/jem.182.2.409; Daher LJ, 2010, INFECT IMMUN, V78, P477, DOI 10.1128/IAI.00941-08; Daubersies P, 2000, NAT MED, V6, P1258, DOI 10.1038/81366; Demanga CG, 2010, INFECT IMMUN, V78, P486, DOI 10.1128/IAI.01359-08; DRUILHE P, 1987, INFECT IMMUN, V55, P888, DOI 10.1128/IAI.55.4.888-891.1987; Druilhe P, 2005, PLOS MED, V2, P1135, DOI 10.1371/journal.pmed.0020344; Druilhe Pierre, 2002, Methods Mol Med, V72, P457, DOI 10.1385/1-59259-271-6:457; Duah NO, 2010, PARASITE IMMUNOL, V32, P125, DOI 10.1111/j.1365-3024.2009.01165.x; FIDOCK DA, 1994, J IMMUNOL, V153, P190; Fontenille D, 1997, T ROY SOC TROP MED H, V91, P647, DOI 10.1016/S0035-9203(97)90506-X; Foth BJ, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r177; Huber W, 1997, MOL BIOCHEM PARASIT, V87, P231, DOI 10.1016/S0166-6851(97)00067-4; Jafarshad A, 2007, J IMMUNOL, V178, P3099, DOI 10.4049/jimmunol.178.5.3099; Jouin H, 2004, CYTOM PART A, V57A, P34, DOI 10.1002/cyto.a.10110; Lusingu JPA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-163; Martin RM, 1998, J IMMUNOL METHODS, V212, P187, DOI 10.1016/S0022-1759(98)00015-5; Martin RM, 1997, IMMUNOGENETICS, V46, P167, DOI 10.1007/s002510050258; McColl DJ, 1997, MOL BIOCHEM PARASIT, V90, P21, DOI 10.1016/S0166-6851(97)00130-8; MORGADO MG, 1989, EMBO J, V8, P3245, DOI 10.1002/j.1460-2075.1989.tb08484.x; Nebie I, 2008, INFECT IMMUN, V76, P759, DOI 10.1128/IAI.01147-07; OEUVRAY C, 1994, BLOOD, V84, P1594; Rogier C, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P255; Roussilhon C, 2007, PLOS MED, V4, P1791, DOI 10.1371/journal.pmed.0040320; SABCHAREON A, 1991, AM J TROP MED HYG, V45, P297, DOI 10.4269/ajtmh.1991.45.297; SEPPALA I, 1981, SCAND J IMMUNOL, V14, P335, DOI 10.1111/j.1365-3083.1981.tb00573.x; Singh S, 2005, INFECT IMMUN, V73, P1235, DOI 10.1128/IAI.73.2.1235-1238.2005; Singh S, 2004, J INFECT DIS, V190, P1010, DOI 10.1086/423208; Singh S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005410; Sirima SB, 2007, VACCINE, V25, P2723, DOI 10.1016/j.vaccine.2006.05.090; Sirima SB, 2011, NEW ENGL J MED, V365, P1062, DOI 10.1056/NEJMc1100670; SNAPPER CM, 1987, SCIENCE, V236, P944, DOI 10.1126/science.3107127; SNAPPER CM, 1988, P NATL ACAD SCI USA, V85, P6107, DOI 10.1073/pnas.85.16.6107; Villard V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000645; Yoshimoto T, 1997, P NATL ACAD SCI USA, V94, P3948, DOI 10.1073/pnas.94.8.3948; Zwetyenga J, 1999, T ROY SOC TROP MED H, V93, P375, DOI 10.1016/S0035-9203(99)90122-0	36	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2011	6	12							e28165	10.1371/journal.pone.0028165	http://dx.doi.org/10.1371/journal.pone.0028165			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MQ	22145028	Green Published, Green Submitted, gold			2022-12-27	WOS:000298168900011
J	Goshima, G				Goshima, Gohta			Identification of a TPX2-Like Microtubule-Associated Protein in Drosophila	PLOS ONE			English	Article							SPINDLE-POLE ORGANIZATION; CELL-CYCLE PROGRESSION; XENOPUS EGG EXTRACTS; AURORA-A KINASE; MITOTIC SPINDLE; MAMMALIAN-CELLS; IMPORTIN-ALPHA; S2 CELLS; TPX2; LOCALIZATION	Chromosome segregation during mitosis and meiosis relies on the spindle and the functions of numerous microtubule-associated proteins (MAPs). One of the best-studied spindle MAPs is the highly conserved TPX2, which has been reported to have characteristic intracellular dynamics and molecular activities, such as nuclear localisation in interphase, poleward movement in the metaphase spindle, microtubule nucleation, microtubule stabilisation, microtubule bundling, Aurora A kinase activation, kinesin-5 binding, and kinesin-12 recruitment. This protein has been shown to be essential for spindle formation in every cell type analysed so far. However, as yet, TPX2 homologues have not been found in the Drosophila genome. In this study, I found that the Drosophila protein Ssp1/Mei-38 has significant homology to TPX2. Sequence conservation was limited to the putative spindle microtubule-associated region of TPX2, and intriguingly, D-TPX2 (Ssp1/Mei-38) lacks Aurora A- and kinesin-5-binding domains, which are highly conserved in other animal and plant species, including many insects such as ants and bees. D-TPX2 uniformly localised to kinetochore microtubule-enriched regions of the metaphase spindle in the S2 cell line, and it had microtubule binding and bundling activities in vitro. In comparison with other systems, the contribution of D-TPX2 to cell division seems to be minor; live cell imaging of microtubules and chromosomes after RNAi knockdown identified significant delay in chromosome congression in only 18% of the cells. Thus, while this conserved spindle protein is present in Drosophila, other mechanisms may largely compensate for its spindle assembly and chromosome segregation functions.	Nagoya Univ, Div Biol Sci, Grad Sch Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Nagoya University	Goshima, G (corresponding author), Nagoya Univ, Div Biol Sci, Grad Sch Sci, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.	goshima@bio.nagoya-u.ac.jp			Japan Society for the Promotion of Science; Naito Foundation; Inoue Foundation; Uehara Foundation; Asahi Glass Foundation; Human Frontier Science Program (HFSP)	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Naito Foundation(Naito Memorial Foundation); Inoue Foundation(Inoue Research Award for Young Scientists); Uehara Foundation(Uehara Memorial Foundation); Asahi Glass Foundation; Human Frontier Science Program (HFSP)(Human Frontier Science Program)	This work was supported by the Next Generation grant (Japan Society for the Promotion of Science), the Naito Foundation, the Inoue Foundation, the Uehara Foundation, the Asahi Glass Foundation, and the Human Frontier Science Program (HFSP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER BS, 1972, GENETICS, V71, P255; Bayliss R, 2003, MOL CELL, V12, P851, DOI 10.1016/S1097-2765(03)00392-7; Bettencourt-Dias M, 2009, METHODS MOL BIOL, V545, P39, DOI 10.1007/978-1-60327-993-2_3; Bieling P, 2010, METHOD CELL BIOL, V95, P555, DOI 10.1016/S0091-679X(10)95028-0; Bird AW, 2008, J CELL BIOL, V182, P289, DOI 10.1083/jcb.200802005; Brunet S, 2004, MOL BIOL CELL, V15, P5318, DOI 10.1091/mbc.E04-05-0385; Brunet S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003338; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Eckerdt F, 2008, CURR BIOL, V18, P519, DOI 10.1016/j.cub.2008.02.077; Ems-McClung SC, 2004, MOL BIOL CELL, V15, P46, DOI 10.1091/mbc.E03-07-0454; Garrett S, 2002, CURR BIOL, V12, P2055, DOI 10.1016/S0960-9822(02)01277-0; Goshima G, 2005, MOL BIOL CELL, V16, P3896, DOI 10.1091/mbc.E05-02-0118; Goshima G, 2003, J CELL BIOL, V162, P1003, DOI 10.1083/jcb.200303022; Goshima G, 2003, J CELL BIOL, V160, P25, DOI 10.1083/jcb.200210005; Goshima G, 2008, J CELL BIOL, V181, P421, DOI 10.1083/jcb.200711053; Goshima G, 2007, SCIENCE, V316, P417, DOI 10.1126/science.1141314; Goshima G, 2010, ANNU REV CELL DEV BI, V26, P21, DOI 10.1146/annurev-cellbio-100109-104006; Goshima G, 2010, METHOD CELL BIOL, V97, P259, DOI 10.1016/S0091-679X(10)97015-5; Goshima G, 2010, CURR OPIN CELL BIOL, V22, P44, DOI 10.1016/j.ceb.2009.11.012; Groen AC, 2009, MOL BIOL CELL, V20, P2766, DOI 10.1091/mbc.E09-01-0043; Gruss OJ, 2002, NAT CELL BIOL, V4, P871, DOI 10.1038/ncb870; Gruss OJ, 2001, CELL, V104, P83, DOI 10.1016/S0092-8674(01)00193-3; Heald R, 1996, NATURE, V382, P420, DOI 10.1038/382420a0; Kalab P, 2008, J CELL SCI, V121, P1577, DOI 10.1242/jcs.005959; Koffa MD, 2006, CURR BIOL, V16, P743, DOI 10.1016/j.cub.2006.03.056; Li WJ, 2011, J CELL BIOL, V193, P973, DOI 10.1083/jcb.201101108; Ma N, 2011, J CELL BIOL, V195, P87, DOI 10.1083/jcb.201106149; Manning AL, 2007, CURR BIOL, V17, P260, DOI 10.1016/j.cub.2006.11.071; Ozlu N, 2005, DEV CELL, V9, P237, DOI 10.1016/j.devcel.2005.07.002; Schatz CA, 2003, EMBO J, V22, P2060, DOI 10.1093/emboj/cdg195; Sillje HHW, 2006, CURR BIOL, V16, P731, DOI 10.1016/j.cub.2006.02.070; Tsai MY, 2005, CURR BIOL, V15, P2156, DOI 10.1016/j.cub.2005.10.054; Tulu US, 2006, CURR BIOL, V16, P536, DOI 10.1016/j.cub.2006.01.060; Uehara R, 2009, P NATL ACAD SCI USA, V106, P6998, DOI 10.1073/pnas.0901587106; Vos JW, 2008, PLANT CELL, V20, P2783, DOI 10.1105/tpc.107.056796; Walczak CE, 2008, INT REV CYTOL, V265, P111, DOI 10.1016/S0074-7696(07)65003-7; Wittmann T, 1998, J CELL BIOL, V143, P673, DOI 10.1083/jcb.143.3.673; Wittmann T, 2000, J CELL BIOL, V149, P1405, DOI 10.1083/jcb.149.7.1405; Wu CJ, 2008, GENETICS, V180, P61, DOI 10.1534/genetics.108.091140; Zhang G, 2009, J CELL SCI, V122, P535, DOI 10.1242/jcs.040352	40	33	33	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e28120	10.1371/journal.pone.0028120	http://dx.doi.org/10.1371/journal.pone.0028120			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140519	Green Published, gold, Green Submitted			2022-12-27	WOS:000298168100038
J	Rehberg, M; Krombach, F; Pohl, U; Dietzel, S				Rehberg, Markus; Krombach, Fritz; Pohl, Ulrich; Dietzel, Steffen			Label-Free 3D Visualization of Cellular and Tissue Structures in Intact Muscle with Second and Third Harmonic Generation Microscopy	PLOS ONE			English	Article							ACTIN-MYOSIN INTERACTIONS; 2ND-HARMONIC GENERATION; 3RD-HARMONIC GENERATION; IN-VIVO; RESONANCE ENHANCEMENT; FLUORESCENCE; PROTEIN; DNA; VASODILATION; ARRANGEMENTS	Second and Third Harmonic Generation (SHG and THG) microscopy is based on optical effects which are induced by specific inherent physical properties of a specimen. As a multi-photon laser scanning approach which is not based on fluorescence it combines the advantages of a label-free technique with restriction of signal generation to the focal plane, thus allowing high resolution 3D reconstruction of image volumes without out-of-focus background several hundred micrometers deep into the tissue. While in mammalian soft tissues SHG is mostly restricted to collagen fibers and striated muscle myosin, THG is induced at a large variety of structures, since it is generated at interfaces such as refraction index changes within the focal volume of the excitation laser. Besides, colorants such as hemoglobin can cause resonance enhancement, leading to intense THG signals. We applied SHG and THG microscopy to murine (Mus musculus) muscles, an established model system for physiological research, to investigate their potential for label-free tissue imaging. In addition to collagen fibers and muscle fiber substructure, THG allowed us to visualize blood vessel walls and erythrocytes as well as white blood cells adhering to vessel walls, residing in or moving through the extravascular tissue. Moreover peripheral nerve fibers could be clearly identified. Structure down to the nuclear chromatin distribution was visualized in 3D and with more detail than obtainable by bright field microscopy. To our knowledge, most of these objects have not been visualized previously by THG or any label-free 3D approach. THG allows label-free microscopy with inherent optical sectioning and therefore may offer similar improvements compared to bright field microscopy as does confocal laser scanning microscopy compared to conventional fluorescence microscopy.	[Rehberg, Markus; Krombach, Fritz; Pohl, Ulrich; Dietzel, Steffen] Univ Munich, Walter Brendel Zentrum Expt Med, Munich, Germany	University of Munich	Rehberg, M (corresponding author), Univ Munich, Walter Brendel Zentrum Expt Med, Munich, Germany.	dietzel@lmu.de		Rehberg, Markus/0000-0001-7314-6332; Dietzel, Steffen/0000-0001-5725-3242	BioImaging Network of the Ludwig-Maximilians-Universitat Munchen; Excellence Initiative of the Deutsche Forschungsgemeinschaft; Bundesministerium fur Bildung und Forschung; Friedrich-Baur-Stiftung	BioImaging Network of the Ludwig-Maximilians-Universitat Munchen; Excellence Initiative of the Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Friedrich-Baur-Stiftung	This study was supported by the BioImaging Network of the Ludwig-Maximilians-Universitat Munchen (www.bin.lmu.de) and the Excellence Initiative of the Deutsche Forschungsgemeinschaft (www.dfg.de) and the Bundesministerium fur Bildung und Forschung (www.bmbf.de). MR received support by the Friedrich-Baur-Stiftung (www.baur-stiftung.de). UP is a member of the Munich Heart Alliance. The funding institutions had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agbulut O, 2006, NAT METHODS, V3, P331, DOI 10.1038/nmeth0506-331; Agbulut O, 2007, J BIOL CHEM, V282, P10465, DOI 10.1074/jbc.M610418200; Amos B, 2011, COMPREHENSIVE BIOPHYSICS, VOL 2: BIOPHYSICAL TECHNIQUES FOR CHARACTERIZATION OF CELLS, P3, DOI 10.1016/B978-0-12-374920-8.00203-4; ANDERS A, 1981, CHEM PHYS LETT, V81, P270, DOI 10.1016/0009-2614(81)80250-3; Aviles-Espinosa R, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3477535; Baens M, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000054; BAEZ S, 1973, MICROVASC RES, V5, P384, DOI 10.1016/0026-2862(73)90054-X; Belisle JM, 2008, BIOPHYS J, V94, pL26, DOI 10.1529/biophysj.107.125443; Bihari P, 2008, PART FIBRE TOXICOL, V5, DOI 10.1186/1743-8977-5-14; Both M, 2004, J BIOMED OPT, V9, P882, DOI 10.1117/1.1783354; Campagnola PJ, 2002, BIOPHYS J, V82, P493, DOI 10.1016/S0006-3495(02)75414-3; Campagnola PJ, 2008, HDB BIOMEDICAL NONLI, P377; Chang CF, 2010, J BIOPHOTONICS, V3, P678, DOI 10.1002/jbio.201000045; Chang CF, 2010, OPT EXPRESS, V18, P7397, DOI 10.1364/OE.18.007397; Chen SY, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2363369; Cheng P.C., 2006, HDB BIOL CONFOCAL MI, P162, DOI DOI 10.1007/978-0-387-45524-2_8; Cheng P-C, 2006, HDB BIOL CONFOCAL MI, P703, DOI DOI 10.1007/978-0-387-45524-2_40; Chu SW, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3080722; Chu SW, 2004, BIOPHYS J, V86, P3914, DOI 10.1529/biophysj.103.034595; Clay GO, 2006, J OPT SOC AM B, V23, P932, DOI 10.1364/JOSAB.23.000932; Cox G, 2004, MICROSC RES TECHNIQ, V63, P18, DOI 10.1002/jemt.10423; Cox Guy, 2006, V319, P15; de Wit C, 2000, CIRC RES, V86, P649, DOI 10.1161/01.RES.86.6.649; Dombeck DA, 2003, P NATL ACAD SCI USA, V100, P7081, DOI 10.1073/pnas.0731953100; Farrar MJ, 2011, BIOPHYS J, V100, P1362, DOI 10.1016/j.bpj.2011.01.031; FERGUSON M, 1992, CHROMOSOMA, V101, P557, DOI 10.1007/BF00660315; Friedl Peter, 2007, Curr Protoc Cell Biol, VChapter 4, DOI 10.1002/0471143030.cb0415s34; GORCZYNSKI RJ, 1978, AM J PHYSIOL, V235, pH505, DOI 10.1152/ajpheart.1978.235.5.H505; Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818; Huang WY, 2000, NAT MED, V6, P482, DOI 10.1038/74914; Kao FJ, 2004, MICROSC RES TECHNIQ, V63, P175, DOI 10.1002/jemt.20026; Khandoga AG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004693; Lee WJ, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3469848; Legare F, 2007, BIOPHYS J, V93, P1312, DOI 10.1529/biophysj.106.100586; Liu HS, 1999, BIOCHEM BIOPH RES CO, V260, P712, DOI 10.1006/bbrc.1999.0954; Mak GWY, 2007, ANAL BIOCHEM, V362, P296, DOI 10.1016/j.ab.2006.12.017; Mayer R, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-44; Mempel TR, 2003, J VASC RES, V40, P435, DOI 10.1159/000073902; Mertz J, 2001, OPT COMMUN, V196, P325, DOI 10.1016/S0030-4018(01)01403-1; Millard AC, 1999, APPL OPTICS, V38, P7393, DOI 10.1364/AO.38.007393; Moreaux L, 2001, BIOPHYS J, V80, P1568, DOI 10.1016/S0006-3495(01)76129-2; Plotnikov SV, 2006, BIOPHYS J, V90, P693, DOI 10.1529/biophysj.105.071555; Rehberg M, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3374337; Schaller RD, 2000, ANAL CHEM, V72, P5361, DOI 10.1021/ac000699r; Shelby RD, 1996, J CELL BIOL, V135, P545, DOI 10.1083/jcb.135.3.545; Solovei I, 2009, CELL, V137, P356, DOI 10.1016/j.cell.2009.01.052; Tai Shih-Peng, 2005, Opt Express, V13, P8231, DOI 10.1364/OPEX.13.008231; Tai SP, 2006, OPT EXPRESS, V14, P6178, DOI 10.1364/OE.14.006178; Vaya I, 2010, J AM CHEM SOC, V132, P11834, DOI 10.1021/ja102800r; WEIMER R, 1992, HUM GENET, V88, P673, DOI 10.1007/BF02265296; Witte S, 2011, P NATL ACAD SCI USA, V108, P5970, DOI 10.1073/pnas.1018743108; Yu CH, 2008, OPT LETT, V33, P387, DOI 10.1364/OL.33.000387; Yu CH, 2007, OPT EXPRESS, V15, P11167, DOI 10.1364/OE.15.011167; Zhao H, 2009, CYTOM PART A, V75A, P510, DOI 10.1002/cyto.a.20727; Zipfel WR, 2003, P NATL ACAD SCI USA, V100, P7075, DOI 10.1073/pnas.0832308100	55	66	67	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2011	6	11							e28237	10.1371/journal.pone.0028237	http://dx.doi.org/10.1371/journal.pone.0028237			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KW	22140560	gold, Green Published, Green Submitted			2022-12-27	WOS:000298163400041
J	Gao, CH; Xue, YF; Ma, YH				Gao, Chenghua; Xue, Yanfen; Ma, Yanhe			Protoplast Transformation of Recalcitrant Alkaliphilic Bacillus sp with Methylated Plasmid DNA and a Developed Hard Agar Regeneration Medium	PLOS ONE			English	Article							SUBTILIS PROTOPLASTS; GENETIC-TRANSFORMATION; ESCHERICHIA-COLI; PSEUDOFIRMUS OF4; RESTRICTION; EFFICIENCY; ENZYMES; EXPRESSION; BACTERIA; CLONING	Among the diverse alkaliphilic Bacillus strains, only a little have been reported to be genetically transformed. In this study, an efficient protoplast transformation procedure was developed for recalcitrant alkaliphilic Bacillus sp. N16-5. The procedure involved polyethylene glycol-induced DNA uptake by the protoplasts and subsequent protoplast regeneration with a developed hard agar regeneration medium. An in vivo methylation strategy was introduced to methylate the exogenous plasmid DNA for improving the transformation efficiency. The transformation efficiency reached to 1.1x10(5) transformants per mu g plasmid DNA with methylated plasmid pHCMC04 and the developed hard agar regeneration medium. This procedure might also be applicable to the genetic transformation of other Bacillus strains.	[Gao, Chenghua; Xue, Yanfen; Ma, Yanhe] Chinese Acad Sci, Inst Microbiol, State Key Lab Microbial Resources, Beijing, Peoples R China; [Gao, Chenghua] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Gao, CH (corresponding author), Chinese Acad Sci, Inst Microbiol, State Key Lab Microbial Resources, Beijing, Peoples R China.	mayanhe@im.ac.cn	MA, YAN/HHN-2912-2022		National Basic Research Program of China (973 Project) [2011CBA00805]; Natural Science Foundation of China [30621005]	National Basic Research Program of China (973 Project)(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China (973 Project, #2011CBA00805) and Natural Science Foundation of China (30621005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAMATSU T, 1982, AGR BIOL CHEM TOKYO, V46, P1617, DOI 10.1080/00021369.1982.10865298; AONO R, 1991, AGR BIOL CHEM TOKYO, V55, P2643, DOI 10.1080/00021369.1991.10871027; Berndt C, 2003, MICROBIOL-SGM, V149, P895, DOI 10.1099/mic.0.26033-0; BHATT YB, 1987, LETT APPL MICROBIOL, V4, P77, DOI 10.1111/j.1472-765X.1987.tb01587.x; BISWAS I, 1993, J BACTERIOL, V175, P3628, DOI 10.1128/JB.175.11.3628-3635.1993; BOURNE N, 1986, J GEN MICROBIOL, V132, P251; CHANG S, 1979, MOL GEN GENET, V168, P111, DOI 10.1007/BF00267940; CLIVE D, 1970, J GEN MICROBIOL, V61, P233, DOI 10.1099/00221287-61-2-233; DUNN RM, 1987, ARCH MICROBIOL, V146, P323, DOI 10.1007/BF00410929; ElhaI J, 1997, J BACTERIOL, V179, P1998, DOI 10.1128/jb.179.6.1998-2005.1997; Fujinami S, 2010, ENVIRON TECHNOL, V31, P845, DOI 10.1080/09593331003762807; GARDENER S, 1984, J GEN MICROBIOL, V130, P731; Gilmour R, 2000, J BACTERIOL, V182, P5969, DOI 10.1128/JB.182.21.5969-5981.2000; HAIMA P, 1987, MOL GEN GENET, V209, P335, DOI 10.1007/BF00329663; Heap JT, 2007, J MICROBIOL METH, V70, P452, DOI 10.1016/j.mimet.2007.05.021; Horikoshi K, 1999, MICROBIOL MOL BIOL R, V63, P735, DOI 10.1128/MMBR.63.4.735-750.1999; HORIKOSHI K, 1971, AGR BIOL CHEM TOKYO, V35, P1407, DOI 10.1080/00021369.1971.10860094; IMANAKA T, 1982, J BACTERIOL, V149, P824, DOI 10.1128/JB.149.3.824-830.1982; Ito M, 1997, J BACTERIOL, V179, P3851, DOI 10.1128/jb.179.12.3851-3857.1997; Ito M, 2001, BIOSCI BIOTECH BIOCH, V65, P2773, DOI 10.1271/bbb.65.2773; Ito S, 1998, EXTREMOPHILES, V2, P185, DOI 10.1007/s007920050059; KIMURA H, 1994, BIOSCI BIOTECH BIOCH, V58, P1002, DOI 10.1271/bbb.58.1002; Krulwich TA, 2011, NAT REV MICROBIOL, V9, P330, DOI 10.1038/nrmicro2549; KUDO T, 1990, J BACTERIOL, V172, P7282, DOI 10.1128/jb.172.12.7282-7283.1990; LANDMAN OE, 1963, J MOL BIOL, V7, P721, DOI 10.1016/S0022-2836(63)80119-9; LANDMAN OE, 1968, J BACTERIOL, V96, P2154, DOI 10.1128/JB.96.6.2154-2170.1968; LEENHOUTS KJ, 1989, APPL ENVIRON MICROB, V55, P394, DOI 10.1128/AEM.55.2.394-400.1989; Li G, 2010, J MICROBIOL BIOTECHN, V20, P670, DOI 10.4014/jmb.0911.11019; LORENZ MG, 1994, MICROBIOL REV, V58, P563, DOI 10.1128/MMBR.58.3.563-602.1994; Ma YH, 2004, EXTREMOPHILES, V8, P447, DOI 10.1007/s00792-004-0405-4; MALLONEE DH, 1989, APPL ENVIRON MICROB, V55, P2517, DOI 10.1128/AEM.55.10.2517-2521.1989; MERCENIER A, 1988, BIOCHIMIE, V70, P503, DOI 10.1016/0300-9084(88)90086-7; MERMELSTEIN LD, 1993, APPL ENVIRON MICROB, V59, P1077, DOI 10.1128/AEM.59.4.1077-1081.1993; Nguyen HD, 2005, PLASMID, V54, P241, DOI 10.1016/j.plasmid.2005.05.001; NIEISEN P, 1995, MICROBIOLOGY, V141, P1745; Nikolajewa S, 2005, NUCLEIC ACIDS RES, V33, P2726, DOI 10.1093/nar/gki575; NIMI O, 1983, BIOTECHNOL LETT, V5, P709, DOI 10.1007/BF01386367; PAAVILAINEN S, 1994, J FERMENT BIOENG, V78, P217, DOI 10.1016/0922-338X(94)90293-3; Padan E, 2005, BBA-BIOMEMBRANES, V1717, P67, DOI 10.1016/j.bbamem.2005.09.010; PUYET A, 1987, FEMS MICROBIOL LETT, V40, P1; Sambrook J., 2001, MOL CLONING LAB MANU; SULLIVAN MA, 1984, GENE, V29, P21, DOI 10.1016/0378-1119(84)90161-6; Thomas CM, 2005, NAT REV MICROBIOL, V3, P711, DOI 10.1038/nrmicro1234; Wallace JG, 2011, LETT APPL MICROBIOL, V52, P430, DOI 10.1111/j.1472-765X.2011.03017.x; WHITEHEAD PR, 1985, ARCH MICROBIOL, V141, P70, DOI 10.1007/BF00446742; WILSON GG, 1991, ANNU REV GENET, V25, P585, DOI 10.1146/annurev.ge.25.120191.003101; Yasui K, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn884; YUAN R, 1981, ANNU REV BIOCHEM, V50, P285, DOI 10.1146/annurev.bi.50.070181.001441; Zhang GM, 2010, BIOTECHNOL LETT, V32, P1915, DOI 10.1007/s10529-010-0372-z	49	13	17	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e28148	10.1371/journal.pone.0028148	http://dx.doi.org/10.1371/journal.pone.0028148			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132233	gold, Green Published, Green Submitted			2022-12-27	WOS:000298162000082
J	Junqueira, DM; de Medeiros, RM; Matte, MCC; Araujo, LAL; Chies, JAB; Ashton-Prolla, P; Almeida, SED				Junqueira, Dennis Maletich; de Medeiros, Rubia Marilia; Cotta Matte, Maria Cristina; Luvison Araujo, Leonardo Augusto; Bogo Chies, Jose Artur; Ashton-Prolla, Patricia; de Matos Almeida, Sabrina Esteves			Reviewing the History of HIV-1: Spread of Subtype B in the Americas	PLOS ONE			English	Article							DEFICIENCY SYNDROME AIDS; MOLECULAR EPIDEMIOLOGY; GENETIC DIVERSITY; EVOLUTIONARY HISTORY; POPULATION-GENETICS; KAPOSIS SARCOMA; SOUTH-AMERICA; TYPE-1; VIRUS; TRANSMISSION	The dispersal of HIV-1 subtype B (HIV-1B) is a reflection of the movement of human populations in response to social, political, and geographical issues. The initial dissemination of HIV-1B outside Africa seems to have included the passive involvement of human populations from the Caribbean in spreading the virus to the United States. However, the exact pathways taken during the establishment of the pandemic in the Americas remain unclear. Here, we propose a geographical scenario for the dissemination of HIV-1B in the Americas, based on phylogenetic and genetic statistical analyses of 313 available sequences of the pol gene from 27 countries. Maximum likelihood and Bayesian inference methods were used to explore the phylogenetic relationships between HIV-1B sequences, and molecular variance estimates were analyzed to infer the genetic structure of the viral population. We found that the initial dissemination and subsequent spread of subtype B in the Americas occurred via a single introduction event in the Caribbean around 1964 (1950-1967). Phylogenetic trees present evidence of several primary outbreaks in countries in South America, directly seeded by the Caribbean epidemic. Cuba is an exception insofar as its epidemic seems to have been introduced from South America. One clade comprising isolates from different countries emerged in the most-derived branches, reflecting the intense circulation of the virus throughout the American continents. Statistical analysis supports the genetic compartmentalization of the virus among the Americas, with a close relationship between the South American and Caribbean epidemics. These findings reflect the complex establishment of the HIV-1B pandemic and contribute to our understanding between the migration process of human populations and virus diffusion.	[Junqueira, Dennis Maletich; de Medeiros, Rubia Marilia; Cotta Matte, Maria Cristina; Bogo Chies, Jose Artur; Ashton-Prolla, Patricia] Univ Fed Rio Grande do Sul, Programa Posgrad Genet & Biol Mol, Porto Alegre, RS, Brazil; [Junqueira, Dennis Maletich; de Medeiros, Rubia Marilia; Cotta Matte, Maria Cristina; Luvison Araujo, Leonardo Augusto; de Matos Almeida, Sabrina Esteves] FEPPS, CDCT, Porto Alegre, RS, Brazil; [Ashton-Prolla, Patricia] Hosp Clin Porto Alegre, Lab Med Genom, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul	Junqueira, DM (corresponding author), Univ Fed Rio Grande do Sul, Programa Posgrad Genet & Biol Mol, Porto Alegre, RS, Brazil.	dennismaletich@hotmail.com	Chies, Jose/K-9664-2015; Junqueira, Dennis/ABC-4378-2021; Ashton-Prolla, Patricia/T-3515-2019; de Medeiros, Rúbia M/L-2761-2015; Ashton-Prolla, Patricia/H-2927-2012	Chies, Jose/0000-0001-7025-0660; de Medeiros, Rúbia M/0000-0001-7403-5650; Luvison Araujo, Leonardo Augusto/0000-0003-0386-7745; Junqueira, Dennis/0000-0003-1576-484X; Esteves De Matos Almeida, Sabrina/0000-0003-3599-8520	Coordenacao de Aperfeicoamento de Pessoal de nivel superior (CAPES); Programa de Pos-Graduacao em Genetica e Biologia Molecular - UFRGS (PPGBM-UFRGS); Centro de Desenvolvimento Cientifico e Tecnologico (CDCT)	Coordenacao de Aperfeicoamento de Pessoal de nivel superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Programa de Pos-Graduacao em Genetica e Biologia Molecular - UFRGS (PPGBM-UFRGS); Centro de Desenvolvimento Cientifico e Tecnologico (CDCT)	Coordenacao de Aperfeicoamento de Pessoal de nivel superior (CAPES), Programa de Pos-Graduacao em Genetica e Biologia Molecular - UFRGS (PPGBM-UFRGS) and Centro de Desenvolvimento Cientifico e Tecnologico (CDCT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; Bello G, 2008, AIDS, V22, P1993, DOI 10.1097/QAD.0b013e328315e0aa; Bethell Leslie, 1993, CUBA A SHORT HIST; Castro E, 2003, JAIDS-J ACQ IMM DEF, V32, P338, DOI 10.1097/00126334-200303010-00015; Chalmet K, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-262; Cuevas MT, 2002, AIDS, V16, P1643, DOI 10.1097/00002030-200208160-00010; Dalai SC, 2009, AIDS, V23, P2523, DOI 10.1097/QAD.0b013e3283320ef3; de Oliveira T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009311; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Durand J, 2009, 200924 UNDP; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; GALLO RC, 1983, SCIENCE, V220, P865, DOI 10.1126/science.6601823; Gilbert MTP, 2007, P NATL ACAD SCI USA, V104, P18566, DOI 10.1073/pnas.0705329104; Gray RR, 2009, AIDS, V23, pF9, DOI 10.1097/QAD.0b013e32832faf61; Guimaraes ML, 2009, RETROVIROLOGY, V1958, P1; Guindon S, 2009, METHODS MOL BIOL, V537, P113, DOI 10.1007/978-1-59745-251-9_6; Hall BG, 2007, PLOS COMPUT BIOL, V3, P473, DOI 10.1371/journal.pcbi.0030051; Hemelaar J, 2006, AIDS, V20, pW13, DOI 10.1097/01.aids.0000247564.73009.bc; Hierholzer J, 2002, AIDS RES HUM RETROV, V18, P1339, DOI 10.1089/088922202320935410; Holmes EC, 2007, P NATL ACAD SCI USA, V104, P18351, DOI 10.1073/pnas.0709179104; Hu DJ, 1999, AIDS, V13, P873, DOI 10.1097/00002030-199905280-00002; Hue S, 2005, P NATL ACAD SCI USA, V102, P4425, DOI 10.1073/pnas.0407534102; Hue S, 2004, AIDS, V18, P719, DOI [10.1097/00002030-200403260-00002, 10.1097/01.aids.0000111455.61782.c3]; Leal E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011833; Lemey P, 2004, GENETICS, V167, P1059, DOI 10.1534/genetics.104.026666; LIAUTAUD B, 1983, ANN DERMATOL VENER, V110, P213; Lukashov VV, 2002, J MOL EVOL, V54, P680, DOI 10.1007/s00239-001-0070-5; Nadai Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004814; Osseo-Asare AD, 2007, SOC HIST MED, V20, P401, DOI 10.1093/shm/hkm049; PAPE J, 1993, CLIN INFECT DIS, V17, pS341, DOI 10.1093/clinids/17.Supplement_2.S341; Paraskevis D, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-49; Parekh B, 1999, AIDS RES HUM RETROV, V15, P133, DOI 10.1089/088922299311556; Pellegrino A, 2000, INT SOC SCI J, V52, P395, DOI 10.1111/1468-2451.00268; Perrin L, 2003, LANCET INFECT DIS, V3, P22, DOI 10.1016/S1473-3099(03)00484-5; Pinto ME, 2008, GENET MOL RES, V7, P1031, DOI 10.4238/vol7-4gmr383; PITCHENIK AE, 1983, ANN INTERN MED, V98, P277, DOI 10.7326/0003-4819-98-3-277; PRESTON BD, 1988, SCIENCE, V242, P1168, DOI 10.1126/science.2460924; Rambaut A, 2004, NAT REV GENET, V5, P52, DOI 10.1038/nrg1246; Rambaut A., 2003, TRACER COMPUTER PROG; Robbins KE, 2003, J VIROL, V77, P6359, DOI 10.1128/JVI.77.11.6359-6366.2003; Rousseau CM, 2007, J VIROL, V81, P4492, DOI 10.1128/JVI.02050-06; Russell KL, 2000, AIDS, V14, P1785, DOI 10.1097/00002030-200008180-00014; Salathe M, 2010, PLOS COMPUTATIONAL B, V6, P11; Sharp PM, 2010, PHILOS T R SOC B, V365, P2487, DOI 10.1098/rstb.2010.0031; Solimano A, 2001, 2720 WORLD BANK; Vidal N, 2000, J VIROL, V74, P10498, DOI 10.1128/JVI.74.22.10498-10507.2000; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0; Worobey M, 2008, NATURE, V455, P661, DOI 10.1038/nature07390; WRIGHT S, 1951, ANN EUGENIC, V15, P323	51	30	32	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e27489	10.1371/journal.pone.0027489	http://dx.doi.org/10.1371/journal.pone.0027489			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132104	Green Submitted, Green Published, gold			2022-12-27	WOS:000298162000021
J	Marcelletti, S; Ferrante, P; Petriccione, M; Firrao, G; Scortichini, M				Marcelletti, Simone; Ferrante, Patrizia; Petriccione, Milena; Firrao, Giuseppe; Scortichini, Marco			Pseudomonas syringae pv. actinidiae Draft Genomes Comparison Reveal Strain-Specific Features Involved in Adaptation and Virulence to Actinidia Species	PLOS ONE			English	Article							SECRETION SYSTEM EFFECTORS; BACTERIAL CANKER; PHYLOGENETIC ANALYSIS; PATHOGENICITY ISLAND; CHINENSIS PLANCHON; ESCHERICHIA-COLI; TOMATO DC3000; GENE; SEQUENCE; IDENTIFICATION	A recent re-emerging bacterial canker disease incited by Pseudomonas syringae pv. actinidiae (Psa) is causing severe economic losses to Actinidia chinensis and A. deliciosa cultivations in southern Europe, New Zealand, Chile and South Korea. Little is known about the genetic features of this pathovar. We generated genome-wide Illumina sequence data from two Psa strains causing outbreaks of bacterial canker on the A. deliciosa cv. Hayward in Japan (J-Psa, type-strain of the pathovar) and in Italy (I-Psa) in 1984 and 1992, respectively as well as from a Psa strain (I2-Psa) isolated at the beginning of the recent epidemic on A. chinensis cv. Hort16A in Italy. All strains were isolated from typical leaf spot symptoms. The phylogenetic relationships revealed that Psa is more closely related to P. s. pv. theae than to P. avellanae within genomospecies 8. Comparative genomic analyses revealed both relevant intrapathovar variations and putative pathovar-specific genomic regions in Psa. The genomic sequences of J-Psa and I-Psa were very similar. Conversely, the I2-Psa genome encodes four additional effector protein genes, lacks a 50 kb plasmid and the phaseolotoxin gene cluster, argK-tox but has acquired a 160 kb plasmid and putative prophage sequences. Several lines of evidence from the analysis of the genome sequences support the hypothesis that this strain did not evolve from the Psa population that caused the epidemics in 1984-1992 in Japan and Italy but rather is the product of a recent independent evolution of the pathovar actinidiae for infecting Actinidia spp. All Psa strains share the genetic potential for copper resistance, antibiotic detoxification, high affinity iron acquisition and detoxification of nitric oxide of plant origin. Similar to other sequenced phytopathogenic pseudomonads associated with woody plant species, the Psa strains isolated from leaves also display a set of genes involved in the catabolism of plantderived aromatic compounds.	[Marcelletti, Simone; Ferrante, Patrizia; Scortichini, Marco] CRA, Res Ctr Fruit Trees, Rome, Italy; [Petriccione, Milena] CRA, Res Unit Fruit Trees, Caserta, Italy; [Firrao, Giuseppe] Univ Udine, Dept Agr & Environm Sci, I-33100 Udine, Italy	Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); University of Udine	Marcelletti, S (corresponding author), CRA, Res Ctr Fruit Trees, Rome, Italy.	marco.scortichini@entecra.it	Petriccione, Milena/AAX-8577-2021; Petriccione, Milena/AAK-9864-2020	Petriccione, Milena/0000-0001-5284-0333; FERRANTE, PATRIZIA/0000-0001-7577-9096; Scortichini, Marco/0000-0003-1565-9097; FIRRAO, Giuseppe/0000-0002-7890-0899	Italian Ministry of Agriculture and Forestry through Agricultural Research Council	Italian Ministry of Agriculture and Forestry through Agricultural Research Council	The work was funded by the Italian Ministry of Agriculture and Forestry through the Agricultural Research Council (C. R. A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrios G. N., 2005, PLANT PATHOL; Ahmed N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005831; Alfano JR, 1997, MOL PLANT MICROBE IN, V10, P580, DOI 10.1094/MPMI.1997.10.5.580; Almeida NF, 2009, MOL PLANT MICROBE IN, V22, P52, DOI 10.1094/MPMI-22-1-0052; Amato P, 2007, FEMS MICROBIOL ECOL, V59, P242, DOI 10.1111/j.1574-6941.2006.00199.x; Arnold DL, 2007, TRENDS GENET, V23, P293, DOI 10.1016/j.tig.2007.03.017; Aschtgen MS, 2010, MOL MICROBIOL, V75, P886, DOI 10.1111/j.1365-2958.2009.07028.x; Balestra G. M., 2010, New Disease Reports, V22, P10, DOI 10.5197/j.2044-0588.2010.022.010; Baltrus DA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002132; Bender CL, 1999, MICROBIOL MOL BIOL R, V63, P266, DOI 10.1128/MMBR.63.2.266-292.1999; Bronstein PA, 2005, J BACTERIOL, V187, P8450, DOI 10.1128/JB.187.24.8450-8461.2005; Brotz H, 2000, J ANTIMICROB CHEMOTH, V46, P1, DOI 10.1093/jac/46.1.1; Buell CR, 2003, P NATL ACAD SCI USA, V100, P10181, DOI 10.1073/pnas.1731982100; Bull CT, 2010, J PLANT PATHOL, V92, P551; Carniel E, 2001, MICROBES INFECT, V3, P561, DOI 10.1016/S1286-4579(01)01412-5; Chapman J, 2011, 10 MIN AGR FOR, P10; COOKSEY DA, 1994, FEMS MICROBIOL REV, V14, P381, DOI 10.1016/0168-6445(94)90056-6; Cunnac S, 2009, CURR OPIN MICROBIOL, V12, P53, DOI 10.1016/j.mib.2008.12.003; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Das A, 2009, MOL PLANT MICROBE IN, V22, P73, DOI 10.1094/MPMI-22-1-0073; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Delledonne M, 1998, NATURE, V394, P585, DOI 10.1038/29087; European Plant Protection Organization, 2011, 3 EPPO; European Plant Protection Organization, 2010, 2010188 EPPO; Feil H, 2005, P NATL ACAD SCI USA, V102, P11064, DOI 10.1073/pnas.0504930102; Ferrante P, 2010, PLANT PATHOL, V59, P954, DOI 10.1111/j.1365-3059.2010.02304.x; Ferrante P, 2009, J PHYTOPATHOL, V157, P768, DOI 10.1111/j.1439-0434.2009.01550.x; Figueroa-Bossi N, 2001, MOL MICROBIOL, V39, P260, DOI 10.1046/j.1365-2958.2001.02234.x; Gal-Mor O, 2006, CELL MICROBIOL, V8, P1707, DOI 10.1111/j.1462-5822.2006.00794.x; Gardan L, 1999, INT J SYST BACTERIOL, V49, P469, DOI 10.1099/00207713-49-2-469; Gassmann W, 2005, MOL PLANT MICROBE IN, V18, P1054, DOI 10.1094/MPMI-18-1054; Genka H, 2006, J MOL EVOL, V63, P401, DOI 10.1007/s00239-005-0271-4; Grant SR, 2006, ANNU REV MICROBIOL, V60, P425, DOI 10.1146/annurev.micro.60.080805.142251; Green S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010224; Guilhabert MR, 2005, MOL PLANT MICROBE IN, V18, P856, DOI 10.1094/MPMI-18-0856; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Harwood CS, 1996, ANNU REV MICROBIOL, V50, P553, DOI 10.1146/annurev.micro.50.1.553; Helmick RA, 2005, ANTIMICROB AGENTS CH, V49, P1837, DOI 10.1128/AAC.49.5.1837-1843.2005; Huelsenbeck JP, 1996, SYST BIOL, V45, P546, DOI 10.2307/2413530; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jackson RW, 2011, TRENDS GENET, V27, P32, DOI 10.1016/j.tig.2010.10.001; Jackson RW, 1999, P NATL ACAD SCI USA, V96, P10875, DOI 10.1073/pnas.96.19.10875; Joardar V, 2005, J BACTERIOL, V187, P6488, DOI 10.1128/JB.187.18.6488-6498.2005; Kim MG, 2009, PLANT J, V57, P645, DOI 10.1111/j.1365-313X.2008.03716.x; Koh JK, 2003, ACTA HORTIC, V610, P437; Koh Y., 1994, KOREAN J PLANT PATHO, V10, P68; Koh YJ, 2010, NEW ZEAL J CROP HORT, V38, P275, DOI 10.1080/01140671.2010.512624; Kumar GS, 2002, J BACTERIOL, V184, P6746, DOI 10.1128/JB.184.23.6746-6749.2002; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Li Miao, 2004, Plant Protection, V30, P51; Li Y, CHINESE J APPL ECOLO; Liang Y, 2000, J NW FORESTRY COLL; Lindeberg M, 2006, MOL PLANT MICROBE IN, V19, P1151, DOI 10.1094/MPMI-19-1151; Manceau C, 2003, PSEUDOMONAS SYRINGAE AND RELATED PATHOGENS: BIOLOGY AND GENETICS, P503; Marcelletti S, 2011, J PLANT PATHOL, V93, P479; Milne I, 2009, BIOINFORMATICS, V25, P126, DOI 10.1093/bioinformatics/btp666; Morris CE, 2008, ISME J, V2, P321, DOI 10.1038/ismej.2007.113; Munkvold KR, 2009, MOL PLANT MICROBE IN, V22, P1341, DOI 10.1094/MPMI-22-11-1341; Murillo J, 2011, RES MICROBIOL, V162, P253, DOI 10.1016/j.resmic.2010.10.011; Nakajima Masami, 2002, Journal of General Plant Pathology, V68, P68, DOI 10.1007/PL00013056; NEILANDS JB, 1995, J BIOL CHEM, V270, P26723, DOI 10.1074/jbc.270.45.26723; Nikaido H, 2009, ANNU REV BIOCHEM, V78, P119, DOI 10.1146/annurev.biochem.78.082907.145923; Papi R, 2003, BIOTECHNOL APPL BIOC, V37, P187, DOI 10.1042/BA20020055; POLLARD AM, 2007, J APPL RES CLIN EXP, V7, P32; Qi MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016451; Raymond KN, 2003, P NATL ACAD SCI USA, V100, P3584, DOI 10.1073/pnas.0630018100; Rees-George J, 2010, PLANT PATHOL, V59, P453, DOI 10.1111/j.1365-3059.2010.02259.x; Reinhardt JA, 2009, GENOME RES, V19, P294, DOI 10.1101/gr.083311.108; Rico A, 2003, PHYTOPATHOLOGY, V93, P1553, DOI 10.1094/PHYTO.2003.93.12.1553; Rodriguez-Palenzuela P, 2010, ENVIRON MICROBIOL, V12, P1604, DOI 10.1111/j.1462-2920.2010.02207.x; Rohmer L, 2004, GENETICS, V167, P1341, DOI 10.1534/genetics.103.019638; Ronning CM, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-202; Sarkar SF, 2006, GENETICS, V174, P1041, DOI 10.1534/genetics.106.060996; Sawada H, 1999, J MOL EVOL, V49, P627, DOI 10.1007/PL00006584; Sawada H, 1997, APPL ENVIRON MICROB, V63, P282, DOI 10.1128/AEM.63.1.282-288.1997; Schliep KP, 2011, BIOINFORMATICS, V27, P592, DOI 10.1093/bioinformatics/btq706; Scortichini M, 2002, EUR J PLANT PATHOL, V108, P269, DOI 10.1023/A:1015178104513; SCORTICHINI M, 1994, PLANT PATHOL, V43, P1035, DOI 10.1111/j.1365-3059.1994.tb01654.x; Sesma A, 2000, MICROBIOL-SGM, V146, P2375, DOI 10.1099/00221287-146-10-2375; Stavrinides J, 2009, APPL ENVIRON MICROB, V75, P2230, DOI 10.1128/AEM.02860-08; Strope CL, 2009, MOL BIOL EVOL, V26, P2581, DOI 10.1093/molbev/msp174; Studholme DJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-395; TAKIKAWA Y, 1989, Annals of the Phytopathological Society of Japan, V55, P437, DOI 10.3186/jjphytopath.55.437; Tamura K, 2002, PHYSIOL MOL PLANT P, V60, P207, DOI 10.1006/pmpp.2002.0405; TAMURA K, 1989, ANN PHYTOPATHOL SOC, V55, P512; TOURTE C, 1995, EUR J PLANT PATHOL, V101, P483, DOI 10.1007/BF01874471; Ushiyama Kinji, 1992, Annals of the Phytopathological Society of Japan, V58, P426, DOI 10.3186/jjphytopath.58.426; Ushiyama Kinji, 1992, Annals of the Phytopathological Society of Japan, V58, P476, DOI 10.3186/jjphytopath.58.476; Van Sluys MA, 2003, J BACTERIOL, V185, P1018, DOI 10.1128/JB.185.3.1018-1026.2003; Vanneste J. L., 2011, New Zealand Plant Protection, V64, P252; Ventura M, 2003, J BACTERIOL, V185, P4603, DOI 10.1128/JB.185.15.4603-4608.2003; Wang Z, J SW AGR U; Wei CF, 2007, PLANT J, V51, P32, DOI 10.1111/j.1365-313X.2007.03126.x	93	105	115	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e27297	10.1371/journal.pone.0027297	http://dx.doi.org/10.1371/journal.pone.0027297			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132095	Green Published, gold, Green Submitted			2022-12-27	WOS:000298162000015
J	Shi, Q; Liu, XY; Bai, YY; Cui, CJ; Li, J; Li, YS; Hu, SS; Wei, YJ				Shi, Qiang; Liu, Xiaoyan; Bai, Yuanyuan; Cui, Chuanjue; Li, Jun; Li, Yishi; Hu, Shengshou; Wei, Yingjie			In Vitro Effects of Pirfenidone on Cardiac Fibroblasts: Proliferation, Myofibroblast Differentiation, Migration and Cytokine Secretion	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; EXPERIMENTAL MYOCARDIAL-INFARCTION; LEFT-VENTRICULAR ENLARGEMENT; HEART-FAILURE; MATRIX-METALLOPROTEINASE; CELL-PROLIFERATION; PHENOTYPIC MODULATION; COLLAGEN PRODUCTION; PULMONARY-FIBROSIS; TISSUE INHIBITORS	Cardiac fibroblasts (CFs) are the primary cell type responsible for cardiac fibrosis during pathological myocardial remodeling. Several studies have illustrated that pirfenidone (5-methyl-1-phenyl-2-[1H]-pyridone) attenuates cardiac fibrosis in different animal models. However, the effects of pirfenidone on cardiac fibroblast behavior have not been examined. In this study, we investigated whether pirfenidone directly modulates cardiac fibroblast behavior that is important in myocardial remodeling such as proliferation, myofibroblast differentiation, migration and cytokine secretion. Fibroblasts were isolated from neonatal rat hearts and bioassays were performed to determine the effects of pirfenidone on fibroblast function. We demonstrated that treatment of CFs with pirfenidone resulted in decreased proliferation, and attenuated fibroblast alpha-smooth muscle actin expression and collagen contractility. Boyden chamber assay illustrated that pirfenidone inhibited fibroblast migration ability, probably by decreasing the ratio of matrix metalloproteinase-9 to tissue inhibitor of metalloproteinase-1. Furthermore, pirfenidone attenuated the synthesis and secretion of transforming growth factor-beta 1 but elevated that of interleukin-10. These direct and pleiotropic effects of pirfenidone on cardiac fibroblasts point to its potential use in the treatment of adverse myocardial remodeling.	[Shi, Qiang; Liu, Xiaoyan; Bai, Yuanyuan; Cui, Chuanjue; Li, Jun; Li, Yishi; Hu, Shengshou; Wei, Yingjie] Chinese Acad Med Sci, Peking Union Med Coll, State Key Lab Cardiovasc Dis, Natl Ctr Cardiovasc Dis,Fuwai Hosp, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Peking Union Medical College	Shi, Q (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll, State Key Lab Cardiovasc Dis, Natl Ctr Cardiovasc Dis,Fuwai Hosp, Beijing 100730, Peoples R China.	shengshouhu@yahoo.com; weiyingjiefw@126.com			National 973 Program [2010CB529505]; National Natural Science Foundation of China [81170206]; National Science and Technology Major Project [2008ZX09312-018]	National 973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Project	This study was supported by research grants from the National 973 Program (2010CB529505 to SSH), the National Natural Science Foundation of China (81170206 to YJW) and by the National Science and Technology Major Project (2008ZX09312-018 to YSL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baudino TA, 2006, AM J PHYSIOL-HEART C, V291, pH1015, DOI 10.1152/ajpheart.00023.2006; Brown RD, 2005, ANNU REV PHARMACOL, V45, P657, DOI 10.1146/annurev.pharmtox.45.120403.095802; Burghardt I, 2007, BIOCHEM BIOPH RES CO, V354, P542, DOI 10.1016/j.bbrc.2007.01.012; Card JW, 2003, TOXICOL SCI, V75, P169, DOI 10.1093/toxsci/kfg167; Cohn JN, 2000, J AM COLL CARDIOL, V35, P569, DOI 10.1016/S0735-1097(99)00630-0; DESMOULIERE A, 1995, AM J PATHOL, V146, P56; Di Sario A, 2002, J HEPATOL, V37, P584, DOI 10.1016/S0168-8278(02)00245-3; Dosanjh AK, 1998, TRANSPLANT P, V30, P1910, DOI 10.1016/S0041-1345(98)00478-3; Ducharme A, 2000, J CLIN INVEST, V106, P55, DOI 10.1172/JCI8768; EGHBALI M, 1992, BASIC RES CARDIOL, V87, P183; Frangogiannis NG, 2006, CURR MED CHEM, V13, P1877, DOI 10.2174/092986706777585086; Garcia L, 2002, J HEPATOL, V37, P797, DOI 10.1016/S0168-8278(02)00272-6; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Hewitson TD, 2001, J NEPHROL, V14, P453; Iyer SN, 1999, J PHARMACOL EXP THER, V291, P367; IYER SN, 1995, J LAB CLIN MED, V125, P779; Kakugawa T, 2004, EUR RESPIR J, V24, P57, DOI 10.1183/09031936.04.00120803; Kaneko M, 1998, CLIN EXP IMMUNOL, V113, P72, DOI 10.1046/j.1365-2249.1998.00618.x; Lan L, 2008, TRANSPL INT, V21, P581, DOI 10.1111/j.1432-2277.2008.00652.x; Lee BS, 1998, J CLIN ENDOCR METAB, V83, P219, DOI 10.1210/jc.83.1.219; Lee KW, 2006, CIRCULATION, V114, P1703, DOI 10.1161/CIRCULATIONAHA.106.624320; Leh S, 2005, NEPHROL DIAL TRANSPL, V20, P71, DOI 10.1093/ndt/gfh562; Li YY, 1998, CIRCULATION, V98, P1728, DOI 10.1161/01.CIR.98.17.1728; Li ZW, 2010, FEBS J, V277, P3688, DOI 10.1111/j.1742-4658.2010.07770.x; Lijnen P, 2003, METHOD FIND EXP CLIN, V25, P79, DOI 10.1358/mf.2003.25.2.723680; Lin XC, 2009, INVEST OPHTH VIS SCI, V50, P3763, DOI 10.1167/iovs.08-2815; Lu B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012963; Miric G, 2001, BRIT J PHARMACOL, V133, P687, DOI 10.1038/sj.bjp.0704131; Mirkovic S, 2002, BRIT J PHARMACOL, V135, P961, DOI 10.1038/sj.bjp.0704539; Mu W, 2005, J AM SOC NEPHROL, V16, P3651, DOI 10.1681/ASN.2005030297; Nakayama S, 2008, LIFE SCI, V82, P210, DOI 10.1016/j.lfs.2007.11.003; Nakazato H, 2002, EUR J PHARMACOL, V446, P177, DOI 10.1016/S0014-2999(02)01758-2; Nguyen DT, 2010, HEART RHYTHM, V7, P1438, DOI 10.1016/j.hrthm.2010.04.030; Oku H, 2002, EUR J PHARMACOL, V446, P167, DOI 10.1016/S0014-2999(02)01757-0; Oku H, 2008, EUR J PHARMACOL, V590, P400, DOI 10.1016/j.ejphar.2008.06.046; Peterson JT, 2001, CIRCULATION, V103, P2303; Petrov V V, 2000, J Renin Angiotensin Aldosterone Syst, V1, P342, DOI 10.3317/jraas.2000.064; Porter KE, 2009, PHARMACOL THERAPEUT, V123, P255, DOI 10.1016/j.pharmthera.2009.05.002; Porter KE, 2002, J VASC SURG, V36, P150, DOI 10.1067/mva.2002.122029; Rohde LE, 1999, CIRCULATION, V99, P3063, DOI 10.1161/01.CIR.99.23.3063; Rosenkranz S, 2004, CARDIOVASC RES, V63, P423, DOI 10.1016/j.cardiores.2004.04.030; Serini G, 1999, EXP CELL RES, V250, P273, DOI 10.1006/excr.1999.4543; Shihab FS, 2002, AM J TRANSPLANT, V2, P111, DOI 10.1034/j.1600-6143.2002.020201.x; Shimizu T, 1998, KIDNEY INT, V54, P99, DOI 10.1046/j.1523-1755.1998.00962.x; Souders CA, 2009, CIRC RES, V105, P1164, DOI 10.1161/CIRCRESAHA.109.209809; Spinale FG, 2002, CIRC RES, V90, P520, DOI 10.1161/01.RES.0000013290.12884.A3; Sun Y, 2000, CARDIOVASC RES, V46, P250, DOI 10.1016/S0008-6363(00)00032-8; Tada S, 2001, CLIN EXP PHARMACOL P, V28, P522, DOI 10.1046/j.1440-1681.2001.03481.x; Towbin JA, 2007, NEW ENGL J MED, V357, P1767, DOI 10.1056/NEJMcibr075397; Visner GA, 2009, TRANSPLANTATION, V88, P330, DOI 10.1097/TP.0b013e3181ae3392; WANG Y, 2011, PHYTOMEDICI IN PRESS; Wei YJ, 2011, J CELL MOL MED, V15, P773, DOI 10.1111/j.1582-4934.2010.01049.x; Wilson EM, 2002, J CARD FAIL, V8, P390, DOI 10.1054/jcaf.2002.129659; Wilson MS, 2007, J CLIN INVEST, V117, P2941, DOI 10.1172/JCI31546	54	72	76	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e28134	10.1371/journal.pone.0028134	http://dx.doi.org/10.1371/journal.pone.0028134			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132230	Green Submitted, Green Published, gold			2022-12-27	WOS:000298162000079
J	Byarugaba, DK; Ducatez, MF; Erima, B; Mworozi, EA; Millard, M; Kibuuka, H; Lukwago, L; Bwogi, J; Kaira, BB; Mimbe, D; Schnabel, DC; Krauss, S; Darnell, D; Webby, RJ; Webster, RG; Wabwire-Mangen, F				Byarugaba, Denis K.; Ducatez, Mariette F.; Erima, Bernard; Mworozi, Edison A.; Millard, Monica; Kibuuka, Hannah; Lukwago, Luswa; Bwogi, Josephine; Kaira, Blanche B.; Mimbe, Derrick; Schnabel, David C.; Krauss, Scott; Darnell, Daniel; Webby, Richard J.; Webster, Robert G.; Wabwire-Mangen, Fred			Molecular Epidemiology of Influenza A/H3N2 Viruses Circulating in Uganda	PLOS ONE			English	Article							A VIRUSES; A(H1N1) VIRUSES; EVOLUTION; PROTEIN; NEURAMINIDASE; AMPLIFICATION; ADAPTATION; GENOME; H1N1; GENE	The increasing availability of complete influenza virus genomes is deepening our understanding of influenza evolutionary dynamics and facilitating the selection of vaccine strains. However, only one complete African influenza virus sequence is available in the public domain. Here we present a complete genome analysis of 59 influenza A/H3N2 viruses isolated from humans in Uganda during the 2008 and 2009 season. Isolates were recovered from hospital-based sentinel surveillance for influenza-like illnesses and their whole genome sequenced. The viruses circulating during these two seasons clearly differed from each other phylogenetically. They showed a slow evolution away from the 2009/10 recommended vaccine strain (A/Brisbane/10/07), instead clustering with the 2010/11 recommended vaccine strain (A/Perth/16/09) in the A/Victoria/208/09 clade, as observed in other global regions. All of the isolates carried the adamantane resistance marker S31N in the M2 gene and carried several markers of enhanced transmission; as expected, none carried any marker of neuraminidase inhibitor resistance. The hemagglutinin gene of the 2009 isolates differed from that of the 2008 isolates in antigenic sites A, B, D, and to a lesser extent, C and E indicating evidence of an early phylogenetic shift from the 2008 to 2009 viruses. The internal genes of the 2009 isolates were similar to those of one 2008 isolate, A/Uganda/MUWRP-050/2008. Another 2008 isolate had a truncated PB1-F2 protein. Whole genome sequencing can enhance surveillance of future seasonal changes in the viral genome which is crucial to ensure that selected vaccine strains are protective against the strains circulating in Eastern Africa. This data provides an important baseline for this surveillance. Overall the influenza virus activity in Uganda appears to mirror that observed in other regions of the southern hemisphere.	[Byarugaba, Denis K.] Makerere Univ, Fac Vet Med, Kampala, Uganda; [Byarugaba, Denis K.; Erima, Bernard; Millard, Monica; Kibuuka, Hannah; Kaira, Blanche B.; Mimbe, Derrick; Wabwire-Mangen, Fred] Makerere Univ, Walter Reed Project, Kampala, Uganda; [Ducatez, Mariette F.; Krauss, Scott; Darnell, Daniel; Webby, Richard J.; Webster, Robert G.] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA; [Mworozi, Edison A.] Makerere Univ, Coll Hlth Sci, Kampala, Uganda; [Lukwago, Luswa] Minist Hlth, Kampala, Uganda; [Bwogi, Josephine] Uganda Virus Res Inst, Entebbe, Uganda; [Schnabel, David C.] USA, Res Unit, Nairobi, Kenya	Makerere University; Makerere University; St Jude Children's Research Hospital; Makerere University; Uganda Virus Research Institute	Byarugaba, DK (corresponding author), Makerere Univ, Fac Vet Med, Kampala, Uganda.	dkb@vetmed.mak.ac.ug	Bwogi, Josephine/AGJ-4829-2022; Webby, Richard J/N-5657-2018	Bwogi, Josephine/0000-0001-6975-7106; Byarugaba, Denis K./0000-0002-4175-5659	US Department of Defense's Global Emerging Infections Surveillance and Response System (DoD-GEIS) [W81XWH-06-C-0414]; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [HHSN266200700005C]; American Lebanese Syrian Associated Charities (ALSAC)	US Department of Defense's Global Emerging Infections Surveillance and Response System (DoD-GEIS)(United States Department of Defense); National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC))	The sample collection and virus isolation of this study was supported by the US Department of Defense's Global Emerging Infections Surveillance and Response System (DoD-GEIS) through Contract No. W81XWH-06-C-0414. The sequencing of the isolates was supported by the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services Contract No. HHSN266200700005C; and the American Lebanese Syrian Associated Charities (ALSAC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias CF, 2009, ARCH MED RES, V40, P643, DOI 10.1016/j.arcmed.2009.10.007; Barr IG, 2010, VACCINE, V28, P1156, DOI 10.1016/j.vaccine.2009.11.043; Bokhari SH, 2010, IEEE ACM T COMPUT BI, V7, P288, DOI 10.1109/TCBB.2008.73; Bulimo WD, 2008, INFLUENZA OTHER RESP, V2, P107, DOI 10.1111/j.1750-2659.2008.00044.x; Chan CH, 2006, J VIROL METHODS, V136, P38, DOI 10.1016/j.jviromet.2006.03.027; Conenello GM, 2007, CELL HOST MICROBE, V2, P207, DOI 10.1016/j.chom.2007.09.010; Deyde VM, 2007, J INFECT DIS, V196, P249, DOI 10.1086/518936; Falagas ME, 2011, EPIDEMIOL INFECT, V139, P27, DOI 10.1017/S0950268810002037; Fereidouni SR, 2009, VET MICROBIOL, V135, P253, DOI 10.1016/j.vetmic.2008.09.077; Fouchier RAM, 2000, J CLIN MICROBIOL, V38, P4096, DOI 10.1128/JCM.38.11.4096-4101.2000; Fricke WF, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000217; Gabriel G, 2005, P NATL ACAD SCI USA, V102, P18590, DOI 10.1073/pnas.0507415102; Gomez-Puertas P, 2000, J VIROL, V74, P11538, DOI 10.1128/JVI.74.24.11538-11547.2000; Greninger AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013381; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hanon E, 2009, Bull Mem Acad R Med Belg, V164, P283; Holmes EC, 2005, PLOS BIOL, V3, P1579, DOI 10.1371/journal.pbio.0030300; Katz JM, 2000, J VIROL, V74, P10807, DOI 10.1128/JVI.74.22.10807-10810.2000; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Lee N, 2010, ANN INTERN MED, V152, P618, DOI 10.7326/0003-4819-152-9-201005040-00021; Lin JH, 2008, J MED VIROL, V80, P316, DOI 10.1002/jmv.21074; MCGREGOR IA, 1979, BRIT MED BULL, V35, P15, DOI 10.1093/oxfordjournals.bmb.a071535; McHardy AC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000566; Memoli MJ, 2008, DRUG DISCOV TODAY, V13, P590, DOI 10.1016/j.drudis.2008.03.024; Memoli MJ, 2009, J INFECT DIS, V200, P1232, DOI 10.1086/605893; Njouom R, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-56; Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945; Schoub Barry D, 2010, Expert Rev Respir Med, V4, P167, DOI 10.1586/ers.10.10; Taubenberger JK, 2010, CELL HOST MICROBE, V7, P440, DOI 10.1016/j.chom.2010.05.009; Thippamom N, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-185; Wagner R, 2002, REV MED VIROL, V12, P159, DOI 10.1002/rmv.352; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992	32	13	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2011	6	11							e27803	10.1371/journal.pone.0027803	http://dx.doi.org/10.1371/journal.pone.0027803			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IO	22132146	Green Published, Green Submitted, gold			2022-12-27	WOS:000297789900022
J	Muzaffar, M; Ahmad, A				Muzaffar, Mahvish; Ahmad, Atta			The Mechanism of Enhanced Insulin Amyloid Fibril Formation by NaCl Is Better Explained by a Conformational Change Model	PLOS ONE			English	Article							ALPHA-SYNUCLEIN; PROTEIN AGGREGATION; MONOMERIC INSULIN; EARLY EVENTS; X-RAY; BEHAVIOR; PATHWAY; CATION; CHAIN; SITE	The high propensity of insulin to fibrillate causes severe biomedical and biotechnological complications. Insulin fibrillation studies attain significant importance considering the prevalence of diabetes and the requirement of functional insulin in each dose. Although studied since the early years of the 20(th) century, elucidation of the mechanism of insulin fibrillation has not been understood completely. We have previously, through several studies, shown that insulin hexamer dissociates into monomer that undergoes partial unfolding before converting into mature fibrils. In this study we have established that NaCl enhances insulin fibrillation mainly due to subtle structural changes and is not a mere salt effect. We have carried out studies both in the presence and absence of urea and Gdn. HCl and compared the relationship between conformation of insulin induced by urea and Gdn. HCl with respect to NaCl at both pH 7.4 (hexamer) and pH 2 (monomer). Fibril formation was followed with a Thioflavin T assay and structural changes were monitored by circular dichroism and size-exclusion chromatography. The results show salt-insulin interactions are difficult to classify as commonly accepted Debye-Huckel or Hofmeister series interactions but instead a strong correlation between the association states and conformational states of insulin and their propensity to fibrillate is evident.	[Muzaffar, Mahvish] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA; Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Muzaffar, M (corresponding author), Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA.	ahmadatt@umich.edu		Ahmad, Atta/0000-0002-6968-192X; Muzaffar, Mahvish/0000-0002-2619-7724	University of Michigan COPE	University of Michigan COPE	This article was made available as Open Access with the support of the University of Michigan COPE Fund, http://lib.umich.edu/cope. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel JJ, 1926, P NATL ACAD SCI USA, V12, P132, DOI 10.1073/pnas.12.2.132; Ahmad A, 2005, J BIOL CHEM, V280, P42669, DOI 10.1074/jbc.M504298200; Ahmad A, 2004, J BIOL CHEM, V279, P14999, DOI 10.1074/jbc.M313134200; Ahmad A, 2003, BIOCHEMISTRY-US, V42, P11404, DOI 10.1021/bi034868o; Ahmad A, 2001, BIOCHEMISTRY-US, V40, P1945, DOI 10.1021/bi001933a; Ahmad A., 2009, BIOCHIM BIOPHYS ACTA, V1794, P1536; Ahmad A, 2010, INT J BIOL MACROMOL, V46, P275, DOI 10.1016/j.ijbiomac.2009.12.017; Albert SG, 2007, DIABETES RES CLIN PR, V75, P374, DOI 10.1016/j.diabres.2006.07.013; Apetri AC, 2003, J BIOL CHEM, V278, P22187, DOI 10.1074/jbc.M302130200; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Baldwin RL, 1996, BIOPHYS J, V71, P2056, DOI 10.1016/S0006-3495(96)79404-3; BEYCHOK S, 1965, P NATL ACAD SCI USA, V53, P999, DOI 10.1073/pnas.53.5.999; Blake C, 1996, STRUCTURE, V4, P989, DOI 10.1016/S0969-2126(96)00104-9; Blatherwick NR, 1927, J BIOL CHEM, V72, P57; Booth DR, 1997, NATURE, V385, P787, DOI 10.1038/385787a0; Brange J, 1997, J PHARM SCI, V86, P517, DOI 10.1021/js960297s; Brange J, 1997, PROTEINS, V27, P507, DOI 10.1002/(SICI)1097-0134(199704)27:4<507::AID-PROT4>3.3.CO;2-H; Brange J, 1993, Pharm Biotechnol, V5, P315; BURKE MJ, 1972, BIOCHEMISTRY-US, V11, P2435, DOI 10.1021/bi00763a008; Bushmarina NA, 2001, CHEMBIOCHEM, V2, P813, DOI 10.1002/1439-7633(20011105)2:11<813::AID-CBIC813>3.0.CO;2-W; Carrell RW, 1997, LANCET, V350, P134, DOI 10.1016/S0140-6736(97)02073-4; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; COLLINS KD, 1985, Q REV BIOPHYS, V18, P323, DOI 10.1017/S0033583500005369; DeBolle X, 1997, BIOCHEM J, V323, P409; Debye P, 1923, PHYS Z, V24, P185; DISCHE FE, 1988, DIABETOLOGIA, V31, P158, DOI 10.1007/BF00276849; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Fandrich M, 2001, NATURE, V410, P165, DOI 10.1038/35065514; Ferrari D, 2001, BIOPOLYMERS, V62, P249, DOI 10.1002/bip.1020; Fink AL, 1998, FOLD DES, V3, pR9, DOI 10.1016/S1359-0278(98)00002-9; Gibson TJ, 2006, PROTEIN SCI, V15, P1133, DOI 10.1110/ps.051879606; GJERDE DT, 1980, J CHROMATOGR, V187, P35, DOI 10.1016/S0021-9673(00)87871-1; GLENNER GG, 1981, PROG HISTOCHEM CYTOC, V13, P1; GOTO Y, 1990, P NATL ACAD SCI USA, V87, P573, DOI 10.1073/pnas.87.2.573; GREGOR HP, 1955, J AM CHEM SOC, V77, P2713, DOI 10.1021/ja01615a011; GURSKY O, 1992, BIOPHYS J, V61, P604, DOI 10.1016/S0006-3495(92)81865-9; Hasegawa K, 2003, BIOCHEM BIOPH RES CO, V304, P101, DOI 10.1016/S0006-291X(03)00543-6; Hofmeister F., 1888, ARCH EXP PATHOL PH, V24, P247, DOI [DOI 10.1007/BF01918191, 10.1007/BF01918191]; HOHENESTER E, 1994, BIOCHEMISTRY-US, V33, P13561, DOI 10.1021/bi00250a008; Hong DP, 2006, BIOCHEMISTRY-US, V45, P9342, DOI 10.1021/bi0604936; Hua QX, 2004, J BIOL CHEM, V279, P21449, DOI 10.1074/jbc.M314141200; Huang K, 2006, BIOCHEMISTRY-US, V45, P10278, DOI 10.1021/bi060879g; Ivanova MI, 2009, P NATL ACAD SCI USA, V106, P18990, DOI 10.1073/pnas.0910080106; Jain S, 2010, BIOCHEMISTRY-US, V49, P7615, DOI 10.1021/bi100745j; Jimenez JL, 2002, P NATL ACAD SCI USA, V99, P9196, DOI 10.1073/pnas.142459399; Klement K, 2007, J MOL BIOL, V373, P1321, DOI 10.1016/j.jmb.2007.08.068; KLOSTERMEYER H, 1966, ANGEW CHEM INT EDIT, V5, P807, DOI 10.1002/anie.196608071; Krogh A, 1928, BIOCHEM J, V22, P1231, DOI 10.1042/bj0221231; Kuznetsova IM, 2002, BBA-PROTEIN STRUCT M, V1596, P138, DOI 10.1016/S0167-4838(02)00212-1; Li J, 2002, NEUROTOXICOLOGY, V23, P553, DOI 10.1016/S0161-813X(02)00066-9; MILLICAN RL, 1994, BIOCHEMISTRY-US, V33, P1116, DOI 10.1021/bi00171a010; Munishkina LA, 2003, BIOCHEMISTRY-US, V42, P2720, DOI 10.1021/bi027166s; Munishkina LA, 2004, BIOCHEMISTRY-US, V43, P3289, DOI 10.1021/bi034938r; Munishkina LA, 2008, BIOCHEMISTRY-US, V47, P8993, DOI 10.1021/bi8008399; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Nielsen L, 2001, BIOCHEMISTRY-US, V40, P6036, DOI 10.1021/bi002555c; Nielsen L, 2001, J PHARM SCI-US, V90, P29, DOI 10.1002/1520-6017(200101)90:1<29::AID-JPS4>3.0.CO;2-4; PACE CN, 1988, BIOCHEMISTRY-US, V27, P3242, DOI 10.1021/bi00409a018; Pedersen JS, 2006, BIOPHYS J, V90, P4181, DOI 10.1529/biophysj.105.070912; Raman B, 2005, BIOCHEMISTRY-US, V44, P1288, DOI 10.1021/bi048029t; Roher AE, 2000, BBA-MOL BASIS DIS, V1502, P31, DOI 10.1016/S0925-4439(00)00030-2; Sahoo S, 2003, DIAGN CYTOPATHOL, V28, P325, DOI 10.1002/dc.10296; Scrocchi LA, 2002, J MOL BIOL, V318, P697, DOI 10.1016/S0022-2836(02)00164-X; Shikama Y, 2010, INTERNAL MED, V49, P397, DOI 10.2169/internalmedicine.49.2633; Singh LR, 2009, J BIOSCIENCES, V34, P321, DOI 10.1007/s12038-009-0036-0; Sipe JD, 2000, J STRUCT BIOL, V130, P88, DOI 10.1006/jsbi.2000.4221; SLUZKY V, 1992, BIOTECHNOL BIOENG, V40, P895, DOI 10.1002/bit.260400805; Soto C, 2001, FEBS LETT, V498, P204, DOI 10.1016/S0014-5793(01)02486-3; Souillac PO, 2002, J BIOL CHEM, V277, P12666, DOI 10.1074/jbc.M109229200; STORKEL S, 1983, LAB INVEST, V48, P108; Strickland E H, 1974, CRC Crit Rev Biochem, V2, P113, DOI 10.3109/10409237409105445; Swift B, 2002, DIABETIC MED, V19, P881, DOI 10.1046/j.1464-5491.2002.07581.x; Tito P, 2000, J MOL BIOL, V303, P267, DOI 10.1006/jmbi.2000.4142; Uversky VN, 2010, FEBS J, V277, P2940, DOI 10.1111/j.1742-4658.2010.07721.x; Uversky VN, 2001, J BIOL CHEM, V276, P10737, DOI 10.1074/jbc.M010907200; Uversky VN, 2002, J BIOL CHEM, V277, P11970, DOI 10.1074/jbc.M109541200; Waugh DF, 1944, J AM CHEM SOC, V66, P663, DOI 10.1021/ja01232a516; WAUGH DF, 1953, J AM CHEM SOC, V75, P2592, DOI 10.1021/ja01107a013; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Yeh V, 2010, PROTEIN SCI, V19, P47, DOI 10.1002/pro.281; Yumlu S, 2009, HUM PATHOL, V40, P1655, DOI 10.1016/j.humpath.2009.02.019	81	44	52	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2011	6	11							e27906	10.1371/journal.pone.0027906	http://dx.doi.org/10.1371/journal.pone.0027906			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IO	22132167	Green Published, Green Submitted, gold			2022-12-27	WOS:000297789900031
J	Varga, Z; Juhasz, T; Matta, C; Fodor, J; Katona, E; Bartok, A; Olah, T; Sebe, A; Csernoch, L; Panyi, G; Zakany, R				Varga, Zoltan; Juhasz, Tamas; Matta, Csaba; Fodor, Janos; Katona, Eva; Bartok, Adam; Olah, Tamas; Sebe, Attila; Csernoch, Laszlo; Panyi, Gyorgy; Zakany, Roza			Switch of Voltage-Gated K+ Channel Expression in the Plasma Membrane of Chondrogenic Cells Affects Cytosolic Ca2+-Oscillations and Cartilage Formation	PLOS ONE			English	Article							ACTIVATED POTASSIUM CHANNEL; ION CHANNELS; CALCIUM OSCILLATIONS; SODIUM-CHANNELS; PROLIFERATION; GROWTH; KV1.5; DIFFERENTIATION; INACTIVATION; CHONDROCYTES	Background: Understanding the key elements of signaling of chondroprogenitor cells at the earliest steps of differentiation may substantially improve our opportunities for the application of mesenchymal stem cells in cartilage tissue engineering, which is a promising approach of regenerative therapy of joint diseases. Ion channels, membrane potential and Ca2+-signaling are important regulators of cell proliferation and differentiation. Our aim was to identify such plasma membrane ion channels involved in signaling during chondrogenesis, which may serve as specific molecular targets for influencing chondrogenic differentiation and ultimately cartilage formation. Methodology/Principal Findings: Using patch-clamp, RT-PCR and Western-blot experiments, we found that chondrogenic cells in primary micromass cell cultures obtained from embryonic chicken limb buds expressed voltage-gated Na(V)1.4, K(V)1.1, K(V)1.3 and K(V)4.1 channels, although K(V)1.3 was not detectable in the plasma membrane. Tetrodotoxin (TTX), the inhibitor of Na(V)1.4 channels, had no effect on cartilage formation. In contrast, presence of 20 mM of the K+ channel blocker tetraethylammonium (TEA) during the time-window of the final commitment of chondrogenic cells reduced K-V currents (to 27+/-3% of control), cell proliferation (thymidine incorporation: to 39+/-4.4% of control), expression of cartilage-specific genes and consequently, cartilage formation (metachromasia: to 18.0+/-6.4% of control) and also depolarized the membrane potential (by 9.3+/-2.1 mV). High-frequency Ca2+-oscillations were also suppressed by 10 mM TEA (confocal microscopy: frequency to 8.5+/-2.6% of the control). Peak expression of TEA-sensitive K(V)1.1 in the plasma membrane overlapped with this period. Application of TEA to differentiated chondrocytes, mainly expressing the TEA-insensitive K(V)4.1 did not affect cartilage formation. Conclusions/Significance: These data demonstrate that the differentiation and proliferation of chondrogenic cells depend on rapid Ca2+-oscillations, which are modulated by K-V-driven membrane potential changes. K(V)1.1 function seems especially critical during the final commitment period. We show the critical role of voltage-gated cation channels in the differentiation of non-excitable cells with potential therapeutic use.	[Varga, Zoltan; Bartok, Adam; Sebe, Attila; Panyi, Gyorgy] Univ Debrecen, Dept Biophys & Cell Biol, H-4012 Debrecen, Hungary; [Varga, Zoltan; Juhasz, Tamas; Matta, Csaba; Fodor, Janos; Katona, Eva; Bartok, Adam; Olah, Tamas; Sebe, Attila; Csernoch, Laszlo; Panyi, Gyorgy; Zakany, Roza] Hlth Sci Ctr, Debrecen, Hungary; [Juhasz, Tamas; Matta, Csaba; Katona, Eva; Zakany, Roza] Univ Debrecen, Dept Anat Histol & Embryol, H-4012 Debrecen, Hungary; [Fodor, Janos; Olah, Tamas; Csernoch, Laszlo] Univ Debrecen, Dept Physiol, H-4012 Debrecen, Hungary	University of Debrecen; University of Debrecen; University of Debrecen	Varga, Z (corresponding author), Univ Debrecen, Dept Biophys & Cell Biol, H-4012 Debrecen, Hungary.	panyi@med.unideb.hu	Matta, Csaba/C-7066-2017; Juhasz, Tamas/M-6878-2019; Bartok, Adam/AAE-9780-2019; Panyi, Gyorgy/H-4406-2013	Matta, Csaba/0000-0002-9678-7420; Juhasz, Tamas/0000-0003-0489-5676; Olah, Tamas/0000-0002-3834-6272; Katona, Eva/0000-0002-8166-1438; Panyi, Gyorgy/0000-0001-6227-3301; Csernoch, Laszlo/0000-0002-2446-1456	Hungarian National Science Fund [OTKA K75604, OTKA-CNK 80709, OTKA CK 78179]; Hungarian Ministry of Education [K-2009-TAMOP-4.2.2-08/1/2008-0019, TAMOP-4.2.1/B-09/1/KONV-2010-007]; Bolyai fellowship;  [ETT 022/09];  [ETT 345/09]	Hungarian National Science Fund; Hungarian Ministry of Education; Bolyai fellowship(Hungarian Academy of Sciences); ; 	This work was supported by the Hungarian National Science Fund (OTKA K75604, OTKA-CNK 80709 and OTKA CK 78179), the Hungarian Ministry of Education (K-2009-TAMOP-4.2.2-08/1/2008-0019 and TAMOP-4.2.1/B-09/1/KONV-2010-007) and grants ETT 022/09, ETT 345/09 and a Bolyai fellowship to ZV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett-Jolley R, 2010, FRONT PHYSIOL, V1, DOI 10.3389/fphys.2010.00135; Beeton C, 2001, P NATL ACAD SCI USA, V98, P13942, DOI 10.1073/pnas.241497298; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Blackiston DJ, 2009, CELL CYCLE, V8, P3527, DOI 10.4161/cc.8.21.9888; Carrithers MD, 2007, J IMMUNOL, V178, P7822, DOI 10.4049/jimmunol.178.12.7822; Centeno CJ, 2008, PAIN PHYSICIAN, V11, P343; Craner MJ, 2005, GLIA, V49, P220, DOI 10.1002/glia.20112; FEWTRELL C, 1993, ANNU REV PHYSIOL, V55, P427, DOI 10.1146/annurev.physiol.55.1.427; Fodor J, 2009, CELL CALCIUM, V45, P421, DOI 10.1016/j.ceca.2009.02.004; Fraser SP, 2004, FEBS LETT, V569, P191, DOI 10.1016/j.febslet.2004.05.063; FREYRIA AM, 2011, INJURY IN PRESS, DOI DOI 10.1016/J.INJURY.2011.05.035; Galle J, 2010, CURR MED CHEM, V17, P2274, DOI 10.2174/092986710791331095; GRANDOLFO M, 1992, BIOCHEM BIOPH RES CO, V182, P1429, DOI 10.1016/0006-291X(92)91893-U; GRANDOLFO M, 1990, CALCIFIED TISSUE INT, V47, P302, DOI 10.1007/BF02555913; GRISSMER S, 1994, MOL PHARMACOL, V45, P1227; Guo ZX, 2010, NEUROSCI LETT, V478, P156, DOI 10.1016/j.neulet.2010.05.007; Hardingham TE, 2006, J ANAT, V209, P469, DOI 10.1111/j.1469-7580.2006.00630.x; Helmlinger G, 1996, J VASC RES, V33, P360, DOI 10.1159/000159164; Jerng HH, 1999, J GEN PHYSIOL, V113, P641, DOI 10.1085/jgp.113.5.641; Jow F, 2004, P NATL ACAD SCI USA, V101, P15535, DOI 10.1073/pnas.0402081101; Juretic N, 2007, J CELL PHYSIOL, V210, P819, DOI 10.1002/jcp.20902; Kawano S, 2006, CELL CALCIUM, V39, P313, DOI 10.1016/j.ceca.2005.11.008; Lang F, 2005, J MEMBRANE BIOL, V205, P147, DOI 10.1007/s00232-005-0780-5; LEONARD RJ, 1992, P NATL ACAD SCI USA, V89, P10094, DOI 10.1073/pnas.89.21.10094; LEWIS R, 2011, J CELL PHYSL; LONG KJ, 1994, BIOCHEM BIOPH RES CO, V201, P776, DOI 10.1006/bbrc.1994.1768; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Matta C, 2008, CELL CALCIUM, V44, P310, DOI 10.1016/j.ceca.2007.12.010; Matzner N, 2008, J IMMUNOL, V181, P6803, DOI 10.4049/jimmunol.181.10.6803; Mobasheri A, 2005, AM J PHYSIOL-REG I, V289, pR172, DOI 10.1152/ajpregu.00710.2004; Mobasheri A, 2010, J CELL PHYSIOL, V223, P511, DOI 10.1002/jcp.22075; Mouw JK, 2007, BIOMECH MODEL MECHAN, V6, P33, DOI 10.1007/s10237-006-0034-1; Muramatsu S, 2007, J BIOL CHEM, V282, P32158, DOI 10.1074/jbc.M706158200; Nesti LJ, 2007, J CELL BIOCHEM, V101, P348, DOI 10.1002/jcb.21180; Ng SY, 2010, J CELL PHYSIOL, V224, P165, DOI 10.1002/jcp.22113; O'Grady SM, 2005, INT J BIOCHEM CELL B, V37, P1578, DOI 10.1016/j.biocel.2005.04.002; PAK MD, 1991, P NATL ACAD SCI USA, V88, P4386, DOI 10.1073/pnas.88.10.4386; Panyi G, 2004, IMMUNOL LETT, V92, P55, DOI 10.1016/j.imlet.2003.11.020; Pardo LA, 2004, PHYSIOLOGY, V19, P285, DOI 10.1152/physiol.00011.2004; Pingguan-Murphy B, 2006, J CELL PHYSIOL, V209, P389, DOI 10.1002/jcp.20747; Salter DM, 2004, BIORHEOLOGY, V41, P273; Szabo I, 2005, J BIOL CHEM, V280, P12790, DOI 10.1074/jbc.M413548200; Tsuga K, 2002, J MEMBRANE BIOL, V185, P75, DOI 10.1007/s00232-001-0112-3; Vicente R, 2008, J BIOL CHEM, V283, P8756, DOI 10.1074/jbc.M708223200; Vicente R, 2006, J BIOL CHEM, V281, P37675, DOI 10.1074/jbc.M605617200; WALSH KB, 1992, AM J PHYSIOL, V262, pC1335, DOI 10.1152/ajpcell.1992.262.5.C1335; Wilson JR, 2004, J PHYSIOL-LONDON, V557, P93, DOI 10.1113/jphysiol.2003.058883; WILTINK A, 1994, CALCIFIED TISSUE INT, V54, P278, DOI 10.1007/BF00295951; Wohlrab D, 2001, J Orthop Sci, V6, P155, DOI 10.1007/s007760100064; Wray S, 2010, PHYSIOL REV, V90, P113, DOI 10.1152/physrev.00018.2008; Wu QQ, 2000, EXP CELL RES, V256, P383, DOI 10.1006/excr.2000.4847; Yu FH, 2005, PHARMACOL REV, V57, P387, DOI 10.1124/pr.57.4.13; Zenisek D, 2001, J NEUROSCI, V21, P4543, DOI 10.1523/JNEUROSCI.21-13-04543.2001; Zsiros E, 2009, J IMMUNOL, V183, P4483, DOI 10.4049/jimmunol.0803003	54	35	35	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2011	6	11							e27957	10.1371/journal.pone.0027957	http://dx.doi.org/10.1371/journal.pone.0027957			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IO	22132179	Green Published, gold, Green Submitted			2022-12-27	WOS:000297789900037
J	Althen, H; Grimm, S; Escera, C				Althen, Heike; Grimm, Sabine; Escera, Carles			Fast Detection of Unexpected Sound Intensity Decrements as Revealed by Human Evoked Potentials	PLOS ONE			English	Article							STIMULUS-SPECIFIC ADAPTATION; AUDITORY BRAIN-STEM; MISMATCH NEGATIVITY; MIDDLE-LATENCY; INFERIOR COLLICULUS; ANESTHETIZED RAT; CORTICAL-NEURONS; SENSORY MEMORY; RESPONSES; CORTEX	The detection of deviant sounds is a crucial function of the auditory system and is reflected by the automatically elicited mismatch negativity (MMN), an auditory evoked potential at 100 to 250 ms from stimulus onset. It has recently been shown that rarely occurring frequency and location deviants in an oddball paradigm trigger a more negative response than standard sounds at very early latencies in the middle latency response of the human auditory evoked potential. This fast and early ability of the auditory system is corroborated by the finding of neurons in the animal auditory cortex and subcortical structures, which restore their adapted responsiveness to standard sounds, when a rare change in a sound feature occurs. In this study, we investigated whether the detection of intensity deviants is also reflected at shorter latencies than those of the MMN. Auditory evoked potentials in response to click sounds were analyzed regarding the auditory brain stem response, the middle latency response (MLR) and the MMN. Rare stimuli with a lower intensity level than standard stimuli elicited (in addition to an MMN) a more negative potential in the MLR at the transition from the Na to the Pa component at circa 24 ms from stimulus onset. This finding, together with the studies about frequency and location changes, suggests that the early automatic detection of deviant sounds in an oddball paradigm is a general property of the auditory system.	[Althen, Heike; Grimm, Sabine; Escera, Carles] Univ Barcelona, Inst Brain Cognit & Behav IR3C, Barcelona, Catalonia, Spain; [Althen, Heike; Grimm, Sabine; Escera, Carles] Univ Barcelona, Dept Psychiat & Clin Psychobiol, Cognit Neurosci Res Grp, Barcelona, Catalonia, Spain	University of Barcelona; University of Barcelona	Althen, H (corresponding author), Univ Barcelona, Inst Brain Cognit & Behav IR3C, Barcelona, Catalonia, Spain.	cescera@ub.edu	Althen, Heike/E-2435-2016; 2010, BRAINGLOT Consolider Ingenio/D-1235-2009; Grimm, Sabine/AAO-1547-2021; Escera, Carles/A-8658-2010	Escera, Carles/0000-0001-8203-2951; Grimm, Sabine/0000-0002-9071-5944	Consolider-Ingenio [CDS2007-00012]; Spanish Ministry of Science and Innovation [PSI2009-08063]; Bial Foundation (Portugal) [37/10]; Catalan Government [SGR2009-11]; ICREA	Consolider-Ingenio(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Bial Foundation (Portugal)(Bial Foundation); Catalan Government; ICREA(ICREA)	This work was supported by the program Consolider-Ingenio 2010 (CDS2007-00012), the National Program for Fundamental Research (PSI2009-08063) from the Spanish Ministry of Science and Innovation, the Bial Foundation (Portugal, grant #37/10), a grant from the Catalan Government (SGR2009-11), and an ICREA Academia Distinguished Professorship awarded to C. E. URLs: http://www.ingenio2010.es/contenido.asp?menu1=&menu2=&menu2=&menu3=&menu3=&dir=./02_instrumentos/02_Caracteristicas/01_CONSOLIDER&id=En. http://www.micinn.es/portal/site/MICINN/menuitem.00d7c011ca2a3753222b7d1001432ea0/?vgnextoid=33881f4368aef110VgnVCM1000001034e20aRCRD&lang_choosen=en. http://www.bial.com/en/bial_foundation.11.html. http://www.gencat.cat/index_eng.htm. http://www.icrea.cat/web/home.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALHO K, 1995, EAR HEARING, V16, P38, DOI 10.1097/00003446-199502000-00004; Antunes FM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014071; Bilecen D, 2002, NEUROIMAGE, V17, P710, DOI 10.1006/nimg.2002.1133; Borgmann C, 2001, HEARING RES, V158, P57, DOI 10.1016/S0378-5955(01)00292-1; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; BUCHWALD JS, 1981, BRAIN RES, V205, P91, DOI 10.1016/0006-8993(81)90722-8; BUTLER RA, 1968, J ACOUST SOC AM, V44, P945, DOI 10.1121/1.1911233; CSEPE V, 1995, EAR HEARING, V16, P91, DOI 10.1097/00003446-199502000-00007; Deouell LY, 2007, J PSYCHOPHYSIOL, V21, P188, DOI 10.1027/0269-8803.21.34.188; ELBERLING C, 1987, J ACOUST SOC AM, V81, P115, DOI 10.1121/1.395019; Escera C, 2007, J PSYCHOPHYSIOL, V21, P251, DOI 10.1027/0269-8803.21.34.251; Farley BJ, 2010, J NEUROSCI, V30, P16475, DOI 10.1523/JNEUROSCI.2793-10.2010; Grimm S, BIOL PSYCHO IN PRESS; Grimm S, 2011, PSYCHOPHYSIOLOGY, V48, P377, DOI 10.1111/j.1469-8986.2010.01073.x; HECOX K, 1974, ARCH OTOLARYNGOL, V99, P30; Jacobsen T, 2003, AUDIOL NEURO-OTOL, V8, P338, DOI 10.1159/000073518; Lazar R, 2003, HEARING RES, V181, P51, DOI 10.1016/S0378-5955(03)00166-7; Malmierca MS, 2011, AUDITORY CORTEX, P189, DOI 10.1007/978-1-4419-0074-6_9; Malmierca MS, 2009, J NEUROSCI, V29, P5483, DOI 10.1523/JNEUROSCI.4153-08.2009; Malmierca MS, 2005, NEUROSCIENCE, V136, P883, DOI 10.1016/j.neuroscience.2005.04.040; Malmierca MS, 2003, INT REV NEUROBIOL, V56, P147, DOI 10.1016/S0074-7742(03)56005-6; MCFADDEN D, 1975, J ACOUST SOC AM, V57, P702, DOI 10.1121/1.380496; Naatanen R, 1987, Electroencephalogr Clin Neurophysiol Suppl, V40, P125; NAATANEN R, 1978, ACTA PSYCHOL, V42, P313, DOI 10.1016/0001-6918(78)90006-9; NAATANEN R, 1989, NEUROSCI LETT, V98, P217, DOI 10.1016/0304-3940(89)90513-2; Nelken I, 2007, J PSYCHOPHYSIOL, V21, P214, DOI 10.1027/0269-8803.21.34.214; PAAVILAINEN P, 1991, ELECTROEN CLIN NEURO, V78, P466, DOI 10.1016/0013-4694(91)90064-B; PAAVILAINEN P, 1993, BIOL PSYCHOL, V35, P139, DOI 10.1016/0301-0511(93)90010-6; Parkkonen L, 2009, HUM BRAIN MAPP, V30, P1772, DOI 10.1002/hbm.20788; Perez-Gonzalez D, 2005, EUR J NEUROSCI, V22, P2879, DOI 10.1111/j.1460-9568.2005.04472.x; Picton TW, 2011, HUMAN AUDITORY EVOKE, P213; Reches A, 2008, J NEUROSCI, V28, P1523, DOI 10.1523/JNEUROSCI.3785-07.2008; Sabri M, 2001, COGNITIVE BRAIN RES, V12, P171, DOI 10.1016/S0926-6410(01)00026-X; Schroger E, 2007, J PSYCHOPHYSIOL, V21, P138, DOI 10.1027/0269-8803.21.34.138; Schroger E, 1996, NEUROREPORT, V7, P3005, DOI 10.1097/00001756-199611250-00041; Slabu L, 2010, EUR J NEUROSCI, V32, P859, DOI 10.1111/j.1460-9568.2010.07324.x; Sonnadara RR, 2006, BRAIN RES, V1076, P187, DOI 10.1016/j.brainres.2005.12.093; Taaseh N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023369; Ulanovsky N, 2004, J NEUROSCI, V24, P10440, DOI 10.1523/JNEUROSCI.1905-04.2004; Ulanovsky N, 2003, NAT NEUROSCI, V6, P391, DOI 10.1038/nn1032; Verhey JL, 2002, J ACOUST SOC AM, V111, P1349, DOI 10.1121/1.1451065; von der Behrens W, 2009, J NEUROSCI, V29, P13837, DOI 10.1523/JNEUROSCI.3475-09.2009; Woods DL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005183; WOODS DL, 1987, ELECTROEN CLIN NEURO, V68, P132, DOI 10.1016/0168-5597(87)90040-2; Yu XJ, 2009, NAT NEUROSCI, V12, P1165, DOI 10.1038/nn.2373; Yvert B, 2005, NEUROIMAGE, V28, P140, DOI 10.1016/j.neuroimage.2005.05.056; Yvert B, 2001, CEREB CORTEX, V11, P411, DOI 10.1093/cercor/11.5.411	47	51	51	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2011	6	12							e28522	10.1371/journal.pone.0028522	http://dx.doi.org/10.1371/journal.pone.0028522			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863OC	22163029	Green Published, gold			2022-12-27	WOS:000298173500029
J	Catala-Rabasa, A; Ndagire, D; Sabio, JM; Fedetz, M; Matesanz, F; Alcina, A				Catala-Rabasa, Antonio; Ndagire, Dorothy; Sabio, Jose Mario; Fedetz, Maria; Matesanz, Fuencisla; Alcina, Antonio			High ACSL5 Transcript Levels Associate with Systemic Lupus Erythematosus and Apoptosis in Jurkat T Lymphocytes and Peripheral Blood Cells	PLOS ONE			English	Article							ACYL-COA SYNTHETASE-5; IMPAIRED EXPRESSION; DISEASE-ACTIVITY; ACID; CARDIOLIPIN; CYTOKINE; GENES; DEATH; MICE	Background: Systemic lupus erythematosus (SLE) is a prototypical autoimmune disease in which increased apoptosis and decreased apoptotic cells removal has been described as most relevant in the pathogenesis. Long-chain acyl-coenzyme A synthetases (ACSLs) have been involved in the immunological dysfunction of mouse models of lupus-like autoimmunity and apoptosis in different in vitro cell systems. The aim of this work was to assess among the ACSL isoforms the involvement of ACSL2, ACSL4 and ACSL5 in SLE pathogenesis. Findings: With this end, we determined the ACSL2, ACSL4 and ACSL5 transcript levels in peripheral blood mononuclear cells (PBMCs) of 45 SLE patients and 49 healthy controls by quantitative real time-PCR (q-PCR). We found that patients with SLE had higher ACSL5 transcript levels than healthy controls [median (range), healthy controls = 16.5 (12.3-18.0) vs. SLE = 26.5 (17.8-41.7), P = 3.9x10 E-5] but no differences were found for ACSL2 and ACSL4. In in vitro experiments, ACSL5 mRNA expression was greatly increased when inducing apoptosis in Jurkat T cells and PBMCs by Phorbol-Myristate-Acetate plus Ionomycin (PMA+Io). On the other hand, short interference RNA (siRNA)-mediated silencing of ACSL5 decreased induced apoptosis in Jurkat T cells up to the control levels as well as decreased mRNA expression of FAS, FASLG and TNF. Conclusions: These findings indicate that ACSL5 may play a role in the apoptosis that takes place in SLE. Our results point to ACSL5 as a potential novel functional marker of pathogenesis and a possible therapeutic target in SLE.	[Catala-Rabasa, Antonio; Ndagire, Dorothy; Fedetz, Maria; Matesanz, Fuencisla; Alcina, Antonio] IPBLN CSIC, Dept Cell Biol & Immunol, Granada, Spain; [Sabio, Jose Mario] Hosp Univ Virgen Nieves, Med Interna Serv, Unidad Enfermedades Autoinmunes Sistem, Granada, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN); Hospital Universitario Virgen de las Nieves	Catala-Rabasa, A (corresponding author), IPBLN CSIC, Dept Cell Biol & Immunol, Granada, Spain.	jmsabio@gmail.com; lindo@ipb.csic.es; pulgoso@ipb.csic.es	Alcina, Antonio/T-1893-2017; Matesanz, Fuencisla/F-3715-2016	Alcina, Antonio/0000-0001-7294-0948; Matesanz, Fuencisla/0000-0002-9429-1819	Ministerio de Ciencia e Innovacion-Fondos Feder [PN-SAF2009-11491]; Junta de Andalucia [P07-CVI-02551]; Fondo de Investigacion Sanitaria [FIS PI081636, CP10/00526]	Ministerio de Ciencia e Innovacion-Fondos Feder(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta de Andalucia(Junta de Andalucia); Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III)	Financial support for the study was provided by the Ministerio de Ciencia e Innovacion-Fondos Feder (PN-SAF2009-11491) and Junta de Andalucia (P07-CVI-02551) to A. Alcina and Fondo de Investigacion Sanitaria (FIS PI081636, CP10/00526) to F. Matesanz. M. Fedetz and D. Ndagire are holders of a fellowship from Fundacion Espanola de Esclerosis Multiple (FEDEM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDO S, 1993, BIOCHIM BIOPHYS ACTA, V1181, P141, DOI 10.1016/0925-4439(93)90103-8; Avramescu C, 2010, ROM J MORPHOL EMBRYO, V51, P633; BENNETT S, 1992, J IMMUNOL METHODS, V146, P229, DOI 10.1016/0022-1759(92)90232-I; Borba EF, 2006, CLIN DEV IMMUNOL, V13, P203, DOI 10.1080/17402520600876945; Bovin LF, 2004, IMMUNOL LETT, V93, P217, DOI 10.1016/j.imlet.2004.03.018; Coleman RA, 2002, J NUTR, V132, P2123, DOI 10.1093/jn/132.8.2123; D'Cruz DP, 2007, LANCET, V369, P587, DOI 10.1016/S0140-6736(07)60279-7; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; Dhir V, 2009, LUPUS, V18, P785, DOI 10.1177/0961203309103152; Faergeman NJ, 1997, BIOCHEM J, V323, P1; Gassler N, 2005, J PATHOL, V207, P295, DOI 10.1002/path.1831; Gassler N, 2004, J PATHOL, V202, P188, DOI 10.1002/path.1504; Han MS, 2008, J LIPID RES, V49, P84, DOI 10.1194/jlr.M700184-JLR200; Hardy S, 2003, J BIOL CHEM, V278, P31861, DOI 10.1074/jbc.M300190200; Herrmann M, 1998, ARTHRITIS RHEUM-US, V41, P1241, DOI 10.1002/1529-0131(199807)41:7<1241::AID-ART15>3.0.CO;2-H; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Iversen Nina, 2005, Genet Vaccines Ther, V3, P2, DOI 10.1186/1479-0556-3-2; Kagan VE, 2004, FREE RADICAL BIO MED, V37, P1963, DOI 10.1016/j.freeradbiomed.2004.08.016; Kurien BT, 2008, AUTOIMMUN REV, V7, P567, DOI 10.1016/j.autrev.2008.04.019; Kurien BT, 2003, LIFE SCI, V73, P1655, DOI 10.1016/S0024-3205(03)00475-2; Lecoeur H, 2002, EXP CELL RES, V277, P1, DOI 10.1006/excr.2002.5537; Liphaus BL, 2010, CLINICS, V65, P327, DOI 10.1590/S1807-59322010000300014; Mashek DG, 2006, J BIOL CHEM, V281, P945, DOI 10.1074/jbc.M507646200; Mashima T, 2009, ONCOGENE, V28, P9, DOI 10.1038/onc.2008.355; Mevorach D, 2003, CLIN REV ALLERG IMMU, V25, P49, DOI 10.1385/CRIAI:25:1:49; Mu YM, 2001, ENDOCRINOLOGY, V142, P3590, DOI 10.1210/en.142.8.3590; Obermuller N, 2006, INT J COLORECTAL DIS, V21, P130, DOI 10.1007/s00384-004-0738-6; Otaki N, 2010, J BIOL CHEM, V285, P33834, DOI 10.1074/jbc.M110.165175; Posadas-Romero C, 2004, ARTHRITIS RHEUM-US, V50, P160, DOI 10.1002/art.11472; Reinartz A, 2010, BBA-MOL CELL BIOL L, V1801, P1025, DOI 10.1016/j.bbalip.2010.04.010; Shah D, 2010, IMMUNOL LETT, V129, P7, DOI 10.1016/j.imlet.2010.01.005; Soupene E, 2008, EXP BIOL MED, V233, P507, DOI 10.3181/0710-MR-287; Sweeney B, 2005, PEDIATR SURG INT, V21, P335, DOI 10.1007/s00383-005-1385-x; Tait JF, 2008, J NUCL MED, V49, P1573, DOI 10.2967/jnumed.108.052803; TOMITAYAMAGUCHI M, 1990, J EXP MED, V171, P787, DOI 10.1084/jem.171.3.787; Vermes I, 1997, ACTA HAEMATOL-BASEL, V98, P8; Yahata T, 1999, EUR J IMMUNOL, V29, P727, DOI 10.1002/(SICI)1521-4141(199903)29:03<727::AID-IMMU727>3.0.CO;2-0	37	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2011	6	12							e28591	10.1371/journal.pone.0028591	http://dx.doi.org/10.1371/journal.pone.0028591			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863OC	22163040	Green Published, gold, Green Submitted			2022-12-27	WOS:000298173500038
J	Nosyk, B; Sharif, B; Sun, HY; Cooper, C; Anis, AH				Nosyk, Bohdan; Sharif, Behnam; Sun, Huiying; Cooper, Curtis; Anis, Aslam H.		CIHR Canadian HIV Trials Network	The Cost-Effectiveness and Value of Information of Three Influenza Vaccination Dosing Strategies for Individuals with Human Immunodeficiency Virus	PLOS ONE			English	Article							HIV-INFECTED INDIVIDUALS; HIV-1-INFECTED PATIENTS; ECONOMIC-EVALUATION; HEALTH-CARE; EFFICACY; METAANALYSIS; PROGNOSIS; ANTIBODY; IMPACT; ADULTS	Background: Influenza vaccine immunogenicity is diminished in patients living with HIV/AIDS. We evaluated the cost-effectiveness and expected value of perfect information (EVPI) of three alternative influenza vaccine dosing strategies intended to increase immunogenicity in those patients. Methods: A randomized, multi-centered, controlled, vaccine trial was conducted at 12 CIHR Canadian HIV Trials Network sites. Three dosing strategies with seasonal, inactivated trivalent, non-adjuvanted intramuscular vaccine were used in HIV infected adults: two standard doses over 28 days (Strategy A), two double doses over 28 days (Strategy B) and a single standard dose of influenza vaccine (Strategy C), administered prior to the 2008 influenza season. The comparator in our analysis was practice in the previous year, in which 82.8% of HIV/AIDS received standard-dose vaccination (Strategy D). A Markov cohort model was developed to estimate the monthly probability of Influenza-like Illness (ILI) over one influenza season. Costs and quality-adjusted life years, extrapolated to the lifetime of the hypothetical study cohorts, were estimated in calculating incremental cost-effectiveness ratios (ICER) and EVPI in conducting further research. Results: 298 patients with median CD4 of 470 cells/mu l and 76% with viral load suppression were randomized. Strategy C was the most cost-effective strategy for the overall trial population and for suppressed and unsuppressed individuals. Mean ICERs for Strategy A for unsuppressed patients could also be considered cost-effective. The level of uncertainty regarding the decision to implement strategy A versus C for unsuppressed individuals was high. The maximum acceptable cost of reducing decision uncertainty in implementing strategy A for individuals with unsuppressed pVL was $418,000 - below the cost of conducting a larger-scale trial. Conclusion: Our results do not support a policy to implement increased antigen dose or booster dosing strategies with seasonal, inactivated trivalent, non-adjuvanted intramuscular vaccine for individuals with HIV in Canada.	[Nosyk, Bohdan; Sharif, Behnam; Sun, Huiying; Cooper, Curtis; Anis, Aslam H.] CIHR Canadian HIV Trials Network, Vancouver, BC, Canada; [Cooper, Curtis] Univ Ottawa, Div Infect Dis, Ottawa, ON, Canada; [Anis, Aslam H.] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada	University of Ottawa; University of British Columbia	Nosyk, B (corresponding author), CIHR Canadian HIV Trials Network, Vancouver, BC, Canada.	aslam.anis@ubc.ca	Cooper, Curtis/M-9320-2019	Boivin, Guy/0000-0003-3027-4662	Public Health Agency of Canada [CTN-237]; Michael Smith Foundation for Health Research	Public Health Agency of Canada; Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research)	This study on which this manuscript was based (CTN-237) was funded by the Public Health Agency of Canada. Curtis Cooper is a Career Scientist with the Ontario HIV Treatment Network. Bohdan Nosyk is a CIHR Bisby Fellow and is also supported by a postdoctoral fellowship from the Michael Smith Foundation for Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson J, 2008, AIDS, V22, P349, DOI 10.1097/QAD.0b013e3282f4709a; Anema A, 2008, HIV MED, V9, P57, DOI 10.1111/j.1468-1293.2008.00515.x; Anis AH, 2009, JAIDS-J ACQ IMM DEF, V51, P631, DOI 10.1097/QAI.0b013e3181a4f00d; [Anonymous], CDC WEEKLY REPORT, V48, P1; [Anonymous], STAT CAN TABL 105 05; Atashili J, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-138; Beyer WEP, 2004, VIRUS RES, V103, P125, DOI 10.1016/j.virusres.2004.02.024; Briggs A, 2006, DECISION MODELLING H; British Columbia Medical Association, BCMA GUID FEES; Centre for Disease Control (CDC) website, INFL VACC PRIC LIST; Centre for Disease Control website, 2002 2009 INFL SEAS; Cooper C, 2008, CAN J INFECT DIS MED, V19, P419, DOI 10.1155/2008/419710; Cooper C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017758; de Jong J C, 2003, Dev Biol (Basel), V115, P63; Dunning AJ, 2006, STAT MED, V25, P1485, DOI 10.1002/sim.2282; Fine AD, 2001, CLIN INFECT DIS, V32, P1784, DOI 10.1086/320747; Gafni A, 2006, SOC SCI MED, V62, P2091, DOI 10.1016/j.socscimed.2005.10.023; Gebo KA, 2010, AIDS, V24, P2705, DOI 10.1097/QAD.0b013e32833f3c14; Humphreys EH, ANTIRETROVIRAL REGIM; Kim SY, 2008, PHARMACOECONOMICS, V26, P191, DOI 10.2165/00019053-200826030-00004; Klein MB, 2007, CLIN INFECT DIS, V45, P234, DOI 10.1086/518986; Koopmanschap M, 2005, PHARMACOECONOMICS, V23, P47, DOI 10.2165/00019053-200523010-00004; Kroon FP, 2000, VACCINE, V18, P3040, DOI 10.1016/S0264-410X(00)00079-7; Lin JC, 2001, ARCH INTERN MED, V161, P441, DOI 10.1001/archinte.161.3.441; May M, 2007, AIDS, V21, P1185, DOI 10.1097/QAD.0b013e328133f285; Mysliwska J, 2004, EXP GERONTOL, V39, P1447, DOI 10.1016/j.exger.2004.08.005; Nauta JJP, 2009, BIOLOGICALS, V37, P216, DOI 10.1016/j.biologicals.2009.02.002; Nichol KL, 2008, VACCINE, V26, pD17, DOI 10.1016/j.vaccine.2008.07.048; Nosyk B, 2009, QUAL LIFE RES, V18, P815, DOI 10.1007/s11136-009-9504-0; Palepu A, 2001, CAN MED ASSOC J, V165, P415; Public Health Agency of Canada, 2008, EST HIV PREV INC CAN; Ramsey S, 2005, VALUE HEALTH, V8, P521, DOI 10.1111/j.1524-4733.2005.00045.x; Riera M, 2010, AIDS, V24, P2460, DOI 10.1097/QAD.0b013e32833e508f; Scuffham PA, 2002, VACCINE, V20, P2562, DOI 10.1016/S0264-410X(02)00154-8; Singh S, 2008, INT J TECHNOL ASSESS, V24, P112, DOI 10.1017/S0266462307080142; Skowronski DM, 2008, J INFECT DIS, V197, P490, DOI 10.1086/524146; Soonawala D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016496; SULLIVAN KM, 1993, AM J PUBLIC HEALTH, V83, P1712, DOI 10.2105/AJPH.83.12.1712; Thompson WW, 2009, INFLUENZA OTHER RESP, V3, P37, DOI 10.1111/j.1750-2659.2009.00073.x; Yamanaka H, 2005, JAIDS-J ACQ IMM DEF, V39, P167	40	14	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2011	6	12							e27059	10.1371/journal.pone.0027059	http://dx.doi.org/10.1371/journal.pone.0027059			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	863OC	22162988	Green Published, Green Submitted, gold			2022-12-27	WOS:000298173500002
J	Chang, CP; Yang, MC; Lei, HY				Chang, Chih-Peng; Yang, Ming-Chen; Lei, Huan-Yao			Concanavalin A/IFN-Gamma Triggers Autophagy-Related Necrotic Hepatocyte Death through IRGM1-Mediated Lysosomal Membrane Disruption	PLOS ONE			English	Article							CELL-DEATH; IFN-GAMMA; INTERFERON-GAMMA; APOPTOSIS; MACROPHAGES; MECHANISMS; HEPATITIS; NECROSIS; TUBERCULOSIS; ACTIVATION	Interferon-gamma (IFN-gamma), a potent Th1 cytokine with multiple biological functions, can induce autophagy to enhance the clearance of the invading microorganism or cause cell death. We have reported that Concanavalin A (Con A) can cause autophagic cell death in hepatocytes and induce both T cell-dependent and -independent acute hepatitis in immunocompetent and immunodeficient mice, respectively. Although IFN-gamma is known to enhance liver injury in Con A-induced hepatitis, its role in autophagy-related hepatocyte death is not clear. In this study we report that IFN-gamma can enhance Con A-induced autophagic flux and cell death in hepatoma cell lines. A necrotic cell death with increased lysosomal membrane permeabilization (LMP) is observed in Con A-treated hepatoma cells in the presence of IFN-gamma. Cathepsin B and L were released from lysosomes to cause cell death. Furthermore, IFN-gamma induces immunity related GTPase family M member 1(IRGM1) translocation to lysosomes and prolongs its activity in Con A-treated hepatoma cells. Knockdown of IRGM1 inhibits the IFN-gamma/Con A-induced LMP change and cell death. Furthermore, IFN-gamma(-/-) mice are resistant to Con A-induced autophagy-associated necrotic hepatocyte death. We conclude that IFN-gamma enhances Con A-induced autophagic flux and causes an IRGM1-dependent lysosome-mediated necrotic cell death in hepatocytes.	[Chang, Chih-Peng; Lei, Huan-Yao] Natl Cheng Kung Univ, Coll Med, Dept Microbiol & Immunol, Tainan 70101, Taiwan; [Yang, Ming-Chen; Lei, Huan-Yao] Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan 70101, Taiwan; [Chang, Chih-Peng; Lei, Huan-Yao] Natl Cheng Kung Univ, Coll Med, Infect Dis & Signaling Res Ctr, Tainan 70101, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University	Chang, CP (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Microbiol & Immunol, Tainan 70101, Taiwan.	hylei@mail.ncku.edu.tw		Chang, Chih-Peng/0000-0002-0061-3478	National Science Council, Taiwan [NSC-98-2320-B-006-031-MY2]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by grant NSC-98-2320-B-006-031-MY2 from the National Science Council, Taiwan (http://web1.nsc.gov.tw/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boya P, 2008, ONCOGENE, V27, P6434, DOI 10.1038/onc.2008.310; Chang CP, 2008, INT J IMMUNOPATH PH, V21, P817, DOI 10.1177/039463200802100406; Chang CP, 2007, HEPATOLOGY, V45, P286, DOI 10.1002/hep.21509; Conus S, 2008, BIOCHEM PHARMACOL, V76, P1374, DOI 10.1016/j.bcp.2008.07.041; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Festjens N, 2006, BBA-BIOENERGETICS, V1757, P1371, DOI 10.1016/j.bbabio.2006.06.014; Foghsgaard L, 2001, J CELL BIOL, V153, P999, DOI 10.1083/jcb.153.5.999; Giammarioli AM, 2009, FEBS J, V276, P5920, DOI 10.1111/j.1742-4658.2009.07271.x; GILLES PN, 1992, HEPATOLOGY, V16, P655, DOI 10.1002/hep.1840160308; Golstein P, 2007, TRENDS BIOCHEM SCI, V32, P37, DOI 10.1016/j.tibs.2006.11.001; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Hotchkiss RS, 2009, NEW ENGL J MED, V361, P1570, DOI 10.1056/NEJMra0901217; Kano A, 1999, BIOCHEM BIOPH RES CO, V257, P672, DOI 10.1006/bbrc.1999.0276; Khalkhali-Ellis Z, 2008, J CELL BIOCHEM, V105, P208, DOI 10.1002/jcb.21814; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Krysko DV, 2008, CELL DEATH DIFFER, V15, P29, DOI 10.1038/sj.cdd.4402271; Lei HY, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-10; Li JH, 2005, J IMMUNOL, V175, P1858, DOI 10.4049/jimmunol.175.3.1858; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; MacMicking JD, 2003, SCIENCE, V302, P654, DOI 10.1126/science.1088063; Mizuhara H, 1996, HEPATOLOGY, V23, P1608, DOI 10.1002/hep.510230643; Petrovski G, 2007, AUTOPHAGY, V3, P509; Pyo JO, 2005, J BIOL CHEM, V280, P20722, DOI 10.1074/jbc.M413934200; Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577; Singh SB, 2010, NAT CELL BIOL, V12, P1154, DOI 10.1038/ncb2119; Suk K, 2001, J IMMUNOL, V166, P4481, DOI 10.4049/jimmunol.166.7.4481; Tagawa Y, 1997, J IMMUNOL, V159, P1418; Tateishi K, 2006, INT J CANCER, V118, P2237, DOI 10.1002/ijc.21658; Thorburn J, 2009, CELL DEATH DIFFER, V16, P175, DOI 10.1038/cdd.2008.143; Turk B, 2009, J BIOL CHEM, V284, P21783, DOI 10.1074/jbc.R109.023820; Uhl M, 2009, CELL DEATH DIFFER, V16, P991, DOI 10.1038/cdd.2009.8; Ulloa L, 2006, CYTOKINE GROWTH F R, V17, P189, DOI 10.1016/j.cytogfr.2006.01.003; Wang CW, 2003, MOL MED, V9, P65, DOI 10.1007/BF03402040; Yorimitsu T, 2005, CELL DEATH DIFFER, V12, P1542, DOI 10.1038/sj.cdd.4401765; Zhao YO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008648	35	17	18	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e28323	10.1371/journal.pone.0028323	http://dx.doi.org/10.1371/journal.pone.0028323			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22163006	Green Published, Green Submitted, gold			2022-12-27	WOS:000298172800025
J	Gomes, CM; Kohlsdorf, T				Gomes, Camilla M.; Kohlsdorf, Tiana			Evolution of Sexual Dimorphism in the Digit Ratio 2D:4D-Relationships with Body Size and Microhabitat Use in Iguanian Lizards	PLOS ONE			English	Article							EVO-DEVO; LENGTH RATIOS; ANOLIS-CAROLINENSIS; HINDLIMB KINEMATICS; ACCELERATION CAPACITY; LOCOMOTOR PERFORMANCE; TROPIDURINAE LIZARDS; INDUCED PLASTICITY; FINGER LENGTH; GREEN ANOLES	The ratio between lengths of digit II and IV (digit ratio 2D:4D) is a morphological feature that likely affects tetrapod locomotor performances in different microhabitats. Modifications of this trait may be triggered by changes in steroids concentrations during embryo development, which might reflect direct selection acting on digit ratio or be solely a consequence of hormonal differences related for example to body size. Here we apply both conventional and phylogenetic analyses on morphological data from 25 lizard species of 3 families of Iguania (Iguanidae, Polychrotidae, and Tropiduridae), in order to verify whether selective pressures related to locomotion in different microhabitats could override the prenatal developmental cues imposed on the digit ratio 2D:4D by differences in body size between males and females. Data suggest that this trait evolved in association with ecological divergence in the species studied, despite the clear effect of body size on the digit ratio 2D:4D. The ecological associations of size-corrected digit ratios were restricted to one sex, and females of species that often use perches exhibited small digit ratios in the front limbs, which translated into larger sexual dimorphism indexes of arboreal species. The results, together with the subsequent discussion, provide outlines for further investigation about possible developmental mechanisms related to the evolution of adaptive changes in digit lengths that may have occurred during the evolution of ecological divergence in squamates.	[Gomes, Camilla M.; Kohlsdorf, Tiana] Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Preto, Dept Biol, BR-14049 Ribeirao Preto, SP, Brazil	Universidade de Sao Paulo	Gomes, CM (corresponding author), Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Preto, Dept Biol, BR-14049 Ribeirao Preto, SP, Brazil.	tiana@usp.br	Kohlsdorf, Tiana/C-3463-2012	Kohlsdorf, Tiana/0000-0002-3873-2042	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil) [2005/60140-4]; Pro-Reitoria de Pesquisa from University of Sao Paulo, Brazil	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Pro-Reitoria de Pesquisa from University of Sao Paulo, Brazil	This study was financed by a FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil) grant to TK (2005/60140-4) and an undergraduate fellowship to CMG (Pro-Reitoria de Pesquisa from University of Sao Paulo, Brazil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts P, 2000, NETH J ZOOL, V50, P261, DOI 10.1163/156854200505865; Bininda-Emonds ORP, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-182; Brakefield PM, 2003, ZOOLOGY, V106, P283, DOI 10.1078/0944-2006-00124; Brown WM, 2002, HORM BEHAV, V42, P380, DOI 10.1006/hbeh.2002.1830; Brown WM, 2002, ANAT RECORD, V267, P231, DOI 10.1002/ar.10108; Buck JJ, 2003, HUM REPROD, V18, P976, DOI 10.1093/humrep/deg198; Burley NT, 2004, P ROY SOC B-BIOL SCI, V271, P239, DOI 10.1098/rspb.2003.2562; CAROTHERS JH, 1986, EVOLUTION, V40, P871, DOI 10.1111/j.1558-5646.1986.tb00550.x; Carrano MT, 1997, ZOOL J LINN SOC-LOND, V121, P77; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; Chang JL, 2006, CAN J ZOOL, V84, P1489, DOI 10.1139/Z06-144; CHIVERS DJ, 1980, J MORPHOL, V166, P337, DOI 10.1002/jmor.1051660306; Collar DC, 2006, EVOLUTION, V60, P2575; COLLI GR, 1992, J HERPETOL, V26, P66, DOI 10.2307/1565023; Conrad JL, 2007, J PALEONTOL, V81, P1365, DOI 10.1666/06-005R.1; Corl A, 2010, EVOLUTION, V64, P79, DOI 10.1111/j.1558-5646.2009.00791.x; Eising CM, 2003, GEN COMP ENDOCR, V132, P241, DOI 10.1016/S0016-6480(03)00090-X; EMERSON SB, 1980, BIOL J LINN SOC, V13, P199, DOI 10.1111/j.1095-8312.1980.tb00082.x; EMERSON SB, 1990, EVOLUTION, V44, P1931, DOI 10.1111/j.1558-5646.1990.tb04300.x; Felsenstein J, 2004, INFERRING PHYLOGENIE, P644; Forstmeier W, 2005, P R SOC B, V272, P2641, DOI 10.1098/rspb.2005.3264; Freeman PW, 2000, EVOL ECOL RES, V2, P317; Frost DR, 2001, MOL PHYLOGENET EVOL, V21, P352, DOI 10.1006/mpev.2001.1015; Galis F, 2010, ARCH SEX BEHAV, V39, P57, DOI 10.1007/s10508-009-9485-7; Garland T, 2000, AM NAT, V155, P346, DOI 10.1086/303327; Garland T, 2005, J EXP BIOL, V208, P3015, DOI 10.1242/jeb.01745; GARLAND T, 1992, SYST BIOL, V41, P18, DOI 10.2307/2992503; GARLAND T, 1993, SYST BIOL, V42, P265, DOI 10.2307/2992464; Garland T, 1999, SYST BIOL, V48, P547, DOI 10.1080/106351599260139; Gartner GEA, 2010, PHYSIOL BIOCHEM ZOOL, V83, P43, DOI 10.1086/648509; GEBO DL, 1988, FOLIA PRIMATOL, V50, P3, DOI 10.1159/000156332; Goodman CS, 2000, P NATL ACAD SCI USA, V97, P4424, DOI 10.1073/pnas.97.9.4424; GRAFEN A, 1989, PHILOS T R SOC B, V326, P119, DOI 10.1098/rstb.1989.0106; Grizante MB, 2010, J EVOLUTION BIOL, V23, P98, DOI 10.1111/j.1420-9101.2009.01868.x; Hall BK, 2003, INT J DEV BIOL, V47, P491; Herrel A, 2002, BIOL J LINN SOC, V77, P149, DOI 10.1046/j.1095-8312.2002.00101.x; Higham TE, 2004, J EXP BIOL, V207, P233, DOI 10.1242/jeb.00763; Higham TE, 2001, J EXP BIOL, V204, P4141; Hoekstra HE, 2007, EVOLUTION, V61, P995, DOI 10.1111/j.1558-5646.2007.00105.x; HORNBRUCH A, 1991, DEVELOPMENT, V111, P725; Irschick DJ, 2005, BIOL J LINN SOC, V85, P211, DOI 10.1111/j.1095-8312.2005.00486.x; Irschick Duncan J., 1996, Contributions to Herpetology, V12, P291; Jayne BC, 1999, J EXP BIOL, V202, P143; Jernvall J, 1996, SCIENCE, V274, P1489, DOI 10.1126/science.274.5292.1489; Kohlsdorf T, 2008, J EVOLUTION BIOL, V21, P781, DOI 10.1111/j.1420-9101.2008.01516.x; Kohlsdorf T, 2004, J EXP BIOL, V207, P1183, DOI 10.1242/jeb.00870; Kohlsdorf T, 2001, J MORPHOL, V248, P151, DOI 10.1002/jmor.1026; Kohlsdorf T, 2007, BIOL J LINN SOC, V91, P393, DOI 10.1111/j.1095-8312.2007.00804.x; Kondo T, 1997, NATURE, V390, P29, DOI 10.1038/36234; Lannoo J.M., 1987, FIELDIANA ZOOL, V38, P1, DOI DOI 10.5962/BHL.TITLE.2932; Laurila A, 2002, OECOLOGIA, V132, P524, DOI 10.1007/s00442-002-0984-7; Lavin SR, 2008, PHYSIOL BIOCHEM ZOOL, V81, P526, DOI 10.1086/590395; Leoni B, 2005, ANAT REC PART A, V286A, P955, DOI 10.1002/ar.a.20226; Lilley T, 2010, PHYSIOL BEHAV, V99, P433, DOI 10.1016/j.physbeh.2009.11.015; Liou NS, 2008, HIST NATURAL DUAS ES; LOSOS JB, 1989, J EXP BIOL, V145, P23; LOSOS JB, 1990, EVOLUTION, V44, P1189, DOI 10.1111/j.1558-5646.1990.tb05225.x; Losos JB, 2000, EVOLUTION, V54, P301, DOI 10.1111/j.0014-3820.2000.tb00032.x; Lovern MB, 2003, J EXP ZOOL PART A, V295A, P206, DOI 10.1002/jez.a.10225; Lovern MB, 2003, GEN COMP ENDOCR, V134, P109, DOI 10.1016/S0016-6480(03)00240-5; Lutchmaya S, 2004, EARLY HUM DEV, V77, P23, DOI 10.1016/j.earlhumdev.2003.12.002; MacFadden BJ, 1997, PALEOBIOLOGY, V23, P77, DOI 10.1017/S0094837300016651; Macrini TE, 2003, J HERPETOL, V37, P52, DOI 10.1670/0022-1511(2003)037[0052:EDITCB]2.0.CO;2; Malas MA, 2006, EARLY HUM DEV, V82, P469, DOI 10.1016/j.earlhumdev.2005.12.002; Manning JT, 2006, ANN HUM BIOL, V33, P480, DOI 10.1080/03014460600802551; Manning JT, 2003, MED HYPOTHESES, V60, P340, DOI 10.1016/S0306-9877(02)00400-0; Manning JT, 2001, DEV MED CHILD NEUROL, V43, P160, DOI 10.1017/S0012162201000317; Manning JT, 1998, HUM REPROD, V13, P3000, DOI 10.1093/humrep/13.11.3000; Manning JT., 2002, DIGIT RATIO POINTER; McCollum SA, 1997, OECOLOGIA, V109, P615, DOI 10.1007/s004420050124; McFadden D, 2005, HORM BEHAV, V47, P99, DOI 10.1016/j.yhbeh.2004.08.013; Melville J, 2000, BIOL J LINN SOC, V70, P667; Miller-Butterworth CM, 2003, NATURE, V424, P187, DOI 10.1038/nature01742; Mortlock DP, 1996, NAT GENET, V13, P284, DOI 10.1038/ng0796-284; Murray DL, 2002, J ZOOL, V256, P289, DOI 10.1017/S095283690200033X; O'Meara BC, 2006, EVOLUTION, V60, P922; PAGEL MD, 1992, J THEOR BIOL, V156, P431, DOI 10.1016/S0022-5193(05)80637-X; Peters M, 2002, AM J PHYS ANTHROPOL, V117, P209, DOI 10.1002/ajpa.10029; PETERSON JA, 1984, J ZOOL, V202, P1; Poe S, 2004, HERPETOL MONOGR, V18, P37, DOI 10.1655/0733-1347(2004)018[0037:POA]2.0.CO;2; Pough F. H., 1998, HERPETOLOGY; PURVIS A, 1995, PHILOS T ROY SOC B, V348, P405, DOI 10.1098/rstb.1995.0078; Raff RA, 2000, NAT REV GENET, V1, P74, DOI 10.1038/35049594; Relyea RA, 2005, ECOLOGY, V86, P1723, DOI 10.1890/04-1920; Relyea RA, 2001, ECOLOGY, V82, P523, DOI 10.1890/0012-9658(2001)082[0523:MABPOL]2.0.CO;2; Revell LJ, 2009, EVOLUTION, V63, P3258, DOI 10.1111/j.1558-5646.2009.00804.x; Ribas SC, 2004, REV CHIL HIST NAT, V77, P599; Romano M, 2005, HORM BEHAV, V48, P342, DOI 10.1016/j.yhbeh.2005.03.007; Rubolini D, 2006, ANAT REC PART A, V288A, P491, DOI 10.1002/ar.a.20323; Saino N, 2007, NATURWISSENSCHAFTEN, V94, P207, DOI 10.1007/s00114-006-0188-9; Spezzano LC, 2004, J EXP BIOL, V207, P2115, DOI 10.1242/jeb.00995; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; STRAIT SG, 1993, J MAMMAL, V74, P391, DOI 10.2307/1382395; TICKLE C, 1994, ANNU REV CELL BIOL, V10, P121; Toro E, 2004, AM NAT, V163, P844, DOI 10.1086/386347; Tulli MJ, 2009, ZOOLOGY, V112, P379, DOI 10.1016/j.zool.2009.02.001; van Sluys M., 1992, Revista Brasileira de Biologia, V52, P181; Vanhooydonck B, 2006, J EXP BIOL, V209, P4515, DOI 10.1242/jeb.02511; Vanhooydonck B, 2006, EVOLUTION, V60, P2137, DOI 10.1111/j.0014-3820.2006.tb01851.x; VANZOLINI P E, 1979, Papeis Avulsos de Zoologia (Sao Paulo), V32, P243; Vidal N, 2004, P ROY SOC B-BIOL SCI, V271, pS226, DOI 10.1098/rsbl.2003.0151; Vitt LJ, 1997, P NATL ACAD SCI USA, V94, P3828, DOI 10.1073/pnas.94.8.3828; Wiens JJ, 2000, SYST BIOL, V49, P143, DOI 10.1080/10635150050207447; Zaaf A, 2001, ZOOMORPHOLOGY, V121, P45, DOI 10.1007/s004350100044; Zani PA, 2000, J EVOLUTION BIOL, V13, P316, DOI 10.1046/j.1420-9101.2000.00166.x	105	14	14	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e28465	10.1371/journal.pone.0028465	http://dx.doi.org/10.1371/journal.pone.0028465			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22162772	gold, Green Published, Green Submitted			2022-12-27	WOS:000298172800039
J	Jendrysik, MA; Vasilevsky, S; Yi, L; Wood, A; Zhu, NN; Zhao, YG; Koontz, SM; Jackson, SH				Jendrysik, Meghan A.; Vasilevsky, Sam; Yi, Liang; Wood, Adam; Zhu, Nannan; Zhao, Yongge; Koontz, Sherry M.; Jackson, Sharon H.			NADPH Oxidase-2 Derived ROS Dictates Murine DC Cytokine-Mediated Cell Fate Decisions during CD4 T Helper-Cell Commitment	PLOS ONE			English	Article							CHRONIC GRANULOMATOUS-DISEASE; NEGATIVE FEEDBACK-REGULATION; MATURE DENDRITIC CELLS; IL-12 PRODUCTION; INNATE IMMUNITY; P38 MAPK; INTERLEUKIN-12; DIFFERENTIATION; MACROPHAGES; MATURATION	NADPH oxidase-2 (Nox2)/gp91(phox) and p47(phox) deficient mice are prone to hyper-inflammatory responses suggesting a paradoxical role for Nox2-derived reactive oxygen species (ROS) as anti-inflammatory mediators. The molecular basis for this mode of control remains unclear. Here we demonstrate that IFN gamma/LPS matured p47(phox-/-)-ROS deficient mouse dendritic cells (DC) secrete more IL-12p70 than similarly treated wild type DC, and in an in vitro co-culture model IFN gamma/LPS matured p47phox(-/-) DC bias more ovalbumin-specific CD4(+) T lymphocytes toward a Th1 phenotype than wild type (WT) DC through a ROS-dependent mechanism linking IL-12p70 expression to regulation of p38-MAPK activation. The Nox2-dependent ROS production in DC negatively regulates proinflammatory IL-12 expression in DC by constraining p38-MAPK activity. Increasing endogenous H(2)O(2) attenuates p38-MAPK activity in IFN gamma/LPS stimulated WT and p47(phox-/-) DC, which suggests that endogenous Nox 2-derived ROS functions as a secondary messenger in the activated p38-MAPK signaling pathway during IL-12 expression. These findings indicate that ROS, generated endogenously by innate and adaptive immune cells, can function as important secondary messengers that can regulate cytokine production and immune cell cross-talk to control during the inflammatory response.	[Jendrysik, Meghan A.] NIAID, Mol Def Sect, Lab Host Def, NIH, Bethesda, MD 20892 USA; [Vasilevsky, Sam; Yi, Liang; Wood, Adam; Zhu, Nannan; Koontz, Sherry M.; Jackson, Sharon H.] NIAID, Monocyte Trafficking Unit, Lab Host Def, NIH, Bethesda, MD 20892 USA; [Zhao, Yongge] NIAID, Clin Immunol Unit, Lab Host Def, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Jendrysik, MA (corresponding author), NIAID, Mol Def Sect, Lab Host Def, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	sjackson@niaid.nih.gov			Division of Intramural Research of the National Institutes of Health/National Institute of Allergy and Infectious Diseases; National Institutes of Health/National Center on Minority Health and Health Disparities; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000792] Funding Source: NIH RePORTER	Division of Intramural Research of the National Institutes of Health/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health/National Center on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the Division of Intramural Research of the National Institutes of Health/National Institute of Allergy and Infectious Diseases. This study was also partially supported by the National Institutes of Health/National Center on Minority Health and Health Disparities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Aksoy E, 2002, EUR J IMMUNOL, V32, P3040, DOI 10.1002/1521-4141(200211)32:11<3040::AID-IMMU3040>3.0.CO;2-M; Antunes F, 2001, BIOCHEM J, V356, P549, DOI 10.1042/0264-6021:3560549; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bentley R, 1966, METHODS ENZYMOLOGY, V9, P86; Bentley R, 1963, ENZYMES, P567; Bohnenkamp HR, 2007, CELL IMMUNOL, V247, P72, DOI 10.1016/j.cellimm.2007.07.008; CLARK RA, 1989, NEW ENGL J MED, V321, P647, DOI 10.1056/NEJM198909073211005; Collison LW, 2008, IMMUNOL REV, V226, P248, DOI 10.1111/j.1600-065X.2008.00704.x; Donaldson M, 2009, CELL DEATH DIFFER, V16, P125, DOI 10.1038/cdd.2008.129; Ebner S, 2001, J IMMUNOL, V166, P633, DOI 10.4049/jimmunol.166.1.633; El-Benna J, 2009, EXP MOL MED, V41, P217, DOI 10.3858/emm.2009.41.4.058; Elsen S, 2004, J CELL SCI, V117, P2215, DOI 10.1242/jcs.01085; Fukao T, 2003, TRENDS IMMUNOL, V24, P358, DOI 10.1016/S1471-4906(03)00139-X; Fukao T, 2002, NAT IMMUNOL, V3, P875, DOI 10.1038/ni825; Hazeki K, 2007, BIOL PHARM BULL, V30, P1617, DOI 10.1248/bpb.30.1617; Heyworth PG, 2003, CURR OPIN IMMUNOL, V15, P578, DOI 10.1016/S0952-7915(03)00109-2; Jackson SH, 2004, NAT IMMUNOL, V5, P818, DOI 10.1038/ni1096; JACKSON SH, 1995, J EXP MED, V182, P751, DOI 10.1084/jem.182.3.751; Kalinski P, 1999, J IMMUNOL, V162, P3231; Kapsenberg ML, 2003, NAT REV IMMUNOL, V3, P984, DOI 10.1038/nri1246; Kikuchi K, 2003, IMMUNOL LETT, V89, P149, DOI 10.1016/S0165-2478(03)00134-2; Kroening PR, 2008, J IMMUNOL, V181, P1536, DOI 10.4049/jimmunol.181.2.1536; Lu HT, 1999, EMBO J, V18, P1845, DOI 10.1093/emboj/18.7.1845; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Ohtani M, 2008, BLOOD, V112, P635, DOI 10.1182/blood-2008-02-137430; POLLOCK JD, 1995, NAT GENET, V9, P202, DOI 10.1038/ng0295-202; Richter C, 2009, J IMMUNOL, V182, P4183, DOI 10.4049/jimmunol.0800795; Rodionova E, 2007, BLOOD, V109, P1584, DOI 10.1182/blood-2006-06-028951; ROOS D, 1994, IMMUNOL REV, V138, P121, DOI 10.1111/j.1600-065X.1994.tb00850.x; Rosenzweig SD, 2008, J CLIN IMMUNOL, V28, pS67, DOI 10.1007/s10875-007-9160-5; Schappi MG, 2008, SEMIN IMMUNOPATHOL, V30, P255, DOI 10.1007/s00281-008-0119-2; Sheng KC, 2010, J IMMUNOL, V184, P2863, DOI 10.4049/jimmunol.0903458; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Turnquist HR, 2010, BLOOD, V115, P4758, DOI 10.1182/blood-2009-10-251488; Vasilevsky S, 2008, J IMMUNOL, V181, P1787, DOI 10.4049/jimmunol.181.3.1787; Viola A, 2006, TRENDS IMMUNOL, V27, P421, DOI 10.1016/j.it.2006.07.004; Vulcano M, 2004, J IMMUNOL, V173, P5749, DOI 10.4049/jimmunol.173.9.5749; WOLF SF, 1991, J IMMUNOL, V146, P3074; Zhang JS, 2000, CELL IMMUNOL, V204, P38, DOI 10.1006/cimm.2000.1690	44	27	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2011	6	12							e28198	10.1371/journal.pone.0028198	http://dx.doi.org/10.1371/journal.pone.0028198			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MQ	22145029	Green Submitted, Green Published, gold			2022-12-27	WOS:000298168900012
J	Cippitelli, A; Astarita, G; Duranti, A; Caprioli, G; Ubaldi, M; Stopponi, S; Kallupi, M; Sagratini, G; de Fonseca, FR; Piomelli, D; Ciccocioppo, R				Cippitelli, Andrea; Astarita, Giuseppe; Duranti, Andrea; Caprioli, Giovanni; Ubaldi, Massimo; Stopponi, Serena; Kallupi, Marsida; Sagratini, Gianni; Rodriguez de Fonseca, Fernando; Piomelli, Daniele; Ciccocioppo, Roberto			Endocannabinoid Regulation of Acute and Protracted Nicotine Withdrawal: Effect of FAAH Inhibition	PLOS ONE			English	Article							ANXIETY-LIKE BEHAVIOR; CORTICOTROPIN-RELEASING FACTOR; BRAIN REWARD FUNCTION; AMIDE HYDROLASE FAAH; ELEVATED PLUS-MAZE; CANNABINOID SYSTEM; LOCOMOTOR-ACTIVITY; RESTRAINT STRESS; TURNOVER RATE; RATS	Evidence shows that the endocannabinoid system modulates the addictive properties of nicotine. In the present study, we hypothesized that spontaneous withdrawal resulting from removal of chronically implanted transdermal nicotine patches is regulated by the endocannabinoid system. A 7-day nicotine dependence procedure (5.2 mg/rat/day) elicited occurrence of reliable nicotine abstinence symptoms in Wistar rats. Somatic and affective withdrawal signs were observed at 16 and 34 hours following removal of nicotine patches, respectively. Further behavioral manifestations including decrease in locomotor activity and increased weight gain also occurred during withdrawal. Expression of spontaneous nicotine withdrawal was accompanied by fluctuation in levels of the endocannabinoid anandamide (AEA) in several brain structures including the amygdala, the hippocampus, the hypothalamus and the prefrontal cortex. Conversely, levels of 2-arachidonoyl-sn-glycerol were not significantly altered. Pharmacological inhibition of fatty acid amide hydrolase (FAAH), the enzyme responsible for the intracellular degradation of AEA, by URB597 (0.1 and 0.3 mg/kg, i.p.), reduced withdrawal-induced anxiety as assessed by the elevated plus maze test and the shock-probe defensive burying paradigm, but did not prevent the occurrence of somatic signs. Together, the results indicate that pharmacological strategies aimed at enhancing endocannabinoid signaling may offer therapeutic advantages to treat the negative affective state produced by nicotine withdrawal, which is critical for the maintenance of tobacco use.	[Cippitelli, Andrea; Ubaldi, Massimo; Stopponi, Serena; Kallupi, Marsida; Piomelli, Daniele; Ciccocioppo, Roberto] Univ Camerino, Sch Pharm, Pharmacol Unit, I-62032 Camerino, Italy; [Astarita, Giuseppe; Piomelli, Daniele] Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92717 USA; [Duranti, Andrea] Univ Urbino Carlo Bo, Dept Biomol Sci, Urbino, Italy; [Duranti, Andrea] Univ Urbino Carlo Bo, Technol Unit, Urbino, Italy; [Caprioli, Giovanni; Sagratini, Gianni] Univ Camerino, Sch Pharm, Med Chem Unit, I-62032 Camerino, Italy; [Rodriguez de Fonseca, Fernando] Hosp Carlos Haya de Malaga, Fdn IMABIS, Malaga, Spain; [Piomelli, Daniele] Italian Inst Technol, Genoa, Italy	University of Camerino; University of California System; University of California Irvine; University of Urbino; University of Urbino; University of Camerino; FIMABIS; Istituto Italiano di Tecnologia - IIT	Cippitelli, A (corresponding author), Univ Camerino, Sch Pharm, Pharmacol Unit, I-62032 Camerino, Italy.	andrea.cippitelli@unicam.it	Caprioli, Giovanni/H-4143-2019; Kallupi, Marsida/AAP-6084-2020; Astarita, Giuseppe/AAD-1239-2019; Sagratini, Gianni/A-2264-2015; DE FONSECA, FERNANDO RODRIGUEZ/E-9767-2012; Astarita, Giuseppe/N-7346-2014	Caprioli, Giovanni/0000-0002-5530-877X; Kallupi, Marsida/0000-0002-8688-709X; Sagratini, Gianni/0000-0001-6231-8709; Ubaldi, Massimo/0000-0002-4089-2483; Astarita, Giuseppe/0000-0001-6700-301X	University of Camerino, Italy; NATIONAL INSTITUTE ON DRUG ABUSE [DP1DA031387] Funding Source: NIH RePORTER	University of Camerino, Italy; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Financial support was from the University of Camerino, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acquas E, 2000, EUR J PHARMACOL, V401, P179, DOI 10.1016/S0014-2999(00)00403-9; Bura SA, 2010, EUR NEUROPSYCHOPHARM, V20, P369, DOI 10.1016/j.euroneuro.2010.02.003; Balerio GN, 2006, PSYCHOPHARMACOLOGY, V184, P504, DOI 10.1007/s00213-005-0251-9; Balerio GN, 2004, EUR J NEUROSCI, V20, P2737, DOI 10.1111/j.1460-9568.2004.03714.x; Berrendero F, 2005, J NEUROSCI, V25, P1103, DOI 10.1523/JNEUROSCI.3008-04.2005; Bruijnzeel AW, 2007, NEUROPSYCHOPHARMACOL, V32, P955, DOI 10.1038/sj.npp.1301192; Cannich A, 2004, LEARN MEMORY, V11, P625, DOI 10.1101/lm.77904; Castane A, 2005, PHARMACOL BIOCHEM BE, V81, P381, DOI 10.1016/j.pbb.2005.01.025; Castane A, 2002, NEUROPHARMACOLOGY, V43, P857, DOI 10.1016/S0028-3908(02)00118-1; Cippitelli A, 2008, PSYCHOPHARMACOLOGY, V198, P449, DOI 10.1007/s00213-008-1104-0; Cohen C, 2005, PHARMACOL BIOCHEM BE, V81, P387, DOI 10.1016/j.pbb.2005.01.024; Damaj MI, 2003, J PHARMACOL EXP THER, V307, P526, DOI 10.1124/jpet.103.054908; De Boer SF, 2003, EUR J PHARMACOL, V463, P145, DOI 10.1016/S0014-2999(03)01278-0; de Fonseca FR, 2005, ALCOHOL ALCOHOLISM, V40, P2, DOI 10.1093/alcalc/agh110; deFonseca FR, 1997, SCIENCE, V276, P2050, DOI 10.1126/science.276.5321.2050; Del Arco I, 2002, EUR J PHARMACOL, V454, P103, DOI 10.1016/S0014-2999(02)02483-4; Epping-Jordan MP, 1998, NATURE, V393, P76, DOI 10.1038/30001; Fegley D, 2005, J PHARMACOL EXP THER, V313, P352, DOI 10.1124/jpet.104.078980; Forget B, 2005, PSYCHOPHARMACOLOGY, V181, P722, DOI 10.1007/s00213-005-0015-6; Forget B, 2009, PSYCHOPHARMACOLOGY, V205, P613, DOI 10.1007/s00213-009-1569-5; George O, 2007, P NATL ACAD SCI USA, V104, P17198, DOI 10.1073/pnas.0707585104; Giuffrida A, 2000, ANAL BIOCHEM, V280, P87, DOI 10.1006/abio.2000.4509; Gonzalez S, 2002, BRAIN RES, V954, P73, DOI 10.1016/S0006-8993(02)03344-9; Haller J, 2009, PSYCHOPHARMACOLOGY, V204, P607, DOI 10.1007/s00213-009-1494-7; HELTON DR, 1993, PSYCHOPHARMACOLOGY, V113, P205, DOI 10.1007/BF02245698; Helton DR, 1997, NEUROPHARMACOLOGY, V36, P1511, DOI 10.1016/S0028-3908(97)00170-6; Hildebrand BE, 1997, PSYCHOPHARMACOLOGY, V129, P348, DOI 10.1007/s002130050200; Hughes JR, 2007, NICOTINE TOB RES, V9, P329, DOI 10.1080/14622200701188927; HUGHES JR, 1991, ARCH GEN PSYCHIAT, V48, P52; Irvine EE, 2001, PHARMACOL BIOCHEM BE, V68, P319, DOI 10.1016/S0091-3057(00)00449-4; Kathuria S, 2003, NAT MED, V9, P76, DOI 10.1038/nm803; Kenny PJ, 2001, PHARMACOL BIOCHEM BE, V70, P531, DOI 10.1016/S0091-3057(01)00651-7; Le Foll B, 2004, NEUROREPORT, V15, P2139, DOI 10.1097/00001756-200409150-00028; LEVIN ED, 1987, PHYSIOL BEHAV, V39, P441, DOI 10.1016/0031-9384(87)90370-2; Lisboa SF, 2008, EUR J PHARMACOL, V593, P73, DOI 10.1016/j.ejphar.2008.07.032; Maldonado R, 2010, CURR DRUG TARGETS, V11, P440, DOI 10.2174/138945010790980358; Malin DH, 2001, PHARMACOL BIOCHEM BE, V70, P551, DOI 10.1016/S0091-3057(01)00699-2; MALIN DH, 1992, PHARMACOL BIOCHEM BE, V43, P779, DOI 10.1016/0091-3057(92)90408-8; Marsicano G, 2002, NATURE, V418, P530, DOI 10.1038/nature00839; Merritt LL, 2008, J PHARMACOL EXP THER, V326, P483, DOI 10.1124/jpet.108.138321; Miksys S, 2000, BIOCHEM PHARMACOL, V59, P1501, DOI 10.1016/S0006-2952(00)00281-1; Mor M, 2004, J MED CHEM, V47, P4998, DOI 10.1021/jm031140x; Moreira FA, 2008, NEUROPHARMACOLOGY, V54, P141, DOI 10.1016/j.neuropharm.2007.07.005; O'Dell LE, 2007, J PHARMACOL EXP THER, V320, P180, DOI 10.1124/jpet.106.105270; Panagis G, 2000, SYNAPSE, V35, P15, DOI 10.1002/(SICI)1098-2396(200001)35:1<15::AID-SYN3>3.0.CO;2-C; Patel S, 2005, EUR J NEUROSCI, V21, P1057, DOI 10.1111/j.1460-9568.2005.03916.x; Patel S, 2006, J PHARMACOL EXP THER, V318, P304, DOI 10.1124/jpet.106.101287; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; Picciotto MR, 2000, NEUROPSYCHOPHARMACOL, V22, P451, DOI 10.1016/S0893-133X(99)00146-3; PICH EM, 1995, J NEUROSCI, V15, P5439; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; POMERLEAU OF, 1986, PSYCHOPHARMACOL BULL, V22, P865; REVUELTA AV, 1978, N-S ARCH PHARMACOL, V304, P107, DOI 10.1007/BF00495546; Richter RM, 1999, SYNAPSE, V32, P254, DOI 10.1002/(SICI)1098-2396(19990615)32:4<254::AID-SYN2>3.0.CO;2-H; RISNER ME, 1983, J PHARMACOL EXP THER, V224, P319; Sarnyai Z, 2001, PHARMACOL REV, V53, P209; Scherma M, 2008, NEUROPHARMACOLOGY, V54, P129, DOI 10.1016/j.neuropharm.2007.08.011; SCHNEIDER NG, 1984, ADDICT BEHAV, V9, P149, DOI 10.1016/0306-4603(84)90052-2; Semba J, 2004, PSYCHONEUROENDOCRINO, V29, P215, DOI 10.1016/S0306-4530(03)00024-6; Slawecki CJ, 2003, PHARMACOL BIOCHEM BE, V75, P355, DOI 10.1016/S0091-3057(03)00093-5; Slawecki CJ, 2002, DEV BRAIN RES, V138, P15, DOI 10.1016/S0165-3806(02)00455-8; Solinas M, 2007, J PHARMACOL EXP THER, V321, P1127, DOI 10.1124/jpet.106.116830; Stella N, 2001, EUR J PHARMACOL, V425, P189, DOI 10.1016/S0014-2999(01)01182-7; Suzuki T, 1999, EUR J PHARMACOL, V369, P159, DOI 10.1016/S0014-2999(99)00086-2; Swanson LW, 1998, TRENDS NEUROSCI, V21, P323, DOI 10.1016/S0166-2236(98)01265-X; TREIT D, 1981, PHARMACOL BIOCHEM BE, V15, P619, DOI 10.1016/0091-3057(81)90219-7; TRIPATHI HL, 1987, ALCOHOL DRUG RES, V7, P525; Tzavara ET, 2002, EUR J NEUROSCI, V16, P149, DOI 10.1046/j.1460-9568.2002.02061.x; Viveros Maria-Paz, 2007, Neural Plasticity, V2007, DOI 10.1155/2007/52908; Watkins SS, 2000, J PHARMACOL EXP THER, V292, P1053; Winders SE, 1998, PSYCHOPHARMACOLOGY, V137, P383, DOI 10.1007/s002130050634; World Health Organization (WHO), 2013, WORLD HLTH REPORT 20	73	51	52	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e28142	10.1371/journal.pone.0028142	http://dx.doi.org/10.1371/journal.pone.0028142			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140525	gold, Green Published			2022-12-27	WOS:000298168100040
J	Kitamura, K; Fujiyoshi, K; Yamane, J; Toyota, F; Hikishima, K; Nomura, T; Funakoshi, H; Nakamura, T; Aoki, M; Toyama, Y; Okano, H; Nakamura, M				Kitamura, Kazuya; Fujiyoshi, Kanehiro; Yamane, Jun-ichi; Toyota, Fumika; Hikishima, Keigo; Nomura, Tatsuji; Funakoshi, Hiroshi; Nakamura, Toshikazu; Aoki, Masashi; Toyama, Yoshiaki; Okano, Hideyuki; Nakamura, Masaya			Human Hepatocyte Growth Factor Promotes Functional Recovery in Primates after Spinal Cord Injury	PLOS ONE			English	Article							DISYNAPTIC PYRAMIDAL EXCITATION; CORTICOSPINAL TRACT; NEUROTROPHIC FACTOR; PROPRIOSPINAL NEURONS; UNILATERAL SECTION; CERVICAL LEVEL; MACAQUE MONKEY; MOTOR CORTEX; FORELIMB MOTONEURONS; HAND REPRESENTATION	Many therapeutic interventions for spinal cord injury (SCI) using neurotrophic factors have focused on reducing the area damaged by secondary, post-injury degeneration, to promote functional recovery. Hepatocyte growth factor (HGF), which is a potent mitogen for mature hepatocytes and a mediator of the inflammatory responses to tissue injury, was recently highlighted as a potent neurotrophic factor in the central nervous system. We previously reported that introducing exogenous HGF into the injured rodent spinal cord using a herpes simplex virus-1 vector significantly reduces the area of damaged tissue and promotes functional recovery. However, that study did not examine the therapeutic effects of administering HGF after injury, which is the most critical issue for clinical application. To translate this strategy to human treatment, we induced a contusive cervical SCI in the common marmoset, a primate, and then administered recombinant human HGF (rhHGF) intrathecally. Motor function was assessed using an original open field scoring system focusing on manual function, including reach-and-grasp performance and hand placement in walking. The intrathecal rhHGF preserved the corticospinal fibers and myelinated areas, thereby promoting functional recovery. In vivo magnetic resonance imaging showed significant preservation of the intact spinal cord parenchyma. rhHGF-treatment did not give rise to an abnormal outgrowth of calcitonin gene related peptide positive fibers compared to the control group, indicating that this treatment did not induce or exacerbate allodynia. This is the first study to report the efficacy of rhHGF for treating SCI in non-human primates. In addition, this is the first presentation of a novel scale for assessing neurological motor performance in non-human primates after contusive cervical SCI.	[Kitamura, Kazuya; Fujiyoshi, Kanehiro; Yamane, Jun-ichi; Toyama, Yoshiaki; Nakamura, Masaya] Keio Univ, Sch Med, Dept Orthoped Surg, Shinjuku Ku, Tokyo, Japan; [Kitamura, Kazuya; Hikishima, Keigo; Okano, Hideyuki] Keio Univ, Sch Med, Dept Physiol, Shinjuku Ku, Tokyo 160, Japan; [Kitamura, Kazuya] Hiratsuka City Hosp, Dept Orthoped Surg, Hiratsuka, Kanagawa, Japan; [Toyota, Fumika; Hikishima, Keigo; Nomura, Tatsuji] Cent Inst Expt Anim, Miyamae Ku, Kawasaki, Kanagawa, Japan; [Funakoshi, Hiroshi] Asahikawa Med Univ, Ctr Adv Res & Educ, Asahikawa, Hokkaido, Japan; [Nakamura, Toshikazu] Osaka Univ, Kringle Pharma Joint Res Div Regenerat Drug Disco, Ctr Adv Sci & Innovat, Osaka, Japan; [Aoki, Masashi] Tohoku Univ, Sch Med, Dept Neurol, Sendai, Miyagi 980, Japan	Keio University; Keio University; Asahikawa Medical College; Osaka University; Tohoku University	Kitamura, K (corresponding author), Keio Univ, Sch Med, Dept Orthoped Surg, Shinjuku Ku, Tokyo, Japan.	hidokano@a2.keio.jp; masa@a8.keio.jp	Okano, Hideyuki/I-7584-2019; Hikishima, Keigo/L-1202-2013; Toyama, Yoshiaki/K-5743-2013; Nakamura, Masaya/K-4111-2013; Hikishima, Keigo/AAP-9586-2020	Hikishima, Keigo/0000-0003-1133-1297; Hikishima, Keigo/0000-0003-1133-1297	JSPS; Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT); MEXT	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from Grants-in-Aid for Scientific Research from JSPS and the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT), the Project for Realization of Regenerative Medicine and Support for the Core Institutes for iPS Cell Research from MEXT, and by a grant-in-aid for the Global COE program from MEXT to Keio University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alstermark B, 1999, J NEUROPHYSIOL, V82, P3580, DOI 10.1152/jn.1999.82.6.3580; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Belci M, 2004, SPINAL CORD, V42, P417, DOI 10.1038/sj.sc.3101613; BERNARD CG, 1953, EXPERIENTIA, V9, P111, DOI 10.1007/BF02178344; Blesch A, 2001, J COMP NEUROL, V436, P399, DOI 10.1002/cne.1076; BORTOFF GA, 1993, J NEUROSCI, V13, P5105, DOI 10.1523/JNEUROSCI.13-12-05105.1993; BOTTARO DP, 1991, SCIENCE, V251, P802, DOI 10.1126/science.1846706; Casella GTB, 2002, EXP NEUROL, V173, P63, DOI 10.1006/exnr.2001.7827; Caton A, 2000, DEVELOPMENT, V127, P1751; Courtine G, 2007, NAT MED, V13, P561, DOI 10.1038/nm1595; Dancause N, 2005, J NEUROSCI, V25, P10167, DOI 10.1523/JNEUROSCI.3256-05.2005; Date I, 2004, J NEUROSCI RES, V78, P442, DOI 10.1002/jnr.20263; Davidson AG, 2007, J NEUROSCI, V27, P8053, DOI 10.1523/JNEUROSCI.0040-07.2007; Davidson AG, 2006, EXP BRAIN RES, V173, P25, DOI 10.1007/s00221-006-0374-1; Freund P, 2006, NAT MED, V12, P790, DOI 10.1038/nm1436; Fujiyoshi K, 2007, J NEUROSCI, V27, P11991, DOI 10.1523/JNEUROSCI.3354-07.2007; Funakoshi H, 2011, CURR SIGNAL TRANSD T, V6, P156, DOI 10.2174/157436211795659982; GELFAN S., 1964, PROGR BRAIN RES, V11, P238; Glaser J, 2004, J NEUROSCI RES, V77, P701, DOI 10.1002/jnr.20204; Grill R, 1997, J NEUROSCI, V17, P5560; Guizar-Sahagun G, 2005, NEUROSCIENCE, V130, P639, DOI 10.1016/j.neuroscience.2004.09.056; Hamanoue M, 1996, J NEUROSCI RES, V43, P554, DOI 10.1002/(SICI)1097-4547(19960301)43:5<554::AID-JNR5>3.0.CO;2-H; HEFFNER R, 1975, BRAIN BEHAV EVOLUT, V12, P161, DOI 10.1159/000124401; HEFFNER RS, 1983, BRAIN BEHAV EVOLUT, V23, P165, DOI 10.1159/000121494; Hofstetter CP, 2005, NAT NEUROSCI, V8, P346, DOI 10.1038/nn1405; HONDA S, 1995, MOL BRAIN RES, V32, P197, DOI 10.1016/0169-328X(95)00075-4; ILLERT M, 1978, EXP BRAIN RES, V33, P101; Isa T, 2006, J NEUROPHYSIOL, V95, P3674, DOI 10.1152/jn.00103.2005; Isa T, 2007, PHYSIOLOGY, V22, P145, DOI 10.1152/physiol.00045.2006; Ishigaki A, 2007, J NEUROPATH EXP NEUR, V66, P1037, DOI 10.1097/nen.0b013e318159886b; Iwanami A, 2005, J NEUROSCI RES, V80, P172, DOI 10.1002/jnr.20435; Iwanami A, 2005, J NEUROSCI RES, V80, P182, DOI 10.1002/jnr.20436; Jackson AB, 2004, ARCH PHYS MED REHAB, V85, P1740, DOI 10.1016/j.apmr.2004.04.035; Jakeman LB, 1998, EXP NEUROL, V154, P170, DOI 10.1006/exnr.1998.6924; Kitamura K, 2007, J NEUROSCI RES, V85, P2332, DOI 10.1002/jnr.21372; Lemon RN, 2004, PROG BRAIN RES, V143, P263, DOI 10.1016/S0079-6123(03)43026-4; Lemon RN, 2008, ANNU REV NEUROSCI, V31, P195, DOI 10.1146/annurev.neuro.31.060407.125547; Liu L J, 1999, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V13, P295; Loy DN, 2002, J COMP NEUROL, V445, P308, DOI 10.1002/cne.10168; Maina F, 1999, NAT NEUROSCI, V2, P213, DOI 10.1038/6310; MANSFIELD K, 2004, WHITE PAPER COMPLETE; Mautes AEM, 2000, PHYS THER, V80, P673, DOI 10.1093/ptj/80.7.673; McTigue DM, 1998, J NEUROSCI, V18, P5354, DOI 10.1523/JNEUROSCI.18-14-05354.1998; Miyazawa T, 1998, J CEREBR BLOOD F MET, V18, P345, DOI 10.1097/00004647-199804000-00001; NAKAMURA T, 1989, NATURE, V342, P440, DOI 10.1038/342440a0; NAKAMURA T, 1984, BIOCHEM BIOPH RES CO, V122, P1450, DOI 10.1016/0006-291X(84)91253-1; Nishimura Y, 2007, SCIENCE, V318, P1150, DOI 10.1126/science.1147243; Nishimura Y, 2009, BRAIN, V132, P709, DOI 10.1093/brain/awn338; Nowak DD, 2009, J AM ACAD ORTHOP SUR, V17, P756, DOI 10.5435/00124635-200912000-00004; PALMER E, 1992, J PHYSIOL-LONDON, V449, P429, DOI 10.1113/jphysiol.1992.sp019094; Pettersson LG, 1997, NEUROSCI RES, V29, P241, DOI 10.1016/S0168-0102(97)00093-X; Pettersson LG, 2002, EUR J NEUROSCI, V16, P1349, DOI 10.1046/j.1460-9568.2002.02203.x; Phillips C G, 1977, Monogr Physiol Soc, pv; RALSTON DD, 1985, J COMP NEUROL, V242, P325, DOI 10.1002/cne.902420303; Rouiller EM, 1996, EUR J NEUROSCI, V8, P1055, DOI 10.1111/j.1460-9568.1996.tb01592.x; Sasaki S, 2004, J NEUROPHYSIOL, V92, P3142, DOI 10.1152/jn.00342.2004; Schmidlin E, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-56; Schmidlin E, 2004, BRAIN RES, V1017, P172, DOI 10.1016/j.brainres.2004.05.036; SHAPOVALOV AI, 1975, REV PHYSIOL BIOCH P, V72, P1, DOI 10.1007/BFb0031545; Shimamura M, 2006, HYPERTENSION, V47, P742, DOI 10.1161/01.HYP.0000208598.57687.3e; TERASHIMA T, 1994, J COMP NEUROL, V340, P469, DOI 10.1002/cne.903400403; Tuszynski MH, 1996, EXP NEUROL, V137, P157, DOI 10.1006/exnr.1996.0016; TUSZYNSKI MH, 1994, EXP NEUROL, V126, P1, DOI 10.1006/exnr.1994.1037; Wannier T, 2005, J NEUROTRAUM, V22, P703, DOI 10.1089/neu.2005.22.703	64	62	71	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2011	6	11							e27706	10.1371/journal.pone.0027706	http://dx.doi.org/10.1371/journal.pone.0027706			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863LT	22140459	Green Submitted, Green Published, gold			2022-12-27	WOS:000298166300010
J	Matthews, B; Hausch, S; Winter, C; Suttle, CA; Shurin, JB				Matthews, Blake; Hausch, Stephen; Winter, Christian; Suttle, Curtis A.; Shurin, Jonathan B.			Contrasting Ecosystem-Effects of Morphologically Similar Copepods	PLOS ONE			English	Article							ADAPTIVE DIVERGENCE; DIAPTOMID COPEPODS; SPECIES COMPLEX; DIVERSIFICATION; EVOLUTION; BIODIVERSITY; POPULATIONS; RATES; CONSEQUENCES; INDIVIDUALS	Organisms alter the biotic and abiotic conditions of ecosystems. They can modulate the availability of resources to other species (ecosystem engineering) and shape selection pressures on other organisms (niche construction). Very little is known about how the engineering effects of organisms vary among and within species, and, as a result, the ecosystem consequences of species diversification and phenotypic evolution are poorly understood. Here, using a common gardening experiment, we test whether morphologically similar species and populations of Diaptomidae copepods (Leptodiaptomus ashlandi, Hesperodiaptomus franciscanus, Skistodiaptomus oregonensis) have similar or different effects on the structure and function of freshwater ecosystems. We found that copepod species had contrasting effects on algal biomass, ammonium concentrations, and sedimentation rates, and that copepod populations had contrasting effects on prokaryote abundance, sedimentation rates, and gross primary productivity. The average size of ecosystem-effect contrasts between species was similar to those between populations, and was comparable to those between fish species and populations measured in previous common gardening experiments. Our results suggest that subtle morphological variation among and within species can cause multifarious and divergent ecosystem-effects. We conclude that using morphological trait variation to assess the functional similarity of organisms may underestimate the importance of species and population diversity for ecosystem functioning.	[Matthews, Blake] Eawag Swiss Fed Inst Aquat Sci & Technol, Dept Aquat Ecol, Ctr Ecol Evolut & Biogeochem, Kastanienbaum, Luzern, Switzerland; [Hausch, Stephen] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; [Winter, Christian] Univ Vienna, Dept Marine Biol, Vienna, Austria; [Suttle, Curtis A.] Univ British Columbia, Dept Earth & Ocean Sci, Vancouver, BC V5Z 1M9, Canada; [Suttle, Curtis A.] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V5Z 1M9, Canada; [Suttle, Curtis A.] Univ British Columbia, Dept Bot, Vancouver, BC V5Z 1M9, Canada; [Shurin, Jonathan B.] Univ Calif San Diego, Sect Ecol Behav & Evolut, La Jolla, CA 92093 USA	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); University of Calgary; University of Vienna; University of British Columbia; University of British Columbia; University of British Columbia; University of California System; University of California San Diego	Matthews, B (corresponding author), Eawag Swiss Fed Inst Aquat Sci & Technol, Dept Aquat Ecol, Ctr Ecol Evolut & Biogeochem, Kastanienbaum, Luzern, Switzerland.	blake.matthews@eawag.ch	Suttle, Curtis A/C-3150-2008; Matthews, Blake/B-5608-2009; suttle, c/N-1144-2019	Suttle, Curtis A/0000-0002-0372-0033; Matthews, Blake/0000-0001-9089-704X; suttle, c/0000-0002-0372-0033; Winter, Christian/0000-0001-6327-0209	Natural Sciences and Engineering Research Council of Canada; Tula Foundation	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Tula Foundation	All authors were supported by the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca). CAS and CW were additionally supported by the Tula Foundation (http://www.tula.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerly D, 2009, P NATL ACAD SCI USA, V106, P19699, DOI 10.1073/pnas.0901635106; Adams DC, 2009, P ROY SOC B-BIOL SCI, V276, P2729, DOI 10.1098/rspb.2009.0543; ANDERSON RS, 1967, CAN J ZOOLOG, V45, P1043, DOI 10.1139/z67-113; [Anonymous], 2009, ARCH SEX BEHAV, DOI DOI 10.1007/s10508-008-9314-4; Arnqvist G, 1998, NATURE, V393, P784, DOI 10.1038/31689; Bailey JK, 2009, NEW PHYTOL, V184, P746, DOI 10.1111/j.1469-8137.2009.03081.x; Bassar RD, 2010, P NATL ACAD SCI USA, V107, P3616, DOI 10.1073/pnas.0908023107; BELL G, 1993, OECOLOGIA, V96, P114, DOI 10.1007/BF00318038; Brussaard CPD, 2004, APPL ENVIRON MICROB, V70, P1506, DOI 10.1128/AEM.70.3.1506-1513.2004; Callaway RM, 2002, NATURE, V417, P844, DOI 10.1038/nature00812; CARTER JCH, 1980, CAN J ZOOL, V58, P1355, DOI 10.1139/z80-188; Chase JM, 2009, ECOL LETT, V12, P1210, DOI 10.1111/j.1461-0248.2009.01362.x; Clark JS, 2010, SCIENCE, V327, P1129, DOI 10.1126/science.1183506; Daleo P, 2007, ECOL LETT, V10, P902, DOI 10.1111/j.1461-0248.2007.01082.x; Diaz S, 2001, TRENDS ECOL EVOL, V16, P646, DOI 10.1016/S0169-5347(01)02283-2; Gamfeldt L, 2008, ECOLOGY, V89, P1223, DOI 10.1890/06-2091.1; GANZ HH, 1995, MAR BIOL, V123, P821, DOI 10.1007/BF00349126; Harmon LJ, 2009, NATURE, V458, P1167, DOI 10.1038/nature07974; Hector A, 2007, NATURE, V448, P188, DOI 10.1038/nature05947; Hillebrand H, 2009, ECOL LETT, V12, P1405, DOI 10.1111/j.1461-0248.2009.01388.x; JACOBY CA, 1983, MAR BIOL, V76, P77, DOI 10.1007/BF00393058; Johnson MTJ, 2009, PHILOS T R SOC B, V364, P1593, DOI 10.1098/rstb.2008.0334; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; Kilham SS, 1998, HYDROBIOLOGIA, V377, P147, DOI 10.1023/A:1003231628456; Kozak KH, 2006, P ROY SOC B-BIOL SCI, V273, P539, DOI 10.1098/rspb.2005.3326; Laland KN, 1999, P NATL ACAD SCI USA, V96, P10242, DOI 10.1073/pnas.96.18.10242; LAVIN PA, 1986, CAN J FISH AQUAT SCI, V43, P2455, DOI 10.1139/f86-305; Lee CE, 2000, EVOLUTION, V54, P2014, DOI 10.1111/j.0014-3820.2000.tb01245.x; Lee CE, 2002, HYDROBIOLOGIA, V480, P111, DOI 10.1023/A:1021293203512; Leibold MA, 2010, ECOL LETT, V13, P1290, DOI 10.1111/j.1461-0248.2010.01523.x; Losos JB, 2010, AM NAT, V175, P623, DOI 10.1086/652433; Lund OT, 1979, HDB COMMON METHODS L; Marsh C.D., 1907, T WIS ACAD SCI ARTS, V15, P381; Marszalek MA, 2009, HYDROBIOLOGIA, V624, P61, DOI 10.1007/s10750-008-9666-8; Matthews B, 2005, LIMNOL OCEANOGR, V50, P1404, DOI 10.4319/lo.2005.50.5.1404; Matthews B, 2011, ECOL LETT, V14, P690, DOI 10.1111/j.1461-0248.2011.01627.x; McIntyre PB, 2008, ECOLOGY, V89, P2335, DOI 10.1890/07-1552.1; McPeek MA, 2000, ECOLOGY, V81, P904; McPeek MA, 2008, AM NAT, V171, pE158, DOI 10.1086/587076; OdlingSmee FJ, 1996, AM NAT, V147, P641, DOI 10.1086/285870; ODUM E P, 1971, P574; Olff H, 2009, PHILOS T R SOC B, V364, P1755, DOI 10.1098/rstb.2008.0222; Palkovacs EP, 2009, PHILOS T R SOC B, V364, P1617, DOI 10.1098/rstb.2009.0016; Palkovacs EP, 2009, ECOLOGY, V90, P300, DOI 10.1890/08-1673.1; Reiss J, 2009, TRENDS ECOL EVOL, V24, P505, DOI 10.1016/j.tree.2009.03.018; Robinson BW, 2000, BEHAVIOUR, V137, P865, DOI 10.1163/156853900502501; Sandercock GA, 1994, INTRO KEY FRESHWATER; Sanders RW, 1996, LIMNOL OCEANOGR, V41, P1295, DOI 10.4319/lo.1996.41.6.1295; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Schluter D, 2009, SCIENCE, V323, P737, DOI 10.1126/science.1160006; Schmitz OJ, 2010, ECOL LETT, V13, P1199, DOI 10.1111/j.1461-0248.2010.01511.x; Schmitz OJ, 2008, ANNU REV ECOL EVOL S, V39, P133, DOI 10.1146/annurev.ecolsys.39.110707.173418; Tabachnick B. G., 2001, USING MULTIVARIATE S; Taylor BW, 2007, J N AM BENTHOL SOC, V26, P167, DOI 10.1899/0887-3593(2007)26[167:ITFAMM]2.0.CO;2; Terborgh J., 2010, TROPHIC CASCADES PRE; Thum RA, 2008, HYDROBIOLOGIA, V614, P197, DOI 10.1007/s10750-008-9506-x; Thum RA, 2009, BIOL J LINN SOC, V96, P150, DOI 10.1111/j.1095-8312.2008.01105.x; Torke B, 2001, HYDROBIOLOGIA, V453, P351, DOI 10.1023/A:1013185916287; Turner JT, 2004, ZOOL STUD, V43, P255; Violle C, 2007, OIKOS, V116, P882, DOI 10.1111/j.2007.0030-1299.15559.x; Webb CT, 2010, ECOL LETT, V13, P267, DOI 10.1111/j.1461-0248.2010.01444.x; Whitham TG, 2003, ECOLOGY, V84, P559, DOI 10.1890/0012-9658(2003)084[0559:CAEGAC]2.0.CO;2; Wilson M. S., 1953, Smithsonian Miscellaneous Collections, V122, P1; Wright JP, 2006, BIOSCIENCE, V56, P203, DOI 10.1641/0006-3568(2006)056[0203:TCOOAE]2.0.CO;2	64	16	18	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2011	6	11							e26700	10.1371/journal.pone.0026700	http://dx.doi.org/10.1371/journal.pone.0026700			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863LT	22140432	Green Published, Green Submitted, gold			2022-12-27	WOS:000298166300002
J	Hu, YF; Shen, Y; Silva, NCE; Zhou, DX				Hu, Yongfeng; Shen, Yuan; Conde e Silva, Natalia; Zhou, Dao-Xiu			The Role of Histone Methylation and H2A.Z Occupancy during Rapid Activation of Ethylene Responsive Genes	PLOS ONE			English	Article							ARABIDOPSIS; TRIMETHYLATION; EXPRESSION; H3; REPRESSION; INDUCTION; LYSINE-4; RICE; LHP1	Ethylene signaling pathway leads to rapid gene activation by two hierarchies of transcription factors with EIN3/EIL proteins as primary ones and ERF proteins as secondary ones. The role of chromatin modifications during the rapid gene activation is not known. In this work we studied trimethylated histone H3 lysine 4 (H3K4me3) and lysine 27 (H3K27me3), two opposite histone methylation marks for gene activity, during the induction course of three ethylene-responsive genes (ERF1, AtERF14 and ChiB). We found that the three genes displayed different histone modification profiles before induction. After induction, H3K4me3 was increased in the 59 region and the gene body of ERF1, while H3K27me3 was decreased in the promoter of AtERF14. But the modification changes were later than the gene activation. Analysis of other rapidly inducible ERF genes confirmed the observation. In addition, histone H2A.Z occupancy on the three genes and the association of the H3K27me3-binding protein LHP1 with AtERF14 and ChiB were not affected by the inductive signal. However, the mutation of genes encoding H2A.Z and LHP1 attenuated and enhanced respectively the induction of target genes and altered H3K4me3. These results indicate that the induction of ethylene-responsive genes does not require immediate modulation of H3K4me3 and H3K27me3 and dissociation of LHP1 and H2A.Z from the targets, and suggest that the chromatin structure of the genes before induction is committed for transcriptional activation and that H3K4me3 is not required for ethylene-responsive gene activation, but may serve as a mark for gene activity.	[Hu, Yongfeng; Shen, Yuan; Conde e Silva, Natalia; Zhou, Dao-Xiu] Univ Paris 11, Inst Biol Plantes, Orsay, France	UDICE-French Research Universities; Universite Paris Saclay	Hu, YF (corresponding author), Univ Paris 11, Inst Biol Plantes, Orsay, France.	dao-xiu.zhou@u-psud.fr		Zhou, Dao-Xiu/0000-0002-1540-0598; Conde e Silva, Natalia/0000-0003-2435-9184	French Agence Nationale de la Recherche	French Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by a grant from the French Agence Nationale de la Recherche. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian J, 2010, PLANT CELL, V22, P1425, DOI 10.1105/tpc.110.074682; Buzas DM, 2010, PLANT J; Deal RB, 2007, PLANT CELL, V19, P74, DOI 10.1105/tpc.106.048447; Finnegan EJ, 2011, PLANT J, V65, P382, DOI 10.1111/j.1365-313X.2010.04428.x; Flanagan JF, 2005, NATURE, V438, P1181, DOI 10.1038/nature04290; Gaudin V, 2001, DEVELOPMENT, V128, P4847; Guo HW, 2004, CURR OPIN PLANT BIOL, V7, P40, DOI 10.1016/j.pbi.2003.11.011; Huang LM, 2007, PLANT PHYSIOL, V144, P1508, DOI 10.1104/pp.107.099473; Kelly TK, 2010, MOL CELL, V39, P901, DOI 10.1016/j.molcel.2010.08.026; Kim DH, 2010, PLANT PHYSIOL, V154, P949, DOI 10.1104/pp.110.161083; Kumar SV, 2010, CELL, V140, P136, DOI 10.1016/j.cell.2009.11.006; Kwon CS, 2009, PLANT J, V60, P112, DOI 10.1111/j.1365-313X.2009.03938.x; Latrasse D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016592; Li XY, 2008, PLANT CELL, V20, P259, DOI 10.1105/tpc.107.056879; Makarevich G, 2006, EMBO REP, V7, P947, DOI 10.1038/sj.embor.7400760; March-Diaz R, 2008, PLANT J, V53, P475, DOI 10.1111/j.1365-313X.2007.03361.x; Muramoto T, 2010, CURR BIOL, V20, P397, DOI 10.1016/j.cub.2010.01.017; Mylne JS, 2006, P NATL ACAD SCI USA, V103, P5012, DOI 10.1073/pnas.0507427103; Onate-Sanchez L, 2007, PLANT PHYSIOL, V143, P400, DOI 10.1104/pp.106.086637; Papamichos-Chronakis M, 2011, CELL, V144, P200, DOI 10.1016/j.cell.2010.12.021; Schubert D, 2006, EMBO J, V25, P4638, DOI 10.1038/sj.emboj.7601311; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Smith AP, 2010, PLANT PHYSIOL, V152, P217, DOI 10.1104/pp.109.145532; Vermeulen M, 2007, CELL, V131, P58, DOI 10.1016/j.cell.2007.08.016; Zhang XY, 2007, PLOS BIOL, V5, P1026, DOI 10.1371/journal.pbio.0050129; Zhang X, 2007, NAT STRUCT MOL BIOL, V14, P869, DOI 10.1038/nsmb1283; Zhang XY, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r62	27	18	20	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2011	6	11							e28224	10.1371/journal.pone.0028224	http://dx.doi.org/10.1371/journal.pone.0028224			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KW	22140554	Green Published, gold, Green Submitted			2022-12-27	WOS:000298163400039
J	Genick, UK; Kutalik, Z; Ledda, M; Destito, MCS; Souza, MM; Cirillo, CA; Godinot, N; Martin, N; Morya, E; Sameshima, K; Bergmann, S; le Coutre, J				Genick, Ulrich K.; Kutalik, Zoltan; Ledda, Mirko; Destito, Maria C. Souza; Souza, Milena M.; Cirillo, Cintia A.; Godinot, Nicolas; Martin, Nathalie; Morya, Edgard; Sameshima, Koichi; Bergmann, Sven; le Coutre, Johannes			Sensitivity of Genome-Wide-Association Signals to Phenotyping Strategy: The PROP-TAS2R38 Taste Association as a Benchmark	PLOS ONE			English	Article							PERCEPTION; BITTERNESS; PHENYLTHIOCARBAMIDE; INDIVIDUALS; RESPONSES; MARKERS; ADULTS; LOCUS; TRAIT	Natural genetic variation can have a pronounced influence on human taste perception, which in turn may influence food preference and dietary choice. Genome-wide association studies represent a powerful tool to understand this influence. To help optimize the design of future genome-wide-association studies on human taste perception we have used the well-known TAS2R38-PROP association as a tool to determine the relative power and efficiency of different phenotyping and data-analysis strategies. The results show that the choice of both data collection and data processing schemes can have a very substantial impact on the power to detect genotypic variation that affects chemosensory perception. Based on these results we provide practical guidelines for the design of future GWAS studies on chemosensory phenotypes. Moreover, in addition to the TAS2R38 gene past studies have implicated a number of other genetic loci to affect taste sensitivity to PROP and the related bitter compound PTC. None of these other locations showed genome-wide significant associations in our study. To facilitate further, target-gene driven, studies on PROP taste perception we provide the genome-wide list of p-values for all SNPs genotyped in the current study.	[Genick, Ulrich K.; Ledda, Mirko; Godinot, Nicolas; Martin, Nathalie; le Coutre, Johannes] Nestle Res Ctr, Dept Food Consumer Interact, CH-1000 Lausanne, Switzerland; [Kutalik, Zoltan; Bergmann, Sven] Univ Lausanne, Dept Med Genet, Lausanne, Switzerland; [Kutalik, Zoltan; Bergmann, Sven] Swiss Inst Bioinformat, Lausanne, Switzerland; [Destito, Maria C. Souza; Souza, Milena M.; Cirillo, Cintia A.; Morya, Edgard] Alberto Santos Dumont Res Support Assoc, Senson Lab, Sao Paulo, Brazil; [Destito, Maria C. Souza; Souza, Milena M.; Cirillo, Cintia A.; Morya, Edgard] IEP Sirio Libanes Hosp, Sao Paulo, Brazil; [Sameshima, Koichi] Univ Sao Paulo, Fac Med, Dept Radiol, Sao Paulo, Brazil; [le Coutre, Johannes] Univ Tokyo, Org Interdisciplinary Res Projects, Bunkyo Ku, Tokyo, Japan	Nestle SA; University of Lausanne; Swiss Institute of Bioinformatics; Universidade de Sao Paulo; University of Tokyo	Genick, UK (corresponding author), Nestle Res Ctr, Dept Food Consumer Interact, CH-1000 Lausanne, Switzerland.	ulrich.genick@rdls.nestle.com	Sameshima, Koichi/AHA-5593-2022; Ledda, Mirko A/L-9996-2014; Souza, Milena/L-5224-2016; Morya, Edgard/K-4153-2012; Kutalik, Zoltan/HHZ-5697-2022; MORYA, EDGARD/R-1251-2019; Souza, Milena Monteiro/AAF-3959-2019; Sameshima, Koichi/C-2857-2012	Sameshima, Koichi/0000-0002-0290-2927; Souza, Milena/0000-0003-0755-0710; Morya, Edgard/0000-0003-0954-5317; Kutalik, Zoltan/0000-0001-8285-7523; MORYA, EDGARD/0000-0003-0954-5317; Souza, Milena Monteiro/0000-0003-0755-0710; Sameshima, Koichi/0000-0002-0290-2927; Bergmann, Sven/0000-0002-6785-9034; Ledda, Mirko/0000-0001-5089-7862; Genick, Ulrich/0000-0002-6526-3552; martin, nathalie/0000-0002-2086-3773; Godinot, Nicolas/0000-0003-3285-9234	Nestec Ltd.	Nestec Ltd.(Nestle SA)	This work was funded by Nestec Ltd. The funders had input in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	BARTOSHUK LM, 1978, AM J CLIN NUTR, V31, P1068, DOI 10.1093/ajcn/31.6.1068; Bartoshuk LM, 2000, CHEM SENSES, V25, P447, DOI 10.1093/chemse/25.4.447; Bartoshuk LM, 2004, PHYSIOL BEHAV, V82, P109, DOI 10.1016/j.physbeh.2004.02.033; Bufe B, 2005, CURR BIOL, V15, P322, DOI 10.1016/j.cub.2005.01.047; CHAUTARD.EA, 1974, ANN HUM GENET, V38, P191, DOI 10.1111/j.1469-1809.1974.tb01950.x; CONNEALLY PM, 1976, HUM HERED, V26, P267, DOI 10.1159/000152813; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Dinehart ME, 2006, PHYSIOL BEHAV, V87, P304, DOI 10.1016/j.physbeh.2005.10.018; Drayna D, 2003, HUM GENET, V112, P567, DOI 10.1007/s00439-003-0911-y; Drewnowski A, 1997, AM J CLIN NUTR, V66, P391, DOI 10.1093/ajcn/66.2.391; Drewnowski A, 2001, DRUG METAB DISPOS, V29, P535; Drewnowski A, 2001, CHEM SENSES, V26, P483, DOI 10.1093/chemse/26.5.483; Duffy VB, 2010, CHEMOSENS PERCEPT, V3, P137, DOI 10.1007/s12078-010-9079-8; Eriksson N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000993; Fox AL, 1932, P NATL ACAD SCI USA, V18, P115, DOI 10.1073/pnas.18.1.115; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Galindo-Cuspinera V, 2009, CHEMOSENS PERCEPT, V2, P214, DOI 10.1007/s12078-009-9059-z; Green BG, 1996, CHEM SENSES, V21, P323, DOI 10.1093/chemse/21.3.323; Hayes JE, 2008, CHEM SENSES, V33, P255, DOI 10.1093/chemse/bjm084; Hayes JE, 2011, CHEM SENSES, V36, P311, DOI 10.1093/chemse/bjq132; Khataan NH, 2009, J NUTRIGENET NUTRIGE, V2, P251, DOI 10.1159/000297217; Kim UK, 2003, SCIENCE, V299, P1221, DOI 10.1126/science.1080190; Kutalik Z, 2011, GENET EPIDEMIOL, V35, P341, DOI 10.1002/gepi.20582; Lao O, 2008, CURR BIOL, V18, P1241, DOI 10.1016/j.cub.2008.07.049; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Mennella JA, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-60; Meyerhof W, 2010, CHEM SENSES, V35, P157, DOI 10.1093/chemse/bjp092; Mojet J, 2001, CHEM SENSES, V26, P845, DOI 10.1093/chemse/26.7.845; Navarro-Allende Alejandra, 2008, Journal of Nutrition for the Elderly, V27, P267, DOI 10.1080/01639360802261920; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Reed DR, 2010, HUM MOL GENET, V19, P4278, DOI 10.1093/hmg/ddq324; Reed DR, 1999, AM J HUM GENET, V64, P1478, DOI 10.1086/302367; Tepper BJ, 2001, PHYSIOL BEHAV, V73, P571, DOI 10.1016/S0031-9384(01)00500-5; Timpson NJ, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-51; Vaeth M, 2004, STAT MED, V23, P1781, DOI 10.1002/sim.1753; Yackinous C, 2001, PHYSIOL BEHAV, V72, P427, DOI 10.1016/S0031-9384(00)00430-3	37	32	32	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e27745	10.1371/journal.pone.0027745	http://dx.doi.org/10.1371/journal.pone.0027745			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132133	gold, Green Published, Green Submitted			2022-12-27	WOS:000298162000038
J	Sperka, T; Geissler, KJ; Merkel, U; Scholl, I; Rubio, I; Herrlich, P; Morrison, HL				Sperka, Tobias; Geissler, Katja J.; Merkel, Ulrike; Scholl, Ingmar; Rubio, Ignacio; Herrlich, Peter; Morrison, Helen L.			Activation of Ras Requires the ERM-Dependent Link of Actin to the Plasma Membrane	PLOS ONE			English	Article							RECEPTOR TYROSINE KINASES; NUCLEOTIDE EXCHANGE; HISTONE DOMAIN; SRF ACTIVITY; IN-VITRO; CD44; SEVENLESS; GROWTH; SON; PROTEINS	Background: Receptor tyrosine kinases (RTKs) participate in a multitude of signaling pathways, some of them via the small G-protein Ras. An important component in the activation of Ras is Son of sevenless (SOS), which catalyzes the nucleotide exchange on Ras. Principal Findings: We can now demonstrate that the activation of Ras requires, in addition, the essential participation of ezrin, radixin and/or moesin (ERM), a family of actin-binding proteins, and of actin. Disrupting either the interaction of the ERM proteins with co-receptors, down-regulation of ERM proteins by siRNA, expression of dominant-negative mutants of the ERM proteins or disruption of F-actin, abolishes growth factor-induced Ras activation. Ezrin/actin catalyzes the formation of a multiprotein complex consisting of RTK, co-receptor, Grb2, SOS and Ras. We also identify binding sites for both Ras and SOS on ezrin; mutations of these binding sites destroy the interactions and inhibit Ras activation. Finally, we show that the formation of the ezrin-dependent complex is necessary to enhance the catalytic activity of SOS and thereby Ras activation. Conclusions: Taking these findings together, we propose that the ERM proteins are novel scaffolds at the level of SOS activity control, which is relevant for both normal Ras function and dysfunction known to occur in several human cancers.	[Sperka, Tobias; Geissler, Katja J.; Merkel, Ulrike; Scholl, Ingmar; Morrison, Helen L.] Fritz Lipmann Inst FLI, Morrison Lab, Leibniz Inst Age Res, Jena, Germany; [Sperka, Tobias; Herrlich, Peter] Fritz Lipmann Inst FLI, Herrlich Lab, Leibniz Inst Age Res, Jena, Germany; [Rubio, Ignacio] Univ Jena, Inst Mol Cell Biol, Ctr Mol Biomed, Jena, Germany	Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Friedrich Schiller University of Jena	Sperka, T (corresponding author), Fritz Lipmann Inst FLI, Morrison Lab, Leibniz Inst Age Res, Jena, Germany.	helen@fli-leibniz.de	Morrison, Helen/F-9748-2014; Sperka, Tobias/E-2659-2017; Morrison, Helen/B-3984-2017	Morrison, Helen/0000-0003-4938-1409; Morrison, Helen/0000-0003-4938-1409	Krebshilfe [107089]; Deutsche Forschungsgemeinschaft [He551/10.3]; DFG [SFB604]	Krebshilfe(Deutsche Krebshilfe); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); DFG(German Research Foundation (DFG))	The authors had three grants that funded this work: 1) Krebshilfe 107089 www.krebshilfe.de, 2) Deutsche Forschungsgemeinschaft (He551/10.3), 3) SFB604 Multi functional signalling proteins (from DFG) www.dfg.de/index.jsp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiatari I, 2010, J CELL MOL MED, V14, P1166, DOI 10.1111/j.1582-4934.2009.00772.x; Block C, 1996, NAT STRUCT BIOL, V3, P244, DOI 10.1038/nsb0396-244; Bundschu K, 2007, BIOESSAYS, V29, P897, DOI 10.1002/bies.20632; Cichowski K, 2001, CELL, V104, P593, DOI 10.1016/S0092-8674(01)00245-8; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; GILLE H, 1995, EMBO J, V14, P951, DOI 10.1002/j.1460-2075.1995.tb07076.x; Giordano S, 1997, P NATL ACAD SCI USA, V94, P13868, DOI 10.1073/pnas.94.25.13868; Grimsley CM, 2006, J BIOL CHEM, V281, P5928, DOI 10.1074/jbc.M510647200; Gureasko J, 2008, NAT STRUCT MOL BIOL, V15, P452, DOI 10.1038/nsmb.1418; Gureasko J, 2010, P NATL ACAD SCI USA, V107, P3430, DOI 10.1073/pnas.0913915107; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hunter KW, 2004, TRENDS MOL MED, V10, P201, DOI 10.1016/j.molmed.2004.03.001; Kholodenko BN, 2010, NAT REV MOL CELL BIO, V11, P414, DOI 10.1038/nrm2901; Klominek J, 1998, CLIN EXP METASTAS, V16, P529, DOI 10.1023/A:1006542301794; Lee JH, 2004, J CELL BIOL, V167, P327, DOI 10.1083/jcb.200403091; Legg JW, 1998, CURR BIOL, V8, P705, DOI 10.1016/S0960-9822(98)70277-5; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; LI N, 1993, NATURE, V363, P85, DOI 10.1038/363085a0; Margarit SM, 2003, CELL, V112, P685, DOI 10.1016/S0092-8674(03)00149-1; MCKERNAN RM, 1990, J NEUROCHEM, V54, P924, DOI 10.1111/j.1471-4159.1990.tb02339.x; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Morrison H, 2001, GENE DEV, V15, P968, DOI 10.1101/gad.189601; Morrison H, 2007, CANCER RES, V67, P520, DOI 10.1158/0008-5472.CAN-06-1608; NASSAR M, 1995, NATURE, V375, P554, DOI 10.1038/375554a0; Orian-Rousseau V, 2002, GENE DEV, V16, P3074, DOI 10.1101/gad.242602; Orian-Rousseau W, 2007, MOL BIOL CELL, V18, P76, DOI 10.1091/mbc.E06-08-0674; Pearson MA, 2000, CELL, V101, P259, DOI 10.1016/S0092-8674(00)80836-3; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; PORFIRI E, 1994, J BIOL CHEM, V269, P22672; RAABE T, 2002, SCI STKE, pPE28; Rubio I, 2000, CURR BIOL, V10, P1225, DOI 10.1016/S0960-9822(00)00731-4; Saleh HS, 2009, J MOL BIOL, V385, P1015, DOI 10.1016/j.jmb.2008.11.051; SHEETZ MJ, 1988, J BIOL CHEM, V263, P19210; Sherman L, 1998, GENE DEV, V12, P1058, DOI 10.1101/gad.12.7.1058; Sondermann H, 2004, CELL, V119, P393, DOI 10.1016/j.cell.2004.10.005; Takahashi K, 1998, ONCOGENE, V16, P3279, DOI 10.1038/sj.onc.1201874; TOMOZAWA Y, 1978, P NATL ACAD SCI USA, V75, P6305, DOI 10.1073/pnas.75.12.6305; Treisman R, 1998, COLD SPRING HARB SYM, V63, P643, DOI 10.1101/sqb.1998.63.643; Trusolino L, 2001, CELL, V107, P643, DOI 10.1016/S0092-8674(01)00567-0; Valastyan S, 2009, GENE DEV, V23, P2592, DOI 10.1101/gad.1832709; Vetrivel KS, 2005, J BIOL CHEM, V280, P25892, DOI 10.1074/jbc.M503570200; Yadav KK, 2010, P NATL ACAD SCI USA, V107, P3436, DOI 10.1073/pnas.0914315107; Zhao C, 2007, NAT CELL BIOL, V9, P706, DOI 10.1038/ncb1594	43	32	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2011	6	11							e27511	10.1371/journal.pone.0027511	http://dx.doi.org/10.1371/journal.pone.0027511			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IO	22132106	Green Published, Green Submitted, gold			2022-12-27	WOS:000297789900012
J	De Vos, D; Bruggeman, FJ; Westerhoff, HV; Bakker, BM				De Vos, Dirk; Bruggeman, Frank J.; Westerhoff, Hans V.; Bakker, Barbara M.			How Molecular Competition Influences Fluxes in Gene Expression Networks	PLOS ONE			English	Article							METABOLIC CONTROL ANALYSIS; SIGMA-FACTOR COMPETITION; MOIETY-CONSERVED CYCLES; CORE RNA-POLYMERASE; ESCHERICHIA-COLI; MESSENGER-RNA; SACCHAROMYCES-CEREVISIAE; RIBOSOMAL-RNA; GROWTH-RATE; TRANSLATION	Often, in living cells different molecular species compete for binding to the same molecular target. Typical examples are the competition of genes for the transcription machinery or the competition of mRNAs for the translation machinery. Here we show that such systems have specific regulatory features and how they can be analysed. We derive a theory for molecular competition in parallel reaction networks. Analytical expressions for the response of network fluxes to changes in the total competitor and common target pools indicate the precise conditions for ultrasensitivity and intuitive rules for competitor strength. The calculations are based on measurable concentrations of the competitor-target complexes. We show that kinetic parameters, which are usually tedious to determine, are not required in the calculations. Given their simplicity, the obtained equations are easily applied to networks of any dimension. The new theory is illustrated for competing sigma factors in bacterial transcription and for a genome-wide network of yeast mRNAs competing for ribosomes. We conclude that molecular competition can drastically influence the network fluxes and lead to negative response coefficients and ultrasensitivity. Competitors that bind a large fraction of the target, like bacterial sigma(70), tend to influence competing pathways strongly. The less a competitor is saturated by the target, the more sensitive it is to changes in the concentration of the target, as well as to other competitors. As a consequence, most of the mRNAs in yeast turn out to respond ultrasensitively to changes in ribosome concentration. Finally, applying the theory to a genome-wide dataset we observe that high and low response mRNAs exhibit distinct Gene Ontology profiles.	[De Vos, Dirk; Bruggeman, Frank J.; Westerhoff, Hans V.; Bakker, Barbara M.] Vrije Univ Amsterdam, Netherlands Inst Syst Biol, Dept Mol Cell Biol, Amsterdam, Netherlands; [De Vos, Dirk; Westerhoff, Hans V.; Bakker, Barbara M.] Kluyver Ctr Genom Ind Fermentat, Delft, Netherlands; [Bruggeman, Frank J.] Ctr Math & Comp Sci, Regulatory Networks Grp, Netherlands Inst Syst Biol, Amsterdam, Netherlands; [Westerhoff, Hans V.] Univ Manchester, Manchester Ctr Integrat Syst Biol, Manchester Interdisciplinary Bioctr, Manchester, Lancs, England; [Bakker, Barbara M.] Univ Groningen, Dept Pediat, Ctr Liver Digest & Metab Dis, Univ Med Ctr Groningen, Groningen, Netherlands	Vrije Universiteit Amsterdam; University of Manchester; University of Groningen	De Vos, D (corresponding author), Univ Antwerp, B-2020 Antwerp, Belgium.	b.m.bakker@med.umcg.nl	Westerhoff, Hans V/I-5762-2012; Bruggeman, Frank/AAS-8371-2020; Bruggeman, Frank/C-4356-2015	Westerhoff, Hans V/0000-0002-0443-6114; Bruggeman, Frank/0000-0002-0255-4766; Bruggeman, Frank/0000-0002-0255-4766; Bakker, Barbara/0000-0001-6274-3633	Netherlands Genomics Initiative, through the Kluyver Centre for Genomics of Industrial Fermentation; IOP Genomics; EU; SysMO; Netherlands Centre for Systems Biology (NCSB); Rosalind Franklin Fellowship; BBSRC [BB/C008219/1, BBE0037291]; NISB; Biotechnology and Biological Sciences Research Council [BB/C008219/1] Funding Source: researchfish	Netherlands Genomics Initiative, through the Kluyver Centre for Genomics of Industrial Fermentation; IOP Genomics; EU(European Commission); SysMO; Netherlands Centre for Systems Biology (NCSB); Rosalind Franklin Fellowship; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NISB; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the Netherlands Genomics Initiative, through the Kluyver Centre for Genomics of Industrial Fermentation. The work of BMB and HVW is further funded by IOP Genomics, EU-FP7, SysMO, the Netherlands Centre for Systems Biology (NCSB), and a Rosalind Franklin Fellowship to BMB and grants from the BBSRC (in particular BB/C008219/1 and BBE0037291) to HVW. FJB is funded by NISB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Arava Y, 2003, P NATL ACAD SCI USA, V100, P3889, DOI 10.1073/pnas.0635171100; Bluthgen N, 2006, FEBS J, V273, P895, DOI 10.1111/j.1742-4658.2006.05105.x; Brockmann R, 2007, PLOS COMPUT BIOL, V3, P531, DOI 10.1371/journal.pcbi.0030057; Dantuma NP, 2006, J CELL BIOL, V173, P19, DOI 10.1083/jcb.200510071; Daran-Lapujade P, 2007, P NATL ACAD SCI USA, V104, P15753, DOI 10.1073/pnas.0707476104; Dennis PP, 2004, MICROBIOL MOL BIOL R, V68, P639, DOI 10.1128/MMBR.68.4.639-668.2004; Dobrzynski M, 2009, P NATL ACAD SCI USA, V106, P2583, DOI 10.1073/pnas.0803507106; Dong T, 2011, MOL MICROBIOL, V79, P375, DOI 10.1111/j.1365-2958.2010.07449.x; Dong T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-349; Dong T, 2009, MOL GENET GENOMICS, V281, P19, DOI 10.1007/s00438-008-0389-3; Farewell A, 1998, MOL MICROBIOL, V29, P1039, DOI 10.1046/j.1365-2958.1998.00990.x; Fell D., 1997, UNDERSTANDING CONTRO; GOLDBETER A, 1982, Q REV BIOPHYS, V15, P555, DOI 10.1017/S0033583500003449; GOLDBETER A, 1981, P NATL ACAD SCI-BIOL, V78, P6840, DOI 10.1073/pnas.78.11.6840; HEINRICH R, 1980, J THEOR BIOL, V86, P279, DOI 10.1016/0022-5193(80)90008-9; HEINRICH R, 1974, EUR J BIOCHEM, V42, P89, DOI 10.1111/j.1432-1033.1974.tb03318.x; HELMANN JD, 1991, MOL MICROBIOL, V5, P2875, DOI 10.1111/j.1365-2958.1991.tb01847.x; HOFMEYR JHS, 1986, EUR J BIOCHEM, V155, P631, DOI 10.1111/j.1432-1033.1986.tb09534.x; Ishihama A, 2000, ANNU REV MICROBIOL, V54, P499, DOI 10.1146/annurev.micro.54.1.499; JENSEN KF, 1990, MICROBIOL REV, V54, P89, DOI 10.1128/MMBR.54.2.89-100.1990; Jishage M, 2002, GENE DEV, V16, P1260, DOI 10.1101/gad.227902; Jishage M, 1996, J BACTERIOL, V178, P5447, DOI 10.1128/jb.178.18.5447-5451.1996; Kacser H, 1973, Symp Soc Exp Biol, V27, P65; KAWAKAMI K, 1979, MOL GEN GENET, V174, P107, DOI 10.1007/BF00268348; KAZAZIAN HH, 1968, J BIOL CHEM, V243, P6446; KHOLODENKO BN, 1994, EUR J BIOCHEM, V225, P179, DOI 10.1111/j.1432-1033.1994.00179.x; Kim SY, 2007, CELL, V128, P1133, DOI 10.1016/j.cell.2007.01.039; KJELDGAARD NO, 1963, J MOL BIOL, V6, P341, DOI 10.1016/S0022-2836(63)80093-5; Kolkman A, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100069; Krogfelt KA, 2000, INFECT IMMUN, V68, P2518, DOI 10.1128/IAI.68.5.2518-2524.2000; LAPORTE DC, 1984, J BIOL CHEM, V259, P4068; Liu XY, 1996, MOL MICROBIOL, V21, P613, DOI 10.1111/j.1365-2958.1996.tb02569.x; Lovmar M, 2006, BIOCHIMIE, V88, P951, DOI 10.1016/j.biochi.2006.04.019; Maaloe O., 1979, BIOL REGUL DEV, P487; MacKay VL, 2004, MOL CELL PROTEOMICS, V3, P478, DOI 10.1074/mcp.M300129-MCP200; Maeda H, 2000, NUCLEIC ACIDS RES, V28, P3497, DOI 10.1093/nar/28.18.3497; Makinoshima H, 2003, J BACTERIOL, V185, P1338, DOI 10.1128/JB.185.4.1338-1345.2003; MALIK S, 1987, NUCLEIC ACIDS RES, V15, P8521, DOI 10.1093/nar/15.20.8521; Mehra A, 2006, BIOPHYS J, V90, P1136, DOI 10.1529/biophysj.105.062521; MERRICK MJ, 1993, MOL MICROBIOL, V10, P903, DOI 10.1111/j.1365-2958.1993.tb00961.x; Mitchell P, 2001, CURR OPIN CELL BIOL, V13, P320, DOI 10.1016/S0955-0674(00)00214-3; Mooney RA, 2005, MOL CELL, V20, P335, DOI 10.1016/j.molcel.2005.10.015; Moore MJ, 2009, CELL, V136, P688, DOI 10.1016/j.cell.2009.02.001; Notley-McRobb L, 2002, J BACTERIOL, V184, P806, DOI 10.1128/JB.184.3.806-811.2002; Nystrom T, 2004, MOL MICROBIOL, V54, P855, DOI 10.1111/j.1365-2958.2004.04342.x; REDER C, 1988, J THEOR BIOL, V135, P175, DOI 10.1016/S0022-5193(88)80073-0; ROSE JK, 1977, P NATL ACAD SCI USA, V74, P3672, DOI 10.1073/pnas.74.9.3672; SAURO HM, 1994, BIOSYSTEMS, V33, P55, DOI 10.1016/0303-2647(94)90061-2; Schwabe A, 2011, METHOD ENZYMOL, V500, P597, DOI 10.1016/B978-0-12-385118-5.00028-1; Shingler V, 1996, MOL MICROBIOL, V19, P409, DOI 10.1046/j.1365-2958.1996.388920.x; Siwiak M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000865; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; ZAMBRANO MM, 1993, SCIENCE, V259, P1757, DOI 10.1126/science.7681219	55	37	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e28494	10.1371/journal.pone.0028494	http://dx.doi.org/10.1371/journal.pone.0028494			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22163025	gold, Green Published			2022-12-27	WOS:000298172800041
J	Fernandes, N; Case, RJ; Longford, SR; Seyedsayamdost, MR; Steinberg, PD; Kjelleberg, S; Thomas, T				Fernandes, Neil; Case, Rebecca J.; Longford, Sharon R.; Seyedsayamdost, Mohammad R.; Steinberg, Peter D.; Kjelleberg, Staffan; Thomas, Torsten			Genomes and Virulence Factors of Novel Bacterial Pathogens Causing Bleaching Disease in the Marine Red Alga Delisea pulchra	PLOS ONE			English	Article							BLACK BAND DISEASE; ESCHERICHIA-COLI; VIBRIO-CHOLERAE; H-NS; PHAEOBACTER-GALLAECIENSIS; SECONDARY METABOLITES; ENVIRONMENTAL SIGNALS; ERWINIA-CHRYSANTHEMI; ALPHA-PROTEOBACTERIA; ROSEOBACTER LINEAGE	Nautella sp. R11, a member of the marine Roseobacter clade, causes a bleaching disease in the temperate-marine red macroalga, Delisea pulchra. To begin to elucidate the molecular mechanisms underpinning the ability of Nautella sp. R11 to colonize, invade and induce bleaching of D. pulchra, we sequenced and analyzed its genome. The genome encodes several factors such as adhesion mechanisms, systems for the transport of algal metabolites, enzymes that confer resistance to oxidative stress, cytolysins, and global regulatory mechanisms that may allow for the switch of Nautella sp. R11 to a pathogenic lifestyle. Many virulence effectors common in phytopathogenic bacteria are also found in the R11 genome, such as the plant hormone indole acetic acid, cellulose fibrils, succinoglycan and nodulation protein L. Comparative genomics with non-pathogenic Roseobacter strains and a newly identified pathogen, Phaeobacter sp. LSS9, revealed a patchy distribution of putative virulence factors in all genomes, but also led to the identification of a quorum sensing (QS) dependent transcriptional regulator that was unique to pathogenic Roseobacter strains. This observation supports the model that a combination of virulence factors and QS-dependent regulatory mechanisms enables indigenous members of the host alga's epiphytic microbial community to switch to a pathogenic lifestyle, especially under environmental conditions when innate host defence mechanisms are compromised.	[Fernandes, Neil; Longford, Sharon R.; Steinberg, Peter D.; Kjelleberg, Staffan; Thomas, Torsten] Univ New S Wales, CMB, Sydney, NSW, Australia; [Fernandes, Neil; Kjelleberg, Staffan; Thomas, Torsten] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Case, Rebecca J.] Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA; [Longford, Sharon R.; Steinberg, Peter D.] Univ New S Wales, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia; [Seyedsayamdost, Mohammad R.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Kjelleberg, Staffan] Nanyang Technol Univ, Singapore Ctr Environm Life Sci Engn, Singapore, Singapore	University of New South Wales Sydney; University of New South Wales Sydney; Harvard University; Harvard Medical School; University of New South Wales Sydney; Harvard University; Harvard Medical School; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Fernandes, N (corresponding author), Univ New S Wales, CMB, Sydney, NSW, Australia.	thomas@unsw.edu.au	Kjelleberg, Staffan/AAB-4641-2020; Seyedsayamdost, Mohammad/AHD-0859-2022; Kjelleberg, Staffan/C-9229-2015; Case, Rebecca/A-2624-2014	Kjelleberg, Staffan/0000-0003-4271-6413; Seyedsayamdost, Mohammad/0000-0003-2707-4854; Kjelleberg, Staffan/0000-0003-4271-6413; Case, Rebecca/0000-0003-2417-2969; Steinberg, Peter/0000-0002-1781-0726; Thomas, Torsten/0000-0001-9557-3001	Australian Research Council; Betty and Gordon Moore Foundation; Centre for Marine Bio-Innovation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R00GM098299, K99GM098299] Funding Source: NIH RePORTER	Australian Research Council(Australian Research Council); Betty and Gordon Moore Foundation(Gordon and Betty Moore Foundation); Centre for Marine Bio-Innovation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The Australian Research Council, the Betty and Gordon Moore Foundation and the Centre for Marine Bio-Innovation supported this work. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of manuscript.	Abe H, 2008, DNA RES, V15, P25, DOI 10.1093/dnares/dsm033; Abramovitch RB, 2004, CURR OPIN PLANT BIOL, V7, P356, DOI 10.1016/j.pbi.2004.05.002; ALVAREZ ME, 1998, BIOPHYS J, V92, P773; Amaro AM, 2005, J EUKARYOT MICROBIOL, V52, P191, DOI 10.1111/j.1550-7408.2005.00031.x; ANTIA NJ, 1991, PHYCOLOGIA, V30, P1, DOI 10.2216/i0031-8884-30-1-1.1; Antunez-Lamas M, 2009, MICROBIOL-SGM, V155, P434, DOI 10.1099/mic.0.022244-0; Ashen JB, 2000, APPL ENVIRON MICROB, V66, P3024, DOI 10.1128/AEM.66.7.3024-3030.2000; BAKER CJ, 1995, ANNU REV PHYTOPATHOL, V33, P299, DOI 10.1146/annurev.py.33.090195.001503; Banin E, 2001, APPL ENVIRON MICROB, V67, P1536, DOI 10.1128/AEM.67.4.1536-1541.2001; Bartsev AV, 2004, PLANT PHYSIOL, V134, P871, DOI 10.1104/pp.103.031740; BEATTIE GA, 1995, ANNU REV PHYTOPATHOL, V33, P145, DOI 10.1146/annurev.py.33.090195.001045; Becker PT, 2009, J INVERTEBR PATHOL, V100, P127, DOI 10.1016/j.jip.2008.11.002; Beier D, 2006, CURR OPIN MICROBIOL, V9, P143, DOI 10.1016/j.mib.2006.01.005; Bell KS, 2004, P NATL ACAD SCI USA, V101, P11105, DOI 10.1073/pnas.0402424101; Boyd KG, 1999, BIOFOULING, V14, P227, DOI 10.1080/08927019909378414; Buchan A, 2005, APPL ENVIRON MICROB, V71, P5665, DOI 10.1128/AEM.71.10.5665-5677.2005; Butler SM, 2004, P NATL ACAD SCI USA, V101, P5018, DOI 10.1073/pnas.0308052101; Cabiscol Elisa, 2000, International Microbiology, V3, P3; Cai W, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024701; Calva E, 2006, MICROB ECOL, V51, P166, DOI 10.1007/s00248-005-0087-1; Campbell AH, 2011, GLOBAL CHAN IN PRESS; Case R, THESIS U NEW S WALES; Case RJ, 2008, ISME J, V2, P345, DOI 10.1038/ismej.2008.13; Case RJ, 2011, ENVIRON MICROBIOL, V13, P529, DOI 10.1111/j.1462-2920.2010.02356.x; Cheng HP, 1998, J BACTERIOL, V180, P5183, DOI 10.1128/JB.180.19.5183-5191.1998; Chowdhury S, 2006, EMBO J, V25, P2487, DOI 10.1038/sj.emboj.7601128; Cohen BA, 2002, PHYTOPATHOLOGY, V92, P590, DOI 10.1094/PHYTO.2002.92.6.590; Cooney RP, 2002, ENVIRON MICROBIOL, V4, P401, DOI 10.1046/j.1462-2920.2002.00308.x; Cotter PA, 2000, ANNU REV MICROBIOL, V54, P519, DOI 10.1146/annurev.micro.54.1.519; Dang HY, 2000, APPL ENVIRON MICROB, V66, P467, DOI 10.1128/AEM.66.2.467-475.2000; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; de Kievit TR, 2000, INFECT IMMUN, V68, P4839, DOI 10.1128/IAI.68.9.4839-4849.2000; de Nys R, 2006, MAR MOL BIOTECHNOL, V42, P55; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; DENYS R, 1995, BIOFOULING, V8, P259, DOI 10.1080/08927019509378279; Ferluga S, 2009, J BACTERIOL, V191, P890, DOI 10.1128/JB.01507-08; Forman S, 2003, INFECT IMMUN, V71, P2253, DOI 10.1128/IAI.71.4.2253-2257.2003; Geider K, 2001, ACTA HORT ISHS, V590, P457; Gledhill M, 2007, MAR CHEM, V103, P393, DOI 10.1016/j.marchem.2006.10.008; Goldberg SMD, 2006, P NATL ACAD SCI USA, V103, P11240, DOI 10.1073/pnas.0604351103; Gonzalez JM, 1999, APPL ENVIRON MICROB, V65, P3810; Gonzalez JM, 2000, APPL ENVIRON MICROB, V66, P4237, DOI 10.1128/AEM.66.10.4237-4246.2000; Gonzalez JE, 2006, MICROBIOL MOL BIOL R, V70, P859, DOI 10.1128/MMBR.00002-06; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Heath MC, 2000, PLANT MOL BIOL, V44, P321, DOI 10.1023/A:1026592509060; Hentzer M, 2003, EMBO J, V22, P3803, DOI 10.1093/emboj/cdg366; Hopkinson BM, 2008, APPL ENVIRON MICROB, V74, P6263, DOI 10.1128/AEM.00964-08; Howard EC, 2006, SCIENCE, V314, P649, DOI 10.1126/science.1130657; Imai I, 2006, AFR J MAR SCI, V28, P319, DOI 10.2989/18142320609504170; Josenhans C, 2002, INT J MED MICROBIOL, V291, P605, DOI 10.1078/1438-4221-00173; Jung A, 2005, P NATL ACAD SCI USA, V102, P12350, DOI 10.1073/pnas.0500722102; KOBAYASHI M, 1995, P NATL ACAD SCI USA, V92, P714, DOI 10.1073/pnas.92.3.714; KOBAYASHI M, 1993, P NATL ACAD SCI USA, V90, P247, DOI 10.1073/pnas.90.1.247; Krukonis ES, 2003, CURR OPIN MICROBIOL, V6, P186, DOI 10.1016/S1369-5274(03)00032-8; Lafferty KD, 2004, ANNU REV ECOL EVOL S, V35, P31, DOI 10.1146/annurev.ecolsys.35.021103.105704; Lally ET, 1999, TRENDS MICROBIOL, V7, P356, DOI 10.1016/S0966-842X(99)01530-9; Lesser MP, 2007, J EXP MAR BIOL ECOL, V346, P36, DOI 10.1016/j.jembe.2007.02.015; LEVINE A, 1994, CELL, V79, P583, DOI 10.1016/0092-8674(94)90544-4; Lindow SE, 2003, APPL ENVIRON MICROB, V69, P1875, DOI 10.1128/AEM.69.4.1875-1883.2003; LITTLER MM, 1995, SCIENCE, V267, P1356, DOI 10.1126/science.267.5202.1356; Littman RA, 2010, MOL ECOL, V19, P1978, DOI 10.1111/j.1365-294X.2010.04620.x; Longford S, 2007, THESIS U NEW S WALES; Maloy AP, 2007, AQUACULTURE, V269, P71, DOI 10.1016/j.aquaculture.2007.04.008; Marie C, 2003, MOL PLANT MICROBE IN, V16, P743, DOI 10.1094/MPMI.2003.16.9.743; Markowitz VM, 2009, BIOINFORMATICS, V25, P2271, DOI 10.1093/bioinformatics/btp393; Martens T, 2006, INT J SYST EVOL MICR, V56, P1293, DOI 10.1099/ijs.0.63724-0; MATTHYSSE AG, 1983, J BACTERIOL, V154, P906, DOI 10.1128/JB.154.2.906-915.1983; Maximilien R, 1998, AQUAT MICROB ECOL, V15, P233, DOI 10.3354/ame015233; Mithofer A, 2002, TRENDS PLANT SCI, V7, P440, DOI 10.1016/S1360-1385(02)02336-1; Mole BM, 2007, TRENDS MICROBIOL, V15, P363, DOI 10.1016/j.tim.2007.06.005; Moran MA, 2007, APPL ENVIRON MICROB, V73, P4559, DOI 10.1128/AEM.02580-06; Moran MA, 2004, NATURE, V432, P910, DOI 10.1038/nature03170; Nasser W, 2001, MOL PLANT MICROBE IN, V14, P10, DOI 10.1094/MPMI.2001.14.1.10; Newton RJ, 2010, ISME J, V4, P784, DOI 10.1038/ismej.2009.150; Ono S, 2005, BIOCHEM J, V391, P203, DOI 10.1042/BJ20050453; OToole R, 1996, MOL MICROBIOL, V19, P625, DOI 10.1046/j.1365-2958.1996.412927.x; Pallen MJ, 2007, NATURE, V449, P835, DOI 10.1038/nature06248; Pantos O, 2003, ENVIRON MICROBIOL, V5, P370, DOI 10.1046/j.1462-2920.2003.00427.x; Parker CT, 2009, CELL MICROBIOL, V11, P363, DOI 10.1111/j.1462-5822.2008.01272.x; Parsek MR, 2003, ANNU REV MICROBIOL, V57, P677, DOI 10.1146/annurev.micro.57.030502.090720; Patankar AV, 2009, FEMS MICROBIOL REV, V33, P739, DOI 10.1111/j.1574-6976.2009.00163.x; Perez JC, 2009, CELL, V138, P233, DOI 10.1016/j.cell.2009.07.002; Perez JC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000428; Persson OP, 2009, ENVIRON MICROBIOL, V11, P1348, DOI 10.1111/j.1462-2920.2008.01861.x; Pizarro-Cerda J, 2006, CELL, V124, P715, DOI 10.1016/j.cell.2006.02.012; Quest B, 2004, EUR J BIOCHEM, V271, P1117, DOI 10.1111/j.1432-1033.2004.04015.x; RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262; Rao D, 2007, APPL ENVIRON MICROB, V73, P7844, DOI 10.1128/AEM.01543-07; Rao D, 2006, APPL ENVIRON MICROB, V72, P5547, DOI 10.1128/AEM.00449-06; Ridgway KR, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030393; Rosenberg E, 2002, ENVIRON MICROBIOL, V4, P318, DOI 10.1046/j.1462-2920.2002.00302.x; Rosenberg E, 2007, NAT REV MICROBIOL, V5, P355, DOI 10.1038/nrmicro1635; Salanoubat M, 2002, NATURE, V415, P497, DOI 10.1038/415497a; Sekar R, 2008, MAR ECOL PROG SER, V362, P85, DOI 10.3354/meps07496; Seyedsayamdost MR, 2011, NAT CHEM, V3, P331, DOI [10.1038/nchem.1002, 10.1038/NCHEM.1002]; SMIT G, 1987, J BACTERIOL, V169, P4294, DOI 10.1128/jb.169.9.4294-4301.1987; Soto GE, 1999, J BACTERIOL, V181, P1059, DOI 10.1128/JB.181.4.1059-1071.1999; Soto MJ, 2006, MICROBIOL-SGM, V152, P3167, DOI 10.1099/mic.0.29112-0; Sperandio V, 2001, J BACTERIOL, V183, P5187, DOI 10.1128/JB.183.17.5187-5197.2001; Strzepek RF, 2004, NATURE, V431, P689, DOI 10.1038/nature02954; Subramoni S, 2009, MICROBIOL-SGM, V155, P1377, DOI 10.1099/mic.0.026849-0; Sunagawa S, 2009, ISME J, V3, P512, DOI 10.1038/ismej.2008.131; Swingley WD, 2007, J BACTERIOL, V189, P683, DOI 10.1128/JB.01390-06; TANCREDE C, 1992, EUR J CLIN MICROBIOL, V11, P1012, DOI 10.1007/BF01967791; Teale WD, 2006, NAT REV MOL CELL BIO, V7, P847, DOI 10.1038/nrm2020; Thomas T, 2010, ISME J, V4, P1557, DOI 10.1038/ismej.2010.74; Thompson FL, 2004, MICROBIOL MOL BIOL R, V68, P403, DOI 10.1128/MMBR.68.3.403-431.2004; Tsolis RM, 2002, P NATL ACAD SCI USA, V99, P12503, DOI 10.1073/pnas.212508599; Vandecandelaere I, 2009, INT J SYST EVOL MICR, V59, P811, DOI 10.1099/ijs.0.002683-0; Wagner-Dobler I, 2006, ANNU REV MICROBIOL, V60, P255, DOI 10.1146/annurev.micro.60.080805.142115; Waldminghaus T, 2005, BIOL CHEM, V386, P1279, DOI 10.1515/BC.2005.145; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; Webster NS, 2008, ISME J, V2, P830, DOI 10.1038/ismej.2008.42; Welch RA, 2001, CURR TOP MICROBIOL, V257, P85; White-Ziegler CA, 2009, J BACTERIOL, V191, P1106, DOI 10.1128/JB.00599-08; Williams P, 2000, PHILOS T R SOC B, V355, P667, DOI 10.1098/rstb.2000.0607; YAMADA T, 1993, ANNU REV PHYTOPATHOL, V31, P253, DOI 10.1146/annurev.py.31.090193.001345; Yoch DC, 2002, APPL ENVIRON MICROB, V68, P5804, DOI 10.1128/AEM.68.12.5804-5815.2002; Zhu J, 2002, P NATL ACAD SCI USA, V99, P3129, DOI 10.1073/pnas.052694299	120	75	75	6	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e27387	10.1371/journal.pone.0027387	http://dx.doi.org/10.1371/journal.pone.0027387			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22162749	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000298172800004
J	Mos, B; Cowden, KL; Nielsen, SJ; Dworjanyn, SA				Mos, Benjamin; Cowden, Kenneth L.; Nielsen, Shaun J.; Dworjanyn, Symon A.			Do Cues Matter? Highly Inductive Settlement Cues Don't Ensure High Post-Settlement Survival in Sea Urchin Aquaculture	PLOS ONE			English	Article							PARACENTROTUS-LIVIDUS LAMARCK; MARINE INVERTEBRATE LARVAE; STRONGYLOCENTROTUS-DROEBACHIENSIS; PSEUDOCENTROTUS-DEPRESSUS; ANTHOCIDARIS-CRASSISPINA; TRIPNEUSTES-GRATILLA; METAMORPHOSIS; ECHINODERMATA; BACTERIA; GROWTH	Increasing settlement and post-settlement survival during the critical transition from planktonic larvae to benthic juveniles will increase efficiency for sea urchin aquaculture. This study investigated the effects of temperature and settlement cues on the settlement and post-settlement survival of the sea urchin Tripneustes gratilla during this phase. The current commercial methodology, which utilises natural biofilm settlement plates, was tested and resulted in low settlement (<2%) and poor post-settlement survival (<1% of settled urchins). In laboratory trials, settlement was high and unaffected by temperatures between 24 and 30 degrees C, but significantly decreased at 33 degrees C. Development of spines, however, was significantly affected by temperatures over 29 degrees C. Mirroring this result, post-settlement survival was optimal between 24-28 degrees C. In laboratory assays, the macroalgae Sargassum linearifolium and Corallina officinalis, and seawater conditioned with these algae, induced significantly higher settlement (>90%) than a natural biofilm (similar to 25%). The addition of macroalgae-conditioned seawater to natural biofilm significantly increased settlement rates (>85%). Mixed consortia and single strains of bacteria isolated from macroalgae, biofilms and adult conspecifics all induced significant settlement, but at significantly lower rates than macroalgae. No evidence was found that higher rates of settlement to bacteria on macroalgae were generated by a cofactor from the macroalgae. Age of bacterial cultures, culturing bacteria on solid and liquid media and concentration of nutrients in cultures had little effect on settlement rates. Finally, macroalgae-conditioned seawater combined with natural biofilm settlement plates induced significantly higher settlement than to the biofilm plates alone in a commercial scale trial. However, high post-settlement mortality resulted in equivalent survival between treatments after 25 days. This study highlights that settlement studies should extend to post-settlement survival, which remains poor for T. gratilla and is a significant obstacle to increasing efficiency for aquaculture.	[Mos, Benjamin; Cowden, Kenneth L.; Dworjanyn, Symon A.] So Cross Univ, Natl Marine Sci Ctr, Coffs Harbour, NSW, Australia; [Nielsen, Shaun J.] Univ New S Wales, Ctr Marine Bioinnovat, Sydney, NSW, Australia; [Nielsen, Shaun J.] Univ New S Wales, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia	Southern Cross University; University of New South Wales Sydney; University of New South Wales Sydney	Mos, B (corresponding author), So Cross Univ, Natl Marine Sci Ctr, Coffs Harbour, NSW, Australia.	bmos@nmsc.edu.au	Mos, Benjamin/P-2538-2017; Dworjanyn, Symon A/O-5633-2017	Mos, Benjamin/0000-0003-3687-516X; Dworjanyn, Symon A/0000-0002-6690-8033	Australian Postgraduate Award; Rural Industries Research and Development (RIRDC)	Australian Postgraduate Award(Australian Government); Rural Industries Research and Development (RIRDC)	BM was supported by an Australian Postgraduate Award and a Rural Industries Research and Development (RIRDC) top-up scholarship. SN was supported by an Australian Postgraduate Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Anderson SC, 2010, FISH FISH, P1; Andrew NL, 2002, OCEANOGR MAR BIOL, V40, P343; Juinio-Menez MA, 2010, MAR ECOL PROG SER, V402, P137, DOI 10.3354/meps08464; Azad AK, 2010, REV AQUACULT, V2, P121, DOI 10.1111/j.1753-5131.2010.01030.x; Berkes F, 2006, SCIENCE, V311, P1557, DOI 10.1126/science.1122804; Buitrago E, 2005, AQUACULT INT, V13, P359, DOI 10.1007/s10499-004-6551-y; Burke R.D., 1989, Echinoderm Studies, V3, P81; Byrne M, 2008, MAR BIOL, V155, P473, DOI 10.1007/s00227-008-1045-5; Byrne M, 2008, FUNCT ECOL, V22, P643, DOI 10.1111/j.1365-2435.2008.01427.x; CAMERON RA, 1974, BIOL BULL-US, V146, P335, DOI 10.2307/1540409; Chao WR, 2010, AQUACULTURE, V307, P89, DOI 10.1016/j.aquaculture.2010.07.012; Chia F.-S., 1978, P219; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; Daggett TL, 2006, AQUAC RES, V37, P339, DOI 10.1111/j.1365-2109.2005.01430.x; Daume S, 2004, J SHELLFISH RES, V23, P1019; Daume S, 2000, J APPL PHYCOL, V12, P479, DOI 10.1023/A:1008110828581; Degnan SM, 2010, PHILOS T R SOC B, V365, P641, DOI 10.1098/rstb.2009.0248; Devin M.G., 2002, P145; Dworjanyn SA, 2008, AQUACULTURE, V274, P268, DOI 10.1016/j.aquaculture.2007.11.030; Dworjanyn SA, 2007, AQUACULTURE, V273, P624, DOI 10.1016/j.aquaculture.2007.08.023; Feng DQ, 2010, MAR FRESHW BEHAV PHY, V43, P11, DOI 10.1080/10236240903523204; FITT WK, 1989, MICROBIAL ECOL, V17, P287, DOI 10.1007/BF02012841; Gosselin P, 1996, OCEANOL ACTA, V19, P293; Gosselin P, 1998, ZOOMORPHOLOGY, V118, P31, DOI 10.1007/s004350050054; Grosjean P, 1998, J SHELLFISH RES, V17, P1523; Hadfield MG, 2011, ANNU REV MAR SCI, V3, P453, DOI 10.1146/annurev-marine-120709-142753; Harris L. G., 2003, J WORLD AQUACULT SOC, V34, P32; HINEGARDNER RT, 1969, BIOL BULL-US, V137, P465, DOI 10.2307/1540168; Huggett MJ, 2006, OECOLOGIA, V149, P604, DOI 10.1007/s00442-006-0470-8; Jimmy RA, 2003, AQUACULTURE, V220, P261, DOI 10.1016/S0044-8486(02)00193-X; JOHNSON CR, 1994, MAR BIOL, V120, P305, DOI 10.1007/BF00349692; Juinio-Menez MA, 2008, REV FISH SCI, V16, P35, DOI 10.1080/10641260701678116; Kelly MS, 2000, AQUACULTURE, V183, P223, DOI 10.1016/S0044-8486(99)00296-3; Khandeparker L, 2002, AQUAT MICROB ECOL, V28, P37, DOI 10.3354/ame028037; Kirby MX, 2004, P NATL ACAD SCI USA, V101, P13096, DOI 10.1073/pnas.0405150101; KITAMURA H, 1993, MAR BIOL, V115, P387, DOI 10.1007/BF00349836; KITAMURA H, 1994, FISHERIES SCI, V60, P311, DOI 10.2331/fishsci.60.311; KRAMER R, 1994, FEMS MICROBIOL REV, V13, P75, DOI 10.1111/j.1574-6976.1994.tb00036.x; Lawrence JM, 2001, EDIBLE SEA URCHINS B, P499; Maldonado M, 1996, MAR ECOL PROG SER, V138, P169, DOI 10.3354/meps138169; McBride SC, 2005, AM FISH S S, V46, P179; Miller BA, 1999, J EXP MAR BIOL ECOL, V235, P67, DOI 10.1016/S0022-0981(98)00164-6; Naidenko TK, 1996, MAR BIOL, V126, P685, DOI 10.1007/BF00351335; Negri AP, 2001, MAR ECOL PROG SER, V223, P121, DOI 10.3354/meps223121; Nunes CDP, 2007, ZOOMORPHOLOGY, V126, P103, DOI 10.1007/s00435-007-0032-6; Pang SJ, 2006, AQUACULTURE, V258, P327, DOI 10.1016/j.aquaculture.2006.03.028; PEARCE CM, 1990, BIOL BULL-US, V179, P304, DOI 10.2307/1542322; PEARCE CM, 1994, INVERTEBR REPROD DEV, V26, P213, DOI 10.1080/07924259.1994.9672420; PEARCE CM, 1991, J EXP MAR BIOL ECOL, V147, P147, DOI 10.1016/0022-0981(91)90179-Z; Rahim SAKA, 2004, MAR BIOL, V144, P71, DOI 10.1007/s00227-003-1171-z; Rahman S, 2009, BIOLOGIA, V64, P768, DOI 10.2478/s11756-009-0135-2; SEARCYBERNAL R, 1992, AQUACULTURE, V105, P241, DOI 10.1016/0044-8486(92)90090-8; Sheppard Brennand H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011372; Shimabukuro S., 1991, AQUACULTURE TROPICAL, P313; Siboni N, 2007, FEMS MICROBIOL LETT, V274, P24, DOI 10.1111/j.1574-6968.2007.00809.x; Smith MM, 2008, J MORPHOL, V269, P713, DOI 10.1002/jmor.10618; Swanson RL, 2006, MAR ECOL PROG SER, V314, P1, DOI 10.3354/meps314001; Swanson RL, 2004, BIOL BULL-US, V206, P161, DOI 10.2307/1543640; Takahashi Y, 2002, MAR BIOL, V140, P763, DOI 10.1007/s00227-001-0749-6; Tebben J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019082; Tolker-Nielsen T, 2000, MICROB ECOL, V40, P75; Vaitilingon D, 2001, J EXP MAR BIOL ECOL, V262, P41, DOI 10.1016/S0022-0981(01)00281-7; Whalan S, 2008, CORAL REEFS, V27, P783, DOI 10.1007/s00338-008-0400-9; Wieczorek SK, 1998, BIOFOULING, V12, P81, DOI 10.1080/08927019809378348; Womersley HBS, 1996, ORDER CORALLINALE 3B, P146; Womersley HBS, 1987, ORDER FUCALES KYLI 2, P340; YAZAKI I, 1995, ZOOL SCI, V12, P105, DOI 10.2108/zsj.12.105	68	46	46	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e28054	10.1371/journal.pone.0028054	http://dx.doi.org/10.1371/journal.pone.0028054			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22162755	Green Submitted, Green Published, gold			2022-12-27	WOS:000298172800013
J	Robinson, KL; Tohidi-Esfahani, D; Lo, N; Simpson, SJ; Sword, GA				Robinson, Katie L.; Tohidi-Esfahani, Donya; Lo, Nathan; Simpson, Stephen J.; Sword, Gregory A.			Evidence for Widespread Genomic Methylation in the Migratory Locust, Locusta migratoria (Orthoptera: Acrididae)	PLOS ONE			English	Article							EGG POD FOAM; DNA METHYLATION; PHASE POLYPHENISM; GENE-EXPRESSION; INSECTICIDE RESISTANCE; CPG METHYLATION; SYSTEM; METHYLTRANSFERASE; CONSERVATION; EVOLUTION	The importance of DNA methylation in mammalian and plant systems is well established. In recent years there has been renewed interest in DNA methylation in insects. Accumulating evidence, both from mammals and insects, points towards an emerging role for DNA methylation in the regulation of phenotypic plasticity. The migratory locust (Locusta migratoria) is a model organism for the study of phenotypic plasticity. Despite this, there is little information available about the degree to which the genome is methylated in this species and genes encoding methylation machinery have not been previously identified. We therefore undertook an initial investigation to establish the presence of a functional DNA methylation system in L. migratoria. We found that the migratory locust possesses genes that putatively encode methylation machinery (DNA methyltransferases and a methyl-binding domain protein) and exhibits genomic methylation, some of which appears to be localised to repetitive regions of the genome. We have also identified a distinct group of genes within the L. migratoria genome that appear to have been historically methylated and show some possible functional differentiation. These results will facilitate more detailed research into the functional significance of DNA methylation in locusts.	[Robinson, Katie L.; Tohidi-Esfahani, Donya; Lo, Nathan; Simpson, Stephen J.] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; [Tohidi-Esfahani, Donya] Australian Natl Univ, Coll Med Biol & Environm, Canberra, ACT, Australia; [Sword, Gregory A.] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA	University of Sydney; Australian National University; Texas A&M University System; Texas A&M University College Station	Robinson, KL (corresponding author), Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia.	katie.robinson@sydney.edu.au	Tohidi-Esfahani, Donya/M-7491-2019; Lo, Nathan/E-6115-2010	Lo, Nathan/0000-0003-2176-2840; Simpson, Stephen J./0000-0003-0256-7687; Sword, Gregory/0000-0003-2094-2436; Tohidi-Esfahani, Donya/0000-0003-3682-7272; Robinson, Katie/0000-0003-0757-910X	Australian Research Council; University of Sydney	Australian Research Council(Australian Research Council); University of Sydney(University of Sydney)	This work was supported by an Australian Research Council Discovery Project grant to GAS, SJS and NL (http://www.arc.gov.au/ncgp/dp/dp_default.htm) and a University of Sydney Postgraduate Award to KLR (http://sydney.edu.au/scholarships/research/postgraduate_awards.shtml). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS RLP, 1990, BIOCHEM J, V265, P309, DOI 10.1042/bj2650309; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ben Hamouda A, 2009, J INSECT PHYSIOL, V55, P617, DOI 10.1016/j.jinsphys.2009.03.008; BESTOR TH, 1990, PHILOS T ROY SOC B, V326, P179, DOI 10.1098/rstb.1990.0002; BIRD AP, 1980, NUCLEIC ACIDS RES, V8, P1485, DOI 10.1093/nar/8.7.1485; BIRD AP, 1980, NUCLEIC ACIDS RES, V8, P1499, DOI 10.1093/nar/8.7.1499; Boerjan B, 2011, GEN COMP ENDOCR, V173, P120, DOI 10.1016/j.ygcen.2011.05.003; Bongiorni S, 2003, GENETICA, V117, P271, DOI 10.1023/A:1022964700446; BRADFIELD JY, 1985, DNA-J MOLEC CELL BIO, V4, P357, DOI 10.1089/dna.1985.4.357; BROWN SJ, 1990, INSECT BIOCHEM, V20, P185, DOI 10.1016/0020-1790(90)90011-I; Chen TP, 2004, CURR TOP DEV BIOL, V60, P55; Clissold FJ, 2010, P ROY SOC B-BIOL SCI, V277, P1751, DOI 10.1098/rspb.2009.2045; Drummond AJ, 2010, GENEIOUS V5 1; Elango N, 2009, P NATL ACAD SCI USA, V106, P11206, DOI 10.1073/pnas.0900301106; Feng SH, 2010, P NATL ACAD SCI USA, V107, P8689, DOI 10.1073/pnas.1002720107; FIELD LM, 1989, FEBS LETT, V243, P323, DOI 10.1016/0014-5793(89)80154-1; Field LM, 2004, INSECT MOL BIOL, V13, P109, DOI 10.1111/j.0962-1075.2004.00470.x; Food and Agriculture Organization of the United Nations, 2010, MIGR LOC; GAGE LP, 1974, CHROMOSOMA, V45, P27; Glastad KM, 2011, INSECT MOL BIOL, V20, P553, DOI 10.1111/j.1365-2583.2011.01092.x; Goll MG, 2006, SCIENCE, V311, P395, DOI 10.1126/science.1120976; Gray LJ, 2009, BIOL LETTERS, V5, P306, DOI 10.1098/rsbl.2008.0764; Gregory TR, 2002, GENETICA, V115, P131, DOI 10.1023/A:1016032400147; Guo W, 2010, J INSECT PHYSIOL, V56, P943, DOI 10.1016/j.jinsphys.2010.05.007; Hendrich B, 2003, TRENDS GENET, V19, P269, DOI 10.1016/S0168-9525(03)00080-5; Hick CA, 1996, INSECT BIOCHEM MOLEC, V26, P41, DOI 10.1016/0965-1748(95)00059-3; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Hsu DW, 1999, P NATL ACAD SCI USA, V96, P9751, DOI 10.1073/pnas.96.17.9751; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hung MS, 1999, P NATL ACAD SCI USA, V96, P11940, DOI 10.1073/pnas.96.21.11940; Kang L, 2004, P NATL ACAD SCI USA, V101, P17611, DOI 10.1073/pnas.0407753101; Kirkness EF, 2011, P NATL ACAD SCI USA, V108, P6335, DOI 10.1073/pnas.1103909108; Krauss V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007223; Kucharski R, 2008, SCIENCE, V319, P1827, DOI 10.1126/science.1153069; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; Lockett GA, 2010, NEUROREPORT, V21, P812, DOI 10.1097/WNR.0b013e32833ce5be; Lyko F, 2000, NATURE, V408, P538, DOI 10.1038/35046205; Lyko F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000506; Ma ZY, 2011, P NATL ACAD SCI USA, V108, P3882, DOI 10.1073/pnas.1015098108; Ma ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-11; Mandrioli M, 2003, GENETICA, V119, P187, DOI 10.1023/A:1026016021415; Marhold J, 2004, INSECT MOL BIOL, V13, P117, DOI 10.1111/j.0962-1075.2004.00466.x; McCaffery AR, 1998, J EXP BIOL, V201, P347; OTT J, 1979, HUM GENET, V51, P79, DOI 10.1007/BF00278296; Pener MP, 2009, ADV INSECT PHYSIOL, V36, P1, DOI 10.1016/S0065-2806(08)36001-9; Regev A, 1998, MOL BIOL EVOL, V15, P880, DOI 10.1093/oxfordjournals.molbev.a025992; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; ROESSINGH P, 1993, P ROY SOC B-BIOL SCI, V252, P43, DOI 10.1098/rspb.1993.0044; Rose TM, 2003, NUCLEIC ACIDS RES, V31, P3763, DOI 10.1093/nar/gkg524; SARKAR S, 1992, GENOME, V35, P163, DOI 10.1139/g92-026; Simpson S. J., 2009, Phenotypic plasticity of insects: mechanisms and consequences, P147; Simpson SJ, 1999, BIOL REV, V74, P461, DOI 10.1017/S000632319900540X; Simpson SJ, 2002, J EXP BIOL, V205, P121; Song Hojun, 2005, Journal of Orthoptera Research, V14, P235, DOI 10.1665/1082-6467(2005)14[235:PPOTEO]2.0.CO;2; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Suzuki MM, 2007, GENOME RES, V17, P625, DOI 10.1101/gr.6163007; Sword GA, 2010, J INSECT PHYSIOL, V56, P949, DOI 10.1016/j.jinsphys.2010.05.005; Szyf M, 2007, REPROD TOXICOL, V24, P9, DOI 10.1016/j.reprotox.2007.05.001; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tanaka S, 2010, J INSECT PHYSIOL, V56, P911, DOI 10.1016/j.jinsphys.2010.05.013; Tweedie S, 1999, NAT GENET, V23, P389, DOI 10.1038/70490; Tweedie S, 1997, MOL CELL BIOL, V17, P1469, DOI 10.1128/MCB.17.3.1469; Uvarov B. P., 1966, GRASSHOPPERS LOCUSTS, V1; Walsh TK, 2010, INSECT MOL BIOL, V19, P215, DOI 10.1111/j.1365-2583.2009.00974.x; Wang Y, 2006, SCIENCE, V314, P645, DOI 10.1126/science.1135213; Wang Y, 2009, J MOL EVOL, V68, P700, DOI 10.1007/s00239-009-9244-3; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Wei YY, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-1-r6; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; WILMORE PJ, 1975, CHROMOSOMA, V51, P337, DOI 10.1007/BF00326320; WYATT GR, 1951, BIOCHEM J, V48, P584, DOI 10.1042/bj0480584; Xiang H, 2010, NAT BIOTECHNOL, V28, P756, DOI 10.1038/nbt0710-756d; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5; Zemach A, 2010, SCIENCE, V328, P916, DOI 10.1126/science.1186366	74	26	28	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e28167	10.1371/journal.pone.0028167	http://dx.doi.org/10.1371/journal.pone.0028167			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22163001	Green Published, gold, Green Submitted			2022-12-27	WOS:000298172800017
J	Braun, G; Nemcsics, B; Enyedi, P; Czirjak, G				Braun, Gabriella; Nemcsics, Balazs; Enyedi, Peter; Czirjak, Gabor			TRESK Background K+ Channel Is Inhibited by PAR-1/MARK Microtubule Affinity-Regulating Kinases in Xenopus Oocytes	PLOS ONE			English	Article							ROOT GANGLION NEURONS; POTASSIUM CHANNELS; NEURITE OUTGROWTH; SENSORY NEURONS; ION CHANNELS; POLARITY; PHOSPHORYLATION; ESTABLISHMENT; LOCALIZATION; BINDING	TRESK (TWIK-related spinal cord K+ channel, KCNK18) is a major background K+ channel of sensory neurons. Dominant-negative mutation of TRESK is linked to familial migraine. This important two-pore domain K+ channel is uniquely activated by calcineurin. The calcium/calmodulin-dependent protein phosphatase directly binds to the channel and activates TRESK current several-fold in Xenopus oocytes and HEK293 cells. We have recently shown that the kinase, which is responsible for the basal inhibition of the K+ current, is sensitive to the adaptor protein 14-3-3. Therefore we have examined the effect of the 14-3-3-inhibited PAR-1/MARK, microtubule-associated-protein/microtubule affinity-regulating kinase on TRESK in the Xenopus oocyte expression system. MARK1, MARK2 and MARK3 accelerated the return of TRESK current to the resting state after the calcium-dependent activation. Several other serine-threonine kinase types, generally involved in the modulation of other ion channels, failed to influence TRESK current recovery. MARK2 phosphorylated the primary determinant of regulation, the cluster of three adjacent serine residues (S274, 276 and 279) in the intracellular loop of mouse TRESK. In contrast, serine 264, the 14-3-3-binding site of TRESK, was not phosphorylated by the kinase. Thus MARK2 selectively inhibits TRESK activity via the S274/276/279 cluster, but does not affect the direct recruitment of 14-3-3 to the channel. TRESK is the first example of an ion channel phosphorylated by the dynamically membrane-localized MARK kinases, also known as general determinants of cellular polarity. These results raise the possibility that microtubule dynamics is coupled to the regulation of excitability in the neurons, which express TRESK background potassium channel.	[Braun, Gabriella; Nemcsics, Balazs; Enyedi, Peter; Czirjak, Gabor] Semmelweis Univ, Dept Physiol, Budapest, Hungary	Semmelweis University	Braun, G (corresponding author), Semmelweis Univ, Dept Physiol, Budapest, Hungary.	czirjak@eok.sote.hu	Braun, Gabriella/D-7494-2015	Braun, Gabriella/0000-0002-1762-7622; Czirjak, Gabor/0000-0002-5485-2327	Hungarian National Research Fund (OTKA) [K75239]; Hungarian Academy of Sciences	Hungarian National Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian Academy of Sciences(Hungarian Academy of Sciences)	This work was supported by the Hungarian National Research Fund (OTKA K75239). Gabor Czirjak was supported by the Janos Bolyai fellowship of the Hungarian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angrand PO, 2006, MOL CELL PROTEOMICS, V5, P2211, DOI 10.1074/mcp.M600147-MCP200; Barnes AP, 2009, ANNU REV NEUROSCI, V32, P347, DOI 10.1146/annurev.neuro.31.060407.125536; Bautista DM, 2008, NAT NEUROSCI, V11, P772, DOI 10.1038/nn.2143; Biernat J, 2002, MOL BIOL CELL, V13, P4013, DOI 10.1091/mbc.02-03-0046; Bohm H, 1997, CURR BIOL, V7, P603, DOI 10.1016/S0960-9822(06)00260-0; Chae YJ, 2010, ANESTHESIOLOGY, V113, P1326, DOI 10.1097/ALN.0b013e3181f90ca5; Chen YM, 2006, P NATL ACAD SCI USA, V103, P8534, DOI 10.1073/pnas.0509955103; Czirjak B, 2004, J BIOL CHEM, V279, P18550, DOI 10.1074/jbc.M312229200; Czirjak G, 2008, J BIOL CHEM, V283, P15672, DOI 10.1074/jbc.M800712200; Czirjak G, 2006, J BIOL CHEM, V281, P14677, DOI 10.1074/jbc.M602495200; Czirjak G, 2010, J BIOL CHEM, V285, P14549, DOI 10.1074/jbc.M110.102020; Dai SP, 2009, PHYSIOL REV, V89, P411, DOI 10.1152/physrev.00029.2007; Dobler T, 2007, J PHYSIOL-LONDON, V585, P867, DOI 10.1113/jphysiol.2007.145649; Drewes G, 1997, CELL, V89, P297, DOI 10.1016/S0092-8674(00)80208-1; Enyedi P, 2010, PHYSIOL REV, V90, P559, DOI 10.1152/physrev.00029.2009; Fink M, 1996, EMBO J, V15, P6854, DOI 10.1002/j.1460-2075.1996.tb01077.x; Gerhold KA, 2009, ANN NY ACAD SCI, V1170, P184, DOI 10.1111/j.1749-6632.2009.03895.x; Gumy LF, 2011, RNA, V17, P85, DOI 10.1261/rna.2386111; Huang Dong-Yue, 2008, Neurosci Bull, V24, P166, DOI 10.1007/s12264-008-0225-0; Hurov JB, 2004, CURR BIOL, V14, P736, DOI 10.1016/j.cub.2004.04.007; Jin J, 2004, CURR BIOL, V14, P1436, DOI 10.1016/j.cub.2004.07.051; Kang D, 2008, BIOCHEM BIOPH RES CO, V367, P609, DOI 10.1016/j.bbrc.2008.01.008; Kang D, 2006, AM J PHYSIOL-CELL PH, V291, pC138, DOI 10.1152/ajpcell.00629.2005; Lafreniere RG, 2010, NAT MED, V16, P1157, DOI 10.1038/nm.2216; Lennertz RC, 2010, J NEUROSCI, V30, P4353, DOI 10.1523/JNEUROSCI.4666-09.2010; Liu CH, 2004, ANESTH ANALG, V99, P1715, DOI 10.1213/01.ANE.0000136849.07384.44; Matenia D, 2009, TRENDS BIOCHEM SCI, V34, P332, DOI 10.1016/j.tibs.2009.03.008; Mathie A, 2010, J PHARM PHARMACOL, V62, P1089, DOI 10.1111/j.2042-7158.2010.01131.x; Moravcevic K, 2010, CELL, V143, P966, DOI 10.1016/j.cell.2010.11.028; Sano Y, 2003, J BIOL CHEM, V278, P27406, DOI 10.1074/jbc.M206810200; Sapir T, 2008, J NEUROSCI, V28, P13008, DOI 10.1523/JNEUROSCI.2363-08.2008; Schachter JB, 1997, NEUROPHARMACOLOGY, V36, P1181, DOI 10.1016/S0028-3908(97)00138-X; Shelly M, 2011, DEV NEUROBIOL, V71, P508, DOI 10.1002/dneu.20884; Smith HS, 2009, PAIN PHYSICIAN, V12, pE309; Suzuki A, 2004, CURR BIOL, V14, P1425, DOI 10.1016/j.cub.2004.08.021; Terabayashi T, 2007, J NEUROSCI, V27, P13098, DOI 10.1523/JNEUROSCI.3986-07.2007; Timm T, 2003, EMBO J, V22, P5090, DOI 10.1093/emboj/cdg447; Trinczek B, 2004, J BIOL CHEM, V279, P5915, DOI 10.1074/jbc.M304528200; Tulleuda A, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-30; Uboha NV, 2007, J NEUROSCI, V27, P4413, DOI 10.1523/JNEUROSCI.0725-07.2007; Watkins JL, 2008, P NATL ACAD SCI USA, V105, P18378, DOI 10.1073/pnas.0809661105; Yoo S, 2009, NEUROSCI LETT, V465, P79, DOI 10.1016/j.neulet.2009.08.062	42	16	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2011	6	12							e28119	10.1371/journal.pone.0028119	http://dx.doi.org/10.1371/journal.pone.0028119			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MQ	22145024	gold, Green Published, Green Submitted			2022-12-27	WOS:000298168900007
J	Collins, SL; Herve, R; Keevil, CW; Blaydes, JP; Webb, JS				Collins, Samuel L.; Herve, Rodolphe; Keevil, C. W.; Blaydes, Jeremy P.; Webb, Jeremy S.			Down-Regulation of DNA Mismatch Repair Enhances Initiation and Growth of Neuroblastoma and Brain Tumour Multicellular Spheroids	PLOS ONE			English	Article							CANCER STEM-CELLS; GENETIC INSTABILITY; MUTATOR PHENOTYPE; ALKYLATING-AGENTS; COLON-CANCER; EXPRESSION; RESISTANCE; HYPOXIA; CULTURE; MODEL	Multicellular tumour spheroid (MCTS) cultures are excellent model systems for simulating the development and microenvironmental conditions of in vivo tumour growth. Many documented cell lines can generate differentiated MCTS when cultured in suspension or in a non-adhesive environment. While physiological and biochemical properties of MCTS have been extensively characterized, insight into the events and conditions responsible for initiation of these structures is lacking. MCTS are formed by only a small subpopulation of cells during surface-associated growth but the processes responsible for this differentiation are poorly understood and have not been previously studied experimentally. Analysis of gene expression within spheroids has provided clues but to date it is not known if the observed differences are a cause or consequence of MCTS growth. One mechanism linked to tumourigenesis in a number of cancers is genetic instability arising from impaired DNA mismatch repair (MMR). This study aimed to determine the role of MMR in MCTS initiation and development. Using surface-associated N2a and CHLA-02-ATRT culture systems we have investigated the impact of impaired MMR on MCTS growth. Analysis of the DNA MMR genes MLH1 and PMS2 revealed both to be significantly down-regulated at the mRNA level compared with non-spheroid-forming cells. By using small interfering RNA (siRNA) against these genes we show that silencing of MLH1 and PMS2 enhances both MCTS initiation and subsequent expansion. This effect was prolonged over several passages following siRNA transfection. Down-regulation of DNA MMR can contribute to tumour initiation and progression in N2a and CHLA-02-ATRT MCTS models. Studies of surface-associated MCTS differentiation may have broader applications in studying events in the initiation of cancer foci.	[Collins, Samuel L.; Herve, Rodolphe; Webb, Jeremy S.] Univ Southampton, Ctr Biol Sci, Southampton, Hants, England; [Keevil, C. W.] Univ Southampton, Environm Hlth Care Unit, Southampton, Hants, England; [Blaydes, Jeremy P.] Univ Southampton, Fac Med, Southampton Canc Res UK Ctr, Southampton SO9 5NH, Hants, England	University of Southampton; University of Southampton; University of Southampton	Collins, SL (corresponding author), Univ Southampton, Ctr Biol Sci, Southampton, Hants, England.	J.S.Webb@soton.ac.uk	Blaydes, Jeremy/AAC-6939-2019	Blaydes, Jeremy/0000-0001-8525-0209; Webb, Jeremy/0000-0003-2068-8589; Collins, Samuel/0000-0003-4721-0040; Keevil, Charles/0000-0003-1917-7706	charitable organisation in the UK; Gerald Kerkut Trust; Biotechnology and Biological Sciences Research Council (BBSRC); Gerald Kerkut Charitable Trust; BBSRC [BB/C520655/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/C520655/1] Funding Source: researchfish	charitable organisation in the UK; Gerald Kerkut Trust; Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Gerald Kerkut Charitable Trust; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The work was funded by a charitable organisation in the UK, the Gerald Kerkut Trust (http://www.soton.ac.uk/similar to gktrust/). This work was also partially supported by a Biotechnology and Biological Sciences Research Council (BBSRC) David Phillips Fellowship awarded to JSW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful to the Gerald Kerkut Charitable Trust for continued support throughout this project.	Baker SM, 1996, NAT GENET, V13, P336, DOI 10.1038/ng0796-336; Bindra RS, 2007, CANCER METAST REV, V26, P249, DOI 10.1007/s10555-007-9061-3; BRONNER CE, 1994, NATURE, V368, P258, DOI 10.1038/368258a0; Cahill DP, 1999, TRENDS BIOCHEM SCI, V24, pM57, DOI 10.1016/S0968-0004(99)01466-8; Condat CA, 2006, PHYSICA A, V371, P76, DOI 10.1016/j.physa.2006.04.082; Coquelle A, 1998, MOL CELL, V2, P259, DOI 10.1016/S1097-2765(00)80137-9; DARLING JL, 1983, CELL BIOL INT REP, V7, P23, DOI 10.1016/0309-1651(83)90101-7; Davis TW, 1998, CANCER RES, V58, P767; Drasdo D, 2005, PHYS BIOL, V2, P133, DOI 10.1088/1478-3975/2/3/001; DUNHAM LJ, 1953, JNCI-J NATL CANCER I, V13, P1299; EVANS SM, 1986, INT J RADIAT ONCOL, V12, P969, DOI 10.1016/0360-3016(86)90393-7; Fink D, 1998, CLIN CANCER RES, V4, P1; Francia G, 2005, MOL CANCER THER, V4, P1484, DOI 10.1158/1535-7163.MCT-04-0214; Francia G, 2004, MOL CELL BIOL, V24, P6837, DOI 10.1128/mcb.24.15.6837-6849.2004; Genc M, 2004, J CANCER RES CLIN, V130, P45, DOI 10.1007/s00432-003-0506-y; Hammond EM, 2003, MUTAT RES-FUND MOL M, V532, P205, DOI 10.1016/j.mrfmmm.2003.08.017; Helmlinger G, 1997, NAT BIOTECHNOL, V15, P778, DOI 10.1038/nbt0897-778; Hsieh P, 2008, MECH AGEING DEV, V129, P391, DOI 10.1016/j.mad.2008.02.012; Jiricny J, 2000, CURR OPIN GENET DEV, V10, P157, DOI 10.1016/S0959-437X(00)00066-6; Jiricny J, 2000, NAT GENET, V24, P6, DOI 10.1038/71698; Kerbel R S, 1990, Adv Cancer Res, V55, P87, DOI 10.1016/S0065-230X(08)60469-8; KERR DJ, 1987, CANCER CHEMOTH PHARM, V19, P1, DOI 10.1007/BF00296245; Kolodner RD, 1999, CURR OPIN GENET DEV, V9, P89, DOI 10.1016/S0959-437X(99)80013-6; Koshiji M, 2005, MOL CELL, V17, P793, DOI 10.1016/j.molcel.2005.02.015; Kumar HR, 2008, PEDIATR SURG INT, V24, P1229, DOI 10.1007/s00383-008-2245-2; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; Kunz-Schughart LA, 1999, CELL BIOL INT, V23, P157, DOI 10.1006/cbir.1999.0384; Lagasse E, 2008, GENE THER, V15, P136, DOI 10.1038/sj.gt.3303068; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Liu B, 1996, NAT MED, V2, P169, DOI 10.1038/nm0296-169; Loeb LA, 2001, CANCER RES, V61, P3230; Loeb LA, 2008, CANCER RES, V68, P3551, DOI 10.1158/0008-5472.CAN-07-5835; LUK CK, 1986, BRIT J CANCER, V54, P25, DOI 10.1038/bjc.1986.148; Mahller YY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004235; Matheson EC, 2003, CARCINOGENESIS, V24, P31, DOI 10.1093/carcin/24.1.31; Mihaylova VT, 2003, MOL CELL BIOL, V23, P3265, DOI 10.1128/MCB.23.9.3265-3273.2003; Mueller J, 2009, CANCER RES, V69, P7053, DOI 10.1158/0008-5472.CAN-09-0358; Nicolaides NC, 1998, MOL CELL BIOL, V18, P1635, DOI 10.1128/MCB.18.3.1635; Papp-Szabo E, 2005, INT J CANCER, V116, P679, DOI 10.1002/ijc.21088; Peltomaki P, 2001, HUM MOL GENET, V10, P735, DOI 10.1093/hmg/10.7.735; Pors K, 2005, CURR TOP MED CHEM, V5, P1133, DOI 10.2174/156802605774370883; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Reynolds TY, 1996, CANCER RES, V56, P5754; RONEN S, 1989, MAGNET RESON MED, V12, P274, DOI 10.1002/mrm.1910120217; Sell S, 2004, CRIT REV ONCOL HEMAT, V51, P1, DOI 10.1016/j.critrevonc.2004.04.007; Shackleton M, 2009, CELL, V138, P822, DOI 10.1016/j.cell.2009.08.017; Spillane JB, 2007, ANZ J SURG, V77, P464, DOI 10.1111/j.1445-2197.2007.04096.x; Surtees JA, 2004, CYTOGENET GENOME RES, V107, P146, DOI 10.1159/000080593; SUTHERLAND R, 1981, CANCER RES, V41, P2980; SUTHERLAND RM, 1977, JNCI-J NATL CANCER I, V58, P1849, DOI 10.1093/jnci/58.6.1849; SUTHERLAND RM, 1971, JNCI-J NATL CANCER I, V46, P113; Takagi A, 2007, ANTICANCER RES, V27, P45; Wu LY, 2008, BIOMED MICRODEVICES, V10, P197, DOI 10.1007/s10544-007-9125-8; Wu XZ, 2008, ANN SURG ONCOL, V15, P407, DOI 10.1245/s10434-007-9695-y; YOUNG SD, 1988, P NATL ACAD SCI USA, V85, P9533, DOI 10.1073/pnas.85.24.9533; Zhang M, 2006, CURR OPIN GENET DEV, V16, P60, DOI 10.1016/j.gde.2005.12.008	56	6	7	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2011	6	12							e28123	10.1371/journal.pone.0028123	http://dx.doi.org/10.1371/journal.pone.0028123			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MQ	22145025	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000298168900008
J	Nasonkin, IO; Ward, RD; Bavers, DL; Beuschlein, F; Mortensen, AH; Keegan, CE; Hammer, GD; Camper, SA				Nasonkin, Igor O.; Ward, Robert D.; Bavers, David L.; Beuschlein, Felix; Mortensen, Amanda H.; Keegan, Catherine E.; Hammer, Gary D.; Camper, Sally A.			Aged PROP1 Deficient Dwarf Mice Maintain ACTH Production	PLOS ONE			English	Article							PITUITARY-HORMONE DEFICIENCY; 2-BASE PAIR DELETION; GROWTH-HORMONE; ANTERIOR-PITUITARY; PIT-1 GENE; X-ZONE; 20-ALPHA-HYDROXYSTEROID DEHYDROGENASE; CELL-PROLIFERATION; BINDING PROTEIN; TRANSGENIC MICE	Humans with PROP1 mutations have multiple pituitary hormone deficiencies (MPHD) that typically advance from growth insufficiency diagnosed in infancy to include more severe growth hormone (GH) deficiency and progressive reduction in other anterior pituitary hormones, eventually including adrenocorticotropic hormone (ACTH) deficiency and hypocortisolism. Congenital deficiencies of GH, prolactin, and thyroid stimulating hormone have been reported in the Prop1(null) (Prop1(-/-)) and the Ames dwarf (Prop1(df/df)) mouse models, but corticotroph and pituitary adrenal axis function have not been thoroughly investigated. Here we report that the C57BL6 background sensitizes mutants to a wasting phenotype that causes approximately one third to die precipitously between weaning and adulthood, while remaining homozygotes live with no signs of illness. The wasting phenotype is associated with severe hypoglycemia. Circulating ACTH and corticosterone levels are elevated in juvenile and aged Prop1 mutants, indicating activation of the pituitary-adrenal axis. Despite this, young adult Prop1 deficient mice are capable of responding to restraint stress with further elevation of ACTH and corticosterone. Low blood glucose, an expected side effect of GH deficiency, is likely responsible for the elevated corticosterone level. These studies suggest that the mouse model differs from the human patients who display progressive hormone loss and hypocortisolism.	[Nasonkin, Igor O.; Mortensen, Amanda H.; Camper, Sally A.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Ward, Robert D.; Keegan, Catherine E.; Hammer, Gary D.; Camper, Sally A.] Univ Michigan, Grad Program Cellular & Mol Biol, Ann Arbor, MI 48109 USA; [Bavers, David L.; Beuschlein, Felix; Hammer, Gary D.; Camper, Sally A.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI USA; [Beuschlein, Felix] Univ Clin Munich, Endocrine Res Unit, Munich, Germany; [Keegan, Catherine E.] Univ Michigan, Sch Med, Dept Pediat & Communicable Dis, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Munich; University of Michigan System; University of Michigan	Nasonkin, IO (corresponding author), NEI, NIH, Bethesda, MD 20892 USA.	scamper@umich.edu		Beuschlein, Felix/0000-0001-7826-3984; Camper, Sally/0000-0001-8556-3379	National Institutes of Health (NIH) [NIH R37HD30428, R01HD34283, T32 GM 07544, T32 HD 07048, T32 GM07863, T32 GM07315]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD030428, R01HD034283] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD030428, T32HD007048] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007863, T32GM007315, T32GM007544] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by National Institutes of Health (NIH) grants and fellowships: NIH R37HD30428, R01HD34283 (SAC), T32 GM 07544 and T32 HD 07048 (ION), T32 GM07863 and T32 GM07315 (RDW). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal G, 2000, J CLIN ENDOCR METAB, V85, P4556, DOI 10.1210/jc.85.12.4556; Andersen B, 1995, DEV BIOL, V172, P495, DOI 10.1006/dbio.1995.8040; Babu PS, 2002, ENDOCRINOLOGY, V143, P665, DOI 10.1210/en.143.2.665; Beuschlein F, 2003, MOL CELL BIOL, V23, P3951, DOI 10.1128/MCB.23.11.3951-3964.2003; BLACK SM, 1993, ENDOCRINOLOGY, V132, P539, DOI 10.1210/en.132.2.539; BORG KE, 1995, P SOC EXP BIOL MED, V210, P126; Bottner A, 2004, J CLIN ENDOCR METAB, V89, P5256, DOI 10.1210/jc.2004-0661; BrownBorg HM, 1996, NATURE, V384, P33, DOI 10.1038/384033a0; BUCKWALTER MS, 1991, GENOMICS, V10, P515, DOI 10.1016/0888-7543(91)90430-M; Burrows HL, 1998, J CLIN INVEST, V101, P1439, DOI 10.1172/JCI1963; Chrousos GP, 1998, ANN NY ACAD SCI, V851, P311, DOI 10.1111/j.1749-6632.1998.tb09006.x; CHROUSOS GP, 1992, JAMA-J AM MED ASSOC, V267, P1244, DOI 10.1001/jama.267.9.1244; Cogan JD, 1998, J CLIN ENDOCR METAB, V83, P3346, DOI 10.1210/jc.83.9.3346; Coll AP, 2004, ENDOCRINOLOGY, V145, P4721, DOI 10.1210/en.2004-0491; Coschigano KT, 2003, ENDOCRINOLOGY, V144, P3799, DOI 10.1210/en.2003-0374; Coulter C. L., 2002, Archives of Physiology and Biochemistry, V110, P99, DOI 10.1076/apab.110.1.99.894; Fluck C, 1998, J CLIN ENDOCR METAB, V83, P3727, DOI 10.1210/jc.83.10.3727; GAGE PJ, 1995, ENDOCRINOLOGY, V136, P1161, DOI 10.1210/en.136.3.1161; Gage PJ, 1996, MOL ENDOCRINOL, V10, P1570, DOI 10.1210/me.10.12.1570; George S, 2004, SCIENCE, V304, P1325, DOI 10.1126/science.1096706; Ghayee HK, 2011, J CLIN ENDOCR METAB, V96, pE243, DOI 10.1210/jc.2010-1222; GOTOH H, 1988, ENDOCRINOLOGY, V123, P1923, DOI 10.1210/endo-123-4-1923; Hershkovitz L, 2007, ENDOCRINOLOGY, V148, P976, DOI 10.1210/en.2006-1100; HOLMES PV, 1971, J ANAT, V108, P159; Hussain K, 2011, SCIENCE, V334, P474, DOI 10.1126/science.1210878; JOB JC, 1989, HORM RES, V31, P149, DOI 10.1159/000181106; Karolyi IJ, 1999, P NATL ACAD SCI USA, V96, P11595, DOI 10.1073/pnas.96.20.11595; Kelberman D, 2009, ENDOCR REV, V30, P790, DOI 10.1210/er.2009-0008; Laron Z, 2004, J CLIN ENDOCR METAB, V89, P1031, DOI 10.1210/jc.2003-031033; Lindsay JR, 2006, J ENDOCRINOL INVEST, V29, P983, DOI 10.1007/BF03349211; Lupu F, 2001, DEV BIOL, V229, P141, DOI 10.1006/dbio.2000.9975; MARKOWSKA A, 1993, CELL TISSUE RES, V272, P439, DOI 10.1007/BF00318550; Mendonca BB, 1999, J CLIN ENDOCR METAB, V84, P942, DOI 10.1210/jc.84.3.942; Mesiano S, 1997, ENDOCR REV, V18, P378, DOI 10.1210/er.18.3.378; Mills JL, 2004, J PEDIATR-US, V144, P430, DOI 10.1016/j.jpeds.2003.12.036; Nasonkin IO, 2004, HUM MOL GENET, V13, P2727, DOI 10.1093/hmg/ddh311; OHTA K, 1992, BIOCHEM BIOPH RES CO, V189, P851, DOI 10.1016/0006-291X(92)92281-2; Parks JS, 1999, J CLIN ENDOCR METAB, V84, P4362, DOI 10.1210/jc.84.12.4362; Pernasetti F, 2000, J CLIN ENDOCR METAB, V85, P390, DOI 10.1210/jc.85.1.390; PFAFFLE RW, 1992, SCIENCE, V257, P1118, DOI 10.1126/science.257.5073.1118; Piekorz RP, 2005, MOL ENDOCRINOL, V19, P431, DOI 10.1210/me.2004-0302; Procter AM, 1998, HUM GENET, V103, P255, DOI 10.1007/s004390050815; RADOVICK S, 1992, SCIENCE, V257, P1115, DOI 10.1126/science.257.5073.1115; Riepe FG, 2001, J CLIN ENDOCR METAB, V86, P4353, DOI 10.1210/jc.86.9.4353; ROUX M, 1982, CELL TISSUE RES, V223, P415, DOI 10.1007/BF01258498; SADEGHIN.A, 1974, J PEDIATR-US, V84, P79, DOI 10.1016/S0022-3476(74)80557-3; Scheys JO, 2011, ENDOCRINOLOGY, V152, P3430, DOI 10.1210/en.2010-0986; SHIRE JGM, 1973, ACTA PATH MICRO IM A, VA 81, P225; Sobrier ML, 2006, J CLIN ENDOCR METAB, V91, P4528, DOI 10.1210/jc.2006-0426; Sornson MW, 1996, NATURE, V384, P327, DOI 10.1038/384327a0; Stratakis CA, 2004, REV ENDOCR METAB DIS, V5, P53, DOI 10.1023/B:REMD.0000016124.44064.8f; Taback SP, 1996, J CLIN ENDOCR METAB, V81, P1693, DOI 10.1210/jc.81.5.1693; TANG KC, 1993, ENDOCRINOLOGY, V132, P2518, DOI 10.1210/en.132.6.2518; VIMPANI GV, 1977, BMJ-BRIT MED J, V2, P427, DOI 10.1136/bmj.2.6084.427; Wang XJ, 1998, ENDOCRINOLOGY, V139, P3903, DOI 10.1210/en.139.9.3903; Ward RD, 2005, MOL ENDOCRINOL, V19, P698, DOI 10.1210/me.2004-0341; Ward RD, 2006, MOL ENDOCRINOL, V20, P1378, DOI 10.1210/me.2005-0409; Wu W, 1998, NAT GENET, V18, P147, DOI 10.1038/ng0298-147; Zhang LP, 2005, CELL METAB, V2, P141, DOI 10.1016/j.cmet.2005.07.002	59	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2011	6	12							e28355	10.1371/journal.pone.0028355	http://dx.doi.org/10.1371/journal.pone.0028355			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MQ	22145038	Green Submitted, Green Published, gold			2022-12-27	WOS:000298168900021
J	Chen, G; Yin, KP; Shi, LM; Fang, YZ; Qi, Y; Li, P; Luo, J; He, B; Liu, MY; Shi, TL				Chen, Geng; Yin, Kangping; Shi, Leming; Fang, Yuanzhang; Qi, Ya; Li, Peng; Luo, Jian; He, Bing; Liu, Mingyao; Shi, Tieliu			Comparative Analysis of Human Protein-Coding and Noncoding RNAs between Brain and 10 Mixed Cell Lines by RNA-Seq	PLOS ONE			English	Article							HUMAN BREAST-CANCER; LEPTIN RECEPTOR; HUMAN GENOME; EXPRESSION; GENE; IDENTIFICATION; TRANSCRIPTS; REVEALS; ELEMENTS; BIOLOGY	In their expression process, different genes can generate diverse functional products, including various protein-coding or noncoding RNAs. Here, we investigated the protein-coding capacities and the expression levels of their isoforms for human known genes, the conservation and disease association of long noncoding RNAs (ncRNAs) with two transcriptome sequencing datasets from human brain tissues and 10 mixed cell lines. Comparative analysis revealed that about two-thirds of the genes expressed between brain and cell lines are the same, but less than one-third of their isoforms are identical. Besides those genes specially expressed in brain and cell lines, about 66% of genes expressed in common encoded different isoforms. Moreover, most genes dominantly expressed one isoform and some genes only generated protein-coding (or noncoding) RNAs in one sample but not in another. We found 282 human genes could encode both protein-coding and noncoding RNAs through alternative splicing in the two samples. We also identified more than 1,000 long ncRNAs, and most of those long ncRNAs contain conserved elements across either 46 vertebrates or 33 placental mammals or 10 primates. Further analysis showed that some long ncRNAs differentially expressed in human breast cancer or lung cancer, several of those differentially expressed long ncRNAs were validated by RT-PCR. In addition, those validated differentially expressed long ncRNAs were found significantly correlated with certain breast cancer or lung cancer related genes, indicating the important biological relevance between long ncRNAs and human cancers. Our findings reveal that the differences of gene expression profile between samples mainly result from the expressed gene isoforms, and highlight the importance of studying genes at the isoform level for completely illustrating the intricate transcriptome.	[Chen, Geng; Yin, Kangping; Fang, Yuanzhang; Qi, Ya; Li, Peng; Luo, Jian; He, Bing; Liu, Mingyao; Shi, Tieliu] E China Normal Univ, Ctr Bioinformat & Comp Biol, Coll Life Sci, Shanghai 200062, Peoples R China; [Chen, Geng; Yin, Kangping; Fang, Yuanzhang; Qi, Ya; Li, Peng; Luo, Jian; He, Bing; Liu, Mingyao; Shi, Tieliu] E China Normal Univ, Inst Biomed Sci, Coll Life Sci, Shanghai 200062, Peoples R China; [Shi, Leming] US FDA, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA; [Shi, Tieliu] Chinese Acad Sci, Shanghai Informat Ctr Life Sci, Shanghai Inst Biol Sci, Shanghai, Peoples R China	East China Normal University; East China Normal University; US Food & Drug Administration (FDA); Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Information Center for Life Sciences	Chen, G (corresponding author), E China Normal Univ, Ctr Bioinformat & Comp Biol, Coll Life Sci, Shanghai 200062, Peoples R China.	tlshi@sibs.ac.cn	Fang, Yuanzhang/H-3047-2019; Shi, Leming/B-3150-2010; Luo, Jian/H-3362-2016	Shi, Leming/0000-0002-7143-2033; Fang, Yuanzhang/0000-0002-6985-9388; Chen, Geng/0000-0002-3452-9434; Liu, Mingyao/0000-0001-7339-5048; He, Bing/0000-0003-1719-9290; Luo, Jian/0000-0003-3583-0154	National 973 Key Basic Research Program [2010CB945401, 2008CB713807, 2007CB108800]; National Natural Science Foundation of China [30870575, 31071162, 31000590]	National 973 Key Basic Research Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National 973 Key Basic Research Program (grant nos. 2010CB945401, 2008CB713807 and 2007CB108800), and the National Natural Science Foundation of China (grant no. 30870575, 31071162, 31000590). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484; Babbitt CC, 2010, GENOME BIOL EVOL, V2, P67, DOI 10.1093/gbe/evq002; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Blume SW, 2003, J CELL BIOCHEM, V88, P165, DOI 10.1002/jcb.10326; Brosnan CA, 2009, CURR OPIN CELL BIOL, V21, P416, DOI 10.1016/j.ceb.2009.04.001; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Cork DMW, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2097; Costa FF, 2005, GENE, V357, P83, DOI 10.1016/j.gene.2005.06.019; Fejes-Toth K, 2009, NATURE, V457, P1028, DOI 10.1038/nature07759; Feng JX, 2011, J COMPUT BIOL, V18, P305, DOI 10.1089/cmb.2010.0243; French PJ, 2007, CANCER RES, V67, P5635, DOI 10.1158/0008-5472.CAN-06-2869; Garofalo C, 2006, CLIN CANCER RES, V12, P1447, DOI 10.1158/1078-0432.CCR-05-1913; Griffith M, 2010, NAT METHODS, V7, P843, DOI [10.1038/NMETH.1503, 10.1038/nmeth.1503]; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Han CZ, 2008, BIOL TRACE ELEM RES, V126, P38, DOI 10.1007/s12011-008-8182-z; Hashimoto K, 2009, BIOCHEM BIOPH RES CO, V390, P1260, DOI 10.1016/j.bbrc.2009.10.132; Huttenhofer A, 2005, TRENDS GENET, V21, P289, DOI 10.1016/j.tig.2005.03.007; Ishikawa M, 2004, CLIN CANCER RES, V10, P4325, DOI 10.1158/1078-0432.CCR-03-0749; Klinck R, 2008, CANCER RES, V68, P657, DOI 10.1158/0008-5472.CAN-07-2580; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Laud K, 2002, MOL CELL ENDOCRINOL, V188, P219, DOI 10.1016/S0303-7207(01)00678-5; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Li B, 2010, BIOINFORMATICS, V26, P493, DOI 10.1093/bioinformatics/btp692; Louro R, 2009, GENOMICS, V93, P291, DOI 10.1016/j.ygeno.2008.11.009; Mallardo M, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-19; Marguerat S, 2010, CELL MOL LIFE SCI, V67, P569, DOI 10.1007/s00018-009-0180-6; Marques AC, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r124; Martianov I, 2007, NATURE, V445, P666, DOI 10.1038/nature05519; Mercer TR, 2008, P NATL ACAD SCI USA, V105, P716, DOI 10.1073/pnas.0706729105; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Nagalakshmi Ugrappa, 2010, Curr Protoc Mol Biol, VChapter 4, DOI 10.1002/0471142727.mb0411s89; Novoradovskaya N, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-20; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Pedraza V, 2010, CANCER-AM CANCER SOC, V116, P486, DOI 10.1002/cncr.24805; Sammeth M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000147; Shi LM, 2010, NAT BIOTECHNOL, V28, P827, DOI 10.1038/nbt.1665; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wilusz JE, 2009, GENE DEV, V23, P1494, DOI 10.1101/gad.1800909; Wrage M, 2009, CLIN CANCER RES, V15, P1566, DOI 10.1158/1078-0432.CCR-08-2188	48	23	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e28318	10.1371/journal.pone.0028318	http://dx.doi.org/10.1371/journal.pone.0028318			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140575	Green Published, Green Submitted, gold			2022-12-27	WOS:000298168100064
J	Dorer, DE; Holtrup, F; Fellenberg, K; Kaufmann, JK; Engelhardt, S; Hoheisel, JD; Nettelbeck, DM				Dorer, Dominik E.; Holtrup, Frank; Fellenberg, Kurt; Kaufmann, Johanna K.; Engelhardt, Sarah; Hoheisel, Joerg D.; Nettelbeck, Dirk M.			Replication and Virus-Induced Transcriptome of HAdV-5 in Normal Host Cells versus Cancer Cells - Differences of Relevance for Adenoviral Oncolysis	PLOS ONE			English	Article							GENE-EXPRESSION; PROTEINS; E1A; IDENTIFICATION; INFECTION; MELANOMA; EFFICACY; MUTANTS; BIOLOGY; VECTORS	Adenoviruses (Ads), especially HAdV-5, have been genetically equipped with tumor-restricted replication potential to enable applications in oncolytic cancer therapy. Such oncolytic adenoviruses have been well tolerated in cancer patients, but their anti-tumor efficacy needs to be enhanced. In this regard, it should be considered that cancer cells, dependent on their tissue of origin, can differ substantially from the normal host cells to which Ads are adapted by complex virus-host interactions. Consequently, viral replication efficiency, a key determinant of oncolytic activity, might be suboptimal in cancer cells. Therefore, we have analyzed both the replication kinetics of HAdV-5 and the virus-induced transcriptome in human bronchial epithelial cells (HBEC) in comparison to cancer cells. This is the first report on genome-wide expression profiling of Ads in their native host cells. We found that E1A expression and onset of viral genome replication are most rapid in HBEC and considerably delayed in melanoma cells. In squamous cell lung carcinoma cells, we observed intermediate HAdV-5 replication kinetics. Infectious particle production, viral spread and lytic activity of HAdV-5 were attenuated in melanoma cells versus HBEC. Expression profiling at the onset of viral genome replication revealed that HAdV-5 induced the strongest changes in the cellular transcriptome in HBEC, followed by lung cancer and melanoma cells. We identified prominent regulation of genes involved in cell cycle and DNA metabolism, replication and packaging in HBEC, which is in accord with the necessity to induce S phase for viral replication. Strikingly, in melanoma cells HAdV-5 triggered opposing regulation of said genes and, in contrast to lung cancer cells, no weak S phase induction was detected when using the E2F promoter as reporter. Our results provide a rationale for improving oncolytic adenoviruses either by adaptation of viral infection to target tumor cells or by modulating tumor cell functions to better support viral replication.	[Dorer, Dominik E.; Kaufmann, Johanna K.; Engelhardt, Sarah; Nettelbeck, Dirk M.] Univ Heidelberg Hosp, Helmholtz Univ Grp Oncolyt Adenoviruses, German Canc Res Ctr, Deutsch Krebsforsch Zentrum DKFZ,Dept Dermatol, Heidelberg, Germany; [Holtrup, Frank; Fellenberg, Kurt; Hoheisel, Joerg D.] German Canc Res Ctr, Deutsch Krebsforschungszentrum DKFZ, Div Funct Genome Anal, Heidelberg, Germany; [Fellenberg, Kurt] Ruhr Univ Bochum, Dept Plant Physiol, Bochum, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruhr University Bochum	Dorer, DE (corresponding author), Univ Heidelberg Hosp, Helmholtz Univ Grp Oncolyt Adenoviruses, German Canc Res Ctr, Deutsch Krebsforsch Zentrum DKFZ,Dept Dermatol, Heidelberg, Germany.	d.nettelbeck@dkfz.de		Nettelbeck, Dirk M./0000-0002-1225-2593	Helmholtz Association of National Research Centers (Helmholtz-University Group); German Cancer Research Center (DKFZ, Deutsches Krebsforschungszentrum); Helmholtz International Graduate School for Cancer Research	Helmholtz Association of National Research Centers (Helmholtz-University Group); German Cancer Research Center (DKFZ, Deutsches Krebsforschungszentrum)(Helmholtz Association); Helmholtz International Graduate School for Cancer Research	This work was supported by the Helmholtz Association of National Research Centers (Helmholtz-University Group Grant), the Intramural Program of the German Cancer Research Center (DKFZ, Deutsches Krebsforschungszentrum) and by fellowships from the Helmholtz International Graduate School for Cancer Research to DED, FH, and JKK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemany R, 2000, NAT BIOTECHNOL, V18, P723, DOI 10.1038/77283; Beissbarth T, 2000, BIOINFORMATICS, V16, P1014; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berk AJ, 2005, ONCOGENE, V24, P7673, DOI 10.1038/sj.onc.1209040; Berk AJ, 2006, FIELDS VIROLOGY, P2356; CLEVELAND WS, 1981, AM STAT, V35, P54, DOI 10.2307/2683591; Cody JJ, 2009, CANCER GENE THER, V16, P473, DOI 10.1038/cgt.2009.3; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dorer DE, 2009, ADV DRUG DELIVER REV, V61, P554, DOI 10.1016/j.addr.2009.03.013; Doronin K, 2000, J VIROL, V74, P6147, DOI 10.1128/JVI.74.13.6147-6155.2000; EBERWINE J, 1992, P NATL ACAD SCI USA, V89, P3010, DOI 10.1073/pnas.89.7.3010; Fellenberg K, 2002, BIOINFORMATICS, V18, P423, DOI 10.1093/bioinformatics/18.3.423; Fellenberg K, 2001, P NATL ACAD SCI USA, V98, P10781, DOI 10.1073/pnas.181597298; Felsani A, 2006, ONCOGENE, V25, P5277, DOI 10.1038/sj.onc.1209621; Glasgow JN, 2006, CANCER GENE THER, V13, P830, DOI 10.1038/sj.cgt.7700928; Granberg F, 2005, VIROLOGY, V343, P236, DOI 10.1016/j.virol.2005.08.023; Granberg F, 2006, VIROLOGY, V353, P1, DOI 10.1016/j.virol.2006.06.019; Gros A, 2008, CANCER RES, V68, P8928, DOI 10.1158/0008-5472.CAN-08-1145; Horwitz MS, 2004, J GENE MED, V6, pS172, DOI 10.1002/jgm.495; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; IKEDA MA, 1993, MOL CELL BIOL, V13, P7029, DOI 10.1128/MCB.13.11.7029; JONES N, 1979, P NATL ACAD SCI USA, V76, P3665, DOI 10.1073/pnas.76.8.3665; Leitner S, 2009, CLIN CANCER RES, V15, P1730, DOI 10.1158/1078-0432.CCR-08-2008; Liu TC, 2007, NAT CLIN PRACT ONCOL, V4, P101, DOI 10.1038/ncponc0736; Liu TC, 2005, GENE THER, V12, P1333, DOI 10.1038/sj.gt.3302555; Lohr K, 2003, J VIROL, V77, P7936, DOI 10.1128/JVI.77.14.7936-7944.2003; Martin MED, 1998, J VIROL, V72, P3146, DOI 10.1128/JVI.72.4.3146-3154.1998; McConnell MJ, 2004, HUM GENE THER, V15, P1022, DOI 10.1089/hum.2004.15.1022; Miller DL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r58; Monfared P, 2008, CANCER RES, V68, P5932, DOI 10.1158/0008-5472.CAN-07-6373; Nettelbeck DM, 2002, CANCER RES, V62, P4663; Oberg D, 2010, CLIN CANCER RES, V16, P541, DOI 10.1158/1078-0432.CCR-09-1960; Pelka P, 2008, J VIROL, V82, P7252, DOI 10.1128/JVI.00104-08; Reid T, 2002, CANCER GENE THER, V9, P979, DOI 10.1038/sj.cgt.7700539; Rohmer S, 2009, VIROLOGY, V395, P243, DOI 10.1016/j.virol.2009.09.030; Sauthoff H, 2004, MOL THER, V10, P749, DOI 10.1016/j.ymthe.2004.07.014; Sauthoff H, 2000, HUM GENE THER, V11, P379, DOI 10.1089/10430340050015851; Schmitz M, 2006, GENE THER, V13, P893, DOI 10.1038/sj.gt.3302739; Simon P, 2003, BIOINFORMATICS, V19, P1439, DOI 10.1093/bioinformatics/btg157; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Steegenga WT, 1998, ONCOGENE, V16, P349, DOI 10.1038/sj.onc.1201540; Subramanian T, 2006, J VIROL, V80, P2000, DOI 10.1128/JVI.80.4.2000-2012.2006; Toth K, 2004, CANCER RES, V64, P3638, DOI 10.1158/0008-5472.CAN-03-3882; Tsukuda K, 2002, CANCER RES, V62, P3438; Wang YH, 2005, CANCER RES, V65, P1523, DOI 10.1158/0008-5472.CAN-04-3113; Weitzman MD, 2005, ONCOGENE, V24, P7686, DOI 10.1038/sj.onc.1209063; Wold WS, 2006, FIELDS VIROLOGY, P2395; Yamamoto M, 2010, MOL THER, V18, P243, DOI 10.1038/mt.2009.266; Yan W, 2003, J VIROL, V77, P2640, DOI 10.1128/JVI.77.4.2640-2650.2003; Zhao HX, 2007, VIROLOGY, V363, P357, DOI 10.1016/j.virol.2007.02.013; Zhao HX, 2003, J VIROL, V77, P11006, DOI 10.1128/JVI.77.20.11006-11015.2003	51	8	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e27934	10.1371/journal.pone.0027934	http://dx.doi.org/10.1371/journal.pone.0027934			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140489	Green Published, gold			2022-12-27	WOS:000298168100026
J	Knierim, E; Lucke, B; Schwarz, JM; Schuelke, M; Seelow, D				Knierim, Ellen; Lucke, Barbara; Schwarz, Jana Marie; Schuelke, Markus; Seelow, Dominik			Systematic Comparison of Three Methods for Fragmentation of Long-Range PCR Products for Next Generation Sequencing	PLOS ONE			English	Article							MUTATIONS	Next Generation Sequencing (NGS) technologies are gaining importance in the routine clinical diagnostic setting. It is thus desirable to simplify the workflow for high-throughput diagnostics. Fragmentation of DNA is a crucial step for preparation of template libraries and various methods are currently known. Here we evaluated the performance of nebulization, sonication and random enzymatic digestion of long-range PCR products on the results of NGS. All three methods produced high-quality sequencing libraries for the 454 platform. However, if long-range PCR products of different length were pooled equimolarly, sequence coverage drastically dropped for fragments below 3,000 bp. All three methods performed equally well with regard to overall sequence quality (PHRED) and read length. Enzymatic fragmentation showed highest consistency between three library preparations but performed slightly worse than sonication and nebulization with regard to insertions/deletions in the raw sequence reads. After filtering for homopolymer errors, enzymatic fragmentation performed best if compared to the results of classic Sanger sequencing. As the overall performance of all three methods was equal with only minor differences, a fragmentation method can be chosen solely according to lab facilities, feasibility and experimental design.	[Knierim, Ellen; Lucke, Barbara; Schwarz, Jana Marie; Schuelke, Markus; Seelow, Dominik] Charite, NeuroCure Clin Res Ctr NCRC, D-13353 Berlin, Germany; [Knierim, Ellen; Lucke, Barbara; Schuelke, Markus] Charite, Dept Neuropediat, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Knierim, E (corresponding author), Charite, NeuroCure Clin Res Ctr NCRC, D-13353 Berlin, Germany.	markus.schuelke@charite.de	Schwarz, Jana Marie/AAZ-7833-2021; Seelow, Dominik/HGB-3124-2022	Schwarz, Jana Marie/0000-0002-7048-208X; Seelow, Dominik/0000-0002-9746-4412; Knierim, Ellen/0000-0002-4769-7322; Schuelke, Markus/0000-0003-2824-3891	Deutsche Forschungsgemeinschaft [SFB 665 C4]; NeuroCure Cluster of Excellence [Exc257]; Einstein Stiftung Berlin [A-2011-63]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NeuroCure Cluster of Excellence; Einstein Stiftung Berlin	This study was supported by grants from the Deutsche Forschungsgemeinschaft (SFB 665 C4 and NeuroCure Cluster of Excellence, Exc257; http://www.dfg.de) and from the Einstein Stiftung Berlin (A-2011-63; http://www.einsteinfoundation.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolze A, 2010, AM J HUM GENET, V87, P873, DOI 10.1016/j.ajhg.2010.10.028; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; Pierce SB, 2011, P NATL ACAD SCI USA, V108, P6543, DOI 10.1073/pnas.1103471108; Richterich P, 1998, GENOME RES, V8, P251, DOI 10.1101/gr.8.3.251; Ronaghi M, 2001, GENOME RES, V11, P3, DOI 10.1101/gr.11.1.3; Seelow D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003874; Trimbuch T, 2009, CELL, V138, P1222, DOI 10.1016/j.cell.2009.06.050; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306	10	81	90	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e28240	10.1371/journal.pone.0028240	http://dx.doi.org/10.1371/journal.pone.0028240			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140562	Green Published, gold, Green Submitted			2022-12-27	WOS:000298168100057
J	Mehla, R; Bivalkar-Mehla, S; Chauhan, A				Mehla, Rajeev; Bivalkar-Mehla, Shalmali; Chauhan, Ashok			A Flavonoid, Luteolin, Cripples HIV-1 by Abrogation of Tat Function	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CARBOXYL-TERMINAL DOMAIN; LOW-LEVEL VIREMIA; GENE-EXPRESSION; ANTIRETROVIRAL THERAPY; QUANTITATIVE ASSAY; AP-1 ACTIVATION; CELL-CYCLE; SUBTYPE-B; T-CELLS	Despite the effectiveness of combination antiretroviral treatment (cART) against HIV-1, evidence indicates that residual infection persists in different cell types. Intensification of cART does not decrease the residual viral load or immune activation. cART restricts the synthesis of infectious virus but does not curtail HIV-1 transcription and translation from either the integrated or unintegrated viral genomes in infected cells. All treated patients with full viral suppression actually have low-level viremia. More than 60% of treated individuals also develop minor HIV-1-associated neurocognitive deficits (HAND) due to residual virus and immune activation. Thus, new therapeutic agents are needed to curtail HIV-1 transcription and residual virus. In this study, luteolin, a dietary supplement, profoundly reduced HIV-1 infection in reporter cells and primary lymphocytes. HIV-1inhibition by luteolin was independent of viral entry, as shown by the fact that wild-type and VSV-pseudotyped HIV-1 infections were similarly inhibited. Luteolin was unable to inhibit viral reverse transcription. Luteolin had antiviral activity in a latent HIV-1 reactivation model and effectively ablated both clade-B- and -C -Tat-driven LTR transactivation in reporter assays but had no effect on Tat expression and its sub-cellular localization. We conclude that luteolin confers anti-HIV-1 activity at the Tat functional level. Given its biosafety profile and ability to cross the blood-brain barrier, luteolin may serve as a base flavonoid to develop potent anti-HIV-1 derivatives to complement cART.	[Mehla, Rajeev; Bivalkar-Mehla, Shalmali; Chauhan, Ashok] Univ S Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC 29208 USA; [Chauhan, Ashok] Univ S Carolina, Sch Med, Dept Pharmacol Physiol & Neurosci, Columbia, SC USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Mehla, R (corresponding author), Univ S Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC 29208 USA.	Ashok.Chauhan@uscmed.sc.edu			National Institutes of Health (NIH) [RO1 NS 050064]; University of South Carolina School of Medicine; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050064] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of South Carolina School of Medicine; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work was supported by the National Institutes of Health (NIH) grant RO1 NS 050064 (AC) and internal funding from the University of South Carolina School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba M, 1998, MOL PHARMACOL, V53, P1097; Bailey JR, 2006, J VIROL, V80, P6441, DOI 10.1128/JVI.00591-06; Boesch-Saadatmandi C, 2011, J NUTR BIOCHEM, V22, P293, DOI 10.1016/j.jnutbio.2010.02.008; Brower ET, 2010, BIOCHEMISTRY-US, V49, P2359, DOI 10.1021/bi1000933; BUKRINSKY MI, 1991, SCIENCE, V254, P423, DOI 10.1126/science.1925601; Butler SL, 2001, NAT MED, V7, P631, DOI 10.1038/87979; Chang LJ, 1999, GENE THER, V6, P715, DOI 10.1038/sj.gt.3300895; Chao SH, 2000, J BIOL CHEM, V275, P28345, DOI 10.1074/jbc.C000446200; Chauhan A, 2003, J BIOL CHEM, V278, P13512, DOI 10.1074/jbc.M209381200; Chauhan A, 2007, FASEB J, V21, P777, DOI 10.1096/fj.06-7054com; Chauhan A, 2007, J CONTROL RELEASE, V117, P148, DOI 10.1016/j.jconrel.2006.10.031; Chen CY, 2007, LIFE SCI, V81, P1602, DOI 10.1016/j.lfs.2007.09.028; Chen HQ, 2008, NEUROSCI LETT, V448, P175, DOI 10.1016/j.neulet.2008.10.046; Choi EM, 2010, FOOD CHEM TOXICOL, V48, P2607, DOI 10.1016/j.fct.2010.06.029; Chun TW, 2011, J INFECT DIS, V204, P135, DOI 10.1093/infdis/jir208; Chun TW, 1999, NAT MED, V5, P651, DOI 10.1038/9498; Col E, 2001, J BIOL CHEM, V276, P28179, DOI 10.1074/jbc.M101385200; Deng LW, 2000, VIROLOGY, V277, P278, DOI 10.1006/viro.2000.0593; Desfosses Y, 2005, J VIROL, V79, P9180, DOI 10.1128/JVI.79.14.9180-9191.2005; Dinoso JB, 2008, CLIN INFECT DIS, V47, P102, DOI 10.1086/588791; ENGELMAN A, 1995, J VIROL, V69, P2729, DOI 10.1128/JVI.69.5.2729-2736.1995; Garber ME, 1998, GENE DEV, V12, P3512, DOI 10.1101/gad.12.22.3512; Gates MA, 2007, INT J CANCER, V121, P2225, DOI 10.1002/ijc.22790; Greene WC, 2002, NAT MED, V8, P673, DOI 10.1038/nm0702-673; Guendel I, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-114; Gulick RM, 1997, NEW ENGL J MED, V337, P734, DOI 10.1056/NEJM199709113371102; Hammer SM, 1997, NEW ENGL J MED, V337, P725, DOI 10.1056/NEJM199709113371101; Hamy F, 2000, CHEM BIOL, V7, P669, DOI 10.1016/S1074-5521(00)00012-0; Hatano H, 2010, AIDS, V24, P2528, DOI 10.1097/QAD.0b013e32833dba03; HE JL, 1995, J VIROL, V69, P6705, DOI 10.1128/JVI.69.11.6705-6711.1995; Hempel J, 1999, NAHRUNG, V43, P201, DOI [10.1002/(SICI)1521-3803(19990601)43:3&lt;201::AID-FOOD201&gt;3.0.CO;2-1, 10.1002/(SICI)1521-3803(19990601)43:3<201::AID-FOOD201>3.3.CO;2-T]; Hwang S, 2003, J BIOL CHEM, V278, P39092, DOI 10.1074/jbc.M301749200; Isel C, 1999, J MOL BIOL, V290, P929, DOI 10.1006/jmbi.1999.2933; Jang S, 2008, P NATL ACAD SCI USA, V105, P7534, DOI 10.1073/pnas.0802865105; Kandathil AJ, 2009, BIOINFORMATION, V4, P237, DOI 10.6026/97320630004237; Karn J, 1999, J MOL BIOL, V293, P235, DOI 10.1006/jmbi.1999.3060; Kiernan RE, 1999, EMBO J, V18, P6106, DOI 10.1093/emboj/18.21.6106; Kim YK, 2002, MOL CELL BIOL, V22, P4622, DOI 10.1128/MCB.22.13.4622-4637.2002; Kurosu T, 2002, MICROBIOL IMMUNOL, V46, P787, DOI 10.1111/j.1348-0421.2002.tb02766.x; Letang E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016946; Levy DN, 2004, P NATL ACAD SCI USA, V101, P4204, DOI 10.1073/pnas.0306764101; Lin PH, 2011, J VIROL, V85, P9114, DOI 10.1128/JVI.00175-11; Liu R, 2011, MOLECULES, V16, P2084, DOI 10.3390/molecules16032084; Mannioui A, 2004, VIROLOGY, V329, P77, DOI 10.1016/j.virol.2004.08.022; Mehla R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011160; Muller M, 2010, LANCET INFECT DIS, V10, P251, DOI 10.1016/S1473-3099(10)70026-8; Noroozi M, 1998, AM J CLIN NUTR, V67, P1210, DOI 10.1093/ajcn/67.6.1210; Ott M, 1999, CURR BIOL, V9, P1489, DOI 10.1016/S0960-9822(00)80120-7; Ozdener H, 2005, J BIOSCIENCES, V30, P391, DOI 10.1007/BF02703676; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Palmer S, 2008, P NATL ACAD SCI USA, V105, P3879, DOI 10.1073/pnas.0800050105; Ranga U, 2004, J VIROL, V78, P2586, DOI 10.1128/JVI.78.5.2586-2590.2004; Richter S, 2004, ANTIMICROB AGENTS CH, V48, P1895, DOI 10.1128/AAC.48.5.1895-1899.2004; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seelinger G, 2008, PLANTA MED, V74, P1667, DOI 10.1055/s-0028-1088314; Shafer RW, 2008, AIDS REV, V10, P67; Shahriar R, 2009, ANTIMICROB AGENTS CH, V53, P4869, DOI 10.1128/AAC.00592-09; Spivak AM, 2011, AIDS RES HUM RETROVI; Stauber RH, 1998, VIROLOGY, V252, P126, DOI 10.1006/viro.1998.9400; Tewtrakul S, 2003, PHYTOTHER RES, V17, P232, DOI 10.1002/ptr.1111; Tilton JC, 2010, J VIROL, V84, P10863, DOI 10.1128/JVI.01109-10; Tilton JC, 2010, AIDS RES HUM RETROV, V26, P13, DOI 10.1089/aid.2009.0132; Vijaykumar TS, 2008, VIROLOGY, V381, P1, DOI 10.1016/j.virol.2008.07.039; VRIJSEN R, 1988, J GEN VIROL, V69, P1749, DOI 10.1099/0022-1317-69-7-1749; Wang D, 2001, J VIROL, V75, P7266, DOI 10.1128/JVI.75.16.7266-7279.2001; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Weinberger LS, 2005, CELL, V122, P169, DOI 10.1016/j.cell.2005.06.006; Wruck CJ, 2007, J NEURAL TRANSM-SUPP, P57; Xu HX, 2000, BIOL PHARM BULL, V23, P1072, DOI 10.1248/bpb.23.1072; Yamamoto N, 2006, VIRUS GENES, V32, P105, DOI 10.1007/s11262-005-5851-2; Yi L, 2004, J VIROL, V78, P11334, DOI 10.1128/JVI.78.20.11334-11339.2004; Yoo DR, 2009, CANCER LETT, V282, P48, DOI 10.1016/j.canlet.2009.02.051; Yuan DK, 2007, BIOORGAN MED CHEM, V15, P265, DOI 10.1016/j.bmc.2006.09.062; Zhang RN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015620; Zhao G, 2010, NEUROBIOL AGING 0409; Zhu YR, 1997, GENE DEV, V11, P2622, DOI 10.1101/gad.11.20.2622	76	43	45	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e27915	10.1371/journal.pone.0027915	http://dx.doi.org/10.1371/journal.pone.0027915			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140483	gold, Green Published, Green Submitted			2022-12-27	WOS:000298168100024
J	Chen, LH; Kuo, WH; Tsai, MH; Chen, PC; Hsiao, CHK; Chuang, EY; Chang, LY; Hsieh, FJ; Lai, LC; Chang, KJ				Chen, Lee H.; Kuo, Wen-Hung; Tsai, Mong-Hsun; Chen, Pei-Chun; Hsiao, Chuhsing K.; Chuang, Eric Y.; Chang, Li-Yun; Hsieh, Fon-Jou; Lai, Liang-Chuan; Chang, King-Jen			Identification of Prognostic Genes for Recurrent Risk Prediction in Triple Negative Breast Cancer Patients in Taiwan	PLOS ONE			English	Article							MOLECULAR PORTRAITS; EXPRESSION; SUBTYPES; RECEPTOR; CARCINOMAS; PATTERNS; SURVIVAL; TUMORS; CELLS	Discrepancies in the prognosis of triple negative breast cancer exist between Caucasian and Asian populations. Yet, the gene signature of triple negative breast cancer specifically for Asians has not become available. Therefore, the purpose of this study is to construct a prediction model for recurrence of triple negative breast cancer in Taiwanese patients. Whole genome expression profiling of breast cancers from 185 patients in Taiwan from 1995 to 2008 was performed, and the results were compared to the previously published literature to detect differences between Asian and Western patients. Pathway analysis and Cox proportional hazard models were applied to construct a prediction model for the recurrence of triple negative breast cancer. Hierarchical cluster analysis showed that triple negative breast cancers from different races were in separate sub-clusters but grouped in a bigger cluster. Two pathways, cAMP-mediated signaling and ephrin receptor signaling, were significantly associated with the recurrence of triple negative breast cancer. After using stepwise model selection from the combination of the initial filtered genes, we developed a prediction model based on the genes SLC22A23, PRKAG3, DPEP3, MORC2, GRB7, and FAM43A. The model had 91.7% accuracy, 81.8% sensitivity, and 94.6% specificity under leave-one-out support vector regression. In this study, we identified pathways related to triple negative breast cancer and developed a model to predict its recurrence. These results could be used for assisting with clinical prognosis and warrant further investigation into the possibility of targeted therapy of triple negative breast cancer in Taiwanese patients.	[Chen, Lee H.; Tsai, Mong-Hsun; Hsiao, Chuhsing K.; Chuang, Eric Y.; Lai, Liang-Chuan] Natl Taiwan Univ, Ctr Genom Med, Taipei 10764, Taiwan; [Kuo, Wen-Hung; Chang, King-Jen] Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan; [Tsai, Mong-Hsun] Natl Taiwan Univ, Inst Biotechnol, Taipei 10764, Taiwan; [Chen, Pei-Chun] Providence Univ, Dept Stat & Bioinformat Sci, Taichung, Taiwan; [Hsiao, Chuhsing K.] Natl Taiwan Univ, Dept Publ Hlth, Taipei 10764, Taiwan; [Chuang, Eric Y.] Natl Taiwan Univ, Grad Inst Biomed Elect & Bioinformat, Taipei 10764, Taiwan; [Chang, Li-Yun; Hsieh, Fon-Jou] Natl Taiwan Univ Hosp, Dept Obstet & Gynecol, Taipei, Taiwan; [Lai, Liang-Chuan] Natl Taiwan Univ, Grad Inst Physiol, Taipei 10764, Taiwan; [Chang, King-Jen] Cheng Ching Gen Hosp, Dept Surg, Taichung, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; Providence University - Taiwan; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University	Chen, LH (corresponding author), Natl Taiwan Univ, Ctr Genom Med, Taipei 10764, Taiwan.	llai@ntu.edu.tw; kingjen@ntu.edu.tw	Lai, Liang-Chuan/B-4768-2009	Lai, Liang-Chuan/0000-0002-3913-5338; TSAI, MONG-HSUN/0000-0001-8777-5818; Chang, King jen/0000-0001-9811-3422; KUO, WEN-HUNG/0000-0002-9881-4605; hsiao, chuhsing kate/0000-0003-4905-8484	National Science Council, Taiwan [97-2314-B-002-154-MY3]; Center of Genomic Medicine, National Taiwan University	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Center of Genomic Medicine, National Taiwan University(National Taiwan University)	Financial support provided by the National Science Council, Taiwan (Grant No. 97-2314-B-002-154-MY3) and the Center of Genomic Medicine, National Taiwan University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bureau of Health Promotion DoH ROC Taiwan, 2010, CANC REG ANN REP 200; Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Cheung PCF, 2000, BIOCHEM J, V346, P659, DOI 10.1042/0264-6021:3460659; Cleator S, 2007, LANCET ONCOL, V8, P235, DOI 10.1016/S1470-2045(07)70074-8; Deblois G, 2009, CANCER RES, V69, P6149, DOI 10.1158/0008-5472.CAN-09-1251; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; El-Rehim DMA, 2004, J PATHOL, V203, P661, DOI 10.1002/path.1559; Fan C, 2006, NEW ENGL J MED, V355, P560, DOI 10.1056/NEJMoa052933; Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang E, 2003, LANCET, V361, P1590, DOI 10.1016/S0140-6736(03)13308-9; Kim MJ, 2006, HUM PATHOL, V37, P1217, DOI 10.1016/j.humpath.2006.04.015; Kurebayashi J, 2007, BREAST, V16, pS72, DOI 10.1016/j.breast.2007.07.017; Lin C, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-192; Ma XJ, 2004, CANCER CELL, V5, P607, DOI 10.1016/j.ccr.2004.05.015; Marsh S, 2001, Clin Colorectal Cancer, V1, P175, DOI 10.3816/CCC.2001.n.018; Milan D, 2000, SCIENCE, V288, P1248, DOI 10.1126/science.288.5469.1248; Peppercorn J, 2008, CANCER INVEST, V26, P1, DOI 10.1080/07357900701784238; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Saif MW, 2008, CUTAN OCUL TOXICOL, V27, P311, DOI 10.1080/15569520802355774; Sato K, 2008, BIOSCI BIOTECH BIOCH, V72, P2589, DOI 10.1271/bbb.80279; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Tripathi A, 2008, INT J CANCER, V122, P1557, DOI 10.1002/ijc.23267; van de Rijn M, 2002, AM J PATHOL, V161, P1991, DOI 10.1016/S0002-9440(10)64476-8; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; West M, 2001, P NATL ACAD SCI USA, V98, P11462, DOI 10.1073/pnas.201162998; Wykosky J, 2007, MOL CANCER THER, V6, P3208, DOI 10.1158/1535-7163.MCT-07-0200; Zhang W, 2010, ONCOGENE, V29, P2467, DOI 10.1038/onc.2010.12	32	19	23	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2011	6	11							e28222	10.1371/journal.pone.0028222	http://dx.doi.org/10.1371/journal.pone.0028222			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863LT	22140552	Green Published, Green Submitted, gold			2022-12-27	WOS:000298166300040
J	del Giudice, EM; Grandone, A; Cirillo, G; Santoro, N; Amato, A; Brienza, C; Savarese, P; Marzuillo, P; Perrone, L				del Giudice, Emanuele Miraglia; Grandone, Anna; Cirillo, Grazia; Santoro, Nicola; Amato, Alessandra; Brienza, Carmine; Savarese, Piera; Marzuillo, Pierluigi; Perrone, Laura			The Association of PNPLA3 Variants with Liver Enzymes in Childhood Obesity Is Driven by the Interaction with Abdominal Fat	PLOS ONE			English	Article							TO-HEIGHT RATIO; INSULIN SENSITIVITY INDEXES; DOMAIN-CONTAINING 3; WAIST CIRCUMFERENCE; DISEASE; CHILDREN; I148M; SEVERITY; RISK; GENE	Background and Aims: A polymorphism in adiponutrin/ patatin-like phospholipase-3 gene (PNPLA3), rs738409 C->G, encoding for the I148M variant, is the strongest genetic determinant of liver fat and ALT levels in adulthood and childhood obesity. Aims of this study were i) to analyse in a large group of obese children the role of the interaction of not-genetic factors such as BMI, waist circumference (W/Hr) and insulin resistance (HOMA-IR) in exposing the association between the I148M polymorphism and ALT levels and ii) to stratify the individual risk of these children to have liver injury on the basis of this gene-environment interaction. Methods: 1048 Italian obese children were investigated. Anthropometric, clinical and metabolic data were collected and the PNPLA3 I148M variant genotyped. Results: Children carrying the 148M allele showed higher ALT and AST levels (p = 0.000006 and p = 0.0002, respectively). Relationships between BMI-SDS, HOMA-IR and W/Hr with ALT were analysed in function of the different PNPLA3 genotypes. Children 148M homozygous showed a stronger correlation between ALT and W/Hr than those carrying the other genotypes (p: 0.0045) and, therefore, 148M homozygotes with high extent of abdominal fat (W/Hr above 0.62) had the highest OR (4.9, 95% C. I. 3.2-7.8, p = 0.00001) to develop pathologic ALT. Conclusions: We have i) showed for the first time that the magnitude of the association of PNPLA3 with liver enzymes is driven by the size of abdominal fat and ii) stratified the individual risk to develop liver damage on the basis of the interaction between the PNPLA3 genotype and abdominal fat.	[del Giudice, Emanuele Miraglia; Grandone, Anna; Cirillo, Grazia; Amato, Alessandra; Brienza, Carmine; Savarese, Piera; Marzuillo, Pierluigi; Perrone, Laura] Univ Naples 2, Dept Pediat, Naples, Italy; [Santoro, Nicola] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA	Universita della Campania Vanvitelli; Yale University	del Giudice, EM (corresponding author), Univ Naples 2, Dept Pediat, Naples, Italy.	emanuele.miraglia@unina2.it	Marzuillo, Pierluigi/J-7447-2018; del Giudice, Emanuele Muraglia/AAC-2824-2019; Santoro, Nicola/A-4897-2014	Marzuillo, Pierluigi/0000-0003-4682-0170; Santoro, Nicola/0000-0001-6437-4173; GRANDONE, Anna/0000-0002-6343-4768; Perrone, Laura/0000-0002-8647-3938				ABATE N, 1995, J CLIN INVEST, V96, P88, DOI 10.1172/JCI118083; Ashwell M, 2005, INT J FOOD SCI NUTR, V56, P303, DOI 10.1080/09637480500195066; Baumeister SE, 2008, GASTROENTEROLOGY, V134, P85, DOI 10.1053/j.gastro.2007.10.024; Browning JD, 2010, HEPATOLOGY, V52, P1189, DOI 10.1002/hep.23946; Chandalia M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000812; COLE TJ, 1990, EUR J CLIN NUTR, V44, P45; Day C P, 2004, Clin Liver Dis, V8, P673, DOI 10.1016/j.cld.2004.04.001; Day CP, 2006, GASTROENTEROLOGY, V130, P207, DOI 10.1053/j.gastro.2005.11.017; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Feldstein AE, 2009, GUT, V58, P1538, DOI 10.1136/gut.2008.171280; Hara Mitsuhiko, 2002, J Atheroscler Thromb, V9, P127; He SQ, 2010, J BIOL CHEM, V285, P6706, DOI 10.1074/jbc.M109.064501; Hsieh SD, 2003, INT J OBESITY, V27, P610, DOI 10.1038/sj.ijo.0802259; Kantartzis K, 2009, DIABETES, V58, P2616, DOI 10.2337/db09-0279; Lohman TG, 1988, ANTROPOMETRIC STANDA; Maffeis C, 2008, J PEDIATR-US, V152, P207, DOI 10.1016/j.jpeds.2007.09.021; Manco M, 2008, GUT, V57, P1283, DOI 10.1136/gut.2007.142919; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; McCarthy HD, 2006, INT J OBESITY, V30, P988, DOI 10.1038/sj.ijo.0803226; Pare G, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000981; Roberts Eve A, 2007, Clin Liver Dis, V11, P155, DOI 10.1016/j.cld.2007.02.008; Roden M, 2006, NAT CLIN PRACT ENDOC, V2, P335, DOI 10.1038/ncpendmet0190; Romeo S, 2010, INT J OBESITY, V34, P190, DOI 10.1038/ijo.2009.216; Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257; Romeo S, 2010, J HEPATOL, V53, P335, DOI 10.1016/j.jhep.2010.02.034; Rotman Y, 2010, HEPATOLOGY, V52, P894, DOI 10.1002/hep.23759; Santoro N, 2010, HEPATOLOGY, V52, P1281, DOI 10.1002/hep.23832; Savva SC, 2000, INT J OBESITY, V24, P1453, DOI 10.1038/sj.ijo.0801401; Speliotes EK, 2010, HEPATOLOGY, V52, P904, DOI 10.1002/hep.23768; Strauss RS, 2000, J PEDIATR-US, V136, P727, DOI 10.1016/S0022-3476(00)24645-3; TANNER JM, 1976, ARCH DIS CHILD, V51, P170, DOI 10.1136/adc.51.3.170; Valenti L, 2010, HEPATOLOGY, V52, P1274, DOI 10.1002/hep.23823; Valenti L, 2010, HEPATOLOGY, V51, P1209, DOI 10.1002/hep.23622; van der Poorten D, 2008, HEPATOLOGY, V48, P449, DOI 10.1002/hep.22350; Wieckowska A, 2007, HEPATOLOGY, V46, P582, DOI 10.1002/hep.21768; Wieckowska A, 2006, HEPATOLOGY, V44, P27, DOI 10.1002/hep.21223; Wilson PA, 2006, J LIPID RES, V47, P1940, DOI 10.1194/jlr.M600185-JLR200; Yeckel CW, 2004, J CLIN ENDOCR METAB, V89, P1096, DOI 10.1210/jc.2003-031503; Yuan X, 2008, AM J HUM GENET, V83, P520, DOI 10.1016/j.ajhg.2008.09.012; Zou CB, 2007, NAT MED, V13, P1078, DOI 10.1038/nm1625	40	66	66	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2011	6	11							e27933	10.1371/journal.pone.0027933	http://dx.doi.org/10.1371/journal.pone.0027933			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KW	22140488	gold, Green Published, Green Submitted			2022-12-27	WOS:000298163400025
J	Johnston, L; Titov, N; Andrews, G; Spence, J; Dear, BF				Johnston, Luke; Titov, Nickolai; Andrews, Gavin; Spence, Jay; Dear, Blake F.			A RCT of a Transdiagnostic Internet-Delivered Treatment for Three Anxiety Disorders: Examination of Support Roles and Disorder-Specific Outcomes	PLOS ONE			English	Article							COGNITIVE-BEHAVIORAL THERAPY; RANDOMIZED CONTROLLED-TRIAL; PSYCHOMETRIC PROPERTIES; SOCIAL PHOBIA; PRIMARY-CARE; DEPRESSION; VALIDATION; COMPUTER; INTERVIEW; SEVERITY	Background: Anxiety disorders share common vulnerabilities and symptoms. Disorder-specific treatment is efficacious, but few access evidence-based care. Administering transdiagnostic cognitive-behavioral therapy via the internet (iCBT) may increase access to evidence-based treatment, with a recent randomized controlled trial (RCT) providing preliminary support for this approach. This study extends those findings and aims to answer three questions: Is a transdiagnostic iCBT program for anxiety disorders efficacious and acceptable? Does it result in change for specific disorders? Can good clinical outcomes be obtained when guidance is provided via a Coach rather than a Clinician? Method: RCT (N = 131) comparing three groups: Clinician-supported (CL) vs. Coach-supported (CO) vs. waitlist control (Control). Individuals met DSM-IV criteria for a principal diagnosis of generalized anxiety disorder (GAD), social phobia (SP) or panic disorder with or without agoraphobia (Pan/Ag). Treatment consisted of an 8-lesson/10 week iCBT program with weekly contact from a Clinician or Coach, and follow-up at 3-months post-treatment. Results: Outcomes for the pooled treatment groups (CL+CO) were superior to the Control group on measures of anxiety, depression and disability, were associated with medium to large effect sizes (Cohen's d=.76 - 1.44) (response rate = 89-100%), and were maintained at follow-up. Significant reductions were found on disorder-specific outcomes for each of the target diagnoses, and were associated with large effect sizes. CO participants achieved similar outcomes to CL participants at post-treatment, yet had significantly lower symptom severity scores on general anxiety, panic-disorder, depression and disability at follow-up (d=.45 - .46). Seventy-four percent of CO and 76% of CL participants completed the program. Less than 70 minutes of Clinician or Coach time was required per participant during the program. Discussion: This transdiagnostic iCBT course for anxiety appears to be efficacious, associated with significant change for three target disorders, and is efficacious when guided by either a Clinician or Coach.	[Johnston, Luke; Andrews, Gavin] Univ New S Wales, Sch Psychiat, CRUfAD, St Vincents Hosp, Sydney, NSW, Australia; [Titov, Nickolai; Spence, Jay; Dear, Blake F.] Macquarie Univ, Dept Psychol, Ctr Emot Hlth, ECentreClin, Sydney, NSW 2109, Australia	St Vincents Hospital Sydney; University of New South Wales Sydney; Macquarie University	Johnston, L (corresponding author), Univ New S Wales, Sch Psychiat, CRUfAD, St Vincents Hosp, Sydney, NSW, Australia.	luke.johnston@mq.edu.au	Andrews, Gavin/J-6537-2012	Andrews, Gavin/0000-0002-4315-2173; Titov, Nickolai/0000-0002-7268-729X; Dear, Blake/0000-0001-9324-3092	National Health and Medical Research Council of Australia; New South Wales Institute of Psychiatry; Australian Rotary Health Research Fund	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); New South Wales Institute of Psychiatry; Australian Rotary Health Research Fund	The authors gratefully acknowledge the National Health and Medical Research Council of Australia: Dora Lush Priority PhD scholarship (http://www.nhmrc.gov.au), the New South Wales Institute of Psychiatry (http://www.nswiop.nsw.edu.au), and the Australian Rotary Health Research Fund (http://www.australianrotaryhealth.org.au) for contributing to the funding of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; Andersson Gerhard, 2009, Cognitive Behaviour Therapy, V38, P55, DOI 10.1080/16506070902916400; Andersson Gerhard, 2011, Cognitive Behaviour Therapy, V40, P57, DOI 10.1080/16506073.2010.529457; Andersson Gerhard, 2009, Cognitive Behaviour Therapy, V38, P196, DOI 10.1080/16506070903318960; ANDREWS G, 2003, TREATMENT ANXIETY DI; Andrews G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013196; Antony MM, 1998, PSYCHOL ASSESSMENT, V10, P176, DOI 10.1037/1040-3590.10.2.176; Barlow DH, 2004, BEHAV THER, V35, P205, DOI 10.1016/S0005-7894(04)80036-4; Bennett-Levy J., 2010, OXFORD GUIDE LOW INT, P3, DOI DOI 10.1093/MED:PSYCH/9780199590117.003.0001; BROWN TA, 1992, BEHAV RES THER, V30, P33, DOI 10.1016/0005-7967(92)90093-V; Burgess PM, 2009, AUST NZ J PSYCHIAT, V43, P615, DOI 10.1080/00048670902970858; Carlbring P, 2007, COMPUT HUM BEHAV, V23, P1421, DOI 10.1016/j.chb.2005.05.002; Carlbring P, 2011, BEHAV RES THER, V49, P18, DOI 10.1016/j.brat.2010.10.002; Clark David A., 2009, Cognitive Behaviour Therapy, V38, P29, DOI 10.1080/16506070902980745; Clark DM, 2009, BEHAV RES THER, V47, P910, DOI 10.1016/j.brat.2009.07.010; Cuijpers Pim, 2009, Cognitive Behaviour Therapy, V38, P66, DOI 10.1080/16506070802694776; Devilly GJ, 2000, J BEHAV THER EXP PSY, V31, P73, DOI 10.1016/S0005-7916(00)00012-4; Donker T, 2010, J AFFECT DISORDERS, V122, P253, DOI 10.1016/j.jad.2009.07.013; Erickson DH, 2009, J COGN PSYCHOTHER, V23, P34, DOI 10.1891/0889-8391.23.1.34; Garb HN, 2007, PSYCHOL ASSESSMENT, V19, P4, DOI 10.1037/1040-3590.19.1.4; Goldberg DP, 2009, PSYCHOL MED, V39, P2043, DOI 10.1017/S0033291709990298; Hedman E, 2010, COMPUT HUM BEHAV, V26, P736, DOI 10.1016/j.chb.2010.01.010; Houck PR, 2002, DEPRESS ANXIETY, V15, P183, DOI 10.1002/da.10049; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kroenke K, 2010, GEN HOSP PSYCHIAT, V32, P345, DOI 10.1016/j.genhosppsych.2010.03.006; Lecrubier Y, 1997, EUR PSYCHIAT, V12, P224, DOI 10.1016/S0924-9338(97)83296-8; Leon AC, 1997, INT J PSYCHIAT MED, V27, P93, DOI 10.2190/T8EM-C8YH-373N-1UWD; Lowe B, 2008, MED CARE, V46, P266, DOI 10.1097/MLR.0b013e318160d093; Lovibond SH., 1995, MANUAL DEPRESSION AN, V56; Mansell W, 2009, J COGN PSYCHOTHER, V23, P6, DOI 10.1891/0889-8391.23.1.6; Marks IM, 2004, PSYCHOL MED, V34, P9, DOI 10.1017/S003329170300878X; Mattick RP, 1998, BEHAV RES THER, V36, P455, DOI 10.1016/S0005-7967(97)10031-6; McEvoy PM, 2009, J COGN PSYCHOTHER, V23, P20, DOI 10.1891/0889-8391.23.1.20; MEYER TJ, 1990, BEHAV RES THER, V28, P487, DOI 10.1016/0005-7967(90)90135-6; Norton PJ, 2008, PSYCHOTHERAPY, V45, P214, DOI 10.1037/0033-3204.45.2.214; Norton PJ, 2007, J NERV MENT DIS, V195, P521, DOI 10.1097/01.nmd.0000253843.70149.9a; Norton PJ, 2005, J BEHAV THER EXP PSY, V36, P79, DOI 10.1016/j.jbtep.2004.07.002; Page AC, 2003, J NERV MENT DIS, V191, P653, DOI 10.1097/01.nmd.0000092174.38770.e9; Peters L, 2011, PSYCHOL ASSESSMENT; Proudfoot J, 2004, BRIT J PSYCHIAT, V185, P46, DOI 10.1192/bjp.185.1.46; Richards DA, 2009, BRIT J CLIN PSYCHOL, V48, P377, DOI 10.1348/014466509X405178; Robinson E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010942; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Sheehan DV., 1983, ANXIETY DIS; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Titov N, 2008, AUST NZ J PSYCHIAT, V42, P595, DOI 10.1080/00048670802119820; Titov N, 2010, BEHAV RES THER, V48, P890, DOI 10.1016/j.brat.2010.05.014; Titov N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010939; Titov N, 2009, AUST NZ J PSYCHIAT, V43, P920, DOI 10.1080/00048670903179228; Titov N, 2009, AUST NZ J PSYCHIAT, V43, P905, DOI 10.1080/00048670903179269; Titov N, 2009, AUST NZ J PSYCHIAT, V43, P913, DOI 10.1080/00048670903179160; Titov N, 2009, AUST NZ J PSYCHIAT, V43, P36, DOI 10.1080/00048670802534424; Vickers AJ, 2005, PSYCHOSOM MED, V67, P652, DOI 10.1097/01.psy.0000172624.52957.a8; Vickers Andrew J, 2005, BMC Med Res Methodol, V5, P35, DOI 10.1186/1471-2288-5-35; Wilamowska ZA, 2010, DEPRESS ANXIETY, V27, P882, DOI 10.1002/da.20735; Wims E, 2010, AUST NZ J PSYCHIAT, V44, P599, DOI 10.3109/00048671003614171	56	89	89	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e28079	10.1371/journal.pone.0028079	http://dx.doi.org/10.1371/journal.pone.0028079			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	863KL	22132216	gold, Green Published, Green Submitted			2022-12-27	WOS:000298162000069
J	Wang, Y; Choi, JY; Roh, JY; Liu, Q; Tao, XY; Park, JB; Kim, JS; Je, YH				Wang, Yong; Choi, Jae Young; Roh, Jong Yul; Liu, Qin; Tao, Xue Ying; Park, Jong Bin; Kim, Jae Su; Je, Yeon Ho			Genomic Sequence Analysis of Granulovirus Isolated from the Tobacco Cutworm, Spodoptera litura	PLOS ONE			English	Article							BOMBYX-MORI-NUCLEOPOLYHEDROVIRUS; NUCLEAR-POLYHEDROSIS-VIRUS; OCCLUSION-DERIVED VIRUS; OPEN READING FRAMES; PHYLOGENETIC ANALYSIS; BACULOVIRUS GENE; PERITROPHIC MEMBRANE; TRICHOPLUSIA-NI; APOPTOSIS; BRO	Background: Spodoptera litura is a noctuid moth that is considered an agricultural pest. The larvae feed on a wide range of plants and have been recorded on plants from 40 plant families (mostly dicotyledons). It is a major pest of many crops. To better understand Spodoptera litura granulovirus (SpliGV), the nucleotide sequence of the SpliGV DNA genome was determined and analyzed. Methodology/Principal Findings: The genome of the SpliGV was completely sequenced. The nucleotide sequence of the SpliGV genome was 124,121 bp long with 61.2% A+T content and contained 133 putative open reading frames (ORFs) of 150 or more nucleotides. The 133 putative ORFs covered 86.3% of the genome. Among these, 31 ORFs were conserved in most completely sequenced baculovirus genomes, 38 were granulovirus (GV)-specific, and 64 were present in some nucleopolyhedroviruses (NPVs) and/or GVs. We proved that 9 of the ORFs were SpliGV specific. Conclusions/Significance: The genome of SpliGV is 124,121 bp in size. One hundred thirty-three ORFs that putatively encode proteins of 50 or more amino acid residues with minimal overlap were determined. No chitinase or cathepsin genes, which are involved in the liquefaction of the infected host, were found in the SpliGV genome, explaining why SpliGV-infected insects do not degrade in a typical manner. The DNA photolyase gene was first found in the genus Granulovirus. When phylogenic relationships were analyzed, the SpliGV was most closely related to Trichoplusia ni granulovirus (TnGV) and Xestia c-nigrum granulovirus (XecnGV), which belong to the Type I-granuloviruses (Type I-GV).	[Wang, Yong; Choi, Jae Young; Roh, Jong Yul; Liu, Qin; Tao, Xue Ying; Park, Jong Bin; Je, Yeon Ho] Seoul Natl Univ, Dept Agr Biotechnol, Coll Agr & Life Sci, Seoul, South Korea; [Kim, Jae Su] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Wang, Y (corresponding author), Lanzhou Univ, Sch Life Sci, Lanzhou 730000, Peoples R China.	btrus@snu.ac.kr	Tao, XueYing/ABG-6993-2021; Kim, Jae Su/L-2194-2013; Choi, Jae Young/G-1731-2010	Tao, XueYing/0000-0002-6539-4659; 	Next-Generation BioGreen 21 Program [PJ008036]; Rural Development Administration, Republic of Korea; Brain Korea 21 project	Next-Generation BioGreen 21 Program(Rural Development Administration (RDA), Republic of Korea); Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea); Brain Korea 21 project(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea)	This work was supported by a grant from the Next-Generation BioGreen 21 Program (No. PJ008036), Rural Development Administration, Republic of Korea. YW, QL, XYT, and JBP were supported by 2nd stage of the Brain Korea 21 project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armes NJ, 1997, PESTIC SCI, V50, P240, DOI 10.1002/(SICI)1096-9063(199707)50:3&lt;240::AID-PS579&gt;3.0.CO;2-9; AYRES MD, 1994, VIROLOGY, V202, P586, DOI 10.1006/viro.1994.1380; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bideshi DK, 2003, J GEN VIROL, V84, P2531, DOI 10.1099/vir.0.19256-0; BIRNBAUM MJ, 1994, J VIROL, V68, P2521, DOI 10.1128/JVI.68.4.2521-2528.1994; Braunagel SC, 2007, CURR DRUG TARGETS, V8, P1084, DOI 10.2174/138945007782151315; Bulach DM, 1999, J INVERTEBR PATHOL, V73, P59, DOI 10.1006/jipa.1998.4797; CLEM RJ, 1991, SCIENCE, V254, P1388, DOI 10.1126/science.1962198; CROOK NE, 1993, J VIROL, V67, P2168, DOI 10.1128/JVI.67.4.2168-2174.1993; DERKSEN ACG, 1988, VIROLOGY, V167, P242, DOI 10.1016/0042-6822(88)90074-8; Du QS, 1999, J VIROL, V73, P1278, DOI 10.1128/JVI.73.2.1278-1285.1999; Escasa SR, 2006, J GEN VIROL, V87, P1917, DOI 10.1099/vir.0.81792-0; Fang MG, 2009, J VIROL, V83, P12569, DOI 10.1128/JVI.01141-09; Faulkner P, 1997, J GEN VIROL, V78, P3091, DOI 10.1099/0022-1317-78-12-3091; Federici B.A., 1997, BACULOVIRUSES VIRUSE, P33, DOI [10.1007/978-1-4899-1834-5_3, DOI 10.1007/978-1-4899-1834-5_3]; FITCH WM, 1971, SYST ZOOL, V20, P406, DOI 10.2307/2412116; Friesen PD, 1997, BACULOVIRUSES, P141; Gomi S, 1999, J GEN VIROL, V80, P1323, DOI 10.1099/0022-1317-80-5-1323; Haas AL, 1996, BIOCHEMISTRY-US, V35, P5385, DOI 10.1021/bi9524981; Haas-Stapleton EJ, 2004, J VIROL, V78, P6786, DOI 10.1128/JVI.78.13.6786-6791.2004; Harrison RL, 2008, VIRUS GENES, V36, P565, DOI 10.1007/s11262-008-0218-0; HASHIMOTO Y, 1991, J GEN VIROL, V72, P2645, DOI 10.1099/0022-1317-72-11-2645; Hashimoto Y, 2000, VIROLOGY, V275, P358, DOI 10.1006/viro.2000.0530; Hay S, 2002, J GEN VIROL, V83, P1547, DOI 10.1099/0022-1317-83-7-1547; Hayakawa T, 1999, VIROLOGY, V262, P277, DOI 10.1006/viro.1999.9894; Herniou EA, 2003, ANNU REV ENTOMOL, V48, P211, DOI 10.1146/annurev.ento.48.091801.112756; IJkel WFJ, 1999, J GEN VIROL, V80, P3289, DOI 10.1099/0022-1317-80-12-3289; Jehle JA, 2006, ARCH VIROL, V151, P1257, DOI 10.1007/s00705-006-0763-6; Jehle JA, 2006, VIROLOGY, V346, P180, DOI 10.1016/j.virol.2005.10.032; Kang WK, 2003, ARCH VIROL, V148, P99, DOI 10.1007/s00705-002-0902-7; Kang WK, 2006, VIROLOGY, V350, P184, DOI 10.1016/j.virol.2006.01.008; Kang WY, 1999, J VIROL, V73, P10339, DOI 10.1128/JVI.73.12.10339-10345.1999; Kikhno I, 2002, J GEN VIROL, V83, P3013, DOI 10.1099/0022-1317-83-12-3013; Kuzio J, 1999, VIROLOGY, V253, P17, DOI 10.1006/viro.1998.9469; Lange M, 2003, VIROLOGY, V317, P220, DOI 10.1016/S0042-6822(03)00515-4; Lu A, 1997, BACULOVIRUSES, P193; LU A, 1997, BACULOVIRUSES, P171; Luque T, 2001, J GEN VIROL, V82, P2531, DOI 10.1099/0022-1317-82-10-2531; MARTIGNONI ME, 1981, MICROBIAL CONTROL PE, P879; MURPHY FA, 1995, ARCH VIROL, P1; Nakai M, 2003, VIROLOGY, V316, P171, DOI 10.1016/j.virol.2003.08.002; Ohkawa T, 2005, J VIROL, V79, P15258, DOI 10.1128/JVI.79.24.15258-15264.2005; OReilly D.R., 1992, BACULOVIRUS EXPRESSI; OREILLY DR, 1997, BACULOVIRUSES, P267; Pang Y, 2001, VIROLOGY, V287, P391, DOI 10.1006/viro.2001.1056; Pei ZF, 2002, J BIOL CHEM, V277, P48677, DOI 10.1074/jbc.M208810200; Pijlman GP, 2003, J GEN VIROL, V84, P2041, DOI 10.1099/vir.0.19133-0; Rapp JC, 1998, J VIROL, V72, P10197, DOI 10.1128/JVI.72.12.10197-10206.1998; Rashidan KK, 2004, J BIOCHEM MOL BIOL, V37, P206; Reilly LM, 1996, VIROLOGY, V218, P243, DOI 10.1006/viro.1996.0185; ROELVINK PW, 1995, J GEN VIROL, V76, P2693, DOI 10.1099/0022-1317-76-11-2693; ROHRMANN GF, 1992, J GEN VIROL, V73, P749, DOI 10.1099/0022-1317-73-4-749; Roulston A, 1999, ANNU REV MICROBIOL, V53, P577, DOI 10.1146/annurev.micro.53.1.577; SALAMA H S, 1971, Zeitschrift fuer Angewandte Entomologie, V67, P261; Shim Hee Jin, 2009, Journal of Asia-Pacific Entomology, V12, P217, DOI 10.1016/j.aspen.2009.04.001; Solovyev VV, 1999, NUCLEIC ACIDS RES, V27, P248, DOI 10.1093/nar/27.1.248; SWFFORD DL, 2003, PAUP PHYLOGENETIC AN; TANADA Y, 1973, J INVERTEBR PATHOL, V21, P31, DOI 10.1016/0022-2011(73)90110-9; THEILMANN DA, 2005, VIRUS TAXONOMY, P177; TOMALSKI MD, 1991, VIROLOGY, V184, P149, DOI 10.1016/0042-6822(91)90831-U; van Oers MM, 2008, DNA REPAIR, V7, P1309, DOI 10.1016/j.dnarep.2008.04.013; van Oers MM, 2007, CURR DRUG TARGETS, V8, P1051, DOI 10.2174/138945007782151333; van Regenmortel M.H.V., 2000, VIRUS TAXONOMY 7 REP; VanOers MM, 1997, J INVERTEBR PATHOL, V70, P1, DOI 10.1006/jipa.1997.4675; Vucic D, 1997, P NATL ACAD SCI USA, V94, P10183, DOI 10.1073/pnas.94.19.10183; Wang P, 1998, J INVERTEBR PATHOL, V72, P57, DOI 10.1006/jipa.1998.4759; Wang Y, 2008, J MICROBIOL, V46, P704, DOI 10.1007/s12275-008-0133-z; Wormleaton S, 2003, VIROLOGY, V311, P350, DOI 10.1016/S0042-6822(03)00149-1; ZANOTTO PMD, 1993, J INVERTEBR PATHOL, V62, P147, DOI 10.1006/jipa.1993.1090; Zemskov EA, 2000, J VIROL, V74, P6784, DOI 10.1128/JVI.74.15.6784-6789.2000; Zhang XX, 2005, VIRUS RES, V113, P36, DOI 10.1016/j.virusres.2005.04.013; Zoog SJ, 2002, EMBO J, V21, P5130	72	12	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e28163	10.1371/journal.pone.0028163	http://dx.doi.org/10.1371/journal.pone.0028163			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132235	Green Published, gold, Green Submitted			2022-12-27	WOS:000298162000083
J	Hadaczek, P; Beyer, J; Kells, A; Narrow, W; Bowers, W; Federoff, HJ; Forsayeth, J; Bankiewicz, KS				Hadaczek, Piotr; Beyer, Janine; Kells, Adrian; Narrow, Wade; Bowers, William; Federoff, Howard J.; Forsayeth, John; Bankiewicz, Krystof S.			Evaluation of an AAV2-Based Rapamycin-Regulated Glial Cell Line-Derived Neurotrophic Factor (GDNF) Expression Vector System	PLOS ONE			English	Article							CONVECTION-ENHANCED DELIVERY; DOPAMINERGIC NIGROSTRIATAL PATHWAY; RECURRENT GLIOBLASTOMA-MULTIFORME; ADENOASSOCIATED VIRAL VECTORS; AMINO-ACID DECARBOXYLASE; PARKINSONS-DISEASE; GENE-EXPRESSION; RHESUS-MONKEYS; INTRAPUTAMENAL INFUSION; TYROSINE-HYDROXYLASE	Effective regulation of transgene product in anatomically circumscribed brain tissue is dependent on the pharmacokinetics of the regulating agent, the kinetics of transcriptional activation and degradation of the transgene product. We evaluated rapamycin-regulated AAV2-GDNF expression in the rat brain (striatum). Regulated (a dual-component system: AAV2-FBZhGDNF + AAV2-TF1Nc) and constitutive (CMV-driven) expression vectors were compared. Constitutively active AAV2-GDNF directed stable GDNF expression in a dose-dependent manner and it increased for the first month, thereafter reaching a plateau that was maintained over a further 3 months. For the AAV2-regGDNF, rapamycin was administered in a 3-days on/4-days off cycle. Intraperitoneal, oral, and direct brain delivery (CED) of rapamycin were evaluated. Two cycles of rapamycin at an intraperitoneal dose of 10 mg/kg gave the highest GDNF level (2.75 +/- 0.01 ng/mg protein). Six cycles at 3 mg/kg resulted in lower GDNF values (1.36 +/- 0.3 ng/mg protein). Interestingly, CED of rapamycin into the brain at a very low dose (50 ng) induced GDNF levels comparable to a 6-week intraperitoneal rapamycin cycle. This study demonstrates the effectiveness of rapamycin regulation in the CNS. However, the kinetics of the transgene in brain tissue, the regulator dosing amount and schedule are critical parameters that influence the kinetics of accumulation and zenith of the encoded transgene product.	[Hadaczek, Piotr; Beyer, Janine; Kells, Adrian; Forsayeth, John; Bankiewicz, Krystof S.] Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA 94143 USA; [Narrow, Wade; Bowers, William] Univ Rochester, Med Ctr, Dept Neurol, Ctr Neural Dev & Dis, Rochester, NY 14642 USA; [Federoff, Howard J.] Georgetown Univ, Med Ctr, Dept Neurol, Washington, DC 20007 USA; [Federoff, Howard J.] Georgetown Univ, Med Ctr, Dept Neurosci, Washington, DC 20007 USA	University of California System; University of California San Francisco; University of Rochester; Georgetown University; Georgetown University	Hadaczek, P (corresponding author), Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA 94143 USA.	piotr.hadaczek@ucsf.edu			National Institutes of Health-National Institute of Neurological Disorders and Stroke [NS061802]	National Institutes of Health-National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by a U54 Cooperative Research Agreement from National Institutes of Health-National Institute of Neurological Disorders and Stroke (NS061802), and through a gift from the Kinetics Foundation (http://kineticsfoundation.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airaksinen MS, 1999, MOL CELL NEUROSCI, V13, P313, DOI 10.1006/mcne.1999.0754; Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; Auricchio A, 2002, MOL THER, V6, P238, DOI 10.1006/mthe.2002.0660; Barker RA, 2006, LANCET NEUROL, V5, P285, DOI 10.1016/S1474-4422(06)70386-6; Chang SM, 2005, INVEST NEW DRUG, V23, P357, DOI 10.1007/s10637-005-1444-0; Chebrolu H, 2006, EXP NEUROL, V198, P450, DOI 10.1016/j.expneurol.2005.12.021; Chyung YH, 2003, HUM GENE THER, V14, P1255, DOI 10.1089/104303403767740795; Eberling JL, 2009, HUM GENE THER, V20, P511, DOI 10.1089/hum.2008.201; Eslamboli A, 2005, J NEUROSCI, V25, P769, DOI 10.1523/JNEUROSCI.4421-04.2005; Fan DS, 1998, HUM GENE THER, V9, P2527, DOI 10.1089/hum.1998.9.17-2527; Galanis E, 2005, J CLIN ONCOL, V23, P5294, DOI 10.1200/JCO.2005.23.622; Hadaczek P, 2010, NEUROPHARMACOLOGY, V58, P1114, DOI 10.1016/j.neuropharm.2010.02.002; Horger BA, 1998, J NEUROSCI, V18, P4929; Hovland DN, 2007, TOXICOL PATHOL, V35, P1013, DOI 10.1177/01926230701481899; Janelsins MC, 2008, AM J PATHOL, V173, P1768, DOI 10.2353/ajpath.2008.080528; Johnston LC, 2009, HUM GENE THER, V20, P497, DOI 10.1089/hum.2008.137; Kells AP, 2010, J NEUROSCI, V30, P9567, DOI 10.1523/JNEUROSCI.0942-10.2010; Kordower JH, 1999, ANN NEUROL, V46, P419, DOI 10.1002/1531-8249(199909)46:3<419::AID-ANA21>3.0.CO;2-Q; Kordower JH, 2000, SCIENCE, V290, P767, DOI 10.1126/science.290.5492.767; Kuhn JG, 2007, CLIN CANCER RES, V13, P7401, DOI 10.1158/1078-0432.CCR-07-0781; Lang AE, 2006, ANN NEUROL, V59, P459, DOI 10.1002/ana.20737; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Milligan ED, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-9; Nutt JG, 2003, NEUROLOGY, V60, P69, DOI 10.1212/WNL.60.1.69; Oiwa Y, 2002, BRAIN RES, V947, P271, DOI 10.1016/S0006-8993(02)02934-7; Pascual A, 2008, NAT NEUROSCI, V11, P755, DOI 10.1038/nn.2136; Patel NK, 2005, ANN NEUROL, V57, P298, DOI 10.1002/ana.20374; Penn RD, 2006, LANCET NEUROL, V5, P202, DOI 10.1016/S1474-4422(06)70360-X; Pollock R, 2000, P NATL ACAD SCI USA, V97, P13221, DOI 10.1073/pnas.230446297; Pollock R, 2002, CURR OPIN BIOTECH, V13, P459, DOI 10.1016/S0958-1669(02)00373-7; Rivera VM, 2005, BLOOD, V105, P1424, DOI 10.1182/blood-2004-06-2501; Rosenblad C, 1999, NEUROREPORT, V10, P1783, DOI 10.1097/00001756-199906030-00029; Salegio EA, 2010, HUM GENE THER, V21, P1093, DOI 10.1089/hum.2010.040; Sanftner LM, 2006, MOL THER, V13, P167, DOI 10.1016/j.ymthe.2005.06.480; Shen Y, 2000, HUM GENE THER, V11, P1509, DOI 10.1089/10430340050083243; Slevin JT, 2006, ANN NEUROL, V59, P989, DOI 10.1002/ana.20880; Smith RH, 2009, MOL THER, V17, P1888, DOI 10.1038/mt.2009.128; Su XM, 2010, MOL THER, V18, P1490, DOI 10.1038/mt.2010.114; Urabe M, 2002, HUM GENE THER, V13, P1935, DOI 10.1089/10430340260355347; Wang S, 2003, MOL THER, V7, P790, DOI 10.1016/S1525-0016(03)00094-7; Yang JS, 1999, J VIROL, V73, P9468, DOI 10.1128/JVI.73.11.9468-9477.1999; Yin D, 2010, J NEUROSCI METH, V187, P46, DOI 10.1016/j.jneumeth.2009.12.008	42	16	16	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2011	6	11							e27728	10.1371/journal.pone.0027728	http://dx.doi.org/10.1371/journal.pone.0027728			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IO	22132130	Green Published, Green Submitted, gold			2022-12-27	WOS:000297789900016
J	Levit, A; Yarnitzky, T; Wiener, A; Meidan, R; Niv, MY				Levit, Anat; Yarnitzky, Talia; Wiener, Ayana; Meidan, Rina; Niv, Masha Y.			Modeling of Human Prokineticin Receptors: Interactions with Novel Small-Molecule Binders and Potential Off-Target Drugs	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; ENDOTHELIAL GROWTH-FACTOR; MELANIN-CONCENTRATING HORMONE; X-RAY CRYSTALLOGRAPHY; LIGAND-BINDING SITE; CRYSTAL-STRUCTURE; HOMOLOGY MODELS; IDENTIFICATION; DOCKING; CELLS	Background and Motivation: The Prokineticin receptor (PKR) 1 and 2 subtypes are novel members of family A GPCRs, which exhibit an unusually high degree of sequence similarity. Prokineticins (PKs), their cognate ligands, are small secreted proteins of similar to 80 amino acids; however, non-peptidic low-molecular weight antagonists have also been identified. PKs and their receptors play important roles under various physiological conditions such as maintaining circadian rhythm and pain perception, as well as regulating angiogenesis and modulating immunity. Identifying binding sites for known antagonists and for additional potential binders will facilitate studying and regulating these novel receptors. Blocking PKRs may serve as a therapeutic tool for various diseases, including acute pain, inflammation and cancer. Methods and Results: Ligand-based pharmacophore models were derived from known antagonists, and virtual screening performed on the DrugBank dataset identified potential human PKR (hPKR) ligands with novel scaffolds. Interestingly, these included several HIV protease inhibitors for which endothelial cell dysfunction is a documented side effect. Our results suggest that the side effects might be due to inhibition of the PKR signaling pathway. Docking of known binders to a 3D homology model of hPKR1 is in agreement with the well-established canonical TM-bundle binding site of family A GPCRs. Furthermore, the docking results highlight residues that may form specific contacts with the ligands. These contacts provide structural explanation for the importance of several chemical features that were obtained from the structure-activity analysis of known binders. With the exception of a single loop residue that might be perused in the future for obtaining subtype-specific regulation, the results suggest an identical TM-bundle binding site for hPKR1 and hPKR2. In addition, analysis of the intracellular regions highlights variable regions that may provide subtype specificity.	[Levit, Anat; Yarnitzky, Talia; Wiener, Ayana; Niv, Masha Y.] Hebrew Univ Jerusalem, Inst Biochem Food Sci & Nutr, Fac Agr Food & Environm, IL-76100 Rehovot, Israel; [Levit, Anat; Meidan, Rina] Hebrew Univ Jerusalem, Dept Anim Sci, Fac Agr Food & Environm, IL-76100 Rehovot, Israel; [Niv, Masha Y.] Hebrew Univ Jerusalem, Fritz Haber Ctr Mol Dynam, IL-76100 Rehovot, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem	Levit, A (corresponding author), Hebrew Univ Jerusalem, Inst Biochem Food Sci & Nutr, Fac Agr Food & Environm, IL-76100 Rehovot, Israel.	niv@agri.huji.ac.il	Niv, Masha/AAL-1123-2020	Niv, Masha/0000-0001-8275-8795	Niedersachsen-Israeli Research cooperation fund; Israeli Science Foundation; Canadian Friends of the Hebrew University; Smith excellence fellowship for PhD students	Niedersachsen-Israeli Research cooperation fund; Israeli Science Foundation(Israel Science Foundation); Canadian Friends of the Hebrew University; Smith excellence fellowship for PhD students	The study was funded in part by the Niedersachsen-Israeli Research cooperation fund to MYN and the Israeli Science Foundation to RM. AL is supported by the Johanna Friedlaender memorial award for excellence from the Canadian Friends of the Hebrew University and by the Smith excellence fellowship for PhD students. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JA, 2011, ANNU REV PHARMACOL, V51, P117, DOI 10.1146/annurev-pharmtox-010510-100553; Balboni G, 2008, J MED CHEM, V51, P7635, DOI 10.1021/jm800854e; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Barnum D, 1996, J CHEM INF COMP SCI, V36, P563, DOI 10.1021/ci950273r; Battersby S, 2004, J CLIN ENDOCR METAB, V89, P2463, DOI 10.1210/jc.2003-032012; BHOGAL N, 1994, J BIOL CHEM, V269, P27269; Bissantz C, 2003, PROTEINS, V50, P5, DOI 10.1002/prot.10237; Bohm Hans-Joachim, 2004, Drug Discov Today Technol, V1, P217, DOI 10.1016/j.ddtec.2004.10.009; Boyd M, 2007, EXPERT OPIN PHARMACO, V8, P957, DOI 10.1517/14656566.8.7.957; Brockhoff A, 2010, P NATL ACAD SCI USA, V107, P11110, DOI 10.1073/pnas.0913862107; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Bullock CM, 2004, MOL PHARMACOL, V65, P582, DOI 10.1124/mol.65.3.582; Bywater RP, 2005, J MOL RECOGNIT, V18, P60, DOI 10.1002/jmr.685; CARLSSON J, 2011, NAT CHEM BIOL; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; COATS SJ, 2009, Patent No. 20090163505; COATS SJ, 2008, Patent No. 20080045535; Coetsee M, 2008, BIOCHEMISTRY-US, V47, P10305, DOI 10.1021/bi800911z; De Clercq E, 2009, INT J ANTIMICROB AG, V33, P307, DOI 10.1016/j.ijantimicag.2008.10.010; Doron-Faigenboim A, 2005, BIOINFORMATICS, V21, P2101, DOI 10.1093/bioinformatics/bti259; Eira M, 2006, BRAZ J MED BIOL RES, V39, P1065, DOI 10.1590/S0100-879X2006000800009; Gloriam DE, 2009, J MED CHEM, V52, P4429, DOI 10.1021/jm900319e; Guilini C, 2010, AM J PHYSIOL-HEART C, V298, pH844, DOI 10.1152/ajpheart.00898.2009; Hanson MA, 2009, STRUCTURE, V17, P8, DOI 10.1016/j.str.2008.12.003; Hernandez M, 2009, NUCLEIC ACIDS RES, V37, pW413, DOI 10.1093/nar/gkp281; Holmberg SD, 2004, NEW ENGL J MED, V350, P730, DOI 10.1056/NEJM200402123500719; Hoogerwerf WA, 2006, NEUROGASTROENT MOTIL, V18, P455, DOI 10.1111/j.1365-2982.2006.00776.x; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Ivanov AA, 2009, J MED CHEM, V52, P3284, DOI 10.1021/jm801533x; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Kaser A, 2003, EMBO REP, V4, P469, DOI 10.1038/sj.embor.embor830; Katritch V, 2009, J MOL RECOGNIT, V22, P307, DOI 10.1002/jmr.949; Keiser MJ, 2009, NATURE, V462, P175, DOI 10.1038/nature08506; Kisliouk T, 2005, ENDOCRINOLOGY, V146, P3950, DOI 10.1210/en.2005-0297; Kisliouk T, 2003, J CLIN ENDOCR METAB, V88, P3700, DOI 10.1210/jc.2003-030492; Krammer A, 2005, J MOL GRAPH MODEL, V23, P395, DOI 10.1016/j.jmgm.2004.11.007; Krivov GG, 2009, PROTEINS, V77, P778, DOI 10.1002/prot.22488; Kufareva I, 2011, STRUCTURE, V19, P1108, DOI 10.1016/j.str.2011.05.012; Laurie ATR, 2005, BIOINFORMATICS, V21, P1908, DOI 10.1093/bioinformatics/bti315; Lazareno S, 2000, MOL PHARMACOL, V58, P194, DOI 10.1124/mol.58.1.194; LeCouter J, 2004, P NATL ACAD SCI USA, V101, P16813, DOI 10.1073/pnas.0407697101; LeCouter J, 2003, P NATL ACAD SCI USA, V100, P2685, DOI 10.1073/pnas.0337667100; LeCouter J, 2001, NATURE, V412, P877, DOI 10.1038/35091000; LEONG SR, 1994, J BIOL CHEM, V269, P19343; Levit A., 2011, METHODS MOL IN PRESS; Li M, 2001, MOL PHARMACOL, V59, P692, DOI 10.1124/mol.59.4.692; Lin DCH, 2002, J BIOL CHEM, V277, P19276, DOI 10.1074/jbc.M202139200; Lin R, 2002, J BIOL CHEM, V277, P8724, DOI 10.1074/jbc.M110594200; Novoa EM, 2010, J CHEM THEORY COMPUT, V6, P2547, DOI 10.1021/ct100246y; Martin C, 2011, ENDOCR REV, V32, P225, DOI 10.1210/er.2010-0007; Masuda Y, 2002, BIOCHEM BIOPH RES CO, V293, P396, DOI 10.1016/S0006-291X(02)00239-5; McRobb FM, 2010, J CHEM INF MODEL, V50, P626, DOI 10.1021/ci900444q; Michino M, 2009, NAT REV DRUG DISCOV, V8, P455, DOI 10.1038/nrd2877; MOBAREC JCR, 2009, J MED CHEM; Monnier C, 2009, HUM MOL GENET, V18, P75, DOI 10.1093/hmg/ddn318; Nebigil CG, 2009, TRENDS CARDIOVAS MED, V19, P55, DOI 10.1016/j.tcm.2009.04.007; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Okada T, 2002, P NATL ACAD SCI USA, V99, P5982, DOI 10.1073/pnas.082666399; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Phatak SS, 2010, J CHEM INF MODEL, V50, P2119, DOI 10.1021/ci100285f; Ralbovsky JL, 2009, BIOORG MED CHEM LETT, V19, P2661, DOI 10.1016/j.bmcl.2009.03.157; Rognan D, 2010, MOL INFORM, V29, P176, DOI 10.1002/minf.200900081; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Ryu GM, 2009, NUCLEIC ACIDS RES, V37, P1297, DOI 10.1093/nar/gkn1008; Sela I, 2010, CURR TOP MED CHEM, V10, P638, DOI 10.2174/156802610791111498; Senderowitz H, 2009, CURR PHARM DESIGN, V15, P4049, DOI 10.2174/138161209789824821; Shankar SS, 2005, AM HEART J, V150, DOI 10.1016/j.ahj.2005.06.005; Shi L, 2002, ANNU REV PHARMACOL, V42, P437, DOI 10.1146/annurev.pharmtox.42.091101.144224; Shimamura T, 2011, NATURE, V475, P65, DOI 10.1038/nature10236; Soga T, 2002, BBA-GENE STRUCT EXPR, V1579, P173, DOI 10.1016/S0167-4781(02)00546-8; Sprang SR, 2011, NATURE, V469, P172, DOI 10.1038/469172a; Stern A, 2007, NUCLEIC ACIDS RES, V35, pW506, DOI 10.1093/nar/gkm382; THOMPSON WJ, 2007, Patent No. 2007067511; Tobin AB, 2008, TRENDS PHARMACOL SCI, V29, P413, DOI 10.1016/j.tips.2008.05.006; Totrov M, 2008, CURR OPIN STRUC BIOL, V18, P178, DOI 10.1016/j.sbi.2008.01.004; Venkatachalam CM, 2003, J MOL GRAPH MODEL, V21, P289, DOI 10.1016/S1093-3263(02)00164-X; Vilar S, 2011, J MOL GRAPH MODEL, V29, P614, DOI 10.1016/j.jmgm.2010.11.005; Vitale RM, 2004, PROTEINS, V56, P430, DOI 10.1002/prot.20125; Vitale RM, 2003, CHEMBIOCHEM, V4, P73, DOI 10.1002/cbic.200390017; Wacker D, 2010, J AM CHEM SOC, V132, P11443, DOI 10.1021/ja105108q; Wang XW, 2009, AM J PATHOL, V174, P771, DOI 10.2353/ajpath.2009.080157; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; YAMANO Y, 1995, J BIOL CHEM, V270, P14024, DOI 10.1074/jbc.270.23.14024; Yang SY, 2010, DRUG DISCOV TODAY, V15, P444, DOI 10.1016/j.drudis.2010.03.013; Yarnitzky T, 2010, CURR OPIN DRUG DISC, V13, P317; Zhou Q. -Y., 2008, V46, P181, DOI 10.1007/400_2007_053	88	32	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2011	6	11							e27990	10.1371/journal.pone.0027990	http://dx.doi.org/10.1371/journal.pone.0027990			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IO	22132188	gold, Green Published, Green Submitted			2022-12-27	WOS:000297789900038
J	Nalwadda, G; Tumwesigye, NM; Faxelid, E; Byamugisha, J; Mirembe, F				Nalwadda, Gorrette; Tumwesigye, Nazarius M.; Faxelid, Elisabeth; Byamugisha, Josaphat; Mirembe, Florence			Quality of Care in Contraceptive Services Provided to Young People in Two Ugandan Districts: A Simulated Client Study	PLOS ONE			English	Article							PROVISION; IMPACT	Background: Low and inconsistent use of contraceptives by young people contributes to unintended pregnancies. This study assessed quality of contraceptive services for young people aged 15-24 in two rural districts in Uganda. Methods: Five female and two male simulated clients (SCs) interacted with 128 providers at public, private not-for-profit (PNFP), and private for profit (PFP) health facilities. After consultations, SCs were interviewed using a structured questionnaire. Six aspects of quality of care (client's needs, choice of contraceptive methods, information given to users, client-provider interpersonal relations, constellation of services, and continuity mechanisms) were assessed. Descriptive statistics and factor analysis were performed. Results: Means and categorized quality scores for all aspects of quality were low in both public and private facilities. The lowest quality scores were observed in PFP, and medium scores in PNFP facilities. The choice of contraceptive methods and interpersonal relations quality scores were slightly higher in public facilities. Needs assessment scores were highest in PNFP facilities. All facilities were classified as having low scores for appropriate constellation of services. Information given to users was suboptimal and providers promoted specific contraceptive methods. Minority of providers offered preferred method of choice and showed respect for privacy. Conclusions: The quality of contraceptive services provided to young people was low. Concurrent quality improvements and strengthening of health systems are needed.	[Nalwadda, Gorrette] Makerere Univ, Coll Hlth Sci, Sch Hlth Sci, Dept Nursing, Kampala, Uganda; [Tumwesigye, Nazarius M.] Makerere Univ, Dept Epidemiol & Biostat, Sch Publ Hlth, Coll Hlth Sci, Kampala, Uganda; [Nalwadda, Gorrette; Faxelid, Elisabeth] Karolinska Inst, Div Global Hlth, Dept Publ Hlth Sci, Stockholm, Sweden; [Nalwadda, Gorrette; Byamugisha, Josaphat; Mirembe, Florence] Makerere Univ, Coll Hlth Sci, Sch Med, Dept Obstet & Gynecol, Kampala, Uganda	Makerere University; Makerere University; Karolinska Institutet; Makerere University	Nalwadda, G (corresponding author), Makerere Univ, Coll Hlth Sci, Sch Hlth Sci, Dept Nursing, Kampala, Uganda.	gnalwadda@gmail.con	Byamugisha, Josaphat/AAL-5776-2020	Byamugisha, Josaphat/0000-0002-3438-9662; Tumwesigye, Nazarius Mbona/0000-0001-7085-8780	Swedish International Development Aid (Sida)	Swedish International Development Aid (Sida)	This article is based on research funded by Swedish International Development Aid (Sida). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agha S, 2010, STUD FAMILY PLANN, V41, P205, DOI 10.1111/j.1728-4465.2010.00244.x; ALIZADEH SM, 2007, EUR J CONTRACEPT REP, V12; [Anonymous], UG DEM HLTH SURV 200; Berendes S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000433; Bertrand J., 1994, HDB INDICATORS FAMIL; Bessinger RE, 2001, INT FAM PLAN PERSPEC, V27, P63, DOI 10.2307/2673816; BRUCE J, 1990, STUD FAMILY PLANN, V21, P61, DOI 10.2307/1966669; BUTLER PA, 2004, RES FAMILY PLANNING, P7; Chin-Quee DS, 2006, STUD FAMILY PLANN, V37, P99, DOI 10.1111/j.1728-4465.2006.00089.x; Cleland J, 2006, LANCET, V368, P1810, DOI 10.1016/S0140-6736(06)69480-4; Dehlendorf C, 2010, CONTRACEPTION, V81, P292, DOI 10.1016/j.contraception.2009.11.006; Fabrigar LR, 1999, PSYCHOL METHODS, V4, P272, DOI 10.1037/1082-989X.4.3.272; Floyd FJ, 1995, PSYCHOL ASSESSMENT, V7, P286, DOI 10.1037/1040-3590.7.3.286; Hubacher D, 2008, CONTRACEPTION, V78, P73, DOI 10.1016/j.contraception.2008.03.002; Huezo C, 1993, Adv Contracept, V9, P129, DOI 10.1007/BF01990143; HUNTINGTON D, 1993, STUD FAMILY PLANN, V24, P187, DOI 10.2307/2939233; Khan SM., 2008, UNMET NEED DEMAND FA; Kipp Walter, 2007, Int J Adolesc Med Health, V19, P383; Koenig MA, 1997, STUD FAMILY PLANN, V28, P278, DOI 10.2307/2137859; *MIT DISTR LOC GOV, 2008, 5 YEAR 2007 2012 ORP; *MOH, 2010, UG NAT HLTH POL, V2; Mugisha JF, 2008, J FAM PLAN REPROD H, V34, P37, DOI 10.1783/147118908783332230; Nalwadda G, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-220; Nalwadda G, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-530; RamaRao S, 2003, INT FAM PLAN PERSPEC, V29, P76, DOI 10.2307/3181061; SENDEROWITZ J, 1992, GROWING BIOSOCIAL GA; Singh S, 2005, INT FAM PLAN PERSPEC, V31, P183, DOI 10.1363/3118305; Smith C, 1997, QUAL HEALTH CARE, V6, P59, DOI 10.1136/qshc.6.2.59; Steele F, 1999, STUD FAMILY PLANN, V30, P28, DOI 10.1111/j.1728-4465.1999.00028.x; *UBOS, 2002, 2002 UG POPN HOUS CE	30	22	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2011	6	11							e27908	10.1371/journal.pone.0027908	http://dx.doi.org/10.1371/journal.pone.0027908			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	858IO	22132168	Green Published, Green Submitted, gold			2022-12-27	WOS:000297789900032
J	Galinanes, GL; Braz, BY; Murer, MG				Galinanes, Gregorio L.; Braz, Barbara Y.; Gustavo Murer, Mario			Origin and Properties of Striatal Local Field Potential Responses to Cortical Stimulation: Temporal Regulation by Fast Inhibitory Connections	PLOS ONE			English	Article							FAST-SPIKING INTERNEURONS; TERM SYNAPTIC PLASTICITY; PROJECTION NEURONS; DOPAMINERGIC MODULATION; EVOKED-POTENTIALS; BASAL GANGLIA; SPINY NEURONS; RAT; CORTEX; OSCILLATIONS	Evoked striatal field potentials are seldom used to study corticostriatal communication in vivo because little is known about their origin and significance. Here we show that striatal field responses evoked by stimulating the prelimbic cortex in mice are reduced by more than 90% after infusing the AMPA receptor antagonist CNQX close to the recording electrode. Moreover, the amplitude of local field responses and dPSPs recorded in striatal medium spiny neurons increase in parallel with increasing stimulating current intensity. Finally, the evoked striatal fields show several of the basic known properties of corticostriatal transmission, including paired pulse facilitation and topographical organization. As a case study, we characterized the effect of local GABA(A) receptor blockade on striatal field and multiunitary action potential responses to prelimbic cortex stimulation. Striatal activity was recorded through a 24 channel silicon probe at about 600 mm from a microdialysis probe. Intrastriatal administration of the GABA(A) receptor antagonist bicuculline increased by 65 +/- 7% the duration of the evoked field responses. Moreover, the associated action potential responses were markedly enhanced during bicuculline infusion. Bicuculline enhancement took place at all the striatal sites that showed a response to cortical stimulation before drug infusion, but sites showing no field response before bicuculline remained unresponsive during GABAA receptor blockade. Thus, the data demonstrate that fast inhibitory connections exert a marked temporal regulation of input-output transformations within spatially delimited striatal networks responding to a cortical input. Overall, we propose that evoked striatal fields may be a useful tool to study corticostriatal synaptic connectivity in relation to behavior.	[Galinanes, Gregorio L.; Braz, Barbara Y.; Gustavo Murer, Mario] Univ Buenos Aires, Dept Physiol & Biophys, Sch Med, Neural Circuit Physiol Lab,Syst Neurosci Grp, Buenos Aires, DF, Argentina	University of Buenos Aires	Galinanes, GL (corresponding author), Univ Buenos Aires, Dept Physiol & Biophys, Sch Med, Neural Circuit Physiol Lab,Syst Neurosci Grp, Buenos Aires, DF, Argentina.	neurofis@fmed.uba.ar		Galinanes, Gregorio/0000-0002-9338-4175	Secretaria de Ciencia; Tecnologia e Innovacion Productiva; Fondo para la Investigacion Cientifica y Tecnologica [PICT 2007 05-1000, PICT 2008 05-2205]; Universidad de Buenos Aires [UBACYT M050]; Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP 0077]	Secretaria de Ciencia; Tecnologia e Innovacion Productiva; Fondo para la Investigacion Cientifica y Tecnologica; Universidad de Buenos Aires(University of Buenos Aires); Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by the following Argentine institutions: Secretaria de Ciencia, Tecnologia e Innovacion Productiva, Fondo para la Investigacion Cientifica y Tecnologica (PICT 2007 05-1000 and PICT 2008 05-2205), Universidad de Buenos Aires (UBACYT M050), and Consejo Nacional de Investigaciones Cientificas y Tecnicas (PIP 0077). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akopian G, 2002, J NEUROPHYSIOL, V87, P157, DOI 10.1152/jn.00115.2001; Berke JD, 2009, EUR J NEUROSCI, V30, P848, DOI 10.1111/j.1460-9568.2009.06843.x; Carrillo-Reid L, 2008, J NEUROPHYSIOL, V99, P1435, DOI 10.1152/jn.01131.2007; Choi SK, 1997, J NEUROSCI, V17, P8613; Chuhma N, 2011, J NEUROSCI, V31, P1183, DOI 10.1523/JNEUROSCI.3833-10.2011; Cohen MX, 2009, NAT NEUROSCI, V12, P32, DOI 10.1038/nn.2228; CORDINGLEY GE, 1986, BRIT J PHARMACOL, V88, P847, DOI 10.1111/j.1476-5381.1986.tb16258.x; Courtemanche R, 2003, J NEUROSCI, V23, P11741; Czubayko U, 2002, P NATL ACAD SCI USA, V99, P15764, DOI 10.1073/pnas.242428599; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Galinanes GL, 2009, J NEUROSCI, V29, P2496, DOI 10.1523/JNEUROSCI.4421-08.2009; Gruart A, 2006, J NEUROSCI, V26, P1077, DOI 10.1523/JNEUROSCI.2834-05.2006; Gruber AJ, 2009, J NEUROPHYSIOL, V101, P1876, DOI 10.1152/jn.91002.2008; Guzman JN, 2003, J NEUROSCI, V23, P8931; Haber SN, 2003, J CHEM NEUROANAT, V26, P317, DOI 10.1016/j.jchemneu.2003.10.003; Hamann M, 2007, BRAIN RES, V1150, P190, DOI 10.1016/j.brainres.2007.02.074; Humphries MD, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001011; Kasanetz F, 2002, J PHYSIOL-LONDON, V543, P577, DOI 10.1113/jphysiol.2002.0024786; Kasanetz F, 2006, J PHYSIOL-LONDON, V577, P97, DOI 10.1113/jphysiol.2006.113050; Kataoka Y, 2010, J COMP NEUROL, V518, P277, DOI 10.1002/cne.22206; Katzner S, 2009, NEURON, V61, P35, DOI 10.1016/j.neuron.2008.11.016; Koos T, 1999, NAT NEUROSCI, V2, P467, DOI 10.1038/8138; LOVINGER DM, 1993, J NEUROPHYSIOL, V69, P1236, DOI 10.1152/jn.1993.69.4.1236; Magill PJ, 2004, J NEUROPHYSIOL, V92, P700, DOI 10.1152/jn.00134.2004; Mahon S, 2004, TRENDS NEUROSCI, V27, P460, DOI 10.1016/j.tins.2004.06.010; Mallet N, 2005, J NEUROSCI, V25, P3857, DOI 10.1523/JNEUROSCI.5027-04.2005; MAREN S, 1995, J NEUROSCI, V15, P7548; MISGELD U, 1979, EXP BRAIN RES, V34, P575; Ou XR, 1997, SYNAPSE, V27, P57, DOI 10.1002/(SICI)1098-2396(199709)27:1<57::AID-SYN6>3.0.CO;2-C; Pan WXX, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00147; Paxinos G, 2001, MOUSE BRAIN STEREOTA, pxxv; PENNARTZ CMA, 1990, VISION RES, V30, P1223, DOI 10.1016/0042-6989(90)90177-M; PENNARTZ CMA, 1990, BRAIN RES, V529, P30, DOI 10.1016/0006-8993(90)90808-O; Planert H, 2010, J NEUROSCI, V30, P3499, DOI 10.1523/JNEUROSCI.5139-09.2010; Plenz D, 1998, J NEUROSCI, V18, P266; Pomata PE, 2008, J NEUROSCI, V28, P13384, DOI 10.1523/JNEUROSCI.4343-08.2008; Ponzi A, 2010, J NEUROSCI, V30, P5894, DOI 10.1523/JNEUROSCI.5540-09.2010; RYAN LJ, 1986, BRAIN RES BULL, V17, P751, DOI 10.1016/0361-9230(86)90086-9; SESACK SR, 1989, J COMP NEUROL, V290, P213, DOI 10.1002/cne.902900205; Sharott A, 2009, J NEUROSCI, V29, P4571, DOI 10.1523/JNEUROSCI.5097-08.2009; Stocker M, 1999, P NATL ACAD SCI USA, V96, P4662, DOI 10.1073/pnas.96.8.4662; Stoetzner CR, 2010, NEUROSCIENCE, V165, P1013, DOI 10.1016/j.neuroscience.2009.11.031; Tecuapetla F, 2007, P NATL ACAD SCI USA, V104, P10258, DOI 10.1073/pnas.0703813104; Tepper JM, 2004, TRENDS NEUROSCI, V27, P662, DOI 10.1016/j.tins.2004.08.007; van der Meer MAA, 2009, FRONT INTEGR NEUROSC, V3, DOI [10.3389/neuro.07.009.2009, 10.3389/neuro.07.001.2009]; Voorn P, 2004, TRENDS NEUROSCI, V27, P468, DOI 10.1016/j.tins.2004.06.006; West AR, 2002, J PHARMACOL EXP THER, V301, P867, DOI 10.1124/jpet.301.3.867; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; Xing DJ, 2009, J NEUROSCI, V29, P11540, DOI 10.1523/JNEUROSCI.2573-09.2009; Yin HH, 2006, NAT REV NEUROSCI, V7, P464, DOI 10.1038/nrn1919; Yin HH, 2009, NAT NEUROSCI, V12, P333, DOI 10.1038/nn.2261; Yin HH, 2005, EUR J NEUROSCI, V22, P513, DOI 10.1111/j.1460-9568.2005.04218.x; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	53	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2011	6	12							e28473	10.1371/journal.pone.0028473	http://dx.doi.org/10.1371/journal.pone.0028473			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863OC	22163020	Green Submitted, Green Published, gold			2022-12-27	WOS:000298173500023
J	Rodhouse, TJ; Irvine, KM; Vierling, KT; Vierling, LA				Rodhouse, Thomas J.; Irvine, Kathryn M.; Vierling, Kerri T.; Vierling, Lee A.			Estimating Temporal Trend in the Presence of Spatial Complexity: A Bayesian Hierarchical Model for a Wetland Plant Population Undergoing Restoration	PLOS ONE			English	Article							AUTOCORRELATION; CAMASSIA; ECOLOGY	Monitoring programs that evaluate restoration and inform adaptive management are important for addressing environmental degradation. These efforts may be well served by spatially explicit hierarchical approaches to modeling because of unavoidable spatial structure inherited from past land use patterns and other factors. We developed Bayesian hierarchical models to estimate trends from annual density counts observed in a spatially structured wetland forb (Camassia quamash [camas]) population following the cessation of grazing and mowing on the study area, and in a separate reference population of camas. The restoration site was bisected by roads and drainage ditches, resulting in distinct subpopulations ("zones") with different land use histories. We modeled this spatial structure by fitting zone-specific intercepts and slopes. We allowed spatial covariance parameters in the model to vary by zone, as in stratified kriging, accommodating anisotropy and improving computation and biological interpretation. Trend estimates provided evidence of a positive effect of passive restoration, and the strength of evidence was influenced by the amount of spatial structure in the model. Allowing trends to vary among zones and accounting for topographic heterogeneity increased precision of trend estimates. Accounting for spatial autocorrelation shifted parameter coefficients in ways that varied among zones depending on strength of statistical shrinkage, autocorrelation and topographic heterogeneity-a phenomenon not widely described. Spatially explicit estimates of trend from hierarchical models will generally be more useful to land managers than pooled regional estimates and provide more realistic assessments of uncertainty. The ability to grapple with historical contingency is an appealing benefit of this approach.	[Rodhouse, Thomas J.; Vierling, Kerri T.] Univ Idaho, Dept Fish & Wildlife, Moscow, ID 83843 USA; [Irvine, Kathryn M.] US Geol Survey, No Rocky Mt Sci Ctr, Bozeman, MT USA; [Vierling, Lee A.] Univ Idaho, Geospatial Lab Environm Dynam, Moscow, ID 83843 USA	Idaho; University of Idaho; United States Department of the Interior; United States Geological Survey; Idaho; University of Idaho	Rodhouse, TJ (corresponding author), Univ Idaho, Dept Fish & Wildlife, Moscow, ID 83843 USA.	Tom_Rodhouse@nps.gov	Vierling, Kerri/N-6653-2016; Vierling, Lee/E-6428-2010	Vierling, Lee/0000-0001-5344-1983; Rodhouse, Thomas/0000-0001-5953-9113	National Park Service Upper Columbia Basin Network;  [NIH/NCRR P20RR16448];  [P20RR016454]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016454, P20RR016448] Funding Source: NIH RePORTER	National Park Service Upper Columbia Basin Network; ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Funding was provided by the National Park Service Upper Columbia Basin Network. Additional material support was provided by Nez Perce National Historical Park and Big Hole National Battlefield. Access to the University of Idaho Institute for Bioinformatics and Evolutionary Studies (IBEST) Unix computing core was made possible by grant NIH/NCRR P20RR16448 and P20RR016454 provided to IBEST (but not to the authors). Staff members of the National Park Service funding organizations provided input into the study design and data collection procedures, but did not influence analysis, decision to publish, or participate in manuscript preparation.	Alpargu G, 2003, J STAT COMPUT SIM, V73, P165, DOI 10.1080/00949650215866; Banerjee S., 2004, HIERARCHICAL MODELIN; Beale CM, 2010, ECOL LETT, V13, P246, DOI 10.1111/j.1461-0248.2009.01422.x; Bini LM, 2009, ECOGRAPHY, V32, P193, DOI 10.1111/j.1600-0587.2009.05717.x; Cressie N., 2011, STAT SPATIO TEMPORAL; Cressie N, 2009, ECOL APPL, V19, P553, DOI 10.1890/07-0744.1; Dahl T., 1990, WETLANDS LOSSES US 1; Fortin MJ, 2005, SPATIAL ANALYSIS: A GUIDE FOR ECOLOGISTS; Gelman A., 2007, DATA ANAL USING REGR; Gould Frank W., 1942, AMER MIDLAND NAT, V28, P712, DOI 10.2307/2420901; Hobbs RJ, 2008, ANNU REV ENV RESOUR, V33, P39, DOI 10.1146/annurev.environ.33.020107.113631; Irvine KM, 2011, ENVIRON ECOL STAT, V18, P447, DOI 10.1007/s10651-010-0146-8; Irvine KM, 2007, J AGR BIOL ENVIR ST, V12, P1; Isaaks EH, 1989, APPL GEOSTATISTICS; Kery M, 2012, BAYESIAN POPULATION ANALYSIS USING WINBUGS: A HIERARCHICAL PERSPECTIVE, P1; Larkin Daniel, 2006, P142; Legendre P, 2002, ECOGRAPHY, V25, P601, DOI 10.1034/j.1600-0587.2002.250508.x; LEGENDRE P, 1993, ECOLOGY, V74, P1659, DOI 10.2307/1939924; Lichstein JW, 2002, ECOL MONOGR, V72, P445, DOI 10.1890/0012-9615(2002)072[0445:SAAAMI]2.0.CO;2; Lunn D, 2009, STAT MED, V28, P3049, DOI 10.1002/sim.3680; Palmer M. A., 2006, FDN RESTORATION ECOL, P1; Pendergrass KL, 1999, ECOL APPL, V9, P1420, DOI 10.1890/1051-0761(1999)009[1420:TROPBI]2.0.CO;2; Piepho HP, 2002, J AGRIC BIOL ENVIR S, V7, P350, DOI 10.1198/108571102366; Rodhouse T.J., 2007, NPSUCBNNRR2007011; STEIN A, 1988, GEODERMA, V43, P163, DOI 10.1016/0016-7061(88)90041-9; Storm L., 2006, ECOLOGICAL RESTORATI, V24, P256, DOI DOI 10.3368/ER.24.4.256; Taft OW, 2003, WETLANDS, V23, P51, DOI 10.1672/0277-5212(2003)023[0051:HWIOWV]2.0.CO;2; Thogmartin WE, 2009, RESTOR ECOL, V17, P290, DOI 10.1111/j.1526-100X.2007.00344.x; Tomimatsu H, 2009, MOL ECOL, V18, P3918, DOI 10.1111/j.1365-294X.2009.04341.x; TURNER NJ, 1983, ECOL FOOD NUTR, V13, P199, DOI 10.1080/03670244.1983.9990754; VanLeeuwen D. M., 1996, Journal of Agricultural, Biological, and Environmental Statistics, V1, P435, DOI 10.2307/1400438; Wallerman J, 2002, CAN J FOREST RES, V32, P509, DOI 10.1139/X01-214; Wang FJ, 2003, BIOSTATISTICS, V4, P569, DOI 10.1093/biostatistics/4.4.569; Wikle CK, 2003, INT STAT REV, V71, P181, DOI 10.1111/j.1751-5823.2003.tb00192.x; Williams BK, 2011, J ENVIRON MANAGE, V92, P1346, DOI 10.1016/j.jenvman.2010.10.041	35	4	4	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2011	6	12							e28635	10.1371/journal.pone.0028635	http://dx.doi.org/10.1371/journal.pone.0028635			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863OC	22163047	Green Published, Green Submitted, gold			2022-12-27	WOS:000298173500043
J	Fatima, R				Fatima, Roshan			Drosophila Dynein Intermediate Chain Gene, Dic61B, Is Required for Spermatogenesis	PLOS ONE			English	Article							CYTOPLASMIC DYNEIN; Y-CHROMOSOME; LIGHT-CHAIN; SPERM INDIVIDUALIZATION; FERTILITY FACTORS; MESSENGER-RNA; BASE DELETION; IDENTIFICATION; DYNACTIN; PROTEIN	This study reports the identification and characterization of a novel gene, Dic61B, required for male fertility in Drosophila. Complementation mapping of a novel male sterile mutation, ms21, isolated in our lab revealed it to be allelic to CG7051 at 61B1 cytogenetic region, since two piggyBac insertion alleles, CG7051(c05439) and CG7051(f07138) failed to complement. CG7051 putatively encodes a Dynein intermediate chain. All three mutants, ms21, CG7051(c05439) and CG7051(f07138), exhibited absolute recessive male sterility with abnormally coiled sperm axonemes causing faulty sperm individualization as revealed by Phalloidin staining in Don Juan-GFP background. Sequencing of PCR amplicons uncovered two point mutations in ms21 allele and confirmed the piggyBac insertions in CG7051(c05439) and CG7051(f07138) alleles to be in 5'UTR and 4(th) exon of CG7051 respectively, excision of which reverted the male sterility. In situ hybridization to polytene chromosomes demonstrated CG7051 to be a single copy gene. RT-PCR of testis RNA revealed defective splicing of the CG7051 transcripts in mutants. Interestingly, expression of cytoplasmic dynein intermediate chain, alpha, beta, gamma tubulins and alpha-spectrin was normal in mutants while ultra structural studies revealed defects in the assembly of sperm axonemes. Bioinformatics further highlighted the homology of CG7051 to axonemal dynein intermediate chain of various organisms, including DNAI1 of humans, mutations in which lead to male sterility due to immotile sperms. Based on these observations we conclude that CG7051 encodes a novel axonemal dynein intermediate chain essential for male fertility in Drosophila and rename it as Dic61B. This is the first axonemal Dic gene of Drosophila to be characterized at molecular level and shown to be required for spermatogenesis.	Banaras Hindu Univ, Dept Zool, Cytogenet Lab, Varanasi 221005, Uttar Pradesh, India	Banaras Hindu University (BHU)	Fatima, R (corresponding author), Banaras Hindu Univ, Dept Zool, Cytogenet Lab, Varanasi 221005, Uttar Pradesh, India.	roshanfatima@rediffmail.com	Fatima, Roshan/AAP-9300-2021	Fatima, Roshan/0000-0002-8926-5026	Indian Council of Medical Research (ICMR), India [2007-01320, 45/5/2007]	Indian Council of Medical Research (ICMR), India(Indian Council of Medical Research (ICMR))	RF was awarded Senior Research Fellow (SRF) from the Indian Council of Medical Research (ICMR, www.icmr.nic.in/), India. Grant No: IRIS ID No. 2007-01320 (File No: 45/5/2007). Department of Science and Technology (DST) (www.dst.gov.in/), India is acknowledged for the National Facility of Confocal Microscopy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akanksha, 2008, J GENET, V87, P87, DOI 10.1007/s12041-008-0012-8; Arama E, 2003, DEV CELL, V4, P687, DOI 10.1016/S1534-5807(03)00120-5; ASAI DJ, 1995, CELL MOTIL CYTOSKEL, V32, P129, DOI 10.1002/cm.970320212; Bonilla E, 2008, MOL HUM REPROD, V14, P137, DOI 10.1093/molehr/gan002; Boylan K, 2000, MOL BIOL CELL, V11, P3791, DOI 10.1091/mbc.11.11.3791; Boylan KLM, 2002, GENETICS, V162, P1211; Bridges CB, 1916, GENETICS, V1, P1; BROSSEAU GE, 1960, GENETICS, V45, P257; Caggese C, 2001, MOL GENET GENOMICS, V265, P436, DOI 10.1007/s004380000431; Carvalho AB, 2000, P NATL ACAD SCI USA, V97, P13239, DOI 10.1073/pnas.230438397; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; DALLAI R, 1993, INT J INSECT MORPHOL, V22, P449, DOI 10.1016/0020-7322(93)90023-T; DiBella LM, 2001, INT REV CYTOL, V210, P227; ElHefnawy T, 1996, MOL CELL ENDOCRINOL, V119, P207; Fabrizio JJ, 1998, DEVELOPMENT, V125, P1833; Fuller Margaret T., 1993, P71; Ghosh-Roy A, 2005, MOL BIOL CELL, V16, P3107, DOI 10.1091/mbc.E05-02-0103; Ghosh-Roy A, 2004, MOL BIOL CELL, V15, P2470, DOI 10.1091/mbc.E03-11-0848; Goldstein LSB, 2000, J CELL BIOL, V150, pF63, DOI 10.1083/jcb.150.2.F63; GOLDSTEIN LSB, 1982, P NATL ACAD SCI-BIOL, V79, P7405, DOI 10.1073/pnas.79.23.7405; Hackstein JHP, 2000, TRENDS GENET, V16, P565, DOI 10.1016/S0168-9525(00)02140-5; Han BG, 2003, ONCOGENE, V22, P5325, DOI 10.1038/sj.onc.1206783; HARDY RW, 1981, CHROMOSOMA, V83, P593, DOI 10.1007/BF00328522; HAYS TS, 1994, J CELL SCI, V107, P1557; Hendrickson TW, 2004, MOL BIOL CELL, V15, P5431, DOI 10.1091/mbc.E04-08-0694; Hennig W, 1996, INT J DEV BIOL, V40, P167; HOLZBAUR ELF, 1994, ANNU REV CELL BIOL, V10, P339, DOI 10.1146/annurev.cb.10.110194.002011; Karki S, 1999, CURR OPIN CELL BIOL, V11, P45, DOI 10.1016/S0955-0674(99)80006-4; KENNISON JA, 1981, GENETICS, V98, P529; KIEFER BI, 1966, GENETICS, V54, P1441; KIEFER BI, 1968, GENETICS, V60, P192; KIEFER BI, 1970, J CELL SCI, V6, P177; Kiger AA, 1999, GENETICS, V153, P799; KLEMENZ R, 1985, EMBO J, V4, P2053, DOI 10.1002/j.1460-2075.1985.tb03891.x; Kondo T, 1998, BLOOD, V92, P1091, DOI 10.1182/blood.V92.4.1091.416a36_1091_1096; Kornblihtt AR, 2004, RNA, V10, P1489, DOI 10.1261/rna.7100104; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li MG, 2004, MOL BIOL CELL, V15, P3005, DOI 10.1091/mbc.E04-01-0013; Lindsley D.L., 1980, Genetics and Biology of Drosophila, V2d, P225; Lindsley D.L., 1992, GENOME DROSOPHILA ME, Veighth; Lopez-Bigas N, 2005, FEBS LETT, V579, P1900, DOI 10.1016/j.febslet.2005.02.047; MCGARRY TJ, 1985, CELL, V42, P903, DOI 10.1016/0092-8674(85)90286-7; Melo EO, 2003, J BIOL CHEM, V278, P46357, DOI 10.1074/jbc.M307624200; Mencarelli C, 2008, INT REV CEL MOL BIO, V268, P95, DOI 10.1016/S1937-6448(08)00804-6; Milisav I, 1998, CELL MOTIL CYTOSKEL, V39, P261, DOI 10.1002/(SICI)1097-0169(1998)39:4<261::AID-CM2>3.0.CO;2-6; MITCHELL DR, 1994, INT REV CYTOL, V155, P141, DOI 10.1016/S0074-7696(08)62098-7; Mohan M, 2007, EMBO J, V26, P4203, DOI 10.1038/sj.emboj.7601851; Nielsen MG, 2002, EVOL DEV, V4, P303, DOI 10.1046/j.1525-142X.2002.02015.x; Noguchi T, 2003, DEVELOPMENT, V130, P1805, DOI 10.1242/dev.00406; Nurminsky DI, 1998, NATURE, V396, P572, DOI 10.1038/25126; Nurminsky DI, 1998, MOL CELL BIOL, V18, P6816, DOI 10.1128/MCB.18.11.6816; Pagani F, 2004, NAT REV GENET, V5, P389, DOI 10.1038/nrg1327; Pennarun G, 1999, AM J HUM GENET, V65, P1508, DOI 10.1086/302683; Porter ME, 1996, CURR OPIN CELL BIOL, V8, P10, DOI 10.1016/S0955-0674(96)80042-1; Porter ME, 2000, J CELL BIOL, V151, pF37, DOI 10.1083/jcb.151.5.F37; Prasanth KV, 2000, J CELL SCI, V113, P3485; PRITCHARD AE, 1992, J VIROL, V66, P1951, DOI 10.1128/JVI.66.4.1951-1958.1992; Quintyne NJ, 2002, J CELL BIOL, V159, P245, DOI 10.1083/jcb.200203089; Rajendra TK, 2001, J GENET, V80, P97, DOI 10.1007/BF02728335; RASMUSSON K, 1994, MOL BIOL CELL, V5, P45, DOI 10.1091/mbc.5.1.45; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Santel A, 1997, MECH DEVELOP, V64, P19, DOI 10.1016/S0925-4773(97)00031-2; Santel A, 1998, J CELL SCI, V111, P3299; Sharp DJ, 2000, NAT CELL BIOL, V2, P922, DOI 10.1038/35046574; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; Timakov B, 2000, GENETICS, V155, P179; Vibranovski MD, 2008, GENETICS, V179, P2325, DOI 10.1534/genetics.108.086819; Wang ZF, 2008, RNA, V14, P802, DOI 10.1261/rna.876308; Wang ZF, 2004, CELL, V119, P831, DOI 10.1016/j.cell.2004.11.010; WILKERSON CG, 1995, J CELL BIOL, V129, P169, DOI 10.1083/jcb.129.1.169; Zhang XHF, 2004, GENE DEV, V18, P1241, DOI 10.1101/gad.1195304; Zheng ZM, 2004, J BIOMED SCI, V11, P278, DOI 10.1159/000077096	72	21	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2011	6	12							e27822	10.1371/journal.pone.0027822	http://dx.doi.org/10.1371/journal.pone.0027822			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MQ	22145020	gold, Green Published, Green Submitted			2022-12-27	WOS:000298168900003
J	Yang, ZJ; Zhang, L; Ma, AH; Liu, LL; Li, JJ; Gu, JR; Liu, YZ				Yang, Zhaojuan; Zhang, Li; Ma, Aihui; Liu, Lanlan; Li, Jinjun; Gu, Jianren; Liu, Yongzhong			Transient mTOR Inhibition Facilitates Continuous Growth of Liver Tumors by Modulating the Maintenance of CD133+Cell Populations	PLOS ONE			English	Article							CANCER STEM-CELLS; MAMMALIAN TARGET; HEPATOCELLULAR-CARCINOMA; EPIGENETIC REGULATION; CELLULAR SENESCENCE; HUMAN GLIOBLASTOMA; COLORECTAL-CANCER; PANCREATIC-CANCER; 1A-DEFICIENT MICE; INITIATING CELLS	The mammalian target of the rapamycin (mTOR) pathway, which drives cell proliferation, is frequently hyperactivated in a variety of malignancies. Therefore, the inhibition of the mTOR pathway has been considered as an appropriate approach for cancer therapy. In this study, we examined the roles of mTOR in the maintenance and differentiation of cancer stem-like cells (CSCs), the conversion of conventional cancer cells to CSCs and continuous tumor growth in vivo. In H-Ras-transformed mouse liver tumor cells, we found that pharmacological inhibition of mTOR with rapamycin greatly increased not only the CD133+ populations both in vitro and in vivo but also the expression of stem cell-like genes. Enhancing mTOR activity by over-expressing Rheb significantly decreased CD133 expression, whereas knockdown of the mTOR yielded an opposite effect. In addition, mTOR inhibition severely blocked the differentiation of CD133+ to CD133-liver tumor cells. Strikingly, single-cell culture experiments revealed that CD133- liver tumor cells were capable of converting to CD133+ cells and the inhibition of mTOR signaling substantially promoted this conversion. In serial implantation of tumor xenografts in nude BALB/c mice, the residual tumor cells that were exposed to rapamycin in vivo displayed higher CD133 expression and had increased secondary tumorigenicity compared with the control group. Moreover, rapamycin treatment also enhanced the level of stem cell-associated genes and CD133 expression in certain human liver tumor cell lines, such as Huh7, PLC/PRC/7 and Hep3B. The mTOR pathway is significantly involved in the generation and the differentiation of tumorigenic liver CSCs. These results may be valuable for the design of more rational strategies to control clinical malignant HCC using mTOR inhibitors.	[Yang, Zhaojuan; Zhang, Li; Ma, Aihui; Liu, Lanlan; Li, Jinjun; Gu, Jianren; Liu, Yongzhong] Shanghai Jiao Tong Univ, State Key Lab Oncogenes & Related Genes, Sch Med, Renji Hosp,Shanghai Canc Inst, Shanghai 200030, Peoples R China; [Liu, Lanlan] Jinan Univ, Inst Reprod Immunol, Guangzhou, Guangdong, Peoples R China	Shanghai Jiao Tong University; Jinan University	Yang, ZJ (corresponding author), Shanghai Jiao Tong Univ, State Key Lab Oncogenes & Related Genes, Sch Med, Renji Hosp,Shanghai Canc Inst, Shanghai 200030, Peoples R China.	liuyzg@yahoo.com			Ministry of Health of China [2008ZX10002-022]	Ministry of Health of China	This work was supported by grants from the Ministry of Health of China (2008ZX10002-022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anido J, 2010, CANCER CELL, V18, P655, DOI 10.1016/j.ccr.2010.10.023; Baba T, 2009, ONCOGENE, V28, P209, DOI 10.1038/onc.2008.374; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Campbell TB, 2009, BLOOD, V114, P3392, DOI 10.1182/blood-2008-12-195214; Castilho RM, 2009, CELL STEM CELL, V5, P279, DOI 10.1016/j.stem.2009.06.017; Chang CJ, 2011, CANCER CELL, V19, P86, DOI 10.1016/j.ccr.2010.10.035; Chen C, 2008, J EXP MED, V205, P2397, DOI 10.1084/jem.20081297; Curtin JC, 2010, ONCOTARGET, V1, P563, DOI 10.18632/oncotarget.191; Demidenko ZN, 2009, CELL CYCLE, V8, P1896, DOI 10.4161/cc.8.12.8809; Demidenko ZN, 2009, CELL CYCLE, V8, P1888, DOI 10.4161/cc.8.12.8606; Ding W, 2009, HEPATOLOGY, V49, P1277, DOI 10.1002/hep.22743; Dubrovska A, 2009, P NATL ACAD SCI USA, V106, P268, DOI 10.1073/pnas.0810956106; Dudkin L, 2001, CLIN CANCER RES, V7, P1758; Easley CA, 2010, CELL REPROGRAM, V12, P263, DOI 10.1089/cell.2010.0011; Easton JB, 2006, ONCOGENE, V25, P6436, DOI 10.1038/sj.onc.1209886; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; Horst D, 2008, BRIT J CANCER, V99, P1285, DOI 10.1038/sj.bjc.6604664; Hudson CC, 2002, MOL CELL BIOL, V22, P7004, DOI 10.1128/MCB.22.20.7004-7014.2002; Inoki K, 2005, NAT GENET, V37, P19, DOI 10.1038/ng1494; Javle MM, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-368; Kemper K, 2010, ONCOTARGET, V1, P387, DOI 10.18632/oncotarget.173; Kenerson HL, 2002, CANCER RES, V62, P5645; Korkaya H, 2008, ONCOGENE, V27, P6120, DOI 10.1038/onc.2008.207; Korotchkina LG, 2010, AGING-US, V2, P344, DOI 10.18632/aging.100160; Lee TKW, 2011, CELL STEM CELL, V9, P50, DOI 10.1016/j.stem.2011.06.005; Liu L, 2006, ONCOGENE, V25, P7029, DOI 10.1038/sj.onc.1209691; Liu SL, 2010, J CLIN ONCOL, V28, P4006, DOI 10.1200/JCO.2009.27.5388; Lu ZH, 2010, CANCER RES, V70, P3287, DOI 10.1158/0008-5472.CAN-09-3467; Ma S, 2008, ONCOGENE, V27, P1749, DOI 10.1038/sj.onc.1210811; Ma S, 2007, GASTROENTEROLOGY, V132, P2542, DOI 10.1053/j.gastro.2007.04.025; Ma S, 2010, CELL STEM CELL, V7, P694, DOI 10.1016/j.stem.2010.11.010; Majumder PK, 2004, NAT MED, V10, P594, DOI 10.1038/nm1052; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Matsumoto K, 2009, CANCER RES, V69, P7160, DOI 10.1158/0008-5472.CAN-09-1289; McCord AM, 2009, MOL CANCER RES, V7, P489, DOI 10.1158/1541-7786.MCR-08-0360; Miki J, 2007, CANCER RES, V67, P3153, DOI 10.1158/0008-5472.CAN-06-4429; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Naka K, 2010, NATURE, V463, P676, DOI 10.1038/nature08734; Nardella C, 2008, GENE DEV, V22, P2172, DOI 10.1101/gad.1699608; Platet N, 2007, CANCER LETT, V258, P286, DOI 10.1016/j.canlet.2007.09.012; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Rountree CB, 2008, HEPATOLOGY, V47, P1288, DOI 10.1002/hep.22141; Rountree CB, 2007, STEM CELLS, V25, P2419, DOI 10.1634/stemcells.2007-0176; Rountree CB, 2009, STEM CELLS, V27, P290, DOI 10.1634/stemcells.2008-0332; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Sansal I, 2004, J CLIN ONCOL, V22, P2954, DOI 10.1200/jco.2004.02.141; Schewe DM, 2008, P NATL ACAD SCI USA, V105, P10519, DOI 10.1073/pnas.0800939105; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Soeda A, 2009, ONCOGENE, V28, P3949, DOI 10.1038/onc.2009.252; Song W, 2008, INT J CLIN PRACT, V62, P1212, DOI 10.1111/j.1742-1241.2008.01777.x; Sunayama J, 2010, STEM CELLS, V28, P1930, DOI 10.1002/stem.521; Tee AR, 2005, FEBS LETT, V579, P4763, DOI 10.1016/j.febslet.2005.07.054; Vignot S, 2005, ANN ONCOL, V16, P525, DOI 10.1093/annonc/mdi113; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wolpin BM, 2009, J CLIN ONCOL, V27, P193, DOI 10.1200/JCO.2008.18.9514; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yin SY, 2007, INT J CANCER, V120, P1444, DOI 10.1002/ijc.22476; You HN, 2010, HEPATOLOGY, V51, P1635, DOI 10.1002/hep.23544; Zender L, 2005, COLD SH Q B, V70, P251, DOI 10.1101/sqb.2005.70.059; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhou JB, 2007, P NATL ACAD SCI USA, V104, P16158, DOI 10.1073/pnas.0702596104	62	33	35	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2011	6	12							e28405	10.1371/journal.pone.0028405	http://dx.doi.org/10.1371/journal.pone.0028405			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MQ	22145042	gold, Green Published, Green Submitted			2022-12-27	WOS:000298168900025
J	Hannemann, J; Meyer-Staeckling, S; Kemming, D; Alpers, I; Joosse, SA; Pospisil, H; Kurtz, S; Gorndt, J; Puschel, K; Riethdorf, S; Pantel, K; Brandt, B				Hannemann, Juliane; Meyer-Staeckling, Soenke; Kemming, Dirk; Alpers, Iris; Joosse, Simon A.; Pospisil, Heike; Kurtz, Stefan; Goerndt, Jennifer; Pueschel, Klaus; Riethdorf, Sabine; Pantel, Klaus; Brandt, Burkhard			Quantitative High-Resolution Genomic Analysis of Single Cancer Cells	PLOS ONE			English	Article							MULTIPLE DISPLACEMENT AMPLIFICATION; BREAST-CANCER; LUNG-CANCER; EGFR GENE; ARRAY CGH; THERAPY	During cancer progression, specific genomic aberrations arise that can determine the scope of the disease and can be used as predictive or prognostic markers. The detection of specific gene amplifications or deletions in single blood-borne or disseminated tumour cells that may give rise to the development of metastases is of great clinical interest but technically challenging. In this study, we present a method for quantitative high-resolution genomic analysis of single cells. Cells were isolated under permanent microscopic control followed by high-fidelity whole genome amplification and subsequent analyses by fine tiling array-CGH and qPCR. The assay was applied to single breast cancer cells to analyze the chromosomal region centred by the therapeutical relevant EGFR gene. This method allows precise quantitative analysis of copy number variations in single cell diagnostics.	[Hannemann, Juliane; Meyer-Staeckling, Soenke; Kemming, Dirk; Alpers, Iris; Joosse, Simon A.; Riethdorf, Sabine; Pantel, Klaus; Brandt, Burkhard] Univ Med Ctr Hamburg Eppendorf, Dept Tumor Biol, Hamburg, Germany; [Pospisil, Heike; Kurtz, Stefan] Univ Hamburg, Ctr Bioinformat, Hamburg, Germany; [Pospisil, Heike] Univ Appl Sci Wildau, Wildau, Germany; [Goerndt, Jennifer; Pueschel, Klaus] Univ Hamburg, Dept Legal Med, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University of Applied Sciences Wildau; University of Hamburg	Hannemann, J (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Tumor Biol, Hamburg, Germany.	Burkhard.Brandt@uksh.de	Pospisil, Heike/G-7377-2016; Joosse, Simon/ABC-2470-2020	Joosse, Simon/0000-0002-4296-5615; Brandt, Burkhard/0000-0003-3681-3049	Bundesministerium Fur Bildung Und Forschung (BMBF) [FKZ: 01ES0724]	Bundesministerium Fur Bildung Und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by Bundesministerium Fur Bildung Und Forschung (BMBF FKZ: 01ES0724, http://www.bmbf.de/de/1398.php). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agelopoulos K, 2008, CURR CANCER DRUG TAR, V8, P431, DOI 10.2174/156800908785133213; Agelopoulos K, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-78; Allison M, 2010, NAT BIOTECHNOL, V28, P117, DOI 10.1038/nbt0210-117; Braun S, 2005, NEW ENGL J MED, V353, P793, DOI 10.1056/NEJMoa050434; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; Dienstmann R, 2011, ONCOTARGET, V2, P165; Duncan CG, 2010, ONCOTARGET, V1, P265, DOI 10.18632/oncotarget.137; Eilers PHC, 2005, BIOINFORMATICS, V21, P1146, DOI 10.1093/bioinformatics/bti148; Fuhrmann C, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn101; Hirsch FR, 2009, LANCET ONCOL, V10, P432, DOI 10.1016/S1470-2045(09)70110-X; Honeth G, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2108; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Maheswaran S, 2008, NEW ENGL J MED, V359, P366, DOI 10.1056/NEJMoa0800668; Moroni M, 2005, LANCET ONCOL, V6, P279, DOI 10.1016/S1470-2045(05)70102-9; Morrison BJ, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2111; Naylor TL, 2005, BREAST CANCER RES, V7, pR1186, DOI 10.1186/bcr1356; Pantel K, 2008, NAT REV CANCER, V8, P329, DOI 10.1038/nrc2375; Selzer RR, 2005, GENE CHROMOSOME CANC, V44, P305, DOI 10.1002/gcc.20243; Spits C, 2006, NAT PROTOC, V1, P1965, DOI 10.1038/nprot.2006.326; Stoecklein NH, 2008, CANCER CELL, V13, P441, DOI 10.1016/j.ccr.2008.04.005; Tidow N, 2003, CANCER RES, V63, P1172; Zhang ZF, 2010, ONCOTARGET, V1, P497	22	31	32	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e26362	10.1371/journal.pone.0026362	http://dx.doi.org/10.1371/journal.pone.0026362			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140428	Green Published, gold, Green Submitted			2022-12-27	WOS:000298168100005
J	Wirsing, A; Senkel, S; Klein-Hitpass, L; Ryffel, GU				Wirsing, Andrea; Senkel, Sabine; Klein-Hitpass, Ludger; Ryffel, Gerhart U.			A Systematic Analysis of the 3 ' UTR of HNF4A mRNA Reveals an Interplay of Regulatory Elements Including miRNA Target Sites	PLOS ONE			English	Article							NUCLEAR FACTOR 4-ALPHA; TRANSCRIPTION FACTORS; GENE-EXPRESSION; CELL-PROLIFERATION; DOWN-REGULATION; UNTRANSLATED REGIONS; P2 PROMOTER; MICRORNAS; HNF4-ALPHA; CARCINOMA	Dysfunction of hepatocyte nuclear factor 4 alpha (HNF4 alpha) has been linked to maturity onset diabetes of the young (MODY1), diabetes type II and possibly to renal cell carcinoma (RCC). Whereas diabetes causing mutations are well known, there are no HNF4A mutations found in RCC. Since so far analyses have been constricted to the promoter and open reading frame of HNF4A, we performed a systematic analysis of the human HNF4A 3'UTR. We identified a short (1724 nt) and long (3180 nt) 3'UTR that are much longer than the open reading frame and conferred a repressive effect in luciferase reporter assays in HEK293 and INS-1 cells. By dissecting the 3'UTR into several pieces, we located two distinct elements of about 400 nt conferring a highly repressive effect. These negative elements A and B are counteracted by a balancer element of 39 nt located within the 59 end of the HNF4A 3'UTR. Dicer knock-down experiments implied that the HNF4A 3'UTR is regulated by miRNAs. More detailed analysis showed that miR-34 alpha and miR-21 both overexpressed in RCC cooperate in downregulation of the HNF4A mRNA. One of the identified miR-34 alpha binding sites is destroyed by SNP rs11574744. The identification of several regulatory elements within the HNF4A 3'UTR justifies the analysis of the 3'UTR sequence to explore the dysfunction of HNF4 alpha in diabetes and RCC.	[Wirsing, Andrea; Senkel, Sabine; Klein-Hitpass, Ludger; Ryffel, Gerhart U.] Univ Duisburg Essen, Univ Klinikum Essen, Inst Zellbiol Tumorforsch, Essen, Germany	University of Duisburg Essen	Wirsing, A (corresponding author), Royal Melbourne Hosp, Ludwig Inst Canc Res, Melbourne Tumour Biol Branch, Melbourne, Vic, Australia.	gerhart.ryffel@uni-due.de			Deutsche Forschungsgemeinschaft [Ry5/9-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (Ry5/9-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asslaber D, 2010, BLOOD, V115, P4191, DOI 10.1182/blood-2009-07-234823; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Beaudoing E, 2000, GENOME RES, V10, P1001, DOI 10.1101/gr.10.7.1001; Bentwich I, 2005, FEBS LETT, V579, P5904, DOI 10.1016/j.febslet.2005.09.040; Bolotin E, 2010, TRANSCRIPTION FACTOR; Bolotin E, 2010, HEPATOLOGY, V51, P642, DOI 10.1002/hep.23357; Chatterjee S, 2009, BIOL CELL, V101, P251, DOI 10.1042/BC20080104; Chiba H, 2005, EXP CELL RES, V302, P11, DOI 10.1016/j.yexcr.2004.08.014; Chow TFF, 2010, CLIN BIOCHEM, V43, P150, DOI 10.1016/j.clinbiochem.2009.07.020; Cok SJ, 2001, J BIOL CHEM, V276, P23179, DOI 10.1074/jbc.M008461200; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; de Moor CH, 2005, SEMIN CELL DEV BIOL, V16, P49, DOI 10.1016/j.semcdb.2004.11.007; Dutta KK, 2007, CANCER SCI, V98, P1845, DOI 10.1111/j.1349-7006.2007.00619.x; Erdmann S, 2007, BIOL CHEM, V388, P91, DOI 10.1515/BC.2007.011; Gao W, 2011, J CANCER RES CLIN, V137, P557, DOI 10.1007/s00432-010-0918-4; Gautreau D, 1997, DEVELOPMENT, V124, P5013; Gottardo F, 2007, UROL ONCOL-SEMIN ORI, V25, P387, DOI 10.1016/j.urolonc.2007.01.019; Grigo K, 2008, BIOL CHEM, V389, P179, DOI 10.1515/BC.2008.011; Grillo G, 2010, NUCLEIC ACIDS RES, V38, pD75, DOI 10.1093/nar/gkp902; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Grzybowska EA, 2001, BIOCHEM BIOPH RES CO, V288, P291, DOI 10.1006/bbrc.2001.5738; Gupta RK, 2004, TRENDS MOL MED, V10, P521, DOI 10.1016/j.molmed.2004.09.004; Harries LW, 2008, DIABETES, V57, P1745, DOI 10.2337/db07-1742; Hatzis P, 2006, MOL CELL BIOL, V26, P7017, DOI 10.1128/MCB.00297-06; Hermeking H, 2010, CELL DEATH DIFFER, V17, P193, DOI 10.1038/cdd.2009.56; Huang JM, 2009, EXP CELL RES, V315, P1200, DOI 10.1016/j.yexcr.2009.01.004; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Juan D, 2010, UROLOGY, V75, P835, DOI 10.1016/j.urology.2009.10.033; Jung M, 2009, J CELL MOL MED, V13, P3918, DOI 10.1111/j.1582-4934.2009.00705.x; Kadonaga JT, 2004, CELL, V116, P247, DOI 10.1016/S0092-8674(03)01078-X; Kolfschoten IGM, 2009, DIABETES OBES METAB, V11, P118, DOI 10.1111/j.1463-1326.2009.01118.x; Kong L, 2011, ACTA DIABETOL, V48, P61, DOI 10.1007/s00592-010-0226-0; Kort EJ, 2008, CANCER RES, V68, P4034, DOI 10.1158/0008-5472.CAN-08-0592; Lausen J, 2000, NUCLEIC ACIDS RES, V28, P430, DOI 10.1093/nar/28.2.430; Lazarevich N, 2004, HEPATOLOGY, V39, P1038, DOI 10.1002/hep.20155; Lenburg ME, 2003, BMC CANCER, V3, DOI 10.1186/1471-2407-3-31; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liu HQ, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-51; Lodygin D, 2008, CELL CYCLE, V7, P2591, DOI 10.4161/cc.7.16.6533; Love-Gregory L, 2007, CURR OPIN CLIN NUTR, V10, P397, DOI 10.1097/MCO.0b013e3281e3888d; Lucas B, 2005, ONCOGENE, V24, P6418, DOI 10.1038/sj.onc.1208794; MACDONALD PM, 1990, DEVELOPMENT, V110, P161; Medina PP, 2008, CELL CYCLE, V7, P2485, DOI 10.4161/cc.7.16.6453; Mignone F, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-3-reviews0004; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; Moncini S, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-111; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; Nakada C, 2008, J PATHOL, V216, P418, DOI 10.1002/path.2437; Nakhei H, 1998, NUCLEIC ACIDS RES, V26, P497, DOI 10.1093/nar/26.2.497; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Pineau P, 2010, P NATL ACAD SCI USA, V107, P264, DOI 10.1073/pnas.0907904107; Portales-Casamar E, 2010, NUCLEIC ACIDS RES, V38, pD105, DOI 10.1093/nar/gkp950; Rajewsky N, 2006, NAT STRUCT MOL BIOL, V13, P754, DOI 10.1038/nsmb0906-754; Ritchie W, 2009, NAT METHODS, V6, P397, DOI 10.1038/nmeth0609-397; Ryffel GU, 2001, J MOL ENDOCRINOL, V27, P11, DOI 10.1677/jme.0.0270011; Scheper W, 1996, BIOCHEM J, V318, P195, DOI 10.1042/bj3180195; Schmitter D, 2006, NUCLEIC ACIDS RES, V34, P4801, DOI 10.1093/nar/gkl646; SEEGER MA, 1990, EMBO J, V9, P2977, DOI 10.1002/j.1460-2075.1990.tb07490.x; Sel S, 1996, CANCER LETT, V101, P205, DOI 10.1016/0304-3835(96)04136-5; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Selcuklu SD, 2009, BIOCHEM SOC T, V37, P918, DOI 10.1042/BST0370918; Shenouda SK, 2009, CANCER METAST REV, V28, P369, DOI 10.1007/s10555-009-9188-5; Silander K, 2004, DIABETES, V53, P1141, DOI 10.2337/diabetes.53.4.1141; Spizzo R, 2009, CELL, V137, P586, DOI 10.1016/j.cell.2009.04.040; Sun GH, 2010, NUCLEIC ACIDS RES, V38, P239, DOI 10.1093/nar/gkp870; Takagi S, 2010, J BIOL CHEM, V285, P4415, DOI 10.1074/jbc.M109.085431; Tang XQ, 2008, BBA-GENE REGUL MECH, V1779, P697, DOI 10.1016/j.bbagrm.2008.06.010; Thomas H, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh144; Thomas H, 2001, HUM MOL GENET, V10, P2089, DOI 10.1093/hmg/10.19.2089; Ventura A, 2009, CELL, V136, P586, DOI 10.1016/j.cell.2009.02.005; Wirsing A, 2010, DIABETIC MED, V27, P631, DOI 10.1111/j.1464-5491.2010.03003.x; Yin C, 2008, HEPATOLOGY, V48, P1528, DOI 10.1002/hep.22510; Zhu SM, 2007, J BIOL CHEM, V282, P14328, DOI 10.1074/jbc.M611393200	78	33	35	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e27438	10.1371/journal.pone.0027438	http://dx.doi.org/10.1371/journal.pone.0027438			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140441	Green Submitted, gold, Green Published			2022-12-27	WOS:000298168100010
J	Won, JH; Ehret, G; Chakravarti, A; Olshen, RA				Won, Joong-Ho; Ehret, Georg; Chakravarti, Aravinda; Olshen, Richard A.			SNPs and Other Features as They Predispose to Complex Disease: Genome-Wide Predictive Analysis of a Quantitative Phenotype for Hypertension	PLOS ONE			English	Article							MEAN ARTERIAL-PRESSURE; FALSE DISCOVERY RATE; BLOOD-PRESSURE; ASSOCIATION; TRAITS; GENE; SUSCEPTIBILITY; COMPONENTS; RISK	Though recently they have fallen into some disrepute, genome-wide association studies (GWAS) have been formulated and applied to understanding essential hypertension. The principal goal here is to use data gathered in a GWAS to gauge the extent to which SNPs and their interactions with other features can be combined to predict mean arterial blood pressure (MAP) in 3138 pre-menopausal and naturally post-menopausal white women. More precisely, we quantify the extent to which data as described permit prediction of MAP beyond what is possible from traditional risk factors such as blood cholesterol levels and glucose levels. Of course, these traditional risk factors are genetic, though typically not explicitly so. In all, there were 44 such risk factors/clinical variables measured and 377,790 single nucleotide polymorphisms (SNPs) genotyped. Data for women we studied are from first visit measurements taken as part of the Atherosclerotic Risk in Communities (ARIC) study. We begin by assessing non-SNP features in their abilities to predict MAP, employing a novel regression technique with two stages, first the discovery of main effects and next discovery of their interactions. The long list of SNPs genotyped is reduced to a manageable list for combining with non-SNP features in prediction. We adapted Efron's local false discovery rate to produce this reduced list. Selected non-SNP and SNP features and their interactions are used to predict MAP using adaptive linear regression. We quantify quality of prediction by an estimated coefficient of determination (R-2). We compare the accuracy of prediction with and without information from SNPs.	[Won, Joong-Ho] VA Cooperat Studies Program, Mountain View, CA USA; [Won, Joong-Ho; Olshen, Richard A.] Stanford Univ, Div Biostat, Stanford, CA 94305 USA; [Ehret, Georg; Chakravarti, Aravinda] Johns Hopkins Univ, McKusick Nathans Inst Genet Med, Baltimore, MD USA; [Ehret, Georg] Univ Hosp Geneva, Div Cardiol, Geneva, Switzerland; [Chakravarti, Aravinda] Johns Hopkins Univ, Dept Epidemiol & Med, Baltimore, MD USA	Stanford University; Johns Hopkins University; University of Geneva; Johns Hopkins University	Won, JH (corresponding author), VA Cooperat Studies Program, Mountain View, CA USA.	olshen@stanford.edu	EHRET, Georg B/A-9532-2009; Won, Joong-Ho/GPF-9286-2022	EHRET, Georg B/0000-0002-5730-0675; 	United States National Institutes of Health (NIH) [R01 HL086694]; MERIT [R37EB02784]; Stanford Medical School; National Heart, Lung and Blood Institute [N01-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-55019, N01-HC-55020, N01-HC-55021, N01-HC-55022, R01HL087641, R01HL59367, R37HL051021, R01HL086694, U10HL054512]; National Human Genome Research Institute [U01HG004402]; NIH [HHSN268200625226C]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC055015, N01HC055022, N01HC055018, N01HC055020, N01HC055019, N01HC055021, N01HC055016] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025005] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087641, R01HL059367, R37HL051021, R42HL055018, R01HL086694, U10HL054512, R41HL055018, R41HL055019] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R37EB002784] Funding Source: NIH RePORTER	United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MERIT; Stanford Medical School; National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	JHW and RAO were supported by the United States National Institutes of Health (NIH) grant R01 HL086694 and MERIT Award R37EB02784. JHW was also supported by the Dean's postdoctoral fellowship from the Stanford Medical School. The Atherosclerosis Risk in Communities Study is a collaborative study supported by National Heart, Lung and Blood Institute contracts N01-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-55019, N01-HC-55020, N01-HC-55021 and N01-HC-55022, and grants R01HL087641, R01HL59367, R37HL051021, R01HL086694 and U10HL054512; National Human Genome Research Institute contract U01HG004402; and NIH contract HHSN268200625226C. Infrastructure was supported in part by Grant Number UL1RR025005, a component of the NIH and the NIH Roadmap for Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Breiman L., 1984, CLASSIFICATION REGRE; Chang YPC, 2007, AM J HUM GENET, V80, P253, DOI 10.1086/510918; Chen X, 2007, P NATL ACAD SCI USA, V104, P19199, DOI 10.1073/pnas.0709868104; de Andrade M, 1999, GENET EPIDEMIOL, V17, P64, DOI 10.1002/(SICI)1098-2272(1999)17:1<64::AID-GEPI5>3.0.CO;2-M; Efron B, 2001, J AM STAT ASSOC, V96, P1151, DOI 10.1198/016214501753382129; Efron B., 2010, LARGE SCALE INFERENC; Evans DM, 2009, HUM MOL GENET, V18, P3525, DOI 10.1093/hmg/ddp295; Franklin SS, 2009, CIRCULATION, V119, P243, DOI 10.1161/CIRCULATIONAHA.108.797936; Goldstein DB, 2009, NEW ENGL J MED, V360, P1696, DOI 10.1056/NEJMp0806284; Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002; Hirschhorn JN, 2009, NEW ENGL J MED, V360, P1699, DOI 10.1056/NEJMp0808934; Huang J, 2004, P NATL ACAD SCI USA, V101, P10529, DOI 10.1073/pnas.0403794101; Jakobsdottir J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000337; Janssens ACJW, 2008, HUM MOL GENET, V17, pR166, DOI 10.1093/hmg/ddn250; Koivukoski L, 2004, HUM MOL GENET, V13, P2325, DOI 10.1093/hmg/ddh237; Kraft P, 2009, NEW ENGL J MED, V360, P1701, DOI 10.1056/NEJMp0810107; Lee SH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000231; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Mitchell GF, 2005, CIRCULATION, V112, P194, DOI 10.1161/CIRCULATIONAHA.104.530675; MORGAN JN, 1963, J AM STAT ASSOC, V58, P415, DOI 10.2307/2283276; Pandey JP, 2010, SCIENCE, V329, P1148, DOI 10.1126/science.329.5996.1148; Park MY, 2008, BIOSTATISTICS, V9, P30, DOI 10.1093/biostatistics/kxm010; Strandberg TE, 2002, J HYPERTENS, V20, P399, DOI 10.1097/00004872-200203000-00014; Sun WG, 2007, J AM STAT ASSOC, V102, P901, DOI 10.1198/016214507000000545; Tobin MD, 2005, STAT MED, V24, P2911, DOI 10.1002/sim.2165; Wang MH, 2009, STAT BIOPHARM RES, V1, P424, DOI 10.1198/sbr.2009.0046; Wei Z, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000678; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Zhang H, 2010, SPRINGER SER STAT, P1, DOI 10.1007/978-1-4419-6824-1	31	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e27891	10.1371/journal.pone.0027891	http://dx.doi.org/10.1371/journal.pone.0027891			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140480	gold, Green Submitted, Green Published			2022-12-27	WOS:000298168100023
J	Hu, LB; Li, LK; Xie, HB; Gu, YL; Peng, T				Hu, Longbo; Li, Leike; Xie, Hongbin; Gu, Yanli; Peng, Tao			The Golgi Localization of GOLPH2 (GP73/GOLM1) Is Determined by the Transmembrane and Cytoplamic Sequences	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; LIVER-DISEASE; ENDOPLASMIC-RETICULUM; MEMBRANE-PROTEIN; GP73; RETENTION; EXPRESSION; DOMAINS; BETA-1,4-GALACTOSYLTRANSFERASE; ALPHA-2,6-SIALYLTRANSFERASE	Golgi phosphoprotein 2 (GOLPH2) is a resident Golgi type-II membrane protein upregulated in liver disease. Given that GOLPH2 traffics through endosomes and can be secreted into the circulation, it is a promising serum marker for liver diseases. The structure of GOLPH2 and the functions of its different protein domains are not known. In the current study, we investigated the structural determinants for Golgi localization using a panel of GOLPH2 truncation mutants. The Golgi localization of GOLPH2 was not affected by the deletion of the C-terminal part of the protein. A truncated mutant containing the N-terminal portion (the cytoplasmic tail and transmembrane domain (TMD)) localized to the Golgi. Sequential deletion analysis of the N-terminal indicated that the TMD with a positively charged residue in the cytoplasmic N-terminal tail were sufficient to support Golgi localization. We also showed that both endogenous and secreted GOLPH2 exist as a disulfide-bonded dimer, and the coiled-coil domain was sufficient for dimerization. This structural knowledge is important for the understanding the pathogenic role of GOLPH2 in liver diseases, and the development of GOLPH2-based hepatocellular cancer diagnostic methods.	[Hu, Longbo; Li, Leike; Xie, Hongbin; Gu, Yanli; Peng, Tao] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China; [Li, Leike; Peng, Tao] Univ Sci & Technol China, Hefei 230026, Peoples R China	Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; State Key Laboratory of Respiratory Disease; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Hu, LB (corresponding author), Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China.	peng_tao@gibh.ac.cn	hu, longbo/S-7060-2018	hu, longbo/0000-0002-3495-6268; Li, Leike/0000-0002-1379-1396; Peng, Tao/0000-0001-5260-7128	National Science Foundation [309701647]; National Basic Research Program (973) [2009CB522306]	National Science Foundation(National Science Foundation (NSF)); National Basic Research Program (973)(National Basic Research Program of China)	This work was supported by National Science Foundation (309701647); National Basic Research Program (973) (Grant No. 2009CB522306). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachert C, 2007, TRAFFIC, V8, P1415, DOI 10.1111/j.1600-0854.2007.00621.x; Bulbarelli A, 2002, J CELL SCI, V115, P1689; Colley KJ, 1997, GLYCOBIOLOGY, V7, P1, DOI 10.1093/glycob/7.1.1-b; Giannelli G, 2006, DIGEST LIVER DIS, V38, P854, DOI 10.1016/j.dld.2006.05.007; Gu YL, 2009, ANN CLIN BIOCHEM, V46, P38, DOI 10.1258/acb.2008.008088; He YX, 2010, J BIOL CHEM, V285, P4603, DOI 10.1074/jbc.M109.044180; Iftikhar R, 2004, AM J GASTROENTEROL, V99, P1087, DOI 10.1111/j.1572-0241.2004.30572.x; Kladney RD, 2002, HEPATOLOGY, V35, P1431, DOI 10.1053/jhep.2002.32525; Kladney RD, 2000, GENE, V249, P53, DOI 10.1016/S0378-1119(00)00136-0; Linstedt AD, 1997, MOL BIOL CELL, V8, P1073, DOI 10.1091/mbc.8.6.1073; Lundbaek JA, 2003, BIOPHYS J, V84, P2080, DOI 10.1016/S0006-3495(03)75015-2; Maitra A, 2004, AM J GASTROENTEROL, V99, P1096, DOI 10.1111/j.1572-0241.2004.40410.x; Marrero JA, 2005, J HEPATOL, V43, P1007, DOI 10.1016/j.jhep.2005.05.028; MASIBAY AS, 1993, J BIOL CHEM, V268, P9908; Munro S, 1998, TRENDS CELL BIOL, V8, P11, DOI 10.1016/S0962-8924(97)01197-5; MUNRO S, 1995, EMBO J, V14, P4695, DOI 10.1002/j.1460-2075.1995.tb00151.x; MUNRO S, 1991, EMBO J, V10, P3577, DOI 10.1002/j.1460-2075.1991.tb04924.x; NILSSON T, 1993, J CELL BIOL, V120, P5, DOI 10.1083/jcb.120.1.5; Norton PA, 2007, J CELL BIOCH; Nufer O, 2003, J CELL SCI, V116, P4429, DOI 10.1242/jcs.00759; Puri S, 2002, TRAFFIC, V3, P641, DOI 10.1034/j.1600-0854.2002.30906.x; Ronchi P, 2008, J CELL BIOL, V181, P105, DOI 10.1083/jcb.200710093; WONG SH, 1992, J CELL BIOL, V117, P245, DOI 10.1083/jcb.117.2.245; Wright LM, 2009, INT J CLIN EXP PATHO, V2, P34; YAMAGUCHI N, 1995, J BIOL CHEM, V270, P12170, DOI 10.1074/jbc.270.20.12170; Zhang P, 2009, TOXICON, V53, P309, DOI 10.1016/j.toxicon.2008.12.006; Zhou Y, 2011, MOL BIOL REP, V38, P1457, DOI 10.1007/s11033-010-0251-7	27	12	14	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2011	6	11							e28207	10.1371/journal.pone.0028207	http://dx.doi.org/10.1371/journal.pone.0028207			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863LT	22140547	Green Submitted, gold, Green Published			2022-12-27	WOS:000298166300038
J	Kastrati, I; Edirisinghe, PD; Hemachandra, LPMP; Chandrasena, ER; Choi, J; Wang, YT; Bolton, JL; Thatcher, GRJ				Kastrati, Irida; Edirisinghe, Praneeth D.; Hemachandra, L-P-Madhubani P.; Chandrasena, Esala R.; Choi, Jaewoo; Wang, Yue-Ting; Bolton, Judy L.; Thatcher, Gregory R. J.			Raloxifene and Desmethylarzoxifene Block Estrogen-Induced Malignant Transformation of Human Breast Epithelial Cells	PLOS ONE			English	Article							ANCHORAGE-INDEPENDENT GROWTH; NUCLEIC ACID ADDUCTS; RECEPTOR MODULATORS; DNA-DAMAGE; EQUINE ESTROGEN; DEPURINATING N3ADENINE; METABOLIC-ACTIVATION; POSTMENOPAUSAL WOMEN; CATECHOL ESTROGENS; N7GUANINE ADDUCTS	There is association between exposure to estrogens and the development and progression of hormone-dependent gynecological cancers. Chemical carcinogenesis by catechol estrogens derived from oxidative metabolism is thought to contribute to breast cancer, yet exact mechanisms remain elusive. Malignant transformation was studied in MCF-10A human mammary epithelial cells, since estrogens are not proliferative in this cell line. The human and equine estrogen components of estrogen replacement therapy (ERT) and their catechol metabolites were studied, along with the influence of co-administration of selective estrogen receptor modulators (SERMs), raloxifene and desmethyl-arzoxifene (DMA), and histone deacetylase inhibitors. Transformation was induced by human estrogens, and selectively by the 4-OH catechol metabolite, and to a lesser extent by an equine estrogen metabolite. The observed estrogen-induced upregulation of CYP450 1B1 in estrogen receptor negative MCF-10A cells, was compatible with a causal role for 4-OH catechol estrogens, as was attenuated transformation by CYP450 inhibitors. Estrogen-induced malignant transformation was blocked by SERMs correlating with a reduction in formation of nucleobase catechol estrogen (NCE) adducts and formation of 8-oxo-dG. NCE adducts can be formed consequent to DNA abasic site formation, but NCE adducts were also observed on incubation of estrogen quinones with free nucleotides. These results suggest that NCE adducts may be a biomarker for cellular electrophilic stress, which together with 8-oxo-dG as a biomarker of oxidative stress correlate with malignant transformation induced by estrogen oxidative metabolites. The observed attenuation of transformation by SERMs correlated with these biomarkers and may also be of clinical significance in breast cancer chemoprevention.	[Kastrati, Irida; Edirisinghe, Praneeth D.; Hemachandra, L-P-Madhubani P.; Chandrasena, Esala R.; Choi, Jaewoo; Wang, Yue-Ting; Bolton, Judy L.; Thatcher, Gregory R. J.] Univ Illinois, Coll Pharm, Dept Med Chem & Pharmacognosy, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Kastrati, I (corresponding author), Univ Illinois, Coll Pharm, Dept Med Chem & Pharmacognosy, Chicago, IL 60607 USA.	thatcher@uic.edu	Kastrati, Irida/L-4641-2019	Kastrati, Irida/0000-0002-8086-1411; Hemachandra, L P Madhubhani/0000-0001-7756-6190	University of Illinois at Chicago (UIC) Graduate College; National Institutes of Health [R01 CA130037, R01 CA102590]; NATIONAL CANCER INSTITUTE [R01CA102590, R01CA130037] Funding Source: NIH RePORTER	University of Illinois at Chicago (UIC) Graduate College; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the University of Illinois at Chicago (UIC) Graduate College Deiss Award in Biomedical Research to Irida Kastrati, UIC Graduate College fellowship, by National Institutes of Health grants R01 CA130037 (JLB) and R01 CA102590 (GRJT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABULHAJJ YJ, 1986, J STEROID BIOCHEM, V25, P245, DOI 10.1016/0022-4731(86)90423-1; Akanni A, 1997, CHEM RES TOXICOL, V10, P477, DOI 10.1021/tx960204m; Akanni A, 1999, CHEM RES TOXICOL, V12, P1247, DOI 10.1021/tx9900932; Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701, DOI 10.1001/jama.291.14.1701; Banks E, 2003, LANCET, V362, P419, DOI 10.1016/S0140-6736(03)14065-2; BASOLO F, 1991, MOL CARCINOGEN, V4, P25, DOI 10.1002/mc.2940040106; BEIS I, 1975, BIOCHEM J, V152, P23, DOI 10.1042/bj1520023; Bicaku E, 2008, CANCER RES, V68, P1513, DOI 10.1158/0008-5472.CAN-07-2822; Cavalieri EL, 1997, P NATL ACAD SCI USA, V94, P10937, DOI 10.1073/pnas.94.20.10937; Chen YM, 2000, CHEM RES TOXICOL, V13, P342, DOI 10.1021/tx990186j; Chen ZH, 2005, TOXICOL APPL PHARM, V208, P46, DOI 10.1016/j.taap.2005.01.010; Chen ZH, 2004, CARCINOGENESIS, V25, P2005, DOI 10.1093/carcin/bgh183; Conzen SD, 2003, CANCER J, V9, P4, DOI 10.1097/00130404-200301000-00003; Cosman F, 1999, ENDOCR REV, V20, P418, DOI 10.1210/er.20.3.418; Cuendet M, 2004, MUTAT RES-FUND MOL M, V550, P109, DOI 10.1016/j.mrfmmm.2004.02.005; Cummings SR, 2010, J BONE MINER RES; Delmas PD, 1997, NEW ENGL J MED, V337, P1641, DOI 10.1056/NEJM199712043372301; Duong V, 2008, MOL CANCER RES, V6, P1908, DOI 10.1158/1541-7786.MCR-08-0299; DWIVEDY I, 1992, CHEM RES TOXICOL, V5, P828, DOI 10.1021/tx00030a016; Fernandez SV, 2006, INT J CANCER, V118, P1862, DOI 10.1002/ijc.21590; Frasor J, 2003, ENDOCRINOLOGY, V144, P4562, DOI 10.1210/en.2003-0567; HAN XL, 1995, CARCINOGENESIS, V16, P2571, DOI 10.1093/carcin/16.10.2571; Hodges-Gallagher L, 2007, BREAST CANCER RES TR, V105, P297, DOI 10.1007/s10549-006-9459-6; Jackson AL, 2001, MUTAT RES-FUND MOL M, V477, P7, DOI 10.1016/S0027-5107(01)00091-4; Lareef MH, 2005, INT J ONCOL, V26, P423; LI JJ, 1987, FED PROC, V46, P1858; Liby K, 2006, CLIN CANCER RES, V12, P5902, DOI 10.1158/1078-0432.CCR-06-1119; Liehr JG, 2000, ENDOCR REV, V21, P40, DOI 10.1210/er.21.1.40; LIEHR JG, 1986, J STEROID BIOCHEM, V24, P353, DOI 10.1016/0022-4731(86)90080-4; Liu H, 2005, CHEM RES TOXICOL, V18, P162, DOI 10.1021/tx049776u; Liu H, 2007, CHEM RES TOXICOL, V20, P1676, DOI 10.1021/tx7001367; Lu F, 2007, J STEROID BIOCHEM, V105, P150, DOI 10.1016/j.jsbmb.2006.12.102; Lu F, 2008, CANCER PREV RES, V1, P135, DOI 10.1158/1940-6207.CAPR-08-0037; MACMAHON B, 1960, J NATL CANCER I, V24, P733, DOI 10.1093/jnci/24.3.733; Marchion DC, 2009, MOL CANCER THER, V8, P794, DOI 10.1158/1535-7163.MCT-08-0985; MILLER EC, 1981, CANCER, V47, P1055, DOI 10.1002/1097-0142(19810301)47:5+<1055::AID-CNCR2820471302>3.0.CO;2-3; Osborne CK, 2000, J CLIN ONCOL, V18, P3172, DOI 10.1200/JCO.2000.18.17.3172; Park JH, 2009, DNA REPAIR, V8, P29, DOI 10.1016/j.dnarep.2008.08.011; Park SA, 2009, CANCER RES, V69, P2416, DOI 10.1158/0008-5472.CAN-08-2177; Qin ZH, 2007, J MED CHEM, V50, P2682, DOI 10.1021/jm070079j; Ravdin PM, 2007, NEW ENGL J MED, V356, P1670, DOI 10.1056/NEJMsr070105; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Russo J, 2002, J STEROID BIOCHEM, V80, P149, DOI 10.1016/S0960-0760(01)00183-2; Russo J, 2003, J STEROID BIOCHEM, V87, P1, DOI 10.1016/S0960-0760(03)00390-X; Saeed M, 2007, CHEM-BIOL INTERACT, V165, P175, DOI 10.1016/j.cbi.2006.12.007; Saeed M, 2007, INT J CANCER, V120, P1821, DOI 10.1002/ijc.22399; Saeed M, 2009, INT J CANCER, V124, P1276, DOI 10.1002/ijc.24113; Shang YF, 2002, SCIENCE, V295, P2465, DOI 10.1126/science.1068537; Shen L, 1998, CHEM RES TOXICOL, V11, P94, DOI 10.1021/tx970181r; Shen L, 1997, CARCINOGENESIS, V18, P1093, DOI 10.1093/carcin/18.5.1093; SHIN SI, 1975, P NATL ACAD SCI USA, V72, P4435, DOI 10.1073/pnas.72.11.4435; Singh R, 2003, RAPID COMMUN MASS SP, V17, P126, DOI 10.1002/rcm.883; SOULE HD, 1990, CANCER RES, V50, P6075; Stack DE, 1996, CHEM RES TOXICOL, V9, P851, DOI 10.1021/tx960002q; Sung JS, 2006, FEBS J, V273, P1620, DOI 10.1111/j.1742-4658.2006.05192.x; TAIT L, 1990, CANCER RES, V50, P6087; Wang ZC, 2009, J BIOL CHEM, V284, P8624, DOI 10.1074/jbc.M807860200; Yu BL, 2007, MOL CANCER THER, V6, P2418, DOI 10.1158/1535-7163.MCT-07-0268; Yu BL, 2009, BIOCONJUGATE CHEM, V20, P728, DOI 10.1021/bc800435m; Zahid M, 2006, CHEM RES TOXICOL, V19, P164, DOI 10.1021/tx050229y; Zahid M, 2011, FREE RADICAL BIO MED, V50, P78, DOI 10.1016/j.freeradbiomed.2010.10.662; Zhang F, 2001, CHEM RES TOXICOL, V14, P1654, DOI 10.1021/tx010158c; Zhang FG, 1999, CHEM RES TOXICOL, V12, P204, DOI 10.1021/tx980217v; Zhu BT, 1996, J BIOL CHEM, V271, P1357, DOI 10.1074/jbc.271.3.1357; ZHU BT, 1994, ENDOCRINOLOGY, V135, P1772, DOI 10.1210/en.135.5.1772	65	8	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2011	6	11							e27876	10.1371/journal.pone.0027876	http://dx.doi.org/10.1371/journal.pone.0027876			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863LT	22140478	gold, Green Submitted, Green Published			2022-12-27	WOS:000298166300016
J	Abbate, A; Salloum, FN; Van Tassell, BW; Vecile, E; Toldo, S; Seropian, I; Mezzaroma, E; Dobrina, A				Abbate, Antonio; Salloum, Fadi N.; Van Tassell, Benjamin W.; Vecile, Elena; Toldo, Stefano; Seropian, Ignacio; Mezzaroma, Eleonora; Dobrina, Aldo			Alterations in the Interleukin-1/Interleukin-1 Receptor Antagonist Balance Modulate Cardiac Remodeling following Myocardial Infarction in the Mouse	PLOS ONE			English	Article							INTERLEUKIN-1; APOPTOSIS; IL-1; CASPASE-1	Background: Healing after acute myocardial infarction (AMI) is characterized by an intense inflammatory response and increased Interleukin-1 (IL-1) tissue activity. Genetically engineered mice lacking the IL-1 receptor (IL-1R1-/-, not responsive to IL-1) or the IL-1 receptor antagonist (IL-1Ra, enhanced response to IL-1) have an altered IL-1/IL-1Ra balance that we hypothesize modulates infarct healing and cardiac remodeling after AMI. Methods: IL-1R1-/- and IL-1Ra-/- male mice and their correspondent wild-types (WT) were subjected to permanent coronary artery ligation or sham surgery. Infarct size (trichrome scar size), apoptotic cell death (TUNEL) and left ventricular (LV) dimensions and function (echocardiography) were measured prior to and 7 days after surgery. Results: When compared with the corresponding WT, IL-1R1-/- mice had significantly smaller infarcts (-25%), less cardiomyocyte apoptosis (-50%), and reduced LV enlargement (LV end-diastolic diameter increase [LVEDD], -20%) and dysfunction (LV ejection fraction [LVEF] decrease, -50%), whereas IL-1Ra-/- mice had significantly larger infarcts (+75%), more apoptosis (5-fold increase), and more severe LV enlargement (LVEDD increase, +30%) and dysfunction (LVEF decrease, +70%)(all P values <0.05). Conclusions: An imbalance in IL-1/IL-1Ra signaling at the IL-1R1 level modulates the severity of cardiac remodeling after AMI in the mouse, with reduced IL-1R1 signaling providing protection and unopposed IL-1R1 signaling providing harm.	[Abbate, Antonio; Salloum, Fadi N.; Toldo, Stefano; Seropian, Ignacio; Mezzaroma, Eleonora] Virginia Commonwealth Univ, Victoria Johnson Res Lab, Richmond, VA 23284 USA; [Abbate, Antonio; Salloum, Fadi N.; Toldo, Stefano; Seropian, Ignacio; Mezzaroma, Eleonora] Virginia Commonwealth Univ, VCU Pauley Heart Ctr, Richmond, VA USA; [Van Tassell, Benjamin W.; Mezzaroma, Eleonora] Virginia Commonwealth Univ, Sch Pharm, Richmond, VA USA; [Vecile, Elena; Dobrina, Aldo] Univ Trieste, Dept Physiol & Pathol, Trieste, Italy	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; University of Trieste	Abbate, A (corresponding author), Virginia Commonwealth Univ, Victoria Johnson Res Lab, Richmond, VA 23284 USA.	aabbate@mcvh-vcu.edu	Salloum, Fadi N/C-2391-2008; Abbate, Antonio/G-8805-2016; Abbate, Antonio/E-3405-2014	Salloum, Fadi N/0000-0002-8947-9315; Abbate, Antonio/0000-0002-1930-785X; Seropian, Ignacio Miguel/0000-0002-6823-4001; Toldo, Stefano/0000-0002-1588-4019; Dobrina, Aldo/0000-0002-8393-1796	American Heart Association;  [KL2RR031989-01]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000058, KL2TR000057] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR031989] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported in part by an American Heart Association Beginning Grant-in-Aid (Mid-Atlantic Affiliate) to Dr. Abbate. Dr. Salloum is supported by an American Heart Association Scientist Development Grant. Dr. Van Tassell is supported by an institutional KL2RR031989-01. The funding sources had no role in determining the study design nor did they participate in data analysis or reporting.	Abbate A, 2008, AM J CARDIOL, V102, P658, DOI 10.1016/j.amjcard.2008.05.007; Abbate A, 2008, EUR HEART J, V29, P1795, DOI 10.1093/eurheartj/ehn281; Abbate A, 2008, CIRCULATION, V117, P2670, DOI 10.1161/CIRCULATIONAHA.107.740233; Abbate A, 2010, EUR J HEART FAIL, V12, P319, DOI 10.1093/eurjhf/hfq017; Abbate A, 2010, AM J CARDIOL, V105, P1371, DOI 10.1016/j.amjcard.2009.12.059; Aksentijevich I, 2009, NEW ENGL J MED, V360, P2426, DOI 10.1056/NEJMoa0807865; Arend WR, 2002, CYTOKINE GROWTH F R, V13, P323, DOI 10.1016/S1359-6101(02)00020-5; Bujak M, 2008, AM J PATHOL, V173, P57, DOI 10.2353/ajpath.2008.070974; DINARELLO CA, 1987, J IMMUNOL, V139, P1902; Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417; Frantz S, 2003, J MOL CELL CARDIOL, V35, P685, DOI 10.1016/S0022-2828(03)00113-5; Hausenloy DJ, 2010, BASIC RES CARDIOL, V105, P677, DOI 10.1007/s00395-010-0121-4; Heusch G, 2009, CIRCULATION, V120, P1822, DOI 10.1161/CIRCULATIONAHA.109.888784; Hirsch E, 1996, P NATL ACAD SCI USA, V93, P11008, DOI 10.1073/pnas.93.20.11008; Hoffman HM, 2010, CURR ALLERGY ASTHM R, V10, P229, DOI 10.1007/s11882-010-0109-z; Horai R, 2000, J EXP MED, V191, P313, DOI 10.1084/jem.191.2.313; Hwang MW, 2001, J AM COLL CARDIOL, V38, P1546, DOI 10.1016/S0735-1097(01)01591-1; Ing DJ, 1999, CIRC RES, V84, P21; Labow M, 1997, J IMMUNOL, V159, P2452; Merkle S, 2007, CIRC RES, V100, P645, DOI 10.1161/01.RES.0000260203.55077.61; Nicklin MJH, 2000, J EXP MED, V191, P303, DOI 10.1084/jem.191.2.303; SEKIYAMA KD, 1994, CLIN EXP IMMUNOL, V98, P71; Suzuki K, 2001, CIRCULATION, V104, pI308; Syed FM, 2005, CIRC RES, V96, P1103, DOI 10.1161/01.RES.0000166925.45995.ed; Toldo S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018102; van den Borne SWM, 2009, CARDIOVASC RES, V84, P273, DOI 10.1093/cvr/cvp207; Van Tassell BW, 2010, J CARDIOVASC PHARM, V55, P117, DOI 10.1097/FJC.0b013e3181c87e53	27	49	50	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2011	6	11							e27923	10.1371/journal.pone.0027923	http://dx.doi.org/10.1371/journal.pone.0027923			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KW	22140485	gold, Green Submitted, Green Published			2022-12-27	WOS:000298163400023
J	Hartney, T; Birari, R; Venkataraman, S; Villegas, L; Martinez, M; Black, SM; Stenmark, KR; Nozik-Grayck, E				Hartney, Tanya; Birari, Rahul; Venkataraman, Sujatha; Villegas, Leah; Martinez, Maylyn; Black, Stephen M.; Stenmark, Kurt R.; Nozik-Grayck, Eva			Xanthine Oxidase-Derived ROS Upregulate Egr-1 via ERK1/2 in PA Smooth Muscle Cells; Model to Test Impact of Extracellular ROS in Chronic Hypoxia	PLOS ONE			English	Article							EARLY GROWTH RESPONSE-1; SUPEROXIDE DISMUTASE EXPRESSION; PULMONARY EC-SOD; HYPERTENSION; ARTERY; EXPOSURE; LUNG; PROLIFERATION; CONTRIBUTES; ACTIVATION	Exposure of newborn calves to chronic hypoxia causes pulmonary artery (PA) hypertension and remodeling. Previous studies showed that the redox-sensitive transcription factor, early growth response-1 (Egr-1), is upregulated in the PA of chronically hypoxic calves and regulates cell proliferation. Furthermore, we established in mice a correlation between hypoxic induction of Egr-1 and reduced activity of extracellular superoxide dismutase (EC-SOD), an antioxidant that scavenges extracellular superoxide. We now hypothesize that loss of EC-SOD in chronically hypoxic calves leads to extracellular superoxide-mediated upregulation of Egr-1. To validate our hypothesis and identify the signaling pathways involved, we utilized PA tissue from normoxic and chronically hypoxic calves and cultured calf and human PA smooth muscle cells (PASMC). Total SOD activity was low in the PA tissue, and only the extracellular SOD component decreased with hypoxia. PA tissue of hypoxic calves showed increased oxidative stress and increased Egr-1 mRNA. To mimic the in vivo hypoxia-induced extracellular oxidant imbalance, cultured calf PASMC were treated with xanthine oxidase (XO), which generates extracellular superoxide and hydrogen peroxide. We found that 1) XO increased Egr-1 mRNA and protein, 2) XO induced the phosphorylation of ERK1/2 and, 3) pretreatment with an ERK1/2 inhibitor prevented induction of Egr-1 by XO. siRNA knock-down of EC-SOD in human PASMC also upregulated Egr-1 mRNA and protein, activated ERK1/2, and enhanced SMC proliferation and reduced apoptosis. We conclude that an oxidant/antioxidant imbalance arising from loss of EC-SOD in the PA with chronic hypoxia induces Egr-1 via activation of ERK1/2 and contributes to pulmonary vascular remodeling.	[Hartney, Tanya; Birari, Rahul; Venkataraman, Sujatha; Villegas, Leah; Martinez, Maylyn; Stenmark, Kurt R.; Nozik-Grayck, Eva] Univ Colorado Denver, Dept Pediat, Aurora, CO USA; [Villegas, Leah; Stenmark, Kurt R.; Nozik-Grayck, Eva] Univ Colorado Denver, Cardiovasc Pulm Res Lab, Aurora, CO USA; [Black, Stephen M.] Georgia Hlth Sci Univ, Augusta, GA USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University System of Georgia; Augusta University	Hartney, T (corresponding author), Univ Colorado Denver, Dept Pediat, Aurora, CO USA.	Eva.Grayck@ucdenver.edu	stenmark, kurt/AFI-6776-2022; stenmark, kurt/AAH-3124-2022; Nozik, Eva/AAP-5395-2020		National Institutes of Health [5RO1-HL086680-04, 5PO1-HL014985-37]; March of Dimes [6-FY06-316]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL014985, R01HL086680] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes(March of Dimes); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health grants 5RO1-HL086680-04 (EN-G) and 5PO1-HL014985-37 (KS) and March of Dimes research grant #6-FY06-316 (EN-G). The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aggeli IKS, 2010, PHYSIOL RES, V59, P443, DOI 10.33549/physiolres.931806; ANDERSON ME, 1985, HDB METHODS OXYGEN R; Banks MF, 2005, J APPL PHYSIOL, V98, P732, DOI 10.1152/japplphysiol.00821.2004; BEERS RF, 1952, J BIOL CHEM, V195, P133; Buettner GR, 2006, FREE RADICAL BIO MED, V41, P1338, DOI 10.1016/j.freeradbiomed.2006.07.015; Das M, 2008, CARDIOVASC RES, V78, P440, DOI 10.1093/cvr/cvn014; Durmowicz AG, 1996, AM J RESP CELL MOL, V14, P569, DOI 10.1165/ajrcmb.14.6.8652185; Fattman CL, 2001, FREE RADICAL BIO MED, V31, P1198, DOI 10.1016/S0891-5849(01)00699-2; Frid MG, 2009, AM J PHYSIOL-LUNG C, V297, pL1059, DOI 10.1152/ajplung.90611.2008; Frid MG, 1997, CIRC RES, V81, P940; FRIDOVICH I, 1970, J BIOL CHEM, V245, P4053; Gerasimovskaya EV, 2002, J BIOL CHEM, V277, P44638, DOI 10.1074/jbc.M203012200; Giles BL, 2002, AM J PHYSIOL-LUNG C, V283, pL549, DOI 10.1152/ajplung.00018.2002; GRIFFITH OW, 1980, ANAL BIOCHEM, V106, P207, DOI 10.1016/0003-2697(80)90139-6; Hasan RN, 2008, CIRC RES, V102, P42, DOI 10.1161/CIRCRESAHA.107.155143; Hassoun PM, 2009, J AM COLL CARDIOL, V54, pS10, DOI 10.1016/j.jacc.2009.04.006; Hoshikawa Y, 2001, J APPL PHYSIOL, V90, P1299, DOI 10.1152/jappl.2001.90.4.1299; HYSLOP PA, 1984, ANAL BIOCHEM, V141, P280, DOI 10.1016/0003-2697(84)90457-3; Jankov RP, 2008, AM J PHYSIOL-LUNG C, V294, pL233, DOI 10.1152/ajplung.00166.2007; Jin NJ, 2000, AM J RESP CELL MOL, V23, P593, DOI 10.1165/ajrcmb.23.5.3921; Kamezaki F, 2008, AM J RESP CRIT CARE, V177, P219, DOI 10.1164/rccm.200702-264OC; Kelley EE, 2006, FREE RADICAL BIO MED, V40, P952, DOI 10.1016/j.freeradbiomed.2005.11.008; Kelley EE, 2010, FREE RADICAL BIO MED, V48, P493, DOI 10.1016/j.freeradbiomed.2009.11.012; Khachigian LM, 2006, CIRC RES, V98, P186, DOI 10.1161/01.RES.0000200177.53882.c3; Li CJ, 2007, AM J PHYSIOL-LUNG C, V292, pL1297, DOI 10.1152/ajplung.00194.2006; Li M, 2009, ANN BIOMED ENG, V37, P1082, DOI 10.1007/s10439-009-9684-3; Liu JQ, 2006, AM J PHYSIOL-LUNG C, V290, pL2, DOI 10.1152/ajplung.00135.2005; Mamo LB, 2004, AM J RESP CRIT CARE, V170, P313, DOI 10.1164/rccm.200309-1282OC; Nozik-Grayck E, 2000, AM J PHYSIOL-LUNG C, V279, pL977, DOI 10.1152/ajplung.2000.279.5.L977; Nozik-Grayck E, 2003, AM J PHYSIOL-HEART C, V285, pH2327, DOI 10.1152/ajpheart.00507.2003; Nozik-Grayck E, 2008, AM J PHYSIOL-LUNG C, V295, pL422, DOI 10.1152/ajplung.90293.2008; Oury TD, 2002, AM J PHYSIOL-LUNG C, V283, pL777, DOI 10.1152/ajplung.00011.2002; Oury TD, 1996, FREE RADICAL BIO MED, V20, P957, DOI 10.1016/0891-5849(95)02222-8; Sharma S, 2007, AM J PHYSL LUNG CELL; Stanic B, 2010, ARTERIOSCL THROM VAS, V30, P2234, DOI 10.1161/ATVBAHA.110.207639; Stenmark KR, 2006, CIRC RES, V99, P675, DOI 10.1161/01.RES.0000243584.45145.3f; Stenmark KR, 2009, AM J PHYSIOL-LUNG C, V297, pL1013, DOI 10.1152/ajplung.00217.2009; Tan RJ, 2004, J APPL PHYSIOL, V97, P2006, DOI 10.1152/japplphysiol.00480.2004; Van Rheen Z, 2011, AM J RESP CELL MOL, V44, P500, DOI 10.1165/rcmb.2010-0065OC; Wu XQ, 2010, ARTERIOSCL THROM VAS, V30, P471, DOI 10.1161/ATVBAHA.109.184259; Yan SF, 1999, ARTERIOSCL THROM VAS, V19, P2029, DOI 10.1161/01.ATV.19.9.2029; Yan SF, 2000, J APPL PHYSIOL, V88, P2303, DOI 10.1152/jappl.2000.88.6.2303; Yan SF, 1999, J BIOL CHEM, V274, P15030, DOI 10.1074/jbc.274.21.15030; Yu HW, 2010, BIOCHEM BIOPH RES CO, V396, P451, DOI 10.1016/j.bbrc.2010.04.115	44	54	56	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2011	6	11							e27531	10.1371/journal.pone.0027531	http://dx.doi.org/10.1371/journal.pone.0027531			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KW	22140445	Green Submitted, Green Published, gold			2022-12-27	WOS:000298163400008
J	Jiao, QJ; Zhang, YK; Li, LN; Shen, HB				Jiao, Qing-Ju; Zhang, Yan-Kai; Li, Lu-Ning; Shen, Hong-Bin			BinTree Seeking: A Novel Approach to Mine Both Bi-Sparse and Cohesive Modules in Protein Interaction Networks	PLOS ONE			English	Article							COMMUNITY STRUCTURE; GENE ONTOLOGY; MODELS; MODULARITY; CYTOSCAPE	Modern science of networks has brought significant advances to our understanding of complex systems biology. As a representative model of systems biology, Protein Interaction Networks (PINs) are characterized by a remarkable modular structures, reflecting functional associations between their components. Many methods were proposed to capture cohesive modules so that there is a higher density of edges within modules than those across them. Recent studies reveal that cohesively interacting modules of proteins is not a universal organizing principle in PINs, which has opened up new avenues for revisiting functional modules in PINs. In this paper, functional clusters in PINs are found to be able to form unorthodox structures defined as bi-sparse module. In contrast to the traditional cohesive module, the nodes in the bi-sparse module are sparsely connected internally and densely connected with other bi-sparse or cohesive modules. We present a novel protocol called the BinTree Seeking (BTS) for mining both bi-sparse and cohesive modules in PINs based on Edge Density of Module (EDM) and matrix theory. BTS detects modules by depicting links and nodes rather than nodes alone and its derivation procedure is totally performed on adjacency matrix of networks. The number of modules in a PIN can be automatically determined in the proposed BTS approach. BTS is tested on three real PINs and the results demonstrate that functional modules in PINs are not dominantly cohesive but can be sparse. BTS software and the supporting information are available at: www.csbio.sjtu.edu.cn/bioinf/BTS/.	[Jiao, Qing-Ju; Shen, Hong-Bin] Shanghai Jiao Tong Univ, Dept Automat, Shanghai 200030, Peoples R China; [Jiao, Qing-Ju; Shen, Hong-Bin] Minist Educ China, Key Lab Syst Control & Informat Proc, Shanghai, Peoples R China; [Zhang, Yan-Kai; Li, Lu-Ning] Shanghai Jiao Tong Univ, Dept Phys, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Ministry of Education, China; Shanghai Jiao Tong University	Jiao, QJ (corresponding author), Shanghai Jiao Tong Univ, Dept Automat, Shanghai 200030, Peoples R China.	hbshen@sjtu.edu.cn			National Natural Science Foundation of China [61175024]; Foundation for the Author of National Excellent Doctoral Dissertation of PR China [201048]; Shanghai Pujiang Program; Shanghai Municipal Education Commission [10ZZ17]; special foundation for innovation program of Shanghai Jiao Tong University [Z-030-010]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation for the Author of National Excellent Doctoral Dissertation of PR China(Foundation for the Author of National Excellent Doctoral Dissertation of China); Shanghai Pujiang Program(Shanghai Pujiang Program); Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC)); special foundation for innovation program of Shanghai Jiao Tong University	This work was supported by National Natural Science Foundation of China (Grant No. 61175024), A Foundation for the Author of National Excellent Doctoral Dissertation of PR China (Grant No. 201048), Shanghai Pujiang Program, Innovation Program of Shanghai Municipal Education Commission (10ZZ17), a special foundation for innovation program of Shanghai Jiao Tong University (Z-030-010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamcsek B, 2006, BIOINFORMATICS, V22, P1021, DOI 10.1093/bioinformatics/btl039; Alon U, 2003, SCIENCE, V301, P1866, DOI 10.1126/science.1089072; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Breitkreutz A, 2010, SCIENCE, V328, P1043, DOI 10.1126/science.1176495; Brohee S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-488; Brown KR, 2005, BIOINFORMATICS, V21, P2076, DOI 10.1093/bioinformatics/bti273; Bu DB, 2003, NUCLEIC ACIDS RES, V31, P2443, DOI 10.1093/nar/gkg340; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Han DS, 2004, NUCLEIC ACIDS RES, V32, P6312, DOI 10.1093/nar/gkh972; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Hwang W, 2006, ALGORITHM MOL BIOL, V1, DOI 10.1186/1748-7188-1-24; Jung SH, 2010, BIOINFORMATICS, V26, P385, DOI 10.1093/bioinformatics/btp668; Kitano H, 2002, NATURE, V420, P206, DOI 10.1038/nature01254; Koonin EV, 2002, NATURE, V420, P218, DOI 10.1038/nature01256; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; Lorrain F., 1971, J MATH SOCIOL, V1, P49, DOI [10.1080/0022250X.1971.9989788, DOI 10.1080/0022250X.1971.9989788, 10.1080/0022250x.1971.9989788]; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Newman MEJ, 2007, P NATL ACAD SCI USA, V104, P9564, DOI 10.1073/pnas.0610537104; Newman MEJ, 2004, EUR PHYS J B, V38, P321, DOI 10.1140/epjb/e2004-00124-y; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Pinkert S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000659; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Reichardt J, 2007, EUR PHYS J B, V60, P217, DOI 10.1140/epjb/e2007-00340-y; Reichardt J, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.015102; Reichardt J, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.016110; Rosvall M, 2007, P NATL ACAD SCI USA, V104, P7327, DOI 10.1073/pnas.0611034104; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Tong AHY, 2002, SCIENCE, V295, P321, DOI 10.1126/science.1064987; Wang Z, 2007, PLOS COMPUT BIOL, V3, P1011, DOI 10.1371/journal.pcbi.0030107; Ye ZQ, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.046115	38	79	80	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2011	6	11							e27646	10.1371/journal.pone.0027646	http://dx.doi.org/10.1371/journal.pone.0027646			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KW	22140454	Green Published, Green Submitted, gold			2022-12-27	WOS:000298163400010
J	Punnen, S; Hardin, J; Cheng, I; Klein, EA; Witte, JS				Punnen, Sanoj; Hardin, Jill; Cheng, Iona; Klein, Eric A.; Witte, John S.			Impact of Meat Consumption, Preparation, and Mutagens on Aggressive Prostate Cancer	PLOS ONE			English	Article							DIETARY PATTERNS; RISK; FAT; MUTAGENS/CARCINOGENS; CARCINOGENICITY; PREVENTION; EXPRESSION; WHITES; HEALTH; PHIP	Background: The association between meat consumption and prostate cancer remains unclear, perhaps reflecting heterogeneity in the types of tumors studied and the method of meat preparation-which can impact the production of carcinogens. Methods: We address both issues in this case-control study focused on aggressive prostate cancer (470 cases and 512 controls), where men reported not only their meat intake but also their meat preparation and doneness level on a semi-quantitative food-frequency questionnaire. Associations between overall and grilled meat consumption, doneness level, ensuing carcinogens and aggressive prostate cancer were assessed using multivariate logistic regression. Results: Higher consumption of any ground beef or processed meats were positively associated with aggressive prostate cancer, with ground beef showing the strongest association (OR = 2.30, 95% CI: 1.39-3.81; P-trend = 0.002). This association primarily reflected intake of grilled or barbequed meat, with more well-done meat conferring a higher risk of aggressive prostate cancer. Comparing high and low consumptions of well/very well cooked ground beef to no consumption gave OR's of 2.04 (95% CI: 1.41-2.96) and 1.51 (95% CI: 1.06-2.14), respectively. In contrast, consumption of rare/medium cooked ground beef was not associated with aggressive prostate cancer. Looking at meat mutagens produced by cooking at high temperatures, we detected an increased risk with 2-amino-3,8-Dimethylimidazo-[4,5-f]Quinolaxine (MelQx) and 2-amino-3,4,8-trimethylimidazo(4,5-f) qunioxaline (DiMelQx), when comparing the highest to lowest quartiles of intake: OR = 1.69 (95% CI: 1.08-2.64; P-trend = 0.02) and OR = 1.53 (95% CI: 1.00-2.35; P-trend = 0.005), respectively. Discussion: Higher intake of well-done grilled or barbequed red meat and ensuing carcinogens could increase the risk of aggressive prostate cancer.	[Punnen, Sanoj; Witte, John S.] Univ Calif San Francisco, Dept Urol, San Francisco, CA 94143 USA; [Hardin, Jill; Witte, John S.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Hardin, Jill; Witte, John S.] Univ Calif San Francisco, Inst Human Genet, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Cheng, Iona] Univ Hawaii, Program Epidemiol, Ctr Canc, Honolulu, HI 96822 USA; [Klein, Eric A.] Cleveland Clin, Glickman Urol & Kidney Inst, Cleveland, OH 44106 USA; [Klein, Eric A.] Taussig Canc Inst, Cleveland, OH USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Cancer Research Center of Hawaii; University of Hawaii System; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Punnen, S (corresponding author), Univ Calif San Francisco, Dept Urol, San Francisco, CA 94143 USA.	wittej@humgen.ucsf.edu			NIH [CA88164, CA127298]; NATIONAL CANCER INSTITUTE [R01CA088164, U01CA127298] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors would like to acknowledge support from the NIH grants CA88164 and CA127298. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agundez JAG, 1998, BRIT J CANCER, V78, P1361, DOI 10.1038/bjc.1998.685; Alexander DD, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-50; American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; Amin M, 2008, CUAJ-CAN UROL ASSOC, V2, P510; Archer CL, 2000, CANCER LETT, V155, P55, DOI 10.1016/S0304-3835(00)00413-4; Chan JM, 2006, CANCER CAUSE CONTROL, V17, P199, DOI 10.1007/s10552-005-0413-4; Colli JL, 2006, UROL ONCOL-SEMIN ORI, V24, P184, DOI 10.1016/j.urolonc.2005.05.023; Cross AJ, 2004, ENVIRON MOL MUTAGEN, V44, P44, DOI 10.1002/em.20030; Cross AJ, 2005, CANCER RES, V65, P11779, DOI 10.1158/0008-5472.CAN-05-2191; Crowe FL, 2008, AM J CLIN NUTR, V87, P1405, DOI 10.1093/ajcn/87.5.1405; GIOVANNUCCI E, 1993, J NATL CANCER I, V85, P1571, DOI 10.1093/jnci/85.19.1571; Hayes RB, 1999, CANCER EPIDEM BIOMAR, V8, P25; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kazerouni N, 2001, FOOD CHEM TOXICOL, V39, P423, DOI 10.1016/S0278-6915(00)00158-7; Koutros S, 2008, CANCER EPIDEM BIOMAR, V17, P80, DOI 10.1158/1055-9965.EPI-07-0392; Koutros S, 2009, CANCER RES, V69, P1877, DOI 10.1158/0008-5472.CAN-08-2447; Ma RWL, 2009, J HUM NUTR DIET, V22, P187, DOI 10.1111/j.1365-277X.2009.00946.x; Michaud DS, 2001, CANCER CAUSE CONTROL, V12, P557, DOI 10.1023/A:1011256201044; Mori M, 2009, MOL NUTR FOOD RES, V53, P191, DOI 10.1002/mnfr.200800285; Park SY, 2007, INT J CANCER, V121, P1339, DOI 10.1002/ijc.22805; Patterson RE, 1999, ANN EPIDEMIOL, V9, P178, DOI 10.1016/S1047-2797(98)00055-6; Richman EL, 2010, AM J CLIN NUTR, V91, P712, DOI 10.3945/ajcn.2009.28474; Rodriguez C, 2006, CANCER EPIDEM BIOMAR, V15, P211, DOI 10.1158/1055-9965.EPI-05-0614; Rohrmann S, 2007, CANCER CAUSE CONTROL, V18, P41, DOI 10.1007/s10552-006-0082-y; Sander A, 2011, CANCER CAUSE CONTROL, V22, P109, DOI 10.1007/s10552-010-9680-9; Satia-Abouta J, 2003, AM J EPIDEMIOL, V158, P951, DOI 10.1093/aje/kwg248; Sharma S, 2010, CANCER EPIDEM BIOMAR, V19, P1866, DOI 10.1158/1055-9965.EPI-10-0231; Shirai T, 1999, CANCER LETT, V143, P217, DOI 10.1016/S0304-3835(99)00128-7; Sinha R, 2002, MUTAT RES-FUND MOL M, V506, P197, DOI 10.1016/S0027-5107(02)00166-5; Sinha R, 2009, AM J EPIDEMIOL, V170, P1165, DOI 10.1093/aje/kwp280; Sugimura T, 2004, CANCER SCI, V95, P290, DOI 10.1111/j.1349-7006.2004.tb03205.x; Tang DL, 2007, CANCER EPIDEM BIOMAR, V16, P803, DOI 10.1158/1055-9965.EPI-06-0973; Tseng M, 2004, CANCER EPIDEM BIOMAR, V13, P71, DOI 10.1158/1055-9965.EPI-03-0076; Venkateswaran V, 2010, NAT REV UROL, V7, P442, DOI 10.1038/nrurol.2010.102; Walker M, 2005, INT J CANCER, V116, P592, DOI 10.1002/ijc.21112; Williams JA, 2000, CARCINOGENESIS, V21, P1683, DOI 10.1093/carcin/21.9.1683; Wu K, 2006, CANCER EPIDEM BIOMAR, V15, P167, DOI 10.1158/1055-9965.EPI-05-0100; Zheng W, 2009, NUTR CANCER, V61, P437, DOI 10.1080/01635580802710741	38	28	28	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e27711	10.1371/journal.pone.0027711	http://dx.doi.org/10.1371/journal.pone.0027711			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132129	Green Submitted, gold, Green Published			2022-12-27	WOS:000298162000037
J	Stivanello, E; Rucci, P; Carretta, E; Pieri, G; Seghieri, C; Nuti, S; Declercq, E; Taglioni, M; Fantini, MP				Stivanello, Elisa; Rucci, Paola; Carretta, Elisa; Pieri, Giulia; Seghieri, Chiara; Nuti, Sabina; Declercq, Eugene; Taglioni, Martina; Fantini, Maria Pia			Risk Adjustment for Inter-Hospital Comparison of Caesarean Delivery Rates in Low-Risk Deliveries	PLOS ONE			English	Article							QUALITY-IMPROVEMENT; CASE-MIX; SECTION; COMPLICATIONS; STRATEGIES; SINGLETON; CARE	Background: Caesarean delivery (CD) rates have been frequently used as quality measures for maternity service comparisons. More recently, primary CD rates (CD in women without previous CD) or CD rates within selected categories such as nulliparous, term, cephalic singleton deliveries (NTCS) have been used. The objective of this study is to determine the extent to which risk adjustment for clinical and socio-demographic variables is needed for inter-hospital comparisons of CD rates in women without previous CD and in NTCS deliveries. Methods: Hospital discharge records of women who delivered in Emilia-Romagna Region (Italy) from January, 2007 to June 2009 and in Tuscany Region for year 2009 were linked with birth certificates. Adjusted RRs of CD in women without a previous Caesarean and NTCS were estimated using Poisson regression. Percentage differences in RR before and after adjustment were calculated and hospital rankings, based on crude and adjusted RRs, were examined. Results: Adjusted RR differed substantially from crude RR in women without a previous Caesarean and only marginally in NTCS group. Hospital ranking was markedly affected by adjustment in women without a previous CD, but less in NTCS. Conclusion: Risk adjustment is warranted for inter-hospital comparisons of primary CD rates but not for NTCS CD rates. Crude NTCS CD rates are a reliable estimate of adjusted NTCS CD.	[Stivanello, Elisa; Rucci, Paola; Carretta, Elisa; Pieri, Giulia; Fantini, Maria Pia] Univ Bologna, Dept Med & Publ Hlth Alma Mater Studiorum, Bologna, Italy; [Seghieri, Chiara; Nuti, Sabina] Scuola Super Sant Anna, Lab MeS, Pisa, Italy; [Declercq, Eugene] Boston Univ, Sch Publ Hlth, Dept Community Hlth Sci, Boston, MA USA; [Taglioni, Martina] Azienda Osped Univ Bologna, Med Directorate, Bologna, Italy	University of Bologna; Scuola Superiore Sant'Anna; Boston University; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna	Stivanello, E (corresponding author), Univ Bologna, Dept Med & Publ Hlth Alma Mater Studiorum, Bologna, Italy.	elisa.stivanello2@unibo.it	; Stivanello, Elisa/HFZ-9911-2022	Declercq, Eugene/0000-0001-5411-3033; Stivanello, Elisa/0000-0001-5479-8730; Rucci, Paola/0000-0002-7704-0831				American College of Obstetricians and Gynecologists, 2000, EV CES DEL; Aron DC, 1998, JAMA-J AM MED ASSOC, V279, P1968, DOI 10.1001/jama.279.24.1968; Bailit JL, 1999, OBSTET GYNECOL, V93, P1025, DOI 10.1016/S0029-7844(98)00536-5; Belizan JM, 2007, EPIDEMIOLOGY, V18, P485, DOI 10.1097/EDE.0b013e318068646a; Bingham D, 2010, J PERINAT NEONAT NUR, V24, P32, DOI 10.1097/JPN.0b013e3181c94a24; Bragg F, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5065; Brennan DJ, 2011, OBSTET GYNECOL, V117, P273, DOI 10.1097/AOG.0b013e318204521a; Brennan DJ, 2009, AM J OBSTET GYNECOL, V200, pE8, DOI 10.1016/j.ajog.2008.09.004; Capon A, 2005, EUR J EPIDEMIOL, V20, P497, DOI 10.1007/s10654-005-5250-y; Chaillet N, 2007, BIRTH-ISS PERINAT C, V34, P53, DOI 10.1111/j.1523-536X.2006.00146.x; Coonrod DV, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2008.03.026; Fantini MP, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-100; Fischer A, 2005, OBSTET GYNECOL, V105, P816, DOI 10.1097/01.AOG.0000156299.52668.e2; Habiba M, 2006, BJOG-INT J OBSTET GY, V113, P647, DOI 10.1111/j.1471-0528.2006.00933.x; Kontopoulos E V, 2004, J Matern Fetal Neonatal Med, V15, P219, DOI 10.1080/14767050410001668707; Korst LM, 2005, MED CARE, V43, P237, DOI 10.1097/00005650-200503000-00006; Lazio Regione, 2008, REG OUTC RES PROGR 2; Lieberman E, 1998, OBSTET GYNECOL, V92, P1; Main EK, 2006, AM J OBSTET GYNECOL, V194, P1644, DOI 10.1016/j.ajog.2006.03.013; Main EK, 2004, AM J OBSTET GYNECOL, V190, P1747, DOI 10.1016/j.ajog.2004.02.055; Main EK, 2008, CURR OPIN OBSTET GYN, V20, P574, DOI 10.1097/GCO.0b013e3283184040; McNutt LA, 2003, AM J EPIDEMIOL, V157, P940, DOI 10.1093/aje/kwg074; Meikle SF, 2005, OBSTET GYNECOL, V105, P751, DOI 10.1097/01.AOG.0000157435.67138.78; Mossialos E, 2005, EUR J PUBLIC HEALTH, V15, P288, DOI 10.1093/eurpub/cki002; Nohr EA, 2008, AM J CLIN NUTR, V87, P1750, DOI 10.1093/ajcn/87.6.1750; Powell AE, 2003, QUAL SAF HEALTH CARE, V12, P122, DOI 10.1136/qhc.12.2.122; Rothman KJ, 2002, EPIDEMIOLOGY INTRO; Stivanello E, 2010, ACTA OBSTET GYN SCAN, V89, P321, DOI 10.3109/00016340903508627; Su M, 2004, BJOG-INT J OBSTET GY, V111, P1065, DOI 10.1111/j.1471-0528.2004.00266.x; Teperi J, 1995, EUROPEAN J PUBLIC HL, V5, P116	30	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e28060	10.1371/journal.pone.0028060	http://dx.doi.org/10.1371/journal.pone.0028060			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	863KL	22132210	Green Published, Green Submitted, gold			2022-12-27	WOS:000298162000065
J	Fanibunda, SE; Modi, DN; Gokral, JS; Bandivdekar, AH				Fanibunda, Sashaina E.; Modi, Deepak N.; Gokral, Jyotsna S.; Bandivdekar, Atmaram H.			HIV gp120 Binds to Mannose Receptor on Vaginal Epithelial Cells and Induces Production of Matrix Metalloproteinases	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ENVELOPE GLYCOPROTEIN; PARTICLES BEARING; MOLECULAR-BASIS; INFECTION; TRANSMISSION; PROTEINS; MODEL; ENTRY; NONOXYNOL-9	Background: During sexual transmission of HIV in women, the virus breaches the multi-layered CD4 negative stratified squamous epithelial barrier of the vagina, to infect the sub-epithelial CD4 positive immune cells. However the mechanisms by which HIV gains entry into the sub-epithelial zone is hitherto unknown. We have previously reported human mannose receptor (hMR) as a CD4 independent receptor playing a role in HIV transmission on human spermatozoa. The current study was undertaken to investigate the expression of hMR in vaginal epithelial cells, its HIV gp120 binding potential, affinity constants and the induction of matrix metalloproteinases (MMPs) downstream of HIV gp120 binding to hMR. Principal Findings: Human vaginal epithelial cells and the immortalized vaginal epithelial cell line Vk2/E6E7 were used in this study. hMR mRNA and protein were expressed in vaginal epithelial cells and cell line, with a molecular weight of 155 kDa. HIV gp120 bound to vaginal proteins with high affinity, (Kd = 1.2 +/- 0.2 nM for vaginal cells, 1.4 +/- 0.2 nM for cell line) and the hMR antagonist mannan dose dependently inhibited this binding. Both HIV gp120 binding and hMR exhibited identical patterns of localization in the epithelial cells by immunofluorescence. HIV gp120 bound to immunopurified hMR and affinity constants were 2.9 +/- 0.4 nM and 3.2 +/- 0.6 nM for vaginal cells and Vk2/E6E7 cell line respectively. HIV gp120 induced an increase in MMP-9 mRNA expression and activity by zymography, which could be inhibited by an anti-hMR antibody. Conclusion: hMR expressed by vaginal epithelial cells has high affinity for HIV gp120 and this binding induces production of MMPs. We propose that the induction of MMPs in response to HIV gp120 may lead to degradation of tight junction proteins and the extracellular matrix proteins in the vaginal epithelium and basement membrane, leading to weakening of the epithelial barrier; thereby facilitating transport of HIV across the vaginal epithelium.	[Fanibunda, Sashaina E.; Bandivdekar, Atmaram H.] Indian Council Med Res, Dept Biochem, Natl Inst Res Reprod Hlth, Bombay, Maharashtra, India; [Modi, Deepak N.] Indian Council Med Res, Mol & Cellular Biol Lab, Natl Inst Res Reprod Hlth, Bombay, Maharashtra, India; [Gokral, Jyotsna S.] Indian Council Med Res, Div Clin Res, Natl Inst Res Reprod Hlth, Bombay, Maharashtra, India	Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Reproductive Health (NIRRH); Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Reproductive Health (NIRRH); Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Reproductive Health (NIRRH)	Fanibunda, SE (corresponding author), Indian Council Med Res, Dept Biochem, Natl Inst Res Reprod Hlth, Bombay, Maharashtra, India.	batmaram@hotmail.com		Modi, Deepak/0000-0002-4230-4219	Indian Council of Medical Research, Government of India [NIRRH/M/33/11]; Indian Council of Medical Research, Government of India	Indian Council of Medical Research, Government of India(Indian Council of Medical Research (ICMR)); Indian Council of Medical Research, Government of India(Indian Council of Medical Research (ICMR))	This work (NIRRH/M/33/11) was funded by grants from the Indian Council of Medical Research, Government of India. We are grateful to the Indian Council of Medical Research, Government of India for the Senior Research Fellowship to SEF. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DJ, 2010, J INFECT DIS, V202, P333, DOI 10.1086/653620; Blaskewicz CD, 2011, BIOL REPROD, V85, P97, DOI 10.1095/biolreprod.110.090423; Bobardt MD, 2007, J VIROL, V81, P395, DOI 10.1128/JVI.01303-06; Bruno R, 2010, GUT, V59, P513, DOI 10.1136/gut.2008.163287; Chertova E, 2002, J VIROL, V76, P5315, DOI 10.1128/JVI.76.11.5315-5325.2002; Collins KB, 2000, NAT MED, V6, P475, DOI 10.1038/74743; Crooks ET, 2007, VIROLOGY, V366, P245, DOI 10.1016/j.virol.2007.04.033; Cummins NW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024876; Fanibunda SE, 2008, JAIDS-J ACQ IMM DEF, V48, P389, DOI 10.1097/QAI.0b013e318179a0fb; Fichorova RN, 1997, BIOL REPROD, V57, P847, DOI 10.1095/biolreprod57.4.847; Fichorova RN, 2001, J INFECT DIS, V184, P418, DOI 10.1086/322047; Gazi U, 2009, IMMUNOBIOLOGY, V214, P554, DOI 10.1016/j.imbio.2008.11.004; Giebel SJ, 2005, LAB INVEST, V85, P597, DOI 10.1038/labinvest.3700251; Godbole G, 2011, FERTIL STERIL, V95, P1278, DOI 10.1016/j.fertnstert.2010.09.045; Greenhead P, 2000, J VIROL, V74, P5577, DOI 10.1128/JVI.74.12.5577-5586.2000; Hicar MD, 2010, JAIDS-J ACQ IMM DEF, V54, P223, DOI 10.1097/QAI.0b013e3181dc98a3; Hladik Florian, 2009, Curr HIV/AIDS Rep, V6, P20, DOI 10.1007/s11904-009-0004-1; Hladik F, 2008, NAT REV IMMUNOL, V8, P447, DOI 10.1038/nri2302; Hladik F, 2007, IMMUNITY, V26, P257, DOI 10.1016/j.immuni.2007.01.007; Hladik F, 2010, ANTIVIR RES, V88, pS3, DOI 10.1016/j.antiviral.2010.09.011; Hope T.J., 2008, MICR 2008 C NEW DELH; Horbul JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022638; Kaushic C, 2011, AM J REPROD IMMUNOL, V65, P253, DOI 10.1111/j.1600-0897.2010.00965.x; KELL PD, 1992, J ROY SOC MED, V85, P706; KELLY DE, 1984, BAILEYS TXB MICROSCO, P113; Kottilil S, 2006, J IMMUNOL, V176, P1107, DOI 10.4049/jimmunol.176.2.1107; Kuznetsov YG, 2003, J VIROL, V77, P11896, DOI 10.1128/JVI.77.22.11896-11909.2003; Lai J, 2009, J BIOL CHEM, V284, P11027, DOI 10.1074/jbc.M809698200; LENNARTZ MR, 1987, J BIOL CHEM, V262, P9942; Lin G, 2007, CURR HIV RES, V5, P514, DOI 10.2174/157016207782418489; Liu Y, 2004, J VIROL, V78, P4120, DOI 10.1128/JVI.78.8.4120-4133.2004; Lopez-Herrera A, 2005, BBA-MOL BASIS DIS, V1741, P55, DOI 10.1016/j.bbadis.2004.12.001; Mastroianni CM, 2007, TRENDS MOL MED, V13, P449, DOI 10.1016/j.molmed.2007.09.001; Miller CJ, 2003, MICROBES INFECT, V5, P59, DOI 10.1016/S1286-4579(02)00056-4; MILLER CJ, 1992, J MED PRIMATOL, V21, P64; Miller CJ, 2005, J VIROL, V79, P9217, DOI 10.1128/JVI.79.14.9217-9227.2005; Misse D, 2001, BLOOD, V98, P541, DOI 10.1182/blood.V98.3.541; Moore PL, 2006, J VIROL, V80, P2515, DOI 10.1128/JVI.80.5.2515-2528.2006; Navaratna D, 2007, DIABETES, V56, P2380, DOI 10.2337/db06-1694; Nazli A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000852; OBRIEN WA, 1994, J VIROL, V68, P5264, DOI 10.1128/JVI.68.8.5264-5269.1994; Parren PWHI, 1997, NAT MED, V3, P366, DOI 10.1038/nm0497-366d; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PYLE SW, 1987, AIDS RES HUM RETROV, V3, P387, DOI 10.1089/aid.1987.3.387; Qiu LB, 2011, TOXICOLOGY, V285, P31, DOI 10.1016/j.tox.2011.03.019; Reijerkerk A, 2006, FASEB J, V20, P2550, DOI 10.1096/fj.06-6099fje; Roseman DS, 2000, P NATL ACAD SCI USA, V97, P9949, DOI 10.1073/pnas.170184597; Salle B, 2010, J INFECT DIS, V202, P337, DOI 10.1086/653619; SCHNEIDER J, 1986, J GEN VIROL, V67, P2533, DOI 10.1099/0022-1317-67-11-2533; Shattock RJ, 2003, NAT REV MICROBIOL, V1, P25, DOI 10.1038/nrmicro729; Steele C, 2002, INFECT IMMUN, V70, P577, DOI 10.1128/IAI.70.2.577-583.2002; Stoddard E, 2007, J IMMUNOL, V179, P3126, DOI 10.4049/jimmunol.179.5.3126; Trifonova RT, 2009, ANTIMICROB AGENTS CH, V53, P1490, DOI 10.1128/AAC.01152-08; Trujillo JR, 2007, P NATL ACAD SCI USA, V104, P5097, DOI 10.1073/pnas.0611263104; UNAIDS, UNAIDS REP GLOB AIDS; Van Damme L, 2002, LANCET, V360, P971, DOI 10.1016/S0140-6736(02)11079-8; WILEMAN TE, 1986, P NATL ACAD SCI USA, V83, P2501, DOI 10.1073/pnas.83.8.2501; Wu WB, 2003, EXP CELL RES, V288, P143, DOI 10.1016/S0014-4827(03)00183-6; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Yang XZ, 2005, J VIROL, V79, P12132, DOI 10.1128/JVI.79.19.12132-12147.2005; Yang Y, 2007, J CEREBR BLOOD F MET, V27, P697, DOI 10.1038/sj.jcbfm.9600375; Zalenskaya IA, 2011, AM J REPROD IMMUNOL, V65, P569, DOI 10.1111/j.1600-0897.2010.00964.x	62	33	33	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2011	6	11							e28014	10.1371/journal.pone.0028014	http://dx.doi.org/10.1371/journal.pone.0028014			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858JH	22132194	Green Submitted, Green Published, gold			2022-12-27	WOS:000297792400032
J	Maguire, JJ; Kirby, HR; Mead, EJ; Kuc, RE; de Tassigny, XD; Colledge, WH; Davenport, AP				Maguire, Janet J.; Kirby, Helen R.; Mead, Emma J.; Kuc, Rhoda E.; de Tassigny, Xavier d'Anglemont; Colledge, William H.; Davenport, Anthony P.			Inotropic Action of the Puberty Hormone Kisspeptin in Rat, Mouse and Human: Cardiovascular Distribution and Characteristics of the Kisspeptin Receptor	PLOS ONE			English	Article							METASTASIS SUPPRESSOR GENE; PROTEIN-COUPLED RECEPTOR; ORPHAN-RECEPTOR; UROTENSIN-II; KISS-1; GPR54; LOCALIZATION; PEPTIDE; CELLS; ACTIVATION	Kisspeptins, the ligands of the kisspeptin receptor known for its roles in reproduction and cancer, are also vasoconstrictor peptides in atherosclerosis-prone human aorta and coronary artery. The aim of this study was to further investigate the cardiovascular localisation and function of the kisspeptins and their receptor in human compared to rat and mouse heart. Immunohistochemistry and radioligand binding techniques were employed to investigate kisspeptin receptor localisation, density and pharmacological characteristics in cardiac tissues from all three species. Radioimmunoassay was used to detect kisspeptin peptide levels in human normal heart and to identify any pathological changes in myocardium from patients transplanted for cardiomyopathy or ischaemic heart disease. The cardiac function of kisspeptin receptor was studied in isolated human, rat and mouse paced atria, with a role for the receptor confirmed using mice with targeted disruption of Kiss1r. The data demonstrated that kisspeptin receptor-like immunoreactivity localised to endothelial and smooth muscle cells of intramyocardial blood vessels and to myocytes in human and rodent tissue. [I-125]KP-14 bound saturably, with subnanomolar affinity to human and rodent myocardium (K-D = 0.12 nM, human; K-D = 0.44 nM, rat). Positive inotropic effects of kisspeptin were observed in rat, human and mouse. No response was observed in mice with targeted disruption of Kiss1r. In human heart a decrease in cardiac kisspeptin level was detected in ischaemic heart disease. Kisspeptin and its receptor are expressed in the human, rat and mouse heart and kisspeptins possess potent positive inotropic activity. The cardiovascular actions of the kisspeptins may contribute to the role of these peptides in pregnancy but the consequences of receptor activation must be considered if kisspeptin receptor agonists are developed for use in the treatment of reproductive disorders or cancer.	[Maguire, Janet J.; Kirby, Helen R.; Mead, Emma J.; Kuc, Rhoda E.; Davenport, Anthony P.] Univ Cambridge, Clin Pharmacol Unit, Cambridge, England; [de Tassigny, Xavier d'Anglemont; Colledge, William H.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England	University of Cambridge; University of Cambridge	Maguire, JJ (corresponding author), Univ Cambridge, Clin Pharmacol Unit, Cambridge, England.	jjm1003@medschl.cam.ac.uk	Colledge, William/X-4976-2019; Maguire, Janet J/Z-2180-2019; Davenport, Anthony Peter/A-5773-2008	Colledge, William/0000-0002-9603-4429; Maguire, Janet J/0000-0002-9254-7040; Hargreaves, Emma/0000-0001-7887-2018; Davenport, Anthony Peter/0000-0002-2096-3117	Medical Research Council; British Heart Foundation;  [PS/02/001];  [PG/09/050/27734]	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); ; 	This work was supported by grants from the Medical Research Council (http://www.mrc.ac.uk) and the British Heart Foundation (http://www.bhf.org.uk). (Grant numbers PS/02/001 and PG/09/050/27734.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLARD M, 1995, J PHARMACOL EXP THER, V274, P577; Bilban M, 2004, J CELL SCI, V117, P1319, DOI 10.1242/jcs.00971; Castellano JM, 2010, BRAIN RES, V1364, P129, DOI 10.1016/j.brainres.2010.08.057; Clarkson J, 2008, J NEUROSCI, V28, P8691, DOI 10.1523/JNEUROSCI.1775-08.2008; Clements MK, 2001, BIOCHEM BIOPH RES CO, V284, P1189, DOI 10.1006/bbrc.2001.5098; Crown A, 2007, NEUROENDOCRINOLOGY, V86, P175, DOI 10.1159/000109095; d'Anglemont de Tassigny X, 2007, P NATL ACAD SCI USA, V104, P10714, DOI 10.1073/pnas.0704114104; DAVENPORT AP, 1989, J CARDIOVASC PHARM, V13, pS166, DOI 10.1097/00005344-198900135-00045; DAVENPORT AP, 2005, RECEPTOR BINDING TEC, P155; de Roux N, 2003, P NATL ACAD SCI USA, V100, P10972, DOI 10.1073/pnas.1834399100; de Tassigny XD, 2010, PHYSIOLOGY, V25, P207, DOI 10.1152/physiol.00009.2010; Dhillo WS, 2005, J CLIN ENDOCR METAB, V90, P6609, DOI 10.1210/jc.2005-1468; Ewert TJ, 2008, NEUROSCI LETT, V436, P163, DOI 10.1016/j.neulet.2008.03.012; Farina A, 2006, PRENATAL DIAG, V26, P1115, DOI 10.1002/pd.1562; Franceschini I, 2006, NEUROSCI LETT, V401, P225, DOI 10.1016/j.neulet.2006.03.039; Funes S, 2003, BIOCHEM BIOPH RES CO, V312, P1357, DOI 10.1016/j.bbrc.2003.11.066; Gottsch ML, 2004, ENDOCRINOLOGY, V145, P4073, DOI 10.1210/en.2004-0431; Hameed S, 2011, J ENDOCRINOL, V208, P97, DOI 10.1677/JOE-10-0265; Horikoshi Y, 2003, J CLIN ENDOCR METAB, V88, P914, DOI 10.1210/jc.2002-021235; Irwig MS, 2004, NEUROENDOCRINOLOGY, V80, P264, DOI 10.1159/000083140; Katugampola SD, 2001, BRIT J PHARMACOL, V132, P1255, DOI 10.1038/sj.bjp.0703939; KATZ R, 1978, CIRCULATION, V58, P434, DOI 10.1161/01.CIR.58.3.434; Kinoshita M, 2005, ENDOCRINOLOGY, V146, P4431, DOI 10.1210/en.2005-0195; Kirby HR, 2010, PHARMACOL REV, V62, P565, DOI 10.1124/pr.110.002774; Kleinz MJ, 2006, CARDIOVASC RES, V69, P227, DOI 10.1016/j.cardiores.2005.09.001; Konyi A, 2010, REGUL PEPTIDES, V159, P9, DOI 10.1016/j.regpep.2009.07.009; Kotani M, 2001, J BIOL CHEM, V276, P34631, DOI 10.1074/jbc.M104847200; Kutzleb C, 2005, CURR PROTEIN PEPT SC, V6, P265, DOI 10.2174/1389203054065419; Lee JH, 1997, CANCER RES, V57, P2384; Lee JH, 1996, JNCI-J NATL CANCER I, V88, P1731, DOI 10.1093/jnci/88.23.1731; Lee YR, 2009, ENDOCRINOLOGY, V150, P2837, DOI 10.1210/en.2008-1679; Maguire JJ, 2009, HYPERTENSION, V54, P598, DOI 10.1161/HYPERTENSIONAHA.109.134619; Maguire JJ, 2000, BRIT J PHARMACOL, V131, P441, DOI 10.1038/sj.bjp.0703601; Mead EJ, 2007, ENDOCRINOLOGY, V148, P140, DOI 10.1210/en.2006-0818; Messager S, 2005, P NATL ACAD SCI USA, V102, P1761, DOI 10.1073/pnas.0409330102; MOLENAAR P, 1993, CIRC RES, V72, P526, DOI 10.1161/01.RES.72.3.526; Muir AI, 2001, J BIOL CHEM, V276, P28969, DOI 10.1074/jbc.M102743200; Navenot JM, 2009, MOL PHARMACOL, V75, P1300, DOI 10.1124/mol.109.055095; Ohtaki T, 2001, NATURE, V411, P613, DOI 10.1038/35079135; Potter EK, 2005, NEUROPEPTIDES, V39, P345, DOI 10.1016/j.npep.2004.12.006; Qiao Chong, 2005, Zhonghua Fu Chan Ke Za Zhi, V40, P585; Ramaesh T, 2010, ENDOCRINOLOGY, V151, P5927, DOI 10.1210/en.2010-0565; Roseweir AK, 2009, J NEUROSCI, V29, P3920, DOI 10.1523/JNEUROSCI.5740-08.2009; Russell FD, 2001, BRIT J PHARMACOL, V132, P5, DOI 10.1038/sj.bjp.0703811; Samson WK, 2000, BRAIN RES, V858, P19, DOI 10.1016/S0006-8993(99)02451-8; Sawyer I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014671; Seminara SB, 2008, J NEUROENDOCRINOL, V20, P727, DOI 10.1111/j.1365-2826.2008.01731.x; Seminara SB, 2003, NEW ENGL J MED, V349, P1614, DOI 10.1056/NEJMoa035322; Shahab M, 2005, P NATL ACAD SCI USA, V102, P2129, DOI 10.1073/pnas.0409822102; Spinale FG, 2002, CIRC RES, V90, P520, DOI 10.1161/01.RES.0000013290.12884.A3; Takino T, 2003, ONCOGENE, V22, P4617, DOI 10.1038/sj.onc.1206542; Thompson EL, 2004, J NEUROENDOCRINOL, V16, P850, DOI 10.1111/j.1365-2826.2004.01240.x; Wu M, 2009, P NATL ACAD SCI USA, V106, P17217, DOI 10.1073/pnas.0908200106; Yan CH, 2001, J BIOL CHEM, V276, P1164, DOI 10.1074/jbc.M008681200; Yoshioka K, 2008, LIFE SCI, V83, P332, DOI 10.1016/j.lfs.2008.06.018	55	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2011	6	11							e27601	10.1371/journal.pone.0027601	http://dx.doi.org/10.1371/journal.pone.0027601			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858JH	22132116	Green Published, Green Submitted, gold			2022-12-27	WOS:000297792400010
J	Saberi, P; Johnson, MO				Saberi, Parya; Johnson, Mallory O.			Technology-Based Self-Care Methods of Improving Antiretroviral Adherence: A Systematic Review	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; RANDOMIZED CONTROLLED-TRIAL; DRUG-RESISTANCE; MEDICATION ADHERENCE; REPORTED ADHERENCE; THERAPY ADHERENCE; PATIENT ADHERENCE; INFECTED PERSONS; HAART ADHERENCE; SOUTH-AFRICA	Background: As HIV infection has shifted to a chronic condition, self-care practices have emerged as an important topic for HIV-positive individuals in maintaining an optimal level of health. Self-care refers to activities that patients undertake to maintain and improve health, such as strategies to achieve and maintain high levels of antiretroviral adherence. Methodology/Principal Findings: Technology-based methods are increasingly used to enhance antiretroviral adherence; therefore, we systematically reviewed the literature to examine technology-based self-care methods that HIV-positive individuals utilize to improve adherence. Seven electronic databases were searched from 1/1/1980 through 12/31/2010. We included quantitative and qualitative studies. Among quantitative studies, the primary outcomes included ARV adherence, viral load, and CD4+ cell count and secondary outcomes consisted of quality of life, adverse effects, and feasibility/acceptability data. For qualitative/descriptive studies, interview themes, reports of use, and perceptions of use were summarized. Thirty-six publications were included (24 quantitative and 12 qualitative/descriptive). Studies with exclusive utilization of medication reminder devices demonstrated less evidence of enhancing adherence in comparison to multicomponent methods. Conclusions/Significance: This systematic review offers support for self-care technology-based approaches that may result in improved antiretroviral adherence. There was a clear pattern of results that favored individually-tailored, multi-function technologies, which allowed for periodic communication with health care providers rather than sole reliance on electronic reminder devices.	[Saberi, Parya; Johnson, Mallory O.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Saberi, P (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	parya.saberi@ucsf.edu			National Institute of Mental Health [F32MH086323, K24MH087220]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K24MH087220, F32MH086323] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Institute of Mental Health (F32MH086323 and K24MH087220) The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastasio C, 1995, J Assoc Nurses AIDS Care, V6, P31, DOI 10.1016/S1055-3290(95)80015-8; Andrade ASA, 2005, CLIN INFECT DIS, V41, P875, DOI 10.1086/432877; Bangsberg DR, 2000, AIDS, V14, P357, DOI 10.1097/00002030-200003100-00008; Barroso J, 1995, Holist Nurs Pract, V10, P44; Bartlett JA, 2002, J ACQ IMMUN DEF SYND, V29, pS2, DOI 10.1097/00126334-200202011-00002; Biadgilign S, 2009, SAHARA J-J SOC ASP H, V6, P148, DOI 10.1080/17290376.2009.9724943; Blower SM, 2001, NAT MED, V7, P1016, DOI 10.1038/nm0901-1016; Chesney MA, 1999, AIDS, V13, pS271; Chou FY, 2004, J ASSOC NURSE AIDS C, V15, P58, DOI 10.1177/1055329003255592; Chou FY, 2004, NURS RES, V53, P332, DOI 10.1097/00006199-200409000-00008; Claborn KR, 2011, ELECT INTERVENTION H; Cook RF, 2010, TEST WEB BASED PROGR; Crankshaw T, 2010, AIDS PATIENT CARE ST, V24, P729, DOI 10.1089/apc.2010.0146; Curioso WH, 2007, BMC MED INFORM DECIS, V7, DOI 10.1186/1472-6947-7-24; Curioso WH, 2011, EVALUATION COMPUTER; DEAN K, 1981, SOC SCI MED-MED SOC, V15, P673, DOI 10.1016/0271-7123(81)90091-2; Dunbar PJ, 2003, J AM MED INFORM ASSN, V10, P11, DOI 10.1197/jamia.M1047; Dybul M, 2011, PANEL ANTIRETROVIRAL; Fairley CK, 2003, INT J STD AIDS, V14, P805, DOI 10.1258/095646203322556129; Garofalo R, 2010, TEXT MESSAGING INTER; Gifford AL, 2000, J ACQ IMMUN DEF SYND, V23, P386; Golin CE, 2002, J GEN INTERN MED, V17, P756, DOI 10.1046/j.1525-1497.2002.11214.x; Grant E, 2008, AIDS CARE, V20, P1155, DOI 10.1080/09540120701854634; Grant RM, 2002, JAMA-J AM MED ASSOC, V288, P181, DOI 10.1001/jama.288.2.181; Harris LT, 2010, TELEMED J E-HEALTH, V16, P1024, DOI 10.1089/tmj.2010.0050; Harvey KM, 2008, W INDIAN MED J, V57, P293; Heckman BD, 2004, AIDS CARE, V16, P219, DOI 10.1080/09540120410001641066; Henry S B, 1999, J Assoc Nurses AIDS Care, V10, P46, DOI 10.1016/S1055-3290(06)60298-7; Holzemer W L, 2000, J Assoc Nurses AIDS Care, V11, P36, DOI 10.1016/S1055-3290(06)60420-2; Holzemer W L, 1998, J Assoc Nurses AIDS Care, V9, P22, DOI 10.1016/S1055-3290(98)80073-3; Holzemer WL, 1999, AIDS PATIENT CARE ST, V13, P185, DOI 10.1089/apc.1999.13.185; Horvath KJ, 2011, PILOT TEST ONLINE HI; Ingersoll KS, 2011, TEXT MESSAGING ADHER; Iroha E, 2010, AJAR-AFR J AIDS RES, V9, P25, DOI 10.2989/16085906.2010.484543; Kahn J, 2011, ADHERENCE IMPROVEMEN; Kalichman S C, 2001, J Assoc Nurses AIDS Care, V12, P58, DOI 10.1016/S1055-3290(06)60217-3; Kalichman SC, 2005, AIDS PATIENT CARE ST, V19, P439, DOI 10.1089/apc.2005.19.439; Kemppainen JK, 2001, AIDS PATIENT CARE ST, V15, P117, DOI 10.1089/108729101750123562; Konkle-Parker DJ, 2010, PATIENT EDUC COUNS, V78, P91, DOI 10.1016/j.pec.2009.04.010; Kumar VS, 2010, AREMIND PERSONALIZED; Lefebvre C., 2011, COCHRANE HDB SYSTEMA, DOI DOI 10.1002/9780470712184.CH6; Levin L S, 1979, J Am Coll Health Assoc, V28, P117; Levin L. S., 1979, SELF CARE LAY INITIA; LEVIN LS, 1983, ANNU REV PUBL HEALTH, V4, P181, DOI 10.1146/annurev.pu.04.050183.001145; Levy RW, 2004, AIDS PATIENT CARE ST, V18, P728, DOI 10.1089/apc.2004.18.728; Lewis MP, 2006, AIDS CARE, V18, P140, DOI 10.1080/09540120500161835; Little SJ, 2002, NEW ENGL J MED, V347, P385, DOI 10.1056/NEJMoa013552; Lyon ME, 2003, AIDS PATIENT CARE ST, V17, P299, DOI 10.1089/108729103322108175; Mannheimer S, 2002, CLIN INFECT DIS, V34, P1115, DOI 10.1086/339074; Mannheimer SB, 2006, JAIDS-J ACQ IMM DEF, V43, pS41, DOI 10.1097/01.qai.0000245887.58886.ac; Martin-Fernandez J, 2001, ARCH INTERN MED, V161, P2739, DOI 10.1001/archinte.161.22.2739; Mills EJ, 2006, PLOS MED, V3, P2039, DOI 10.1371/journal.pmed.0030438; Moatti JP, 2000, AIDS, V14, P151, DOI 10.1097/00002030-200001280-00010; Moore DJ, 2011, PERSONALIZED TEXT ME; Murphy DA, 2000, AIDS PATIENT CARE ST, V14, P47, DOI 10.1089/108729100318127; Murphy Debra A, 2002, J Assoc Nurses AIDS Care, V13, P57, DOI 10.1177/1055329002238026; Murphy Debra A, 2007, J Int Assoc Physicians AIDS Care (Chic), V6, P113, DOI 10.1177/1545109707301243; Nieuwkerk PT, 2001, ARCH INTERN MED, V161, P1962, DOI 10.1001/archinte.161.16.1962; Ostrop NJ, 2000, AIDS PATIENT CARE ST, V14, P351, DOI 10.1089/108729100413220; Ostrop NJ, 2000, ANN PHARMACOTHER, V34, P703, DOI 10.1345/aph.19201; Ownby RL, 2011, AUTOMATED TAILORED I; Paterson DL, 2000, ANN INTERN MED, V133, P21, DOI 10.7326/0003-4819-133-1-200007040-00004; Poppa A, 2004, HIV MED, V5, P46, DOI 10.1111/j.1468-1293.2004.00215.x; Powell-Cope GM, 2003, AIDS CARE, V15, P239, DOI 10.1080/0954012031000068380; Riegel B, 2008, J CARDIOVASC NURS, V23, P190, DOI 10.1097/01.JCN.0000305091.35259.85; Safren SA, 2003, AIDS CARE, V15, P787, DOI 10.1080/09540120310001618630; Samet JH, 2005, ANTIVIR THER, V10, P83; SAMET JH, 1992, AM J MED, V92, P495, DOI 10.1016/0002-9343(92)90746-X; Shet A, 2010, AIDS BEHAV, V14, P716, DOI 10.1007/s10461-009-9658-3; Simon V, 2002, AIDS, V16, P1511, DOI 10.1097/00002030-200207260-00008; Simoni JM, 2006, JAIDS-J ACQ IMM DEF, V43, pS23, DOI 10.1097/01.qai.0000248342.05438.52; Simoni JM, 2009, JAIDS-J ACQ IMM DEF, V52, P465, DOI 10.1097/QAI.0b013e3181b9300c; Simoni JM, 2010, AIDS BEHAV; Smith SR, 2005, J AM PHARM ASSOC, V45, P625, DOI 10.1331/1544345055001292; Sowell R L, 1997, Holist Nurs Pract, V11, P18; Starks H, 2008, AIDS CARE, V20, P607, DOI 10.1080/09540120701660379; UNAIDS, 2009, WHAT COUNTR NEED INV; United Nations Children's Fund World Health Organization UNA-IDS, 2009, UN ACC SCAL PRIOR HI; WH Organization, 2003, ADH LONG TERM THER E; Wise J, 2008, AIDS PATIENT CARE ST, V22, P495, DOI 10.1089/apc.2007.0180; Wong IY, 2006, JAIDS-J ACQ IMM DEF, V43, pS142, DOI 10.1097/01.qai.0000248345.02760.03; Wu AW, 2006, AIDS PATIENT CARE ST, V20, P773, DOI 10.1089/apc.2006.20.773	82	46	46	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e27533	10.1371/journal.pone.0027533	http://dx.doi.org/10.1371/journal.pone.0027533			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	863MI	22140446	Green Submitted, Green Published, gold			2022-12-27	WOS:000298168100011
J	Adams, MN; Christensen, ME; He, YW; Waterhouse, NJ; Hooper, JD				Adams, Mark N.; Christensen, Melinda E.; He, Yaowu; Waterhouse, Nigel J.; Hooper, John D.			The Role of Palmitoylation in Signalling, Cellular Trafficking and Plasma Membrane Localization of Protease-Activated Receptor-2	PLOS ONE			English	Article							ARRESTIN-DEPENDENT ENDOCYTOSIS; 4TH CYTOPLASMIC LOOP; COUPLED RECEPTOR; BETA(1)-ADRENERGIC RECEPTOR; VASOPRESSIN RECEPTOR; FLUORESCENT PROTEIN; ERK1/2 ACTIVATION; MOLECULAR-CLONING; HELIX 8; PHOSPHORYLATION	Protease-activated receptor-2 (PAR2) is a G protein coupled receptor (GPCR) activated by proteolytic cleavage of its amino terminal domain by trypsin-like serine proteases. This irreversible activation mechanism leads to rapid receptor desensitization by internalisation and degradation. We have explored the role of palmitoylation, the post-translational addition of palmitate, in PAR2 signalling, trafficking, cell surface expression and desensitization. Experiments using the palmitoylation inhibitor 2-bromopalmitate indicated that palmitate addition is important in trafficking of PAR2 endogenously expressed by prostate cancer cell lines. This was supported by palmitate labelling using two approaches, which showed that PAR2 stably expressed by CHO-K1 cells is palmitoylated and that palmitoylation occurs on cysteine 361. Palmitoylation is required for optimal PAR2 signalling as Ca(2+) flux assays indicated that in response to trypsin agonism, palmitoylation deficient PAR2 is similar to 9 fold less potent than wildtype receptor with a reduction of about 33% in the maximum signal induced via the mutant receptor. Confocal microscopy, flow cytometry and cell surface biotinylation analyses demonstrated that palmitoylation is required for efficient cell surface expression of PAR2. We also show that receptor palmitoylation occurs within the Golgi apparatus and is required for efficient agonist-induced rab11a-mediated trafficking of PAR2 to the cell surface. Palmitoylation is also required for receptor desensitization, as agonist-induced beta-arrestin recruitment and receptor endocytosis and degradation were markedly reduced in CHO-PAR2-C361A cells compared with CHO-PAR2 cells. These data provide new insights on the life cycle of PAR2 and demonstrate that palmitoylation is critical for efficient signalling, trafficking, cell surface localization and degradation of this receptor.	[Adams, Mark N.; Christensen, Melinda E.; He, Yaowu; Waterhouse, Nigel J.; Hooper, John D.] Mater Med Res Inst, Brisbane, Qld, Australia; [Adams, Mark N.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Kelvin Grove, Qld, Australia	Mater Research; Queensland University of Technology (QUT)	Adams, MN (corresponding author), Mater Med Res Inst, Aubigny Pl, Brisbane, Qld, Australia.	jhooper@mmri.mater.org.au	Hooper, John/C-1481-2016; Adams, Mark/AAE-1209-2021; Waterhouse, Nigel/I-9813-2016	Hooper, John/0000-0003-1054-8486; Adams, Mark/0000-0003-1906-5018; HE, Yaowu/0000-0002-7828-263X	National Health and Medical Research Council [614206]; Cancer Council Queensland; Australian Post-Graduate Award; Australian Research Council [FT0991446]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council Queensland(Cancer Council Queensland); Australian Post-Graduate Award(Australian Government); Australian Research Council(Australian Research Council)	This work was supported by National Health and Medical Research Council grant #614206 and a Cancer Council Queensland grant (J. D. H.), an Australian Post-Graduate Award (M. N. A.) and an Australian Research Council Future Fellowship #FT0991446 (N. J. W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MN, 2011, PHARMACOL THERAPEUT, V130, P248, DOI 10.1016/j.pharmthera.2011.01.003; Ahn KH, 2010, BIOCHEMISTRY-US, V49, P502, DOI 10.1021/bi901619r; Anavi-Goffer S, 2007, J BIOL CHEM, V282, P25100, DOI 10.1074/jbc.M703388200; Blanpain C, 2001, J BIOL CHEM, V276, P23795, DOI 10.1074/jbc.M100583200; Bohm SK, 1996, J BIOL CHEM, V271, P22003; Botham A, 2011, BIOCHEM J, V438, P359, DOI 10.1042/BJ20101958; Camerer E, 2000, P NATL ACAD SCI USA, V97, P5255, DOI 10.1073/pnas.97.10.5255; Camerer E, DEV CELL, V18, P25; Charest PG, 2003, J BIOL CHEM, V278, P41541, DOI 10.1074/jbc.M306589200; CHAVRIER P, 1990, MOL CELL BIOL, V10, P6578, DOI 10.1128/MCB.10.12.6578; Compton SJ, 2002, BIOCHEM J, V368, P495, DOI 10.1042/BJ20020706; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; Delos Santos NM, 2006, J BIOL CHEM, V281, P12896, DOI 10.1074/jbc.M508500200; Dery O, 1999, J BIOL CHEM, V274, P18524, DOI 10.1074/jbc.274.26.18524; Dinter A, 1998, HISTOCHEM CELL BIOL, V109, P571, DOI 10.1007/s004180050256; Drisdel RC, 2004, BIOTECHNIQUES, V36, P276, DOI 10.2144/04362RR02; Ernst OP, 2000, J BIOL CHEM, V275, P1937, DOI 10.1074/jbc.275.3.1937; Escriba PV, 2007, BBA-BIOMEMBRANES, V1768, P836, DOI 10.1016/j.bbamem.2006.09.001; Fernandez-Hernando C, 2006, J CELL BIOL, V174, P369, DOI 10.1083/jcb.200601051; Ferrell WR, 2003, J CLIN INVEST, V111, P35, DOI 10.1172/JCI200316913; Fukata Y, 2010, NAT REV NEUROSCI, V11, P161, DOI 10.1038/nrn2788; Fukushima Y, 2001, BBA-MOL CELL RES, V1539, P181, DOI 10.1016/S0167-4889(01)00104-5; Gehret AU, 2010, MOL PHARMACOL, V77, P288, DOI 10.1124/mol.109.059733; Grimsey N, 2011, IUBMB LIFE, V63, P403, DOI 10.1002/iub.442; Groarke DA, 2001, MOL PHARMACOL, V59, P375, DOI 10.1124/mol.59.2.375; Hasdemir B, 2009, J BIOL CHEM, V284, P28453, DOI 10.1074/jbc.M109.025692; Hawtin SR, 2001, J BIOL CHEM, V276, P38139; He YW, 2008, J BIOL CHEM, V283, P24000, DOI 10.1074/jbc.M803361200; Jacob C, 2005, J BIOL CHEM, V280, P16076, DOI 10.1074/jbc.M500109200; Jennings BC, 2009, J LIPID RES, V50, P233, DOI 10.1194/jlr.M800270-JLR200; Katragadda M, 2004, BBA-BIOMEMBRANES, V1663, P74, DOI 10.1016/j.bbamem.2004.01.012; Kraft K, 2001, J BIOL CHEM, V276, P34408, DOI 10.1074/jbc.M102782200; Lin DT, 2009, NAT NEUROSCI, V12, P879, DOI 10.1038/nn.2351; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; MAGEE AI, 1985, EMBO J, V4, P1137, DOI 10.1002/j.1460-2075.1985.tb03751.x; Marin EP, 2000, J BIOL CHEM, V275, P1930, DOI 10.1074/jbc.275.3.1930; Martin BR, 2009, NAT METHODS, V6, P135, DOI [10.1038/NMETH.1293, 10.1038/nmeth.1293]; MOFFETT S, 1993, EMBO J, V12, P349, DOI 10.1002/j.1460-2075.1993.tb05663.x; Molino M, 1997, J BIOL CHEM, V272, P4043, DOI 10.1074/jbc.272.7.4043; Morimoto S, 2005, J BIOL CHEM, V280, P2220, DOI 10.1074/jbc.M406906200; NG GYK, 1994, EUR J PHARM-MOLEC PH, V267, P7, DOI 10.1016/0922-4106(94)90219-4; NYSTEDT S, 1994, P NATL ACAD SCI USA, V91, P9208, DOI 10.1073/pnas.91.20.9208; Ohno Y, 2006, BBA-MOL CELL BIOL L, V1761, P474, DOI 10.1016/j.bbalip.2006.03.010; Oikonomopoulou K, 2006, J BIOL CHEM, V281, P32095, DOI 10.1074/jbc.M513138200; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Percherancier Y, 2001, J BIOL CHEM, V276, P31936, DOI 10.1074/jbc.M104013200; Petaja-Repo UE, 2006, J BIOL CHEM, V281, P15780, DOI 10.1074/jbc.M602267200; PHILLIPS WJ, 1992, J BIOL CHEM, V267, P17032; Ponimaskin E, 2005, MOL PHARMACOL, V67, P1434, DOI 10.1124/mol.104.008748; PROBST WC, 1992, DNA CELL BIOL, V11, P1, DOI 10.1089/dna.1992.11.1; Qanbar R, 2003, PHARMACOL THERAPEUT, V97, P1, DOI 10.1016/S0163-7258(02)00300-5; Ramachandran R, 2008, BRIT J PHARMACOL, V153, pS263, DOI 10.1038/sj.bjp.0707507; Ramsay AJ, 2008, J BIOL CHEM, V283, P12293, DOI 10.1074/jbc.M709493200; Reid HM, 2010, J BIOL CHEM, V285, P18709, DOI 10.1074/jbc.M110.106476; Ricks TK, 2009, J BIOL CHEM, V284, P34444, DOI 10.1074/jbc.M109.048942; Roosterman D, 2003, AM J PHYSIOL-CELL PH, V284, pC1319, DOI 10.1152/ajpcell.00540.2002; Rzomp KA, 2003, INFECT IMMUN, V71, P5855, DOI 10.1128/IAI.71.10.5855-5870.2003; Sadeghi HM, 1997, MOL PHARMACOL, V52, P21, DOI 10.1124/mol.52.1.21; Schulein R, 1996, BIOCHEM J, V313, P611, DOI 10.1042/bj3130611; Sevigny LM, 2011, P NATL ACAD SCI USA, V108, P8491, DOI 10.1073/pnas.1017091108; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Sharma C, 2008, MOL BIOL CELL, V19, P3415, DOI 10.1091/mbc.E07-11-1164; STANLEY P, 1975, CELL, V6, P121, DOI 10.1016/0092-8674(75)90002-1; Storrie B, 1998, BBA-MOL CELL RES, V1404, P127, DOI 10.1016/S0167-4889(98)00053-6; Swift S, 2006, J BIOL CHEM, V281, P4109, DOI 10.1074/jbc.M509525200; Tanaka K, 1998, ENDOCRINOLOGY, V139, P803, DOI 10.1210/en.139.2.803; Ulloa-Aguirre A, 2007, MOL CELL ENDOCRINOL, V260, P153, DOI 10.1016/j.mce.2005.11.050; Vergnolle N, 2005, GUT, V54, P867, DOI 10.1136/gut.2004.048876; Vergnolle N, 1999, BRIT J PHARMACOL, V127, P1083, DOI 10.1038/sj.bjp.0702634; Vergnolle N, 2001, NAT MED, V7, P821, DOI 10.1038/89945; Versteeg HH, 2008, CANCER RES, V68, P7219, DOI 10.1158/0008-5472.CAN-08-0419; Wan J, 2007, NAT PROTOC, V2, P1573, DOI 10.1038/nprot.2007.225; Wei HJ, 2003, P NATL ACAD SCI USA, V100, P10782, DOI 10.1073/pnas.1834556100; Wilcke M, 2000, J CELL BIOL, V151, P1207, DOI 10.1083/jcb.151.6.1207; Yang XW, 2004, J CELL BIOL, V167, P1231, DOI 10.1083/jcb.200404100; Yang XW, 2002, MOL BIOL CELL, V13, P767, DOI 10.1091/mbc.01-05-0275; ZHU HY, 1995, MOL ENDOCRINOL, V9, P141, DOI 10.1210/me.9.2.141; Zuckerman DM, 2011, J BIOL CHEM, V286, P19014, DOI 10.1074/jbc.M110.189977	78	35	35	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2011	6	11							e28018	10.1371/journal.pone.0028018	http://dx.doi.org/10.1371/journal.pone.0028018			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863LT	22140500	Green Submitted, Green Published, gold			2022-12-27	WOS:000298166300021
J	Wang, XW; Nath, A; Yang, XR; Portis, A; Walton, SP; Chan, C				Wang, Xuewei; Nath, Aritro; Yang, Xuerui; Portis, Amanda; Walton, S. Patrick; Chan, Christina			Synergy Analysis Reveals Association between Insulin Signaling and Desmoplakin Expression in Palmitate Treated HepG2 Cells	PLOS ONE			English	Article							FATTY LIVER-DISEASE; CARDIOVASCULAR-DISEASE; SKELETAL-MUSCLE; PROTEIN-KINASE; BINDING PROTEINS; CROSS-TALK; ACID; IDENTIFICATION; RESISTANCE; IDENTIFY	The regulation of complex cellular activities in palmitate treated HepG2 cells, and the ensuing cytotoxic phenotype, involves cooperative interactions between genes. While previous approaches have largely focused on identifying individual target genes, elucidating interacting genes has thus far remained elusive. We applied the concept of information synergy to reconstruct a "gene-cooperativity" network for palmititate-induced cytotoxicity in liver cells. Our approach integrated gene expression data with metabolic profiles to select a subset of genes for network reconstruction. Subsequent analysis of the network revealed insulin signaling as the most significantly enriched pathway, and desmoplakin (DSP) as its top neighbor. We determined that palmitate significantly reduces DSP expression, and treatment with insulin restores the lost expression of DSP. Insulin resistance is a common pathological feature of fatty liver and related ailments, whereas loss of DSP has been noted in liver carcinoma. Reduced DSP expression can lead to loss of cell-cell adhesion via desmosomes, and disrupt the keratin intermediate filament network. Our findings suggest that DSP expression may be perturbed by palmitate and, along with insulin resistance, may play a role in palmitate induced cytotoxicity, and serve as potential targets for further studies on non-alcoholic fatty liver disease (NAFLD).	[Wang, Xuewei; Yang, Xuerui; Portis, Amanda; Walton, S. Patrick; Chan, Christina] Michigan State Univ, Dept Chem Engn & Mat Sci, E Lansing, MI 48824 USA; [Nath, Aritro; Chan, Christina] Michigan State Univ, Genet Program, E Lansing, MI 48824 USA; [Yang, Xuerui; Chan, Christina] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Chan, Christina] Michigan State Univ, Dept Comp Sci & Engn, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; Michigan State University; Michigan State University	Wang, XW (corresponding author), Michigan State Univ, Dept Chem Engn & Mat Sci, E Lansing, MI 48824 USA.	krischan@egr.msu.edu	Nath, Aritro/AAV-8720-2020; wang, xuewei/C-7773-2009	Nath, Aritro/0000-0002-3225-4203; Yang, Xuerui/0000-0002-7731-2147; Wang, Xuewei/0000-0003-3679-7421; Walton, S. Patrick/0000-0003-1708-8603	National Institutes of Health (NIH) [R01GM079688-01, R21RR024439]; National Science Foundation (NSF) [CBET 0941055, CBET 1049127]; MSU Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [R21RR024439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079688] Funding Source: NIH RePORTER; Directorate For Engineering [1049127] Funding Source: National Science Foundation	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); MSU Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This research was supported in part by the National Institutes of Health (NIH) (R01GM079688-01 and R21RR024439), the National Science Foundation (NSF) (CBET 0941055 and CBET 1049127), and the MSU Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiola M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008509; Amemiya-Kudo M, 2005, J BIOL CHEM, V280, P34577, DOI 10.1074/jbc.M506718200; Anastassiou D, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100124; Anderson Abraham A, 2009, Pathogenetics, V2, P1, DOI 10.1186/1755-8417-2-1; Angulo P, 2007, NUTR REV, V65, pS57, DOI [10.1111/j.1753-4887.2007.tb00329.x, 10.1301/nr.2007.jun.S57-S63]; ARDEN KC, 1995, GENOMICS, V25, P743, DOI 10.1016/0888-7543(95)80023-F; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Bass-Zubek AE, 2008, J CELL BIOL, V181, P605, DOI 10.1083/jcb.200712133; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Borradaile NM, 2006, MOL BIOL CELL, V17, P770, DOI 10.1091/mbc.E05-08-0742; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Buffa L, 2008, EUR J CELL BIOL, V87, P197, DOI 10.1016/j.ejcb.2007.11.003; Bugianesi E, 2005, HEPATOLOGY, V42, P987, DOI 10.1002/hep.20920; Cao Y, 2007, HISTOPATHOLOGY, V51, P528, DOI 10.1111/j.1365-2559.2007.02820.x; Carmona-Saez P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r3; Ceddia RB, 2005, INT J OBESITY, V29, P1175, DOI 10.1038/sj.ijo.0803025; Chidgey M, 2007, BRIT J CANCER, V96, P1783, DOI 10.1038/sj.bjc.6603808; Chong MP, 2004, BIOCHEM BIOPH RES CO, V322, P535, DOI 10.1016/j.bbrc.2004.07.150; de Alwis NMW, 2008, J HEPATOL, V48, pS104, DOI 10.1016/j.jhep.2008.01.009; de la Fuente A, 2010, TRENDS GENET, V26, P326, DOI 10.1016/j.tig.2010.05.001; Dettling M, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r88; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI200523621; Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607; Dyck DJ, 2001, AM J PHYSIOL-ENDOC M, V281, pE600, DOI 10.1152/ajpendo.2001.281.3.E600; Edens MA, 2009, OBES REV, V10, P412, DOI 10.1111/j.1467-789X.2009.00594.x; Ekinci FJ, 1999, BRAIN RES, V850, P207, DOI 10.1016/S0006-8993(99)02146-0; Ekstedt M, 2006, HEPATOLOGY, V44, P865, DOI 10.1002/hep.21327; Franch-Marro X, 2008, J CELL SCI, V121, P1587, DOI 10.1242/jcs.015958; Gao D, 2010, J BIOL CHEM, V285, P29965, DOI 10.1074/jbc.M110.128694; Garcia-Gras E, 2006, J CLIN INVEST, V116, P2012, DOI 10.1172/JCI27751; Getsios S, 2004, NAT REV MOL CELL BIO, V5, P271, DOI 10.1038/nrm1356; Guo W, 2007, AM J PHYSIOL-ENDOC M, V293, pE576, DOI 10.1152/ajpendo.00523.2006; Han Sheng-fang, 2007, Yingyong Shengtai Xuebao, V18, P2462; Hegmans JPJJ, 2004, AM J PATHOL, V164, P1807, DOI 10.1016/S0002-9440(10)63739-X; Higuchi N, 2008, HEPATOL RES, V38, P1122, DOI 10.1111/j.1872-034X.2008.00382.x; HOBBS RP, 2010, FASEB J; HUANG L, 2010, EXP CELL RES; Jonkman MF, 2005, AM J HUM GENET, V77, P653, DOI 10.1086/496901; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Leonardi R, 2005, PROG LIPID RES, V44, P125, DOI 10.1016/j.plipres.2005.04.001; Letiges M, 2002, MOL ENDOCRINOL, V16, P847, DOI 10.1210/me.16.4.847; Li Z, 2008, BIOTECHNOL PROGR, V24, P29, DOI 10.1021/bp070120b; Li Z, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-21; Li Z, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-202; Lorch JH, 2004, J BIOL CHEM, V279, P37191, DOI 10.1074/jbc.M405123200; Mattar SG, 2005, ANN SURG, V242, P610, DOI 10.1097/01.sla.0000179652.07502.3f; Musso G, 2003, HEPATOLOGY, V37, P909, DOI 10.1053/jhep.2003.50132; Musso G, 2009, PROG LIPID RES, V48, P1, DOI 10.1016/j.plipres.2008.08.001; Nicolson TJ, 2009, DIABETES, V58, P2070, DOI 10.2337/db09-0551; Polakis P, 2000, GENE DEV, V14, P1837; Prada PO, 2009, DIABETES, V58, P2910, DOI 10.2337/db08-0506; Rampazzo A, 2002, AM J HUM GENET, V71, P1200, DOI 10.1086/344208; Reed BD, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000133; Remenyi A, 2004, NAT STRUCT MOL BIOL, V11, P812, DOI 10.1038/nsmb820; Rong R, 2003, NAT NEUROSCI, V6, P1153, DOI 10.1038/nn1134; Ruddock MW, 2008, J BIOCHEM, V144, P599, DOI 10.1093/jb/mvn105; Shiraishi Y, 2004, J COMP NEUROL, V473, P582, DOI 10.1002/cne.20116; Slawik M, 2006, AGEING RES REV, V5, P144, DOI 10.1016/j.arr.2006.03.004; Smidt K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005684; Smith JJ, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb1400157; Smith J, 2008, J BIOL CHEM, V283, P13578, DOI 10.1074/jbc.M800008200; Srivastava S, 2008, BIOTECHNOL BIOENG, V99, P399, DOI 10.1002/bit.21568; Srivastava S, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-364; Storz P, 1999, EUR J BIOCHEM, V266, P17, DOI 10.1046/j.1432-1327.1999.00809.x; Sumi K, 2007, MOL CELL BIOL, V27, P4248, DOI 10.1128/MCB.01894-06; Swagell CD, 2005, BIOCHEM BIOPH RES CO, V328, P432, DOI 10.1016/j.bbrc.2004.12.188; Tan NS, 2002, MOL CELL BIOL, V22, P5114, DOI 10.1128/MCB.22.14.5114-5127.2002; Targher G, 2008, DIABETOLOGIA, V51, P444, DOI 10.1007/s00125-007-0897-4; Targher G, 2010, J HEPATOL, V53, P713, DOI 10.1016/j.jhep.2010.04.030; TOPPING DL, 1972, BIOCHEM J, V126, P295, DOI 10.1042/bj1260295; Tsang MYC, 2004, NITRIC OXIDE-BIOL CH, V10, P11, DOI 10.1016/j.niox.2004.01.005; Uzumcu A, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.032904; Vinken M, 2006, CRIT REV TOXICOL, V36, P299, DOI 10.1080/10408440600599273; Wang XW, 2008, CURR OPIN BIOTECH, V19, P482, DOI 10.1016/j.copbio.2008.07.011; Watkinson J, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-10; Whittock NV, 2002, J INVEST DERMATOL, V118, P232, DOI 10.1046/j.0022-202x.2001.01664.x; Yang XR, 2010, MOL BIOL CELL, V21, P3449, DOI 10.1091/mbc.E10-06-0481; Yang XR, 2009, ARTECH HSE METH BIOE, P75; Yang XR, 2009, BIOINFORMATICS, V25, P2236, DOI 10.1093/bioinformatics/btp376; Yang Z, 2006, CIRC RES, V99, P646, DOI 10.1161/01.RES.0000241482.19382.c6; Yoon JC, 2010, GENE DEV, V24, P1507, DOI 10.1101/gad.1924910; Zelber-Sagil S, 2007, J HEPATOL, V47, P711, DOI 10.1016/j.jhep.2007.06.020; Zhang JG, 2008, AM J HUM GENET, V83, P269, DOI 10.1016/j.ajhg.2008.07.009; Zhou Q, 2007, ENDOCRINOLOGY, V148, P5696, DOI 10.1210/en.2007-0183	84	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e28138	10.1371/journal.pone.0028138	http://dx.doi.org/10.1371/journal.pone.0028138			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132232	Green Published, gold, Green Submitted			2022-12-27	WOS:000298162000081
J	Martinez, J; Lisa, S; Sanchez, R; Kowalczyk, W; Zurita, E; Teixido, M; Giralt, E; Andreu, D; Avila, J; Gasset, M				Martinez, Javier; Lisa, Silvia; Sanchez, Rosa; Kowalczyk, Wioleta; Zurita, Esther; Teixido, Meritxell; Giralt, Ernest; Andreu, David; Avila, Jesus; Gasset, Maria			Selenomethionine Incorporation into Amyloid Sequences Regulates Fibrillogenesis and Toxicity	PLOS ONE			English	Article							SOLID-PHASE SYNTHESIS; PRION PROTEIN; OXIDATIVE STRESS; METHIONINE; DISEASE; AGGREGATION; PEPTIDES; NEUROTOXICITY; SELENIUM; POLYMORPHISM	Background: The capacity of a polypeptide chain to engage in an amyloid formation process and cause a conformational disease is contained in its sequence. Some of the sequences undergoing fibrillation contain critical methionine (Met) residues which in vivo can be synthetically substituted by selenomethionine (SeM) and alter their properties. Methodology/Principal Findings: Using peptide synthesis, biophysical techniques and cell viability determinations we have studied the effect of the substitution of methionine (Met) by selenomethionine (SeM) on the fibrillogenesis and toxic properties of A beta 40 and HuPrP(106-140). We have found that the effects display site-specificity and vary from inhibition of fibrillation and decreased toxicity ([SeM35]A beta 40, [SeM129]HuPrP(106-140) and [SeM134]HuPrP(106-140)), retarded assembly, modulation of polymer shape and retention of toxicity ([SeM112]HuPrP(106-140) to absence of effects ([SeM109]HuPrP(106-140)). Conclusions/Significance: This work provides direct evidence that the substitution of Met by SeM in proamyloid sequences has a major impact on their self-assembly and toxic properties, suggesting that the SeM pool can play a major role in dictating the allowance and efficiency of a polypeptide chain to undergo toxic polymerization.	[Martinez, Javier; Lisa, Silvia; Sanchez, Rosa; Gasset, Maria] CSIC, Inst Quim Fis Rocasolano, Madrid, Spain; [Kowalczyk, Wioleta; Andreu, David] Pompeu Fabra Univ, Dept Expt & Hlth Sci, Barcelona, Spain; [Zurita, Esther; Teixido, Meritxell; Giralt, Ernest] Inst Res Biomed, Barcelona, Spain; [Giralt, Ernest] Univ Barcelona, Dept Organ Chem, Barcelona, Spain; [Avila, Jesus] Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, Consejo Super Invest Cient, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); Pompeu Fabra University; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Barcelona; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Martinez, J (corresponding author), CSIC, Inst Quim Fis Rocasolano, Madrid, Spain.	mgasset@iqfr.csic.es	Andreu, David/I-4359-2014; Avila, Jesus/I-2610-2015; Gasset, Maria/K-4339-2012; Kowalczyk, Wioleta/F-5904-2014; Gasset, Maria/I-2050-2014; teixido, meritxell/I-3282-2015; giralt, ernest/N-1669-2014	Andreu, David/0000-0002-6317-6666; Avila, Jesus/0000-0002-6288-0571; Gasset, Maria/0000-0001-6436-4055; Gasset, Maria/0000-0001-6436-4055; teixido, meritxell/0000-0002-7825-3695; giralt, ernest/0000-0001-8381-1797; Martinez, Javier/0000-0002-0104-5652; Kowalczyk, Wioleta/0000-0001-5180-594X	Spanish Ministry of Science and Innovation [BFU2009-07975, BIO2008-04487-CO3-02, BIO2008-00799]; Fundacion Cien-Fundacion Reina Sofia; Generalitat de Catalunya (XRB and Grups Consolidats)	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion Cien-Fundacion Reina Sofia; Generalitat de Catalunya (XRB and Grups Consolidats)(Generalitat de Catalunya)	This work was supported in part by gra'ts BFU2009-07975 (MG), BIO2008-04487-CO3-02 (DA) and BIO2008-00799 (EG) from the Spanish Ministry of Science and Innovation, from the Fundacion Cien-Fundacion Reina Sofia, and from Generalitat de Catalunya (XRB and Grups Consolidats). Wioleta Kowalczyk is supported by a Juan de la Cierva fellowship from the Spanish Ministry of Science and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi A, 2009, PHYSIOL REV, V89, P1105, DOI 10.1152/physrev.00006.2009; Apostol MI, 2010, J BIOL CHEM, V285, P29671, DOI 10.1074/jbc.C110.158303; Baskakov I, 2005, FEBS LETT, V579, P2589, DOI 10.1016/j.febslet.2005.03.075; Bergstrom AL, 2007, BBA-PROTEINS PROTEOM, V1774, P1118, DOI 10.1016/j.bbapap.2007.06.016; BISHOP MF, 1984, BIOPHYS J, V46, P631, DOI 10.1016/S0006-3495(84)84062-X; Bitan G, 2003, J AM CHEM SOC, V125, P15359, DOI 10.1021/ja0349296; Budisa N, 1998, EUR J BIOCHEM, V253, P1, DOI 10.1046/j.1432-1327.1998.2530001.x; Butterfield DA, 2005, BBA-PROTEINS PROTEOM, V1703, P149, DOI 10.1016/j.bbapap.2004.10.014; Butterfield DA, 2004, NEUROBIOL AGING, V25, P563, DOI 10.1016/j.neurobiolaging.2003.12.027; Carrell RW, 1997, LANCET, V350, P134, DOI 10.1016/S0140-6736(97)02073-4; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Clementi ME, 2005, FEBS LETT, V579, P2913, DOI 10.1016/j.febslet.2005.04.041; COLLINGE J, 1991, LANCET, V337, P1441, DOI 10.1016/0140-6736(91)93128-V; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; Dettin M, 1997, J PEPT RES, V49, P103; Duennwald ML, 2006, P NATL ACAD SCI USA, V103, P11045, DOI 10.1073/pnas.0604547103; Fioriti L, 2007, J NEUROSCI, V27, P1576, DOI 10.1523/JNEUROSCI.5145-06.2007; Garcia-Martin F, 2006, J COMB CHEM, V8, P213, DOI 10.1021/cc0600019; GASSET M, 1992, P NATL ACAD SCI USA, V89, P10940, DOI 10.1073/pnas.89.22.10940; Gassner NC, 1999, J MOL BIOL, V294, P17, DOI 10.1006/jmbi.1999.3220; Ghetti B, 1996, P NATL ACAD SCI USA, V93, P744, DOI 10.1073/pnas.93.2.744; Goldschmidt L, 2010, P NATL ACAD SCI USA, V107, P3487, DOI 10.1073/pnas.0915166107; Green KM, 2008, J GEN VIROL, V89, P598, DOI 10.1099/vir.0.83168-0; GRIFFITHS NM, 1976, BRIT J NUTR, V35, P373, DOI 10.1079/BJN19760043; Grillo-Bosch D, 2011, J PEPT SCI, V17, P32, DOI 10.1002/psc.1293; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Haigh CL, 2009, CELL RES, V19, P1062, DOI 10.1038/cr.2009.86; Hakansson K, 2000, ACTA CRYSTALLOGR D, V56, P924, DOI 10.1107/S0907444900006375; Itkin A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018250; Johansson AS, 2007, NEUROREPORT, V18, P559, DOI 10.1097/WNR.0b013e3280b07c21; Krause RJ, 2009, BIOCHEM PHARMACOL, V77, P134, DOI 10.1016/j.bcp.2008.09.022; Le DT, 2008, BIOCHEMISTRY-US, V47, P6685, DOI 10.1021/bi800422s; Lee S, 2010, EMBO J, V29, P251, DOI 10.1038/emboj.2009.333; Lee YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020244; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Lisa S, 2010, CELL MOL LIFE SCI, V67, P2825, DOI 10.1007/s00018-010-0363-1; Maiti P, 2011, BIOCHEM J, V433, P323, DOI 10.1042/BJ20101391; Maji SK, 2009, FEBS LETT, V583, P2610, DOI 10.1016/j.febslet.2009.07.003; Makarava N, 2009, J BIOL CHEM, V284, P14386, DOI 10.1074/jbc.M900533200; McCann JC, 2011, FASEB J, V25, P1793, DOI 10.1096/fj.11-180885; MEPLAN C, 2011, J TRACE ELEMENTS MED, V255, P511; NASLUND J, 1994, P NATL ACAD SCI USA, V91, P8378, DOI 10.1073/pnas.91.18.8378; Ostapchenko VG, 2010, J MOL BIOL, V400, P908, DOI 10.1016/j.jmb.2010.05.051; Palmblad M, 2002, J BIOL CHEM, V277, P19506, DOI 10.1074/jbc.M112218200; Parchi P, 2011, ACTA NEUROPATHOL, V121, P91, DOI 10.1007/s00401-010-0779-6; Petchanikow C, 2001, FEBS LETT, V509, P451, DOI 10.1016/S0014-5793(01)03147-7; Rayman MP, 2008, BRIT J NUTR, V100, P254, DOI 10.1017/S0007114508939830; Salmona M, 2003, J BIOL CHEM, V278, P48146, DOI 10.1074/jbc.M307295200; Sanchez L, 2011, J AM CHEM SOC, V133, P6505, DOI 10.1021/ja1117123; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Schrauzer GN, 2000, J NUTR, V130, P1653, DOI 10.1093/jn/130.7.1653; Shahar A, 2010, MOVEMENT DISORD, V25, P1909, DOI 10.1002/mds.23218; Shewmaker F, 2011, J BIOL CHEM, V286, P16533, DOI 10.1074/jbc.R111.227108; Smith JL, 1998, STRUCT FOLD DES, V6, P815, DOI 10.1016/S0969-2126(98)00083-5; Sohma Y, 2005, J PEPT SCI, V11, P441, DOI 10.1002/psc.649; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; Toyama BH, 2011, ANNU REV BIOCHEM, V80, P557, DOI 10.1146/annurev-biochem-090908-120656; Wernimont AK, 2003, J BIOL INORG CHEM, V8, P185, DOI 10.1007/s00775-002-0404-9; Wiltzius JJW, 2009, NAT STRUCT MOL BIOL, V16, P973, DOI 10.1038/nsmb.1643; Yamniuk AP, 2009, BIOPHYS J, V96, P1495, DOI 10.1016/j.bpj.2008.10.060; Yokoyama S, 2003, CURR OPIN CHEM BIOL, V7, P39, DOI 10.1016/S1367-5931(02)00019-4	61	16	16	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2011	6	11							e27999	10.1371/journal.pone.0027999	http://dx.doi.org/10.1371/journal.pone.0027999			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858JH	22132190	Green Published, gold			2022-12-27	WOS:000297792400030
J	He, B; Tang, J; Ding, Y; Wang, HJ; Sun, YY; Shin, JH; Chen, B; Moorthy, G; Qiu, J; Desai, P; Wild, DJ				He, Bing; Tang, Jie; Ding, Ying; Wang, Huijun; Sun, Yuyin; Shin, Jae Hong; Chen, Bin; Moorthy, Ganesh; Qiu, Judy; Desai, Pankaj; Wild, David J.			Mining Relational Paths in Integrated Biomedical Data	PLOS ONE			English	Article							IBUPROFEN; INFLAMMATION; SHORTEST; MODEL; VASOSPASM; DELIVERY; RISK	Much life science and biology research requires an understanding of complex relationships between biological entities (genes, compounds, pathways, diseases, and so on). There is a wealth of data on such relationships in publicly available datasets and publications, but these sources are overlapped and distributed so that finding pertinent relational data is increasingly difficult. Whilst most public datasets have associated tools for searching, there is a lack of searching methods that can cross data sources and that in particular search not only based on the biological entities themselves but also on the relationships between them. In this paper, we demonstrate how graph-theoretic algorithms for mining relational paths can be used together with a previous integrative data resource we developed called Chem2Bio2RDF to extract new biological insights about the relationships between such entities. In particular, we use these methods to investigate the genetic basis of side-effects of thiazolinedione drugs, and in particular make a hypothesis for the recently discovered cardiac side-effects of Rosiglitazone (Avandia) and a prediction for Pioglitazone which is backed up by recent clinical studies.	[He, Bing; Ding, Ying; Sun, Yuyin] Indiana Univ, Sch Lib & Informat Sci, Bloomington, IN 47401 USA; [Wang, Huijun; Shin, Jae Hong; Chen, Bin; Qiu, Judy; Wild, David J.] Indiana Univ, Sch Comp & Informat, Bloomington, IN USA; [Tang, Jie] Tsinghua Univ, Dept Comp Sci & Technol, Beijing 100084, Peoples R China; [Moorthy, Ganesh; Desai, Pankaj] Univ Cincinnati, Sch Pharm, Cincinnati, OH USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Tsinghua University; University System of Ohio; University of Cincinnati	He, B (corresponding author), Indiana Univ, Sch Lib & Informat Sci, Bloomington, IN 47401 USA.	djwild@indiana.edu	wang, hui/GRS-4730-2022; Moorthy, Ganesh/K-4432-2019; wang, huimin/HDM-8421-2022	Ding, Ying/0000-0003-2567-2009				Alako BTF, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-51; Alkhateeb Faisal, 2008, Proceedings of the 2008 International Conference on Semantic Web & Web Services (SWWS 2008), P91; [Anonymous], SPARQL QUERY LANGUAG; [Anonymous], RXPATH SPECIFICATION; Anyanwu K., 2003, WWW, P690, DOI DOI 10.1145/775152.775249; Anyanwu K., 2007, P 16 INT C WORLD WID, P797, DOI DOI 10.1145/1242572.1242680; Anyanwu K, 2003, SIGMOD REC, P42; Bartels AL, 2010, CURR NEUROPHARMACOL, V8, P62, DOI 10.2174/157015910790909485; Belleau F, 2008, J BIOMED INFORM, V41, P706, DOI 10.1016/j.jbi.2008.03.004; Bennet AM, 2007, JAMA-J AM MED ASSOC, V298, P1300, DOI 10.1001/jama.298.11.1300; Blei DM, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-250; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Brander A. W., 1995, P 11 UK PERF ENG WOR, P370; Bredel M, 2004, NAT REV GENET, V5, P262, DOI 10.1038/nrg1317; Bundschus M, 2008, BIOKDD 08; BYERS TH, 1984, OPER RES, V32, P1381, DOI 10.1287/opre.32.6.1381; Carlyle WM, 2005, NETWORKS, V46, P98, DOI 10.1002/net.20077; Chen B, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-255; Cohen KB, 2004, COMPU BIOL, V5, P147; Dani C, 2005, PEDIATRICS, V115, P1529, DOI 10.1542/peds.2004-1178; Dijkstra E.W, 1959, NUMER MATH, V1, P269, DOI DOI 10.1007/BF01386390; Dong X, 2010, WORKSH FUT WEB COLL; Eppstein D, 1998, SIAM J COMPUT, V28, P652, DOI 10.1137/S0097539795290477; ERTEL W, 1992, J SURG RES, V53, P55, DOI 10.1016/0022-4804(92)90013-P; Faloutsos C, 2004, P 10 ACM SIGKDD INT, P118, DOI DOI 10.1145/1014052.1014068; FLOYD RW, 1962, COMMUN ACM, V5, P345, DOI 10.1145/367766.368168; Ford LR, 1999, FLOWS NETWORKS; Frazier JL, 2004, J NEUROSURG, V101, P93, DOI 10.3171/jns.2004.101.1.0093; Frijters R, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000943; Gao XA, 2011, NEUROLOGY, V76, P863, DOI 10.1212/WNL.0b013e31820f2d79; Hadjiconstantinou E, 1999, NETWORKS, V34, P88, DOI 10.1002/(SICI)1097-0037(199909)34:2<88::AID-NET2>3.0.CO;2-1; Hershberger J, 2003, SIAM PROC S, P26; Inagaki T, 1996, PSYCHIAT CLIN NEUROS, V50, P231, DOI 10.1111/j.1440-1819.1996.tb02747.x; Jentzsch A, 2009, P INT C SEM SYST I S; JOHNSON DB, 1977, J ACM, V24, P1, DOI 10.1145/321992.321993; Klegeris A, 2007, CURR OPIN NEUROL, V20, P351, DOI 10.1097/WCO.0b013e3280adc943; Kochut KJ, 2007, LECT NOTES COMPUT SC, V4519, P145; Lawler E, 1976, COMBINATIONAL OPTIMI; Moghaddam Hadi Fathi, 2007, Pak J Biol Sci, V10, P3853, DOI 10.3923/pjbs.2007.3853.3858; Morchen F., 2008, P 14 ACM SIGKDD INT, P954, DOI DOI 10.1145/1401890.1402004; Mulla A, 2005, J CLIN ENDOCR METAB, V90, P557, DOI 10.1210/jc.2004-1230; Nilsson D., 2001, INT JOINT C ART INT, P1280; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Olsson T, 2001, Curr Opin Drug Discov Devel, V4, P308; Oprea TI, 2007, NAT CHEM BIOL, V3, P447, DOI 10.1038/nchembio0807-447; Perry M, 2005, P INT WORKSH PEER TO; Pradilla G, 2005, NEUROSURGERY, V57, P184, DOI 10.1227/01.NEU.0000163604.52273.28; Rosen-Zvi M., 2004, AUTHOR TOPIC MODEL A, P487, DOI DOI 10.5555/1036843.1036902; Sheth A, 2005, J DATABASE MANAGE, V16, P33, DOI 10.4018/jdm.2005010103; Teismann P, 2003, P NATL ACAD SCI USA, V100, P5473, DOI 10.1073/pnas.0837397100; Wang HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017243; Williams CS, 1999, ONCOGENE, V18, P7908, DOI 10.1038/sj.onc.1203286; Wilms H, 2007, CURR PHARM DESIGN, V13, P1925; Yang HH, 2005, COMPUT OPER RES, V32, P571, DOI 10.1016/j.cor.2003.08.004; Zheng B, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-58	55	23	23	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2011	6	12							e27506	10.1371/journal.pone.0027506	http://dx.doi.org/10.1371/journal.pone.0027506			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863OC	22162991	Green Published, gold			2022-12-27	WOS:000298173500005
J	Biehl, SC; Dresler, T; Reif, A; Scheuerpflug, P; Deckert, J; Herrmann, MJ				Biehl, Stefanie C.; Dresler, Thomas; Reif, Andreas; Scheuerpflug, Peter; Deckert, Juergen; Herrmann, Martin J.			Dopamine Transporter (DAT1) and Dopamine Receptor D4 (DRD4) Genotypes Differentially Impact on Electrophysiological Correlates of Error Processing	PLOS ONE			English	Article							DEFICIT HYPERACTIVITY DISORDER; CATECHOL-O-METHYLTRANSFERASE; MESSENGER-RNA EXPRESSION; PARKINSONS-DISEASE; HEALTHY-VOLUNTEERS; PERSONALITY-TRAIT; ANTISACCADE TASK; NOVELTY SEEKING; ERP COMPONENTS; ADULT PATIENTS	Recent studies as well as theoretical models of error processing assign fundamental importance to the brain's dopaminergic system. Research about how the electrophysiological correlates of error processing-the error-related negativity (ERN) and the error positivity (Pe)-are influenced by variations of common dopaminergic genes, however, is still relatively scarce. In the present study, we therefore investigated whether polymorphisms in the DAT1 gene and in the DRD4 gene, respectively, lead to interindividual differences in these error processing correlates. One hundred sixty participants completed a version of the Eriksen Flanker Task while a 26-channel EEG was recorded. The task was slightly modified in order to increase error rates. During data analysis, participants were split into two groups depending on their DAT1 and their DRD4 genotypes, respectively. ERN and Pe amplitudes after correct responses and after errors as well as difference amplitudes between errors and correct responses were analyzed. We found a differential effect of DAT1 genotype on the Pe difference amplitude but not on the ERN difference amplitude, while the reverse was true for DRD4 genotype. These findings are in line with predictions from theoretical models of dopaminergic transmission in the brain. They furthermore tie results from clinical investigations of disorders impacting on the dopamine system to genetic variations known to be at-risk genotypes.	[Biehl, Stefanie C.; Dresler, Thomas; Reif, Andreas; Deckert, Juergen; Herrmann, Martin J.] Univ Wurzburg, Dept Psychiat Psychosomat & Psychotherapy, Wurzburg, Germany; [Scheuerpflug, Peter] Univ Wurzburg, Dept Child & Adolescent Psychiat & Psychotherapy, Wurzburg, Germany	University of Wurzburg; University of Wurzburg	Biehl, SC (corresponding author), Univ Wurzburg, Dept Psychiat Psychosomat & Psychotherapy, Wurzburg, Germany.	Biehl_S@klinik.uni-wuerzburg.de	Herrmann, Martin J./C-9904-2009; Biehl, Stefanie/L-2771-2019; herrmann, martin/AAT-9836-2020; Dresler, Thomas/F-8631-2010	Herrmann, Martin J./0000-0001-9970-2122; 	German Research Foundation (DFG) [HE 4531/1-1, RTG 1253/1]; German Research Foundation; University of Wuerzburg	German Research Foundation (DFG)(German Research Foundation (DFG)); German Research Foundation(German Research Foundation (DFG)); University of Wuerzburg	This research was supported by the German Research Foundation (DFG; HE 4531/1-1 and RTG 1253/1). This publication was funded by the German Research Foundation and the University of Wuerzburg in the funding programme Open Access Publishing. http://www.dfg.de/index.jsp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althaus M, 2010, BIOL PSYCHOL, V85, P19, DOI 10.1016/j.biopsycho.2010.04.007; APA, 2000, DIAGN STAT MAN MENT; Beste C, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000086; Bilder RM, 2004, NEUROPSYCHOPHARMACOL, V29, P1943, DOI 10.1038/sj.npp.1300542; de Bruijn ERA, 2006, BRAIN RES, V1105, P122, DOI 10.1016/j.brainres.2006.01.006; de Bruijn ERA, 2004, PSYCHOPHARMACOLOGY, V177, P151, DOI 10.1007/s00213-004-1915-6; Dresler T, 2010, NEUROPSYCHOPHARMACOL, V35, P2193, DOI 10.1038/npp.2010.91; Ebstein RP, 1996, NAT GENET, V12, P78, DOI 10.1038/ng0196-78; Endrass T, 2007, EUR J NEUROSCI, V26, P1714, DOI 10.1111/j.1460-9568.2007.05785.x; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; Falkenstein M, 2001, NEUROREPORT, V12, P157, DOI 10.1097/00001756-200101220-00039; FALKENSTEIN M, 1991, ELECTROEN CLIN NEURO, V78, P447, DOI 10.1016/0013-4694(91)90062-9; Falkenstein M, 2000, BIOL PSYCHOL, V51, P87, DOI 10.1016/S0301-0511(99)00031-9; Frank MJ, 2007, COGN AFFECT BEHAV NE, V7, P297, DOI 10.3758/CABN.7.4.297; Franke B, 2010, NEUROPSYCHOPHARMACOL, V35, P656, DOI 10.1038/npp.2009.170; Fuke S., 2001, Pharmacogenomics Journal, V1, P152; Garcia JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014162; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; Goldberg TE, 2003, ARCH GEN PSYCHIAT, V60, P889, DOI 10.1001/archpsyc.60.9.889; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Hautzinger M, 1994, BECK DEPRESSIONS INV; Herrmann MJ, 2010, WORLD J BIOL PSYCHIA, V11, P457, DOI [10.3109/15622970902977552, 10.1080/15622970902977552]; Herrmann MJ, 2009, PSYCHIAT RES, V169, P144, DOI 10.1016/j.psychres.2008.06.015; Holroyd CB, 2002, NEUROPSYCHOLOGIA, V40, P2116, DOI 10.1016/S0028-3932(02)00052-0; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Huennerkopf R, 2007, NEUROPSYCHOPHARMACOL, V32, P2552, DOI 10.1038/sj.npp.1301383; Jocham G, 2009, J NEUROSCI, V29, P3695, DOI 10.1523/JNEUROSCI.5195-08.2009; Jocham G, 2009, NEUROSCI BIOBEHAV R, V33, P48, DOI 10.1016/j.neubiorev.2008.08.011; Jonkman LM, 2007, BIOL PSYCHOL, V76, P217, DOI 10.1016/j.biopsycho.2007.08.004; Kereszturi E, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-18; Kessler RC, 2005, PSYCHOL MED, V35, P245, DOI 10.1017/S0033291704002892; Klein TA, 2007, SCIENCE, V318, P1642, DOI 10.1126/science.1145044; Kramer UM, 2007, J NEUROSCI, V27, P14190, DOI 10.1523/JNEUROSCI.4229-07.2007; Krause KH, 2000, NEUROSCI LETT, V285, P107, DOI 10.1016/S0304-3940(00)01040-5; Lewis DA, 2001, J COMP NEUROL, V432, P119, DOI 10.1002/cne.1092; Liotti M, 2005, CORTEX, V41, P377, DOI 10.1016/S0010-9452(08)70274-0; MeadorWoodruff JH, 1996, NEUROPSYCHOPHARMACOL, V15, P17, DOI 10.1016/0893-133X(95)00150-C; Michelhaugh SK, 2001, J NEUROCHEM, V79, P1033, DOI 10.1046/j.1471-4159.2001.00647.x; Mill J, 2002, AM J MED GENET, V114, P975, DOI 10.1002/ajmg.b.10948; Miller GM, 2002, MOL PSYCHIATR, V7, P44, DOI 10.1038/sj/mp/4000921; Nieuwenhuis S, 2001, PSYCHOPHYSIOLOGY, V38, P752, DOI 10.1017/S0048577201001111; Oak JN, 2000, EUR J PHARMACOL, V405, P303, DOI 10.1016/S0014-2999(00)00562-8; Okuyama Y, 2000, MOL PSYCHIATR, V5, P64, DOI 10.1038/sj.mp.4000563; Overtoom CCE, 2002, BIOL PSYCHIAT, V51, P668, DOI 10.1016/S0006-3223(01)01290-2; Potts GF, 2006, NEUROSCI LETT, V397, P130, DOI 10.1016/j.neulet.2005.12.003; Rubinstein M, 1997, CELL, V90, P991, DOI 10.1016/S0092-8674(00)80365-7; Schoots O, 2003, PHARMACOGENOMICS J, V3, P343, DOI 10.1038/sj.tpj.6500208; Sesack SR, 1998, J NEUROSCI, V18, P2697; Simpson J, 2010, AM J MED GENET B, V153B, P1228, DOI 10.1002/ajmg.b.31084; Thapar A, 2005, HUM MOL GENET, V14, pR275, DOI 10.1093/hmg/ddi263; Ullsperger M, 2010, NEUROSCI BIOBEHAV R, V34, P649, DOI 10.1016/j.neubiorev.2009.06.009; van de Giessen EM, 2009, J NUCL MED, V50, P45, DOI 10.2967/jnumed.108.053652; van Dyck CH, 2005, J NUCL MED, V46, P745; VanNess SH, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-55; Wiersema JR, 2005, J NEURAL TRANSM, V112, P1417, DOI 10.1007/s00702-005-0276-6; Willemssen R, 2008, J NEURAL TRANSM, V115, P461, DOI 10.1007/s00702-007-0842-1; Zirnheld PJ, 2004, J COGNITIVE NEUROSCI, V16, P1098, DOI 10.1162/0898929041502779	57	18	18	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e28396	10.1371/journal.pone.0028396	http://dx.doi.org/10.1371/journal.pone.0028396			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22162768	Green Published, gold, Green Submitted			2022-12-27	WOS:000298172800034
J	Cope, EK; Goldstein-Daruech, N; Kofonow, JM; Christensen, L; McDermott, B; Monroy, F; Palmer, JN; Chiu, AG; Shirtliff, ME; Cohen, NA; Leid, JG				Cope, Emily K.; Goldstein-Daruech, Natalia; Kofonow, Jennifer M.; Christensen, Lanette; McDermott, Bridget; Monroy, Fernando; Palmer, James N.; Chiu, Alexander G.; Shirtliff, Mark E.; Cohen, Noam A.; Leid, Jeff G.			Regulation of Virulence Gene Expression Resulting from Streptococcus pneumoniae and Nontypeable Haemophilus influenzae Interactions in Chronic Disease	PLOS ONE			English	Article							IN-VIVO; BIOFILM FORMATION; OTITIS-MEDIA; CHINCHILLA MODEL; BACTERIAL; HOST; INFECTION; COLONIZATION; PATHOGENESIS; PNEUMOLYSIN	Chronic rhinosinusitis (CRS) is a common inflammatory disease of the sinonasal cavity mediated, in part, by polymicrobial communities of bacteria. Recent molecular studies have confirmed the importance of Streptococcus pneumoniae and nontypeable Haemophilus influenzae (NTHi) in CRS. Here, we hypothesize that interaction between S. pneumoniae and NTHi mixed-species communities cause a change in bacterial virulence gene expression. We examined CRS as a model human disease to validate these polymicrobial interactions. Clinical strains of S. pneumoniae and NTHi were grown in mono-and co-culture in a standard biofilm assay. Reverse transcriptase real-time PCR (RTqPCR) was used to measure gene expression of key virulence factors. To validate these results, we investigated the presence of the bacterial RNA transcripts in excised human tissue from patients with CRS. Consequences of physical or chemical interactions between microbes were also investigated. Transcription of NTHi type IV pili was only expressed in co-culture in vitro, and expression could be detected ex vivo in diseased tissue. S. pneumoniae pyruvate oxidase was up-regulated in co-culture, while pneumolysin and pneumococcal adherence factor A were down-regulated. These results were confirmed in excised human CRS tissue. Gene expression was differentially regulated by physical contact and secreted factors. Overall, these data suggest that interactions between H. influenzae and S. pneumoniae involve physical and chemical mechanisms that influence virulence gene expression of mixed-species biofilm communities present in chronically diseased human tissue. These results extend previous studies of population-level virulence and provide novel insight into the importance of S. pneumoniae and NTHi in CRS.	[Cope, Emily K.; Christensen, Lanette; McDermott, Bridget; Monroy, Fernando; Leid, Jeff G.] No Arizona Univ, Dept Biol Sci, Flagstaff, AZ 86011 USA; [Goldstein-Daruech, Natalia; Kofonow, Jennifer M.; Palmer, James N.; Chiu, Alexander G.; Cohen, Noam A.] Univ Penn, Dept Otorhinolaryngol Head & Neck Surg, Philadelphia, PA 19104 USA; [Cohen, Noam A.] Univ Penn, Philadelphia Vet Affairs Med Ctr, Surg Serv, Philadelphia, PA 19104 USA; [Shirtliff, Mark E.] Univ Maryland, Sch Dent, Dept Microbial Pathogenesis, Baltimore, MD 21201 USA	Northern Arizona University; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Philadelphia Veterans Affairs Medical Center; University System of Maryland; University of Maryland Baltimore	Cope, EK (corresponding author), No Arizona Univ, Dept Biol Sci, Box 5640, Flagstaff, AZ 86011 USA.	Emily.Cope@nau.edu	Chiu, Alexander G/J-1230-2014; Shirtliff, Mark E/H-2563-2017; Monroy, Francisco/N-2763-2013	Chiu, Alexander G/0000-0002-7592-6575; Shirtliff, Mark E/0000-0002-8913-3445; Monroy, Francisco/0000-0001-6455-3083; Cohen, Noam/0000-0002-9462-3932	Science Foundation Arizona [GRF 0204-08]; Flight Attendants Medical Research Institute [103019]	Science Foundation Arizona; Flight Attendants Medical Research Institute	This work was supported by Science Foundation Arizona GRF 0204-08 (http://www.sfaz.org) and the Flight Attendants Medical Research Institute, Clinical Innovator Award #103019. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdeldaim GMK, 2009, DIAGN MICR INFEC DIS, V64, P366, DOI 10.1016/j.diagmicrobio.2009.03.030; Allegrucci M, 2006, J BACTERIOL, V188, P2325, DOI 10.1128/JB.188.7.2325-2335.2006; Alverdy J, 2000, ANN SURG, V232, P480, DOI 10.1097/00000658-200010000-00003; Battig P, 2008, J BACTERIOL, V190, P1184, DOI 10.1128/JB.01517-07; Bakaletz LO, 2005, INFECT IMMUN, V73, P1635, DOI 10.1128/IAI.73.3.1635-1643.2005; Bishop JL, 2006, TRENDS MOL MED, V12, P3, DOI 10.1016/j.molmed.2005.11.001; Brogden KA, 2005, LANCET, V365, P253, DOI 10.1016/S0140-6736(05)70155-0; Chan J, 2001, Ear Nose Throat J, V80, P143; Cheadle WG, 2003, AM J SURG, V186, p15S, DOI 10.1016/j.amjsurg.2003.10.003; Cheung YB, 2009, PEDIATR INFECT DIS J, V28, P990, DOI 10.1097/INF.0b013e3181a78185; Crook DW, 2006, CLIN INFECT DIS, V42, P460, DOI 10.1086/499248; Ehrlich GD, 2010, FEMS IMMUNOL MED MIC, V59, P269, DOI 10.1111/j.1574-695X.2010.00704.x; Ehrlich GD, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-225; Ehrlich GD, 2005, CLIN ORTHOP RELAT R, P20, DOI 10.1097/01.blo.0000175124.52590.c0; Ehrlich GD, 2002, JAMA-J AM MED ASSOC, V287, P1710, DOI 10.1001/jama.287.13.1710; ELLIS ME, 1984, ARCH DIS CHILD, V59, P848, DOI 10.1136/adc.59.9.848; Fisher MM, 1999, APPL ENVIRON MICROB, V65, P4630; Foreman A, 2009, AM J RHINOL ALLERGY, V23, P556, DOI 10.2500/ajra.2009.23.3413; Gupta R, 2009, MICROB PATHOGENESIS, V47, P101, DOI 10.1016/j.micpath.2009.05.003; Hardy Gail G, 2003, Methods Mol Med, V71, P1; Healy DY, 2008, OTOLARYNG HEAD NECK, V138, P641, DOI 10.1016/j.otohns.2008.02.002; Henriques-Normark B, 2010, EXP CELL RES, V316, P1408, DOI 10.1016/j.yexcr.2010.03.003; Hirst RA, 2008, J INFECT DIS, V197, P744, DOI 10.1086/527322; Holmes AR, 2001, MOL MICROBIOL, V41, P1395, DOI 10.1046/j.1365-2958.2001.02610.x; Hu FZ, 2008, FUTURE MICROBIOL, V3, P31, DOI 10.2217/17460913.3.1.31; Itani KMF, 2003, AM J SURG, V186, p31S, DOI 10.1016/j.amjsurg.2003.10.005; Jenkinson HF, 2005, TRENDS MICROBIOL, V13, P589, DOI 10.1016/j.tim.2005.09.006; Johnson HL, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000348; Jurcisek JA, 2007, MOL MICROBIOL, V65, P1288, DOI 10.1111/j.1365-2958.2007.05864.x; Jurcisek JA, 2007, J BACTERIOL, V189, P3868, DOI 10.1128/JB.01935-06; Kadioglu A, 2002, INFECT IMMUN, V70, P2886, DOI 10.1128/IAI.70.6.2886-2890.2002; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Kennedy BJ, 2000, INFECT IMMUN, V68, P2756, DOI 10.1128/IAI.68.5.2756-2765.2000; Kuramitsu HK, 2007, MICROBIOL MOL BIOL R, V71, P653, DOI 10.1128/MMBR.00024-07; Leid JG, 2005, J IMMUNOL, V175, P7512, DOI 10.4049/jimmunol.175.11.7512; Leid JG, 2009, INFECT IMMUN; LUO GY, 1993, INFECT IMMUN, V61, P830, DOI 10.1128/IAI.61.3.830-835.1993; Mantovani K, 2010, BRAZ J OTORHINOLAR, V76, P548, DOI 10.1590/S1808-86942010000500002; Mason KM, 2003, INFECT IMMUN, V71, P3454, DOI 10.1128/IAI.71.6.3454-3462.2003; Morton DJ, 2007, MICROBES INFECT, V9, P932, DOI 10.1016/j.micinf.2007.03.013; Niederfuhr A, 2009, ARCH OTOLARYNGOL, V135, P131, DOI 10.1001/archoto.2008.531; Novotny LA, 2011, MUCOSAL IMMUNOL, V4, P456, DOI 10.1038/mi.2011.6; Novotny LA, 2009, VACCINE, V28, P279, DOI 10.1016/j.vaccine.2009.08.017; Orihuela CJ, 2004, J INFECT DIS, V190, P1661, DOI 10.1086/424596; Pericone CD, 2000, INFECT IMMUN, V68, P3990, DOI 10.1128/IAI.68.7.3990-3997.2000; Pettigrew MM, 2008, EMERG INFECT DIS, V14, P1584, DOI 10.3201/eid1410.080119; Pracht D, 2005, INFECT IMMUN, V73, P2680, DOI 10.1128/IAI.73.5.2680-2689.2005; PreventionCfDCa, 2007, PNEUM DIS EP PREV VA; Psaltis AJ, 2008, LARYNGOSCOPE, V118, P895, DOI 10.1097/MLG.0b013e31816381d4; Regev-Yochay G, 2007, J BACTERIOL, V189, P6532, DOI 10.1128/JB.00813-07; Regev-Yochay G, 2006, J BACTERIOL, V188, P4996, DOI 10.1128/JB.00317-06; Rogers GB, 2003, J CLIN MICROBIOL, V41, P3548, DOI 10.1128/JCM.41.8.3548-3558.2003; Sanderson AR, 2006, LARYNGOSCOPE, V116, P1121, DOI 10.1097/01.mlg.0000221954.05467.54; Schleimer Robert P, 2009, Proc Am Thorac Soc, V6, P288, DOI 10.1513/pats.200808-088RM; Sjostrom K, 2006, CLIN INFECT DIS, V42, P451, DOI 10.1086/499242; Spellerberg B, 1996, MOL MICROBIOL, V19, P803, DOI 10.1046/j.1365-2958.1996.425954.x; St Geme JW, 2000, VACCINE, V19, pS41, DOI 10.1016/S0264-410X(00)00277-2; Stephenson MF, 2010, J OTOLARYNGOL-HEAD N, V39, P182, DOI 10.2310/7070.2009.090060; Tieu DD, 2009, J ALLERGY CLIN IMMUN, V124, P37, DOI 10.1016/j.jaci.2009.04.045; van der Linden M, 2010, EUR J CLIN MICROBIOL, V29, P749, DOI 10.1007/s10096-010-0945-8; Weimer KED, 2010, J INFECT DIS, V202, P1068, DOI 10.1086/656046; Wu Licheng R, 2005, Surg Infect (Larchmt), V6, P185, DOI 10.1089/sur.2005.6.185	62	34	35	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e28523	10.1371/journal.pone.0028523	http://dx.doi.org/10.1371/journal.pone.0028523			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22162775	Green Published, Green Submitted, gold			2022-12-27	WOS:000298172800045
J	Hussain, A; Moodley, D; Naidoo, S; Esterhuizen, TM				Hussain, Akthar; Moodley, Dhayendre; Naidoo, Sudhindra; Esterhuizen, Tonya M.			Pregnant Women's Access to PMTCT and ART Services in South Africa and Implications for Universal Antiretroviral Treatment	PLOS ONE			English	Article							PRETERM DELIVERY; INCREASED RISK; THERAPY; HIV; OUTCOMES; BIRTH; PREVENTION; INFECTION; DRUGS; TIME	Objectives: We describe pregnant womens' access to PMTCT and HAART services and associated birth outcomes in South Africa. Methods: Women recuperating in postnatal wards of a referral hospital participated in an evaluation during February-May 2010 during which their maternity records were examined to describe their access to VCT, CD4 Counts, dual ART or HAART during pregnancy. Results: Of the 1609 women who participated in this evaluation, 39% (95%CI36.7-41.5%) tested HIV-positive during their pregnancy. Of the HIV-positive women 2.9% did not have a CD4 count done and an additional 31.3% did not receive their CD4 results. The majority (96.8%) of the HIV-positive women commenced dual ART at their first antenatal visit independent of their CD4 result. During February-May 2010, 48.0% of the women who had a CD4 result were eligible for HAART (CD4<200 cells/mm(3)) and 29.1% of these initiated HAART during pregnancy. Under the current South African PMTCT guidelines 71.1% (95%CI66.4-75.4%) of HIV positive pregnant women could be eligible for HAART (CD4<350 cells/mm(3)). There were significantly more preterm births among HIV-positive women (p = 0.01) and women who received HAART were no more at risk of preterm deliveries (AOR 0.73; 95%CI0.39-1.36; p = 0.2) as compared to women who received dual ART. Nine (2.4%; 95%CI1.1-4.5%) HIV exposed infants were confirmed HIV infected at birth. The in-utero transmission rate was highest among women who required HAART but did not initiate treatment (8.5%) compared to 2.7% and 0.4% among women who received HAART and women who were not eligible for HAART and received PMTCT prophylaxis respectively. Conclusion: In this urban South African community the antenatal HIV prevalence remains high (39%) and timeous access to CD4 results during pregnancy is limited. Under the current South African guidelines, and assuming that access to CD4 results has improved, more than 70% of HIV-positive pregnant women in this community would be requiring HAART.	[Hussain, Akthar] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Dept Family Med, Durban, Kwazulu Natal, South Africa; [Moodley, Dhayendre; Naidoo, Sudhindra] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Womens Hlth & HIV Res Unit, Dept Obstet & Gynaecol, Durban, Kwazulu Natal, South Africa; [Esterhuizen, Tonya M.] Univ KwaZulu Natal, Coll Hlth Sci, Dept Res Eth & Med Law, Programme Biostat, Durban, Kwazulu Natal, South Africa	University of Kwazulu Natal; University of Kwazulu Natal; University of Kwazulu Natal	Hussain, A (corresponding author), Univ KwaZulu Natal, Nelson R Mandela Sch Med, Dept Family Med, Durban, Kwazulu Natal, South Africa.	maleeha@mweb.co.za	Moodley, Dhayendre/U-6802-2019					[Anonymous], SAV MOTH 2005 2007 4; Carter RJ, 2010, J ACQUIR IMMUNE DEFI; Chasela CS, 2010, NEW ENGL J MED, V362, P2271, DOI 10.1056/NEJMoa0911486; Cotter AM, 2006, J INFECT DIS, V193, P1195, DOI 10.1086/503045; Horwood C, 2010, TROP MED INT HLTH; Joint United Nations Program on HIV/AIDS (UNAIDS) World Health Organization (WHO), 2010, REP GLOB AIDS EP; Kalish LA, 1997, J INFECT DIS, V175, P712, DOI 10.1093/infdis/175.3.712; Kuhn L, 2010, AIDS, V24, P1374, DOI 10.1097/QAD.0b013e3283394f5b; Meda N, 2011, LANCET INFECT DIS, V11, P171, DOI 10.1016/S1473-3099(10)70288-7; Meyers T, 2007, J INFECT DIS, V196, pS474, DOI 10.1086/521116; Nakakeeto ON, 2009, AIDS, V23, P987, DOI 10.1097/QAD.0b013e32832a17e9; National Department of Health, 2010, POL GUID IMPL PMTCT; National Department of Health, 2008, POL GUID IMPL PMTCT; Patel K, 2010, J INFECT DIS, V201, P1035, DOI 10.1086/651232; Shapiro RL, 2010, NEW ENGL J MED, V362, P2282, DOI 10.1056/NEJMoa0907736; Sprague C, 2011, AIDS RES THER, V8, DOI 10.1186/1742-6405-8-10; Taha TE, 2011, AIDS; Thorne C, 2004, AIDS, V18, P2337, DOI 10.1097/00002030-200411190-00019; Townsend CL, 2010, BJOG-INT J OBSTET GY, V117, P1399, DOI 10.1111/j.1471-0528.2010.02689.x; Tsague L, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-753; Tuomala RK, 2005, JAIDS-J ACQ IMM DEF, V38, P449, DOI 10.1097/01.qai.0000139398.38236.4d; van der Merwe K, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-42; *WHO, 2009, RAP ADV US ANT DRUGS; Zolfo M, 2010, JAIDS-J ACQ IMM DEF, V55, P287, DOI 10.1097/QAI.0b013e3181eef3da	24	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e27907	10.1371/journal.pone.0027907	http://dx.doi.org/10.1371/journal.pone.0027907			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22162993	Green Submitted, Green Published, gold			2022-12-27	WOS:000298172800007
J	van der Veen, S; Abee, T				van der Veen, Stijn; Abee, Tjakko			Generation of Variants in Listeria monocytogenes Continuous-Flow Biofilms Is Dependent on Radical-Induced DNA Damage and RecA-Mediated Repair	PLOS ONE			English	Article							SOS RESPONSE; DISINFECTANT RESISTANCE; INDUCED MUTAGENESIS; EGD-E; OXYGEN; PATHOGENESIS; ENVIRONMENT; COMMUNITIES; SUPEROXIDE; ATTACHMENT	The food-borne pathogen Listeria monocytogenes is a Gram-positive microaerophilic facultative anaerobic rod and the causative agent of the devastating disease listeriosis. L. monocytogenes is able to form biofilms in the food processing environment. Since biofilms are generally hard to eradicate, they can function as a source for food contamination. In several occasions biofilms have been identified as a source for genetic variability, which potentially can result in adaptation of strains to food processing or clinical conditions. However, nothing is known about mutagenesis in L. monocytogenes biofilms and the possible mechanisms involved. In this study, we showed that the generation of genetic variants was specifically induced in continuous-flow biofilms of L. monocytogenes, but not in static biofilms. Using specific dyes and radical inhibitors, we showed that the formation of superoxide and hydroxyl radicals was induced in continuous-flow biofilms, which was accompanied with in an increase in DNA damage. Promoter reporter studies showed that recA, which is an important component in DNA repair and the activator of the SOS response, is activated in continuous-flow biofilms and that activation was dependent on radical-induced DNA damage. Furthermore, continuous-flow biofilm experiments using an in-frame recA deletion mutant verified that RecA is required for induced generation of genetic variants. Therefore, we can conclude that generation of genetic variants in L. monocytogenes continuous-flow biofilms results from radical-induced DNA damage and RecA-mediated mutagenic repair of the damaged DNA.	[van der Veen, Stijn; Abee, Tjakko] TIFN, Wageningen, Netherlands; [van der Veen, Stijn; Abee, Tjakko] Univ Wageningen & Res Ctr, Food Microbiol Lab, Wageningen, Netherlands	Top Institute Food & Nutrition; Wageningen University & Research	van der Veen, S (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	Tjakko.Abee@wur.nl		van der Veen, Stijn/0000-0002-8176-391X				Allegrucci M, 2007, J BACTERIOL, V189, P2030, DOI 10.1128/JB.01369-06; Baharoglu Z, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001165; Banas JA, 2007, APPL ENVIRON MICROB, V73, P357, DOI 10.1128/AEM.02014-06; BOISIVON A, 1990, EUR J CLIN MICROBIOL, V9, P206, DOI 10.1007/BF01963839; Boles BR, 2008, P NATL ACAD SCI USA, V105, P12503, DOI 10.1073/pnas.0801499105; Boles BR, 2004, P NATL ACAD SCI USA, V101, P16630, DOI 10.1073/pnas.0407460101; Buchrieser C, 2003, FEMS IMMUNOL MED MIC, V35, P207, DOI 10.1016/S0928-8244(02)00448-0; Camejo A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000449; Chatterjee SS, 2006, INFECT IMMUN, V74, P1323, DOI 10.1128/IAI.74.2.1323-1338.2006; Cirz RT, 2005, PLOS BIOL, V3, P1024, DOI 10.1371/journal.pbio.0030176; Conter M, 2009, INT J FOOD MICROBIOL, V128, P497, DOI 10.1016/j.ijfoodmicro.2008.10.018; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; COSTERTON JW, 1987, ANNU REV MICROBIOL, V41, P435, DOI 10.1146/annurev.mi.41.100187.002251; Cox MM, 2007, CRIT REV BIOCHEM MOL, V42, P41, DOI 10.1080/10409230701260258; Dalton CB, 1997, NEW ENGL J MED, V336, P100, DOI 10.1056/NEJM199701093360204; Dwyer DJ, 2009, CURR OPIN MICROBIOL, V12, P482, DOI 10.1016/j.mib.2009.06.018; Foster PL, 2007, CRIT REV BIOCHEM MOL, V42, P373, DOI 10.1080/10409230701648494; Glaser P, 2001, SCIENCE, V294, P849; Guerin E, 2009, SCIENCE, V324, P1034, DOI 10.1126/science.1172914; IMLAY JA, 1988, SCIENCE, V240, P1302, DOI 10.1126/science.3287616; Imlay JA, 2006, MOL MICROBIOL, V59, P1073, DOI 10.1111/j.1365-2958.2006.05028.x; Imlay JA, 2008, ANNU REV BIOCHEM, V77, P755, DOI 10.1146/annurev.biochem.77.061606.161055; Jeong KC, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-181; Justice SS, 2006, P NATL ACAD SCI USA, V103, P19884, DOI 10.1073/pnas.0606329104; Kalmokoff ML, 2001, J APPL MICROBIOL, V91, P725, DOI 10.1046/j.1365-2672.2001.01419.x; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Kohanski MA, 2010, MOL CELL, V37, P311, DOI 10.1016/j.molcel.2010.01.003; Krasovec R, 2003, MED HYPOTHESES, V60, P484, DOI 10.1016/S0306-9877(02)00394-8; Lewis K, 2001, ANTIMICROB AGENTS CH, V45, P999, DOI 10.1128/AAC.45.4.999-1007.2001; Li BR, 2010, MICROBES INFECT, V12, P662, DOI 10.1016/j.micinf.2010.04.009; Ligeza A, 1998, BBA-BIOENERGETICS, V1365, P453, DOI 10.1016/S0005-2728(98)00098-X; Lungu B, 2010, FOODBORNE PATHOG DIS, DOI 10.1089=fpd.2010.0718; Lusetti SL, 2002, ANNU REV BIOCHEM, V71, P71, DOI 10.1146/annurev.biochem.71.083101.133940; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Mols M, 2010, ENVIRON MICROBIOL, V12, P873, DOI 10.1111/j.1462-2920.2009.02132.x; Mols M, 2009, INT J FOOD MICROBIOL, V135, P303, DOI 10.1016/j.ijfoodmicro.2009.09.002; Morse R, 1999, J CLIN MICROBIOL, V37, P2913, DOI 10.1128/JCM.37.9.2913-2919.1999; Morvan A, 2010, ANTIMICROB AGENTS CH, V54, P2728, DOI 10.1128/AAC.01557-09; Nuryastuti T, 2008, ANTON LEEUW INT J G, V94, P317, DOI 10.1007/s10482-008-9249-8; PRITCHARD TJ, 1995, INT J FOOD MICROBIOL, V26, P375, DOI 10.1016/0168-1605(94)00130-X; Rieu A, 2008, APPL ENVIRON MICROB, V74, P4491, DOI 10.1128/AEM.00255-08; Robinson KM, 2006, P NATL ACAD SCI USA, V103, P15038, DOI 10.1073/pnas.0601945103; Rodriguez A, 2008, J FOOD PROTECT, V71, P170, DOI 10.4315/0362-028X-71.1.170; Salmelin C, 2002, MUTAT RES-FUND MOL M, V500, P125, DOI 10.1016/S0027-5107(02)00004-0; Setsukinai K, 2003, J BIOL CHEM, V278, P3170, DOI 10.1074/jbc.M209264200; Silva IMM, 2003, INT J FOOD MICROBIOL, V81, P241, DOI 10.1016/S0168-1605(02)00223-4; Spooner R, 2011, INT J MOL SCI, V12, P334, DOI 10.3390/ijms12010334; Tompkin RB, 2002, J FOOD PROTECT, V65, P709, DOI 10.4315/0362-028X-65.4.709; van der Veen S, 2010, CURR OPIN BIOTECH, DOI [10.1016/j.copbio.2010.1011.1012, DOI 10.1016/J.COPBIO.2010.1011.1012]; van der Veen S, 2011, INT J MED MICROBIOL, V301, P334, DOI 10.1016/j.ijmm.2010.11.006; van der Veen S, 2010, MICROBIOL-SGM, V156, P3782, DOI 10.1099/mic.0.043000-0; van der Veen S, 2010, APPL ENVIRON MICROB, V76, P7854, DOI 10.1128/AEM.01519-10; van der Veen S, 2010, MICROBIOL-SGM, V156, P374, DOI 10.1099/mic.0.035196-0; van der Veen S, 2010, APPL ENVIRON MICROB, V76, P1992, DOI 10.1128/AEM.02680-09; Varhimo E, 2007, J BACTERIOL, V189, P5210, DOI 10.1128/JB.00473-07; Vazquez-Boland JA, 2001, CLIN MICROBIOL REV, V14, P584, DOI 10.1128/CMR.14.3.584-640.2001; Waite RD, 2001, MOL MICROBIOL, V42, P1223, DOI 10.1046/j.1365-2958.2001.02674.x	57	18	19	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e28590	10.1371/journal.pone.0028590	http://dx.doi.org/10.1371/journal.pone.0028590			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22163039	gold, Green Published, Green Submitted			2022-12-27	WOS:000298172800050
J	Cai, XW; Gaudet, JJ; Mangan, JK; Chen, MJ; De Obaldia, ME; Oo, Z; Ernst, P; Speck, NA				Cai, Xiongwei; Gaudet, Justin J.; Mangan, James K.; Chen, Michael J.; De Obaldia, Maria Elena; Oo, Zaw; Ernst, Patricia; Speck, Nancy A.			Runx1 Loss Minimally Impacts Long-Term Hematopoietic Stem Cells	PLOS ONE			English	Article							CHRONIC MYELOMONOCYTIC LEUKEMIA; X-RAY-SENSITIVITY; CBF-BETA-SMMHC; BONE-MARROW; STEM/PROGENITOR CELLS; PROGENITOR CELLS; POINT MUTATIONS; SELF-RENEWAL; PROLIFERATION; CYCLE	RUNX1 encodes a DNA binding subunit of the core-binding transcription factors and is frequently mutated in acute leukemia, therapy-related leukemia, myelodysplastic syndrome, and chronic myelomonocytic leukemia. Mutations in RUNX1 are thought to confer upon hematopoietic stem cells (HSCs) a pre-leukemic state, but the fundamental properties of Runx1 deficient pre-leukemic HSCs are not well defined. Here we show that Runx1 deficiency decreases both apoptosis and proliferation, but only minimally impacts the frequency of long term repopulating HSCs (LT-HSCs). It has been variously reported that Runx1 loss increases LT-HSC numbers, decreases LT-HSC numbers, or causes age-related HSC exhaustion. We attempt to resolve these discrepancies by showing that Runx1 deficiency alters the expression of several key HSC markers, and that the number of functional LT-HSCs varies depending on the criteria used to score them. Finally, we identify genes and pathways, including the cell cycle and p53 pathways that are dysregulated in Runx1 deficient HSCs.	[Cai, Xiongwei; Mangan, James K.; Chen, Michael J.; De Obaldia, Maria Elena; Oo, Zaw; Speck, Nancy A.] Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Cai, Xiongwei; Mangan, James K.; Chen, Michael J.; De Obaldia, Maria Elena; Oo, Zaw; Speck, Nancy A.] Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Gaudet, Justin J.] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Biochem, Hanover, NH 03756 USA; [Ernst, Patricia] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Genet, Hanover, NH 03756 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Dartmouth College; Dartmouth College	Cai, XW (corresponding author), Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA.	patricia.ernst@dartmouth.edu; nancyas@exchange.upenn.edu	Cai, Xiongwei/G-3169-2015	Ernst, Patricia/0000-0001-7638-2939; De Obaldia, Maria/0000-0003-2488-3672	Norris Cotton Cancer Center [CA23108]; National Institutes of Health [R01CA149976, T32AR07576]; Abramson Family Cancer Research Institute; NATIONAL CANCER INSTITUTE [T32CA009615, P30CA023108, R01CA149976] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007576] Funding Source: NIH RePORTER	Norris Cotton Cancer Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Abramson Family Cancer Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The microarray core was supported in part by the Core Grant of the Norris Cotton Cancer Center (CA23108). This work was supported by National Institutes of Health R01CA149976 and T32AR07576, and funds from the Abramson Family Cancer Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson K, 2011, NATURE, V469, P356, DOI 10.1038/nature09650; Bernardin F, 2002, ONCOGENE, V21, P3247, DOI 10.1038/sj.onc.1205447; Bloomfield CD, 1998, CANCER RES, V58, P4173; Bowie MB, 2007, P NATL ACAD SCI USA, V104, P5878, DOI 10.1073/pnas.0700460104; Bowie MB, 2006, J CLIN INVEST, V116, P2808, DOI 10.1172/JCI28310; Burel SA, 2001, MOL CELL BIOL, V22, P144; Cao WS, 1997, ONCOGENE, V15, P1315, DOI 10.1038/sj.onc.1201305; Chen MJ, 2009, NATURE, V457, P887, DOI 10.1038/nature07619; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; Chuikov S, 2010, NAT CELL BIOL, V12, P999, DOI 10.1038/ncb2101; D'Costa J, 2005, LEUKEMIA, V19, P921, DOI 10.1038/sj.leu.2403755; Du Y, 2005, BLOOD, V106, P3932, DOI 10.1182/blood-2005-03-1113; Foudi A, 2009, NAT BIOTECHNOL, V27, P84, DOI 10.1038/nbt.1517; Friedman AD, 2009, J CELL PHYSIOL, V219, P520, DOI 10.1002/jcp.21738; Gaidzik VI, 2011, J CLIN ONCOL, V29, P1364, DOI 10.1200/JCO.2010.30.7926; Growney JD, 2005, BLOOD, V106, P494, DOI 10.1182/blood-2004-08-3280; Gupta R, 2007, SCIENCE, V316, P590, DOI 10.1126/science.1136031; Harada H, 2003, BLOOD, V101, P673, DOI 10.1182/blood-2002-04-1010; HARRISON DE, 1993, EXP HEMATOL, V21, P206; Hock H, 2004, NATURE, V431, P1002, DOI 10.1038/nature02994; Hong DL, 2008, SCIENCE, V319, P336, DOI 10.1126/science.1150648; Ichikawa M, 2004, NAT MED, V10, P299, DOI 10.1038/nm997; Ichikawa M, 2008, J IMMUNOL, V180, P4402, DOI 10.4049/jimmunol.180.7.4402; Jacob B, 2010, BLOOD, V115, P1610, DOI 10.1182/blood-2009-07-232249; Johnson SM, 2010, J CLIN INVEST, V120, P2528, DOI 10.1172/JCI41402; Jude CD, 2008, CELL CYCLE, V7, P586, DOI 10.4161/cc.7.5.5549; Jude CD, 2007, CELL STEM CELL, V1, P324, DOI 10.1016/j.stem.2007.05.019; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kohlmann A, 2010, J CLIN ONCOL, V28, P3858, DOI 10.1200/JCO.2009.27.1361; Kubota Y, 2009, BLOOD, V114, P4383, DOI 10.1182/blood-2009-07-230292; Kuo MC, 2009, LEUKEMIA, V23, P1426, DOI 10.1038/leu.2009.48; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Linggi B, 2002, NAT MED, V8, P743, DOI 10.1038/nm726; Liu Y, 2009, CELL STEM CELL, V4, P37, DOI 10.1016/j.stem.2008.11.006; Lou JR, 2000, ONCOGENE, V19, P2695, DOI 10.1038/sj.onc.1203588; Motoda L, 2007, STEM CELLS, V25, P2976, DOI 10.1634/stemcells.2007-0061; Nimmo R, 2005, DEVELOPMENT, V132, P5043, DOI 10.1242/dev.02102; NISHI N, 1995, STEM CELLS, V13, P517, DOI 10.1002/stem.5530130509; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Oliveros J.C., 2007, VENNY INTERACTIVE TO; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Osato M, 1999, BLOOD, V93, P1817, DOI 10.1182/blood.V93.6.1817.406k36_1817_1824; Osorio KM, 2008, DEVELOPMENT, V135, P1059, DOI 10.1242/dev.012799; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Qian H, 2007, CELL STEM CELL, V1, P671, DOI 10.1016/j.stem.2007.10.008; Robertson AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003770; Schindler JW, 2009, CELL STEM CELL, V5, P43, DOI 10.1016/j.stem.2009.04.019; Schnittger S, 2011, BLOOD, V117, P2348, DOI 10.1182/blood-2009-11-255976; SINCLAIR WK, 1966, RADIAT RES, V29, P450, DOI 10.2307/3572025; Stadtfeld M, 2005, DEVELOPMENT, V132, P203, DOI 10.1242/dev.01558; Strom DK, 2000, J BIOL CHEM, V275, P3438, DOI 10.1074/jbc.275.5.3438; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tang JL, 2009, BLOOD, V114, P5352, DOI 10.1182/blood-2009-05-223784; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; TERASIMA T, 1963, SCIENCE, V140, P490, DOI 10.1126/science.140.3566.490; Theriault FM, 2005, J NEUROSCI, V25, P2050, DOI 10.1523/JNEUROSCI.5108-04.2005; Thomas T, 2006, GENE DEV, V20, P1175, DOI 10.1101/gad.1382606; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Tsuzuki S, 2007, PLOS MED, V4, P880, DOI 10.1371/journal.pmed.0040172; Wang Q, 1996, P NATL ACAD SCI USA, V93, P3444, DOI 10.1073/pnas.93.8.3444; Wilson NK, 2010, CELL STEM CELL, V7, P532, DOI 10.1016/j.stem.2010.07.016; Wolyniec K, 2009, ONCOGENE, V28, P2502, DOI 10.1038/onc.2009.101; Wotton SF, 2004, ONCOGENE, V23, P5476, DOI 10.1038/sj.onc.1207729; Yang LP, 2005, BLOOD, V105, P2717, DOI 10.1182/blood-2004-06-2159; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Zeng H, 2004, EMBO J, V23, P4116, DOI 10.1038/sj.emboj.7600419; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747; Zharlyganova D, 2008, J RADIAT RES, V49, P549, DOI 10.1269/jrr.08040	68	53	54	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2011	6	12							e28430	10.1371/journal.pone.0028430	http://dx.doi.org/10.1371/journal.pone.0028430			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MQ	22145044	Green Published, gold, Green Submitted			2022-12-27	WOS:000298168900027
J	Capparelli, R; Nocerino, N; Medaglia, C; Blaiotta, G; Bonelli, P; Iannelli, D				Capparelli, Rosanna; Nocerino, Nunzia; Medaglia, Chiara; Blaiotta, Giuseppe; Bonelli, Patrizia; Iannelli, Domenico			The Staphylococcus aureus Peptidoglycan Protects Mice against the Pathogen and Eradicates Experimentally Induced Infection	PLOS ONE			English	Article							POLYMORPHISM; IDENTIFICATION; ASSOCIATION; ANTIBODIES; STRAINS; ACID; GENE; PCR	Staphylococcus aureus, in spite of antibiotics, is still a major human pathogen causing a wide range of infections. The present study describes the new vaccine A170PG, a peptidoglycan-based vaccine. In a mouse model of infection, A170PG protects mice against a lethal dose of S. aureus. Protection lasts at least 40 weeks and correlates with increased survival and reduced colonization. Protection extends into drug-resistant (MRSA or VISA) and genetically diverse clinical strains. The vaccine is effective when administered - in a single dose and without adjuvant - by the intramuscular, intravenous or the aerosol routes and induces active as well as passive immunization. Of note, A170PG also displays therapeutic activity, eradicating staphylococci, even when infection is systemic. Sustained antibacterial activity and induction of a strong and rapid anti-inflammatory response are the mechanisms conferring therapeutic efficacy to A170PG.	[Capparelli, Rosanna] Univ Naples Federico II, Fac Biotechnol, Naples, Italy; [Nocerino, Nunzia; Medaglia, Chiara; Blaiotta, Giuseppe; Iannelli, Domenico] Univ Naples Federico II, Fac Agr, Naples, Italy; [Bonelli, Patrizia] Fdn G Pascale, Ist Nazl & Tumori, Naples, Italy	University of Naples Federico II; University of Naples Federico II; IRCCS Fondazione Pascale	Capparelli, R (corresponding author), Univ Naples Federico II, Fac Biotechnol, Naples, Italy.	iannelli@unina.it	Bonelli, Patrizia/AAA-5106-2020; Capparelli, Rosanna/Q-3144-2017	Bonelli, Patrizia/0000-0002-0916-4015; Capparelli, Rosanna/0000-0001-8614-6251; BLAIOTTA, Giuseppe/0000-0002-2174-8259				Blaiotta G, 2004, J APPL MICROBIOL, V97, P719, DOI 10.1111/j.1365-2672.2004.02349.x; Blaiotta G, 2003, SYST APPL MICROBIOL, V26, P423, DOI 10.1078/072320203322497455; Blaiotta G, 2001, J DAIRY RES, V68, P139, DOI 10.1017/S0022029900004672; Blaiotta G, 2006, APPL ENVIRON MICROB, V72, P6117, DOI 10.1128/AEM.00773-06; Boneca IG, 2005, CURR OPIN MICROBIOL, V8, P46, DOI 10.1016/j.mib.2004.12.008; Capparelli R, 2009, J INFECT DIS, V201, P52; Dziarski R, 2005, INFECT IMMUN, V73, P5212, DOI 10.1128/IAI.73.8.5212-5216.2005; Fournier B, 2005, CLIN MICROBIOL REV, V18, P521, DOI 10.1128/CMR.18.3.521-540.2005; Francius G, 2008, J BACTERIOL, V190, P7904, DOI 10.1128/JB.01116-08; Gantner BN, 2007, NATURE, V447, P916, DOI 10.1038/447916a; GODING JW, 1978, J IMMUNOL METHODS, V20, P241, DOI 10.1016/0022-1759(78)90259-4; Goodner K, 1935, J EXP MED, V62, P359, DOI 10.1084/jem.62.3.359; Graham PL, 2006, ANN INTERN MED, V144, P318, DOI 10.7326/0003-4819-144-5-200603070-00006; Holtfreter S, 2010, INT J MED MICROBIOL, V300, P176, DOI 10.1016/j.ijmm.2009.10.002; KOWALSKI JJ, 1971, INFECT IMMUN, V4, P205, DOI 10.1128/IAI.4.3.205-211.1971; Liu GY, 2009, PEDIATR RES, V65, p71R, DOI 10.1203/PDR.0b013e31819dc44d; Lorenz E, 2000, INFECT IMMUN, V68, P6398, DOI 10.1128/IAI.68.11.6398-6401.2000; Lowy FD, 2003, J CLIN INVEST, V111, P1265, DOI 10.1172/JC1200318535; MARKS MI, 1990, INFECTION, V18, P53, DOI 10.1007/BF01644186; Mellmann A, 2006, PLOS MED, V3, P348, DOI 10.1371/journal.pmed.0030033; Moore CE, 2004, CLIN DIAGN LAB IMMUN, V11, P1194, DOI 10.1128/CDLI.11.6.1194-1197.2004; Muller-Ansett M, 2010, PLOS ONE, V5, P1; Nau GJ, 2002, P NATL ACAD SCI USA, V99, P1503, DOI 10.1073/pnas.022649799; Peschel A, 1999, J BIOL CHEM, V274, P8405, DOI 10.1074/jbc.274.13.8405; PETERSON PK, 1978, J CLIN INVEST, V61, P597, DOI 10.1172/JCI108971; Schaffer AC, 2008, INT J ANTIMICROB AG, V32, pS71, DOI 10.1016/j.ijantimicag.2008.06.009; Verdier I, 2007, J CLIN MICROBIOL, V45, P725, DOI 10.1128/JCM.01572-06; von Kockritz-Blickwede M, 2008, AM J PATHOL, V173, P1657, DOI 10.2353/ajpath.2008.080337; Wardenburg JB, 2008, J EXP MED, V205, P287, DOI 10.1084/jem.20072208; WERGELAND HI, 1989, J CLIN MICROBIOL, V27, P1286, DOI 10.1128/JCM.27.6.1286-1291.1989; WERGELAND HI, 1987, J CLIN MICROBIOL, V25, P540, DOI 10.1128/JCM.25.3.540-545.1987	31	20	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2011	6	12							e28377	10.1371/journal.pone.0028377	http://dx.doi.org/10.1371/journal.pone.0028377			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MQ	22145040	Green Published, gold, Green Submitted			2022-12-27	WOS:000298168900023
J	Chavada, R; Kok, J; van Hal, S; Chen, SCA				Chavada, Ruchir; Kok, Jen; van Hal, Sebastiaan; Chen, Sharon C-A.			Seeking Clarity within Cloudy Effluents: Differentiating Fungal from Bacterial Peritonitis in Peritoneal Dialysis Patients	PLOS ONE			English	Article							PROPHYLAXIS; EXPERIENCE; RISK	Background: Fungal peritonitis is a serious complication of peritoneal dialysis (PD) therapy with the majority of patients ceasing PD permanently. The aims of this study were to identify risk factors and clinical associations that may discriminate between fungal from bacterial peritonitis. Methods: We retrospectively identified episodes of fungal peritonitis from 2001-2010 in PD patients at Liverpool and Westmead Hospitals (Australia). Fungal peritonitis cases were matched in a 1: 2 ratio with patients with bacterial peritonitis from each institution's dialysis registry, occurring closest in time to the fungal episode. Patient demographic, clinical and outcome data were obtained from the medical records. Results: Thirty-nine episodes of fungal peritonitis (rate of 0.02 episodes per patient-year of dialysis) were matched with 78 episodes of bacterial peritonitis. Candida species were the commonest pathogens (35/39; 90% episodes) with Candida albicans (37%), Candida parapsilosis (32%) and Candida glabrata (13%) the most frequently isolated species. Compared to bacterial peritonitis, fungal peritonitis patients had received PD for significantly longer (1133 vs. 775 catheter-days; p = 0.016), were more likely to have had previous episodes of bacterial peritonitis (51% vs. 10%; p = 0.01), and to have received prior antibacterial therapy (51% vs. 10%; p = 0.01). Patients with fungal peritonitis were less likely to have fever and abdominal pain on presentation, but had higher rates of PD catheter removal (79% vs. 22%; p < 0.005), and permanent transfer to haemodialysis (87% vs. 24%; p < 0.005). Hospital length of stay was significantly longer in patients with fungal peritonitis (26.1 days vs. 12.6 days; p = 0.017), but the all-cause 30-day mortality rate was similar in both groups. Fluconazole was a suitable empiric antifungal agent; with no Candida resistance detected. Conclusion: Prompt recognition of clinical risk factors, initiation of antifungal therapy and removal of PD catheters are key considerations in optimising outcomes.	[Chavada, Ruchir; van Hal, Sebastiaan] Liverpool Hosp, Sydney SW Pathol Serv, Dept Microbiol & Infect Dis, Liverpool, Merseyside, England; [Kok, Jen; Chen, Sharon C-A.] Westmead Hosp, Inst Clin Pathol & Med Res, Ctr Infect Dis & Microbiol Lab Serv, Westmead, NSW 2145, Australia	University of Sydney	Chavada, R (corresponding author), Liverpool Hosp, Sydney SW Pathol Serv, Dept Microbiol & Infect Dis, Liverpool, Merseyside, England.	sharon.chen@swahs.health.nsw.gov.au		van Hal, Sebastiaan/0000-0001-5852-4155				[Anonymous], 2010, 33 AUSTR NZ DIAL TRA; Bren A, 1998, EUR J CLIN MICROBIOL, V17, P839, DOI 10.1007/s100960050203; Chang TI, 2011, PERITON DIALYSIS INT, V31, P60, DOI 10.3747/pdi.2009.00057; Chen Chih-Ming, 2004, Journal of Microbiology Immunology and Infection, V37, P115; CLSI, 2010, M27A3 CLSI; Gandhi B. V., 2005, Journal of Postgraduate Medicine, V51, P30; Kestenbaum B, 2005, J AM SOC NEPHROL, V16, P520, DOI 10.1681/ASN.2004070602; Li PKT, 2010, PERITON DIALYSIS INT, V30, P393, DOI 10.3747/pdi.2010.00049; Matuszkiewicz-Rowinska J, 2009, PERITON DIALYSIS INT, V29, pS161; Miles R, 2009, KIDNEY INT, V76, P622, DOI 10.1038/ki.2009.202; Mohanram A, 2004, KIDNEY INT, V66, P1131, DOI 10.1111/j.1523-1755.2004.00863.x; Mujais S, 2006, KIDNEY INT, V70, pS55, DOI 10.1038/sj.ki.5001916; Oygar DD, 2009, RENAL FAILURE, V31, P25, DOI 10.1080/08860220802546446; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Prasad N, 2005, PERITON DIALYSIS INT, V25, P207; Ram R, 2008, NEPHRON CLIN PRACT, V110, pC207, DOI 10.1159/000167867; Restrepo C, 2010, PERITON DIALYSIS INT, V30, P619, DOI 10.3747/pdi.2008.00189; Troidle L, 2003, SEMIN DIALYSIS, V16, P428, DOI 10.1046/j.1525-139X.2003.16095.x; US Renal Data System, 2010, USRDS 2010 ANN DAT R; Wang AYM, 2000, AM J KIDNEY DIS, V36, P1183, DOI 10.1053/ajkd.2000.19833; Wong PN, 2008, PERITON DIALYSIS INT, V28, P155; Wong PN, 2007, PERITON DIALYSIS INT, V27, P531	22	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2011	6	12							e28247	10.1371/journal.pone.0028247	http://dx.doi.org/10.1371/journal.pone.0028247			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MQ	22145033	Green Published, Green Submitted, gold			2022-12-27	WOS:000298168900016
J	Dudok, JJ; Groffen, AJA; Toonen, RFT; Verhage, M				Dudok, Jacobus J.; Groffen, Alexander J. A.; Toonen, Ruud F. T.; Verhage, Matthijs			Deletion of Munc18-1 in 5-HT Neurons Results in Rapid Degeneration of the 5-HT System and Early Postnatal Lethality	PLOS ONE			English	Article							SEROTONIN NEURONS; REGULATED SECRETION; BRAIN-SEROTONIN; KNOCKOUT MICE; ABSENCE; INNERVATION	The serotonin (5-HT) system densely innervates many brain areas and is important for proper brain development. To specifically ablate the 5-HT system we generated mutant mice carrying a floxed Munc18-1 gene and Cre recombinase driven by the 5-HT-specific serotonin reuptake transporter (SERT) promoter. The majority of mutant mice died within a few days after birth. Immunohistochemical analysis of brains of these mice showed that initially 5-HT neurons are formed and the cortex is innervated with 5-HT projections. From embryonic day 16 onwards, however, 5-HT neurons started to degenerate and at postnatal day 2 hardly any 5-HT projections were present in the cortex. The 5-HT system of mice heterozygous for the floxed Munc18-1 allele was indistinguishable from control mice. These data show that deletion of Munc18-1 in 5-HT neurons results in rapid degeneration of the 5-HT system and suggests that the 5-HT system is important for postnatal survival.	[Dudok, Jacobus J.; Groffen, Alexander J. A.; Toonen, Ruud F. T.; Verhage, Matthijs] Vrije Univ Amsterdam, Dept Funct Genom, CNCR, Amsterdam, Netherlands	Vrije Universiteit Amsterdam	Dudok, JJ (corresponding author), Netherlands Inst Neurosci, Dept Neuromed Genet, Amsterdam, Netherlands.	matthijs.verhage@cncr.vu.nl	Groffen, A.J.A./C-1118-2009	Groffen, A.J.A./0000-0003-0046-4027; Dudok, Jacobus/0000-0002-7407-2491; Toonen, Ruud/0000-0002-9900-4233; verhage, matthijs/0000-0002-6085-7503	Dutch Organization for Scientific Research (Zon-MW Pionier) [MW-PIO900-01-001]	Dutch Organization for Scientific Research (Zon-MW Pionier)	This work was supported by the Dutch Organization for Scientific Research (Zon-MW Pionier MW-PIO900-01-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alenina N, 2009, P NATL ACAD SCI USA, V106, P10332, DOI 10.1073/pnas.0810793106; BENNETTCLARKE CA, 1995, BRAIN RES, V702, P255, DOI 10.1016/0006-8993(95)00867-5; Bunin MA, 1998, J NEUROSCI, V18, P4854; Cote F, 2007, P NATL ACAD SCI USA, V104, P329, DOI 10.1073/pnas.0606722104; Donovan SL, 2002, J NEUROSCI, V22, P3543; Gutknecht L, 2008, J NEURAL TRANSM, V115, P1127, DOI 10.1007/s00702-008-0096-6; Heeroma JH, 2004, EUR J NEUROSCI, V20, P623, DOI 10.1111/j.1460-9568.2004.03503.x; Heeroma JH, 2003, NEUROSCIENCE, V120, P733, DOI 10.1016/S0306-4522(03)00258-6; Hodges MR, 2008, J NEUROSCI, V28, P2495, DOI 10.1523/JNEUROSCI.4729-07.2008; Hodges MR, 2009, J NEUROSCI, V29, P10341, DOI 10.1523/JNEUROSCI.1963-09.2009; Hohmann CF, 2007, BRAIN RES, V1139, P163, DOI 10.1016/j.brainres.2006.12.095; JACOBS BL, 1992, PHYSIOL REV, V72, P165, DOI 10.1152/physrev.1992.72.1.165; Korteweg N, 2004, EUR J NEUROSCI, V19, P2944, DOI 10.1111/j.0953-816X.2004.03383.x; Lebrand C, 1996, NEURON, V17, P823, DOI 10.1016/S0896-6273(00)80215-9; Maier DL, 1999, P NATL ACAD SCI USA, V96, P9397, DOI 10.1073/pnas.96.16.9397; Narboux-Neme N, 2008, NEUROPHARMACOLOGY, V55, P994, DOI 10.1016/j.neuropharm.2008.08.020; RIDET JL, 1993, NEUROSCIENCE, V52, P143, DOI 10.1016/0306-4522(93)90189-M; Savelieva KV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003301; Scott MM, 2005, P NATL ACAD SCI USA, V102, P16472, DOI 10.1073/pnas.0504510102; Toonen RFG, 2007, TRENDS NEUROSCI, V30, P564, DOI 10.1016/j.tins.2007.08.008; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; WALLACE JA, 1983, BRAIN RES BULL, V10, P459, DOI 10.1016/0361-9230(83)90144-2; Zhao ZQ, 2006, J NEUROSCI, V26, P12781, DOI 10.1523/JNEUROSCI.4143-06.2006; Zhuang XX, 2005, J NEUROSCI METH, V143, P27, DOI 10.1016/j.jneumeth.2004.09.020	24	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2011	6	11							e28137	10.1371/journal.pone.0028137	http://dx.doi.org/10.1371/journal.pone.0028137			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863LT	22140524	Green Published, Green Submitted, gold			2022-12-27	WOS:000298166300028
J	Lai, HC; Wu, MJ; Chen, PY; Sheu, TT; Chiu, SP; Lin, MH; Ho, CT; Yen, JH				Lai, Hui-Chi; Wu, Ming-Jiuan; Chen, Pei-Yi; Sheu, Ting-Ting; Chiu, Szu-Ping; Lin, Meng-Han; Ho, Chi-Tang; Yen, Jui-Hung			Neurotrophic Effect of Citrus 5-Hydroxy-3,6,7,8,3 ',4 '-Hexamethoxyflavone: Promotion of Neurite Outgrowth via cAMP/PKA/CREB Pathway in PC12 Cells	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; IMPROVES MEMORY IMPAIRMENT; LONG-TERM POTENTIATION; HYDROXYLATED POLYMETHOXYFLAVONES; TRANSCRIPTIONAL REGULATION; PHEOCHROMOCYTOMA CELLS; MOLECULAR-MECHANISMS; SIGNAL-TRANSDUCTION; FLAVONOIDS; CREB	5-Hydroxy-3,6,7,8,3',4'-hexamethoxyflavone (5-OH-HxMF), a hydroxylated polymethoxyflavone, is found exclusively in the Citrus genus, particularly in the peels of sweet orange. In this research, we report the first investigation of the neurotrophic effects and mechanism of 5-OH-HxMF in PC12 pheochromocytoma cells. We found that 5-OH-HxMF can effectively induce PC12 neurite outgrowth accompanied with the expression of neuronal differentiation marker protein growth-associated protein-43(GAP-43). 5-OH-HxMF caused the enhancement of cyclic AMP response element binding protein (CREB) phosphorylation, c-fos gene expression and CRE-mediated transcription, which was inhibited by 2-naphthol AS-E phosphate (KG-501), a specific antagonist for the CREB-CBP complex formation. Moreover, 5-OH-HxMF-induced both CRE transcription activity and neurite outgrowth were inhibited by adenylate cyclase and protein kinase A (PKA) inhibitor, but not MEK1/2, protein kinase C (PKC), phosphatidylinositol 3-kinase (PI3K) or calcium/calmodulin-dependent protein kinase (CaMK) inhibitor. Consistently, 5-OH-HxMF treatment increased the intracellular cAMP level and downstream component, PKA activity. We also found that addition of K252a, a TrKA antagonist, significantly inhibited NGF- but not 5-OH-HxMF-induced neurite outgrowth. These results reveal for the first time that 5-OH-HxMF is an effective neurotrophic agent and its effect is mainly through a cAMP/PKA-dependent, but TrKA-independent, signaling pathway coupling with CRE-mediated gene transcription. A PKC-dependent and CREB-independent pathway was also involved in its neurotrophic action.	[Lai, Hui-Chi; Chiu, Szu-Ping; Yen, Jui-Hung] Tzu Chi Univ, Dept Mol Biol & Human Genet, Hualien, Taiwan; [Wu, Ming-Jiuan; Lin, Meng-Han] Chia Nan Univ Pharm & Sci, Dept Biotechnol, Tainan, Taiwan; [Chen, Pei-Yi; Yen, Jui-Hung] Tzu Chi Univ, Inst Med Sci, Hualien, Taiwan; [Chen, Pei-Yi] Buddhist Tzu Chi Gen Hosp, Ctr Med Genet, Hualien, Taiwan; [Sheu, Ting-Ting] Tzu Chi Univ, Inst Microbiol Immunol & Biochem, Hualien, Taiwan; [Ho, Chi-Tang] Rutgers State Univ, Dept Food Sci, New Brunswick, NJ 08903 USA	Tzu Chi University; Chia Nan University of Pharmacy & Science; Tzu Chi University; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Tzu Chi University; Rutgers State University New Brunswick	Lai, HC (corresponding author), Tzu Chi Univ, Dept Mol Biol & Human Genet, Hualien, Taiwan.	imyenjh@mail.tcu.edu.tw		Wu, Ming-Jiuan/0000-0003-3327-828X; Sheu, Ting-Ting/0000-0001-5183-357X	National Science Council, Taiwan, Republic of China [NSC-97-2320-B-320-011-MY3, NSC-99-2320-B-041-005-MY3]	National Science Council, Taiwan, Republic of China(Ministry of Science and Technology, Taiwan)	This study was supported by grant NSC-97-2320-B-320-011-MY3 and NSC-99-2320-B-041-005-MY3 from National Science Council, Taiwan, Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Rahim M, 2009, BIOCHEMISTRY-US, V48, P7713, DOI 10.1021/bi901088w; Benavente-Garcia O, 2008, J AGR FOOD CHEM, V56, P6185, DOI 10.1021/jf8006568; Best JL, 2004, P NATL ACAD SCI USA, V101, P17622, DOI 10.1073/pnas.0406374101; Boss V, 2001, J NEUROSCI, V21, P18, DOI 10.1523/JNEUROSCI.21-01-00018.2001; BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J; Bui NT, 2002, J NEUROCHEM, V81, P594, DOI 10.1046/j.1471-4159.2002.00841.x; COSTELLO B, 1990, J NEUROSCI, V10, P1398; Das KP, 2004, NEUROTOXICOL TERATOL, V26, P397, DOI 10.1016/j.ntt.2004.02.006; Dijkmans TF, 2009, BRAIN RES, V1249, P19, DOI 10.1016/j.brainres.2008.10.050; Dworkin S, 2010, EXPERT OPIN THER TAR, V14, P869, DOI 10.1517/14728222.2010.501332; Finkbeiner S, 2000, NEURON, V25, P11, DOI 10.1016/S0896-6273(00)80866-1; Fox K, 2002, NEUROSCIENCE, V111, P799, DOI 10.1016/S0306-4522(02)00027-1; GREENE LA, 1987, METHOD ENZYMOL, V147, P207; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Honda K, 2001, J NEUROSCI RES, V64, P466, DOI 10.1002/jnr.1098; Impey S, 1998, NEURON, V21, P869, DOI 10.1016/S0896-6273(00)80602-9; Katoh S, 1997, BIOCHEM BIOPH RES CO, V241, P347, DOI 10.1006/bbrc.1997.7514; Lai CS, 2007, CARCINOGENESIS, V28, P2581, DOI 10.1093/carcin/bgm231; Lai CS, 2011, MOL NUTR FOOD RES, V55, P278, DOI 10.1002/mnfr.201000224; Leinninger GM, 2004, FASEB J, V18, P1544, DOI 10.1096/fj.04-1581fje; Levy YS, 2005, BIODRUGS, V19, P97, DOI 10.2165/00063030-200519020-00003; Li SM, 2007, BIOORGAN MED CHEM, V15, P3381, DOI 10.1016/j.bmc.2007.03.021; Li SM, 2006, J AGR FOOD CHEM, V54, P4176, DOI 10.1021/jf060234n; Lin CW, 2010, J AGR FOOD CHEM, V58, P4477, DOI 10.1021/jf904061x; Lotito SB, 2006, FREE RADICAL BIO MED, V41, P1727, DOI 10.1016/j.freeradbiomed.2006.04.033; Manthey JA, 2001, CURR MED CHEM, V8, P135, DOI 10.2174/0929867013373723; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Matsuzaki K, 2008, EUR J PHARMACOL, V578, P194, DOI 10.1016/j.ejphar.2007.09.028; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; MEINKOTH JL, 1993, MOL CELL BIOCHEM, V128, P179, DOI 10.1007/BF01076769; Miyamoto E, 2006, J PHARMACOL SCI, V100, P433, DOI 10.1254/jphs.CPJ06007X; Mosevitsky MI, 2005, INT REV CYTOL, V245, P245, DOI 10.1016/S0074-7696(05)45007-X; Nagase H, 2005, BIOCHEMISTRY-US, V44, P13683, DOI 10.1021/bi050643x; Nagase H, 2005, BIOCHEM BIOPH RES CO, V337, P1330, DOI 10.1016/j.bbrc.2005.10.001; Nakajima A, 2007, J PHARMACOL SCI, V105, P122, DOI 10.1254/jphs.SC0070155; Onozuka H, 2008, J PHARMACOL EXP THER, V326, P739, DOI 10.1124/jpet.108.140293; Pan MH, 2007, J AGR FOOD CHEM, V55, P5081, DOI 10.1021/jf070068z; Persengiev SP, 2003, APOPTOSIS, V8, P225, DOI 10.1023/A:1023633704132; Poduslo JF, 1996, J NEUROCHEM, V67, P734; Pollard SE, 2006, BIOCHEM BIOPH RES CO, V350, P960, DOI 10.1016/j.bbrc.2006.09.131; Price RD, 2007, PHARMACOL THERAPEUT, V115, P292, DOI 10.1016/j.pharmthera.2007.03.005; Qiu PJ, 2010, MOL NUTR FOOD RES, V54, pS244, DOI 10.1002/mnfr.200900605; Riccio A, 1997, SCIENCE, V277, P1097, DOI 10.1126/science.277.5329.1097; RiceEvans CA, 1996, BIOCHEM SOC T, V24, P790, DOI 10.1042/bst0240790; SAN ERAJT, 1991, J NEUROSCI RES, V29, P149, DOI 10.1002/jnr.490290203; Sands WA, 2008, CELL SIGNAL, V20, P460, DOI 10.1016/j.cellsig.2007.10.005; Scholzke MN, 2007, J MOL MED, V85, P577, DOI 10.1007/s00109-007-0196-z; Schulte-Herbruggen O, 2008, CURR ALZHEIMER RES, V5, P38; Spedding M, 2008, NOVART FDN SYMP, V289, P222, DOI [DOI 10.1002/9780470751251.CH18, DOI 10.1002/SERIES1767]; Spencer JPE, 2007, GENES NUTR, V2, P257, DOI 10.1007/s12263-007-0056-z; Spencer JPE, 2010, BRIT J NUTR, V104, pS40, DOI 10.1017/S0007114510003934; Spencer JPE, 2009, ARCH BIOCHEM BIOPHYS, V492, P1, DOI 10.1016/j.abb.2009.10.003; Spencer JPE, 2009, GENES NUTR, V4, P243, DOI 10.1007/s12263-009-0136-3; Spencer JPE, 2009, CHEM SOC REV, V38, P1152, DOI 10.1039/b800422f; VANHOOFF COM, 1989, J CELL BIOL, V108, P1115, DOI 10.1083/jcb.108.3.1115; Vitolo OV, 2002, P NATL ACAD SCI USA, V99, P13217, DOI 10.1073/pnas.172504199; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; Yamamoto Y, 2009, BRAIN RES, V1295, P218, DOI 10.1016/j.brainres.2009.07.081; Yen JH, 2011, MOL NUTR FOOD RES, V55, P733, DOI 10.1002/mnfr.201000226; Zhao LX, 2003, J NEUROSCI, V23, P4228	60	41	41	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2011	6	11							e28280	10.1371/journal.pone.0028280	http://dx.doi.org/10.1371/journal.pone.0028280			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863LT	22140566	gold, Green Published, Green Submitted			2022-12-27	WOS:000298166300044
J	Lawrence, DP; Kroken, S; Pryor, BM; Arnold, AE				Lawrence, Daniel P.; Kroken, Scott; Pryor, Barry M.; Arnold, A. Elizabeth			Interkingdom Gene Transfer of a Hybrid NPS/PKS from Bacteria to Filamentous Ascomycota	PLOS ONE			English	Article							NONRIBOSOMAL PEPTIDE SYNTHETASES; POLYKETIDE SYNTHASE GENES; FUNCTIONAL-ANALYSIS; HORIZONTAL TRANSFER; EVOLUTION; REVEALS; VIRULENCE; GENOMES; CLUSTER; FUNGI	Nonribosomal peptides (NRPs) and polyketides (PKs) are ecologically important secondary metabolites produced by bacteria and fungi using multidomain enzymes called nonribosomal peptide synthetases (NRPSs) and polyketide synthases (PKSs), respectively. Previous phylogenetic analyses of fungal NRPSs and PKSs have suggested that a few of these genes were acquired by fungi via horizontal gene transfer (HGT) from bacteria, including a hybrid NPS/PKS found in Cochliobolus heterostrophus (Dothideomycetes, Ascomycota). Here, we identify this hybrid gene in fungi representing two additional classes of Ascomycota (Aspergillus spp., Microsporum canis, Arthroderma spp., and Trichophyton spp., Eurotiomycetes; Chaetomium spp. and Metarhizium spp., Sordariomycetes) and use phylogenetic analyses of the most highly conserved domains from NRPSs (adenylation (A) domain) and PKSs (ketoacyl synthase (KS) domain) to examine the hypothesis that the hybrid NPS7/PKS24 was acquired by fungi from bacteria via HGT relatively early in the evolution of the Pezizomycotina. Our results reveal a unique ancestry of the A domain and KS domain in the hybrid gene relative to known fungal NRPSs and PKSs, provide strong evidence for HGT of the hybrid gene from a putative bacterial donor in the Burkholderiales, and suggest the HGT event occurred early in the evolution of the filamentous Ascomycota.	[Lawrence, Daniel P.; Kroken, Scott; Pryor, Barry M.; Arnold, A. Elizabeth] Univ Arizona, Sch Plant Sci, Tucson, AZ 85719 USA	University of Arizona	Lawrence, DP (corresponding author), Univ Arizona, Sch Plant Sci, Tucson, AZ 85719 USA.				School of Plant Sciences at the University of Arizona; College of Agriculture and Life Sciences at the University of Arizona; National Science Foundation; University of Arizona	School of Plant Sciences at the University of Arizona; College of Agriculture and Life Sciences at the University of Arizona; National Science Foundation(National Science Foundation (NSF)); University of Arizona	This study was supported by the School of Plant Sciences and College of Agriculture and Life Sciences at the University of Arizona, by the National Science Foundation-Integrative Graduate Education Research Traineeship (NSF-IGERT) and by the Graduate Fellowship program in Genomics at the University of Arizona (DPL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; AHARONOWITZ Y, 1992, ANNU REV MICROBIOL, V46, P461, DOI 10.1146/annurev.mi.46.100192.002333; Ansari MZ, 2004, NUCLEIC ACIDS RES, V32, pW405, DOI 10.1093/nar/gkh359; Arnold AE, 2007, MYCOLOGIA, V99, P185, DOI 10.3852/mycologia.99.2.185; Bhatnagar D, 2003, APPL MICROBIOL BIOT, V61, P83, DOI 10.1007/s00253-002-1199-x; Bohnert HU, 2004, PLANT CELL, V16, P2499, DOI 10.1105/tpc.104.022715; Buades C, 1996, J MOL EVOL, V42, P537, DOI 10.1007/BF02352283; Bushley KE, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-26; Cox RJ, 2007, ORG BIOMOL CHEM, V5, P2010, DOI 10.1039/b704420h; Doolittle WE, 1998, TRENDS GENET, V14, P307; Eisen JA, 2000, CURR OPIN GENET DEV, V10, P606, DOI 10.1016/S0959-437X(00)00143-X; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Fedorova ND, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000046; Finking R, 2004, ANNU REV MICROBIOL, V58, P453, DOI 10.1146/annurev.micro.58.030603.123615; Fitzpatrick DA, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-181; Friesen TL, 2006, NAT GENET, V38, P953, DOI 10.1038/ng1839; Gaffoor I, 2005, EUKARYOT CELL, V4, P1926, DOI 10.1128/EC.4.11.1926-1933.2005; Garcia-Vallve S, 1999, MOL BIOL EVOL, V16, P1125, DOI 10.1093/oxfordjournals.molbev.a026203; Ginolhac A, 2005, J MOL EVOL, V60, P716, DOI 10.1007/s00239-004-0161-1; Hibbett DS, 2007, MYCOL RES, V111, P509, DOI 10.1016/j.mycres.2007.03.004; Hotopp JCD, 2007, SCIENCE, V317, P1753, DOI 10.1126/science.1142490; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jain R, 1999, P NATL ACAD SCI USA, V96, P3801, DOI 10.1073/pnas.96.7.3801; Johnson RD, 2000, MOL PLANT MICROBE IN, V13, P742, DOI 10.1094/MPMI.2000.13.7.742; Katz LA, 2002, INT J SYST EVOL MICR, V52, P1893, DOI 10.1099/00207713-52-5-1893; Keeling PJ, 2008, NAT REV GENET, V9, P605, DOI 10.1038/nrg2386; Keeling PJ, 2005, TRENDS ECOL EVOL, V20, P670, DOI 10.1016/j.tree.2005.09.005; Khaldi N, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r18; KONO Y, 1979, BIOORG CHEM, V8, P391, DOI 10.1016/0045-2068(79)90064-6; Kroken S, 2003, P NATL ACAD SCI USA, V100, P15670, DOI 10.1073/pnas.2532165100; Kurland CG, 2003, P NATL ACAD SCI USA, V100, P9658, DOI 10.1073/pnas.1632870100; LANDAN G, 1990, MOL BIOL EVOL, V7, P399; Lee BN, 2005, EUKARYOT CELL, V4, P545, DOI 10.1128/EC.4.3.545-555.2005; Liras P, 2006, INT MICROBIOL, V9, P9; Ma LJ, 2010, NATURE, V464, P367, DOI 10.1038/nature08850; MADDISON DR, 2003, MACCLADE 4 06 ANAL P; PENALVA MA, 1990, P ROY SOC B-BIOL SCI, V241, P164, DOI 10.1098/rspb.1990.0081; Richards TA, 2006, CURR BIOL, V16, P1857, DOI 10.1016/j.cub.2006.07.052; Rogers MB, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-89; Rosewich UL, 2000, ANNU REV PHYTOPATHOL, V38, P325, DOI 10.1146/annurev.phyto.38.1.325; Schmitt I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004437; Slot JC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001097; SMITH MW, 1992, TRENDS BIOCHEM SCI, V17, P489, DOI 10.1016/0968-0004(92)90335-7; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Swofford DL., 2003, PAUP PHYLOGENETIC AN; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thomas CM, 2005, NAT REV MICROBIOL, V3, P711, DOI 10.1038/nrmicro1234; WEBER G, 1994, CURR GENET, V26, P120, DOI 10.1007/BF00313798; Wenzl P, 2005, MOL BIOL EVOL, V22, P308, DOI 10.1093/molbev/msi018; Zaneveld JR, 2008, MICROBIOL-SGM, V154, P1, DOI 10.1099/mic.0.2007/011833-0; Zhang YQ, 2005, MYCOLOGY S, V22, P355	51	37	37	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2011	6	11							e28231	10.1371/journal.pone.0028231	http://dx.doi.org/10.1371/journal.pone.0028231			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863LT	22140558	Green Published, Green Submitted, gold			2022-12-27	WOS:000298166300042
J	Perez-Losada, M; Breinholt, JW; Porto, PG; Aira, M; Dominguez, J				Perez-Losada, Marcos; Breinholt, Jesse W.; Porto, Pablo G.; Aira, Manuel; Dominguez, Jorge			An Earthworm Riddle: Systematics and Phylogeography of the Spanish Lumbricid Postandrilus	PLOS ONE			English	Article							SPECIES DELIMITATION; DNA; OLIGOCHAETA; EVOLUTION; MITOCHONDRIAL; POPULATION; DIVERGENCE; INFERENCE; SELECTION; MODELS	Backgroud: As currently defined, the genus Postandrilus Qui and Bouche, 1998, (Lumbricidae) includes six earthworm species, five occurring in Majorca (Baleares Islands, western Mediterranean) and another in Galicia (NW Spain). This disjunct and restricted distribution raises some interesting phylogeographic questions: (1) Is Postandrilus distribution the result of the separation of the Baleares-Kabylies (BK) microplate from the proto-Iberian Peninsula in the Late Oligocene (30-28 Mya) - vicariant hypothesis? (2) Did Postandrilus diversify in Spain and then colonize the Baleares during the Messinian salinity crisis (MSC) 5.96-5.33 Mya - dispersal hypothesis? (3) Is the distribution the result of a two-step process - vicariance with subsequent dispersal? Methodology/Principal Findings: To answer these questions and assess Postandrilus evolutionary relationships and systematics, we collected all of the six Postandrilus species (46 specimens - 16 locations) and used Aporrectodea morenoe and three Prosellodrilus and two Cataladrilus species as the outgroup. Regions of the nuclear 28S rDNA and mitochondrial 16S rDNA, 12S rDNA, ND1, COII and tRNA genes (4,666 bp) were sequenced and analyzed using maximum likelihood and Bayesian methods of phylogenetic and divergence time estimation. The resulting trees revealed six new Postandrilus species in Majorca that clustered with the other five species already described. This Majorcan clade was sister to an Iberian clade including A. morenoe (outgroup) and Postandrilus bertae. Our phylogeny and divergence time estimates indicated that the split between the Iberian and Majorcan Postandrilus clades took place 30.1 Mya, in concordance with the break of the BK microplate from the proto-Iberian Peninsula, and that the present Majorcan clade diversified 5.7 Mya, during the MSC. Conclusions: Postandrilus is highly diverse including multiple cryptic species in Majorca. The genus is not monophyletic and invalid as currently defined. Postandrilus is of vicariant origin and its radiation began in the Late Oligocene.	[Perez-Losada, Marcos] Univ Porto, Ctr Invest Biodiversidade & Recursos Genet CIBIO, Vairao, Portugal; [Breinholt, Jesse W.] Brigham Young Univ, Dept Biol, Provo, UT 84602 USA; [Porto, Pablo G.; Aira, Manuel; Dominguez, Jorge] Univ Vigo, Dept Ecol & Biol Anim, Vigo 36310, Spain	Universidade do Porto; Brigham Young University; Universidade de Vigo	Perez-Losada, M (corresponding author), Univ Porto, Ctr Invest Biodiversidade & Recursos Genet CIBIO, Campus Agr Vairao, Vairao, Portugal.	mlosada323@gmail.com	Domínguez, Jorge/T-7647-2019; Aira, Manuel/B-4506-2016; Domínguez, Jorge/M-2046-2014; Breinholt, Jesse/K-6252-2019; Breinholt, Jesse/F-4330-2014; Perez-Losada, Marcos/I-4407-2013	Domínguez, Jorge/0000-0002-4313-8582; Aira, Manuel/0000-0002-2513-4609; Domínguez, Jorge/0000-0002-4313-8582; Breinholt, Jesse/0000-0002-3867-2430; Breinholt, Jesse/0000-0002-3867-2430; Perez-Losada, Marcos/0000-0002-2585-4657	Spanish Ministerio de Ciencia e Innovacion [CTM2009-08477]; Xunta de Galicia [GCR2008/073]; Xunta de Galicia (Spain); Ministerio de Educacion y Ciencia (Spain)	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Xunta de Galicia(Xunta de GaliciaEuropean Commission); Xunta de Galicia (Spain)(Xunta de Galicia); Ministerio de Educacion y Ciencia (Spain)(Spanish Government)	This study was financially supported by the Spanish Ministerio de Ciencia e Innovacion (CTM2009-08477) and by the Xunta de Galicia (GCR2008/073). MA was financially supported by a Parga Pondal fellowship from the Xunta de Galicia (Spain). PGP was financially supported by a predoctoral fellowship from the Ministerio de Educacion y Ciencia (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVAREZ W, 1974, NATURE, V248, P309, DOI 10.1038/248309a0; Blakemore RJ, 2007, SERIES SEARCHABLE TE, P1; Bond JE, 2008, SYST BIOL, V57, P628, DOI 10.1080/10635150802302443; Chang CH, 2005, PEDOBIOLOGIA, V49, P591, DOI 10.1016/j.pedobi.2005.07.002; Chang CH, 2009, PEDOBIOLOGIA, V52, P171, DOI 10.1016/j.pedobi.2008.08.002; Chang CH, 2008, MOL PHYLOGENET EVOL, V49, P958, DOI 10.1016/j.ympev.2008.08.025; Dawson AG, 1992, ICE AGE EARTH LATE Q; Diaz Cosin D.J., 1986, Revue d'Ecologie et de Biologie du Sol, V22, P507; Diaz Cosin DJ, 1985, MEGADRILOGICA, V4, P131; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Edwards CA, 1996, BIOL ECOLOGY EARTHWO, DOI DOI 10.1016/S0167-8809(97)88859-7; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Garcia-Castellanos D, 2009, NATURE, V462, P778, DOI 10.1038/nature08555; Huang J, 2007, PEDOBIOLOGIA, V51, P301, DOI 10.1016/j.pedobi.2007.05.003; Huelsenbeck JP, 2002, SYST BIOL, V51, P673, DOI 10.1080/10635150290102366; Briones MJI, 2009, SOIL BIOL BIOCHEM, V41, P2257, DOI 10.1016/j.soilbio.2009.07.008; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; King RA, 2008, MOL ECOL, V17, P4684, DOI 10.1111/j.1365-294X.2008.03931.x; Krijgsman W, 1999, NATURE, V400, P652, DOI 10.1038/23231; Krijgsman W, 2002, EARTH PLANET SC LETT, V205, P1, DOI 10.1016/S0012-821X(02)01008-7; LEE K. E., 1959, NEW ZEALAND DEPT SCI AND INDUST REA BULL, V130, P1; Marshall JC, 2006, EVOLUTION, V60, P1050; MEIJER J, 1972, PEDOBIOLOGIA, V12, P409; Meulenkamp JE, 2003, PALAEOGEOGR PALAEOCL, V196, P209, DOI 10.1016/S0031-0182(03)00319-5; Miller M.A., 2010, P GAT COMP ENV WORKS; Minamiya Y, 2009, EUR J SOIL BIOL, V45, P423, DOI 10.1016/j.ejsobi.2009.06.004; Novo M, 2011, MOL PHYLOGENET EVOL, V61, P125, DOI 10.1016/j.ympev.2011.05.018; Novo M, 2010, MOL PHYLOGENET EVOL, V56, P507, DOI 10.1016/j.ympev.2010.04.010; Patarnello T, 2007, MOL ECOL, V16, P4426, DOI 10.1111/j.1365-294X.2007.03477.x; Perez-Losada M, 2005, PEDOBIOLOGIA, V49, P317, DOI 10.1016/j.pedobi.2005.02.004; Perez-Losada M, 2004, SYST BIOL, V53, P244, DOI 10.1080/10635150490423458; Perez-Losada M, 2011, EUR J SOIL BIO UNPUB; Perez-Losada M, 2009, MOL PHYLOGENET EVOL, V52, P293, DOI 10.1016/j.ympev.2009.04.003; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Posada D, 2009, METHODS MOL BIOL, V537, P93, DOI 10.1007/978-1-59745-251-9_5; Qiu J-P, 1998, DOC PEDOZOOLOGIQ INT, V4, P65; Rambaut A., 2009, TRACER MCMC TRACE AN; Rissler LJ, 2007, SYST BIOL, V56, P924, DOI 10.1080/10635150701703063; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rosenbaum G., 2002, J VIRTUAL EXPLORER, V8, P107, DOI DOI 10.3809/JVIRTEX.2002.00053; Rouchy JM, 2006, SEDIMENT GEOL, V188, P35, DOI 10.1016/j.sedgeo.2006.02.005; Sei M, 2007, MOL ECOL, V16, P3313, DOI 10.1111/j.1365-294X.2007.03384.x; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Sites JW, 2004, ANNU REV ECOL EVOL S, V35, P199, DOI 10.1146/annurev.ecolsys.35.112202.130128; Sites JW, 2003, TRENDS ECOL EVOL, V18, P462, DOI 10.1016/S0169-5347(03)00184-8; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57; Thomas JA, 2006, P NATL ACAD SCI USA, V103, P7366, DOI 10.1073/pnas.0510251103; Thomas JA, 2010, MOL BIOL EVOL, V27, P1173, DOI 10.1093/molbev/msq009; Waelbroeck C, 2002, QUATERNARY SCI REV, V21, P295, DOI 10.1016/S0277-3791(01)00101-9; Wiens JJ, 1998, SYST BIOL, V47, P568, DOI 10.1080/106351598260581; Will KW, 2005, SYST BIOL, V54, P844, DOI 10.1080/10635150500354878	55	35	37	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2011	6	11							e28153	10.1371/journal.pone.0028153	http://dx.doi.org/10.1371/journal.pone.0028153			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863LT	22140529	Green Submitted, Green Published, gold			2022-12-27	WOS:000298166300032
J	Mielcarek, M; Benn, CL; Franklin, SA; Smith, DL; Woodman, B; Marks, PA; Bates, GP				Mielcarek, Michal; Benn, Caroline L.; Franklin, Sophie A.; Smith, Donna L.; Woodman, Ben; Marks, Paul A.; Bates, Gillian P.			SAHA Decreases HDAC 2 and 4 Levels In Vivo and Improves Molecular Phenotypes in the R6/2 Mouse Model of Huntington's Disease	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITORS; NEURONAL INTRANUCLEAR INCLUSIONS; SUBEROYLANILIDE HYDROXAMIC ACID; NEUROTROPHIC FACTOR; EXPRESSION; TRANSCRIPTION; PATHOGENESIS; UNDERLIES; TRIALS	Huntington's disease (HD) is a progressive neurological disorder for which there are no disease-modifying treatments. Transcriptional dysregulation is a major molecular feature of HD, which significantly contributes to disease progression. Therefore, the development of histone deacetylase (HDAC) inhibitors as therapeutics for HD has been energetically pursued. Suberoylanilide hydroxamic acid (SAHA) - a class I HDAC as well an HDAC6 inhibitor, improved motor impairment in the R6/2 mouse model of HD. Recently it has been found that SAHA can also promote the degradation of HDAC4 and possibly other class IIa HDACs at the protein level in various cancer cell lines. To elucidate whether SAHA is a potent modifier of HDAC protein levels in vivo, we performed two independent mouse trials. Both WT and R6/2 mice were chronically treated with SAHA and vehicle. We found that prolonged SAHA treatment causes the degradation of HDAC4 in cortex and brain stem, but not hippocampus, without affecting its transcript levels in vivo. Similarly, SAHA also decreased HDAC2 levels without modifying the expression of its mRNA. Consistent with our previous data, SAHA treatment diminishes Hdac7 transcript levels in both wild type and R6/2 brains and unexpectedly was found to decrease Hdac11 in R6/2 but not wild type. We investigated the effects of SAHA administration on well-characterised molecular readouts of disease progression. We found that SAHA reduces SDS-insoluble aggregate load in the cortex and brain stem but not in the hippocampus of the R6/2 brains, and that this was accompanied by restoration of Bdnf cortical transcript levels.	[Mielcarek, Michal; Franklin, Sophie A.; Smith, Donna L.; Woodman, Ben; Bates, Gillian P.] Kings Coll London, Dept Med & Mol Genet, London WC2R 2LS, England; [Benn, Caroline L.] Pfizer Inc, Neusentis, Cambridge, England; [Marks, Paul A.] Mem Sloan Kettering Canc Ctr, Cell Biol Program, Sloan Kettering Inst Canc Res, New York, NY 10021 USA	University of London; King's College London; Pfizer; Memorial Sloan Kettering Cancer Center	Mielcarek, M (corresponding author), Kings Coll London, Dept Med & Mol Genet, London WC2R 2LS, England.	gillian.bates@kcl.ac.uk	Mielcarek, Michal/M-6302-2018; Bates, Gillian P/E-1146-2012	Mielcarek, Michal/0000-0002-9874-6753; Bates, Gillian P/0000-0002-4041-6305	CHDI Foundation	CHDI Foundation	This work was funded by the CHDI Foundation, a privately-funded non-profit biomedical research organization exclusively dedicated to discovering and developing therapeutics that slow the progression of Huntington's disease. For this study, the CHDI Foundation assisted with the analysis of SAHA stability, purity and pharmacokinetics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2008, CURR OPIN PHARMACOL, V8, P57, DOI 10.1016/j.coph.2007.12.002; Bates EA, 2006, J NEUROSCI, V26, P2830, DOI 10.1523/JNEUROSCI.3344-05.2006; BATES G, 2002, HUNTINGTONS DIS; Benn CL, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-17; Benn CL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005747; Butler R, 2006, NAT REV NEUROSCI, V7, P784, DOI 10.1038/nrn1989; Cha JHJ, 2007, PROG NEUROBIOL, V83, P228, DOI 10.1016/j.pneurobio.2007.03.004; Cha JHJ, 1998, P NATL ACAD SCI USA, V95, P6480, DOI 10.1073/pnas.95.11.6480; Chen H, 2011, J CELL BIOCH; Codd R, 2009, INT J BIOCHEM CELL B, V41, P736, DOI 10.1016/j.biocel.2008.05.026; Darcy MJ, 2010, J COMP NEUROL, V518, P722, DOI 10.1002/cne.22241; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Dokmanovic M, 2007, MOL CANCER THER, V6, P2525, DOI 10.1158/1535-7163.MCT-07-0251; Dokmanovic M, 2007, MOL CANCER RES, V5, P981, DOI 10.1158/1541-7786.MCR-07-0324; Ferrante RJ, 2003, J NEUROSCI, V23, P9418; Gardian G, 2005, J BIOL CHEM, V280, P556, DOI 10.1074/jbc.M410210200; Gharami K, 2008, J NEUROCHEM, V105, P369, DOI 10.1111/j.1471-4159.2007.05137.x; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Hockly E, 2003, P NATL ACAD SCI USA, V100, P2041, DOI 10.1073/pnas.0437870100; Hockly E, 2003, BRAIN RES BULL, V61, P469, DOI 10.1016/S0361-9230(03)00185-0; Hughes RE, 2001, P NATL ACAD SCI USA, V98, P13201, DOI 10.1073/pnas.191498198; Labbadia J, 2011, J CLIN INVEST, V121, P3306, DOI 10.1172/JCI57413; Li SH, 2004, TRENDS GENET, V20, P146, DOI 10.1016/j.tig.2004.01.008; Luthi-Carter R, 2000, HUM MOL GENET, V9, P1259, DOI 10.1093/hmg/9.9.1259; Marks PA, 2009, J CELL BIOCHEM, V107, P600, DOI 10.1002/jcb.22185; Marks PA, 2007, NAT BIOTECHNOL, V25, P84, DOI 10.1038/nbt1272; Novak MJU, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c3109; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784; Pallos J, 2008, HUM MOL GENET, V17, P3767, DOI 10.1093/hmg/ddn273; Parmigiani RB, 2008, P NATL ACAD SCI USA, V105, P9633, DOI 10.1073/pnas.0803749105; Richon VM, 1998, P NATL ACAD SCI USA, V95, P3003, DOI 10.1073/pnas.95.6.3003; Salisbury CM, 2007, P NATL ACAD SCI USA, V104, P1171, DOI 10.1073/pnas.0608659104; Sathasivam K, 2010, HUM MOL GENET, V19, P65, DOI 10.1093/hmg/ddp467; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Scognamiglio A, 2008, BBA-MOL CELL RES, V1783, P2030, DOI 10.1016/j.bbamcr.2008.07.007; Silvestroni A, 2009, NEUROREPORT, V20, P1098, DOI 10.1097/WNR.0b013e32832e34ee; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Takahashi T, 2010, J MOL CELL BIOL, V2, P180, DOI 10.1093/jmcb/mjq005; Villagra A, 2009, NAT IMMUNOL, V10, P92, DOI 10.1038/ni.1673; Wu XF, 2008, INT J NEUROPSYCHOPH, V11, P1123, DOI 10.1017/S1461145708009024; Zuccato C, 2009, NAT REV NEUROL, V5, P311, DOI 10.1038/nrneurol.2009.54	42	122	128	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2011	6	11							e27746	10.1371/journal.pone.0027746	http://dx.doi.org/10.1371/journal.pone.0027746			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KW	22140466	gold, Green Submitted, Green Published			2022-12-27	WOS:000298163400018
J	Downar, J; Bhatt, M; Montague, PR				Downar, Jonathan; Bhatt, Meghana; Montague, P. Read			Neural Correlates of Effective Learning in Experienced Medical Decision-Makers	PLOS ONE			English	Article							HUMAN BRAIN; PREDICTION ERRORS; HUMAN STRIATUM; PSYCHOSIS; RESPONSES; REWARD; SENSITIVITY; OXYGENATION; CONTRAST; CORTEX	Accurate associative learning is often hindered by confirmation bias and success-chasing, which together can conspire to produce or solidify false beliefs in the decision-maker. We performed functional magnetic resonance imaging in 35 experienced physicians, while they learned to choose between two treatments in a series of virtual patient encounters. We estimated a learning model for each subject based on their observed behavior and this model divided clearly into high performers and low performers. The high performers showed small, but equal learning rates for both successes (positive outcomes) and failures (no response to the drug). In contrast, low performers showed very large and asymmetric learning rates, learning significantly more from successes than failures; a tendency that led to sub-optimal treatment choices. Consistently with these behavioral findings, high performers showed larger, more sustained BOLD responses to failed vs. successful outcomes in the dorsolateral prefrontal cortex and inferior parietal lobule while low performers displayed the opposite response profile. Furthermore, participants' learning asymmetry correlated with anticipatory activation in the nucleus accumbens at trial onset, well before outcome presentation. Subjects with anticipatory activation in the nucleus accumbens showed more success-chasing during learning. These results suggest that high performers' brains achieve better outcomes by attending to informative failures during training, rather than chasing the reward value of successes. The differential brain activations between high and low performers could potentially be developed into biomarkers to identify efficient learners on novel decision tasks, in medical or other contexts.	[Downar, Jonathan] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Downar, Jonathan] Toronto Western Hosp, Toronto, ON M5T 2S8, Canada; [Bhatt, Meghana] City Hope Hosp, Beckman Res Inst, Duarte, CA USA; [Montague, P. Read] Virginia Tech, Human Neuroimaging Lab, Caril Res Inst, Roanoke, VA USA; [Montague, P. Read] Virginia Tech, Dept Phys, Roanoke, VA USA; [Montague, P. Read] UCL, Wellcome Trust Ctr Neuroimaging, London, England	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; City of Hope; Beckman Research Institute of City of Hope; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; University of London; University College London	Downar, J (corresponding author), Univ Toronto, Dept Psychiat, Toronto, ON, Canada.	read@vt.edu	Downar, Jonathan/I-9002-2016	Downar, Jonathan/0000-0002-5140-174X; Lauwereyns, Jan/0000-0003-0551-2550	National Institutes of Health [1 RC4 AG039067, R01 DA11723-02, 2R01 MH085496-05A2]; The Kane Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085496] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RC4AG039067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA011723] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Kane Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was funded by the following grants: National Institutes of Health grant # 1 RC4 AG039067, National Institutes of Health grant # R01 DA11723-02, National Institutes of Health grant # 2R01 MH085496-05A2 The Kane Foundation Fellowship. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	[Anonymous], 1988, LANCET, V2, P349; Aron AR, 2004, J NEUROPHYSIOL, V92, P1144, DOI 10.1152/jn.01209.2003; Berns GS, 2001, J NEUROSCI, V21, P2793, DOI 10.1523/JNEUROSCI.21-08-02793.2001; Corbetta M, 2000, NAT NEUROSCI, V3, P292, DOI 10.1038/73009; Corlett PR, 2007, BRAIN, V130, P2387, DOI 10.1093/brain/awm173; Corlett PR, 2006, ARCH GEN PSYCHIAT, V63, P611, DOI 10.1001/archpsyc.63.6.611; Corlett PR, 2004, NEURON, V44, P877, DOI 10.1016/j.neuron.2004.11.022; Downar J, 2002, J NEUROPHYSIOL, V87, P615, DOI 10.1152/jn.00636.2001; Downar J, 2001, NEUROIMAGE, V14, P1256, DOI 10.1006/nimg.2001.0946; Fletcher PC, 2001, NAT NEUROSCI, V4, P1043, DOI 10.1038/nn733; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; Izuma K, 2008, NEURON, V58, P284, DOI 10.1016/j.neuron.2008.03.020; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Knutson B, 2007, NEURON, V53, P147, DOI 10.1016/j.neuron.2006.11.010; KWONG KK, 1992, P NATL ACAD SCI USA, V89, P5675, DOI 10.1073/pnas.89.12.5675; McClure SM, 2003, NEURON, V38, P339, DOI 10.1016/S0896-6273(03)00154-5; Murray GK, 2010, SCHIZOPHRENIA BULL, V36, P465, DOI 10.1093/schbul/sbq005; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; O'Doherty JP, 2003, NEURON, V38, P329, DOI 10.1016/S0896-6273(03)00169-7; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; OGAWA S, 1990, MAGNET RESON MED, V14, P68, DOI 10.1002/mrm.1910140108; Popper K. R., 1934, LOGIC SCI DISCOVERY; Rescorla, 1972, CLASSICAL CONDITION, P64, DOI DOI 10.1101/GR.110528.110; Rodriguez PF, 2006, HUM BRAIN MAPP, V27, P306, DOI 10.1002/hbm.20186; Scott DJ, 2007, NEURON, V55, P325, DOI 10.1016/j.neuron.2007.06.028; SKINNER BF, 1948, J EXP PSYCHOL, V38, P168, DOI 10.1037//0096-3445.121.3.273; Tanaka SC, 2004, NAT NEUROSCI, V7, P887, DOI 10.1038/nn1279; Wason P., 1966, NEW HORIZONS PSYCHOL	28	9	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e27768	10.1371/journal.pone.0027768	http://dx.doi.org/10.1371/journal.pone.0027768			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132137	Green Published, Green Submitted, gold			2022-12-27	WOS:000298162000039
J	Pan, S; Chen, R; Stevens, T; Bronner, MP; May, D; Tamura, Y; McIntosh, MW; Brentnall, TA				Pan, Sheng; Chen, Ru; Stevens, Tyler; Bronner, Mary P.; May, Damon; Tamura, Yasuko; McIntosh, Martin W.; Brentnall, Teresa A.			Proteomics Portrait of Archival Lesions of Chronic Pancreatitis	PLOS ONE			English	Article							PARAFFIN-EMBEDDED TISSUES; TANDEM MASS-SPECTROMETRY; SPLENIC VEIN-THROMBOSIS; EXTRACELLULAR-MATRIX; BIOMARKER DISCOVERY; STATISTICAL-MODEL; CANCER-TISSUE; PROTEINS; ADENOCARCINOMA; CELLS	Chronic pancreatitis is a chronic inflammatory disorder of the pancreas. The etiology is multi-fold, but all lead to progressive scarring and loss of pancreatic function. Early diagnosis is difficult; and the understanding of the molecular events that underlie this progressive disease is limited. In this study, we investigated differential proteins associated with mild and severe chronic pancreatitis in comparison with normal pancreas and pancreatic cancer. Paraffin-embedded formalin-fixed tissues from five well-characterized specimens each of normal pancreas (NL), mild chronic pancreatitis (MCP), severe chronic pancreatitis (SCP) and pancreatic ductal adenocarcinoma (PDAC) were subjected to proteomic analysis using a "label-free" comparative approach. Our results show that the numbers of differential proteins increase substantially with the disease severity, from mild to severe chronic pancreatitis, while the number of dysregulated proteins is highest in pancreatic adenocarcinoma. Important functional groups and biological processes associated with chronic pancreatitis and cancer include acinar cell secretory proteins, pancreatic fibrosis/stellate cell activation, glycoproteins, and inflammatory proteins. Three differential proteins were selected for verification by immunohistochemistry, including collagen 14A1, lumican and versican. Further canonical pathway analysis revealed that acute phase response signal, prothrombin activation pathway, and pancreatic fibrosis/pancreatic stellate cell activation pathway were the most significant pathways involved in chronic pancreatitis, while pathways relating to metabolism were the most significant pathways in pancreatic adenocarcinoma. Our study reveals a group of differentially expressed proteins and the related pathways that may shed light on the pathogenesis of chronic pancreatitis and the common molecular events associated with chronic pancreatitis and pancreatic adenocarcinoma.	[Pan, Sheng; Chen, Ru; Tamura, Yasuko; Brentnall, Teresa A.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Stevens, Tyler] Cleveland Clin Fdn, Inst Digest Dis, Cleveland, OH 44195 USA; [Bronner, Mary P.] Univ Utah, Dept Anat Pathol, Salt Lake City, UT USA; [May, Damon; McIntosh, Martin W.] Fred Hutchinson Canc Res Ctr, Mol Diagnost Program, Seattle, WA 98104 USA	University of Washington; University of Washington Seattle; Cleveland Clinic Foundation; Utah System of Higher Education; University of Utah; Fred Hutchinson Cancer Center	Pan, S (corresponding author), Univ Washington, Dept Med, Seattle, WA 98195 USA.	shengp@medicine.washington.edu; teribr@u.washington.edu		May, Damon/0000-0001-6902-3153	National Institutes of Health [R01CA107209, K25CA137222, K07CA116296, R01DK081368, R21CA149772]; NATIONAL CANCER INSTITUTE [R01CA107209, K07CA116296, R21CA149772, K25CA137222] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081368] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported in part with federal funds from the National Institutes of Health under grants R01CA107209, K25CA137222, K07CA116296, R01DK081368 and R21CA149772, and gifts from the Canary Foundation and Gene and Mary Ann Walters Pancreatic Cancer Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addis MF, 2009, PROTEOMICS, V9, P3815, DOI 10.1002/pmic.200800971; Agarwal AK, 2008, AM J SURG, V196, P149, DOI 10.1016/j.amjsurg.2007.07.039; Albashir S, 2010, AM J GASTROENTEROL, V105, P2498, DOI 10.1038/ajg.2010.274; Ammann RW, 1996, GASTROENTEROLOGY, V111, P224, DOI 10.1053/gast.1996.v111.pm8698203; Balgley BM, 2009, J PROTEOME RES, V8, P917, DOI 10.1021/pr800503u; Bellew M, 2006, BIOINFORMATICS, V22, P1902, DOI 10.1093/bioinformatics/btl276; BHUIYA FA, 2010, EMERGENCY DEP VISITS, P1; Blonder J, 2009, CLIN LAB MED, V29, P101, DOI 10.1016/j.cll.2009.01.006; Chen JH, 2009, HEPATOB PANCREAT DIS, V8, P193; Chen R, 2005, MOL CELL PROTEOMICS, V4, P523, DOI 10.1074/mcp.R500004-MCP200; Chen R, 2005, GASTROENTEROLOGY, V129, P1187, DOI 10.1053/j.gastro.2005.08.001; Chen R, 2007, PROTEOM CLIN APPL, V1, P1582, DOI 10.1002/prca.200700414; Chen R, 2007, MOL CELL PROTEOMICS, V6, P1331, DOI 10.1074/mcp.M700072-MCP200; Chen R, 2006, PROTEOMICS, V6, P3871, DOI 10.1002/pmic.200500702; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; Crnogorac-Jurcevic T, 2005, GASTROENTEROLOGY, V129, P1454, DOI 10.1053/j.gastro.2005.08.012; Cui YZ, 2009, PANCREATOLOGY, V9, P89, DOI 10.1159/000178879; Cui YZ, 2009, INT J CANCER, V124, P1614, DOI 10.1002/ijc.24163; Dai L, 2010, J PROTEOME RES, V9, P3394, DOI 10.1021/pr100231m; Deutsch EW, 2010, PROTEOMICS, V10, P1150, DOI 10.1002/pmic.200900375; Esposito I, 2001, HUM PATHOL, V32, P1174, DOI 10.1053/hupa.2001.28947; Everhart JE, 2009, GASTROENTEROLOGY, V136, P1134, DOI 10.1053/j.gastro.2009.02.038; Friess H, 2001, ANN SURG, V234, P769, DOI 10.1097/00000658-200112000-00008; Grantzdorffer I, 2008, PANCREAS, V36, P329, DOI 10.1097/MPA.0b013e31815cc452; GREENBERGER NJ, 2008, MED HARRISONS PRIN E, V17, pCH307; Gronborg M, 2006, MOL CELL PROTEOMICS, V5, P157, DOI 10.1074/mcp.M500178-MCP200; Hood BL, 2006, PROTEOMICS, V6, P4106, DOI 10.1002/pmic.200600016; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hwang SI, 2007, ONCOGENE, V26, P65, DOI 10.1038/sj.onc.1209755; Ishiwata T, 2007, ONCOL REP, V18, P537; Jarvelainen H, 2009, PHARMACOL REV, V61, P198, DOI 10.1124/pr.109.001289; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Keller A, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100024; Koninger J, 2004, BIOCHEM BIOPH RES CO, V322, P943, DOI 10.1016/j.bbrc.2004.08.008; Kudo Y, 2007, HISTOL HISTOPATHOL, V22, P1167, DOI 10.14670/HH-22.1167; Lohr M, 2004, PANCREATOLOGY, V4, P67, DOI 10.1159/000077212; Lowenfels AB, 1997, J NATL CANCER I, V89, P442, DOI 10.1093/jnci/89.6.442; LOWENFELS AB, 1993, NEW ENGL J MED, V328, P1433, DOI 10.1056/NEJM199305203282001; Malka D, 2002, GUT, V51, P849, DOI 10.1136/gut.51.6.849; MAY D, 2008, J PROTEOME RES; May D, 2007, J PROTEOME RES, V6, P2685, DOI 10.1021/pr070146y; May D, 2011, J PROTEOME RES, V10, P200, DOI 10.1021/pr100574p; Mikuriya K, 2007, INT J ONCOL, V30, P849; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Ozaki N, 2009, MOL CANCER RES, V7, P1572, DOI 10.1158/1541-7786.MCR-08-0567; PAN S, 2011, J PROTEOME RES; Pan S, 2009, ELECTROPHORESIS, V30, P1132, DOI 10.1002/elps.200800752; Pawlak G, 2001, CURR OPIN GENET DEV, V11, P41, DOI 10.1016/S0959-437X(00)00154-4; PING LY, 2002, J PATHOL, V196, P324; Rosty C, 2003, AM J SURG PATHOL, V27, P1495, DOI 10.1097/00000478-200312000-00001; Scarlett CJ, 2006, GASTROENTEROLOGY, V130, P1670, DOI 10.1053/j.gastro.2006.02.036; Shimizu K, 2008, J GASTROENTEROL, V43, P823, DOI 10.1007/s00535-008-2249-7; Shimosegawa T, 2009, CLIN GASTROENTEROL H, V7, pS23, DOI 10.1016/j.cgh.2009.07.042; Spanler BWM, 2008, EUR J GASTROEN HEPAT, V20, P653, DOI 10.1097/MEG.0b013e3282f52f83; Sprung RW, 2009, MOL CELL PROTEOMICS, V8, P1988, DOI 10.1074/mcp.M800518-MCP200; Van Acker GJD, 2002, AM J PHYSIOL-GASTR L, V283, pG794, DOI 10.1152/ajpgi.00363.2001; VANDERSLICE P, 1990, P NATL ACAD SCI USA, V87, P3811, DOI 10.1073/pnas.87.10.3811; Vimalachandran D, 2004, EXPERT REV PROTEOMIC, V1, P493, DOI 10.1586/14789450.1.4.493; Wang Pei, 2006, Pac Symp Biocomput, P315; Weber SM, 2003, WORLD J SURG, V27, P1271, DOI 10.1007/s00268-003-7247-6	60	41	43	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e27574	10.1371/journal.pone.0027574	http://dx.doi.org/10.1371/journal.pone.0027574			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132114	Green Submitted, Green Published, gold			2022-12-27	WOS:000298162000027
J	Zhou, ZY; Wagar, N; Devos, JR; Rottinghaus, E; Diallo, K; Nguyen, DB; Bassey, O; Ugbena, R; Wadonda-Kabondo, N; McConnell, MS; Zulu, I; Chilima, B; Nkengasong, J; Yang, CF				Zhou, Zhiyong; Wagar, Nick; Devos, Joshua R.; Rottinghaus, Erin; Diallo, Karidia; Nguyen, Duc B.; Bassey, Orji; Ugbena, Richard; Wadonda-Kabondo, Nellie; McConnell, Michelle S.; Zulu, Isaac; Chilima, Benson; Nkengasong, John; Yang, Chunfu			Optimization of a Low Cost and Broadly Sensitive Genotyping Assay for HIV-1 Drug Resistance Surveillance and Monitoring in Resource-Limited Settings	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; DRIED BLOOD SPOTS; WORLD-HEALTH-ORGANIZATION; SEQUENCE-BASED ANALYSIS; ANTIRETROVIRAL TREATMENT; SUBTYPE-A; MUTATIONS; PERFORMANCE; SYSTEM; PLASMA	Commercially available HIV-1 drug resistance (HIVDR) genotyping assays are expensive and have limitations in detecting non-B subtypes and circulating recombinant forms that are co-circulating in resource-limited settings (RLS). This study aimed to optimize a low cost and broadly sensitive in-house assay in detecting HIVDR mutations in the protease (PR) and reverse transcriptase (RT) regions of pol gene. The overall plasma genotyping sensitivity was 95.8% (N = 96). Compared to the original in-house assay and two commercially available genotyping systems, TRUGENE (R) and ViroSeq (R), the optimized in-house assay showed a nucleotide sequence concordance of 99.3%, 99.6% and 99.1%, respectively. The optimized in-house assay was more sensitive in detecting mixture bases than the original in-house (N=87, P<0.001) and TRUGENE (R) and ViroSeq (R) assays. When the optimized in-house assay was applied to genotype samples collected for HIVDR surveys (N = 230), all 72 (100%) plasma and 69 (95.8%) of the matched dried blood spots (DBS) in the Vietnam transmitted HIVDR survey were genotyped and nucleotide sequence concordance was 98.8%; Testing of treatment-experienced patient plasmas with viral load (VL) >= and < 3 log10 copies/ml from the Nigeria and Malawi surveys yielded 100% (N=46) and 78.6% (N = 14) genotyping rates, respectively. Furthermore, all 18 matched DBS stored at room temperature from the Nigeria survey were genotyped. Phylogenetic analysis of the 236 sequences revealed that 43.6% were CRF01_AE, 25.9% subtype C, 13.1% CRF02_AG, 5.1% subtype G, 4.2% subtype B, 2.5% subtype A, 2.1% each subtype F and unclassifiable, 0.4% each CRF06_CPX, CRF07_BC and CRF09_CPX. Conclusions: The optimized in-house assay is broadly sensitive in genotyping HIV-1 group M viral strains and more sensitive than the original in-house, TRUGENE (R) and ViroSeq (R) in detecting mixed viral populations. The broad sensitivity and substantial reagent cost saving make this assay more accessible for RLS where HIVDR surveillance is recommended to minimize the development and transmission of HIVDR.	[Zhou, Zhiyong; Wagar, Nick; Devos, Joshua R.; Rottinghaus, Erin; Diallo, Karidia; McConnell, Michelle S.; Nkengasong, John; Yang, Chunfu] Ctr Dis Control & Prevent CDC, Div Global HIV AIDS, Ctr Global Hlth, Atlanta, GA 30333 USA; [Nguyen, Duc B.] Dept Hlth & Human Serv US CDC, Hanoi, Vietnam; [Bassey, Orji; Ugbena, Richard] CDC GAP, Abuja, Nigeria; [Wadonda-Kabondo, Nellie; Chilima, Benson] Malawi Minist Hlth, Community Hlth Sci Unit, Lilongwe, Malawi; [McConnell, Michelle S.] Thailand Minist Publ Hlth US CDC Collaborat, Nonthaburi, Thailand; [Zulu, Isaac] Global AIDS Program CDC Zambia, Lusaka, Zambia	Centers for Disease Control & Prevention - USA; Ministry of Public Health - Thailand	Zhou, ZY (corresponding author), Ctr Dis Control & Prevent CDC, Div Global HIV AIDS, Ctr Global Hlth, Atlanta, GA 30333 USA.	cxy0@cdc.gov	Yang, Chunfu/G-6890-2013		American Public Health Laboratory (APHL); CDC	American Public Health Laboratory (APHL); CDC(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Dr. Erin Rottinghaus is a recipient of the 2009-2011 Emerging Infectious Disease (EID) Fellowship program sponsored by American Public Health Laboratory (APHL) and CDC. The authors thank Dr. Guoqing Zhang, a recipient of APHL/CDC 2011 International EID program for statistical assistance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abegaz WE, 2008, ANTIVIR THER, V13, P89; Aghokeng AF, 2011, J CLIN MICROBIOL, V49, P1635, DOI 10.1128/JCM.01478-10; Beddows S, 2003, J MED VIROL, V70, P337, DOI 10.1002/jmv.10401; BENNETT DE, 2008, PLOS ONE S2, V13, pE4724; Bennett DE, 2008, ANTIVIR THER, V13, P1; Bennett DE, 2006, CURR OPIN INFECT DIS, V19, P607, DOI 10.1097/QCO.0b013e3280109ff1; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Bertagnolio S, 2010, AIDS REV, V12, P195; Bertognolio S, 2008, ANTIVIR THER, V13, P49; Buckton AJ, 2008, CURR OPIN INFECT DIS, V21, P653, DOI 10.1097/QCO.0b013e3283186d1a; Chen JHK, 2007, J CLIN VIROL, V39, P125, DOI 10.1016/j.jcv.2007.03.008; de Oliveira T, 2005, BIOINFORMATICS, V21, P3797, DOI 10.1093/bioinformatics/bti607; Eshleman SH, 2005, J CLIN MICROBIOL, V43, P813, DOI 10.1128/JCM.43.2.813-817.2005; Eshleman SH, 2004, J CLIN MICROBIOL, V42, P2711, DOI 10.1128/JCM.42.6.2711-2717.2004; Eshleman SH, 2004, JAIDS-J ACQ IMM DEF, V35, P126, DOI 10.1097/00126334-200402010-00004; Eshleman SH, 2003, BIOTECHNIQUES, V35, P614, DOI 10.2144/03353dd05; Eshleman SH, 2001, AIDS, V15, P1951, DOI 10.1097/00002030-200110190-00006; Fontaine E, 2001, J ACQ IMMUN DEF SYND, V28, P254, DOI 10.1097/00042560-200111010-00008; Galli RA, 2003, J CLIN MICROBIOL, V41, P2900, DOI 10.1128/JCM.41.7.2900-2907.2003; Garcia-Lerma JG, 2009, J ANTIMICROB CHEMOTH, V64, P33, DOI 10.1093/jac/dkp150; Garrido C, 2008, J ANTIMICROB CHEMOTH, V61, P694, DOI 10.1093/jac/dkm515; Geretti AM, 2007, CURR OPIN INFECT DIS, V20, P22, DOI 10.1097/QCO.0b013e328013caff; Gilks CF, 2006, LANCET, V368, P505, DOI 10.1016/S0140-6736(06)69158-7; GOODENOW M, 1989, J ACQ IMMUN DEF SYND, V2, P344; Grant RM, 2002, JAMA-J AM MED ASSOC, V288, P181, DOI 10.1001/jama.288.2.181; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hallack R, 2008, J CLIN VIROL, V41, P283, DOI 10.1016/j.jcv.2007.12.011; Harrigan PR, 2002, 14 INT AIDS C BARC S; Hearps AC, 2010, CURR HIV RES, V8, P134, DOI 10.2174/157016210790442740; Hirsch MS, 2008, CLIN INFECT DIS, V47, P266, DOI 10.1086/589297; Hirsch MS, 2003, CLIN INFECT DIS, V37, P113, DOI 10.1086/375597; Jagodzinski LL, 2003, J CLIN MICROBIOL, V41, P998, DOI 10.1128/JCM.41.3.998-1003.2003; Johnson JA, 2008, PLOS MED, V5, P1112, DOI 10.1371/journal.pmed.0050158; Jordan MR, 2008, ANTIVIR THER, V13, P15; Kijak GH, 2002, J VIROL, V76, P7000, DOI 10.1128/JVI.76.14.7000-7009.2002; Lira R, 2010, ARCH VIROL, V155, P1117, DOI 10.1007/s00705-010-0696-y; Masciotra S, 2007, AIDS, V21, P2503, DOI 10.1097/QAD.0b013e3281c618db; MCCONNELL M, 2010, 17 C RETR OPP INF PO, P243; McNulty A, 2007, J CLIN MICROBIOL, V45, P517, DOI 10.1128/JCM.02016-06; Mracna M, 2001, J CLIN MICROBIOL, V39, P4323, DOI 10.1128/JCM.39.12.4323-4327.2001; Parkin NT, 2009, ANTIVIR THER, V14, pA162; Saravanan S, 2009, J VIROL METHODS, V159, P211, DOI 10.1016/j.jviromet.2009.03.021; Schuurman R, 1999, J CLIN MICROBIOL, V37, P2291, DOI 10.1128/JCM.37.7.2291-2296.1999; Shafer RW, 2001, J CLIN MICROBIOL, V39, P1522, DOI 10.1128/JCM.39.4.1522-1529.2001; Simen BB, 2009, J INFECT DIS, V199, P693, DOI 10.1086/596736; Stringer JSA, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000233; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Wallis CL, 2010, J VIROL METHODS, V163, P505, DOI 10.1016/j.jviromet.2009.11.011; World Health Organization, 2010, WHO HIVRESNET HIV DR; World Health Organization, 2010, WHO MAN HIV DRUG RES; Yang CF, 2010, J CLIN MICROBIOL, V48, P3158, DOI 10.1128/JCM.00564-10; Youngpairoj AS, 2008, J ANTIMICROB CHEMOTH, V61, P1217, DOI 10.1093/jac/dkn100	52	80	88	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e28184	10.1371/journal.pone.0028184	http://dx.doi.org/10.1371/journal.pone.0028184			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132237	gold, Green Published, Green Submitted			2022-12-27	WOS:000298162000084
J	Landfors, M; Philip, P; Ryden, P; Stenberg, P				Landfors, Mattias; Philip, Philge; Ryden, Patrik; Stenberg, Per			Normalization of High Dimensional Genomics Data Where the Distribution of the Altered Variables Is Skewed	PLOS ONE			English	Article							HIDDEN MARKOV MODEL; MICROARRAY DATA; ARRAYS; EXPRESSION	Genome-wide analysis of gene expression or protein binding patterns using different array or sequencing based technologies is now routinely performed to compare different populations, such as treatment and reference groups. It is often necessary to normalize the data obtained to remove technical variation introduced in the course of conducting experimental work, but standard normalization techniques are not capable of eliminating technical bias in cases where the distribution of the truly altered variables is skewed, i.e. when a large fraction of the variables are either positively or negatively affected by the treatment. However, several experiments are likely to generate such skewed distributions, including ChIP-chip experiments for the study of chromatin, gene expression experiments for the study of apoptosis, and SNP-studies of copy number variation in normal and tumour tissues. A preliminary study using spike-in array data established that the capacity of an experiment to identify altered variables and generate unbiased estimates of the fold change decreases as the fraction of altered variables and the skewness increases. We propose the following work-flow for analyzing high-dimensional experiments with regions of altered variables: (1) Pre-process raw data using one of the standard normalization techniques. (2) Investigate if the distribution of the altered variables is skewed. (3) If the distribution is not believed to be skewed, no additional normalization is needed. Otherwise, re-normalize the data using a novel HMM-assisted normalization procedure. (4) Perform downstream analysis. Here, ChIP-chip data and simulated data were used to evaluate the performance of the work-flow. It was found that skewed distributions can be detected by using the novel DSE-test (Detection of Skewed Experiments). Furthermore, applying the HMM-assisted normalization to experiments where the distribution of the truly altered variables is skewed results in considerably higher sensitivity and lower bias than can be attained using standard and invariant normalization methods.	[Landfors, Mattias] Umea Univ, Div Clin Bacteriol, Umea, Sweden; [Landfors, Mattias; Ryden, Patrik] Umea Univ, Dept Math & Math Stat, Umea, Sweden; [Philip, Philge; Stenberg, Per] Umea Univ, Dept Mol Biol, Umea, Sweden	Umea University; Umea University; Umea University	Landfors, M (corresponding author), Umea Univ, Div Clin Bacteriol, Umea, Sweden.	Patrik.Ryden@math.umu.se; Per.Stenberg@molbiol.umu.se	Rydén, Patrik/I-4201-2016	Rydén, Patrik/0000-0002-0577-123X	Carl Trygger Foundation; Erik Philip-Sorensen Foundation; Ake Wiberg Foundation; Wallenberg Consortium North	Carl Trygger Foundation; Erik Philip-Sorensen Foundation; Ake Wiberg Foundation; Wallenberg Consortium North	The authors acknowledge support from the Carl Trygger Foundation (http://www.carltryggersstiftelse.se/), the Erik Philip-Sorensen Foundation (http://www.epss.se/), Ake Wiberg Foundation (http://www.ake-wiberg.com/), and the Wallenberg Consortium North (http://www.wallenberg.com/kaw/in_english/default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bowley AL, 1920, ELEMENTS STAT; Dudoit S, 2002, STAT SINICA, V12, P111; Freyhult E, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-503; HARTE DS, 2005, PACKAGE HIDDENMARKOV; Knott SRV, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-305; Li W, 2005, BIOINFORMATICS, V21, pI274, DOI 10.1093/bioinformatics/bti1046; Munch K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-239; Negre N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000814; Ni TT, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-505; Oshlack A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r2; Pelz CR, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-520; Peng SY, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-219; Qin ZHS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-369; Risso D, 2009, BIOINFORMATICS, V25, P2685, DOI 10.1093/bioinformatics/btp443; Ryden P, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-300; Schwartz YB, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000805; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Xiong HL, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-25; Zhang Y, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000320	21	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2011	6	11							e27942	10.1371/journal.pone.0027942	http://dx.doi.org/10.1371/journal.pone.0027942			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858JH	22132175	Green Published, gold, Green Submitted			2022-12-27	WOS:000297792400024
J	Wang, L; Xu, T; Lei, WW; Liu, DM; Li, YJ; Xuan, RJ; Ma, JJ				Wang, Lan; Xu, Tuan; Lei, Wen-wen; Liu, Dong-mei; Li, Ying-jun; Xuan, Rui-jing; Ma, Jing-jin			Cadmium-Induced Oxidative Stress and Apoptotic Changes in the Testis of Freshwater Crab, Sinopotamon henanense	PLOS ONE			English	Article							INDUCED TESTICULAR DAMAGE; DIPHENYL DISELENIDE; LIPID-PEROXIDATION; VITAMIN-E; RAT; CELLS; ACID; ACCUMULATION; MITOCHONDRIA; TESTOSTERONE	Cadmium (Cd), one of the most toxic environmental and industrial pollutants, is known to exert gonadotoxic and spermiotoxic effects. In the present study, we examined the toxic effect of Cd on the testis of freshwater crab, Sinopotamon henanense. Crabs were exposed to different Cd concentrations (from 0 to 116.00 mg.L-1) for 7 d. Oxidative stress and apoptotic changes in the testes were detected. The activities of SOD, GPx and CAT initially increased and subsequently decreased with increasing Cd concentrations, which was accompanied with the increase in malondialdehyde (MDA) and H2O2 content in a concentration-dependent manner. Typical morphological characteristic and physiological changes of apoptosis were observed using a variety of methods (HE staining, AO/EB double fluorescent staining, Transmission Electron Microscope observation and DNA fragmentation analysis), and the activities of caspase-3 and caspase-9 were increased in a concentration-dependent manner after Cd exposure. These results led to the conclusion that Cd could induced oxidative damage as well as apoptosis in the testis, and the apoptotic processes may be mediated via mitochondria-dependent apoptosis pathway by regulating the activities of caspase-3 and caspase-9.	[Wang, Lan; Xu, Tuan; Lei, Wen-wen; Liu, Dong-mei; Li, Ying-jun; Xuan, Rui-jing; Ma, Jing-jin] Shanxi Univ, Sch Life Sci, Taiyuan, Peoples R China	Shanxi University	Wang, L (corresponding author), Shanxi Univ, Sch Life Sci, Taiyuan, Peoples R China.	lanwang@sxu.edu.cn	xu, tuan/AAL-4781-2021		National Natural Science Foundation of China [30870267]; Natural Sciences Foundation of Shanxi Province [2008011069]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Sciences Foundation of Shanxi Province(Natural Science Foundation of Shanxi Province)	This work was supported by National Natural Science Foundation of China (no. 30870267, to Lan Wang) and the Natural Sciences Foundation of Shanxi Province (no. 2008011069). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AOKI A, 1978, BIOL REPROD, V18, P579, DOI 10.1095/biolreprod18.4.579; *ATSDR, 1997, TOX PROF CADM DRAFT; Aydilek N, 2004, ANDROLOGIA, V36, P277, DOI 10.1111/j.1439-0272.2004.00618.x; AYRES RU, 1992, P NATL ACAD SCI USA, V89, P815, DOI 10.1073/pnas.89.3.815; Baskic D, 2006, CELL BIOL INT, V30, P924, DOI 10.1016/j.cellbi.2006.06.016; [闭向阳 Bi Xiangyang], 2005, [环境化学, Environmental Chemistry], V24, P260; Blanco A, 2007, ENVIRON TOXICOL PHAR, V23, P96, DOI 10.1016/j.etap.2006.07.008; Blottner S, 1999, REPROD TOXICOL, V13, P261, DOI 10.1016/S0890-6238(99)00014-3; Bridges CC, 2005, TOXICOL APPL PHARM, V204, P274, DOI 10.1016/j.taap.2004.09.007; BULLOCK G, 1993, EXP HEMATOL, V21, P1640; [成杭新 Cheng hangxin], 2008, [地学前缘, Earth Science Frontiers], V15, P167; [成杭新 Cheng hangxin], 2008, [地学前缘, Earth Science Frontiers], V15, P203; Deiana L, 1999, FREE RADICAL RES, V31, P237, DOI 10.1080/10715769900300801; Edinger AL, 2004, CURR OPIN CELL BIOL, V16, P663, DOI 10.1016/j.ceb.2004.09.011; El-Ashmawy IM, 1999, TOXICOL APPL PHARM, V161, P34, DOI 10.1006/taap.1999.8785; El-Maraghy SA, 2001, J BIOCHEM MOL TOXIC, V15, P207, DOI 10.1002/jbt.18.abs; Filipic M, 2006, HUM EXP TOXICOL, V25, P67, DOI 10.1191/0960327106ht590oa; GORNALL AG, 1949, J BIOL CHEM, V177, P751; GOTH L, 1991, CLIN CHIM ACTA, V196, P143, DOI 10.1016/0009-8981(91)90067-M; Haouem S, 2008, EXP TOXICOL PATHOL, V59, P307, DOI 10.1016/j.etp.2007.10.002; Hetts SW, 1998, JAMA-J AM MED ASSOC, V279, P300, DOI 10.1001/jama.279.4.300; Ji YL, 2010, REPROD TOXICOL, V29, P176, DOI 10.1016/j.reprotox.2009.10.014; Johnson TM, 1996, P NATL ACAD SCI USA, V93, P11848, DOI 10.1073/pnas.93.21.11848; Kim J, 2006, J TOXICOL ENV HEAL A, V69, P1181, DOI 10.1080/15287390600631144; KOIZUMI T, 1992, J TOXICOL ENV HEALTH, V37, P25, DOI 10.1080/15287399209531654; Lasfer M, 2008, CELL BIOL TOXICOL, V24, P55, DOI 10.1007/s10565-007-9015-0; [李静 Li Jing], 2010, [环境科学学报, Acta Scientiae Circumstantiae], V30, P2277; LOHMANN RD, 1993, BIOCHEM BIOPH RES CO, V190, P1097, DOI 10.1006/bbrc.1993.1162; MANCA D, 1991, TOXICOLOGY, V67, P303, DOI 10.1016/0300-483X(91)90030-5; MCGAHON AJ, 1995, METHOD CELL BIOL, V46, P153; Messaoudi I, 2010, EXP TOXICOL PATHOL, V62, P281, DOI 10.1016/j.etp.2009.04.004; Migliarini B, 2005, GEN COMP ENDOCR, V142, P241, DOI 10.1016/j.ygcen.2004.12.012; Murugesan P, 2005, FREE RADICAL RES, V39, P1259, DOI 10.1080/10715760500308154; NISHIKIMI M, 1975, BIOCHEM BIOPH RES CO, V63, P463, DOI 10.1016/0006-291X(75)90710-X; Ognjanovic BI, 2010, REPROD TOXICOL, V29, P191, DOI 10.1016/j.reprotox.2009.11.009; Oh SH, 2006, TOXICOL APPL PHARM, V212, P212, DOI 10.1016/j.taap.2005.07.018; Parikh V, 2003, J PSYCHIATR RES, V37, P43, DOI 10.1016/S0022-3956(02)00048-1; Pathak N, 2006, TOXICOLOGY, V220, P26, DOI 10.1016/j.tox.2005.11.027; Pathak N, 2006, TOXICOL LETT, V165, P121, DOI 10.1016/j.toxlet.2006.02.004; Pignatti C, 2004, AMINO ACIDS, V27, P359, DOI 10.1007/s00726-004-0115-3; Qian YF, 2008, CELL BIOL INT, V32, P304, DOI 10.1016/j.cellbi.2007.10.004; Reinecke AJ, 2003, WATER AIR SOIL POLL, V145, P395, DOI 10.1023/A:1023602121272; ROTRUCK JT, 1973, SCIENCE, V179, P588, DOI 10.1126/science.179.4073.588; Santamaria A, 1997, TOXICOL LETT, V93, P117, DOI 10.1016/S0378-4274(97)00082-9; Santos FW, 2006, REPROD TOXICOL, V22, P546, DOI 10.1016/j.reprotox.2005.12.009; Santos FW, 2005, FOOD CHEM TOXICOL, V43, P1723, DOI 10.1016/j.fct.2005.05.015; Santos FW, 2004, TOXICOL LETT, V152, P255, DOI 10.1016/j.toxlet.2004.05.009; Schuwerack PMM, 2001, ECOTOXICOLOGY, V10, P159, DOI 10.1023/A:1016689810391; SCHWARTZMAN RA, 1993, ENDOCR REV, V14, P133, DOI 10.1210/er.14.2.133; Shaikh ZA, 1999, TOXICOL APPL PHARM, V154, P256, DOI 10.1006/taap.1998.8586; Stohs Sidney J., 2000, Journal of Environmental Pathology Toxicology and Oncology, V19, P201; SUGITA M, 1995, ENVIRON RES, V68, P31, DOI 10.1006/enrs.1995.1005; Thompson J, 2008, REPROD TOXICOL, V25, P304, DOI 10.1016/j.reprotox.2008.02.001; Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009; Waalkes MP, 1997, TOXICOL APPL PHARM, V142, P40, DOI 10.1006/taap.1996.8005; Waisberg M, 2003, TOXICOLOGY, V192, P95, DOI 10.1016/S0300-483X(03)00305-6; Walker N I, 1988, Methods Achiev Exp Pathol, V13, P18; Wang J, 2002, NEUROBIOL DIS, V10, P128, DOI 10.1006/nbdi.2002.0498; Wang Lan, 2002, Acta Zoologica Sinica, V48, P677; [夏锦霞 XIA Jin-xia], 2009, [吉林大学学报. 地球科学版, Journal of Jilin University. Earth Science Edition], V39, P305; Xie H, 2007, APOPTOSIS, V12, P247, DOI 10.1007/s10495-006-0489-7; Xu CY, 1996, TOXICOLOGY, V107, P1, DOI 10.1016/0300-483X(95)03195-L; Xu LC, 2001, BIOMED ENVIRON SCI, V14, P312; Yadav N, 2008, FOOD CHEM TOXICOL, V46, P494, DOI 10.1016/j.fct.2007.08.035; Yan Bo, 2007, Acta Zoologica Sinica, V53, P1121; Yang JM, 2003, REPROD TOXICOL, V17, P553, DOI 10.1016/S0890-6238(03)00100-X; Ye JL, 2007, ENVIRON TOXICOL PHAR, V24, P45, DOI 10.1016/j.etap.2007.01.007; Zhang LC, 1996, CHEM ELEMENT WATER E; [赵传冬 Zhao Chuandong], 2008, [地学前缘, Earth Science Frontiers], V15, P179; ZIELINSKAPSUJA B, 1979, INT J ANDROL, V2, P150, DOI 10.1111/j.1365-2605.1979.tb00048.x	70	35	50	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2011	6	11							e27853	10.1371/journal.pone.0027853	http://dx.doi.org/10.1371/journal.pone.0027853			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858JH	22132153	Green Submitted, Green Published, gold			2022-12-27	WOS:000297792400018
J	Lustoza, ACDM; Palma, LM; Facanha, AR; Okorokov, LA; Okorokova-Facanha, AL				Lustoza, Ana Cristina D. M.; Palma, Livia M.; Facanha, Arnoldo R.; Okorokov, Lev A.; Okorokova-Facanha, Anna L.			P-5A-Type ATPase Cta4p Is Essential for Ca2+ Transport in the Endoplasmic Reticulum of Schizosaccharomyces pombe	PLOS ONE			English	Article							P-TYPE ATPASE; UNFOLDED PROTEIN RESPONSE; YEAST SECRETORY PATHWAY; SACCHAROMYCES-CEREVISIAE; FISSION YEAST; TRANSCRIPTION FACTOR; GENE-EXPRESSION; CALCINEURIN; CALCIUM; HOMEOSTASIS	This study establishes the role of P-5A-type Cta4 ATPase in Ca2+ sequestration in the endoplasmic reticulum by detecting an ATP-dependent, vanadate-sensitive and FCCP insensitive Ca-45(2+)-transport in fission yeast membranes isolated by cellular fractionation. Specifically, the Ca2+-ATPase transport activity was decreased in ER membranes isolated from cells lacking a cta4(+) gene. Furthermore, a disruption of cta4(+) resulted in 6-fold increase of intracellular Ca2+ levels, sensitivity towards accumulation of misfolded proteins in ER and ER stress, stimulation of the calcineurin phosphatase activity and vacuolar Ca2+ pumping. These data provide compelling biochemical evidence for a P-5A-type Cta4 ATPase as an essential component of Ca2+ transport system and signaling network which regulate, in conjunction with calcineurin, the ER functionality in fission yeast.	[Lustoza, Ana Cristina D. M.; Palma, Livia M.; Okorokov, Lev A.; Okorokova-Facanha, Anna L.] Univ Estadual Norte Fluminense, Lab Fisiol & Bioquim Microrganismos, Ctr Biociencias & Biotecnol, Rio De Janeiro, Brazil; [Facanha, Arnoldo R.] Univ Estadual Norte Fluminense, Lab Biol Celular & Tecidual, Ctr Biociencias & Biotecnol, Rio De Janeiro, Brazil	Universidade Estadual do Norte Fluminense; Universidade Estadual do Norte Fluminense	Lustoza, ACDM (corresponding author), Univ Estadual Norte Fluminense, Lab Fisiol & Bioquim Microrganismos, Ctr Biociencias & Biotecnol, Rio De Janeiro, Brazil.	anna@uenf.br	Facanha, Arnoldo Rocha/A-2833-2008	Okorokov, Lev/0000-0002-8469-0701; Rocha Facanha, Arnoldo/0000-0002-5641-6852; Okorokova-Facanha, Anna/0000-0002-6856-7711	CNPq (Conselho Nacional de Pesquisa e Desenvolvimento); FAPERJ (Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro); CAPES (Coordenacao de Aperfeicoamento de Pessoal no Nivel Superior)	CNPq (Conselho Nacional de Pesquisa e Desenvolvimento)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ (Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CAPES (Coordenacao de Aperfeicoamento de Pessoal no Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by CNPq (Conselho Nacional de Pesquisa e Desenvolvimento) and FAPERJ (Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro). ACDML and LMP received a PhD fellowship from CAPES (Coordenacao de Aperfeicoamento de Pessoal no Nivel Superior). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEIJON C, 1989, P NATL ACAD SCI USA, V86, P6935, DOI 10.1073/pnas.86.18.6935; Axelsen KB, 1998, J MOL EVOL, V46, P84, DOI 10.1007/PL00006286; Benko Z, 2004, MOL GENET GENOMICS, V271, P161, DOI 10.1007/s00438-003-0967-3; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bonilla M, 2003, MOL BIOL CELL, V14, P4296, DOI 10.1091/mbc.E03-02-0113; Bonilla M, 2002, EMBO J, V21, P2343, DOI 10.1093/emboj/21.10.2343; BUSH DS, 1995, ANNU REV PLANT PHYS, V46, P95, DOI 10.1146/annurev.pp.46.060195.000523; Carafoli E, 2000, CURR OPIN CHEM BIOL, V4, P152, DOI 10.1016/S1367-5931(99)00069-1; Catty P, 1997, FEBS LETT, V409, P325, DOI 10.1016/S0014-5793(97)00446-8; Corbett EF, 2000, TRENDS BIOCHEM SCI, V25, P307, DOI 10.1016/S0968-0004(00)01588-7; Cortes JCG, 2004, EUKARYOT CELL, V3, P1124, DOI 10.1128/EC.3.5.1124-1135.2004; Cronin SR, 2002, J CELL BIOL, V157, P1017, DOI 10.1083/jcb.200203052; Cunningham KW, 1996, MOL CELL BIOL, V16, P2226; Cyert MS, 2003, BIOCHEM BIOPH RES CO, V311, P1143, DOI 10.1016/S0006-291X(03)01552-3; Deng L, 2006, MOL BIOL CELL, V17, P4790, DOI 10.1091/mbc.E06-06-0526; Durr G, 1998, MOL BIOL CELL, V9, P1149, DOI 10.1091/mbc.9.5.1149; Eckford PDW, 2005, BIOCHEM J, V389, P517, DOI 10.1042/BJ20050047; Facanha ALO, 2002, J CELL BIOL, V157, P1029, DOI 10.1083/jcb.200111012; Furune T, 2008, GENES GENET SYST, V83, P373, DOI 10.1266/ggs.83.373; Groenendyk J, 2004, MOL CELLS, V17, P383; Jakobsen MK, 2005, GENE DEV, V19, P2757, DOI 10.1101/gad.357305; KOZUTSUMI Y, 1988, NATURE, V332, P462, DOI 10.1038/332462a0; Locke EG, 2000, MOL CELL BIOL, V20, P6686, DOI 10.1128/MCB.20.18.6686-6694.2000; Martin DC, 2011, J BIOL CHEM, V286, P10744, DOI 10.1074/jbc.M110.177451; Matheos DP, 1997, GENE DEV, V11, P3445, DOI 10.1101/gad.11.24.3445; Okorokov LA, 1998, FEMS MICROBIOL LETT, V162, P83, DOI 10.1111/j.1574-6968.1998.tb12982.x; Okorokov LA, 2001, FEBS LETT, V505, P321, DOI 10.1016/S0014-5793(01)02852-6; Okorokova-Facanha AL, 2003, CURR GENET, V43, P273, DOI 10.1007/s00294-003-0395-2; Pimpl P, 2006, PLANT CELL, V18, P198, DOI 10.1105/tpc.105.036665; Poulsen LR, 2008, CELL MOL LIFE SCI, V65, P3119, DOI 10.1007/s00018-008-8341-6; PRICE BD, 1992, J CELL PHYSIOL, V152, P545, DOI 10.1002/jcp.1041520314; Putney JW, 2009, IMMUNOL REV, V231, P10, DOI 10.1111/j.1600-065X.2009.00810.x; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; SAMARAO SS, 2009, BIOCHIM BIOPHYS ACTA, V2, P303; Sanders D, 1999, PLANT CELL, V11, P691, DOI 10.1105/tpc.11.4.691; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Sorensen DM, 2010, BBA-BIOENERGETICS, V1797, P846, DOI 10.1016/j.bbabio.2010.04.010; Sugiura R, 2002, GENES CELLS, V7, P619, DOI 10.1046/j.1365-2443.2002.00557.x; Suzuki C, 1999, MOL MICROBIOL, V32, P813, DOI 10.1046/j.1365-2958.1999.01400.x; Suzuki C, 2001, BIOSCI BIOTECH BIOCH, V65, P2405, DOI 10.1271/bbb.65.2405; Thever MD, 2009, J MEMBRANE BIOL, V229, P115, DOI 10.1007/s00232-009-9176-2; Yoshimoto H, 2002, J BIOL CHEM, V277, P31079, DOI 10.1074/jbc.M202718200; Zhou XM, 2009, P NATL ACAD SCI USA, V106, P16586, DOI 10.1073/pnas.0904293106	43	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2011	6	11							e27843	10.1371/journal.pone.0027843	http://dx.doi.org/10.1371/journal.pone.0027843			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IO	22132152	Green Submitted, gold, Green Published			2022-12-27	WOS:000297789900025
J	Milczarski, P; Bolibok-Bragoszewska, H; Myskow, B; Stojalowski, S; Heller-Uszynska, K; Goralska, M; Bragoszewski, P; Uszynski, G; Kilian, A; Rakoczy-Trojanowska, M				Milczarski, Pawel; Bolibok-Bragoszewska, Hanna; Myskow, Beata; Stojalowski, Stefan; Heller-Uszynska, Katarzyna; Goralska, Magdalena; Bragoszewski, Piotr; Uszynski, Grzegorz; Kilian, Andrzej; Rakoczy-Trojanowska, Monika			A High Density Consensus Map of Rye (Secale cereale L.) Based on DArT Markers	PLOS ONE			English	Article							ARRAYS TECHNOLOGY DART; POLYMORPHIC DNA RAPD; GENETIC-MAP; DIVERSITY ARRAYS; LINKAGE MAP; GENOME; MICROSATELLITE; LOCI; SSR; RFLP	Background: Rye (Secale cereale L.) is an economically important crop, exhibiting unique features such as outstanding resistance to biotic and abiotic stresses and high nutrient use efficiency. This species presents a challenge to geneticists and breeders due to its large genome containing a high proportion of repetitive sequences, self incompatibility, severe inbreeding depression and tissue culture recalcitrance. The genomic resources currently available for rye are underdeveloped in comparison with other crops of similar economic importance. The aim of this study was to create a highly saturated, multilocus linkage map of rye via consensus mapping, based on Diversity Arrays Technology (DArT) markers. Methodology/Principal Findings: Recombinant inbred lines (RILs) from 5 populations (564 in total) were genotyped using DArT markers and subjected to linkage analysis using Join Map 4.0 and Multipoint Consensus 2.2 software. A consensus map was constructed using a total of 9703 segregating markers. The average chromosome map length ranged from 199.9 cM (2R) to 251.4 cM (4R) and the average map density was 1.1 cM. The integrated map comprised 4048 loci with the number of markers per chromosome ranging from 454 for 7R to 805 for 4R. In comparison with previously published studies on rye, this represents an eight-fold increase in the number of loci placed on a consensus map and a more than two-fold increase in the number of genetically mapped DArT markers. Conclusions/Significance: Through the careful choice of marker type, mapping populations and the use of software packages implementing powerful algorithms for map order optimization, we produced a valuable resource for rye and triticale genomics and breeding, which provides an excellent starting point for more in-depth studies on rye genome organization.	[Milczarski, Pawel; Myskow, Beata; Stojalowski, Stefan; Goralska, Magdalena] W Pomeranian Univ Technol, Dept Plant Genet Breeding & Biotechnol, Szczecin, Poland; [Bolibok-Bragoszewska, Hanna; Rakoczy-Trojanowska, Monika] Warsaw Univ Life Sci, Dept Plant Genet Breeding & Biotechnol, Warsaw, Poland; [Heller-Uszynska, Katarzyna; Uszynski, Grzegorz; Kilian, Andrzej] Divers Arrays Technol PL, Canberra, ACT, Australia; [Bragoszewski, Piotr] Int Inst Mol & Cell Biol, Lab Mitochondrial Biogenesis, Warsaw, Poland	West Pomeranian University of Technology; Warsaw University of Life Sciences; Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej	Milczarski, P (corresponding author), W Pomeranian Univ Technol, Dept Plant Genet Breeding & Biotechnol, Szczecin, Poland.	tapatik@yahoo.com	Brągoszewski, Piotr/ABD-7014-2020; Milczarski, Paweł/M-6657-2016; Stojałowski, Stefan/H-2161-2016; Myśków, Beata/H-2024-2016	Brągoszewski, Piotr/0000-0002-9684-6750; Milczarski, Paweł/0000-0003-2622-8938; Stojałowski, Stefan/0000-0002-2666-9090; Myśków, Beata/0000-0001-5062-9841; Bolibok-Bragoszewska, Hanna/0000-0002-8030-2716; Goralska, Magdalena/0000-0003-0219-6281; Rakoczy-Trojanowska, Monika/0000-0001-6891-0471; Kilian, Andrzej/0000-0002-2730-7462	Ministry of Science and Higher Education [NN 302361833]	Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work has been financially supported by the Ministry of Science and Higher Education [http://www.nauka.gov.pl/home/] grant NN 302361833. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbari M, 2006, THEOR APPL GENET, V113, P1409, DOI 10.1007/s00122-006-0365-4; Alheit KV, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-380; Areshchenkova T, 2002, THEOR APPL GENET, V104, P229, DOI 10.1007/s00122-001-0775-2; Badea A, 2011, THEOR APPL GENET, V122, P1547, DOI 10.1007/s00122-011-1554-3; Bartos J, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-95; BAUM M, 1991, CHROMOSOMA, V101, P1, DOI 10.1007/BF00360680; Bednarek PT, 2003, J APPL GENET, V44, P21; Bolibok H, 2005, EUPHYTICA, V146, P109, DOI 10.1007/s10681-005-0548-0; Bolibok H, 2007, CELL MOL BIOL LETT, V12, P523, DOI 10.2478/s11658-007-0023-0; Bolibok-Bragoszewska H, 2011, CEREAL RES IN PRESS; Bolibok-Bragoszewska H, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-578; Borner A, 1998, THEOR APPL GENET, V97, P1279, DOI 10.1007/s001220051020; DEVOS KM, 1993, THEOR APPL GENET, V85, P673, DOI 10.1007/BF00225004; Ferreira A, 2006, GENET MOL BIOL, V29, P187, DOI 10.1590/S1415-47572006000100033; Gupta PK, 2008, HEREDITY, V101, P5, DOI 10.1038/hdy.2008.35; Gustafson JP, 2009, THEOR APPL GENET, V118, P793, DOI 10.1007/s00122-008-0939-4; Hackauf B, 2009, THEOR APPL GENET, V118, P371, DOI 10.1007/s00122-008-0906-0; Hackauf B, 2002, PLANT BREEDING, V121, P17, DOI 10.1046/j.1439-0523.2002.00649.x; Isidore E, 2003, GENETICS, V165, P2107; Jaccard P., 1908, B SOC VAUD SCI N, V44, P223; Jaccoud D, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.4.e25; Khlestkina EK, 2004, THEOR APPL GENET, V109, P725, DOI 10.1007/s00122-004-1659-z; Korol A, 2009, PLANT GENET GENOMICS, V7, P163, DOI 10.1007/978-0-387-77489-3_6; Korzun V, 2001, THEOR APPL GENET, V102, P709, DOI 10.1007/s001220051701; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Li YL, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-6; Loarce Y, 1996, THEOR APPL GENET, V93, P1112, DOI 10.1007/BF00230133; LUKASZEWSKI AJ, 1982, THEOR APPL GENET, V62, P145, DOI 10.1007/BF00293347; Lumpkin TA, 2010, MOLECULAR PLANT BREEDING, P113, DOI 10.1079/9781845933920.0113; Ma XF, 2001, THEOR APPL GENET, V102, P517, DOI 10.1007/s001220051676; Mace ES, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-13; Madej L. J., 1996, Vortrage fur Pflanzenzuchtung, P1; Masojc P, 2001, THEOR APPL GENET, V102, P1273, DOI 10.1007/s001220000512; Milczarski P, 2010, IDENTIFICATION COMP; Milczarski P, 2007, J APPL GENET, V48, P11, DOI 10.1007/BF03194653; Myskow B, 2010, J APPL GENET, V51, P283; Myskow Beata, 2001, Journal of Applied Genetics, V42, P1; Myskow B, 2012, MOL BREEDING, V30, P367, DOI 10.1007/s11032-011-9627-1; Paux E, 2008, SCIENCE, V322, P101, DOI 10.1126/science.1161847; PHILIPP U, 1994, THEOR APPL GENET, V88, P243, DOI 10.1007/BF00225904; Ren Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005795; Rohlf FJ, 2000, NTSYS PC NUMERICAL T; Saal B, 1999, GENOME, V42, P964, DOI 10.1139/gen-42-5-964; Schiantarelli E, 2001, THEOR APPL GENET, V102, P335, DOI 10.1007/s001220051650; SCHLEGEL R, 1987, THEOR APPL GENET, V74, P820, DOI 10.1007/BF00247563; Schlegel R, 2008, GENES MARKERS LINKAG; Senft P, 1996, PLANT BREEDING, V115, P508, DOI 10.1111/j.1439-0523.1996.tb00966.x; Sharopova N, 2002, PLANT MOL BIOL, V48, P463, DOI 10.1023/A:1014868625533; Stojalowski Stefan, 2005, Journal of Applied Genetics, V46, P371; Stojalowski S, 2009, CELL MOL BIOL LETT, V14, P190, DOI 10.2478/s11658-008-0042-5; Stojalowski SA, 2011, J APPL GENET, V52, P313, DOI 10.1007/s13353-011-0049-x; Tenhola-Roininen T, 2011, J APPL GENET, V52, P299, DOI 10.1007/s13353-011-0029-1; Tyrka M, 2011, GENOME, V54, P391, DOI [10.1139/g11-009, 10.1139/G11-009]; Van Ooijen J.W, 2006, JOINMAP R 4 SOFTWARE; van Os H, 2006, GENETICS, V173, P1075, DOI 10.1534/genetics.106.055871; Varshney RK, 2007, THEOR APPL GENET, V114, P1091, DOI 10.1007/s00122-007-0503-7; Varshney RK, 2007, THEOR APPL GENET, V114, P1105, DOI 10.1007/s00122-007-0504-6; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wenzl P, 2004, P NATL ACAD SCI USA, V101, P9915, DOI 10.1073/pnas.0401076101; Wenzl P, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-206	60	61	65	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2011	6	12							e28495	10.1371/journal.pone.0028495	http://dx.doi.org/10.1371/journal.pone.0028495			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863OC	22163026	gold, Green Submitted, Green Published			2022-12-27	WOS:000298173500027
J	Anderegg, F; Geblinger, D; Horvath, P; Charnley, M; Textor, M; Addadi, L; Geiger, B				Anderegg, Fabian; Geblinger, Dafna; Horvath, Peter; Charnley, Mirren; Textor, Marcus; Addadi, Lia; Geiger, Benjamin			Substrate Adhesion Regulates Sealing Zone Architecture and Dynamics in Cultured Osteoclasts	PLOS ONE			English	Article							CELL-MATRIX ADHESIONS; EXTRACELLULAR-MATRIX; MECHANOSENSORY FUNCTION; INTEGRIN; PODOSOMES; GROWTH; DIFFERENTIATION; ORGANIZATION; RESORPTION; TURNOVER	The bone-degrading activity of osteoclasts depends on the formation of a cytoskeletal-adhesive super-structure known as the sealing zone (SZ). The SZ is a dynamic structure, consisting of a condensed array of podosomes, the elementary adhesion-mediating structures of osteoclasts, interconnected by F-actin filaments. The molecular composition and structure of the SZ were extensively investigated, yet despite its major importance for bone formation and remodelling, the mechanisms underlying its assembly and dynamics are still poorly understood. Here we determine the relations between matrix adhesiveness and the formation, stability and expansion of the SZ. By growing differentiated osteoclasts on micro-patterned glass substrates, where adhesive areas are separated by non-adhesive PLL-g-PEG barriers, we show that SZ growth and fusion strictly depend on the continuity of substrate adhesiveness, at the micrometer scale. We present a possible model for the role of mechanical forces in SZ formation and reorganization, inspired by the current data.	[Anderegg, Fabian; Charnley, Mirren; Textor, Marcus] Swiss Fed Inst Technol, Lab Surface Sci & Technol, Dept Mat, Zurich, Switzerland; [Geblinger, Dafna; Addadi, Lia] Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel; [Anderegg, Fabian; Geblinger, Dafna; Geiger, Benjamin] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; [Horvath, Peter] Swiss Fed Inst Technol, Dept Biol, Light Microscopy Ctr, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Weizmann Institute of Science; Weizmann Institute of Science; Swiss Federal Institutes of Technology Domain; ETH Zurich	Anderegg, F (corresponding author), Swiss Fed Inst Technol, Lab Surface Sci & Technol, Dept Mat, Zurich, Switzerland.	benny.geiger@weizmann.ac.il	Textor, Marcus/A-6200-2012	Textor, Marcus/0000-0002-0178-1801; Charnley, Mirren/0000-0003-3845-9290	Israel Science Foundation; Swiss Society of Friends of the Weizmann Institute of Science; Eidgenossische Technische Hochshule Zurich [TH-31 06-2]; European Union [FP7/2007-2013, 237946]	Israel Science Foundation(Israel Science Foundation); Swiss Society of Friends of the Weizmann Institute of Science; Eidgenossische Technische Hochshule Zurich; European Union(European Commission)	This study was supported by grants from the Israel Science Foundation and the Swiss Society of Friends of the Weizmann Institute of Science. Additionally, financial support by Eidgenossische Technische Hochshule Zurich (grant No. TH-31 06-2) and the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement No. 237946 is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon R, 2005, J CELL BIOL, V171, P1073, DOI 10.1083/jcb.200503155; Arnold M, 2004, CHEMPHYSCHEM, V5, P383, DOI 10.1002/cphc.200301014; AVNUR Z, 1981, J MOL BIOL, V153, P361, DOI 10.1016/0022-2836(81)90283-7; Berrier AL, 2007, J CELL PHYSIOL, V213, P565, DOI 10.1002/jcp.21237; Bershadsky AD, 2006, EUR J CELL BIOL, V85, P165, DOI 10.1016/j.ejcb.2005.11.001; Bershadsky AD, 2003, ANNU REV CELL DEV BI, V19, P677, DOI 10.1146/annurev.cellbio.19.111301.153011; Bryce NS, 2005, CURR BIOL, V15, P1276, DOI 10.1016/j.cub.2005.06.043; Cavalcanti-Adam EA, 2006, EUR J CELL BIOL, V85, P219, DOI 10.1016/j.ejcb.2005.09.011; Cavalcanti-Adam EA, 2007, BIOPHYS J, V92, P2964, DOI 10.1529/biophysj.106.089730; Chen CS, 2004, ANNU REV BIOMED ENG, V6, P275, DOI 10.1146/annurev.bioeng.6.040803.140040; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; Collin O, 2008, CURR BIOL, V18, P1288, DOI 10.1016/j.cub.2008.07.046; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Destaing O, 2003, MOL BIOL CELL, V14, P407, DOI 10.1091/mbc.E02-07-0389; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Falconnet D, 2004, ADV FUNCT MATER, V14, P749, DOI 10.1002/adfm.200305182; Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9; FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0; Geblinger D, 2011, J ROYAL SOC IN PRESS; Geblinger D, 2010, J CELL SCI, V123, P1503, DOI 10.1242/jcs.060954; Geblinger D, 2009, CHEMBIOCHEM, V10, P158, DOI 10.1002/cbic.200800549; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Geiger B, 2001, CURR OPIN CELL BIOL, V13, P584, DOI 10.1016/S0955-0674(00)00255-6; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; Henriksen K, 2007, OSTEOPOROSIS INT, V18, P751, DOI 10.1007/s00198-006-0298-4; INGBER DE, 1989, J CELL BIOL, V109, P317, DOI 10.1083/jcb.109.1.317; Jimi E, 1999, J IMMUNOL, V163, P434; Jurdic P, 2006, EUR J CELL BIOL, V85, P195, DOI 10.1016/j.ejcb.2005.09.008; Kunzler TP, 2007, BIOMATERIALS, V28, P2175, DOI 10.1016/j.biomaterials.2007.01.019; LANYON LE, 1993, CALCIFIED TISSUE INT, V53, pS102, DOI 10.1007/BF01673415; Luxenburg C, 2006, EUR J CELL BIOL, V85, P203, DOI 10.1016/j.ejcb.2005.11.002; Luxenburg C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000179; MARCHISIO PC, 1984, J CELL BIOL, V99, P1696, DOI 10.1083/jcb.99.5.1696; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Nakamura I, 1999, J CELL SCI, V112, P3985; Nakamura I, 1996, J BONE MINER RES, V11, P1873; NERMUT MV, 1991, EXP CELL RES, V193, P382, DOI 10.1016/0014-4827(91)90111-7; Nesbitt SA, 1997, SCIENCE, V276, P266, DOI 10.1126/science.276.5310.266; Owen KA, 2007, J CELL BIOL, V179, P1275, DOI 10.1083/jcb.200708093; Pfaff M, 2001, J CELL SCI, V114, P2775; Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175; Rodan GA, 2000, SCIENCE, V289, P1508, DOI 10.1126/science.289.5484.1508; Roodman GD, 1996, ENDOCR REV, V17, P308, DOI 10.1210/er.17.4.308; Salo J, 1997, SCIENCE, V276, P270, DOI 10.1126/science.276.5310.270; Saltel F, 2004, MOL BIOL CELL, V15, P5231, DOI 10.1091/mbc.E04-06-0522; SHIMIZU H, 1989, BONE MINER, V6, P261, DOI 10.1016/0169-6009(89)90033-0; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Thery M, 2005, NAT CELL BIOL, V7, P947, DOI 10.1038/ncb1307; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Vaananen HK, 2000, J CELL SCI, V113, P377; VAANANEN HK, 1988, ANN CHIR GYNAECOL FE, V77, P193; Wang HB, 2000, AM J PHYSIOL-CELL PH, V279, pC1345, DOI 10.1152/ajpcell.2000.279.5.C1345; Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153; Zaidel-Bar R, 2004, BIOCHEM SOC T, V32, P416, DOI 10.1042/BST0320416; Zaidel-Bar R, 2003, J CELL SCI, V116, P4605, DOI 10.1242/jcs.00792; Zaidel-Bar R, 2010, J CELL SCI, V123, P1385, DOI 10.1242/jcs.066183; ZALLONE AZ, 1989, CONNECT TISSUE RES, V20, P143, DOI 10.3109/03008208909023882; ZAMBONINZALLONE A, 1989, EXP CELL RES, V182, P645, DOI 10.1016/0014-4827(89)90266-8; Zamir E, 2000, NAT CELL BIOL, V2, P191, DOI 10.1038/35008607; Zimerman B, 2004, IEE Proc Nanobiotechnol, V151, P62, DOI 10.1049/ip-nbt:20040474	60	35	35	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e28583	10.1371/journal.pone.0028583	http://dx.doi.org/10.1371/journal.pone.0028583			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22162778	Green Published, gold, Green Submitted			2022-12-27	WOS:000298172800049
J	Beyersdorf, N; Werner, S; Wolf, N; Herrmann, T; Kerkau, T				Beyersdorf, Niklas; Werner, Sandra; Wolf, Nelli; Herrmann, Thomas; Kerkau, Thomas			Characterization of a New Mouse Model for Peripheral T Cell Lymphoma in Humans	PLOS ONE			English	Article							MONOCLONAL-ANTIBODY; CYTOKINE STORM; RELEASE; DISEASE; MICE	Peripheral T cell lymphomas (PTCLs) are associated with a poor prognosis due to often advanced disease at the time of diagnosis and due to a lack of efficient therapeutic options. Therefore, appropriate animal models of PTCL are vital to improve clinical management of this disease. Here, we describe a monoclonal CD8(+) CD4(-) alpha beta T cell receptor V beta 2(+) CD28(+) T cell lymphoma line, termed T8-28. T8-28 cells were isolated from an un-manipulated adult BALB/c mouse housed under standard pathogen-free conditions. T8-28 cells induced terminal malignancy upon adoptive transfer into syngeneic BALB/c mice. Despite intracellular expression of the cytotoxic T cell differentiation marker granzyme B, T8-28 cells appeared to be defective with respect to cytotoxic activity as read-out in vitro. Among the protocols tested, only addition of interleukin 2 in vitro could partially compensate for the in vivo micro-milieu in promoting growth of the T8-28 lymphoma cells.	[Beyersdorf, Niklas; Werner, Sandra; Wolf, Nelli; Herrmann, Thomas; Kerkau, Thomas] Univ Wurzburg, Inst Virol & Immunobiol, D-8700 Wurzburg, Germany	University of Wurzburg	Beyersdorf, N (corresponding author), Univ Wurzburg, Inst Virol & Immunobiol, Versbacher Str 7, D-8700 Wurzburg, Germany.	niklas.beyersdorf@vim.uni-wuerzburg.de	Kerkau, Thomas/ABE-8007-2020; Beyersdorf, Niklas/S-3845-2016; Herrmann, Thomas/J-4943-2012	Beyersdorf, Niklas/0000-0002-9236-5415; Herrmann, Thomas/0000-0002-1093-0194	Wilhelm Sander-Stiftung [2005.133.1, 2005.133.2]; The Deutsche Forschungsgemeinschaft	Wilhelm Sander-Stiftung; The Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the Wilhelm Sander-Stiftung (2005.133.1 and 2005.133.2; http://www.sanst.de). The Deutsche Forschungsgemeinschaft (http://www.dfg.de) supported the publication of this article as 'open access'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMOWICZ D, 1989, TRANSPLANTATION, V47, P606, DOI 10.1097/00007890-198904000-00008; Aschan J, 2006, BRIT MED BULL, V77-78, P23, DOI 10.1093/bmb/ldl005; Beyersdorf N, 2008, BLOOD, V112, P4328, DOI 10.1182/blood-2008-03-146662; Beyersdorf N, 2009, BLOOD, V114, P4575, DOI 10.1182/blood-2009-04-218248; Brochet X, 2008, NUCLEIC ACIDS RES, V36, pW503, DOI 10.1093/nar/gkn316; Dennehy KM, 2006, J IMMUNOL, V176, P5725, DOI 10.4049/jimmunol.176.10.5725; Dierks C, 2010, CANCER RES, V70, P6193, DOI 10.1158/0008-5472.CAN-08-3719; Gogishvili T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004643; GOLDMAN M, 1989, LANCET, V2, P802; GORER PA, 1950, BRIT J CANCER, V4, P372, DOI 10.1038/bjc.1950.36; Kolb HJ, 2004, BLOOD, V103, P767, DOI 10.1182/blood-2003-02-0342; Mulloy JC, 2010, J EXP MED, V207, P911, DOI 10.1084/jem.20100608; Pechloff K, 2010, J EXP MED, V207, P1031, DOI 10.1084/jem.20092042; Savage KJ, 2007, BLOOD REV, V21, P201, DOI 10.1016/j.blre.2007.03.001; Suntharalingam G, 2006, NEW ENGL J MED, V355, P1018, DOI 10.1056/NEJMoa063842; van Hall T, 2000, J IMMUNOL, V165, P869, DOI 10.4049/jimmunol.165.2.869	16	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e28546	10.1371/journal.pone.0028546	http://dx.doi.org/10.1371/journal.pone.0028546			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22163033	gold, Green Published, Green Submitted			2022-12-27	WOS:000298172800046
J	Dubey, R; Chhabra, R; Saini, N				Dubey, Richa; Chhabra, Ravindresh; Saini, Neeru			Small Interfering RNA against Transcription Factor STAT6 Leads to Increased Cholesterol Synthesis in Lung Cancer Cell Lines	PLOS ONE			English	Article							ALLERGIC AIRWAY INFLAMMATION; SIGNAL TRANSDUCER; HODGKIN LYMPHOMA; GENE-EXPRESSION; FORK HEAD; APOPTOSIS; MICE; INTERLEUKIN-4; ACTIVATION; RESPONSES	STAT6 transcription factor has become a potential molecule for therapeutic intervention because it regulates broad range of cellular processes in a large variety of cell types. Although some target genes and interacting partners of STAT6 have been identified, its exact mechanism of action needs to be elucidated. In this study, we sought to further characterize the molecular interactions, networks, and functions of STAT6 by profiling the mRNA expression of STAT6 silenced human lung cells (NCI-H460) using microarrays. Our analysis revealed 273 differentially expressed genes after STAT6 silencing. Analysis of the gene expression data with Ingenuity Pathway Analysis (IPA) software revealed Gene expression, Cell death, Lipid metabolism as the functions associated with highest rated network. Cholesterol biosynthesis was among the most enriched pathways in IPA as well as in PANTHER analysis. These results have been validated by real-time PCR and cholesterol assay using scrambled siRNA as a negative control. Similar findings were also observed with human type II pulmonary alveolar epithelial cells, A549. In the present study we have, for the first time, shown the inverse relationship of STAT6 with the cholesterol biosynthesis in lung cancer cells. The present findings are potentially significant to advance the understanding and design of therapeutics for the pathological conditions where both STAT6 and cholesterol biosynthesis are implicated viz. asthma, atherosclerosis etc.	[Dubey, Richa; Chhabra, Ravindresh; Saini, Neeru] Inst Genom & Integrat Biol CSIR, Funct Genom Unit, Delhi, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB)	Dubey, R (corresponding author), Inst Genom & Integrat Biol CSIR, Funct Genom Unit, Delhi, India.	nsaini@igib.in	Chhabra, Ravindresh/GSE-1747-2022; Chhabra, Ravindresh/X-5251-2018; Chhabra, Ravindresh/AAM-4994-2021	Chhabra, Ravindresh/0000-0002-2734-7368; 	Department of Biotechnology (DBT) [GAP0047]; DBT [GAP0047]; CSIR (Council of Scientific and Industrial Research)	Department of Biotechnology (DBT)(Department of Biotechnology (DBT) India); DBT(Department of Biotechnology (DBT) India); CSIR (Council of Scientific and Industrial Research)(Council of Scientific & Industrial Research (CSIR) - India)	The authors acknowledge the Department of Biotechnology (DBT) for funding the project titled 'Study of STAT6 transcription factor in apoptosis regulation using RNAi Technology' (GAP0047). RD was financially supported by DBT project GAP0047. RC was supported with CSIR-Senior Research Fellowship (Council of Scientific and Industrial Research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimoto T, 1998, J EXP MED, V187, P1537, DOI 10.1084/jem.187.9.1537; Aprahamian T, 2006, J IMMUNOL, V177, P3028, DOI 10.4049/jimmunol.177.5.3028; Bailey DP, 2004, EXP HEMATOL, V32, P52, DOI 10.1016/j.exphem.2003.10.011; Baus D, 2009, LEUKEMIA, V23, P1885, DOI 10.1038/leu.2009.103; Black HES NJ, 1993, USE INTERLEUKIN 4 LO; Blais A, 2005, GENE DEV, V19, P1499, DOI 10.1101/gad.1325605; Cui X, 2007, ONCOGENE, V26, P4253, DOI 10.1038/sj.onc.1210222; Darcan-Nicolaisen Y, 2009, J IMMUNOL, V182, P7501, DOI 10.4049/jimmunol.0713433; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Das S, 2007, PROSTATE, V67, P1550, DOI 10.1002/pros.20640; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fessler MB, 2009, J ALLERGY CLIN IMMUN, V124, P967, DOI 10.1016/j.jaci.2009.08.005; Gomez-Ferreria MA, 2003, J MOL BIOL, V329, P631, DOI 10.1016/S0022-2836(03)00524-2; Guiter C, 2004, BLOOD, V104, P543, DOI 10.1182/blood-2003-10-3545; Hebenstreit D, 2006, CYTOKINE GROWTH F R, V17, P173, DOI 10.1016/j.cytogfr.2006.01.004; Hubbard TJP, 2009, NUCLEIC ACIDS RES, V37, pD690, DOI 10.1093/nar/gkn828; Iff J, 2009, J PROTEOME RES, V8, P4511, DOI 10.1021/pr9003272; Jaruga B, 2003, J IMMUNOL, V171, P3233, DOI 10.4049/jimmunol.171.6.3233; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; Kaplan MH, 1998, MOL CELL BIOL, V18, P1996, DOI 10.1128/MCB.18.4.1996; Kato A, 2000, INFLAMM RES, V49, P275, DOI 10.1007/PL00000207; Kaufmann E, 1996, MECH DEVELOP, V57, P3, DOI 10.1016/0925-4773(96)00539-4; King VL, 2002, J LIPID RES, V43, P768; Kuperman D, 1998, J EXP MED, V187, P939, DOI 10.1084/jem.187.6.939; Li BH, 2008, BIOCHEM BIOPH RES CO, V369, P554, DOI 10.1016/j.bbrc.2008.02.052; Low SH, 2006, DEV CELL, V10, P57, DOI 10.1016/j.devcel.2005.12.005; Martin-de-Lara F, 2008, TRANSGENIC RES, V17, P1131, DOI 10.1007/s11248-008-9214-3; Matsumoto M, 2004, J IMMUNOL, V172, P7377, DOI 10.4049/jimmunol.172.12.7377; Meulmeester E, 2008, CURR CANCER DRUG TAR, V8, P87, DOI 10.2174/156800908783769337; Ni ZY, 2002, J UROLOGY, V167, P1859, DOI 10.1016/S0022-5347(05)65249-4; Oren M, 2003, CELL DEATH DIFFER, V10, P431, DOI 10.1038/sj.cdd.4401183; Pandey AK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009063; Perez-Sanchez C, 2000, J BIOL CHEM, V275, P12909, DOI 10.1074/jbc.275.17.12909; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; SCHINDLER C, 1995, ANNU REV BIOCHEM, V64, P621, DOI 10.1146/annurev.bi.64.070195.003201; Shimoda K, 1996, NATURE, V380, P630, DOI 10.1038/380630a0; Shum BOV, 2006, J CLIN INVEST, V116, P2183, DOI 10.1172/JCI24767; Skinnider BF, 2002, BLOOD, V99, P618, DOI 10.1182/blood.V99.2.618; Takeda K, 1996, J IMMUNOL, V157, P3220; Takeda K, 1996, NATURE, V380, P627, DOI 10.1038/380627a0; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Yap YL, 2005, NUCLEIC ACIDS RES, V33, P409, DOI 10.1093/nar/gki188; Yu HH, 2010, LUPUS, V19, P1219, DOI 10.1177/0961203310371152; Zhang MS, 2006, CHINESE MED J-PEKING, V119, P801, DOI 10.1097/00029330-200605020-00002; Zhang MS, 2006, CANCER LETT, V243, P38, DOI 10.1016/j.canlet.2005.11.020; Zheng JS, 2003, NUCLEIC ACIDS RES, V31, P1995, DOI 10.1093/nar/gkg287; Zhu JF, 2001, J IMMUNOL, V166, P7276, DOI 10.4049/jimmunol.166.12.7276	47	16	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e28509	10.1371/journal.pone.0028509	http://dx.doi.org/10.1371/journal.pone.0028509			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22162773	gold, Green Published, Green Submitted			2022-12-27	WOS:000298172800043
J	Sato, Y; Watanabe, N; Fukushima, N; Mita, S; Hirata, T				Sato, Yasufumi; Watanabe, Naoki; Fukushima, Nanae; Mita, Sakura; Hirata, Tatsumi			Actin-Independent Behavior and Membrane Deformation Exhibited by the Four-Transmembrane Protein M6a	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; MU-OPIOID RECEPTOR; PROTEOLIPID PROTEIN; GLYCOPROTEIN M6A; LIPID RAFTS; CNS MYELIN; GENE FAMILY; SIGNAL-TRANSDUCTION; NEURITE OUTGROWTH; CELL-MEMBRANE	M6a is a four-transmembrane protein that is abundantly expressed in the nervous system. Previous studies have shown that over-expression of this protein induces various cellular protrusions, such as neurites, filopodia, and dendritic spines. In this detailed characterization of M6a-induced structures, we found their varied and peculiar characteristics. Notably, the M6a-induced protrusions were mostly devoid of actin filaments or microtubules and exhibited free random vibrating motion. Moreover, when an antibody bound to M6a, the membrane-wrapped protrusions were suddenly disrupted, leading to perturbation of the surrounding membrane dynamics involving phosphoinositide signaling. During single-molecule analysis, M6a exhibited cytoskeleton-independent movement and became selectively entrapped along the cell perimeter in an actin-independent manner. These observations highlight the unusual characteristics of M6a, which may have a significant yet unappreciated role in biological systems.	[Sato, Yasufumi; Mita, Sakura; Hirata, Tatsumi] Grad Univ Adv Studies Sokendai, Natl Inst Genet, Div Brain Funct, Mishima, Shizuoka, Japan; [Watanabe, Naoki] Tohoku Univ, Grad Sch Life Sci, Lab Single Mol Cell Biol, Sendai, Miyagi 980, Japan; [Fukushima, Nanae] Shinshu Univ, Sch Med, Dept Anat, Matsumoto, Nagano 390, Japan	Graduate University for Advanced Studies - Japan; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Tohoku University; Shinshu University	Sato, Y (corresponding author), Natl Inst Basic Biol, Div Embryol, Okazaki, Aichi 444, Japan.	tathirat@lab.nig.ac.jp	Sato, Yasufumi/AAF-3367-2019		Ministry of Education, Sports, Science and Technology; Japan Science and Technology Agency [20500298, 18500250]; Next Program [LS013]; Takeda Science Foundation; Grants-in-Aid for Scientific Research [23657151] Funding Source: KAKEN	Ministry of Education, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Next Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Ministry of Education, Sports, Science and Technology and the Japan Science and Technology Agency (20500298, 18500250) that were awarded to T.H. This work was also supported by the Next Program grant (LS013) and a grant from Takeda Science Foundation that were awarded to N.W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfonso J, 2005, P NATL ACAD SCI USA, V102, P17196, DOI 10.1073/pnas.0504262102; Baumgart T, 2007, BBA-BIOMEMBRANES, V1768, P2182, DOI 10.1016/j.bbamem.2007.05.012; BAUMRIND NL, 1992, DEV DYNAM, V194, P311, DOI 10.1002/aja.1001940407; Bear JE, 2000, CELL, V101, P717, DOI 10.1016/S0092-8674(00)80884-3; BOISON D, 1994, P NATL ACAD SCI USA, V91, P11709, DOI 10.1073/pnas.91.24.11709; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Cooper B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0003659; Dawson JC, 2006, TRENDS CELL BIOL, V16, P493, DOI 10.1016/j.tcb.2006.08.004; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; DIAZ RS, 1990, J NEUROCHEM, V55, P1304, DOI 10.1111/j.1471-4159.1990.tb03139.x; Earle WR, 1943, J NATL CANCER I, V4, P165; Fernandez ME, 2010, J NEUROSCI RES, V88, P1298, DOI 10.1002/jnr.22298; Fivaz M, 2003, NEURON, V40, P319, DOI 10.1016/S0896-6273(03)00634-2; Fjorback AW, 2009, J MOL NEUROSCI, V37, P191, DOI 10.1007/s12031-008-9092-4; Fuchsova B, 2009, J BIOL CHEM, V284, P32075, DOI 10.1074/jbc.M109.012377; Fujiwara T, 2002, J CELL BIOL, V157, P1071, DOI 10.1083/jcb.200202050; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; Gow A, 1997, J NEUROSCI, V17, P181, DOI 10.1523/JNEUROSCI.17-01-00181.1997; Gow A, 1997, J NEUROSCI RES, V50, P659, DOI 10.1002/(SICI)1097-4547(19971201)50:5<659::AID-JNR3>3.0.CO;2-G; GOW A, 1994, J NEUROSCI RES, V37, P574, DOI 10.1002/jnr.490370504; Gow A, 1996, NAT GENET, V13, P422, DOI 10.1038/ng0896-422; Hao MM, 2001, P NATL ACAD SCI USA, V98, P13072, DOI 10.1073/pnas.231377398; INOUYE H, 1991, J NEUROSCI RES, V28, P1, DOI 10.1002/jnr.490280102; Kahya N, 2003, J BIOL CHEM, V278, P28109, DOI 10.1074/jbc.M302969200; KITAGAWA K, 1993, NEURON, V11, P433, DOI 10.1016/0896-6273(93)90148-K; KLEBE RJ, 1969, J CELL BIOL, V43, P69; Klugmann M, 1997, NEURON, V18, P59, DOI 10.1016/S0896-6273(01)80046-5; Ko M, 2005, J BIOL CHEM, V280, P42759, DOI 10.1074/jbc.M509164200; Kramer-Albers EM, 2006, J NEUROSCI, V26, P11743, DOI 10.1523/JNEUROSCI.3581-06.2006; LAGENAUR C, 1992, J NEUROBIOL, V23, P71, DOI 10.1002/neu.480230108; Liang YJ, 2008, CELL RES, V18, P768, DOI 10.1038/cr.2008.71; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; Michibata H, 2008, STEM CELLS DEV, V17, P641, DOI 10.1089/scd.2008.0088; Mobius W, 2008, NEURON GLIA BIOL, V4, P111, DOI 10.1017/S1740925X0900009X; Mukobata S, 2002, BIOCHEM BIOPH RES CO, V297, P722, DOI 10.1016/S0006-291X(02)02284-2; Nakagawa H, 2003, J CELL SCI, V116, P2577, DOI 10.1242/jcs.00462; NAVE KA, 1987, P NATL ACAD SCI USA, V84, P5665, DOI 10.1073/pnas.84.16.5665; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Nozumi M, 2003, J CELL SCI, V116, P239, DOI 10.1242/jcs.00233; Palaniyar N, 1998, BBA-BIOMEMBRANES, V1415, P85, DOI 10.1016/S0005-2736(98)00180-1; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; PUCK TT, 1958, J EXP MED, V108, P945, DOI 10.1084/jem.108.6.945; Qian H, 1991, BIOPHYS J, V60, P910, DOI 10.1016/S0006-3495(91)82125-7; Rodgers W, 2005, TRENDS IMMUNOL, V26, P97, DOI 10.1016/j.it.2004.11.016; Sato Y, 2011, DEV NEUROBIOL, V71, P733, DOI 10.1002/dneu.20941; Scorticati C, 2011, J NEUROCHEM, DOI [10.1111/j.1471-4159.2011.07252.x, DOI 10.1111/J.1471-4159.2011.07252.X]; Servant G, 2000, SCIENCE, V287, P1037, DOI 10.1126/science.287.5455.1037; SHEETZ MP, 1989, NATURE, V340, P284, DOI 10.1038/340284a0; SHEETZ MP, 1990, CELL, V61, P231, DOI 10.1016/0092-8674(90)90804-N; Shimada A, 2007, CELL, V129, P761, DOI 10.1016/j.cell.2007.03.040; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons M, 2000, J CELL BIOL, V151, P143, DOI 10.1083/jcb.151.1.143; Stecca B, 2000, J NEUROSCI, V20, P4002; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; van Meer G, 2005, EMBO REP, V6, P418, DOI 10.1038/sj.embor.7400410; Watanabe N, 2002, SCIENCE, V295, P1083, DOI 10.1126/science.1067470; WEIMBS T, 1992, BIOCHEMISTRY-US, V31, P12289, DOI 10.1021/bi00164a002; Werner HB, 2007, J NEUROSCI, V27, P7717, DOI 10.1523/JNEUROSCI.1254-07.2007; Wu DF, 2007, J BIOL CHEM, V282, P22239, DOI 10.1074/jbc.M700941200; Yamatani H, 2010, DEV NEUROBIOL, V70, P523, DOI 10.1002/dneu.20794; YAN YM, 1993, NEURON, V11, P423, DOI 10.1016/0896-6273(93)90147-J; Yan YM, 1996, J COMP NEUROL, V370, P465, DOI 10.1002/(SICI)1096-9861(19960708)370:4<465::AID-CNE4>3.0.CO;2-2; YONEMURA S, 1995, J CELL SCI, V108, P127; Zhao J, 2008, MOL VIS, V14, P1623	65	18	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e26702	10.1371/journal.pone.0026702	http://dx.doi.org/10.1371/journal.pone.0026702			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22162747	Green Published, gold, Green Submitted			2022-12-27	WOS:000298172800002
J	Saito, H; Takeuchi, M; Chida, K; Miyajima, A				Saito, Hiroki; Takeuchi, Masaki; Chida, Kazuhiro; Miyajima, Atsushi			Generation of Glucose-Responsive Functional Islets with a Three-Dimensional Structure from Mouse Fetal Pancreatic Cells and iPS Cells In Vitro	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; BETA-CELLS; KEY ROLE; DIFFERENTIATION; INSULIN; ENDOCRINE; ENDODERM; CLUSTERS; QUANTIFICATION; HEPATOBLASTS	Islets of Langerhans are a pancreatic endocrine compartment consisting of insulin-producing beta cells together with several other hormone-producing cells. While some insulin-producing cells or immature pancreatic cells have been generated in vitro from ES and iPS cells, islets with proper functions and a three-dimensional (3D) structure have never been successfully produced. To test whether islets can be formed in vitro, we first examined the potential of mouse fetal pancreatic cells. We found that E16.5 pancreatic cells, just before forming islets, were able to develop cell aggregates consisting of beta cells surrounded by glucagon-producing alpha cells, a structure similar to murine adult islets. Moreover, the transplantation of these cells improved blood glucose levels in hyperglycemic mice. These results indicate that functional islets are formed in vitro from fetal pancreatic cells at a specific developmental stage. By adopting these culture conditions to the differentiation of mouse iPS cells, we developed a two-step system to generate islets, i.e. immature pancreatic cells were first produced from iPS cells, and then transferred to culture conditions that allowed the formation of islets from fetal pancreatic cells. The islets exhibited distinct 3D structural features similar to adult pancreatic islets and secreted insulin in response to glucose concentrations. Transplantation of the islets improved blood glucose levels in hyperglycemic mice. In conclusion, the two-step culture system allows the generation of functional islets with a 3D structure from iPS cells.	[Saito, Hiroki; Takeuchi, Masaki; Miyajima, Atsushi] Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo, Japan; [Saito, Hiroki; Chida, Kazuhiro] Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo, Japan	University of Tokyo; University of Tokyo	Saito, H (corresponding author), Shionogi & Co Ltd, Shionogi Innovat Ctr Drug Discovery, Innovat Drug Discovery Res Labs, Sapporo, Hokkaido, Japan.	hiroki.saito@shionogi.co.jp; miyajima@iam.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Core Research for Evolutional Science and Technology (CREST); Japan Science and Technology Agency (JST); Takeda Science Foundation; JST	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Core Research for Evolutional Science and Technology (CREST)(Core Research for Evolutional Science and Technology (CREST)); Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Takeda Science Foundation(Takeda Science Foundation (TSF)); JST(Japan Science & Technology Agency (JST))	This work was supported in part by research grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan, the Core Research for Evolutional Science and Technology (CREST) project and the project for realization of regenerative medicine from the Japan Science and Technology Agency (JST), and Takeda Science Foundation. H.S. was supported by the project to promote a career path for research personnel of academia and accelerate technology transfer of JST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alanentalo T, 2007, NAT METHODS, V4, P31, DOI 10.1038/NMETH985; Alipio Z, 2010, P NATL ACAD SCI USA, V107, P13426, DOI 10.1073/pnas.1007884107; Apelqvist A, 1999, NATURE, V400, P877, DOI 10.1038/23716; Castaing M, 2005, DEV DYNAM, V234, P339, DOI 10.1002/dvdy.20547; Castaing M, 2001, DIABETOLOGIA, V44, P2066, DOI 10.1007/s001250100012; Chen S, 2009, NAT CHEM BIOL, V5, P258, DOI 10.1038/nchembio.154; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Gu GQ, 2002, DEVELOPMENT, V129, P2447; Hansson M, 2004, DIABETES, V53, P2603, DOI 10.2337/diabetes.53.10.2603; Hao E, 2006, NAT MED, V12, P310, DOI 10.1038/nm1367; Hara A, 2007, DEV DYNAM, V236, P3451, DOI 10.1002/dvdy.21359; Jiang W, 2007, CELL RES, V17, P333, DOI 10.1038/cr.2007.28; Kilimnik G, 2009, AM J PHYSIOL-ENDOC M, V297, pE1331, DOI 10.1152/ajpendo.00479.2009; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Miller K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007739; Miralles F, 1998, DEVELOPMENT, V125, P1017; Miralles F, 1999, P NATL ACAD SCI USA, V96, P6267, DOI 10.1073/pnas.96.11.6267; Miralles F, 1998, J CELL BIOL, V143, P827, DOI 10.1083/jcb.143.3.827; Nostro MC, 2011, DEVELOPMENT, V138, P861, DOI 10.1242/dev.055236; Paek HJ, 2005, CLONING STEM CELLS, V7, P226, DOI 10.1089/clo.2005.7.226; Paek HJ, 2005, STEM CELLS, V23, P862, DOI 10.1634/stemcells.2004-0288; Polak M, 2000, DIABETES, V49, P225, DOI 10.2337/diabetes.49.2.225; Rajagopal J, 2003, SCIENCE, V299, P363; Sipione S, 2004, DIABETOLOGIA, V47, P499, DOI 10.1007/s00125-004-1349-z; Stanger BZ, 2007, NATURE, V445, P886, DOI 10.1038/nature05537; Suzuki A, 2002, CELL TRANSPLANT, V11, P451; Tada S, 2005, DEVELOPMENT, V132, P4363, DOI 10.1242/dev.02005; Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Tanimizu N, 2004, J CELL SCI, V117, P6425, DOI 10.1242/jcs.01572; Tanimizu N, 2003, J CELL SCI, V116, P1775, DOI 10.1242/jcs.00388; Yasunaga M, 2005, NAT BIOTECHNOL, V23, P1542, DOI 10.1038/nbt1167	32	34	41	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2011	6	12							e28209	10.1371/journal.pone.0028209	http://dx.doi.org/10.1371/journal.pone.0028209			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MQ	22145030	Green Published, Green Submitted, gold			2022-12-27	WOS:000298168900013
J	Haraksingh, RR; Abyzov, A; Gerstein, M; Urban, AE; Snyder, M				Haraksingh, Rajini R.; Abyzov, Alexej; Gerstein, Mark; Urban, Alexander E.; Snyder, Michael			Genome-Wide Mapping of Copy Number Variation in Humans: Comparative Analysis of High Resolution Array Platforms	PLOS ONE			English	Article							STRUCTURAL VARIATION; VARIANTS; COMMON; SCALE; ASSOCIATION; DISCOVERY; DISEASE; MAP	Accurate and efficient genome-wide detection of copy number variants (CNVs) is essential for understanding human genomic variation, genome-wide CNV association type studies, cytogenetics research and diagnostics, and independent validation of CNVs identified from sequencing based technologies. Numerous, array-based platforms for CNV detection exist utilizing array Comparative Genome Hybridization (aCGH), Single Nucleotide Polymorphism (SNP) genotyping or both. We have quantitatively assessed the abilities of twelve leading genome-wide CNV detection platforms to accurately detect Gold Standard sets of CNVs in the genome of HapMap CEU sample NA12878, and found significant differences in performance. The technologies analyzed were the NimbleGen 4.2 M, 2.1 M and 3x720 K Whole Genome and CNV focused arrays, the Agilent 1x1 M CGH and High Resolution and 2x400 K CNV and SNP+CGH arrays, the Illumina Human Omni1Quad array and the Affymetrix SNP 6.0 array. The Gold Standards used were a 1000 Genomes Project sequencing-based set of 3997 validated CNVs and an ultra high-resolution aCGH-based set of 756 validated CNVs. We found that sensitivity, total number, size range and breakpoint resolution of CNV calls were highest for CNV focused arrays. Our results are important for cost effective CNV detection and validation for both basic and clinical applications.	[Haraksingh, Rajini R.; Urban, Alexander E.; Snyder, Michael] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Haraksingh, Rajini R.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT USA; [Abyzov, Alexej] Yale Univ, Program Computat Biol & Bioinformat, New Haven, CT USA; [Abyzov, Alexej; Gerstein, Mark] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT USA; [Gerstein, Mark] Yale Univ, Dept Comp Sci, New Haven, CT 06520 USA; [Urban, Alexander E.] Stanford Univ, Dept Psychiat & Behav Sci, Sch Med, Stanford, CA 94305 USA	Stanford University; Yale University; Yale University; Yale University; Yale University; Stanford University	Haraksingh, RR (corresponding author), Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA.	mpsnyder@stanford.edu	Abyzov, Alexej/AAT-4615-2020; Abyzov, Alexej/M-4284-2013	Abyzov, Alexej/0000-0001-5405-6729; Snyder, Michael/0000-0003-0784-7987; Haraksingh, Rajini/0000-0002-6644-8874	NHGRI (National Human Genome Research Institute) [PAR05-163]	NHGRI (National Human Genome Research Institute)	Funding Source: NHGRI (National Human Genome Research Institute), Grant Title "Centers of Excellence in Genomic Science'', Project Title "Analysis of Human Genome Using Integrated Technologies'', Grant Number: PAR05-163. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abyzov A, 2011, GENOME RES; Abyzov A, 2011, BIOINFORMATICS, V27, P595, DOI 10.1093/bioinformatics/btq713; Alkan C, 2011, NAT REV GENET, V12, P363, DOI 10.1038/nrg2958; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Craddock N, 2010, NATURE, V464, P713, DOI 10.1038/nature08979; Curtis C, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-588; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Hasin Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000249; Hastings PJ, 2009, NAT REV GENET, V10, P551, DOI 10.1038/nrg2593; Hinrichs AS, 2006, NUCLEIC ACIDS RES, V34, pD590, DOI 10.1093/nar/gkj144; Hurles ME, 2008, TRENDS GENET, V24, P238, DOI 10.1016/j.tig.2008.03.001; Ionita-Laza I, 2009, GENOMICS, V93, P22, DOI 10.1016/j.ygeno.2008.08.012; Jarick I, 2011, HUM MOL GENET, V20, P840, DOI 10.1093/hmg/ddq518; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Matsuzaki H, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r125; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; Medvedev P, 2009, NAT METHODS, V6, pS13, DOI [10.1038/NMETH.1374, 10.1038/nmeth.1374]; Miller DT, 2010, AM J HUM GENET, V86, P749, DOI 10.1016/j.ajhg.2010.04.006; Mills RE, 2011, NATURE, V470, P59, DOI 10.1038/nature09708; Oldridge DA, 2010, NUCLEIC ACIDS RES, V38, P3275, DOI 10.1093/nar/gkq073; Pang AW, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r52; Park H, 2010, NAT GENET, V42, P400, DOI 10.1038/ng.555; Perry GH, 2008, AM J HUM GENET, V82, P685, DOI 10.1016/j.ajhg.2007.12.010; Pinto D, 2011, NAT BIOTECHNOL, V29, P512, DOI 10.1038/nbt.1852; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Schuster-Bockler B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009474; Stankiewicz P, 2010, ANNU REV MED, V61, P437, DOI 10.1146/annurev-med-100708-204735; Tucker T, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-25	31	48	49	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e27859	10.1371/journal.pone.0027859	http://dx.doi.org/10.1371/journal.pone.0027859			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140474	Green Published, gold, Green Submitted			2022-12-27	WOS:000298168100021
J	Llorens-Martin, M; Trejo, JL				Llorens-Martin, Maria; Trejo, Jose L.			Mifepristone Prevents Stress-Induced Apoptosis in Newborn Neurons and Increases AMPA Receptor Expression in the Dentate Gyrus of C57/BL6 Mice	PLOS ONE			English	Article							ADULT HIPPOCAMPAL NEUROGENESIS; NEUROTROPHIC FACTOR TRANSCRIPTS; GENERATED GRANULE CELLS; GLUCOCORTICOID-RECEPTOR; OXIDATIVE STRESS; PSYCHOSOCIAL STRESS; PROTEIN EXPRESSION; ADRENAL-STEROIDS; MAJOR DEPRESSION; PROGENITOR CELLS	Chronic stress produces sustained elevation of corticosteroid levels, which is why it is considered one of the most potent negative regulators of adult hippocampal neurogenesis (AHN). Several mood disorders are accompanied by elevated glucocorticoid levels and have been linked to alterations in AHN, such as major depression (MD). Nevertheless, the mechanism by which acute stress affects the maturation of neural precursors in the dentate gyrus is poorly understood. We analyzed the survival and differentiation of 1 to 8 week-old cells in the dentate gyrus of female C57/BL6 mice following exposure to an acute stressor (the Porsolt or forced swimming test). Furthermore, we evaluated the effects of the glucocorticoid receptor (GR) antagonist mifepristone on the cell death induced by the Porsolt test. Forced swimming induced selective apoptotic cell death in 1 week-old cells, an effect that was abolished by pretreatment with mifepristone. Independent of its antagonism of GR, mifepristone also induced an increase in the percentage of 1 week-old cells that were AMPA(+). We propose that the induction of AMPA receptor expression in immature cells may mediate the neuroprotective effects of mifepristone, in line with the proposed antidepressant effects of AMPA receptor potentiators.	[Llorens-Martin, Maria; Trejo, Jose L.] CSIC, Inst Cajal, E-28002 Madrid, Spain; [Llorens-Martin, Maria; Trejo, Jose L.] Ctr Investigac Red Enfermedades Neurodegenerat CI, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC)	Llorens-Martin, M (corresponding author), CSIC, Inst Cajal, E-28002 Madrid, Spain.	mllorens@cbm.uam.es	Trejo, Jose Luis/F-5518-2016; Llorens-Martin, Maria/R-4613-2017	Llorens-Martin, Maria/0000-0001-9129-5198	Ministerio de Educacion y Ciencia [BFU2007-60195/BFI, BFU2010-20396]	Ministerio de Educacion y Ciencia(Spanish Government)	This work was funded by grant BFU2007-60195/BFI and BFU2010-20396 from Ministerio de Educacion y Ciencia to Jose Luis Trejo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed T, 2006, J NEUROSCI, V26, P3951, DOI 10.1523/JNEUROSCI.4901-05.2006; Alonso R, 2004, MOL PSYCHIATR, V9, P278, DOI 10.1038/sj.mp.4001464; Ambrogini P, 2006, ARCH ITAL BIOL, V144, P115; Autry AE, 2006, NEUROENDOCRINOLOGY, V83, P371, DOI 10.1159/000096092; Bai F, 2003, NEUROPHARMACOLOGY, V44, P1013, DOI 10.1016/S0028-3908(03)00104-7; Becker S, 2007, TRENDS COGN SCI, V11, P70, DOI 10.1016/j.tics.2006.10.013; Behl C, 1997, ENDOCRINOLOGY, V138, P101, DOI 10.1210/en.138.1.101; Behl C, 1997, EUR J NEUROSCI, V9, P912, DOI 10.1111/j.1460-9568.1997.tb01442.x; Belanoff JK, 2002, BIOL PSYCHIAT, V52, P386, DOI 10.1016/S0006-3223(02)01432-4; Belanoff JK, 2001, J CLIN PSYCHOPHARM, V21, P516, DOI 10.1097/00004714-200110000-00009; Boyer PA, 1998, J MOL NEUROSCI, V10, P219, DOI 10.1007/BF02761776; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; Brummelte S, 2010, NEUROSCIENCE, V168, P680, DOI 10.1016/j.neuroscience.2010.04.023; CAMERON HA, 1993, BRAIN RES, V611, P342, DOI 10.1016/0006-8993(93)90524-Q; CAMERON HA, 1994, NEUROSCIENCE, V61, P203, DOI 10.1016/0306-4522(94)90224-0; Castren E, 2007, CURR OPIN PHARMACOL, V7, P18, DOI 10.1016/j.coph.2006.08.009; Czeh B, 2007, EUR ARCH PSY CLIN N, V257, P250, DOI 10.1007/s00406-007-0728-0; Dagyte G, 2009, NEUROSCIENCE, V162, P904, DOI 10.1016/j.neuroscience.2009.05.053; Das S, 2008, J NEUROSCI RES, V86, P1199, DOI 10.1002/jnr.21585; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; DeBattista C, 2006, BIOL PSYCHIAT, V60, P1343, DOI 10.1016/j.biopsych.2006.05.034; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; DETKE MJ, 1995, PSYCHOPHARMACOLOGY, V121, P66, DOI 10.1007/BF02245592; Dhikav V, 2007, MED HYPOTHESES, V68, P1088, DOI 10.1016/j.mehy.2006.09.038; Dias BG, 2003, NEUROPHARMACOLOGY, V45, P553, DOI 10.1016/S0028-3908(03)00198-9; Duman RS, 2005, NEUROBIOL AGING, V26, pS88, DOI 10.1016/j.neurobiolaging.2005.08.018; Duman RS, 2004, NEUROMOL MED, V5, P11, DOI 10.1385/NMM:5:1:011; Dupret D, 2007, PLOS BIOL, V5, P1683, DOI 10.1371/journal.pbio.0050214; Elizalde N, 2010, PSYCHOPHARMACOLOGY, V210, P393, DOI 10.1007/s00213-010-1835-6; Encinas JM, 2006, P NATL ACAD SCI USA, V103, P8233, DOI 10.1073/pnas.0601992103; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Fitzsimons CP, 2009, MINI-REV MED CHEM, V9, P249, DOI 10.2174/138955709787316001; Flores BH, 2006, NEUROPSYCHOPHARMACOL, V31, P628, DOI 10.1038/sj.npp.1300884; Frank MG, 2010, BRAIN BEHAV IMMUN, V24, P19, DOI 10.1016/j.bbi.2009.07.008; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Garcia A, 2004, AGING CELL, V3, P363, DOI 10.1111/j.1474-9728.2004.00130.x; Garthe A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005464; GOULD E, 1991, J COMP NEUROL, V313, P479, DOI 10.1002/cne.903130308; GOULD E, 1994, J COMP NEUROL, V340, P551, DOI 10.1002/cne.903400408; Gould E, 1997, J NEUROSCI, V17, P2492; Heine VM, 2004, EUR J NEUROSCI, V19, P131, DOI 10.1046/j.1460-9568.2003.03100.x; Joels M, 2007, PROG BRAIN RES, V163, P355, DOI 10.1016/S0079-6123(07)63021-0; Karasawa J, 2005, BRAIN RES, V1042, P92, DOI 10.1016/j.brainres.2005.02.032; Kee N, 2007, NAT NEUROSCI, V10, P355, DOI 10.1038/nn1847; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; Korte SM, 1996, EUR J PHARMACOL, V301, P19, DOI 10.1016/0014-2999(96)00064-7; Kronenberg G, 2009, EUR ARCH PSY CLIN N, V259, P499, DOI 10.1007/s00406-009-0036-y; Lagace DC, 2010, P NATL ACAD SCI USA, V107, P4436, DOI 10.1073/pnas.0910072107; Lee KJ, 2006, EXP MOL MED, V38, P44, DOI 10.1038/emm.2006.6; Leuner B, 2009, J COMP NEUROL, V517, P123, DOI 10.1002/cne.22107; Leverenz JB, 1999, J NEUROSCI, V19, P2356; Li WZ, 2010, EUR J PHARMACOL, V628, P108, DOI 10.1016/j.ejphar.2009.11.045; Li X, 2001, NEUROPHARMACOLOGY, V40, P1028, DOI 10.1016/S0028-3908(00)00194-5; Llorens-Martin M, 2006, HIPPOCAMPUS, V16, P480, DOI 10.1002/hipo.20175; Llorens-Martin MV, 2007, NEUROSCIENCE, V147, P631, DOI 10.1016/j.neuroscience.2007.04.054; Llorens-Martin M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012188; LLorens-Martin M, 2010, MOL CELL NEUROSCI, V44, P109, DOI 10.1016/j.mcn.2010.02.006; LOWY MT, 1995, J NEUROCHEM, V65, P268; Lucassen PJ, 2010, EUR NEUROPSYCHOPHARM, V20, P1, DOI 10.1016/j.euroneuro.2009.08.003; LUINE V, 1994, ANN NY ACAD SCI, V746, P403; Lussier AL, 2009, NEUROSCI LETT, V460, P170, DOI 10.1016/j.neulet.2009.05.050; Maeng S, 2008, BIOL PSYCHIAT, V63, P349, DOI 10.1016/j.biopsych.2007.05.028; Maes M, 2009, METAB BRAIN DIS, V24, P27, DOI 10.1007/s11011-008-9118-1; Malberg JE, 2003, NEUROPSYCHOPHARMACOL, V28, P1562, DOI 10.1038/sj.npp.1300234; Manji HK, 2003, BIOL PSYCHIAT, V53, P707, DOI 10.1016/S0006-3223(03)00117-3; Martinez-Turrillas R, 2007, BIOCHEM BIOPH RES CO, V353, P750, DOI 10.1016/j.bbrc.2006.12.078; Mayer JL, 2006, J NEUROENDOCRINOL, V18, P629, DOI 10.1111/j.1365-2826.2006.01455.x; McEwen BS, 2003, BIOL PSYCHIAT, V54, P200, DOI 10.1016/S0006-3223(03)00177-X; Mirescu C, 2006, HIPPOCAMPUS, V16, P233, DOI 10.1002/hipo.20155; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; MURPHY BEP, 1993, J PSYCHIATR NEUROSCI, V18, P209; Nair A, 2007, NEUROPSYCHOPHARMACOL, V32, P1504, DOI 10.1038/sj.npp.1301276; Nihalani ND, 2007, CURR OPIN INVEST DR, V8, P563; Oomen CA, 2007, EUR J NEUROSCI, V26, P3395, DOI 10.1111/j.1460-9568.2007.05972.x; Overstreet DH, 2004, EUR J PHARMACOL, V497, P49, DOI 10.1016/j.ejphar.2004.06.035; Papp Mariusz, 1993, Polish Journal of Pharmacology, V45, P549; Peeters BWMM, 2008, ANN NY ACAD SCI, V1148, P536, DOI 10.1196/annals.1410.072; Pfaffl MW, 2010, METHODS, V50, P215, DOI 10.1016/j.ymeth.2010.02.005; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; Quirarte GL, 2009, LEARN MEMORY, V16, P586, DOI 10.1101/lm.1493609; Reagan LP, 1997, J CHEM NEUROANAT, V13, P149, DOI 10.1016/S0891-0618(97)00031-8; Sairanen M, 2005, J NEUROSCI, V25, P1089, DOI 10.1523/JNEUROSCI.3741-04.2005; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Sapolsky RM, 2000, BIOL PSYCHIAT, V48, P755, DOI 10.1016/S0006-3223(00)00971-9; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Schanzer A, 2004, BRAIN PATHOL, V14, P237; Schmidt-Hieber C, 2004, NATURE, V429, P184, DOI 10.1038/nature02553; Sousa N, 2002, REV NEUROSCIENCE, V13, P59; Sousa N, 2008, BRAIN RES REV, V57, P561, DOI 10.1016/j.brainresrev.2007.06.007; Sterner EY, 2010, PROG NEURO-PSYCHOPH, V34, P777, DOI 10.1016/j.pnpbp.2010.03.005; Su XWW, 2009, PSYCHOPHARMACOLOGY, V206, P215, DOI 10.1007/s00213-009-1598-0; Suppiramaniam V, 2001, SYNAPSE, V40, P154, DOI 10.1002/syn.1037; Tanapat P, 1998, INT J DEV NEUROSCI, V16, P235, DOI 10.1016/S0736-5748(98)00029-X; Tata DA, 2010, PHYSIOL BEHAV, V99, P186, DOI 10.1016/j.physbeh.2009.09.008; Thomas RM, 2007, J NEUROSCI, V27, P2734, DOI 10.1523/JNEUROSCI.3849-06.2007; Thomas RM, 2006, EXP NEUROL, V201, P308, DOI 10.1016/j.expneurol.2006.04.010; Trejo JL, 2008, MOL CELL NEUROSCI, V37, P402, DOI 10.1016/j.mcn.2007.10.016; Trejo JL, 2001, J NEUROSCI, V21, P1628, DOI 10.1523/JNEUROSCI.21-05-01628.2001; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; VELDHUIS HD, 1985, EUR J PHARMACOL, V115, P211, DOI 10.1016/0014-2999(85)90693-4; Voss OP, 2007, NEUROPHARMACOLOGY, V52, P590, DOI 10.1016/j.neuropharm.2006.09.001; Wang S, 2000, J NEUROBIOL, V42, P248, DOI 10.1002/(SICI)1097-4695(20000205)42:2<248::AID-NEU8>3.3.CO;2-A; Whitney NP, 2009, J NEUROCHEM, V108, P1343, DOI 10.1111/j.1471-4159.2009.05886.x; Wiskott L, 2006, HIPPOCAMPUS, V16, P329, DOI 10.1002/hipo.20167; Wong EYH, 2006, NEUROSCIENCE, V137, P83, DOI 10.1016/j.neuroscience.2005.08.073; Wong EYH, 2005, EUR J NEUROSCI, V22, P785, DOI 10.1111/j.1460-9568.2005.04277.x; You JM, 2009, CAN J PHYSIOL PHARM, V87, P440, DOI [10.1139/y09-027, 10.1139/Y09-027]; Zarate CA, 2003, ANN NY ACAD SCI, V1003, P273, DOI 10.1196/annals.1300.017; Zarate CA, 2008, EXP NEUROL, V211, P7, DOI 10.1016/j.expneurol.2008.01.011	111	26	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e28376	10.1371/journal.pone.0028376	http://dx.doi.org/10.1371/journal.pone.0028376			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140582	Green Published, gold, Green Submitted			2022-12-27	WOS:000298168100068
J	Shim, BS; Choi, YK; Yun, CH; Lee, EG; Jeon, YS; Park, SM; Cheon, IS; Joo, DH; Cho, CH; Song, MS; Seo, SU; Byun, YH; Park, HJ; Poo, H; Seong, BL; Kim, JO; Nguyen, HH; Stadler, K; Kim, DW; Hong, KJ; Czerkinsky, C; Song, MK				Shim, Byoung-Shik; Choi, Young Ki; Yun, Cheol-Heui; Lee, Eu-Gene; Jeon, Yoon Seong; Park, Sung-Moo; Cheon, In Su; Joo, Dong-Hyun; Cho, Chung Hwan; Song, Min-Suk; Seo, Sang-Uk; Byun, Young-Ho; Park, Hae-Jung; Poo, Haryoung; Seong, Baik Lin; Kim, Jae Ouk; Nguyen, Huan Huu; Stadler, Konrad; Kim, Dong Wook; Hong, Kee-Jong; Czerkinsky, Cecil; Song, Man Ki			Sublingual Immunization with M2-Based Vaccine Induces Broad Protective Immunity against Influenza	PLOS ONE			English	Article							INTEGRAL MEMBRANE-PROTEIN; ANTIGENIC PEPTIDE VACCINE; MONOCLONAL-ANTIBODY; H5N1 INFLUENZA; EXTRACELLULAR DOMAIN; VIRUS-INFECTION; M2; MUCOSAL; MICE; ECTODOMAIN	Background: The ectodomain of matrix protein 2 (M2e) of influenza A virus is a rationale target antigen candidate for the development of a universal vaccine against influenza as M2e undergoes little sequence variation amongst human influenza A strains. Vaccine-induced M2e-specific antibodies (Abs) have been shown to display significant cross-protective activity in animal models. M2e-based vaccine constructs have been shown to be more protective when administered by the intranasal (i.n.) route than after parenteral injection. However, i.n. administration of vaccines poses rare but serious safety issues associated with retrograde passage of inhaled antigens and adjuvants through the olfactory epithelium. In this study, we examined whether the sublingual (s.l.) route could serve as a safe and effective alternative mucosal delivery route for administering a prototype M2e-based vaccine. The mechanism whereby s.l. immunization with M2e vaccine candidate induces broad protection against infection with different influenza virus subtypes was explored. Methods and Results: A recombinant M2 protein with three tandem copies of the M2e (3M2eC) was expressed in Escherichia coli. Parenteral immunizations of mice with 3M2eC induced high levels of M2e-specific serum Abs but failed to provide complete protection against lethal challenge with influenza virus. In contrast, s.l. immunization with 3M2eC was superior for inducing protection in mice. In the latter animals, protection was associated with specific Ab responses in the lungs. Conclusions: The results demonstrate that s.l. immunization with 3M2eC vaccine induced airway mucosal immune responses along with broad cross-protective immunity to influenza. These findings may contribute to the understanding of the M2-based vaccine approach to control epidemic and pandemic influenza infections.	[Shim, Byoung-Shik; Lee, Eu-Gene; Jeon, Yoon Seong; Park, Sung-Moo; Cheon, In Su; Joo, Dong-Hyun; Cho, Chung Hwan; Seo, Sang-Uk; Park, Hae-Jung; Kim, Jae Ouk; Nguyen, Huan Huu; Stadler, Konrad; Czerkinsky, Cecil; Song, Man Ki] Int Vaccine Inst, Div Sci Lab, Seoul, South Korea; [Shim, Byoung-Shik; Yun, Cheol-Heui; Cheon, In Su; Cho, Chung Hwan] Seoul Natl Univ, Dept Agr Biotechnol, Res Inst Agr & Life Sci, Ctr Agr Biomat, Seoul, South Korea; [Choi, Young Ki; Song, Min-Suk] Chungbuk Natl Univ, Coll Med, Cheongju, South Korea; [Choi, Young Ki; Song, Min-Suk] Chungbuk Natl Univ, Med Res Inst, Cheongju, South Korea; [Byun, Young-Ho; Seong, Baik Lin] Yonsei Univ, Dept Biotechnol, Coll Engn, Seoul 120749, South Korea; [Poo, Haryoung] Korean Res Inst Biosci & Biotechnol, Taejon, South Korea; [Kim, Dong Wook] Hanyang Univ, Dept Pharm, Coll Pharm, Kyeonggi Do, South Korea; [Hong, Kee-Jong] Korea Natl Inst Hlth, Div Influenza Viruses, Osong, South Korea	International Vaccine Institute; Seoul National University (SNU); Chungbuk National University; Chungbuk National University; Yonsei University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Hanyang University; Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH)	Shim, BS (corresponding author), Int Vaccine Inst, Div Sci Lab, Seoul, South Korea.	mksong@ivi.int	CZERKINSKY, CECIL/G-6520-2015; YUN, Cheol-Heui/AAR-2775-2020	YUN, Cheol-Heui/0000-0002-0041-2887	Korea Research Council of Fundamental Science and Technology; Korea Research Institute for Bioscience and Biotechnology (KRIBB) [KGM0821113]; government of the Republic of Korea; government of the Kuwait; government of the Sweden (Swedish International Development Cooperation Agency [SIDA])	Korea Research Council of Fundamental Science and Technology; Korea Research Institute for Bioscience and Biotechnology (KRIBB); government of the Republic of Korea(Korean Government); government of the Kuwait; government of the Sweden (Swedish International Development Cooperation Agency [SIDA])	This work was supported by a Top Brand Project grant from Korea Research Council of Fundamental Science and Technology and Korea Research Institute for Bioscience and Biotechnology (KRIBB) Initiative program (KGM0821113). The International Vaccine Institute is supported in part by grants from the governments of the Republic of Korea, Kuwait, and Sweden (Swedish International Development Cooperation Agency [SIDA]). The funders had no roles in the study design, in the data analysis, or in the preparation of the manuscript.	ADA GL, 1986, CURR TOP MICROBIOL, V128, P1; Armstrong ME, 2005, J INFECT DIS, V192, P1628, DOI 10.1086/491739; Bessa J, 2008, EUR J IMMUNOL, V38, P114, DOI 10.1002/eji.200636959; BLACK RA, 1993, J GEN VIROL, V74, P143, DOI 10.1099/0022-1317-74-1-143; Cox NJ, 2000, ANNU REV MED, V51, P407, DOI 10.1146/annurev.med.51.1.407; Cuburu N, 2007, VACCINE, V25, P8598, DOI 10.1016/j.vaccine.2007.09.073; DAWOOD FS, 2009, NEW ENGL J MED, V361, P1; De Filette M, 2006, VACCINE, V24, P544, DOI 10.1016/j.vaccine.2005.08.061; deJong JC, 1997, NATURE, V389, P554, DOI 10.1038/39218; El Bakkouri K, 2011, J IMMUNOL, V186, P1022, DOI 10.4049/jimmunol.0902147; Eliasson DG, 2008, VACCINE, V26, P1243, DOI 10.1016/j.vaccine.2007.12.027; Ernst WA, 2006, VACCINE, V24, P5158, DOI 10.1016/j.vaccine.2006.04.008; Fan JA, 2004, VACCINE, V22, P2993, DOI 10.1016/j.vaccine.2004.02.021; Feng JQ, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-102; Fiers W, 2004, VIRUS RES, V103, P173, DOI 10.1016/j.virusres.2004.02.030; Frace AM, 1999, VACCINE, V17, P2237, DOI 10.1016/S0264-410X(99)00005-5; Fu TM, 2009, VIROLOGY, V385, P218, DOI 10.1016/j.virol.2008.11.035; Holmgren J, 2005, NAT MED, V11, pS45, DOI 10.1038/nm1213; HOLSINGER LJ, 1994, J VIROL, V68, P1551, DOI 10.1128/JVI.68.3.1551-1563.1994; HOLSINGER LJ, 1991, VIROLOGY, V183, P32, DOI 10.1016/0042-6822(91)90115-R; Huleatt JW, 2008, VACCINE, V26, P201, DOI 10.1016/j.vaccine.2007.10.062; ITO T, 1991, J VIROL, V65, P5491, DOI 10.1128/JVI.65.10.5491-5498.1991; Jegerlehner A, 2004, J IMMUNOL, V172, P5598, DOI 10.4049/jimmunol.172.9.5598; Kandun IN, 2006, NEW ENGL J MED, V355, P2186, DOI 10.1056/NEJMoa060930; Kitikoon P, 2009, VACCINE, V28, P523, DOI 10.1016/j.vaccine.2009.09.130; LAMB RA, 1985, CELL, V40, P627, DOI 10.1016/0092-8674(85)90211-9; Lemiale F, 2003, J VIROL, V77, P10078, DOI 10.1128/JVI.77.18.10078-10087.2003; Liu WL, 2003, FEMS IMMUNOL MED MIC, V35, P141, DOI 10.1016/S0928-8244(03)00009-9; Mozdzanowska K, 2003, VACCINE, V21, P2616, DOI 10.1016/S0264-410X(03)00040-9; Mozdzanowska K, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-118; Neirynck S, 1999, NAT MED, V5, P1157, DOI 10.1038/13484; Neutra MR, 2006, NAT REV IMMUNOL, V6, P148, DOI 10.1038/nri1777; Okuda K, 2001, VACCINE, V19, P3681, DOI 10.1016/S0264-410X(01)00078-0; Oshitani H, 2008, EMERG INFECT DIS, V14, P875, DOI 10.3201/eid1406.070839; Rao SS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009812; REED L. J., 1938, AMER JOUR HYG, V27, P493; Schotsaert M, 2009, EXPERT REV VACCINES, V8, P499, DOI [10.1586/erv.09.6, 10.1586/ERV.09.6]; SLEPUSHKIN VA, 1995, VACCINE, V13, P1399, DOI 10.1016/0264-410X(95)92777-Y; Song JH, 2008, P NATL ACAD SCI USA, V105, P1644, DOI 10.1073/pnas.0708684105; Song MS, 2009, J VIROL, V83, P12325, DOI 10.1128/JVI.01373-09; Steinhauer DA, 2002, ANNU REV GENET, V36, P305, DOI 10.1146/annurev.genet.36.052402.152757; Takeda M, 2002, J VIROL, V76, P1391, DOI 10.1128/JVI.76.3.1391-1399.2002; Tissot AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009809; TREANOR JJ, 1990, J VIROL, V64, P1375, DOI 10.1128/JVI.64.3.1375-1377.1990; Wang RF, 2008, ANTIVIR RES, V80, P168, DOI 10.1016/j.antiviral.2008.06.002; ZEBEDEE SL, 1988, J VIROL, V62, P2762, DOI 10.1128/JVI.62.8.2762-2772.1988; Zhao GY, 2010, VACCINE, V28, P7233, DOI 10.1016/j.vaccine.2010.08.049; Zhao GY, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-9	48	59	62	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e27953	10.1371/journal.pone.0027953	http://dx.doi.org/10.1371/journal.pone.0027953			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140491	Green Submitted, Green Published, gold			2022-12-27	WOS:000298168100027
J	Ansari, A; Hasan, Z; Dawood, G; Hussain, R				Ansari, Ambreen; Hasan, Zahra; Dawood, Ghaffar; Hussain, Rabia			Differential Combination of Cytokine and Interferon- gamma+874 T/A Polymorphisms Determines Disease Severity in Pulmonary Tuberculosis	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; GENE POLYMORPHISMS; MYCOBACTERIUM-TUBERCULOSIS; SUSCEPTIBILITY; ASSOCIATION; IFNG+874T/A; RECEPTOR	Background: Mycobacterium tuberculosis infects nearly 1/3 of the world population and this reservoir forms the largest pool from which new cases arise. Among the cytokines, IFN-gamma is a key determinant in protection against tuberculosis. Single nucleotide polymorphisms (SNPs) in IFN-gamma gene (+874 T/A) which determine TT high ((hi)), AA low ((lo)) and TA intermediate ((int)) responder phenotypes have shown variable associations with tuberculosis disease outcome in different ethnic populations. The objective of the current study was to analyze IFN-gamma gene combinations with other IFN-gamma regulating cytokine genes (IL-10, TNF -alpha, IL-6) to see the effect of gene-combinations on disease severity outcome in pulmonary tuberculosis. Methods and Findings: Study groups comprised of pulmonary TB patients stratified according to lung tissue involvement into mild (Pmd = 74) or advance (Pad = 23) lung disease and compared with healthy controls (TBNA = 166). Genotype analysis was carried out using amplification refractory mutation system-PCR (ARMS-PCR). IFN-gamma gene (+874 T/A) functional SNP combinations in TNF alpha (-308 G/A), IL-10 (-1082 A/G) and IL-6 (-174 G/C) were analyzed. Single gene analysis (Pearson chi(2)) showed a dominant association of IFN-gamma TThi genotype (p = 0.001) and T allele (p = 0.001) with mild disease. IFN-gamma(lo) -IL-10(lo) genotype combination was associated with advanced disease (p = 0.002). IFN-gamma(hi) -IL-6(hi) combination was associated with mild disease (p = 0.0005) while IFN-gamma(lo) -IL-6(int) was associated with protection against both forms of pulmonary disease (p = 0.002). Conclusion: Our results show that a limited number of IFN-gamma gene combinations with other cytokine functional SNPs determine the outcome of disease severity in tuberculosis.	[Ansari, Ambreen; Hasan, Zahra; Hussain, Rabia] Aga Khan Univ, Dept Pathol & Microbiol, Karachi, Pakistan; [Dawood, Ghaffar] Masoomeen Trust Hosp, Karachi, Pakistan	Aga Khan University	Ansari, A (corresponding author), Aga Khan Univ, Dept Pathol & Microbiol, Karachi, Pakistan.	rabia.hussain@aku.edu	Hasan, Zahra/F-5111-2015; Hasan, Zahra/AAF-2191-2020; Hussain, Rabia/E-9982-2015	Hasan, Zahra/0000-0001-7580-372X; 	Higher Education Commission of Pakistan [20-796/R]; Government of Pakistan [D/07]	Higher Education Commission of Pakistan(Higher Education Commission of Pakistan); Government of Pakistan	This work was funded by the Higher Education Commission of Pakistan Grant No 20-796/R and D/07 Government of Pakistan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar S, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-70; Ansari A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004778; Bagheri M, 2006, TRANSFUSION MED, V16, P192, DOI 10.1111/j.1365-3148.2006.00666.x; Bellamy R, 2003, GENES IMMUN, V4, P4, DOI 10.1038/sj.gene.6363915; BOGDAN C, 1991, J EXP MED, V174, P1549, DOI 10.1084/jem.174.6.1549; CABRERA M, 1995, J EXP MED, V182, P1259, DOI 10.1084/jem.182.5.1259; Casanova JL, 2007, EMBO J, V26, P915, DOI 10.1038/sj.emboj.7601558; Chapgier A, 2006, PLOS GENET, V2, P1193, DOI 10.1371/journal.pgen.0020131; COMSTOCK GW, 1982, AM REV RESPIR DIS, V125, P8; Cooke GS, 2006, AM J RESP CRIT CARE, V174, P339, DOI 10.1164/rccm.200601-088OC; COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243; CROFTON J, 1990, CROFTON DOUGLAS RESP, P395; Delgado JC, 2002, J INFECT DIS, V186, P1463, DOI 10.1086/344891; Doganci A, 2005, J CLIN INVEST, V115, P313, DOI 10.1172/JCI200522433; Dupuis S, 2000, IMMUNOL REV, V178, P129, DOI 10.1034/j.1600-065X.2000.17810.x; Etokebe GE, 2006, SCAND J IMMUNOL, V63, P136, DOI 10.1111/j.1365-3083.2005.01716.x; Fishman D, 1998, J CLIN INVEST, V102, P1369, DOI 10.1172/JCI2629; Fitness J, 2004, AM J TROP MED HYG, V71, P341, DOI 10.4269/ajtmh.2004.71.341; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; Hashemi M, 2011, Prague Med Rep, V112, P38; Henao MI, 2006, TUBERCULOSIS, V86, P11, DOI 10.1016/j.tube.2005.03.001; HOWARD M, 1992, IMMUNOL TODAY, V13, P198, DOI 10.1016/0167-5699(92)90153-X; Hussain R, 2011, J CLIN IMMUNOL, V31, P913, DOI 10.1007/s10875-011-9566-y; Hussain R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007444; Jamil B, 2007, TUBERCULOSIS, V87, P279, DOI 10.1016/j.tube.2007.03.004; Jouanguy E, 2000, J CLIN INVEST, V105, P1429, DOI 10.1172/JCI9166; Kaufmann SHE, 2005, J EXP MED, V201, P1693, DOI 10.1084/jem.20050842; Keane J, 2005, RHEUMATOLOGY, V44, P714, DOI 10.1093/rheumatology/keh567; KINDLER V, 1989, CELL, V56, P731, DOI 10.1016/0092-8674(89)90676-4; Kumar V, 2008, NATL MED J INDIA, V21, P120; Leandro ACCS, 2009, BRAZ J MED BIOL RES, V42, P312, DOI 10.1590/S0100-879X2009000400002; Lio D, 2002, EUR J IMMUNOGENET, V29, P371, DOI 10.1046/j.1365-2370.2002.00327.x; Lopez-Maderuelo D, 2003, AM J RESP CRIT CARE, V167, P970, DOI 10.1164/rccm.200205-438BC; Maher D., 1997, Treatment of tuberculosis: guidelines for national programmes. Second edition., P1; Mansouri D, 2005, EUR J PEDIATR, V164, P753, DOI 10.1007/s00431-005-1689-9; MCGUIRE W, 1994, NATURE, V371, P508, DOI 10.1038/371508a0; Moller M, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-154; O'Garra A, 2004, J CLIN INVEST, V114, P1372, DOI 10.1172/JCI200423215; Pacheco AG, 2008, HUM GENET, V123, P477, DOI 10.1007/s00439-008-0497-5; Rossouw M, 2003, LANCET, V361, P1871, DOI 10.1016/S0140-6736(03)13491-5; Sallakci N, 2007, TUBERCULOSIS, V87, P225, DOI 10.1016/j.tube.2006.10.002; Santos AR, 2000, INT J LEPROSY, V68, P325; Selvaraj P, 2008, CYTOKINE, V43, P26, DOI 10.1016/j.cyto.2008.04.011; Vallinoto ACR, 2010, HUM IMMUNOL, V71, P692, DOI 10.1016/j.humimm.2010.03.008; Velez DR, 2009, HUM GENET, V126, P643, DOI 10.1007/s00439-009-0713-y; WHO, 2009, WHO TECH REP SER, V958, P1; World Health Organization, 2009, GLOB TUB CONTR EP ST; Zhang J, 2011, INT J TUBERC LUNG D, V15, P594, DOI 10.5588/ijtld.09.0703	48	27	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2011	6	11							e27848	10.1371/journal.pone.0027848	http://dx.doi.org/10.1371/journal.pone.0027848			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863LT	22140472	Green Published, gold, Green Submitted			2022-12-27	WOS:000298166300013
J	Karki, S; Chakrabarti, P; Huang, GR; Wang, H; Farmer, SR; Kandror, KV				Karki, Shakun; Chakrabarti, Partha; Huang, Guanrong; Wang, Hong; Farmer, Stephen R.; Kandror, Konstantin V.			The Multi-Level Action of Fatty Acids on Adiponectin Production by Fat Cells	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; INDUCED INSULIN-RESISTANCE; NECROSIS-FACTOR-ALPHA; ADIPOSE-TISSUE; LIPOPROTEIN-LIPASE; 3T3-L1 ADIPOCYTES; LYSOSOMAL TRAFFICKING; ENDOCRINE ORGAN; TNF-ALPHA; ER STRESS	Current epidemics of diabetes mellitus is largely caused by wide spread obesity. The best-established connection between obesity and insulin resistance is the elevated and/or dysregulated levels of circulating free fatty acids that cause and aggravate insulin resistance, type 2 diabetes, cardiovascular disease and other hazardous metabolic conditions. Here, we investigated the effect of a major dietary saturated fatty acid, palmitate, on the insulin-sensitizing adipokine adiponectin produced by cultured adipocytes. We have found that palmitate rapidly inhibits transcription of the adiponectin gene and the release of adiponectin from adipocytes. Adiponectin gene expression is controlled primarily by PPAR gamma and C/EBP alpha. Using mouse embryonic fibroblasts from C/EBP alpha-null mice, we have determined that the latter transcription factor may not solely mediate the inhibitory effect of palmitate on adiponectin transcription leaving PPAR gamma as a likely target of palmitate. In agreement with this model, palmitate increases phosphorylation of PPAR gamma on Ser273, and substitution of PPAR gamma for the unphosphorylated mutant Ser273Ala blocks the effect of palmitate on adiponectin transcription. The inhibitory effect of palmitate on adiponectin gene expression requires its intracellular metabolism via the acyl-CoA synthetase 1-mediated pathway. In addition, we found that palmitate stimulates degradation of intracellular adiponectin by lysosomes, and the lysosomal inhibitor, chloroquine, suppressed the effect of palmitate on adiponectin release from adipocytes. We present evidence suggesting that the intracellular sorting receptor, sortilin, plays an important role in targeting of adiponectin to lysosomes. Thus, palmitate not only decreases adiponectin expression at the level of transcription but may also stimulate lysosomal degradation of newly synthesized adiponectin.	[Karki, Shakun; Chakrabarti, Partha; Huang, Guanrong; Wang, Hong; Farmer, Stephen R.; Kandror, Konstantin V.] Boston Univ, Sch Med, Boston, MA 02118 USA	Boston University	Karki, S (corresponding author), Boston Univ, Sch Med, Boston, MA 02118 USA.	kkandror@bu.edu		Farmer, Stephen/0000-0003-2483-2795; Kandror, Konstantin/0000-0002-8601-9313	National Institutes of Health (NIH) [DK51586, DK58825, DK52057, DK56736];  [T32HL007969-07]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK052057, R01DK056736, R01DK051586, R56DK051586, R01DK052057, R56DK058825, R01DK058825] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by research grants from the National Institutes of Health (NIH) DK51586 and DK58825 to S.R.F., DK52057 and DK56736 to K.V.K. and by cardiovascular training grant T32HL007969-07 to S. K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahima RS, 2008, MOL ENDOCRINOL, V22, P1023, DOI 10.1210/me.2007-0529; Ajuwon KM, 2005, J NUTR, V135, P1841, DOI 10.1093/jn/135.8.1841; APPEL B, 1992, AM J PHYSIOL, V262, pE695, DOI 10.1152/ajpendo.1992.262.5.E695; Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255; Bradley RL, 2008, OBESITY, V16, P938, DOI 10.1038/oby.2008.39; Bueno AA, 2008, PFLUG ARCH EUR J PHY, V455, P701, DOI 10.1007/s00424-007-0330-3; Choi JH, 2010, NATURE, V466, P451, DOI 10.1038/nature09291; Coleman RA, 2002, J NUTR, V132, P2123, DOI 10.1093/jn/132.8.2123; Deguil J, 2011, TRAFFIC, V12, P349, DOI 10.1111/j.1600-0854.2010.01150.x; Evans SF, 2011, J BIOL CHEM, V286, P29556, DOI 10.1074/jbc.M111.219675; Fernandez-Real JM, 2005, CLIN CHEM, V51, P603, DOI 10.1373/clinchem.2004.041350; GORDON ES, 1960, AM J CLIN NUTR, V8, P740, DOI 10.1093/ajcn/8.5.740; GREEN H, 1976, CELL, V7, P105, DOI 10.1016/0092-8674(76)90260-9; Gregor MF, 2007, J LIPID RES, V48, P1905, DOI 10.1194/jlr.R700007-JLR200; Halberg N, 2009, DIABETES, V58, P1961, DOI 10.2337/db08-1750; Hu E, 1996, J BIOL CHEM, V271, P10697, DOI 10.1074/jbc.271.18.10697; JENSEN MD, 1989, J CLIN INVEST, V83, P1168, DOI 10.1172/JCI113997; Jiao P, 2011, OBESITY, V19, P483, DOI 10.1038/oby.2010.200; Karaskov E, 2006, ENDOCRINOLOGY, V147, P3398, DOI 10.1210/en.2005-1494; Kennedy A, 2009, J NUTR, V139, P1, DOI 10.3945/jn.108.098269; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Kwon S, 2011, J BIOL CHEM, V286, P21876, DOI 10.1074/jbc.M111.228262; Lavoie F, 2009, J CLIN ENDOCR METAB, V94, P998, DOI 10.1210/jc.2008-1021; Lee MJ, 2006, J LIPID RES, V47, P1984, DOI 10.1194/jlr.M600065-JLR200; Lefrancois S, 2003, EMBO J, V22, P6430, DOI 10.1093/emboj/cdg629; Liu ML, 2010, BIOCHEM J, V425, P41, DOI 10.1042/BJ20091045; Lobo S, 2009, J BIOL CHEM, V284, P18347, DOI 10.1074/jbc.M109.017244; Loo LH, 2009, J CELL BIOL, V187, P375, DOI 10.1083/jcb.200904140; Nguyen MTA, 2005, J BIOL CHEM, V280, P35361, DOI 10.1074/jbc.M504611200; Ni XY, 2006, TRAFFIC, V7, P889, DOI 10.1111/j.1600-0854.2006.00429.x; Nielsen MS, 1999, J BIOL CHEM, V274, P8832, DOI 10.1074/jbc.274.13.8832; OLIVECRONA T, 1987, J BIOL CHEM, V262, P10748; do Nascimento CMO, 2009, AN ACAD BRAS CIENC, V81, P453, DOI 10.1590/S0001-37652009000300010; Peng G, 2011, ENDOCRINOLOGY, V152, P2206, DOI 10.1210/en.2010-1369; Qatanani M, 2007, GENE DEV, V21, P1443, DOI 10.1101/gad.1550907; Qiang L, 2007, MOL CELL BIOL, V27, P4698, DOI 10.1128/MCB.02279-06; REAVEN GM, 1988, DIABETES, V37, P1020, DOI 10.2337/diabetes.37.8.1020; Ruan H, 2003, J BIOL CHEM, V278, P47585, DOI 10.1074/jbc.M305257200; Savage DB, 2007, PHYSIOL REV, V87, P507, DOI 10.1152/physrev.00024.2006; Schaffer JE, 2003, CURR OPIN LIPIDOL, V14, P281, DOI 10.1097/00041433-200306000-00008; Scherer PE, 2006, DIABETES, V55, P1537, DOI 10.2337/db06-0263; SEMB H, 1987, BIOCHIM BIOPHYS ACTA, V921, P104, DOI 10.1016/0005-2760(87)90176-7; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Shi J, 2005, DEV CELL, V9, P99, DOI 10.1016/j.devcel.2005.04.004; Stryjecki C, 2011, EUR J CLIN NUTR, V65, P285, DOI 10.1038/ejcn.2010.277; Tsukumo DML, 2007, DIABETES, V56, P1986, DOI 10.2337/db06-1595; VANNIER C, 1989, J BIOL CHEM, V264, P13206; Vernochet C, 2009, MOL CELL BIOL, V29, P4714, DOI 10.1128/MCB.01899-08; Wang ZV, 2007, MOL CELL BIOL, V27, P3716, DOI 10.1128/MCB.00931-06; Wellen KE, 2010, MOL CELL, V40, P323, DOI 10.1016/j.molcel.2010.10.004; Xi L, 2007, BRIT J PHARMACOL, V151, P610, DOI 10.1038/sj.bjp.0707276; Xu Z, 2002, J BIOL CHEM, V277, P47972, DOI 10.1074/jbc.C200486200; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Zhou LJ, 2010, DIABETES, V59, P2809, DOI 10.2337/db10-0412; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	56	32	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2011	6	11							e28146	10.1371/journal.pone.0028146	http://dx.doi.org/10.1371/journal.pone.0028146			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863LT	22140527	Green Published, Green Submitted, gold			2022-12-27	WOS:000298166300030
J	Lannergard, J; Cao, S; Norstrom, T; Delgado, A; Gustafson, JE; Hughes, D				Lannergard, Jonas; Cao, Sha; Norstrom, Tobias; Delgado, Alejandro; Gustafson, John E.; Hughes, Diarmaid			Genetic Complexity of Fusidic Acid-Resistant Small Colony Variants (SCV) in Staphylococcus aureus	PLOS ONE			English	Article							HEMB MUTANTS; PHENOTYPE; INFECTIONS; PERSISTENT; MENADIONE; IDENTIFICATION; DETERMINANTS; MUTATIONS; MEND; SITE	FusE mutants are fusidic acid-resistant small colony variants (SCVs) of Staphylococcus aureus that can be selected with aminoglycosides. All FusE SCVs have mutations in rplF, encoding ribosomal protein L6. However, individual FusE mutants including some with the same mutation in rplF display auxotrophy for either hemin or menadione, suggesting that additional mutations are involved. Here we show that FusE SCVs can be divided into three genetic sub-groups and that some carry an additional mutation, in one of the genes required for hemin biosynthesis, or in one of the genes required for menadione biosynthesis. Reversion analysis and genome sequencing support the hypothesis that these combinations of mutations in the rplF, hem, and/or men genes can account for the SCV and auxotrophic phenotypes of FusE mutants.	[Lannergard, Jonas; Norstrom, Tobias] Uppsala Univ, Biomed Ctr, Dept Cell & Mol Biol, Uppsala, Sweden; [Cao, Sha; Hughes, Diarmaid] Uppsala Univ, Biomed Ctr, Dept Med Biochem & Microbiol, Uppsala, Sweden; [Delgado, Alejandro; Gustafson, John E.] New Mexico State Univ, Dept Biol, Microbiol Grp, Las Cruces, NM 88003 USA	Uppsala University; Uppsala University; New Mexico State University	Lannergard, J (corresponding author), Uppsala Univ, Biomed Ctr, Dept Cell & Mol Biol, Uppsala, Sweden.	diarmaid.hughes@imbim.uu.se	Lannergård, Jonas/L-6513-2013; Hughes, Diarmaid/A-9487-2014	Hughes, Diarmaid/0000-0002-7456-9182; Lannergard, Jonas/0000-0001-9072-6486	Swedish Science Research Council (VR); European Union; Vinnova [P35553-1]; SSF [(RBa08-0063)-JL]; Carl Trygger Foundation-JEG; National Institutes of Health [SC1GM083882-01, R25 GM07667-30, S06 GM61222-05]; National Center for Research Resources [P20RR016480]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016480] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM061222, T34GM007667] Funding Source: NIH RePORTER	Swedish Science Research Council (VR)(Swedish Research Council); European Union(European Commission); Vinnova(Vinnova); SSF(Swedish Foundation for Strategic Research); Carl Trygger Foundation-JEG; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	DH acknowledges support from the Swedish Science Research Council (VR), the European Union (FP6 and FP7 programmes; projects EAR and PAR), Vinnova (P35553-1), and SSF (RBa08-0063)-JL and SC were each supported by postdoctoral stipends from the Carl Trygger Foundation-JEG and AD acknowledges support from the National Institutes of Health: SC1GM083882-01; R25 GM07667-30 (NMSU-MARC PROGRAM); S06 GM61222-05 (NMSU-MBRS-RISE PROGRAM); and P20RR016480 from the NM-INBRE Program of the National Center for Research Resources-The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Albert TJ, 2005, NAT METHODS, V2, P951, DOI 10.1038/NMETH805; BALWIT JM, 1994, J INFECT DIS, V170, P1033, DOI 10.1093/infdis/170.4.1033; Bates DM, 2003, J INFECT DIS, V187, P1654, DOI 10.1086/374642; Besier S, 2007, INT J MED MICROBIOL, V297, P217, DOI 10.1016/j.ijmm.2007.02.003; Chatterjee I, 2008, J BACTERIOL, V190, P834, DOI 10.1128/JB.00912-07; CHOPRA I, 1976, J GEN MICROBIOL, V96, P229, DOI 10.1099/00221287-96-2-229; Chuard C, 1997, J ANTIMICROB CHEMOTH, V39, P603, DOI 10.1093/jac/39.5.603; Clements MO, 1999, J BACTERIOL, V181, P501, DOI 10.1128/JB.181.2.501-507.1999; Jonsson IM, 2003, MICROB PATHOGENESIS, V34, P73, DOI 10.1016/S0882-4010(02)00208-5; Lannergard J, 2008, ANTIMICROB AGENTS CH, V52, P4017, DOI 10.1128/AAC.00668-08; Lannergard J, 2009, ANTIMICROB AGENTS CH, V53, P2059, DOI 10.1128/AAC.00871-08; Laurberg M, 2000, J MOL BIOL, V303, P593, DOI 10.1006/jmbi.2000.4168; Nagaev I, 2001, MOL MICROBIOL, V40, P433, DOI 10.1046/j.1365-2958.2001.02389.x; Norstrom T, 2007, ANTIMICROB AGENTS CH, V51, P4438, DOI 10.1128/AAC.00328-07; O'Brien FG, 2002, J ANTIMICROB CHEMOTH, V50, P313, DOI 10.1093/jac/dkf153; O'Neill AJ, 2007, ANTIMICROB AGENTS CH, V51, P1737, DOI 10.1128/AAC.01542-06; O'Neill AJ, 2007, J CLIN MICROBIOL, V45, P1505, DOI 10.1128/JCM.01984-06; O'Neill AJ, 2006, MOL MICROBIOL, V59, P664, DOI 10.1111/j.1365-2958.2005.04971.x; PROCTOR RA, 1995, CLIN INFECT DIS, V20, P95, DOI 10.1093/clinids/20.1.95; Proctor RA, 2006, NAT REV MICROBIOL, V4, P295, DOI 10.1038/nrmicro1384; Schaaff F, 2003, INT J MED MICROBIOL, V293, P427, DOI 10.1078/1438-4221-00282; von Eiff C, 2006, J BACTERIOL, V188, P687, DOI 10.1128/JB.188.2.687-693.2006; von Eiff C, 2006, INJURY, V37, P26, DOI 10.1016/j.injury.2006.04.006; vonEiff C, 1997, J BACTERIOL, V179, P4706, DOI 10.1128/jb.179.15.4706-4712.1997	24	21	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2011	6	11							e28366	10.1371/journal.pone.0028366	http://dx.doi.org/10.1371/journal.pone.0028366			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863LT	22140579	Green Submitted, gold, Green Published			2022-12-27	WOS:000298166300050
J	Chersi, F; Ferrari, PF; Fogassi, L				Chersi, Fabian; Ferrari, Pier Francesco; Fogassi, Leonardo			Neuronal Chains for Actions in the Parietal Lobe: A Computational Model	PLOS ONE			English	Article							VENTRAL PREMOTOR; FUNCTIONAL-ORGANIZATION; MACAQUE MONKEY; CORTEX; BEHAVIOR; MOTOR; REPRESENTATION; CONNECTIONS; PROPAGATION; GENERATION	The inferior part of the parietal lobe (IPL) is known to play a very important role in sensorimotor integration. Neurons in this region code goal-related motor acts performed with the mouth, with the hand and with the arm. It has been demonstrated that most IPL motor neurons coding a specific motor act (e.g., grasping) show markedly different activation patterns according to the final goal of the action sequence in which the act is embedded (grasping for eating or grasping for placing). Some of these neurons (parietal mirror neurons) show a similar selectivity also during the observation of the same action sequences when executed by others. Thus, it appears that the neuronal response occurring during the execution and the observation of a specific grasping act codes not only the executed motor act, but also the agent's final goal (intention). In this work we present a biologically inspired neural network architecture that models mechanisms of motor sequences execution and recognition. In this network, pools composed of motor and mirror neurons that encode motor acts of a sequence are arranged in form of action goal-specific neuronal chains. The execution and the recognition of actions is achieved through the propagation of activity bursts along specific chains modulated by visual and somatosensory inputs. The implemented spiking neuron network is able to reproduce the results found in neurophysiological recordings of parietal neurons during task performance and provides a biologically plausible implementation of the action selection and recognition process. Finally, the present paper proposes a mechanism for the formation of new neural chains by linking together in a sequential manner neurons that represent subsequent motor acts, thus producing goal-directed sequences.	[Chersi, Fabian] CNR, Inst Sci & Technol Cognit, Rome, Italy; [Chersi, Fabian; Ferrari, Pier Francesco; Fogassi, Leonardo] Univ Parma, Dept Neurosci, I-43100 Parma, Italy; [Ferrari, Pier Francesco] Univ Parma, Dept Evolutionary & Funct Biol, I-43100 Parma, Italy; [Fogassi, Leonardo] Univ Parma, Dept Psychol, I-43100 Parma, Italy; [Ferrari, Pier Francesco; Fogassi, Leonardo] Italian Inst Technol RTM, Parma, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze e Tecnologie della Cognizione (ISTC-CNR); University of Parma; University of Parma; University of Parma; Istituto Italiano di Tecnologia - IIT	Chersi, F (corresponding author), CNR, Inst Sci & Technol Cognit, Rome, Italy.	fabian.chersi@nemo.unipr.it	Ferrari, Pier Francesco/G-5547-2017; FOGASSI, Leonardo/K-3541-2018	FOGASSI, Leonardo/0000-0003-3348-039X	Italian Space Agency (ASI) [PR-DCMC-GO-1B1125-003]; Italian MIUR [2006052343, 2008J7YFNR002]; Italian Institute of Technology; European project "Goal-Leaders" [FP7 270108]	Italian Space Agency (ASI)(Agenzia Spaziale Italiana (ASI)); Italian MIUR(Ministry of Education, Universities and Research (MIUR)); Italian Institute of Technology(Istituto Italiano di Tecnologia - IIT); European project "Goal-Leaders"	This work was supported by the Italian Space Agency (ASI) PR-DCMC-GO-1B1125-003, by the Italian MIUR 2006052343 and 2008J7YFNR002, by the Italian Institute of Technology program (Motor cognition), and by the European project FP7 270108 "Goal-Leaders". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; Abeles M., 1982, LOCAL CORTICAL CIRCU; Abeles M., 1991, CORTICONICS NEURAL C, DOI DOI 10.1017/CBO9780511574566; AMIT DJ, 1988, P NATL ACAD SCI USA, V85, P2141, DOI 10.1073/pnas.85.7.2141; Andersen RA, 2002, ANNU REV NEUROSCI, V25, P189, DOI 10.1146/annurev.neuro.25.112701.142922; Andersen RA, 1997, ANNU REV NEUROSCI, V20, P303, DOI 10.1146/annurev.neuro.20.1.303; ANDERSEN RA, 1990, J COMP NEUROL, V296, P65, DOI 10.1002/cne.902960106; Bi GQ, 2001, ANNU REV NEUROSCI, V24, P139, DOI 10.1146/annurev.neuro.24.1.139; BIENENSTOCK E, 1995, NETWORK-COMP NEURAL, V6, P179, DOI 10.1088/0954-898X/6/2/004; Bonini L, 2011, J NEUROSCI, V31, P5876, DOI 10.1523/JNEUROSCI.5186-10.2011; Bonini L, 2010, CEREB CORTEX, V20, P1372, DOI 10.1093/cercor/bhp200; Cattaneo L, 2007, P NATL ACAD SCI USA, V104, P17825, DOI 10.1073/pnas.0706273104; CAVADA C, 1989, J COMP NEUROL, V287, P422, DOI 10.1002/cne.902870403; Chersi F, 2005, SOC NEUROSCI ABS, V412, P8; Colby CL, 1998, NEURON, V20, P15, DOI 10.1016/S0896-6273(00)80429-8; Deco G, 2005, J COGNITIVE NEUROSCI, V17, P294, DOI 10.1162/0898929053124875; Destexhe A, 1996, METHODS NEURONAL MOD; Diesmann M, 1999, NATURE, V402, P529, DOI 10.1038/990101; FAUGIERGRIMAUD S, 1978, NEUROPSYCHOLOGIA, V16, P151, DOI 10.1016/0028-3932(78)90103-3; Ferrari PF, 2003, EUR J NEUROSCI, V17, P1703, DOI 10.1046/j.1460-9568.2003.02601.x; Fogassi L, 2005, CURR OPIN NEUROBIOL, V15, P626, DOI 10.1016/j.conb.2005.10.015; Fogassi L, 2005, SCIENCE, V308, P662, DOI 10.1126/science.1106138; Fuster JM, 2008, PREFRONTAL CORTEX, 4TH EDITION, P1; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gallese V, 2002, ATTENTION PERFORM, V19, P334; Gonzalez-Burgos G, 2004, CEREB CORTEX, V14, P530, DOI 10.1093/cercor/bhh015; Gregoriou GG, 2005, NEUROIMAGE, V27, P442, DOI 10.1016/j.neuroimage.2005.02.038; HYVARINEN J, 1982, PHYSIOL REV, V62, P1060, DOI 10.1152/physrev.1982.62.3.1060; HYVARINEN J, 1981, BRAIN RES, V206, P287, DOI 10.1016/0006-8993(81)90533-3; Ijspeert AJ, 1999, LECT NOTES ARTIF INT, V1674, P195; Ijspeert AJ, 1999, ADAPT BEHAV, V7, P151, DOI 10.1177/105971239900700202; Ikegaya Y, 2004, SCIENCE, V304, P559, DOI 10.1126/science.1093173; JAHR CE, 1990, J NEUROSCI, V10, P3178; Jeannerod M., 1988, NEURAL BEHAV ORG GOA; Jin DZ, 2007, J COMPUT NEUROSCI, V23, P283, DOI 10.1007/s10827-007-0032-z; Kepecs A, 2002, BIOL CYBERN, V87, P446, DOI 10.1007/s00422-002-0358-6; KLEINFELD D, 1986, P NATL ACAD SCI USA, V83, P9469, DOI 10.1073/pnas.83.24.9469; Kraskov A, 2009, NEURON, V64, P922, DOI 10.1016/j.neuron.2009.12.010; Leiguarda RC, 2000, BRAIN, V123, P860, DOI 10.1093/brain/123.5.860; Long MA, 2010, NATURE, V468, P394, DOI 10.1038/nature09514; Lucke J, 2004, NEURAL COMPUT, V16, P501, DOI 10.1162/089976604772744893; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; Mountcastle VB, 1997, BRAIN, V120, P701, DOI 10.1093/brain/120.4.701; MOUNTCASTLE VB, 1975, J NEUROPHYSIOL, V38, P871, DOI 10.1152/jn.1975.38.4.871; PERRETT DI, 1989, J EXP BIOL, V146, P87; PETRIDES M, 1984, J COMP NEUROL, V228, P105, DOI 10.1002/cne.902280110; Reyes AD, 2003, NAT NEUROSCI, V6, P593, DOI 10.1038/nn1056; Rigotti M, 2006, SOC NEUROSCIENCE ABS, V569, P14; Rizzolatti G, 2001, NEURON, V31, P889, DOI 10.1016/S0896-6273(01)00423-8; RIZZOLATTI G, 1988, EXP BRAIN RES, V71, P491, DOI 10.1007/BF00248742; Rizzolatti Giacomo, 2006, Novartis Found Symp, V270, P129; Rosenbaum DA, 2007, HUM MOVEMENT SCI, V26, P525, DOI 10.1016/j.humov.2007.04.001; Rozzi S, 2008, EUR J NEUROSCI, V28, P1569, DOI 10.1111/j.1460-9568.2008.06395.x; Rozzi S, 2006, CEREB CORTEX, V16, P1389, DOI 10.1093/cercor/bhj076; Rushworth MFS, 1997, EXP BRAIN RES, V117, P292, DOI 10.1007/s002210050224; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; Tanji J, 2008, PHYSIOL REV, V88, P37, DOI 10.1152/physrev.00014.2007; Tuckwell H. C., 1988, INTRO THEORETICAL NE, V1; Umilta MA, 2001, NEURON, V31, P155, DOI 10.1016/S0896-6273(01)00337-3; WANG DL, 1990, P IEEE, V78, P1536, DOI 10.1109/5.58329; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	62	45	45	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2011	6	11							e27652	10.1371/journal.pone.0027652	http://dx.doi.org/10.1371/journal.pone.0027652			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KW	22140455	gold, Green Published, Green Submitted			2022-12-27	WOS:000298163400011
J	Kogot, JM; Zhang, YT; Moore, SJ; Pagano, P; Stratis-Cullum, DN; Chang-Yen, D; Turewicz, M; Pellegrino, PM; de Fusco, A; Soh, HT; Stagliano, NE				Kogot, Joshua M.; Zhang, Yanting; Moore, Stephen J.; Pagano, Paul; Stratis-Cullum, Dimitra N.; Chang-Yen, David; Turewicz, Marek; Pellegrino, Paul M.; de Fusco, Andre; Soh, H. Tom; Stagliano, Nancy E.			Screening of Peptide Libraries against Protective Antigen of Bacillus anthracis in a Disposable Microfluidic Cartridge	PLOS ONE			English	Article							SURFACE DISPLAY; AFFINITY; PROTEINS; CELLS; MICROARRAYS; ENRICHMENT; ANTIBODY; SCAFFOLD; SELECT	Bacterial surface peptide display has gained popularity as a method of affinity reagent generation for a wide variety of applications ranging from drug discovery to pathogen detection. In order to isolate the bacterial clones that express peptides with high affinities to the target molecule, multiple rounds of manual magnetic activated cell sorting ( MACS) followed by multiple rounds of fluorescence activated cell sorting (FACS) are conventionally used. Although such manual methods are effective, alternative means of library screening which improve the reproducibility, reduce the cost, reduce cross contamination, and minimize exposure to hazardous target materials are highly desired for practical application. Toward this end, we report the first semi-automated system demonstrating the potential for screening bacterially displayed peptides using disposable microfluidic cartridges. The Micro-Magnetic Separation platform (MMS) is capable of screening a bacterial library containing 3610 10 members in 15 minutes and requires minimal operator training. Using this system, we report the isolation of twenty-four distinct peptide ligands that bind to the protective antigen (PA) of Bacilus anthracis in three rounds of selection. A consensus motif WXCFTC was found using the MMS and was also found in one of the PA binders isolated by the conventional MACS/FACS approach. We compared MMS and MACS rare cell recovery over cell populations ranging from 0.1% to 0.0000001% and found that both magnetic sorting methods could recover cells down to 0.0000001% initial cell population, with the MMS having overall lower standard deviation of cell recovery. We believe the MMS system offers a compelling approach towards highly efficient, semi-automated screening of molecular libraries that is at least equal to manual magnetic sorting methods and produced, for the first time, 15-mer peptide binders to PA protein that exhibit better affinity and specificity than peptides isolated using conventional MACS/FACS.	[Kogot, Joshua M.; Stratis-Cullum, Dimitra N.; Pellegrino, Paul M.] USA, Res Lab, Sensors & Electron Devices Directorate, Adelphi, MD USA; [Zhang, Yanting; Pagano, Paul; Chang-Yen, David; Turewicz, Marek; de Fusco, Andre] Cynvenio Biosyst Inc, Westlake Village, CA USA; [Moore, Stephen J.; Stagliano, Nancy E.] CytomX Therapeut LLC, Santa Barbara, CA USA; [Soh, H. Tom] Univ Calif Santa Barbara, Dept Mech Engn, Santa Barbara, CA 93106 USA	United States Department of Defense; US Army Research, Development & Engineering Command (RDECOM); US Army Research Laboratory (ARL); University of California System; University of California Santa Barbara	Kogot, JM (corresponding author), USA, Res Lab, Sensors & Electron Devices Directorate, Adelphi, MD USA.	dimitra.n.stratis-cullum.civ@mail.mil	Stratis-Cullum, Dimitra/F-9363-2013	Stratis-Cullum, Dimitra/0000-0002-4832-6945	U.S. Army, through the Institute of Collaborative Biology at University of California Santa Barbara [DAAD19-03-D-0004]; U.S. Department of Energy; U.S. Army Research Laboratory; Defense Threat Reduction Agency-Joint Science and Technology Office for Chemical and Biological Defense [BRCALL08-Per3-P-2-0028]	U.S. Army, through the Institute of Collaborative Biology at University of California Santa Barbara; U.S. Department of Energy(United States Department of Energy (DOE)); U.S. Army Research Laboratory(United States Department of DefenseUS Army Research Laboratory (ARL)); Defense Threat Reduction Agency-Joint Science and Technology Office for Chemical and Biological Defense(United States Department of DefenseDefense Threat Reduction Agency)	This work was supported in part by the U.S. Army, through the Institute of Collaborative Biology at University of California Santa Barbara, under grant DAAD19-03-D-0004, in part by an appointment to the Internship/Research Participation Program for the U.S. Army Research Laboratory administered by the Oak Ridge Institute for Science and Education through an agreement between the U.S. Department of Energy and the U.S. Army Research Laboratory, and in part by the Defense Threat Reduction Agency-Joint Science and Technology Office for Chemical and Biological Defense (Grant no. BRCALL08-Per3-P-2-0028). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bessette PH, 2007, ANAL CHEM, V79, P2174, DOI 10.1021/ac0616916; Bessette PH, 2004, PROTEIN ENG DES SEL, V17, P731, DOI 10.1093/protein/gzh084; Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; Bupp K, 2002, MOL THER, V5, P329, DOI 10.1006/mthe.2002.0546; Cho M, 2010, P NATL ACAD SCI USA, V107, P15373, DOI 10.1073/pnas.1009331107; Christmann A, 1999, PROTEIN ENG, V12, P797, DOI 10.1093/protein/12.9.797; Dane KY, 2009, MOL CANCER THER, V8, P1312, DOI 10.1158/1535-7163.MCT-08-1105; Daugherty PS, 2000, J IMMUNOL METHODS, V243, P211, DOI 10.1016/S0022-1759(00)00236-2; Georgiou G, 1997, NAT BIOTECHNOL, V15, P29, DOI 10.1038/nbt0197-29; Hu XY, 2005, P NATL ACAD SCI USA, V102, P15757, DOI 10.1073/pnas.0507719102; Kenrick SA, 2010, PROTEIN ENG DES SEL, V23, P9, DOI 10.1093/protein/gzp065; Kodadek T, 2001, CHEM BIOL, V8, P105, DOI 10.1016/S1074-5521(00)90067-X; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Krivacic RT, 2004, P NATL ACAD SCI USA, V101, P10501, DOI 10.1073/pnas.0404036101; Lara O, 2004, EXP HEMATOL, V32, P891, DOI 10.1016/j.exphem.2004.07.007; Leary JF, 2005, CYTOM PART A, V67A, P76, DOI 10.1002/cyto.a.20160; Levin AM, 2006, MOL BIOSYST, V2, P49, DOI 10.1039/b511782h; Little LE, 2011, BIOMATERIALS, V32, P1484, DOI 10.1016/j.biomaterials.2010.10.032; MacBeath G, 2001, NAT BIOTECHNOL, V19, P828, DOI 10.1038/nbt0901-828; Muller OJ, 2003, NAT BIOTECHNOL, V21, P1040, DOI 10.1038/nbt856; Nixon Andrew E., 2002, Current Pharmaceutical Biotechnology, V3, P1; Rice JJ, 2008, PROTEIN ENG DES SEL, V21, P435, DOI 10.1093/protein/gzn020; Rice JJ, 2006, PROTEIN SCI, V15, P825, DOI 10.1110/ps.051897806; Siegel RW, 2004, J IMMUNOL METHODS, V286, P141, DOI 10.1016/j.jim.2004.01.005; Thomas JM, 2009, PROTEIN SCI, V18, P2053, DOI 10.1002/pro.217; Wilson DS, 2001, P NATL ACAD SCI USA, V98, P3750, DOI 10.1073/pnas.061028198; Xu Y, 2009, ANAL CHEM, V81, P7436, DOI 10.1021/ac9012072; Yan H, 2009, J ZHEJIANG UNIV-SC B, V10, P928, DOI 10.1631/jzus.B0920205; Yeung YA, 2002, BIOTECHNOL PROGR, V18, P212, DOI 10.1021/bp010186l	29	23	23	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2011	6	11							e26925	10.1371/journal.pone.0026925	http://dx.doi.org/10.1371/journal.pone.0026925			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KW	22140433	Green Published, gold			2022-12-27	WOS:000298163400003
J	Leder, K; Foo, J; Skaggs, B; Gorre, M; Sawyers, CL; Michor, F				Leder, Kevin; Foo, Jasmine; Skaggs, Brian; Gorre, Mercedes; Sawyers, Charles L.; Michor, Franziska			Fitness Conferred by BCR-ABL Kinase Domain Mutations Determines the Risk of Pre-Existing Resistance in Chronic Myeloid Leukemia	PLOS ONE			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; DRUG-RESISTANCE; TYROSINE KINASE; CHRONIC-PHASE; IMATINIB; MODEL; EVOLUTION; CANCER; MECHANISMS; STRATEGIES	Chronic myeloid leukemia (CML) is the first human malignancy to be successfully treated with a small molecule inhibitor, imatinib, targeting a mutant oncoprotein (BCR-ABL). Despite its successes, acquired resistance to imatinib leads to reduced drug efficacy and frequent progression of disease. Understanding the characteristics of pre-existing resistant cells is important for evaluating the benefits of first-line combination therapy with second generation inhibitors. However, due to limitations of assay sensitivity, determining the existence and characteristics of resistant cell clones at the start of therapy is difficult. Here we combined a mathematical modeling approach using branching processes with experimental data on the fitness changes (i.e., changes in net reproductive rate) conferred by BCR-ABL kinase domain mutations to investigate the likelihood, composition, and diversity of pre-existing resistance. Furthermore, we studied the impact of these factors on the response to tyrosine kinase inhibitors. Our approach predicts that in most patients, there is at most one resistant clone present at the time of diagnosis of their disease. Interestingly, patients are no more likely to harbor the most aggressive, pan-resistant T315I mutation than any other resistance mutation; however, T315I cells on average establish larger-sized clones at the time of diagnosis. We established that for patients diagnosed late, the relative benefit of combination therapy over monotherapy with imatinib is significant, while this benefit is modest for patients with a typically early diagnosis time. These findings, after pre-clinical validation, will have implications for the clinical management of CML: we recommend that patients with advanced-phase disease be treated with combination therapy with at least two tyrosine kinase inhibitors.	[Leder, Kevin] Univ Minnesota, Program Ind & Syst Engn, Minneapolis, MN 55455 USA; [Foo, Jasmine] Univ Minnesota, Sch Math, Minneapolis, MN 55455 USA; [Skaggs, Brian] David Geffen Univ Calif Los Angeles, Sch Med, Div Rheumatol, Los Angeles, CA USA; [Gorre, Mercedes] Combimatrix, Irvine, CA USA; [Sawyers, Charles L.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA; [Michor, Franziska] Harvard Univ, Sch Publ Hlth, Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Michor, Franziska] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Memorial Sloan Kettering Cancer Center; Harvard University; Dana-Farber Cancer Institute; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Leder, K (corresponding author), Univ Minnesota, Program Ind & Syst Engn, Minneapolis, MN 55455 USA.	michor@jimmy.harvard.edu	Sawyers, Charles/G-5327-2016		NCI (National Cancer Institute) [U54CA143798]; NATIONAL CANCER INSTITUTE [U54CA143798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR059095] Funding Source: NIH RePORTER	NCI (National Cancer Institute)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported through NCI (National Cancer Institute) grant U54CA143798. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angerer WP, 2001, J MATH BIOL, V42, P145, DOI 10.1007/s002850000053; Chanock SJ, 2007, NAT GENET, V39, P283, DOI 10.1038/ng0307-283; Chmielecki J, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002356; COLDMAN AJ, 1986, B MATH BIOL, V48, P279, DOI 10.1016/S0092-8240(86)90028-5; Dewanji A, 2005, MATH BIOSCI, V197, P140, DOI 10.1016/j.mbs.2005.07.003; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Durrett R, 2010, THEOR POPUL BIOL, V77, P42, DOI 10.1016/j.tpb.2009.10.008; FOKAS AS, 1991, CANCER RES, V51, P2084; Foo J, 2009, PLOS COMPUTATIONAL B; Frank SA, 2003, J THEOR BIOL, V223, P405, DOI 10.1016/S0022-5193(03)00117-6; Gambacorti-Passerini CB, 2003, LANCET ONCOL, V4, P75, DOI 10.1016/S1470-2045(03)00979-3; Gibbons D, 2011, CANCER IN PRESS; Goldman JM, 2003, NEW ENGL J MED, V349, P1451, DOI 10.1056/NEJMra020777; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Graham SM, 2002, BLOOD, V99, P319, DOI 10.1182/blood.V99.1.319; Haeno H, 2007, GENETICS, V177, P2209, DOI 10.1534/genetics.107.078915; HARNEVO LE, 1992, CANCER CHEMOTH PHARM, V30, P469, DOI 10.1007/BF00685599; Hochhaus A, 2004, LEUKEMIA, V18, P1321, DOI 10.1038/sj.leu.2403426; Hochhaus A, 2006, ANN ONCOL, V17, pX274, DOI 10.1093/annonc/mdl273; Holyoake T, 1999, BLOOD, V94, P2056, DOI 10.1182/blood.V94.6.2056; ICHIMARU M, 1991, J RADIAT RES, V32, P14, DOI 10.1269/jrr.32.SUPPLEMENT2_14; Iwasa Y, 2006, GENETICS, V172, P2557, DOI 10.1534/genetics.105.049791; Jabbour E, 2006, TARGET ONCOL, V1, P186, DOI 10.1007/s11523-006-0032-3; Kim PS, 2008, B MATH BIOL, V70, P1994, DOI 10.1007/s11538-008-9336-z; Kim PS, 2008, B MATH BIOL, V70, P728, DOI 10.1007/s11538-007-9276-z; Komarova N, 2006, J THEOR BIOL, V239, P351, DOI 10.1016/j.jtbi.2005.08.003; Komarova NL, 2007, THEOR POPUL BIOL, V72, P523, DOI 10.1016/j.tpb.2007.08.003; Komarova NL, 2005, P NATL ACAD SCI USA, V102, P9714, DOI 10.1073/pnas.0501870102; Koptyra M, 2006, BLOOD, V108, P319, DOI 10.1182/blood-2005-07-2815; Kunkel TA, 2000, ANNU REV BIOCHEM, V69, P497, DOI 10.1146/annurev.biochem.69.1.497; Luria SE, 1943, GENETICS, V28, P491; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Michor F, 2005, NATURE, V435, P1267, DOI 10.1038/nature03669; NOWELL PC, 1960, CANCER RES, V20, P462; O'Brien SG, 2003, NEW ENGL J MED, V348, P994, DOI 10.1056/NEJMoa022457; Pierce A, 2002, ONCOGENE, V21, P3068, DOI 10.1038/sj.onc.1205424; Quintas-Cardama A, 2007, NAT REV DRUG DISCOV, V6, P834, DOI 10.1038/nrd2324; Roeder I, 2006, NATURE MED, V12; SESHADRI R, 1987, CANCER RES, V47, P407; Shah NP, 2002, CANCER CELL, V2, P117, DOI 10.1016/S1535-6108(02)00096-X; SHTIVELMAN E, 1985, NATURE, V315, P550, DOI 10.1038/315550a0; Skaggs BJ, 2006, P NATL ACAD SCI USA, V103, P19466, DOI 10.1073/pnas.0609239103	42	38	39	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2011	6	11							e27682	10.1371/journal.pone.0027682	http://dx.doi.org/10.1371/journal.pone.0027682			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KW	22140458	Green Published, Green Submitted, gold			2022-12-27	WOS:000298163400012
J	Mukhopadhyay, P; Reddy, MK; Singla-Pareek, SL; Sopory, SK				Mukhopadhyay, Pradipto; Reddy, Malireddy K.; Singla-Pareek, Sneh Lata; Sopory, Sudhir K.			Transcriptional Downregulation of Rice rpL32 Gene under Abiotic Stress Is Associated with Removal of Transcription Factors within the Promoter Region	PLOS ONE			English	Article							RIBOSOMAL-PROTEIN GENES; CELL NUCLEAR ANTIGEN; SIGNAL-TRANSDUCTION; MOLECULAR-CLONING; CIS-ELEMENTS; S6 KINASE; EXPRESSION; ORGANIZATION; IDENTIFICATION; BINDING	Background: The regulation of ribosomal proteins in plants under stress conditions has not been well studied. Although a few reports have shown stress-specific post-transcriptional and translational mechanisms involved in downregulation of ribosomal proteins yet stress-responsive transcriptional regulation of ribosomal proteins is largely unknown in plants. Methodology/Principal Findings: In the present work, transcriptional regulation of genes encoding rice 60S ribosomal protein L32 (rpL32) in response to salt stress has been studied. Northern and RT-PCR analyses showed a significant downregulation of rpL32 transcripts under abiotic stress conditions in rice. Of the four rpL32 genes in rice genome, the gene on chromosome 8 (rpL32_8.1) showed a higher degree of stress-responsive downregulation in salt sensitive rice variety than in tolerant one and its expression reverted to its original level upon withdrawal of stress. The nuclear run-on and promoter: reporter assays revealed that the downregulation of this gene is transcriptional and originates within the promoter region. Using in vivo footprinting and electrophoretic mobility shift assay (EMSA), cis-elements in the promoter of rpL32_8.1 showing reduced binding to proteins in shoots of salt stressed rice seedlings were identified. Conclusions: The present work is one of the few reports on study of stress downregulated genes. The data revealed that rpL32 gene is transcriptionally downregulated under abiotic stress in rice and that this transcriptional downregulation is associated with the removal of transcription factors from specific promoter elements.	[Mukhopadhyay, Pradipto; Reddy, Malireddy K.; Singla-Pareek, Sneh Lata; Sopory, Sudhir K.] Int Ctr Genet Engn & Biotechnol, Plant Mol Biol Grp, Delhi, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Mukhopadhyay, P (corresponding author), Int Ctr Genet Engn & Biotechnol, Plant Mol Biol Grp, Delhi, India.	sopory@icgeb.res.in			Department of Biotechnology [BT/PR2965/AGR/155-III/2002]; Government of India; International Centre for Genetic Engineering and Biotechnology; University Grant Commission (UGC), Government of India	Department of Biotechnology; Government of India; International Centre for Genetic Engineering and Biotechnology; University Grant Commission (UGC), Government of India(University Grants Commission, India)	This work has been supported by grants from the Department of Biotechnology (grant number BT/PR2965/AGR/155-III/2002), Government of India and internal grants from International Centre for Genetic Engineering and Biotechnology. PM is thankful to University Grant Commission (UGC), Government of India for providing research fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey-Serres J, 1998, LOOK BEYOND TRANSCRIPTION, P125; Barakat A, 2001, PLANT PHYSIOL, V127, P398, DOI 10.1104/pp.010265; BELTRANPENA E, 1995, PLANT MOL BIOL, V28, P327, DOI 10.1007/BF00020251; Brosche M, 1999, BBA-GENE STRUCT EXPR, V1445, P342, DOI 10.1016/S0167-4781(99)00050-0; Busk PK, 2002, PLANT MOL BIOL REP, V20, P287, DOI 10.1007/BF02782464; Folta KM, 2006, NAT PROTOC, V1, P3094, DOI 10.1038/nprot.2006.471; GAO JW, 1994, PLANT MOL BIOL, V25, P761, DOI 10.1007/BF00028872; Giannino D, 2000, MOL GEN GENET, V263, P201, DOI 10.1007/s004380051161; He XY, 2000, J BIOL CHEM, V275, P11799, DOI 10.1074/jbc.275.16.11799; Hirose N, 1999, PLANT PHYSIOL, V121, P805, DOI 10.1104/pp.121.3.805; Jing W, 2006, FEBS LETT, V580, P1827, DOI 10.1016/j.febslet.2006.02.040; Kanazawa A, 2000, PLANT MOL BIOL REP, V18, P377, DOI 10.1007/BF02825066; Kawaguchi R, 2004, PLANT J, V38, P823, DOI 10.1111/j.1365-313X.2004.02090.x; Kim KY, 2004, J EXP BOT, V55, P1153, DOI 10.1093/jxb/erh125; Klein DJ, 2001, EMBO J, V20, P4214, DOI 10.1093/emboj/20.15.4214; KOSUGI S, 1995, PLANT J, V7, P877, DOI 10.1046/j.1365-313X.1995.07060877.x; Kosugi S, 1997, PLANT CELL, V9, P1607, DOI 10.1105/tpc.9.9.1607; Kosugi S, 2002, PLANT J, V30, P337, DOI 10.1046/j.1365-313X.2002.01294.x; Lambertsson A, 1998, ADV GENET, V38, P69, DOI 10.1016/S0065-2660(08)60142-X; LARKIN JC, 1989, GENE DEV, V3, P500, DOI 10.1101/gad.3.4.500; Lauchli A., 2007, ADV MOL BREEDING DRO, P1, DOI DOI 10.1007/978-1-4020-5578-2_1; Liu XN, 2003, AM J BOT, V90, P526, DOI 10.3732/ajb.90.4.526; Ludwig A, 2001, PLANTA, V212, P792, DOI 10.1007/s004250000427; Ma SS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r49; Mahfouz MM, 2006, PLANT CELL, V18, P477, DOI 10.1105/tpc.105.035931; Planta RJ, 1998, YEAST, V14, P471, DOI 10.1002/(SICI)1097-0061(19980330)14:5<471::AID-YEA241>3.0.CO;2-U; Richards RA, 1996, PLANT GROWTH REGUL, V20, P157, DOI 10.1007/BF00024012; Rogalski M, 2008, PLANT CELL, V20, P2221, DOI 10.1105/tpc.108.060392; Saez-Vasquez J, 2000, PLANT SCI, V156, P35, DOI 10.1016/S0168-9452(00)00229-6; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Singer MS, 1998, GENETICS, V150, P613; Tatematsu K, 2005, PLANT PHYSIOL, V138, P757, DOI 10.1104/pp.104.057984; Tester M, 2005, PLANT PHYSIOL, V137, P791, DOI 10.1104/pp.104.900138; Tremousaygue D, 2003, PLANT J, V33, P957, DOI 10.1046/j.1365-313X.2003.01682.x; Turck F, 2004, PLANT PHYSIOL, V134, P1527, DOI 10.1104/pp.103.035873; Ueda A, 2006, ABIOTIC STRESS TOLERANCE IN PLANTS: TOWARD THE IMPROVEMENT OF GLOBAL ENVIRONMENT AND FOOD, P31, DOI 10.1007/1-4020-4389-9_2; WANNER LA, 1991, PLANT CELL, V3, P1289, DOI 10.1105/tpc.3.12.1289; WILLIAMS ME, 1995, PLANT J, V8, P65, DOI 10.1046/j.1365-313X.1995.08010065.x; Wu JZ, 1995, GENOME, V38, P1189, DOI 10.1139/g95-157; Wullschleger S, 2005, J BIOL CHEM, V280, P30697, DOI 10.1074/jbc.M505553200; Xiong L, 2002, PLANT CELL ENVIRON, V25, P131, DOI 10.1046/j.1365-3040.2002.00782.x; Xiong LM, 2002, PLANT CELL, V14, pS165, DOI 10.1105/tpc.000596; Xiong LM, 2001, PHYSIOL PLANTARUM, V112, P152, DOI 10.1034/j.1399-3054.2001.1120202.x; Yamamoto YY, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-67; Yoshida S., 1976, LAB MANUAL PHYSL STU; Yu XD, 1998, PLANT PHYSIOL, V116, P1091, DOI 10.1104/pp.116.3.1091	46	18	18	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e28058	10.1371/journal.pone.0028058	http://dx.doi.org/10.1371/journal.pone.0028058			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132208	Green Published, Green Submitted, gold			2022-12-27	WOS:000298162000063
J	Prabhakaran, V; Rypma, B; Narayanan, NS; Meier, TB; Austin, BP; Nair, VA; Naing, L; Thomas, LE; Gabrieli, JDE				Prabhakaran, Vivek; Rypma, Bart; Narayanan, Nandakumar S.; Meier, Timothy B.; Austin, Benjamin P.; Nair, Veena A.; Naing, Lin; Thomas, Lisa E.; Gabrieli, John D. E.			Capacity-Speed Relationships in Prefrontal Cortex	PLOS ONE			English	Article							WORKING-MEMORY CAPACITY; GENERAL INTELLIGENCE; CORTICAL ACTIVITY; AGE-DIFFERENCES; ADULT AGE; INFORMATION; SPAN; MAINTENANCE; PERFORMANCE; STRATEGIES	Working memory (WM) capacity and WM processing speed are simple cognitive measures that underlie human performance in complex processes such as reasoning and language comprehension. These cognitive measures have shown to be interrelated in behavioral studies, yet the neural mechanism behind this interdependence has not been elucidated. We have carried out two functional MRI studies to separately identify brain regions involved in capacity and speed. Experiment 1, using a block-design WM verbal task, identified increased WM capacity with increased activity in right prefrontal regions, and Experiment 2, using a single-trial WM verbal task, identified increased WM processing speed with increased activity in similar regions. Our results suggest that right prefrontal areas may be a common region interlinking these two cognitive measures. Moreover, an overlap analysis with regions associated with binding or chunking suggest that this strategic memory consolidation process may be the mechanism interlinking WM capacity and WM speed.	[Prabhakaran, Vivek; Meier, Timothy B.] Univ Wisconsin, Neurosci Training Program, Madison, WI 53715 USA; [Prabhakaran, Vivek; Naing, Lin] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI USA; [Rypma, Bart] Univ Texas Dallas, Ctr Brain Hlth, Dallas, TX 75230 USA; [Narayanan, Nandakumar S.] Yale Univ, Dept Neurol, New Haven, CT USA; [Austin, Benjamin P.] Univ Wisconsin, Cardiovasc Res Ctr, Madison, WI USA; [Thomas, Lisa E.] Brigham & Womens Hosp, Dept Emergency Med, Boston, MA 02115 USA; [Thomas, Lisa E.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Gabrieli, John D. E.] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Texas System; University of Texas Dallas; Yale University; University of Wisconsin System; University of Wisconsin Madison; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT)	Prabhakaran, V (corresponding author), Univ Wisconsin, Neurosci Training Program, Madison, WI 53715 USA.	vprabhakaran@uwhealth.org	Nair, Veena A/E-4037-2013; Vasudevan, prabhakaran/C-7240-2012; Gabrieli, John/AAJ-2869-2020	prabhakaran, vivek/0000-0002-1974-3125; NAIR, VEENA/0000-0002-5666-3239; Narayanan, Nandakumar/0000-0002-0427-0003	National Center for Research Resources (NCRR), National Institutes of Health (NIH) [UL1RR025011]; NIH [RO1 DC05375]; Coulter Foundation; NIH NIMH [RC1MH090912-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025011] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [RC1MH090912] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005375] Funding Source: NIH RePORTER	National Center for Research Resources (NCRR), National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Coulter Foundation; NIH NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Supported by grants UL1RR025011 from the Clinical and Translational Science Award (CTSA) program of the National Center for Research Resources (NCRR), National Institutes of Health (NIH), NIH RO1 DC05375, Coulter Foundation, and RC1MH090912-01 NIH NIMH Challenge Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barch DM, 2005, ANNU REV CLIN PSYCHO, V1, P321, DOI 10.1146/annurev.clinpsy.1.102803.143959; Barch DM, 1997, NEUROPSYCHOLOGIA, V35, P1373, DOI 10.1016/S0028-3932(97)00072-9; Bays PM, 2008, SCIENCE, V321, P851, DOI 10.1126/science.1158023; Bor D, 2003, NEURON, V37, P361, DOI 10.1016/S0896-6273(02)01171-6; Bor D, 2007, CEREB CORTEX, V17, P778, DOI 10.1093/cercor/bhk035; CAVANAGH JP, 1972, PSYCHOL REV, V79, P525, DOI 10.1037/h0033482; Conway ARA, 2003, TRENDS COGN SCI, V7, P547, DOI 10.1016/j.tics.2003.10.005; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; D'Esposito M, 1999, BRAIN COGNITION, V41, P66, DOI 10.1006/brcg.1999.1096; D'Esposito M, 1999, NEUROPSYCHOLOGIA, V37, P1303, DOI 10.1016/S0028-3932(99)00021-4; Fleck MS, 2006, CEREB CORTEX, V16, P1623, DOI 10.1093/cercor/bhj097; Glover GH, 1996, MAGNET RESON MED, V35, P299, DOI 10.1002/mrm.1910350306; Kail R, 1997, J EXP CHILD PSYCHOL, V64, P67, DOI 10.1006/jecp.1996.2337; Kail R, 1994, ACTA PSYCHOL, V86; Kane MJ, 2004, J EXP PSYCHOL GEN, V133, P189, DOI 10.1037/0096-3445.133.2.189; Kane MJ, 2002, PSYCHON B REV, V9, P637, DOI 10.3758/BF03196323; KYLLONEN PC, 1990, INTELLIGENCE, V14, P389, DOI 10.1016/S0160-2896(05)80012-1; MILLER GA, 1956, PSYCHOL REV, V63, P81, DOI 10.1037/h0043158; Mitchell KJ, 2000, PSYCHOL AGING, V15, P527, DOI 10.1037//0882-7974.15.3.527; Owen AM, 1997, NEUROPSYCHOLOGIA, V35, P519, DOI 10.1016/S0028-3932(96)00101-7; Owen AM, 2000, EXP BRAIN RES, V133, P33, DOI 10.1007/s002210000398; Park DC, 2009, ANNU REV PSYCHOL, V60, P173, DOI 10.1146/annurev.psych.59.103006.093656; Petrides Michael, 1994, Current Opinion in Neurobiology, V4, P207, DOI 10.1016/0959-4388(94)90074-4; Philipose LE, 2007, BEHAV NEUROL, V18, P37, DOI 10.1155/2007/396946; Phillips S, 2002, NEUROIMAGE, V17, P1031, DOI 10.1006/nimg.2002.1190; Prabhakaran V, 2000, NAT NEUROSCI, V3, P85, DOI 10.1038/71156; Rajah MN, 2008, NEUROPSYCHOLOGIA, V46, P1088, DOI 10.1016/j.neuropsychologia.2007.10.023; Rypma B, 2002, J COGNITIVE NEUROSCI, V14, P721, DOI 10.1162/08989290260138627; Rypma B, 2003, COGNITIVE BRAIN RES, V16, P162, DOI 10.1016/S0926-6410(02)00247-1; Rypma B, 1999, NEUROIMAGE, V9, P216, DOI 10.1006/nimg.1998.0404; Rypma B, 2001, PSYCHOL AGING, V16, P371, DOI 10.1037//0882-7974.16.3.371; SALTHOUSE TA, 1991, PSYCHOL AGING, V6, P118, DOI 10.1037/0882-7974.6.1.118; Salthouse TA, 1996, PSYCHOL REV, V103, P403, DOI 10.1037/0033-295X.103.3.403; Spearman C, 1904, AM J PSYCHOL, V15, P201, DOI 10.2307/1412107; STERNBERG S, 1966, SCIENCE, V153, P652, DOI 10.1126/science.153.3736.652; Talairach J, 1988, CO PLANAR STEREOTAXI; Theios J, 1973, PSYCHOL LEARN MOTIV, P44; Verhaeghen P, 1997, PSYCHOL BULL, V122, P231, DOI 10.1037/0033-2909.122.3.231; Vernon PA, 1987, A JENSEN CONSENSUS C	39	10	10	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e27504	10.1371/journal.pone.0027504	http://dx.doi.org/10.1371/journal.pone.0027504			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	863KL	22132105	Green Published, gold			2022-12-27	WOS:000298162000022
J	Meng, R; Tang, HY; Westfall, J; London, D; Cao, JH; Mousa, SA; Luidens, M; Hercbergs, A; Davis, FB; Davis, PJ; Lin, HY				Meng, Ran; Tang, Heng-Yuan; Westfall, Jennifer; London, David; Cao, James H.; Mousa, Shaker A.; Luidens, Mary; Hercbergs, Aleck; Davis, Faith B.; Davis, Paul J.; Lin, Hung-Yun			Crosstalk between Integrin alpha v beta 3 and Estrogen Receptor-alpha Is Involved in Thyroid Hormone-Induced Proliferation in Human Lung Carcinoma Cells	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; THYROXINE VS. 3,5,3'-TRIIODO-L-THYRONINE; ENDOTHELIAL GROWTH-FACTOR; PHOSPHATIDYLINOSITOL 3-KINASE; TETRAIODOTHYROACETIC ACID; SERINE PHOSPHORYLATION; SURFACE RECEPTOR; GLIOMA-CELLS; CANCER CELLS; MAP KINASE	A cell surface receptor for thyroid hormone that activates extracellular regulated kinase (ERK) 1/2 has been identified on integrin alpha v beta 3. We have examined the actions of thyroid hormone initiated at the integrin on human NCI-H522 non-small cell lung carcinoma and NCI-H510A small cell lung cancer cells. At a physiologic total hormone concentration (10(-7) M), T(4) significantly increased proliferating cell nuclear antigen (PCNA) abundance in these cell lines, as did 3, 5, 39-triiodo-L-thyronine (T(3)) at a supraphysiologic concentration. Neutralizing antibody to integrin alpha v beta 3 and an integrin-binding Arg-GlyAsp (RGD) peptide blocked thyroid hormone-induced PCNA expression. Tetraiodothyroacetic acid (tetrac) lacks thyroid hormone function but inhibits binding of T(4) and T(3) to the integrin receptor; tetrac eliminated thyroid hormone-induced lung cancer cell proliferation and ERK1/2 activation. In these estrogen receptor-alpha (ER alpha)-positive lung cancer cells, thyroid hormone (T(4)>T(3)) caused phosphorylation of ER alpha; the specific ER alpha antagonist ICI 182,780 blocked T(4)-induced, but not T(3)-induced ERK1/2 activation, as well as ER alpha phosphorylation, proliferating-cell nuclear antigen (PCNA) expression and hormone-dependent thymidine uptake by tumor cells. Thus, in ER alpha-positive human lung cancer cells, the proliferative action of thyroid hormone initiated at the plasma membrane is at least in part mediated by ER alpha. In summary, thyroid hormone may be one of several endogenous factors capable of supporting proliferation of lung cancer cells. Activity as an inhibitor of lung cancer cell proliferation induced at the integrin receptor makes tetrac a novel anti-proliferative agent.	[Meng, Ran; Tang, Heng-Yuan; Westfall, Jennifer; London, David; Cao, James H.; Luidens, Mary; Davis, Faith B.; Davis, Paul J.; Lin, Hung-Yun] Ordway Signal Transduct, Albany, NY 12208 USA; [Meng, Ran; Mousa, Shaker A.; Davis, Paul J.; Lin, Hung-Yun] Albany Coll Pharm, Pharmaceut Res Inst, Albany, NY USA; [Luidens, Mary; Davis, Paul J.] Albany Med Coll, Albany, NY 12208 USA; [Hercbergs, Aleck] Cleveland Clin, Cleveland, OH 44106 USA; [Mousa, Shaker A.] King Saud Univ, Coll Med, Riyadh 11461, Saudi Arabia	Albany College of Pharmacy & Health Sciences; Albany Medical College; Cleveland Clinic Foundation; King Saud University	Meng, R (corresponding author), Ordway Signal Transduct, Albany, NY 12208 USA.	ordwayst@gmail.com	Mousa, Shaker A/A-7151-2017	Mousa, Shaker A/0000-0002-9294-015X; Doering, Jennifer/0000-0001-8749-774X	Charitable Leadership Foundation	Charitable Leadership Foundation	This work was supported in part by the Charitable Leadership Foundation and an endowment established at the Ordway Research Institute by M. Frank and Margaret C. Rudy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belmadani S, 2008, AM J PHYSIOL-HEART C, V295, pH69, DOI 10.1152/ajpheart.00341.2008; Bergh JJ, 2005, ENDOCRINOLOGY, V146, P2864, DOI 10.1210/en.2005-0102; Bhargava M, 2009, AM J PHYSIOL-CELL PH, V296, pC977, DOI 10.1152/ajpcell.00116.2009; Byzova TV, 2000, EXP CELL RES, V254, P299, DOI 10.1006/excr.1999.4765; Cai Weibo, 2006, Anti-Cancer Agents in Medicinal Chemistry, V6, P407, DOI 10.2174/187152006778226530; Cao X, 2005, MOL ENDOCRINOL, V19, P102, DOI 10.1210/me.2004-0093; Chaban VV, 2004, ENDOCRINOLOGY, V145, P3788, DOI 10.1210/en.2004-0149; Chattergoon NN, 2007, J ENDOCRINOL, V192, pR1, DOI 10.1677/JOE-06-0114; Cheng SY, 2010, ENDOCR REV, V31, P139, DOI 10.1210/er.2009-0007; Cody V, 2007, STEROIDS, V72, P165, DOI 10.1016/j.steroids.2006.11.008; Davis FB, 2006, CANCER RES, V66, P7270, DOI 10.1158/0008-5472.CAN-05-4365; Davis FB, 2004, CIRC RES, V94, P1500, DOI 10.1161/01.RES.0000130784.90237.4a; Davis PJ, 2009, AM J PHYSIOL-ENDOC M, V297, pE1238, DOI 10.1152/ajpendo.00480.2009; Davis PJ, 2000, J BIOL CHEM, V275, P38032, DOI 10.1074/jbc.M002560200; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Di Fulvio M, 2000, J ENDOCRINOL, V166, P173, DOI 10.1677/joe.0.1660173; FRANCAVILLA A, 1994, HEPATOLOGY, V20, P1237, DOI 10.1002/hep.1840200521; Garcia-Silva S, 2002, TOXICOLOGY, V181, P179, DOI 10.1016/S0300-483X(02)00277-9; Lin C, 2011, CARCINOGENESIS, V32, P19, DOI 10.1093/carcin/bgq212; Lin HY, 2008, CARCINOGENESIS, V29, P62, DOI 10.1093/carcin/bgm239; Lin HY, 2007, STEROIDS, V72, P180, DOI 10.1016/j.steroids.2006.11.014; Lin HY, 2009, AM J PHYSIOL-CELL PH, V296, pC980, DOI 10.1152/ajpcell.00305.2008; Lin HY, 2003, BIOCHEMISTRY-US, V42, P7571, DOI 10.1021/bi0273967; LIN HY, 2007, THYROID S1, V17, pS129; Mahabeleshwar GH, 2007, CIRC RES, V101, P570, DOI 10.1161/CIRCRESAHA.107.155655; Malik R, 2003, HEPATOLOGY, V37, P79, DOI 10.1053/jhep.2003.50001; Moreno M, 2008, THYROID, V18, P239, DOI 10.1089/thy.2007.0248; Mori S, 2008, J BIOL CHEM, V283, P18066, DOI 10.1074/jbc.M801213200; Mousa SA, 2008, ANGIOGENESIS, V11, P183, DOI 10.1007/s10456-007-9088-7; Razandi M, 1999, MOL ENDOCRINOL, V13, P307, DOI 10.1210/me.13.2.307; Rebbaa A, 2008, ANGIOGENESIS, V11, P269, DOI 10.1007/s10456-008-9110-8; Shih A, 2004, ENDOCRINOLOGY, V145, P1708, DOI 10.1210/en.2003-0742; Shih A, 2001, BIOCHEMISTRY-US, V40, P2870, DOI 10.1021/bi001978b; Somanath PR, 2009, ANGIOGENESIS, V12, P177, DOI 10.1007/s10456-009-9141-9; Tang HY, 2004, ENDOCRINOLOGY, V145, P3265, DOI 10.1210/en.2004-0308; Woodfield GW, 2009, CLIN CANCER RES, V15, P3672, DOI 10.1158/1078-0432.CCR-08-2343; Yen PM, 2006, ENDOCRINOLOGY, V147, P1598, DOI 10.1210/en.2006-0074	37	71	74	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2011	6	11							e27547	10.1371/journal.pone.0027547	http://dx.doi.org/10.1371/journal.pone.0027547			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858JH	22132110	Green Published, Green Submitted, gold			2022-12-27	WOS:000297792400008
J	Taegtmeyer, M; MacPherson, P; Jones, K; Hopkins, M; Moorcroft, J; Lalloo, DG; Chawla, A				Taegtmeyer, Miriam; MacPherson, Peter; Jones, Kathy; Hopkins, Mark; Moorcroft, Jay; Lalloo, David G.; Chawla, Anu			Programmatic Evaluation of a Combined Antigen and Antibody Test for Rapid HIV Diagnosis in a Community and Sexual Health Clinic Screening Programme	PLOS ONE			English	Article							CARE; SERVICES; POINT	Background: A substantial proportion of HIV-infected individuals in the UK are unaware of their status and late presentations continue, especially in low prevalence areas. Fourth generation antigen/antibody rapid test kits could facilitate earlier diagnosis of HIV in non-clinical settings but lack data on performance under programmatic conditions. Methods and Findings: We evaluated the performance of Determine HIV-1/2 Ag/Ab Combo Test (Determine Combo), a rapid test with indicators for both HIV antibodies and p24 antigen, in participants recruited from community outreach and hospital-based sexual health clinics. HIV infection was confirmed using laboratory enzyme-linked immunosorbent assay (EIA), Line Immuno Assay (LIA) and quantitative polymerase chain reaction (PCR). In total, 953 people underwent HIV testing. HIV antibody (Ab) prevalence was 1.8% (17/953). Four false positive rapid tests were identified: two antibody and two p24 antigen (Ag) reactions. Of participants diagnosed as HIV Ab positive, 2/17 (12%) were recent seroconverters based on clinical history and HIV antibody avidity test results. However, none of these were detected by the p24 antigen component of the rapid test kit. There were no other true positive p24 Ag tests. Conclusion: These data lend support to an increasing body of evidence suggesting that 4th generation rapid HIV tests have little additional benefit over 3rd generation HIV kits for routine screening in low prevalence settings and have high rates of false positives. In order to optimally combine community-based case-finding among hard-to-reach groups with reliable and early diagnosis 3rd generation kits should be primarily used with laboratory testing of individuals thought to be at risk of acute HIV infection. A more reliable point of care diagnostic is required for the accurate detection of acute HIV infection under programmatic conditions.	[Taegtmeyer, Miriam; MacPherson, Peter; Lalloo, David G.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [MacPherson, Peter] Univ Liverpool, Wellcome Trust Trop Ctr, Liverpool L3 5QA, Merseyside, England; [Jones, Kathy] Royal Liverpool & Broadgreen Univ Hosp NHS Trust, Liverpool Ctr Sexual Hlth, Liverpool, Merseyside, England; [Hopkins, Mark; Moorcroft, Jay; Chawla, Anu] Royal Liverpool & Broadgreen Univ Hosp NHS Trust, Liverpool Specialist Virol Ctr, Liverpool, Merseyside, England	Liverpool School of Tropical Medicine; University of Liverpool; University of Liverpool; Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital	Taegtmeyer, M (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England.	miriamt@liverpool.ac.uk	MacPherson, Peter/AHD-2477-2022	MacPherson, Peter/0000-0002-0329-9613; Taegtmeyer, Miriam/0000-0002-5377-2536; Lalloo, David/0000-0001-7680-2200	Gilead UK; Ireland Fellowship Programme	Gilead UK(Gilead Sciences); Ireland Fellowship Programme	This project was funded by the Gilead UK and Ireland Fellowship Programme 2009. Additionally 200 Determine test kits were donated by Inverness Medicine for use in the Liverpool Centre for Sexual Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1996, MMWR Recomm Rep, V45, P1; Beelaert G, 2010, J VIROL METHODS, V168, P218, DOI 10.1016/j.jviromet.2010.06.002; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; *BRIT HIV ASS HIV, 2008, UK NAT GUID HIV TEST; Burns FM, 2008, AIDS, V22, P115, DOI 10.1097/QAD.0b013e3282f1d4b6; Fox J, 2011, SEX TRANSM INFECT, V87, P178, DOI 10.1136/sti.2010.042564; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; *HLTH PROT AG UK, 2009, HIV UK 2009 REP; *HLTH PROT AG UK, 2008, DIAGN HIV PREV STRAT; *INV MED INN INC, 2010, DET HIV 1 2 AG AB CO; MacPherson P, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-419; Marum E, 2006, JAMA-J AM MED ASSOC, V296, P859, DOI 10.1001/jama.296.7.859; Mavedzenge S, 2011, HIV SELF TESTING HLT; Merson MH, 2008, LANCET, V372, P475, DOI 10.1016/S0140-6736(08)60884-3; Miller WC, 2011, 18 C RETR OPP INF BO; Obermeyer CM, 2007, AM J PUBLIC HEALTH, V97, P1762, DOI 10.2105/AJPH.2006.096263; PILCHER CD, 2009, 18 C RETR OPP INF MO; Pilcher CD, 2010, J INFECT DIS, V201, pS7, DOI 10.1086/650393; Prost A, 2009, SEX TRANSM INFECT, V85, P326, DOI 10.1136/sti.2008.033233; Sudarshi D, 2007, SEX TRANSM INFECT, V84, P14, DOI 10.1136/sti.2007.026963; Surah S, 2009, INT J STD AIDS, V20, P168, DOI 10.1258/ijsa.2008.008220; Thomas S, 2009, HIV MED, V10, P44; Weber B, 2006, CLIN LAB, V52, P463; Weber B, 2002, J CLIN VIROL, V25, P357, DOI 10.1016/S1386-6532(02)00013-6; World Health Organization, 2007, GUID PROV IN HIV TES	25	19	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2011	6	11							e28019	10.1371/journal.pone.0028019	http://dx.doi.org/10.1371/journal.pone.0028019			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858JH	22132195	Green Accepted, gold, Green Published			2022-12-27	WOS:000297792400033
J	Ding, C; Vidanes, GM; Maguire, SL; Guida, A; Synnott, JM; Andes, DR; Butler, G				Ding, Chen; Vidanes, Genevieve M.; Maguire, Sarah L.; Guida, Alessandro; Synnott, John M.; Andes, David R.; Butler, Geraldine			Conserved and Divergent Roles of Bcr1 and CFEM Proteins in Candida parapsilosis and Candida albicans	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; BIOFILM FORMATION; SACCHAROMYCES-CEREVISIAE; IRON-DEFICIENCY; MESSENGER-RNA; HYPOXIC RESPONSE; MICROARRAY DATA; EVOLUTION; OUTBREAK; METABOLISM	Candida parapsilosis is a pathogenic fungus that is major cause of hospital-acquired infection, predominantly due to growth as biofilms on indwelling medical devices. It is related to Candida albicans, which remains the most common cause of candidiasis disease in humans. The transcription factor Bcr1 is an important regulator of biofilm formation in vitro in both C. parapsilosis and C. albicans. We show here that C. parapsilosis Bcr1 is required for in vivo biofilm development in a rat catheter model, like C. albicans. By comparing the transcription profiles of a bcr1 deletion in both species we found that regulation of expression of the CFEM family is conserved. In C. albicans, three of the five CFEM cell wall proteins (Rbt5, Pga7 and Csa1) are associated with both biofilm formation and acquisition of iron from heme, which is an important virulence characteristic. In C. parapsilosis, the CFEM family has undergone an expansion to 7 members. Expression of three genes (CFEM2, CFEM3, and CFEM6) is dependent on Bcr1, and is induced in low iron conditions. All three are involved in the acquisition of iron from heme. However, deletion of the three CFEM genes has no effect on biofilm formation in C. parapsilosis. Our data suggest that the role of the CFEM family in iron acquisition is conserved between C. albicans and C. parapsilosis, but their role in biofilm formation is not.	[Ding, Chen; Vidanes, Genevieve M.; Maguire, Sarah L.; Synnott, John M.; Butler, Geraldine] Univ Coll Dublin, Conway Inst, Sch Biomol & Biomed Sci, Dublin 2, Ireland; [Guida, Alessandro] Univ Coll Dublin, Conway Inst, Sch Med & Med Sci, Dublin 2, Ireland; [Andes, David R.] Univ Wisconsin, Dept Microbiol & Immunol, Madison, WI USA	University College Dublin; University College Dublin; University of Wisconsin System; University of Wisconsin Madison	Ding, C (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27708 USA.	gbutler@ucd.ie	Andes, David/ABE-8033-2020; Ding, Chen/C-4113-2013; Guida, Alessandro/H-6930-2019	Ding, Chen/0000-0002-2296-7963; Guida, Alessandro/0000-0002-8733-4470; Andes, David/0000-0002-7927-9950; Maguire, Sarah/0000-0001-6654-3620; Butler, Geraldine/0000-0002-1770-5301	Science Foundation Ireland [08IN1B1865]; Health Research Board [RP/2008/4]; Irish Research Council for Science, Engineering and Technology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073289] Funding Source: NIH RePORTER	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Health Research Board; Irish Research Council for Science, Engineering and Technology(Irish Research Council for Science, Engineering and TechnologyCGIAR); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Science Foundation Ireland (08IN1B1865), the Health Research Board (RP/2008/4) and by a studentship to AG from the Irish Research Council for Science, Engineering and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida RS, 2009, FEMS YEAST RES, V9, P1000, DOI 10.1111/j.1567-1364.2009.00570.x; Almeida RS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000217; Andes D, 2004, INFECT IMMUN, V72, P6023, DOI 10.1128/IAI.72.10.6023-6031.2004; Baek YU, 2008, EUKARYOT CELL, V7, P1168, DOI 10.1128/EC.00108-08; Baker HM, 2003, P NATL ACAD SCI USA, V100, P3579, DOI 10.1073/pnas.0637295100; Barchiesi F, 2004, DIAGN MICR INFEC DIS, V49, P269, DOI 10.1016/j.diagmicrobio.2004.03.011; Bensen ES, 2004, MOL MICROBIOL, V54, P1335, DOI 10.1111/j.1365-2958.2004.04350.x; BIRSE CE, 1993, INFECT IMMUN, V61, P3648, DOI 10.1128/IAI.61.9.3648-3655.1993; Blankenship JR, 2006, CURR OPIN MICROBIOL, V9, P588, DOI 10.1016/j.mib.2006.10.003; Borneman AR, 2007, SCIENCE, V317, P815, DOI 10.1126/science.1140748; Braun BR, 2000, GENETICS, V156, P31; Brillowska-Dabrowska A, 2009, SCAND J INFECT DIS, V41, P135, DOI 10.1080/00365540802585301; Butler G, 2009, NATURE, V459, P657, DOI 10.1038/nature08064; Chandra J, 2001, J BACTERIOL, V183, P5385, DOI 10.1128/JB.183.18.5385-5394.2001; Chen CB, 2011, CELL HOST MICROBE, V10, P118, DOI 10.1016/j.chom.2011.07.005; Clark TA, 2004, J CLIN MICROBIOL, V42, P4468, DOI 10.1128/JCM.42.10.4468-4472.2004; DiazGranados CA, 2008, BRAZ J INFECT DIS, V12, P390, DOI 10.1590/S1413-86702008000500009; Ding C, 2007, EUKARYOT CELL, V6, P1310, DOI 10.1128/EC.00136-07; Dizbay M, 2008, BRAZ J INFECT DIS, V12, P395, DOI 10.1590/S1413-86702008000500010; Douglas LJ, 2003, TRENDS MICROBIOL, V11, P30, DOI 10.1016/S0966-842X(02)00002-1; Enjalbert B, 2006, MOL BIOL CELL, V17, P1018, DOI 10.1091/mbc.E05-06-0501; Fitzpatrick DA, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-99; Fitzpatrick DA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-290; Hlynialuk C, 2008, MICROBIOL-SGM, V154, P2482, DOI 10.1099/mic.0.2008/019976-0; Hogues H, 2008, MOL CELL, V29, P552, DOI 10.1016/j.molcel.2008.02.006; Hoot SJ, 2008, MICROBIOL-SGM, V154, P2748, DOI 10.1099/mic.0.2008/017475-0; Hsu PC, 2011, EUKARYOT CELL, V10, P207, DOI 10.1128/EC.00158-10; Ihmels J, 2005, SCIENCE, V309, P938, DOI 10.1126/science.1113833; Jackson AP, 2009, GENOME RES, V19, P2231, DOI 10.1101/gr.097501.109; Kadosh D, 2001, MOL CELL BIOL, V21, P2496, DOI 10.1128/MCB.21.7.2496-2505.2001; Kuhn DM, 2002, INFECT IMMUN, V70, P878, DOI 10.1128/IAI.70.2.878-888.2002; Kulkarni RD, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r24; Kulkarni RD, 2003, TRENDS BIOCHEM SCI, V28, P118, DOI 10.1016/S0968-0004(03)00025-2; Laffey SF, 2005, MICROBIOL-SGM, V151, P1073, DOI 10.1099/mic.0.27739-0; Lan CY, 2004, MOL MICROBIOL, V53, P1451, DOI 10.1111/j.1365-2958.2004.04214.x; Lass-Florl C, 2009, MYCOSES, V52, P197, DOI 10.1111/j.1439-0507.2009.01691.x; Lattif AA, 2010, INT J MED MICROBIOL, V300, P265, DOI 10.1016/j.ijmm.2009.09.001; Limjindaporn T, 2003, MOL MICROBIOL, V50, P993, DOI 10.1046/j.1365-2958.2003.03747.x; Logue ME, 2005, EUKARYOT CELL, V4, P1009, DOI 10.1128/EC.4.6.1009-1017.2005; Martchenko M, 2007, CURR BIOL, V17, P1007, DOI 10.1016/j.cub.2007.05.017; Mean M, 2008, CRIT CARE, V12, DOI 10.1186/cc6212; Melo AS, 2011, MED MYCOL, V49, P253, DOI 10.3109/13693786.2010.530032; Nantel A, 2002, MOL BIOL CELL, V13, P3452, DOI 10.1091/mbc.E02-05-0272; Nobile CJ, 2005, CURR BIOL, V15, P1150, DOI 10.1016/j.cub.2005.05.047; Nobile CJ, 2006, CELL MICROBIOL, V8, P1382, DOI 10.1111/j.1462-5822.2006.00761.x; Nobile CJ, 2006, EUKARYOT CELL, V5, P1604, DOI 10.1128/EC.00194-06; Nobile CJ, 2006, PLOS PATHOG, V2, P636, DOI 10.1371/journal.ppat.0020063; Pedro-Segura E, 2008, J BIOL CHEM, V283, P28527, DOI 10.1074/jbc.M804910200; Perez A, 2006, FEMS YEAST RES, V6, P1074, DOI 10.1111/j.1567-1364.2006.00131.x; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Pfaller MA, 2010, DIAGN MICR INFEC DIS, V68, P278, DOI 10.1016/j.diagmicrobio.2010.06.015; Philpott CC, 2008, EUKARYOT CELL, V7, P20, DOI 10.1128/EC.00354-07; Puig S, 2005, CELL, V120, P99, DOI 10.1016/j.cell.2004.11.032; Puig S, 2008, CELL METAB, V7, P555, DOI 10.1016/j.cmet.2008.04.010; Rossignol T, 2009, EUKARYOT CELL, V8, P550, DOI 10.1128/EC.00350-08; Sai SX, 2011, EUKARYOT CELL, V10, P578, DOI 10.1128/EC.00276-10; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Seneviratne CJ, 2008, ORAL DIS, V14, P582, DOI 10.1111/j.1601-0825.2007.01424.x; SILVA S, 2009, MED MYCOL, V20, P1, DOI DOI 10.1080/13693780802549594; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Sorgo AG, 2010, YEAST, V27, P661, DOI 10.1002/yea.1775; Synnott JM, 2010, EUKARYOT CELL, V9, P1734, DOI 10.1128/EC.00159-10; Tavanti A, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-203; Tuch BB, 2008, PLOS BIOL, V6, P352, DOI 10.1371/journal.pbio.0060038; Tuch BB, 2008, SCIENCE, V319, P1797, DOI 10.1126/science.1152398; Weissman Z, 2004, MOL MICROBIOL, V53, P1209, DOI 10.1111/j.1365-2958.2004.04199.x; Weissman Z, 2008, MOL MICROBIOL, V69, P201, DOI 10.1111/j.1365-2958.2008.06277.x; Yi S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001117; Zahurak M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-142	69	65	366	3	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2011	6	12							e28151	10.1371/journal.pone.0028151	http://dx.doi.org/10.1371/journal.pone.0028151			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MQ	22145027	gold, Green Published, Green Submitted			2022-12-27	WOS:000298168900010
J	Jung, HJ; Park, JY; Jeon, HS; Kwon, TH				Jung, Hyun Jun; Park, Ji-Young; Jeon, Hyo-Sung; Kwon, Tae-Hwan			Aquaporin-5: A Marker Protein for Proliferation and Migration of Human Breast Cancer Cells	PLOS ONE			English	Article							HUMAN BRAIN-TUMORS; LUNG-CANCER; WATER CHANNEL; COLORECTAL CARCINOGENESIS; ALKALINE-PHOSPHATASE; GENE-EXPRESSION; KNOCKOUT MICE; PATHWAY; TISSUE; LOCALIZATION	Aquaporin (AQP) is a family of transmembrane proteins for water transport. Recent studies revealed that AQPs are likely to play a role in tumor progression and invasion. We aimed to examine the potential role of AQP5 in the progression of human breast cancer cells. Expression of AQP5 mRNA and protein was seen in human breast cancer cell line (both MCF7 and MDA-MB-231) by RT-PCR and immunoblotting analysis. Immunoperoxidase labeling of AQP5 was observed at ductal epithelial cells of human breast tissues. In benign tumor, AQP5 labeling was mainly seen at the apical domains of ductal epithelial cells. In contrast, in invasive ductal carcinoma, prominent AQP5 labeling was associated with cancer cells, whereas some ducts were unlabeled and apical polarity of AQP5 in ducts was lost. Cell proliferation (BrdU incorporation assay) and migration of MCF7 cells were significantly attenuated by lentivirus-mediated AQP5-shRNA transduction. Hyperosmotic stress induced by sorbitol treatment (100 mM, 24 h) reduced AQP5 expression in MCF7 cells, which was also associated with a significant reduction in cell proliferation and migration. Taken together, prominent AQP5 expression in breast cancer cells with the loss of polarity of ductal epithelial cells was seen during the progression of breast carcinoma. shRNA-or hyperosmotic stress-induced reduction in AQP5 expression of MCF7 cells was associated with significantly reduced cell proliferation and migration. In conclusion, AQP5 overexpression is likely to play a role in cell growth and metastasis of human breast cancer and could be a novel target for anti-breast cancer treatment.	[Jung, Hyun Jun; Jeon, Hyo-Sung; Kwon, Tae-Hwan] Kyungpook Natl Univ, Dept Biochem & Cell Biol, Sch Med, Taegu 702701, South Korea; [Park, Ji-Young] Kyungpook Natl Univ, Dept Pathol, Sch Med, Taegu 702701, South Korea	Kyungpook National University; Kyungpook National University	Jung, HJ (corresponding author), Kyungpook Natl Univ, Dept Biochem & Cell Biol, Sch Med, Taegu 702701, South Korea.	thkwon@knu.ac.kr	Kwon, Tae-Hwan/ABA-1981-2020	Jung, Hyun Jun/0000-0003-0519-5858	National Research Foundation [2010-0019393]; Converging Research Center [2010K001054]; Ministry of Education, Science and Technology (MEST), Korea; Ministry of Health and Welfare, Korea [A100617]; Health Fellowship Foundation	National Research Foundation; Converging Research Center; Ministry of Education, Science and Technology (MEST), Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); Ministry of Health and Welfare, Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Health Fellowship Foundation	This study was supported by grants from the National Research Foundation (2010-0019393), the Converging Research Center Program (2010K001054) funded by the Ministry of Education, Science and Technology (MEST), Korea; the Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Korea (A100617); and the Health Fellowship Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arima H, 2003, J BIOL CHEM, V278, P44525, DOI 10.1074/jbc.M304368200; Brennan K, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/460607; Burg MB, 2007, PHYSIOL REV, V87, P1441, DOI 10.1152/physrev.00056.2006; Chae YK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002162; Chae YK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002594; Chen ZH, 2011, RESP PHYSIOL NEUROBI, V176, P110, DOI 10.1016/j.resp.2011.02.001; Coradini D, 2002, BRIT J CANCER, V87, P1105, DOI 10.1038/sj.bjc.6600556; Gresz V, 2001, AM J PHYSIOL-GASTR L, V281, pG247, DOI 10.1152/ajpgi.2001.281.1.G247; Hara-Chikuma M, 2008, MOL CELL BIOL, V28, P326, DOI 10.1128/MCB.01482-07; Hoque MO, 2006, AM J PATHOL, V168, P1345, DOI 10.2353/ajpath.2006.050596; Hu J, 2006, FASEB J, V20, P1892, DOI 10.1096/fj.06-5930fje; HUI M, 1993, CELL TISSUE RES, V274, P429, DOI 10.1007/BF00314539; Jeon HS, 2008, CANCER RES, V68, P9686, DOI 10.1158/0008-5472.CAN-08-1083; Kang SK, 2008, AM J PATHOL, V173, P518, DOI 10.2353/ajpath.2008.071198; KATO M, 1992, BREAST CANCER RES TR, V23, P241, DOI 10.1007/BF01833521; Kermer V, 2010, NEUROSCI LETT, V485, P208, DOI 10.1016/j.neulet.2010.09.013; Kim HY, 2011, AM J PHYSIOL-RENAL, V301, pF151, DOI 10.1152/ajprenal.00519.2010; Lee YJ, 2011, AM J PHYSIOL-RENAL, V301, pF883, DOI 10.1152/ajprenal.00117.2011; Miller EW, 2010, P NATL ACAD SCI USA, V107, P15681, DOI 10.1073/pnas.1005776107; Mobasheri A, 2005, INT J ONCOL, V26, P1149; Moon C, 2003, ONCOGENE, V22, P6699, DOI 10.1038/sj.onc.1206762; Nejsum LN, 2002, P NATL ACAD SCI USA, V99, P511, DOI 10.1073/pnas.012588099; Nielsen S, 2002, PHYSIOL REV, V82, P205, DOI 10.1152/physrev.00024.2001; Rojek AM, 2007, P NATL ACAD SCI USA, V104, P3609, DOI 10.1073/pnas.0610894104; Saadoun S, 2002, BRIT J CANCER, V87, P621, DOI 10.1038/sj.bjc.6600512; Saadoun S, 2002, J NEUROL NEUROSUR PS, V72, P262, DOI 10.1136/jnnp.72.2.262; Shillingford JM, 2003, J HISTOCHEM CYTOCHEM, V51, P555, DOI 10.1177/002215540305100501; Stoica GE, 2003, ONCOGENE, V22, P7998, DOI 10.1038/sj.onc.1206769; Storm R, 2003, AM J PHYSIOL-RENAL, V284, pF189, DOI 10.1152/ajprenal.00245.2002; Sugiyama Y, 2001, BBA-GENE STRUCT EXPR, V1522, P82, DOI 10.1016/S0167-4781(01)00320-7; Wang DW, 2011, J CLIN NEUROSCI, V18, P122, DOI 10.1016/j.jocn.2010.07.115; Warth A, 2007, APPL IMMUNOHISTO M M, V15, P193, DOI 10.1097/01.pai.0000213110.05108.e9; Watanabe T, 2009, J PHYSIOL SCI, V59, P113, DOI 10.1007/s12576-008-0017-3; Woo J, 2008, BIOCHEM BIOPH RES CO, V367, P291, DOI 10.1016/j.bbrc.2007.12.073; Yang JH, 2006, GYNECOL ONCOL, V100, P294, DOI 10.1016/j.ygyno.2005.08.054; Yong B, 2008, RESP PHYSIOL NEUROBI, V161, P111, DOI 10.1016/j.resp.2007.12.007; Zhang ZQ, 2010, J PATHOL, V221, P210, DOI 10.1002/path.2702	37	115	124	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2011	6	12							e28492	10.1371/journal.pone.0028492	http://dx.doi.org/10.1371/journal.pone.0028492			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MQ	22145049	Green Published, gold, Green Submitted			2022-12-27	WOS:000298168900032
J	Martins, CIM; Silva, PIM; Conceicao, LEC; Costas, B; Hoglund, E; Overli, O; Schrama, JW				Martins, Catarina I. M.; Silva, Patricia I. M.; Conceicao, Luis E. C.; Costas, Benjamin; Hoglund, Erik; Overli, Oyvind; Schrama, Johan W.			Linking Fearfulness and Coping Styles in Fish	PLOS ONE			English	Article							GUPPY POECILIA-RETICULATA; RAINBOW-TROUT; STRESS RESPONSIVENESS; ONCORHYNCHUS-MYKISS; PERSONALITY-TRAITS; INVESTIGATING FEAR; PLASMA-CORTISOL; NILE TILAPIA; BEHAVIOR; NEUROENDOCRINE	Consistent individual differences in cognitive appraisal and emotional reactivity, including fearfulness, are important personality traits in humans, non-human mammals, and birds. Comparative studies on teleost fishes support the existence of coping styles and behavioral syndromes also in poikilothermic animals. The functionalist approach to emotions hold that emotions have evolved to ensure appropriate behavioral responses to dangerous or rewarding stimuli. Little information is however available on how evolutionary widespread these putative links between personality and the expression of emotional or affective states such as fear are. Here we disclose that individual variation in coping style predicts fear responses in Nile tilapia Oreochromis niloticus, using the principle of avoidance learning. Fish previously screened for coping style were given the possibility to escape a signalled aversive stimulus. Fearful individuals showed a range of typically reactive traits such as slow recovery of feed intake in a novel environment, neophobia, and high post-stress cortisol levels. Hence, emotional reactivity and appraisal would appear to be an essential component of animal personality in species distributed throughout the vertebrate subphylum.	[Martins, Catarina I. M.; Silva, Patricia I. M.; Conceicao, Luis E. C.; Costas, Benjamin] Univ Algarve, Ctr Ciencias Mar CCMAR, Faro, Portugal; [Martins, Catarina I. M.; Schrama, Johan W.] Wageningen Univ, Aquaculture & Fisheries Grp, Wageningen, Netherlands; [Costas, Benjamin] Univ Porto, Ctr Interdisciplinar Invest Marinha & Ambiental C, P-4100 Oporto, Portugal; [Silva, Patricia I. M.; Hoglund, Erik] Danish Tech Univ, Inst Aquat Resources, Aquaculture Sect, N Sea Ctr, Hirtshals, Denmark; [Silva, Patricia I. M.; Overli, Oyvind] Norwegian Univ Life Sci, Dept Anim & Aquacultural Sci, As, Norway	Universidade do Algarve; Wageningen University & Research; Universidade do Porto; Technical University of Denmark; Norwegian University of Life Sciences	Martins, CIM (corresponding author), Univ Algarve, Ctr Ciencias Mar CCMAR, Faro, Portugal.	cimartins@ualg.pt	Costas, Benjamín/F-9350-2010; Conceicao, Luis E.C./H-6257-2011	Costas, Benjamín/0000-0003-3758-0849; Conceicao, Luis E.C./0000-0001-6102-2068; Schrama, Johan/0000-0001-7156-8806	Foundation for Science and Technology, Portugal [SFRH/BPD/42015/2007, SFRH/BD/38697/2007, SFRH/BD/44103/2008]	Foundation for Science and Technology, Portugal(Portuguese Foundation for Science and Technology)	This research was supported by the following grants provided by the Foundation for Science and Technology, Portugal (to CM: SFRH/BPD/42015/2007, to BC: SFRH/BD/38697/2007 and to PS: SFRH/BD/44103/2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barreto RE, 2007, PHYSIOL BEHAV, V92, P867, DOI 10.1016/j.physbeh.2007.06.013; Bell AM, 2007, NATURE, V447, P539, DOI 10.1038/447539a; Braithwaite Victoria A., 2006, Fish Physiology, V24, P1; Brown C, 2005, ANIM BEHAV, V70, P1003, DOI 10.1016/j.anbehav.2004.12.022; Budaev SV, 1998, J COMP PSYCHOL, V112, P92, DOI 10.1037/0735-7036.112.1.92; Budaev SV, 1997, J COMP PSYCHOL, V111, P399, DOI 10.1037/0735-7036.111.4.399; Cabanac M, 2009, BEHAV BRAIN RES, V198, P267, DOI 10.1016/j.bbr.2008.11.028; Chandroo KP, 2004, FISH FISH, V5, P281, DOI 10.1111/j.1467-2679.2004.00163.x; Chandroo KP, 2004, APPL ANIM BEHAV SCI, V86, P225, DOI 10.1016/j.applanim.2004.02.004; Coppens CM, 2010, PHILOS T R SOC B, V365, P4021, DOI 10.1098/rstb.2010.0217; Dadda M, 2007, PHYSIOL BEHAV, V92, P764, DOI 10.1016/j.physbeh.2007.06.001; Dadda M, 2010, BEHAV BRAIN RES, V206, P208, DOI 10.1016/j.bbr.2009.09.019; Ruiz-Gomez MD, 2011, PHYSIOL BEHAV, V102, P317, DOI 10.1016/j.physbeh.2010.11.023; Frijda NH, 1986, EMOTIONS, P56; Frost AJ, 2007, P ROY SOC B-BIOL SCI, V274, P333, DOI 10.1098/rspb.2006.3751; Garamszegi LZ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002647; Irwin S, 1999, COMP BIOCHEM PHYS C, V124, P27, DOI 10.1016/S0742-8413(99)00043-2; Izard C. E., 1991, PSYCHOL EMOTIONS; Koolhaas JM, 1999, NEUROSCI BIOBEHAV R, V23, P925, DOI 10.1016/S0149-7634(99)00026-3; Korte SM, 2005, NEUROSCI BIOBEHAV R, V29, P3, DOI 10.1016/j.neubiorev.2004.08.009; Kristiansen TS, 2007, APPL ANIM BEHAV SCI, V104, P236, DOI 10.1016/j.applanim.2006.09.007; LeDoux J, 2003, CELL MOL NEUROBIOL, V23, P727, DOI 10.1023/A:1025048802629; MacKenzie S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005314; Martins CIM, 2011, APPL ANIM BEHAV SCI, V130, P135, DOI 10.1016/j.applanim.2010.12.007; Martins CIM, 2009, AQUACULTURE, V298, P43, DOI 10.1016/j.aquaculture.2009.09.030; McCrae RR, 1997, AM PSYCHOL, V52, P509, DOI 10.1037/0003-066X.52.5.509; Moreira PSA, 2004, J FISH BIOL, V64, P961, DOI 10.1111/j.1095-8649.2004.00362.x; Silva PIM, 2010, APPL ANIM BEHAV SCI, V124, P75, DOI 10.1016/j.applanim.2010.01.008; Overli O, 2006, PHYSIOL BEHAV, V87, P506, DOI 10.1016/j.physbeh.2005.11.012; Overli O, 2005, INTEGR COMP BIOL, V45, P463, DOI 10.1093/icb/45.3.463; Overli O, 2002, J EXP BIOL, V205, P391; Overli O, 2007, NEUROSCI BIOBEHAV R, V31, P396, DOI 10.1016/j.neubiorev.2006.10.006; Panksepp J, 2005, CONSCIOUS COGN, V14, P30, DOI 10.1016/j.concog.2004.10.004; Pineles SL, 2009, PERS INDIV DIFFER, V46, P48, DOI 10.1016/j.paid.2008.09.003; Portavella M, 2005, EUR J NEUROSCI, V21, P2800, DOI 10.1111/j.1460-9568.2005.04114.x; Portavella M, 2004, J NEUROSCI, V24, P2335, DOI 10.1523/JNEUROSCI.4930-03.2004; Pottinger TG, 1999, GEN COMP ENDOCR, V116, P122, DOI 10.1006/gcen.1999.7355; Reale D, 2007, BIOL REV, V82, P291, DOI 10.1111/j.1469-185X.2007.00010.x; Rodriguez F., 2006, FISH COGN BEHAV, V9, P243, DOI [10.1002/9780470996058.ch13, DOI 10.1002/9780470996058.CH13]; Romero LM, 2009, HORM BEHAV, V55, P375, DOI 10.1016/j.yhbeh.2008.12.009; Rose JD, 2007, DIS AQUAT ORGAN, V75, P139, DOI 10.3354/dao075139; Rose JD, 2002, REV FISH SCI, V10, P1, DOI 10.1080/20026491051668; Rothbart MK, 1998, SCHOOL PSYCHOL REV, V27, P479; Schjolden J, 2007, BRAIN BEHAV EVOLUT, V70, P227, DOI 10.1159/000105486; Schulkin J, 2005, TRENDS NEUROSCI, V28, P629, DOI 10.1016/j.tins.2005.09.009; Shin LM, 2010, NEUROPSYCHOPHARMACOL, V35, P169, DOI 10.1038/npp.2009.83; Sih A, 2004, Q REV BIOL, V79, P241, DOI 10.1086/422893; Sneddon L, 2007, COMP BIOCHEM PHYS A, V146, pS78, DOI 10.1016/j.cbpa.2007.01.092; Steimer T, 2003, STRESS, V6, P87, DOI 10.1080/1025389031000111320; Steimer T, 1997, BEHAV GENET, V27, P503, DOI 10.1023/A:1021448713665; Svartberg K, 2002, APPL ANIM BEHAV SCI, V79, P133, DOI 10.1016/S0168-1591(02)00121-1; Thomas RJ, 2010, BEHAV ECOL, V21, P669, DOI 10.1093/beheco/arq037; Tong EMW, 2010, J PERS, V78, DOI 10.1111/j.1467-6494.2010.00620.x; van Oers K, 2004, P ROY SOC B-BIOL SCI, V271, P65, DOI 10.1098/rspb.2003.2518; Whittle S, 2006, NEUROSCI BIOBEHAV R, V30, P511, DOI 10.1016/j.neubiorev.2005.09.003; Wingfield JC, 2003, ANIM BEHAV, V66, P807, DOI 10.1006/anbe.2003.2298; Yue S, 2004, APPL ANIM BEHAV SCI, V87, P343, DOI 10.1016/j.applanim.2004.01.004; Yue S, 2008, J APPL ANIM WELF SCI, V11, P14, DOI 10.1080/10888700701729106	58	41	42	4	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e28084	10.1371/journal.pone.0028084	http://dx.doi.org/10.1371/journal.pone.0028084			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140511	Green Published, Green Submitted, gold			2022-12-27	WOS:000298168100034
J	Park, WJ; Kothapalli, KSD; Lawrence, P; Brenna, JT				Park, Woo Jung; Kothapalli, Kumar S. D.; Lawrence, Peter; Brenna, J. Thomas			FADS2 Function Loss at the Cancer Hotspot 11q13 Locus Diverts Lipid Signaling Precursor Synthesis to Unusual Eicosanoid Fatty Acids	PLOS ONE			English	Article							METHYL-ESTERS; LOCALIZATION; DESATURASES; PATHWAY; CLONING; CELLS; GENE; N-6	Background: Genes coding for the fatty acid desaturases (FADS1, 2, 3) localized at the cancer genomic hotspot 11q13 locus are required for the biosynthesis of 20 carbon polyunsaturated fatty acids (PUFA) that are direct eicosanoid precursors. In several cancer cell lines, FADS2 encoded Delta 6 and Delta 8 desaturation is not functional. Methodology/Principal Findings: Analyzing MCF7 cell fatty acids with detailed structural mass spectrometry, we show that in the absence of FADS2 activity, the FADS1 product Delta 5-desaturase operates to produce 5,11,14-20:3 and 5,11,14,17-20:4. These PUFA are missing the 8-9 double bond of the eicosanoid signaling precursors arachidonic acid (5,8,11,14-20:4) and eicosapentaenoic acid (5,8,11,14,17-20:5). Heterologous expression of FADS2 restores Delta 6 and Delta 8-desaturase activity and normal eicosanoid precursor synthesis. Conclusions/Significance: The loss of FADS2-encoded activities in cancer cells shuts down normal PUFA biosynthesis, deleting the endogenous supply of eicosanoid and downstream docosanoid precursors, and replacing them with unusual butylene-interrupted fatty acids. If recapitulated in vivo, the normal eicosanoid and docosanoid cell signaling milieu would be depleted and altered due to reduction and substitution of normal substrates with unusual substrates, with unpredictable consequences for cellular communication.	[Park, Woo Jung; Kothapalli, Kumar S. D.; Lawrence, Peter; Brenna, J. Thomas] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA	Cornell University	Park, WJ (corresponding author), Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA.	ksk25@cornell.edu; jtb4@cornell.edu		Brenna, James Thomas/0000-0001-9494-4245				Chandrasekharappa SC, 1997, SCIENCE, V276, P404, DOI 10.1126/science.276.5311.404; Chung CC, 2011, HUM MOL GENET, V20, P2869, DOI 10.1093/hmg/ddr189; Diau GY, 2005, BMC MED, V3, DOI 10.1186/1741-7015-3-11; DUNBAR LM, 1975, J BIOL CHEM, V250, P1152; GARCES R, 1993, ANAL BIOCHEM, V211, P139, DOI 10.1006/abio.1993.1244; GRAMMATIKOS SI, 1994, BRIT J CANCER, V70, P219, DOI 10.1038/bjc.1994.283; GRAMMATIKOS SI, 1994, ANN NY ACAD SCI, V745, P92; Koreth J, 1999, J PATHOL, V187, P28, DOI 10.1002/(SICI)1096-9896(199901)187:1<28::AID-PATH166>3.0.CO;2-R; Lattka E, 2010, CLIN NUTR, V29, P277, DOI 10.1016/j.clnu.2009.11.005; Rosa-Rosa JM, 2009, BREAST CANCER RES TR, V118, P151, DOI 10.1007/s10549-009-0317-1; Marks F, 2000, EUR J CANCER, V36, P314, DOI 10.1016/S0959-8049(99)00318-4; Marquardt A, 2000, GENOMICS, V66, P175, DOI 10.1006/geno.2000.6196; Merino DM, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-63; Nakamura MT, 2004, ANNU REV NUTR, V24, P345, DOI 10.1146/annurev.nutr.24.121803.063211; NEGRINI M, 1994, CANCER RES, V54, P1331; Panigrahy D, 2010, CANCER METAST REV, V29, P723, DOI 10.1007/s10555-010-9264-x; Park WJ, 2009, J LIPID RES, V50, P1195, DOI 10.1194/jlr.M800630-JLR200; Serhan CN, 2005, CURR OPIN CLIN NUTR, V8, P115, DOI 10.1097/00075197-200503000-00003; Simopoulos AP, 1999, AM J CLIN NUTR, V70, p560S, DOI 10.1093/ajcn/70.3.560s; Srivatsan ES, 2002, ONCOGENE, V21, P5631, DOI 10.1038/sj.onc.1205698; Van Pelt CK, 1999, ANAL CHEM, V71, P1981, DOI 10.1021/ac981387f; Vane JR, 1998, ANNU REV PHARMACOL, V38, P97, DOI 10.1146/annurev.pharmtox.38.1.97; WEI YF, 1985, PROSTAGLANDINS, V29, P537, DOI 10.1016/0090-6980(85)90078-4	23	42	43	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e28186	10.1371/journal.pone.0028186	http://dx.doi.org/10.1371/journal.pone.0028186			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140540	Green Published, gold, Green Submitted			2022-12-27	WOS:000298168100046
J	Liu, F; Struchalin, MV; van Duijn, K; Hofman, A; Uitterlinden, AG; van Duijn, C; Aulchenko, YS; Kayser, M				Liu, Fan; Struchalin, Maksim V.; van Duijn, Kate; Hofman, Albert; Uitterlinden, Andre G.; van Duijn, Cornelia; Aulchenko, Yurii S.; Kayser, Manfred			Detecting Low Frequent Loss-of-Function Alleles in Genome Wide Association Studies with Red Hair Color as Example	PLOS ONE			English	Article							HEREDITARY HYPOPHOSPHATEMIC RICKETS; COMPOUND HETEROZYGOUS MUTATIONS; COMPLEX DISEASES; COMMON DISEASES; GENE; VARIANTS; HYPERCALCIURIA; IDENTIFICATION; DETERMINANTS; EUROPEANS	Multiple loss-of-function (LOF) alleles at the same gene may influence a phenotype not only in the homozygote state when alleles are considered individually, but also in the compound heterozygote (CH) state. Such LOF alleles typically have low frequencies and moderate to large effects. Detecting such variants is of interest to the genetics community, and relevant statistical methods for detecting and quantifying their effects are sorely needed. We present a collapsed double heterozygosity (CDH) test to detect the presence of multiple LOF alleles at a gene. When causal SNPs are available, which may be the case in next generation genome sequencing studies, this CDH test has overwhelmingly higher power than single SNP analysis. When causal SNPs are not directly available such as in current GWA settings, we show the CDH test has higher power than standard single SNP analysis if tagging SNPs are in linkage disequilibrium with the underlying causal SNPs to at least a moderate degree (r(2)>0.1). The test is implemented for genome-wide analysis in the publically available software package GenABEL which is based on a sliding window approach. We provide the proof of principle by conducting a genome-wide CDH analysis of red hair color, a trait known to be influenced by multiple loss-of-function alleles, in a total of 7,732 Dutch individuals with hair color ascertained. The association signals at the MC1R gene locus from CDH were uniformly more significant than traditional GWA analyses (the most significant P for CDH = 3.11x10(-142) vs. P for rs258322 = 1.33x10(-66)). The CDH test will contribute towards finding rare LOF variants in GWAS and sequencing studies.	[Liu, Fan; van Duijn, Kate; Kayser, Manfred] Erasmus MC, Dept Forens Mol Biol, Rotterdam, Netherlands; [Struchalin, Maksim V.; Hofman, Albert; Uitterlinden, Andre G.; van Duijn, Cornelia; Aulchenko, Yurii S.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Uitterlinden, Andre G.] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Liu, F (corresponding author), Erasmus MC, Dept Forens Mol Biol, Rotterdam, Netherlands.	f.liu@erasmusmc.nl	Liu, Fan/B-8833-2013; Aulchenko, Yurii/M-8270-2013	Liu, Fan/0000-0001-9241-8161; Aulchenko, Yurii/0000-0002-7899-1575; Van Duijn, Cornelia/0000-0002-2374-9204	Netherlands Genomics Initiative (NGI)/Netherlands Organization for Scientific Research (NWO) [050-060-810]; Forensic Genomics Consortium Netherlands (FGCN); Netherlands Forensic Institute; Research Institute for Diseases in the Elderly (RIDE) [014-93-015]; NWO [175.010.2005.011, 911-03-012]; Erasmus University Medical Center; Erasmus University Rotterdam; Netherlands Organization for the Health Research and Development (ZonMw); RIDE; Ministry of Education, Culture and Science; Ministry for Health, Welfare and Sports of the Netherlands; European Commission (DG XII); Municipality of Rotterdam	Netherlands Genomics Initiative (NGI)/Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Forensic Genomics Consortium Netherlands (FGCN); Netherlands Forensic Institute; Research Institute for Diseases in the Elderly (RIDE); NWO(Netherlands Organization for Scientific Research (NWO)); Erasmus University Medical Center; Erasmus University Rotterdam; Netherlands Organization for the Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); RIDE; Ministry of Education, Culture and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry for Health, Welfare and Sports of the Netherlands; European Commission (DG XII)(European CommissionEuropean Commission Joint Research Centre); Municipality of Rotterdam	This study is supported by the Netherlands Genomics Initiative (NGI)/Netherlands Organization for Scientific Research (NWO) (nr. 050-060-810) within the framework of the Forensic Genomics Consortium Netherlands (FGCN), the Netherlands Forensic Institute and the Research Institute for Diseases in the Elderly (RIDE) (nr. 014-93-015). The generation and management of GWAS genotype data for the Rotterdam Study (RS-I, RS-II) was supported by a NWO investments grant (nr. 175.010.2005.011, 911-03-012). The Rotterdam Study is funded by the Erasmus University Medical Center, the Erasmus University Rotterdam, the Netherlands Organization for the Health Research and Development (ZonMw), the RIDE, the Ministry of Education, Culture and Science, the Ministry for Health, Welfare and Sports of the Netherlands, the European Commission (DG XII), and the Municipality of Rotterdam. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama M, 2010, HUM MUTAT, V31, P1090, DOI 10.1002/humu.21326; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Aulchenko YS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-134; Beaumont Kimberley A, 2008, Hum Mutat, V29, pE88, DOI 10.1002/humu.20788; Bergwitz C, 2006, AM J HUM GENET, V78, P179, DOI 10.1086/499409; Bezzina CR, 2001, CARDIOVASC RES, V49, P257, DOI 10.1016/S0008-6363(00)00272-8; Borg K, 2009, HUM MUTAT, V30, pE831, DOI 10.1002/humu.21063; Box NF, 1997, HUM MOL GENET, V6, P1891, DOI 10.1093/hmg/6.11.1891; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Enomoto A, 2002, NATURE, V417, P447, DOI 10.1038/nature742; Estrada K, 2009, HUM MOL GENET, V18, P3516, DOI 10.1093/hmg/ddp296; Evans DM, 2008, EUR J HUM GENET, V16, P718, DOI 10.1038/sj.ejhg.5202011; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gitelman H J, 1966, Trans Assoc Am Physicians, V79, P221; Goldstein DB, 2009, NEW ENGL J MED, V360, P1696, DOI 10.1056/NEJMp0806284; Hampson G, 2008, BMC NEPHROL, V9, DOI 10.1186/1471-2369-9-12; HOFMAN A, 1991, EUR J EPIDEMIOL, V7, P403, DOI 10.1007/BF00145007; Hofman A, 2009, EUR J EPIDEMIOL; Hofman A, 2007, EUR J EPIDEMIOL, V22, P819, DOI 10.1007/s10654-007-9199-x; Hong J, 2009, ENDOCRINE, V35, P151, DOI 10.1007/s12020-009-9145-7; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; IEIRI T, 1991, J CLIN INVEST, V88, P1901, DOI 10.1172/JCI115513; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Liu F, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000934; Lorenz-Depiereux B, 2006, AM J HUM GENET, V78, P193, DOI 10.1086/499410; MacArthur DG, 2010, HUM MOL GENET, V19, pR125, DOI 10.1093/hmg/ddq365; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marchini J, 2005, NAT GENET, V37, P413, DOI 10.1038/ng1537; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; Matsuo H, 2008, AM J HUM GENET, V83, P744, DOI 10.1016/j.ajhg.2008.11.001; Morgenthaler S, 2007, MUTAT RES-FUND MOL M, V615, P28, DOI 10.1016/j.mrfmmm.2006.09.003; Romeo S, 2007, NAT GENET, V39, P513, DOI 10.1038/ng1984; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Shemon AN, 2006, J BIOL CHEM, V281, P2079, DOI 10.1074/jbc.M507816200; Singleton AB, 2010, TRENDS GENET, V26, P438, DOI 10.1016/j.tig.2010.07.004; Song K. N. M., 2011, PHARMACOGENOMICS J; Sulem P, 2007, NAT GENET, V39, P1443, DOI 10.1038/ng.2007.13; VALVERDE P, 1995, NAT GENET, V11, P328, DOI 10.1038/ng1195-328; Vanakker OM, 2007, J INVEST DERMATOL, V127, P581, DOI 10.1038/sj.jid.5700610; Via M, 2010, GENOME MED, V2, DOI 10.1186/gm124; Wang K, 2010, AM J HUM GENET, V86, P730, DOI 10.1016/j.ajhg.2010.04.003; Wang RR, 2011, INT J MOL MED, V28, P41, DOI 10.3892/ijmm.2011.642	45	16	16	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2011	6	11							e28145	10.1371/journal.pone.0028145	http://dx.doi.org/10.1371/journal.pone.0028145			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863LT	22140526	Green Published, gold, Green Submitted			2022-12-27	WOS:000298166300029
J	Fu, SJ; Fei, Q; Jiang, H; Chuai, SN; Shi, S; Xiong, W; Jiang, L; Lu, C; Atadja, P; Li, E; Shou, JY				Fu, Shijun; Fei, Qi; Jiang, Hua; Chuai, Shannon; Shi, Song; Xiong, Wen; Jiang, Lei; Lu, Chris; Atadja, Peter; Li, En; Shou, Jianyong			Involvement of Histone Acetylation of Sox17 and Foxa2 Promoters during Mouse Definitive Endoderm Differentiation Revealed by MicroRNA Profiling	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; BETA-CATENIN; EFFICIENT DIFFERENTIATION; EXPRESSION; HEPATOCYTES; SIGNATURE	Generation of hepatocyte from embryonic stem cells (ESCs) holds great promise for hepatocyte replacement therapy to treat liver diseases. Achieving high efficiency of directed differentiation of ESCs to hepatocyte is of critical importance. Previously, Wnt3a has been reported to promote Activin A-induced human definitive endoderm (DE) differentiation, the early stage of hepatocyte differentiation. However, the underlying molecular mechanisms are not clear. Growing evidence demonstrated that microRNAs (miRNAs) are key regulators involved in various important biological processes including the regulation of stem cell differentiation. In the present study, we profiled genome wide miRNA expression during Wnt3a and Activin A induced mouse DE differentiation. We uncovered distinct miRNA expression patterns during DE differentiation with the identification of a subset of miRNAs whose expression is synergistically regulated by Wnt3a/Activin A treatment at different stages of DE differentiation. Forced expression of a pool of such synergistically regulated miRNAs alone could partially promote DE differentiation, indicating a regulatory role of them. Using TargetScan and GeneGO pathway analyses, the synergistically regulated miRNAs are predicted to regulate key pathways involved in DE differentiation; among them includes the regulation of histone acetylation. Consistently, Wnt3a and Activin A treatment increased global histone acetylation which can be partially mimicked by over expression of the pooled miRNAs. Chromatin IP (ChIP) experiments demonstrated that the promoter regions of Sox17 and Foxa2 are subjected to histone acetylation regulation. Administration of Hdac inhibitors greatly augmented DE differentiation. Our data uncovered a novel epigenetic mechanism of Wnt3a and Activin A induced DE differentiation, whereby the treatment of growth factors induced histone acetylation at least in part by the regulation of miRNA expression.	[Fu, Shijun; Fei, Qi; Jiang, Hua; Chuai, Shannon; Shi, Song; Xiong, Wen; Jiang, Lei; Lu, Chris; Atadja, Peter; Li, En; Shou, Jianyong] China Novartis Inst BioMed Res, Shanghai, Peoples R China	Novartis	Fu, SJ (corresponding author), China Novartis Inst BioMed Res, Shanghai, Peoples R China.	jianyong.shou@novartis.com		Shou, Jianyong/0000-0002-3752-7215	educational office in Novartis Institutes for BioMedical Research	educational office in Novartis Institutes for BioMedical Research	The project is supported by a post-doc program from the educational office in Novartis Institutes for BioMedical Research. The educational office had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avnit-Sagi T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005033; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bi Y, 2009, J CELL BIOCHEM, V108, P295, DOI 10.1002/jcb.22254; Billin AN, 2000, MOL CELL BIOL, V20, P6882, DOI 10.1128/MCB.20.18.6882-6890.2000; Bonifacio LN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012519; Borowiak M, 2009, CELL STEM CELL, V4, P348, DOI 10.1016/j.stem.2009.01.014; Cai J, 2007, HEPATOLOGY, V45, P1229, DOI 10.1002/hep.21582; Chen YF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-264; Dovey OM, 2010, P NATL ACAD SCI USA, V107, P8242, DOI 10.1073/pnas.1000478107; Duan YY, 2010, STEM CELLS, V28, P674, DOI 10.1002/stem.315; Foshay KM, 2009, DEV BIOL, V326, P431, DOI 10.1016/j.ydbio.2008.11.016; Fu SJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-369; HAEGEL H, 1995, DEVELOPMENT, V121, P3529; Hansson M, 2009, DEV BIOL, V330, P286, DOI 10.1016/j.ydbio.2009.03.026; Hay DC, 2008, P NATL ACAD SCI USA, V105, P12301, DOI 10.1073/pnas.0806522105; Hay DC, 2008, STEM CELLS, V26, P894, DOI 10.1634/stemcells.2007-0718; Hinton A, 2010, STEM CELLS DEV, V19, P797, DOI 10.1089/scd.2009.0224; Hosseinkhani M, 2007, BIOCHEM BIOPH RES CO, V356, P386, DOI 10.1016/j.bbrc.2007.02.151; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Jang JS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-144; Karantzali E, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r65; Lakshmipathy U, 2007, STEM CELLS DEV, V16, P1003, DOI 10.1089/scd.2007.0026; Laurent LC, 2008, STEM CELLS, V26, P1506, DOI 10.1634/stemcells.2007-1081; Lee S, 2009, CELL PROLIFERAT, V42, P711, DOI 10.1111/j.1365-2184.2009.00633.x; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Li M, 2005, DEV CELL, V9, P415, DOI 10.1016/j.devcel.2005.08.002; Liu PT, 1999, NAT GENET, V22, P361, DOI 10.1038/11932; Liu Y, 2004, DEV BIOL, V270, P411, DOI 10.1016/j.ydbio.2004.03.017; Lowe LA, 2001, DEVELOPMENT, V128, P1831; Margariti A, 2010, CIRC RES, V106, P1202, DOI 10.1161/CIRCRESAHA.109.213165; Miro JM, 2006, J HEPATOL, V44, pS140, DOI 10.1016/j.jhep.2005.11.028; Morrison GM, 2008, CELL STEM CELL, V3, P402, DOI 10.1016/j.stem.2008.07.021; Neves A, 2007, DEVELOPMENT, V134, P4459, DOI 10.1242/dev.008680; Simion A, 2010, BIOCHEM BIOPH RES CO, V391, P293, DOI 10.1016/j.bbrc.2009.11.052; Soto-Gutierrez A, 2007, NAT PROTOC, V2, P347, DOI 10.1038/nprot.2007.18; Stainier DYR, 2002, GENE DEV, V16, P893, DOI 10.1101/gad.974902; Turovets N, 2011, DIFFERENTIATION 0207, V7; Tzur G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003726; Vincent SD, 2003, GENE DEV, V17, P1646, DOI 10.1101/gad.1100503; Viswanathan SR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006143; Watabe T, 2009, CELL RES, V19, P103, DOI 10.1038/cr.2008.323; Yao X, 2010, CHINESE MED J-PEKING, V123, P734, DOI 10.3760/cma.j.issn.0366-6999.2010.06.018; ZHANG H, 2010, DEV BIOL; Zupkovitz G, 2006, MOL CELL BIOL, V26, P7913, DOI 10.1128/MCB.01220-06	45	22	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e27965	10.1371/journal.pone.0027965	http://dx.doi.org/10.1371/journal.pone.0027965			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132182	gold, Green Published, Green Submitted			2022-12-27	WOS:000298162000053
J	Sharma, N; Kumar, R; Renaux, B; Saifeddine, M; Nishikawa, S; Mihara, K; Ramachandran, R; Hollenberg, MD; Rancourt, DE				Sharma, Navneet; Kumar, Rajeev; Renaux, Bernard; Saifeddine, Mahmoud; Nishikawa, Sandra; Mihara, Koichiro; Ramachandran, Rithwik; Hollenberg, Morley D.; Rancourt, Derrick E.			Implantation Serine Proteinase 1 Exhibits Mixed Substrate Specificity that Silences Signaling via Proteinase-Activated Receptors	PLOS ONE			English	Article							PHAGE-DISPLAY; EMBRYO IMPLANTATION; EXPRESSION; PROMISCUITY; MECHANISM; PREGNANCY; TRYPTASE; MICE; ISP2; PROGESTERONE	Implantation S1 family serine proteinases (ISPs) are tryptases involved in embryo hatching and uterine implantation in the mouse. The two different ISP proteins (ISP1 and ISP2) have been detected in both pre- and post-implantation embryo tissue. To date, native ISP obtained from uterus and blastocyst tissues has been isolated only as an active hetero-dimer that exhibits trypsin-like substrate specificity. We hypothesised that in isolation, ISP1 might have a unique substrate specificity that could relate to its role when expressed alone in individual tissues. Thus, we isolated recombinant ISP1 expressed in Pichia pastoris and evaluated its substrate specificity. Using several chromogenic substrates and serine proteinase inhibitors, we demonstrate that ISP1 exhibits trypsin-like substrate specificity, having a preference for lysine over arginine at the P1 position. Phage display peptide mimetics revealed an expanded but mixed substrate specificity of ISP1, including chymotryptic and elastase activity. Based upon targets observed using phage display, we hypothesised that ISP1 might signal to cells by cleaving and activating proteinase-activated receptors (PARs) and therefore assessed PARs 1, 2 and 4 as potential ISP1 targets. We observed that ISP1 silenced enzyme-triggered PAR signaling by receptor-disarming. This PAR-disarming action of ISP1 may be important for embryo development and implantation.	[Sharma, Navneet; Kumar, Rajeev; Nishikawa, Sandra; Rancourt, Derrick E.] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada; [Renaux, Bernard; Saifeddine, Mahmoud; Mihara, Koichiro; Ramachandran, Rithwik; Hollenberg, Morley D.] Univ Calgary, Dept Physiol & Pharmacol, Calgary, AB, Canada; [Hollenberg, Morley D.] Univ Calgary, Fac Med, Dept Med, Calgary, AB, Canada	University of Calgary; University of Calgary; University of Calgary	Sharma, N (corresponding author), Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada.	navsharm@ucalgary.ca	Hollenberg, Morley/AFV-6966-2022; Ramachandran, Rithwik/N-7815-2015	Ramachandran, Rithwik/0000-0001-9557-9905	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research Operating Grants awarded to DR and MH, who contributed equally to this project. DR is an AHFMR Senior Scholar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addington AK, 1996, BIOCHEMISTRY-US, V35, P13511, DOI 10.1021/bi960042t; Bell JK, 2003, NAT STRUCT BIOL, V10, P527, DOI 10.1038/nsb944; Coughlin SR, 2005, J THROMB HAEMOST, V3, P1800, DOI 10.1111/j.1538-7836.2005.01377.x; Ekroos M, 2006, P NATL ACAD SCI USA, V103, P13682, DOI 10.1073/pnas.0603236103; Even-Ram SC, 2003, J PATHOL, V200, P47, DOI 10.1002/path.1338; Felber LM, 2005, BIOL CHEM, V386, P291, DOI 10.1515/BC.2005.035; Fukuoka Y, 2007, INT IMMUNOPHARMACOL, V7, P1900, DOI 10.1016/j.intimp.2007.07.007; Griswold KE, 2006, J MOL BIOL, V364, P400, DOI 10.1016/j.jmb.2006.09.012; Hague S., 2002, Angiogenesis, V5, P93, DOI 10.1023/A:1021510723157; Hawthorne S, 2004, ANAL BIOCHEM, V326, P273, DOI 10.1016/j.ab.2003.12.002; Hirota Y, 2005, J CLIN ENDOCR METAB, V90, P1662, DOI 10.1210/jc.2004-0726; Hollenberg MD, 2002, PHARMACOL REV, V54, P203, DOI 10.1124/pr.54.2.203; Huang ZP, 2004, REPROD FERT DEVELOP, V16, P379, DOI 10.1071/RD03102; Isermann B, 2003, NAT MED, V9, P331, DOI 10.1038/nm825; Jahan I, 2007, ONCOL REP, V17, P345; Karlson L, 2002, J BIOL CHEM, V277, P18579, DOI 10.1074/jbc.M110356200; Karlson U, 2003, J BIOL CHEM, V278, P39625, DOI 10.1074/jbc.M301512200; Knecht W, 2007, J BIOL CHEM, V282, P26089, DOI 10.1074/jbc.M703840200; Krikun G, 2008, ANN NY ACAD SCI, V1127, P101, DOI 10.1196/annals.1434.008; MATTHEWS DJ, 1993, SCIENCE, V260, P1113, DOI 10.1126/science.8493554; MCCAFFERTY J, 1990, NATURE, V348, P552, DOI 10.1038/348552a0; Mitchell SE, 2005, REPROD FERT DEVELOP, V17, P693, DOI 10.1071/RD05032; Nath A, 2008, BIOCHEMISTRY-US, V47, P157, DOI 10.1021/bi701448p; O'Brien M, 2008, BIOL REPROD, V78, P20, DOI 10.1095/biolreprod.107.062182; O'Sullivan CM, 2004, MOL REPROD DEV, V69, P252, DOI 10.1002/mrd.20169; O'Sullivan CM, 2004, MOL REPROD DEV, V69, P126, DOI 10.1002/mrd.20115; O'Sullivan CM, 2002, MOL REPROD DEV, V62, P328, DOI 10.1002/mrd.10142; O'Sullivan CM, 2001, REPRODUCTION, V122, P235, DOI 10.1530/rep.0.1220235; O'Sullivan CM, 2001, REPRODUCTION, V122, P61, DOI 10.1530/rep.0.1220061; Oikonomopoulou K, 2006, J BIOL CHEM, V281, P32095, DOI 10.1074/jbc.M513138200; Pan ZY, 2006, BIOORG MED CHEM LETT, V16, P2882, DOI 10.1016/j.bmcl.2006.03.012; Perona JJ, 1997, J BIOL CHEM, V272, P29987, DOI 10.1074/jbc.272.48.29987; Ramachandran R, 2008, BRIT J PHARMACOL, V153, pS263, DOI 10.1038/sj.bjp.0707507; Ramachandran R, 2009, MOL PHARMACOL, V76, P791, DOI 10.1124/mol.109.055509; SCARBOROUGH RM, 1992, J BIOL CHEM, V267, P13146; Sharma N, 2008, BIOL CHEM, V389, P1097, DOI 10.1515/BC.2008.118; Sharma N, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-61; Shintani Y, 2001, BRIT J PHARMACOL, V133, P1276, DOI 10.1038/sj.bjp.0704206; SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944; Steinhoff M, 2005, ENDOCR REV, V26, P1, DOI 10.1210/er.2003-0025; Sun ZG, 2007, CONTRACEPTION, V76, P250, DOI 10.1016/j.contraception.2007.05.084; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005	43	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e27888	10.1371/journal.pone.0027888	http://dx.doi.org/10.1371/journal.pone.0027888			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132161	Green Published, gold, Green Submitted			2022-12-27	WOS:000298162000047
J	Strong, TC; Kaur, G; Thomas, JH				Strong, Taylor C.; Kaur, Gurvinder; Thomas, Jeffrey H.			Mutations in the Catalytic Loop HRD Motif Alter the Activity and Function of Drosophila Src64	PLOS ONE			English	Article							TYROSINE KINASE; CRYSTAL-STRUCTURE; ACTIN ORGANIZATION; STRUCTURAL BASIS; PROTEIN-KINASES; FAMILY; ACTIVATION; DOMAIN; CELLULARIZATION; MORPHOGENESIS	The catalytic loop HRD motif is found in most protein kinases and these amino acids are predicted to perform functions in catalysis, transition to, and stabilization of the active conformation of the kinase domain. We have identified mutations in a Drosophila src gene, src64, that alter the three HRD amino acids. We have analyzed the mutants for both biochemical activity and biological function during development. Mutation of the aspartate to asparagine eliminates biological function in cytoskeletal processes and severely reduces fertility, supporting the amino acid's critical role in enzymatic activity. The arginine to cysteine mutation has little to no effect on kinase activity or cytoskeletal reorganization, suggesting that the HRD arginine may not be critical for coordinating phosphotyrosine in the active conformation. The histidine to leucine mutant retains some kinase activity and biological function, suggesting that this amino acid may have a biochemical function in the active kinase that is independent of its side chain hydrogen bonding interactions in the active site. We also describe the phenotypic effects of other mutations in the SH2 and tyrosine kinase domains of src64, and we compare them to the phenotypic effects of the src64 null allele.	[Strong, Taylor C.; Kaur, Gurvinder; Thomas, Jeffrey H.] Texas Tech Univ, Hlth Sci Ctr, Dept Cell Biol & Biochem, Lubbock, TX 79430 USA	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center	Strong, TC (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Cell Biol & Biochem, Lubbock, TX 79430 USA.	jeffrey.thomas@ttuhsc.edu		Thomas, Jeffrey H./0000-0003-4748-9045	American Heart Association, South Central [09BGIA2260616]; Department of Cell Biology and Biochemistry, Texas Tech University Health Sciences Center	American Heart Association, South Central(American Heart Association); Department of Cell Biology and Biochemistry, Texas Tech University Health Sciences Center	This work was supported by American Heart Association, South Central Affiliate Beginning Grant-in-Aid 09BGIA2260616 and start-up funds from the Department of Cell Biology and Biochemistry, Texas Tech University Health Sciences Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JA, 2001, CHEM REV, V101, P2271, DOI 10.1021/cr000230w; Azam M, 2008, NAT STRUCT MOL BIOL, V15, P1109, DOI 10.1038/nsmb.1486; Barrett CP, 2005, J BIOL CHEM, V280, P13993, DOI 10.1074/jbc.M407371200; Breitenlechner CB, 2005, J MOL BIOL, V353, P222, DOI 10.1016/j.jmb.2005.08.023; Broome MA, 1996, J BIOL CHEM, V271, P16798, DOI 10.1074/jbc.271.28.16798; Bukhtiyarova M, 2007, BIOCHEMISTRY-US, V46, P5687, DOI 10.1021/bi0622221; COLE PA, 1995, J BIOL CHEM, V270, P22105, DOI 10.1074/jbc.270.38.22105; Collier LS, 2004, GENETICS, V167, P783, DOI 10.1534/genetics.103.024992; Cooper JL, 2008, FLY, V2, P300, DOI 10.4161/fly.7366; Cowan-Jacob SW, 2005, STRUCTURE, V13, P861, DOI 10.1016/j.str.2005.03.012; Dodson GS, 1998, DEVELOPMENT, V125, P2883; Frame MC, 2002, NAT REV MOL CELL BIO, V3, P233, DOI 10.1038/nrm779; FULLILOVE SL, 1971, DEV BIOL, V26, P560, DOI 10.1016/0012-1606(71)90141-2; GIBBS CS, 1991, J BIOL CHEM, V266, P8923; Guarnieri DJ, 1998, MOL CELL, V1, P831, DOI 10.1016/S1097-2765(00)80082-9; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Harrison SC, 2003, CELL, V112, P737, DOI 10.1016/S0092-8674(03)00196-X; Johnson LN, 2001, CHEM REV, V101, P2209, DOI 10.1021/cr000225s; Kannan N, 2005, J MOL BIOL, V351, P956, DOI 10.1016/j.jmb.2005.06.057; Kannan N, 2007, PLOS BIOL, V5, P467, DOI 10.1371/journal.pbio.0050017; Kelso RJ, 2002, J CELL BIOL, V156, P703, DOI 10.1083/jcb.200110063; Kornev AP, 2008, P NATL ACAD SCI USA, V105, P14377, DOI 10.1073/pnas.0807988105; Kornev AP, 2006, P NATL ACAD SCI USA, V103, P17783, DOI 10.1073/pnas.0607656103; Kornev AP, 2010, BBA-PROTEINS PROTEOM, V1804, P440, DOI 10.1016/j.bbapap.2009.10.017; Koundakjian EJ, 2004, GENETICS, V167, P203, DOI 10.1534/genetics.167.1.203; Lecuit T, 2000, J CELL BIOL, V150, P849, DOI 10.1083/jcb.150.4.849; Mazumdar A, 2002, BIOESSAYS, V24, P1012, DOI 10.1002/bies.10184; MUKHOPADHYAY D, 1995, NATURE, V375, P577, DOI 10.1038/375577a0; O'Reilly AM, 2006, DEVELOPMENT, V133, P2627, DOI 10.1242/dev.02423; Ozkirimli E, 2006, PROTEIN SCI, V15, P1051, DOI 10.1110/ps.051999206; Ozkirimli E, 2008, PROTEIN SCI, V17, P1871, DOI 10.1110/ps.037457.108; Pane A, 2007, DEV CELL, V12, P851, DOI 10.1016/j.devcel.2007.03.022; ROBINSON DN, 1994, DEVELOPMENT, V120, P2015; Roskoski R, 2004, BIOCHEM BIOPH RES CO, V324, P1155, DOI 10.1016/j.bbrc.2004.09.171; Roulier EM, 1998, MOL CELL, V1, P819, DOI 10.1016/S1097-2765(00)80081-7; Royou A, 2004, MOL BIOL CELL, V15, P838, DOI 10.1091/mbc.E03-06-0440; SCHEJTER ED, 1993, ANNU REV CELL BIOL, V9, P67, DOI 10.1146/annurev.cellbio.9.1.67; Schindler T, 1999, MOL CELL, V3, P639, DOI 10.1016/S1097-2765(00)80357-3; Schwartzberg PL, 1997, GENE DEV, V11, P2835, DOI 10.1101/gad.11.21.2835; SENFTEN M, 1995, ONCOGENE, V10, P199; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; Skamnaki VT, 1999, BIOCHEMISTRY-US, V38, P14718, DOI 10.1021/bi991454f; Sokac AM, 2008, J CELL SCI, V121, P1815, DOI 10.1242/jcs.025171; Sokac AM, 2008, DEV CELL, V14, P775, DOI 10.1016/j.devcel.2008.02.014; Strong TC, 2011, GENESIS, V49, P912, DOI 10.1002/dvg.20783; Takahashi M, 2005, DEVELOPMENT, V132, P2547, DOI 10.1242/dev.01850; Tateno M, 2000, SCIENCE, V287, P324, DOI 10.1126/science.287.5451.324; Ten Eyck LF, 2008, BBA-PROTEINS PROTEOM, V1784, P238, DOI 10.1016/j.bbapap.2007.11.002; Thomas JH, 2004, DEVELOPMENT, V131, P863, DOI 10.1242/dev.00989; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Tilney LG, 1996, J CELL BIOL, V133, P61, DOI 10.1083/jcb.133.1.61; TWAMLEYSTEIN GM, 1993, P NATL ACAD SCI USA, V90, P7696, DOI 10.1073/pnas.90.16.7696; Tweedie S, 2009, NUCLEIC ACIDS RES, V37, pD555, DOI 10.1093/nar/gkn788; Vidal M, 2007, CANCER RES, V67, P10278, DOI 10.1158/0008-5472.CAN-07-1376; WARN RM, 1990, J CELL SCI, V96, P35; Wieschaus E., 1998, DROSOPHILA PRACTICAL, P179; Williams DM, 2002, J AM CHEM SOC, V124, P5956, DOI 10.1021/ja025993a; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; Yamaguchi H, 1996, NATURE, V384, P484, DOI 10.1038/384484a0; YOUNG PE, 1991, DEVELOPMENT, V111, P1	62	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e28100	10.1371/journal.pone.0028100	http://dx.doi.org/10.1371/journal.pone.0028100			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132220	gold, Green Published, Green Submitted			2022-12-27	WOS:000298162000071
J	Kim, SN; Doo, AR; Park, JY; Bae, H; Chae, Y; Shim, I; Lee, H; Moon, W; Lee, H; Park, HJ				Kim, Seung-Nam; Doo, Ah-Reum; Park, Ji-Yeun; Bae, Hyungjin; Chae, Younbyoung; Shim, Insop; Lee, Hyangsook; Moon, Woongjoon; Lee, Hyejung; Park, Hi-Joon			Acupuncture Enhances the Synaptic Dopamine Availability to Improve Motor Function in a Mouse Model of Parkinson's Disease	PLOS ONE			English	Article							INDUCED ROTATIONAL BEHAVIOR; ELECTROACUPUNCTURE STIMULATION; MESSENGER-RNA; EXERCISE; DEFICITS	Parkinson's disease (PD) is caused by the selective loss of dopaminergic neurons in the substantia nigra (SN) and the depletion of striatal dopamine (DA). Acupuncture, as an alternative therapy for PD, has beneficial effects in both PD patients and PD animal models, although the underlying mechanisms therein remain uncertain. The present study investigated whether acupuncture treatment affected dopamine neurotransmission in a PD mouse model using 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). We found that acupuncture treatment at acupoint GB34 improved motor function with accompanying dopaminergic neuron protection against MPTP but did not restore striatal dopamine depletion. Instead, acupuncture treatment increased dopamine release that in turn, may lead to the enhancement of dopamine availability in the synaptic cleft. Moreover, acupuncture treatment mitigated MPTP-induced abnormal postsynaptic changes, suggesting that acupuncture treatment may increase postsynaptic dopamine neurotransmission and facilitate the normalization of basal ganglia activity. These results suggest that the acupuncture-induced enhancement of synaptic dopamine availability may play a critical role in motor function improvement against MPTP.	[Kim, Seung-Nam; Doo, Ah-Reum; Park, Ji-Yeun; Bae, Hyungjin; Chae, Younbyoung; Shim, Insop; Lee, Hyangsook; Moon, Woongjoon; Lee, Hyejung; Park, Hi-Joon] Kyung Hee Univ, Acupuncture & Meridian Sci Res Ctr, Seoul, South Korea; [Kim, Seung-Nam] Kyung Hee Univ, Dept Oriental Med Sci, Seoul, South Korea	Kyung Hee University; Kyung Hee University	Kim, SN (corresponding author), Kyung Hee Univ, Acupuncture & Meridian Sci Res Ctr, Seoul, South Korea.	wm9306@naver.com; acufind@khu.ac.kr	Park, Hi-Joon/AAG-1196-2021; LEE, HYANGSOOK/D-2070-2017; Chae, Younbyoung/AAM-1243-2020	LEE, HYANGSOOK/0000-0002-1107-9389; Shim, Insop/0000-0002-8014-9782; Chae, Younbyoung/0000-0001-6787-2215; Park, Hi-Joon/0000-0002-0538-2664	National Research Foundation of Korea (NRF); Korea government (MEST) [2010-0008834, 2005-0049404]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) [2010-0008834 and 2005-0049404]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson M, 1999, NEUROBIOL DIS, V6, P461, DOI 10.1006/nbdi.1999.0259; Antonini A, 2009, LANCET NEUROL, V8, P929, DOI 10.1016/S1474-4422(09)70225-X; CHERAMY A, 1981, NATURE, V289, P537, DOI 10.1038/289537a0; Crocker SJ, 2003, J NEUROSCI, V23, P4081; Fahn S, 2003, ANN NY ACAD SCI, V991, P1, DOI 10.1111/j.1749-6632.2003.tb07458.x; Gash DM, 1996, NATURE, V380, P252, DOI 10.1038/380252a0; Greengard P, 1999, NEURON, V23, P435, DOI 10.1016/S0896-6273(00)80798-9; Hirsch EC, 1998, MOVEMENT DISORD, V13, P39; Hirsch EC, 1998, ANN NEUROL, V44, pS115, DOI 10.1002/ana.410440717; Jeon S, 2008, PROTEOMICS, V8, P4822, DOI 10.1002/pmic.200700955; Jeun SS, 2005, AM J CHINESE MED, V33, P573, DOI 10.1142/S0192415X0500317X; Jia J, 2010, BEHAV NEUROSCI, V124, P305, DOI 10.1037/a0018931; Jia J, 2009, BEHAV BRAIN RES, V205, P214, DOI 10.1016/j.bbr.2009.06.024; Kang JM, 2007, BRAIN RES, V1131, P211, DOI 10.1016/j.brainres.2006.10.089; Keith B.J., 2008, MOUSE BRAIN STEREOTA; Kim ST, 2010, J PHYSIOL SCI, V60, P27, DOI 10.1007/s12576-009-0061-7; KIM SN, 2011, INT J NEURO IN PRESS; Liang XB, 2003, NEUROREPORT, V14, P1177, DOI 10.1097/00001756-200306110-00015; LIANGYUE D, 2004, CHINESE ACUPUNCTURE; Mount MP, 2007, J NEUROSCI, V27, P3328, DOI 10.1523/JNEUROSCI.5321-06.2007; MOURADIAN MM, 1987, CLIN NEUROPHARMACOL, V10, P351, DOI 10.1097/00002826-198708000-00005; Na BJ, 2009, NEUROSCI LETT, V464, P1, DOI 10.1016/j.neulet.2009.08.009; Nishi A, 2008, J NEUROSCI, V28, P10460, DOI 10.1523/JNEUROSCI.2518-08.2008; Park HJ, 2003, EXP NEUROL, V180, P92, DOI 10.1016/S0014-4886(02)00031-6; Petzinger GM, 2007, J NEUROSCI, V27, P5291, DOI 10.1523/JNEUROSCI.1069-07.2007; Picconi B, 2003, NAT NEUROSCI, V6, P501, DOI 10.1038/nn1040; ROBERTSON GS, 1989, J NEUROSCI, V9, P3326; Rozas G, 1997, BRAIN RES PROTOC, V2, P75, DOI 10.1016/S1385-299X(97)00034-2; Rozas G, 1998, J NEUROSCI METH, V83, P165, DOI 10.1016/S0165-0270(98)00078-8; Santini E, 2008, FEBS J, V275, P1392, DOI 10.1111/j.1742-4658.2008.06296.x; Smith PD, 2003, P NATL ACAD SCI USA, V100, P13650, DOI 10.1073/pnas.2232515100; Tseng JL, 1997, J NEUROSCI, V17, P325, DOI 10.1523/JNEUROSCI.17-01-00325.1997; Vuckovic MG, 2008, NEUROBIOL DIS, V32, P319, DOI 10.1016/j.nbd.2008.07.015; World Health Organization, 2008, WHO STAND AC POINT L, P226; Yin CS, 2008, RES VET SCI, V84, P159, DOI 10.1016/j.rvsc.2007.04.004; Yu YP, 2010, BRAIN RES, V1336, P58, DOI 10.1016/j.brainres.2010.04.020	36	60	63	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2011	6	11							e27566	10.1371/journal.pone.0027566	http://dx.doi.org/10.1371/journal.pone.0027566			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858JH	22132113	Green Published, Green Submitted, gold			2022-12-27	WOS:000297792400009
J	Shan, Q; Han, L; Lynch, JW				Shan, Qiang; Han, Lu; Lynch, Joseph W.			beta Subunit M2-M3 Loop Conformational Changes Are Uncoupled from alpha 1 beta Glycine Receptor Channel Gating: Implications for Human Hereditary Hyperekplexia	PLOS ONE			English	Article							GATED ION-CHANNEL; NICOTINIC ACETYLCHOLINE-RECEPTOR; LIGAND-BINDING DOMAIN; X-RAY-STRUCTURE; AGONIST BINDING; GABA(A) RECEPTOR; CHLORIDE CHANNEL; K+ CHANNEL; OPEN STATE; M2 DOMAIN	Hereditary hyperekplexia, or startle disease, is a neuromotor disorder caused mainly by mutations that either prevent the surface expression of, or modify the function of, the human heteromeric alpha 1 beta glycine receptor (GlyR) chloride channel. There is as yet no explanation as to why hyperekplexia mutations that modify channel function are almost exclusively located in the alpha 1 to the exclusion of b subunit. The majority of these mutations are identified in the M2-M3 loop of the alpha 1 subunit. Here we demonstrate that alpha 1 beta GlyR channel function is less sensitive to hyperekplexia-mimicking mutations introduced into the M2-M3 loop of the b than into the alpha 1 subunit. This suggests that the M2-M3 loop of the a subunit dominates the b subunit in gating the alpha 1 beta GlyR channel. A further attempt to determine the possible mechanism underlying this phenomenon by using the voltage-clamp fluorometry technique revealed that agonist-induced conformational changes in the b subunit M2-M3 loop were uncoupled from alpha 1 beta GlyR channel gating. This is in contrast to the a subunit, where the M2-M3 loop conformational changes were shown to be directly coupled to alpha 1 beta GlyR channel gating. Finally, based on analysis of alpha 1 beta chimeric receptors, we demonstrate that the structural components responsible for this are distributed throughout the b subunit, implying that the b subunit has evolved without the functional constraint of a normal gating pathway within it. Our study provides a possible explanation of why hereditary hyperekplexia-causing mutations that modify alpha 1 beta GlyR channel function are almost exclusively located in the alpha 1 to the exclusion of the b subunit.	[Shan, Qiang; Han, Lu; Lynch, Joseph W.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Lynch, Joseph W.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia	University of Queensland; University of Queensland	Shan, Q (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia.	qshan@yahoo.com	Lynch, Joseph/C-8636-2009		National Health and Medical Research Council of Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by a research grant from the National Health and Medical Research Council of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beato M, 2004, J NEUROSCI, V24, P895, DOI 10.1523/JNEUROSCI.4420-03.2004; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Bouzat C, 2004, NATURE, V430, P896, DOI 10.1038/nature02753; Breitinger HG, 2002, CHEMBIOCHEM, V3, P1043, DOI 10.1002/1439-7633(20021104)3:11<1042::AID-CBIC1042>3.0.CO;2-7; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Burzomato V, 2004, J NEUROSCI, V24, P10924, DOI 10.1523/JNEUROSCI.3424-04.2004; Chung SK, 2010, J NEUROSCI, V30, P9612, DOI 10.1523/JNEUROSCI.1763-10.2010; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; Dahan DS, 2004, P NATL ACAD SCI USA, V101, P10195, DOI 10.1073/pnas.0301885101; Engel AG, 2003, NAT REV NEUROSCI, V4, P339, DOI 10.1038/nrn1101; Gandhi CS, 2005, TRENDS NEUROSCI, V28, P472, DOI 10.1016/j.tins.2005.07.005; Gentet LJ, 2002, J PHYSIOL-LONDON, V544, P97, DOI 10.1113/jphysiol.2001.015321; Grewer C, 1999, BIOPHYS J, V77, P727, DOI 10.1016/S0006-3495(99)76927-4; Grosman C, 2000, J GEN PHYSIOL, V116, P327, DOI 10.1085/jgp.116.3.327; Grosman C, 2000, NATURE, V403, P773, DOI 10.1038/35001586; Grudzinska J, 2005, NEURON, V45, P727, DOI 10.1016/j.neuron.2005.01.028; Harvey RJ, 2008, TRENDS GENET, V24, P439, DOI 10.1016/j.tig.2008.06.005; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Kash TL, 2003, NATURE, V421, P272, DOI 10.1038/nature01280; Le Novere N, 2002, J NEUROBIOL, V53, P447, DOI 10.1002/neu.10153; Lee WY, 2009, J NEUROSCI, V29, P3189, DOI 10.1523/JNEUROSCI.6185-08.2009; Lewis TM, 2003, J PHYSIOL-LONDON, V549, P361, DOI 10.1113/jphysiol.2002.037796; Lewis TM, 1998, J PHYSIOL-LONDON, V507, P25, DOI 10.1111/j.1469-7793.1998.025bu.x; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Lummis SCR, 2005, NATURE, V438, P248, DOI 10.1038/nature04130; Lynch JW, 2009, NEUROPHARMACOLOGY, V56, P303, DOI 10.1016/j.neuropharm.2008.07.034; Lynch JW, 1997, EMBO J, V16, P110, DOI 10.1093/emboj/16.1.110; Lynch JW, 2001, J NEUROSCI, V21, P2589, DOI 10.1523/JNEUROSCI.21-08-02589.2001; Lynch JW, 2004, PHYSIOL REV, V84, P1051, DOI 10.1152/physrev.00042.2003; Macdonald RL, 2004, BIOCHEM PHARMACOL, V68, P1497, DOI 10.1016/j.bcp.2004.07.029; Miller PS, 2010, TRENDS PHARMACOL SCI, V31, P161, DOI 10.1016/j.tips.2009.12.005; ORTELLS MO, 1995, TRENDS NEUROSCI, V18, P121, DOI 10.1016/0166-2236(95)93887-4; Pless SA, 2008, CLIN EXP PHARMACOL P, V35, P1137, DOI 10.1111/j.1440-1681.2008.04954.x; Pless SA, 2007, J BIOL CHEM, V282, P36057, DOI 10.1074/jbc.M706468200; PRIBILLA I, 1992, EMBO J, V11, P4305, DOI 10.1002/j.1460-2075.1992.tb05529.x; Purohit P, 2007, NATURE, V446, P930, DOI 10.1038/nature05721; Rayes D, 2009, J NEUROSCI, V29, P6022, DOI 10.1523/JNEUROSCI.0627-09.2009; Shan Q, 2003, J NEUROCHEM, V86, P498, DOI 10.1046/j.1471-4159.2003.01872.x; Shan Q, 2001, J NEUROCHEM, V76, P1109, DOI 10.1046/j.1471-4159.2001.00124.x; Shan QA, 2010, J NEUROSCI METH, V193, P86, DOI 10.1016/j.jneumeth.2010.08.033; Thompson AJ, 2010, Q REV BIOPHYS, V43, P449, DOI 10.1017/S0033583510000168; Tsunoyama K, 1998, MOL BIOL EVOL, V15, P518, DOI 10.1093/oxfordjournals.molbev.a025951; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Vogel N, 2009, J BIOL CHEM, V284, P36128, DOI 10.1074/jbc.M109.043448; Wang QA, 2010, J BIOL CHEM, V285, P40373, DOI 10.1074/jbc.M110.161513; Yifrach O, 2002, CELL, V111, P231, DOI 10.1016/S0092-8674(02)01013-9	47	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2011	6	11							e28105	10.1371/journal.pone.0028105	http://dx.doi.org/10.1371/journal.pone.0028105			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858JH	22132222	Green Published, gold			2022-12-27	WOS:000297792400038
J	Loggia, ML; Jensen, K; Gollub, RL; Wasan, AD; Edwards, RR; Kong, J				Loggia, Marco L.; Jensen, Karin; Gollub, Randy L.; Wasan, Ajay D.; Edwards, Robert R.; Kong, Jian			The Catechol-O-Methyltransferase (COMT) val(158)met Polymorphism Affects Brain Responses to Repeated Painful Stimuli	PLOS ONE			English	Article							GENE POLYMORPHISMS; SENSITIVITY; PERCEPTION; MECHANISMS; DISSOCIATION; ASSOCIATION; EXPECTANCY; ACTIVATION; ANALGESIA; GENOTYPE	Despite the explosion of interest in the genetic underpinnings of individual differences in pain sensitivity, conflicting findings have emerged for most of the identified "pain genes". Perhaps the prime example of this inconsistency is represented by catechol-O-methyltransferase (COMT), as its substantial association to pain sensitivity has been reported in various studies, but rejected in several others. In line with findings from behavioral studies, we hypothesized that the effect of COMT on pain processing would become apparent only when the pain system was adequately challenged (i.e., after repeated pain stimulation). In the present study, we used functional Magnetic Resonance Imaging (fMRI) to investigate the brain response to heat pain stimuli in 54 subjects genotyped for the common COMT val158met polymorphism (val/val = n 22, val/met = n 20, met/met = n 12). Met/met subjects exhibited stronger pain-related fMRI signals than val/val in several brain structures, including the periaqueductal gray matter, lingual gyrus, cerebellum, hippocampal formation and precuneus. These effects were observed only for high intensity pain stimuli after repeated administration. In spite of our relatively small sample size, our results suggest that COMT appears to affect pain processing. Our data demonstrate that the effect of COMT on pain processing can be detected in presence of 1) a sufficiently robust challenge to the pain system to detect a genotype effect, and/or 2) the recruitment of pain-dampening compensatory mechanisms by the putatively more pain sensitive met homozygotes. These findings may help explain the inconsistencies in reported findings of the impact of COMT in pain regulation.	[Loggia, Marco L.; Wasan, Ajay D.; Edwards, Robert R.] Harvard Univ, Brigham & Womens Hosp, Dept Anesthesiol Perioperat & Pain Med, Sch Med, Boston, MA 02115 USA; [Loggia, Marco L.; Jensen, Karin; Gollub, Randy L.; Kong, Jian] Harvard Univ, Sch Med, Dept Psychiat, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Loggia, Marco L.; Jensen, Karin; Gollub, Randy L.; Kong, Jian] MGH MIT HMS Athinoula A Martinos Ctr Biomed Imagi, Boston, MA USA; [Wasan, Ajay D.; Edwards, Robert R.] Harvard Univ, Brigham & Womens Hosp, Dept Psychiat, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Loggia, ML (corresponding author), Harvard Univ, Brigham & Womens Hosp, Dept Anesthesiol Perioperat & Pain Med, Sch Med, Boston, MA 02115 USA.	marco@nmr.mgh.harvard.edu	Wasan, Ajay D./M-8084-2019	Wasan, Ajay D./0000-0002-6394-6077; Jensen, Karin/0000-0003-2521-3160; Gollub, Randy L./0000-0002-9434-4044	NIH (NCCAM) [PO1-AT002048]; National Center for Research Resources (NCRR) [M01-RR-01066, UL1 RR025758-01, P41RR14075]; MIND Research Network [DE-FG03-99ER62764]; Swedish Society for Medical Research;  [R01AT005280];  [R21AT00949];  [KO1AT003883];  [R21AT004497]; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [R01AT005280] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R21AT004497, K01AT003883, P01AT002048, R21AT000949] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758, M01RR001066, P41RR014075] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034982] Funding Source: NIH RePORTER	NIH (NCCAM)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); MIND Research Network; Swedish Society for Medical Research; ; ; ; ; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding and support for this study came from: R01AT005280 and R21AT00949 to Randy Gollub, KO1AT003883 and R21AT004497 to Jian Kong, NIH (NCCAM) PO1-AT002048 to Bruce Rosen, M01-RR-01066 and UL1 RR025758-01 for Clinical Research Center Biomedical Imaging Core from National Center for Research Resources (NCRR), P41RR14075 for Center for Functional Neuroimaging Technologies from NCRR and the MIND Research Network, DE-FG03-99ER62764 to Bruce Rosen. Karin Jensen is supported by the Swedish Society for Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen S, 2009, PHARMACOGENOMICS, V10, P669, DOI 10.2217/PGS.09.13; Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Birklein F, 2008, PAIN, V138, P111, DOI 10.1016/j.pain.2007.11.012; Campbell CM, 2009, PAIN, V141, P114, DOI 10.1016/j.pain.2008.10.023; CHEN JF, 1993, NEUROSCIENCE, V54, P669, DOI 10.1016/0306-4522(93)90238-B; Cohen H, 2009, CLIN EXP RHEUMATOL, V27, pS51; DAI F, 2010, SPINE J; Diatchenko L, 2005, HUM MOL GENET, V14, P135, DOI 10.1093/hmg/ddi013; Diatchenko L, 2006, PAIN, V125, P216, DOI 10.1016/j.pain.2006.05.024; Erdal ME, 2001, MOL BRAIN RES, V94, P193; Fields H, 2004, NAT REV NEUROSCI, V5, P565, DOI 10.1038/nrn1431; FIELDS HL, 2005, WALL MELZACKS TXB PA, P125; GEORGE SR, 1987, PEPTIDES, V8, P487, DOI 10.1016/0196-9781(87)90014-3; GRACELY RH, 1978, PAIN, V5, P5, DOI 10.1016/0304-3959(78)90020-9; Gursoy S, 2003, RHEUMATOL INT, V23, P104, DOI 10.1007/s00296-002-0260-5; Hagen K, 2006, BMC MUSCULOSKEL DIS, V7, DOI 10.1186/1471-2474-7-40; Heinz A, 2006, REV NEUROSCIENCE, V17, P359; Jakobi J, 2010, GENET TEST MOL BIOMA, V14, P293, DOI 10.1089/gtmb.2009.0142; Jensen KB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006016; Kim HS, 2004, PAIN, V109, P488, DOI 10.1016/j.pain.2004.02.027; Kim H, 2006, MOL PAIN, V2, DOI 10.1186/1744-8069-2-24; Kong J, 2006, J NEUROSCI, V26, P381, DOI 10.1523/JNEUROSCI.3556-05.2006; Kong J, 2006, HUM BRAIN MAPP, V27, P715, DOI 10.1002/hbm.20213; Kong J, 2010, BEHAV BRAIN RES, V211, P215, DOI 10.1016/j.bbr.2010.03.042; Kong J, 2010, PAIN, V148, P257, DOI 10.1016/j.pain.2009.11.008; Kong J, 2009, NEUROIMAGE, V47, P1066, DOI 10.1016/j.neuroimage.2009.05.087; Kong J, 2009, NEUROIMAGE, V45, P940, DOI 10.1016/j.neuroimage.2008.12.025; Kong J, 2008, J NEUROSCI, V28, P13354, DOI 10.1523/JNEUROSCI.2944-08.2008; Kunugi H, 1997, PSYCHIAT GENET, V7, P97, DOI 10.1097/00041444-199723000-00001; Lachman HM, 1996, PHARMACOGENETICS, V6, P243, DOI 10.1097/00008571-199606000-00007; LaCroix-Fralish ML, 2007, PAIN, V131, DOI 10.1016/j.pain.2007.04.041; LAHIRI DK, 1991, NUCLEIC ACIDS RES, V19, P5444, DOI 10.1093/nar/19.19.5444; Loggia ML, 2009, J NEUROSCI, V29, P2162, DOI 10.1523/JNEUROSCI.4633-08.2009; LOTTA T, 1995, BIOCHEMISTRY-US, V34, P4202, DOI 10.1021/bi00013a008; Mai JK., 2008, ATLAS HUMAN BRAIN, V3rd ed; Mannisto PT, 1999, PHARMACOL REV, V51, P593; Max MB, 2006, MOL PAIN, V2, DOI 10.1186/1744-8069-2-14; MCLEAN SA, 2010, J PAIN; Mobascher A, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-32; Naidich T.P., 2009, DUVERNOYS ATLAS HUMA; Nicholl BI, 2010, ANN RHEUM DIS, V69, P2009, DOI 10.1136/ard.2009.126086; Niddam DM, 2007, CLIN J PAIN, V23, P440, DOI 10.1097/AJP.0b013e318058accb; Nielsen CS, 2008, PAIN, V136, P21, DOI 10.1016/j.pain.2007.06.008; Norbury TA, 2007, BRAIN, V130, P3041, DOI 10.1093/brain/awm233; Potvin S, 2009, J PAIN, V10, P969, DOI 10.1016/j.jpain.2009.03.013; Ritter C, 2009, NEUROSCIENCE, V164, P141, DOI 10.1016/j.neuroscience.2009.05.039; Tegeder I, 2006, NAT MED, V12, P1269, DOI 10.1038/nm1490; UNTERWALD EM, 1994, NEUROREPORT, V5, P1613, DOI 10.1097/00001756-199408150-00018; Vossen H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013641; Zubieta JK, 2003, SCIENCE, V299, P1240, DOI 10.1126/science.1078546; Zyloney CE, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-80	51	44	48	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2011	6	11							e27764	10.1371/journal.pone.0027764	http://dx.doi.org/10.1371/journal.pone.0027764			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IO	22132136	Green Published, Green Submitted, gold			2022-12-27	WOS:000297789900019
J	de Brouwer, SJM; Kraaimaat, FW; Sweep, FCGJ; Donders, RT; Eijsbouts, A; van Koulil, S; van Riel, PLCM; Evers, AWM				de Brouwer, Sabine J. M.; Kraaimaat, Floris W.; Sweep, Fred C. G. J.; Donders, Rogier T.; Eijsbouts, Agnes; van Koulil, Saskia; van Riel, Piet L. C. M.; Evers, Andrea W. M.			Psychophysiological Responses to Stress after Stress Management Training in Patients with Rheumatoid Arthritis	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; PITUITARY-ADRENAL AXIS; PROGRESSIVE MUSCLE-RELAXATION; IMMUNE-SYSTEM RECONSTITUTION; COGNITIVE-BEHAVIOR THERAPY; SALIVARY ALPHA-AMYLASE; STAGE BREAST-CANCER; OF-THE-ART; PSYCHOLOGICAL INTERVENTIONS; CORTISOL RESPONSES	Background: Stress management interventions may prove useful in preventing the detrimental effects of stress on health. This study assessed the effects of a stress management intervention on the psychophysiological response to stress in patients with rheumatoid arthritis (RA). Methods: Seventy-four patients with RA, who were randomly assigned to either a control group or a group that received short-term stress management training, performed a standardized psychosocial stress task (Trier Social Stress Test; TSST) 1 week after the stress management training and at a 9-week follow-up. Psychological and physical functioning, and the acute psychophysiological response to the stress test were assessed. Results: Patients in the intervention group showed significantly lower psychological distress levels of anxiety after the training than did the controls. While there were no between-group differences in stress-induced tension levels, and autonomic (alpha-amylase) or endocrine (cortisol) responses to the stress test 1 week after the intervention, levels of stress-induced tension and cortisol were significantly lower in the intervention group at the 9-week follow-up. Overall, the response to the intervention was particularly evident in a subgroup of patients with a psychological risk profile. Conclusion: A relatively short stress management intervention can improve psychological functioning and influences the psychophysiological response to stress in patients with RA, particularly those psychologically at risk. These findings might help understand how stress can affect health and the role of individual differences in stress responsiveness.	[de Brouwer, Sabine J. M.; Kraaimaat, Floris W.; van Koulil, Saskia; Evers, Andrea W. M.] Radboud Univ Nijmegen, Dept Med Psychol, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Sweep, Fred C. G. J.] Radboud Univ Nijmegen, Dept Lab Med, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Donders, Rogier T.] Radboud Univ Nijmegen, Dept Epidemiol Biostat & HTA, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Eijsbouts, Agnes] Sint Maartenskliniek, Dept Rheumatol, Nijmegen, Netherlands; [van Riel, Piet L. C. M.] Radboud Univ Nijmegen, Dept Rheumatol, Med Ctr, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Sint Maartens Clinic; Radboud University Nijmegen	de Brouwer, SJM (corresponding author), Radboud Univ Nijmegen, Dept Med Psychol, Med Ctr, NL-6525 ED Nijmegen, Netherlands.	S.deBrouwer@mps.umcn.nl	Evers, Andrea/GWV-9705-2022; van Riel, P.L.C.M./H-8082-2014; Donders, A.R.T./L-4277-2015; Kraaimaat, F.W./L-4455-2015; Koulil, S. Spillekom-van/L-4662-2015; Evers, A.W.M./L-4299-2015; Sweep, C.G.J./H-8096-2014	Donders, A.R.T./0000-0002-0484-1419; Sweep, C.G.J./0000-0003-1103-3070	Dutch Arthritis Association	Dutch Arthritis Association	This study was supported by a grant from the Dutch Arthritis Association ("Reumafonds", http://www.reumafonds.nl/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADER R, 1995, LANCET, V345, P99, DOI 10.1016/S0140-6736(95)90066-7; [Anonymous], 1980, HANDLEIDING BIJ ZELF; Antoni MH, 2005, J PSYCHOSOM RES, V58, P3, DOI 10.1016/j.jpsychores.2004.05.010; Antoni MH, 2003, STRESS, V6, P173, DOI 10.1080/1025389031000156727; ANTONI MH, 1991, J CONSULT CLIN PSYCH, V59, P906, DOI 10.1037/0022-006X.59.6.906; Antoni MH, 2002, AM J PSYCHIAT, V159, P143, DOI 10.1176/appi.ajp.159.1.143; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Astin JA, 2002, ARTHRIT RHEUM-ARTHR, V47, P291, DOI 10.1002/art.10416; BENSON H, 1975, INT J PSYCHIAT MED, V6, P87, DOI 10.2190/376W-E4MT-QM6Q-H0UM; Conrad A, 2007, J ANXIETY DISORD, V21, P243, DOI 10.1016/j.janxdis.2006.08.001; Cruess DG, 2000, PSYCHOSOM MED, V62, P304, DOI 10.1097/00006842-200005000-00002; Cruess DG, 2000, J BEHAV MED, V23, P107, DOI 10.1023/A:1005419917023; Cruess S, 2000, PSYCHOSOM MED, V62, P828, DOI 10.1097/00006842-200011000-00013; Cutolo M, 2006, NEUROIMMUNOMODULAT, V13, P277, DOI 10.1159/000104855; de Brouwer SJM, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3016; Denson TF, 2009, PSYCHOL BULL, V135, P823, DOI 10.1037/a0016909; Dickerson SS, 2004, PSYCHOL BULL, V130, P355, DOI 10.1037/0033-2909.130.3.355; Dixon KE, 2007, HEALTH PSYCHOL, V26, P241, DOI 10.1037/0278-6133.26.3.241; Evers AWM, 2010, BRIT J DERMATOL, V163, P986, DOI 10.1111/j.1365-2133.2010.09984.x; Evers AWM, 1998, BRIT J RHEUMATOL, V37, P157; Evers AWM, 1997, J BEHAV MED, V20, P489, DOI 10.1023/A:1025555600896; Evers AWM, 2002, PAIN, V100, P141, DOI 10.1016/S0304-3959(02)00274-9; Evers AWM, 2002, J RHEUMATOL, V29, P2327; FRANKENHAEUSER M, 1980, BIOL PSYCHOL, V10, P79, DOI 10.1016/0301-0511(80)90029-0; Gaab J, 2003, PSYCHONEUROENDOCRINO, V28, P767, DOI 10.1016/S0306-4530(02)00069-0; Gerra G, 2001, PSYCHONEUROENDOCRINO, V26, P91, DOI 10.1016/S0306-4530(00)00046-9; Hammerfald K, 2006, PSYCHONEUROENDOCRINO, V31, P333, DOI 10.1016/j.psyneuen.2005.08.007; Hammond A, 2001, RHEUMATOLOGY, V40, P1044, DOI 10.1093/rheumatology/40.9.1044; Helmick CG, 2008, ARTHRITIS RHEUM-US, V58, P15, DOI 10.1002/art.23177; HOFFMAN JW, 1982, SCIENCE, V215, P190, DOI 10.1126/science.7031901; HUISKES CJA, 1990, J REHABIL SCI, V3, P65; Jessop DS, 2005, RHEUMATOLOGY, V44, P1097, DOI 10.1093/rheumatology/keh644; Keefe FJ, 2002, J CONSULT CLIN PSYCH, V70, P640, DOI 10.1037//0022-006X.70.3.640; Kirschbaum C, 1999, PSYCHOSOM MED, V61, P154, DOI 10.1097/00006842-199903000-00006; KIRSCHBAUM C, 1993, NEUROPSYCHOBIOLOGY, V28, P76, DOI 10.1159/000119004; KIRSCHBAUM C, 1995, PSYCHOSOM MED, V57, P468, DOI 10.1097/00006842-199509000-00009; Knittle K, 2010, ARTHRIT CARE RES, V62, P1460, DOI 10.1002/acr.20251; KRAAIMAAT FW, 1995, BEHAV RES THER, V33, P487, DOI 10.1016/0005-7967(94)00094-Z; Kudielka BM, 2004, PSYCHONEUROENDOCRINO, V29, P83, DOI 10.1016/S0306-4530(02)00146-4; Kudielka BM, 1998, J CLIN ENDOCR METAB, V83, P1756, DOI 10.1210/jc.83.5.1756; Lawrence RC, 1998, ARTHRITIS RHEUM-US, V41, P778, DOI 10.1002/1529-0131(199805)41:5<778::AID-ART4>3.0.CO;2-V; LEHRER PM, 1978, J CONSULT CLIN PSYCH, V46, P389, DOI 10.1037/0022-006X.46.3.389; LEHRER PM, 1972, BEHAV THER, V3, P193, DOI 10.1016/S0005-7894(72)80080-7; Leibing E, 1999, CLIN J PAIN, V15, P58, DOI 10.1097/00002508-199903000-00009; McGregor BA, 2004, J PSYCHOSOM RES, V56, P1, DOI 10.1016/S0022-3999(03)00036-9; MEENAN RF, 1980, ARTHRITIS RHEUM, V23, P146, DOI 10.1002/art.1780230203; Miller GE, 2001, HEALTH PSYCHOL, V20, P47, DOI 10.1037/0278-6133.20.1.47; Miller GE, 2007, PSYCHOL BULL, V133, P25, DOI 10.1037/0033-2909.133.1.25; Nater UM, 2009, PSYCHONEUROENDOCRINO, V34, P486, DOI 10.1016/j.psyneuen.2009.01.014; OST LG, 1988, BEHAV RES THER, V26, P13, DOI 10.1016/0005-7967(88)90029-0; OST LG, 1995, BEHAV RES THER, V33, P145, DOI 10.1016/0005-7967(94)E0026-F; PAUL GL, 1970, BEHAV THER, V1, P285, DOI 10.1016/S0005-7894(70)80108-3; Pawlow LA, 2005, APPL PSYCHOPHYS BIOF, V30, P375, DOI 10.1007/s10484-005-8423-2; Pawlow LA, 2002, BIOL PSYCHOL, V60, P1, DOI 10.1016/S0301-0511(02)00010-8; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Pruessner JC, 1997, PSYCHONEUROENDOCRINO, V22, P615, DOI 10.1016/S0306-4530(97)00072-3; Pruessner JC, 2003, PSYCHONEUROENDOCRINO, V28, P916, DOI 10.1016/S0306-4530(02)00108-7; Richards HL, 2005, BRIT J DERMATOL, V153, P1114, DOI 10.1111/j.1365-2133.2005.06817.x; Riemsma RP, 2002, BRIT MED J, V325, P558, DOI 10.1136/bmj.325.7364.558; Rohleder N, 2009, PSYCHONEUROENDOCRINO, V34, P469, DOI 10.1016/j.psyneuen.2008.12.004; Schommer NC, 2003, PSYCHOSOM MED, V65, P450, DOI 10.1097/01.PSY.0000035721.12441.17; Sharpe L, 2001, PAIN, V89, P275, DOI 10.1016/S0304-3959(00)00379-1; SHEARN MA, 1985, AM J MED, V78, P771, DOI 10.1016/0002-9343(85)90282-7; Smyth JM, 1999, JAMA-J AM MED ASSOC, V281, P1304, DOI 10.1001/jama.281.14.1304; SORBI M, 1989, HEADACHE, V29, P111, DOI 10.1111/j.1526-4610.1989.hed2902111.x; Sorbi M, 2000, GREEP HOOFDPIJN; Spielberger C.D., 1983, MANUAL STATE TRAIT A; Straub RH, 2005, ARTHRITIS RHEUM-US, V52, P16, DOI 10.1002/art.20747; Thieme K, 2005, ARTHRIT RHEUM-ARTHR, V53, P343, DOI 10.1002/art.21158; Turk DC, 2005, CLIN J PAIN, V21, P44, DOI 10.1097/00002508-200501000-00006; van Koulil S, 2007, ANN RHEUM DIS, V66, P571, DOI 10.1136/ard.2006.054692; van Middendorp H, 2009, PSYCHOTHER PSYCHOSOM, V78, P145, DOI 10.1159/000206868; van Vollenhoven RF, 2009, NAT REV RHEUMATOL, V5, P531, DOI 10.1038/nrrheum.2009.182; Walker JG, 1999, RHEUMATOLOGY, V38, P1050, DOI 10.1093/rheumatology/38.11.1050; Watanabe E, 2006, ALTERN THER HEALTH M, V12, P60; Zautra AJ, 1998, ARTHRIT CARE RES, V11, P271, DOI 10.1002/art.1790110408; Zautra AJ, 2004, J RHEUMATOL, V31, P457	77	23	23	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2011	6	12							e27432	10.1371/journal.pone.0027432	http://dx.doi.org/10.1371/journal.pone.0027432			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	863OC	22162990	Green Published, gold, Green Submitted			2022-12-27	WOS:000298173500004
J	Djadid, ND; Jazayeri, H; Raz, A; Favia, G; Ricci, I; Zakeri, S				Djadid, Navid Dinparast; Jazayeri, Hoda; Raz, Abbasali; Favia, Guido; Ricci, Ignacio; Zakeri, Sedigheh			Identification of the Midgut Microbiota of An. stephensi and An. maculipennis for Their Application as a Paratransgenic Tool against Malaria	PLOS ONE			English	Article							ANOPHELES-STEPHENSI; SPOROGONIC DEVELOPMENT; CULEX-QUINQUEFASCIATUS; SYMBIOTIC BACTERIA; MOSQUITO MIDGUT; GAMBIAE; CULICIDAE; DIPTERA; VECTOR	The midgut microbiota associated with Anopheles stephensi and Anopheles maculipennis (Diptera: Culicidae) was investigated for development of a paratransgenesis-based approach to control malaria transmission in Eastern Mediterranean Region (EMR). Here, we present the results of a polymerase chain reaction (PCR) and biochemical-based approaches to identify the female adult and larvae mosquitoe microbiota of these two major malaria vectors, originated from South Eastern and North of Iran. Plating the mosquito midgut contents from lab-reared and field-collected Anopheles spp. was used for microbiota isolation. The Gram-negative and Gram-positive bacterial colonies were identified by Gram staining and specific mediums. Selected colonies were identified by differential biochemical tests and 16S rRNA gene sequence analysis. A number of 10 An. stephensi and 32 An. maculipennis adult mosquitoes and 15 An. stephensi and 7 An. maculipennis larvae were analyzed and 13 sequences of 16S rRNA gene bacterial species were retrieved, that were categorized in 3 classes and 8 families. The majority of the identified bacteria were belonged to the gamma-proteobacteria class, including Pseudomonas sp. and Aeromonas sp. and the others were some closely related to those found in other vector mosquitoes, including Pantoea, Acinetobacter, Brevundimonas, Bacillus, Sphingomonas, Lysinibacillus and Rahnella. The 16S rRNA sequences in the current study aligned with the reference strains available in GenBank were used for construction of the phylogenetic tree that revealed the relatedness among the bacteria identified. The presented data strongly encourage further investigations, to verify the potential role of the detected bacteria for the malaria control in Iran and neighboring countries.	[Djadid, Navid Dinparast; Jazayeri, Hoda; Raz, Abbasali; Zakeri, Sedigheh] Pasteur Inst Iran, Biotechnol Res Ctr BRC, Malaria & Vector Res Grp MVRG, Tehran, Iran; [Favia, Guido; Ricci, Ignacio] Univ Camerino, Sch Biosci & Biotechnol, I-62032 Camerino, Italy	Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran; University of Camerino	Djadid, ND (corresponding author), Pasteur Inst Iran, Biotechnol Res Ctr BRC, Malaria & Vector Res Grp MVRG, Tehran, Iran.	navidmvrg@gmail.com	Jazayeri, Seyede Hoda/AAO-3652-2021; Djadid, Navid D/L-2910-2017; Raz, Abbasali/L-1319-2017; Zakeri, Sedigheh/L-1274-2017	Jazayeri, Seyede Hoda/0000-0002-9620-7684; Djadid, Navid D/0000-0002-2277-4504; Raz, Abbasali/0000-0002-7937-8350; Zakeri, Sedigheh/0000-0003-0933-0981; Favia, Guido/0000-0002-4420-8482	MOH, Iran; Pasteur Institute of Iran	MOH, Iran; Pasteur Institute of Iran	This work has been jointly funded by Deputy for Research, MOH, I.R. Iran and Pasteur Institute of Iran in the frame of "International Research Cooperation and Grant Scheme" dme.behdasht.gov.ir; www.pasteur.ac.ir. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben Beard C, 2002, ANNU REV ENTOMOL, V47, P123, DOI 10.1146/annurev.ento.47.091201.145144; Chao J., 1960, Journal of Insect Pathology, V2, P220; CHAO JOWETT, 1959, JOUR INSECT PATHOL, V1, P311; Cirimotich CM, 2011, SCIENCE, V332, P855, DOI 10.1126/science.1201618; Damiani C, 2010, MICROB ECOL, V60, P644, DOI 10.1007/s00248-010-9704-8; Damiani C, 2008, CURR BIOL, V18, pR1087, DOI 10.1016/j.cub.2008.10.040; DeMaio J, 1996, AM J TROP MED HYG, V54, P219, DOI 10.4269/ajtmh.1996.54.219; Durvasula RV, 1997, P NATL ACAD SCI USA, V94, P3274, DOI 10.1073/pnas.94.7.3274; Favia G, 2007, P NATL ACAD SCI USA, V104, P9047, DOI 10.1073/pnas.0610451104; FERGUSON MJ, 1961, J INSECT PATHOL, V3, P112; Fouda M. A., 2001, Journal of the Egyptian Society of Parasitology, V31, P767; Gonzalez-Ceron L, 2003, J MED ENTOMOL, V40, P371, DOI 10.1603/0022-2585-40.3.371; JADIN J, 1966, Bulletin de la Societe de Pathologie Exotique, V59, P514; Lindh JM, 2005, APPL ENVIRON MICROB, V71, P7217, DOI 10.1128/AEM.71.11.7217-7223.2005; Manson P., 1897, British Medical Journal, Vii, P1786; Pidiyar V, 2002, INT J SYST EVOL MICR, V52, P1723, DOI [10.1099/ijs.0.02019-0, 10.1099/00207713-52-5-1723]; Pidiyar VJ, 2004, AM J TROP MED HYG, V70, P597, DOI 10.4269/ajtmh.2004.70.597; Pumpuni CB, 1996, AM J TROP MED HYG, V54, P214, DOI 10.4269/ajtmh.1996.54.214; PUMPUNI CB, 1993, EXP PARASITOL, V77, P195, DOI 10.1006/expr.1993.1076; Ramirez JL, 2009, CURR MOL MED, V9, P116, DOI 10.2174/156652409787581600; Rani A, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-96; Riehle MA, 2007, INT J PARASITOL, V37, P595, DOI 10.1016/j.ijpara.2006.12.002; Ross R, 1897, Br Med J, V1, P251; SEITZ HM, 1987, ZBL BAKT-INT J MED M, V266, P155; SHAHGUDIAN E R, 1960, Acta Med Iran, V3, P38; Straif SC, 1998, J MED ENTOMOL, V35, P222, DOI 10.1093/jmedent/35.3.222; Terenius O, 2008, J MED ENTOMOL, V45, P172, DOI 10.1603/0022-2585(2008)45[172:SRGSFB]2.0.CO;2; Vasanthi V., 1992, Southeast Asian Journal of Tropical Medicine and Public Health, V23, P312; Yoshida S, 2001, MOL BIOCHEM PARASIT, V113, P89, DOI 10.1016/S0166-6851(00)00387-X	29	79	80	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2011	6	12							e28484	10.1371/journal.pone.0028484	http://dx.doi.org/10.1371/journal.pone.0028484			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863OC	22163022	Green Published, gold, Green Submitted			2022-12-27	WOS:000298173500025
J	Wang, X; Li, GX; Ren, YD; Ren, XF				Wang, Xin; Li, Guangxing; Ren, Yudong; Ren, Xiaofeng			Phages Bearing Affinity Peptides to Bovine Rotavirus Differentiate the Virus from Other Viruses	PLOS ONE			English	Article							A ROTAVIRUS; DIARRHEA; VACCINE	The aim of this study was to identify potential ligands and develop a novel diagnostic test to pathogenic bovine rotavirus (BRV) using phage display technology. The viruses were used as an immobilized target followed by incubation with a 12-mer phage display random peptide library. After five rounds of biopanning, phages had a specific binding activity to BRV were isolated. DNA sequencing indicated that phage displayed peptides HVHPPLRPHSDK, HATNHLPTPHNR or YPTHHAHTTPVR were potential ligands to BRV. Using the specific peptide-expressing phages, we developed a phage-based ELISA to differentiate BRV from other viruses. Compared with quantitative real-time PCR (qPCR), the phage-mediated ELISA was more suitable for the capture of BRV and the detection limitation of this approach was 0.1 mu g/ml of samples. The high sensitivity, specificity and low cross-reactivity for the phage-based ELISA were confirmed in receiver operating characteristics (ROC) analysis.	[Wang, Xin; Li, Guangxing; Ren, Xiaofeng] NE Agr Univ, Coll Vet Med, Dept Vet Prevent Med, Harbin, Peoples R China; [Ren, Yudong] NE Agr Univ, Coll Engn, Dept Comp, Harbin, Peoples R China	Northeast Agricultural University - China; Northeast Agricultural University - China	Wang, X (corresponding author), NE Agr Univ, Coll Vet Med, Dept Vet Prevent Med, Harbin, Peoples R China.	rxfemail@yahoo.com.cn	wang, xin/HGT-7291-2022	wang, xin/0000-0002-2968-3082	Natural Science Foundation of China [30972195, 31172295]; Heilongjiang Provincial University [1155-NCET-005, 2011TD001]; University of Ministry of Education of People's Republic of China [NCET-10-0144]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Heilongjiang Provincial University; University of Ministry of Education of People's Republic of China	The authors acknowledge National Natural Science Foundation of China (30972195; 31172295), funding supported by Program for New Century Excellent Talents in Heilongjiang Provincial University (1155-NCET-005), Research Team Program on Scientific and Technological Innovation in Heilongjiang Provincial University (2011TD001) and Program for New Century Excellent Talents in University of Ministry of Education of People's Republic of China (NCET-10-0144). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATHANASSIOUS R, 1994, CAN VET J, V35, P163; Estes MK, 2001, FIELDS VIROLOGY, V2, P1917; Ha TPM, 2009, J CLIN MICROBIOL, V47, P3329, DOI 10.1128/JCM.01583-08; Hayden MS, 1997, CURR OPIN IMMUNOL, V9, P201, DOI 10.1016/S0952-7915(97)80136-7; Kang SK, 2008, J BIOTECHNOL, V135, P210, DOI 10.1016/j.jbiotec.2008.01.021; Kay BK, 1998, DRUG DISCOV TODAY, V3, P370, DOI 10.1016/S1359-6446(98)01220-3; Knipe DM, 2001, FIELDS VIROLOGY, V2, P1747; Kwon HJ, 2010, BIOORGAN MED CHEM, V18, P7668, DOI 10.1016/j.bmc.2010.07.073; Latzka J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019383; Lee S, 2010, CLIN VACCINE IMMUNOL, V17, P1647, DOI 10.1128/CVI.00135-10; Lesinski GB, 2001, J MICROBIOL METH, V47, P135, DOI 10.1016/S0167-7012(01)00290-1; Li X, 2010, CHINES J PREVENTIVE, V9, P664; Liu XJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019848; MADKOUR AA, 1993, J PEDIATR GASTR NUTR, V17, P176, DOI 10.1097/00005176-199308000-00008; Maes RK, 2003, J CLIN MICROBIOL, V41, P290, DOI 10.1128/JCM.41.1.290-294.2003; Ren XF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018669; Ren XF, 2011, VIROLOGY, V410, P299, DOI 10.1016/j.virol.2010.11.014; Ren XF, 2010, J CLIN MICROBIOL, V48, P1875, DOI 10.1128/JCM.01707-09; SCOTT JK, 1990, SCIENCE, V249, P386, DOI 10.1126/science.1696028; World Health Organization, 2008, WHOIVB0816; Wu D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023058	21	8	10	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2011	6	12							e28667	10.1371/journal.pone.0028667	http://dx.doi.org/10.1371/journal.pone.0028667			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863OC	22163050	Green Published, gold, Green Submitted			2022-12-27	WOS:000298173500045
J	Yimer, G; Ueda, N; Habtewold, A; Amogne, W; Suda, A; Riedel, KD; Burhenne, J; Aderaye, G; Lindquist, L; Makonnen, E; Aklillu, E				Yimer, Getnet; Ueda, Nobuhisa; Habtewold, Abiy; Amogne, Wondwossen; Suda, Akira; Riedel, Klaus-Dieter; Burhenne, Juergen; Aderaye, Getachew; Lindquist, Lars; Makonnen, Eyasu; Aklillu, Eleni			Pharmacogenetic & Pharmacokinetic Biomarker for Efavirenz Based ARV and Rifampicin Based Anti-TB Drug Induced Liver Injury in TB-HIV Infected Patients	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; INDUCED HEPATOTOXICITY; N-ACETYLTRANSFERASE-2 GENE; ANTITUBERCULOSIS THERAPY; RAPID ACETYLATORS; TUBERCULOSIS; POLYMORPHISM; CYP2B6; NAT2; INDIVIDUALS	Background: Implication of pharmacogenetic variations and efavirenz pharmacokinetics in concomitant efavirenz based antiviral therapy and anti-tubercular drug induced liver injury (DILI) has not been yet studied. We performed a prospective case-control association study to identify the incidence, pharmacogenetic, pharmacokinetic and biochemical predictors for anti-tubercular and antiretroviral drugs induced liver injury (DILI) in HIV and tuberculosis (TB) co-infected patients. Methods and Findings: Newly diagnosed treatment naive TB-HIV co-infected patients (n = 353) were enrolled to receive efavirenz based ART and rifampicin based anti-TB therapy, and assessed clinically and biochemically for DILI up to 56 weeks. Quantification of plasma efavirenz and 8-hydroxyefaviernz levels and genotyping for NAT2, CYP2B6, CYP3A5, ABCB1, UGT2B7 and SLCO1B1 genes were done. The incidence of DILI and identification of predictors was evaluated using survival analysis and the Cox Proportional Hazards Model. The incidence of DILI was 30.0%, or 14.5 per 1000 person-week, and that of severe was 18.4%, or 7.49 per 1000 person-week. A statistically significant association of DILI with being of the female sex (p = 0.001), higher plasma efavirenz level (p = 0.009), efavirenz/8-hydroxyefavirenz ratio (p = 0.036), baseline AST (p = 0.022), ALT (p = 0.014), lower hemoglobin (p = 0.008), and serum albumin (p = 0.007), NAT2 slow-acetylator genotype (p = 0.039) and ABCB1 3435TT genotype (p = 0.001). Conclusion: We report high incidence of anti-tubercular and antiretroviral DILI in Ethiopian patients. Between patient variability in systemic efavirenz exposure and pharmacogenetic variations in NAT2, CYP2B6 and ABCB1 genes determines susceptibility to DILI in TB-HIV co-infected patients. Close monitoring of plasma efavirenz level and liver enzymes during early therapy and/or genotyping practice in HIV clinics is recommended for early identification of patients at risk of DILI.	[Yimer, Getnet; Ueda, Nobuhisa; Habtewold, Abiy; Suda, Akira; Aklillu, Eleni] Karolinska Inst, Div Clin Pharmacol, Dept Lab Med, Stockholm, Sweden; [Yimer, Getnet; Habtewold, Abiy; Makonnen, Eyasu] Univ Addis Ababa, Dept Pharmacol, Fac Med, Addis Ababa, Ethiopia; [Amogne, Wondwossen; Aderaye, Getachew] Univ Addis Ababa, Dept Internal Med, Fac Med, Addis Ababa, Ethiopia; [Amogne, Wondwossen; Lindquist, Lars] Karolinska Inst, Div Infect Dis, Dept Med, Stockholm, Sweden; [Riedel, Klaus-Dieter; Burhenne, Juergen] Heidelberg Univ, Dept Clin Pharmacol & Pharmacoepidemiol, Heidelberg, Germany	Karolinska Institutet; Addis Ababa University; Addis Ababa University; Karolinska Institutet; Ruprecht Karls University Heidelberg	Yimer, G (corresponding author), Karolinska Inst, Div Clin Pharmacol, Dept Lab Med, Stockholm, Sweden.	Eleni.Aklillu@ki.se	Degu, Wondwossen Amogne/GON-3590-2022; Aklillu, Eleni/ABG-3461-2021; Burhenne, Jürgen/AAU-2769-2021; Yimer, Getnet/A-9436-2015	Burhenne, Jürgen/0000-0002-2190-1698; Makonnen, Eyasu/0000-0002-9259-5288; Yimer, Getnet/0000-0002-1469-837X; Aklillu, Eleni/0000-0002-9788-0790	EDCTP (European & Developing Countries Clinical Trials Partnership) [CG_TA.05.40204_005, CT.2005.32030.001]; SIDA/SAREC [HIV-2006-031, SWE 2007-270]	EDCTP (European & Developing Countries Clinical Trials Partnership); SIDA/SAREC	This study was supported by grants from EDCTP (European & Developing Countries Clinical Trials Partnership), CG_TA.05.40204_005, CT.2005.32030.001 and SIDA/SAREC HIV-2006-031, SWE 2007-270. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anitha A, 2003, INT J MOL MED, V11, P125; Apostolova N, 2010, BRIT J PHARMACOL, V160, P2069, DOI 10.1111/j.1476-5381.2010.00866.x; Apostolova N, 2011, HEPATOLOGY, V54, P1009, DOI 10.1002/hep.24459; Bae SK, 2011, XENOBIOTICA, V41, P437, DOI 10.3109/00498254.2011.551849; BENICHOU C, 1990, J HEPATOL, V11, P272; Cain KP, 2009, EMERG INFECT DIS, V15, P258, DOI 10.3201/eid1502.080942; Coffie PA, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-188; Cohen K, 2010, CURR OPIN HIV AIDS, V5, P61, DOI 10.1097/COH.0b013e3283339309; Cohen K, 2009, ANTIVIR THER, V14, P687; Daly AK, 2010, PHARMACOGENOMICS, V11, P607, DOI [10.2217/pgs.10.24, 10.2217/PGS.10.24]; Dean GL, 2002, AIDS, V16, P75, DOI 10.1097/00002030-200201040-00010; Desta Z, 2001, ANTIMICROB AGENTS CH, V45, P382, DOI 10.1128/AAC.45.2.382-392.2001; di Iulio J, 2009, PHARMACOGENET GENOM, V19, P300, DOI 10.1097/FPC.0b013e328328d577; Diaz-Molina R, 2008, MOL MED REP, V1, P875, DOI 10.3892/mmr_00000044; Djordjevic N, 2011, J CLIN PHARMACOL, V51, P994, DOI 10.1177/0091270010377630; Donald PR, 2007, EUR J CLIN PHARMACOL, V63, P633, DOI 10.1007/s00228-007-0305-5; Elens L, 2010, PHARMACOGENOMICS, V11, P1223, DOI 10.2217/PGS.10.94; Faucette SR, 2004, DRUG METAB DISPOS, V32, P348, DOI 10.1124/dmd.32.3.348; Faucette SR, 2007, J PHARMACOL EXP THER, V320, P72, DOI 10.1124/jpet.106.112136; Haas DW, 2009, JAIDS-J ACQ IMM DEF, V50, P290, DOI 10.1097/QAI.0b013e318189a7df; Haas DW, 2005, J INFECT DIS, V192, P1931, DOI 10.1086/497610; Habtewold A, 2011, J ANTIMICROB CHEMOTH, V66, P2350, DOI 10.1093/jac/dkr304; Higuchi N, 2007, WORLD J GASTROENTERO, V13, P6003, DOI 10.3748/wjg.13.6003; Hoffmann CJ, 2007, AIDS, V21, P1301, DOI 10.1097/QAD.0b013e32814e6b08; Huang YS, 2002, HEPATOLOGY, V35, P883, DOI 10.1053/jhep.2002.32102; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Kontorinis N, 2003, SEMIN LIVER DIS, V23, P173; Kwara A, 2005, INT J TUBERC LUNG D, V9, P248; McIlleron H, 2007, J INFECT DIS, V196, pS63, DOI 10.1086/518655; MITCHELL JR, 1976, ANN INTERN MED, V84, P181, DOI 10.7326/0003-4819-84-2-181; MITCHELL JR, 1975, CLIN PHARMACOL THER, V18, P70; Mukonzo JK, 2009, BRIT J CLIN PHARMACO, V68, P690, DOI 10.1111/j.1365-2125.2009.03516.x; Mutlib AE, 1999, DRUG METAB DISPOS, V27, P1319; Ngaimisi E, 2010, CLIN PHARMACOL THER, V88, P676, DOI 10.1038/clpt.2010.172; Niemi M, 2006, PHARMACOGENET GENOM, V16, P565, DOI 10.1097/01.fpc.0000215070.52212.0e; Nunez M, 2010, HEPATOLOGY, V52, P1143, DOI 10.1002/hep.23716; Ohno M, 2000, INT J TUBERC LUNG D, V4, P256; Possuelo LG, 2008, EUR J CLIN PHARMACOL, V64, P673, DOI 10.1007/s00228-008-0484-8; Ramachandran G, 2009, ANTIMICROB AGENTS CH, V53, P863, DOI 10.1128/AAC.00899-08; Reisler RB, 2003, JAIDS-J ACQ IMM DEF, V34, P379, DOI 10.1097/00126334-200312010-00004; Ren Y, 2009, JAIDS-J ACQ IMM DEF, V50, P439, DOI 10.1097/QAI.0b013e31819c33a3; Rodriguez-Rosado R, 1998, AIDS, V12, P1256, DOI 10.1097/00002030-199810000-00025; Russmann S, 2010, HEPATOLOGY, V52, P748, DOI 10.1002/hep.23720; Saitoh A, 2007, JAIDS-J ACQ IMM DEF, V45, P280; Saukkonen JJ, 2006, AM J RESP CRIT CARE, V174, P935, DOI 10.1164/rccm.200510-1666ST; Shipton LK, 2009, INT J TUBERC LUNG D, V13, P360; Stohr W, 2008, ANTIVIR THER, V13, P675; Tostmann A, 2008, J GASTROEN HEPATOL, V23, P192, DOI 10.1111/j.1440-1746.2007.05207.x; *UNAIDS, 2008, 2008 REP GLOB AIDS E; Vavricka SR, 2002, HEPATOLOGY, V36, P164, DOI 10.1053/jhep.2002.34133; Vidal F, 2010, AIDS REV, V12, P15; Vuilleumier Nicolas, 2006, Eur J Clin Pharmacol, V62, P423; Walker UA, 2007, CURR OPIN HIV AIDS, V2, P293, DOI 10.1097/COH.0b013e328122dbaa; Ward BA, 2003, J PHARMACOL EXP THER, V306, P287, DOI 10.1124/jpet.103.049601; Wares DF, 2003, INT J TUBERC LUNG D, V7, P327; Wen X, 2002, EUR J CLIN PHARMACOL, V57, P799, DOI 10.1007/s00228-001-0396-3; Yamada S, 2009, PHARMACOGENOMICS, V10, P1433, DOI [10.2217/pgs.09.66, 10.2217/PGS.09.66]; YAMAMOTO T, 1986, HEPATOLOGY, V6, P295, DOI 10.1002/hep.1840060223; Yimer G, 2012, PHARMACOGENOMICS J, V12, P499, DOI 10.1038/tpj.2011.34; Yimer G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001809	60	76	83	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2011	6	12							e27810	10.1371/journal.pone.0027810	http://dx.doi.org/10.1371/journal.pone.0027810			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863OC	22162992	gold, Green Published, Green Submitted			2022-12-27	WOS:000298173500006
J	Hench, J; Hench, IB; Pujol, C; Ipsen, S; Brodesser, S; Mourier, A; Tolnay, M; Frank, S; Trifunovic, A				Hench, Juergen; Hench, Ivana Bratic; Pujol, Claire; Ipsen, Sabine; Brodesser, Susanne; Mourier, Arnaud; Tolnay, Markus; Frank, Stephan; Trifunovic, Aleksandra			A Tissue-Specific Approach to the Analysis of Metabolic Changes in Caenorhabditis elegans	PLOS ONE			English	Article							C-ELEGANS; ENERGY-METABOLISM; OXIDATIVE STRESS; GENETICS; DEFICIENCY; PROTEINS; SCREEN; DEFECT; MODEL	The majority of metabolic principles are evolutionarily conserved from nematodes to humans. Caenorhabditis elegans has widely accelerated the discovery of new genes important to maintain organismic metabolic homeostasis. Various methods exist to assess the metabolic state in worms, yet they often require large animal numbers and tend to be performed as bulk analyses of whole worm homogenates, thereby largely precluding a detailed studies of metabolic changes in specific worm tissues. Here, we have adapted well-established histochemical methods for the use on C. elegans fresh frozen sections and demonstrate their validity for analyses of morphological and metabolic changes on tissue level in wild type and various mutant strains. We show how the worm presents on hematoxylin and eosin (H&E) stained sections and demonstrate their usefulness in monitoring and the identification of morphological abnormalities. In addition, we demonstrate how Oil-Red-O staining on frozen worm cross-sections permits quantification of lipid storage, avoiding the artifact-prone fixation and permeabilization procedures of traditional whole-mount protocols. We also adjusted standard enzymatic stains for respiratory chain subunits (NADH, SDH, and COX) to monitor metabolic states of various C. elegans tissues. In summary, the protocols presented here provide technical guidance to obtain robust, reproducible and quantifiable tissue-specific data on worm morphology as well as carbohydrate, lipid and mitochondrial energy metabolism that cannot be obtained through traditional biochemical bulk analyses of worm homogenates. Furthermore, analysis of worm cross-sections overcomes the common problem with quantification in three-dimensional whole-mount specimens.	[Hench, Juergen; Ipsen, Sabine; Tolnay, Markus; Frank, Stephan] Univ Basel Hosp, Dept Neuropathol, Inst Pathol, CH-4031 Basel, Switzerland; [Hench, Ivana Bratic; Trifunovic, Aleksandra] Karolinska Inst, Dept Lab Med, Div Metab Dis, Stockholm, Sweden; [Hench, Ivana Bratic; Pujol, Claire; Trifunovic, Aleksandra] Univ Cologne, Inst Genet, Cologne Excellence Cluster Cellular Stress Respon, Cologne, Germany; [Brodesser, Susanne] CECAD, Lipid Core Facil, Cologne, Germany; [Brodesser, Susanne] Inst Med Microbiol Immunol & Hyg, Cologne, Germany; [Mourier, Arnaud] Max Planck Inst Biol Ageing, Cologne, Germany	University of Basel; Karolinska Institutet; University of Cologne; University of Cologne; University of Cologne; Max Planck Society	Hench, J (corresponding author), Univ Basel Hosp, Dept Neuropathol, Inst Pathol, CH-4031 Basel, Switzerland.	jurgen.hench@gmail.com	MOURIER, Arnaud/I-8117-2012; MOURIER, Arnaud/F-9657-2019	MOURIER, Arnaud/0000-0002-5413-611X; MOURIER, Arnaud/0000-0002-5413-611X	Swedish Research Council [K2006-03P-20237-01-4]; CECAD (Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases) Cologne; Jeanssons Foundation; Ake Wiberg Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); CECAD (Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases) Cologne; Jeanssons Foundation; Ake Wiberg Foundation	This study was supported by grants from Swedish Research Council (K2006-03P-20237-01-4), CECAD (Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases) Cologne, Jeanssons Foundation (http://www.jeanssonsstiftelser.se/stipendiater.html), Ake Wiberg Foundation (http://www.ake-wiberg.com/) to AT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; Bancroft JD, 2002, J NEUROPATH EXP NEUR, V5th; Barrientos A, 2002, METHODS, V26, P307, DOI 10.1016/S1046-2023(02)00036-1; Bianchi L, CULTURE EMBRYONIC C; Braeckman BP, 2002, MECH AGEING DEV, V123, P1447, DOI 10.1016/S0047-6374(02)00085-4; Braeckman BP, 2002, MECH AGEING DEV, V123, P105, DOI 10.1016/S0047-6374(01)00331-1; Bratic I, 2010, METHODS, V51, P437, DOI 10.1016/j.ymeth.2010.03.003; Bratic I, 2009, NUCLEIC ACIDS RES, V37, P1817, DOI 10.1093/nar/gkp018; BRENNER S, 1974, GENETICS, V77, P71; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Cheng JX, 2002, BIOPHYS J, V83, P502, DOI 10.1016/S0006-3495(02)75186-2; Duerr JS, IMMUNOHISTOCHEMISTRY; Gellerich FN, 2004, MITOCHONDRION, V4, P427, DOI 10.1016/j.mito.2004.07.007; Grad LI, 2004, HUM MOL GENET, V13, P303, DOI 10.1093/hmg/ddh027; Haun C, 1998, P NATL ACAD SCI USA, V95, P5072, DOI 10.1073/pnas.95.9.5072; Hellerer T, 2007, P NATL ACAD SCI USA, V104, P14658, DOI 10.1073/pnas.0703594104; Ichishita R, 2008, J BIOCHEM, V143, P449, DOI 10.1093/jb/mvm245; Ishii N, 1998, NATURE, V394, P694, DOI 10.1038/29331; Jung CW, 2002, J NEUROSCI METH, V114, P165, DOI 10.1016/S0165-0270(01)00524-6; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; KIMBLE J, 1983, DEV BIOL, V96, P189, DOI 10.1016/0012-1606(83)90322-6; Kruse SE, 2008, CELL METAB, V7, P312, DOI 10.1016/j.cmet.2008.02.004; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; McGhee J. D, C ELEGANS INTESTINE; Mullaney BC, 2009, BBA-MOL CELL BIOL L, V1791, P474, DOI 10.1016/j.bbalip.2008.12.013; Narbonne P, 2009, NATURE, V457, P210, DOI 10.1038/nature07536; O'Rourke EJ, 2009, CELL METAB, V10, P430, DOI 10.1016/j.cmet.2009.10.002; Paepe BD, 2009, CURRENT PROTOCOLS HU; Pearse AG, 1972, HISTOCHEMISTRY THEOR, V3; Perez CL, 2008, CELL METAB, V8, P266, DOI 10.1016/j.cmet.2008.08.007; Pulak Rock, 2006, V351, P275; Rasband W, IMAGEJ; Ristow M, 2000, P NATL ACAD SCI USA, V97, P12239, DOI 10.1073/pnas.220403797; Senoo-Matsuda N, 2003, J BIOL CHEM, V278, P22031, DOI 10.1074/jbc.M211377200; Senoo-Matsuda N, 2001, J BIOL CHEM, V276, P41553, DOI 10.1074/jbc.M104718200; Sheehan D.C., 1987, THEORY PRACTICE HIST; Signorelli P, 2002, METHOD ENZYMOL, V345, P275; Soukas AA, 2009, GENE DEV, V23, P496, DOI 10.1101/gad.1775409; Stiernagle T, MAINTENANCE C ELEGAN; Suthammarak W, 2010, J BIOL CHEM, V285, P40724, DOI 10.1074/jbc.M110.159608; Van Voorhies WA, 2002, FREE RADICAL BIO MED, V33, P587; Wang MC, 2011, NAT METHODS, V8, P135, DOI 10.1038/NMETH.1556; Watts JL, 2009, TRENDS ENDOCRIN MET, V20, P58, DOI 10.1016/j.tem.2008.11.002; WormBase Gene Summary for lpd-3, WORMBASE GEN SUMM LP; Xie GF, 1995, GENET ANAL-BIOMOL E, V12, P95, DOI 10.1016/1050-3862(95)00112-3; YAO JK, 1985, ANAL BIOCHEM, V150, P111, DOI 10.1016/0003-2697(85)90447-6; Yen K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012810	48	10	11	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e28417	10.1371/journal.pone.0028417	http://dx.doi.org/10.1371/journal.pone.0028417			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22162770	Green Submitted, Green Published, gold			2022-12-27	WOS:000298172800036
J	Osundiji, MA; Godes, ML; Evans, ML; Danial, NN				Osundiji, Mayowa A.; Godes, Marina L.; Evans, Mark L.; Danial, Nika N.			BAD Modulates Counterregulatory Responses to Hypoglycemia and Protective Glucoprivic Feeding	PLOS ONE			English	Article							SENSITIVE K+ CHANNELS; VENTROMEDIAL HYPOTHALAMUS CONTRIBUTES; ALPHA-CELL FUNCTION; GLUCAGON-SECRETION; BLOOD-GLUCOSE; FOOD-INTAKE; RAT-BRAIN; ANTECEDENT HYPOGLYCEMIA; ENERGY HOMEOSTASIS; HORMONE RESPONSES	Hypoglycemia or glucoprivation triggers protective hormonal counterregulatory and feeding responses to aid the restoration of normoglycemia. Increasing evidence suggests pertinent roles for the brain in sensing glucoprivation and mediating counterregulation, however, the precise nature of the metabolic signals and molecular mediators linking central glucose sensing to effector functions are not fully understood. Here, we demonstrate that protective hormonal and feeding responses to hypoglycemia are regulated by BAD, a BCL-2 family protein with dual functions in apoptosis and metabolism. BAD-deficient mice display impaired glycemic and hormonal counterregulatory responses to systemic glucoprivation induced by 2-deoxy-D-glucose. BAD is also required for proper counterregulatory responses to insulin-induced hypoglycemia as evident from significantly higher glucose infusion rates and lower plasma epinephrine levels during hyperinsulinemic hypoglycemic clamps. Importantly, RNA interference-mediated acute knockdown of Bad in the brain provided independent genetic evidence for its relevance in central glucose sensing and proper neurohumoral responses to glucoprivation. Moreover, BAD deficiency is associated with impaired glucoprivic feeding, suggesting that its role in adaptive responses to hypoglycemia extends beyond hormonal responses to regulation of feeding behavior. Together, these data indicate a previously unappreciated role for BAD in the control of central glucose sensing.	[Osundiji, Mayowa A.; Godes, Marina L.; Danial, Nika N.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Danial, Nika N.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA USA; [Evans, Mark L.] Univ Cambridge, Dept Med, Metab Res Labs, Cambridge CB2 2QQ, England; [Evans, Mark L.] Cambridge Biomed Res Ctr, Natl Inst Hlth Res, Cambridge, England	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; University of Cambridge; University of Cambridge	Osundiji, MA (corresponding author), Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA.	nika_danial@dfci.harvard.edu		Evans, Mark/0000-0001-8122-8987; Osundiji, Mayowa/0000-0001-6658-3964	Juvenile Diabetes Research Foundation [3-2010-472]; Burroughs Wellcome Fund Career Award in Biomedical Sciences; United States National Institutes of Health [K01CA10659, R01DK078081]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078081] Funding Source: NIH RePORTER; Medical Research Council [G0600717B] Funding Source: researchfish	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Burroughs Wellcome Fund Career Award in Biomedical Sciences(Burroughs Wellcome Fund); United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	MAO was supported by a post-doctoral fellowship from the Juvenile Diabetes Research Foundation (3-2010-472). NND is a recipient of the Burroughs Wellcome Fund Career Award in Biomedical Sciences. This work was supported by United States National Institutes of Health grants K01CA10659 and R01DK078081 (NND). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTON AH, 1962, J PHARMACOL EXP THER, V138, P360; Ayala JE, 2010, DIS MODEL MECH, V3, P525, DOI 10.1242/dmm.006239; Bady I, 2006, DIABETES, V55, P988, DOI 10.2337/diabetes.55.04.06.db05-1386; BEVERLY JL, 1995, AM J PHYSIOL-REG I, V269, pR1174; Beverly JL, 2000, AM J PHYSIOL-REG I, V279, pR990, DOI 10.1152/ajpregu.2000.279.3.R990; Blouet C, 2010, BEHAV BRAIN RES, V209, P1, DOI 10.1016/j.bbr.2009.12.024; Borg MA, 1997, J CLIN INVEST, V99, P361, DOI 10.1172/JCI119165; BORG WP, 1994, J CLIN INVEST, V93, P1677, DOI 10.1172/JCI117150; BORG WP, 1995, DIABETES, V44, P180, DOI 10.2337/diabetes.44.2.180; BRANN DW, 1995, NEUROENDOCRINOLOGY, V61, P213, DOI 10.1159/000126843; Bu LH, 2005, NEUROSCI LETT, V385, P153, DOI 10.1016/j.neulet.2005.05.040; Chan O, 2008, DIABETES, V57, P1363, DOI 10.2337/db07-1559; Chan O, 2011, DIABETES, V60, P1582, DOI 10.2337/db10-1579; Cryer PE, 2003, DIABETES CARE, V26, P1902, DOI 10.2337/diacare.26.6.1902; DAGOGOJACK SE, 1993, J CLIN INVEST, V91, P819, DOI 10.1172/JCI116302; Danial NN, 2008, ONCOGENE, V27, pS53, DOI 10.1038/onc.2009.44; Danial NN, 2008, NAT MED, V14, P144, DOI 10.1038/nm1717; Danial NN, 2010, ADV EXP MED BIOL, V687, P1; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Dunn-Meynell AA, 2009, J NEUROSCI, V29, P7015, DOI 10.1523/JNEUROSCI.0334-09.2009; Elmquist JK, 1999, NEURON, V22, P221, DOI 10.1016/S0896-6273(00)81084-3; Evans ML, 2004, DIABETES, V53, P2542, DOI 10.2337/diabetes.53.10.2542; HEPBURN DA, 1993, DIABETIC MED, V10, P940, DOI 10.1111/j.1464-5491.1993.tb00010.x; Jacobson L, 2006, AM J PHYSIOL-ENDOC M, V290, pE678, DOI 10.1152/ajpendo.00383.2005; Jiao S, 2011, NEURON, V70, P758, DOI 10.1016/j.neuron.2011.04.004; Kang L, 2006, DIABETES, V55, P412, DOI 10.2337/diabetes.55.02.06.db05-1229; Kawamori D, 2009, CELL METAB, V9, P350, DOI 10.1016/j.cmet.2009.02.007; Le Marchand SJ, 2010, J BIOL CHEM, V285, P14389, DOI 10.1074/jbc.M109.069195; Levin BE, 2008, DIABETES, V57, P1371, DOI 10.2337/db07-1755; Lynch RM, 2000, DIABETES, V49, P693, DOI 10.2337/diabetes.49.5.693; Marty N, 2005, J CLIN INVEST, V115, P3545, DOI 10.1172/JCI26309; Marty N, 2007, PHYSIOLOGY, V22, P241, DOI 10.1152/physiol.00010.2007; MAYER J, 1952, Bull New Engl Med Cent, V14, P43; McCrimmon RJ, 2006, J CLIN INVEST, V116, P1723, DOI 10.1172/JCI27775; McCrimmon RJ, 2005, DIABETES, V54, P3169, DOI 10.2337/diabetes.54.11.3169; McCrimmon RJ, 2002, AM J PHYSIOL-ENDOC M, V283, pE1076, DOI 10.1152/ajpendo.00195.2002; McCrimmon RJ, 2008, DIABETES, V57, P444, DOI 10.2337/db07-0837; Miki T, 2001, NAT NEUROSCI, V4, P507, DOI 10.1038/87455; Mobbs CV, 2001, AM J PHYSIOL-ENDOC M, V281, pE649, DOI 10.1152/ajpendo.2001.281.4.E649; Molina PE, 2001, BRAIN RES, V899, P201, DOI 10.1016/S0006-8993(01)02236-3; Osundiji MA, 2011, CURR DIABETES REV, V7, P84, DOI 10.2174/157339911794940701; Osundiji MA, 2010, ENDOCRINOLOGY, V151, P1499, DOI 10.1210/en.2009-0989; Ranger AM, 2003, P NATL ACAD SCI USA, V100, P9324, DOI 10.1073/pnas.1533446100; Ritter S, 2000, BRAIN RES, V856, P37, DOI 10.1016/S0006-8993(99)02327-6; Rogers IT, 1999, CONTEMP TOP LAB ANIM, V38, P25; Roncero I, 2000, J NEUROCHEM, V74, P1848, DOI 10.1046/j.1471-4159.2000.0741848.x; Roy SS, 2009, MOL CELL, V33, P377, DOI 10.1016/j.molcel.2009.01.018; Saper CB, 2002, NEURON, V36, P199, DOI 10.1016/S0896-6273(02)00969-8; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Slucca M, 2010, DIABETES, V59, P128, DOI 10.2337/db09-1098; Tong QC, 2007, CELL METAB, V5, P383, DOI 10.1016/j.cmet.2007.04.001; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; UNGER RH, 1970, J CLIN INVEST, V49, P837, DOI 10.1172/JCI106297; WALL JS, 1957, AM J PHYSIOL, V189, P43, DOI 10.1152/ajplegacy.1957.189.1.43; Watts AG, 2010, FRONT NEUROENDOCRIN, V31, P32, DOI 10.1016/j.yfrne.2009.10.006; Yang XJ, 2004, DIABETES, V53, P67, DOI 10.2337/diabetes.53.1.67; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhou HR, 2004, DIABETES, V53, P1482, DOI 10.2337/diabetes.53.6.1482	59	9	9	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e28016	10.1371/journal.pone.0028016	http://dx.doi.org/10.1371/journal.pone.0028016			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22162752	Green Published, Green Submitted, gold			2022-12-27	WOS:000298172800009
J	Burdge, GC; Hoile, SP; Uller, T; Thomas, NA; Gluckman, PD; Hanson, MA; Lillycrop, KA				Burdge, Graham C.; Hoile, Samuel P.; Uller, Tobias; Thomas, Nicola A.; Gluckman, Peter D.; Hanson, Mark A.; Lillycrop, Karen A.			Progressive, Transgenerational Changes in Offspring Phenotype and Epigenotype following Nutritional Transition	PLOS ONE			English	Article							PROTEIN-RESTRICTED DIET; DEVELOPMENTAL PLASTICITY; EPIGENETIC INHERITANCE; PREGNANT RATS; IN-UTERO; METHYLATION; EVOLUTION; HSP90; ACCOMMODATION; MECHANISMS	Induction of altered phenotypes during development in response to environmental input involves epigenetic changes. Phenotypic traits can be passed between generations by a variety of mechanisms, including direct transmission of epigenetic states or by induction of epigenetic marks de novo in each generation. To distinguish between these possibilities we measured epigenetic marks over four generations in rats exposed to a sustained environmental challenge. Dietary energy was increased by 25% at conception in F0 female rats and maintained at this level to generation F3. F0 dams showed higher pregnancy weight gain, but lower weight gain and food intake during lactation than F1 and F2 dams. On gestational day 8, fasting plasma glucose concentration was higher and beta-hydroxybutyrate lower in F0 and F1 dams than F2 dams. This was accompanied by decreased phosphoenolpyruvate carboxykinase (PEPCK) and increased PPAR alpha and carnitine palmitoyl transferase-1 mRNA expression. PEPCK mRNA expression was inversely related to the methylation of specific CpG dinucleotides in its promoter. DNA methyltransferase (Dnmt) 3a2, but not Dnmt1 or Dnmt3b, expression increased and methylation of its promoter decreased from F1 to F3 generations. These data suggest that the regulation of energy metabolism during pregnancy and lactation within a generation is influenced by the maternal phenotype in the preceding generation and the environment during the current pregnancy. The transgenerational effects on phenotype were associated with altered DNA methylation of specific genes in a manner consistent with induction de novo of epigenetic marks in each generation.	[Burdge, Graham C.; Hoile, Samuel P.; Thomas, Nicola A.; Hanson, Mark A.] Univ Southampton, Fac Med, Acad Unit Human Dev & Hlth, Inst Dev Sci,Southampton Gen Hosp, Southampton SO9 5NH, Hants, England; [Uller, Tobias] Univ Oxford, Dept Zool, Edward Grey Inst, Oxford OX1 3PS, England; [Gluckman, Peter D.] Univ Auckland, Liggins Inst & Natl Res, Ctr Growth & Dev, Auckland 1, New Zealand; [Lillycrop, Karen A.] Univ Southampton, Fac Nat & Environm Sci, Inst Dev Sci, Southampton Gen Hosp, Southampton SO9 5NH, Hants, England	University of Southampton; University of Oxford; University of Auckland; University of Southampton	Burdge, GC (corresponding author), Univ Southampton, Fac Med, Acad Unit Human Dev & Hlth, Inst Dev Sci,Southampton Gen Hosp, Southampton SO9 5NH, Hants, England.	g.c.burdge@southampton.ac.uk	Hanson, Mark/AAE-8236-2019; Burdge, Graham/A-2370-2014	Hanson, Mark/0000-0002-6907-613X; Burdge, Graham/0000-0002-7665-2967; Lillycrop, Karen/0000-0001-7350-5489	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/F013043/1]; British Heart Foundation [CH/02/01]; BBSRC [BB/F013043/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F013043/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grants from the Biotechnology and Biological Sciences Research Council (BBSRC) (BB/F013043/1) to GCB, KAL and MAH. MAH receives salary support from the British Heart Foundation (CH/02/01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badyaev AV, 2008, ANN NY ACAD SCI, V1133, P151, DOI 10.1196/annals.1438.009; Badyaev AV, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-3; Badyaev Alexander V., 2005, P277, DOI 10.1016/B978-012088777-4/50015-6; Badyaev AV, 2009, PHILOS T R SOC B, V364, P1169, DOI 10.1098/rstb.2008.0302; Badyaev AV, 2009, PHILOS T R SOC B, V364, P1125, DOI 10.1098/rstb.2008.0285; BEALE EG, 1985, J BIOL CHEM, V260, P748; Benyshek DC, 2006, DIABETOLOGIA, V49, P1117, DOI 10.1007/s00125-006-0196-5; Bonduriansky R, 2009, ANNU REV ECOL EVOL S, V40, P103, DOI 10.1146/annurev.ecolsys.39.110707.173441; Burdge GC, 2008, BRIT J NUTR, V99, P540, DOI 10.1017/S0007114507815819; Burdge GC, 2007, BRIT J NUTR, V97, P435, DOI 10.1017/S0007114507352392; Burdge GC, 2010, ANNU REV NUTR, V30, P315, DOI 10.1146/annurev.nutr.012809.104751; Burdge GC, 2009, J NUTR, V139, P1054, DOI 10.3945/jn.109.104653; Chen TP, 2002, J BIOL CHEM, V277, P38746, DOI 10.1074/jbc.M205312200; Crews D, 2008, FRONT NEUROENDOCRIN, V29, P344, DOI 10.1016/j.yfrne.2008.01.003; Drake AJ, 2005, AM J PHYSIOL-REG I, V288, pR34, DOI 10.1152/ajpregu.00106.2004; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Gluckman PD, 2007, BIOESSAYS, V29, P145, DOI 10.1002/bies.20522; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Guerrero-Bosagna CM, 2009, SEMIN REPROD MED, V27, P403, DOI 10.1055/s-0029-1237428; Herrera E, 2000, EUR J CLIN NUTR, V54, pS47, DOI 10.1038/sj.ejcn.1600984; Jablonka E, 1995, PHILOS T R SOC B, V350, P133, DOI 10.1098/rstb.1995.0147; Jablonka E, 2009, Q REV BIOL, V84, P131, DOI 10.1086/598822; Kimura M, 1984, NEUTRAL THEORY MOL E; Lane N, 2003, GENESIS, V35, P88, DOI 10.1002/gene.10168; Lillycrop KA, 2008, BRIT J NUTR, V100, P278, DOI 10.1017/S0007114507894438; Lillycrop KA, 2007, BRIT J NUTR, V97, P1064, DOI 10.1017/S000711450769196X; Maestripieri D., 2009, MATERNAL EFFECTS MAM; Pimm SL, 2009, CURR BIOL, V19, pR595, DOI 10.1016/j.cub.2009.05.055; Rountree MR, 2000, NAT GENET, V25, P269, DOI 10.1038/77023; Ruden DM, 2003, SEMIN CELL DEV BIOL, V14, P301, DOI 10.1016/j.semcdb.2003.09.024; Ruden DM, 2005, HUM MOL GENET, V14, pR149, DOI 10.1093/hmg/ddi103; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Rutherford SL, 2003, NAT REV GENET, V4, P263, DOI 10.1038/nrg1041; Skinner MK, 2008, REPROD TOXICOL, V25, P2, DOI 10.1016/j.reprotox.2007.09.001; Uller T, 2008, TRENDS ECOL EVOL, V23, P432, DOI 10.1016/j.tree.2008.04.005; Uller T, 2009, SEMIN CELL DEV BIOL, V20, P304, DOI 10.1016/j.semcdb.2008.11.013; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; West-Eberhard Mary Jane, 2003, pi; West-Eberhard MJ, 2005, J EXP ZOOL PART B, V304B, P610, DOI 10.1002/jez.b.21071; Yang JQ, 2009, J BIOL CHEM, V284, P27031, DOI 10.1074/jbc.R109.040535	40	82	83	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e28282	10.1371/journal.pone.0028282	http://dx.doi.org/10.1371/journal.pone.0028282			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140567	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000298168100060
J	Das, C; Ghosh, TS; Mande, SS				Das, Chandrani; Ghosh, Tarini Shankar; Mande, Sharmila S.			Computational Analysis of the ESX-1 Region of Mycobacterium tuberculosis: Insights into the Mechanism of Type VII Secretion System	PLOS ONE			English	Article							VIRULENCE FACTORS; CALMETTE-GUERIN; GENE-CLUSTER; IDENTIFICATION; ESAT-6; PREDICTION; PROTEINS; RD1; COMPLEX; PATHOGENESIS	Type VII secretion system (T7SS) is a recent discovery in bacterial secretion systems. First identified in Mycobacterium tuberculosis, this secretion system has later been reported in organisms belonging to the Actinomycetales order and even to distant phyla like Firmicutes. The genome of M. tuberculosis H37Rv contains five gene clusters that have evolved through gene duplication events and include components of the T7SS secretion machinery. These clusters are called ESAT-6 secretion system (ESX) 1 through 5. Out of these, ESX-1 has been the most widely studied region because of its pathological importance. In spite of this, the overall mechanism of protein translocation through ESX-1 secretion machinery is not clearly understood. Specifically, the structural components contributing to the translocation through the mycomembrane have not been characterized yet. In this study, we have carried out a comprehensive in silico analysis of the genes known to be involved in ESX-1 secretion pathway and identified putative proteins having high probability to be associated with this particular pathway. Our study includes analysis of phylogenetic profiles, identification of domains, transmembrane helices, 3D folds, signal peptides and prediction of protein-protein associations. Based on our analysis, we could assign probable novel functions to a few of the ESX-1 components. Additionally, we have identified a few proteins with probable role in the initial activation and formation of mycomembrane translocon of ESX-1 secretion machinery. We also propose a probable working model of T7SS involving ESX-1 secretion pathway.	[Das, Chandrani; Ghosh, Tarini Shankar; Mande, Sharmila S.] Tata Consultancy Serv Ltd, Tata Consultancy ServicesInnovat Labs, Biosci R&D Div, Hyderabad, Andhra Pradesh, India	Tata Sons; Tata Consultancy Services Limited (TCS)	Das, C (corresponding author), Tata Consultancy Serv Ltd, Tata Consultancy ServicesInnovat Labs, Biosci R&D Div, Hyderabad, Andhra Pradesh, India.	sharmila@atc.tcs.com	Ghosh, Tarini/AAW-5456-2020	Ghosh, Tarini/0000-0001-9570-0365				Abdallah AM, 2007, NAT REV MICROBIOL, V5, P883, DOI 10.1038/nrmicro1773; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Brodin P, 2006, INFECT IMMUN, V74, P88, DOI 10.1128/IAI.74.1.88-98.2006; Burts ML, 2005, P NATL ACAD SCI USA, V102, P1169, DOI 10.1073/pnas.0405620102; Cascales E, 2003, NAT REV MICROBIOL, V1, P137, DOI 10.1038/nrmicro753; Champion PAD, 2006, SCIENCE, V313, P1632, DOI 10.1126/science.1131167; Champion PAD, 2009, MOL MICROBIOL, V73, P950, DOI 10.1111/j.1365-2958.2009.06821.x; Correa NE, 2005, J BACTERIOL, V187, P6324, DOI 10.1128/JB.187.18.6324-6332.2005; Daugelat S, 2003, MICROBES INFECT, V5, P1082, DOI 10.1016/S1286-4579(03)00205-3; Dell Anne, 2010, Int J Microbiol, V2010, P148178, DOI 10.1155/2010/148178; Filloux A, 2004, BBA-MOL CELL RES, V1694, P163, DOI 10.1016/j.bbamcr.2004.05.003; Fortune SM, 2005, P NATL ACAD SCI USA, V102, P10676, DOI 10.1073/pnas.0504922102; Frigui W, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040033; Fung E, 2001, EMBO J, V20, P4901, DOI 10.1093/emboj/20.17.4901; Gao LY, 2004, MOL MICROBIOL, V53, P1677, DOI 10.1111/j.1365-2958.2004.04261.x; Geiman DE, 2006, ANTIMICROB AGENTS CH, V50, P2836, DOI 10.1128/AAC.00295-06; Gordon SV, 1999, MOL MICROBIOL, V32, P643, DOI 10.1046/j.1365-2958.1999.01383.x; Guinn KM, 2004, MOL MICROBIOL, V51, P359, DOI 10.1046/j.1365-2958.2003.03844.x; Hansen JE, 1998, GLYCOCONJUGATE J, V15, P115, DOI 10.1023/A:1006960004440; Henderson IR, 2004, MICROBIOL MOL BIOL R, V68, P692, DOI 10.1128/MMBR.68.4.692-744.2004; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; HO PS, 1994, P NATL ACAD SCI USA, V91, P9549, DOI 10.1073/pnas.91.20.9549; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Hsu T, 2003, P NATL ACAD SCI USA, V100, P12420, DOI 10.1073/pnas.1635213100; Kostakioti M, 2005, J BACTERIOL, V187, P4306, DOI 10.1128/JB.187.13.4306-4314.2005; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lewis KN, 2003, J INFECT DIS, V187, P117, DOI 10.1086/345862; Liu XQ, 2004, INFECT IMMUN, V72, P2574, DOI 10.1128/IAI.72.5.2574-2581.2004; MacGurn JA, 2005, MOL MICROBIOL, V57, P1653, DOI 10.1111/j.1365-2958.2005.04800.x; Mah N, 2010, MICROBIOL-SGM, V156, P2506, DOI 10.1099/mic.0.040089-0; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Massey TH, 2006, MOL CELL, V23, P457, DOI 10.1016/j.molcel.2006.06.019; McLaughlin B, 2007, PLOS PATHOG, V3, P1051, DOI 10.1371/journal.ppat.0030105; Millson SH, 2008, BIOCHEM J, V413, P261, DOI 10.1042/BJ20080105; Ohol YM, 2010, CELL HOST MICROBE, V7, P210, DOI 10.1016/j.chom.2010.02.006; Pallen MJ, 2002, TRENDS MICROBIOL, V10, P209, DOI 10.1016/S0966-842X(02)02345-4; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Pym AS, 2003, NAT MED, V9, P533, DOI 10.1038/nm859; Pym AS, 2002, MOL MICROBIOL, V46, P709, DOI 10.1046/j.1365-2958.2002.03237.x; Rajan I, 2007, BIOINFORMATICS, V23, P2672, DOI 10.1093/bioinformatics/btm405; Renshaw PS, 2002, J BIOL CHEM, V277, P21598, DOI 10.1074/jbc.M201625200; Renshaw PS, 2005, EMBO J, V24, P2491, DOI 10.1038/sj.emboj.7600732; RICH A, 1984, ANNU REV BIOCHEM, V53, P791, DOI 10.1146/annurev.bi.53.070184.004043; Rohde KH, 2007, CELL HOST MICROBE, V2, P352, DOI 10.1016/j.chom.2007.09.006; Schmidt H, 2004, CLIN MICROBIOL REV, V17, P14, DOI 10.1128/CMR.17.1.14-56.2004; Servant Florence, 2002, Brief Bioinform, V3, P246, DOI 10.1093/bib/3.3.246; Shrivastava S, 2010, J BIOSCIENCES, V35, P351, DOI 10.1007/s12038-010-0040-4; Shrivastava S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002955; Siroy A, 2008, J BIOL CHEM, V283, P17827, DOI 10.1074/jbc.M800866200; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Song H, 2008, TUBERCULOSIS, V88, P526, DOI 10.1016/j.tube.2008.02.004; Stahl C, 2001, MOL MICROBIOL, V40, P451, DOI 10.1046/j.1365-2958.2001.02394.x; Stanley SA, 2003, P NATL ACAD SCI USA, V100, P13001, DOI 10.1073/pnas.2235593100; Steyn AJC, 2002, P NATL ACAD SCI USA, V99, P3147, DOI 10.1073/pnas.052705399; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Tekaia F., 1999, Tubercle and Lung Disease, V79, P329, DOI 10.1054/tuld.1999.0220; Teutschbein J, 2009, MICROBIOL RES, V164, P253, DOI 10.1016/j.micres.2006.11.016; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Van Pittius NG, 2001, GENOME BIOL, V2	61	27	29	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e27980	10.1371/journal.pone.0027980	http://dx.doi.org/10.1371/journal.pone.0027980			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140496	Green Submitted, gold, Green Published			2022-12-27	WOS:000298168100029
J	Pedercini, M; Blanco, SM; Kopainsky, B				Pedercini, Matteo; Blanco, Santiago Movilla; Kopainsky, Birgit			Application of the Malaria Management Model to the Analysis of Costs and Benefits of DDT versus Non-DDT Malaria Control	PLOS ONE			English	Article							PUBLIC-EXPENDITURE; PREVENTION; EFFICACY; EXPOSURE	Introduction: DDT is considered to be the most cost-effective insecticide for combating malaria. However, it is also the most environmentally persistent and can pose risks to human health when sprayed indoors. Therefore, the use of DDT for vector control remains controversial. Methods: In this paper we develop a computer-based simulation model to assess some of the costs and benefits of the continued use of DDT for Indoor Residual Spraying (IRS) versus its rapid phase out. We apply the prototype model to the aggregated sub Saharan African region. For putting the question about the continued use of DDT for IRS versus its rapid phase out into perspective we calculate the same costs and benefits for alternative combinations of integrated vector management interventions. Results: Our simulation results confirm that the current mix of integrated vector management interventions with DDT as the main insecticide is cheaper than the same mix with alternative insecticides when only direct costs are considered. However, combinations with a stronger focus on insecticide-treated bed nets and environmental management show higher levels of cost-effectiveness than interventions with a focus on IRS. Thus, this focus would also allow phasing out DDT in a cost-effective manner. Although a rapid phase out of DDT for IRS is the most expensive of the tested intervention combinations it can have important economic benefits in addition to health and environmental impacts that are difficult to assess in monetary terms. Those economic benefits captured by the model include the avoided risk of losses in agricultural exports. Conclusions: The prototype simulation model illustrates how a computer-based scenario analysis tool can inform debates on malaria control policies in general and on the continued use of DDT for IRS versus its rapid phase out in specific. Simulation models create systematic mechanisms for analyzing alternative interventions and making informed trade offs.	[Pedercini, Matteo; Blanco, Santiago Movilla] Millennium Inst, Washington, DC USA; [Blanco, Santiago Movilla; Kopainsky, Birgit] Univ Bergen, Dept Geog, Syst Dynam Grp, Bergen, Norway; [Kopainsky, Birgit] Flury&Giuliani GmbH, Zurich, Switzerland	University of Bergen	Pedercini, M (corresponding author), Millennium Inst, Washington, DC USA.	birgit.kopainsky@flury-giuliani.ch	Kopainsky, Birgit/H-5091-2019; Pedercini, Matteo/AAC-8330-2020	Kopainsky, Birgit/0000-0002-1271-8365; Pedercini, Matteo/0000-0002-5452-9116	Biovision Foundation; Swiss National Science Foundation	Biovision Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study benefited from a grant from Biovision Foundation (www.biovision.ch). In addition, part of the work done by one author (BK) was supported by the Swiss National Science Foundation under a Fellowship for Advanced Researchers. The views and conclusions expressed in this paper are those of the authors alone and do not necessarily reflect the views of the Swiss National Science Foundation. The funders had no role in study design, data collection and analysis, or decision to publish.	Alonso PL, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000406; [Anonymous], 2007, OPERATIONS COSTS COS; [Anonymous], 2009, WORLD MAL REP 2009; [Anonymous], GLOB MAL ACT PLAN MA; [Anonymous], 2010, TECHN BAS COORD ACT; [Anonymous], 1983, REGIONAL MODEL LIFE; [Anonymous], 2006, MAL VECT CONTR PERS; Barney GO, 2002, SYST DYNAM REV, V18, P123, DOI 10.1002/sdr.233; Beier JC, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S4; Birdsall N, 1988, HDB DEV EC, P447; Castro MC, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-57; Chanda E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024336; Chanda E, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-164; Demeny Coale AJ., 1966, REGIONAL MODEL LIFE; Fillinger U, 2009, B WORLD HEALTH ORGAN, V87, P645; Fillinger U, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-20; Fillinger Ulrike, 2006, Trop Med Int Health, V11, P1629, DOI 10.1111/j.1365-3156.2006.01733.x; Geissbuhler Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005107; Guyatt HL, 2002, TROP MED INT HEALTH, V7, P298, DOI 10.1046/j.1365-3156.2002.00874.x; Kirby MJ, 2009, LANCET, V374, P998, DOI 10.1016/S0140-6736(09)60871-0; Konradsen F, 1999, B WORLD HEALTH ORGAN, V77, P301; Kramer RA, 2009, HEALTH POLICY, V92, P133, DOI 10.1016/j.healthpol.2009.02.011; Lengeler C, 2006, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD14000363.pub14651852, DOI 10.1002/14651858.CD14000363.PUB14651852]; Lindsay SW, 2003, TROP MED INT HEALTH, V8, P512, DOI 10.1046/j.1365-3156.2003.01059.x; Lindsay SW, 2002, TRENDS PARASITOL, V18, P510, DOI 10.1016/S1471-4922(02)02382-6; Lindsay SW, 2004, COMMUNITY BASED ENV; *MALERA CONS GROUP, 2011, PLOS MED, V0008; Mueller D, 2008, MALARIA J, V7, DOI [10.1186/1475-2875-1187-1173, DOI 10.1186/1475-2875-1187-1173]; N'Guessan R, 2007, EMERG INFECT DIS, V13, P199, DOI 10.3201/eid1302.060631; N'Guessan R, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-44; Ng'ang'a PN, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-146; Pedercini M, 2010, DECISION MAKING SUPP; Pedercini M., 2010, SOCIO-ECON PLAN SCI, V44, P89, DOI [10.1016/j.seps.2009.08.002, DOI 10.1016/J.SEPS.2009.08.002]; Pluess B, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006657.pub2; PopulationDivision of the Department of Economic and Social Affairs of theUnited Nations Secretariat, 2010, WORLD POP PROSP 2010; Poulos C, 2006, HANDBOOK ON CONTINGENT VALUATION, P324; Qureshi MA, 2009, INT J SOC ECON, V36, P93, DOI 10.1108/03068290910921217; Qureshi MA, 2008, INT J SOC ECON, V35, P269, DOI 10.1108/03068290810854547; Richardson G.P., 1991, QUALITATIVE SIMULATI, P144, DOI DOI 10.1007/978-1-4613-9072-5_7; RODGERS GB, 1979, POP STUD-J DEMOG, V33, P343, DOI 10.2307/2173539; Roll Back Malaria, 2011, MAL AFR; Roll Back Malaria, 2011, EC COSTS MAL; Ruth M, 1997, MODELING DYNAMIC EC; Samuelsen H, 2004, SOC SCI MED, V59, P2361, DOI 10.1016/j.socscimed.2004.03.031; Sehgal J., 1986, INTRO TECHNIQUES POP; Shaukat AM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-122; Shorter F.C., 1995, COMPUTATIONAL METHOD; Sine J, 2010, INDOOR RESIDUAL SPRA; Small J, 2003, P NATL ACAD SCI USA, V100, P15341, DOI 10.1073/pnas.2236969100; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Sterman J.D., 2000, BUSINESS DYNAMICS, DOI DOI 10.4324/9781351152723-7; STERMAN JD, 1994, SYST DYNAM REV, V10, P291, DOI 10.1002/sdr.4260100214; Trape J-F, 2011, LANCET INFECT DIS, DOI [10.1016/S1473-3099(1011)70194-70193, DOI 10.1016/S1473-3099(1011)70194-70193]; United Nations Children's Fund, 2009, MAL CHILDR PROGR INT; Utzinger J, 2001, TROP MED INT HEALTH, V6, P677, DOI 10.1046/j.1365-3156.2001.00769.x; van den Berg H, 2009, ENVIRON HEALTH PERSP, V117, P1656, DOI 10.1289/ehp.0900785; Vanek MJ, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-154; Walker K, 2000, MED VET ENTOMOL, V14, P345, DOI 10.1046/j.1365-2915.2000.00262.x; WHO, 2010, WORLD MALARIA REPORT 2010, P1; *WHO, 2005, ATL INS RES MAL VECT; World Economic Forum, 2006, GLOB HLTH IN PUBL PR; World Health Organization, 2011, DDT IND RES SPRAYING, P309; World Health Organization, 2011, US DDT MAL VECT CONT; World Health Organization United Nations Environment Programme, 2011, HLTH ENV LINK POL SE; Worrall E, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-263; Zaim M., 2007, GLOBAL INSECTICIDE U	66	9	10	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e27771	10.1371/journal.pone.0027771	http://dx.doi.org/10.1371/journal.pone.0027771			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	863MI	22140467	Green Published, gold			2022-12-27	WOS:000298168100018
J	Milano, G; Bianciardi, P; Rochemont, V; Vassalli, G; von Segesser, LK; Corno, AF; Guazzi, M; Samaja, M				Milano, Giuseppina; Bianciardi, Paola; Rochemont, Viviane; Vassalli, Giuseppe; von Segesser, Ludwig K.; Corno, Antonio F.; Guazzi, Marco; Samaja, Michele			Phosphodiesterase-5 Inhibition Mimics Intermittent Reoxygenation and Improves Cardioprotection in the Hypoxic Myocardium	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; K-ATP CHANNEL; NITRIC-OXIDE; NA+/CA2+ EXCHANGE; IN-VIVO; SILDENAFIL; APOPTOSIS; ERYTHROPOIETIN; CARDIOMYOCYTES; DYSFUNCTION	Although chronic hypoxia is a claimed myocardial risk factor reducing tolerance to ischemia/reperfusion (I/R), intermittent reoxygenation has beneficial effects and enhances heart tolerance to I/R. Aim of the study: To test the hypothesis that, by mimicking intermittent reoxygenation, selective inhibition of phosphodiesterase-5 activity improves ischemia tolerance during hypoxia. Adult male Sprague-Dawley rats were exposed to hypoxia for 15 days (10% O-2) and treated with placebo, sildenafil (1.4 mg/kg/day, i. p.), intermittent reoxygenation (1 h/day exposure to room air) or both. Controls were normoxic hearts. To assess tolerance to I/R all hearts were subjected to 30-min regional ischemia by left anterior descending coronary artery ligation followed by 3 h-reperfusion. Whereas hypoxia depressed tolerance to I/R, both sildenafil and intermittent reoxygenation reduced the infarct size without exhibiting cumulative effects. The changes in myocardial cGMP, apoptosis (DNA fragmentation), caspase-3 activity (alternative marker for cardiomyocyte apoptosis), eNOS phosphorylation and Akt activity paralleled the changes in cardioprotection. However, the level of plasma nitrates and nitrites was higher in the sildenafil+intermittent reoxygenation than sildenafil and intermittent reoxygenation groups, whereas total eNOS and Akt proteins were unchanged throughout. Conclusions: Sildenafil administration has the potential to mimic the cardioprotective effects led by intermittent reoxygenation, thereby opening the possibility to treat patients unable to be reoxygenated through a pharmacological modulation of NO-dependent mechanisms.	[Milano, Giuseppina; Rochemont, Viviane; Vassalli, Giuseppe; von Segesser, Ludwig K.] CHU Vaudois, CH-1011 Lausanne, Switzerland; [Milano, Giuseppina; Guazzi, Marco] IRCSS, Lab Biol Vasc & Med Regenerativa, Ctr Cardiol Monzino, Milan, Italy; [Bianciardi, Paola; Samaja, Michele] Univ Milan, Dept Med Surg & Dent, Milan, Italy; [Vassalli, Giuseppe] Fdn Cardioctr Ticino, Lugano, Switzerland; [Corno, Antonio F.] Prince Salman Heart Ctr, Riyadh, Saudi Arabia	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); IRCCS Centro Cardiologico Monzino; University of Milan	Milano, G (corresponding author), CHU Vaudois, CH-1011 Lausanne, Switzerland.	giuseppina.milano@chuv.ch	Samaja, Michele/N-3499-2013; Guazzi, Marco/J-3165-2016	Samaja, Michele/0000-0002-0705-340X; Guazzi, Marco/0000-0002-8456-609X; Milano, Giuseppina/0000-0002-5560-4667	Swiss National Science Foundation [FN 310000-110058/1]; Italian Ministry of University and Research	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR))	This study was supported by grants from the Swiss National Science Foundation (FN 310000-110058/1) and from the Italian Ministry of University and Research (PRIN 2007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldashev AA, 2005, THORAX, V60, P683, DOI 10.1136/thx.2005.041954; Allen BS, 1997, ANN THORAC SURG, V64, P1381, DOI 10.1016/S0003-4975(97)00905-3; Baker JE, 2001, J MOL CELL CARDIOL, V33, P331, DOI 10.1006/jmcc.2000.1305; Bianciardi P, 2006, BIOCHEM BIOPH RES CO, V342, P875, DOI 10.1016/j.bbrc.2006.02.042; Bolli R, 2007, AM J PHYSIOL-HEART C, V292, pH19, DOI 10.1152/ajpheart.00712.2006; Boolell M, 1996, Int J Impot Res, V8, P47; Caretti A, 2008, EXP BIOL MED, V233, P1222, DOI 10.3181/0802-RM-73; Chen L, 2006, AM J PHYSIOL-CELL PH, V290, pC1221, DOI 10.1152/ajpcell.00526.2005; Corno AF, 2004, J THORAC CARDIOV SUR, V127, P1301, DOI 10.1016/j.jtcvs.2003.06.012; Das A, 2005, J BIOL CHEM, V280, P12944, DOI 10.1074/jbc.M404706200; Das A, 2006, J BIOL CHEM, V281, P38644, DOI 10.1074/jbc.M606142200; Das S, 2002, DRUG EXP CLIN RES, V28, P213; Fantacci M, 2006, P NATL ACAD SCI USA, V103, P17531, DOI 10.1073/pnas.0608814103; Fisher PW, 2005, CIRCULATION, V111, P1601, DOI 10.1161/01.CIR.0000160359.49478.C2; Fitzpatrick CM, 2005, AM J PHYSIOL-HEART C, V288, pH62, DOI 10.1152/ajpheart.00701.2004; Forkel J, 2004, AM J PHYSIOL-HEART C, V286, pH545, DOI 10.1152/ajpheart.00022.2003; Ghofrani HA, 2002, LANCET, V360, P895, DOI 10.1016/S0140-6736(02)11024-5; Ghofrani HA, 2006, NAT REV DRUG DISCOV, V5, P689, DOI 10.1038/nrd2030; Guazzi M, 2007, J AM COLL CARDIOL, V50, P2136, DOI 10.1016/j.jacc.2007.07.078; Guazzi M, 2007, CURR MED CHEM, V14, P2181; Jackson G, 1999, AM J CARDIOL, V83, p13C; Kukreja RC, 2005, VASC PHARMACOL, V42, P219, DOI 10.1016/j.vph.2005.02.010; Kukreja RC, 2004, J MOL CELL CARDIOL, V36, P165, DOI 10.1016/j.yjmcc.2003.11.001; Liu LP, 2004, CANCER BIOL THER, V3, P492, DOI 10.4161/cbt.3.6.1010; McCabe TJ, 2000, J BIOL CHEM, V275, P6123, DOI 10.1074/jbc.275.9.6123; Milano G, 2004, EXP BIOL MED, V229, P1196, DOI 10.1177/153537020422901115; Milano G, 2002, EXP BIOL MED, V227, P389, DOI 10.1177/153537020222700604; Milano G, 2007, AM J PHYSIOL-HEART C, V292, pH1828, DOI 10.1152/ajpheart.01117.2006; Milano G, 2010, EUR J CARDIO-THORAC, V37, P942, DOI 10.1016/j.ejcts.2009.10.030; Milano G, 2010, EXP BIOL MED, V235, P401, DOI 10.1258/ebm.2009.009153; Morel S, 2006, BASIC RES CARDIOL, V101, P336, DOI 10.1007/s00395-006-0596-1; Ockaili R, 2002, AM J PHYSIOL-HEART C, V283, pH1263, DOI 10.1152/ajpheart.00324.2002; Park AM, 2007, ANTIOXID REDOX SIGN, V9, P723, DOI 10.1089/ars.2007.1460; Richalet JP, 2005, AM J RESP CRIT CARE, V171, P275, DOI 10.1164/rccm.200406-804OC; Ripamonti M, 2006, ELECTROPHORESIS, V27, P3897, DOI 10.1002/elps.200600104; Salloum F, 2003, CIRC RES, V92, P595, DOI 10.1161/01.RES.0000066853.09821.98; Salloum FN, 2008, AM J PHYSIOL-HEART C, V294, pH1398, DOI [10.1152/ajpheart.ajpheart.91438.2007, 10.1152/ajpheart.91438.2007]; Shi Y, 2004, BASIC RES CARDIOL, V99, P173, DOI 10.1007/s00395-004-0455-x; Shi Y, 2002, CIRC RES, V91, P300, DOI 10.1161/01.RES.0000031799.12850.1E; Tarricone E, 2008, CELL STRESS CHAPERON, V13, P483, DOI 10.1007/s12192-008-0048-y; Webster KA, 2005, J MOL CELL CARDIOL, V38, P35, DOI 10.1016/j.yjmcc.2004.11.007; Yeung HM, 2007, AM J PHYSIOL-CELL PH, V292, pC2046, DOI 10.1152/ajpcell.00458.2006	42	22	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2011	6	11							e27910	10.1371/journal.pone.0027910	http://dx.doi.org/10.1371/journal.pone.0027910			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KW	22140481	Green Published, Green Submitted, gold			2022-12-27	WOS:000298163400021
J	Bhomkar, P; Materi, W; Wishart, DS				Bhomkar, Prasanna; Materi, Wayne; Wishart, David S.			The Bacterial Nanorecorder: Engineering E. coli to Function as a Chemical Recording Device	PLOS ONE			English	Article							ESCHERICHIA-COLI; CELL-DIVISION; OPTIMIZATION; BISTABILITY; EXPRESSION; PLACEMENT; INHIBITOR; MINC; SITE	Synthetic biology is an emerging branch of molecular biology that uses synthetic genetic constructs to create man-made cells or organisms that are capable of performing novel and/or useful applications. Using a synthetic chemically sensitive genetic toggle switch to activate appropriate fluorescent protein indicators (GFP, RFP) and a cell division inhibitor (minC), we have created a novel E. coli strain that can be used as a highly specific, yet simple and inexpensive chemical recording device. This biological "nanorecorder" can be used to determine both the type and the time at which a brief chemical exposure event has occurred. In particular, we show that the short-term exposure (15-30 min) of cells harboring this synthetic genetic circuit to small molecule signals (anhydrotetracycline or IPTG) triggered long-term and uniform cell elongation, with cell length being directly proportional to the time elapsed following a brief chemical exposure. This work demonstrates that facile modification of an existing genetic toggle switch can be exploited to generate a robust, biologically-based "nanorecorder" that could potentially be adapted to detect, respond and record a wide range of chemical stimuli that may vary over time and space.	[Bhomkar, Prasanna; Materi, Wayne; Wishart, David S.] Natl Inst Nanotechnol, Edmonton, AB, Canada; [Wishart, David S.] Univ Alberta, Dept Comp Sci, Edmonton, AB, Canada; [Wishart, David S.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada	National Research Council Canada; University of Alberta; University of Alberta	Bhomkar, P (corresponding author), Natl Inst Nanotechnol, Edmonton, AB, Canada.	bhomkar@ualberta.ca	Wishart, David Scott/ABI-3181-2020	Wishart, David S/0000-0002-3207-2434	National Research Council of Canada; Canadian Institutes of Health Research (CIHR); Natural Sciences and Engineering Research Council (NSERC)	National Research Council of Canada; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	National Research Council of Canada, The Canadian Institutes of Health Research (CIHR) and the Natural Sciences and Engineering Research Council (NSERC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JC, 2006, J MOL BIOL, V355, P619, DOI 10.1016/j.jmb.2005.10.076; Andrianantoandro E, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100073; Arends SJR, 2004, J BACTERIOL, V186, P880, DOI 10.1128/JB.186.3.880-884.2004; BI E, 1993, J BACTERIOL, V175, P1118, DOI 10.1128/JB.175.4.1118-1125.1993; Chen YY, 2010, P NATL ACAD SCI USA, V107, P8531, DOI 10.1073/pnas.1001721107; Danino T, 2010, NATURE, V463, P326, DOI 10.1038/nature08753; DEBOER PAJ, 1989, CELL, V56, P641, DOI 10.1016/0092-8674(89)90586-2; DEBOER PAJ, 1990, P NATL ACAD SCI USA, V87, P1129, DOI 10.1073/pnas.87.3.1129; DEBOER PAJ, 1988, J BACTERIOL, V170, P2106, DOI 10.1128/jb.170.5.2106-2112.1988; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Friedland AE, 2009, SCIENCE, V324, P1199, DOI 10.1126/science.1172005; Fritz Georg, 2007, Syst Synth Biol, V1, P89, DOI 10.1007/s11693-007-9006-8; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Ham TS, 2006, BIOTECHNOL BIOENG, V94, P1, DOI 10.1002/bit.20916; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kobayashi H, 2004, P NATL ACAD SCI USA, V101, P8414, DOI 10.1073/pnas.0402940101; Kramer BP, 2005, P NATL ACAD SCI USA, V102, P9517, DOI 10.1073/pnas.0500345102; Levskaya A, 2005, NATURE, V438, P441, DOI 10.1038/nature04405; Lu TK, 2007, P NATL ACAD SCI USA, V104, P11197, DOI 10.1073/pnas.0704624104; Pfleger BF, 2005, BIOTECHNOL BIOENG, V92, P553, DOI 10.1002/bit.20630; Raskin DM, 1999, J BACTERIOL, V181, P6419, DOI 10.1128/JB.181.20.6419-6424.1999; Rinaudo K, 2007, NAT BIOTECHNOL, V25, P795, DOI 10.1038/nbt1307; Sambrook J., 2001, MOL CLONING LAB MANU; Stupak E E, 2010, Genetika, V46, P610; Tabor JJ, 2009, CELL, V137, P1272, DOI 10.1016/j.cell.2009.04.048; Tan C, 2009, NAT CHEM BIOL, V5, P842, DOI 10.1038/nchembio.218; Veening JW, 2008, ANNU REV MICROBIOL, V62, P193, DOI 10.1146/annurev.micro.62.081307.163002; Weber W, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp014; Wu CH, 2009, BIOTECHNOL PROGR, V25, P898, DOI 10.1002/btpr.203	29	6	6	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e27559	10.1371/journal.pone.0027559	http://dx.doi.org/10.1371/journal.pone.0027559			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132112	gold, Green Published, Green Submitted			2022-12-27	WOS:000298162000026
J	Van Otterloo, J; Richards, JL; Seib, K; Weiss, P; Omer, SB				Van Otterloo, Joshua; Richards, Jennifer L.; Seib, Katherine; Weiss, Paul; Omer, Saad B.			Gift Card Incentives and Non-Response Bias in a Survey of Vaccine Providers: The Role of Geographic and Demographic Factors	PLOS ONE			English	Article							RESPONSE RATES; PHYSICIAN RESPONSE; MAIL SURVEY	This study investigates the effects of non-response bias in a 2010 postal survey assessing experiences with H1N1 influenza vaccine administration among a diverse sample of providers (N = 765) in Washington state. Though we garnered a high response rate (80.9%) by using evidence-based survey design elements, including intensive follow-up and a gift card incentive from Target, non-response bias could exist if there were differences between respondents and non-respondents. We investigated differences between the two groups for seven variables: road distance to the nearest Target store, practice type, previous administration of vaccines, region, urbanicity, size of practice, and Vaccines for Children (VFC) program enrollment. We also examined the effect of non-response bias on survey estimates. Statistically significant differences between respondents and non-respondents were found for four variables: miles to the nearest Target store, type of medical practice, whether the practice routinely administered additional vaccines besides H1N1, and urbanicity. Practices were more likely to respond if they were from a small town or rural area (OR = 7.68, 95% CI = 1.44-40.88), were a non-traditional vaccine provider type (OR = 2.08, 95% CI = 1.06-4.08) or a pediatric provider type (OR = 4.03, 95% CI = 1.36-11.96), or administered additional vaccines besides H1N1 (OR = 1.80, 95% CI = 1.03-3.15). Of particular interest, for each ten mile increase in road distance from the nearest Target store, the likelihood of provider response decreased (OR = 0.73, 95% CI = 0.60-0.89). Of those variables associated with response, only small town or rural practice location was associated with a survey estimate of interest, suggesting that non-response bias had a minimal effect on survey estimates. These findings show that gift card incentives alongside survey design elements and follow-up can achieve high response rates. However, there is evidence that practices farther from the nearest place to redeem gift cards may be less likely to respond to the survey.	[Van Otterloo, Joshua; Richards, Jennifer L.; Seib, Katherine; Weiss, Paul; Omer, Saad B.] Emory Univ, Preparedness & Emergency Response Res Ctr, Atlanta, GA 30322 USA; [Seib, Katherine; Omer, Saad B.] Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA	Emory University; Emory University; Rollins School Public Health	Van Otterloo, J (corresponding author), Emory Univ, Preparedness & Emergency Response Res Ctr, Atlanta, GA 30322 USA.	jvanott@emory.edu	Omer, Saad B/K-1182-2012	Omer, Saad B/0000-0002-5383-3474; Beauregard, Jennifer/0000-0003-2587-5148	Centers for Disease Control and Prevention (CDC) [5P01TP000300]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD052460] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was supported by a grant from the Centers for Disease Control and Prevention (CDC), grant # 5P01TP000300, to the Emory Preparedness and Emergency Response Research Center, Emory University (Atlanta, GA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asch DA, 1997, J CLIN EPIDEMIOL, V50, P1129, DOI 10.1016/S0895-4356(97)00126-1; BARTON J, 1980, AM J PUBLIC HEALTH, V70, P823, DOI 10.2105/AJPH.70.8.823; Bjertnaes OA, 2008, EVAL HEALTH PROF, V31, P65, DOI 10.1177/0163278707311874; Burritt C, 2009, BLOOMBERG NEWS  0102; Cull WL, 2005, HEALTH SERV RES, V40, P213, DOI 10.1111/j.1475-6773.2005.00350.x; Delnevo CD, 2004, AM J PREV MED, V26, P234, DOI 10.1016/j.amepre.2003.12.013; Field TS, 2002, MED CARE, V40, P596, DOI 10.1097/00005650-200207000-00006; Hammett TM., 2007, NATL SURVEY INFECT D; Hansen Richard A, 2007, Res Social Adm Pharm, V3, P249, DOI 10.1016/j.sapharm.2006.10.001; Kasprzyk D, 2001, EVAL HEALTH PROF, V24, P3, DOI 10.1177/01632780122034740; Kellerman SE, 2001, AM J PREV MED, V20, P61, DOI 10.1016/S0749-3797(00)00258-0; Liu ST, 2011, MATERN CHILD HLTH J, V15, P527, DOI 10.1007/s10995-010-0609-4; McFarlane E, 2007, EVAL HEALTH PROF, V30, P170, DOI 10.1177/0163278707300632; Parashos P, 2005, COMMUNITY DENT ORAL, V33, P9, DOI 10.1111/j.1600-0528.2004.00181.x; Rural Health Research Center, 2004, RUCA DAT ZIP COD RUC; VanGeest JB, 2007, EVAL HEALTH PROF, V30, P303, DOI 10.1177/0163278707307899; Washington State Department of Health, 2005, EM PREP RESP PUBL HL	17	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e28108	10.1371/journal.pone.0028108	http://dx.doi.org/10.1371/journal.pone.0028108			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	863KL	22132224	Green Published, gold			2022-12-27	WOS:000298162000074
J	Bob, P; Jasova, D; Raboch, J				Bob, Petr; Jasova, Denisa; Raboch, Jiri			Subclinical Epileptiform Process in Patients with Unipolar Depression and Its Indirect Psychophysiological Manifestations	PLOS ONE			English	Article							STRESS; SYMPTOMS; SENSITIZATION; DISSOCIATION; AMYGDALA; ILLNESS	Background: According to recent clinical findings epileptiform activity in temporolimbic structures may cause and other psychiatric symptoms that may occur independently of any seizure in patient's history. In addition in patients subclinical seizure-like activity with indirect clinical manifestations likely may occur in a form of various forms cognitive, affective, memory, sensory, behavioral and somatic symptoms (the so-called complex partial seizure-like symptoms). A typical characteristic of epileptiform changes is increased neural synchrony related to spreading epileptiform activity between hemispheres even in subclinical conditions i.e. without seizures. These findings suggest hypothesis that measures reflecting a level of synchronization and information transfer between hemispheres could spreading of epileptiform activity and might be related to complex partial seizure-like symptoms. Methods and Findings: Suitable data for such analysis may provide various physiological signals reflecting brain as for example bilateral electrodermal activity (EDA) that is closely related to limbic modulation influences. With purpose we have performed measurement and analysis of bilateral EDA and compared the results with measures of complex partial seizure-like symptoms, depression and actually experienced stress in 44 patients with depression and 35 healthy controls. The results in unipolar depressive patients show that during rest conditions the with higher level of complex partial seizure like symptoms (CPSI) display increased level of EDA transinformation (PTI) calculated between left and right EDA records (Spearman correlation between CPSI and PTI is r = 0.43, p = 0.004). Conclusions: The result may present potentially useful clinical finding suggesting that increased EDA transinformation (PTI) could indirectly indicate increased neural synchrony as a possible indicator of epileptiform activity in unipolar patients treated by serotoninergic antidepresants.	[Bob, Petr] Charles Univ Prague, Dept Psychiat, Fac Med 1, Ctr Neuropsychiat Res Traumat Stress, Prague, Czech Republic; Charles Univ Prague, UHSL, Fac Med 1, Ctr Neuropsychiat Res Traumat Stress, Prague, Czech Republic	Charles University Prague; General University Hospital Prague; Charles University Prague	Bob, P (corresponding author), Charles Univ Prague, Dept Psychiat, Fac Med 1, Ctr Neuropsychiat Res Traumat Stress, Prague, Czech Republic.	petrbob@netscape.net	raboch, jiri/N-7445-2017; Bob, Petr/E-3414-2012	raboch, jiri/0000-0001-6667-1497; 	Czech Ministry of Education [1M06039];  [MSM0021620849];  [MSM0021622404];  [SVV262508]	Czech Ministry of Education(Ministry of Education, Youth & Sports - Czech Republic); ; ; 	This work was supported by research grants MSM0021620849, MSM0021622404, and SVV262508 and support of research project of Center for Neuropsychiatric Research of Traumatic Stress 1M06039 by Czech Ministry of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AM PSYCH ASS, 1994, AM PSYCH ASS DSM 4 D; Baumgartner C, 2001, EPILEPTIC DISORD, V3, P103; Beck AT, 1996, PSYCHOL ASSESS; Bob P, 2003, INT J NEUROSCI, V113, P903, DOI 10.1080/00207450390220376; Bob P., 2008, ACTIV NERV SUPER, V50, P9; Bob P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018678; Bob P, 2010, PSYCHOL REP, V107, P685, DOI 10.2466/02.15.16.PR0.107.6.685-696; Bob P, 2010, PROG NEURO-PSYCHOPH, V34, P143, DOI 10.1016/j.pnpbp.2009.10.015; Caldji C, 2003, NEUROPSYCHOPHARMACOL, V28, P1950, DOI 10.1038/sj.npp.1300237; Critchley HD, 2002, NEUROSCIENTIST, V8, P132, DOI 10.1177/107385840200800209; Devinsky Orrin, 2004, Epilepsy Curr, V4, P43, DOI 10.1111/j.1535-7597.2004.42001.x; Furmark T, 1997, NEUROREPORT, V8, P3957, DOI 10.1097/00001756-199712220-00021; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; Kantz H., 1997, NONLINEAR TIME SERIE; Keller MB, 2003, JAMA-J AM MED ASSOC, V289, P3152, DOI 10.1001/jama.289.23.3152; Kraus JE, 2000, J NEUROPSYCH CLIN N, V12, P328, DOI 10.1176/appi.neuropsych.12.3.328; Lambertz M, 2000, J AUTONOM NERV SYST, V78, P141, DOI 10.1016/S0165-1838(99)00072-7; Landmark CJ, 2008, CNS DRUGS, V22, P27; Mangina CA, 1996, INT J PSYCHOPHYSIOL, V22, P1, DOI 10.1016/0167-8760(96)00022-0; McIntyre DC, 2008, EPILEPSIA, V49, P23, DOI 10.1111/j.1528-1167.2008.01507.x; Monroe SM, 2005, PSYCHOL REV, V112, P417, DOI 10.1037/0033-295X.112.2.417; Phelps EA, 2001, NAT NEUROSCI, V4, P437, DOI 10.1038/86110; POH MZ, 2010, C P IEEE ENG MED BIO, P4415; Post R M, 1988, Adv Exp Med Biol, V245, P441; POST RM, 1992, AM J PSYCHIAT, V149, P999; ROBERTS RJ, 1992, EPILEPSY RES, V13, P167, DOI 10.1016/0920-1211(92)90073-3; Roca V, 2002, J NEUROPSYCH CLIN N, V14, P185, DOI 10.1176/appi.neuropsych.14.2.185; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; SILBERMAN EK, 1985, BRIT J PSYCHIAT, V146, P81, DOI 10.1192/bjp.146.1.81; Teicher MH, 2003, NEUROSCI BIOBEHAV R, V27, P33, DOI 10.1016/S0149-7634(03)00007-1; Varney N R, 1993, Ann Clin Psychiatry, V5, P117, DOI 10.3109/10401239309148973; Weinand Martin E, 2006, Pathophysiology, V13, P233, DOI 10.1016/j.pathophys.2006.08.002; Weinand ME, 2001, EPILEPSY RES, V44, P33, DOI 10.1016/S0920-1211(00)00205-9	33	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2011	6	11							e28041	10.1371/journal.pone.0028041	http://dx.doi.org/10.1371/journal.pone.0028041			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858JH	22132204	gold, Green Submitted, Green Published			2022-12-27	WOS:000297792400035
J	Chis, OT; Banga, JR; Balsa-Canto, E				Chis, Oana-Teodora; Banga, Julio R.; Balsa-Canto, Eva			Structural Identifiability of Systems Biology Models: A Critical Comparison of Methods	PLOS ONE			English	Article							NF-KAPPA-B; PARAMETER IDENTIFIABILITY; GLOBAL IDENTIFIABILITY; NONLINEAR-SYSTEMS; EXPERIMENTAL-DESIGN; NETWORKS; IDENTIFICATION; DYNAMICS; CHECK	Analysing the properties of a biological system through in silico experimentation requires a satisfactory mathematical representation of the system including accurate values of the model parameters. Fortunately, modern experimental techniques allow obtaining time-series data of appropriate quality which may then be used to estimate unknown parameters. However, in many cases, a subset of those parameters may not be uniquely estimated, independently of the experimental data available or the numerical techniques used for estimation. This lack of identifiability is related to the structure of the model, i.e. the system dynamics plus the observation function. Despite the interest in knowing a priori whether there is any chance of uniquely estimating all model unknown parameters, the structural identifiability analysis for general non-linear dynamic models is still an open question. There is no method amenable to every model, thus at some point we have to face the selection of one of the possibilities. This work presents a critical comparison of the currently available techniques. To this end, we perform the structural identifiability analysis of a collection of biological models. The results reveal that the generating series approach, in combination with identifiability tableaus, offers the most advantageous compromise among range of applicability, computational complexity and information provided.	[Chis, Oana-Teodora; Banga, Julio R.; Balsa-Canto, Eva] IIM CSIC, Bioproc Engn Grp, Vigo, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Marinas (IIM)	Chis, OT (corresponding author), IIM CSIC, Bioproc Engn Grp, Vigo, Spain.	ebalsa@iim.csic.es	Banga, Julio R./A-8388-2008; Banga, Julio R./ABD-8629-2020; Balsa-Canto, Eva/A-9339-2008	Banga, Julio R./0000-0002-4245-0320; Banga, Julio R./0000-0002-4245-0320; Balsa-Canto, Eva/0000-0002-1978-2626	Spanish government, MICINN [DPI2008-06880-C03-02]; Xunta de Galicia [08DPI007402PR]; CSIC [PIE-201170E018]	Spanish government, MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Xunta de Galicia(Xunta de GaliciaEuropean Commission); CSIC	This work was financially supported by the Spanish government, MICINN project "MultiSysBio" (ref. DPI2008-06880-C03-02), by Xunta de Galicia project "IDECOP" (ref. 08DPI007402PR) and by CSIC intramural project "BioREDES" (ref. PIE-201170E018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard P, 2006, PLOS COMPUT BIOL, V2, P794, DOI 10.1371/journal.pcbi.0020094; Balsa-Canto E, 2008, IET SYST BIOL, V2, P163, DOI 10.1049/iet-syb:20070069; Balsa-Canto E, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-11; Bandara S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000558; Banga JR, 2008, ESSAYS BIOCHEM, V45, P195, DOI 10.1042/BSE0450195; Bartl M, 2010, P 55 INT SCI C 2010; BELLU G, 2007, BIOMEDICINE, V88, P52; Brendel M, 2006, CHEM ENG SCI, V61, P5404, DOI 10.1016/j.ces.2006.04.028; Brown KS, 2004, PHYS BIOL, V1, P184, DOI 10.1088/1478-3967/1/3/006; Buchberger B., 1976, ACM SIGSAM B, V10, P19, DOI DOI 10.1145/1088216.1088219; Chapman MJ, 2003, INT J CONTROL, V76, P209, DOI 10.1080/0020717031000067420; CHAPPELL MJ, 1990, MATH BIOSCI, V102, P41, DOI 10.1016/0025-5564(90)90055-4; Chis O, 2011, BIOINFORMATICS, V27, P2610, DOI 10.1093/bioinformatics/btr431; Craciun G, 2008, J MATH CHEM, V44, P244, DOI 10.1007/s10910-007-9307-x; Davidescu FP, 2008, CHEM ENG SCI, V63, P4754, DOI 10.1016/j.ces.2008.06.009; Denis-Vidal L, 2001, MATH COMPUT SIMULAT, V57, P35, DOI 10.1016/S0378-4754(01)00274-9; Denis-Vidal L, 2000, IEEE T AUTOMAT CONTR, V45, P768, DOI 10.1109/9.847119; DENISVIDAL L, 1996, P 3 WORKSH MOD CHEM; DOMURADO M, 1995, J CONTROL RELEASE, V33, P115, DOI 10.1016/0168-3659(94)00074-5; GOODWIN ARH, 1992, INT J THERMOPHYS, V13, P837, DOI 10.1007/BF00503911; GOODWIN BRIAN C., 1965, ADVANCE ENZYME REGULAT, V3, P425, DOI 10.1016/0065-2571(65)90067-1; Gutenkunst RN, 2007, PLOS COMPUT BIOL, V3, P1871, DOI 10.1371/journal.pcbi.0030189; He F, 2010, INT J ROBUST NONLIN, V20, P1059, DOI 10.1002/rnc.1558; Hengl S, 2007, BIOINFORMATICS, V23, P2612, DOI 10.1093/bioinformatics/btm382; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Janes KA, 2006, CURR OPIN CHEM BIOL, V10, P73, DOI 10.1016/j.cbpa.2005.12.016; Kholodenko BN, 2006, NAT REV MOL CELL BIO, V7, P165, DOI 10.1038/nrm1838; Kolchin E. R, 1973, DIFFERENTIAL ALGEBRA; Kreutz C, 2009, FEBS J, V276, P923, DOI 10.1111/j.1742-4658.2008.06843.x; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Lipniacki T, 2004, J THEOR BIOL, V228, P195, DOI 10.1016/j.jtbi.2004.01.001; LJUNG L, 1994, AUTOMATICA, V30, P265, DOI 10.1016/0005-1098(94)90029-9; Locke JCW, 2005, J THEOR BIOL, V234, P383, DOI 10.1016/j.jtbi.2004.11.038; Margaria G, 2001, MATH BIOSCI, V174, P1, DOI 10.1016/S0025-5564(01)00079-7; Miao HY, 2011, SIAM REV, V53, P3, DOI 10.1137/090757009; Ollivier F, 1990, THESIS ECOLE POLYTEC; Peeters RLM, 2005, AUTOMATICA, V41, P513, DOI 10.1016/j.automatica.2004.11.019; Piazza M, 2008, J THEOR BIOL, V251, P628, DOI 10.1016/j.jtbi.2007.12.009; POHJANPALO H, 1978, MATH BIOSCI, V41, P21, DOI 10.1016/0025-5564(78)90063-9; Ritt J., 1950, AMS C PUBLICATIONS; Rodriguez-Fernandez M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-483; Roper RT, 2010, J THEOR BIOL, V264, P528, DOI 10.1016/j.jtbi.2010.02.029; SACCOMANI M, 2003, CHEM ENG SCI, V39, P619; Saccomani MP, 2010, COMPUT BIOL MED, V40, P402, DOI 10.1016/j.compbiomed.2010.02.004; Srinath S, 2010, J BIOTECHNOL, V149, P132, DOI 10.1016/j.jbiotec.2010.02.019; SZEDERKENYI G, 2011, BMC SYSTEMS IN PRESS; Szederkenyi G, 2009, J MATH CHEM, V45, P1172, DOI 10.1007/s10910-008-9499-8; VAJDA S, 1989, MATH BIOSCI, V93, P217, DOI 10.1016/0025-5564(89)90024-2; VAJDA S, 1989, IEEE T AUTOMAT CONTR, V34, P220, DOI 10.1109/9.21105; VAJDA S, 1984, P 9 IFAC WORLD C BUD; VAJDA S, 1987, IDENTIFIABILITY POLY; Verdiere N, 2005, INT J AP MAT COM-POL, V15, P517; Walter E, 1996, MATH COMPUT SIMULAT, V42, P125, DOI 10.1016/0378-4754(95)00123-9; Walter E, 2004, LECT NOTES COMPUT SC, V2991, P124; WALTER E, 1982, MATH COMPUT SIMULAT, V24, P472, DOI 10.1016/0378-4754(82)90645-0; Walter E, 1997, IDENTIFICATION PARAM; Wolkenhauer O, 2004, IEEE T NANOBIOSCI, V3, P200, DOI 10.1109/TNB.2004.833694; Wu HL, 2008, B MATH BIOL, V70, P785, DOI 10.1007/s11538-007-9279-9; Xia X, 2003, IEEE T AUTOMAT CONTR, V48, P330, DOI 10.1109/TAC.2002.808494	59	226	230	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2011	6	11							e27755	10.1371/journal.pone.0027755	http://dx.doi.org/10.1371/journal.pone.0027755			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858JH	22132135	Green Published, gold, Green Submitted			2022-12-27	WOS:000297792400014
J	Miyama, A; Saito, Y; Yamanaka, K; Hayashi, K; Hamakubo, T; Noguchi, N				Miyama, Akiko; Saito, Yoshiro; Yamanaka, Kazunori; Hayashi, Kojiro; Hamakubo, Takao; Noguchi, Noriko			Oxidation of DJ-1 Induced by 6-Hydroxydopamine Decreasing Intracellular Glutathione	PLOS ONE			English	Article							NEURONAL CELL-DEATH; PARKINSONS-DISEASE; HYDROGEN-PEROXIDE; RELATIVE IMPORTANCE; ALPHA-SYNUCLEIN; OXIDIZED DJ-1; STRESS; NEUROTOXICITY; TOXICITY; QUINONE	DJ-1, the causative gene of a familial form of Parkinson's disease (PD), has been reported to undergo preferential oxidation of the cysteine residue at position 106 (Cys-106) under oxidative stress; however, details of the molecular mechanisms are not well known. In the present study, mechanisms of DJ-1 oxidation induced by 6-hydroxydopamine (6-OHDA) were investigated by using SH-SY5Y cells. The treatment of these cells with 6-OHDA caused an obvious acidic spot sift of DJ-1 due to its oxidation. However, when catalase, which is an hydrogen peroxide (H2O2)-removing enzyme, was added during the treatment, it failed to prevent the oxidation induced by 6-OHDA, suggesting that electrophilic p-quinone formed from 6-OHDA, but not H2O2, was responsible for the DJ-1 oxidation. Benzoquinone, another electrophilic p-quinone, also induced DJ-1 oxidation. The intracellular glutathione (GSH) levels were significantly decreased by 6-OHDA, irrespective of the presence or absence of catalase. The inhibition of GSH synthesis by buthionine sulfoximine resulted in a decrease in GSH levels and enhancement of DJ-1 oxidation. The pretreatment of cells with N-acetyl-cysteine prevented the loss of intracellular GSH and subsequently DJ-1 oxidation induced by 6-OHDA. Collectively, these results suggest that electrophilic p-quinone formed from 6-OHDA induces DJ-1 oxidation by decreasing intracellular GSH.	[Miyama, Akiko; Saito, Yoshiro; Yamanaka, Kazunori; Hayashi, Kojiro; Noguchi, Noriko] Doshisha Univ, Fac Med & Life Sci, Dept Med Life Syst, Kyoto 602, Japan; [Hamakubo, Takao] Univ Tokyo, Lab Syst Biol & Med, Res Ctr Adv Sci & Technol, Meguro Ku, Tokyo, Japan	Doshisha University; University of Tokyo	Miyama, A (corresponding author), Doshisha Univ, Fac Med & Life Sci, Dept Med Life Syst, Kyoto 602, Japan.	ysaito@mail.doshisha.ac.jp; nnoguchi@mail.doshisha.ac.jp	Saito, Yoshiro/H-4597-2019	Saito, Yoshiro/0000-0002-0559-5889	Ministry of Education, Culture, Sports, Science and Technology	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported, in part, by the Academic Frontier Research Project on "New Frontier of Biomedical Engineering Research'' of the Ministry of Education, Culture, Sports, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Akazawa YO, 2010, NEUROSCI LETT, V483, P201, DOI 10.1016/j.neulet.2010.08.007; Akazawa YO, 2010, FREE RADICAL RES, V44, P410, DOI 10.3109/10715760903536349; ANDERSON ME, 1985, METHOD ENZYMOL, V113, P548; Blackinton J, 2009, J BIOL CHEM, V284, P6476, DOI 10.1074/jbc.M806599200; Blum D, 2001, PROG NEUROBIOL, V65, P135, DOI 10.1016/S0301-0082(01)00003-X; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; COHEN G, 1974, J BIOL CHEM, V249, P2447; Cornwell DG, 2003, LIPIDS, V38, P973, DOI 10.1007/s11745-003-1151-4; Forno LS, 1996, J NEUROPATH EXP NEUR, V55, P259, DOI 10.1097/00005072-199603000-00001; GANT TW, 1988, CHEM-BIOL INTERACT, V65, P157, DOI 10.1016/0009-2797(88)90052-X; GEE P, 1989, FREE RADICAL BIO MED, V6, P271, DOI 10.1016/0891-5849(89)90054-3; Guzman JN, 2010, NATURE, V468, P696, DOI 10.1038/nature09536; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Izumi Y, 2005, J NEUROSCI RES, V79, P849, DOI 10.1002/jnr.20382; Jenner P, 2003, ANN NEUROL, V53, pS26, DOI 10.1002/ana.10483; Khanna S, 2003, J BIOL CHEM, V278, P43508, DOI 10.1074/jbc.M307075200; Khanna S, 2010, J NEUROCHEM, V112, P1249, DOI 10.1111/j.1471-4159.2009.06550.x; Kinumi T, 2004, BIOCHEM BIOPH RES CO, V317, P722, DOI 10.1016/j.bbrc.2004.03.110; Lang AE, 1998, NEW ENGL J MED, V339, P1044, DOI 10.1056/NEJM199810083391506; LIANG YO, 1977, J MED CHEM, V20, P581, DOI 10.1021/jm00214a026; Lotharius J, 2002, NAT REV NEUROSCI, V3, P932, DOI 10.1038/nrn983; Mitsumoto A, 2001, FREE RADICAL RES, V35, P301, DOI 10.1080/10715760100300831; PERRY TL, 1982, NEUROSCI LETT, V33, P305, DOI 10.1016/0304-3940(82)90390-1; Saito Y, 2007, FREE RADICAL BIO MED, V42, P675, DOI 10.1016/j.freeradbiomed.2006.12.004; Saito Y, 2006, FREE RADICAL RES, V40, P619, DOI 10.1080/10715760600632552; Saito Y, 2010, FREE RADICAL BIO MED, V49, P1542, DOI 10.1016/j.freeradbiomed.2010.08.016; Saito Y, 2009, NEUROSCI LETT, V465, P1, DOI 10.1016/j.neulet.2009.08.074; Sayre LM, 2008, CHEM RES TOXICOL, V21, P172, DOI 10.1021/tx700210j; Shimizu E, 2002, NEUROPHARMACOLOGY, V43, P434, DOI 10.1016/S0028-3908(02)00108-9; Sie H, 1991, AM J MED, V9, P31, DOI DOI 10.1016/0002-9343(91)90281-2; Sies H, 1999, FREE RADICAL BIO MED, V27, P916, DOI 10.1016/S0891-5849(99)00177-X; Soto-Otero R, 2000, J NEUROCHEM, V74, P1605, DOI 10.1046/j.1471-4159.2000.0741605.x; Taira T, 2004, EMBO REP, V5, P213, DOI 10.1038/sj.embor.7400074; Takahashi K, 2001, J BIOL CHEM, V276, P37556, DOI 10.1074/jbc.M101730200; Toppo S, 2009, BBA-GEN SUBJECTS, V1790, P1486, DOI 10.1016/j.bbagen.2009.04.007; Wang XH, 2006, P NATL ACAD SCI USA, V103, P3604, DOI 10.1073/pnas.0510962103; WILSON MA, ANTIOXID REDOX SIGNA, V15, P111; WOLF PS, 1994, METHOD ENZYMOL, V233, P182; Yamanaka K, 2011, J BIOL CHEM, V286, P24666, DOI 10.1074/jbc.M111.236273; Yokota T, 2003, BIOCHEM BIOPH RES CO, V312, P1342, DOI 10.1016/j.bbrc.2003.11.056; Zhou WB, 2005, J BIOL CHEM, V280, P43150, DOI 10.1074/jbc.M507124200	42	26	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2011	6	11							e27883	10.1371/journal.pone.0027883	http://dx.doi.org/10.1371/journal.pone.0027883			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IO	22132160	Green Submitted, Green Published, gold			2022-12-27	WOS:000297789900029
J	Nunes, SS; Rekapally, H; Chang, CC; Hoying, JB				Nunes, Sara S.; Rekapally, Harish; Chang, Carlos C.; Hoying, James B.			Vessel Arterial-Venous Plasticity in Adult Neovascularization	PLOS ONE			English	Article							VEIN GRAFT ADAPTATION; ENDOTHELIAL-CELLS; CARDIOVASCULAR DEVELOPMENT; VASCULAR MORPHOGENESIS; SMOOTH-MUSCLE; EPHRIN-B2; ANGIOGENESIS; EXPRESSION; DIFFERENTIATION; VEGF	Objective: Proper arterial and venous specification is a hallmark of functional vascular networks. While arterial-venous identity is genetically pre-determined during embryo development, it is unknown whether an analogous pre-specification occurs in adult neovascularization. Our goal is to determine whether vessel arterial-venous specification in adult neovascularization is pre-determined by the identity of the originating vessels. Methods and Results: We assessed identity specification during neovascularization by implanting isolated microvessels of arterial identity from both mice and rats and assessing the identity outcomes of the resulting, newly formed vasculature. These microvessels of arterial identity spontaneously formed a stereotypical, perfused microcirculation comprised of the full complement of microvessel types intrinsic to a mature microvasculature. Changes in microvessel identity occurred during sprouting angiogenesis, with neovessels displaying an ambiguous arterial-venous phenotype associated with reduced EphrinB2 phosphorylation. Conclusions: Our findings indicate that microvessel arterial-venous identity in adult neovascularization is not necessarily pre-determined and that adult microvessels display a considerable level of phenotypic plasticity during neovascularization. In addition, we show that vessels of arterial identity also hold the potential to undergo sprouting angiogenesis.	[Nunes, Sara S.] Univ Louisville, Cardiovasc Innovat Inst, Louisville, KY 40292 USA; Jewish Hosp St Marys Hlth Care, Louisville, KY USA	University of Louisville	Nunes, SS (corresponding author), Univ Louisville, Cardiovasc Innovat Inst, Louisville, KY 40292 USA.	sara.vasconcelos@utoronto.ca	Nunes, Sara S./G-9096-2012; Nunes, Sara/GVS-8426-2022	Nunes, Sara/0000-0003-4795-6061; S Nunes Vasconcelos, Sara/0000-0003-0906-7204	National Institutes of Health [EB007556]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB007556] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by National Institutes of Health [http://www.nih.gov grant number EB007556] to JBH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RH, 1999, GENE DEV, V13, P295, DOI 10.1101/gad.13.3.295; Aitsebaomo J, 2008, CIRC RES, V103, P929, DOI 10.1161/CIRCRESAHA.108.184937; Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7; Benjamin LE, 1998, DEVELOPMENT, V125, P1591; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Buschmann I, 2010, DEVELOPMENT, V137, P2187, DOI 10.1242/dev.045351; Chang CC, 2010, TISSUE ENG PT A, V16, P795, DOI [10.1089/ten.tea.2009.0370, 10.1089/ten.TEA.2009.0370]; Chen RR, 2007, PHARM RES, V24, P258, DOI 10.1007/s11095-006-9173-4; Davy A, 2006, PLOS BIOL, V4, P1763, DOI 10.1371/journal.pbio.0040315; dela Paz NG, 2009, CELL TISSUE RES, V335, P5, DOI 10.1007/s00441-008-0706-5; Diaz-Flores L, 2009, HISTOL HISTOPATHOL, V24, P909, DOI 10.14670/HH-24.909; Foo SS, 2006, CELL, V124, P161, DOI 10.1016/j.cell.2005.10.034; Gale NW, 2001, DEV BIOL, V230, P151, DOI 10.1006/dbio.2000.0112; Gerety SS, 1999, MOL CELL, V4, P403, DOI 10.1016/S1097-2765(00)80342-1; Gerhardt H, 2003, CELL TISSUE RES, V314, P15, DOI 10.1007/s00441-003-0745-x; Hayashi S, 2005, CIRCULATION, V111, P2210, DOI 10.1161/01.CIR.0000163566.07427.73; Hellberg C, 2010, RECENT RESULTS CANC, V180, P103, DOI 10.1007/978-3-540-78281-0_7; Hellstrom M, 2001, J CELL BIOL, V153, P543, DOI 10.1083/jcb.153.3.543; Jakobsson L, 2010, NAT CELL BIOL, V12, P943, DOI 10.1038/ncb2103; Kudo FA, 2007, ARTERIOSCL THROM VAS, V27, P1562, DOI 10.1161/ATVBAHA.107.143032; Kuijper S, 2007, TRENDS CARDIOVAS MED, V17, P145, DOI 10.1016/j.tcm.2007.03.003; Kume T, 2010, HISTOL HISTOPATHOL, V25, P637, DOI 10.14670/HH-25.637; Lamont RE, 2006, SCI STKE, DOI [10.1126/stke.3552006pe39, DOI 10.1126/STKE.3552006PE39]; Lawson ND, 2002, DEV CELL, V3, P127, DOI 10.1016/S1534-5807(02)00198-3; Lawson ND, 2002, NAT REV GENET, V3, P674, DOI 10.1038/nrg888; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Masumura T, 2009, ARTERIOSCL THROM VAS, V29, P2125, DOI 10.1161/ATVBAHA.109.193185; Moyon D, 2001, DEVELOPMENT, V128, P3359; Muto A, 2010, CIRC J, V74, P1501, DOI 10.1253/circj.CJ-10-0495; Nunes SS, 2010, MICROCIRCULATION, V17, P557, DOI 10.1111/j.1549-8719.2010.00052.x; Nunes SS, 2010, MICROVASC RES, V79, P10, DOI 10.1016/j.mvr.2009.10.001; Obi S, 2009, J APPL PHYSIOL, V106, P203, DOI 10.1152/japplphysiol.00197.2008; Rocha SF, 2009, ANGIOGENESIS, V12, P139, DOI 10.1007/s10456-009-9132-x; Salvucci O, 2009, BLOOD, V114, P1707, DOI 10.1182/blood-2008-12-192294; Sawamiphak S, 2010, NATURE, V465, P487, DOI 10.1038/nature08995; Shepherd BR, 2007, TISSUE ENG, V13, P2871, DOI 10.1089/ten.2007.0025; Shepherd BR, 2004, ARTERIOSCL THROM VAS, V24, P898, DOI 10.1161/01.ATV.0000124103.86943.1e; Shin D, 2001, DEV BIOL, V230, P139, DOI 10.1006/dbio.2000.9957; Skalak Thomas C., 1996, Microcirculation (Philadelphia), V3, P143, DOI 10.3109/10739689609148284; Swift MR, 2009, CIRC RES, V104, P576, DOI 10.1161/CIRCRESAHA.108.188805; Taylor AC, 2007, MICROCIRCULATION, V14, P253, DOI 10.1080/10739680601141829; Wang HU, 1998, CELL, V93, P741, DOI 10.1016/S0092-8674(00)81436-1; Wang YD, 2010, NATURE, V465, P483, DOI 10.1038/nature09002; Weinstein BM, 2002, COLD SPRING HARB SYM, V67, P155, DOI 10.1101/sqb.2002.67.155; Yancopoulos GD, 1998, CELL, V93, P661, DOI 10.1016/S0092-8674(00)81426-9; You LR, 2005, NATURE, V435, P98, DOI 10.1038/nature03511	46	23	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2011	6	11							e27332	10.1371/journal.pone.0027332	http://dx.doi.org/10.1371/journal.pone.0027332			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IO	22132096	gold, Green Submitted, Green Published			2022-12-27	WOS:000297789900011
J	De Filippis, D; Esposito, G; Cirillo, C; Cipriano, M; De Winter, BY; Scuderi, C; Sarnelli, G; Cuomo, R; Steardo, L; De Man, JG; Iuvone, T				De Filippis, Daniele; Esposito, Giuseppe; Cirillo, Carla; Cipriano, Mariateresa; De Winter, Benedicte Y.; Scuderi, Caterina; Sarnelli, Giovanni; Cuomo, Rosario; Steardo, Luca; De Man, Joris G.; Iuvone, Teresa			Cannabidiol Reduces Intestinal Inflammation through the Control of Neuroimmune Axis	PLOS ONE			English	Article							ENTERIC NERVOUS-SYSTEM; NITRIC-OXIDE PRODUCTION; CELLS; PROTEIN; GUT; PATHOGENESIS; EXPRESSION; MODEL	Enteric glial cells (EGC) actively mediate acute and chronic inflammation in the gut; EGC proliferate and release neurotrophins, growth factors, and pro-inflammatory cytokines which, in turn, may amplify the immune response, representing a very important link between the nervous and immune systems in the intestine. Cannabidiol (CBD) is an interesting compound because of its ability to control reactive gliosis in the CNS, without any unwanted psychotropic effects. Therefore the rationale of our study was to investigate the effect of CBD on intestinal biopsies from patients with ulcerative colitis (UC) and from intestinal segments of mice with LPS-induced intestinal inflammation. CBD markedly counteracted reactive enteric gliosis in LPS-mice trough the massive reduction of astroglial signalling neurotrophin S100B. Histological, biochemical and immunohistochemical data demonstrated that S100B decrease was associated with a considerable decrease in mast cell and macrophages in the intestine of LPS-treated mice after CBD treatment. Moreover the treatment of LPS-mice with CBD reduced TNF-alpha expression and the presence of cleaved caspase-3. Similar results were obtained in ex vivo cultured human derived colonic biopsies. In biopsies of UC patients, both during active inflammation and in remission stimulated with LPS+INF-gamma, an increased glial cell activation and intestinal damage were evidenced. CBD reduced the expression of S100B and iNOS proteins in the human biopsies confirming its well documented effect in septic mice. The activity of CBD is, at least partly, mediated via the selective PPAR-gamma receptor pathway. CBD targets enteric reactive gliosis, counteracts the inflammatory environment induced by LPS in mice and in human colonic cultures derived from UC patients. These actions lead to a reduction of intestinal damage mediated by PPARgamma receptor pathway. Our results therefore indicate that CBD indeed unravels a new therapeutic strategy to treat inflammatory bowel diseases.	[De Filippis, Daniele; Cipriano, Mariateresa; Iuvone, Teresa] Univ Naples Federico II, Dept Expt Pharmacol, Naples, Italy; [Esposito, Giuseppe; Scuderi, Caterina; Steardo, Luca] Univ Roma La Sapienza, Dept Human Physiol & Pharmacol Erspamer 5, Rome, Italy; [Cirillo, Carla; Sarnelli, Giovanni; Cuomo, Rosario] Univ Naples Federico II, Dept Clin & Expt Med, Naples, Italy; [De Winter, Benedicte Y.; De Man, Joris G.] Univ Antwerp, Div Gastroenterol, Lab Expt Med & Pediat, B-2020 Antwerp, Belgium; [De Filippis, Daniele; Cipriano, Mariateresa; Iuvone, Teresa] Endocannabinoid Res Grp, Pozzuoli, Italy	University of Naples Federico II; Sapienza University Rome; University of Naples Federico II; University of Antwerp	De Filippis, D (corresponding author), Univ Naples Federico II, Dept Expt Pharmacol, Naples, Italy.	iuvone@unina.it	Scuderi, Caterina/J-4189-2012; Esposito, Giuseppe/AAA-7949-2019; De Man, Joris/E-2980-2013; De Winter, Benedicte Y/G-2616-2011; Sarnelli, Giovanni/AAB-4050-2019; Cuomo, Rosario/C-3446-2011	Scuderi, Caterina/0000-0002-7314-1539; Esposito, Giuseppe/0000-0001-8080-8218; De Winter, Benedicte Y/0000-0003-0327-6304; Sarnelli, Giovanni/0000-0002-1467-1134; Cuomo, Rosario/0000-0003-0768-8381; Cirillo, Carla/0000-0002-8445-5955; Cipriano, Mariateresa/0000-0001-6644-7137; Steardo, Luca/0000-0003-3570-2195				Barbara G, 2007, GASTROENTEROLOGY, V132, P26, DOI 10.1053/j.gastro.2006.11.039; Ben-Horin S, 2008, CURR OPIN PHARMACOL, V8, P490, DOI 10.1016/j.coph.2008.07.010; Borrelli F, 2009, J MOL MED, V87, P1111, DOI 10.1007/s00109-009-0512-x; Burns AJ, 2009, NEUROGASTROENT MOTIL, V21, P100, DOI 10.1111/j.1365-2982.2008.01255.x; Burzynski G, 2009, NEUROGASTROENT MOTIL, V21, P113, DOI 10.1111/j.1365-2982.2008.01256.x; Capasso R, 2008, BRIT J PHARMACOL, V154, P1001, DOI 10.1038/bjp.2008.177; Caprioli F, 2008, GUT, V57, P1674, DOI 10.1136/gut.2008.149286; Caruso R, 2008, EUR J IMMUNOL, V38, P470, DOI 10.1002/eji.200737635; Cirillo C, 2009, NEUROGASTROENT MOTIL, V21, P1209, DOI 10.1111/j.1365-2982.2009.01346.x; Collins SM, 2009, GASTROENTEROLOGY, V136, P2003, DOI 10.1053/j.gastro.2009.01.075; Cornet A, 2001, P NATL ACAD SCI USA, V98, P13306, DOI 10.1073/pnas.231474098; De Backer O, 2009, J PHARMACOL EXP THER, V331, P496, DOI 10.1124/jpet.109.155135; De Filippis D, 2008, BRIT J PHARMACOL, V154, P1672, DOI 10.1038/bjp.2008.211; De Filippis D, 2008, J NEUROENDOCRINOL, V20, P20, DOI 10.1111/j.1365-2826.2008.01674.x; De Winter BY, 2005, NEUROGASTROENT MOTIL, V17, P251, DOI 10.1111/j.1365-2982.2004.00618.x; Echtenacher B, 1996, NATURE, V381, P75, DOI 10.1038/381075a0; Esposito G, 2007, GASTROENTEROLOGY, V133, P918, DOI 10.1053/j.gastro.2007.06.009; FERRI GL, 1982, NATURE, V297, P409, DOI 10.1038/297409a0; Gershon MD, 2005, J CLIN GASTROENTEROL, V39, pS184, DOI 10.1097/01.mcg.0000156403.37240.30; Iuvone T, 2009, CNS NEUROSCI THER, V15, P65, DOI 10.1111/j.1755-5949.2008.00065.x; Kim JY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004561; O'Sullivan SE, 2010, IMMUNOBIOLOGY, V215, P611, DOI 10.1016/j.imbio.2009.09.007; O'Sullivan SE, 2009, EUR J PHARMACOL, V612, P61, DOI 10.1016/j.ejphar.2009.03.010; Petrosino S, 2009, CURR OPIN CHEM BIOL, V13, P309, DOI 10.1016/j.cbpa.2009.04.616; Qiao S, 2009, CLIN NEUROPATHOL, V28, P105; Ruhl A, 2004, NEUROGASTROENT MOTIL, V16, P44, DOI 10.1111/j.1743-3150.2004.00474.x; von Boyen GBT, 2006, J NEUROENDOCRINOL, V18, P820, DOI 10.1111/j.1365-2826.2006.01478.x; Westbrook AM, 2009, CANCER RES, V69, P4827, DOI 10.1158/0008-5472.CAN-08-4416; Zimmer DB, 2003, MICROSC RES TECHNIQ, V60, P552, DOI 10.1002/jemt.10297	29	103	105	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2011	6	12							e28159	10.1371/journal.pone.0028159	http://dx.doi.org/10.1371/journal.pone.0028159			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863OC	22163000	Green Published, Green Submitted, gold			2022-12-27	WOS:000298173500011
J	Lai, DY; Li, HZ; Fan, SL; Song, MZ; Pang, CY; Wei, HL; Liu, JJ; Wu, D; Gong, WF; Yu, SX				Lai, Deyong; Li, Huaizhu; Fan, Shuli; Song, Meizhen; Pang, Chaoyou; Wei, Hengling; Liu, Junjie; Wu, Dong; Gong, Wenfang; Yu, Shuxun			Generation of ESTs for Flowering Gene Discovery and SSR Marker Development in Upland Cotton	PLOS ONE			English	Article							MICROSATELLITE MARKERS; IDENTIFICATION; TRANSCRIPTOME; ACCUMULATION; POLYPLOIDY; INITIATION; EXPRESSION; RESOURCE; IDENTITY; ARBOREUM	Background: Upland cotton, Gossypium hirsutum L., is one of the world's most important economic crops. In the absence of the entire genomic sequence, a large number of expressed sequence tag (EST) resources of upland cotton have been generated and used in several studies. However, information about the flower development of this species is rare. Methodology/Principal Findings: To clarify the molecular mechanism of flower development in upland cotton, 22,915 high-quality ESTs were generated and assembled into 14,373 unique sequences consisting of 4,563 contigs and 9,810 singletons from a normalized and full-length cDNA library constructed from pooled RNA isolated from shoot apexes, squares, and flowers. Comparative analysis indicated that 5,352 unique sequences had no high-degree matches to the cotton public database. Functional annotation showed that several upland cotton homologs with flowering-related genes were identified in our library. The majority of these genes were specifically expressed in flowering-related tissues. Three GhSEP (G. hirsutum L. SEPALLATA) genes determining floral organ development were cloned, and quantitative real-time PCR (qRT-PCR) revealed that these genes were expressed preferentially in squares or flowers. Furthermore, 670 new putative microsatellites with flanking sequences sufficient for primer design were identified from the 645 unigenes. Twenty-five EST-simple sequence repeats were randomly selected for validation and transferability testing in 17 Gossypium species. Of these, 23 were identified as true-to-type simple sequence repeat loci and were highly transferable among Gossypium species. Conclusions/Significance: A high-quality, normalized, full-length cDNA library with a total of 14,373 unique ESTs was generated to provide sequence information for gene discovery and marker development related to upland cotton flower development. These EST resources form a valuable foundation for gene expression profiling analysis, functional analysis of newly discovered genes, genetic linkage, and quantitative trait loci analysis.	[Lai, Deyong] Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Hubei, Peoples R China; [Lai, Deyong; Li, Huaizhu; Fan, Shuli; Song, Meizhen; Pang, Chaoyou; Wei, Hengling; Liu, Junjie; Wu, Dong; Gong, Wenfang; Yu, Shuxun] Chinese Acad Agr Sci, Cotton Res Inst, Minist Agr, Key Lab Cotton Genet Improvement, Anyang, Henan, Peoples R China; [Li, Huaizhu] NW A&F Univ, Coll Agron, Yangling, Shanxi, Peoples R China; [Wei, Hengling] Zhejiang Univ, Coll Agr & Biotechnol, Hangzhou 310003, Zhejiang, Peoples R China	Huazhong Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS; Ministry of Agriculture & Rural Affairs; Northwest A&F University - China; Zhejiang University	Yu, SX (corresponding author), Chinese Acad Agr Sci, Cotton Res Inst, Minist Agr, Key Lab Cotton Genet Improvement, Anyang, Henan, Peoples R China.	yu@cricaas.com.cn	Li, Huaizhu/AAE-1585-2022; Li, Huaizhu/GWN-4445-2022	Li, Huaizhu/0000-0003-0212-822X; 	National Science and Technology Major Project of China [2008ZX08005-002]	National Science and Technology Major Project of China	This work was supported by the National Science and Technology Major Project of China (No. 2008ZX08005-002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KL, 2003, P NATL ACAD SCI USA, V100, P4649, DOI 10.1073/pnas.0630618100; Ahmad S, 2008, PAK J BOT, V40, P1201; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Blenda A, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-132; BOWMAN JL, 1991, DEVELOPMENT, V112, P1; Carre IA, 2001, J BIOL RHYTHM, V16, P415, DOI 10.1177/074873001129002006; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Fujiwara S, 2008, PLANT CELL, V20, P2960, DOI 10.1105/tpc.108.061531; Guo WZ, 2006, THEOR APPL GENET, V112, P1573, DOI 10.1007/s00122-006-0261-y; GUSTAFSONBROWN C, 1994, CELL, V76, P131, DOI 10.1016/0092-8674(94)90178-3; Han ZG, 2004, MOL GENET GENOMICS, V272, P308, DOI 10.1007/s00438-004-1059-8; Jackson SD, 2009, NEW PHYTOL, V181, P517, DOI 10.1111/j.1469-8137.2008.02681.x; Johanson U, 2000, SCIENCE, V290, P344, DOI 10.1126/science.290.5490.344; Jung C, 2009, TRENDS PLANT SCI, V14, P563, DOI 10.1016/j.tplants.2009.07.005; Jung Sook, 2005, Functional & Integrative Genomics, V5, P136, DOI 10.1007/s10142-005-0139-0; Karsi A, 2002, GENE, V285, P157, DOI 10.1016/S0378-1119(02)00414-6; Lee BY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-278; Lightfoot DJ, 2008, MOL GENET GENOMICS, V279, P75, DOI 10.1007/s00438-007-0297-y; Lindqvist C, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-16; MANDEL MA, 1992, NATURE, V360, P273, DOI 10.1038/360273a0; MANDEL MA, 1995, NATURE, V377, P522, DOI 10.1038/377522a0; Mei M, 2004, THEOR APPL GENET, V108, P280, DOI 10.1007/s00122-003-1433-7; Michaels SD, 2009, CURR OPIN PLANT BIOL, V12, P75, DOI 10.1016/j.pbi.2008.09.005; Morgante M, 2002, NAT GENET, V30, P194, DOI 10.1038/ng822; Mutasa-Gottgens E, 2009, J EXP BOT, V60, P1979, DOI 10.1093/jxb/erp040; Ni ZF, 2009, NATURE, V457, P327, DOI 10.1038/nature07523; Paterson A. H., 1993, Plant Molecular Biology Reporter, V11, P122, DOI 10.1007/BF02670470; Pelaz S, 2000, NATURE, V405, P200, DOI 10.1038/35012103; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rozen S, 2000, Methods Mol Biol, V132, P365; Schmitz RJ, 2007, BBA-GENE STRUCT EXPR, V1769, P269, DOI 10.1016/j.bbaexp.2007.02.003; Scott KD, 2000, THEOR APPL GENET, V100, P723, DOI 10.1007/s001220051344; Shi YH, 2006, PLANT CELL, V18, P651, DOI 10.1105/tpc.105.040303; SMYTH DR, 1990, PLANT CELL, V2, P755, DOI 10.1105/tpc.2.8.755; Somers DE, 2000, CELL, V101, P319, DOI 10.1016/S0092-8674(00)80841-7; Taliercio E, 2006, GENOME, V49, P306, DOI 10.1139/G05-115; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Temnykh S, 2001, GENOME RES, V11, P1441, DOI 10.1101/gr.184001; Tomkins JP, 2001, MOL BREEDING, V8, P255, DOI 10.1023/A:1013798716098; Tzeng TY, 2003, PLANT PHYSIOL, V133, P1091, DOI 10.1104/pp.103.026997; Udall JA, 2006, GENOME RES, V16, P441, DOI 10.1101/gr.4602906; USA The Angiosperm Phylogeny Group, 2003, Botanical Journal of the Linnean Society, V141, P399, DOI 10.1046/j.1095-8339.2003.t01-1-00158.x; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; Wang C, 2006, THEOR APPL GENET, V112, P770, DOI 10.1007/s00122-005-0183-0; WEIGEL D, 1992, CELL, V69, P843, DOI 10.1016/0092-8674(92)90295-N; WEIGEL D, 1995, NATURE, V377, P495, DOI 10.1038/377495a0; Wendel JF, 2003, ADV AGRON, V78, P139, DOI 10.1016/S0065-2113(02)78004-8; Wu YR, 2006, PLANT CELL PHYSIOL, V47, P107, DOI 10.1093/pcp/pci228; Xue TT, 2009, J EXP BOT, V60, P339, DOI 10.1093/jxb/ern291; Yang SS, 2006, PLANT J, V47, P761, DOI 10.1111/j.1365-313X.2006.02829.x; Yanovsky MJ, 2002, NATURE, V419, P308, DOI 10.1038/nature00996; Zhang Hong-Bin, 2008, Int J Plant Genomics, V2008, P742304, DOI 10.1155/2008/742304; Zhulidov PA, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh031	53	15	18	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2011	6	12							e28676	10.1371/journal.pone.0028676	http://dx.doi.org/10.1371/journal.pone.0028676			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863OC	22163052	Green Published, gold, Green Submitted			2022-12-27	WOS:000298173500046
J	Schmidt, AKD; Romer, H				Schmidt, Arne K. D.; Roemer, Heiner			Solutions to the Cocktail Party Problem in Insects: Selective Filters, Spatial Release from Masking and Gain Control in Tropical Crickets	PLOS ONE			English	Article							ACOUSTIC COMMUNICATION; TETTIGONIA-VIRIDISSIMA; AUDITORY-SENSITIVITY; SOUND LOCALIZATION; EVERGREEN FOREST; AMBIENT NOISE; CA2+ DYNAMICS; URBAN NOISE; RECOGNITION; EVOLUTION	Background: Insects often communicate by sound in mixed species choruses; like humans and many vertebrates in crowded social environments they thus have to solve cocktail-party-like problems in order to ensure successful communication with conspecifics. This is even more a problem in species-rich environments like tropical rainforests, where background noise levels of up to 60 dB SPL have been measured. Principal Findings: Using neurophysiological methods we investigated the effect of natural background noise (masker) on signal detection thresholds in two tropical cricket species Paroecanthus podagrosus and Diatrypa sp., both in the laboratory and outdoors. We identified three 'bottom-up' mechanisms which contribute to an excellent neuronal representation of conspecific signals despite the masking background. First, the sharply tuned frequency selectivity of the receiver reduces the amount of masking energy around the species-specific calling song frequency. Laboratory experiments yielded an average signal-to-noise ratio (SNR) of 28 dB, when masker and signal were broadcast from the same side. Secondly, displacing the masker by 180 degrees from the signal improved SNRs by further 6 to 9 dB, a phenomenon known as spatial release from masking. Surprisingly, experiments carried out directly in the nocturnal rainforest yielded SNRs of about -23 dB compared with those in the laboratory with the same masker, where SNRs reached only -14.5 and -16 dB in both species. Finally, a neuronal gain control mechanism enhances the contrast between the responses to signals and the masker, by inhibition of neuronal activity in interstimulus intervals. Conclusions: Thus, conventional speaker playbacks in the lab apparently do not properly reconstruct the masking noise situation in a spatially realistic manner, since under real world conditions multiple sound sources are spatially distributed in space. Our results also indicate that without knowledge of the receiver properties and the spatial release mechanisms the detrimental effect of noise may be strongly overestimated.	[Schmidt, Arne K. D.; Roemer, Heiner] Karl Franzens Univ Graz, Dept Zool, Graz, Styria, Austria	University of Graz	Schmidt, AKD (corresponding author), Karl Franzens Univ Graz, Dept Zool, Graz, Styria, Austria.	arne.schmidt@uni-graz.at			Austrian Science Fund (FWF) [P20882-B09]; Austrian Science Fund (FWF) [P 20882] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund (FWF): Project Grant P20882-B09 to HR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amezquita A, 2006, EVOLUTION, V60, P1874; ARAK A, 1992, BEHAV ECOL SOCIOBIOL, V30, P365; Baden T, 2007, DEV NEUROBIOL, V67, P68, DOI 10.1002/dneu.20323; Bee MA, 2008, J COMP PSYCHOL, V122, P235, DOI 10.1037/0735-7036.122.3.235; Bee MA, 2008, ANIM BEHAV, V75, P1781, DOI 10.1016/j.anbehav.2007.10.032; Bee MA, 2007, ANIM BEHAV, V74, P549, DOI 10.1016/j.anbehav.2006.12.012; Bermudez-Cuamatzin E, 2011, BIOL LETTERS, V7, P36, DOI 10.1098/rsbl.2010.0437; Bradbury Jack W., 1998, pi; Bregman A.S., 1990, AUDITORY SCENE ANAL; Bronkhorst AW, 2000, ACUSTICA, V86, P117; Brumm H, 2005, ADV STUD BEHAV, V35, P151, DOI 10.1016/S0065-3454(05)35004-2; Brumm H, 2004, J EXP BIOL, V207, P443, DOI 10.1242/jeb.00768; Brumm H, 2004, J ANIM ECOL, V73, P434, DOI 10.1111/j.0021-8790.2004.00814.x; Brumm H, 2006, BEHAV ECOL SOCIOBIOL, V60, P475, DOI 10.1007/s00265-006-0188-y; Candolin U, 2003, BIOL REV, V78, P575, DOI 10.1017/S1464793103006158; Capranica Robert R., 1992, Seminars in the Neurosciences, V4, P401, DOI 10.1016/1044-5765(92)90048-7; CHERRY EC, 1953, J ACOUST SOC AM, V25, P975, DOI 10.1121/1.1907229; Dent ML, 1997, BEHAV NEUROSCI, V111, P590, DOI 10.1037/0735-7044.111.3.590; Diwakar S, 2007, J TROP ECOL, V23, P479, DOI 10.1017/S0266467407004208; Diwakar S, 2007, BIOACOUSTICS, V16, P113, DOI 10.1080/09524622.2007.9753571; Douglas SB, 2010, J FIELD ORNITHOL, V81, P115, DOI 10.1111/j.1557-9263.2010.00268.x; DUELLMAN WE, 1983, COPEIA, P639, DOI 10.2307/1444328; Ellinger Norbert, 2003, Bioacoustics, V13, P297; Faulkes Z, 2000, J NEUROPHYSIOL, V84, P1247, DOI 10.1152/jn.2000.84.3.1247; FORREST T G, 1991, Bioacoustics, V3, P93; Freyman RL, 2001, J ACOUST SOC AM, V109, P2112, DOI 10.1121/1.1354984; Gerhardt HC., 2002, ACOUSTIC COMMUNICATI; Gogala Matija, 1995, Malayan Nature Journal, V48, P297; GREENFIELD MD, 1988, ANIM BEHAV, V36, P684, DOI 10.1016/S0003-3472(88)80151-9; Hawley ML, 2004, J ACOUST SOC AM, V115, P833, DOI 10.1121/1.1639908; HORSEMAN G, 1994, J COMP PHYSIOL A, V175, P399, DOI 10.1007/BF00199248; Hulse SH, 2002, ADV STUD BEHAV, V31, P163, DOI 10.1016/S0065-3454(02)80008-0; Klump Georg M., 1996, P321; Kostarakos K, 2010, J COMP PHYSIOL A, V196, P669, DOI 10.1007/s00359-010-0557-x; Kostarakos K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003005; Lang Alexander B., 2005, P152, DOI 10.1017/CBO9780511610363.011; Langemann U, 1998, ANIM BEHAV, V56, P763, DOI 10.1006/anbe.1998.0879; Lengagne T, 1999, P ROY SOC B-BIOL SCI, V266, P1623, DOI 10.1098/rspb.1999.0824; Lin WY, 2001, J COMP PHYSIOL A, V187, P699, DOI 10.1007/s00359-001-0241-2; Michelsen A, 1998, SPR HDB AUD, V10, P18; Pollack G, 2000, CURR OPIN NEUROBIOL, V10, P763, DOI 10.1016/S0959-4388(00)00161-6; POLLACK GS, 1988, J NEUROSCI, V8, P2635; Pollack GS, 1998, SPR HDB AUD, V10, P139; POTASH LM, 1972, ANIM BEHAV, V20, P192, DOI 10.1016/S0003-3472(72)80191-X; Ratnam R, 1998, J NEUROPHYSIOL, V80, P2848, DOI 10.1152/jn.1998.80.6.2848; RHEINLAENDER J, 1986, J COMP PHYSIOL A, V158, P647, DOI 10.1007/BF00603821; ROMER H, 1992, BEHAV ECOL SOCIOBIOL, V29, P437, DOI 10.1007/BF00170174; Romer H, 2000, J COMP PHYSIOL A, V186, P181, DOI 10.1007/s003590050018; Romer H, 1998, J EXP BIOL, V201, P1023; ROMER H, 1989, J COMP PHYSIOL A, V164, P609, DOI 10.1007/BF00614503; Ronacher B, 2003, J COMP PHYSIOL A, V189, P419, DOI 10.1007/s00359-003-0417-z; RYAN MJ, 1985, AM NAT, V126, P87, DOI 10.1086/284398; SCHILDBERGER K, 1988, J COMP PHYSIOL A, V163, P621, DOI 10.1007/BF00603846; Schmidt AKD, 2011, J EXP BIOL, V214, P1754, DOI 10.1242/jeb.053819; Schul J, 1998, J COMP PHYSIOL A, V182, P687, DOI 10.1007/s003590050213; Slabbekoorn H, 2003, NATURE, V424, P267, DOI 10.1038/424267a; Slabbekoorn H, 2006, CURR BIOL, V16, P2326, DOI 10.1016/j.cub.2006.10.008; SOBEL EC, 1994, SCIENCE, V263, P823, DOI 10.1126/science.263.5148.823; STABEL J, 1989, J COMP PHYSIOL A, V165, P165, DOI 10.1007/BF00619191; Stumpner A, 1998, J NEUROPHYSIOL, V79, P2408, DOI 10.1152/jn.1998.79.5.2408; Sueur J, 2002, BIOL J LINN SOC, V75, P379, DOI 10.1111/j.1095-8312.2002.tb02079.x; THIELE D, 1980, AUST J ECOL, V5, P275, DOI 10.1111/j.1442-9993.1980.tb01253.x; VONHELVERSEN D, 1984, J COMP PHYSIOL, V154, P837, DOI 10.1007/BF00610684; VONHELVERSEN D, 1995, J COMP PHYSIOL A, V177, P767, DOI 10.1007/BF00187635; Witte K, 2005, BEHAV ECOL, V16, P571, DOI 10.1093/beheco/ari032; YOST WA, 1991, HEARING RES, V56, P8, DOI 10.1016/0378-5955(91)90148-3	67	44	44	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2011	6	12							e28593	10.1371/journal.pone.0028593	http://dx.doi.org/10.1371/journal.pone.0028593			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863OC	22163041	gold, Green Submitted, Green Published			2022-12-27	WOS:000298173500039
J	Wani, NA; Nada, R; Kaur, J				Wani, Nissar Ahmad; Nada, Ritambhara; Kaur, Jyotdeep			Biochemical and Molecular Mechanisms of Folate Transport in Rat Pancreas; Interference with Ethanol Ingestion	PLOS ONE			English	Article							METHYL-GROUP METABOLISM; DNA METHYLATION; BRUSH-BORDER; GENE-EXPRESSION; DOWN-REGULATION; CELL BIOLOGY; ACINAR-CELLS; LIPID RAFTS; FOLIC-ACID; ALCOHOL	Folic acid is an essential nutrient that is required for one-carbon biosynthetic processes and for methylation of biomolecules. Deficiency of this micronutrient leads to disturbances in normal physiology of cell. Chronic alcoholism is well known to be associated with folate deficiency which is due, in part to folate malabsorption. The present study deals with the mechanistic insights of reduced folate absorption in pancreas during chronic alcoholism. Male Wistar rats were fed 1 g/kg body weight/day ethanol (20% solution) orally for 3 months and the mechanisms of alcohol associated reduced folate uptake was studied in pancreas. The folate transport system in the pancreatic plasma membrane (PPM) was found to be acidic pH dependent one. The transporters proton coupled folate transporter (PCFT) and reduced folate carrier (RFC) are involved in folate uptake across PPM. The folate transporters were found to be associated with lipid raft microdomain of the PPM. Ethanol ingestion decreased the folate transport by reducing the levels of folate transporter molecules in lipid rafts at the PPM. The decreased transport efficiency of the PPM was reflected as reduced folate levels in pancreas. The chronic ethanol ingestion led to decreased pancreatic folate uptake. The decreased levels of PCFT and RFC expression in rat PPM were due to decreased association of these proteins with lipid rafts (LR) at the PPM.	[Wani, Nissar Ahmad; Kaur, Jyotdeep] Postgrad Inst Med Educ & Res, Dept Biochem, Chandigarh 160012, India; [Nada, Ritambhara] Postgrad Inst Med Educ & Res, Dept Histopathol, Chandigarh 160012, India	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh	Wani, NA (corresponding author), Postgrad Inst Med Educ & Res, Dept Biochem, Chandigarh 160012, India.	jyotdeep2001@yahoo.co.in	Wani, Nissar Ahmad/AAC-7210-2022	Wani, Nissar Ahmad/0000-0002-9248-9039; Nada, Ritambhra/0000-0002-8955-1428				Anderson RGW, 2002, SCIENCE, V296, P1821, DOI 10.1126/science.1068886; Ashokkumar B, 2007, AM J CLIN NUTR, V86, P159, DOI 10.1093/ajcn/86.1.159; BALAGHI M, 1993, AM J CLIN NUTR, V58, P198, DOI 10.1093/ajcn/58.2.198; BALAGHI M, 1992, J NUTR, V122, P1391, DOI 10.1093/jn/122.7.1391; BALAGHI M, 1995, AM J CLIN NUTR, V61, P90, DOI 10.1093/ajcn/61.1.90; BECK IT, 1981, DIGEST DIS SCI, V26, P817, DOI 10.1007/BF01309614; Bielawski DM, 2002, ALCOHOL CLIN EXP RES, V26, P347, DOI 10.1097/00000374-200203000-00007; Bonsch D, 2006, J NEURAL TRANSM, V113, P1299, DOI 10.1007/s00702-005-0413-2; Capdevila A, 1997, ARCH BIOCHEM BIOPHYS, V345, P47, DOI 10.1006/abbi.1997.0249; DELISLE RC, 1991, ANAL BIOCHEM, V192, P1, DOI 10.1016/0003-2697(91)90173-Q; Dev S, 2011, BRIT J NUTR, V105, P827, DOI 10.1017/S0007114510004538; Eichholzer M, 2006, LANCET, V367, P1352, DOI 10.1016/S0140-6736(06)68582-6; Friso S, 2002, J NUTR, V132, p2382S, DOI 10.1093/jn/132.8.2382S; GARRO AJ, 1991, ALCOHOL CLIN EXP RES, V15, P395, DOI 10.1111/j.1530-0277.1991.tb00536.x; Gukovskaya AS, 2002, GASTROENTEROLOGY, V122, P106, DOI 10.1053/gast.2002.30302; Halsted CH, 2002, P NATL ACAD SCI USA, V99, P10072, DOI 10.1073/pnas.112336399; Hamid A, 2007, J MEMBRANE BIOL, V220, P69, DOI 10.1007/s00232-007-9075-3; Hamid A, 2007, FEBS J, V274, P6317, DOI 10.1111/j.1742-4658.2007.06150.x; Hamid A, 2007, MOL CELL BIOCHEM, V304, P265, DOI 10.1007/s11010-007-9509-3; Hamid A, 2006, ALCOHOL, V38, P59, DOI 10.1016/j.alcohol.2006.01.004; Hamid A, 2009, IUBMB LIFE, V61, P236, DOI 10.1002/iub.153; Hamid A, 2009, J NUTR BIOCHEM, V20, P291, DOI 10.1016/j.jnutbio.2008.03.004; Hamid A, 2009, FEBS J, V276, P2175, DOI 10.1111/j.1742-4658.2009.06959.x; Hanwell D, 2002, J BIOL CHEM, V277, P9772, DOI 10.1074/jbc.M110904200; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jhaveri MS, 2001, MOL PHARMACOL, V60, P1288, DOI 10.1124/mol.60.6.1288; Kim YI, 2005, J NUTR, V135, P2703, DOI 10.1093/jn/135.11.2703; Kubisch CH, 2006, PANCREAS, V33, P68, DOI 10.1097/01.mpa.0000226878.81377.94; LAKSHMAIAH N, 1975, INT J VITAM NUTR RES, V45, P262; Li XH, 2001, J PHYSIOL-LONDON, V537, P537, DOI 10.1111/j.1469-7793.2001.00537.x; Lieber Charles S, 2005, Clin Liver Dis, V9, P1, DOI 10.1016/j.cld.2004.10.005; LIEBER CS, 1979, CANCER RES, V39, P2863; Longnecker DS, 2002, J NUTR, V132, p2373S, DOI 10.1093/jn/132.8.2373S; McCabe DC, 2005, NUTR REV, V63, P183, DOI [10.1301/nr.2005.Jun.183-195, 10.1111/j.1753-4887.2005.tb00136.x]; Oliferenko S, 1999, J CELL BIOL, V146, P843, DOI 10.1083/jcb.146.4.843; ORLOWSKI M, 1963, BIOCHIM BIOPHYS ACTA, V73, P679; PERSSON J, 1991, SCAND J GASTROENTERO, V26, P3, DOI 10.3109/00365529108996478; Qiu AD, 2006, CELL, V127, P917, DOI 10.1016/j.cell.2006.09.041; QUIGLEY JP, 1969, BIOCHIM BIOPHYS ACTA, V173, P456, DOI 10.1016/0005-2736(69)90010-8; Said HM, 2010, AM J PHYSIOL-GASTR L, V298, pG985, DOI 10.1152/ajpgi.00068.2010; Said HM, 2004, ANNU REV PHYSIOL, V66, P419, DOI 10.1146/annurev.physiol.66.032102.144611; Said HM, 2000, AM J PHYSIOL-CELL PH, V279, pC1889, DOI 10.1152/ajpcell.2000.279.6.C1889; Schalinske KL, 2005, NUTR REV, V63, P387, DOI [10.1111/j.1753-4887.2005.tb00375.x, 10.1301/nr.2005.nov.387-391]; Simons K, 2000, SCIENCE, V290, P1721, DOI 10.1126/science.290.5497.1721; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Stolzenberg-Solomon RZ, 1999, JNCI-J NATL CANCER I, V91, P535, DOI 10.1093/jnci/91.6.535; Subramanian VS, 2008, AM J PHYSIOL-CELL PH, V295, pC828, DOI 10.1152/ajpcell.00249.2008; Tamura T., 1990, CONT ISSUES CLIN NU, V13, P121; THEVENOD F, 1989, J MEMBRANE BIOL, V107, P263, DOI 10.1007/BF01871941; Toskes P P, 1983, Dis Mon, V29, P1; Towbin H, 1992, Biotechnology, V24, P145; Wani NA, 2011, BR J NUTR, V1-9, DOI [10.1017/S0007114511003710, DOI 10.1017/S0007114511003710]; Wani NA, 2011, J CELL PHYSIOL, V226, P579, DOI 10.1002/jcp.22525; Wani NA, 2008, IUBMB LIFE, V60, P834, DOI 10.1002/iub.133; Werner J, 2002, AM J PHYSIOL-GASTR L, V283, pG65, DOI 10.1152/ajpgi.00419.2001; Werner J, 2001, SURGERY, V129, P736, DOI 10.1067/msy.2001.113891; Wojdacz TK, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm013; Wojdacz TK, 2008, NAT PROTOC, V3, P1903, DOI 10.1038/nprot.2008.191; Zhang YQ, 1996, GASTROENTEROLOGY, V110, P478, DOI 10.1053/gast.1996.v110.pm8566595; Zhao RB, 2001, J BIOL CHEM, V276, P1114, DOI 10.1074/jbc.M007919200	60	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2011	6	12							e28599	10.1371/journal.pone.0028599	http://dx.doi.org/10.1371/journal.pone.0028599			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863OC	22163044	Green Published, Green Submitted, gold			2022-12-27	WOS:000298173500040
J	Wesener, T; Raupach, MJ; Decker, P				Wesener, Thomas; Raupach, Michael J.; Decker, Peter			Mountain Refugia Play a Role in Soil Arthropod Speciation on Madagascar: A Case Study of the Endemic Giant Fire-Millipede Genus Aphistogoniulus	PLOS ONE			English	Article							BIOGEOGRAPHY; EVOLUTION; COLONIZATION; BIODIVERSITY; SPIROBOLIDA; PHYLOGENY; DIPLOPODA; PATTERNS; REVISION; BREAKUP	To elucidate the speciation mechanisms prevalent within hotspots of biodiversity, and the evolutionary processes behind the rise of their species-rich and endemic biota, we investigated the phylogeny of the giant fire-millipede genus Aphistogoniulus Silvestri, 1897, a Malagasy endemic. This study is the first comprehensive (molecular and morphological) phylogenetic study focusing on millipede (class Diplopoda) speciation on Madagascar. The morphological analysis is based on 35 morphological characters and incorporates ten described as well as two newly described species (A. rubrodorsalis n. sp. and A. jeekeli n. sp.) of Aphistogoniulus. The molecular analysis is based on both mitochondrial (COI and 16S), and nuclear genes (complete 18S rDNA), together comprised of 3031 base pairs, which were successfully sequenced for 31 individual specimens and eight species of Aphistogoniulus. In addition to the null-model (speciation by distance), two diversification models, mountain refugia and ecotone shift, were discovered to play a role in the speciation of soil arthropods on Madagascar. Mountain refugia were important in the speciation of the A. cowani clade, with three species occurring in the Andringitra and Ranomafana Mountains in the southeast (A. cowani), the Ambohijanahary and Ambohitantely Mountains in the mid-west (A. sanguineus), and the Marojejy Mountain in the northeast (A. rubrodorsalis n. sp.). An ecotone shift from the eastern rainforest to the unique subarid spiny forest of Mahavelo was discovered in the A. vampyrus - A. aridus species-pair. In the monophyletic A. diabolicus clade, evidence for divergent evolution of sexual morphology was detected: species with greatly enlarged gonopods are sister-taxa to species with normal sized gonopods. Among the large-bodied Spirobolida genera of Madagascar, Colossobolus and Sanguinobolus were found to be close sister-genera to Aphistogoniulus. Forest destruction has caused forest corridors between populations to disappear, which might limit the possible resolution of biogeographic analyses on Madagascar.	[Wesener, Thomas] Zool Res Museum Alexander Koenig, Bonn, Germany; [Raupach, Michael J.] Deutsch Zentrum Marine Biodiversitatsforsch, AG Mol Taxonomie Mariner Organismen, Wilhelmshaven, Germany; [Decker, Peter] Senckenberg Museum Nat Kunde Gorlitz, Gorlitz, Germany	Zoologisches Forschungsmuseum Alexander Koenig (ZFMK); Senckenberg Gesellschaft fur Naturforschung (SGN)	Wesener, T (corresponding author), Zool Res Museum Alexander Koenig, Bonn, Germany.	thomas.wesener@rub.de	Decker, Peter/S-6574-2019; Raupach, Michael J./AAF-7566-2020; Raupach, Michael/G-7072-2012	Decker, Peter/0000-0003-0345-7738; Raupach, Michael J./0000-0001-8299-6697; 	German Science Foundation [DFG WA 530/37-1]; PEET from the National Science Foundation of the United States (NSF) [05-29715]; Field Museum's Pritzker Laboratory of Molecular Systematics and Evolution	German Science Foundation(German Research Foundation (DFG)); PEET from the National Science Foundation of the United States (NSF)(National Science Foundation (NSF)); Field Museum's Pritzker Laboratory of Molecular Systematics and Evolution	This study was supported by both a German Science Foundation (www.dfg.de) fund for the 'Biodiversity and Biogeography of the Diplopoda from Madagascar' DFG WA 530/37-1 and a PEET grant from the National Science Foundation (nsf.gov) of the United States (NSF Grant 05-29715) to Petra Sierwald, William Shear and Jason Bond. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Our highest regards to Steven M. Goodman (FMNH), Brian L. Fisher and Charles Griswold (both CAS) for their numerous millipede collection efforts on Madagascar. The loan of the CAS millipedes was arranged by Darrel Ubick and Anthea Carmichael. Betty Strack (FMNH) thankfully advised at the SEM during frequent sessions. Intern Ioulia Bespalova (Mount Holyoke College) provided SEM images of A. cowani. Kai Schutte and Arne Hartig provided colour photographs of living specimens. We also thank Yan Yu for his help using RASP. The three anonymous reviewers and the editor greatly improved the quality of an earlier version of this paper. The authors gratefully acknowledge support from Kevin Feldheim and his colleagues in the Field Museum's Pritzker Laboratory of Molecular Systematics and Evolution. Specimens of A. hova were thankfully provided by OdenwaldExoten. Peter Schwendinger and the Musee d'Histoire Naturelle, Geneve graciously hosted P. D. during a visit. Holly Wesener proof read the English text. Dr. S. Goodman corrected the Malagasy locality names.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Briggs JC, 2003, J BIOGEOGR, V30, P381, DOI 10.1046/j.1365-2699.2003.00809.x; Bruhl CA, 1997, J BIOGEOGR, V24, P233, DOI 10.1046/j.1365-2699.1997.00073.x; Butler A. G., 1882, Annals of Natural History, V(5), P328; Cracraft J, 2001, P ROY SOC B-BIOL SCI, V268, P459, DOI 10.1098/rspb.2000.1368; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emberton KC, 2001, BIOL J LINN SOC, V72, P567, DOI 10.1006/bijl.2000.0517; Fisher BL, 1997, J NAT HIST, V31, P269, DOI 10.1080/00222939700770141; Fuller S, 2005, J BIOGEOGR, V32, P2135, DOI 10.1111/j.1365-2699.2005.01354.x; Gamble T, 2008, J BIOGEOGR, V35, P88, DOI 10.1111/j.1365-2699.2007.01770.x; Ganzhorn JU, 2001, ORYX, V35, P346, DOI 10.1046/j.1365-3008.2001.00201.x; GASTON KJ, 1995, BIODIVERS CONSERV, V4, P119, DOI 10.1007/BF00137780; Gillespie RG, 2002, ANNU REV ENTOMOL, V47, P595, DOI 10.1146/annurev.ento.47.091201.145244; Goodman SM, 2004, J BIOGEOGR, V31, P47, DOI 10.1111/j.1365-2699.2004.00953.x; Goodman SM, 2008, INTRO FORETS SECHES, V1, P12; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Harvey MS, 2002, INVERTEBR SYST, V16, P555, DOI 10.1071/IS02009; Huber BA, 2003, ZOOL J LINN SOC-LOND, V137, P261, DOI 10.1046/j.1096-3642.2003.00046.x; Jokat W, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB001802; Kohler F, 2010, BIOL J LINN SOC, V99, P867, DOI 10.1111/j.1095-8312.2009.01390.x; Maddison WP, 2019, MESQUITE MODULAR SYS; Moat J., 2007, ATLAS VEGETATION MAD; Monaghan MT, 2005, P ROY SOC B-BIOL SCI, V272, P1829, DOI 10.1098/rspb.2005.3139; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nixon K.C., 2002, WINCLADA VER 1 00 08; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Poux C, 2005, SYST BIOL, V54, P719, DOI 10.1080/10635150500234534; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Silvestri F., 1897, ANN MUSEO CIVICO STO, V18, P644; Sota T, 2010, P ROY SOC B-BIOL SCI, V277, P689, DOI 10.1098/rspb.2009.1822; Sparks JS, 2004, CLADISTICS, V20, P501, DOI 10.1111/j.1096-0031.2004.00038.x; Sparks JS, 2004, MOL PHYLOGENET EVOL, V33, P719, DOI 10.1016/j.ympev.2004.07.002; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; STOREY BC, 1995, NATURE, V377, P301, DOI 10.1038/377301a0; Swofford DL, 2002, PAUP 4 0B10 PHYLOGEN; Townsend TM, 2009, SYST BIOL, V58, P641, DOI 10.1093/sysbio/syp073; Vences Miguel, 2002, Spixiana, V25, P79; Vences M, 2004, ITAL J ZOOL, V71, P217, DOI 10.1080/11250000409356639; Vences M, 2009, TRENDS ECOL EVOL, V24, P456, DOI 10.1016/j.tree.2009.03.011; Walker MJ, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-25; Wesener T, 2009, TROP ZOOL, V22, P71; Wesener T, 2010, MOL PHYL EVO, DOI [10.1016/j.physletb.2003.10.071, DOI 10.1016/J.PHYSLETB.2003.10.071]; Wesener T, 2008, INVERTEBR SYST, V22, P37, DOI 10.1071/IS07008; Wesener Thomas, 2005, Proceedings of the California Academy of Sciences, V56, P557; Wesener T, 2009, ZOOTAXA, P1; Wesener Thomas, 2009, International Journal of Myriapodology, V2, P15, DOI 10.1163/187525409X462403; Wesener T, 2009, CLADISTICS, V25, P545, DOI 10.1111/j.1096-0031.2009.00267.x; Wesener T, 2009, ZOOKEYS, P1, DOI 10.3897/zookeys.19.221; Wilme L, 2006, SCIENCE, V312, P1063, DOI 10.1126/science.1122806; Wollenberg KC, 2008, EVOLUTION, V62, P1890, DOI 10.1111/j.1558-5646.2008.00420.x; Yeates DK, 2002, INVERTEBR SYST, V16, P605, DOI 10.1071/IT01032; Yoder AD, 2003, NATURE, V421, P734, DOI 10.1038/nature01303; Yoder AD, 2006, DEV PRIMATOL, P255, DOI 10.1007/0-387-31710-4_9; Yu Y., 2011, RASP RECONSTRUCT ANC	56	23	23	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2011	6	12							e28035	10.1371/journal.pone.0028035	http://dx.doi.org/10.1371/journal.pone.0028035			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863OC	22162998	Green Submitted, gold, Green Published			2022-12-27	WOS:000298173500009
J	Holzer, B; Bakshi, S; Bridgen, A; Baron, MD				Holzer, Barbara; Bakshi, Siddharth; Bridgen, Anne; Baron, Michael D.			Inhibition of Interferon Induction and Action by the Nairovirus Nairobi Sheep Disease Virus/Ganjam Virus	PLOS ONE			English	Article							CONGO-HEMORRHAGIC-FEVER; RESPIRATORY SYNDROME CORONAVIRUS; UBIQUITIN-LIKE PROTEIN; PAPAIN-LIKE PROTEASE; STRAND RNA VIRUSES; HUMAN MXA PROTEIN; GANJAM VIRUS; NEGATIVE REGULATION; ANTIVIRAL ACTIVITY; ISG15 CONJUGATION	The Nairoviruses are an important group of tick-borne viruses that includes pathogens of man (Crimean Congo hemorrhagic fever virus) and livestock animals (Dugbe virus, Nairobi sheep disease virus (NSDV)). NSDV is found in large parts of East Africa and the Indian subcontinent (where it is known as Ganjam virus). We have investigated the ability of NSDV to antagonise the induction and actions of interferon. Both pathogenic and apathogenic isolates could actively inhibit the induction of type 1 interferon, and also blocked the signalling pathways of both type 1 and type 2 interferons. Using transient expression of viral proteins or sections of viral proteins, these activities all mapped to the ovarian tumour-like protease domain (OTU) found in the viral RNA polymerase. Virus infection, or expression of this OTU domain in transfected cells, led to a great reduction in the incorporation of ubiquitin or ISG15 protein into host cell proteins. Point mutations in the OTU that inhibited the protease activity also prevented it from antagonising interferon induction and action. Interestingly, a mutation at a peripheral site, which had little apparent effect on the ability of the OTU to inhibit ubiquitination and ISG15ylation, removed the ability of the OTU to block the induction of type 1 and the action of type 2 interferons, but had a lesser effect on the ability to block type 1 interferon action, suggesting that targets other than ubiquitin and ISG15 may be involved in the actions of the viral OTU.	[Holzer, Barbara; Bakshi, Siddharth; Baron, Michael D.] Inst Anim Hlth, Pirbright, Surrey, England; [Bakshi, Siddharth; Bridgen, Anne] Univ Ulster, Sch Biomed Sci, Coleraine BT52 1SA, Londonderry, North Ireland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; Ulster University	Holzer, B (corresponding author), Inst Anim Hlth, Pirbright, Surrey, England.	michael.baron@iah.ac.uk		Bakshi, Siddharth/0000-0002-1179-8623; Holzer, Barbara/0000-0003-0203-0601	United Kingdom Biotechnology and Biological Sciences Research Council (BBSRC) [BB/F00740X/1, BB/F006764/1]; BBSRC [BB/F006764/2, BB/F00740X/1, BBS/E/I/00001433, BB/F006764/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F006764/1, BBS/E/I/00001433, BB/F006764/2, BB/F00740X/1] Funding Source: researchfish	United Kingdom Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the United Kingdom Biotechnology and Biological Sciences Research Council (BBSRC) (grants BB/F00740X/1 and BB/F006764/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akutsu M, 2011, P NATL ACAD SCI USA, V108, P2228, DOI 10.1073/pnas.1015287108; Andersson I, 2004, J VIROL, V78, P4323, DOI 10.1128/JVI.78.8.4323-4329.2004; Andersson I, 2008, J MED VIROL, V80, P1397, DOI 10.1002/jmv.21222; Ank N, 2006, J INTERF CYTOK RES, V26, P373, DOI 10.1089/jir.2006.26.373; Arimoto K, 2010, P NATL ACAD SCI USA, V107, P15856, DOI 10.1073/pnas.1004621107; Barretto N, 2005, J VIROL, V79, P15189, DOI 10.1128/JVI.79.24.15189-15198.2005; Bhoj VG, 2009, NATURE, V458, P430, DOI 10.1038/nature07959; Boxer EL, 2009, VIROLOGY, V385, P134, DOI 10.1016/j.virol.2008.11.022; Bridgen A, 2004, VIRUS RES, V99, P47, DOI 10.1016/j.virusres.2003.10.002; Capodagli GC, 2011, J VIROL, V85, P3621, DOI 10.1128/JVI.02496-10; CHANG KC, 1990, ARCH VIROL, V110, P151, DOI 10.1007/BF01311285; Clementz MA, 2010, J VIROL, V84, P4619, DOI 10.1128/JVI.02406-09; Courtois G, 2008, CELL MOL LIFE SCI, V65, P1123, DOI 10.1007/s00018-007-7465-4; DANDAWAT.CN, 1969, INDIAN J MED RES, V57, P975; DANDAWAT.CN, 1969, INDIAN J MED RES, V57, P799; DAUBNEY R., 1934, PARASITOLOGY, V26, P496, DOI 10.1017/S0031182000023817; DAUBNEY R., 1931, PARASITOLOGY, V23, P507, DOI 10.1017/S0031182000013895; DAVIES FG, 1978, J HYG-CAMBRIDGE, V81, P259, DOI 10.1017/S0022172400025092; DAVIES FG, 1978, J HYG-CAMBRIDGE, V81, P251, DOI 10.1017/S0022172400025080; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; DIAZ MO, 1988, P NATL ACAD SCI USA, V85, P5259, DOI 10.1073/pnas.85.14.5259; DiDonato J, 1996, MOL CELL BIOL, V16, P1295; EMENY JM, 1979, J GEN VIROL, V43, P247, DOI 10.1099/0022-1317-43-1-247; Ergonul O, 2006, LANCET INFECT DIS, V6, P203, DOI 10.1016/S1473-3099(06)70435-2; FARRELL PJ, 1979, NATURE, V279, P523, DOI 10.1038/279523a0; Frias-Staheli N, 2007, CELL HOST MICROBE, V2, P404, DOI 10.1016/j.chom.2007.09.014; Frias-Staheli N, 2011, BUNYAVIRIDAE: MOLECULAR AND CELLULAR BIOLOGY, P129; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Habjan M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002032; Harty RN, 2009, J INNATE IMMUN, V1, P397, DOI 10.1159/000226245; Heyninck K, 2005, TRENDS BIOCHEM SCI, V30, P1, DOI 10.1016/j.tibs.2004.11.001; Honig JE, 2004, VIROLOGY, V321, P29, DOI 10.1016/j.virol.2003.09.042; Hu M, 2006, PLOS BIOL, V4, P228, DOI 10.1371/journal.pbio.0040027; James TW, 2011, P NATL ACAD SCI USA, V108, P2222, DOI 10.1073/pnas.1013388108; Kayagaki N, 2007, SCIENCE, V318, P1628, DOI 10.1126/science.1145918; Lai C, 2009, J VIROL, V83, P1147, DOI 10.1128/JVI.00105-08; Lenschow DJ, 2007, P NATL ACAD SCI USA, V104, P1371, DOI 10.1073/pnas.0607038104; Li S, 2010, J BIOL CHEM, V285, P4291, DOI 10.1074/jbc.M109.074971; Lindner HA, 2005, J VIROL, V79, P15199, DOI 10.1128/JVI.79.24.15199-15208.2005; Malakhov MP, 2003, J BIOL CHEM, V278, P16608, DOI 10.1074/jbc.M208435200; Malynn BA, 2010, IMMUNITY, V33, P843, DOI 10.1016/j.immuni.2010.12.007; Marczinke BI, 2002, VIROLOGY, V303, P146, DOI 10.1006/viro.2002.1514; MONTGOMERY E., 1917, Journal of Comparative Pathology and Therapeutics, V30, P28; Nanda SK, 2006, J VIROL, V80, P7555, DOI 10.1128/JVI.02720-05; Onoguchi K, 2007, J BIOL CHEM, V282, P7576, DOI 10.1074/jbc.M608618200; Osiak A, 2005, MOL CELL BIOL, V25, P6338, DOI 10.1128/MCB.25.15.6338-6345.2005; Park MS, 2003, J VIROL, V77, P9522, DOI 10.1128/JVI.77.17.9522-9532.2003; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Randow F, 2009, NAT CELL BIOL, V11, P527, DOI 10.1038/ncb0509-527; RAO CVRM, 1981, INDIAN J MED RES, V74, P319; Schmaljohn C. S., 2007, FIELDS VIROLOGY, P1743; Shi HX, 2010, MOL CELL BIOL, V30, P2424, DOI 10.1128/MCB.01466-09; Skaug B, 2010, CELL, V143, P187, DOI 10.1016/j.cell.2010.09.033; Strahle L, 2006, VIROLOGY, V351, P101, DOI 10.1016/j.virol.2006.03.022; Sun Z, 2010, J VIROL, V84, P7832, DOI 10.1128/JVI.00217-10; Takeuchi T, 2006, FEBS LETT, V580, P4521, DOI 10.1016/j.febslet.2006.07.032; Uze G, 2007, BIOCHIMIE, V89, P729, DOI 10.1016/j.biochi.2007.01.008; Versteeg GA, 2010, J VIROL, V84, P5423, DOI 10.1128/JVI.02395-09; Viswanathan K, 2010, CURR OPIN MICROBIOL, V13, P517, DOI 10.1016/j.mib.2010.05.012; Weber F, 2006, J VIROL, V80, P5059, DOI 10.1128/JVI.80.10.5059-5064.2006; Wilkinson KD, 2009, J CELL SCI, V122, P2325, DOI 10.1242/jcs.041046; Yuan WM, 2001, EMBO J, V20, P362, DOI 10.1093/emboj/20.3.362; Zhao C, 2005, P NATL ACAD SCI USA, V102, P10200, DOI 10.1073/pnas.0504754102	64	28	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e28594	10.1371/journal.pone.0028594	http://dx.doi.org/10.1371/journal.pone.0028594			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22163042	Green Submitted, Green Published, gold			2022-12-27	WOS:000298172800051
J	Huang, SH; Hainzl, T; Grundstrom, C; Forsman, C; Samuelsson, G; Sauer-Eriksson, AE				Huang, Shenghua; Hainzl, Tobias; Grundstrom, Christin; Forsman, Cecilia; Samuelsson, Goran; Sauer-Eriksson, A. Elisabeth			Structural Studies of beta-Carbonic Anhydrase from the Green Alga Coccomyxa: Inhibitor Complexes with Anions and Acetazolamide	PLOS ONE			English	Article							PH-DEPENDENT ACTIVITY; CRYSTAL-STRUCTURE; PISUM-SATIVUM; ACTIVE-SITE; CO2 HYDRATION; MOLECULAR-GRAPHICS; REFINED STRUCTURE; ESCHERICHIA-COLI; BINDING; ENZYME	The beta-class carbonic anhydrases (beta-CAs) are widely distributed among lower eukaryotes, prokaryotes, archaea, and plants. Like all CAs, the beta-enzymes catalyze an important physiological reaction, namely the interconversion between carbon dioxide and bicarbonate. In plants the enzyme plays an important role in carbon fixation and metabolism. To further explore the structure-function relationship of beta-CA, we have determined the crystal structures of the photoautotroph unicellular green alga Coccomyxa beta-CA in complex with five different inhibitors: acetazolamide, thiocyanate, azide, iodide, and phosphate ions. The tetrameric Coccomyxa beta-CA structure is similar to other beta-CAs but it has a 15 amino acid extension in the C-terminal end, which stabilizes the tetramer by strengthening the interface. Four of the five inhibitors bind in a manner similar to what is found in complexes with alpha-type CAs. Iodide ions, however, make contact to the zinc ion via a zinc-bound water molecule or hydroxide ion - a type of binding mode not previously observed in any CA. Binding of inhibitors to Coccomyxa beta-CA is mediated by side-chain movements of the conserved residue Tyr-88, extending the width of the active site cavity with 1.5-1.8 angstrom. Structural analysis and comparisons with other alpha- and beta-class members suggest a catalytic mechanism in which the movements of Tyr-88 are important for the CO2-HCO3- interconversion, whereas a structurally conserved water molecule that bridges residues Tyr-88 and Gln-38, seems important for proton transfer, linking water molecules from the zinc-bound water to His-92 and buffer molecules.	[Huang, Shenghua; Hainzl, Tobias; Grundstrom, Christin; Forsman, Cecilia; Sauer-Eriksson, A. Elisabeth] Umea Univ, Dept Chem, Umea, Sweden; [Samuelsson, Goran] Umea Univ, Dept Plant Physiol, Umea Plant Sci Ctr, Umea, Sweden	Umea University; Umea University	Huang, SH (corresponding author), Umea Univ, Dept Chem, Umea, Sweden.	elisabeth.sauer-eriksson@chem.umu.se	Samuelsson, Goran/E-1824-2015	Sauer-Eriksson, Elisabeth/0000-0003-0124-0199	Swedish Research Council; Kempe Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Kempe Foundation	This work is funded by the Swedish Research Council and Kempe Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERTI G, 1981, BIOCHIM BIOPHYS ACTA, V668, P16, DOI 10.1016/0005-2795(81)90144-6; ATKINS CA, 1972, PLANT PHYSIOL, V50, P214, DOI 10.1104/pp.50.2.214; ATKINS CA, 1972, PLANT PHYSIOL, V50, P218, DOI 10.1104/pp.50.2.218; Avvaru BS, 2010, BIOCHEMISTRY-US, V49, P249, DOI 10.1021/bi902007b; BADGER MR, 1994, ANNU REV PLANT PHYS, V45, P369, DOI 10.1146/annurev.pp.45.060194.002101; Badger MR, 2003, J EXP BOT, V54, P609, DOI 10.1093/jxb/erg076; Bjorkbacka H, 1997, BIOCHEMISTRY-US, V36, P4287, DOI 10.1021/bi962825k; Bjorkbacka H, 1999, ARCH BIOCHEM BIOPHYS, V361, P17, DOI 10.1006/abbi.1998.0961; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHAKRAVARTY S, 1994, J MOL BIOL, V243, P298, DOI 10.1006/jmbi.1994.1655; Covarrubias AS, 2006, J BIOL CHEM, V281, P4993, DOI 10.1074/jbc.M510756200; Covarrubias AS, 2005, J BIOL CHEM, V280, P18782, DOI 10.1074/jbc.M414348200; Cronk JD, 2006, BIOCHEMISTRY-US, V45, P4351, DOI 10.1021/bi052272q; Cronk JD, 2001, PROTEIN SCI, V10, P911, DOI 10.1110/ps.46301; Di Fiore A, 2009, PROTEINS, V74, P164, DOI 10.1002/prot.22144; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ERIKSSON AE, 1988, PROTEINS, V4, P274, DOI 10.1002/prot.340040406; ERIKSSON AE, 1988, PROTEINS, V4, P283, DOI 10.1002/prot.340040407; Ferry JG, 2010, BBA-PROTEINS PROTEOM, V1804, P374, DOI 10.1016/j.bbapap.2009.08.026; GUILLOTON MB, 1992, J BIOL CHEM, V267, P3731; HewettEmmett D, 1996, MOL PHYLOGENET EVOL, V5, P50, DOI 10.1006/mpev.1996.0006; HILTONEN T, 1995, PLANTA, V195, P345; Hiltonen T, 1998, PLANT PHYSIOL, V117, P1341, DOI 10.1104/pp.117.4.1341; Hoffmann KM, 2011, ARCH BIOCHEM BIOPHYS, V511, P80, DOI 10.1016/j.abb.2011.04.013; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Huang SH, 1998, J MOL BIOL, V283, P301, DOI 10.1006/jmbi.1998.2077; JOHANSSON IM, 1994, EUR J BIOCHEM, V224, P901, DOI 10.1111/j.1432-1033.1994.00901.x; JOHANSSON IM, 1993, EUR J BIOCHEM, V218, P439, DOI 10.1111/j.1432-1033.1993.tb18394.x; Kimber MS, 2000, EMBO J, V19, P1407, DOI 10.1093/emboj/19.7.1407; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; KUMAR V, 1994, ACTA CRYSTALLOGR D, V50, P731, DOI 10.1107/S0907444994001873; Liljas A, 2000, EMBO REP, V1, P16, DOI 10.1093/embo-reports/kvd016; LILJAS A, 1972, NATURE-NEW BIOL, V235, P131, DOI 10.1038/newbio235131a0; LILJAS A, 1994, EUR J BIOCHEM, V219, P1, DOI 10.1111/j.1432-1033.1994.tb19909.x; Lindskog S, 2000, EXS, V90, P175; Lindskog S, 1997, PHARMACOL THERAPEUT, V74, P1, DOI 10.1016/S0163-7258(96)00198-2; Mitsuhashi S, 2000, J BIOL CHEM, V275, P5521, DOI 10.1074/jbc.275.8.5521; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nash TH, 2008, LICHEN BIOLOGY, 2ND EDITION, P1, DOI 10.1017/CBO9780511790478; Otwinowski Z, 2003, ACTA CRYSTALLOGR A, V59, P228, DOI 10.1107/S0108767303005488; Pacchiano F, 2011, BIOORG MED CHEM LETT, V21, P102, DOI 10.1016/j.bmcl.2010.11.064; PALMQVIST K, 1995, PLANTA, V197, P352; Potterton E, 2002, ACTA CRYSTALLOGR D, V58, P1955, DOI 10.1107/S0907444902015391; Rowlett RS, 2010, BBA-PROTEINS PROTEOM, V1804, P362, DOI 10.1016/j.bbapap.2009.08.002; Rowlett RS, 2002, ARCH BIOCHEM BIOPHYS, V404, P197, DOI 10.1016/S0003-9861(02)00243-6; ROWLETT RS, 1994, BIOCHEMISTRY-US, V33, P13967, DOI 10.1021/bi00251a003; Sawaya MR, 2006, J BIOL CHEM, V281, P7546, DOI 10.1074/jbc.M510464200; Sippel KH, 2009, ACTA CRYSTALLOGR F, V65, P992, DOI 10.1107/S1744309109036665; Strop P, 2001, J BIOL CHEM, V276, P10299, DOI 10.1074/jbc.M009182200; Supuran CT, 2008, CURR PHARM DESIGN, V14, P641, DOI 10.2174/138161208783877947; Supuran CT, 2008, CURR PHARM DESIGN, V14, P603, DOI 10.2174/138161208783877884; TIBELL L, 1984, BIOCHIM BIOPHYS ACTA, V789, P302, DOI 10.1016/0167-4838(84)90186-9; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; VIDGREN J, 1990, INT J BIOL MACROMOL, V12, P342, DOI 10.1016/0141-8130(90)90040-H; Whittington DA, 2004, J BIOL CHEM, V279, P7223, DOI 10.1074/jbc.M310809200	56	35	36	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e28458	10.1371/journal.pone.0028458	http://dx.doi.org/10.1371/journal.pone.0028458			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22162771	Green Published, Green Submitted, gold			2022-12-27	WOS:000298172800038
J	Liu, B; Jiang, GF; Zhang, YF; Li, JL; Li, XJ; Yue, JS; Chen, F; Liu, HQ; Li, HJ; Zhu, SP; Wang, JJ; Ran, C				Liu, Bin; Jiang, Gaofei; Zhang, Yunfei; Li, Junli; Li, Xiaojiao; Yue, Jiansu; Chen, Fei; Liu, Haoqiang; Li, Hongjun; Zhu, Shiping; Wang, Jinjun; Ran, Chun			Analysis of Transcriptome Differences between Resistant and Susceptible Strains of the Citrus Red Mite Panonychus citri (Acari: Tetranychidae)	PLOS ONE			English	Article							COMMON SENSITIZING ALLERGEN; EUKARYOTIC TRANSCRIPTOME; HEXYTHIAZOX RESISTANCE; GENE-EXPRESSION; MCGREGOR; VECTOR; GENOME; TOOL	Background: The citrus red mite is a worldwide citrus pest and a common sensitizing allergen of asthma and rhinitis. It has developed strong resistance to many registered acaricides, However, the molecular mechanisms of resistance remain unknown. we therefore used next generation sequencing technology to investigate the global transcriptomes between resistant strains and susceptible strains. Results: We obtained 34,159, 30,466 and 32,217 unigenes by assembling the SS reads, RS reads and SS&RS reads respectively. There are total 17,581 annotated unigenes from SS&RS reads by BLAST searching databases of nr, the Clusters of Orthologous Groups (COGs) and Kyoto Encyclopedia of Genes and Genomes (KEGG) with an E-value <= 1e-5, in which 7,075 unigenes were annotated in the COG database, 12, 712 unigenes were found in the KEGG database and 3,812 unigenes were assigned to Gene ontology (GO). Moreover, 2,701 unigenes were judged to be the differentially expressed genes (DEGs) based on the uniquely mapped reads. There are 219 pathways in all annotated unigenes and 198 pathways in DEGs that mapped to the KEGG database. We identified 211 metabolism genes and target genes related to general insecticide resistance such as P450 and Cytochrome b, and further compared their differences between RS and SS. Meanwhile, we identified 105 and 194 genes related to growth and reproduction, respectively, based on the mode of action of Hexythiazox. After further analyses, we found variation in sequences but not in gene expression related to mite growth and reproduction between different strains. Conclusion: To our knowledge, this is the first comparative transcriptome study to discover candidate genes involved in phytophagous mite resistance. This study identified differential unigenes related to general pesticide resistance and organism growth and reproduction in P. citri. The assembled, annotated transcriptomes provide a valuable genomic resource for further understanding the molecular basis of resistance mechanisms.	[Liu, Bin; Li, Xiaojiao; Yue, Jiansu] Southwest Univ, Key Lab Hort Sci So Mountainous Reg, Coll Hort & Landscape Architecture, Minist Educ, Chongqing, Peoples R China; [Liu, Bin; Jiang, Gaofei; Zhang, Yunfei; Li, Junli; Li, Xiaojiao; Yue, Jiansu; Chen, Fei; Liu, Haoqiang; Li, Hongjun; Zhu, Shiping; Ran, Chun] Chinese Acad Agr Sci, Citrus Res Inst, Natl Engn Res Ctr Citrus, Chongqing, Peoples R China; [Chen, Fei; Wang, Jinjun] Southwest Univ, Key Lab Entomol & Pest Control Engn, Coll Plant Protect, Chongqing, Peoples R China	Southwest University - China; Chinese Academy of Agricultural Sciences; Southwest University - China	Liu, B (corresponding author), Southwest Univ, Key Lab Hort Sci So Mountainous Reg, Coll Hort & Landscape Architecture, Minist Educ, Chongqing, Peoples R China.	ranchun@sohu.com			Science and Technique Foundation of CQ (CSTC) [2010AC1018]; Program for Changjiang Scholars and Innovative Research Team in University [IRT0976]	Science and Technique Foundation of CQ (CSTC); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by the Science and Technique Foundation of CQ (CSTC, 2010AC1018) and the Program for Changjiang Scholars and Innovative Research Team in University (IRT0976). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bolland HR., 1998, WORLD CATALOGUE SPID; Campos FJ, 2002, EXP APPL ACAROL, V26, P243, DOI 10.1023/A:1021103209193; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Chen ZY, 2009, INT J ACAROL, V35, P33, DOI 10.1080/01647950802655293; Crawford JE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014202; Daborn PJ, 2002, SCIENCE, V297, P2253, DOI 10.1126/science.1074170; Faunes F, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-r15; Feng XP, 2002, J NEUROCHEM, V83, P870, DOI 10.1046/j.1471-4159.2002.01199.x; Furuhashi K., 1994, P KANSAI PLANT PROT, V41, P267; GOUGH N, 1990, CROP PROT, V9, P119, DOI 10.1016/0261-2194(90)90090-T; Hegedus Z, 2009, MOL IMMUNOL, V46, P2918, DOI 10.1016/j.molimm.2009.07.002; HOY MA, 1986, J ECON ENTOMOL, V79, P1377, DOI 10.1093/jee/79.5.1377; Hu JF, 2010, PEST MANAG SCI, V66, P1025, DOI 10.1002/ps.1978; Hudson ME, 2008, MOL ECOL RESOUR, V8, P3, DOI 10.1111/j.1471-8286.2007.02019.x; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Jiang HB, 2010, ARCH INSECT BIOCHEM, V74, P17, DOI 10.1002/arch.20358; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Karunker I, 2008, INSECT BIOCHEM MOLEC, V38, P634, DOI 10.1016/j.ibmb.2008.03.008; KATAOKA H, 1991, AGR BIOL CHEM TOKYO, V55, P73, DOI 10.1080/00021369.1991.10870535; Kim YK, 1999, CLIN EXP ALLERGY, V29, P1102, DOI 10.1046/j.1365-2222.1999.00607.x; Kim YK, 1999, ANN ALLERG ASTHMA IM, V82, P223, DOI 10.1016/S1081-1206(10)62601-4; Komagata O, 2010, INSECT BIOCHEM MOLEC, V40, P146, DOI 10.1016/j.ibmb.2010.01.006; Lee MH, 2000, ANN ALLERG ASTHMA IM, V85, P200, DOI 10.1016/S1081-1206(10)62467-2; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Masui S., 1995, P KANTO TOSAN PLANT, V42, P245; Meng H.S., 2000, PESTICIDES, P26; Morin S, 2002, INSECT BIOCHEM MOLEC, V32, P1781, DOI 10.1016/S0965-1748(02)00137-6; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Nikou D, 2003, GENE, V318, P91, DOI 10.1016/S0378-1119(03)00763-7; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Price DP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022573; Ran Chun, 2008, Acta Phytophylacica Sinica, V35, P537; Ran C, 2009, INT J ACAROL, V35, P115, DOI 10.1080/01647950902917593; Van Leeuwen T, 2011, INSECT MOL BIOL, V20, P135, DOI 10.1111/j.1365-2583.2010.01040.x; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002; Xue JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014233; Yamamoto A, 1996, J PESTIC SCI, V21, P37; YAMAMOTO A, 1995, J PESTIC SCI, V20, P513; Yassour M, 2009, P NATL ACAD SCI USA, V106, P3264, DOI 10.1073/pnas.0812841106; Yuan ML, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-597; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang ZhiQiang, 2003, Mites of greenhouses: identification, biology and control, DOI 10.1079/9780851995908.0000; Zhou L, 2009, J MED ENTOMOL, V46, P321, DOI 10.1603/033.046.0217	47	58	63	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e28516	10.1371/journal.pone.0028516	http://dx.doi.org/10.1371/journal.pone.0028516			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22162774	gold, Green Published, Green Submitted			2022-12-27	WOS:000298172800044
J	Marquez, B; Ameye, G; Vallet, CM; Tulkens, PM; Poirel, HA; Van Bambeke, F				Marquez, Beatrice; Ameye, Genevieve; Vallet, Coralie M.; Tulkens, Paul M.; Poirel, Helene A.; Van Bambeke, Francoise			Characterization of Abcc4 Gene Amplification in Stepwise-Selected Mouse J774 Macrophages Resistant to the Topoisomerase II Inhibitor Ciprofloxacin	PLOS ONE			English	Article							MULTIDRUG-RESISTANCE; IN-VITRO; EFFLUX TRANSPORTER; EPIGENETIC CHANGES; CELL-LINES; QUINOLONES; DNA; IDENTIFICATION; MRP4/ABCC4; MRP4	Exposure of J774 mouse macrophages to stepwise increasing concentrations of ciprofloxacin, an antibiotic inhibiting bacterial topoisomerases, selects for resistant cells that overexpress the efflux transporter Abcc4 (Marquez et al. [2009] Antimicrob. Agents Chemother. 53:2410-2416), encoded by the Abcc4 gene located on Chromosome 14qE4. In this study, we report the genomic alterations occurring along the selection process. Abcc4 expression progressively increased upon selection rounds, with exponential changes observed between cells exposed to 150 and 200 mu M of ciprofloxacin, accompanied by a commensurate decrease in ciprofloxacin accumulation. Molecular cytogenetics experiments showed that this overexpression is linked to Abcc4 gene overrepresentation, grading from a partial trisomy of Chr 14 at the first step of selection (cells exposed to 100 mu M ciprofloxacin), to low-level amplifications (around three copies) of Abcc4 locus on 1 or 2 Chr 14 (cells exposed to 150 mu M ciprofloxacin), followed by high-level amplification of Abcc4 as homogeneous staining region (hsr), inserted on 3 different derivative Chromosomes (cells exposed to 200 mu M ciprofloxacin). In revertant cells obtained after more than 60 passages of culture without drug, the Abcc4 hsr amplification was lost in approx. 70% of the population. These data suggest that exposing cells to sufficient concentrations of an antibiotic with low affinity for eukaryotic topoisomerases can cause major genomic alterations that may lead to the overexpression of the transporter responsible for its efflux. Gene amplification appears therefore as a mechanism of resistance that can be triggered by non-anticancer agents but contribute to cross-resistance, and is partially and slowly reversible.	[Marquez, Beatrice] Hosp Univ Virgen del Rocio, Grp Tumorigenesis Endocrina & Regulac Hormonal Ca, Inst Biomed Sevilla, Seville, Spain; [Marquez, Beatrice; Vallet, Coralie M.; Tulkens, Paul M.; Van Bambeke, Francoise] Catholic Univ Louvain, Louvain Drug Res Inst, Brussels, Belgium; [Ameye, Genevieve; Poirel, Helene A.] Catholic Univ Louvain, Clin Univ St Luc, Ctr Genet Humaine, Brussels, Belgium	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; Universite Catholique Louvain; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc	Marquez, B (corresponding author), Hosp Univ Virgen del Rocio, Grp Tumorigenesis Endocrina & Regulac Hormonal Ca, Inst Biomed Sevilla, Seville, Spain.	francoise.vanbambeke@uclouvain.be	Van Bambeke, Françoise/H-5934-2019; IBIS, TUMORIGENESIS/P-3506-2015; Tulkens, Paul/B-2087-2015	Van Bambeke, Françoise/0000-0002-0052-7991; Tulkens, Paul/0000-0002-7121-3623	Fonds National belge de la Recherche Medicale [3.4.597.06, 3.4.583.08]; Belgian Fonds de la Recherche Scientifique [1.5.195.07, 1.5.137.10]; Belgian Federal Science Policy Office [P6/19]	Fonds National belge de la Recherche Medicale(Fonds de la Recherche Scientifique - FNRS); Belgian Fonds de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); Belgian Federal Science Policy Office(Belgian Federal Science Policy Office)	This work was supported by the Fonds National belge de la Recherche Medicale (grants no. 3.4.597.06 and 3.4.583.08), the Belgian Fonds de la Recherche Scientifique (grants no. 1.5.195.07 and 1.5.137.10), and the Belgian Federal Science Policy Office (Research project P6/19 [research action P6]). C.M.V. is Boursier of the Belgian Fonds pour la Recherche dans l'Industrie et l'Agriculture (F.R.I.A.), B.M. was successively post-doctoral fellow of the First post-doc program of the Belgian Region wallonne and of the Fonds speciaux de recherche de l'Universite catholique de Louvain, F.V.B. is Maitre de Recherches of the Belgian Fonds de la Recherche Scientifique (F.R.S.-FNRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERTINI S, 1995, MUTAGENESIS, V10, P343, DOI 10.1093/mutage/10.4.343; Albertson DG, 2006, TRENDS GENET, V22, P447, DOI 10.1016/j.tig.2006.06.007; Ansari M, 2009, BLOOD, V114, P1383, DOI 10.1182/blood-2008-11-191098; Anupama M, 2010, ARCH TOXICOL, V84, P411, DOI 10.1007/s00204-009-0509-9; Baker EK, 2005, ONCOGENE, V24, P8061, DOI 10.1038/sj.onc.1208955; Belinsky MG, 2007, CANCER RES, V67, P262, DOI 10.1158/0008-5472.CAN-06-2680; Calcagno AM, 2008, BRIT J CANCER, V98, P1515, DOI 10.1038/sj.bjc.6604334; Choi HK, 2007, ENDOCR-RELAT CANCER, V14, P293, DOI 10.1677/ERC-06-0016; Drlica K, 2008, ANTIMICROB AGENTS CH, V52, P385, DOI 10.1128/AAC.01617-06; Eckford PDW, 2009, CHEM REV, V109, P2989, DOI 10.1021/cr9000226; ELSEA SH, 1992, J BIOL CHEM, V267, P13150; European Medicines Agency, 2009, WHIT PAP RES ENG ATM, P1; Fojo T, 2007, DRUG RESIST UPDATE, V10, P59, DOI 10.1016/j.drup.2007.02.002; Foroumadi A, 2009, BIOMED PHARMACOTHER, V63, P216, DOI 10.1016/j.biopha.2008.01.016; Gorla N, 1999, TOXICOL LETT, V104, P43, DOI 10.1016/S0378-4274(98)00230-6; Gottesman MM, 1998, METHOD ENZYMOL, V292, P248; Graux C, 2009, LEUKEMIA, V23, P125, DOI 10.1038/leu.2008.278; Haslam IS, 2011, DRUG METAB DISPOS; Helmrich A, 2006, GENOME RES, V16, P1222, DOI 10.1101/gr.5335506; Herbold BA, 2001, MUTAT RES-GEN TOX EN, V498, P193, DOI 10.1016/S1383-5718(01)00275-3; Ho LL, 2008, PROSTATE, V68, P1421, DOI 10.1002/pros.20809; Itoh S, 2002, MUTAT RES-GEN TOX EN, V517, P113, DOI 10.1016/S1383-5718(02)00058-X; Itoh T, 2006, MUTAT RES-GEN TOX EN, V603, P135, DOI 10.1016/j.mrgentox.2005.11.003; Knutsen T, 1998, GENE CHROMOSOME CANC, V23, P44, DOI 10.1002/(SICI)1098-2264(199809)23:1<44::AID-GCC7>3.0.CO;2-6; Krishnamurthy P, 2008, CANCER RES, V68, P4983, DOI 10.1158/0008-5472.CAN-07-6790; LEE JJ, 1990, ANAL BIOCHEM, V189, P1, DOI 10.1016/0003-2697(90)90036-9; Lee W, 2008, EXP MOL MED, V40, P109, DOI 10.3858/emm.2008.40.1.109; LEPAGE P, 1993, MOL CELL BIOL, V13, P7380, DOI 10.1128/MCB.13.12.7380; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lynch A, 2003, MUTAGENESIS, V18, P345, DOI 10.1093/mutage/geg003; Marquez B, 2011, CURR DRUG TARGETS, V12, P600, DOI 10.2174/138945011795378504; Marquez B, 2009, ANTIMICROB AGENTS CH, V53, P2410, DOI 10.1128/AAC.01428-08; Michot JM, 2005, ANTIMICROB AGENTS CH, V49, P2429, DOI 10.1128/AAC.49.6.2429-2437.2005; Michot JM, 2006, ANTIMICROB AGENTS CH, V50, P1689, DOI 10.1128/AAC.50.5.1689-1695.2006; Michot JM, 2004, ANTIMICROB AGENTS CH, V48, P2673, DOI 10.1128/AAC.48.7.2673-2682.2004; Mickley LA, 1997, J CLIN INVEST, V99, P1947, DOI 10.1172/JCI119362; MITELMAN F, 1988, ANTIMICROB AGENTS CH, V32, P936, DOI 10.1128/AAC.32.6.936; Mottino AD, 2008, WORLD J GASTROENTERO, V14, P7068, DOI 10.3748/wjg.14.7068; MUKHERJEE A, 1993, MUTAT RES, V301, P87, DOI 10.1016/0165-7992(93)90029-U; Norris MD, 2005, MOL CANCER THER, V4, P547, DOI 10.1158/1535-7163.MCT-04-0161; Peng XX, 2008, LEUKEMIA RES, V32, P799, DOI 10.1016/j.leukres.2007.09.015; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rajabalian S, 2007, J PHARM PHARM SCI, V10, P153; Rao VK, 2005, CANCER GENET CYTOGEN, V160, P126, DOI 10.1016/j.cancergencyto.2004.12.013; Rosen JE, 1996, TOXICOL APPL PHARM, V140, P254, DOI 10.1006/taap.1996.0220; Rund D, 1999, ADV EXP MED BIOL, V457, P71; Russel FGM, 2008, TRENDS PHARMACOL SCI, V29, P200, DOI 10.1016/j.tips.2008.01.006; Schuetz JD, 1999, NAT MED, V5, P1048, DOI 10.1038/12487; SLOVAK ML, 1993, CANCER RES, V53, P3221; SLOVAK ML, 1988, LEUKEMIA, V2, P453; SNYDERMAN R, 1977, J IMMUNOL, V119, P2060; TULKENS PM, 1991, EUR J CLIN MICROBIOL, V10, P100, DOI 10.1007/BF01964420; Wielinga PR, 2002, MOL PHARMACOL, V62, P1321, DOI 10.1124/mol.62.6.1321; Yasui K, 2004, CANCER RES, V64, P1403, DOI 10.1158/0008-5472.CAN-3263-2	54	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e28368	10.1371/journal.pone.0028368	http://dx.doi.org/10.1371/journal.pone.0028368			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22162766	Green Submitted, gold, Green Published			2022-12-27	WOS:000298172800029
J	Staats, M; Cuenca, A; Richardson, JE; Vrielink-van Ginkel, R; Petersen, G; Seberg, O; Bakker, FT				Staats, Martijn; Cuenca, Argelia; Richardson, James E.; Vrielink-van Ginkel, Ria; Petersen, Gitte; Seberg, Ole; Bakker, Freek T.			DNA Damage in Plant Herbarium Tissue	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; MISCODING LESIONS; ANCIENT; AMPLIFICATION; PRESERVATION; SPECIMENS; SEQUENCES; REVEALS; REPAIR; EXTRACTION	Dried plant herbarium specimens are potentially a valuable source of DNA. Efforts to obtain genetic information from this source are often hindered by an inability to obtain amplifiable DNA as herbarium DNA is typically highly degraded. DNA post-mortem damage may not only reduce the number of amplifiable template molecules, but may also lead to the generation of erroneous sequence information. A qualitative and quantitative assessment of DNA post-mortem damage is essential to determine the accuracy of molecular data from herbarium specimens. In this study we present an assessment of DNA damage as miscoding lesions in herbarium specimens using 454-sequencing of amplicons derived from plastid, mitochondrial, and nuclear DNA. In addition, we assess DNA degradation as a result of strand breaks and other types of polymerase non-bypassable damage by quantitative real-time PCR. Comparing four pairs of fresh and herbarium specimens of the same individuals we quantitatively assess post-mortem DNA damage, directly after specimen preparation, as well as after long-term herbarium storage. After specimen preparation we estimate the proportion of gene copy numbers of plastid, mitochondrial, and nuclear DNA to be 2.4-3.8% of fresh control DNA and 1.0-1.3% after long-term herbarium storage, indicating that nearly all DNA damage occurs on specimen preparation. In addition, there is no evidence of preferential degradation of organelle versus nuclear genomes. Increased levels of C -> T/G -> A transitions were observed in old herbarium plastid DNA, representing 21.8% of observed miscoding lesions. We interpret this type of post-mortem DNA damage-derived modification to have arisen from the hydrolytic deamination of cytosine during long-term herbarium storage. Our results suggest that reliable sequence data can be obtained from herbarium specimens.	[Staats, Martijn; Vrielink-van Ginkel, Ria; Bakker, Freek T.] Wageningen Univ, Biosyst Grp, Wageningen, Netherlands; [Cuenca, Argelia; Petersen, Gitte; Seberg, Ole] Univ Copenhagen, Lab Mol Syst, Nat Hist Museum Denmark, Copenhagen, Denmark; [Richardson, James E.] Royal Bot Garden Edinburgh, Trop Divers Sect, Edinburgh, Midlothian, Scotland; [Richardson, James E.] Univ Los Andes, Lab Botan & Sistemat, Bogota, Colombia	Wageningen University & Research; University of Copenhagen; Universidad de los Andes (Colombia)	Staats, M (corresponding author), Wageningen Univ, Biosyst Grp, Wageningen, Netherlands.	freek.bakker@wur.nl	Richardson, James-Edward/L-2768-2016; Petersen, Gitte/H-1903-2011; Cuenca, Argelia/AAK-9053-2021; Seberg, Ole/A-5111-2013	Richardson, James-Edward/0000-0001-9014-4865; Petersen, Gitte/0000-0002-2325-0059; Cuenca, Argelia/0000-0001-8596-1086; Seberg, Ole/0000-0001-9675-4090; Bakker, Freek T./0000-0003-0227-6687	European Community	European Community(European Commission)	This work was supported by SYNTHESYS2 made available by the European Community Research Infrastructure under FP7 [Synthesis of Systematic Resources', 226506-CP-CSA-Infra]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Bebber DP, 2010, P NATL ACAD SCI USA, V107, P22169, DOI 10.1073/pnas.1011841108; Blankenberg D., 2010, CURR PROTOC MOL BIOL, V19, P101; Blankenberg D, 2010, BIOINFORMATICS, V26, P1783, DOI 10.1093/bioinformatics/btq281; Boesch P, 2011, BBA-MOL CELL RES, V1813, P186, DOI 10.1016/j.bbamcr.2010.10.002; Briggs AW, 2007, P NATL ACAD SCI USA, V104, P14616, DOI 10.1073/pnas.0704665104; Briggs AW, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1163; Brotherton P, 2007, NUCLEIC ACIDS RES, V35, P5717, DOI 10.1093/nar/gkm588; CHASE MW, 1991, TAXON, V40, P215, DOI 10.2307/1222975; Cubero OF, 1999, PLANT SYST EVOL, V216, P243, DOI 10.1007/BF01084401; Doyle J. J., 1987, PHYTOCHEM B, P11; DOYLE JJ, 1987, TAXON, V36, P715, DOI 10.2307/1221122; Drabkova L, 2002, PLANT MOL BIOL REP, V20, P161, DOI 10.1007/BF02799431; Gilbert MTP, 2003, AM J HUM GENET, V72, P48, DOI 10.1086/345379; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Hansen AJ, 2001, MOL BIOL EVOL, V18, P262, DOI 10.1093/oxfordjournals.molbev.a003800; Hansen AJ, 2006, GENETICS, V173, P1175, DOI 10.1534/genetics.106.057349; HARRIS SA, 1993, PLANT SYST EVOL, V188, P57, DOI 10.1007/BF00937835; Heyn P, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq572; Hofreiter M, 2001, NUCLEIC ACIDS RES, V29, P4793, DOI 10.1093/nar/29.23.4793; Joppa LN, 2011, P ROY SOC B-BIOL SCI, V278, P554, DOI 10.1098/rspb.2010.1004; Lindahl T, 1999, SCIENCE, V286, P1897, DOI 10.1126/science.286.5446.1897; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; LINDAHL T, 1990, MUTAT RES, V238, P305, DOI 10.1016/0165-1110(90)90022-4; LINDAHL T, 1972, BIOCHEMISTRY-US, V11, P3610, DOI 10.1021/bi00769a018; McCabe PF, 1997, PLANT J, V12, P267, DOI 10.1046/j.1365-313X.1997.12020267.x; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Millar CD, 2008, TRENDS ECOL EVOL, V23, P386, DOI 10.1016/j.tree.2008.04.002; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; PAABO S, 1990, J BIOL CHEM, V265, P4718; Proost S, 2009, PLANT CELL, V21, P3718, DOI 10.1105/tpc.109.071506; PYLE MM, 1989, TAXON, V38, P576, DOI 10.2307/1222632; Reape TJ, 2008, J EXP BOT, V59, P435, DOI 10.1093/jxb/erm258; Roldan-Arjona T, 2009, MUTAT RES-REV MUTAT, V681, P169, DOI 10.1016/j.mrrev.2008.07.003; Rowan BA, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-3; SAVOLAINEN V, 1995, PLANT SYST EVOL, V197, P87, DOI 10.1007/BF00984634; Sebastian P, 2010, P NATL ACAD SCI USA, V107, P14269, DOI 10.1073/pnas.1005338107; Shapiro B, 2008, TRENDS BIOTECHNOL, V26, P285, DOI 10.1016/j.tibtech.2008.03.005; Smith DR, 2009, PLANT MOL BIOL, V71, P627, DOI 10.1007/s11103-009-9545-3; Srinivasan M, 2002, AM J PATHOL, V161, P1961, DOI 10.1016/S0002-9440(10)64472-0; Stiller M, 2006, P NATL ACAD SCI USA, V103, P13578, DOI 10.1073/pnas.0605327103; Telle S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003584; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306	44	126	139	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e28448	10.1371/journal.pone.0028448	http://dx.doi.org/10.1371/journal.pone.0028448			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22163018	Green Published, Green Submitted, gold			2022-12-27	WOS:000298172800037
J	Zhai, QT; Landesman, MB; Robinson, H; Sundquist, WI; Hill, CP				Zhai, Qianting; Landesman, Michael B.; Robinson, Howard; Sundquist, Wesley I.; Hill, Christopher P.			Structure of the Bro1 Domain Protein BROX and Functional Analyses of the ALIX Bro1 Domain in HIV-1 Budding	PLOS ONE			English	Article							ESCRT MACHINERY; BINDING-PROTEIN; HD-PTP; ALIX/AIP1; IDENTIFICATION; RHOPHILIN-2; INTERACT; SCISSION; MIDBODY; TARGETS	Background: Bro1 domains are elongated, banana-shaped domains that were first identified in the yeast ESCRT pathway protein, Bro1p. Humans express three Bro1 domain-containing proteins: ALIX, BROX, and HD-PTP, which function in association with the ESCRT pathway to help mediate intraluminal vesicle formation at multivesicular bodies, the abscission stage of cytokinesis, and/or enveloped virus budding. Human Bro1 domains share the ability to bind the CHMP4 subset of ESCRT-III proteins, associate with the HIV-1 NCGag protein, and stimulate the budding of viral Gag proteins. The curved Bro1 domain structure has also been proposed to mediate membrane bending. To date, crystal structures have only been available for the related Bro1 domains from the Bro1p and ALIX proteins, and structures of additional family members should therefore aid in the identification of key structural and functional elements. Methodology/Principal Findings: We report the crystal structure of the human BROX protein, which comprises a single Bro1 domain. The Bro1 domains from BROX, Bro1p and ALIX adopt similar overall structures and share two common exposed hydrophobic surfaces. Surface 1 is located on the concave face and forms the CHMP4 binding site, whereas Surface 2 is located at the narrow end of the domain. The structures differ in that only ALIX has an extended loop that projects away from the convex face to expose the hydrophobic Phe105 side chain at its tip. Functional studies demonstrated that mutations in Surface 1, Surface 2, or Phe105 all impair the ability of ALIX to stimulate HIV-1 budding. Conclusions/Significance: Our studies reveal similarities in the overall folds and hydrophobic protein interaction sites of different Bro1 domains, and show that a unique extended loop contributes to the ability of ALIX to function in HIV-1 budding.	[Zhai, Qianting; Landesman, Michael B.; Sundquist, Wesley I.; Hill, Christopher P.] Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84112 USA; [Robinson, Howard] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA	Utah System of Higher Education; University of Utah; United States Department of Energy (DOE); Brookhaven National Laboratory	Zhai, QT (corresponding author), Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84112 USA.	wes@biochem.utah.edu; chris@biochem.utah.edu	zhai, qianting/G-1301-2013		National Institutes of Health (NIH) [AI051174, P50 082545]; Office of Basic Energy Sciences at the United States Department of Energy; National Center for Research Resources; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI051174, R01AI051174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM082545] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Basic Energy Sciences at the United States Department of Energy(United States Department of Energy (DOE)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) Grants AI051174 (to WIS) and P50 082545 (CPH). Operations of the National Synchrotron Light Source (NSLS) are supported by the Office of Basic Energy Sciences at the United States Department of Energy and by the NIH. Data collection at the NSLS was funded by the National Center for Research Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ahmed S, 2010, SEMIN CELL DEV BIOL, V21, P350, DOI 10.1016/j.semcdb.2009.11.008; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Caballe A, 2011, TRAFFIC; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; Chernomordik LV, 2003, ANNU REV BIOCHEM, V72, P175, DOI 10.1146/annurev.biochem.72.121801.161504; Doyotte A, 2008, P NATL ACAD SCI USA, V105, P6308, DOI 10.1073/pnas.0707601105; Dussupt V, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000339; Eekels JJM, 2011, ANTIVIR RES, V89, P43, DOI 10.1016/j.antiviral.2010.11.005; Fisher RD, 2007, CELL, V128, P841, DOI 10.1016/j.cell.2007.01.035; Grosse-Kunstleve RW, 2003, ACTA CRYSTALLOGR D, V59, P1966, DOI 10.1107/S0907444903018043; Henne WM, 2011, DEV CELL, V21, P77, DOI 10.1016/j.devcel.2011.05.015; Hurley JH, 2006, BBA-MOL CELL BIOL L, V1761, P805, DOI 10.1016/j.bbalip.2006.02.020; Hurley JH, 2010, NAT REV MOL CELL BIO, V11, P556, DOI 10.1038/nrm2937; Ichioka F, 2008, FEBS J, V275, P682, DOI 10.1111/j.1742-4658.2007.06230.x; Ichioka F, 2007, ARCH BIOCHEM BIOPHYS, V457, P142, DOI 10.1016/j.abb.2006.11.008; Kim JW, 2005, DEV CELL, V8, P937, DOI 10.1016/j.devcel.2005.04.001; Lee HH, 2008, SCIENCE, V322, P576, DOI 10.1126/science.1162042; Lee S, 2007, NAT STRUCT MOL BIOL, V14, P194, DOI 10.1038/nsmb1203; McCoy AJ, 2004, ACTA CRYSTALLOGR D, V60, P1220, DOI 10.1107/S0907444904009990; McCullough J, 2008, P NATL ACAD SCI USA, V105, P7687, DOI 10.1073/pnas.0801567105; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; Mircescu H, 2002, EUR J BIOCHEM, V269, P6241, DOI 10.1046/j.1432-1033.2002.03343.x; Morita E, 2007, EMBO J, V26, P4215, DOI 10.1038/sj.emboj.7601850; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Painter J, 2005, ACTA CRYSTALLOGR D, V61, P465, DOI 10.1107/S0907444905001897; Peck JW, 2002, J BIOL CHEM, V277, P43924, DOI 10.1074/jbc.M203569200; Peck JW, 2004, BIOCHEM J, V377, P693, DOI 10.1042/bj20031347; Pires R, 2009, STRUCTURE, V17, P843, DOI 10.1016/j.str.2009.04.007; Popov S, 2008, J VIROL, V82, P1389, DOI 10.1128/JVI.01912-07; Popov S, 2009, J VIROL, V83, P7185, DOI 10.1128/JVI.00198-09; Roberts-Galbraith RH, 2010, CELL CYCLE, V9, P4091, DOI 10.4161/cc.9.20.13587; Rual JF, 2004, GENOME RES, V14, P2128, DOI 10.1101/gr.2973604; Salmon P, 2000, MOL THER, V2, P404, DOI 10.1006/mthe.2000.0141; Schmidt MHH, 2005, J BIOL CHEM, V280, P3414, DOI 10.1074/jbc.M409839200; Sette P, 2011, STRUCTURE; Shnyrova AV, 2009, CURR BIOL, V19, pR772, DOI 10.1016/j.cub.2009.07.063; Stefani F, 2011, CURR BIOL, V21, P1245, DOI 10.1016/j.cub.2011.06.028; Steuve S, 2006, EXP CELL RES, V312, P3981, DOI 10.1016/j.yexcr.2006.08.028; Strack B, 2003, CELL, V114, P689, DOI 10.1016/S0092-8674(03)00653-6; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; TERWILLIGER TC, 1994, ACTA CRYSTALLOGR D, V50, P11, DOI 10.1107/S0907444993008224; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Toyooka S, 2000, BIOCHEM BIOPH RES CO, V278, P671, DOI 10.1006/bbrc.2000.3870; Usami Y, 2007, J VIROL, V81, P6614, DOI 10.1128/JVI.00314-07; Watanabe G, 1996, SCIENCE, V271, P645, DOI 10.1126/science.271.5249.645; Wemmer M, 2011, J CELL BIOL, V192, P295, DOI 10.1083/jcb.201007018; Zhai Q, 2008, NAT STRUCT MOL BIOL, V15, P43, DOI 10.1038/nsmb1319; Zhai QT, 2011, J VIROL, V85, P632, DOI 10.1128/JVI.01683-10	50	21	21	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e27466	10.1371/journal.pone.0027466	http://dx.doi.org/10.1371/journal.pone.0027466			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22162750	Green Published, Green Submitted, gold			2022-12-27	WOS:000298172800005
J	Sato, W; Kochiyama, T; Uono, S; Matsuda, K; Usui, K; Inoue, Y; Toichi, M				Sato, Wataru; Kochiyama, Takanori; Uono, Shota; Matsuda, Kazumi; Usui, Keiko; Inoue, Yushi; Toichi, Motomi			Rapid Amygdala Gamma Oscillations in Response to Eye Gaze	PLOS ONE			English	Article							ATTENTIONAL SHIFT; RANDOM-FIELD; PERCEPTION; MECHANISMS; INFERENCE; AUTISM	Background: The eye gaze of other individuals conveys important social information and can trigger multiple psychological activities; some of which, such as emotional reactions and attention orienting, occur very rapidly. Although some neuroscientific evidence has suggested that the amygdala may be involved in such rapid gaze processing, no evidence has been reported concerning the speed at which the amygdala responds to eye gaze. Methodology/Principal Findings: To investigate this issue, we recorded electrical activity within the amygdala of six subjects using intracranial electrodes. Subjects observed images of eyes and mosaics pointing in averted and straight directions. The amygdala showed higher gamma-band oscillations for eye gaze than for mosaics, which peaked at 200 ms regardless of the direction of the gaze. Conclusion: These results indicate that the human amygdala rapidly processes eye gaze.	[Sato, Wataru; Kochiyama, Takanori] Kyoto Univ, Hakubi Project, Inuyama, Aichi, Japan; [Uono, Shota; Toichi, Motomi] Kyoto Univ, Fac Human Hlth Sci, Kyoto, Japan; [Matsuda, Kazumi; Usui, Keiko; Inoue, Yushi] Shizuoka Inst Epilepsy & Neurol Disorders, Natl Epilepsy Ctr, Shizuoka, Shizuoka, Japan	Kyoto University; Kyoto University	Sato, W (corresponding author), Kyoto Univ, Hakubi Project, Inuyama, Aichi, Japan.	sato@pri.kyoto-u.ac.jp	Sato, Wataru/E-7503-2017	Sato, Wataru/0000-0002-5335-1272; Kochiyama, Takanori/0000-0002-4023-0674; Uono, Shota/0000-0003-0547-0522	Benesse Corporation	Benesse Corporation	This study was supported by funds from the Benesse Corporation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Adolphs R, 2010, ANN NY ACAD SCI, V1191, P42, DOI 10.1111/j.1749-6632.2010.05445.x; Akiyama T, 2007, CEREB CORTEX, V17, P2593, DOI 10.1093/cercor/bhl166; Amunts K, 2005, ANAT EMBRYOL, V210, P343, DOI 10.1007/s00429-005-0025-5; Argyle M., 1976, GAZE MUTUAL GAZE; BaronCohen S, 1997, J CHILD PSYCHOL PSYC, V38, P813, DOI 10.1111/j.1469-7610.1997.tb01599.x; Friesen CK, 1998, PSYCHON B REV, V5, P490, DOI 10.3758/BF03208827; Friston KJ, 2002, NEUROIMAGE, V16, P484, DOI 10.1006/nimg.2002.1091; Friston KJ, 1999, NEUROIMAGE, V10, P1, DOI 10.1006/nimg.1999.0439; Hayasaka S, 2004, NEUROIMAGE, V22, P676, DOI 10.1016/j.neuroimage.2004.01.041; JONES EG, 1976, BRAIN RES, V104, P142, DOI 10.1016/0006-8993(76)90654-5; Kawashima R, 1999, BRAIN, V122, P779, DOI 10.1093/brain/122.4.779; Kilner JM, 2005, NEUROSCI LETT, V374, P174, DOI 10.1016/j.neulet.2004.10.052; Kovach CK, 2011, NEUROIMAGE, V54, P213, DOI 10.1016/j.neuroimage.2010.08.002; Lachaux JP, 2003, J PHYSIOLOGY-PARIS, V97, P613, DOI 10.1016/j.jphysparis.2004.01.018; Larsen A, 2009, SCAND J PSYCHOL, V50, P526, DOI 10.1111/j.1467-9450.2009.00782.x; Menon V, 1996, ELECTROEN CLIN NEURO, V98, P89, DOI 10.1016/0013-4694(95)00206-5; Mihara T, 2001, EPILEPSY SURG, P613; Nation K, 2008, DEV PSYCHOPATHOL, V20, P79, DOI 10.1017/S0954579408000047; Okada T, 2008, SOC COGN AFFECT NEUR, V3, P80, DOI 10.1093/scan/nsm027; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pare D, 2003, PROG NEUROBIOL, V70, P409, DOI 10.1016/S0301-0082(03)00104-7; Sato W, 2004, NEUROIMAGE, V22, P1006, DOI 10.1016/j.neuroimage.2004.02.030; Sato W, 2007, EXP BRAIN RES, V183, P87, DOI 10.1007/s00221-007-1025-x; Sato W, 2011, NEUROPSYCHOLOGIA, V49, P612, DOI 10.1016/j.neuropsychologia.2010.12.025; Sato W, 2009, NEUROIMAGE, V45, P984, DOI 10.1016/j.neuroimage.2008.12.052; STROM JC, 1979, PERS SOC PSYCHOL B, V5, P114, DOI 10.1177/014616727900500125; vonGrunau M, 1995, PERCEPTION, V24, P1297, DOI 10.1068/p241297; Whalen PJ, 2004, SCIENCE, V306, P2061, DOI 10.1126/science.1103617; Wicker B, 1998, NEUROIMAGE, V8, P221, DOI 10.1006/nimg.1998.0357; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O; YOUNG AW, 1995, BRAIN, V118, P15, DOI 10.1093/brain/118.1.15	31	17	17	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e28188	10.1371/journal.pone.0028188	http://dx.doi.org/10.1371/journal.pone.0028188			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	863MI	22140541	Green Published, gold, Green Submitted			2022-12-27	WOS:000298168100047
J	Clark, AT; Rykken, JJ; Farrell, BD				Clark, Adam T.; Rykken, Jessica J.; Farrell, Brian D.			The Effects of Biogeography on Ant Diversity and Activity on the Boston Harbor Islands, Massachusetts, USA	PLOS ONE			English	Article							EXPERIMENTAL ZOOGEOGRAPHY; ASSEMBLY RULES; COMMUNITIES; POPULATION; COLONIZATION; BIODIVERSITY; DISTURBANCE; HABITAT	Many studies have examined how island biogeography affects diversity on the scale of island systems. In this study, we address how diversity varies over very short periods of time on individual islands. To do this, we compile an inventory of the ants living in the Boston Harbor Islands National Recreation Area, Boston, Massachusetts, USA using data from a five-year All Taxa Biodiversity Inventory of the region's arthropods. Consistent with the classical theory of island biogeography, species richness increased with island size, decreased with island isolation, and remained relatively constant over time. Additionally, our inventory finds that almost half of the known Massachusetts ant fauna can be collected in the BHI, and identifies four new species records for Massachusetts, including one new to the United States, Myrmica scabrinodis. We find that the number of species actually active on islands depended greatly on the timescale under consideration. The species that could be detected during any given week of sampling could by no means account for total island species richness, even when correcting for sampling effort. Though we consistently collected the same number of species over any given week of sampling, the identities of those species varied greatly between weeks. This variation does not result from local immigration and extinction of species, nor from seasonally-driven changes in the abundance of individual species, but rather from weekly changes in the distribution and activity of foraging ants. This variation can be upwards of 50% of ant species per week. This suggests that numerous ant species on the BHI share the same physical space at different times. This temporal partitioning could well explain such unexpectedly high ant diversity in an isolated, urban site.	[Clark, Adam T.] Harvard Univ, Cambridge, MA 02138 USA; [Rykken, Jessica J.; Farrell, Brian D.] Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA; [Farrell, Brian D.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA	Harvard University; Harvard University; Harvard University	Clark, AT (corresponding author), Harvard Univ, Cambridge, MA 02138 USA.	adam.tclark@post.harvard.edu	Clark, Adam/AAC-1039-2022; Clark, Adam Thomas/S-7544-2017	Clark, Adam/0000-0002-8843-3278; Clark, Adam Thomas/0000-0002-8843-3278	Harvard Forest REU; National Park Service; Green Fund; Stone Foundation; University's Center for the Environment, Herchel Smith Summer Undergraduate Research Fellowship; Museum of Comparative Zoolog	Harvard Forest REU; National Park Service; Green Fund; Stone Foundation; University's Center for the Environment, Herchel Smith Summer Undergraduate Research Fellowship; Museum of Comparative Zoolog	Public Funding: Harvard Forest REU, the National Park Service. Private Funding: Green Fund, the Stone Foundation. Harvard University internal grants: University's Center for the Environment, Herchel Smith Summer Undergraduate Research Fellowship, Museum of Comparative Zoology's Grants in aid of Undergraduate Research, and Undergraduate Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN AN, 1995, J BIOGEOGR, V22, P15, DOI 10.2307/2846070; Baselga A, 2010, ECOLOGY, V91, P1974, DOI 10.1890/09-0320.1; Bossert WH, 2010, STOCHASTIC FINITE ST; CHAO A, 1984, SCAND J STAT, V11, P265; Chase J.M., 2009, ECOLOGICAL NICHES LI; CONNOR EF, 1979, ECOLOGY, V60, P1132, DOI 10.2307/1936961; Coovert GA, 2005, B OHIO BIOL SURVEY N, V15, p[vi, 1]; Dunn RR, 2007, BIOL J LINN SOC, V91, P191, DOI 10.1111/j.1095-8312.2007.00783.x; Ellison AM, 2010, ECOLOGY, V91, P1962, DOI 10.1890/09-1692.1; Gause GF, 1932, J EXP BIOL, V9, P389; GOLDSTEIN EL, 1975, EVOLUTION, V29, P750, DOI 10.1111/j.1558-5646.1975.tb00869.x; Gotelli NJ, 2010, OECOLOGIA, V162, P463, DOI 10.1007/s00442-009-1474-y; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Gotelli NJ, 2002, OIKOS, V99, P591, DOI 10.1034/j.1600-0706.2002.11734.x; Groden E, 2005, J ECON ENTOMOL, V98, P1774, DOI 10.1603/0022-0493-98.6.1774; HAVEL JE, 1987, HYDROBIOLOGIA, V150, P273, DOI 10.1007/BF00008708; Holldobler B., 1990, pi; HUFFAKER C. B., 1958, HILGARDIA, V27, P343; Hurd P, 2001, G TEST; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; Kaspari Michael, 2000, P89; Kaspari Michael, 2000, P9; Lach L., 2009, ANT ECOLOGY; LEVIN SA, 1974, AM NAT, V108, P207, DOI 10.1086/282900; Lomolino MV, 2001, J BIOGEOGR, V28, P431, DOI 10.1046/j.1365-2699.2001.00550.x; Long JD, 2009, ECOLOGY, V90, P863, DOI 10.1890/08-1337.1; Losos JB, THEORY ISLAND BIOGEO; MacArthur R.H., 1972, pvii; MacArthur R.H., 1967, THEORY ISLAND BIOGEO; MACARTHUR RH, 1963, EVOLUTION, V17, P373, DOI 10.2307/2407089; MassGIS, 2010, MASSGIS; McGlynn TP, 2004, OIKOS, V106, P611, DOI 10.1111/j.0030-1299.2004.13135.x; Molles M, CONCEPTS APPL; National Weather Service, 1999, US STAT TERR; Niemel? J., 1999, URBAN ECOSYST, V3, P57, DOI [10.1023/A:1009595932440, DOI 10.1023/A:1009595932440]; Osborn F, 1999, STUD NEOTROP FAUNA E, V34, P59, DOI 10.1076/snfe.34.1.59.8918; Pereira HM, 2006, ECOLOGY, V87, P1877, DOI 10.1890/0012-9658(2006)87[1877:MBDICL]2.0.CO;2; Pratt SC, 2005, ANIM BEHAV, V70, P1023, DOI 10.1016/j.anbehav.2005.01.022; Pratt SC, 2005, BEHAV ECOL, V16, P488, DOI 10.1093/beheco/ari020; R Development Core Team, 2006, R LANG ENV STAT COMP; Ricketts TH, 2001, AM NAT, V158, P87, DOI 10.1086/320863; Rizali A, 2010, J BIOGEOGR, V37, P229, DOI 10.1111/j.1365-2699.2009.02194.x; Rosenzweig ML, 2003, CONSERV BIOL, V17, P864, DOI 10.1046/j.1523-1739.2003.01281.x; ROSENZWEIG ML, 1999, ADV ECOLOGICAL THEOR, P249; ROSENZWEIG ML, SPECIES DIVERSITY SP; SANDERS HL, 1968, AM NAT, V102, P243, DOI 10.1086/282541; Sanders NJ, 2007, J BIOGEOGR, V34, P1632, DOI 10.1111/j.1365-2699.2007.01714.x; Schoereder JH, 2004, AUSTRAL ECOL, V29, P391, DOI 10.1111/j.1442-9993.2004.01378.x; SIMBERLOFF D, 1976, ECOLOGY, V57, P629, DOI 10.2307/1936179; SIMBERLOFF DS, 1969, ECOLOGY, V50, P278, DOI 10.2307/1934856; Suarez AV, 1998, ECOLOGY, V79, P2041, DOI 10.1890/0012-9658(1998)079[2041:EOFAIO]2.0.CO;2; Tilman D, 2011, AM NAT, V178, P355, DOI 10.1086/661245; Turner IIBL, 1990, EARTH TRANSFORMED HU; Venegas SA, 1996, GEOPHYS RES LETT, V23, P2673, DOI 10.1029/96GL02373; Wilkie KTR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013146; Williams MR, 2009, J BIOGEOGR, V36, P1994, DOI 10.1111/j.1365-2699.2009.02110.x; Wilsey BJ, 2010, ECOLOGY, V91, P1984, DOI 10.1890/09-0351.1; Wilson E.O., 1987, Conservation Biology, V1, P344, DOI 10.1111/j.1523-1739.1987.tb00055.x; Wilson EO, 2005, P NATL ACAD SCI USA, V102, P13367, DOI 10.1073/pnas.0505858102; WRIGHT S, 1945, P NATL ACAD SCI USA, V31, P382, DOI 10.1073/pnas.31.12.382	61	12	14	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2011	6	11							e28045	10.1371/journal.pone.0028045	http://dx.doi.org/10.1371/journal.pone.0028045			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863LT	22140504	Green Submitted, gold, Green Published			2022-12-27	WOS:000298166300024
J	Lampert, TJ; Coleman, KD; Hennessey, TM				Lampert, Thomas J.; Coleman, Kevin D.; Hennessey, Todd M.			A Knockout Mutation of a Constitutive GPCR in Tetrahymena Decreases Both G-Protein Activity and Chemoattraction	PLOS ONE			English	Article							HETEROTRIMERIC G-PROTEIN; COUPLED RECEPTOR GPR1; GTP-GAMMA-S; GENE-EXPRESSION; ALPHA-SUBUNIT; BIOELECTRIC CONTROL; STIMULATED BINDING; SWIMMING BEHAVIOR; CRYSTAL-STRUCTURE; INVERSE AGONISTS	Although G-protein coupled receptors (GPCRs) are a common element in many chemosensory transduction pathways in eukaryotic cells, no GPCR or regulated G-protein activity has yet been shown in any ciliate. To study the possible role for a GPCR in the chemoresponses of the ciliate Tetrahymena, we have generated a number of macronuclear gene knockouts of putative GPCRs found in the Tetrahymena Genome database. One of these knockout mutants, called G6, is a complete knockout of a gene that we call GPCR6 (TTHERM_00925490). Based on sequence comparisons, the Gpcr6p protein belongs to the Rhodopsin Family of GPCRs. Notably, Gpcr6p shares highest amino acid sequence homologies to GPCRs from Paramecium and several plants. One of the phenotypes of the G6 mutant is a decreased responsiveness to the depolarizing ions Ba2+ and K+, suggesting a decrease in basal excitability (decrease in Ca2+ channel activity). The other major phenotype of G6 is a loss of chemoattraction to lysophosphatidic acid (LPA) and proteose peptone (PP), two known chemoattractants in Tetrahymena. Using microsomal [S-35]GTP gamma S binding assays, we found that wild-type (CU427) have a prominent basal G-protein activity. This activity is decreased to the same level by pertussis toxin (a G-protein inhibitor), addition of chemoattractants, or the G6 mutant. Since the basal G-protein activity is decreased by the GPCR6 knockout, it is likely that this gene codes for a constitutively active GPCR in Tetrahymena. We propose that chemoattractants like LPA and PP cause attraction in Tetrahymena by decreasing the basal G-protein stimulating activity of Gpcr6p. This leads to decreased excitability in wild-type and longer runs of smooth forward swimming (less interrupted by direction changes) towards the attractant. Therefore, these attractants may work as inverse agonists through the constitutively active Gpcr6p coupled to a pertussis-sensitive G-protein.	[Lampert, Thomas J.; Coleman, Kevin D.; Hennessey, Todd M.] SUNY Buffalo, Dept Biol Sci, Amherst, NY 14221 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Lampert, TJ (corresponding author), SUNY Buffalo, Dept Biol Sci, Amherst, NY 14221 USA.	thennes@buffalo.edu			NSF [MCB-0445362]	NSF(National Science Foundation (NSF))	This work was supported by the NSF [grant number MCB-0445362] to T. H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adl SM, 2005, J EUKARYOT MICROBIOL, V52, P399, DOI 10.1111/j.1550-7408.2005.00053.x; ADLER J, 1987, ANN NY ACAD SCI, V510, P95; ASANO T, 1984, BIOCHEMISTRY-US, V23, P5460, DOI 10.1021/bi00318a013; Bell WE, 2007, J EXP BIOL, V210, P357, DOI 10.1242/jeb.02642; BERNAL J, 1991, J EXP BIOL, V155, P505; Burki F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000790; CassidyHanley D, 1997, GENETICS, V146, P135; CLAROS MG, 1994, COMPUT APPL BIOSCI, V10, P685; Couty JP, 2009, J PHARMACOL EXP THER, V329, P1142, DOI 10.1124/jpet.108.147686; De Ondarza J, 2003, J EUKARYOT MICROBIOL, V50, P349; Deber CM, 2001, PROTEIN SCI, V10, P212, DOI 10.1110/ps.30301; Deng Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018605; Drummond AJ, 2010, GENEIOUS V5 3; Dyer M, 2000, MOL BIOCHEM PARASIT, V110, P435, DOI 10.1016/S0166-6851(00)00312-1; ECKERT R, 1972, SCIENCE, V176, P473, DOI 10.1126/science.176.4034.473; Eisen JA, 2006, PLOS BIOL, V4, P1620, DOI 10.1371/journal.pbio.0040286; FABCZAK H, 1993, J PHOTOCH PHOTOBIO B, V21, P47, DOI 10.1016/1011-1344(93)80163-4; FRANCIS JT, 1995, J EUKARYOT MICROBIOL, V42, P78, DOI 10.1111/j.1550-7408.1995.tb01544.x; Fredriksson R, 2005, MOL PHARMACOL, V67, P1414, DOI 10.1124/mol.104.009001; GAERTIG J, 1994, NUCLEIC ACIDS RES, V22, P5391, DOI 10.1093/nar/22.24.5391; Gronlien HK, 2010, J EXP BIOL, V213, P3980, DOI 10.1242/jeb.042903; Gudi S, 1998, P NATL ACAD SCI USA, V95, P2515, DOI 10.1073/pnas.95.5.2515; Hai B, 1997, P NATL ACAD SCI USA, V94, P1310, DOI 10.1073/pnas.94.4.1310; HANYU N, 1986, EMBO J, V5, P1307, DOI 10.1002/j.1460-2075.1986.tb04360.x; HELLUNGLARSEN P, 1986, BIOL BULL, V170, P357, DOI 10.2307/1541847; Hennessey TM, 2000, METHODS CELL BIOL, V62, P363; Hennessey Todd M, 2005, Purinergic Signal, V1, P101, DOI 10.1007/s11302-005-6213-1; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Ji TH, 1998, J BIOL CHEM, V273, P17299, DOI 10.1074/jbc.273.28.17299; JOHNSON RL, 1993, GENE DEV, V7, P273, DOI 10.1101/gad.7.2.273; Jones JC, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001446; Koppelhus U, 2001, METH MOL B, V161, P101; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kuruvilla HG, 1997, J EUKARYOT MICROBIOL, V44, P263, DOI 10.1111/j.1550-7408.1997.tb05710.x; Lampert TJ, 2011, CELL BIOL INT, V35, P519, DOI 10.1042/CBI20100320; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LEICK V, 1994, J EUKARYOT MICROBIOL, V41, P546, DOI 10.1111/j.1550-7408.1994.tb01515.x; Lemaire K, 2004, MOL CELL, V16, P293, DOI 10.1016/j.molcel.2004.10.004; Leurs R, 2003, INT CONGR SER, V1249, P131, DOI 10.1016/S0531-5131(03)00608-3; Levoye A, 2006, EMBO REP, V7, P1094, DOI 10.1038/sj.embor.7400838; Lin WZ, 2009, PROTEIN ENG DES SEL, V22, P699, DOI 10.1093/protein/gzp057; Lunn CA, 2008, BRIT J PHARMACOL, V153, P226, DOI 10.1038/sj.bjp.0707480; MACHEMER H, 1977, FORTS ZOOL, V24, P195; Maidan MM, 2005, BIOCHEM SOC T, V33, P291, DOI 10.1042/BST0330291; Marinissen MT, 2001, GENE DEV, V15, P535, DOI 10.1101/gad.855801; Marino MJ, 2001, J EUKARYOT MICROBIOL, V48, P527, DOI 10.1111/j.1550-7408.2001.tb00188.x; Miao W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004429; Nakagawa T, 2009, CURR OPIN NEUROBIOL, V19, P284, DOI 10.1016/j.conb.2009.07.015; Nilson SE, 2010, PLANT PHYSIOL, V152, P2067, DOI 10.1104/pp.109.148262; NODA K, 1994, J BIOL CHEM, V269, P6743; ONIMARU H, 1980, P JPN ACAD B-PHYS, V56, P538, DOI 10.2183/pjab.56.538; Pandey S, 2004, PLANT CELL, V16, P1616, DOI 10.1105/tpc.020321; Papasaikas PK, 2004, NUCLEIC ACIDS RES, V32, pW380, DOI 10.1093/nar/gkh431; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; RENAUD FL, 1995, J EUKARYOT MICROBIOL, V42, P205, DOI 10.1111/j.1550-7408.1995.tb01566.x; Risk JM, 2009, PLANT PHYSIOL, V150, P6, DOI 10.1104/pp.109.135749; Rodgers LF, 2008, J EUKARYOT MICROBIOL, V55, P27, DOI 10.1111/j.1550-7408.2007.00300.x; Rohrer DK, 1998, PHYSIOL REV, V78, P35, DOI 10.1152/physrev.1998.78.1.35; SAIMI Y, 1987, ANNU REV GENET, V21, P47, DOI 10.1146/annurev.genet.21.1.47; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; SCHEIN SJ, 1976, GENETICS, V84, P453; Schenk PW, 2001, BIOCHEM BIOPH RES CO, V282, P765, DOI 10.1006/bbrc.2001.4649; Seifert R, 2002, N-S ARCH PHARMACOL, V366, P381, DOI 10.1007/s00210-002-0588-0; Shang YH, 2002, P NATL ACAD SCI USA, V99, P3734, DOI 10.1073/pnas.052016199; Smit MJ, 2007, ANNU REV PHARMACOL, V47, P53, DOI 10.1146/annurev.pharmtox.47.120505.105126; SNAARJAGALSKA BE, 1988, FEBS LETT, V232, P148, DOI 10.1016/0014-5793(88)80405-8; Suwa M, 2011, PHARMACEUTICALS, V4, P652, DOI 10.3390/ph4040652; TAKAHASHI M, 1992, DEV GENET, V13, P174, DOI 10.1002/dvg.1020130212; Terakita A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-213; TIBERI M, 1994, J BIOL CHEM, V269, P27925; Touhara K, 2009, ANNU REV PHYSIOL, V71, P307, DOI 10.1146/annurev.physiol.010908.163209; UI M, 1990, ADP RIBOSYLATING TOX, P45; van Es S, 1999, CELL MOL LIFE SCI, V55, P1341, DOI 10.1007/s000180050374; VANHOUTEN J, 1978, J COMP PHYSIOL, V127, P167, DOI 10.1007/BF01352301; Welton RM, 2000, GENETICS, V156, P513; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Xue CY, 2008, FEMS MICROBIOL REV, V32, P1010, DOI 10.1111/j.1574-6976.2008.00131.x; Zhang W, 2011, J EXP BOT, V62, P2371, DOI 10.1093/jxb/erq424	80	9	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2011	6	11							e28022	10.1371/journal.pone.0028022	http://dx.doi.org/10.1371/journal.pone.0028022			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863LT	22140501	Green Submitted, gold, Green Published			2022-12-27	WOS:000298166300022
J	Chen, YS; Wu, MJ; Huang, CY; Lin, SC; Chuang, TH; Yu, CC; Lo, JF				Chen, Yu-Syuan; Wu, Meng-Ju; Huang, Chih-Yang; Lin, Shu-Chun; Chuang, Tsung-Hsien; Yu, Cheng-Chia; Lo, Jeng-Fan			CD133/Src Axis Mediates Tumor Initiating Property and Epithelial-Mesenchymal Transition of Head and Neck Cancer	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTORS; STEM-CELLS; ACTIVATION; IDENTIFICATION; PHOSPHORYLATION; SUBPOPULATION; EXPRESSION; CAPACITY; PROMOTES	Background: Head and Neck squamous cell carcinoma (HNSCC) is a human lethal cancer with clinical, pathological, phenotypical and biological heterogeneity. Caner initiating cells (CICs), which are responsible for tumor growth and coupled with gain of epithelial-mesenchymal transition (EMT), have been identified. Previously, we enriched a subpopulation of head and neck cancer initiating cells (HN-CICs) with up-regulation of CD133 and enhancement of EMT. Others demonstrate that Src kinase interacts with and phosphorylates the cytoplasmic domain of CD133. However, the physiological function of CD133/Src signaling in HNSCCs has not been uncovered. Methodology/Principal Finding: Herein, we determined the critical role of CD133/Src axis modulating stemness, EMT and tumorigenicity of HNSCC and HN-CICs. Initially, down-regulation of CD133 significantly reduced the self-renewal ability and expression of stemness genes, and promoted the differentiation and apoptotic capability of HN-CICs. Additionally, knockdown of CD133 in HN-CICs also lessened both in vitro malignant properties including cell migration/cell invasiveness/anchorage independent growth, and in vivo tumor growth by nude mice xenotransplantation assay. In opposite, overexpression of CD133 enhanced the stemness properties and tumorigenic ability of HNSCCs. Lastly, up-regulation of CD133 increased phosphorylation of Src coupled with EMT transformation in HNSCCs, on the contrary, silence of CD133 or treatment of Src inhibitor inversely abrogated above phenotypic effects, which were induced by CD133 up-regulation in HNSCCs or HN-CICs. Conclusion/Significance: Our results suggested that CD133/Src signaling is a regulatory switch to gain of EMT and of stemness properties in HNSCC. Finally, CD133/Src axis might be a potential therapeutic target for HNSCC by eliminating HN-CICs.	[Chen, Yu-Syuan; Wu, Meng-Ju; Lin, Shu-Chun; Yu, Cheng-Chia; Lo, Jeng-Fan] Natl Yang Ming Univ, Inst Oral Biol, Taipei 112, Taiwan; [Huang, Chih-Yang; Lo, Jeng-Fan] China Med Univ, Grad Inst Chinese Med Sci, Taichung, Taiwan; [Huang, Chih-Yang; Lo, Jeng-Fan] China Med Univ, Inst Med Sci, Taichung, Taiwan; [Huang, Chih-Yang] China Med Univ, Inst Basic Med Sci, Taichung, Taiwan; [Huang, Chih-Yang] Asia Univ, Dept Hlth & Nutr Biotechnol, Taichung, Taiwan; [Chuang, Tsung-Hsien] Natl Hlth Res Inst, Immunol Res Ctr, Zhunan, Miaoli County, Taiwan; [Yu, Cheng-Chia] Chung Shan Med Univ, Inst Oral Biol & Biomat Sci, Taichung, Taiwan; [Yu, Cheng-Chia] Chung Shan Med Univ, Sch Dent, Taichung, Taiwan; [Yu, Cheng-Chia] Chung Shan Med Univ Hosp, Dept Dent, Taichung, Taiwan; [Lo, Jeng-Fan] Natl Yang Ming Univ, Dept Dent, Taipei 112, Taiwan; [Lo, Jeng-Fan] Taipei Vet Gen Hosp, Dept Dent, Taipei, Taiwan	National Yang Ming Chiao Tung University; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; Asia University Taiwan; National Health Research Institutes - Taiwan; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital	Chen, YS (corresponding author), Natl Yang Ming Univ, Inst Oral Biol, Taipei 112, Taiwan.	ccyu@csmu.edu.tw; jflo@ym.edu.tw	Wu, Meng-Ju/AAY-9410-2021; Wu, Meng-Ju/AAY-9406-2021; Lo, Jeng-Fan/ABB-2820-2020; Lo, Jeng-Fan/AAE-9626-2020; Chuang, Tsung-Hsien/F-9679-2010; Yuang, Chih-Yang/O-5111-2015	Wu, Meng-Ju/0000-0001-6847-7065; Lo, Jeng-Fan/0000-0001-7188-9140; Lo, Jeng-Fan/0000-0001-7188-9140; 	National Science Council [NSC95N444, NSC97N456, NSC99N024, NSC100-2314-B-040-001]; Taipei Veterans General Hospital [V97ER2018, V98ER2018]; National Yang-Ming University (Ministry of Education, Aim for the Top University Plan) [97ACD113, 97ACT302, 98ACT302]	National Science Council(Ministry of Science and Technology, Taiwan); Taipei Veterans General Hospital(Taipei Veterans General Hospital); National Yang-Ming University (Ministry of Education, Aim for the Top University Plan)(Ministry of Education, Taiwan)	This study is supported by research grants from National Science Council (NSC95N444, NSC97N456, NSC99N024 and NSC100-2314-B-040-001), Taipei Veterans General Hospital (V97ER2018 and V98ER2018) and National Yang-Ming University (Ministry of Education, Aim for the Top University Plan: 97ACD113, 97ACT302 and 98ACT302). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acloque H, 2009, J CLIN INVEST, V119, P1438, DOI 10.1172/JCI38019; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Baumann M, 2008, NAT REV CANCER, V8, P545, DOI 10.1038/nrc2419; Beier D, 2008, BRAIN PATHOL, V18, P370, DOI 10.1111/j.1750-3639.2008.00130.x; Boivin D, 2009, BIOCHEMISTRY-US, V48, P3998, DOI 10.1021/bi900159d; Chen CYC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015939; Chen YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002637; Chiou SH, 2008, CLIN CANCER RES, V14, P4085, DOI 10.1158/1078-0432.CCR-07-4404; Chiou SH, 2010, CANCER RES, V70, P10433, DOI 10.1158/0008-5472.CAN-10-2638; Chu P, 2009, INT J CANCER, V124, P1312, DOI 10.1002/ijc.24061; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Covello KL, 2006, GENE DEV, V20, P557, DOI 10.1101/gad.1399906; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; Das B, 2008, STEM CELLS, V26, P1818, DOI 10.1634/stemcells.2007-0724; Dong L, 2010, NEUROSCI LETT, V484, P210, DOI 10.1016/j.neulet.2010.08.057; Elsaba TMA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010714; Fujimoto M, 2000, IMMUNITY, V13, P47, DOI 10.1016/S1074-7613(00)00007-8; Griend DJV, 2008, CANCER RES, V68, P9703, DOI 10.1158/0008-5472.CAN-08-3084; Guarino M, 2010, J CELL PHYSIOL, V223, P14, DOI 10.1002/jcp.22011; Gupta PB, 2009, NAT MED, V15, P1010, DOI 10.1038/nm0909-1010; Haddad RI, 2008, NEW ENGL J MED, V359, P1143, DOI 10.1056/NEJMra0707975; Harper LJ, 2007, J ORAL PATHOL MED, V36, P594, DOI 10.1111/j.1600-0714.2007.00617.x; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; Keith B, 2007, CELL, V129, P465, DOI 10.1016/j.cell.2007.04.019; Kelly SE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010035; Kong DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012445; Li Z, 2009, CANCER CELL, V15, P501, DOI 10.1016/j.ccr.2009.03.018; Lo JF, 2011, CANCER RES, V71, P1912, DOI 10.1158/0008-5472.CAN-10-2350; Ma S, 2008, ONCOGENE, V27, P1749, DOI 10.1038/sj.onc.1210811; Mandal M, 2008, CANCER-AM CANCER SOC, V112, P2088, DOI 10.1002/cncr.23410; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Matsumoto K, 2009, CANCER RES, V69, P7160, DOI 10.1158/0008-5472.CAN-09-1289; Mazumdar J, 2009, J CELL MOL MED; McCord AM, 2009, MOL CANCER RES, V7, P489, DOI 10.1158/1541-7786.MCR-08-0360; Mizrak D, 2008, J PATHOL, V214, P3, DOI 10.1002/path.2283; Nagaharu K, 2011, AM J PATHOL, V178, P754, DOI 10.1016/j.ajpath.2010.10.015; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Rappa G, 2008, STEM CELLS, V26, P3008, DOI 10.1634/stemcells.2008-0601; Rosen JM, 2009, SCIENCE, V324, P1670, DOI 10.1126/science.1171837; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Soeda A, 2009, ONCOGENE, V28, P3949, DOI 10.1038/onc.2009.252; Sun X, MOL CANC, V9, P17; Tabu K, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-39; Takahashi K, 1989, J JPN STOMATOL SOC, V38, P20, DOI DOI 10.11277/stomatology1952.38.20; Tirino V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003469; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wang Q, 2009, HISTOPATHOLOGY, V55, P284, DOI 10.1111/j.1365-2559.2009.03378.x; Wu MJ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-283; Yang MH, 2008, NAT CELL BIOL, V10, P295, DOI 10.1038/ncb1691; Yang MH, 2010, NAT CELL BIOL, V12, P982, DOI 10.1038/ncb2099; Yang SC, 2003, J ORAL PATHOL MED, V32, P600, DOI 10.1034/j.1600-0714.2003.00199.x; Yin AH, 1997, BLOOD, V90, P5002, DOI 10.1182/blood.V90.12.5002.5002_5002_5012; Yin SY, 2007, INT J CANCER, V120, P1444, DOI 10.1002/ijc.22476; Zeppernick F, 2008, CLIN CANCER RES, V14, P123, DOI 10.1158/1078-0432.CCR-07-0932; Zhang Q, 2009, CANC LETT; Zhou BBS, 2009, NAT REV DRUG DISCOV, V8, P806, DOI 10.1038/nrd2137; Zito G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003544	59	14	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2011	6	11							e28053	10.1371/journal.pone.0028053	http://dx.doi.org/10.1371/journal.pone.0028053			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KW	22140506	Green Published, gold, Green Submitted			2022-12-27	WOS:000298163400029
J	He, JQ; Vu, DM; Hunt, G; Chugh, A; Bhatnagar, A; Bolli, R				He, Jia-Qiang; Duc Minh Vu; Hunt, Greg; Chugh, Atul; Bhatnagar, Aruni; Bolli, Roberto			Human Cardiac Stem Cells Isolated from Atrial Appendages Stably Express c-kit	PLOS ONE			English	Article							PROGENITOR CELLS; MAST-CELLS; HEART; IDENTIFICATION; DIFFERENTIATE; MULTIPOTENT; MYOCARDIUM; EXPANSION; PROLIFERATION; FIBROBLASTS	The in vivo studies of myocardial infarct using c-kit(+)/Lin(-) cardiac stem cells (CSCs) are still in the early stage with margin or no beneficial effects for cardiac function. One of the potential reasons may be related to the absence of fully understanding the properties of these cells both in vitro and in vivo. In the present study, we aimed to systematically examine how CSCs adapted to in vitro cell processes and whether there is any cell contamination after long-term culture. Human CSCs were enzymatically isolated from the atrial appendages of patients. The fixed tissue sections, freshly isolated or cultured CSCs were then used for identification of c-kit(+)/Lin(-) cells, detection of cell contamination, or differentiation of cardiac lineages. By specific antibody staining, we demonstrated that tissue sections from atrial appendages contained less than 0.036% c-kit(+)/Lin(-) cells. For the first time, we noted that without magnetic activated cell sorting ( MACS), the percentages of c-kit(+)/Lin(-) cells gradually increased up to similar to 40% during continuously culture between passage 2 to 8, but could not exceed.80% unless c-kit MACS was carried out. The resulting c-kit(+)/Lin(-) cells were negative for CD34, CD45, CD133, and Lin markers, but positive for KDR and CD31 in few patients after c-kit MACS. Lin depletion seemed unnecessary for enrichment of c-kit(+)/Lin(-) cell population. Following induced differentiation, c-kit(+)/Lin(-) CSCs demonstrated strong differentiation towards cardiomyocytes but less towards smooth and endothelial cells. We concluded that by using an enzymatic dissociation method, a large number, or higher percentage, of relative pure human CSCs with stable expression of c-kit(+) could be obtained from atrial appendage specimens within,4 weeks following c-kit MACS without Lin depletion. This simple but cost-effective approach can be used to obtain enough numbers of stably-expressed c-kit(+)/Lin(-) cells for clinical trials in repairing myocardial infarction.	[He, Jia-Qiang; Duc Minh Vu; Hunt, Greg; Chugh, Atul; Bhatnagar, Aruni; Bolli, Roberto] Univ Louisville, Inst Mol Cardiol, Louisville, KY 40292 USA	University of Louisville	He, JQ (corresponding author), Univ Louisville, Inst Mol Cardiol, Louisville, KY 40292 USA.	rbolli@louisville.edu	Chugh, Atul R/M-9667-2018; Bolli, Roberto/A-6870-2010		National Institutes of Health [5P20RR024489, 5P01HL078825]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR024489] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL078825] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the National Institutes of Health 5P20RR024489 (to AB/JQH) and 5P01HL078825 (to RB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen DC, 2009, STEM CELLS, V27, P1571, DOI 10.1002/stem.72; Anversa P, 2006, CIRCULATION, V113, P1451, DOI 10.1161/CIRCULATIONAHA.105.595181; Bailey B, 2009, REGEN MED, V4, P823, DOI [10.2217/rme.09.51, 10.2217/RME.09.51]; Barile Lucio, 2007, Nat Clin Pract Cardiovasc Med, V4 Suppl 1, pS9, DOI 10.1038/ncpcardio0738; Barile L, 2007, PROG CARDIOVASC DIS, V50, P31, DOI 10.1016/j.pcad.2007.03.005; Bearzi C, 2007, P NATL ACAD SCI USA, V104, P14068, DOI 10.1073/pnas.0706760104; Bearzi C, 2009, P NATL ACAD SCI USA, V106, P15885, DOI 10.1073/pnas.0907622106; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Bolli P, 2010, ANN NY ACAD SCI, V1211, P113, DOI 10.1111/j.1749-6632.2010.05814.x; Bollini S, 2011, J MOL CELL CARDIOL, V50, P296, DOI 10.1016/j.yjmcc.2010.07.006; Boni A, 2008, P NATL ACAD SCI USA, V105, P15529, DOI 10.1073/pnas.0808357105; Bu L, 2009, NATURE, V460, P113, DOI 10.1038/nature08191; Cai CL, 2008, NATURE, V454, P104, DOI 10.1038/nature06969; Camelliti P, 2005, CARDIOVASC RES, V65, P40, DOI 10.1016/j.cardiores.2004.08.020; Chimenti I, 2009, P NATL ACAD SCI USA, V106, pE78, DOI 10.1073/pnas.0903261106; Cottage CT, 2010, CIRC RES, V106, P891, DOI 10.1161/CIRCRESAHA.109.208629; D'Alessandro DA, 2009, CIRC RES, V105, P1128, DOI 10.1161/CIRCRESAHA.109.207266; D'Amario D, 2011, CIRC RES, V108, P857, DOI 10.1161/CIRCRESAHA.111.241380; Davis DR, 2010, J MOL CELL CARDIOL, V49, P312, DOI 10.1016/j.yjmcc.2010.02.019; Davis DR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007195; Ellison Georgina M, 2010, Front Biosci (Schol Ed), V2, P641; ESTERRE P, 1992, CELL MOL BIOL, V38, P297; Fajtova M, 2010, NEOPLASMA, V57, P392, DOI 10.4149/neo_2010_05_392; Genovese A, 2010, CHEM IMMUNOL ALLERGY, V95, P98, DOI 10.1159/000315945; Gittenberger-de Groot AC, 2010, J CELL MOL MED, V14, P1056, DOI 10.1111/j.1582-4934.2010.01077.x; Guan K, 2007, J MOL CELL CARDIOL, V43, P377, DOI 10.1016/j.yjmcc.2007.07.056; Hatzistergos KE, 2010, CIRC RES, V107, P913, DOI 10.1161/CIRCRESAHA.110.222703; Hierlihy AM, 2002, FEBS LETT, V530, P239, DOI 10.1016/S0014-5793(02)03477-4; Itzhaki-Alfia A, 2009, CIRCULATION, V120, P2559, DOI 10.1161/CIRCULATIONAHA.109.849588; Johnston PV, 2009, CIRCULATION, V120, P1075, DOI 10.1161/CIRCULATIONAHA.108.816058; Kashiwakura I, 2003, BRIT J HAEMATOL, V122, P479, DOI 10.1046/j.1365-2141.2003.04444.x; KATAYAMA N, 1993, BLOOD, V82, P2353; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Kostin S, 2009, J CELL MOL MED, V13, P295, DOI 10.1111/j.1582-4934.2008.00668.x; Kuhn EN, 2010, J CELL PHYSIOL, V225, P321, DOI 10.1002/jcp.22281; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Leong KG, 2008, NATURE, V456, P804, DOI 10.1038/nature07427; Li TS, 2010, STEM CELLS, V28, P2088, DOI 10.1002/stem.532; Linke A, 2005, P NATL ACAD SCI USA, V102, P8966, DOI 10.1073/pnas.0502678102; Lovell MJ, 2010, HEART, V96, P1531, DOI 10.1136/hrt.2009.192385; Matsuura K, 2004, J BIOL CHEM, V279, P11384, DOI 10.1074/jbc.M310822200; Matsuura K, 2005, J BIOL CHEM, V280, P9088, DOI 10.1074/jbc.M413042200; Messina E, 2004, CIRC RES, V95, P911, DOI 10.1161/01.RES.0000147315.71699.51; Meuser-Batista M, 2008, TISSUE CELL, V40, P309, DOI 10.1016/j.tice.2008.02.006; Miettinen M, 2005, APPL IMMUNOHISTO M M, V13, P205, DOI 10.1097/01.pai.0000173054.83414.22; Mishra R, 2011, CIRCULATION, V123, P364, DOI 10.1161/CIRCULATIONAHA.110.971622; Monsel G, 2010, ONCOGENE, V29, P227, DOI 10.1038/onc.2009.320; Mouquet F, 2005, CIRC RES, V97, P1090, DOI 10.1161/01.RES.0000194330.66545.f5; MUTA K, 1995, BLOOD, V86, P572, DOI 10.1182/blood.V86.2.572.bloodjournal862572; Oh H, 2003, P NATL ACAD SCI USA, V100, P12313, DOI 10.1073/pnas.2132126100; ORLIC D, 1993, BLOOD, V82, P762, DOI 10.1182/blood.V82.3.762.bloodjournal823762; Orlic D, 2001, ANN NY ACAD SCI, V938, P221; Pfister O, 2005, CIRC RES, V97, P52, DOI 10.1161/01.RES.0000173297.53793.fa; Pfister O, 2008, CIRC RES, V103, P825, DOI 10.1161/CIRCRESAHA.108.174615; Reid AC, 2007, IMMUNOL REV, V217, P123, DOI 10.1111/j.1600-065X.2007.00514.x; RONNOVJESSEN L, 1992, J HISTOCHEM CYTOCHEM, V40, P475, DOI 10.1177/40.4.1552184; Rota M, 2006, CIRC RES, V99, P42, DOI 10.1161/01.RES.0000231289.63468.08; Sandstedt J, 2010, BASIC RES CARDIOL, V105, P545, DOI 10.1007/s00395-010-0088-1; SINGER KH, 1989, J INVEST DERMATOL, V92, P166, DOI 10.1111/1523-1747.ep12276685; Smith RR, 2008, HEART RHYTHM, V5, P880, DOI 10.1016/j.hrthm.2008.02.011; Smith RR, 2007, CIRCULATION, V115, P896, DOI 10.1161/CIRCULATIONAHA.106.655209; Smith RR, 2008, HEART RHYTHM, V5, P749, DOI 10.1016/j.hrthm.2008.02.010; Smits AM, 2009, NAT PROTOC, V4, P232, DOI 10.1038/nprot.2008.229; SPERR WR, 1994, BLOOD, V84, P3876, DOI 10.1182/blood.V84.11.3876.bloodjournal84113876; STRUTZ F, 1995, J CELL BIOL, V130, P393, DOI 10.1083/jcb.130.2.393; Tang XL, 2010, CIRCULATION, V121, P293, DOI 10.1161/CIRCULATIONAHA.109.871905; van Vliet Patrick, 2007, Expert Rev Cardiovasc Ther, V5, P33, DOI 10.1586/14779072.5.1.33; Wu JC, 2010, J NUCL MED, V51, p128S, DOI 10.2967/jnumed.109.068239; Yeoh JSG, 2007, MECH AGEING DEV, V128, P17, DOI 10.1016/j.mad.2006.11.005; Zeisberg EM, 2010, CIRC RES, V107, P1304, DOI 10.1161/CIRCRESAHA.110.231910; Zhou Y, 2010, J HISTOCHEM CYTOCHEM, V58, P309, DOI 10.1369/jhc.2009.955146	71	73	78	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2011	6	11							e27719	10.1371/journal.pone.0027719	http://dx.doi.org/10.1371/journal.pone.0027719			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KW	22140461	Green Submitted, Green Published, gold			2022-12-27	WOS:000298163400014
J	Rauf, Z; O'Brien, E; Stampalija, T; Ilioniu, FP; Lavender, T; Alfirevic, Z				Rauf, Zubair; O'Brien, Ediri; Stampalija, Tamara; Ilioniu, Florin P.; Lavender, Tina; Alfirevic, Zarko			Home Labour Induction with Retrievable Prostaglandin Pessary and Continuous Telemetric Trans-Abdominal Fetal ECG Monitoring	PLOS ONE			English	Article							TRIAL	Objective: To evaluate the feasibility of continuous telemetric trans-abdominal fetal electrocardiogram (a-fECG) in women undergoing labour induction at home. Study Design: Low risk women with singleton term pregnancy undergoing labour induction with retrievable, slow-release dinoprostone pessaries (n = 70) were allowed home for up to 24 hours, while a-fECG and uterine activity were monitored in hospital via wireless technology. Semi-structured diaries were analysed using a combined descriptive and interpretive approach. Results: 62/70 women (89%) had successful home monitoring; 8 women (11%) were recalled because of signal loss. Home monitoring lasted between 2-22 hours (median 10 hours). Good quality signal was achieved most of the time (86%, SD 10%). 3 women were recalled back to hospital for suspicious a-fECG. In 2 cases suspicious a-fECG persisted, requiring Caesarean section after recall to hospital. 48/51 women who returned the diary coped well (94%); 46/51 were satisfied with home monitoring (90%). Conclusions: Continuous telemetric trans-abdominal fetal ECG monitoring of ambulatory women undergoing labour induction is feasible and acceptable to women.	[Rauf, Zubair; Stampalija, Tamara; Ilioniu, Florin P.; Alfirevic, Zarko] Univ Liverpool, Liverpool Womens Hosp, Dept Womens & Childrens Hlth, Liverpool L69 3BX, Merseyside, England; [O'Brien, Ediri; Lavender, Tina] Univ Manchester, Sch Nursing Midwifery & Social Work, Manchester, Lancs, England	University of Liverpool; University of Manchester	Rauf, Z (corresponding author), Univ Liverpool, Liverpool Womens Hosp, Dept Womens & Childrens Hlth, Liverpool L69 3BX, Merseyside, England.	zarko@liv.ac.uk	Stampalija, Tamara/K-4900-2014; Lavender, Tina/B-1211-2011	Lavender, Tina/0000-0003-1473-4956; stampalija, tamara/0000-0002-9080-3848	Ferring Pharmaceuticals; Monica Healthcare Ltd	Ferring Pharmaceuticals(Ferring Pharmaceuticals); Monica Healthcare Ltd	This study was supported by an unrestricted educational grant to the University of Liverpool provided jointly by Ferring Pharmaceuticals and Monica Healthcare Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American College of Obstetricians and Gynecologists (ACOG), 2009, ACOG PRACT B, V107; Austin SC, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.03.014; Biem Sandra R D, 2003, J Obstet Gynaecol Can, V25, P23; Boers KE, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c7087; Bollapragada SS, 2009, BJOG-INT J OBSTET GY, V116, P1185, DOI 10.1111/j.1471-0528.2009.02216.x; Carter B, 2004, DEMYSTIFYING QUALITA; Dowswell T, 2010, COCHRANE DB SYST REV, V8; Kelly AJ, 2009, COCHRANE DB SYST REV, V4; Kelly AJ, 2009, COCHRANE DB SYST REV, V2; Koopmans CM, 2009, LANCET, V374, P979, DOI 10.1016/S0140-6736(09)60736-4; Reid M, 2011, MIDWIFERY, V27, P30, DOI 10.1016/j.midw.2009.11.003; Shetty A, 2005, EUR J OBSTET GYN R B, V123, P56, DOI 10.1016/j.ejogrb.2005.03.004; Witkop CT, 2009, OBSTET GYNECOL, V113, P206, DOI 10.1097/AOG.0b013e31818db36f	13	31	31	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2011	6	11							e28129	10.1371/journal.pone.0028129	http://dx.doi.org/10.1371/journal.pone.0028129			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KW	22140522	Green Published, gold, Green Submitted			2022-12-27	WOS:000298163400034
J	Bschor, T; Ritter, D; Winkelmann, P; Erbe, S; Uhr, M; Ising, M; Lewitzka, U				Bschor, Tom; Ritter, Dirk; Winkelmann, Patricia; Erbe, Sebastian; Uhr, Manfred; Ising, Marcus; Lewitzka, Ute			Lithium Monotherapy Increases ACTH and Cortisol Response in the Dex/CRH Test in Unipolar Depressed Subjects. A Study with 30 Treatment-Naive Patients	PLOS ONE			English	Article							STRUCTURED CLINICAL INTERVIEW; DSM-III-R; COMBINED DEXAMETHASONE/CRH TEST; HPA AXIS; MAJOR DEPRESSION; DOUBLE-BLIND; GLUCOCORTICOID-RECEPTOR; AUGMENTATION INCREASES; ARGININE-VASOPRESSIN; PSYCHOTROPIC-DRUGS	Background: Distorted activity of the hypothalamic-pituitary-adrenocortical (HPA) system is one of the most robustly documented biological abnormalities in major depression. Lithium is central to the treatment of affective disorders, but little is known about its effects on the HPA system of depressed subjects. Objective: To assess the effects of lithium monotherapy on the HPA system of patients with major depression by means of the combined DEX/CRH test. Method: Thirty drug-naive outpatients with major depression (single episode or unipolar recurrent; SCID I-and II-confirmed) were treated with lithium monotherapy for four weeks. The DEX/CRH test was conducted directly before intake of the first lithium tablet and four weeks thereafter. Weekly ratings with the HDRS21 were used to determine response (>= 50% symptom reduction) and remission (HDRS <= 7). Results: Lithium levels within the therapeutic range were achieved rapidly. Tolerability was good; no patient terminated the treatment prematurely. Response and remission rates were 50% and 33% respectively. Compared to the DEX/CRH test before the start of the treatment, a considerable and significant increase in all CRH-stimulated ACTH and cortisol parameters could be detected in the second DEX/CRH test. When analysed with particular regard to responders and non-responders, that significant increase was only present in the responders. Conclusions: We were able to demonstrate that lithium leads to a significant activation of the HPA system. This is possibly connected to stimulation of hypothalamic arginine vasoporessin (AVP), to direct intracellular effects of lithium on pituitary cells and to an induction of gene expression.	[Bschor, Tom; Erbe, Sebastian] Schlosspk Clin, Dept Psychiat, Berlin, Germany; [Bschor, Tom; Ritter, Dirk; Winkelmann, Patricia; Lewitzka, Ute] Tech Univ Dresden, Univ Hosp, Dept Psychiat, D-01062 Dresden, Germany; [Uhr, Manfred; Ising, Marcus] Max Planck Inst Psychiat, D-80804 Munich, Germany; [Lewitzka, Ute] Dalhousie Univ, Mood Disorder Res Clin, IWK Hlth Ctr, Halifax, NS, Canada	Technische Universitat Dresden; Carl Gustav Carus University Hospital; Max Planck Society; Dalhousie University	Bschor, T (corresponding author), Schlosspk Clin, Dept Psychiat, Berlin, Germany.	bschor@mailbox.tu-dresden.de			German Federal Ministry of Education and Research	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	Over the past five years TB has received honoraria for speaking from Lilly, AstraZeneca, Esparma, Bristol-Myers Squibb, Sanofi-Aventis, Servier, and Lundbeck, and has accepted reimbursements of travelling expenses to congresses from AstraZeneca and Lilly. Over the past five years SE has accepted reimbursements of travelling expenses to congresses from AstraZeneca. Over the past five years MI has received grant support from the German Federal Ministry of Education and Research, and has been consultant to MSD Merck, Whitehouse Station, New Jersey, United States of America. UL has received honoraria for speaking from AstraZeneca and has accepted reimbursements of travelling expenses to congresses from AstraZeneca and Lundbeck. The authors DR, PW and MU - except for income received from their primary employer - have received no financial support or compensation from any individual or corporate entity over the past five years for research or professional service. The authors declare for all authors that there are no personal financial holdings that could be perceived as constituting a potential conflict of interest. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Adli M, 1998, FORTSCHR NEUROL PSYC, V66, P435, DOI 10.1055/s-2007-995282; Anai H, 1997, BRAIN RES, V772, P161, DOI 10.1016/S0006-8993(97)00887-1; Appelhof BC, 2006, BIOL PSYCHIAT, V59, P696, DOI 10.1016/j.biopsych.2005.09.008; Arieli A, 1981, Curr Dev Psychopharmacol, V6, P165; Bauer M, 2007, WORLD J BIOL PSYCHIA, V8, P67, DOI 10.1080/15622970701227829; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Belmaker RH, 2008, NEW ENGL J MED, V358, P55, DOI [10.1056/NEJMra073096, 10.1038/nrdp.2016.65]; Berghofer A, 2006, LITHIUM NEUROPSYCHIA, P443; Bschor T, 2003, J PSYCHIATR RES, V37, P135, DOI 10.1016/S0022-3956(02)00088-2; Bschor T, 2003, DEPRESS ANXIETY, V17, P43, DOI 10.1002/da.10078; Bschor T, 2002, NEUROPSYCHOPHARMACOL, V27, P470, DOI 10.1016/S0893-133X(02)00323-8; Bschor T, 2006, CURR PHARM DESIGN, V12, P2985, DOI 10.2174/138161206777947650; Bschor T, 2010, EXPERT REV NEUROTHER, V10, P77, DOI 10.1586/ERN.09.137; Burgess S.S.A., 2001, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003013, DOI 10.1002/14651858.CD003013]; Cipriani A, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003492.pub2; Cowen PJ, 2010, PSYCHOL MED, V40, P1, DOI 10.1017/S0033291709005558; Crossley NA, 2007, J CLIN PSYCHIAT, V68, P935, DOI 10.4088/JCP.v68n0617; DEBELLIS MD, 1993, AM J PSYCHIAT, V150, P656; DEMONTIGNY C, 1981, BRIT J PSYCHIAT, V138, P252, DOI 10.1192/bjp.138.3.252; DEMONTIGNY C, 1981, J PHYSIOLOGY PARIS, V77, P455; Deuschle M, 1997, J CLIN PSYCHOPHARM, V17, P156, DOI 10.1097/00004714-199706000-00003; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Frieboes RM, 2003, PHARMACOPSYCHIATRY, V36, P12, DOI 10.1055/s-2003-38087; Gitlin M, 1999, DRUG SAFETY, V20, P231, DOI 10.2165/00002018-199920030-00004; Guy W, 1976, ECDEU ASSESSMENT MAN, DOI DOI 10.1037/E591322011-001; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hatzinger M, 2002, J PSYCHIATR RES, V36, P287, DOI 10.1016/S0022-3956(02)00021-3; HEUSER I, 1994, J PSYCHIAT RES, V28, P341, DOI 10.1016/0022-3956(94)90017-5; Heuser IJE, 1996, AM J PSYCHIAT, V153, P93; Hirschfeld RMA, 2002, J CLIN PSYCHIAT, V63, P826, DOI 10.4088/JCP.v63n0913; Holsboer F, 2000, Curr Psychiatry Rep, V2, P454, DOI 10.1007/s11920-000-0001-y; Holsboer F, 2000, NEUROPSYCHOPHARMACOL, V23, P477, DOI 10.1016/S0893-133X(00)00159-7; Holsboer F, 1996, ENDOCR REV, V17, P187, DOI 10.1210/er.17.2.187; HOLSBOERTRACHSLER E, 1994, J PSYCHIATR RES, V28, P381, DOI 10.1016/0022-3956(94)90020-5; Horstmann S, 2009, PSYCHONEUROENDOCRINO, V34, P238, DOI 10.1016/j.psyneuen.2008.09.004; Ising M, 2005, PROG NEURO-PSYCHOPH, V29, P1085, DOI 10.1016/j.pnpbp.2005.03.014; JACOBS JJ, 1978, P SOC EXP BIOL MED, V157, P163; Keck ME, 2002, NEUROPSYCHOPHARMACOL, V26, P94, DOI 10.1016/S0893-133X(01)00351-7; Khan M C, 1981, Bibl Psychiatr, P244; KHAN MC, 1987, INT CLIN PSYCHOPHARM, V2, P47, DOI 10.1097/00004850-198701000-00004; Kunugi H, 2006, NEUROPSYCHOPHARMACOL, V31, P212, DOI 10.1038/sj.npp.1300868; LAAKMANN G, 1984, PSYCHOPHARMACOLOGY, V84, P66, DOI 10.1007/BF00432027; LAAKMANN G, 1990, PHARMACOPSYCHIATRY, V23, P18, DOI 10.1055/s-2007-1014477; LAAKMANN G, 1992, CLIN NEUROPHARMACO S, V15, P206; Landgraf Rainer, 2006, CNS & Neurological Disorders-Drug Targets, V5, P167, DOI 10.2174/187152706776359664; LINDER J, 1989, ACTA PSYCHIAT SCAND, V80, P27; McKay MS, 2010, J PSYCHIATR RES, V44, P183, DOI 10.1016/j.jpsychires.2009.07.012; MENDELS J, 1972, ARCH GEN PSYCHIAT, V26, P154; Muller-Oerlinghausen B, 2002, LANCET, V359, P241, DOI 10.1016/S0140-6736(02)07450-0; Murgatroyd C, 2004, J NEUROSCI, V24, P7762, DOI 10.1523/JNEUROSCI.1614-04.2004; *NICE NAT COLL CTR, 2006, CLIN PRACT GUID; Nickel T, 2003, J CLIN PSYCHOPHARM, V23, P155, DOI 10.1097/00004714-200304000-00008; Nikisch G, 2005, PSYCHOPHARMACOLOGY, V181, P751, DOI 10.1007/s00213-005-0034-3; Papakostas GI, 2009, EUR NEUROPSYCHOPHARM, V19, P34, DOI 10.1016/j.euroneuro.2008.08.009; Pariante CM, 2008, TRENDS NEUROSCI, V31, P464, DOI 10.1016/j.tins.2008.06.006; Pariante CM, 2009, ANN NY ACAD SCI, V1179, P144, DOI 10.1111/j.1749-6632.2009.04978.x; Pasquali L, 2010, BEHAV PHARMACOL, V21, P473, DOI 10.1097/FBP.0b013e32833da5da; PEIFFER A, 1991, PSYCHONEUROENDOCRINO, V16, P505, DOI 10.1016/0306-4530(91)90034-Q; PLATMAN SR, 1971, DIS NERV SYST, V32, P542; PLATMAN SR, 1968, ARCH GEN PSYCHIAT, V18, P591; Quiroz JA, 2004, MOL INTERV, V4, P259, DOI 10.1124/mi.4.5.6; REISINE T, 1987, J NEUROCHEM, V49, P884, DOI 10.1111/j.1471-4159.1987.tb00976.x; Riedel M, 2010, J PSYCHIATR RES, V44, P1063, DOI 10.1016/j.jpsychires.2010.03.006; SACHAR EJ, 1970, ARCH GEN PSYCHIAT, V22, P304; SCHOU M, 2006, LITHIUM NEUROPSYCHIA, P251; Schule C, 2007, J NEUROENDOCRINOL, V19, P213, DOI 10.1111/j.1365-2826.2006.01516.x; Schule C, 2003, PSYCHOPHARMACOLOGY, V166, P271, DOI 10.1007/s00213-002-1356-z; SEGAL DL, 1994, COMPR PSYCHIAT, V35, P316, DOI 10.1016/0010-440X(94)90025-6; Semba J, 2000, NEUROSCI RES, V38, P313, DOI 10.1016/S0168-0102(00)00180-2; SMIGAN L, 1984, NEUROPSYCHOBIOLOGY, V11, P219, DOI 10.1159/000118082; Spencer CM, 2005, J NEUROSCI RES, V82, P273, DOI 10.1002/jnr.20617; SPITZER RL, 1992, ARCH GEN PSYCHIAT, V49, P624; SUGAWARA M, 1988, ENDOCRINOL JAPON, V35, P655; Thomson F, 2008, NEUROCHEM RES, V33, P691, DOI 10.1007/s11064-007-9518-3; VANCALKER D, 2006, LITHIUM NEUROPSYCHIA, P341; VATAL M, 1983, CHEM-BIOL INTERACT, V45, P277, DOI 10.1016/0009-2797(83)90074-1; VONBARDELEBEN U, 1985, LIFE SCI, V37, P1613, DOI 10.1016/0024-3205(85)90480-1; WATANABE S, 1975, ARCH GEN PSYCHIAT, V32, P659; Watson S, 2007, PSYCHONEUROENDOCRINO, V32, P464, DOI 10.1016/j.psyneuen.2007.02.010; WILLIAMS JBW, 1992, ARCH GEN PSYCHIAT, V49, P630; WORRALL EP, 1979, BRIT J PSYCHIAT, V135, P255, DOI 10.1192/bjp.135.3.255; Yatham LN, 2009, BIPOLAR DISORD, V11, P225, DOI 10.1111/j.1399-5618.2009.00672.x; ZATZ M, 1985, P NATL ACAD SCI USA, V82, P1286, DOI 10.1073/pnas.82.4.1286	83	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e27613	10.1371/journal.pone.0027613	http://dx.doi.org/10.1371/journal.pone.0027613			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	863KL	22132117	Green Published, Green Submitted, gold			2022-12-27	WOS:000298162000029
J	Cantarel, BL; Erickson, AR; VerBerkmoes, NC; Erickson, BK; Carey, PA; Pan, CL; Shah, M; Mongodin, EF; Jansson, JK; Fraser-Liggett, CM; Hettich, RL				Cantarel, Brandi L.; Erickson, Alison R.; VerBerkmoes, Nathan C.; Erickson, Brian K.; Carey, Patricia A.; Pan, Chongle; Shah, Manesh; Mongodin, Emmanuel F.; Jansson, Janet K.; Fraser-Liggett, Claire M.; Hettich, Robert L.			Strategies for Metagenomic-Guided Whole-Community Proteomics of Complex Microbial Environments	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; PROTEIN IDENTIFICATION; GUT MICROBIOTA; GENE; SEQUENCES; GENOME; METAPROTEOMICS; VERSATILE; SOFTWARE; DATABASE	Accurate protein identification in large-scale proteomics experiments relies upon a detailed, accurate protein catalogue, which is derived from predictions of open reading frames based on genome sequence data. Integration of mass spectrometry-based proteomics data with computational proteome predictions from environmental metagenomic sequences has been challenging because of the variable overlap between proteomic datasets and corresponding short-read nucleotide sequence data. In this study, we have benchmarked several strategies for increasing microbial peptide spectral matching in metaproteomic datasets using protein predictions generated from matched metagenomic sequences from the same human fecal samples. Additionally, we investigated the impact of mass spectrometry-based filters (high mass accuracy, delta correlation), and de novo peptide sequencing on the number and robustness of peptide-spectrum assignments in these complex datasets. In summary, we find that high mass accuracy peptide measurements searched against non-assembled reads from DNA sequencing of the same samples significantly increased identifiable proteins without sacrificing accuracy.	[Cantarel, Brandi L.; Mongodin, Emmanuel F.; Fraser-Liggett, Claire M.] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA; [Erickson, Alison R.; VerBerkmoes, Nathan C.; Erickson, Brian K.; Carey, Patricia A.; Pan, Chongle; Shah, Manesh; Hettich, Robert L.] Oak Ridge Natl Lab, Div Chem Sci, Oak Ridge, TN USA; [Erickson, Alison R.; Erickson, Brian K.] Univ Tennessee, Grad Sch Genome Sci & Technol, Knoxville, TN USA; [Jansson, Janet K.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Earth Sci, Dept Ecol, Berkeley, CA 94720 USA	University System of Maryland; University of Maryland Baltimore; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Tennessee System; University of Tennessee Knoxville; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Cantarel, BL (corresponding author), Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA.	hettichrl@ornl.gov	Jansson, Janet/H-5478-2018; Mongodin, Emmanuel/AAF-1850-2020; Cantarel, Brandi/ABF-5756-2020; Hettich, Robert L/N-1458-2016; Pan, Chongle/C-6960-2008	Jansson, Janet/0000-0002-5487-4315; Mongodin, Emmanuel/0000-0003-3833-7437; Cantarel, Brandi/0000-0003-4126-4478; Hettich, Robert L/0000-0001-7708-786X; Pan, Chongle/0000-0003-2860-0334; Fraser, Claire/0000-0003-1462-2428; Erickson, Brian/0000-0002-1150-5042	National Institutes of Health [UH2DK83991]; Crohn's and Collitis Foundation of America [2458]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [UH2DK083991] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Collitis Foundation of America; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was funded by the National Institutes of Health, Human Microbiome Project, grant UH2DK83991. A portion of the metagenome sequencing was also supported in part by a grant entitled "Metagenomic and metaproteomic analysis of the human gut microbiota in Crohn's disease" (reference # 2458) from the Crohn's and Collitis Foundation of America. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Callister SJ, 2010, ENVIRON SCI TECHNOL, V44, P8897, DOI 10.1021/es101029f; Castellana NE, 2008, P NATL ACAD SCI USA, V105, P21034, DOI 10.1073/pnas.0811066106; Chourey K, 2010, J PROTEOME RES, V9, P6615, DOI 10.1021/pr100787q; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; Dicksved J, 2008, ISME J, V2, P716, DOI 10.1038/ismej.2008.37; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Everley PA, 2007, MOL CELL PROTEOMICS, V6, P1771, DOI 10.1074/mcp.M700057-MCP200; Fermin D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r35; Frank A, 2005, ANAL CHEM, V77, P964, DOI 10.1021/ac048788h; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Hoff KJ, 2009, NUCLEIC ACIDS RES, V37, pW101, DOI 10.1093/nar/gkp327; Hsieh EJ, 2010, J PROTEOME RES, V9, P1138, DOI 10.1021/pr900816a; Kim S, 2009, MOL CELL PROTEOMICS, V8, P53, DOI 10.1074/mcp.M800103-MCP200; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lo I, 2007, NATURE, V446, P537, DOI 10.1038/nature05624; Ma B, 2003, RAPID COMMUN MASS SP, V17, P2337, DOI 10.1002/rcm.1196; Mackey AJ, 2002, MOL CELL PROTEOMICS, V1, P139, DOI 10.1074/mcp.M100004-MCP200; Noguchi H, 2006, NUCLEIC ACIDS RES, V34, P5623, DOI 10.1093/nar/gkl723; Noguchi H, 2008, DNA RES, V15, P387, DOI 10.1093/dnares/dsn027; Olsen JV, 2004, MOL CELL PROTEOMICS, V3, P608, DOI 10.1074/mcp.T400003-MCP200; Pearson W R, 2000, Methods Mol Biol, V132, P185; Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Ram RJ, 2005, SCIENCE, V308, P1915, DOI 10.1126/science. 1109070; RAVEL J, 2010, P NATL ACAD SCI US; Rho MN, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq747; Ronaghi M, 1998, SCIENCE, V281, P363, DOI 10.1126/science.281.5375.363; SOWELL SM, 2010, ISME J; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Thompson MR, 2008, ANAL CHEM, V80, P9517, DOI 10.1021/ac801707s; Verberkmoes NC, 2009, ISME J, V3, P179, DOI 10.1038/ismej.2008.108; VerBerkmoes NC, 2006, J PROTEOME RES, V5, P287, DOI 10.1021/pr0503230; Wicker T, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-275; Wilkins MJ, 2009, APPL ENVIRON MICROB, V75, P6591, DOI 10.1128/AEM.01064-09; Wilmes P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001778; Zhu WH, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq275	40	46	47	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e27173	10.1371/journal.pone.0027173	http://dx.doi.org/10.1371/journal.pone.0027173			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132090	gold, Green Submitted, Green Published			2022-12-27	WOS:000298162000011
J	Carvalho, FC; Soares, SG; Tamarozzi, MB; Rego, EM; Roque-Barreira, MC				Carvalho, Fernanda Caroline; Soares, Sandro Gomes; Tamarozzi, Mirela Barros; Rego, Eduardo Magalhaes; Roque-Barreira, Maria-Cristina			The Recognition of N-Glycans by the Lectin ArtinM Mediates Cell Death of a Human Myeloid Leukemia Cell Line	PLOS ONE			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; ACETYLGLUCOSAMINYLTRANSFERASE-V; ARTOCARPUS-INTEGRIFOLIA; BINDING SPECIFICITY; ARSENIC TRIOXIDE; NB4 CELLS; KM PLUS; KM+; AUTOPHAGY; CANCER	ArtinM, a D-mannose-binding lectin from Artocarpus heterophyllus (jackfruit), interacts with N-glycosylated receptors on the surface of several cells of hematopoietic origin, triggering cell migration, degranulation, and cytokine release. Because malignant transformation is often associated with altered expression of cell surface glycans, we evaluated the interaction of ArtinM with human myelocytic leukemia cells and investigated cellular responses to lectin binding. The intensity of ArtinM binding varied across 3 leukemia cell lines: NB4>K562>U937. The binding, which was directly related to cell growth suppression, was inhibited in the presence of Man alpha 1-3(Man alpha 1-6)Man beta 1, and was reverted in underglycosylated NB4 cells. ArtinM interaction with NB4 cells induced cell death (IC50 = 10 mu g/mL), as indicated by cell surface exposure of phosphatidylserine and disruption of mitochondrial membrane potential unassociated with caspase activation or DNA fragmentation. Moreover, ArtinM treatment of NB4 cells strongly induced reactive oxygen species generation and autophagy, as indicated by the detection of acidic vesicular organelles in the treated cells. NB4 cell death was attributed to ArtinM recognition of the trimannosyl core of N-glycans containing a beta 1,6-GlcNAc branch linked to alpha 1,6-mannose. This modification correlated with higher levels of N-acetylglucosaminyltransferase V transcripts in NB4 cells than in K562 or U937 cells. Our results provide new insights into the potential of N-glycans containing a beta 1,6-GlcNAc branch linked to alpha 1,6-mannose as a novel target for anti-leukemia treatment.	[Carvalho, Fernanda Caroline; Roque-Barreira, Maria-Cristina] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Biol Celular & Mol & Bioagentes Patogen, Sao Paulo, Brazil; [Soares, Sandro Gomes; Tamarozzi, Mirela Barros] Invent Biotecnol Ltda, Sao Paulo, Brazil; [Rego, Eduardo Magalhaes] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Clin Med, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Carvalho, FC (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Biol Celular & Mol & Bioagentes Patogen, Sao Paulo, Brazil.	mcrbarre@fmrp.usp.br	Rego, Eduardo M/A-1058-2012; Roque-Barreira, Maria-Cristina/A-4552-2008; Gomes Soares, Sandro/AGA-3968-2022; Soares, Sandro/O-7114-2016; Rego, Eduardo M./Y-5572-2019; Soares, Sandro/B-3601-2008; Rego, Eduardo/AFS-7973-2022	Rego, Eduardo M/0000-0003-1567-4086; Roque-Barreira, Maria-Cristina/0000-0001-7425-0908; Gomes Soares, Sandro/0000-0001-7205-2510; Soares, Sandro/0000-0001-7205-2510; Rego, Eduardo M./0000-0003-1567-4086; Rego, Eduardo/0000-0003-1567-4086	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [06/60642-2, 09/3032-5]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, fellowship 06/60642-2), and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). FCC received a scholarship from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, 09/3032-5). As a company, Invent Biotecnologia encourages its employees to submit manuscripts to journals. Besides this role, the company and the funders did not have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apel A, 2009, INT J CANCER, V125, P991, DOI 10.1002/ijc.24500; Brinck U, 1998, ACTA ANAT, V161, P219; Buckhaults P, 1997, J BIOL CHEM, V272, P19575, DOI 10.1074/jbc.272.31.19575; Chahud F, 2009, INT J EXP PATHOL, V90, P166, DOI 10.1111/j.1365-2613.2008.00626.x; Chen L, 1998, ONCOGENE, V17, P2087, DOI 10.1038/sj.onc.1202124; Chen YJ, 2009, AUTOPHAGY, V5, P173, DOI 10.4161/auto.5.2.7360; Coltri KC, 2008, AM J PATHOL, V173, P423, DOI 10.2353/ajpath.2008.080126; Degos L, 2003, BRIT J HAEMATOL, V122, P539, DOI 10.1046/j.1365-2141.2003.04460.x; Eisenberg-Lerner A, 2009, APOPTOSIS, V14, P376, DOI 10.1007/s10495-008-0307-5; Ganiko L, 2005, BBA-GEN SUBJECTS, V1721, P152, DOI 10.1016/j.bbagen.2004.10.012; Goussetis DJ, 2010, J BIOL CHEM, V285, P29989, DOI 10.1074/jbc.M109.090530; Guo HB, 2000, J CANCER RES CLIN, V126, P263, DOI 10.1007/s004320050341; He LZ, 2001, J CLIN INVEST, V108, P1321, DOI 10.1172/JCI200111537; Jeyaprakash AA, 2004, J MOL BIOL, V338, P757, DOI 10.1016/j.jmb.2004.03.040; Kim YS, 2009, PROTEIN PEPTIDE LETT, V16, P499, DOI 10.2174/092986609788167798; LANOTTE M, 1991, BLOOD, V77, P1080; Lau KS, 2008, GLYCOBIOLOGY, V18, P750, DOI 10.1093/glycob/cwn071; Lin RJ, 1998, NATURE, V391, P811, DOI 10.1038/35895; Litynska A, 2001, MELANOMA RES, V11, P205, DOI 10.1097/00008390-200106000-00001; Liu AH, 1998, CELL BIOL INT, V22, P545, DOI 10.1006/cbir.1998.0293; Liu JJ, 2006, J BIOMED SCI, V13, P813, DOI 10.1007/s11373-006-9110-x; LOEWENSTEIN WR, 1979, BIOCHIM BIOPHYS ACTA, V560, P1, DOI 10.1016/0304-419X(79)90002-7; Lowenberg B, 2003, NEW ENGL J MED, V349, P743, DOI 10.1056/NEJMoa025406; LOZZIO CB, 1975, BLOOD, V45, P321, DOI 10.1182/blood.V45.3.321.321; Mateo W, 2002, BLOOD, V100, P2882, DOI 10.1182/blood-2001-12-0217; MISQUITH S, 1994, J BIOL CHEM, V269, P30393; Moreno AN, 2003, INT ARCH ALLERGY IMM, V132, P221, DOI 10.1159/000074303; Murayama T, 1997, INT J CANCER, V70, P575, DOI 10.1002/(SICI)1097-0215(19970304)70:5<575::AID-IJC14>3.3.CO;2-3; Naeem A, 2007, CURR PROTEIN PEPT SC, V8, P261, DOI 10.2174/138920307780831811; Nakamura-Tsuruta S, 2008, FEBS J, V275, P1227, DOI 10.1111/j.1742-4658.2008.06282.x; Numata C, 1998, BIOL PHARM BULL, V21, P214; Ohba H, 2004, TOXICOL APPL PHARM, V195, P182, DOI 10.1016/j.taap.2003.11.018; Ohyama C, 2004, GLYCOBIOLOGY, V14, P671, DOI 10.1093/glycob/cwh071; Panunto-Castelo A, 2001, GLYCOBIOLOGY, V11, P1035, DOI 10.1093/glycob/11.12.1035; Pereira-Da-Silva G, 2006, BBA-GEN SUBJECTS, V1760, P86, DOI 10.1016/j.bbagen.2005.09.011; Pereira-Da-Silva G, 2008, IMMUNOL LETT, V119, P114, DOI 10.1016/j.imlet.2008.06.002; Queiroz AFS, 2009, CANCER CHEMOTH PHARM, V63, P1023, DOI 10.1007/s00280-008-0825-4; Ren YL, 2011, MED ONCOL, V28, P231, DOI 10.1007/s12032-010-9430-6; Roue G, 2003, BIOCHIMIE, V85, P741, DOI 10.1016/S0300-9084(03)00129-9; SANTOSDEOLIVEIRA R, 1994, J IMMUNOL, V153, P1798; Saumet A, 2005, BLOOD, V106, P658, DOI 10.1182/blood-2004-09-3585; Segalla S, 2003, MOL CELL BIOL, V23, P8795, DOI 10.1128/MCB.23.23.8795-8808.2003; Shih CM, 2003, J CELL BIOCHEM, V89, P335, DOI 10.1002/jcb.10488; SUNDSTROM C, 1976, INT J CANCER, V17, P565, DOI 10.1002/ijc.2910170504; Suzuki O, 2007, ONCOL REP, V17, P775; Taniguchi N, 1999, BBA-MOL BASIS DIS, V1455, P287, DOI 10.1016/S0925-4439(99)00066-6; Teixeira CR, 2006, VACCINE, V24, P3001, DOI 10.1016/j.vaccine.2005.11.067; Toledo KA, 2009, IMMUNOL LETT, V123, P14, DOI 10.1016/j.imlet.2009.01.009; Yang N, 2005, J BIOCHEM, V138, P145, DOI 10.1093/jb/mvi109	49	25	25	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e27892	10.1371/journal.pone.0027892	http://dx.doi.org/10.1371/journal.pone.0027892			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132163	Green Published, Green Submitted, gold			2022-12-27	WOS:000298162000048
J	Sood, N; Burger, N; Yoong, J; Kopf, D; Spreng, C				Sood, Neeraj; Burger, Nicholas; Yoong, Joanne; Kopf, Dan; Spreng, Connor			Firm-Level Perspectives on Public Sector Engagement with Private Healthcare Providers: Survey Evidence from Ghana and Kenya	PLOS ONE			English	Article							LOW-INCOME COUNTRIES; CHILD HEALTH; QUALITY; INDIA; PROVISION; DELIVERY	Background: Health systems in Sub-Saharan Africa (SSA) are in urgent need of improvement. The private health sector is a major provider of care in the region and it will remain a significant actor in the future. Any efforts by SSA governments to improve health systems performance therefore has to account for the private health sector. Regional and international actors increasingly recognize importance of effectively engaging with the private health sector, and initiatives to improve engagement are underway in several countries. However, there is little systematic analysis of private health providers' view and experience with engagement. Methodology/Principal Findings: In this study we surveyed private health facilities in Kenya and Ghana to understand the extent to which and how governments interact and engage with these facilities. The results suggest that government engagement with private health facilities is quite limited. The primary focus of this engagement is "command-and-control" type regulations to improve the quality of care. There is little attention paid to building the capacity of health care businesses through either technical or financial assistance. The vast majority of these facilities also receive no government assistance in meeting public health and social goals. Finally, government engagement with private pharmacies is often neglected and clinics receive a disproportionate share of government assistance. Conclusions/Significance: Overall, our findings suggest that there may be considerable untapped potential for greater engagement with private health facilities-particularly pharmacies. Improving engagement will likely help governments with limited resources to better take advantage of the private sector capacity to meet access and equity objectives and to accelerate the achievement of the Millennium Development Goals.	[Sood, Neeraj] Univ So Calif, Los Angeles, CA 90089 USA; [Burger, Nicholas; Yoong, Joanne; Kopf, Dan] RAND Corp, Arlington, VA USA; [Spreng, Connor] World Bank, Washington, DC 20433 USA	University of Southern California; RAND Corporation; The World Bank	Sood, N (corresponding author), Univ So Calif, Los Angeles, CA 90089 USA.	nsood@sppd.usc.edu		Yoong, Joanne/0000-0002-0162-9885; Sood, Neeraj/0000-0001-9805-213X	World Bank Group	World Bank Group	This research was supported by a grant from the World Bank Group. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. All views expressed are those of the authors.	[Anonymous], 2011, HLTH PARTNERSHIPS GO; [Anonymous], COMPARISON HLTH SYST; Bennett S, 2005, WORKING NONSTATE SEC; Berman PA, 1998, WORLD DEV, V26, P1463, DOI 10.1016/S0305-750X(98)00059-X; Brugha R, 1998, HEALTH POLICY PLANN, V13, P107, DOI 10.1093/heapol/13.2.107; Bustreo F, 2003, B WORLD HEALTH ORGAN, V81, P886; Chakraborty S, 2002, SOC SCI MED, V55, P1579, DOI 10.1016/S0277-9536(01)00292-1; Corporation IF, 2008, BUS HLTH AFR PARTN P; International Finance Corporation, 2008, BUS HLTH AFR PARTN P; Kamat VR, 2001, SOC SCI MED, V52, P885, DOI 10.1016/S0277-9536(00)00191-X; Lagomarsino G, 2009, LANCET, V374, P1577, DOI 10.1016/S0140-6736(09)61241-1; Loevinsohn B, 2005, LANCET, V366, P676, DOI 10.1016/S0140-6736(05)67140-1; Marriott G, 2019, CHALLENGING SAFETY Q; Mills A, 2004, SOC SCI MED, V59, P931, DOI 10.1016/j.socscimed.2003.12.015; Mills A, 2002, B WORLD HEALTH ORGAN, V80, P325; Preker AS, 2003, PRIVATE PARTICIPATIO; Sauerborn R, 2001, INT J QUAL HEALTH C, V13, P281, DOI 10.1093/intqhc/13.4.281; Waters H, 2003, HEALTH POLICY PLANN, V18, P127, DOI 10.1093/heapol/czg017; Yoong J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013243; Zwi AB, 2001, BRIT MED J, V323, P463, DOI 10.1136/bmj.323.7311.463	20	11	11	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e27194	10.1371/journal.pone.0027194	http://dx.doi.org/10.1371/journal.pone.0027194			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	863KL	22132092	Green Published, Green Submitted, gold			2022-12-27	WOS:000298162000013
J	Reperant, LA; van de Bildt, MWG; van Amerongen, G; Buehler, DM; Osterhaus, ADME; Jenni-Eiermann, S; Piersma, T; Kuiken, T				Reperant, Leslie A.; van de Bildt, Marco W. G.; van Amerongen, Geert; Buehler, Debbie M.; Osterhaus, Albert D. M. E.; Jenni-Eiermann, Susi; Piersma, Theunis; Kuiken, Thijs			Highly Pathogenic Avian Influenza Virus H5N1 Infection in a Long-Distance Migrant Shorebird under Migratory and Non-Migratory States	PLOS ONE			English	Article							CONSTITUTIVE IMMUNE FUNCTION; COST-BENEFIT-ANALYSIS; BASE-LINE; HEMAGGLUTINATION ASSAY; CALIDRIS-CANUTUS; ASIAN LINEAGE; ORGAN SIZE; CORTICOSTERONE; BIRDS; STRESS	Corticosterone regulates physiological changes preparing wild birds for migration. It also modulates the immune system and may lead to increased susceptibility to infection, with implications for the spread of pathogens, including highly pathogenic avian influenza virus (HPAIV) H5N1. The red knot (Calidris canutus islandica) displays migratory changes in captivity and was used as a model to assess the effect of high plasma concentration of corticosterone on HPAIV H5N1 infection. We inoculated knots during pre-migration (N = 6), fueling (N = 5), migration (N = 9) and post-migration periods (N = 6). Knots from all groups shed similar viral titers for up to 5 days post-inoculation (dpi), peaking at 1 to 3 dpi. Lesions of acute encephalitis, associated with virus replication in neurons, were seen in 1 to 2 knots per group, leading to neurological disease and death at 5 to 11 dpi. Therefore, the risk of HPAIV H5N1 infection in wild birds and of potential transmission between wild birds and poultry may be similar at different times of the year, irrespective of wild birds' migratory status. However, in knots inoculated during the migration period, viral shedding levels positively correlated with pre-inoculation plasma concentration of corticosterone. Of these, knots that did not become productively infected had lower plasma concentration of corticosterone. Conversely, elevated plasma concentration of corticosterone did not result in an increased probability to develop clinical disease. These results suggest that birds with elevated plasma concentration of corticosterone at the time of migration (ready to migrate) may be more susceptible to acquisition of infection and shed higher viral titers-before the onset of clinical disease-than birds with low concentration of corticosterone (not ready for take-off). Yet, they may not be more prone to the development of clinical disease. Therefore, assuming no effect of subclinical infection on the likelihood of migratory take-off, this may favor the spread of HPAIV H5N1 by migratory birds over long distances.	[Reperant, Leslie A.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Reperant, Leslie A.; van de Bildt, Marco W. G.; van Amerongen, Geert; Osterhaus, Albert D. M. E.; Kuiken, Thijs] Erasmus MC, Dept Virol, Rotterdam, Netherlands; [Buehler, Debbie M.; Piersma, Theunis] Univ Groningen, Ctr Ecol & Evolutionary Studies, Anim Ecol Grp, Groningen, Netherlands; [Jenni-Eiermann, Susi] Swiss Ornithol Inst, Sempach, Switzerland; [Piersma, Theunis] Royal Netherlands Inst Sea Res, Texel, Netherlands	Princeton University; Erasmus University Rotterdam; Erasmus MC; University of Groningen; Swiss Ornithological Institute; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ)	Reperant, LA (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	t.kuiken@erasmusmc.nl	Buehler, Deborah/ABB-2088-2021; Piersma, Theunis/D-1871-2012	Buehler, Deborah/0000-0003-3669-6364; Jenni-Eiermann, Susanne/0000-0002-0610-3428; Reperant, Leslie/0000-0002-7212-1595; Piersma, Theunis/0000-0001-9668-466X; Osterhaus, Albert/0000-0002-6074-1172; Kuiken, Thijs/0000-0001-5501-9049	European Commission [044490]; Dutch Ministry of Economic Affairs; Royal Netherlands Institute for Sea Research	European Commission(European CommissionEuropean Commission Joint Research Centre); Dutch Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); Royal Netherlands Institute for Sea Research	This study was supported by European Commission grant no. 044490, "New-FluBird," by the Program "Impulse Veterinary Avian Influenza Research in the Netherlands" of the Dutch Ministry of Economic Affairs, and by an operating grant of Royal Netherlands Institute for Sea Research to TP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altizer S, 2011, SCIENCE, V331, P296, DOI 10.1126/science.1194694; Apanius V, 1998, ADV STUD BEHAV, V27, P133; APPLEGATE J E, 1970, Journal of Wildlife Diseases, V6, P443; APPLEGATE J E, 1971, Journal of Wildlife Diseases, V7, P37; Brojer C, 2009, J VET DIAGN INVEST, V21, P579, DOI 10.1177/104063870902100501; Brown JD, 2008, EMERG INFECT DIS, V14, P136, DOI 10.3201/eid1401.070740; Buehler DM, 2008, PHYSIOL BIOCHEM ZOOL, V81, P673, DOI 10.1086/588591; Buehler DM, 2009, PHYSIOL BIOCHEM ZOOL, V82, P561, DOI 10.1086/603635; Buehler DM, 2008, AM NAT, V172, P783, DOI 10.1086/592865; Campbell TW, 1995, AVIAN HEMATOLOGY CYT; FREEMAN GH, 1951, BIOMETRIKA, V38, P141, DOI 10.2307/2332323; Garvin MC, 2006, J PARASITOL, V92, P659, DOI 10.1645/GE-759R.1; Gauthier-Clerc M, 2007, IBIS, V149, P202, DOI 10.1111/j.1474-919X.2007.00699.x; Gilbert M, 2006, EMERG INFECT DIS, V12, P1650, DOI 10.3201/eid1211.060223; Globig A, 2009, TRANSBOUND EMERG DIS, V56, P57, DOI 10.1111/j.1865-1682.2008.01061.x; Guglielmo CG, 2010, INTEGR COMP BIOL, V50, P336, DOI 10.1093/icb/icq097; Gylfe A, 2000, NATURE, V403, P724, DOI 10.1038/35001663; Hall JS, 2011, INFLUENZA OTHER RESP, V5, P365, DOI 10.1111/j.1750-2659.2011.00238.x; Holberton RL, 1999, GEN COMP ENDOCR, V116, P49, DOI 10.1006/gcen.1999.7336; Jenni L, 1998, J AVIAN BIOL, V29, P521, DOI 10.2307/3677171; Jenni-Eiermann S, 2002, ZOOLOGY, V105, P239, DOI 10.1078/0944-2006-00066; Kalthoff D, 2008, EMERG INFECT DIS, V14, P1267, DOI 10.3201/eid1408.080078; Kalthoff D, 2008, PLOS ONE, V4, DOI 10.1371/journal.pone.0006170; Keawcharoen J, 2008, EMERG INFECT DIS, V14, P600, DOI 10.3201/eid1404.071016; Kilpatrick AM, 2006, P NATL ACAD SCI USA, V103, P19368, DOI 10.1073/pnas.0609227103; Matson KD, 2005, DEV COMP IMMUNOL, V29, P275, DOI 10.1016/j.dci.2004.07.006; MEIER AH, 1964, GEN COMP ENDOCR, V4, P584, DOI 10.1016/0016-6480(64)90067-X; Mendes L, 2006, J EXP BIOL, V209, P284, DOI 10.1242/jeb.02015; Mueller C, 2006, GEN COMP ENDOCR, V148, P163, DOI 10.1016/j.ygcen.2006.02.012; MUNRO C, 1984, J ENDOCRINOL, V101, P41, DOI 10.1677/joe.0.1010041; MUNRO CJ, 1988, NONRADIOMETRIC ASSAY, P289; Munster VJ, 2005, EMERG INFECT DIS, V11, P1545, DOI 10.3201/eid1110.050546; Piersma T, 1998, J AVIAN BIOL, V29, P97, DOI 10.2307/3677186; Piersma T, 2000, GEN COMP ENDOCR, V120, P118, DOI 10.1006/gcen.2000.7543; Piersma T, 2003, J EXP BIOL, V206, P3361, DOI 10.1242/jeb.00545; Piersma T, 2002, NATURWISSENSCHAFTEN, V89, P278, DOI 10.1007/s00114-002-0325-z; Piersma T, 1999, PHYSIOL BIOCHEM ZOOL, V72, P405, DOI 10.1086/316680; Piersma T, 1998, J AVIAN BIOL, V29, P511, DOI 10.2307/3677170; Piersma T, 2011, J EXP BIOL, V214, P295, DOI 10.1242/jeb.046748; Reneerkens J, 2002, PHYSIOL BIOCHEM ZOOL, V75, P200, DOI 10.1086/340853; Reneerkens J, 2002, J EXP ZOOL, V293, P81, DOI 10.1002/jez.10113; Reperant LA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000854; Rimmelzwaan GF, 1998, J VIROL METHODS, V74, P57, DOI 10.1016/S0166-0934(98)00071-8; Rimmelzwaan GF, 2001, J VIROL, V75, P6687, DOI 10.1128/JVI.75.14.6687-6691.2001; Romero LM, 2005, COMP BIOCHEM PHYS A, V140, P73, DOI 10.1016/j.cbpb.2004.11.004; Schekkerman H, 2003, OECOLOGIA, V134, P332, DOI 10.1007/s00442-002-1124-0; SCHWABL H, 2004, J COMP PHYSIOL B, V161, P576; Suarez DL, 2000, DEV COMP IMMUNOL, V24, P269, DOI 10.1016/S0145-305X(99)00078-6; Teifke JP, 2007, VET PATHOL, V44, P137, DOI 10.1354/vp.44-2-137; USGS, 2011, REF REP HIGHL PATH A; van Gils JA, 2003, J EXP BIOL, V206, P3369, DOI 10.1242/jeb.00546; Vezina F, 2006, J EXP BIOL, V209, P3141, DOI 10.1242/jeb.02338; Weber TP, 2007, EMERG INFECT DIS, V13, P1139, DOI 10.3201/eid1308.070319; Weber TP, 1996, J AVIAN BIOL, V27, P215, DOI 10.2307/3677225; 2010, AVIAN INFLUENZA POUL	55	13	17	3	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2011	6	11							e27814	10.1371/journal.pone.0027814	http://dx.doi.org/10.1371/journal.pone.0027814			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858JH	22132150	Green Published, Green Submitted, gold			2022-12-27	WOS:000297792400016
J	Latch, EK; Boarman, WI; Walde, A; Fleischer, RC				Latch, Emily K.; Boarman, William I.; Walde, Andrew; Fleischer, Robert C.			Fine-Scale Analysis Reveals Cryptic Landscape Genetic Structure in Desert Tortoises	PLOS ONE			English	Article							SPATIAL AUTOCORRELATION ANALYSIS; PARTIAL MANTEL TESTS; FALSE DISCOVERY RATE; POPULATION-STRUCTURE; GOPHERUS-AGASSIZII; PHYLOGEOGRAPHIC PATTERNS; MICROSATELLITE LOCI; MITOCHONDRIAL-DNA; COMPUTER-PROGRAM; FLOW	Characterizing the effects of landscape features on genetic variation is essential for understanding how landscapes shape patterns of gene flow and spatial genetic structure of populations. Most landscape genetics studies have focused on patterns of gene flow at a regional scale. However, the genetic structure of populations at a local scale may be influenced by a unique suite of landscape variables that have little bearing on connectivity patterns observed at broader spatial scales. We investigated fine-scale spatial patterns of genetic variation and gene flow in relation to features of the landscape in desert tortoise (Gopherus agassizii), using 859 tortoises genotyped at 16 microsatellite loci with associated data on geographic location, sex, elevation, slope, and soil type, and spatial relationship to putative barriers (power lines, roads). We used spatially explicit and non-explicit Bayesian clustering algorithms to partition the sample into discrete clusters, and characterize the relationships between genetic distance and ecological variables to identify factors with the greatest influence on gene flow at a local scale. Desert tortoises exhibit weak genetic structure at a local scale, and we identified two subpopulations across the study area. Although genetic differentiation between the subpopulations was low, our landscape genetic analysis identified both natural (slope) and anthropogenic (roads) landscape variables that have significantly influenced gene flow within this local population. We show that desert tortoise movements at a local scale are influenced by features of the landscape, and that these features are different than those that influence gene flow at larger scales. Our findings are important for desert tortoise conservation and management, particularly in light of recent translocation efforts in the region. More generally, our results indicate that recent landscape changes can affect gene flow at a local scale and that their effects can be detected almost immediately.	[Latch, Emily K.] Univ Wisconsin, Dept Biol Sci, Behav & Mol Ecol Res Grp, Milwaukee, WI 53201 USA; [Latch, Emily K.; Fleischer, Robert C.] Smithsonian Inst, Natl Zool Pk, Ctr Conservat & Evolutionary Genet, Washington, DC 20008 USA; [Boarman, William I.] Conservat Sci Res & Consulting, Spring Valley, VA USA; [Walde, Andrew] Walde Res & Environm Consulting, Atascadero, CA USA	University of Wisconsin System; University of Wisconsin Milwaukee; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute	Latch, EK (corresponding author), Univ Wisconsin, Dept Biol Sci, Behav & Mol Ecol Res Grp, POB 413, Milwaukee, WI 53201 USA.	latch@uwm.edu			United States Department of Defense [W9124J-0-c-0011]	United States Department of Defense(United States Department of Defense)	The United States Department of Defense funded this work through a grant to the ITS Corporation, reference code W9124J-0-c-0011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BERRY KH, 1986, HERPETOLOGICA, V42, P113; Berry Kristin H., 2002, Chelonian Conservation and Biology, V4, P249; Boarman W.I., 2002, THREATS DESERT TORTO; Boarman W.I., 1996, TRANSPORTATION WILDL, P169; BOARMAN WI, 1993, P 1992 DES TORT COUN, P126; Bonnet E, 2002, J STAT SOFTW, V7, P1, DOI DOI 10.18637/JSS.V007.I10; Britten HB, 1997, COPEIA, P523; BURY RB, 1977, US FISH WILDL SERV W, V8, P1; Castellano S, 2002, EVOLUTION, V56, P1871; Chen C, 2007, MOL ECOL NOTES, V7, P747, DOI 10.1111/j.1471-8286.2007.01769.x; Corander J, 2003, GENETICS, V163, P367; Coulon A, 2006, MOL ECOL, V15, P1669, DOI 10.1111/j.1365-294X.2006.02861.x; Cushman SA, 2006, AM NAT, V168, P486, DOI 10.1086/506976; Edwards T, 2004, CONSERV GENET, V5, P485, DOI 10.1023/B:COGE.0000041031.58192.7c; Edwards T, 2003, MOL ECOL NOTES, V3, P589, DOI 10.1046/j.1471-8286.2003.00521.x; Epperson BK, 2004, THEOR POPUL BIOL, V65, P227, DOI 10.1016/j.tpb.2003.11.003; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Falush D, 2003, GENETICS, V164, P1567; Frantz AC, 2010, HEREDITY, V104, P493, DOI 10.1038/hdy.2009.136; Frantz AC, 2010, MOL ECOL, V19, P1663, DOI 10.1111/j.1365-294X.2010.04605.x; Funk WC, 2005, MOL ECOL, V14, P483, DOI 10.1111/j.1365-294X.2005.02426.x; Gauffre B, 2008, MOL ECOL, V17, P4619, DOI 10.1111/j.1365-294X.2008.03950.x; Gerlach G, 2000, CONSERV BIOL, V14, P1066, DOI 10.1046/j.1523-1739.2000.98519.x; GERMANO DJ, 1993, AM MIDL NAT, V129, P319, DOI 10.2307/2426513; Giordano AR, 2007, MOL ECOL, V16, P1625, DOI 10.1111/j.1365-294X.2006.03223.x; Grandmaison DD, 2010, J HERPETOL, V44, P581, DOI 10.1670/08-291.1; Guillot G, 2005, GENETICS, V170, P1261, DOI 10.1534/genetics.104.033803; Guillot G, 2005, MOL ECOL NOTES, V5, P712, DOI 10.1111/j.1471-8286.2005.01031.x; Guillot G, 2008, BIOINFORMATICS, V24, P1406, DOI 10.1093/bioinformatics/btn136; Hagerty BE, 2008, MOL ECOL RESOUR, V8, P1149, DOI 10.1111/j.1755-0998.2008.02208.x; Hagerty BE, 2011, LANDSCAPE ECOL, V26, P267, DOI 10.1007/s10980-010-9550-6; Hagerty BE, 2010, CONSERV GENET, V11, P1795, DOI 10.1007/s10592-010-0073-0; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Hedrick PW, 1999, EVOLUTION, V53, P313, DOI 10.1111/j.1558-5646.1999.tb03767.x; Hedrick PW, 2005, EVOLUTION, V59, P1633, DOI 10.1111/j.0014-3820.2005.tb01814.x; Holderegger R, 2008, BIOSCIENCE, V58, P199, DOI 10.1641/B580306; LAMB T, 1989, EVOLUTION, V43, P76, DOI 10.1111/j.1558-5646.1989.tb04208.x; Lamb Trip, 2002, P67; Landguth EL, 2010, MOL ECOL, V19, P4179, DOI 10.1111/j.1365-294X.2010.04808.x; Latch EK, 2006, CONSERV GENET, V7, P295, DOI 10.1007/s10592-005-9098-1; Latch EK, 2008, J HERED, V99, P265, DOI 10.1093/jhered/esn009; Lee-Yaw JA, 2009, MOL ECOL, V18, P1863, DOI 10.1111/j.1365-294X.2009.04152.x; LIGHTFOOT DC, 1991, AM MIDL NAT, V125, P310, DOI 10.2307/2426235; Lovich Jeffrey E., 2000, Chelonian Conservation and Biology, V3, P714; Lowe WH, 2006, ECOLOGY, V87, P334, DOI 10.1890/05-0232; Luckenbach R.A., 1982, U S FISH AND WILDLIFE SERVICE WILDLIFE RESEARCH REPORT, V12, P1; Manel S, 2003, TRENDS ECOL EVOL, V18, P189, DOI 10.1016/S0169-5347(03)00008-9; Marlow, 1979, THESIS U CALIFORNIA; Murphy RW, 2007, CHELONIAN CONSERV BI, V6, P229, DOI 10.2744/1071-8443(2007)6[229:AGAOTR]2.0.CO;2; Murphy RW, 2011, ZOOKEYS, P39, DOI 10.3897/zookeys.113.1353; NAGY KA, 1986, HERPETOLOGICA, V42, P73; Narum SR, 2006, CONSERV GENET, V7, P783, DOI 10.1007/s10592-005-9056-y; Oftedal Olav T., 2002, Chelonian Conservation and Biology, V4, P341; Paetkau D, 1998, CONSERV BIOL, V12, P418, DOI 10.1046/j.1523-1739.1998.96457.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2003, EVOLUTION, V57, P1182, DOI 10.1111/j.0014-3820.2003.tb00327.x; PEAKALL R, 1995, MOL ECOL, V4, P135, DOI 10.1111/j.1365-294X.1995.tb00203.x; Pritchard J, 2003, DOCUMENTATION STRUCT; Pritchard JK, 2000, GENETICS, V155, P945; Raufaste N, 2001, EVOLUTION, V55, P1703, DOI 10.1111/j.0014-3820.2001.tb00689.x; Richards-Zawacki CL, 2009, DIVERS DISTRIB, V15, P796, DOI 10.1111/j.1472-4642.2009.00582.x; Riedle JD, 2010, J HERPETOL, V44, P164; Riley SPD, 2006, MOL ECOL, V15, P1733, DOI 10.1111/j.1365-294X.2006.02907.x; Rousset F, 2002, EVOLUTION, V56, P1874; Rousset F, 2000, J EVOLUTION BIOL, V13, P58; Schwartz MK, 2009, ECOLOGY, V90, P3222, DOI 10.1890/08-1287.1; Schwartz TS, 2003, MOL ECOL NOTES, V3, P283, DOI 10.1046/j.1471-8286.2003.00428.x; Smouse PE, 1999, HEREDITY, V82, P561, DOI 10.1038/sj.hdy.6885180; Spear SF, 2005, MOL ECOL, V14, P2553, DOI 10.1111/j.1365-294X.2005.02573.x; STEBBINS RC, 1974, AM BIOL TEACH, V36, P203, DOI 10.2307/4444747; Storfer A, 2007, HEREDITY, V98, P128, DOI 10.1038/sj.hdy.6800917; Tracy C.R., 2004, DESERT TORTOISE RECO; U.S. Fish and Wildlife Service, 1990, FED REG, V55, P12178; USFWS, 2008, REV REC PLA IN PRESS; USFWS (U.S. Fish and Wildlife Service), 1994, DES TORT MOJ POP REC; VASEK F C, 1975, Madrono, V23, P114; Vekemans X, 2004, MOL ECOL, V13, P921, DOI 10.1046/j.1365-294X.2004.02076.x; Verhoeven KJF, 2005, OIKOS, V108, P643, DOI 10.1111/j.0030-1299.2005.13727.x; Walde AD, 2009, SOUTHWEST NAT, V54, P375, DOI 10.1894/MH-41.1; Walker FM, 2008, MOL ECOL, V17, P1361, DOI 10.1111/j.1365-294X.2008.03670.x; Wang IJ, 2010, MOL ECOL, V19, P447, DOI 10.1111/j.1365-294X.2009.04465.x; Wang IJ, 2009, MOL ECOL, V18, P3847, DOI 10.1111/j.1365-294X.2009.04338.x; Waples RS, 1998, J HERED, V89, P438, DOI 10.1093/jhered/89.5.438; Waples RS, 2006, MOL ECOL, V15, P1419, DOI 10.1111/j.1365-294X.2006.02890.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wiens John A., 2001, P96	88	28	28	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2011	6	11							e27794	10.1371/journal.pone.0027794	http://dx.doi.org/10.1371/journal.pone.0027794			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IO	22132143	gold, Green Published			2022-12-27	WOS:000297789900020
J	Xia, LC; Cram, JA; Chen, T; Fuhrman, JA; Sun, FZ				Xia, Li C.; Cram, Jacob A.; Chen, Ting; Fuhrman, Jed A.; Sun, Fengzhu			Accurate Genome Relative Abundance Estimation Based on Shotgun Metagenomic Reads	PLOS ONE			English	Article							INTERPOLATED MARKOV-MODELS; HUMAN MICROBIOME PROJECT; GUT MICROBIOME; PHYLOGENETIC CLASSIFICATION; DNA-SEQUENCES; ONE-CELL; METABOLISM; ALGORITHM; FRAGMENTS; ALIGNMENT	Accurate estimation of microbial community composition based on metagenomic sequencing data is fundamental for subsequent metagenomics analysis. Prevalent estimation methods are mainly based on directly summarizing alignment results or its variants; often result in biased and/or unstable estimates. We have developed a unified probabilistic framework (named GRAMMy) by explicitly modeling read assignment ambiguities, genome size biases and read distributions along the genomes. Maximum likelihood method is employed to compute Genome Relative Abundance of microbial communities using the Mixture Model theory (GRAMMy). GRAMMy has been demonstrated to give estimates that are accurate and robust across both simulated and real read benchmark datasets. We applied GRAMMy to a collection of 34 metagenomic read sets from four metagenomics projects and identified 99 frequent species (minimally 0.5% abundant in at least 50% of the datasets) in the human gut samples. Our results show substantial improvements over previous studies, such as adjusting the over-estimated abundance for Bacteroides species for human gut samples, by providing a new reference-based strategy for metagenomic sample comparisons. GRAMMy can be used flexibly with many read assignment tools (mapping, alignment or composition-based) even with low-sensitivity mapping results from huge short-read datasets. It will be increasingly useful as an accurate and robust tool for abundance estimation with the growing size of read sets and the expanding database of reference genomes.	[Xia, Li C.; Chen, Ting; Sun, Fengzhu] Univ So Calif, Dept Biol Sci, Mol & Computat Biol Program, Los Angeles, CA 90089 USA; [Chen, Ting; Sun, Fengzhu] Tsinghua Univ, Tsinghua Natl Lab Informat Sci & Technol, Beijing 100084, Peoples R China	University of Southern California; Tsinghua University	Xia, LC (corresponding author), Univ So Calif, Dept Biol Sci, Mol & Computat Biol Program, Los Angeles, CA 90089 USA.	fsun@usc.edu	Sun, Fengzhu/G-4373-2010; Cram, Jacob/AFK-2633-2022; Xia, Li (Charlie)/AAD-8271-2020; Fuhrman, Jed A/C-6461-2013; Xia, Charlie/H-4755-2012	Sun, Fengzhu/0000-0002-8552-043X; Xia, Li (Charlie)/0000-0003-0868-1923; Fuhrman, Jed A/0000-0002-2361-1985; Xia, Charlie/0000-0003-0868-1923; Cram, Jacob/0000-0001-9546-1130	National Science Foundation (NSF) [DMS1043075, OCE1136818]	National Science Foundation (NSF)(National Science Foundation (NSF))	This research is partially supported by National Science Foundation (NSF) DMS1043075 and OCE1136818. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Angly FE, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000593; Beszteri B, 2010, ISME J, V4, P1075, DOI 10.1038/ismej.2010.29; Biers EJ, 2009, APPL ENVIRON MICROB, V75, P2221, DOI 10.1128/AEM.02118-08; Brady A, 2009, NAT METHODS, V6, P673, DOI [10.1038/NMETH.1358, 10.1038/nmeth.1358]; Case RJ, 2007, APPL ENVIRON MICROB, V73, P278, DOI 10.1128/AEM.01177-06; Chatterji S, 2008, LECT N BIOINFORMAT, V4955, P17; Chen YH, 2009, BIOINFORMATICS, V25, P2514, DOI 10.1093/bioinformatics/btp486; Diaz NN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-56; ENGEMAN RM, 1994, ECOLOGY, V75, P1769, DOI 10.2307/1939636; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Haque MM, 2009, BIOINFORMATICS, V25, P1722, DOI 10.1093/bioinformatics/btp317; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Kelley DR, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-544; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Liolios K, 2010, NUCLEIC ACIDS RES, V38, pD346, DOI 10.1093/nar/gkp848; Liu J.S., 2008, SPRINGER SERIES STAT, DOI [10.1007/978-0-387-76371-2, DOI 10.1007/978-0-387-76371-2]; Markowitz VM, 2010, NUCLEIC ACIDS RES, V38, pD382, DOI 10.1093/nar/gkp887; Mavromatis K, 2007, NAT METHODS, V4, P495, DOI 10.1038/nmeth1043; McHardy AC, 2007, NAT METHODS, V4, P63, DOI 10.1038/NMETH976; Morgan JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010209; Nelson KE, 2010, SCIENCE, V328, P994, DOI 10.1126/science.1183605; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Richter DC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003373; Rosen GL, 2009, CURR GENOMICS, V10, P493, DOI 10.2174/138920209789208255; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Sandberg R, 2001, GENOME RES, V11, P1404, DOI 10.1101/gr.186401; Stepanauskas R, 2007, P NATL ACAD SCI USA, V104, P9052, DOI 10.1073/pnas.0700496104; Teeling H, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-163; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Vaishampayan PA, 2010, GENOME BIOL EVOL, V2, P53, DOI 10.1093/gbe/evp057; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Woyke T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005299; Wu YW, 2011, J COMPUT BIOL, V18, P523, DOI 10.1089/cmb.2010.0245	40	73	77	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2011	6	12							e27992	10.1371/journal.pone.0027992	http://dx.doi.org/10.1371/journal.pone.0027992			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863OC	22162995	Green Published, gold, Green Submitted			2022-12-27	WOS:000298173500008
J	Clementi, N; De Marco, D; Mancini, N; Solforosi, L; Moreno, GJ; Gubareva, LV; Mishin, V; Di Pietro, A; Vicenzi, E; Siccardi, AG; Clementi, M; Burioni, R				Clementi, Nicola; De Marco, Donata; Mancini, Nicasio; Solforosi, Laura; Moreno, Guisella J.; Gubareva, Larisa V.; Mishin, Vasiliy; Di Pietro, Andrea; Vicenzi, Elisa; Siccardi, Antonio G.; Clementi, Massimo; Burioni, Roberto			A Human Monoclonal Antibody with Neutralizing Activity against Highly Divergent Influenza Subtypes	PLOS ONE			English	Article							H1N1 2009 VIRUS; A VIRUSES; SEASONAL INFLUENZA; B-CELLS; S-OIV; PROTECTION; OSELTAMIVIR; INFECTION; VACCINE; EPITOPE	The interest in broad-range anti-influenza A monoclonal antibodies (mAbs) has recently been strengthened by the identification of anti-hemagglutinin (HA) mAbs endowed with heterosubtypic neutralizing activity to be used in the design of "universal" prophylactic or therapeutic tools. However, the majority of the single mAbs described to date do not bind and neutralize viral isolates belonging to highly divergent subtypes clustering into the two different HA-based influenza phylogenetic groups: the group 1 including, among others, subtypes H1, H2, H5 and H9 and the group 2 including, among others, H3 subtype. Here, we describe a human mAb, named PN-SIA28, capable of binding and neutralizing all tested isolates belonging to phylogenetic group 1, including H1N1, H2N2, H5N1 and H9N2 subtypes and several isolates belonging to group 2, including H3N2 isolates from the first period of the 1968 pandemic. Therefore, PN-SIA28 is capable of neutralizing isolates belonging to subtypes responsible of all the reported pandemics, as well as other subtypes with pandemic potential. The region recognized by PN-SIA28 has been identified on the stem region of HA and includes residues highly conserved among the different influenza subtypes. A deep characterization of PN-SIA28 features may represent a useful help in the improvement of available anti-influenza therapeutic strategies and can provide new tools for the development of universal vaccinal strategies.	[Clementi, Nicola; De Marco, Donata; Mancini, Nicasio; Solforosi, Laura; Moreno, Guisella J.; Clementi, Massimo; Burioni, Roberto] Univ Vita Salute San Raffaele, Lab Microbiol & Virol, Milan, Italy; [Gubareva, Larisa V.; Mishin, Vasiliy] Ctr Dis Control & Prevent, Virus Surveillance & Diag Branch, Influenza Div, NCIRD, Atlanta, GA USA; [Di Pietro, Andrea; Vicenzi, Elisa] Ist Sci San Raffaele, Viral Pathogens & Biosafety Unit, Div Immunol Trapianti & Malattie Infett, Milan, Italy; [Siccardi, Antonio G.] Univ Milan, Dipartimento Biol & Genet Sci Med, Milan, Italy	Vita-Salute San Raffaele University; Centers for Disease Control & Prevention - USA; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Milan	Clementi, N (corresponding author), Univ Vita Salute San Raffaele, Lab Microbiol & Virol, Milan, Italy.	burioni.roberto@hsr.it	Di Pietro, Andrea/X-6373-2018; Burioni, Roberto/F-2396-2012; Mancini, Nicasio/AAN-6203-2020; Clementi, Nicola/G-8545-2014; Vicenzi, Elisa/AAL-3980-2020; Clementi, Massimo/F-6646-2013	Di Pietro, Andrea/0000-0003-2497-3862; Clementi, Nicola/0000-0002-1822-9861; MANCINI, Nicasio/0000-0003-0637-0910; Vicenzi, Elisa/0000-0003-0051-3968; Clementi, Massimo/0000-0002-7461-5898				Ansaldi F, 2009, VACCINE, V27, P3345, DOI 10.1016/j.vaccine.2009.01.081; Beigel J, 2008, ANTIVIR RES, V78, P91, DOI 10.1016/j.antiviral.2008.01.003; Burioni R, 2010, VIROLOGY, V399, P144, DOI 10.1016/j.virol.2009.12.014; Burioni R, 2009, NEW MICROBIOL, V32, P319; Burioni R, 2009, LANCET, V374, P1417, DOI 10.1016/S0140-6736(09)61853-5; Burioni R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003423; Burioni Roberto, 2008, J Hepatol, V49, P299, DOI 10.1016/j.jhep.2008.05.008; Carrat F, 2007, VACCINE, V25, P6852, DOI 10.1016/j.vaccine.2007.07.027; Chan AC, 2010, NAT REV IMMUNOL, V10, P301, DOI 10.1038/nri2761; Cheng PKC, 2009, EMERG INFECT DIS, V15, P966, DOI 10.3201/eid1506.081357; Clementi M, 2007, DRUG DISCOV TODAY TH, V4, P267; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; Corti D, 2010, J CLIN INVEST, V120, P1663, DOI 10.1172/JCI41902; Ekiert DC, 2011, SCIENCE, V333, P843, DOI 10.1126/science.1204839; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Ramirez-Gonzalez JE, 2011, EMERG INFECT DIS, V17, P283, DOI 10.3201/eid1702.100897; Friesen RHE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009106; Gamblin SJ, 2010, J BIOL CHEM, V285, P28403, DOI 10.1074/jbc.R110.129809; Hedestam GBK, 2008, NAT REV MICROBIOL, V6, P143, DOI 10.1038/nrmicro1819; Kashyap AK, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000990; Keizer RJ, 2010, CLIN PHARMACOKINET, V49, P493, DOI 10.2165/11531280-000000000-00000; Kitching A, 2009, EUROSURVEILLANCE, V14, P2; Koudstaal W, 2009, J INFECT DIS, V200, P1870, DOI 10.1086/648378; LAMARRE A, 1995, J IMMUNOL, V154, P3975; Lambert LC, 2010, NEW ENGL J MED, V363, P2036, DOI 10.1056/NEJMra1002842; MA JKC, 1990, INFECT IMMUN, V58, P3407, DOI 10.1128/IAI.58.10.3407-3414.1990; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; Monto AS, 2009, VACCINE, V27, P5043, DOI 10.1016/j.vaccine.2009.06.032; Morens DM, 2010, CLIN INFECT DIS, V51, P1442, DOI 10.1086/657429; Nabel GJ, 2010, NAT MED, V16, P1389, DOI 10.1038/nm1210-1389; OKUNO Y, 1993, J VIROL, V67, P2552, DOI 10.1128/JVI.67.5.2552-2558.1993; Sakabe S, 2010, ANTIVIR RES, V88, P249, DOI 10.1016/j.antiviral.2010.09.007; Stanekova Z, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-351; Steel J, 2010, MBIO, V1, DOI 10.1128/mBio.00018-10; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Taubenberger JK, 2010, PUBLIC HEALTH REP, V125, P16, DOI 10.1177/00333549101250S305; Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942; Wang TT, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000796; Xue Y, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-724; YODEN S, 1985, ARCH VIROL, V85, P209, DOI 10.1007/BF01314232; Zhang MY, 2004, J VIROL, V78, P9233, DOI 10.1128/JVI.78.17.9233-9242.2004	41	48	63	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e28001	10.1371/journal.pone.0028001	http://dx.doi.org/10.1371/journal.pone.0028001			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22162996	Green Submitted, Green Published, gold			2022-12-27	WOS:000298172800008
J	Esposito, G; Scuderi, C; Valenza, M; Togna, GI; Latina, V; De Filippis, D; Cipriano, M; Carratu, MR; Iuvone, T; Steardo, L				Esposito, Giuseppe; Scuderi, Caterina; Valenza, Marta; Togna, Giuseppina Ines; Latina, Valentina; De Filippis, Daniele; Cipriano, Mariateresa; Carratu, Maria Rosaria; Iuvone, Teresa; Steardo, Luca			Cannabidiol Reduces Ab- Induced Neuroinflammation and Promotes Hippocampal Neurogenesis through PPAR gamma Involvement	PLOS ONE			English	Article							TAU-PROTEIN HYPERPHOSPHORYLATION; NITRIC-OXIDE SYNTHASE; MOTOR IMPAIRMENTS; NUCLEAR; MICE; THERAPEUTICS; INFLAMMATION; MECHANISMS; EXPRESSION; COMPONENT	Peroxisome proliferator-activated receptor-gamma (PPAR gamma) has been reported to be involved in the etiology of pathological features of Alzheimer's disease (AD). Cannabidiol (CBD), a Cannabis derivative devoid of psychomimetic effects, has attracted much attention because of its promising neuroprotective properties in rat AD models, even though the mechanism responsible for such actions remains unknown. This study was aimed at exploring whether CBD effects could be subordinate to its activity at PPAR gamma, which has been recently indicated as its putative binding site. CBD actions on beta-amyloid-induced neurotoxicity in rat AD models, either in presence or absence of PPAR antagonists were investigated. Results showed that the blockade of PPAR gamma was able to significantly blunt CBD effects on reactive gliosis and subsequently on neuronal damage. Moreover, due to its interaction at PPAR gamma, CBD was observed to stimulate hippocampal neurogenesis. All these findings report the inescapable role of this receptor in mediating CBD actions, here reported.	[Esposito, Giuseppe; Scuderi, Caterina; Togna, Giuseppina Ines; Latina, Valentina; Steardo, Luca] Univ Roma La Sapienza, Dept Physiol & Pharmacol Vittorio Erspamer, Rome, Italy; [Valenza, Marta; Carratu, Maria Rosaria] Univ Bari, Dept Pharmacol & Human Physiol, Bari, Italy; [De Filippis, Daniele; Cipriano, Mariateresa; Iuvone, Teresa] Univ Naples Federico II, Dept Expt Pharmacol, Naples, Italy	Sapienza University Rome; Universita degli Studi di Bari Aldo Moro; University of Naples Federico II	Esposito, G (corresponding author), Univ Roma La Sapienza, Dept Physiol & Pharmacol Vittorio Erspamer, Rome, Italy.	luca.steardo@uniroma1.it	Scuderi, Caterina/J-4189-2012; Valenza, Marta/HDN-9003-2022; Esposito, Giuseppe/AAA-7949-2019; LATINA, VALENTINA/ABF-6504-2020; Valenza, Marta/AAG-6163-2019	Scuderi, Caterina/0000-0002-7314-1539; Valenza, Marta/0000-0002-2326-3896; Esposito, Giuseppe/0000-0001-8080-8218; LATINA, VALENTINA/0000-0002-6057-6154; Valenza, Marta/0000-0002-2326-3896; Cipriano, Mariateresa/0000-0001-6644-7137; Carratu, Maria/0000-0002-9709-6533; Steardo, Luca/0000-0003-3570-2195	Italian Ministry of Education, University and Research (FIRB)	Italian Ministry of Education, University and Research (FIRB)(Ministry of Education, Universities and Research (MIUR))	This work was partially supported by the Italian Ministry of Education, University and Research (FIRB 2006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; Avraham Y, 2011, BRIT J PHARMACOL, V162, P1650, DOI 10.1111/j.1476-5381.2010.01179.x; Bensinger SJ, 2008, NATURE, V454, P470, DOI 10.1038/nature07202; Bianchi R, 2010, NEUROBIOL AGING, V31, P665, DOI 10.1016/j.neurobiolaging.2008.05.017; Bodles AM, 2005, NEUROBIOL AGING, V26, P9, DOI 10.1016/j.neurobiolaging.2004.02.022; Bookout AL, 2006, CELL, V126, P789, DOI 10.1016/j.cell.2006.06.049; Bright JJ, 2008, PPAR RES, V2008, DOI 10.1155/2008/658520; Castillo A, 2010, NEUROBIOL DIS, V37, P434, DOI 10.1016/j.nbd.2009.10.023; de la Monte SM, 2006, J ALZHEIMERS DIS, V9, P167; DIROSA M, 1990, BIOCHEM BIOPH RES CO, V172, P1246, DOI 10.1016/0006-291X(90)91583-E; Esposito G, 2007, BRIT J PHARMACOL, V151, P1272, DOI 10.1038/sj.bjp.0707337; Esposito G, 2006, J MOL MED, V84, P253, DOI 10.1007/s00109-005-0025-1; Esposito G, 2008, J CELL MOL MED, V12, P914, DOI 10.1111/j.1582-4934.2008.00159.x; Esposito G, 2006, NEUROSCI LETT, V399, P91, DOI 10.1016/j.neulet.2006.01.047; Feinstein Douglas L, 2003, Diabetes Technol Ther, V5, P67, DOI 10.1089/152091503763816481; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Hampson AJ, 1998, P NATL ACAD SCI USA, V95, P8268, DOI 10.1073/pnas.95.14.8268; Ho Gilbert J., 2005, Current Drug Targets - Inflammation and Allergy, V4, P247, DOI 10.2174/1568010053586237; Iuvone T, 2004, J NEUROCHEM, V89, P134, DOI 10.1111/j.1471-4159.2003.02327.x; Iuvone T, 2009, CNS NEUROSCI THER, V15, P65, DOI 10.1111/j.1755-5949.2008.00065.x; Kapadia R, 2008, FRONT BIOSCI-LANDMRK, V13, P1813, DOI 10.2741/2802; Kersten S, 2008, PPAR RES, V2008, DOI 10.1155/2008/132960; Landreth G, 2008, NEUROTHERAPEUTICS, V5, P481, DOI 10.1016/j.nurt.2008.05.003; Landreth GE, 2001, NEUROBIOL AGING, V22, P937, DOI 10.1016/S0197-4580(01)00296-2; Lazarov O, 2010, EXP NEUROL, V223, P267, DOI 10.1016/j.expneurol.2009.08.009; Li B, 2008, J NEUROPATH EXP NEUR, V67, P78, DOI 10.1097/nen.0b013e318160c5db; Magen I, 2010, BRIT J PHARMACOL, V159, P950, DOI 10.1111/j.1476-5381.2009.00589.x; Magen I, 2009, J HEPATOL, V51, P528, DOI 10.1016/j.jhep.2009.04.021; Mayo W, 2005, NEUROBIOL AGING, V26, P103, DOI 10.1016/j.neurobiolaging.2004.03.013; Miglio G, 2009, NEUROSCI LETT, V454, P134, DOI 10.1016/j.neulet.2009.03.014; Mori T, 2010, GLIA, V58, P300, DOI 10.1002/glia.20924; Mrak RE, 2001, NEUROBIOL AGING, V22, P903, DOI 10.1016/S0197-4580(01)00287-1; O'Banion, 1999, Expert Opin Investig Drugs, V8, P1521, DOI 10.1517/13543784.8.10.1521; O'Sullivan SE, 2007, BRIT J PHARMACOL, V152, P576, DOI 10.1038/sj.bjp.0707423; Phiel CJ, 2003, NATURE, V423, P435, DOI 10.1038/nature01640; Prins ND, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt28; Scuderi C, 2009, PHYTOTHER RES, V23, P597, DOI 10.1002/ptr.2625; Vairano M, 2002, EUR J NEUROSCI, V16, P584, DOI 10.1046/j.1460-9568.2002.02125.x; Wada K, 2006, J BIOL CHEM, V281, P12673, DOI 10.1074/jbc.M513786200; Wolf SA, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-12; Zhang D, 2010, MOL NEUROBIOL, V41, P232, DOI 10.1007/s12035-010-8098-4	41	228	231	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e28668	10.1371/journal.pone.0028668	http://dx.doi.org/10.1371/journal.pone.0028668			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22163051	Green Published, Green Submitted, gold			2022-12-27	WOS:000298172800055
J	Dennison, SM; Sutherland, LL; Jaeger, FH; Anasti, KM; Parks, R; Stewart, S; Bowman, C; Xia, SM; Zhang, RJ; Shen, XY; Scearce, RM; Ofek, G; Yang, YP; Kwong, PD; Santra, S; Liao, HX; Tomaras, G; Letvin, NL; Chen, B; Alam, SM; Haynes, BF				Dennison, S. Moses; Sutherland, Laura L.; Jaeger, Frederick H.; Anasti, Kara M.; Parks, Robert; Stewart, Shelley; Bowman, Cindy; Xia, Shi-Mao; Zhang, Ruijun; Shen, Xiaoying; Scearce, Richard M.; Ofek, Gilad; Yang, Yongping; Kwong, Peter D.; Santra, Sampa; Liao, Hua-Xin; Tomaras, Georgia; Letvin, Norman L.; Chen, Bing; Alam, S. Munir; Haynes, Barton F.			Induction of Antibodies in Rhesus Macaques That Recognize a Fusion-Intermediate Conformation of HIV-1 gp41	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; PROXIMAL EXTERNAL REGION; BROADLY NEUTRALIZING ANTIBODIES; HUMAN MONOCLONAL-ANTIBODIES; AUTOREACTIVE B-CELLS; SURFACE-ANTIGEN; VACCINE DESIGN; 2F5 EPITOPE; MEMBRANE; ENVELOPE	A component to the problem of inducing broad neutralizing HIV-1 gp41 membrane proximal external region (MPER) antibodies is the need to focus the antibody response to the transiently exposed MPER pre-hairpin intermediate neutralization epitope. Here we describe a HIV-1 envelope (Env) gp140 oligomer prime followed by MPER peptide-liposomes boost strategy for eliciting serum antibody responses in rhesus macaques that bind to a gp41 fusion intermediate protein. This Env-liposome immunization strategy induced antibodies to the 2F5 neutralizing epitope (664)DKW residues, and these antibodies preferentially bound to a gp41 fusion intermediate construct as well as to MPER scaffolds stabilized in the 2F5-bound conformation. However, no serum lipid binding activity was observed nor was serum neutralizing activity for HIV-1 pseudoviruses present. Nonetheless, the Env-liposome prime-boost immunization strategy induced antibodies that recognized a gp41 fusion intermediate protein and was successful in focusing the antibody response to the desired epitope.	[Dennison, S. Moses; Sutherland, Laura L.; Jaeger, Frederick H.; Anasti, Kara M.; Parks, Robert; Stewart, Shelley; Bowman, Cindy; Xia, Shi-Mao; Zhang, Ruijun; Shen, Xiaoying; Scearce, Richard M.; Liao, Hua-Xin; Tomaras, Georgia; Alam, S. Munir; Haynes, Barton F.] Duke Univ, Sch Med, Human Vaccine Inst, Durham, NC 27710 USA; [Santra, Sampa; Letvin, Norman L.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Childrens Hosp,Dept Med, Boston, MA 02215 USA; [Chen, Bing] Harvard Univ, Childrens Hosp, Sch Med, Div Mol Med, Boston, MA 02115 USA; [Ofek, Gilad; Yang, Yongping; Kwong, Peter D.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA	Duke University; Harvard University; Beth Israel Deaconess Medical Center; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Dennison, SM (corresponding author), Duke Univ, Sch Med, Human Vaccine Inst, Durham, NC 27710 USA.	alam0004@mc.duke.edu; hayne002@mc.duke.edu	Tomaras, Georgia/J-5041-2016; Zhang, RUIJUN/AAD-6887-2021; Alam, S. Munir/AAC-6711-2019	Zhang, RUIJUN/0000-0001-6785-9619; 	Bill & Melinda Gates Foundation [38643]; Center for HIV/AIDS Vaccine Immunology (CHAVI) from the NIH, NIAID [AI067854]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI060354, U01AI067854, U19AI067854, ZIAAI005022] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Center for HIV/AIDS Vaccine Immunology (CHAVI) from the NIH, NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was conducted as part of the Collaboration for AIDS Vaccine Discovery (CAVD) with support from the Bill & Melinda Gates Foundation to BFH (38643) and from the Center for HIV/AIDS Vaccine Immunology (CHAVI) AI067854 from the NIH, NIAID. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam SM, 2008, J VIROL, V82, P115, DOI 10.1128/JVI.00927-07; Alam SM, 2007, J IMMUNOL, V178, P4424, DOI 10.4049/jimmunol.178.7.4424; Alam SM, 2009, P NATL ACAD SCI USA, V106, P20234, DOI 10.1073/pnas.0908713106; Arnold GF, 2009, J VIROL, V83, P5087, DOI 10.1128/JVI.00184-09; Barbato G, 2003, J MOL BIOL, V330, P1101, DOI 10.1016/S0022-2836(03)00611-9; Biron Z, 2005, BIOCHEMISTRY-US, V44, P13602, DOI 10.1021/bi0509245; Cardoso RMF, 2005, IMMUNITY, V22, P163, DOI 10.1016/j.immuni.2004.12.011; Chakrabarti BK, 2005, VACCINE, V23, P3434, DOI 10.1016/j.vaccine.2005.01.099; Coeffier E, 2000, VACCINE, V19, P684, DOI 10.1016/S0264-410X(00)00267-X; Dennison SM, 2011, J VIROL, V85, P1340, DOI 10.1128/JVI.01680-10; Dennison SM, 2009, J VIROL, V83, P10211, DOI 10.1128/JVI.00571-09; Eckhart L, 1996, J GEN VIROL, V77, P2001, DOI 10.1099/0022-1317-77-9-2001; Frey G, 2008, P NATL ACAD SCI USA, V105, P3739, DOI 10.1073/pnas.0800255105; Frey G, 2010, NAT STRUCT MOL BIOL, V17, P1486, DOI 10.1038/nsmb.1950; Gorny MK, 2000, J VIROL, V74, P6186, DOI 10.1128/JVI.74.13.6186-6192.2000; Gray ES, 2007, J VIROL, V81, P6187, DOI 10.1128/JVI.00239-07; Guenaga J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016074; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Herlands RA, 2008, IMMUNITY, V29, P249, DOI 10.1016/j.immuni.2008.06.009; Hessell AJ, 2010, J VIROL, V84, P1302, DOI 10.1128/JVI.01272-09; Hinz A, 2009, VIROLOGY, V390, P221, DOI 10.1016/j.virol.2009.05.015; Ho J, 2005, VACCINE, V23, P1559, DOI 10.1016/j.vaccine.2004.09.037; Joyce JG, 2002, J BIOL CHEM, V277, P45811, DOI 10.1074/jbc.M205862200; Julien JP, 2008, J MOL BIOL, V384, P377, DOI 10.1016/j.jmb.2008.09.024; Liang XP, 1999, VACCINE, V17, P2862, DOI 10.1016/S0264-410X(99)00125-5; Liao HX, 2006, VIROLOGY, V353, P268, DOI 10.1016/j.virol.2006.04.043; Matyas GR, 2009, AIDS, V23, P2069, DOI 10.1097/QAD.0b013e32832faea5; McGaughey GB, 2003, BIOCHEMISTRY-US, V42, P3214, DOI 10.1021/bi026952u; Montero M, 2008, MICROBIOL MOL BIOL R, V72, P54, DOI 10.1128/MMBR.00020-07; Morris L., 2011, PLOS ONE IN PRESS; Munoz-Barroso I, 1999, J VIROL, V73, P6089; Nicely NI, 2010, NAT STRUCT MOL BIOL, V17, P1492, DOI 10.1038/nsmb.1944; Ofek G, 2004, J VIROL, V78, P10724, DOI 10.1128/JVI.78.19.10724-10737.2004; Ofek G, 2010, P NATL ACAD SCI USA, V107, P17880, DOI 10.1073/pnas.1004728107; Phogat S, 2008, VIROLOGY, V373, P72, DOI 10.1016/j.virol.2007.11.005; Salzwedel K, 1999, J VIROL, V73, P2469, DOI 10.1128/JVI.73.3.2469-2480.1999; Sather DN, 2009, J VIROL, V83, P757, DOI 10.1128/JVI.02036-08; Schibli DJ, 2001, BIOCHEMISTRY-US, V40, P9570, DOI 10.1021/bi010640u; Shen XY, 2010, P NATL ACAD SCI USA, V107, P5972, DOI 10.1073/pnas.0912381107; Shen XY, 2009, J VIROL, V83, P3617, DOI 10.1128/JVI.02631-08; Shlomchik MJ, 2008, IMMUNITY, V28, P18, DOI 10.1016/j.immuni.2007.12.004; Song LK, 2009, P NATL ACAD SCI USA, V106, P9057, DOI 10.1073/pnas.0901474106; Stiegler G, 2001, AIDS RES HUM RETROV, V17, P1757, DOI 10.1089/08892220152741450; Sun ZYJ, 2008, IMMUNITY, V28, P52, DOI 10.1016/j.immuni.2007.11.018; Tran TT, 2003, CLIN IMMUNOL, V109, P278, DOI 10.1016/j.clim.2003.08.012; Uccellini MB, 2008, J IMMUNOL, V181, P5875, DOI 10.4049/jimmunol.181.9.5875; Verkoczy L, 2011, CURR OPIN IMMUNOL, V23, P383, DOI 10.1016/j.coi.2011.04.003; Verkoczy L, 2010, P NATL ACAD SCI USA, V107, P181, DOI 10.1073/pnas.0912914107; Wang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018233; Watson DS, 2009, VACCINE, V27, P4672, DOI 10.1016/j.vaccine.2009.05.059; Ye L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014813; Yuan W, 2009, AIDS RES HUM RETROV, V25, P319, DOI 10.1089/aid.2008.0213; Zhang HT, 2004, J VIROL, V78, P8342, DOI 10.1128/jvi.78.15.8342-8348.2004	53	58	61	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e27824	10.1371/journal.pone.0027824	http://dx.doi.org/10.1371/journal.pone.0027824			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140469	Green Published, gold, Green Submitted			2022-12-27	WOS:000298168100019
J	de Amorim, IFG; da Silva, SM; Figueiredo, MM; Moura, EP; de Castro, RS; Lima, TKD; Gontijo, ND; Michalick, MSM; Gollob, KJ; Tafuri, WL				Gontijo de Amorim, Izabela Ferreira; da Silva, Sydnei Magno; Figueiredo, Maria Marta; Moura, Eliane Perlatto; de Castro, Rodrigo Soares; de Souza Lima, Tatjana Keesen; Gontijo, Nelder de Figueiredo; Marques Michalick, Marilene Suzan; Gollob, Kenneth John; Tafuri, Wagner Luiz			Toll Receptors Type-2 and CR3 Expression of Canine Monocytes and Its Correlation with Immunohistochemistry and Xenodiagnosis in Visceral Leishmaniasis	PLOS ONE			English	Article							LUTZOMYIA-LONGIPALPIS; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORS; ASYMPTOMATIC DOGS; IMMUNE-RESPONSES; MACROPHAGES; INFECTION; INFANTUM; CHAGASI; TOLL-LIKE-RECEPTOR-2; RECOGNITION	The aim of the present study was to investigate TLR2 expression in peripheral blood monocytes from dogs naturally infected with Leishmania (Leishmania) infantum to determine whether it correlates with CD11b/CD18 (CR3) expression, and to evaluate the potential of dogs as sources of infection using phlebotomine xenodiagnosis. Forty eight dogs were serologically diagnosed with L. infantum infection by indirect immunofluorescence antibody test (IFAT) and enzyme linked immunosorbent assay (ELISA). Parasitological exams from bone-marrow aspirates were positive by PCR analysis. All dogs were clinical defined as symptomatic. Ear skin tissue samples were obtained for immunohistochemistry (IHQ) analysis. The potential of these dogs as a source of infection using phlebotomine xenodiagnosis (XENO) was evaluated. Flow cytometry was carried out on peripheral blood mononuclear cells using superficial receptors including CD14, CD11b, TLR2 and MHCII. IHQ ear skin tissue parasite load and XENO where done where we found a strict correlation (r = 0.5373). Dogs with higher expression of MFI of CD11b inside CD14 monocytes were represented by dogs without parasite ear tissue load that were unable to infect phlebotomines (IHQ(-)/XENO-). Dogs with lower expression of MFI of CD11b inside CD14 monocytes were represented by dogs with parasite ear tissue load and able to infect phlebotomines (IHQ(+)/XENO+) (p = 0,0032). Comparable results were obtained for MFI of MHCII (p = 0.0054). In addition, considering the population frequency of CD11b(+)TLR2(+) and CD11b(+)MHCII(+), higher values were obtained from dogs with IHQ(-)/XENO- than dogs with IHQ(+)/XENO+ (p = 0.01; p = 0.0048, respectively). These data, together with the TLR2 and NO assays results (CD11b(+)TLR2(+) and NO with higher values for dogs with IHQ(-)/XENO- than dogs with IHQ(+)/XENO+), led to the conclusion that IHQ(-)/XENO- dogs are more resistant or could modulate the cellular immune response essential for Leishmania tissue clearance.	[Gontijo de Amorim, Izabela Ferreira; Figueiredo, Maria Marta; de Castro, Rodrigo Soares; Tafuri, Wagner Luiz] Univ Fed Minas Gerais, Escola Med, Dept Patol Geral, Belo Horizonte, MG, Brazil; [da Silva, Sydnei Magno; Gontijo, Nelder de Figueiredo; Marques Michalick, Marilene Suzan] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Belo Horizonte, MG, Brazil; [Moura, Eliane Perlatto] Univ Fed Minas Gerais, Escola Med, Dept Parasitol, Belo Horizonte, MG, Brazil; [de Souza Lima, Tatjana Keesen; Gollob, Kenneth John] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	de Amorim, IFG (corresponding author), Univ Fed Minas Gerais, Escola Med, Dept Patol Geral, Belo Horizonte, MG, Brazil.	wagnertafuri@gmail.com	Gollob, Kenneth J/C-1341-2008; Gontijo, Nelder F/D-2539-2013; Silva, Sydnei/K-4089-2012; Gollob, Kenneth J/GPX-8434-2022; DoenÃas Tropicais, Inct/K-2308-2013	Gollob, Kenneth J/0000-0003-4184-3867; Gontijo, Nelder F/0000-0003-3357-2497; Silva, Sydnei/0000-0003-3154-5663; Tafuri, Wagner Luiz/0000-0002-7556-0737; FERREIRA GONTIJO DE AMORIM, IZABELA/0000-0003-3660-4167	Fundacao de Amparo e Pesquisa do Estado de Minas Gerais (FAPEMIG) [DS-AQP 00068-08, CBB00219/09]; Pro-reitoria de Pesquisa (PRPq), Universidade Federal de Minas Gerais, UFMG, Minas Gerais State, Brazil [Edital 07/2010]	Fundacao de Amparo e Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Pro-reitoria de Pesquisa (PRPq), Universidade Federal de Minas Gerais, UFMG, Minas Gerais State, Brazil	This study was supported by Fundacao de Amparo e Pesquisa do Estado de Minas Gerais (FAPEMIG CDS-AQP 00068-08 and FAPEMIG CBB00219/09) and Pro-reitoria de Pesquisa (PRPq-Edital 07/2010), Universidade Federal de Minas Gerais, UFMG, Minas Gerais State, Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvar J, 2004, ADV PARASIT, V57, P1, DOI 10.1016/S0065-308X(04)57001-X; Alves CF, 2009, VET IMMUNOL IMMUNOP, V128, P349, DOI 10.1016/j.vetimm.2008.11.020; Amusategui I, 2003, EUR J EPIDEMIOL, V18, P147, DOI 10.1023/A:1023090929302; Bazzocchi C, 2005, VET IMMUNOL IMMUNOP, V104, P15, DOI 10.1016/j.vetimm.2004.08.023; Becker I, 2003, MOL BIOCHEM PARASIT, V130, P65, DOI 10.1016/S0166-6851(03)00160-9; Bretagne S, 2001, CLIN DIAGN LAB IMMUN, V8, P828, DOI 10.1128/CDLI.8.4.828-831.2001; Campos MA, 2001, J IMMUNOL, V167, P416, DOI 10.4049/jimmunol.167.1.416; Carpenter S, 2007, CELL MICROBIOL, V9, P1891, DOI 10.1111/j.1462-5822.2007.00965.x; Carter CR, 2009, INFECT IMMUN, V77, P5668, DOI 10.1128/IAI.00802-08; Chandra D, 2008, CLIN EXP IMMUNOL, V154, P224, DOI 10.1111/j.1365-2249.2008.03741.x; Ciaramella P, 2005, VET J, V169, P465, DOI 10.1016/j.tvjl.2004.03.009; Ciaramella P, 1997, VET REC, V141, P539, DOI 10.1136/vr.141.21.539; Ciaramella P, 2002, PLATELETS, V13, P331; da Costa-Val AP, 2007, VET J, V174, P636, DOI 10.1016/j.tvjl.2006.11.006; da Silva SM, 2010, VET PARASITOL, V174, P150, DOI 10.1016/j.vetpar.2010.08.005; da Silva SM, 2009, VET PARASITOL, V166, P159, DOI 10.1016/j.vetpar.2009.08.011; De Almeida MC, 2003, INT J PARASITOL, V33, P153, DOI 10.1016/S0020-7519(02)00266-7; de Amorim IFG, 2010, VET PARASITOL, V173, P55, DOI 10.1016/j.vetpar.2010.06.021; de Veer MJ, 2003, EUR J IMMUNOL, V33, P2822, DOI 10.1002/eji.200324128; do Rosario EY, 2005, MEM I OSWALDO CRUZ, V100, P197, DOI 10.1590/S0074-02762005000200015; Ehlers MRW, 2000, MICROBES INFECT, V2, P289, DOI 10.1016/S1286-4579(00)00299-9; Engwerda CR, 2004, TRENDS PARASITOL, V20, P524, DOI 10.1016/j.pt.2004.08.009; Ferguson MAJ, 1999, J CELL SCI, V112, P2799; Figueiredo MM, 2010, HISTOL HISTOPATHOL, V25, P877, DOI 10.14670/HH-25.877; Flandin JF, 2006, EUR J IMMUNOL, V36, P411, DOI 10.1002/eji.200535079; Giunchetti RC, 2006, J COMP PATHOL, V135, P100, DOI 10.1016/j.jcpa.2006.06.005; Giunchetti RC, 2008, RES VET SCI, V84, P269, DOI 10.1016/j.rvsc.2007.04.020; Goncalves R, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-39; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Guarga JL, 2000, ACTA TROP, V77, P203, DOI 10.1016/S0001-706X(00)00141-8; Guerra CS, 2010, INT J EXP PATHOL, V91, P451, DOI 10.1111/j.1365-2613.2010.00717.x; Hawn TR, 2002, MICROBES INFECT, V4, P763, DOI 10.1016/S1286-4579(02)01596-4; Ishii M, 2006, VET IMMUNOL IMMUNOP, V110, P87, DOI 10.1016/j.vetimm.2005.09.007; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kavoosi G, 2010, EXP PARASITOL, V124, P214, DOI 10.1016/j.exppara.2009.09.017; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Koutinas AF, 1999, J AM ANIM HOSP ASSOC, V35, P376, DOI 10.5326/15473317-35-5-376; Lage RS, 2007, VET IMMUNOL IMMUNOP, V115, P135, DOI 10.1016/j.vetimm.2006.10.001; Lima WG, 2007, VET IMMUNOL IMMUNOP, V117, P129, DOI 10.1016/j.vetimm.2007.02.012; Lima WG, 2004, ACTA TROP, V92, P43, DOI 10.1016/j.actatropica.2004.04.007; Marth T, 1997, J EXP MED, V185, P1987, DOI 10.1084/jem.185.11.1987; MAUEL J, 1991, J LEUKOCYTE BIOL, V49, P73, DOI 10.1002/jlb.49.1.73; Mauricio IL, 2000, PARASITOL TODAY, V16, P188, DOI 10.1016/S0169-4758(00)01637-9; Melo FA, 2009, INT J EXP PATHOL, V90, P538, DOI 10.1111/j.1365-2613.2009.00681.x; Michalsky EM, 2007, VET PARASITOL, V147, P67, DOI 10.1016/j.vetpar.2007.03.004; Mosser David M., 1993, Seminars in Cell Biology, V4, P315, DOI 10.1006/scel.1993.1038; MOSSER DM, 1987, NATURE, V327, P329, DOI 10.1038/327329b0; PIARROUX R, 1993, AM J TROP MED HYG, V49, P364, DOI 10.4269/ajtmh.1993.49.364; Reis AB, 2009, VET IMMUNOL IMMUNOP, V128, P87, DOI 10.1016/j.vetimm.2008.10.307; Ribeiro RR, 2008, ANTIMICROB AGENTS CH, V52, P2564, DOI 10.1128/AAC.00223-08; Sampaio Weverton M, 2007, BMC Vet Res, V3, P11, DOI 10.1186/1746-6148-3-11; Sanchez MA, 2004, AM J TROP MED HYG, V70, P618, DOI 10.4269/ajtmh.2004.70.618; Silvestre R, 2009, IMMUNOLOGY, V128, P484, DOI 10.1111/j.1365-2567.2009.03132.x; Strauss-Ayali D, 2007, VET RES, V38, P547, DOI 10.1051/vetres:2007015; Tafuri WL, 2004, J IMMUNOL METHODS, V292, P17, DOI 10.1016/j.jim.2004.05.009; Takeda K, 2001, JPN J INFECT DIS, V54, P209; Teixeira MJ, 2006, TRENDS PARASITOL, V22, P32, DOI 10.1016/j.pt.2005.11.010; Travi BL, 2001, AM J TROP MED HYG, V64, P119, DOI 10.4269/ajtmh.2001.64.119; Triantafilou M, 2002, TRENDS IMMUNOL, V23, P301, DOI 10.1016/S1471-4906(02)02233-0; Tuon FF, 2008, INFECT IMMUN, V76, P866, DOI 10.1128/IAI.01090-07; Vercosa BLA, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-45; VOLLER A, 1978, Ricerca in Clinica e in Laboratorio, V8, P289; Xavier SC, 2006, BMC VET RES, V2, P17, DOI [10.1186/1746-6148-2-17, DOI 10.1186/1746-6148-2-17]; Zafra R, 2008, VET IMMUNOL IMMUNOP, V123, P353, DOI 10.1016/j.vetimm.2008.02.022	64	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e27679	10.1371/journal.pone.0027679	http://dx.doi.org/10.1371/journal.pone.0027679			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140456	Green Published, Green Submitted, gold			2022-12-27	WOS:000298168100015
J	Goodin, DS; Jones, J; Li, D; Traboulsee, A; Reder, AT; Beckmann, K; Konieczny, A; Knappertz, V				Goodin, Douglas S.; Jones, Jason; Li, David; Traboulsee, Anthony; Reder, Anthony T.; Beckmann, Karola; Konieczny, Andreas; Knappertz, Volker		16-Year Long-Term Follow-Up Study	Establishing Long-Term Efficacy in Chronic Disease: Use of Recursive Partitioning and Propensity Score Adjustment to Estimate Outcome in MS	PLOS ONE			English	Article							PLACEBO-CONTROLLED TRIAL; REMITTING MULTIPLE-SCLEROSIS; INTERFERON BETA-1A; DOUBLE-BLIND; MULTICENTER; STRATIFICATION; NATALIZUMAB; DISABILITY	Context: Establishing the long-term benefit of therapy in chronic diseases has been challenging. Long-term studies require non-randomized designs and, thus, are often confounded by biases. For example, although disease-modifying therapy in MS has a convincing benefit on several short-term outcome-measures in randomized trials, its impact on long-term function remains uncertain. Objective: Data from the 16-year Long-Term Follow-up study of interferon-beta-1b is used to assess the relationship between drug-exposure and long-term disability in MS patients. Design/Setting: To mitigate the bias of outcome-dependent exposure variation in non-randomized long-term studies, drug-exposure was measured as the medication-possession-ratio, adjusted up or down according to multiple different weighting-schemes based on MS severity and MS duration at treatment initiation. A recursive-partitioning algorithm assessed whether exposure (using any weighing scheme) affected long-term outcome. The optimal cut-point that was used to define "high'' or "low'' exposure-groups was chosen by the algorithm. Subsequent to verification of an exposure-impact that included all predictor variables, the two groups were compared using a weighted propensity-stratified analysis in order to mitigate any treatment-selection bias that may have been present. Finally, multiple sensitivity-analyses were undertaken using different definitions of long-term outcome and different assumptions about the data. Main Outcome Measure: Long-Term Disability. Results: In these analyses, the same weighting-scheme was consistently selected by the recursive-partitioning algorithm. This scheme reduced (down-weighted) the effectiveness of drug exposure as either disease duration or disability at treatment-onset increased. Applying this scheme and using propensity-stratification to further mitigate bias, high-exposure had a consistently better clinical outcome compared to low-exposure (Cox proportional hazard ratio = 0.30-0.42; p < 0.0001). Conclusions: Early initiation and sustained use of interferon-beta-1b has a beneficial impact on long-term outcome in MS. Our analysis strategy provides a methodological framework for bias-mitigation in the analysis of non-randomized clinical data.	[Goodin, Douglas S.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Jones, Jason] Intermt Healthcare, Salt Lake City, UT USA; [Li, David; Traboulsee, Anthony] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Reder, Anthony T.] Univ Chicago, Dept Neurol, Chicago, IL 60637 USA; [Beckmann, Karola] Bayer Schering Pharma AG, Berlin, Germany; [Konieczny, Andreas] Lampe Konieczny & Co, Berlin, Germany; [Knappertz, Volker] Bayer HealthCare, Montville, NJ USA	University of California System; University of California San Francisco; Intermountain Healthcare; Intermountain Medical Center; University of British Columbia; University of Chicago; Bayer AG; Bayer Healthcare Pharmaceuticals; Bayer AG; Bayer Healthcare Pharmaceuticals	Goodin, DS (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA.	douglas.goodin@ucsf.edu	Traboulsee, Anthony L/AAB-2051-2020	Traboulsee, Anthony/0000-0002-0351-9639	Bayer HealthCare	Bayer HealthCare(Bayer AGBayer Healthcare Pharmaceuticals)	The 16-yrfollow-up study was designed by the steering committee (DG, Dl, AT, AR) which also included the neurologist representative from Bayer HealthCare (VK). Data collection was done by the participating centers and was collated by the CRO (Parexl) overseen by the consultant (AK), both funded by Bayer HealthCare. The statistical analysis was performed by (JJ), a consultant paid by Bayer HealthCare and was independently confirmed by (KB), a statistician working in the department of Biostatistics at Bayer HealthCAre. The decision to publish was made by the steering committee members (DG, Dl, AT, AR). The primary manuscript was written by (DG), although this was modified substantially according to the input received from each member of the author panel.	[Anonymous], 2008, PARTY PACKAGE; BASS FM, 1969, MANAGE SCI, V15, P215, DOI 10.1287/mnsc.15.5.215; CIAMPI A, 1988, COMPUT METH PROG BIO, V26, P239, DOI 10.1016/0169-2607(88)90004-1; Cohen JA, 2010, NEW ENGL J MED, V362, P402, DOI 10.1056/NEJMoa0907839; Coles AJ, 2008, NEW ENGL J MED, V359, P1786, DOI 10.1056/NEJMoa0802670; Comi G, 2009, LANCET, V374, P1503, DOI 10.1016/S0140-6736(09)61259-9; Comi G, 2001, LANCET, V357, P1576, DOI 10.1016/S0140-6736(00)04725-5; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; DUQUETTE P, 1993, NEUROLOGY, V43, P655, DOI 10.1212/wnl.43.4.655; Durelli L, 2002, LANCET, V359, P1453, DOI 10.1016/S0140-6736(02)08430-1; Ebers G, 1999, NEUROLOGY, V53, P679; Ebers GC, 1998, LANCET, V352, P1498, DOI 10.1016/S0140-6736(98)03334-0; Ebers GC, 2009, CLIN THER, V31, P1724, DOI 10.1016/j.clinthera.2009.08.003; Ernst MD, 2004, STAT SCI, V19, P676, DOI 10.1214/088342304000000396; Frohman EM, 2006, ARCH NEUROL-CHICAGO, V63, P614, DOI 10.1001/archneur.63.4.614; Giovannoni G, 2010, NEW ENGL J MED, V362, P416, DOI 10.1056/NEJMoa0902533; Goodin DS, 2009, MULT SCLER, V15, P1175, DOI 10.1177/1352458509107007; Goodin DS, 2002, NEUROLOGY, V58, P169, DOI 10.1212/WNL.58.2.169; Goodin DS, 2011, RELATIONSHIP E UNPUB; Heagerty PJ, 2005, BIOMETRICS, V61, P92, DOI 10.1111/j.0006-341X.2005.030814.x; Hothorn T, 2006, J COMPUT GRAPH STAT, V15, P651, DOI 10.1198/106186006X133933; Jacobs LD, 2000, NEW ENGL J MED, V343, P898, DOI 10.1056/NEJM200009283431301; Jacobs LD, 1996, ANN NEUROL, V39, P285, DOI 10.1002/ana.410390304; JOHNSON KP, 1995, NEUROLOGY, V45, P1268, DOI 10.1212/WNL.45.7.1268; Kappos L, 1998, LANCET, V352, P1491, DOI 10.1016/S0140-6736(98)10039-9; Kappos L, 2006, NEUROLOGY, V67, P1242, DOI 10.1212/01.wnl.0000237641.33768.8d; Kappos L, 2010, NEW ENGL J MED, V362, P387, DOI 10.1056/NEJMoa0909494; Lunceford JK, 2004, STAT MED, V23, P2937, DOI 10.1002/SIM.1903; Mikol DD, 2008, LANCET NEUROL, V7, P903, DOI 10.1016/S1474-4422(08)70200-X; Novikov I, 2007, JAMA-J AM MED ASSOC, V297, P2077, DOI 10.1001/jama.297.19.2077-a; O'Connor P, 2009, LANCET NEUROL, V8, P889, DOI 10.1016/S1474-4422(09)70226-1; Panitch H, 2002, NEUROLOGY, V59, P1496, DOI 10.1212/01.WNL.0000034080.43681.DA; PATY DW, 1993, NEUROLOGY, V43, P662, DOI 10.1212/WNL.43.4.662; Platform R, 2008, R PLATFORM; Polman CH, 2006, NEW ENGL J MED, V354, P899, DOI 10.1056/NEJMoa044397; Reder AT, 2010, NEUROLOGY, V74, P1877, DOI 10.1212/WNL.0b013e3181e240d0; Reder AT, 2011, EARLY DISABILI UNPUB; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Roxburgh RHSR, 2005, NEUROLOGY, V64, P1144, DOI 10.1212/01.WNL.0000156155.19270.F8; Rudick RA, 2006, NEW ENGL J MED, V354, P911, DOI 10.1056/NEJMoa044396; SCLAR DA, 1991, CLIN THER, V13, P489; Senn S, 2007, STAT MED, V26, P5529, DOI 10.1002/sim.3133; Siannis F, 2005, BIOSTATISTICS, V6, P77, DOI 10.1093/biostatistics/kxh019; Sikka R, 2005, AM J MANAG CARE, V11, P453; Trojano M, 2007, ANN NEUROL, V61, P300, DOI 10.1002/ana.21102	45	34	34	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e22444	10.1371/journal.pone.0022444	http://dx.doi.org/10.1371/journal.pone.0022444			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140424	Green Published, gold, Green Submitted			2022-12-27	WOS:000298168100001
J	Jurkowski, TP; Jeltsch, A				Jurkowski, Tomasz P.; Jeltsch, Albert			On the Evolutionary Origin of Eukaryotic DNA Methyltransferases and Dnmt2	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; MODIFICATION ENZYMES; MOLECULAR EVOLUTION; MAXIMUM-LIKELIHOOD; PROTEIN SEQUENCES; FISSION YEAST; IN-VIVO; METHYLATION; HOMOLOG; GENES	The Dnmt2 enzymes show strong amino acid sequence similarity with eukaryotic and prokaryotic DNA-(cytosine C5)-methyltransferases. Yet, Dnmt2 enzymes from several species were shown to methylate tRNA-Asp and had been proposed that eukaryotic DNA methyltransferases evolved from a Dnmt2-like tRNA methyltransferase ancestor [Goll et al., 2006, Science, 311, 395-8]. It was the aim of this study to investigate if this hypothesis could be supported by evidence from sequence alignments. We present phylogenetic analyses based on sequence alignments of the methyltransferase catalytic domains of more than 2300 eukaryotic and prokaryotic DNA-(cytosine C5)-methyltransferases and analyzed the distribution of DNA methyltransferases in eukaryotic species. The Dnmt2 homologues were reliably identified by an additional conserved CFT motif next to motif IX. All DNA methyltransferases and Dnmt2 enzymes were clearly separated from other RNA-(cytosine-C5)-methyltransferases. Our sequence alignments and phylogenetic analyses indicate that the last universal eukaryotic ancestor contained at least one member of the Dnmt1, Dnmt2 and Dnmt3 families of enzymes and additional RNA methyltransferases. The similarity of Dnmt2 enzymes with DNA methyltransferases and absence of similarity with RNA methyltransferases combined with their strong RNA methylation activity suggest that the ancestor of Dnmt2 was a DNA methyltransferase and an early Dnmt2 enzyme changed its substrate preference to tRNA. There is no phylogenetic evidence that Dnmt2 was the precursor of eukaryotic Dnmts. Most likely, the eukaryotic Dnmt1 and Dnmt3 families of DNA methyltransferases had an independent origin in the prokaryotic DNA methyltransferase sequence space.	[Jurkowski, Tomasz P.; Jeltsch, Albert] Univ Bremen, Sch Sci & Engn, Bremen, Germany	University of Bremen	Jurkowski, TP (corresponding author), Univ Bremen, Sch Sci & Engn, Campus Ring Bremen, Bremen, Germany.	t.jurkowski@jacobs-university.de; a.jeltsch@jacobs-university.de	Jeltsch, Albert/O-7404-2014	Jeltsch, Albert/0000-0001-6113-9290; Jurkowski, Tomasz/0000-0002-2012-0240	Deutsche Forschungsgemeinschaft [JE 252/8]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (JE 252/8). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergsten J, 2005, CLADISTICS, V21, P163, DOI 10.1111/j.1096-0031.2005.00059.x; Brack A., 1998, MOL ORIGINS LIFE; Bujnicki JM, 2002, BMC EVOL BIOL, V2, DOI 10.1186/1471-2148-2-3; Bujnicki JM, 1999, NUCLEIC ACIDS RES, V27, P4501, DOI 10.1093/nar/27.22.4501; Bujnicki JM, 2004, NUCLEIC ACIDS RES, V32, P2453, DOI 10.1093/nar/gkh564; Cheng XD, 2001, NUCLEIC ACIDS RES, V29, P3784, DOI 10.1093/nar/29.18.3784; CHENG XD, 1995, ANNU REV BIOPH BIOM, V24, P293, DOI 10.1146/annurev.bb.24.060195.001453; Dong AP, 2001, NUCLEIC ACIDS RES, V29, P439, DOI 10.1093/nar/29.2.439; FAUMAN EB, 1999, S ADENOSYLMETHIONINE, P1, DOI DOI 10.1142/9789812813077_0001; Felsenstein J., 2004, INFERRING PHYLOGENIE; Feng SH, 2010, P NATL ACAD SCI USA, V107, P8689, DOI 10.1073/pnas.1002720107; Fisher O, 2004, NUCLEIC ACIDS RES, V32, P287, DOI 10.1093/nar/gkh161; Frickey T, 2004, BIOINFORMATICS, V20, P3702, DOI 10.1093/bioinformatics/bth444; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Goll MG, 2006, SCIENCE, V311, P395, DOI 10.1126/science.1120976; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gutierrez A, 2004, NUCLEIC ACIDS RES, V32, P6388, DOI 10.1093/nar/gkh982; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hermann A, 2003, J BIOL CHEM, V278, P31717, DOI 10.1074/jbc.M305448200; Iyer LM, 2011, PROG MOL BIOL TRANSL, V101, P25, DOI 10.1016/B978-0-12-387685-0.00002-0; Jeltsch A, 1996, J MOL EVOL, V42, P91, DOI 10.1007/BF02198833; Jeltsch A, 2002, CHEMBIOCHEM, V3, P275, DOI 10.1002/1439-7633(20020402)3:4<274::AID-CBIC274>3.0.CO;2-S; Jeltsch A, 2006, TRENDS BIOCHEM SCI, V31, P306, DOI 10.1016/j.tibs.2006.04.005; Jeltsch A, 2010, SCIENCE, V328, P837, DOI 10.1126/science.1190738; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Jurkowska RZ, 2011, CHEMBIOCHEM, V12, P206, DOI 10.1002/cbic.201000195; Jurkowski TP, 2008, RNA, V14, P1663, DOI 10.1261/rna.970408; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Kuhlmann M, 2005, NUCLEIC ACIDS RES, V33, P6405, DOI 10.1093/nar/gki952; KUMAR S, 1994, NUCLEIC ACIDS RES, V22, P1, DOI 10.1093/nar/22.1.1; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Kunert N, 2003, DEVELOPMENT, V130, P5083, DOI 10.1242/dev.00716; Kurowski MA, 2003, NUCLEIC ACIDS RES, V31, P3305, DOI 10.1093/nar/gkg557; Liu K, 2003, MOL CELL BIOL, V23, P2709, DOI 10.1128/MCB.23.8.2709-2719.2003; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Pei JM, 2003, BIOINFORMATICS, V19, P427, DOI 10.1093/bioinformatics/btg008; Phalke S, 2009, NAT GENET, V41, P696, DOI 10.1038/ng.360; Roberts RJ, 2010, NUCLEIC ACIDS RES, V38, pD234, DOI 10.1093/nar/gkp874; Schaefer M, 2010, GENE DEV, V24, P1590, DOI 10.1101/gad.586710; Schopf W, 2002, LIFES ORIGIN; Schubert HL, 2003, TRENDS BIOCHEM SCI, V28, P329, DOI 10.1016/S0968-0004(03)00090-2; SCHWARTZ RM, 1979, SCIENCE, V205, P1038, DOI 10.1126/science.205.4410.1038; Sunita S, 2008, J MOL BIOL, V383, P652, DOI 10.1016/j.jmb.2008.08.062; Tang LY, 2003, J BIOL CHEM, V278, P33613, DOI 10.1074/jbc.C300255200; Van den Wyngaert I, 1998, FEBS LETT, V426, P283, DOI 10.1016/S0014-5793(98)00362-7; Vilkaitis G, 2002, NUCLEIC ACIDS RES, V30, P1547, DOI 10.1093/nar/30.7.1547; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; WILKINSON CRM, 1995, NUCLEIC ACIDS RES, V23, P203, DOI 10.1093/nar/23.2.203; Yoder JA, 1998, HUM MOL GENET, V7, P279, DOI 10.1093/hmg/7.2.279; Zemach A, 2010, SCIENCE, V328, P916, DOI 10.1126/science.1186366	50	80	83	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e28104	10.1371/journal.pone.0028104	http://dx.doi.org/10.1371/journal.pone.0028104			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140515	gold, Green Published, Green Submitted			2022-12-27	WOS:000298168100036
J	Li, CG; Fang, R; Sun, YH; Han, XK; Li, F; Gao, B; Iafrate, AJ; Liu, XY; Pao, W; Chen, HQ; Ji, HB				Li, Chenguang; Fang, Rong; Sun, Yihua; Han, Xiangkun; Li, Fei; Gao, Bin; Iafrate, A. John; Liu, Xin-Yuan; Pao, William; Chen, Haiquan; Ji, Hongbin			Spectrum of Oncogenic Driver Mutations in Lung Adenocarcinomas from East Asian Never Smokers	PLOS ONE			English	Article							CANCER; EGFR; DIAGNOSIS; SURVIVAL; FUSION; TRIAL	Purpose: We previously showed that 90% (47 of 52; 95% CI, 0.79 to 0.96) of lung adenocarcinomas from East Asian never-smokers harbored well-known oncogenic mutations in just four genes: EGFR, HER2, ALK, and KRAS. Here, we sought to extend these findings to more samples and identify driver alterations in tumors negative for these mutations. Experimental Design: We have collected and analyzed 202 resected lung adenocarcinomas from never smokers seen at Fudan University Shanghai Cancer Center. Since mutations were mutually exclusive in the first 52 examined, we determined the status of EGFR, KRAS, HER2, ALK, and BRAF in stepwise fashion as previously described. Samples negative for mutations in these 5 genes were subsequently examined for known ROS1 fusions by RT-PCR and direct sequencing. Results: 152 tumors (75.3%) harbored EGFR mutations, 12 (6%) had HER2 mutations, 10 (5%) had ALK fusions all involving EML4 as the 59 partner, 4 (2%) had KRAS mutations, and 2 (1%) harbored ROS1 fusions. No BRAF mutation were detected. Conclusion: The vast majority (176 of 202; 87.1%, 95% CI: 0.82 to 0.91) of lung adenocarcinomas from never smokers harbor mutant kinases sensitive to available TKIs. Interestingly, patients with EGFR mutant patients tend to be older than those without EGFR mutations (58.3 Vs 54.3, P = 0.016) and patient without any known oncogenic driver tend to be diagnosed at a younger age (52.3 Vs 57.9, P = 0.013). Collectively, these data indicate that the majority of never smokers with lung adenocarcinoma could benefit from treatment with a specific tyrosine kinase inhibitor.	[Li, Chenguang; Fang, Rong; Han, Xiangkun; Li, Fei; Gao, Bin; Liu, Xin-Yuan; Ji, Hongbin] Chinese Acad Sci, State Key Lab Cell Biol, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Li, Chenguang; Sun, Yihua; Chen, Haiquan] Fudan Univ, Dept Thorac Surg, Shanghai Canc Ctr, Shanghai 200433, Peoples R China; [Li, Chenguang; Sun, Yihua; Chen, Haiquan] Shanghai Med Coll, Dept Oncol, Shanghai, Peoples R China; [Iafrate, A. John] Massachusetts Gen Hosp, Dept Pathol, Ctr Canc, Boston, MA 02114 USA; [Pao, William] Vanderbilt Ingram Canc Ctr, Nashville, TN USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Fudan University; Harvard University; Massachusetts General Hospital; Vanderbilt University	Li, CG (corresponding author), Chinese Acad Sci, State Key Lab Cell Biol, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, Shanghai, Peoples R China.	william.pao@vanderbilt.edu; hqchen1@yahoo.com; hbji@sibs.ac.cn	Liu, Xinyuan/HDM-5505-2022	CHEN, Gao Bin/0000-0001-9988-1773	National Basic Research Program of China [2010CB912102, 2012CB910800]; National Natural Science Foundation of China [30871284, 30971461]; Chinese Academy of Sciences [2010KIP504]; Science and Technology Commission of Shanghai Municipality [09JC1416300]; National Cancer Institute (USA) [R01 CA121210]; Specialized Program of Research Excellence in Lung Cancer [CA90949]; Vanderbilt-Ingram Cancer Center [CA68485]; Xcovery; NATIONAL CANCER INSTITUTE [P30CA068485, R01CA121210, P50CA090949] Funding Source: NIH RePORTER	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); National Cancer Institute (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Specialized Program of Research Excellence in Lung Cancer; Vanderbilt-Ingram Cancer Center; Xcovery; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Basic Research Program of China (2010CB912102; 2012CB910800), the National Natural Science Foundation of China (30871284 and 30971461), the Chinese Academy of Sciences (2010KIP504), and the Science and Technology Commission of Shanghai Municipality (09JC1416300). H.J. is a scholar of the Hundred Talents Program of the Chinese Academy of Sciences. W. P. received funding from the National Cancer Institute (USA): R01 CA121210; the Specialized Program of Research Excellence in Lung Cancer Grant (CA90949), and the Vanderbilt-Ingram Cancer Center Core Grant (CA68485). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: Dr. William Pao has consulted for AstraZeneca and MolecularMD and has received research funding from Xcovery. Dr. A. John Iafrate has consulted for Pfizer and Abbott Molecular. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	[Anonymous], 2010, CHIN MOHOTPSRO; Cappuzzo F, 2006, NEW ENGL J MED, V354, P2619, DOI 10.1056/NEJMc060020; Charest A, 2003, GENE CHROMOSOME CANC, V37, P58, DOI 10.1002/gcc.10207; Choi YH, 2010, J THORAC ONCOL, V5, P1949, DOI 10.1097/JTO.0b013e3181f38816; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Henschke CI, 2006, JAMA-J AM MED ASSOC, V296, P180; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Sequist LV, 2010, J CLIN ONCOL, V28, P3076, DOI 10.1200/JCO.2009.27.9414; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; Subramanian J, 2007, J CLIN ONCOL, V25, P561, DOI 10.1200/JCO.2006.06.8015; Sun YH, 2010, ACTA PHARMACOL SIN, V31, P647, DOI 10.1038/aps.2010.43; Sun YH, 2010, J CLIN ONCOL, V28, P4616, DOI 10.1200/JCO.2010.29.6038; Takeuchi K, 2009, CLIN CANCER RES, V15, P3143, DOI 10.1158/1078-0432.CCR-08-3248; Thun MJ, 2008, PLOS MED, V5, P1357, DOI 10.1371/journal.pmed.0050185; Toh CK, 2006, J CLIN ONCOL, V24, P2245, DOI 10.1200/JCO.2005.04.8033; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Wong DW, 2011, CANCER; Yap TA, 2010, J CLIN ONCOL, V28, P3965, DOI 10.1200/JCO.2009.26.7278	20	153	170	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e28204	10.1371/journal.pone.0028204	http://dx.doi.org/10.1371/journal.pone.0028204			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140546	Green Published, Green Submitted, gold			2022-12-27	WOS:000298168100050
J	Kosugi, M; Ahmad, R; Alam, M; Uchida, Y; Kufe, D				Kosugi, Michio; Ahmad, Rehan; Alam, Maroof; Uchida, Yasumitsu; Kufe, Donald			MUC1-C Oncoprotein Regulates Glycolysis and Pyruvate Kinase m2 Activity in Cancer Cells	PLOS ONE			English	Article							BETA-CATENIN; TUMOR-GROWTH; CARCINOMA ANTIGEN; SURVIVAL RESPONSE; LUNG-CANCER; C-SRC; METABOLISM; PROTEIN; PHOSPHORYLATION; PROLIFERATION	Aerobic glycolysis in cancer cells is regulated by multiple effectors that include Akt and pyruvate kinase M2 (PKM2). Mucin 1 (MUC1) is a heterodimeric glycoprotein that is aberrantly overexpressed by human breast and other carcinomas. Here we show that transformation of rat fibroblasts by the oncogenic MUC1-C subunit is associated with Akt-mediated increases in glucose uptake and lactate production, consistent with the stimulation of glycolysis. The results also demonstrate that the MUC1-C cytoplasmic domain binds directly to PKM2 at the B-and C-domains. Interaction between the MUC1-C cytoplasmic domain Cys-3 and the PKM2 C-domain Cys-474 was found to stimulate PKM2 activity. Conversely, epidermal growth factor receptor (EGFR)-mediated phosphorylation of the MUC1-C cytoplasmic domain on Tyr-46 conferred binding to PKM2 Lys-433 and inhibited PKM2 activity. In human breast cancer cells, silencing MUC1-C was associated with decreases in glucose uptake and lactate production, confirming involvement of MUC1-C in the regulation of glycolysis. In addition, EGFR-mediated phosphorylation of MUC1-C in breast cancer cells was associated with decreases in PKM2 activity. These findings indicate that the MUC1-C subunit regulates glycolysis and that this response is conferred in part by PKM2. Thus, the overexpression of MUC1-C oncoprotein in diverse human carcinomas could be of importance to the Warburg effect of aerobic glycolysis.	[Kosugi, Michio; Ahmad, Rehan; Alam, Maroof; Uchida, Yasumitsu; Kufe, Donald] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Kosugi, M (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, 44 Binney St, Boston, MA 02115 USA.	donald_kufe@dfci.harvard.edu	Rather, R A/J-3509-2019		National Cancer Institute [CA97098, CA42802, CA100707]; NATIONAL CANCER INSTITUTE [R01CA097098, P50CA100707, R01CA042802] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Grants CA97098, CA42802 and CA100707 awarded by the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad R, 2007, NAT CELL BIOL, V9, P1419, DOI 10.1038/ncb1661; Ahmad R, 2009, CANCER RES, V69, P7013, DOI 10.1158/0008-5472.CAN-09-0523; Altenberg B, 2004, GENOMICS, V84, P1014, DOI 10.1016/j.ygeno.2004.08.010; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; DeBerardinis RJ, 2008, CURR OPIN GENET DEV, V18, P54, DOI 10.1016/j.gde.2008.02.003; Dombrauckas JD, 2005, BIOCHEMISTRY-US, V44, P9417, DOI 10.1021/bi0474923; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hitosugi T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000431; Huang L, 2005, CANCER RES, V65, P10413, DOI 10.1158/0008-5472.CAN-05-2474; Khodarev NN, 2009, CANCER RES, V69, P2833, DOI 10.1158/0008-5472.CAN-08-4513; Kufe DW, 2009, NAT REV CANCER, V9, P874, DOI 10.1038/nrc2761; Lee JW, 2008, INT J BIOCHEM CELL B, V40, P1043, DOI 10.1016/j.biocel.2007.11.009; Leng YM, 2007, J BIOL CHEM, V282, P19321, DOI 10.1074/jbc.M703222200; Levine AJ, 2010, SCIENCE, V330, P1340, DOI 10.1126/science.1193494; Li YQ, 2003, ONCOGENE, V22, P6107, DOI 10.1038/sj.onc.1206732; Li YQ, 2001, J BIOL CHEM, V276, P35239, DOI 10.1074/jbc.C100359200; Li YQ, 2001, J BIOL CHEM, V276, P6061, DOI 10.1074/jbc.C000754200; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; MacDermed DM, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-16; Majumder PK, 2004, NAT MED, V10, P594, DOI 10.1038/nm1052; Mazurek S, 2005, SEMIN CANCER BIOL, V15, P300, DOI 10.1016/j.semcancer.2005.04.009; Mazurek S, 1997, J BIOENERG BIOMEMBR, V29, P315, DOI 10.1023/A:1022490512705; Monteys AM, 2010, RNA, V16, P495, DOI 10.1261/rna.1731910; Pitroda SP, 2009, P NATL ACAD SCI USA, V106, P5837, DOI 10.1073/pnas.0812029106; Raina D, 2004, J BIOL CHEM, V279, P20607, DOI 10.1074/jbc.M310538200; Raina D, 2011, MOL CANCER THER, V10, P806, DOI 10.1158/1535-7163.MCT-10-1050; Ramasamy S, 2007, MOL CELL, V27, P992, DOI 10.1016/j.molcel.2007.07.031; Ren J, 2004, CANCER CELL, V5, P163, DOI 10.1016/S1535-6108(04)00020-0; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Yin L, 2003, J BIOL CHEM, V278, P35458, DOI 10.1074/jbc.M301987200; Yin L, 2007, J BIOL CHEM, V282, P257, DOI 10.1074/jbc.M610156200; Yin L, 2009, INT J ONCOL, V34, P1691, DOI 10.3892/ijo_00000300	33	39	42	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2011	6	11							e28234	10.1371/journal.pone.0028234	http://dx.doi.org/10.1371/journal.pone.0028234			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KW	22140559	Green Submitted, gold, Green Published			2022-12-27	WOS:000298163400040
J	Xiang, X; Lee, CY; Li, T; Chen, W; Lou, JZ; Zhu, C				Xiang, Xue; Lee, Cho-yin; Li, Tian; Chen, Wei; Lou, Jizhong; Zhu, Cheng			Structural Basis and Kinetics of Force-Induced Conformational Changes of an alpha A Domain-Containing Integrin	PLOS ONE			English	Article							I-LIKE DOMAIN; CRYSTAL-STRUCTURE; ADHESION; BINDING; LFA-1; CHEMOKINES; DYNAMICS; SUBUNIT; PATHWAY; ARREST	Background: Integrin alpha(L)beta(2) (lymphocyte function-associated antigen, LFA-1) bears force upon binding to its ligand intercellular adhesion molecule 1 (ICAM-1) when a leukocyte adheres to vascular endothelium or an antigen presenting cell (APC) during immune responses. The ligand binding propensity of LFA-1 is related to its conformations, which can be regulated by force. Three conformations of the LFA-1 alpha A domain, determined by the position of its alpha(7)-helix, have been suggested to correspond to three different affinity states for ligand binding. Methodology/Principal Findings: The kinetics of the force-driven transitions between these conformations has not been defined and dynamically coupled to the force-dependent dissociation from ligand. Here we show, by steered molecular dynamics (SMD) simulations, that the alpha A domain was successively transitioned through three distinct conformations upon pulling the C-terminus of its alpha(7)-helix. Based on these sequential transitions, we have constructed a mathematical model to describe the coupling between the alpha A domain conformational changes of LFA-1 and its dissociation from ICAM-1 under force. Using this model to analyze the published data on the force-induced dissociation of single LFA-1/ICAM-1 bonds, we estimated the force-dependent kinetic rates of interstate transition from the short-lived to intermediate-lived and from intermediate-lived to long-lived states. Interestingly, force increased these transition rates; hence activation of LFA-1 was accelerated by pulling it via an engaged ICAM-1. Conclusions/Significance: Our study defines the structural basis for mechanical regulation of the kinetics of LFA-1 alpha A domain conformational changes and relates these simulation results to experimental data of force-induced dissociation of single LFA-1/ICAM-1 bonds by a new mathematical model, thus provided detailed structural and kinetic characterizations for force-stabilization of LFA-1/ICAM-1 interaction.	[Xiang, Xue] Sun Yat Sen Univ, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China; [Xiang, Xue; Lee, Cho-yin; Chen, Wei; Lou, Jizhong; Zhu, Cheng] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Xiang, Xue; Lee, Cho-yin; Chen, Wei; Lou, Jizhong; Zhu, Cheng] Emory Univ, Atlanta, GA 30322 USA; [Lee, Cho-yin] Natl Taiwan Univ Hosp, Dept Oncol, Taipei, Taiwan; [Li, Tian; Lou, Jizhong] Chinese Acad Sci, Inst Biophys, Lab Noncoding RNA, Beijing 100080, Peoples R China	Sun Yat Sen University; University System of Georgia; Georgia Institute of Technology; Emory University; National Taiwan University; National Taiwan University Hospital; Chinese Academy of Sciences; Institute of Biophysics, CAS	Xiang, X (corresponding author), Sun Yat Sen Univ, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China.	jlou@ibp.ac.cn; cheng.zhu@bme.gatech.edu			Natural Science Foundations of China [31070827]; Chinese Academy of Sciences; National Institutes of Health (NIH) [AI44902]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044902, R21AI044902] Funding Source: NIH RePORTER	Natural Science Foundations of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Natural Science Foundations of China under 31070827 (to J. L.), by the Knowledge Innovation Program of the Chinese Academy of Sciences (to J. L.) and by a National Institutes of Health (NIH) grant AI44902 (to C.Z.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astrof NS, 2006, BIOCHEMISTRY-US, V45, P15020, DOI 10.1021/bi061566o; Bednar B, 1997, CYTOMETRY, V28, P58, DOI 10.1002/(SICI)1097-0320(19970501)28:1<58::AID-CYTO7>3.0.CO;2-D; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Campbell JJ, 1998, SCIENCE, V279, P381, DOI 10.1126/science.279.5349.381; Chen W, 2010, J BIOL CHEM, V285, P35967, DOI 10.1074/jbc.M110.155770; Jin M, 2004, STRUCTURE, V12, P2137, DOI 10.1016/j.str.2004.10.005; Kallen J, 1999, J MOL BIOL, V292, P1, DOI 10.1006/jmbi.1999.3047; Kinashi T, 2005, NAT REV IMMUNOL, V5, P546, DOI 10.1038/nri1646; LEE JO, 1995, CELL, V80, P631, DOI 10.1016/0092-8674(95)90517-0; Lee JO, 1995, STRUCTURE, V3, P1333, DOI 10.1016/S0969-2126(01)00271-4; Legge GB, 2000, J MOL BIOL, V295, P1251, DOI 10.1006/jmbi.1999.3409; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MULLER B, 1993, J BIOL CHEM, V268, P6800; Neelamegham S, 2000, J IMMUNOL, V164, P3798, DOI 10.4049/jimmunol.164.7.3798; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Qu AD, 1996, STRUCTURE, V4, P931, DOI 10.1016/S0969-2126(96)00100-1; QU AD, 1995, P NATL ACAD SCI USA, V92, P10277, DOI 10.1073/pnas.92.22.10277; Rainger GE, 1997, AM J PHYSIOL-HEART C, V272, pH114, DOI 10.1152/ajpheart.1997.272.1.H114; Salas A, 2004, IMMUNITY, V20, P393, DOI 10.1016/S1074-7613(04)00082-2; Shamri R, 2005, NAT IMMUNOL, V6, P497, DOI 10.1038/ni1194; Shimaoka M, 2003, IMMUNITY, V19, P391, DOI 10.1016/S1074-7613(03)00238-3; Shimaoka M, 2003, CELL, V112, P99, DOI 10.1016/S0092-8674(02)01257-6; Welzenbach K, 2002, J BIOL CHEM, V277, P10590, DOI 10.1074/jbc.M110521200; Woolf E, 2007, NAT IMMUNOL, V8, P1076, DOI 10.1038/ni1499; Zhang F, 2005, J BIOL CHEM, V280, P42207, DOI 10.1074/jbc.M510407200	26	21	25	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2011	6	11							e27946	10.1371/journal.pone.0027946	http://dx.doi.org/10.1371/journal.pone.0027946			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KW	22140490	Green Published, gold, Green Submitted			2022-12-27	WOS:000298163400026
J	Cook, AR; Teo, SWL				Cook, Alex R.; Teo, Shanice W. L.			The Communicability of Graphical Alternatives to Tabular Displays of Statistical Simulation Studies	PLOS ONE			English	Article							CONFIDENCE-INTERVALS; TABLES	Simulation studies are often used to assess the frequency properties and optimality of statistical methods. They are typically reported in tables, which may contain hundreds of figures to be contrasted over multiple dimensions. To assess the degree to which these tables are fit for purpose, we performed a randomised cross-over experiment in which statisticians were asked to extract information from (i) such a table sourced from the literature and (ii) a graphical adaptation designed by the authors, and were timed and assessed for accuracy. We developed hierarchical models accounting for differences between individuals of different experience levels (under-and post-graduate), within experience levels, and between different table-graph pairs. In our experiment, information could be extracted quicker and, for less experienced participants, more accurately from graphical presentations than tabular displays. We also performed a literature review to assess the prevalence of hard-to-interpret design features in tables of simulation studies in three popular statistics journals, finding that many are presented innumerately. We recommend simulation studies be presented in graphical form.	[Cook, Alex R.] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Cook, Alex R.; Teo, Shanice W. L.] Natl Univ Singapore, Dept Stat & Appl Probabil, Singapore 117548, Singapore; [Cook, Alex R.] Natl Univ Singapore, Program Hlth Serv & Syst Res, Duke NUS Grad Med Sch Singapore, Singapore 117548, Singapore	National University of Singapore; National University of Singapore; National University of Singapore	Cook, AR (corresponding author), Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore.	alex.richard.cook@gmail.com	Cook, Alex/B-5941-2011; Cook, Alex/S-3576-2019	Cook, Alex/0000-0002-6271-5832; 	National University of Singapore	National University of Singapore(National University of Singapore)	ARC was supported by a research grant from the National University of Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Briggs WM, 2011, J COMPUT GRAPH STAT, V20, P16, DOI 10.1198/jcgs.2011.09166a; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Cleveland WS, 1994, ELEMENTS GRAPHING DA; Cleveland WS., 1993, VISUALIZING DATA; Conti PL, 2008, STAT SINICA, V18, P559; EHRENBERG ASC, 1977, J R STAT SOC A STAT, V140, P277, DOI 10.2307/2344922; Farquhar AB, 1891, EC IND DELUSIONS DIS; Feinberg RA, 2011, J COMP GRAPH STAT, V20; Friendly M, 2011, J COMPUT GRAPH STAT, V20, P18, DOI 10.1198/jcgs.2011.09166b; Gelman A, 2002, AM STAT, V56, P121, DOI 10.1198/000313002317572790; Gelman A., 2003, BAYESIAN DATA ANAL; Gelman A., 2006, DATA ANAL USING REGR, DOI DOI 10.1017/CBO9780511790942.005; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Gelman A, 2011, J COMPUT GRAPH STAT, V20, P36, DOI 10.1198/jcgs.2011.09166rej; Gelman A, 2011, J COMPUT GRAPH STAT, V20, P3, DOI 10.1198/jcgs.2011.09166; Gilks W. R., 1995, MARKOV CHAIN MONTE C, DOI 10.1201/b14835; HASTINGS WK, 1970, BIOMETRIKA, V57, P97, DOI 10.2307/2334940; Ho YHS, 2005, ANN STAT, V33, P437, DOI 10.1214/009053604000000878; LOH WY, 1991, STAT SINICA, V1, P477; Mahon BH, 1977, J R STAT SOC A GEN, V140, P297; Metropolis N, 1953, CHEM PHYS, V21, P1087, DOI DOI 10.1063/1.1699114; Meyer J, 1997, HUM FACTORS, V39, P268, DOI 10.1518/001872097778543921; Meyer J, 1999, HUM FACTORS, V41, P570, DOI 10.1518/001872099779656707; Murrell P., 2005, R GRAPHICS; Plummer M., 2015, PACKAGE CODA; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; REMUS W, 1984, MANAGE SCI, V30, P533, DOI 10.1287/mnsc.30.5.533; Roy A, 2004, J AM STAT ASSOC, V99, P1082, DOI 10.1198/016214504000000520; SPENCE I, 1991, APPL COGNITIVE PSYCH, V5, P61, DOI 10.1002/acp.2350050106; Thomas A., 2006, R NEWS, V6, P12, DOI DOI 10.1159/000323281; Tufte ER, 2001, VISUAL DISPLAY QUANT; Wainer H, 1997, J EDUC BEHAV STAT, V22, P1, DOI 10.3102/10769986022001001; Wainer H, 2009, CHANCE, V22, P46; Wainer H, 2011, J COMPUT GRAPH STAT, V20, P8, DOI 10.1198/jcgs.2011.09166c; Wainer H, 2009, AM SCI, V97, P272, DOI 10.1511/2009.79.272; Wang CL, 2006, STAT SINICA, V16, P1169; Wills G, 2011, J COMPUT GRAPH STAT, V20, P28, DOI 10.1198/jcgs.2011.09166d; Zhang M, 2010, STAT SINICA, V20, P911	38	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e27974	10.1371/journal.pone.0027974	http://dx.doi.org/10.1371/journal.pone.0027974			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	863KL	22132184	Green Published, Green Submitted, gold			2022-12-27	WOS:000298162000054
J	Talukdar, I; Sen, S; Urbano, R; Thompson, J; Yates, JR; Webster, NJG				Talukdar, Indrani; Sen, Supriya; Urbano, Rodolfo; Thompson, James; Yates, John R., III; Webster, Nicholas J. G.			hnRNP A1 and hnRNP F Modulate the Alternative Splicing of Exon 11 of the Insulin Receptor Gene	PLOS ONE			English	Article							PRE-MESSENGER-RNA; SR PROTEINS; NUCLEOTIDE-SEQUENCES; BINDING SPECIFICITY; RICH PROTEIN; U1 SNRNP; RIBONUCLEOPROTEIN; COMPLEX; IDENTIFICATION; PREDICTION	Exon 11 of the insulin receptor gene (INSR) is alternatively spliced in a developmentally and tissue-specific manner. Linker scanning mutations in a 5' GA-rich enhancer in intron 10 identified AGGGA sequences that are important for enhancer function. Using RNA-affinity purification and mass spectrometry, we identified hnRNP F and hnRNP A1 binding to these AGGGA sites and also to similar motifs at the 3' end of the intron. The hnRNPs have opposite functional effects with hnRNP F promoting and hnRNP A1 inhibiting exon 11 inclusion, and deletion of the GA-rich elements eliminates both effects. We also observed specific binding of hnRNP A1 to the 5' splice site of intron 11. The SR protein SRSF1 (SF2/ASF) co-purified on the GA-rich enhancer and, interestingly, also competes with hnRNP A1 for binding to the splice site. A point mutation - 3U -> C decreases hnRNP A1 binding, increases SRSF1 binding and renders the exon constitutive. Lastly, our data point to a functional interaction between hnRNP F and SRSF1 as a mutant that eliminates SRSF1 binding to exon 11, or a SRSF1 knockdown, which prevents the stimulatory effect of hnRNP F over expression.	[Talukdar, Indrani; Sen, Supriya; Urbano, Rodolfo; Webster, Nicholas J. G.] VA San Diego Healthcare Syst, San Diego, CA USA; [Talukdar, Indrani; Sen, Supriya; Urbano, Rodolfo; Webster, Nicholas J. G.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Talukdar, Indrani; Sen, Supriya; Urbano, Rodolfo; Webster, Nicholas J. G.] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA; [Thompson, James; Yates, John R., III] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego; University of California System; University of California San Diego; Scripps Research Institute	Talukdar, I (corresponding author), Burnham Inst Med Res, La Jolla, CA USA.	nwebster@ucsd.edu	Webster, Nick/AAI-8410-2021; Sen, Supriya/J-1750-2015	Sen, Supriya/0000-0002-0417-9322; Urbano, Rodolfo/0000-0001-7404-774X	Department of Veterans Affairs; National Institutes of Health National Center for Research Resources [RR11823]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD012303] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD047400] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA023100] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000130] Funding Source: NIH RePORTER	Department of Veterans Affairs(US Department of Veterans Affairs); National Institutes of Health National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work is supported by a Merit Review Award from the Department of Veterans Affairs and the National Institutes of Health National Center for Research Resources (RR11823). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Bladen CL, 2005, J BIOL CHEM, V280, P5205, DOI 10.1074/jbc.M412758200; Boukis LA, 2004, J BIOL CHEM, V279, P29647, DOI 10.1074/jbc.M313209200; BURD CG, 1994, EMBO J, V13, P1197, DOI 10.1002/j.1460-2075.1994.tb06369.x; Buxade M, 2008, J BIOL CHEM, V283, P57, DOI 10.1074/jbc.M705286200; Caputi M, 1999, EMBO J, V18, P4060, DOI 10.1093/emboj/18.14.4060; Caputi M, 2001, J BIOL CHEM, V276, P43850, DOI 10.1074/jbc.M102861200; Crawford JB, 2006, MOL CELL BIOL, V26, P8791, DOI 10.1128/MCB.01677-06; CRISPINO JD, 1994, SCIENCE, V265, P1866, DOI 10.1126/science.8091213; Dominguez C, 2006, NUCLEIC ACIDS RES, V34, P3634, DOI 10.1093/nar/gkl488; Eperon IC, 2000, MOL CELL BIOL, V20, P8303, DOI 10.1128/MCB.20.22.8303-8318.2000; EPERON LP, 1986, NATURE, V324, P280, DOI 10.1038/324280a0; Golovkin M, 1999, J BIOL CHEM, V274, P36428, DOI 10.1074/jbc.274.51.36428; GUI JF, 1994, NATURE, V369, P678, DOI 10.1038/369678a0; GUTHRIE C, 1991, SCIENCE, V253, P157, DOI 10.1126/science.1853200; Hallay H, 2006, J BIOL CHEM, V281, P37159, DOI 10.1074/jbc.M603864200; Han K, 2005, PLOS BIOL, V3, P843, DOI 10.1371/journal.pbio.0030158; Kosaki A, 1998, J BIOL CHEM, V273, P10331, DOI 10.1074/jbc.273.17.10331; Makarova OV, 2001, EMBO J, V20, P2553, DOI 10.1093/emboj/20.10.2553; Martinez-Contreras R, 2006, PLOS BIOL, V4, P172, DOI 10.1371/journal.pbio.0040021; Martinez-Contreras R, 2007, ADV EXP MED BIOL, V623, P123, DOI 10.1007/978-0-387-77374-2_8; Mauger DM, 2008, MOL CELL BIOL, V28, P5403, DOI 10.1128/MCB.00739-08; MOLLER DE, 1989, MOL ENDOCRINOL, V3, P1263, DOI 10.1210/mend-3-8-1263; MOSTHAF L, 1990, EMBO J, V9, P2409, DOI 10.1002/j.1460-2075.1990.tb07416.x; NAKATA K, 1985, NUCLEIC ACIDS RES, V13, P5327, DOI 10.1093/nar/13.14.5327; NAORA H, 1980, J THEOR BIOL, V85, P83, DOI 10.1016/0022-5193(80)90282-9; Paul S, 2006, EMBO J, V25, P4271, DOI 10.1038/sj.emboj.7601296; RIO D C, 1992, Current Opinion in Cell Biology, V4, P444, DOI 10.1016/0955-0674(92)90010-A; ROGERS J, 1980, P NATL ACAD SCI-BIOL, V77, P1877, DOI 10.1073/pnas.77.4.1877; Rooke N, 2003, MOL CELL BIOL, V23, P1874, DOI 10.1128/MCB.23.6.1874-1884.2003; Rosonina E, 2005, MOL CELL BIOL, V25, P6734, DOI 10.1128/MCB.25.15.6734-6746.2005; SEINO S, 1989, BIOCHEM BIOPH RES CO, V159, P312, DOI 10.1016/0006-291X(89)92439-X; SEINO S, 1989, P NATL ACAD SCI USA, V86, P114, DOI 10.1073/pnas.86.1.114; Sen S, 2009, MOL CELL BIOL, V29, P871, DOI 10.1128/MCB.01709-08; Smith PJ, 2006, HUM MOL GENET, V15, P2490, DOI 10.1093/hmg/ddl171; Zhu J, 2001, MOL CELL, V8, P1351, DOI 10.1016/S1097-2765(01)00409-9	36	48	48	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e27869	10.1371/journal.pone.0027869	http://dx.doi.org/10.1371/journal.pone.0027869			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132154	Green Published, Green Submitted, gold			2022-12-27	WOS:000298162000046
J	Williams, PT				Williams, Paul T.			Evidence That Obesity Risk Factor Potencies Are Weight Dependent, a Phenomenon That May Explain Accelerated Weight Gain in Western Societies	PLOS ONE			English	Article							BODY-MASS INDEX; PUTATIVE CONTRIBUTORS; WALKING DISTANCE; HEART-DISEASE; ASSOCIATION; EXERCISE; HEALTH; DIET; AGE; PERCENTILES	Background: We have shown that individuals at the highest percentiles of the body mass index (BMI) distribution (i.e., most overweight) experience greater increases in body weight from sedentary lifestyle than those from the lowest percentiles. The purpose of the current analyses was to assess whether recent, accelerated increases in obesity could potentially be due to increased vulnerability to obesity risk factors as the population has become more overweight. Methodology/Principal Findings: Quantile regression was used to compare BMI population percentiles to obesity risk factors (lower education, diets characterized by high-meat/low-fruit content, parental adiposity) in two independent samples of men (N-1 = 3,513, N-2 = 11,365) and women (N-1 = 15,809, N-2 = 10,159). The samples were subsets of the National Walkers' (Study 1) and Runners' (Study 2) Health Studies whose physical activities fell short of nationally recommended activity levels. The data were adjusted for age, race, and any residual effects of physical activity. The regression slopes for BMI vs. education, diet, and family history became progressively stronger from the lowest (e.g., 5(th), 6(th).) to the highest (e.g.,., 94(th), 95(th)) BMI percentiles. Compared to the 10(th) BMI percentile, their effects on the 90(th) BMI percentile were: 1) 2.7- to 8.6-fold greater in women and 2.0- to 2.4-fold greater in men for education; 2) 3.6- to 4.8-fold greater in women and 1.7- to 2.7-fold greater in men for diet; and 3) 2.0- to 2.6-fold greater in women and 1.7-fold greater in men for family history. Conclusions/Significance: Thus we propose risk factors that produce little weight gain in lean individuals may become more potent with increasing adiposity. This leads us to hypothesize that an individual's obesity is itself a major component of their obesogenic environment, and that, the cycle of weight gain and increased sensitivity to obesity risk factors may partly explain recent increases in obesity in western societies.	Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Williams, PT (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA.	ptwilliams@lbl.gov			National Heart, Lung and Blood Institute [HL094717]; Institute of Aging [AG032004]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094717] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG032004] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Institute of Aging; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by grant HL094717 from the National Heart, Lung and Blood Institute and by grant AG032004 from the Institute of Aging. The research was conducted at the Ernest Orlando Lawrence Berkeley National Laboratory (Department of Energy DE-AC03-76SF00098 to the University of California). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Allison DB, 1996, INT J OBESITY, V20, P990; Baird J, 2005, BMJ-BRIT MED J, V331, P929, DOI 10.1136/bmj.38586.411273.E0; Beyerlein A, 2010, INT J OBESITY, V34, P642, DOI 10.1038/ijo.2009.301; Beyerlein A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019057; Beyerlein A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015739; Beyerlein A, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-59; Booth FW, 2007, PHYSIOL GENOMICS, V28, P146, DOI 10.1152/physiolgenomics.00174.2006; Bray GA, 2004, AM J CLIN NUTR, V79, P537; Classen TJ, 2010, ECON HUM BIOL, V8, P30, DOI 10.1016/j.ehb.2009.11.002; Eckel RH, 1997, CIRCULATION, V96, P3248, DOI 10.1161/01.CIR.96.9.3248; Freedman David S, 2007, MedGenMed, V9, P26; Helmchen LA, 2004, ANN HUM BIOL, V31, P174, DOI 10.1080/03014460410001663434; Hu FB, 1999, AM J CLIN NUTR, V69, P243; Institute of Medicine, 2005, DIET REF INT EN CARB, P880; Johnson Richard J, 2010, Trans Am Clin Climatol Assoc, V121, P295; Keith SW, 2006, INT J OBESITY, V30, P1585, DOI 10.1038/sj.ijo.0803326; Koenker R, 2001, J ECON PERSPECT, V15, P143, DOI 10.1038/s41592-019-0406-y; Lake A, 2006, J R SOC PROMO HEALTH, V126, P262, DOI 10.1177/1466424006070487; Lee JH, 1997, INT J OBESITY, V21, P935, DOI 10.1038/sj.ijo.0800498; Lofgren P, 2005, J CLIN ENDOCR METAB, V90, P6207, DOI 10.1210/jc.2005-0596; McAllister EJ, 2009, CRIT REV FOOD SCI, V49, P868, DOI 10.1080/10408390903372599; McLaren L, 2010, INT J PUBLIC HEALTH, V55, P193, DOI 10.1007/s00038-009-0085-z; Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296; NEEL JV, 1962, AM J HUM GENET, V14, P353; Ogden CL, 2007, GASTROENTEROLOGY, V132, P2087, DOI 10.1053/j.gastro.2007.03.052; Parsons TJ, 1999, INT J OBESITY, V23, pS1; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; ROCHE AF, 1994, AM J HUM BIOL, V6, P33, DOI 10.1002/ajhb.1310060107; Saris W H M, 2003, Obes Rev, V4, P101, DOI 10.1046/j.1467-789X.2003.00101.x; Smith PK, 2003, ECON HUM BIOL, V1, P145, DOI 10.1016/S1570-677X(02)00032-1; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; Sturm R, 2007, PUBLIC HEALTH, V121, P492, DOI 10.1016/j.puhe.2007.01.006; Summerbell CD, 2009, INT J OBESITY, V33, pS1, DOI 10.1038/ijo.2009.80; Terry MB, 2007, AM J EPIDEMIOL, V166, P5, DOI 10.1093/aje/kwm094; U.S. Department of Health and Human Services, 1996, PHYS ACT HLTH REP SU; Wang YF, 2008, OBESITY, V16, P2323, DOI 10.1038/oby.2008.351; Williams P. T., 2011, Medicine and Science in Sports & Exercise, V43, P2120, DOI 10.1249/MSS.0b013e31821cd128; Williams PT, 2008, BRIT J SPORT MED, V42, DOI 10.1136/bjsm.2007.041822; Williams PT, 2008, MED SCI SPORT EXER, V40, P296, DOI 10.1249/mss.0b013e31815b6475; Williams PT, 2007, ARTERIOSCL THROM VAS, V27, P1811, DOI 10.1161/ATVBAHA.107.141853; Williams PT, 2007, MED SCI SPORT EXER, V39, P801, DOI 10.1249/mss.0b013e31803349b1; Williams PT, 2011, PREV MED, V52, P293, DOI 10.1016/j.ypmed.2011.03.008; Williams PT, 2009, OBESITY, V17, P1428, DOI 10.1038/oby.2008.680; Williams PT, 2005, MED SCI SPORT EXER, V37, P1893, DOI 10.1249/01.mss.0000175860.51204.85; Williams PT, 2005, OBES RES, V13, P1370, DOI 10.1038/oby.2005.166; Williams PT, 2005, MED SCI SPORT EXER, V37, P1329, DOI 10.1249/01.mss.0000174894.05236.45; Williams PT, 2004, INT J OBESITY, V28, P120, DOI 10.1038/sj.ijo.0802480; Williams PT, 2011, OBESITY IN PRESS	49	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e27657	10.1371/journal.pone.0027657	http://dx.doi.org/10.1371/journal.pone.0027657			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132124	Green Submitted, Green Published, gold			2022-12-27	WOS:000298162000033
J	Mack, AA; Kroboth, S; Rajesh, D; Wang, WB				Mack, Amanda A.; Kroboth, Stacie; Rajesh, Deepika; Wang, Wen Bo			Generation of Induced Pluripotent Stem Cells from CD34+Cells across Blood Drawn from Multiple Donors with Non-Integrating Episomal Vectors	PLOS ONE			English	Article							EFFICIENT NEURAL CONVERSION; PLASMID REPLICON; PERIPHERAL-BLOOD; PROGENITOR CELLS; B-LYMPHOCYTES; IN-VITRO; FIBROBLASTS; INHIBITION; INDUCTION; EXPANSION	The methodology to create induced pluripotent stem cells (iPSCs) affords the opportunity to generate cells specific to the individual providing the host tissue. However, existing methods of reprogramming as well as the types of source tissue have significant limitations that preclude the ability to generate iPSCs in a scalable manner from a readily available tissue source. We present the first study whereby iPSCs are derived in parallel from multiple donors using episomal, non-integrating, oriP/EBNA1-based plasmids from freshly drawn blood. Specifically, successful reprogramming was demonstrated from a single vial of blood or less using cells expressing the early lineage marker CD34 as well as from unpurified peripheral blood mononuclear cells. From these experiments, we also show that proliferation and cell identity play a role in the number of iPSCs per input cell number. Resulting iPSCs were further characterized and deemed free of transfected DNA, integrated transgene DNA, and lack detectable gene rearrangements such as those within the immunoglobulin heavy chain and T cell receptor loci of more differentiated cell types. Furthermore, additional improvements were made to incorporate completely defined media and matrices in an effort to facilitate a scalable transition for the production of clinic-grade iPSCs.	[Mack, Amanda A.; Kroboth, Stacie; Rajesh, Deepika; Wang, Wen Bo] Cellular Dynam Int Inc, Madison, WI 53711 USA		Mack, AA (corresponding author), Cellular Dynam Int Inc, Madison, WI 53711 USA.	amack@cellulardynamics.com		Kroboth, Stacie/0000-0001-8767-4021; Rajesh, Deepika/0000-0002-8820-4328				Brown ME, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011373; Cashen AF, 2007, BONE MARROW TRANSPL, V39, P577, DOI 10.1038/sj.bmt.1705616; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Cho SK, 1999, P NATL ACAD SCI USA, V96, P9797, DOI 10.1073/pnas.96.17.9797; Chou B.K., 2011, CELL RES; Delaney C, 2010, NAT MED, V16, P232, DOI 10.1038/nm.2080; Haase A, 2009, CELL STEM CELL, V5, P434, DOI 10.1016/j.stem.2009.08.021; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; Hernandez JM, 2005, LEUKEMIA, V19, P1088, DOI 10.1038/sj.leu.2403753; HU K, 2011, BLOOD; Li WL, 2009, CELL STEM CELL, V4, P16, DOI 10.1016/j.stem.2008.11.014; Lin TX, 2009, NAT METHODS, V6, P805, DOI [10.1038/NMETH.1393, 10.1038/nmeth.1393]; Lindner SE, 2007, PLASMID, V58, P1, DOI 10.1016/j.plasmid.2007.01.003; Loh YH, 2009, BLOOD, V113, P5476, DOI 10.1182/blood-2009-02-204800; Miura K, 2009, NAT BIOTECHNOL, V27, P743, DOI 10.1038/nbt.1554; Nagler A, 2004, EXP HEMATOL, V32, P122, DOI 10.1016/j.exphem.2003.09.007; Nakagawa M, 2010, P NATL ACAD SCI USA, V107, P14152, DOI 10.1073/pnas.1009374107; Nakano T, 1995, Semin Immunol, V7, P197, DOI 10.1016/1044-5323(95)90047-0; Nanbo A, 2007, EMBO J, V26, P4252, DOI 10.1038/sj.emboj.7601853; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Patani R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007327; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Saha K, 2009, CELL STEM CELL, V5, P584, DOI 10.1016/j.stem.2009.11.009; Szilvassy SJ, 2001, BLOOD, V98, P2108, DOI 10.1182/blood.V98.7.2108; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; van den Akker E, 2010, HAEMATOL-HEMATOL J, V95, P1594, DOI 10.3324/haematol.2009.019828; Wada H, 2011, INT IMMUNOL, V23, P65, DOI 10.1093/intimm/dxq458; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Yamanaka S, 2010, CELL STEM CELL, V7, P1, DOI 10.1016/j.stem.2010.06.009; YU J, 2009, HUMAN INDUCED PLURIP; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017557	33	62	72	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2011	6	11							e27956	10.1371/journal.pone.0027956	http://dx.doi.org/10.1371/journal.pone.0027956			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858JH	22132178	Green Published, Green Submitted, gold			2022-12-27	WOS:000297792400026
J	Wingo, TS; Cutler, DJ; Yarab, N; Kelly, CM; Glass, JD				Wingo, Thomas S.; Cutler, David J.; Yarab, Nicole; Kelly, Crystal M.; Glass, Jonathan D.			The Heritability of Amyotrophic Lateral Sclerosis in a Clinically Ascertained United States Research Registry	PLOS ONE			English	Article							HEXANUCLEOTIDE REPEAT; ALS; POPULATION; EPIDEMIOLOGY; PREVALENCE; MUTATIONS; GENETICS; DISEASES; C9ORF72; TWIN	Background: The genetic basis of amyotrophic highly penetrant mutations in Cu/Zn superoxide dismutase 1 and several other genes that cause apparent Mendelian inheritance of the disease, most ALS occurs in families without another affected individual. However, twin studies suggest that all ALS has a substantial genetic basis. Herein, we estimate the genetic contribution to ALS in a clinically ascertained case series from the United States. Methodology/Principal Findings: We used the database of the Emory ALS Center to ascertain individuals with ALS along with their family histories to determine the concordance among parents and offspring for the disease. We found that concordance for all parent-offspring pairs was low (<2%). With this concordance we found that ALS heritability, or the proportion of the disease explained by genetic factors, is between 40 and 45% for all likely estimates of ALS lifetime prevalence. Conclusions/Significance: We found the lifetime risk of ALS is 1.1% in first-degree relatives of those with ALS. Environmental and genetic factors appear nearly equally important for the development of ALS.	[Wingo, Thomas S.] Atlanta Vet Adm Med Ctr, Atlanta, GA 30312 USA; [Wingo, Thomas S.; Yarab, Nicole; Kelly, Crystal M.; Glass, Jonathan D.] Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA; [Cutler, David J.] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA USA	Emory University; Emory University	Wingo, TS (corresponding author), Atlanta Vet Adm Med Ctr, Atlanta, GA 30312 USA.	thomas.wingo@emory.edu	Wingo, Thomas/AEM-2481-2022	Wingo, Thomas/0000-0002-7679-6282	Department of Veterans Affairs [CDA1-002-09F]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER	Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	TSW is supported by a career development grant by the Department of Veterans Affairs (CDA1-002-09F). This study does not have any specific funding, and the Department of Veteran Affairs had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Chalabi A, 2010, J NEUROL NEUROSUR PS, V81, P1324, DOI 10.1136/jnnp.2010.207464; Al-Chalabi A, 2011, HUM HERED, V71, P281, DOI 10.1159/000330167; [Anonymous], 2001, NEUROLOGY, V56, P239; Beghi E, 2006, BBA-MOL BASIS DIS, V1762, P1150, DOI 10.1016/j.bbadis.2006.09.008; Chio A, 2008, NEUROLOGY, V70, P533, DOI 10.1212/01.wnl.0000299187.90432.3f; Chio A, 2009, NEUROLOGY, V72, P725, DOI 10.1212/01.wnl.0000343008.26874.d1; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; FALCONER DS, 1965, ANN HUM GENET, V29, P51, DOI 10.1111/j.1469-1809.1965.tb00500.x; Fang F, 2009, ANN NEUROL, V66, P94, DOI 10.1002/ana.21580; Graham AJ, 1997, J NEUROL NEUROSUR PS, V62, P562, DOI 10.1136/jnnp.62.6.562; Hanby MF, 2011, BRAIN; Johnston CA, 2006, J NEUROL, V253, P1642, DOI 10.1007/s00415-006-0195-y; Logroscino G, 2005, J NEUROL NEUROSUR PS, V76, P1094, DOI 10.1136/jnnp.2004.039180; Maruyama H, 2010, NATURE, V465, P223, DOI 10.1038/nature08971; McGuire V, 1996, NEUROLOGY, V47, P571, DOI 10.1212/WNL.47.2.571; Mitchell JD, 2007, LANCET, V369, P2031, DOI 10.1016/S0140-6736(07)60944-1; MORTON NE, 1959, AM J HUM GENET, V11, P1; Orrell RW, 2001, NEUROLOGY, V57, P9, DOI 10.1212/WNL.57.1.9; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Schymick JC, 2007, HUM MOL GENET, V16, pR233, DOI 10.1093/hmg/ddm215; Traynor BJ, 1999, NEUROLOGY, V52, P504, DOI 10.1212/WNL.52.3.504	21	43	43	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2011	6	11							e27985	10.1371/journal.pone.0027985	http://dx.doi.org/10.1371/journal.pone.0027985			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858JH	22132186	Green Published, Green Submitted, gold			2022-12-27	WOS:000297792400029
J	Haridas, V; Xu, ZX; Kitchen, D; Jiang, A; Michels, P; Gutterman, JU				Haridas, Valsala; Xu, Zhi-Xiang; Kitchen, Doug; Jiang, Anna; Michels, Peter; Gutterman, Jordan U.			The Anticancer Plant Triterpenoid, Avicin D, Regulates Glucocorticoid Receptor Signaling: Implications for Cellular Metabolism	PLOS ONE			English	Article							ACACIA-VICTORIAE BENTHAM; FACTOR-KAPPA-B; ACTIVATED PROTEIN-KINASE; INDUCED APOPTOSIS; IN-VIVO; MOLECULAR-MECHANISMS; INDUCE APOPTOSIS; SAPONINS; GENE; STRESS	Avicins, a family of apoptotic triterpene electrophiles, are known to regulate cellular metabolism and energy homeostasis, by targeting the mitochondria. Having evolved from "ancient hopanoids,'' avicins bear a structural resemblance with glucocorticoids (GCs), which are the endogenous regulators of metabolism and energy balance. These structural and functional similarities prompted us to compare the mode of action of avicin D with dexamethasone (Dex), a prototypical GC. Using cold competition assay, we show that Avicin D competes with Dex for binding to the GC receptor (GR), leading to its nuclear translocation. In contrast to Dex, avicin-induced nuclear translocation of GR does not result in transcriptional activation of GC-dependent genes. Instead we observe a decrease in the expression of GC-dependent metabolic proteins such as PEPCK and FASN. However, like Dex, avicin D treatment does induce a transrepressive effect on the pro-inflammatory transcription factor NF-kappa B. While avicin's ability to inhibit NF-kappa B and its downstream targets appear to be GR-dependent, its pro-apoptotic effects were independent of GR expression. Using various deletion mutants of GR, we demonstrate the requirement of both the DNA and ligand binding domains of GR in mediating avicin D's transrepressive effects. Modeling of avicin-GR interaction revealed that avicin molecule binds only to the antagonist confirmation of GR. These findings suggest that avicin D has properties of being a selective GR modulator that separates transactivation from transrepression. Since the gene-activating properties of GR are mainly linked to its metabolic effects, and the negative interference with the activity of transcription factors to its anti-inflammatory and immune suppressive effects, the identification of such a dissociated GR ligand could have great potential for therapeutic use.	[Haridas, Valsala; Xu, Zhi-Xiang; Jiang, Anna; Gutterman, Jordan U.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Kitchen, Doug] Albany Mol Res Inc, Dept Comp Aided Drug Discovery, Albany, NY USA; [Michels, Peter] Albany Mol Res Inc, Dept Metab & Biotransformat, Albany, NY USA	University of Texas System; UTMD Anderson Cancer Center	Haridas, V (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA.	vharidas@mdanderson.org		Kitchen, Douglas/0000-0001-8988-759X	Clayton Foundation for Research; Welch Foundation	Clayton Foundation for Research; Welch Foundation(The Welch Foundation)	Research was supported by the Clayton Foundation for Research. Additional support was provided by a research grant from the Welch Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Albany Molecular Inc. has not provided any funding for the study.	BAMBERGER CM, 1995, J CLIN INVEST, V95, P2435, DOI 10.1172/JCI117943; Barnes PJ, 2006, BRIT J PHARMACOL, V148, P245, DOI 10.1038/sj.bjp.0706736; Belvisi MG, 2001, J IMMUNOL, V166, P1975, DOI 10.4049/jimmunol.166.3.1975; Brewer JA, 2002, J IMMUNOL, V169, P1837, DOI 10.4049/jimmunol.169.4.1837; Clark AR, 2007, MOL CELL ENDOCRINOL, V275, P79, DOI 10.1016/j.mce.2007.04.013; De Bosscher K, 2003, ENDOCR REV, V24, P488, DOI 10.1210/er.2002-0006; De Bosscher K, 2010, BRAIN BEHAV IMMUN, V24, P1035, DOI 10.1016/j.bbi.2010.06.010; De Bosscher K, 2010, J STEROID BIOCHEM, V120, P96, DOI 10.1016/j.jsbmb.2010.02.027; Distelhorst CW, 2002, CELL DEATH DIFFER, V9, P6, DOI 10.1038/sj.cdd.4400969; Dutta J, 2006, ONCOGENE, V25, P6800, DOI 10.1038/sj.onc.1209938; Ehrchen J, 2007, BLOOD, V109, P1265, DOI 10.1182/blood-2006-02-001115; Frankfurt O, 2004, CURR OPIN ONCOL, V16, P553, DOI 10.1097/01.cco.0000142072.22226.09; Furst R, 2007, FASEB J, V21, P74, DOI 10.1096/fj.06-6752com; GIGUERE V, 1986, CELL, V46, P645, DOI 10.1016/0092-8674(86)90339-9; Hanausek M, 2001, P NATL ACAD SCI USA, V98, P11551, DOI 10.1073/pnas.191363198; Haridas V, 2005, P NATL ACAD SCI USA, V102, P10088, DOI 10.1073/pnas.0504430102; Haridas V, 2004, J CLIN INVEST, V113, P65, DOI 10.1172/JCI200418699; Haridas V, 2001, P NATL ACAD SCI USA, V98, P5821, DOI 10.1073/pnas.101619098; Haridas V, 2001, P NATL ACAD SCI USA, V98, P11557, DOI 10.1073/pnas.191363498; Haridas V, 2007, MITOCHONDRION, V7, P234, DOI 10.1016/j.mito.2006.12.005; Haridas V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005578; HELMBERG A, 1995, EMBO J, V14, P452, DOI 10.1002/j.1460-2075.1995.tb07021.x; Herold MJ, 2006, CELL MOL LIFE SCI, V63, P60, DOI 10.1007/s00018-005-5390-y; HOLLENBERG SM, 1987, CELL, V49, P39, DOI 10.1016/0092-8674(87)90753-7; Jayatilake GS, 2003, J NAT PROD, V66, P779, DOI 10.1021/np020400v; JOHNSON IS, 1992, SCIENCE, V258, P203; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kordula T, 1996, BIOCHEM J, V313, P1019, DOI 10.1042/bj3131019; Masuzaki H, 2001, SCIENCE, V294, P2166, DOI 10.1126/science.1066285; MITSIADES N, 2004, BLOOD, V104, P2403; Mujoo K, 2001, CANCER RES, V61, P5486; Newton R, 2003, BIODRUGS, V17, P113, DOI 10.2165/00063030-200317020-00004; Newton R, 2007, MOL PHARMACOL, V72, P799, DOI 10.1124/mol.107.038794; OTTEN U, 1979, NATURE, V282, P413, DOI 10.1038/282413a0; Paterson I, 2005, SCIENCE, V310, P451, DOI 10.1126/science.1116364; Polizzi D, 1999, CANCER RES, V59, P1036; Pratt W B, 1996, EXS, V77, P79; Reichardt HM, 2000, Z RHEUMATOL, V59, P1; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Schacke H, 2002, PHARMACOL THERAPEUT, V96, P23, DOI 10.1016/S0163-7258(02)00297-8; Surjit M, 2011, CELL, V145, P224, DOI 10.1016/j.cell.2011.03.027; Tuckermann JP, 2005, CRIT REV CL LAB SCI, V42, P71, DOI 10.1080/10408360590888983; Vanden Berghe W, 1999, MOL PHARMACOL, V56, P797; Wang Z, 2002, J BIOL CHEM, V277, P26573, DOI 10.1074/jbc.M110530200; Wesselborg S, 1997, J BIOL CHEM, V272, P12422, DOI 10.1074/jbc.272.19.12422; Xu ZX, 2007, CELL DEATH DIFFER, V14, P1948, DOI 10.1038/sj.cdd.4402207; ZORA JA, 1986, J ALLERGY CLIN IMMUN, V77, P9, DOI 10.1016/0091-6749(86)90315-5	47	15	15	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2011	6	11							e28037	10.1371/journal.pone.0028037	http://dx.doi.org/10.1371/journal.pone.0028037			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IO	22132201	Green Submitted, Green Published, gold			2022-12-27	WOS:000297789900042
J	Wingfield, DK; Peckham, SH; Foley, DG; Palacios, DM; Lavaniegos, BE; Durazo, R; Nichols, WJ; Croll, DA; Bograd, SJ				Wingfield, Dana K.; Hoyt Peckham, S.; Foley, David G.; Palacios, Daniel M.; Lavaniegos, Bertha E.; Durazo, Reginaldo; Nichols, Wallace J.; Croll, Donald A.; Bograd, Steven J.			The Making of a Productivity Hotspot in the Coastal Ocean	PLOS ONE			English	Article							CRAB PLEURONCODES-PLANIPES; BAJA-CALIFORNIA; UPWELLING SHADOWS; PACIFIC-OCEAN; EXTINCTION; RETENTION; MOVEMENTS; DECAPODA; SITES	Background: Highly productive hotspots in the ocean often occur where complex physical forcing mechanisms lead to aggregation of primary and secondary producers. Understanding how hotspots persist, however, requires combining knowledge of the spatio-temporal linkages between geomorphology, physical forcing, and biological responses with the physiological requirements and movement of top predators. Methodology/Principal Findings: Here we integrate remotely sensed oceanography, ship surveys, and satellite telemetry to show how local geomorphology interacts with physical forcing to create a region with locally enhanced upwelling and an adjacent upwelling shadow that promotes retentive circulation, enhanced year-round primary production, and prey aggregation. These conditions provide an area within the upwelling shadow where physiologically optimal water temperatures can be found adjacent to a region of enhanced prey availability, resulting in a foraging hotspot for loggerhead sea turtles (Caretta caretta) off the Baja California peninsula, Mexico. Significance/Conclusions: We have identified the set of conditions that lead to a persistent top predator hotspot, which increases our understanding of how highly migratory species exploit productive regions of the ocean. These results will aid in the development of spatially and environmentally explicit management strategies for marine species of conservation concern.	[Wingfield, Dana K.] Univ Calif Santa Cruz, Inst Marine Sci, Santa Cruz, CA 95064 USA; [Hoyt Peckham, S.] Ocean Fdn, Grp Tortuguero AC, La Paz, Baja California, Mexico; [Hoyt Peckham, S.] Duke Univ, Ctr Marine Conservat, Beaufort, NC USA; [Foley, David G.; Palacios, Daniel M.; Bograd, Steven J.] NOAA Fisheries, Div Environm Res, SW Fisheries Sci Ctr, Pacific Grove, CA USA; [Foley, David G.; Palacios, Daniel M.] Univ Hawaii Manoa, Joint Inst Marine & Atmospher Res, Honolulu, HI 96822 USA; [Lavaniegos, Bertha E.] Ctr Invest Cient & Educ Super Ensenada, Dept Oceanog Biol, Ensenada, Baja California, Mexico; [Durazo, Reginaldo] Univ Autonoma Baja California, Fac Ciencias Marinas, Ensenada, Baja California, Mexico; [Nichols, Wallace J.] Calif Acad Sci, San Francisco, CA 94118 USA; [Nichols, Wallace J.] Ocean Revolut, Davenport, CA USA; [Croll, Donald A.] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz; Duke University; National Oceanic Atmospheric Admin (NOAA) - USA; University of Hawaii System; University of Hawaii Manoa; CICESE - Centro de Investigacion Cientifica y de Educacion Superior de Ensenada; Universidad Autonoma de Baja California; California Academy of Sciences; University of California System; University of California Santa Cruz	Wingfield, DK (corresponding author), Univ Calif Santa Cruz, Inst Marine Sci, Santa Cruz, CA 95064 USA.	danawing@sfsu.edu	Bograd, Steven/AAA-4824-2021; Palacios, Daniel M./B-9180-2008	Palacios, Daniel M./0000-0001-7069-7913; Chiaradia, Andre/0000-0002-6178-4211	David and Lucile Packard Foundation; Secretaria de medio ambiente y recursos naturales-Consejo nacional de ciencia y technologia (SEMARNAT-CONACYT); University of California Institute for Mexico and the United States (UC-MEXUS); National Marine Fisheries Service (NMFS); PADI Foundation; TE Foundation; Wallace Research Foundation; Earthwatch Institute; Tagging of Pacific Predators (TOPP); Office of Naval Research/National Oceanographic Partnership Program (ONR/NOPP)	David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Secretaria de medio ambiente y recursos naturales-Consejo nacional de ciencia y technologia (SEMARNAT-CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); University of California Institute for Mexico and the United States (UC-MEXUS); National Marine Fisheries Service (NMFS); PADI Foundation; TE Foundation; Wallace Research Foundation; Earthwatch Institute; Tagging of Pacific Predators (TOPP); Office of Naval Research/National Oceanographic Partnership Program (ONR/NOPP)(Office of Naval Research)	Funding was provided by the David and Lucile Packard Foundation, Secretaria de medio ambiente y recursos naturales-Consejo nacional de ciencia y technologia (SEMARNAT-CONACYT), University of California Institute for Mexico and the United States (UC-MEXUS), National Marine Fisheries Service (NMFS), PADI Foundation, T&E Foundation, Wallace Research Foundation, Earthwatch Institute, Tagging of Pacific Predators (TOPP), and the Office of Naval Research/National Oceanographic Partnership Program (ONR/NOPP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*ARG CLS, 1989, GUID ARG SYST; AURIOLESGAMBOA D, 1992, CRUSTACEANA, V62, P71, DOI 10.1163/156854092X00064; Becker JJ, 2009, MAR GEOD, V32, P355, DOI 10.1080/01490410903297766; BLACKBURN M, 1969, BAJA CALIFORNIA FISH, V68, P147; BOYD CM, 1960, BIOL BULL, V118, P17, DOI 10.2307/1539052; BREAKER LC, 2005, MAPPING MONITORING L; Coles WC, 2000, COPEIA, P551, DOI 10.1643/0045-8511(2000)000[0551:SSSTAA]2.0.CO;2; Croll DA, 2005, MAR ECOL PROG SER, V289, P117, DOI 10.3354/meps289117; Crowder L, 2008, MAR POLICY, V32, P772, DOI 10.1016/j.marpol.2008.03.012; DUNHAM A, 1989, INTERFACES BIOPHYSIC; Etnoyer P, 2006, DEEP-SEA RES PT II, V53, P340, DOI 10.1016/j.dsr2.2006.01.010; Gomez-Gutierrez J, 2000, MAR ECOL PROG SER, V208, P283, DOI 10.3354/meps208283; GRAHAM WM, 1992, MAR BIOL, V114, P561, DOI 10.1007/BF00357253; Graham WM, 1997, CONT SHELF RES, V17, P509, DOI 10.1016/S0278-4343(96)00045-3; Guinet C, 2001, MAR ECOL PROG SER, V219, P251, DOI 10.3354/meps219251; Hatase H, 2010, MAR BIOL, V157, P1337, DOI 10.1007/s00227-010-1413-9; Jackson JBC, 2008, P NATL ACAD SCI USA, V105, P11458, DOI 10.1073/pnas.0802812105; Lavaniegos BE, 2009, MAR ECOL PROG SER, V394, P137, DOI 10.3354/meps08285; LONGHURST AR, 1967, ECOLOGY, V48, P190, DOI 10.2307/1933100; LONGHURST AR, 2004, OCEANOGRAPHY, V17, P6; McClellan CM, 2010, J EXP MAR BIOL ECOL, V387, P44, DOI 10.1016/j.jembe.2010.02.020; Myers RA, 2005, PHILOS T R SOC B, V360, P13, DOI 10.1098/rstb.2004.1573; NICHOLS WJ, 2003, THESIS U ARIZONA TUC; PECKHAM S, 2008, THESIS U CALIFORNIA; Peckham SH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001041; Powell R., 2000, RES TECHNIQUES ANIMA, P64; Risien CM, 2008, J PHYS OCEANOGR, V38, P2379, DOI 10.1175/2008JPO3881.1; Robinson CJ, 2004, DEEP-SEA RES PT II, V51, P753, DOI 10.1016/j.dsr2.2004.05.018; Roughan M, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2005JC002898; Schaefer KM, 2007, MAR BIOL, V152, P503, DOI 10.1007/s00227-007-0689-x; Shanks AL, 2003, J PLANKTON RES, V25, P1251, DOI 10.1093/plankt/fbg090; Stearns S.C., 1992, pi; Sydeman WJ, 2006, DEEP-SEA RES PT II, V53, P247, DOI 10.1016/j.dsr2.2006.03.001; Tremblay Y, 2006, J EXP BIOL, V209, P128, DOI 10.1242/jeb.01970; VILLANUEVA D, 1991, TORTUGA PERICA CARET; Ware DM, 2005, SCIENCE, V308, P1280, DOI 10.1126/science.1109049; Wolf SG, 2009, ECOLOGY, V90, P742, DOI 10.1890/07-1267.1; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423	38	56	57	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2011	6	11							e27874	10.1371/journal.pone.0027874	http://dx.doi.org/10.1371/journal.pone.0027874			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IO	22132156	Green Submitted, Green Published, gold			2022-12-27	WOS:000297789900027
J	Presicce, P; Orsborn, K; King, E; Pratt, J; Fichtenbaum, CJ; Chougnet, CA				Presicce, Pietro; Orsborn, Kris; King, Eileen; Pratt, Jesse; Fichtenbaum, Carl J.; Chougnet, Claire A.			Frequency of Circulating Regulatory T Cells Increases during Chronic HIV Infection and Is Largely Controlled by Highly Active Antiretroviral Therapy	PLOS ONE			English	Article							IMMUNODEFICIENCY VIRUS-INFECTION; DISEASE PROGRESSION; IMMUNE ACTIVATION; ECTONUCLEOTIDASE CD39; CUTTING EDGE; EXPRESSION; CD4(+); RESTORATION; DISTINCT; CTLA-4	Regulatory T cells (Tregs) act by suppressing the activation and effector functions of innate and adaptive immune responses. HIV infection impacts Treg proportion and phenotype, although discrepant results have been reported depending on the patient population and the way Tregs were characterized. The effects of highly active antiretroviral therapy (HAART) on Treg frequency have not been thoroughly documented. We performed a detailed longitudinal analysis of Treg frequency and phenotype in 11 HIV-infected individuals enrolled in a single, prospective clinical trial, in which all patients underwent the same treatment protocol and were sampled at the same time points. Tregs were characterized for their expression of molecules associated with activation, cell cycle, apoptosis, or function, and compared to circulating Tregs from a group of age-matched healthy individuals. Our results revealed increased proportions, but reduced absolute numbers of circulating CD3(+)CD4(+)FOXP3(+) Tregs in chronically infected HIV-infected patients. Treg frequency was largely normalized by HAART. Importantly, we show that similar conclusions were drawn regardless of the combination of markers used to define Tregs. Our results also showed increased expression of cell cycle markers (Ki67 and cyclin B) in Tregs from untreated infected individuals, which were decreased by HAART. However, the Treg phenotype in untreated patients was not consistent with a higher level of generalized activation, as they expressed very low levels of CD69, slightly elevated levels of HLA-DR and similar levels of GARP compared to Tregs from uninfected donors. Moreover, none of these markers was significantly changed by HAART. Treg expression of CTLA-4 and cytotoxic molecules was identical between patients and controls. The most striking difference in terms of functional molecules was the high expression of CD39 by Tregs in untreated patients, which HAART only partially controlled.	[Presicce, Pietro; Orsborn, Kris; Chougnet, Claire A.] Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp, Div Mol Immunol,Res Fdn,Dept Pediat, Cincinnati, OH 45221 USA; [King, Eileen; Pratt, Jesse] Cincinnati Childrens Hosp, Med Ctr, Div Biostat & Epidemiol, Cincinnati, OH USA; [Fichtenbaum, Carl J.] Univ Cincinnati, Coll Med, Dept Med, Div Infect Dis, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Presicce, P (corresponding author), Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp, Div Mol Immunol,Res Fdn,Dept Pediat, Cincinnati, OH 45221 USA.	Claire.Chougnet@cchmc.org	King, Eileen/Q-1815-2015; Presicce, Pietro/AAN-8719-2020	Presicce, Pietro/0000-0002-2690-1814; Fichtenbaum, Carl/0000-0002-6778-7253	United States National Institutes of Health (NIH) [R01 AI068524]; NIH/NCRR [5UL1RR026314-02]; Abbott Laboratories; Gilead Sciences; PHS [P30 DK078392]; CEMH [1P30DK090971-01]; DHC [AR47363]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000077] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR026314] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR047363] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK078392, P30DK090971] Funding Source: NIH RePORTER	United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Abbott Laboratories(Abbott Laboratories); Gilead Sciences(Gilead Sciences); PHS(United States Department of Health & Human ServicesUnited States Public Health Service); CEMH; DHC; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	PP, KO and CAC were partially supported by United States National Institutes of Health (NIH) R01 AI068524. This publication was also partially supported by an Institutional Clinical and Translational Science Award, NIH/NCRR 5UL1RR026314-02. CJF received grant funding from Abbott Laboratories and Gilead Sciences. The authors acknowledge the Research Flow Cytometry Core, and the support provided in part by PHS Grant P30 DK078392, CEMH Grant 1P30DK090971-01 and DHC Grant AR47363. The funders had no role in the design of the study, data collection and analysis, decision to publish, or preparation of the manuscript.	Allers K, 2010, J VIROL, V84, P3259, DOI 10.1128/JVI.01715-09; Andersson J, 2005, J IMMUNOL, V174, P3143, DOI 10.4049/jimmunol.174.6.3143; Aswad F, 2005, J IMMUNOL, V175, P3075, DOI 10.4049/jimmunol.175.5.3075; Becker C, 2009, BLOOD, V114, P1263, DOI 10.1182/blood-2009-02-206730; Bi X, 2009, EUR J IMMUNOL, V39, P301, DOI 10.1002/eji.200838667; Boasso A, 2006, AIDS REV, V8, P141; Borsellino G, 2007, BLOOD, V110, P1225, DOI 10.1182/blood-2006-12-064527; Brichacek B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012831; Campbell DJ, 2011, NAT REV IMMUNOL, V11, P119, DOI 10.1038/nri2916; Caramalho I, 2003, J EXP MED, V197, P403, DOI 10.1084/jem.20021633; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Eller MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018779; Estes JD, 2006, J INFECT DIS, V193, P703, DOI 10.1086/500368; Gaardbo JC, 2008, CLIN EXP IMMUNOL, V154, P80, DOI 10.1111/j.1365-2249.2008.03725.x; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Grossman WJ, 2004, IMMUNITY, V21, P589, DOI 10.1016/j.immuni.2004.09.002; Kaufmann DE, 2007, NAT IMMUNOL, V8, P1246, DOI 10.1038/ni1515; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Kurtulus S, 2010, IMMUNOL REV, V236, P54, DOI 10.1111/j.1600-065X.2010.00920.x; Lages CS, 2008, J IMMUNOL, V181, P1835, DOI 10.4049/jimmunol.181.3.1835; Lederman MM, 2001, AIDS, V15, pS11, DOI 10.1097/00002030-200102002-00003; Li S, 2008, J VIROL, V82, P21, DOI 10.1128/JVI.01768-07; Liao H, 2010, J BIOL CHEM, V285, P14791, DOI 10.1074/jbc.M110.116905; Lim A, 2007, AIDS, V21, P1525, DOI 10.1097/QAD.0b013e32825eab8b; Lim A, 2009, JAIDS-J ACQ IMM DEF, V51, P248, DOI 10.1097/QAI.0b013e3181a74fad; Littman DR, 2010, CELL, V140, P845, DOI 10.1016/j.cell.2010.02.021; Liu JU, 2009, J IMMUNOL, V182, P3855, DOI 10.4049/jimmunol.0803330; Meintjes G, 2008, AM J RESP CRIT CARE, V178, P1083, DOI 10.1164/rccm.200806-858OC; Moncrieffe H, 2010, J IMMUNOL, V185, P134, DOI 10.4049/jimmunol.0803474; Moreno Fernandez ME, 2011, BLOOD IN PRESS; Moreno-Fernandez ME, 2009, J VIROL, V83, P12925, DOI 10.1128/JVI.01352-09; Nigam P, 2010, J IMMUNOL, V184, P1690, DOI 10.4049/jimmunol.0902955; Nikolova M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002110; Nilsson J, 2006, BLOOD, V108, P3808, DOI 10.1182/blood-2006-05-021576; Oswald-Richter K, 2004, PLOS BIOL, V2, P955, DOI 10.1371/journal.pbio.0020198; Paiardini M, 2004, AIDS, V18, P393, DOI 10.1097/00002030-200402200-00004; Pandrea I, 2008, J IMMUNOL, V181, P6687, DOI 10.4049/jimmunol.181.10.6687; Piedimonte G, 1999, AIDS, V13, P1159, DOI 10.1097/00002030-199907090-00003; Presicce P, 2010, CYTOM PART A, V77A, P571, DOI 10.1002/cyto.a.20875; Ramsdell F, 2003, IMMUNITY, V19, P165, DOI 10.1016/S1074-7613(03)00207-3; Rubtsov YP, 2010, SCIENCE, V329, P1667, DOI 10.1126/science.1191996; Sachdeva M, 2010, JAIDS-J ACQ IMM DEF, V54, P447, DOI 10.1097/QAI.0b013e3181e0c7d0; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Schulze Zur Wiesch J, 2010, J VIROL; Sitkovsky M, 2008, BRIT J PHARMACOL, V153, pS457, DOI 10.1038/bjp.2008.23; Tan D, 2008, HIV MED, V9, P307, DOI 10.1111/j.1468-1293.2008.00565.x; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Vukmanovic-Stejic M, 2006, J CLIN INVEST, V116, P2423, DOI 10.1172/JCI28941; Wang R, 2009, P NATL ACAD SCI USA, V106, P13439, DOI 10.1073/pnas.0901965106; Weiss L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011659; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Xing SJ, 2010, JAIDS-J ACQ IMM DEF, V54, P455, DOI 10.1097/QAI.0b013e3181e453b9; Zhang SM, 2010, FASEB J, V24, P495, DOI 10.1096/fj.09-143925	53	57	63	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e28118	10.1371/journal.pone.0028118	http://dx.doi.org/10.1371/journal.pone.0028118			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22162758	gold, Green Submitted, Green Published			2022-12-27	WOS:000298172800016
J	Scheffzuk, C; Kukushka, VI; Vyssotski, AL; Draguhn, A; Tort, ABL; Brankack, J				Scheffzuek, Claudia; Kukushka, Valeriy I.; Vyssotski, Alexei L.; Draguhn, Andreas; Tort, Adriano B. L.; Brankack, Jurij			Selective Coupling between Theta Phase and Neocortical Fast Gamma Oscillations during REM-Sleep in Mice	PLOS ONE			English	Article							MULTIITEM WORKING-MEMORY; SOURCE DENSITY ANALYSIS; FREELY MOVING RAT; CAT VISUAL-CORTEX; BEHAVING RAT; NEURONAL OSCILLATIONS; SLOW OSCILLATIONS; HUMAN HIPPOCAMPUS; FIELD POTENTIALS; FLYING PIGEONS	Background: The mammalian brain expresses a wide range of state-dependent network oscillations which vary in frequency and spatial extension. Such rhythms can entrain multiple neurons into coherent patterns of activity, consistent with a role in behaviour, cognition and memory formation. Recent evidence suggests that locally generated fast network oscillations can be systematically aligned to long-range slow oscillations. It is likely that such cross-frequency coupling supports specific tasks including behavioural choice and working memory. Principal Findings: We analyzed temporal coupling between high-frequency oscillations and EEG theta activity (4-12 Hz) in recordings from mouse parietal neocortex. Theta was exclusively present during active wakefulness and REM-sleep. Fast oscillations occurred in two separate frequency bands: gamma (40-100 Hz) and fast gamma (120-160 Hz). Theta, gamma and fast gamma were more prominent during active wakefulness as compared to REM-sleep. Coupling between theta and the two types of fast oscillations, however, was more pronounced during REM-sleep. This state-dependent cross-frequency coupling was particularly strong for theta-fast gamma interaction which increased 9-fold during REM as compared to active wakefulness. Theta-gamma coupling increased only by 1.5-fold. Significance: State-dependent cross-frequency-coupling provides a new functional characteristic of REM-sleep and establishes a unique property of neocortical fast gamma oscillations. Interactions between defined patterns of slow and fast network oscillations may serve selective functions in sleep-dependent information processing.	[Scheffzuek, Claudia; Draguhn, Andreas; Brankack, Jurij] Heidelberg Univ, Inst Physiol & Pathophysiol, Heidelberg, Germany; [Kukushka, Valeriy I.] Dniepropetrovsk Natl Univ, Quantum Chromoplasma Lab, Dnepropetrovsk, Ukraine; [Vyssotski, Alexei L.] Univ Zurich ETH, Inst Neuroinformat, Zurich, Switzerland; [Tort, Adriano B. L.] Univ Fed Rio Grande do Norte, Inst Brain, BR-59072970 Natal, RN, Brazil	Ruprecht Karls University Heidelberg; Ministry of Education & Science of Ukraine; Oles Honchar Dnipro National University; Universidade Federal do Rio Grande do Norte	Scheffzuk, C (corresponding author), Heidelberg Univ, Inst Physiol & Pathophysiol, Heidelberg, Germany.	jurij.brankack@physiologie.uni-heidelberg.de	Brankack, Jurij/L-8179-2017; Tort, Adriano/A-9945-2009	Tort, Adriano/0000-0002-9877-7816; Vyssotski, Alexei/0000-0002-9021-1471	Deutsche Forschungsgemeinschaft [SFB 636/B06]; Bernstein Center for Computational Neurosciences (BMBF); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bernstein Center for Computational Neurosciences (BMBF)(Federal Ministry of Education & Research (BMBF)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The study was supported by the Deutsche Forschungsgemeinschaft (SFB 636/B06) and the Bernstein Center for Computational Neurosciences (BMBF). ABL Tort was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastassiou CA, 2011, NAT NEUROSCI, V14, P217, DOI 10.1038/nn.2727; Axmacher N, 2010, P NATL ACAD SCI USA, V107, P3228, DOI 10.1073/pnas.0911531107; Axmacher N, 2009, CELL MOL LIFE SCI, V66, P2285, DOI 10.1007/s00018-009-0019-1; Berger H, 1929, ARCH PSYCHIAT NERVEN, V87, P527, DOI 10.1007/BF01797193; BLAND BH, 1976, BRAIN RES, V118, P259, DOI 10.1016/0006-8993(76)90711-3; BRAGIN A, 1995, J NEUROSCI, V15, P47; BRANKACK J, 1993, BRAIN RES, V615, P310, DOI 10.1016/0006-8993(93)90043-M; Brankack J, 2010, BRAIN RES, V1322, P59, DOI 10.1016/j.brainres.2010.01.069; Brankack J, 2009, PROG NEURO-PSYCHOPH, V33, P806, DOI 10.1016/j.pnpbp.2009.03.027; BUZSAKI G, 1986, BRAIN RES, V398, P242, DOI 10.1016/0006-8993(86)91483-6; Buzsaki G, 1996, CEREB CORTEX, V6, P81, DOI 10.1093/cercor/6.2.81; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Buzsaki G, 2003, NEUROSCIENCE, V116, P201, DOI 10.1016/S0306-4522(02)00669-3; BUZSAKI G, 1983, BRAIN RES REV, V6, P139, DOI 10.1016/0165-0173(83)90037-1; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; BUZSAKI G, 1986, BRAIN RES, V365, P125, DOI 10.1016/0006-8993(86)90729-8; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Buzsaki G., 2006, RHYTHMS BRAIN; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; Canolty RT, 2010, TRENDS COGN SCI, V14, P506, DOI 10.1016/j.tics.2010.09.001; Cantero JL, 2003, J NEUROSCI, V23, P10897; Choleris E, 2001, NEUROSCI BIOBEHAV R, V25, P235, DOI 10.1016/S0149-7634(01)00011-2; Csicsvari J, 2003, NEURON, V37, P311, DOI 10.1016/S0896-6273(02)01169-8; Demiralp T, 2007, INT J PSYCHOPHYSIOL, V64, P24, DOI 10.1016/j.ijpsycho.2006.07.005; Eckhorn R, 2000, Neurol Neurochir Pol, V34, P27; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Engel AK, 1997, CEREB CORTEX, V7, P571, DOI 10.1093/cercor/7.6.571; Fell J, 2011, NAT REV NEUROSCI, V12, P105, DOI 10.1038/nrn2979; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Fries P, 2009, ANNU REV NEUROSCI, V32, P209, DOI 10.1146/annurev.neuro.051508.135603; Frohlich F, 2010, NEURON, V67, P129, DOI 10.1016/j.neuron.2010.06.005; Gaona CM, 2011, J NEUROSCI, V31, P2091, DOI 10.1523/JNEUROSCI.4722-10.2011; GERBRANDT LK, 1978, ELECTROEN CLIN NEURO, V45, P454, DOI 10.1016/0013-4694(78)90290-0; GRAY CM, 1989, P NATL ACAD SCI USA, V86, P1698, DOI 10.1073/pnas.86.5.1698; Grenier FO, 2001, J NEUROPHYSIOL, V86, P1884, DOI 10.1152/jn.2001.86.4.1884; Gujar N, 2011, CEREB CORTEX, V21, P115, DOI 10.1093/cercor/bhq064; [Institute of Laboratory Animal Research Commission on Life Sciences National Research Council], 1996, GUID CAR US LAB AN; Jensen O, 2005, TRENDS NEUROSCI, V28, P67, DOI 10.1016/j.tins.2004.12.001; Jensen O, 2007, TRENDS NEUROSCI, V30, P317, DOI 10.1016/j.tins.2007.05.001; Jones MW, 2005, PLOS BIOL, V3, P2187, DOI 10.1371/journal.pbio.0030402; JOUVET M, 1969, SCIENCE, V163, P32, DOI 10.1126/science.163.3862.32; KONIG P, 1995, P NATL ACAD SCI USA, V92, P290, DOI 10.1073/pnas.92.1.290; Lisman J, 2008, SCHIZOPHRENIA BULL, V34, P974, DOI 10.1093/schbul/sbn060; LISTER RG, 1987, PSYCHOPHARMACOLOGY, V92, P180; Marshall L, 2006, NATURE, V444, P610, DOI 10.1038/nature05278; Marshall L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016905; Marshall U, 2007, TRENDS COGN SCI, V11, P442, DOI 10.1016/j.tics.2007.09.001; Molle M, 2006, J NEUROPHYSIOL, V96, P62, DOI 10.1152/jn.00014.2006; Montgomery SM, 2008, J NEUROSCI, V28, P6731, DOI 10.1523/JNEUROSCI.1227-08.2008; Montgomery SM, 2007, P NATL ACAD SCI USA, V104, P14495, DOI 10.1073/pnas.0701826104; MORGANE PJ, 1985, DEV BRAIN RES, V22, P211, DOI 10.1016/0165-3806(85)90172-5; Nishida M, 2004, NEUROSCI RES, V50, P331, DOI 10.1016/j.neures.2004.08.004; O'Neill J, 2010, TRENDS NEUROSCI, V33, P220, DOI 10.1016/j.tins.2010.01.006; Ray S, 2008, J NEUROSCI, V28, P11526, DOI 10.1523/JNEUROSCI.2848-08.2008; Ray S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000610; Schack B, 2002, INT J PSYCHOPHYSIOL, V44, P143, DOI 10.1016/S0167-8760(01)00199-4; Scheffer-Teixeira R, 2012, CEREB CORTEX, V22, P2404, DOI 10.1093/cercor/bhr319; Silvestri AJ, 2005, PHYSIOL BEHAV, V84, P343, DOI 10.1016/j.physbeh.2004.11.011; SINGER W, 1993, ANNU REV PHYSIOL, V55, P349, DOI 10.1146/annurev.physiol.55.1.349; Sirota A, 2003, P NATL ACAD SCI USA, V100, P2065, DOI 10.1073/pnas.0437938100; Sirota A, 2008, NEURON, V60, P683, DOI 10.1016/j.neuron.2008.09.014; Steriade M, 2001, J NEUROPHYSIOL, V86, P1, DOI 10.1152/jn.2001.86.1.1; SUZUKI SS, 1987, ELECTROEN CLIN NEURO, V67, P348, DOI 10.1016/0013-4694(87)90123-4; Tort ABL, 2010, J NEUROPHYSIOL, V104, P1195, DOI 10.1152/jn.00106.2010; Tort ABL, 2009, P NATL ACAD SCI USA, V106, P20942, DOI 10.1073/pnas.0911331106; Tort ABL, 2008, P NATL ACAD SCI USA, V105, P20517, DOI 10.1073/pnas.0810524105; VANDERWOLF CH, 1969, ELECTROEN CLIN NEURO, V26, P407, DOI 10.1016/0013-4694(69)90092-3; Vyssotski AL, 2006, J NEUROPHYSIOL, V95, P1263, DOI 10.1152/jn.00879.2005; Vyssotski AL, 2009, CURR BIOL, V19, P1159, DOI 10.1016/j.cub.2009.05.070; Walker MP, 2009, ANN NY ACAD SCI, V1156, P168, DOI 10.1111/j.1749-6632.2009.04416.x; Whittington MA, 2011, DEV NEUROBIOL, V71, P92, DOI 10.1002/dneu.20814; WINSON J, 1974, ELECTROEN CLIN NEURO, V36, P291, DOI 10.1016/0013-4694(74)90171-0	72	81	84	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e28489	10.1371/journal.pone.0028489	http://dx.doi.org/10.1371/journal.pone.0028489			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22163023	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000298172800040
J	Srikhanta, YN; Gorrell, RJ; Steen, JA; Gawthorne, JA; Kwok, T; Grimmond, SM; Robins-Browne, RM; Jennings, MP				Srikhanta, Yogitha N.; Gorrell, Rebecca J.; Steen, Jason A.; Gawthorne, Jayde A.; Kwok, Terry; Grimmond, Sean M.; Robins-Browne, Roy M.; Jennings, Michael P.			Phasevarion Mediated Epigenetic Gene Regulation in Helicobacter pylori	PLOS ONE			English	Article							RESTRICTION-MODIFICATION SYSTEMS; III DNA RESTRICTION; GASTRIC-CANCER; HAEMOPHILUS-INFLUENZAE; FUNCTIONAL-ANALYSIS; FLAGELLIN GENES; PHASE VARIATION; MULTIPLE GENES; COLONIZATION; SEQUENCE	Many host-adapted bacterial pathogens contain DNA methyltransferases (mod genes) that are subject to phase-variable expression (high-frequency reversible ON/OFF switching of gene expression). In Haemophilus influenzae and pathogenic Neisseria, the random switching of the modA gene, associated with a phase-variable type III restriction modification (R-M) system, controls expression of a phase-variable regulon of genes (a "phasevarion''), via differential methylation of the genome in the modA ON and OFF states. Phase-variable type III R-M systems are also found in Helicobacter pylori, suggesting that phasevarions may also exist in this key human pathogen. Phylogenetic studies on the phase-variable type III modH gene revealed that there are 17 distinct alleles in H. pylori, which differ only in their DNA recognition domain. One of the most commonly found alleles was modH5 (16% of isolates). Microarray analysis comparing the wild-type P12modH5 ON strain to a P12 Delta modH5 mutant revealed that six genes were either up-or down-regulated, and some were virulence-associated. These included flaA, which encodes a flagella protein important in motility and hopG, an outer membrane protein essential for colonization and associated with gastric cancer. This study provides the first evidence of this epigenetic mechanism of gene expression in H. pylori. Characterisation of H. pylori modH phasevarions to define stable immunological targets will be essential for vaccine development and may also contribute to understanding H. pylori pathogenesis.	[Srikhanta, Yogitha N.; Gawthorne, Jayde A.; Jennings, Michael P.] Griffith Univ, Inst Glyc, Gold Coast, Qld, Australia; [Srikhanta, Yogitha N.; Gorrell, Rebecca J.; Robins-Browne, Roy M.] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic, Australia; [Gorrell, Rebecca J.; Robins-Browne, Roy M.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Gorrell, Rebecca J.; Kwok, Terry] Monash Univ, Dept Biochem & Mol Biol, Melbourne, Vic 3004, Australia; [Steen, Jason A.; Grimmond, Sean M.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia	Griffith University; University of Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Monash University; University of Queensland	Srikhanta, YN (corresponding author), Griffith Univ, Inst Glyc, Gold Coast, Qld, Australia.	m.jennings@griffith.edu.au	Gorrell, Rebecca/H-5259-2019; Jennings, Michael P/G-4822-2013; Steen, Jason/A-6031-2010; Grimmond, Sean M/J-5304-2016; Robinsbrowne, Roy/ABF-8434-2020; Grimmond, Sean/K-3246-2019; Gorrell, Rebecca/J-1454-2012	Gorrell, Rebecca/0000-0003-0728-3325; Jennings, Michael P/0000-0002-1027-4684; Grimmond, Sean M/0000-0002-8102-7998; Robinsbrowne, Roy/0000-0001-9179-7884; Grimmond, Sean/0000-0002-8102-7998; Kwok, Terry/0000-0002-5905-3233; Steen, Jason/0000-0003-1351-5815; Srikhanta, Yogitha/0000-0002-7513-9969	Australian National Health and Medical Research Council (NHMRC); NHMRC [565526, 284214, 519704]	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by an Australian National Health and Medical Research Council (NHMRC) Biomedical Research Fellowship to YNS, NHMRC Program Grant 565526 to MPJ, NHMRC Program Grant 284214 to MPJ and RRB, and NHMRC Project Grant 519704 to MPJ and SMG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alm RA, 1999, NATURE, V397, P176, DOI 10.1038/16495; Andersen-Nissen E, 2005, P NATL ACAD SCI USA, V102, P9247, DOI 10.1073/pnas.0502040102; BACHI B, 1979, J MOL BIOL, V128, P143, DOI 10.1016/0022-2836(79)90123-2; Bayliss CD, 2006, NUCLEIC ACIDS RES, V34, P4046, DOI 10.1093/nar/gkl568; Bernarde C, 2010, MOL CELL PROTEOMICS, V9, P2796, DOI 10.1074/mcp.M110.001065; BICKLE TA, 1993, MICROBIOL REV, V57, P434, DOI 10.1128/MMBR.57.2.434-450.1993; Bjorkholm BM, 2002, J BIOL CHEM, V277, P34191, DOI 10.1074/jbc.M203613200; Blaser MJ, 1997, J CLIN INVEST, V100, P759, DOI 10.1172/JCI119588; Bourniquel AA, 2002, BIOCHIMIE, V84, P1047, DOI 10.1016/S0300-9084(02)00020-2; BOYER HW, 1971, ANNU REV MICROBIOL, V25, P153, DOI 10.1146/annurev.mi.25.100171.001101; de Vries N, 2002, J BACTERIOL, V184, P6615, DOI 10.1128/JB.184.23.6615-6624.2002; Doig P, 1999, MICROBIOL MOL BIOL R, V63, P675, DOI 10.1128/MMBR.63.3.675-707.1999; Eaton KA, 1996, INFECT IMMUN, V64, P2445, DOI 10.1128/IAI.64.7.2445-2448.1996; Ernst PB, 2000, ANNU REV MICROBIOL, V54, P615, DOI 10.1146/annurev.micro.54.1.615; Fischer W, 2010, NUCLEIC ACIDS RES, V38, P6089, DOI 10.1093/nar/gkq378; Fox KL, 2007, NUCLEIC ACIDS RES, V35, P5242, DOI 10.1093/nar/gkm571; Fox KL, 2007, MOL MICROBIOL, V65, P1375, DOI 10.1111/j.1365-2958.2007.05873.x; Gewirtz AT, 2004, J INFECT DIS, V189, P1914, DOI 10.1086/386289; Giannakis M, 2008, P NATL ACAD SCI USA, V105, P4358, DOI 10.1073/pnas.0800668105; Gorrell RJ, 2005, FEMS IMMUNOL MED MIC, V44, P213, DOI 10.1016/j.femsim.2004.10.019; HUMBELIN M, 1988, J MOL BIOL, V200, P23, DOI 10.1016/0022-2836(88)90330-0; JOSENHANS C, 1995, J BACTERIOL, V177, P3010, DOI 10.1128/jb.177.11.3010-3020.1995; Kavermann H, 2003, J EXP MED, V197, P813, DOI 10.1084/jem.20021531; Kong HM, 2000, NUCLEIC ACIDS RES, V28, P3216, DOI 10.1093/nar/28.17.3216; KOSTRZYNSKA M, 1991, J BACTERIOL, V173, P937, DOI 10.1128/jb.173.3.937-946.1991; Lee SK, 2003, MICROBES INFECT, V5, P1345, DOI 10.1016/j.micinf.2003.09.018; Lin LF, 2001, P NATL ACAD SCI USA, V98, P2740, DOI 10.1073/pnas.051612298; MEISEL A, 1995, EMBO J, V14, P2958, DOI 10.1002/j.1460-2075.1995.tb07296.x; Moss SF, 2003, CURR OPIN INFECT DIS, V16, P445, DOI 10.1097/00001432-200310000-00011; Moxon ER, 1997, NATURE, V387, P659, DOI 10.1038/42607; Peck B, 2001, MICROBES INFECT, V3, P171, DOI 10.1016/S1286-4579(01)01377-6; Peek RM, 2006, J PATHOL, V208, P233, DOI 10.1002/path.1868; Ryan KA, 2005, J BACTERIOL, V187, P5742, DOI 10.1128/JB.187.16.5742-5750.2005; Skoglund A, 2007, J BACTERIOL, V189, P8914, DOI 10.1128/JB.00108-07; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth Gordon K, 2003, Methods Mol Biol, V224, P111; Srikhanta YN, 2005, P NATL ACAD SCI USA, V102, P5547, DOI 10.1073/pnas.0501169102; Srikhanta YN, 2010, NAT REV MICROBIOL, V8, P196, DOI 10.1038/nrmicro2283; Srikhanta YN, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000400; SUERBAUM S, 1993, J BACTERIOL, V175, P3278, DOI 10.1128/jb.175.11.3278-3288.1993; van Belkum A, 1998, MICROBIOL MOL BIOL R, V62, P275, DOI 10.1128/MMBR.62.2.275-293.1998; Vitkute J, 2001, J BACTERIOL, V183, P443, DOI 10.1128/JB.183.2.443-450.2001	42	78	78	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e27569	10.1371/journal.pone.0027569	http://dx.doi.org/10.1371/journal.pone.0027569			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22162751	Green Published, gold			2022-12-27	WOS:000298172800006
J	McCann, CK; Growdon, WB; Kulkarni-Datar, K; Curley, MD; Friel, AM; Proctor, JL; Sheikh, H; Deyneko, I; Ferguson, JA; Vathipadiekal, V; Birrer, MJ; Borger, DR; Mohapatra, G; Zukerberg, LR; Foster, R; MacDougall, JR; Rueda, BR				McCann, Christopher K.; Growdon, Whitfield B.; Kulkarni-Datar, Kashmira; Curley, Michael D.; Friel, Anne M.; Proctor, Jennifer L.; Sheikh, Hana; Deyneko, Igor; Ferguson, Jeanne A.; Vathipadiekal, Vinod; Birrer, Michael J.; Borger, Darrell R.; Mohapatra, Gayatry; Zukerberg, Lawrence R.; Foster, Rosemary; MacDougall, John R.; Rueda, Bo R.			Inhibition of Hedgehog Signaling Antagonizes Serous Ovarian Cancer Growth in a Primary Xenograft Model	PLOS ONE			English	Article							PROSTATE-CANCER; STEM-CELL; PATHWAY; MEDULLOBLASTOMA; PROLIFERATION; ACTIVATION; PARADIGMS; THERAPY	Background: Recent evidence links aberrant activation of Hedgehog (Hh) signaling with the pathogenesis of several cancers including medulloblastoma, basal cell, small cell lung, pancreatic, prostate and ovarian. This investigation was designed to determine if inhibition of this pathway could inhibit serous ovarian cancer growth. Methodology: We utilized an in vivo pre-clinical model of serous ovarian cancer to characterize the anti-tumor activity of Hh pathway inhibitors cyclopamine and a clinically applicable derivative, IPI-926. Primary human serous ovarian tumor tissue was used to generate tumor xenografts in mice that were subsequently treated with cyclopamine or IPI-926. Principal Findings: Both compounds demonstrated significant anti-tumor activity as single agents. When IPI-926 was used in combination with paclitaxel and carboplatinum (T/C), no synergistic effect was observed, though sustained treatment with IPI-926 after cessation of T/C continued to suppress tumor growth. Hh pathway activity was analyzed by RT-PCR to assess changes in Gli1 transcript levels. A single dose of IPI-926 inhibited mouse stromal Gli1 transcript levels at 24 hours with unchanged human intra-tumor Gli1 levels. Chronic IPI-926 therapy for 21 days, however, inhibited Hh signaling in both mouse stromal and human tumor cells. Expression data from the micro-dissected stroma in human serous ovarian tumors confirmed the presence of Gli1 transcript and a significant association between elevated Gli1 transcript levels and worsened survival. Conclusions/Significance: IPI-926 treatment inhibits serous tumor growth suggesting the Hh signaling pathway contributes to the pathogenesis of ovarian cancer and may hold promise as a novel therapeutic target, especially in the maintenance setting.	[McCann, Christopher K.; Growdon, Whitfield B.; Kulkarni-Datar, Kashmira; Curley, Michael D.; Friel, Anne M.; Foster, Rosemary; Rueda, Bo R.] Massachusetts Gen Hosp, Dept Vincent Obstet & Gynecol, Vincent Ctr Reprod Biol, Boston, MA 02114 USA; [McCann, Christopher K.; Growdon, Whitfield B.; Rueda, Bo R.] Massachusetts Gen Hosp, Div Gynecol Oncol, Dept Vincent Obstet & Gynecol, Boston, MA 02114 USA; [McCann, Christopher K.; Growdon, Whitfield B.; Kulkarni-Datar, Kashmira; Curley, Michael D.; Friel, Anne M.; Vathipadiekal, Vinod; Birrer, Michael J.; Borger, Darrell R.; Mohapatra, Gayatry; Zukerberg, Lawrence R.; Foster, Rosemary; Rueda, Bo R.] Harvard Univ, Sch Med, Boston, MA USA; [Proctor, Jennifer L.; Sheikh, Hana; Deyneko, Igor; Ferguson, Jeanne A.; MacDougall, John R.] Infin Pharmaceut, Cambridge, MA USA; [Vathipadiekal, Vinod; Birrer, Michael J.; Borger, Darrell R.; Mohapatra, Gayatry] Massachusetts Gen Hosp, Div Hematol Oncol, Ctr Canc, Boston, MA 02114 USA; [Zukerberg, Lawrence R.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	McCann, CK (corresponding author), Massachusetts Gen Hosp, Dept Vincent Obstet & Gynecol, Vincent Ctr Reprod Biol, Boston, MA 02114 USA.	brueda@partners.org		/0000-0002-8181-6890; Friel, Anne/0000-0001-9876-5332	Ovarian Cancer Research Fund; Advanced Medical Research Foundation; Vincent Memorial Research Funds	Ovarian Cancer Research Fund; Advanced Medical Research Foundation; Vincent Memorial Research Funds	This research was funded by grants from the Ovarian Cancer Research Fund (BRR), Advanced Medical Research Foundation (BRR), and the Vincent Memorial Research Funds (BRR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berman DM, 2002, SCIENCE, V297, P1559, DOI 10.1126/science.1073733; Bhattacharya R, 2008, CLIN CANCER RES, V14, P7659, DOI 10.1158/1078-0432.CCR-08-1414; Bonome T, 2005, CANCER RES, V65, P10602, DOI 10.1158/0008-5472.CAN-05-2240; Chen XJ, 2007, CANCER SCI, V98, P68, DOI 10.1111/j.1349-7006.2006.00353.x; Curley MD, 2009, STEM CELLS, V27, P2875, DOI 10.1002/stem.236; Evangelista M, 2006, CLIN CANCER RES, V12, P5924, DOI 10.1158/1078-0432.CCR-06-1736; Grichnik JM, 2006, J INVEST DERMATOL, V126, P142, DOI 10.1038/sj.jid.5700017; Growdon WB, 2010, EXPERT REV OBSTET GY, V5, P409; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; Liao XY, 2009, CARCINOGENESIS, V30, P131, DOI 10.1093/carcin/bgn230; Lou H, 2007, ONCOGENE, V26, P1357, DOI 10.1038/sj.onc.1210200; Merchant AA, 2010, CLIN CANCER RES, V16, P3130, DOI 10.1158/1078-0432.CCR-09-2846; Romer J, 2005, CANCER RES, V65, P4975, DOI 10.1158/0008-5472.CAN-05-0481; Rubin LL, 2006, NAT REV DRUG DISCOV, V5, P1026, DOI 10.1038/nrd2086; Sanchez P, 2004, P NATL ACAD SCI USA, V101, P12561, DOI 10.1073/pnas.0404956101; Sanchez P, 2005, CANCER RES, V65, P2990, DOI 10.1158/0008-5472.CAN-05-0439; Stecca B, 2007, P NATL ACAD SCI USA, V104, P5895, DOI 10.1073/pnas.0700776104; Taipale J, 2001, NATURE, V411, P349, DOI 10.1038/35077219; Thayer SP, 2003, NATURE, V425, P851, DOI 10.1038/nature02009; Tremblay MR, 2009, J MED CHEM, V52, P4400, DOI 10.1021/jm900305z; Wang Y, 2007, CURR OPIN CELL BIOL, V19, P159, DOI 10.1016/j.ceb.2007.02.005; Watkins DN, 2003, CELL CYCLE, V2, P196, DOI 10.4161/cc.2.3.378; Xie JW, 2008, CURR ONCOL REP, V10, P107, DOI 10.1007/s11912-008-0018-7; Yang L, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-112; Yauch RL, 2008, NATURE, V455, P406, DOI 10.1038/nature07275	27	52	56	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2011	6	11							e28077	10.1371/journal.pone.0028077	http://dx.doi.org/10.1371/journal.pone.0028077			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863LT	22140510	Green Published, gold, Green Submitted			2022-12-27	WOS:000298166300025
J	dos Santos, TAT; Portes, JD; Damasceno-Sa, JC; Caldas, LA; de Souza, W; DaMatta, RA; Seabra, SH				Teixeira dos Santos, Thiago Alves; Portes, Juliana de Araujo; Damasceno-Sa, Joao Claudio; Caldas, Lucio Ayres; de Souza, Wanderley; DaMatta, Renato Augusto; Seabra, Sergio Henrique			Phosphatidylserine Exposure by Toxoplasma gondii Is Fundamental to Balance the Immune Response Granting Survival of the Parasite and of the Host	PLOS ONE			English	Article							ACTIVATED MURINE MACROPHAGES; NITRIC-OXIDE SYNTHASE; APOPTOTIC CELLS; MIMICRY; MECHANISM; DYNAMIN; INHIBITION; INFECTION; INVASION; EVASION	Phosphatidylserine (PS) exposure on the cell surface indicates apoptosis, but has also been related to evasion mechanisms of parasites, a concept known as apoptotic mimicry. Toxoplasma gondii mimics apoptotic cells by exposing PS, inducing secretion of TGF-beta1 by infected activated macrophages leading to degradation of inducible nitric oxide (NO) synthase, NO production inhibition and consequently persisting in these cells. Here PS+ and PS- subpopulation of tachyzoites were separated and the entrance mechanism, growth and NO inhibition in murine macrophages, and mice survival and pathology were analyzed. Infection index in resident macrophages was similar for both PS subpopulations but lower when compared to the total T. gondii population. Growth in resident macrophages was higher for the total T. gondii population, intermediate for the PS+ and lower for the PS- subpopulation. Production of NO by activated macrophages was inhibited after infection with the PS+ subpopulation and the total populations of tachyzoites. However, the PS- subpopulation was not able to inhibit NO production. PS+ subpopulation invaded macrophages by active penetration as indicated by tightfitting vacuoles, but the PS- subpopulation entered macrophages by phagocytosis as suggested by loose-fitting vacuoles containing these tachyzoites. The entrance mechanism of both subpopulations was confirmed in a non-professional phagocytic cell line where only the PS+ tachyzoites were found inside these cells in tight-fitting vacuoles. Both subpopulations of T. gondii killed mice faster than the total population. Clear signs of inflammation and no tachyzoites were seen in the peritoneal cavity of mice infected with the PS- subpopulation. Moreover, mice infected with the PS+ subpopulation had no sign of inflammation and the parasite burden was intense. These results show that PS+ and PS- subpopulations of T. gondii are necessary for a successful toxoplasma infection indicating that both subpopulations are required to maintain the balance between inflammation and parasite growth.	[Teixeira dos Santos, Thiago Alves; Portes, Juliana de Araujo; Seabra, Sergio Henrique] Ctr Univ Estadual Zona Oeste UEZO, Lab Tecnol Bioquim & Microscopia LTBM, Colegiado Ciencias Biol & Saude, Rio De Janeiro, Brazil; [Teixeira dos Santos, Thiago Alves; Damasceno-Sa, Joao Claudio; DaMatta, Renato Augusto] Univ Estadual Norte Fluminense Darcy Ribeiro UENF, Lab Biol Celular & Tecidual, Ctr Biociencias & Biotecnol, Campos Dos Goytacazes, Brazil; [Portes, Juliana de Araujo; Caldas, Lucio Ayres; de Souza, Wanderley] Univ Fed Rio de Janeiro UFRJ, Lab Ultraestrutura Celular Hertha Meyer, Inst Biofis Carlos Chagas Filho, Rio De Janeiro, Brazil	Centro Universitario Estadual da Zona Oeste; Universidade Estadual do Norte Fluminense; Universidade Federal do Rio de Janeiro	dos Santos, TAT (corresponding author), Ctr Univ Estadual Zona Oeste UEZO, Lab Tecnol Bioquim & Microscopia LTBM, Colegiado Ciencias Biol & Saude, Rio De Janeiro, Brazil.	seabra@pq.cnpq.br	DaMatta, Renato/G-8367-2015	DaMatta, Renato/0000-0002-0108-9268; Portes, Juliana de Araujo/0000-0001-5701-0793; Caldas, Lucio Ayres/0000-0002-1187-557X	FAPERJ (Research Support Foundation of Rio de Janeiro); CNPQ (National Research Council of Brazil)	FAPERJ (Research Support Foundation of Rio de Janeiro)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CNPQ (National Research Council of Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This research was supported by FAPERJ (Research Support Foundation of Rio de Janeiro) and CNPQ (National Research Council of Brazil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS LB, 1990, J IMMUNOL, V144, P2725; Bajno L, 2000, J CELL BIOL, V149, P697, DOI 10.1083/jcb.149.3.697; Balanco JMD, 2001, CURR BIOL, V11, P1870, DOI 10.1016/S0960-9822(01)00563-2; Barcinski Marcello A, 2003, Kinetoplastid Biol Dis, V2, P6, DOI 10.1186/1475-9292-2-6; Caldas LA, 2009, FEMS MICROBIOL LETT, V301, P103, DOI 10.1111/j.1574-6968.2009.01799.x; Carruthers VB, 2002, ACTA TROP, V81, P111, DOI 10.1016/S0001-706X(01)00201-7; DaMatta RA, 2007, FEMS MICROBIOL LETT, V266, P29, DOI 10.1111/j.1574-6968.2006.00495.x; de Souza W, 2008, MICRON, V39, P77, DOI 10.1016/j.micron.2006.11.003; de Souza W, 2009, MEM I OSWALDO CRUZ, V104, P149, DOI 10.1590/S0074-02762009000200004; Fadok VA, 2001, J CLIN INVEST, V108, P957, DOI 10.1172/JCI14122; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Gu C, 2010, EMBO J, V29, P3593, DOI 10.1038/emboj.2010.249; Guillermo LVC, 2004, POULTRY SCI, V83, P776, DOI 10.1093/ps/83.5.776; Huynh MLN, 2002, J CLIN INVEST, V109, P41, DOI 10.1172/JCI200211638; JONES TC, 1972, J EXP MED, V136, P1157, DOI 10.1084/jem.136.5.1157; Kirchhausen T, 2008, METHOD ENZYMOL, V438, P77, DOI 10.1016/S0076-6879(07)38006-3; Kozmar A, 2010, J INNATE IMMUN, V2, P248, DOI 10.1159/000295790; Luder CGK, 2003, INT J PARASITOL, V33, P833, DOI 10.1016/S0020-7519(03)00092-4; Mercer J, 2008, SCIENCE, V320, P531, DOI 10.1126/science.1155164; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; MORISAKI JH, 1995, J CELL SCI, V108, P2457; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Rozenfeld C, 2005, AM J PATHOL, V167, P1021, DOI 10.1016/S0002-9440(10)61191-1; Seabra SH, 2004, BIOCHEM BIOPH RES CO, V324, P744, DOI 10.1016/j.bbrc.2004.09.114; Seabra SJ, 2002, EXP PARASITOL, V100, P62, DOI 10.1006/expr.2001.4675; Tenter AM, 2000, INT J PARASITOL, V30, P1217, DOI 10.1016/S0020-7519(00)00124-7; Wanderley JLM, 2006, J IMMUNOL, V176, P1834, DOI 10.4049/jimmunol.176.3.1834; Wanderley JLM, 2010, CELL MOL LIFE SCI, V67, P1653, DOI 10.1007/s00018-010-0291-0	29	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2011	6	11							e27867	10.1371/journal.pone.0027867	http://dx.doi.org/10.1371/journal.pone.0027867			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863LT	22140476	gold, Green Submitted, Green Published			2022-12-27	WOS:000298166300015
J	Bernstein, J; Long, JS; Veillette, C; Ahn, J				Bernstein, Joseph; Long, Joy S.; Veillette, Christian; Ahn, Jaimo			Crowd Intelligence for the Classification of Fractures and Beyond	PLOS ONE			English	Article							FEMORAL-NECK FRACTURES	Background: Medical diagnosis, like all products of human cognition, is subject to error. We tested the hypothesis that errors of diagnosis in the realm of fracture classification can be reduced by a consensus (group) diagnosis; and that digital imaging and Internet access makes feasible the compilation of a diagnostic consensus in real time. Methods: Twelve orthopaedic surgeons were asked to evaluate 20 hip radiographs demonstrating a femoral neck fracture. The surgeons were asked to determine if the fractures were displaced or not. Because no reference standard is available, the maximal accuracy of the diagnosis of displacement can be inferred from inter-observer reliability: if two readers disagree about displacement, one of them must be wrong. That method was employed here. Additionally, virtual reader groups of 3 and 5 individual members were amalgamated, with the response of those groups defined by majority vote. The purpose of this step was to see if increasing the number of readers would improve accuracy. In a second experiment, to study the feasibility of amassing a reader group on the Internet in real time, 40 volunteers were sent 10 periodic email requests to answer questions and their response times were assessed. Results: The mean kappa coefficient for individual inter-observer reliability for the diagnosis of displacement was 0.69, comparable to prior published values. For 3-member virtual reader groups, inter-observer reliability was 0.77; and for 5-member groups, it was 0.80. In the experiment studying the feasibility of amassing a reader group in real time, the mean response time was 594 minutes. For all cases, a 9-member group (theoretically 99% accurate) was amassed in 135.8 minutes or less. Conclusions: Consensus may improve diagnosis. Amassing a group for this purpose on the Internet is feasible.	[Bernstein, Joseph] Vet Hosp, Dept Orthoped Surg, Philadelphia, PA USA; [Bernstein, Joseph; Long, Joy S.; Ahn, Jaimo] Univ Penn, Sch Med, Dept Orthoped Surg, Philadelphia, PA 19104 USA; [Veillette, Christian] Univ Toronto, Dept Orthoped Surg, Toronto, ON, Canada	University of Pennsylvania; University of Toronto	Bernstein, J (corresponding author), Vet Hosp, Dept Orthoped Surg, Philadelphia, PA USA.	orthodoc@uphs.upenn.edu	Veillette, Christian/AAF-5089-2021		Orthopaedic Trauma Association; Orthopaedic Research and Education Foundation	Orthopaedic Trauma Association; Orthopaedic Research and Education Foundation	This study was funded, in part, by research grants from the Orthopaedic Trauma Association (to JA, JB, CV) and the Orthopaedic Research and Education Foundation (to JB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BURSTEIN AH, 1993, J BONE JOINT SURG AM, V75A, P1743, DOI 10.2106/00004623-199312000-00001; Galton F, 1907, NATURE, V75, P450, DOI 10.1038/075450a0; Garbuz Donald S, 2002, J Am Acad Orthop Surg, V10, P290; GARDEN RS, 1961, J BONE JOINT SURG BR, V43, P647, DOI 10.1302/0301-620X.43B4.647; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Mackay Charles, 1995, EXTRAORDINARY POPULA; Oakes DA, 2003, CLIN ORTHOP RELAT R, P232, DOI 10.1097/01.blo.0000059583.08469.e5; Schmidt Andrew H, 2005, Instr Course Lect, V54, P417; Surowiecki J., 2004, WISDOM CROWDS WHY MA, VXXI, P295; Thomsen NOB, 1996, INT ORTHOP, V20, P326, DOI 10.1007/s002640050087; Totterman A, 2007, ARCH ORTHOP TRAUM SU, V127, P185, DOI 10.1007/s00402-006-0276-5; Woolley AW, 2010, SCIENCE, V330, P686, DOI 10.1126/science.1193147; Zlowodzki M, 2005, ARCH ORTHOP TRAUM SU, V125, P503, DOI 10.1007/s00402-005-0022-4	13	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e27620	10.1371/journal.pone.0027620	http://dx.doi.org/10.1371/journal.pone.0027620			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132118	Green Submitted, gold, Green Published			2022-12-27	WOS:000298162000030
J	Kalinina, O; Zeller, SL; Schmid, B				Kalinina, Olena; Zeller, Simon L.; Schmid, Bernhard			Competitive Performance of Transgenic Wheat Resistant to Powdery Mildew	PLOS ONE			English	Article							GENETICALLY-ENGINEERED ORGANISMS; BARLEY SEED PROTEINS; DISEASE-RESISTANCE; PATHOGEN DEFENSE; ECOLOGICAL COSTS; RISK-ASSESSMENT; FITNESS COSTS; PLANTS; DIVERSITY; ABILITY	Genetically modified (GM) plants offer an ideal model system to study the influence of single genes that confer constitutive resistance to pathogens on the ecological behaviour of plants. We used phytometers to study competitive interactions between GM lines of spring wheat Triticum aestivum carrying such genes and control lines. We hypothesized that competitive performance of GM lines would be reduced due to enhanced transgene expression under pathogen levels typically encountered in the field. The transgenes pm3b from wheat (resistance against powdery mildew Blumeria graminis) or chitinase and glucanase genes from barley (resistance against fungi in general) were introduced with the ubiquitin promoter from maize (pm3b and chitinase genes) or the actin promoter from rice (glucanase gene). Phytometers of 15 transgenic and non-transgenic wheat lines were transplanted as seedlings into plots sown with the same 15 lines as competitive environments and subject to two soil nutrient levels. Pm3b lines had reduced mildew incidence compared with control lines. Chitinase and chitinase/glucanase lines showed the same high resistance to mildew as their control in low-nutrient treatment and slightly lower mildew rates than the control in high-nutrient environment. Pm3b lines were weaker competitors than control lines. This resulted in reduced yield and seed number. The Pm3b line with the highest transgene expression had 53.2% lower yield than the control whereas the Pm3b line which segregated in resistance and had higher mildew rates showed only minor costs under competition. The line expressing both chitinase and glucanase genes also showed reduced yield and seed number under competition compared with its control. Our results suggest that single transgenes conferring constitutive resistance to pathogens can have ecological costs and can weaken plant competitiveness even in the presence of the pathogen. The magnitude of these costs appears related to the degree of expression of the transgenes.	[Kalinina, Olena; Zeller, Simon L.; Schmid, Bernhard] Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland	University of Zurich	Kalinina, O (corresponding author), Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland.	olena.kalinina@ieu.uzh.ch	Kalinina, Olena/H-6275-2011; Kalinina, Olena/J-5986-2019; Schmid, Bernhard/C-8625-2009	Schmid, Bernhard/0000-0002-8430-3214	Swiss National Science Foundation; wheat-cluster.ch [SNF 405940-115607]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); wheat-cluster.ch	This project was supported by the Swiss National Science Foundation and is a part of the wheat-cluster.ch, a sub-unit of the national research programme NRP 59 (SNF 405940-115607). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2000, ECOLOGY, V81, P1804, DOI 10.1890/0012-9658(2000)081[1804:BACOIP]2.0.CO;2; ALLARD RW, 1969, AM NAT, V103, P621, DOI 10.1086/282630; Alvarez-Alfageme F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022690; Ammann K, 2000, Z PFLANZENK PFLANZEN, P19; Andersson HC, 2011, EFSA J, V9, DOI 10.2903/j.efsa.2011.2150; BAINBRIDGE A, 1974, PLANT PATHOL, V23, P160, DOI 10.1111/j.1365-3059.1974.tb01842.x; Baker H. G., 1975, Annual Review of Ecology and Systematics, V5, P1, DOI 10.1146/annurev.es.05.110174.000245; Baldwin IT, 2000, J CHEM ECOL, V26, P915, DOI 10.1023/A:1005408208826; BALDWIN IT, 1988, J CHEM ECOL, V14, P1113, DOI 10.1007/BF01019339; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Bartsch D, 1996, MOL ECOL, V5, P199, DOI 10.1111/j.1365-294X.1996.tb00307.x; Bergelson J, 1996, AM NAT, V148, P536, DOI 10.1086/285938; Bieri S, 2003, MOL BREEDING, V11, P37, DOI 10.1023/A:1022145915983; Brown JKM, 2002, CURR OPIN PLANT BIOL, V5, P339, DOI 10.1016/S1369-5266(02)00270-4; Brunner S, 2011, PLANT BIOTECHNOL J, V9, P897, DOI 10.1111/j.1467-7652.2011.00603.x; Cao AH, 2011, P NATL ACAD SCI USA, V108, P7727, DOI 10.1073/pnas.1016981108; Cellini F, 2004, FOOD CHEM TOXICOL, V42, P1089, DOI 10.1016/j.fct.2004.02.003; Chen LY, 2006, AM J BOT, V93, P94, DOI 10.3732/ajb.93.1.94; Chen YX, 2007, PLANT SOIL, V291, P1, DOI 10.1007/s11104-006-9161-9; Clements F.E., 1924, PHYTOMETER METHOD EC; CRAWLEY MJ, 1993, NATURE, V363, P620, DOI 10.1038/363620a0; Crawley MJ, 1992, P 2 INT S BIOS RES F, P43; Dale PJ, 2002, NAT BIOTECHNOL, V20, P567, DOI 10.1038/nbt0602-567; Filipecki M, 2006, J APPL GENET, V47, P277, DOI 10.1007/BF03194637; Fredshavn JR, 1996, FIELD CROP RES, V45, P11, DOI 10.1016/0378-4290(95)00054-2; Fuchs Marc, 2004, Environmental Biosafety Research, V3, P17, DOI 10.1051/ebr:2004004; Gurr SJ, 2005, TRENDS BIOTECHNOL, V23, P275, DOI 10.1016/j.tibtech.2005.04.007; Hautier Y, 2009, SCIENCE, V324, P636, DOI 10.1126/science.1169640; Heil M, 2000, J ECOL, V88, P645, DOI 10.1046/j.1365-2745.2000.00479.x; Heil M, 2002, TRENDS PLANT SCI, V7, P61, DOI 10.1016/S1360-1385(01)02186-0; Heil M, 2002, CURR OPIN PLANT BIOL, V5, P345, DOI 10.1016/S1369-5266(02)00267-4; HERMS DA, 1992, Q REV BIOL, V67, P283, DOI 10.1086/417659; Joshi J, 2001, ECOL LETT, V4, P536, DOI 10.1046/j.1461-0248.2001.00262.x; LAST FT, 1953, ANN APPL BIOL, V40, P312, DOI 10.1111/j.1744-7348.1953.tb01085.x; Laughlin KD, 2009, ECOL APPL, V19, P1091, DOI 10.1890/08-0105.1; LEAH R, 1991, J BIOL CHEM, V266, P1564; LUBY JJ, 1995, THEOR APPL GENET, V90, P1133, DOI 10.1007/BF00222933; McCullagh P, 1989, GEN LINEAR MODELS; MCGILCHRIST CA, 1965, BIOMETRICS, V21, P975, DOI 10.2307/2528258; MCGRAW JB, 1985, NEW PHYTOL, V100, P233, DOI 10.1111/j.1469-8137.1985.tb02775.x; Melchers LS, 2000, CURR OPIN PLANT BIOL, V3, P147, DOI 10.1016/S1369-5266(99)00055-2; Mwangi PN, 2007, J ECOL, V95, P65, DOI 10.1111/j.1365-2745.2006.01189.x; Pellegrineschi A, 2002, GENOME, V45, P421, DOI 10.1139/G01-154; Petermann JS, 2008, ECOLOGY, V89, P2399, DOI 10.1890/07-2056.1; Rooke L, 2000, ANN APPL BIOL, V136, P167, DOI 10.1111/j.1744-7348.2000.tb00022.x; SCHMID B, 1994, J ECOL, V82, P165, DOI 10.2307/2261395; SHANER G, 1977, PHYTOPATHOLOGY, V67, P1051, DOI 10.1094/Phyto-67-1051; Smithson JB, 1996, ANN APPL BIOL, V128, P127, DOI 10.1111/j.1744-7348.1996.tb07096.x; Snow AA, 2005, ECOL APPL, V15, P377, DOI 10.1890/04-0539; Somssich IE, 1998, TRENDS PLANT SCI, V3, P86, DOI 10.1016/S1360-1385(98)01199-6; Strauss SY, 2002, TRENDS ECOL EVOL, V17, P278, DOI 10.1016/S0169-5347(02)02483-7; TIEDJE JM, 1989, ECOLOGY, V70, P298, DOI 10.2307/1937535; Tollrian Ralph, 1999, P306; Van Dam NM, 2001, FUNCT ECOL, V15, P406, DOI 10.1046/j.1365-2435.2001.00533.x; van Kleunen M, 2003, ECOLOGY, V84, P2816, DOI 10.1890/02-0494; Violle C, 2009, OECOLOGIA, V160, P747, DOI 10.1007/s00442-009-1333-x; von Burg S, 2011, BIOL LETTERS, V7, P387, DOI 10.1098/rsbl.2010.1147; von Burg S, 2010, BASIC APPL ECOL, V11, P257, DOI 10.1016/j.baae.2010.02.003; WILLIAMSON M, 1990, TRENDS ECOL EVOL, V5, P417, DOI 10.1016/0169-5347(90)90028-C; WILLIAMSON M, 1994, MOL ECOL, V3, P75, DOI 10.1111/j.1365-294X.1994.tb00048.x; WILSON SD, 1993, ECOLOGY, V74, P599, DOI 10.2307/1939319; WOLFE MS, 1985, ANNU REV PHYTOPATHOL, V23, P251, DOI 10.1146/annurev.py.23.090185.001343; Yahiaoui N, 2004, PLANT J, V37, P528, DOI 10.1046/j.1365-313X.2003.01977.x; ZADOKS JC, 1974, WEED RES, V14, P415, DOI 10.1111/j.1365-3180.1974.tb01084.x; Zeller SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011405; ZHU Q, 1994, BIO-TECHNOL, V12, P807, DOI 10.1038/nbt0894-807; Zhu YY, 2000, NATURE, V406, P718, DOI 10.1038/35021046	67	13	13	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e28091	10.1371/journal.pone.0028091	http://dx.doi.org/10.1371/journal.pone.0028091			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132219	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000298162000070
J	Yin, N; Zhang, N; Lal, G; Xu, JN; Yan, MH; Ding, YZ; Bromberg, JS				Yin, Na; Zhang, Nan; Lal, Girdhari; Xu, Jiangnan; Yan, Minhong; Ding, Yaozhong; Bromberg, Jonathan S.			Lymphangiogenesis Is Required for Pancreatic Islet Inflammation and Diabetes	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; LYMPHATIC VESSELS; DENDRITIC CELLS; VEGF-C; TYROSINE KINASES; MYELOID CELLS; BONE-MARROW; NOD MICE; RECEPTOR; MACROPHAGES	Lymphangiogenesis is a common phenomenon observed during inflammation and engraftment of transplants, but its precise role in the immune response and underlying mechanisms of regulation remain poorly defined. Here we showed that in response to injury and autoimmunity, lymphangiogenesis occurred around islets and played a key role in the islet inflammation in mice. Vascular endothelial growth factors receptor 3 (VEGFR3) is specifically involved in lymphangiogenesis, and blockade of VEGFR3 potently inhibited lymphangiogenesis in both islets and the draining LN during multiple low-dose streptozotocin (MLDS) induced autoimmune insulitis, which resulted in less T cell infiltration, preservation of islets and prevention of the onset of diabetes. In addition to their well-known conduit function, lymphatic endothelial cells (LEC) also produced chemokines in response to inflammation. These LEC attracted two distinct CX3CR1(hi) and LYVE-1(+) macrophage subsets to the inflamed islets and CX3CR1(hi) cells were influenced by LEC to differentiate into LYVE-1(+) cells closely associated with lymphatic vessels. These observations indicate a linkage among lymphangiogenesis and myeloid cell inflammation during insulitis. Thus, inhibition of lymphangiogenesis holds potential for treating insulitis and autoimmune diabetes.	[Yin, Na; Lal, Girdhari; Xu, Jiangnan; Ding, Yaozhong; Bromberg, Jonathan S.] Univ Maryland, Ctr Vasc & Inflammatory Dis, Baltimore, MD 21201 USA; [Lal, Girdhari; Xu, Jiangnan; Ding, Yaozhong; Bromberg, Jonathan S.] Univ Maryland, Dept Surg & Microbiol, Baltimore, MD 21201 USA; [Lal, Girdhari; Xu, Jiangnan; Ding, Yaozhong; Bromberg, Jonathan S.] Univ Maryland, Dept Immunol, Baltimore, MD 21201 USA; [Zhang, Nan] Marshall Univ, Dept Surg, Huntington, WV USA; [Yan, Minhong] Genentech Inc, Div Res, Dept Tumor Biol & Angiogenesis, San Francisco, CA 94080 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Marshall University; Roche Holding; Genentech	Yin, N (corresponding author), Univ Maryland, Ctr Vasc & Inflammatory Dis, Baltimore, MD 21201 USA.	NYin@som.umaryland.edu; JBromberg@smail.umaryland.edu	Lal, Girdhari/C-1752-2012; Lal, Girdhari/AAU-8179-2021	Lal, Girdhari/0000-0002-3799-3603; Lal, Girdhari/0000-0002-3799-3603	Emerald Foundation; Juvenile Diabetes Research Foundation (JDRF) [S-2007-236, 1-2008-90]; National Institutes of Health (NIH) [AI72039, AI41428]; American Society of Transplant Surgeons-Genentech Laboratories; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI072039, R01AI072039, R21AI041428, R01AI041428] Funding Source: NIH RePORTER	Emerald Foundation; Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Society of Transplant Surgeons-Genentech Laboratories; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the Emerald Foundation, Juvenile Diabetes Research Foundation (JDRF) S-2007-236 and 1-2008-90, National Institutes of Health (NIH) AI72039 and AI41428 (all to JSB); and the American Society of Transplant Surgeons-Genentech Laboratories Scientist Scholarship (to NY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achen MG, 1998, P NATL ACAD SCI USA, V95, P548, DOI 10.1073/pnas.95.2.548; Alitalo K, 2005, NATURE, V438, P946, DOI 10.1038/nature04480; Allen SJ, 2007, ANNU REV IMMUNOL, V25, P787, DOI 10.1146/annurev.immunol.24.021605.090529; Angeli V, 2006, IMMUNITY, V24, P203, DOI 10.1016/j.immuni.2006.01.003; Baluk P, 2005, J CLIN INVEST, V115, P247, DOI 10.1172/JCI200522037; Banerji S, 1999, J CELL BIOL, V144, P789, DOI 10.1083/jcb.144.4.789; BreitenederGeleff S, 1997, AM J PATHOL, V151, P1141; Dietrich T, 2010, J IMMUNOL, V184, P535, DOI 10.4049/jimmunol.0903180; Ebos JML, 2007, P NATL ACAD SCI USA, V104, P17069, DOI 10.1073/pnas.0708148104; Edirisinghe I, 2008, FASEB J, V22, P2297, DOI 10.1096/fj.07-099481; El-Chemaly S, 2008, ANN NY ACAD SCI, V1131, P195, DOI 10.1196/annals.1413.017; Faivre S, 2007, NAT REV DRUG DISCOV, V6, P734, DOI 10.1038/nrd2380; Fu FM, 2002, TRANSPLANTATION, V73, P1425, DOI 10.1097/00007890-200205150-00011; Guo RL, 2009, ARTHRITIS RHEUM-US, V60, P2666, DOI 10.1002/art.24764; Hamrah P, 2004, EXP EYE RES, V79, P553, DOI 10.1016/j.exer.2004.06.028; Hamrah P, 2003, AM J PATHOL, V163, P57, DOI 10.1016/S0002-9440(10)63630-9; Hipp MM, 2008, BLOOD, V111, P5610, DOI 10.1182/blood-2007-02-075945; Huggenberger R, 2011, BLOOD, V117, P4667, DOI 10.1182/blood-2010-10-316356; Huggenberger R, 2010, J EXP MED, V207, P2255, DOI 10.1084/jem.20100559; JANSEN A, 1994, DIABETES, V43, P667, DOI 10.2337/diabetes.43.5.667; Joukov V, 1996, EMBO J, V15, P290; Jun HS, 1999, DIABETES, V48, P34, DOI 10.2337/diabetes.48.1.34; Kallskog O, 2006, AM J TRANSPLANT, V6, P680, DOI 10.1111/j.1600-6143.2006.01234.x; Kang S, 2009, BLOOD, V113, P2605, DOI 10.1182/blood-2008-07-166934; Karpanen T, 2008, ANNU REV PATHOL-MECH, V3, P367, DOI 10.1146/annurev.pathol.3.121806.151515; Kataru RP, 2009, BLOOD, V113, P5650, DOI 10.1182/blood-2008-09-176776; Kerjaschki D, 2005, J CLIN INVEST, V115, P2316, DOI 10.1172/JCI26354; Kerjaschki D, 2004, J AM SOC NEPHROL, V15, P603, DOI 10.1097/01.ASN.0000113316.52371.2E; Kubota Y, 2009, J EXP MED, V206, P1089, DOI 10.1084/jem.20081605; Leclers D, 2006, ANTICANCER RES, V26, P1885; Ledgerwood LG, 2008, NAT IMMUNOL, V9, P42, DOI 10.1038/ni1534; Liao S, 2006, J IMMUNOL, V177, P3369, DOI 10.4049/jimmunol.177.5.3369; Louvet C, 2008, P NATL ACAD SCI USA, V105, P18895, DOI 10.1073/pnas.0810246105; Maki T, 2005, TRANSPLANTATION, V79, P1051, DOI 10.1097/01.TP.0000161220.87548.EE; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Martin AP, 2008, DIABETES, V57, P3025, DOI 10.2337/db08-0625; Maruyama K, 2005, J CLIN INVEST, V115, P2363, DOI 10.1172/JCI23874; Mounzer RH, 2010, BLOOD, V116, P2173, DOI 10.1182/blood-2009-12-256065; Niessen K, 2010, BLOOD, V115, P1654, DOI 10.1182/blood-2009-07-235655; Nykanen AI, 2010, CIRCULATION, V121, P1413, DOI 10.1161/CIRCULATIONAHA.109.910703; O'Farrell AM, 2003, BLOOD, V101, P3597, DOI 10.1182/blood-2002-07-2307; Oliver G, 2005, ANNU REV CELL DEV BI, V21, P457, DOI 10.1146/annurev.cellbio.21.012704.132338; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; PAIK SG, 1980, P NATL ACAD SCI-BIOL, V77, P6129, DOI 10.1073/pnas.77.10.6129; Pepper MS, 2003, J CELL BIOL, V163, P209, DOI 10.1083/jcb.200308082; Pytowski B, 2005, JNCI-J NATL CANCER I, V97, P14, DOI 10.1093/jnci/dji003; Qu P, 2003, J ANAT, V203, P523, DOI 10.1046/j.1469-7580.2003.00234.x; Regoli M, 2001, ANAT REC, V263, P155, DOI 10.1002/ar.1090; Schoppmann SF, 2002, AM J PATHOL, V161, P947, DOI 10.1016/S0002-9440(10)64255-1; Sundar SS, 2007, J CLIN ONCOL, V25, P4298, DOI 10.1200/JCO.2006.07.1092; Tammela T, 2008, NATURE, V454, P656, DOI 10.1038/nature07083; Tammela T, 2010, CELL, V140, P460, DOI 10.1016/j.cell.2010.01.045; Vigl B, 2011, BLOOD, V118, P205, DOI 10.1182/blood-2010-12-326447; Wigle JT, 2002, EMBO J, V21, P1505, DOI 10.1093/emboj/21.7.1505; Wirzenius M, 2007, J EXP MED, V204, P1431, DOI 10.1084/jem.20062642; Yin N, 2011, TRANSPLANTATION, V92, P25, DOI 10.1097/TP.0b013e31821d2661; Yoon CM, 2008, BLOOD, V112, P1129, DOI 10.1182/blood-2007-11-125203; Zumsteg A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007067	58	29	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e28023	10.1371/journal.pone.0028023	http://dx.doi.org/10.1371/journal.pone.0028023			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132197	Green Published, gold, Green Submitted			2022-12-27	WOS:000298162000060
J	Zakostelska, Z; Kverka, M; Klimesova, K; Rossmann, P; Mrazek, J; Kopecny, J; Hornova, M; Srutkova, D; Hudcovic, T; Ridl, J; Tlaskalova-Hogenova, H				Zakostelska, Zuzana; Kverka, Miloslav; Klimesova, Klara; Rossmann, Pavel; Mrazek, Jakub; Kopecny, Jan; Hornova, Michaela; Srutkova, Dagmar; Hudcovic, Tomas; Ridl, Jakub; Tlaskalova-Hogenova, Helena			Lysate of Probiotic Lactobacillus casei DN-114 001 Ameliorates Colitis by Strengthening the Gut Barrier Function and Changing the Gut Microenvironment	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; LACTIC-ACID BACTERIA; DEXTRAN SULFATE; CROHNS-DISEASE; ULCERATIVE-COLITIS; INTESTINAL INFLAMMATION; COMMENSAL BACTERIA; DOUBLE-BLIND; GERM-FREE; MICROBIOTA	Background: Probiotic bacteria can be used for the prevention and treatment of human inflammatory diseases including inflammatory bowel diseases (IBD). However, the nature of active components and exact mechanisms of this beneficial effects have not been fully elucidated. Our aim was to investigate if lysate of probiotic bacterium L. casei DN-114 001 (Lc) could decrease the severity of intestinal inflammation in a murine model of IBD. Methodology/Principal Findings: The preventive effect of oral administration of Lc significantly reduces the severity of acute dextran sulfate sodium (DSS) colitis in BALB/c but not in SCID mice. In order to analyze how this beneficial effect interferes with well-known phases of intestinal inflammation pathogenesis in vivo and in vitro, we evaluated intestinal permeability using the FITC-labeled dextran method and analysed tight junction proteins expression by immunofluorescence and PCR. We also measured CD4(+)FoxP3(+) regulatory T cells proportion by FACS analysis, microbiota composition by pyrosequencing, and local cytokine production by ELISA. Lc leads to a significant protection against increased intestinal permeability and barrier dysfunction shown by preserved ZO-1 expression. We found that the Lc treatment increases the numbers of CD4(+)FoxP3(+) regulatory T cells in mesenteric lymph nodes (MLN), decreases production of pro-inflammatory cytokines TNF-alpha and IFN-gamma, and anti-inflammatory IL-10 in Peyer's patches and large intestine, and changes the gut microbiota composition. Moreover, Lc treatment prevents lipopolysaccharide-induced TNF-alpha expression in RAW 264.7 cell line by down-regulating the NF-kappa B signaling pathway. Conclusion/Significance: Our study provided evidence that even non-living probiotic bacteria can prevent the development of severe forms of intestinal inflammation by strengthening the integrity of intestinal barrier and modulation of gut microenvironment.	[Zakostelska, Zuzana; Kverka, Miloslav; Klimesova, Klara; Rossmann, Pavel; Hornova, Michaela; Tlaskalova-Hogenova, Helena] Acad Sci Czech Republ, Inst Microbiol, Prague, Czech Republic; [Srutkova, Dagmar; Hudcovic, Tomas] Acad Sci Czech Republ, Inst Microbiol, Novy Hradek, Czech Republic; [Mrazek, Jakub; Kopecny, Jan] Acad Sci Czech Republ, Inst Anim Physiol & Genet, Prague, Czech Republic; [Ridl, Jakub] Acad Sci Czech Republ, Inst Mol Genet, Prague, Czech Republic	Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Animal Physiology & Genetics of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences	Zakostelska, Z (corresponding author), Acad Sci Czech Republ, Inst Microbiol, Prague, Czech Republic.	kverka@biomed.cas.cz	Mrazek, Jakub/B-7764-2017; Hudcovic, Tomas/H-7917-2014; Zákostelská, Zuzana/ABB-9807-2021; Šrůtková, Dagmar/H-8511-2014; Kopecny, Jan/C-3899-2011; Hornova, Michaela/J-8064-2014; Tlaskalová-Hogenová, Helena/J-8008-2014; Mrazek, Jakub/AAS-9861-2020; Zakostelska, Zuzana/D-6518-2012; Kverka, Miloslav/H-2507-2014; Mrazek, Jakub/G-7198-2014; Kostovcikova, Klara/J-6851-2014	Mrazek, Jakub/0000-0003-1907-3333; Hudcovic, Tomas/0000-0002-4761-5040; Šrůtková, Dagmar/0000-0003-0054-5396; Kopecny, Jan/0000-0002-2428-2511; Mrazek, Jakub/0000-0003-1907-3333; Kverka, Miloslav/0000-0002-1335-5252; Mrazek, Jakub/0000-0003-1907-3333; Kostovcikova, Klara/0000-0003-1821-398X; Zakostelska, Zuzana/0000-0002-6695-8188	Danone Institute of Czech Republic [2005-2006, 2010-2011]; Czech Science Foundation [P304/11/1252, 310/08/H077, 305/08/0535, 303/08/0367]; Academy of Sciences of Czech Republic [KJB500200904]; Ministry of Education, Youth and Sports of the Czech Republic [2B06155]; Grant Agency of the Ministry of Health of the Czech Republic [IGA MZ NS10340]; Institutional Research Concept Grant [AV0Z50200510]	Danone Institute of Czech Republic(Danone Nutricia); Czech Science Foundation(Grant Agency of the Czech Republic); Academy of Sciences of Czech Republic(Czech Academy of Sciences); Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Grant Agency of the Ministry of Health of the Czech Republic; Institutional Research Concept Grant	This work was supported by grants from Danone Institute of Czech Republic (2005-2006 and 2010-2011), the Czech Science Foundation (P304/11/1252, 310/08/H077, 305/08/0535 and 303/08/0367), http://www.gacr.cz/; the Academy of Sciences of Czech Republic (KJB500200904), http://www.gaav.cz/; the Ministry of Education, Youth and Sports of the Czech Republic (2B06155), http://www.msmt.cz; the Grant Agency of the Ministry of Health of the Czech Republic (IGA MZ NS10340), http://www.mzcr.cz/; and by Institutional Research Concept Grant AV0Z50200510, http://www.isvav.cz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Besselink MGH, 2008, LANCET, V371, P651, DOI 10.1016/S0140-6736(08)60207-X; Bibiloni R, 2005, AM J GASTROENTEROL, V100, P1539, DOI 10.1111/j.1572-0241.2005.41794.x; Biswas A, 2011, EUR J IMMUNOL, V41, P182, DOI 10.1002/eji.201040479; Boyer M, 2009, FEMS MICROBIOL ECOL, V70, P1, DOI 10.1111/j.1574-6941.2009.00745.x; CHEN HQ, 2010, AM J PHYSL GASTROINT; Chuang L, 2007, J AGR FOOD CHEM, V55, P11080, DOI 10.1021/jf071786o; Delcenserie V, 2008, CURR ISSUES MOL BIOL, V10, P37; DIELEMAN LA, 1994, GASTROENTEROLOGY, V107, P1643, DOI 10.1016/0016-5085(94)90803-6; Dieleman LA, 1998, CLIN EXP IMMUNOL, V114, P385; Donohoe DR, 2011, CELL METAB, V13, P517, DOI 10.1016/j.cmet.2011.02.018; Ewaschuk JB, 2008, AM J PHYSIOL-GASTR L, V295, pG1025, DOI 10.1152/ajpgi.90227.2008; Fasano A, 2011, PHYSIOL REV, V91, P151, DOI 10.1152/physrev.00003.2008; Fava F, 2011, WORLD J GASTROENTERO, V17, P557, DOI 10.3748/wjg.v17.i5.557; Gontcharova Viktoria, 2010, Open Microbiol J, V4, P47, DOI 10.2174/1874285801004010047; Gupta P, 2000, J PEDIATR GASTR NUTR, V31, P453, DOI 10.1097/00005176-200010000-00024; Hanniffy S, 2004, ADV APPL MICROBIOL, V56, P1, DOI 10.1016/S0065-2164(04)56001-X; Hotel ACP., 2001, PREVENTION, V5, P1; Hudcovic T, 2001, FOLIA MICROBIOL, V46, P565, DOI 10.1007/BF02818004; Ingrassia I, 2005, APPL ENVIRON MICROB, V71, P2880, DOI 10.1128/AEM.71.6.2880-2887.2005; Jamuna M, 2004, J GEN APPL MICROBIOL, V50, P79, DOI 10.2323/jgam.50.79; Kitajima S, 1999, EXP ANIM TOKYO, V48, P137, DOI 10.1538/expanim.48.137; Kleerebezem M, 2009, ANNU REV MICROBIOL, V63, P269, DOI 10.1146/annurev.micro.091208.073341; Kokesova A, 2006, FOLIA MICROBIOL, V51, P478, DOI 10.1007/BF02931595; Kruis W, 2004, GUT, V53, P1617, DOI 10.1136/gut.2003.037747; Kverka M, 2011, CLIN EXP IMMUNOL, V163, P250, DOI 10.1111/j.1365-2249.2010.04286.x; Lebeer S, 2010, NAT REV MICROBIOL, V8, P171, DOI 10.1038/nrmicro2297; Lee JM, 2008, J MICROBIOL BIOTECHN, V18, P1683; Liu ZH, 2011, MOL BIOL REP, V38, P1353, DOI 10.1007/s11033-010-0237-5; Llopis M, 2009, INFLAMM BOWEL DIS, V15, P275, DOI 10.1002/ibd.20736; MacDonald TT, 2000, SCAND J IMMUNOL, V51, P2; MADARA JL, 1989, J CLIN INVEST, V83, P724, DOI 10.1172/JCI113938; Matsumoto S, 2005, CLIN EXP IMMUNOL, V140, P417, DOI 10.1111/j.1365-2249.2005.02790.x; Mennigen R, 2009, AM J PHYSIOL-GASTR L, V296, pG1140, DOI 10.1152/ajpgi.90534.2008; Merenstein D, 2010, EUR J CLIN NUTR, V64, P669, DOI 10.1038/ejcn.2010.65; Mileti E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007056; Mondel M, 2009, MUCOSAL IMMUNOL, V2, P166, DOI 10.1038/mi.2008.77; Mowat Allan McI, 2003, Novartis Found Symp, V252, P291; MUNKHOLM P, 1994, GUT, V35, P68, DOI 10.1136/gut.35.1.68; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Packey CD, 2009, CURR OPIN INFECT DIS, V22, P292, DOI 10.1097/QCO.0b013e32832a8a5d; Poritz LS, 2007, J SURG RES, V140, P12, DOI 10.1016/j.jss.2006.07.050; Reiff C, 2009, INFLAMM BOWEL DIS, V15, P1721, DOI 10.1002/ibd.20999; Sartor RB, 2006, NAT CLIN PRACT GASTR, V3, P390, DOI 10.1038/ncpgasthep0528; Servin AL, 2004, FEMS MICROBIOL REV, V28, P405, DOI 10.1016/j.femsre.2004.01.003; Sheil B, 2007, J NUTR, V137, p819S, DOI 10.1093/jn/137.3.819S; Singh B, 2001, IMMUNOL REV, V182, P190, DOI 10.1034/j.1600-065X.2001.1820115.x; Sokol H, 2006, INFLAMM BOWEL DIS, V12, P106, DOI 10.1097/01.MIB.0000200323.38139.c6; Tannock GW, 2000, APPL ENVIRON MICROB, V66, P2578, DOI 10.1128/AEM.66.6.2578-2588.2000; Thomas CM, 2010, GUT MICROBES, V1, P148, DOI 10.4161/gmic.1.3.11712; Tlaskalova-Hogenova H, 2011, CELL MOL IMMUNOL, V8, P110, DOI 10.1038/cmi.2010.67; Ukena SN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001308; Wang Q, 2001, AM J PHYSIOL-REG I, V281, pR1013, DOI 10.1152/ajpregu.2001.281.3.R1013; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Yan YT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006073; Zanvit P, 2010, IMMUNOL LETT, V134, P26, DOI 10.1016/j.imlet.2010.08.006; Zhao Ying, 2003, Methods Mol Biol, V224, P183	56	136	138	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2011	6	11							e27961	10.1371/journal.pone.0027961	http://dx.doi.org/10.1371/journal.pone.0027961			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858JH	22132181	Green Submitted, gold, Green Published			2022-12-27	WOS:000297792400027
J	Konishi, K; Watanabe, Y; Shen, LL; Guo, Y; Castoro, RJ; Kondo, K; Chung, W; Ahmed, S; Jelinek, J; Boumber, YA; Estecio, MR; Maegawa, S; Kondo, Y; Itoh, F; Imawari, M; Hamilton, SR; Issa, JPJ				Konishi, Kazuo; Watanabe, Yoshiyuki; Shen, Lanlan; Guo, Yi; Castoro, Ryan J.; Kondo, Kimie; Chung, Woonbok; Ahmed, Saira; Jelinek, Jaroslav; Boumber, Yanis A.; Estecio, Marcos R.; Maegawa, Shinji; Kondo, Yutaka; Itoh, Fumio; Imawari, Michio; Hamilton, Stanley R.; Issa, Jean-Pierre J.			DNA Methylation Profiles of Primary Colorectal Carcinoma and Matched Liver Metastasis	PLOS ONE			English	Article							COLON-CANCER; O-6-METHYLGUANINE-DNA METHYLTRANSFERASE; MICROSATELLITE INSTABILITY; K-RAS; PROMOTER HYPERMETHYLATION; POOR-PROGNOSIS; PHENOTYPE; GENE; SURVIVAL; INACTIVATION	Background: The contribution of DNA methylation to the metastatic process in colorectal cancers (CRCs) is unclear. Methods: We evaluated the methylation status of 13 genes (MINT1, MINT2, MINT31, MLH1, p16, p14, TIMP3, CDH1, CDH13, THBS1, MGMT, HPP1 and ER alpha) by bisulfite-pyrosequencing in 79 CRCs comprising 36 CRCs without liver metastasis and 43 CRCs with liver metastasis, including 16 paired primary CRCs and liver metastasis. We also performed methylated CpG island amplification microarrays (MCAM) in three paired primary and metastatic cancers. Results: Methylation of p14, TIMP3 and HPP1 in primary CRCs progressively decreased from absence to presence of liver metastasis (13.1% vs. 4.3%; 14.8% vs. 3.7%; 43.9% vs. 35.8%, respectively) (P<.05). When paired primary and metastatic tumors were compared, only MGMT methylation was significantly higher in metastatic cancers (27.4% vs. 13.4%, P=.013), and this difference was due to an increase in methylation density rather than frequency in the majority of cases. MCAM showed an average 7.4% increase in DNA methylated genes in the metastatic samples. The numbers of differentially hypermethylated genes in the liver metastases increased with increasing time between resection of the primary and resection of the liver metastasis. Bisulfite-pyrosequencing validation in 12 paired samples showed that most of these increases were not conserved, and could be explained by differences in methylation density rather than frequency. Conclusions: Most DNA methylation differences between primary CRCs and matched liver metastasis are due to random variation and an increase in DNA methylation density rather than de-novo inactivation and silencing. Thus, DNA methylation changes occur for the most part before progression to liver metastasis.	[Konishi, Kazuo; Watanabe, Yoshiyuki; Shen, Lanlan; Guo, Yi; Castoro, Ryan J.; Kondo, Kimie; Chung, Woonbok; Ahmed, Saira; Jelinek, Jaroslav; Boumber, Yanis A.; Estecio, Marcos R.; Maegawa, Shinji; Issa, Jean-Pierre J.] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Div Canc Med, Houston, TX 77030 USA; [Hamilton, Stanley R.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Div Pathol & Lab Med, Houston, TX 77030 USA; [Imawari, Michio] Showa Univ, Sch Med, Dept Med, Div Gastroenterol, Tokyo 142, Japan; [Itoh, Fumio] St Marianna Univ, Sch Med, Dept Internal Med, Div Gastroenterol & Hepatol, Kawasaki, Kanagawa, Japan; [Kondo, Yutaka] Aichi Canc Ctr, Div Mol Oncol, Nagoya, Aichi 464, Japan	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Showa University; Saint Marianna University; Aichi Cancer Center	Konishi, K (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Div Canc Med, Houston, TX 77030 USA.	konishimd@med.showa-u.ac.jp	Jelinek, Jaroslav/O-6876-2019; Jelinek, Jaroslav/D-2282-2012; Boumber, Yanis/AAP-8901-2021	Jelinek, Jaroslav/0000-0002-2533-0220; Issa, Jean-Pierre/0000-0003-2258-5030; Castoro, Ryan/0000-0002-3242-3775; Boumber, Yanis/0000-0001-5003-248X; Castoro, Ryan/0000-0003-3619-484X; Estecio, Marcos/0000-0002-6874-7413	National Institutes of Health [CA098006, CA105346]; Frederick F. Becker Distinguished University Chair in Cancer Research of the University of Texas; NATIONAL CANCER INSTITUTE [R01CA105346, R01CA098006] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Frederick F. Becker Distinguished University Chair in Cancer Research of the University of Texas; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Institutes of Health grants CA098006 and CA105346 (J-PI). J-PI is an American Cancer Society Clinical Research Professor supported by a generous gift from the F. M. Kirby Foundation. SH is supported by the Frederick F. Becker Distinguished University Chair in Cancer Research of the University of Texas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja N, 1998, CANCER RES, V58, P5489; Baylin SB, 1998, ADV CANCER RES, V72, P141; Carter SL, 2006, NAT GENET, V38, P1043, DOI 10.1038/ng1861; Chambers AF, 1997, J NATL CANCER I, V89, P1260, DOI 10.1093/jnci/89.17.1260; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; Colella S, 2003, BIOTECHNIQUES, V35, P146, DOI 10.2144/03351md01; Esteller M, 2000, CANCER RES, V60, P2368; Esteller M, 2001, J CLIN ONCOL, V19, P299, DOI 10.1200/JCO.2001.19.2.299; Hiraga J, 2006, INT J HEMATOL, V84, P248, DOI 10.1532/IJH97.06087; Issa JP, 2004, NAT REV CANCER, V4, P988, DOI 10.1038/nrc1507; ISSA JPJ, 1994, NAT GENET, V7, P536, DOI 10.1038/ng0894-536; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Jones PA, 1999, NAT GENET, V21, P163, DOI 10.1038/5947; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Kohonen-Corish MRJ, 2005, J CLIN ONCOL, V23, P2318, DOI 10.1200/JCO.2005.00.109; Konishi K, 2003, GASTROINTEST ENDOSC, V57, P48, DOI 10.1067/mge.2003.31; Konishi K, 2007, GASTROENTEROLOGY, V132, P1254, DOI 10.1053/j.gastro.2007.01.035; Li Q, 1999, ONCOGENE, V18, P3284, DOI 10.1038/sj.onc.1202663; LINDAHL T, 1982, EMBO J, V1, P1359, DOI 10.1002/j.1460-2075.1982.tb01323.x; Ogino S, 2007, VIRCHOWS ARCH, V450, P529, DOI 10.1007/s00428-007-0398-3; Park TJ, 2001, CANCER, V92, P2760, DOI 10.1002/1097-0142(20011201)92:11<2760::AID-CNCR10123>3.0.CO;2-8; POTTER JD, 1993, EPIDEMIOL REV, V15, P499, DOI 10.1093/oxfordjournals.epirev.a036132; Powe DG, 1997, BRIT J CANCER, V75, P1678, DOI 10.1038/bjc.1997.285; Pulukuri SM, 2007, ONCOGENE, V26, P5229, DOI 10.1038/sj.onc.1210329; RADINSKY R, 1992, In Vivo (Attiki), V6, P325; Rhei E, 1998, CANCER RES, V58, P3193; Shen L, 2003, GASTROENTEROLOGY, V124, P626, DOI 10.1053/gast.2003.50102; Shen LL, 2007, P NATL ACAD SCI USA, V104, P18654, DOI 10.1073/pnas.0704652104; Shen L, 2007, PLOS GENET, V3, P2023, DOI 10.1371/journal.pgen.0030181; Shen L, 2007, CLIN CANCER RES, V13, P6093, DOI 10.1158/1078-0432.CCR-07-1011; Shen LL, 2005, JNCI-J NATL CANCER I, V97, P1330, DOI 10.1093/jnci/dji275; Suehiro Y, 2008, CLIN CANCER RES, V14, P2560, DOI 10.1158/1078-0432.CCR-07-1802; Takeichi M, 1993, CURR OPIN CELL BIOL, V5, P806, DOI 10.1016/0955-0674(93)90029-P; Toyooka S, 2002, CANCER RES, V62, P3382; Toyota M, 1999, CANCER RES, V59, P2307; Toyota M, 2000, P NATL ACAD SCI USA, V97, P710, DOI 10.1073/pnas.97.2.710; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; van Rijnsoever M, 2003, CLIN CANCER RES, V9, P2898; Ward RL, 2003, J CLIN ONCOL, V21, P3729, DOI 10.1200/JCO.2003.03.123	40	24	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2011	6	11							e27889	10.1371/journal.pone.0027889	http://dx.doi.org/10.1371/journal.pone.0027889			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IO	22132162	Green Submitted, Green Published, gold			2022-12-27	WOS:000297789900030
J	Hussack, G; Hirama, T; Ding, W; MacKenzie, R; Tanha, J				Hussack, Greg; Hirama, Tomoko; Ding, Wen; MacKenzie, Roger; Tanha, Jamshid			Engineered Single-Domain Antibodies with High Protease Resistance and Thermal Stability	PLOS ONE			English	Article							MILK IMMUNOGLOBULIN CONCENTRATE; SITE-DIRECTED MUTAGENESIS; MONOCLONAL-ANTIBODIES; IN-VITRO; V-H; DISULFIDE BOND; III SECRETION; FRAGMENTS; PROTEINS; PHAGE	The extreme pH and protease-rich environment of the upper gastrointestinal tract is a major obstacle facing orally-administered protein therapeutics, including antibodies. Through protein engineering, several Clostridium difficile toxin A-specific heavy chain antibody variable domains (V(H)Hs) were expressed with an additional disulfide bond by introducing Ala/Gly54Cys and Ile78Cys mutations. Mutant antibodies were compared to their wild-type counterparts with respect to expression yield, non-aggregation status, affinity for toxin A, circular dichroism (CD) structural signatures, thermal stability, protease resistance, and toxin A-neutralizing capacity. The mutant V(H)Hs were found to be well expressed, although with lower yields compared to wild-type counterparts, were non-aggregating monomers, retained low nM affinity for toxin A, albeit the majority showed somewhat reduced affinity compared to wild-type counterparts, and were capable of in vitro toxin A neutralization in cell-based assays. Far-UV and near-UV CD spectroscopy consistently showed shifts in peak intensity and selective peak minima for wild-type and mutant VHH pairs; however, the overall CD profile remained very similar. A significant increase in the thermal unfolding midpoint temperature was observed for all mutants at both neutral and acidic pH. Digestion of the V(H)Hs with the major gastrointestinal proteases, at biologically relevant concentrations, revealed a significant increase in pepsin resistance for all mutants and an increase in chymotrypsin resistance for the majority of mutants. Mutant VHH trypsin resistance was similar to that of wild-type V(H)Hs, although the trypsin resistance of one VHH mutant was significantly reduced. Therefore, the introduction of a second disulfide bond in the hydrophobic core not only increases VHH thermal stability at neutral pH, as previously shown, but also represents a generic strategy to increase VHH stability at low pH and impart protease resistance, with only minor perturbations in target binding affinities. These are all desirable characteristics for the design of protein-based oral therapeutics.	[Hussack, Greg; Hirama, Tomoko; Ding, Wen; MacKenzie, Roger; Tanha, Jamshid] Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada; [Hussack, Greg; Tanha, Jamshid] Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [MacKenzie, Roger; Tanha, Jamshid] Univ Guelph, Sch Environm Sci, Guelph, ON N1G 2W1, Canada	National Research Council Canada; University of Ottawa; University of Guelph	Hussack, G (corresponding author), Natl Res Council Canada, Inst Biol Sci, 100 Sussex Dr, Ottawa, ON K1A 0R6, Canada.	Jamshid.Tanha@nrc-cnrc.gc.ca			National Research Council Canada	National Research Council Canada	The work was supported by an internal fund from National Research Council Canada. The funder had no role in study design, data collection and analysis, or preparation of the manuscript.	Amorij JP, 2010, LANCET INFECT DIS, V10, P699, DOI 10.1016/S1473-3099(10)70157-2; Arbabi-Ghahroudi M, 2010, METHODS MOL BIOL, V634, P309, DOI 10.1007/978-1-60761-652-8_22; Arbabi-Ghahroudi Mehdi, 2009, V525, P187, DOI 10.1007/978-1-59745-554-1_10; Babcock GJ, 2006, INFECT IMMUN, V74, P6339, DOI 10.1128/IAI.00982-06; Balan KK, 1996, AM J GASTROENTEROL, V91, P1400; Bebbington C, 2008, CURR OPIN BIOTECH, V19, P613, DOI 10.1016/j.copbio.2008.10.002; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Cegelski L, 2008, NAT REV MICROBIOL, V6, P17, DOI 10.1038/nrmicro1818; Chan PH, 2008, BIOCHEMISTRY-US, V47, P11041, DOI 10.1021/bi8005797; Christ D, 2007, PROTEIN ENG DES SEL, V20, P413, DOI 10.1093/protein/gzm037; Clatworthy AE, 2007, NAT CHEM BIOL, V3, P541, DOI 10.1038/nchembio.2007.24; DAVIDSON GP, 1989, LANCET, V2, P709, DOI 10.1016/S0140-6736(89)90771-X; Dumoulin M, 2002, PROTEIN SCI, V11, P500, DOI 10.1110/ps.34602; Famm K, 2006, PROTEIN ENG DES SEL, V19, P479, DOI 10.1093/protein/gzl032; Famm K, 2008, J MOL BIOL, V376, P926, DOI 10.1016/j.jmb.2007.10.075; FRENKEN LGJ, 1993, PROTEIN ENG, V6, P637, DOI 10.1093/protein/6.6.637; Ghahroudi MA, 1997, FEBS LETT, V414, P521, DOI 10.1016/S0014-5793(97)01062-4; Gong R, 2009, J BIOL CHEM, V284, P14203, DOI 10.1074/jbc.M900769200; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Greenfield NJ, 2006, NAT PROTOC, V1, P2891, DOI 10.1038/nprot.2006.244; Hagihara Y, 2007, J BIOL CHEM, V282, P36489, DOI 10.1074/jbc.M707078200; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Harmsen MM, 2006, APPL MICROBIOL BIOT, V72, P544, DOI 10.1007/s00253-005-0300-7; Harmsen MM, 2005, VET MICROBIOL, V111, P89, DOI 10.1016/j.vetmic.2005.09.005; Hinkson PL, 2008, ANTIMICROB AGENTS CH, V52, P2190, DOI 10.1128/AAC.00041-08; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hubbard SJ, 1998, PROTEIN ENG, V11, P349, DOI 10.1093/protein/11.5.349; Hudson DL, 2007, ANTIMICROB AGENTS CH, V51, P2631, DOI 10.1128/AAC.01492-06; Hussack G, 2010, TOXINS, V2, P998, DOI 10.3390/toxins2050998; Hussack G, 2011, J BIOL CHEM, V286, P8961, DOI 10.1074/jbc.M110.198754; Jank T, 2008, TRENDS MICROBIOL, V16, P222, DOI 10.1016/j.tim.2008.01.011; Jermutus L, 2001, P NATL ACAD SCI USA, V98, P75, DOI 10.1073/pnas.011311398; Jespers L, 2004, NAT BIOTECHNOL, V22, P1161, DOI 10.1038/nbt1000; Jung S, 1999, J MOL BIOL, V294, P163, DOI 10.1006/jmbi.1999.3196; Kim DY, 2011, METHODS MOL IN PRESS; Kink JA, 1998, INFECT IMMUN, V66, P2018, DOI 10.1128/IAI.66.5.2018-2025.1998; Kruger C, 2006, APPL MICROBIOL BIOT, V72, P732, DOI 10.1007/s00253-006-0347-0; Kurtz CB, 2001, ANTIMICROB AGENTS CH, V45, P2340, DOI 10.1128/AAC.45.8.2340-2347.2001; Li SH, 2009, MOL IMMUNOL, V46, P1718, DOI 10.1016/j.molimm.2009.02.007; Lowy I, 2010, NEW ENGL J MED, V362, P197, DOI 10.1056/NEJMoa0907635; Lynch SV, 2008, CURR OPIN CRIT CARE, V14, P593, DOI 10.1097/MCC.0b013e32830f1dd5; Lyon GJ, 2002, BIOCHEMISTRY-US, V41, P10095, DOI 10.1021/bi026049u; Matsuura T, 2003, FEBS LETT, V539, P24, DOI 10.1016/S0014-5793(03)00178-9; Muschiol S, 2006, P NATL ACAD SCI USA, V103, P14566, DOI 10.1073/pnas.0606412103; Nowakowski A, 2002, P NATL ACAD SCI USA, V99, P11346, DOI 10.1073/pnas.172229899; Panchal RG, 2004, NAT STRUCT MOL BIOL, V11, P67, DOI 10.1038/nsmb711; PETERSON JW, 1979, INFECT IMMUN, V24, P774, DOI 10.1128/IAI.24.3.774-779.1979; Reilly RM, 1997, CLIN PHARMACOKINET, V32, P313, DOI 10.2165/00003088-199732040-00004; Saerens D, 2004, J BIOL CHEM, V279, P51965, DOI 10.1074/jbc.M409292200; Saerens D, 2008, J MOL BIOL, V377, P478, DOI 10.1016/j.jmb.2008.01.022; SCHMIDT P, 1989, J VET MED B, V36, P619, DOI 10.1111/j.1439-0450.1989.tb00653.x; Schneemann A, 2009, FUTURE MICROBIOL, V4, P35, DOI 10.2217/17460913.4.1.35; Shoop WL, 2005, P NATL ACAD SCI USA, V102, P7958, DOI 10.1073/pnas.0502159102; Sieber V, 1998, NAT BIOTECHNOL, V16, P955, DOI 10.1038/nbt1098-955; Spinelli S, 2000, BIOCHEMISTRY-US, V39, P1217, DOI 10.1021/bi991830w; STROCKBINE NA, 1985, INFECT IMMUN, V50, P695, DOI 10.1128/IAI.50.3.695-700.1985; Svensson A, 2001, CHEMBIOCHEM, V2, P915, DOI 10.1002/1439-7633(20011203)2:12<915::AID-CBIC915>3.3.CO;2-D; TACKET CO, 1992, AM J TROP MED HYG, V47, P276, DOI 10.4269/ajtmh.1992.47.276; TACKET CO, 1988, NEW ENGL J MED, V318, P1240, DOI 10.1056/NEJM198805123181904; Thiagarajah JR, 2005, TRENDS PHARMACOL SCI, V26, P172, DOI 10.1016/j.tips.2005.02.003; TJELLSTROM B, 1993, LANCET, V341, P701, DOI 10.1016/0140-6736(93)90477-X; To R, 2005, J BIOL CHEM, V280, P41395, DOI 10.1074/jbc.M509900200; van der Vaart JM, 2006, VACCINE, V24, P4130, DOI 10.1016/j.vaccine.2006.02.045; Wang W, 2010, INT J PHARMACEUT, V390, P89, DOI 10.1016/j.ijpharm.2010.02.025; Werle Martin, 2009, Recent Pat Drug Deliv Formul, V3, P94; Wesolowski J, 2009, MED MICROBIOL IMMUN, V198, P157, DOI 10.1007/s00430-009-0116-7; Worn A, 1998, BIOCHEMISTRY-US, V37, P13120, DOI 10.1021/bi980712q; Wu SL, 2009, ANAL CHEM, V81, P112, DOI 10.1021/ac801560k; YOKOYAMA H, 1992, INFECT IMMUN, V60, P998, DOI 10.1128/IAI.60.3.998-1007.1992; Young NM, 1995, FEBS LETT, V377, P135, DOI 10.1016/0014-5793(95)01325-3	70	86	102	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e28218	10.1371/journal.pone.0028218	http://dx.doi.org/10.1371/journal.pone.0028218			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140551	Green Published, Green Submitted, gold			2022-12-27	WOS:000298168100052
J	Jalaguier, P; Turcotte, K; Danylo, A; Cantin, R; Tremblay, MJ				Jalaguier, Pascal; Turcotte, Karine; Danylo, Alexis; Cantin, Rejean; Tremblay, Michel J.			Efficient Production of HIV-1 Virus-Like Particles from a Mammalian Expression Vector Requires the N-Terminal Capsid Domain	PLOS ONE			English	Article							TYPE-1 GAG PRECURSOR; BACULOVIRUS-INFECTED CELLS; LATE ASSEMBLY DOMAIN; MEMBRANE-BINDING; PLASMA-MEMBRANE; MATRIX PROTEIN; NUCLEOCAPSID PROTEIN; VIRAL INFECTIVITY; RELEASE; REGION	It is now well accepted that the structural protein Pr55(Gag) is sufficient by itself to produce HIV-1 virus-like particles (VLPs). This polyprotein precursor contains different domains including matrix, capsid, SP1, nucleocapsid, SP2 and p6. In the present study, we wanted to determine by mutagenesis which region(s) is essential to the production of VLPs when Pr55(Gag) is inserted in a mammalian expression vector, which allows studying the protein of interest in the absence of other viral proteins. To do so, we first studied a minimal Pr55(Gag) sequence called Gag min that was used previously. We found that Gag min fails to produce VLPs when expressed in an expression vector instead of within a molecular clone. This failure occurs early in the cell at the assembly of viral proteins. We then generated a series of deletion and substitution mutants, and examined their ability to produce VLPs by combining biochemical and microscopic approaches. We demonstrate that the matrix region is not necessary, but that the efficiency of VLP production depends strongly on the presence of its basic region. Moreover, the presence of the N-terminal domain of capsid is required for VLP production when Gag is expressed alone. These findings, combined with previous observations indicating that HIV-1 Pr55(Gag)-derived VLPs act as potent stimulators of innate and acquired immunity, make the use of this strategy worth considering for vaccine development.	[Jalaguier, Pascal; Turcotte, Karine; Danylo, Alexis; Cantin, Rejean; Tremblay, Michel J.] Univ Quebec CHUL, Ctr Rech Infectiol, Ctr Hosp, Quebec City, PQ, Canada; [Tremblay, Michel J.] Univ Laval, Fac Med, Dept Microbiol Infectiol & Immunol, Quebec City, PQ G1K 7P4, Canada	Laval University; University of Quebec; Laval University	Jalaguier, P (corresponding author), Univ Quebec CHUL, Ctr Rech Infectiol, Ctr Hosp, Quebec City, PQ, Canada.	michel.j.tremblay@crchul.ulaval.ca			Canadian Institutes of Health Research (CIHR) [MOP-14438]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by an operating grant to M.J.T. from the Canadian Institutes of Health Research (CIHR) (MOP-14438). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdurahman S, 2004, J GEN VIROL, V85, P2903, DOI 10.1099/vir.0.80137-0; Accola MA, 2000, J VIROL, V74, P5395, DOI 10.1128/JVI.74.12.5395-5402.2000; Adamson CS, 2007, ADV PHARMACOL, V55, P347, DOI 10.1016/S1054-3589(07)55010-6; Adamson CS, 2004, REV MED VIROL, V14, P107, DOI 10.1002/rmv.418; Ako-Adjei D, 2005, J VIROL, V79, P13463, DOI 10.1128/JVI.79.21.13463-13472.2005; Berthet-Colominas C, 1999, EMBO J, V18, P1124, DOI 10.1093/emboj/18.5.1124; Bieniasz PD, 2009, CELL HOST MICROBE, V5, P550, DOI 10.1016/j.chom.2009.05.015; Borsetti A, 1998, J VIROL, V72, P9313, DOI 10.1128/JVI.72.11.9313-9317.1998; Briggs JAG, 2004, NAT STRUCT MOL BIOL, V11, P672, DOI 10.1038/nsmb785; BRYANT M, 1990, P NATL ACAD SCI USA, V87, P523, DOI 10.1073/pnas.87.2.523; Cantin R, 1997, J VIROL, V71, P1922, DOI 10.1128/JVI.71.3.1922-1930.1997; CHAZAL N, 1994, J VIROL, V68, P111, DOI 10.1128/JVI.68.1.111-122.1994; Chukkapalli V, 2008, J VIROL, V82, P2405, DOI 10.1128/JVI.01614-07; Cimarelli A, 2002, CELL MOL LIFE SCI, V59, P1166, DOI 10.1007/s00018-002-8495-6; Crist RM, 2009, J VIROL, V83, P2216, DOI 10.1128/JVI.02031-08; Darlix JL, 2011, J MOL BIOL, V410, P565, DOI 10.1016/j.jmb.2011.03.037; Demirov DG, 2004, VIRUS RES, V106, P87, DOI 10.1016/j.virusres.2004.08.007; Deml L, 2005, MOL IMMUNOL, V42, P259, DOI 10.1016/j.molimm.2004.06.028; Doan LX, 2005, REV MED VIROL, V15, P75, DOI 10.1002/rmv.449; DORFMAN T, 1994, J VIROL, V68, P1689, DOI 10.1128/JVI.68.3.1689-1696.1994; Feng YX, 1996, P NATL ACAD SCI USA, V93, P7577, DOI 10.1073/pnas.93.15.7577; Fortin JF, 1997, J VIROL, V71, P3588, DOI 10.1128/JVI.71.5.3588-3596.1997; FREED EO, 1994, J VIROL, V68, P5311, DOI 10.1128/JVI.68.8.5311-5320.1994; Furumoto Hiroyuki, 2002, Journal of Medical Investigation, V49, P124; Ganser-Pornillos BK, 2008, CURR OPIN STRUC BIOL, V18, P203, DOI 10.1016/j.sbi.2008.02.001; Ganser-Pornillos BK, 2007, CELL, V131, P70, DOI 10.1016/j.cell.2007.08.018; Garland SM, 2010, DRUGS, V70, P1079, DOI 10.2165/10898580-000000000-00000; GHEYSEN D, 1989, CELL, V59, P103, DOI 10.1016/0092-8674(89)90873-8; GOTTLINGER HG, 1989, P NATL ACAD SCI USA, V86, P5781, DOI 10.1073/pnas.86.15.5781; GOTTLINGER HG, 1991, P NATL ACAD SCI USA, V88, P3195, DOI 10.1073/pnas.88.8.3195; HANSEN M, 1990, J VIROL, V64, P5306, DOI 10.1128/JVI.64.11.5306-5316.1990; HONG SS, 1993, J VIROL, V67, P2787, DOI 10.1128/JVI.67.5.2787-2798.1993; JONES TA, 1990, J VIROL, V64, P2265, DOI 10.1128/JVI.64.5.2265-2279.1990; Joshi A, 2006, J VIROL, V80, P7939, DOI 10.1128/JVI.00355-06; Khorchid A, 2002, J VIROL, V76, P4131, DOI 10.1128/JVI.76.8.4131-4137.2002; Kiernan RE, 1998, J VIROL, V72, P4116, DOI 10.1128/JVI.72.5.4116-4126.1998; Kwak K, 2011, CURR OPIN IMMUNOL, V23, P244, DOI 10.1016/j.coi.2010.11.009; Liang C, 2003, J VIROL, V77, P1772, DOI 10.1128/JVI.77.3.1772-1783.2003; Liang C, 2002, J VIROL, V76, P11729, DOI 10.1128/JVI.76.22.11729-11737.2002; LODGE R, 1994, J VIROL, V68, P4857, DOI 10.1128/JVI.68.8.4857-4861.1994; Muriaux D, 1996, J BIOL CHEM, V271, P33686, DOI 10.1074/jbc.271.52.33686; Ono A, 2005, J VIROL, V79, P14131, DOI 10.1128/JVI.79.22.14131-14140.2005; Ono A, 2004, P NATL ACAD SCI USA, V101, P14889, DOI 10.1073/pnas.0405596101; Ono A, 2004, J VIROL, V78, P1552, DOI 10.1128/JVI.78.3.1552-1563.2004; Ono A, 2000, J VIROL, V74, P2855, DOI 10.1128/JVI.74.6.2855-2866.2000; Ono A, 2010, VACCINE, V28, pB55, DOI 10.1016/j.vaccine.2009.10.021; Ono Akira, 2007, Virus (Nagoya), V57, P9; Ott DE, 2005, J VIROL, V79, P9038, DOI 10.1128/JVI.79.14.9038-9045.2005; Paliard X, 2000, AIDS RES HUM RETROV, V16, P273, DOI 10.1089/088922200309368; Petry H, 2003, CURR OPIN MOL THER, V5, P524; Reil H, 1998, EMBO J, V17, P2699, DOI 10.1093/emboj/17.9.2699; Roy BB, 2006, J BIOL CHEM, V281, P12625, DOI 10.1074/jbc.M510596200; Sandefur S, 1998, J VIROL, V72, P2723, DOI 10.1128/JVI.72.4.2723-2732.1998; Strack B, 2003, CELL, V114, P689, DOI 10.1016/S0092-8674(03)00653-6; Strack B, 2002, J VIROL, V76, P5472, DOI 10.1128/JVI.76.11.5472-5479.2002; TRONO D, 1989, CELL, V59, P113, DOI 10.1016/0092-8674(89)90874-X; VerPlank L, 2001, P NATL ACAD SCI USA, V98, P7724, DOI 10.1073/pnas.131059198; von Schwedler UK, 2003, J VIROL, V77, P5439, DOI 10.1128/JVI.77.9.5439-5450.2003; WADA KN, 1990, NUCLEIC ACIDS RES, V18, P2367, DOI 10.1093/nar/18.suppl.2367; Wang CT, 1998, J VIROL, V72, P7950, DOI 10.1128/JVI.72.10.7950-7959.1998; WILLS JW, 1991, AIDS, V5, P639, DOI 10.1097/00002030-199106000-00002; Worthylake DK, 1999, ACTA CRYSTALLOGR D, V55, P85, DOI 10.1107/S0907444998007689; Wright ER, 2007, EMBO J, V26, P2218, DOI 10.1038/sj.emboj.7601664; Young KR, 2006, METHODS, V40, P98, DOI 10.1016/j.ymeth.2006.05.024; YUAN X, 1993, J VIROL, V67, P6387, DOI 10.1128/JVI.67.11.6387-6394.1993; Zhang YQ, 1998, J VIROL, V72, P1782, DOI 10.1128/JVI.72.3.1782-1789.1998; ZHOU WJ, 1994, J VIROL, V68, P2556, DOI 10.1128/JVI.68.4.2556-2569.1994	67	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e28314	10.1371/journal.pone.0028314	http://dx.doi.org/10.1371/journal.pone.0028314			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140574	gold, Green Published			2022-12-27	WOS:000298168100063
J	Zhu, JL; Jiang, ZM; Gao, F; Hu, XD; Zhou, L; Chen, JH; Luo, HJ; Sun, JH; Wu, S; Han, YH; Yin, GL; Chen, MS; Han, ZJ; Li, XX; Huang, Y; Zhang, WX; Zhou, FJ; Chen, T; Fa, PP; Wang, Y; Sun, L; Leng, HM; Sun, FH; Liu, YC; Ye, MZ; Yang, HM; Cai, ZM; Gui, YT; Zhang, XQ				Zhu, Jialou; Jiang, Zhimao; Gao, Fei; Hu, Xueda; Zhou, Liang; Chen, Jiahao; Luo, Huijuan; Sun, Jihua; Wu, Song; Han, Yonghua; Yin, Guangliang; Chen, Maoshan; Han, Zujing; Li, Xianxin; Huang, Yi; Zhang, Weixing; Zhou, Fangjian; Chen, Tong; Fa, Pingping; Wang, Yong; Sun, Liang; Leng, Huimin; Sun, Fenghao; Liu, Yuchen; Ye, Mingzhi; Yang, Huanming; Cai, Zhiming; Gui, Yaoting; Zhang, Xiuqing			A Systematic Analysis on DNA Methylation and the Expression of Both mRNA and microRNA in Bladder Cancer	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENE; CERVICAL INTRAEPITHELIAL NEOPLASIA; PROMOTER HYPERMETHYLATION; SLIT2 GENE; GROWTH; GUIDANCE; TARGETS; LUNG; OVEREXPRESSION; INACTIVATION	Background: DNA methylation aberration and microRNA (miRNA) deregulation have been observed in many types of cancers. A systematic study of methylome and transcriptome in bladder urothelial carcinoma has never been reported. Methodology/Principal Findings: The DNA methylation was profiled by modified methylation-specific digital karyotyping (MMSDK) and the expression of mRNAs and miRNAs was analyzed by digital gene expression (DGE) sequencing in tumors and matched normal adjacent tissues obtained from 9 bladder urothelial carcinoma patients. We found that a set of significantly enriched pathways disrupted in bladder urothelial carcinoma primarily related to "neurogenesis" and "cell differentiation" by integrated analysis of -omics data. Furthermore, we identified an intriguing collection of cancer-related genes that were deregulated at the levels of DNA methylation and mRNA expression, and we validated several of these genes (HIC1, SLIT2, RASAL1, and KRT17) by Bisulfite Sequencing PCR and Reverse Transcription qPCR in a panel of 33 bladder cancer samples. Conclusions/Significance: We characterized the profiles between methylome and transcriptome in bladder urothelial carcinoma, identified a set of significantly enriched key pathways, and screened four aberrantly methylated and expressed genes. Conclusively, our findings shed light on a new avenue for basic bladder cancer research.	[Zhu, Jialou; Gao, Fei; Hu, Xueda; Chen, Jiahao; Luo, Huijuan; Sun, Jihua; Yin, Guangliang; Chen, Maoshan; Han, Zujing; Ye, Mingzhi; Yang, Huanming; Zhang, Xiuqing] Beijing Genom Inst Shenzhen, Shenzhen, Peoples R China; [Zhu, Jialou] Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China; [Jiang, Zhimao; Zhou, Liang; Wu, Song; Han, Yonghua; Li, Xianxin; Huang, Yi; Fa, Pingping; Wang, Yong; Sun, Liang; Leng, Huimin; Sun, Fenghao; Liu, Yuchen; Cai, Zhiming; Gui, Yaoting] Peking Univ, Shenzhen Hosp, Guangdong & Shenzhen Key Lab Male Reprod Med & Ge, Inst Urol,Shenzhen PKU HKUST Med Ctr, Shenzhen, Peoples R China; [Hu, Xueda] Chinese Acad Sci, Beijing Inst Genom, Beijing, Peoples R China; [Hu, Xueda] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Cai, Zhiming] Second Peoples Hosp Shenzhen, Dept Urol, Shenzhen, Peoples R China; [Zhang, Weixing] Zhengzhou Univ, Affiliated Hosp 1, Dept Urol, Zhengzhou, Peoples R China; [Zhou, Fangjian] Sun Yat Sen Univ, Ctr Canc, Dept Urol, Guangzhou 510275, Guangdong, Peoples R China; [Chen, Tong; Liu, Yuchen] Shenzhen Peoples Hosp, Dept Urol, Shenzhen, Peoples R China; [Sun, Fenghao] Shantou Univ, Coll Med, Shantou, Peoples R China	Beijing Genomics Institute (BGI); Wuhan University; Hong Kong University of Science & Technology; Peking University; Shenzhen PKU-HKUST Medical Center; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Second People's Hospital of Shenzhen; Zhengzhou University; Sun Yat Sen University; Jinan University; Shantou University	Zhu, JL (corresponding author), Beijing Genom Inst Shenzhen, Shenzhen, Peoples R China.	guiyaoting2007@yahoo.com.cn; zhangxq@genomics.org.cn	liu, yuchen/GYQ-6286-2022; gui, yaoting/GLT-3684-2022; Zhu, Jialou/Q-5218-2016	Zhu, Jialou/0000-0003-0630-4964; CHEN, MAOSHAN/0000-0002-3827-4969; Chen, Jiahao/0000-0001-7719-3216	National High Technology Research and Development Program of China (863 Program) [2009AA022707]; Promotion Program for Shenzhen Key Laboratory, Shenzhen, China [CXB200903090055A, CXB201005250016A]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Promotion Program for Shenzhen Key Laboratory, Shenzhen, China	This work was supported by grants from the National High Technology Research and Development Program of China (863 Program, 2009AA022707 to XZ), the Promotion Program for Shenzhen Key Laboratory, Shenzhen, China (CXB200903090055A and CXB201005250016A to ZC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Ayala de la Pena F, 2011, J BIOL CHEM; Ayala GE, 2008, CLIN CANCER RES, V14, P7593, DOI 10.1158/1078-0432.CCR-08-1164; Baylin SB, 2006, NAT REV CANCER, V6, P107, DOI 10.1038/nrc1799; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; BOS JL, 1989, CANCER RES, V49, P4682; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Carrilho C, 2004, HUM PATHOL, V35, P546, DOI 10.1016/j.humpath.2004.01.021; Catto JWF, 2005, J CLIN ONCOL, V23, P2903, DOI 10.1200/JCO.2005.03.163; Chen WY, 2005, CELL, V123, P437, DOI 10.1016/j.cell.2005.08.011; Chen WY, 2004, CANCER CELL, V6, P387, DOI 10.1016/j.ccr.2004.08.030; Clark SJ, 2002, ONCOGENE, V21, P5380, DOI 10.1038/sj.onc.1205598; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Cullum R, 2011, RESPIROLOGY, V16, P210, DOI 10.1111/j.1440-1843.2010.01899.x; Dallol A, 2003, ONCOGENE, V22, P4611, DOI 10.1038/sj.onc.1206687; Dallol A, 2003, CANCER RES, V63, P1054; Dallol A, 2002, CANCER RES, V62, P5874; DePianto D, 2010, NAT GENET, V42, P910, DOI 10.1038/ng.665; Dyrskjot L, 2009, CANCER RES, V69, P4851, DOI 10.1158/0008-5472.CAN-08-4043; Eden A, 2003, SCIENCE, V300, P455, DOI 10.1126/science.1083557; Fleuriel C, 2009, INT J BIOCHEM CELL B, V41, P26, DOI 10.1016/j.biocel.2008.05.028; Frateschi S, 2010, OPEN DERMATOLOGY J, P27, DOI DOI 10.2174/1874372201004010027; Friedman JM, 2009, CANCER RES, V69, P2623, DOI 10.1158/0008-5472.CAN-08-3114; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Fujii H, 1998, ONCOGENE, V16, P2159, DOI 10.1038/sj.onc.1201976; Gottardo F, 2007, UROL ONCOL-SEMIN ORI, V25, P387, DOI 10.1016/j.urolonc.2007.01.019; Han YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018286; Hegedus Z, 2009, MOL IMMUNOL, V46, P2918, DOI 10.1016/j.molimm.2009.07.002; Ichimi T, 2009, INT J CANCER, V125, P345, DOI 10.1002/ijc.24390; Jarmalaite S, 2008, ONCOLOGY-BASEL, V75, P145, DOI 10.1159/000158665; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jin HC, 2007, P NATL ACAD SCI USA, V104, P12353, DOI 10.1073/pnas.0700153104; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kekeeva TV, 2007, MOL BIOL+, V41, P70, DOI 10.1134/S0026893307010104; Kim HK, 2008, NEOPLASIA, V10, P1411, DOI 10.1593/neo.08804; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lazaris AC, 2006, ANTICANCER RES, V26, P1535; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li J, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-223; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li XX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022570; Luo AP, 2004, ONCOGENE, V23, P1291, DOI 10.1038/sj.onc.1207218; Maddox P, 1999, J CLIN PATHOL, V52, P41, DOI 10.1136/jcp.52.1.41; Maragkakis M, 2009, NUCLEIC ACIDS RES, V37, pW273, DOI 10.1093/nar/gkp292; Marsit CJ, 2007, CARCINOGENESIS, V28, P1745, DOI 10.1093/carcin/bgm116; Marsit CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012334; Melki JR, 1999, LEUKEMIA, V13, P877, DOI 10.1038/sj.leu.2401401; Morrissy AS, 2009, GENOME RES, V19, P1825, DOI 10.1101/gr.094482.109; Narayan G, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-16; Nasarre P, 2010, CELL ADHES MIGR, V4, P130, DOI 10.4161/cam.4.1.10882; Nasser MW, 2008, J BIOL CHEM, V283, P33394, DOI 10.1074/jbc.M804788200; Natali PG, 1996, INT J CANCER, V69, P212, DOI 10.1002/(SICI)1097-0215(19960621)69:3<212::AID-IJC11>3.0.CO;2-9; Ohta M, 2009, GASTROENTEROLOGY, V136, P206, DOI 10.1053/j.gastro.2008.09.063; Oosterlinck W, 2002, EUR UROL, V41, P105, DOI 10.1016/S0302-2838(01)00026-4; Papadopoulos GL, 2009, NUCLEIC ACIDS RES, V37, pD155, DOI 10.1093/nar/gkn809; Prasad A, 2004, J BIOL CHEM, V279, P9115, DOI 10.1074/jbc.M308083200; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Regauer S, 2007, HISTOPATHOLOGY, V50, P629, DOI 10.1111/j.1365-2559.2007.02652.x; Reinert T, 2011, CLIN CANC RES; Seto M, 2011, INT J CANCER, V128, P1293, DOI 10.1002/ijc.25459; Shen LL, 2007, P NATL ACAD SCI USA, V104, P18654, DOI 10.1073/pnas.0704652104; Sugimura T, 2000, MUTAT RES-REV MUTAT, V462, P235, DOI 10.1016/S1383-5742(00)00005-3; Taby R, 2010, CA-CANCER J CLIN, V60, P376, DOI 10.3322/caac.20085; Toyoshima T, 2008, J CANCER RES CLIN, V134, P515, DOI 10.1007/s00432-007-0308-8; Uchida Y, 2011, UROL ONCOL; WALES MM, 1995, NAT MED, V1, P570, DOI 10.1038/nm0695-570; Wallenius V, 2000, AM J PATHOL, V156, P821, DOI 10.1016/S0002-9440(10)64950-4; Wang G, 2010, INT UROL NEPHROL, V42, P95, DOI 10.1007/s11255-009-9584-3; Wolff EM, 2010, CANCER RES, V70, P8169, DOI 10.1158/0008-5472.CAN-10-1335; Wolff EM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000917; Wu W, 1999, NATURE, V400, P331, DOI 10.1038/22477; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Xu Y, 2009, BMB REP, V42, P344, DOI 10.5483/BMBRep.2009.42.6.344; Yamamura H, 2008, BIOCHEM BIOPH RES CO, V366, P489, DOI 10.1016/j.bbrc.2007.11.177; Yan D, 2009, J BIOL CHEM, V284, P29596, DOI 10.1074/jbc.M109.020511; Yates DR, 2007, CLIN CANCER RES, V13, P2046, DOI 10.1158/1078-0432.CCR-06-2476; Ye H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-69; Yoshino H, 2011, BRIT J CANCER, V104, P808, DOI 10.1038/bjc.2011.23	82	31	32	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e28223	10.1371/journal.pone.0028223	http://dx.doi.org/10.1371/journal.pone.0028223			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140553	Green Submitted, Green Published, gold			2022-12-27	WOS:000298168100053
J	Jost, KL; Rottach, A; Milden, M; Bertulat, B; Becker, A; Wolf, P; Sandoval, J; Petazzi, P; Huertas, D; Esteller, M; Kremmer, E; Leonhardt, H; Cardoso, MC				Jost, K. Laurence; Rottach, Andrea; Milden, Manuela; Bertulat, Bianca; Becker, Annette; Wolf, Patricia; Sandoval, Juan; Petazzi, Paolo; Huertas, Dori; Esteller, Manel; Kremmer, Elisabeth; Leonhardt, Heinrich; Cardoso, M. Cristina			Generation and Characterization of Rat and Mouse Monoclonal Antibodies Specific for MeCP2 and Their Use in X-Inactivation Studies	PLOS ONE			English	Article							CPG-BINDING PROTEIN-2; RETT-SYNDROME; METHYLATED DNA; TERMINAL DIFFERENTIATION; HISTONE DEACETYLASE; MUTATIONS; CHROMATIN; CELLS; PURIFICATION; PHENOTYPE	Methyl CpG binding protein 2 (MeCP2) binds DNA, and has a preference for methylated CpGs and, hence, in cells, it accumulates in heterochromatin. Even though it is expressed ubiquitously MeCP2 is particularly important during neuronal maturation. This is underscored by the fact that in Rett syndrome, a neurological disease, 80% of patients carry a mutation in the MECP2 gene. Since the MECP2 gene lies on the X chromosome and is subjected to X chromosome inactivation, affected patients are usually chimeric for wild type and mutant MeCP2. Here, we present the generation and characterization of the first rat monoclonal MeCP2 specific antibodies as well as mouse monoclonal antibodies and a rabbit polyclonal antibody. We demonstrate that our antibodies are suitable for immunoblotting, (chromatin) immunoprecipitation and immunofluorescence of endogenous and ectopically expressed MeCP2. Epitope mapping revealed that most of the MeCP2 monoclonal antibodies recognize the C-terminal domain and one the N-terminal domain of MeCP2. Using slot blot analysis, we determined a high sensitivity of all antibodies, detecting amounts as low as 1 ng of MeCP2 protein. Moreover, the antibodies recognize MeCP2 from different species, including human, mouse, rat and pig. Lastly, we have validated their use by analyzing and quantifying X chromosome inactivation skewing using brain tissue of MeCP2 heterozygous null female mice. The new MeCP2 specific monoclonal antibodies described here perform well in a large variety of immunological applications making them a very valuable set of tools for studies of MeCP2 pathophysiology in situ and in vitro.	[Jost, K. Laurence; Milden, Manuela; Bertulat, Bianca; Becker, Annette; Cardoso, M. Cristina] Tech Univ Darmstadt, Dept Biol, Darmstadt, Germany; [Rottach, Andrea; Wolf, Patricia; Leonhardt, Heinrich] Univ Munich, Dept Biol 2, Planegg Martinsried, Germany; [Sandoval, Juan; Petazzi, Paolo; Huertas, Dori; Esteller, Manel] Bellvitge Biomed Res Inst IDIBELL, Canc Epigenet & Biol Program, Barcelona, Spain; [Kremmer, Elisabeth] German Res Ctr Environm Hlth, Helmholtz Ctr Munich, Inst Mol Immunol, Munich, Germany	Technical University of Darmstadt; University of Munich; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Jost, KL (corresponding author), Tech Univ Darmstadt, Dept Biol, Darmstadt, Germany.	Cardoso@bio.tu-darmstadt.de	Cardoso, M. Cristina/F-5215-2011; Bertulat, Bianca/F-5330-2012; Esteller, Manel/L-5956-2014; Petazzi, Paolo/H-7707-2013; sandoval, juan/M-4593-2015; Becker, Annette/F-5331-2012; Leonhardt, Heinrich/B-2791-2014	Esteller, Manel/0000-0003-4490-6093; sandoval, juan/0000-0002-5100-973X; Petazzi, Paolo/0000-0002-1036-2895	Deutsche Forschungsgemeinschaft; E-Rare EuroRETT network; European Commission [PITN-GA-2009-238242]; Juan de la Cierva [JCI-2009-04490]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); E-Rare EuroRETT network; European Commission(European CommissionEuropean Commission Joint Research Centre); Juan de la Cierva(Instituto de Salud Carlos III)	This work was funded in part by grants of the Deutsche Forschungsgemeinschaft to H.L. and M.C.C. and the E-Rare EuroRETT network to M.C.C. P.P. has a fellowship from the FP7 DisChrom Project (PITN-GA-2009-238242), which is funded by the European Commission, and J.S. is a Juan de la Cierva researcher (JCI-2009-04490). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal N, 2007, NUCLEIC ACIDS RES, V35, P5402, DOI 10.1093/nar/gkm599; Amir RE, 2000, AM J MED GENET, V97, P147, DOI 10.1002/1096-8628(200022)97:2<147::AID-AJMG6>3.0.CO;2-O; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Brero A, 2005, J CELL BIOL, V169, P733, DOI 10.1083/jcb.200502062; CARDOSO MC, 1993, CELL, V74, P979, DOI 10.1016/0092-8674(93)90721-2; Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001; Georgel PT, 2003, J BIOL CHEM, V278, P32181, DOI 10.1074/jbc.M305308200; Gibson JH, 2005, BRAIN DEV-JPN, V27, P266, DOI 10.1016/j.braindev.2004.07.002; Gloeckner CJ, 2007, PROTEOMICS, V7, P4228, DOI 10.1002/pmic.200700038; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; HAGBERG B, 1983, ANN NEUROL, V14, P471, DOI 10.1002/ana.410140412; HAGBERG B, 1985, ACTA PAEDIATR SCAND, V74, P405, DOI 10.1111/j.1651-2227.1985.tb10993.x; JONES KW, 1970, NATURE, V225, P912, DOI 10.1038/225912a0; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Kudo S, 2003, J MED GENET, V40, P487, DOI 10.1136/jmg.40.7.487; LEWIS JD, 1992, CELL, V69, P905, DOI 10.1016/0092-8674(92)90610-O; MEEHAN RR, 1992, NUCLEIC ACIDS RES, V20, P5085, DOI 10.1093/nar/20.19.5085; Nan XS, 1997, CELL, V88, P471, DOI 10.1016/S0092-8674(00)81887-5; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Prusov AN, 2002, BIOCHEMISTRY-MOSCOW+, V67, P423, DOI 10.1023/A:1015229922183; Rett A, 1966, Wien Med Wochenschr, V116, P723; Rottach A, 2008, HYBRIDOMA, V27, P91, DOI 10.1089/hyb.2007.0555; Rottach A, 2008, HYBRIDOMA, V27, P337, DOI 10.1089/hyb.2008.0031; Roux JC, 2008, NEUROSCI LETT, V447, P82, DOI 10.1016/j.neulet.2008.09.045; Shahbazian MD, 2002, HUM MOL GENET, V11, P115, DOI 10.1093/hmg/11.2.115; Solovei I, 2009, CELL, V137, P356, DOI 10.1016/j.cell.2009.01.052; Suetake I, 2011, BIOCHEM J, V437, P141, DOI 10.1042/BJ20110241; Vasiliou SA, 2012, ADDICT BIOL, V17, P156, DOI 10.1111/j.1369-1600.2010.00288.x; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Young JI, 2004, AM J HUM GENET, V74, P511, DOI 10.1086/382228; Yusufzai TM, 2000, NUCLEIC ACIDS RES, V28, P4172, DOI 10.1093/nar/28.21.4172	31	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2011	6	11							e26499	10.1371/journal.pone.0026499	http://dx.doi.org/10.1371/journal.pone.0026499			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KW	22140431	Green Submitted, Green Published, gold			2022-12-27	WOS:000298163400002
J	Nunes, MC; von Gottberg, A; de Gouveia, L; Cohen, C; Kuwanda, L; Karstaedt, AS; Klugman, KP; Madhi, SA				Nunes, Marta C.; von Gottberg, Anne; de Gouveia, Linda; Cohen, Cheryl; Kuwanda, Locadiah; Karstaedt, Alan S.; Klugman, Keith P.; Madhi, Shabir A.			Persistent High Burden of Invasive Pneumococcal Disease in South African HIV-Infected Adults in the Era of an Antiretroviral Treatment Program	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; STREPTOCOCCUS-PNEUMONIAE; TRIMETHOPRIM-SULFAMETHOXAZOLE; POLYSACCHARIDE VACCINE; HAEMOPHILUS-INFLUENZAE; CONTROLLED-TRIAL; UGANDAN ADULTS; UNITED-STATES; COTE-DIVOIRE; THERAPY	Background: Highly active antiretroviral treatment (HAART) programs have been associated with declines in the burden of invasive pneumococcal disease (IPD) in industrialized countries. The aim of this study was to evaluate trends in IPD hospitalizations in HIV-infected adults in Soweto, South Africa, associated with up-scaling of the HAART program from 2003 to 2008. Methods: Laboratory-confirmed IPD cases were identified from 2003 through 2008 through an existing surveillance program. The period 2003-04 was designated as the early-HAART era, 2005-06 as the intermediate-HAART era and 2007-08 as the established-HAART era. The incidence of IPD was compared between the early-HAART and established-HAART eras in HIV-infected and-uninfected individuals. Results: A total of 2,567 IPD cases among individuals older than 18 years were reported from 2003 through 2008. Overall incidence of IPD (per 100,000) did not change during the study period in HIV-infected adults (207.4 cases in the early-HAART and 214.0 cases in the established-HAART era; p = 0.55). IPD incidence, actually increased 1.16-fold (95% CI: 1.01; 1.62) in HIV-infected females between the early-and established-HAART eras (212.1 cases and 246.2 cases, respectively; p = 0.03). The incidence of IPD remained unchanged in HIV-uninfected adults across the three time periods. Conclusion: Despite a stable prevalence of HIV and the increased roll-out of HAART for treatment of AIDS patients in our setting, the burden of IPD has not decreased among HIV-infected adults. The study indicates a need for ongoing monitoring of disease and HAART program effectiveness to reduce opportunistic infections in African adults with HIV/AIDS, as well as the need to consider alternate strategies including pneumococcal conjugate vaccine immunization for the prevention of IPD in HIV-infected adults.	[Nunes, Marta C.; Kuwanda, Locadiah; Madhi, Shabir A.] Univ Witwatersrand, Dept Sci & Technol, Natl Res Fdn Vaccine Preventable Dis, Fac Hlth Sci, Johannesburg, South Africa; [von Gottberg, Anne; de Gouveia, Linda; Klugman, Keith P.; Madhi, Shabir A.] Natl Inst Communicable Dis, Resp & Meningeal Pathogens Reference Unit, Johannesburg, South Africa; [Cohen, Cheryl] Natl Inst Communicable Dis, Epidemiol & Surveillance Unit, Johannesburg, South Africa; [Karstaedt, Alan S.] Univ Witwatersrand, Dept Med, ZA-2001 Johannesburg, South Africa; [Karstaedt, Alan S.] Chris Hani Baragwanath Acad Hosp, Johannesburg, South Africa; [Nunes, Marta C.; Kuwanda, Locadiah; Madhi, Shabir A.] Univ Witwatersrand, Med Res Council Resp & Meningeal Pathogens Res Un, Fac Hlth Sci, Johannesburg, South Africa; [Klugman, Keith P.] Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA; [Klugman, Keith P.] Emory Univ, Sch Med, Div Infect Dis, Atlanta, GA USA	National Research Foundation - South Africa; University of Witwatersrand; National Institute for Communicable Diseases (NICD); National Institute for Communicable Diseases (NICD); University of Witwatersrand; University of Witwatersrand; Emory University; Rollins School Public Health; Emory University	Nunes, MC (corresponding author), Univ Witwatersrand, Dept Sci & Technol, Natl Res Fdn Vaccine Preventable Dis, Fac Hlth Sci, Johannesburg, South Africa.	shabirm@nicd.ac.za		de Gouveia, Linda/0000-0002-1418-8468; von Gottberg, Anne/0000-0002-0243-7455; Nunes, Marta/0000-0003-3788-878X; Cohen, Cheryl/0000-0003-0376-2302	University of the Witwatersrand; United States Agency for International Development's Antimicrobial Resistance Initiative from the Centers for Disease Control and Prevention (CDC), Atlanta, Georgia [U60/CCU022088]; CDC; National Center for HIV/AIDS; Viral Hepatitis, STD, and TB Prevention (NCHHSTP) [U62/PSO022901]; Pfizer; GSK	University of the Witwatersrand; United States Agency for International Development's Antimicrobial Resistance Initiative from the Centers for Disease Control and Prevention (CDC), Atlanta, Georgia(United States Agency for International Development (USAID)); CDC(Centre National de la Recherche Scientifique (CNRS)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Center for HIV/AIDS; Viral Hepatitis, STD, and TB Prevention (NCHHSTP); Pfizer(Pfizer); GSK(GlaxoSmithKline)	MCN had financial support from the University of the Witwatersrand. This study was funded in part in 2003-2006 by the United States Agency for International Development's Antimicrobial Resistance Initiative, transferred via a cooperative agreement (number U60/CCU022088) from the Centers for Disease Control and Prevention (CDC), Atlanta, Georgia. In 2005-2007, the study was also supported by the CDC, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), Global AIDS Program (GAP) Cooperative Agreement U62/PSO022901. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: Receipt of research funding (SAM, AvG, KPK) and consultancy from Pfizer (SAM, KPK). Receipt of research funding (SAM, AvG, KPK), consultancies and honoraria from GSK (SAM, KPK). Consultancy for Merck (KPK). This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Adam MA, 2009, SAMJ S AFR MED J, V99, P661; Anglaret X, 1999, LANCET, V353, P1463, DOI 10.1016/S0140-6736(98)07399-1; ASSA2003, FULL PROV AIDS DEM M; Barry PM, 2006, AIDS, V20, P437, DOI 10.1097/01.aids.0000206507.54901.84; Bliss SJ, 2008, LANCET INFECT DIS, V8, P67, DOI 10.1016/S1473-3099(07)70242-6; *CDCP, 2005, MMWR-MORBID MORTAL W, V54, P893; Cohen AL, 2010, AIDS, V24, P2253, DOI 10.1097/QAD.0b013e32833d46fd; Everett DB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017765; FARRINGTON CP, 1993, INT J EPIDEMIOL, V22, P742, DOI 10.1093/ije/22.4.742; Feldman C, 1999, CHEST, V116, P107, DOI 10.1378/chest.116.1.107; French N, 2000, LANCET, V355, P2106, DOI 10.1016/S0140-6736(00)02377-1; French N, 2016, MALAWI MED J, V28, P115, DOI 10.1056/NEJMoa0903029; Gill CJ, 2008, B WORLD HEALTH ORGAN, V86, P929, DOI 10.2471/BLT.07.049668; Grau I, 2005, ARCH INTERN MED, V165, P1533, DOI 10.1001/archinte.165.13.1533; Heffernan RT, 2005, J INFECT DIS, V191, P2038, DOI 10.1086/430356; Huebner RE, 1999, S AFR MED J, V89, P924; Jones N, 1998, AIDS, V12, P2177, DOI 10.1097/00002030-199816000-00013; Jordano Q, 2004, CLIN INFECT DIS, V38, P1623, DOI 10.1086/420933; Karstaedt AS, 2001, CLIN INFECT DIS, V33, P610, DOI 10.1086/322589; Kourtis AP, 2010, JAIDS-J ACQ IMM DEF, V55, P128, DOI 10.1097/QAI.0b013e3181e8ed15; Mayanja BN, 2010, TROP MED INT HEALTH, V15, P697, DOI 10.1111/j.1365-3156.2010.02528.x; McEllistrem MC, 2002, J INFECT DIS, V185, P1364, DOI 10.1086/339882; Morrison KE, 2000, J CLIN MICROBIOL, V38, P434; National Department of Health, 2003, OP PLAN COMPR HIV AI; Nunes MC, 2011, AIDS, V25, P453, DOI 10.1097/QAD.0b013e328341b7f1; Nuorti JP, 2000, ANN INTERN MED, V132, P182, DOI 10.7326/0003-4819-132-3-200002010-00003; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Pemba L, 2008, J INFECTION, V56, P171, DOI 10.1016/j.jinf.2007.12.003; RADSTROM P, 1994, J CLIN MICROBIOL, V32, P2738; REDD SC, 1990, J INFECT DIS, V162, P1012, DOI 10.1093/infdis/162.5.1012; SHISANA O, 2005, S AFRICAN NATL HIV P; SHISANA O, 2010, S AFRICAN NATL HIV P; STATSSA, MID POP EST 2003 200; Teshale EH, 2008, VACCINE, V26, P5830, DOI 10.1016/j.vaccine.2008.08.032; Watera C, 2004, AIDS, V18, P1210, DOI 10.1097/00002030-200405210-00018; Wiktor SZ, 1999, LANCET, V353, P1469, DOI 10.1016/S0140-6736(99)03465-0; Winn W, 2006, INTRO MICROBIOLOGY 2, P68; World Health Organization/UNAIDS, 2001, AFR HEALTH SCI, V1, P30	38	42	43	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2011	6	11							e27929	10.1371/journal.pone.0027929	http://dx.doi.org/10.1371/journal.pone.0027929			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KW	22140487	Green Submitted, gold, Green Published			2022-12-27	WOS:000298163400024
J	Ouyang, YS; Song, Y; Lu, BW				Ouyang, Yingshi; Song, Yan; Lu, Bingwei			dp53 Restrains Ectopic Neural Stem Cell Formation in the Drosophila Brain in a Non-Apoptotic Mechanism Involving Archipelago and Cyclin E	PLOS ONE			English	Article							DEPENDENT KINASE INHIBITOR; ASYMMETRIC DIVISION; TUMOR-SUPPRESSOR; SELF-RENEWAL; FATE SPECIFICATION; S-PHASE; P53; CANCER; NUMB; PROTEIN	Accumulating evidence suggests that tumor-initiating stem cells or cancer stem cells (CSCs) possibly originating from normal stem cells may be the root cause of certain malignancies. How stem cell homeostasis is impaired in tumor tissues is not well understood, although certain tumor suppressors have been implicated. In this study, we use the Drosophila neural stem cells (NSCs) called neuroblasts as a model to study this process. Loss-of-function of Numb, a key cell fate determinant with well-conserved mammalian counterparts, leads to the formation of ectopic neuroblasts and a tumor phenotype in the larval brain. Overexpression of the Drosophila tumor suppressor p53 (dp53) was able to suppress ectopic neuroblast formation caused by numb loss-of-function. This occurred in a non-apoptotic manner and was independent of Dacapo, the fly counterpart of the well-characterized mammalian p53 target p21 involved in cellular senescence. The observation that dp53 affected Edu incorporation into neuroblasts led us to test the hypothesis that dp53 acts through regulation of factors involved in cell cycle progression. Our results show that the inhibitory effect of dp53 on ectopic neuroblast formation was mediated largely through its regulation of Cyclin E (Cyc E). Overexpression of Cyc E was able to abrogate dp539s ability to rescue numb loss-of-function phenotypes. Increasing Cyc E levels by attenuating Archipelago (Ago), a recently identified transcriptional target of dp53 and a negative regulator of Cyc E, had similar effects. Conversely, reducing Cyc E activity by overexpressing Ago blocked ectopic neuroblast formation in numb mutant. Our results reveal an intimate connection between cell cycle progression and NSC self-renewal vs. differentiation control, and indicate that p53-mediated regulation of ectopic NSC self-renewal through the Ago/Cyc E axis becomes particularly important when NSC homeostasis is perturbed as in numb loss-of-function condition. This has important clinical implications.	[Ouyang, Yingshi; Song, Yan; Lu, Bingwei] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA	Stanford University	Ouyang, YS (corresponding author), Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA.	bingwei@stanford.edu		Lu, Bingwei/0000-0002-5807-7014	National Institutes of Health [NS043167]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043167] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding was provided by National Institutes of Health grant NS043167 to B.L. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertoni M, 1998, ONCOGENE, V16, P321, DOI 10.1038/sj.onc.1201544; Berger C, 2010, DEV BIOL, V337, P415, DOI 10.1016/j.ydbio.2009.11.012; Bhalerao S, 2005, CURR BIOL, V15, P1583, DOI 10.1016/j.cub.2005.07.061; Bowman SK, 2008, DEV CELL, V14, P535, DOI 10.1016/j.devcel.2008.03.004; Brodsky MH, 2000, CELL, V101, P103, DOI 10.1016/S0092-8674(00)80627-3; Buttitta LA, 2010, J CELL BIOL, V189, P981, DOI 10.1083/jcb.200910006; Calegari F, 2003, J CELL SCI, V116, P4947, DOI 10.1242/jcs.00825; Casaccia-Bonnefil P, 1999, DEVELOPMENT, V126, P4027; Caussinus E, 2005, NAT GENET, V37, P1125, DOI 10.1038/ng1632; Clarke MF, 2006, CELL, V124, P1111, DOI 10.1016/j.cell.2006.03.011; Colaluca IN, 2008, NATURE, V451, P76, DOI 10.1038/nature06412; deNooij JC, 1996, CELL, V87, P1237, DOI 10.1016/S0092-8674(00)81819-X; Doe CQ, 2008, DEVELOPMENT, V135, P1575, DOI 10.1242/dev.014977; Doetsch F, 2002, J NEUROSCI, V22, P2255, DOI 10.1523/JNEUROSCI.22-06-02255.2002; Fan Y, 2010, CELL DEATH DIFFER, V17, P912, DOI 10.1038/cdd.2009.182; Fasano CA, 2009, GENE DEV, V23, P561, DOI 10.1101/gad.1743709; Gil-Perotin S, 2006, J NEUROSCI, V26, P1107, DOI 10.1523/JNEUROSCI.3970-05.2006; GJERSET RA, 1995, IN VITRO CELL DEV-AN, V31, P207; He SH, 2009, ANNU REV CELL DEV BI, V25, P377, DOI 10.1146/annurev.cellbio.042308.113248; Hede SM, 2011, J ONCOL, V2011, DOI 10.1155/2011/852970; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Januschke J, 2008, ONCOGENE, V27, P6994, DOI 10.1038/onc.2008.349; Jin SK, 2000, P NATL ACAD SCI USA, V97, P7301, DOI 10.1073/pnas.97.13.7301; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Kippin TE, 2005, GENE DEV, V19, P756, DOI 10.1101/gad.1272305; KNOBLICH JA, 1994, CELL, V77, P107, DOI 10.1016/0092-8674(94)90239-9; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; KOFF A, 1991, CELL, V66, P1217, DOI 10.1016/0092-8674(91)90044-Y; KOFF A, 1992, SCIENCE, V257, P1689, DOI 10.1126/science.1388288; Krizhanovsky V, 2009, NATURE, V460, P1085, DOI 10.1038/4601085a; Lane ME, 1996, CELL, V87, P1225, DOI 10.1016/S0092-8674(00)81818-8; Leung SY, 2000, ONCOGENE, V19, P4079, DOI 10.1038/sj.onc.1203740; Lu WJ, 2010, SCIENCE, V328, P1278, DOI 10.1126/science.1185640; Mandal S, 2005, DEV CELL, V9, P843, DOI 10.1016/j.devcel.2005.11.006; Mandal S, 2010, J CELL BIOL, V188, P473, DOI 10.1083/jcb.200912024; Meletis K, 2006, DEVELOPMENT, V133, P363, DOI 10.1242/dev.02208; Menendez D, 2009, NAT REV CANCER, V9, P724, DOI 10.1038/nrc2730; Mesquita D, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000566; Moberg KH, 2004, CURR BIOL, V14, P965, DOI 10.1016/j.cub.2004.04.040; Moberg KH, 2001, NATURE, V413, P311, DOI 10.1038/35095068; Mortimer NT, 2007, DEV BIOL, V312, P560, DOI 10.1016/j.ydbio.2007.10.002; NEWCOMB EW, 1993, BRAIN PATHOL, V3, P229, DOI 10.1111/j.1750-3639.1993.tb00749.x; Ollmann M, 2000, CELL, V101, P91, DOI 10.1016/S0092-8674(00)80626-1; Ouyang YS, 2011, DEVELOPMENT, V138, P2185, DOI 10.1242/dev.058347; Pece S, 2011, BBA-REV CANCER, V1815, P26, DOI 10.1016/j.bbcan.2010.10.001; Rahman R, 2009, BBA-MOL BASIS DIS, V1792, P280, DOI 10.1016/j.bbadis.2009.01.011; RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0; RICHARDSON HE, 1993, DEVELOPMENT, V119, P673; Rosen JM, 2009, SCIENCE, V324, P1670, DOI 10.1126/science.1171837; Ruiz S, 2011, CURR BIOL, V21, P45, DOI 10.1016/j.cub.2010.11.049; Simon F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000594; Smith CA, 2007, EMBO J, V26, P468, DOI 10.1038/sj.emboj.7601495; Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076; Tio M, 2001, NATURE, V409, P1063, DOI 10.1038/35059124; UEMURA T, 1989, CELL, V58, P349, DOI 10.1016/0092-8674(89)90849-0; Vanderluit JL, 2007, J CELL BIOL, V178, P129, DOI 10.1083/jcb.200703176; Vanderluit JL, 2004, J CELL BIOL, V166, P853, DOI 10.1083/jcb.200403156; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wang HY, 2007, NATURE, V449, P96, DOI 10.1038/nature06056; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Wells BS, 2006, CURR BIOL, V16, P1606, DOI 10.1016/j.cub.2006.07.046; Weng M, 2010, DEV CELL, V18, P126, DOI 10.1016/j.devcel.2009.12.007; Wirtz-Peitz F, 2008, CELL, V135, P161, DOI 10.1016/j.cell.2008.07.049; Wodarz A, 2006, CELL, V124, P1121, DOI 10.1016/j.cell.2006.03.004; Yamaguchi M, 1999, ONCOGENE, V18, P6767, DOI 10.1038/sj.onc.1203113; Yu FW, 2006, NEURON, V51, P13, DOI 10.1016/j.neuron.2006.06.016; Zheng HW, 2008, NATURE, V455, P1129, DOI 10.1038/nature07443	67	5	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2011	6	11							e28098	10.1371/journal.pone.0028098	http://dx.doi.org/10.1371/journal.pone.0028098			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KW	22140513	Green Published, gold, Green Submitted			2022-12-27	WOS:000298163400032
J	Beattie, RL; Lu, ZL; Manis, FR				Beattie, Rachel L.; Lu, Zhong-Lin; Manis, Franklin R.			Dyslexic Adults Can Learn from Repeated Stimulus Presentation but Have Difficulties in Excluding External Noise	PLOS ONE			English	Article							SPEECH-PERCEPTION; DEFICITS; ANCHOR; INSIGHTS	We examined whether the characteristic impairments of dyslexia are due to a deficit in excluding external noise or a deficit in taking advantage of repeated stimulus presentation. We compared non-impaired adults and adults with poor reading performance on a visual letter detection task that varied two aspects: the presence or absence of background visual noise, and a small or large stimulus set. There was no interaction between group and stimulus set size, indicating that the poor readers took advantage of repeated stimulus presentation as well as the non-impaired readers. The poor readers had higher thresholds than non-impaired readers in the presence of high external noise, but not in the absence of external noise. The results support the hypothesis that an external noise exclusion deficit, not a perceptual anchoring deficit, impairs reading for adults.	[Beattie, Rachel L.; Lu, Zhong-Lin; Manis, Franklin R.] Univ So Calif, Dept Psychol, Los Angeles, CA 90089 USA; [Lu, Zhong-Lin] Ohio State Univ, Dept Psychol, Columbus, OH 43210 USA	University of Southern California; University System of Ohio; Ohio State University	Beattie, RL (corresponding author), Univ So Calif, Dept Psychol, Los Angeles, CA 90089 USA.	beattie@usc.edu	Beattie, Rachel/B-8574-2013	Beattie, Rachel/0000-0002-9828-4720; Lu, Zhong-Lin/0000-0002-7295-727X	National Institure of Child Health and Human Development [HD29891]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD029891] Funding Source: NIH RePORTER	National Institure of Child Health and Human Development; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This project was supported by National Institure of Child Health and Human Development Grant #HD29891 to FM, PI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahissar M, 2008, TRENDS COGN SCI, V12, P245, DOI 10.1016/j.tics.2008.05.001; Ahissar M, 2007, TRENDS COGN SCI, V11, P458, DOI 10.1016/j.tics.2007.08.015; Ahissar M, 2006, NAT NEUROSCI, V9, P1558, DOI 10.1038/nn1800; [Anonymous], 1992, GRAY ORAL READING TE; Bailey CE, 2004, J EXP CHILD PSYCHOL, V87, P125, DOI 10.1016/j.jecp.2003.10.004; BANAI K, 2010, ADV NEURAL IN PRESS; Banai K, 2006, CEREB CORTEX, V16, P1718, DOI 10.1093/cercor/bhj107; Besner D., 1991, BASIC PROCESSES READ; Boets B, 2008, BRAIN LANG, V106, P29, DOI 10.1016/j.bandl.2007.12.004; Boets B, 2011, RES DEV DISABIL, V32, P560, DOI 10.1016/j.ridd.2010.12.020; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; BROWN JI, 1993, NELSONDENNY READING; Di Filippo G, 2008, DEVELOPMENTAL SCI, V11, pF40, DOI 10.1111/j.1467-7687.2008.00752.x; Faes L, 2007, PERCEPT PSYCHOPHYS, V69, P254, DOI 10.3758/BF03193747; Harm MW, 1999, PSYCHOL REV, V106, P491, DOI 10.1037/0033-295X.106.3.491; HARRIS JD, 1948, AM J PSYCHOL, V61, P309, DOI 10.2307/1417151; KESTEN H, 1958, ANN MATH STAT, V29, P41, DOI 10.1214/aoms/1177706705; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Ramus F, 2003, BRAIN, V126, P841, DOI 10.1093/brain/awg076; ROBBINS H, 1951, ANN MATH STAT, V22, P400, DOI 10.1214/aoms/1177729586; Rosen S, 2003, J PHONETICS, V31, P509, DOI 10.1016/S0095-4470(03)00046-9; Shaywitz SE, 1998, NEW ENGL J MED, V338, P307, DOI 10.1056/NEJM199801293380507; Sperling AJ, 2005, NAT NEUROSCI, V8, P862, DOI 10.1038/nn1474; Sperling AJ, 2006, PSYCHOL SCI, V17, P1047, DOI 10.1111/j.1467-9280.2006.01825.x; STANOVICH KE, 1994, J EDUC PSYCHOL, V86, P24, DOI 10.1037/0022-0663.86.1.24; Torgesen J.K., 1999, COMPREHENSIVE TEST P; TORGESEN JK, 1992, TEST WORD READING EF; TREUTWEIN B, 1995, VISION RES, V35, P2503, DOI 10.1016/0042-6989(95)00016-X; Whitney C, 2005, J RES READ, V28, P274, DOI 10.1111/j.1467-9817.2005.00270.x; Woodcock R. W, 2001, WOODCOCK JOHNSON TES; Ziegler JC, 2008, TRENDS COGN SCI, V12, P244, DOI 10.1016/j.tics.2008.04.001; Ziegler JC, 2009, DEVELOPMENTAL SCI, V12, P732, DOI 10.1111/j.1467-7687.2009.00817.x	32	11	11	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e27893	10.1371/journal.pone.0027893	http://dx.doi.org/10.1371/journal.pone.0027893			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	863KL	22132164	Green Submitted, Green Published, gold			2022-12-27	WOS:000298162000049
J	Kvist, S; Narechania, A; Oceguera-Figueroa, A; Fuks, B; Siddall, ME				Kvist, Sebastian; Narechania, Apurva; Oceguera-Figueroa, Alejandro; Fuks, Bella; Siddall, Mark E.			Phylogenomics of Reichenowia parasitica, an Alphaproteobacterial Endosymbiont of the Freshwater Leech Placobdella parasitica	PLOS ONE			English	Article							SYMBIOTIC NITROGEN-FIXATION; ESCHERICHIA-COLI; RHIZOBIUM-LEGUMINOSARUM; FAMILY GLOSSIPHONIIDAE; PHYLOGENETIC ANALYSIS; TSETSE-FLIES; BACTERIA; EVOLUTION; SEQUENCE; GENOMICS	Although several commensal alphaproteobacteria form close relationships with plant hosts where they aid in (e. g.,) nitrogen fixation and nodulation, only a few inhabit animal hosts. Among these, Reichenowia picta, R. ornata and R. parasitica, are currently the only known mutualistic, alphaproteobacterial endosymbionts to inhabit leeches. These bacteria are harbored in the epithelial cells of the mycetomal structures of their freshwater leech hosts, Placobdella spp., and these structures have no other obvious function than housing bacterial symbionts. However, the function of the bacterial symbionts has remained unclear. Here, we focused both on exploring the genomic makeup of R. parasitica and on performing a robust phylogenetic analysis, based on more data than previous hypotheses, to test its position among related bacteria. We sequenced a combined pool of host and symbiont DNA from 36 pairs of mycetomes and performed an in silico separation of the different DNA pools through subtractive scaffolding. The bacterial contigs were compared to 50 annotated bacterial genomes and the genome of the freshwater leech Helobdella robusta using a BLASTn protocol. Further, amino acid sequences inferred from the contigs were used as queries against the 50 bacterial genomes to establish orthology. A total of 358 orthologous genes were used for the phylogenetic analyses. In part, results suggest that R. parasitica possesses genes coding for proteins related to nitrogen fixation, iron/vitamin B translocation and plasmid survival. Our results also indicate that R. parasitica interacts with its host in part by transmembrane signaling and that several of its genes show orthology across Rhizobiaceae. The phylogenetic analyses support the nesting of R. parasitica within the Rhizobiaceae, as sister to a group containing Agrobacterium and Rhizobium species.	[Kvist, Sebastian] Amer Museum Nat Hist, Richard Gilder Grad Sch, New York, NY 10024 USA; [Kvist, Sebastian; Oceguera-Figueroa, Alejandro; Siddall, Mark E.] Amer Museum Nat Hist, Div Invertebrate Zool, New York, NY 10024 USA; [Narechania, Apurva; Siddall, Mark E.] Amer Museum Nat Hist, Sackler Inst Comparat Genom, New York, NY 10024 USA; [Oceguera-Figueroa, Alejandro] CUNY, Grad Ctr, Dept Biol, New York, NY USA; [Fuks, Bella] Long Isl Univ, Brooklyn, NY USA	American Museum of Natural History (AMNH); American Museum of Natural History (AMNH); American Museum of Natural History (AMNH); City University of New York (CUNY) System; Long Island University-Brooklyn Campus	Kvist, S (corresponding author), Amer Museum Nat Hist, Richard Gilder Grad Sch, New York, NY 10024 USA.	skvist@amnh.org		Kvist, Sebastian/0000-0003-3200-6207	Swedish American Foundation; Helge Ax:sson Johnson's Foundation; National Science Foundation [DEB-0640463]	Swedish American Foundation; Helge Ax:sson Johnson's Foundation; National Science Foundation(National Science Foundation (NSF))	This work was supported by a Swedish American Foundation Fellowship and a Helge Ax:sson Johnson's Foundation Fellowship, as well as a National Science Foundation Grant DEB-0640463. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akman L, 2002, NAT GENET, V32, P402, DOI 10.1038/ng986; Andersson SGE, 1998, TRENDS MICROBIOL, V6, P263, DOI 10.1016/S0966-842X(98)01312-2; Ausmees N, 2001, MICROBIOL-UK, V147, P549, DOI 10.1099/00221287-147-3-549; Batut J., 1985, Nitrogen fixation research progress. Proceedings of the 6th International Symposium on Nitrogen Fixation, Corvallis, OR, USA, August 4-10, 1985., P109; BATUT J, 1985, MOL GEN GENET, V199, P232, DOI 10.1007/BF00330264; Borths EL, 2002, P NATL ACAD SCI USA, V99, P16642, DOI 10.1073/pnas.262659699; Bouchon D, 1998, P ROY SOC B-BIOL SCI, V265, P1081, DOI 10.1098/rspb.1998.0402; Burnett WJ, 1997, APPL ENVIRON MICROB, V63, P1721, DOI 10.1128/AEM.63.5.1721-1724.1997; Carpenter SR, 1998, ECOL APPL, V8, P559, DOI 10.1890/1051-0761(1998)008[0559:NPOSWW]2.0.CO;2; Casjens S, 1998, ANNU REV GENET, V32, P339, DOI 10.1146/annurev.genet.32.1.339; Chiu JC, 2006, BIOINFORMATICS, V22, P699, DOI 10.1093/bioinformatics/btk040; Engelberg-Kulka H, 2005, J CELL SCI, V118, P4327, DOI 10.1242/jcs.02619; FISCHER HM, 1994, MICROBIOL REV, V58, P352, DOI 10.1128/MMBR.58.3.352-386.1994; FONTANA R, 1979, J BACTERIOL, V139, P1028, DOI 10.1128/JB.139.3.1028-1038.1979; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Graf J, 2006, TRENDS MICROBIOL, V14, P365, DOI 10.1016/j.tim.2006.06.009; HENNING U, 1972, EUR J BIOCHEM, V26, P570, DOI 10.1111/j.1432-1033.1972.tb01800.x; Higgins CF, 2001, RES MICROBIOL, V152, P205, DOI 10.1016/S0923-2508(01)01193-7; HOWARTH RW, 1988, LIMNOL OCEANOGR, V33, P688, DOI 10.4319/lo.1988.33.4_part_2.0688; KAHN D, 1989, J BACTERIOL, V171, P929, DOI 10.1128/jb.171.2.929-939.1989; Kaneko T, 2002, DNA RES, V9, P189, DOI 10.1093/dnares/9.6.189; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kennaway CK, 2009, NUCLEIC ACIDS RES, V37, P762, DOI 10.1093/nar/gkn988; Kikuchi Y, 2002, APPL ENVIRON MICROB, V68, P4637, DOI 10.1128/AEM.68.9.4637-4641.2002; Lechene CP, 2007, SCIENCE, V317, P1563, DOI 10.1126/science.1145557; Lefevre C, 2004, MOL BIOL EVOL, V21, P965, DOI 10.1093/molbev/msh063; LEHNHERR H, 1995, P NATL ACAD SCI USA, V92, P3274, DOI 10.1073/pnas.92.8.3274; Light JE, 1999, J PARASITOL, V85, P815, DOI 10.2307/3285816; Lukashin AV, 1998, NUCLEIC ACIDS RES, V26, P1107, DOI 10.1093/nar/26.4.1107; Manz W, 1996, MICROBIOL-SGM, V142, P1097, DOI 10.1099/13500872-142-5-1097; Masoudi-Nejad A, 2006, NUCLEIC ACIDS RES, V34, pW459, DOI 10.1093/nar/gkl066; Moran NA, 2000, CURR OPIN MICROBIOL, V3, P270, DOI 10.1016/S1369-5274(00)00088-6; Moran NA, 2000, TRENDS ECOL EVOL, V15, P321, DOI 10.1016/S0169-5347(00)01902-9; Moran NA, 2008, ANNU REV GENET, V42, P165, DOI 10.1146/annurev.genet.41.110306.130119; Moreno E, 1998, FEMS MICROBIOL REV, V22, P255, DOI 10.1111/j.1574-6976.1998.tb00370.x; Nekrasov SV, 2007, J MOL BIOL, V365, P284, DOI 10.1016/j.jmb.2006.09.087; NOGGE G, 1976, EXPERIENTIA, V32, P995, DOI 10.1007/BF01933932; NOGGE G, 1981, PARASITOLOGY, V82, P101; Ochman H, 2001, SCIENCE, V292, P1096, DOI 10.1126/science.1058543; Perkins SL, 2005, APPL ENVIRON MICROB, V71, P5219, DOI 10.1128/AEM.71.9.5219-5224.2005; REICHENOW E, 1922, INTRAZELLULARE SYMBI, V45; REICHENOW E, 1921, ARCH SCHIFFS U TROPE, V25; Rogers GB, 2009, J MED MICROBIOL, V58, P1401, DOI 10.1099/jmm.0.013334-0; ROTHER D, 2001, EUR J BIOCHEM, V268, P6011; RUBINSTEIN B, 1986, PLANT PHYSIOL, V80, P805, DOI 10.1104/pp.80.4.805; Siddall ME, 2011, PARASITOLOGY, V138, P1815, DOI 10.1017/S0031182011000539; Siddall ME, 2010, CLADISTICS, V26, P444, DOI 10.1111/j.1096-0031.2009.00295.x; Siddall ME, 2005, INVERTEBR SYST, V19, P105, DOI 10.1071/IS04034; Siddall ME, 2004, MOL PHYLOGENET EVOL, V30, P178, DOI 10.1016/S1055-7903(03)00184-2; Snel B, 1999, NAT GENET, V21, P108, DOI 10.1038/5052; Spaepen S, 2009, FEMS MICROBIOL LETT, V291, P195, DOI 10.1111/j.1574-6968.2008.01453.x; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Tamames J, 2001, TRENDS GENET, V17, P124, DOI 10.1016/S0168-9525(00)02212-5; Townsend AR, 2003, FRONT ECOL ENVIRON, V1, P240, DOI 10.2307/3868011; van Borm S, 2002, P ROY SOC B-BIOL SCI, V269, P2023, DOI 10.1098/rspb.2002.2101; VANBRUSSEL AAN, 1977, J GEN MICROBIOL, V101, P51, DOI 10.1099/00221287-101-1-51; Weidner S, 2003, CURR OPIN BIOTECH, V14, P200, DOI 10.1016/S0958-1669(03)00022-3	58	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e28192	10.1371/journal.pone.0028192	http://dx.doi.org/10.1371/journal.pone.0028192			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132238	Green Published, gold, Green Submitted			2022-12-27	WOS:000298162000085
J	Shepard, CC; Crain, CM; Beck, MW				Shepard, Christine C.; Crain, Caitlin M.; Beck, Michael W.			The Protective Role of Coastal Marshes: A Systematic Review and Meta-analysis	PLOS ONE			English	Review							SEA-LEVEL RISE; HURRICANE-KATRINA; VEGETATION BIOSHIELDS; MANAGED REALIGNMENT; ECOSYSTEM SERVICES; MISSISSIPPI DELTA; ELEVATION; WETLANDS; EROSION; VULNERABILITY	Background: Salt marshes lie between many human communities and the coast and have been presumed to protect these communities from coastal hazards by providing important ecosystem services. However, previous characterizations of these ecosystem services have typically been based on a small number of historical studies, and the consistency and extent to which marshes provide these services has not been investigated. Here, we review the current evidence for the specific processes of wave attenuation, shoreline stabilization and floodwater attenuation to determine if and under what conditions salt marshes offer these coastal protection services. Methodology/Principal Findings: We conducted a thorough search and synthesis of the literature with reference to these processes. Seventy-five publications met our selection criteria, and we conducted meta-analyses for publications with sufficient data available for quantitative analysis. We found that combined across all studies (n = 7), salt marsh vegetation had a significant positive effect on wave attenuation as measured by reductions in wave height per unit distance across marsh vegetation. Salt marsh vegetation also had a significant positive effect on shoreline stabilization as measured by accretion, lateral erosion reduction, and marsh surface elevation change (n = 30). Salt marsh characteristics that were positively correlated to both wave attenuation and shoreline stabilization were vegetation density, biomass production, and marsh size. Although we could not find studies quantitatively evaluating floodwater attenuation within salt marshes, there are several studies noting the negative effects of wetland alteration on water quantity regulation within coastal areas. Conclusions/Significance: Our results show that salt marshes have value for coastal hazard mitigation and climate change adaptation. Because we do not yet fully understand the magnitude of this value, we propose that decision makers employ natural systems to maximize the benefits and ecosystem services provided by salt marshes and exercise caution when making decisions that erode these services.	[Shepard, Christine C.] Univ Calif Santa Cruz, Dept Ocean Sci, Santa Cruz, CA 95064 USA; [Crain, Caitlin M.] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Beck, Michael W.] Univ Calif Santa Cruz, Inst Marine Sci, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz	Shepard, CC (corresponding author), Univ Calif Santa Cruz, Dept Ocean Sci, Santa Cruz, CA 95064 USA.	cshepard@ucsc.edu	Beck, Michael W./AAB-2844-2019	Beck, Michael W./0000-0002-5107-9973	David and Lucile Packard Foundation; Graduate Assistance in Areas of National Need (GAANN)	David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Graduate Assistance in Areas of National Need (GAANN)(US Department of Education)	This work was supported by the David and Lucile Packard Foundation. CS was additionally supported by the Graduate Assistance in Areas of National Need (GAANN) program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN JRL, 1990, MAR GEOL, V95, P77, DOI 10.1016/0025-3227(90)90042-I; AMS, 1973, B AM METEOROL SOC, V54, P46; Batker D., 2010, ENV LAW REPORTER NEW, V40, P11106; Boesch D.F., 2006, NEW FRAMEWORK PLANNI; Bohannon J, 2005, SCIENCE, V309, P1808, DOI 10.1126/science.309.5742.1808; BOUMANS RMJ, 1993, ESTUARIES, V16, P375, DOI 10.2307/1352509; Brody SD, 2007, NAT HAZARDS, V40, P413, DOI 10.1007/s11069-006-9003-3; Bullock A, 2003, HYDROL EARTH SYST SC, V7, P358, DOI 10.5194/hess-7-358-2003; Cahoon D. R., 1999, CURR TOP WETLAND BIO, V3, P72; Cahoon DR, 2006, ECOL STUD-ANAL SYNTH, V190, P271; Coops H, 1996, AQUAT BOT, V53, P187, DOI 10.1016/0304-3770(96)01027-3; Corbett CW, 1997, J EXP MAR BIOL ECOL, V213, P133, DOI 10.1016/S0022-0981(97)00013-0; Costanza R, 2008, AMBIO, V37, P241, DOI 10.1579/0044-7447(2008)37[241:TVOCWF]2.0.CO;2; Craft C, 2009, FRONT ECOL ENVIRON, V7, P127, DOI 10.1890/09.WB.006; Craft C, 2009, FRONT ECOL ENVIRON, V7, P73, DOI 10.1890/070219; Dahdouh-Guebas F, 2005, CURR BIOL, V15, pR443, DOI 10.1016/j.cub.2005.06.008; Das S, 2009, P NATL ACAD SCI USA, V106, P7357, DOI 10.1073/pnas.0810440106; Day J, 2002, CONCEPTS CONTROVERSI; Day JW, 2007, SCIENCE, V315, P1679, DOI 10.1126/science.1137030; Dixon M, 2008, P I CIVIL ENG-MAR EN, V161, P61, DOI 10.1680/maen.2008.161.2.61; Feagin RA, 2010, CONSERV LETT, V3, P1, DOI 10.1111/j.1755-263X.2009.00087.x; Fischetti M, 2005, SCI AM, V293, P18, DOI 10.1038/scientificamerican1105-18; French PW, 2006, ESTUAR COAST SHELF S, V67, P409, DOI 10.1016/j.ecss.2005.11.035; Gurevitch J., 2001, DESIGNS ANAL ECOLOGI, P347; Hale L. Z., 2009, Renewable Resources Journal, V25, P21; Harvey MM, 2007, J ENVIRON RADIOACTIV, V95, P126, DOI 10.1016/j.jenvrad.2007.02.005; Kathiresan K, 2005, ESTUAR COAST SHELF S, V65, P601, DOI 10.1016/j.ecss.2005.06.022; Kennish MJ, 2001, J COASTAL RES, V17, P731; Kirwan M, 2009, QUATERNARY SCI REV, V28, P1801, DOI 10.1016/j.quascirev.2009.02.022; Kirwan ML, 2008, GLOBAL PLANET CHANGE, V60, P471, DOI 10.1016/j.gloplacha.2007.05.005; Kirwan ML, 2009, FRONT ECOL ENVIRON, V7, P126, DOI 10.1890/09.WB.005; Kite-Powell HL, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-S2-S6; Koch EW, 2009, FRONT ECOL ENVIRON, V7, P29, DOI 10.1890/080126; Langley JA, 2009, P NATL ACAD SCI USA, V106, P6182, DOI 10.1073/pnas.0807695106; Leonard L, 2006, HYDROBIOLOGIA, V569, P5, DOI 10.1007/s10750-006-0119-y; Loder NM, 2009, ESTUAR COAST SHELF S, V84, P625, DOI 10.1016/j.ecss.2009.07.036; Lovelace, 1994, STORM TID EL PROD HU; Mckee KL, 2009, WETLANDS, V29, P2, DOI 10.1672/08-32.1; Michener WK, 1997, ECOL APPL, V7, P770, DOI 10.1890/1051-0761(1997)007[0770:CCHATS]2.0.CO;2; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Morris JT, 2002, ECOLOGY, V83, P2869, DOI 10.1890/0012-9658(2002)083[2869:ROCWTR]2.0.CO;2; Nicholls RJ, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P315; PENLAND S, 1990, J COASTAL RES, V6, P323; Perez-Maqueo O, 2007, ECOL ECON, V63, P273, DOI 10.1016/j.ecolecon.2006.11.011; Perillo G. M. E., 2009, COASTAL WETLANDS INT; REED DJ, 1995, EARTH SURF PROC LAND, V20, P39, DOI 10.1002/esp.3290200105; Roland RM, 2005, J COASTAL RES, V21, P453, DOI 10.2112/03-0079.1; Rybczyk JM, 1998, ECOL MODEL, V112, P23, DOI 10.1016/S0304-3800(98)00125-2; Tanaka N, 2009, LANDSC ECOL ENG, V5, P71, DOI 10.1007/s11355-008-0058-z; Thomalla F, 2006, DISASTERS, V30, P39, DOI 10.1111/j.1467-9523.2006.00305.x; Tornqvist TE, 2008, NAT GEOSCI, V1, P173, DOI 10.1038/ngeo129; Tsihrintzis VA, 2000, WATER RESOUR MANAG, V14, P285, DOI 10.1023/A:1008130827797; U.S. EPA, 2006, WETL PROT LIF PROP F; U.S.EPA, 2009, 430F08024 US EPA; US Army COE, 1963, 63 USA COE; VANEERDT MM, 1985, VEGETATIO, V62, P367; Vermaat JE, 2007, ESTUAR COAST SHELF S, V75, P564, DOI 10.1016/j.ecss.2007.08.009; WALDRON LJ, 1977, SOIL SCI SOC AM J, V41, P843, DOI 10.2136/sssaj1977.03615995004100050005x; Wamsley TV, 2010, OCEAN ENG, V37, P59, DOI 10.1016/j.oceaneng.2009.07.018; Wamsley TV, 2009, NAT HAZARDS, V51, P207, DOI 10.1007/s11069-009-9378-z; World Bank, 2010, ENVIRON DEV, P1, DOI 10.1596/978-0-8213-8126-7	61	372	376	21	291	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e27374	10.1371/journal.pone.0027374	http://dx.doi.org/10.1371/journal.pone.0027374			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132099	Green Published, Green Submitted, gold			2022-12-27	WOS:000298162000017
J	Breitling, LP; Arndt, V; Drath, C; Brenner, H				Breitling, Lutz P.; Arndt, Volker; Drath, Christoph; Brenner, Hermann			Liver Enzymes: Interaction Analysis of Smoking with Alcohol Consumption or BMI, Comparing AST and ALT to gamma-GT	PLOS ONE			English	Article							BODY-MASS INDEX; SERUM ALANINE AMINOTRANSFERASE; UNITED-STATES POPULATION; GLUTAMYL-TRANSFERASE; CONSTRUCTION WORKERS; GLUTAMYLTRANSFERASE ACTIVITY; GENERAL-POPULATION; CIGARETTE-SMOKING; CANCER INCIDENCE; CAUSE MORTALITY	Background: A detrimental interaction between smoking and alcohol consumption with respect serum gamma-glutamyltransferase (gamma-GT) has recently been described. The underlying mechanisms remain unknown. The present work aimed to provide further insights by examining similar interactions pertaining to aspartate and alanine transaminase (AST, ALT), routine liver markers less prone to enzyme induction. Methodology/Principal Findings: The present cross-sectional analysis was based on records from routine occupational health examinations of 15,281 male employees predominantly of the construction industry, conducted from 1986 to 1992 in Southern Germany. Associations of smoking intensity with log-transformed activities of gamma-GT, AST, and ALT were examined in regression models adjusted for potential confounders and including an interaction of smoking with alcohol consumption or body mass index (BMI). Statistically significant interactions of smoking were observed with both alcohol consumption (AST and ALT, each with P<0.0001) and BMI (AST only, P<0.0001). The interactions all were in the same directions as for gamma-GT, i.e. synergistic with alcohol and opposite with BMI. Conclusion: The patterns of interaction between smoking and alcohol consumption or BMI with respect to AST and ALT resembled those observed for gamma-GT. This renders enzyme induction a less probable mechanism for these associations, whereas it might implicate exacerbated hepatocellular vulnerability and injury.	[Breitling, Lutz P.; Arndt, Volker; Brenner, Hermann] German Canc Res Ctr, Div Clin Epidemiol & Aging Res C070, Heidelberg, Germany; [Drath, Christoph] Occupat Hlth Serv, Workmens Compensat Board Construct Workers, Boblingen, Germany	Helmholtz Association; German Cancer Research Center (DKFZ)	Breitling, LP (corresponding author), German Canc Res Ctr, Div Clin Epidemiol & Aging Res C070, Heidelberg, Germany.	L.Breitling@dkfz-heidelberg.de	Arndt, Volker/AAI-7282-2020; Brenner, Hermann/ABE-6383-2020; Arndt, Volker/B-4999-2014; /AAM-5330-2020; Brenner, Hermann/B-4627-2017	Arndt, Volker/0000-0001-9320-8684; Brenner, Hermann/0000-0002-6129-1572; Arndt, Volker/0000-0001-9320-8684; Brenner, Hermann/0000-0002-6129-1572	Association of the Workmen's Compensation Board for Construction Workers, Germany; German and Baden Wurttemberg Pension Fund	Association of the Workmen's Compensation Board for Construction Workers, Germany; German and Baden Wurttemberg Pension Fund	Funding by the Association of the Workmen's Compensation Board for Construction Workers, Germany, and the German and Baden Wurttemberg Pension Fund is gratefully acknowledged. The funders had no role in study design, collection, analysis and interpretation of data, or in the decision to publish.	Adams LA, 2008, J GASTROEN HEPATOL, V23, P1089, DOI 10.1111/j.1440-1746.2008.05451.x; Alatalo PI, 2008, AM J CLIN NUTR, V88, P1097, DOI 10.1093/ajcn/88.4.1097; Arndt V, 1998, INT ARCH OCC ENV HEA, V71, P405, DOI 10.1007/s004200050299; Breitling LP, 2010, ATHEROSCLEROSIS, V210, P649, DOI 10.1016/j.atherosclerosis.2009.12.037; Breitling LP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013116; Breitling LP, 2011, J HEPATOL, V55, P594, DOI 10.1016/j.jhep.2010.12.029; Breitling LP, 2009, HEPATOLOGY, V49, P802, DOI 10.1002/hep.22727; Brenner H, 1997, PREV MED, V26, P305, DOI 10.1006/pmed.1997.0144; Fabbrini E, 2009, CURR OPIN CLIN NUTR, V12, P474, DOI 10.1097/MCO.0b013e32832eb587; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Giannini EG, 2005, CAN MED ASSOC J, V172, P367, DOI 10.1503/cmaj.1040752; Koh WP, 2010, BRIT J CANCER, V102, P610, DOI 10.1038/sj.bjc.6605496; Lee DH, 2001, INT J EPIDEMIOL, V30, P766, DOI 10.1093/ije/30.4.766; Meisinger C, 2006, ATHEROSCLEROSIS, V189, P297, DOI 10.1016/j.atherosclerosis.2006.01.010; Meisinger C, 2005, J INTERN MED, V258, P527, DOI 10.1111/j.1365-2796.2005.01572.x; NISHIMURA M, 1983, KLIN WOCHENSCHR, V61, P265, DOI 10.1007/BF01497775; ROBINSON D, 1989, ANN CLIN BIOCHEM, V26, P393, DOI 10.1177/000456328902600503; Ruhl CE, 2005, CLIN GASTROENTEROL H, V3, P1260, DOI 10.1016/S1542-3565(05)00743-3; Ruhl CE, 2009, GASTROENTEROLOGY, V136, P477, DOI 10.1053/j.gastro.2008.10.052; Steffensen FH, 1997, INT J EPIDEMIOL, V26, P92, DOI 10.1093/ije/26.1.92; Strasak AM, 2008, INT J CANCER, V123, P1902, DOI 10.1002/ijc.23714; Strasak AM, 2008, CANCER RES, V68, P3970, DOI 10.1158/0008-5472.CAN-07-6686; Tanaka K, 1998, INT J EPIDEMIOL, V27, P438, DOI 10.1093/ije/27.3.438; TESCHKE R, 1977, BIOCHEM BIOPH RES CO, V75, P718, DOI 10.1016/0006-291X(77)91531-5; TESCHKE R, 1983, GUT, V24, P625, DOI 10.1136/gut.24.7.625; THOMAS L, 2005, J LAB MED, V29, P301, DOI DOI 10.1515/JLM.2005.041; Wannamethee SG, 2008, ATHEROSCLEROSIS, V201, P168, DOI 10.1016/j.atherosclerosis.2008.01.019; Wannamethee SG, 2010, ANN CLIN BIOCHEM, V47, P321, DOI 10.1258/acb.2010.009303; Whitehead TP, 1996, ANN CLIN BIOCHEM, V33, P530, DOI 10.1177/000456329603300607; Whitfield JB, 2001, CRIT REV CL LAB SCI, V38, P263, DOI 10.1080/20014091084227	30	18	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2011	6	11							e27951	10.1371/journal.pone.0027951	http://dx.doi.org/10.1371/journal.pone.0027951			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858JH	22132177	gold, Green Submitted, Green Published			2022-12-27	WOS:000297792400025
J	Anderson, BA; Laurent, PA; Yantis, S				Anderson, Brian A.; Laurent, Patryk A.; Yantis, Steven			Learned Value Magnifies Salience-Based Attentional Capture	PLOS ONE			English	Article							SELECTIVE VISUAL-ATTENTION; CONTROL SETTINGS; HUMAN VISION; CORTEX; REWARD; TASK; REPRESENTATIONS; CONSEQUENCES; CONTINGENT; SINGLETONS	Visual attention is captured by physically salient stimuli (termed salience-based attentional capture), and by otherwise task-irrelevant stimuli that contain goal-related features (termed contingent attentional capture). Recently, we reported that physically nonsalient stimuli associated with value through reward learning also capture attention involuntarily (Anderson, Laurent, & Yantis, PNAS, 2011). Although it is known that physical salience and goal-relatedness both influence attentional priority, it is unknown whether or how attentional capture by a salient stimulus is modulated by its associated value. Here we show that a physically salient, task-irrelevant distractor previously associated with a large reward slows visual search more than an equally salient distractor previously associated with a smaller reward. This magnification of salience-based attentional capture by learned value extinguishes over several hundred trials. These findings reveal a broad influence of learned value on involuntary attentional capture.	[Anderson, Brian A.; Laurent, Patryk A.; Yantis, Steven] Johns Hopkins Univ, Dept Psychol & Brain Sci, Baltimore, MD 21218 USA	Johns Hopkins University	Anderson, BA (corresponding author), Johns Hopkins Univ, Dept Psychol & Brain Sci, Baltimore, MD 21218 USA.	bander33@jhu.edu		Lauwereyns, Jan/0000-0003-0551-2550	National Institutes of Health [R01-DA013165]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA013165, F31DA033754] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The research was supported by the National Institutes of Health grant R01-DA013165 to Steven Yantis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson BA, 2011, P NATL ACAD SCI USA, V108, P10367, DOI 10.1073/pnas.1104047108; Anderson BA, 2010, ATTEN PERCEPT PSYCHO, V72, P342, DOI 10.3758/APP.72.2.342; BACON WF, 1994, PERCEPT PSYCHOPHYS, V55, P485, DOI 10.3758/BF03205306; Belopolsky AV, 2010, ATTEN PERCEPT PSYCHO, V72, P326, DOI 10.3758/APP.72.2.326; BUNDESEN C, 1990, PSYCHOL REV, V97, P523, DOI 10.1037/0033-295X.97.4.523; Bush G, 2010, NEUROPSYCHOPHARMACOL, V35, P278, DOI 10.1038/npp.2009.120; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Davis C, 2010, CURR PSYCHIAT REP, V12, P389, DOI 10.1007/s11920-010-0133-7; Della Libera C, 2006, PSYCHOL SCI, V17, P222; Della Libera C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019460; Della Libera C, 2009, PSYCHOL SCI, V20, P778, DOI 10.1111/j.1467-9280.2009.02360.x; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; DUNCAN J, 1994, NATURE, V369, P313, DOI 10.1038/369313a0; Field M, 2008, DRUG ALCOHOL DEPEN, V97, P1, DOI 10.1016/j.drugalcdep.2008.03.030; Folk CL, 1998, J EXP PSYCHOL HUMAN, V24, P847, DOI 10.1037/0096-1523.24.3.847; FOLK CL, 1992, J EXP PSYCHOL HUMAN, V18, P1030, DOI 10.1037/0096-1523.18.4.1030; Garavan H, 2007, NEUROPSYCHOL REV, V17, P337, DOI 10.1007/s11065-007-9034-x; Hickey C, 2006, J COGNITIVE NEUROSCI, V18, P604, DOI 10.1162/jocn.2006.18.4.604; Hickey C, 2011, VIS COGN, V19, P117, DOI 10.1080/13506285.2010.503946; Hickey C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014087; Hickey C, 2010, J NEUROSCI, V30, P11096, DOI 10.1523/JNEUROSCI.1026-10.2010; Krebs RM, 2010, COGNITION, V117, P341, DOI 10.1016/j.cognition.2010.08.018; Kyllingsbaek S, 2001, PERCEPT PSYCHOPHYS, V63, P85, DOI 10.3758/BF03200505; Lamy D, 2004, J EXP PSYCHOL HUMAN, V30, P1019, DOI 10.1037/0096-1523.30.6.1019; Laurent PA, 2008, NEURAL NETWORKS, V21, P1493, DOI 10.1016/j.neunet.2008.09.004; Lien MC, 2010, J EXP PSYCHOL HUMAN, V36, P1, DOI 10.1037/a0015875; Maunsell JHR, 2004, TRENDS COGN SCI, V8, P261, DOI 10.1016/j.tics.2004.04.003; Navalpakkam V, 2010, P NATL ACAD SCI USA, V107, P5232, DOI 10.1073/pnas.0911972107; Peck CJ, 2009, J NEUROSCI, V29, P11182, DOI 10.1523/JNEUROSCI.1929-09.2009; Raymond JE, 2009, PSYCHOL SCI, V20, P981, DOI 10.1111/j.1467-9280.2009.02391.x; Robinson TE, 2008, PHILOS T R SOC B, V363, P3137, DOI 10.1098/rstb.2008.0093; Serences JT, 2007, CEREB CORTEX, V17, P284, DOI 10.1093/cercor/bhj146; Serences JT, 2010, J NEUROPHYSIOL, V104, P76, DOI 10.1152/jn.01090.2009; Serences JT, 2008, NEURON, V60, P1169, DOI 10.1016/j.neuron.2008.10.051; Serences JT, 2005, PSYCHOL SCI, V16, P114, DOI 10.1111/j.0956-7976.2005.00791.x; Sheppard B, 2010, DEPRESS ANXIETY, V27, P667, DOI 10.1002/da.20691; SHIFFRIN RM, 1977, PSYCHOL REV, V84, P127, DOI 10.1037/0033-295X.84.2.127; Shuler MG, 2006, SCIENCE, V311, P1606, DOI 10.1126/science.1123513; Theeuwes J, 2002, PERCEPT PSYCHOPHYS, V64, P764, DOI 10.3758/BF03194743; THEEUWES J, 1992, PERCEPT PSYCHOPHYS, V51, P599, DOI 10.3758/BF03211656; Theeuwes J, 2010, ACTA PSYCHOL, V135, P77, DOI 10.1016/j.actpsy.2010.02.006; Yantis S., 1984, J EXPT PSYCHOL HUMAN, V10, P350, DOI DOI 10.1037/0096-1523.10.5.601	42	197	201	5	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2011	6	11							e27926	10.1371/journal.pone.0027926	http://dx.doi.org/10.1371/journal.pone.0027926			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	858IO	22132170	Green Published, gold			2022-12-27	WOS:000297789900034
J	Barboni, B; Russo, V; Cecconi, S; Curini, V; Colosimo, A; Garofalo, MLA; Capacchietti, G; Di Giacinto, O; Mattioli, M				Barboni, Barbara; Russo, Valentina; Cecconi, Sandra; Curini, Valentina; Colosimo, Alessia; Garofalo, Maria Luigia A.; Capacchietti, Giulia; Di Giacinto, Oriana; Mattioli, Mauro			In Vitro Grown Sheep Preantral Follicles Yield Oocytes with Normal Nuclear-Epigenetic Maturation	PLOS ONE			English	Article							GERMINAL VESICLE GV; STIMULATING-HORMONE; MOUSE OOCYTES; IMPRINTING ESTABLISHMENT; SITU HYBRIDIZATION; TELOMERE THEORY; CELL COMPLEXES; CULTURE-MEDIUM; CHROMATIN; METHYLATION	Background: Assisted reproductive technologies allow to utilize a limited number of fully grown oocytes despite the presence in the ovary of a large pool of meiotically incompetent gametes potentially able to produce live births. In vitro folliculogenesis could be useful to recruit these oocytes by promoting their growth and differentiation. Methodology/Principal Findings: In vitro folliculogenesis was performed starting from sheep preantral (PA) follicles to evaluate oocyte nuclear/epigenetic maturation. Chromatin configuration, quantification of global DNA methylation, and epigenetic remodelling enzymes were evaluated with immunocytochemistry, telomere elongation was assessed with the Q-FISH technique, while the DNA methylation status at the DMRs of maternally IGF2R and BEGAIN, and paternally H19 methylated imprinted genes was determined by bisulfite sequencing and COBRA. Specifically, 70% of PA underwent early antrum (EA) differentiation and supported in culture oocyte global DNA methylation, telomere elongation, TERT and Dnmt3a redistribution thus mimicking the physiological events that involve the oocyte during the transition from secondary to tertiary follicle. Dnmt1 anticipated cytoplasmic translocation in in vitro grown oocytes did not impair global and single gene DNA methylation. Indeed, the in vitro grown oocytes acquired a methylation profile of IGF2R and BEGAIN compatible with the follicle/oocyte stage reached, and maintained an unmethylated status of H19. In addition, the percentage of oocytes displaying a condensed chromatin configuration resulted lower in in vitro grown oocytes, however, their ability to undergo meiosis and early embryo development after IVF and parthenogenetic activation was similar to that recorded in EA follicle in vivo grown oocytes. Conclusions/Significance: In conclusion, the in vitro folliculogenesis was able to support the intracellular/nuclear mechanisms leading the oocytes to acquire a meiotic and developmental competence. Thus, the in vitro culture may increase the availability of fertilizable oocytes in sheep, and become an in vitro translational model to investigate the mechanisms governing nuclear/epigenetic oocyte maturation.	[Barboni, Barbara; Russo, Valentina; Curini, Valentina; Colosimo, Alessia; Garofalo, Maria Luigia A.; Capacchietti, Giulia; Di Giacinto, Oriana; Mattioli, Mauro] Univ Teramo, Dept Comparat Biomed Sci, Teramo, Italy; [Cecconi, Sandra] Univ Aquila, Dept Biomed Sci & Technol, I-67100 Laquila, Italy	University of Teramo; University of L'Aquila	Barboni, B (corresponding author), Univ Teramo, Dept Comparat Biomed Sci, Teramo, Italy.	vrusso@unite.it	Russo, Valentina/G-8209-2011; Curini, Valentina VC/C-1094-2016	Russo, Valentina/0000-0003-4368-2534; Curini, Valentina VC/0000-0002-2335-3154; CECCONI, Sandra/0000-0003-1931-394X	Tercas Foundation	Tercas Foundation	This work was supported by a Tercas Foundation grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anckaert E, 2010, BIOL REPROD, V83, P377, DOI 10.1095/biolreprod.109.082164; Anckaert E, 2009, BIOL REPROD, V81, P666, DOI 10.1095/biolreprod.109.076810; Anckaert E, 2009, INT J DEV BIOL, V53, P541, DOI 10.1387/ijdb.082619ea; Arney KL, 2001, INT J DEV BIOL, V45, P533; Bao SQ, 2000, BIOL REPROD, V62, P616, DOI 10.1095/biolreprod62.3.616; Barboni B, 1996, REPROD DOMEST ANIM, V31, P589; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Borghol N, 2006, GENOMICS, V87, P417, DOI 10.1016/j.ygeno.2005.10.008; Bouniol-Baly C, 1999, BIOL REPROD, V60, P580, DOI 10.1095/biolreprod60.3.580; Bowdin S, 2007, HUM REPROD, V22, P3237, DOI 10.1093/humrep/dem268; Cecconi S, 1999, BIOL REPROD, V60, P594, DOI 10.1095/biolreprod60.3.594; Cecconi S, 2004, BIOL REPROD, V70, P12, DOI 10.1095/biolreprod.103.016774; Cecconi S, 2008, ENDOCRINOLOGY, V149, P100, DOI 10.1210/en.2007-0874; Colosimo A, 2009, ANIM GENET, V40, P900, DOI 10.1111/j.1365-2052.2009.01939.x; De La Fuente R, 2006, DEV BIOL, V292, P1, DOI 10.1016/j.ydbio.2006.01.008; De La Fuente R, 2004, DEV BIOL, V275, P447, DOI 10.1016/j.ydbio.2004.08.028; Dean Wendy, 2005, Birth Defects Res C Embryo Today, V75, P98, DOI 10.1002/bdrc.20037; delaSena C, 1995, HEREDITAS, V123, P269; Desai N, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-119; Eppig JJ, 1996, BIOL REPROD, V54, P197, DOI 10.1095/biolreprod54.1.197; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Gioia L, 2005, REPRODUCTION, V130, P29, DOI 10.1530/rep.1.00550; Hiura H, 2006, GENES CELLS, V11, P353, DOI 10.1111/j.1365-2443.2006.00943.x; Kaneda M, 2004, NATURE, V429, P900, DOI 10.1038/nature02633; Keefe DL, 2006, CURR OPIN OBSTET GYN, V18, P280, DOI 10.1097/01.gco.0000193019.05686.49; Keefe DL, 2005, AM J OBSTET GYNECOL, V192, P1256, DOI 10.1016/j.ajog.2005.01.036; Kerjean A, 2003, EUR J HUM GENET, V11, P493, DOI 10.1038/sj.ejhg.5200990; Lane N, 2003, GENESIS, V35, P88, DOI 10.1002/gene.10168; Laprise SL, 2009, MOL REPROD DEV, V76, P1006, DOI 10.1002/mrd.21058; Ledda S, 1999, REPROD NUTR DEV, V39, P503, DOI 10.1051/rnd:19990409; Li YF, 2011, CELL RES, V21, P466, DOI 10.1038/cr.2011.15; Lima-Verde IB, 2010, CELLS TISSUES ORGANS, V191, P240, DOI 10.1159/000231484; Liu L, 2002, DEV BIOL, V249, P74, DOI 10.1006/dbio.2002.0735; Liu Y, 2006, MICROSC RES TECHNIQ, V69, P799, DOI 10.1002/jemt.20349; Lodde V, 2007, MOL REPROD DEV, V74, P740, DOI 10.1002/mrd.20639; Lucidi P, 2001, THERIOGENOLOGY, V55, P1797, DOI 10.1016/S0093-691X(01)00522-2; Lucifero D, 2004, HUM MOL GENET, V13, P839, DOI 10.1093/hmg/ddh104; Maher ER, 2005, HUM MOL GENET, V14, pR133, DOI 10.1093/hmg/ddi107; Manipalviratn S, 2009, FERTIL STERIL, V91, P305, DOI 10.1016/j.fertnstert.2009.01.002; Mao JD, 2002, BIOL REPROD, V67, P1197, DOI 10.1095/biolreprod67.4.1197; Market-Velker BA, 2010, BIOL REPROD, V83, P938, DOI 10.1095/biolreprod.110.085480; Market-Velker BA, 2010, HUM MOL GENET, V19, P36, DOI 10.1093/hmg/ddp465; Meeker AK, 2002, AM J PATHOL, V160, P1259, DOI 10.1016/S0002-9440(10)62553-9; Miracco C, 2002, BRIT J DERMATOL, V146, P399, DOI 10.1046/j.1365-2133.2002.04600.x; MOOR RM, 1977, J REPROD FERTIL, V49, P101, DOI 10.1530/jrf.0.0490101; Newton H, 1999, J REPROD FERTIL, V115, P141, DOI 10.1530/jrf.0.1150141; O'Brien MJ, 2003, BIOL REPROD, V68, P1682, DOI 10.1095/biolreprod.102.013029; Russo V, 2006, J HISTOCHEM CYTOCHEM, V54, P443, DOI 10.1369/jhc.4A6603.2006; Russo V, 2007, MICROSC RES TECHNIQ, V70, P733, DOI 10.1002/jemt.20462; Sato A, 2007, HUM REPROD, V22, P26, DOI 10.1093/humrep/del316; Steele W, 2005, REPROD BIOMED ONLINE, V10, P755, DOI 10.1016/S1472-6483(10)61120-0; Su YQ, 2002, ENDOCRINOLOGY, V143, P2221, DOI 10.1210/en.143.6.2221; Swales AKE, 2005, REPRODUCTION, V130, P389, DOI 10.1530/rep.1.00395; Tanemura K, 2005, DEV BIOL, V281, P196, DOI 10.1016/j.ydbio.2005.02.025; TINGEN CM, 2011, H REPROD, V141, P809; Van der Auwera I, 2001, HUM REPROD, V16, P1237, DOI 10.1093/humrep/16.6.1237; Webb R., 2004, J ANIM SCI, V82, P63; Willard ST, 2006, ANIM REPROD SCI, V93, P280, DOI 10.1016/j.anireprosci.2005.08.002; Xu M, 2011, BIOL REPROD, V84, P689, DOI 10.1095/biolreprod.110.088674; Xu M, 2009, BIOTECHNOL BIOENG, V103, P378, DOI 10.1002/bit.22250; Young LE, 2001, NAT GENET, V27, P153, DOI 10.1038/84769; ZUCCOTTI M, 1995, MOL REPROD DEV, V41, P479, DOI 10.1002/mrd.1080410410	62	31	32	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2011	6	11							e27550	10.1371/journal.pone.0027550	http://dx.doi.org/10.1371/journal.pone.0027550			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IO	22132111	Green Published, Green Submitted, gold			2022-12-27	WOS:000297789900013
J	Feig, JE; Shang, YT; Rotllan, N; Vengrenyuk, Y; Wu, CW; Shamir, R; Torra, IP; Fernandez-Hernando, C; Fisher, EA; Garabedian, MJ				Feig, Jonathan E.; Shang, Yueting; Rotllan, Noemi; Vengrenyuk, Yuliya; Wu, Chaowei; Shamir, Raanan; Torra, Ines Pineda; Fernandez-Hernando, Carlos; Fisher, Edward A.; Garabedian, Michael J.			Statins Promote the Regression of Atherosclerosis via Activation of the CCR7-Dependent Emigration Pathway in Macrophages	PLOS ONE			English	Article							MONOCYTE-DERIVED CELLS; CORONARY ATHEROSCLEROSIS; RAPID REGRESSION; APOLIPOPROTEIN-E; GENE-EXPRESSION; BONE-MARROW; MOUSE; PLAQUES; MICE; CHOLESTEROL	HMG-CoA reductase inhibitors (statins) decrease atherosclerosis by lowering low-density-lipoprotein cholesterol. Statins are also thought to have additional anti-atherogenic properties, yet defining these non-conventional modes of statin action remains incomplete. We have previously developed a novel mouse transplant model of atherosclerosis regression in which aortic segments from diseased donors are placed into normolipidemic recipients. With this model, we demonstrated the rapid loss of CD68+ cells (mainly macrophages) in plaques through the induction of a chemokine receptor CCR7-dependent emigration process. Because the human and mouse CCR7 promoter contain Sterol Response Elements (SREs), we hypothesized that Sterol Regulatory Element Binding Proteins (SREBPs) are involved in increasing CCR7 expression and through this mechanism, statins would promote CD68+ cell emigration from plaques. We examined whether statin activation of the SREBP pathway in vivo would induce CCR7 expression and promote macrophage emigration from plaques. We found that western diet-fed apoE(-/-) mice treated with either atorvastatin or rosuvastatin led to a substantial reduction in the CD68+ cell content in the plaques despite continued hyperlipidemia. We also observed a significant increase in CCR7 mRNA in CD68+ cells from both the atorvastatin and rosuvastatin treated mice associated with emigration of CD68+ cells from plaques. Importantly, CCR7(-/-)/apoE(-/-) double knockout mice failed to display a reduction in CD68+ cell content upon statin treatment. Statins also affected the recruitment of transcriptional regulatory proteins and the organization of the chromatin at the CCR7 promoter to increase the transcriptional activity. Statins promote the beneficial remodeling of plaques in diseased mouse arteries through the stimulation of the CCR7 emigration pathway in macrophages. Therefore, statins may exhibit some of their clinical benefits by not only retarding the progression of atherosclerosis, but also accelerating its regression.	[Feig, Jonathan E.; Shang, Yueting; Rotllan, Noemi; Vengrenyuk, Yuliya; Shamir, Raanan; Fernandez-Hernando, Carlos; Fisher, Edward A.] NYU, Sch Med, Dept Med, Div Cardiol,Marc & Ruti Bell Program Vasc Biol, New York, NY USA; [Wu, Chaowei; Torra, Ines Pineda; Garabedian, Michael J.] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA	New York University; New York University	Feig, JE (corresponding author), NYU, Sch Med, Dept Med, Div Cardiol,Marc & Ruti Bell Program Vasc Biol, New York, NY USA.	edward.fisher@nyumc.org; michael.garabedian@nyumc.org	Rotllan, Noemi/P-1375-2014; Vila, Noemi Rotllan/AAQ-8050-2020; Fisher, Edward/ABE-7469-2020	Rotllan, Noemi/0000-0002-0587-8045; Vila, Noemi Rotllan/0000-0002-0587-8045; Pineda Torra, Ines/0000-0002-7349-2208; Fisher, Edward/0000-0001-9802-143X	National Institutes of Health [R01HL084312, P01HL098055, AG029748, T32HL098129]; Pfizer; Astra-Zeneca; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL098055, T32HL098129, R01HL084312] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F30AG029748] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pfizer(Pfizer); Astra-Zeneca(AstraZeneca); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	These studies were supported by the National Institutes of Health [R01HL084312 and P01HL098055, (EAF, MJG), pre-doctoral fellowship AG029748 (JEF), training grant T32HL098129 (YV)] and grants from Pfizer and Astra-Zeneca (EAF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Boyault C, 2007, ONCOGENE, V26, P5468, DOI 10.1038/sj.onc.1210614; Breslow JL, 1996, SCIENCE, V272, P685, DOI 10.1126/science.272.5262.685; Chereshnev I, 2003, J SURG RES, V111, P171, DOI 10.1016/S0022-4804(03)00039-8; Crisby M, 2001, CIRCULATION, V103, P926, DOI 10.1161/01.cir.103.7.926; Feig JE, 2010, J CLIN INVEST, V120, P4415, DOI 10.1172/JCI38911; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Francavilla V, 2004, EUR J IMMUNOL, V34, P427, DOI 10.1002/eji.200324539; Grundy SM, 2004, ARTERIOSCL THROM VAS, V24, P1329, DOI 10.1161/01.ATV.0000139012.45265.e0; Li AC, 2004, J CLIN INVEST, V114, P1564, DOI 10.1172/JCI200418730; Liao JK, 2005, CURR OPIN LIPIDOL, V16, P624, DOI 10.1097/01.mol.0000191913.16321.60; Llodra J, 2004, P NATL ACAD SCI USA, V101, P11779, DOI 10.1073/pnas.0403259101; Nicholls SJ, 2007, JAMA-J AM MED ASSOC, V297, P499, DOI 10.1001/jama.297.5.499; Nissen SE, 2006, JAMA-J AM MED ASSOC, V295, P1556, DOI 10.1001/jama.295.13.jpc60002; Nissen SE, 2004, JAMA-J AM MED ASSOC, V291, P1071, DOI 10.1001/jama.291.9.1071; Osborne TF, 2009, GENE DEV, V23, P2578, DOI 10.1101/gad.1854309; Parra M, 2010, CURR OPIN PHARMACOL, V10, P454, DOI 10.1016/j.coph.2010.04.004; Rayner KJ, 2010, SCIENCE, V328, P1570, DOI 10.1126/science.1189862; Reis ED, 2001, J VASC SURG, V34, P541, DOI 10.1067/mva.2001.115963; Rong JX, 2003, P NATL ACAD SCI USA, V100, P13531, DOI 10.1073/pnas.1735526100; Rosenson RS, 1998, JAMA-J AM MED ASSOC, V279, P1643, DOI 10.1001/jama.279.20.1643; Saederup N, 2008, CIRCULATION, V117, P1642, DOI 10.1161/CIRCULATIONAHA.107.743872; Schneider F, 2008, CIRCULATION, V117, P931, DOI 10.1161/CIRCULATIONAHA.107.707448; Shang YT, 2008, J CELL BIOL, V181, P461, DOI 10.1083/jcb.200711145; SHENG ZQ, 1995, P NATL ACAD SCI USA, V92, P935, DOI 10.1073/pnas.92.4.935; Tabibiazar R, 2005, ARTERIOSCL THROM VAS, V25, P302, DOI 10.1161/01.ATV.0000151372.86863.a5; Tacke F, 2006, J EXP MED, V203, P583, DOI 10.1084/jem.20052119; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; Toth JI, 2004, MOL CELL BIOL, V24, P8288, DOI 10.1128/MCB.24.18.8288-8300.2004; Trogan E, 2004, ARTERIOSCL THROM VAS, V24, P1714, DOI 10.1161/01.ATV.0000139313.69015.1c; Trogan E, 2006, P NATL ACAD SCI USA, V103, P3781, DOI 10.1073/pnas.0511043103; Trogan Eugene, 2005, Methods Mol Biol, V293, P221; Valenzuela-Fernandez A, 2008, TRENDS CELL BIOL, V18, P291, DOI 10.1016/j.tcb.2008.04.003; Williams KJ, 2008, NAT CLIN PRACT CARD, V5, P91, DOI 10.1038/ncpcardio1086; Williams KJ, 2007, CURR OPIN LIPIDOL, V18, P443, DOI 10.1097/MOL.0b013e32823bcb15; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543; Zhang Y, 2008, MOL CELL BIOL, V28, P1688, DOI 10.1128/MCB.01154-06	38	118	125	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2011	6	12							e28534	10.1371/journal.pone.0028534	http://dx.doi.org/10.1371/journal.pone.0028534			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863OC	22163030	Green Published, gold, Green Submitted			2022-12-27	WOS:000298173500030
J	Hovakimyan, M; Petersen, J; Maass, F; Reichard, M; Witt, M; Lukas, J; Stachs, O; Guthoff, R; Rolfs, A; Wree, A				Hovakimyan, Marine; Petersen, Jana; Maass, Fabian; Reichard, Maria; Witt, Martin; Lukas, Jan; Stachs, Oliver; Guthoff, Rudolf; Rolfs, Arndt; Wree, Andreas			Corneal Alterations during Combined Therapy with Cyclodextrin/Allopregnanolone and Miglustat in a Knock-Out Mouse Model of NPC1 Disease	PLOS ONE			English	Article							NIEMANN-PICK-DISEASE; C-DISEASE; PROTEIN; ACTIVATION; ADULT	Background: Niemann Pick disease type C1 is a neurodegenerative disease caused by mutations in the NPC1 gene, which result in accumulation of unesterified cholesterol and glycosphingolipids in the endosomal-lysosomal system as well as limiting membranes. We have previously shown the corneal involvement in NPC1 pathology in form of intracellular inclusions in epithelial cells and keratocytes. The purpose of the present study was to clarify if these inclusions regress during combined substrate reduction-and by-product therapy (SRT and BPT). Methodology/Principal Findings: Starting at postnatal day 7 (P7) and thereafter, NPC1 knock-out mice (NPC1(-/-)) and wild type controls (NPC1(+/+)) were injected with cyclodextrin/allopregnanolone weekly. Additionally, a daily miglustat injection started at P10 until P23. Starting at P23 the mice were fed powdered chow with daily addition of miglustat. The sham group was injected with 0.9% NaCl at P7, thereafter daily starting at P10 until P23, and fed powdered chow starting at P23. For corneal examination, in vivo confocal laser-scanning microscopy (CLSM) was performed one day before experiment was terminated. Excised corneas were harvested for lipid analysis (HPLC/MS) and electron microscopy. In vivo CLSM demonstrated a regression of hyperreflective inclusions in all treated NPC1(-/-) mice. The findings varied between individual mice, demonstrating a regression, ranging from complete absence to pronounced depositions. The reflectivity of inclusions, however, was significantly lower when compared to untreated and sham-injected NPC1(-/-) mice. These confocal findings were confirmed by lipid analysis and electron microscopy. Another important CLSM finding revealed a distinct increase of mature dendritic cell number in corneas of all treated mice (NPC1(-/-) and NPC1(+/+)), including sham-treated ones. Conclusions/Significance: The combined substrate reduction-and by-product therapy revealed beneficial effects on the cornea. In vivo CLSM is a non-invasive tool to monitor disease progression and treatment effects in NPC1 disorder.	[Hovakimyan, Marine; Reichard, Maria; Stachs, Oliver; Guthoff, Rudolf] Univ Rostock, Dept Ophthalmol, Rostock, Germany; [Hovakimyan, Marine; Petersen, Jana; Maass, Fabian; Witt, Martin; Wree, Andreas] Univ Rostock, Dept Anat, Rostock, Germany; [Lukas, Jan; Rolfs, Arndt] Univ Rostock, Albrecht Kossel Inst Neuroregenerat, Rostock, Germany	University of Rostock; University of Rostock; University of Rostock	Hovakimyan, M (corresponding author), Univ Rostock, Dept Ophthalmol, Rostock, Germany.	marine.hovakimyan@uni-rostock.de	Witt, Martin/AAU-7529-2020	Witt, Martin/0000-0002-4538-877X; Maass, Fabian/0000-0002-4077-2852	DFG (Deutsche Forschungsgemeinschaft) [Transregio 37]	DFG (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	The study was generously supported by the DFG (Deutsche Forschungsgemeinschaft) (Transregio 37, Micro- and Nanosystems in Medicine - Reconstruction of Biological Functions). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel LA, 2009, NEUROLOGY, V72, P1083, DOI 10.1212/01.wnl.0000345040.01917.9d; Altmann SW, 2004, SCIENCE, V303, P1201, DOI 10.1126/science.1093131; Biswas J, 2008, CURR OPIN OPHTHALMOL, V19, P507, DOI 10.1097/ICU.0b013e32831215c3; BRADY RO, 1978, OPHTHALMOLOGY, V85, P1007; Chien YH, 2007, J INHERIT METAB DIS, V30, P826, DOI 10.1007/s10545-007-0630-y; Claudepierre T, 2010, MOL CELL NEUROSCI, V43, P164, DOI 10.1016/j.mcn.2009.10.007; Davidson CD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006951; ELLEDER M, 1985, ACTA NEUROPATHOL, V66, P325, DOI 10.1007/BF00690966; EMERY JM, 1972, AM J OPHTHALMOL, V74, P1144, DOI 10.1016/0002-9394(72)90736-2; Falke K, 2009, GRAEF ARCH CLIN EXP, V247, P523, DOI 10.1007/s00417-008-0962-9; Griffin LD, 2004, NAT MED, V10, P704, DOI 10.1038/nm1073; HARZER K, 1978, ACTA NEUROCHIR, V43, P97; Herrmann WA, 2004, CORNEA, V23, P825, DOI 10.1097/01.ico.0000126331.84852.f6; HERS HG, 1965, GASTROENTEROLOGY, V48, P625; Hovakimyan M, 2011, CORNEA, V30, P796, DOI 10.1097/ICO.0b013e3182012a33; Iturriaga C, 2006, J NEUROL SCI, V249, P1, DOI 10.1016/j.jns.2006.05.054; Lachmann RH, 2004, NEUROBIOL DIS, V16, P654, DOI 10.1016/j.nbd.2004.05.002; Langmade SJ, 2006, P NATL ACAD SCI USA, V103, P13807, DOI 10.1073/pnas.0606218103; Liscum L, 1998, CURR OPIN LIPIDOL, V9, P131, DOI 10.1097/00041433-199804000-00009; Loftus SK, 1997, SCIENCE, V277, P232, DOI 10.1126/science.277.5323.232; Maegawa GHB, 2009, MOL GENET METAB, V97, P284, DOI 10.1016/j.ymgme.2009.04.013; Millat G, 1999, AM J HUM GENET, V65, P1321, DOI 10.1086/302626; MORRIS MD, 1982, AM J PATHOL, V108, P140; Nunes A, 2011, NEUROBIOL DIS, V42, P349, DOI 10.1016/j.nbd.2011.01.028; PALMER M, 1985, ARCH OPHTHALMOL-CHIC, V103, P817, DOI 10.1001/archopht.1985.01050060077030; Patterson MC, 2007, LANCET NEUROL, V6, P765, DOI 10.1016/S1474-4422(07)70194-1; Pineda M, 2009, MOL GENET METAB, V98, P243, DOI 10.1016/j.ymgme.2009.07.003; Poupetova H, 2010, J INHERIT METAB DIS, V33, P387, DOI 10.1007/s10545-010-9093-7; Sawamura N, 2001, J BIOL CHEM, V276, P10314, DOI 10.1074/jbc.M009733200; Strauss JF, 2002, STEROIDS, V67, P947, DOI 10.1016/S0039-128X(02)00042-9; SUZUKI K, 1995, ACTA NEUROPATHOL, V89, P227; Tavakoli M, 2011, CONTACT LENS ANTERIO, V34, P7, DOI 10.1016/j.clae.2010.08.007; Tavares R, 2009, CORNEA, V28, P938, DOI 10.1097/ICO.0b013e318199eb5b; Vanier MT, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-16; VANIER MT, 1988, CLIN GENET, V33, P331; Vanier MT, 2003, CLIN GENET, V64, P269, DOI 10.1034/j.1399-0004.2003.00147.x; Vanier MT, 1998, BRAIN PATHOL, V8, P163; Wraith JE, 2010, MOL GENET METAB, V99, P351, DOI 10.1016/j.ymgme.2009.12.006; Xie CL, 1999, P NATL ACAD SCI USA, V96, P11992, DOI 10.1073/pnas.96.21.11992; Zervas M, 2001, CURR BIOL, V11, P1283, DOI 10.1016/S0960-9822(01)00396-7; Zhang M, 2004, AM J PATHOL, V165, P843, DOI 10.1016/S0002-9440(10)63347-0; Zhang M, 2008, J NEUROCHEM, V107, P814, DOI 10.1111/j.1471-4159.2008.05657.x	42	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2011	6	12							e28418	10.1371/journal.pone.0028418	http://dx.doi.org/10.1371/journal.pone.0028418			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863OC	22163015	Green Published, gold, Green Submitted			2022-12-27	WOS:000298173500019
J	Vizlin-Hodzic, D; Runnberg, R; Ryme, J; Simonsson, S; Simonsson, T				Vizlin-Hodzic, Dzeneta; Runnberg, Rikard; Ryme, Jessica; Simonsson, Stina; Simonsson, Tomas			SAF-A Forms a Complex with BRG1 and Both Components Are Required for RNA Polymerase II Mediated Transcription	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; NUCLEAR RIBONUCLEOPROTEIN U; PROTEIN HNRNP-U; ATTACHMENT FACTOR; BINDING-PROTEIN; SELF-RENEWAL; IN-VIVO; EXPRESSION; CHROMATIN; BROMODOMAIN	Background: Scaffold attachment factor A (SAF-A) participates in the regulation of gene expression by organizing chromatin into transcriptionally active domains and by interacting directly with RNA polymerase II. Methodology: Here we use co-localization, co-immunoprecipitation (co-IP) and in situ proximity ligation assay (PLA) to identify Brahma Related Gene 1 (BRG1), the ATP-driven motor of the human SWI-SNF chromatin remodeling complex, as another SAF-A interaction partner in mouse embryonic stem (mES) cells. We also employ RNA interference to investigate functional aspects of the SAF-A/BRG1 interaction. Principal Findings: We find that endogenous SAF-A protein interacts with endogenous BRG1 protein in mES cells, and that the interaction does not solely depend on the presence of mRNA. Moreover the interaction remains intact when cells are induced to differentiate. Functional analyses reveal that dual depletion of SAF-A and BRG1 abolishes global transcription by RNA polymerase II, while the nucleolar RNA polymerase I transcription machinery remains unaffected. Conclusions: We demonstrate that SAF-A interacts with BRG1 and that both components are required for RNA Polymerase II Mediated Transcription.	[Vizlin-Hodzic, Dzeneta; Runnberg, Rikard; Ryme, Jessica; Simonsson, Tomas] Univ Gothenburg, Dept Med Biochem & Cell Biol, Inst Biomed, Gothenburg, Sweden; [Simonsson, Stina] Sahlgrens Univ Hosp, Dept Clin Chem & Transfus Med, Inst Biomed, Gothenburg, Sweden	University of Gothenburg; Sahlgrenska University Hospital	Vizlin-Hodzic, D (corresponding author), Univ Gothenburg, Dept Med Biochem & Cell Biol, Inst Biomed, Gothenburg, Sweden.	Stina.simonsson@medkem.gu.se; tomas.simonsson@gu.se	Simonsson, Stina/R-2699-2016	Simonsson, Stina/0000-0001-9020-3714	Swedish Research Council; Swedish Cancer Society; Clas Groschinsky Memory Foundation; Ake Wiberg Foundation; Magnus Bergvall Research Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Clas Groschinsky Memory Foundation; Ake Wiberg Foundation; Magnus Bergvall Research Foundation	This work was supported by the Swedish Research Council, the Swedish Cancer Society, the Clas Groschinsky Memory Foundation, the Ake Wiberg Foundation, and the Magnus Bergvall Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad N, 2005, BIOCHEMISTRY-US, V44, P6276, DOI 10.1021/bi050018s; Asp P, 2002, J CELL SCI, V115, P2735; Batsche E, 2006, NAT STRUCT MOL BIOL, V13, P22, DOI 10.1038/nsmb1030; Bultman S, 2000, MOL CELL, V6, P1287, DOI 10.1016/S1097-2765(00)00127-1; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; DREYFUSS G, 1993, ANNU REV BIOCHEM, V62, P289, DOI 10.1146/annurev.bi.62.070193.001445; Eggert M, 1997, J BIOL CHEM, V272, P28471, DOI 10.1074/jbc.272.45.28471; Gohring F, 1997, EMBO J, V16, P7361, DOI 10.1093/emboj/16.24.7361; Gohring F, 1997, BIOCHEMISTRY-US, V36, P8276, DOI 10.1021/bi970480f; Ho L, 2009, P NATL ACAD SCI USA, V106, P5181, DOI 10.1073/pnas.0812889106; Jacobson RH, 2000, SCIENCE, V288, P1422, DOI 10.1126/science.288.5470.1422; Kawano S, 2010, J BIOL CHEM, V285, P26451, DOI 10.1074/jbc.M110.112979; KHAVARI PA, 1993, NATURE, V366, P170, DOI 10.1038/366170a0; Kidder BL, 2009, STEM CELLS, V27, P317, DOI 10.1634/stemcells.2008-0710; Kim MK, 1999, MOL CELL BIOL, V19, P6833; Kim SI, 2009, NUCLEIC ACIDS RES, V37, P6019, DOI 10.1093/nar/gkp677; Kingston RE, 1999, GENE DEV, V13, P2339, DOI 10.1101/gad.13.18.2339; Kukalev A, 2005, NAT STRUCT MOL BIOL, V12, P238, DOI 10.1038/nsmb904; Levros LC, 2010, BBA-MOL CELL RES, V1803, P1062, DOI 10.1016/j.bbamcr.2010.04.011; Lin RK, 2010, J CLIN INVEST, V120, P521, DOI 10.1172/JCI40706; Liu K, 2004, GENE DEV, V18, P673, DOI 10.1101/gad.1180204; Luo L, 2009, J CELL SCI, V122, P3729, DOI 10.1242/jcs.052555; Malik KF, 1997, MOL BRAIN RES, V45, P99, DOI 10.1016/S0169-328X(96)00238-0; Martens JHA, 2002, MOL CELL BIOL, V22, P2598, DOI 10.1128/MCB.22.8.2598-2606.2002; Muchardt C, 1998, EMBO J, V17, P223, DOI 10.1093/emboj/17.1.223; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Neish AS, 1998, NUCLEIC ACIDS RES, V26, P847, DOI 10.1093/nar/26.3.847; Obrdlik A, 2008, MOL CELL BIOL, V28, P6342, DOI 10.1128/MCB.00766-08; Onishi Y, 2008, MOL CELL BIOL, V28, P3477, DOI 10.1128/MCB.02227-07; Orphanides G, 2002, CELL, V108, P439, DOI 10.1016/S0092-8674(02)00655-4; Reyes JC, 1997, J CELL BIOL, V137, P263, DOI 10.1083/jcb.137.2.263; ROMIG H, 1992, EMBO J, V11, P3431, DOI 10.1002/j.1460-2075.1992.tb05422.x; Roshon MJ, 2005, TRANSGENIC RES, V14, P179, DOI 10.1007/s11248-004-8147-8; Shen WQ, 2007, BIOCHEMISTRY-US, V46, P2100, DOI 10.1021/bi0611208; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Spraggon L, 2007, ONCOGENE, V26, P1484, DOI 10.1038/sj.onc.1209922; Subtil-Rodriguez A, 2010, EMBO REP, V11, P751, DOI 10.1038/embor.2010.131; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; Zhao J, 2009, HUM MOL GENET, V18, P3090, DOI 10.1093/hmg/ddp250	41	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2011	6	12							e28049	10.1371/journal.pone.0028049	http://dx.doi.org/10.1371/journal.pone.0028049			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863OC	22162999	Green Published, Green Submitted, gold			2022-12-27	WOS:000298173500010
J	Thayil, SM; Albini, TA; Nazari, H; Moshfeghi, AA; Parel, JMA; Rao, NA; Karakousis, PC				Thayil, Seema M.; Albini, Thomas A.; Nazari, Hossein; Moshfeghi, Andrew A.; Parel, Jean-Marie A.; Rao, Narsing A.; Karakousis, Petros C.			Local Ischemia and Increased Expression of Vascular Endothelial Growth Factor Following Ocular Dissemination of Mycobacterium tuberculosis	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; PROINFLAMMATORY CYTOKINES; INTRAOCULAR TUBERCULOSIS; PULMONARY TUBERCULOSIS; PLEURAL EFFUSIONS; DISEASE-ACTIVITY; AQUEOUS-HUMOR; GUINEA-PIGS; SERUM; ANGIOGENESIS	The pathogenesis of intraocular tuberculosis remains poorly understood partly due to the lack of adequate animal models that accurately simulate human disease. Using a recently developed model of ocular tuberculosis following aerosol infection of guinea pigs with Mycobacterium tuberculosis, we studied the microbiological, histological, and clinical features of intraocular tuberculosis infection. Viable tubercle bacilli were cultivated from all eyes by Day 56 after aerosol delivery of similar to 200 bacilli to guinea pig lungs. Choroidal tuberculous granulomas showed reduced oxygen tension, as evidenced by staining with the hypoxia-specific probe pimonidazole, and expression of vascular endothelial growth factor (VEGF) was detected in the retinal pigment epithelium (RPE) and photoreceptors. Fundoscopic examination of M. tuberculosis-infected guinea pig eyes revealed altered vascular architecture and chorioretinal hemorrhage by Day 56 after infection. This model may be useful in further elucidating the pathogenesis of ocular tuberculosis, as well as in developing tools for diagnosis and assessment of antituberculosis treatment responses in the eye.	[Thayil, Seema M.; Karakousis, Petros C.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Albini, Thomas A.; Moshfeghi, Andrew A.; Parel, Jean-Marie A.] Univ Miami, Bascom Palmer Eye Inst, Miami, FL USA; [Nazari, Hossein; Rao, Narsing A.] Univ So Calif, Doheny Eye Inst, Los Angeles, CA USA; [Karakousis, Petros C.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA	Johns Hopkins University; Bascom Palmer Eye Institute; University of Miami; Doheny Eye Institute; University of Southern California; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Thayil, SM (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA.	petros@jhmi.edu	Karakousis, Petros Constantine/AAR-7899-2020	Albini, Thomas/0000-0003-2199-9047; Thayil, SEEMA/0000-0002-3111-6861	Bill & Melinda Gates foundation [42851]; National Institutes of Health (NIH) [K08AI064229, R01AI083125, R01HL106786, P30EY14801]; Florida Lions Eye Bank; Henri and Flore Lesieur Foundation; Morris Morgenstern Foundation; Palm Beach Community Trust Fund; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [P30EY014801] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL106786] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI064229, R01AI083125] Funding Source: NIH RePORTER	Bill & Melinda Gates foundation(Bill & Melinda Gates Foundation); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Florida Lions Eye Bank; Henri and Flore Lesieur Foundation; Morris Morgenstern Foundation; Palm Beach Community Trust Fund; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by TB Accelerator grant #42851 from the Bill & Melinda Gates foundation and National Institutes of Health (NIH) grants K08AI064229, R01AI083125, and R01HL106786 to P.C.K. Development of the fundus camera was supported by NIH P30EY14801 (Center Grant), the Florida Lions Eye Bank, the Henri and Flore Lesieur Foundation (J.M.P.), the Morris Morgenstern Foundation (T.A.A.), an unrestricted grant from the Palm Beach Community Trust Fund (T.A.A.), and an unrestricted grant from Research to Prevent Blindness (T.A.A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad Z, 2011, ANTIMICROB AGENTS CH, V55, P1527, DOI 10.1128/AAC.01524-10; Ahmad Z, 2009, J INFECT DIS, V200, P1136, DOI 10.1086/605605; Alagappan VKT, 2005, CELL BIOCHEM BIOPHYS, V43, P119, DOI 10.1385/CBB:43:1:119; Alatas F, 2004, CHEST, V125, P2156, DOI 10.1378/chest.125.6.2156; Aly S, 2007, J PATHOL, V212, P295, DOI 10.1002/path.2185; Angelo LS, 2007, CLIN CANCER RES, V13, P2825, DOI 10.1158/1078-0432.CCR-06-2416; Araujo AP, 2010, EXP MOL PATHOL, V89, P327, DOI 10.1016/j.yexmp.2010.09.003; Beek LAMT, 2006, EMERG INFECT DIS, V12, P1375, DOI 10.3201/eid1209.050553; *CDC, 2007, REP TUB US 2006; Cekmen M, 2003, INT J DERMATOL, V42, P870, DOI 10.1046/j.1365-4362.2003.01688.x; Charalambous C, 2005, CANCER RES, V65, P10347, DOI 10.1158/0008-5472.CAN-05-0949; Chegou Novel N, 2009, BMC Pulm Med, V9, P21, DOI 10.1186/1471-2466-9-21; Chu SC, 2004, J ENDODONT, V30, P704, DOI 10.1097/01.DON.0000129962.65752.C6; Cutrufello NJ, 2010, OCUL IMMUNOL INFLAMM, V18, P281, DOI 10.3109/09273948.2010.489729; Djoba Siawaya JF, 2009, CLIN EXP IMMUNOL, V156, P69, DOI 10.1111/j.1365-2249.2009.03875.x; Euro TB, 2008, SURV TUB EUR; Ferrara N, 2010, RETINAL PHARMACOTHER, P230; Fine HF, 2001, AM J OPHTHALMOL, V132, P794, DOI 10.1016/S0002-9394(01)01103-5; Gupta V, 2007, SURV OPHTHALMOL, V52, P561, DOI 10.1016/j.survophthal.2007.08.015; Hernandez VM, VET OPHTHAL IN PRESS; Husain N, 2008, J INFECTION, V56, P114, DOI 10.1016/j.jinf.2007.11.004; Klinkenberg LG, 2008, J INFECT DIS, V198, P275, DOI 10.1086/589515; Lim SC, 2000, J KOREAN MED SCI, V15, P279, DOI 10.3346/jkms.2000.15.3.279; Liu JN, 2010, CARDIOLOGY, V116, P37, DOI 10.1159/000313465; Machein MR, 1999, NEUROPATH APPL NEURO, V25, P104; Maruotti N, 2006, HISTOL HISTOPATHOL, V21, P557, DOI 10.14670/HH-21.557; Matsuyama W, 2002, IMMUNOLOGY, V106, P96, DOI 10.1046/j.1365-2567.2002.01395.x; Matsuyama W, 2001, J NEUROL SCI, V186, P75, DOI 10.1016/S0022-510X(01)00515-9; Matsuyama W, 2000, AM J RESP CRIT CARE, V162, P1120, DOI 10.1164/ajrccm.162.3.9911010; Mitsuyama H, 2006, CHEST, V129, P407, DOI 10.1378/chest.129.2.407; Paques M, 2007, INVEST OPHTH VIS SCI, V48, P2769, DOI 10.1167/iovs.06-1099; Paroli MP, 2007, EUR J OPHTHALMOL, V17, P938, DOI 10.1177/112067210701700611; Rajappa M, 2010, ADV CLIN CHEM, V50, P103, DOI 10.1016/S0065-2423(10)50006-4; Raleigh JA, 1998, CANCER RES, V58, P3765; Rao NA, 2009, ARCH OPHTHALMOL-CHIC, V127, P1162, DOI 10.1001/archophthalmol.2009.220; RIEDER HL, 1990, AM REV RESPIR DIS, V141, P347, DOI 10.1164/ajrccm/141.2.347; ROL P, 1995, OPT ENG, V34, P2070, DOI 10.1117/12.204800; Saint-Geniez M, 2009, P NATL ACAD SCI USA, V106, P18751, DOI 10.1073/pnas.0905010106; Seiscento M, 2010, INT J TUBERC LUNG D, V14, P1153; SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0; Thwaites GE, 2004, NEW ENGL J MED, V351, P1741, DOI 10.1056/NEJMoa040573; Tolnay E, 1998, VIRCHOWS ARCH, V432, P61, DOI 10.1007/s004280050135; Tsai MC, 2006, CELL MICROBIOL, V8, P218, DOI 10.1111/j.1462-5822.2005.00612.x; van der Flier M, 2004, PEDIATR INFECT DIS J, V23, P608, DOI 10.1097/01.inf.0000131634.57368.45; Varia MA, 1998, GYNECOL ONCOL, V71, P270, DOI 10.1006/gyno.1998.5163; Via LE, 2008, INFECT IMMUN, V76, P2333, DOI 10.1128/IAI.01515-07; Vinores SA, 1997, HISTOL HISTOPATHOL, V12, P99; Wiertz K, 2010, RETINA-J RET VIT DIS, V30, P1734, DOI 10.1097/IAE.0b013e3181dde70b; World Health Organization, 2008, GLOB TUB CONTR SURV; Yeh HH, 2006, ONCOGENE, V25, P4300, DOI 10.1038/sj.onc.1209464; Zhou WB, 2009, INT J TUBERC LUNG D, V13, P381	51	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e28383	10.1371/journal.pone.0028383	http://dx.doi.org/10.1371/journal.pone.0028383			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22162767	gold, Green Submitted, Green Published			2022-12-27	WOS:000298172800032
J	Spijkerman, E; de Castro, F; Gaedke, U				Spijkerman, Elly; de Castro, Francisco; Gaedke, Ursula			Independent Colimitation for Carbon Dioxide and Inorganic Phosphorus	PLOS ONE			English	Article							CO2 CONCENTRATING MECHANISMS; FRESH-WATER ALGAE; CHLAMYDOMONAS-ACIDOPHILA; MARINE-PHYTOPLANKTON; MIXOTROPHIC GROWTH; LIMITATION; ACQUISITION; EVOLUTION; PHOSPHATE; NITROGEN	Simultaneous limitation of plant growth by two or more nutrients is increasingly acknowledged as a common phenomenon in nature, but its cellular mechanisms are far from understood. We investigated the uptake kinetics of CO(2) and phosphorus of the algae Chlamydomonas acidophila in response to growth at limiting conditions of CO(2) and phosphorus. In addition, we fitted the data to four different Monod-type models: one assuming Liebigs Law of the minimum, one assuming that the affinity for the uptake of one nutrient is not influenced by the supply of the other (independent colimitation) and two where the uptake affinity for one nutrient depends on the supply of the other (dependent colimitation). In addition we asked whether the physiological response under colimitation differs from that under single nutrient limitation. We found no negative correlation between the affinities for uptake of the two nutrients, thereby rejecting a dependent colimitation. Kinetic data were supported by a better model fit assuming independent uptake of colimiting nutrients than when assuming Liebigs Law of the minimum or a dependent colimitation. Results show that cell nutrient homeostasis regulated nutrient acquisition which resulted in a trade-off in the maximum uptake rates of CO(2) and phosphorus, possibly driven by space limitation on the cell membrane for porters for the different nutrients. Hence, the response to colimitation deviated from that to a single nutrient limitation. In conclusion, responses to single nutrient limitation cannot be extrapolated to situations where multiple nutrients are limiting, which calls for colimitation experiments and models to properly predict growth responses to a changing natural environment. These deviations from single nutrient limitation response under colimiting conditions and independent colimitation may also hold for other nutrients in algae and in higher plants.	[Spijkerman, Elly; de Castro, Francisco; Gaedke, Ursula] Univ Potsdam, Dept Ecol & Ecosyst Modelling, Potsdam, Germany	University of Potsdam	Spijkerman, E (corresponding author), Univ Potsdam, Dept Ecol & Ecosyst Modelling, Potsdam, Germany.	spijker@uni-potsdam.de	de Castro, Francisco/G-2213-2011	de Castro, Francisco/0000-0001-8834-3363	German research foundation (DFG) [SP695/2, GA401/12-1]	German research foundation (DFG)(German Research Foundation (DFG))	This work was supported by the German research foundation (DFG, SP695/2 & GA401/12-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKSNES DL, 1991, MAR ECOL PROG SER, V70, P65, DOI 10.3354/meps070065; Arrigo KR, 2005, NATURE, V437, P349, DOI 10.1038/nature04159; Beardall J, 2005, CAN J BOT, V83, P859, DOI 10.1139/B05-070; BEARDALL J, 1991, CAN J BOT, V69, P1146, DOI 10.1139/b91-147; Beardall J, 2002, FUNCT PLANT BIOL, V29, P335, DOI 10.1071/PP01195; Bolker M. B., 2008, ECOLOGICAL MODELS DA; Buitenhuis ET, 2003, LIMNOL OCEANOGR, V48, P1575, DOI 10.4319/lo.2003.48.4.1575; Clark DR, 2000, P ROY SOC B-BIOL SCI, V267, P953, DOI 10.1098/rspb.2000.1096; Clegg MR, 2004, PLANT CELL ENVIRON, V27, P123, DOI 10.1111/j.1365-2478.2004.01138.x; Davidson EA, 2007, NATURE, V449, P1000, DOI 10.1038/4491000a; Dietrich P, 1998, PLANTA, V205, P277, DOI 10.1007/s004250050322; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; Franks PJ, 2009, P NATL ACAD SCI USA, V106, P10343, DOI 10.1073/pnas.0904209106; Gerhart LM, 2010, NEW PHYTOL, V188, P674, DOI 10.1111/j.1469-8137.2010.03441.x; Giordano M, 2005, ANNU REV PLANT BIOL, V56, P99, DOI 10.1146/annurev.arplant.56.032604.144052; Giordano M, 2001, J PLANT PHYSIOL, V158, P577, DOI 10.1078/0176-1617-00234; GROVER JP, 1989, LIMNOL OCEANOGR, V34, P341, DOI 10.4319/lo.1989.34.2.0341; Ibelings BW, 1998, LIMNOL OCEANOGR, V43, P408, DOI 10.4319/lo.1998.43.3.0408; Kilham SS, 1977, J GREAT LAKES RES, V31, P93; Klausmeier CA, 2007, J THEOR BIOL, V246, P278, DOI 10.1016/j.jtbi.2006.12.032; Klausmeier CA, 2004, NATURE, V429, P171, DOI 10.1038/nature02454; Kooijman SALM, 1998, BIOPHYS CHEM, V73, P179, DOI 10.1016/S0301-4622(98)00162-8; Kozlowska-Szerenos B, 2004, PLANT PHYSIOL BIOCH, V42, P403, DOI 10.1016/j.plaphy.2004.02.010; MEDVECZKY N, 1971, BIOCHIM BIOPHYS ACTA, V241, P494, DOI 10.1016/0005-2736(71)90048-4; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; Nagai T, 2006, AQUAT MICROB ECOL, V44, P231, DOI 10.3354/ame044231; Nichols HW., 1975, HDB PHYCOLOGICAL MET, P7; North RL, 2007, LIMNOL OCEANOGR, V52, P315, DOI 10.4319/lo.2007.52.1.0315; ONEILL RV, 1989, ECOL MODEL, V46, P147, DOI 10.1016/0304-3800(89)90015-X; PERRY MJ, 1976, LIMNOL OCEANOGR, V21, P88, DOI 10.4319/lo.1976.21.1.0088; Raven J A, 1980, Adv Microb Physiol, V21, P47; RAVEN JA, 1982, NEW PHYTOL, V92, P1, DOI 10.1111/j.1469-8137.1982.tb03358.x; Raven JA, 2008, PHILOS T R SOC B, V363, P2641, DOI 10.1098/rstb.2008.0020; Raven JA, 2008, PHYSIOL PLANTARUM, V133, P4, DOI 10.1111/j.1399-3054.2007.01024.x; Rhee G-Y, 1980, ADV AQUATIC MICROB, P151; RHEE GY, 1973, J PHYCOL, V9, P495, DOI 10.1111/j.1529-8817.1973.tb04126.x; RIEBESELL U, 1993, NATURE, V361, P249, DOI 10.1038/361249a0; Rost B, 2003, LIMNOL OCEANOGR, V48, P55, DOI 10.4319/lo.2003.48.1.0055; Saito MA, 2008, LIMNOL OCEANOGR, V53, P276, DOI 10.4319/lo.2008.53.1.0276; SANDWELL DT, 1987, GEOPHYS RES LETT, V14, P139, DOI 10.1029/GL014i002p00139; SCHINDLER DW, 1977, SCIENCE, V195, P260, DOI 10.1126/science.195.4275.260; Schrader PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018753; Spijkerman E, 2005, CAN J BOT, V83, P872, DOI 10.1139/B05-073; Spijkerman E, 1996, EUR J PHYCOL, V31, P53, DOI 10.1080/09670269600651191; Spijkerman E, 1997, J PLANKTON RES, V19, P1899, DOI 10.1093/plankt/19.12.1899; Spijkerman E, 1998, FRESHWATER BIOL, V39, P503, DOI 10.1046/j.1365-2427.1998.00299.x; Spijkerman E, 2008, PHYSIOL PLANTARUM, V133, P41, DOI 10.1111/j.1399-3054.2008.01062.x; Spijkerman E, 2007, J EXP BOT, V58, P4195, DOI 10.1093/jxb/erm276; Spijkerman E, 2007, EUR J PHYCOL, V42, P327, DOI 10.1080/09670260701529596; Spijkerman E, 2011, PHOTOSYNTH RES, V109, P179, DOI 10.1007/s11120-010-9607-z; Spijkerman E, 2011, EXTREMOPHILES, V15, P597, DOI 10.1007/s00792-011-0390-3; Spijkerman E, 2010, J PHYCOL, V46, P658, DOI 10.1111/j.1529-8817.2010.00859.x; Spijkerman E, 2008, AQUAT MICROB ECOL, V53, P201, DOI 10.3354/ame01244; STUMM W, 1970, AQUATIC CHEM CHEM EQ; TILMAN D, 1981, ECOLOGY, V62, P802, DOI 10.2307/1937747; Tittel J, 2005, PROTIST, V156, P63, DOI 10.1016/j.protis.2004.09.001; Turpin D.H., 1988, P316; van Hunnik E, 2002, PLANTA, V215, P763, DOI 10.1007/s00425-002-0817-2; Vance P, 2005, CAN J BOT, V83, P796, DOI 10.1139/B05-064; Wilson JB, 2007, AM NAT, V169, P700, DOI 10.1086/513113; Wolf-Gladrow D, 1997, MAR CHEM, V59, P17, DOI 10.1016/S0304-4203(97)00069-8; [No title captured]	62	21	22	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2011	6	12							e28219	10.1371/journal.pone.0028219	http://dx.doi.org/10.1371/journal.pone.0028219			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MQ	22145031	gold, Green Published, Green Submitted			2022-12-27	WOS:000298168900014
J	Biesold, SE; Ritz, D; Gloza-Rausch, F; Wollny, R; Drexler, JF; Corman, VM; Kalko, EKV; Oppong, S; Drosten, C; Muller, MA				Biesold, Susanne E.; Ritz, Daniel; Gloza-Rausch, Florian; Wollny, Robert; Drexler, Jan Felix; Corman, Victor M.; Kalko, Elisabeth K. V.; Oppong, Samuel; Drosten, Christian; Mueller, Marcel A.			Type I Interferon Reaction to Viral Infection in Interferon-Competent, Immortalized Cell Lines from the African Fruit Bat Eidolon helvum	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; PTEROPUS-GIGANTEUS; GENE-EXPRESSION; RESERVOIR HOSTS; VIRUS-INFECTION; SINDBIS VIRUS; MARBURG VIRUS; V-PROTEIN; ASSAY; EVOLUTION	Bats harbor several highly pathogenic zoonotic viruses including Rabies, Marburg, and henipaviruses, without overt clinical symptoms in the animals. It has been suspected that bats might have evolved particularly effective mechanisms to suppress viral replication. Here, we investigated interferon (IFN) response, -induction, -secretion and -signaling in epithelial-like cells of the relevant and abundant African fruit bat species, Eidolon helvum (E. helvum). Immortalized cell lines were generated; their potential to induce and react on IFN was confirmed, and biological assays were adapted to application in bat cell cultures, enabling comparison of landmark IFN properties with that of common mammalian cell lines. E. helvum cells were fully capable of reacting to viral and artificial IFN stimuli. E. helvum cells showed highest IFN mRNA induction, highly productive IFN protein secretion, and evidence of efficient IFN stimulated gene induction. In an Alphavirus infection model, O'nyong-nyong virus exhibited strong IFN induction but evaded the IFN response by translational rather than transcriptional shutoff, similar to other Alphavirus infections. These novel IFN-competent cell lines will allow comparative research on zoonotic, bat-borne viruses in order to model mechanisms of viral maintenance and emergence in bat reservoirs.	[Biesold, Susanne E.; Ritz, Daniel; Gloza-Rausch, Florian; Wollny, Robert; Drexler, Jan Felix; Corman, Victor M.; Drosten, Christian; Mueller, Marcel A.] Univ Bonn, Inst Virol, Med Ctr, Bonn, Germany; [Gloza-Rausch, Florian] Noctalis, Ctr Bat Protect & Informat, Bad Segeberg, Germany; [Kalko, Elisabeth K. V.] Univ Ulm, Inst Expt Ecol, Ulm, Germany; [Kalko, Elisabeth K. V.] Smithsonian Trop Res Inst, Balboa, Panama; [Oppong, Samuel] Kwame Nkrumah Univ Sci & Technol, Kumasi, Ghana	University of Bonn; Ulm University; Smithsonian Institution; Smithsonian Tropical Research Institute; Kwame Nkrumah University Science & Technology	Biesold, SE (corresponding author), Univ Bonn, Inst Virol, Med Ctr, Bonn, Germany.	drosten@virology-bonn.de	Drexler, Jan Felix/GMW-5098-2022; Drexler, Jan Felix/C-1004-2014; Corman, Victor M/K-1319-2019; Müller, Marcel A./O-2425-2019	Corman, Victor M/0000-0002-3605-0136; Müller, Marcel A./0000-0003-2242-5117; Zweerink, Susanne/0000-0003-0926-8436; Drexler, Jan Felix/0000-0002-3509-0232	German Ministry of Education [SARS II 01KI1005A]; European Commission [228292, 223498]	German Ministry of Education; European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the German Ministry of Education (project code SARS II 01KI1005A) and grants from the European Commission (contracts FP7-EVA number 228292 and FP7-EMPERIE number 223498). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARRETT ADT, 1984, J VIROL METHODS, V8, P349, DOI 10.1016/0166-0934(84)90072-7; Beitzel BF, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001146; Billecocq A, 2004, J VIROL, V78, P9798, DOI 10.1128/JVI.78.18.9798-9806.2004; BLACKBURN NK, 1982, CENT AFR J MED, V28, P201; BOULGER L. R., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P421, DOI 10.1016/0035-9203(58)90127-5; Breakwell L, 2007, J VIROL, V81, P8677, DOI 10.1128/JVI.02411-06; Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06; CHAKRAVARTY AK, 1994, LYMPHOLOGY, V27, P97; CORREAGIRON P, 1972, SCIENCE, V175, P546, DOI 10.1126/science.175.4021.546; Cowled C, 2011, DEV COMP IMMUNOL, V35, P7, DOI 10.1016/j.dci.2010.07.006; Crameri G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008266; Drexler JF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006367; EMENY JM, 1979, J GEN VIROL, V43, P247, DOI 10.1099/0022-1317-43-1-247; Frolova EI, 2002, J VIROL, V76, P11254, DOI 10.1128/JVI.76.22.11254-11264.2002; Hagmaier K, 2007, J GEN VIROL, V88, P956, DOI 10.1099/vir.0.82579-0; Hagmaier K, 2006, J GEN VIROL, V87, P3649, DOI 10.1099/vir.0.82261-0; Heaton PR, 1997, J CLIN MICROBIOL, V35, P2762, DOI 10.1128/JCM.35.11.2762-2766.1997; Herzog P, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-138; Hiscott J, 2003, ANN NY ACAD SCI, V1010, P237, DOI 10.1196/annals.1299.042; Hofmann A, 2006, MOL THER, V13, P59, DOI 10.1016/j.ymthe.2005.07.685; Holzinger D, 2007, J VIROL, V81, P7776, DOI 10.1128/JVI.00546-06; Iha K, 2010, J VET MED SCI, V72, P217, DOI 10.1292/jvms.09-0050; IRWIN DM, 1991, J MOL EVOL, V32, P128, DOI 10.1007/BF02515385; Johara MY, 2001, EMERG INFECT DIS, V7, P439; Jones G, 2006, TRENDS ECOL EVOL, V21, P149, DOI 10.1016/j.tree.2006.01.001; Jordan I, 2009, VIRUS RES, V145, P54, DOI 10.1016/j.virusres.2009.06.007; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kuhl A, 2011, J INFECT DIS, V204, pS840, DOI 10.1093/infdis/jir306; Kulasegaran-Shylini R, 2009, VIROLOGY, V387, P211, DOI 10.1016/j.virol.2009.02.027; Kuri T, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-50; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MCMURRAY DN, 1982, DEV COMP IMMUNOL, V6, P557, DOI 10.1016/S0145-305X(82)80042-6; MOSCA JD, 1986, MOL CELL BIOL, V6, P2279, DOI 10.1128/MCB.6.6.2279; Muller MA, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-6; Panning M, 2007, J INFECT DIS, V196, pS199, DOI 10.1086/520600; Park MS, 2003, J VIROL, V77, P1501, DOI 10.1128/JVI.77.2.1501-1511.2003; Perler L, 1999, J IMMUNOL METHODS, V222, P189, DOI 10.1016/S0022-1759(98)00198-7; Pfefferle S, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-131; Ryman KD, 2008, IMMUNOL REV, V225, P27, DOI 10.1111/j.1600-065X.2008.00670.x; SARKAR SK, 1991, DEV COMP IMMUNOL, V15, P423, DOI 10.1016/0145-305X(91)90034-V; Simmons NB, 2005, SCIENCE, V307, P527, DOI 10.1126/science.1108871; STEWART WE, 1969, J VIROL, V4, P147, DOI 10.1128/JVI.4.2.147-153.1969; Stormer M, 2009, INT J MED MICROBIOL, V299, P291, DOI 10.1016/j.ijmm.2008.08.002; Swanepoel R, 1996, EMERG INFECT DIS, V2, P321, DOI 10.3201/eid0204.960407; Swanepoel R, 2007, EMERG INFECT DIS, V13, P1847, DOI 10.3201/eid1312.071115; Teeling EC, 2005, SCIENCE, V307, P580, DOI 10.1126/science.1105113; Towner JS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000764; Towner JS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000536; Vallo P, 2008, ACTA CHIROPTEROL, V10, P193, DOI 10.3161/150811008X414782; Virtue ER, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022488; Volkova E, 2008, VIROLOGY, V377, P160, DOI 10.1016/j.virol.2008.04.020; Weingartl HM, 2009, VET J, V181, P211, DOI 10.1016/j.tvjl.2008.10.016; White LK, 2011, J VIROL, V85, P606, DOI 10.1128/JVI.00767-10; Zhou P, 2011, J IMMUNOL, V186, P3138, DOI 10.4049/jimmunol.1003115	54	53	54	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e28131	10.1371/journal.pone.0028131	http://dx.doi.org/10.1371/journal.pone.0028131			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140523	Green Published, Green Submitted, gold			2022-12-27	WOS:000298168100039
J	Tallon-Baudry, C; Meyniel, F; Bourgeois-Gironde, S				Tallon-Baudry, Catherine; Meyniel, Florent; Bourgeois-Gironde, Sacha			Fast and Automatic Activation of an Abstract Representation of Money in the Human Ventral Visual Pathway	PLOS ONE			English	Article							HUMAN BRAIN; CORTEX; PERCEPTION; REWARD; EXPERIENCE; TASK	Money, when used as an incentive, activates the same neural circuits as rewards associated with physiological needs. However, unlike physiological rewards, monetary stimuli are cultural artifacts: how are monetary stimuli identified in the first place? How and when does the brain identify a valid coin, i.e. a disc of metal that is, by social agreement, endowed with monetary properties? We took advantage of the changes in the Euro area in 2002 to compare neural responses to valid coins (Euros, Australian Dollars) with neural responses to invalid coins that have lost all monetary properties (French Francs, Finnish Marks). We show in magneto-encephalographic recordings, that the ventral visual pathway automatically distinguishes between valid and invalid coins, within only similar to 150 ms. This automatic categorization operates as well on coins subjects were familiar with as on unfamiliar coins. No difference between neural responses to scrambled controls could be detected. These results could suggest the existence of a generic, all-purpose neural representation of money that is independent of experience. This finding is reminiscent of a central assumption in economics, money fungibility, or the fact that a unit of money is substitutable to another. From a neural point of view, our findings may indicate that the ventral visual pathway, a system previously thought to analyze visual features such as shape or color and to be influenced by daily experience, could also able to use conceptual attributes such as monetary validity to categorize familiar as well as unfamiliar visual objects. The symbolic abilities of the posterior fusiform region suggested here could constitute an efficient neural substrate to deal with culturally defined symbols, independently of experience, which probably fostered money's cultural emergence and success.	[Tallon-Baudry, Catherine; Meyniel, Florent] Univ Paris 06, CNRS, Ctr Rech,Inst Cerveau Moelle, INSERM, Paris, France; [Bourgeois-Gironde, Sacha] ENS, Inst Jean Nicod, F-75230 Paris 05, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Tallon-Baudry, C (corresponding author), Univ Paris 06, CNRS, Ctr Rech,Inst Cerveau Moelle, INSERM, Paris, France.	catherine.tallon-baudry@upmc.fr	Tallon-Baudry, Catherine/J-8637-2015	Tallon-Baudry, Catherine/0000-0001-8480-5831; Meyniel, Florent/0000-0002-6992-678X	Agence Nationale de la Recherche [ANR-07-BLAN-0025]	Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by the Agence Nationale de la Recherche, grant ANR-07-BLAN-0025. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLISON T, 1994, CEREB CORTEX, V4, P544, DOI 10.1093/cercor/4.5.544; Alter AL, 2008, PSYCHON B REV, V15, P985, DOI 10.3758/PBR.15.5.985; Barber HA, 2007, BRAIN RES REV, V53, P98, DOI 10.1016/j.brainresrev.2006.07.002; Breiter HC, 2001, NEURON, V30, P619, DOI 10.1016/S0896-6273(01)00303-8; Burgoyne CB, 2006, SCIENCE, V314, P1091, DOI 10.1126/science.1135429; Chen MK, 2006, J POLIT ECON, V114, P517, DOI 10.1086/503550; de Saussure F., 1916, COURS LINGUISTIQUE G; Dehaene S, 2007, NEURON, V56, P384, DOI 10.1016/j.neuron.2007.10.004; Delgado MR, 2006, SOC COGN AFFECT NEUR, V1, P250, DOI 10.1093/scan/nsl025; Gauthier I, 1999, NAT NEUROSCI, V2, P568, DOI 10.1038/9224; Grill-Spector K, 2003, CURR OPIN NEUROBIOL, V13, P159, DOI 10.1016/S0959-4388(03)00040-0; Knutson B, 2000, NEUROIMAGE, V12, P20, DOI 10.1006/nimg.2000.0593; Kourtzi Z, 2001, SCIENCE, V293, P1506, DOI 10.1126/science.1061133; Krawczyk DC, 2007, BRAIN RES, V1141, P168, DOI 10.1016/j.brainres.2007.01.052; Lea SE, 1987, INDIVIDUAL EC; Lebreton M, 2009, NEURON, V64, P431, DOI 10.1016/j.neuron.2009.09.040; Mahon BZ, 2009, NEURON, V63, P397, DOI 10.1016/j.neuron.2009.07.012; Maurer B, 2006, ANNU REV ANTHROPOL, V35, P15, DOI 10.1146/annurev.anthro.35.081705.123127; Miller EK, 2003, CURR OPIN NEUROBIOL, V13, P198, DOI 10.1016/S0959-4388(03)00037-0; Pessiglione M, 2007, SCIENCE, V316, P904, DOI 10.1126/science.1140459; Rangel A, 2008, NAT REV NEUROSCI, V9, P545, DOI 10.1038/nrn2357; Serences JT, 2008, NEURON, V60, P1169, DOI 10.1016/j.neuron.2008.10.051; Shuler MG, 2006, SCIENCE, V311, P1606, DOI 10.1126/science.1123513; Sigala N, 2002, NATURE, V415, P318, DOI 10.1038/415318a; SNELDERS HMJJ, 1992, J ECON PSYCHOL, V13, P71, DOI 10.1016/0167-4870(92)90053-A; Tadel F, COMPUTATION IN PRESS; Thut G, 1997, NEUROREPORT, V8, P1225, DOI 10.1097/00001756-199703240-00033; Tsao DY, 2008, ANNU REV NEUROSCI, V31, P411, DOI 10.1146/annurev.neuro.30.051606.094238; ZELIZER VA, 1989, AM J SOCIOL, V95, P342, DOI 10.1086/229272	30	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e28229	10.1371/journal.pone.0028229	http://dx.doi.org/10.1371/journal.pone.0028229			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	863MI	22140556	Green Published, gold, Green Submitted			2022-12-27	WOS:000298168100054
J	Diaz-Rodriguez, E; Alvarez-Fernandez, S; Chen, X; Paiva, B; Lopez-Perez, R; Garcia-Hernandez, JL; Miguel, JFS; Pandiella, A				Diaz-Rodriguez, Elena; Alvarez-Fernandez, Stela; Chen, Xi; Paiva, Bruno; Lopez-Perez, Ricardo; Luis Garcia-Hernandez, Juan; San Miguel, Jesus F.; Pandiella, Atanasio			Deficient Spindle Assembly Checkpoint in Multiple Myeloma	PLOS ONE			English	Article							CELL-CYCLE PROGRESSION; MITOTIC CHECKPOINT; KINASE INHIBITOR; TUMOR-SUPPRESSOR; AURORA KINASES; IN-VIVO; ANEUPLOIDY; CANCER; INSTABILITY; MAD2	Multiple myeloma (MM) is a hematological disease characterized by an abnormal accumulation of plasma cells in the bone marrow. These cells have frequent cytogenetic abnormalities including translocations of the immunoglobulin heavy chain gene and chromosomal gains and losses. In fact, a singular characteristic differentiating MM from other hematological malignancies is the presence of a high degree of aneuploidies. As chromosomal abnormalities can be generated by alterations in the spindle assembly checkpoint (SAC), the functionality of such checkpoint was tested in MM. When SAC components were analyzed in MM cell lines, the RNA levels of most of them were conserved. Nevertheless, the protein content of some key constituents was very low in several cell lines, as was the case of MAD2 or CDC20 in RPMI-8226 or RPMI-LR5 cells. The recovery of their cellular content did not substantially affect cell growth, but improved their ability to segregate chromosomes. Finally, SAC functionality was tested by challenging cells with agents disrupting microtubule dynamics. Most of the cell lines analyzed exhibited functional defects in this checkpoint. Based on the data obtained, alterations both in SAC components and their functionality have been detected in MM, pointing to this pathway as a potential target in MM treatment.	[Diaz-Rodriguez, Elena; Alvarez-Fernandez, Stela; Chen, Xi; Paiva, Bruno; Lopez-Perez, Ricardo; Luis Garcia-Hernandez, Juan; San Miguel, Jesus F.; Pandiella, Atanasio] Univ Salamanca, CSIC, Inst Biol Mol & Celular Canc, E-37008 Salamanca, Spain; [Paiva, Bruno; Luis Garcia-Hernandez, Juan; San Miguel, Jesus F.] Hosp Univ Salamanca, Serv Hematol, Salamanca, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; University of Salamanca	Diaz-Rodriguez, E (corresponding author), Univ Salamanca, CSIC, Inst Biol Mol & Celular Canc, E-37008 Salamanca, Spain.	ediaz@usal.es	Díaz-Rodriguez, Elena/I-4784-2015; Pandiella, Atanasio/O-5180-2014; Paiva, Bruno/AAB-8881-2021; San-Miguel, Jesús F./V-8977-2018	Díaz-Rodriguez, Elena/0000-0002-6240-6327; Pandiella, Atanasio/0000-0002-4704-8971; Paiva, Bruno/0000-0003-1977-3815; San-Miguel, Jesús F./0000-0002-9183-4857; Lopez-Perez, Ricardo/0000-0001-9495-8604	Ministry of Science and Education of Spain [BFU2006-01813/BMC, BFU2009-07728/BMC]; Instituto de Salud Carlos III [RD06/0020/0041]; European Community; Fundacion Ramon Areces; Spanish Association for Cancer Research (AACR)	Ministry of Science and Education of Spain(Spanish Government); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); European Community(European Commission); Fundacion Ramon Areces; Spanish Association for Cancer Research (AACR)	This work was supported by grants from the Ministry of Science and Education of Spain (BFU2006-01813/BMC and BFU2009-07728/BMC) and Instituto de Salud Carlos III (RD06/0020/0041). The Cancer Research Institute, and the work carried out at the authors' laboratory received support from the European Community through the regional development funding program (FEDER), and from the Fundacion Ramon Areces. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We want to thank Dr. M. P. Sacristan for helpful discussion of the project and members of the Pandiella lab for discussion and encouragement. We also want to thank Dr. Pintor-Toro for the generous gift of the anti-PTTG antibody and Dr. Hernando for the MSCV and MSCV-IG-hMAD2 retroviral vectors. E.D-R. is supported by the Spanish Association for Cancer Research (AACR).	Amiel A, 2005, CANCER GENET CYTOGEN, V163, P12, DOI 10.1016/j.cancergencyto.2005.04.007; Bergsagel PL, 2005, J CLIN ONCOL, V23, P6333, DOI 10.1200/JCO.2005.05.021; Bharadwaj R, 2004, ONCOGENE, V23, P2016, DOI 10.1038/sj.onc.1207374; Bolanos-Garcia VM, 2011, TRENDS BIOCHEM SCI, V36, P141, DOI 10.1016/j.tibs.2010.08.004; Carrasco DR, 2006, CANCER CELL, V9, P313, DOI 10.1016/j.ccr.2006.03.019; Carro A, 2010, NUCLEIC ACIDS RES, V38, pW182, DOI 10.1093/nar/gkq441; Carvajal-Vergara X, 2005, BLOOD, V105, P4492, DOI 10.1182/blood-2004-08-2985; Ching WJ, 2009, ENVIRON MOL MUTAGEN, V50, P697, DOI 10.1002/em.20528; Diaz-Rodriguez E, 2008, P NATL ACAD SCI USA, V105, P16719, DOI 10.1073/pnas.0803504105; Diaz-Rodriguez E, 2010, J CELL SCI, V123, P3146, DOI 10.1242/jcs.070516; Dobles M, 2000, CELL, V101, P635, DOI 10.1016/S0092-8674(00)80875-2; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Evans RP, 2008, BRIT J HAEMATOL, V140, P295, DOI 10.1111/j.1365-2141.2007.06913.x; Fonseca R, 2003, BLOOD, V101, P4569, DOI 10.1182/blood-2002-10-3017; Gorgun G, 2010, BLOOD, V115, P5202, DOI 10.1182/blood-2009-12-259523; Gutierrez NC, 2007, CLIN TRANSL ONCOL, V9, P618, DOI 10.1007/s12094-007-0114-4; Hernando E, 2004, NATURE, V430, P797, DOI 10.1038/nature02820; Ho P Joy, 2002, Rev Clin Exp Hematol, V6, P276, DOI 10.1046/j.1468-0734.2002.00081.x; Hose D, 2009, BLOOD, V113, P4331, DOI 10.1182/blood-2008-09-178350; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Kops GJPL, 2005, NAT REV CANCER, V5, P773, DOI 10.1038/nrc1714; Kuehl WM, 2002, NAT REV CANCER, V2, P175, DOI 10.1038/nrc746; KUNG AL, 1990, P NATL ACAD SCI USA, V87, P9553, DOI 10.1073/pnas.87.24.9553; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma MH, 2003, CLIN CANCER RES, V9, P1136; Michel L, 2004, P NATL ACAD SCI USA, V101, P4459, DOI 10.1073/pnas.0306069101; Negri JM, 2009, BRIT J HAEMATOL, V147, P672, DOI 10.1111/j.1365-2141.2009.07891.x; Ocio EM, 2008, LANCET ONCOL, V9, P1157, DOI 10.1016/S1470-2045(08)70304-8; Pandiella A, 2003, BRIT J HAEMATOL, V123, P858, DOI 10.1046/j.1365-2141.2003.04706.x; Raab MS, 2009, LANCET, V374, P324, DOI 10.1016/S0140-6736(09)60221-X; Sawyer JR, 2011, CANCER GENET-NY, V204, P3, DOI 10.1016/j.cancergencyto.2010.11.002; Schliekelman M, 2009, CANCER RES, V69, P45, DOI 10.1158/0008-5472.CAN-07-6330; Schvartzman JM, 2010, NAT REV CANCER, V10, P102, DOI 10.1038/nrc2781; Shepard JL, 2007, GENE DEV, V21, P55, DOI 10.1101/gad.1470407; Shi YJ, 2007, BLOOD, V109, P3915, DOI 10.1182/blood-2006-07-037671; Sotillo R, 2007, CANCER CELL, V11, P9, DOI 10.1016/j.ccr.2006.10.019; Stewart HJ, 2011, EXP HEMATOL, V39, P330, DOI 10.1016/j.exphem.2010.12.006; Sudakin V, 2001, J CELL BIOL, V154, P925, DOI 10.1083/jcb.200102093; Wang XJ, 2010, BRIT J HAEMATOL, V150, P313, DOI 10.1111/j.1365-2141.2010.08248.x; Wassmann K, 2001, CURR OPIN GENET DEV, V11, P83, DOI 10.1016/S0959-437X(00)00161-1; Weaver BAA, 2007, CANCER CELL, V11, P25, DOI 10.1016/j.ccr.2006.12.003	41	30	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e27583	10.1371/journal.pone.0027583	http://dx.doi.org/10.1371/journal.pone.0027583			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132115	Green Published, gold, Green Submitted			2022-12-27	WOS:000298162000028
J	Ma, N; Huang, ZB; Chen, XH; He, F; Wang, K; Liu, W; Zhao, LF; Xu, XM; Liao, WJ; Ruan, H; Luo, SQ; Zhang, WQ				Ma, Ning; Huang, Zhibin; Chen, Xiaohui; He, Fei; Wang, Kun; Liu, Wei; Zhao, Linfeng; Xu, Xiangmin; Liao, Wangjun; Ruan, Hua; Luo, Shenqiu; Zhang, Wenqing			Characterization of a Weak Allele of Zebrafish cloche Mutant	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; DEFINITIVE HEMATOPOIESIS; AORTIC ENDOTHELIUM; MOUSE EMBRYO; GENE CLOCHE; DIFFERENTIATION; VERTEBRATE; MUTATIONS; PRECURSOR; LINEAGES	Hematopoiesis is a complicated and dynamic process about which the molecular mechanisms remain poorly understood. Danio rerio (zebrafish) is an excellent vertebrate system for studying hematopoiesis and developmental mechanisms. In the previous study, we isolated and identified a cloche(172) (clo(172)) mutant, a novel allele compared to the original cloche (clo) mutant, through using complementation test and initial mapping. Here, according to whole mount in-situ hybridization, we report that the endothelial cells in clo(172) mutant embryos, although initially developed, failed to form the functional vascular system eventually. In addition, further characterization indicates that the clo(172) mutant exhibited weaker defects instead of completely lost in primitive erythroid cells and definitive hematopoietic cells compared with the clo(s5) mutant. In contrast, primitive myeloid cells were totally lost in clo(172) mutant. Furthermore, these reappeared definitive myeloid cells were demonstrated to initiate from the remaining hematopoietic stem cells (HSCs) in clo 172 mutant, confirmed by the dramatic decrease of lyc in clo(172)runx1(w84x) double mutant. Collectively, the clo(172) mutant is a weak allele compared to the clo(s5) mutant, therefore providing a model for studying the early development of hematopoietic and vascular system, as well as an opportunity to further understand the function of the cloche gene.	[Ma, Ning; Huang, Zhibin; Chen, Xiaohui; Wang, Kun; Liu, Wei; Zhao, Linfeng; Luo, Shenqiu; Zhang, Wenqing] So Med Univ, Key Lab Zebrafish Modeling & Drug Screening Human, Guangdong Higher Educ Inst, Dept Cell Biol,Sch Basic Med Sci, Guangzhou, Guangdong, Peoples R China; [He, Fei] Key Lab Shock & Microcirculat Res Guangdong, Guangzhou, Guangdong, Peoples R China; [Xu, Xiangmin] So Med Univ, Dept Med Genet, Sch Basic Med Sci, Guangzhou, Guangdong, Peoples R China; [Liao, Wangjun] So Med Univ, Dept Oncol, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China; [Ruan, Hua] Southwest Univ, Key Lab Freshwater Fish Reprod & Dev, Minist Educ,Sch Life Sci, State Key Lab Breeding Base Ecoenviroments & Bio, Chongqing, Peoples R China	Southern Medical University - China; Southern Medical University - China; Southern Medical University - China; Southwest University - China	Ma, N (corresponding author), So Med Univ, Key Lab Zebrafish Modeling & Drug Screening Human, Guangdong Higher Educ Inst, Dept Cell Biol,Sch Basic Med Sci, Guangzhou, Guangdong, Peoples R China.	zzwwqq@smu.edu.cn	zhang, wenqing/GYA-0786-2022		National Basic Research Program of China [2012CB945102]; National Natural Science Foundation of China [31171403, 30671074]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (Grant No.: 2012CB945102) and the National Natural Science Foundation of China (Grant No.: 31171403 and 30671074). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, ZEBRAFISH BOOK GUIDE; Baldessari D, 2008, PHARMACOL THERAPEUT, V118, P206, DOI 10.1016/j.pharmthera.2008.02.010; Bennett CM, 2001, BLOOD, V98, P643, DOI 10.1182/blood.V98.3.643; Bertrand JY, 2007, DEVELOPMENT, V134, P4147, DOI 10.1242/dev.012385; Bertrand JY, 2010, NATURE, V464, P108, DOI 10.1038/nature08738; Chen AT, 2009, J CELL BIOCHEM, V108, P35, DOI 10.1002/jcb.22251; CHEN MJ, 2009, RUNX1 IS REQUIRED EN, P887; Choi K, 1998, DEVELOPMENT, V125, P725; Crowhurst MO, 2002, INT J DEV BIOL, V46, P483; Cumano A, 2001, IMMUNITY, V15, P477, DOI 10.1016/S1074-7613(01)00190-X; Davidson AJ, 2004, ONCOGENE, V23, P7233, DOI 10.1038/sj.onc.1207943; de Jong JLO, 2005, ANNU REV GENET, V39, P481, DOI 10.1146/annurev.genet.39.073003.095931; Dooley K, 2000, CURR OPIN GENET DEV, V10, P252, DOI 10.1016/S0959-437X(00)00074-5; Driever W, 1996, DEVELOPMENT, V123, P37; Ellertsdottir E, 2010, DEV BIOL, V341, P56, DOI 10.1016/j.ydbio.2009.10.035; Ellett F, 2010, CURR OPIN PHARMACOL, V10, P563, DOI 10.1016/j.coph.2010.05.004; Fehling HJ, 2003, DEVELOPMENT, V130, P4217, DOI 10.1242/dev.00589; Galloway JL, 2003, CURR TOP DEV BIOL, V53, P139, DOI 10.1016/S0070-2153(03)53004-6; Herbert SP, 2009, SCIENCE, V326, P294, DOI 10.1126/science.1178577; Herbomel P, 1999, DEVELOPMENT, V126, P3735; Huber TL, 2004, NATURE, V432, P625, DOI 10.1038/nature03122; Jin H, 2007, BLOOD, V109, P5208, DOI 10.1182/blood-2007-01-069005; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kissa K, 2010, NATURE, V464, P112, DOI 10.1038/nature08761; Liao EC, 1998, GENE DEV, V12, P621, DOI 10.1101/gad.12.5.621; Liao W, 1997, DEVELOPMENT, V124, P381; Liao W, 2000, DEVELOPMENT, V127, P4303; Lieschke GJ, 2002, DEV BIOL, V246, P274, DOI 10.1006/dbio.2002.0657; Long QM, 1997, DEVELOPMENT, V124, P4105; Ma Ning, 2010, Nan Fang Yi Ke Da Xue Xue Bao, V30, P458; Mikkola HKA, 2006, DEVELOPMENT, V133, P3733, DOI 10.1242/dev.02568; MULLER AM, 1994, IMMUNITY, V1, P291, DOI 10.1016/1074-7613(94)90081-7; MULLINS MC, 1994, CURR BIOL, V4, P189, DOI 10.1016/S0960-9822(00)00048-8; Murayama E, 2006, IMMUNITY, V25, P963, DOI 10.1016/j.immuni.2006.10.015; North TE, 2009, CELL, V137, P736, DOI 10.1016/j.cell.2009.04.023; Parker L, 1999, DEVELOPMENT, V126, P2643; Roman BL, 2000, BIOESSAYS, V22, P882; Roman BL, 2002, DEVELOPMENT, V129, P3009; Sood R, 2010, BLOOD, V115, P2806, DOI 10.1182/blood-2009-08-236729; STAINIER DYR, 1995, DEVELOPMENT, V121, P3141; Thompson MA, 1998, DEV BIOL, V197, P248, DOI 10.1006/dbio.1998.8887; Weber GJ, 2005, BLOOD, V106, P521, DOI 10.1182/blood-2004-11-4541; Weinstein BM, 1996, DEVELOPMENT, V123, P303; Xiong JW, 2008, CIRC RES, V102, P1057, DOI 10.1161/CIRCRESAHA.107.163907	44	3	3	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e27540	10.1371/journal.pone.0027540	http://dx.doi.org/10.1371/journal.pone.0027540			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132109	gold, Green Submitted, Green Published			2022-12-27	WOS:000298162000025
J	Ngo-Giang-Huong, N; Jourdain, G; Amzal, B; Sang-A-Gad, P; Lertkoonalak, R; Eiamsirikit, N; Tansuphasawasdikul, S; Buranawanitchakorn, Y; Yutthakasemsunt, N; Mekviwattanawong, S; McIntosh, K; Lallemant, M				Ngo-Giang-Huong, Nicole; Jourdain, Gonzague; Amzal, Billy; Sang-a-Gad, Pensiriwan; Lertkoonalak, Rittha; Eiamsirikit, Naree; Tansuphasawasdikul, Somboon; Buranawanitchakorn, Yuwadee; Yutthakasemsunt, Naruepon; Mekviwattanawong, Sripetcharat; McIntosh, Kenneth; Lallemant, Marc		Program HIV Prevention & Treatment	Resistance Patterns Selected by Nevirapine vs. Efavirenz in HIV-Infected Patients Failing First-Line Antiretroviral Treatment: A Bayesian Analysis	PLOS ONE			English	Article							TRANSCRIPTASE INHIBITOR RESISTANCE; THYMIDINE ANALOG MUTATIONS; DRUG-RESISTANCE; CROSS-RESISTANCE; VIROLOGICAL FAILURE; NAIVE PATIENTS; K65R MUTATION; TENOFOVIR DF; VIRAL LOAD; THERAPY	Background: WHO recommends starting therapy with a non-nucleoside reverse transcriptase inhibitor (NNRTI) and two nucleoside reverse transcriptase inhibitors (NRTIs), i.e. nevirapine or efavirenz, with lamivudine or emtricitabine, plus zidovudine or tenofovir. Few studies have compared resistance patterns induced by efavirenz and nevirapine in patients infected with the CRF01_AE Southeast Asian HIV-subtype. We compared patterns of NNRTI-and NRTI-associated mutations in Thai adults failing first-line nevirapine-and efavirenz-based combinations, using Bayesian statistics to optimize use of data. Methods and Findings: In a treatment cohort of HIV-infected adults on NNRTI-based regimens, 119 experienced virologic failure (<500 copies/mL), with resistance mutations detected by consensus sequencing. Mutations were analyzed in relation to demographic, clinical, and laboratory variables at time of genotyping. The Geno2Pheno system was used to evaluate second-line drug options. Eighty-nine subjects were on nevirapine and 30 on efavirenz. The NRTI backbone consisted of lamivudine or emtricitabine plus either zidovudine (37), stavudine (65), or tenofovir (19). The K103N mutation was detected in 83% of patients on efavirenz vs. 28% on nevirapine, whereas Y181C was detected in 56% on nevirapine vs. 20% efavirenz. M184V was more common with nevirapine (87%) than efavirenz (63%). Nevirapine favored TAM-2 resistance pathways whereas efavirenz selected both TAM-2 and TAM-1 pathways. Emergence of TAM-2 mutations increased with the duration of virologic replication (OR 1.25-1.87 per month increment). In zidovudine-containing regimens, the overall risk of resistance across all drugs was lower with nevirapine than with efavirenz, whereas in tenofovir-containing regimen the opposite was true. Conclusions: TAM-2 was the major NRTI resistance pathway for CRF01_ AE, particularly with nevirapine; it appeared late after virological failure. In patients who failed, there appeared to be more second-line drug options when zidovudine was combined with nevirapine or tenofovir with efavirenz than with alternative combinations.	[Ngo-Giang-Huong, Nicole; Jourdain, Gonzague; Amzal, Billy; Lallemant, Marc] Inst Rech Dev, PHPT, UMI 174, Marseilles, France; [Ngo-Giang-Huong, Nicole; Jourdain, Gonzague; Amzal, Billy; Lallemant, Marc] Chiang Mai Univ, Dept Med Technol, Fac Associated Med Sci, Chiang Mai 50000, Thailand; [Ngo-Giang-Huong, Nicole; Jourdain, Gonzague; McIntosh, Kenneth; Lallemant, Marc] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Sang-a-Gad, Pensiriwan] Ratchaburi Hosp, Ratchaburi, Thailand; [Lertkoonalak, Rittha] Maharat Nakonratchasima Hosp, Nakonratchasima, Thailand; [Tansuphasawasdikul, Somboon] Buddhachinaraj Hosp, Phitsanulok, Thailand; [Buranawanitchakorn, Yuwadee] Chiang Kham Hosp, Chiang Kham, Thailand; [Yutthakasemsunt, Naruepon] Nong Khai Hosp, Nong Khai, Thailand; [Mekviwattanawong, Sripetcharat] Pranangklao Hosp, Bangkok, Thailand; [McIntosh, Kenneth] Childrens Hosp, Div Infect Dis, Boston, MA 02115 USA	Institut de Recherche pour le Developpement (IRD); Chiang Mai University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Boston Children's Hospital	Ngo-Giang-Huong, N (corresponding author), Inst Rech Dev, PHPT, UMI 174, Marseilles, France.	nicole@phpt.org	Jourdain, Gonzague/F-9117-2017; Ngo-Giang-Huong, Nicole/G-2860-2017; Lerksuthirat, Tassanee/A-1930-2016	Jourdain, Gonzague/0000-0002-3365-7020; Ngo-Giang-Huong, Nicole/0000-0001-8950-3234; Lerksuthirat, Tassanee/0000-0001-9526-951X; DECKER, Luc/0000-0002-4808-3568	Global Fund; Tuberculosis and Malaria Thailand [PR-A-N-008]; National Institutes of Health, USA [R01-HD042964, PHPT-3]; Institut de Recherche pour le Developpement, France; Department of Technical and Economic Cooperation, Thailand; Thai Ministry of Public Health, Thailand; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD042964] Funding Source: NIH RePORTER	Global Fund; Tuberculosis and Malaria Thailand; National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institut de Recherche pour le Developpement, France; Department of Technical and Economic Cooperation, Thailand; Thai Ministry of Public Health, Thailand; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the Global Fund to Fight AIDS, Tuberculosis and Malaria Thailand Grant Round 1 sub recipient PR-A-N-008, National Institutes of Health (R01-HD042964, PHPT-3), USA; Institut de Recherche pour le Developpement, France; Department of Technical and Economic Cooperation, Thailand; Thai Ministry of Public Health, Thailand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, AIDS, V22, P367, DOI 10.1097/QAD.0b013e3282f3cc35; Ariyoshi K, 2003, JAIDS-J ACQ IMM DEF, V33, P336, DOI 10.1097/00126334-200307010-00007; Bacheler LT, 2000, ANTIMICROB AGENTS CH, V44, P2475, DOI 10.1128/AAC.44.9.2475-2484.2000; Back NKT, 1996, EMBO J, V15, P4040, DOI 10.1002/j.1460-2075.1996.tb00777.x; Beerenwinkel N, 2003, NUCLEIC ACIDS RES, V31, P3850, DOI 10.1093/nar/gkg575; Bocket L, 2004, J ANTIMICROB CHEMOTH, V53, P89, DOI 10.1093/jac/dkh006; Casado JL, 2002, AIDS RES HUM RETROV, V18, P771, DOI 10.1089/08892220260139503; Cozzi-Lepri A, 2009, J INFECT DIS, V200, P687, DOI 10.1086/604731; Deforche K, 2008, AIDS, V22, P2107, DOI 10.1097/QAD.0b013e32830fe940; Delaugerre C, 2001, J MED VIROL, V65, P445, DOI 10.1002/jmv.2055; *DEP HLTH HUM SERV, 2009, PAN ANT GUID AD AD G; Deshpande A, 2010, AIDS RES HUM RETROV, V26, P343, DOI 10.1089/aid.2009.0217; Gallant JE, 2004, JAMA-J AM MED ASSOC, V292, P191, DOI 10.1001/jama.292.2.191; Gelman A., BAYESIAN DATA ANAL, VThird; Hanna GJ, 2000, J INFECT DIS, V181, P904, DOI 10.1086/315329; Hawkins CA, 2009, JAIDS-J ACQ IMM DEF, V52, P228, DOI 10.1097/QAI.0b013e3181b06125; Hosseinipour MC, 2009, AIDS, V23, P1127, DOI 10.1097/QAD.0b013e32832ac34e; Kuritzkes DR, 2004, JAIDS-J ACQ IMM DEF, V36, P600, DOI 10.1097/00126334-200405010-00008; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Lyagoba F, 2010, JAIDS-J ACQ IMM DEF, V55, P277, DOI 10.1097/QAI.0b013e3181ea0df8; Machouf N, 2006, J MED VIROL, V78, P608, DOI 10.1002/jmv.20582; Manosuthi W, 2010, AIDS RES HUM RETROV, V26, P609, DOI 10.1089/aid.2009.0107; Marcelin AG, 2004, J MED VIROL, V72, P162, DOI 10.1002/jmv.10550; Marconi VC, 2008, CLIN INFECT DIS, V46, P1589, DOI 10.1086/587109; Miller V, 1998, ANTIMICROB AGENTS CH, V42, P3123, DOI 10.1128/AAC.42.12.3123; National AIDS Prevention and Alleviation Committee, 2010, UNGASS COUNTR PROGR; Novitsky V, 2007, AIDS RES HUM RETROV, V23, P868, DOI 10.1089/aid.2006.0298; Orrell C, 2009, ANTIVIR THER, V14, P523; Parikh UM, 2006, J VIROL, V80, P4971, DOI 10.1128/JVI.80.10.4971-4977.2006; Reuman EC, 2010, J ANTIMICROB CHEMOTH, V65, P1477, DOI 10.1093/jac/dkq140; Rey D, 2006, JAIDS-J ACQ IMM DEF, V43, P530; RICHMAN DD, 1994, J VIROL, V68, P1660, DOI 10.1128/JVI.68.3.1660-1666.1994; Ross L, 2009, AIDS RES HUM RETROV, V25, P665, DOI 10.1089/aid.2008.0302; Soria A, 2009, ANTIVIR THER, V14, P339; Spiegelhalter DJ, 2002, J ROY STAT SOC B, V64; Sukasema C, 2008, INT J ANTIMICROB AG, V31, P277, DOI 10.1016/j.ijantimicag.2007.10.029; Sungkanuparph S, 2007, CLIN INFECT DIS, V44, P447, DOI 10.1086/510745; Sutthent R, 2005, J CLIN VIROL, V34, P272, DOI 10.1016/j.jcv.2005.02.014; Wakefield J, 1994, APPL STATS, V43; Wallis CL, 2010, JAIDS-J ACQ IMM DEF, V53, P480, DOI 10.1097/QAI.0b013e3181bc478b; WHO, 2010, ANT THER HIV INF AD	41	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e27427	10.1371/journal.pone.0027427	http://dx.doi.org/10.1371/journal.pone.0027427			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132100	gold, Green Published, Green Submitted			2022-12-27	WOS:000298162000018
J	Prado, BR; Pozo, C; Valdez-Moreno, M; Hebert, PDN				Prado, Blanca R.; Pozo, Carmen; Valdez-Moreno, Martha; Hebert, Paul D. N.			Beyond the Colours: Discovering Hidden Diversity in the Nymphalidae of the Yucatan Peninsula in Mexico through DNA Barcoding	PLOS ONE			English	Article							SKIPPER BUTTERFLIES; LEPIDOPTERA; SYSTEMATICS; INVENTORY	Background: Recent studies have demonstrated the utility of DNA barcoding in the discovery of overlooked species and in the connection of immature and adult stages. In this study, we use DNA barcoding to examine diversity patterns in 121 species of Nymphalidae from the Yucatan Peninsula in Mexico. Our results suggest the presence of cryptic species in 8 of these 121 taxa. As well, the reference database derived from the analysis of adult specimens allowed the identification of nymphalid caterpillars providing new details on host plant use. Methodology/Principal Findings: We gathered DNA barcode sequences from 857 adult Nymphalidae representing 121 different species. This total includes four species (Adelpha iphiclus, Adelpha malea, Hamadryas iphtime and Taygetis laches) that were initially overlooked because of their close morphological similarity to other species. The barcode results showed that each of the 121 species possessed a diagnostic array of barcode sequences. In addition, there was evidence of cryptic taxa; seven species included two barcode clusters showing more than 2% sequence divergence while one species included three clusters. All 71 nymphalid caterpillars were identified to a species level by their sequence congruence to adult sequences. These caterpillars represented 16 species, and included Hamadryas julitta, an endemic species from the Yucatan Peninsula whose larval stages and host plant (Dalechampia schottii, also endemic to the Yucatan Peninsula) were previously unknown. Conclusions/Significance: This investigation has revealed overlooked species in a well-studied museum collection of nymphalid butterflies and suggests that there is a substantial incidence of cryptic species that await full characterization. The utility of barcoding in the rapid identification of caterpillars also promises to accelerate the assembly of information on life histories, a particularly important advance for hyperdiverse tropical insect assemblages.	[Prado, Blanca R.; Pozo, Carmen; Valdez-Moreno, Martha] Colegio Frontera Sur, Unidad Chetumal, Quintana Roo, Mexico; [Hebert, Paul D. N.] Univ Guelph, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada	El Colegio de la Frontera Sur (ECOSUR); University of Guelph	Prado, BR (corresponding author), Colegio Frontera Sur, Unidad Chetumal, Quintana Roo, Mexico.	cpozo@ecosur.mx	Hebert, Paul DN/C-4161-2013; Pozo, Carmen/GPK-5969-2022	Hebert, Paul DN/0000-0002-3081-6700; Pozo, Carmen/0000-0002-8685-1134	Natural Sciences and Engineering Research Council; Government of Canada through Genome Canada; Ontario Genomics Institute; The Ontario Ministry of Research and Innovation; Consejo Nacional de Ciencia y Tecnologia (CONACyT) [207930]	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Government of Canada through Genome Canada(Genome Canada); Ontario Genomics Institute; The Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	Funding for sequence analysis was provided by a Discovery Grant from Natural Sciences and Engineering Research Council to PH and by a grant from the Government of Canada through Genome Canada and the Ontario Genomics Institute in support of the International Barcode of Life Project. The Ontario Ministry of Research and Innovation provided funds for the analysis and curation of the barcode records. This work is part of the MSc thesis of Blanca R. Prado and was supported with a grant provided by the Consejo Nacional de Ciencia y Tecnologia (CONACyT grant 207930). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamski D, 2010, P ENTOMOL SOC WASH, V112, P183, DOI 10.4289/0013-8797-112.2.183; Burns John M., 2007, Journal of the Lepidopterists' Society, V61, P138; Burns JM, 2008, P NATL ACAD SCI USA, V105, P6350, DOI 10.1073/pnas.0712181105; Butler A.G., 1868, CATALOGUE DIURNAL LE; DELAMAZA RF, 1987, MARIPOSAS MEXICANAS; DeVries P.J., 1987, BUTTERFLIES COSTA RI; Escalante P, 2010, MITOCHONDR DNA, V21, P30, DOI 10.3109/19401736.2010.535527; Freitas AVL, 2004, SYST BIOL, V53, P363, DOI 10.1080/10635150490445670; GODMAN FD, 1879, LEPIDOPTERA RHOPALOC, V1; Grimaldi David, 2005, pi; Grund R, 2010, ENTOMOL SCI, V13, P134, DOI 10.1111/j.1479-8298.2010.00368.x; Hebert PDN, 2010, BIOL LETTERS, V6, P359, DOI 10.1098/rsbl.2009.0848; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; HEPPNER J B, 1991, Tropical Lepidoptera, V2, P1; Hrcek J, 2011, MOL ECOL RESOUR, V11, P786, DOI 10.1111/j.1755-0998.2011.03016.x; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Janzen DH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019874; Janzen DH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018123; Janzen DH, 2009, MOL ECOL RESOUR, V9, P1, DOI 10.1111/j.1755-0998.2009.02628.x; Janzen DH, 2005, PHILOS T R SOC B, V360, P1835, DOI 10.1098/rstb.2005.1715; JANZEN DH, DYNAMIC DATABASE INV; JENKINS DW, 1983, B ALLYN MUSEUM, V81, P1, DOI DOI 10.2307/3259456; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Lamas G., 2004, ATLAS NEOTROPICAL LE, V5A; Llorente Bousquets Jorge, 1996, P3; LUISMARTINEZ A, 2003, NYMPHALIDAE MEXICO 1; MILLER JC, 2006, 100 CATERPILLARS POR; MILLER JC, 2007, 100 BUTTERFLIES MOTH; PETERSON A, 1962, LEPIDOPTERA PLANT IN, P112; Powell J. A., 2009, MOTHS W N AM; Pozo C, 2003, SOUTHWEST NAT, V48, P505, DOI 10.1894/0038-4909(2003)048<0505:BPAHOC>2.0.CO;2; Scoble M. J., 1995, LEPIDOPTERA FORM FUN; STANCELAND E. M., 2011, INTERACTIVE LISTING; STANDLEY PAUL C., 1930, FIELD MUS NAT HIST PUBL BOT SER, V3, P157; Stehr F.W., 1987, P288; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; *TROP, 2011, MISS BOT GARD; van Velzen Robin, 2007, Proceedings of the Netherlands Entomological Society Meeting, V18, P95; Wahlberg N, 2003, MOL PHYLOGENET EVOL, V28, P473, DOI 10.1016/S1055-7903(03)00052-6; Willmott KR., 2003, GENUS ADELPHA ITS SY; Wilson John James, 2010, ZooKeys, V46, P41	42	26	30	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e27776	10.1371/journal.pone.0027776	http://dx.doi.org/10.1371/journal.pone.0027776			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132140	gold, Green Published, Green Submitted			2022-12-27	WOS:000298162000042
J	Schmeink, CE; Melchers, WJG; Siebers, AG; Quint, WGV; Massuger, LFAG; Bekkers, RLM				Schmeink, Channa E.; Melchers, Willem J. G.; Siebers, Albertus G.; Quint, Wim G. V.; Massuger, Leon F. A. G.; Bekkers, Ruud L. M.			Human Papillomavirus Persistence in Young Unscreened Women, a Prospective Cohort Study	PLOS ONE			English	Article							FORMER SOVIET-UNION; NATURAL-HISTORY; CERVICAL-CANCER; HPV INFECTIONS; HORMONAL CONTRACEPTIVES; INDEPENDENT STATES; VIRAL PERSISTENCE; RISK-FACTORS; PREVALENCE; CLEARANCE	Objective: To evaluate hr-HPV persistence and associated risk factors in a prospective cohort of young unscreened women. Additionally, the relation between hr-HPV status and cytology/histology results is examined. Methods and Principal Findings: Two year follow-up of 235 out of 2065 young women (18-29 years), participating in a large, one year epidemiological study, with questionnaires, self-collected cervico-vaginal samples (Vibabrush), and SPF(10)LiPA for HPV detection. Only women hr-HPV positive at sample month 12 were invited for a second year of follow-up. After study follow-up, available cytology/histology data were requested from PALGA (the national network and registry of histo-and cytopathology in The Netherlands). These data were compared with available cytology/histology data of the month 12 hr-HPV negative women from the same cohort. 44.1% of the hr-HPV types detected at study month 12, persisted during follow-up. HPV types 45, 31, 16 and 18 were most likely to persist with percentages of 60.0%, 56.8%, 54.4%, and 50.0%, respectively. Compared to newly detected infections at month 12, infections present since 6 months or baseline had an increased risk to persist (OR 3.09 [95% CI: 1.74-5.51] and OR 4.99 [95% CI: 2.67-9.32], respectively). Other co-factors influencing persistence were, multiple HPV infections, smoking and multiple lifetime sexual partners. The percentage of women with a HSIL/CIN2+ (12.1%) in the persistent HPV group, was not significantly different (p = 0.107) from the 5.3% of the women who cleared the hr-HPV infection, but was significantly (p 0.000) higher than to the 1.6% of women in the hr-HPV negative control group. Conclusion: We showed that HPV genotype, multiple infections, smoking, and multiple lifetime sexual partners are co-factors that increase the risk of hr-HPV persistency. Most importantly, we showed that hr-HPV infections are more likely to persist the longer they have been present and that women with a persistent hr-HPV infection have a high risk of HSIL/CIN2+ development.	[Schmeink, Channa E.; Massuger, Leon F. A. G.; Bekkers, Ruud L. M.] Radboud Univ Nijmegen, Med Ctr, Dept Obstet & Gynaecol, NL-6525 ED Nijmegen, Netherlands; [Melchers, Willem J. G.] Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, NL-6525 ED Nijmegen, Netherlands; [Siebers, Albertus G.] Radboud Univ Nijmegen, Med Ctr, Dept Pathol, NL-6525 ED Nijmegen, Netherlands; [Quint, Wim G. V.] DDL Diagnost Lab, Voorburg, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; DDL Diagnostic Laboratory	Schmeink, CE (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Obstet & Gynaecol, NL-6525 ED Nijmegen, Netherlands.	c.schmeink@obgyn.umcn.nl	Massuger, Leon F.A.G./H-8072-2014; Bekkers, Ruud/AAU-5319-2020; Siebers, Albert/D-6300-2015; Bekkers, Ruud/M-3866-2014; Melchers, Willem/C-8819-2015	Siebers, Albert/0000-0002-6085-0678; Bekkers, Ruud/0000-0002-4577-8495; Melchers, Willem/0000-0002-5446-2230; Siebers, Albert Siebers/0000-0001-5413-9903	GlaxoSmithKline (GSK) [2702-HPV-109932]	GlaxoSmithKline (GSK)(GlaxoSmithKline)	GlaxoSmithKline (GSK 2702-HPV-109932 to R.L.B., L.F.M.). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appleby P, 2007, LANCET, V370, P1609, DOI 10.1016/S0140-6736(07)61684-5; BAE J, 2009, GYNECOL ONCOL; BOSCH FX, 1995, JNCI-J NATL CANCER I, V87, P796, DOI 10.1093/jnci/87.11.796; Brink AATP, 2006, BEST PRACT RES CL OB, V20, P253, DOI 10.1016/j.bpobgyn.2005.10.009; Casparie M, 2007, CELL ONCOL, V29, P19; Castellsague Xavier, 2003, J Natl Cancer Inst Monogr, P20; Castle PE, 2008, AM J EPIDEMIOL, V168, P138, DOI 10.1093/aje/kwn037; Castle PE, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2569; Cuschieri KS, 2005, J CLIN PATHOL, V58, P946, DOI 10.1136/jcp.2004.022863; Dal Bello B, 2009, J MED VIROL, V81, P703, DOI 10.1002/jmv.21429; Franco EL, 2009, ARCH MED RES, V40, P478, DOI 10.1016/j.arcmed.2009.06.003; FUKUCHI E, 2009, SEX TRANSM DIS; Giuliano AR, 2002, J INFECT DIS, V186, P462, DOI 10.1086/341782; Ho GYF, 1998, NEW ENGL J MED, V338, P423, DOI 10.1056/NEJM199802123380703; Iftner T, 2010, J MED VIROL, V82, P1928, DOI 10.1002/jmv.21910; Koshiol J, 2008, AM J EPIDEMIOL, V168, P123, DOI 10.1093/aje/kwn036; Kulmala SMA, 2007, CANCER EPIDEM BIOMAR, V16, P17, DOI 10.1158/1055-9965.EPI-06-0649; Lai CH, 2008, INT J CANCER, V123, P1685, DOI 10.1002/ijc.23679; Lenselink CH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003743; Louvanto K, 2010, J INFECT DIS, V202, P436, DOI 10.1086/653826; MAUCORTBOULCH D, 2009, INT J CANC; Melchers WJG, 1999, AM J PATHOL, V155, P1473, DOI 10.1016/S0002-9440(10)65462-4; Moscicki AB, 1998, J PEDIATR-US, V132, P277, DOI 10.1016/S0022-3476(98)70445-7; Munoz N, 2000, J CLIN VIROL, V19, P1, DOI 10.1016/S1386-6532(00)00125-6; MUNOZ N, 2009, BR J CANC; Nielsen A, 2010, J MED VIROL, V82, P616, DOI 10.1002/jmv.21750; Nobbenhuis MAE, 1999, LANCET, V354, P20, DOI 10.1016/S0140-6736(98)12490-X; Plummer M, 2007, J INFECT DIS, V195, P1582, DOI 10.1086/516784; Richardson H, 2003, CANCER EPIDEM BIOMAR, V12, P485; Schiffman M, 2005, VIROLOGY, V337, P76, DOI 10.1016/j.virol.2005.04.002; Schiffman Mark, 2003, J Natl Cancer Inst Monogr, P14; Schiffman M, 2007, LANCET, V370, P890, DOI [10.1016/S0140-6736(07)61416-0, 10.1016/S0140-6736(13)60022-7]; Schiffman M, 2010, CANCER RES, V70, P3159, DOI 10.1158/0008-5472.CAN-09-4179; SCHIFFMAN MH, 1993, JNCI-J NATL CANCER I, V85, P958, DOI 10.1093/jnci/85.12.958; Schmeink CE, 2010, OBSTET GYNECOL, V116, P67, DOI 10.1097/AOG.0b013e3181e238f0; SUNDSTROM K, 2010, CANC EPIDEMIOL BIOMA; Syrjanen K, 2008, EUR J GYNAECOL ONCOL, V29, P114; Syrjanen K, 2009, INT J GYNECOL CANCER, V19, P934, DOI 10.1111/IGC.0b013e3181a834fe; Trottier H, 2008, J INFECT DIS, V197, P1436, DOI 10.1086/587698; van Duin M, 2002, INT J CANCER, V98, P590, DOI 10.1002/ijc.10232; van Hamont D, 2006, J CLIN MICROBIOL, V44, P3122, DOI 10.1128/JCM.00517-06; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Winer RL, 2003, AM J EPIDEMIOL, V157, P218, DOI 10.1093/aje/kwf180; Woodman CBJ, 2007, NAT REV CANCER, V7, P11, DOI 10.1038/nrc2050	44	31	33	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e27937	10.1371/journal.pone.0027937	http://dx.doi.org/10.1371/journal.pone.0027937			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132173	Green Published, Green Submitted, gold			2022-12-27	WOS:000298162000050
J	Burioni, R; Scalco, R; Casartelli, M				Burioni, Raffaella; Scalco, Riccardo; Casartelli, Mario			Rohlin Distance and the Evolution of Influenza A Virus: Weak Attractors and Precursors	PLOS ONE			English	Article							GENETIC EVOLUTION; NETWORK; H3N2	The evolution of the hemagglutinin amino acids sequences of Influenza A virus is studied by a method based on an informational metrics, originally introduced by Rohlin for partitions in abstract probability spaces. This metrics does not require any previous functional or syntactic knowledge about the sequences and it is sensitive to the correlated variations in the characters disposition. Its efficiency is improved by algorithmic tools, designed to enhance the detection of the novelty and to reduce the noise of useless mutations. We focus on the USA data from 1993/94 to 2010/2011 for A/H3N2 and on USA data from 2006/07 to 2010/2011 for A/H1N1. We show that the clusterization of the distance matrix gives strong evidence to a structure of domains in the sequence space, acting as weak attractors for the evolution, in very good agreement with the epidemiological history of the virus. The structure proves very robust with respect to the variations of the clusterization parameters, and extremely coherent when restricting the observation window. The results suggest an efficient strategy in the vaccine forecast, based on the presence of "precursors" (or "buds") populating the most recent attractor.	[Burioni, Raffaella; Casartelli, Mario] Univ Parma, Dipartimento Fis, I-43100 Parma, Italy; [Burioni, Raffaella; Casartelli, Mario] Univ Parma, Inst Nazl Si Fis Nucl INFN, I-43100 Parma, Italy; [Scalco, Riccardo] Univ Zurich, Dept Biochem, Zurich, Switzerland	University of Parma; University of Parma; University of Zurich	Burioni, R (corresponding author), Univ Parma, Dipartimento Fis, Viale Sci, I-43100 Parma, Italy.	raffaella.burioni@fis.unipr.it	Burioni, Raffaella/C-6780-2017		MIUR FIRB [RBFR08EKEV]; Instituto Nazionale di Fisca Nucleare (INF)	MIUR FIRB(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); Instituto Nazionale di Fisca Nucleare (INF)	This work was partially supported by the MIUR FIRB grant RBFR08EKEV and by the Instituto Nazionale di Fisca Nucleare (INF) project "Biological applications of theoretical physics methods". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agliari E, 2010, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2010/09/P09002; Arnold V.I., 1967, PROBLEMES ERGODIQUES; Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Baxevanis A.D., 2005, BIOINFORMATICS PRACT; Butte A J, 2000, Pac Symp Biocomput, P418; Casartelli M, 2004, J PHYS A-MATH GEN, V37, P11731, DOI 10.1088/0305-4470/37/49/001; Fitch WM, 1997, P NATL ACAD SCI USA, V94, P7712, DOI 10.1073/pnas.94.15.7712; Gupta V, 2006, VACCINE, V24, P3881, DOI 10.1016/j.vaccine.2006.01.010; HAMMING RW, 1950, BELL SYST TECH J, V29, P147, DOI 10.1002/j.1538-7305.1950.tb00463.x; Hampson A, 2002, INUENZA; Hastie T., 2009, UNSUPERVISED LEARNIN; He JK, 2010, PROTEIN ENG DES SEL, V23, P935, DOI 10.1093/protein/gzq078; Hirst GK, 1943, J EXP MED, V78, p4O7, DOI 10.1084/jem.78.5.407; Hoft DF, 2004, NEW ENGL J MED, V351, P2550, DOI 10.1056/NEJMcibr043708; Holmes EC, 2005, PLOS BIOL, V3, P1579, DOI 10.1371/journal.pbio.0030300; Khinchin AI., 1957, MATH FDN INFORM THEO; Koelle K, 2006, SCIENCE, V314, P1898, DOI 10.1126/science.1132745; Liao YC, 2008, BIOINFORMATICS, V24, P505, DOI 10.1093/bioinformatics/btm638; Martin N.F.G., 1981, MATH THEORY ENTROPY; Morens DM, 2010, MBIO, V1, DOI 10.1128/mBio.00211-10; Nelson MI, 2007, NAT REV GENET, V8, P196, DOI 10.1038/nrg2053; Otu HH, 2003, BIOINFORMATICS, V19, P2122, DOI 10.1093/bioinformatics/btg295; Ouyang Zhengqing, 2004, J Bioinform Comput Biol, V2, P353, DOI 10.1142/S0219720004000624; Pevzner P. A., 2000, COMPUTATIONAL MOL BI; Plotkin JB, 2002, P NATL ACAD SCI USA, V99, P6263, DOI 10.1073/pnas.082110799; Pybus OG, 2009, NAT REV GENET, V10, P540, DOI 10.1038/nrg2583; Rao Suyog, 2005, Genome Inform, V16, P3; Recker M, 2007, P NATL ACAD SCI USA, V104, P7711, DOI 10.1073/pnas.0702154104; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; Sun J, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.228107; Waterman M.S., 1995, INTRO COMPUTATIONAL; Wolf Y, 2010, PLOS CURR, V3; Xia Z, 2009, BIOINFORMATICS, V25, P2309, DOI 10.1093/bioinformatics/btp423	33	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2011	6	12							e27924	10.1371/journal.pone.0027924	http://dx.doi.org/10.1371/journal.pone.0027924			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863OC	22162994	Green Published, gold, Green Submitted			2022-12-27	WOS:000298173500007
J	Schlick, SN; Wood, CD; Gunnell, A; Webb, HM; Khasnis, S; Schepers, A; West, MJ				Schlick, Sandra N.; Wood, C. David; Gunnell, Andrea; Webb, Helen M.; Khasnis, Sarika; Schepers, Aloys; West, Michelle J.			Upregulation of the Cell-Cycle Regulator RGC-32 in Epstein-Barr Virus-Immortalized Cells	PLOS ONE			English	Article							NUCLEAR ANTIGEN 3C; B-CELLS; C-MYC; KINASE-ACTIVITY; GENE; ACTIVATION; EXPRESSION; PROTEIN; RNA; PROGRESSION	Epstein-Barr virus (EBV) is implicated in the pathogenesis of multiple human tumours of lymphoid and epithelial origin. The virus infects and immortalizes B cells establishing a persistent latent infection characterized by varying patterns of EBV latent gene expression (latency 0, I, II and III). The CDK1 activator, Response Gene to Complement-32 (RGC-32, C13ORF15), is overexpressed in colon, breast and ovarian cancer tissues and we have detected selective high-level RGC-32 protein expression in EBV-immortalized latency III cells. Significantly, we show that overexpression of RGC-32 in B cells is sufficient to disrupt G2 cell-cycle arrest consistent with activation of CDK1, implicating RGC-32 in the EBV transformation process. Surprisingly, RGC-32 mRNA is expressed at high levels in latency I Burkitt's lymphoma (BL) cells and in some EBV-negative BL cell-lines, although RGC-32 protein expression is not detectable. We show that RGC-32 mRNA expression is elevated in latency I cells due to transcriptional activation by high levels of the differentially expressed RUNX1c transcription factor. We found that proteosomal degradation or blocked cytoplasmic export of the RGC-32 message were not responsible for the lack of RGC-32 protein expression in latency I cells. Significantly, analysis of the ribosomal association of the RGC-32 mRNA in latency I and latency III cells revealed that RGC-32 transcripts were associated with multiple ribosomes in both cell-types implicating post-initiation translational repression mechanisms in the block to RGC-32 protein production in latency I cells. In summary, our results are the first to demonstrate RGC-32 protein upregulation in cells transformed by a human tumour virus and to identify post-initiation translational mechanisms as an expression control point for this key cell-cycle regulator.	[Schlick, Sandra N.; Wood, C. David; Gunnell, Andrea; Webb, Helen M.; Khasnis, Sarika; Schepers, Aloys; West, Michelle J.] Univ Sussex, Sch Life Sci, Brighton, E Sussex, England	University of Sussex	Schlick, SN (corresponding author), Res Ctr Borstel, Borstel, Germany.	M.J.West@sussex.ac.uk		Schepers, Aloys/0000-0002-5442-5608; Gunnell, Andrea/0000-0001-5162-5391; West, Michelle/0000-0002-9497-9365	Wellcome Trust [076990, 088140]; Royal Society; University of Sussex	Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London); University of Sussex	This work was supported by grants from the Wellcome Trust (076990 and 088140) and the Royal Society and by a PhD studentship from the University of Sussex to SNS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderton E, 2008, ONCOGENE, V27, P421, DOI 10.1038/sj.onc.1210668; Babcock GJ, 2000, P NATL ACAD SCI USA, V97, P12250, DOI 10.1073/pnas.200366597; Badea T, 2002, J BIOL CHEM, V277, P502, DOI 10.1074/jbc.M109354200; Badea TC, 1998, J BIOL CHEM, V273, P26977, DOI 10.1074/jbc.273.41.26977; Bajaj BG, 2008, J VIROL, V82, P4082, DOI 10.1128/JVI.02500-07; Bark-Jones SJ, 2006, ONCOGENE, V25, P1775, DOI 10.1038/sj.onc.1209205; BENBASSAT H, 1977, INT J CANCER, V19, P27, DOI 10.1002/ijc.2910190105; Blyth K, 2005, NAT REV CANCER, V5, P376, DOI 10.1038/nrc1607; Brady G, 2009, J VIROL, V83, P6909, DOI 10.1128/JVI.00216-09; Bredel M, 2006, J CLIN ONCOL, V24, P274, DOI 10.1200/JCO.2005.02.9405; Cameron JE, 2008, VIROLOGY, V382, P257, DOI 10.1016/j.virol.2008.09.018; Cannell EJ, 1998, FEBS LETT, V439, P297, DOI 10.1016/S0014-5793(98)01391-X; Cheng AY, 2008, CELL CYCLE, V7, P3037, DOI 10.4161/cc.7.19.6736; Choudhuri T, 2007, J VIROL, V81, P6718, DOI 10.1128/JVI.00053-07; Cohen MM, 2009, AM J MED GENET A, V149A, P2629, DOI 10.1002/ajmg.a.33021; Donninger H, 2004, ONCOGENE, V23, P8065, DOI 10.1038/sj.onc.1207959; Ferby I, 1999, GENE DEV, V13, P2177, DOI 10.1101/gad.13.16.2177; Fosbrink M, 2005, EXP MOL PATHOL, V78, P116, DOI 10.1016/j.yexmp.2004.11.001; Fosbrink M, 2009, EXP MOL PATHOL, V86, P87, DOI 10.1016/j.yexmp.2008.12.005; Fox M, 2005, GENOMICS, V85, P92, DOI 10.1016/j.ygeno.2004.10.003; Galgano A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003164; Gallagher WM, 2005, CARCINOGENESIS, V26, P1856, DOI 10.1093/carcin/bgi152; Gastwirt RF, 2007, CELL CYCLE, V6, P1188, DOI 10.4161/cc.6.10.4252; GREGORY CD, 1991, NATURE, V349, P612, DOI 10.1038/349612a0; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hertle ML, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000506; Hochberg D, 2004, P NATL ACAD SCI USA, V101, P239, DOI 10.1073/pnas.2237267100; Jakowlew SB, 2006, CANCER METAST REV, V25, P435, DOI 10.1007/s10555-006-9006-2; Jo M, 2006, MOL ENDOCRINOL, V20, P2156, DOI 10.1210/me.2005-0512; Johannes G, 1998, RNA, V4, P1500, DOI 10.1017/S1355838298981080; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kim DS, 2011, CANCER-AM CANCER SOC, V117, P590, DOI 10.1002/cncr.25451; KING W, 1980, J VIROL, V36, P506, DOI 10.1128/JVI.36.2.506-518.1980; Knight JS, 2005, P NATL ACAD SCI USA, V102, P18562, DOI 10.1073/pnas.0503886102; Knight JS, 2005, MOL CELL BIOL, V25, P1749, DOI 10.1128/MCB.25.5.1749-1763.2005; Knight JS, 2004, J VIROL, V78, P12857, DOI 10.1128/JVI.78.23.12857-12867.2004; Knight JS, 2004, J VIROL, V78, P1981, DOI 10.1128/JVI.78.4.1981-1991.2004; Krauer KG, 2004, ONCOGENE, V23, P1342, DOI 10.1038/sj.onc.1207253; Lau YFC, 2003, CYTOGENET GENOME RES, V101, P250, DOI 10.1159/000074345; Lau YFC, 1999, AM J HUM GENET, V64, P921, DOI 10.1086/302353; Leao M, 2007, J VIROL, V81, P248, DOI 10.1128/JVI.01096-06; Lenormand JL, 1999, EMBO J, V18, P1869, DOI 10.1093/emboj/18.7.1869; Maier S, 2006, J VIROL, V80, P9761, DOI 10.1128/JVI.00665-06; Maruo S, 2006, P NATL ACAD SCI USA, V103, P19500, DOI 10.1073/pnas.0604919104; Maruo S, 2011, P NATL ACAD SCI USA, V108, P1919, DOI 10.1073/pnas.1019599108; MENEZES J, 1975, BIOMEDICINE, V22, P276; O'Nions J, 2003, ONCOGENE, V22, P7181, DOI 10.1038/sj.onc.1206838; O'Nions J, 2006, J VIROL, V80, P12408, DOI 10.1128/JVI.01363-06; Oram SW, 2006, BMC CANCER, V6, P1, DOI 10.1186/1471-2407-6-154; Park ES, 2008, ENDOCRINOLOGY, V149, P3025, DOI 10.1210/en.2007-1129; Parker GA, 1996, ONCOGENE, V13, P2541; Parker GA, 2000, ONCOGENE, V19, P700, DOI 10.1038/sj.onc.1203327; POPE JH, 1968, INT J CANCER, V3, P857, DOI 10.1002/ijc.2910030619; Porter LA, 2002, J CELL BIOL, V157, P357, DOI 10.1083/jcb.200109045; Ritzi M, 2003, J CELL SCI, V116, P3971, DOI 10.1242/jcs.00708; Saha A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001275; Saha A, 2011, J VIROL, V85, P2079, DOI 10.1128/JVI.02279-10; Saha A, 2009, J VIROL, V83, P4652, DOI 10.1128/JVI.02408-08; Saigusa K, 2007, ONCOGENE, V26, P1110, DOI 10.1038/sj.onc.1210148; SINCLAIR AJ, 1994, EMBO J, V13, P3321, DOI 10.1002/j.1460-2075.1994.tb06634.x; Skalska L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000951; Spender LC, 2005, ONCOGENE, V24, P1873, DOI 10.1038/sj.onc.1208404; Spender LC, 2002, J VIROL, V76, P4919, DOI 10.1128/JVI.76.10.4919-4927.2002; Topisirovic I, 2002, MOL CELL BIOL, V22, P6183, DOI 10.1128/MCB.22.17.6183-6198.2002; Vlaicu SI, 2008, ARCH IMMUNOL THER EX, V56, P115, DOI 10.1007/s00005-008-0016-3; Vlaicu SI, 2010, EXP MOL PATHOL, V88, P67, DOI 10.1016/j.yexmp.2009.10.010; Wade M, 2000, MOL CELL BIOL, V20, P1344, DOI 10.1128/MCB.20.4.1344-1360.2000; WANG F, 1990, J VIROL, V64, P2309, DOI 10.1128/JVI.64.5.2309-2318.1990; West MJ, 2004, J VIROL, V78, P9431, DOI 10.1128/JVI.78.17.9431-9445.2004; West MJ, 2001, J VIROL, V75, P8524, DOI 10.1128/JVI.75.18.8524-8537.2001; West MJ, 1995, ONCOGENE, V11, P2515; White RE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013979; Wotton S, 2008, ONCOGENE, V27, P5856, DOI 10.1038/onc.2008.195; Yi FM, 2009, VIROLOGY, V388, P236, DOI 10.1016/j.virol.2009.03.027; Yin YH, 2005, BRIT J CANCER, V93, P458, DOI 10.1038/sj.bjc.6602716; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452; Zhan F, 2006, BLOOD, V108, P2020, DOI 10.1182/blood-2005-11-013458	77	18	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2011	6	12							e28638	10.1371/journal.pone.0028638	http://dx.doi.org/10.1371/journal.pone.0028638			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863OC	22163048	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000298173500044
J	Gilbert, DF; Erdmann, G; Zhang, X; Fritzsche, A; Demir, K; Jaedicke, A; Muehlenberg, K; Wanker, EE; Boutros, M				Gilbert, Daniel F.; Erdmann, Gerrit; Zhang, Xian; Fritzsche, Anja; Demir, Kubilay; Jaedicke, Andreas; Muehlenberg, Katja; Wanker, Erich E.; Boutros, Michael			A Novel Multiplex Cell Viability Assay for High-Throughput RNAi Screening	PLOS ONE			English	Article							HUNTINGTONS-DISEASE MUTATION; SYNTHETIC LETHALITY; MUTANT HUNTINGTIN; CANCER; DYSFUNCTION; INHIBITORS; TOXICITY; NUCLEUS; PATHWAY	Cell-based high-throughput RNAi screening has become a powerful research tool in addressing a variety of biological questions. In RNAi screening, one of the most commonly applied assay system is measuring the fitness of cells that is usually quantified using fluorescence, luminescence and absorption-based readouts. These methods, typically implemented and scaled to large-scale screening format, however often only yield limited information on the cell fitness phenotype due to evaluation of a single and indirect physiological indicator. To address this problem, we have established a cell fitness multiplexing assay which combines a biochemical approach and two fluorescence-based assaying methods. We applied this assay in a large-scale RNAi screening experiment with siRNA pools targeting the human kinome in different modified HEK293 cell lines. Subsequent analysis of ranked fitness phenotypes assessed by the different assaying methods revealed average phenotype intersections of 50.7 +/- 2.3%-58.7 +/- 14.4% when two indicators were combined and 40-48% when a third indicator was taken into account. From these observations we conclude that combination of multiple fitness measures may decrease false-positive rates and increases confidence for hit selection. Our robust experimental and analytical method improves the classical approach in terms of time, data comprehensiveness and cost.	[Gilbert, Daniel F.; Erdmann, Gerrit; Zhang, Xian; Fritzsche, Anja; Demir, Kubilay; Jaedicke, Andreas; Boutros, Michael] German Canc Res Ctr, Div Signaling & Funct Genom, Heidelberg, Germany; [Gilbert, Daniel F.; Erdmann, Gerrit; Zhang, Xian; Fritzsche, Anja; Demir, Kubilay; Jaedicke, Andreas; Boutros, Michael] Heidelberg Univ, Dept Cell & Mol Biol, Heidelberg, Germany; [Muehlenberg, Katja; Wanker, Erich E.] Max Delbrueck Ctr Mol Med MDC, Berlin, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Gilbert, DF (corresponding author), German Canc Res Ctr, Div Signaling & Funct Genom, Heidelberg, Germany.	daniel.gilbert@mbt.uni-erlangen.de	Boutros, Michael/C-3566-2008; Gilbert, Daniel F./F-8714-2011	Boutros, Michael/0000-0002-9458-817X; Erdmann, Gerrit/0000-0002-4183-3995; /0000-0003-4431-4741; Wanker, Erich/0000-0001-8072-1630	Nationales Genomforschungsnetz Plus (BMBF) [01GS08173]	Nationales Genomforschungsnetz Plus (BMBF)	This project was funded by the Nationales Genomforschungsnetz Plus (BMBF, Grant No. 01GS08173). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ataullakhanov FI, 2002, BIOSCIENCE REP, V22, P501, DOI 10.1023/A:1022069718709; Aziz NA, 2010, J NEUROL NEUROSUR PS, V81, P1233, DOI 10.1136/jnnp.2009.191833; Bieschke J, 2010, P NATL ACAD SCI USA, V107, P7710, DOI 10.1073/pnas.0910723107; BRAUTBOUCHER F, 1995, J IMMUNOL METHODS, V178, P41, DOI 10.1016/0022-1759(94)00239-S; Carmichael J, 2002, J BIOL CHEM, V277, P33791, DOI 10.1074/jbc.m204861200; Caviston JP, 2011, MOL BIOL CELL, V22, P478, DOI 10.1091/mbc.E10-03-0233; Chan DA, 2011, NAT REV DRUG DISCOV, V10, P351, DOI 10.1038/nrd3374; CHEN AY, 1993, P NATL ACAD SCI USA, V90, P8131, DOI 10.1073/pnas.90.17.8131; Chiang MC, 2011, BBA-MOL BASIS DIS, V1812, P1111, DOI 10.1016/j.bbadis.2011.05.006; Crowder RJ, 2009, CANCER RES, V69, P3955, DOI 10.1158/0008-5472.CAN-08-4450; da Silveira MG, 2002, APPL ENVIRON MICROB, V68, P6087, DOI 10.1128/AEM.68.12.6087-6093.2002; das Neves RP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000560; Einav Y, 2003, MOL CANCER THER, V2, P1121; Falschlehner C, 2010, BIOTECHNOL J, V5, P368, DOI 10.1002/biot.200900277; Giacomello M, 2011, BIOFACTORS, V37, P206, DOI 10.1002/biof.162; Godin JD, 2010, EMBO J, V29, P2433, DOI 10.1038/emboj.2010.117; Iglehart JD, 2009, NEW ENGL J MED, V361, P189, DOI 10.1056/NEJMe0903044; Jin YN, 2010, J BIOENERG BIOMEMBR, V42, P199, DOI 10.1007/s10863-010-9286-7; Kaltenbach LS, 2007, PLOS GENET, V3, P689, DOI 10.1371/journal.pgen.0030082; Karachitos Andonis, 2010, Postepy Biochem, V56, P174; King MA, 2008, J NEUROSCI, V28, P14401, DOI 10.1523/JNEUROSCI.4751-08.2008; LARSSON R, 1989, ANTICANCER RES, V9, P1111; Licchesi JD, 2010, ONCOGENE; Marcora E, 2010, HUM MOL GENET, V19, P4373, DOI 10.1093/hmg/ddq358; Martin-Aparicio E, 2002, EUR J NEUROSCI, V16, P355, DOI 10.1046/j.1460-9568.2002.02075.x; Mollapour M, 2010, CELL CYCLE, V9; Nguyen AV, 2010, INT J MOL MED, V26, P121, DOI 10.3892/ijmm_00000443; Pelz O, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-185; Perrin V, 2009, EXP NEUROL, V215, P191, DOI 10.1016/j.expneurol.2008.10.008; Ross BM, 1998, J NEUROCHEM, V70, P786; Saji M, 2010, MOL CELL ENDOCRINOL, V321, P20, DOI 10.1016/j.mce.2009.10.016; Steffan JS, 2010, CELL CYCLE, V9, P3401, DOI [10.4161/cc.9.17.12718, 10.4161/cc.9.17.12671]; Titus S, 2010, PROBE REPORTS NIH MO; Tomashevski A, 2001, J ALZHEIMERS DIS, V3, P195; Willingham AT, 2004, ONCOGENE, V23, P8392, DOI 10.1038/sj.onc.1208217; Womac AD, 2009, EUR J NEUROSCI, V30, P869, DOI 10.1111/j.1460-9568.2009.06874.x	36	31	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e28338	10.1371/journal.pone.0028338	http://dx.doi.org/10.1371/journal.pone.0028338			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22162763	Green Published, Green Submitted, gold			2022-12-27	WOS:000298172800026
J	Zou, HD; Zhang, X; Xu, X; Liu, HY; Bai, L; Xu, X				Zou, Haidong; Zhang, Xi; Xu, Xun; Liu, Haiyun; Bai, Lin; Xu, Xian			Vision-Related Quality of Life and Self-Rated Satisfaction Outcomes of Rhegmatogenous Retinal Detachment Surgery: 3-Year Prospective Study	PLOS ONE			English	Article							VITREORETINAL SURGERY; VISUAL FUNCTION; QUESTIONNAIRE; RECOVERY	Background: Subjective functional outcomes measurements, such as vision health-related quality of life (VRQoL) and self-rated satisfaction measures can provide helpful multidimensional vision health information that is more comprehensive than traditional objective measures, such as best corrected visual acuity (BCVA). The purpose of this study is to demonstrate 3-year longitudinal postoperative VRQoL and self-rated satisfaction changes after rhegmatogenous retinal detachment (RRD) surgery. Methodology/Principal Findings: A prospective case series report was conducted in 92 RRD patients who underwent surgery during January 2004 through December 2006. Preoperative, 3-month, 1-year and 3-year postoperative patient VRQoL and self-rated satisfaction were assessed by face-to-face interviews. The importance of objective variables for predicting three dependent variables: CLVQOL composite scores change, 3-year postoperative CVLQOL composite score and self-rated satisfaction degree scores were calculated by stepwise multivariate linear or logistic regression analysis methods. Results: The total CLVQOL composite scores change ranged between -48 and 90 (mean +/- standard deviation: 19.48 +/- 31.34), including positive changes in 62 patients. The self-rated satisfaction degree scores ultimately improved in 86 patients as compared with preoperative degrees. Statistically significant increases occurred only in the composite scores of subscale mobility and self-rated satisfaction degrees in the first 3 months, while the composite scores of the remaining subscales, and the total CLVQOL, BCVA in the RRD eye and weighted average BCVA, increased steadily throughout the first postoperative year. A better 3-year postoperative weighted average BCVA was associated with all of the 3 dependent outcome variables. Conclusions: VRQoL of RRD patients improved substantially after surgery and they were satisfied with their postoperative vision. The BCVA, VRQoL and self-rated satisfactory degree scores recovered in different patterns, and supplemented each other in the RRD surgery outcomes evaluated. Surgeons are advised to pay closer attention to binocular vision in RRD patients, and make efforts to explain the results of surgery.	[Zou, Haidong; Zhang, Xi; Xu, Xun; Liu, Haiyun; Bai, Lin; Xu, Xian] Shanghai Jiao Tong Univ, Dept Ophthalmol, Shanghai Peoples Hosp 1, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Zou, HD (corresponding author), Shanghai Jiao Tong Univ, Dept Ophthalmol, Shanghai Peoples Hosp 1, Shanghai 200030, Peoples R China.	zouhaidong@hotmail.com		Zou, Haidong/0000-0002-6831-7560	Shanghai Health Bureau; Hong Kong K.C. Wong Education foundation	Shanghai Health Bureau; Hong Kong K.C. Wong Education foundation	Supported by a grant from Shanghai Health Bureau and a grant from Hong Kong K.C. Wong Education foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	HILTON G, 1983, OPHTHALMOLOGY, V90, P121, DOI 10.1016/s0161-6420(83)34588-7; HOLLADAY JT, 1991, AM J OPHTHALMOL, V111, P372, DOI 10.1016/S0002-9394(14)72328-1; Kusaka S, 1998, JPN J OPHTHALMOL, V42, P218, DOI 10.1016/S0021-5155(97)00136-6; Liu F, 2006, OPHTHALMOLOGICA, V220, P174, DOI 10.1159/000091761; Okamoto F, 2008, AM J OPHTHALMOL, V146, P85, DOI 10.1016/j.ajo.2008.02.011; Okamoto F, 2010, INVEST OPHTH VIS SCI, V51, P744, DOI 10.1167/iovs.09-3992; Ranta P, 2002, OPHTHALMOLOGY, V109, P1432, DOI 10.1016/S0161-6420(02)01111-9; Ross W H, 2000, Curr Opin Ophthalmol, V11, P191, DOI 10.1097/00055735-200006000-00007; Scott IU, 1998, OPHTHALMOLOGY, V105, P795, DOI 10.1016/S0161-6420(98)95017-5; Scott IU, 1997, OPHTHALMOLOGY, V104, P1041, DOI 10.1016/S0161-6420(97)30189-4; SULLIVAN PM, 1993, EYE, V7, P433, DOI 10.1038/eye.1993.86; Wolffsohn JS, 2000, AM J OPHTHALMOL, V130, P793, DOI 10.1016/S0002-9394(00)00610-3; Zou H, 2005, QUAL LIFE RES, V14, P1633, DOI 10.1007/s11136-004-0026-5; Zou HD, 2008, OPHTHAL EPIDEMIOL, V15, P212, DOI 10.1080/09286580701843804	14	17	20	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e28597	10.1371/journal.pone.0028597	http://dx.doi.org/10.1371/journal.pone.0028597			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22162779	Green Published, gold, Green Submitted			2022-12-27	WOS:000298172800052
J	Farrer, L; Christensen, H; Griffiths, KM; Mackinnon, A				Farrer, Louise; Christensen, Helen; Griffiths, Kathleen M.; Mackinnon, Andrew			Internet-Based CBT for Depression with and without Telephone Tracking in a National Helpline: Randomised Controlled Trial	PLOS ONE			English	Article							COGNITIVE-BEHAVIORAL THERAPY; PRIMARY-CARE; CONFIDENCE-INTERVALS; CES-D; INTERVENTIONS; EFFICACY; PROGRAM; ANXIETY; SCALE; PSYCHOTHERAPY	Background: Telephone helplines are frequently and repeatedly used by individuals with chronic mental health problems and web interventions may be an effective tool for reducing depression in this population. Aim: To evaluate the effectiveness of a 6 week, web-based cognitive behaviour therapy (CBT) intervention with and without proactive weekly telephone tracking in the reduction of depression in callers to a helpline service. Method: 155 callers to a national helpline service with moderate to high psychological distress were recruited and randomised to receive either Internet CBT plus weekly telephone follow-up; Internet CBT only; weekly telephone follow-up only; or treatment as usual. Results: Depression was lower in participants in the web intervention conditions both with and without telephone tracking compared to the treatment as usual condition both at post intervention and at 6 month follow-up. Telephone tracking provided by a lay telephone counsellor did not confer any additional advantage in terms of symptom reduction or adherence. Conclusions: A web-based CBT program is effective both with and without telephone tracking for reducing depression in callers to a national helpline.	[Farrer, Louise; Christensen, Helen; Griffiths, Kathleen M.] Australian Natl Univ, Mental Hlth Res Ctr, Canberra, ACT, Australia; [Mackinnon, Andrew] Univ Melbourne, Biostat Unit, Orygen Youth Hlth Res Ctr, Melbourne, Vic, Australia	Australian National University; Orygen, The National Centre of Excellence in Youth Mental Health; University of Melbourne	Farrer, L (corresponding author), Australian Natl Univ, Mental Hlth Res Ctr, Canberra, ACT, Australia.	Louise.Farrer@anu.edu.au	Christensen, Helen/F-5053-2012; Mackinnon, Andrew J/A-4901-2008; Griffiths, Kathleen/A-9872-2012	Christensen, Helen/0000-0003-0435-2065; Mackinnon, Andrew/0000-0003-0831-9801	Australian Research Council [LP0667970]; Australian Postgraduate Award; National Health and Medical Research Council [525413, 525411]	Australian Research Council(Australian Research Council); Australian Postgraduate Award(Australian Government); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	Funding for the trial was provided by an Australian Research Council Linkage Project Grant (LP0667970) (http://www.arc.gov.au/). LF is supported by an Australian Postgraduate Award Industry scholarship. KG is supported by a National Health and Medical Research Council Fellowship (No. 525413) and HC is supported by a National Health and Medical Research Council Fellowship (No. 525411). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.; HC and KG are authors of the web based treatment programs BluePages (bluepages.anu.edu.au) and MoodGYM (moodgym.anu.edu.au). LF has received a postgraduate scholarship from the Australian Research Council. KG has received funding from the National Health and Medical Research Council and receives support from numerous sources (list of funders upon request, for conference support) to deliver conference presentations on the MoodGYM and BluePages programs. HC has received funding from industry partner Lifeline for consultancy following completion of the research involving the submitted work and receives support (list of funders upon request, for conference support) to deliver presentations on the MoodGYM and BluePages programs. HC and KG receive royalties from editing a book containing information about the MoodGYM and BluePages programs. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Altman DG, 1998, BRIT MED J, V317, P1309, DOI 10.1136/bmj.317.7168.1309; Andersson Gerhard, 2009, Cognitive Behaviour Therapy, V38, P196, DOI 10.1080/16506070903318960; Andrews G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013196; Barak A, 2008, J TECHNOL HUMAN SERV, V26, P109, DOI 10.1080/15228830802094429; Bender R, 2001, CONTROL CLIN TRIALS, V22, P102, DOI 10.1016/S0197-2456(00)00134-3; Bollini P, 1999, BRIT J PSYCHIAT, V174, P297, DOI 10.1192/bjp.174.4.297; Butler AC, 2006, CLIN PSYCHOL REV, V26, P17, DOI 10.1016/j.cpr.2005.07.003; Calear AL, 2009, J CONSULT CLIN PSYCH, V77, P1021, DOI 10.1037/a0017391; Christensen H, 2004, MED J AUSTRALIA, V180, P604, DOI 10.5694/j.1326-5377.2004.tb06118.x; Christensen H, 2004, BRIT MED J, V328, P265, DOI 10.1136/bmj.37945.566632.EE; Christensen H, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1194; Clarke G, 2005, J MED INTERNET RES, V7, DOI 10.2196/jmir.7.2.e16; Clarke Greg, 2009, Cognitive Behaviour Therapy, V38, P222, DOI 10.1080/16506070802675353; de Graaf LE, 2009, BRIT J PSYCHIAT, V195, P73, DOI 10.1192/bjp.bp.108.054429; DeRubeis RJ, 2005, ARCH GEN PSYCHIAT, V62, P409, DOI 10.1001/archpsyc.62.4.409; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; FLAY BR, 1986, PREV MED, V15, P451, DOI 10.1016/0091-7435(86)90024-1; Griffiths KM, 2010, MED J AUSTRALIA, V192, pS4, DOI 10.5694/j.1326-5377.2010.tb03685.x; Hamer RM, 2009, AM J PSYCHIAT, V166, P639, DOI 10.1176/appi.ajp.2009.09040458; Hedges LV, 2014, STAT METHODS META AN; Hickie IB, 2010, MED J AUSTRALIA, V192, pS31; Husaini BA, 1980, J COMMUNITY PSYCHOL, V8, P20, DOI DOI 10.1002/1520-6629(198001; Kelley K, 2007, J STAT SOFTW, V20, P1; Kessler D, 2009, LANCET, V374, P628, DOI 10.1016/S0140-6736(09)61257-5; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Knight RG, 1997, BEHAV RES THER, V35, P373, DOI 10.1016/S0005-7967(96)00107-6; Leach LS, 2006, J TELEMED TELECARE, V12, P122, DOI 10.1258/135763306776738558; McHugh RK, 2010, AM PSYCHOL, V65, P73, DOI 10.1037/a0018121; Meyer B, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1151; Mohr DC, 2005, PSYCHIATRY, V65, P1007; Perini S, 2009, AUST NZ J PSYCHIAT, V43, P571, DOI 10.1080/00048670902873722; Perkins D., 2004, WHO CALLS LIFELINE B; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rhee WK, 2005, SUICIDE LIFE-THREAT, V35, P317, DOI 10.1521/suli.2005.35.3.317; ROBERTS RE, 1980, PSYCHIAT RES, V2, P125, DOI 10.1016/0165-1781(80)90069-4; ROBERTS RE, 1983, AM J PSYCHIAT, V140, P41; ROBINS LN, 1988, ARCH GEN PSYCHIAT, V45, P1069; ROSS CE, 1984, AM J EPIDEMIOL, V119, P997, DOI 10.1093/oxfordjournals.aje.a113819; Ruwaard Jeroen, 2009, Cognitive Behaviour Therapy, V38, P206, DOI 10.1080/16506070802408086; Sethi S, 2010, J TECHNOL HUMAN SERV, V28, P144, DOI 10.1080/15228835.2010.508317; Seward J, 2010, OXFORD GUIDE LOW INT; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Spek V, 2007, PSYCHOL MED, V37, P1797, DOI 10.1017/S0033291707000542; Spek V, 2007, PSYCHOL MED, V37, P319, DOI 10.1017/S0033291706008944; SPSS Inc, 2009, PASW REL 18 0; The Samaritans, 2010, SAM FACTS FIG; Titov N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010939; Titov N, 2008, AUST NZ J PSYCHIAT, V42, P1030, DOI 10.1080/00048670802512107; Urbis Keys Young, 2003, NAT REV TEL COUNS WE; Verbeke G, 2000, LINEAR MIXED MODELS; Warmerdam L, 2008, J MED INTERNET RES, V10, DOI 10.2196/jmir.954; Whooley MA, 1997, J GEN INTERN MED, V12, P439, DOI 10.1046/j.1525-1497.1997.00076.x; Williams JW, 2002, GEN HOSP PSYCHIAT, V24, P225, DOI 10.1016/S0163-8343(02)00195-0	53	95	98	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e28099	10.1371/journal.pone.0028099	http://dx.doi.org/10.1371/journal.pone.0028099			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	863MI	22140514	Green Published, Green Submitted, gold			2022-12-27	WOS:000298168100035
J	Magistroni, V; Mologni, L; Sanselicio, S; Reid, JF; Redaelli, S; Piazza, R; Viltadi, M; Bovo, G; Strada, G; Grasso, M; Gariboldi, M; Gambacorti-Passerini, C				Magistroni, Vera; Mologni, Luca; Sanselicio, Stefano; Reid, James Frances; Redaelli, Sara; Piazza, Rocco; Viltadi, Michela; Bovo, Giorgio; Strada, Guido; Grasso, Marco; Gariboldi, Manuela; Gambacorti-Passerini, Carlo			ERG Deregulation Induces PIM1 Over-Expression and Aneuploidy in Prostate Epithelial Cells	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; EMBRYONIC STEM-CELLS; ETS-RELATED GENE; TRANSCRIPTION FACTOR; FUSION PROTEIN; CANCER CELLS; CHROMOSOMAL TRANSLOCATION; HEMATOPOIETIC-CELLS; EWINGS-SARCOMA; EWS-ERG	The ERG gene belongs to the ETS family of transcription factors and has been found to be involved in atypical chromosomal rearrangements in several cancers. To gain insight into the oncogenic activity of ERG, we compared the gene expression profile of NIH-3T3 cells stably expressing the coding regions of the three main ERG oncogenic fusions: TMPRSS2/ERG (tERG), EWS/ERG and FUS/ERG. We found that all three ERG fusions significantly up-regulate PIM1 expression in the NIH-3T3 cell line. PIM1 is a serine/threonine kinase frequently over-expressed in cancers of haematological and epithelial origin. We show here that tERG expression induces PIM1 in the non-malignant prostate cell line RWPE-1, strengthening the relation between tERG and PIM1 up-regulation in the initial stages of prostate carcinogenesis. Silencing of tERG reversed PIM1 induction. A significant association between ERG and PIM1 expression in clinical prostate carcinoma specimens was found, suggesting that such a mechanism may be relevant in vivo. Chromatin Immunoprecipitation experiments showed that tERG directly binds to PIM1 promoter in the RWPE-1 prostate cell line, suggesting that tERG could be a direct regulator of PIM1 expression. The up-regulation of PIM1 induced by tERG over-expression significantly modified Cyclin B1 levels and increased the percentage of aneuploid cells in the RWPE-1 cell line after taxane-based treatment. Here we provide the first evidence for an ERG-mediated PIM1 up-regulation in prostate cells in vitro and in vivo, suggesting a direct effect of ERG transcriptional activity in the alteration of genetic stability.	[Magistroni, Vera; Mologni, Luca; Sanselicio, Stefano; Redaelli, Sara; Piazza, Rocco; Viltadi, Michela; Gambacorti-Passerini, Carlo] Univ Milano Bicocca, Dept Clin Med, Monza, Italy; [Reid, James Frances; Gariboldi, Manuela] Fdn IRCCS Ist Nazl Tumori, Dept Expt Oncol & Mol Med, Milan, Italy; [Reid, James Frances; Gariboldi, Manuela] IFOM Fdn, Unit Mol Genet Canc, Milan, Italy; [Bovo, Giorgio] S Gerardo Hosp, Dept Pathol, Monza, Italy; [Strada, Guido] Bassini ICP Hosp, Div Urol, Milan, Italy; [Grasso, Marco] San Gerardo Hosp, Dept Urol, Monza, Italy; [Gambacorti-Passerini, Carlo] San Gerardo Hosp, Sect Haematol, Monza, Italy	University of Milano-Bicocca; Fondazione IRCCS Istituto Nazionale Tumori Milan; IFOM - FIRC Institute of Molecular Oncology; San Gerardo Hospital; San Gerardo Hospital	Magistroni, V (corresponding author), Univ Milano Bicocca, Dept Clin Med, Monza, Italy.	vera.magistroni@unimib.it	Piazza, Rocco/I-3540-2012; Reid, James/G-2496-2010; redaelli, sara/I-5146-2012; Mologni, Luca/AAC-1065-2022; Magistroni, Vera/AAA-5582-2020; Gariboldi, Manuela/K-4744-2016	redaelli, sara/0000-0003-0166-1188; Mologni, Luca/0000-0002-6365-5149; Magistroni, Vera/0000-0002-7334-9401; Reid, James/0000-0001-6997-2850; GAMBACORTI PASSERINI, CARLO/0000-0001-6058-515X; Rocco, Piazza/0000-0003-4198-9620; Gariboldi, Manuela/0000-0001-8406-165X	Italian Ministry of Health [RFPS-2006-333974]; Italian Association for Cancer Research (AIRC) [IG-10092]; Progetti di Ricerca di Interesse Nazionale (PRIN) [20084XBENM_004]; CARIPLO Foundation [2009-2667]; Regione Lombardia [ID-16871, ID-14546A]	Italian Ministry of Health; Italian Association for Cancer Research (AIRC); Progetti di Ricerca di Interesse Nazionale (PRIN); CARIPLO Foundation; Regione Lombardia	This work was supported by the Italian Ministry of Health (RFPS-2006-333974); the Italian Association for Cancer Research (AIRC) (IG-10092); Progetti di Ricerca di Interesse Nazionale (PRIN) (20084XBENM_004); CARIPLO Foundation (2009-2667); Regione Lombardia (ID-16871 and ID-14546A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babel I, 2009, MOL CELL PROTEOMICS, V8, P2382, DOI 10.1074/mcp.M800596-MCP200; Bachmann PS, 2010, BLOOD, V116, P3013, DOI 10.1182/blood-2010-05-284968; Baldus CD, 2006, J CLIN ONCOL, V24, P4714, DOI 10.1200/JCO.2006.06.1580; Beier UH, 2007, INT J ONCOL, V30, P1381; Bhattacharya N, 2002, CHROMOSOMA, V111, P80, DOI 10.1007/s00412-002-0192-6; Birdsey GM, 2008, BLOOD, V111, P3498, DOI 10.1182/blood-2007-08-105346; Brenner JC, 2011, CANCER CELL, V19, P664, DOI 10.1016/j.ccr.2011.04.010; Carver BS, 2009, NATURE, V457, pE1, DOI 10.1038/nature07738; Chen J, 2009, ONCOGENE, V28, P2581, DOI 10.1038/onc.2009.124; Chinnaiyan AM, 2008, NEOPLASIA, V10, P177, DOI 10.1593/neo.07822; Chu QJ, 2006, CARCINOGENESIS, V27, P2180, DOI 10.1093/carcin/bgl054; Cibull TL, 2006, J CLIN PATHOL, V59, P285, DOI 10.1136/jcp.2005.027672; Clark J, 2007, ONCOGENE, V26, P2667, DOI 10.1038/sj.onc.1210070; Codrington R, 2005, PLOS BIOL, V3, P1459, DOI 10.1371/journal.pbio.0030242; DELATTRE O, 1992, NATURE, V359, P162, DOI 10.1038/359162a0; Dhanasekaran SM, 2001, NATURE, V412, P822, DOI 10.1038/35090585; Diaz FJ, 2006, DEV BIOL, V299, P91, DOI 10.1016/j.ydbio.2006.07.012; Diecke S, 2008, CELLS TISSUES ORGANS, V188, P52, DOI 10.1159/000121282; GIOVANNINI M, 1994, J CLIN INVEST, V94, P489, DOI 10.1172/JCI117360; Harb JG, 2008, BLOOD, V111, P3760, DOI 10.1182/blood-2007-08-108803; ICHIKAWA H, 1994, CANCER RES, V54, P2865; Ichikawa H, 1999, MOL CELL BIOL, V19, P7639; Kim J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-248; Kim KT, 2005, BLOOD, V105, P1759, DOI 10.1182/blood-2004-05-2006; King JC, 2009, NAT GENET, V41, P524, DOI 10.1038/ng.371; Klezovitch O, 2008, P NATL ACAD SCI USA, V105, P2105, DOI 10.1073/pnas.0711711105; Kong XT, 1997, BLOOD, V90, P1192; Kunderfranco P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010547; Marcucci G, 2005, J CLIN ONCOL, V23, P9234, DOI 10.1200/JCO.2005.03.6137; Mologni L, 2010, CANCER RES, V70, P7253, DOI 10.1158/0008-5472.CAN-10-1108; Mumenthaler SM, 2009, MOL CANCER THER, V8, P2882, DOI 10.1158/1535-7163.MCT-09-0293; Nawijn MC, 2011, NAT REV CANCER, V11, P23, DOI 10.1038/nrc2986; PANAGOPOULOS I, 1994, GENE CHROMOSOME CANC, V11, P256, DOI 10.1002/gcc.2870110408; Peltola K, 2009, NEOPLASIA, V11, P629, DOI 10.1593/neo.81038; Pereira DS, 1998, P NATL ACAD SCI USA, V95, P8239, DOI 10.1073/pnas.95.14.8239; Perner S, 2007, AM J SURG PATHOL, V31, P882, DOI 10.1097/01.pas.0000213424.38503.aa; Reiser-Erkan C, 2008, CANCER BIOL THER, V7, P1352, DOI 10.4161/cbt.7.9.6418; Roh M, 2005, J BIOL CHEM, V280, P40568, DOI 10.1074/jbc.M509369200; Roh M, 2003, CANCER RES, V63, P8079; Roh M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002572; Sahlberg C, 2007, J DENT RES, V86, P600, DOI 10.1177/154405910708600704; SHIMIZU K, 1993, P NATL ACAD SCI USA, V90, P10280, DOI 10.1073/pnas.90.21.10280; SORENSEN PHB, 1994, NAT GENET, V6, P146, DOI 10.1038/ng0294-146; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Torres EM, 2008, GENETICS, V179, P737, DOI 10.1534/genetics.108.090878; Valdman A, 2004, PROSTATE, V60, P367, DOI 10.1002/pros.20064; Van Orman JR, 2009, AM J PHYSIOL-HEART C, V297, pH1369, DOI 10.1152/ajpheart.00172.2009; Willems E, 2006, INT J DEV BIOL, V50, P627, DOI 10.1387/ijdb.052130ew; Xie Y, 2006, ONCOGENE, V25, P70, DOI 10.1038/sj.onc.1209058; Xie Y, 2008, J BIOL CHEM, V283, P3349, DOI 10.1074/jbc.M707773200; Yang L, 2000, MOL CELL BIOL, V20, P3345, DOI 10.1128/MCB.20.10.3345-3354.2000; Zemskova M, 2008, J BIOL CHEM, V283, P20635, DOI 10.1074/jbc.M709479200; Zong Y, 2009, P NATL ACAD SCI USA, V106, P12465, DOI 10.1073/pnas.0905931106; Zou JH, 2005, MOL CELL BIOL, V25, P6235, DOI 10.1128/MCB.25.14.6235-6246.2005; ZUCMAN J, 1993, EMBO J, V12, P4481, DOI 10.1002/j.1460-2075.1993.tb06137.x	55	26	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e28162	10.1371/journal.pone.0028162	http://dx.doi.org/10.1371/journal.pone.0028162			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140532	Green Published, Green Submitted, gold			2022-12-27	WOS:000298168100042
J	Kaushansky, N; de Rosbo, NK; Zilkha-Falb, R; Yosef-Hemo, R; Cohen, L; Ben-Nun, A				Kaushansky, Nathali; de Rosbo, Nicole Kerlero; Zilkha-Falb, Rina; Yosef-Hemo, Reut; Cohen, Lydia; Ben-Nun, Avraham			'Multi-Epitope-Targeted' Immune-Specific Therapy for a Multiple Sclerosis-Like Disease via Engineered Multi-Epitope Protein Is Superior to Peptides	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MYELIN BASIC-PROTEIN; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; OLIGODENDROCYTE-SPECIFIC PROTEIN; T-CELL AUTOIMMUNITY; CLASS-II; H-2(B) MICE; SJL/J MICE; DEMYELINATING DISEASE; ANTIGEN PRESENTATION	Antigen-induced peripheral tolerance is potentially one of the most efficient and specific therapeutic approaches for autoimmune diseases. Although highly effective in animal models, antigen-based strategies have not yet been translated into practicable human therapy, and several clinical trials using a single antigen or peptidic-epitope in multiple sclerosis (MS) yielded disappointing results. In these clinical trials, however, the apparent complexity and dynamics of the pathogenic autoimmunity associated with MS, which result from the multiplicity of potential target antigens and "epitope spread", have not been sufficiently considered. Thus, targeting pathogenic T-cells reactive against a single antigen/epitope is unlikely to be sufficient; to be effective, immunospecific therapy to MS should logically neutralize concomitantly T-cells reactive against as many major target antigens/epitopes as possible. We investigated such "multi-epitope-targeting" approach in murine experimental autoimmune encephalomyelitis (EAE) associated with a single ("classical") or multiple ("complex") anti-myelin autoreactivities, using cocktail of different encephalitogenic peptides vis-a-vis artificial multi-epitope-protein (designated Y-MSPc) encompassing rationally selected MS-relevant epitopes of five major myelin antigens, as "multi-epitope-targeting" agents. Y-MSPc was superior to peptide(s) in concomitantly downregulating pathogenic T-cells reactive against multiple myelin antigens/epitopes, via inducing more effective, longer lasting peripheral regulatory mechanisms (cytokine shift, anergy, and Foxp3+ CTLA4+ regulatory T-cells). Y-MSPc was also consistently more effective than the disease-inducing single peptide or peptide cocktail, not only in suppressing the development of "classical" or "complex EAE" or ameliorating ongoing disease, but most importantly, in reversing chronic EAE. Overall, our data emphasize that a "multi-epitope-targeting" strategy is required for effective immune-specific therapy of organ-specific autoimmune diseases associated with complex and dynamic pathogenic autoimmunity, such as MS; our data further demonstrate that the "multi-epitope-targeting" approach to therapy is optimized through specifically designed multi-epitope-proteins, rather than myelin peptide cocktails, as "multi-epitope-targeting" agents. Such artificial multi-epitope proteins can be tailored to other organ-specific autoimmune diseases.	[Kaushansky, Nathali; de Rosbo, Nicole Kerlero; Zilkha-Falb, Rina; Yosef-Hemo, Reut; Cohen, Lydia; Ben-Nun, Avraham] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Kaushansky, N (corresponding author), Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel.	avraham.ben-nun@weizmann.ac.il	KAUSHANSKY, NATHALI/K-1722-2012; Kerlero de Rosbo, Nicole/I-1134-2018	Kerlero de Rosbo, Nicole/0000-0002-0493-0964	Israel Academy of Science and Humanities (ISF); National Multiple Sclerosis Society of New York; Israel Ministry of Health; Estate of the Late Florence Blau; William Sahm Foundation; Rubin & Gladys Wollowick Foundation; Kirk Center for Childhood Cancer and Immunological Disorders	Israel Academy of Science and Humanities (ISF); National Multiple Sclerosis Society of New York(National Multiple Sclerosis Society); Israel Ministry of Health; Estate of the Late Florence Blau; William Sahm Foundation; Rubin & Gladys Wollowick Foundation; Kirk Center for Childhood Cancer and Immunological Disorders	This work was supported in part by the Israel Academy of Science and Humanities (ISF), the National Multiple Sclerosis Society of New York, the Israel Ministry of Health, the Estate of the Late Florence Blau, the William Sahm Foundation, the Rubin & Gladys Wollowick Foundation, and The Kirk Center for Childhood Cancer and Immunological Disorders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adorini L, 2004, J NEUROL SCI, V223, P13, DOI 10.1016/j.jns.2004.04.014; AMOR S, 1994, J IMMUNOL, V153, P4349; Ben-Nun A, 2006, EUR J IMMUNOL, V36, P478, DOI 10.1002/eji.200535363; BENNUN A, 1983, J IMMUNOL, V130, P1205; BENNUN A, 1981, EUR J IMMUNOL, V11, P195, DOI 10.1002/eji.1830110307; Bielekova B, 2000, NAT MED, V6, P1167, DOI 10.1038/80516; CAMPBELL B, 1973, ARCH NEUROL-CHICAGO, V29, P10, DOI 10.1001/archneur.1973.00490250028003; Chen CC, 2001, BLOOD, V97, P886, DOI 10.1182/blood.V97.4.886; CLAYTON JP, 1989, J EXP MED, V169, P1681, DOI 10.1084/jem.169.5.1681; CRITCHFIELD JM, 1994, SCIENCE, V263, P1139, DOI 10.1126/science.7509084; de Rosbo NK, 1998, J AUTOIMMUN, V11, P287, DOI 10.1006/jaut.1998.0202; de Rosbo NK, 2004, J IMMUNOL, V173, P1426, DOI 10.4049/jimmunol.173.2.1426; Devaux B, 1997, J NEUROIMMUNOL, V75, P169, DOI 10.1016/S0165-5728(97)00019-2; Elliott EA, 1996, J CLIN INVEST, V98, P1602, DOI 10.1172/JCI118954; Ellmerich S, 2004, EUR J IMMUNOL, V34, P1839, DOI 10.1002/eji.200324044; Fritz RB, 1996, J NEUROSCI RES, V45, P471, DOI 10.1002/(SICI)1097-4547(19960815)45:4<471::AID-JNR17>3.0.CO;2-3; GAUR A, 1992, SCIENCE, V258, P1491, DOI 10.1126/science.1279812; GONSETTE RE, 1977, J NEUROL, V216, P27, DOI 10.1007/BF00312812; Hohlfeid R, 2004, P NATL ACAD SCI USA, V101, P14599, DOI 10.1073/pnas.0404874101; HOWELL MD, 1989, SCIENCE, V246, P668, DOI 10.1126/science.2814489; Huan JY, 2004, J IMMUNOL, V172, P4556, DOI 10.4049/jimmunol.172.7.4556; Jin Y, 2004, HUM IMMUNOL, V65, P93, DOI 10.1016/j.humimm.2003.11.002; Jurynczyk M, 2010, ANN NEUROL, V68, P593, DOI 10.1002/ana.22219; Kappos L, 2000, NAT MED, V6, P1176, DOI 10.1038/80525; Kaushansky N, 2007, EUR J IMMUNOL, V37, P2018, DOI 10.1002/eji.200636965; Kaushansky N, 2006, J IMMUNOL, V177, P7364, DOI 10.4049/jimmunol.177.10.7364; Kaye JF, 2000, J NEUROIMMUNOL, V102, P189, DOI 10.1016/S0165-5728(99)00168-X; Korn T, 2007, NAT MED, V13, P423, DOI 10.1038/nm1564; Leadbetter EA, 1998, J IMMUNOL, V161, P504; LEHMANN PV, 1992, NATURE, V358, P155, DOI 10.1038/358155a0; LIDER O, 1988, SCIENCE, V239, P181, DOI 10.1126/science.2447648; Liu E, 2002, J CLIN INVEST, V110, P1021, DOI 10.1172/JCI200215488; MCRAE BL, 1995, J EXP MED, V182, P75, DOI 10.1084/jem.182.1.75; Mendel I, 1996, EUR J IMMUNOL, V26, P2470, DOI 10.1002/eji.1830261030; MENDEL I, 1995, EUR J IMMUNOL, V25, P1951, DOI 10.1002/eji.1830250723; OWHASHI M, 1988, J EXP MED, V168, P2153, DOI 10.1084/jem.168.6.2153; Pathak SS, 2000, TRAFFIC, V1, P561, DOI 10.1034/j.1600-0854.2000.010706.x; Pedotti R, 2001, NAT IMMUNOL, V2, P216, DOI 10.1038/85266; Pedotti Rosetta, 2003, BMC Immunol, V4, P2, DOI 10.1186/1471-2172-4-2; Racke MK, 1996, ANN NEUROL, V39, P46, DOI 10.1002/ana.410390108; Ruiz PJ, 1999, J IMMUNOL, V162, P3336; SAKAI K, 1988, J NEUROIMMUNOL, V19, P21, DOI 10.1016/0165-5728(88)90032-X; SHARMA SD, 1991, P NATL ACAD SCI USA, V88, P11465, DOI 10.1073/pnas.88.24.11465; Simpson D, 2002, CNS DRUGS, V16, P825, DOI 10.2165/00023210-200216120-00004; Smith CE, 2006, J AUTOIMMUN, V27, P218, DOI 10.1016/j.jaut.2006.12.002; Smith CE, 2005, P NATL ACAD SCI USA, V102, P9595, DOI 10.1073/pnas.0504131102; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Stevens DB, 1999, J IMMUNOL, V162, P7501; TUOHY VK, 1994, NEUROCHEM RES, V19, P935, DOI 10.1007/BF00968703; Tuohy VK, 1998, IMMUNOL REV, V164, P93, DOI 10.1111/j.1600-065X.1998.tb01211.x; Tuohy VK, 1997, J CLIN INVEST, V99, P1682, DOI 10.1172/JCI119331; URBAN JL, 1988, CELL, V54, P577, DOI 10.1016/0092-8674(88)90079-7; VANDENBARK AA, 1989, NATURE, V341, P541, DOI 10.1038/341541a0; Vanderlugt CL, 2002, NAT REV IMMUNOL, V2, P85, DOI 10.1038/nri724; Warren KG, 2006, EUR J NEUROL, V13, P887, DOI 10.1111/j.1468-1331.2006.01533.x; Watts C, 2004, NAT IMMUNOL, V5, P685, DOI 10.1038/ni1088; WRAITH DC, 1989, CELL, V59, P247, DOI 10.1016/0092-8674(89)90287-0; Yu M, 1998, HUM IMMUNOL, V59, P15, DOI 10.1016/S0198-8859(97)00252-8; ZAMVIL S, 1985, NATURE, V317, P355, DOI 10.1038/317355a0; Zhong MC, 2000, J NEUROIMMUNOL, V105, P39, DOI 10.1016/S0165-5728(00)00186-7; Zhong MC, 2002, J CLIN INVEST, V110, P81, DOI 10.1172/JCI200215692	62	22	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2011	6	11							e27860	10.1371/journal.pone.0027860	http://dx.doi.org/10.1371/journal.pone.0027860			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863LT	22140475	Green Published, Green Submitted, gold			2022-12-27	WOS:000298166300014
J	Sharma, A; Bode, B; Wenger, RH; Lehmann, K; Sartori, AA; Moch, H; Knuth, A; von Boehmer, L; van den Broek, M				Sharma, Anu; Bode, Beata; Wenger, Roland H.; Lehmann, Kuno; Sartori, Alessandro A.; Moch, Holger; Knuth, Alexander; von Boehmer, Lotta; van den Broek, Maries			gamma-Radiation Promotes Immunological Recognition of Cancer Cells through Increased Expression of Cancer-Testis Antigens In Vitro and In Vivo	PLOS ONE			English	Article							CD8(+) T-CELLS; DNA-DAMAGE RESPONSE; GENE-EXPRESSION; TUMOR; IMMUNOTHERAPY; MELANOMA; THERAPY; ATM; RADIOTHERAPY; INDIVIDUALS	Background: gamma-radiation is an effective treatment for cancer. There is evidence that radiotherapy supports tumor-specific immunity. It was described that irradiation induces de novo protein synthesis and enhances antigen presentation, we therefore investigated whether gamma-radiation results in increased expression of cancer-testis (CT) antigens and MHC-I, thus allowing efficient immunological control. This is relevant because the expression of CT-antigens and MHC-I on tumor cells is often heterogeneous. We found that the changes induced by gamma-radiation promote the immunological recognition of the tumor, which is illustrated by the increased infiltration by lymphocytes after radiotherapy. Methods/Findings: We compared the expression of CT-antigens and MHC-I in various cancer cell lines and fresh biopsies before and after in vitro irradiation (20 Gy). Furthermore, we compared paired biopsies that were taken before and after radiotherapy from sarcoma patients. To investigate whether the changed expression of CT-antigens and MHC-I is specific for gamma-radiation or is part of a generalized stress response, we analyzed the effect of hypoxia, hyperthermia and genotoxic stress on the expression of CT-antigens and MHC-I. In vitro irradiation of cancer cell lines and of fresh tumor biopsies induced a higher or de novo expression of different CT-antigens and a higher expression of MHC-I in a time-and dose-dependent fashion. Importantly, we show that irradiation of cancer cells enhances their recognition by tumor-specific CD8+ T cells. The analysis of paired biopsies taken from a cohort of sarcoma patients before and after radiotherapy confirmed our findings and, in addition showed that irradiation resulted in higher infiltration by lymphocytes. Other forms of stress did not have an impact on the expression of CT-antigens or MHC-I. Conclusions: Our findings suggest that gamma-radiation promotes the immunological recognition of the tumor. We therefore propose that combining radiotherapy with treatments that support tumor specific immunity may result in increased therapeutic efficacy.	[Sharma, Anu; Knuth, Alexander; von Boehmer, Lotta; van den Broek, Maries] Univ Zurich Hosp, Dept Oncol, CH-8091 Zurich, Switzerland; [Bode, Beata; Moch, Holger] Univ Zurich Hosp, Dept Pathol, CH-8091 Zurich, Switzerland; [Wenger, Roland H.] Univ Zurich, Inst Physiol, Zurich, Switzerland; [Lehmann, Kuno] Univ Zurich Hosp, Dept Visceral Surg, CH-8091 Zurich, Switzerland; [Sartori, Alessandro A.] Univ Zurich, Inst Mol Canc Res, Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich; University of Zurich; University Zurich Hospital; University of Zurich	Sharma, A (corresponding author), Univ Zurich Hosp, Dept Oncol, CH-8091 Zurich, Switzerland.	maries@van-den-broek.ch	van den Broek, Maries/L-6532-2019; Sartori, Alessandro/AAK-7840-2021; Lehmann, Kuno/M-8504-2016; Wenger, Roland H./B-7953-2009; knuth, alexander/H-2608-2014	Sartori, Alessandro/0000-0003-2770-0333; Lehmann, Kuno/0000-0002-6177-9543; Wenger, Roland H./0000-0001-7592-4839; knuth, alexander/0000-0002-9318-2784; SHARMA, ANU/0000-0002-5934-994X	Ludwig Institute for Cancer Research/Cancer Research Institute (Cancer Antigen Discovery Collaborative); Cancer Research Institute; Hanne Liebermann Foundation; Hartmann Muller Foundation; Terry Fox Foundation; Ellinger Foundation; Med Alumini University of Zurich; Vontobel-Foundation; Swiss National Science Foundation (SNSF)	Ludwig Institute for Cancer Research/Cancer Research Institute (Cancer Antigen Discovery Collaborative); Cancer Research Institute; Hanne Liebermann Foundation; Hartmann Muller Foundation; Terry Fox Foundation; Ellinger Foundation; Med Alumini University of Zurich; Vontobel-Foundation; Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF))	This work was supported by the Ludwig Institute for Cancer Research/Cancer Research Institute (Cancer Antigen Discovery Collaborative), Atlantic Philanthropies, the Cancer Research Institute, the Hanne Liebermann Foundation, the Hartmann Muller Foundation, the Terry Fox Foundation and the Ellinger Foundation, Med Alumini University of Zurich (www.alumuni.uzh.ch). Alessandro A. Sartori is supported by the Vontobel-Foundation and by an Ambizione fellowship from the Swiss National Science Foundation (SNSF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BYERS VS, 1975, J CLIN INVEST, V55, P500, DOI 10.1172/JCI107956; Chiriva-Internati M, 2006, IN VITRO CELL DEV-AN, V42, P89; Coral S, 2002, CLIN CANCER RES, V8, P2690; Demaria S, 2005, INT J RADIAT ONCOL, V63, P655, DOI 10.1016/j.ijrobp.2005.06.032; Feldmeyer L, 2007, CURR BIOL, V17, P1140, DOI 10.1016/j.cub.2007.05.074; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Garnett CT, 2004, CANCER RES, V64, P7985, DOI 10.1158/0008-5472.CAN-04-1525; Gehring AJ, 2009, GASTROENTEROLOGY, V137, P682, DOI 10.1053/j.gastro.2009.04.045; Gotter J, 2004, J EXP MED, V199, P155, DOI 10.1084/jem.20031677; HAUSER SH, 1993, CANCER RES, V53, P1952; Horig H, 2000, Expert Rev Mol Med, V2, P1, DOI 10.1017/S146239940000168X; Huen MS, 2008, CELL RES, V18, P8, DOI 10.1038/cr.2007.109; Jang ER, 2010, EXP MOL MED, V42, P195, DOI 10.3858/emm.2010.42.3.020; Karanikas V, 2009, J BUON, V14, pS153; Kastan MB, 2000, NAT REV MOL CELL BIO, V1, P179, DOI 10.1038/35043058; Lee YJ, 2009, BLOOD, V114, P589, DOI 10.1182/blood-2009-02-206870; Lugade AA, 2005, J IMMUNOL, V174, P7516, DOI 10.4049/jimmunol.174.12.7516; Mairs Robert J., 2007, Dose-Response, V5, P204, DOI 10.2203/dose-response.07-002.Mairs; Matsumura S, 2008, J IMMUNOL, V181, P3099, DOI 10.4049/jimmunol.181.5.3099; NORTH RJ, 1984, CANCER IMMUNOL IMMUN, V16, P175; Pandey R, 2005, INT J RADIAT BIOL, V81, P801, DOI 10.1080/09553000500531886; Pandita TK, 2000, ONCOGENE, V19, P1386, DOI 10.1038/sj.onc.1203444; Park SK, 2003, MOL CELL BIOL, V23, P4959, DOI 10.1128/MCB.23.14.4959-4971.2003; Parmigiani RB, 2006, P NATL ACAD SCI USA, V103, P18066, DOI 10.1073/pnas.0608853103; PENN I, 1988, ANNU REV MED, V39, P63, DOI 10.1146/annurev.me.39.020188.000431; Prise KM, 2009, NAT REV CANCER, V9, P351, DOI 10.1038/nrc2603; Reits EA, 2006, J EXP MED, V203, P1259, DOI 10.1084/jem.20052494; Rubio V, 2003, NAT MED, V9, P1377, DOI 10.1038/nm942; Scanlan Matthew J, 2004, Cancer Immun, V4, P1; Scanlan MJ, 2002, IMMUNOL REV, V188, P22, DOI 10.1034/j.1600-065X.2002.18803.x; Schulz TF, 2009, INT J CANCER, V125, P1755, DOI 10.1002/ijc.24741; Shiao SL, 2010, J MAMMARY GLAND BIOL, V15, P411, DOI 10.1007/s10911-010-9194-9; Stewart-Jones G, 2009, P NATL ACAD SCI USA, V106, P5784, DOI 10.1073/pnas.0901425106; Suni MA, 2005, CURR OPIN IMMUNOL, V17, P434, DOI 10.1016/j.coi.2005.05.002; Suri A, 2006, EXPERT OPIN BIOL TH, V6, P379, DOI 10.1517/14712598.6.4.379; van den Beucken T, 2009, J BIOL CHEM, V284, P24204, DOI 10.1074/jbc.M109.006510; van der Bruggen P, 2007, J IMMUNOL, V178, P2617; Wischnewski F, 2006, MOL CANCER RES, V4, P339, DOI 10.1158/1541-7786.MCR-05-0229	38	94	100	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2011	6	11							e28217	10.1371/journal.pone.0028217	http://dx.doi.org/10.1371/journal.pone.0028217			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863LT	22140550	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000298166300039
J	Tominaga, W; Matsubayashi, J; Furuya, M; Matsuhashi, M; Mima, T; Fukuyama, H; Mitani, A				Tominaga, Wataru; Matsubayashi, Jun; Furuya, Makiko; Matsuhashi, Masao; Mima, Tatsuya; Fukuyama, Hidenao; Mitani, Akira			Asymmetric Activation of the Primary Motor Cortex during Observation of a Mirror Reflection of a Hand	PLOS ONE			English	Article							PAIN SYNDROME TYPE-1; PHANTOM LIMB PAIN; VISUAL FEEDBACK; 20-HZ ACTIVITY; THERAPY; STROKE; REHABILITATION; HEMIPARESIS; IMAGERY; RHYTHMS	Mirror therapy is an effective technique for pain relief and motor function recovery. It has been demonstrated that magnetic 20-Hz activity is induced in the primary motor cortex (M1) after median nerve stimulation and that the amount of the stimulus-induced 20-Hz activity is decreased when the M1 is activated. In the present study, we investigated how the image or the mirror reflection of a hand holding a pencil modulates the stimulus-induced 20-Hz activity in the M1. Neuromagnetic brain activity was recorded from 13 healthy right-handed subjects while they were either viewing directly their hand holding a pencil or viewing a mirror reflection of their hand holding a pencil. The 20-Hz activity in the left or the right M1 was examined after the right or the left median nerve stimulation, respectively, and the suppression of the stimulus-induced 20-Hz in the M1 by viewing directly one hand holding a pencil or by viewing the mirror image of the hand holding a pencil was assumed to indicate the activation of the M1. The results indicated that the M1 innervating the dominant hand was suppressed either by viewing directly the dominant hand holding a pencil or by viewing the mirror image of the non-dominant hand holding a pencil. On the other hand, the M1 innervating the non-dominant hand was activated by viewing the mirror image of the dominant hand holding a pencil, but was not activated by viewing directly the non-dominant hand holding a pencil. The M1 innervating either the dominant or the non-dominant hand, however, was not activated by viewing the hand on the side ipsilateral to the M1 examined or the mirror image of the hand on the side contralateral to the M1 exaimined. Such activation of the M1 might induce some therapeutic effects of mirror therapy.	[Tominaga, Wataru; Matsubayashi, Jun; Furuya, Makiko; Mitani, Akira] Kyoto Univ, Dept Human Hlth Sci, Grad Sch Med, Lab Neurorehabil, Kyoto, Japan; [Matsuhashi, Masao; Mima, Tatsuya; Fukuyama, Hidenao] Kyoto Univ, Human Brain Res Ctr, Grad Sch Med, Kyoto, Japan	Kyoto University; Kyoto University	Tominaga, W (corresponding author), Kyoto Univ, Dept Human Hlth Sci, Grad Sch Med, Lab Neurorehabil, Kyoto, Japan.	amitani@hs.med.kyoto-u.ac.jp	Fukuyama, Hidenao/AAI-7118-2020	Mima, Tatsuya/0000-0001-7787-4855; Matsubayashi, Jun/0000-0003-4104-6833	Japan Society for the Promotion of Science [22300187, 21613003, 21700288, 21700529]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research is partly supported by Grants-in-Aid for Scientific Research (B) 22300187 (to A.M.) and (C) 21613003 (to T.M.), and for Young Scientists (B) 21700288 (to M.M.) and (B) 21700529 (to J.M.) from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Altschuler EL, 1999, LANCET, V353, P2035, DOI 10.1016/S0140-6736(99)00920-4; Cacchio A, 2009, NEW ENGL J MED, V361, P634, DOI 10.1056/NEJMc0902799; Chan BL, 2007, NEW ENGL J MED, V357, P2206, DOI 10.1056/NEJMc071927; Garry MI, 2005, EXP BRAIN RES, V163, P118, DOI 10.1007/s00221-005-2226-9; HAMALAINEN M, 1993, REV MOD PHYS, V65, P413, DOI 10.1103/RevModPhys.65.413; Hari R, 1998, P NATL ACAD SCI USA, V95, P15061, DOI 10.1073/pnas.95.25.15061; Holmes NP, 2004, COGN AFFECT BEHAV NE, V4, P193, DOI 10.3758/CABN.4.2.193; Ichikawa A, 2007, NEUROSCI RES, V58, P285, DOI 10.1016/j.neures.2007.03.012; Jarvelainen J, 2004, NEUROIMAGE, V23, P187, DOI 10.1016/j.neuroimage.2004.06.010; McCabe CS, 2003, RHEUMATOLOGY, V42, P97, DOI 10.1093/rheumatology/keg041; Mercier C, 2009, NEUROREHAB NEURAL RE, V23, P587, DOI 10.1177/1545968308328717; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; RAMACHANDRAN VS, 1995, NATURE, V377, P489, DOI 10.1038/377489a0; Ro T, 2004, J COGNITIVE NEUROSCI, V16, P24, DOI 10.1162/089892904322755520; Salenius S, 1997, NEUROIMAGE, V5, P221, DOI 10.1006/nimg.1997.0261; SALMELIN R, 1994, NEUROSCIENCE, V60, P537, DOI 10.1016/0306-4522(94)90263-1; Schnitzler A, 1997, NEUROIMAGE, V6, P201, DOI 10.1006/nimg.1997.0286; Stevens JA, 2003, ARCH PHYS MED REHAB, V84, P1090, DOI 10.1016/S0003-9993(03)00042-X; Tominaga W, 2009, NEUROIMAGE, V46, P500, DOI 10.1016/j.neuroimage.2009.02.021; Touzalin-Chretien P, 2008, J NEUROPHYSIOL, V100, P19, DOI 10.1152/jn.90260.2008; Yavuzer G, 2008, ARCH PHYS MED REHAB, V89, P393, DOI 10.1016/j.apmr.2007.08.162	21	15	15	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2011	6	11							e28226	10.1371/journal.pone.0028226	http://dx.doi.org/10.1371/journal.pone.0028226			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863LT	22140555	gold, Green Published, Green Submitted			2022-12-27	WOS:000298166300041
J	Yuan, CB; Chen, MH; Covey, DF; Johnston, LJ; Treistman, SN				Yuan, Chunbo; Chen, Maohui; Covey, Douglas F.; Johnston, Linda J.; Treistman, Steven N.			Cholesterol Tuning of BK Ethanol Response Is Enantioselective, and Is a Function of Accompanying Lipids	PLOS ONE			English	Article							CA2+-ACTIVATED K+ CHANNELS; CONTENT MODULATES ACTIVATION; ATOMIC-FORCE MICROSCOPY; MEMBRANE CHOLESTEROL; LARGE-CONDUCTANCE; POTASSIUM CHANNELS; ENDOTHELIAL-CELLS; MODEL MEMBRANES; ALCOHOL ACTION; RAFTS	In the search to uncover ethanol's molecular mechanisms, the calcium and voltage activated, large conductance potassium channel (BK) has emerged as an important molecule. We examine how cholesterol content in bilayers of 1,2-dioleoyl-3-phosphatidylethanolamine (DOPE)/sphingomyelin (SPM) and 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphatidylethanolamine (POPE)/1-palmitoyl-2-oleoyl-sn-glycero-3-phosphatidylserine (POPS) affect the function and ethanol sensitivity of BK. In addition, we examine how manipulation of cholesterol in biological membranes modulates ethanol's actions on BK. We report that cholesterol levels regulate the change in BK channel open probability elicited by 50 mM ethanol. Low levels of cholesterol (<20%, molar ratio) supports ethanol activation, while high levels of cholesterol leads to ethanol inhibition of BK. To determine if cholesterol affects BK and its sensitivity to ethanol through a direct cholesterol-protein interaction or via an indirect action on the lipid bilayer, we used the synthetic enantiomer of cholesterol (ent-CHS). We found that 20% and 40% ent-CHS had little effect on the ethanol sensitivity of BK, when compared with the same concentration of nat-CHS. We accessed the effects of ent-CHS and nat-CHS on the molecular organization of DOPE/SPM monolayers at the air/water interface. The isotherm data showed that ent-CHS condensed DOPE/SPM monolayer equivalently to nat-CHS at a 20% concentration, but slightly less at a 40% concentration. Atomic force microscopy (AFM) images of DOPE/SPM membranes in the presence of ent-CHS or nat-CHS prepared with LB technique or vesicle deposition showed no significant difference in topographies, supporting the interpretation that the differences in actions of nat-CHS and ent-CHS on BK channel are not likely from a generalized action on bilayers. We conclude that membrane cholesterol influences ethanol's modulation of BK in a complex manner, including an interaction with the channel protein. Finally, our results suggest that an understanding of membrane protein function and modulation is impossible unless protein and surrounding lipid are considered as a functional unit.	[Yuan, Chunbo; Treistman, Steven N.] Univ Puerto Rico, Inst Neurobiol, San Juan, PR 00901 USA; [Chen, Maohui; Johnston, Linda J.] Natl Res Council Canada, Steacie Inst Mol Sci, Ottawa, ON, Canada; [Covey, Douglas F.] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO USA	University of Puerto Rico; National Research Council Canada; Washington University (WUSTL)	Yuan, CB (corresponding author), Univ Puerto Rico, Inst Neurobiol, San Juan, PR 00901 USA.	steven.treistman@upr.edu		Chen, Maohui/0000-0001-6931-8875; Johnston, Linda/0000-0002-9136-4920	National Institutes of Health [GM47969, AA 018038-05]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM047969, P20GM103642] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA018038, R01AA017920] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This research was supported by grants from National Institutes of Health GM47969 (DC), and AA 018038-05 (ST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addona GH, 1998, BBA-BIOMEMBRANES, V1370, P299, DOI 10.1016/S0005-2736(97)00280-0; Aguayo Luis G., 2002, Current Topics in Medicinal Chemistry, V2, P869, DOI 10.2174/1568026023393426; Ahring PK, 1997, FEBS LETT, V415, P67, DOI 10.1016/S0014-5793(97)01096-X; BOLOTINA V, 1989, PFLUG ARCH EUR J PHY, V415, P262, DOI 10.1007/BF00370875; Brainard AM, 2005, AM J PHYSIOL-CELL PH, V289, pC49, DOI 10.1152/ajpcell.00399.2004; BREGESTOVSKI PD, 1989, BIOMED BIOCHIM ACTA, V48, pS382; BRETSCHER MS, 1993, SCIENCE, V261, P1280, DOI 10.1126/science.8362242; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; BROWN EM, 1988, BRIT J OBSTET GYNAEC, V95, P286, DOI 10.1111/j.1471-0528.1988.tb06871.x; Bukiya AN, 2011, J GEN PHYSIOL, V137, P93, DOI 10.1085/jgp.201010519; CHANG HM, 1995, J MEMBRANE BIOL, V143, P51; Chu BS, 1998, MOL PHARMACOL, V54, P397, DOI 10.1124/mol.54.2.397; Coban O, 2007, BIOPHYS J, V92, P2842, DOI 10.1529/biophysj.106.088419; Connell RJO, 2006, J MEMBRANE BIOL, V213, P143, DOI 10.1007/s00232-006-0034-1; Cornelius F, 2003, BIOCHEMISTRY-US, V42, P8541, DOI 10.1021/bi034532e; Covey DF, 2009, STEROIDS, V74, P577, DOI 10.1016/j.steroids.2008.11.019; Crowder CM, 2001, J BIOL CHEM, V276, P44369, DOI 10.1074/jbc.C100535200; Crowley JJ, 2005, MOL PHARMACOL, V68, P4, DOI 10.1124/mol.105.012971; Crowley JJ, 2003, MOL PHARMACOL, V64, P365, DOI 10.1124/mol.64.2.365; D'Avanzo N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019393; Dopico AM, 1996, MOL PHARMACOL, V49, P40; Finol-Urdaneta RK, 2010, BIOPHYS J, V98, P762, DOI 10.1016/j.bpj.2009.10.053; Fullekrug J, 2004, ANN NY ACAD SCI, V1014, P164, DOI 10.1196/annals.1294.017; Gillis KD, 2000, PFLUG ARCH EUR J PHY, V439, P655, DOI 10.1007/s004240050990; Goldstein JL, 2001, SCIENCE, V292, P1310, DOI 10.1126/science.1061815; Jiang X, 2002, J ORG CHEM, V67, P4893, DOI 10.1021/jo025535k; Johnston LJ, 2007, LANGMUIR, V23, P5886, DOI 10.1021/la070108t; Koudinov AR, 2005, PLOS MED, V2, P265, DOI 10.1371/journal.pmed.0020081; Koudinov AR, 2005, J NEUROL SCI, V229, P233, DOI 10.1016/j.jns.2004.11.036; Lam RS, 2004, BBA-BIOMEMBRANES, V1667, P241, DOI 10.1016/j.bbamem.2004.11.004; Levitan I, 2000, J GEN PHYSIOL, V115, P405, DOI 10.1085/jgp.115.4.405; LI CY, 1994, P NATL ACAD SCI USA, V91, P8200, DOI 10.1073/pnas.91.17.8200; Lin MW, 2006, CHINESE J PHYSIOL, V49, P1; London E, 2005, BBA-MOL CELL RES, V1746, P203, DOI 10.1016/j.bbamcr.2005.09.002; London E, 2002, CURR OPIN STRUC BIOL, V12, P480, DOI 10.1016/S0959-440X(02)00351-2; Martin G, 2004, J NEUROSCI, V24, P6563, DOI 10.1523/JNEUROSCI.0684-04.2004; Maxfield FR, 2005, NATURE, V438, P612, DOI 10.1038/nature04399; Peoples RW, 1996, ANNU REV PHARMACOL, V36, P185, DOI 10.1146/annurev.pa.36.040196.001153; Pfrieger FW, 2003, BBA-BIOMEMBRANES, V1610, P271, DOI 10.1016/S0005-2736(03)00024-5; Pfrieger FW, 2003, BIOESSAYS, V25, P72, DOI 10.1002/bies.10195; Puglielli L, 2003, NAT NEUROSCI, V6, P345, DOI 10.1038/nn0403-345; Romanenko VG, 2004, BIOPHYS J, V87, P3850, DOI 10.1529/biophysj.104.043273; Romanenko VG, 2009, AM J PHYSIOL-CELL PH, V296, pC878, DOI 10.1152/ajpcell.00438.2008; Shmygol A, 2007, J PHYSIOL-LONDON, V581, P445, DOI 10.1113/jphysiol.2007.129452; Simons K, 2004, ANNU REV BIOPH BIOM, V33, P269, DOI 10.1146/annurev.biophys.32.110601.141803; SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720; SUN TY, 1994, BIOCHEMISTRY-US, V33, P9992, DOI 10.1021/bi00199a024; Tajima N, 2010, J BIOL CHEM; Toselli M, 2005, BIOPHYS J, V89, P2443, DOI 10.1529/biophysj.105.065623; Treistman SN, 2009, TRENDS NEUROSCI, V32, P629, DOI 10.1016/j.tins.2009.08.001; Vial C, 2005, J BIOL CHEM, V280, P30705, DOI 10.1074/jbc.M504256200; Wang XL, 2005, J BIOL CHEM, V280, P11656, DOI 10.1074/jbc.M410987200; Weaver AK, 2007, J BIOL CHEM, V282, P31558, DOI 10.1074/jbc.M702866200; WEIGHT FF, 1991, ANN NY ACAD SCI, V625, P97, DOI 10.1111/j.1749-6632.1991.tb33833.x; West TA, 2005, CELL PHYSIOL BIOCHEM, V16, P263, DOI 10.1159/000089852; Westover EJ, 2004, J MEMBRANE BIOL, V202, P61, DOI 10.1007/s00232-004-0714-7; Westover EJ, 2003, J BIOL CHEM, V278, P51125, DOI 10.1074/jbc.M304332200; Westover EJ, 2003, STEROIDS, V68, P159, DOI 10.1016/S0039-128X(02)00174-5; Westover EJ, 2006, STEROIDS, V71, P484, DOI 10.1016/j.steroids.2006.01.007; Yuan C, 2002, J MICROSC-OXFORD, V205, P136, DOI 10.1046/j.0022-2720.2001.00982.x; Yuan CB, 2002, BIOPHYS J, V82, P2526, DOI 10.1016/S0006-3495(02)75596-3; Yuan C, 2008, J BIOL CHEM, V283, P5090, DOI 10.1074/jbc.M708214200; Yuan CB, 2007, J BIOL CHEM, V282, P7276, DOI 10.1074/jbc.M607593200	63	27	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2011	6	11							e27572	10.1371/journal.pone.0027572	http://dx.doi.org/10.1371/journal.pone.0027572			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863LT	22140451	gold, Green Submitted, Green Published			2022-12-27	WOS:000298166300008
J	Badisco, L; Ott, SR; Rogers, SM; Matheson, T; Knapen, D; Vergauwen, L; Verlinden, H; Marchal, E; Sheehy, MRJ; Burrows, M; Vanden Broeck, J				Badisco, Liesbeth; Ott, Swidbert R.; Rogers, Stephen M.; Matheson, Thomas; Knapen, Dries; Vergauwen, Lucia; Verlinden, Heleen; Marchal, Elisabeth; Sheehy, Matt R. J.; Burrows, Malcolm; Vanden Broeck, Jozef			Microarray-Based Transcriptomic Analysis of Differences between Long-Term Gregarious and Solitarious Desert Locusts	PLOS ONE			English	Article							MATURATION FACTOR-BETA; THAUMATIN-LIKE PROTEINS; HEAT-SHOCK PROTEINS; BEHAVIORAL GREGARIZATION; CHANNEL SUBUNITS; EXPRESSION; GENE; K+; METHYLATION; ANNOTATION	Desert locusts (Schistocerca gregaria) show an extreme form of phenotypic plasticity and can transform between a cryptic solitarious phase and a swarming gregarious phase. The two phases differ extensively in behavior, morphology and physiology but very little is known about the molecular basis of these differences. We used our recently generated Expressed Sequence Tag (EST) database derived from S. gregaria central nervous system (CNS) to design oligonucleotide microarrays and compare the expression of thousands of genes in the CNS of long-term gregarious and solitarious adult desert locusts. This identified 214 differentially expressed genes, of which 40% have been annotated to date. These include genes encoding proteins that are associated with CNS development and modeling, sensory perception, stress response and resistance, and fundamental cellular processes. Our microarray analysis has identified genes whose altered expression may enable locusts of either phase to deal with the different challenges they face. Genes for heat shock proteins and proteins which confer protection from infection were upregulated in gregarious locusts, which may allow them to respond to acute physiological challenges. By contrast the longer-lived solitarious locusts appear to be more strongly protected from the slowly accumulating effects of ageing by an upregulation of genes related to anti-oxidant systems, detoxification and anabolic renewal. Gregarious locusts also had a greater abundance of transcripts for proteins involved in sensory processing and in nervous system development and plasticity. Gregarious locusts live in a more complex sensory environment than solitarious locusts and may require a greater turnover of proteins involved in sensory transduction, and possibly greater neuronal plasticity.	[Badisco, Liesbeth; Verlinden, Heleen; Marchal, Elisabeth; Vanden Broeck, Jozef] Katholieke Univ Leuven, Dept Anim Physiol & Neurobiol, Louvain, Belgium; [Ott, Swidbert R.; Rogers, Stephen M.; Burrows, Malcolm] Univ Cambridge, Dept Zool, Cambridge, England; [Matheson, Thomas; Sheehy, Matt R. J.] Univ Leicester, Dept Biol, Leicester, Leics, England; [Knapen, Dries; Vergauwen, Lucia] Univ Antwerp, Dept Biol, B-2020 Antwerp, Belgium; [Sheehy, Matt R. J.] Univ Nottingham, Fac Med & Hlth Sci, Nottingham NG7 2RD, England	KU Leuven; University of Cambridge; University of Leicester; University of Antwerp; University of Nottingham	Badisco, L (corresponding author), Katholieke Univ Leuven, Dept Anim Physiol & Neurobiol, Louvain, Belgium.	jozef.vandenbroeck@bio.kuleuven.be	Vergauwen, Lucia/AAP-5933-2021; Verlinden, Heleen/D-1033-2011	Verlinden, Heleen/0000-0001-6721-3973; Ott, Swidbert/0000-0003-4278-2613; Marchal, Elisabeth/0000-0003-1310-4792; Vergauwen, Lucia/0000-0002-6534-7473; Matheson, Thomas/0000-0002-6061-9038; Knapen, Dries/0000-0003-0472-8114; Vanden Broeck, Jozef/0000-0001-7653-0516	K.U. Leuven Research Foundation [GOA/11/002]; Research Foundation of Flanders (FWO-Flanders); Interuniversity Attraction Poles program (Belgian Science Policy) [P6/14]; 'Agentschap voor Innovatie door Wetenschap en Technologie' (IWT); Biotechnology and Biological Science Research Council (UK) [BB/H002510/1, BB/D018587/1, BB/H002537/1, BB/D018854/1]; Royal Society (UK); Royal Society; BBSRC [BB/D018587/1, BB/H002510/1, BB/D018854/1, BB/H002537/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D018854/1, BB/H002510/1, BB/D018587/1, BB/H002537/1] Funding Source: researchfish	K.U. Leuven Research Foundation; Research Foundation of Flanders (FWO-Flanders)(FWO); Interuniversity Attraction Poles program (Belgian Science Policy)(Belgian Federal Science Policy Office); 'Agentschap voor Innovatie door Wetenschap en Technologie' (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Biotechnology and Biological Science Research Council (UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society (UK)(Royal Society of London); Royal Society(Royal Society of London); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors gratefully acknowledge the K.U. Leuven Research Foundation (GOA/11/002), the Research Foundation of Flanders (FWO-Flanders) and the Interuniversity Attraction Poles program (Belgian Science Policy Grant P6/14). LB, HV and EM have been supported by a scholarship from the 'Agentschap voor Innovatie door Wetenschap en Technologie' (IWT) and HV obtained a postdoctoral research fellowship from the K.U. Leuven Research Foundation. This work was also supported by grants from the Biotechnology and Biological Science Research Council (UK) to TM, MRJS, MB, SMR and SRO (BB/H002510/1; BB/D018587/1; BB/H002537/1; BB/D018854/1). SRO is recipient of a University Research Fellowship from the Royal Society (UK). SRO and SMR also obtained a Royal Society Research Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angeli S, 1999, EUR J BIOCHEM, V262, P745, DOI 10.1046/j.1432-1327.1999.00438.x; Anstey ML, 2009, SCIENCE, V323, P627, DOI 10.1126/science.1165939; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Badisco L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017274; Baig J, 2010, GENETICS, V184, P731, DOI 10.1534/genetics.109.109967; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berthier K, 2010, ADV INSECT PHYSIOL, V39, P1, DOI 10.1016/S0065-2806(10)39001-1; BOERJAN B, 2011, GEN COMP ENDOCRINOL; Bolanos JP, 2010, IUBMB LIFE, V62, P14, DOI 10.1002/iub.280; BOSCH EP, 1989, J NEUROSCI, V9, P3690; Brandazza A, 2004, FEBS LETT, V572, P3, DOI 10.1016/j.febslet.2004.07.003; Breugelmans B, 2008, INSECT MOL BIOL, V17, P137, DOI 10.1111/j.1365-2583.2008.00793.x; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Collins RT, 1999, EMBO J, V18, P7029, DOI 10.1093/emboj/18.24.7029; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Djagaeva I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007598; DUGAN LL, 2005, SCI AGING KNOWLEDGE; Engel JE, 1998, J NEUROSCI, V18, P2254; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; FEYEREISEN R, 1980, MOL CELL ENDOCRINOL, V20, P157, DOI 10.1016/0303-7207(80)90079-9; Fonseca DB, 2005, P ROY SOC B-BIOL SCI, V272, P1941, DOI 10.1098/rspb.2005.3192; Fuchs E, 2003, J NEUROBIOL, V57, P152, DOI 10.1002/neu.10261; Gardner PP, 2009, NUCLEIC ACIDS RES, V37, pD136, DOI 10.1093/nar/gkn766; Goll MG, 2006, SCIENCE, V311, P395, DOI 10.1126/science.1120976; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Grenier J, 1999, PLANT J, V19, P473, DOI 10.1046/j.1365-313X.1999.00551.x; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones Sam, 2006, V342, P129, DOI 10.1385/1-59745-123-1:129; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Griffiths-Jones Sam, 2010, Curr Protoc Bioinformatics, VChapter 12, DOI 10.1002/0471250953.bi1209s29; Guo W, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001291; Hardie RC, 2001, J EXP BIOL, V204, P3403; Ho L, 2010, NATURE, V463, P474, DOI 10.1038/nature08911; Hoste B, 2002, ENTOMOL EXP APPL, V104, P281, DOI 10.1023/A:1021207518712; Hughes AL, 1999, IMMUNOGENETICS, V49, P106, DOI 10.1007/s002510050469; Jensen KB, 2000, NEURON, V25, P359, DOI 10.1016/S0896-6273(00)80900-9; Joiner MA, 2007, J NEUROGENET, V21, P45, DOI 10.1080/01677060701247375; Kang L, 2004, P NATL ACAD SCI USA, V101, P17611, DOI 10.1073/pnas.0407753101; Knapen D, 2009, TRENDS BIOTECHNOL, V27, P406, DOI 10.1016/j.tibtech.2009.03.007; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kunert N, 2003, DEVELOPMENT, V130, P5083, DOI 10.1242/dev.00716; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee J, 2008, NEUROSCIENCE, V154, P1283, DOI 10.1016/j.neuroscience.2008.04.043; Lee J, 2010, J NEUROSCI, V30, P15821, DOI 10.1523/JNEUROSCI.3448-10.2010; Lester RL, 2005, J INSECT PHYSIOL, V51, P737, DOI 10.1016/j.jinsphys.2005.03.015; LIM R, 1989, P NATL ACAD SCI USA, V86, P3901, DOI 10.1073/pnas.86.10.3901; LIM R, 1990, DEV BIOL, V137, P444, DOI 10.1016/0012-1606(90)90269-O; Liu CH, 2008, NEURON, V59, P778, DOI 10.1016/j.neuron.2008.07.007; Lyko F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000506; Ma ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-11; Matheson T, 2004, J NEUROPHYSIOL, V91, P1, DOI 10.1152/jn.00795.2003; Mattick JS, 2006, HUM MOL GENET, V15, pR17, DOI 10.1093/hmg/ddl046; Menu-Bouaouiche L, 2003, BIOCHIMIE, V85, P123, DOI 10.1016/S0300-9084(03)00058-0; Mituyama T, 2009, NUCLEIC ACIDS RES, V37, pD89, DOI 10.1093/nar/gkn805; Nakano K, 2010, CYTOSKELETON, V67, P373, DOI 10.1002/cm.20451; Okabe M, 2001, NATURE, V411, P94, DOI 10.1038/35075094; Ott SR, 2010, P ROY SOC B-BIOL SCI, V277, P3087, DOI 10.1098/rspb.2010.0694; Parrish JZ, 2006, GENE DEV, V20, P820, DOI 10.1101/gad.1391006; Pener MP, 2009, ADV INSECT PHYSIOL, V36, P1, DOI 10.1016/S0065-2806(08)36001-9; Pener MP, 1998, J INSECT PHYSIOL, V44, P365, DOI 10.1016/S0022-1910(97)00169-8; Rai K, 2007, GENE DEV, V21, P261, DOI 10.1101/gad.1472907; RAMING K, 1993, CELL SIGNAL, V5, P69, DOI 10.1016/0898-6568(93)90009-B; Ranson H, 2005, METHOD ENZYMOL, V401, P226, DOI 10.1016/S0076-6879(05)01014-1; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; Roessingh P, 1998, J INSECT PHYSIOL, V44, P883, DOI 10.1016/S0022-1910(98)00070-5; Rogers SM, 2004, J EXP BIOL, V207, P3603, DOI 10.1242/jeb.01183; Rogers SM, 2003, J EXP BIOL, V206, P3991, DOI 10.1242/jeb.00648; Rogers SM, 2007, J NEUROSCI, V27, P4621, DOI 10.1523/JNEUROSCI.4615-06.2007; Rogers SM, 2010, J NEUROPHYSIOL, V103, P779, DOI 10.1152/jn.00855.2009; Schaefer M, 2010, GENE DEV, V24, P1590, DOI 10.1101/gad.586710; Sclep G, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-400; Scott JG, 2001, PEST MANAG SCI, V57, P958, DOI 10.1002/ps.354; Seshaiah P, 2001, DEV BIOL, V239, P309, DOI 10.1006/dbio.2001.0429; Simonet G, 2002, COMP BIOCHEM PHYS B, V132, P247, DOI 10.1016/S1096-4959(01)00530-9; Simonet G, 2004, BIOCHEM BIOPH RES CO, V317, P565, DOI 10.1016/j.bbrc.2004.03.078; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Sword GA, 2002, P ROY SOC B-BIOL SCI, V269, P1639, DOI 10.1098/rspb.2002.2060; Szymanski M, 2007, NUCLEIC ACIDS RES, V35, pD162, DOI 10.1093/nar/gkl994; TELFER WH, 1991, ANNU REV ENTOMOL, V36, P205, DOI 10.1146/annurev.en.36.010191.001225; Towner P, 1997, VISION RES, V37, P495, DOI 10.1016/S0042-6989(96)00198-8; Tu CPD, 2005, METHOD ENZYMOL, V401, P204, DOI 10.1016/S0076-6879(05)01013-X; Uvarov B, 1977, GRASSHOPPERS LOCUSTS; UVAROV BP, 1966, GRASSHOPPERS LOCUSTS, P332; Verlinden H, 2009, GEN COMP ENDOCR, V162, P79, DOI 10.1016/j.ygcen.2008.11.016; Wang HS, 2007, INSECT MOL BIOL, V16, P207, DOI 10.1111/j.1365-2583.2006.00715.x; Warbington L, 1996, INVERTEBR NEUROSCI, V2, P51, DOI 10.1007/BF02336660; Wilson K, 2002, P NATL ACAD SCI USA, V99, P5471, DOI 10.1073/pnas.082461999; Winter J, 1999, BIOCHEM BIOPH RES CO, V259, P305, DOI 10.1006/bbrc.1999.0783; Zhou X, 2006, GENE, V376, P47, DOI 10.1016/j.gene.2006.02.002; Zhou XG, 2006, P NATL ACAD SCI USA, V103, P4499, DOI 10.1073/pnas.0508866103	93	29	30	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e28110	10.1371/journal.pone.0028110	http://dx.doi.org/10.1371/journal.pone.0028110			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132225	Green Published, gold, Green Submitted			2022-12-27	WOS:000298162000075
J	Molnar, I; Kubalakova, M; Simkova, H; Cseh, A; Molnar-Lang, M; Dolezel, J				Molnar, Istvan; Kubalakova, Marie; Simkova, Hana; Cseh, Andras; Molnar-Lang, Marta; Dolezel, Jaroslav			Chromosome Isolation by Flow Sorting in Aegilops umbellulata and Ae. comosa and Their Allotetraploid Hybrids Ae. biuncialis and Ae. geniculata	PLOS ONE			English	Article							TRITICUM-AESTIVUM L.; BREAD WHEAT; ADDITION LINES; WILD WHEATS; VICIA-FABA; SHORT ARM; GENOME DIFFERENTIATION; MICROSATELLITE MARKERS; MITOTIC CHROMOSOMES; GENETIC DIVERSITY	This study evaluates the potential of flow cytometry for chromosome sorting in two wild diploid wheats Aegilops umbellulata and Ae. comosa and their natural allotetraploid hybrids Ae. biuncialis and Ae. geniculata. Flow karyotypes obtained after the analysis of DAPI-stained chromosomes were characterized and content of chromosome peaks was determined. Peaks of chromosome 1U could be discriminated in flow karyotypes of Ae. umbellulata and Ae. biuncialis and the chromosome could be sorted with purities exceeding 95%. The remaining chromosomes formed composite peaks and could be sorted in groups of two to four. Twenty four wheat SSR markers were tested for their position on chromosomes of Ae. umbellulata and Ae. comosa using PCR on DNA amplified from flow-sorted chromosomes and genomic DNA of wheat-Ae. geniculata addition lines, respectively. Six SSR markers were located on particular Aegilops chromosomes using sorted chromosomes, thus confirming the usefulness of this approach for physical mapping. The SSR markers are suitable for marker assisted selection of wheat-Aegilops introgression lines. The results obtained in this work provide new opportunities for dissecting genomes of wild relatives of wheat with the aim to assist in alien gene transfer and discovery of novel genes for wheat improvement.	[Molnar, Istvan; Cseh, Andras; Molnar-Lang, Marta] Hungarian Acad Sci, Agr Res Inst, H-2462 Martonvasar, Hungary; [Kubalakova, Marie; Simkova, Hana; Dolezel, Jaroslav] Ctr Reg Hana Biotechnol & Agr Res, Inst Expt Bot, Olomouc, Czech Republic	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences	Molnar, I (corresponding author), Hungarian Acad Sci, Agr Res Inst, H-2462 Martonvasar, Hungary.	dolezel@ueb.cas.cz	Cseh, Andras/AAP-3999-2021; Simkova, Hana/F-7734-2014; Dolezel, Jaroslav/B-7716-2008; Kubaláková, Marie/F-8269-2014; Molnar, istvan/L-9779-2019	Cseh, Andras/0000-0002-8681-6654; Simkova, Hana/0000-0003-4159-7619; Dolezel, Jaroslav/0000-0002-6263-0492; Molnar, Istvan/0000-0002-7167-9319	Hungarian National Research Fund [PD83444]; Czech Ministry of Education, Youth and Sport [LC06004, OC08025]; European Regional Development Fund (Operational Programme Research and Development for Innovations) [CZ.1.05/2.1.00/01.0007]	Hungarian National Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Czech Ministry of Education, Youth and Sport(Ministry of Education, Youth & Sports - Czech Republic); European Regional Development Fund (Operational Programme Research and Development for Innovations)	This research was supported by the Hungarian National Research Fund (PD83444), Czech Ministry of Education, Youth and Sports (grant awards LC06004 and OC08025), and the European Regional Development Fund (Operational Programme Research and Development for Innovations No. CZ.1.05/2.1.00/01.0007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badaeva ED, 2004, PLANT SYST EVOL, V246, P45, DOI 10.1007/s00606-003-0072-4; Badaeva ED, 1996, GENOME, V39, P293, DOI 10.1139/g96-040; Bartos J, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-95; Berkman PJ, 2011, PLANT BIOTECHNOL J, V9, P768, DOI 10.1111/j.1467-7652.2010.00587.x; CHEE PW, 1995, GENOME, V38, P290, DOI 10.1139/g95-036; Cifuentes M, 2006, THEOR APPL GENET, V112, P657, DOI 10.1007/s00122-005-0168-z; Cifuentes M, 2009, THEOR APPL GENET, V119, P805, DOI 10.1007/s00122-009-1090-6; Colmer TD, 2006, J EXP BOT, V57, P1059, DOI 10.1093/jxb/erj124; Contento A, 2005, CYTOGENET GENOME RES, V109, P34, DOI 10.1159/000082379; DOLEZEL J, 1989, BIOL PLANTARUM, V31, P113, DOI 10.1007/BF02907241; Dolezel J, 2004, CHROMOSOME RES, V12, P77, DOI 10.1023/B:CHRO.0000009293.15189.e5; DOLEZEL J, 1992, PLANTA, V188, P93, DOI 10.1007/BF00198944; Dolezel J, 2007, CHROMOSOME RES, V15, P51, DOI 10.1007/s10577-006-1106-x; Edwards D, 2010, PLANT BIOTECHNOL J, V8, P2, DOI 10.1111/j.1467-7652.2009.00459.x; Eilam T, 2008, GENOME, V51, P616, DOI 10.1139/G08-043; Feldman M, 2005, CYTOGENET GENOME RES, V109, P250, DOI 10.1159/000082407; Feuillet C, 2008, TRENDS GENET, V24, P24, DOI 10.1016/j.tig.2007.11.001; Friebe B, 1996, EUPHYTICA, V91, P59, DOI 10.1007/BF00035277; Friebe BR, 1999, GENOME, V42, P374, DOI 10.1139/gen-42-3-374; Furuta Y., 1970, WHEAT INF SER, V30, P20; GERLACH WL, 1979, NUCLEIC ACIDS RES, V7, P1869, DOI 10.1093/nar/7.7.1869; HOHMANN U, 1995, THEOR APPL GENET, V91, P611, DOI 10.1007/BF00223287; JIANG JM, 1994, EUPHYTICA, V73, P199, DOI 10.1007/BF00036700; Kofler R, 2008, THEOR APPL GENET, V117, P915, DOI 10.1007/s00122-008-0831-2; Kubalakova M, 1997, THEOR APPL GENET, V94, P758, DOI 10.1007/s001220050475; Kubalakova M, 2005, GENETICS, V170, P823, DOI 10.1534/genetics.104.039180; Kubalakova M, 2003, GENOME, V46, P893, DOI [10.1139/g03-054, 10.1139/G03-054]; Kubalakova M, 2002, THEOR APPL GENET, V104, P1362, DOI 10.1007/s00122-002-0888-2; Lelley T, 2000, GENOME, V43, P661, DOI 10.1139/gen-43-4-661; Lysak MA, 1999, CHROMOSOME RES, V7, P431, DOI 10.1023/A:1009293628638; Mayer KFX, 2011, PLANT CELL, V23, P1249, DOI 10.1105/tpc.110.082537; Mayer KFX, 2009, PLANT PHYSIOL, V151, P496, DOI 10.1104/pp.109.142612; MICKELSONYOUNG L, 1995, THEOR APPL GENET, V90, P1007, DOI 10.1007/BF00222914; Molnar I, 2004, FUNCT PLANT BIOL, V31, P1149, DOI 10.1071/FP03143; Molnar I, 2011, ANN BOT-LONDON, V107, P65, DOI 10.1093/aob/mcq215; Monte JV, 2001, HEREDITAS, V135, P233, DOI 10.1111/j.1601-5223.2001.00233.x; NAGAKI K, 1995, GENOME, V38, P479, DOI 10.1139/g95-063; Nagy ED, 2006, GENOME, V49, P289, DOI 10.1139/G05-109; Paux E, 2008, SCIENCE, V322, P101, DOI 10.1126/science.1161847; PAYNE PI, 1987, ANNU REV PLANT PHYS, V38, P141, DOI 10.1146/annurev.pp.38.060187.001041; Peil A, 1998, THEOR APPL GENET, V96, P138, DOI 10.1007/s001220050720; Pestsova E, 2000, THEOR APPL GENET, V101, P100, DOI 10.1007/s001220051456; Pozarkova D, 2002, BIOL PLANTARUM, V45, P337, DOI 10.1023/A:1016253214182; Rekika D, 1997, J PLANT PHYSIOL, V150, P734, DOI 10.1016/S0176-1617(97)80291-X; Resta P, 1996, AM J BOT, V83, P1556, DOI 10.2307/2445829; Roder MS, 1998, GENETICS, V149, P2007; Roman B, 2004, THEOR APPL GENET, V108, P1079, DOI 10.1007/s00122-003-1515-6; Sabot F, 2005, MOL GENET GENOMICS, V274, P119, DOI 10.1007/s00438-005-0012-9; Safar J, 2010, CYTOGENET GENOME RES, V129, P211, DOI 10.1159/000313072; Schneider A, 2005, GENOME, V48, P1070, DOI 10.1139/G05-062; Schneider A, 2008, EUPHYTICA, V163, P1, DOI 10.1007/s10681-007-9624-y; Schneider A, 2010, EUPHYTICA, V175, P357, DOI 10.1007/s10681-010-0180-5; SHARP PJ, 1988, THEOR APPL GENET, V75, P286, DOI 10.1007/BF00303966; Simkova H, 2008, BMC GENOMICS, V9, DOI [10.1186/1471-2164-9-237, 10.1186/1471-2164-9-294]; Somers DJ, 2004, THEOR APPL GENET, V109, P1105, DOI 10.1007/s00122-004-1740-7; Sourdille Pierre, 2004, Functional & Integrative Genomics, V4, P12, DOI 10.1007/s10142-004-0106-1; Van Slageren M.W., 1994, WAGENINGEN AGR U PAP, P514; Vrana J, 2000, GENETICS, V156, P2033; Wendel JF, 2000, PLANT MOL BIOL, V42, P225, DOI 10.1023/A:1006392424384; Wenzl P, 2010, THEOR APPL GENET, V121, P465, DOI 10.1007/s00122-010-1323-8; Wicker T, 2011, PLANT CELL, V23, P1706, DOI 10.1105/tpc.111.086629; Zaharieva M, 2006, CROP SCI, V46, P512, DOI 10.2135/cropsci2005.0023; ZAHARIEVA M, 2003, ANN WHEAT NEWSLETTER, V49, P75; Zaharieva M, 2002, ANN WHEAT NEWSLETTER, V48, P108; ZELLER FJ, 1983, Z PFLANZENZUCHT, V90, P285; Zhang H, 1998, THEOR APPL GENET, V96, P69, DOI 10.1007/s001220050710	66	34	36	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e27708	10.1371/journal.pone.0027708	http://dx.doi.org/10.1371/journal.pone.0027708			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132127	Green Submitted, gold, Green Published			2022-12-27	WOS:000298162000035
J	Narita, K; Nagao, K; Bannai, M; Ichimaru, T; Nakano, S; Murata, T; Higuchi, T; Takahashi, M				Narita, Kazumi; Nagao, Kenji; Bannai, Makoto; Ichimaru, Toru; Nakano, Sayako; Murata, Takuya; Higuchi, Takashi; Takahashi, Michio			Dietary Deficiency of Essential Amino Acids Rapidly Induces Cessation of the Rat Estrous Cycle	PLOS ONE			English	Article							GONADOTROPIN-RELEASING-HORMONE; CALORIC RESTRICTION; ANOREXIA-NERVOSA; LH-SECRETION; IN-VIVO; METABOLISM; SUPPRESSION; ACTIVATION; DEPLETION; PEPTIDE	Reproductive functions are regulated by the sophisticated coordination between the neuronal and endocrine systems and are sustained by a proper nutritional environment. Female reproductive function is vulnerable to effects from dietary restrictions, suggesting a transient adaptation that prioritizes individual survival over reproduction until a possible future opportunity for satiation. This adaptation could also partially explain the existence of amenorrhea in women with anorexia nervosa. Because amino acid nutritional conditions other than caloric restriction uniquely alters amino acid metabolism and affect the hormonal levels of organisms, we hypothesized that the supply of essential amino acids in the diet plays a pivotal role in the maintenance of the female reproductive system. To test this hypothesis, we examined ovulatory cyclicity in female rats under diets that were deficient in threonine, lysine, tryptophan, methionine or valine. Ovulatory cyclicity was monitored by daily cytological evaluations of vaginal smears. After continuous feeding of the deficient diet, a persistent diestrus or anovulatory state was induced most quickly by the valine-deficient diet and most slowly by the lysine-deficient diet. A decline in the systemic insulin-like growth factor 1 level was associated with a dietary amino acid deficiency. Furthermore, a paired group of rats that were fed an isocaloric diet with balanced amino acids maintained normal estrous cyclicity. These disturbances of the estrous cycle by amino acid deficiency were quickly reversed by the consumption of a normal diet. The continuous anovulatory state in this study is not attributable to a decrease in caloric intake but to an imbalance in the dietary amino acid composition. With a shortage of well-balanced amino acid sources, reproduction becomes risky for both the mother and the fetus. It could be viewed as an adaptation to the diet, diverting resources away from reproduction and reallocating them to survival until well-balanced amino acid sources are found.	[Narita, Kazumi; Ichimaru, Toru; Murata, Takuya; Higuchi, Takashi] Univ Fukui, Dept Integrat Physiol, Fac Med Sci, Fukui 910, Japan; [Nagao, Kenji; Bannai, Makoto; Nakano, Sayako; Takahashi, Michio] Ajinomoto Co Inc, Frontier Res Labs, Inst Innovat, Kawasaki, Kanagawa, Japan	University of Fukui; Ajinomoto Co Inc	Narita, K (corresponding author), Univ Fukui, Dept Integrat Physiol, Fac Med Sci, Fukui 910, Japan.	makoto_bannai@ajinomoto.com	Nagao, Kenji/AAE-7377-2021	Nagao, Kenji/0000-0002-0946-1431	Ajinomoto Co., Inc.	Ajinomoto Co., Inc.	This study was funded by Ajinomoto Co., Inc. The funder had no role in the study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Biggers JD, 2000, BIOL REPROD, V63, P281, DOI 10.1095/biolreprod63.1.281; BIGWOOD EJ, 1972, PROTEIN AMINO ACID F; Carew LB, 1997, POULTRY SCI, V76, P1398, DOI 10.1093/ps/76.10.1398; Casanueva FF, 1999, FRONT NEUROENDOCRIN, V20, P317, DOI 10.1006/frne.1999.0187; Chapman T, 1996, P ROY SOC B-BIOL SCI, V263, P755, DOI 10.1098/rspb.1996.0113; Deligeoroglou E, 2010, ANN NY ACAD SCI, V1205, P23, DOI 10.1111/j.1749-6632.2010.05669.x; Della Torre S, 2011, CELL METAB, V13, P205, DOI 10.1016/j.cmet.2011.01.002; Donato J, 2009, J NEUROSCI, V29, P5240, DOI 10.1523/JNEUROSCI.0405-09.2009; Fernandez-Fernandez R, 2005, ENDOCRINOLOGY, V146, P1403, DOI 10.1210/en.2004-0858; Fernandez-Fernandez R, 2005, NEUROENDOCRINOLOGY, V82, P245, DOI 10.1159/000092753; Fontana L, 2008, AGING CELL, V7, P681, DOI 10.1111/j.1474-9726.2008.00417.x; Furuta M, 2002, NEUROENDOCRINOLOGY, V75, P151, DOI 10.1159/000048232; Gems D, 1998, GENETICS, V150, P129; Genazzani Alessandro D, 2005, Pediatr Endocrinol Rev, V2, P661; Gietzen DW, 2006, TRENDS NEUROSCI, V29, P91, DOI 10.1016/j.tins.2005.12.007; Goto S, 2010, NEUROSCIENCE, V166, P333, DOI 10.1016/j.neuroscience.2009.12.013; Grandison RC, 2009, NATURE, V462, P1061, DOI 10.1038/nature08619; Heilbronn LK, 2003, AM J CLIN NUTR, V78, P361, DOI 10.1093/ajcn/78.3.361; HOLEHAN AM, 1985, MECH AGEING DEV, V32, P179, DOI 10.1016/0047-6374(85)90078-8; Huang WY, 2008, AM J PHYSIOL-ENDOC M, V295, pE1439, DOI 10.1152/ajpendo.90615.2008; I'Anson H, 2003, HORM BEHAV, V43, P388, DOI 10.1016/S0018-506X(03)00007-2; Inderdeo DS, 1996, BIOL REPROD, V55, P498, DOI 10.1095/biolreprod55.3.498; Jans LAW, 2007, NEUROSCIENCE, V147, P304, DOI 10.1016/j.neuroscience.2007.04.028; KALRA SP, 1992, FRONT NEUROENDOCRIN, V13, P1; KNUTH UA, 1983, ACTA ENDOCRINOL-COP, V104, P402, DOI 10.1530/acta.0.1040402; Lane M, 1997, J REPROD FERTIL, V109, P153, DOI 10.1530/jrf.0.1090153; Masoro EJ, 2005, MECH AGEING DEV, V126, P913, DOI 10.1016/j.mad.2005.03.012; Maxwell SRJ, 1998, BASIC RES CARDIOL, V93, P79; McShane TM, 1996, BIOL REPROD, V54, P70, DOI 10.1095/biolreprod54.1.70; Misra M, 2004, PEDIATRICS, V114, P1574, DOI 10.1542/peds.2004-0540; Miyaji K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013808; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Munoz MT, 2002, EUR J ENDOCRINOL, V147, P275, DOI 10.1530/eje.0.1470275; Murahashi K, 1996, ENDOCRINOLOGY, V137, P1171, DOI 10.1210/en.137.4.1171; Nagao K, 2010, AM J PHYSIOL-ENDOC M, V298, pE1170, DOI 10.1152/ajpendo.00763.2009; Nagao K, 2009, AMINO ACIDS, V36, P555, DOI 10.1007/s00726-008-0117-7; NAKAHARA K, 2011, AMINO ACIDS; NELSON JF, 1995, NEUROBIOL AGING, V16, P837, DOI 10.1016/0197-4580(95)00072-M; Noguchi Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012057; Noguchi Y, 2008, PHYSIOL GENOMICS, V34, P315, DOI 10.1152/physiolgenomics.00007.2008; Ogata R, 2009, NEUROENDOCRINOLOGY, V90, P364, DOI 10.1159/000257421; Ottinger MA, 2005, MECH AGEING DEV, V126, P967, DOI 10.1016/j.mad.2005.03.017; Pelland AMD, 2009, BIOL REPROD, V81, P1041, DOI 10.1095/biolreprod.109.079046; Rees WD, 2006, J NUTR, V136, p1701S, DOI 10.1093/jn/136.6.1701S; Rudell JB, 2011, J NEUROSCI, V31, P1583, DOI 10.1523/JNEUROSCI.4934-10.2011; Shikata N, 2007, AMINO ACIDS, V33, P113, DOI 10.1007/s00726-006-0412-0; Shikata N, 2010, AMINO ACIDS, V38, P179, DOI 10.1007/s00726-008-0226-3; Takenaka A, 2000, J NUTR, V130, P2910, DOI 10.1093/jn/130.12.2910; Vabulas RM, 2005, SCIENCE, V310, P1960, DOI 10.1126/science.1121925; Van Winkle LJ, 2001, BIOL REPROD, V64, P1, DOI 10.1095/biolreprod64.1.1; Vigo E, 2007, ENDOCRINOLOGY, V148, P813, DOI 10.1210/en.2006-0636; Vigo E, 2007, AM J PHYSIOL-ENDOC M, V293, pE1265, DOI 10.1152/ajpendo.00425.2007; Wade GN, 2004, AM J PHYSIOL-REG I, V287, pR1277, DOI 10.1152/ajpregu.00475.2004	53	10	15	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e28136	10.1371/journal.pone.0028136	http://dx.doi.org/10.1371/journal.pone.0028136			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132231	Green Submitted, Green Published, gold			2022-12-27	WOS:000298162000080
J	Wu, T; Fu, F; Wang, L				Wu, Te; Fu, Feng; Wang, Long			Moving Away from Nasty Encounters Enhances Cooperation in Ecological Prisoner's Dilemma Game	PLOS ONE			English	Article							EVOLUTIONARY GAMES; RAPID EVOLUTION; EMERGENCE; PROMOTES; INDIVIDUALS	We study the role of migration in the evolution of cooperation. Individuals spatially located on a square lattice play the prisoner's dilemma game. Dissatisfied players, who have been exploited by defectors, tend to terminate interaction with selfish partners by leaving the current habitats, and explore unknown physical niches available surrounding them. The time scale ratio of game interaction to natural selection governs how many game rounds occur before individuals experience strategy updating. Under local migration and strong selection, simulation results demonstrate that cooperation can be stabilized for a wide range of model parameters, and the slower the natural selection, the more favorable for the emergence of cooperation. Besides, how the selection intensity affects cooperators' evolutionary fate is also investigated. We find that increasing it weakens cooperators' viability at different speeds for different time scale ratios. However, cooperation is greatly improved provided that individuals are offered with enough chance to agglomerate, while cooperation can always establish under weak selection but vanishes under very strong selection whenever individuals have less odds to migrate. Whenever the migration range restriction is removed, the parameter area responsible for the emergence of cooperation is, albeit somewhat compressed, still remarkable, validating the effectiveness of collectively migrating in promoting cooperation.	[Wu, Te; Wang, Long] Peking Univ, Coll Engn, State Key Lab Turbulence & Complex Syst, Ctr Syst & Control, Beijing 100871, Peoples R China; [Fu, Feng] Harvard Univ, Program Evolutionary Dynam, Cambridge, MA 02138 USA	Peking University; Harvard University	Wu, T (corresponding author), Peking Univ, Coll Engn, State Key Lab Turbulence & Complex Syst, Ctr Syst & Control, Beijing 100871, Peoples R China.	wute@pku.edu.cn	Fu, Feng/R-3686-2017; Wang, Long/A-7798-2010; Gao, Y./GWZ-3665-2022	Fu, Feng/0000-0001-8252-1990; Wang, Long/0000-0001-5600-8157; 				AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; Binmore K., 1994, PLAYING FAIR GAME TH; Brock WA, 2007, P NATL ACAD SCI USA, V104, P15206, DOI 10.1073/pnas.0702096104; Burtsev M, 2006, NATURE, V440, P1041, DOI 10.1038/nature04470; Chen XJ, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.051104; Chen X, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.051120; Colman AM, 2013, GAME THEORY ITS APPL; Dugatkin LA, 1995, COOPERATION ANIMALS; Fu F, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.036101; Fu F, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.026117; Hauert C, 2004, NATURE, V428, P643, DOI 10.1038/nature02360; Helbing D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012530; Helbing D, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/8/083005; Helbing D, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.057104; Helbing D, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000758; Helbing D, 2009, P NATL ACAD SCI USA, V106, P3680, DOI 10.1073/pnas.0811503106; Hendry AP, 2000, SCIENCE, V290, P516, DOI 10.1126/science.290.5491.516; Hendry AP, 1999, EVOLUTION, V53, P1637, DOI 10.1111/j.1558-5646.1999.tb04550.x; Hofbauer J, 1998, EVOLUTIONARY GAMES P; Kerr B, 2006, NATURE, V442, P75, DOI 10.1038/nature04864; McNamara JM, 2004, NATURE, V428, P745, DOI 10.1038/nature02432; Milinski M, 2008, P NATL ACAD SCI USA, V105, P2291, DOI 10.1073/pnas.0709546105; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Nowak MA, 2004, NATURE, V428, P646, DOI 10.1038/nature02414; Pacheco JM, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.258103; Perc M, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.011904; Perc M, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/8/142; Perc M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015117; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; Perc M, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/3/033027; Roca CP, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.158701; Santos FC, 2008, NATURE, V454, P213, DOI 10.1038/nature06940; Santos FC, 2006, PLOS COMPUT BIOL, V2, P1284, DOI 10.1371/journal.pcbi.0020140; Smaldino PE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023019; SMITH JM, 1973, NATURE, V246, P15, DOI 10.1038/246015a0; Szabo G, 1998, PHYS REV E, V58, P69, DOI 10.1103/PhysRevE.58.69; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Szolnoki A, 2010, EPL-EUROPHYS LETT, V92, DOI 10.1209/0295-5075/92/38003; Szolnoki A, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.036101; Szolnoki A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.056109; Szolnoki A, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/9/093033; Szolnoki A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.021901; Traulsen A, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.238701; Traulsen A, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.011909; Traulsen A, 2010, P NATL ACAD SCI USA, V107, P2962, DOI 10.1073/pnas.0912515107; Woelfing B, 2009, J THEOR BIOL, V257, P689, DOI 10.1016/j.jtbi.2008.12.025; Wu B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011187; Wu T, 2009, EPL-EUROPHYS LETT, V88, DOI 10.1209/0295-5075/88/30011; Yoshida T, 2003, NATURE, V424, P303, DOI 10.1038/nature01767; Zimmermann MG, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.056118; Zimmermann MG, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.065102	52	35	36	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e27669	10.1371/journal.pone.0027669	http://dx.doi.org/10.1371/journal.pone.0027669			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132125	gold, Green Published, Green Submitted			2022-12-27	WOS:000298162000034
J	Zhou, WY; Dosey, TL; Biechele, T; Moon, RT; Horwitz, MS; Ruohola-Baker, H				Zhou, Wenyu; Dosey, Timothy L.; Biechele, Travis; Moon, Randall T.; Horwitz, Marshall S.; Ruohola-Baker, Hannele			Assessment of Hypoxia Inducible Factor Levels in Cancer Cell Lines upon Hypoxic Induction Using a Novel Reporter Construct	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; HIPPEL-LINDAU PROTEIN; IN-VIVO; HUMAN PAPILLOMAVIRUSES; TUMOR ANGIOGENESIS; DEVELOPING MOUSE; GENE-EXPRESSION; HIF-1-ALPHA; DIFFERENTIATION; HSP90	Hypoxia Inducible Factor (HIF) signaling pathway is important for tumor cells with limited oxygen supplies, as it is shown to be involved in the process of proliferation and angiogenesis. Given its pivotal role in cancer biology, robust assays for tracking changes in HIF expression are necessary for understanding its regulation in cancer as well as developing therapies that target HIF signaling. Here we report a novel HIF reporter construct containing tandem repeats of minimum HIF binding sites upstream of eYFP coding sequence. We show that the reporter construct has an excellent signal to background ratio and the reporter activity is HIF dependent and directly correlates with HIF protein levels. By utilizing this new construct, we assayed HIF activity levels in different cancer cell lines cultured in various degrees of hypoxia. This analysis reveals a surprising cancer cell line specific variation of HIF activity in the same level of hypoxia. We further show that in two cervical cancer cell lines, ME180 and HeLa, the different HIF activity levels observed correlate with the levels of hsp90, a cofactor that protects HIF against VHL-independent degradation. This novel HIF reporter construct serves as a tool to rapidly define HIF activity levels and therefore the therapeutic capacity of potential HIF repressors in individual cancers.	[Zhou, Wenyu; Horwitz, Marshall S.; Ruohola-Baker, Hannele] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Dosey, Timothy L.; Ruohola-Baker, Hannele] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Biechele, Travis; Moon, Randall T.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Horwitz, Marshall S.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Zhou, Wenyu; Dosey, Timothy L.; Biechele, Travis; Moon, Randall T.; Horwitz, Marshall S.; Ruohola-Baker, Hannele] Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Zhou, WY (corresponding author), Univ Washington, Dept Biol, Seattle, WA 98195 USA.	hannele@u.washington.edu	Moon, Randall/M-5605-2019; Zhou, Wenyu/I-1278-2014; Moon, Randall T/B-1743-2014	Moon, Randall/0000-0002-9352-1408; Moon, Randall T/0000-0002-9352-1408; Horwitz, Marshall/0000-0002-1683-1680	National Institute of General Medical Sciences [R01GM083867-01, R01GM097372-01, 1P01GM081619]; Breast Cancer Research Program Pilot project grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097372, P01GM081619, R01GM083867] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Breast Cancer Research Program Pilot project grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by R01GM083867-01, R01GM097372-01, and 1P01GM081619 from the National Institute of General Medical Sciences and a Breast Cancer Research Program Pilot project grant to HR-B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarilio R, 2007, DEVELOPMENT, V134, P3917, DOI 10.1242/dev.008441; BARBOSA MS, 1991, J VIROL, V65, P292, DOI 10.1128/JVI.65.1.292-298.1991; Bardos JI, 2005, BBA-REV CANCER, V1755, P107, DOI 10.1016/j.bbcan.2005.05.001; Barry SC, 2001, HUM GENE THER, V12, P1103, DOI 10.1089/104303401750214311; Berchner-Pfannschmidt U, 2008, EUR RESPIR J, V32, P210, DOI 10.1183/09031936.00013408; Biechele TL, 2009, COLD SPRING HARB PRO, V2009; Bilechele Travis L., 2008, V468, P99, DOI 10.1007/978-1-59745-249-6_8; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Chiarotto JA, 1999, BRIT J CANCER, V80, P1518, DOI 10.1038/sj.bjc.6690555; Covello KL, 2006, GENE DEV, V20, P557, DOI 10.1101/gad.1399906; GHODA L, 1989, SCIENCE, V243, P1493, DOI 10.1126/science.2928784; Harvey RP, 2002, NAT REV GENET, V3, P544, DOI 10.1038/nrg843; Huh K, 2007, J VIROL, V81, P9737, DOI 10.1128/JVI.00881-07; Isaacs JS, 2002, J BIOL CHEM, V277, P29936, DOI 10.1074/jbc.M204733200; Jain S, 1998, MECH DEVELOP, V73, P117, DOI 10.1016/S0925-4773(98)00038-0; Katschinski DM, 2004, CELL PHYSIOL BIOCHEM, V14, P351, DOI 10.1159/000080345; Kong XG, 2007, J BIOL CHEM, V282, P15498, DOI 10.1074/jbc.M700704200; Krishnan J, 2008, CIRC RES, V103, P1139, DOI 10.1161/01.RES.0000338613.89841.c1; Lee YM, 2001, DEV DYNAM, V220, P175, DOI 10.1002/1097-0177(20010201)220:2<175::AID-DVDY1101>3.0.CO;2-F; Lin ZH, 2009, CLIN CANCER RES, V15, P570, DOI 10.1158/1078-0432.CCR-08-1813; Liu YV, 2007, MOL CELL, V25, P207, DOI 10.1016/j.molcel.2007.01.001; Macfarlane CM, 1997, LIFE SCI, V60, P1923, DOI 10.1016/S0024-3205(97)00154-9; Mathieu J, 2011, CANCER RES, V71, P4640, DOI 10.1158/0008-5472.CAN-10-3320; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Modarressi A, 2010, J INVEST DERMATOL, V130, P2818, DOI 10.1038/jid.2010.224; Nakamura M, 2009, VIROLOGY, V387, P442, DOI 10.1016/j.virol.2009.02.036; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Pilch H, 2001, INT J GYNECOL CANCER, V11, P137, DOI 10.1046/j.1525-1438.2001.01002.x; PLATE KH, 1992, NATURE, V359, P845, DOI 10.1038/359845a0; Pollard PJ, 2005, HUM MOL GENET, V14, P2231, DOI 10.1093/hmg/ddi227; Post DE, 2001, GENE THER, V8, P1801, DOI 10.1038/sj.gt.3301605; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Provot S, 2007, J CELL BIOL, V177, P451, DOI 10.1083/jcb.200612023; Safran M, 2006, P NATL ACAD SCI USA, V103, P105, DOI 10.1073/pnas.0509459103; SAHAI A, 1994, J CELL PHYSIOL, V160, P107, DOI 10.1002/jcp.1041600113; Schipani E, 2001, GENE DEV, V15, P2865; Schipani E, 2006, ANN NY ACAD SCI, V1068, P66, DOI 10.1196/annals.1346.009; Schulte TW, 1998, CANCER CHEMOTH PHARM, V42, P273, DOI 10.1007/s002800050817; Schwock J, 2008, CANCER CHEMOTH PHARM, V61, P669, DOI 10.1007/s00280-007-0522-8; Shibata T, 1998, INT J RADIAT ONCOL, V42, P913, DOI 10.1016/S0360-3016(98)00298-3; Shibata T, 2000, GENE THER, V7, P493, DOI 10.1038/sj.gt.3301124; SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0; Staab A, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-213; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wang Y, 2011, CELL STEM CELL, V8, P399, DOI 10.1016/j.stem.2011.02.006; Wykoff CC, 2000, CANCER RES, V60, P7075; Xenaki G, 2008, ONCOGENE, V27, P5785, DOI 10.1038/onc.2008.192; Yan Q, 2007, MOL CELL BIOL, V27, P2092, DOI 10.1128/MCB.01514-06	49	29	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e27460	10.1371/journal.pone.0027460	http://dx.doi.org/10.1371/journal.pone.0027460			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132102	Green Published, gold, Green Submitted			2022-12-27	WOS:000298162000020
J	Christensen, ASH; Roed, C; Omland, LH; Andersen, PH; Obel, N; Andersen, AB				Christensen, Anne-Sophie Halkjaer; Roed, Casper; Omland, Lars Haukali; Andersen, Peter Henrik; Obel, Niels; Andersen, Ase Bengaard			Long-Term Mortality in Patients with Tuberculous Meningitis: A Danish Nationwide Cohort Study	PLOS ONE			English	Article							HIV-INFECTION; ADULTS; EPIDEMIOLOGY; PREDICTORS; DENMARK	Background: With high short-term mortality and substantial excess morbidity among survivors, tuberculous meningitis (TBM) is the most severe manifestation of extra-pulmonary tuberculosis (TB). The objective of this study was to assess the long-term mortality and causes of death in a TBM patient population compared to the background population. Methods: A nationwide cohort study was conducted enrolling patients notified with TBM in Denmark from 1972-2008 and alive one year after TBM diagnosis. Data was extracted from national registries. From the background population we identified a control cohort of individuals matched on gender and date of birth. Kaplan-Meier survival curves and Cox regression analysis were used to estimate mortality rate ratios (MRR) and analyse causes of death. Findings: A total of 55 TBM patients and 550 individuals from the background population were included in the study. Eighteen patients (32.7%) and 107 population controls (19.5%) died during the observation period. The overall MRR was 1.79 (95% CI: 1.09-2.95) for TBM patients compared to the population control cohort. TBM patients in the age group 31-60 years at time of diagnosis had the highest relative risk of death (MRR 2.68; 95% CI 1.34-5.34). The TBM patients had a higher risk of death due to infectious disease, but not from other causes of death. Conclusion: Adult TBM patients have an almost two-fold increased long-term mortality and the excess mortality stems from infectious disease related causes of death.	[Christensen, Anne-Sophie Halkjaer; Roed, Casper; Omland, Lars Haukali; Obel, Niels] Rigshosp, Dept Infect Dis, Copenhagen Univ Hosp, DK-2100 Copenhagen, Denmark; [Andersen, Peter Henrik] Statens Serum Inst, Dept Epidemiol, DK-2300 Copenhagen, Denmark; [Andersen, Ase Bengaard] Odense Univ Hosp, Dept Infect Dis, DK-5000 Odense, Denmark	Rigshospitalet; University of Copenhagen; Statens Serum Institut; University of Southern Denmark; Odense University Hospital	Christensen, ASH (corresponding author), Rigshosp, Dept Infect Dis, Copenhagen Univ Hosp, DK-2100 Copenhagen, Denmark.	annesophiechristensen@gmail.com		Roed, Casper/0000-0001-8987-5230; Omland, Lars Haukali/0000-0002-5338-8948; Obel, Niels/0000-0002-5031-0045	Research Foundation at Copenhagen University Hospital, Rigshospitalet	Research Foundation at Copenhagen University Hospital, Rigshospitalet	The study was funded by the Research Foundation at Copenhagen University Hospital, Rigshospitalet. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN PH, 2001, EPI NEWS WEEK, V43; ANDERSEN PH, 2010, EPI NEWS WEEK, V49; Andersen TF, 1999, DAN MED BULL, V46, P263; Anderson NE, 2010, J CLIN NEUROSCI, V17, P1114, DOI 10.1016/j.jocn.2010.01.006; Bang D, 2010, J INFECTION, V60, P452, DOI 10.1016/j.jinf.2010.03.017; Bang D, 2010, SCAND J INFECT DIS, V42, P288, DOI 10.3109/00365540903456282; Bang D, 2010, DAN MED BULL, V57; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Christensen ASH, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-47; Frank L, 2000, SCIENCE, V287, P2398, DOI 10.1126/science.287.5462.2398; Hosoglu S, 2002, INT J TUBERC LUNG D, V6, P64; Juel K, 1999, DAN MED BULL, V46, P354; Kalita J, 2007, EUR J NEUROL, V14, P33, DOI 10.1111/j.1468-1331.2006.01534.x; Karstaedt AS, 1998, QJM-INT J MED, V91, P743, DOI 10.1093/qjmed/91.11.743; Lohse N, 2005, SCAND J INFECT DIS, V37, P338, DOI 10.1080/00365540510031692; MARSHALL G, 1948, LANCET, V254, P582; Padayatchi NI, 2006, PEDIATR INFECT DIS J, V25, P147, DOI 10.1097/01.inf.0000199314.88063.4c; Porkert MT, 1997, AM J MED SCI, V313, P325, DOI 10.1097/00000441-199706000-00002; Poulsen S, 1999, Ugeskr Laeger, V161, P3452; Roed C, 2010, AM J EPIDEMIOL, V172, P309, DOI 10.1093/aje/kwq126; Roed C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009662; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Sengoz G, 2008, NEUROSCIENCES, V13, P402; Shaw JET, 2010, MEDICINE, V89, P189, DOI 10.1097/MD.0b013e3181df9070; *STAT DENM, 2009, POP EL POP DENM; Thwaites GE, 2005, J INFECT DIS, V192, P2134, DOI 10.1086/498220; Thwaites GE, 2004, NEW ENGL J MED, V351, P1741, DOI 10.1056/NEJMoa040573; Verdon R, 1996, CLIN INFECT DIS, V22, P982, DOI 10.1093/clinids/22.6.982; Yechoor VK, 1996, ARCH INTERN MED, V156, P1710, DOI 10.1001/archinte.156.15.1710	29	23	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2011	6	11							e27900	10.1371/journal.pone.0027900	http://dx.doi.org/10.1371/journal.pone.0027900			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858JH	22132165	Green Published, Green Submitted, gold			2022-12-27	WOS:000297792400021
J	Dang, RH; Torigoe, D; Sasaki, N; Agui, T				Dang, Ruihua; Torigoe, Daisuke; Sasaki, Nobuya; Agui, Takashi			QTL Analysis Identifies a Modifier Locus of Aganglionosis in the Rat Model of Hirschsprung Disease Carrying Ednrb(sl) Mutations	PLOS ONE			English	Article							B RECEPTOR GENE; SHAH-WAARDENBURG-SYNDROME; NEURAL CREST DEVELOPMENT; MOUSE MODEL; GERMLINE MUTATIONS; ENDOTHELIN-3 GENE; SOX10(DOM) MOUSE; RET; GDNF; CHROMOSOME-10	Hirschsprung disease (HSCR) exhibits complex genetics with incomplete penetrance and variable severity thought to result as a consequence of multiple gene interactions that modulate the ability of enteric neural crest cells to populate the developing gut. As reported previously, when the same null mutation of the Ednrb gene, Ednrb(sl), was introgressed into the F344 strain, almost 60% of F344-Ednrb(sl/sl) pups did not show any symptoms of aganglionosis, appearing healthy and normally fertile. These findings strongly suggested that the severity of HSCR was affected by strain-specific genetic factor (s). In this study, the genetic basis of such large strain differences in the severity of aganglionosis in the rat model was studied by whole-genome scanning for quantitative trait loci (QTLs) using an intercross of (AGH-Ednrb(sl) x F344-Ednrb(sl)) F-1 with the varying severity of aganglionosis. Genome linkage analysis identified one significant QTL on chromosome 2 for the severity of aganglionosis. Our QTL analyses using rat models of HSCR revealed that multiple genetic factors regulated the severity of aganglionosis. Moreover, a known HSCR susceptibility gene, Gdnf, was found in QTL that suggested a novel non-coding sequence mutation in GDNF that modifies the penetrance and severity of the aganglionosis phenotype in EDNRB-deficient rats. A further identification and analysis of responsible genes located on the identified QTL could lead to the richer understanding of the genetic basis of HSCR development.	[Dang, Ruihua; Torigoe, Daisuke; Sasaki, Nobuya; Agui, Takashi] Hokkaido Univ, Lab Lab Anim Sci & Med, Dept Dis Control, Grad Sch Vet Med, Sapporo, Hokkaido 060, Japan	Hokkaido University	Dang, RH (corresponding author), Hokkaido Univ, Lab Lab Anim Sci & Med, Dept Dis Control, Grad Sch Vet Med, Sapporo, Hokkaido 060, Japan.	agui@vetmed.hokudai.ac.jp	Sasaki, Nobuya/F-6579-2012					Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; Alves MMM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015144; Amiel J, 2008, J MED GENET, V45, P1, DOI 10.1136/jmg.2007.053959; Amiel J, 1996, HUM MOL GENET, V5, P355, DOI 10.1093/hmg/5.3.355; ANGRIST M, 1993, NAT GENET, V4, P351, DOI 10.1038/ng0893-351; Angrist M, 1996, NAT GENET, V14, P341, DOI 10.1038/ng1196-341; ATTIE T, 1995, HUM MOL GENET, V4, P2407, DOI 10.1093/hmg/4.12.2407; Auricchio A, 1996, HUM MOL GENET, V5, P351, DOI 10.1093/hmg/5.3.351; BADNER JA, 1990, AM J HUM GENET, V46, P568; Barlow A, 2003, NEURON, V40, P905, DOI 10.1016/S0896-6273(03)00730-X; Boardman JP, 2001, J MED GENET, V38, P646, DOI 10.1136/jmg.38.9.646; BORREGO S, 2011, J MOL MED-JMM, V89, P471; Brooks AS, 2005, AM J HUM GENET, V77, P120, DOI 10.1086/431244; Cantrell VA, 2004, HUM MOL GENET, V13, P2289, DOI 10.1093/hmg/ddh243; Carrasquillo MM, 2002, NAT GENET, V32, P237, DOI 10.1038/ng998; COHEN IT, 1982, J PEDIATR SURG, V17, P632, DOI 10.1016/S0022-3468(82)80124-3; Cozma D, 2002, GENOME RES, V12, P969, DOI 10.1101/gr.210502; Dang RH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024086; Edery P, 1996, NAT GENET, V12, P442, DOI 10.1038/ng0496-442; Emison ES, 2005, NATURE, V434, P857, DOI 10.1038/nature03467; Fitze G, 2008, AM J MED GENET A, V146A, P1486, DOI 10.1002/ajmg.a.32300; Gariepy CE, 1996, P NATL ACAD SCI USA, V93, P867, DOI 10.1073/pnas.93.2.867; Heanue TA, 2007, NAT REV NEUROSCI, V8, P466, DOI 10.1038/nrn2137; Hofstra RMW, 1996, NAT GENET, V12, P445, DOI 10.1038/ng0496-445; Ivanchuk SM, 1996, HUM MOL GENET, V5, P2023, DOI 10.1093/hmg/5.12.2023; Jiang Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021219; Kusafuka T, 1996, HUM MOL GENET, V5, P347, DOI 10.1093/hmg/5.3.347; LUO Y, 1993, HUM MOL GENET, V2, P1803, DOI 10.1093/hmg/2.11.1803; LYONNET S, 1993, NAT GENET, V4, P346, DOI 10.1038/ng0893-346; Manly KF, 2001, MAMM GENOME, V12, P930, DOI 10.1007/s00335-001-1016-3; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; McCallion AS, 2003, P NATL ACAD SCI USA, V100, P1826, DOI 10.1073/pnas.0337540100; Moore MW, 1996, NATURE, V382, P76, DOI 10.1038/382076a0; Nadeau JH, 2003, CURR OPIN GENET DEV, V13, P290, DOI 10.1016/S0959-437X(03)00061-3; Owens SE, 2005, HUM MOL GENET, V14, P1549, DOI 10.1093/hmg/ddi163; Passarge E, 2002, NAT GENET, V31, P11, DOI 10.1038/ng878; Pingault V, 1998, NAT GENET, V18, P171, DOI 10.1038/ng0298-171; PUFFENBERGER EG, 1994, CELL, V79, P1257, DOI 10.1016/0092-8674(94)90016-7; Salomon R, 1996, NAT GENET, V14, P345, DOI 10.1038/ng1196-345; Sasongko Teguh Haryo, 2007, Kobe J Med Sci, V53, P157; Shin MK, 1999, NATURE, V402, P496, DOI 10.1038/990040; Skinner MA, 1996, CURR PROB SURG, V33, P394, DOI 10.1016/S0011-3840(96)80009-8; Southard-Smith EM, 1998, NAT GENET, V18, P60, DOI 10.1038/ng0198-60; Southard-Smith EM, 1999, GENOME RES, V9, P215; Syrris P, 1999, AM J MED GENET, V87, P69, DOI 10.1002/(SICI)1096-8628(19991105)87:1<69::AID-AJMG14>3.0.CO;2-R; Tanaka H, 1998, J BIOL CHEM, V273, P11378, DOI 10.1074/jbc.273.18.11378; Yanagisawa H, 1998, DEVELOPMENT, V125, P825	47	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2011	6	11							e27902	10.1371/journal.pone.0027902	http://dx.doi.org/10.1371/journal.pone.0027902			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858JH	22132166	Green Published, gold			2022-12-27	WOS:000297792400022
J	Santos, AL; Siqueira, JF; Rocas, IN; Jesus, EC; Rosado, AS; Tiedje, JM				Santos, Adriana L.; Siqueira, Jose F., Jr.; Rocas, Isabela N.; Jesus, Ederson C.; Rosado, Alexandre S.; Tiedje, James M.			Comparing the Bacterial Diversity of Acute and Chronic Dental Root Canal Infections	PLOS ONE			English	Article							BLACK-PIGMENTED BACTEROIDES; ENDODONTIC INFECTIONS; PYROSEQUENCING ANALYSIS; MICROBIOTA; COMMUNITIES; GUT; MICROFLORA; ABSCESSES; SOIL	This study performed barcoded multiplex pyrosequencing with a 454 FLX instrument to compare the microbiota of dental root canal infections associated with acute (symptomatic) or chronic (asymptomatic) apical periodontitis. Analysis of samples from 9 acute abscesses and 8 chronic infections yielded partial 16S rRNA gene sequences that were taxonomically classified into 916 bacterial species-level operational taxonomic units (OTUs) (at 3% divergence) belonging to 67 genera and 13 phyla. The most abundant phyla in acute infections were Firmicutes (52%), Fusobacteria (17%) and Bacteroidetes (13%), while in chronic infections the dominant were Firmicutes (59%), Bacteroidetes (14%) and Actinobacteria (10%). Members of Fusobacteria were much more prevalent in acute (89%) than in chronic cases (50%). The most abundant/prevalent genera in acute infections were Fusobacterium and Parvimonas. Twenty genera were exclusively detected in acute infections and 18 in chronic infections. Only 18% (n = 165) of the OTUs at 3% divergence were shared by acute and chronic infections. Diversity and richness estimators revealed that acute infections were significantly more diverse than chronic infections. Although a high interindividual variation in bacterial communities was observed, many samples tended to group together according to the type of infection (acute or chronic). This study is one of the most comprehensive in-deep comparisons of the microbiota associated with acute and chronic dental root canal infections and highlights the role of diverse polymicrobial communities as the unit of pathogenicity in acute infections. The overall diversity of endodontic infections as revealed by the pyrosequencing technique was much higher than previously reported for endodontic infections.	[Santos, Adriana L.; Rosado, Alexandre S.] Univ Fed Rio de Janeiro, Inst Microbiol Prof Paulo de Goes, Rio De Janeiro, Brazil; [Siqueira, Jose F., Jr.; Rocas, Isabela N.] Univ Estacio Sa, Dept Endodont & Mol Microbiol Lab, Rio De Janeiro, Brazil; [Tiedje, James M.] Michigan State Univ, Ctr Microbial Ecol, E Lansing, MI 48824 USA; [Jesus, Ederson C.] EMBRAPA, Soil Microbiol Lab, Seropedica, Brazil	Universidade Federal do Rio de Janeiro; Universidade Estacio de Sa; Michigan State University; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Santos, AL (corresponding author), Univ Fed Rio de Janeiro, Inst Microbiol Prof Paulo de Goes, Rio De Janeiro, Brazil.	jf_siqueira@yahoo.com	Rosado, Alexandre Soares/G-1955-2012; Siqueira Jr, José/C-8229-2013; Jesus, Ederson/D-1690-2010; Jesus, Ederson/AAC-5305-2019; dos Santos, Adriana Lopes/B-7252-2018; dos Santos, Adriana Lopes/J-6960-2019; Rôças, Isabela/I-4063-2013	Rosado, Alexandre Soares/0000-0001-5135-1394; dos Santos, Adriana Lopes/0000-0002-0736-4937; dos Santos, Adriana Lopes/0000-0002-0736-4937; 	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This study was supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), and Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Brazilian Governmental Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, BIOFILM PRIMER; Baumgartner JC, 1999, J ENDODONT, V25, P413, DOI 10.1016/S0099-2399(99)80268-4; Caplan DJ, 2006, J DENT RES, V85, P996, DOI 10.1177/154405910608501104; Chao A, 2002, BIOMETRICS, V58, P531, DOI 10.1111/j.0006-341X.2002.00531.x; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; de Oliveira JCM, 2007, ORAL MICROBIOL IMMUN, V22, P14, DOI 10.1111/j.1399-302X.2007.00311.x; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Dowd SE, 2008, BMC MICROBIOL, V8, DOI [10.1186/1471-2180-8-125, 10.1186/1471-2180-8-43]; Gomes BPFA, 1996, J DENT, V24, P47, DOI 10.1016/0300-5712(95)00042-9; HAAPASALO M, 1986, INFECT IMMUN, V53, P149, DOI 10.1128/IAI.53.1.149-153.1986; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; Huse SM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000255; Jukes T., 1969, MAMMALIAN PROTEIN ME, P21; Keijser BJF, 2008, J DENT RES, V87, P1016, DOI 10.1177/154405910808701104; Kindt R., 2005, WORLD; Koren O, 2011, P NATL ACAD SCI USA, V108, P4592, DOI 10.1073/pnas.1011383107; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Kuramitsu HK, 2007, MICROBIOL MOL BIOL R, V71, P653, DOI 10.1128/MMBR.00024-07; Lazarevic V, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-523; Li L, 2010, J DENT RES, V89, P980, DOI 10.1177/0022034510370026; Munson MA, 2002, J DENT RES, V81, P761, DOI 10.1177/154405910208101108; Nasidze I, 2009, ANAL BIOCHEM, V391, P64, DOI 10.1016/j.ab.2009.04.034; Oksanen J., 2016, R PACKAG; Rajilic-Stojanovic M, 2007, ENVIRON MICROBIOL, V9, P2125, DOI 10.1111/j.1462-2920.2007.01369.x; Robertson D, 2009, J MED MICROBIOL, V58, P155, DOI 10.1099/jmm.0.003517-0; Rocas IN, 2008, J CLIN MICROBIOL, V46, P3599, DOI 10.1128/JCM.00431-08; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Sakamoto M, 2006, ORAL MICROBIOL IMMUN, V21, P112, DOI 10.1111/j.1399-302X.2006.00270.x; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Shannon C. E., 1949, MATH THEORY COMMUNIC; Siqueira JF, 2009, J DENT RES, V88, P969, DOI 10.1177/0022034509346549; Siqueira JF, 2009, J DENT RES, V88, P61, DOI 10.1177/0022034508328124; Siqueira JF, 2004, ORAL MICROBIOL IMMUN, V19, P363, DOI 10.1111/j.1399-302x.2004.00170.x; Siqueira JF, 2002, ORAL SURG ORAL MED O, V94, P281, DOI 10.1067/moe.2002.126163; Siqueira JF, 2000, ORAL SURG ORAL MED O, V89, P744, DOI 10.1067/moe.2000.106576; Siqueira JF, 2011, TREATMENT ENDODONTIC; Siqueira JF, 2011, J ENDODONT, V37, P1499, DOI 10.1016/j.joen.2011.08.012; Siqueira JF, 2008, J ENDODONT, V34, P1457, DOI 10.1016/j.joen.2008.08.037; Siqueira JF, 2009, ORAL SURG ORAL MED O, V107, P870, DOI 10.1016/j.tripleo.2009.01.044; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Sundararajan A, 2007, BE J THEOR ECON, V7, DOI 10.1186/1471-2180-7-108; SUNDQVIST G, 1989, J ENDODONT, V15, P13, DOI 10.1016/S0099-2399(89)80092-5; SUNDQVIST G, 1992, ORAL MICROBIOL IMMUN, V7, P257, DOI 10.1111/j.1399-302X.1992.tb00584.x; Sundqvist G., 1976, THESIS U UMEA UMEA; Teixeira LCRS, 2010, ISME J, V4, P989, DOI 10.1038/ismej.2010.35; Villanueva LECD, 2002, ORAL SURG ORAL MED O, V93, P179, DOI 10.1067/moe.2002.120803; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; WILLIAMS BL, 1983, J CLIN MICROBIOL, V18, P770, DOI 10.1128/JCM.18.4.770-774.1983; Wu GD, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-206; Zaura E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-259	51	82	86	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2011	6	11							e28088	10.1371/journal.pone.0028088	http://dx.doi.org/10.1371/journal.pone.0028088			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IO	22132218	Green Published, gold, Green Submitted			2022-12-27	WOS:000297789900047
J	Chang, FM; Lemmon, C; Lietha, D; Eck, M; Romer, L				Chang, Fumin; Lemmon, Christopher; Lietha, Daniel; Eck, Michael; Romer, Lewis			Tyrosine Phosphorylation of Rac1: A Role in Regulation of Cell Spreading	PLOS ONE			English	Article							FOCAL ADHESION KINASE; SRC FAMILY KINASES; IN-VIVO; DEPENDENT REGULATION; STRUCTURAL BASIS; RHO GTPASES; PROTEIN; ACTIVATION; DYNAMICS; FAK	Rac1 influences a multiplicity of vital cellular-and tissue-level control functions, making it an important candidate for targeted therapeutics. The activity of the Rho family member Cdc42 has been shown to be modulated by tyrosine phosphorylation at position 64. We therefore investigated consequences of the point mutations Y64F and Y64D in Rac1. Both mutations altered cell spreading from baseline in the settings of wild type, constitutively active, or dominant negative Rac1 expression, and were accompanied by differences in Rac1 targeting to focal adhesions. Rac1-Y64F displayed increased GTP-binding, increased association with beta PIX, and reduced binding with RhoGDI as compared with wild type Rac1. Rac1-Y64D had less binding to PAK than Rac1-WT or Rac1-64F. In vitro assays demonstrated that Y64 in Rac1 is a target for FAK and Src. Taken together, these data suggest a mechanism for the regulation of Rac1 activity by non-receptor tyrosine kinases, with consequences for membrane extension.	[Chang, Fumin; Romer, Lewis] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA; [Lemmon, Christopher] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Lietha, Daniel] Spanish Natl Canc Res Ctr CNIO, Madrid, Spain; [Eck, Michael] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA USA; [Eck, Michael] Dana Farber Canc Inst, Boston, MA 02115 USA; [Romer, Lewis] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA; [Romer, Lewis] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA; [Romer, Lewis] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Romer, Lewis] Johns Hopkins Univ, Sch Med, Ctr Cell Dynam, Baltimore, MD 21205 USA	Johns Hopkins University; Duke University; Centro Nacional de Investigaciones Oncologicas (CNIO); Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Chang, FM (corresponding author), Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA.	lromer@jhmi.edu	Lemmon, Christopher/GPP-1470-2022; Lietha, Daniel/AAD-1952-2022; Lietha, Daniel/L-8041-2014	Lietha, Daniel/0000-0002-6133-6486; Lietha, Daniel/0000-0002-6133-6486; Lemmon, Christopher/0000-0002-9049-6366	National Institutes of Health [AI061042, HL088203]; National Science Foundation [MCB-0923661]; Department of Defense [BC06911]; Maryland Stem Cell Research Fund [MSCRFE-0043-00]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K18HL088203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI061042] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Department of Defense(United States Department of Defense); Maryland Stem Cell Research Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants to L.R. from the National Institutes of Health (AI061042 and HL088203), the National Science Foundation (MCB-0923661), the Department of Defense (BC06911), and MSCRFE-0043-00 from the Maryland Stem Cell Research Fund. None of these funding sources had any role in conducting the research or preparing the manuscript.	Abramovici H, 2009, MOL BIOL CELL, V20, P2049, DOI 10.1091/mbc.E07-12-1248; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Bosco EE, 2009, CELL MOL LIFE SCI, V66, P370, DOI 10.1007/s00018-008-8552-x; Briancon-Marjollet A, 2008, MOL CELL BIOL, V28, P2314, DOI 10.1128/MCB.00998-07; Bryce NS, 2005, CURR BIOL, V15, P1276, DOI 10.1016/j.cub.2005.06.043; Bustelo XR, 2007, BIOESSAYS, V29, P356, DOI 10.1002/bies.20558; Carragher NO, 2003, CURR BIOL, V13, P1442, DOI 10.1016/S0960-9822(03)00544-X; Chang FM, 2007, MOL BIOL CELL, V18, P253, DOI 10.1091/mbc.E06-03-0207; Choi JH, 2007, CELL SIGNAL, V19, P1784, DOI 10.1016/j.cellsig.2007.04.002; Chrencik JE, 2008, J MOL BIOL, V380, P828, DOI 10.1016/j.jmb.2008.05.024; Del Pozo MA, 2007, TRENDS CELL BIOL, V17, P246, DOI 10.1016/j.tcb.2007.03.001; DerMardirossian C, 2005, TRENDS CELL BIOL, V15, P356, DOI 10.1016/j.tcb.2005.05.001; DerMardirossian C, 2004, MOL CELL, V15, P117, DOI 10.1016/j.molcel.2004.05.019; Dovas A, 2005, BIOCHEM J, V390, P1, DOI 10.1042/BJ20050104; Forget MA, 2002, BIOCHEM J, V361, P243, DOI 10.1042/0264-6021:3610243; Fuss H, 2007, J COMPUT BIOL, V14, P1185, DOI 10.1089/cmb.2007.0095; Gao Y, 2001, J BIOL CHEM, V276, P47530, DOI 10.1074/jbc.M108865200; Grunicke HH, 2009, CRIT REV EUKAR GENE, V19, P139, DOI 10.1615/CritRevEukarGeneExpr.v19.i2.40; HART MJ, 1990, J BIOL CHEM, V265, P5990; Hordijk PL, 2006, CIRC RES, V98, P453, DOI 10.1161/01.RES.0000204727.46710.5e; Hunter T, 2009, CURR OPIN CELL BIOL, V21, P140, DOI 10.1016/j.ceb.2009.01.028; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jezyk MR, 2006, NAT STRUCT MOL BIOL, V13, P1135, DOI 10.1038/nsmb1175; Katz BZ, 2003, J BIOL CHEM, V278, P29115, DOI 10.1074/jbc.M212396200; Kissil JL, 2007, CANCER RES, V67, P8089, DOI 10.1158/0008-5472.CAN-07-2300; Kwon T, 2000, J BIOL CHEM, V275, P423, DOI 10.1074/jbc.275.1.423; LAEMMLI UK, 1970, J MOL BIOL, V47, P69, DOI 10.1016/0022-2836(70)90402-X; Lang P, 1996, EMBO J, V15, P510, DOI 10.1002/j.1460-2075.1996.tb00383.x; Li SF, 2008, ADV CANCER RES, V101, P45, DOI 10.1016/S0065-230X(08)00403-X; Lietha D, 2007, CELL, V129, P1177, DOI 10.1016/j.cell.2007.05.041; MILBURN MV, 1990, SCIENCE, V247, P939, DOI 10.1126/science.2406906; Moissoglu K, 2006, MOL BIOL CELL, V17, P2770, DOI 10.1091/mbc.E06-01-0005; MOODIE SA, 1995, ONCOGENE, V11, P447; Myers KR, 2008, TRENDS CELL BIOL, V18, P184, DOI 10.1016/j.tcb.2008.02.002; Nikolova E, 2007, BIOCHEM BIOPH RES CO, V359, P834, DOI 10.1016/j.bbrc.2007.05.214; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Oyama M, 2009, MOL CELL PROTEOMICS, V8, P226, DOI 10.1074/mcp.M800186-MCP200; Playford MP, 2004, ONCOGENE, V23, P7928, DOI 10.1038/sj.onc.1208080; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Roepstorff K, 2008, J BIOL CHEM, V283, P7983, DOI 10.1074/jbc.M708281200; Romer LH, 2006, CIRC RES, V98, P606, DOI 10.1161/01.RES.0000207408.31270.db; Schaller MD, 2001, BBA-MOL CELL RES, V1540, P1, DOI 10.1016/S0167-4889(01)00123-9; Schaller MD, 1999, MOL BIOL CELL, V10, P3489, DOI 10.1091/mbc.10.10.3489; Tu S, 2003, J BIOL CHEM, V278, P49293, DOI 10.1074/jbc.M307021200; Tzima E, 2006, CIRC RES, V98, P176, DOI 10.1161/01.RES.0000200162.94463.d7; Wu XY, 2005, DEV CELL, V9, P185, DOI 10.1016/j.devcel.2005.06.006	46	43	45	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2011	6	12							e28587	10.1371/journal.pone.0028587	http://dx.doi.org/10.1371/journal.pone.0028587			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863OC	22163037	Green Published, Green Submitted, gold			2022-12-27	WOS:000298173500036
J	Dangaj, D; Abbott, KL; Mookerjee, A; Zhao, AZ; Kirby, PS; Sandaltzopoulos, R; Powell, DJ; Lamaziere, A; Siegel, DL; Wolf, C; Scholler, N				Dangaj, Denarda; Abbott, Karen L.; Mookerjee, Ananda; Zhao, Aizhi; Kirby, Pamela S.; Sandaltzopoulos, Raphael; Powell, Daniel J., Jr.; Lamaziere, Antonin; Siegel, Don L.; Wolf, Claude; Scholler, Nathalie			Mannose Receptor (MR) Engagement by Mesothelin GPI Anchor Polarizes Tumor-Associated Macrophages and Is Blocked by Anti-MR Human Recombinant Antibody	PLOS ONE			English	Article							EPITHELIAL OVARIAN-CANCER; SEPTICUM ALPHA-TOXIN; CARBOHYDRATE-RECOGNITION DOMAIN; GENE-EXPRESSION ANALYSIS; DENDRITIC CELLS; IMMUNE-RESPONSES; ENDOTHELIAL-CELLS; MASS-SPECTROMETRY; PROSTATE-CANCER; DOWN-REGULATION	Tumor-infiltrating macrophages respond to microenvironmental signals by developing a tumor-associated phenotype characterized by high expression of mannose receptor (MR, CD206). Antibody cross-linking of CD206 triggers anergy in dendritic cells and CD206 engagement by tumoral mucins activates an immune suppressive phenotype in tumor-associated macrophages (TAMs). Many tumor antigens are heavily glycosylated, such as tumoral mucins, and/or attached to tumor cells by mannose residue-containing glycolipids (GPI anchors), as for example mesothelin and the family of carcinoembryonic antigen (CEA). However, the binding to mannose receptor of soluble tumor antigen GPI anchors via mannose residues has not been systematically studied. To address this question, we analyzed the binding of tumor-released mesothelin to ascites-infiltrating macrophages from ovarian cancer patients. We also modeled functional interactions between macrophages and soluble mesothelin using an in vitro system of co-culture in transwells of healthy donor macrophages with human ovarian cancer cell lines. We found that soluble mesothelin bound to human macrophages and that the binding depended on the presence of GPI anchor and of mannose receptor. We next challenged the system with antibodies directed against the mannose receptor domain 4 (CDR4-MR). We isolated three novel anti-CDR4-MR human recombinant antibodies (scFv) using a yeast-display library of human scFv. Anti-CDR4-MR scFv #G11 could block mesothelin binding to macrophages and prevent tumor-induced phenotype polarization of CD206(low) macrophages towards TAMs. Our findings indicate that tumor-released mesothelin is linked to GPI anchor, engages macrophage mannose receptor, and contributes to macrophage polarization towards TAMs. We propose that compounds able to block tumor antigen GPI anchor/CD206 interactions, such as our novel anti-CRD4-MR scFv, could prevent tumor-induced TAM polarization and have therapeutic potential against ovarian cancer, through polarization control of tumor-infiltrating innate immune cells.	[Dangaj, Denarda; Mookerjee, Ananda; Zhao, Aizhi; Powell, Daniel J., Jr.; Scholler, Nathalie] Univ Penn, Dept Obstet & Gynecol, Penn Ovarian Canc Res Ctr, Philadelphia, PA 19104 USA; [Dangaj, Denarda; Sandaltzopoulos, Raphael] Democritus Univ Thrace, Dept Mol Biol & Genet, Alexandroupolis, Greece; [Abbott, Karen L.; Kirby, Pamela S.] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Powell, Daniel J., Jr.; Siegel, Don L.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Lamaziere, Antonin; Wolf, Claude] Univ Paris 06, Sch Med St Antoine, Dept Biochem, Paris, France	University of Pennsylvania; Democritus University of Thrace; University System of Georgia; University of Georgia; University of Pennsylvania; UDICE-French Research Universities; Sorbonne Universite	Dangaj, D (corresponding author), Univ Penn, Dept Obstet & Gynecol, Penn Ovarian Canc Res Ctr, Philadelphia, PA 19104 USA.	naths@mail.med.upenn.edu	Lamaziere, Antonin/AAH-2285-2022; Lamaziere, Antonin/AFM-0000-2022; Scholler, Nathalie/O-9003-2014		ovarian SPORE; University of Pennsylvania (National Institutes of Health/National Cancer Institute (NIH/NCI)) [P50 CA83638]; American Cancer Society [IRG-78-002-29]; Department of Defense [BC075534]; National Heart, Lung, and Blood Institute [P50-HL81012]; NATIONAL CANCER INSTITUTE [P50CA083638] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL081012] Funding Source: NIH RePORTER	ovarian SPORE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of Pennsylvania (National Institutes of Health/National Cancer Institute (NIH/NCI)); American Cancer Society(American Cancer Society); Department of Defense(United States Department of Defense); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Career Development Award (N.S.) from the ovarian SPORE grant to Fox Chase Cancer Center and University of Pennsylvania (National Institutes of Health/National Cancer Institute (NIH/NCI) P50 CA83638), in part by the grant #IRG-78-002-29 from the American Cancer Society (Pilot Project, N.S.), by the Breast Cancer Concept Award from Department of Defense (BC075534) (K. L. A.) and by the National Heart, Lung, and Blood Institute (P50-HL81012) (D. L. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allavena P, 2010, CLIN DEV IMMUNOL, DOI 10.1155/2010/547179; Balkwill F, 2005, CANCER CELL, V7, P211, DOI 10.1016/j.ccr.2005.02.013; Belisle JA, 2007, IMMUNOLOGY, V122, P418, DOI 10.1111/j.1365-2567.2007.02660.x; Bergan L, 2007, CANCER LETT, V255, P263, DOI 10.1016/j.canlet.2007.04.012; Bharadwaj U, 2008, MOL CANCER RES, V6, P1755, DOI 10.1158/1541-7786.MCR-08-0095; Bones J, 2011, J PROTEOME RES, V10, P1246, DOI 10.1021/pr101036b; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Butikofer P, 2001, FASEB J, V15, P545, DOI 10.1096/fj.00-0415hyp; Chan C H F, 2007, Curr Oncol, V14, P70; Chang K, 1996, P NATL ACAD SCI USA, V93, P136, DOI 10.1073/pnas.93.1.136; Cheng WF, 2009, BRIT J CANCER, V100, P1144, DOI 10.1038/sj.bjc.6604964; Chieppa M, 2003, J IMMUNOL, V171, P4552, DOI 10.4049/jimmunol.171.9.4552; Coffelt SB, 2009, BBA-REV CANCER, V1796, P11, DOI 10.1016/j.bbcan.2009.02.004; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Coussens LM, 2001, J EXP MED, V193, pF23, DOI 10.1084/jem.193.6.F23; Dube DH, 2005, NAT REV DRUG DISCOV, V4, P477, DOI 10.1038/nrd1751; East L, 2002, BBA-GEN SUBJECTS, V1572, P364, DOI 10.1016/S0304-4165(02)00319-7; Edidin M, 2003, ANNU REV BIOPH BIOM, V32, P257, DOI 10.1146/annurev.biophys.32.110601.142439; Engering AJ, 1997, ADV EXP MED BIOL, V417, P183; EZEKOWITZ RAB, 1982, ADV EXP MED BIOL, V155, P401; Feinberg H, 2000, J BIOL CHEM, V275, P21539, DOI 10.1074/jbc.M002366200; Feldhaus Michael, 2004, Methods Mol Biol, V263, P311; FIETE D, 1991, CELL, V67, P1103, DOI 10.1016/0092-8674(91)90287-9; Foged C, 2004, VACCINE, V22, P1903, DOI 10.1016/j.vaccine.2003.11.008; Fujita M, 2008, BBA-GEN SUBJECTS, V1780, P410, DOI 10.1016/j.bbagen.2007.08.009; Gordon VM, 1999, J BIOL CHEM, V274, P27274, DOI 10.1074/jbc.274.38.27274; Gubbels JAA, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-50; Gubbels JAA, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-11; Hagemann T, 2006, J IMMUNOL, V176, P5023, DOI 10.4049/jimmunol.176.8.5023; Hammarstrom S, 1999, SEMIN CANCER BIOL, V9, P67, DOI 10.1006/scbi.1998.0119; HARRIS N, 1992, BLOOD, V80, P2363; Hassan R, 2004, CLIN CANCER RES, V10, P3937, DOI 10.1158/1078-0432.CCR-03-0801; He LZ, 2007, J IMMUNOL, V178, P6259, DOI 10.4049/jimmunol.178.10.6259; Hellstrom I, 2006, CANCER EPIDEM BIOMAR, V15, P1014, DOI 10.1158/1055-9965.EPI-05-0334; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Kelemen LE, 2006, INT J CANCER, V119, P243, DOI 10.1002/ijc.21712; Kim S, 2009, NATURE, V457, P102, DOI 10.1038/nature07623; Kondoh G, 2005, NAT MED, V11, P160, DOI 10.1038/nm1179; Kusumoto T, 2010, ONCOL REP, V23, P917, DOI 10.3892/or_00000715; Lauc G, 2006, BBA-GEN SUBJECTS, V1760, P584, DOI 10.1016/j.bbagen.2005.11.014; Lee SJ, 2002, SCIENCE, V295, P1898, DOI 10.1126/science.1069540; LENNARTZ MR, 1987, BIOCHEM J, V245, P705, DOI 10.1042/bj2450705; Leteux C, 2000, J EXP MED, V191, P1117, DOI 10.1084/jem.191.7.1117; Liebisch G, 2006, BBA-MOL CELL BIOL L, V1761, P121, DOI 10.1016/j.bbalip.2005.12.007; Lin WW, 2007, J CLIN INVEST, V117, P1175, DOI 10.1172/JCI31537; Linehan SA, 2001, EUR J IMMUNOL, V31, P1857, DOI 10.1002/1521-4141(200106)31:6<1857::AID-IMMU1857>3.0.CO;2-D; MacRae JI, 2005, GLYCOBIOLOGY, V15, P131, DOI 10.1093/glycob/cwh149; MAGNUSSON S, 1993, BIOCHEM J, V291, P749, DOI 10.1042/bj2910749; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Martinez-Pomares L, 2001, IMMUNOBIOLOGY, V204, P527, DOI 10.1078/0171-2985-00089; Martinez-Pomares Luisa, 2009, V531, P103, DOI 10.1007/978-1-59745-396-7_8; Marttila-Ichihara F, 2008, BLOOD, V112, P64, DOI 10.1182/blood-2007-10-118984; Melton-Witt JA, 2006, BIOCHEMISTRY-US, V45, P14347, DOI 10.1021/bi061334p; MIOTTI S, 1992, INT J CANCER, V51, P499, DOI 10.1002/ijc.2910510326; MULLIN NP, 1994, J BIOL CHEM, V269, P28405; Nebl T, 2005, PARASITOLOGY, V130, pS45, DOI 10.1017/S0031182005008152; Ochsenbein AF, 1999, P NATL ACAD SCI USA, V96, P2233, DOI 10.1073/pnas.96.5.2233; Ojalvo LS, 2010, J IMMUNOL, V184, P702, DOI 10.4049/jimmunol.0902360; Ojalvo LS, 2009, AM J PATHOL, V174, P1048, DOI 10.2353/ajpath.2009.080676; Orntoft TF, 1999, ELECTROPHORESIS, V20, P362, DOI 10.1002/(SICI)1522-2683(19990201)20:2<362::AID-ELPS362>3.3.CO;2-M; Patankar MS, 2005, GYNECOL ONCOL, V99, P704, DOI 10.1016/j.ygyno.2005.07.030; Paulick MG, 2008, BIOCHEMISTRY-US, V47, P6991, DOI 10.1021/bi8006324; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Porcheray F, 2005, CLIN EXP IMMUNOL, V142, P481, DOI 10.1111/j.1365-2249.2005.02934.x; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Qiu YH, 2008, J PROTEOME RES, V7, P1693, DOI 10.1021/pr700706s; QUINN PJ, 2009, METH MOL B, V579, P127, DOI DOI 10.1007/978-1-60761-322-0_7; Rajaram MVS, 2010, J IMMUNOL, V185, P929, DOI 10.4049/jimmunol.1000866; Ricciardelli C, 1998, CLIN CANCER RES, V4, P963; Robinson BWS, 2003, LANCET, V362, P1612, DOI 10.1016/S0140-6736(03)14794-0; Rooney IA, 1996, J CLIN INVEST, V97, P1675, DOI 10.1172/JCI118594; Rosen DG, 2005, GYNECOL ONCOL, V99, P267, DOI 10.1016/j.ygyno.2005.06.040; Rump A, 2004, J BIOL CHEM, V279, P9190, DOI 10.1074/jbc.M312372200; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; Sasaroli D, 2009, BIOMARK MED, V3, P275, DOI 10.2217/BMM.09.21; Scholler N, 1999, P NATL ACAD SCI USA, V96, P11531, DOI 10.1073/pnas.96.20.11531; Scholler N, 2006, J IMMUNOL METHODS, V317, P132, DOI 10.1016/j.jim.2006.10.003; Scholler N, 2007, CANCER LETT, V247, P130, DOI 10.1016/j.canlet.2006.03.029; Sellman BR, 1997, MOL MICROBIOL, V23, P551, DOI 10.1046/j.1365-2958.1997.d01-1876.x; Semmes OJ, 2006, J CELL BIOCHEM, V98, P496, DOI 10.1002/jcb.20855; Sharma P, 2004, CELL, V116, P577, DOI 10.1016/S0092-8674(04)00167-9; Sharom FJ, 2002, BIOCHEM CELL BIOL, V80, P535, DOI 10.1139/O02-146; Sica A, 2008, SEMIN CANCER BIOL, V18, P349, DOI 10.1016/j.semcancer.2008.03.004; Singh V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016097; Solinas G, 2010, J IMMUNOL, V185, P642, DOI 10.4049/jimmunol.1000413; Stahl PD, 1998, CURR OPIN IMMUNOL, V10, P50, DOI 10.1016/S0952-7915(98)80031-9; Tachado SD, 1997, P NATL ACAD SCI USA, V94, P4022, DOI 10.1073/pnas.94.8.4022; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Tang CK, 2007, IMMUNOLOGY, V120, P325, DOI 10.1111/j.1365-2567.2006.02506.x; Tanyi JL, 2010, ONCOL REV, V4, P43, DOI 10.1007/s12156-010-0035-2; Theocharis AD, 2010, FEBS J, V277, P3904, DOI 10.1111/j.1742-4658.2010.07800.x; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Tiede A, 1999, BIOL CHEM, V380, P503, DOI 10.1515/BC.1999.066; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; Uehara N, 2008, MOL CANCER RES, V6, P186, DOI 10.1158/1541-7786.MCR-07-0254; Varma R, 1998, NATURE, V394, P798, DOI 10.1038/29563; Vautier S, 2010, CYTOKINE GROWTH F R, V21, P405, DOI 10.1016/j.cytogfr.2010.10.001; Xaplanteri P, 2009, EUR J IMMUNOL, V39, P730, DOI 10.1002/eji.200838872; Zacks MA, 2006, MOL MEMBR BIOL, V23, P209, DOI 10.1080/09687860600601494; Zhang JM, 2004, INFECT IMMUN, V72, P3147, DOI 10.1128/IAI.72.6.3147-3160.2004; Zhao AZ, 2011, J IMMUNOL METHODS, V363, P221, DOI 10.1016/j.jim.2010.09.001	102	25	29	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2011	6	12							e28386	10.1371/journal.pone.0028386	http://dx.doi.org/10.1371/journal.pone.0028386			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863OC	22163010	Green Submitted, Green Published, gold			2022-12-27	WOS:000298173500015
J	Hawkins, JB; Jones, MT; Plassmann, PE; Thorley-Lawson, DA				Hawkins, Jared B.; Jones, Mark T.; Plassmann, Paul E.; Thorley-Lawson, David A.			Chemotaxis in Densely Populated Tissue Determines Germinal Center Anatomy and Cell Motility: A New Paradigm for the Development of Complex Tissues	PLOS ONE			English	Article							AFFINITY MATURATION; IMMUNE-RESPONSE; LYMPHOCYTE; MIGRATION; SELECTION; DYNAMICS; SYSTEM; ORGANIZATION; MICROSCOPY; PHENOTYPE	Germinal centers (GCs) are complex dynamic structures that form within lymph nodes as an essential process in the humoral immune response. They represent a paradigm for studying the regulation of cell movement in the development of complex anatomical structures. We have developed a simulation of a modified cyclic re-entry model of GC dynamics which successfully employs chemotaxis to recapitulate the anatomy of the primary follicle and the development of a mature GC, including correctly structured mantle, dark and light zones. We then show that correct single cell movement dynamics (including persistent random walk and inter-zonal crossing) arise from this simulation as purely emergent properties. The major insight of our study is that chemotaxis can only achieve this when constrained by the known biological properties that cells are incompressible, exist in a densely packed environment, and must therefore compete for space. It is this interplay of chemotaxis and competition for limited space that generates all the complex and biologically accurate behaviors described here. Thus, from a single simple mechanism that is well documented in the biological literature, we can explain both higher level structure and single cell movement behaviors. To our knowledge this is the first GC model that is able to recapitulate both correctly detailed anatomy and single cell movement. This mechanism may have wide application for modeling other biological systems where cells undergo complex patterns of movement to produce defined anatomical structures with sharp tissue boundaries.	[Hawkins, Jared B.; Thorley-Lawson, David A.] Tufts Univ, Sch Med, Dept Pathol, Boston, MA 02111 USA; [Jones, Mark T.; Plassmann, Paul E.] Virginia Tech, Bradley Dept Elect & Comp Engn, Blacksburg, VA USA	Tufts University; Virginia Polytechnic Institute & State University	Hawkins, JB (corresponding author), Tufts Univ, Sch Med, Dept Pathol, Boston, MA 02111 USA.	david.thorley-lawson@tufts.edu		Hawkins, Jared/0000-0002-6352-1618	Public Health Service [R01 CA65883, R01 AI18757, RO1 AI062989]; National Science Foundation [CCF-0728901]; NATIONAL CANCER INSTITUTE [R01CA065883] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI062989, R01AI018757] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Public Health Service grants R01 CA65883, R01 AI18757 and RO1 AI062989 to DT-L and partially supported by National Science Foundation grant CCF-0728901 to MJ/PP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen CDC, 2004, NAT IMMUNOL, V5, P943, DOI 10.1038/ni1100; Allen CDC, 2008, SEMIN IMMUNOL, V20, P14, DOI 10.1016/j.smim.2007.12.001; Allen CDC, 2007, IMMUNITY, V27, P190, DOI 10.1016/j.immuni.2007.07.009; Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011; Beltman JB, 2007, J EXP MED, V204, P771, DOI 10.1084/jem.20061278; Beltman JB, 2009, NAT REV IMMUNOL, V9, P789, DOI 10.1038/nri2638; BEREK C, 1991, CELL, V67, P1121, DOI 10.1016/0092-8674(91)90289-B; Berg HC, 1983, RANDOM WALKS BIOL, P142; Camacho SA, 1998, IMMUNOL TODAY, V19, P511, DOI 10.1016/S0167-5699(98)01327-9; El Shikh ME, 2006, EUR J IMMUNOL, V36, P2715, DOI 10.1002/eji.200636122; Figge MT, 2008, J EXP MED, V205, P3019, DOI 10.1084/jem.20081160; GERISCH G, 1981, J CELL SCI, V52, P1; Germain RN, 2008, IMMUNOL REV, V221, P163, DOI 10.1111/j.1600-065X.2008.00591.x; Hauser AE, 2007, NAT REV IMMUNOL, V7, P499, DOI 10.1038/nri2120; Hauser AE, 2007, IMMUNITY, V26, P655, DOI 10.1016/j.immuni.2007.04.008; Haynes NM, 2007, J IMMUNOL, V179, P5099, DOI 10.4049/jimmunol.179.8.5099; JACOB J, 1991, NATURE, V354, P389, DOI 10.1038/354389a0; JACOB J, 1991, J EXP MED, V173, P1165, DOI 10.1084/jem.173.5.1165; Kay RR, 2008, NAT REV MOL CELL BIO, V9, P455, DOI 10.1038/nrm2419; KEPLER TB, 1993, IMMUNOL TODAY, V14, P412, DOI 10.1016/0167-5699(93)90145-B; LIU YJ, 1991, EUR J IMMUNOL, V21, P2951, DOI 10.1002/eji.1830211209; Luther SA, 2002, J IMMUNOL, V169, P424, DOI 10.4049/jimmunol.169.1.424; MACLENNAN ICM, 1990, CURR TOP MICROBIOL, V159, P37; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.iy.12.040194.001001; Mueller SN, 2009, NAT REV IMMUNOL, V9, P618, DOI 10.1038/nri2588; Okada T, 2005, PLOS BIOL, V3, P1047, DOI 10.1371/journal.pbio.0030150; Oprea M, 1997, J IMMUNOL, V158, P5155; Perry M, 1998, IMMUNOL TODAY, V19, P414, DOI 10.1016/S0167-5699(98)01307-3; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Reif K, 2002, NATURE, V416, P94, DOI 10.1038/416094a; Schwab SR, 2007, NAT IMMUNOL, V8, P1295, DOI 10.1038/ni1545; Schwickert TA, 2007, NATURE, V446, P83, DOI 10.1038/nature05573; Stachowiak AN, 2006, J IMMUNOL, V177, P2340, DOI 10.4049/jimmunol.177.4.2340; Sumen C, 2004, IMMUNITY, V21, P315, DOI 10.1016/S1074-7613(04)00237-7; Swaney KF, 2010, ANNU REV BIOPHYS, V39, P265, DOI 10.1146/annurev.biophys.093008.131228; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; Wang Y, 2005, IMMUNITY, V22, P749, DOI 10.1016/j.immuni.2005.04.012; ZIGMOND SH, 1978, J CELL BIOL, V77, P269, DOI 10.1083/jcb.77.2.269; ZIGMOND SH, 1981, J CELL BIOL, V89, P585, DOI 10.1083/jcb.89.3.585	40	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2011	6	12							e27650	10.1371/journal.pone.0027650	http://dx.doi.org/10.1371/journal.pone.0027650			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MQ	22145018	Green Published, gold, Green Submitted			2022-12-27	WOS:000298168900001
J	Peletskaya, E; Andrake, M; Gustchina, A; Merkel, G; Alexandratos, J; Zhou, DW; Bojja, RS; Satoh, T; Potapov, M; Kogon, A; Potapov, V; Wlodawer, A; Skalka, AM				Peletskaya, Elena; Andrake, Mark; Gustchina, Alla; Merkel, George; Alexandratos, Jerry; Zhou, Dongwen; Bojja, Ravi S.; Satoh, Tadashi; Potapov, Mikhail; Kogon, Alex; Potapov, Viktor; Wlodawer, Alexander; Skalka, Anna Marie			Localization of ASV Integrase-DNA Contacts by Site-Directed Crosslinking and their Structural Analysis	PLOS ONE			English	Article							SARCOMA-VIRUS INTEGRASE; TYPE-1 REVERSE-TRANSCRIPTASE; HIV-1 INTEGRASE; VIRAL-DNA; RETROVIRAL INTEGRATION; FINGERS SUBDOMAIN; CRYSTAL-STRUCTURE; TERMINAL DOMAINS; BINDING; PROTEIN	Background: We applied crosslinking techniques as a first step in preparation of stable avian sarcoma virus (ASV) integrase (IN)-DNA complexes for crystallographic investigations. These results were then compared with the crystal structures of the prototype foamy virus (PFV) intasome and with published data for other retroviral IN proteins. Methodology/Results: Photoaffinity crosslinking and site-directed chemical crosslinking were used to localize the sites of contacts with DNA substrates on the surface of ASV IN. Sulfhydryl groups of cysteines engineered into ASV IN and amino-modified nucleotides in DNA substrates were used for attachment of photocrosslinkers. Analysis of photocrosslinking data revealed several specific DNA-protein contacts. To confirm contact sites, thiol-modified nucleotides were introduced into oligo-DNA substrates at suggested points of contact and chemically crosslinked to the cysteines via formation of disulfide bridges. Cysteines incorporated in positions 124 and 146 in the ASV IN core domain were shown to interact directly with host and viral portions of the Y-mer DNA substrate, respectively. Crosslinking of an R244C ASV IN derivative identified contacts at positions 11 and 12 on both strands of viral DNA. The most efficient disulfide crosslinking was observed for complexes of the ASV IN E157C and D64C derivatives with linear viral DNA substrate carrying a thiol-modified scissile phosphate. Conclusion: Analysis of our crosslinking results as well as published results of retroviral IN protein from other laboratories shows good agreement with the structure of PFV IN and derived ASV, HIV, and MuLV models for the core domain, but only partial agreement for the N- and C-terminal domains. These differences might be explained by structural variations and evolutionary selection for residues at alternate positions to perform analogous functions, and by methodological differences: i.e., a static picture of a particular assembly from crystallography vs. a variety of interactions that might occur during formation of functional IN complexes in solution.	[Peletskaya, Elena; Kogon, Alex] Biolinx LLC, Alburgh, VT USA; [Andrake, Mark; Merkel, George; Bojja, Ravi S.; Skalka, Anna Marie] Fox Chase Canc Ctr, Inst Canc Res, Philadelphia, PA 19111 USA; [Gustchina, Alla; Alexandratos, Jerry; Zhou, Dongwen; Satoh, Tadashi; Wlodawer, Alexander] NCI, Macromol Crystallog Lab, Ctr Canc Res, NIH, Frederick, MD 21701 USA; [Potapov, Mikhail; Potapov, Viktor] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow, Russia	Fox Chase Cancer Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences	Peletskaya, E (corresponding author), Biolinx LLC, Alburgh, VT USA.	wlodawer@nih.gov	Zhou, Dongwen/O-1889-2019; Satoh, Tadashi/M-5157-2017	Satoh, Tadashi/0000-0002-4493-4978	National Institutes of Health (NIH) [AI064098, AI40385, CA71515, CA06927]; Civilian Research and Development Foundation [RUXO-2713-MO-06]; Commonwealth of Pennsylvania; NIH, National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010348, R01CA071515, P30CA006927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040385, R21AI064098] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Civilian Research and Development Foundation; Commonwealth of Pennsylvania; NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the National Institutes of Health (NIH) grants AI064098 (EP), AI40385, CA71515, CA06927 (AS), by the Civilian Research and Development Foundation grant RUXO-2713-MO-06 (VP and AK), by an appropriation from the Commonwealth of Pennsylvania, and by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Al-Mawsawi LQ, 2011, CHEMMEDCHEM, V6, P228, DOI 10.1002/cmdc.201000443; Alian A, 2009, P NATL ACAD SCI USA, V106, P8192, DOI 10.1073/pnas.0811919106; Asante-Appiah E, 1998, J BIOL CHEM, V273, P35078, DOI 10.1074/jbc.273.52.35078; AsanteAppiah E, 1997, J BIOL CHEM, V272, P16196, DOI 10.1074/jbc.272.26.16196; Bojja RS, 2011, J BIOL CHEM, V286, P17047, DOI 10.1074/jbc.M110.212571; Chen AP, 2006, J BIOL CHEM, V281, P4173, DOI 10.1074/jbc.M510628200; Chen JCH, 2000, P NATL ACAD SCI USA, V97, P8233, DOI 10.1073/pnas.150220297; Chen ZG, 2000, J MOL BIOL, V296, P521, DOI 10.1006/jmbi.1999.3451; Davies DR, 2000, SCIENCE, V289, P77, DOI 10.1126/science.289.5476.77; Dirac AMG, 2001, EUR J BIOCHEM, V268, P743, DOI 10.1046/j.1432-1327.2001.01932.x; Dolan J, 2009, J MOL BIOL, V385, P568, DOI 10.1016/j.jmb.2008.10.083; ELLISON V, 1994, P NATL ACAD SCI USA, V91, P7316, DOI 10.1073/pnas.91.15.7316; ERLANSON DA, 1993, J AM CHEM SOC, V115, P12583, DOI 10.1021/ja00079a047; Esposito D, 1998, EMBO J, V17, P5832, DOI 10.1093/emboj/17.19.5832; Gao K, 2001, EMBO J, V20, P3565, DOI 10.1093/emboj/20.13.3565; Hare S, 2010, NATURE, V464, P232, DOI 10.1038/nature08784; Harper AL, 2001, J VIROL, V75, P7756, DOI 10.1128/JVI.75.16.7756-7762.2001; Heuer TS, 1998, BIOCHEMISTRY-US, V37, P6667, DOI 10.1021/bi972949c; Heuer TS, 1997, BIOCHEMISTRY-US, V36, P10655, DOI 10.1021/bi970782h; Hobaika Z, 2009, NUCLEIC ACIDS RES, V37, P7691, DOI 10.1093/nar/gkp824; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; Jaskolski M, 2009, FEBS J, V276, P2926, DOI 10.1111/j.1742-4658.2009.07009.x; Jenkins TM, 1996, J BIOL CHEM, V271, P7712, DOI 10.1074/jbc.271.13.7712; Jenkins TM, 1997, EMBO J, V16, P6849, DOI 10.1093/emboj/16.22.6849; Johnson AA, 2006, J BIOL CHEM, V281, P461, DOI 10.1074/jbc.M511348200; Katz RA, 2001, J BIOL CHEM, V276, P34213, DOI 10.1074/jbc.M104632200; Katz RA, 2011, J BIOL CHEM IN PRESS; Krishnan L, 2010, P NATL ACAD SCI USA, V107, P15910, DOI 10.1073/pnas.1002346107; Kulinski J, 2000, BIOTECHNIQUES, V29, P44, DOI 10.2144/00291bm07; Lubkowski J, 1999, BIOCHEMISTRY-US, V38, P13512, DOI 10.1021/bi991362q; Lubkowski J, 1998, J BIOL CHEM, V273, P32685, DOI 10.1074/jbc.273.49.32685; Lutzke RAP, 1998, J VIROL, V72, P4841, DOI 10.1128/JVI.72.6.4841-4848.1998; LUTZKE RAP, 1994, NUCLEIC ACIDS RES, V22, P4125, DOI 10.1093/nar/22.20.4125; Maertens GN, 2010, NATURE, V468, P326, DOI 10.1038/nature09517; Mazumder A, 1997, MOL PHARMACOL, V51, P567, DOI 10.1124/mol.51.4.567; Merkel G, 2009, METHODS, V47, P243, DOI 10.1016/j.ymeth.2008.10.024; Michel F, 2009, EMBO J, V28, P980, DOI 10.1038/emboj.2009.41; Miller MD, 1997, J VIROL, V71, P5382, DOI 10.1128/JVI.71.7.5382-5390.1997; MORELAND RB, 1982, ANAL BIOCHEM, V121, P321, DOI 10.1016/0003-2697(82)90487-0; Nowal MG, 2009, VIROLOGY, V389, P141, DOI 10.1016/j.virol.2009.04.014; Oleykowski CA, 1998, NUCLEIC ACIDS RES, V26, P4597, DOI 10.1093/nar/26.20.4597; Oleykowski CA, 1999, BIOCHEMISTRY-US, V38, P2200, DOI 10.1021/bi982318y; Peletskaya EN, 2004, J VIROL, V78, P3387, DOI 10.1128/JVI.78.7.3387-3397.2004; Peletskaya EN, 2001, J VIROL, V75, P9435, DOI 10.1128/JVI.75.19.9435-9445.2001; Pommier Y, 1997, ANTIVIR CHEM CHEMOTH, V8, P463, DOI 10.1177/095632029700800601; Powderly WG, 2010, J ANTIMICROB CHEMOTH, V65, P2485, DOI 10.1093/jac/dkq350; Prada N, 2010, EXPERT OPIN INV DRUG, V19, P1087, DOI 10.1517/13543784.2010.501078; Renisio JG, 2005, NUCLEIC ACIDS RES, V33, P1970, DOI 10.1093/nar/gki346; RICE P, 1995, CELL, V82, P209, DOI 10.1016/0092-8674(95)90308-9; Scottoline BP, 1997, GENE DEV, V11, P371, DOI 10.1101/gad.11.3.371; Vera J, 2008, BIOL RES, V41, P69, DOI [10.4067/S0716-97602008000100009, /S0716-97602008000100009]; Wang JY, 2001, EMBO J, V20, P7333, DOI 10.1093/emboj/20.24.7333; Yang B, 2000, BIOCHEMISTRY-US, V39, P3533, DOI 10.1021/bi992376z; Yang ZN, 2000, J MOL BIOL, V296, P535, DOI 10.1006/jmbi.1999.3463; Zhao Z, 2008, J BIOL CHEM, V283, P5632, DOI 10.1074/jbc.M705241200	55	7	7	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2011	6	12							e27751	10.1371/journal.pone.0027751	http://dx.doi.org/10.1371/journal.pone.0027751			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MQ	22145019	Green Submitted, gold, Green Published			2022-12-27	WOS:000298168900002
J	Wojtovich, AP; Sherman, TA; Nadtochiy, SM; Urciuoli, WR; Brookes, PS; Nehrke, K				Wojtovich, Andrew P.; Sherman, Teresa A.; Nadtochiy, Sergiy M.; Urciuoli, William R.; Brookes, Paul S.; Nehrke, Keith			SLO-2 Is Cytoprotective and Contributes to Mitochondrial Potassium Transport	PLOS ONE			English	Article							K-ATP CHANNEL; VOLATILE ANESTHETICS; LARGE-CONDUCTANCE; NEUROTRANSMITTER RELEASE; BK CHANNELS; SODIUM; PROTEIN; SLACK; INHIBITION; ACTIVATION	Mitochondrial potassium channels are important mediators of cell protection against stress. The mitochondrial large-conductance "big" K+ channel (mBK) mediates the evolutionarily-conserved process of anesthetic preconditioning (APC), wherein exposure to volatile anesthetics initiates protection against ischemic injury. Despite the role of the mBK in cardioprotection, the molecular identity of the channel remains unknown. We investigated the attributes of the mBK using C. elegans and mouse genetic models coupled with measurements of mitochondrial K+ transport and APC. The canonical Ca2+-activated BK (or "maxi-K") channel SLO1 was dispensable for both mitochondrial K+ transport and APC in both organisms. Instead, we found that the related but physiologically-distinct K+ channel SLO2 was required, and that SLO2-dependent mitochondrial K+ transport was triggered directly by volatile anesthetics. In addition, a SLO2 channel activator mimicked the protective effects of volatile anesthetics. These findings suggest that SLO2 contributes to protection from hypoxic injury by increasing the permeability of the mitochondrial inner membrane to K+.	[Wojtovich, Andrew P.; Sherman, Teresa A.; Nehrke, Keith] Univ Rochester, Med Ctr, Dept Med, Rochester, NY 14642 USA; [Nadtochiy, Sergiy M.; Urciuoli, William R.; Brookes, Paul S.] Univ Rochester, Med Ctr, Dept Anesthesiol, Rochester, NY 14642 USA; [Brookes, Paul S.; Nehrke, Keith] Univ Rochester, Med Ctr, Dept Physiol & Pharmacol, Rochester, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester	Wojtovich, AP (corresponding author), Univ Rochester, Med Ctr, Dept Med, Rochester, NY 14642 USA.	Keith_Nehrke@urmc.rochester.edu		Wojtovich, Andrew/0000-0002-7725-5349; Nehrke, Keith/0000-0001-9697-726X; Brookes, Paul/0000-0002-8639-8413	American Heart Association [11POST7290028]; US National Institutes of Health [HL071158, GM087483]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071158] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087483] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by an American Heart Association, Founder Affiliate Postdoctoral Fellowship award 11POST7290028 (to APW), and by US National Institutes of Health grants HL071158 (to PSB), GM087483 (to PSB & KWN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bargmann CI, 1998, SCIENCE, V282, P2028, DOI 10.1126/science.282.5396.2028; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Bhattacharjee A, 2005, TRENDS NEUROSCI, V28, P422, DOI 10.1016/j.tins.2005.06.003; Bhattacharjee A, 2003, J NEUROSCI, V23, P11681; Cancherini DV, 2007, CARDIOVASC RES, V73, P720, DOI 10.1016/j.cardiores.2006.11.035; Chen HJ, 2009, J NEUROSCI, V29, P5654, DOI 10.1523/JNEUROSCI.5978-08.2009; Cohen MV, 2007, CIRCULATION, V115, P1895, DOI 10.1161/CIRCULATIONAHA.106.675710; Costa ADT, 2009, J BIOENERG BIOMEMBR, V41, P123, DOI 10.1007/s10863-009-9213-y; De Hert SG, 2005, ANESTH ANALG, V100, P1584, DOI 10.1213/01.ANE.0000153483.61170.0C; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; Facundo HTF, 2006, BBA-MOL BASIS DIS, V1762, P202, DOI 10.1016/j.bbadis.2005.06.003; Garlid KD, 2001, IUBMB LIFE, V52, P153, DOI 10.1080/15216540152845948; Hausenloy DJ, 2007, BASIC RES CARDIOL, V102, P445, DOI 10.1007/s00395-007-0656-1; Hawasli AH, 2004, GENETICS, V168, P831, DOI 10.1534/genetics.104.030502; Imlach WL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008698; Jaburek M, 1998, J BIOL CHEM, V273, P13578; Jia BS, 2008, ANESTHESIOLOGY, V108, P426, DOI 10.1097/ALN.0b013e318164d013; Joiner WJ, 1998, NAT NEUROSCI, V1, P462, DOI 10.1038/2176; Lamberts RR, 2009, CIRCULATION, V120, pS10, DOI 10.1161/CIRCULATIONAHA.108.828426; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Luo Hai-lan, 2008, ACTA BOTANICA BOREALI-OCCIDENTALIA SINICA, V28, P28; Meera P, 2000, P NATL ACAD SCI USA, V97, P5562, DOI 10.1073/pnas.100118597; Meredith AL, 2004, J BIOL CHEM, V279, P36746, DOI 10.1074/jbc.M405621200; Murphy E, 2009, CIRC RES, V104, P292, DOI 10.1161/CIRCRESAHA.108.189050; Nadtochiy SM, 2011, CARDIOVASC RES, V89, P643, DOI 10.1093/cvr/cvq287; Nadtochiy SM, 2009, J MOL CELL CARDIOL, V46, P960, DOI 10.1016/j.yjmcc.2009.01.012; O'Rourke B, 2004, CIRC RES, V94, P420, DOI 10.1161/01.RES.0000117583.66950.43; Perocchi F, 2010, NATURE, V467, P291, DOI 10.1038/nature09358; PIKE MM, 1990, AM J PHYSIOL, V259, pH1767, DOI 10.1152/ajpheart.1990.259.6.H1767; Redel A, 2008, ANESTH ANALG, V106, P384, DOI 10.1213/ane.0b013e318160650f; Riess ML, 2004, AM J PHYSIOL-HEART C, V286, pH1603, DOI 10.1152/ajpheart.00963.2003; Ruffin VA, 2008, NEUROSCIENCE, V151, P410, DOI 10.1016/j.neuroscience.2007.10.031; Salkoff L, 2006, NAT REV NEUROSCI, V7, P921, DOI 10.1038/nrn1992; Schreiber M, 1998, J BIOL CHEM, V273, P3509, DOI 10.1074/jbc.273.6.3509; Siemen D, 1999, BIOCHEM BIOPH RES CO, V257, P549, DOI 10.1006/bbrc.1999.0496; Wang ZW, 2001, NEURON, V32, P867, DOI 10.1016/S0896-6273(01)00522-0; Weaver CD, 2004, J BIOMOL SCREEN, V9, P671, DOI 10.1177/1087057104268749; Wojtovich AP, 2008, BIOCHEM BIOPH RES CO, V376, P625, DOI 10.1016/j.bbrc.2008.09.043; Wojtovich AP, 2010, ACTA BIOCHIM POL, V57, P431; Wojtovich AP, 2010, CIRC RES, V106, P1190, DOI 10.1161/CIRCRESAHA.109.215400; Wojtovich AP, 2009, BASIC RES CARDIOL, V104, P121, DOI 10.1007/s00395-009-0001-y; Xu WH, 2002, SCIENCE, V298, P1029, DOI 10.1126/science.1074360; Yang B, 2007, J NEUROSCI, V27, P2617, DOI 10.1523/JNEUROSCI.5308-06.2007; Yang B, 2006, NEUROPHARMACOLOGY, V51, P896, DOI 10.1016/j.neuropharm.2006.06.003; Yuan A, 2003, NEURON, V37, P765, DOI 10.1016/S0896-6273(03)00096-5; Yuan A, 2000, NAT NEUROSCI, V3, P771, DOI 10.1038/77670; Zhou XB, 2010, P NATL ACAD SCI USA, V107, P8005, DOI 10.1073/pnas.0912029107; Zhou Y, 2010, J GEN PHYSIOL, V135, P481, DOI 10.1085/jgp.201010403	48	56	56	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2011	6	12							e28287	10.1371/journal.pone.0028287	http://dx.doi.org/10.1371/journal.pone.0028287			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MQ	22145034	Green Submitted, Green Published, gold			2022-12-27	WOS:000298168900017
J	Albrecht, N; Jatzwauk, L; Slickers, P; Ehricht, R; Monecke, S				Albrecht, Nicole; Jatzwauk, Lutz; Slickers, Peter; Ehricht, Ralf; Monecke, Stefan			Clonal Replacement of Epidemic Methicillin-Resistant Staphylococcus aureus Strains in a German University Hospital over a Period of Eleven Years	PLOS ONE			English	Article							CASSETTE CHROMOSOME MEC; PANTON-VALENTINE LEUCOCIDIN; CATABOLIC MOBILE ELEMENT; ANTIBIOTIC-RESISTANCE; LEUKOCIDIN GENES; FITNESS COST; RISK-FACTORS; MRSA; SURVEILLANCE; INFECTIONS	Worldwide, methicillin-resistant Staphylococcus aureus (MRSA) pose an increased risk for healthcare- and community-associated infections. Since the first report of MRSA in England in 1961, several distinct clones or strains have emerged. Changes within the MRSA population of whole countries, small regions or of single hospitals have been observed with some clones replacing others. In this study, the clonal replacement of MRSA isolates in a South-eastern German tertiary care hospital between 2000 and 2010 is described based on microarray analyses of 778 isolates and at least 50 MRSA per year. Within these eleven years, four common epidemic strains, CC22-MRSA-IV, CC45-MRSA-IV, CC5/ST228-MRSA-I (including a variant with a truncated SCCmec element) and CC5-MRSA-II were identified. The PVL-negative CC22-MRSA-IV strain (Barnim Epidemic Strain, UK-EMRSA-15) was detected for the first time in 2001 and its abundance increased since then to 58.6% in 2010. CC5-MRSA-II increased from 2% (2000) to about 30% (2003), and since then it fluctuates between 23 and 37% of isolates. CC5/ST228-MRSA-I decreased from about the half of tested isolates (2000) to 2.3% (2010). A similar trend was observed for CC45-MRSA-IV, which decreased drastically down to 3.4% in 2010 after reaching a maximum of 62.0% in 2002. Seventeen other PVL-negative MRSA strains were identified sporadically with no significant trend being observed. Seven PVL-positive MRSA strains were found, but they remained rare during the study period accounting together for 2.7% of isolates.	[Albrecht, Nicole; Monecke, Stefan] Tech Univ Dresden, Inst Med Microbiol & Hyg, D-01062 Dresden, Germany; [Albrecht, Nicole] Univ Appl Sci, Hsch Lausitz FH, Senftenberg, Germany; [Jatzwauk, Lutz] Dresden Univ Hosp, Dept Hosp Infect Control, Dresden, Germany; [Slickers, Peter; Ehricht, Ralf; Monecke, Stefan] Alere Technol GmbH, Jena, Germany	Technische Universitat Dresden; Brandenburg University of Technology Cottbus; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Alere	Albrecht, N (corresponding author), Tech Univ Dresden, Inst Med Microbiol & Hyg, D-01062 Dresden, Germany.	monecke@rocketmail.com						Adler A, 2010, J CLIN MICROBIOL, V48, P531, DOI 10.1128/JCM.02290-08; Aires-De-Sousa M, 2008, J CLIN MICROBIOL, V46, P2912, DOI 10.1128/JCM.00692-08; Amorim ML, 2007, J CLIN MICROBIOL, V45, P2881, DOI 10.1128/JCM.00603-07; Amorim ML, 2002, MICROB DRUG RESIST, V8, P301, DOI 10.1089/10766290260469561; Barbier F, 2011, J ANTIMICROB CHEMOTH, V66, P29, DOI 10.1093/jac/dkq410; Bekkhoucha SN, 2009, EUR J CLIN MICROBIOL, V28, P553, DOI 10.1007/s10096-008-0660-x; Ben Nejma M, 2008, DIAGN MICROBIOL INFE; Campanile F, 2009, ANN CLIN MICROB ANTI, V8, DOI 10.1186/1476-0711-8-22; Conceicao T, 2007, CLIN MICROBIOL INFEC, V13, P971, DOI 10.1111/j.1469-0691.2007.01794.x; Conceicao T, 2010, EUR J CLIN MICROBIOL, V29, P543, DOI 10.1007/s10096-010-0892-4; Coombs GW, 2006, EMERG INFECT DIS, V12, P241; Cuevas O, 2007, CLIN MICROBIOL INFEC, V13, P250, DOI 10.1111/j.1469-0691.2006.01672.x; Cuny C, 2006, Euro Surveill, V11, P44; D'Souza N, 2010, J CLIN MICROBIOL, V48, P1806, DOI 10.1128/JCM.01867-09; Deurenberg RH, 2009, EMERG INFECT DIS, V15, P727, DOI 10.3201/eid1505.071618; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Diep BA, 2008, TRENDS MICROBIOL, V16, P361, DOI 10.1016/j.tim.2008.05.002; Ellington MJ, 2010, J ANTIMICROB CHEMOTH, V65, P446, DOI 10.1093/jac/dkp448; Ellington MJ, 2010, J ANTIMICROB CHEMOTH, V65, P46, DOI 10.1093/jac/dkp386; Enany S, 2010, MICROBIOL RES, V165, P152, DOI 10.1016/j.micres.2009.03.005; Ender M, 2004, ANTIMICROB AGENTS CH, V48, P2295, DOI 10.1128/AAC.48.6.2295-2297.2004; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Grundmann H, 2002, J INFECT DIS, V185, P481, DOI 10.1086/338568; HARTMAN B, 1981, ANTIMICROB AGENTS CH, V19, P726, DOI 10.1128/AAC.19.5.726; Hiramatsu K, 2001, TRENDS MICROBIOL, V9, P486, DOI 10.1016/S0966-842X(01)02175-8; Huggan PJ, 2010, INTERN MED J, V40, P117, DOI 10.1111/j.1445-5994.2009.01910.x; Huijsdens Xander W, 2006, Ann Clin Microbiol Antimicrob, V5, P26, DOI 10.1186/1476-0711-5-26; HUMPHREYS H, 1990, J HOSP INFECT, V15, P127, DOI 10.1016/0195-6701(90)90121-4; Ito T, 2003, DRUG RESIST UPDATE, V6, P41, DOI 10.1016/S1368-7646(03)00003-7; Ito T, 2004, ANTIMICROB AGENTS CH, V48, P2637, DOI 10.1128/AAC.48.7.2637-2651.2004; Ito T, 2001, ANTIMICROB AGENTS CH, V45, P1323, DOI 10.1128/AAC.45.5.1323-1336.2001; Ito T, 2009, ANTIMICROB AGENTS CH, V53, P4961, DOI 10.1128/AAC.00579-09; JEVONS MP, 1961, BRIT MED J, V1, P124, DOI 10.1136/bmj.1.5219.124-a; Kupfer M, 2009, EPIDEMIOLOGISCHE UNT; Kupfer M, 2010, GMS HYG INFECT CONTR, V5, DOI 10.3205/dgkh000154; Lee SM, 2007, ANTIMICROB AGENTS CH, V51, P1497, DOI 10.1128/AAC.01239-06; Linde H, 2005, EUR J CLIN MICROBIOL, V24, P419, DOI 10.1007/s10096-005-1341-7; Ma XX, 2006, J CLIN MICROBIOL, V44, P4515, DOI 10.1128/JCM.00985-06; Maier J, 2005, EUR J CLIN MICROBIOL, V24, P637, DOI 10.1007/s10096-005-0008-8; Melter O, 1999, J CLIN MICROBIOL, V37, P2798, DOI 10.1128/JCM.37.9.2798-2803.1999; Melter O, 2003, J CLIN MICROBIOL, V41, P4998, DOI 10.1128/JCM.41.11.4998-5005.2003; Miragaia M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007722; Monecke S, 2008, CLIN MICROBIOL INFEC, V14, P534, DOI 10.1111/j.1469-0691.2008.01986.x; Monecke S, 2006, CLIN MICROBIOL INFEC, V12, P718, DOI 10.1111/j.1469-0691.2006.01420.x; Monecke S, 2008, FEMS IMMUNOL MED MIC, V53, P237, DOI 10.1111/j.1574-695X.2008.00426.x; Monecke S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017936; Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356; Otter JA, 2009, EUR J CLIN MICROBIOL, V28, P835, DOI 10.1007/s10096-008-0698-9; Panton PN, 1932, LANCET, V1, P506; Rossney AS, 2006, EUR J CLIN MICROBIOL, V25, P79, DOI 10.1007/s10096-006-0091-5; Scicluna EA, 2010, EUR J CLIN MICROBIOL, V29, P163, DOI 10.1007/s10096-009-0834-1; Shore A, 2005, ANTIMICROB AGENTS CH, V49, P2070, DOI 10.1128/AAC.49.5.2070-2083.2005; Shore AC, 2010, J CLIN MICROBIOL, V48, P1839, DOI 10.1128/JCM.02155-09; Smyth DS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008582; Tavares DA, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-110; Tenover FC, 2006, J CLIN MICROBIOL, V44, P108, DOI 10.1128/JCM.44.1.108-118.2006; Tenover FC, 2008, J CLIN MICROBIOL, V46, P2837, DOI 10.1128/JCM.00480-08; Tokajian ST, 2010, EPIDEMIOL INFECT, V138, P707, DOI 10.1017/S0950268810000440; Tristan A, 2007, EMERG INFECT DIS, V13, P594, DOI 10.3201/eid1304.061316; Udo EE, 2008, J CLIN MICROBIOL, V46, P3514, DOI 10.1128/JCM.00966-08; van Loo I, 2007, EMERG INFECT DIS, V13, P1834, DOI 10.3201/eid1312.070384; Vandenesch F, 2003, EMERG INFECT DIS, V9, P978; VANDEVELDE H, 1894, CELLULE, V10, P401; Velazquez-Meza ME, 2004, J CLIN MICROBIOL, V42, P3877, DOI 10.1128/JCM.42.8.3877-3880.2004; Voss A, 2005, EMERG INFECT DIS, V11, P1965, DOI 10.3201/eid1112.050428; Vourli S, 2005, Euro Surveill, V10, P78; Walther B, 2009, J CLIN MICROBIOL, V47, P704, DOI 10.1128/JCM.01626-08; Witte W, 2000, Euro Surveill, V5, P31; Witte W, 2001, INT J MED MICROBIOL, V290, P677, DOI 10.1016/S1438-4221(01)80006-0; Witte W, 1997, Euro Surveill, V2, P25; WITTE W, 2000, BUNDESGESUNDHEITSBLA, V43, P633; Witte W, 2005, EPIDEMIOLOGISCHES B, P376	72	42	45	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e28189	10.1371/journal.pone.0028189	http://dx.doi.org/10.1371/journal.pone.0028189			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140542	Green Published, gold, Green Submitted			2022-12-27	WOS:000298168100048
J	Geisel, N				Geisel, Nico			Constitutive versus Responsive Gene Expression Strategies for Growth in Changing Environments	PLOS ONE			English	Article							BACTERIAL PERSISTENCE; NETWORK DYNAMICS; LAC OPERON; NOISE; EVOLUTION; REVEALS; SYSTEM; DIFFERENTIATION; HETEROGENEITY; CONSEQUENCES	Microbes respond to changing environments by adjusting gene expression levels to the demand for the corresponding proteins. Adjusting protein levels is slow, consequently cells may reach the optimal protein level only by a time when the demand changed again. It is therefore not a priori clear whether expression "on demand'' is always the optimal strategy. Indeed, many genes are constitutively expressed at intermediate levels, which represents a permanent cost but provides an immediate benefit when the protein is needed. Which are the conditions that select for a responsive or a constitutive expression strategy, what determines the optimal constitutive expression level in a changing environment, and how is the fitness of the two strategies affected by gene expression noise? Based on an established model of the lac-and gal-operon expression dynamics, we study the fitness of a constitutive and a responsive expression strategy in time-varying environments. We find that the optimal constitutive expression level differs from the average demand for the gene product and from the average optimal expression level; depending on the shape of the growth rate function, the optimal expression level either provides intermediate fitness in all environments, or maximizes fitness in only one of them. We find that constitutive expression can provide higher fitness than responsive expression even when regulatory machinery comes at no cost, and we determine the minimal response rate necessary for "expression on demand'' to confer a benefit. Environmental and inter-cellular noise favor the responsive strategy while reducing fitness of the constitutive one. Our results show the interplay between the demand-frequency for a gene product, the genetic response rate, and the fitness, and address important questions on the evolution of gene regulation. Some of our predictions agree with recent yeast high throughput data, for others we propose the experiments that are needed to verify them.	Univ Barcelona, Fac Fis, Dept Fis Fonamental, E-08028 Barcelona, Spain	University of Barcelona	Geisel, N (corresponding author), Univ Barcelona, Fac Fis, Dept Fis Fonamental, E-08028 Barcelona, Spain.	Nico.Geisel@ffn.ub.es			Spanish Ministry of Science and Innovation [FIS2008-04386]; Spanish Ministry of Education [FPU2007-00975]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Ministry of Education(Spanish Government)	This work was supported by the Spanish Ministry of Science and Innovation grant no. FIS2008-04386, and the Spanish Ministry of Education grant no. FPU2007-00975. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acar M, 2008, NAT GENET, V40, P471, DOI 10.1038/ng.110; Alby K, 2009, MOL BIOL CELL, V20, P3178, DOI 10.1091/mbc.E09-01-0040; Alon U, 2007, INTRO SYSTEMS BIOL, P1; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Bar-Even A, 2006, NAT GENET, V38, P636, DOI 10.1038/ng1807; Bennett MR, 2008, NATURE, V454, P1119, DOI 10.1038/nature07211; Bennett MR, 2009, NAT REV GENET, V10, P628, DOI 10.1038/nrg2625; Blaauw M, 2000, GENE, V252, P71, DOI 10.1016/S0378-1119(00)00227-4; Blake WJ, 2006, MOL CELL, V24, P853, DOI 10.1016/j.molcel.2006.11.003; Cagatay T, 2009, CELL, V139, P512, DOI 10.1016/j.cell.2009.07.046; Cai L, 2006, NATURE, V440, P358, DOI 10.1038/nature04599; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; Dekel E, 2005, NATURE, V436, P588, DOI 10.1038/nature03842; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Fraser HB, 2004, PLOS BIOL, V2, P834, DOI 10.1371/journal.pbio.0020137; Fritz G, 2009, J MOL BIOL, V393, P272, DOI 10.1016/j.jmb.2009.08.037; Gaal B, 2010, GENETICS, V184, P1113, DOI 10.1534/genetics.109.113431; Gefen O, 2008, P NATL ACAD SCI USA, V105, P6145, DOI 10.1073/pnas.0711712105; Gefen O, 2009, FEMS MICROBIOL REV, V33, P704, DOI 10.1111/j.1574-6976.2008.00156.x; Geisel N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018622; Ghosh S, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-18; Kalisky T, 2007, PHYS BIOL, V4, P229, DOI 10.1088/1478-3975/4/4/001; Khlebnikov A, 2000, J BACTERIOL, V182, P7029, DOI 10.1128/JB.182.24.7029-7034.2000; KJELLEBERG S, 1993, ANTON LEEUW INT J G, V63, P333, DOI 10.1007/BF00871228; KOCH AL, 1983, J MOL EVOL, V19, P455, DOI 10.1007/BF02102321; Kussell E, 2005, GENETICS, V169, P1807, DOI 10.1534/genetics.104.035352; Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383; Lachmann M, 1996, J THEOR BIOL, V181, P1, DOI 10.1006/jtbi.1996.0109; Lang GI, 2009, P NATL ACAD SCI USA, V106, P5755, DOI 10.1073/pnas.0901620106; Lehner B, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.11; Levin-Reisman I, 2010, NAT METHODS, V7, P737, DOI 10.1038/nmeth.1485; Lopez-Maury L, 2008, NAT REV GENET, V9, P583, DOI 10.1038/nrg2398; Mangan S, 2006, J MOL BIOL, V356, P1073, DOI 10.1016/j.jmb.2005.12.003; Megerle JA, 2008, BIOPHYS J, V95, P2103, DOI 10.1529/biophysj.107.127191; Mitchell A, 2011, P NATL ACAD SCI US, P11; Mitchell A, 2009, NATURE, V460, P220, DOI 10.1038/nature08112; Morgan-Kiss RM, 2002, P NATL ACAD SCI USA, V99, P7373, DOI 10.1073/pnas.122227599; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; NORDSTROM K, 1974, ANTIMICROB AGENTS CH, V6, P734, DOI 10.1128/AAC.6.6.734; NYSTROM T, 1990, FEMS MICROBIOL ECOL, V74, P129, DOI 10.1111/j.1574-6968.1990.tb04059.x; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Polz MF, 2006, PHILOS T R SOC B, V361, P2009, DOI 10.1098/rstb.2006.1928; Ptashne M, 2001, GENES SIGNALS; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Rosenfeld N, 2003, J MOL BIOL, V329, P645, DOI 10.1016/S0022-2836(03)00506-0; Rotem E, 2010, P NATL ACAD SCI USA, V107, P12541, DOI 10.1073/pnas.1004333107; Salathe M, 2009, GENETICS, V182, P1159, DOI 10.1534/genetics.109.103333; SAVAGEAU MA, 1977, P NATL ACAD SCI USA, V74, P5647, DOI 10.1073/pnas.74.12.5647; Tanase-Nicola S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000125; Thattai M, 2004, GENETICS, V167, P523, DOI 10.1534/genetics.167.1.523; Vilar JMG, 2003, J CELL BIOL, V161, P471, DOI 10.1083/jcb.200301125; Wang Z, 2011, P NATL ACAD SCI USA, V108, pE67, DOI 10.1073/pnas.1100059108; Wolf Denise M., 2002, OMICS A Journal of Integrative Biology, V6, P91, DOI 10.1089/15362310252780852; Yu J, 2006, SCIENCE, V311, P1600, DOI 10.1126/science.1119623; Zhang XS, 2005, EVOLUTION, V59, P1237	55	24	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e27033	10.1371/journal.pone.0027033	http://dx.doi.org/10.1371/journal.pone.0027033			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140435	Green Published, Green Submitted, gold			2022-12-27	WOS:000298168100007
J	Jiang, YS; Zhang, RJ; Sun, P; Tang, GP; Zhang, XH; Wang, X; Guo, XD; Wang, QY; Li, X				Jiang, Yongshuai; Zhang, Ruijie; Sun, Peng; Tang, Guoping; Zhang, Xuehong; Wang, Xing; Guo, Xiaodan; Wang, Qiuyu; Li, Xia			Identifying Highly Conserved and Highly Differentiated Gene Ontology Categories in Human Populations	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; GENOME-WIDE ASSOCIATION; LINKAGE DISEQUILIBRIUM; DEMOGRAPHIC HISTORY; TAGSNP TRANSFERABILITY; SIGNAL-TRANSDUCTION; KYOTO ENCYCLOPEDIA; HAPLOTYPE; SELECTION; RECOMBINATION	Detecting and interpreting certain system-level characteristics associated with human population genetic differences is a challenge for human geneticists. In this study, we conducted a population genetic study using the HapMap genotype data to identify certain special Gene Ontology (GO) categories associated with high/low genetic difference among 11 Hapmap populations. Initially, the genetic differences in each gene region among these populations were measured using allele frequency, linkage disequilibrium (LD) pattern, and transferability of tagSNPs. The associations between each GO term and these genetic differences were then identified. The results showed that cellular process, catalytic activity, binding, and some of their sub-terms were associated with high levels of genetic difference, and genes involved in these functional categories displayed, on average, high genetic diversity among different populations. By contrast, multicellular organismal processes, molecular transducer activity, and some of their sub-terms were associated with low levels of genetic difference. In particular, the neurological system process under the multicellular organismal process category had low levels of genetic difference; the neurological function also showed high evolutionary conservation between species in some previous studies. These results may provide a new insight into the understanding of human evolutionary history at the system-level.	[Jiang, Yongshuai; Zhang, Ruijie; Sun, Peng; Tang, Guoping; Zhang, Xuehong; Wang, Xing; Guo, Xiaodan; Wang, Qiuyu; Li, Xia] Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Peoples R China	Harbin Medical University	Jiang, YS (corresponding author), Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Peoples R China.	zhangruijie2009@yahoo.com.cn; lixia6@yahoo.com	li, xia/HHZ-7468-2022	Jiang, Yongshuai/0000-0002-7163-6554	National Natural Science Foundation of China [81172842, 30871394, 61170154]; Natural Science Foundation of Heilongjiang Province [F2008-02]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Heilongjiang Province(Natural Science Foundation of Heilongjiang Province)	This work was supported in part by the National Natural Science Foundation of China (Grant nos. 81172842, 30871394, 61170154), Natural Science Foundation of Heilongjiang Province (Grant No. F2008-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Aerts S, 2006, NAT BIOTECHNOL, V24, P537, DOI 10.1038/nbt1203; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler D, 2007, NAT GENET, V39, P813, DOI 10.1038/ng0707-813; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; [Anonymous], GO DATABASE; Ardlie KG, 2002, NAT REV GENET, V3, P299, DOI 10.1038/nrg777; Balaresque PL, 2007, HUM MOL GENET, V16, pR134, DOI 10.1093/hmg/ddm242; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Blake J. A., 2008, CURR PROTOC BIOINFOR, DOI DOI 10.1002/0471250953.BI0702S23; Bowcock AM, 2007, NATURE, V447, P645, DOI 10.1038/447645a; Camon E, 2003, GENOME RES, V13, P662, DOI 10.1101/gr.461403; De Bakker Paul I W, 2006, Pac Symp Biocomput, P478, DOI 10.1142/9789812701626_0044; De la Vega FM, 2005, GENOME RES, V15, P454, DOI 10.1101/gr.3241705; Du P, 2009, BIOINFORMATICS, V25, pI63, DOI 10.1093/bioinformatics/btp193; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Harris MA, 2008, NUCLEIC ACIDS RES, V36, pD440, DOI 10.1093/nar/gkm883; Harris MA, 2006, NUCLEIC ACIDS RES, V34, pD322, DOI 10.1093/nar/gkj021; Holmans P, 2009, AM J HUM GENET, V85, P13, DOI 10.1016/j.ajhg.2009.05.011; Huang H, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-7-r47; Jones WD, 2005, CURR BIOL, V15, pR119, DOI 10.1016/j.cub.2005.02.007; Kanehisa M, 2002, NOVART FDN SYMP, V247, P91; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kang HJ, 2005, NUCLEIC ACIDS RES, V33, pD518; Kawashima S, 2000, NUCLEIC ACIDS RES, V28, P374, DOI 10.1093/nar/28.1.374; Laan M, 1997, NAT GENET, V17, P435, DOI 10.1038/ng1297-435; Lopez-Bigas N, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r33; Lundmark PE, 2008, EUR J HUM GENET, V16, P1142, DOI 10.1038/ejhg.2008.77; Mahasirimongkol S, 2006, J HUM GENET, V51, P896, DOI 10.1007/s10038-006-0041-1; Marvelle AF, 2007, J HUM GENET, V52, P729, DOI 10.1007/s10038-007-0175-9; Mattson MP, 2002, MECH AGEING DEV, V123, P947, DOI 10.1016/S0047-6374(02)00032-5; Mizutani T, 2001, P NATL ACAD SCI USA, V98, P9026, DOI 10.1073/pnas.161269998; Mueller JC, 2005, AM J HUM GENET, V76, P387, DOI 10.1086/427925; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Nakajima T, 2004, AM J HUM GENET, V74, P898, DOI 10.1086/420793; Nejentsev S, 2004, HUM MOL GENET, V13, P1633, DOI 10.1093/hmg/ddh169; Newton-Cheh C., 2009, NAT GENET, V41, P666, DOI [10.1038/ng.361, DOI 10.1038/NG.361]; Peng G, 2009, EUR J HUM GENET; Porst H, 2007, J SEX MED, V4, P372, DOI 10.1111/j.1743-6109.2006.00422.x; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Rapley EA, 2009, NAT GENET, V41, P807, DOI 10.1038/ng.394; Ribas G, 2006, HUM GENET, V118, P669, DOI 10.1007/s00439-005-0094-9; Service S, 2006, NAT GENET, V38, P556, DOI 10.1038/ng1770; Srivastava S, 2009, BMC P S7, V3, pS21; Walsh EC, 2006, HUM GENET, V119, P92, DOI 10.1007/s00439-005-0090-0; Wang N, 2002, AM J HUM GENET, V71, P1227, DOI 10.1086/344398; Weedon MN, 2006, AM J HUM GENET, V79, P991, DOI 10.1086/509517; WELLS J A, 1992, Current Opinion in Biotechnology, V3, P355, DOI 10.1016/0958-1669(92)90163-D; Wixon J, 2000, YEAST, V17, P48, DOI 10.1002/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H; Xing JC, 2008, GENOMICS, V92, P41, DOI 10.1016/j.ygeno.2008.03.011; Zheng W, 2009, NAT GENET, V41, P324, DOI 10.1038/ng.318	52	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e27871	10.1371/journal.pone.0027871	http://dx.doi.org/10.1371/journal.pone.0027871			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140477	gold, Green Published, Green Submitted			2022-12-27	WOS:000298168100022
J	Piemontese, P; Gianni, ML; Braegger, CP; Chirico, G; Gruber, C; Riedler, J; Arslanoglu, S; van Stuijvenberg, M; Boehm, G; Jelinek, J; Roggero, P				Piemontese, Pasqua; Gianni, Maria L.; Braegger, Christian P.; Chirico, Gaetano; Grueber, Christoph; Riedler, Josef; Arslanoglu, Sertac; van Stuijvenberg, Margriet; Boehm, Guenther; Jelinek, Juergen; Roggero, Paola		MIPS 1 Working Grp Berlin	Tolerance and Safety Evaluation in a Large Cohort of Healthy Infants Fed an Innovative Prebiotic Formula: A Randomized Controlled Trial	PLOS ONE			English	Article							INTESTINAL FLORA; HUMAN-MILK; OLIGOSACCHARIDE; SUPPLEMENTATION	Background: the addition of oligosaccharides to infant formula has been shown to mimic some of the beneficial effects of human milk. The aim of the study was to assess the tolerance and safety of a formula containing an innovative mixture of oligosaccharides in early infancy. Methodology/Principal Findings: this study was performed as a multi-center, randomized, double-blind, placebo-controlled trial including healthy term infants. Infants were recruited before the age of 8 weeks, either having started with formula feeding or being fully breast-fed (breastfeeding group). Formula-fed infants were randomized to feeding with a regular formula containing a mixture of neutral oligosaccharides and pectin-derived acidic oligosaccharides (prebiotic formula group) or regular formula without oligosaccharides (control formula group). Growth, tolerance and adverse events were assessed at 8, 16, 24 and 52 weeks of age. The prebiotic and control groups showed similar mean weight, length and head circumference, skin fold thicknesses, arm circumference gains and stool frequency at each study point. As far as the anthropometric parameters are concerned, the prebiotic group and the control group did not attain the values shown by the breastfeeding group at any study point. The skin fold thicknesses assessed in the breastfeeding group at 8 weeks were strikingly larger than those in formula fed infants, whereas at 52 weeks were strikingly smaller. The stool consistency in the prebiotic group was softer than in the control group at 8, 16 and 24 weeks (p < 0.001) and closer to that of the breastfeeding group. There was no difference in the incidence of adverse events between the two formula groups. Conclusions: our findings demonstrate the tolerability and the long term safety of a formula containing an innovative mixture of oligosaccharides in a large cohort of healthy infants.	[Piemontese, Pasqua; Gianni, Maria L.; Roggero, Paola] Univ Milan, Dept Maternal & Pediat Sci, Fondazione IRCCS CaGranda, Osped Maggiore Policlin, Milan, Italy; [Braegger, Christian P.] Univ Childrens Hosp, Div Paediat Gastroenterol & Nutr, Zurich, Switzerland; [Chirico, Gaetano] Spedali Civil Brescia, Dept Neonatol, I-25125 Brescia, Italy; [Grueber, Christoph] Charite, Dept Pediat Pneumol & Immunol, D-13353 Berlin, Germany; [Riedler, Josef] Childrens Hosp Schwarzach, Schwarzach Pg, Austria; [Arslanoglu, Sertac] Hosp Macedonio Melloni, Ctr Infant Nutr, Milan, Italy; [van Stuijvenberg, Margriet] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Div Neonatol, Groningen, Netherlands; Danone Res Ctr Specialized Nutr, Friedrichsdorf, Germany	IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; University Children's Hospital Zurich; Hospital Spedali Civili Brescia; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Groningen; Danone Nutricia	Piemontese, P (corresponding author), Univ Milan, Dept Maternal & Pediat Sci, Fondazione IRCCS CaGranda, Osped Maggiore Policlin, Milan, Italy.	paola.roggero@unimi.it	garssen, johan/I-7159-2016; Braegger, Christian Peter/ABC-9884-2021; Arslanoglu, Sertac/ABE-8915-2021; Giannì, Maria/C-2026-2017; riedler, josef/AAQ-4666-2020	Giannì, Maria/0000-0003-3901-9131; Braegger, Christian/0000-0001-8069-9875	Danone research, Friedrichsdorf Germany; Danone; MIPS	Danone research, Friedrichsdorf Germany(Danone Nutricia); Danone(Danone Nutricia); MIPS	This study was supported by Danone research, Friedrichsdorf Germany. The role of the funder has been to supply the study formulas and facilitate the data collection and data analysis.; CG and GC receive research support from Danone. CB has consultant arrangements and receives research support from Danone. JR is on the advisory board for Numico and receives research support from MIPS. JJ and GB are employed by Danone Research - Centre for Specialised Nutrition. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. The rest of the authors have declared that they have no conflict of interest.	Agostoni C, 1999, ARCH DIS CHILD, V81, P395, DOI 10.1136/adc.81.5.395; ANDERSON MA, 1995, B WORLD HEALTH ORGAN, V73, P165; Boehm G, 2005, ACTA PAEDIATR, V94, P18, DOI 10.1080/08035320510043493; Boehm G., 2003, Functional dairy products, P203, DOI 10.1533/9781855736917.2.203; Boehm G, 2002, ARCH DIS CHILD-FETAL, V86, P178, DOI 10.1136/fn.86.3.F178; Boehm G, 2008, J NUTR, V138, p1818S, DOI 10.1093/jn/138.9.1818S; Braegger C, 2010, J PEDIAT GASTROENTER, V52, P238; Fanaro S, 2005, J PEDIATR GASTR NUTR, V41, P186, DOI 10.1097/01.mpg.0000172747.64103.d7; Field CJ, 2005, J NUTR, V135, P1; Gruber C, 2010, J ALLERGY CLIN IMMUN, V126, P791, DOI 10.1016/j.jaci.2010.07.022; Harmsen HJM, 2000, J PEDIATR GASTR NUTR, V30, P61, DOI 10.1097/00005176-200001000-00019; Haschke F, 2000, J PEDIATR GASTR NUTR, V31, pS14, DOI 10.1097/00005176-200007001-00003; Lee JH, 2006, CARBOHYD RES, V341, P1154, DOI 10.1016/j.carres.2006.03.032; Moro G, 2002, J PEDIATR GASTR NUTR, V34, P291, DOI 10.1097/00005176-200203000-00014; Pabst HF, 1997, ACTA PAEDIATR, V86, P1291, DOI 10.1111/j.1651-2227.1997.tb14900.x; Rao S, 2009, ARCH PEDIAT ADOL MED, V163, P755, DOI 10.1001/archpediatrics.2009.94; Rogers IS, 1997, EARLY HUM DEV, V49, pS157, DOI 10.1016/S0378-3782(97)00061-3; TANNER JM, 1975, ARCH DIS CHILD, V50, P142, DOI 10.1136/adc.50.2.142; US Food and Drug Administration, 1988, CLIN TEST INF FORM R; van Stuijvenberg M, 2011, NUTR IN PRESS; WHO, 2006, WHO CHILD GROWTH STA; Ziegler E, 2007, J PEDIATR GASTR NUTR, V44, P359, DOI 10.1097/MPG.0b013e31802fca8c	22	42	42	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e28010	10.1371/journal.pone.0028010	http://dx.doi.org/10.1371/journal.pone.0028010			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140499	Green Published, Green Submitted, gold			2022-12-27	WOS:000298168100030
J	Ahn, HJ; Kim, KI; Kim, G; Moon, E; Yang, SS; Lee, JS				Ahn, Hak Jun; Kim, Kang Il; Kim, Geunyoung; Moon, Eunpyo; Yang, Sang Sik; Lee, Jong-Soo			Atmospheric-Pressure Plasma Jet Induces Apoptosis Involving Mitochondria via Generation of Free Radicals	PLOS ONE			English	Article							NITRIC-OXIDE; CELL-DEATH; MEMBRANE; PERMEABILIZATION; BCL-2; SKIN	The plasma jet has been proposed as a novel therapeutic method for anticancer treatment. However, its biological effects and mechanism of action remain elusive. Here, we investigated its cell death effects and underlying molecular mechanisms, using air and N2 plasma jets from a micro nozzle array. Treatment with air or N2 plasma jets caused apoptotic death in human cervical cancer HeLa cells, simultaneously with depolarization of mitochondrial membrane potential. In addition, the plasma jets were able to generate reactive oxygen species (ROS), which function as surrogate apoptotic signals by targeting the mitochondrial membrane potential. Antioxidants or caspase inhibitors ameliorated the apoptotic cell death induced by the air and N2 plasma jets, suggesting that the plasma jet may generate ROS as a proapoptotic cue, thus initiating mitochondria-mediated apoptosis. Taken together, our data suggest the potential employment of plasma jets as a novel therapy for cancer.	[Ahn, Hak Jun; Moon, Eunpyo; Lee, Jong-Soo] Ajou Univ, Dept Mol Sci & Technol, Suwon 441749, Gyounggi Do, South Korea; [Ahn, Hak Jun; Moon, Eunpyo; Lee, Jong-Soo] Ajou Univ, Dept Life Sci, Suwon 441749, Gyounggi Do, South Korea; [Kim, Kang Il; Kim, Geunyoung; Yang, Sang Sik] Ajou Univ, Dept Elect & Comp Engn, Suwon 441749, Gyounggi Do, South Korea	Ajou University; Ajou University; Ajou University	Ahn, HJ (corresponding author), Ajou Univ, Dept Mol Sci & Technol, Suwon 441749, Gyounggi Do, South Korea.	ssyang@ajou.ac.kr; jsjlee@ajou.ac.kr	Kim, Geunyoung/GQR-0665-2022; Kim, Kangil/F-2165-2013	Kim, Kangil/0000-0003-4790-7593	Ministry of Health and Welfare, Korea [1020210]; Korea National Research Foundation [313-2008-2-C00626, 2009-0074556, 2010-0018546]	Ministry of Health and Welfare, Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Korea National Research Foundation(National Research Foundation of Korea)	This work was supported by a grant from the National R&D Program for Cancer Control, Ministry of Health and Welfare, Korea (1020210) and grants from the Korea National Research Foundation (313-2008-2-C00626, 2009-0074556, 2010-0018546), for data collection and analysis and preparation of the manuscript.	Ahn HJ, 2006, J CELL BIOCHEM, V99, P807, DOI 10.1002/jcb.20973; Ameisen JC, 2002, CELL DEATH DIFFER, V9, P367, DOI 10.1038/sj.cdd.4400950; Barros LF, 2003, CELL DEATH DIFFER, V10, P687, DOI 10.1038/sj.cdd.4401236; Birbes H, 2001, FASEB J, V15, P2669, DOI 10.1096/fj.01-0539com; Brune B, 2003, CELL DEATH DIFFER, V10, P864, DOI 10.1038/sj.cdd.4401261; Cook SA, 1999, CIRC RES, V85, P940; Deng XT, 2007, J APPL PHYS, V101, DOI 10.1063/1.2717576; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Fadeel B, 1999, BIOCHEM BIOPH RES CO, V266, P699, DOI 10.1006/bbrc.1999.1888; Franco R, 2007, J BIOL CHEM, V282, P30452, DOI 10.1074/jbc.M703091200; Fridman G, 2007, PLASMA CHEM PLASMA P, V27, P163, DOI 10.1007/s11090-007-9048-4; Hong YC, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2400078; Jacotot E, 2001, J EXP MED, V193, P509, DOI 10.1084/jem.193.4.509; Kalghatgi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016270; Kim GC, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/3/032005; Kim GJ, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3292206; Kim K, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3555434; Kim K, 2010, MICROELECTRON ENG, V87, P1177, DOI 10.1016/j.mee.2009.12.045; Kolb JF, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2940325; Lee HJ, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115026; Madesh M, 2001, J CELL BIOL, V155, P1003, DOI 10.1083/jcb.200105057; Ptasinska S, 2010, PHYS CHEM CHEM PHYS, V12, P7779, DOI [10.1039/c001188f, 10.1039/e001188f]; Skulachev VP, 2006, APOPTOSIS, V11, P473, DOI 10.1007/s10495-006-5881-9; Tsujimoto Y, 2007, APOPTOSIS, V12, P835, DOI 10.1007/s10495-006-0525-7; Wang HW, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2975831; Yang J, 2008, FREE RADICAL RES, V42, P492, DOI 10.1080/10715760802112791; Zhang XH, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2959735	27	248	251	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2011	6	11							e28154	10.1371/journal.pone.0028154	http://dx.doi.org/10.1371/journal.pone.0028154			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863LT	22140530	Green Published, gold, Green Submitted			2022-12-27	WOS:000298166300033
J	Carriere, C; Young, AL; Gunn, JR; Longnecker, DS; Korc, M				Carriere, Catherine; Young, Alison L.; Gunn, Jason R.; Longnecker, Daniel S.; Korc, Murray			Acute Pancreatitis Accelerates Initiation and Progression to Pancreatic Cancer in Mice Expressing Oncogenic Kras in the Nestin Cell Lineage	PLOS ONE			English	Article							INTRAEPITHELIAL NEOPLASIA; ACINAR-CELLS; DUCTAL ADENOCARCINOMA; GROWTH-FACTOR; RAS ACTIVITY; ADULT MICE; K-RAS; MOUSE; REGENERATION; PRECURSORS	Targeting of oncogenic Kras to the pancreatic Nestin-expressing embryonic progenitor cells and subsequently to the adult acinar compartment and Nestin-expressing cells is sufficient for the development of low grade pancreatic intraepithelial neoplasia (PanIN) between 2 and 4 months. The mice die around 6 month-old of unrelated causes, and it is therefore not possible to assess whether the lesions will progress to carcinoma. We now report that two brief episodes of caerulein-induced acute pancreatitis in 2 month-old mice causes rapid PanIN progression and pancreatic ductal adenocarcinoma (PDAC) development by 4 months of age. These events occur with similar frequency as observed in animals where the oncogene is targeted during embryogenesis to all pancreatic cell types. Thus, these data show that oncogenic Kras-driven PanIN originating in a non-ductal compartment can rapidly progress to PDAC when subjected to a brief inflammatory insult.	[Carriere, Catherine; Young, Alison L.; Gunn, Jason R.; Korc, Murray] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Med, Hanover, NH 03756 USA; [Longnecker, Daniel S.] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Pathol, Hanover, NH 03756 USA; [Korc, Murray] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Pharmacol & Toxicol, Hanover, NH 03756 USA; [Carriere, Catherine; Korc, Murray] Dartmouth Hitchcock Med Ctr, Norris Cotton Canc Ctr, Lebanon, NH 03766 USA	Dartmouth College; Dartmouth College; Dartmouth College; Dartmouth College; Norris Cotton Cancer Center	Carriere, C (corresponding author), Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Med, Hanover, NH 03756 USA.	Carriere@Dartmouth.edu			National Cancer Institute [CA- R37-075059, CA-127095]; Lustgarten Foundation for Pancreatic Cancer Research; NATIONAL CANCER INSTITUTE [R37CA075059, R21CA127095] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Lustgarten Foundation for Pancreatic Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from: The National Cancer Institute: CA- R37-075059 to Murray Korc and CA- 127095 to Catherine Carriere; The Lustgarten Foundation for Pancreatic Cancer Research to Catherine Carriere. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre AJ, 2003, GENE DEV, V17, P3112, DOI 10.1101/gad.1158703; Blaine SA, 2010, DEVELOPMENT, V137, P2289, DOI 10.1242/dev.048421; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Carriere C, 2007, P NATL ACAD SCI USA, V104, P4437, DOI 10.1073/pnas.0701117104; Carriere C, 2009, BIOCHEM BIOPH RES CO, V382, P561, DOI 10.1016/j.bbrc.2009.03.068; Desai BM, 2007, J CLIN INVEST, V117, P971, DOI 10.1172/JCI29988; Ebert M, 1999, PANCREAS, V18, P240, DOI 10.1097/00006676-199904000-00004; Esni F, 2004, MECH DEVELOP, V121, P15, DOI 10.1016/j.mod.2003.08.010; Fendrich V, 2008, GASTROENTEROLOGY, V135, P621, DOI 10.1053/j.gastro.2008.04.011; Friedlander SYG, 2009, CANCER CELL, V16, P379, DOI 10.1016/j.ccr.2009.09.027; Fukuda A, 2011, CANCER CELL, V19, P441, DOI 10.1016/j.ccr.2011.03.002; Gu GQ, 2002, DEVELOPMENT, V129, P2447; Guerra C, 2007, CANCER CELL, V11, P291, DOI 10.1016/j.ccr.2007.01.012; Habbe N, 2008, P NATL ACAD SCI USA, V105, P18913, DOI 10.1073/pnas.0810097105; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hruban RH, 2005, METH MOLEC MED, V103, P1; Ishiwata T, 2006, PANCREAS, V32, P360, DOI 10.1097/01.mpa.0000220860.01120.21; Jean-Paul D, 2008, P NATL ACAD SCI USA, V105, P18907, DOI 10.1073/pnas.0810111105; Jensen JN, 2005, GASTROENTEROLOGY, V128, P728, DOI 10.1053/j.gastro.2004.12.008; Ji BA, 2009, GASTROENTEROLOGY, V137, P1072, DOI 10.1053/j.gastro.2009.05.052; Lesina M, 2011, CANCER CELL, V19, P456, DOI 10.1016/j.ccr.2011.03.009; Logsdon CD, 2009, CLIN GASTROENTEROL H, V7, pS40, DOI 10.1016/j.cgh.2009.07.040; Lowenfels AB, 2006, BEST PRACT RES CL GA, V20, P197, DOI 10.1016/j.bpg.2005.10.001; Morris JP, 2010, J CLIN INVEST, V120, P508, DOI 10.1172/JCI40045; Neuschwander-Tetri BA, 2000, DIGEST DIS SCI, V45, P665, DOI 10.1023/A:1005423122127; Ray KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016786; Scholz A, 2003, GASTROENTEROLOGY, V125, P891, DOI 10.1016/S0016-5085(03)01064-3; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Strobel O, 2007, GASTROENTEROLOGY, V133, P1999, DOI 10.1053/j.gastro.2007.09.009; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Tuveson DA, 2005, COLD SH Q B, V70, P65, DOI 10.1101/sqb.2005.70.040; WARSHAW AL, 1992, NEW ENGL J MED, V326, P455, DOI 10.1056/NEJM199202133260706; WILLEMER S, 1992, EUR SURG RES, V24, P29, DOI 10.1159/000129237; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Zhu LQ, 2007, AM J PATHOL, V171, P263, DOI 10.2353/ajpath.2007.061176	35	48	49	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2011	6	11							e27725	10.1371/journal.pone.0027725	http://dx.doi.org/10.1371/journal.pone.0027725			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KW	22140463	Green Submitted, Green Published, gold			2022-12-27	WOS:000298163400016
J	Dublineau, A; Batejat, C; Pinon, A; Burguiere, AM; Leclercq, I; Manuguerra, JC				Dublineau, Amelie; Batejat, Christophe; Pinon, Anthony; Burguiere, Ana Maria; Leclercq, India; Manuguerra, Jean-Claude			Persistence of the 2009 Pandemic Influenza A (H1N1) Virus in Water and on Non-Porous Surface	PLOS ONE			English	Article							SURVIVAL; TRANSMISSION; INACTIVATION	Knowledge of influenza A virus survival in different environmental conditions is a key element for the implementation of hygiene and personal protection measures by health authorities. As it is dependent on virus isolates even within the same subtype, we studied the survival of the 2009 H1N1 pandemic (H1N1pdm) virus in water and on non-porous surface. The H1N1pdm virus was subjected to various environmental parameters over time and tested for infectivity. In water, at low and medium salinity levels and 4 degrees C, virus survived at least 200 days. Increasing temperature and salinity had a strong negative effect on the survival of the virus which remained infectious no more than 1 day at 35 degrees C and 270 parts per thousand (ppt) of salt. Based on modeled data, the H1N1pdm virus retained its infectivity on smooth non-porous surface for at least 7 days at 35 degrees C and up to 66 days at 4 degrees C. The H1N1pdm virus has thus the ability to persist in water and on glass surface for extended periods of time, even at 35 degrees C. Additional experiments suggest that external viral structures in direct contact with the environment are mostly involved in loss of virus infectivity.	[Dublineau, Amelie; Batejat, Christophe; Burguiere, Ana Maria; Leclercq, India; Manuguerra, Jean-Claude] Inst Pasteur, Lab Urgent Response Biol Threats, Paris, France; [Pinon, Anthony] Inst Pasteur, Microbiol Safety Unit, F-59019 Lille, France; [Leclercq, India] Univ Paris Diderot, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; UDICE-French Research Universities; Universite Paris Cite	Dublineau, A (corresponding author), Inst Pasteur, Lab Urgent Response Biol Threats, Paris, France.	jean-claude.manuguerra@pasteur.fr		Batejat, Christophe/0000-0002-2344-5710; Pinon, Anthony/0000-0001-7048-3085	European Union [SSP-5-B-INFLUENZA 04 405]; BNP-Paribas	European Union(European Commission); BNP-Paribas	This study was supported by the European Union funded RIVERS program (Sixth Framework Program SSP-5-B-INFLUENZA 04 405: Resistance of Influenza Viruses in Environmental Reservoirs and Systems: http://cordis.europa.eu/fp6). The authors are grateful to BNP-Paribas and its foundation (http://mecenat.bnpparibas.com/) for their financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEAN B, 1982, J INFECT DIS, V146, P47, DOI 10.1093/infdis/146.1.47; Brown JD, 2007, AVIAN DIS, V51, P285, DOI 10.1637/7636-042806R.1; Davidson I, 2010, AVIAN DIS, V54, P725, DOI 10.1637/8736-032509-ResNote.1; De Benedictis P, 2007, ZOONOSES PUBLIC HLTH, V54, P51, DOI 10.1111/j.1863-2378.2007.01029.x; Geeraerd AH, 2005, INT J FOOD MICROBIOL, V102, P95, DOI 10.1016/j.ijfoodmicro.2004.11.038; Graiver DA, 2009, ENVIRON SCI TECHNOL, V43, P4063, DOI 10.1021/es900370x; HINSHAW VS, 1979, INTERVIROLOGY, V11, P66, DOI 10.1159/000149014; Muench H, 1938, AM J HYG, V27; Negovetich NJ, J VIROL; Noyce JO, 2007, APPL ENVIRON MICROB, V73, P2748, DOI 10.1128/AEM.01139-06; Shahid MA, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-38; Stallknecht DE, 2009, REV SCI TECH OIE, V28, P59; Stallknecht DE, 2010, AVIAN DIS, V54, P461, DOI 10.1637/8760-033109-Reg.1; STALLKNECHT DE, 1990, AVIAN DIS, V34, P406, DOI 10.2307/1591428; STALLKNECHT DE, 1990, AVIAN DIS, V34, P412, DOI 10.2307/1591429; Tellier R, 2006, EMERG INFECT DIS, V12, P1657, DOI 10.3201/eid1211.060426; Tellier R, 2009, J R SOC INTERFACE, V6, pS783, DOI 10.1098/rsif.2009.0302.focus; Thomas Y, 2008, APPL ENV MICROBIOL; Tiwari A, 2006, AVIAN DIS, V50, P284, DOI 10.1637/7453-101205R.1; Wood JP, 2010, ENVIRON SCI TECHNOL, V44, P7515, DOI 10.1021/es1016153; Zhou HB, 2011, EMERG INFECT DIS, V17, P1757, DOI 10.3201/eid1709.101916	21	40	41	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e28043	10.1371/journal.pone.0028043	http://dx.doi.org/10.1371/journal.pone.0028043			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132205	Green Submitted, Green Published, gold			2022-12-27	WOS:000298162000061
J	Pandey, R; Blanco, J; Udolph, G				Pandey, Rahul; Blanco, Jorge; Udolph, Gerald			The Glucuronyltransferase GlcAT-P Is Required for Stretch Growth of Peripheral Nerves in Drosophila	PLOS ONE			English	Article							HNK-1 CARBOHYDRATE EPITOPE; MYELIN-ASSOCIATED GLYCOPROTEIN; CELL-ADHESION MOLECULES; PROTEIN LINKAGE REGION; NERVOUS-SYSTEM; CYTOSKELETAL DYNAMICS; EXTRACELLULAR-MATRIX; L2/HNK-1 CARBOHYDRATE; MICROTUBULE DYNAMICS; AXON OUTGROWTH	During development, the growth of the animal body is accompanied by a concomitant elongation of the peripheral nerves, which requires the elongation of integrated nerve fibers and the axons projecting therein. Although this process is of fundamental importance to almost all organisms of the animal kingdom, very little is known about the mechanisms regulating this process. Here, we describe the identification and characterization of novel mutant alleles of GlcAT-P, the Drosophila ortholog of the mammalian glucuronyltransferase b3gat1. GlcAT-P mutants reveal shorter larval peripheral nerves and an elongated ventral nerve cord (VNC). We show that GlcAT-P is expressed in a subset of neurons in the central brain hemispheres, in some motoneurons of the ventral nerve cord as well as in central and peripheral nerve glia. We demonstrate that in GlcAT-P mutants the VNC is under tension of shorter peripheral nerves suggesting that the VNC elongates as a consequence of tension imparted by retarded peripheral nerve growth during larval development. We also provide evidence that for growth of peripheral nerve fibers GlcAT-P is critically required in hemocytes; however, glial cells are also important in this process. The glial specific repo gene acts as a modifier of GlcAT-P and loss or reduction of repo function in a GlcAT-P mutant background enhances VNC elongation. We propose a model in which hemocytes are required for aspects of glial cell biology which in turn affects the elongation of peripheral nerves during larval development. Our data also identifies GlcAT-P as a first candidate gene involved in growth of integrated peripheral nerves and therefore establishes Drosophila as an amenable in-vivo model system to study this process at the cellular and molecular level in more detail.	[Pandey, Rahul; Blanco, Jorge; Udolph, Gerald] Inst Med Biol, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB)	Pandey, R (corresponding author), Inst Med Biol, Singapore, Singapore.	gerald.udolph@gmail.com			Institute of Medical Biology; NICHD	Institute of Medical Biology(Agency for Science Technology & Research (A*STAR)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was funded by the Institute of Medical Biology. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the mansucript.; We thank R. White, J. Casanova, F. Matsuzaki and S. Oka for antibodies and S. Luschnig for flies. The Elav, Repo, Nrt, Antp and AbdB monoclonal antibodies developed by G. M. Rubin, C. Goodman, D. Brower and S. Celniker, respectively, were obtained from the Developmental Studies Hybridoma Bank, developed under the auspices of the NICHD and maintained by The University of Iowa, Department of Biological Sciences, Iowa City, IA 52242. The Bloomington Drosophila Stock Center resources contributed to this work and FlyBase provided important information used in this work. We are grateful to C. Lehner, X.H. Yang, B. Reversade and B. Knowles for critical comments on the manuscript.	AKAM M, 1987, DEVELOPMENT, V101, P1; Anzai D, 2009, GLYCOBIOLOGY, V19, P868, DOI 10.1093/glycob/cwp060; Aoki K, 2008, J BIOL CHEM, V283, P30385, DOI 10.1074/jbc.M804925200; Bannister J, 1996, ACTION PLAN AUSTR CE; Bello BC, 2003, NEURON, V37, P209, DOI 10.1016/S0896-6273(02)01181-9; Bernal R, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.018301; BOLLENSEN E, 1987, NEUROSCI LETT, V82, P77, DOI 10.1016/0304-3940(87)90174-1; Breloy I, 2008, FEBS LETT, V582, P1593, DOI 10.1016/j.febslet.2008.04.003; Broadie K, 2011, DEV NEUROBIOL; Chang SH, 1998, J NEUROSCI, V18, P821; Chetta J, 2010, CYTOSKELETON, V67, P650, DOI 10.1002/cm.20478; Chou TB, 1996, GENETICS, V144, P1673; Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104; Dagg AI, 1982, GIRAFFE ITS BIOL BEH; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; DODD J, 1988, NEURON, V1, P105, DOI 10.1016/0896-6273(88)90194-8; Edenfeld G, 2005, CURR OPIN NEUROBIOL, V15, P34, DOI 10.1016/j.conb.2005.01.007; Geraldo S, 2009, J CELL SCI, V122, P3595, DOI 10.1242/jcs.042309; HALTER DA, 1995, DEVELOPMENT, V121, P317; Hummel T, 2000, GENE DEV, V14, P863; Imiya K, 2002, GENE, V296, P29, DOI 10.1016/S0378-1119(02)00840-5; Inoue M, 2007, BRAIN RES, V1179, P1, DOI 10.1016/j.brainres.2007.05.012; Jeffries AR, 2003, MOL PSYCHIATR, V8, P654, DOI 10.1038/sj.mp.4001382; Kakuda S, 2005, GLYCOBIOLOGY, V15, P203, DOI 10.1093/glycob/cwi001; Kakuda S, 2004, PROTEIN EXPRES PURIF, V35, P111, DOI 10.1016/j.pep.2003.12.021; Kim BT, 2003, J BIOL CHEM, V278, P9116, DOI 10.1074/jbc.M209344200; Kim SH, 2011, J ENDOCRINOL, V209, P139, DOI 10.1530/JOE-10-0377; Kitagawa H, 1998, J BIOL CHEM, V273, P6615, DOI 10.1074/jbc.273.12.6615; Kizuka Y, 2009, J BIOL CHEM, V284, P9247, DOI 10.1074/jbc.M807517200; Kleene R, 2004, NAT REV NEUROSCI, V5, P195, DOI 10.1038/nrn1349; KNIBIEHLER M, 1987, FEBS LETT, V216, P183, DOI 10.1016/0014-5793(87)80686-5; KRUSE J, 1984, NATURE, V311, P153, DOI 10.1038/311153a0; KUNEMUND V, 1988, J CELL BIOL, V106, P213, DOI 10.1083/jcb.106.1.213; LaJeunesse DR, 2004, BIOTECHNIQUES, V36, P784, DOI 10.2144/04365ST01; Lamoureux P, 2010, DEV NEUROBIOL, V70, P135, DOI 10.1002/dneu.20764; Lee AC, 2008, DEV NEUROBIOL, V68, P1363, DOI 10.1002/dneu.20662; Li H, 2000, CURR BIOL, V10, P211, DOI 10.1016/S0960-9822(00)00340-7; Lin YR, 2008, DEV DYNAM, V237, P3703, DOI 10.1002/dvdy.21775; MARTINI R, 1992, EUR J NEUROSCI, V4, P628, DOI 10.1111/j.1460-9568.1992.tb00171.x; MCGARRY RC, 1983, NATURE, V306, P376, DOI 10.1038/306376a0; Miller KE, 2006, J CELL BIOL, V173, P373, DOI 10.1083/jcb.200510097; MIRRE C, 1988, DEVELOPMENT, V102, P369; Morita I, 2008, J BIOCHEM, V143, P719, DOI 10.1093/jb/mvm221; Morita I, 2009, J BIOL CHEM, V284, P30209, DOI 10.1074/jbc.M109.024208; Myers JP, 2011, DEV NEUROBIOL; Nave KA, 2008, ANNU REV NEUROSCI, V31, P535, DOI 10.1146/annurev.neuro.30.051606.094309; OKA S, 1992, J BIOL CHEM, V267, P22711; Olofsson B, 2005, DEV BIOL, V279, P233, DOI 10.1016/j.ydbio.2004.12.020; Ozoka VC, 2011, J NEUROTRAUMA; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; Pereanu W, 2006, J NEUROSCI, V26, P5534, DOI 10.1523/JNEUROSCI.4708-05.2006; Rodrigues F, 2011, CELL MOL LIFE SCI, V68, P55, DOI 10.1007/s00018-010-0512-6; Rozario T, 2010, DEV BIOL, V341, P126, DOI 10.1016/j.ydbio.2009.10.026; Sanchez-Soriano N, 2010, DEV NEUROBIOL, V70, P58, DOI 10.1002/dneu.20762; SAUDOU F, 1992, EMBO J, V11, P7, DOI 10.1002/j.1460-2075.1992.tb05021.x; Schaefer AW, 2008, DEV CELL, V15, P146, DOI 10.1016/j.devcel.2008.05.003; Schafer MKE, 2010, CELL MOL LIFE SCI, V67, P2425, DOI 10.1007/s00018-010-0339-1; Schweitzer J, 2005, DEV DYNAM, V234, P550, DOI 10.1002/dvdy.20525; Seiki T, 1999, BIOCHEM BIOPH RES CO, V255, P182, DOI 10.1006/bbrc.1999.0151; SHASHOUA VE, 1986, J NEUROCHEM, V47, P738; Siddiqui S, 2008, NEURON GLIA BIOL, V4, P271, DOI 10.1017/S1740925X09990020; Smith DH, 2009, PROG NEUROBIOL, V89, P231, DOI 10.1016/j.pneurobio.2009.07.006; STAEHLINGHAMPTON K, 1994, DEV BIOL, V164, P502, DOI 10.1006/dbio.1994.1219; Sun BH, 1999, P NATL ACAD SCI USA, V96, P10438, DOI 10.1073/pnas.96.18.10438; Suter DM, 2011, PROG NEUROBIOL, V94, P91, DOI 10.1016/j.pneurobio.2011.04.002; Terayama K, 1997, P NATL ACAD SCI USA, V94, P6093, DOI 10.1073/pnas.94.12.6093; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; Udolph G, 2009, DEV BIOL, V336, P156, DOI 10.1016/j.ydbio.2009.09.030; Uusitalo M, 2001, PROG RETIN EYE RES, V20, P1, DOI 10.1016/S1350-9462(00)00018-5; Venken KJT, 2005, NAT REV GENET, V6, P167, DOI 10.1038/nrg1553; Venken KJT, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn486; WEISS P, 1941, GROWTH             S, V5, P163; Wood W, 2007, NAT REV MOL CELL BIO, V8, P542, DOI 10.1038/nrm2202; XIONG WC, 1994, GENE DEV, V8, P981, DOI 10.1101/gad.8.8.981; Yamamoto S, 2002, J BIOL CHEM, V277, P27227, DOI 10.1074/jbc.C200296200; Yu Robert K., 2006, CNS & Neurological Disorders-Drug Targets, V5, P415, DOI 10.2174/187152706777950675; Yuasa Y, 2003, DEVELOPMENT, V130, P2419, DOI 10.1242/dev.00468	78	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e28106	10.1371/journal.pone.0028106	http://dx.doi.org/10.1371/journal.pone.0028106			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132223	Green Published, gold, Green Submitted			2022-12-27	WOS:000298162000073
J	Sterrenburg, L; Gaszner, B; Boerrigter, J; Santbergen, L; Bramini, M; Elliott, E; Chen, A; Peeters, BWMM; Roubos, EW; Kozicz, T				Sterrenburg, Linda; Gaszner, Balazs; Boerrigter, Jeroen; Santbergen, Lennart; Bramini, Mattia; Elliott, Evan; Chen, Alon; Peeters, Bernard W. M. M.; Roubos, Eric W.; Kozicz, Tamas			Chronic Stress Induces Sex-Specific Alterations in Methylation and Expression of Corticotropin-Releasing Factor Gene in the Rat	PLOS ONE			English	Article							EDINGER-WESTPHAL NUCLEUS; CHRONIC MILD STRESS; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; MESSENGER-RNA LEVELS; STRIA TERMINALIS; BED NUCLEUS; SOCIAL STRESS; DELTA-FOSB; IMMUNOREACTIVE NEURONS; TYROSINE-HYDROXYLASE	Background: Although the higher prevalence of depression in women than in men is well known, the neuronal basis of this sex difference is largely elusive. Methods: Male and female rats were exposed to chronic variable mild stress (CVMS) after which immediate early gene products, corticotropin-releasing factor (CRF) mRNA and peptide, various epigenetic-associated enzymes and DNA methylation of the Crf gene were determined in the hypothalamic paraventricular nucleus (PVN), oval (BSTov) and fusiform (BSTfu) parts of the bed nucleus of the stria terminalis, and central amygdala (CeA). Results: CVMS induced site-specific changes in Crf gene methylation in all brain centers studied in female rats and in the male BST and CeA, whereas the histone acetyltransferase, CREB-binding protein was increased in the female BST and the histone-deacetylase-5 decreased in the male CeA. These changes were accompanied by an increased amount of c-Fos in the PVN, BSTfu and CeA in males, and of FosB in the PVN of both sexes and in the male BSTov and BSTfu. In the PVN, CVMS increased CRF mRNA in males and CRF peptide decreased in females. Conclusions: The data confirm our hypothesis that chronic stress affects gene expression and CRF transcriptional, translational and secretory activities in the PVN, BSTov, BSTfu and CeA, in a brain center-specific and sex-specific manner. Brain region-specific and sex-specific changes in epigenetic activity and neuronal activation may play, too, an important role in the sex specificity of the stress response and the susceptibility to depression.	[Sterrenburg, Linda; Boerrigter, Jeroen; Santbergen, Lennart; Bramini, Mattia; Peeters, Bernard W. M. M.; Roubos, Eric W.; Kozicz, Tamas] Radboud Univ Nijmegen, Dept Cellular Anim Physiol, Donders Inst Brain Cognit & Behav, Ctr Neurosci, NL-6525 ED Nijmegen, Netherlands; [Gaszner, Balazs] Univ Pecs, Dept Anat, Pecs, Hungary; [Elliott, Evan; Chen, Alon] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Elliott, Evan] Bar Ilan Univ, Fac Med, Safed, Israel	Radboud University Nijmegen; University of Pecs; Weizmann Institute of Science; Bar Ilan University	Sterrenburg, L (corresponding author), Radboud Univ Nijmegen, Dept Cellular Anim Physiol, Donders Inst Brain Cognit & Behav, Ctr Neurosci, NL-6525 ED Nijmegen, Netherlands.	t.kozicz@science.ru.nl	Kozicz, Tamas/N-5154-2014; Kozicz, Tamas/G-3161-2012; Bramini, Mattia/Q-6130-2016; Roubos, Eric W/D-1912-2010; Gaszner, Balázs/AAL-5382-2020	Kozicz, Tamas/0000-0001-6915-4364; Kozicz, Tamas/0000-0001-6915-4364; Bramini, Mattia/0000-0002-0381-9391; Gaszner, Balázs/0000-0003-2830-2732; Chen, Alon/0000-0003-3625-8233; Elliott, Evan/0000-0002-1630-969X	Netherlands Organization for Scientific Research [864.05.008]; MSD (Merck Sharp Dohme); Oss; EU; Hungarian Academy of Sciences; Pecs University [PTE KA-34039/10-8]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); MSD (Merck Sharp Dohme); Oss; EU(European Commission); Hungarian Academy of Sciences(Hungarian Academy of Sciences); Pecs University	This study was supported by grants from the Netherlands Organization for Scientific Research (#864.05.008) to TK, from MSD (Merck Sharp & Dohme), Oss to L. Sterrenburg, and by an EU ERASMUS grant to MB. BG was supported by the "Bolyai Janos" Scholarschip of the Hungarian Academy of Sciences and by the research grant of Pecs University no: PTE KA-34039/10-8. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albeck DS, 1997, J NEUROSCI, V17, P4895; Arborelius L, 1999, J ENDOCRINOL, V160, P1, DOI 10.1677/joe.0.1600001; Bale TL, 2006, HORM BEHAV, V50, P529, DOI 10.1016/j.yhbeh.2006.06.033; Barha C.K., 2010, HIPPOCAMPUS; CAREY MP, 1995, J ENDOCRINOL, V144, P311, DOI 10.1677/joe.0.1440311; CHAPPELL PB, 1986, J NEUROSCI, V6, P2908; Choi DC, 2008, PSYCHONEUROENDOCRINO, V33, P659, DOI 10.1016/j.psyneuen.2008.02.006; Choi DC, 2007, J NEUROSCI, V27, P2025, DOI 10.1523/JNEUROSCI.4301-06.2007; Csaki A, 2000, NEUROSCIENCE, V101, P637, DOI 10.1016/S0306-4522(00)00411-5; Davis M, 2010, NEUROPSYCHOPHARMACOL, V35, P105, DOI 10.1038/npp.2009.109; Day HEW, 1999, J COMP NEUROL, V413, P113; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; Derks NM, 2008, NEUROSCIENCE, V156, P305, DOI 10.1016/j.neuroscience.2008.07.047; Derks NM, 2007, GEN COMP ENDOCR, V153, P228, DOI 10.1016/j.ygcen.2007.04.009; Dong HW, 2001, J COMP NEUROL, V436, P430, DOI 10.1002/cne.1079; Duncko R, 2001, PSYCHONEUROENDOCRINO, V26, P77, DOI 10.1016/S0306-4530(00)00040-8; Elliott E, 2010, NAT NEUROSCI, V13, P1351, DOI 10.1038/nn.2642; Forray MI, 2004, BRAIN RES REV, V47, P145, DOI 10.1016/j.brainresrev.2004.07.011; Gaszner B, 2009, STRESS, V12, P115, DOI 10.1080/10253890802057221; Gaszner B, 2004, J COMP NEUROL, V480, P170, DOI 10.1002/cne.20343; Gorka Z, 1996, PHARMACOL BIOCHEM BE, V54, P229, DOI 10.1016/0091-3057(95)02173-6; Gorman Jack M, 2006, Gend Med, V3, P93, DOI 10.1016/S1550-8579(06)80199-3; GRAY TS, 1993, ANN NY ACAD SCI, V697, P53, DOI 10.1111/j.1749-6632.1993.tb49922.x; Herman JP, 2005, PROG NEURO-PSYCHOPH, V29, P1201, DOI 10.1016/j.pnpbp.2005.08.006; HERMAN JP, 1994, J NEUROENDOCRINOL, V6, P433, DOI 10.1111/j.1365-2826.1994.tb00604.x; Holsboer F, 2000, NEUROPSYCHOPHARMACOL, V23, P477, DOI 10.1016/S0893-133X(00)00159-7; Jozsa R, 2005, BIOMED PHARMACOTHER, V59, pS109, DOI 10.1016/S0753-3322(05)80018-6; Kessler RC, 2003, J AFFECT DISORDERS, V74, P5, DOI 10.1016/S0165-0327(02)00426-3; Kim HR, 2007, J IMMUNOL, V178, P5473, DOI 10.4049/jimmunol.178.9.5473; Kim SJ, 2006, NEUROPHARMACOLOGY, V50, P824, DOI 10.1016/j.neuropharm.2005.12.003; Kovacs KJ, 1998, NEUROCHEM INT, V33, P287, DOI 10.1016/S0197-0186(98)00023-0; Kozicz T, 2008, PSYCHONEUROENDOCRINO, V33, P741, DOI 10.1016/j.psyneuen.2008.02.012; Kozicz T, 2002, EUR J NEUROSCI, V16, P823, DOI 10.1046/j.1460-9568.2002.02129.x; Kozicz T, 1997, BRAIN RES, V767, P109, DOI 10.1016/S0006-8993(97)00737-3; Kuipers SD, 2006, NEUROPHARMACOLOGY, V50, P428, DOI 10.1016/j.neuropharm.2005.10.006; Lamont Elaine Waddington, 2007, Dialogues Clin Neurosci, V9, P333; Lopez AD, 1998, NAT MED, V4, P1241, DOI 10.1038/3218; Marcus SM, 2005, J AFFECT DISORDERS, V87, P141, DOI 10.1016/j.jad.2004.09.008; Marin MT, 2007, PHYSIOL BEHAV, V90, P29, DOI 10.1016/j.physbeh.2006.08.021; Martinez M, 1998, EUR J NEUROSCI, V10, P20, DOI 10.1046/j.1460-9568.1998.00011.x; MERCHENTHALER I, 1982, AM J ANAT, V165, P385, DOI 10.1002/aja.1001650404; Morin SM, 1999, NEUROSCIENCE, V92, P281, DOI 10.1016/S0306-4522(98)00732-5; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; Nestler EJ, 1999, BRAIN RES, V835, P10, DOI 10.1016/S0006-8993(98)01191-3; Nestler EJ, 2001, P NATL ACAD SCI USA, V98, P11042, DOI 10.1073/pnas.191352698; Neufeld-Cohen A, 2010, MOL PSYCHIATR, V15, P426, DOI 10.1038/mp.2009.115; Nock MK, 2010, MOL PSYCHIATR, V15, P868, DOI 10.1038/mp.2009.29; Parihar VK, 2011, MOL PSYCHIATR, V16, P171, DOI 10.1038/mp.2009.130; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Perrotti LI, 2004, J NEUROSCI, V24, P10594, DOI 10.1523/JNEUROSCI.2542-04.2004; RAADSHEER FC, 1995, AM J PSYCHIAT, V152, P1372; RAADSHEER FC, 1994, NEUROENDOCRINOLOGY, V60, P436, DOI 10.1159/000126778; REGEV L, 2010, MOL PSYCHIAT; Renthal W, 2007, NEURON, V56, P517, DOI 10.1016/j.neuron.2007.09.032; Reul JMHM, 2002, CURR OPIN PHARMACOL, V2, P23, DOI 10.1016/S1471-4892(01)00117-5; Rouwette TPH, 2010, J PAIN, V11, P930, DOI 10.1016/j.jpain.2009.12.017; SARACCI R, 1969, LANCET, V1, P416; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Snedecor GW, 1989, STAT METHODS, VEighth, P503; STERRENBURG L, 2011, J NEUROSCI IN PRESS; SWANSON LW, 1983, NEUROENDOCRINOLOGY, V36, P165, DOI 10.1159/000123454; Tafet GE, 2003, PROG NEURO-PSYCHOPH, V27, P893, DOI 10.1016/S0278-5846(03)00162-3; Takkinen S, 2004, AGING MENT HEALTH, V8, P187, DOI 10.1080/13607860410001669714; Tsankova NM, 2006, NAT NEUROSCI, V9, P519, DOI 10.1038/nn1659; VALE W, 1981, SCIENCE, V213, P1394, DOI 10.1126/science.6267699; VanElzakker M, 2008, LEARN MEMORY, V15, P899, DOI 10.1101/lm.1196508; Verma P, 2010, PHYSIOL BEHAV, V99, P276, DOI 10.1016/j.physbeh.2009.11.002; VIAU V, 1991, ENDOCRINOLOGY, V129, P2503, DOI 10.1210/endo-129-5-2503; Viau V, 2002, J COMP NEUROL, V445, P293, DOI 10.1002/cne.10178; Walker DL, 2008, BRAIN STRUCT FUNCT, V213, P29, DOI 10.1007/s00429-008-0183-3; Walker DL, 2003, EUR J PHARMACOL, V463, P199, DOI 10.1016/S0014-2999(03)01282-2; Westenbroek C, 2003, NEUROSCIENCE, V121, P189, DOI 10.1016/S0306-4522(03)00367-1; Willner P, 2005, NEUROPSYCHOBIOLOGY, V52, P90, DOI 10.1159/000087097; Xu L, 2010, NEUROSCIENCE, V170, P478, DOI 10.1016/j.neuroscience.2010.07.001; Yao M, 2007, ENDOCRINOLOGY, V148, P2518, DOI 10.1210/en.2006-1413; ZHOU JN, 1995, NATURE, V378, P68, DOI 10.1038/378068a0	76	113	115	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e28128	10.1371/journal.pone.0028128	http://dx.doi.org/10.1371/journal.pone.0028128			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132228	Green Published, gold			2022-12-27	WOS:000298162000077
J	Kato, Y; Muramatsu, T; Kato, M; Shibukawa, Y; Shintani, M; Mimura, M				Kato, Yutaka; Muramatsu, Taro; Kato, Motoichiro; Shibukawa, Yoshiyuki; Shintani, Masuro; Mimura, Masaru			Magnetoencephalography Study of Right Parietal Lobe Dysfunction of the Evoked Mirror Neuron System in Antipsychotic-Free Schizophrenia	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; SOCIAL COGNITION; PREMOTOR CORTEX; HUMAN BRAIN; EEG; RECOGNITION; ATTENTION; AGENCY; MIND; SYNCHRONIZATION	Introduction: Patients with schizophrenia commonly exhibit deficits of non-verbal communication in social contexts, which may be related to cognitive dysfunction that impairs recognition of biological motion. Although perception of biological motion is known to be mediated by the mirror neuron system, there have been few empirical studies of this system in patients with schizophrenia. Methods: Using magnetoencephalography, we examined whether antipsychotic-free schizophrenia patients displayed mirror neuron system dysfunction during observation of biological motion (jaw movement of another individual). Results: Compared with normal controls, the patients with schizophrenia had fewer components of both the waveform and equivalent current dipole, suggesting aberrant brain activity resulting from dysfunction of the right inferior parietal cortex. They also lacked the changes of alpha band and gamma band oscillation seen in normal controls, and had weaker phase-locking factors and gamma-synchronization predominantly in right parietal cortex. Conclusions: Our findings demonstrate that untreated patients with schizophrenia exhibit aberrant mirror neuron system function based on the right inferior parietal cortex, which is characterized by dysfunction of gamma-synchronization in the right parietal lobe during observation of biological motion.	[Kato, Yutaka; Muramatsu, Taro; Kato, Motoichiro; Mimura, Masaru] Keio Univ, Sch Med, Dept Neuropsychiat, Tokyo, Japan; [Kato, Yutaka; Kato, Motoichiro; Shibukawa, Yoshiyuki; Shintani, Masuro] Tokyo Dent Coll, Brain Res Lab, Oral Hlth Sci Ctr, Chiba, Japan; [Shibukawa, Yoshiyuki] Tokyo Dent Coll, Dept Physiol, Chiba, Japan	Keio University; Tokyo Dental College; Tokyo Dental College	Kato, Y (corresponding author), Keio Univ, Sch Med, Dept Neuropsychiat, Tokyo, Japan.	yutaka-k@db3.so-net.ne.jp	Kato, Yutaka/Q-7706-2019	Kato, Yutaka/0000-0001-7622-5001	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [HRC6A02];  [23120009]	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); 	This work was supported by a grant (HRC6A02) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan to M.K. and by a Grant-in-Aid for Scientific Research on Innovative Areas: Prediction and Decision Making (23120009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHONEN AI, 1993, PHYS SCRIPTA, VT49A, P198, DOI 10.1088/0031-8949/1993/T49A/033; Aichhorn M, 2009, J COGNITIVE NEUROSCI, V21, P1179, DOI 10.1162/jocn.2009.21082; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Andreasen NC, 2008, SCHIZOPHRENIA BULL, V34, P708, DOI 10.1093/schbul/sbn034; Bauer M, 2006, J NEUROSCI, V26, P490, DOI 10.1523/JNEUROSCI.5228-04.2006; Bernier R, 2007, BRAIN COGNITION, V64, P228, DOI 10.1016/j.bandc.2007.03.004; Breakspear M, 2003, NEUROIMAGE, V20, P466, DOI 10.1016/S1053-8119(03)00332-X; Brunet-Gouet E, 2006, PSYCHIAT RES-NEUROIM, V148, P75, DOI 10.1016/j.pscychresns.2006.05.001; Decety Jean, 2004, Behav Cogn Neurosci Rev, V3, P71, DOI 10.1177/1534582304267187; DIPELLEGRINO G, 1992, EXP BRAIN RES, V91, P176, DOI 10.1007/BF00230027; DOUGHERTY FE, 1974, J CLIN PSYCHOL, V30, P243, DOI 10.1002/1097-4679(197407)30:3<243::AID-JCLP2270300304>3.0.CO;2-0; Farrer C, 2004, PSYCHIAT RES-NEUROIM, V131, P31, DOI 10.1016/j.pscychresns.2004.02.004; Farrer C, 2003, NEUROIMAGE, V18, P324, DOI 10.1016/S1053-8119(02)00041-1; Farrer C, 2002, NEUROIMAGE, V15, P596, DOI 10.1006/nimg.2001.1009; First M.B., 1997, STRUCTURAL CLIN INTE; Fogassi L, 2005, SCIENCE, V308, P662, DOI 10.1126/science.1106138; Ford JM, 2007, AM J PSYCHIAT, V164, P458, DOI 10.1176/appi.ajp.164.3.458; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Frith CD, 1996, PSYCHOL MED, V26, P521, DOI 10.1017/S0033291700035601; Frith CD, 2000, BRAIN RES REV, V31, P357, DOI 10.1016/S0165-0173(99)00052-1; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gallese V, 2002, ATTENTION PERFORM, V19, P334; GASTAUT HJ, 1954, ELECTROEN CLIN NEURO, V6, P433, DOI 10.1016/0013-4694(54)90058-9; HAMALAINEN M, 1993, REV MOD PHYS, V65, P413, DOI 10.1103/RevModPhys.65.413; HAMALAINEN MS, 1994, MED BIOL ENG COMPUT, V32, P35, DOI 10.1007/BF02512476; Hong LE, 2004, SCHIZOPHR RES, V70, P293, DOI 10.1016/j.schres.2003.12.011; Kilner JM, 2009, J NEUROSCI, V29, P10153, DOI 10.1523/JNEUROSCI.2668-09.2009; Kim JJ, 2005, SCHIZOPHR RES, V77, P299, DOI 10.1016/j.schres.2005.04.006; KONIG P, 1995, CURR OPIN NEUROBIOL, V5, P511, DOI 10.1016/0959-4388(95)80013-1; Lee Kwang-Hyuk, 2003, Cogn Neuropsychiatry, V8, P57, DOI 10.1080/713752240; McGuire PK, 1996, BRIT J PSYCHIAT, V169, P148, DOI 10.1192/bjp.169.2.148; Nishitani N, 2002, NEURON, V36, P1211, DOI 10.1016/S0896-6273(02)01089-9; Nishitani N, 2000, P NATL ACAD SCI USA, V97, P913, DOI 10.1073/pnas.97.2.913; NURNBERGER JI, 1992, ACTA PSYCHIAT SCAND, V86, P1, DOI 10.1111/j.1600-0447.1992.tb03217.x; Oberman LM, 2005, COGNITIVE BRAIN RES, V24, P190, DOI 10.1016/j.cogbrainres.2005.01.014; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Penn DL, 1997, PSYCHOL BULL, V121, P114, DOI 10.1037/0033-2909.121.1.114; Rizzolatti G, 1996, COGNITIVE BRAIN RES, V3, P131, DOI 10.1016/0926-6410(95)00038-0; Rizzolatti G, 2008, CURR OPIN NEUROBIOL, V18, P179, DOI 10.1016/j.conb.2008.08.001; Rizzolatti G, 2004, COGNITIVE NEUROSCIENCES III, THIRD EDITION, P427; Ruby P, 2001, NAT NEUROSCI, V4, P546, DOI 10.1038/87510; Schurmann M, 2007, BRIT J PSYCHIAT, V191, P178, DOI 10.1192/bjp.bp.106.024604; Shibukawa Y, 2007, PAIN, V128, P180, DOI 10.1016/j.pain.2006.10.006; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; SPENCE SA, 2003, DISORDERS BRAIN MIND, P223; Spencer KM, 2008, BIOL PSYCHIAT, V64, P369, DOI 10.1016/j.biopsych.2008.02.021; Spencer KM, 2004, P NATL ACAD SCI USA, V101, P17288, DOI 10.1073/pnas.0406074101; Takahashi H, 2010, SCHIZOPHRENIA BULL, V36, P642, DOI 10.1093/schbul/sbn132; Toomey R, 2002, SCHIZOPHR RES, V53, P83, DOI 10.1016/S0920-9964(01)00177-3; Uddin LQ, 2006, SOC COGN AFFECT NEUR, V1, P65, DOI 10.1093/scan/nsl003; Uusitalo MA, 1997, MED BIOL ENG COMPUT, V35, P135, DOI 10.1007/BF02534144	51	26	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2011	6	11							e28087	10.1371/journal.pone.0028087	http://dx.doi.org/10.1371/journal.pone.0028087			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858JH	22132217	Green Published, Green Submitted, gold			2022-12-27	WOS:000297792400037
J	Morin, N; Cescut, J; Beopoulos, A; Lelandais, G; Le Berre, V; Uribelarrea, JL; Molina-Jouve, C; Nicaud, JM				Morin, Nicolas; Cescut, Julien; Beopoulos, Athanasios; Lelandais, Gaelle; Le Berre, Veronique; Uribelarrea, Jean-Louis; Molina-Jouve, Carole; Nicaud, Jean-Marc			Transcriptomic Analyses during the Transition from Biomass Production to Lipid Accumulation in the Oleaginous Yeast Yarrowia lipolytica	PLOS ONE			English	Article							RHODOSPORIDIUM-TORULOIDES; SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; BIODIESEL PRODUCTION; ACID BIOSYNTHESIS; ENCODING GENE; GATA FACTORS; NITROGEN; METABOLISM; REPRESSION	We previously developed a fermentation protocol for lipid accumulation in the oleaginous yeast Y. lipolytica. This process was used to perform transcriptomic time-course analyses to explore gene expression in Y. lipolytica during the transition from biomass production to lipid accumulation. In this experiment, a biomass concentration of 54.6 g(CDW)/l, with 0.18 g/g(CDW) lipid was obtained in ca. 32 h, with low citric acid production. A transcriptomic profiling was performed on 11 samples throughout the fermentation. Through statistical analyses, 569 genes were highlighted as differentially expressed at one point during the time course of the experiment. These genes were classified into 9 clusters, according to their expression profiles. The combination of macroscopic and transcriptomic profiles highlighted 4 major steps in the culture: (i) a growth phase, (ii) a transition phase, (iii) an early lipid accumulation phase, characterized by an increase in nitrogen metabolism, together with strong repression of protein production and activity; (iv) a late lipid accumulation phase, characterized by the rerouting of carbon fluxes within cells. This study explores the potential of Y. lipolytica as an alternative oil producer, by identifying, at the transcriptomic level, the genes potentially involved in the metabolism of oleaginous species.	[Morin, Nicolas; Beopoulos, Athanasios; Nicaud, Jean-Marc] INRA, Micalis UMR1319, Jouy En Josas, France; [Cescut, Julien; Le Berre, Veronique; Uribelarrea, Jean-Louis; Molina-Jouve, Carole] Univ Toulouse, INSA, UPS, INP,LISBP, Toulouse, France; [Cescut, Julien; Le Berre, Veronique; Uribelarrea, Jean-Louis; Molina-Jouve, Carole] INRA, UMR792, F-31931 Toulouse, France; [Cescut, Julien; Le Berre, Veronique; Uribelarrea, Jean-Louis; Molina-Jouve, Carole] CNRS, UMR5504, Toulouse, France; [Lelandais, Gaelle] Univ Paris 07, INTS, UMR S 665, Paris, France; [Le Berre, Veronique] INSA DGBA 135, Toulouse, France; [Nicaud, Jean-Marc] CNRS, Jouy En Josas, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; UDICE-French Research Universities; Universite Paris Cite; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite de Toulouse; Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS)	Morin, N (corresponding author), INRA, Micalis UMR1319, Jouy En Josas, France.	jean-marc.nicaud@grignon.inra.fr	Nicaud, jean marc/G-4204-2016; Anton Leberre, veronique/U-9208-2018; NICAUD, Jean-marc/ABA-9076-2021	Nicaud, jean marc/0000-0002-6679-972X; Molina Jouve, Carole/0000-0003-2097-4120	CALIN French national research program (DGCIS); ANR-PNRB [0701C0089]; EU	CALIN French national research program (DGCIS); ANR-PNRB(French National Research Agency (ANR)); EU(European Commission)	This work was labellized by Aerospace Valley (a non-profit association) and financially supported in part by CALIN French national research program (DGCIS), by the Lipicaero French national research program (ANR-PNRB) No. 0701C0089 and by the EU in the 7th Framework Programme for Research and Technological Development, under ALFA-BIRD (Alternative Fuels and Biofuels for Aircraft Development) project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Athenstaedt K, 2006, PROTEOMICS, V6, P1450, DOI 10.1002/pmic.200500339; Barth G, 1997, FEMS MICROBIOL REV, V19, P219, DOI 10.1016/S0168-6445(97)00002-8; Becker B, 1998, MOL MICROBIOL, V29, P151, DOI 10.1046/j.1365-2958.1998.00916.x; BEOPOULOS A, 2011, APPL MICROBIOL BIOTE; Beopoulos A, 2011, APPL MICROBIOL BIOT, V90, P1193, DOI 10.1007/s00253-011-3212-8; Beopoulos A, 2009, PROG LIPID RES, V48, P375, DOI 10.1016/j.plipres.2009.08.005; Beopoulos A, 2008, APPL ENVIRON MICROB, V74, P7779, DOI 10.1128/AEM.01412-08; Beopoulos A, 2009, BIOCHIMIE, V91, P692, DOI 10.1016/j.biochi.2009.02.004; Boczko EM, 2005, P NATL ACAD SCI USA, V102, P5647, DOI 10.1073/pnas.0501339102; Boles E, 2004, TOP CURR GENET, V9, P121; Bras LP, 2007, BIOMOL ENG, V24, P273, DOI 10.1016/j.bioeng.2007.04.003; Cescut J, 2011, J CHROMATOGR A, V1218, P373, DOI 10.1016/j.chroma.2010.12.003; CESCUT J, 2009, THESIS U TOULOUSE FR; Christensen T, 1998, APPL ENVIRON MICROB, V64, P3232; Coffman JA, 1997, J BACTERIOL, V179, P3416, DOI 10.1128/jb.179.11.3416-3429.1997; COOPER AJ, 1992, GENE, V114, P145; Cooper TG, 2002, FEMS MICROBIOL REV, V26, P223, DOI 10.1111/j.1574-6976.2002.tb00612.x; COSTES P, 2010, Patent No. 2010076432; Daugherty M, 2002, J BIOL CHEM, V277, P21431, DOI 10.1074/jbc.M201708200; DRAPKIN R, 1994, NATURE, V368, P769, DOI 10.1038/368769a0; DUBOIS E, 1978, J MOL BIOL, V122, P383, DOI 10.1016/0022-2836(78)90417-5; Dujon B, 2004, NATURE, V430, P35, DOI 10.1038/nature02579; Dulermo T, 2011, METAB ENG, V13, P482, DOI 10.1016/j.ymben.2011.05.002; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; EVANS CT, 1985, CAN J MICROBIOL, V31, P1000, DOI 10.1139/m85-189; Fickers P, 2005, FEMS YEAST RES, V5, P527, DOI 10.1016/j.femsyr.2004.09.004; Fickers P, 2011, BIOTECHNOL ADV, V29, P632, DOI 10.1016/j.biotechadv.2011.04.005; Finogenova TV, 2005, APPL BIOCHEM MICRO+, V41, P418, DOI 10.1007/s10438-005-0076-7; Forsberg H, 2001, CURR GENET, V40, P91, DOI 10.1007/s002940100244; FUKUI S, 1979, TRENDS BIOCHEM SCI, V4, P246, DOI 10.1016/0968-0004(79)90214-7; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Godard P, 2007, MOL CELL BIOL, V27, P3065, DOI 10.1128/MCB.01084-06; GRANGER LM, 1992, APPL MICROBIOL BIOT, V37, P13; HEDGES D, 1995, MOL CELL BIOL, V15, P1915; HINNEBUSCH AG, 1988, MICROBIOL REV, V52, P248, DOI 10.1128/MMBR.52.2.248-273.1988; HOLDSWORTH JE, 1988, J GEN MICROBIOL, V134, P2907; Kingsbury JM, 2006, EUKARYOT CELL, V5, P816, DOI 10.1128/EC.5.5.816-824.2006; Kohlhaw GB, 2003, MICROBIOL MOL BIOL R, V67, P1, DOI 10.1128/MMBR.67.1.1-15.2003; Li YH, 2007, ENZYME MICROB TECH, V41, P312, DOI 10.1016/j.enzmictec.2007.02.008; Liu HW, 2011, FEMS YEAST RES, V11, P42, DOI 10.1111/j.1567-1364.2010.00687.x; Liu HW, 2009, YEAST, V26, P553, DOI 10.1002/yea.1706; MacPherson S, 2006, MICROBIOL MOL BIOL R, V70, P583, DOI 10.1128/MMBR.00015-06; Madzak C, 2004, J BIOTECHNOL, V109, P63, DOI 10.1016/j.jbiotec.2003.10.027; Marzluf GA, 1997, MICROBIOL MOL BIOL R, V61, P17, DOI 10.1128/.61.1.17-32.1997; Mendizabal I, 1998, FEBS LETT, V425, P323, DOI 10.1016/S0014-5793(98)00249-X; Messick TE, 2008, J BIOL CHEM, V283, P11038, DOI 10.1074/jbc.M704398200; Minami E, 2006, FUEL, V85, P2479, DOI 10.1016/j.fuel.2006.04.017; Mlickova K, 2004, APPL ENVIRON MICROB, V70, P3918, DOI 10.1128/AEM.70.7.3918-3924.2004; Morgunov IG, 2004, BIOCHEMISTRY-MOSCOW+, V69, P1391, DOI 10.1007/s10541-005-0086-3; Nie KL, 2006, J MOL CATAL B-ENZYM, V43, P142, DOI 10.1016/j.molcatb.2006.07.016; Papanikolaou S, 2006, CURR MICROBIOL, V52, P134, DOI 10.1007/s00284-005-0223-7; Papanikolaou S, 2003, CURR MICROBIOL, V46, P398, DOI 10.1007/s00284-002-3907-2; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; PFEIFER K, 1989, CELL, V56, P291, DOI 10.1016/0092-8674(89)90903-3; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ramadhas AS, 2005, FUEL, V84, P335, DOI 10.1016/j.fuel.2004.09.016; Ratledge C, 2004, BIOCHIMIE, V86, P807, DOI 10.1016/j.biochi.2004.09.017; Ratledge C, 2002, ADV APPL MICROBIOL, V51, P1, DOI 10.1016/S0065-2164(02)51000-5; Ratledge C, 2002, BIOCHEM SOC T, V30, P1047, DOI 10.1042/bst0301047; Ratledge C., 2010, SINGLE CELL OILS, DOI [10.1016/B978-1-893997-73-8.50005-0, DOI 10.1016/B978-1-893997-73-8.50005-0]; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; SALTZGABERMULLER J, 1983, J BIOL CHEM, V258, P1465; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Spielewoy N, 2010, EUKARYOT CELL, V9, P592, DOI 10.1128/EC.00192-09; Steen EJ, 2010, NATURE, V463, P559, DOI 10.1038/nature08721; Thomas D, 1997, MICROBIOL MOL BIOL R, V61, P503, DOI 10.1128/.61.4.503-532.1997; THORPE RF, 1972, J GEN MICROBIOL, V72, P151, DOI 10.1099/00221287-72-1-151; Todd RB, 1997, FUNGAL GENET BIOL, V21, P388, DOI 10.1006/fgbi.1997.0993; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498	72	93	102	2	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2011	6	11							e27966	10.1371/journal.pone.0027966	http://dx.doi.org/10.1371/journal.pone.0027966			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858JH	22132183	Green Submitted, Green Published, gold			2022-12-27	WOS:000297792400028
J	Birch, AH; Arcand, SL; Oros, KK; Rahimi, K; Watters, AK; Provencher, D; Greenwood, CM; Mes-Masson, AM; Tonin, PN				Birch, Ashley H.; Arcand, Suzanna L.; Oros, Kathleen K.; Rahimi, Kurosh; Watters, A. Kevin; Provencher, Diane; Greenwood, Celia M.; Mes-Masson, Anne-Marie; Tonin, Patricia N.			Chromosome 3 Anomalies Investigated by Genome Wide SNP Analysis of Benign, Low Malignant Potential and Low Grade Ovarian Serous Tumours	PLOS ONE			English	Article							BORDERLINE TUMORS; GENETIC ALTERATIONS; TYROSINE KINASE; PRIMARY CULTURES; TP53 MUTATIONS; CANCER; HETEROZYGOSITY; HYBRIDIZATION; HOMOZYGOSITY; METHYLATION	Ovarian carcinomas exhibit extensive heterogeneity, and their etiology remains unknown. Histological and genetic evidence has led to the proposal that low grade ovarian serous carcinomas (LGOSC) have a different etiology than high grade carcinomas (HGOSC), arising from serous tumours of low malignant potential (LMP). Common regions of chromosome (chr) 3 loss have been observed in all types of serous ovarian tumours, including benign, suggesting that these regions contain genes important in the development of all ovarian serous carcinomas. A high-density genome-wide genotyping bead array technology, which assayed >600,000 markers, was applied to a panel of serous benign and LMP tumours and a small set of LGOSC, to characterize somatic events associated with the most indolent forms of ovarian disease. The genomic patterns inferred were related to TP53, KRAS and BRAF mutations. An increasing frequency of genomic anomalies was observed with pathology of disease: 3/22 (13.6%) benign cases, 40/53 (75.5%) LMP cases and 10/11 (90.9%) LGOSC cases. Low frequencies of chr3 anomalies occurred in all tumour types. Runs of homozygosity were most commonly observed on chr3, with the 3p12-p11 candidate tumour suppressor region the most frequently homozygous region in the genome. An LMP harboured a homozygous deletion on chr6 which created a GOPC-ROS1 fusion gene, previously reported as oncogenic in other cancer types. Somatic TP53, KRAS and BRAF mutations were not observed in benign tumours. KRAS-mutation positive LMP cases displayed significantly more chromosomal aberrations than BRAF-mutation positive or KRAS and BRAF mutation negative cases. Gain of 12p, which harbours the KRAS gene, was particularly evident. A pathology review reclassified all TP53-mutation positive LGOSC cases, some of which acquired a HGOSC status. Taken together, our results support the view that LGOSC could arise from serous benign and LMP tumours, but does not exclude the possibility that HGOSC may derive from LMP tumours.	[Birch, Ashley H.; Tonin, Patricia N.] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Arcand, Suzanna L.; Tonin, Patricia N.] McGill Univ Hlth Ctr, Res Inst, Montreal, PQ, Canada; [Oros, Kathleen K.; Greenwood, Celia M.] McGill Univ, Jewish Gen Hosp, Div Clin Epidemiol, Lady Davis Res Inst, Montreal, PQ H3T 1E2, Canada; [Oros, Kathleen K.; Greenwood, Celia M.] McGill Univ, Jewish Gen Hosp, Lady Davis Res Inst, Segal Canc Ctr, Montreal, PQ H3T 1E2, Canada; [Rahimi, Kurosh] Ctr Hosp Univ Montreal CHUM, Dept Pathol, Montreal, PQ, Canada; [Watters, A. Kevin] McGill Univ, Dept Pathol, Montreal, PQ, Canada; [Watters, A. Kevin] McGill Univ Hlth Ctr MUHC, Montreal, PQ, Canada; [Provencher, Diane; Mes-Masson, Anne-Marie] Ctr Rech Ctr Hosp Univ Montreal CRCHUM, Inst Canc Montreal, Montreal, PQ, Canada; [Provencher, Diane] Univ Montreal, Div Gynecol Oncol, Montreal, PQ, Canada; [Greenwood, Celia M.] McGill Univ, Dept Oncol, Montreal, PQ, Canada; [Greenwood, Celia M.] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Mes-Masson, Anne-Marie] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada; [Tonin, Patricia N.] McGill Univ, Dept Med, Montreal, PQ, Canada	McGill University; McGill University; McGill University; McGill University; Universite de Montreal; McGill University; Universite de Montreal; Universite de Montreal; McGill University; McGill University; Universite de Montreal; McGill University	Birch, AH (corresponding author), McGill Univ, Dept Human Genet, Montreal, PQ, Canada.	patricia.tonin@mcgill.ca		Mes-Masson, Anne-Marie/0000-0002-6498-266X; Greenwood, Celia/0000-0002-2427-5696	Fonds de la recherche du Quebec - Sante (FRQS); Canadian Institute of Health Research (CIHR); Ovarian Cancer Canada	Fonds de la recherche du Quebec - Sante (FRQS); Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Ovarian Cancer Canada	We thank Manon de Ladurantaye for her helpful expertise. Research was conducted at The Research Institute of the McGill University Health Centre which receives support from the Fonds de la recherche du Quebec - Sante (FRQS). Clinical specimens were provided by the Banque de tissus et de donnees of the Reseau de recherche sur le cancer of the FRQS affiliated with the Canadian Tumour Repository Network (CRTNet).; A.H.B. is a recipient of the Frederick Banting and Charles Best Canada Graduate Scholarships from the Canadian Institute of Health Research (CIHR). This research was supported by grants from the CIHR to P.N.T., D. P. and A.-M. M.-M., and from Ovarian Cancer Canada to P.N.T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALMOGUERA C, 1988, CELL, V53, P549, DOI 10.1016/0092-8674(88)90571-5; Angeloni D, 2006, GENE CHROMOSOME CANC, V45, P676, DOI 10.1002/gcc.20332; Arcand SL, 2008, BREAST CANCER RES TR, V108, P399, DOI 10.1007/s10549-007-9608-6; Assie G, 2008, AM J HUM GENET, V82, P903, DOI 10.1016/j.ajhg.2008.01.012; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bernardini M, 2004, BIOMED PHARMACOTHER, V58, P17, DOI 10.1016/j.biopha.2003.11.002; Birch AH, 2008, MOL CARCINOGEN, V47, P56, DOI 10.1002/mc.20361; Bonome T, 2005, CANCER RES, V65, P10602, DOI 10.1158/0008-5472.CAN-05-2240; Burbee DG, 2001, JNCI-J NATL CANCER I, V93, P691, DOI 10.1093/jnci/93.9.691; Charest A, 2003, GENE CHROMOSOME CANC, V37, P58, DOI 10.1002/gcc.10207; Charest A, 2003, P NATL ACAD SCI USA, V100, P916, DOI 10.1073/pnas.242741799; Charest A, 2006, CANCER RES, V66, P7473, DOI 10.1158/0008-5472.CAN-06-1193; Chen VW, 2003, CANCER, V97, P2631, DOI 10.1002/cncr.11345; Choi YL, 2006, VIRCHOWS ARCH, V448, P331, DOI 10.1007/s00428-005-0091-3; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; Cody NAL, 2007, ONCOGENE, V26, P618, DOI 10.1038/sj.onc.1209821; Cody NAL, 2009, MOL CARCINOGEN, V48, P1077, DOI 10.1002/mc.20535; Crispens MA, 2002, OBSTET GYNECOL, V99, P3, DOI 10.1016/S0029-7844(01)01649-0; DENICTOLIS M, 1992, CANCER, V70, P152, DOI 10.1002/1097-0142(19920701)70:1<152::AID-CNCR2820700125>3.0.CO;2-6; Fullwood P, 1999, CANCER RES, V59, P4662; Gibson J, 2006, HUM MOL GENET, V15, P789, DOI 10.1093/hmg/ddi493; Gorringe KL, 2007, CLIN CANCER RES, V13, P4731, DOI 10.1158/1078-0432.CCR-07-0502; Gorringe KL, 2009, MOL ONCOL, V3, P157, DOI 10.1016/j.molonc.2008.12.005; Gu TL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015640; Hauptmann S, 2002, HUM PATHOL, V33, P632, DOI 10.1053/hupa.2002.124913; Helou K, 2006, CANCER GENET CYTOGEN, V170, P1, DOI 10.1016/j.cancergencyto.2006.04.010; Henrichsen CN, 2009, HUM MOL GENET, V18, pR1, DOI 10.1093/hmg/ddp011; Herman JG, 1998, P NATL ACAD SCI USA, V95, P6870, DOI 10.1073/pnas.95.12.6870; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Hu J, 2002, CANCER GENET CYTOGEN, V139, P18, DOI 10.1016/S0165-4608(02)00603-9; Imura M, 2006, CANCER LETT, V241, P213, DOI 10.1016/j.canlet.2005.10.010; IWABUCHI H, 1995, CANCER RES, V55, P6172; Katsaros D, 2004, GYNECOL ONCOL, V94, P685, DOI 10.1016/j.ygyno.2004.06.018; Kiechle M, 2001, CANCER, V91, P534, DOI 10.1002/1097-0142(20010201)91:3<534::AID-CNCR1031>3.3.CO;2-K; Ku CS, 2011, HUM GENET, V129, P1, DOI 10.1007/s00439-010-0920-6; Kuo KT, 2009, CANCER RES, V69, P4036, DOI 10.1158/0008-5472.CAN-08-3913; Landen CN, 2008, J CLIN ONCOL, V26, P995, DOI 10.1200/JCO.2006.07.9970; Lencz T, 2007, P NATL ACAD SCI USA, V104, P19942, DOI 10.1073/pnas.0710021104; Li A J, 2001, Curr Oncol Rep, V3, P27, DOI 10.1007/s11912-001-0039-y; Lounis H, 1998, ONCOGENE, V17, P2359, DOI 10.1038/sj.onc.1202152; LOUNIS H, 1994, EXP CELL RES, V215, P303, DOI 10.1006/excr.1994.1346; Manderson EN, 2009, INT J GYNECOL CANCER, V19, P513, DOI 10.1111/IGC.0b013e3181a3cd38; Manderson EN, 2002, MOL CARCINOGEN, V34, P78, DOI 10.1002/mc.10051; McCluskey LL, 1999, GYNECOL ONCOL, V72, P87, DOI 10.1006/gyno.1998.5235; McQuillan R, 2008, AM J HUM GENET, V83, P359, DOI 10.1016/j.ajhg.2008.08.007; Mertens F, 1997, CANCER RES, V57, P2765; Modrek B, 2009, MOL CANCER RES, V7, P1244, DOI 10.1158/1541-7786.MCR-08-0532; Murphy MA, 2010, INT J CANC      1207; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; Osterberg L, 2006, CANCER GENET CYTOGEN, V167, P103, DOI 10.1016/j.cancergencyto.2006.01.009; Ouellet V, 2005, ONCOGENE, V24, P4672, DOI 10.1038/sj.onc.1208214; Ouellet V, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-152; PEJOVIC T, 1991, INT J CANCER, V47, P358, DOI 10.1002/ijc.2910470308; Pejovic T, 1996, CANCER GENET CYTOGEN, V92, P95, DOI 10.1016/S0165-4608(96)00169-0; Presneau N, 2005, MOL CARCINOGEN, V43, P141, DOI 10.1002/mc.20096; Presneau N, 2003, ONCOGENE, V22, P1568, DOI 10.1038/sj.onc.1206219; Provencher DM, 2000, IN VITRO CELL DEV-AN, V36, P357; Rhead B, 2010, NUCLEIC ACIDS RES, V38, pD613, DOI 10.1093/nar/gkp939; Roy WJ, 1997, ONCOGENE, V15, P2031, DOI 10.1038/sj.onc.1201372; Roy-Gagnon MH, 2011, HUM GENET, V129, P521, DOI 10.1007/s00439-010-0945-x; Sasaki H, 2011, J THORAC ONCOL, V6, P15, DOI 10.1097/JTO.0b013e31820594f0; Schmeler KM, 2008, GYNECOL ONCOL, V108, P510, DOI 10.1016/j.ygyno.2007.11.013; SCHULTZ DC, 1995, CANCER RES, V55, P2150; Schuyer M, 1999, EUR J OBSTET GYN R B, V82, P147, DOI 10.1016/S0301-2115(98)00217-6; Shepherd R, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar018; Simon-Sanchez J, 2007, HUM MOL GENET, V16, P1, DOI 10.1093/hmg/ddl436; Singer G, 2005, AM J SURG PATHOL, V29, P218, DOI 10.1097/01.pas.0000146025.91953.8d; Singer G, 2003, J NATL CANCER I, V95, P484, DOI 10.1093/jnci/95.6.484; Staebler A, 2002, HUM PATHOL, V33, P47, DOI 10.1053/hupa.2002.30212; Sun W, 2009, NUCLEIC ACIDS RES, V37, P5365, DOI 10.1093/nar/gkp493; Tang W, 2009, COLD SPRING HARB PRO; Thomas NA, 2003, INT J CANCER, V105, P499, DOI 10.1002/ijc.11107; Trimble CL, 2002, GYNECOL ONCOL, V86, P34, DOI 10.1006/gyno.2002.6711; Vang R, 2009, ADV ANAT PATHOL, V16, P267, DOI 10.1097/PAP.0b013e3181b4fffa; Wang S, 2009, GENET EPIDEMIOL, V33, P172, DOI 10.1002/gepi.20344; Wolf NG, 1999, GENE CHROMOSOME CANC, V25, P307, DOI 10.1002/(SICI)1098-2264(199908)25:4<307::AID-GCC1>3.0.CO;2-1; YANGFENG TL, 1991, INT J CANCER, V48, P678, DOI 10.1002/ijc.2910480508; Zhang GL, 2002, INT J GYNECOL CANCER, V12, P198	78	72	91	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2011	6	12							e28250	10.1371/journal.pone.0028250	http://dx.doi.org/10.1371/journal.pone.0028250			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863OC	22163003	Green Published, Green Submitted, gold			2022-12-27	WOS:000298173500012
J	Ding, F; Zarlenga, DS; Ren, YD; Li, GX; Luan, J; Ren, XF				Ding, Fan; Zarlenga, Dante S.; Ren, Yudong; Li, Guangxing; Luan, Jin; Ren, Xiaofeng			Use of the D-R Model to Define Trends in the Emergence of Ceftazidime-Resistant Escherichia coli in China	PLOS ONE			English	Article							INFECTION	Objective: To assess the efficacy of the D-R model for defining trends in the appearance of Ceftazidime-resistant Escherichia coli. Methods: Actual data related to the manifestation of Ceftazidime-resistant E. coli spanning years 1996-2009 were collected from the China National Knowledge Internet. These data originated from 430 publications encompassing 1004 citations of resistance. The GM(1,1) and the novel D-R models were used to fit current data and from this, predict trends in the appearance of the drug-resistant phenotype. The results were evaluated by Relative Standard Error (RSE), Mean Absolute Deviation (MAD) and Mean Absolute Error (MAE). Results: Results from the D-R model showed a rapid increase in the appearance of Ceftazidime-resistant E. coli in this region of the world. These results were considered accurate based upon the minor values calculated for RSE, MAD and MAE, and were equivalent to or better than those generated by the GM(1,1) model. Conclusion: The D-R model which was originally created to define trends in the transmission of swine viral diseases can be adapted to evaluating trends in the appearance of Ceftazidime-resistant E. coli. Using only a limited amount of data to initiate the study, our predictions closely mirrored the changes in drug resistance rates which showed a steady increase through 2005, a decrease between 2005 and 2008, and a dramatic inflection point and abrupt increase beginning in 2008. This is consistent with a resistance profile where changes in drug intervention temporarily delayed the upward trend in the appearance of the resistant phenotype; however, resistance quickly resumed its upward momentum in 2008 and this change was better predicted using the D-R model. Additional work is needed to determine if this pattern of "increase-control-increase" is indicative of Ceftazidime-resistant E. coli or can be generally ascribed to bacteria acquiring resistance to drugs in the absence of alternative intervention.	[Ding, Fan; Li, Guangxing; Ren, Xiaofeng] NE Agr Univ, Coll Vet Med, Harbin, Peoples R China; [Zarlenga, Dante S.] ARS, Anim Parasit Dis Lab, Beltsville, MD USA; [Ren, Yudong] NE Agr Univ, Coll Engn, Dept Comp, Harbin, Peoples R China; [Luan, Jin] Chinas Armed Police Force Ctr Dis Control, Beijing, Peoples R China	Northeast Agricultural University - China; Northeast Agricultural University - China	Ding, F (corresponding author), Chinese Armed Police Forest Force Command, Dept Hlth, Beijing, Peoples R China.	rxfemail@yahoo.com.cn			Heilongjiang Provincial University [1155-NCET-005]; Ministry of Education of the People's Republic of China	Heilongjiang Provincial University; Ministry of Education of the People's Republic of China(Ministry of Education, China)	The work of XR is funded by the Program for New Century Excellent Talents at the Heilongjiang Provincial University (1155-NCET-005), and the New Century Excellent Talents program from the Ministry of Education of the People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publishe, or preparation of the manuscript.	BENTLEY R, 1982, MICROBIOL REV, V46, P241, DOI 10.1128/MMBR.46.3.241-280.1982; CDC Division of Bacterial and Mycotic Diseases, 2009, ESCH COL O157 H7; DENG JL, 1982, SYST CONTROL LETT, V1, P288, DOI 10.1016/S0167-6911(82)80025-X; Ding F, 2011, INFECT GENET EVOL, V11, P222, DOI 10.1016/j.meegid.2010.09.015; Hudault S, 2001, GUT, V49, P47, DOI 10.1136/gut.49.1.47; Johnson JR, 2006, J INFECT DIS, V194, P71, DOI 10.1086/504921; Reid G, 2001, TRENDS MICROBIOL, V9, P424, DOI 10.1016/S0966-842X(01)02132-1; Vogt RL, 2005, PUBLIC HEALTH REP, V120, P174, DOI 10.1177/003335490512000211; XIONG HJ, 2005, GREY CONTROL; Yu PH, 2005, TIME SERIES ANAL	10	4	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2011	6	12							e27295	10.1371/journal.pone.0027295	http://dx.doi.org/10.1371/journal.pone.0027295			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863OC	22162989	Green Published, gold, Green Submitted			2022-12-27	WOS:000298173500003
J	Monk, AC; Siddall, NA; Fraser, B; McLaughlin, EA; Hime, GR				Monk, Adrian C.; Siddall, Nicole A.; Fraser, Barbara; McLaughlin, Eileen A.; Hime, Gary R.			Differential Roles of HOW in Male and Female Drosophila Germline Differentiation	PLOS ONE			English	Article							CELL SELF-RENEWAL; BAG-OF-MARBLES; RNA-BINDING PROTEIN; EMBRYONIC STEM-CELLS; DEVELOPMENTAL REGULATORS; ASYMMETRIC DIVISION; 2 ISOFORMS; TESTIS; OVARY; GENE	The adult gonads in both male and female Drosophila melanogaster produce gametes that originate from a regenerative pool of germline stem cells (GSCs). The differentiation programme that produces gametes must be co-ordinated with GSC maintenance and proliferation in order to regulate tissue regeneration. The HOW RNA-binding protein has been shown to maintain mitotic progression of male GSCs and their daughters by maintenance of Cyclin B expression as well as suppressing accumulation of the differentiation factor Bam. Loss of HOW function in the male germline results in loss of GSCs due to a delay in G2 and subsequent apoptosis. Here we show that female how mutant GSCs do not have any cell cycle defects although HOW continues to bind bam mRNA and suppress Bam expression. The role of HOW in suppressing germ cell Bam expression appears to be conserved between sexes, leading to different cellular outcomes in how mutants due to the different functions of Bam. In addition the role in maintaining Cyclin B expression has not been conserved so female how GSCs differentiate rather than arrest.	[Monk, Adrian C.; Siddall, Nicole A.; Hime, Gary R.] Univ Melbourne, Dept Anat & Cell Biol, Parkville, Vic 3052, Australia; [Fraser, Barbara; McLaughlin, Eileen A.] Univ Newcastle, Sch Environm & Life Sci, Callaghan, NSW 2308, Australia	University of Melbourne; University of Newcastle	Monk, AC (corresponding author), Univ Melbourne, Dept Anat & Cell Biol, Parkville, Vic 3052, Australia.	n.siddall@unimelb.edu.au	McLaughlin, Eileen A/G-7620-2013; McLaughlin, Eileen/AAF-5588-2021; Hime, Gary/B-7162-2015	Hime, Gary/0000-0003-4732-3184; McLaughlin, Eileen/0000-0002-5837-3876; Fraser, Barbara/0000-0002-8270-2860	Australian Research Council Centre of Excellence in Biotechnology and Development; National Health and Medical Research Council [509158]	Australian Research Council Centre of Excellence in Biotechnology and Development(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	The Australian Research Council Centre of Excellence in Biotechnology and Development and the National Health and Medical Research Council project grant #509158 supported this work (www.arc.gov.au, www.nhmrc.gov.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acquaviva C, 2006, J CELL SCI, V119, P2401, DOI 10.1242/jcs.02937; Asaoka-Taguchi M, 1999, NAT CELL BIOL, V1, P431, DOI 10.1038/15666; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bunt SM, 2004, GENESIS, V39, P84, DOI 10.1002/gene.20030; Chen DH, 2005, CURR BIOL, V15, P179, DOI 10.1016/j.cub.2005.01.004; Chen DH, 2003, CURR BIOL, V13, P1786, DOI 10.1016/j.cub.2003.09.033; Chen DH, 2003, DEVELOPMENT, V130, P1159, DOI 10.1242/dev.00325; Cox DN, 2000, DEVELOPMENT, V127, P503; Decotto E, 2005, DEV CELL, V9, P501, DOI 10.1016/j.devcel.2005.08.012; Forbes A, 1998, DEVELOPMENT, V125, P679; Fuller MT, 2007, SCIENCE, V316, P402, DOI 10.1126/science.1140861; Gonczy P, 1997, DEVELOPMENT, V124, P4361; HARDY RW, 1979, J ULTRA MOL STRUCT R, V69, P180, DOI 10.1016/S0022-5320(79)90108-4; Harris RE, 2011, DEV CELL, V20, P72, DOI 10.1016/j.devcel.2010.11.019; Insco ML, 2009, P NATL ACAD SCI USA, V106, P22311, DOI 10.1073/pnas.0912454106; Israeli D, 2007, DEVELOPMENT, V134, P2107, DOI 10.1242/dev.001594; Jacobs HW, 2002, CURR BIOL, V12, P1435, DOI 10.1016/S0960-9822(02)01074-6; Jiang XY, 2008, DEV CELL, V14, P494, DOI 10.1016/j.devcel.2008.02.018; Jung J, 2007, SCIENCE, V315, P1857, DOI 10.1126/science.1139517; Kawase E, 2004, DEVELOPMENT, V131, P1365, DOI 10.1242/dev.01025; Kiger AA, 2001, SCIENCE, V294, P2542, DOI 10.1126/science.1066707; Leatherman JL, 2008, DEV BIOL, V319, P548, DOI 10.1016/j.ydbio.2008.05.292; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Li Y, 2009, P NATL ACAD SCI USA, V106, P9304, DOI 10.1073/pnas.0901452106; Lin HF, 1997, DEVELOPMENT, V124, P2463; Maines JZ, 2007, DEVELOPMENT, V134, P1471, DOI 10.1242/dev.02810; MCKEARIN D, 1995, DEVELOPMENT, V121, P2937; MCKEARIN DM, 1990, GENE DEV, V4, P2242, DOI 10.1101/gad.4.12b.2242; Monk AC, 2010, CELL STEM CELL, V6, P348, DOI 10.1016/j.stem.2010.02.016; Nabel-Rosen H, 1999, MOL CELL, V4, P573, DOI 10.1016/S1097-2765(00)80208-7; Nabel-Rosen H, 2002, DEV CELL, V2, P183, DOI 10.1016/S1534-5807(01)00118-6; Ohlstein B, 1997, DEVELOPMENT, V124, P3651; Prout M, 1997, GENETICS, V146, P275; Schulz C, 2004, GENETICS, V167, P707, DOI 10.1534/genetics.103.023184; Shen R, 2009, P NATL ACAD SCI USA, V106, P11623, DOI 10.1073/pnas.0903325106; Shivdasani AA, 2003, CURR BIOL, V13, P2065, DOI 10.1016/j.cub.2003.10.063; Sigrist SJ, 1997, CELL, V90, P671, DOI 10.1016/S0092-8674(00)80528-0; Song XQ, 2004, DEVELOPMENT, V131, P1353, DOI 10.1242/dev.01026; Song XQ, 2002, SCIENCE, V296, P1855, DOI 10.1126/science.1069871; Tulina N, 2001, SCIENCE, V294, P2546, DOI 10.1126/science.1066700; Van Doren M, 1998, CURR BIOL, V8, P243; Volk T, 2008, TRENDS GENET, V24, P94, DOI 10.1016/j.tig.2007.11.009; Wang Z, 2005, CURR BIOL, V15, P328, DOI 10.1016/j.cub.2005.02.016; WHITFIELD WGF, 1989, NATURE, V338, P337, DOI 10.1038/338337a0; Xi RW, 2005, SCIENCE, V310, P1487, DOI 10.1126/science.1120140; Xie T, 1998, CELL, V94, P251, DOI 10.1016/S0092-8674(00)81424-5	46	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2011	6	12							e28508	10.1371/journal.pone.0028508	http://dx.doi.org/10.1371/journal.pone.0028508			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863OC	22163028	Green Published, gold			2022-12-27	WOS:000298173500028
J	Schurch, AC; Kremer, K; Hendriks, ACA; Freyee, B; McEvoy, CRE; van Crevel, R; Boeree, MJ; van Helden, P; Warren, RM; Siezen, RJ; van Soolingen, D				Schurch, Anita C.; Kremer, Kristin; Hendriks, Amber C. A.; Freyee, Benthe; McEvoy, Christopher R. E.; van Crevel, Reinout; Boeree, Martin J.; van Helden, Paul; Warren, Robin M.; Siezen, Roland J.; van Soolingen, Dick			SNP/RD Typing of Mycobacterium tuberculosis Beijing Strains Reveals Local and Worldwide Disseminated Clonal Complexes	PLOS ONE			English	Article							GENOMIC DELETIONS; NUCLEOTIDE POLYMORPHISMS; DISCRIMINATORY POWER; POPULATION-STRUCTURE; DIVERSITY; EVOLUTION; GENOTYPE; PHYLOGEOGRAPHY; LINEAGE; FAMILY	The Beijing strain is one of the most successful genotypes of Mycobacterium tuberculosis worldwide and appears to be highly homogenous according to existing genotyping methods. To type Beijing strains reliably we developed a robust typing scheme using single nucleotide polymorphisms (SNPs) and regions of difference (RDs) derived from whole-genome sequencing data of eight Beijing strains. SNP/RD typing of 259 M. tuberculosis isolates originating from 45 countries worldwide discriminated 27 clonal complexes within the Beijing genotype family. A total of 16 Beijing clonal complexes contained more than one isolate of known origin, of which two clonal complexes were strongly associated with South African origin. The remaining 14 clonal complexes encompassed isolates from different countries. Even highly resolved clonal complexes comprised isolates from distinct geographical sites. Our results suggest that Beijing strains spread globally on multiple occasions and that the tuberculosis epidemic caused by the Beijing genotype is at least partially driven by modern migration patterns. The SNPs and RDs presented in this study will facilitate future molecular epidemiological and phylogenetic studies on Beijing strains.	[Schurch, Anita C.; Kremer, Kristin; Hendriks, Amber C. A.; Freyee, Benthe; van Soolingen, Dick] Natl Inst Publ Hlth & Environm RIVM, TB Reference Lab, Ctr Infect Dis Control, Bilthoven, Netherlands; [Schurch, Anita C.; Siezen, Roland J.] Radboud Univ Nijmegen Med Ctr NCMLS, Ctr Mol & Biomol Informat, Nijmegen, Netherlands; [McEvoy, Christopher R. E.; van Helden, Paul; Warren, Robin M.] Univ Stellenbosch, Dept Sci & Technol, Natl Res Fdn Ctr Excellence Biomed TB Res, Med Res Council Ctr Mol & Cellular Biol, Cape Town, South Africa; [McEvoy, Christopher R. E.] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic 3010, Australia; [van Crevel, Reinout] Radboud Univ Nijmegen Med Ctr, Dept Med, Nijmegen, Netherlands; [Boeree, Martin J.; van Soolingen, Dick] Radboud Univ Nijmegen Med Ctr Univ Lung Ctr Dekke, Dept Pulm Dis, Nijmegen, Netherlands	Netherlands National Institute for Public Health & the Environment; Radboud University Nijmegen; National Research Foundation - South Africa; Stellenbosch University; University of Melbourne; Radboud University Nijmegen; Radboud University Nijmegen	Schurch, AC (corresponding author), Natl Inst Publ Hlth & Environm RIVM, TB Reference Lab, Ctr Infect Dis Control, CIb-LIS,Pb 22, Bilthoven, Netherlands.	dick.van.soolingen@rivm.nl	van Crevel, reinout/A-6636-2010; Boeree, Martin J./G-6132-2010; Siezen, Roland J/P-5745-2015	van Crevel, reinout/0000-0002-6233-6410; Schurch, Anita/0000-0003-1894-7545; Warren, Robin/0000-0001-5741-7358	RIVM [S/3230136/01/GA]; EU [LSHP-CT-2007-037919]	RIVM; EU(European Commission)	This study was supported by the Strategical Research (SOR) fund of the RIVM (S/3230136/01/GA) and the EU-funded TBadapt project (LSHP-CT-2007-037919). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadia E, 2010, INFECT GENET EVOL, V10, P1066, DOI 10.1016/j.meegid.2010.07.006; Achtman M, 2008, ANNU REV MICROBIOL, V62, P53, DOI 10.1146/annurev.micro.62.081307.162832; Alland D, 2003, J BACTERIOL, V185, P3392, DOI 10.1128/JB.185.11.3392-3399.2003; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 2010, Wkly Epidemiol Rec, V85, P69; Baker L, 2004, EMERG INFECT DIS, V10, P1568, DOI 10.3201/eid1009.040046; Bifani PJ, 2002, TRENDS MICROBIOL, V10, P168, DOI 10.1016/S0966-842X(02)02318-1; Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cubillos-Ruiz Andres, 2008, BMC Res Notes, V1, P110, DOI 10.1186/1756-0500-1-110; Devaux I, 2009, EMERG INFECT DIS, V15, P1052, DOI 10.3201/eid1507.080994; Ding CM, 2009, METHODS MOL BIOL, V578, P245, DOI 10.1007/978-1-60327-411-1_16; Dos Vultos T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001538; Fleischmann RD, 2002, J BACTERIOL, V184, P5479, DOI 10.1128/JB.184.19.5479-5490.2002; Flores L, 2007, J CLIN MICROBIOL, V45, P3393, DOI 10.1128/JCM.00828-07; Fournier PE, 2007, LANCET INFECT DIS, V7, P711, DOI 10.1016/S1473-3099(07)70260-8; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; Gilmour MW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-120; Glynn JR, 2006, EMERG INFECT DIS, V12, P736, DOI 10.3201/eid1205.050400; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gutacker MM, 2002, GENETICS, V162, P1533; Hanekom M, 2007, J CLIN MICROBIOL, V45, P1483, DOI 10.1128/JCM.02191-06; Hershberg R, 2008, PLOS BIOL, V6, P2658, DOI 10.1371/journal.pbio.0060311; Huard RC, 2003, J CLIN MICROBIOL, V41, P1637, DOI 10.1128/JCM.41.4.1637-1650.2003; HUNTER PR, 1990, J CLIN MICROBIOL, V28, P1903, DOI 10.1128/JCM.28.9.1903-1905.1990; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Iwamoto T, 2008, ANTIMICROB AGENTS CH, V52, P3805, DOI 10.1128/AAC.00579-08; Jurinke C, 2001, Methods Mol Biol, V170, P103; Kremer K, 2005, J CLIN MICROBIOL, V43, P314, DOI 10.1128/JCM.43.1.314-320.2005; Kremer K, 2004, J CLIN MICROBIOL, V42, P4040, DOI 10.1128/JCM.42.9.4040-4049.2004; Kremer K, 1999, J CLIN MICROBIOL, V37, P2607, DOI 10.1128/JCM.37.8.2607-2618.1999; Kremer K, 2009, EMERG INFECT DIS, V15, P335, DOI 10.3201/eid1502.080795; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Kuroda M, 2010, J CLIN MICROBIOL, V48, P2821, DOI 10.1128/JCM.00137-10; Lopez B, 2003, CLIN EXP IMMUNOL, V133, P30, DOI 10.1046/j.1365-2249.2003.02171.x; MacLean D, 2009, NAT REV MICROBIOL, V7, P287, DOI [10.1038/nrmicro2088, 10.1038/nrmicro2122]; Mathema B, 2006, CLIN MICROBIOL REV, V19, P658, DOI 10.1128/CMR.00061-05; Mestre O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016020; Mokrousov I, 2002, RES MICROBIOL, V153, P629, DOI 10.1016/S0923-2508(02)01374-8; Mokrousov I, 2008, INFECT GENET EVOL, V8, P777, DOI 10.1016/j.meegid.2008.07.003; Monot M, 2009, NAT GENET, V41, P1282, DOI 10.1038/ng.477; Morelli G, 2010, NAT GENET, V42, P1140, DOI 10.1038/ng.705; Mostowy S, 2002, J INFECT DIS, V186, P74, DOI 10.1086/341068; Narayanan S, 2008, INFECT GENET EVOL, V8, P474, DOI 10.1016/j.meegid.2007.09.007; Niemann S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007407; Parwati I, 2010, LANCET INFECT DIS, V10, P103, DOI 10.1016/S1473-3099(09)70330-5; Pearson T, 2009, INFECT GENET EVOL, V9, P1010, DOI 10.1016/j.meegid.2009.05.014; PLIKAYTIS BB, 1994, J CLIN MICROBIOL, V32, P1542, DOI 10.1128/JCM.32.6.1542-1546.1994; Qi WH, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000580; Rad ME, 2003, EMERG INFECT DIS, V9, P838, DOI 10.3201/eid0907.020803; Reed MB, 2009, J CLIN MICROBIOL, V47, P1119, DOI 10.1128/JCM.02142-08; Roltgen K, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000751; Schurch AC, 2011, INFECT GENET EVOL, V49, P1318; Smith NH, 2006, J THEOR BIOL, V239, P220, DOI 10.1016/j.jtbi.2005.08.036; Smith NH, 2009, NAT REV MICROBIOL, V7, P537, DOI 10.1038/nrmicro2165; Stavrum R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001973; Tsolaki AG, 2005, J CLIN MICROBIOL, V43, P3185, DOI 10.1128/JCM.43.7.3185-3191.2005; Tsolaki AG, 2004, P NATL ACAD SCI USA, V101, P4865, DOI 10.1073/pnas.0305634101; van Gent M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020340; van Helden PD, 2002, TRENDS MICROBIOL, V10, P167, DOI 10.1016/S0966-842X(02)02317-X; van Soolingen D, 2000, J INFECT DIS, V182, P1788, DOI 10.1086/317598; van Soolingen D, 2007, TUBERCULOSIS, V1; Vogler AJ, 2009, J BACTERIOL, V191, P2474, DOI 10.1128/JB.01786-08	66	24	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e28365	10.1371/journal.pone.0028365	http://dx.doi.org/10.1371/journal.pone.0028365			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22162765	Green Published, Green Submitted, gold			2022-12-27	WOS:000298172800028
J	Moore, MS; Reichard, JD; Murtha, TD; Zahedi, B; Fallier, RM; Kunz, TH				Moore, Marianne S.; Reichard, Jonathan D.; Murtha, Timothy D.; Zahedi, Bita; Fallier, Renee M.; Kunz, Thomas H.			Specific Alterations in Complement Protein Activity of Little Brown Myotis (Myotis lucifugus) Hibernating in White-Nose Syndrome Affected Sites	PLOS ONE			English	Article							IMMUNE-RESPONSE; FUNGAL-INFECTIONS; GROUND-SQUIRRELS; CITELLUS TRIDECEMLINEATUS; HUMORAL IMMUNITY; ADIPOSE-TISSUE; TRADE-OFFS; BODY-FAT; BATS; COST	White-nose syndrome (WNS) is the most devastating condition ever reported for hibernating bats, causing widespread mortality in the northeastern United States. The syndrome is characterized by cutaneous lesions caused by a recently identified psychrophilic and keratinophylic fungus (Geomyces destructans), depleted fat reserves, atypical behavior, and damage to wings; however, the proximate cause of mortality is still uncertain. To assess relative levels of immunocompetence in bats hibernating in WNS-affected sites compared with levels in unaffected bats, we describe blood plasma complement protein activity in hibernating little brown myotis (Myotis lucifugus) based on microbicidal competence assays using Escherichia coli, Staphylococcus aureus and Candida albicans. Blood plasma from bats collected during mid-hibernation at WNS-affected sites had higher bactericidal ability against E. coli and S. aureus, but lower fungicidal ability against C. albicans when compared with blood plasma from bats collected at unaffected sites. Within affected sites during mid-hibernation, we observed no difference in microbicidal ability between bats displaying obvious fungal infections compared to those without. Bactericidal ability against E. coli decreased significantly as hibernation progressed in bats collected from an affected site. Bactericidal ability against E. coli and fungicidal ability against C. albicans were positively correlated with body mass index (BMI) during late hibernation. We also compared complement activity against the three microbes within individuals and found that the ability of blood plasma from hibernating M. lucifugus to lyse microbial cells differed as follows: E. coli > S. aureus > C. albicans. Overall, bats affected by WNS experience both relatively elevated and reduced innate immune responses depending on the microbe tested, although the cause of observed immunological changes remains unknown. Additionally, considerable trade-offs may exist between energy conservation and immunological responses. Relationships between immune activity and torpor, including associated energy expenditure, are likely critical components in the development of WNS.	[Moore, Marianne S.; Reichard, Jonathan D.; Murtha, Timothy D.; Zahedi, Bita; Fallier, Renee M.; Kunz, Thomas H.] Boston Univ, Dept Biol, Ctr Ecol & Conservat Biol, Boston, MA 02215 USA	Boston University	Moore, MS (corresponding author), Bucknell Univ, Dept Biol, Lewisburg, PA 17837 USA.	msm035@bucknell.edu		Murtha, Timothy/0000-0001-5427-9340	Bat Conservation International; National Speleological Society; New York Department of Environmental Conservation; United States Fish and Wildlife Service	Bat Conservation International; National Speleological Society; New York Department of Environmental Conservation; United States Fish and Wildlife Service(US Fish & Wildlife Service)	Funding for this study was provided by Bat Conservation International (http://batcon.org/), the National Speleological Society (http://www.caves.org/index.shtml), New York Department of Environmental Conservation (http://www.dec.ny.gov/) and the United States Fish and Wildlife Service (http://www.fws.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahima RS, 2000, TRENDS ENDOCRIN MET, V11, P327, DOI 10.1016/S1043-2760(00)00301-5; ARDAWI MSM, 1985, ESSAYS BIOCHEM, V21, P1; Barr DP, 1922, ARCH INTERN MED, V29, P608, DOI 10.1001/archinte.1922.00110050055004; Blanco JL, 2008, VET IMMUNOL IMMUNOP, V125, P47, DOI 10.1016/j.vetimm.2008.04.020; Blehert DS, 2009, SCIENCE, V323, P227, DOI 10.1126/science.1163874; Bonneaud C, 2003, AM NAT, V161, P367, DOI 10.1086/346134; BROWN MB, 1974, J AM STAT ASSOC, V69, P364, DOI 10.2307/2285659; Burton RS, 1999, FUNCT ECOL, V13, P232, DOI 10.1046/j.1365-2435.1999.00302.x; CAHILL JE, 1967, J PARASITOL, V53, P110, DOI 10.2307/3276633; CALDER PC, 1994, BIOCHEM J, V300, P509, DOI 10.1042/bj3000509; Carey HV, 2003, PHYSIOL REV, V83, P1153, DOI 10.1152/physrev.00008.2003; Chaturvedi V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010783; CHUTE RM, 1960, J PARASITOL, V46, P855, DOI 10.2307/3275550; Chute RM, 1960, J PARASITOLOGY S, V46, P21; Courtin F, 2010, VET PATHOL, V47, P214, DOI 10.1177/0300985809358614; Cryan PM, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-135; Demas GE, 2005, P ROY SOC B-BIOL SCI, V272, P1845, DOI 10.1098/rspb.2005.3126; Demas GE, 2003, P ROY SOC B-BIOL SCI, V270, P905, DOI 10.1098/rspb.2003.2341; Demas GE, 2004, HORM BEHAV, V45, P173, DOI 10.1016/j.yhbeh.2003.11.002; Demas GE, 1997, AM J PHYSIOL-REG I, V273, pR1631, DOI 10.1152/ajpregu.1997.273.5.R1631; EMMONS RW, 1966, AM J TROP MED HYG, V15, P428, DOI 10.4269/ajtmh.1966.15.428; Eraud C, 2005, FUNCT ECOL, V19, P110, DOI 10.1111/j.0269-8463.2005.00934.x; Frick WF, 2010, SCIENCE, V329, P679, DOI 10.1126/science.1188594; Galletti G, 1982, ACTA LEPROL, V88, P23; Gargas A, 2009, MYCOTAXON, V108, P147, DOI 10.5248/108.147; JAROSLOW BN, 1972, J EXP ZOOL, V181, P111, DOI 10.1002/jez.1401810112; JAROSLOW BN, 1968, P NATL ACAD SCI USA, V61, P69, DOI 10.1073/pnas.61.1.69; KALABUKHOV N. I., 1958, Journal of Microbiology, Epidemiology and Immunobiology, V29, P1453; Kurtz CC, 2007, DEV COMP IMMUNOL, V31, P415, DOI 10.1016/j.dci.2006.07.003; LARSEN B, 1971, COMP BIOCHEM PHYSIOL, V38, P571, DOI 10.1016/0300-9629(71)90124-1; LEHMANN PF, 1985, VET IMMUNOL IMMUNOP, V10, P33, DOI 10.1016/0165-2427(85)90038-8; Lochmiller RL, 2000, OIKOS, V88, P87, DOI 10.1034/j.1600-0706.2000.880110.x; Lorch JM, 2011, NATURE, V480, P376, DOI 10.1038/nature10590; MANASEK FJ, 1965, J CELL COMPAR PHYSL, V65, P319, DOI 10.1002/jcp.1030650305; Maniero GD, 2002, DEV COMP IMMUNOL, V26, P563, DOI 10.1016/S0145-305X(02)00006-X; Maniero GD, 2000, LIFE IN THE COLD, P493; Martin LB, 2003, P ROY SOC B-BIOL SCI, V270, P153, DOI 10.1098/rspb.2002.2185; Martin LB, 2006, INTEGR COMP BIOL, V46, P1030, DOI 10.1093/icb/icl039; Martinkova N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013853; Meteyer CU, 2009, J VET DIAGN INVEST, V21, P411, DOI 10.1177/104063870902100401; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Nicola AM, 2008, CURR OPIN MICROBIOL, V11, P313, DOI 10.1016/j.mib.2008.05.011; Ots I, 2001, P ROY SOC B-BIOL SCI, V268, P1175, DOI 10.1098/rspb.2001.1636; Prendergast BJ, 2002, AM J PHYSIOL-REG I, V282, pR1054, DOI 10.1152/ajpregu.00562.2001; Puechmaille SJ, 2010, EMERG INFECT DIS, V16, P290, DOI 10.3201/eid1602.091391; Reichard JD, 2009, ACTA CHIROPTEROL, V11, P457, DOI 10.3161/150811009X485684; Romani L, 2008, MED MYCOL, V46, P515, DOI 10.1080/13693780801971450; Sadd BM, 2009, EVOL APPL, V2, P113, DOI 10.1111/j.1752-4571.2008.00057.x; Shoman S, 2005, BRIT J HAEMATOL, V129, P569; Speth C, 2004, MYCOSES, V47, P93, DOI 10.1111/j.1439-0507.2004.00979.x; Speth C, 2008, MYCOSES, V51, P477, DOI 10.1111/j.1439-0507.2008.01597.x; Sulkin S E, 1974, Monogr Virol, V8, P1; THOMAS DW, 1990, J MAMMAL, V71, P475, DOI 10.2307/1381967; Tieleman BI, 2005, P ROY SOC B-BIOL SCI, V272, P1715, DOI 10.1098/rspb.2005.3155; Turner Gregory G., 2009, Bat Research News, V50, P47; Wibbelt G, 2010, EMERG INFECT DIS, V16, P1237, DOI 10.3201/eid1608.100002; Xu DL, 2010, COMP BIOCHEM PHYS A, V155, P25, DOI 10.1016/j.cbpa.2009.09.003; Zysling DA, 2007, J COMP PHYSIOL B, V177, P339, DOI 10.1007/s00360-006-0133-4	58	44	45	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e27430	10.1371/journal.pone.0027430	http://dx.doi.org/10.1371/journal.pone.0027430			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140440	Green Published, gold			2022-12-27	WOS:000298168100009
J	Park, JB; Kim, BK; Kwon, YW; Muller, DN; Lee, HC; Youn, SW; Choi, YE; Lee, SW; Yang, HM; Cho, HJ; Park, KW; Kim, HS				Park, Jun-Bean; Kim, Baek-Kyung; Kwon, Yoo-Wook; Muller, Dominik N.; Lee, Hyun-Chae; Youn, Seock-Won; Choi, Young-Eun; Lee, Sae-Won; Yang, Han-Mo; Cho, Hyun-Jai; Park, Kyung Woo; Kim, Hyo-Soo			Peroxisome Proliferator-Activated Receptor-Gamma Agonists Suppress Tissue Factor Overexpression in Rat Balloon Injury Model with Paclitaxel Infusion	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; ISCHEMIA-REPERFUSION INJURY; FACTOR PATHWAY INHIBITOR; HUMAN ENDOTHELIAL-CELLS; DRUG-ELUTING STENTS; FACTOR EXPRESSION; NEOINTIMAL HYPERPLASIA; PPAR-GAMMA; ROSIGLITAZONE; MECHANISM	The role and underlying mechanisms of rosiglitazone, a peroxisome proliferator-activated receptor-gamma (PPAR-gamma) agonist, on myocardial infarction are poorly understood. We investigated the effects of this PPAR-gamma agonist on the expression of tissue factor (TF), a primary molecule for thrombosis, and elucidated its underlying mechanisms. The PPAR-gamma agonist inhibited TF expression in response to TNF-alpha in human umbilical vein endothelial cells, human monocytic leukemia cell line, and human umbilical arterial smooth muscle cells. The overexpression of TF was mediated by increased phosphorylation of mitogen-activated protein kinase (MAPK), which was blocked by the PPAR-gamma agonist. The effective MAPK differed depending on each cell type. Luciferase and ChIP assays showed that transcription factor, activator protein-1 (AP-1), was a pivotal target of the PPAR-gamma agonist to lower TF transcription. Intriguingly, two main drugs for drug-eluting stent, paclitaxel or rapamycin, significantly exaggerated thrombin-induced TF expression, which was also effectively blocked by the PPAR-gamma agonist in all cell types. This PPAR-gamma agonist did not impair TF pathway inhibitor (TFPI) in three cell types. In rat balloon injury model (Sprague-Dawley rats, n = 10/group) with continuous paclitaxel infusion, the PPAR-gamma agonist attenuated TF expression by 70 +/- 5% (n = 4; P,<0.0001) in injured vasculature. Taken together, rosiglitazone reduced TF expression in three critical cell types involved in vascular thrombus formation via MAPK and AP-1 inhibitions. Also, this PPAR-gamma agonist reversed the paclitaxel-induced aggravation of TF expression, which suggests a possibility that the benefits might outweigh its risks in a group of patients with paclitaxel-eluting stent implanted.	[Park, Jun-Bean; Yang, Han-Mo; Cho, Hyun-Jai; Park, Kyung Woo; Kim, Hyo-Soo] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea; [Kim, Baek-Kyung; Kwon, Yoo-Wook; Lee, Hyun-Chae; Youn, Seock-Won; Choi, Young-Eun; Lee, Sae-Won; Cho, Hyun-Jai; Kim, Hyo-Soo] Seoul Natl Univ, Coll Med, Natl Res Lab Stem Cell Niche, Seoul, South Korea; [Kwon, Yoo-Wook; Lee, Sae-Won; Cho, Hyun-Jai; Kim, Hyo-Soo] Seoul Natl Univ Hosp, Innovat Res Inst Cell Therapy, Seoul 110744, South Korea; [Muller, Dominik N.] Max Delbruck Ctr, Berlin, Germany; [Muller, Dominik N.] Expt & Clin Res Ctr, Berlin, Germany	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Park, JB (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea.	hyosoo@snu.ac.kr	Park, Kyung Woo/AAX-3046-2020; Park, Jun-Bean/AAN-3026-2021	Park, Jun-Bean/0000-0003-4053-8713; Muller, Dominik N/0000-0003-3650-5644; Youn, Seock-Won/0000-0003-3275-2170	National Research Foundation; Korea government (MEST) [2010-0020257]; Ministry of Health & Welfare, Republic of Korea [A100476]	National Research Foundation; Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by the National Research Foundation grant funded by the Korea government (MEST) [grant number: 2010-0020257, URL: http://www.mest.go.kr/]; and the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [grant number: A100476, URL:http://mw.go.kr/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelrahman M, 2005, CARDIOVASC RES, V65, P772, DOI 10.1016/j.cardiores.2004.12.008; Bari D Study Grp, 2009, NEW ENGL J MED, V360, P2503, DOI 10.1056/NEJMoa0805796; Bavendiek U, 2002, J BIOL CHEM, V277, P25032, DOI 10.1074/jbc.M204003200; BIERHAUS A, 1995, J BIOL CHEM, V270, P26419, DOI 10.1074/jbc.270.44.26419; Boyle JG, 2008, J BIOL CHEM, V283, P11210, DOI 10.1074/jbc.M710048200; Calkin AC, 2005, ARTERIOSCL THROM VAS, V25, P1903, DOI 10.1161/01.ATV.0000177813.99577.6b; Camera M, 1999, ARTERIOSCL THROM VAS, V19, P531, DOI 10.1161/01.ATV.19.3.531; Caplice NM, 1998, CIRC RES, V83, P1264, DOI 10.1161/01.RES.83.12.1264; Chen M, 2007, HYPERTENS RES, V30, P971, DOI 10.1291/hypres.30.971; Coyle AT, 2006, BIOCHEM PHARMACOL, V71, P1308, DOI 10.1016/j.bcp.2006.01.011; Farb A, 2001, CIRCULATION, V104, P473, DOI 10.1161/hc3001.092037; He MX, 2006, THROMB RES, V117, P579, DOI 10.1016/j.thromres.2005.04.033; Home PD, 2009, LANCET, V373, P2125, DOI 10.1016/S0140-6736(09)60953-3; Lagerqvist B, 2007, NEW ENGL J MED, V356, P1009, DOI 10.1056/NEJMoa067722; Lee CS, 2009, ARTERIOSCL THROM VAS, V29, P472, DOI 10.1161/ATVBAHA.108.176230; Li DJ, 2008, BLOOD, V111, P3522, DOI 10.1182/blood-2007-09-111518; Liu HR, 2009, CARDIOVASC RES, V81, P344, DOI 10.1093/cvr/cvn308; Llorente-Cortes V, 2004, CIRCULATION, V110, P452, DOI 10.1161/01.CIR.0000136032.40666.3D; Lloyd S, 2002, CHEM-BIOL INTERACT, V142, P57, DOI 10.1016/S0009-2797(02)00054-6; Loke YK, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d1309; Lupu C, 1997, ARTERIOSCL THROM VAS, V17, P2964, DOI 10.1161/01.ATV.17.11.2964; Mackman N, 2004, ARTERIOSCL THROM VAS, V24, P1015, DOI 10.1161/01.ATV.0000130465.23430.74; MACKMAN N, 1995, FASEB J, V9, P883, DOI 10.1096/fasebj.9.10.7615158; MARMUR JD, 1993, J CLIN INVEST, V91, P2253, DOI 10.1172/JCI116452; Mohanty P, 2004, J CLIN ENDOCR METAB, V89, P2728, DOI 10.1210/jc.2003-032103; Morrison A, 2011, AM J PHYSIOL-HEART C, V301, pH895, DOI 10.1152/ajpheart.00137.2011; Muller DN, 2000, AM J PATHOL, V157, P111, DOI 10.1016/S0002-9440(10)64523-3; Napoleone E, 1997, BLOOD, V89, P541, DOI 10.1182/blood.V89.2.541; NEMERSON Y, 1988, BLOOD, V71, P1; Nesto RW, 2003, CIRCULATION, V108, P2941, DOI 10.1161/01.CIR.0000103683.99399.7E; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Paget MB, 2011, DIABETES OBES METAB, V13, P662, DOI 10.1111/j.1463-1326.2011.01392.x; Park KW, 2003, ARTERIOSCL THROM VAS, V23, P1364, DOI 10.1161/01.ATV.0000081633.53390.B4; Parulkar AA, 2001, ANN INTERN MED, V134, P61, DOI 10.7326/0003-4819-134-1-200101020-00014; Pickavance LC, 1999, BRIT J PHARMACOL, V128, P1570, DOI 10.1038/sj.bjp.0702932; Pucci A, 2011, ATHEROSCLEROSIS, V218, P479, DOI 10.1016/j.atherosclerosis.2011.06.009; Schecter AD, 1997, J CLIN INVEST, V100, P2276, DOI 10.1172/JCI119765; SOLLOTT SJ, 1995, J CLIN INVEST, V95, P1869, DOI 10.1172/JCI117867; Stahli BE, 2006, CIRC RES, V99, P149, DOI 10.1161/01.RES.0000233379.92010.fd; Steffel J, 2006, CIRCULATION, V113, P722, DOI 10.1161/CIRCULATIONAHA.105.567297; Steffel J, 2005, CIRCULATION, V112, P2002, DOI 10.1161/CIRCULATIONAHA.105.569129; Steffel J, 2005, CIRCULATION, V112, P341, DOI 10.1161/CIRCULATIONAHA.105.553735; Thornton SR, 1997, EUR J PHARMACOL, V340, P161, DOI 10.1016/S0014-2999(97)01434-9; Watt J, 2008, CLIN SCI, V114, P265, DOI 10.1042/CS20070207; Yang HM, 2004, CIRCULATION, V110, P301, DOI 10.1161/01.CIR.0000135467.43430.16; Yuan L, 2003, ACTA PHARMACOL SIN, V24, P429	46	2	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2011	6	11							e28327	10.1371/journal.pone.0028327	http://dx.doi.org/10.1371/journal.pone.0028327			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863LT	22140576	Green Published, gold, Green Accepted			2022-12-27	WOS:000298166300048
J	Raju, I; Abraham, EC				Raju, Ilangovan; Abraham, Edathara C.			Congenital Cataract Causing Mutants of alpha A-Crystallin/sHSP Form Aggregates and Aggresomes Degraded through Ubiquitin-Proteasome Pathway	PLOS ONE			English	Article							DEGRADATION; MUTATION; CRYAA; CELLS; HDAC6	Background: Mutations of human alpha A-crystallin cause congenital cataract by protein aggregation. How mutations of alpha A-crystallin cause disease pathogenesis through protein aggregation is not well understood. To better understand the cellular events leading to protein aggregation, we transfected cataract causing mutants, R12C, R21L, R21W, R49C, R54C, R116C and R116H, of human alpha A-crystallin in HeLa cells and examined the formation of intracellular protein aggregates and aggresomes by confocal microscopy. Methodology/Principal Findings: YFP-tagged human alpha A-wild-type (alpha A-wt) was sub-cloned and the mutants were generated by site-directed mutagenesis. The alpha A-wt and the mutants were individually transfected or co-transfected with CFP-tagged alpha A-wt or alpha B-wild-type (alpha B-wt) in HeLa cells(Overexpression of these mutants forms multiple small dispersed cytoplasmic aggregates as well as aggresomes(Co-expression of aB-wt with these mutants significantly inhibited protein aggregates where as co-expression with alpha A-wt enhanced protein aggregates which seems to be due to co-aggregation of the mutants with alpha A-wt. Aggresomes were validated by double immunofluorescence by co-localization of gamma-tubulin, a centrosome marker protein with alpha A-crystallin. Furthermore, increased ubiquitination was detected in R21W, R116C and R116H as assessed by western blot analyses. Immunostaining with an ubiquitin antibody revealed that ubiquitin inclusions in the perinuclear regions were evident only in R116C transfected cells(Pulse chase assay, after cycloheximide treatment, suggested that R116C degraded faster than the wild-type control. Conclusions/Significance: Mutants of alpha A-crystallin form aggregates and aggresomes. Co-expression of alpha A-wt with the mutants increased aggregates and co-expression of alpha B-wt with the mutants significantly decreased the aggregates. The mutant, R116C protein degraded faster than wild-type control and increased ubiquitination was evident in R116C expressing cells.	[Raju, Ilangovan; Abraham, Edathara C.] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences	Raju, I (corresponding author), Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA.	ecabraham@uams.edu			National Institute of Health from National Eye Institute [5RO1EY001352-15]; NATIONAL EYE INSTITUTE [R01EY011352] Funding Source: NIH RePORTER	National Institute of Health from National Eye Institute; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institute of Health grant 5RO1EY001352-15 from National Eye Institute to ECA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; DEJONG WW, 1975, FEBS LETT, V58, P310, DOI 10.1016/0014-5793(75)80286-9; DeMartino GN, 2007, CELL, V129, P659, DOI 10.1016/j.cell.2007.05.007; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Graw J, 2006, GRAEF ARCH CLIN EXP, V244, P912, DOI 10.1007/s00417-005-0234-x; Hansen L, 2007, INVEST OPHTH VIS SCI, V48, P3937, DOI 10.1167/iovs.07-0013; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Iwata A, 2005, J BIOL CHEM, V280, P40282, DOI 10.1074/jbc.M508786200; Junn E, 2002, J BIOL CHEM, V277, P47870, DOI 10.1074/jbc.M203159200; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Kore RA, 2010, STRUCTURAL FUNCTIONA; Kumarasamy A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003175; Litt M, 1998, HUM MOL GENET, V7, P471, DOI 10.1093/hmg/7.3.471; Luciani A, 2010, NAT CELL BIOL, V12, P863, DOI 10.1038/ncb2090; Mackay DS, 2003, EUR J HUM GENET, V11, P784, DOI 10.1038/sj.ejhg.5201046; Pickart CM, 2004, NAT REV MOL CELL BIO, V5, P177, DOI 10.1038/nrm1336; Raju I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019876; RECHSTEINER M, 1993, J BIOL CHEM, V268, P6065; Reddy MA, 2004, SURV OPHTHALMOL, V49, P300, DOI 10.1016/j.survophthal.2004.02.013; Ren PH, 2009, NAT CELL BIOL, V11, P219, DOI 10.1038/ncb1830; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Santhiya S, 2006, MOL VIS, V12, P768; Tanaka M, 2004, J BIOL CHEM, V279, P4625, DOI 10.1074/jbc.M310994200; Taylor JP, 2003, HUM MOL GENET, V12, P749, DOI 10.1093/hmg/ddg074; Vanita V, 2006, MOL VIS, V12, P518; Wileman T, 2007, ANNU REV MICROBIOL, V61, P149, DOI 10.1146/annurev.micro.57.030502.090836; Xia CH, 2006, INVEST OPHTH VIS SCI, V47, P3004, DOI 10.1167/iovs.06-0178; Zaarur N, 2008, J BIOL CHEM, V283, P27575, DOI 10.1074/jbc.M802216200; Zhang HL, 2010, J MOL CELL CARDIOL, V49, P918, DOI 10.1016/j.yjmcc.2010.09.004; Zhang XY, 2007, INVEST OPHTH VIS SCI, V48, P4200, DOI 10.1167/iovs.07-0196; Zobel ATC, 2003, HUM MOL GENET, V12, P1609, DOI 10.1093/hmg/ddg173	33	22	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2011	6	11							e28085	10.1371/journal.pone.0028085	http://dx.doi.org/10.1371/journal.pone.0028085			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863LT	22140512	Green Submitted, Green Published, gold			2022-12-27	WOS:000298166300026
J	Sirois, M; Robitaille, L; Allary, R; Shah, M; Woelk, CH; Estaquier, J; Corbeil, J				Sirois, Melissa; Robitaille, Lynda; Allary, Robin; Shah, Mohak; Woelk, Christopher H.; Estaquier, Jerome; Corbeil, Jacques			TRAF6 and IRF7 Control HIV Replication in Macrophages	PLOS ONE			English	Article							NF-KAPPA-B; IMMUNODEFICIENCY-VIRUS TYPE-1; REGULATORY FACTORS 3; TOLL-LIKE RECEPTORS; RIG-I; INTERFERON-ALPHA; TRANSCRIPTION FACTORS; DIFFERENTIAL REGULATION; INDUCED ACTIVATION; POSITIVE FEEDBACK	The innate immune system recognizes virus infection and evokes antiviral responses which include producing type I interferons (IFNs). The induction of IFN provides a crucial mechanism of antiviral defense by upregulating interferon-stimulated genes (ISGs) that restrict viral replication. ISGs inhibit the replication of many viruses by acting at different steps of their viral cycle. Specifically, IFN treatment prior to in vitro human immunodeficiency virus (HIV) infection stops or significantly delays HIV-1 production indicating that potent inhibitory factors are generated. We report that HIV-1 infection of primary human macrophages decreases tumor necrosis factor receptor-associated factor 6 (TRAF6) and virus-induced signaling adaptor (VISA) expression, which are both components of the IFN signaling pathway controlling viral replication. Knocking down the expression of TRAF6 in macrophages increased HIV-1 replication and augmented the expression of IRF7 but not IRF3. Suppressing VISA had no impact on viral replication. Overexpression of IRF7 resulted in enhanced viral replication while knocking down IRF7 expression in macrophages significantly reduced viral output. These findings are the first demonstration that TRAF6 can regulate HIV-1 production and furthermore that expression of IRF7 promotes HIV-1 replication.	[Sirois, Melissa; Robitaille, Lynda; Allary, Robin; Estaquier, Jerome; Corbeil, Jacques] CHUL Res Ctr, Infect Dis Res Ctr, Dept Mol Med, Quebec City, PQ, Canada; [Sirois, Melissa; Robitaille, Lynda; Allary, Robin; Estaquier, Jerome; Corbeil, Jacques] Univ Laval, Quebec City, PQ, Canada; [Shah, Mohak] McGill Univ, Ctr Intelligent Machines, Dept Elect & Comp Engn, Montreal, PQ, Canada; [Woelk, Christopher H.] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA; [Estaquier, Jerome] Univ Paris 05, CNRS FRE3235, Paris, France	Laval University; Laval University; McGill University; University of California System; University of California San Diego; UDICE-French Research Universities; Universite Paris Cite	Sirois, M (corresponding author), CHUL Res Ctr, Infect Dis Res Ctr, Dept Mol Med, Quebec City, PQ, Canada.	jacques.corbeil@crchul.ulaval.ca	Corbeil, Jacques/AAW-9739-2020; , ESTAQUIER/AAR-7799-2020	Corbeil, Jacques/0000-0002-9973-2740; , ESTAQUIER/0000-0002-9432-8044; Woelk, Christopher/0000-0002-1977-0502	Canadian Institute of Health Research (CIHR); Center for AIDS Research (CFAR) at the University of California San Diego [AI36214]; Canada Research Chair in Medical Genomics; NIH [AI065242]; UCSD CFAR; CIHR HIV/AIDS; CIHR; Agence Nationale de la Recherche sur le SIDA et les Hepatites; Canada Research Chair; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI065242, P30AI036214] Funding Source: NIH RePORTER	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Center for AIDS Research (CFAR) at the University of California San Diego; Canada Research Chair in Medical Genomics(Canada Research Chairs); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCSD CFAR; CIHR HIV/AIDS(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR)); Agence Nationale de la Recherche sur le SIDA et les Hepatites(French National Research Agency (ANR)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	JC acknowledges the support of Canadian Institute of Health Research (CIHR), the Genomics Core at the Center for AIDS Research (CFAR) at the University of California San Diego (AI36214), and the Canada Research Chair in Medical Genomics. CHW is supported by the NIH (AI065242) and a UCSD CFAR developmental award. MSirois is the recipient of a Doctoral Research Award from CIHR HIV/AIDS Research Program. M. Shah acknowledges the support of the CIHR training grant while at CHUL Research Center. JE acknowledges the financial support of Agence Nationale de la Recherche sur le SIDA et les Hepatites and the Canada Research Chair Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barr SD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000007; Beutler B, 2003, J LEUKOCYTE BIOL, V74, P479, DOI 10.1189/jlb.0203082; Bishop KN, 2006, J VIROL, V80, P8450, DOI 10.1128/JVI.00839-06; Buettner N, 2010, J GEN VIROL, V91, P220, DOI 10.1099/vir.0.015172-0; Campillo-Gimenez L, 2010, J IMMUNOL, V184, P984, DOI 10.4049/jimmunol.0902316; Chen H, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-147; Colina R, 2008, NATURE, V452, P323, DOI 10.1038/nature06730; Covic M, 2005, EMBO J, V24, P85, DOI 10.1038/sj.emboj.7600500; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Fortin JF, 1997, J VIROL, V71, P3588, DOI 10.1128/JVI.71.5.3588-3596.1997; Genin P, 2009, MOL CELL BIOL, V29, P3435, DOI 10.1128/MCB.01805-08; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Izmailova E, 2003, NAT MED, V9, P191, DOI 10.1038/nm822; Jouvenet N, 2009, J VIROL, V83, P1837, DOI 10.1128/JVI.02211-08; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Konno H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005674; KORNBLUTH RS, 1989, J EXP MED, V169, P1137, DOI 10.1084/jem.169.3.1137; KUNZI MS, 1995, J INFECT DIS, V171, P822, DOI 10.1093/infdis/171.4.822; Laforge M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002087; Lambert AA, 2008, BLOOD, V112, P1299, DOI 10.1182/blood-2008-01-136473; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986; Marie I, 1998, EMBO J, V17, P6660, DOI 10.1093/emboj/17.22.6660; Matsuda A, 2003, ONCOGENE, V22, P3307, DOI 10.1038/sj.onc.1206406; Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; MEYLAN PRA, 1993, VIROLOGY, V193, P138, DOI 10.1006/viro.1993.1110; Muto NF, 1999, J VIROL, V73, P9021, DOI 10.1128/JVI.73.11.9021-9028.1999; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Ning S, 2011, GENES IMMUN; Nuovo GJ, 1999, J HISTOCHEM CYTOCHEM, V47, P273, DOI 10.1177/002215549904700301; Oldak M, 2011, J VIROL, V85, P178, DOI 10.1128/JVI.00998-10; Peng G, 2006, J EXP MED, V203, P41, DOI 10.1084/jem.20051512; PESTKA S, 1987, ANNU REV BIOCHEM, V56, P727, DOI 10.1146/annurev.biochem.56.1.727; Richman DD, 2001, CURR PROTOC IMMUNOL; Ruland J, 2001, CELL, V104, P33, DOI 10.1016/S0092-8674(01)00189-1; SAMUEL CE, 1988, PROG NUCLEIC ACID RE, V35, P27, DOI 10.1016/S0079-6603(08)60609-1; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Sato M, 1998, FEBS LETT, V425, P112, DOI 10.1016/S0014-5793(98)00210-5; Sato M, 1998, FEBS LETT, V441, P106, DOI 10.1016/S0014-5793(98)01514-2; Sato S, 2003, J IMMUNOL, V171, P4304, DOI 10.4049/jimmunol.171.8.4304; SCHRODER HC, 1990, FASEB J, V4, P3124, DOI 10.1096/fasebj.4.13.1698680; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Sgarbanti M, 2002, J EXP MED, V195, P1359, DOI 10.1084/jem.20010753; Sgarbanti M, 2008, J VIROL, V82, P3632, DOI 10.1128/JVI.00599-07; Shah M, 2011, IEEE ACM T COMPUT BI, V8, P14, DOI 10.1109/TCBB.2009.51; Shah Mohak CJ, 2009, IEEE COMPUTER SOC, V8, P14; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Smith AJ, 2010, J IMMUNOL, V185, P5417, DOI 10.4049/jimmunol.1002197; Song L, 2007, BIOINFORMATICS, V23, pI490, DOI 10.1093/bioinformatics/btm216; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Takeda K, 2003, CELL MICROBIOL, V5, P143, DOI 10.1046/j.1462-5822.2003.00264.x; Wathelet MG, 1998, MOL CELL, V1, P507, DOI 10.1016/S1097-2765(00)80051-9; Weaver BK, 1998, MOL CELL BIOL, V18, P1359, DOI 10.1128/MCB.18.3.1359; Wu ZJ, 2005, J COMPUT BIOL, V12, P882, DOI 10.1089/cmb.2005.12.882; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yoneyama M, 1998, EMBO J, V17, P1087, DOI 10.1093/emboj/17.4.1087; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoshida R, 2008, J BIOL CHEM, V283, P36211, DOI 10.1074/jbc.M806576200	63	31	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2011	6	11							e28125	10.1371/journal.pone.0028125	http://dx.doi.org/10.1371/journal.pone.0028125			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KW	22140520	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000298163400033
J	Gagnon, AE; Heimpel, GE; Brodeur, J				Gagnon, Annie-Eve; Heimpel, George E.; Brodeur, Jacques			The Ubiquity of Intraguild Predation among Predatory Arthropods	PLOS ONE			English	Article							BIOLOGICAL-CONTROL AGENT; GUT-CONTENT-ANALYSIS; SOYBEAN APHID; GENERALIST PREDATORS; MOLECULAR ANALYSIS; HARMONIA-AXYRIDIS; INSECT PREDATORS; ALTERNATIVE PREY; CANNIBALISM; DENSITY	Intraguild predation (IGP) occurs when one predator species attacks another predator species with which it competes for a shared prey species. Despite the apparent omnipresence of intraguild interactions in natural and managed ecosystems, very few studies have quantified rates of IGP in various taxa under field conditions. We used molecular analyses of gut contents to assess the nature and incidence of IGP among four species of coccinellid predators in soybean fields. Over half of the 368 predator individuals collected in soybean contained the DNA of other coccinellid species indicating that IGP was very common at our field site. Furthermore, 13.2% of the sampled individuals contained two and even three other coccinellid species in their gut. The interaction was reciprocal, as each of the four coccinellid species has the capacity to feed on the others. To our knowledge, this study represents the most convincing field evidence of a high prevalence of IGP among predatory arthropods. The finding has important implications for conservation biology and biological control.	[Gagnon, Annie-Eve] Univ Laval, Dept Phytol, Quebec City, PQ G1K 7P4, Canada; [Heimpel, George E.] Univ Minnesota, Dept Entomol, St Paul, MN USA; [Brodeur, Jacques] Univ Montreal, Dept Sci Biol, Inst Rech Biol Vegetale, Montreal, PQ H3C 3J7, Canada	Laval University; University of Minnesota System; University of Minnesota Twin Cities; Universite de Montreal	Gagnon, AE (corresponding author), Univ Laval, Dept Phytol, Quebec City, PQ G1K 7P4, Canada.	jacques.brodeur@umontreal.ca			Fonds Quebecois de Recherche sur la Nature et les Technologies; Canada Research Chair program	Fonds Quebecois de Recherche sur la Nature et les Technologies(FQRNT); Canada Research Chair program(Canada Research Chairs)	This work was funded by the Fonds Quebecois de Recherche sur la Nature et les Technologies and the Canada Research Chair program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi A, 2011, BIOCONTROL, V56, P429, DOI 10.1007/s10526-011-9378-2; Arim M, 2004, ECOL LETT, V7, P557, DOI 10.1111/j.1461-0248.2004.00613.x; BENDER W, 1983, J MOL BIOL, V168, P17, DOI 10.1016/S0022-2836(83)80320-9; Borer ET, 2003, ECOL LETT, V6, P929, DOI 10.1046/j.1461-0248.2003.00515.x; Briggs CJ, 2005, ECOL APPL, V15, P1111, DOI 10.1890/04-1776; Camus PA, 2008, MAR ECOL PROG SER, V361, P35, DOI 10.3354/meps07421; Chacon JM, 2008, BIOL CONTROL, V46, P216, DOI 10.1016/j.biocontrol.2008.04.018; Chacon JM, 2010, OECOLOGIA, V164, P213, DOI 10.1007/s00442-010-1611-7; Chapman EG, 2010, MOL ECOL RESOUR, V10, P1023, DOI 10.1111/j.1755-0998.2010.02857.x; Chen Y, 2000, MOL ECOL, V9, P1887, DOI 10.1046/j.1365-294x.2000.01100.x; Donaldson JR, 2007, BIOL CONTROL, V43, P111, DOI 10.1016/j.biocontrol.2007.06.004; EVANS EW, 1992, J KANSAS ENTOMOL SOC, V65, P30; Foltan P, 2005, MOL ECOL, V14, P4147, DOI 10.1111/j.1365-294X.2005.02732.x; Fournier V, 2008, OECOLOGIA, V157, P629, DOI 10.1007/s00442-008-1095-x; Gagnon AE, 2011, MOL ECOL RESOUR, V11, P1022, DOI 10.1111/j.1755-0998.2011.03047.x; Gardiner MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023576; Glen AS, 2005, BIOL REV, V80, P387, DOI 10.1017/S1464793105006718; Greenstone MH, 2011, MOL ECOL RESOUR, V11, P286, DOI 10.1111/j.1755-0998.2010.02922.x; Greenstone MH, 2010, ENTOMOL EXP APPL, V136, P97, DOI 10.1111/j.1570-7458.2010.01006.x; Hall RJ, 2011, ECOLOGY, V92, P352, DOI 10.1890/09-2314.1; Harwood JD, 2008, ENVIRON ENTOMOL, V37, P990, DOI 10.1603/0046-225X(2008)37[990:ASNSAP]2.0.CO;2; Harwood JD, 2007, MOL ECOL, V16, P4390, DOI 10.1111/j.1365-294X.2007.03482.x; Harwood JD, 2009, BIOL INVASIONS, V11, P895, DOI 10.1007/s10530-008-9302-6; Harwood JD, 2005, EUR J ENTOMOL, V102, P335, DOI 10.14411/eje.2005.051; Hautier L, 2008, CHEMOECOLOGY, V18, P191, DOI 10.1007/s00049-008-0405-4; Hironori Y, 1997, ENTOMOPHAGA, V42, P153, DOI 10.1007/BF02769893; Holt RD, 1997, AM NAT, V149, P745, DOI 10.1086/286018; Holt RD, 2007, ECOLOGY, V88, P2706, DOI 10.1890/06-1525.1; Hoogendoorn M, 2004, ENTOMOL EXP APPL, V111, P19, DOI 10.1111/j.0013-8703.2004.00157.x; Hoogendoorn M, 2001, MOL ECOL, V10, P2059, DOI 10.1046/j.1365-294X.2001.01316.x; IVES AR, 1993, ECOLOGY, V74, P1929, DOI 10.2307/1940836; Kindlmann P, 2006, POPUL ECOL, V48, P317, DOI 10.1007/s10144-006-0006-4; Law YH, 2011, ECOLOGY, V92, P333, DOI 10.1890/10-0156.1; Lucas E, 1998, ECOLOGY, V79, P1084, DOI 10.1890/0012-9658(1998)079[1084:IPAAPC]2.0.CO;2; Lucas E, 2001, ECOLOGY, V82, P3246, DOI 10.1890/0012-9658(2001)082[3246:AFISSC]2.0.CO;2; Lundgren JG, 2009, ECOL APPL, V19, P2157, DOI 10.1890/08-1882.1; Majerus M. E. N, 1994, LADYBIRDS; Messing R, 2006, ENVIRONMENTAL IMPACT OF INVERTEBRATES FOR BIOLOGICAL CONTROL OF ARTHROPODS: METHODS AND RISK ASSESSMENT, P64, DOI 10.1079/9780851990583.0064; Mignault MP, 2006, BIOCONTROL, V51, P89, DOI 10.1007/s10526-005-1517-1; Muller CB, 2002, BIOL CONTROL, V25, P216, DOI 10.1016/S1049-9644(02)00102-0; Noda H, 1997, APPL ENVIRON MICROB, V63, P3926, DOI 10.1128/AEM.63.10.3926-3932.1997; PAINE RT, 1969, AM NAT, V103, P91, DOI 10.1086/282586; Palomares F, 1999, AM NAT, V153, P492, DOI 10.1086/303189; POLIS GA, 1987, ECOLOGY, V68, P332, DOI 10.2307/1939264; POLIS GA, 1989, ANNU REV ECOL SYST, V20, P297, DOI 10.1146/annurev.es.20.110189.001501; Ragsdale DW, 2011, ANNU REV ENTOMOL, V56, P375, DOI 10.1146/annurev-ento-120709-144755; Rhainds M, 2007, CAN ENTOMOL, V139, P728, DOI 10.4039/N06-095; Rosenheim JA, 1999, ECOL APPL, V9, P409, DOI 10.1890/1051-0761(1999)009[0409:IOGPOA]2.0.CO;2; Rosenheim JA, 1998, ANNU REV ENTOMOL, V43, P421, DOI 10.1146/annurev.ento.43.1.421; Rosenheim JA, 2004, ECOLOGY, V85, P3362, DOI 10.1890/03-0825; ROSENHEIM JA, 1995, BIOL CONTROL, V5, P303, DOI 10.1006/bcon.1995.1038; ROSENHEIM JA, 1993, OECOLOGIA, V96, P439, DOI 10.1007/BF00317517; Rosenheim JA, 2006, PROG BIOL CONTROL, V3, P1; Salo P, 2008, J ANIM ECOL, V77, P1092, DOI 10.1111/j.1365-2656.2008.01430.x; Sergio F, 2007, ANIM BEHAV, V74, P1607, DOI 10.1016/j.anbehav.2006.10.022; Sheppard SK, 2005, FUNCT ECOL, V19, P751, DOI 10.1111/j.1365-2435.2005.01041.x; Sheppard SK, 2005, MOL ECOL, V14, P4461, DOI 10.1111/j.1365-294X.2005.02742.x; Sigsgaard L, 2002, BIOCONTROL, V47, P151, DOI 10.1023/A:1014577114915; Snyder WE, 2004, OECOLOGIA, V140, P559, DOI 10.1007/s00442-004-1612-5; Snyder WE, 2000, ENVIRON ENTOMOL, V29, P1173, DOI 10.1603/0046-225X-29.6.1173; Sulkava S, 1997, ORNIS FENNICA, V74, P65; Symondson WOC, 2002, MOL ECOL, V11, P627, DOI 10.1046/j.1365-294X.2002.01471.x; Szendrei Z, 2010, BASIC APPL ECOL, V11, P153, DOI 10.1016/j.baae.2009.10.006; Takizawa T, 2011, ENVIRON ENTOMOL, V40, P8, DOI 10.1603/EN10047; Traugott M, 2008, B ENTOMOL RES, V98, P223, DOI 10.1017/S0007485308005968; van der Hammen T, 2010, OECOLOGIA, V163, P79, DOI 10.1007/s00442-010-1575-7; Vance-Chalcraft HD, 2007, ECOLOGY, V88, P2689, DOI 10.1890/06-1869.1	67	80	84	0	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e28061	10.1371/journal.pone.0028061	http://dx.doi.org/10.1371/journal.pone.0028061			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132211	Green Published, Green Submitted, gold			2022-12-27	WOS:000298162000066
J	Lo, YL; Lin, TY; Fang, YF; Wang, TY; Chen, HC; Chou, CL; Chung, FT; Kuo, CH; Feng, PH; Liu, CY; Kuo, HP				Lo, Yu-Lun; Lin, Ting-Yu; Fang, Yueh-Fu; Wang, Tsai-Yu; Chen, Hao-Cheng; Chou, Chun-Liang; Chung, Fu-Tsai; Kuo, Chih-Hsi; Feng, Po-Hao; Liu, Chien-Ying; Kuo, Han-Pin			Feasibility of Bispectral Index-Guided Propofol Infusion for Flexible Bronchoscopy Sedation: A Randomized Controlled Trial	PLOS ONE			English	Article							DOUBLE-BLIND; ALFENTANIL; MIDAZOLAM; CONSCIOUSNESS; COMBINATION; ISOFLURANE; RECOVERY; FASTER	Objectives: There are safety issues associated with propofol use for flexible bronchoscopy (FB). The bispectral index (BIS) correlates well with the level of consciousness. The aim of this study was to show that BIS-guided propofol infusion is safe and may provide better sedation, benefiting the patients and bronchoscopists. Methods: After administering alfentanil bolus, 500 patients were randomized to either propofol infusion titrated to a BIS level of 65-75 (study group) or incremental midazolam bolus based on clinical judgment to achieve moderate sedation. The primary endpoint was safety, while the secondary endpoints were recovery time, patient tolerance, and cooperation. Results: The proportion of patients with hypoxemia or hypotensive events were not different in the 2 groups (study vs. control groups: 39.9% vs. 35.7%, p = 0.340; 7.4% vs. 4.4%, p = 0.159, respectively). The mean lowest blood pressure was lower in the study group. Logistic regression revealed male gender, higher American Society of Anesthesiologists physical status, and electrocautery were associated with hypoxemia, whereas lower propofol dose for induction was associated with hypotension in the study group. The study group had better global tolerance (p<0.001), less procedural interference by movement or cough (13.6% vs. 36.1%, p<0.001; 30.0% vs. 44.2%, p = 0.001, respectively), and shorter time to orientation and ambulation (11.7 +/- 10.2 min vs. 29.7 +/- 26.8 min, p<0.001; 30.0 +/- 18.2 min vs. 55.7 +/- 40.6 min, p<0.001, respectively) compared to the control group. Conclusions: BIS-guided propofol infusion combined with alfentanil for FB sedation provides excellent patient tolerance, with fast recovery and less procedure interference.	[Lo, Yu-Lun; Lin, Ting-Yu; Fang, Yueh-Fu; Wang, Tsai-Yu; Chen, Hao-Cheng; Chou, Chun-Liang; Chung, Fu-Tsai; Kuo, Chih-Hsi; Feng, Po-Hao; Liu, Chien-Ying; Kuo, Han-Pin] Chang Gung Univ, Chang Gung Mem Hosp, Sch Med, Dept Thorac Med, Taipei, Taiwan	Chang Gung Memorial Hospital; Chang Gung University	Lo, YL (corresponding author), Chang Gung Univ, Chang Gung Mem Hosp, Sch Med, Dept Thorac Med, Taipei, Taiwan.	q8828@ms11.hinet.net			Chang Gung Medical Research Program [CMRPG380251]	Chang Gung Medical Research Program	This study was supported by a grant from the Chang Gung Medical Research Program (CMRPG380251). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bower AL, 2000, GASTROINTEST ENDOSC, V52, P192, DOI 10.1067/mge.2000.107284; Clark G, 2009, EUR RESPIR J, V34, P1277, DOI 10.1183/09031936.00142108; CLARKSON K, 1993, CHEST, V104, P1029, DOI 10.1378/chest.104.4.1029; CRAWFORD M, 1993, BRIT J ANAESTH, V70, P419, DOI 10.1093/bja/70.4.419; Diette GB, 1998, CHEST, V114, P1446, DOI 10.1378/chest.114.5.1446; Friend JAR, 2001, THORAX, V56, P1, DOI 10.1136/thorax.56.1.1; Gan TJ, 1999, ANESTHESIOLOGY, V90, P1283, DOI 10.1097/00000542-199905000-00010; Gan TJ, 1997, ANESTHESIOLOGY, V87, P808, DOI 10.1097/00000542-199710000-00014; Gepts E, 1998, ANAESTHESIA, V53, P4, DOI 10.1111/j.1365-2044.1998.53s111.x; Glass PS, 1997, ANESTHESIOLOGY, V86, P836, DOI 10.1097/00000542-199704000-00014; Graber RG, 1999, GASTROINTEST ENDOSC, V49, P803, DOI 10.1016/S0016-5107(99)70308-1; Gross JB, 2002, ANESTHESIOLOGY, V96, P1004; Houghton CM, 2004, RESP MED, V98, P1102, DOI 10.1016/j.rmed.2004.03.023; Hu CP, 2005, ANESTHESIOLOGY, V102, P639, DOI 10.1097/00000542-200503000-00024; Hwang J, 2005, ACTA ANAESTH SCAND, V49, P1334, DOI 10.1111/j.1399-6576.2005.00842.x; Iohom G, 2007, EUR J ANAESTH, V24, P912, DOI 10.1017/S0265021507000476; Iselin-Chaves IA, 1998, ANESTH ANALG, V87, P949; Kuo CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016877; Lichtenbelt BJ, 2004, CLIN PHARMACOKINET, V43, P577, DOI 10.2165/00003088-200443090-00002; Lysakowski C, 2001, BRIT J ANAESTH, V86, P523, DOI 10.1093/bja/86.4.523; Matot I, 2000, RESP MED, V94, P1145, DOI 10.1053/rmed.2000.0926; Miner JR, 2005, ACAD EMERG MED, V12, P190, DOI 10.1197/j.aem.2004.10.004; Pickles J, 2003, EUR RESPIR J, V22, P203, DOI 10.1183/09031936.03.00118302; Stolz D, 2004, THORAX, V59, P773, DOI 10.1136/thx.2003.019836; Stolz D, 2009, EUR RESPIR J, V34, P1024, DOI 10.1183/09031936.00180808; VERNON JM, 1995, ANESTH ANALG, V80, P780, DOI 10.1097/00000539-199504000-00023; Watts MR, 2005, RESP MED, V99, P220, DOI 10.1016/j.rmed.2004.06.002; Williams TJ, 1999, RESP MED, V93, P361, DOI 10.1016/S0954-6111(99)90320-7; Yoon HI, 2011, ACTA ANAESTH SCAND, V55, P104, DOI 10.1111/j.1399-6576.2010.02336.x	29	50	52	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e27769	10.1371/journal.pone.0027769	http://dx.doi.org/10.1371/journal.pone.0027769			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132138	Green Submitted, Green Published, gold			2022-12-27	WOS:000298162000040
J	Wagar, LE; Rosella, L; Crowcroft, N; Lowcock, B; Drohomyrecky, PC; Foisy, J; Gubbay, J; Rebbapragada, A; Winter, AL; Achonu, C; Ward, BJ; Watts, TH				Wagar, Lisa E.; Rosella, Laura; Crowcroft, Natasha; Lowcock, Beth; Drohomyrecky, Paulina C.; Foisy, Julie; Gubbay, Jonathan; Rebbapragada, Anu; Winter, Anne-Luise; Achonu, Camille; Ward, Brian J.; Watts, Tania H.			Humoral and Cell-Mediated Immunity to Pandemic H1N1 Influenza in a Canadian Cohort One Year Post-Pandemic: Implications for Vaccination	PLOS ONE			English	Article							CD8(+) T-CELLS; HEMAGGLUTINATION-INHIBITING ANTIBODY; VIRUS; MEMORY; PROTECTION; INFECTION; LYMPHOCYTES; CHALLENGE; RESPONSES; HUMANS	We evaluated a cohort of Canadian donors for T cell and antibody responses against influenza A/California/7/2009 (pH1N1) at 8-10 months after the 2nd pandemic wave by flow cytometry and microneutralization assays. Memory CD8 T cell responses to pH1N1 were detectable in 58% (61/105) of donors. These responses were largely due to cross-reactive CD8 T cell epitopes as, for those donors tested, similar recall responses were obtained to A/California 2009 and A/PR8 1934 H1N1 Hviruses. Longitudinal analysis of a single infected individual showed only a small and transient increase in neutralizing antibody levels, but a robust CD8 T cell response that rose rapidly post symptom onset, peaking at 3 weeks, followed by a gradual decline to the baseline levels seen in a seroprevalence cohort post-pandemic. The magnitude of the influenzaspecific CD8 T cell memory response at one year post-pandemic was similar in cases and controls as well as in vaccinated and unvaccinated donors, suggesting that any T cell boosting from infection was transient. Pandemic H1-specific antibodies were only detectable in approximately half of vaccinated donors. However, those who were vaccinated within a few months following infection had the highest persisting antibody titers, suggesting that vaccination shortly after influenza infection can boost or sustain antibody levels. For the most part the circulating influenza-specific T cell and serum antibody levels in the population at one year post-pandemic were not different between cases and controls, suggesting that natural infection does not lead to higher long term T cell and antibody responses in donors with pre-existing immunity to influenza. However, based on the responses of one longitudinal donor, it is possible for a small population of pre-existing crossreactive memory CD8 T cells to expand rapidly following infection and this response may aid in viral clearance and contribute to a lessening of disease severity.	[Wagar, Lisa E.; Drohomyrecky, Paulina C.; Watts, Tania H.] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Rosella, Laura; Crowcroft, Natasha; Lowcock, Beth; Foisy, Julie; Gubbay, Jonathan; Rebbapragada, Anu; Winter, Anne-Luise; Achonu, Camille] Publ Hlth Ontario, Toronto, ON, Canada; [Rosella, Laura; Crowcroft, Natasha] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Crowcroft, Natasha; Gubbay, Jonathan; Rebbapragada, Anu] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Ward, Brian J.] McGill Univ, Res Inst, Ctr Hlth, Montreal, PQ, Canada	University of Toronto; University of Toronto; University of Toronto; McGill University	Wagar, LE (corresponding author), Univ Toronto, Dept Immunol, Toronto, ON, Canada.	tania.watts@utoronto.ca	Gubbay, Jonathan/Q-8580-2019	Gubbay, Jonathan/0000-0003-0026-3786; Tripp, Ralph/0000-0002-2924-9956; Wagar, Lisa/0000-0001-5980-3586	Canadian Institutes of Health Research (CIHR) [MOP-74492, TPA-90194]; Public Health Agency of Canada; GlaxoSmithKline Inc.; Hoffmann-La Roche Ltd Inc.	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Public Health Agency of Canada; GlaxoSmithKline Inc.(GlaxoSmithKline); Hoffmann-La Roche Ltd Inc.	This research was supported by grants MOP-74492 and TPA-90194 from the Canadian Institutes of Health Research (CIHR) to T.H.W. and by a contract from the Public Health Agency of Canada to N.C. T.H.W. holds the Sanofi Pasteur Chair in Human Immunology at the University of Toronto. L.E.W. was funded by a CIHR doctoral award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: Jonathan Gubbay has received grants from GlaxoSmithKline Inc. and Hoffmann-La Roche Ltd Inc. B.J.W. is co-investigator on a CIHR grant with the VP research of GSK; he is on the Scientific advisory board of Medicago and has served on ad hoc advisory committees (clinical and scientific) for all of the major vaccine manufacturers. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. Please note: Although the GSK vaccine was mentioned in this study, they did not provide vaccine for the study. The authors did not vaccinate the cohort but asked the participants to report on whether they had received the vaccine, which in the season reported was available through a public vaccine program, using vaccine purchased by the Canadian Government from GSK. Similarly the longitudinal donor in the study who reports 2 vaccinations obtained these vaccines through the public mechanism, not through the study.	Achonu C, 2010, SEROPREVALENCE STUDY; Appay V, 2002, NAT MED, V8, P379, DOI 10.1038/nm0402-379; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Bodewes R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005538; Bui HH, 2007, P NATL ACAD SCI USA, V104, P246, DOI 10.1073/pnas.0609330104; Champagne P, 2001, NATURE, V410, P106, DOI 10.1038/35065118; CLEMENTS ML, 1986, J CLIN MICROBIOL, V24, P157, DOI 10.1128/JCM.24.1.157-160.1986; Coudeville L, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-18; Crotty S, 2004, SEMIN IMMUNOL, V16, P197, DOI 10.1016/j.smim.2004.02.008; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; de Jong J C, 2003, Dev Biol (Basel), V115, P63; Girard MP, 2010, VACCINE, V28, P4895, DOI [10.1016/j.vaccine.2010.05.031, 10.1016/j.vaccine.2010.07.034]; Gras S, 2010, P NATL ACAD SCI USA, V107, P12599, DOI 10.1073/pnas.1007270107; Hamann D, 1997, J EXP MED, V186, P1407, DOI 10.1084/jem.186.9.1407; Hamann D, 1999, INT IMMUNOL, V11, P1027, DOI 10.1093/intimm/11.7.1027; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Harari A, 2004, BLOOD, V103, P966, DOI 10.1182/blood-2003-04-1203; HOBSON D, 1972, J HYG-CAMBRIDGE, V70, P767, DOI 10.1017/S0022172400022610; Louie JK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018221; Louie JK, 2009, JAMA-J AM MED ASSOC, V302, P1896, DOI 10.1001/jama.2009.1583; Mavrouli MD, 2011, VIRAL IMMUNOL, V24, P221, DOI 10.1089/vim.2010.0137; MCMICHAEL AJ, 1981, CLIN EXP IMMUNOL, V43, P276; Reed C, 2009, EMERG INFECT DIS, V15, P2004, DOI 10.3201/eid1512.091413; Roman F, 2010, VACCINE, V28, P1740, DOI 10.1016/j.vaccine.2009.12.014; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Scheible K, 2011, VACCINE, V29, P2159, DOI 10.1016/j.vaccine.2010.12.073; Skowronski DM, 2011, J INFECT DIS, V203, P158, DOI 10.1093/infdis/jiq039; Skowronski DM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000258; Tu WW, 2010, J VIROL, V84, P6527, DOI 10.1128/JVI.00519-10; Wagar LE, 2011, PLOS ONE IN PRESS; Wichmann O, 2010, EURO SURVEILL, V15; World Health Organization, 2002, WHO MAN AN INFL DIAG; World Health Organization, 2010, SER DIAGN INFL MICR; Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352; Xu R, 2010, SCIENCE, V328, P357, DOI 10.1126/science.1186430; Yu XC, 2008, NATURE, V455, P532, DOI 10.1038/nature07231	38	32	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e28063	10.1371/journal.pone.0028063	http://dx.doi.org/10.1371/journal.pone.0028063			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132212	Green Published, gold, Green Submitted			2022-12-27	WOS:000298162000067
J	Sosnoff, JJ; Socie, MJ; Boes, MK; Sandroff, BM; Pula, JH; Suh, Y; Weikert, M; Balantrapu, S; Morrison, S; Motl, RW				Sosnoff, Jacob J.; Socie, Michael J.; Boes, Morgan K.; Sandroff, Brian M.; Pula, John H.; Suh, Yoojin; Weikert, Madeline; Balantrapu, Swathi; Morrison, Steven; Motl, Robert W.			Mobility, Balance and Falls in Persons with Multiple Sclerosis	PLOS ONE			English	Article							ACCIDENTAL FALLS; POSTURAL CONTROL; PEOPLE; RISK; WALK; IMPAIRMENT; TESTS; WOMEN	Background: There is a lack of information concerning the relation between objective measures of gait and balance and fall history in persons with MS (PwMS). This investigation assessed the relation between demographic, clinical, mobility and balance metrics and falls history in persons with multiple sclerosis (MS). Methods: 52 ambulatory persons with MS (PwMS) participated in the investigation. All persons provided demographic information including fall history over the last 12 months. Disease status was assessed with Expanded Disability Status Scale (EDSS). Walking speed, coordination, endurance and postural control were quantified with a multidimensional mobility battery. Results: Over 51% of the participants fell in the previous year with 79% of these people being suffering recurrent falls. Overall, fallers were older, had a greater prevalence of assistive devices use, worse disability, decreased walking endurance, and greater postural sway velocity with eyes closed compared to non-fallers. Additionally, fallers had greater impairment in cerebellar, sensory, pyramidal, and bladder/bowel subscales of the EDSS. Conclusions: The current observations suggest that PwMS who are older, more disabled, utilize an assistive device, have decreased walking coordination and endurance and have diminished balance have fallen in the previous year. This suggests that individuals who meet these criteria need to be carefully monitored for future falls. Future research is needed to determine a prospective model of falls specific to PwMS. Additionally, the utility of interventions aimed at reducing falls and fall risk in PwMS needs to be established.	[Sosnoff, Jacob J.; Sandroff, Brian M.; Suh, Yoojin; Weikert, Madeline; Balantrapu, Swathi; Motl, Robert W.] Univ Illinois, Dept Kinesiol & Community Hlth, Urbana, IL 61801 USA; [Socie, Michael J.] Univ Illinois, Dept Mech Sci & Engn, Urbana, IL USA; [Sosnoff, Jacob J.] Univ Illinois, Dept Bioengn, Urbana, IL USA; [Pula, John H.] Univ Illinois, Coll Med Peoria, Peoria, IL USA; [Morrison, Steven] Old Dominion Univ, Sch Phys Therapy, Norfolk, VA USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Peoria; Old Dominion University	Sosnoff, JJ (corresponding author), Univ Illinois, Dept Kinesiol & Community Hlth, Urbana, IL 61801 USA.	jsosnoff@illinois.edu	Sosnoff, Jacob/P-3397-2019	Sosnoff, Jacob/0000-0002-0286-9207; Boes, Morgan/0000-0002-2832-2306; Sandroff, Brian/0000-0002-2013-7632; Morrison, Steven/0000-0001-7485-0305	Olaf-Saint Francis Foundation	Olaf-Saint Francis Foundation	The research was funded in part with support from the Olaf-Saint Francis Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Bateni H, 2005, ARCH PHYS MED REHAB, V86, P134, DOI 10.1016/j.apmr.2004.04.023; Brown JS, 2000, J AM GERIATR SOC, V48, P721, DOI 10.1111/j.1532-5415.2000.tb04744.x; Cameron MH, 2008, SOMATOSENS MOT RES, V25, P113, DOI 10.1080/08990220802131127; Cameron MH, 2011, J REHABIL RES DEV, V48, P13, DOI 10.1682/JRRD.2009.12.0192; Cattaneo D, 2007, CLIN REHABIL, V21, P771, DOI 10.1177/0269215507077602; Cattaneo D, 2009, MULT SCLER, V15, P59, DOI 10.1177/1352458508096874; Cattaneo D, 2002, ARCH PHYS MED REHAB, V83, P864, DOI 10.1053/apmr.2002.32825; Cohen J.E., 1988, STAT POWER ANAL BEHA; Coote S, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-34; Finlayson ML, 2006, ARCH PHYS MED REHAB, V87, P1274, DOI 10.1016/j.apmr.2006.06.002; Finlayson ML, 2010, PHYS MED REH CLIN N, V21, P357, DOI 10.1016/j.pmr.2009.12.003; Gillespie L, 2009, INJURY PREV, V15, P354, DOI 10.1136/ip.2009.023101; Goldman MD, 2008, MULT SCLER J, V14, P383, DOI 10.1177/1352458507082607; HEBERT JR, 2011, PHYS THER; KASSER SL, 2011, ARCH PHYS MED REHABI; Kaufman M, 2000, MULT SCLER, V6, P286, DOI 10.1177/135245850000600411; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Kuspinar A, 2010, ARCH PHYS MED REHAB, V91, P1410, DOI 10.1016/j.apmr.2010.06.005; LORD SR, 1993, AUST J PUBLIC HEALTH, V17, P240, DOI 10.1111/j.1753-6405.1993.tb00143.x; MAKI BE, 1994, J GERONTOL, V49, pM72, DOI 10.1093/geronj/49.2.M72; Matsuda PN, 2011, PM&R, V3, P624, DOI 10.1016/j.pmrj.2011.04.015; Morrison S, 2010, DIABETES CARE, V33, P748, DOI 10.2337/dc09-1699; Nieuwenhuis MM, 2006, MULT SCLER J, V12, P495, DOI 10.1191/1352458506ms1293oa; Nilsagard Y, 2009, CLIN REHABIL, V23, P259, DOI 10.1177/0269215508095087; Nilsagard Y, 2007, PHYSIOTHER RES INT, V12, P105, DOI 10.1002/pri.358; Peterson EW, 2008, ARCH PHYS MED REHAB, V89, P1031, DOI 10.1016/j.apmr.2007.10.043; Piirtola M, 2006, GERONTOLOGY, V52, P1, DOI 10.1159/000089820; Prosperini L, 2011, J NEUROL SCI, V304, P55, DOI 10.1016/j.jns.2011.02.014; SOSNOFF J, J NEUROLOGI IN PRESS; Sosnoff JJ, 2011, GAIT POSTURE, V34, P145, DOI 10.1016/j.gaitpost.2011.03.020; Sosnoff JJ, 2010, ARCH PHYS MED REHAB, V91, P93, DOI 10.1016/j.apmr.2009.09.013; Van Emmerik REA, 2010, GAIT POSTURE, V32, P608, DOI 10.1016/j.gaitpost.2010.09.002; Winter D. A., 1993, BIOMECHANICS MOTOR C	33	143	143	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2011	6	11							e28021	10.1371/journal.pone.0028021	http://dx.doi.org/10.1371/journal.pone.0028021			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858JH	22132196	Green Published, Green Submitted, gold			2022-12-27	WOS:000297792400034
J	Beutler, LR; Eldred, KC; Quintana, A; Keene, CD; Rose, SE; Postupna, N; Montine, TJ; Palmiter, RD				Beutler, Lisa R.; Eldred, Kiara C.; Quintana, Albert; Keene, C. Dirk; Rose, Shannon E.; Postupna, Nadia; Montine, Thomas J.; Palmiter, Richard D.			Severely Impaired Learning and Altered Neuronal Morphology in Mice Lacking NMDA Receptors in Medium Spiny Neurons	PLOS ONE			English	Article							LONG-TERM POTENTIATION; BASAL GANGLIA; DORSOMEDIAL STRIATUM; SYNAPTIC PLASTICITY; NUCLEUS-ACCUMBENS; DEFICIENT MICE; DOPAMINE; EXPRESSION; D1; MEMORY	The striatum is composed predominantly of medium spiny neurons (MSNs) that integrate excitatory, glutamatergic inputs from the cortex and thalamus, and modulatory dopaminergic inputs from the ventral midbrain to influence behavior. Glutamatergic activation of AMPA, NMDA, and metabotropic receptors on MSNs is important for striatal development and function, but the roles of each of these receptor classes remain incompletely understood. Signaling through NMDA-type glutamate receptors (NMDARs) in the striatum has been implicated in various motor and appetitive learning paradigms. In addition, signaling through NMDARs influences neuronal morphology, which could underlie their role in mediating learned behaviors. To study the role of NMDARs on MSNs in learning and in morphological development, we generated mice lacking the essential NR1 subunit, encoded by the Grin1 gene, selectively in MSNs. Although these knockout mice appear normal and display normal 24-hour locomotion, they have severe deficits in motor learning, operant conditioning and active avoidance. In addition, the MSNs from these knockout mice have smaller cell bodies and decreased dendritic length compared to littermate controls. We conclude that NMDAR signaling in MSNs is critical for normal MSN morphology and many forms of learning.	[Beutler, Lisa R.; Palmiter, Richard D.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Beutler, Lisa R.; Eldred, Kiara C.; Quintana, Albert; Palmiter, Richard D.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Beutler, Lisa R.; Eldred, Kiara C.; Quintana, Albert; Palmiter, Richard D.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Keene, C. Dirk; Rose, Shannon E.; Postupna, Nadia; Montine, Thomas J.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Beutler, LR (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	palmiter@uw.edu	Quintana, Albert/N-5544-2015; Keene, Christopher D/N-1806-2015	Quintana, Albert/0000-0003-1674-7160; Keene, Christopher/0000-0002-5291-1469; Beutler, Lisa/0000-0002-9489-8098; Eldred, Kiara/0000-0002-4067-8639	Howard Hughes Medical Institute; Udall Center [NS062684]; NIGMS [T32 GM07735]; ARCS Foundation; MCINN; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS062684] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Udall Center; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); ARCS Foundation; MCINN(European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Howard Hughes Medical Institute and grants from the Udall Center (NS062684), NIGMS T32 GM07735, and the ARCS Foundation. A. Q. is a recipient of a MCINN postdoctoral mobility program fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; ALBIN RL, 1992, NEUROSCIENCE, V46, P35, DOI 10.1016/0306-4522(92)90006-N; Baydyuk M, 2011, P NATL ACAD SCI USA, V108, P1669, DOI 10.1073/pnas.1004744108; Beutler LR, 2011, P NATL ACAD SCI USA, V108, P4206, DOI 10.1073/pnas.1101424108; Cabrera-Vera TM, 2004, P NATL ACAD SCI USA, V101, P16339, DOI 10.1073/pnas.0407416101; Ciccolini F, 2003, J NEUROSCI, V23, P103; Dalley JW, 2005, P NATL ACAD SCI USA, V102, P6189, DOI 10.1073/pnas.0502080102; Dang MT, 2006, P NATL ACAD SCI USA, V103, P15254, DOI 10.1073/pnas.0601758103; Darvas M, 2011, LEARN MEMORY, V18, P136, DOI 10.1101/lm.2041211; DELONG MR, 1990, TRENDS NEUROSCI, V13, P281, DOI 10.1016/0166-2236(90)90110-V; FACCHINETTI F, 1993, DEV BRAIN RES, V74, P219, DOI 10.1016/0165-3806(93)90007-W; Fadok JP, 2009, J NEUROSCI, V29, P11089, DOI 10.1523/JNEUROSCI.1616-09.2009; Ferreira TL, 2003, BRAIN RES, V987, P17, DOI 10.1016/S0006-8993(03)03217-7; GERFEN CR, 1990, SCIENCE, V250, P1429, DOI 10.1126/science.2147780; GLASER EM, 1981, J NEUROSCI METH, V4, P117, DOI 10.1016/0165-0270(81)90045-5; GRAYBIEL AM, 1994, SCIENCE, V265, P1826, DOI 10.1126/science.8091209; Herlenius E, 2004, EXP NEUROL, V190, pS8, DOI 10.1016/j.expneurol.2004.03.027; Hnasko TS, 2006, P NATL ACAD SCI USA, V103, P8858, DOI 10.1073/pnas.0603081103; JAHR CE, 1987, NATURE, V325, P522, DOI 10.1038/325522a0; Jin X, 2010, NATURE, V466, P457, DOI 10.1038/nature09263; Jongen-Relo AL, 2003, BEHAV NEUROSCI, V117, P150, DOI 10.1037/0735-7044.117.1.150; Kelley AE, 1997, P NATL ACAD SCI USA, V94, P12174, DOI 10.1073/pnas.94.22.12174; Kelley AE, 2004, NEUROSCI BIOBEHAV R, V27, P765, DOI 10.1016/j.neubiorev.2003.11.015; Kreitzer AC, 2008, NEURON, V60, P543, DOI 10.1016/j.neuron.2008.11.005; LESTER RAJ, 1990, NATURE, V346, P565, DOI 10.1038/346565a0; LLEDO PM, 1995, P NATL ACAD SCI USA, V92, P11175, DOI 10.1073/pnas.92.24.11175; Luscher C, 2010, NEURON, V65, P445, DOI 10.1016/j.neuron.2010.01.016; Massart R, 2009, EUR J NEUROSCI, V30, P397, DOI 10.1111/j.1460-9568.2009.06842.x; MATTSON MP, 1987, J NEUROSCI, V7, P4034; McKee BL, 2010, BEHAV NEUROSCI, V124, P500, DOI 10.1037/a0020270; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; Ohtsuka N, 2008, P NATL ACAD SCI USA, V105, P12961, DOI 10.1073/pnas.0806180105; Packard MG, 2002, ANNU REV NEUROSCI, V25, P563, DOI 10.1146/annurev.neuro.25.112701.142937; Parker JG, 2011, J NEUROSCI, V31, P11362, DOI 10.1523/JNEUROSCI.2411-11.2011; Perez FA, 2005, P NATL ACAD SCI USA, V102, P2174, DOI 10.1073/pnas.0409598102; Riedel G, 2003, BEHAV BRAIN RES, V140, P1, DOI 10.1016/S0166-4328(02)00272-3; Schenberg EE, 2006, BRAIN RES BULL, V69, P440, DOI 10.1016/j.brainresbull.2006.02.010; Surmeier DJ, 2007, TRENDS NEUROSCI, V30, P228, DOI 10.1016/j.tins.2007.03.008; Thomas EA, 1998, J NEUROSCI RES, V52, P118, DOI 10.1002/(SICI)1097-4547(19980401)52:1<118::AID-JNR11>3.0.CO;2-6; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; Yin HH, 2005, EUR J NEUROSCI, V22, P513, DOI 10.1111/j.1460-9568.2005.04218.x; Yin HH, 2004, EUR J NEUROSCI, V19, P181, DOI 10.1111/j.1460-9568.2004.03095.x; Zaja-Milatovic S, 2005, NEUROLOGY, V64, P545, DOI 10.1212/01.WNL.0000150591.33787.A4	44	25	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2011	6	11							e28168	10.1371/journal.pone.0028168	http://dx.doi.org/10.1371/journal.pone.0028168			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IO	22132236	gold, Green Submitted, Green Published			2022-12-27	WOS:000297789900050
J	Thayil, SM; Morrison, N; Schechter, N; Rubin, H; Karakousis, PC				Thayil, Seema M.; Morrison, Norman; Schechter, Norman; Rubin, Harvey; Karakousis, Petros C.			The Role of the Novel Exopolyphosphatase MT0516 in Mycobacterium tuberculosis Drug Tolerance and Persistence	PLOS ONE			English	Article							INORGANIC POLYPHOSPHATE; ESCHERICHIA-COLI; STRINGENT RESPONSE; STATIONARY-PHASE; GUINEA-PIGS; SURVIVAL; LATENT; INFECTION; GROWTH; GENES	Inorganic polyphosphate (poly P) has been postulated to play a regulatory role in the transition to bacterial persistence. In bacteria, poly P balance in the cell is maintained by the hydrolysis activity of the exopolyphosphatase PPX. However, the Mycobacterium tuberculosis PPX has not been characterized previously. Here we show that recombinant MT0516 hydrolyzes poly P, and an MT0516-deficient M. tuberculosis mutant exhibits elevated intracellular levels of poly P and increased expression of the genes mprB, sigE, and rel relative to the isogenic wild-type strain, indicating poly P-mediated signaling. Deficiency of MT0516 resulted in decelerated growth during logarithmic-phase in axenic cultures, and tolerance to the cell wall-active drug isoniazid. The MT0516-deficient mutant showed a significant survival defect in activated human macrophages and reduced persistence in the lungs of guinea pigs. We conclude that exopolyphosphatase is required for long-term survival of M. tuberculosis in necrotic lung lesions.	[Thayil, Seema M.; Morrison, Norman; Karakousis, Petros C.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Schechter, Norman; Rubin, Harvey] Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Karakousis, Petros C.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA	Johns Hopkins University; University of Pennsylvania; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Thayil, SM (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA.	petros@jhmi.edu	Karakousis, Petros Constantine/AAR-7899-2020	Thayil, SEEMA/0000-0002-3111-6861	Bill and Melinda Gates Foundation [42851]; National Institutes of Health [K08AI064229, R01AI083125, R01HL106786]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL106786] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083125, K08AI064229] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by TB Accelerator grant # 42851 from the Bill and Melinda Gates Foundation and National Institutes of Health grants K08AI064229, R01AI083125, and R01HL106786 to P. C. K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KN, 2011, CELL, V145, P39, DOI 10.1016/j.cell.2011.02.022; Ahmad Z, 2011, ANTIMICROB AGENTS CH; Ahmad Z, 2009, J INFECT DIS, V200, P1136, DOI 10.1086/605605; Aschar-Sobbi R, 2008, J FLUORESC, V18, P859, DOI 10.1007/s10895-008-0315-4; Ault-Riche D, 1998, J BACTERIOL, V180, P1841; Avarbock D, 2000, BIOCHEMISTRY-US, V39, P11640, DOI 10.1021/bi001256k; BLOCH H, 1956, JBACTERIOL, V72, P132; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; Dahl JL, 2003, P NATL ACAD SCI USA, V100, P10026, DOI 10.1073/pnas.1631248100; Fauci AS, 2008, J INFECT DIS, V197, P1493, DOI 10.1086/587904; Fleischmann RD, 2002, J BACTERIOL, V184, P5479, DOI 10.1128/JB.184.19.5479-5490.2002; Gomez JE, 2004, TUBERCULOSIS, P101; HAAPANEN JH, 1959, AM REV RESPIR DIS, V80, P1; Hengge-Aronis R, 2002, MICROBIOL MOL BIOL R, V66, P373, DOI 10.1128/MMBR.66.3.373-395.2002; Horsburgh CR, 2011, NEW ENGL J MED, V364, P1441, DOI 10.1056/NEJMcp1005750; Karakousis PC, 2004, J EXP MED, V200, P647, DOI 10.1084/jem.20040646; Karakousis PC, 2009, INFECT DIS-SER, P271, DOI 10.1007/978-1-59745-180-2_24; KEASLING JD, 1993, P NATL ACAD SCI USA, V90, P7029, DOI 10.1073/pnas.90.15.7029; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Klinkenberg LG, 2008, J INFECT DIS, V198, P275, DOI 10.1086/589515; Klinkenberg LG, 2010, J INFECT DIS, V202, P1397, DOI 10.1086/656524; Kornberg A, 1999, ANNU REV BIOCHEM, V68, P89, DOI 10.1146/annurev.biochem.68.1.89; Kristensen O, 2008, J MOL BIOL, V375, P1469, DOI 10.1016/j.jmb.2007.11.073; Kuroda A, 1997, J BIOL CHEM, V272, P21240, DOI 10.1074/jbc.272.34.21240; Lamichhane G, 2005, INFECT IMMUN, V73, P2533, DOI 10.1128/IAI.73.4.2533-2540.2005; Lamichhane G, 2003, P NATL ACAD SCI USA, V100, P7213, DOI 10.1073/pnas.1231432100; Lenaerts AJ, 2007, ANTIMICROB AGENTS CH, V51, P3338, DOI 10.1128/AAC.00276-07; Lindner SN, 2009, APPL ENVIRON MICROB, V75, P3161, DOI 10.1128/AEM.02705-08; Manganelli R, 1999, MOL MICROBIOL, V31, P715, DOI 10.1046/j.1365-2958.1999.01212.x; MCDERMOTT W, 1959, PUBLIC HEALTH REP, V74, P485, DOI 10.2307/4590490; Nuermberger E, 2004, SEMIN RESP CRIT CARE, V25, P317, DOI 10.1055/s-2004-829504; Opie EL, 1927, ARCH PATHOL LAB MED, V4, P1; POTRYKUS K, 2008, ANN REV MICROBIOL; Primm TP, 2000, J BACTERIOL, V182, P4889, DOI 10.1128/JB.182.17.4889-4898.2000; Rangarajan ES, 2006, J MOL BIOL, V359, P1249, DOI 10.1016/j.jmb.2006.04.031; Rao N N, 1999, Prog Mol Subcell Biol, V23, P183; Rao NN, 2009, ANNU REV BIOCHEM, V78, P605, DOI 10.1146/annurev.biochem.77.083007.093039; Rao NN, 1998, J BACTERIOL, V180, P2186, DOI 10.1128/JB.180.8.2186-2193.1998; Rao NN, 1996, J BACTERIOL, V178, P1394, DOI 10.1128/jb.178.5.1394-1400.1996; Rengarajan J, 2005, P NATL ACAD SCI USA, V102, P8327, DOI 10.1073/pnas.0503272102; Rifat D, 2009, J INFECT DIS, V200, P1126, DOI 10.1086/605700; Sable SB, 2005, INFECT IMMUN, V73, P3547, DOI 10.1128/IAI.73.6.3547-3558.2005; Shi XB, 2004, P NATL ACAD SCI USA, V101, P17061, DOI 10.1073/pnas.0407787101; Shiba T, 1997, P NATL ACAD SCI USA, V94, P11210, DOI 10.1073/pnas.94.21.11210; Sureka K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001771; Sureka K, 2007, MOL MICROBIOL, V65, P261, DOI 10.1111/j.1365-2958.2007.05814.x; TAKAYAMA K, 1972, ANTIMICROB AGENTS CH, V2, P29, DOI 10.1128/AAC.2.1.29; TOMASZ A, 1970, NATURE, V227, P138, DOI 10.1038/227138a0; Via LE, 2008, INFECT IMMUN, V76, P2333, DOI 10.1128/IAI.01515-07; WAYNE LG, 1994, ANTIMICROB AGENTS CH, V38, P2054, DOI 10.1128/AAC.38.9.2054; Wayne LG, 1996, INFECT IMMUN, V64, P2062, DOI 10.1128/IAI.64.6.2062-2069.1996; Werner TP, 2005, ARCH MICROBIOL, V184, P129, DOI 10.1007/s00203-005-0031-2; WINDER F G, 1970, Journal of General Microbiology, V63, P41; WINDER FG, 1957, J GEN MICROBIOL, V17, P573, DOI 10.1099/00221287-17-3-573; Xie ZF, 2005, ANTIMICROB AGENTS CH, V49, P4778, DOI 10.1128/AAC.49.11.4778-4780.2005; Zhang QA, 2010, J BIOL CHEM, V285, P34259, DOI 10.1074/jbc.M110.154393; Zhang TY, 2009, AM J RESP CRIT CARE, V180, P1151, DOI 10.1164/rccm.200905-0795OC	58	49	52	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2011	6	11							e28076	10.1371/journal.pone.0028076	http://dx.doi.org/10.1371/journal.pone.0028076			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IO	22132215	Green Submitted, Green Published, gold			2022-12-27	WOS:000297789900046
J	Tong, YQ; Liu, B; Zheng, HY; He, YJ; Gu, J; Li, F; Li, Y				Tong, Yong-Qing; Liu, Bei; Zheng, Hong-Yun; He, Yu-Juan; Gu, Jian; Li, Feng; Li, Yan			BMI-1 Autoantibody as a New Potential Biomarker for Cervical Carcinoma	PLOS ONE			English	Article							POLYCOMB GROUP PROTEINS; HUMAN-PAPILLOMAVIRUS; UNITED-STATES; NASOPHARYNGEAL CARCINOMA; DEVELOPING-COUNTRIES; BREAST-CANCER; C-MYC; GENE; OVEREXPRESSION; EXPRESSION	BMI-1 is overexpressed in a variety of cancers, which can elicit an immune response leading to the induction of autoantibodies. However, BMI-1 autoantibody as a biomarker has seldom been studied with the exception of nasopharyngeal carcinoma. Whether BMI-1 autoantibodies can be used as a biomarker for cervical carcinoma is unclear. In this study, BMI-1 proteins were isolated by screening of a T7 phage cDNA library from mixed cervical carcinoma tissues. We analyzed BMI-1 autoantibody levels in serum samples from 67 patients with cervical carcinoma and 65 controls using ELISA and immunoblot. BMI-1 mRNA or protein levels were over-expressed in cervical carcinoma cell lines. Immunoblot results exhibited increased BMI-1 autoantibody levels in patient sera compared to normal sera. Additionally, the results for antibody affinity assay showed that there was no difference between cervical polyps and normal sera of BMI-1 autoantibody levels, but it was significantly greater in patient sera than that in normal controls (patient 0.827 +/- 0.043 and normal 0.445 +/- 0.023; P<0.001). What's more, the levels of BMI-1 autoantibody increased significantly at stage I (0.672 +/- 0.019) compared to normal sera (P<0.001), and levels of BMI-1 autoantibodies were increased gradually during the tumor progression (stage I 0.672 +/- 0.019; stage II 0.775 +/- 0.019; stage III 0.890 +/- 0.027; stage IV 1.043 +/- 0.041), which were significantly correlated with disease progression of cervical carcer (P<0.001). Statistical analyses using logistic regression and receiver operating characteristics (ROC) curves indicated that the BMI-1 autoantibody level can be used as a biomarker for cervical carcinoma (sensitivity 0.78 and specificity 0.76; AUC = 0.922). In conclusion, measuring BMI-1 autoantibody levels of patients with cervical cancer could have clinical prognostic value as well as a non-tissue specific biomarker for neoplasms expressing BMI-1.	[Tong, Yong-Qing; Zheng, Hong-Yun; Gu, Jian; Li, Feng; Li, Yan] Wuhan Univ, Dept Clin Lab, Renmin Hosp, Wuhan 430072, Hubei, Peoples R China; [Tong, Yong-Qing; Zheng, Hong-Yun; Li, Feng; Li, Yan] Wuhan Univ, Clin Mol Diagnost Ctr, Renmin Hosp, Wuhan 430072, Hubei, Peoples R China; [Liu, Bei; He, Yu-Juan] Wuhan Univ Sci & Technol, Dept Pathol, Affiliated Tianyou Hosp, Wuhan, Hubei, Peoples R China	Wuhan University; Wuhan University; Wuhan University of Science & Technology	Tong, YQ (corresponding author), Wuhan Univ, Dept Clin Lab, Renmin Hosp, Wuhan 430072, Hubei, Peoples R China.	yanlitf@yahoo.com.cn			Fundamental Research Funds for the Central Universities [302275751]; Hubei Provincial Natural Science Foundation of China [2010CDB06903]; National Natural Science Foundation of China [81000771]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Hubei Provincial Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work supported by the Fundamental Research Funds for the Central Universities (Grant No. 302275751, www.whu.edu.cn), Hubei Provincial Natural Science Foundation of China (Grant No. 2010CDB06903, www.hbstd.gov.cn), and National Natural Science Foundation of China (Grant No. 81000771, www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bea S, 2001, CANCER RES, V61, P2409; Bracken AP, 2009, NAT REV CANCER, V9, P773, DOI 10.1038/nrc2736; Breuer RHJ, 2005, LUNG CANCER, V48, P299, DOI 10.1016/j.lungcan.2004.11.026; Carozzi F, 2008, LANCET ONCOL, V9, P937, DOI 10.1016/S1470-2045(08)70208-0; Chan KS, 2009, P NATL ACAD SCI USA, V106, P14016, DOI 10.1073/pnas.0906549106; Chmura A, 2009, GINEKOL POL, V80, P361; Cuzick J, 2008, VACCINE, V26, pK29, DOI 10.1016/j.vaccine.2008.06.019; Honig A, 2010, ANTICANCER RES, V30, P1559; Insinga RP, 2011, CANCER EPIDEM BIOMAR, V20, P287, DOI 10.1158/1055-9965.EPI-10-0791; Jacobs JJL, 1999, GENE DEV, V13, P2678, DOI 10.1101/gad.13.20.2678; Kalushkova A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011483; Liu R, 2007, NEW ENGL J MED, V356, P217, DOI 10.1056/NEJMoa063994; Munoz N, 2000, J CLIN VIROL, V19, P1, DOI 10.1016/S1386-6532(00)00125-6; Pecorelli S, 2009, INT J GYNECOL OBSTET, V105, P107, DOI 10.1016/j.ijgo.2009.02.009; Puthucode-Easwaran S, 2005, J Obstet Gynaecol, V25, P486; Qiao YL, 2008, LANCET ONCOL, V9, P929, DOI 10.1016/S1470-2045(08)70210-9; Reeler A, 2009, ASIAN PAC J CANCER P, V10, P519; Riis MLH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-686; Ronco G, 2010, LANCET ONCOL; Ronco G, 2010, LANCET ONCOL, V11, P249, DOI 10.1016/S1470-2045(09)70360-2; Silva J, 2006, CLIN CANCER RES, V12, P6929, DOI 10.1158/1078-0432.CCR-06-0788; Smith RA, 2007, CA-CANCER J CLIN, V57, P90, DOI 10.3322/canjclin.57.2.90; Smith R, 2008, CA-CANCER J CLIN, V58, P161, DOI 10.3322/CA.2007.0017; Solomon D, 2007, CA-CANCER J CLIN, V57, P105, DOI 10.3322/canjclin.57.2.105; Steele JC, 2006, BRIT J CANCER, V95, P1202, DOI 10.1038/sj.bjc.6603369; Stoler MH, 2011, AM J CLIN PATHOL, V135, P468, DOI 10.1309/AJCPZ5JY6FCVNMOT; SUN ZR, 2010, INT J GYNAECOL OBSTE; Tao YP, 1997, DEVELOPMENT, V124, P3587; Thomas M, 2008, ONCOGENE, V27, P7018, DOI 10.1038/onc.2008.351; Tong YQ, 2008, PROTEOMICS, V8, P3185, DOI 10.1002/pmic.200700651; Tong YQ, 2008, CANCER BIOL THER, V7, P340, DOI 10.4161/cbt.7.3.5422; Villa LL, 2008, LANCET ONCOL, V9, P910, DOI 10.1016/S1470-2045(08)70238-9; Yang JC, 2007, P NATL ACAD SCI USA, V104, P10494, DOI 10.1073/pnas.0704001104; Zhang CL, 2007, HUM PATHOL, V38, P995, DOI 10.1016/j.humpath.2006.10.021; Zhang X, 2010, INT J GYNECOL CANCER, V20, P1597, DOI 10.1111/IGC.0b013e3181fd080e	35	21	21	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2011	6	11							e27804	10.1371/journal.pone.0027804	http://dx.doi.org/10.1371/journal.pone.0027804			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IO	22132147	Green Submitted, Green Published, gold			2022-12-27	WOS:000297789900023
J	Ilany, A; Barocas, A; Koren, L; Kam, M; Geffen, E				Ilany, Amiyaal; Barocas, Adi; Koren, Lee; Kam, Michael; Geffen, Eli			Do Singing Rock Hyraxes Exploit Conspecific Calls to Gain Attention?	PLOS ONE			English	Article							SPLENDID FAIRY-WREN; TESTOSTERONE LEVELS; COMMUNICATION; SIGNAL; SELECTION; SCREAMS; DANGER; FROG	Signal detection theory predicts that signals directed at distant or busy receivers in noisy backgrounds will begin with an alert component, in order to draw attention. Instead of an alert component, however, animals could get the same effect by using an external stimulus. Here we combined observations of free-living rock hyraxes (Procavia capensis) with playback experiments to elucidate the circumstances under which males begin singing. We show that males sing following hyrax pup screams, which elicit a strong response from hyraxes within hearing distance, which are potential receivers. We hypothesize that singers enhance their singing display by exploiting the rarely emitted pup screams. To our knowledge, our findings are the first indication that animals may enhance signal reception by exploiting conspecifics' signals and the differential attention to these signals. We suggest that the utilization of external stimuli by signalers may be widespread, as an adaptive strategy for communication in complex environments.	[Ilany, Amiyaal; Barocas, Adi; Koren, Lee; Geffen, Eli] Tel Aviv Univ, Dept Zool, IL-69978 Tel Aviv, Israel; [Barocas, Adi] Univ Wyoming, Program Ecol, Laramie, WY 82071 USA; [Barocas, Adi] Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA; [Koren, Lee] Univ Calgary, Dept Comparat Biol & Expt Med, Calgary, AB, Canada; [Kam, Michael] Ben Gurion Univ Negev, Jacob Blaustein Inst Desert Res, Wyler Dept Dryland Agr, IL-84105 Beer Sheva, Israel	Tel Aviv University; University of Wyoming; University of Wyoming; University of Calgary; Ben Gurion University	Ilany, A (corresponding author), Tel Aviv Univ, Dept Zool, IL-69978 Tel Aviv, Israel.	amiyaal@gmail.com	Kam, Michael/Q-8764-2019	Kam, Michael/0000-0002-1062-7654; Ilany, Amiyaal/0000-0001-8089-569X	Israel Sciences Foundation [577/99, 488/05, 461/09]	Israel Sciences Foundation(Israel Science Foundation)	The Israel Sciences Foundation funded the study (grants 577/99, 488/05, 461/09; url: www.isf.org.il/english/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blumstein DT, 2008, ANIM BEHAV, V76, P1055, DOI 10.1016/j.anbehav.2008.06.002; Byers J, 2010, ANIM BEHAV, V79, P771, DOI 10.1016/j.anbehav.2010.01.009; FOURIE PB, 1977, Z TIERPSYCHOL, V44, P194; Greig EI, 2010, BEHAV ECOL, V21, P1360, DOI 10.1093/beheco/arq155; Greig EI, 2009, ANIM BEHAV, V78, P45, DOI 10.1016/j.anbehav.2009.02.030; HOECK HN, 1982, Z TIERPSYCHOL, V59, P265; Koren L, 2006, HORM BEHAV, V49, P470, DOI 10.1016/j.yhbeh.2005.10.004; Koren L, 2000, HYRAX SOCIALIZATION; Koren L, 2008, HORM BEHAV, V54, P212, DOI 10.1016/j.yhbeh.2008.02.020; Koren L, 2011, BEHAV ECOL SOCIOBIOL, V65, P675, DOI 10.1007/s00265-010-1069-y; Koren L, 2009, BEHAV ECOL SOCIOBIOL, V63, P581, DOI 10.1007/s00265-008-0693-2; Lohr B, 2003, ANIM BEHAV, V65, P763, DOI 10.1006/anbe.2003.2093; Manser MB, 2001, P ROY SOC B-BIOL SCI, V268, P2315, DOI 10.1098/rspb.2001.1773; Narins PM, 2003, P NATL ACAD SCI USA, V100, P577, DOI 10.1073/pnas.0237165100; NEAVES WB, 1973, BIOL REPROD, V8, P451, DOI 10.1093/biolreprod/8.4.451; Ord TJ, 2008, P NATL ACAD SCI USA, V105, P18830, DOI 10.1073/pnas.0807657105; Peters RA, 2008, BIOL LETTERS, V4, P2, DOI 10.1098/rsbl.2007.0422; Reby D, 2012, ANIM COGN, V15, P265, DOI 10.1007/s10071-011-0451-0; RICHARDS DG, 1981, BEHAVIOUR, V76, P223, DOI 10.1163/156853981X00095; RYAN MJ, 1990, NATURE, V343, P66, DOI 10.1038/343066a0; Slocombe KE, 2007, P NATL ACAD SCI USA, V104, P17228, DOI 10.1073/pnas.0706741104; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3; Zelano B, 2001, ETHOLOGY, V107, P201, DOI 10.1046/j.1439-0310.2001.00645.x	23	15	15	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2011	6	12							e28612	10.1371/journal.pone.0028612	http://dx.doi.org/10.1371/journal.pone.0028612			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863OC	22163045	Green Published, Green Submitted, gold			2022-12-27	WOS:000298173500041
J	Kim, YJ; Park, SJ; Choi, EY; Kim, S; Kwak, HJ; Yoo, BC; Yoo, H; Lee, SH; Kim, D; Park, JB; Kim, JH				Kim, Youn-Jae; Park, Se-Jeong; Choi, Eun Young; Kim, Sol; Kwak, Hee Jin; Yoo, Byong Chul; Yoo, Heon; Lee, Seung-Hoon; Kim, Daesoo; Park, Jong Bae; Kim, Jong Heon			PTEN Modulates miR-21 Processing via RNA-Regulatory Protein RNH1	PLOS ONE			English	Article							POSTTRANSCRIPTIONAL REGULATION; MICRORNA BIOGENESIS; MESSENGER-RNA; NUCLEAR PTEN; HNRNP A1; COMPLEX; PHOSPHATASE; EXPRESSION; SUBSET; LIN28	Aberrant miR-21 expression is closely associated with cell proliferation, anti-apoptosis, migration, invasion, and metastasis in various cancers. However, the regulatory mechanism of miR-21 biogenesis is largely unknown. Here, we demonstrated that the tumor suppressor PTEN negatively regulates the expression of oncogenic miR-21 at the post-transcriptional level. Moreover, our results suggest that PTEN plays such a role through the indirect interaction with the Drosha complex. To elucidate how PTEN regulates pri- to pre-miR-21 processing, we attempted to find PTEN-interacting proteins and identified an RNA-regulatory protein, RNH1. Using the sensor to monitor pri-miR-21 processing, we demonstrated that RNH1 is necessary and sufficient for pri-miR-21 processing. Moreover, our results propose that the nuclear localization of RNH1 is important for this function. Further analysis showed that RNH1 directly interacts with the Drosha complex and that PTEN blocks this interaction. Taken together, these results suggest that the PTEN-mediated miR-21 regulation is achieved by inhibiting the interaction between the Drosha complex and RNH1, revealing previously unidentified role of PTEN in the oncogenic miR-21 biogenesis.	[Kim, Youn-Jae; Kim, Daesoo] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; [Park, Se-Jeong; Kim, Sol; Kim, Jong Heon] Natl Canc Ctr, Res Inst, Carcinogenesis Branch, Ilsan, South Korea; [Kim, Youn-Jae; Choi, Eun Young; Kwak, Hee Jin; Yoo, Heon; Lee, Seung-Hoon; Park, Jong Bae] Natl Canc Ctr, Res Inst, Specif Organs Canc Branch, Ilsan, South Korea; [Yoo, Byong Chul] Natl Canc Ctr, Res Inst, Colorectal Canc Branch, Ilsan, South Korea	Korea Advanced Institute of Science & Technology (KAIST); National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC)	Kim, YJ (corresponding author), Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea.	jbp@ncc.re.kr; jhkim@ncc.re.kr	Kim, Daesoo/C-1625-2011	Kim, Daesoo/0000-0001-9915-1463; Yoo, Heon/0000-0001-6186-3262	National Cancer Center [1110110, 1010171, 1010172, 1110120]; National Research Foundation [2011-0024692]	National Cancer Center; National Research Foundation	JHK was supported by the National Cancer Center Grant (1110110) and the National Research Foundation Grant (2011-0024692). JBP was supported by the National Cancer Center Grants (1010171, 1010172, and 1110120). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bella J, 2008, CELL MOL LIFE SCI, V65, P2307, DOI 10.1007/s00018-008-8019-0; Chalhoub N, 2009, ANNU REV PATHOL-MECH, V4, P127, DOI 10.1146/annurev.pathol.4.110807.092311; Cho SC, 2005, MOL CELL BIOL, V25, P1283, DOI 10.1128/MCB.25.4.1283-1297.2005; Cho SC, 2007, MOL CELL BIOL, V27, P368, DOI 10.1128/MCB.00814-06; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Dickson KA, 2005, PROG NUCLEIC ACID RE, V80, P349, DOI 10.1016/S0079-6603(05)80009-1; Farazi TA, 2011, J PATHOL, V223, P102, DOI 10.1002/path.2806; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fukuda T, 2007, NAT CELL BIOL, V9, P604, DOI 10.1038/ncb1577; Furia A, 2011, FEBS LETT, V585, P613, DOI 10.1016/j.febslet.2011.01.034; Garofalo M, 2011, ANNU REV PHARMACOL, V51, P25, DOI 10.1146/annurev-pharmtox-010510-100517; Gruber JJ, 2009, CELL, V138, P328, DOI 10.1016/j.cell.2009.04.046; Guil S, 2007, NAT STRUCT MOL BIOL, V14, P591, DOI 10.1038/nsmb1250; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Hollander MC, 2011, NAT REV CANCER, V11, P289, DOI 10.1038/nrc3037; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Jeong SH, 2009, EXP MOL MED, V41, P912, DOI 10.3858/emm.2009.41.12.097; Kim H, 2007, NAT STRUCT MOL BIOL, V14, P710, DOI 10.1038/nsmb1277; Kim JH, 2000, J MOL BIOL, V298, P395, DOI 10.1006/jmbi.2000.3687; Kim JH, 2006, MOL CELL, V24, P173, DOI 10.1016/j.molcel.2006.08.016; Kim S, 2009, FEBS J, V276, P2165, DOI 10.1111/j.1742-4658.2009.06935.x; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Krichevsky AM, 2009, J CELL MOL MED, V13, px, DOI 10.1111/j.1582-4934.2008.00556.x; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Kwak HJ, 2011, ONCOGENE, V30, P2433, DOI 10.1038/onc.2010.620; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2007, METHOD ENZYMOL, V427, P89, DOI 10.1016/S0076-6879(07)27005-3; Li AG, 2006, MOL CELL, V23, P575, DOI 10.1016/j.molcel.2006.06.028; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Michlewski G, 2010, NAT STRUCT MOL BIOL, V17, P1011, DOI 10.1038/nsmb.1874; Pflieger D, 2011, PROTEOMICS, V11, P1824, DOI 10.1002/pmic.201000635; Planchon SM, 2008, J CELL SCI, V121, P249, DOI 10.1242/jcs.022459; Rau F, 2011, NAT STRUCT MOL BIOL, V18, P840, DOI 10.1038/nsmb.2067; Sabin LR, 2009, CELL, V138, P340, DOI 10.1016/j.cell.2009.04.045; Selcuklu SD, 2009, BIOCHEM SOC T, V37, P918, DOI 10.1042/BST0370918; Shen WH, 2007, CELL, V128, P157, DOI 10.1016/j.cell.2006.11.042; Siomi H, 2010, MOL CELL, V38, P323, DOI 10.1016/j.molcel.2010.03.013; Song MS, 2008, NATURE, V455, P813, DOI 10.1038/nature07290; Song MS, 2011, CELL, V144, P187, DOI 10.1016/j.cell.2010.12.020; Suzuki HI, 2011, J BIOCHEM, V149, P15, DOI 10.1093/jb/mvq113; Suzuki HI, 2009, NATURE, V460, P529, DOI 10.1038/nature08199; Teplova M, 2011, NAT STRUCT MOL BIOL, V18, P990, DOI 10.1038/nsmb.2094; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; Trabucchi M, 2009, NATURE, V459, P1010, DOI 10.1038/nature08025; Trotman LC, 2007, CELL, V128, P141, DOI 10.1016/j.cell.2006.11.040; Vinciguerra M, 2009, HEPATOLOGY, V49, P1176, DOI 10.1002/hep.22737; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Volkel P, 2010, BIOCHEM SOC T, V38, P883, DOI 10.1042/BST0380883; Wu H, 2010, MOL CELL, V38, P67, DOI 10.1016/j.molcel.2010.02.021; Yamagata K, 2009, MOL CELL, V36, P340, DOI 10.1016/j.molcel.2009.08.017; Yang XJ, 2010, CANCER RES, V70, P9463, DOI 10.1158/0008-5472.CAN-10-2388	53	23	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e28308	10.1371/journal.pone.0028308	http://dx.doi.org/10.1371/journal.pone.0028308			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22162762	Green Submitted, Green Published, gold			2022-12-27	WOS:000298172800024
J	Yu, LL; Lu, W; Wei, YN				Yu, Linliang; Lu, Wei; Wei, Yinan			AcrB Trimer Stability and Efflux Activity, Insight from Mutagenesis Studies	PLOS ONE			English	Article							MULTIDRUG-RESISTANCE; ESCHERICHIA-COLI; PUMP ACRB; LIMITED PROTEOLYSIS; ROTATING MECHANISM; CRYSTAL-STRUCTURE; DISULFIDE BONDS; PROTEIN; PROLINE; COMPLEX	The multidrug transporter AcrB in Escherichia coli exists and functions as a homo-trimer. The assembly process of obligate membrane protein oligomers, including AcrB, remains poorly understood. In a previous study, we have shown that individual AcrB subunit is capable of folding independently, suggesting that trimerization of AcrB follows a three-stage pathway in which monomers first fold, and then assemble. Here we destabilized the AcrB trimer through mutating a single Pro (P223) in the protruding loop of AcrB, which drastically reduced the protein activity. We replaced P223 separately with five residues, including Ala, Val, Tyr, Asn, and Gly, and found that AcrB(P223G) was the least active. Detailed characterization of AcrB(P223G) revealed that the protein existed as a well-folded monomer after purification, but formed a trimer in vivo. The function of the mutant could be partly restored through strengthening the stability of the trimer using an inter-subunit disulfide bond. Our results also suggested that the protruding loop is well structured during AcrB assembly with P223 served as a "wedge'' close to the tip to stabilize the AcrB trimer structure. When this wedge is disrupted, the stability of the trimer is reduced, accompanied by a decrease of drug efflux activity.	[Yu, Linliang; Lu, Wei; Wei, Yinan] Univ Kentucky, Dept Chem, Lexington, KY 40506 USA	University of Kentucky	Yu, LL (corresponding author), Univ Kentucky, Dept Chem, Lexington, KY 40506 USA.	yinan.wei@uky.edu			Oak Ridge Associated Universities (ORAU) Ralph E. Powe Junior Faculty Enhancement Award	Oak Ridge Associated Universities (ORAU) Ralph E. Powe Junior Faculty Enhancement Award	Yinan Wei thanks the Oak Ridge Associated Universities (ORAU) Ralph E. Powe Junior Faculty Enhancement Award for supporting this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MH, 2005, BIOORGAN MED CHEM, V13, P5013, DOI 10.1016/j.bmc.2005.05.037; Bakos E, 1996, J BIOL CHEM, V271, P12322, DOI 10.1074/jbc.271.21.12322; Bantscheff M, 1999, BIOCHEMISTRY-US, V38, P11012, DOI 10.1021/bi990781k; Blair JMA, 2009, CURR OPIN MICROBIOL, V12, P512, DOI 10.1016/j.mib.2009.07.003; Bowie JU, 2005, NATURE, V438, P581, DOI 10.1038/nature04395; Daley DO, 2008, CURR OPIN STRUC BIOL, V18, P420, DOI 10.1016/j.sbi.2008.04.006; GOODSELL DS, 1991, TRENDS BIOCHEM SCI, V16, P203, DOI 10.1016/0968-0004(91)90083-8; Goodsell DS, 2000, ANNU REV BIOPH BIOM, V29, P105, DOI 10.1146/annurev.biophys.29.1.105; Gunasekaran K, 1998, J MOL BIOL, V275, P917, DOI 10.1006/jmbi.1997.1505; Heuberger EHML, 2002, J MOL BIOL, V317, P591, DOI 10.1006/jmbi.2002.5416; Kadokura H, 2003, ANNU REV BIOCHEM, V72, P111, DOI 10.1146/annurev.biochem.72.121801.161459; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Lu W, 2011, PROTEIN PEP IN PRESS; Lu W, 2011, J MOL BIOL, V411, P264, DOI 10.1016/j.jmb.2011.05.042; Michelle A., 2011, BIOCHEMISTRY-US, V49, P9181; Middlemiss JK, 2004, J BACTERIOL, V186, P1258, DOI 10.1128/JB.186.5.1258-1269.2004; Murakami S, 2002, NATURE, V419, P587, DOI 10.1038/nature01050; Murakami S, 2006, NATURE, V443, P173, DOI 10.1038/nature05076; Nikaido H, 2009, ANNU REV BIOCHEM, V78, P119, DOI 10.1146/annurev.biochem.78.082907.145923; Nikaido H, 2009, BBA-PROTEINS PROTEOM, V1794, P769, DOI 10.1016/j.bbapap.2008.10.004; Nooren IMA, 2003, J MOL BIOL, V325, P991, DOI 10.1016/S0022-2836(02)01281-0; Nouwen N, 2000, EMBO J, V19, P2229, DOI 10.1093/emboj/19.10.2229; Pavlicek J, 2008, J BIOL CHEM, V283, P14552, DOI 10.1074/jbc.M800593200; Poole K, 2001, CURR OPIN MICROBIOL, V4, P500, DOI 10.1016/S1369-5274(00)00242-3; Proshkin S, 2010, SCIENCE, V328, P504, DOI 10.1126/science.1184939; Reynolds C, 2009, BIOINFORMATICS, V25, P413, DOI 10.1093/bioinformatics/btn584; Schulz R, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000806; Seeger MA, 2008, CURR DRUG TARGETS, V9, P729, DOI 10.2174/138945008785747789; Seeger MA, 2008, NAT STRUCT MOL BIOL, V15, P199, DOI 10.1038/nsmb.1379; Seeger MA, 2006, SCIENCE, V313, P1295, DOI 10.1126/science.1131542; Sennhauser G, 2007, PLOS BIOL, V5, P106, DOI 10.1371/journal.pbio.0050007; Suh JY, 1999, EUR J BIOCHEM, V266, P665, DOI 10.1046/j.1432-1327.1999.00917.x; Symmons MF, 2009, P NATL ACAD SCI USA, V106, P7173, DOI 10.1073/pnas.0900693106; Takatsuka Y, 2010, P NATL ACAD SCI USA, V107, P6559, DOI 10.1073/pnas.1001460107; Takatsuka Y, 2009, J BACTERIOL, V191, P1729, DOI 10.1128/JB.01441-08; Tikhonova EB, 2004, J BIOL CHEM, V279, P32116, DOI 10.1074/jbc.M402230200; Wallace BA, 2009, BIOCHIM BIOPHYS ACTA, V1788, P1279; Wedemeyer WJ, 2000, BIOCHEMISTRY-US, V39, P4207, DOI 10.1021/bi992922o; White SH, 1999, ANNU REV BIOPH BIOM, V28, P319, DOI 10.1146/annurev.biophys.28.1.319; Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62	46	20	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e28390	10.1371/journal.pone.0028390	http://dx.doi.org/10.1371/journal.pone.0028390			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22163011	Green Submitted, Green Published, gold			2022-12-27	WOS:000298172800033
J	Li, YL; Hoxha, V; Lama, C; Dinh, BH; Vo, CN; Dauwalder, B				Li, Yuanli; Hoxha, Valbona; Lama, Chamala; Dinh, Bich Hien; Vo, Christina N.; Dauwalder, Brigitte			The hector G-Protein Coupled Receptor Is Required in a Subset of fruitless Neurons for Male Courtship Behavior	PLOS ONE			English	Article							DROSOPHILA TAKEOUT GENE; CENTRAL-NERVOUS-SYSTEM; SEXUAL-BEHAVIOR; NEURAL CIRCUITRY; MUSHROOM BODIES; DOUBLESEX GENE; EXPRESSION; DIFFERENTIATION; NEUROPEPTIDES; MELANOGASTER	Male courtship behavior in Drosophila melanogaster is controlled by two main regulators, fruitless (fru) and doublesex (dsx). Their sex-specific expression in brain neurons has been characterized in detail, but little is known about the downstream targets of the sex-specific FRU and DSX proteins and how they specify the function of these neurons. While sexual dimorphism in the number and connections of fru and dsx expressing neurons has been observed, a majority of the neurons that express the two regulators are present in both sexes. This poses the question which molecules define the sex-specific function of these neurons. Signaling molecules are likely to play a significant role. We have identified a predicted G-protein coupled receptor (GPCR), CG4395, that is required for male courtship behavior. The courtship defect in the mutants can be rescued by expression of the wildtype protein in fru neurons of adult males. The GPCR is expressed in a subset of fru-positive antennal glomeruli that have previously been shown to be essential for male courtship. Expression of 4395-RNAi in GH146 projection neurons lowers courtship. This suggests that signaling through the CG4395 GPCR in this subset of fru neurons is critical for male courtship behavior.	[Li, Yuanli; Hoxha, Valbona; Lama, Chamala; Dinh, Bich Hien; Vo, Christina N.; Dauwalder, Brigitte] Univ Houston, Dept Biol & Biochem, Houston, TX 77002 USA	University of Houston System; University of Houston	Li, YL (corresponding author), Univ Houston, Dept Biol & Biochem, Houston, TX 77002 USA.	bdauwalder@uh.edu		Hoxha, Valbona/0000-0002-7515-4288	GEAR grant; University of Houston; National Science Foundation [IOS 0919697]; Division Of Integrative Organismal Systems [0919697] Funding Source: National Science Foundation	GEAR grant; University of Houston; National Science Foundation(National Science Foundation (NSF)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The study was funded by GEAR grant, University of Houston, National Science Foundation Grant IOS 0919697, http://www.nsf.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbeitman MN, 2004, DEVELOPMENT, V131, P2007, DOI 10.1242/dev.01077; Arthur BI, 1998, CURR BIOL, V8, P1187, DOI 10.1016/S0960-9822(07)00491-5; BELOTE JM, 1987, P NATL ACAD SCI USA, V84, P8026, DOI 10.1073/pnas.84.22.8026; Billeter JC, 2006, CURR BIOL, V16, pR766, DOI 10.1016/j.cub.2006.08.025; Billeter JC, 2006, CURR BIOL, V16, P1063, DOI 10.1016/j.cub.2006.04.039; Cachero S, 2010, CURR BIOL, V20, P1589, DOI 10.1016/j.cub.2010.07.045; Carlsson MA, 2010, J COMP NEUROL, V518, P3359, DOI 10.1002/cne.22405; Datta SR, 2008, NATURE, V452, P473, DOI 10.1038/nature06808; Dauwalder B, 2002, GENE DEV, V16, P2879, DOI 10.1101/gad.1010302; Dauwalder B, 2008, CURR GENOMICS, V9, P517, DOI 10.2174/138920208786847980; Demir E, 2005, CELL, V121, P785, DOI 10.1016/j.cell.2005.04.027; Diegelmann S, 2008, FLY, V2, P236, DOI 10.4161/fly.6817; Dornan AJ, 2005, GENESIS, V42, P236, DOI 10.1002/gene.20143; Ferveur JF, 2005, BEHAV GENET, V35, P279, DOI 10.1007/s10519-005-3220-5; FERVEUR JF, 1995, SCIENCE, V267, P902, DOI 10.1126/science.7846534; Goldman TD, 2007, PLOS GENET, V3, P2278, DOI 10.1371/journal.pgen.0030216; Ha TS, 2006, J NEUROSCI, V26, P8727, DOI 10.1523/JNEUROSCI.0876-06.2006; Heimbeck G, 2001, P NATL ACAD SCI USA, V98, P15336, DOI 10.1073/pnas.011314898; Hewes RS, 2001, GENOME RES, V11, P1126, DOI 10.1101/gr.169901; Kido A, 2002, J NEUROBIOL, V52, P302, DOI 10.1002/neu.10100; Kimura K, 2008, NEURON, V59, P759, DOI 10.1016/j.neuron.2008.06.007; Kimura KI, 2005, NATURE, V438, P229, DOI 10.1038/nature04229; Koganezawa M, 2010, CURR BIOL, V20, P1, DOI 10.1016/j.cub.2009.11.038; Kurtovic A, 2007, NATURE, V446, P542, DOI 10.1038/nature05672; Lee G, 2002, J NEUROGENET, V16, P229, DOI 10.1080/01677060216292; Lee G, 2000, J NEUROBIOL, V43, P404, DOI 10.1002/1097-4695(20000615)43:4<404::AID-NEU8>3.0.CO;2-D; Lutz TA, 2010, FORUM NUTR, V63, P64, DOI 10.1159/000264394; Manoli DS, 2006, TRENDS NEUROSCI, V29, P444, DOI 10.1016/j.tins.2006.06.006; Manoli DS, 2005, NATURE, V436, P395, DOI 10.1038/nature03859; Marcillac F, 2005, P ROY SOC B-BIOL SCI, V272, P303, DOI 10.1098/rspb.2004.2971; McGuire SE, 2004, TRENDS GENET, V20, P384, DOI 10.1016/j.tig.2004.06.012; Mellert DJ, 2010, DEVELOPMENT, V137, P323, DOI 10.1242/dev.045047; Potter CJ, 2010, CELL, V141, P536, DOI 10.1016/j.cell.2010.02.025; Poyner DR, 2002, PHARMACOL REV, V54, P233, DOI 10.1124/pr.54.2.233; Rideout EJ, 2007, CURR BIOL, V17, P1473, DOI 10.1016/j.cub.2007.07.047; Rideout EJ, 2010, NAT NEUROSCI, V13, P458, DOI 10.1038/nn.2515; Ruta V, 2010, NATURE, V468, P686, DOI 10.1038/nature09554; Sanders LE, 2008, DEV BIOL, V320, P378, DOI 10.1016/j.ydbio.2008.05.543; Sarov-Blat L, 2000, CELL, V101, P647, DOI 10.1016/S0092-8674(00)80876-4; Sharma Y, 2002, GENESIS, V34, P115, DOI 10.1002/gene.10127; Skoulakis EMC, 2006, CELL MOL LIFE SCI, V63, P975, DOI 10.1007/s00018-006-6023-9; SKOULAKIS EMC, 1993, NEURON, V11, P197, DOI 10.1016/0896-6273(93)90178-T; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; STRAUSS R, 1993, J NEUROSCI, V13, P1852, DOI 10.1523/jneurosci.13-05-01852.1993; TAYLOR BJ, 1989, J NEUROGENET, V5, P173, DOI 10.3109/01677068909066207; Villella A, 2008, ADV GENET, V62, P67, DOI 10.1016/S0065-2660(08)00603-2; Yamamoto D, 2007, ADV GENET, V59, P39, DOI 10.1016/S0065-2660(07)59002-4; Yu JY, 2010, CURR BIOL, V20, P1602, DOI 10.1016/j.cub.2010.08.025; Zars T, 2000, SCIENCE, V288, P672, DOI 10.1126/science.288.5466.672	49	59	61	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e28269	10.1371/journal.pone.0028269	http://dx.doi.org/10.1371/journal.pone.0028269			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140564	Green Published, gold, Green Submitted			2022-12-27	WOS:000298168100058
J	Marini, NJ; Hoffmann, TJ; Lammer, EJ; Hardin, J; Lazaruk, K; Stein, JB; Gilbert, DA; Wright, C; Lipzen, A; Pennacchio, LA; Carmichael, SL; Witte, JS; Shaw, GM; Rine, J				Marini, Nicholas J.; Hoffmann, Thomas J.; Lammer, Edward J.; Hardin, Jill; Lazaruk, Katherine; Stein, Jason B.; Gilbert, Dennis A.; Wright, Crystal; Lipzen, Anna; Pennacchio, Len A.; Carmichael, Suzan L.; Witte, John S.; Shaw, Gary M.; Rine, Jasper			A Genetic Signature of Spina Bifida Risk from Pathway-Informed Comprehensive Gene-Variant Analysis	PLOS ONE			English	Article							NEURAL-TUBE DEFECTS; ONE-CARBON METABOLISM; ISOLATED CLEFT-LIP; FOLIC-ACID; FOLATE METABOLISM; METHYLENETETRAHYDROFOLATE REDUCTASE; MATHEMATICAL-MODEL; DNA METHYLATION; DIETARY-FOLATE; MOUSE MUTANTS	Despite compelling epidemiological evidence that folic acid supplements reduce the frequency of neural tube defects (NTDs) in newborns, common variant association studies with folate metabolism genes have failed to explain the majority of NTD risk. The contribution of rare alleles as well as genetic interactions within the folate pathway have not been extensively studied in the context of NTDs. Thus, we sequenced the exons in 31 folate-related genes in a 480-member NTD case-control population to identify the full spectrum of allelic variation and determine whether rare alleles or obvious genetic interactions within this pathway affect NTD risk. We constructed a pathway model, predetermined independent of the data, which grouped genes into coherent sets reflecting the distinct metabolic compartments in the folate/one-carbon pathway (purine synthesis, pyrimidine synthesis, and homocysteine recycling to methionine). By integrating multiple variants based on these groupings, we uncovered two provocative, complex genetic risk signatures. Interestingly, these signatures differed by race/ethnicity: a Hispanic risk profile pointed to alterations in purine biosynthesis, whereas that in non-Hispanic whites implicated homocysteine metabolism. In contrast, parallel analyses that focused on individual alleles, or individual genes, as the units by which to assign risk revealed no compelling associations. These results suggest that the ability to layer pathway relationships onto clinical variant data can be uniquely informative for identifying genetic risk as well as for generating mechanistic hypotheses. Furthermore, the identification of ethnic-specific risk signatures for spina bifida resonated with epidemiological data suggesting that the underlying pathogenesis may differ between Hispanic and non-Hispanic groups.	[Marini, Nicholas J.; Rine, Jasper] Univ Calif Berkeley, Dept Mol & Cellular Biol, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA; [Hoffmann, Thomas J.; Witte, John S.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Hoffmann, Thomas J.; Witte, John S.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Lammer, Edward J.] Childrens Hosp, Oakland Res Inst, Oakland, CA 94609 USA; [Hardin, Jill; Lazaruk, Katherine; Stein, Jason B.; Gilbert, Dennis A.] VitaPath Genet Inc, Foster City, CA USA; [Wright, Crystal; Lipzen, Anna; Pennacchio, Len A.] Joint Genome Inst, Dept Energy, Walnut Creek, CA USA; [Carmichael, Suzan L.; Shaw, Gary M.] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA	University of California System; University of California Berkeley; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; Stanford University	Marini, NJ (corresponding author), Univ Calif Berkeley, Dept Mol & Cellular Biol, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA.	nmarini@berkeley.edu; jrine@berkeley.edu		Lipzen, Anna/0000-0003-2293-9329; Pennacchio, Len/0000-0002-8748-3732; Shaw, Gary/0000-0001-7438-4914	National Institutes of Health [R01 GM072859, RC1 DE020640, R25 CA112355]; Department of Energy, University of California [DE-AC02-05CH11231];  [R01 NS05249]; NATIONAL CANCER INSTITUTE [R25CA112355] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [RC1DE020640] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072859] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy, University of California(United States Department of Energy (DOE)University of California System); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants R01 GM072859 and RC1 DE020640 from the National Institutes of Health (NJM, SLC, EJL, GMS, JR). Partial support for SLC, EJL, and GMS was also provided by R01 NS05249. TJH was supported by National Institutes of Health Training Grant (R25 CA112355). Research was conducted at the E.O. Lawrence Berkeley National Laboratory and performed under Department of Energy contract DE-AC02-05CH11231, University of California. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afman LA, 2003, BIRTH DEFECTS RES A, V67, P421, DOI 10.1002/bdra.10040; Ahituv N, 2007, AM J HUM GENET, V80, P779, DOI 10.1086/513471; Amorim MR, 2007, AM J MED GENET A, V143A, P1726, DOI 10.1002/ajmg.a.31812; Anderson DD, 2007, CLIN CHEM LAB MED, V45, P1760, DOI 10.1515/CCLM.2007.355; Anguera MC, 2006, J BIOL CHEM, V281, P18335, DOI 10.1074/jbc.M510623200; Au KS, 2010, DEV DISABIL RES REV, V16, P6, DOI 10.1002/ddrr.93; Beaudin Anna E., 2007, Birth Defects Research, V81, P183, DOI 10.1002/bdrc.20100; Beaudin AE, 2011, AM J CLIN NUTR, V93, P789, DOI 10.3945/ajcn.110.002766; Blanton SH, 2005, AM J MED GENET A, V137A, P259, DOI 10.1002/ajmg.a.30887; Blom HJ, 2006, NAT REV NEUROSCI, V7, P724, DOI 10.1038/nrn1986; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Carmichael SL, 2003, MED HYPOTHESES, V60, P351, DOI 10.1016/S0306-9877(02)00402-4; Carroll N, 2009, HUM GENET, V125, P247, DOI 10.1007/s00439-008-0616-3; Christensen KE, 2006, BIOESSAYS, V28, P595, DOI 10.1002/bies.20420; Christensen KE, 2009, HUM MUTAT, V30, P212, DOI 10.1002/humu.20830; Christensen KE, 2005, J BIOL CHEM, V280, P7597, DOI 10.1074/jbc.M409380200; Cirulli ET, 2010, NAT REV GENET, V11, P415, DOI 10.1038/nrg2779; Copp AJ, 2003, NAT REV GENET, V4, P784, DOI 10.1038/nrg1181; Croen L A, 1991, Paediatr Perinat Epidemiol, V5, P423, DOI 10.1111/j.1365-3016.1991.tb00728.x; De Marco P, 2006, J HUM GENET, V51, P98, DOI 10.1007/s10038-005-0329-6; Dudoit S, 2003, STAT SCI, V18, P71, DOI 10.1214/ss/1056397487; Dunlevy LPE, 2006, BIRTH DEFECTS RES A, V76, P544, DOI 10.1002/bdra.20286; Fleming A, 1998, SCIENCE, V280, P2107, DOI 10.1126/science.280.5372.2107; Food and Drug Administration, 1996, FED REGISTER, V61, P8781; Franke B, 2009, BIRTH DEFECTS RES A, V85, P216, DOI 10.1002/bdra.20556; Friso S, 2002, P NATL ACAD SCI USA, V99, P5606, DOI 10.1073/pnas.062066299; Greene NDE, 2009, HUM MOL GENET, V18, pR113, DOI 10.1093/hmg/ddp347; HARRIS JA, 1995, ENVIRON HEALTH PERSP, V103, P163, DOI 10.2307/3432368; Harris MJ, 2007, BIRTH DEFECTS RES A, V79, P187, DOI 10.1002/bdra.20333; Harris MJ, 2009, BIRTH DEFECTS RES A, V85, P331, DOI 10.1002/bdra.20552; Hendricks KA, 1999, AM J EPIDEMIOL, V149, P1119; Herbig K, 2002, J BIOL CHEM, V277, P38381, DOI 10.1074/jbc.M205000200; Hernandez-Diaz S, 2001, AM J EPIDEMIOL, V153, P961, DOI 10.1093/aje/153.10.961; Hoffmann TJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013584; Johansen CT, 2010, NAT GENET, V42, P684, DOI 10.1038/ng.628; MacFarlane AJ, 2008, J BIOL CHEM, V283, P25846, DOI 10.1074/jbc.M802671200; MacFarlane AJ, 2009, J BIOL CHEM, V284, P1533, DOI 10.1074/jbc.M808281200; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; Marini NJ, 2008, P NATL ACAD SCI USA, V105, P8055, DOI 10.1073/pnas.0802813105; MASSEY FJ, 1951, J AM STAT ASSOC, V46, P68, DOI 10.2307/2280095; MILLS JL, 1995, LANCET, V345, P149, DOI 10.1016/S0140-6736(95)90165-5; Moreno LM, 2009, HUM MOL GENET, V18, P4879, DOI 10.1093/hmg/ddp444; Morgenthaler S, 2007, MUTAT RES-FUND MOL M, V615, P28, DOI 10.1016/j.mrfmmm.2006.09.003; NEUMANN PE, 1994, NAT GENET, V6, P357, DOI 10.1038/ng0494-357; Niihout HF, 2008, VITAM HORM, V79, P45, DOI 10.1016/S0083-6729(08)00402-0; Nijhout HF, 2004, J BIOL CHEM, V279, P55008, DOI 10.1074/jbc.M410818200; Parle-McDermott A, 2006, EUR J HUM GENET, V14, P768, DOI 10.1038/sj.ejhg.5201603; Parle-McDermott A, 2009, HUM MUTAT, V30, P1650, DOI 10.1002/humu.21109; Pike ST, 2010, J BIOL CHEM, V285, P4612, DOI 10.1074/jbc.M109.079855; Reed MC, 2004, J THEOR BIOL, V226, P33, DOI 10.1016/j.jtbi.2003.08.001; Ross ME, 2010, WIRES SYST BIOL MED, V2, P471, DOI 10.1002/wsbm.72; Schork NJ, 2009, CURR OPIN GENET DEV, V19, P212, DOI 10.1016/j.gde.2009.04.010; SHAW GM, 1995, EPIDEMIOLOGY, V6, P219, DOI 10.1097/00001648-199505000-00005; Shelnutt KP, 2004, J NUTR BIOCHEM, V15, P554, DOI 10.1016/j.jnutbio.2004.04.003; STEEGERSTHEUNISSEN RPM, 1994, METABOLISM, V43, P1475, DOI 10.1016/0026-0495(94)90004-3; Suarez L, 2000, AM J EPIDEMIOL, V152, P1017, DOI 10.1093/aje/152.11.1017; Ulrich CM, 2008, CANCER EPIDEM BIOMAR, V17, P1822, DOI 10.1158/1055-9965.EPI-07-2937; Williams LJ, 2002, TERATOLOGY, V66, P33, DOI 10.1002/tera.10060; Woeller CF, 2007, J BIOL CHEM, V282, P17623, DOI 10.1074/jbc.M702526200; Yamada K, 2001, P NATL ACAD SCI USA, V98, P14853, DOI 10.1073/pnas.261469998; Zamar D, 2007, J STAT SOFTW, V21, P1; Zucchero TM, 2004, NEW ENGL J MED, V351, P769, DOI 10.1056/NEJMoa032909	62	21	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e28408	10.1371/journal.pone.0028408	http://dx.doi.org/10.1371/journal.pone.0028408			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140583	Green Published, Green Submitted, gold			2022-12-27	WOS:000298168100069
J	Mori, K; Haruyama, T; Nagata, K				Mori, Kotaro; Haruyama, Takahiro; Nagata, Kyosuke			Tamiflu-Resistant but HA-Mediated Cell-to-Cell Transmission through Apical Membranes of Cell-Associated Influenza Viruses	PLOS ONE			English	Article							POLARIZED EPITHELIAL-CELLS; RESPIRATORY SYNCYTIAL VIRUS; ION-CHANNEL ACTIVITY; A VIRUS; VIROLOGICAL SYNAPSES; NEURAMINIDASE; ENTRY; HEMAGGLUTININ; SPREAD; RELEASE	The infection of viruses to a neighboring cell is considered to be beneficial in terms of evasion from host anti-virus defense systems. There are two pathways for viral infection to "right next door": one is the virus transmission through cell-cell fusion by forming syncytium without production of progeny virions, and the other is mediated by virions without virus diffusion, generally designated cell-to-cell transmission. Influenza viruses are believed to be transmitted as cell-free virus from infected cells to uninfected cells. Here, we demonstrated that influenza virus can utilize cell-to-cell transmission pathway through apical membranes, by handover of virions on the surface of an infected cell to adjacent host cells. Live cell imaging techniques showed that a recombinant influenza virus, in which the neuraminidase gene was replaced with the green fluorescence protein gene, spreads from an infected cell to adjacent cells forming infected cell clusters. This type of virus spreading requires HA activation by protease treatment. The cell-to-cell transmission was also blocked by amantadine, which inhibits the acidification of endosomes required for uncoating of influenza virus particles in endosomes, indicating that functional hemagglutinin and endosome acidification by M2 ion channel were essential for the cell-to-cell influenza virus transmission. Furthermore, in the cell-to-cell transmission of influenza virus, progeny virions could remain associated with the surface of infected cell even after budding, for the progeny virions to be passed on to adjacent uninfected cells. The evidence that cell-to-cell transmission occurs in influenza virus lead to the caution that local infection proceeds even when treated with neuraminidase inhibitors.	[Mori, Kotaro] Univ Tsukuba, Dept Infect Biol, Fac Med, Tsukuba, Ibaraki, Japan; Univ Tsukuba, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki, Japan	University of Tsukuba; University of Tsukuba	Mori, K (corresponding author), Univ Tsukuba, Dept Infect Biol, Fac Med, Tsukuba, Ibaraki, Japan.	knagata@md.tsukuba.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [20249025]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a grant-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to KN: #20249025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors received no additional external funding for this study.	AIR GM, 1989, PROTEINS, V6, P341, DOI 10.1002/prot.340060402; Balfe Peter, 2009, J Hepatol, V51, P609, DOI 10.1016/j.jhep.2009.06.014; Barton ES, 2001, CELL, V104, P441, DOI 10.1016/S0092-8674(01)00231-8; BLAU DM, 1995, VIROLOGY, V210, P91, DOI 10.1006/viro.1995.1320; Brock SC, 2003, P NATL ACAD SCI USA, V100, P15143, DOI 10.1073/pnas.2434327100; BULLOUGH PA, 1994, NATURE, V371, P37, DOI 10.1038/371037a0; Carrasco M, 2004, TRAFFIC, V5, P979, DOI 10.1111/j.1600-0854.2004.00237.x; Chodosh J, 2000, VIROLOGY, V266, P387, DOI 10.1006/viro.1999.0082; Cresawn KO, 2007, EMBO J, V26, P3737, DOI 10.1038/sj.emboj.7601813; DAVIES WL, 1964, SCIENCE, V144, P862, DOI 10.1126/science.144.3620.862; Doceul V, 2010, SCIENCE, V327, P873, DOI 10.1126/science.1183173; Dustin M, 2003, NAT CELL BIOL, V5, P271, DOI 10.1038/ncb0403-271; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Fujii Y, 2003, P NATL ACAD SCI USA, V100, P2002, DOI 10.1073/pnas.0437772100; FULLER S, 1984, CELL, V38, P65, DOI 10.1016/0092-8674(84)90527-0; Gubareva LV, 2002, J GEN VIROL, V83, P2683, DOI 10.1099/0022-1317-83-11-2683; Guerriero CJ, 2008, J BIOL CHEM, V283, P18040, DOI 10.1074/jbc.M802048200; GUPTA P, 1989, J VIROL, V63, P2361, DOI 10.1128/JVI.63.5.2361-2365.1989; Guyader M, 2002, J VIROL, V76, P10356, DOI 10.1128/JVI.76.20.10356-10364.2002; Huang IC, 2008, J VIROL, V82, P4834, DOI 10.1128/JVI.00079-08; Hubner W, 2009, SCIENCE, V323, P1743, DOI 10.1126/science.1167525; Igakura T, 2003, SCIENCE, V299, P1713, DOI 10.1126/science.1080115; Jolly C, 2005, J VIROL, V79, P12088, DOI 10.1128/JVI.79.18.12088-12094.2005; Kawaguchi A, 2005, J VIROL, V79, P732, DOI 10.1128/JVI.79.2.732-744.2005; Kawaguchi A, 2011, J VIROL, V85, P6197, DOI 10.1128/JVI.00277-11; KIDO H, 1992, J BIOL CHEM, V267, P13573; KLENK HD, 1975, VIROLOGY, V68, P426, DOI 10.1016/0042-6822(75)90284-6; LAZAROWITZ SG, 1975, VIROLOGY, V68, P440, DOI 10.1016/0042-6822(75)90285-8; Lew W, 2000, CURR MED CHEM, V7, P663, DOI 10.2174/0929867003374886; Mothes W, 2010, J VIROL, V84, P8360, DOI 10.1128/JVI.00443-10; Nayak DP, 2004, VIRUS RES, V106, P147, DOI 10.1016/j.virusres.2004.08.012; Nedyalkova MS, 2002, J INFECT DIS, V185, P591, DOI 10.1086/339358; Pais-Correia AM, 2010, NAT MED, V16, P83, DOI 10.1038/nm.2065; PALESE P, 1974, VIROLOGY, V61, P397, DOI 10.1016/0042-6822(74)90276-1; PHILLIPS DM, 1994, AIDS, V8, P719, DOI 10.1097/00002030-199406000-00001; PINTO LH, 1992, CELL, V69, P517, DOI 10.1016/0092-8674(92)90452-I; Ploss A, 2009, NATURE, V457, P882, DOI 10.1038/nature07684; ROBERTS SR, 1995, J VIROL, V69, P2667, DOI 10.1128/JVI.69.4.2667-2673.1995; SATO H, 1992, VIROLOGY, V186, P712, DOI 10.1016/0042-6822(92)90038-Q; Sato M, 2003, BIOL CHEM, V384, P219, DOI 10.1515/BC.2003.024; Sattentau Q, 2008, NAT REV MICROBIOL, V6, P815, DOI 10.1038/nrmicro1972; Schlie K, 2010, J VIROL, V84, P3178, DOI 10.1128/JVI.02240-09; SHIBATA S, 1993, J VIROL, V67, P3264, DOI 10.1128/JVI.67.6.3264-3273.1993; Shinya K, 2004, J VIROL, V78, P3083, DOI 10.1128/JVI.78.6.3083-3088.2004; SKEHEL JJ, 1975, P NATL ACAD SCI USA, V72, P93, DOI 10.1073/pnas.72.1.93; SKEHEL JJ, 1982, P NATL ACAD SCI-BIOL, V79, P968, DOI 10.1073/pnas.79.4.968; SUGIURA A, 1975, VIROLOGY, V65, P363, DOI 10.1016/0042-6822(75)90042-2; Suzuki Y, 2000, J VIROL, V74, P11825, DOI 10.1128/JVI.74.24.11825-11831.2000; Takeda M, 2002, J VIROL, V76, P1391, DOI 10.1128/JVI.76.3.1391-1399.2002; Tamm LK, 2002, BIOPOLYMERS, V66, P249, DOI 10.1002/bip.10261; Timpe JM, 2008, HEPATOLOGY, V47, P17, DOI 10.1002/hep.21959; Tseng CTK, 2005, J VIROL, V79, P9470, DOI 10.1128/JVI.79.15.9470-9479.2005; Watanabe K, 1996, J VIROL, V70, P241, DOI 10.1128/JVI.70.1.241-247.1996; WILEY DC, 1987, ANNU REV BIOCHEM, V56, P365, DOI 10.1146/annurev.bi.56.070187.002053	54	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e28178	10.1371/journal.pone.0028178	http://dx.doi.org/10.1371/journal.pone.0028178			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140536	Green Published, Green Submitted, gold			2022-12-27	WOS:000298168100044
J	Rose, JI; Usik, VI; Marks, AE; Hilbert, YH; Galletti, CS; Parton, A; Geiling, JM; Cerny, V; Morley, MW; Roberts, RG				Rose, Jeffrey I.; Usik, Vitaly I.; Marks, Anthony E.; Hilbert, Yamandu H.; Galletti, Christopher S.; Parton, Ash; Geiling, Jean Marie; Cerny, Viktor; Morley, Mike W.; Roberts, Richard G.			The Nubian Complex of Dhofar, Oman: An African Middle Stone Age Industry in Southern Arabia	PLOS ONE			English	Article							ANATOMICALLY MODERN HUMANS; PALEOLITHIC OCCUPATION; ESR DATES; SEA; DESERT; SPELEOTHEMS; SETTLEMENT; EVENTS; REGION; SITE	Despite the numerous studies proposing early human population expansions from Africa into Arabia during the Late Pleistocene, no archaeological sites have yet been discovered in Arabia that resemble a specific African industry, which would indicate demographic exchange across the Red Sea. Here we report the discovery of a buried site and more than 100 new surface scatters in the Dhofar region of Oman belonging to a regionally-specific African lithic industry - the late Nubian Complex - known previously only from the northeast and Horn of Africa during Marine Isotope Stage 5, similar to 128,000 to 74,000 years ago. Two optically stimulated luminescence age estimates from the open-air site of Aybut Al Auwal in Oman place the Arabian Nubian Complex at similar to 106,000 years ago, providing archaeological evidence for the presence of a distinct northeast African Middle Stone Age technocomplex in southern Arabia sometime in the first half of Marine Isotope Stage 5.	[Rose, Jeffrey I.; Hilbert, Yamandu H.] Univ Birmingham, Inst Archaeol & Antiqu, Birmingham, W Midlands, England; [Usik, Vitaly I.] Natl Acad Sci Ukraine, Archaeol Museum, Inst Archaeol, Kiev, Ukraine; [Marks, Anthony E.] So Methodist Univ, Dept Anthropol, Dallas, TX 75275 USA; [Galletti, Christopher S.] Arizona State Univ, Sch Geog Sci & Urban Planning, Tempe, AZ USA; [Parton, Ash; Morley, Mike W.] Oxford Brookes Univ, Dept Geog & Anthropol, Oxford OX3 0BP, England; [Geiling, Jean Marie] Univ Tubingen, Inst Nat Wissensch Archaol, Tubingen, Germany; [Cerny, Viktor] Acad Sci, Inst Archaeol, Prague, Czech Republic; [Roberts, Richard G.] Univ Wollongong, Ctr Archaeol Sci, Sch Earth & Environm Sci, Wollongong, NSW, Australia	University of Birmingham; National Academy of Sciences Ukraine; Institute of Archaeology, National Academy of Sciences of Ukraine; Southern Methodist University; Arizona State University; Arizona State University-Tempe; Oxford Brookes University; Eberhard Karls University of Tubingen; Czech Academy of Sciences; Institute of Archaeology of the Czech Academy of Sciences - Prague; University of Wollongong	Rose, JI (corresponding author), Univ Birmingham, Inst Archaeol & Antiqu, Birmingham, W Midlands, England.	jeffrey.i.rose@gmail.com	Rose, Jeffrey/GVS-2435-2022; Geiling, Jeanne Marie/AAX-1248-2020; Cerny, Viktor/G-7842-2014; Roberts, Richard Graham/B-8245-2013; Galletti, Christopher/H-7002-2019; Morley, Mike/C-2675-2013	Geiling, Jeanne Marie/0000-0003-0147-3611; Roberts, Richard Graham/0000-0002-0128-4119; Galletti, Christopher/0000-0003-1203-9378; Rose, Jeffrey Ian/0000-0003-0006-7064; Morley, Mike/0000-0001-7730-9637; Hilbert, Yamandu/0000-0002-5469-2933	UK Arts and Humanities Research Council [AH/H033912/1]; Australian Research Council [DP0880675]; Oman Ministry of Heritage and Culture; AHRC [AH/G012733/1] Funding Source: UKRI; Arts and Humanities Research Council [AH/G012733/1] Funding Source: researchfish	UK Arts and Humanities Research Council(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC)); Australian Research Council(Australian Research Council); Oman Ministry of Heritage and Culture; AHRC(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC)); Arts and Humanities Research Council(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC))	The Dhofar Archaeological Project fieldwork and analysis is funded by an Early Career Research grant from the UK Arts and Humanities Research Council (AH/H033912/1): www.ahrc.ac.uk. Funding for OSL dating comes from the Australian Research Council (DP0880675): www.arc.gov.au. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; DAP is conducted under the auspices of the Oman Ministry of Heritage and Culture. We are grateful to His Royal Highness Sayyid Haitham bin Tarik Al Said, Salim Al Mahruqi, and Biubwa Al Sabri for their permission to carry out this research. We thank Salim Al Abri, Ali Al Mahruqi, Said Al Suqry, Said Al Salmi, and Yaqoub Al Busaidi for their council and assistance supporting our fieldwork in Oman, and Yasaman Jafari, Frederick Kleszczewska, and Yusef Ibrahim bin Werda for laboratory assistance. Finally, we offer special thanks to Juris Zarins for suggesting DAP survey Mudayy.	Armitage SJ, 2011, SCIENCE, V331, P453, DOI 10.1126/science.1199113; Balter M, 2011, SCIENCE, V331, P20, DOI 10.1126/science.331.6013.20; BANAKAR VK, 2010, ARABIAN SEA, V73, P535; Bar-Matthews M, 2003, GEOCHIM COSMOCHIM AC, V67, P3181, DOI 10.1016/S0016-7037(02)01031-1; Bar-Matthews M, 2000, CHEM GEOL, V169, P145, DOI 10.1016/S0009-2541(99)00232-6; Behar DM, 2008, AM J HUM GENET, V82, P1130, DOI 10.1016/j.ajhg.2008.04.002; Beyin A., 2006, AFR ARCHAEOL REV, V23, P5, DOI DOI 10.1007/S10437-006-9005-2; Blechschmidt I, 2009, GEOMORPHOLOGY, V110, P128, DOI 10.1016/j.geomorph.2009.04.002; Bordes F., 1980, B SOC PREHISTORIQUE, V77, P45, DOI [10.3406/BSPF.1980.5242, DOI 10.3406/BSPF.1980.5242]; BRAUER G, 1988, J PHYS, V75, P69; Burns SJ, 2001, GEOLOGY, V29, P623, DOI 10.1130/0091-7613(2001)029<0623:SEFOFC>2.0.CO;2; Burns SJ, 1998, GEOLOGY, V26, P499, DOI 10.1130/0091-7613(1998)026<0499:SBPRFN>2.3.CO;2; CERNY V, 2008, J PHYS, V136, P128; Chiotti L., 2007, ARCHAEOLOGY ART ANCI, P169; Chiotti L, 2009, ANTHROPOLOGIE, V113, P341, DOI 10.1016/j.anthro.2009.04.007; CHMIELEWSKI W, 1968, PREHISTORY NUBIA, V1, P110; Clark G., 2000, ARCHAEOLOGY WADI AL, V2, P17; Clark J.D., 1954, PREHISTORIC CULTURES; Clark JD, 2003, NATURE, V423, P747, DOI 10.1038/nature01670; CLARK JD, 1988, J WORLD PREHIST, V2, P235, DOI 10.1007/BF00975618; Copeland L., 1975, PROBLEMS PREHISTORY, P317; Crassard R, 2009, VERTEBR PALEOBIOL PA, P151, DOI 10.1007/978-90-481-2719-1_12; Demidenko Y.E., 2003, NEANDERTHALS LEVANT, P107; Endicott P, 2009, TRENDS ECOL EVOL, V24, P515, DOI 10.1016/j.tree.2009.04.006; Fernandes CA, 2006, J BIOGEOGR, V33, P961, DOI 10.1111/j.1365-2699.2006.01478.x; Fernandes CA, 2009, VERTEBR PALEOBIOL PA, P89, DOI 10.1007/978-90-481-2719-1_7; Fleitmann D, 2003, QUATERNARY RES, V60, P223, DOI 10.1016/S0033-5894(03)00086-3; FLEITMANN D, 2011, HOLOCENE, V30, P783; Fleitmann D, 2009, CR GEOSCI, V341, P633, DOI 10.1016/j.crte.2009.01.006; Forster P, 2001, MOL BIOL EVOL, V18, P1864, DOI 10.1093/oxfordjournals.molbev.a003728; Garrod DA, 1937, STONE AGE MOUNT CARM, DOI DOI 10.1038/140186D0; Ghazanfar SA, 1999, PALEOENVIRONMENTAL RECONSTRUCTION IN ARID LANDS, P263; GHAZANFAR SA, VEGETATION ARABIAN P; Ghirotto S, 2011, HUM BIOL, V83, P477, DOI 10.3378/027.083.0403; Govil P, 2010, PALEOCEANOGRAPHY, V25, DOI 10.1029/2008PA001687; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Guichard J., 1965, CONTRIBUTIONS PREHIS, P57; Hammer MF, 2011, P NATL ACAD SCI USA, V108, P15123, DOI 10.1073/pnas.1109300108; Hauck TC, 2011, J HUM EVOL, V61, P519, DOI 10.1016/j.jhevol.2011.01.014; Henry D.O., 1995, PREHISTORIC CULTURAL; Inizan M.-L., 1987, PALEORIENT, V13, P5, DOI DOI 10.3406/PALE0.1987.4414; Jacobs Z, 2007, EVOL ANTHROPOL, V16, P210, DOI 10.1002/evan.20150; Jagher R, 2009, VERTEBR PALEOBIOL PA, P139, DOI 10.1007/978-90-481-2719-1_11; JELINEK AJ, 1982, BAR INT SERIES, V151, P81; Jones M., 1983, PREHISTORY PALEOENVI, P283; Keinan A, 2010, MOL BIOL EVOL, V27, P2312, DOI 10.1093/molbev/msq117; Kurashina H., 1978, EXAMINATION PREHISTO; Lahr Marta Mirazon, 1994, Evolutionary Anthropology, V3, P48, DOI 10.1002/evan.1360030206; Macaulay V, 2005, SCIENCE, V308, P1034, DOI 10.1126/science.1109792; Marks A.E., 1990, EMERGENCE MODERN HUM, P56; Marks A. E., 1995, DEFINITION INTERPRET, P267; Marks A.E., 1968, PREHISTORY NUBIA, V1, P194; McDermott F, 1996, J HUM EVOL, V31, P507, DOI 10.1006/jhev.1996.0076; McDougall I, 2005, NATURE, V433, P733, DOI 10.1038/nature03258; McLaren SJ, 2009, J QUATERNARY SCI, V24, P198, DOI 10.1002/jqs.1199; Meignen L, 1992, EVOLUTION DISPERSAL, V129, P148; Meignen L., 1988, PALEORIENT, V14, P168; Mele M, 2012, MOL BIOL EVOL, V29, P25, DOI 10.1093/molbev/msr213; Mercier N, 1999, J ARCHAEOL SCI, V26, P1339, DOI 10.1006/jasc.1998.0369; Metspalu M, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-26; Monigal K., 2002, THESIS SO METHODIST; MORDAN PB, 1980, J OMAN STUD SP REPT, V2, P103; Musilova E, 2011, AM J PHYS ANTHROPOL, V145, P592, DOI 10.1002/ajpa.21522; Olszewski DI, 2010, J HUM EVOL, V59, P188, DOI 10.1016/j.jhevol.2010.06.001; Pattan JN, 2009, PALAEOGEOGR PALAEOCL, V280, P396, DOI 10.1016/j.palaeo.2009.06.027; Petit-Maire N, 2010, GLOBAL PLANET CHANGE, V72, P368, DOI 10.1016/j.gloplacha.2010.01.012; Petraglia MD, 2003, ANTIQUITY, V77, P671, DOI 10.1017/S0003598X00061639; Petraglia MD, 2011, QUATERNARY SCI REV, V30, P1555, DOI 10.1016/j.quascirev.2011.04.006; PLATEL JP, 1992, GEOLOGICAL MAP SALAL; Preusser F, 2002, SCIENCE, V296, P2018, DOI 10.1126/science.1069875; Preusser F, 2009, CR GEOSCI, V341, P621, DOI 10.1016/j.crte.2009.02.003; Radies D, 2004, SEDIMENTOLOGY, V51, P1359, DOI 10.1111/j.1365-3091.2004.00678.x; Reichart GJ, 1998, PALEOCEANOGRAPHY, V13, P607, DOI 10.1029/98PA02203; Rose J.I., 2006, THESIS SO METHODIST; Rose JI, 2009, VERTEBR PALEOBIOL PA, P169, DOI 10.1007/978-90-481-2719-1_13; Rostek F, 1997, DEEP-SEA RES PT II, V44, P1461, DOI 10.1016/S0967-0645(97)00008-8; Rowold DJ, 2007, J HUM GENET, V52, P436, DOI 10.1007/s10038-007-0132-7; Saher MH, 2009, PALEOCEANOGRAPHY, V24, DOI 10.1029/2007PA001557; Sanlaville P., 1993, Paleorient, V18, P5, DOI 10.3406/paleo.1992.4560; Saraswat R, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024093; SCHILD R, 1998, CURR ANTHROPOL, V39, pS134; SCHWARCZ HP, 1988, J HUM EVOL, V17, P733, DOI 10.1016/0047-2484(88)90063-2; Scott-Jackson J, 2009, VERTEBR PALEOBIOL PA, P125, DOI 10.1007/978-90-481-2719-1_10; Smith JR, 2007, J HUM EVOL, V52, P690, DOI 10.1016/j.jhevol.2007.01.004; Smith TM, 2007, P NATL ACAD SCI USA, V104, P6128, DOI 10.1073/pnas.0700747104; Stringer C, 2000, NATURE, V405, P24, DOI 10.1038/35011166; Uerpmann HP, 2009, VERTEBR PALEOBIOL PA, P205, DOI 10.1007/978-90-481-2719-1_15; Vaks A, 2006, EARTH PLANET SC LETT, V249, P384, DOI 10.1016/j.epsl.2006.07.009; Vaks A, 2010, QUATERNARY SCI REV, V29, P2647, DOI 10.1016/j.quascirev.2010.06.014; VALLADAS H, 1988, NATURE, V331, P614, DOI 10.1038/331614a0; Van Peer P, 2003, J HUM EVOL, V45, P187, DOI 10.1016/S0047-2484(03)00103-9; Van Peer P, 1998, CURR ANTHROPOL, V39, pS115, DOI 10.1086/204692; Van Peer P, 2000, PALAEOLITHIC LIVING, P91; Van Peer P., 2007, RETHINKING HUMAN REV, P187; Van Peer P., 1996, ASPECTS AFRICAN ARCH, P149; Van Peer P., 1992, MONOGRAPHS WORLD ARC, V13; Vermeersch P, 2010, S E MEDITERRANEAN PE, P66; Vermeersch PM, 1998, ANTIQUITY, V72, P475, DOI 10.1017/S0003598X00086919; Vermeersch PM, 2001, QUATERN INT, V75, P103, DOI 10.1016/S1040-6182(00)00082-3; Wahida G, 2009, VERTEBR PALEOBIOL PA, P117, DOI 10.1007/978-90-481-2719-1_9; Waldmann N, 2010, GEOLOGY, V38, P567, DOI 10.1130/G30654.1; Wendorf F, 1994, LATE QUATERNARY CHRO, P147; Yotova V, 2011, MOL BIOL EVOL, V28, P1957, DOI 10.1093/molbev/msr024; Zarins J., 2001, LAND INCENSE ARCHAEO; ZARINS J, 1998, BAR INT SERIES, V705, P179; [No title captured]	106	153	153	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e28239	10.1371/journal.pone.0028239	http://dx.doi.org/10.1371/journal.pone.0028239			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	863MI	22140561	Green Submitted, Green Published, gold			2022-12-27	WOS:000298168100056
J	Voss, M; Nimtz, M; Leimkuhler, S				Voss, Martin; Nimtz, Manfred; Leimkuehler, Silke			Elucidation of the Dual Role of Mycobacterial MoeZR in Molybdenum Cofactor Biosynthesis and Cysteine Biosynthesis	PLOS ONE			English	Article							ESCHERICHIA-COLI; MOLYBDOPTERIN SYNTHASE; UBIQUITIN ACTIVATION; CRYSTAL-STRUCTURE; SULFUR DONOR; TUBERCULOSIS; PROTEIN; PATHWAY; IDENTIFICATION; SPECIFICITY	The pathway of molybdenum cofactor biosynthesis has been studied in detail by using proteins from Mycobacterium species, which contain several homologs associated with the first steps of Moco biosynthesis. While all Mycobacteria species contain a MoeZR, only some strains have acquired an additional homolog, MoeBR, by horizontal gene transfer. The role of MoeBR and MoeZR was studied in detail for the interaction with the two MoaD-homologs involved in Moco biosynthesis, MoaD1 and MoaD2, in addition to the CysO protein involved in cysteine biosynthesis. We show that both proteins have a role in Moco biosynthesis, while only MoeZR, but not MoeBR, has an additional role in cysteine biosynthesis. MoeZR and MoeBR were able to complement an E. coli moeB mutant strain, but only in conjunction with the Mycobacterial MoaD1 or MoaD2 proteins. Both proteins were able to sulfurate MoaD1 and MoaD2 in vivo, while only MoeZR additionally transferred the sulfur to CysO. Our in vivo studies show that Mycobacteria have acquired several homologs to maintain Moco biosynthesis. MoeZR has a dual role in Moco- and cysteine biosynthesis and is involved in the sulfuration of MoaD and CysO, whereas MoeBR only has a role in Moco biosynthesis, which is not an essential function for Mycobacteria.	[Voss, Martin; Leimkuehler, Silke] Univ Potsdam, Inst Biochem & Biol, Potsdam, Germany; [Nimtz, Manfred] Helmholtz Ctr Infect Res, Braunschweig, Germany	University of Potsdam; Helmholtz Association; Helmholtz-Center for Infection Research	Voss, M (corresponding author), Univ Potsdam, Inst Biochem & Biol, Potsdam, Germany.	sleim@uni-potsdam.de		Leimkuhler, Silke/0000-0003-3238-2122	Deutsche Forschungsgemeinschaft [LE1171/5-3]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant (LE1171/5-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agren D, 2008, J BIOL CHEM, V283, P31567, DOI 10.1074/jbc.M804877200; Brodin P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001100; Burns KE, 2005, J AM CHEM SOC, V127, P11602, DOI 10.1021/ja053476x; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cortese MS, 2002, BMC EVOL BIOL, V2, DOI 10.1186/1471-2148-2-8; Dahl JU, 2011, J BIOL CHEM, V286, P35801, DOI 10.1074/jbc.M111.282368; Dutta NK, 2010, J INFECT DIS, V201, P1743, DOI 10.1086/652497; JONES RW, 1977, BIOCHEM J, V164, P199, DOI 10.1042/bj1640199; Jurgenson CT, 2008, BIOCHEMISTRY-US, V47, P10354, DOI 10.1021/bi800915j; Krepinsky K, 2007, FEBS J, V274, P2778, DOI 10.1111/j.1742-4658.2007.05811.x; Lake MW, 2001, NATURE, V414, P325, DOI 10.1038/35104586; Leimkuhler S, 2011, COORDIN CHEM REV, V255, P1129, DOI 10.1016/j.ccr.2010.12.003; Leimkuhler S, 2001, J BIOL CHEM, V276, P34695, DOI 10.1074/jbc.M102787200; MacGurn JA, 2007, INFECT IMMUN, V75, P2668, DOI 10.1128/IAI.01872-06; Marelja Z, 2008, J BIOL CHEM, V283, P25178, DOI 10.1074/jbc.M804064200; Marquet A, 2001, CURR OPIN CHEM BIOL, V5, P541, DOI 10.1016/S1367-5931(00)00249-0; Matthies A, 2004, P NATL ACAD SCI USA, V101, P5946, DOI 10.1073/pnas.0308191101; O'Leary SE, 2008, BIOCHEMISTRY-US, V47, P11606, DOI 10.1021/bi8013664; Rosas-Magallanes V, 2007, INFECT IMMUN, V75, P504, DOI 10.1128/IAI.00058-06; Rudolph MJ, 2001, NAT STRUCT BIOL, V8, P42; Schmitz J, 2008, BIOCHEMISTRY-US, V47, P6479, DOI 10.1021/bi800477u; Singh A, 2007, P NATL ACAD SCI USA, V104, P11562, DOI 10.1073/pnas.0700490104; SORBO B, 1957, BIOCHIM BIOPHYS ACTA, V23, P412, DOI 10.1016/0006-3002(57)90346-3; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Talaat AM, 2004, P NATL ACAD SCI USA, V101, P4602, DOI 10.1073/pnas.0306023101; Taylor SV, 1998, J BIOL CHEM, V273, P16555, DOI 10.1074/jbc.273.26.16555; Williams MJ, 2011, J BACTERIOL, V193, P98, DOI 10.1128/JB.00774-10; Zhang WJ, 2010, J BIOL CHEM, V285, P2302, DOI 10.1074/jbc.M109.082172	28	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e28170	10.1371/journal.pone.0028170	http://dx.doi.org/10.1371/journal.pone.0028170			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140533	Green Published, Green Submitted, gold			2022-12-27	WOS:000298168100043
J	Geiger, JA; Carvalho, L; Campos, I; Santos, AC; Jacinto, A				Geiger, Jennifer A.; Carvalho, Lara; Campos, Isabel; Santos, Ana Catarina; Jacinto, Antonio			Hole-in-One Mutant Phenotypes Link EGFR/ERK Signaling to Epithelial Tissue Repair in Drosophila	PLOS ONE			English	Article							MAP KINASE; EGF-RECEPTOR; GRAINY-HEAD; PATHWAY; SCREEN; GENES; GYF; INTERACTS; DYNAMICS; HOMOLOG	Background: Epithelia act as physical barriers protecting living organisms and their organs from the surrounding environment. Simple epithelial tissues have the capacity to efficiently repair wounds through a resealing mechanism. The known molecular mechanisms underlying this process appear to be conserved in both vertebrates and invertebrates, namely the involvement of the transcription factors Grainy head (Grh) and Fos. In Drosophila, Grh and Fos lead to the activation of wound response genes required for epithelial repair. ERK is upstream of this pathway and known to be one of the first kinases to be activated upon wounding. However, it is still unclear how ERK activation contributes to a proper wound response and which molecular mechanisms regulate its activation. Methodology/Principal Findings: In a previous screen, we isolated mutants with defects in wound healing. Here, we describe the role of one of these genes, hole-in-one (holn1), in the wound healing process. Holn1 is a GYF domain containing protein that we found to be required for the activation of several Grh and Fos regulated wound response genes at the wound site. We also provide evidence suggesting that Holn1 may be involved in the Ras/ERK signaling pathway, by acting downstream of ERK. Finally, we show that wound healing requires the function of EGFR and ERK signaling. Conclusions/Significance: Based on these data, we conclude that holn1 is a novel gene required for a proper wound healing response. We further propose and discuss a model whereby Holn1 acts downstream of EGFR and ERK signaling in the Grh/Fos mediated wound closure pathway.	[Geiger, Jennifer A.; Carvalho, Lara; Campos, Isabel; Santos, Ana Catarina; Jacinto, Antonio] Univ Lisbon, Tissue Morphogenesis & Repair Unit, Inst Mol Med, Fac Med, Lisbon, Portugal	Universidade de Lisboa	Geiger, JA (corresponding author), Seattle Biomed Res Inst, 4 Nickerson St, Seattle, WA 98109 USA.	ajacinto@fm.ul.pt	Jacinto, Antonio/F-5729-2013; Carvalho, Lara/C-9721-2019; carvalho, lara/P-5102-2019; CAMPOS, ISABEL SOARES/ABE-4545-2020	Jacinto, Antonio/0000-0002-4193-6089; Carvalho, Lara/0000-0001-6350-3279; carvalho, lara/0000-0001-6350-3279; CAMPOS, ISABEL SOARES/0000-0002-2396-3163; Campos, Isabel/0000-0002-1541-8552	Fundacao para a Ciencia e a Tecnologia (FCT) [PTDC/SAU/OBD/65872/2006, SFRH/BD/21895/2005, SFRH/BPD/62896/2009, SFRH/BPD/17729/2004, SFRH/BPD/24976/2005]; European Research Fund [ERC-208631-RESEAL]; Marie Curie/FP7; Marie Curie Intra-European Fellowship	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); European Research Fund; Marie Curie/FP7; Marie Curie Intra-European Fellowship(European Commission)	This work was supported by Fundacao para a Ciencia e a Tecnologia (FCT) PTDC/SAU/OBD/65872/2006, European Research Fund, ERC-208631-RESEAL, and Marie Curie/FP7. JAG was supported by a FCT fellowship, SFRH/BD/21895/2005, LC by a FCT fellowship, SFRH/BPD/62896/2009, and by Marie Curie Intra-European Fellowship, IC by a FCT fellowship, SFRH/BPD/17729/2004, and ACS by a FCT fellowship, SFRH/BPD/24976/2005. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BIGGS WH, 1994, EMBO J, V13, P1628, DOI 10.1002/j.1460-2075.1994.tb06426.x; Blanchette M, 2005, GENE DEV, V19, P1306, DOI 10.1101/gad.1314205; Campos I, 2010, GENETICS, V184, P129, DOI 10.1534/genetics.109.110288; Ciapponi L, 2001, GENE DEV, V15, P1540, DOI 10.1101/gad.886301; CLIFFORD R, 1994, GENETICS, V137, P531; Culi J, 2001, DEVELOPMENT, V128, P299; Dieckgraefe BK, 1997, BIOCHEM BIOPH RES CO, V233, P389, DOI 10.1006/bbrc.1997.6469; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Freund C, 2002, EMBO J, V21, P5985, DOI 10.1093/emboj/cdf602; Gabay L, 1997, DEVELOPMENT, V124, P3535; Galko MJ, 2004, PLOS BIOL, V2, P1114, DOI 10.1371/journal.pbio.0020239; Garcia-Fernandez B, 2009, INT J DEV BIOL, V53, P1549, DOI 10.1387/ijdb.072308bg; Heinze M, 2007, INT IMMUNOL, V19, P1313, DOI 10.1093/intimm/dxm100; Karim FD, 1996, GENETICS, V143, P315; Kim M, 2010, P NATL ACAD SCI US; Kofler M, 2005, J BIOL CHEM, V280, P33397, DOI 10.1074/jbc.M503989200; Kofler M, 2004, J BIOL CHEM, V279, P28292, DOI 10.1074/jbc.M402008200; Kofler MM, 2006, FEBS J, V273, P245, DOI 10.1111/j.1742-4658.2005.05078.x; Laggerbauer B, 2005, RNA, V11, P598, DOI 10.1261/rna.2300805; LEHMANN R, 1994, METHOD CELL BIOL, V44, P575, DOI 10.1016/S0091-679X(08)60933-4; Lesokhin AM, 1999, DEV BIOL, V205, P129, DOI 10.1006/dbio.1998.9121; Li GC, 2003, DEV CELL, V4, P865, DOI 10.1016/S1534-5807(03)00159-X; Liaw GJ, 1995, GENE DEV, V9, P3163, DOI 10.1101/gad.9.24.3163; Mace KA, 2005, SCIENCE, V308, P381, DOI 10.1126/science.1107573; Millard TH, 2008, DEVELOPMENT, V135, P621, DOI 10.1242/dev.014001; Nishizawa K, 1998, P NATL ACAD SCI USA, V95, P14897, DOI 10.1073/pnas.95.25.14897; Pearson JC, 2009, P NATL ACAD SCI USA, V106, P2224, DOI 10.1073/pnas.0810219106; Ramet M, 2002, DEV BIOL, V241, P145, DOI 10.1006/dbio.2001.0502; Roignant JY, 2010, CELL, V143, P238, DOI 10.1016/j.cell.2010.09.036; Royou A, 2004, MOL BIOL CELL, V15, P838, DOI 10.1091/mbc.E03-06-0440; Schuldiner O, 2008, DEV CELL, V14, P227, DOI 10.1016/j.devcel.2007.11.001; Shilo BZ, 2005, DEVELOPMENT, V132, P4017, DOI 10.1242/dev.02006; Shilo BZ, 2003, EXP CELL RES, V284, P140, DOI 10.1016/S0014-4827(02)00094-0; Stroschein-Stevenson SL, 2006, PLOS BIOL, V4, P87, DOI 10.1371/journal.pbio.0040004; STURTEVANT MA, 1993, GENE DEV, V7, P961, DOI 10.1101/gad.7.6.961; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; Ting SB, 2005, SCIENCE, V308, P411, DOI 10.1126/science.1107511; Uv AE, 1997, MOL CELL BIOL, V17, P6727, DOI 10.1128/MCB.17.11.6727; Wang SQ, 2009, NAT CELL BIOL, V11, P890, DOI 10.1038/ncb1898; Wood W, 2002, NAT CELL BIOL, V4, P907, DOI 10.1038/ncb875; Wright TRF, 1996, J HERED, V87, P175, DOI 10.1093/oxfordjournals.jhered.a022983	41	18	21	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2011	6	11							e28349	10.1371/journal.pone.0028349	http://dx.doi.org/10.1371/journal.pone.0028349			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863LT	22140578	gold, Green Submitted, Green Published			2022-12-27	WOS:000298166300049
J	Azare, J; Doane, A; Leslie, K; Chang, Q; Berishaj, M; Nnoli, J; Mark, K; Al-Ahmadie, H; Gerald, W; Hassimi, M; Viale, A; Stracke, M; Lyden, D; Bromberg, J				Azare, Janeen; Doane, Ashley; Leslie, Kenneth; Chang, Qing; Berishaj, Marjan; Nnoli, Jennifer; Mark, Kevin; Al-Ahmadie, Hikmat; Gerald, William; Hassimi, Maryam; Viale, Agnes; Stracke, Mary; Lyden, David; Bromberg, Jacqueline			Stat3 Mediates Expression of Autotaxin in Breast Cancer	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; MOTILITY-STIMULATING PROTEIN; ACTIVATED SIGNAL TRANSDUCER; CIRCULATING TUMOR-CELLS; HUMAN-MELANOMA CELLS; NF-KAPPA-B; LYSOPHOSPHATIDIC ACID; CARCINOMA CELLS; GENE-EXPRESSION; CONSTITUTIVE ACTIVATION	We determined that signal transducer and activator of transcription 3 (Stat3) is tyrosine phosphorylated in 37% of primary breast tumors and 63% of paired metastatic axillary lymph nodes. Examination of the distribution of tyrosine phosphorylated (pStat3) in primary tumors revealed heterogenous expression within the tumor with the highest levels found in cells on the edge of tumors with relatively lower levels in the central portion of tumors. In order to determine Stat3 target genes that may be involved in migration and metastasis, we identified those genes that were differentially expressed in primary breast cancer samples as a function of pStat3 levels. In addition to known Stat3 transcriptional targets (Twist, Snail, Tenascin-C and IL-8), we identified ENPP2 as a novel Stat3 regulated gene, which encodes autotaxin (ATX), a secreted lysophospholipase which mediates mammary tumorigenesis and cancer cell migration. A positive correlation between nuclear pStat3 and ATX was determined by immunohistochemical analysis of primary breast cancer samples and matched axillary lymph nodes and in several breast cancer derived cell lines. Inhibition of pStat3 or reducing Stat3 expression led to a decrease in ATX levels and cell migration. An association between Stat3 and the ATX promoter, which contains a number of putative Stat3 binding sites, was determined by chromatin immunoprecipitation. These observations suggest that activated Stat3 may regulate the migration of breast cancer cells through the regulation of ATX.	[Azare, Janeen; Leslie, Kenneth; Chang, Qing; Berishaj, Marjan; Nnoli, Jennifer; Mark, Kevin; Bromberg, Jacqueline] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; [Doane, Ashley; Al-Ahmadie, Hikmat; Gerald, William] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; [Hassimi, Maryam; Viale, Agnes] Mem Sloan Kettering Canc Ctr, Genom Core Lab, New York, NY 10021 USA; [Lyden, David] Mem Sloan Kettering Canc Ctr, Dept Pediat, New York, NY 10021 USA; [Stracke, Mary] NCI, Pathol Lab, Div Clin Sci, NIH, Bethesda, MD 20892 USA; [Lyden, David] Weill Cornell Med Coll, Dept Pediat, New York, NY USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Cornell University	Azare, J (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA.	dcl2001@med.cornell.edu; bromberj@mskcc.org	Doane, Ashley Stephen/B-7027-2008; Doane, Ashley Stephen/A-6442-2015; Doane, Ashley/R-4263-2016	Doane, Ashley Stephen/0000-0002-1489-1786; Doane, Ashley Stephen/0000-0002-1489-1786; Doane, Ashley/0000-0002-1489-1786; chang, qing/0000-0002-8290-6687; Al-Ahmadie, Hikmat/0000-0002-2938-6627; Mark, Kevin/0000-0001-5132-031X	National Institutes of Health [R01 CA87637]; Marjorie and Charles Holloway Foundation; Breast Cancer Alliance Award; Sussman Family Fund; Lerner Awards; Cancer Research and Prevention Foundation; Intercultural Cancer Council; National Cancer Institute, CMBB (Comprehensive Minority Biomedical Branch); NATIONAL CANCER INSTITUTE [R01CA087637] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Marjorie and Charles Holloway Foundation; Breast Cancer Alliance Award; Sussman Family Fund; Lerner Awards; Cancer Research and Prevention Foundation; Intercultural Cancer Council; National Cancer Institute, CMBB (Comprehensive Minority Biomedical Branch); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was supported by grants from the National Institutes of Health (R01 CA87637), Marjorie and Charles Holloway Foundation, Breast Cancer Alliance Award, Sussman Family Fund and Lerner Awards to JB and a Cancer Research and Prevention Foundation and Intercultural Cancer Council Fellowship and a National Cancer Institute, CMBB (Comprehensive Minority Biomedical Branch) Training Award to JA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez JV, 2005, CANCER RES, V65, P5054, DOI 10.1158/0008-5472.CAN-04-4281; Azare J, 2007, MOL CELL BIOL, V27, P4444, DOI 10.1128/MCB.02404-06; Berishaj M, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1680; Black EJ, 2004, ONCOGENE, V23, P2357, DOI 10.1038/sj.onc.1207377; Braun S, 2005, NEW ENGL J MED, V353, P793, DOI 10.1056/NEJMoa050434; Bromberg J, 2002, J CLIN INVEST, V109, P1139, DOI 10.1172/JCI200215617; Chambers AF, 2009, CANCER RES, V69, P5292, DOI 10.1158/0008-5472.CAN-09-1528; Chan KS, 2004, J CLIN INVEST, V114, P720, DOI 10.1172/JCI200421032; Chen M, 2005, ONCOGENE, V24, P5125, DOI 10.1038/sj.onc.1208729; Cheng GZ, 2008, J BIOL CHEM, V283, P14665, DOI 10.1074/jbc.M707429200; Clair T, 1997, J BIOL CHEM, V272, P996, DOI 10.1074/jbc.272.2.996; Cooper AB, 2007, J GASTROINTEST SURG, V11, P1628, DOI 10.1007/s11605-007-0322-9; Cotarla I, 2004, INT J CANCER, V108, P665, DOI 10.1002/ijc.11619; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; Dauer DJ, 2005, ONCOGENE, V24, P3397, DOI 10.1038/sj.onc.1208469; David M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009741; de la Iglesia N, 2008, J NEUROSCI, V28, P5870, DOI 10.1523/JNEUROSCI.5385-07.2008; Dechow TN, 2004, P NATL ACAD SCI USA, V101, P10602, DOI 10.1073/pnas.0404100101; Diaz N, 2006, CLIN CANCER RES, V12, P20, DOI 10.1158/1078-0432.CCR-04-1749; Doane AS, 2006, ONCOGENE, V25, P3994, DOI 10.1038/sj.onc.1209415; Dolled-Filhart M, 2003, CLIN CANCER RES, V9, P594; Garcia R, 1997, CELL GROWTH DIFFER, V8, P1267; Garcia R, 2001, ONCOGENE, V20, P2499, DOI 10.1038/sj.onc.1204349; Gariboldi MB, 2007, CANCER LETT, V258, P181, DOI 10.1016/j.canlet.2007.08.019; Geretti E, 2008, ANGIOGENESIS, V11, P31, DOI 10.1007/s10456-008-9097-1; Giganti A, 2008, J BIOL CHEM, V283, P7776, DOI 10.1074/jbc.M708705200; Ginsberg M, 2007, MOL CELL BIOL, V27, P6300, DOI 10.1128/MCB.00613-07; Gritsko T, 2006, CLIN CANCER RES, V12, P11, DOI 10.1158/1078-0432.CCR-04-1752; Guo WJ, 2006, CELL, V126, P489, DOI 10.1016/j.cell.2006.05.047; Gupta GP, 2005, COLD SH Q B, V70, P149, DOI 10.1101/sqb.2005.70.018; Hedvat M, 2009, CANCER CELL, V16, P487, DOI 10.1016/j.ccr.2009.10.015; Ho HH, 2006, J BIOL CHEM, V281, P14111, DOI 10.1074/jbc.M511797200; Hoelzinger DB, 2005, NEOPLASIA, V7, P7, DOI 10.1593/neo.04535; Hsieh FC, 2005, BIOCHEM BIOPH RES CO, V335, P292, DOI 10.1016/j.bbrc.2005.07.075; Jonkers J, 2009, CANCER CELL, V15, P457, DOI 10.1016/j.ccr.2009.05.003; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Katoh M, 2009, INT J MOL MED, V23, P763, DOI 10.3892/ijmm_00000190; Kehlen A, 2004, INT J CANCER, V109, P833, DOI 10.1002/ijc.20022; Kim MY, 2009, CELL, V139, P1315, DOI 10.1016/j.cell.2009.11.025; Kishi Y, 2006, J BIOL CHEM, V281, P17492, DOI 10.1074/jbc.M601803200; Kotha A, 2006, MOL CANCER THER, V5, P621, DOI 10.1158/1535-7163.MCT-05-0268; Lee HY, 2002, FEBS LETT, V515, P137, DOI 10.1016/S0014-5793(02)02457-2; Leslie K, 2006, CANCER RES, V66, P2544, DOI 10.1158/0008-5472.CAN-05-2203; Leslie K, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2725; Ling XY, 2005, CANCER RES, V65, P2532, DOI 10.1158/0008-5472.CAN-04-2425; Liu SY, 2009, CANCER CELL, V15, P539, DOI 10.1016/j.ccr.2009.03.027; Lo HW, 2007, CANCER RES, V67, P9066, DOI 10.1158/0008-5472.CAN-07-0575; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Mills GB, 2003, NAT REV CANCER, V3, P582, DOI 10.1038/nrc1143; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Minn AJ, 2005, J CLIN INVEST, V115, P44, DOI 10.1172/JCI200522320; Montserrat N, 2011, HUM PATHOL, V42, P103, DOI 10.1016/j.humpath.2010.05.019; Muller V, 2005, CLIN CANCER RES, V11, P3678, DOI 10.1158/1078-0432.CCR-04-2469; MURATA J, 1994, J BIOL CHEM, V269, P30479; Nam SW, 2001, CANCER RES, V61, P6938; Niu GL, 2002, ONCOGENE, V21, P2000, DOI 10.1038/sj.onc.1205260; Noh JH, 2006, MOL CELL BIOCHEM, V288, P91, DOI 10.1007/s11010-006-9124-8; Oka M, 2010, EXP DERMATOL, V19, pE50, DOI 10.1111/j.1600-0625.2009.00972.x; Pamuklar Z, 2009, J BIOL CHEM, V284, P7385, DOI 10.1074/jbc.M807820200; Pantel K, 2004, NAT REV CANCER, V4, P448, DOI 10.1038/nrc1370; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Ptaszynska MM, 2008, MOL CANCER RES, V6, P352, DOI 10.1158/1541-7786.MCR-07-0143; Rae JM, 2007, BREAST CANCER RES TR, V104, P13, DOI 10.1007/s10549-006-9392-8; Ranger JJ, 2009, CANCER RES, V69, P6823, DOI 10.1158/0008-5472.CAN-09-1684; Sano S, 1999, EMBO J, V18, P4657, DOI 10.1093/emboj/18.17.4657; Sansone P, 2007, J CLIN INVEST, V117, P3988, DOI 10.1172/JCI32533; Selander KS, 2004, CANCER RES, V64, P6924, DOI 10.1158/0008-5472.CAN-03-2516; Sellappan S, 2004, CANCER RES, V64, P3479, DOI 10.1158/0008-5472.CAN-3299-2; Shen H, 2009, MOL BIOL REP, V36, P653, DOI 10.1007/s11033-008-9225-4; Song J, 2006, BIOCHEM BIOPH RES CO, V340, P175, DOI 10.1016/j.bbrc.2005.11.171; STRACKE M, 1993, SYM SOC EXP BIOL, V47, P197; Stracke ML, 1997, ADV ENZYME REGUL, V37, P135, DOI 10.1016/S0065-2571(96)00017-9; STRACKE ML, 1992, J BIOL CHEM, V267, P2524; Sullivan NJ, 2009, ONCOGENE, V28, P2940, DOI 10.1038/onc.2009.180; Turkson J, 2004, MOL CANCER THER, V3, P1533; Turkson J, 2004, MOL CANCER THER, V3, P261; van Meeteren LA, 2007, PROG LIPID RES, V46, P145, DOI 10.1016/j.plipres.2007.02.001; Walker SR, 2009, MOL CANCER RES, V7, P966, DOI 10.1158/1541-7786.MCR-08-0238; WATSON CJ, 1995, BRIT J CANCER, V71, P840, DOI 10.1038/bjc.1995.162; Yamashita S, 2004, NATURE, V429, P298, DOI 10.1038/nature02545; Yamashita S, 2002, DEV CELL, V2, P363, DOI 10.1016/S1534-5807(02)00126-0; Yang JB, 2007, GENE DEV, V21, P1396, DOI 10.1101/gad.1553707; Yang J, 2006, CANCER RES, V66, P4549, DOI 10.1158/0008-5472.CAN-05-3850; Yang SY, 2002, CLIN EXP METASTAS, V19, P603, DOI 10.1023/A:1020950420196; Yang Y, 1999, AM J RESP CELL MOL, V21, P216, DOI 10.1165/ajrcmb.21.2.3667; Yano Y, 2003, INT J MOL MED, V12, P763; Zhang GX, 1999, CHINESE MED J-PEKING, V112, P330; Zhou JB, 2007, P NATL ACAD SCI USA, V104, P16158, DOI 10.1073/pnas.0702596104	89	55	56	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2011	6	11							e27851	10.1371/journal.pone.0027851	http://dx.doi.org/10.1371/journal.pone.0027851			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KW	22140473	Green Published, Green Submitted, gold			2022-12-27	WOS:000298163400019
J	Cappello, F; Caramori, G; Campanella, C; Vicari, C; Gnemmi, I; Zanini, A; Spanevello, A; Capelli, A; La Rocca, G; Anzalone, R; Bucchieri, F; D'Anna, SE; Ricciardolo, FLM; Brun, P; Balbi, B; Carone, M; Zummo, G; de Macario, EC; Macario, AJL; Di Stefano, A				Cappello, Francesco; Caramori, Gaetano; Campanella, Claudia; Vicari, Chiara; Gnemmi, Isabella; Zanini, Andrea; Spanevello, Antonio; Capelli, Armando; La Rocca, Giampiero; Anzalone, Rita; Bucchieri, Fabio; D'Anna, Silvestro Ennio; Ricciardolo, Fabio L. M.; Brun, Paola; Balbi, Bruno; Carone, Mauro; Zummo, Giovanni; de Macario, Everly Conway; Macario, Alberto J. L.; Di Stefano, Antonino			Convergent Sets of Data from In Vivo and In Vitro Methods Point to an Active Role of Hsp60 in Chronic Obstructive Pulmonary Disease Pathogenesis	PLOS ONE			English	Article							HEAT-SHOCK-PROTEIN; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; SPINAL-CORD; KAPPA-B; HEAT-SHOCK-PROTEIN-60; STRESS; EXPRESSION; ACTIVATION; SMOKERS; SUPPRESSES	Background: It is increasingly clear that some heat shock proteins (Hsps) play a role in inflammation. Here, we report results showing participation of Hsp60 in the pathogenesis of chronic obstructive pulmonary diseases (COPD), as indicated by data from both in vivo and in vitro analyses. Methods and Results: Bronchial biopsies from patients with stable COPD, smoker controls with normal lung function, and non-smoker controls were studied. We quantified by immunohistochemistry levels of Hsp10, Hsp27, Hsp40, Hsp60, Hsp70, Hsp90, and HSF-1, along with levels of inflammatory markers. Hsp10, Hsp40, and Hsp60 were increased during progression of disease. We found also a positive correlation between the number of neutrophils and Hsp60 levels. Double-immunostaining showed that Hsp60-positive neutrophils were significantly increased in COPD patients. We then investigated in vitro the effect on Hsp60 expression in bronchial epithelial cells (16HBE) caused by oxidative stress, a hallmark of COPD mucosa, which we induced with H2O2. This stressor determined increased levels of Hsp60 through a gene up-regulation mechanism involving NFkB-p65. Release of Hsp60 in the extracellular medium by the bronchial epithelial cells was also increased after H2O2 treatment in the absence of cell death. Conclusions: This is the first report clearly pointing to participation of Hsps, particularly Hsp60, in COPD pathogenesis. Hsp60 induction by NFkB-p65 and its release by epithelial cells after oxidative stress can have a role in maintaining inflammation, e. g., by stimulating neutrophils activity. The data open new scenarios that might help in designing efficacious anti-inflammatory therapies centered on Hsp60 and applicable to COPD.	[Cappello, Francesco; Campanella, Claudia; La Rocca, Giampiero; Anzalone, Rita; Bucchieri, Fabio; Zummo, Giovanni] Univ Palermo, Sez Anat Umana, Dipartimento Biomed Sperimentale & Neurosci Clin, Palermo, Italy; [Cappello, Francesco; Campanella, Claudia; La Rocca, Giampiero; Bucchieri, Fabio; Macario, Alberto J. L.] Ist Euromediterraneo Sci & Tecnol IEMEST, Palermo, Italy; [Caramori, Gaetano] Univ Ferrara, Sez Malattie Apparato Resp, Dipartimento Med Clin & Sperimentale, I-44100 Ferrara, Italy; [Vicari, Chiara; Gnemmi, Isabella; Zanini, Andrea; Spanevello, Antonio; Capelli, Armando; D'Anna, Silvestro Ennio; Balbi, Bruno; Carone, Mauro; Di Stefano, Antonino] IRCCS, Fdn S Maugeri, Veruno, NO, Italy; [Vicari, Chiara; Gnemmi, Isabella; Zanini, Andrea; Spanevello, Antonio; Capelli, Armando; D'Anna, Silvestro Ennio; Balbi, Bruno; Carone, Mauro; Di Stefano, Antonino] IRCCS, Fdn S Maugeri, Tradate, VA, Italy; [Vicari, Chiara; Gnemmi, Isabella; Zanini, Andrea; Spanevello, Antonio; Capelli, Armando; D'Anna, Silvestro Ennio; Balbi, Bruno; Carone, Mauro; Di Stefano, Antonino] IRCCS, Fdn S Maugeri, Cassano, BA, Italy; [Ricciardolo, Fabio L. M.] Univ Turin, Dipartimento Sci Clin & Biol, Turin, Italy; [Brun, Paola] Univ Padua, Dipartimento Istol Microbiol & Biotecnol Med, Padua, Italy; [de Macario, Everly Conway; Macario, Alberto J. L.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [de Macario, Everly Conway; Macario, Alberto J. L.] Inst Marine & Environm Sci IMET, Baltimore, MD USA	University of Palermo; University of Ferrara; Istituti Clinici Scientifici Maugeri IRCCS; Istituti Clinici Scientifici Maugeri IRCCS; Istituti Clinici Scientifici Maugeri IRCCS; University of Turin; University of Padua; University System of Maryland; University of Maryland Baltimore	Cappello, F (corresponding author), Univ Palermo, Sez Anat Umana, Dipartimento Biomed Sperimentale & Neurosci Clin, Palermo, Italy.	francapp@hotmail.com	D'anna, Silvestro ennio/AAC-2738-2020; SPANEVELLO, ANTONIO/AAB-9503-2020; Ricciardolo, F. L. M./K-5330-2018; Brun, Paola/K-5729-2016; Bucchieri, Fabio/F-8877-2012; Di Stefano, Antonino/AAB-8041-2020; La Rocca, Giampiero/G-4730-2012; Caramori, Gaetano/AAS-8611-2020; Carone, Mauro/E-1241-2019; Balbi, Bruno/E-8380-2019; Gnemmi, Isabella IG/F-3098-2019; Cappello, Francesco/F-9153-2012	D'anna, Silvestro ennio/0000-0003-1986-1495; SPANEVELLO, ANTONIO/0000-0002-3595-9903; Ricciardolo, F. L. M./0000-0003-1826-5018; Di Stefano, Antonino/0000-0003-3479-0875; La Rocca, Giampiero/0000-0002-1334-5054; Caramori, Gaetano/0000-0002-9807-327X; Carone, Mauro/0000-0002-5478-8521; Balbi, Bruno/0000-0002-4439-1424; Gnemmi, Isabella IG/0000-0003-0045-6369; Brun, Paola/0000-0002-4204-3549; Capelli, Armando/0000-0002-9505-2350; BUCCHIERI, Fabio/0000-0002-0209-8668; Cappello, Francesco/0000-0001-9288-1148; Anzalone, Rita/0000-0002-3620-2507	"Fondazione 'Salvatore Maugeri' IRCCS'' (Istituto di Ricovero e Cura a Carattere Scientifico), Ricerca Corrente; "Regione Piemonte'', Ricerca Sanitaria Finalizzata; "Istituto Euro-Mediterraneo di Scienza e Tecnologia'' (IEMEST)	"Fondazione 'Salvatore Maugeri' IRCCS'' (Istituto di Ricovero e Cura a Carattere Scientifico), Ricerca Corrente; "Regione Piemonte'', Ricerca Sanitaria Finalizzata(Regione Piemonte); "Istituto Euro-Mediterraneo di Scienza e Tecnologia'' (IEMEST)	This work was supported by the "Fondazione 'Salvatore Maugeri' IRCCS'' (Istituto di Ricovero e Cura a Carattere Scientifico), Ricerca Corrente; the "Regione Piemonte'', Ricerca Sanitaria Finalizzata 2009; the "Istituto Euro-Mediterraneo di Scienza e Tecnologia'' (IEMEST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalberse JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024119; Arrigo AP, 1998, BIOL CHEM, V379, P19; Athanasas-Platsis S, 2003, J NEUROL SCI, V214, P27, DOI 10.1016/S0022-510X(03)00170-9; Barnes PJ, 2000, NEW ENGL J MED, V343, P269, DOI 10.1056/NEJM200007273430407; Cappello F, 2005, LANCET ONCOL, V6, P816, DOI 10.1016/S1470-2045(05)70393-4; Cappello F, 2006, CANCER-AM CANCER SOC, V107, P2417, DOI 10.1002/cncr.22265; Chen W, 1999, J IMMUNOL, V162, P3212; Chu S, 2011, INT IMMUNOPHARM 0723; Corrao S, 2010, LIFE SCI, V86, P145, DOI 10.1016/j.lfs.2009.11.004; De Maio A, 2011, CELL STRESS CHAPERON, V16, P235, DOI 10.1007/s12192-010-0236-4; Di Stefano A, 2002, EUR RESPIR J, V20, P556, DOI 10.1183/09031936.02.00272002; Di Stefano A, 2009, THORAX, V64, P968, DOI 10.1136/thx.2009.113647; Di Stefano A, 2004, CLIN EXP ALLERGY, V34, P1156, DOI 10.1111/j.1365-2222.2004.02030.x; Goebel U, 2009, BRIT J ANAESTH, V103, P173, DOI 10.1093/bja/aep087; Habich C, 2007, CELL MOL LIFE SCI, V64, P742, DOI 10.1007/s00018-007-6413-7; Hacker S, 2009, CLIN LAB, V55, P31; Henderson B, 2010, CELL STRESS CHAPERON, V15, P123, DOI 10.1007/s12192-009-0137-6; Isajevs S, 2009, EUR RESPIR J, V33, P61, DOI 10.1183/09031936.00145307; Johnson BJ, 2005, J BIOL CHEM, V280, P4037, DOI 10.1074/jbc.M411569200; Kol A, 2000, J IMMUNOL, V164, P13, DOI 10.4049/jimmunol.164.1.13; Macario AJL, 2010, ANN NY ACAD SCI, V1197, P85, DOI 10.1111/j.1749-6632.2010.05187.x; Merendino AM, 2006, AM J RESP CELL MOL, V35, P155, DOI 10.1165/rcmb.2005-0433OC; Merendino AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009247; Mustafi SB, 2009, CELL STRESS CHAPERON, V14, P579, DOI 10.1007/s12192-009-0109-x; National Institutes of Health National Heart Lung and Blood Institute, NIH PUBL A; Osterloh A, 2009, J LEUKOCYTE BIOL, V86, P423, DOI 10.1189/jlb.0109011; Pespeni M, 2005, J SURG RES, V126, P41, DOI 10.1016/j.jss.2005.01.012; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Ricciardolo FLM, 2005, J ALLERGY CLIN IMMUN, V116, P1028, DOI 10.1016/j.jaci.2005.06.034; Sethi S, 2006, AM J RESP CRIT CARE, V173, P991, DOI 10.1164/rccm.200509-1525OC; Takuma K, 2002, BRAIN RES, V946, P232, DOI 10.1016/S0006-8993(02)02888-3; Wang Y, 2010, J MOL CELL CARDIOL, V48, P360, DOI 10.1016/j.yjmcc.2009.11.009; Wheeler DS, 2007, FREE RADICAL BIO MED, V42, P1, DOI 10.1016/j.freeradbiomed.2006.08.028; Yoo CG, 2000, J IMMUNOL, V164, P5416, DOI 10.4049/jimmunol.164.10.5416; Yoshikawa T, 2007, AM J RESP CRIT CARE, V175, P473, DOI 10.1164/rccm.200507-1152OC; Younce CW, 2010, BIOCHEM J, V426, P43, DOI 10.1042/BJ20090976; Zanin-Zhorov A, 2006, J CLIN INVEST, V116, P2022, DOI 10.1172/JCI28423; Zhang B, 2003, J NEUROL SCI, V212, P37, DOI 10.1016/S0022-510X(03)00103-5	38	47	48	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2011	6	11							e28200	10.1371/journal.pone.0028200	http://dx.doi.org/10.1371/journal.pone.0028200			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KW	22140545	Green Submitted, gold, Green Published			2022-12-27	WOS:000298163400037
J	Lockwood, S; Voth, DE; Brayton, KA; Beare, PA; Brown, WC; Heinzen, RA; Broschat, SL				Lockwood, Svetlana; Voth, Daniel E.; Brayton, Kelly A.; Beare, Paul A.; Brown, Wendy C.; Heinzen, Robert A.; Broschat, Shira L.			Identification of Anaplasma marginale Type IV Secretion System Effector Proteins	PLOS ONE			English	Article							LEGIONELLA-PNEUMOPHILA; ANKYRIN REPEAT; COXIELLA-BURNETII; HUMAN MACROPHAGES; MEMBRANE VACCINE; DIVERSITY; TRANSLOCATION; INFECTION; GENOME; MECHANISMS	Background: Anaplasma marginale, an obligate intracellular alphaproteobacterium in the order Rickettsiales, is a tick-borne pathogen and the leading cause of anaplasmosis in cattle worldwide. Complete genome sequencing of A. marginale revealed that it has a type IV secretion system (T4SS). The T4SS is one of seven known types of secretion systems utilized by bacteria, with the type III and IV secretion systems particularly prevalent among pathogenic Gram-negative bacteria. The T4SS is predicted to play an important role in the invasion and pathogenesis of A. marginale by translocating effector proteins across its membrane into eukaryotic target cells. However, T4SS effector proteins have not been identified and tested in the laboratory until now. Results: By combining computational methods with phylogenetic analysis and sequence identity searches, we identified a subset of potential T4SS effectors in A. marginale strain St. Maries and chose six for laboratory testing. Four (AM185, AM470, AM705 [AnkA], and AM1141) of these six proteins were translocated in a T4SS-dependent manner using Legionella pneumophila as a reporter system. Conclusions: The algorithm employed to find T4SS effector proteins in A. marginale identified four such proteins that were verified by laboratory testing. L. pneumophila was shown to work as a model system for A. marginale and thus can be used as a screening tool for A. marginale effector proteins. The first T4SS effector proteins for A. marginale have been identified in this work.	[Lockwood, Svetlana; Broschat, Shira L.] Washington State Univ, Sch Elect Engn & Comp Sci, Pullman, WA 99164 USA; [Voth, Daniel E.] Univ Arkansas Med Sci, Dept Microbiol & Immunol, Little Rock, AR 72205 USA; [Brayton, Kelly A.; Brown, Wendy C.; Broschat, Shira L.] Washington State Univ, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA; [Brayton, Kelly A.; Brown, Wendy C.; Broschat, Shira L.] Washington State Univ, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA; [Beare, Paul A.; Heinzen, Robert A.] NIAID, Coxiella Pathogenesis Sect, Intracellular Parasites Lab, Rocky Mt Labs,NIH, Hamilton, MT USA	Washington State University; University of Arkansas System; University of Arkansas Medical Sciences; Washington State University; Washington State University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Lockwood, S (corresponding author), Washington State Univ, Sch Elect Engn & Comp Sci, Pullman, WA 99164 USA.	shira@eecs.wsu.edu		Lockwood, Svetlana/0000-0002-9401-239X	National Institutes of Health (NIH) National Institutes of Allergy and Infectious Diseases (NIAID) [AI44005, AI053692, R01AI087669]; Carl M. Hansen Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI044005, R01AI044005, R01AI053692, R01AI087669] Funding Source: NIH RePORTER	National Institutes of Health (NIH) National Institutes of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Carl M. Hansen Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by National Institutes of Health (NIH) National Institutes of Allergy and Infectious Diseases (NIAID) grants AI44005 and AI053692 (to KAB and WCB) and R01AI087669 (DEV) and by the Intramural Research Program of the NIH, NIAID (to RAH and PAB). SL was supported in part by the Carl M. Hansen Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Khodor S, 2008, MOL MICROBIOL, V70, P908, DOI 10.1111/j.1365-2958.2008.06453.x; Al-Khodor S, 2010, TRENDS MICROBIOL, V18, P132, DOI 10.1016/j.tim.2009.11.004; Alvarez-Martinez CE, 2009, MICROBIOL MOL BIOL R, V73, P775, DOI 10.1128/MMBR.00023-09; Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Barbet AF, 2000, INFECT IMMUN, V68, P6133, DOI 10.1128/IAI.68.11.6133-6138.2000; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; BORK P, 1993, PROTEINS, V17, P363, DOI 10.1002/prot.340170405; Brayton KA, 2005, P NATL ACAD SCI USA, V102, P844, DOI 10.1073/pnas.0406656102; Bruggemann H, 2006, CURR OPIN MICROBIOL, V9, P86, DOI 10.1016/j.mib.2005.12.009; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; Burstein D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000508; Carey KL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002056; Cazalet C, 2004, NAT GENET, V36, P1165, DOI 10.1038/ng1447; Chen C, 2010, P NATL ACAD SCI USA, V107, P21755, DOI 10.1073/pnas.1010485107; Dark MJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-16; de Felipe KS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000117; Delahay RM, 2002, MOL MICROBIOL, V45, P905, DOI 10.1046/j.1365-2958.2002.03083.x; Hotopp JCD, 2006, PLOS GENET, V2, P208, DOI 10.1371/journal.pgen.0020021; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; GARCIAGARCIA JC, 2009, INFECT IMMUN; Gillespie JJ, 2010, INFECT IMMUN, V78, P1809, DOI 10.1128/IAI.01384-09; Huang B, 2010, MICROB PATHOGENESIS, V49, P273, DOI 10.1016/j.micpath.2010.06.009; IJDO JW, 2007, CELL MICROBIOL; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lin MQ, 2007, CELL MICROBIOL, V9, P2644, DOI 10.1111/j.1462-5822.2007.00985.x; Lohr CV, 2002, INFECT IMMUN, V70, P6005, DOI 10.1128/IAI.70.11.6005-6012.2002; Lopez JE, 2005, INFECT IMMUN, V73, P8109, DOI 10.1128/IAI.73.12.8109-8118.2005; Lopez JE, 2008, J IMMUNOL METHODS, V332, P129, DOI 10.1016/j.jim.2007.12.018; Lopez JE, 2007, INFECT IMMUN, V75, P2333, DOI 10.1128/IAI.00061-07; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Medini D, 2006, PLOS COMPUT BIOL, V2, P1543, DOI 10.1371/journal.pcbi.0020173; Mosavi LK, 2004, PROTEIN SCI, V13, P1435, DOI 10.1110/ps.03554604; Nagai H, 2005, P NATL ACAD SCI USA, V102, P826, DOI 10.1073/pnas.0406239101; Natale P, 2008, BBA-BIOMEMBRANES, V1778, P1735, DOI 10.1016/j.bbamem.2007.07.015; Niu H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000774; Noh SM, 2008, INFECT IMMUN; Ogata H, 2001, SCIENCE, V293, P2093, DOI 10.1126/science.1061471; Ohashi N, 2002, INFECT IMMUN, V70, P2128, DOI 10.1128/IAI.70.4.2128-2138.2002; Pan XX, 2008, SCIENCE, V320, P1651, DOI 10.1126/science.1158160; Ramabu SS, 2010, INFECT IMMUN, V78, P3047, DOI 10.1128/IAI.00300-10; Ramabu SS, 2011, INFECT IMMUN; Reynolds SM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000213; SADOSKY AB, 1993, INFECT IMMUN, V61, P5361, DOI 10.1128/IAI.61.12.5361-5373.1993; Schultz J, 2000, NUCLEIC ACIDS RES, V28, P231, DOI 10.1093/nar/28.1.231; SORY MP, 1994, MOL MICROBIOL, V14, P583, DOI 10.1111/j.1365-2958.1994.tb02191.x; Stich RW, 2004, INFECT IMMUN, V72, P7257, DOI 10.1128/IAI.72.12.7257-7264.2004; Sutten EL, 2010, INFECT IMMUN, V78, P1314, DOI 10.1128/IAI.01207-09; Voth DE, 2011, J BACTERIOL, V193, P1493, DOI 10.1128/JB.01359-10; Voth DE, 2009, J BACTERIOL, V191, P4232, DOI 10.1128/JB.01656-08; Wallden K, 2010, CELL MICROBIOL, V12, P1203, DOI 10.1111/j.1462-5822.2010.01499.x	51	34	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2011	6	11							e27724	10.1371/journal.pone.0027724	http://dx.doi.org/10.1371/journal.pone.0027724			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KW	22140462	gold, Green Published, Green Submitted			2022-12-27	WOS:000298163400015
J	Dickinson, RE; Fegan, KS; Ren, X; Hillier, SG; Duncan, WC				Dickinson, Rachel E.; Fegan, K. Scott; Ren, Xia; Hillier, Stephen G.; Duncan, W. Colin			Glucocorticoid Regulation of SLIT/ROBO Tumour Suppressor Genes in the Ovarian Surface Epithelium and Ovarian Cancer Cells	PLOS ONE			English	Article							SLIT-ROBO PATHWAY; CHEMOTHERAPY RESISTANCE; CERVICAL-CANCER; EXPRESSION; GROWTH; BREAST; GUIDANCE; RECEPTORS; QUANTIFICATION; INACTIVATION	The three SLIT ligands and their four ROBO receptors have fundamental roles in mammalian development by promoting apoptosis and repulsing aberrant cell migration. SLITs and ROBOs have emerged as candidate tumour suppressor genes whose expression is inhibited in a variety of epithelial tumours. We demonstrated that their expression could be negatively regulated by cortisol in normal ovarian luteal cells. We hypothesised that after ovulation the locally produced cortisol would inhibit SLIT/ROBO expression in the ovarian surface epithelium (OSE) to facilitate its repair and that this regulatory pathway was still present, and could be manipulated, in ovarian epithelial cancer cells. Here we examined the expression and regulation of the SLIT/ROBO pathway in OSE, ovarian cancer epithelial cells and ovarian tumour cell lines. Basal SLIT2, SLIT3, ROBO1, ROBO2 and ROBO4 expression was lower in primary cultures of ovarian cancer epithelial cells when compared to normal OSE (P<0.05) and in poorly differentiated SKOV-3 cells compared to the more differentiated PEO-14 cells (P<0.05). Cortisol reduced the expression of certain SLITs and ROBOs in normal OSE and PEO-14 cells (P<0.05). Furthermore blocking SLIT/ROBO activity reduced apoptosis in both PEO-14 and SKOV-3 tumour cells (P<0.05). Interestingly SLIT/ROBO expression could be increased by reducing the expression of the glucocorticoid receptor using siRNA (P<0.05). Overall our findings indicate that in the post-ovulatory phase one role of cortisol may be to temporarily inhibit SLIT/ROBO expression to facilitate regeneration of the OSE. Therefore this pathway may be a target to develop strategies to manipulate the SLIT/ROBO system in ovarian cancer.	[Dickinson, Rachel E.; Fegan, K. Scott; Ren, Xia; Hillier, Stephen G.; Duncan, W. Colin] Univ Edinburgh, MRC, Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland	University of Edinburgh	Dickinson, RE (corresponding author), Univ Edinburgh, MRC, Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland.	W.C.Duncan@ed.ac.uk		Fegan, Kenneth Scott/0000-0003-1604-203X; hillier, stephen/0000-0001-7378-5855	Scottish Funding Council; CSO [SCD/02]; Medical Research Council [G1002033] Funding Source: researchfish; Chief Scientist Office [SCD/02] Funding Source: researchfish; MRC [G1002033] Funding Source: UKRI	Scottish Funding Council; CSO; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	WCD is supported by a Scottish Senior Clinical Fellowship from the Scottish Funding Council and this work was funded by the CSO (SCD/02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argento M, 2008, ANTICANCER RES, V28, P3135; Avci ME, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-392; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Chebotaev D, 2007, MOL CARCINOGEN, V46, P732, DOI 10.1002/mc.20349; Chedotal A, 2005, CELL DEATH DIFFER, V12, P1044, DOI 10.1038/sj.cdd.4401707; Dallol A, 2003, CANCER RES, V63, P1054; Dallol A, 2002, CANCER RES, V62, P5874; Dallol A, 2005, CAN META BIO TREAT, V7, P191; Dickinson RE, 2008, ENDOCRINOLOGY, V149, P5024, DOI 10.1210/en.2008-0204; Dickinson RE, 2010, REPRODUCTION, V139, P697, DOI 10.1530/REP-10-0017; Dickinson RE, 2010, REPRODUCTION, V139, P395, DOI 10.1530/REP-09-0182; Duncan WC, 2010, MOL HUM REPROD, V16, P950, DOI 10.1093/molehr/gaq055; Duncan W. C., 2009, Animal Reproduction, V6, P34; El Etreby MF, 2000, PROSTATE, V43, P31, DOI 10.1002/(SICI)1097-0045(20000401)43:1<31::AID-PROS5>3.0.CO;2-#; Gascoyne DM, 2003, J BIOL CHEM, V278, P18022, DOI 10.1074/jbc.M301812200; Goyeneche AA, 2007, CLIN CANCER RES, V13, P3370, DOI 10.1158/1078-0432.CCR-07-0164; Gubbay O, 2005, BRIT J CANCER, V92, P1927, DOI 10.1038/sj.bjc.6602568; Hillier SG, 1998, J REPROD IMMUNOL, V39, P21, DOI 10.1016/S0165-0378(98)00011-4; Hinck L, 2004, DEV CELL, V7, P783, DOI 10.1016/j.devcel.2004.11.002; Jin J, 2009, BIOCHEM BIOPH RES CO, V379, P86, DOI 10.1016/j.bbrc.2008.12.022; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kim HK, 2008, NEOPLASIA, V10, P1411, DOI 10.1593/neo.08804; Latil A, 2003, INT J CANCER, V103, P306, DOI 10.1002/ijc.10821; Leung PCK, 2007, HUM REPROD UPDATE, V13, P143, DOI 10.1093/humupd/dml002; Liao WX, 2010, HISTOL HISTOPATHOL, V25, P1181, DOI 10.14670/HH-25.1181; Ma SL, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.07.040; Marlow R, 2008, CANCER RES, V68, P7819, DOI 10.1158/0008-5472.CAN-08-1357; Mertsch S, 2008, J NEURO-ONCOL, V87, P1, DOI 10.1007/s11060-007-9484-2; MORRISSEY C, 2004, P AM ASS CANC RES, V45; Myers M, 2007, ENDOCRINOLOGY, V148, P5769, DOI 10.1210/en.2007-0742; Narayan G, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-16; Papacleovoulou G, 2009, MOL HUM REPROD, V15, P379, DOI 10.1093/molehr/gap022; Prasad A, 2004, J BIOL CHEM, V279, P9115, DOI 10.1074/jbc.M308083200; Purdie DM, 2003, INT J CANCER, V104, P228, DOI 10.1002/ijc.10927; Rae MT, 2009, FERTIL STERIL, V92, P703, DOI 10.1016/j.fertnstert.2008.06.040; Rae MT, 2004, J CLIN ENDOCR METAB, V89, P4538, DOI 10.1210/jc.2003-032225; Runnebaum IB, 2005, CLIN CANCER RES, V11, P6325, DOI 10.1158/1078-0432.CCR-05-0182; SEEGER M, 1993, NEURON, V10, P409, DOI 10.1016/0896-6273(93)90330-T; Sengupta S, 2000, EMBO J, V19, P6051, DOI 10.1093/emboj/19.22.6051; Singh RK, 2007, HUM GENET, V122, P71, DOI 10.1007/s00439-007-0375-6; Stella MC, 2009, MOL BIOL CELL, V20, P642, DOI 10.1091/mbc.E08-03-0321; Strickland P, 2006, DEVELOPMENT, V133, P823, DOI 10.1242/dev.02261; Sui MH, 2006, INT J CANCER, V119, P712, DOI 10.1002/ijc.21743; van den Driesche S, 2008, REPRODUCTION, V135, P509, DOI 10.1530/REP-07-0427; Yu J, 2010, ONCOGENE, V29, P5370, DOI 10.1038/onc.2010.269; Zhang C, 2006, CANCER BIOL THER, V5, P59, DOI 10.4161/cbt.5.1.2272; Zhang CW, 2006, INT J ONCOL, V29, P1295	47	38	41	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e27792	10.1371/journal.pone.0027792	http://dx.doi.org/10.1371/journal.pone.0027792			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132142	Green Published, Green Submitted, gold			2022-12-27	WOS:000298162000044
J	Lacoue-Labarthe, T; Villanueva, R; Rouleau, C; Oberhansli, F; Teyssie, JL; Jeffree, R; Bustamante, P				Lacoue-Labarthe, Thomas; Villanueva, Roger; Rouleau, Claude; Oberhaensli, Francois; Teyssie, Jean-Louis; Jeffree, Ross; Bustamante, Paco			Radioisotopes Demonstrate the Contrasting Bioaccumulation Capacities of Heavy Metals in Embryonic Stages of Cephalopod Species	PLOS ONE			English	Article							CUTTLEFISH SEPIA-OFFICINALIS; TRACE-ELEMENT ACCUMULATION; SQUID LOLIGO-VULGARIS; OCTOPUS-VULGARIS; NONESSENTIAL ELEMENTS; PORTUGUESE COAST; LIFE-CYCLE; CADMIUM; TISSUES; MOLLUSKS	Cephalopods play a key role in many marine trophic food webs and also constitute alternative fishery resources in the context of the ongoing decline in finfish stocks. Most coastal cephalopod species of commercial importance migrate into shallow waters during the breeding season to lay their eggs, and are consequently subjected to coastal contamination. Eggs of common cuttlefish Sepia officinalis, European squid Loligo vulgaris, common octopus Octopus vulgaris and the sepiolid Rossia macrosoma were exposed during embryonic development to dissolved Ag-110m, Cd-109, Co-60, Mn-54 and Zn-65 in order to determine their metal accumulation efficiencies and distribution among different egg compartments. Cuttlefish eggs, in which hard shells enclose the embryos, showed the lowest concentration factor (CF) values despite a longer duration of exposure. In contrast, octopus eggs, which are only protected by the chorionic membrane, accumulated the most metal. Uptake appears to be linked to the selective retention properties of the egg envelopes with respect to each element. The study also demonstrated that the octopus embryo accumulated Ag-110m directly from the dissolved phase and also indirectly through assimilation of the contaminated yolk. These results raise questions regarding the potential contrasting vulnerability of early life stages of cephalopods to the metallic contamination of coastal waters.	[Lacoue-Labarthe, Thomas; Oberhaensli, Francois; Teyssie, Jean-Louis; Jeffree, Ross] IAEA, Environm Labs, Monaco, Monaco; [Lacoue-Labarthe, Thomas; Bustamante, Paco] Univ La Rochelle, CNRS, UMR 6250, Littoral Environm & Societes LIENSs, La Rochelle, France; [Villanueva, Roger] CSIC, Inst Ciencias Mar, Barcelona, Spain; [Rouleau, Claude] Inst Maurice Lamontagne, Mont Joli, PQ G5H 3Z4, Canada; [Jeffree, Ross] Univ Technol Sydney, Fac Sci, Sydney, NSW 2007, Australia	Centre National de la Recherche Scientifique (CNRS); La Rochelle Universite; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); Fisheries & Oceans Canada; University of Technology Sydney	Lacoue-Labarthe, T (corresponding author), IAEA, Environm Labs, Monaco, Monaco.	tlacouel@gmail.com	Bustamante, Paco/G-5833-2011; Lacoue-Labarthe, Thomas/H-4963-2019; Villanueva, Roger/D-6911-2011	Bustamante, Paco/0000-0003-3877-9390; Lacoue-Labarthe, Thomas/0000-0002-4682-8730; Villanueva, Roger/0000-0001-8122-3449	Conseil General de Charente-Maritime (France); Spanish Ministry of Science and Innovation [AGL2009-11546]	Conseil General de Charente-Maritime (France)(Region Nouvelle-Aquitaine); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	TLL was supported by a post-doctoral grant from the Conseil General de Charente-Maritime (France). RV was funded by the research project CALOCEAN (AGL2009-11546) from the Spanish Ministry of Science and Innovation. This work was a contribution to the research programs of the IAEA and LIENSs. Both supported the study design and data collection and allowed publication of this study in PLoS ONE.	BOLETZKY SV, 1973, HELGOLAND WISS MEER, V25, P135, DOI 10.1007/BF01609965; BOLETZKY SV, 1986, AM MALACOL BULL, V4, P217; Bruland K. W., 1983, CHEM OCEANOGR, V8, P157, DOI 10.1016/b978-0-12-588608-6.50009-2.; Bustamante P, 2006, SCI TOTAL ENVIRON, V368, P585, DOI 10.1016/j.scitotenv.2006.01.038; Bustamante P, 2006, VIE MILIEU, V56, P153; Bustamante P, 1998, SCI TOTAL ENVIRON, V220, P71, DOI 10.1016/S0048-9697(98)00250-2; Bustamante P, 2004, MAR ECOL PROG SER, V269, P185, DOI 10.3354/meps269185; Bustamante P, 2002, MAR ENVIRON RES, V53, P227, DOI 10.1016/S0141-1136(01)00108-8; Bustamante P, 2002, MAR ECOL PROG SER, V231, P167, DOI 10.3354/meps231167; Chouvelon T, 2011, MAR ECOL PROG SER, V433, P107, DOI 10.3354/meps09159; Clarke MR, 1996, PHILOS T ROY SOC B, V351, P1053, DOI 10.1098/rstb.1996.0093; D'Aniello A, 1990, ITAL J BIOCHEM, V32, p130A; FAO Yearbook, 2007, FAO YB; Hedouin L, 2006, SCI TOTAL ENVIRON, V366, P154, DOI 10.1016/j.scitotenv.2005.10.022; Kojadinovic J, 2011, ECOTOX ENVIRON SAFE, V74, P1238, DOI 10.1016/j.ecoenv.2011.03.015; Lacoue-Labarthe T, 2008, AQUAT TOXICOL, V86, P437, DOI 10.1016/j.aquatox.2007.12.005; Lacoue-Labarthe T, 2011, AQUAT TOXICOL, V105, P166, DOI 10.1016/j.aquatox.2011.05.021; Lacoue-Labarthe T, 2009, SCI TOTAL ENVIRON, V407, P6188, DOI 10.1016/j.scitotenv.2009.09.003; Lacoue-Labarthe T, 2008, MAR POLLUT BULL, V57, P826, DOI 10.1016/j.marpolbul.2008.01.042; Lacoue-Labarthe T, 2010, ICES J MAR SCI, V67, P1517, DOI 10.1093/icesjms/fsq044; Lacoue-Labarthe T, 2010, J EXP MAR BIOL ECOL, V382, P131, DOI 10.1016/j.jembe.2009.10.008; MARTIN JH, 1975, MAR BIOL, V30, P51, DOI 10.1007/BF00393752; Metian M, 2009, MAR ECOL PROG SER, V375, P161, DOI 10.3354/meps07766; MIRAMAND P, 1992, MAR BIOL, V114, P407, DOI 10.1007/BF00350031; Moltschaniwskyj NA, 2007, REV FISH BIOL FISHER, V17, P455, DOI 10.1007/s11160-007-9056-8; Naef A., 1928, CEPHALOPODEN EMBRYOL; Nixon M, 1998, J ZOOL, V245, P407, DOI 10.1017/S0952836998008048; Pierce GJ, 2010, CEPHALOPOD BIOL FISH, P181; Raimundo J, 2004, SCI TOTAL ENVIRON, V325, P71, DOI 10.1016/j.scitotenv.2003.12.001; Rouleau C, 2003, ENVIRON SCI TECHNOL, V37, P3298, DOI 10.1021/es020984n; Seixas S, 2005, SCI TOTAL ENVIRON, V340, P113, DOI 10.1016/j.scitotenv.2004.08.012; Seixas S, 2005, CHEMOSPHERE, V59, P1113, DOI 10.1016/j.chemosphere.2004.11.099; Sen H, 2007, ENVIRON MONIT ASSESS, V133, P371, DOI 10.1007/s10661-006-9591-0; Storelli MM, 2010, FOOD ADDIT CONTAM B, V3, P14, DOI 10.1080/19440040903552390; Storelli MM, 2006, FOOD ADDIT CONTAM A, V23, P25, DOI 10.1080/02652030500242023; Storelli MM, 2005, J FOOD PROTECT, V68, P577, DOI 10.4315/0362-028X-68.3.577; Storelli MM, 1999, FOOD ADDIT CONTAM, V16, P261, DOI 10.1080/026520399284028; Storelli MM, 2001, FOOD ADDIT CONTAM, V18, P303, DOI 10.1080/02652030010021413; von Boletzky S, 1998, OCEANOGR MAR BIOL<D>, V36, P341; Villanueva R, 1997, J EXP MAR BIOL ECOL, V208, P169, DOI 10.1016/S0022-0981(96)02670-6; Villanueva R, 2006, AQUACULTURE, V261, P225, DOI 10.1016/j.aquaculture.2006.07.006; Wang WX, 1997, MAR ECOL PROG SER, V161, P103, DOI 10.3354/meps161103	42	11	12	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e27653	10.1371/journal.pone.0027653	http://dx.doi.org/10.1371/journal.pone.0027653			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132123	Green Submitted, Green Published, gold			2022-12-27	WOS:000298162000032
J	Walsh, MC; Buzoianu, SG; Gardiner, GE; Rea, MC; Gelencser, E; Janosi, A; Epstein, MM; Ross, RP; Lawlor, PG				Walsh, Maria C.; Buzoianu, Stefan G.; Gardiner, Gillian E.; Rea, Mary C.; Gelencser, Eva; Janosi, Anna; Epstein, Michelle M.; Ross, R. Paul; Lawlor, Peadar G.			Fate of Transgenic DNA from Orally Administered Bt MON810 Maize and Effects on Immune Response and Growth in Pigs	PLOS ONE			English	Article							ENDOGENOUS PLANT DNA; SALMO-SALAR L.; BACILLUS-THURINGIENSIS; ATLANTIC SALMON; CORN; PERFORMANCE; FRAGMENTS; FEED; NUTRITION; PRODUCTS	We assessed the effect of short-term feeding of genetically modified (GM: Bt MON810) maize on immune responses and growth in weanling pigs and determined the fate of the transgenic DNA and protein in-vivo. Pigs were fed a diet containing 38.9% GM or non-GM isogenic parent line maize for 31 days. We observed that IL-12 and IFN gamma production from mitogenic stimulated peripheral blood mononuclear cells decreased (P<0.10) following 31 days of GM maize exposure. While Cry1Ab-specific IgG and IgA were not detected in the plasma of GM maize-fed pigs, the detection of the cry1Ab gene and protein was limited to the gastrointestinal digesta and was not found in the kidneys, liver, spleen, muscle, heart or blood. Feeding GM maize to weanling pigs had no effect on growth performance or body weight. IL-6 and IL-4 production from isolated splenocytes were increased (P<0.05) in response to feeding GM maize while the proportion of CD4(+) T cells in the spleen decreased. In the ileum, the proportion of B cells and macrophages decreased while the proportion of CD4(+) T cells increased in GM maize-fed pigs. IL-8 and IL-4 production from isolated intraepithelial and lamina propria lymphocytes were also increased (P<0.05) in response to feeding GM maize. In conclusion, there was no evidence of cry1Ab gene or protein translocation to the organs and blood of weaning pigs. The growth of pigs was not affected by feeding GM maize. Alterations in immune responses were detected; however, their biologic relevance is questionable.	[Walsh, Maria C.; Buzoianu, Stefan G.; Lawlor, Peadar G.] TEAGASC, Pig Dev Dept, Anim & Grassland Res & Innovat Ctr, Fermoy, Cork, Ireland; [Buzoianu, Stefan G.; Gardiner, Gillian E.] Waterford Inst Technol, Dept Chem & Life Sci, Waterford, Ireland; [Rea, Mary C.; Ross, R. Paul] TEAGASC, Food Res Ctr, Fermoy, Cork, Ireland; [Gelencser, Eva; Janosi, Anna] Cent Food Technol Res Inst, Dept Biol, Budapest, Hungary; [Epstein, Michelle M.] Med Univ Vienna, Div Immunobiol, Inst Immunol, Vienna, Austria	Teagasc; South East Technological University (SETU); Teagasc; Medical University of Vienna	Walsh, MC (corresponding author), TEAGASC, Pig Dev Dept, Anim & Grassland Res & Innovat Ctr, Moorepk, Fermoy, Cork, Ireland.	peadar.lawlor@teagasc.ie	Ross, Paul/A-7584-2015; Stefan, Buzoianu/F-3030-2010; Jánosi, Anna/A-6921-2013; Gelencser, Eva/A-2842-2013	Ross, Paul/0000-0003-4876-8839; Rea, Mary/0000-0003-3782-0232; Epstein, Michelle/0000-0002-4755-0224	European Union [FP7/2007-2013, 211820]; Teagasc Walsh Fellowship programme	European Union(European Commission); Teagasc Walsh Fellowship programme	The research leading to these results received funding from the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 211820 and the Teagasc Walsh Fellowship programme and independently of any commercial input, financial or otherwise. The authors have no financial or personal conflict of interest in regard to the present study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adel-Patient K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016346; Alexander TW, 2006, BRIT J NUTR, V96, P997, DOI 10.1017/BJN20061935; Bertoni G, 2005, VET RES COMMUN, V29, P13, DOI 10.1007/s11259-005-0004-6; Bressener G, 2002, J ANIM SCI S2, V80, P128; Chowdhury EH, 2003, J ANIM SCI, V81, P2546; Custodio MG, 2006, CAN J ANIM SCI, V86, P461, DOI 10.4141/A05-082; Deaville ER, 2005, J AGR FOOD CHEM, V53, P10268, DOI 10.1021/jf051652f; EFSA, 2009, EFSA J, P1149; Einspanier R, 2004, EUR FOOD RES TECHNOL, V218, P269, DOI 10.1007/s00217-003-0842-9; Finamore A, 2008, J AGR FOOD CHEM, V56, P11533, DOI 10.1021/jf802059w; Fischer R, 2002, J ANIM SCI S1, V80, P894; Flachowsky G, 2007, ANIM FEED SCI TECH, V133, P2, DOI 10.1016/j.anifeedsci.2006.08.002; Ganiere P, 2006, J AGR RESOUR ECON, V31, P129; Hug K, 2008, MEDICINA-LITHUANIA, V44, P87, DOI 10.3390/medicina44020012; Hyun Y, 2004, J ANIM SCI, V82, P571; Kirouac M, 2006, APPL ENVIRON MICROB, V72, P506, DOI 10.1128/AEM.72.1.506-515.2006; Malarkey T, 2003, MUTAT RES-REV MUTAT, V544, P217, DOI 10.1016/j.mrrev.2003.06.001; Mazza R, 2005, TRANSGENIC RES, V14, P775, DOI 10.1007/s11248-005-0009-5; MEYER R, 1994, J AOAC INT, V77, P617; Moses V, 1999, BIOTECHNOL ADV, V17, P647, DOI 10.1016/S0734-9750(99)00023-3; Murtaugh MP, 2009, DEV COMP IMMUNOL, V33, P344, DOI 10.1016/j.dci.2008.06.014; Nemeth A, 2004, J AGR FOOD CHEM, V52, P6129, DOI 10.1021/jf049567f; NRC, 1998, NUTR REQ SWIN, DOI [10.17226/6016, DOI 10.17226/6016]; Paparini Andrea, 2004, Biotechnol Annu Rev, V10, P85, DOI 10.1016/S1387-2656(04)10004-5; Prescott VE, 2005, J AGR FOOD CHEM, V53, P9023, DOI 10.1021/jf050594v; Randhawa GJ, 2011, FOOD CHEM TOXICOL, V49, P356, DOI 10.1016/j.fct.2010.11.008; Reuter T, 2003, EUR FOOD RES TECHNOL, V216, P185, DOI 10.1007/s00217-002-0642-7; Reuter T, 2002, ARCH ANIM NUTR, V56, P319, DOI 10.1080/00039420215628; Rincon M, 1997, J EXP MED, V185, P461, DOI 10.1084/jem.185.3.461; Sanden M, 2006, AQUACULT NUTR, V12, P1, DOI 10.1111/j.1365-2095.2006.00367.x; Sanden M, 2005, J FISH DIS, V28, P317, DOI 10.1111/j.1365-2761.2005.00618.x; SAS Institute Inc, 2000, SAS US GUID; Schiavi E, 2010, ALLERGY; Schnepf E, 1998, MICROBIOL MOL BIOL R, V62, P775, DOI 10.1128/MMBR.62.3.775-806.1998; Schwarz A, 2004, J BIOL CHEM, V279, P5641, DOI 10.1074/jbc.M309317200; Sharma R, 2006, J AGR FOOD CHEM, V54, P1699, DOI 10.1021/jf052459o; Shimada N, 2006, J VET MED SCI, V68, P1113, DOI 10.1292/jvms.68.1113; Trabalza-Marinucci M, 2008, LIVEST SCI, V113, P178, DOI 10.1016/j.livsci.2007.03.009; Walsh MC, 2008, FEMS MICROBIOL ECOL, V64, P317, DOI 10.1111/j.1574-6941.2008.00454.x; Walsh MC, 2012, BRIT J NUTR, V107, P364, DOI 10.1017/S0007114511003011; Weber TE, 2001, J ANIM SCI, V79, P2542; Ye XD, 2000, SCIENCE, V287, P303, DOI 10.1126/science.287.5451.303; Yonemochi C, 2010, ANIM SCI J, V81, P94, DOI 10.1111/j.1740-0929.2009.00718.x	43	56	59	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e27177	10.1371/journal.pone.0027177	http://dx.doi.org/10.1371/journal.pone.0027177			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132091	gold, Green Submitted, Green Published			2022-12-27	WOS:000298162000012
J	Weaver, PG; Doguzhaeva, LA; Lawver, DR; Tacker, RC; Ciampaglio, CN; Crate, JM; Zheng, WX				Weaver, Patricia G.; Doguzhaeva, Larisa A.; Lawver, Daniel R.; Tacker, R. Christopher; Ciampaglio, Charles N.; Crate, Jon M.; Zheng, Wenxia			Characterization of Organics Consistent with beta-Chitin Preserved in the Late Eocene Cuttlefish Mississaepia mississippiensis	PLOS ONE			English	Article							ANTIGEN RETRIEVAL; BONE; CEPHALOPOD; JACKSON; MATRIX; FTIR	Background: Preservation of original organic components in fossils across geological time is controversial, but the potential such molecules have for elucidating evolutionary processes and phylogenetic relationships is invaluable. Chitin is one such molecule. Ancient chitin has been recovered from both terrestrial and marine arthropods, but prior to this study had not been recovered from fossil marine mollusks. Methodology/Principal Findings: Organics consistent with beta-chitin are recovered in cuttlebones of Mississaepia mississippiensis from the Late Eocene (34.36 million years ago) marine clays of Hinds County, Mississippi, USA. These organics were determined and characterized through comparisons with extant taxa using Scanning Electron Microscopy/Energy Dispersive Spectrometry (SEM/EDS), Field Emission Scanning Electron Microscopy (Hyperprobe), Fourier Transmission Infrared Spectroscopy (FTIR) and Immunohistochemistry (IHC). Conclusions/Significance: Our study presents the first evidence for organics consistent with chitin from an ancient marine mollusk and discusses how these organics have been degraded over time. As mechanisms for their preservation, we propose that the inorganic/organic lamination of the cuttlebone, combined with a suboxic depositional environment with available free Fe2+ ions, inhibited microbial or enzymatic degradation.	[Weaver, Patricia G.; Tacker, R. Christopher] N Carolina Museum Nat Sci, Raleigh, NC 27601 USA; [Doguzhaeva, Larisa A.] Swedish Museum Nat Hist, Dept Palaeozool, S-10405 Stockholm, Sweden; [Lawver, Daniel R.] Montana State Univ, Dept Earth Sci, Bozeman, MT 59717 USA; [Ciampaglio, Charles N.] Wright State Univ, Celina, OH USA; [Crate, Jon M.] FAI Mat Testing Lab Inc, Analyt Chem, Marietta, GA USA; [Zheng, Wenxia] N Carolina State Univ, Dept Marine Earth & Atmospher Sci, Raleigh, NC 27695 USA	Swedish Museum of Natural History; Montana State University System; Montana State University Bozeman; University System of Ohio; Wright State University Dayton; University of North Carolina; North Carolina State University	Weaver, PG (corresponding author), N Carolina Museum Nat Sci, Raleigh, NC 27601 USA.	trish.weaver@ncdenr.gov		Tacker, Robert/0000-0002-4442-1793	NSF [EAR-0929898]; Swedish Academy of Sciences; FAI Materials Testing Lab Inc.	NSF(National Science Foundation (NSF)); Swedish Academy of Sciences; FAI Materials Testing Lab Inc.	FTIR analysis in this study was supported by NSF grant EAR-0929898 to RT. LD received travel and subsisitence support from the Swedish Academy of Sciences and PW received travel support from the NC Museum of Natural Sciences and the NC Fossil Club. FAI Materials Testing Lab Inc. supported the study through the employment of JC, who contributed to all aspects of the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER HH, 1962, AM MINERAL, V47, P700; Avci R, 2005, LANGMUIR, V21, P3584, DOI 10.1021/la047682e; Balmain J, 1999, J BIOMED MATER RES, V48, P749, DOI 10.1002/(SICI)1097-4636(1999)48:5<749::AID-JBM22>3.0.CO;2-P; BUTTERFIELD NJ, 1990, PALEOBIOLOGY, V16, P272, DOI 10.1017/S0094837300009994; Cardenas G, 2004, J APPL POLYM SCI, V93, P1876, DOI 10.1002/app.20647; CHROST RJ, 1991, BROCK SPR S, P29; Cody GD, 2011, GEOLOGY, V39, P255, DOI 10.1130/G31648.1; Collins MJ, 2002, ARCHAEOMETRY, V44, P383, DOI 10.1111/1475-4754.t01-1-00071; Doguzhaeva Larisa A., 2007, Acta Universitatis Carolinae Geologica, V49, P83; ENGLINTON G, 1991, PHILOS T R SOC LON B, V333, P315; Florek M, 2009, MAT SCI ENG C-BIO S, V29, P1220, DOI 10.1016/j.msec.2008.09.040; Fluegeman RH, 2009, GEOL SOC AM SPEC PAP, V452, P261, DOI 10.1130/2009.2452(17); GILLILAND WA, 1980, MISSISSIPPI DEP NATU, V121; Gooday GW, 1990, BIODEGRADATION, V1, P177, DOI 10.1007/BF00058835; Hedges REM, 2002, ARCHAEOMETRY, V44, P319, DOI 10.1111/1475-4754.00064; Kumirska J, 2010, MAR DRUGS, V8, P1567, DOI 10.3390/md8051567; Majtan J, 2007, INT J BIOL MACROMOL, V40, P237, DOI 10.1016/j.ijbiomac.2006.07.010; MAPES RH, 1987, J PALEONTOL, V61, P521, DOI 10.1017/S0022336000028687; MARTILL DM, 1994, KAUPIA, V2, P71; Martin R, 2007, BIOL BULL-US, V213, P307, DOI 10.2307/25066648; May J. H., 1974, MISSISSIPPI GEOLOGIC, V117; McNicol AM, 1998, HISTOPATHOLOGY, V32, P97; MILLER RF, 1991, BIOCHEM SYST ECOL, V19, P401, DOI 10.1016/0305-1978(91)90057-7; MOORE WH, 1965, MISSISSIPPI GEOLOGIC, V105; MUZZARELLI RA, 1969, TALANTA, V16, P1571, DOI 10.1016/0039-9140(69)80218-3; Muzzarelli RAA, 1999, EXS, V87, P1; Nudelman F, 2006, J STRUCT BIOL, V153, P176, DOI 10.1016/j.jsb.2005.09.009; Oehler Dorothy Z., 2009, V12, P3; Petrovich R, 2001, AM J SCI, V301, P683, DOI 10.2475/ajs.301.8.683; Ramos-Vara JA, 2005, VET PATHOL, V42, P405, DOI 10.1354/vp.42-4-405; Ratajska M, 1998, REACT FUNCT POLYM, V38, P35, DOI 10.1016/S1381-5148(98)00031-5; Schmidt-Schultz TH, 2004, AM J PHYS ANTHROPOL, V123, P30, DOI 10.1002/ajpa.10308; Schweitzer MH, 2009, SCIENCE, V324, P626, DOI 10.1126/science.1165069; Stankiewicz BA, 1997, SCIENCE, V276, P1541, DOI 10.1126/science.276.5318.1541; TEW B.H., 1992, GEOL SURV ALA BULL, V146, P1; TEW BH, 1995, PALAIOS, V10, P133, DOI 10.2307/3515179; TULCHINSKY VM, 1976, CARBOHYD RES, V51, P1, DOI 10.1016/S0008-6215(00)84031-8; Weaver PG, 2010, PALAEONTOGR ABT A, V292, P53; Werner M, 1996, HISTOCHEM CELL BIOL, V105, P253, DOI 10.1007/BF01463928	39	21	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e28195	10.1371/journal.pone.0028195	http://dx.doi.org/10.1371/journal.pone.0028195			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132239	Green Submitted, Green Published, gold			2022-12-27	WOS:000298162000086
J	Fatakia, SN; Costanzi, S; Chow, CC				Fatakia, Sarosh N.; Costanzi, Stefano; Chow, Carson C.			Molecular Evolution of the Transmembrane Domains of G Protein-Coupled Receptors	PLOS ONE			English	Article							ADAPTIVE EVOLUTION; PHYLOGENETIC ANALYSIS; FUNCTIONAL EVOLUTION; GENE; RHODOPSIN; CRYSTAL; MODELS; REPERTOIRE; SELECTION; MATRICES	G protein-coupled receptors (GPCRs) are a superfamily of integral membrane proteins vital for signaling and are important targets for pharmaceutical intervention in humans. Previously, we identified a group of ten amino acid positions (called key positions), within the seven transmembrane domain (7TM) interhelical region, which had high mutual information with each other and many other positions in the 7TM. Here, we estimated the evolutionary selection pressure at those key positions. We found that the key positions of receptors for small molecule natural ligands were under strong negative selection. Receptors naturally activated by lipids had weaker negative selection in general when compared to small molecule-activated receptors. Selection pressure varied widely in peptide-activated receptors. We used this observation to predict that a subgroup of orphan GPCRs not under strong selection may not possess a natural small-molecule ligand. In the subgroup of MRGX1-type GPCRs, we identified a key position, along with two non-key positions, under statistically significant positive selection.	[Fatakia, Sarosh N.; Costanzi, Stefano; Chow, Carson C.] NIDDK, Lab Biol Modeling, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Fatakia, SN (corresponding author), NIDDK, Lab Biol Modeling, NIH, Bethesda, MD USA.	carsonc@mail.nih.gov	Costanzi, Stefano/G-8990-2013; Chow, Carson C/A-7970-2009	Costanzi, Stefano/0000-0003-3183-7332; Fatakia, Sarosh/0000-0003-0430-3191	National Institutes of Health (NIH)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK013026, ZIADK013025] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by the Intramural Research Program of the National Institutes of Health (NIH)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres AM, 2007, MOL BIOL EVOL, V24, P2707, DOI 10.1093/molbev/msm202; Anisimova M, 2007, HEREDITY, V99, P567, DOI 10.1038/sj.hdy.6801052; [Anonymous], NCBI NUCL DAT; [Anonymous], 2010, NCBI PROT DAT; Archer E, 2003, TRENDS PHARMACOL SCI, V24, P36, DOI 10.1016/S0165-6147(02)00009-3; Ault AD, 2006, PROTEIN ENG DES SEL, V19, P1, DOI 10.1093/protein/gzi069; Bairoch A, 2009, NUCLEIC ACIDS RES, V37, pD169, DOI 10.1093/nar/gkn664; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Choi SS, 2003, GENOME RES, V13, P2252, DOI 10.1101/gr.1431603; Choi SS, 2006, MOL BIOL EVOL, V23, P2131, DOI 10.1093/molbev/msl086; Fatakia SN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004681; FATAKIA SN, 2011, RECENT ADV BIOSTATIS; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Foord SM, 2005, PHARMACOL REV, V57, P279, DOI 10.1124/pr.57.2.5; Fredriksson R, 2005, ANN NY ACAD SCI, V1040, P89, DOI 10.1196/annals.1327.011; Fredriksson R, 2005, MOL PHARMACOL, V67, P1414, DOI 10.1124/mol.104.009001; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Gibbons A, 2010, SCIENCE, V329, P740, DOI 10.1126/science.329.5993.740; Gloriam DE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-338; Gloriam DEI, 2005, ANN NY ACAD SCI, V1040, P323, DOI 10.1196/annals.1327.052; GONG S, 2009, BIOCH SOC T ENGLAND, P727; Harmar AJ, 2009, NUCLEIC ACIDS RES, V37, pD680, DOI 10.1093/nar/gkn728; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Hurst LD, 2002, TRENDS GENET, V18, P486, DOI 10.1016/S0168-9525(02)02722-1; Huzurbazar S, 2010, J MOL BIOL, V396, P1410, DOI 10.1016/j.jmb.2009.11.075; *IUPHAR, IUPHAR 7TM REC DAT; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Karlin S, 1996, J BACTERIOL, V178, P1881, DOI 10.1128/jb.178.7.1881-1894.1996; Koonin EV, 2010, NAT REV GENET, V11, P487, DOI 10.1038/nrg2810; Kosiol C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000144; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; Liu Q, 2009, CELL, V139, P1353, DOI 10.1016/j.cell.2009.11.034; Mundy NI, 2003, AM J PHYS ANTHROPOL, V121, P67, DOI 10.1002/ajpa.10169; *NBCI, NBCI GEN DAT; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nei M., 1987, MOL EVOLUTIONARY GEN; NEI M, 1983, GENETIC POLYMORPHISM; Nei M., 1975, MOL POPULATION GENET; Nekrutenko A, 2002, GENOME RES, V12, P198, DOI 10.1101/gr.200901; Ohno S., 1970, EVOLUTION GENE DUPLI; Pal C, 2003, NATURE, V421, P496, DOI 10.1038/421496b; Pal C, 2001, GENETICS, V158, P927; Pal C, 2001, MOL BIOL EVOL, V18, P2323, DOI 10.1093/oxfordjournals.molbev.a003779; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Peirson SN, 2009, PHILOS T R SOC B, V364, P2849, DOI 10.1098/rstb.2009.0050; Perez DM, 2005, MOL PHARMACOL, V67, P1383, DOI 10.1124/mol.105.011890; Perez DM, 2003, MOL PHARMACOL, V63, P1202, DOI 10.1124/mol.63.6.1202; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Plakidou-Dymock S, 1998, CURR BIOL, V8, P315, DOI 10.1016/S0960-9822(98)70131-9; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Rodriguez GJ, 2010, P NATL ACAD SCI USA, V107, P7787, DOI 10.1073/pnas.0914877107; Rompler H, 2007, MOL INTERV, V7, P17, DOI 10.1124/mi.7.1.5; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schoneberg T, 2007, PURINERG SIGNAL, V3, P255, DOI 10.1007/s11302-007-9064-0; Schoneberg T, 2007, TRENDS PHARMACOL SCI, V28, P117, DOI 10.1016/j.tips.2007.01.001; Schulz A, 2003, J BIOL CHEM, V278, P35531, DOI 10.1074/jbc.M303346200; Staubert C, 2007, ENDOCRINOLOGY, V148, P4642, DOI 10.1210/en.2007-0138; Staubert C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011133; Strotmann R, 2011, MOL CELL ENDOCRINOL, V331, P170, DOI 10.1016/j.mce.2010.07.012; Surgand JS, 2006, PROTEINS, V62, P509, DOI 10.1002/prot.20768; Takeda S, 2002, FEBS LETT, V520, P97, DOI 10.1016/S0014-5793(02)02775-8; TATUSOVA T, NCBI OPEN READEING F; Valdar WSJ, 2002, PROTEINS, V48, P227, DOI 10.1002/prot.10146; Vallender EJ, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-51; Worth CL, 2009, NAT REV MOL CELL BIO, V10, P709, DOI 10.1038/nrm2762; Yang S, 2005, GENE, V352, P30, DOI 10.1016/j.gene.2005.03.001; Yang ZH, 2002, MOL BIOL EVOL, V19, P49, DOI 10.1093/oxfordjournals.molbev.a003981; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; YOKOYAMA S, 1989, MOL BIOL EVOL, V6, P186	70	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2011	6	11							e27813	10.1371/journal.pone.0027813	http://dx.doi.org/10.1371/journal.pone.0027813			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IO	22132149	Green Submitted, Green Published, gold			2022-12-27	WOS:000297789900024
J	Kim, GL; Wang, XM; Chalmers, JA; Thompson, DR; Dhillon, SS; Koletar, MM; Belsham, DD				Kim, Ginah L.; Wang, Xiaomei; Chalmers, Jennifer A.; Thompson, David R.; Dhillon, Sandeep S.; Koletar, Margaret M.; Belsham, Denise D.			Generation of Immortal Cell Lines from the Adult Pituitary: Role of cAMP on Differentiation of SOX2-Expressing Progenitor Cells to Mature Gonadotropes	PLOS ONE			English	Article							COLONY-FORMING CELLS; NEURONAL DIFFERENTIATION; RAT PITUITARY; STEM-CELLS; MURINE PITUITARY; TRANSGENIC MICE; GNRH RECEPTOR; TUMOR CELLS; HORMONE; POPULATION	The pituitary is a complex endocrine tissue composed of a number of unique cell types distinguished by the expression and secretion of specific hormones, which in turn control critical components of overall physiology. The basic function of these cells is understood; however, the molecular events involved in their hormonal regulation are not yet fully defined. While previously established cell lines have provided much insight into these regulatory mechanisms, the availability of representative cell lines from each cell lineage is limited, and currently none are derived from adult pituitary. We have therefore used retroviral transfer of SV40 T-antigen to mass immortalize primary pituitary cell culture from an adult mouse. We have generated 19 mixed cell cultures that contain cells from pituitary cell lineages, as determined by RT-PCR analysis and immunocytochemistry for specific hormones. Some lines expressed markers associated with multipotent adult progenitor cells or transit-amplifying cells, including SOX2, nestin, S100, and SOX9. The progenitor lines were exposed to an adenylate cyclase activator, forskolin, over 7 days and were induced to differentiate to a more mature gonadotrope cell, expressing significant levels of a-subunit, LH beta, and FSH beta mRNAs. Additionally, clonal populations of differentiated gonadotropes were exposed to 30 nM gonadotropin-releasing hormone and responded appropriately with a significant increase in alpha-subunit and LH beta transcription. Further, exposure of the lines to a pulse paradigm of GnRH, in combination with 17 beta-estradiol and dexamethasone, significantly increased GnRH receptor mRNA levels. This array of adult-derived pituitary cell models will be valuable for both studies of progenitor cell characteristics and modulation, and the molecular analysis of individual pituitary cell lineages.	[Kim, Ginah L.; Wang, Xiaomei; Chalmers, Jennifer A.; Thompson, David R.; Dhillon, Sandeep S.; Koletar, Margaret M.; Belsham, Denise D.] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Belsham, Denise D.] Univ Toronto, Dept Obstet & Gynaecol, Toronto, ON, Canada; [Belsham, Denise D.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Belsham, Denise D.] Toronto Gen Hosp, Div Cellular & Mol Biol, Res Inst, Univ Hlth Network, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	Kim, GL (corresponding author), Univ Toronto, Dept Physiol, Toronto, ON, Canada.	d.belsham@utoronto.ca			Canadian Institutes for Health Research; Natural Sciences and Engineering Research Council; Canada Foundation for Innovation; Canada Research Chairs Program; OGS	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Canada Research Chairs Program(Canada Research Chairs); OGS(Ontario Graduate Scholarship)	The authors acknowledge funding from Canadian Institutes for Health Research, Natural Sciences and Engineering Research Council, Canada Foundation for Innovation, and the Canada Research Chairs Program to DDB. GLK was supported by OGS and NSERC post graduate studentships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarid ET, 1996, DEVELOPMENT, V122, P3319; BELCHETZ PE, 1978, SCIENCE, V202, P631, DOI 10.1126/science.100883; Belsham DD, 2004, ENDOCRINOLOGY, V145, P393, DOI 10.1210/en.2003-0946; BELSHAM DD, 2009, FASEB J; BUONASSISI V, 1962, P NATL ACAD SCI USA, V48, P1184, DOI 10.1073/pnas.48.7.1184; Chen JH, 2005, ENDOCRINOLOGY, V146, P3985, DOI 10.1210/en.2005-0185; Chen JH, 2009, STEM CELLS, V27, P1182, DOI 10.1002/stem.51; COWANSAGE KK, 2009, CURR MOL PHARM; DHILLON SS, 2010, OPEN NEUROENDOCRIN J, V3, P6; Drouin J, 2007, CLIN GENET, V72, P175, DOI 10.1111/j.1399-0004.2007.00877.x; Drouin J, 2006, FRONT HORM RES, V35, P74, DOI 10.1159/000094310; Fauquier T, 2008, P NATL ACAD SCI USA, V105, P2907, DOI 10.1073/pnas.0707886105; FURTH J, 1953, P SOC EXP BIOL MED, V84, P253; Garcia-Lavandeira M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004815; GHARIB SD, 1990, ENDOCR REV, V11, P177, DOI 10.1210/edrv-11-1-177; Gleiberman AS, 2008, P NATL ACAD SCI USA, V105, P6332, DOI 10.1073/pnas.0801644105; Hapgood JP, 2005, J NEUROENDOCRINOL, V17, P619, DOI 10.1111/j.1365-2826.2005.01353.x; HOWARD MK, 1993, J NEUROCHEM, V60, P1783, DOI 10.1111/j.1471-4159.1993.tb13404.x; Hsieh J, 2004, P NATL ACAD SCI USA, V101, P16659, DOI 10.1073/pnas.0407643101; Jacobson A, 1996, ANNU REV BIOCHEM, V65, P693, DOI 10.1146/annurev.bi.65.070196.003401; JUDD AM, 1988, ENDOCRINOLOGY, V123, P2341, DOI 10.1210/endo-123-5-2341; Kaiser UB, 1997, ENDOCRINOLOGY, V138, P1224, DOI 10.1210/en.138.3.1224; Krylyshkina O, 2005, ENDOCRINOLOGY, V146, P2376, DOI 10.1210/en.2004-1209; Lepore DA, 2005, EXP CELL RES, V308, P166, DOI 10.1016/j.yexcr.2005.04.023; Lepore DA, 2007, STEM CELLS, V25, P1730, DOI 10.1634/stemcells.2007-0012; Lepore DA, 2006, STEM CELLS, V24, P2382, DOI 10.1634/stemcells.2006-0085; Mayer CM, 2009, FRONT NEUROENDOCRIN, V30, P405, DOI 10.1016/j.yfrne.2009.03.005; Monaghan TK, 2008, J NEUROCHEM, V104, P74, DOI 10.1111/j.1471-4159.2007.05018.x; Obayashi S, 2009, CELL MOL NEUROBIOL, V29, P423, DOI 10.1007/s10571-008-9338-2; Oh JE, 2007, ELECTROPHORESIS, V28, P2009, DOI 10.1002/elps.200600833; Ooi GT, 2004, MOL CELL ENDOCRINOL, V228, P1, DOI 10.1016/j.mce.2004.07.018; Palmer TD, 1997, MOL CELL NEUROSCI, V8, P389, DOI 10.1006/mcne.1996.0595; Pernasetti F, 2001, ENDOCRINOLOGY, V142, P2284, DOI 10.1210/en.142.6.2284; Ravni A, 2008, MOL PHARMACOL, V73, P1688, DOI 10.1124/mol.107.044792; REYMOND MJ, 1984, ACTA ENDOCRINOL-COP, V106, P459, DOI 10.1530/acta.0.1060459; RIDGWAY EC, 1983, ENDOCRINOLOGY, V113, P1587, DOI 10.1210/endo-113-5-1587; Shi GX, 2008, MOL CELL BIOL, V28, P4940, DOI 10.1128/MCB.02193-07; Skaper SD, 2008, CNS NEUROL DISORD-DR, V7, P46, DOI 10.2174/187152708783885174; Suh H, 2009, ANNU REV CELL DEV BI, V25, P253, DOI 10.1146/annurev.cellbio.042308.113256; TASHJIAN AH, 1970, J CELL BIOL, V47, P61, DOI 10.1083/jcb.47.1.61; Thomas P, 1996, ENDOCRINOLOGY, V137, P2979, DOI 10.1210/en.137.7.2979; Tremblay RG, 2010, J NEUROSCI METH, V186, P60, DOI 10.1016/j.jneumeth.2009.11.004; Turgeon JL, 1996, MOL ENDOCRINOL, V10, P439, DOI 10.1210/me.10.4.439; VANKELECOM H, 2009, GEN COMP ENDOCRINOL; Vankelecom H, 2007, NEUROENDOCRINOLOGY, V85, P110, DOI 10.1159/000100278; WEISS J, 1990, MOL ENDOCRINOL, V4, P557, DOI 10.1210/mend-4-4-557; Weiss S, 2009, CLIN NEUROPATHOL, V28, P309; WINDLE JJ, 1990, MOL ENDOCRINOL, V4, P597, DOI 10.1210/mend-4-4-597; Zahir T, 2009, STEM CELLS DEV, V18, P1423, DOI 10.1089/scd.2008.0412	49	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2011	6	11							e27799	10.1371/journal.pone.0027799	http://dx.doi.org/10.1371/journal.pone.0027799			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IO	22132145	Green Submitted, gold, Green Published			2022-12-27	WOS:000297789900021
J	Urushihara, H; Doi, Y; Arai, M; Matsunaga, T; Fujii, Y; Iino, N; Kawamura, T; Kawakami, K				Urushihara, Hisashi; Doi, Yuko; Arai, Masaru; Matsunaga, Toshiyuki; Fujii, Yosuke; Iino, Naoko; Kawamura, Takashi; Kawakami, Koji			Oseltamivir Prescription and Regulatory Actions Vis-a-Vis Abnormal Behavior Risk in Japan: Drug Utilization Study Using a Nationwide Pharmacy Database	PLOS ONE			English	Article							NEUROPSYCHIATRIC ADVERSE EVENTS; INFLUENZA; MEDICATIONS	Background: In March 2007, a regulatory advisory was issued in Japan to restrict oseltamivir use in children aged 10-19 years because of safety concerns over abnormal behavior. The effectiveness and validity of regulatory risk minimization actions remain to be reviewed, despite their significant public health implications. To assess the impact of the regulatory actions on prescribing practices and safety reporting. Methodoloy/Prinicpal Findings: In this retrospective review of a nationwide pharmacy database, we analyzed 100,344 dispensation records for oseltamivir and zanamivir for the period from November 2006 to March 2009. The time trend in dispensations for these antiviral agents was presented before and after the regulatory actions, contrasted with intensity of media coverage and the numbers of spontaneous adverse reaction reports with regard to antivirals. The 2007 regulatory actions, together with its intense media coverage, reduced oseltamivir dispensation in targeted patients in fiscal year 2008 to 20.4% of that in fiscal year 2006, although influenza activities were comparable between these fiscal years. In contrast, zanamivir dispensation increased approximately nine-fold across all age groups. The number of abnormal behavior reports associated with oseltamivir in children aged 10-19 years decreased from fiscal year 2006 to 2008 (24 to 9 cases); this decline was offset by the increased number of reports of abnormal behavior in children under age 10 (12 to 28 cases). The number of reports associated with zanamivir increased in proportion to increased dispensation of this drug (11 to 114 cases). Conclusions/Significance: The 2007 actions effectively reduced oseltamivir prescriptions and the number of reports of abnormal behavior in the targeted group. The observed increase in abnormal behavior reports in oseltamivir patients under age 10 and in zanamivir patients suggests that these patient groups may also be at risk, calling into question the validity of the current discrimination by age and agent (Abstract translation is available in Japanese: Appendix S1).	[Urushihara, Hisashi; Kawakami, Koji] Kyoto Univ, Grad Sch Med & Publ Hlth, Dept Pharmacoepidemiol, Kyoto, Japan; [Doi, Yuko; Fujii, Yosuke] Ain Pharmaciez Inc, Tokyo, Japan; [Arai, Masaru; Matsunaga, Toshiyuki] Kraft Inc, Tokyo, Japan; [Iino, Naoko] Res Inst Natl Ctr Global Hlth & Med, Dept Clin Res & Informat, Tokyo, Japan; [Kawamura, Takashi] Kyoto Univ, Grad Sch Med & Publ Hlth, Dept Prevent Serv, Kyoto, Japan	Kyoto University; Kraft Heinz; Kyoto University	Urushihara, H (corresponding author), Kyoto Univ, Grad Sch Med & Publ Hlth, Dept Pharmacoepidemiol, Kyoto, Japan.	kawakami.koji.4e@kyoto-u.ac.jp	Kawakami, Koji/GZA-6582-2022	Kawakami, Koji/0000-0002-7477-4071; Urushihara, Hisashi/0000-0001-6913-9930	Ministry of Education, Culture, Sports, Science and Technology; Ministry of Health Labor and Welfare for Medicines; Medical Devices Regulatory Science Multidisciplinary Research Project [H21-Iyaku-Ippan-020]	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health Labor and Welfare for Medicines; Medical Devices Regulatory Science Multidisciplinary Research Project	HU was supported by the Special Coordination Funds for Promoting Science and Technology from the Ministry of Education, Culture, Sports, Science and Technology, and by a grant from the Ministry of Health Labor and Welfare for Medicines and Medical Devices Regulatory Science Multidisciplinary Research Project (Grant Number H21-Iyaku-Ippan-020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, MED DICT REG ACT; Blumentals William A, 2007, MedGenMed, V9, P23; Center for Drug Evaluation and Research, 2005, PED SAF UPD TAM PED; Chugai Pharmaceutical Co. Ltd., 2010, TAM PACK INS; Chugai Pharmaceutical Co Ltd., 2009, 15 CHUG PHARM CO LTD; Fujita T, 2011, JPN J PHARMACOEPIDEM, V15, P73; G-Search Limited, 2010, G SEARCH DAT; GlaxoSmithKline KK, 2009, REL PACK INS; Infectious Disease Surveillance Center, 2010, SENT SURV; Jefferson T, 2006, LANCET, V367, P303, DOI 10.1016/S0140-6736(06)67970-1; Jefferson T, 2009, LANCET, V374, P1312, DOI 10.1016/S0140-6736(09)61804-3; Matheson NJ, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002744.pub2; Medicines and Healthcare Products Regulatory Agency, 2010, SUSP ADV DRUG REACT; Moore N, 2003, PHARMACOEPIDEM DR S, V12, P271, DOI 10.1002/pds.848; MORGENSTERN H, 1998, MODERN EPIDEMIOLOGY; Morishima T, 2002, CLIN INFECT DIS, V35, P512, DOI 10.1086/341407; Nakamura K, 2010, CLIN INFECT DIS, V50, pE47, DOI 10.1086/651166; National Statistics Center, 2008, PAT SURV PORT SIT OF; Nikkei Medical, 2010, VAL CLIN FEAT INH ZA; Pariente A, 2007, DRUG SAFETY, V30, P891, DOI 10.2165/00002018-200730100-00007; Pharmaceuticals and Medical Devices Agency, 2007, REG ABN BEH TAM INT; Pharmaceuticals and Medical Devices Agency, 2010, INF SERV WEBS PHARM; Reaserch Division Health Insurance Bureau, 2010, TRENDS PRESCR HEALTH; Satoh K, 2007, BIOL PHARM BULL, V30, P1816, DOI 10.1248/bpb.30.1816; Smith JR, 2009, INT J CLIN PRACT, V63, P596, DOI 10.1111/j.1742-1241.2009.02010.x; Subcommittee on Safety Measurement Committee of Safety of Drugs the Pharmaceutical Affairs and Food Sanitation Council, 2009, MIN 1 FISC 2009 SUBC; The Federation of Pharmaceutical Manufacturers' Associations of Japan, 2008, DRUG SAF UPD 166; The Federation of Pharmaceutical Manufacturers' Associations of Japan, 2004, DRUG SAF UPD 129; Toovey S, 2008, DRUG SAFETY, V31, P1097, DOI 10.2165/0002018-200831120-00006; Weatherby LB, 2001, PHARMACOEPIDEM DR S, V10, P211, DOI 10.1002/pds.592; Whitley RJ, 2001, PEDIATR INFECT DIS J, V20, P127, DOI 10.1097/00006454-200102000-00002; Yokota S, 2006, RES REPORT RES GROUP; Yorifuji T, 2009, EPIDEMIOLOGY, V20, P619, DOI 10.1097/EDE.0b013e3181a3d3f6; Yoshida M, 2009, JPN J INFECT DIS, V62, P233	34	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2011	6	12							e28483	10.1371/journal.pone.0028483	http://dx.doi.org/10.1371/journal.pone.0028483			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863OC	22163021	Green Published, gold, Green Submitted			2022-12-27	WOS:000298173500024
J	Cheung, CYY; Tso, AWK; Cheung, BMY; Xu, AM; Fong, CHY; Ong, KL; Law, LSC; Wat, NMS; Janus, ED; Sham, PC; Lam, KSL				Cheung, Chloe Y. Y.; Tso, Annette W. K.; Cheung, Bernard M. Y.; Xu, Aimin; Fong, Carol H. Y.; Ong, K. L.; Law, Lawrence S. C.; Wat, Nelson M. S.; Janus, Edward D.; Sham, Pak C.; Lam, Karen S. L.			The KCNJ11 E23K Polymorphism and Progression of Glycaemia in Southern Chinese: A Long-Term Prospective Study	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; LARGE-SCALE ASSOCIATION; DIABETES-MELLITUS; INSULIN-RESISTANCE; KIR6.2 KCNJ11; SUR1 ABCC8; TYPE-2; POPULATION; RISK; GENE	Context: The KCNJ11 E23K variant is associated with type 2 diabetes mellitus (T2DM) in cross-sectional studies, but conflicting findings have been reported from prospective studies. Objective: This study aimed to evaluate whether the E23K variant could predict glycaemic progression in a Southern Chinese population. Methods/Principal Findings: We performed a long-term prospective study on 1912 subjects from the Hong Kong Cardiovascular Risk Factors Prevalence Study (CRISPS). The KCNJ11 E23K variant was associated with the progression to prediabetes after a median interval of 12 years on multinomial logistic regression analysis, even after adjustment for traditional risk factors (OR 1.29, P(age, sex, BMI and fasting plasma glucose [ FPG] adjusted) = 0.02). Based on Cox proportional hazard regression analysis, the E23K variant also predicted incident prediabetes (HR 1.18, P(age, sex, BMI and FPG adjusted) = 0.021). However, E23K was not associated with the progression to T2DM in either multinomial or Cox regression analysis, and the association of E23K with glycaemic progression to either prediabetes or T2DM was significant only in unadjusted Cox regression analysis (P = 0.039). In a meta-analysis of eight prospective studies including our own, involving 15680 subjects, the E23K variant was associated with incident T2DM (fixed effect: OR 1.10, P = 4 x 10(-3); random effect: OR 1.11, P = 0.035). Conclusions: Our study has provided supporting evidence for the role of the E23K variant in glycaemic progression in Chinese, with its effect being more evident in the early stage of T2DM, as the subjects progressed from normal glucose tolerance to prediabetes.	[Cheung, Chloe Y. Y.; Tso, Annette W. K.; Cheung, Bernard M. Y.; Xu, Aimin; Fong, Carol H. Y.; Ong, K. L.; Law, Lawrence S. C.; Wat, Nelson M. S.; Lam, Karen S. L.] Univ Hong Kong, Li Ka Shing Fac Med, Dept Med, Pokfulam, Hong Kong, Peoples R China; [Sham, Pak C.] Univ Hong Kong, Li Ka Shing Fac Med, Dept Psychiat, Pokfulam, Hong Kong, Peoples R China; [Tso, Annette W. K.; Xu, Aimin; Lam, Karen S. L.] Univ Hong Kong, Li Ka Shing Fac Med, Res Ctr Heart Brain Hormone & Healthy Aging, Pokfulam, Hong Kong, Peoples R China; [Janus, Edward D.] Univ Melbourne, Western Hosp, Dept Med, Footscray, Vic, Australia; [Sham, Pak C.] Univ Hong Kong, Li Ka Shing Fac Med, Genome Res Ctr, Pokfulam, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Melbourne; Western Hospital; University of Hong Kong	Cheung, CYY (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Med, Pokfulam, Hong Kong, Peoples R China.	pcsham@hku.hk; ksllam@hku.hk	Janus, Edward/AAU-8652-2020; Xu, Aimin/D-3291-2013; Ong, Kwok Leung/B-9018-2009; /E-9829-2010	Xu, Aimin/0000-0002-0668-033X; Ong, Kwok Leung/0000-0001-7229-7614; /0000-0001-9106-7363; Cheung, Chloe Yu Yan/0000-0002-7884-5295; Law, Lawrence Siu-Chun/0000-0002-0429-2632	University of Hong Kong	University of Hong Kong(University of Hong Kong)	This study was financially supported by the CRCG seeding fund for basic research from the University of Hong Kong to Karen SL Lam. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Bennett K, 2010, REV ENDOCR METAB DIS, V11, P157, DOI 10.1007/s11154-010-9144-2; Chauhan G, 2010, DIABETES, V59, P2068, DOI 10.2337/db09-1386; Cheung BMY, 2007, DIABETES CARE, V30, P1430, DOI 10.2337/dc06-1820; Chistiakov DA, 2009, ACTA DIABETOL, V46, P43, DOI 10.1007/s00592-008-0056-5; Doi Y, 2007, DIABETES, V56, P2829, DOI 10.2337/db06-1709; Fischer A, 2008, DIABETES CARE, V31, P87, DOI 10.2337/dc07-1157; Florez JC, 2007, DIABETES, V56, P531, DOI 10.2337/db06-0966; Gloyn AL, 2003, DIABETES, V52, P568, DOI 10.2337/diabetes.52.2.568; Hani EH, 1998, DIABETOLOGIA, V41, P1511, DOI 10.1007/s001250051098; Hu C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007643; Janus ED, 1997, CLIN EXP PHARMACOL P, V24, P987, DOI 10.1111/j.1440-1681.1997.tb02736.x; Koo BK, 2007, DIABETIC MED, V24, P178, DOI 10.1111/j.1464-5491.2006.02050.x; Laukkanen O, 2004, J CLIN ENDOCR METAB, V89, P6286, DOI 10.1210/jc.2004-1204; Lyssenko V, 2005, PLOS MED, V2, P1299, DOI 10.1371/journal.pmed.0020345; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Qi L, 2007, DIABETIC MED, V24, P1187, DOI 10.1111/j.1464-5491.2007.02255.x; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Schwanstecher C, 2002, DIABETES, V51, P875, DOI 10.2337/diabetes.51.3.875; van Hoek M, 2008, DIABETES, V57, P3122, DOI 10.2337/db08-0425; Vaxillaire M, 2008, DIABETES, V57, P244, DOI 10.2337/db07-0615; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Weyer C, 1999, J CLIN INVEST, V104, P787, DOI 10.1172/JCI7231; Xu M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014022; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; Zhou DZ, 2009, J HUM GENET, V54, P433, DOI 10.1038/jhg.2009.54	26	8	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e28598	10.1371/journal.pone.0028598	http://dx.doi.org/10.1371/journal.pone.0028598			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22163043	Green Published, gold			2022-12-27	WOS:000298172800053
J	Chien, S; Ono, F; Watanabe, K				Chien, Sung-en; Ono, Fuminori; Watanabe, Katsumi			Mislocalization of Visual Stimuli: Independent Effects of Static and Dynamic Attention	PLOS ONE			English	Article							SPACE; COMPRESSION; POSITION; SHIFTS; MEMORY	Shifts of visual attention cause systematic distortions of the perceived locations of visual objects around the focus of attention. In the attention repulsion effect, the perceived location of a visual target is shifted away from an attention-attracting cue when the cue is presented before the target. Recently it has been found that, if the visual cue is presented after the target, the perceived location of the target shifts toward the location of the following cue. One unanswered question is whether a single mechanism underlies both attentional repulsion and attraction effects. We presented participants with two disks at diagonal locations as visual cues and two vertical lines as targets. Participants were asked to perform a forced-choice task to judge targets' positions. The present study examined whether the magnitude of the repulsion effect and the attraction effect would differ (Experiment 1), whether the two effects would interact (Experiment 2), and whether the location or the dynamic shift of attentional focus would determine the distortions effects (Experiment 3). The results showed that the effect size of the attraction effect was slightly larger than the repulsion effect and the preceding and following cues have independent influences on the perceived positions. The repulsion effect was caused by the location of attnetion and the attraction effect was due to the dynamic shift of attentional focus, suggesting that the underlying mechanisms for the retrospective attraction effect might be different from those for the repulsion effect.	[Chien, Sung-en; Ono, Fuminori; Watanabe, Katsumi] Univ Tokyo, Res Ctr Adv Sci & Technol Cognit Sci, Tokyo, Japan; [Watanabe, Katsumi] Japan Sci & Technol Agcy, Saitama, Japan	University of Tokyo; Japan Science & Technology Agency (JST)	Chien, S (corresponding author), Univ Tokyo, Res Ctr Adv Sci & Technol Cognit Sci, Tokyo, Japan.	chiensungen@gmail.com		Watanabe, Katsumi/0000-0003-1282-9994	Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science and Technology [21730587, 21300301]	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported by the Japan Science and Technology Agency and the Ministry of Education, Culture, Sports, Science and Technology's Grants-in-Aid for Scientific Research (21730587, 21300301). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnott SR, 2006, VISION RES, V46, P1553, DOI 10.1016/j.visres.2005.11.020; Eagleman DM, 2007, J VISION, V7, DOI 10.1167/7.4.3; Hamker FH, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040031; He S, 1996, NATURE, V383, P334, DOI 10.1038/383334a0; Hubbard TL, 2000, PSYCHOL RES-PSYCH FO, V64, P41, DOI 10.1007/s004260000029; Kerzel D, 2002, VISION RES, V42, P159, DOI 10.1016/S0042-6989(01)00274-7; Kosovicheva AA, 2010, J VISION, V10, DOI 10.1167/10.12.33; Ono F, 2011, PSYCHOL SCI, V22, P472, DOI 10.1177/0956797611403319; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Pratt J, 2008, ACTA PSYCHOL, V127, P137, DOI 10.1016/j.actpsy.2007.03.003; Ross J, 1997, NATURE, V386, P598, DOI 10.1038/386598a0; Sheth BR, 2001, VISION RES, V41, P329, DOI 10.1016/S0042-6989(00)00230-3; Shim WM, 2004, VISION RES, V44, P2393, DOI 10.1016/j.visres.2004.05.003; Suzuki S, 1997, J EXP PSYCHOL HUMAN, V23, P443, DOI 10.1037/0096-1523.23.2.443; Womelsdorf T, 2006, NAT NEUROSCI, V9, P1156, DOI 10.1038/nn1748; Yamada Y, 2008, PSYCHOL RES-PSYCH FO, V72, P273, DOI 10.1007/s00426-007-0109-3; Yamada Y, 2011, J VISION, V11, DOI 10.1167/11.6.6; Yeshurun Y, 1998, NATURE, V396, P72, DOI 10.1038/23936; Zirnsak M, 2010, VISION RES, V50, P1328, DOI 10.1016/j.visres.2010.02.002	19	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e28371	10.1371/journal.pone.0028371	http://dx.doi.org/10.1371/journal.pone.0028371			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22163009	Green Submitted, Green Published, gold			2022-12-27	WOS:000298172800031
J	Lee, M; Choy, WC; Abid, MR				Lee, Monica; Choy, Wing C.; Abid, Md. Ruhul			Direct Sensing of Endothelial Oxidants by Vascular Endothelial Growth Factor Receptor-2 and c-Src	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; PROTEIN-TYROSINE PHOSPHATASES; TGF-BETA RECEPTOR; NADPH OXIDASE; ANGIOTENSIN-II; REVERSIBLE OXIDATION; SIGNALING PATHWAYS; CRITICAL COMPONENT; NAD(P)H OXIDASE; KINASE-ACTIVITY	Background: ADPH oxidase-derived reactive oxygen species (ROS) play important roles in redox homeostasis and signal transduction in endothelial cells (ECs). We previously demonstrated that c-Src plays a key role in VEGF-induced, ROS-dependent selective activation of PI3K-Akt but not PLC gamma-1-ERK1/2 signaling pathways. The aim of the present study was to understand how VEGFR-2-c-Src signaling axis 'senses' NADPH oxidase-derived ROS levels and couples VEGF activation of c-Src to the redox state of ECs. Methodology/Principal Findings: Using biotinylated probe that detects oxidation of cysteine thiol (cys-OH) in intracellular proteins, we demonstrate that VEGF induced oxidative modification in c-Src and VEGFR-2, and that reduction in ROS levels using siRNA against p47(phox) subunit of Rac1-dependent NADPH oxidase inhibited this phenomenon. Co-immunoprecipitation studies using human coronary artery ECs (HCAEC) showed that VEGF-induced ROS-dependent interaction between VEGFR-2 and c-Src correlated with their thiol oxidation status. Immunofluorescence studies using antibodies against internalized VEGFR-2 and c-Src demonstrated that VEGF-induced subcellular co-localization of these tyrosine kinases were also dependent on NADPH oxidsase-derived ROS. Conclusion/Significance: These results demonstrate that VEGF induces cysteine oxidation in VEGFR-2 and c-Src in an NADPH oxidase-derived ROS-dependent manner, suggesting that VEGFR-2 and c-Src can 'sense' redox levels in ECs. The data also suggest that thiol oxidation status of VEGFR-2 and c-Src correlates with their ability to physically interact with each other and c-Src activation. Taken together, these findings suggest that prior to activating downstream c-Src-PI3K-Akt signaling pathway, VEGFR-2-c-Src axis requires an NADPH oxidase-derived ROS threshold in ECs.	[Lee, Monica; Choy, Wing C.; Abid, Md. Ruhul] Brown Univ, Rhode Isl Hosp, Div Cardiothorac Surg, Cardiovasc Res Ctr,Warren Alpert Med Sch, Providence, RI 02903 USA; [Lee, Monica] Texas Tech Univ, Hlth Sci Ctr, Sch Med, Lubbock, TX 79430 USA; [Choy, Wing C.] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA	Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Harvard University; Beth Israel Deaconess Medical Center	Lee, M (corresponding author), Brown Univ, Rhode Isl Hosp, Div Cardiothorac Surg, Cardiovasc Res Ctr,Warren Alpert Med Sch, Providence, RI 02903 USA.	Ruhul_Abid@brown.edu			American Heart Association [SDG 0453284N];  [10GRNT3640011]	American Heart Association(American Heart Association); 	This work was supported by the American Heart Association grants SDG 0453284N and Grant-in-Aid 10GRNT3640011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abid MR, 2007, J BIOL CHEM, V282, P35373, DOI 10.1074/jbc.M702175200; Abid MR, 2001, FASEB J, V15, P2548, DOI 10.1096/fj.01-0338fje; Abid MR, 2000, FEBS LETT, V486, P252, DOI 10.1016/S0014-5793(00)02305-X; Abid R, 2004, ARTERIOSCL THROM VAS, V24, P294, DOI 10.1161/01.ATV.0000110502.10593.06; Akhand AK, 1999, J BIOL CHEM, V274, P25821, DOI 10.1074/jbc.274.36.25821; BAAS AS, 1995, CIRC RES, V77, P29, DOI 10.1161/01.RES.77.1.29; Boivin B, 2008, P NATL ACAD SCI USA, V105, P9959, DOI 10.1073/pnas.0804336105; Chou MT, 2002, BMC BIOCHEM, V3, DOI 10.1186/1471-2091-3-32; Colavitti R, 2002, J BIOL CHEM, V277, P3101, DOI 10.1074/jbc.M107711200; Dansen TB, 2009, NAT CHEM BIOL, V5, P664, DOI 10.1038/nchembio.194; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; DVORAK HF, 1995, AM J PATHOL, V146, P1029; Ehrlich M, 2001, J CELL SCI, V114, P1777; Ewan LC, 2006, TRAFFIC, V7, P1270, DOI 10.1111/j.1600-0854.2006.00462.x; Feng J, 2010, ARTERIOSCL THROM VAS, V30, P1703, DOI 10.1161/ATVBAHA.110.209726; Ferrara N, 2001, AM J PHYSIOL-CELL PH, V280, pC1358, DOI 10.1152/ajpcell.2001.280.6.C1358; Fichtlscherer S, 2004, CIRCULATION, V109, P178, DOI 10.1161/01.CIR.0000105763.51286.7F; Giannoni E, 2005, MOL CELL BIOL, V25, P6391, DOI 10.1128/MCB.25.15.6391-6403.2005; GRIENDLING KK, 1994, CIRC RES, V74, P1141, DOI 10.1161/01.RES.74.6.1141; Halcox JPJ, 2002, CIRCULATION, V106, P653, DOI 10.1161/01.CIR.0000025404.78001.D8; Irani K, 2000, CIRC RES, V87, P179, DOI 10.1161/01.RES.87.3.179; Kunsch C, 1999, CIRC RES, V85, P753, DOI 10.1161/01.RES.85.8.753; Lampugnani MG, 2006, J CELL BIOL, V174, P593, DOI 10.1083/jcb.200602080; Lanahan AA, 2010, DEV CELL, V18, P713, DOI 10.1016/j.devcel.2010.02.016; Marumo T, 1997, CIRCULATION, V96, P2361; Meng TC, 2004, J BIOL CHEM, V279, P37716, DOI 10.1074/jbc.M404606200; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Oo ML, 2003, ONCOGENE, V22, P1411, DOI 10.1038/sj.onc.1206286; Oshikawa J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010189; Patterson C, 1999, J BIOL CHEM, V274, P19814, DOI 10.1074/jbc.274.28.19814; Pu MY, 1996, ONCOGENE, V13, P2615; Rahman MA, 2010, J BIOL CHEM, V285, P3806, DOI 10.1074/jbc.M109.059782; Ray R, 2005, CLIN SCI, V109, P217, DOI 10.1042/CS20050067; Ushio-Fukai M, 2002, CIRC RES, V91, P1160, DOI 10.1161/01.RES.0000046227.65158.F8; Ushio-Fukai M, 1999, J BIOL CHEM, V274, P22699, DOI 10.1074/jbc.274.32.22699; Ushio-Fukai M, 1998, J BIOL CHEM, V273, P15022, DOI 10.1074/jbc.273.24.15022; UshioFukai M, 1996, J BIOL CHEM, V271, P23317, DOI 10.1074/jbc.271.38.23317; Veikkola T, 2000, CANCER RES, V60, P203; Zafari AM, 1998, HYPERTENSION, V32, P488, DOI 10.1161/01.HYP.32.3.488	40	26	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2011	6	12							e28454	10.1371/journal.pone.0028454	http://dx.doi.org/10.1371/journal.pone.0028454			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MQ	22145046	Green Published, gold, Green Submitted			2022-12-27	WOS:000298168900029
J	Mahajan, M; Ahuja, PS; Yadav, SK				Mahajan, Monika; Ahuja, Paramvir Singh; Yadav, Sudesh Kumar			Post-Transcriptional Silencing of Flavonol Synthase mRNA in Tobacco Leads to Fruits with Arrested Seed Set	PLOS ONE			English	Article							ROOT-NODULE FORMATION; CHALCONE SYNTHASE; AUXIN TRANSPORT; MALE-FERTILITY; TUBE GROWTH; BIOSYNTHESIS; ARABIDOPSIS; ANTHOCYANIN; GERMINATION; GENES	Flavonoids are synthesized by phenylpropanoid pathway. They are known to participate in large number of physiological and biochemical processes in plants. Parthenocarpy and male sterility has earlier been reported by silencing chalcone synthase (CHS) encoding gene. Silencing of CHS has blocked the synthesis of most of useful flavonoids including flavan-3-ols and flavonols. Also, these studies could not identify whether parthenocarpy/male sterility were due to lack of flavan-3-ols or flavonols or both. Flavonol synthase (FLS) is an important enzyme of flavonoid pathway that catalyzes the formation of flavonols. In this article, we propose a novel strategy towards the generation of seedless or less-seeded fruits by downregulation of flavonol biosynthesis in tobacco (Nicotiana tabacum cv Xanthi) through post-transcriptional gene silencing (PTGS) of FLS encoding mRNA. The FLS silenced lines were observed for 20-80% reduction in FLS encoding gene expression and 25-93% reduction in flavonol (quercetin) content. Interestingly, these FLS silenced tobacco lines also showed reduction in their anthocyanidins content. While the content of flavan-3-ols (catechin, epi-catechin and epigallocatechin) was found to be increased in FLS silenced lines. The delayed flowering in FLS silenced lines could be due to decrease in level of indole acetic acid (IAA) at apical region of their shoots. Furthermore, the pollen germination was hampered and pollens were unable to produce functional pollen tube in FLS silenced tobacco lines. Pods of FLS silenced lines contained significantly less number of seeds. The in vitro and in vivo studies where 1 mu M quercetin was supplied to germination media, documented the restoration of normal pollen germination and pollen tube growth. This finding identified the role of flavonols particularly quercetin in pollen germination as well as in the regulation of plant fertility. Results also suggest a novel approach towards generation of seedless/less-seeded fruits via PTGS of FLS encoding gene in plants.	[Mahajan, Monika; Ahuja, Paramvir Singh; Yadav, Sudesh Kumar] CSIR, Inst Himalayan Bioresource Technol, Council Sci & Ind Res, Plant Metab Engn Lab,Biotechnol Div, Palampur, Himachal Prades, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Himalayan Bioresource Technology (IHBT)	Mahajan, M (corresponding author), CSIR, Inst Himalayan Bioresource Technol, Council Sci & Ind Res, Plant Metab Engn Lab,Biotechnol Div, Palampur, Himachal Prades, India.	sudeshkumar@ihbt.res.in		Mahajan, Monika/0000-0003-1061-579X	Council of Scientific and Industrial Research under NMITLI [TLP-0003]; Council of Scientific and Industrial Research	Council of Scientific and Industrial Research under NMITLI; Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by grants from Council of Scientific and Industrial Research under NMITLI (TLP-0003) research program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Authors are thankful to Mr. Robin Joshi and Mr. Digvijay Singh for their help in HPLC analysis and sequencing respectively. MM is thankful to Council of Scientific and Industrial Research for providing research fellowship as SRF.	Boase MR, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-107; Brown DE, 2001, PLANT PHYSIOL, V126, P524, DOI 10.1104/pp.126.2.524; Burbulis IE, 1996, PLANT CELL, V8, P1013, DOI 10.1105/tpc.8.6.1013; Casimiro I, 2003, TRENDS PLANT SCI, V8, P165, DOI 10.1016/S1360-1385(03)00051-7; Deluc L, 2008, PLANT PHYSIOL, V147, P2041, DOI 10.1104/pp.108.118919; Fan LM, 2001, J EXP BOT, V52, P1603, DOI 10.1093/jexbot/52.361.1603; Feng XL, 2006, PLANT MOL BIOL, V61, P215, DOI 10.1007/s11103-006-0005-z; Friml J, 2003, CURR OPIN PLANT BIOL, V6, P7, DOI 10.1016/S1369526602000031; Grebe M, 2004, BIOESSAYS, V26, P719, DOI 10.1002/bies.20065; HORSCH RB, 1985, SCIENCE, V227, P1229, DOI 10.1126/science.227.4691.1229; JACOBS M, 1988, SCIENCE, V241, P346, DOI 10.1126/science.241.4863.346; KUBASEK WL, 1992, PLANT CELL, V4, P1229, DOI 10.1105/tpc.4.10.1229; Ljung K, 2001, PLANT J, V28, P465, DOI 10.1046/j.1365-313X.2001.01173.x; Lu QM, 2008, RAPID COMMUN MASS SP, V22, P2565, DOI 10.1002/rcm.3642; Mathesius U, 1998, PLANT J, V14, P23, DOI 10.1046/j.1365-313X.1998.00090.x; MO YY, 1992, P NATL ACAD SCI USA, V89, P7213, DOI 10.1073/pnas.89.15.7213; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nakatsuka T, 2007, PLANT CELL REP, V26, P1951, DOI 10.1007/s00299-007-0401-0; Napoli CA, 1999, PLANT PHYSIOL, V120, P615, DOI 10.1104/pp.120.2.615; Nielsen K, 2002, MOL BREEDING, V9, P217, DOI 10.1023/A:1020320809654; POLLAK PE, 1993, PLANT PHYSIOL, V102, P925, DOI 10.1104/pp.102.3.925; RABINO I, 1986, PLANT PHYSIOL, V81, P922, DOI 10.1104/pp.81.3.922; Rubery P. H., 1990, Plant growth substances 1988., P428; Schijlen EGWM, 2007, PLANT PHYSIOL, V144, P1520, DOI 10.1104/pp.107.100305; Schwab R, 2006, PLANT CELL, V18, P1121, DOI 10.1105/tpc.105.039834; Sharma V, 2005, J FOOD COMPOS ANAL, V18, P583, DOI 10.1016/j.jfca.2004.02.015; Singh K, 2004, ANAL BIOCHEM, V335, P330, DOI 10.1016/j.ab.2004.08.030; Subramanian S, 2005, PLANT PHYSIOL, V137, P1345, DOI 10.1104/pp.104.057257; TAYLOR LP, 1992, J HERED, V83, P11, DOI 10.1093/oxfordjournals.jhered.a111149; Taylor LP, 2005, CURR OPIN PLANT BIOL, V8, P317, DOI 10.1016/j.pbi.2005.03.005; VANDERMEER IM, 1992, PLANT CELL, V4, P253, DOI 10.1105/tpc.4.3.253; Ververidis Filippos, 2007, Biotechnology Journal, V2, P1214, DOI 10.1002/biot.200700084; Wasson AP, 2006, PLANT CELL, V18, P1617, DOI 10.1105/tpc.105.038232; Wiermann R, 1979, REGULATION SECONDARY, P231; Wu JZ, 2008, J EXP BOT, V59, P2529, DOI 10.1093/jxb/ern119; Xu P, 1997, PLANTA, V202, P257, DOI 10.1007/s004250050127; YLSTRA B, 1992, PLANT PHYSIOL, V100, P902, DOI 10.1104/pp.100.2.902; Ylstra B, 1996, PLANT MOL BIOL, V32, P1155, DOI 10.1007/BF00041399	39	46	57	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2011	6	12							e28315	10.1371/journal.pone.0028315	http://dx.doi.org/10.1371/journal.pone.0028315			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MQ	22145036	Green Published, gold, Green Submitted			2022-12-27	WOS:000298168900019
J	Brault, V; Martin, B; Costet, N; Bizot, JC; Herault, Y				Brault, Veronique; Martin, Benoit; Costet, Nathalie; Bizot, Jean-Charles; Herault, Yann			Characterization of PTZ-Induced Seizure Susceptibility in a Down Syndrome Mouse Model That Overexpresses CSTB	PLOS ONE			English	Article							PROGRESSIVE MYOCLONUS EPILEPSY; CYSTATIN-B GENE; UNVERRICHT-LUNDBORG-DISEASE; CYSTEINE PROTEINASE-INHIBITORS; RECEPTOR-IONOPHORE COMPLEX; AMYLOID PRECURSOR PROTEIN; HUMAN STEFIN-B; TRANSGENIC MICE; TS65DN MOUSE; MURINE MODEL	Down syndrome (DS) is a complex genetic syndrome characterized by intellectual disability, dysmorphism and variable additional physiological traits. Current research progress has begun to decipher the neural mechanisms underlying cognitive impairment, leading to new therapeutic perspectives. Pentylenetetrazol (PTZ) has recently been found to have positive effects on learning and memory capacities of a DS mouse model and is foreseen to treat DS patients. But PTZ is also known to be a convulsant drug at higher dose and DS persons are more prone to epileptic seizures than the general population. This raises concerns over what long-term effects of treatment might be in the DS population. The cause of increased propensity for epilepsy in the DS population and which Hsa21 gene(s) are implicated remain unknown. Among Hsa21 candidate genes in epilepsy, CSTB, coding for the cystein protease inhibitor cystatin B, is involved in progressive myoclonus epilepsy and ataxia in both mice and human. Thus we aim to evaluate the effect of an increase in Cstb gene dosage on spontaneous epileptic activity and susceptibility to PTZ-induced seizure. To this end we generated a new mouse model trisomic for Cstb by homologous recombination. We verified that increasing copy number of Cstb from Trisomy (Ts) to Tetrasomy (Tt) was driving overexpression of the gene in the brain, we checked transgenic animals for presence of locomotor activity and electroencephalogram (EEG) abnormalities characteristic of myoclonic epilepsy and we tested if those animals were prone to PTZ-induced seizure. Overall, the results of the analysis shows that an increase in Cstb does not induce any spontaneous epileptic activity and neither increase or decrease the propensity of Ts and Tt mice to myoclonic seizures suggesting that Ctsb dosage should not interfere with PTZ-treatment.	[Brault, Veronique; Herault, Yann] Univ Strasbourg, IGBMC, Dept Translat Med & Neurogenet, CNRS UMR7104,Inserm U596, Illkirch Graffenstaden, France; [Martin, Benoit; Costet, Nathalie] INSERM, U642, Rennes, France; [Martin, Benoit; Costet, Nathalie] Univ Rennes 1, Lab Traitement Signal & Image, Rennes, France; [Bizot, Jean-Charles] Key Obs SAS, Orleans, France; [Herault, Yann] CNRS, TAAM, UPS44, F-45071 Orleans, France; [Herault, Yann] CERBM, GIE, Inst Francais Clin Souris, Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Brault, V (corresponding author), Univ Strasbourg, IGBMC, Dept Translat Med & Neurogenet, CNRS UMR7104,Inserm U596, Illkirch Graffenstaden, France.	herault@igbmc.fr	Herault, Yann/B-5500-2012	Herault, Yann/0000-0001-7049-6900; Costet, Nathalie/0000-0002-3706-4812; Brault, Veronique/0000-0002-1418-5849	National Centre for Scientific Research (CNRS); INSERM; University of Strasbourg; European commission; AnEUploidy; EUMODIC (EU) [LSHG-CT-2006-037627, LSHG-CT-2006-037811]; Fondation Jerome Lejeune; Fondation pour la Recherche Medicale	National Centre for Scientific Research (CNRS)(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); University of Strasbourg; European commission(European CommissionEuropean Commission Joint Research Centre); AnEUploidy; EUMODIC (EU); Fondation Jerome Lejeune; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This study was supported by grants from the National Centre for Scientific Research (CNRS), the INSERM, the University of Strasbourg, the European commission with the AnEUploidy and the EUMODIC projects (EU-FP6 Integrated Project: LSHG-CT-2006-037627; LSHG-CT-2006-037811 respectively), the Fondation Jerome Lejeune and the Fondation pour la Recherche Medicale. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAMSON M, 1986, J BIOL CHEM, V261, P1282; Alakurtti K, 2005, EUR J HUM GENET, V13, P208, DOI 10.1038/sj.ejhg.5201300; Altafaj X, 2001, HUM MOL GENET, V10, P1915, DOI 10.1093/hmg/10.18.1915; Aylward EH, 1999, AM J PSYCHIAT, V156, P564; Baxter LL, 2000, HUM MOL GENET, V9, P195, DOI 10.1093/hmg/9.2.195; Belichenko PV, 2007, J COMP NEUROL, V504, P329, DOI 10.1002/cne.21433; Belichenko PV, 2009, J COMP NEUROL, V512, P453, DOI 10.1002/cne.21895; Belichenko PV, 2004, J COMP NEUROL, V480, P281, DOI 10.1002/cne.20337; Bespalova IN, 1997, AM J MED GENET, V74, P467, DOI 10.1002/(SICI)1096-8628(19970919)74:5<467::AID-AJMG1>3.0.CO;2-L; Bjarnadottir M, 2001, AMYLOID, V8, P1, DOI 10.3109/13506120108993809; Brault V, 2006, PLOS GENET, V2, P911, DOI 10.1371/journal.pgen.0020086; BROMME D, 1991, BIOMED BIOCHIM ACTA, V50, P631; Buffo A, 2005, P NATL ACAD SCI USA, V102, P18183, DOI 10.1073/pnas.0506535102; Ceru S, 2005, MED HYPOTHESES, V64, P955, DOI 10.1016/j.mehy.2004.11.038; Ceru S, 2010, BIOL CELL, V102, P319, DOI 10.1042/BC20090163; Chioza B, 2002, EPILEPSY RES, V52, P107, DOI 10.1016/S0920-1211(02)00195-X; Cipollini E, 2008, BBA-MOL CELL RES, V1783, P312, DOI 10.1016/j.bbamcr.2007.08.007; Clark D, 2003, AM J MED GENET A, V118A, P210, DOI 10.1002/ajmg.a.20007; Conti A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-268; Crawley JN, 2008, NEURON, V57, P809, DOI 10.1016/j.neuron.2008.03.001; D'amato E, 2000, EUR J NEUROSCI, V12, P1687, DOI 10.1046/j.1460-9568.2000.00058.x; Di Giaimo R, 2002, HUM MOL GENET, V11, P2941, DOI 10.1093/hmg/11.23.2941; Dierssen M, 2003, GENES BRAIN BEHAV, V2, P152, DOI 10.1034/j.1601-183X.2003.00027.x; Dierssen M, 2009, PHYSIOL REV, V89, P887, DOI 10.1152/physrev.00032.2007; ELSON A, 1994, BIOCHEM J, V299, P409, DOI 10.1042/bj2990409; Ema M, 1999, HUM MOL GENET, V8, P1409, DOI 10.1093/hmg/8.8.1409; EPSTEIN CJ, 1987, P NATL ACAD SCI USA, V84, P8044, DOI 10.1073/pnas.84.22.8044; Fernandez F, 2007, NAT NEUROSCI, V10, P411, DOI 10.1038/nn1860; FitzPatrick DR, 2002, HUM MOL GENET, V11, P3249, DOI 10.1093/hmg/11.26.3249; Fotaki V, 2002, MOL CELL BIOL, V22, P6636, DOI 10.1128/MCB.22.18.6636-6647.2002; Franceschetti S, 2007, NEUROBIOL DIS, V25, P675, DOI 10.1016/j.nbd.2006.11.006; GAMES D, 1995, NATURE, V373, P523, DOI 10.1038/373523a0; Gardiner K, 2003, GENE, V318, P137, DOI 10.1016/S0378-1119(03)00769-8; Gardiner KJ, 2010, TRENDS PHARMACOL SCI, V31, P66, DOI 10.1016/j.tips.2009.10.010; Gerlai R, 1996, NEUROBIOL LEARN MEM, V66, P143, DOI 10.1006/nlme.1996.0055; GERLAI R, 1993, BEHAV BRAIN RES, V59, P119, DOI 10.1016/0166-4328(93)90157-L; GREEN GDJ, 1984, BIOCHEM J, V218, P939, DOI 10.1042/bj2180939; Hallmann K, 2000, AM J MED GENET, V96, P8, DOI 10.1002/(SICI)1096-8628(20000207)96:1<8::AID-AJMG3>3.0.CO;2-S; Hattori D, 2007, NATURE, V449, P223, DOI 10.1038/nature06099; Higuchi M, 2000, NATURE, V406, P78, DOI 10.1038/35017558; Hodapp RM, 2005, MENT RETARD DEV D R, V11, P340, DOI 10.1002/mrdd.20087; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Insausti AM, 1998, NEUROSCI LETT, V253, P175, DOI 10.1016/S0304-3940(98)00641-7; JARVINEN M, 1982, BIOCHIM BIOPHYS ACTA, V708, P210, DOI 10.1016/0167-4838(82)90222-9; JERALA R, 1988, FEBS LETT, V239, P41, DOI 10.1016/0014-5793(88)80541-6; Joensuu T, 2007, EUR J HUM GENET, V15, P185, DOI 10.1038/sj.ejhg.5201723; Kagitani-Shimono K, 2002, PEDIATR NEUROL, V26, P55, DOI 10.1016/S0887-8994(01)00336-8; Kleschevnikov AM, 2004, J NEUROSCI, V24, P8153, DOI 10.1523/JNEUROSCI.1766-04.2004; Krasuski JS, 2002, AM J PSYCHIAT, V159, P74, DOI 10.1176/appi.ajp.159.1.74; Kurt MA, 2000, BRAIN RES, V858, P191, DOI 10.1016/S0006-8993(00)01984-3; Lafreniere RG, 1997, NAT GENET, V15, P298, DOI 10.1038/ng0397-298; Lalioti MD, 1997, AM J HUM GENET, V60, P342; Lalioti MD, 1997, NATURE, V386, P847, DOI 10.1038/386847a0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lyle R, 2004, GENOME RES, V14, P1268, DOI 10.1101/gr.2090904; MAGIN TM, 1992, NUCLEIC ACIDS RES, V20, P3795, DOI 10.1093/nar/20.14.3795; Mao R, 2003, GENOMICS, V81, P457, DOI 10.1016/S0888-7543(03)00035-1; MARCELL MM, 1982, AM J MENT DEF, V87, P86; Martinez-Cue C, 1999, NEUROREPORT, V10, P1119, DOI 10.1097/00001756-199904060-00039; McPherson PS, 1996, NATURE, V379, P353, DOI 10.1038/379353a0; MCVICKER RW, 1994, BRIT J PSYCHIAT, V164, P528, DOI 10.1192/bjp.164.4.528; Moechars D, 1998, NEUROREPORT, V9, P3561, DOI 10.1097/00001756-199811160-00004; Moller JC, 2001, SEIZURE-EUR J EPILEP, V10, P303, DOI 10.1053/seiz.2000.0500; Moulard B, 2002, HUM GENET, V111, P255, DOI 10.1007/s00439-002-0755-x; Nadel L, 2003, GENES BRAIN BEHAV, V2, P156, DOI 10.1034/j.1601-183X.2003.00026.x; OLSEN RW, 1981, MOL CELL BIOCHEM, V39, P261, DOI 10.1007/BF00232579; Osawa M, 2003, GENOMICS, V81, P78, DOI 10.1016/S0888-7543(02)00010-1; PATIL N, 1995, NAT GENET, V11, P126, DOI 10.1038/ng1095-126; Pennacchio LA, 1998, NAT GENET, V20, P251, DOI 10.1038/3059; Pennacchio LA, 1996, SCIENCE, V271, P1731, DOI 10.1126/science.271.5256.1731; Pennington BF, 2003, CHILD DEV, V74, P75, DOI 10.1111/1467-8624.00522; Pinter JD, 2001, NEUROLOGY, V56, P972, DOI 10.1212/WNL.56.7.972; PUESCHEL SM, 1991, ARCH NEUROL-CHICAGO, V48, P318, DOI 10.1001/archneur.1991.00530150088024; RAFF MC, 1983, NATURE, V303, P390, DOI 10.1038/303390a0; RAMANJANEYULU R, 1984, EUR J PHARMACOL, V98, P337, DOI 10.1016/0014-2999(84)90282-6; REEVES RH, 1995, NAT GENET, V11, P177, DOI 10.1038/ng1095-177; RITONJA A, 1985, BIOCHEM BIOPH RES CO, V131, P1187, DOI 10.1016/0006-291X(85)90216-5; Rueda N, 2008, METHOD FIND EXP CLIN, V30, P92; Salehi A, 2007, MENT RETARD DEV D R, V13, P207, DOI 10.1002/mrdd.20164; SturchlerPierrat C, 1997, P NATL ACAD SCI USA, V94, P13287, DOI 10.1073/pnas.94.24.13287; Sultan M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r91; Sumarsono SH, 1996, NATURE, V379, P534, DOI 10.1038/379534a0; SYLVESTER PE, 1983, J MENT DEFIC RES, V27, P227; TANGYE SR, 1979, J MENT DEFIC RES, V23, P17; TURK V, 1991, FEBS LETT, V285, P213, DOI 10.1016/0014-5793(91)80804-C; VEALL RM, 1974, J MENT DEFIC RES, V18, P99; Vicari S, 2000, J INTELL DISABIL RES, V44, P504; Virtaneva K, 1997, NAT GENET, V15, P393, DOI 10.1038/ng0497-393; Voronov SV, 2008, P NATL ACAD SCI USA, V105, P9415, DOI 10.1073/pnas.0803756105; WILSON WA, 1974, BRAIN RES, V72, P168, DOI 10.1016/0006-8993(74)90662-3; Xiao F, 2009, BRAIN RES, V1255, P180, DOI 10.1016/j.brainres.2008.12.008; Yahya-Graison EA, 2007, AM J HUM GENET, V81, P475, DOI 10.1086/520000; Yamakawa K, 1998, HUM MOL GENET, V7, P227, DOI 10.1093/hmg/7.2.227; Zheng BH, 1999, NUCLEIC ACIDS RES, V27, P2354, DOI 10.1093/nar/27.11.2354	94	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e27845	10.1371/journal.pone.0027845	http://dx.doi.org/10.1371/journal.pone.0027845			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140471	Green Published, gold, Green Submitted			2022-12-27	WOS:000298168100020
J	Lindenfors, P; Jansson, F; Sandberg, M				Lindenfors, Patrik; Jansson, Fredrik; Sandberg, Mikael			The Cultural Evolution of Democracy: Saltational Changes in A Political Regime Landscape	PLOS ONE			English	Article							DIFFUSION; TRANSMISSION; TRANSITIONS; DOMINOES	Transitions to democracy are most often considered the outcome of historical modernization processes. Socio-economic changes, such as increases in per capita GNP, education levels, urbanization and communication, have traditionally been found to be correlates or 'requisites' of democratic reform. However, transition times and the number of reform steps have not been studied comprehensively. Here we show that historically, transitions to democracy have mainly occurred through rapid leaps rather than slow and incremental transition steps, with a median time from autocracy to democracy of 2.4 years, and overnight in the reverse direction. Our results show that autocracy and democracy have acted as peaks in an evolutionary landscape of possible modes of institutional arrangements. Only scarcely have there been slow incremental transitions. We discuss our results in relation to the application of phylogenetic comparative methods in cultural evolution and point out that the evolving unit in this system is the institutional arrangement, not the individual country which is instead better regarded as the 'host' for the political system.	[Lindenfors, Patrik; Jansson, Fredrik; Sandberg, Mikael] Stockholm Univ, Ctr Study Cultural Evolut, S-10691 Stockholm, Sweden; [Lindenfors, Patrik] Stockholm Univ, Dept Zool, S-10691 Stockholm, Sweden; [Jansson, Fredrik] Malardalen Univ, Div Appl Math, Sch Educ Culture & Commun, Vasteras, Sweden; [Sandberg, Mikael] Halmstad Univ, Sch Social & Hlth Sci, Halmstad, Sweden	Stockholm University; Stockholm University; Malardalen University; Halmstad University	Lindenfors, P (corresponding author), Stockholm Univ, Ctr Study Cultural Evolut, S-10691 Stockholm, Sweden.	Patrik.Lindenfors@zoologi.su.se	Lindenfors, Patrik/G-6401-2011; Lindenfors, Patrik/N-2801-2019; Sandberg, Mikael/I-2821-2014; Jansson, Fredrik/B-7616-2011	Lindenfors, Patrik/0000-0003-3245-0850; Lindenfors, Patrik/0000-0003-3245-0850; Sandberg, Mikael/0000-0001-9495-3571; Jansson, Fredrik/0000-0001-8357-0276	European Commission [FP6-2004-NEST-PATH-043434]; Swedish Research Council [2008-5519]	European Commission(European CommissionEuropean Commission Joint Research Centre); Swedish Research Council(Swedish Research CouncilEuropean Commission)	This research was supported by the CULTAPTATION project (European Commission contract FP6-2004-NEST-PATH-043434) and through a research grant from the Swedish Research Council (2008-5519) (PL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almond Gabriel A., 1989, CIVIC CULTURE POLITI; Boyd R, 1997, ORIGIN EVOLUTION CUL, P310; Carothers T, 2002, J DEMOCR, V13, P5, DOI 10.1353/jod.2002.0003; Currie TE, 2010, PHILOS T R SOC B, V365, P3903, DOI 10.1098/rstb.2010.0014; Currie TE, 2010, NATURE, V467, P801, DOI 10.1038/nature09461; Dahl Robert, 1971, POLYARCHY PARTICIPAT; DEUTSCH KW, 1961, AM POLIT SCI REV, V55, P493, DOI 10.2307/1952679; Enquist M, 2011, PHILOS T R SOC B, V366, P412, DOI 10.1098/rstb.2010.0132; Gleditsch KS, 2006, INT ORGAN, V60, P911, DOI 10.1017/S0020818306060309; Gray RD, 2009, SCIENCE, V323, P479, DOI 10.1126/science.1166858; Hamalainen P, 2003, J AM HIST, V90, P833; Huntington Samuel P., 1991, 3 WAVE DEMOCRATIZATI; Inglehart R., 1997, MODERNIZATION POSTMO; JAGGERS K, 1995, J PEACE RES, V32, P469, DOI 10.1177/0022343395032004007; Leeson PT, 2009, AM J POLIT SCI, V53, P533, DOI 10.1111/j.1540-5907.2009.00385.x; Lerner D., 1958, PASSING TRADITIONAL; Linz JJ, 1998, INT POLIT SCI REV, V19, P19, DOI 10.1177/019251298019001002; Linz JJ., 1996, PROBLEMS DEMOCRATIC; Lipset SeymourMartin., 1981, POLITICAL MAN SOCIAL; LIPSET SM, 1959, AM POLIT SCI REV, V53, P69, DOI 10.2307/1951731; Marshall M., 2010, POLITY 4 PROJECT POL; McCann JC, 2005, MAIZE GRACE AFRICAS; Modelski G, 2002, TECHNOL FORECAST SOC, V69, P359, DOI 10.1016/S0040-1625(01)00152-4; Mulder MB, 2006, EVOL ANTHROPOL, V15, P52, DOI 10.1002/evan.20088; Nunn CL, 2010, PHILOS T R SOC B, V365, P3807, DOI 10.1098/rstb.2010.0009; Nunn CL, 2010, PHIL T R SOC B, V364, P61; O'Donell G, 1986, TRANSITIONS AUTHORIT; O'Loughlin J, 1998, ANN ASSOC AM GEOGR, V88, P545, DOI 10.1111/0004-5608.00112; Pye L. W., 1963, COMMUNICATION POLITI; RUSTOW DA, 1970, COMP POLIT, V2, P337, DOI 10.2307/421307; Schumpeter J. A., 1943, CAPITALISM SOCIALISM, DOI DOI 10.1007/s11135-015-0230-0; STARR H, 1991, J CONFLICT RESOLUT, V35, P356, DOI 10.1177/0022002791035002010; Starr H, 2003, J CONFLICT RESOLUT, V47, P490, DOI 10.1177/0022002703252373; Valenzuela A., 1978, BREAKDOWN DEMOCRATIC; Vanhanen T., 1997, PROSPECTS DEMOCRACY; Wejnert B, 2005, AM SOCIOL REV, V70, P53, DOI 10.1177/000312240507000104	36	8	8	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e28270	10.1371/journal.pone.0028270	http://dx.doi.org/10.1371/journal.pone.0028270			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	863MI	22140565	Green Published, gold			2022-12-27	WOS:000298168100059
J	Secka, O; Antonio, M; Berg, DE; Tapgun, M; Bottomley, C; Thomas, V; Walton, R; Corrah, T; Thomas, JE; Adegbola, RA				Secka, Ousman; Antonio, Martin; Berg, Douglas E.; Tapgun, Mary; Bottomley, Christian; Thomas, Vivat; Walton, Robert; Corrah, Tumani; Thomas, Julian E.; Adegbola, Richard A.			Mixed Infection with cagA Positive and cagA Negative Strains of Helicobacter pylori Lowers Disease Burden in The Gambia	PLOS ONE			English	Article							HIGH PREVALENCE; AFRICAN ENIGMA; MULTIPLE STRAINS; BIOPSY SPECIMENS; GASTRIC-CANCER; ICEA GENOTYPES; VACA; ASSOCIATION; DIVERSITY; HOST	Background: The prevalence of Helicobacter pylori including strains with putatively virulent genotypes is high, whereas the H. pylori-associated disease burden is low, in Africa compared to developed countries. In this study, we investigated the prevalence of virulence-related H. pylori genotypes and their association with gastroduodenal diseases in The Gambia. Methods and Findings: DNA extracted from biopsies and H. pylori cultures from 169 subjects with abdominal pain, dyspepsia or other gastroduodenal diseases were tested by PCR for H. pylori. The H. pylori positive samples were further tested for the cagA oncogene and vacA toxin gene. One hundred and twenty one subjects (71.6%) were H. pylori positive. The cagA gene and more toxigenic s1 and m1 alleles of the vacA gene were found in 61.2%, 76.9% and 45.5% respectively of Gambian patients harbouring H. pylori. There was a high prevalence of cagA positive strains in patients with overt gastric diseases than those with non-ulcerative dyspepsia (NUD) (p = 0.05); however, mixed infection by cagA positive and cagA negative strains was more common in patients with NUD compared to patients with gastric disease (24.5% versus 0%; p = 0.002). Conclusion: This study shows that the prevalence of H. pylori is high in dyspeptic patients in The Gambia and that many strains are of the putatively more virulent cagA(+), vacAs1 and vacAm1 genotypes. This study has also shown significantly lower disease burden in Gambians infected with a mixture of cag-positive and cag-negative strains, relative to those containing only cag-positive or only cag-negative strains, which suggests that harbouring both cag-positive and cag-negative strains is protective.	[Secka, Ousman; Antonio, Martin; Tapgun, Mary; Thomas, Vivat; Walton, Robert; Corrah, Tumani; Adegbola, Richard A.] MRC Unit, Fajara, Gambia; [Thomas, Julian E.] Newcastle Univ, Sch Clin Med Sci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Berg, Douglas E.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Bottomley, Christian] London Sch Hyg & Trop Med, MRC, Trop Epidemiol Grp, London WC1, England	University of London; London School of Hygiene & Tropical Medicine; Newcastle University - UK; Washington University (WUSTL); University of London; London School of Hygiene & Tropical Medicine	Secka, O (corresponding author), MRC Unit, Fajara, Gambia.	osecka@mrc.gm		Bottomley, Christian/0000-0002-5241-8412; Walton, Robert/0000-0001-7700-1907	US National Institutes of Health [RO3-AI061308]; Medical Research Council Unit, The Gambia; MRC [MC_U190074190, MC_U190081991, G0700837, MC_U190092710] Funding Source: UKRI; Medical Research Council [G0700837, MC_U190081991, MC_U190092710, MC_U190074190] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI061308] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council Unit, The Gambia; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grant RO3-AI061308 from the US National Institutes of Health and The Medical Research Council Unit, The Gambia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agha A, 2005, SCAND J GASTROENTERO, V40, P523, DOI 10.1080/00365520510012280; Ahmed Niyaz, 2005, Ann Clin Microbiol Antimicrob, V4, P1, DOI 10.1186/1476-0711-4-1; Akada JK, 2003, MICROBIOL-SGM, V149, P1901, DOI 10.1099/mic.0.26129-0; Alam SI, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-194; Berg S, 2006, SCAND J INFECT DIS, V38, P427, DOI 10.1080/00365540500532852; Blaser MJ, 2001, J CLIN INVEST, V107, P767, DOI 10.1172/JCI12672; Boyanova L, 2009, DIAGN MICR INFEC DIS, V64, P374, DOI 10.1016/j.diagmicrobio.2009.04.005; Campbell DI, 2001, HELICOBACTER, V6, P263, DOI 10.1046/j.1083-4389.2001.00047.x; Chen XJ, 2005, CHINESE MED J-PEKING, V118, P460; Figueiredo C, 2001, SCAND J GASTROENTERO, V36, P128, DOI 10.1080/003655201750065861; Graham DY, 2009, J DIGEST DIS, V10, P77, DOI 10.1111/j.1751-2980.2009.00368.x; HOLCOMBE C, 1992, GUT, V33, P429, DOI 10.1136/gut.33.4.429; Jemilohun AC, 2010, PAN AFR MED J, V6; Kim YS, 2009, EUR J GASTROEN HEPAT, V21, P522, DOI 10.1097/MEG.0b013e3283196af0; Kumar S, 2010, J MED MICROBIOL, V59, P32, DOI 10.1099/jmm.0.013763-0; Linz B, 2007, NATURE, V445, P915, DOI 10.1038/nature05562; Matteo MJ, 2007, J MED MICROBIOL, V56, P664, DOI 10.1099/jmm.0.46885-0; Miernyk K, 2011, J CLIN MICROBIOL, V49, P3114, DOI 10.1128/JCM.00469-11; Momynaliev K, 2003, EUR J CLIN MICROBIOL, V22, P573, DOI 10.1007/s10096-003-0987-2; Mukhopadhyay AK, 2000, J BACTERIOL, V182, P3219, DOI 10.1128/JB.182.11.3219-3227.2000; Nguyen LT, 2008, J MED MICROBIOL, V57, P1445, DOI 10.1099/jmm.0.2008/003160-0; OWEN RJ, 1994, FEMS IMMUNOL MED MIC, V9, P307; Palacios G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008540; Pan ZJ, 1998, J INFECT DIS, V178, P220, DOI 10.1086/515601; Panangala VS, 2009, AQUAC RES, V40, P915, DOI 10.1111/j.1365-2109.2009.02185.x; Park CY, 2003, J CLIN MICROBIOL, V41, P3336, DOI 10.1128/JCM.41.7.3336-3338.2003; Rieder G, 2005, CURR OPIN MICROBIOL, V8, P67, DOI 10.1016/j.mib.2004.12.004; Secka O, 2011, GUT PATHOG, V3, DOI 10.1186/1757-4749-3-5; Segal I, 2001, QJM-INT J MED, V94, P561, DOI 10.1093/qjmed/94.10.561; Serge B, 2002, VET RES, V33, P55; Smith SI, 2002, J MED MICROBIOL, V51, P851, DOI 10.1099/0022-1317-51-10-851; Soto G, 2003, J INFECT DIS, V188, P1263, DOI 10.1086/379046; Sugimoto M, 2009, CLIN MICROBIOL INFEC, V15, P835, DOI 10.1111/j.1469-0691.2009.02769.x; Tanih NF, 2010, ACTA TROP, V116, P68, DOI 10.1016/j.actatropica.2010.05.011; TAYLOR NS, 1995, J CLIN MICROBIOL, V33, P918, DOI 10.1128/JCM.33.4.918-923.1995; Tegtmeyer N, 2009, CELL MICROBIOL, V11, P488, DOI 10.1111/j.1462-5822.2008.01269.x; Thomas JE, 1999, PEDIATR RES, V45, P218, DOI 10.1203/00006450-199902000-00010; van Doorn LJ, 1998, GASTROENTEROLOGY, V115, P58, DOI 10.1016/S0016-5085(98)70365-8; Yamaoka Y, 1999, J CLIN MICROBIOL, V37, P2274, DOI 10.1128/JCM.37.7.2274-2279.1999; Yamaoka Y, 2008, INTERNAL MED, V47, P1077, DOI 10.2169/internalmedicine.47.0975	40	27	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2011	6	11							e27954	10.1371/journal.pone.0027954	http://dx.doi.org/10.1371/journal.pone.0027954			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863LT	22140492	Green Published, gold, Green Accepted			2022-12-27	WOS:000298166300018
J	Stringer, S; Wray, NR; Kahn, RS; Derks, EM				Stringer, Sven; Wray, Naomi R.; Kahn, Rene S.; Derks, Eske M.			Underestimated Effect Sizes in GWAS: Fundamental Limitations of Single SNP Analysis for Dichotomous Phenotypes	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; INDIVIDUAL GENETIC RISK; LOGISTIC-REGRESSION; STATISTICAL-METHODS; COMPLEX DISEASES; COLLAPSIBILITY; SCHIZOPHRENIA; HERITABILITY; METAANALYSIS; PREDICTION	Complex diseases are often highly heritable. However, for many complex traits only a small proportion of the heritability can be explained by observed genetic variants in traditional genome-wide association (GWA) studies. Moreover, for some of those traits few significant SNPs have been identified. Single SNP association methods test for association at a single SNP, ignoring the effect of other SNPs. We show using a simple multi-locus odds model of complex disease that moderate to large effect sizes of causal variants may be estimated as relatively small effect sizes in single SNP association testing. This underestimation effect is most severe for diseases influenced by numerous risk variants. We relate the underestimation effect to the concept of non-collapsibility found in the statistics literature. As described, continuous phenotypes generated with linear genetic models are not affected by this underestimation effect. Since many GWA studies apply single SNP analysis to dichotomous phenotypes, previously reported results potentially underestimate true effect sizes, thereby impeding identification of true effect SNPs. Therefore, when a multi-locus model of disease risk is assumed, a multi SNP analysis may be more appropriate.	[Stringer, Sven; Kahn, Rene S.; Derks, Eske M.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Psychiat, Utrecht, Netherlands; [Wray, Naomi R.] Queensland Inst Med Res, Psychiat Genet Lab, Brisbane, Qld 4006, Australia; [Wray, Naomi R.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia	Utrecht University; Utrecht University Medical Center; QIMR Berghofer Medical Research Institute; University of Queensland	Stringer, S (corresponding author), Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Psychiat, Utrecht, Netherlands.	s.stringer@umcutrecht.nl	Wray, Naomi/C-8639-2015; Derks, Eske M/A-1652-2017	Wray, Naomi/0000-0001-7421-3357; Derks, Eske M/0000-0002-6292-6883	Netherlands Scientific Organization (NWO) [451-08-010]	Netherlands Scientific Organization (NWO)(Netherlands Organization for Scientific Research (NWO))	Eske Derks is supported by the Netherlands Scientific Organization (NWO; project number 451-08-010; www.nwo.nl). NWO had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cantor RM, 2010, AM J HUM GENET, V86, P6, DOI 10.1016/j.ajhg.2009.11.017; Cardno AG, 2000, AM J MED GENET, V97, P12, DOI 10.1002/(SICI)1096-8628(200021)97:1<12::AID-AJMG3>3.3.CO;2-L; DeMaris A, 2002, SOCIOL METHOD RES, V31, P27, DOI 10.1177/0049124102031001002; Flint J, 2009, GENOME RES, V19, P723, DOI 10.1101/gr.086660.108; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; GAIL MH, 1984, BIOMETRIKA, V71, P431; Garner C, 2007, GENET EPIDEMIOL, V31, P288, DOI 10.1002/gepi.20209; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; Greenland S, 1999, STAT SCI, V14, P29; GUO JH, 1995, J ROY STAT SOC B MET, V57, P263; Hakonarson H, 2007, NATURE, V448, P591, DOI 10.1038/nature06010; Hernan M, 2011, INT J EPIDEMIOL, P1; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hoggart CJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000130; Janssens ACJW, 2006, GENET MED, V8, P395, DOI 10.1097/01.gim.0000229689.18263.f4; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kraft P, 2008, EPIDEMIOLOGY, V19, P649, DOI 10.1097/EDE.0b013e318181b865; Ku CS, 2010, J HUM GENET, V55, P195, DOI 10.1038/jhg.2010.19; Lee SH, 2011, AM J HUM GENET, V88, P294, DOI 10.1016/j.ajhg.2011.02.002; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; MCKELVEY RD, 1975, J MATH SOCIOL, V4, P103, DOI 10.1080/0022250X.1975.9989847; NEUHAUS JM, 1993, BIOMETRIKA, V80, P807, DOI 10.2307/2336872; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Robinson LD, 1991, INT STAT REV, V58, P227; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; SIMPSON EH, 1951, J ROY STAT SOC B, V13, P238; Stephens M, 2009, NAT REV GENET, V10, P681, DOI 10.1038/nrg2615; Sullivan PF, 2003, ARCH GEN PSYCHIAT, V60, P1187, DOI 10.1001/archpsyc.60.12.1187; van Heel DA, 2007, NAT GENET, V39, P827, DOI 10.1038/ng2058; Visscher PM, 2011, MOL PSYCHIATR, P1; Wei YC, 2010, EUR J HUM GENET, V18, P942, DOI 10.1038/ejhg.2010.51; Wray NR, 2008, CURR OPIN GENET DEV, V18, P257, DOI 10.1016/j.gde.2008.07.006; Wray NR, 2007, GENOME RES, V17, P1520, DOI 10.1101/gr.6665407; Wray NR, 2010, MOL PSYCHIATR, V37, P1; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zondervan KT, 2004, NAT REV GENET, V5, P89, DOI 10.1038/nrg1270	37	37	39	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2011	6	11							e27964	10.1371/journal.pone.0027964	http://dx.doi.org/10.1371/journal.pone.0027964			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KW	22140493	Green Submitted, Green Published, gold			2022-12-27	WOS:000298163400027
J	Bull, JJ; Heineman, RH; Wilke, CO				Bull, James J.; Heineman, Richard H.; Wilke, Claus O.			The Phenotype-Fitness Map in Experimental Evolution of Phages	PLOS ONE			English	Article							LIFE-HISTORY; LYSIS TIME; BACTERIOPHAGE; MODEL; OPTIMALITY; VIRUSES; T7	Evolutionary biologists commonly interpret adaptations of organisms by reference to a phenotype-fitness map, a model of how different states of a phenotype affect fitness. Notwithstanding the popularity of this approach, it remains difficult to directly test these mappings, both because the map often describes only a small subset of phenotypes contributing to total fitness and because direct measures of fitness are difficult to obtain and compare to the map. Both limitations can be overcome for bacterial viruses (phages) grown in the experimental condition of unlimited hosts. A complete accounting of fitness requires 3 easily measured phenotypes, and total fitness is also directly measurable for arbitrary genotypes. Yet despite the presumed transparency of this system, directly estimated fitnesses often differ from fitnesses calculated from the phenotype-fitness map. This study attempts to resolve these discrepancies, both by developing a more exact analytical phenotype-fitness map and by exploring the empirical foundations of direct fitness estimates. We derive an equation (the phenotype-fitness map) for exponential phage growth that allows an arbitrary distribution of lysis times and burst sizes. We also show that direct estimates of fitness are, in many cases, plausibly in error because the population has not attained stable age distribution and thus violates the model underlying the phenotype-fitness map. In conjunction with data provided here, the new understanding appears to resolve a discrepancy between the reported fitness of phage T7 and the substantially lower value calculated from its phenotype-fitness map.	[Bull, James J.; Wilke, Claus O.] Univ Texas Austin, Inst Cellular & Mol Biol, Ctr Computat Biol & Bioinformat, Sect Integrat Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Bull, JJ (corresponding author), Univ Texas Austin, Inst Cellular & Mol Biol, Ctr Computat Biol & Bioinformat, Sect Integrat Biol, Austin, TX 78712 USA.	bull@mail.utexas.edu	Wilke, Claus O./B-4643-2008	Wilke, Claus/0000-0002-7470-9261	National Institutes of Health (NIH) [GM 57756, R01 GM088344]; Miescher Regents Professorship; National Science Foundation (NSF) [EF-0742373, DBI-0939454]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057756, R01GM088344] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Miescher Regents Professorship; National Science Foundation (NSF)(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) GM 57756 and the Miescher Regents Professorship (to JJB) and National Science Foundation (NSF) Grant EF-0742373, NSF Cooperative Agreement No.\ DBI-0939454, and NIH R01 GM088344 (to COW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedon ST, 2001, APPL ENVIRON MICROB, V67, P4233, DOI 10.1128/AEM.67.9.4233-4241.2001; Adams MH, 1959, BACTERIOPHAGES; Alexander HK, 2008, EVOLUTION, V62, P1600, DOI 10.1111/j.1558-5646.2008.00396.x; BOWES JM, 1974, J VIROL, V13, P53, DOI 10.1128/JVI.13.1.53-61.1974; Bull JJ, 2006, J THEOR BIOL, V241, P928, DOI 10.1016/j.jtbi.2006.01.027; Bull JJ, 2010, VIROLOGY, V398, P79, DOI 10.1016/j.virol.2009.11.040; Domingo-Calap P, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000742; Ellis EL, 1939, J GEN PHYSIOL, V22, P365, DOI 10.1085/jgp.22.3.365; Endy D, 2000, P NATL ACAD SCI USA, V97, P5375, DOI 10.1073/pnas.090101397; Guyader S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001946; Heineman RH, 2005, J MOL EVOL, V61, P181, DOI 10.1007/s00239-004-0304-4; Heineman RH, 2007, EVOLUTION, V61, P1695, DOI 10.1111/j.1558-5646.2007.00132.x; Patwa Z, 2008, GENETICS, V180, P459, DOI 10.1534/genetics.108.090555; Patwa Z, 2009, J THEOR BIOL, V259, P799, DOI 10.1016/j.jtbi.2009.05.008; Peris JB, 2010, GENETICS, V185, P603, DOI 10.1534/genetics.110.115162; Rokyta DR, 2008, J MOL EVOL, V67, P368, DOI 10.1007/s00239-008-9153-x; Rokyta DR, 2005, NAT GENET, V37, P441, DOI 10.1038/ng1535; Shao YP, 2008, GENETICS, V180, P471, DOI 10.1534/genetics.108.090100; Springman R, 2010, GENETICS, V184, P221, DOI 10.1534/genetics.109.108803; Wang IN, 1996, EVOL ECOL, V10, P545, DOI 10.1007/BF01237884; Wang IN, 2006, GENETICS, V172, P17, DOI 10.1534/genetics.105.045922	21	24	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2011	6	11							e27796	10.1371/journal.pone.0027796	http://dx.doi.org/10.1371/journal.pone.0027796			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858JH	22132144	gold, Green Submitted, Green Published			2022-12-27	WOS:000297792400015
J	Walchli, B; Loset, GA; Kumari, S; Johansen, JN; Yang, WW; Sandlie, I; Olweus, J				Walchli, Bastien; Loset, Geir Age; Kumari, Shraddha; Johansen, Jorunn Nergard; Yang, Weiwen; Sandlie, Inger; Olweus, Johanna			A Practical Approach to T-Cell Receptor Cloning and Expression	PLOS ONE			English	Article							TCR GENE-THERAPY; DENDRITIC CELLS; ALPHA-CHAIN; REPERTOIRE; LYMPHOCYTES; USAGE; BETA; IDENTIFICATION; VECTORS; CLONES	Although cloning and expression of T-cell Receptors (TcRs) has been performed for almost two decades, these procedures are still challenging. For example, the use of T-cell clones that have undergone limited expansion as starting material to limit the loss of interesting TcRs, must be weighed against the introduction of mutations by excess PCR cycles. The recent interest in using specific TcRs for cancer immunotherapy has, however, increased the demand for practical and robust methods to rapidly clone and express TcRs. Two main technologies for TcR cloning have emerged; the use of a set of primers specifically annealing to all known TcR variable domains, and 5'-RACE amplification. We here present an improved 5'-RACE protocol that represents a fast and reliable way to identify a TcR from 10(5) cells only, making TcR cloning feasible without a priori knowledge of the variable domain sequence. We further present a detailed procedure for the subcloning of TcR alpha and beta chains into an expression system. We show that a recombination-based cloning protocol facilitates simple and rapid transfer of the TcR transgene into different expression systems. The presented comprehensive method can be performed in any laboratory with standard equipment and with a limited amount of starting material. We finally exemplify the straightforwardness and reliability of our procedure by cloning and expressing several MART-1-specific TcRs and demonstrating their functionality.	[Walchli, Bastien; Kumari, Shraddha; Johansen, Jorunn Nergard; Yang, Weiwen; Olweus, Johanna] Oslo Univ Hosp Radiumhosp, Inst Canc Res, Dept Immunol, Oslo, Norway; [Loset, Geir Age; Sandlie, Inger] Univ Oslo, Dept Mol Biosci, Oslo, Norway; [Loset, Geir Age; Sandlie, Inger] Univ Oslo, Ctr Immune Regulat, Oslo, Norway; [Olweus, Johanna] Univ Oslo, Inst Clin Med, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo	Walchli, B (corresponding author), Oslo Univ Hosp Radiumhosp, Inst Canc Res, Dept Immunol, Oslo, Norway.	sebastw@rr-research.no; johanna.olweus@medisin.uio.no	Olweus, Johanna/G-8008-2015; Løset, Geir/I-6413-2015	Olweus, Johanna/0000-0002-1898-3100; Løset, Geir/0000-0002-5257-8571; Walchli, Sebastien/0000-0001-5869-1746	Norwegian Research Council; Oslo University Hospital; University of Oslo; Health Region South-East; OA stiftelsen	Norwegian Research Council(Research Council of NorwayEuropean Commission); Oslo University Hospital; University of Oslo; Health Region South-East; OA stiftelsen	This study was financed by the The Norwegian Research Council (JO, SK, JNJ), Oslo University Hospital (JO, WY, SW), The University of Oslo (JO), Health Region South-East (SW) and OA stiftelsen (JO). The authors are grateful to the Groseth, Moen Stjern and Stokke families for inspiration and funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarnoudse CA, 2002, INT J CANCER, V99, P7, DOI 10.1002/ijc.10317; Ahmadi M, 2011, BLOOD, V118, P3528, DOI 10.1182/blood-2011-04-346338; BAER R, 1987, CELL, V50, P97, DOI 10.1016/0092-8674(87)90666-0; Birkholz K, 2009, J IMMUNOL METHODS, V346, P45, DOI 10.1016/j.jim.2009.05.001; Boria I, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-50; Carrasco YR, 2001, J EXP MED, V193, P1045, DOI 10.1084/jem.193.9.1045; Coccoris M, 2010, EXPERT OPIN BIOL TH, V10, P547, DOI 10.1517/14712591003614756; COULIE PG, 1994, J EXP MED, V180, P35, DOI 10.1084/jem.180.1.35; Dash P, 2011, J CLIN INVEST, V121, P288, DOI 10.1172/JCI44752; DEMBIC Z, 1986, NATURE, V320, P232, DOI 10.1038/320232a0; Dietrich PY, 2003, J IMMUNOL, V170, P5103, DOI 10.4049/jimmunol.170.10.5103; Engels B, 2003, HUM GENE THER, V14, P1155, DOI 10.1089/104303403322167993; Ferradini Laurent, 1993, Molecular Immunology, V30, P1143, DOI 10.1016/0161-5890(93)90132-U; GENEVEE C, 1992, EUR J IMMUNOL, V22, P1261, DOI 10.1002/eji.1830220522; Giudicelli V, 2006, NUCLEIC ACIDS RES, V34, pD781, DOI 10.1093/nar/gkj088; Govers C, 2010, TRENDS MOL MED, V16, P77, DOI 10.1016/j.molmed.2009.12.004; HEDRICK SM, 1984, NATURE, V308, P149, DOI 10.1038/308149a0; Johnson LA, 2006, J IMMUNOL, V177, P6548, DOI 10.4049/jimmunol.177.9.6548; Kieback E, 2010, EXPERT OPIN BIOL TH, V10, P749, DOI 10.1517/14712591003689998; Leisegang M, 2008, J MOL MED, V86, P573, DOI 10.1007/s00109-008-0317-3; Lissina A, 2009, J IMMUNOL METHODS, V340, P11, DOI 10.1016/j.jim.2008.09.014; MILLS DR, 1979, P NATL ACAD SCI USA, V76, P2232, DOI 10.1073/pnas.76.5.2232; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; Moysey R, 2004, ANAL BIOCHEM, V326, P284, DOI 10.1016/j.ab.2003.12.011; Ochi T, 2011, EXPERT OPIN BIOL TH, V11, P699, DOI 10.1517/14712598.2011.566853; Osborn MJ, 2005, MOL THER, V12, P569, DOI 10.1016/j.ymthe.2005.04.013; Ozawa T, 2008, BIOCHEM BIOPH RES CO, V367, P820, DOI 10.1016/j.bbrc.2008.01.011; PADOVAN E, 1993, SCIENCE, V262, P422, DOI 10.1126/science.8211163; PALIARD X, 1991, SCIENCE, V253, P325, DOI 10.1126/science.1857971; ROSENBERG WMC, 1992, EUR J IMMUNOL, V22, P541, DOI 10.1002/eji.1830220237; Rubio V, 2003, NAT MED, V9, P1377, DOI 10.1038/nm942; Saeboe-Larssen S, 2002, J IMMUNOL METHODS, V259, P191, DOI 10.1016/S0022-1759(01)00506-3; Schmitt TM, 2009, HUM GENE THER, V20, P1240, DOI 10.1089/hum.2009.146; Schumacher TNM, 2002, NAT REV IMMUNOL, V2, P512, DOI 10.1038/nri841; SENSI M, 1995, P NATL ACAD SCI USA, V92, P5674, DOI 10.1073/pnas.92.12.5674; SIU G, 1984, CELL, V37, P393, DOI 10.1016/0092-8674(84)90369-6; Stronen E, 2009, SCAND J IMMUNOL, V69, P319, DOI 10.1111/j.1365-3083.2008.02223.x; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Trautmann L, 2002, EUR J IMMUNOL, V32, P3181, DOI 10.1002/1521-4141(200211)32:11<3181::AID-IMMU3181>3.0.CO;2-2; TSURUTA Y, 1993, J IMMUNOL METHODS, V161, P7, DOI 10.1016/0022-1759(93)90193-B; Uckert W, 2009, CANCER IMMUNOL IMMUN, V58, P809, DOI 10.1007/s00262-008-0649-4; Wilde S, 2009, BLOOD, V114, P2131, DOI 10.1182/blood-2009-03-209387; Yang S, 2008, GENE THER, V15, P1411, DOI 10.1038/gt.2008.90; Zhao YB, 2005, J IMMUNOL, V174, P4415, DOI 10.4049/jimmunol.174.7.4415	44	32	71	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2011	6	11							e27930	10.1371/journal.pone.0027930	http://dx.doi.org/10.1371/journal.pone.0027930			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IO	22132171	Green Published, gold, Green Submitted			2022-12-27	WOS:000297789900035
J	Lim, TP; Lee, W; Tan, TY; Sasikala, S; Teo, J; Hsu, LY; Tan, TT; Syahidah, N; Kwa, AL				Lim, Tze-Peng; Lee, Winnie; Tan, Thean-Yen; Sasikala, Suranthran; Teo, Jocelyn; Hsu, Li-Yang; Tan, Thuan-Tong; Syahidah, Nur; Kwa, Andrea L.			Effective Antibiotics in Combination against Extreme Drug-Resistant Pseudomonas aeruginosa with Decreased Susceptibility to Polymyxin B	PLOS ONE			English	Article							GRAM-NEGATIVE BACTERIA; EXTENDED-SPECTRUM VARIANT; METALLO-BETA-LACTAMASES; INFECTIONS; MECHANISMS; PNEUMONIA; PHARMACOKINETICS; HOSPITALS; SINGAPORE; COLISTIN	Objective: Extreme drug-resistant Pseudomonas aeruginosa (XDR-PA) with decreased susceptibility to polymyxin B (PB) has emerged in Singapore, causing infections in immunocompromised hosts. Combination therapy may be the only viable therapeutic option until new antibiotics become available. The objective of this study is to assess the in vitro activity of various antibiotics against local XDR-PA isolates. Methods: PA isolates from all public hospitals in Singapore were systematically collected between 2006 and 2007. MICs were determined according to CLSI guidelines. All XDR-PA isolates identified were genotyped using a PCR-based method. Time-kill studies (TKS) were performed with approximately 10(5) CFU/ml at baseline using clinically achievable unbound concentrations of amikacin (A), levofloxacin (L), meropenem (M), rifampicin (R) and PB alone and in combination. Bactericidal activity (primary endpoint) was defined as a >= 3 log(10) CFU/ml decrease in the colony count from the initial inoculum at 24 hours. Results: 22 clinical XDR-PA isolates with PB MIC 2-16 mu g/ml were collected. From clonal typing, 5 clonal groups were identified and nine isolates exhibited clonal diversity. In TKS, meropenem plus PB, amikacin plus meropenem, amikacin plus rifampicin, amikacin plus PB exhibited bactericidal activity in 8/22, 3/22, 1/22 and 6/22 isolates at 24 hours respectively. Against the remaining ten isolates where none of the dual-drug combination achieved bactericidal activity against, only the triple-antibiotic combinations of ARP and AMP achieved bactericidal activity against 7/10 and 6/10 isolates respectively. Conclusion: Bactericidal activity with sustained killing effect of >= 99.9% is critical for eradicating XDR-PA infections, especially in immunocompromised hosts. These findings underscore the difficulty of developing combination therapeutic options against XDR-PA, demonstrating that at least 3 antibiotics are required in combination and that efficacy is strain dependant.	[Lim, Tze-Peng; Lee, Winnie; Sasikala, Suranthran; Teo, Jocelyn; Syahidah, Nur; Kwa, Andrea L.] Singapore Gen Hosp, Dept Pharm, Singapore 0316, Singapore; [Tan, Thean-Yen] Changi Gen Hosp, Dept Lab Med, Singapore, Singapore; [Tan, Thuan-Tong] Singapore Gen Hosp, Dept Infect Dis, Singapore 0316, Singapore; [Lim, Tze-Peng; Hsu, Li-Yang] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Div Infect Dis, Singapore 117595, Singapore	Singapore General Hospital; Changi General Hospital; Singapore General Hospital; National University of Singapore	Lim, TP (corresponding author), Singapore Gen Hosp, Dept Pharm, Singapore 0316, Singapore.	andrea.kwa.l.h@sgh.com.sg		Teo, Jocelyn Qi-Min/0000-0003-2508-3941; Tan, Thean Yen/0000-0003-4358-1098; Hsu, Li Yang/0000-0002-0396-066X	SingHealth Foundation (Singapore); Janssen-Cilag; Pfizer.Inc; Merck Sharp & Dohme (I.A.) Corp	SingHealth Foundation (Singapore); Janssen-Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Pfizer.Inc(Pfizer); Merck Sharp & Dohme (I.A.) Corp(Merck & Company)	This study was supported in part by research grants from the SingHealth Foundation (Singapore). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.; T-YT and L-YH have received funding for research from, and have been an invited as speakers for Wyeth Pharmaceuticals and Pfizer. ALK, WL and T-PL have received funding for research from Janssen-Cilag, Pfizer.Inc & Merck Sharp & Dohme (I.A.) Corp. None of these companies provided any funding for this particular study. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Bergen PJ, 2011, ANTIMICROB AGENTS CH, V55, P5134, DOI 10.1128/AAC.05028-11; Bonomo RA, 2006, CLIN INFECT DIS, V43, pS49, DOI 10.1086/504477; Clinical and Laboratory Standards Institute, 2011, M100S21 CLSI; Clinical and Laboratory Standards Institute, 2009, METH DIL ANT SUSC TE, V29; DANEL F, 1995, ANTIMICROB AGENTS CH, V39, P1881, DOI 10.1128/AAC.39.8.1881; Dawson SL, 2002, J MICROBIOL METH, V50, P9, DOI 10.1016/S0167-7012(02)00003-9; Ellington MJ, 2007, J ANTIMICROB CHEMOTH, V59, P321, DOI 10.1093/jac/dkl481; Furtado GHC, 2007, INT J ANTIMICROB AG, V30, P315, DOI 10.1016/j.ijantimicag.2007.05.017; Giamarellou H, 2010, INT J ANTIMICROB AG, V36, pS50, DOI 10.1016/j.ijantimicag.2010.11.014; Gumbo T, 2007, ANTIMICROB AGENTS CH, V51, P3781, DOI 10.1128/AAC.01533-06; Hsu LY, 2010, ANTIMICROB AGENTS CH, V54, P1173, DOI 10.1128/AAC.01076-09; Jaruratanasirikul S, 2005, ANTIMICROB AGENTS CH, V49, P1337, DOI 10.1128/AAC.49.4.1337-1339.2005; Juan C, 2005, ANTIMICROB AGENTS CH, V49, P4733, DOI 10.1128/AAC.49.11.4733-4738.2005; Koh TH, 2004, J CLIN MICROBIOL, V42, P5378, DOI 10.1128/JCM.42.11.5378-5380.2004; KUNIN CM, 1973, ANN NY ACAD SCI, V226, P214, DOI 10.1111/j.1749-6632.1973.tb20483.x; Kwa A, 2007, EXPERT REV ANTI-INFE, V5, P811, DOI 10.1586/14787210.5.5.811; Kwa AL, 2008, ANN ACAD MED SINGAP, V37, P870; Kwa ALH, 2008, DIAGN MICR INFEC DIS, V60, P163, DOI 10.1016/j.diagmicrobio.2007.08.008; LETENDRE ED, 1988, J ANTIMICROB CHEMOTH, V22, P557, DOI 10.1093/jac/22.4.557; Lister PD, 2009, CLIN MICROBIOL REV, V22, P582, DOI 10.1128/CMR.00040-09; Livermore DM, 2007, INT J ANTIMICROB AG, V29, pS1, DOI 10.1016/S0924-8579(07)00158-6; Magiorakos AP, 2011, CLIN MICROBIOL INFEC; Mesaros N, 2007, CLIN MICROBIOL INFEC, V13, P560, DOI 10.1111/j.1469-0691.2007.01681.x; Mikulska M, 2009, BIOL BLOOD MARROW TR, V15, P47, DOI 10.1016/j.bbmt.2008.10.024; Navon-Venezia S, 2005, CURR OPIN INFECT DIS, V18, P306, DOI 10.1097/01.qco.0000171920.44809.f0; Ostronoff M, 2006, INT J INFECT DIS, V10, P339, DOI 10.1016/j.ijid.2005.06.003; Ouderkirk JP, 2003, ANTIMICROB AGENTS CH, V47, P2659, DOI 10.1128/AAC.47.8.2659-2662.2003; Pereira GH, 2007, DIAGN MICR INFEC DIS, V58, P235, DOI 10.1016/j.diagmicrobio.2007.01.008; Pitout JDD, 2005, J CLIN MICROBIOL, V43, P3129, DOI 10.1128/JCM.43.7.3129-3135.2005; Poirel L, 2001, ANTIMICROB AGENTS CH, V45, P447, DOI 10.1128/AAC.45.2.447-453.2001; Sobieszczyk ME, 2004, J ANTIMICROB CHEMOTH, V54, P566, DOI 10.1093/jac/dkh369; Tan TY, 2008, ANN ACAD MED SINGAP, V37, P819; Tan TT, 2010, 20 EUR C CLIN MICR I; Tod M, 1998, ANTIMICROB AGENTS CH, V42, P849, DOI 10.1128/AAC.42.4.849; Zavascki AP, 2008, CLIN INFECT DIS, V47, P1298, DOI 10.1086/592577	35	44	50	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e28177	10.1371/journal.pone.0028177	http://dx.doi.org/10.1371/journal.pone.0028177			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22162759	Green Published, Green Submitted, gold			2022-12-27	WOS:000298172800018
J	Martin, NA; Patrick, SKM; Estrada, TE; Frisk, HA; Rogan, DT; Dvorak, B; Halpern, MD				Martin, Nina A.; Patrick, Sarah K. Mount; Estrada, Teresa E.; Frisk, Harrison A.; Rogan, Daniel T.; Dvorak, Bohuslav; Halpern, Melissa D.			Active Transport of Bile Acids Decreases Mucin 2 in Neonatal Ileum: Implications for Development of Necrotizing Enterocolitis	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; COLON-CANCER CELLS; RAT MODEL; DEOXYCHOLIC-ACID; SMALL-INTESTINE; EPITHELIAL-CELLS; UP-REGULATION; EXPRESSION; SALTS; OVEREXPRESSION	Necrotizing enterocolitis (NEC) is the most common gastrointestinal emergency of premature infants, but its etiology remains unclear. We have previously shown that mucin 2 (Muc2) positive goblet cells are significantly decreased in NEC. We have also shown that ileal bile acids (BAs) are significantly increased during the development of this disease. Because BAs can affect mucins, we hypothesized that elevated ileal BAs contribute to decreased Muc2 in experimental NEC. The role of Muc2 in NEC was evaluated in Winnie +/+ mice, a strain that produces aberrant Muc2. Muc2 and trefoil factor 3 (Tff3) were assessed in neonatal rats subjected to the NEC protocol when bile acids were removed, and in ileal explants from newborn and older rats cultured with and without BAs. Further, the role of active transport of BAs was determined using neonatal rats given the apical sodium dependent bile acid transporter (Asbt) inhibitor SC-435 and in neonatal Asbt knockout mice subjected to the NEC protocol. Mice with aberrant Muc2 had significantly greater incidence and severity of NEC. Using both in vivo and ex vivo techniques, we determined that BAs decrease Muc2 positive cells in neonatal but not older ileum. However, Tff3 positive cells are not decreased by BAs. In addition, active transport of BAs is required for BAs to decrease Muc2 in immature ileum. These data show that functional Muc2 plays a critical role in the prevention of NEC and BAs can potentiate the decreased Muc2 in disease development. Further, BAs have a more profound effect on Muc2 in immature versus older ileum, which may explain at least in part why NEC occurs almost exclusively in premature infants.	[Martin, Nina A.] Univ Arizona, Dept Pediat, Tucson, AZ 85721 USA; Univ Arizona, Steele Childrens Res Ctr, Tucson, AZ 85721 USA	University of Arizona; University of Arizona	Martin, NA (corresponding author), Univ Arizona, Dept Pediat, Tucson, AZ 85721 USA.	mhalpern@peds.arizona.edu		Rogan, Daniel/0000-0003-0313-2204	Arizona Biomedical Research Committee; Eunice Kennedy Shriver National Institute of Child Health and Human Development [RO1 HD-54485]; Howard Hughes Medical Institute HHMI [52005889]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD054485] Funding Source: NIH RePORTER	Arizona Biomedical Research Committee; Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Howard Hughes Medical Institute HHMI(Howard Hughes Medical Institute); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the Arizona Biomedical Research Committee and by the Eunice Kennedy Shriver National Institute of Child Health and Human Development grant RO1 HD-54485 (to M.D. Halpern) and the Howard Hughes Medical Institute HHMI 52005889 (to the University of Arizona Undergraduate Biology Program, which partially supports N.A. Martin and D.T. Rogan). The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bernstein H, 2006, INFLAMM BOWEL DIS, V12, P278, DOI 10.1097/01.MIB.0000209789.14114.63; CAPLAN MS, 1993, PEDIATR PATHOL, V13, P357, DOI 10.3109/15513819309048223; Clark JA, 2006, AM J PHYSIOL-GASTR L, V291, pG938, DOI 10.1152/ajpgi.00090.2006; COLEMAN R, 1980, Biochemical Society Transactions, V8, P126; COLEMAN R, 1987, BIOCHEM SOC T, V15, P68; CRAVEN PA, 1986, CANCER RES, V46, P5754; CRAVEN PA, 1988, GASTROENTEROLOGY, V95, P676, DOI 10.1016/S0016-5085(88)80014-3; De Plaen IG, 2007, PEDIATR RES, V61, P716, DOI 10.1203/pdr.0b013e3180534219; Dvorak B, 2003, PEDIATR RES, V53, P426, DOI 10.1203/01.PDR.0000050657.56817.E0; Dvorak B, 2002, AM J PHYSIOL-GASTR L, V282, pG156, DOI 10.1152/ajpgi.00196.2001; Dvorak B, 1998, FEBS LETT, V435, P119, DOI 10.1016/S0014-5793(98)01050-3; Einerhand AWC, 2002, EUR J GASTROEN HEPAT, V14, P757, DOI 10.1097/00042737-200207000-00008; Hackam David J, 2005, Semin Pediatr Surg, V14, P49, DOI 10.1053/j.sempedsurg.2004.10.025; Halpern MD, 2006, GASTROENTEROLOGY, V130, P359, DOI 10.1053/j.gastro.2005.10.023; Halpern MD, 2003, AM J PHYSIOL-GASTR L, V284, pG695, DOI 10.1152/ajpgi.00353.2002; Halpern MD, 2003, J PEDIATR GASTR NUTR, V36, P126, DOI 10.1097/00005176-200301000-00024; Halpern MD, 2002, PEDIATR RES, V51, P733, DOI 10.1023/01.PDR.0000017480.64723.56; Halpern MD, 2008, SEMIN PERINATOL, V32, P114, DOI 10.1053/j.semperi.2008.01.005; Halpern MD, 2008, AM J PHYSIOL-GASTR L, V294, pG20, DOI 10.1152/ajpgi.00168.2007; Halpern MD, 2010, AM J PHYSIOL-GASTR L, V299, pG623, DOI 10.1152/ajpgi.00242.2010; Heazlewood CK, 2008, PLOS MED, V5, P440, DOI 10.1371/journal.pmed.0050054; Hu YC, 2007, ARCH SURG-CHICAGO, V142, P540, DOI 10.1001/archsurg.142.6.540; ISRAEL EJ, 1994, ACTA PAEDIATR, V83, P27, DOI 10.1111/j.1651-2227.1994.tb13238.x; Jackson GDF, 2000, INFECT IMMUN, V68, P4714, DOI 10.1128/IAI.68.8.4714-4719.2000; Khailova L, 2009, AM J PHYSIOL-GASTR L, V297, pG940, DOI 10.1152/ajpgi.00141.2009; Kim YD, 2002, MOL PHARMACOL, V62, P1112, DOI 10.1124/mol.62.5.1112; Klinkspoor JH, 1998, BIOCHEM J, V332, P257, DOI 10.1042/bj3320257; Klinkspoor JH, 1999, GLYCOBIOLOGY, V9, P13, DOI 10.1093/glycob/9.1.13; Lee HY, 2010, INT J ONCOL, V36, P941, DOI 10.3892/ijo_00000573; Lemons JA, 2001, PEDIATRICS, V107, part. no., DOI 10.1542/peds.107.1.e1; McElroy SJ, 2011, AM J PHYSIOL-GASTR L, V301, pG656, DOI 10.1152/ajpgi.00550.2010; Milovic V, 2002, EUR J CLIN INVEST, V32, P29, DOI 10.1046/j.0014-2972.2001.00938.x; Muhlbauer M, 2004, AM J PHYSIOL-GASTR L, V286, pG1000, DOI 10.1152/ajpgi.00338.2003; Neu J, 1996, PEDIATR CLIN N AM, V43, P409, DOI 10.1016/S0031-3955(05)70413-2; Perrais M, 2001, J BIOL CHEM, V276, P30923, DOI 10.1074/jbc.M104204200; Podolsky Daniel K., 2000, Journal of Gastroenterology, V35, P69; Schanler RJ, 1999, CLIN PERINATOL, V26, P379, DOI 10.1016/S0095-5108(18)30058-7; Shekels LL, 1996, INT J BIOCHEM CELL B, V28, P193, DOI 10.1016/1357-2725(95)00125-5; Shneider BL, 1997, PEDIATR RES, V42, P189, DOI 10.1203/00006450-199708000-00010; SHUB MD, 1983, BIOCHEM J, V215, P405, DOI 10.1042/bj2150405; Song SM, 2005, CANCER-AM CANCER SOC, V103, P1606, DOI 10.1002/cncr.21015; SPECIAN RD, 1991, AM J PHYSIOL, V260, pC183, DOI 10.1152/ajpcell.1991.260.2.C183; SUEMORI S, 1991, P NATL ACAD SCI USA, V88, P11017, DOI 10.1073/pnas.88.24.11017; Taupin D, 2003, NAT REV MOL CELL BIO, V4, P721, DOI 10.1038/nrm1203; THOMPSON JF, 1994, GASTROENTEROLOGY, V107, P1278, DOI 10.1016/0016-5085(94)90528-2; Walker WA, 2002, J PEDIATR GASTR NUTR, V34, pS33, DOI 10.1097/00005176-200205001-00009; Wiedmann TS, 2004, LIPIDS, V39, P51, DOI 10.1007/s11745-004-1201-y; Wu JT, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-333; Yajima M, 2007, BIOSCI BIOTECH BIOCH, V71, P2420, DOI 10.1271/bbb.70121; Zhong SP, 2001, AM J PHYSIOL-REG I, V280, pR376, DOI 10.1152/ajpregu.2001.280.2.R376	50	39	43	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e27191	10.1371/journal.pone.0027191	http://dx.doi.org/10.1371/journal.pone.0027191			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22162748	Green Published, Green Submitted, gold			2022-12-27	WOS:000298172800003
J	Singhal, A; Mathys, V; Kiass, M; Creusy, C; Delaire, B; Aliouat, E; Dartois, V; Kaplan, G; Bifani, P				Singhal, Amit; Mathys, Vanessa; Kiass, Mehdi; Creusy, Colette; Delaire, Baptiste; Aliouat, El Moukhtar; Dartois, Veronique; Kaplan, Gilla; Bifani, Pablo			BCG Induces Protection against Mycobacterium tuberculosis Infection in the Wistar Rat Model	PLOS ONE			English	Article							HELPER-CELL-DIFFERENTIATION; CALMETTE-GUERIN VACCINATION; IMMUNE-RESPONSE; MICE; EXPRESSION; STRAINS; CORRELATE; LUNG; METAANALYSIS; ACTIVATION	Our understanding of the correlation of Mycobacterium bovis Bacille Calmette-Guerin (BCG)-mediated immune responses and protection against Mycobacterium tuberculosis (Mtb) infection is still limited. We have recently characterized a Wistar rat model of experimental tuberculosis (TB). In the present study, we evaluated the efficacy of BCG vaccination in this model. Upon Mtb challenge, BCG vaccinated rats controlled growth of the bacilli earlier than unvaccinated rats. Histopathology analysis of infected lungs demonstrated a reduced number of granulomatous lesions and lower parenchymal inflammation in vaccinated animals. Vaccine-mediated protection correlated with the rapid accumulation of antigen specific CD4(+) and CD8(+) T cells in the infected lungs. Immunohistochemistry further revealed higher number of CD8(+) cells in the pulmonary granulomas of vaccinated animals. Evaluation of pulmonary immune responses in vaccinated and Mtb infected rats by real time PCR at day 15 post-challenge showed reduced expression of genes responsible for negative regulation of Th1 immune responses. Thus, early protection observed in BCG vaccinated rats correlated with a similarly timed shift of immunity towards the Th1 type response. Our data support the importance of (i) the Th1-Th2 balance in the control of mycobacterial infection and (ii) the value of the Wistar rats in understanding the biology of TB.	[Singhal, Amit; Bifani, Pablo] Novartis Inst Trop Dis, Singapore, Singapore; [Mathys, Vanessa; Kiass, Mehdi] Sci Inst Publ Hlth, Brussels, Belgium; [Creusy, Colette; Delaire, Baptiste] Univ Catholique Lille, Hop St Vincent, Inst Catholique Lillois, Grp Hosp, Lille, France; [Aliouat, El Moukhtar] Univ Lille Nord France, Dept Parasitol, Fac Biol & Pharmaceut Sci, Lille, France; [Dartois, Veronique; Kaplan, Gilla] Univ Med & Dent New Jersey, Publ Hlth Res Inst Ctr, Newark, NJ 07103 USA; [Singhal, Amit] ASTAR, Singapore Immunol Network, Singapore, Singapore	Novartis; Universite Catholique de Lille; Universite de Lille - ISITE; Universite de Lille; Rutgers State University New Brunswick; Rutgers State University Medical Center; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN)	Singhal, A (corresponding author), Novartis Inst Trop Dis, Singapore, Singapore.	Amit_Singhal@immunol.a-star.edu.sg; pablo.bifani@novartis.com	Aliouat, El Moukhtar/D-2859-2018	Aliouat, El Moukhtar/0000-0003-2905-7126; Bifani, Pablo/0000-0001-9651-6439; Singhal, Amit/0000-0003-3913-8798	Bill and Melinda Gates Foundation [42758]; Novartis Institute for Tropical Diseases, Singapore	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Novartis Institute for Tropical Diseases, Singapore	The work has been supported primarily by the Bill and Melinda Gates Foundation Accelerator Grant (#42758). The rest of the project has been funded internally by the Novartis Institute for Tropical Diseases, Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida AS, 2009, J IMMUNOL, V183, P718, DOI 10.4049/jimmunol.0801212; Bifani PJ, 1999, JAMA-J AM MED ASSOC, V282, P2321, DOI 10.1001/jama.282.24.2321; Black GF, 2002, LANCET, V359, P1393, DOI 10.1016/S0140-6736(02)08353-8; Capuano SV, 2003, INFECT IMMUN, V71, P5831, DOI 10.1128/IAI.71.10.5831-5844.2003; Chackerian AA, 2001, INFECT IMMUN, V69, P2666, DOI 10.1128/IAI.69.4.2666-2674.2001; Chen CY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000392; COLDITZ GA, 1994, JAMA-J AM MED ASSOC, V271, P698, DOI 10.1001/jama.271.9.698; Commandeur S, 2011, CLIN VACCINE IMMUNOL, V18, P676, DOI 10.1128/CVI.00492-10; da Fonseca DM, 2009, INFECT IMMUN, V77, P5311, DOI 10.1128/IAI.00580-09; Ellner JJ, 2000, CLIN INFECT DIS, V30, pS279, DOI 10.1086/313874; Eriksen J, 2010, THORAX, V65, P1067, DOI 10.1136/thx.2010.140186; Glynn JR, 2002, EMERG INFECT DIS, V8, P843; Goter-Robinson C, 2006, VACCINE, V24, P3522, DOI 10.1016/j.vaccine.2006.02.005; Grover A, 2009, INFECT IMMUN, V77, P4837, DOI 10.1128/IAI.00704-09; Gupta UD, 2009, INDIAN J MED RES, V129, P11; Hamoudi RA, 2010, LEUKEMIA, V24, P1487, DOI 10.1038/leu.2010.118; Hernandez-Pando R, 2004, EUR J IMMUNOL, V34, P174, DOI 10.1002/eji.200324253; Huang HY, 2010, J CLIN MICROBIOL, V48, P4474, DOI 10.1128/JCM.00930-10; Jeevan A, 2003, INFECT IMMUN, V71, P354, DOI 10.1128/IAI.71.1.354-364.2003; Jeevan A, 2011, TUBERCULOSIS, V91, P47, DOI 10.1016/j.tube.2010.11.006; Jeon BY, 2008, INFECT IMMUN, V76, P5173, DOI 10.1128/IAI.00019-08; Kagina BMN, 2010, AM J RESP CRIT CARE, V182, P1073, DOI 10.1164/rccm.201003-0334OC; Kamath AB, 2004, J EXP MED, V200, P1479, DOI 10.1084/jem.20041690; Kaufmann SHE, 2006, NAT REV IMMUNOL, V6, P699, DOI 10.1038/nri1920; Kaufmann SHE, 2010, IMMUNITY, V33, P567, DOI 10.1016/j.immuni.2010.09.015; Kobayashi T, 2006, NAT IMMUNOL, V7, P123, DOI 10.1038/ni0206-123; Lalvani A, 2010, THORAX, V65, P1036, DOI 10.1136/thx.2010.140996; Li BY, 1999, EMBO J, V18, P420, DOI 10.1093/emboj/18.2.420; Lienhardt C, 2002, EUR J IMMUNOL, V32, P1605, DOI 10.1002/1521-4141(200206)32:6<1605::AID-IMMU1605>3.0.CO;2-6; Lohoff M, 2002, P NATL ACAD SCI USA, V99, P11808, DOI 10.1073/pnas.182425099; Manca C, 2005, J INTERF CYTOK RES, V25, P694, DOI 10.1089/jir.2005.25.694; Manca C, 2001, P NATL ACAD SCI USA, V98, P5752, DOI 10.1073/pnas.091096998; McMurray David N., 1994, P135; Mendez A, 2011, TUBERCULOSIS, V91, P140, DOI 10.1016/j.tube.2010.12.008; Mittrucker HW, 2007, P NATL ACAD SCI USA, V104, P12434, DOI 10.1073/pnas.0703510104; Mogues T, 2001, J EXP MED, V193, P271, DOI 10.1084/jem.193.3.271; Murray RA, 2006, J IMMUNOL, V177, P5647, DOI 10.4049/jimmunol.177.8.5647; Ordway D, 2008, CLIN VACCINE IMMUNOL, V15, P1248, DOI 10.1128/CVI.00019-08; Reed MB, 2004, NATURE, V431, P84, DOI 10.1038/nature02837; Rook GAW, 2007, CURR MOL MED, V7, P327; Seah GT, 2000, J INFECT DIS, V181, P385, DOI 10.1086/315200; Singhal A, 2010, COLOR ATLAS COMP PAT, P157; Singhal A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018632; Ting LM, 1999, J IMMUNOL, V163, P3898; Trunz BB, 2006, LANCET, V367, P1173, DOI 10.1016/S0140-6736(06)68507-3; Tsenova L, 2007, VACCINE, V25, P5126, DOI 10.1016/j.vaccine.2006.11.024; Walker V, 2006, ARCH DIS CHILD, V91, P789, DOI 10.1136/adc.2006.098459; Wassie L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001522; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093	49	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e28082	10.1371/journal.pone.0028082	http://dx.doi.org/10.1371/journal.pone.0028082			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22162757	Green Submitted, Green Published, gold			2022-12-27	WOS:000298172800015
J	Aung, KM; Boldbaatar, D; Umemiya-Shirafuji, R; Liao, M; Xuan, XN; Suzuki, H; Galay, RL; Tanaka, T; Fujisaki, K				Aung, Kyaw Min; Boldbaatar, Damdinsuren; Umemiya-Shirafuji, Rika; Liao, Min; Xuan Xuenan; Suzuki, Hiroshi; Galay, Remil Linggatong; Tanaka, Tetsuya; Fujisaki, Kozo			Scavenger Receptor Mediates Systemic RNA Interference in Ticks	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; HAEMAPHYSALIS-LONGICORNIS; HARD TICK; PROTECTIVE ANTIGENS; OOCYTE DEVELOPMENT; GENE; IDENTIFICATION	RNA interference is an efficient method to silence gene and protein expressions. Here, the class B scavenger receptor CD36 (SRB) mediated the uptake of exogenous dsRNAs in the induction of the RNAi responses in ticks. Unfed female Haemaphysalis longicornis ticks were injected with a single or a combination of H. longicornis SRB (HlSRB) dsRNA, vitellogenin-1 (HlVg-1) dsRNA, and vitellogenin receptor (HlVgR) dsRNA. We found that specific and systemic silencing of the HlSRB, HlVg-1, and HlVgR genes was achieved in ticks injected with a single dsRNA of HlSRB, HlVg-1, and HlVgR. In ticks injected first with HlVg-1 or HlVgR dsRNA followed 96 hours later with HlSRB dsRNA (HlVg-1/HlSRB or HlVgR/HlSRB), gene silencing of HlSRB was achieved in addition to first knockdown in HlVg-1 or HlVgR, and prominent phenotypic changes were observed in engorgement, mortality, and hatchability, indicating that a systemic and specific double knockdown of target genes had been simultaneously attained in these ticks. However, in ticks injected with HlSRB dsRNA followed 96 hours later with HlVg-1 or HlVgR dsRNAs, silencing of HlSRB was achieved, but no subsequent knockdown in HlVgR or HlVg-1 was observed. The Westernblot and immunohistochemical examinations revealed that the endogenous HlSRB protein was fully abolished in midguts of ticks injected with HlSRB/HlVg-1 dsRNAs but HlVg-1 was normally expressed in midguts, suggesting that HlVg-1 dsRNA-mediated RNAi was fully inhibited by the first knockdown of HlSRB. Similarly, the abolished localization of HlSRB protein was recognized in ovaries of ticks injected with HlSRB/HlVgR, while normal localization of HlVgR was observed in ovaries, suggesting that the failure to knock-down HlVgR could be attributed to the first knockdown of HlSRB. In summary, we demonstrated for the first time that SRB may not only mediate the effective knock-down of gene expression by RNAi but also play essential roles for systemic RNAi of ticks.	[Aung, Kyaw Min; Galay, Remil Linggatong; Tanaka, Tetsuya; Fujisaki, Kozo] Yamaguchi Univ, Dept Pathol & Prevent Vet Sci, United Grad Sch Vet Sci, Yamaguchi, Japan; [Aung, Kyaw Min; Boldbaatar, Damdinsuren; Umemiya-Shirafuji, Rika; Liao, Min; Galay, Remil Linggatong; Tanaka, Tetsuya; Fujisaki, Kozo] Kagoshima Univ, Fac Agr, Lab Emerging Infect Dis, Dept Frontier Vet Med, Kagoshima 890, Japan; [Xuan Xuenan; Suzuki, Hiroshi] Obihiro Univ Agr & Vet Med, Natl Res Ctr Protozoan Dis, Obihiro, Hokkaido 080, Japan	Yamaguchi University; Kagoshima University; Obihiro University of Agriculture & Veterinary Medicine	Aung, KM (corresponding author), Yamaguchi Univ, Dept Pathol & Prevent Vet Sci, United Grad Sch Vet Sci, Yamaguchi, Japan.	tick@ms.kagoshima-u.ac.jp	Galay, Remil/AAN-4392-2021; Umemiya-Shirafuji, Rika/AFT-5139-2022	Galay, Remil/0000-0001-9749-8308; Umemiya-Shirafuji, Rika/0000-0001-7641-5526; Damdinsuren, Boldbaatar/0000-0002-0541-3766	Japan Society for the Promotion of Science (JSPS); National Researh Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine [23-joint-4]; Japanese Government (Ministry of Education, Culture, Sports, Science, and Technology)	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Researh Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine; Japanese Government (Ministry of Education, Culture, Sports, Science, and Technology)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by a Grant-in-Aid for Scientific Research (A) from the Japan Society for the Promotion of Science (JSPS) and a Cooperative Research Grant (23-joint-4) of the National Researh Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine. The first author (Kyaw Min Aung) is supported by the Japanese Government (Ministry of Education, Culture, Sports, Science, and Technology) scholarship for PhD study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aung KM, 2011, PARASITOL RES, V108, P273, DOI 10.1007/s00436-010-2053-1; Boldbaatar D, 2006, INSECT BIOCHEM MOLEC, V36, P25, DOI 10.1016/j.ibmb.2005.10.003; Boldbaatar D, 2008, BIOCHEM CELL BIOL, V86, P331, DOI [10.1139/O08-071, 10.1139/o08-071]; Boldbaatar D, 2010, J INSECT PHYSIOL, V56, P1587, DOI 10.1016/j.jinsphys.2010.05.019; De la Fuente J, 2006, BIOCHEM BIOPH RES CO, V344, P332, DOI 10.1016/j.bbrc.2006.03.109; de la Fuente J, 2005, PARASITOL RES, V96, P137, DOI 10.1007/s00436-005-1351-5; de la Fuente J, 2007, TRENDS PARASITOL, V23, P427, DOI 10.1016/j.pt.2007.07.002; FUJISAKI K, 1978, NATL I ANIM HEALTH Q, V18, P27; Gong HY, 2009, INSECT BIOCHEM MOLEC, V39, P372, DOI 10.1016/j.ibmb.2009.03.002; Huvenne H, 2010, J INSECT PHYSIOL, V56, P227, DOI 10.1016/j.jinsphys.2009.10.004; Liao M, 2008, INSECT BIOCHEM MOLEC, V38, P285, DOI 10.1016/j.ibmb.2007.11.006; Miyoshi T, 2004, J VET MED SCI, V66, P1471, DOI 10.1292/jvms.66.1471; Nijhof AM, 2007, INT J PARASITOL, V37, P653, DOI 10.1016/j.ijpara.2006.11.005; Peter RJ, 2005, VET PARASITOL, V132, P205, DOI 10.1016/j.vetpar.2005.07.004; Rajagopal R, 2002, J BIOL CHEM, V277, P46849, DOI 10.1074/jbc.C200523200; Ramet M, 2001, IMMUNITY, V15, P1027, DOI 10.1016/S1074-7613(01)00249-7; Saleh MC, 2006, NAT CELL BIOL, V8, P793, DOI 10.1038/ncb1439; Tomoyasu Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r10; Ulvila J, 2006, J BIOL CHEM, V281, P14370, DOI 10.1074/jbc.M513868200; Whyard S, 2009, INSECT BIOCHEM MOLEC, V39, P824, DOI 10.1016/j.ibmb.2009.09.007	20	23	23	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2011	6	12							e28407	10.1371/journal.pone.0028407	http://dx.doi.org/10.1371/journal.pone.0028407			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MQ	22145043	Green Published, gold, Green Submitted			2022-12-27	WOS:000298168900026
J	Langner, R; Eickhoff, SB; Steinborn, MB				Langner, Robert; Eickhoff, Simon B.; Steinborn, Michael B.			Mental Fatigue Modulates Dynamic Adaptation to Perceptual Demand in Speeded Detection	PLOS ONE			English	Article							SIMPLE REACTION-TIME; STIMULUS-INTENSITY; COGNITIVE CONTROL; SENSITIVITY DECREMENT; SUSTAINED ATTENTION; SIGNAL INTENSITY; MONITORING TASK; VIGILANCE TASK; INFORMATION; PERFORMANCE	When stimulus intensity in simple reaction-time tasks randomly varies across trials, detection speed usually improves after a low-intensity trial. With auditory stimuli, this improvement was often found to be asymmetric, being greater on current low-intensity trials. Our study investigated (1) whether asymmetric sequential intensity adaptation also occurs with visual stimuli; (2) whether these adjustments reflect decision-criterion shifts or, rather, a modulation of perceptual sensitivity; and (3) how sequential intensity adaptation and its underlying mechanisms are affected by mental fatigue induced through prolonged performance. In a continuous speeded detection task with randomly alternating high- and low-intensity visual stimuli, the reaction-time benefit after low-intensity trials was greater on subsequent low- than high-intensity trials. This asymmetry, however, only developed with time on task (TOT). Signal-detection analyses showed that the decision criterion transiently became more liberal after a low- intensity trial, whereas observer sensitivity increased when the preceding and current stimulus were of equal intensity. TOT-induced mental fatigue only affected sensitivity, which dropped more on low-than on high- intensity trials. This differential fatigue-related sensitivity decrease selectively enhanced the impact of criterion down-shifts on low- intensity trials, revealing how the interplay of two perceptual mechanisms and their modulation by fatigue combine to produce the observed overall pattern of asymmetric performance adjustments to varying visual intensity in continuous speeded detection. Our results have implications for similar patterns of sequential demand adaptation in other cognitive domains as well as for real-world prolonged detection performance.	[Langner, Robert; Eickhoff, Simon B.] Rhein Westfal TH Aachen, Sch Med, Dept Psychiat Psychotherapy & Psychosomat, Aachen, Germany; [Langner, Robert] Rhein Westfal TH Aachen, Sch Med, Neuropsychol Sect, Dept Neurol, Aachen, Germany; [Langner, Robert; Eickhoff, Simon B.] Res Ctr Julich, Inst Neurosci & Med INM 2, Julich, Germany; [Eickhoff, Simon B.] Univ Dusseldorf, Inst Clin Neurosci & Med Psychol, D-40225 Dusseldorf, Germany; [Steinborn, Michael B.] Univ Tubingen, Inst Psychol, Tubingen, Germany	RWTH Aachen University; RWTH Aachen University; Helmholtz Association; Research Center Julich; Heinrich Heine University Dusseldorf; Eberhard Karls University of Tubingen	Langner, R (corresponding author), Rhein Westfal TH Aachen, Sch Med, Dept Psychiat Psychotherapy & Psychosomat, Aachen, Germany.	robert.langner@rwth-aachen.de	Eickhoff, Simon B./K-2061-2013	Eickhoff, Simon B./0000-0001-6363-2759; Langner, Robert/0000-0002-3237-001X	Human Brain Project [R01-MH074457-01A1]; Helmholtz Association within the Helmholtz Alliance on Systems Biology (Human Brain Model); Deutsche Forschungsgemeinschaft [IRTG 1328]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH074457] Funding Source: NIH RePORTER	Human Brain Project(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Helmholtz Association within the Helmholtz Alliance on Systems Biology (Human Brain Model); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	SBE was supported by the Human Brain Project (R01-MH074457-01A1), the Initiative and Networking Fund of the Helmholtz Association within the Helmholtz Alliance on Systems Biology (Human Brain Model), and the Deutsche Forschungsgemeinschaft (IRTG 1328). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAUMEISTER AA, 1967, PSYCHOL REC, V17, P503, DOI 10.1007/BF03393724; Blatter K, 2007, PHYSIOL BEHAV, V90, P196, DOI 10.1016/j.physbeh.2006.09.009; Boksem MAS, 2008, BRAIN RES REV, V59, P125, DOI 10.1016/j.brainresrev.2008.07.001; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Carrasco M, 2000, VISION RES, V40, P1203, DOI 10.1016/S0042-6989(00)00024-9; Carrasco M, 2001, P NATL ACAD SCI USA, V98, P5363, DOI 10.1073/pnas.081074098; Correa A, 2005, PSYCHON B REV, V12, P328, DOI 10.3758/BF03196380; Davies DR, 1982, PSYCHOL VIGILANCE; Dreisbach G, 2011, PSYCHOL RES-PSYCH FO, V75, P376, DOI 10.1007/s00426-010-0319-y; Drummond SPA, 2005, SLEEP, V28, P1059; Dukas R, 2001, BEHAV ECOL, V12, P192, DOI 10.1093/beheco/12.2.192; Egner T, 2007, COGN AFFECT BEHAV NE, V7, P380, DOI 10.3758/CABN.7.4.380; Fischer R, 2008, J EXP PSYCHOL LEARN, V34, P712, DOI 10.1037/0278-7393.34.3.712; GENDRON RP, 1986, ANIM BEHAV, V34, P898, DOI 10.1016/S0003-3472(86)80076-8; GRATTON G, 1992, J EXP PSYCHOL GEN, V121, P480, DOI 10.1037/0096-3445.121.4.480; GRICE GR, 1968, PSYCHOL REV, V75, P359, DOI 10.1037/h0026287; Helton WS, 2008, ACTA PSYCHOL, V129, P18, DOI 10.1016/j.actpsy.2008.04.002; HENRIKSEN K, 1971, J EXP PSYCHOL, V90, P287, DOI 10.1037/h0031551; Hommel B, 2004, PSYCHOL RES-PSYCH FO, V68, P1, DOI 10.1007/s00426-003-0132-y; Jaskowski P, 2006, INT J PSYCHOPHYSIOL, V61, P98, DOI 10.1016/j.ijpsycho.2005.07.010; Jha AP, 2010, J EXP PSYCHOL LEARN, V36, P1036, DOI 10.1037/a0019337; JOHN ID, 1967, AUST J PSYCHOL, V19, P35, DOI 10.1080/00049536708255559; KELLAS G, 1969, J COMP PHYSIOL PSYCH, V68, P303, DOI 10.1037/h0027610; KOHFELD DL, 1969, J EXP PSYCHOL, V82, P88, DOI 10.1037/h0028033; KOHFELD DL, 1969, AM J PSYCHOL, V82, P104, DOI 10.2307/1420611; Langner R, 2012, HUM BRAIN MAPP, V33, P398, DOI 10.1002/hbm.21220; Langner R, 2010, PSYCHOL RES-PSYCH FO, V74, P499, DOI 10.1007/s00426-010-0275-6; Langner R, 2010, ACTA PSYCHOL, V133, P64, DOI 10.1016/j.actpsy.2009.10.001; Lim JL, 2008, ANN NY ACAD SCI, V1129, P305, DOI 10.1196/annals.1417.002; LISPER HO, 1973, J EXP PSYCHOL, V98, P316, DOI 10.1037/h0034360; Los SA, 1996, ACTA PSYCHOL, V94, P145, DOI 10.1016/0001-6918(95)00050-X; Mayr U, 2003, NAT NEUROSCI, V6, P450, DOI 10.1038/nn1051; McNicol D., 1972, PRIMER SIGNAL DETECT; Miller J, 2003, COGNITIVE PSYCHOL, V46, P101, DOI 10.1016/S0010-0285(02)00517-0; Montagna B, 2009, VISION RES, V49, P735, DOI 10.1016/j.visres.2009.02.001; MURRAY HG, 1970, J EXP PSYCHOL, V84, P383, DOI 10.1037/h0029284; Murray HG, 1965, PSYCHON SCI, V3, P439; NICKERSON RA, 1969, J EXP PSYCHOL, V79, P452, DOI 10.1037/h0026889; NICKERSON RS, 1967, ACTA PSYCHOL, V27, P23, DOI 10.1016/0001-6918(67)90041-8; NIEMI P, 1982, ACTA PSYCHOL, V50, P73, DOI 10.1016/0001-6918(82)90052-X; NIEMI P, 1981, PERCEPT MOTOR SKILL, V53, P615, DOI 10.2466/pms.1981.53.2.615; NISSEN MJ, 1977, PERCEPT PSYCHOPHYS, V22, P338, DOI 10.3758/BF03199699; NUECHTERLEIN KH, 1983, SCIENCE, V220, P327, DOI 10.1126/science.6836276; PARASURAMAN R, 1976, J EXP PSYCHOL HUMAN, V2, P578, DOI 10.1037/0096-1523.2.4.578; Reynolds JH, 2000, NEURON, V26, P703, DOI 10.1016/S0896-6273(00)81206-4; Rolike B, 2007, PSYCHON B REV, V14, P522, DOI 10.3758/BF03194101; SANDERS AF, 1982, ACTA PSYCHOL, V51, P41, DOI 10.1016/0001-6918(82)90018-X; Schmidt C, 2009, SCIENCE, V324, P516, DOI 10.1126/science.1167337; SEE JE, 1995, PSYCHOL BULL, V117, P230, DOI 10.1037/0033-2909.117.2.230; SHIU LP, 1995, VISION RES, V35, P337, DOI 10.1016/0042-6989(94)00148-F; Smit AS, 2004, ACTA PSYCHOL, V115, P35, DOI 10.1016/j.actpsy.2003.11.001; Spence C, 2010, CONSCIOUS COGN, V19, P364, DOI 10.1016/j.concog.2009.12.001; SPITZER H, 1988, SCIENCE, V240, P338, DOI 10.1126/science.3353728; TANNER WP, 1954, PSYCHOL REV, V61, P401, DOI 10.1037/h0058700; Temple JG, 2000, HUM FACTORS, V42, P183, DOI 10.1518/001872000779656480; Willer B, 1993, KURZFRAGEBOGEN AKTUE; WILLIGES RC, 1969, J EXP PSYCHOL, V81, P61, DOI 10.1037/h0027432; Wilson BA, 2000, J INT NEUROPSYCH SOC, V6, P469, DOI 10.1017/S1355617700644053; Woodworth R.S., 1938, EXP PSYCHOL	59	20	20	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2011	6	12							e28399	10.1371/journal.pone.0028399	http://dx.doi.org/10.1371/journal.pone.0028399			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	863MQ	22145041	Green Published, gold, Green Submitted			2022-12-27	WOS:000298168900024
J	Ricks, PM; Cain, KP; Oeltmann, JE; Kammerer, JS; Moonan, PK				Ricks, Philip M.; Cain, Kevin P.; Oeltmann, John E.; Kammerer, J. Steve; Moonan, Patrick K.			Estimating the Burden of Tuberculosis among Foreign-Born Persons Acquired Prior to Entering the US, 2005-2009	PLOS ONE			English	Article							LATENT TUBERCULOSIS; MYCOBACTERIUM-TUBERCULOSIS; CONTACT INVESTIGATIONS; UNITED-STATES; MOLECULAR EPIDEMIOLOGY; TRANSMISSION; IMMIGRATION; INFECTION; COUNTRIES; OUTCOMES	Background: The true burden of reactivation of remote latent tuberculosis infection (reactivation TB) among foreign-born persons with tuberculosis (TB) within the United States is not known. Our study objectives were to estimate the proportion of foreign-born persons with TB due reactivation TB and to describe characteristics of foreign-born persons with reactivation TB. Methods: We conducted a cross-sectional study of patients with an M. tuberculosis isolate genotyped by the U. S. National TB Genotyping Service, 2005-2009. TB cases were attributed to reactivation TB if they were not a member of a localized cluster of cases. Localized clusters were determined by a spatial scan statistic of cases with isolates with matching TB genotype results. Crude odds ratios and 95% confidence intervals were used to assess relations between reactivation TB and select factors among foreign-born persons. Main Results: Among the 36,860 cases with genotyping and surveillance data reported, 22,151 (60%) were foreign-born. Among foreign-born persons with TB, 18,540 (83.7%) were attributed to reactivation TB. Reactivation TB among foreign-born persons was associated with increasing age at arrival, incidence of TB in the country of origin, and decreased time in the U. S. at the time of TB diagnosis. Conclusions: Four out of five TB cases among foreign-born persons can be attributed to reactivation TB and present the largest challenge to TB elimination in the U. S. TB control strategies among foreign-born persons should focus on finding and treating latent tuberculosis infection prior to or shortly after arrival to the United States and on reducing the burden of LTBI through improvements in global TB control.	[Ricks, Philip M.; Cain, Kevin P.; Oeltmann, John E.; Kammerer, J. Steve; Moonan, Patrick K.] US Ctr Dis Control & Prevent, Div TB Eliminat, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Ricks, PM (corresponding author), US Ctr Dis Control & Prevent, Div TB Eliminat, Atlanta, GA 30333 USA.	pmoonan@cdc.gov	Moonan, Patrick K/F-4307-2014; Moonan, Patrick/AAD-2169-2021	Moonan, Patrick/0000-0002-3550-2065				Abubakar I, 2011, BMJ-BRIT MED J, V29, P343; [Anonymous], 1991, TECHN INSTR MED EX A; Barnes PF, 2003, NEW ENGL J MED, V349, P1149, DOI 10.1056/NEJMra021964; Barniol J, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-197; Borgdorff MW, 2000, INT J TUBERC LUNG D, V4, P287; Cain KP, 2008, JAMA-J AM MED ASSOC, V300, P405, DOI 10.1001/jama.300.4.405; *CDCP, 2005, MMWR-MORBID MORTAL W, V54, P47; Centers for Disease Control and Prevention, 2010, REP TUB US 2009; Centers for Disease Control and Prevention, 2009, CDC IMM REQ TECHN IN; Centers for Disease Control and Prevention U. S. Department of Health and Human Services, 2010, REP VER CAS TUB RVCT; Cohn DL, 2000, AM J RESP CRIT CARE, V161, pS221; Cowan LS, 2005, J CLIN MICROBIOL, V43, P688, DOI 10.1128/JCM.43.2.688-695.2005; Diel R, 2009, CHEST, V135, P1010, DOI 10.1378/chest.08-2048; El Sahly HM, 2001, J INFECT DIS, V183, P461, DOI 10.1086/318079; Geng E, 2002, NEW ENGL J MED, V346, P1453, DOI 10.1056/NEJMoa012972; Ghosh S, 2011, INFECT GENE IN PRESS; Gilbert RL, 2009, INT J TUBERC LUNG D, V13, P645; Haddad MB, 2007, AM J PREV MED, V32, P239, DOI 10.1016/j.amepre.2006.10.013; Hernandez-Garduno E, 2002, CAN MED ASSOC J, V167, P349; Hill A, 2010, MODELING IMPACT INTE; Hirsch-Moverman Y, 2008, INT J TUBERC LUNG D, V12, P1235; Jereb J, 2003, INT J TUBERC LUNG D, V7, pS384; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; Langlois-Klassen D, 2011, EUR RESPIR J, V38, P895, DOI 10.1183/09031936.00196610; Linas BP, 2011, AM J RESP CRIT CARE, V184, P590, DOI 10.1164/rccm.201101-0181OC; Love J, 2009, INT J TUBERC LUNG D, V13, P201; Marks SM, 2000, AM J RESP CRIT CARE, V162, P2033, DOI 10.1164/ajrccm.162.6.2004022; Menzies D, 2001, AM J RESP CRIT CARE, V164, P914, DOI 10.1164/ajrccm.164.6.2107090b; Oppong JR, 2007, PROF GEOGR, V59, P478, DOI 10.1111/j.1467-9272.2007.00636.x; Oxlade O, 2007, INT J TUBERC LUNG D, V11, P16; Pareek M, 2011, LANCET INFECT DIS, V11, P435, DOI 10.1016/S1473-3099(11)70069-X; Sandegren L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016647; Savine E, 2002, J CLIN MICROBIOL, V40, P4561, DOI 10.1128/JCM.40.12.4561-4566.2002; Schechter M, 2006, AM J RESP CRIT CARE, V173, P922, DOI 10.1164/rccm.200512-1953OC; Schwartzman K, 2005, NEW ENGL J MED, V353, P1008, DOI 10.1056/NEJMsa043194; Sharnprapai S, 2002, EMERG INFECT DIS, V8, P1239; Sterling TR, 2010, PREVENT TB STUDY TB; Stop TB USA Tuberculosis Elimination Plan Committee, 2010, CALL ACT TUB EL PLAN; Supply P, 2000, MOL MICROBIOL, V36, P762, DOI 10.1046/j.1365-2958.2000.01905.x; Talbot EA, 2000, JAMA-J AM MED ASSOC, V284, P2894, DOI 10.1001/jama.284.22.2894; Taylor Zachary, 2005, Morbidity and Mortality Weekly Report, V54, P1; Van Loon Frederik P. L., 1995, Morbidity and Mortality Weekly Report, V44, P1; Walter ND, 2008, CLIN INFECT DIS, V46, P103, DOI 10.1086/523733; WHO, 2020, WHO REPORT; World Health Organization, 2011, WHOHTMTB2010411; Zuber PLF, 1997, JAMA-J AM MED ASSOC, V278, P304, DOI 10.1001/jama.278.4.304	47	77	79	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2011	6	11							e27405	10.1371/journal.pone.0027405	http://dx.doi.org/10.1371/journal.pone.0027405			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863LT	22140439	Green Published, gold			2022-12-27	WOS:000298166300004
J	Jung, CJ; Iyengar, S; Blahnik, KR; Ajuha, TP; Jiang, JX; Farnham, PJ; Zern, M				Jung, Christine J.; Iyengar, Sushma; Blahnik, Kimberly R.; Ajuha, Tijess P.; Jiang, Joy X.; Farnham, Peggy J.; Zern, Mark			Epigenetic Modulation of miR-122 Facilitates Human Embryonic Stem Cell Self-Renewal and Hepatocellular Carcinoma Proliferation	PLOS ONE			English	Article							PYRUVATE-KINASE M2; EFFICIENT DIFFERENTIATION; MICRORNA GENES; IN-VIVO; LIVER; CANCER; EXPRESSION; TARGET; IDENTIFICATION; HEPATOCYTES	The self-renewal capacity ascribed to hESCs is paralleled in cancer cell proliferation, suggesting that a common network of genes may facilitate the promotion of these traits. However, the molecular mechanisms that are involved in regulating the silencing of these genes as stem cells differentiate into quiescent cellular lineages remain poorly understood. Here, we show that a differentiated cell specific miR-122 exemplifies this regulatory attribute by suppressing the translation of a gene, Pkm2, which is commonly enriched in hESCs and liver cancer cells (HCCs), and facilitates self-renewal and proliferation. Through a series of gene expression analysis, we show that miR-122 expression is highly elevated in quiescent human primary hepatocytes (hPHs) but lost or attenuated in hESCs and HCCs, while an opposing expression pattern is observed for Pkm2. Depleting hESCs and HCCs of Pkm2, or overexpressing miR-122, leads to a common deficiency in self-renewal and proliferation. Likewise, during the differentiation process of hESCs into hepatocytes, a reciprocal expression pattern is observed between miR-122 and Pkm2. An examination of the genomic region upstream of miR-122 uncovered hypermethylation in hESCs and HCCs, while the same region is de-methylated and occupied by a transcription initiating protein, RNA polymerase II (RNAPII), in hPHs. These findings indicate that one possible mechanism by which hESC self-renewal is modulated in quiescent hepatic derivatives of hESCs is through the regulatory activity of a differentiated cell-specific miR-122, and that a failure to properly turn "on" this miRNA is observed in uncontrollably proliferating HCCs.	[Jung, Christine J.; Ajuha, Tijess P.; Zern, Mark] Univ Calif Davis, Med Ctr, Transplant Res Program, Sacramento, CA 95817 USA; [Iyengar, Sushma; Blahnik, Kimberly R.; Farnham, Peggy J.] Univ Calif Davis, Dept Pharmacol, Genome Ctr, Davis, CA 95616 USA; [Jiang, Joy X.] Univ Calif Davis, Med Ctr, Dept Internal Med, Div Gastroenterol & Hepatol, Sacramento, CA 95817 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Jung, CJ (corresponding author), Univ Calif Davis, Med Ctr, Transplant Res Program, Sacramento, CA 95817 USA.	cjjung@ucdavis.edu		Farnham, Peggy/0000-0003-4469-7914	California Institute for Regenerative Medicine (CIRM) [TG-00006]; CIRM [RC1-00359-1]	California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); CIRM(California Institute for Regenerative Medicine)	This work was supported in part by California Institute for Regenerative Medicine (CIRM) Training Grant (TG-00006) to CJJ and a CIRM Comprehensive Research Grant (RC1-00359-1) to MAZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2008, STEM CELLS, V26, P1117, DOI 10.1634/stemcells.2007-1102; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bai SM, 2009, J BIOL CHEM, V284, P32015, DOI 10.1074/jbc.M109.016774; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Chang Jinhong, 2004, RNA Biol, V1, P106, DOI 10.4161/rna.1.2.1066; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; Coulouarn C, 2009, ONCOGENE, V28, P3526, DOI 10.1038/onc.2009.211; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; Elmen J, 2008, NUCLEIC ACIDS RES, V36, P1153, DOI 10.1093/nar/gkm1113; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Ferguson EC, 2008, TRENDS BIOCHEM SCI, V33, P359, DOI 10.1016/j.tibs.2008.05.006; Fornari F, 2009, CANCER RES, V69, P5761, DOI 10.1158/0008-5472.CAN-08-4797; Gatfield D, 2009, INTEGRATION MICRORNA; Girard M, 2008, J HEPATOL, V48, P648, DOI 10.1016/j.jhep.2008.01.019; Gramantieri L, 2007, CANCER RES, V67, P6092, DOI 10.1158/0008-5472.CAN-06-4607; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hay DC, 2008, STEM CELLS, V26, P894, DOI 10.1634/stemcells.2007-0718; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; He SH, 2009, ANNU REV CELL DEV BI, V25, P377, DOI 10.1146/annurev.cellbio.042308.113248; Hochedlinger K, 2006, NATURE, V441, P1061, DOI 10.1038/nature04955; Hsu PWC, 2006, NUCLEIC ACIDS RES, V34, pD135, DOI 10.1093/nar/gkj135; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Judson RL, 2009, NAT BIOTECHNOL, V27, P459, DOI 10.1038/nbt.1535; Knudsen S, 1999, BIOINFORMATICS, V15, P356, DOI 10.1093/bioinformatics/15.5.356; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Kutay H, 2006, J CELL BIOCHEM, V99, P671, DOI 10.1002/jcb.20982; LAIRD PW, 1994, HUM MOL GENET, V3, P1487, DOI 10.1093/hmg/3.suppl_1.1487; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Morris John P 4th, 2005, Sci STKE, V2005, ppe41, DOI 10.1126/stke.2972005pe41; Ochsner SA, 2007, STEM CELLS, V25, P2476, DOI 10.1634/stemcells.2007-0101; Ohler U, 2006, NUCLEIC ACIDS RES, V34, P5943, DOI 10.1093/nar/gkl608; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; STEINBERG P, 1994, CARCINOGENESIS, V15, P125, DOI 10.1093/carcin/15.1.125; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tian YW, 1997, HISTOCHEM CELL BIOL, V107, P243, DOI 10.1007/s004180050109; Tsai WC, 2009, HEPATOLOGY, V49, P1571, DOI 10.1002/hep.22806; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; Zaret KS, 2008, NAT REV GENET, V9, P329, DOI 10.1038/nrg2318; Zhao Y, 2007, TRENDS BIOCHEM SCI, V32, P189, DOI 10.1016/j.tibs.2007.02.006	47	56	62	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2011	6	11							e27740	10.1371/journal.pone.0027740	http://dx.doi.org/10.1371/journal.pone.0027740			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KW	22140464	gold, Green Published, Green Submitted			2022-12-27	WOS:000298163400017
J	Ivanisevic, J; Thomas, OP; Pedel, L; Penez, N; Ereskovsky, AV; Culioli, G; Perez, T				Ivanisevic, Julijana; Thomas, Olivier P.; Pedel, Laura; Penez, Nicolas; Ereskovsky, Alexander V.; Culioli, Gerald; Perez, Thierry			Biochemical Trade-Offs: Evidence for Ecologically Linked Secondary Metabolism of the Sponge Oscarella balibaloi	PLOS ONE			English	Article							TEMPORAL VARIATION; CHEMICAL ECOLOGY; MICROBIAL COMMUNITY; SEXUAL REPRODUCTION; NATURAL TOXICITY; GROWTH DYNAMICS; PATTERNS; DEMOSPONGIAE; VARIABILITY; BIOACTIVITY	Secondary metabolite production is assumed to be costly and therefore the resource allocation to their production should be optimized with respect to primary biological functions such as growth or reproduction. Sponges are known to produce a great diversity of secondary metabolites with powerful biological activities that may explain their domination in some hard substrate communities both in terms of diversity and biomass. Oscarella balibaloi (Homoscleromorpha) is a recently described, highly dynamic species, which often overgrows other sessile marine invertebrates. Bioactivity measurements (standardized Microtox assay) and metabolic fingerprints were used as indicators of the baseline variations of the O. balibaloi secondary metabolism, and related to the sponge reproductive effort over two years. The bioactivity showed a significant seasonal variation with the lowest values at the end of spring and in early summer followed by the highest bioactivity in the late summer and autumn. An effect of the seawater temperature was detected, with a significantly higher bioactivity in warm conditions. There was also a tendency of a higher bioactivity when O. balibaloi was found overgrowing other sponge species. Metabolic fingerprints revealed the existence of three principal metabolic phenotypes: phenotype 1 exhibited by a majority of low bioactive, female individuals, whereas phenotypes 2 and 3 correspond to a majority of highly bioactive, non-reproductive individuals. The bioactivity was negatively correlated to the reproductive effort, minimal bioactivities coinciding with the period of embryogenesis and larval development. Our results fit the Optimal Defense Theory with an investment in the reproduction mainly shaping the secondary metabolism variability, and a less pronounced influence of other biotic (species interaction) and abiotic (temperature) factors.	[Ivanisevic, Julijana; Pedel, Laura; Ereskovsky, Alexander V.; Perez, Thierry] Aix Marseille Univ, Univ Mediterranee, Ctr Oceanol Marseille, CNRS UMR DIMAR 6540,Stn Marine Endoume, Marseille, France; [Ivanisevic, Julijana; Thomas, Olivier P.] Univ Nice Sophia Antipolis, Lab Chim Mol Bioact & Aromes, CNRS UMR 6001, Inst Chim Nice, Nice, France; [Penez, Nicolas; Culioli, Gerald] Univ Sud Toulon Var, Lab MAPIEM, EA 4323, La Garde, France	UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Universite Cote d'Azur	Ivanisevic, J (corresponding author), Aix Marseille Univ, Univ Mediterranee, Ctr Oceanol Marseille, CNRS UMR DIMAR 6540,Stn Marine Endoume, Marseille, France.	thierry.perez@univmed.fr	Ereskovsky, Alexander/W-1504-2019; Culioli, Gérald/C-2040-2013; Ivanisevic, Julijana/AAT-3901-2021; Ereskovsky, Alexander/B-3136-2013	Culioli, Gérald/0000-0001-5760-6394; Ivanisevic, Julijana/0000-0001-8267-2705; Ereskovsky, Alexander/0000-0003-1079-7204; THOMAS, Olivier/0000-0002-5708-1409	ECIMAR [ANR-06-BDIV-001-04]; European Marie Curie Mobility program [MIF1-CT-2006-040065]	ECIMAR; European Marie Curie Mobility program(European Commission)	This work was supported by the ECIMAR program (ANR-06-BDIV-001-04) and European Marie Curie Mobility program (MIF1-CT-2006-040065). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdo DA, 2007, J CHEM ECOL, V33, P1635, DOI 10.1007/s10886-007-9326-x; Baldacconi R, 2007, MAR BIOL, V152, P969, DOI 10.1007/s00227-007-0747-4; Ballesteros E, 2006, OCEANOGR MAR BIOL, V44, P123; Becerro MA, 2003, OECOLOGIA, V135, P91, DOI 10.1007/s00442-002-1138-7; Becerro MA, 1995, J CHEM ECOL, V21, P1931, DOI 10.1007/BF02033853; Becerro MA, 1997, HYDROBIOLOGIA, V355, P77, DOI 10.1023/A:1003019221354; Becerro MA, 1997, J CHEM ECOL, V23, P1527, DOI 10.1023/B:JOEC.0000006420.04002.2e; Bolser RC, 1996, ECOLOGY, V77, P2269, DOI 10.2307/2265730; Botsford JL, 2002, ATLA-ALTERN LAB ANIM, V30, P539, DOI 10.1177/026119290203000507; Bundy JG, 2009, METABOLOMICS, V5, P3, DOI 10.1007/s11306-008-0152-0; Coma R, 2003, OIKOS, V101, P205, DOI 10.1034/j.1600-0706.2003.12028.x; Cronin G, 2001, CRC MAR SCI, P325; Dewick P.M., 2002, MED NATURAL PRODUCTS, Vsecond, P7; Duckworth AR, 2004, AQUACULTURE, V242, P237, DOI 10.1016/j.aquaculture.2004.08.046; Dworjanyn SA, 2006, OIKOS, V113, P13; Engel S, 2005, MAR ECOL PROG SER, V303, P133, DOI 10.3354/meps303133; Ferretti C, 2009, MAR ECOL-EVOL PERSP, V30, P327, DOI 10.1111/j.1439-0485.2008.00278.x; Friedrich AB, 2001, FEMS MICROBIOL ECOL, V38, P105, DOI 10.1111/j.1574-6941.2001.tb00888.x; HARVELL CD, 1993, MAR ECOL PROG SER, V93, P165, DOI 10.3354/meps093165; Hentschel U, 2001, FEMS MICROBIOL ECOL, V35, P305, DOI 10.1111/j.1574-6941.2001.tb00816.x; Hentschel U, 2002, APPL ENVIRON MICROB, V68, P4431, DOI 10.1128/AEM.68.9.4431-4440.2002; Ivanisevic J, 2011, SEASONAL VARIABILITY, V37, P537; Ivanisevic J, 2011, METABOLOMICS, V7, P289, DOI 10.1007/s11306-010-0239-2; JACKSON JBC, 1975, P NATL ACAD SCI USA, V72, P5160, DOI 10.1073/pnas.72.12.5160; LABOREL J, 1959, CR HEBD ACAD SCI, V248, P2619; Laubier L, 1966, THESIS U PARIS 6 PAR; Leong W, 2010, MAR ECOL PROG SER, V406, P71, DOI 10.3354/meps08541; Lopez-Legentil S, 2006, J CHEM ECOL, V32, P2079, DOI 10.1007/s10886-006-9148-2; Lopez-Legentil S, 2007, MAR BIOL, V151, P293, DOI 10.1007/s00227-006-0472-4; Luter HM, 2007, MAR BIOL RES, V3, P312, DOI 10.1080/17451000701635102; Luter HM, 2010, BIOCHEM SYST ECOL, V38, P146, DOI 10.1016/j.bse.2009.12.024; MAIDA M, 1993, J CHEM ECOL, V19, P2285, DOI 10.1007/BF00979664; Marti R, 2005, SCI MAR, V69, P485; Marti R, 2004, MAR ECOL PROG SER, V282, P73, DOI 10.3354/meps282073; Marti R, 2003, J CHEM ECOL, V29, P1307, DOI 10.1023/A:1024201100811; Mercurio M, 2007, MAR BIOL, V151, P1491, DOI 10.1007/s00227-006-0584-x; Mohamed NM, 2008, APPL ENVIRON MICROB, V74, P1209, DOI 10.1128/AEM.02047-07; Muller WEG, 2004, MAR BIOL, V144, P19, DOI 10.1007/s00227-003-1184-7; Page M, 2005, J CHEM ECOL, V31, P1161, DOI 10.1007/s10886-005-4254-0; Pawlik JR, 2008, MAR ECOL PROG SER, V368, P137, DOI 10.3354/meps07615; Perez T, 2011, MAR ECOL-EVOL PERSP, V32, P174, DOI 10.1111/j.1439-0485.2011.00435.x; Prince EK, 2010, ANAL BIOANAL CHEM, V396, P193, DOI 10.1007/s00216-009-3162-5; Puyana M, 2002, DISS ABSTR INT B, V62, P5576; Sara M, 1973, SPONGIAIRES ANATOMIE, V3, P462; Schmitt S, INT SOC MIC IN PRESS, DOI [10.1038/ismej.2011.116, DOI 10.1038/ISMEJ.2011.116]; Sipkema D, 2005, MAR BIOTECHNOL, V7, P142, DOI 10.1007/s10126-004-0405-5; Steel HC, 2002, APMIS, V110, P158, DOI 10.1034/j.1600-0463.2002.100206.x; Takken W, 2006, WAG UR FRON, V16, P1; Taylor MW, 2004, ENVIRON MICROBIOL, V6, P121, DOI 10.1046/j.1462-2920.2003.00545.x; Taylor MW, 2005, ENVIRON MICROBIOL, V7, P419, DOI 10.1111/j.1462-2920.2004.00711.x; Thacker RW, 1998, ECOLOGY, V79, P1740; THOMPSON JE, 1985, MAR BIOL, V88, P23, DOI 10.1007/BF00393039; Turon X, 1996, OECOLOGIA, V108, P351, DOI 10.1007/BF00334661; Turon X, 1998, FUNCT ECOL, V12, P631, DOI 10.1046/j.1365-2435.1998.00225.x; Turon X, 1996, OIKOS, V75, P33, DOI 10.2307/3546318; Turon X, 2009, SCI MAR, V73, P387, DOI 10.3989/scimar.2009.73n2387; Uriz MJ, 1996, J EXP MAR BIOL ECOL, V205, P187, DOI 10.1016/S0022-0981(96)02609-3; URIZ MJ, 1995, MAR ECOL PROG SER, V124, P159, DOI 10.3354/meps124159; Viant MR, 2009, METABOLOMICS, V5, P1, DOI 10.1007/s11306-009-0157-3; Vishnyakov AE, 2009, MAR BIOL, V156, P1625, DOI 10.1007/s00227-009-1198-x; Webster NS, 2012, ENVIRON MICROBIOL, V14, P335, DOI 10.1111/j.1462-2920.2011.02460.x; Webster NS, 2011, MAR BIOTECHNOL, V13, P296, DOI 10.1007/s10126-010-9300-4; Webster NS, 2010, ENVIRON MICROBIOL, V12, P2070, DOI 10.1111/j.1462-2920.2009.02065.x; Weis B, 1996, BIOCHEM SYST ECOL, V24, P1, DOI 10.1016/0305-1978(95)00101-8; Wink M, 2003, PHYTOCHEMISTRY, V64, P3, DOI 10.1016/S0031-9422(03)00300-5; Wishart DS, 2007, BRIEF BIOINFORM, V8, P279, DOI 10.1093/bib/bbm030; ZABALA M, 1989, Scientia Marina, V53, P3	67	28	29	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e28059	10.1371/journal.pone.0028059	http://dx.doi.org/10.1371/journal.pone.0028059			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132209	Green Published, gold			2022-12-27	WOS:000298162000064
J	Poupin, N; Bos, C; Mariotti, F; Huneau, JF; Tome, D; Fouillet, H				Poupin, Nathalie; Bos, Cecile; Mariotti, Francois; Huneau, Jean-Francois; Tome, Daniel; Fouillet, Helene			The Nature of the Dietary Protein Impacts the Tissue-to-Diet N-15 Discrimination Factors in Laboratory Rats	PLOS ONE			English	Article							NITROGEN ISOTOPES; STABLE CARBON; KINETIC FRACTIONATION; FACTORS DELTA-N-15; TEMPORAL VARIATION; HAIR PROTEIN; METABOLISM; DELTA-C-13; BALANCE; ACID	Due to the existence of isotope effects on some metabolic pathways of amino acid and protein metabolism, animal tissues are N-15-enriched relative to their dietary nitrogen sources and this N-15 enrichment varies among different tissues and metabolic pools. The magnitude of the tissue-to-diet discrimination (Delta N-15) has also been shown to depend on dietary factors. Since dietary protein sources affect amino acid and protein metabolism, we hypothesized that they would impact this discrimination factor, with selective effects at the tissue level. To test this hypothesis, we investigated in rats the influence of a milk or soy protein-based diet on Delta N-15 in various nitrogen fractions (urea, protein and non-protein fractions) of blood and tissues, focusing on visceral tissues. Regardless of the diet, the different protein fractions of blood and tissues were generally N-15-enriched relative to their non-protein fraction and to the diet (Delta N-15. 0), with large variations in the Delta N-15 between tissue proteins. Delta N-15 values were markedly lower in tissue proteins of rats fed milk proteins compared to those fed soy proteins, in all sampled tissues except in the intestine, and the amplitude of Delta N-15 differences between diets differed between tissues. Both between-tissue and between-diet Delta N-15 differences are probably related to modulations of the relative orientation of dietary and endogenous amino acids in the different metabolic pathways. More specifically, the smaller Delta N-15 values observed in tissue proteins with milk than soy dietary protein may be due to a slightly more direct channeling of dietary amino acids for tissue protein renewal and to a lower recycling of amino acids through fractionating pathways. In conclusion, the present data indicate that natural Delta N-15 of tissue are sensitive markers of the specific subtle regional modifications of the protein and amino acid metabolism induced by the protein dietary source.	[Poupin, Nathalie; Bos, Cecile; Mariotti, Francois; Huneau, Jean-Francois; Tome, Daniel; Fouillet, Helene] INRA, CRNH IdF, Nutr Physiol & Ingest Behav UMR914, Paris, France; [Poupin, Nathalie; Bos, Cecile; Mariotti, Francois; Huneau, Jean-Francois; Tome, Daniel; Fouillet, Helene] AgroParisTech, CRNH IdF, Nutr Physiol & Ingest Behav UMR914, Paris, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay	Poupin, N (corresponding author), INRA, CRNH IdF, Nutr Physiol & Ingest Behav UMR914, Paris, France.	Helene.Fouillet@agroparistech.fr	Fouillet, Helene/K-7314-2012; Mariotti, François/F-9651-2017	Fouillet, Helene/0000-0003-3932-251X; Mariotti, François/0000-0002-4516-3853; Poupin, Nathalie/0000-0002-3393-1405	French Ministry for Research	French Ministry for Research(Ministry of Research, France)	Nathalie Poupin is supported by a doctoral fellowship from the French Ministry for Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMBROSE SH, 2000, BIOGEOCHEMICAL APPRO, P243; Arneson LS, 2005, CAN J ZOOL, V83, P989, DOI 10.1139/Z05-083; Arneson LS, 2006, CAN J ZOOL, V84, P992, DOI 10.1139/Z06-081; Balter V, 2006, OECOLOGIA, V147, P212, DOI 10.1007/s00442-005-0263-5; Barboza PS, 2006, PHYSIOL BIOCHEM ZOOL, V79, P628, DOI 10.1086/502811; Blakey GE, 1997, J PHARMACOKINET BIOP, V25, P277, DOI 10.1023/A:1025771608474; Boutry C, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-52; Caut S, 2008, FUNCT ECOL, V22, P255, DOI 10.1111/j.1365-2435.2007.01360.x; Caut S, 2009, J APPL ECOL, V46, P443, DOI 10.1111/j.1365-2664.2009.01620.x; Dalerum F, 2005, OECOLOGIA, V144, P647, DOI 10.1007/s00442-005-0118-0; del Rio CM, 2009, BIOL REV, V84, P91, DOI 10.1111/j.1469-185X.2008.00064.x; del Rio CM, 2005, PHYSIOLOGICAL ADAPTATIONS TO FEEDING INVERTEBRATES, P141; DeMots RL, 2010, CAN J ZOOL, V88, P961, DOI 10.1139/Z10-063; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; Deutz NEP, 1998, J NUTR, V128, P2435, DOI 10.1093/jn/128.12.2435; Fouillet H, 2002, J NUTR, V132, p3208S, DOI 10.1093/jn/131.10.3208S; Fouillet H, 2002, J NUTR, V132, P125, DOI 10.1093/jn/132.1.125; Fouillet H, 2009, AM J PHYSIOL-REG I, V297, pR1691, DOI 10.1152/ajpregu.00281.2009; Fuller BT, 2005, RAPID COMMUN MASS SP, V19, P2497, DOI 10.1002/rcm.2090; Fuller BT, 2004, RAPID COMMUN MASS SP, V18, P2889, DOI 10.1002/rcm.1708; GAEBLER OH, 1966, CAN J BIOCHEM CELL B, V44, P1249, DOI 10.1139/o66-142; Gannes LZ, 1998, COMP BIOCHEM PHYS A, V119, P725, DOI 10.1016/S1095-6433(98)01016-2; Gaye-Siessegger J, 2004, NATURWISSENSCHAFTEN, V91, P90, DOI 10.1007/s00114-003-0496-2; HAYES JM, 2001, FRACTIONATION CARBON, P225; Hobson KA, 1999, OECOLOGIA, V120, P314, DOI 10.1007/s004420050865; Kurle CM, 2009, FUNCT ECOL, V23, P733, DOI 10.1111/j.1365-2435.2009.01553.x; Lacroix M, 2004, AM J PHYSIOL-REG I, V287, pR934, DOI 10.1152/ajpregu.00100.2004; Lohrke B, 2001, BRIT J NUTR, V85, P447, DOI 10.1079/BJN2000291; MacAvoy SE, 2005, CAN J ZOOL, V83, P631, DOI 10.1139/Z05-038; MacAvoy SE, 2006, OECOLOGIA, V150, P190, DOI 10.1007/s00442-006-0522-0; MACKO SA, 1986, GEOCHIM COSMOCHIM AC, V50, P2143, DOI 10.1016/0016-7037(86)90068-2; Mekota AM, 2006, RAPID COMMUN MASS SP, V20, P1604, DOI 10.1002/rcm.2477; Morens C, 2000, J NUTR, V130, P2312, DOI 10.1093/jn/130.9.2312; Morens C, 2003, J NUTR, V133, P2733, DOI 10.1093/jn/133.9.2733; Morens C, 2001, AM J PHYSIOL-ENDOC M, V281, pE826, DOI 10.1152/ajpendo.2001.281.4.E826; O'Brien DM, 2009, AM J CLIN NUTR, V89, P913, DOI 10.3945/ajcn.2008.27054; Petzke KJ, 2005, J NUTR, V135, P1515; Petzke KJ, 2006, RAPID COMMUN MASS SP, V20, P2973, DOI 10.1002/rcm.2695; Ponsard S, 1999, RAPID COMMUN MASS SP, V13, P1305; Robbins CT, 2010, OECOLOGIA, V162, P571, DOI 10.1007/s00442-009-1485-8; Robbins CT, 2005, OECOLOGIA, V144, P534, DOI 10.1007/s00442-005-0021-8; Roth JD, 2000, CAN J ZOOL, V78, P848, DOI 10.1139/cjz-78-5-848; Schoeller DA, 1999, J ARCHAEOL SCI, V26, P667, DOI 10.1006/jasc.1998.0391; Seila AC, 2005, BIOCHEMISTRY-US, V44, P4018, DOI 10.1021/bi047742f; Sharp PE, 1998, LAB RAT LAB ANIMAL P; Sick H, 1997, Z ERNAHRUNGSWISS, V36, P340, DOI 10.1007/BF01617819; SILFER JA, 1992, CHEM GEOL, V101, P211, DOI 10.1016/0009-2541(92)90003-N; Smith K, 1996, BAILLIERE CLIN ENDOC, V10, P469, DOI 10.1016/S0950-351X(96)80651-3; Sponheimer M, 2003, J ARCHAEOL SCI, V30, P1649, DOI 10.1016/S0305-4403(03)00066-9; STEELE KW, 1978, J AGR SCI-CAMBRIDGE, V90, P7, DOI 10.1017/S002185960004853X; Vander Zanden MJ, 2001, LIMNOL OCEANOGR, V46, P2061; Vanderklift MA, 2003, OECOLOGIA, V136, P169, DOI 10.1007/s00442-003-1270-z; Waters-Rist AL, 2010, INT J OSTEOARCHAEOL, V20, P172, DOI 10.1002/oa.1017; Waynforth H. B., 1980, EXPT SURG TECHNIQUE; YONEYAMA T, 1983, Radioisotopes, V32, P330	55	47	47	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2011	6	11							e28046	10.1371/journal.pone.0028046	http://dx.doi.org/10.1371/journal.pone.0028046			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858JH	22132207	Green Published, gold, Green Submitted			2022-12-27	WOS:000297792400036
J	Alhede, M; Kragh, KN; Qvortrup, K; Allesen-Holm, M; van Gennip, M; Christensen, LD; Jensen, PO; Nielsen, AK; Parsek, M; Wozniak, D; Molin, S; Tolker-Nielsen, T; Hoiby, N; Givskov, M; Bjarnsholt, T				Alhede, Morten; Kragh, Kasper Norskov; Qvortrup, Klaus; Allesen-Holm, Marie; van Gennip, Maria; Christensen, Louise D.; Jensen, Peter Ostrup; Nielsen, Anne K.; Parsek, Matt; Wozniak, Dan; Molin, Soren; Tolker-Nielsen, Tim; Hoiby, Niels; Givskov, Michael; Bjarnsholt, Thomas			Phenotypes of Non-Attached Pseudomonas aeruginosa Aggregates Resemble Surface Attached Biofilm	PLOS ONE			English	Article							POLYMORPHONUCLEAR LEUKOCYTES; BACTERIAL BIOFILMS; HOST-DEFENSE; TOBRAMYCIN; MECHANISMS; TOLERANCE; VARIANTS; GENES; PSL; EXOPOLYSACCHARIDE	For a chronic infection to be established, bacteria must be able to cope with hostile conditions such as low iron levels, oxidative stress, and clearance by the host defense, as well as antibiotic treatment. It is generally accepted that biofilm formation facilitates tolerance to these adverse conditions. However, microscopic investigations of samples isolated from sites of chronic infections seem to suggest that some bacteria do not need to be attached to surfaces in order to establish chronic infections. In this study we employed scanning electron microscopy, confocal laser scanning microscopy, RT-PCR as well as traditional culturing techniques to study the properties of Pseudomonas aeruginosa aggregates. We found that non-attached aggregates from stationary-phase cultures have comparable growth rates to surface attached biofilms. The growth rate estimations indicated that, independently of age, both aggregates and flow-cell biofilm had the same slow growth rate as a stationary phase shaking cultures. Internal structures of the aggregates matrix components and their capacity to survive otherwise lethal treatments with antibiotics (referred to as tolerance) and resistance to phagocytes were also found to be strikingly similar to flow-cell biofilms. Our data indicate that the tolerance of both biofilms and non-attached aggregates towards antibiotics is reversible by physical disruption. We provide evidence that the antibiotic tolerance is likely to be dependent on both the physiological states of the aggregates and particular matrix components. Bacterial surface-attachment and subsequent biofilm formation are considered hallmarks of the capacity of microbes to cause persistent infections. We have observed non-attached aggregates in the lungs of cystic fibrosis patients; otitis media; soft tissue fillers and non-healing wounds, and we propose that aggregated cells exhibit enhanced survival in the hostile host environment, compared with non-aggregated bacterial populations.	[Alhede, Morten; Kragh, Kasper Norskov; Allesen-Holm, Marie; van Gennip, Maria; Christensen, Louise D.; Nielsen, Anne K.; Tolker-Nielsen, Tim] Univ Copenhagen, Inst Int Hlth Immunol & Microbiol, Copenhagen, Denmark; [Qvortrup, Klaus] Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark; [Parsek, Matt; Givskov, Michael; Bjarnsholt, Thomas] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Jensen, Peter Ostrup; Hoiby, Niels] Rigshosp, Dept Clin Microbiol, DK-2100 Copenhagen, Denmark; [Wozniak, Dan; Bjarnsholt, Thomas] Ohio State Univ, Div Infect Dis, Ctr Microbial Interface Biol, Columbus, OH 43210 USA; [Molin, Soren] Tech Univ Denmark, Dept Syst Biol, DK-2800 Lyngby, Denmark	University of Copenhagen; University of Copenhagen; University of Washington; University of Washington Seattle; Rigshospitalet; University of Copenhagen; University System of Ohio; Ohio State University; Technical University of Denmark	Alhede, M (corresponding author), Univ Copenhagen, Inst Int Hlth Immunol & Microbiol, Copenhagen, Denmark.	tbjarnsholt@sund.ku.dk	Jensen, Peter Ostrup/HGD-7725-2022; Hultqvist, Louise/M-1352-2015; Bjarnsholt, Thomas/ABD-6178-2021; Kragh, Kasper Nørskov/AAZ-8432-2021	Hultqvist, Louise/0000-0003-0256-892X; Kragh, Kasper Nørskov/0000-0002-7662-9118; Bjarnsholt, Thomas/0000-0002-8003-7414; Tolker-Nielsen, Tim/0000-0002-9751-474X; Qvortrup, Klaus/0000-0001-8811-0260; Jensen, Peter Ostrup/0000-0003-1648-7186; Alhede, Maria/0000-0001-6721-2516; Givskov, Michael/0000-0001-5004-8609; Molin, Soren/0000-0002-7973-2639; Hoiby, Niels/0000-0002-1347-725X	Villum Foundation; Novo Nordic Foundation	Villum Foundation(Villum Fonden); Novo Nordic Foundation(Novo Nordisk Foundation)	MG was supported by the Villum Foundation and Novo Nordic Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron SD, 2002, J CLIN MICROBIOL, V40, P4172, DOI 10.1128/JCM.40.11.4172-4179.2002; Aendekerk S, 2005, MICROBIOL-SGM, V151, P1113, DOI 10.1099/mic.0.27631-0; Alhede M, 2009, MICROBIOL-SGM, V155, P3500, DOI 10.1099/mic.0.031443-0; Allesen-Holm M, 2006, MOL MICROBIOL, V59, P1114, DOI 10.1111/j.1365-2958.2005.05008.x; Anderson GG, 2008, CURR TOP MICROBIOL, V322, P85; Barclay ML, 1996, J ANTIMICROB CHEMOTH, V37, P1155, DOI 10.1093/jac/37.6.1155; Bjarnsholt T, 2005, MICROBIOL-SGM, V151, P373, DOI 10.1099/mic.0.27463-0; Bjarnsholt T, 2009, PEDIATR PULM, V44, P547, DOI 10.1002/ppul.21011; Bossier P, 1996, APPL MICROBIOL BIOT, V45, P1, DOI 10.1007/s002530050640; Christensen LH, 2009, DERMATOL SURG, V35, P1612, DOI 10.1111/j.1524-4725.2009.01338.x; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Donlan RM, 2002, EMERG INFECT DIS, V8, P881, DOI 10.3201/eid0809.020063; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; Fazli M, 2009, J CLIN MICROBIOL, V47, P4084, DOI 10.1128/JCM.01395-09; Friedman L, 2004, J BACTERIOL, V186, P4457, DOI 10.1128/JB.186.14.4457-4465.2004; Friedman L, 2004, MOL MICROBIOL, V51, P675, DOI 10.1046/j.1365-2958.2003.03877.x; Hentzer M, 2001, J BACTERIOL, V183, P5395, DOI 10.1128/JB.183.18.5395-5401.2001; Herrmann G, 2010, J INFECT DIS, V202, P1585, DOI 10.1086/656788; Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011; Homoe P, 2009, EUR ARCH OTO-RHINO-L, V266, P1533, DOI 10.1007/s00405-009-0940-9; Hoyle B D, 1991, Prog Drug Res, V37, P91; Jackson KD, 2004, J BACTERIOL, V186, P4466, DOI 10.1128/JB.186.14.4466-4475.2004; JENSEN ET, 1993, MICROB PATHOGENESIS, V15, P377, DOI 10.1006/mpat.1993.1087; JENSEN ET, 1992, APMIS, V100, P727, DOI 10.1111/j.1699-0463.1992.tb03991.x; JENSEN ET, 1990, INFECT IMMUN, V58, P2383, DOI 10.1128/IAI.58.7.2383-2385.1990; Jensen PO, 2007, MICROBIOL-SGM, V153, P1329, DOI 10.1099/mic.0.2006/003863-0; Jesaitis AJ, 2003, J IMMUNOL, V171, P4329, DOI 10.4049/jimmunol.171.8.4329; KHARAZMI A, 1991, IMMUNOL LETT, V30, P201, DOI 10.1016/0165-2478(91)90026-7; Kirisits MJ, 2005, APPL ENVIRON MICROB, V71, P4809, DOI 10.1128/AEM.71.8.4809-4821.2005; Klausen M, 2003, MOL MICROBIOL, V48, P1511, DOI 10.1046/j.1365-2958.2003.03525.x; Ma LY, 2007, J BACTERIOL, V189, P8353, DOI 10.1128/JB.00620-07; Ma L, 2006, J BACTERIOL, V188, P8213, DOI 10.1128/JB.01202-06; Ma LM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000354; Matsukawa M, 2004, J BACTERIOL, V186, P4449, DOI 10.1128/JB.186.14.4449-4456.2004; Moreau-Marquis S, 2008, PULM PHARMACOL THER, V21, P595, DOI 10.1016/j.pupt.2007.12.001; Pamp SJ, 2008, MOL MICROBIOL, V68, P223, DOI 10.1111/j.1365-2958.2008.06152.x; Parsek MR, 2003, ANNU REV MICROBIOL, V57, P677, DOI 10.1146/annurev.micro.57.030502.090720; QVORTRUP K, 1995, ANN OTO RHINOL LARYN, V104, P120, DOI 10.1177/000348949510400207; Starkey M, 2009, J BACTERIOL, V191, P3492, DOI 10.1128/JB.00119-09; Sutherland IW, 2001, TRENDS MICROBIOL, V9, P222, DOI 10.1016/S0966-842X(01)02012-1; Vasseur P, 2005, MICROBIOL-SGM, V151, P985, DOI 10.1099/mic.0.27410-0; Walters MC, 2003, ANTIMICROB AGENTS CH, V47, P317, DOI 10.1128/AAC.47.1.317-323.2003; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487; Xu KD, 1998, APPL ENVIRON MICROB, V64, P4035; Yang L, 2008, J BACTERIOL, V190, P2767, DOI 10.1128/JB.01581-07	47	176	178	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2011	6	11							e27943	10.1371/journal.pone.0027943	http://dx.doi.org/10.1371/journal.pone.0027943			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IO	22132176	Green Submitted, Green Published, gold			2022-12-27	WOS:000297789900036
J	Bodger, O; Byrne, A; Evans, PA; Rees, S; Jones, G; Cowell, C; Gravenor, MB; Williams, R				Bodger, Owen; Byrne, Aidan; Evans, Philip A.; Rees, Sarah; Jones, Gwen; Cowell, Claire; Gravenor, Mike B.; Williams, Rhys			Graduate Entry Medicine: Selection Criteria and Student Performance	PLOS ONE			English	Article							ADMISSION TEST; UNIVERSITY; INTERVIEW; PROGRAM	Background: Graduate entry medicine raises new questions about the suitability of students with different backgrounds. We examine this, and the broader issue of effectiveness of selection and assessment procedures. Methods: The data included background characteristics, academic record, interview score and performance in pre-clinical modular assessment for two years intake of graduate entry medical students. Exploratory factor analysis is a powerful method for reducing a large number of measures to a smaller group of underlying factors. It was used here to identify patterns within and between the selection and performance data. Principal Findings: Basic background characteristics were of little importance in predicting exam success. However, easily interpreted components were detected within variables comprising the 'selection' and 'assessment' criteria. Three selection components were identified ('Academic', 'GAMSAT', 'Interview') and four assessment components ('General Exam', 'Oncology', 'OSCE', 'Family Case Study'). There was a striking lack of relationships between most selection and performance factors. Only 'General Exam' and 'Academic' showed a correlation (Pearson's r = 0.55, p<0.001). Conclusions: This study raises questions about methods of student selection and their effectiveness in predicting performance and assessing suitability for a medical career. Admissions tests and most exams only confirmed previous academic achievement, while interview scores were not correlated with any consequent assessment.	[Bodger, Owen; Byrne, Aidan; Evans, Philip A.; Rees, Sarah; Jones, Gwen; Cowell, Claire; Gravenor, Mike B.; Williams, Rhys] Swansea Univ, Sch Med, Swansea, W Glam, Wales	Swansea University	Bodger, O (corresponding author), Swansea Univ, Sch Med, Swansea, W Glam, Wales.	O.Bodger@swansea.ac.uk	Byrne, Aidan/F-4091-2012	Byrne, Aidan/0000-0001-9289-1995; Bodger, Owen/0000-0002-4022-9964; Evans, Phillip Adrian/0000-0002-0814-5162				Aldous CJH, 1997, MED J AUSTRALIA, V166, P247, DOI 10.5694/j.1326-5377.1997.tb140105.x; Craig PL, 2004, MED EDUC, V38, P1164, DOI 10.1111/j.1365-2929.2004.02043.x; De Clercq L, 2001, Educ Health (Abingdon), V14, P417; Groves M, 2003, MED TEACH, V25, P626, DOI 10.1080/01421590310001605679; Groves MA, 2007, MED J AUSTRALIA, V187, P255, DOI 10.5694/j.1326-5377.2007.tb01228.x; Harris S, 2007, MED EDUC, V41, P234, DOI 10.1111/j.1365-2929.2007.02682.x; MITCHELL K, 1994, ACAD MED, V69, P393, DOI 10.1097/00001888-199405000-00017; Rahbar MH, 2001, MED EDUC, V35, P374, DOI 10.1046/j.1365-2923.2001.00760.x; Searle J, 2004, MED EDUC, V38, P1130, DOI 10.1111/j.1365-2929.2004.01984.x; Tabachnick B.G., 2007, USING MULTIVARIATE S, P613; Wilkinson D, 2008, MED J AUSTRALIA, V189, P235	11	15	15	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2011	6	11							e27161	10.1371/journal.pone.0027161	http://dx.doi.org/10.1371/journal.pone.0027161			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IO	22132089	Green Published, gold			2022-12-27	WOS:000297789900010
J	Novosad, BD; Astley, RA; Callegan, MC				Novosad, Billy D.; Astley, Roger A.; Callegan, Michelle C.			Role of Toll-Like Receptor (TLR) 2 in Experimental Bacillus cereus Endophthalmitis	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA KERATITIS; STAPHYLOCOCCUS-EPIDERMIDIS ENDOPHTHALMITIS; NECROSIS-FACTOR-ALPHA; LIPOTEICHOIC ACID; CROSS-TOLERANCE; BACTERIAL ENDOPHTHALMITIS; INNATE IMMUNITY; HUMAN SEPSIS; EXPRESSION; LIPOPOLYSACCHARIDE	Bacillus cereus causes a uniquely rapid and blinding intraocular infection, endophthalmitis. B. cereus replicates in the eye, synthesizes numerous toxins, and incites explosive intraocular inflammation. The mechanisms involved in the rapid and explosive intraocular immune response have not been addressed. Because Toll-like receptors (TLRs) are integral to the initial recognition of organisms during infection, we hypothesized that the uniquely explosive immune response observed during B. cereus endophthalmitis is directly influenced by the presence of TLR2, a known Gram-positive pathogen recognition receptor. To address this hypothesis, we compared the courses of experimental B. cereus endophthalmitis in wild type C57BL/6J mice to that of age-matched homozygous TLR2(-/-) mice. Output parameters included analysis of bacterial growth, inflammatory cell (PMN) infiltration, cytokine/chemokine kinetics, retinal function testing, and histology, with N >= 4 eyes/assay/time point/mouse strain. B. cereus grew at similar rates to 10(8) CFU/eye by 12 h, regardless of the mouse strain. Retinal function was preserved to a greater degree in infected TLR2(-/-) eyes compared to that of infected wild type eyes, but infected eyes of both mouse strains lost significant function. Retinal architecture was preserved in infected TLR2(-/-) eyes, with limited retinal and vitreal cellular infiltration compared to that of infected wild type eyes. Ocular myeloperoxidase activities corroborated these results. In general, TNF alpha, IFN gamma, IL6, and KC were detected in greater concentrations in infected wild type eyes than in infected TLR2(-/-) eyes. The absence of TLR2 resulted in decreased intraocular proinflammatory cytokine/chemokine levels and altered recruitment of inflammatory cells into the eye, resulting in less intraocular inflammation and preservation of retinal architecture, and a slightly greater degree of retinal function. These results demonstrate TLR2 is an important component of the initial ocular response to B. cereus endophthalmitis.	[Novosad, Billy D.; Callegan, Michelle C.] Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73190 USA; [Astley, Roger A.; Callegan, Michelle C.] Univ Oklahoma, Hlth Sci Ctr, Dept Ophthalmol, Oklahoma City, OK 73190 USA; [Callegan, Michelle C.] Dean A McGee Eye Inst, Oklahoma City, OK USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Novosad, BD (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73190 USA.	michelle-callegan@ouhsc.edu		Astley, Roger/0000-0002-2243-119X	National Institutes of Health (NIH) [R01EY012985, P30EY12191]; NCRR [P20RR17703]; Dean A. McGee Eye Institute from Research to Prevent Blindness; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017703] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY012190, R01EY012985] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Dean A. McGee Eye Institute from Research to Prevent Blindness; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was funded by National Institutes of Health (NIH) Grant R01EY012985 (to MCC, http://www.nih.gov/). The authors' research is also supported in part by NIH Grants P30EY12191 (NIH CORE grant to Robert E. Anderson, OUHSC), Research Resources Grant P20RR17703 (NCRR COBRE grant to Robert E. Anderson, OUHSC), and an unrestricted grant to the Dean A. McGee Eye Institute from Research to Prevent Blindness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Armstrong L, 2004, CLIN EXP IMMUNOL, V136, P312, DOI 10.1111/j.1365-2249.2004.02433.x; BEECHER DJ, 1995, INFECT IMMUN, V63, P632, DOI 10.1128/IAI.63.2.632-639.1995; Beutler BA, 2009, BLOOD, V113, P1399, DOI 10.1182/blood-2008-07-019307; Brozou CG, 2009, OPHTHALMIC RES, V41, P181, DOI 10.1159/000217721; Burrough ER, 2010, VET PATHOL IN PRESS; Callegan MC, 1999, INFECT IMMUN, V67, P3348, DOI 10.1128/IAI.67.7.3348-3356.1999; Callegan MC, 2005, INVEST OPHTH VIS SCI, V46, P3233, DOI 10.1167/iovs.05-0410; Callegan MC, 2003, INFECT IMMUN, V71, P3116, DOI 10.1128/IAI.71.6.3116-3124.2003; Callegan MC, 2007, PROG RETIN EYE RES, V26, P189, DOI 10.1016/j.preteyeres.2006.12.001; Chang JH, 2006, BRIT J OPHTHALMOL, V90, P103, DOI 10.1136/bjo.2005.072686; Chui JJY, 2010, INVEST OPHTH VIS SCI, V51, P2558, DOI 10.1167/iovs.09-3923; DAVID DB, 1994, BRIT J OPHTHALMOL, V78, P577, DOI 10.1136/bjo.78.7.577; Hei ZQ, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/519589; Hosseini H, 2009, CURR EYE RES, V34, P145, DOI 10.1080/02713680802585938; Huang X, 2007, INVEST OPHTH VIS SCI, V48, P4626, DOI 10.1167/iovs.07-0316; Huang X, 2006, INVEST OPHTH VIS SCI, V47, P4910, DOI 10.1167/iovs.06-0537; Hughes MA, 2005, INFECT IMMUN, V73, P7535, DOI 10.1128/IAI.73.11.7535-7540.2005; Ito Y, 2005, INT IMMUNOL, V17, P1597, DOI 10.1093/intimm/dxh341; Jacinto R, 2002, J IMMUNOL, V168, P6136, DOI 10.4049/jimmunol.168.12.6136; Jin X, 2010, EUR J CLIN MICROBIOL, V29, P231, DOI 10.1007/s10096-009-0844-z; Kim HG, 2008, J MICROBIOL BIOTECHN, V18, P1191; Kumar A, 2010, J INFECT DIS, V201, P255, DOI 10.1086/649589; Lehner MD, 2001, J IMMUNOL, V166, P5161, DOI 10.4049/jimmunol.166.8.5161; Li CH, 2006, J LEUKOCYTE BIOL, V79, P867, DOI 10.1189/jlb.0905505; Li FL, 2010, AM J NEPHROL, V32, P179, DOI 10.1159/000317023; Matsumura Naoki, 2007, Kobe J Med Sci, V53, P219; Moyer AL, 2009, INVEST OPHTH VIS SCI, V50, P3783, DOI 10.1167/iovs.08-3051; Netea MG, 2004, J LEUKOCYTE BIOL, V75, P749, DOI 10.1189/jlb.1103543; Park JM, 2004, J EXP MED, V200, P1647, DOI 10.1084/jem.20041215; Pimentel-Nunes P, 2010, LIVER INT, V30, P1003, DOI 10.1111/j.1478-3231.2010.02251.x; Ramadan RT, 2008, INVEST OPHTH VIS SCI, V49, P4482, DOI 10.1167/iovs.08-2085; Ramadan RT, 2006, CURR EYE RES, V31, P955, DOI 10.1080/02713680600976925; Schaaf B, 2009, DIAGN PATHOL, V4, DOI 10.1186/1746-1596-4-12; Srivastava A, 2005, INFECT IMMUN, V73, P6479, DOI 10.1128/IAI.73.10.6479-6487.2005; Sun Y, 2006, INFECT IMMUN, V74, P5325, DOI 10.1128/IAI.00645-06; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Tu XK, 2010, NEUROCHEM RES, V35, P1147, DOI 10.1007/s11064-010-0167-6; Vilas-Boas GT, 2007, CAN J MICROBIOL, V53, P673, DOI 10.1139/W07-029; Wang JP, 2010, APMIS, V118, P261, DOI 10.1111/j.1600-0463.2010.02586.x; Yuan X, 2009, INVEST OPHTH VIS SCI, V1, P2094	41	29	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2011	6	12							e28619	10.1371/journal.pone.0028619	http://dx.doi.org/10.1371/journal.pone.0028619			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863OC	22163046	gold, Green Submitted, Green Published			2022-12-27	WOS:000298173500042
J	Badgaiyan, RD; Wack, D				Badgaiyan, Rajendra D.; Wack, David			Evidence of Dopaminergic Processing of Executive Inhibition	PLOS ONE			English	Article							REFERENCE TISSUE MODEL; RESPONSE ANTICIPATION; PARKINSONS-DISEASE; CAUDATE-NUCLEUS; RELEASE; ATTENTION; CONFLICT; PET; TASK; CATECHOLAMINES	Inhibition of unwanted response is an important function of the executive system. Since the inhibitory system is impaired in patients with dysregulated dopamine system, we examined dopamine neurotransmission in the human brain during processing of a task of executive inhibition. The experiment used a recently developed dynamic molecular imaging technique to detect and map dopamine released during performance of a modified Eriksen's flanker task. In this study, young healthy volunteers received an intravenous injection of a dopamine receptor ligand (C-11-raclopride) after they were positioned in the PET camera. After the injection, volunteers performed the flanker task under Congruent and Incongruent conditions in a single scan session. They were required to inhibit competing options to select an appropriate response in the Incongruent but not in the Congruent condition. The PET data were dynamically acquired during the experiment and analyzed using two variants of the simplified reference region model. The analysis included estimation of a number of receptor kinetic parameters before and after initiation of the Incongruent condition. We found increase in the rate of ligand displacement (from receptor sites) and decrease in the ligand binding potential in the Incongruent condition, suggesting dopamine release during task performance. These changes were observed in small areas of the putamen and caudate bilaterally but were most significant on the dorsal aspect of the body of left caudate. The results provide evidence of dopaminergic processing of executive inhibition and demonstrate that neurochemical changes associated with cognitive processing can be detected and mapped in a single scan session using dynamic molecular imaging.	[Badgaiyan, Rajendra D.] SUNY Buffalo, Dept Psychiat, Buffalo, NY 14260 USA; [Badgaiyan, Rajendra D.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Badgaiyan, Rajendra D.] Vet Affairs Med Ctr, Dept Psychiat, Buffalo, NY USA; [Wack, David] SUNY Buffalo, Dept Nucl Med, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Harvard University; Harvard Medical School; US Department of Veterans Affairs; Veterans Health Administration (VHA); State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Badgaiyan, RD (corresponding author), SUNY Buffalo, Dept Psychiat, Buffalo, NY 14260 USA.	rbrb@buffalo.edu	Badgaiyan, Rajendra D/B-8183-2012		National Institutes of Health (NIH)	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The study was partially funded by a National Institutes of Health (NIH) grant awarded to RDB. No additional external funding received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpert NM, 2003, NEUROIMAGE, V19, P1049, DOI 10.1016/S1053-8119(03)00186-1; Badgaiyan RD, 2008, NEUROREPORT, V19, P409, DOI 10.1097/WNR.0b013e3282f6435f; Badgaiyan RD, 2007, NEUROIMAGE, V38, P549, DOI 10.1016/j.neuroimage.2007.07.052; Badgaiyan RD, 2011, CURR MED IMAGING, V7, P98; Badgaiyan RD, 2011, CURR MED IMAGING REV, V7, P96; Badgaiyan RD, 2010, NEUROREPORT, V21, P1172, DOI 10.1097/WNR.0b013e3283410955; Badgaiyan RD, 2009, NEUROIMAGE, V47, P2041, DOI 10.1016/j.neuroimage.2009.06.008; Badgaiyan RD, 2003, NEUROREPORT, V14, P1421, DOI 10.1097/00001756-200308060-00003; Barto A.G., 1995, MODELS INFORM PROCES; Boraud T, 2000, J NEUROPHYSIOL, V83, P1760, DOI 10.1152/jn.2000.83.3.1760; Cai JX, 1997, J PHARMACOL EXP THER, V283, P183; Casey BJ, 2000, P NATL ACAD SCI USA, V97, P8728, DOI 10.1073/pnas.97.15.8728; CASTELLANOS FX, 1994, AM J PSYCHIAT, V151, P1791; Chaddock L, 2010, DEV NEUROSCI-BASEL, V32, P249, DOI 10.1159/000316648; CLARK CR, 1987, NEUROSCI BIOBEHAV R, V11, P341, DOI 10.1016/S0149-7634(87)80006-4; CLARK CR, 1987, NEUROSCI BIOBEHAV R, V11, P353, DOI 10.1016/S0149-7634(87)80007-6; Di Martino A, 2008, CEREB CORTEX, V18, P2735, DOI 10.1093/cercor/bhn041; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; Fan J, 2008, CEREB CORTEX, V18, P796, DOI 10.1093/cercor/bhm125; Fan J, 2007, J NEUROSCI, V27, P2272, DOI 10.1523/JNEUROSCI.3470-06.2007; Frank MJ, 2004, SCIENCE, V306, P1940, DOI 10.1126/science.1102941; Goghari VM, 2009, BRAIN COGNITION, V71, P72, DOI 10.1016/j.bandc.2009.04.004; Hedden T, 2010, NEUROIMAGE, V51, P421, DOI 10.1016/j.neuroimage.2010.01.089; Ko JH, 2008, EUR J NEUROSCI, V28, P2147, DOI 10.1111/j.1460-9568.2008.06501.x; Lammertsma AA, 1996, NEUROIMAGE, V4, P153, DOI 10.1006/nimg.1996.0066; Lutcke H, 2009, J COGNITIVE NEUROSCI, V21, P2172, DOI 10.1162/jocn.2008.21165; Luk G, 2010, BRAIN COGNITION, V74, P347, DOI 10.1016/j.bandc.2010.09.004; MARQUARDT DW, 1963, J SOC IND APPL MATH, V11, P431, DOI 10.1137/0111030; MCGHIE A, 1961, BRIT J MED PSYCHOL, V34, P103, DOI 10.1111/j.2044-8341.1961.tb00936.x; Monchi O, 2006, NEUROIMAGE, V33, P907, DOI 10.1016/j.neuroimage.2006.06.058; Moody M, 2005, AM J PHYSIOL-REG I, V288, pR1581, DOI 10.1152/ajpregu.00837.2004; Nee DE, 2007, COGN AFFECT BEHAV NE, V7, P1, DOI 10.3758/CABN.7.1.1; Nigg JT, 2000, PSYCHOL BULL, V126, P220, DOI 10.1037/0033-2909.126.2.220; Riley JD, 2011, EPILEPSY BEHAV, V21, P80, DOI 10.1016/j.yebeh.2011.03.013; Rosell A, 1999, NEUROSCI RES, V34, P257, DOI 10.1016/S0168-0102(99)00060-7; SARTER M, 1994, PSYCHOPHARMACOLOGY, V114, P539, DOI 10.1007/BF02244983; Sawamoto N, 2008, BRAIN, V131, P1294, DOI 10.1093/brain/awn054; Schultz W, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-24; Vaidya CJ, 2005, AM J PSYCHIAT, V162, P1605, DOI 10.1176/appi.ajp.162.9.1605; Wager TD, 2005, NEUROIMAGE, V27, P323, DOI 10.1016/j.neuroimage.2005.01.054; Waltz RA, 2006, MATH PROGRAM, V107, P391, DOI 10.1007/s10107-004-0560-5; Wylie SA, 2009, NEUROPSYCHOLOGIA, V47, P145, DOI 10.1016/j.neuropsychologia.2008.08.001; Zhou Y, 2006, NEUROIMAGE, V33, P550, DOI 10.1016/j.neuroimage.2006.06.038	43	22	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e28075	10.1371/journal.pone.0028075	http://dx.doi.org/10.1371/journal.pone.0028075			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22162756	Green Published, Green Submitted, gold			2022-12-27	WOS:000298172800014
J	Okorie, PN; McKenzie, FE; Ademowo, OG; Bockarie, M; Kelly-Hope, L				Okorie, Patricia Nkem; McKenzie, F. Ellis; Ademowo, Olusegun George; Bockarie, Moses; Kelly-Hope, Louise			Nigeria Anopheles Vector Database: An Overview of 100 Years' Research	PLOS ONE			English	Article							VILLAGE-SCALE TRIAL; POPULATION GENETIC-STRUCTURE; PYRETHROID INSECTICIDE RESISTANCE; RESIDUAL FUMIGANT INSECTICIDE; GAMBIAE-SENSU-STRICTO; CHAIN-REACTION ASSAY; MALARIA VECTORS; LYMPHATIC FILARIASIS; MOLECULAR-FORMS; CHROMOSOMAL FORMS	Anopheles mosquitoes are important vectors of malaria and lymphatic filariasis (LF), which are major public health diseases in Nigeria. Malaria is caused by infection with a protozoan parasite of the genus Plasmodium and LF by the parasitic worm Wuchereria bancrofti. Updating our knowledge of the Anopheles species is vital in planning and implementing evidence based vector control programs. To present a comprehensive report on the spatial distribution and composition of these vectors, all published data available were collated into a database. Details recorded for each source were the locality, latitude/longitude, time/period of study, species, abundance, sampling/collection methods, morphological and molecular species identification methods, insecticide resistance status, including evidence of the kdr allele, and P. falciparum sporozoite rate and W. bancrofti microfilaria prevalence. This collation resulted in a total of 110 publications, encompassing 484,747 Anopheles mosquitoes in 632 spatially unique descriptions at 142 georeferenced locations being identified across Nigeria from 1900 to 2010. Overall, the highest number of vector species reported included An. gambiae complex (65.2%), An. funestus complex (17.3%), An. gambiae s.s. (6.5%). An. arabiensis (5.0%) and An. funestus s.s. (2.5%), with the molecular forms An. gambiae M and S identified at 120 locations. A variety of sampling/collection and species identification methods were used with an increase in molecular techniques in recent decades. Insecticide resistance to pyrethroids and organochlorines was found in the main Anopheles species across 45 locations. Presence of P. falciparum and W. bancrofti varied between species with the highest sporozoite rates found in An. gambiae s.s, An. funestus s.s. and An. moucheti, and the highest microfilaria prevalence in An. gambiae s.l., An. arabiensis, and An. gambiae s.s. This comprehensive georeferenced database provides an essential baseline on Anopheles vectors and will be an important resource for malaria and LF vector control programmes in Nigeria.	[Okorie, Patricia Nkem; Ademowo, Olusegun George] Univ Ibadan, Inst Adv Med Res & Training, Coll Med, Ibadan, Nigeria; [McKenzie, F. Ellis] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Bockarie, Moses; Kelly-Hope, Louise] Univ Liverpool, Liverpool Sch Trop Med, Ctr Neglected Trop Dis, Liverpool L3 5QA, Merseyside, England	University of Ibadan; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); Liverpool School of Tropical Medicine; University of Liverpool	Okorie, PN (corresponding author), Univ Ibadan, Inst Adv Med Res & Training, Coll Med, Ibadan, Nigeria.	triciaokoye@yahoo.com	Bockarie, Moses/AAV-4578-2020; Bockarie, Moses/AAW-3130-2021	Kelly-Hope, Louise/0000-0002-3330-7629; Ademowo, Olusegun/0000-0003-4020-5134	MRC [G1001337] Funding Source: UKRI; Medical Research Council [G1001337] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Adeleke M A, 2008, Tanzan J Health Res, V10, P103; Adeleke MA, 2010, J VECTOR DIS, V47, P33; Adeleke Monsuru Adebayo, 2008, Acta Entomologica Sinica, V51, P1289; Afolabi BM, 2006, MED PRIN PRACT, V15, P200, DOI 10.1159/000092182; Agi P. I., 2009, Journal of Applied Sciences and Environmental Management, V13, P15; Amusan A A S, 2005, Tanzan Health Res Bull, V7, P111; Amusan AAS, 2003, NIGERIAN J PARASITOL, V24, P167; Annett E, 1901, LIVERPOOL SCH TROP M, VIV, P69; [Anonymous], 2004, COCHRANE DB SYST REV; [Anonymous], 2007, ANVR Q NEWSLETTER, V2; [Anonymous], DIR CIT TOWNS WORLD; [Anonymous], 2006, ANVR NEWSLETTER, V1; Anosike JC, 2005, ANN AGR ENV MED, V12, P181; Anosike JC, 2007, ANN AGR ENV MED, V14, P31; Anyanwu IN, 2000, VET PARASITOL, V92, P319, DOI 10.1016/S0304-4017(00)00311-3; ARCHIBALD H. MUNRO, 1956, BULL WORLD HEALTH ORGAN, V15, P695; Armstrong JA, 1957, ANN TROP MED PARASIT, V52, P247; Awolola TS, 2009, T ROY SOC TROP MED H, V103, P1139, DOI 10.1016/j.trstmh.2008.08.021; Awolola T. S., 2007, Journal of Vector Borne Diseases, V44, P181; Awolola TS, 2005, ACTA TROP, V95, P204, DOI 10.1016/j.actatropica.2005.06.002; Awolola TS, 2005, T ROY SOC TROP MED H, V99, P525, DOI 10.1016/j.trstmh.2004.12.003; Awolola TS, 2002, ANN TROP MED PARASIT, V96, P75, DOI 10.1179/000349802125000538; Awolola TS, 2003, AFR ENTOMOL, V11, P227; Awolola TS, 2003, TROP MED INT HEALTH, V8, P420, DOI 10.1046/j.1365-3156.2003.01034.x; Awolola TS, 2002, ANN TROP MED PARASIT, V96, P849, DOI 10.1179/000349802125002581; Awolola TS, 2007, MALARIA ENTOMOLOGICA, P50; Ayanda OI, 2009, J PARASITOL, V1, P005; BARZEEV M, 1965, B WORLD HEALTH ORGAN, V33, P583; BARZEEV M, 1965, B WORLD HEALTH ORGAN, V33, P461; Bayoh MN, 2001, MED VET ENTOMOL, V15, P267, DOI 10.1046/j.0269-283x.2001.00298.x; Bockarie MJ, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1686; BOREHAM PFL, 1979, T ROY SOC TROP MED H, V73, P418, DOI 10.1016/0035-9203(79)90167-6; Brooke BD, 1999, J AM MOSQUITO CONTR, V15, P565; Bruce-Chwatt LJ, 1985, ESSENTIAL MALARIOLOG; Brunhes J, 1998, ANN SOC ENTOMOL FR, V34, P397; Chandler AC, 1955, INTRO PARASITOLOGY, P693; Coetzee M, 2000, PARASITOL TODAY, V16, P74, DOI 10.1016/S0169-4758(99)01563-X; COLUZZI M, 1979, T ROY SOC TROP MED H, V73, P483, DOI 10.1016/0035-9203(79)90036-1; Coluzzi M, 1975, 24 WHO, P16; DAVIDSON G, 1962, B WORLD HEALTH ORGAN, V27, P303; De Meillon B, 1931, S AFRICA INVEST MED, V28, P578; de MEILLON BOTHA, 1947, JOUR ENT SOC SO AFRICA, V10, P110; de Souza D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009927; Dialynas E, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000465; Djouaka RF, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-159; Djouaka RF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-538; Dodge JS, WHOMAL52065; Edwards FW, 1941, PUB I MED RES, V23, P28; ELLIOTT R, 1956, NATURE, V177, P532, DOI 10.1038/177532a0; ELLIOTT R, 1963, B WORLD HEALTH ORGAN, V28, P35; Fanello C, 2002, MED VET ENTOMOL, V16, P461, DOI 10.1046/j.1365-2915.2002.00393.x; Favia G, 1997, INSECT MOL BIOL, V6, P377, DOI 10.1046/j.1365-2583.1997.00189.x; FMEN (Federal Ministry of Environment of Nigeria), 2001, NAT ACT PROGR COMB D; FMH (Federal Ministry of Health), 2008, STRAT PLAN 2009 2013; FOLL CV, 1965, B WORLD HEALTH ORGAN, V32, P531; FOLL CV, 1966, B WORLD HEALTH ORGAN, V34, P395; Fontaine RE, 1971, WHOVBC71284; GARRETTJONES C, 1969, B WORLD HEALTH ORGAN, V40, P531; Gillett J. D., 1972, COMMON AFRICAN MOSQU, P1; GILLIES M. T., 1968, The Anophelinae of Africa south of the Sahara (Ethiopian Zoogeographical Region).; Gillies M. T., 1987, A supplement to the Anophelinae of Africa south of the Sahara (Afrotropical Region).; Gordon RM, 1978, ENTOMOLOGY STUDENTS; Govella N, 2010, AM J TROP MED HYG, V83, P596, DOI 10.4269/ajtmh.2010.09-0682; GRATZ NG, 1963, B WORLD HEALTH ORGAN, V29, P251; Greenwood BM, 2006, TRENDS PARASITOL, V22, P278, DOI 10.1016/j.pt.2006.05.005; Hackett BJ, 2000, INSECT MOL BIOL, V9, P369, DOI 10.1046/j.1365-2583.2000.00198.x; HANNEY P. W., 1960, BULL ENT RES, V51, P145, DOI 10.1017/S0007485300055024; Hay SI, 2000, T ROY SOC TROP MED H, V94, P113, DOI 10.1016/S0035-9203(00)90246-3; Hopkins GHE, 1952, MOSQUITOES ETHIOPIAN, p[1, 100, 136, 194, 250, 305]; Iloeje N.P., 2001, NEW GEOGRAPHY NIGERI; IRAC (Insecticide Resistance Action Committee), 2011, PREV MAN INS RES VEC, P72; IRAC (Insecticide Resistance Action Committee), 2010, IMP INS RES MAN CONT; IRAC (Insecticide Resistance Action Committee), 2010, INCR UT IMP BIOM TEC; Ivoke N, 2009, ANI RES INT, V6, P1072; Johnson W. B., 1919, Bulletin of Entomological Research London, V9, DOI 10.1017/S0007485300038049; Katz I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017166; Kelly-Hope LA, 2006, TROP MED INT HEALTH, V11, P129, DOI 10.1111/j.1365-3156.2005.01558.x; Kelly-Hope LA, 2005, T ROY SOC TROP MED H, V99, P751, DOI 10.1016/j.trstmh.2005.05.008; Kelly-Hope L, 2008, LANCET INFECT DIS, V8, P387, DOI 10.1016/S1473-3099(08)70045-8; Kelly-Hope LA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-19; Kengne P, 2007, MED VET ENTOMOL, V21, P177, DOI 10.1111/j.1365-2915.2007.00681.x; Kengne P, 2003, MED VET ENTOMOL, V17, P67, DOI 10.1046/j.1365-2915.2003.00411.x; Koekemoer LL, 2002, AM J TROP MED HYG, V66, P804, DOI 10.4269/ajtmh.2002.66.804; Kristan M, 2003, MED VET ENTOMOL, V17, P326, DOI 10.1046/j.1365-2915.2003.00449.x; KUHLOW F, 1962, B WORLD HEALTH ORGAN, V26, P93; Lehmann T, 2003, J HERED, V94, P133, DOI 10.1093/jhered/esg024; Lehmann T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004549; Lenhart Audrey, 2007, Filaria J, V6, P14, DOI 10.1186/1475-2883-6-14; Lindsay SW, 1998, P ROY SOC B-BIOL SCI, V265, P847, DOI 10.1098/rspb.1998.0369; Lindsay SW, 2000, T ROY SOC TROP MED H, V94, P37, DOI 10.1016/S0035-9203(00)90431-0; Manga SB, 2008, NIG J PARASITOL, V29, P103; Manguin S, 2010, INFECT GENET EVOL, V10, P159, DOI 10.1016/j.meegid.2009.11.014; MELLANBY K., 1956, Bulletin of Entomological Research, V47, P125, DOI 10.1017/S0007485300046587; Michel AP, 2005, MOL ECOL, V14, P4235, DOI 10.1111/j.1365-294X.2005.02754.x; MOLINEAUX L, 1976, B WORLD HEALTH ORGAN, V54, P379; MOLINEAUX L, 1979, B WORLD HEALTH ORGAN, V57, P265; Molineaux L, 1980, WHO, V312, P53; Morgan JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011872; Ndams IS, 2006, SCI WORLD J, V1, P15; Ndo C, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-161; NGA, 2008, NGA GEONET NAM SERV; Nigeria FY, 2010, 2011 MALARIA OPERATI; Njenga SM, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-90; Noutcha MAE, 2010, J VECTOR DIS, V47, P51; Noutcha MAE, 2009, J VECTOR DIS, V46, P43; Obomanu FG, 2006, AFR J BIOTECHNOL, V5, P761; Oduola A. O., 2010, Journal of Rural and Tropical Public Health, V9, P114; Ogba OM, 2007, J MED LAB SCI, V16, P1; OGUNBA EO, 1971, ANN TROP MED PARASIT, V65, P399, DOI 10.1080/00034983.1971.11686769; Oguoma V., 2009, ANIM RES INT, DOI [10.4314/ari.v5i2.48748, DOI 10.4314/ARI.V5I2.48748]; Oguoma V. M., 2010, Reviews in Infection, V1, P192; Okara RM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-69; Okogun Godwin R. A., 2005, Journal of Vector Borne Diseases, V42, P1; Okwa OO, 2009, ANN AFR MED, V8, P1, DOI 10.4103/1596-3519.55756; Okwa OO., 2007, J CELL ANIMAL BIOL, V1, P19; Olayemi I, 2008, J HLTH ALLIED SCI, V7, P1; Olayemi IK, 2009, J VECTOR DIS, V46, P295; Onyabe DY, 2003, T ROY SOC TROP MED H, V97, P605, DOI 10.1016/S0035-9203(03)80045-7; Onyabe DY, 2001, MOL ECOL, V10, P2577, DOI 10.1046/j.0962-1083.2001.01387.x; Onyabe DY, 2001, MEM I OSWALDO CRUZ, V96, P1081, DOI 10.1590/S0074-02762001000800009; Oparaocha ET, 2010, J VECTOR DIS, V47, P45; Oyewole I.O., 2010, International Journal of Insect Science, V2, P51; Oyewole I. O., 2007, Journal of Vector Borne Diseases, V44, P56; Oyewole I. O., 2006, Journal of Vector Borne Diseases, V43, P173; Oyewole IO, 2005, BIOKEMISTRI, V17, P171; PANT CP, 1969, B WORLD HEALTH ORGAN, V41, P311; PANT CP, 1969, B WORLD HEALTH ORGAN, V41, P316; PANT CP, 1966, B WORLD HEALTH ORGAN, V35, P709; Pant CP, 1968, WHOVBC68104; Penilla RP, 1998, MED VET ENTOMOL, V12, P217, DOI 10.1046/j.1365-2915.1998.00123.x; Pinto J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001243; Pluess B, INDOOR RESIDUAL SPRA; Pombi M, 2008, BMC EVOL BIOL, V8, P309, DOI DOI 10.1186/1471-2148-8-309; RAMAKRISHNA V, 1957, NATURE, V179, P1140, DOI 10.1038/1791140b0; RAMSDALE CD, 1967, B WORLD HEALTH ORGAN, V36, P494; Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004; RBM Report, 2005, BUILD CAP MON EV ROL; Richards F O Jr, 2005, Filaria J, V4, P6, DOI 10.1186/1475-2883-4-6; Richards FO, 2005, ANN TROP MED PARASIT, V99, P155, DOI 10.1179/136485905X19838; RISHIKESH N, 1985, ACTA TROP, V42, P165; Rosen P, 1970, WHOVBC70192; Santolamazza F, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-74; SCOTT JA, 1993, AM J TROP MED HYG, V49, P520, DOI 10.4269/ajtmh.1993.49.520; SELF LS, 1966, B WORLD HEALTH ORGAN, V34, P960; SERVICE M W, 1961, West Afr Med J, V10, P109; SERVICE M. W., 1964, Bulletin of Entomological Research, V55, P29, DOI 10.1017/S0007485300049257; SERVICE M. W., 1963, Bulletin of Entomological Research, V54, P601, DOI 10.1017/S000748530004904X; SERVICE MW, 1971, B WORLD HEALTH ORGAN, V45, P169; SERVICE MW, 1964, J TROP MED HYG, V67, P190; SERVICE MW, 1977, B ENTOMOL RES, V67, P343, DOI 10.1017/S0007485300011184; SERVICE MW, 1964, J TROP MED HYG, V67, P11; SERVICE MW, 1970, ANN TROP MED PARASIT, V64, P131, DOI 10.1080/00034983.1970.11686674; SERVICE MW, 1964, NATURE, V203, P209, DOI 10.1038/203209a0; Service MW, 1976, MOSQUITO BIOL FIELD; Service MW, 1980, GUIDE MEDICAL ENTOMO; Service MW, 1964, T R SOC TROP MED HYG, V58, P1; Service MW, 1964, P R ENT SOC LOND B, V33, P73; Shidrawi GR, 1972, WHOMAL72776; Sikulu M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-197; Sinka ME, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-117; Smart J, 1956, HDB IDENTIFICATION I; SMITH DMS, 1981, J TROP MED HYG, V84, P95; Sogoba N, 2007, GEOSPATIAL HEALTH, V1, P213, DOI 10.4081/gh.2007.269; Sogoba N, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-205; Sow G.J., 2007, SCI WORLD J, V2, P5, DOI [10.4314/swj.v2i4.51753, DOI 10.4314/SWJ.V2I4.51753]; TAYLOR A. W., 1930, ANN TROP MED AND PARASITOL, V24, P425; THOMSON RCM, 1948, B ENTOMOL RES, V38, P527, DOI 10.1017/S0007485300023221; UDONSI JK, 1988, FOLIA PARASIT, V35, P147; WHITE GB, 1973, B ENTOMOL RES, V62, P613, DOI 10.1017/S0007485300005502; WHO, 2010, WORLD MALARIA REPORT 2010, P1; *WHO, 2005, ATL INS RES MAL VECT; *WHO, 1957, B WORLD HEALTH ORGAN, V16, P874; WHO, 2010, PROGR REP 2000 2009; WHO, 2011, WEEKLY EPIDEMIOLOGIC, V86, P113; WRIGHT JW, 1969, B WORLD HEALTH ORGAN, V40, P67	175	28	30	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e28347	10.1371/journal.pone.0028347	http://dx.doi.org/10.1371/journal.pone.0028347			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22162764	gold, Green Published, Green Accepted			2022-12-27	WOS:000298172800027
J	Forsyth, CB; Shannon, KM; Kordower, JH; Voigt, RM; Shaikh, M; Jaglin, JA; Estes, JD; Dodiya, HB; Keshavarzian, A				Forsyth, Christopher B.; Shannon, Kathleen M.; Kordower, Jeffrey H.; Voigt, Robin M.; Shaikh, Maliha; Jaglin, Jean A.; Estes, Jacob D.; Dodiya, Hemraj B.; Keshavarzian, Ali			Increased Intestinal Permeability Correlates with Sigmoid Mucosa alpha-Synuclein Staining and Endotoxin Exposure Markers in Early Parkinson's Disease	PLOS ONE			English	Article							LEWY BODIES; METAGENOMIC ANALYSIS; NERVOUS-SYSTEM; LPS; LIPOPOLYSACCHARIDE; GUT; NEURONS; BARRIER; PROTEIN; BRAIN	Parkinson's disease (PD) is the second most common neurodegenerative disorder of aging. The pathological hallmark of PD is neuronal inclusions termed Lewy bodies whose main component is alpha-synuclein protein. The finding of these Lewy bodies in the intestinal enteric nerves led to the hypothesis that the intestine might be an early site of PD disease in response to an environmental toxin or pathogen. One potential mechanism for environmental toxin(s) and proinflammatory luminal products to gain access to mucosal neuronal tissue and promote oxidative stress is compromised intestinal barrier integrity. However, the role of intestinal permeability in PD has never been tested. We hypothesized that PD subjects might exhibit increased intestinal permeability to proinflammatory bacterial products in the intestine. To test our hypothesis we evaluated intestinal permeability in subjects newly diagnosed with PD and compared their values to healthy subjects. In addition, we obtained intestinal biopsies from both groups and used immunohistochemistry to assess bacterial translocation, nitrotyrosine (oxidative stress), and alpha-synuclein. We also evaluated serum markers of endotoxin exposure including LPS binding protein (LBP). Our data show that our PD subjects exhibit significantly greater intestinal permeability (gut leakiness) than controls. In addition, this intestinal hyperpermeability significantly correlated with increased intestinal mucosa staining for E. coli bacteria, nitrotyrosine, and alpha-synuclein as well as serum LBP levels in PD subjects. These data represent not only the first demonstration of abnormal intestinal permeability in PD subjects but also the first correlation of increased intestinal permeability in PD with intestinal alpha-synuclein (the hallmark of PD), as well as staining for gram negative bacteria and tissue oxidative stress. Our study may thus shed new light on PD pathogenesis as well as provide a new method for earlier diagnosis of PD and suggests potential therapeutic targets in PD subjects.	[Forsyth, Christopher B.; Voigt, Robin M.; Shaikh, Maliha; Keshavarzian, Ali] Rush Univ, Med Ctr, Gastroenterol Sect, Dept Internal Med, Chicago, IL 60612 USA; [Shannon, Kathleen M.; Jaglin, Jean A.] Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA; [Kordower, Jeffrey H.; Dodiya, Hemraj B.] Rush Med Coll, Ctr Brain Repair, Chicago, IL 60612 USA; [Estes, Jacob D.] NCI, AIDS & Canc Virus Program, SAIC Frederick Inc, Frederick, MD 21701 USA	Rush University; Rush University; Rush University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Forsyth, CB (corresponding author), Rush Univ, Med Ctr, Gastroenterol Sect, Dept Internal Med, Chicago, IL 60612 USA.	christopher_b_forsyth@rush.edu		Dodiya, Hemraj/0000-0002-0908-0014	Parkinson's Research Center from the Parkinson's Disease Foundation	Parkinson's Research Center from the Parkinson's Disease Foundation	Funding provided by a gift from Mr. and Mrs. Larry Field (to AK) and Parkinson's Research Center Grant from the Parkinson's Disease Foundation (to KS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braak H, 2003, J NEURAL TRANSM, V110, P517, DOI 10.1007/s00702-002-0808-2; Braak H, 2008, NEUROLOGY, V70, P1916, DOI 10.1212/01.wnl.0000312279.49272.9f; Cirillo C, 2009, NEUROGASTROENT MOTIL, V21, P1209, DOI 10.1111/j.1365-2982.2009.01346.x; Davies KN, 1996, POSTGRAD MED J, V72, P164, DOI 10.1136/pgmj.72.845.164; Dorsey ER, 2007, NEUROLOGY, V68, P384, DOI 10.1212/01.wnl.0000247740.47667.03; Emanuele E, 2010, NEUROSCI LETT, V471, P162, DOI 10.1016/j.neulet.2010.01.033; Estes JD, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001052; Farhadi A, 2003, J GASTROEN HEPATOL, V18, P479, DOI 10.1046/j.1440-1746.2003.03032.x; Farhadi A, 2003, J CHROMATOGR B, V784, P145, DOI 10.1016/S1570-0232(02)00787-0; Farhadi A, 2006, J CHROMATOGR B, V836, P63, DOI 10.1016/j.jchromb.2006.03.046; Gao HM, 2011, ENV HLTH PERSPECT; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Greene JG, 2009, EXP NEUROL, V218, P154, DOI 10.1016/j.expneurol.2009.04.023; Gutsmann T, 2001, INFECT IMMUN, V69, P6942, DOI 10.1128/IAI.69.11.6942-6950.2001; Hawkes CH, 2007, NEUROPATH APPL NEURO, V33, P599, DOI 10.1111/j.1365-2990.2007.00874.x; Hirsch EC, 2009, LANCET NEUROL, V8, P382, DOI 10.1016/S1474-4422(09)70062-6; Hobson P, 2010, J NEUROL NEUROSUR PS, V81, P1093, DOI 10.1136/jnnp.2009.198689; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; John LJ, 2011, EPITHELIAL BARRIERS; Keck S, 2011, J IMMUNOL, V186, P5478, DOI 10.4049/jimmunol.1000458; Kim WG, 2000, J NEUROSCI, V20, P6309, DOI 10.1523/JNEUROSCI.20-16-06309.2000; Kitchens RL, 2005, J ENDOTOXIN RES, V11, P225, DOI 10.1179/096805105X46565; KUPSKY WJ, 1987, NEUROLOGY, V37, P1253, DOI 10.1212/WNL.37.7.1253; Lebouvier T, 2008, GUT, V57, P1741, DOI 10.1136/gut.2008.162503; Lebouvier T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012728; Lebouvier T, 2009, EUR J NEUROSCI, V30, P735, DOI 10.1111/j.1460-9568.2009.06873.x; Lees AJ, 2009, LANCET, V373, P2055, DOI 10.1016/S0140-6736(09)60492-X; Maes M, 2008, NEUROENDOCRINOL LETT, V29, P117; McGeer PL, 2004, ANN NY ACAD SCI, V1035, P104, DOI 10.1196/annals.1332.007; McOmber ME, 2010, J PEDIATR GASTR NUTR, V50, P269, DOI 10.1097/MPG.0b013e3181aa3aa9; Menard S, 2010, MUCOSAL IMMUNOL, V3, P247, DOI 10.1038/mi.2010.5; Minter RM, 2009, AM J PHYSIOL-GASTR L, V296, pG45, DOI 10.1152/ajpgi.00041.2008; Murakami M, 2009, J NEUROSCI RES, V87, P2095, DOI 10.1002/jnr.22036; Niehaus I, 2003, OCCUP ENVIRON MED, V60, P378, DOI 10.1136/oem.60.5.378; Ouchi Y, 2009, PARKINSONISM RELAT D, V15, pS200, DOI 10.1016/S1353-8020(09)70814-4; Phillips RJ, 2008, NEUROSCIENCE, V153, P733, DOI 10.1016/j.neuroscience.2008.02.074; Qin LY, 2007, GLIA, V55, P453, DOI 10.1002/glia.20467; QUALMAN SJ, 1984, GASTROENTEROLOGY, V87, P848; Savidge TC, 2007, LAB INVEST, V87, P731, DOI 10.1038/labinvest.3700600; Shannon K, 2011, MOVEMENT DI IN PRESS; Shannon K.M., 2011, MOV DISORD; Shults CW, 2006, P NATL ACAD SCI USA, V103, P1661, DOI 10.1073/pnas.0509567103; Thomas B, 2007, HUM MOL GENET, V16, pR183, DOI 10.1093/hmg/ddm159; TOBIAS PS, 1995, J BIOL CHEM, V270, P10482, DOI 10.1074/jbc.270.18.10482; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Wakabayashi K, 1997, EUR NEUROL, V38, P2, DOI 10.1159/000113469; WAKABAYASHI K, 1988, ACTA NEUROPATHOL, V76, P217, DOI 10.1007/BF00687767; WAKABAYASHI K, 1990, ACTA NEUROPATHOL, V79, P581, DOI 10.1007/BF00294234; Wang S, 2009, BRAIN RES, V1265, P196, DOI 10.1016/j.brainres.2009.02.022; Whitton PS, 2007, BRIT J PHARMACOL, V150, P963, DOI 10.1038/sj.bjp.0707167; Zhang R, 2009, J NEUROIMMUNOL, V206, P121, DOI 10.1016/j.jneuroim.2008.09.017	51	516	543	4	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2011	6	12							e28032	10.1371/journal.pone.0028032	http://dx.doi.org/10.1371/journal.pone.0028032			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MQ	22145021	Green Published, gold, Green Submitted			2022-12-27	WOS:000298168900004
J	Dolic, K; Weinstock-Guttman, B; Marr, K; Valnarov, V; Carl, E; Hagemeier, J; Brooks, C; Kilanowski, C; Hojnacki, D; Ramanathan, M; Zivadinov, R				Dolic, Kresimir; Weinstock-Guttman, Bianca; Marr, Karen; Valnarov, Vesela; Carl, Ellen; Hagemeier, Jesper; Brooks, Christina; Kilanowski, Colleen; Hojnacki, David; Ramanathan, Murali; Zivadinov, Robert			Risk Factors for Chronic Cerebrospinal Venous Insufficiency (CCSVI) in a Large Cohort of Volunteers	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; FISH-OIL; GINKGO-BILOBA; JUGULAR VALVE; THROMBOEMBOLISM; SMOKING; THROMBOSIS; FLOW; EPIDEMIOLOGY; INCOMPETENCE	Background: The role of intra-and extra-cranial venous system impairment in the pathogenesis of various vascular, inflammatory and neurodegenerative neurological disorders, as well as in aging, has not been studied in detail. Nor have risk factors been determined for increased susceptibility of venous pathology in the intra-cranial and extra-cranial veins. The aim of this study was to investigate the association between presence of a newly proposed vascular condition called chronic cerebrospinal venous insufficiency (CCSVI) and environmental factors in a large volunteer control group without known central nervous system pathology. Methods and Findings: The data were collected in a prospective study from 252 subjects who were screened for medical history as part of the entry criteria and participated in the case-control study of CCSVI prevalence in multiple sclerosis (MS) patients, and then were analyzed post-hoc. All participants underwent physical and Doppler sonography examinations, and were assessed with a structured environmental questionnaire. Fullfilment of >= 2 positive venous hemodynamic (VH) criteria on Doppler sonography was considered indicative of CCSVI diagnosis. Risk and protective factors associated with CCSVI were analyzed using logistic regression analysis. Seventy (27.8%) subjects presented with CCSVI diagnosis and 153 (60.7%) presented with one or more VH criteria. The presence of heart disease (p = .001), especially heart murmurs (p = .007), a history of infectious mononucleosis (p = .002), and irritable bowel syndrome (p = .005) were associated with more frequent CCSVI diagnosis. Current or previous smoking (p = .029) showed a trend for association with more frequent CCSVI diagnosis, while use of dietary supplements (p = .018) showed a trend for association with less frequent CCSVI diagnosis. Conclusions: Risk factors for CCSVI differ from established risk factors for peripheral venous diseases. Vascular, infectious and inflammatory factors were associated with higher CCSVI frequency.	[Dolic, Kresimir; Marr, Karen; Valnarov, Vesela; Carl, Ellen; Hagemeier, Jesper; Brooks, Christina; Kilanowski, Colleen; Ramanathan, Murali; Zivadinov, Robert] SUNY Buffalo, Buffalo Neuroimaging Anal Ctr, Buffalo, NY 14260 USA; [Weinstock-Guttman, Bianca; Hojnacki, David; Zivadinov, Robert] SUNY Buffalo, Dept Neurol, Jacobs Neurol Inst, Buffalo, NY 14260 USA; [Ramanathan, Murali] SUNY Buffalo, Dept Pharmaceut Sci, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Dolic, K (corresponding author), SUNY Buffalo, Buffalo Neuroimaging Anal Ctr, Buffalo, NY 14260 USA.	rzivadinov@bnac.net	Dolic, Kresimir/D-8350-2017; Zivadinov, Robert/Q-2054-2019; Weinstock-Guttman, Bianca/AAI-4694-2021; Carl, Ellen/AAC-9162-2020	Zivadinov, Robert/0000-0002-7799-1485; Weinstock-Guttman, Bianca/0000-0001-6732-151X; Carl, Ellen/0000-0002-0930-8285	Buffalo Neuroimaging Analysis Center; Baird MS Center; Jacobs Neurological Institute; University of Buffalo; MS Foundation; Jacquemin Foundation; Biogen Idec; Teva Pharmaceutical Industries Ltd.; EMD Serono; Pfizer Inc; Novartis; National Multiple Sclerosis Society (NMSS); National Institutes of Health; Immune Tolerance Network; Teva Neuroscience; Aspreva; Pfizer; National Science Foundation; Questcor Pharmaceuticals; Genzyme; Bracco	Buffalo Neuroimaging Analysis Center; Baird MS Center; Jacobs Neurological Institute; University of Buffalo; MS Foundation; Jacquemin Foundation; Biogen Idec(Biogen); Teva Pharmaceutical Industries Ltd.(Teva Pharmaceutical Industries); EMD Serono; Pfizer Inc(Pfizer); Novartis(Novartis); National Multiple Sclerosis Society (NMSS)(National Multiple Sclerosis Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Immune Tolerance Network; Teva Neuroscience(Teva Pharmaceutical Industries); Aspreva; Pfizer(Pfizer); National Science Foundation(National Science Foundation (NSF)); Questcor Pharmaceuticals; Genzyme(Sanofi-AventisGenzyme Corporation); Bracco	This study was funded with internal resources of the Buffalo Neuroimaging Analysis Center and Baird MS Center, the Jacobs Neurological Institute, University of Buffalo. In addition, the authors received support from the Direct MS Foundation and the Jacquemin Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; DH has received speaker honoraria and consultant fees from Biogen Idec, Teva Pharmaceutical Industries Ltd., EMD Serono, Pfizer Inc, and Novartis. BW-G received personal compensation for consulting, speaking and serving on a scientific advisory board for Biogen Idec, Teva Neuroscience and EMD Serono. BW-G also received financial support for research activities from the National Multiple Sclerosis Society (NMSS), National Institutes of Health, Immune Tolerance Network, Teva Neuroscience, Biogen Idec, EMD Serono, and Aspreva. MR served as an editor for the American Association of Pharmaceutical Scientists Journal, receives royalties for publishing The Pharmacy Calculations Workbook [Pinnacle, Summit and Zenith, 2008], and received research support from EMD Serono, Novartis, Pfizer, NMSS, and the National Science Foundation. RZ received personal compensation from Teva Neuroscience, Biogen Idec, EMD Serono and Questcor Pharmaceuticals for speaking and consultant fees. RZ also received financial support for research activities from Biogen Idec, Teva Neuroscience, Genzyme, Bracco, Questcor Pharmaceuticals and EMD Serono. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Ageno W, 2008, CIRCULATION, V117, P93, DOI 10.1161/CIRCULATIONAHA.107.709204; Anderson FA, 2003, CIRCULATION, V107, pI9, DOI 10.1161/01.CIR.0000078469.07362.E6; Arnould T, 1998, J CARDIOVASC PHARM, V31, P456, DOI 10.1097/00005344-199803000-00018; Ascherio A, 2007, ANN NEUROL, V61, P288, DOI 10.1002/ana.21117; Baracchini C, 2011, ANN NEUROL, V69, P90, DOI 10.1002/ana.22228; Bronnum-Hansen H, 2004, BRAIN, V127, P844, DOI 10.1093/brain/awh104; Centonze D, 2011, ANN NEUROL; Christiansen CF, 2010, NEUROEPIDEMIOLOGY, V35, P267, DOI 10.1159/000320245; Chuang YM, 2005, EUR NEUROL, V53, P78, DOI 10.1159/000084651; Chung CP, 2007, ULTRASOUND MED BIOL, V33, P1727, DOI 10.1016/j.ultrasmedbio.2007.05.018; Chung CP, 2011, ANN NEUROL, V69, P553, DOI 10.1002/ana.22276; Chung CP, 2010, ULTRASOUND MED BIOL, V36, P1776, DOI 10.1016/j.ultrasmedbio.2010.07.006; Compston A, 1999, PHILOS T R SOC B, V354, P1623, DOI 10.1098/rstb.1999.0507; D'haeseleer M, 2011, LANCET NEUROL, V10, P657, DOI 10.1016/S1474-4422(11)70105-3; Dalpke AH, 2003, J MED VIROL, V71, P408, DOI 10.1002/jmv.10501; De Giorgio Roberto, 2008, Curr Gastroenterol Rep, V10, P385, DOI 10.1007/s11894-008-0073-0; Doepp F, 2008, CEPHALALGIA, V28, P182, DOI 10.1111/j.1468-2982.2007.01484.x; Doepp F, 2008, J CLIN ULTRASOUND, V36, P480, DOI 10.1002/jcu.20470; Doepp F, 2010, ANN NEUROL, V68, P173, DOI 10.1002/ana.22085; Hausmann S, 1997, CURR OPIN IMMUNOL, V9, P831, DOI 10.1016/S0952-7915(97)80186-0; Hawkes CH, 2007, MULT SCLER J, V13, P610, DOI 10.1177/1352458506073501; Hsu HY, 2008, ANN NEUROL, V63, P247, DOI 10.1002/ana.21299; JUNG F, 1990, ARZNEIMITTELFORSCH, V40-1, P589; Khan O, 2010, ANN NEUROL, V67, P286, DOI 10.1002/ana.22001; KIM DN, 1995, ANN NY ACAD SCI, V748, P474; Lee BB, 2010, INT ANGIOL, V29, P95; Lowe GDO, 2004, MATURITAS, V47, P259, DOI 10.1016/j.maturitas.2003.12.009; Marrie RA, 2010, NEUROLOGY, V74, P1041, DOI 10.1212/WNL.0b013e3181d6b125; Mashav N, 2008, THROMB RES, V122, P570, DOI 10.1016/j.thromres.2008.03.005; Mayer CA, 2011, J NEUROL NEUROSUR PS, V82, P436, DOI 10.1136/jnnp.2010.231613; Nedelmann M, 2009, J NEUROL, V256, P964, DOI 10.1007/s00415-009-5056-z; Nielsen NM, 2008, MULT SCLER J, V14, P823, DOI 10.1177/1352458508088936; OLSZEWSKI AJ, 1993, CORONARY ARTERY DIS, V4, P53, DOI 10.1097/00019501-199301000-00007; Phang M, 2011, SEMIN THROMB HEMOST, V37, P199, DOI 10.1055/s-0031-1273084; Pomp ER, 2008, AM J HEMATOL, V83, P97, DOI 10.1002/ajh.21059; PURRMANN J, 1992, J CLIN GASTROENTEROL, V14, P43, DOI 10.1097/00004836-199201000-00011; Rudick RA, 2010, NAT REV NEUROL, V6, P472, DOI 10.1038/nrneurol.2010.117; SACKS FM, 1995, J AM COLL CARDIOL, V25, P1492, DOI 10.1016/0735-1097(95)00095-L; Severinsen MT, 2009, J THROMB HAEMOST, V7, P1297, DOI 10.1111/j.1538-7836.2009.03490.x; Smith PF, 1996, J ETHNOPHARMACOL, V50, P131, DOI 10.1016/0378-8741(96)01379-7; Solem CA, 2004, AM J GASTROENTEROL, V99, P97, DOI 10.1046/j.1572-0241.2003.04026.x; Sorensen HT, 2009, J THROMB HAEMOST, V7, P521, DOI 10.1111/j.1538-7836.2009.03279.x; Sundstrom P, 2008, MULT SCLER J, V14, P1031, DOI 10.1177/1352458508093615; Sundstrom P, 2010, ANN NEUROL, V68, P255, DOI 10.1002/ana.22132; Taylor BV, 1998, CAN J CARDIOL, V14, P1129; Wattjes MP, 2010, J NEUROL NEUROSURG P; YAMAZAKI M, 1991, BLOOD COAGUL FIBRIN, V2, P771, DOI 10.1097/00001721-199112000-00012; Zamboni P, 2009, J NEUROL NEUROSUR PS, V80, P392, DOI 10.1136/jnnp.2008.157164; Zivadinov R, 2011, NEUROLOGY; Zivadinov R, 2011, RADIOLOGY, V258, P562, DOI 10.1148/radiol.10101387	50	33	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e28062	10.1371/journal.pone.0028062	http://dx.doi.org/10.1371/journal.pone.0028062			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140507	Green Published, Green Submitted, gold			2022-12-27	WOS:000298168100033
J	Krawetz, RJ; Taiani, J; Greene, A; Kelly, GM; Rancourt, DE				Krawetz, Roman J.; Taiani, Jaymi; Greene, Alexis; Kelly, Gregory M.; Rancourt, Derrick E.			Inhibition of Rho Kinase Regulates Specification of Early Differentiation Events in P19 Embryonal Carcinoma Stem Cells	PLOS ONE			English	Article							NEURONAL DIFFERENTIATION; BETA-CATENIN; G-ALPHA-13; ACTIVATION; SURVIVAL; PHOSPHORYLATION; DOWNSTREAM; P160(ROCK); APOPTOSIS; PROTEINS	Background: The Rho kinase pathway plays a key role in many early cell/tissue determination events that take place in embryogenesis. Rho and its downstream effector Rho kinase (ROCK) play pivotal roles in cell migration, apoptosis (membrane blebbing), cell proliferation/cell cycle, cell-cell adhesion and gene regulation. We and others have previously demonstrated that inhibition of ROCK blocks endoderm differentiation in embryonal carcinoma stem cells, however, the effect of ROCK inhibition on mesoderm and ectoderm specification has not been fully examined. In this study, the role of ROCK within the specification and differentiation of all three germ layers was examined. Methodology/Principal Findings: P19 cells were treated with the specific ROCK inhibitor Y-27623, and increase in differentiation efficiency into neuro-ectodermal and mesodermal lineages was observed. However, as expected a dramatic decrease in early endodermal markers was observed when ROCK was inhibited. Interestingly, within these ROCK-inhibited RA treated cultures, increased levels of mesodermal or ectodermal markers were not observed, instead it was found that the pluripotent markers SSEA-1 and Oct-4 remained up-regulated similar to that seen in undifferentiated cultures. Using standard and widely accepted methods for reproducible P19 differentiation into all three germ layers, an enhancement of mesoderm and ectoderm differentiation with a concurrent loss of endoderm lineage specification was observed with Y-27632 treatment. Evidence would suggest that this effect is in part mediated through TGF-beta and SMAD signaling as ROCK-inhibited cells displayed aberrant SMAD activation and did not return to a 'ground' state after the inhibition had been removed. Conclusions/Significance: Given this data and the fact that only a partial rescue of normal differentiation capacity occurred when ROCK inhibition was alleviated, the effect of ROCK inhibition on the differentiation capacity of pluripotent cell populations should be further examined to elucidate the role of the Rho-ROCK pathway in early cellular 'fate' decision making processes.	[Krawetz, Roman J.] Univ Calgary, Dept Surg, Calgary, AB, Canada; [Greene, Alexis; Rancourt, Derrick E.] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada; [Taiani, Jaymi] Univ Calgary, Fac Med, Dept Med Sci, Calgary, AB, Canada; [Kelly, Gregory M.] Univ Western Ontario, Dept Biol, Mol Genet Unit, London, ON, Canada	University of Calgary; University of Calgary; University of Calgary; Western University (University of Western Ontario)	Krawetz, RJ (corresponding author), Univ Calgary, Dept Surg, Calgary, AB, Canada.	rkrawetz@ucalgary.ca	Kelly, Gregory/AAF-3400-2020	Kelly, Gregory/0000-0001-8612-364X	Canadian Stem Cell Network and Canadian Institutes of Health Research [CIHR7rpar, RMF-8249]; Natural Sciences and Engineering Research Council of Canada (NSERC); Canadian Institutes of Health Research - Skeletal Regenerative Medicine Team (CIHR-SRMT)	Canadian Stem Cell Network and Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research - Skeletal Regenerative Medicine Team (CIHR-SRMT)(Canadian Institutes of Health Research (CIHR))	This research was supported by Canadian Stem Cell Network and Canadian Institutes of Health Research (CIHR7rpar; Regenerative Medicine and Nanomedicine Team Grants (RMF-8249) to DER, and by a Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant to GMK. RJK and JT were supported by a Canadian Institutes of Health Research - Skeletal Regenerative Medicine Team (CIHR-SRMT) fellowship and studentship, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano M, 1997, SCIENCE, V275, P1308, DOI 10.1126/science.275.5304.1308; Bendall SC, 2007, NATURE, V448, P1015, DOI 10.1038/nature06027; Cho HJ, 2007, CELL BIOL INT, V31, P1225, DOI 10.1016/j.cellbi.2007.04.006; DENHERTOG J, 1993, EMBO J, V12, P3789, DOI 10.1002/j.1460-2075.1993.tb06057.x; Fujita A, 1997, BIOCHEM J, V328, P769, DOI 10.1042/bj3280769; Gao X, 2001, BIOCHEM BIOPH RES CO, V284, P1098, DOI 10.1006/bbrc.2001.5089; HALL A, 1994, ANNU REV CELL BIOL, V10, P31, DOI 10.1146/annurev.cb.10.110194.000335; Harb N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003001; Hebert M, 2008, J IMMUNOL, V181, P5963, DOI 10.4049/jimmunol.181.9.5963; Ishizaki T, 1997, FEBS LETT, V404, P118, DOI 10.1016/S0014-5793(97)00107-5; Ishizaki T, 2000, MOL PHARMACOL, V57, P976; JONESVILLENEUVE EMV, 1983, MOL CELL BIOL, V3, P2271, DOI 10.1128/MCB.3.12.2271; JONESVILLENEUVE EMV, 1982, J CELL BIOL, V94, P253, DOI 10.1083/jcb.94.2.253; Kamaraju SK, 2005, J BIOL CHEM, V280, P1024, DOI 10.1074/jbc.M403960200; Kawabata S, 2004, GENES CELLS, V9, P653, DOI 10.1111/j.1356-9597.2004.00749.x; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; Krawetz R, 2008, CELL SIGNAL, V20, P506, DOI 10.1016/j.cellsig.2007.11.001; Krawetz R, 2008, CELL SIGNAL, V20, P163, DOI 10.1016/j.cellsig.2007.10.011; Krawetz R, 2006, EXP CELL RES, V312, P3224, DOI 10.1016/j.yexcr.2006.06.016; Krawetz R, 2009, BIOCHEM CELL BIOL, V87, P567, DOI [10.1139/o09-014, 10.1139/O09-014]; Lee YN, 2004, J BIOL CHEM, V279, P54896, DOI 10.1074/jbc.M407581200; Li XY, 2009, HUM REPROD, V24, P580, DOI 10.1093/humrep/den404; Liu T, 2001, SCIENCE, V292, P1718, DOI 10.1126/science.1060100; Liu YL, 2009, FASEB J, V23, P2299, DOI 10.1096/fj.08-127910; MCBURNEY MW, 1982, DEV BIOL, V89, P503, DOI 10.1016/0012-1606(82)90338-4; MCBURNEY MW, 1993, INT J DEV BIOL, V37, P135; MCBURNEY MW, 1982, NATURE, V299, P165, DOI 10.1038/299165a0; Mills E, 2005, CELL COMMUN ADHES, V12, P9, DOI 10.1080/15419060500305948; Nakamura N, 2000, GENES CELLS, V5, P571, DOI 10.1046/j.1365-2443.2000.00348.x; PRUITT SC, 1992, DIFFERENTIATION, V50, P57, DOI 10.1111/j.1432-0436.1992.tb00486.x; Reuters I, 2006, NEPHRON PHYSIOL, V104, P95, DOI 10.1159/000094573; Diez RR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014145; Shao MY, 2011, CELL BIOL INT, V35, P105, DOI 10.1042/CBI20100114; Shi JJ, 2007, ARCH IMMUNOL THER EX, V55, P61, DOI 10.1007/s00005-007-0009-7; Shiokawa S, 2002, J CLIN ENDOCR METAB, V87, P5808, DOI 10.1210/jc.2002-020376; Shook D, 2003, MECH DEVELOP, V120, P1351, DOI 10.1016/j.mod.2003.06.005; Sivasubramaniyan K, 2010, CURR STEM CELL RES T, V5, P2, DOI 10.2174/157488810790442769; SMITH SC, 1987, J CELL PHYSIOL, V131, P74, DOI 10.1002/jcp.1041310112; Tang K, 2002, BIOCHEM BIOPH RES CO, V293, P167, DOI 10.1016/S0006-291X(02)00215-2; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Xu RH, 2008, CELL STEM CELL, V3, P196, DOI 10.1016/j.stem.2008.07.001; Xu Y, 2010, P NATL ACAD SCI USA, V107, P8129, DOI 10.1073/pnas.1002024107	42	14	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e26484	10.1371/journal.pone.0026484	http://dx.doi.org/10.1371/journal.pone.0026484			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140430	Green Submitted, gold, Green Published			2022-12-27	WOS:000298168100006
J	Partridge, BJ; Bell, SK; Lucke, JC; Yeates, S; Hall, WD				Partridge, Bradley J.; Bell, Stephanie K.; Lucke, Jayne C.; Yeates, Sarah; Hall, Wayne D.			Smart Drugs "As Common As Coffee": Media Hype about Neuroenhancement	PLOS ONE			English	Article							NEWS MEDIA; COVERAGE; STORIES; ABUSE	Background: The use of prescription drugs to improve cognitive functioning in normal persons -"neuroenhancement" - has gained recent attention from bioethicists and neuroscientists. Enthusiasts claim that the practice is widespread and increasing, and has many potential benefits; however recent evidence provides weak support for these claims. In this study we explored how the newsprint media portrays neuroenhancement. Aims: We conducted an empirical study of media reporting of neuroenhancement to explore: media portrayals of the prevalence of neuroenhancement; the types of evidence used by the media to support claims about its prevalence; and, the possible benefits and risks of neuroenhancement mentioned in these media articles. Methods: Using the Factiva database, we found 142 newspaper articles about the non-medical use prescription drugs for neuroenhancement for the period 2008-2010. We conducted a thematic content analysis of how articles portrayed the prevalence of neuroenhancement; what type of evidence they used in support; and, the potential benefits and risks/side-effects of neuroenhancement that were mentioned. Results: 87% of media articles mentioned the prevalence of neuroenhancement, and 94% portrayed it as common, increasing or both. 66% referred to the academic literature to support these claims and 44% either named an author or a journal. 95% of articles mentioned at least one possible benefit of using prescription drugs for neuroenhancement, but only 58% mentioned any risks/side effects. 15% questioned the evidence for efficacy of prescription drugs to produce benefits to users. Conclusions: News media articles mentioned the possible benefits of using drugs for neuroenhancement more than the potential risks/side effects, and the main source for media claims that neuroenhancement is common and increasingly widespread has been reports from the academic literature that provide weak support for this claim. We urge journalists and researchers to be cautious in their portrayal of the non-medical use of drugs for neuroenhancement.	[Partridge, Bradley J.; Bell, Stephanie K.; Lucke, Jayne C.; Yeates, Sarah; Hall, Wayne D.] Univ Queensland, UQ Ctr Clin Res, Herston, Qld, Australia	University of Queensland	Partridge, BJ (corresponding author), Univ Queensland, UQ Ctr Clin Res, Herston, Qld, Australia.	b.partridge@uq.edu.au	Lucke, Jayne C/A-5538-2008; Yeates, Sarah/M-6569-2013; Hall, Wayne D/A-3283-2008	Lucke, Jayne C/0000-0002-2885-5292; Yeates, Sarah/0000-0001-6675-8154; Hall, Wayne D/0000-0003-1984-0096	ARC; Bayer Australia [LP100200349]; NHMRC [2010000604, 569738]	ARC(Australian Research Council); Bayer Australia; NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	JL has been awarded an ARC Linkage Grant, which involves some cash and in-kind support from Bayer Australia (LP100200349). BP has been awarded an NHMRC Training Fellowship (2010000604). WH has been awarded an NHMRC Australia Fellowship (569738). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Academy of Medical Sciences, 2008, BRAIN SCI ADD DRUGS; *AUSTR PRESS COUNC, 246II AUSTR PRESS CO; Babcock Q, 2000, J AM COLL HEALTH, V49, P143, DOI 10.1080/07448480009596296; BOOT BP, 2011, NEUROCASE, P1; *BRIT MED ASS, 2007, BOOST YOUR BRAINP ET; Bubela TM, 2004, CAN MED ASSOC J, V170, P1399, DOI 10.1503/cmaj.1030762; Cakic V, 2009, J MED ETHICS, V35, P611, DOI 10.1136/jme.2009.030882; Cassels A, 2003, CAN MED ASSOC J, V168, P1133; Chatterjee A, 2006, J MED ETHICS, V32, P110, DOI 10.1136/jme.2005.013599; Dasgupta N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007758; Fins JJ, 2002, LANCET NEUROL, V1, P213, DOI 10.1016/S1474-4422(02)00099-6; Forlini C, 2009, NEUROETHICS-NETH, V2, P163, DOI 10.1007/s12152-009-9043-y; Forlini C, 2009, BMC MED ETHICS, V10, DOI 10.1186/1472-6939-10-9; Franke AG, 2011, PHARMACOPSYCHIATRY, V44, P60, DOI 10.1055/s-0030-1268417; Gonon F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014618; Greely H, 2008, NATURE, V456, P702, DOI 10.1038/456702a; Hall WD, 2010, ADDICTION, V105, P2041, DOI 10.1111/j.1360-0443.2010.03211.x; Larriviere D, 2009, NEUROLOGY, V73, P1406, DOI 10.1212/WNL.0b013e3181beecfe; Lucke Jayne C., 2011, AJOB NEUROSCIENCE, V2, P38, DOI [10.1080/21507740.2011.611122, DOI 10.1080/21507740.2011.611122]; Maher B, 2008, NATURE, V452, P674, DOI 10.1038/452674a; McCabe SE, 2005, ADDICTION, V100, P96, DOI 10.1111/j.1360-0443.2005.00944.x; Mohamed AD, 2012, INT J NEUROPSYCHOPH, V15, P559, DOI 10.1017/S146114571100037X; Moynihan R, 2000, NEW ENGL J MED, V342, P1645, DOI 10.1056/NEJM200006013422206; Outram SM, 2010, J MED ETHICS, V36, P198, DOI 10.1136/jme.2009.034421; Racine E, 2005, NAT REV NEUROSCI, V6, P159, DOI 10.1038/nrn1609; Racine E, 2010, SOC SCI MED, V71, P725, DOI 10.1016/j.socscimed.2010.05.017; Repantis D, 2010, PHARMACOL RES, V62, P187, DOI 10.1016/j.phrs.2010.04.002; Repantis D, 2010, PHARMACOL RES, V61, P473, DOI 10.1016/j.phrs.2010.02.009; Riesch H, 2011, HEALTH RISK SOC, V13, P47, DOI 10.1080/13698575.2010.540645; Sahakian B, 2007, NATURE, V450, P1157, DOI 10.1038/4501157a; SMITH ME, 2011, PSYCHOL BULL, V137; Soothill K, 1997, SOCIOLOGY, V31, P591, DOI 10.1177/0038038597031003014; White BP, 2006, J AM COLL HEALTH, V54, P261, DOI 10.3200/JACH.54.5.261-268	33	117	119	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e28416	10.1371/journal.pone.0028416	http://dx.doi.org/10.1371/journal.pone.0028416			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	863MI	22140584	gold, Green Published, Green Submitted			2022-12-27	WOS:000298168100070
J	Ehrnhoefer, DE; Skotte, NH; Savill, J; Nguyen, YTN; Ladha, S; Cao, LP; Dullaghan, E; Hayden, MR				Ehrnhoefer, Dagmar E.; Skotte, Niels H.; Savill, Jane; Nguyen, Yen T. N.; Ladha, Safia; Cao, Li-Ping; Dullaghan, Edie; Hayden, Michael R.			A Quantitative Method for the Specific Assessment of Caspase-6 Activity in Cell Culture	PLOS ONE			English	Article							NUCLEAR LAMIN-A; INDUCED APOPTOSIS; AXONAL DEGENERATION; ALZHEIMERS-DISEASE; MUTANT HUNTINGTIN; HUMAN NEURONS; IN-VIVO; CLEAVAGE; ACTIVATION; DEATH	Aberrant activation of caspase-6 has recently emerged as a major contributor to the pathogeneses of neurodegenerative disorders such as Alzheimer's and Huntington disease. Commercially available assays to measure caspase-6 activity commonly use the VEID peptide as a substrate. However these methods are not well suited to specifically assess caspase-6 activity in the presence of other, confounding protease activities, as often encountered in cell and tissue samples. Here we report the development of a method that overcomes this limitation by using a protein substrate, lamin A, which is highly specific for caspase-6 cleavage at amino acid 230. Using a neo-epitope antibody against cleaved lamin A, we developed an electrochemiluminescence-based ELISA assay that is suitable to specifically detect and quantify caspase-6 activity in highly apoptotic cell extracts. The method is more sensitive than VEID-based assays and can be adapted to a high-content imaging platform for high-throughput screening. This method should be useful to screen for and characterize caspase-6 inhibitor compounds and other interventions to decrease intracellular caspase-6 activity for applications in neurodegenerative disorders.	[Ehrnhoefer, Dagmar E.; Skotte, Niels H.; Nguyen, Yen T. N.; Ladha, Safia; Cao, Li-Ping; Hayden, Michael R.] Univ British Columbia, Dept Med Genet, Ctr Mol Med & Therapeut CMMT, CFRI, Vancouver, BC, Canada; [Savill, Jane; Dullaghan, Edie] Ctr Drug Res & Dev CDRD, Vancouver, BC, Canada; [Skotte, Niels H.] Univ Copenhagen, Inst Cellular & Mol Med ICMM, Dept Med Genet, Copenhagen, Denmark	University of British Columbia; University of Copenhagen	Ehrnhoefer, DE (corresponding author), Univ British Columbia, Dept Med Genet, Ctr Mol Med & Therapeut CMMT, CFRI, Vancouver, BC, Canada.	mrh@cmmt.ubc.ca	Hayden, Michael R/D-8581-2011; Skotte, Niels Henning/AFK-2715-2022; Ehrnhoefer, Dagmar/B-7231-2008; Skotte, Niels Henning/AAG-1023-2022; Ehrnhöfer, Dagmar/O-2514-2016	Hayden, Michael R/0000-0001-5159-1419; Ehrnhoefer, Dagmar/0000-0003-3411-5415; Ehrnhöfer, Dagmar/0000-0003-3411-5415; Skotte, Niels Henning/0000-0001-7027-7193	Canadian Institutes of Health Research (CIHR) [MOP-84438]; Cure Huntington Disease Initiative (CHDI); Austrian Science Fund (FWF) [J2797-B09]; Pfizer-CDRD	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Cure Huntington Disease Initiative (CHDI); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Pfizer-CDRD	This work was supported by the Canadian Institutes of Health Research (CIHR MOP-84438) and the Cure Huntington Disease Initiative (CHDI) 'TREAT HD' grants to MRH. DEE is a CIHR fellowship awardee and held a postdoctoral fellowship of the Austrian Science Fund (FWF), project no. J2797-B09. MRH is a University Killam Professor and holds a Canada Research Chair in Human Genetics. The authors gratefully acknowledge partial funding by the Pfizer-CDRD Innovation Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The Pfizer Innovation fund funded part of the work that was done at the Centre for Drug Research and Development (CDRD). The authors do not have any employment or consultant relationships with Pfizer, there are no relevant patents or products. The authors confirm that the funding does not alter their adherence to the PLos ONE policies on sharing data and materials.	Akpan N, 2011, J NEUROSCI, V31, P8894, DOI 10.1523/JNEUROSCI.0698-11.2011; Albrecht S, 2007, AM J PATHOL, V170, P1200, DOI 10.2353/ajpath.2007.060974; Dix MM, 2008, CELL, V134, P679, DOI 10.1016/j.cell.2008.06.038; Eleouet JF, 2000, J VIROL, V74, P3975, DOI 10.1128/JVI.74.9.3975-3983.2000; Feinstein-Rotkopf Y, 2009, APOPTOSIS, V14, P980, DOI 10.1007/s10495-009-0346-6; FISHER DZ, 1986, P NATL ACAD SCI USA, V83, P6450, DOI 10.1073/pnas.83.17.6450; Gettins PGW, 2009, J BIOL CHEM, V284, P20441, DOI 10.1074/jbc.R800064200; Graham RK, 2006, CELL, V125, P1179, DOI 10.1016/j.cell.2006.04.026; Graham RK, 2010, J NEUROSCI, V30, P15019, DOI 10.1523/JNEUROSCI.2071-10.2010; Gray DC, 2010, CELL, V142, P637, DOI 10.1016/j.cell.2010.07.014; Guo HS, 2004, AM J PATHOL, V165, P523, DOI 10.1016/S0002-9440(10)63317-2; Kalinin AE, 2005, J INVEST DERMATOL, V124, P46, DOI 10.1111/j.0022-202X.2004.23507.x; Klaiman G, 2008, MOL CELL PROTEOMICS, V7, P1541, DOI 10.1074/mcp.M800007-MCP200; Klaiman G, 2009, BBA-MOL CELL RES, V1793, P592, DOI 10.1016/j.bbamcr.2008.12.004; Krishnaswamy S, 2005, J THROMB HAEMOST, V3, P54, DOI 10.1111/j.1538-7836.2004.01021.x; LeBlanc A, 1999, J BIOL CHEM, V274, P23426, DOI 10.1074/jbc.274.33.23426; LIN F, 1993, J BIOL CHEM, V268, P16321; Metzler M, 2010, J NEUROSCI, V30, P14318, DOI 10.1523/JNEUROSCI.1589-10.2010; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Nyormoi O, 2001, MOL CELL BIOL, V21, P4856, DOI 10.1128/MCB.21.15.4856-4867.2001; Orme M, 2009, APOPTOSIS, V14, P950, DOI 10.1007/s10495-009-0358-2; Orth K, 1996, J BIOL CHEM, V271, P16443, DOI 10.1074/jbc.271.28.16443; Park KJ, 2010, NAT NEUROSCI, V13, P559, DOI 10.1038/nn.2513; Rhyne PW, 2009, BIOANALYSIS, V1, P919, DOI [10.4155/bio.09.80, 10.4155/BIO.09.80]; ROBER RA, 1989, DEVELOPMENT, V105, P365; Ruchaud S, 2002, EMBO J, V21, P1967, DOI 10.1093/emboj/21.8.1967; Samejima K, 1999, J BIOL CHEM, V274, P4335, DOI 10.1074/jbc.274.7.4335; Schoenmann Z, 2010, J NEUROSCI, V30, P6375, DOI 10.1523/JNEUROSCI.0922-10.2010; Stefanis L, 1999, J NEUROSCI, V19, P6235; Stennicke HR, 2000, BIOCHEM J, V350, P563, DOI 10.1042/0264-6021:3500563; Talanian RV, 1997, J BIOL CHEM, V272, P9677; Thornberry NA, 1998, CHEM BIOL, V5, pR97, DOI 10.1016/S1074-5521(98)90615-9; Timmer JC, 2007, CELL DEATH DIFFER, V14, P66, DOI 10.1038/sj.cdd.4402059; Tu S, 2006, NAT CELL BIOL, V8, P72, DOI 10.1038/ncb1340; Uribe V, RESCUE EXCITOT UNPUB; van de Craen M, 1999, FEBS LETT, V445, P149, DOI 10.1016/S0014-5793(99)00108-8; Walsh JG, 2008, P NATL ACAD SCI USA, V105, P12815, DOI 10.1073/pnas.0707715105; Wellington CL, 2000, J BIOL CHEM, V275, P19831, DOI 10.1074/jbc.M001475200; Wen LP, 1997, J BIOL CHEM, V272, P26056, DOI 10.1074/jbc.272.41.26056	39	23	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2011	6	11							e27680	10.1371/journal.pone.0027680	http://dx.doi.org/10.1371/journal.pone.0027680			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863LT	22140457	gold, Green Submitted, Green Published			2022-12-27	WOS:000298166300009
J	Alvino, CL; Ong, SC; McNeil, KA; Delaine, C; Booker, GW; Wallace, JC; Forbes, BE				Alvino, Clair L.; Ong, Shee Chee; McNeil, Kerrie A.; Delaine, Carlie; Booker, Grant W.; Wallace, John C.; Forbes, Briony E.			Understanding the Mechanism of Insulin and Insulin-Like Growth Factor (IGF) Receptor Activation by IGF-II	PLOS ONE			English	Article							LIGAND-BINDING; NEGATIVE COOPERATIVITY; SIGNAL-TRANSDUCTION; B-ISOFORM; A-ISOFORM; PROTEINS; HORMONE; ANALOGS; CANCER; SITE	Background: Insulin-like growth factor-II (IGF-II) promotes cell proliferation and survival and plays an important role in normal fetal development and placental function. IGF-II binds both the insulin-like growth factor receptor (IGF-1R) and insulin receptor isoform A (IR-A) with high affinity. Interestingly both IGF-II and the IR-A are often upregulated in cancer and IGF-II acts via both receptors to promote cancer proliferation. There is relatively little known about the mechanism of ligand induced activation of the insulin (IR) and IGF-1R. The recently solved IR structure reveals a folded over dimer with two potential ligand binding pockets arising from residues on each receptor half. Site-directed mutagenesis has mapped receptor residues important for ligand binding to two separate sites within the ligand binding pocket and we have recently shown that the IGFs have two separate binding surfaces which interact with the receptor sites 1 and 2. Methodology/Principal Findings: In this study we describe a series of partial IGF-1R and IR agonists generated by mutating Glu12 of IGF-II. By comparing receptor binding affinities, abilities to induce negative cooperativity and potencies in receptor activation, we provide evidence that residue Glu12 bridges the two receptor halves leading to receptor activation. Conclusions/Significance: This study provides novel insight into the mechanism of receptor binding and activation by IGF-II, which may be important for the future development of inhibitors of its action for the treatment of cancer.	[Alvino, Clair L.; Ong, Shee Chee; McNeil, Kerrie A.; Delaine, Carlie; Booker, Grant W.; Wallace, John C.; Forbes, Briony E.] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA, Australia	University of Adelaide	Alvino, CL (corresponding author), Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA, Australia.	briony.forbes@adelaide.edu.au	, John/AAP-5150-2020; Forbes, Briony/R-1838-2019	Forbes, Briony/0000-0003-4360-9927	National Health and Medical Research Council Australia [ID399169]	National Health and Medical Research Council Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical Research Council Australia, ID399169. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvino CL, 2009, J BIOL CHEM, V284, P7656, DOI 10.1074/jbc.M808061200; Belfiore A, 2009, ENDOCR REV, V30, P586, DOI 10.1210/er.2008-0047; Benyoucef S, 2007, BIOCHEM J, V403, P603, DOI 10.1042/BJ20061709; CHRISTOFFERSEN CT, 1994, ENDOCRINOLOGY, V135, P472, DOI 10.1210/en.135.1.472; De Meyts P, 2008, TRENDS BIOCHEM SCI, V33, P376, DOI 10.1016/j.tibs.2008.06.003; Delaine C, 2007, J BIOL CHEM, V282, P18886, DOI 10.1074/jbc.M700531200; DEMEYTS P, 1994, DIABETOLOGIA, V37, pS135, DOI 10.1007/BF00400837; DEMEYTS P, 1994, HORM RES, V42, P152, DOI 10.1159/000184188; DeMeyts P, 1995, ANN NY ACAD SCI, V766, P388, DOI 10.1111/j.1749-6632.1995.tb26688.x; Denley A, 2004, MOL ENDOCRINOL, V18, P2502, DOI 10.1210/me.2004-0183; Denley A, 2003, HORM METAB RES, V35, P778; FRANCIS GL, 1993, BIOCHEM J, V293, P713, DOI 10.1042/bj2930713; Frasca F, 1999, MOL CELL BIOL, V19, P3278, DOI 10.1128/mcb.19.5.3278; Gallagher EJ, 2010, TRENDS ENDOCRIN MET, V21, P610, DOI 10.1016/j.tem.2010.06.007; Gauguin L, 2008, J BIOL CHEM, V283, P20821, DOI 10.1074/jbc.M802620200; Gicquel C, 2006, HORM RES, V65, P28, DOI 10.1159/000091503; Glendorf T, 2008, BIOCHEMISTRY-US, V47, P4743, DOI 10.1021/bi800054z; Jensen M, 2000, THESIS U COPENHAGEN; Keyhanfar M, 2007, BIOCHEM J, V401, P269, DOI 10.1042/BJ20060890; KING R, 1992, J MOL ENDOCRINOL, V8, P29, DOI 10.1677/jme.0.0080029; Kiselyov VV, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.78; Kurtzhals P, 2000, DIABETES, V49, P999, DOI 10.2337/diabetes.49.6.999; Magee BA, 1999, BIOCHEMISTRY-US, V38, P15863, DOI 10.1021/bi9910070; McKern NM, 2006, NATURE, V443, P218, DOI 10.1038/nature05106; MILNER SJ, 1995, BIOCHEM J, V308, P865, DOI 10.1042/bj3080865; PIETRZKOWSKI Z, 1992, CELL GROWTH DIFFER, V3, P199; Renehan AG, 2008, BEST PRACT RES CL EN, V22, P639, DOI 10.1016/j.beem.2008.08.011; Sacco A, 2009, ENDOCRINOLOGY, V150, P3594, DOI 10.1210/en.2009-0377; Sadick M D, 1999, Dev Biol Stand, V97, P121; Sajid W, 2009, BIOCHEMISTRY-US, V48, P11283, DOI 10.1021/bi901269j; SCHWARTZ GP, 1987, P NATL ACAD SCI USA, V84, P6408, DOI 10.1073/pnas.84.18.6408; Sciacca L, 2003, ENDOCRINOLOGY, V144, P2650, DOI 10.1210/en.2002-0136; Smith BJ, 2010, P NATL ACAD SCI USA, V107, P6771, DOI 10.1073/pnas.1001813107; Surinya KH, 2008, J BIOL CHEM, V283, P5355, DOI 10.1074/jbc.M707054200; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Ulanet DB, 2010, P NATL ACAD SCI USA, V107, P10791, DOI 10.1073/pnas.0914076107; Walenkamp MJE, 2006, HORM RES, V66, P221, DOI 10.1159/000095161; Ward C, 2008, ACTA PHYSIOL, V192, P3, DOI 10.1111/j.1748-1716.2007.01781.x; WELLS JA, 1991, METHOD ENZYMOL, V202, P390; Whittaker J, 2002, J BIOL CHEM, V277, P47380, DOI 10.1074/jbc.M208371200; Whittaker J, 2001, J BIOL CHEM, V276, P43980, DOI 10.1074/jbc.M102863200; Whittaker L, 2008, BIOCHEMISTRY-US, V47, P12900, DOI 10.1021/bi801693h	42	48	49	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2011	6	11							e27488	10.1371/journal.pone.0027488	http://dx.doi.org/10.1371/journal.pone.0027488			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KW	22140443	gold, Green Published, Green Submitted			2022-12-27	WOS:000298163400006
J	Ramamoorthy, R; Jiang, SY; Ramachandran, S				Ramamoorthy, Rengasamy; Jiang, Shu-Ye; Ramachandran, Srinivasan			Oryza sativa Cytochrome P450 Family Member OsCYP96B4 Reduces Plant Height in a Transcript Dosage Dependent Manner	PLOS ONE			English	Article							DELLA PROTEIN SLR1; FUNCTIONAL-ANALYSIS; RICE; GIBBERELLIN; ARABIDOPSIS; ENCODES; GENE; ENZYME; CELLS; ELONGATION	Background: Plant cytochromes P450 are involved in a wide range of biosynthetic reactions and play various roles in plant development. However, little is known about the biological functions of the subfamily CYP96 in plants. Methodology/Principal Findings: Here, we report a novel semi-dwarf rice mutant, in which a single copy of transposon dissociator (Ds) was inserted into the gene OsCYP96B4 (Oryza sativa Cytochrome P450 96B4). The mutant exhibits the defects in cell elongation and pollen germination, which can be complemented by the wild type OsCYP96B4 and be rescued by remobilization of the Ds element with the presence of the transposase Activator (Ac). Transgenic plants harboring OsCYP96B4 double-stranded RNA interference construct mimicked the mutant phenotype. The oscyp96b4 mutant phenotype could not be rescued by all the tested phytohormones and it was found that OsCYP96B4 reduced plant height in a transcript dosage dependent manner. Heterologous expression of OsCYP96B4 in Schizosaccharomyces pombe resulted in missegregation and wider cells. Further investigation showed that the mutant exhibited the defects in the metabolism of some lipid molecular species when compared with the wild type. Conclusions/Significance: The oscyp96b4 mutant is a novel rice semi-dwarf mutant. Our data suggest that OsCYP96B4 might be involved in lipid metabolism and regulate cell elongation.	[Ramamoorthy, Rengasamy; Jiang, Shu-Ye; Ramachandran, Srinivasan] Natl Univ Singapore, Temasek Life Sci Lab, Rice Funct Genom Grp, Singapore 117548, Singapore	National University of Singapore	Ramamoorthy, R (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore.	shuye@tll.org.sg; sri@tll.org.sg	Ramamoorthy, Rengasamy/AAW-8518-2020; Ramamoorthy, Rengasamy/C-2656-2011; Ramamoorthy, Rengasamy/L-3982-2015	Ramamoorthy, Rengasamy/0000-0003-1045-9109; Ramamoorthy, Rengasamy/0000-0003-1045-9109; Jiang, Shu-Ye/0000-0003-4867-2335	Temasek Life Sciences Laboratory in Singapore	Temasek Life Sciences Laboratory in Singapore(National University of Singapore)	This work was supported by Strategic Research Program from Temasek Life Sciences Laboratory in Singapore. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard P, 2009, J EXP BOT, V60, P1085, DOI 10.1093/jxb/ern301; Asano K, 2010, P JPN ACAD B-PHYS, V86, P265, DOI 10.2183/pjab.86.265; Ashikari M, 1999, P NATL ACAD SCI USA, V96, P10284, DOI 10.1073/pnas.96.18.10284; Banerjee J, 2010, BIOCHEM BIOPH RES CO, V394, P178, DOI 10.1016/j.bbrc.2010.02.142; BASI G, 1993, GENE, V123, P131, DOI 10.1016/0378-1119(93)90552-E; Benveniste I, 2006, PLANT SCI, V170, P326, DOI 10.1016/j.plantsci.2005.08.028; Benveniste I, 1998, BIOCHEM BIOPH RES CO, V243, P688, DOI 10.1006/bbrc.1998.8156; Dai C, 2010, EMBO J, V29, P1916, DOI 10.1038/emboj.2010.75; Duan H, 2005, PLANT PHYSIOL, V137, P1067, DOI 10.1104/pp.104.055715; Fernandez MGS, 2009, TRENDS PLANT SCI, V14, P454, DOI 10.1016/j.tplants.2009.06.005; Greer S, 2007, PLANT PHYSIOL, V145, P653, DOI 10.1104/pp.107.107300; Hartweck LM, 2008, PLANTA, V229, P1, DOI 10.1007/s00425-008-0830-1; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Hirano K, 2010, PLANT CELL, V22, P2680, DOI 10.1105/tpc.110.075549; HIRANO T, 1986, EMBO J, V5, P2973, DOI 10.1002/j.1460-2075.1986.tb04594.x; Hofer R, 2008, J EXP BOT, V59, P2347, DOI 10.1093/jxb/ern101; Hong Z, 2003, PLANT CELL, V15, P2900, DOI 10.1105/tpc.014712; Hong Z, 2002, PLANT J, V32, P495, DOI 10.1046/j.1365-313X.2002.01438.x; Hu J, 2010, PLANT MOL BIOL, V73, P283, DOI 10.1007/s11103-010-9614-7; Itoh H, 2004, PLANT MOL BIOL, V54, P533, DOI 10.1023/B:PLAN.0000038261.21060.47; Itoh H, 2001, P NATL ACAD SCI USA, V98, P8909, DOI 10.1073/pnas.141239398; Jiang S, 2005, PLANT MOL BIOL, V57, P835, DOI 10.1007/s11103-005-2859-x; Jiang SY, 2007, PLANT MOL BIOL, V65, P385, DOI 10.1007/s11103-007-9233-0; Jiang SY, 2007, DEV BIOL, V304, P579, DOI 10.1016/j.ydbio.2007.01.008; Kim YS, 2011, PLANTA, V233, P251, DOI 10.1007/s00425-010-1303-x; Kolesnik T, 2004, PLANT J, V37, P301, DOI 10.1046/j.1365-313X.2003.01948.x; Li JM, 2007, TRENDS PLANT SCI, V12, P37, DOI 10.1016/j.tplants.2006.11.002; Li JA, 2011, PLANT CELL, V23, P628, DOI 10.1105/tpc.110.081901; Li WQ, 2010, PLANTA, V232, P1383, DOI 10.1007/s00425-010-1263-1; Luan WJ, 2011, PLANT BIOTECHNOL J, V9, P513, DOI 10.1111/j.1467-7652.2010.00570.x; Mishra NN, 2005, BIOSENS BIOELECTRON, V21, P696, DOI 10.1016/j.bios.2005.01.011; Nelson DR, 2004, PLANT PHYSIOL, V135, P756, DOI 10.1104/pp.104.039826; Ohnishi T, 2006, PLANT CELL, V18, P3275, DOI 10.1105/tpc.106.045443; Oudin A, 1999, PLANT SCI, V149, P105, DOI 10.1016/S0168-9452(99)00144-2; Park JJ, 2010, PLANT MOL BIOL, V74, P91, DOI 10.1007/s11103-010-9656-x; Rupasinghe SG, 2007, PROTEINS, V68, P279, DOI 10.1002/prot.21335; Saitoh S, 1996, J CELL BIOL, V134, P949, DOI 10.1083/jcb.134.4.949; Sakamoto T, 2004, CURR OPIN BIOTECH, V15, P144, DOI 10.1016/j.copbio.2004.02.003; Sakamoto T, 2004, PLANT PHYSIOL, V134, P1642, DOI 10.1104/pp.103.033696; Scott L, 1996, GENETICS, V142, P237; Spielmeyer W, 2002, P NATL ACAD SCI USA, V99, P9043, DOI 10.1073/pnas.132266399; Szekeres M, 1996, CELL, V85, P171, DOI 10.1016/S0092-8674(00)81094-6; Tang WQ, 2010, CURR OPIN PLANT BIOL, V13, P27, DOI 10.1016/j.pbi.2009.10.007; Ueguchi-Tanaka M, 2008, PLANT CELL, V20, P2437, DOI 10.1105/tpc.108.061648; Umehara M, 2008, NATURE, V455, P195, DOI 10.1038/nature07272; Wang L, 2009, PLANT J, V57, P498, DOI 10.1111/j.1365-313X.2008.03707.x; Wang M, 2004, PLANT MOL BIOL REP, V22, P409, DOI 10.1007/BF02772683; Wellesen K, 2001, P NATL ACAD SCI USA, V98, P9694, DOI 10.1073/pnas.171285998; Zhang M, 2010, PLANT J, V63, P312, DOI 10.1111/j.1365-313X.2010.04238.x; Zhang XR, 2006, NAT PROTOC, V1, P641, DOI 10.1038/nprot.2006.97	50	28	31	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2011	6	11							e28069	10.1371/journal.pone.0028069	http://dx.doi.org/10.1371/journal.pone.0028069			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KW	22140509	Green Published, gold, Green Submitted			2022-12-27	WOS:000298163400031
J	Webster, RJ; Carter, KW; Warrington, NM; Loh, AM; Zaloumis, S; Kuijpers, TW; Palmer, LJ; Burgner, DP				Webster, Rebecca J.; Carter, Kim W.; Warrington, Nicole M.; Loh, Angeline M.; Zaloumis, Sophie; Kuijpers, Taco W.; Palmer, Lyle J.; Burgner, David P.			Hospitalisation with Infection, Asthma and Allergy in Kawasaki Disease Patients and Their Families: Genealogical Analysis Using Linked Population Data	PLOS ONE			English	Article							MANNOSE-BINDING LECTIN; CORONARY-ARTERY LESIONS; WESTERN-AUSTRALIA; ASSOCIATION; RISK; POLYMORPHISMS; CHILDREN; ALLELES; GENE	Background: Kawasaki disease results from an abnormal immunological response to one or more infectious triggers. We hypothesised that heritable differences in immune responses in Kawasaki disease-affected children and their families would result in different epidemiological patterns of other immune-related conditions. We investigated whether hospitalisation for infection and asthma/allergy were different in Kawasaki disease-affected children and their relatives. Methods/Major Findings: We used Western Australian population-linked health data from live births (1970-2006) to compare patterns of hospital admissions in Kawasaki disease cases, age-and sex-matched controls, and their relatives. There were 295 Kawasaki disease cases and 598 age-and sex-matched controls, with 1,636 and 3,780 relatives, respectively. Compared to controls, cases were more likely to have been admitted at least once with an infection (cases, 150 admissions (50.8%) vs controls, 210 admissions (35.1%); odds ratio (OR) = 1.9, 95% confidence interval (CI) 1.4-2.6, P = 7.2 x 10(-6)), and with asthma/allergy (cases, 49 admissions (16.6%) vs controls, 42 admissions (7.0%); OR = 2.6, 95% CI 1.7-4.2, P = 1.3 x 10(-5)). Cases also had more admissions per person with infection (cases, median 2 admissions, 95% CI 1-5, vs controls, median 1 admission, 95% CI 1-4, P = 1.09 x 10(-5)). The risk of admission with infection was higher in the first degree relatives of Kawasaki disease cases compared to those of controls, but the differences were not significant. Conclusion: Differences in the immune phenotype of children who develop Kawasaki disease may influence the severity of other immune-related conditions, with some similar patterns observed in relatives. These data suggest the influence of shared heritable factors in these families.	[Webster, Rebecca J.; Loh, Angeline M.; Palmer, Lyle J.] Univ Western Australia, Ctr Genet Epidemiol & Biostat, Perth, WA 6009, Australia; [Carter, Kim W.] Univ Western Australia, UWA Ctr Child Hlth Res, Telethon Inst Child Hlth Res, Div Bioinformat & Biostat, Perth, WA 6009, Australia; [Warrington, Nicole M.] Univ Western Australia, Sch Womens & Infants Hlth, Perth, WA 6009, Australia; [Zaloumis, Sophie] Univ Melbourne, Ctr Mol Environm Genet & Analyt Epidemiol, Melbourne, Vic, Australia; [Kuijpers, Taco W.] Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Dept Pediat Hematol Immunol & Infect Dis, NL-1105 AZ Amsterdam, Netherlands; [Burgner, David P.] Univ Western Australia, Sch Pediat & Child Hlth, Perth, WA 6009, Australia; [Burgner, David P.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia	University of Western Australia; Telethon Kids Institute; University of Western Australia; University of Western Australia; University of Melbourne; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Western Australia; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne	Webster, RJ (corresponding author), Univ Western Australia, Ctr Genet Epidemiol & Biostat, Perth, WA 6009, Australia.	david.burgner@mcri.edu.au	Palmer, Lyle John/N-1948-2019; Palmer, Lyle John/K-3196-2014; Zaloumis, Sophie/AAI-4396-2020; Warrington, Nicole/P-4868-2014	Palmer, Lyle John/0000-0002-1628-3055; Palmer, Lyle John/0000-0002-1628-3055; Zaloumis, Sophie/0000-0002-8253-8896; Warrington, Nicole/0000-0003-4195-775X; Burgner, David/0000-0002-8304-4302				Anaya JM, 2006, CLIN DEV IMMUNOL, V13, P185, DOI 10.1080/17402520600876762; Baker AL, 2009, J PEDIATR-US, V154, P592, DOI 10.1016/j.jpeds.2008.10.006; Benseler SM, 2005, PEDIATRICS, V116, pE760, DOI 10.1542/peds.2005-0559; Biezeveld MH, 2006, ARTHRITIS RHEUM-US, V54, P369, DOI 10.1002/art.21529; Biezeveld MH, 2005, CLIN EXP IMMUNOL, V141, P183, DOI 10.1111/j.1365-2249.2005.02829.x; BROSIUS CL, 1988, PEDIATR INFECT DIS J, V7, P863; Burgner D, 2005, INT J INFECT DIS, V9, P185, DOI 10.1016/j.ijid.2005.03.002; Burgner D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000319; Burns JC, 2004, LANCET, V364, P533, DOI 10.1016/S0140-6736(04)16814-1; Carville KS, 2007, PEDIATR INFECT DIS J, V26, P210, DOI 10.1097/01.inf.0000254148.09831.7f; Chahal N, 2010, J PEDIATR HEALTH CAR, V24, P250, DOI 10.1016/j.pedhc.2009.07.002; Cheung YF, 2007, ARCH DIS CHILD, V92, P43, DOI 10.1136/adc.2006.096628; Dietert RR, 2010, WORLD J PEDIATR, V6, P111, DOI 10.1007/s12519-010-0026-1; Ding K, 2009, CIRC-CARDIOVASC GENE, V2, P63, DOI 10.1161/CIRCGENETICS.108.816751; ELIXHAUSER A, 2006, CLIN CLASSIFICATIONS; FUJITA Y, 1989, PEDIATRICS, V84, P666; Gee V, 1994, VALIDATION STUDY W A; Glasson EJ, 2008, INT J EPIDEMIOL, V37, P30, DOI 10.1093/ije/dym136; GLODE MP, 1986, PEDIATR INFECT DIS J, V5, P644, DOI 10.1097/00006454-198611000-00009; Gualano RC, 2006, PULM PHARMACOL THER, V19, P18, DOI 10.1016/j.pupt.2005.02.009; Harnden A, 2009, BMJ-BRIT MED J, V338, P1133; Holman CDJ, 1999, AUST NZ J PUBL HEAL, V23, P453, DOI 10.1111/j.1467-842X.1999.tb01297.x; Holman RC, 2005, PEDIATR INFECT DIS J, V24, P429, DOI 10.1097/01.inf.0000160946.05295.91; Ihaka R, 2001, J COMPUTATIONAL GRAP, V5, P299; Kim JJ, 2011, HUM GENET, V129, P487, DOI 10.1007/s00439-010-0937-x; Kimura J, 2004, CLIN EXP IMMUNOL, V137, P444, DOI 10.1111/j.1365-2249.2004.02506.x; Kuijpers TW, 1999, J INFECT DIS, V180, P1869, DOI 10.1086/315111; Kuo HC, 2009, PEDIAT ALLERG IMM-UK, V20, P266, DOI 10.1111/j.1399-3038.2008.00779.x; Liew WK, 2011, PEDIAT ALLERGY IMMUN; Mackay IR, 2009, J AUTOIMMUN, V33, P170, DOI 10.1016/j.jaut.2009.09.006; Maier LM, 2009, IMMUNOL REV, V229, P322, DOI 10.1111/j.1600-065X.2009.00777.x; Matsubara T, 1999, CLIN EXP IMMUNOL, V116, P554; Matsuoka S, 1997, EUR J PEDIATR, V156, P30; Newburger JW, 2004, PEDIATRICS, V114, P1708, DOI 10.1542/peds.2004-2182; Nielsen NM, 2011, AM J EPIDEMIOL, V173, P990, DOI 10.1093/aje/kwq492; Onouchi Y, 2008, NAT GENET, V40, P35, DOI 10.1038/ng.2007.59; Read A, 1996, P BRISB WORKSH NOV; Rowley AH, 2011, J INFECT DIS, V203, P1021, DOI 10.1093/infdis/jiq136; Royle JA, 1998, ARCH DIS CHILD, V78, P33, DOI 10.1136/adc.78.1.33; Sato S, 2009, INT J RHEUM DIS, V12, P307, DOI 10.1111/j.1756-185X.2009.01428.x; Selarnet Tierney ES, 2007, J PEDIATR-US, V151, P225, DOI 10.1016/j.jpeds.2007.05.011; SHAM PC, 1995, ANN HUM GENET, V59, P97, DOI 10.1111/j.1469-1809.1995.tb01608.x; Shikishima Y, 2003, ASIAN PAC J ALLERGY, V21, P139; STANLEY FJ, 1994, PAEDIATR PERINAT EP, V8, P433, DOI 10.1111/j.1365-3016.1994.tb00482.x; Tsai FJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016853; Uehara R, 2003, ACTA PAEDIATR, V92, P694, DOI 10.1080/08035320310002768; Worthley DL, 2005, INTERN MED J, V35, P548, DOI 10.1111/j.1445-5994.2005.00908.x	47	20	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2011	6	11							e28004	10.1371/journal.pone.0028004	http://dx.doi.org/10.1371/journal.pone.0028004			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KW	22140498	Green Published, gold			2022-12-27	WOS:000298163400028
J	Ameis, SH; Fan, J; Rockel, C; Voineskos, AN; Lobaugh, NJ; Soorya, L; Wang, AT; Hollander, E; Anagnostou, E				Ameis, Stephanie H.; Fan, Jin; Rockel, Conrad; Voineskos, Aristotle N.; Lobaugh, Nancy J.; Soorya, Latha; Wang, A. Ting; Hollander, Eric; Anagnostou, Evdokia			Impaired Structural Connectivity of Socio-Emotional Circuits in Autism Spectrum Disorders: A Diffusion Tensor Imaging Study	PLOS ONE			English	Article							HIGH-FUNCTIONING AUTISM; WHITE-MATTER; IN-VIVO; SENTENCE COMPREHENSION; ATYPICAL DEVELOPMENT; SPATIAL-STATISTICS; BRAIN CONNECTIVITY; ASPERGER-SYNDROME; AMYGDALA DAMAGE; TEMPORAL STEM	Background: Abnormal white matter development may disrupt integration within neural circuits, causing particular impairments in higher-order behaviours. In autism spectrum disorders (ASDs), white matter alterations may contribute to characteristic deficits in complex socio-emotional and communication domains. Here, we used diffusion tensor imaging (DTI) and tract based spatial statistics (TBSS) to evaluate white matter microstructure in ASD. Methods/Principal Findings: DTI scans were acquired for 19 children and adolescents with ASD (>8-18 years; mean 12.4 +/- 3.1) and 16 age and IQ matched controls (>8-18 years; mean 12.3 +/- 3.6) on a 3T MRI system. DTI values for fractional anisotropy, mean diffusivity, radial diffusivity and axial diffusivity, were measured. Age by group interactions for global and voxel-wise white matter indices were examined. Voxel-wise analyses comparing ASD with controls in: (i) the full cohort (ii), children only (<= 12 yrs.), and (iii) adolescents only (>12 yrs.) were performed, followed by tract-specific comparisons. Significant age-by-group interactions on global DTI indices were found for all three diffusivity measures, but not for fractional anisotropy. Voxel-wise analyses revealed prominent diffusion measure differences in ASD children but not adolescents, when compared to healthy controls. Widespread increases in mean and radial diffusivity in ASD children were prominent in frontal white matter voxels. Follow-up tract-specific analyses highlighted disruption to pathways integrating frontal, temporal, and occipital structures involved in socio-emotional processing. Conclusions/Significance: Our findings highlight disruption of neural circuitry in ASD, particularly in those white matter tracts that integrate the complex socio-emotional processing that is impaired in this disorder.	[Ameis, Stephanie H.] Univ Toronto, Hosp Sick Children, Dept Psychiat, Toronto, ON M5G 1X8, Canada; [Fan, Jin] CUNY Queens Coll, Dept Psychol, Flushing, NY 11367 USA; [Fan, Jin; Wang, A. Ting] Mt Sinai Sch Med, Dept Psychiat, New York, NY USA; [Fan, Jin; Wang, A. Ting] Mt Sinai Sch Med, Dept Neurosci, New York, NY USA; [Rockel, Conrad] Univ Toronto, Hosp Sick Children, Dept Psychol, Toronto, ON M5G 1X8, Canada; [Voineskos, Aristotle N.] Univ Toronto, Ctr Addict & Mental Hlth, Toronto, ON, Canada; [Lobaugh, Nancy J.] Univ Toronto, Sunnybrook Hlth Sci Ctr, Fac Med, Sunnybrook Res Inst,LC Campbell Cognit Neurol Res, Toronto, ON, Canada; [Lobaugh, Nancy J.] Univ Toronto, Sunnybrook Hlth Sci Ctr, Fac Med, Sunnybrook Res Inst,Brain Sci Res Program, Toronto, ON, Canada; [Soorya, Latha; Anagnostou, Evdokia] Mt Sinai Sch Med, Dept Psychiat, New York, NY USA; [Hollander, Eric] Univ Hosp, Albert Einstein Coll Med, Dept Psychiat, Montefiore Med Ctr, Bronx, NY USA; [Anagnostou, Evdokia] Univ Toronto, Dept Pediat, Bloorview Res Inst, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); City University of New York (CUNY) System; Queens College NY (CUNY); Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Icahn School of Medicine at Mount Sinai; Montefiore Medical Center; State University of New York (SUNY) System; Yeshiva University; Albert Einstein College of Medicine; University of Toronto	Ameis, SH (corresponding author), Univ Toronto, Hosp Sick Children, Dept Psychiat, Toronto, ON M5G 1X8, Canada.	eanagnostou@hollandbloorview.ca	Fan, Jin/A-6716-2009; Ameis, Stephanie H./Q-4822-2018; Fan, Jin/L-2055-2019; Voineskos, Aristotle/J-5014-2013	Fan, Jin/0000-0001-9630-8330; Fan, Jin/0000-0001-9630-8330; Voineskos, Aristotle/0000-0003-0156-0395	NARSAD; Autism Speaks; NIMH [MH083164]; Autism Research Training Program; Canadian Institutes of Health Research (CIHR); Clinician Scientist Award; American Psychiatric Association; Heart and Stroke Foundation Centre for Stroke Recovery; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH083164] Funding Source: NIH RePORTER	NARSAD(NARSAD); Autism Speaks; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Autism Research Training Program; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Clinician Scientist Award; American Psychiatric Association; Heart and Stroke Foundation Centre for Stroke Recovery(Heart & Stroke Foundation of Canada); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by NARSAD (PI: Anagnostou), Autism Speaks (PI: Anagnostou), NIMH MH083164 (PI: Fan), the Autism Research Training Program (salary support to SA), funded by the Canadian Institutes of Health Research (CIHR), CIHR for support from the Clinician Scientist Award to AV, and the American Psychiatric Association for support from the Young Minds in Psychiatry Award to AV. NJL received salary support from the Heart and Stroke Foundation Centre for Stroke Recovery. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 1999, NEUROPSYCHOLOGIA, V37, P1111, DOI 10.1016/S0028-3932(99)00039-1; Adolphs R, 1999, NEUROPSYCHOLOGIA, V37, P1285, DOI 10.1016/S0028-3932(99)00023-8; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Barnea-Goraly N, 2004, BIOL PSYCHIAT, V55, P323, DOI 10.1016/j.biopsych.2003.10.022; Barnea-Goraly N, 2010, ARCH GEN PSYCHIAT, V67, P1052, DOI 10.1001/archgenpsychiatry.2010.123; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Beckmann CF, 2003, NEUROIMAGE, V20, P1052, DOI 10.1016/S1053-8119(03)00435-X; Belmonte MK, 2004, J NEUROSCI, V24, P9228, DOI 10.1523/JNEUROSCI.3340-04.2004; Bloemen OJN, 2010, AUTISM RES, V3, P203, DOI 10.1002/aur.146; Carper RA, 2005, BIOL PSYCHIAT, V57, P126, DOI 10.1016/j.biopsych.2004.11.005; Carper RA, 2002, NEUROIMAGE, V16, P1038, DOI 10.1006/nimg.2002.1099; Castelli F, 2002, BRAIN, V125, P1839, DOI 10.1093/brain/awf189; Catani M, 2002, NEUROIMAGE, V17, P77, DOI 10.1006/nimg.2002.1136; Catani M, 2008, CORTEX, V44, P1105, DOI 10.1016/j.cortex.2008.05.004; Cheng YW, 2010, NEUROIMAGE, V50, P873, DOI 10.1016/j.neuroimage.2010.01.011; Cheung C, 2009, J CHILD PSYCHOL PSYC, V50, P1102, DOI 10.1111/j.1469-7610.2009.02086.x; Chiang MC, 2009, J NEUROSCI, V29, P2212, DOI 10.1523/JNEUROSCI.4184-08.2009; Ciccarelli O, 2008, LANCET NEUROL, V7, P715, DOI 10.1016/S1474-4422(08)70163-7; Conturo TE, 2008, J INT NEUROPSYCH SOC, V14, P933, DOI 10.1017/S1355617708081381; Courchesne E, 2004, CURR OPIN NEUROL, V17, P489, DOI 10.1097/01.wco.0000137542.14610.b4; Courchesne E, 2001, NEUROLOGY, V57, P245, DOI 10.1212/WNL.57.2.245; DeFelipe J, 2010, FRONT NEUROANAT, V4, DOI 10.3389/neuro.05.004.2010; Di Martino A, 2009, BIOL PSYCHIAT, V65, P63, DOI 10.1016/j.biopsych.2008.09.022; Dubischar-Krivec AM, 2009, PSYCHOL MED, V39, P1355, DOI 10.1017/S0033291708004601; Ebisch SJH, 2010, HUM BRAIN MAPP; Faria AV, 2010, NEUROIMAGE, V52, P415, DOI 10.1016/j.neuroimage.2010.04.238; Fields RD, 2008, TRENDS NEUROSCI, V31, P361, DOI 10.1016/j.tins.2008.04.001; Fields RD, 2008, SCI AM, V298, P54; Fuentes CT, 2009, NEUROLOGY, V73, P1532, DOI 10.1212/WNL.0b013e3181c0d48c; Gao W, 2009, AM J NEURORADIOL, V30, P290, DOI 10.3174/ajnr.A1363; Herbert MR, 2004, ANN NEUROL, V55, P530, DOI 10.1002/ana.20032; Herbert MR, 2003, BRAIN, V126, P1182, DOI 10.1093/brain/awg110; HOLM S, 1979, SCAND J STAT, V6, P65; Huppi PS, 2006, SEMIN FETAL NEONAT M, V11, P489, DOI 10.1016/j.siny.2006.07.006; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jones DK, 2005, NEUROIMAGE, V26, P546, DOI 10.1016/j.neuroimage.2005.02.013; Just MA, 2004, BRAIN, V127, P1811, DOI 10.1093/brain/awh199; Just MA, 2007, CEREB CORTEX, V17, P951, DOI 10.1093/cercor/bhl006; Kana RK, 2006, BRAIN, V129, P2484, DOI 10.1093/brain/awl164; Ke XY, 2009, BRAIN RES, V1265, P171, DOI 10.1016/j.brainres.2009.02.013; Kier EL, 2004, AM J NEURORADIOL, V25, P677; Klawiter E. C., 2011, NEUROIMAGE; Koshino H, 2005, NEUROIMAGE, V24, P810, DOI 10.1016/j.neuroimage.2004.09.028; Kumar A, 2009, CEREB CORTEX; Lee JE, 2007, NEUROSCI LETT, V424, P127, DOI 10.1016/j.neulet.2007.07.042; Lo YC, 2011, PSYCHIAT RES-NEUROIM, V192, P60, DOI 10.1016/j.pscychresns.2010.09.008; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Nation K, 2006, J AUTISM DEV DISORD, V36, P911, DOI 10.1007/s10803-006-0130-1; Odegard TN, 2009, NEUROPSYCHOLOGIA, V47, P1972, DOI 10.1016/j.neuropsychologia.2009.03.009; Pardini M, 2009, EUR J NEUROL, V16, P1185, DOI 10.1111/j.1468-1331.2009.02699.x; Paus T, 1999, SCIENCE, V283, P1908, DOI 10.1126/science.283.5409.1908; Pelphrey K, 2004, MENT RETARD DEV D R, V10, P259, DOI 10.1002/mrdd.20040; Pelphrey KA, 2008, DEV PSYCHOPATHOL, V20, P1081, DOI 10.1017/S0954579408000515; Pierce K, 2004, BRAIN, V127, P2703, DOI 10.1093/brain/awh289; Pierce K, 2008, BIOL PSYCHIAT, V64, P552, DOI 10.1016/j.biopsych.2008.05.013; Poutska L, 2011, WORLD J BIOL PSYCHIA; Pugliese L, 2009, NEUROIMAGE, V47, P427, DOI 10.1016/j.neuroimage.2009.05.014; Radua J, 2010, PSYCHOL MED, V16, P1; Robb RA, 2001, IEEE T MED IMAGING, V20, P854, DOI 10.1109/42.952724; ROBB RA, 1989, IEEE T MED IMAGING, V8, P217, DOI 10.1109/42.34710; ROBB RA, 1989, COMPUT MED IMAG GRAP, V13, P433, DOI 10.1016/0895-6111(89)90285-1; Sahyoun CP, 2010, BRAIN COGNITION, V73, P180, DOI 10.1016/j.bandc.2010.05.002; Sakurai T, 2010, BIOL PSYCHIAT, V67, P887, DOI 10.1016/j.biopsych.2009.08.042; Schmahmann JD, 2007, BRAIN, V130, P630, DOI 10.1093/brain/awl359; Schumann CM, 2004, J NEUROSCI, V24, P6392, DOI 10.1523/JNEUROSCI.1297-04.2004; Schumann CM, 2010, J NEUROSCI, V30, P4419, DOI 10.1523/JNEUROSCI.5714-09.2010; Shukla DK, 2011, NEUROPSYCHOLOGIA, V49, P1378, DOI 10.1016/j.neuropsychologia.2011.02.022; Shukla DK, 2011, J CHILD PSYCHOL PSYC, V52, P286, DOI 10.1111/j.1469-7610.2010.02342.x; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Thakkar KN, 2008, BRAIN, V131, P2464, DOI 10.1093/brain/awn099; Thomas C, 2011, CORTEX, V47, P863, DOI 10.1016/j.cortex.2010.07.006; van Eimeren L, 2008, NEUROREPORT, V19, P1117, DOI 10.1097/WNR.0b013e328307f5c1; Wakana S, 2004, RADIOLOGY, V230, P77, DOI 10.1148/radiol.2301021640; Weschler D, 2004, WESCHLER INTELLIGENC; Wheeler-Kingshott CAM, 2009, MAGN RESON MED, V61, P1255, DOI 10.1002/mrm.21965; Wicker B, 2008, SOC COGN AFFECT NEUR, V3, P135, DOI 10.1093/scan/nsn007; Zikopoulos B, 2010, J NEUROSCI, V30, P14595, DOI 10.1523/JNEUROSCI.2257-10.2010	83	78	80	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e28044	10.1371/journal.pone.0028044	http://dx.doi.org/10.1371/journal.pone.0028044			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	863KL	22132206	Green Published, gold			2022-12-27	WOS:000298162000062
J	Frenzel, A; Zirath, H; Vita, M; Albihn, A; Henriksson, MA				Frenzel, Anna; Zirath, Hanna; Vita, Marina; Albihn, Ami; Henriksson, Marie Arsenian			Identification of Cytotoxic Drugs That Selectively Target Tumor Cells with MYC Overexpression	PLOS ONE			English	Article							C-MYC; INDUCED APOPTOSIS; NEUROBLASTOMA-CELLS; N-MYC; SMALL MOLECULES; ADULT BURKITT; INHIBITION; EXPRESSION; THERAPY; CANCER	Expression of MYC is deregulated in a wide range of human cancers, and is often associated with aggressive disease and poorly differentiated tumor cells. Identification of compounds with selectivity for cells overexpressing MYC would hence be beneficial for the treatment of these tumors. For this purpose we used cell lines with conditional MYCN or c-MYC expression, to screen a library of 80 conventional cytotoxic compounds for their ability to reduce tumor cell viability and/or growth in a MYC dependent way. We found that 25% of the studied compounds induced apoptosis and/or inhibited proliferation in a MYC-specific manner. The activities of the majority of these were enhanced both by c-MYC or MYCN over-expression. Interestingly, these compounds were acting on distinct cellular targets, including microtubules (paclitaxel, podophyllotoxin, vinblastine) and topoisomerases (10-hydroxycamptothecin, camptothecin, daunorubicin, doxorubicin, etoposide) as well as DNA, RNA and protein synthesis and turnover (anisomycin, aphidicholin, gliotoxin, MG132, methotrexate, mitomycin C). Our data indicate that MYC overexpression sensitizes cells to disruption of specific pathways and that in most cases c-MYC and MYCN overexpression have similar effects on the responses to cytotoxic compounds. Treatment of the cells with topoisomerase I inhibitors led to down-regulation of MYC protein levels, while doxorubicin and the small molecule MYRA-A was found to disrupt MYC-Max interaction. We conclude that the MYC pathway is only targeted by a subset of conventional cytotoxic drugs currently used in the clinic. Elucidating the mechanisms underlying their specificity towards MYC may be of importance for optimizing treatment of tumors with MYC deregulation. Our data also underscores that MYC is an attractive target for novel therapies and that cellular screenings of chemical libraries can be a powerful tool for identifying compounds with a desired biological activity.	[Frenzel, Anna; Zirath, Hanna; Vita, Marina; Albihn, Ami; Henriksson, Marie Arsenian] Karolinska Inst, Dept Microbiol Tumor & Cell Biol MTC, Stockholm, Sweden	Karolinska Institutet	Frenzel, A (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol MTC, Stockholm, Sweden.	Marie.Henriksson@ki.se	Henriksson, Marie Arsenian/F-5010-2015	Arsenian Henriksson, Marie/0000-0001-6376-7792; Zirath, Herbert/0000-0002-5721-4793	Swedish Cancer Society; Petrus and Augusta Hedlund Foundation; Ake Olsson Foundation; Swedish Childhood Cancer Foundation; Karolinska Institutet	Swedish Cancer Society(Swedish Cancer Society); Petrus and Augusta Hedlund Foundation; Ake Olsson Foundation; Swedish Childhood Cancer Foundation(European Commission); Karolinska Institutet(Karolinska Institutet)	MAH was the recipient of a Senior Investigator Award by the Swedish Cancer Society. This work has been supported by the Swedish Cancer Society, the Petrus and Augusta Hedlund Foundation, the Ake Olsson Foundation, the Swedish Childhood Cancer Foundation and Karolinska Institutet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikary S, 2005, NAT REV MOL CELL BIO, V6, P635, DOI 10.1038/nrm1703; Albihn A, 2007, INT J CANCER, V121, P1821, DOI 10.1002/ijc.22866; Albihn A, 2006, J CELL BIOCHEM, V98, P1597, DOI 10.1002/jcb.20816; Albihn A, 2010, ADV CANCER RES, V107, P163, DOI 10.1016/S0065-230X(10)07006-5; AMATI B, 1992, NATURE, V359, P423, DOI 10.1038/359423a0; Bejarano MT, 2000, EXP CELL RES, V260, P61, DOI 10.1006/excr.2000.4996; Bottone MG, 2003, EXP CELL RES, V290, P49, DOI 10.1016/S0014-4827(03)00312-4; Bourgarel-Rey V, 2000, EUR J CANCER, V36, P1043, DOI 10.1016/S0959-8049(00)00042-3; Boxer LM, 2001, ONCOGENE, V20, P5595, DOI 10.1038/sj.onc.1204595; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Citro G, 1998, CANCER RES, V58, P283; Courapied S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-205; Di Nicola M, 2004, BRIT J HAEMATOL, V126, P815, DOI 10.1111/j.1365-2141.2004.05141.x; Dorjsuren D, 2006, ANTIVIR RES, V69, P9, DOI 10.1016/j.antiviral.2005.09.005; Dumontet C, 2010, NAT REV DRUG DISCOV, V9, P790, DOI 10.1038/nrd3253; Felsher Dean W, 2010, Genes Cancer, V1, P597, DOI 10.1177/1947601910377798; Felsher DW, 1999, MOL CELL, V4, P199, DOI 10.1016/S1097-2765(00)80367-6; Fong A, 2009, PEDIATR HEMAT ONCOL, V26, P539, DOI 10.3109/08880010903121173; Fredlund E, 2008, P NATL ACAD SCI USA, V105, P14094, DOI 10.1073/pnas.0804455105; Fulda S, 2000, MED PEDIATR ONCOL, V35, P582, DOI 10.1002/1096-911X(20001201)35:6<582::AID-MPO19>3.0.CO;2-2; Gatti G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005442; Goga A, 2007, NAT MED, V13, P820, DOI 10.1038/nm1606; Grassilli E, 2004, J BIOL CHEM, V279, P21318, DOI 10.1074/jbc.M313532200; Guerra L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008924; Jain M, 2002, SCIENCE, V297, P102, DOI 10.1126/science.1071489; Kujawski LA, 2007, CANCER INVEST, V25, P87, DOI 10.1080/07357900701205507; Larsson LG, 2010, EXP CELL RES, V316, P1429, DOI 10.1016/j.yexcr.2010.03.025; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; Luscher B, 1999, ONCOGENE, V18, P2955, DOI 10.1038/sj.onc.1202750; Lutz W, 1996, ONCOGENE, V13, P803; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Meyer N, 2006, SEMIN CANCER BIOL, V16, P275, DOI 10.1016/j.semcancer.2006.07.011; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Mo H, 2006, P NATL ACAD SCI USA, V103, P6344, DOI 10.1073/pnas.0601418103; Mo H, 2006, CELL CYCLE, V5, P2191, DOI 10.4161/cc.5.19.3320; Nesbit CE, 1998, CELL GROWTH DIFFER, V9, P731; Otto T, 2009, CANCER CELL, V15, P67, DOI 10.1016/j.ccr.2008.12.005; Paffhausen T, 2007, CANCER LETT, V250, P17, DOI 10.1016/j.canlet.2006.09.010; Pelengaris S, 2002, CELL, V109, P321, DOI 10.1016/S0092-8674(02)00738-9; Prochownik Edward V, 2010, Genes Cancer, V1, P650; Schuhmacher M, 1999, CURR BIOL, V9, P1255, DOI 10.1016/S0960-9822(99)80507-7; Shachaf CM, 2004, NATURE, V431, P1112, DOI 10.1038/nature03043; SKLAR MD, 1991, CANCER RES, V51, P2118; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; Soucie EL, 2001, MOL CELL BIOL, V21, P4725, DOI 10.1128/MCB.21.14.4725-4736.2001; Thomas DA, 2006, CANCER-AM CANCER SOC, V106, P1569, DOI 10.1002/cncr.21776; Vita M, 2006, SEMIN CANCER BIOL, V16, P318, DOI 10.1016/j.semcancer.2006.07.015; Westermann F, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r150; Westermark UK, 2011, SEMIN CANCER BIOL, V21, P256, DOI 10.1016/j.semcancer.2011.08.001; Yang D, 2010, P NATL ACAD SCI USA, V107, P13836, DOI 10.1073/pnas.1008366107; YEN YT, 1991, BIOCHEM BIOPH RES CO, V179, P1241, DOI 10.1016/0006-291X(91)91705-H	51	21	23	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e27988	10.1371/journal.pone.0027988	http://dx.doi.org/10.1371/journal.pone.0027988			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132187	Green Submitted, Green Published, gold			2022-12-27	WOS:000298162000056
J	Laarhoven, LM; de Heus, P; van Luijn, J; Duim, B; Wagenaar, JA; van Duijkeren, E				Laarhoven, Laura M.; de Heus, Phebe; van Luijn, Jeanine; Duim, Birgitta; Wagenaar, Jaap A.; van Duijkeren, Engeline			Longitudinal Study on Methicillin-Resistant Staphylococcus pseudintermedius in Households	PLOS ONE			English	Article							CLINICAL-SAMPLES; AUREUS; COLONIZATION; DOGS; EMERGENCE; CARRIAGE; HEALTHY; SCCMEC; SPREAD; MEC	Methicillin-resistant Staphylococcus pseudintermedius (MRSP) is an emerging pathogen in dogs and has been found in Europe, Asia and North America. To date most studies are one-point prevalence studies and therefore little is known about the dynamics of MRSP in dogs and their surrounding. In this longitudinal study MRSP colonization in dogs and the transmission of MRSP to humans, contact animals and the environment was investigated. Sixteen dogs with a recent clinical MRSP infection were included. The index dogs, contact animals, owners and environments were sampled once a month for six months. Samples taken from the nose, perineum and infection site (if present) of the index cases and contact animals, and the nares of the owners were cultured using pre-enrichment. Index cases were found positive for prolonged periods of time, in two cases during all six samplings. In five of the 12 households that were sampled during six months, the index case was intermittently found MRSP-positive. Contact animals and the environment were also found MRSP-positive, most often in combination with a MRSP-positive index dog. In four households positive environmental samples were found while no animals or humans were MRSP-positive, indicating survival of MRSP in the environment for prolonged periods of time. Genotyping revealed that generally similar or indistinguishable MRSP isolates were found in patients, contact animals and environmental samples within the same household. Within two households, however, genetically distinct MRSP isolates were found. These results show that veterinarians should stay alert with (former) MRSP patients, even after repeated MRSP-negative cultures or after the disappearance of the clinical infection. There is a considerable risk of transmission of MRSP to animals in close contact with MRSP patients. Humans were rarely MRSP-positive and never tested MRSP-positive more than once suggesting occasional contamination or rapid elimination of colonization of the owners.	[Laarhoven, Laura M.; de Heus, Phebe; van Luijn, Jeanine; Duim, Birgitta; Wagenaar, Jaap A.; van Duijkeren, Engeline] Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, Utrecht, Netherlands; [Wagenaar, Jaap A.] Cent Vet Inst Wageningen UR, Lelystad, Netherlands; [van Duijkeren, Engeline] Natl Inst Publ Hlth & Environm, Lab Zoonoses & Environm Microbiol, NL-3720 BA Bilthoven, Netherlands	Utrecht University; Wageningen University & Research; Netherlands National Institute for Public Health & the Environment	Laarhoven, LM (corresponding author), Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, Utrecht, Netherlands.	Engeline.van.duijkeren@rivm.nl		de Heus, Phebe/0000-0002-3799-2096	Royal Dutch Veterinary Association	Royal Dutch Veterinary Association	This study was supported by a grant from the Royal Dutch Veterinary Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bannoehr J, 2007, J BACTERIOL, V189, P8685, DOI 10.1128/JB.01150-07; Bannoehr J, 2009, J CLIN MICROBIOL, V47, P469, DOI 10.1128/JCM.01915-08; Campanile F, 2007, MICROB DRUG RESIST, V13, P7, DOI 10.1089/mdr.2006.9991; Descloux S, 2008, J CLIN MICROBIOL, V46, P1818, DOI 10.1128/JCM.02255-07; Fazakerley J, 2010, VET DERMATOL, V21, P578, DOI 10.1111/j.1365-3164.2010.00894.x; Francois P, 2003, J CLIN MICROBIOL, V41, P254, DOI 10.1128/JCM.41.1.254-260.2003; Gerstadt K, 1999, CLIN INFECT DIS, V29, P218, DOI 10.1086/520168; Graveland H, 2009, VET MICROBIOL, V139, P121, DOI 10.1016/j.vetmic.2009.05.019; Griffeth GC, 2008, VET DERMATOL, V19, P142, DOI 10.1111/j.1365-3164.2008.00663.x; Hanselman BA, 2008, VET MICROBIOL, V126, P277, DOI 10.1016/j.vetmic.2007.06.015; Hanselman BA, 2009, CAN VET J, V50, P954; Kempker R, 2009, AM J MED SCI, V338, P425, DOI 10.1097/MAJ.0b013e3181b0baa9; Kluytmans J, 1997, CLIN MICROBIOL REV, V10, P505, DOI 10.1128/CMR.10.3.505; Kondo Y, 2007, ANTIMICROB AGENTS CH, V51, P264, DOI 10.1128/AAC.00165-06; Moodley A, 2009, VET MICROBIOL, V135, P320, DOI 10.1016/j.vetmic.2008.09.070; Murchan S, 2003, J CLIN MICROBIOL, V41, P1574, DOI 10.1128/JCM.41.4.1574-1585.2003; Nienhoff U, 2011, VET MICROBIOL, V150, P191, DOI 10.1016/j.vetmic.2010.12.018; Paul NC, 2011, ZOONOSES PUBLIC HLTH, V58, P533, DOI 10.1111/j.1863-2378.2011.01398.x; Penna B, 2010, CAN VET J, V51, P738; Penna B, 2010, VET DERMATOL, V21, P292, DOI 10.1111/j.1365-3164.2009.00842.x; Perreten V, 2010, J ANTIMICROB CHEMOTH, V65, P1145, DOI 10.1093/jac/dkq078; Ruscher C, 2010, VET MICROBIOL, V144, P340, DOI 10.1016/j.vetmic.2010.01.008; Ruscher C, 2009, VET MICROBIOL, V136, P197, DOI 10.1016/j.vetmic.2008.10.023; Sasaki T, 2007, J CLIN MICROBIOL, V45, P1118, DOI 10.1128/JCM.02193-06; Stegmann R, 2010, J ANTIMICROB CHEMOTH, V65, P2047, DOI 10.1093/jac/dkq241; van Duijkeren E, 2011, VET MICROBIOL, V150, P338, DOI 10.1016/j.vetmic.2011.02.012; Vengust M, 2006, LETT APPL MICROBIOL, V43, P602, DOI 10.1111/j.1472-765X.2006.02018.x; Wagenvoort JHT, 2000, J HOSP INFECT, V45, P231, DOI 10.1053/jhin.2000.0757; Weese JS, 2010, VET MICROBIOL, V140, P418, DOI 10.1016/j.vetmic.2009.01.039	29	67	67	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e27788	10.1371/journal.pone.0027788	http://dx.doi.org/10.1371/journal.pone.0027788			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132141	Green Submitted, Green Published, gold			2022-12-27	WOS:000298162000043
J	Nakamura, S; Nagata, Y; Tan, L; Takemura, T; Shibata, K; Fujie, M; Fujisawa, S; Tanaka, Y; Toda, M; Makita, R; Tsunekawa, K; Yamada, M; Yamaoka, M; Yamashita, J; Ohnishi, K; Yamashita, M				Nakamura, Satoki; Nagata, Yasuyuki; Tan, Lin; Takemura, Tomonari; Shibata, Kiyoshi; Fujie, Michio; Fujisawa, Shinya; Tanaka, Yasutaka; Toda, Mitsuo; Makita, Reiko; Tsunekawa, Kenji; Yamada, Manabu; Yamaoka, Mayumi; Yamashita, Junko; Ohnishi, Kazunori; Yamashita, Mitsuji			Transcriptional Repression of Cdc25B by IER5 Inhibits the Proliferation of Leukemic Progenitor Cells through NF-YB and p300 in Acute Myeloid Leukemia	PLOS ONE			English	Article							HUMAN LYMPHOBLASTOID-CELLS; GENOTOXIC STRESS; GENE-EXPRESSION; DNA-DAMAGE; GAMMA-RAY; CYCLE; PHOSPHATASES; CANCER; OVEREXPRESSION; CARCINOMAS	The immediately-early response gene 5 (IER5) has been reported to be induced by c-ray irradiation and to play a role in the induction of cell death caused by radiation. We previously identified IER5 as one of the 2,3,4-tribromo-3-methyl-1-phenylphospholane 1-oxide (TMPP)-induced transcriptional responses in AML cells, using microarrays that encompassed the entire human genome. However, the biochemical pathway and mechanisms of IER5 function in regulation of the cell cycle remain unclear. In this study, we investigated the involvement of IER5 in the cell cycle and in cell proliferation of acute myeloid leukemia (AML) cells. We found that the over-expression of IER5 in AML cell lines and in AML-derived ALDH(hi) (High Aldehyde Dehydrogenase activity)/CD34(+) cells inhibited their proliferation compared to control cells, through induction of G2/M cell cycle arrest and a decrease in Cdc25B expression. Moreover, the over-expression of IER5 reduced colony formation of AML-derived ALDH(hi) /CD34(+) cells due to a decrease in Cdc25B expression. In addition, over-expression of Cdc25B restored TMPP inhibitory effects on colony formation in IER5-suppressed AML-derived ALDH(hi) /CD34(+) cells. Furthermore, the IER5 reduced Cdc25B mRNA expression through direct binding to Cdc25B promoter and mediated its transcriptional attenuation through NF-YB and p300 transcriptinal factors. In summary, we found that transcriptional repression mediated by IER5 regulates Cdc25B expression levels via the release of NF-YB and p300 in AML-derived ALDH(hi) /CD34(+) cells, resulting in inhibition of AML progenitor cell proliferation through modulation of cell cycle. Thus, the induction of IER5 expression represents an attractive target for AML therapy.	[Nakamura, Satoki; Nagata, Yasuyuki; Tan, Lin; Takemura, Tomonari; Ohnishi, Kazunori] Hamamatsu Univ Sch Med, Dept Internal Med 3, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan; [Nagata, Yasuyuki; Tan, Lin; Takemura, Tomonari; Ohnishi, Kazunori] Hamamatsu Univ Sch Med, Ctr Canc, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan; [Shibata, Kiyoshi; Fujie, Michio] Hamamatsu Univ Sch Med, Equipment Ctr, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan; [Fujisawa, Shinya] Hamamatsu Med Ctr, Div Hematol, Naka Ku, Hamamatsu, Shizuoka, Japan; [Tanaka, Yasutaka; Toda, Mitsuo; Makita, Reiko; Tsunekawa, Kenji; Yamada, Manabu; Yamaoka, Mayumi; Yamashita, Junko; Yamashita, Mitsuji] Shizuoka Univ, Grad Sch Sci & Technol, Dept Nano Mat, Naka Ku, Hamamatsu, Shizuoka 4328011, Japan	Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; Shizuoka University	Nakamura, S (corresponding author), Hamamatsu Univ Sch Med, Dept Internal Med 3, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan.	satonaka@hama-med.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [17590987]; Grants-in-Aid for Scientific Research [21650108, 21590621] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for scientific research (#17590987) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aressy B, 2008, ANTI-CANCER AGENT ME, V8, P818, DOI 10.2174/187152008786847756; Bansal P, 2007, CANCER RES, V67, P3356, DOI 10.1158/0008-5472.CAN-06-3685; Boutros R, 2006, CURR OPIN CELL BIOL, V18, P185, DOI 10.1016/j.ceb.2006.02.003; Boutros R, 2007, NAT REV CANCER, V7, P495, DOI 10.1038/nrc2169; Broggini M, 2000, ANTICANCER RES, V20, P4835; Bugler B, 2006, MOL CANCER THER, V5, P1446, DOI 10.1158/1535-7163.MCT-06-0099; Chung KC, 1998, MOL CELL BIOL, V18, P2272, DOI 10.1128/MCB.18.4.2272; Cirelli C, 2000, BRAIN RES, V885, P303, DOI 10.1016/S0006-8993(00)03008-0; Dalvai M, 2011, ONCOGENE, V30, P2282, DOI 10.1038/onc.2010.588; Didier C, 2008, ONCOGENE, V27, P3811, DOI 10.1038/sj.onc.1211041; Ding KK, 2009, RADIAT ENVIRON BIOPH, V48, P205, DOI 10.1007/s00411-009-0213-4; Freter RR, 1996, J BIOL CHEM, V271, P17417, DOI 10.1074/jbc.271.29.17417; GALAKTIONOV K, 1995, SCIENCE, V269, P1575, DOI 10.1126/science.7667636; Guo JC, 2004, ONCOGENE, V23, P71, DOI 10.1038/sj.onc.1206926; Korner K, 2001, J BIOL CHEM, V276, P9662, DOI 10.1074/jbc.M008696200; Kristjansdottir K, 2004, CHEM BIOL, V11, P1043, DOI 10.1016/j.chembiol.2004.07.007; Kudo Y, 1997, JPN J CANCER RES, V88, P947, DOI 10.1111/j.1349-7006.1997.tb00313.x; Lindqvist A, 2005, J CELL BIOL, V171, P35, DOI 10.1083/jcb.200503066; Long XH, 2007, INT J MOL MED, V19, P607; Mailand N, 2000, SCIENCE, V288, P1425, DOI 10.1126/science.288.5470.1425; Mantovani R, 1999, GENE, V239, P15, DOI 10.1016/S0378-1119(99)00368-6; Miyata H, 2000, CLIN CANCER RES, V6, P4859; Nakamura S, 2010, CARCINOGENESIS, V31, P2012, DOI 10.1093/carcin/bgq185; Nakamura S, 2010, INVEST NEW DRUG, V28, P381, DOI 10.1007/s10637-009-9255-3; Ngan ESW, 2003, ONCOGENE, V22, P734, DOI 10.1038/sj.onc.1206121; Nishioka K, 2001, BRIT J CANCER, V85, P412, DOI 10.1054/bjoc.2001.1934; Okada A, 2005, BIRTH DEFECTS RES A, V73, P229, DOI 10.1002/bdra.20131; Rodriguez S, 2005, CANCER GENET CYTOGEN, V157, P140, DOI 10.1016/j.cancergencyto.2004.08.017; Sasaki H, 2001, CANCER LETT, V173, P187, DOI 10.1016/S0304-3835(01)00669-3; Takemasa I, 2000, CANCER RES, V60, P3043; Tsuda H, 2003, ONCOLOGY-BASEL, V65, P159, DOI 10.1159/000072342; van Vugt MATM, 2004, MOL CELL, V15, P799, DOI 10.1016/j.molcel.2004.07.015; Wang HP, 2006, INT J RADIAT BIOL, V82, P181, DOI 10.1080/09553000600632261; Wierstra I, 2008, BIOCHEM BIOPH RES CO, V372, P1, DOI 10.1016/j.bbrc.2008.03.074; Williams M, 1999, GENOMICS, V55, P327, DOI 10.1006/geno.1998.5679; Winkles JA, 1998, PROG NUCLEIC ACID RE, V58, P41; Xu B, 2002, MOL CELL BIOL, V22, P1049, DOI 10.1128/MCB.22.4.1049-1059.2002	37	28	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e28011	10.1371/journal.pone.0028011	http://dx.doi.org/10.1371/journal.pone.0028011			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132193	Green Submitted, Green Published, gold			2022-12-27	WOS:000298162000059
J	Noh, JH; Jung, KH; Kim, JK; Eun, JW; Bae, HJ; Xie, HJ; Chang, YG; Kim, MG; Park, WS; Lee, JY; Nam, SW				Noh, Ji Heon; Jung, Kwang Hwa; Kim, Jeong Kyu; Eun, Jung Woo; Bae, Hyun Jin; Xie, Hong Jian; Chang, Young Gyoon; Kim, Min Gyu; Park, Won Sang; Lee, Jung Young; Nam, Suk Woo			Aberrant Regulation of HDAC2 Mediates Proliferation of Hepatocellular Carcinoma Cells by Deregulating Expression of G1/S Cell Cycle Proteins	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITORS; WAF1/CIP1 GENE PROMOTER; HEPATOMA-CELLS; SP1 SITES; CANCER; APOPTOSIS; TRANSCRIPTION; VALPROATE; GROWTH	Histone deacetylase 2 (HDAC2) is crucial for embryonic development, affects cytokine signaling relevant for immune responses and is often significantly overexpressed in solid tumors; but little is known about its role in human hepatocellular carcinoma (HCC). In this study, we showed that targeted-disruption of HDAC2 resulted in reduction of both tumor cell growth and de novo DNA synthesis in Hep3B cells. We then demonstrated that HDAC2 regulated cell cycle and that disruption of HDAC2 caused G1/S arrest in cell cycle. In G1/S transition, targeted-disruption of HDAC2 selectively induced the expression of p16(INK4A) and p21(WAF1/Cip1), and simultaneously suppressed the expression of cyclin D1, CDK4 and CDK2. Consequently, HDAC2 inhibition led to the down-regulation of E2F/DP1 target genes through a reduction in phosphorylation status of pRb protein. In addition, sustained suppression of HDAC2 attenuated in vitro colony formation and in vivo tumor growth in a mouse xenograft model. Further, we found that HDAC2 suppresses p21(WAF1/Cip1) transcriptional activity via Sp1-binding site enriched proximal region of p21(WAF1/Cip1) promoter. In conclusion, we suggest that the aberrant regulation of HDAC2 may play a pivotal role in the development of HCC through its regulation of cell cycle components at the transcription level providing HDAC2 as a relevant target in liver cancer therapy.	[Nam, Suk Woo] Catholic Univ Korea, Dept Pathol, Coll Med, Seoul, South Korea; Catholic Univ Korea, Funct RN Res Ctr, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea	Noh, JH (corresponding author), Catholic Univ Korea, Dept Pathol, Coll Med, Seoul, South Korea.	swnam@catholic.ac.kr	Eun, Jung Woo/ABB-5127-2020	Eun, Jung Woo/0000-0002-2461-6702	Ministry for Health, Welfare & Family Affairs, the Republic of Korea [A084930]	Ministry for Health, Welfare & Family Affairs, the Republic of Korea	This work was supported by a grant from the Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, the Republic of Korea (A084930). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armeanu S, 2005, J HEPATOL, V42, P210, DOI 10.1016/j.jhep.2004.10.020; Batty N, 2009, CANCER LETT, V280, P192, DOI 10.1016/j.canlet.2009.03.013; Brehm A, 1998, NATURE, V391, P597, DOI 10.1038/35404; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Gallinari P, 2007, CELL RES, V17, P195, DOI 10.1038/sj.cr.7310149; Glozak MA, 2007, ONCOGENE, V26, P5420, DOI 10.1038/sj.onc.1210610; GRANA X, 1995, ONCOGENE, V11, P211; Gui CY, 2004, P NATL ACAD SCI USA, V101, P1241, DOI 10.1073/pnas.0307708100; Hrzenjak A, 2006, MOL CANCER THER, V5, P2203, DOI 10.1158/1535-7163.MCT-05-0480; Huang BH, 2005, CELL DEATH DIFFER, V12, P395, DOI 10.1038/sj.cdd.4401567; Huang WF, 2006, BIOCHEM BIOPH RES CO, V339, P165, DOI 10.1016/j.bbrc.2005.11.010; Kaler P, 2008, EXP CELL RES, V314, P1507, DOI 10.1016/j.yexcr.2008.01.010; Laherty CD, 1997, CELL, V89, P349, DOI 10.1016/S0092-8674(00)80215-9; Laurent-Puig P, 2001, GASTROENTEROLOGY, V120, P1763, DOI 10.1053/gast.2001.24798; Lu YS, 2007, HEPATOLOGY, V46, P1119, DOI 10.1002/hep.21804; Luo JY, 2000, NATURE, V408, P377, DOI 10.1038/35042612; Marks PA, 2001, NAT REV CANCER, V1, P194, DOI 10.1038/35106079; Nakano K, 1997, J BIOL CHEM, V272, P22199, DOI 10.1074/jbc.272.35.22199; Nam SW, 2005, HEPATOLOGY, V42, P809, DOI 10.1002/hep.20878; Niyazi M, 2007, RADIAT ONCOL, V2, DOI 10.1186/1748-717X-2-4; Noh JH, 2006, MOL CELL TOXICOL, V2, P166; Pathil A, 2006, HEPATOLOGY, V43, P425, DOI 10.1002/hep.21054; Song J, 2005, APMIS, V113, P264, DOI 10.1111/j.1600-0463.2005.apm_04.x; Sowa Y, 1997, BIOCHEM BIOPH RES CO, V241, P142, DOI 10.1006/bbrc.1997.7786; Weichert W, 2008, BRIT J CANCER, V98, P604, DOI 10.1038/sj.bjc.6604199; Weichert W, 2009, CANCER LETT, V280, P168, DOI 10.1016/j.canlet.2008.10.047; Witt O, 2009, CANCER LETT, V277, P8, DOI 10.1016/j.canlet.2008.08.016; Yang XJ, 2007, ONCOGENE, V26, P5310, DOI 10.1038/sj.onc.1210599; Yarden RI, 1999, P NATL ACAD SCI USA, V96, P4983, DOI 10.1073/pnas.96.9.4983; Zhu P, 2004, CANCER CELL, V5, P455, DOI 10.1016/S1535-6108(04)00114-X	30	82	86	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e28103	10.1371/journal.pone.0028103	http://dx.doi.org/10.1371/journal.pone.0028103			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132221	gold, Green Submitted, Green Published			2022-12-27	WOS:000298162000072
J	Martinez-Falcon, AP; Durban, A; Latorre, A; Anton, J; Marcos-Garcia, MDLA				Paola Martinez-Falcon, Ana; Durban, Ana; Latorre, Amparo; Anton, Josefa; de los Angeles Marcos-Garcia, Maria			Bacteria Associated with Copestylum (Diptera, Syrphidae) Larvae and Their Cactus Host Isolatocereus dumortieri	PLOS ONE			English	Article							CACTOPHILIC DROSOPHILA; IMMATURE STAGES; COLUMNAR CACTI; FLY; ECOLOGY; TISSUE; ADULT; FRUIT	We describe the gut bacterial diversity inhabiting two saprophagous syrphids and their breeding substrate (decayed tissues of the columnar cactus Isolatocereus dumortieri). We analyzed the gut microbiota of Copestylum latum (scooping larvae that feed on decayed cactus tissues) and Copestylum limbipenne (whose larvae can also feed on semiliquid tissues) using molecular techniques. DNA was extracted from larval guts and cactus tissues. The V1-V3 region of the 16S rRNA genes was amplified and sequenced. A total of 31079 sequences were obtained. The main findings are: C. limbipenne is dominated by several Enterobacteriaceae, including putative nitrogen-fixing genera and pectinolitic species and some denitrifying species, whereas in C. latum unclassified Gammaproteobacteria predominate. Decayed tissues have a dominant lactic acid bacterial community. The bacterial communities were more similar between larval species than between each larva and its breeding substrate. The results suggest that the gut bacterial community in these insects is not strongly affected by diet and must be dependent on other factors, such as vertical transmission, evolutionary history and host innate immunity.	[Paola Martinez-Falcon, Ana; de los Angeles Marcos-Garcia, Maria] Univ Alicante, Inst Biodiversidad CIBIO, E-03080 Alicante, Spain; [Durban, Ana; Latorre, Amparo] Univ Alicante, Unidad Mixta Inst Cavanilles Biodiversidad & Biol, E-03080 Alicante, Spain; [Anton, Josefa] Univ Alicante, Dept Fisiol Genet & Microbiol, E-03080 Alicante, Spain	Universitat d'Alacant; Universitat d'Alacant; Universitat d'Alacant	Martinez-Falcon, AP (corresponding author), Univ Alicante, Inst Biodiversidad CIBIO, Campus Univ San Vicente del Raspeig, E-03080 Alicante, Spain.	AnaPaola.Martinez@ua.es	Anton, Josefa/L-5283-2014; Latorre, Amparo/E-4997-2015; Marcos García, Maria Angeles/H-7925-2015	Anton, Josefa/0000-0002-5823-493X; Latorre, Amparo/0000-0002-9146-7284; Marcos García, Maria Angeles/0000-0002-2439-2630; Martinez-Falcon, Ana Paola/0000-0003-3307-3989	AECID [A/020305/08]; FOMIX CONACYT-Hidalgo [95828]; SEP-CONACYT [84127]; Ministerio de Ciencia e Inovacion [BFU2009-12895-C02-01]; European Union [E07D401138MX]; CONACYT [207522]; Instituto de Salud Carlos III, Spain	AECID; FOMIX CONACYT-Hidalgo; SEP-CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Ministerio de Ciencia e Inovacion(Spanish Government); European Union(European Commission); CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Instituto de Salud Carlos III, Spain(Instituto de Salud Carlos III)	This research was funded by AECID (project A/020305/08), FOMIX CONACYT-Hidalgo (project 95828) and SEP-CONACYT (project 84127) to M. A. M.-G., and BFU2009-12895-C02-01 from the Ministerio de Ciencia e Inovacion to A. L. We extend our gratitude to the management of the Barranca de Metztitlan Biosphere Reserve for assisting us in this research. We appreciate discussions with Dr. Graham Rotheray and P. E. Cruz-Dominguez. C Aguilar-Miguel and M. C. Garcia-Chavez assisted with fieldwork. A. P. M. acknowledge the scholarship provided by The Alban programme, the European Union Programme of High Level Scholarships for Latin America, No. E07D401138MX and CONACYT program (207522) for doctoral fellowship. A. D. is recipient of a fellowship from the Instituto de Salud Carlos III, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behar A, 2008, MOL ECOL, V17, P1375, DOI 10.1111/j.1365-294X.2008.03674.x; Ben-Yosef M, 2008, PHYSIOL ENTOMOL, V33, P145, DOI 10.1111/j.1365-3032.2008.00617.x; Bravo-Hollis H., 1978, CACTACEAS MEXICO, V1, P743; Castrezana S, 2001, CAN ENTOMOL, V133, P301, DOI 10.4039/Ent133301-3; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; Cole JR, 2007, NUCLEIC ACIDS RES, V35, pD169, DOI 10.1093/nar/gkl889; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; ETGES WJ, 1989, EVOLUTION, V43, P1316, DOI 10.1111/j.1558-5646.1989.tb02579.x; Euzeby J. P., LIST PROKARYOTIC NAM; Fogleman J. C., 1989, SPECIAL BIOTIC RELAT, P1; FOGLEMAN JC, 1981, P NATL ACAD SCI-BIOL, V78, P4435, DOI 10.1073/pnas.78.7.4435; FOGLEMAN JC, 1989, APPL ENVIRON MICROB, V55, P100, DOI 10.1128/AEM.55.1.100-105.1989; Fogleman JC, 2001, AM ZOOL, V41, P877, DOI 10.1668/0003-1569(2001)041[0877:CIITCM]2.0.CO;2; Fogleman JC, 1989, LIPIDS, V21, P92; FOSTER JLM, 1993, APPL ENVIRON MICROB, V59, P1; Heed WB, 1986, GENETICS BIOL DROS E, V3e, P311; Ishak HD, 2011, BACTERIAL DIVERSITY; Jaenike J, 2010, SCIENCE, V329, P212, DOI 10.1126/science.1188235; Jimenez-Sierra C, 2004, CACTACEAS SUCULENTAS, V49, P96; Kinoshita K, 2000, J NAT PROD, V63, P701, DOI 10.1021/np9903907; LATORRE A, 1986, P NATL ACAD SCI USA, V83, P8649, DOI 10.1073/pnas.83.22.8649; Lauzon CR, 1998, ENVIRON ENTOMOL, V27, P853, DOI 10.1093/ee/27.4.853; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lindh JM, 2011, ANTON LEEUW INT J G, V99, P711, DOI 10.1007/s10482-010-9546-x; Lindh JM, 2005, APPL ENVIRON MICROB, V71, P72; Marcos-Garcia M, 2001, EUR J ENTOMOL, V98, P375, DOI 10.14411/eje.2001.058; Marcos-Garcia MA, 2002, ANN ENTOMOL SOC AM, V95, P432, DOI 10.1603/0013-8746(2002)095[0432:LCAAIS]2.0.CO;2; Martinez-Falcon AP, 2010, ECOL ENTOMOL, V35, P754, DOI 10.1111/j.1365-2311.2010.01236.x; Martinez-Falcon AP, 2011, ECOL RES, V26, P341, DOI 10.1007/s11284-010-0788-x; Martinez-Falcon AP, 2008, ENTOMOLOGIA MEXICANA, V7, P176; Oksanen J., 2008, VEGAN COMMUNITY ECOL; R Development Core Team R, 2009, R LANG ENV STAT COMP; Rotheray GE, 2007, ZOOL J LINN SOC-LOND, V150, P267, DOI 10.1111/j.1096-3642.2007.00288.x; Rotheray GE, 2009, ZOOL J LINN SOC-LOND, V156, P697, DOI 10.1111/j.1096-3642.2008.00503.x; Sacchetti P, 2008, J APPL ENTOMOL, V132, P682, DOI 10.1111/j.1439-0418.2008.01334.x; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; STARMER WT, 1982, EVOL BIOL, V14, P269; THOMPSON F C, 1972, Arquivos de Zoologia (Sao Paulo), V23, P73; Toth EM, 2006, MICROB ECOL, V51, P13, DOI 10.1007/s00248-005-0090-6; Zahner V, 2008, CURR MICROBIOL, V57, P564, DOI 10.1007/s00284-008-9243-4	41	9	11	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e27443	10.1371/journal.pone.0027443	http://dx.doi.org/10.1371/journal.pone.0027443			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132101	Green Published, Green Submitted, gold			2022-12-27	WOS:000298162000019
J	Frezzetti, D; Reale, C; Cali, G; Nitsch, L; Fagman, H; Nilsson, O; Scarfo, M; De Vita, G; Di Lauro, R				Frezzetti, Daniela; Reale, Carla; Cali, Gaetano; Nitsch, Lucio; Fagman, Henrik; Nilsson, Ola; Scarfo, Marzia; De Vita, Gabriella; Di Lauro, Roberto			The microRNA-Processing Enzyme Dicer Is Essential for Thyroid Function	PLOS ONE			English	Article							MORPHOGENESIS; DELETION; BIOGENESIS; GENE; TRANSCRIPTION; MECHANISMS; EXPRESSION; DISEASE; MIR-21; TTF-1	Dicer is a type III ribonuclease required for the biogenesis of microRNAs (miRNAs), a class of small non-coding RNAs regulating gene expression at the post-transcriptional level. To explore the functional role of miRNAs in thyroid gland function, we generated a thyrocyte-specific Dicer conditional knockout mouse. Here we show that development and early differentiation of the thyroid gland are not affected by the absence of Dicer, while severe hypothyroidism gradually develops after birth, leading to reduced body weight and shortened life span. Histological and molecular characterization of knockout mice reveals a dramatic loss of the thyroid gland follicular architecture associated with functional aberrations and down-regulation of several differentiation markers. The data presented in this study show for the first time that an intact miRNAs processing machinery is essential for thyroid physiology, suggesting that deregulation of specific miRNAs could be also involved in human thyroid dysfunctions.	[Frezzetti, Daniela; Reale, Carla; Scarfo, Marzia] IRGS Biogem Scarl, Ariano Irpino, Italy; [Frezzetti, Daniela; Nitsch, Lucio; De Vita, Gabriella; Di Lauro, Roberto] Univ Naples Federico 2, Dipartimento Biol & Patol Cellulare & Mol, Naples, Italy; [Cali, Gaetano] Ist Endocrinol & Oncol Sperimentale CNR, Naples, Italy; [Fagman, Henrik; Nilsson, Ola] Univ Gothenburg, Sahlgrenska Canc Ctr, Sahlgrenska Acad, Gothenburg, Sweden; [Fagman, Henrik; Nilsson, Ola] Univ Gothenburg, Dept Pathol, Sahlgrenska Acad, Gothenburg, Sweden	University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); University of Gothenburg; University of Gothenburg	Frezzetti, D (corresponding author), IRGS Biogem Scarl, Ariano Irpino, Italy.	gdevita@unina.it; rdilauro@unina.it	De Vita, Gabriella/H-4422-2011; Reale, Carla/AAB-7939-2020; Frezzetti, Daniela/AAI-2410-2019; Di Lauro, Roberto/A-2746-2012	De Vita, Gabriella/0000-0002-7302-1174; Reale, Carla/0000-0001-7682-4784; Frezzetti, Daniela/0000-0002-7500-5506; Di Lauro, Roberto/0000-0001-9493-3036; Fagman, Henrik/0000-0001-5853-6295	EU [LSHG-CT-2006-037900]; Associazione Italiana per la Ricerca sul Cancro (AIRC) [IG 9471-2009]; Assar Gabrielssons Foundation; Magnus Bergvalls Foundation	EU(European Commission); Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Assar Gabrielssons Foundation; Magnus Bergvalls Foundation	This work was supported by EU-Project-SIROCCO (URL: http://cordis.europa.eu/fp6/dc/index.cfm), Grant LSHG-CT-2006-037900, and by Associazione Italiana per la Ricerca sul Cancro (AIRC, URL: https://www.direzionescientifica.airc.it), grant IG 9471-2009. HF was supported by the Assar Gabrielssons and Magnus Bergvalls Foundations. Funders supported fellowships costs and consumable costs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amendola E, 2005, ENDOCRINOLOGY, V146, P5038, DOI 10.1210/en.2005-0882; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Bouchard M, 2004, GENESIS, V38, P105, DOI 10.1002/gene.20008; Braun J, 2010, ONCOGENE, V29, P4237, DOI 10.1038/onc.2010.169; Cali G, 2007, ENDOCRINOLOGY, V148, P2737, DOI 10.1210/en.2006-1344; Chen JF, 2008, P NATL ACAD SCI USA, V105, P2111, DOI 10.1073/pnas.0710228105; Davis TH, 2008, J NEUROSCI, V28, P4322, DOI 10.1523/JNEUROSCI.4815-07.2008; De Felice M, 2004, ENDOCR REV, V25, P722, DOI 10.1210/er.2003-0028; Di Palma T, 2003, J BIOL CHEM, V278, P3395, DOI 10.1074/jbc.M205977200; Fagman H, 2010, MOL CELL ENDOCRINOL, V323, P35, DOI 10.1016/j.mce.2009.12.008; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Frezzetti D, 2011, ONCOGENE, V30, P275, DOI 10.1038/onc.2010.416; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; Harris KS, 2006, P NATL ACAD SCI USA, V103, P2208, DOI 10.1073/pnas.0510839103; Harvey SJ, 2008, J AM SOC NEPHROL, V19, P2150, DOI 10.1681/ASN.2008020233; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Ho J, 2008, J AM SOC NEPHROL, V19, P2069, DOI 10.1681/ASN.2008020162; Kawase-Koga Y, 2009, DEV DYNAM, V238, P2800, DOI 10.1002/dvdy.22109; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; LAZZARO D, 1991, DEVELOPMENT, V113, P1093; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Martello G, 2010, CELL, V141, P1195, DOI 10.1016/j.cell.2010.05.017; Missero C, 2000, MOL CELL BIOL, V20, P2783, DOI 10.1128/MCB.20.8.2783-2793.2000; Morita S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004212; Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102; Sekine S, 2009, J PATHOL, V219, P365, DOI 10.1002/path.2606; Shi SL, 2008, J AM SOC NEPHROL, V19, P2159, DOI 10.1681/ASN.2008030312; Talotta F, 2009, ONCOGENE, V28, P73, DOI 10.1038/onc.2008.370; Zhang L, 2010, STEM CELLS, V28, P1260, DOI 10.1002/stem.455	33	45	45	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2011	6	11							e27648	10.1371/journal.pone.0027648	http://dx.doi.org/10.1371/journal.pone.0027648			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IO	22132122	Green Submitted, gold, Green Published			2022-12-27	WOS:000297789900015
J	Van der Veer, T; Frings-Dresen, MHW; Sluiter, JK				Van der Veer, Tjeerd; Frings-Dresen, Monique H. W.; Sluiter, Judith K.			Health Behaviors, Care Needs and Attitudes towards Self-Prescription: A Cross-Sectional Survey among Dutch Medical Students	PLOS ONE			English	Article							ALCOHOL-CONSUMPTION; PHYSICAL-ACTIVITY; PREVALENCE; SEEKING; HABITS; DOCTORS; RESIDENTS; SMOKING; OBESITY; TOBACCO	Purpose: There is a growing awareness of the potent ways in which the wellbeing of physicians impacts the health of their patients. The purpose of this study was to investigate the health behaviors, care needs and attitudes towards self-prescription of Dutch medical students, and any differences between junior preclinical and senior clinically active students. Methods: All students (n = 2695) of a major Dutch medical school were invited for an online survey. Physical activity, eating habits, alcohol consumption, smoking, Body Mass Index, substance use and amount of sleep per night were inquired, as well as their need for different forms of care and their attitude towards self-prescription. Results: Data of 902 students were used. Physical activity levels (90% sufficient) and smoking prevalence (94% non-smokers) were satisfying. Healthy eating habits (51% insufficient) and alcohol consumption (46% excessive) were worrying. Body Mass Indexes were acceptable (20% unhealthy). We found no significant differences in health behaviors between preclinical and clinically active students. Care needs were significantly lower among clinically active students. (p<0.05) Student acceptance of self-prescription was significantly higher among clinically active students. (p<0.001) Conclusions: Unhealthy behaviors are prevalent among medical students, but are no more prevalent during the clinical study phase. The need for specific forms of care appears lower with study progression. This could be worrying as the acceptance of self-care and self-prescription is higher among senior clinical students. Medical faculties need to address students' unhealthy behaviors and meet their care needs for the benefit of both the future physicians as well as their patients.	[Van der Veer, Tjeerd; Frings-Dresen, Monique H. W.; Sluiter, Judith K.] Univ Amsterdam, Acad Med Ctr, Coronel Inst Occupat Hlth, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam	Van der Veer, T (corresponding author), Univ Amsterdam, Acad Med Ctr, Coronel Inst Occupat Hlth, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	j.sluiter@amc.nl	van der Veer, Tjeerd/N-8975-2019	van der Veer, Tjeerd/0000-0003-3085-603X				Ahmed I, 2009, J CRIT CARE, V24, DOI 10.1016/j.jcrc.2009.06.003; Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Angyan L., 2004, Acta Physiologica Hungarica, V91, P157, DOI 10.1556/APhysiol.91.2004.2.7; Barss P, 2008, MED TEACH, V30, pE196, DOI 10.1080/01421590802334267; Boo NY, 2010, SINGAP MED J, V51, P126; Brimstone R, 2007, MED EDUC, V41, P74, DOI 10.1111/j.1365-2929.2006.02649.x; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; Cape G, 2006, ADDICTION, V101, P841, DOI 10.1111/j.1360-0443.2006.01476.x; Cappuccio FP, 2010, SLEEP, V33, P585, DOI 10.1093/sleep/33.5.585; *CBS, 2010, PREV UNH BEH; Chew-Graham CA, 2003, MED EDUC, V37, P873, DOI 10.1046/j.1365-2923.2003.01627.x; Chourdakis M, 2010, APPETITE, V55, P722, DOI 10.1016/j.appet.2010.08.013; Compton MT, 2008, J NERV MENT DIS, V196, P891, DOI 10.1097/NMD.0b013e3181924d03; Davidson SK, 2003, MED J AUSTRALIA, V179, P302, DOI 10.5694/j.1326-5377.2003.tb05552.x; Duperly J, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-218; Dyrbye LN, 2006, ACAD MED, V81, P354, DOI 10.1097/00001888-200604000-00009; FerroLuzzi A, 1995, WHO TECH REP SER, V854, P1; FLAHERTY JA, 1993, PSYCHIAT CLIN N AM, V16, P189; Frank E, 2004, JAMA-J AM MED ASSOC, V291, P637, DOI 10.1001/jama.291.5.637; Frank E, 2000, ARCH FAM MED, V9, P287, DOI 10.1001/archfami.9.3.287; Frank E, 2006, AM J PREV MED, V31, P499, DOI 10.1016/j.amepre.2006.08.009; Frank E, 2010, CAN J PUBLIC HEALTH, V101, P390, DOI 10.1007/BF03404859; Frank E, 2009, PREV MED, V49, P233, DOI 10.1016/j.ypmed.2009.06.020; Frank E, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a2155; Gawlikowska-Sroka A, 2009, EUR J MED RES, V14, P86, DOI 10.1186/2047-783X-14-S4-86; Goebert D, 2009, ACAD MED, V84, P236, DOI 10.1097/ACM.0b013e31819391bb; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Hem E, 2005, BMC MED, V3, DOI 10.1186/1741-7015-3-16; Hooper C, 2005, MED EDUC, V39, P588, DOI 10.1111/j.1365-2929.2005.02175.x; Howe Michael, 2010, Prev Cardiol, V13, P180, DOI 10.1111/j.1751-7141.2010.00079.x; Keller S, 2007, ADDICT BEHAV, V32, P505, DOI 10.1016/j.addbeh.2006.05.017; Kumar P, 2000, J Indian Med Assoc, V98, P447; Lobelo F, 2009, BRIT J SPORT MED, V43, P89, DOI 10.1136/bjsm.2008.055426; Nguyen VH, 2008, ASIA-PAC J PUBLIC HE, V20, P16, DOI 10.1177/1010539507308504; Owens J A, 2001, Curr Opin Pulm Med, V7, P411, DOI 10.1097/00063198-200111000-00009; Ozasa K, 2005, MED EDUC, V39, P971, DOI 10.1111/j.1365-2929.2005.02251.x; Payne D, 2002, LANCET, V359, P1220, DOI 10.1016/S0140-6736(02)08264-8; Price Marilyn, 2007, Med Health R I, V90, P178; Richmond R, 2009, DRUG ALCOHOL REV, V28, P463, DOI 10.1111/j.1465-3362.2009.00115.x; Roberts LW, 2000, COMPR PSYCHIAT, V41, P303, DOI 10.1053/comp.2000.0410303; Roberts LW, 2000, ACAD MED, V75, P272, DOI 10.1097/00001888-200003000-00019; Roberts LW, 2001, COMPR PSYCHIAT, V42, P1, DOI 10.1053/comp.2001.19747; Rose AE, 2011, ACAD MED, V86, P1463, DOI 10.1097/ACM.0b013e3182312471; Single EW, 1995, CAN J PUBLIC HEALTH, V86, P402; Tanaka M, 2008, NUTRITION, V24, P985, DOI 10.1016/j.nut.2008.05.003	45	25	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2011	6	11							e28038	10.1371/journal.pone.0028038	http://dx.doi.org/10.1371/journal.pone.0028038			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	858IO	22132202	gold, Green Published, Green Submitted			2022-12-27	WOS:000297789900043
J	Folli, F; Okada, T; Perego, C; Gunton, J; Liew, CW; Akiyama, M; D'Amico, A; La Rosa, S; Placidi, C; Lupi, R; Marchetti, P; Sesti, G; Hellerstein, M; Perego, L; Kulkarni, RN				Folli, Franco; Okada, Terumasa; Perego, Carla; Gunton, Jenny; Liew, Chong Wee; Akiyama, Masaru; D'Amico, Anna; La Rosa, Stefano; Placidi, Claudia; Lupi, Roberto; Marchetti, Piero; Sesti, Giorgio; Hellerstein, Marc; Perego, Lucia; Kulkarni, Rohit N.			Altered Insulin Receptor Signalling and beta-Cell Cycle Dynamics in Type 2 Diabetes Mellitus	PLOS ONE			English	Article							HUMAN PANCREATIC-ISLETS; IN-VIVO; GENE-EXPRESSION; GROWTH-FACTOR; NUDE-MICE; APOPTOSIS; INHIBITORS; GLUCOSE; TRANSCRIPTION; REPLICATION	Insulin resistance, reduced beta-cell mass, and hyperglucagonemia are consistent features in type 2 diabetes mellitus (T2DM). We used pancreas and islets from humans with T2DM to examine the regulation of insulin signaling and cell-cycle control of islet cells. We observed reduced beta-cell mass and increased alpha-cell mass in the Type 2 diabetic pancreas. Confocal microscopy, real-time PCR and western blotting analyses revealed increased expression of PCNA and down-regulation of p27-Kip1 and altered expression of insulin receptors, insulin receptor substrate-2 and phosphorylated BAD. To investigate the mechanisms underlying these findings, we examined a mouse model of insulin resistance in beta-cells - which also exhibits reduced beta-cell mass, the beta-cell-specific insulin receptor knockout (beta IRKO). Freshly isolated islets and beta-cell lines derived from beta IRKO mice exhibited poor cell-cycle progression, nuclear restriction of FoxO1 and reduced expression of cell-cycle proteins favoring growth arrest. Re-expression of insulin receptors in beta IRKO beta-cells reversed the defects and promoted cell cycle progression and proliferation implying a role for insulin-signaling in beta-cell growth. These data provide evidence that human beta- and alpha-cells can enter the cell-cycle, but proliferation of beta-cells in T2DM fails due to G1-to-S phase arrest secondary to defective insulin signaling. Activation of insulin signaling, FoxO1 and proteins in beta-cell-cycle progression are attractive therapeutic targets to enhance beta-cell regeneration in the treatment of T2DM.	[Folli, Franco] Univ Texas Hlth Sci Ctr San Antonio, Div Diabet, Dept Med, San Antonio, TX 78229 USA; [Okada, Terumasa; Liew, Chong Wee; Akiyama, Masaru; Kulkarni, Rohit N.] Harvard Univ, Sch Med, Joslin Diabet Ctr, Div Res, Boston, MA 02115 USA; [Okada, Terumasa; Liew, Chong Wee; Akiyama, Masaru; Kulkarni, Rohit N.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Perego, Carla; D'Amico, Anna; Perego, Lucia] Univ Milan, Dept Mol Sci Appl Biosyst, Milan, Italy; [Gunton, Jenny] Garvan Inst Med Res, Sydney, NSW, Australia; [La Rosa, Stefano; Placidi, Claudia] Univ Insubria, Dept Pathol, Osped Circolo, Varese, Italy; [La Rosa, Stefano; Placidi, Claudia] Univ Insubria, Dept Human Morphol, Varese, Italy; [Lupi, Roberto; Marchetti, Piero] Univ Pisa, Div Endocrinol, Pisa, Italy; [Sesti, Giorgio] Magna Graecia Univ Catanzaro, Dept Clin & Expt Med, Catanzaro, Italy; [Hellerstein, Marc] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA	University of Texas System; University of Texas Health San Antonio; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School; University of Milan; Garvan Institute of Medical Research; Ospedale Circolo & Fondazione Macchi; University of Insubria; University of Insubria; University of Pisa; Magna Graecia University of Catanzaro; University of California System; University of California Berkeley	Folli, F (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Div Diabet, Dept Med, San Antonio, TX 78229 USA.	folli@uthscsa.edu; Rohit.Kulkarni@joslin.harvard.edu	Marchetti, Piero/J-7439-2013; folli, franco/J-2795-2018; Gunton, Jenny/E-1561-2012; Perego, Carla/L-6147-2015; Sesti, Giorgio/B-1509-2012; Gunton, Jenny E/AAH-7719-2021	Marchetti, Piero/0000-0003-4907-0635; folli, franco/0000-0001-9824-5222; Perego, Carla/0000-0003-3027-1779; Sesti, Giorgio/0000-0002-1618-7688; Liew, Chong Wee/0000-0001-9904-0958	National Institutes of Health (NIH) [RO1 67536, 1-K99 DK090210-01]; National Health and Medical Research Council of Australia; Royal Australian College of Physicians; Ministero della Salute; MIUR; University of Milano, School of Medicine; Sunstar Fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067536, K99DK090210] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Royal Australian College of Physicians; Ministero della Salute(Ministry of Health, Italy); MIUR(Ministry of Education, Universities and Research (MIUR)); University of Milano, School of Medicine; Sunstar Fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by grants from the National Institutes of Health (NIH) RO1 67536 (RNK). JG was supported by a C.J. Martin Fellowship from the National Health and Medical Research Council of Australia and Royal Australian College of Physicians Servier Award. FF was supported by Ministero della Salute and MIUR. LP was supported by a postdoctoral fellowship from the University of Milano, School of Medicine. CWL was supported by NIH 1-K99 DK090210-01, and MA is supported by a Sunstar Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accili D, 2004, DIABETES, V53, P1633, DOI 10.2337/diabetes.53.7.1633; Anello M, 2005, DIABETOLOGIA, V48, P282, DOI 10.1007/s00125-004-1627-9; Arden KC, 2004, MOL CELL, V14, P416, DOI 10.1016/S1097-2765(04)00213-8; Assmann A, 2009, PEDIATR DIABETES, V10, P14, DOI 10.1111/j.1399-5448.2008.00468.x; Assmann A, 2009, MOL CELL BIOL, V29, P3219, DOI 10.1128/MCB.01489-08; Bonner-Weir S, 2000, J MOL ENDOCRINOL, V24, P297, DOI 10.1677/jme.0.0240297; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Chavez AO, 2008, DIABETES, V57, P899, DOI 10.2337/db07-0790; Coqueret O, 2003, TRENDS CELL BIOL, V13, P65, DOI 10.1016/S0962-8924(02)00043-0; Cozar-Castellano I, 2005, P NATL ACAD SCI USA, V102, P7781, DOI 10.1073/pnas.0503261102; Cozar-Castellano I, 2006, ENDOCR REV, V27, P356, DOI 10.1210/er.2006-0004; Dahl U, 1996, DEVELOPMENT, V122, P2895; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Davalli AM, 2008, CELL TRANSPLANT, V17, P1323, DOI 10.3727/096368908787648137; DeFronzo RA, 2004, MED CLIN N AM, V88, P787, DOI 10.1016/j.mcna.2004.04.013; Del Guerra S, 2005, DIABETES, V54, P727, DOI 10.2337/diabetes.54.3.727; Deng SP, 2004, DIABETES, V53, P624, DOI 10.2337/diabetes.53.3.624; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Drexler HCA, 2003, CELL CYCLE, V2, P438, DOI 10.4161/cc.2.5.461; Federici M, 2001, DIABETES, V50, P1290, DOI 10.2337/diabetes.50.6.1290; Finzi G, 2005, ULTRASTRUCT PATHOL, V29, P525, DOI 10.1080/01913120500323563; Fox JT, 2011, FEBS LETT, V585, P2780, DOI 10.1016/j.febslet.2011.05.053; Furukawa-Hibi Y, 2005, ANTIOXID REDOX SIGN, V7, P752, DOI 10.1089/ars.2005.7.752; Georgia S, 2004, J CLIN INVEST, V114, P963, DOI 10.1172/JCI200422098; Gershengorn MC, 2004, SCIENCE, V306, P2261, DOI 10.1126/science.1101968; Guardado-Mendoza R, 2009, P NATL ACAD SCI USA, V106, P13992, DOI 10.1073/pnas.0906471106; Gunton JE, 2005, CELL, V122, P337, DOI 10.1016/j.cell.2005.05.027; Hori Y, 2002, P NATL ACAD SCI USA, V99, P16105, DOI 10.1073/pnas.252618999; Hribal ML, 2003, FASEB J; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661; Kawamori D, 2009, CELL METAB, V9, P350, DOI 10.1016/j.cmet.2009.02.007; Kitamura T, 2002, J CLIN INVEST, V110, P1839, DOI 10.1172/JCI200216857; KLOPPEL G, 1985, SURV SYN PATHOL RES, V4, P110; Kulkarni RN, 2005, REV ENDOCR METAB DIS, V6, P199, DOI 10.1007/s11154-005-3051-y; Kulkarni RN, 2004, J CLIN INVEST, V114, P828, DOI 10.1172/JCI200421845; Kulkarni RN, 1999, CELL, V96, P329, DOI 10.1016/S0092-8674(00)80546-2; Kulkarni RN, 1999, J CLIN INVEST, V104, pR69, DOI 10.1172/JCI8339; Kushner JA, 2005, MOL CELL BIOL, V25, P3752, DOI 10.1128/MCB.25.9.3752-3762.2005; Lechner A, 2005, BIOCHEM BIOPH RES CO, V327, P581, DOI 10.1016/j.bbrc.2004.12.043; Leibiger B, 2001, MOL CELL, V7, P559, DOI 10.1016/S1097-2765(01)00203-9; Ling C, 2009, DIABETES, V58, P2718, DOI 10.2337/db09-1003; Liu SM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007983; Lupi R, 2006, EUR J ENDOCRINOL, V154, P355, DOI 10.1530/eje.1.02086; Maga G, 2003, J CELL SCI, V116, P3051, DOI 10.1242/jcs.00653; Marselli L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011499; Muller D, 2007, DIABETOLOGIA, V50, P1239, DOI 10.1007/s00125-007-0671-7; Neese RA, 2002, P NATL ACAD SCI USA, V99, P15345, DOI 10.1073/pnas.232551499; Otani K, 2004, AM J PHYSIOL-ENDOC M, V286, pE41, DOI 10.1152/ajpendo.00533.2001; Petersen KF, 2006, AM J MED, V119, p10S, DOI 10.1016/j.amjmed.2006.01.009; Porzio O, 1999, J CLIN INVEST, V104, P357, DOI 10.1172/JCI5870; Rane SG, 1999, NAT GENET, V22, P44, DOI 10.1038/8751; Rhodes CJ, 2000, J MOL ENDOCRINOL, V24, P303, DOI 10.1677/jme.0.0240303; Ritzel RA, 2003, DIABETES, V52, P1701, DOI 10.2337/diabetes.52.7.1701; SADOWSKI HB, 1993, NATURE, V362, P79, DOI 10.1038/362079a0; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Sesti G, 2002, ANN MED, V34, P444, DOI 10.1080/078538902321012397; UNGER RH, 1981, NEW ENGL J MED, V304, P1575, DOI 10.1056/NEJM198106253042604; Unger RH, 2002, ANNU REV MED, V53, P319, DOI 10.1146/annurev.med.53.082901.104057; Yoon KH, 2003, J CLIN ENDOCR METAB, V88, P2300, DOI 10.1210/jc.2002-020735	59	61	64	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e28050	10.1371/journal.pone.0028050	http://dx.doi.org/10.1371/journal.pone.0028050			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140505	Green Published, Green Submitted, gold			2022-12-27	WOS:000298168100032
J	Veljkovic, M; Dopsaj, V; Dopsaj, M; Branch, DR; Veljkovic, N; Sakarellos-Daitsiotis, MM; Veljkovic, V; Glisic, S; Colombatti, A				Veljkovic, Milena; Dopsaj, Violeta; Dopsaj, Milivoj; Branch, Donald R.; Veljkovic, Nevena; Sakarellos-Daitsiotis, Maria M.; Veljkovic, Veljko; Glisic, Sanja; Colombatti, Alfonso			Physical Activity and Natural Anti-VIP Antibodies: Potential Role in Breast and Prostate Cancer Therapy	PLOS ONE			English	Article							VASOACTIVE-INTESTINAL-PEPTIDE; HORMONE-RELEASING HORMONE; POLYPEPTIDE VIP; NEUROENDOCRINE DIFFERENTIATION; MOLECULAR-IDENTIFICATION; PLASMA-CONCENTRATIONS; RECEPTOR ANTAGONISTS; HUMAN AUTOANTIBODY; MUSCULAR EXERCISE; PROLONGED STRAIN	Background: There is convincing evidence from numerous clinical and epidemiological studies that physical activity can reduce the risk for breast and prostate cancer. The biological mechanisms underlying this phenomenon remain elusive. Herein we suggest a role for naturally produced antibodies reactive with the vasoactive intestinal peptide (VIP) in the suppression of breast and prostate cancer, which we believe could offer a possible molecular mechanism underlying control of these cancers by physical exercise. Methodology and Results: We found that sera from individuals having breast and prostate cancers have decreased titers of VIP natural antibodies as demonstrated by a lower reactivity against peptide NTM1, having similar informational and structural properties as VIP. In contrast, sera collected from elite athletes, exhibited titers of natural NTM1-reactive antibodies that are significantly increased, suggesting that physical activity boosts production of these antibodies. Significance: Presented results suggest that physical exercise stimulates production of natural anti-VIP antibodies and likely results in suppression of VIP. This, in turn, may play a protective role against breast and prostate cancers. Physical exercise should be further investigated as a potential tool in the treatment of these diseases.	[Veljkovic, Milena] Sveti Sava Hosp, Belgrade, Serbia; [Dopsaj, Violeta] Clin Ctr Serbia, Inst Med Biochem, Belgrade, Serbia; [Dopsaj, Milivoj] Univ Belgrade, Fac Sport & Phys Educ, Belgrade, Serbia; [Branch, Donald R.] Canadian Blood Serv, Toronto, ON, Canada; [Veljkovic, Nevena; Veljkovic, Veljko; Glisic, Sanja] Inst Nucl Sci VINCA, Ctr Multidisciplinary Res, Belgrade, Serbia; [Sakarellos-Daitsiotis, Maria M.] Univ Ioannina, Dept Chem, Sect Organ Chem & Biochem, GR-45110 Ioannina, Greece; [Colombatti, Alfonso] Ctr Riferimento Oncol CRO IRCCS, Div Oncol Sperimentale, Aviano, Italy	Clinical Centre of Serbia; University of Belgrade; Canadian Blood Services; University of Belgrade; University of Ioannina; IRCCS Aviano (CRO)	Veljkovic, M (corresponding author), Sveti Sava Hosp, Belgrade, Serbia.	vv@vinca.rs	Dopsaj, Milivoj/P-4237-2019; Glisic, Sanja/AAE-8590-2019	Glisic, Sanja/0000-0001-5691-1055; colombatti, alfonso/0000-0002-3676-2379; Dopsaj, Milivoj/0000-0001-7153-2993; Veljkovic, Nevena/0000-0001-6562-5800	Ministry of Science and Technological Development of the Republic of Serbia [173001]	Ministry of Science and Technological Development of the Republic of Serbia(Ministry of Education, Science & Technological Development, Serbia)	This work was supported by the Ministry of Science and Technological Development of the Republic of Serbia (Grant no. 173001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOMPA TO, 2005, PERIODIZATION TRAINI, pR9; Collado B, 2006, MOL CELL ENDOCRINOL, V249, P116, DOI 10.1016/j.mce.2006.02.004; Collado B, 2004, REGUL PEPTIDES, V119, P69, DOI 10.1016/j.regpep.2004.01.013; Collado B, 2007, PEPTIDES, V28, P1896, DOI 10.1016/j.peptides.2007.04.015; Dagar S, 2001, BREAST CANCER RES TR, V65, P49, DOI 10.1023/A:1006406617497; Djordjevic A, 2007, CURR HIV RES, V5, P443, DOI 10.2174/157016207781662470; Fernandez-Martinez AB, 2010, CANCER LETT, V299, P11, DOI 10.1016/j.canlet.2010.07.019; Fernandez-Martinez AB, 2009, PROSTATE, V69, P774, DOI 10.1002/pros.20930; FRIEDENREICH CM, 2010, PHYS ACTIVITY BREAST, V188, P125; FRISCH RE, 1987, INT J FERTIL, V32, P217; FRISCH RE, 1992, ADV EXP MED BIOL, V322, P29; GALBO H, 1979, ACTA PHYSIOL SCAND, V105, P374, DOI 10.1111/j.1748-1716.1979.tb06353.x; Garcia-Fernandez MO, 2005, GYNECOL ENDOCRINOL, V20, P327, DOI 10.1080/09513590500098240; GESPACH C, 1988, BIOCHEM BIOPH RES CO, V151, P939, DOI 10.1016/S0006-291X(88)80372-3; GESPACH C, 1988, CANCER RES, V48, P5079; Gkonos PJ, 1996, REGUL PEPTIDES, V65, P153, DOI 10.1016/0167-0115(96)00086-9; Gutierrez-Canas I, 2005, PROSTATE, V63, P44, DOI 10.1002/pros.20173; IBRAHIM EM, 2010, MED ONCOLOGY; Irwin ML, 2008, J CLIN ONCOL, V26, P3958, DOI 10.1200/JCO.2007.15.9822; Kenfield SA, 2011, J CLIN ONCOL, V29, P726, DOI 10.1200/JCO.2010.31.5226; Leitzmann MF, 2011, RECENT RESULTS CANC, V186, P43, DOI 10.1007/978-3-642-04231-7_3; MACLAREN DP, 1995, CLIN SCI, V89, P137, DOI 10.1042/cs0890137; Madsen B, 2000, ANN NY ACAD SCI, V921, P33; McTiernan A, 2010, J CLIN ONCOL, V28, P4074, DOI 10.1200/JCO.2010.27.9752; MEI S, 1991, J BIOL CHEM, V266, P15571; Moody TW, 2007, PEPTIDES, V28, P1883, DOI 10.1016/j.peptides.2007.04.017; Moody TW, 2007, CURR PHARM DESIGN, V13, P1099, DOI 10.2174/138161207780619000; Moody TW, 2006, ANN NY ACAD SCI, V1070, P436, DOI 10.1196/annals.1317.058; Moody TW, 2003, PEPTIDES, V24, P163, DOI 10.1016/S0196-9781(02)00290-5; Moody TW, 2004, LIFE SCI, V74, P1345, DOI 10.1016/j.lfs.2003.07.043; Moody TW, 2002, LIFE SCI, V71, P1005, DOI 10.1016/S0024-3205(02)01741-1; Moody TW, 2001, BREAST CANCER RES TR, V68, P55, DOI 10.1023/A:1017994722130; Moody TW, 1998, ANN NY ACAD SCI, V865, P290, DOI 10.1111/j.1749-6632.1998.tb11189.x; Nagakawa O, 2005, ONCOL REP, V13, P1217; OEKTEDALEN O, 1983, REGUL PEPTIDES, V5, P235, DOI 10.1016/0167-0115(83)90254-9; OKTEDALEN O, 1983, SCAND J GASTROENTERO, V18, P1057, DOI 10.3109/00365528309181840; OKTEDALEN O, 1983, EUR J APPL PHYSIOL O, V52, P5, DOI 10.1007/BF00429017; OPSTAD PK, 1987, PEPTIDES, V8, P175, DOI 10.1016/0196-9781(87)90183-5; PAUL S, 1991, J BIOL CHEM, V266, P16128; PAUL S, 1985, BIOCHEM BIOPH RES CO, V130, P479, DOI 10.1016/0006-291X(85)90442-5; PAUL S, 1989, SCIENCE, V244, P1158, DOI 10.1126/science.2727702; PAUL S, 1988, LIFE SCI, V43, P1079, DOI 10.1016/0024-3205(88)90203-2; PAUL S, 1990, J BIOL CHEM, V265, P11910; Plonowski A, 2002, INT J CANCER, V98, P624, DOI 10.1002/ijc.10221; Rekasi Z, 2001, PROSTATE, V48, P188, DOI 10.1002/pros.1097; Richman EL, 2011, CANC RES; Sotomayor S, 2007, INT J ONCOL, V31, P1223; Torti DC, 2004, SPORTS MED, V34, P363, DOI 10.2165/00007256-200434060-00003; VALDEHITA A, 2011, MOL CELLULAR ENDOCRI; Valdehita A, 2007, REGUL PEPTIDES, V144, P101, DOI 10.1016/j.regpep.2007.06.006; Valdehita A, 2010, PEPTIDES, V31, P2035, DOI 10.1016/j.peptides.2010.07.024; Valdehita A, 2009, MOL CELL ENDOCRINOL, V302, P41, DOI 10.1016/j.mce.2008.11.024; Veljkovic M, 2010, SCAND J MED SCI SPOR, V20, P469, DOI 10.1111/j.1600-0838.2009.00962.x; Veljkovic N, 2003, J PEPT RES, V62, P158, DOI 10.1034/j.1399-3011.2003.00081.x; Veljkovic V, 2004, INT REV IMMUNOL, V23, P383, DOI 10.1080/08830180490432749; VELJKOVIC V, 1993, BIOCHEM BIOPH RES CO, V196, P1019, DOI 10.1006/bbrc.1993.2353; VELJKOVIC V, 1992, BIOCHEM BIOPH RES CO, V189, P705, DOI 10.1016/0006-291X(92)92258-Y; WOIE L, 1986, GEN PHARMACOL, V17, P321, DOI 10.1016/0306-3623(86)90047-9; Wyshak G, 2000, BRIT J CANCER, V82, P726; Zia H, 1996, CANCER RES, V56, P3486	60	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e28304	10.1371/journal.pone.0028304	http://dx.doi.org/10.1371/journal.pone.0028304			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140573	Green Published, gold, Green Submitted			2022-12-27	WOS:000298168100062
J	Nasser, KM; Obiols, AQ; Silverman, SL				Nasser, Keaton M.; Obiols, Alejandro Quinonez; Silverman, Stuart L.			Identifying Individuals at Risk for Fracture in Guatemala	PLOS ONE			English	Article								Introduction: The FRAX calculator combines a set of clinical risk factors with country-specific incidence rates to determine the ten-year absolute risk of major osteoporotic fracture. However, regional or country-specific databases from Central American countries are not available. We compared the use of various FRAX databases and the Pluijm algorithm in determining risk of fracture. Methods: We collected clinical risk factor data needed for the FRAX calculator and Pluijm algorithm of Hispanic women in Guatemala and calculated the FRAX absolute risk measures of major osteoporotic fracture and hip fracture. Subjects were postmenopausal women greater than age 40 with no history of using medication that affect bone. A random sample of 204 women in 34 different regions women in Guatemala City was visited in their homes to complete the surveys. The Pluijm risk score and FRAX risk score using the US Hispanic, Spain, and Mexican databases were calculated. Results: We used the US NOF guidelines for treatment which suggest a treatment threshold for patients with a 10-year hip fracture probability >= 3% or a 10-year major osteoporotic fracture risk >= 20%. The number of patients meeting the suggested threshold limits for treatment using the Spain and Mexico calculators were identical. There was 100% conformity in threshold limits for both hip and major osteoporotic fracture risk. The mean conformity for any fracture risk between US Hispanic and the other two databases was 97.5%. Conformity was 99.0% based on major osteoporotic fracture and 97.5% based on risk of hip fracture. The Pluijm evaluation shows conformity of 87.2% and 83.3%, respectively, when compared to the US Hispanic and Spain/Mexico FRAX thresholds for risk of fracture. Discussion: Although the different FRAX databases provide variations in the absolute risk of fracture, the overall conformity to treatment thresholds amongst the US Hispanic, Spain, and Mexico databases show the database used would have little effect as to the decision to treat. The Pluijm tool conforms to the FRAX thresholds and can be used as well. It does not matter which country-specific calculator or assessment tool is used, as there are a similar number of patients that would meet the intervention threshold.	[Nasser, Keaton M.] Osteoporosis Med Ctr, Beverly Hills, CA 90211 USA; [Obiols, Alejandro Quinonez] Univ Mariano Galvez Guatemala, Guatemala City, Guatemala; [Silverman, Stuart L.] Cedars Sinai UCLA, Los Angeles, CA USA	Cedars Sinai Medical Center	Nasser, KM (corresponding author), Osteoporosis Med Ctr, Beverly Hills, CA 90211 USA.	keatonn@omcresearch.org		Nasser, Keaton/0000-0003-3133-6028	Procter Gamble; Eli Lilly and Co.; Alliance for Better Bone Health	Procter Gamble(Procter & Gamble); Eli Lilly and Co.(Eli Lilly); Alliance for Better Bone Health	Funding for this study was provided by Procter & Gamble. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Dr. Stuart Silverman has received grants from Eli Lilly and Co. and Alliance for Better Bone Health. He has received honoraria from Eli Lilly, Roche Pharmaceuticals, and Pfizer, and he has consulted for Warner Chilcott, Roche Pharmaceuticals, Roche Diagnostics, Novartis, Pfizer, and Eli Lilly and Co. Funding for this study was provided by Procter & Gamble. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Kanis JA, 2002, J BONE MINER RES, V17, P1237, DOI 10.1359/jbmr.2002.17.7.1237; National Osteoporosis Foundation, 2013, CLIN GUID PREV TREAT; Pluijm SMF, 2009, J BONE MINER RES, V24, P768, DOI [10.1359/JBMR.081244, 10.1359/jbmr.081244]; Quinonez A, 2010, J CLIN RHEUM S, V16; Silverman Stuart L, 2010, Curr Osteoporos Rep, V8, P192, DOI 10.1007/s11914-010-0032-1; [No title captured]	6	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2011	6	11							e28042	10.1371/journal.pone.0028042	http://dx.doi.org/10.1371/journal.pone.0028042			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863LT	22140503	gold, Green Published, Green Submitted			2022-12-27	WOS:000298166300023
J	Seaver, LH; He, XY; Abe, K; Cowan, T; Enns, GM; Sweetman, L; Philipp, M; Lee, S; Malik, M; Yang, SY				Seaver, Laurie H.; He, Xue-Ying; Abe, Keith; Cowan, Tina; Enns, Gregory M.; Sweetman, Lawrence; Philipp, Manfred; Lee, Sansan; Malik, Mazhar; Yang, Song-Yu			A Novel Mutation in the HSD17B10 Gene of a 10-Year-Old Boy with Refractory Epilepsy, Choreoathetosis and Learning Disability	PLOS ONE			English	Article							2-METHYL-3-HYDROXYBUTYRYL-COA DEHYDROGENASE-DEFICIENCY; COENZYME-A DEHYDROGENASE; MENTAL-RETARDATION; ISOLEUCINE METABOLISM; ABNORMAL-BEHAVIOR; HUMAN HEALTH; 17-BETA-HYDROXYSTEROID-DEHYDROGENASE; DISEASE; ENZYME; HADH2	Hydroxysteroid (17beta) dehydrogenase 10 (HSD10) is a mitochondrial multifunctional enzyme encoded by the HSD17B10 gene. Missense mutations in this gene result in HSD10 deficiency, whereas a silent mutation results in mental retardation, X-linked, syndromic 10 (MRXS10). Here we report a novel missense mutation found in the HSD17B10 gene, namely c.194T>C transition (rs104886492), brought about by the loss of two forked methyl groups of valine 65 in the HSD10 active site. The affected boy, who possesses mutant HSD10 (p.V65A), has a neurological syndrome with metabolic derangements, choreoathetosis, refractory epilepsy and learning disability. He has no history of acute decompensation or metabolic acidosis whereas his urine organic acid profile, showing elevated levels of 2-methyl-3-hydroxybutyrate and tiglylglycine, is characteristic of HSD10 deficiency. His HSD10 activity was much lower than the normal control level, with normal beta-ketothiolase activity. The c.194T>C mutation in HSD17B10 can be identified by the restriction fragment polymorphism analysis, thereby facilitating the screening of this novel mutation in individuals with intellectual disability of unknown etiology and their family members much easier. The patient's mother is an asymptomatic carrier, and has a mixed ancestry (Hawaiian, Japanese and Chinese). This demonstrates that HSD10 deficiency patients are not confined to a particular ethnicity although previously reported cases were either Spanish or German descendants.	[Seaver, Laurie H.; Lee, Sansan] Kapiolani Med Specialists, Hawaii Community Genet, Honolulu, HI 96826 USA; [Seaver, Laurie H.; Abe, Keith] Univ Hawaii, John A Burns Sch Med, Dept Pediat, Honolulu, HI 96822 USA; [He, Xue-Ying; Malik, Mazhar; Yang, Song-Yu] New York State Inst Basic Res Dev Disabil, Dept Neurochem, New York, NY USA; [Cowan, Tina] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; [Enns, Gregory M.] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA; [Sweetman, Lawrence] Baylor Res Inst, Inst Metab Dis, Dallas, TX USA; [Philipp, Manfred] CUNY Herbert H Lehman Coll, Dept Chem, New York, NY USA	University of Hawaii System; Institute for Basic Research in Developmental Disabilities; Stanford University; Stanford University; Baylor Scott & White Health; Baylor University Medical Center; City University of New York (CUNY) System; Lehman College (CUNY)	Seaver, LH (corresponding author), Kapiolani Med Specialists, Hawaii Community Genet, Honolulu, HI 96826 USA.	songyu.yang@csi.cuny.edu	Philipp, Manfred/R-8940-2019	Philipp, Manfred/0000-0002-9010-9813	New York State Office for People With Developmental Disabilities	New York State Office for People With Developmental Disabilities	This study was partially supported by the New York State Office for People With Developmental Disabilities. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ensenauer R, 2002, ANN NEUROL, V51, P656, DOI 10.1002/ana.10169; Froyen G, 2008, AM J HUM GENET, V82, P432, DOI 10.1016/j.ajhg.2007.11.002; Garcia-Villoria J, 2005, PEDIATR RES, V58, P488, DOI 10.1203/01.pdr.0000176916.94328.cd; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; He XY, 2011, EUR J HUM GENET, V19, P123, DOI 10.1038/ejhg.2010.192; He XY, 2005, BRAIN RES, V1040, P29, DOI 10.1016/j.brainres.2005.01.022; He XY, 1999, J BIOL CHEM, V274, P15014, DOI 10.1074/jbc.274.21.15014; He XY, 2001, EUR J BIOCHEM, V268, P4899, DOI 10.1046/j.0014-2956.2001.02421.2421.x; He XY, 1998, J BIOL CHEM, V273, P10741, DOI 10.1074/jbc.273.17.10741; Holzmann J, 2008, CELL, V135, P462, DOI 10.1016/j.cell.2008.09.013; Kissinger CR, 2004, J MOL BIOL, V342, P943, DOI 10.1016/j.jmb.2004.07.071; Korman SH, 2005, CLIN CHEM, V51, P610, DOI 10.1373/clinchem.2004.043265; Korman SH, 2007, MOL GENET METAB, V91, P115, DOI 10.1016/j.ymgme.2007.01.001; Kristofikova Z, 2009, MOL BIOSYST, V5, P1174, DOI 10.1039/b904799a; Lenski C, 2007, AM J HUM GENET, V80, P372, DOI 10.1086/511527; LUO MJ, 1995, ARCH BIOCHEM BIOPHYS, V321, P214, DOI 10.1006/abbi.1995.1388; Ofman R, 2003, AM J HUM GENET, V72, P1300, DOI 10.1086/375116; Olpin SE, 2002, J INHERIT METAB DIS, V25, P477, DOI 10.1023/A:1021251202287; Poll-The BT, 2004, MOL GENET METAB, V81, P295, DOI 10.1016/j.ymgme.2003.11.013; Reyniers E, 1999, AM J HUM GENET, V65, P1406, DOI 10.1086/302638; Rodriguez R, 1998, BIOINFORMATICS, V14, P523, DOI 10.1093/bioinformatics/14.6.523; Sutton VR, 2003, J INHERIT METAB DIS, V26, P69, DOI 10.1023/A:1024083715568; Yang SY, 2007, MOL GENET METAB, V92, P36, DOI 10.1016/j.ymgme.2007.06.001; Yang SY, 2011, MOL CELL ENDOCRINOL, V343, P1, DOI 10.1016/j.mce.2011.06.011; Yang SY, 2009, P NATL ACAD SCI USA, V106, P14820, DOI 10.1073/pnas.0902377106; Yang SY, 2005, FEBS J, V272, P4874, DOI 10.1111/j.1742-4658.2005.04911.x; Yang SY, 2005, TRENDS ENDOCRIN MET, V16, P167, DOI 10.1016/j.tem.2005.03.006	27	19	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2011	6	11							e27348	10.1371/journal.pone.0027348	http://dx.doi.org/10.1371/journal.pone.0027348			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858JH	22132097	Green Published, gold			2022-12-27	WOS:000297792400006
J	Barreto, GE; Sun, XY; Xu, LJ; Giffard, RG				Barreto, George E.; Sun, Xiaoyun; Xu, Lijun; Giffard, Rona G.			Astrocyte Proliferation Following Stroke in the Mouse Depends on Distance from the Infarct	PLOS ONE			English	Article							FIBRILLARY ACIDIC PROTEIN; TRANSIENT CEREBRAL-ISCHEMIA; RAT-BRAIN; CNS INJURY; WALLERIAN DEGENERATION; REACTIVE ASTROCYTES; GLIAL REACTION; OLIGODENDROCYTES; ACTIVATION; CELLS	Reactive gliosis is a hallmark of brain pathology and the injury response, yet the extent to which astrocytes proliferate, and whether this is central to astrogliosis is still controversial. We determined the fraction of mature astrocytes that proliferate in a mouse stroke model using unbiased stereology as a function of distance from the infarct edge. Cumulatively 11.1+/-1.2% of Aldh1l1(+) astrocytes within 400 mu m in the cortical penumbra incorporate BrdU in the first week following stroke, while the overall number of astrocytes does not change. The number of astrocytes proliferating fell sharply with distance with more than half of all proliferating astrocytes found within 100 mu m of the edge of the infarct. Despite extensive cell proliferation primarily of microglia and neutrophils/monocytes in the week following stroke, few mature astrocytes re-enter cell cycle, and these are concentrated close to the infarct boundary.	[Barreto, George E.; Sun, Xiaoyun; Xu, Lijun; Giffard, Rona G.] Stanford Univ, Dept Anesthesia, Sch Med, Stanford, CA 94305 USA; [Barreto, George E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia	Stanford University; Pontificia Universidad Javeriana	Barreto, GE (corresponding author), Stanford Univ, Dept Anesthesia, Sch Med, Stanford, CA 94305 USA.	rona.giffard@stanford.edu	Barreto, George E./B-5747-2014; Barreto, George E./AAD-7420-2020	Barreto, George E./0000-0002-6644-1971; Barreto, George E./0000-0002-6644-1971; Giffard, Rona/0000-0003-2173-4436	National Institutes of Health (NIH) [RO1 GM49831]; Department of Anesthesia, Stanford University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049831] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Anesthesia, Stanford University(Stanford University); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health (NIH) grant RO1 GM49831 to RGG, and in part by support from the Department of Anesthesia, Stanford University. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alonso G, 2005, GLIA, V49, P318, DOI 10.1002/glia.20121; Broughton BRS, 2009, STROKE, V40, pE331, DOI 10.1161/STROKEAHA.108.531632; Buffo A, 2008, P NATL ACAD SCI USA, V105, P3581, DOI 10.1073/pnas.0709002105; Burns KA, 2009, GLIA, V57, P1115, DOI 10.1002/glia.20835; Bushong EA, 2002, J NEUROSCI, V22, P183, DOI 10.1523/JNEUROSCI.22-01-00183.2002; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; CAVANAGH JB, 1970, J ANAT, V106, P471; Dihne M, 2001, BRAIN RES, V902, P178, DOI 10.1016/S0006-8993(01)02378-2; Dingman A, 2006, J NEUROCHEM, V96, P1467, DOI 10.1111/j.1471-4159.2006.03672.x; Dziewulska D, 1997, FOLIA NEUROPATHOL, V35, P99; FERNAUDESPINOSA I, 1993, GLIA, V8, P277, DOI 10.1002/glia.440080408; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Hajos F., 1993, Neurobiology (Budapest), V1, P123; Halassa MM, 2007, J NEUROSCI, V27, P6473, DOI 10.1523/JNEUROSCI.1419-07.2007; Han RQ, 2009, ANESTH ANALG, V108, P280, DOI 10.1213/ane.0b013e318187ba6b; HATTEN ME, 1991, GLIA, V4, P233, DOI 10.1002/glia.440040215; JANECZKO K, 1988, BRAIN RES, V456, P280, DOI 10.1016/0006-8993(88)90229-6; JANECZKO K, 1989, BRAIN RES, V485, P236, DOI 10.1016/0006-8993(89)90566-0; LATOV N, 1979, DEV BIOL, V72, P381, DOI 10.1016/0012-1606(79)90127-1; LINDSAY RM, 1986, ASTROCYTES, P231; Liu Y, 2010, NEUROSCIENCE, V166, P241, DOI 10.1016/j.neuroscience.2009.12.026; LUDWIN SK, 1985, LAB INVEST, V52, P20; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; NORENBERG MD, 1994, J NEUROPATH EXP NEUR, V53, P213, DOI 10.1097/00005072-199405000-00001; Ogata K, 2002, NEUROSCIENCE, V113, P221, DOI 10.1016/S0306-4522(02)00041-6; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; PETITO CK, 1990, J CEREBR BLOOD F MET, V10, P850, DOI 10.1038/jcbfm.1990.141; Popa-Wagner A, 2007, ACTA NEUROPATHOL, V113, P277, DOI 10.1007/s00401-006-0164-7; Reier PJ, 1986, ASTROCYTES, V3, P263; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; SCHIFFER D, 1986, BRAIN RES, V374, P110, DOI 10.1016/0006-8993(86)90399-9; SCHIFFER D, 1993, INT J DEV NEUROSCI, V11, P269, DOI 10.1016/0736-5748(93)90085-R; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; VAUGHN JE, 1970, J COMP NEUROL, V140, P207, DOI 10.1002/cne.901400205	35	94	98	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2011	6	11							e27881	10.1371/journal.pone.0027881	http://dx.doi.org/10.1371/journal.pone.0027881			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IO	22132159	Green Submitted, gold, Green Published			2022-12-27	WOS:000297789900028
J	Riley, MC; Lee, JE; Lesho, E; Kirkup, BC				Riley, Matthew C.; Lee, James Eric; Lesho, Emil; Kirkup, Benjamin C., Jr.			Optically Mapping Multiple Bacterial Genomes Simultaneously in a Single Run	PLOS ONE			English	Article								Optical mapping of bacterial chromosomes provides an unambiguous low-resolution sequence scaffold of the entire chromosome. In comparison to some techniques, such as pulse field gel electrophoresis, cost and throughput limit the application of this technique outside of genome finishing. We have demonstrated the production of multiple bacterial maps using a single set of consumables; this significantly reduces the time and expense of map production.	[Riley, Matthew C.; Lee, James Eric; Lesho, Emil; Kirkup, Benjamin C., Jr.] Walter Reed Army Inst Res, Silver Spring, MD 20910 USA; [Riley, Matthew C.; Lesho, Emil; Kirkup, Benjamin C., Jr.] USA, Multidrug Resistant Organism Repository & Surveil, Silver Spring, MD USA; [Lesho, Emil; Kirkup, Benjamin C., Jr.] Uniformed Serv Univ Hlth Sci, Silver Spring, MD USA	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	Riley, MC (corresponding author), Walter Reed Army Inst Res, Silver Spring, MD 20910 USA.	bckirkup@post.harvard.edu	Kirkup, Benjamin/C-3610-2009	Kirkup, Benjamin/0000-0002-8722-6218	Department of Defense; Division of Bacterial and Rickettsial Diseases	Department of Defense(United States Department of Defense); Division of Bacterial and Rickettsial Diseases	This research was funded entirely by the Department of Defense. No current external funding sources for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge the assistance of the OpGen technical support staff, the support of our respective departments and the Division of Bacterial and Rickettsial Diseases. Disclaimer: The findings and opinions expressed herein belong to the authors and do not necessarily reflect the official views of the WRAIR, the U.S. Army or the Department of Defense.	Janda J. M., 2005, ENTEROBACTERIA; Latreille P, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-321; Nagarajan N, 2008, BIOINFORMATICS, V24, P1229, DOI 10.1093/bioinformatics/btn102; 2011, GENETIC ENG BIOTECHN, V31	4	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2011	6	11							e27085	10.1371/journal.pone.0027085	http://dx.doi.org/10.1371/journal.pone.0027085			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IO	22132087	gold, Green Published, Green Submitted			2022-12-27	WOS:000297789900009
J	Belevych, AE; Sansom, SE; Terentyeva, R; Ho, HT; Nishijima, Y; Martin, MM; Jindal, HK; Rochira, JA; Kunitomo, Y; Abdellatif, M; Carnes, CA; Elton, TS; Gyorke, S; Terentyev, D				Belevych, Andriy E.; Sansom, Sarah E.; Terentyeva, Radmila; Ho, Hsiang-Ting; Nishijima, Yoshinori; Martin, Mickey M.; Jindal, Hitesh K.; Rochira, Jennifer A.; Kunitomo, Yukiko; Abdellatif, Maha; Carnes, Cynthia A.; Elton, Terry S.; Gyoerke, Sandor; Terentyev, Dmitry			MicroRNA-1 and-133 Increase Arrhythmogenesis in Heart Failure by Dissociating Phosphatase Activity from RyR2 Complex	PLOS ONE			English	Article							RYANODINE RECEPTOR PHOSPHORYLATION; RETICULUM CA2+ LEAK; CARDIAC-HYPERTROPHY; MYOCARDIAL-INFARCTION; HUMAN CARDIOMYOPATHY; CALCIUM-RELEASE; DOWN-REGULATION; FAILING HEARTS; ARRHYTHMIAS; MODEL	In heart failure (HF), arrhythmogenic spontaneous sarcoplasmic reticulum (SR) Ca2+ release and afterdepolarizations in cardiac myocytes have been linked to abnormally high activity of ryanodine receptors (RyR2s) associated with enhanced phosphorylation of the channel. However, the specific molecular mechanisms underlying RyR2 hyperphosphorylation in HF remain poorly understood. The objective of the current study was to test the hypothesis that the enhanced expression of muscle-specific microRNAs (miRNAs) underlies the HF-related alterations in RyR2 phosphorylation in ventricular myocytes by targeting phosphatase activity localized to the RyR2. We studied hearts isolated from canines with chronic HF exhibiting increased left ventricular (LV) dimensions and decreased LV contractility. qRT-PCR revealed that the levels of miR-1 and miR-133, the most abundant muscle-specific miRNAs, were significantly increased in HF myocytes compared with controls (2- and 1.6-fold, respectively). Western blot analyses demonstrated that expression levels of the protein phosphatase 2A (PP2A) catalytic and regulatory subunits, which are putative targets of miR-133 and miR-1, were decreased in HF cells. PP2A catalytic subunit mRNAs were validated as targets of miR-133 by using luciferase reporter assays. Pharmacological inhibition of phosphatase activity increased the frequency of diastolic Ca2+ waves and afterdepolarizations in control myocytes. The decreased PP2A activity observed in HF was accompanied by enhanced Ca2+/calmodulin-dependent protein kinase (CaMKII)-mediated phosphorylation of RyR2 at sites Ser-2814 and Ser-2030 and increased frequency of diastolic Ca2+ waves and afterdepolarizations in HF myocytes compared with controls. In HF myocytes, CaMKII inhibitory peptide normalized the frequency of pro-arrhythmic spontaneous diastolic Ca2+ waves. These findings suggest that altered levels of major muscle-specific miRNAs contribute to abnormal RyR2 function in HF by depressing phosphatase activity localized to the channel, which in turn, leads to the excessive phosphorylation of RyR2s, abnormal Ca2+ cycling, and increased propensity to arrhythmogenesis.	[Belevych, Andriy E.; Sansom, Sarah E.; Ho, Hsiang-Ting; Nishijima, Yoshinori; Martin, Mickey M.; Carnes, Cynthia A.; Elton, Terry S.; Gyoerke, Sandor] Ohio State Univ, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; [Nishijima, Yoshinori; Carnes, Cynthia A.; Elton, Terry S.] Ohio State Univ, Coll Pharm, Div Pharmacol, Columbus, OH 43210 USA; [Belevych, Andriy E.; Ho, Hsiang-Ting; Nishijima, Yoshinori; Carnes, Cynthia A.; Elton, Terry S.; Gyoerke, Sandor] Ohio State Univ, Coll Med, Dept Med, Div Cardiol, Columbus, OH 43210 USA; [Belevych, Andriy E.; Ho, Hsiang-Ting; Nishijima, Yoshinori; Carnes, Cynthia A.; Gyoerke, Sandor] Ohio State Univ, Dept Physiol & Cell Biol, Columbus, OH 43210 USA; [Terentyeva, Radmila; Jindal, Hitesh K.; Rochira, Jennifer A.; Kunitomo, Yukiko; Terentyev, Dmitry] Rhode Isl Hosp, Dept Med, Cardiovasc Res Ctr, Providence, RI 02903 USA; [Terentyeva, Radmila; Jindal, Hitesh K.; Rochira, Jennifer A.; Kunitomo, Yukiko; Terentyev, Dmitry] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA; [Abdellatif, Maha] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Cell Biol & Mol Med, Newark, NJ 07103 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Rutgers State University New Brunswick; Rutgers State University Medical Center	Belevych, AE (corresponding author), Ohio State Univ, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA.	Dmitry_Terentyev@brown.edu	Terentyev, Dmitry/V-2037-2019; Carnes, Cynthia A/C-9540-2012	Carnes, Cynthia A/0000-0003-0420-6973; Kunitomo, Yukiko/0000-0001-5564-8902; , Yoshinori/0000-0002-5547-4508; Sansom, Sarah/0000-0002-1924-8941; Terentyev, Dmitry/0000-0002-9530-7384; Belevych, Andriy/0000-0002-1272-5784; Terentyeva, Radmila/0000-0002-0133-3515	American Heart Association; National Institutes of Health [HL074045, HL063043, HL089836, HL048848, HD058997, 5T32HL094300]; Foundation Jerome Lejeune Research	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation Jerome Lejeune Research	This work was supported by the American Heart Association (to AEB and DT); National Institutes of Health grants (HL074045 and HL063043 to SG, HL089836 to CAC HL048848, and HD058997 to TSE and 5T32HL094300 to Rhode Island Hospital for funding for JAR) and Foundation Jerome Lejeune Research Grant to TSE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai X, 2005, CIRC RES, V97, P1314, DOI 10.1161/01.RES.0000194329.41863.89; Banyasz T, 2008, EXP PHYSIOL, V93, P370, DOI 10.1113/expphysiol.2007.040659; Barringhaus KG, 2009, CIRCULATION, V119, P2217, DOI 10.1161/CIRCULATIONAHA.107.715839; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Belevych AE, 2011, CARDIOVASC RES; Blayney LM, 2009, PHARMACOL THERAPEUT, V123, P151, DOI 10.1016/j.pharmthera.2009.03.006; Bostjancic E, 2010, CARDIOLOGY, V115, P163, DOI 10.1159/000268088; Bridge JHB, 2008, CIRC RES, V102, pE65, DOI 10.1161/CIRCRESAHA.108.176172; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Callis TE, 2009, J CLIN INVEST, V119, P2772, DOI 10.1172/JCI36154; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Dubell WH, 2002, AM J PHYSIOL-HEART C, V282, pH38, DOI 10.1152/ajpheart.00536.2001; El-Armouche A, 2008, CARDIOVASC RES, V80, P396, DOI 10.1093/cvr/cvn208; Elton TS, 2011, LIFE SCI, V88, P373, DOI 10.1016/j.lfs.2010.11.022; George CH, 2007, CURR PHARM DESIGN, V13, P3195, DOI 10.2174/138161207782341259; George CH, 2008, CARDIOVASC RES, V77, P302, DOI 10.1093/cvr/cvm006; Girmatsion Z, 2009, HEART RHYTHM, V6, P1802, DOI 10.1016/j.hrthm.2009.08.035; Hasenfuss G, 2002, J MOL CELL CARDIOL, V34, P951, DOI 10.1006/jmcc.2002.2037; Huke S, 2008, BIOCHEM BIOPH RES CO, V376, P80, DOI 10.1016/j.bbrc.2008.08.084; Ikeda S, 2009, MOL CELL BIOL, V29, P2193, DOI 10.1128/MCB.01222-08; Janse MJ, 2004, CARDIOVASC RES, V61, P208, DOI 10.1016/j.cardiores.2003.11.018; Latronico MVG, 2011, EXP BIOL MED, V236, P125, DOI 10.1258/ebm.2010.010269; Laurita KR, 2008, J MOL CELL CARDIOL, V44, P31, DOI 10.1016/j.yjmcc.2007.10.012; Liu N, 2010, DEV CELL, V18, P510, DOI 10.1016/j.devcel.2010.03.010; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu YJ, 2009, CARDIOVASC RES, V84, P434, DOI 10.1093/cvr/cvp232; Luo XB, 2008, J BIOL CHEM, V283, P20045, DOI 10.1074/jbc.M801035200; Martin M, 2010, BIOTECHNOL AGRON SOC, V14, P243; Matkovich SJ, 2009, CIRCULATION, V119, P1263, DOI 10.1161/CIRCULATIONAHA.108.813576; Mozaffarian D, 2007, CIRCULATION, V116, P392, DOI 10.1161/CIRCULATIONAHA.106.687103; Nishijima Y, 2005, J CARD FAIL, V11, P638, DOI 10.1016/j.cardfail.2005.05.006; Pogwizd SM, 2004, TRENDS CARDIOVAS MED, V14, P61, DOI 10.1016/j.tcm.2003.12.002; Reiken S, 2003, J BIOL CHEM, V278, P444, DOI 10.1074/jbc.M207028200; Sayed D, 2007, CIRC RES, V100, P416, DOI 10.1161/01.RES.0000257913.42552.23; Strack S., 2011, ENZYME RES, V2011, DOI DOI 10.4061/2011/398751; Ter Keurs HEDJ, 2007, PHYSIOL REV, V87, P457, DOI 10.1152/physrev.00011.2006; Terentyev D, 2003, J PHYSIOL-LONDON, V552, P109, DOI 10.1113/jphysiol.2003.046367; Terentyev D, 2009, CIRC RES, V104, P514, DOI 10.1161/CIRCRESAHA.108.181651; Thum T, 2007, CIRCULATION, V116, P258, DOI 10.1161/CIRCULATIONAHA.107.687947; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Topkara VK, 2011, CARDIOVASC DRUG THER, V25, P171, DOI 10.1007/s10557-011-6289-5; Walsh AH, 1997, FEBS LETT, V416, P230, DOI 10.1016/S0014-5793(97)01210-6; Wu YJ, 2002, CIRCULATION, V106, P1288, DOI 10.1161/01.CIR.0000027583.73268.E7; Xiao BL, 2006, BIOCHEM J, V396, P7, DOI 10.1042/BJ20060116; Xie LH, 2009, AM J PHYSIOL-HEART C, V297, pH997, DOI 10.1152/ajpheart.00390.2009; Yang BF, 2007, NAT MED, V13, P486, DOI 10.1038/nm1569; Ye Y, 2010, PHYSL GENOMICS	47	115	124	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2011	6	12							e28324	10.1371/journal.pone.0028324	http://dx.doi.org/10.1371/journal.pone.0028324			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863OC	22163007	Green Published, Green Submitted, gold			2022-12-27	WOS:000298173500014
J	Botelho, FM; Bauer, CMT; Finch, D; Nikota, JK; Zavitz, CCJ; Kelly, A; Lambert, KN; Piper, S; Foster, ML; Goldring, JJP; Wedzicha, JA; Bassett, J; Bramson, J; Iwakura, Y; Sleeman, M; Kolbeck, R; Coyle, AJ; Humbles, AA; Stampfli, MR				Botelho, Fernando M.; Bauer, Carla M. T.; Finch, Donna; Nikota, Jake K.; Zavitz, Caleb C. J.; Kelly, Ashling; Lambert, Kristen N.; Piper, Sian; Foster, Martyn L.; Goldring, James J. P.; Wedzicha, Jadwiga A.; Bassett, Jennifer; Bramson, Jonathan; Iwakura, Yoichiro; Sleeman, Matthew; Kolbeck, Roland; Coyle, Anthony J.; Humbles, Alison A.; Staempfli, Martin R.			IL-1 alpha/IL-1R1 Expression in Chronic Obstructive Pulmonary Disease and Mechanistic Relevance to Smoke-Induced Neutrophilia in Mice	PLOS ONE			English	Article							CIGARETTE-SMOKE; LUNG INFLAMMATION; VIRUS; INFECTION; EMPHYSEMA; IL-1-BETA; RESPONSES	Background: Cigarette smoking is the main risk factor for the development of chronic obstructive pulmonary disease (COPD), a major cause of morbidity and mortality worldwide. Despite this, the cellular and molecular mechanisms that contribute to COPD pathogenesis are still poorly understood. Methodology and Principal Findings: The objective of this study was to assess IL-1 alpha and beta expression in COPD patients and to investigate their respective roles in perpetuating cigarette smoke-induced inflammation. Functional studies were pursued in smoke-exposed mice using gene-deficient animals, as well as blocking antibodies for IL-1 alpha and beta. Here, we demonstrate an underappreciated role for IL-1 alpha expression in COPD. While a strong correlation existed between IL-1 alpha and beta levels in patients during stable disease and periods of exacerbation, neutrophilic inflammation was shown to be IL-1 alpha-dependent, and IL-1 beta- and caspase-1-independent in a murine model of cigarette smoke exposure. As IL-1 alpha was predominantly expressed by hematopoietic cells in COPD patients and in mice exposed to cigarette smoke, studies pursued in bone marrow chimeric mice demonstrated that the crosstalk between IL-1 alpha+ hematopoietic cells and the IL-1R1+ epithelial cells regulates smoke-induced inflammation. IL-1 alpha/IL-1R1-dependent activation of the airway epithelium also led to exacerbated inflammatory responses in H1N1 influenza virus infected smoke-exposed mice, a previously reported model of COPD exacerbation. Conclusions and Significance: This study provides compelling evidence that IL-1 alpha is central to the initiation of smoke-induced neutrophilic inflammation and suggests that IL-1 alpha/IL-1R1 targeted therapies may be relevant for limiting inflammation and exacerbations in COPD.	[Botelho, Fernando M.; Zavitz, Caleb C. J.; Kelly, Ashling; Lambert, Kristen N.; Bassett, Jennifer; Bramson, Jonathan; Staempfli, Martin R.] McMaster Univ, Dept Pathol & Mol Med, Ctr Gene Therapeut, Hamilton, ON, Canada; [Bauer, Carla M. T.; Nikota, Jake K.; Bassett, Jennifer] McMaster Univ, Med Sci Grad Program, Hamilton, ON, Canada; [Finch, Donna; Piper, Sian; Sleeman, Matthew] MedImmune LTD, Cambridge, England; [Goldring, James J. P.; Wedzicha, Jadwiga A.] UCL, Acad Unit Resp Med, London, England; [Iwakura, Yoichiro] Univ Tokyo, Inst Med Sci, Ctr Expt Med & Syst Biol, Tokyo, Japan; [Kolbeck, Roland; Coyle, Anthony J.; Humbles, Alison A.] MedImmune LLC, Gaithersburg, MD USA; [Staempfli, Martin R.] McMaster Univ, Dept Med, Hamilton, ON, Canada	McMaster University; McMaster University; AstraZeneca; Medimmune; University of London; University College London; University of Tokyo; AstraZeneca; Medimmune; McMaster University	Botelho, FM (corresponding author), McMaster Univ, Dept Pathol & Mol Med, Ctr Gene Therapeut, Hamilton, ON, Canada.	stampfli@mcmaster.ca	Iwakura, Yoichiro/E-5457-2011; Sleeman, Matthew A/E-6675-2016; Zavitz, Caleb CJ/D-4659-2009	Iwakura, Yoichiro/0000-0002-9934-5775; Zavitz, Caleb CJ/0000-0002-1097-041X; Bramson, Jonathan/0000-0003-2874-6886; Stampfli, Martin/0000-0003-4918-5889	CIHR; Ontario's Early Research Award program (ERA); MedImmune; AstraZeneca; Canadian Thoracic Society; Medical Research Council [G0800570] Funding Source: researchfish; National Institute for Health Research [NF-SI-0510-10270] Funding Source: researchfish; MRC [G0800570] Funding Source: UKRI	CIHR(Canadian Institutes of Health Research (CIHR)); Ontario's Early Research Award program (ERA); MedImmune(AstraZenecaMedimmune); AstraZeneca(AstraZeneca); Canadian Thoracic Society; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The work described herein was funded in-part by the CIHR, Ontario's Early Research Award program (ERA), MedImmune and AstraZeneca; CMTB holds a Canadian Thoracic Society Studentship; MRS holds a Canadian Institutes for Health Research New Investigator Award. The funders (DF and AAH) participated in study design, as well as data collection and analysis.	Aaron SD, 2001, AM J RESP CRIT CARE, V163, P349, DOI 10.1164/ajrccm.163.2.2003122; Bauer CMT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013251; Botelho FM, 2009, AM J RESP CELL MOL B; Botelho FM, EUR RESP J, V38, P285; BROWN EG, 1990, J VIROL, V64, P4523, DOI 10.1128/JVI.64.9.4523-4533.1990; Caschler GJ, 2008, AM J RESP CELL MOL, V38, P218, DOI 10.1165/rcmb.2007-0053OC; Castro P, 2004, EUR J PHARMACOL, V498, P279, DOI 10.1016/j.ejphar.2004.07.047; Chen CJ, 2007, NAT MED, V13, P851, DOI 10.1038/nm1603; Churg A, 2009, AM J RESP CELL MOL, V40, P482, DOI 10.1165/rcmb.2008-0038OC; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Doz E, 2008, J IMMUNOL, V180, P1169, DOI 10.4049/jimmunol.180.2.1169; Falk Jeremy A, 2008, Proc Am Thorac Soc, V5, P506, DOI 10.1513/pats.200707-096ET; Gaschler GJ, 2009, AM J RESP CRIT CARE, V179, P666, DOI 10.1164/rccm.200808-1306OC; Gualano RC, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-53; Hautamaki RD, 1997, SCIENCE, V277, P2002, DOI 10.1126/science.277.5334.2002; Holmes J, 2010, 10 FACTS TOBACCO EPI; Horai R, 1998, J EXP MED, V187, P1463, DOI 10.1084/jem.187.9.1463; Kang MJ, 2008, J CLIN INVEST, V118, P2771, DOI 10.1172/JCI32709; Kim Victor, 2008, Proc Am Thorac Soc, V5, P478, DOI 10.1513/pats.200802-014ET; Kuschner WG, 1996, EUR RESPIR J, V9, P1989, DOI 10.1183/09031936.96.09101989; Lappalainen U, 2005, AM J RESP CELL MOL, V32, P311, DOI 10.1165/rcmb.2004-0309OC; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; Maelfait J, 2008, J EXP MED, V205, P1967, DOI 10.1084/jem.20071632; Papi A, 2006, AM J RESP CRIT CARE, V173, P1114, DOI 10.1164/rccm.200506-859OC; Patel RR, 2008, DRUGS, V68, P1511, DOI 10.2165/00003495-200868110-00004; Pauwels Romain A., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1256; Robbins CS, 2006, AM J RESP CRIT CARE; Rock KL, ANN REV IMMUNOL, V28, P321; Rusznak C, 2000, AM J RESP CELL MOL, V23, P530, DOI 10.1165/ajrcmb.23.4.3959; Schmitz N, 2005, J VIROL, V79, P6441, DOI 10.1128/JVI.79.10.6441-6448.2005; Schonbeck U, 1998, J IMMUNOL, V161, P3340; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Schultz K, 2007, AM J PHYSIOL-HEART C, V292, pH2927, DOI 10.1152/ajpheart.00700.2006; Sims JE, 2010, NAT REV IMMUNOL, V10, P89, DOI 10.1038/nri2691; Vlahos R, 2010, AM J RESP CRIT CARE, V182, P34, DOI 10.1164/rccm.200912-1794OC; Yao Y, 2009, HUM GENOMICS PROTEOM, V2009, P1	36	113	116	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2011	6	12							e28457	10.1371/journal.pone.0028457	http://dx.doi.org/10.1371/journal.pone.0028457			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863OC	22163019	Green Submitted, Green Published, gold			2022-12-27	WOS:000298173500022
J	Woolston, BM; Schlagnhaufer, C; Wilkinson, J; Larsen, J; Shi, ZX; Mayer, KM; Walters, DS; Curtis, WR; Romaine, CP				Woolston, Benjamin M.; Schlagnhaufer, Carl; Wilkinson, Jack; Larsen, Jeffrey; Shi, Zhixin; Mayer, Kimberly M.; Walters, Donald S.; Curtis, Wayne R.; Romaine, C. Peter			Long-Distance Translocation of Protein during Morphogenesis of the Fruiting Body in the Filamentous Fungus, Agaricus bisporus	PLOS ONE			English	Article							2 LACCASE GENES; ASPERGILLUS-NIDULANS; BUTTON MUSHROOM; EXPRESSION; GROWTH; TISSUE; IDENTIFICATION; ORGANIZATION; CULTIVATION; AUTOLYSIS	Commercial cultivation of the mushroom fungus, Agaricus bisporus, utilizes a substrate consisting of a lower layer of compost and upper layer of peat. Typically, the two layers are seeded with individual mycelial inoculants representing a single genotype of A. bisporus. Studies aimed at examining the potential of this fungal species as a heterologous protein expression system have revealed unexpected contributions of the mycelial inoculants in the morphogenesis of the fruiting body. These contributions were elucidated using a dual-inoculant method whereby the two layers were differientially inoculated with transgenic beta-glucuronidase (GUS) and wild-type (WT) lines. Surprisingly, use of a transgenic GUS line in the lower substrate and a WT line in the upper substrate yielded fruiting bodies expressing GUS activity while lacking the GUS transgene. Results of PCR and RT-PCR analyses for the GUS transgene and RNA transcript, respectively, suggested translocation of the GUS protein from the transgenic mycelium colonizing the lower layer into the fruiting body that developed exclusively from WT mycelium colonizing the upper layer. Effective translocation of the GUS protein depended on the use of a transgenic line in the lower layer in which the GUS gene was controlled by a vegetative mycelium-active promoter (laccase 2 and beta-actin), rather than a fruiting body-active promoter (hydrophobin A). GUS-expressing fruiting bodies lacking the GUS gene had a bonafide WT genotype, confirmed by the absence of stably inherited GUS and hygromycin phosphotransferase selectable marker activities in their derived basidiospores and mycelial tissue cultures. Differientially inoculating the two substrate layers with individual lines carrying the GUS gene controlled by different tissue-preferred promoters resulted in up to similar to 3.5-fold increase in GUS activity over that obtained with a single inoculant. Our findings support the existence of a previously undescribed phenomenon of long-distance protein translocation in A. bisporus that has potential application in recombinant protein expression and biotechnological approaches for crop improvement.	[Woolston, Benjamin M.; Larsen, Jeffrey; Curtis, Wayne R.] Penn State Univ, Dept Chem Engn, University Pk, PA 16802 USA; [Schlagnhaufer, Carl; Romaine, C. Peter] Penn State Univ, Dept Plant Pathol, University Pk, PA 16802 USA; [Schlagnhaufer, Carl; Wilkinson, Jack; Shi, Zhixin; Mayer, Kimberly M.; Walters, Donald S.; Romaine, C. Peter] Agarigen Inc, Durham, NC USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Woolston, BM (corresponding author), Penn State Univ, Dept Chem Engn, University Pk, PA 16802 USA.	cpr2@psu.edu		/0000-0002-6570-2236; Curtis, Wayne/0000-0001-6976-0890	Defense Advanced Research Projects Agency (DARPA) [HR0011-07-9-0004]; Penn State JB Swayne Endowed Chair; Penn State Chemical Engineering Endowment Fund	Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Penn State JB Swayne Endowed Chair; Penn State Chemical Engineering Endowment Fund	This work was funded by the Defense Advanced Research Projects Agency (DARPA) under contract no. HR0011-07-9-0004 to CPR and DSW, Penn State JB Swayne Endowed Chair to CPR, and a summer undergraduate research fellowship from the Penn State Chemical Engineering Endowment Fund to BMW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Broothaerts W, 2005, NATURE, V433, P629, DOI 10.1038/nature03309; Callis J, 1995, STRUCTURE EVOLUTION; Chang ST, 2005, ACTA EDULIS FUNGI S, P3; Chen X, 1999, APPL MICROBIOL BIOT, V52, P246, DOI 10.1007/s002530051516; Chen X, 2000, APPL ENVIRON MICROB, V66, P4510, DOI 10.1128/AEM.66.10.4510-4513.2000; Darrah PR, 2006, EUKARYOT CELL, V5, P1111, DOI 10.1128/EC.00026-06; Deacon JW, 2006, FUNGAL BIOL-UK; DeGroot PWJ, 1996, J MOL BIOL, V257, P1008, DOI 10.1006/jmbi.1996.0219; Emri T, 2008, APPL BIOCHEM BIOTECH, V151, P211, DOI 10.1007/s12010-008-8174-7; HAMMOND JBW, 1976, J GEN MICROBIOL, V93, P309, DOI 10.1099/00221287-93-2-309; Heaton LLM, 2010, P ROY SOC B-BIOL SCI, V277, P3265, DOI 10.1098/rspb.2010.0735; HOLTZ RB, 1971, J AGR FOOD CHEM, V19, P1272, DOI 10.1021/jf60178a052; Ibrahim AS, 2010, MOL MICROBIOL, V77, P587, DOI 10.1111/j.1365-2958.2010.07234.x; KERRIGAN RW, 1995, CAN J BOT, V73, pS973, DOI 10.1139/b95-347; Lee JW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015394; MACCANNA C, 1972, MUSHROOM SCI, V8, P727; Meyer V, 2009, EUKARYOT CELL, V8, P1677, DOI 10.1128/EC.00050-09; Neveu B, 2007, APPL MICROBIOL BIOT, V74, P1300, DOI 10.1007/s00253-006-0786-7; O'Neill KA, 2008, BIOTECHNOL PROGR, V24, P372, DOI 10.1021/bp0703127; PERRY CR, 1993, J GEN MICROBIOL, V139, P1209, DOI 10.1099/00221287-139-6-1209; Pollack JK, 2009, FUNGAL GENET BIOL, V46, P1, DOI 10.1016/j.fgb.2008.10.010; Romaine C. Peter, 2006, V344, P453; ROMAINE CP, 1992, APPL ENVIRON MICROB, V58, P3060, DOI 10.1128/AEM.58.9.3060-3066.1992; Romaine CP, 2002, DSRNA GENETIC ELEMEN, P237, DOI [10.1201/9781420039122, DOI 10.1201/9781420039122]; Semighini CP, 2008, GENETICS, V179, P1919, DOI 10.1534/genetics.108.089318; Smith M, 1998, MICROBIOL-UK, V144, P1063, DOI 10.1099/00221287-144-4-1063; Steinberg G, 2007, TRENDS MICROBIOL, V15, P14, DOI 10.1016/j.tim.2006.11.007; Tlalka M, 2007, FUNGAL GENET BIOL, V44, P1085, DOI 10.1016/j.fgb.2007.02.013; van Peer AF, 2010, ENVIRON MICROBIOL, V12, P833, DOI 10.1111/j.1462-2920.2009.02122.x; White S, 2002, CRIT REV BIOTECHNOL, V22, P1, DOI 10.1080/07388550490465817; Wichers HJ, 2003, APPL MICROBIOL BIOT, V61, P336, DOI 10.1007/s00253-002-1194-2; Wuest P.J., 1982, PENN STATE HDB COMME; Xu J, 1997, J HERED, V88, P482, DOI 10.1093/oxfordjournals.jhered.a023141	34	6	7	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2011	6	12							e28412	10.1371/journal.pone.0028412	http://dx.doi.org/10.1371/journal.pone.0028412			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863OC	22163014	gold, Green Published, Green Submitted			2022-12-27	WOS:000298173500018
J	Brezillon, N; Brunelle, MN; Massinet, H; Giang, E; Lamant, C; DaSilva, L; Berissi, S; Belghiti, J; Hannoun, L; Puerstinger, G; Wimmer, E; Neyts, J; Hantz, O; Soussan, P; Morosan, S; Kremsdorf, D				Brezillon, Nicolas; Brunelle, Marie-Noelle; Massinet, Helene; Giang, Eric; Lamant, Celine; DaSilva, Lucie; Berissi, Sophie; Belghiti, Jacques; Hannoun, Laurent; Puerstinger, Gherard; Wimmer, Eva; Neyts, Johan; Hantz, Olivier; Soussan, Patrick; Morosan, Serban; Kremsdorf, Dina			Antiviral Activity of Bay 41-4109 on Hepatitis B Virus in Humanized Alb-uPA/SCID Mice	PLOS ONE			English	Article							UPA-SCID MOUSE; HUMAN LIVER; HBV; HEPATOCYTES; REPLICATION; MODEL; NUCLEOCAPSIDS; REPOPULATION; INHIBITION; PARTICLES	Current treatments for HBV chronic carriers using interferon alpha or nucleoside analogues are not effective in all patients and may induce the emergence of HBV resistant strains. Bay 41-4109, a member of the heteroaryldihydropyrimidine family, inhibits HBV replication by destabilizing capsid assembly. The aim of this study was to determine the antiviral effect of Bay 41-4109 in a mouse model with humanized liver and the spread of active HBV. Antiviral assays of Bay 41-4109 on HepG2.2.15 cells constitutively expressing HBV, displayed an IC(50) of about 202 nM with no cell toxicity. Alb-uPA/SCID mice were transplanted with human hepatocytes and infected with HBV. Ten days post-infection, the mice were treated with Bay 41-4109 for five days. During the 30 days of follow-up, the HBV load was evaluated by quantitative PCR. At the end of treatment, decreased HBV viremia of about 1 log(10) copies/ml was observed. By contrast, increased HBV viremia of about 0.5 log(10) copies/ml was measured in the control group. Five days after the end of treatment, a rebound of HBV viremia occurred in the treated group. Furthermore, 15 days after treatment discontinuation, a similar expression of the viral capsid was evidenced in liver biopsies. Our findings demonstrate that Bay 41-4109 displayed antiviral properties against HBV in humanized Alb-uPA/SCID mice and confirm the usefulness of Alb-uPA/SCID mice for the evaluation of pharmaceutical compounds. The administration of Bay 41-4109 may constitute a new strategy for the treatment of patients in escape from standard antiviral therapy.	[Brezillon, Nicolas; Brunelle, Marie-Noelle; Massinet, Helene; Giang, Eric; Lamant, Celine; DaSilva, Lucie; Berissi, Sophie; Soussan, Patrick; Kremsdorf, Dina] Natl Inst Hlth & Med Res, INSERM, U845, Paris, France; [Brezillon, Nicolas; Brunelle, Marie-Noelle; Massinet, Helene; Giang, Eric; Lamant, Celine; DaSilva, Lucie; Berissi, Sophie; Soussan, Patrick; Kremsdorf, Dina] Univ Paris 05, Fac Med Rene Descartes, CHU Necker, Paris, France; [Brezillon, Nicolas; Brunelle, Marie-Noelle; Massinet, Helene; Giang, Eric; Lamant, Celine; DaSilva, Lucie; Soussan, Patrick; Kremsdorf, Dina] Inst Pasteur, Dept Virol, Paris, France; [Belghiti, Jacques] Hop Beaujon, Dept Hepatobilary & Digest Surg, Clichy, France; [Hannoun, Laurent] Hop La Pitie Salpetriere, Dept Hepatobilary & Digest Surg, Paris, France; [Puerstinger, Gherard; Wimmer, Eva] Univ Innsbruck, Inst Pharm, Dept Pharmaceut Chem, A-6020 Innsbruck, Austria; [Neyts, Johan] Univ Louvain, Rega Inst Med Res, Louvain, Belgium; [Hantz, Olivier] Natl Inst Hlth & Med Res, INSERM, U871, Lyon, France; [Morosan, Serban] Univ Paris 06, Fac Med Pitie Salpetriere, Ctr Expt Fonct, Paris, France; [Morosan, Serban] Fac Med Vet, Iasi, Romania	Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Innsbruck; KU Leuven; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Brezillon, N (corresponding author), Natl Inst Hlth & Med Res, INSERM, U845, Paris, France.	dina.kremsdorf@inserm.fr	Neyts, Johan/U-8267-2017; soussan, patrick/O-9801-2017; Kremsdorf, Dina/O-9797-2017	Neyts, Johan/0000-0002-0033-7514; soussan, patrick/0000-0003-2706-7371; Hantz, Olivier/0000-0002-1170-6186	Medicen Paris Region (Conseil General de l'Essonne and Direction Generale des Entreprises); VIRGIL (European surveillance network for Vigilance against Viral Resistance); INSERM (Institut National pour la Sante Et de la Recherche Medicale); Bill and Melinda Gates Foundation; Medicen Paris Region (Direction Generale des Entreprises)	Medicen Paris Region (Conseil General de l'Essonne and Direction Generale des Entreprises); VIRGIL (European surveillance network for Vigilance against Viral Resistance); INSERM (Institut National pour la Sante Et de la Recherche Medicale); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Medicen Paris Region (Direction Generale des Entreprises)	This work received financial support from Medicen Paris Region (Conseil General de l'Essonne and Direction Generale des Entreprises), VIRGIL (European surveillance network for Vigilance against Viral Resistance) and INSERM (Institut National pour la Sante Et de la Recherche Medicale). NB, HM, CL and LD received grant support from the Bill and Melinda Gates Foundation. M-NB and HM benefited from a grant from the Medicen Paris Region (Direction Generale des Entreprises). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brezillon NM, 2008, CELL TRANSPLANT, V17, P803, DOI 10.3727/096368908786516800; Chemin I, 2009, CANCER LETT, V286, P52, DOI 10.1016/j.canlet.2008.12.003; Dandri M, 2005, J HEPATOL, V42, P54, DOI 10.1016/j.jhep.2004.09.021; Dandri M, 2001, HEPATOLOGY, V33, P981, DOI 10.1053/jhep.2001.23314; Deres K, 2003, SCIENCE, V299, P893, DOI 10.1126/science.1077215; Dienstag JL, 2009, HEPATOLOGY, V49, pS112, DOI 10.1002/hep.22920; Feld JJ, 2007, ANTIVIR RES, V76, P168, DOI 10.1016/j.antiviral.2007.06.014; Hacker HJ, 2003, BIOCHEM PHARMACOL, V66, P2273, DOI 10.1016/j.bcp.2003.08.001; Hantz O, 2009, J GEN VIROL, V90, P127, DOI 10.1099/vir.0.004861-0; Liang TJ, 2009, HEPATOLOGY, V49, pS13, DOI 10.1002/hep.22881; Lu XY, 2003, J VIROL, V77, P11933, DOI 10.1128/JVI.77.22.11933-11940.2003; Meuleman P, 2006, J VIROL, V80, P2797, DOI 10.1128/JVI.80.6.2797-2807.2006; Meuleman P, 2005, HEPATOLOGY, V41, P847, DOI 10.1002/hep.20657; Meuleman P, 2008, ANTIVIR RES, V80, P231, DOI 10.1016/j.antiviral.2008.07.006; Morosan S, 2006, J INFECT DIS, V193, P996, DOI 10.1086/500840; Perrillo R, 2009, HEPATOLOGY, V49, pS103, DOI 10.1002/hep.22956; SELLS MA, 1987, P NATL ACAD SCI USA, V84, P1005, DOI 10.1073/pnas.84.4.1005; Shi C, 2007, TOXICOL LETT, V173, P161, DOI 10.1016/j.toxlet.2007.07.010; Soussan P, 2008, J INFECT DIS, V198, P218, DOI 10.1086/589623; Stolting J, 2000, DIHYDROPYRIMIDINES T; Stray SJ, 2006, NAT BIOTECHNOL, V24, P358, DOI 10.1038/nbt1187; Stray SJ, 2005, P NATL ACAD SCI USA, V102, P8138, DOI 10.1073/pnas.0409732102; Stray SJ, 2006, J MOL RECOGNIT, V19, P542, DOI 10.1002/jmr.801; Tateno C, 2004, AM J PATHOL, V165, P901, DOI 10.1016/S0002-9440(10)63352-4; Weber O, 2002, ANTIVIR RES, V54, P69, DOI 10.1016/S0166-3542(01)00216-9; Xu CX, 2010, J VIROL, V84, P9332, DOI 10.1128/JVI.00918-10; Zlotnick A, 2002, J VIROL, V76, P4848, DOI 10.1128/JVI.76.10.4848-4854.2002; Zoulim F, 2008, J HEPATOL, V48, pS2, DOI 10.1016/j.jhep.2008.01.011	28	67	95	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e25096	10.1371/journal.pone.0025096	http://dx.doi.org/10.1371/journal.pone.0025096			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22162746	Green Published, Green Submitted, gold			2022-12-27	WOS:000298172800001
J	Verweyen, L; Klimpel, S; Palm, HW				Verweyen, Lisa; Klimpel, Sven; Palm, Harry W.			Molecular Phylogeny of the Acanthocephala (Class Palaeacanthocephala) with a Paraphyletic Assemblage of the Orders Polymorphida and Echinorhynchida	PLOS ONE			English	Article							CLASS POLYACANTHOCEPHALA; SEQUENCES; POSITION; ERECTION; NUCLEAR; MODEL	Acanthocephalans are attractive candidates as model organisms for studying the ecology and co-evolutionary history of parasitic life cycles in the marine ecosystem. Adding to earlier molecular analyses of this taxon, a total of 36 acanthocephalans belonging to the classes Archiacanthocephala (3 species), Eoacanthocephala (3 species), Palaeacanthocephala (29 species), Polyacanthocephala (1 species) and Rotifera as outgroup (3 species) were analyzed by using Bayesian Inference and Maximum Likelihood analyses of nuclear 18S rDNA sequence. This data set included three re-collected and six newly collected taxa, Bolbosoma vasculosum from Lepturacanthus savala, Filisoma rizalinum from Scatophagus argus, Rhadinorhynchus pristis from Gempylus serpens, R. lintoni from Selar crumenophthalmus, Serrasentis sagittifer from Johnius coitor, and Southwellina hispida from Epinephelus coioides, representing 5 new host and 3 new locality records. The resulting trees suggest a paraphyletic arrangement of the Echinorhynchida and Polymorphida inside the Palaeacanthocephala. This questions the placement of the genera Serrasentis and Gorgorhynchoides within the Echinorhynchida and not the Polymorphida, necessitating further insights into the systematic position of these taxa based on morphology.	[Verweyen, Lisa; Klimpel, Sven] Goethe Univ Frankfurt, Inst Ecol Evolut & Diver, SGN, Biodivers & Climate Res Ctr Bik F, Frankfurt, Germany; [Palm, Harry W.] Univ Rostock, Fac Agr & Environm Sci, Rostock, Germany	Goethe University Frankfurt; Senckenberg Biodiversitat & Klima- Forschungszentrum (BiK-F); Senckenberg Gesellschaft fur Naturforschung (SGN); University of Rostock	Verweyen, L (corresponding author), Goethe Univ Frankfurt, Inst Ecol Evolut & Diver, SGN, Biodivers & Climate Res Ctr Bik F, Frankfurt, Germany.	sven.klimpel@senckenberg.de			BiK-F (LOEWE); German Research Council (DFG) [PA 664/4-2, 6-1]	BiK-F (LOEWE); German Research Council (DFG)(German Research Foundation (DFG))	The present study was financially supported by BiK-F (LOEWE) and by the German Research Council (DFG PA 664/4-2, 6-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin O.M., 1985, P27; AMIN OM, 1994, J PARASITOL, V80, P768, DOI 10.2307/3283256; AMIN OM, 1987, J PARASITOL, V73, P1216, DOI 10.2307/3282307; [Anonymous], 2002, PAUP 4 0 PHYLOGENETI; Aznar FJ, 2006, J PARASITOL, V92, P548, DOI 10.1645/GE-715R.1; Bhattacharya S.B, 2007, HDB INDIAN ACANTHOCE, P1; BULLOCK W. L., 1969, Problems in systematics of parasites., P9; Garcia-Varela M, 2005, J PARASITOL, V91, P1401, DOI 10.1645/GE-523R.1; Garcia-Varela M, 2002, MOL PHYLOGENET EVOL, V23, P288, DOI 10.1016/S1055-7903(02)00020-9; Garcia-Varela M, 2008, J PARASITOL, V94, P959, DOI 10.1645/GE-1420.1; Garcia-Varela M, 2006, MOL PHYLOGENET EVOL, V40, P61, DOI 10.1016/j.ympev.2006.02.010; Garey JR, 1996, J MOL EVOL, V43, P287, DOI 10.1007/BF02338837; Giribet G, 2000, SYST BIOL, V49, P539, DOI 10.1080/10635159950127385; Golvan Y. J., 1969, ZOOLOGIE A, VLVII, P1; Herlyn H, 2003, MOL PHYLOGENET EVOL, V26, P155, DOI 10.1016/S1055-7903(02)00309-3; Herlyn H, 2001, SYST PARASITOL, V50, P105, DOI 10.1023/A:1011925516086; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kennedy CR, 2006, ECOLOGY OF THE ACANTHOCEPHALA, P1; KISHINO H, 1989, J MOL EVOL, V29, P170, DOI 10.1007/BF02100115; Mark Welch D, 2005, HYDROBIOLOGIA, V546, P47, DOI 10.1007/s10750-005-4100-y; Monks S, 2001, SYST PARASITOL, V48, P81, DOI 10.1023/A:1006400207434; Near TJ, 1998, MOL PHYLOGENET EVOL, V10, P287, DOI 10.1006/mpev.1998.0569; Petrochenko V.I., 1971, P1; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; RODRIGUEZ F, 1990, J THEOR BIOL, V142, P485, DOI 10.1016/S0022-5193(05)80104-3; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Stover BC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-7; Taraschewski H, 2005, MARINE PARASITOLOGY, P116; TELFORD MJ, 1993, MOL BIOL EVOL, V10, P660; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wayland MT, 2004, SYST PARASITOL, V58, P149, DOI 10.1023/B:SYPA.0000029419.07989.1a; Witek A., 2008, BMC EVOL BIOL, V345, P1; Yamaguti S, 1963, SYST HELMINTHUM, P1; YANG ZB, 1994, J MOL EVOL, V39, P105; Zrzavy J, 2003, ZOOL SCR, V32, P61, DOI 10.1046/j.1463-6409.2003.00104.x	36	60	62	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e28285	10.1371/journal.pone.0028285	http://dx.doi.org/10.1371/journal.pone.0028285			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22163005	Green Published, Green Submitted, gold			2022-12-27	WOS:000298172800021
J	Cheng, C; Gong, XH				Cheng, Catherine; Gong, Xiaohua			Diverse Roles of Eph/ephrin Signaling in the Mouse Lens	PLOS ONE			English	Article							RECEPTOR TYROSINE KINASE; BETA-CATENIN; N-CADHERIN; CATARACT; EPHA2; GENE; MORPHOGENESIS; EXPRESSION; MUTATIONS; GROWTH	Recent genetic studies show that the Eph/ephrin bidirectional signaling pathway is associated with both congenital and age-related cataracts in mice and humans. We have investigated the molecular mechanisms of cataractogenesis and the roles of ephrin-A5 and EphA2 in the lens. Ephrin-A5 knockout (-/-) mice often display anterior polar cataracts while EphA2(-/-) lenses show very mild cortical or nuclear cataracts at weaning age. The anterior polar cataract of ephrin-A5(-/-) lenses is correlated with multilayers of aberrant cells that express alpha smooth muscle actin, a marker for mesenchymal cells. Only select fiber cells are altered in ephrin-A5(-/-) lenses. Moreover, the disruption of membrane-associated beta-catenin and E-cadherin junctions is observed in ephrin-A5(-/-) lens central epithelial cells. In contrast, EphA2(-/-) lenses display normal monolayer epithelium while disorganization is apparent in all lens fiber cells. Immunostaining of ephrin-A5 proteins, highly expressed in lens epithelial cells, were not colocalized with EphA2 proteins, mainly expressed in lens fiber cells. Besides the previously reported function of ephrin-A5 in lens fiber cells, this work suggests that ephrin-A5 regulates b-catenin signaling and E-cadherin to prevent lens anterior epithelial cells from undergoing the epithelial-to-mesenchymal transition while EphA2 is essential for controlling the organization of lens fiber cells through an unknown mechanism. Ephrin-A5 and EphA2 likely interacting with other members of Eph/ephrin family to play diverse functions in lens epithelial cells and/or fiber cells.	[Cheng, Catherine] Univ Calif Berkeley, Sch Optometry, Berkeley, CA 94720 USA; Univ Calif Berkeley, Vis Sci Program, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Cheng, C (corresponding author), Univ Calif Berkeley, Sch Optometry, Berkeley, CA 94720 USA.	xgong@berkeley.edu			National Eye Institute [EY013849]; NATIONAL EYE INSTITUTE [R01EY013849] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by grant EY013849 (X.G.) from the National Eye Institute. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizadeh A, 2004, INVEST OPHTH VIS SCI, V45, P884, DOI 10.1167/iovs.03-0677; Bassnett S, 1999, J CELL SCI, V112, P2155; Bassnett S, 2003, EXP EYE RES, V76, P291, DOI 10.1016/S0014-4835(02)00315-9; Bassnett S, 2009, MOL VIS, V15, P2448; Cain S, 2008, DEV BIOL, V321, P420, DOI 10.1016/j.ydbio.2008.07.002; Cheng C, 2008, EXP EYE RES, V86, P966, DOI 10.1016/j.exer.2008.03.015; Cooper MA, 2008, P NATL ACAD SCI USA, V105, P16620, DOI 10.1073/pnas.0808987105; Davy A, 1999, GENE DEV, V13, P3125, DOI 10.1101/gad.13.23.3125; Frieden LA, 2010, DEV DYNAM, V239, P3226, DOI 10.1002/dvdy.22458; Frisen J, 1998, NEURON, V20, P235, DOI 10.1016/S0896-6273(00)80452-3; Gong XH, 1997, CELL, V91, P833, DOI 10.1016/S0092-8674(00)80471-7; Gong XH, 1999, DEV GENET, V24, P27, DOI 10.1002/(SICI)1520-6408(1999)24:1/2<27::AID-DVG4>3.0.CO;2-7; Goodenough D.A., 1992, Seminars in Cell Biology, V3, P49; Himanen JP, 2004, NAT NEUROSCI, V7, P501, DOI 10.1038/nn1237; Holland SJ, 1996, NATURE, V383, P722, DOI 10.1038/383722a0; Jun G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000584; Kaul H, 2010, MOL VIS, V16, P511; Kreslova J, 2007, GENESIS, V45, P157, DOI 10.1002/dvg.20277; KUSZAK JR, 1995, EXP EYE RES, V61, P579, DOI 10.1016/S0014-4835(05)80052-1; Leonard M, 2011, DEV BIOL, V349, P363, DOI 10.1016/j.ydbio.2010.10.009; Martinez G, 2009, INVEST OPHTH VIS SCI, V50, P4794, DOI 10.1167/iovs.09-3567; Mathias RT, 1997, PHYSIOL REV, V77, P21, DOI 10.1152/physrev.1997.77.1.21; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; PIATIGORSKY J, 1981, DIFFERENTIATION, V19, P134, DOI 10.1111/j.1432-0436.1981.tb01141.x; Poliakov A, 2004, DEV CELL, V7, P465, DOI 10.1016/j.devcel.2004.09.006; Pontoriero GF, 2009, DEV BIOL, V326, P403, DOI 10.1016/j.ydbio.2008.10.011; RUNGE PE, 1992, INVEST OPHTH VIS SCI, V33, P3202; Sandilands A, 2004, EXP EYE RES, V78, P109, DOI 10.1016/j.exer.2003.09.001; Shestopalov VI, 2003, J CELL SCI, V116, P4191, DOI 10.1242/jcs.00738; Shiels A, 2008, MOL VIS, V14, P2042; Simirskii VN, 2006, INVEST OPHTH VIS SCI, V47, P4931, DOI 10.1167/iovs.06-0423; Stephen LJ, 2007, DEV BIOL, V302, P66, DOI 10.1016/j.ydbio.2006.08.058; Straub BK, 2003, J CELL SCI, V116, P4985, DOI 10.1242/jcs.00815; Sugiyama Y, 2010, DEV BIOL, V338, P193, DOI 10.1016/j.ydbio.2009.11.033; Takemoto M, 2002, EUR J NEUROSCI, V16, P1168, DOI 10.1046/j.1460-9568.2002.02166.x; Tan W, 2011, MOL VIS, V17, P1553; Xu L, 2002, EXP EYE RES, V74, P753, DOI 10.1006/exer.2002.1175; Yamamoto N, 2008, MED MOL MORPHOL, V41, P83, DOI 10.1007/s00795-008-0395-x; Zampighi GA, 2000, EXP EYE RES, V71, P415, DOI 10.1006/exer.2000.0895; Zhang TX, 2009, HUM MUTAT, V30, pE603, DOI 10.1002/humu.20995	41	35	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2011	6	11							e28147	10.1371/journal.pone.0028147	http://dx.doi.org/10.1371/journal.pone.0028147			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863LT	22140528	gold, Green Submitted, Green Published			2022-12-27	WOS:000298166300031
J	Fialova, L; Bartos, A; Svarcova, J; Malbohan, I				Fialova, Lenka; Bartos, Ales; Svarcova, Jana; Malbohan, Ivan			Increased Intrathecal High-Avidity Anti-Tau Antibodies in Patients with Multiple Sclerosis	PLOS ONE			English	Article							IMMUNOGLOBULIN-G AVIDITY; CEREBROSPINAL-FLUID ANTIBODIES; AXONAL CYTOSKELETAL PROTEINS; NEUROFILAMENT SUBUNIT; VIRUS-INFECTION; SERUM; AUTOANTIBODIES; CELLS; LIGHT; AUTOIMMUNITY	Background: Antibodies against tau protein indicate an interaction between the immune system and the neurocytoskeleton and therefore may reflect axonal injury in multiple sclerosis (MS). Methodology/Principal Findings: The levels and avidities of anti-tau IgG antibodies were measured using ELISA in paired cerebrospinal fluid (CSF) and serum samples obtained from 49 MS patients and 47 controls. Anti-tau antibodies were significantly elevated intrathecally (p < 0.0001) in the MS group. The CSF anti-tau antibody levels were lower in MS patients receiving therapy than those without treatment (p < 0.05). The avidities of anti-tau antibodies were higher in the CSF than in the serum (MS group p < 0.0001; controls p < 0.005). Anti-tau avidities in the CSF were elevated in MS patients in comparison with controls (p < 0.05), but not in serum. Conclusions: MS patients have higher levels of intrathecal anti-tau antibodies. Anti-tau antibodies have different avidities in different compartments with the highest values in the CSF of MS patients.	[Fialova, Lenka; Malbohan, Ivan] Charles Univ Prague, Inst Med Biochem, Fac Med 1, Prague, Czech Republic; [Bartos, Ales] Charles Univ Prague, Dept Neurol, Fac Med 3, Univ Hosp Kralovske Vinohrady, Prague, Czech Republic; [Bartos, Ales; Svarcova, Jana] Prague Psychiat Ctr, Prague, Czech Republic; [Svarcova, Jana; Malbohan, Ivan] Charles Univ Prague, Inst Clin Biochem & Lab Diagnost, Fac Med 1, Gen Teaching Hosp, Prague, Czech Republic	Charles University Prague; Charles University Prague; University Hospital Vinohrady; Charles University Prague; General University Hospital Prague	Fialova, L (corresponding author), Charles Univ Prague, Inst Med Biochem, Fac Med 1, Prague, Czech Republic.	bartos@pcp.lf3.cuni.cz	Bartos, Ales/C-4353-2019; Fialová, Lenka/G-9419-2017; Malbohan, Ivan/K-2807-2017	Bartos, Ales/0000-0002-8020-8252; Fialová, Lenka/0000-0001-8137-7771; Malbohan, Ivan/0000-0003-1714-0192	Ministry of Education, Youth and Sports [0021620816]; Ministry of Health [10369-3]; Czech Academy of Sciences GA AV CR [KAN200520701]	Ministry of Education, Youth and Sports(Ministry of Education, Youth & Sports - Czech Republic); Ministry of Health; Czech Academy of Sciences GA AV CR	The study was supported by research project 0021620816 from the Ministry of Education, Youth and Sports, by grant from the Ministry of Health No 10369-3 and by grant of Czech Academy of Sciences GA AV CR KAN200520701. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartos A, 2007, ACTA NEUROL SCAND, V116, P100, DOI 10.1111/j.1600-0404.2006.00794.x; Bartos A, 2003, J NEUROL, V250, P1420, DOI 10.1007/s00415-003-0202-5; Bartos A, 2007, J NEUROL, V254, P20, DOI 10.1007/s00415-006-0185-0; BINDER LI, 1985, J CELL BIOL, V101, P1371, DOI 10.1083/jcb.101.4.1371; Brettschneider J, 2006, MULT SCLER J, V12, P143, DOI 10.1191/135248506ms1263oa; Brettschneider J, 2005, MULT SCLER J, V11, P261, DOI 10.1191/1352458505ms1159oa; CLEVELAND DW, 1977, J MOL BIOL, V116, P207, DOI 10.1016/0022-2836(77)90213-3; Cucnik S, 2004, ANN RHEUM DIS, V63, P1478, DOI 10.1136/ard.2003.017939; Cui Z, 2006, KIDNEY INT, V69, P894, DOI 10.1038/sj.ki.5000135; DRUBIN DG, 1986, J CELL BIOL, V103, P2739, DOI 10.1083/jcb.103.6.2739; Ehling R, 2004, MULT SCLER J, V10, P601, DOI 10.1191/1352458504ms1100oa; Fialova L, 2009, FOLIA BIOL-PRAGUE, V55, P23; Flori P, 2004, CLIN DIAGN LAB IMMUN, V11, P669, DOI 10.1128/CDLI.11.4.669-674.2004; Graus F, 2010, J NEUROL, V257, P509, DOI 10.1007/s00415-009-5431-9; HEDMAN K, 1989, J MED VIROL, V27, P293, DOI 10.1002/jmv.1890270407; HIMMLER A, 1989, MOL CELL BIOL, V9, P1381, DOI 10.1128/MCB.9.4.1381; Huizinga R, 2008, TRENDS IMMUNOL, V29, P54, DOI 10.1016/j.it.2007.11.002; Huizinga R, 2007, J NEUROPATH EXP NEUR, V66, P295, DOI 10.1097/nen.0b013e318040ad5c; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lublin FD, 1996, NEUROLOGY, V46, P907, DOI 10.1212/WNL.46.4.907; Matheus S, 2005, J CLIN MICROBIOL, V43, P2793, DOI 10.1128/JCM.43.6.2793-2797.2005; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; McFarland HF, 2007, NAT IMMUNOL, V8, P913, DOI 10.1038/ni1507; Milosevic-Jovcic N, 2004, RHEUMATOLOGY, V43, P1190, DOI 10.1093/rheumatology/keh287; Narita M, 1996, CLIN DIAGN LAB IMMUN, V3, P211, DOI 10.1128/CDLI.3.2.211-215.1996; Niebroj-Dobosz I, 2006, FOLIA NEUROPATHOL, V44, P191; Racke MK, 2008, CURR OPIN NEUROL, V21, pS9, DOI 10.1097/01.wco.0000313359.61176.15; Rosenmann H, 2006, NEUROSCI LETT, V410, P90, DOI 10.1016/j.neulet.2006.01.072; Rosenmann H, 2006, ARCH NEUROL-CHICAGO, V63, P1459, DOI 10.1001/archneur.63.10.1459; Semra YK, 2002, J NEUROIMMUNOL, V122, P132, DOI 10.1016/S0165-5728(01)00455-6; Silber E, 2002, NEUROLOGY, V58, P1372, DOI 10.1212/WNL.58.9.1372; Svarcova J, 2008, EUR J NEUROL, V15, P1173, DOI 10.1111/j.1468-1331.2008.02223.x; Terryberry JW, 1998, NEUROBIOL AGING, V19, P205, DOI 10.1016/S0197-4580(98)00049-9; Terzi M, 2007, ACTA NEUROL SCAND, V115, P325, DOI 10.1111/j.1600-0404.2007.00782.x; Villalta D, 2003, LUPUS, V12, P31, DOI 10.1191/0961203303lu277oa; Zamecnik J, 2004, Cesk Patol, V40, P63	36	26	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2011	6	11							e27476	10.1371/journal.pone.0027476	http://dx.doi.org/10.1371/journal.pone.0027476			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863LT	22140442	Green Submitted, Green Published, gold			2022-12-27	WOS:000298166300005
J	Richardson, K; Weinberg, A				Richardson, Kelly; Weinberg, Adriana			Dynamics of Regulatory T-Cells during Pregnancy: Effect of HIV Infection and Correlations with Other Immune Parameters	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ANTIRETROVIRAL THERAPY; ACTIVATION MARKERS; PERIPHERAL-BLOOD; TYPE-1 INFECTION; PRETERM DELIVERY; INCREASED RISK; CUTTING EDGE; VIRAL LOAD; DISEASE	Objectives: Regulatory T cells (Treg) increase in the context of HIV infection and pregnancy. We studied Treg subpopulations in HIV-infected and uninfected women during pregnancy and their relationship with inflammation, activation and cell-mediated immunity (CMI). Design and Methods: Blood obtained from 20 HIV-infected and 18 uninfected women during early and late gestation was used to measure Treg and activated T cells (Tact) by flow cytometry; plasma cytokines and inflammatory markers by ELISA and chemoluminescence; and CMI against varicella-zoster virus (VZV) by lymphocyte proliferation. Results and Conclusions: Compared with uninfected women, HIV-infected participants had higher frequencies of Treg subpopulations in early pregnancy, including CD4+CD25+FoxP3+%, CD8+CD25+FoxP3+%, CD4+TGF beta+% and CD4+IL10+%. In contrast, Treg frequencies were lower during late pregnancy in HIV-infected compared with uninfected women, including CD8+TGF beta+%, CD4+CTLA4+% and CD8+CTLA4+%. VZV-CMI, which was lower in HIV-infected compared with uninfected pregnant women, was inversely correlated with CD4+FoxP3+%, CD8+FoxP3+% and CD8+TGF beta+% in HIV-infected, but not in uninfected pregnant women. beta(2)-microglobulin, neopterin, IL1, IL4, IL8, IL10, IFN gamma and TNFA plasma concentrations as well as Tact were higher in HIV-infected compared with uninfected women throughout pregnancy. In HIV-infected, but not in uninfected women, inflammatory, Th1, Th2 and regulatory cytokines increased with higher Treg%, suggesting that inflammation and regulation have a common pathophysiologic origin in the context of HIV infection. In HIV-infected and more commonly in uninfected pregnant women, higher Treg% correlated with lower Tact%. We conclude that Treg have different dynamics during pregnancy in HIV-infected and uninfected women. Higher levels of inflammatory cytokines and lower Treg% during late pregnancy in HIV-infected women may contribute to their increased incidence of maternal-fetal morbidity.	[Richardson, Kelly; Weinberg, Adriana] Univ Colorado Denver, Dept Pediat, Aurora, CO 80045 USA; [Weinberg, Adriana] Univ Colorado Denver, Dept Med, Aurora, CO USA; [Weinberg, Adriana] Univ Colorado Denver, Dept Pathol, Aurora, CO USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Richardson, K (corresponding author), Univ Colorado Denver, Dept Pediat, Aurora, CO 80045 USA.	Adriana.Weinberg@ucdenver.edu			NIH/National Center for Research Resources Colorado CTSI [UL1 RR025780]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025780] Funding Source: NIH RePORTER	NIH/National Center for Research Resources Colorado CTSI; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was supported by the NIH/National Center for Research Resources Colorado CTSI grant UL1 RR025780. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aandahl EM, 2004, BLOOD, V104, P3672, DOI 10.1182/blood-2004-07-2540; Aandahl EM, 2004, J VIROL, V78, P2454, DOI 10.1128/JVI.78.5.2454-2459.2004; Adeegbe D, 2006, J IMMUNOL, V176, P7149, DOI 10.4049/jimmunol.176.12.7149; Aluvihare VR, 2004, NAT IMMUNOL, V5, P266, DOI 10.1038/ni1037; Andersson J, 2005, J IMMUNOL, V174, P3143, DOI 10.4049/jimmunol.174.6.3143; Blois SM, 2007, NAT MED, V13, P1450, DOI 10.1038/nm1680; Blois SM, 2004, J IMMUNOL, V172, P5893, DOI 10.4049/jimmunol.172.10.5893; Boasso A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002961; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; BRETTLE RP, 1995, AIDS, V9, P1177, DOI 10.1097/00002030-199510000-00010; Brooks DG, 2006, J CLIN INVEST, V116, P1675, DOI 10.1172/JCI26856; Burns DN, 1999, J REPROD IMMUNOL, V42, P147, DOI 10.1016/S0165-0378(98)00085-0; Cao W, 2009, AIDS RES HUM RETROV, V25, P183, DOI 10.1089/aid.2008.0140; Chase AJ, 2008, J VIROL, V82, P8307, DOI 10.1128/JVI.00520-08; Chikuma S, 2003, IMMUNOL RES, V28, P241, DOI 10.1385/IR:28:3:241; Confavreux C, 1998, NEW ENGL J MED, V339, P285, DOI 10.1056/NEJM199807303390501; Cotter AM, 2006, J INFECT DIS, V193, P1195, DOI 10.1086/503045; Dubicke A, 2010, J REPROD IMMUNOL, V84, P176, DOI 10.1016/j.jri.2009.12.004; Eggena MP, 2005, J IMMUNOL, V174, P4407, DOI 10.4049/jimmunol.174.7.4407; El-Bastawissi AY, 2000, OBSTET GYNECOL, V95, P1056, DOI 10.1016/S0029-7844(00)00875-9; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Epple HJ, 2006, BLOOD, V108, P3072, DOI 10.1182/blood-2006-04-016923; Fahey JL, 1998, AIDS, V12, P1581, DOI 10.1097/00002030-199813000-00004; Ford ES, 2010, AIDS, V24, P1509, DOI 10.1097/QAD.0b013e32833ad914; French MA, 2009, J INFECT DIS, V200, P1212, DOI 10.1086/605890; Georgiou HM, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.12.005; Giorgi JV, 1999, J INFECT DIS, V179, P859, DOI 10.1086/314660; Goldenberg RL, 2005, AM J OBSTET GYNECOL, V192, pS36, DOI 10.1016/j.ajog.2005.02.015; Gomez-Lopez N, 2010, BIOL REPROD, V82, P809, DOI 10.1095/biolreprod.109.080432; Gray RH, 2005, LANCET, V366, P1182, DOI 10.1016/S0140-6736(05)67481-8; Hata A, 2002, NEW ENGL J MED, V347, P26, DOI 10.1056/NEJMoa013441; Hebisch G, 2001, ACTA OBSTET GYN SCAN, V80, P840, DOI 10.1034/j.1600-0412.2001.080009840.x; Jain N, 2010, P NATL ACAD SCI USA, V107, P1524, DOI 10.1073/pnas.0910341107; Kalayjian RC, 2010, J INFECT DIS, V201, P1796, DOI 10.1086/652750; Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7; Kared H, 2008, AIDS, V22, P2451, DOI 10.1097/QAD.0b013e328319edc0; Kinter A, 2007, P NATL ACAD SCI USA, V104, P3390, DOI 10.1073/pnas.0611423104; Kinter AL, 2007, AIDS RES HUM RETROV, V23, P438, DOI 10.1089/aid.2006.0162; Kolte L, 2011, BLOOD, V117, P1861, DOI 10.1182/blood-2010-07-298992; Kourtis AP, 2006, AIDS, V20, P1823, DOI 10.1097/01.aids.0000244201.11006.1c; Kramer MS, 2010, CYTOKINE, V49, P10, DOI 10.1016/j.cyto.2009.08.014; Kuller LH, 2008, PLOS MED, V5, P1496, DOI 10.1371/journal.pmed.0050203; KUMAR RM, 1995, INT J GYNECOL OBSTET, V49, P137, DOI 10.1016/0020-7292(95)02356-H; Lim A, 2007, AIDS, V21, P1525, DOI 10.1097/QAD.0b013e32825eab8b; Maier CL, 2011, ARTERIOSCL THROM VAS, V31, P183, DOI 10.1161/ATVBAHA.110.217117; Marzi M, 1996, CLIN EXP IMMUNOL, V106, P127, DOI 10.1046/j.1365-2249.1996.d01-809.x; McClain MA, 2007, J IMMUNOL, V179, P8146, DOI 10.4049/jimmunol.179.12.8146; Mikyas Y, 1997, J REPROD IMMUNOL, V33, P157, DOI 10.1016/S0165-0378(97)00018-1; Montes M, 2011, J INFECT DIS, V203, P496, DOI 10.1093/infdis/jiq073; Neuhaus J, 2010, J INFECT DIS, V201, P1788, DOI 10.1086/652749; Nixon DF, 2005, MICROBES INFECT, V7, P1063, DOI 10.1016/j.micinf.2005.03.026; Patel K, 2010, J INFECT DIS, V201, P1035, DOI 10.1086/651232; RICH KC, 1995, J INFECT DIS, V172, P1221, DOI 10.1093/infdis/172.5.1221; Rodger AJ, 2009, J INFECT DIS, V200, P973, DOI 10.1086/605447; Romero R, 2007, SEMIN REPROD MED, V25, P21, DOI 10.1055/s-2006-956773; Santner-Nanan B, 2009, J IMMUNOL, V183, P7023, DOI 10.4049/jimmunol.0901154; Sharma D, 2011, HUM IMMUNOL, V72, P436, DOI 10.1016/j.humimm.2011.02.007; Somerset DA, 2004, IMMUNOLOGY, V112, P38, DOI 10.1111/j.1365-2567.2004.01869.x; Tenorio AR, 2008, JAIDS-J ACQ IMM DEF, V48, P577, DOI 10.1097/QAI.0b013e31817bbea5; Tovar-Salazar A, 2010, VIROLOGY, V398, P158, DOI 10.1016/j.virol.2009.11.038; Wang WJ, 2010, HUM REPROD, V25, P2591, DOI 10.1093/humrep/deq198; WEGMANN TG, 1993, IMMUNOL TODAY, V14, P353, DOI 10.1016/0167-5699(93)90235-D; Weinberg A, 2010, J ACQUIR IMMUNE DEFI; Weinberg A, 2009, J INFECT DIS, V200, P1068, DOI 10.1086/605611; Weinberg A, 2009, CLIN VACCINE IMMUNOL, V16, P1176, DOI 10.1128/CVI.00342-08; Zenclussen AC, 2005, AM J PATHOL, V166, P811, DOI 10.1016/S0002-9440(10)62302-4	66	19	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2011	6	11							e28172	10.1371/journal.pone.0028172	http://dx.doi.org/10.1371/journal.pone.0028172			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863LT	22140535	Green Submitted, Green Published, gold			2022-12-27	WOS:000298166300035
J	Ung, CY; Lam, SH; Zhang, X; Li, H; Ma, J; Zhang, LX; Li, BW; Gong, ZY				Ung, Choong Yong; Lam, Siew Hong; Zhang, Xun; Li, Hu; Ma, Jing; Zhang, Louxin; Li, Baowen; Gong, Zhiyuan			Existence of Inverted Profile in Chemically Responsive Molecular Pathways in the Zebrafish Liver	PLOS ONE			English	Article							HEPATIC GENE-EXPRESSION; DANIO-RERIO; SPOTTED-MICROARRAY; PARA-NITROPHENOL; HUMAN EXPOSURE; AMINO-ACIDS; YIN-YANG; METABOLISM; RATS; TOXICITY	How a living organism maintains its healthy equilibrium in response to endless exposure of potentially harmful chemicals is an important question in current biology. By transcriptomic analysis of zebrafish livers treated by various chemicals, we defined hubs as molecular pathways that are frequently perturbed by chemicals and have high degree of functional connectivity to other pathways. Our network analysis revealed that these hubs were organized into two groups showing inverted functionality with each other. Intriguingly, the inverted activity profiles in these two groups of hubs were observed to associate only with toxicopathological states but not with physiological changes. Furthermore, these inverted profiles were also present in rat, mouse, and human under certain toxicopathological conditions. Thus, toxicopathological-associated anti-correlated profiles in hubs not only indicate their potential use in diagnosis but also development of systems-based therapeutics to modulate gene expression by chemical approach in order to rewire the deregulated activities of hubs back to normal physiology.	[Ung, Choong Yong; Lam, Siew Hong; Gong, Zhiyuan] Natl Univ Singapore, Dept Biol Sci, Queenstown, Singapore; [Ung, Choong Yong; Zhang, Louxin] Natl Univ Singapore, Dept Math, Queenstown, Singapore; [Zhang, Xun; Ma, Jing; Zhang, Louxin; Li, Baowen] Natl Univ Singapore, Grad Sch Integrat Sci & Engn, Queenstown, Singapore; [Zhang, Xun; Ma, Jing; Li, Baowen] Natl Univ Singapore, Dept Phys, Queenstown, Singapore; [Zhang, Xun; Ma, Jing; Li, Baowen] Natl Univ Singapore, Ctr Computat Sci & Engn, Queenstown, Singapore; [Li, Hu] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA	National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; Boston University	Ung, CY (corresponding author), Natl Univ Singapore, Dept Biol Sci, Queenstown, Singapore.	matucy@nus.edu.sg; dbsgzy@nus.edu.sg	Gong, Zhiyuan/H-8794-2012; Ung, Choong Yong/D-4525-2012; Zhang, Louxin/M-4865-2016; Lam, Siew Hong/H-8483-2012; Li, Baowen/G-3003-2011	Gong, Zhiyuan/0000-0002-9660-5260; Zhang, Louxin/0000-0003-0260-824X; Li, Baowen/0000-0002-8728-520X	Environment and Water Industry Grant of Singapore	Environment and Water Industry Grant of Singapore	This work was supported by Environment and Water Industry Grant of Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhouri Naim, 2009, Expert Rev Gastroenterol Hepatol, V3, P445, DOI 10.1586/egh.09.32; Anderson SP, 2002, HEPATOLOGY, V36, P544, DOI 10.1053/jhep.2002.35276; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Chen F, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-240; Chowdhury TR, 1999, NATURE, V401, P545, DOI 10.1038/44056; Clarkson TW, 2002, ENVIRON HEALTH PERSP, V110, P11, DOI 10.1289/ehp.02110s111; De Wit M, 2010, GEN COMP ENDOCR, V167, P190, DOI 10.1016/j.ygcen.2010.03.003; Dennis JW, 2009, CELL, V139, P1229, DOI 10.1016/j.cell.2009.12.008; Drew RE, 2008, PHYSIOL GENOMICS, V35, P283, DOI 10.1152/physiolgenomics.90213.2008; Dueber JE, 2004, CURR OPIN STRUC BIOL, V14, P690, DOI 10.1016/j.sbi.2004.10.004; Esteban E, 1996, J EXPO ANAL ENV EPID, V6, P375; Gatfield D, 2007, SCIENCE, V316, P1135, DOI 10.1126/science.1144165; Hamadeh HK, 2002, TOXICOL SCI, V67, P219, DOI 10.1093/toxsci/67.2.219; Hamel FG, 2003, METABOLISM, V52, P810, DOI 10.1016/S0026-0495(03)00094-5; Heinloth AN, 2004, TOXICOL SCI, V80, P193, DOI 10.1093/toxsci/kfh145; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Hoffmann JL, 2006, AQUAT TOXICOL, V79, P233, DOI 10.1016/j.aquatox.2006.06.009; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Huang QH, 2004, MUTAT RES-FUND MOL M, V549, P147, DOI 10.1016/j.mrfmmm.2003.12.020; Hylander LD, 2006, SCI TOTAL ENVIRON, V368, P352, DOI 10.1016/j.scitotenv.2005.11.029; Ji JF, 2010, J HEPATOL, V53, P974, DOI 10.1016/j.jhep.2010.07.001; Kitano H, 2007, NAT REV DRUG DISCOV, V6, P202, DOI 10.1038/nrd2195; Kummer V, 2008, TOXICOL LETT, V180, P212, DOI 10.1016/j.toxlet.2008.06.862; La Thangue NB, 2003, NAT CELL BIOL, V5, P587, DOI 10.1038/ncb0703-587; Lam SH, 2006, NAT BIOTECHNOL, V24, P73, DOI 10.1038/nbt1169; Lam SH, 2006, PHYSIOL GENOMICS, V27, P351, DOI 10.1152/physiolgenomics.00201.2005; Lam Siew Hong, 2009, V546, P175, DOI 10.1007/978-1-60327-977-2_12; Lam Siew Hong, 2009, V546, P197, DOI 10.1007/978-1-60327-977-2_13; Lam SH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000121; Lehar J, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100116; Li CM, 2006, TOXICOL APPL PHARM, V217, P1, DOI 10.1016/j.taap.2006.06.010; Liu XE, 2010, LIVER INT, V30, P1221, DOI 10.1111/j.1478-3231.2010.02279.x; Luch A, 2005, NAT REV CANCER, V5, P113, DOI 10.1038/nrc1546; MacArthur BD, 2009, NAT REV MOL CELL BIO, V10, P672, DOI 10.1038/nrm2766; Michalak A, 1996, HEPATOLOGY, V24, P908, DOI 10.1002/hep.510240425; Ortiz PA, 2010, J PROTEOME RES, V9, P1268, DOI 10.1021/pr900755q; Ou BX, 2003, FASEB J, V17, P127, DOI 10.1096/fj.02-0527hyp; Pizon AF, 2009, CLIN TOXICOL, V47, P132, DOI 10.1080/15563650801971390; Reddy AB, 2006, CURR BIOL, V16, P1107, DOI 10.1016/j.cub.2006.04.026; Robison BD, 2008, COMP BIOCHEM PHYS D, V3, P141, DOI 10.1016/j.cbd.2008.01.001; Ruepp SU, 2002, TOXICOL SCI, V65, P135, DOI 10.1093/toxsci/65.1.135; Sachdeva M, 2009, CELL CYCLE, V8, P1303, DOI 10.4161/cc.8.9.8362; SHAPIRO B, 1967, ANNU REV BIOCHEM, V36, P247, DOI 10.1146/annurev.bi.36.070167.001335; SMITH LW, 1988, DRUG CHEM TOXICOL, V11, P319, DOI 10.3109/01480548809017886; Spicker JS, 2008, TOXICOL SCI, V102, P444, DOI 10.1093/toxsci/kfn001; Strogatz SH, 2001, NONLINEAR DYNAMICS C, P512; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Symonds ME, 2009, NAT REV ENDOCRINOL, V5, P604, DOI 10.1038/nrendo.2009.195; Tugues S, 2005, GASTROENTEROLOGY, V129, P1686, DOI 10.1053/j.gastro.2005.09.006; Ung CY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-212; Vanhooren V, 2009, MECH AGEING DEV, V130, P92, DOI 10.1016/j.mad.2008.11.008; Yang LX, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r227; Yang MH, 2006, J ENVIRON SCI HEAL C, V24, P183, DOI 10.1080/10590500600936474; Yi CX, 2010, BBA-MOL BASIS DIS, V1802, P416, DOI 10.1016/j.bbadis.2010.01.006; Zimmermann GR, 2007, DRUG DISCOV TODAY, V12, P34, DOI 10.1016/j.drudis.2006.11.008	56	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2011	6	11							e27819	10.1371/journal.pone.0027819	http://dx.doi.org/10.1371/journal.pone.0027819			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863LT	22140468	Green Published, gold, Green Submitted			2022-12-27	WOS:000298166300011
J	Weber, T; Schonig, K; Tews, B; Bartsch, D				Weber, Tillmann; Schoenig, Kai; Tews, Bjoern; Bartsch, Dusan			Inducible Gene Manipulations in Brain Serotonergic Neurons of Transgenic Rats	PLOS ONE			English	Article							KNOCKOUT RATS; STEM-CELLS; MICE; MUTAGENESIS; GENERATION; SYSTEM; GLIA; TOOL	The serotonergic (5-HT) system has been implicated in various physiological processes and neuropsychiatric disorders, but in many aspects its role in normal and pathologic brain function is still unclear. One reason for this might be the lack of appropriate animal models which can address the complexity of physiological and pathophysiological 5-HT functioning. In this respect, rats offer many advantages over mice as they have been the animal of choice for sophisticated neurophysiological and behavioral studies. However, only recently technologies for the targeted and tissue specific modification of rat genes - a prerequisite for a detailed study of the 5-HT system - have been successfully developed. Here, we describe a rat transgenic system for inducible gene manipulations in 5-HT neurons. We generated a Cre driver line consisting of a tamoxifen-inducible CreERT2 recombinase under the control of mouse Tph2 regulatory sequences. Tissue-specific serotonergic Cre recombinase expression was detected in four transgenic TPH2-CreERT2 rat founder lines. For functional analysis of Cre-mediated recombination, we used a rat Cre reporter line (CAG-loxP.EGFP), in which EGFP is expressed after Cre-mediated removal of a loxP-flanked lacZ STOP cassette. We show an in-depth characterisation of this rat Cre reporter line and demonstrate its applicability for monitoring Cre-mediated recombination in all major neuronal subpopulations of the rat brain. Upon tamoxifen induction, double transgenic TPH2-CreERT2/CAG-loxP. EGFP rats show selective and efficient EGFP expression in 5-HT neurons. Without tamoxifen administration, EGFP is only expressed in few 5-HT neurons which confirms minimal background recombination. This 5-HT neuron specific CreERT2 line allows Cre-mediated, inducible gene deletion or gene overexpression in transgenic rats which provides new opportunities to decipher the complex functions of the mammalian serotonergic system.	[Weber, Tillmann; Schoenig, Kai; Bartsch, Dusan] Cent Inst Mental Hlth, Dept Mol Biol, D-6800 Mannheim, Germany; [Weber, Tillmann] Cent Inst Mental Hlth, Dept Addict Behav & Addict Med, D-6800 Mannheim, Germany; [Weber, Tillmann] Cent Inst Mental Hlth, Dept Psychiat & Psychotherapy, D-6800 Mannheim, Germany; [Tews, Bjoern] Swiss Fed Inst Technol, Brain Res Inst, Zurich, Switzerland; [Bartsch, Dusan] Heidelberg Univ, Med Fac Mannheim, D-6800 Mannheim, Germany	Central Institute of Mental Health; Central Institute of Mental Health; Central Institute of Mental Health; ETH Zurich; Ruprecht Karls University Heidelberg	Weber, T (corresponding author), Cent Inst Mental Hlth, Dept Mol Biol, D-6800 Mannheim, Germany.	dusan.bartsch@zi-mannheim.de			German Ministry for Education and Research (BMBF) [01GQ1003B]; National Bernstein Network for Computational Neuroscience [HEALTH-F2-2007-201714]; Deutsche Forschungsgemeinschaft [SFB 636]	German Ministry for Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); National Bernstein Network for Computational Neuroscience; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was funded by grants from the German Ministry for Education and Research (BMBF, 01GQ1003B) National Bernstein Network for Computational Neuroscience (http://www.gesundheitsforschung-bmbf.de/en/2478.php#Heidelberg), HEALTH-F2-2007-201714 DEVANX (http://devanx.vitamib.com), and the Deutsche Forschungsgemeinschaft SFB 636 (http://www.sfb636.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitman TJ, 2008, NAT GENET, V40, P516, DOI 10.1038/ng.147; Alenina N, 2009, P NATL ACAD SCI USA, V106, P10332, DOI 10.1073/pnas.0810793106; Audero E, 2008, SCIENCE, V321, P130, DOI 10.1126/science.1157871; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Brown BD, 2009, NAT REV GENET, V10, P578, DOI 10.1038/nrg2628; Buchanan GF, 2010, P NATL ACAD SCI USA, V107, P16354, DOI 10.1073/pnas.1004587107; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; Chandler KJ, 2007, MAMM GENOME, V18, P693, DOI 10.1007/s00335-007-9056-y; Cools R, 2008, TRENDS COGN SCI, V12, P31, DOI 10.1016/j.tics.2007.10.011; Cui XX, 2011, NAT BIOTECHNOL, V29, P64, DOI 10.1038/nbt.1731; Dai JX, 2008, P NATL ACAD SCI USA, V105, P11981, DOI 10.1073/pnas.0801329105; Dayan P, 2009, ANNU REV NEUROSCI, V32, P95, DOI 10.1146/annurev.neuro.051508.135607; Deisseroth K, 2006, J NEUROSCI, V26, P10380, DOI 10.1523/JNEUROSCI.3863-06.2006; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Giraldo P, 2001, TRANSGENIC RES, V10, P83, DOI 10.1023/A:1008918913249; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Hakamata Y, 2001, BIOCHEM BIOPH RES CO, V286, P779, DOI 10.1006/bbrc.2001.5452; Hodges MR, 2008, J NEUROSCI, V28, P2495, DOI 10.1523/JNEUROSCI.4729-07.2008; Hodges MR, 2009, J NEUROSCI, V29, P10341, DOI 10.1523/JNEUROSCI.1963-09.2009; Homberg JR, 2007, NEUROSCIENCE, V146, P1662, DOI 10.1016/j.neuroscience.2007.03.030; Izsvak Z, 2010, NAT METHODS, V7, P443, DOI [10.1038/NMETH.1461, 10.1038/nmeth.1461]; Jacob HJ, 2010, TRENDS GENET, V26, P510, DOI 10.1016/j.tig.2010.08.006; Kim JC, 2009, NEURON, V63, P305, DOI 10.1016/j.neuron.2009.07.010; Kiyasova V, 2011, J NEUROSCI, V31, P2756, DOI 10.1523/JNEUROSCI.4080-10.2011; Lagace DC, 2007, J NEUROSCI, V27, P12623, DOI 10.1523/JNEUROSCI.3812-07.2007; Leonardo ED, 2008, NEUROPSYCHOPHARMACOL, V33, P134, DOI 10.1038/sj.npp.1301569; Leone DP, 2003, MOL CELL NEUROSCI, V22, P430, DOI 10.1016/S1044-7431(03)00029-0; Li MA, 2011, NAT BIOTECHNOL, V29, P39, DOI 10.1038/nbt.1749; Li T, 2011, NUCL ACIDS RES; Liu C, 2010, NAT NEUROSCI, V13, P1190, DOI 10.1038/nn.2623; Michalkiewicz M, 2007, AM J PHYSIOL-HEART C, V293, pH881, DOI 10.1152/ajpheart.00060.2007; Mori T, 2006, GLIA, V54, P21, DOI 10.1002/glia.20350; Murphy DL, 2008, NEUROPHARMACOLOGY, V55, P932, DOI 10.1016/j.neuropharm.2008.08.034; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Rogers RD, 2011, NEUROPSYCHOPHARMACOL, V36, P114, DOI 10.1038/npp.2010.165; Sato Y, 2004, BIOCHEM BIOPH RES CO, V319, P1197, DOI 10.1016/j.bbrc.2004.04.204; Schonig K, 2011, TRANSGENIC RES, V20, P709, DOI 10.1007/s11248-010-9427-0; Scott MM, 2005, P NATL ACAD SCI USA, V102, P16472, DOI 10.1073/pnas.0504510102; Smits BMG, 2006, PHARMACOGENET GENOM, V16, P159; Song NN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015998; Walther DJ, 2003, SCIENCE, V299, P76, DOI 10.1126/science.1078197; Weber T, 2009, FRONT MOL NEUROSCI, V2, DOI 10.3389/neuro.02.024.2009; Zan YH, 2003, NAT BIOTECHNOL, V21, P645, DOI 10.1038/nbt830; Zhao ZQ, 2007, P NATL ACAD SCI USA, V104, P14519, DOI 10.1073/pnas.0705740104; Zhao ZQ, 2007, J NEUROSCI, V27, P6045, DOI 10.1523/JNEUROSCI.1623-07.2007	46	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2011	6	11							e28283	10.1371/journal.pone.0028283	http://dx.doi.org/10.1371/journal.pone.0028283			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863LT	22140568	Green Published, gold, Green Submitted			2022-12-27	WOS:000298166300045
J	Kumar, V; Sivaraman, J				Kumar, Veerendra; Sivaraman, J.			A Conformational Switch in the Active Site of BT_2972, a Methyltransferase from an Antibiotic Resistant Pathogen B. thetaiotaomicron	PLOS ONE			English	Article							S-ADENOSYLMETHIONINE; CRYSTAL-STRUCTURE; BACTEROIDES-THETAIOTAOMICRON; MYCOBACTERIUM-TUBERCULOSIS; ESCHERICHIA-COLI; BIOSYNTHESIS; SUBSTRATE; BINDING; TOOL; PROTEINS	Methylation is one of the most common biochemical reactions involved in cellular and metabolic functions and is catalysed by the action of methyltransferases. Bacteroides thetaiotaomicron is an antibiotic-resistant bacterium that confers resistance through methylation, and as yet, there is no report on the structure of methyltransferases from this bacterium. Here, we report the crystal structure of an AdoMet-dependent methyltransferase, BT_2972 and its complex with AdoMet and AdoHcy for B. thetaiotaomicron VPI-5482 strain along with isothermal titration calorimetric assessment of the binding affinities. Comparison of the apo and complexed BT_2972 structures reveals a significant conformational change between open and closed forms of the active site that presumably regulates the association with cofactors and may aid interaction with substrate. Together, our analysis suggests that BT_2972 is a small molecule methyltransferase and might catalyze two O-methylation reaction steps involved in the ubiquinone biosynthesis pathway.	[Kumar, Veerendra; Sivaraman, J.] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore	National University of Singapore	Kumar, V (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore.	dbsjayar@nus.edu.sg	Sivaraman, J/H-8028-2012	Kumar, Veerendra/0000-0002-9241-1303; J, Sivaraman/0000-0001-9781-5326	Biomedical Research Council of Singapore (BMRC), A*STAR [R154000362305]; National University of Singapore (NUS)	Biomedical Research Council of Singapore (BMRC), A*STAR(Agency for Science Technology & Research (A*STAR)); National University of Singapore (NUS)(National University of Singapore)	The authors are grateful to the Biomedical Research Council of Singapore (BMRC), A*STAR for providing a research grant (R154000362305) to support this study. X-ray diffraction data were measured at beam line X-12B1 of National Synchrotron Radiation Research Centre (NSRRC), Taiwan. VK is a graduate scholar in receipt of a research scholarship from the National University of Singapore (NUS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; Bjursell MK, 2006, J BIOL CHEM, V281, P36269, DOI 10.1074/jbc.M606509200; Boissier F, 2006, J BIOL CHEM, V281, P4434, DOI 10.1074/jbc.M510250200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bujnicki Janusz M., 1999, In Silico Biology, V1, P175; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; DeLano WL, 2005, ABSTR PAP AM CHEM S, V230, pU1371; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gonzalez B, 2004, J MOL BIOL, V338, P771, DOI 10.1016/j.jmb.2004.03.005; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Griffith SC, 2001, J MOL BIOL, V313, P1103, DOI 10.1006/jmbi.2001.5095; HENGEN PN, 1995, TRENDS BIOCHEM SCI, V20, P285, DOI 10.1016/S0968-0004(00)89045-3; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Huang CC, 2002, J BIOL CHEM, V277, P11559, DOI 10.1074/jbc.M111698200; Kozbial PZ, 2005, BMC STRUCT BIOL, V5, DOI 10.1186/1472-6807-5-19; Kumar V, 2011, J STRUCTURA IN PRESS; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lim K, 2001, PROTEINS, V45, P397, DOI 10.1002/prot.10004; Loenen WAM, 2006, BIOCHEM SOC T, V34, P330, DOI 10.1042/BST0340330; Martin JL, 2002, CURR OPIN STRUC BIOL, V12, P783, DOI 10.1016/S0959-440X(02)00391-3; McFerrin MB, 2002, J APPL CRYSTALLOGR, V35, P538, DOI 10.1107/S0021889802009238; Meganathan R, 2001, FEMS MICROBIOL LETT, V203, P131, DOI 10.1016/S0378-1097(01)00330-5; Miller DJ, 2003, PROTEIN SCI, V12, P1432, DOI 10.1110/ps.0302403; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pierce MM, 1999, METHODS, V19, P213, DOI 10.1006/meth.1999.0852; Poon WW, 1999, J BIOL CHEM, V274, P21665, DOI 10.1074/jbc.274.31.21665; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Schubert HL, 2003, TRENDS BIOCHEM SCI, V28, P329, DOI 10.1016/S0968-0004(03)00090-2; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Tsuji E, 2009, J STRUCT BIOL, V165, P133, DOI 10.1016/j.jsb.2008.11.012; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029	33	1	1	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2011	6	11							e27543	10.1371/journal.pone.0027543	http://dx.doi.org/10.1371/journal.pone.0027543			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KW	22140448	Green Published, gold, Green Submitted			2022-12-27	WOS:000298163400009
J	Flores, GE; Bates, ST; Knights, D; Lauber, CL; Stombaugh, J; Knight, R; Fierer, N				Flores, Gilberto E.; Bates, Scott T.; Knights, Dan; Lauber, Christian L.; Stombaugh, Jesse; Knight, Rob; Fierer, Noah			Microbial Biogeography of Public Restroom Surfaces	PLOS ONE			English	Article							BACTERIAL COMMUNITY; JAPANESE HOUSEHOLDS; COLLEGE-STUDENTS; DIVERSITY; CONTAMINATION; BATHROOMS; INFECTION; PATHOGENS; SEQUENCES; SURVIVAL	We spend the majority of our lives indoors where we are constantly exposed to bacteria residing on surfaces. However, the diversity of these surface-associated communities is largely unknown. We explored the biogeographical patterns exhibited by bacteria across ten surfaces within each of twelve public restrooms. Using high-throughput barcoded pyrosequencing of the 16 S rRNA gene, we identified 19 bacterial phyla across all surfaces. Most sequences belonged to four phyla: Actinobacteria, Bacteriodetes, Firmicutes and Proteobacteria. The communities clustered into three general categories: those found on surfaces associated with toilets, those on the restroom floor, and those found on surfaces routinely touched with hands. On toilet surfaces, gut-associated taxa were more prevalent, suggesting fecal contamination of these surfaces. Floor surfaces were the most diverse of all communities and contained several taxa commonly found in soils. Skin-associated bacteria, especially the Propionibacteriaceae, dominated surfaces routinely touched with our hands. Certain taxa were more common in female than in male restrooms as vagina-associated Lactobacillaceae were widely distributed in female restrooms, likely from urine contamination. Use of the SourceTracker algorithm confirmed many of our taxonomic observations as human skin was the primary source of bacteria on restroom surfaces. Overall, these results demonstrate that restroom surfaces host relatively diverse microbial communities dominated by human-associated bacteria with clear linkages between communities on or in different body sites and those communities found on restroom surfaces. More generally, this work is relevant to the public health field as we show that human-associated microbes are commonly found on restroom surfaces suggesting that bacterial pathogens could readily be transmitted between individuals by the touching of surfaces. Furthermore, we demonstrate that we can use high-throughput analyses of bacterial communities to determine sources of bacteria on indoor surfaces, an approach which could be used to track pathogen transmission and test the efficacy of hygiene practices.	[Flores, Gilberto E.; Bates, Scott T.; Lauber, Christian L.; Fierer, Noah] Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA; [Knights, Dan] Univ Colorado, Dept Comp Sci, Boulder, CO 80309 USA; [Stombaugh, Jesse; Knight, Rob] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; [Knight, Rob] Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA; [Fierer, Noah] Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Flores, GE (corresponding author), Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA.	noah.fierer@colorado.edu	Knight, Rob/D-1299-2010	Bates, Scott/0000-0002-6184-4296; Knight, Rob/0000-0002-0975-9019; Flores, Gilberto/0000-0002-3338-611X; Stombaugh, Jesse/0000-0001-9631-0748; FIERER, NOAH/0000-0002-6432-4261	Alfred P. Sloan Foundation; National Institutes of Health; Howard Hughes Medical Institute	Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This work was supported with funding from the Alfred P. Sloan Foundation and their Indoor Environment program, and in part by the National Institutes of Health and the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JL, 2008, AM J INFECT CONTROL, V36, P361, DOI 10.1016/j.ajic.2007.09.007; Barker J, 2000, J APPL MICROBIOL, V89, P137, DOI 10.1046/j.1365-2672.2000.01091.x; Barker J, 2005, J APPL MICROBIOL, V99, P339, DOI 10.1111/j.1365-2672.2005.02610.x; Bowers RM, 2011, APPL ENVIRON MICROB, V77, P6350, DOI 10.1128/AEM.05498-11; Brooke JS, 2009, J ENVIRON HEALTH, V71, P17; Bures S, 2000, AM J INFECT CONTROL, V28, P465, DOI 10.1067/mic.2000.107267; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Claesson MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006669; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dong QF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019709; Drankiewicz D, 2003, AM J INFECT CONTROL, V31, P67, DOI 10.1067/mic.2003.6; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Faith DP, 2006, EVOL BIOINFORM, V2, P121; Fierer N, 2007, APPL ENVIRON MICROB, V73, P7059, DOI 10.1128/AEM.00358-07; Fierer N, 2010, P NATL ACAD SCI USA, V107, P6477, DOI 10.1073/pnas.1000162107; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; GERBA CP, 1975, APPL MICROBIOL, V30, P229, DOI 10.1128/AEM.30.2.229-237.1975; Gorley C.K., 2006, GETTING STARTED PRIM; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Kelley ST, 2004, APPL ENVIRON MICROB, V70, P4187, DOI 10.1128/AEM.70.7.4187-4192.2004; KNIGHTS D, 2011, NATURE METHODS; Lamont RF, 2011, BJOG-INT J OBSTET GY, V118, P533, DOI 10.1111/j.1471-0528.2010.02840.x; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Lee L, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-27; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; McManus CJ, 2005, J APPL MICROBIOL, V99, P502, DOI 10.1111/j.1365-2672.2005.02651.x; Medrano-Felix A, 2011, J APPL MICROBIOL, V110, P463, DOI 10.1111/j.1365-2672.2010.04901.x; Morawska L, 2006, INDOOR AIR, V16, P335, DOI 10.1111/j.1600-0668.2006.00432.x; Nelson DE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014116; NOSKIN GA, 1995, INFECT CONT HOSP EP, V16, P577; Ojima M, 2002, INT J ENVIRON HEAL R, V12, P41, DOI 10.1080/09603120120110040; Ojima M, 2002, J APPL MICROBIOL, V93, P800, DOI 10.1046/j.1365-2672.2002.01746.x; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Rintala H, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-56; Rusin P, 1998, J APPL MICROBIOL, V85, P819, DOI 10.1046/j.1365-2672.1998.00598.x; Sinclair RG, 2011, LETT APPL MICROBIOL, V52, P144, DOI 10.1111/j.1472-765X.2010.02978.x; Smith SM, 1996, J MED, V27, P293; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Zhou X, 2010, INFECT DIS OBSTET GY, V2010	44	180	181	4	169	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e28132	10.1371/journal.pone.0028132	http://dx.doi.org/10.1371/journal.pone.0028132			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132229	Green Published, Green Submitted, gold			2022-12-27	WOS:000298162000078
J	Voorbij, AMWY; van Steenbeek, FG; Vos-Loohuis, M; Martens, EECP; Hanson-Nilsson, JM; van Oost, BA; Kooistra, HS; Leegwater, PA				Voorbij, Annemarie M. W. Y.; van Steenbeek, Frank G.; Vos-Loohuis, Manon; Martens, Ellen E. C. P.; Hanson-Nilsson, Jeanette M.; van Oost, Bernard A.; Kooistra, Hans S.; Leegwater, Peter A.			A Contracted DNA Repeat in LHX3 Intron 5 Is Associated with Aberrant Splicing and Pituitary Dwarfism in German Shepherd Dogs	PLOS ONE			English	Article							HORMONE DEFICIENCY; MESSENGER-RNA; MINIMAL INTRON; GENE; MUTATIONS; PIT-1; IDENTIFICATION; CANDIDATE; DELETION; LENGTH	Dwarfism in German shepherd dogs is due to combined pituitary hormone deficiency of unknown genetic cause. We localized the recessively inherited defect by a genome wide approach to a region on chromosome 9 with a lod score of 9.8. The region contains LHX3, which codes for a transcription factor essential for pituitary development. Dwarfs have a deletion of one of six 7 bp repeats in intron 5 of LHX3, reducing the intron size to 68 bp. One dwarf was compound heterozygous for the deletion and an insertion of an asparagine residue in the DNA-binding homeodomain of LHX3, suggesting involvement of the gene in the disorder. An exon trapping assay indicated that the shortened intron is not spliced efficiently, probably because it is too small. We applied bisulfite conversion of cytosine to uracil in RNA followed by RT-PCR to analyze the splicing products. The aberrantly spliced RNA molecules resulted from either skipping of exon 5 or retention of intron 5. The same splicing defects were observed in cDNA derived from the pituitary of dwarfs. A survey of similarly mutated introns suggests that there is a minimal distance requirement between the splice donor and branch site of 50 nucleotides. In conclusion, a contraction of a DNA repeat in intron 5 of canine LHX3 leads to deficient splicing and is associated with pituitary dwarfism.	[Voorbij, Annemarie M. W. Y.; van Steenbeek, Frank G.; Vos-Loohuis, Manon; Martens, Ellen E. C. P.; Hanson-Nilsson, Jeanette M.; Kooistra, Hans S.; Leegwater, Peter A.] Univ Utrecht, Fac Vet Med, Dept Clin Sci Compan Anim, Utrecht, Netherlands; [van Oost, Bernard A.] Amer Univ Caribbean, Dept Biochem, Cupecoy, St Maarten, Netherlands	Utrecht University	Voorbij, AMWY (corresponding author), Univ Utrecht, Fac Vet Med, Dept Clin Sci Compan Anim, Utrecht, Netherlands.	P.A.J.Leegwater@uu.nl	van Steenbeek, F.G./AFL-0046-2022; Hanson, Jeanette/Q-9283-2018	van Steenbeek, F.G./0000-0001-5460-6540; Hanson, Jeanette/0000-0001-5596-9538; Leegwater, Peter/0000-0002-4100-015X				ANDRESEN E, 1976, NORD VET MED, V28, P481; Auffray C, 2006, EXP CELL RES, V312, P233, DOI 10.1016/j.yexcr.2005.10.014; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Banerjee-Basu S, 2001, NUCLEIC ACIDS RES, V29, P3258, DOI 10.1093/nar/29.15.3258; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bhangoo APS, 2006, J CLIN ENDOCR METAB, V91, P747, DOI 10.1210/jc.2005-2360; Brock JE, 2008, RNA, V14, P2430, DOI 10.1261/rna.1189008; BURN TC, 1995, GENE, V161, P183, DOI 10.1016/0378-1119(95)00223-S; Chi YI, 2005, HUM GENET, V116, P433, DOI 10.1007/s00439-004-1252-1; Chua K, 2001, MOL CELL BIOL, V21, P1509, DOI 10.1128/MCB.21.5.1509-1514.2001; Fofanova O, 1998, J CLIN ENDOCR METAB, V83, P2601; Hamann F, 1999, VET REC, V144, P644, DOI 10.1136/vr.144.23.644; Hentze MW, 1999, CELL, V96, P307, DOI 10.1016/S0092-8674(00)80542-5; HIMMELSPACH M, 1991, MOL CELL BIOL, V11, P1258, DOI 10.1128/MCB.11.3.1258; Hunter C, 2005, MOL BIOL REP, V32, P67, DOI 10.1007/s11033-004-7657-z; Ichikawa S, 2006, J CLIN ENDOCR METAB, V91, P4022, DOI 10.1210/jc.2005-2840; Kooistra HS, 2000, DOMEST ANIM ENDOCRIN, V19, P177, DOI 10.1016/S0739-7240(00)00074-6; Kristrom B, 2009, J CLIN ENDOCR METAB, V94, P1154, DOI 10.1210/jc.2008-0325; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Lantinga-van Leeuwen IS, 2000, CYTOGENET CELL GENET, V88, P140, DOI 10.1159/000015507; Leegwater PAJ, 1999, AM J HUM GENET, V65, P728, DOI 10.1086/302548; Leeuwen ISL, 2000, MAMM GENOME, V11, P31, DOI 10.1007/s003350010006; LI S, 1990, NATURE, V347, P528, DOI 10.1038/347528a0; Lohi H, 2005, SCIENCE, V307, P81, DOI 10.1126/science.1102832; Meij BP, 1996, DOMEST ANIM ENDOCRIN, V13, P465, DOI 10.1016/0739-7240(96)00075-6; Meij BP, 1996, DOMEST ANIM ENDOCRIN, V13, P161, DOI 10.1016/0739-7240(95)00066-6; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Mirkin SM, 2007, NATURE, V447, P932, DOI 10.1038/nature05977; Netchine I, 2000, NAT GENET, V25, P182, DOI 10.1038/76041; Nishioka M, 2001, J BIOTECHNOL, V88, P141, DOI 10.1016/S0168-1656(01)00275-9; PellegriniBouiller I, 1996, J CLIN ENDOCR METAB, V81, P2790, DOI 10.1210/jc.81.8.2790; Peral B, 1997, AM J HUM GENET, V60, P1399, DOI 10.1086/515467; PERAL B, 1995, HUM MOL GENET, V4, P569, DOI 10.1093/hmg/4.4.569; Persichetti E, 2009, HUM MUTAT, V30, P978, DOI 10.1002/humu.20959; Pfaeffle RW, 2007, J CLIN ENDOCR METAB, V92, P1909, DOI 10.1210/jc.2006-2177; Pfaffle R, 1996, HORM RES, V45, P25, DOI 10.1159/000184824; Rajab A, 2008, HUM MOL GENET, V17, P2150, DOI 10.1093/hmg/ddn114; RUSKIN B, 1985, CELL, V41, P833, DOI 10.1016/S0092-8674(85)80064-7; Sasaki F, 1998, ANAT RECORD, V251, P143; Sheng HZ, 1997, SCIENCE, V278, P1809, DOI 10.1126/science.278.5344.1809; Sheng HZ, 1996, SCIENCE, V272, P1004, DOI 10.1126/science.272.5264.1004; SIMMONS DM, 1990, GENE DEV, V4, P695, DOI 10.1101/gad.4.5.695; Sornson MW, 1996, NATURE, V384, P327, DOI 10.1038/384327a0; Stabej P, 2005, CYTOGENET GENOME RES, V111, P140, DOI 10.1159/000086383; Sultana A, 2007, MOL VIS, V13, P1327; ULFENDAHL PJ, 1985, NUCLEIC ACIDS RES, V13, P6299, DOI 10.1093/nar/13.17.6299; Voorbij AMWY KooistraHS., 2009, J VET CLIN SCI, V2, P4; Wang LL, 2002, AM J HUM GENET, V71, P165, DOI 10.1086/341234; WIERINGA B, 1984, CELL, V37, P915, DOI 10.1016/0092-8674(84)90426-4; Wu W, 1998, NAT GENET, V18, P147, DOI 10.1038/ng0298-147; Zhu XY, 2007, PHYSIOL REV, V87, P933, DOI 10.1152/physrev.00006.2006	51	17	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e27940	10.1371/journal.pone.0027940	http://dx.doi.org/10.1371/journal.pone.0027940			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132174	Green Published, gold, Green Submitted			2022-12-27	WOS:000298162000051
J	Waugh, JL; Celver, J; Sharma, M; Dufresne, RL; Terzi, D; Risch, SC; Fairbrother, WG; Neve, RL; Kane, JP; Malloy, MJ; Pullinger, CR; Gu, HF; Tsatsanis, C; Hamilton, SP; Gold, SJ; Zachariou, V; Kovoor, A				Waugh, Jeffrey L.; Celver, Jeremy; Sharma, Meenakshi; Dufresne, Robert L.; Terzi, Dimitra; Risch, S. Craig; Fairbrother, William G.; Neve, Rachael L.; Kane, John P.; Malloy, Mary J.; Pullinger, Clive R.; Gu, Harvest F.; Tsatsanis, Christos; Hamilton, Steven P.; Gold, Stephen J.; Zachariou, Venetia; Kovoor, Abraham			Association between Regulator of G Protein Signaling 9-2 and Body Weight	PLOS ONE			English	Article							RGS PROTEINS; EXTRACELLULAR DOPAMINE; MICE LACKING; EXPRESSION; RAT; RECEPTORS; COCAINE; COMPLEX; REWARD; R9AP	Regulator of G protein signaling 9-2 (RGS9-2) is a protein that is highly enriched in the striatum, a brain region that mediates motivation, movement and reward responses. We identified a naturally occurring 5 nucleotide deletion polymorphism in the human RGS9 gene and found that the mean body mass index (BMI) of individuals with the deletion was significantly higher than those without. A splicing reporter minigene assay demonstrated that the deletion had the potential to significantly decrease the levels of correctly spliced RGS9 gene product. We measured the weights of rats after virally transduced overexpression of RGS9-2 or the structurally related RGS proteins, RGS7, or RGS11, in the nucleus accumbens (NAc) and observed a reduction in body weight after overexpression of RGS9-2 but not RGS7 or 11. Conversely, we found that the RGS9 knockout mice were heavier than their wild-type littermates and had significantly higher percentages of abdominal fat. The constituent adipocytes were found to have a mean cross-sectional area that was more than double that of corresponding cells from wild-type mice. However, food intake and locomotion were not significantly different between the two strains. These studies with humans, rats and mice implicate RGS9-2 as a factor in regulating body weight.	[Waugh, Jeffrey L.; Gold, Stephen J.] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Celver, Jeremy; Sharma, Meenakshi; Kovoor, Abraham] Univ Rhode Isl, Dept Biomed & Pharmaceut Sci, Kingston, RI 02881 USA; [Celver, Jeremy; Kovoor, Abraham] Kovogen LLC, Mystic, CT USA; [Dufresne, Robert L.] Univ Rhode Isl, Dept Pharm Practice, Kingston, RI 02881 USA; [Terzi, Dimitra; Tsatsanis, Christos; Zachariou, Venetia] Univ Crete, Fac Med, Dept Basic Sci, Iraklion, Crete, Greece; [Risch, S. Craig; Hamilton, Steven P.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA; [Fairbrother, William G.] Brown Univ, Dept Mol & Cell Biol & Biochem, Providence, RI 02912 USA; [Neve, Rachael L.] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Kane, John P.; Malloy, Mary J.; Pullinger, Clive R.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Kane, John P.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Kane, John P.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Pullinger, Clive R.] Univ Calif San Francisco, Dept Physiol Nursing, San Francisco, CA USA; [Gu, Harvest F.] Karolinska Univ Hosp, Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Rhode Island; University of Rhode Island; University of Crete; University of California System; University of California San Francisco; Brown University; Massachusetts Institute of Technology (MIT); University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Karolinska Institutet; Karolinska University Hospital	Waugh, JL (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA.	abekovoor@uri.edu	Tsatsanis, Christos/AAM-9362-2020; Zachariou, Venetia/L-2726-2016	Tsatsanis, Christos/0000-0003-1214-4151; Waugh, Jeff/0000-0001-7526-1342; Fairbrother, William/0000-0002-6312-5615; Hamilton, Steven/0000-0001-8106-6260	National Institute of Mental Health (NIMH), NIH [R41MH78570]; National Center for Research Resources (NCRR), NIH [P20RR016457-10]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016457] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R41MH078570] Funding Source: NIH RePORTER	National Institute of Mental Health (NIMH), NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Center for Research Resources (NCRR), NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The project described was supported by an R41MH78570 award from the National Institute of Mental Health (NIMH), NIH (to AK, JC and SPH), and a Rhode Island IDeA Network of Biomedical Research Excellence (RI-INBRE) Award, P20RR016457-10, from the National Center for Research Resources (NCRR), NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agenes F, 2005, IMMUNOLOGY, V115, P179, DOI 10.1111/j.1365-2567.2005.02146.x; Aissani B, 2006, OBESITY, V14, P1605, DOI 10.1038/oby.2006.185; Anderson GR, 2010, NEUROPSYCHOPHARMACOL, V35, P1040, DOI 10.1038/npp.2009.212; Anderson GR, 2009, CELL BIOCHEM BIOPHYS, V54, P33, DOI 10.1007/s12013-009-9052-9; Baldo BA, 2003, J COMP NEUROL, V464, P220, DOI 10.1002/cne.10783; Bansal G, 2007, PHARMACOL THERAPEUT, V116, P473, DOI 10.1016/j.pharmthera.2007.09.005; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Berridge KC, 2010, BRAIN RES, V1350, P43, DOI 10.1016/j.brainres.2010.04.003; Bodnar RJ, 2004, PEPTIDES, V25, P697, DOI 10.1016/j.peptides.2004.01.006; Bubser M, 2005, EUR J NEUROSCI, V21, P2993, DOI 10.1111/j.1460-9568.2005.04121.x; Cabrera-Vera TM, 2004, P NATL ACAD SCI USA, V101, P16339, DOI 10.1073/pnas.0407416101; Cao Y, 2009, J NEUROSCI, V29, P9301, DOI 10.1523/JNEUROSCI.1367-09.2009; Carlezon WA, 2000, CRIT REV NEUROBIOL, V14, P47; Carlezon WA, 1997, SCIENCE, V277, P812, DOI 10.1126/science.277.5327.812; Celver J, 2010, J NEUROCHEM, V114, P739, DOI 10.1111/j.1471-4159.2010.06805.x; Chen CK, 2000, NATURE, V403, P557, DOI 10.1038/35000601; Chen CK, 2003, P NATL ACAD SCI USA, V100, P6604, DOI 10.1073/pnas.0631825100; Cho H, 2008, MOL CELL BIOL, V28, P2590, DOI 10.1128/MCB.01889-07; Cooper TA, 2005, METHODS, V37, P331, DOI 10.1016/j.ymeth.2005.07.015; Coopersmith R, 1999, BIOTECHNIQUES, V27, P1156, DOI 10.2144/99276st01; Gaildrat P, 2010, METHODS MOL BIOL, V653, P249, DOI 10.1007/978-1-60761-759-4_15; Gainetdinov RR, 2007, AM J PHYSIOL-REG I, V293, pR601, DOI 10.1152/ajpregu.00450.2007; Gold SJ, 1997, J NEUROSCI, V17, P8024; Gold SJ, 2007, J NEUROSCI, V27, P14338, DOI 10.1523/JNEUROSCI.4223-07.2007; Graybiel AM, 2000, CURR BIOL, V10, pR509, DOI 10.1016/S0960-9822(00)00593-5; Hooks SB, 2008, BIOCHEM PHARMACOL, V75, P76, DOI 10.1016/j.bcp.2007.07.045; Huang XY, 2008, DIABETES, V57, P77, DOI 10.2337/db07-0599; Jayaraman M, 2009, TRENDS PHARMACOL SCI, V30, P17, DOI 10.1016/j.tips.2008.10.002; Johnson PM, 2010, NAT NEUROSCI, V13, P635, DOI 10.1038/nn.2519; KALIVAS PW, 1990, SYNAPSE, V5, P48, DOI 10.1002/syn.890050104; Kelley AE, 2005, PHYSIOL BEHAV, V86, P773, DOI 10.1016/j.physbeh.2005.08.066; Keresztes G, 2004, J BIOL CHEM, V279, P1581, DOI 10.1074/jbc.C300456200; Kiernan J, 2008, HISTOLOGICAL HISTOCH; Kovoor A, 2005, J NEUROSCI, V25, P2157, DOI 10.1523/JNEUROSCI.2840-04.2005; Laroche G, 2010, AM J PHYSIOL-CELL PH, V299, pC654, DOI 10.1152/ajpcell.00441.2009; Le Merrer J, 2009, PHYSIOL REV, V89, P1379, DOI 10.1152/physrev.00005.2009; Martemyanov KA, 2005, J BIOL CHEM, V280, P5133, DOI 10.1074/jbc.C400596200; Masuho I, 2010, J BIOL CHEM, V285, P4781, DOI 10.1074/jbc.M109.058511; Neve RL, 2005, BIOTECHNIQUES, V39, P381, DOI 10.2144/05393PS01; Nunn C, 2011, CELL SIGNAL, V23, P1375, DOI 10.1016/j.cellsig.2011.03.020; Pacey LKK, 2011, MOL CELL NEUROSCI, V46, P563, DOI 10.1016/j.mcn.2010.12.005; Posokhova E, 2010, CIRC RES, V107, P1350, DOI 10.1161/CIRCRESAHA.110.224212; Psifogeorgou K, 2007, J NEUROCHEM, V103, P617, DOI 10.1111/j.1471-4159.2007.04812.x; Psigfogeorgou K, 2011, J NEUROSCI, V31, P5617, DOI 10.1523/JNEUROSCI.4146-10.2011; Pullinger CR, 2008, J LIPID RES, V49, P1846, DOI 10.1194/jlr.P800011-JLR200; Rahman Z, 1999, J NEUROSCI, V19, P2016; Rahman Z, 2003, NEURON, V38, P941, DOI 10.1016/S0896-6273(03)00321-0; Reid DC, 2009, RNA, V15, P2385, DOI 10.1261/rna.1821809; Rouge-Pont F, 2002, J NEUROSCI, V22, P3293, DOI 10.1523/JNEUROSCI.22-08-03293.2002; Saito Y, 2001, J COMP NEUROL, V435, P26, DOI 10.1002/cne.1191; Sartori M, 2008, METABOLISM, V57, P421, DOI 10.1016/j.metabol.2007.10.021; Sawicka K, 2008, BIOCHEM SOC T, V36, P641, DOI 10.1042/BST0360641; Sethakorn N, 2010, CELL SIGNAL, V22, P1274, DOI 10.1016/j.cellsig.2010.03.016; Shiffman D, 2005, AM J HUM GENET, V77, P596, DOI 10.1086/491674; Soares P, 2011, AM J HUM GENET, V88, P239, DOI 10.1016/j.ajhg.2011.01.009; Song JH, 2007, MOL CELL NEUROSCI, V35, P311, DOI 10.1016/j.mcn.2007.03.006; Su B, 2000, P NATL ACAD SCI USA, V97, P8225, DOI 10.1073/pnas.97.15.8225; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Thomas EA, 1998, J NEUROSCI RES, V52, P118, DOI 10.1002/(SICI)1097-4547(19980401)52:1<118::AID-JNR11>3.0.CO;2-6; Toonen RJ, 2001, BIOTECHNIQUES, V31, P1320; Uhl GR, 2002, MOL PSYCHIATR, V7, P21, DOI 10.1038/sj/mp/4000964; Wang Q, 2011, FASEB J; Wang ZF, 2004, CELL, V119, P831, DOI 10.1016/j.cell.2004.11.010; Willars GB, 2006, SEMIN CELL DEV BIOL, V17, P363, DOI 10.1016/j.semcdb.2006.03.005; Yang JQ, 2010, CIRC RES, V107, P1345, DOI 10.1161/CIRCRESAHA.110.224220; Zachariou V, 2003, P NATL ACAD SCI USA, V100, P13656, DOI 10.1073/pnas.2232594100; Zhang K, 1999, GENE, V240, P23, DOI 10.1016/S0378-1119(99)00393-5	67	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e27984	10.1371/journal.pone.0027984	http://dx.doi.org/10.1371/journal.pone.0027984			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132185	Green Published, Green Submitted, gold			2022-12-27	WOS:000298162000055
J	Souza, CEA; Maitra, D; Saed, GM; Diamond, MP; Moura, AA; Pennathur, S; Abu-Soud, HM				Souza, Carlos Eduardo A.; Maitra, Dhiman; Saed, Ghassan M.; Diamond, Michael P.; Moura, Arlindo A.; Pennathur, Subramaniam; Abu-Soud, Husam M.			Hypochlorous Acid-Induced Heme Degradation from Lactoperoxidase as a Novel Mechanism of Free Iron Release and Tissue Injury in Inflammatory Diseases	PLOS ONE			English	Article							HUMAN ATHEROSCLEROTIC LESIONS; HYDROGEN PEROXIDE SYSTEM; CYSTIC-FIBROSIS; NITRIC-OXIDE; HOST-DEFENSE; EOSINOPHIL PEROXIDASE; MAMMALIAN PEROXIDASES; PROTEIN AGGREGATION; HUMAN-NEUTROPHILS; OXIDATIVE STRESS	Lactoperoxidase (LPO) is the major consumer of hydrogen peroxide (H2O2) in the airways through its ability to oxidize thiocyanate (SCN-) to produce hypothiocyanous acid, an antimicrobial agent. In nasal inflammatory diseases, such as cystic fibrosis, both LPO and myeloperoxidase (MPO), another mammalian peroxidase secreted by neutrophils, are known to colocalize. The aim of this study was to assess the interaction of LPO and hypochlorous acid (HOCl), the final product of MPO. Our rapid kinetic measurements revealed that HOCl binds rapidly and reversibly to LPO-Fe(III) to form the LPO-Fe(III)-OCl complex, which in turn decayed irreversibly to LPO Compound II through the formation of Compound I. The decay rate constant of Compound II decreased with increasing HOCl concentration with an inflection point at 100 mu M HOCl, after which the decay rate increased. This point of inflection is the critical concentration of HOCl beyond which HOCl switches its role, from mediating destabilization of LPO Compound II to LPO heme destruction. Lactoperoxidase heme destruction was associated with protein aggregation, free iron release, and formation of a number of fluorescent heme degradation products. Similar results were obtained when LPO-Fe(II)-O-2, Compound III, was exposed to HOCl. Heme destruction can be partially or completely prevented in the presence of SCN-. On the basis of the present results we concluded that a complex bi-directional relationship exists between LPO activity and HOCl levels at sites of inflammation; LPO serve as a catalytic sink for HOCl, while HOCl serves to modulate LPO catalytic activity, bioavailability, and function.	[Souza, Carlos Eduardo A.; Maitra, Dhiman; Saed, Ghassan M.; Diamond, Michael P.; Abu-Soud, Husam M.] Wayne State Univ, Sch Med, Dept Obstet & Gynecol, CS Mott Ctr Human Growth & Dev, Detroit, MI 48201 USA; [Moura, Arlindo A.] Univ Fed Ceara, Fortaleza, Ceara, Brazil; [Pennathur, Subramaniam] Univ Michigan, Dept Internal Med, Div Nephrol, Sch Med, Ann Arbor, MI 48109 USA; [Abu-Soud, Husam M.] Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48201 USA	Wayne State University; Universidade Federal do Ceara; University of Michigan System; University of Michigan; Wayne State University	Souza, CEA (corresponding author), Wayne State Univ, Sch Med, Dept Obstet & Gynecol, CS Mott Ctr Human Growth & Dev, Detroit, MI 48201 USA.	habusoud@med.wayne.edu	Maitra, Dhiman/E-4362-2012; MOURA, ARLINDO A/P-6697-2018	MOURA, ARLINDO A/0000-0002-8271-5733; , dhiman/0000-0002-8775-2963; Diamond, Michael/0000-0001-6353-4489; Maitra, Dhiman/0000-0003-4604-3551	National Institutes of Health [RO1 HL066367, R01HL094230]; Children's Hospital of Michigan; Doris Duke Foundation; Molecular Phenotyping Core of the Michigan Nutrition and Obesity Research Center [DK089503]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066367, R01HL094230] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK089503, R24DK082841] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Hospital of Michigan; Doris Duke Foundation(Doris Duke Charitable Foundation (DDCF)); Molecular Phenotyping Core of the Michigan Nutrition and Obesity Research Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health grant RO1 HL066367 and R01HL094230, the Children's Hospital of Michigan, the Doris Duke Foundation Clinical Scientist Development Award and the Molecular Phenotyping Core of the Michigan Nutrition and Obesity Research Center (DK089503). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Soud HM, 2000, J BIOL CHEM, V275, P37524, DOI 10.1074/jbc.275.48.37524; Abu-Soud HM, 2004, BIOCHEMISTRY-US, V43, P11589, DOI 10.1021/bi049541h; Abu-Soud HM, 2001, BIOCHEMISTRY-US, V40, P11866, DOI 10.1021/bi011206v; Adak S, 1997, J BIOL CHEM, V272, P11049; AGBAI O, 1986, J NATL MED ASSOC, V78, P1053; ARUOMA OI, 1987, BIOCHEM J, V248, P973, DOI 10.1042/bj2480973; Ashby MT, 2004, J AM CHEM SOC, V126, P15976, DOI 10.1021/ja0438361; AUNE TM, 1977, EUR J BIOCHEM, V80, P209, DOI 10.1111/j.1432-1033.1977.tb11873.x; BOLSCHER BGJM, 1984, BIOCHIM BIOPHYS ACTA, V784, P177, DOI 10.1016/0167-4838(84)90125-0; Bouckenooghe T, 2006, CURR OPIN CLIN NUTR, V9, P728, DOI 10.1097/01.mco.0000247469.26414.55; Brennan ML, 2003, CURR OPIN LIPIDOL, V14, P353, DOI 10.1097/00041433-200308000-00003; CARTER P, 1971, ANAL BIOCHEM, V40, P450, DOI 10.1016/0003-2697(71)90405-2; Chapman ALP, 2003, BIOCHEM J, V375, P33, DOI 10.1042/BJ20030685; CHAU LY, 2000, LIFE SCI B, V24, P151; CHUNG J, 1970, ARCH BIOCHEM BIOPHYS, V141, P73, DOI 10.1016/0003-9861(70)90108-6; Clark RAF, 2008, J INVEST DERMATOL, V128, P2361, DOI 10.1038/jid.2008.257; Conner GE, 2002, AM J RESP CRIT CARE, V166, pS57, DOI 10.1164/rccm.2206018; Conner GE, 2007, FEBS LETT, V581, P271, DOI 10.1016/j.febslet.2006.12.025; Crichton RR, 2002, J INORG BIOCHEM, V91, P9, DOI 10.1016/S0162-0134(02)00461-0; DAUGHERTY A, 1994, J CLIN INVEST, V94, P437, DOI 10.1172/JCI117342; Davies MJ, 2008, ANTIOXID REDOX SIGN, V10, P1199, DOI 10.1089/ars.2007.1927; Defrere S, 2008, MOL HUM REPROD, V14, P377, DOI 10.1093/molehr/gan033; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; DULL TJ, 1990, DNA CELL BIOL, V9, P499, DOI 10.1089/dna.1990.9.499; Ekmekci OB, 2004, BIOCHEMISTRY-MOSCOW+, V69, P462, DOI 10.1023/B:BIRY.0000026205.89894.25; El-Chemaly S, 2003, AM J RESP CRIT CARE, V167, P425, DOI 10.1164/rccm.200206-531OC; Everse J., 1991, PEROXIDASES CHEM BIO; Fiedler TJ, 2000, J BIOL CHEM, V275, P11964, DOI 10.1074/jbc.275.16.11964; Furman CS, 1998, INORG CHEM, V37, P4321, DOI 10.1021/ic980262q; Furtmuller PG, 2005, J INORG BIOCHEM, V99, P1220, DOI 10.1016/j.jinorgbio.2005.02.021; Furtmuller PG, 2004, JPN J INFECT DIS, V57, pS30; Furtmuller PG, 2002, BIOCHEMISTRY-US, V41, P11895, DOI 10.1021/bi026326x; Galijasevic S, 2006, BIOCHEMISTRY-US, V45, P1255, DOI 10.1021/bi051438k; Galijasevic S, 2004, J BIOL CHEM, V279, P39465, DOI 10.1074/jbc.M406003200; Galijasevic S, 2009, FREE RADICAL BIO MED, V47, P431, DOI 10.1016/j.freeradbiomed.2009.05.017; Gerson C, 2000, AM J RESP CELL MOL, V22, P665, DOI 10.1165/ajrcmb.22.6.3980; GOULD NS, RESP RES, V11, P119; Gray RD, 2010, CHEST, V137, P635, DOI 10.1378/chest.09-1047; Heinecke JW, 2010, J CLIN LIPIDOL, V4, P371, DOI 10.1016/j.jacl.2010.08.005; HEINECKE JW, 1993, J BIOL CHEM, V268, P4069; Horwich A, 2002, J CLIN INVEST, V110, P1221, DOI 10.1172/JCI200216781; HU SH, 1991, J AM CHEM SOC, V113, P7189, DOI 10.1021/ja00019a015; Ihalin R, 2006, ARCH BIOCHEM BIOPHYS, V445, P261, DOI 10.1016/j.abb.2005.07.004; Jantschko W, 2005, ARCH BIOCHEM BIOPHYS, V434, P51, DOI 10.1016/j.abb.2004.10.014; KETTLE AJ, 1994, METHOD ENZYMOL, V233, P502; Kettle AJ, 2007, BIOCHEMISTRY-US, V46, P4888, DOI 10.1021/bi602587k; Klebanoff SJ, 2005, J LEUKOCYTE BIOL, V77, P598, DOI 10.1189/jlb.1204697; Koo EH, 1999, P NATL ACAD SCI USA, V96, P9989, DOI 10.1073/pnas.96.18.9989; Kumar S, 2005, TOXICOL LETT, V157, P175, DOI 10.1016/j.toxlet.2005.03.004; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee JY, 2010, ARCH ORAL BIOL, V55, P607, DOI 10.1016/j.archoralbio.2010.06.001; MAITRA D, FREE RADIC BIOL MED, V51, P374; MAITRA D, FREE RADIC BIOL MED, V51, P364; MALECH HL, 1987, NEW ENGL J MED, V317, P687, DOI 10.1056/NEJM198709103171107; Malle E, 2000, EUR J BIOCHEM, V267, P4495, DOI 10.1046/j.1432-1327.2000.01498.x; Malle E, 2003, KIDNEY INT, V64, P1956, DOI 10.1046/j.1523-1755.2003.00336.x; MARQUEZ LA, 1990, J BIOL CHEM, V265, P5666; Mertz W, 1986, TRACE ELEMENTS HUMAN; Moskwa P, 2007, AM J RESP CRIT CARE, V175, P174, DOI 10.1164/rccm.200607-1029OC; Nagababu E, 2004, ANTIOXID REDOX SIGN, V6, P967, DOI 10.1089/1523086042259823; NAUSEEF WM, 1986, BLOOD, V67, P1504; Newman A. A., 1975, CHEM BIOCH THIOCYANI; Ohshima H, 2003, ARCH BIOCHEM BIOPHYS, V417, P3, DOI 10.1016/S0003-9861(03)00283-2; Ong WY, 2004, ANN NY ACAD SCI, V1012, P51, DOI 10.1196/annals.1306.005; Pattison DI, 2009, CHEM RES TOXICOL, V22, P807, DOI 10.1021/tx800372d; PENNATHUR S, FREE RADIC BIOL MED, V49, P205; Podrez EA, 2000, FREE RADICAL BIO MED, V28, P1717, DOI 10.1016/S0891-5849(00)00229-X; Pullar JM, 2000, IUBMB LIFE, V50, P259, DOI 10.1080/15216540051080958; Reid DW, 2008, AM J PHYSIOL-LUNG C, V295, pL23, DOI 10.1152/ajplung.90299.2008; Reid DW, 2004, EUR RESPIR J, V24, P286, DOI 10.1183/09031936.04.00104803; Schaffer SW, 2009, CAN J PHYSIOL PHARM, V87, P91, DOI 10.1139/Y08-110; Shishehbor Mehdi H, 2004, Curr Atheroscler Rep, V6, P243, DOI 10.1007/s11883-004-0038-1; Singh AK, 2010, J BIOL INORG CHEM, V15, P1099, DOI 10.1007/s00775-010-0669-3; Stadtman ER, 1997, CHEM RES TOXICOL, V10, P485, DOI 10.1021/tx960133r; Stanley N, 2006, FREE RADICAL BIO MED, V40, P1636, DOI 10.1016/j.freeradbiomed.2005.12.031; SUBRAMANI S, 1992, J MEMBRANE BIOL, V125, P99; Tahboub YR, 2005, J BIOL CHEM, V280, P26129, DOI 10.1074/jbc.M503027200; TENOVUO J, 1991, Proceedings of the Finnish Dental Society, V87, P197; THOMSON E, FREE RADIC BIOL MED, V49, P1354; Trinder D, 2002, GUT, V51, P290, DOI 10.1136/gut.51.2.290; van der Vliet A, 2000, AM J PHYSIOL-LUNG C, V279, pL537, DOI 10.1152/ajplung.2000.279.3.L537; Wang L, 2007, J Burns Wounds, V6, pe5; WEISS SJ, 1989, NEW ENGL J MED, V320, P365; WEISS SJ, 1982, J CLIN INVEST, V70, P598, DOI 10.1172/JCI110652; Wijkstrom-Frei C, 2003, AM J RESP CELL MOL, V29, P206, DOI 10.1165/rcmb.2002-0152OC; Yamaguchi K, 2008, CLIN CANCER RES, V14, P32, DOI 10.1158/1078-0432.CCR-07-1614	86	30	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2011	6	11							e27641	10.1371/journal.pone.0027641	http://dx.doi.org/10.1371/journal.pone.0027641			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858JH	22132121	Green Submitted, gold, Green Published			2022-12-27	WOS:000297792400011
J	Tong, HV; Toan, NL; Song, LH; Abou Ouf, E; Boc, CT; Kremsner, PG; Kun, JFJ; Velavan, TP				Tong, Hoang V.; Toan, Nguyen L.; Song, Le H.; Abou Ouf, Eman; Boc, C. -Thomas; Kremsner, Peter G.; Kun, Juergen F. J.; Velavan, T. P.			Ficolin-2 Levels and FCN2 Haplotypes Influence Hepatitis B Infection Outcome in Vietnamese Patients	PLOS ONE			English	Article							MANNOSE-BINDING LECTIN; VIRUS-INFECTION; FUNCTIONAL POLYMORPHISMS; GENE POLYMORPHISMS; INNATE IMMUNITY; DISEASE BURDEN; LIVER-DISEASE; ASSOCIATION; VARIANTS; CHILDREN	Human Ficolin-2 (L-ficolins) encoded by FCN2 gene is a soluble serum protein that plays an important role in innate immunity and is mainly expressed in the liver. Ficolin-2 serum levels and FCN2 single nucleotide polymorphisms were associated to several infectious diseases. We initially screened the complete FCN2 gene in 48 healthy individuals of Vietnamese ethnicity. We genotyped a Vietnamese cohort comprising of 423 clinically classified hepatitis B virus patients and 303 controls for functional single nucleotide polymorphisms in the promoter region (-986G>A, -602G>A, -4A>G) and in exon 8 (+6424G>T) by real-time PCR and investigated the contribution of FCN2 genotypes and haplotypes to serum Ficolin-2 levels, viral load and liver enzyme levels. Haplotypes differed significantly between patients and controls (P = 0.002) and the haplotype AGGG was found frequently in controls in comparison to patients with hepatitis B virus and hepatocellular carcinoma (P = 0.0002 and P<0.0001) conferring a protective effect. Ficolin-2 levels differed significantly between patients and controls (p<0.0001). Patients with acute hepatitis B had higher serum Ficolin-2 levels compared to other patient groups and controls. The viral load was observed to be significantly distributed among the haplotypes (P = 0.04) and the AAAG haplotype contributed to higher Ficolin-2 levels and to viral load. Four novel single nucleotide polymorphisms in introns (-941G>T, -310G>A, +2363G>A, +4882G>A) and one synonymous mutation in exon 8 (+6485G>T) was observed. Strong linkage was found between the variant -986G>A and -4A>G. The very first study on Vietnamese cohort associates both Ficolin-2 serum levels and FCN2 haplotypes to hepatitis B virus infection and subsequent disease progression.	[Tong, Hoang V.; Abou Ouf, Eman; Kremsner, Peter G.; Kun, Juergen F. J.; Velavan, T. P.] Univ Tubingen, Inst Trop Med, Tubingen, Germany; [Toan, Nguyen L.] Vietnam Mil Med Univ, Dept Pathophysiol, Hanoi, Vietnam; [Song, Le H.] Tran Hung Dao Hosp, Hanoi, Vietnam; [Boc, C. -Thomas] Univ Tubingen Hosp, Dept Mol Pathol, Tubingen, Germany; [Boc, C. -Thomas] Robert Koch Inst, Berlin, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Robert Koch Institute	Tong, HV (corresponding author), Univ Tubingen, Inst Trop Med, Tubingen, Germany.	tong.van-hoang@uni-tuebingen.de	Velavan, Thirumalaisamy P/C-1223-2010; van Tong, Hoang/E-9448-2011; Bock, C.-Thomas/A-3518-2012	Velavan, Thirumalaisamy P/0000-0002-9809-9883; van Tong, Hoang/0000-0002-7170-8810; Bock, C.-Thomas/0000-0002-2773-486X	Vietnamese Government	Vietnamese Government	HVT was supported by a Vietnamese Government scholarship. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson APM, 2004, CLIN EXP IMMUNOL, V138, P517, DOI 10.1111/j.1365-2249.2004.02634.x; Chapman SJ, 2007, MOL IMMUNOL, V44, P3267, DOI 10.1016/j.molimm.2006.04.013; Chong WP, 2005, HEPATOLOGY, V42, P1037, DOI 10.1002/hep.20891; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Endo Y, 2007, IMMUNOBIOLOGY, V212, P371, DOI 10.1016/j.imbio.2006.11.014; Faik I, 2011, HUM IMMUNOL, V72, P74, DOI 10.1016/j.humimm.2010.10.003; Gao B, 2008, HEPATOLOGY, V47, P729, DOI 10.1002/hep.22034; He YL, 2006, WORLD J GASTROENTERO, V12, P4788; Hummelshoj T, 2005, HUM MOL GENET, V14, P1651, DOI 10.1093/hmg/ddi173; Hummelshoj T, 2008, MOL IMMUNOL, V45, P2508, DOI 10.1016/j.molimm.2008.01.003; Hummelshoj T, 2007, MOL IMMUNOL, V44, P401, DOI 10.1016/j.molimm.2006.02.023; Jensen ML, 2007, MOL IMMUNOL, V44, P856, DOI 10.1016/j.molimm.2006.04.002; Kamatani Y, 2009, NAT GENET, V41, P591, DOI 10.1038/ng.348; Kilpatrick DC, 1999, IMMUNOL LETT, V67, P109, DOI 10.1016/S0165-2478(98)00147-3; Lavanchy D, 2004, J VIRAL HEPATITIS, V11, P97, DOI 10.1046/j.1365-2893.2003.00487.x; Le Y, 1998, FEBS LETT, V425, P367, DOI 10.1016/S0014-5793(98)00267-1; Lee WM, 1997, NEW ENGL J MED, V337, P1733, DOI 10.1056/NEJM199712113372406; Liu J, 2009, CELL MOL IMMUNOL, V6, P235, DOI 10.1038/cmi.2009.32; Messias-Reason IJ, 2009, CLIN EXP IMMUNOL, V157, P395, DOI 10.1111/j.1365-2249.2009.03975.x; MESSIASREASON I, 2009, J INFECT DIS, V199, P801; Munthe-Fog L, 2007, SCAND J IMMUNOL, V65, P383, DOI 10.1111/j.1365-3083.2007.01915.x; Nguyen VTT, 2008, LIVER INT, V28, P525, DOI 10.1111/j.1478-3231.2007.01646.x; Qin XB, 2006, CELL MOL IMMUNOL, V3, P333; Racanelli V, 2006, HEPATOLOGY, V43, pS54, DOI 10.1002/hep.21060; Ruskamp JM, 2009, CLIN EXP IMMUNOL, V155, P433, DOI 10.1111/j.1365-2249.2008.03844.x; Song LH, 2006, MUTAT RES-FUND MOL M, V601, P137, DOI 10.1016/j.mrfmmm.2006.06.011; Song LH, 2008, EUR CYTOKINE NETW, V19, P204, DOI 10.1684/ecn.2008.0137; Song LH, 2003, MUTAT RES-FUND MOL M, V522, P119, DOI 10.1016/S0027-5107(02)00284-1; Thio CL, 2005, J VIROL, V79, P9192, DOI 10.1128/JVI.79.14.9192-9196.2005; Toan NL, 2006, HEPATOLOGY, V43, P1375, DOI 10.1002/hep.21188; Truelove AL, 2008, INT J IMMUNOGENET, V35, P255, DOI 10.1111/j.1744-313X.2008.00770.x; Wieland S, 2004, P NATL ACAD SCI USA, V101, P6669, DOI 10.1073/pnas.0401771101	32	38	40	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2011	6	11							e28113	10.1371/journal.pone.0028113	http://dx.doi.org/10.1371/journal.pone.0028113			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858JH	22140517	Green Published, Green Submitted, gold			2022-12-27	WOS:000297792400039
J	Fink, P; Pflitsch, C; Marin, K				Fink, Patrick; Pflitsch, Claudia; Marin, Kay			Dietary Essential Amino Acids Affect the Reproduction of the Keystone Herbivore Daphnia pulex	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; PREDATOR-INDUCED DIAPAUSE; RESTING-EGG-PRODUCTION; FRESH-WATER; PHOSPHORUS LIMITATION; NUTRIENT LIMITATION; PENAEUS-MONODON; FOOD QUALITY; MAGNA; MARINE	Recent studies have indicated that nitrogen availability can be an important determinant of primary production in freshwater lakes and that herbivore growth can be limited by low dietary nitrogen availability. Furthermore, a lack of specific essential nitrogenous biochemicals (such as essential amino acids) might be another important constraint on the fitness of consumers. This might be of particular importance for cladoceran zooplankton, which can switch between two alternative reproductive strategies - the production of subitaneously developing and resting eggs. Here, we hypothesize that both the somatic growth and the type of reproduction of the aquatic keystone herbivore Daphnia is limited by the availability of specific essential amino acids in the diet. In laboratory experiments, we investigated this hypothesis by feeding a high quality phytoplankton organism (Cryptomonas) and a green alga of moderate nutritional quality (Chlamydomonas) to a clone of Daphnia pulex with and without the addition of essential amino acids. The somatic growth of D. pulex differed between the algae of different nutritional quality, but not dependent on the addition of dissolved amino acids. However, in reproduction experiments, where moderate crowding conditions at saturating food quantities were applied, addition of the essential amino acids arginine and histidine (but not lysine and threonine) increased the total number and the developmental stage of subitaneous eggs. While D. pulex did not produce resting eggs on Cryptomonas, relatively high numbers of resting eggs were released on Chlamydomonas. When arginine and histidine were added to the green algal diet, the production of resting eggs was effectively suppressed. This demonstrates the high, but previously overlooked importance of single essential amino acids for the reproductive strategy of the aquatic keystone herbivore Daphnia.	[Fink, Patrick; Pflitsch, Claudia] Univ Cologne, Cologne Bioctr, Dept Aquat Chem Ecol, D-50931 Cologne, Germany; [Marin, Kay] Univ Cologne, Inst Biochem, D-50931 Cologne, Germany	University of Cologne; University of Cologne	Fink, P (corresponding author), Univ Cologne, Cologne Bioctr, Dept Aquat Chem Ecol, D-50931 Cologne, Germany.	fink@limno.net	Fink, Patrick/A-5901-2009	Fink, Patrick/0000-0002-5927-8977	University of Cologne; Deutsche Forschungsgemeinschaft [FI 1548/4-1]	University of Cologne; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was funded by the University of Cologne (www.uni-koeln.de) and the Deutsche Forschungsgemeinschaft (www.dfg.de), Grant FI 1548/4-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrusan G, 2007, LIMNOL OCEANOGR, V52, P1724, DOI 10.4319/lo.2007.52.4.1724; AHLGREN G, 1990, J PLANKTON RES, V12, P809, DOI 10.1093/plankt/12.4.809; AHLGREN G, 1992, J PHYCOL, V28, P37, DOI 10.1111/j.0022-3646.1992.00037.x; Alekseev V, 2001, NATURE, V414, P899, DOI 10.1038/414899a; Alekseev VR, 2007, DIAPAUSE AQUATIC INV; Anderson TR, 2004, ECOLOGY, V85, P1193, DOI 10.1890/02-0252; Arbaciauskas K, 2003, FUNCT ECOL, V17, P431, DOI 10.1046/j.1365-2435.2003.00748.x; Caceres CE, 1998, ECOLOGY, V79, P1699, DOI 10.2307/176789; CHEN HY, 1992, MAR BIOL, V114, P229, DOI 10.1007/BF00349523; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; Elser JJ, 2009, SCIENCE, V326, P835, DOI 10.1126/science.1176199; Fink P, 2006, OIKOS, V115, P484, DOI 10.1111/j.2006.0030-1299.14951.x; Finn RN, 2010, AQUAC RES, V41, P684, DOI 10.1111/j.1365-2109.2009.02220.x; GARDNER WS, 1981, CAN J FISH AQUAT SCI, V38, P157, DOI 10.1139/f81-021; Guisande C, 1999, LIMNOL OCEANOGR, V44, P691, DOI 10.4319/lo.1999.44.3.0691; HARRISON K E, 1990, Journal of Shellfish Research, V9, P1; Innes DJ, 2000, P ROY SOC B-BIOL SCI, V267, P991, DOI 10.1098/rspb.2000.1101; INNES DJ, 1993, J EVOLUTION BIOL, V6, P559, DOI 10.1046/j.1420-9101.1993.6040559.x; JUTTNER F, 1983, J GEN MICROBIOL, V129, P407; Kamjunke N, 2008, LIMNOLOGICA, V38, P360, DOI 10.1016/j.limno.2008.05.002; KLEIVEN OT, 1992, OIKOS, V65, P197, DOI 10.2307/3545010; Kleppel GS, 1998, LIMNOL OCEANOGR, V43, P1000, DOI 10.4319/lo.1998.43.5.1000; Koch U, 2009, OECOLOGIA, V159, P317, DOI 10.1007/s00442-008-1216-6; LaFont R, 2000, ECOTOXICOLOGY, V9, P41, DOI 10.1023/A:1008912127592; Lampert W., 2007, LIMNOECOLOGY ECOLOGY, V2; Lurling M, 2003, J PLANKTON RES, V25, P967, DOI 10.1093/plankt/25.8.967; Martin-Creuzburg D, 2008, LIMNOL OCEANOGR, V53, P456, DOI 10.4319/lo.2008.53.2.0456; Millamena OM, 1999, AQUACULTURE, V179, P169, DOI 10.1016/S0044-8486(99)00160-X; Minelli A, 2006, TRENDS ECOL EVOL, V21, P474, DOI 10.1016/j.tree.2006.06.017; Olmstead AW, 2001, J EXP ZOOL, V290, P148, DOI 10.1002/jez.1044; Paland S, 2005, EVOLUTION, V59, P800; Panov Vadim E., 2007, Monographiae Biologicae, V84, P187; Peters R.H., 1987, Memorie dell'Istituto Italiano di Idrobiologia Dott Marco de Marchi, V45, P193; Prabhakar V, 2010, PLANT CELL, V22, P2594, DOI 10.1105/tpc.109.073171; REDFIELD AC, 1958, AM SCI, V46, P205; Ronnestad I, 1999, AQUACULTURE, V177, P201, DOI 10.1016/S0044-8486(99)00082-4; Ronnestad I, 2003, AQUACULTURE, V227, P147, DOI 10.1016/S0044-8486(03)00500-3; Rosa R, 2005, HYDROBIOLOGIA, V537, P207, DOI 10.1007/s10750-004-2841-7; Rosa R, 2005, COMP BIOCHEM PHYS B, V140, P241, DOI 10.1016/j.cbpc.2004.10.009; SCHINDLER DW, 1977, SCIENCE, V195, P260, DOI 10.1126/science.195.4275.260; Slusarczyk M, 1999, OECOLOGIA, V119, P159, DOI 10.1007/s004420050772; SLUSARCZYK M, 1995, ECOLOGY, V76, P1008, DOI 10.2307/1939364; Sterner Robert W., 1998, Aquatic Ecology, V32, P261, DOI 10.1023/A:1009949400573; STROSS RG, 1965, SCIENCE, V150, P1462, DOI 10.1126/science.150.3702.1462; THRELKELD ST, 1979, LIMNOL OCEANOGR, V24, P601, DOI 10.4319/lo.1979.24.4.0601; Tonheim SK, 2000, AQUACULTURE, V190, P223, DOI 10.1016/S0044-8486(00)00402-6; von Elert E, 2003, P ROY SOC B-BIOL SCI, V270, P1209, DOI 10.1098/rspb.2003.2357; von Elert E, 2002, LIMNOL OCEANOGR, V47, P1764, DOI 10.4319/lo.2002.47.6.1764; Wacker A, 2001, ECOLOGY, V82, P2507, DOI 10.2307/2679932; Wojewodzic MW, 2011, FUNCT ECOL, V25, P1154, DOI 10.1111/j.1365-2435.2011.01864.x; Zaffagnini F., 1987, Memorie dell'Istituto Italiano di Idrobiologia Dott Marco de Marchi, V45, P245	51	35	35	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e28498	10.1371/journal.pone.0028498	http://dx.doi.org/10.1371/journal.pone.0028498			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22163027	Green Published, gold			2022-12-27	WOS:000298172800042
J	Iriyama, A; Oba, M; Ishii, T; Nishiyama, N; Kataoka, K; Tamaki, Y; Yanagi, Y				Iriyama, Aya; Oba, Makoto; Ishii, Takehiko; Nishiyama, Nobuhiro; Kataoka, Kazunori; Tamaki, Yasuhiro; Yanagi, Yasuo			Gene Transfer Using Micellar Nanovectors Inhibits Choroidal Neovascularization In Vivo	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; MACULAR DEGENERATION; FACTOR RECEPTOR; POLYPLEX NANOMICELLES; RANIBIZUMAB; THERAPY; PEGAPTANIB; CELLS; RATS; SUPPRESSION	Purpose: Age-related macular degeneration caused by choroidal neovascularization (CNV) remains difficult to be treated despite the recent advent of several treatment options. In this study, we investigated the in vivo angiogenic control by intravenous injection of polyion complex (PIC) micelle encapsulating plasmid DNA (pDNA) using a mice CNV model. Methods: The transfection efficiency of the PIC micelle was investigated using the laser-induced CNV in eight-week-old male C57 BJ/6 mice. Firstly, each mouse received intravenous injection of micelle encapsulating pDNA of Yellow Fluorescent Protein (pYFP) on days 1,3 and 5. The expression of YFP was analyzed using fluorescein microscopy and western blotting analysis. In the next experiments, each mouse received intravenous injection of micelle encapsulating pDNA of soluble Fms-like tyrosine kinase-1 (psFlt-1) 1,3 and 5 days after the induction of CNV and the CNV lesion was analyzed by choroidal flatmounts on day 7. Results: Fluorescein microscopy and western blotting analysis revealed that the expression of YFP was confirmed in the CNV area after injection of the PIC micelle, but the expression was not detected neither in mice that received naked pDNA nor those without CNV. Furthermore, the CNV area in the mice that received intravenous injection of the psFlt-1-encapsulated PIC micelle was significantly reduced by 65% compared to that in control mice (p<0.01). Conclusions: Transfection of sFlt-1 with the PIC micelle by intravenous injection to mice CNV models showed significant inhibition of CNV. The current results revealed the significant potential of nonviral gene therapy for regulation of CNV using the PIC micelle encapsulating pDNA.	[Iriyama, Aya] Tokyo Metropolitan Geriatr Hosp, Tokyo 173, Japan; [Iriyama, Aya; Tamaki, Yasuhiro; Yanagi, Yasuo] Univ Tokyo, Sch Med, Dept Ophthalmol, Bunkyo Ku, Tokyo 113, Japan; [Oba, Makoto] Univ Tokyo, Dept Clin Vasc Regenerat, Grad Sch Med, Bunkyo Ku, Tokyo, Japan; [Ishii, Takehiko; Kataoka, Kazunori] Univ Tokyo, Dept Bioengn, Grad Sch Engn, Bunkyo Ku, Tokyo, Japan; [Nishiyama, Nobuhiro; Kataoka, Kazunori] Univ Tokyo, Ctr Dis Biol & Integrat Med, Grad Sch Med, Bunkyo Ku, Tokyo, Japan; [Kataoka, Kazunori] Univ Tokyo, Dept Mat Engn, Grad Sch Engn, Bunkyo Ku, Tokyo, Japan	Tokyo Metropolitan Institute of Gerontology; University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo	Iriyama, A (corresponding author), Tokyo Metropolitan Geriatr Hosp, Tokyo 173, Japan.	akagi-tky@umin.ac.jp	Kataoka, Kazunori/K-7108-2012; Yanagi, Yasuo/AAA-5441-2022; Nishiyama, Nobuhiro/F-1867-2014; Yanagi, Yasuo/AAF-2670-2020	Kataoka, Kazunori/0000-0002-8591-413X; Nishiyama, Nobuhiro/0000-0002-6886-9357; Oba, Makoto/0000-0002-3691-3608; Yanagi, Yasuo/0000-0002-0362-7285	Ministry of Education, Science, Sports and Culture of Japan	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The work is supported in part by a grant-in-aid from the Ministry of Education, Science, Sports and Culture of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Andreoli CM, 2007, CURR OPIN OPHTHALMOL, V18, P502, DOI 10.1097/ICU.0b013e3282f0ca54; Bressler NM, 2009, OPHTHALMOLOGY, V116, pS15, DOI 10.1016/j.ophtha.2009.06.048; Brown DM, 2006, NEW ENGL J MED, V355, P1432, DOI 10.1056/NEJMoa062655; Chakravarthy U, 2006, OPHTHALMOLOGY, V113, P1508, DOI 10.1016/j.ophtha.2006.02.064; FERRIS FL, 1984, ARCH OPHTHALMOL-CHIC, V102, P1640; Gragoudas ES, 2004, NEW ENGL J MED, V351, P2805, DOI 10.1056/NEJMoa042760; Harada-Shiba M, 2009, MOL THER, V17, P1180, DOI 10.1038/mt.2009.63; Honda M, 2000, GENE THER, V7, P978, DOI 10.1038/sj.gt.3301203; Hoshida T, 2002, PANCREAS, V25, P111, DOI 10.1097/00006676-200208000-00001; Ideta R, 2004, FEBS LETT, V557, P21, DOI 10.1016/S0014-5793(03)01315-2; Ideta R, 2005, NANO LETT, V5, P2426, DOI 10.1021/nl051679d; Iriyama AUT, 2011, CORNEA; Iriyama A, 2008, J BIOL CHEM, V283, P11947, DOI 10.1074/jbc.M708989200; Iriyama A, 2007, BRIT J OPHTHALMOL, V91, P1230, DOI 10.1136/bjo.2007.117309; Itaka K, 2007, MOL THER, V15, P1655, DOI 10.1038/sj.mt.6300218; Itaka K, 2010, BIOMATERIALS, V31, P3707, DOI 10.1016/j.biomaterials.2009.11.072; Kaiser PK, 2007, AM J OPHTHALMOL, V144, P850, DOI 10.1016/j.ajo.2007.08.012; Kanayama N, 2006, CHEMMEDCHEM, V1, P439, DOI 10.1002/cmdc.200600008; Maclachlan TK, 2010, MOL THER; Mendrinos E, 2009, INVEST OPHTHALMOL VI; Miyata K, 2008, J AM CHEM SOC, V130, P16287, DOI 10.1021/ja804561g; Murakami Y, 2010, HUM GENE THER, V21, P199, DOI 10.1089/hum.2009.102; Papadopoulou DN, 2009, OPHTHALMOLOGY, V116, P1755, DOI 10.1016/j.ophtha.2009.03.017; Rosenfeld Philip J, 2006, Ophthalmol Clin North Am, V19, P361; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Sacu S, 2010, INVEST OPHTHALMOL VI; Schwesinger C, 2001, AM J PATHOL, V158, P1161, DOI 10.1016/S0002-9440(10)64063-1; Takahashi H, 2008, INVEST OPHTH VIS SCI, V49, P2143, DOI 10.1167/iovs.07-0523; Takahashi H, 2008, CURR EYE RES, V33, P1002, DOI 10.1080/02713680802492440; Takayama K, 2000, CANCER RES, V60, P2169; Takeda AL, 2007, BRIT J OPHTHALMOL, V91, P1177, DOI 10.1136/bjo.2007.118562; Tunon J, 2009, SURV OPHTHALMOL, V54, P339, DOI 10.1016/j.survophthal.2009.02.003; Wormald R., 2000, COCHRANE DB SYST REV; Yasukawa T, 1999, INVEST OPHTH VIS SCI, V40, P2690	34	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e28560	10.1371/journal.pone.0028560	http://dx.doi.org/10.1371/journal.pone.0028560			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22162776	Green Published, Green Submitted, gold			2022-12-27	WOS:000298172800047
J	Li, H; Sorenson, AL; Poczobutt, J; Amin, J; Joyal, T; Sullivan, T; Crossno, JT; Weiser-Evans, MCM; Nemenoff, RA				Li, Howard; Sorenson, Amber L.; Poczobutt, Joanna; Amin, Jay; Joyal, Teresa; Sullivan, Timothy; Crossno, Joseph T., Jr.; Weiser-Evans, Mary C. M.; Nemenoff, Raphael A.			Activation of PPAR gamma in Myeloid Cells Promotes Lung Cancer Progression and Metastasis	PLOS ONE			English	Article							RECEPTOR-GAMMA; GENE-EXPRESSION; COLON TUMORS; TARGET; THIAZOLIDINEDIONE; MACROPHAGES; SUPPRESSION; INHIBITION; APOPTOSIS; RAS	Activation of peroxisome proliferator-activated receptor-gamma (PPAR gamma) inhibits growth of cancer cells including non-small cell lung cancer (NSCLC). Clinically, use of thiazolidinediones, which are pharmacological activators of PPAR gamma is associated with a lower risk of developing lung cancer. However, the role of this pathway in lung cancer metastasis has not been examined well. The systemic effect of pioglitazone was examined in two models of lung cancer metastasis in immune-competent mice. In an orthotopic model, murine lung cancer cells implanted into the lungs of syngeneic mice metastasized to the liver and brain. As a second model, cancer cells injected subcutaneously metastasized to the lung. In both models systemic administration of pioglitazone increased the rate of metastasis. Examination of tissues from the orthotopic model demonstrated increased numbers of arginase I-positive macrophages in tumors from pioglitazone-treated animals. In co-culture experiments of cancer cells with bone marrow-derived macrophages, pioglitazone promoted arginase I expression in macrophages and this was dependent on the expression of PPAR gamma in the macrophages. To assess the contribution of PPAR gamma in macrophages to cancer progression, experiments were performed in bone marrow-transplanted animals receiving bone marrow from Lys-M-Cre+/PPAR gamma(flox/flox) mice, in which PPAR gamma is deleted specifically in myeloid cells (PPAR gamma-Mac(neg)), or control PPAR gamma(flox/flox) mice. In both models, mice receiving PPAR gamma-Mac(neg) bone marrow had a marked decrease in secondary tumors which was not significantly altered by treatment with pioglitazone. This was associated with decreased numbers of arginase I-positive cells in the lung. These data support a model in which activation of PPAR gamma may have opposing effects on tumor progression, with anti-tumorigenic effects on cancer cells, but pro-tumorigenic effects on cells of the microenvironment, specifically myeloid cells.	[Li, Howard; Crossno, Joseph T., Jr.] Univ Colorado, Dept Med, Div Pulm Sci & Crit Care Med, Aurora, CO 80045 USA; [Sorenson, Amber L.; Poczobutt, Joanna; Amin, Jay; Joyal, Teresa; Weiser-Evans, Mary C. M.; Nemenoff, Raphael A.] Univ Colorado, Dept Med, Div Renal Dis & Hypertens, Aurora, CO USA; [Sullivan, Timothy; Crossno, Joseph T., Jr.] Univ Colorado, Dept Med, Cardiovasc Pulm Res Lab, Aurora, CO USA; [Li, Howard; Crossno, Joseph T., Jr.] Vet Affairs Med Ctr, Denver, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Li, H (corresponding author), Univ Colorado, Dept Med, Div Pulm Sci & Crit Care Med, Anschutz Med Campus, Aurora, CO 80045 USA.	Raphael.Nemenoff@ucdenver.edu	Li, Howard/AAM-3544-2021		NIH [CA103618, CA108610, CA58187]; SPORE on Lung Cancer; NATIONAL CANCER INSTITUTE [P50CA058187, R01CA108610, R01CA103618] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007171] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SPORE on Lung Cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the NIH (CA103618, CA108610, and CA58187), as well as a Pilot Grant from the SPORE on Lung Cancer to Dr. Weiser-Evans. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bak SP, 2008, MOL IMMUNOL, V46, P258, DOI 10.1016/j.molimm.2008.08.266; Bonfield TL, 2008, J IMMUNOL, V181, P235, DOI 10.4049/jimmunol.181.1.235; Bren-Mattison Y, 2005, ONCOGENE, V24, P1412, DOI 10.1038/sj.onc.1208333; Bren-Mattison Y, 2008, MOL PHARMACOL, V73, P709, DOI 10.1124/mol.107.042002; Budde K, 2003, BRIT J CLIN PHARMACO, V55, P368, DOI 10.1046/j.1365-2125.2003.01785.x; Choudhary R, 2010, NEOPLASIA, V12, P224, DOI 10.1593/neo.91638; Crossno JT, 2007, AM J PHYSIOL-LUNG C, V292, pL885, DOI 10.1152/ajplung.00258.2006; FRANKS LM, 1976, CANCER RES, V36, P1049; Girnun GD, 2002, P NATL ACAD SCI USA, V99, P13771, DOI 10.1073/pnas.162480299; Govindarajan R, 2007, J CLIN ONCOL, V25, P1476, DOI 10.1200/JCO.2006.07.2777; Gupta RA, 2002, AM J PHYSIOL-GASTR L, V283, pG266, DOI 10.1152/ajpgi.00486.2001; Han SW, 2008, PPAR RES, V2008, DOI 10.1155/2008/254108; Heasley LE, 1997, J BIOL CHEM, V272, P14501, DOI 10.1074/jbc.272.23.14501; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Kenny PA, 2007, FRONT BIOSCI-LANDMRK, V12, P3468, DOI 10.2741/2327; Lefebvre AM, 1998, NAT MED, V4, P1053, DOI 10.1038/2036; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Lewis CE, 2006, CANCER RES, V66, P605, DOI 10.1158/0008-5472.CAN-05-4005; Li MY, 2010, AM J RESP CELL MOL, V43, P674, DOI 10.1165/rcmb.2009-0349OC; Li MY, 2006, J CELL PHYSIOL, V209, P428, DOI 10.1002/jcp.20738; Liu QY, 2009, J IMMUNOL, V182, P6207, DOI 10.4049/jimmunol.0803926; Maeda N, 2001, DIABETES, V50, P2094, DOI 10.2337/diabetes.50.9.2094; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Mantovani A, 2007, BREAST, V16, pS27, DOI 10.1016/j.breast.2007.07.013; Nemenoff R, 2008, CANCER PREV RES, V1, P349, DOI 10.1158/1940-6207.CAPR-08-0145; Nemenoff RA, 2007, J THORAC ONCOL, V2, P989, DOI 10.1097/JTO.0b013e318158cf0a; Norian LA, 2009, CANCER RES, V69, P3086, DOI 10.1158/0008-5472.CAN-08-2826; Oberlies J, 2009, J IMMUNOL, V182, P5259, DOI 10.4049/jimmunol.0803523; Pino MV, 2004, TOXICOL PATHOL, V32, P58, DOI 10.1080/01926230490261320; RICHES DWH, 1988, J IMMUNOL, V141, P180; Rodriguez PC, 2004, CANCER RES, V64, P5839, DOI 10.1158/0008-5472.CAN-04-0465; Sasaki H, 2002, LUNG CANCER-J IASLC, V36, P71, DOI 10.1016/S0169-5002(01)00449-4; SMITH GJ, 1984, CELL BIOL INT REP, V8, P161, DOI 10.1016/0309-1651(84)90083-3; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Weiser-Evans MCM, 2009, CANCER RES, V69, P1733, DOI 10.1158/0008-5472.CAN-08-3766; Wick M, 2002, MOL PHARMACOL, V62, P1207, DOI 10.1124/mol.62.5.1207; Zou W, 2007, CANCER BIOL THER, V6, P99, DOI 10.4161/cbt.6.1.3555	38	51	53	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2011	6	12							e28133	10.1371/journal.pone.0028133	http://dx.doi.org/10.1371/journal.pone.0028133			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MQ	22145026	Green Published, Green Submitted, gold			2022-12-27	WOS:000298168900009
J	Dieterich, C; Relman, DA				Dieterich, Christine; Relman, David A.			Modulation of the Host Interferon Response and ISGylation Pathway by B. pertussis Filamentous Hemagglutinin	PLOS ONE			English	Article							ADENYLATE-CYCLASE TOXIN; UBIQUITIN-LIKE PROTEIN; RESPIRATORY EPITHELIAL-CELLS; INNATE ANTIVIRAL RESPONSE; GENE TRANSCRIPT ABUNDANCE; BORDETELLA-PERTUSSIS; EXPRESSION PATTERNS; ISG15 CONJUGATION; PERIPHERAL-BLOOD; BACTERIAL-INFECTION	Bordetella pertussis filamentous hemagglutinin (FHA) is a surface-associated and secreted protein that serves as a crucial adherence factor, and displays immunomodulatory activity in human peripheral blood mononuclear cells (PBMCs). In order to appreciate more fully the role of secreted FHA in pathogenesis, we analyzed FHA-induced changes in genome-wide transcript abundance in human PBMCs. Among the 683 known unique genes with greater than 3-fold change in transcript abundance following FHA treatment, 125 (18.3%) were identified as interferon (IFN)-regulated. Among the latter group were genes encoding several members of the IFN type I response, as well as 3 key components of the ISGylation pathway. Using real-time RT-PCR, we confirmed FHA-associated increases in transcript abundance for the genes encoding ubiquitin-like protein, ISG15, and its specific protease USP18. Western-blot analysis demonstrated the presence of both, free ISG15 and several ISGylated conjugates in FHA-stimulated PBMC lysates, but not in unstimulated cells. Intracellular FACS analysis provided evidence that monocytes and a natural killer-enriched cell population were the primary producers of ISG15 in PBMCs after FHA stimulation. Our data reveal previously-unrecognized effects of B. pertussis FHA on host IFN and ISGylation responses, and suggest previously-unsuspected mechanisms by which FHA may alter the outcome of the host-pathogen interaction.	[Dieterich, Christine; Relman, David A.] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA; [Relman, David A.] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Dieterich, Christine; Relman, David A.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA	Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Dieterich, C (corresponding author), Lipopeptide AB, Solna, Sweden.	relman@stanford.edu		Relman, David A./0000-0001-8331-1354	National Institute for Allergy and Infectious Diseases/National Institutes of Health (NIH) [AI54970, AI057188]; NIH; Thomas C. and Joan M. Merigan Endowment; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R33AI057188, R03AI054970, R21AI057188] Funding Source: NIH RePORTER	National Institute for Allergy and Infectious Diseases/National Institutes of Health (NIH); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Thomas C. and Joan M. Merigan Endowment; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institute for Allergy and Infectious Diseases/National Institutes of Health (NIH) (grants AI54970, AI057188) (to D. R.). D. R. is the recipient of an NIH Director's Pioneer Award, and is supported by the Thomas C. and Joan M. Merigan Endowment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson T, 2001, INFECT IMMUN, V69, P2650, DOI 10.1128/IAI.69.4.2650-2658.2001; Abramson T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003825; Alizadeh A, 1999, COLD SPRING HARB SYM, V64, P71, DOI 10.1101/sqb.1999.64.71; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Andersen JB, 2006, CYTOKINE GROWTH F R, V17, P411, DOI 10.1016/j.cytogfr.2006.10.001; Belcher CE, 2000, P NATL ACAD SCI USA, V97, P13847, DOI 10.1073/pnas.230262797; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; Boldrick JC, 2002, P NATL ACAD SCI USA, V99, P972, DOI 10.1073/pnas.231625398; Brinig MM, 2006, J BACTERIOL, V188, P2375, DOI 10.1128/JB.188.7.2375-2382.2006; Cheung GYC, 2008, MICROB PATHOGENESIS, V44, P61, DOI 10.1016/j.micpath.2007.08.007; Cotter PA, 2003, TRENDS MICROBIOL, V11, P367, DOI 10.1016/S0966-842X(03)00156-2; Cotter PA, 1998, INFECT IMMUN, V66, P5921, DOI 10.1128/IAI.66.12.5921-5929.1998; Coutte L, 2003, J EXP MED, V197, P735, DOI 10.1084/jem.20021153; Dao CT, 2005, FRONT BIOSCI-LANDMRK, V10, P2701, DOI 10.2741/1730; Dao CT, 2005, FRONT BIOSCI, V10, P2346; DCunha J, 1996, P NATL ACAD SCI USA, V93, P211, DOI 10.1073/pnas.93.1.211; DCunha J, 1996, J IMMUNOL, V157, P4100; Decker T, 2005, NAT REV IMMUNOL, V5, P675, DOI 10.1038/nri1684; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; DesJardin LE, 2002, MICROBIOL-SGM, V148, P3161, DOI 10.1099/00221287-148-10-3161; DETMERS PA, 1991, J IMMUNOL, V147, P4211; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Farizo KM, 2000, INFECT IMMUN, V68, P4049, DOI 10.1128/IAI.68.7.4049-4054.2000; FARRELL PJ, 1979, NATURE, V279, P523, DOI 10.1038/279523a0; FRIEDMAN RL, 1992, INFECT IMMUN, V60, P4578, DOI 10.1128/IAI.60.11.4578-4585.1992; Gao JJ, 2002, J LEUKOCYTE BIOL, V72, P1234; Giannakopoulos NV, 2005, BIOCHEM BIOPH RES CO, V336, P496, DOI 10.1016/j.bbrc.2005.08.132; Haller O, 2006, VIROLOGY, V344, P119, DOI 10.1016/j.virol.2005.09.024; HANNAH JH, 1994, INFECT IMMUN, V62, P5010, DOI 10.1128/IAI.62.11.5010-5019.1994; Harty RN, 2009, J INNATE IMMUN, V1, P397, DOI 10.1159/000226245; Hewlett EL, 2006, MOL MICROBIOL, V59, P447, DOI 10.1111/j.1365-2958.2005.04958.x; HORTON JK, 1992, J IMMUNOL METHODS, V155, P31, DOI 10.1016/0022-1759(92)90268-X; Inatsuka CS, 2005, P NATL ACAD SCI USA, V102, P18578, DOI 10.1073/pnas.0507910102; ISHIBASHI Y, 1994, J EXP MED, V180, P1225, DOI 10.1084/jem.180.4.1225; Ishibashi Y, 2001, MICROB PATHOGENESIS, V30, P279, DOI 10.1006/mpat.2001.0432; Jenner RG, 2005, NAT REV MICROBIOL, V3, P281, DOI 10.1038/nrmicro1126; Julio SM, 2009, MOL MICROBIOL, V71, P1574, DOI 10.1111/j.1365-2958.2009.06623.x; KNIGHT E, 1991, J IMMUNOL, V146, P2280; Lee CH, 1999, ANAL BIOCHEM, V267, P161, DOI 10.1006/abio.1998.2961; Lenschow DJ, 2005, J VIROL, V79, P13974, DOI 10.1128/JVI.79.22.13974-13983.2005; Liu MJ, 2004, J INTERF CYTOK RES, V24, P647, DOI 10.1089/jir.2004.24.647; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu G, 2006, CELL MOL BIOL, V52, P29, DOI 10.1170/T695; Malakhov MP, 2002, J BIOL CHEM, V277, P9976, DOI 10.1074/jbc.M109078200; Malakhova OA, 2003, GENE DEV, V17, P455, DOI 10.1101/gad.1056303; Malakhova OA, 2006, EMBO J, V25, P2358, DOI 10.1038/sj.emboj.7601149; Manthey CL, 1998, J LEUKOCYTE BIOL, V64, P409, DOI 10.1002/jlb.64.3.409; Martin C, 2010, J BIOL CHEM, V285, P357, DOI 10.1074/jbc.M109.003491; Mattoo S, 2005, CLIN MICROBIOL REV, V18, P326, DOI 10.1128/CMR.18.2.326-382.2005; Mazar J, 2006, MOL MICROBIOL, V62, P641, DOI 10.1111/j.1365-2958.2006.05392.x; McGuirk P, 2000, EUR J IMMUNOL, V30, P415, DOI 10.1002/1521-4141(200002)30:2<415::AID-IMMU415>3.3.CO;2-O; Medzhitov R, 2000, NEW ENGL J MED, V343, P338, DOI 10.1056/NEJM200008033430506; MENOZZI FD, 1991, FEMS MICROBIOL LETT, V78, P59; Mills KHG, 2001, MICROBES INFECT, V3, P655, DOI 10.1016/S1286-4579(01)01421-6; Minakawa M, 2008, BIOL PHARM BULL, V31, P2223, DOI 10.1248/bpb.31.2223; Mobberley-Schuman PS, 2005, INFECT IMMUN, V73, P7317, DOI 10.1128/IAI.73.11.7317-7323.2005; Nau GJ, 2002, P NATL ACAD SCI USA, V99, P1503, DOI 10.1073/pnas.022649799; Okumura A, 2006, P NATL ACAD SCI USA, V103, P1440, DOI 10.1073/pnas.0510518103; Paccani SR, 2008, INFECT IMMUN, V76, P2822, DOI 10.1128/IAI.00200-08; PIZZA M, 1990, J BIOL CHEM, V265, P17759; PIZZA M, 1989, SCIENCE, V246, P497, DOI 10.1126/science.2683073; Popper SJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-r261; Popper SJ, 2009, J INFECT DIS, V200, P657, DOI 10.1086/603538; PRASAD SM, 1993, INFECT IMMUN, V61, P2780, DOI 10.1128/IAI.61.7.2780-2785.1993; RECHT M, 1991, J IMMUNOL, V147, P2617; RELMAN D, 1990, CELL, V61, P1375, DOI 10.1016/0092-8674(90)90701-F; RELMAN DA, 1989, P NATL ACAD SCI USA, V86, P2637, DOI 10.1073/pnas.86.8.2637; Rubins KH, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r174; Rubins KH, 2004, P NATL ACAD SCI USA, V101, P15190, DOI 10.1073/pnas.0405759101; Simmons CP, 2007, J INFECT DIS, V195, P1097, DOI 10.1086/512162; Spensieri F, 2006, INFECT IMMUN, V74, P2831, DOI 10.1128/IAI.74.5.2831-2838.2006; STAINER DW, 1970, J GEN MICROBIOL, V63, P211, DOI 10.1099/00221287-63-2-211; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Takeuchi T, 2006, FEBS LETT, V580, P4521, DOI 10.1016/j.febslet.2006.07.032; Thornton J, 2005, INFECT IMMUN, V73, P6493, DOI 10.1128/IAI.73.10.6493-6498.2005; VADDI K, 1994, J IMMUNOL, V153, P4721; Walduck A, 2004, CURR OPIN MICROBIOL, V7, P33, DOI 10.1016/j.mib.2003.12.010; WEISS AA, 1983, INFECT IMMUN, V42, P33, DOI 10.1128/IAI.42.1.33-41.1983; Whitney AR, 2003, P NATL ACAD SCI USA, V100, P1896, DOI 10.1073/pnas.252784499; Wood N, 2008, PAEDIATR RESPIR REV, V9, P201, DOI 10.1016/j.prrv.2008.05.010; Yeh Sylvia H, 2003, Expert Rev Vaccines, V2, P113, DOI 10.1586/14760584.2.1.113; Yuan WM, 2001, EMBO J, V20, P362, DOI 10.1093/emboj/20.3.362; Zhao C, 2010, P NATL ACAD SCI USA, V107, P2253, DOI 10.1073/pnas.0909144107; Zou WG, 2005, BIOCHEM BIOPH RES CO, V336, P61, DOI 10.1016/j.bbrc.2005.08.038	84	21	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e27535	10.1371/journal.pone.0027535	http://dx.doi.org/10.1371/journal.pone.0027535			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140447	Green Published, gold, Green Submitted			2022-12-27	WOS:000298168100012
J	Franzosa, EA; Albanese, V; Frydman, J; Xia, Y; McClellan, AJ				Franzosa, Eric A.; Albanese, Veronique; Frydman, Judith; Xia, Yu; McClellan, Amie J.			Heterozygous Yeast Deletion Collection Screens Reveal Essential Targets of Hsp90	PLOS ONE			English	Article							SIGNAL RECOGNITION PARTICLE; HEAT-SHOCK PROTEINS; SACCHAROMYCES-CEREVISIAE; ATPASE ACTIVITY; CHAPERONE COMPLEX; CO-CHAPERONE; BINDING; LOCALIZATION; BIOGENESIS; RECEPTOR	Hsp90 is an essential eukaryotic chaperone with a role in folding specific "client" proteins such as kinases and hormone receptors. Previously performed homozygous diploid yeast deletion collection screens uncovered broad requirements for Hsp90 in cellular transport and cell cycle progression. These screens also revealed that the requisite cellular functions of Hsp90 change with growth temperature. We present here for the first time the results of heterozygous deletion collection screens conducted at the hypothermic stress temperature of 15 degrees C. Extensive bioinformatic analyses were performed on the resulting data in combination with data from homozygous and heterozygous screens previously conducted at normal (30 degrees C) and hyperthermic stress (37 degrees C) growth temperatures. Our resulting meta-analysis uncovered extensive connections between Hsp90 and (1) general transcription, (2) ribosome biogenesis and (3) GTP binding proteins. Predictions from bioinformatic analyses were tested experimentally, supporting a role for Hsp90 in ribosome stability. Importantly, the integrated analysis of the 15 degrees C heterozygous deletion pool screen with previously conducted 30 degrees C and 37 degrees C screens allows for essential genetic targets of Hsp90 to emerge. Altogether, these novel contributions enable a more complete picture of essential Hsp90 functions.	[Franzosa, Eric A.; Xia, Yu] Boston Univ, Bioinformat Program, Boston, MA 02215 USA; [Xia, Yu] Boston Univ, Dept Chem, Boston, MA 02215 USA; [Albanese, Veronique; Frydman, Judith] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [McClellan, Amie J.] Bennington Coll, Div Nat Sci & Math, Bennington, VT USA	Boston University; Boston University; Stanford University	Franzosa, EA (corresponding author), Boston Univ, Bioinformat Program, Boston, MA 02215 USA.	amcclellan@bennington.edu	Xia, Yu/W-6150-2019; McClellan, Amie/V-8950-2019	Xia, Yu/0000-0002-5596-5518; , judith/0000-0003-2302-6943; Albanese, Veronique/0000-0002-5947-7415; McClellan, Amie/0000-0002-8033-6748	National Institutes of Health (NIH) [GM56433, GM087654-01, R15]; National Science Foundation IGERT [DGE-0654108]; Pharmaceutical Research and Manufacturers of America Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056433, R15GM087654] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation IGERT(National Science Foundation (NSF)); Pharmaceutical Research and Manufacturers of America Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH; www.nih.gov) grant GM56433 to JF, NIH R15 AREA grant GM087654-01 to AJM, National Science Foundation IGERT (http://www.igert.org/) grant DGE-0654108 to EAF, and Pharmaceutical Research and Manufacturers of America (PhRMA; http://www.phrmafoundation.org/) Foundation Research Starter Grant in Informatics to YX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKNER G, 1992, EUR J CELL BIOL, V58, P356; Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; Banerji U, 2009, CLIN CANCER RES, V15, P9, DOI 10.1158/1078-0432.CCR-08-0132; Biggiogera M, 1996, EXP CELL RES, V229, P77, DOI 10.1006/excr.1996.0345; Blagosklonny MV, 2002, LEUKEMIA, V16, P455, DOI 10.1038/sj.leu.2402415; Boulon S, 2008, J CELL BIOL, V180, P579, DOI 10.1083/jcb.200708110; Brachmann CB, 1998, YEAST, V14, P115; Catlett MG, 2006, J BIOL CHEM, V281, P33739, DOI 10.1074/jbc.M603847200; CHANG HCJ, 1994, J BIOL CHEM, V269, P24983; Chaudhuri TK, 2005, CELL STRESS CHAPERON, V10, P24, DOI 10.1379/CSC-64R1.1; Chen CY, 2006, MOL BIOL CELL, V17, P3494, DOI 10.1091/mbc.E05-12-1096; Dolinski KJ, 1998, MOL CELL BIOL, V18, P7344, DOI 10.1128/MCB.18.12.7344; Dollins DE, 2007, MOL CELL, V28, P41, DOI 10.1016/j.molcel.2007.08.024; Donze O, 1999, MOL CELL BIOL, V19, P8422, DOI 10.1128/mcb.19.12.8422; Dou F, 2003, P NATL ACAD SCI USA, V100, P721, DOI 10.1073/pnas.242720499; Falsone SF, 2005, FEBS LETT, V579, P6350, DOI 10.1016/j.febslet.2005.10.020; FLYNN GC, 1991, NATURE, V353, P726, DOI 10.1038/353726a0; FOURIE AM, 1994, J BIOL CHEM, V269, P30470; Freeman BC, 2002, SCIENCE, V296, P2232, DOI 10.1126/science.1073051; Geller R, 2007, GENE DEV, V21, P195, DOI 10.1101/gad.1505307; Gelperin D, 2001, RNA, V7, P1268, DOI 10.1017/S1355838201013073; Giaever G, 2003, TRENDS PHARMACOL SCI, V24, P444, DOI 10.1016/S0165-6147(03)00225-6; Gonzales FA, 2005, J MOL BIOL, V346, P437, DOI 10.1016/j.jmb.2004.11.071; HANN BC, 1992, NATURE, V356, P532, DOI 10.1038/356532a0; HANN BC, 1991, CELL, V67, P131, DOI 10.1016/0092-8674(91)90577-L; JAKOB U, 1995, J BIOL CHEM, V270, P7288, DOI 10.1074/jbc.270.13.7288; Kakimura J, 2002, FASEB J, V16, P601, DOI 10.1096/fj.01-0530fje; Karbstein K, 2005, MOL CELL, V20, P633, DOI 10.1016/j.molcel.2005.09.017; Kim TS, 2006, MOL BIOL CELL, V17, P824, DOI 10.1091/mbc.E05-08-0713; King TH, 2001, MOL CELL BIOL, V21, P7731, DOI 10.1128/MCB.21.22.7731-7746.2001; Kitagawa K, 1999, MOL CELL, V4, P21, DOI 10.1016/S1097-2765(00)80184-7; Langer T, 2003, CELL BIOL INT, V27, P47, DOI 10.1016/S1065-6995(02)00256-1; Lee YT, 2004, J BIOL CHEM, V279, P16511, DOI 10.1074/jbc.M400215200; Li J, 2011, NAT STRUCT MOL BIOL, V18, P61, DOI 10.1038/nsmb.1965; Li YL, 2009, J BIOL CHEM, V284, P4324, DOI 10.1074/jbc.M804818200; Liu J, 2009, J NEUROSCI, V29, P1480, DOI 10.1523/JNEUROSCI.6202-08.2009; Lotz GP, 2008, J CELL SCI, V121, P717, DOI 10.1242/jcs.015610; Louvion JF, 1998, MOL BIOL CELL, V9, P3071, DOI 10.1091/mbc.9.11.3071; Luo WJ, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-24; Marsh JA, 1998, MOL CELL BIOL, V18, P7353, DOI 10.1128/MCB.18.12.7353; McClellan AJ, 2005, CELL, V121, P739, DOI 10.1016/j.cell.2005.03.024; McClellan AJ, 2007, CELL, V131, P121, DOI 10.1016/j.cell.2007.07.036; McLaughlin SH, 2006, J MOL BIOL, V356, P746, DOI 10.1016/j.jmb.2005.11.085; McLaughlin SH, 2002, J MOL BIOL, V315, P787, DOI 10.1006/jmbi.2001.5245; McLean PJ, 2002, J NEUROCHEM, V83, P846, DOI 10.1046/j.1471-4159.2002.01190.x; Meyer P, 2003, MOL CELL, V11, P647, DOI 10.1016/S1097-2765(03)00065-0; Millson SH, 2005, EUKARYOT CELL, V4, P849, DOI 10.1128/EC.4.5.849-860.2005; Mimnaugh EG, 1996, J BIOL CHEM, V271, P22796, DOI 10.1074/jbc.271.37.22796; Nathan DF, 1999, P NATL ACAD SCI USA, V96, P1409, DOI 10.1073/pnas.96.4.1409; NATHAN DF, 1995, MOL CELL BIOL, V15, P3917; Obermann WMJ, 1998, J CELL BIOL, V143, P901, DOI 10.1083/jcb.143.4.901; Panaretou B, 1998, EMBO J, V17, P4829, DOI 10.1093/emboj/17.16.4829; Panaretou B, 2002, MOL CELL, V10, P1307, DOI 10.1016/S1097-2765(02)00785-2; Pearl LH, 2005, CURR OPIN GENET DEV, V15, P55, DOI 10.1016/j.gde.2004.12.011; Pratt WB, 2004, CELL SIGNAL, V16, P857, DOI 10.1016/j.cellsig.2004.02.004; Pratt WB, 1998, P SOC EXP BIOL MED, V217, P420; Prodromou C, 2000, EMBO J, V19, P4383, DOI 10.1093/emboj/19.16.4383; Prodromou C, 1999, EMBO J, V18, P754, DOI 10.1093/emboj/18.3.754; Sangster TA, 2003, CELL CYCLE, V2, P166; Schneider C, 1996, P NATL ACAD SCI USA, V93, P14536, DOI 10.1073/pnas.93.25.14536; SCHULTE TW, 1995, J BIOL CHEM, V270, P24585, DOI 10.1074/jbc.270.41.24585; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shiau AK, 2006, CELL, V127, P329, DOI 10.1016/j.cell.2006.09.027; Siligardi G, 2002, J BIOL CHEM, V277, P20151, DOI 10.1074/jbc.M201287200; Sopko R, 2006, MOL CELL, V21, P319, DOI 10.1016/j.molcel.2005.12.011; Southworth DR, 2008, MOL CELL, V32, P631, DOI 10.1016/j.molcel.2008.10.024; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; STIRLING CJ, 1992, NATURE, V356, P534, DOI 10.1038/356534a0; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Tapia H, 2010, MOL BIOL CELL, V21, P63, DOI 10.1091/mbc.E09-05-0376; Tsaytler PA, 2009, CELL STRESS CHAPERON, V14, P629, DOI 10.1007/s12192-009-0115-z; Uryu K, 2006, AM J PATHOL, V168, P947, DOI 10.2353/ajpath.2006.050770; Vaughan CK, 2006, MOL CELL, V23, P697, DOI 10.1016/j.molcel.2006.07.016; Vaughan CK, 2009, FEBS J, V276, P199, DOI 10.1111/j.1742-4658.2008.06773.x; Wegierski T, 2001, RNA, V7, P1254, DOI 10.1017/S1355838201012079; Whitesell L, 1996, MOL ENDOCRINOL, V10, P705, DOI 10.1210/me.10.6.705; Zhao RM, 2005, CELL, V120, P715, DOI 10.1016/j.cell.2004.12.024; Zhu H, 2001, SCIENCE, V293, P2101, DOI 10.1126/science.1062191	78	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e28211	10.1371/journal.pone.0028211	http://dx.doi.org/10.1371/journal.pone.0028211			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140548	gold, Green Published, Green Submitted			2022-12-27	WOS:000298168100051
J	Kallert, TW; Katsakou, C; Adamowski, T; Dembinskas, A; Fiorillo, A; Kjellin, L; Mastrogianni, A; Nawka, P; Onchev, G; Raboch, J; Schutzwohl, M; Solomon, Z; Torres-Gonzalez, F; Bremner, S; Priebe, S				Kallert, Thomas W.; Katsakou, Christina; Adamowski, Tomasz; Dembinskas, Algirdas; Fiorillo, Andrea; Kjellin, Lars; Mastrogianni, Anastasia; Nawka, Petr; Onchev, Georgi; Raboch, Jiri; Schuetzwohl, Matthias; Solomon, Zahava; Torres-Gonzalez, Francisco; Bremner, Stephen; Priebe, Stefan			Coerced Hospital Admission and Symptom Change-A Prospective Observational Multi-Centre Study	PLOS ONE			English	Article							PSYCHIATRIC RATING-SCALE; PERCEIVED COERCION; EUROPEAN COUNTRIES; PATIENTS VIEWS; SATISFACTION; VOLUNTARY; SCHIZOPHRENIA; PERCEPTIONS; CARE	Introduction: Coerced admission to psychiatric hospitals, defined by legal status or patient's subjective experience, is common. Evidence on clinical outcomes however is limited. This study aimed to assess symptom change over a three month period following coerced admission and identify patient characteristics associated with outcomes. Method: At study sites in 11 European countries consecutive legally involuntary patients and patients with a legally voluntary admission who however felt coerced, were recruited and assessed by independent researchers within the first week after admission. Symptoms were assessed on the Brief Psychiatric Rating Scale. Patients were re-assessed after one and three months. Results: The total sample consisted of 2326 legally coerced patients and 764 patients with a legally voluntary admission who felt coerced. Symptom levels significantly improved over time. In a multivariable analysis, higher baseline symptoms, being unemployed, living alone, repeated hospitalisation, being legally a voluntary patient but feeling coerced, and being initially less satisfied with treatment were all associated with less symptom improvement after one month and, other than initial treatment satisfaction, also after three months. The diagnostic group was not linked with outcomes. Discussion: On average patients show significant but limited symptom improvements after coerced hospital admission, possibly reflecting the severity of the underlying illnesses. Social factors, but not the psychiatric diagnosis, appear important predictors of outcomes. Legally voluntary patients who feel coerced may have a poorer prognosis than legally involuntary patients and deserve attention in research and clinical practice.	[Kallert, Thomas W.] Klin Psychiat Psychosomat & Psychotherapie, Leipzig, Germany; [Katsakou, Christina; Bremner, Stephen; Priebe, Stefan] Univ London, Social & Community Psychiat Unit, London, England; [Adamowski, Tomasz] Wroclaw Med Univ, Dept Psychiat, Wroclaw, Poland; [Dembinskas, Algirdas] Vilnius State Univ, Vilnius Mental Hlth Ctr, Psychiat Clin, Vilnius, Lithuania; [Fiorillo, Andrea] Univ Naples Federico 2, Dept Psychiat, Naples, Italy; [Kjellin, Lars] Psychiat Res Ctr, Orebro, Sweden; [Mastrogianni, Anastasia] Hosp Psychiat, Thessaloniki, Greece; [Nawka, Petr] Hosp Psychiat, Michalovce, Slovakia; [Onchev, Georgi] Med Univ Sofia, Dept Psychiat, Sofia, Bulgaria; [Raboch, Jiri] Charles Univ Prague, Dept Psychiat, Prague, Czech Republic; [Schuetzwohl, Matthias] Tech Univ Dresden, Dept Psychiat & Psychotherapy, Dresden, Germany; [Solomon, Zahava] Tel Aviv Univ, Sch Social Work, IL-69978 Tel Aviv, Israel; [Solomon, Zahava] Tel Aviv Univ, Geha Mental Hlth Ctr, IL-69978 Tel Aviv, Israel; [Torres-Gonzalez, Francisco] Univ Granada, Dept Legal Med & Psychiat, Fac Med, Granada, Spain	University of London; Wroclaw Medical University; Vilnius University; University of Naples Federico II; Medical University Sofia; Charles University Prague; Technische Universitat Dresden; Tel Aviv University; Tel Aviv University; University of Granada	Kallert, TW (corresponding author), Klin Psychiat Psychosomat & Psychotherapie, Leipzig, Germany.	s.priebe@qmul.ac.uk	Fiorillo, Andrea/AHH-4551-2022; raboch, jiri/N-7445-2017; Bremner, Stephen/R-4038-2016	Fiorillo, Andrea/0000-0002-6926-0762; raboch, jiri/0000-0001-6667-1497; Bremner, Stephen/0000-0003-0790-7070; Adamowski, Tomasz/0000-0002-2872-3644; Onchev, Georgi/0000-0002-5139-5917; Priebe, Stefan/0000-0001-9864-3394	European Commission [QLG4-CT-2002-01036]	European Commission(European CommissionEuropean Commission Joint Research Centre)	The multi-site research project (Acronym: EUNOMIA) "European Evaluation of Coercion in Psychiatry and Harmonisation of Best Clinical Practise" was funded by the European Commission (Quality of Life and Management of Living Resources Programme, contract no. QLG4-CT-2002-01036). The researchers were independent from the funders and the European Commission had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bindman J, 2005, SOC PSYCH PSYCH EPID, V40, P160, DOI 10.1007/s00127-005-0861-x; Chamberlin J, 2007, DECLARATION DRESDEN; Commission of the European Communities, 2005, GREEN PAP IMPR MENT; Crespo-Facorro B, 2007, J PSYCHIATR RES, V41, P659, DOI 10.1016/j.jpsychires.2006.05.002; Fiorillo A, 2010, EUR PSYCHIA IN PRESS; GARDNER W, 1993, BEHAV SCI LAW, V11, P307, DOI 10.1002/bsl.2370110308; Hoge SK, 1997, INT J LAW PSYCHIAT, V20, P167, DOI 10.1016/S0160-2527(97)00001-0; Iversen KI, 2007, INT J LAW PSYCHIAT, V30, P504, DOI 10.1016/j.ijlp.2007.09.001; Jager M, 2009, WORLD J BIOL PSYCHIA, V10, P426, DOI 10.3109/15622970701541054; Johnsen L, 2007, NORD J PSYCHIAT, V61, P213, DOI 10.1080/08039480701352579; Kallert TW, 2008, EUR ARCH PSY CLIN N, V258, P195, DOI 10.1007/s00406-007-0777-4; Kallert Thomas W, 2005, World Psychiatry, V4, P168; Kallert TW, 2006, LEGISLATION COERCIVE; Kallert TW, 2007, INT J FORENSIC MENTA, V6, P197, DOI DOI 10.1186/1471-244X-7-S1-S83; KaltialaHeino R, 1997, INT J LAW PSYCHIAT, V20, P311, DOI 10.1016/S0160-2527(97)00013-7; Katsakou C, 2006, ACTA PSYCHIAT SCAND, V114, P232, DOI 10.1111/j.1600-0447.2006.00823.x; Katsakou C, 2011, PSYCHIAT RE IN PRESS; Katsakou C, 2007, EPIDEMIOL PSICHIAT S, V16, P172, DOI 10.1017/S1121189X00004802; Katsakou C, 2010, PSYCHIAT SERV, V61, P286, DOI 10.1176/ps.2010.61.3.286; Kjellin L, 2006, SOC PSYCH PSYCH EPID, V41, P241, DOI 10.1007/s00127-005-0024-0; Kjellin L., 2011, COERCIVE TREATMENT P, P271; LIDZ CW, 1995, ARCH GEN PSYCHIAT, V52, P1034; PRIEBE S, 1995, PSYCHIAT PRAX, V22, P140; Priebe S, 2011, PSYCHIAT SE IN PRESS; Priebe S, 2010, EUR PSYCHIA IN PRESS; Priebe S, 2010, EUR ARCH PSYCHIAT CL; Priebe S, 2008, PSYCHIAT SERV, V59, P570, DOI 10.1176/ps.2008.59.5.570; Priebe S, 2010, SCHIZOPHR RES, V121, P251, DOI 10.1016/j.schres.2009.12.020; Priebe S, 2010, BRIT J PSYCHIAT, V196, P179, DOI 10.1192/bjp.bp.109.068916; Priebe S, 2009, BRIT J PSYCHIAT, V194, P49, DOI 10.1192/bjp.bp.108.052266; Richardson M, 2010, SOC PSYCHIA IN PRESS; Richardson M, 2011, PSYCHIAT RES, V188, P156, DOI 10.1016/j.psychres.2011.01.020; Salize HJ, 2004, BRIT J PSYCHIAT, V184, P163, DOI 10.1192/bjp.184.2.163; Schutzwohl M, 2003, INT J METH PSYCH RES, V12, P197, DOI 10.1002/mpr.157; Sorgaard KW, 2007, SCAND J CARING SCI, V21, P214, DOI 10.1111/j.1471-6712.2007.00458.x; UN Convention on the Rights of Persons with Disabilities, 2006, HUM RIGHTS CONV RIGH; VENTURA J, 1993, INT J METH PSYCH RES, V3, P221	37	52	52	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e28191	10.1371/journal.pone.0028191	http://dx.doi.org/10.1371/journal.pone.0028191			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	863MI	22140543	gold, Green Published, Green Submitted			2022-12-27	WOS:000298168100049
J	Lopes dos Santos Santiago, G; Cools, P; Verstraelen, H; Trog, M; Missine, G; El Aila, N; Verhelst, R; Tency, I; Claeys, G; Temmerman, M; Vaneechoutte, M				Lopes dos Santos Santiago, Guido; Cools, Piet; Verstraelen, Hans; Trog, Marijke; Missine, Griet; El Aila, Nabil; Verhelst, Rita; Tency, Inge; Claeys, Geert; Temmerman, Marleen; Vaneechoutte, Mario			Longitudinal Study of the Dynamics of Vaginal Microflora during Two Consecutive Menstrual Cycles	PLOS ONE			English	Article							BACTERIAL VAGINOSIS; GARDNERELLA-VAGINALIS; ATOPOBIUM-VAGINAE; GENITAL-TRACT; RISK-FACTORS; L.-GASSERI; GRAM STAIN; WOMEN; FLORA; IDENTIFICATION	Background: Although the vaginal microflora (VMF) has been well studied, information on the fluctuation of the different bacterial species throughout the menstrual cycle and the information on events preceding the presence of disturbed VMF is still very limited. Documenting the dynamics of the VMF during the menstrual cycle might provide better insights. In this study, we assessed the presence of different Lactobacillus species in relation to the BV associated species during the menstrual cycle, assessed the influence of the menstrual cycle on the different categories of vaginal microflora and assessed possible causes, such as menstruation and sexual intercourse, of VMF disturbance. To our knowledge, this is the first longitudinal study in which swabs and Gram stains were available for each day of two consecutive menstrual cycles, whereby 8 grades of VMF were distinguished by Gram stain analysis, and whereby the swabs were cultured every 7(th) day and identification of the bacterial isolates was carried out with a molecular technique. Methods: Self-collected vaginal swabs were obtained daily from 17 non pregnant, menarchal volunteers, and used for daily Gram staining and weekly culture. Bacterial isolates were identified with tDNA-PCR and 16 S rRNA gene sequencing. Results: Nine women presented with predominantly normal VMF and the 8 others had predominantly disturbed VMF. The overall VMF of each volunteer was characteristic and rather stable. Menses and antimicrobials were the major disturbing factors of the VMF. Disturbances were always accompanied by a rise in Gram positive cocci, which also appeared to be a significant group within the VMF in general. Conclusions: We observed a huge interindividual variability of predominantly stable VMF types. The importance of Gram positive cocci in VMF is underestimated. L. crispatus was the species that was most negatively affected by the menses, whereas the presence of the other lactobacilli was less variable.	[Lopes dos Santos Santiago, Guido; Cools, Piet; Missine, Griet; El Aila, Nabil; Vaneechoutte, Mario] Univ Ghent, Lab Bacteriol Res, Dept Clin Chem Microbiol & Immunol, Fac Med & Hlth Sci, B-9000 Ghent, Belgium; [Verstraelen, Hans; Trog, Marijke; Verhelst, Rita; Tency, Inge; Temmerman, Marleen] Univ Ghent, Fac Med & Hlth Sci, Dept Obstet & Gynaecol, B-9000 Ghent, Belgium; [Claeys, Geert] Ghent Univ Hosp, Lab Clin Biol, Ghent, Belgium	Ghent University; Ghent University; Ghent University; Ghent University Hospital	Lopes dos Santos Santiago, G (corresponding author), Univ Ghent, Lab Bacteriol Res, Dept Clin Chem Microbiol & Immunol, Fac Med & Hlth Sci, B-9000 Ghent, Belgium.	Guido.LopesdosSantosSantiago@ugent.be	Verstraelen, Hans/AAA-8694-2019; Verstraelen, Hans/A-5602-2008; Verhelst, Rita/A-6195-2008; Vaneechoutte, Mario/A-6189-2009	Verstraelen, Hans/0000-0002-4070-1587; Verhelst, Rita/0000-0002-2716-5599; Vaneechoutte, Mario/0000-0002-4586-203X; Cools, Piet/0000-0003-2980-5307	University of Gent	University of Gent	This research was made possible by a research grant of the Concerted Research Actions of the University of Gent. Guido Lopes dos Santos Santiago is indebted for PhD research funded by a research grant of the Concerted Research Actions of the University of Gent. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson Matthew, 2004, MedGenMed, V6, P49; Baele M, 2002, J MICROBIOL METH, V50, P263, DOI 10.1016/S0167-7012(02)00035-0; Baele M, 2000, J CLIN MICROBIOL, V38, P4201, DOI 10.1128/JCM.38.11.4201-4207.2000; Baele M, 2009, COLD SPRING HARB PRO, V4; BARTLETT JG, 1977, J INFECT DIS, V136, P271, DOI 10.1093/infdis/136.2.271; Berger BJ, 1995, CLIN INFECT DIS, V21, P1402, DOI 10.1093/clinids/21.6.1402; Brotman RM, 2010, SEX TRANSM INFECT, V86, P297, DOI 10.1136/sti.2009.040592; Cherpes TL, 2008, SEX TRANSM DIS, V35, P78, DOI 10.1097/OLQ.0b013e318156a5d0; Chiaffarino F, 2004, EUR J OBSTET GYN R B, V117, P222, DOI 10.1016/j.ejogrb.2004.05.012; De Backer E, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-115; El Aila NA, 2011, RES MICROBIOL, V162, P506, DOI 10.1016/j.resmic.2011.04.004; El Aila NA, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-167; El Aila NA, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-153; Eschenbach DA, 2000, CLIN INFECT DIS, V30, P901, DOI 10.1086/313818; ESCHENBACH DA, 1989, J CLIN MICROBIOL, V27, P251, DOI 10.1128/JCM.27.2.251-256.1989; Ferris MJ, 2004, J CLIN MICROBIOL, V42, P5892, DOI [10.1128/JCM.42.12.5892-5894.2004, 10.1128/jcm.42.12.5892-5894.2004]; Forney LJ, 2010, J CLIN MICROBIOL, V48, P1741, DOI 10.1128/JCM.01710-09; Fredricks DN, 2005, NEW ENGL J MED, V353, P1899, DOI 10.1056/NEJMoa043802; Hay P, 2005, SEX TRANSM INFECT, V81, P100, DOI 10.1136/sti.2003.007161; Hay PE, 1997, INT J STD AIDS, V8, P603, DOI 10.1258/0956462971918850; Hellberg D, 2000, INT J STD AIDS, V11, P603, DOI 10.1258/0956462001916461; Hill DR, 2005, J APPL PHYSIOL, V99, P1582, DOI 10.1152/japplphysiol.01422.2004; Hummelen R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012078; Jin L, 2007, J APPL MICROBIOL, V102, P1107, DOI 10.1111/j.1365-2672.2006.03147.x; JOHNSON SR, 1985, AM J REPROD IM MIC, V9, P1; Jovita MR, 1999, INT J SYST BACTERIOL, V49, P1573, DOI 10.1099/00207713-49-4-1573; Keane FEA, 1997, INT J STD AIDS, V8, P489, DOI 10.1258/0956462971920631; Klebanoff MA, 2010, SEX TRANSM DIS, V37, P94, DOI 10.1097/OLQ.0b013e3181bc063c; Lamont RF, 2011, BJOG-INT J OBSTET GY, V118, P533, DOI 10.1111/j.1471-0528.2010.02840.x; Marrazzo JM, 2010, SEX TRANSM DIS, V37, P732, DOI 10.1097/OLQ.0b013e3181fbbc95; Martinez RCR, 2009, CAN J MICROBIOL, V55, P133, DOI [10.1139/w08-102, 10.1139/W08-102]; Mastromarino P, 2009, CLIN MICROBIOL INFEC, V15, P67, DOI 10.1111/j.1469-0691.2008.02112.x; Morison L, 2005, SEX TRANSM INFECT, V81, P242, DOI 10.1136/sti.2004.011684; Nam H, 2007, J MICROBIOL, V45, P515; Nansel TR, 2006, AM J OBSTET GYNECOL, V194, P381, DOI 10.1016/j.ajog.2005.07.047; Priestley CJF, 1997, GENITOURIN MED, V73, P23; Rabe LK, 2003, J CLIN MICROBIOL, V41, P3260, DOI 10.1128/JCM.41.7.3260-3264.2003; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Reid G, 1999, APPL ENVIRON MICROB, V65, P3763; Rossi A, 2010, ARCH GYNECOL OBSTET, V281, P1065, DOI 10.1007/s00404-009-1287-6; Schwebke JR, 1999, J INFECT DIS, V180, P1632, DOI 10.1086/315065; Schwebke JR, 1997, SEX TRANSM DIS, V24, P236, DOI 10.1097/00007435-199704000-00009; Skinner CJ, 1996, GENITOURIN MED, V72, P277; Srinivasan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010197; Swidsinski A, 2010, GYNECOL OBSTET INVES, V70, P256, DOI 10.1159/000314015; Taha TE, 1998, AIDS, V12, P1699, DOI 10.1097/00002030-199813000-00019; Thoma ME, 2011, SEX TRANSM DIS, V38, P111, DOI 10.1097/OLQ.0b013e3181f0bdd0; Vallor AC, 2001, J INFECT DIS, V184, P1431, DOI 10.1086/324445; Verhelst R, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-61; Verhelst R, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-16; Verstraelen H, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-81; Verstraelen H, 2009, EXPERT REV ANTI-INFE, V7, P1109, DOI [10.1586/eri.09.87, 10.1586/ERI.09.87]; Verstraelen H, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-116; WAGNER G, 1982, ANN INTERN MED, V96, P921, DOI 10.7326/0003-4819-96-6-921; Wira CR, 2010, AM J REPROD IMMUNOL, V63, P544, DOI 10.1111/j.1600-0897.2010.00842.x; Witkin SS, 2007, BEST PRACT RES CL OB, V21, P347, DOI 10.1016/j.bpobgyn.2006.12.004; Zhou X, 2004, MICROBIOL-SGM, V150, P2565, DOI 10.1099/mic.0.26905-0; Zozaya-Hinchliffe M, 2010, J CLIN MICROBIOL, V48, P1812, DOI 10.1128/JCM.00851-09	58	60	63	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e28180	10.1371/journal.pone.0028180	http://dx.doi.org/10.1371/journal.pone.0028180			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140538	Green Published, Green Submitted, gold			2022-12-27	WOS:000298168100045
J	Sun, L; Yu, F; Ullah, A; Hubrack, S; Daalis, A; Jung, P; Machaca, K				Sun, Lu; Yu, Fang; Ullah, Aman; Hubrack, Satanay; Daalis, Arwa; Jung, Peter; Machaca, Khaled			Endoplasmic Reticulum Remodeling Tunes IP3-Dependent Ca2+ Release Sensitivity	PLOS ONE			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; INDUCED CALCIUM OSCILLATIONS; XENOPUS OOCYTE MATURATION; SIGNALING DIFFERENTIATION; DEPENDENT REGULATION; MEIOTIC MATURATION; MOUSE OOCYTES; CELL-CYCLE; TRISPHOSPHATE; FERTILIZATION	The activation of vertebrate development at fertilization relies on IP(3-)dependent Ca2+ release, a pathway that is sensitized during oocyte maturation. This sensitization has been shown to correlate with the remodeling of the endoplasmic reticulum into large ER patches, however the mechanisms involved are not clear. Here we show that IP3 receptors within ER patches have a higher sensitivity to IP3 than those in the neighboring reticular ER. The lateral diffusion rate of IP3 receptors in both ER domains is similar, and ER patches dynamically fuse with reticular ER, arguing that IP3 receptors exchange freely between the two ER compartments. These results suggest that increasing the density of IP3 receptors through ER remodeling is sufficient to sensitize IP3-dependent Ca2+ release. Mathematical modeling supports this concept of 'geometric sensitization' of IP3 receptors as a population, and argues that it depends on enhanced Ca2+-dependent cooperativity at sub-threshold IP3 concentrations. This represents a novel mechanism of tuning the sensitivity of IP3 receptors through ER remodeling during meiosis.	[Sun, Lu; Yu, Fang; Hubrack, Satanay; Daalis, Arwa; Machaca, Khaled] Educ City Qatar Fdn, Weill Cornell Med Coll Qatar, Dept Physiol & Biophys, Doha, Qatar; [Ullah, Aman; Jung, Peter] Ohio Univ, Dept Phys & Astron, Athens, OH 45701 USA; [Ullah, Aman; Jung, Peter] Ohio Univ, Quantitat Biol Inst, Athens, OH 45701 USA	Qatar Foundation (QF); Weill Cornell Medical College Qatar; University System of Ohio; Ohio University; University System of Ohio; Ohio University	Sun, L (corresponding author), Educ City Qatar Fdn, Weill Cornell Med Coll Qatar, Dept Physiol & Biophys, Doha, Qatar.	Khm2002@qatar-med.cornell.edu	Machaca, Khaled/AAF-3579-2019; Jung, Peter/D-2934-2014	Machaca, Khaled/0000-0001-6215-2411	Qatar National Research Fund (QNRF) [NPRP08-395-3-088, NPRP08-138-3-050]; Weill Cornell Medical College; Qatar Foundation	Qatar National Research Fund (QNRF)(National Research Foundation of KoreaQatar National Research Fund (QNRF)); Weill Cornell Medical College; Qatar Foundation(Qatar Foundation (QF)Qatar National Research Fund (QNRF))	This work was funded by grants from the Qatar National Research Fund (QNRF) NPRP08-395-3-088 and NPRP08-138-3-050. Additional support for the authors comes from Biomedical Research Program funds at Weill Cornell Medical College, a program funded by Qatar Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEZPROZVANNY I, 1991, NATURE, V351, P751, DOI 10.1038/351751a0; Bootman M, 1997, J PHYSIOL-LONDON, V499, P307, DOI 10.1113/jphysiol.1997.sp021928; Boulware MJ, 2008, J PHYSIOL-LONDON, V586, P2873, DOI 10.1113/jphysiol.2008.153379; Boulware MJ, 2005, CURR BIOL, V15, P765, DOI 10.1016/j.cub.2005.02.065; Callamaras N, 1998, J PHYSIOL-LONDON, V509, P81, DOI 10.1111/j.1469-7793.1998.081bo.x; CAMPANELLA C, 1984, J EXP ZOOL, V229, P283, DOI 10.1002/jez.1402290214; CANNELL MB, 1995, SCIENCE, V268, P1045, DOI 10.1126/science.7754384; Chalmers M, 2006, BIOCHEM J, V394, P57, DOI 10.1042/BJ20051130; CHIBA K, 1990, DEV BIOL, V140, P300, DOI 10.1016/0012-1606(90)90080-3; Deng MQ, 2000, BIOL REPROD, V62, P873, DOI 10.1095/biolreprod62.4.873; El-Jouni W, 2005, DEV BIOL, V288, P514, DOI 10.1016/j.ydbio.2005.10.034; El-Jouni W, 2008, DEV BIOL, V324, P99, DOI 10.1016/j.ydbio.2008.09.007; FitzHarris G, 2003, MOL BIOL CELL, V14, P288, DOI 10.1091/mbc.E02-07-0431; Gordo AC, 2002, MOL HUM REPROD, V8, P619, DOI 10.1093/molehr/8.7.619; Horner VL, 2008, DEV DYNAM, V237, P527, DOI 10.1002/dvdy.21454; Ionescu L, 2006, J PHYSIOL-LONDON, V573, P645, DOI 10.1113/jphysiol.2006.109504; Ito J, 2008, DEV BIOL, V320, P402, DOI 10.1016/j.ydbio.2008.05.548; JAFFE LA, 1994, DEV BIOL, V164, P579, DOI 10.1006/dbio.1994.1225; JONES KT, 1995, J BIOL CHEM, V270, P6671, DOI 10.1074/jbc.270.12.6671; Kline D, 2000, CURR TOP DEV BIOL, V50, P125, DOI 10.1016/S0070-2153(00)50007-6; Kline D, 1999, DEV BIOL, V215, P431, DOI 10.1006/dbio.1999.9445; Lee B, 2006, DEVELOPMENT, V133, P4355, DOI 10.1242/dev.02624; Levasseur M, 2000, DEVELOPMENT, V127, P631; Lipp P, 1996, PROG BIOPHYS MOL BIO, V65, P265, DOI 10.1016/S0079-6107(96)00014-4; Lu L, 2009, MOL BIOL CELL, V20, P3471, DOI 10.1091/mbc.E09-04-0327; Machaca K, 2004, DEV BIOL, V275, P170, DOI 10.1016/j.ydbio.2004.08.004; Machaca K, 2002, J CELL BIOL, V156, P75, DOI 10.1083/jcb.200110059; Machaca K, 2000, J BIOL CHEM, V275, P38710, DOI 10.1074/jbc.M007887200; Machaca K, 2007, J CELL PHYSIOL, V213, P331, DOI 10.1002/jcp.21194; Mak DOD, 1998, P NATL ACAD SCI USA, V95, P15821, DOI 10.1073/pnas.95.26.15821; Marchant JS, 1998, BIOCHEMISTRY-US, V37, P11524, DOI 10.1021/bi980808k; McCullough S, 2005, J ANAT, V206, P415, DOI 10.1111/j.1469-7580.2005.00407.x; MEHLMANN LM, 1994, BIOL REPROD, V51, P1088, DOI 10.1095/biolreprod51.6.1088; Mehlmann LM, 1996, DEV BIOL, V180, P489, DOI 10.1006/dbio.1996.0322; Nebreda AR, 2000, CURR OPIN CELL BIOL, V12, P666, DOI 10.1016/S0955-0674(00)00150-2; Parker I, 1996, CELL CALCIUM, V20, P105, DOI 10.1016/S0143-4160(96)90100-1; Patterson RL, 2004, ANNU REV BIOCHEM, V73, P437, DOI 10.1146/annurev.biochem.73.071403.161303; Puhka M, 2007, J CELL BIOL, V179, P895, DOI 10.1083/jcb.200705112; SHIRAISHI K, 1995, DEV BIOL, V170, P594, DOI 10.1006/dbio.1995.1239; Smith IF, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000466; Smith IF, 2009, SCI SIGNAL, V2, P7; Sneyd J, 2002, P NATL ACAD SCI USA, V99, P2398, DOI 10.1073/pnas.032281999; Stricker SA, 1999, DEV BIOL, V211, P157, DOI 10.1006/dbio.1999.9340; Stricker SA, 2003, DEVELOPMENT, V130, P2867, DOI 10.1242/dev.00508; Sun L, 2004, J CELL BIOL, V165, P63, DOI 10.1083/jcb.200309138; Sun L, 2009, J BIOL CHEM, V284, P20184, DOI 10.1074/jbc.M109.004515; Tateishi Y, 2005, J BIOL CHEM, V280, P6816, DOI 10.1074/jbc.M405469200; TaufiqUrRahman, 2009, NATURE, V458, P655, DOI 10.1038/nature07763; Terasaki M, 2001, MOL BIOL CELL, V12, P1103, DOI 10.1091/mbc.12.4.1103; Ullah G, 2007, CELL CALCIUM, V42, P556, DOI 10.1016/j.ceca.2007.01.010; Vais H, 2010, J GEN PHYSIOL, V136, P687, DOI 10.1085/jgp.201010513; Wilson BS, 1998, MOL BIOL CELL, V9, P1465, DOI 10.1091/mbc.9.6.1465; YAO Y, 1995, J PHYSIOL-LONDON, V482, P533, DOI 10.1113/jphysiol.1995.sp020538; Yu F, 2010, J CELL BIOL, V191, P523, DOI 10.1083/jcb.201006022; Yu F, 2009, P NATL ACAD SCI USA, V106, P17401, DOI 10.1073/pnas.0904651106	55	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e27928	10.1371/journal.pone.0027928	http://dx.doi.org/10.1371/journal.pone.0027928			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140486	Green Published, gold, Green Submitted			2022-12-27	WOS:000298168100025
J	Thomas, AG; Tran, BR; Cranston, M; Brown, MC; Kumar, R; Tlelai, M				Thomas, Anne Goldzier; Tran, Bonnie Robin; Cranston, Marcus; Brown, Malerato Cecilia; Kumar, Rajiv; Tlelai, Matsotetsi			Voluntary Medical Male Circumcision: A Cross-Sectional Study Comparing Circumcision Self-Report and Physical Examination Findings in Lesotho	PLOS ONE			English	Article							PREVALENT HIV-INFECTION; EASTERN CAPE; AFRICA; PREVENTION; MEN; UGANDA; KENYA; RAKAI; RISK	Background: Overwhelming evidence, including three clinical trials, shows that male circumcision (MC) reduces the risk of HIV infection among men. However, data from recent Lesotho Demographic and Health Surveys do not demonstrate MC to be protective against HIV. These contradictory findings could partially be due to inaccurate self-reported MC status used to estimate MC prevalence. This study describes MC characteristics among men applying for Lesotho Defence Force recruitment and seeks to assess MC self-reported accuracy through comparison with physical-examination-based data. Methods and Findings: During Lesotho Defence Force applicant screening in 2009, 241 (77%) of 312 men, aged 18-25 y, consented to a self-administered demographic and MC characteristic survey and physician-performed genital examination. The extent of foreskin removal was graded on a scale of 1 (no evidence of MC) to 4 (complete MC). MC was self-reported by 27% (n = 64/239) of participants. Of the 64 men self-reporting being circumcised, physical exam showed that 23% had no evidence of circumcision, 27% had partial circumcision, and 50% had complete circumcision. Of the MCs reportedly performed by a medical provider, 3% were Grade 1 and 73% were Grade 4. Of the MCs reportedly performed by traditional circumcisers, 41% were Grade 1, while 28% were Grade 4. Among participants self-reporting being circumcised, the odds of MC status misclassification were seven times higher among those reportedly circumcised by initiation school personnel (odds ratio = 7.22; 95% CI = 2.29-22.75). Conclusions: Approximately 27% of participants self-reported being circumcised. However, only 50% of these men had complete MC as determined by a physical exam. Given this low MC self-report accuracy, countries scaling up voluntary medical MC (VMMC) should obtain physical-exam-based MC data to guide service delivery and cost estimates. HIV prevention messages promoting VMMC should provide comprehensive education regarding the definition of VMMC.	[Thomas, Anne Goldzier; Tran, Bonnie Robin] USN, Dept Def HIV AIDS Prevent Program, Hlth Res Ctr, San Diego, CA 92132 USA; [Cranston, Marcus] USAF, Dept Def, Keesler AFB, MS USA; [Brown, Malerato Cecilia] US Embassy, US Presidents Emergency Plan AIDS Relif Lesotho, Maseru, Lesotho; [Kumar, Rajiv] Indian Armed Forces, Pune, Maharashtra, India; [Tlelai, Matsotetsi] Lesotho Def Force, Maseru, Lesotho	United States Department of Defense; United States Navy; Naval Medical Research Center (NMRC); Naval Health Research Center (NHRC); United States Department of Defense; United States Air Force	Thomas, AG (corresponding author), USN, Dept Def HIV AIDS Prevent Program, Hlth Res Ctr, San Diego, CA 92132 USA.	anne.thomas@med.navy.mil			PEPFAR	PEPFAR	Our program is supported by PEPFAR. DoD/DHAPP is a USG PEPFAR implementing agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views expressed in this article are those of the authors and do not necessarily reflect the official policy or position of the Department of the Navy, Department of Defense, or the U. S. Government.	11. Malawi National Statistical Office ORC Macro, 2005, MAL DEM HLTH SURV 20; 9. Lesotho Ministry of Health and Social Welfare Lesotho Bureau of Statistics ORC Macro, 2005, LES DEM HLTH SURV 20; ALCENA V, 1986, NEW YORK STATE J MED, V86, P446; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 2008, B WORLD HEALTH ORGAN, V86, P669, DOI 10.2471/BLT.08.051482; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Brewer DD, 2007, ANN EPIDEMIOL, V17, P217, DOI 10.1016/j.annepidem.2006.10.010; FINK AJ, 1986, NEW ENGL J MED, V315, P1167; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Joint United Nations Programme on HIV/AIDS, 2010, GLOB REP UNAIDS REP; Kelly R, 1999, AIDS, V13, P399, DOI 10.1097/00002030-199902250-00013; Kepe T, 2010, SOC SCI MED, V70, P729, DOI 10.1016/j.socscimed.2009.11.016; Kigozi G, 2009, AIDS, V23, P2209, DOI 10.1097/QAD.0b013e328330eda8; Lagarde E, 2003, AIDS, V17, P89, DOI 10.1097/00002030-200301030-00012; Lesotho Ministry of Health and Social Welfare ICF Macro, 2010, LES DEM HLTH SURV 20; MOSES S, 1990, INT J EPIDEMIOL, V19, P693, DOI 10.1093/ije/19.3.693; Njeuhmeli E, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001132; Peltzer K, 2009, CULT HEALTH SEX, V11, P83, DOI 10.1080/13691050802389777; Risser JMH, 2004, AM J EPIDEMIOL, V159, P1095, DOI 10.1093/aje/kwh149; Templeton DJ, 2008, SEX TRANSM INFECT, V84, P187, DOI 10.1136/sti.2007.029645; Urassa M, 1997, AIDS, V11, P73, DOI 10.1097/00002030-199701000-00011; Weiss HA, 2000, AIDS, V14, P2361, DOI 10.1097/00002030-200010200-00018; Weiss HA, 2008, TROP MED INT HEALTH, V13, P1054, DOI 10.1111/j.1365-3156.2008.02107.x; Wilcken A, 2010, B WORLD HEALTH ORGAN, V88, P907, DOI 10.2471/BLT.09.072975; World Health Organization, 2007, NEW DAT MAL CIRC HIV; WYNDER EL, 1960, CANCER, V13, P442, DOI 10.1002/1097-0142(196005/06)13:3<442::AID-CNCR2820130304>3.0.CO;2-L	26	39	39	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2011	6	11							e27561	10.1371/journal.pone.0027561	http://dx.doi.org/10.1371/journal.pone.0027561			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863LT	22140449	Green Published, gold			2022-12-27	WOS:000298166300006
J	Caskey, CF; Hlawitschka, M; Qin, SP; Mahakian, LM; Cardiff, RD; Boone, JM; Ferrara, KW				Caskey, Charles F.; Hlawitschka, Mario; Qin, Shengping; Mahakian, Lisa M.; Cardiff, Robert D.; Boone, John M.; Ferrara, Katherine W.			An Open Environment CT-US Fusion for Tissue Segmentation during Interventional Guidance	PLOS ONE			English	Article							RADIOFREQUENCY ABLATION; MILD HYPERTHERMIA; ABDOMINAL FAT; ULTRASOUND; CALIBRATION; TRANSDUCER; DELIVERY; SYSTEM	Therapeutic ultrasound (US) can be noninvasively focused to activate drugs, ablate tumors and deliver drugs beyond the blood brain barrier. However, well-controlled guidance of US therapy requires fusion with a navigational modality, such as magnetic resonance imaging (MRI) or X-ray computed tomography (CT). Here, we developed and validated tissue characterization using a fusion between US and CT. The performance of the CT/US fusion was quantified by the calibration error, target registration error and fiducial registration error. Met-1 tumors in the fat pads of 12 female FVB mice provided a model of developing breast cancer with which to evaluate CT-based tissue segmentation. Hounsfield units (HU) within the tumor and surrounding fat pad were quantified, validated with histology and segmented for parametric analysis (fat: -300 to 0 HU, protein-rich: 1 to 300 HU, and bone: HU>300). Our open source CT/US fusion system differentiated soft tissue, bone and fat with a spatial accuracy of similar to 1 mm. Region of interest (ROI) analysis of the tumor and surrounding fat pad using a 1 mm(2) ROI resulted in mean HU of 68 +/- 44 within the tumor and -97 +/- 52 within the fat pad adjacent to the tumor (p<0.005). The tumor area measured by CT and histology was correlated (r(2) = 0.92), while the area designated as fat decreased with increasing tumor size (r(2) = 0.51). Analysis of CT and histology images of the tumor and surrounding fat pad revealed an average percentage of fat of 65.3% vs. 75.2%, 36.5% vs. 48.4%, and 31.6% vs. 38.5% for tumors,75 mm 3, 75150 mm(3) and >150 mm(3), respectively. Further, CT mapped bone-soft tissue interfaces near the acoustic beam during real-time imaging. Combined CT/US is a feasible method for guiding interventions by tracking the acoustic focus within a pre-acquired CT image volume and characterizing tissues proximal to and surrounding the acoustic focus.	[Caskey, Charles F.; Qin, Shengping; Mahakian, Lisa M.; Ferrara, Katherine W.] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA; [Hlawitschka, Mario] Univ Calif Davis, Dept Comp Sci, Davis, CA 95616 USA; [Cardiff, Robert D.] Univ Calif Davis, Dept Pathol & Lab Med, Davis, CA 95616 USA; [Boone, John M.] Univ Calif Davis, Dept Radiol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Caskey, CF (corresponding author), Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA.	cfcaskey@ucdavis.edu	Hlawitschka, Mario/AAU-8942-2020	Ferrara, Katherine/0000-0002-4976-9107	National Institutes of Health [NIH R01CA103828]; NATIONAL CANCER INSTITUTE [R01CA103828, P30CA093373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB002138] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the National Institutes of Health under grant NIH R01CA103828. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abolhassani MD, 2007, J ULTRAS MED, V26, P215, DOI 10.7863/jum.2007.26.2.215; [Anonymous], IMAGE GUIDED THERAPY; Boone JM, 2001, RADIOLOGY, V221, P657, DOI 10.1148/radiol.2213010334; BORKAN GA, 1982, AM J CLIN NUTR, V36, P172, DOI 10.1093/ajcn/36.1.172; Brizel DM, 1996, CANCER RES, V56, P5347; Chivers R C, 1975, Ultrasound Med Biol, V2, P25, DOI 10.1016/0301-5629(75)90038-1; Cleary K, 2004, INT CONGR SER, V1268, P473, DOI 10.1016/j.ics.2004.03.038; DASTOUS FT, 1986, ULTRASOUND MED BIOL, V12, P795, DOI 10.1016/0301-5629(86)90077-3; DEWEY WC, 1977, RADIOLOGY, V123, P463, DOI 10.1148/123.2.463; Dromi S, 2007, CLIN CANCER RES, V13, P2722, DOI 10.1158/1078-0432.CCR-06-2443; Egorov V, 2008, MED ENG PHYS, V30, P206, DOI 10.1016/j.medengphy.2007.02.007; Fitzpatrick JM, 2001, IEEE T MED IMAGING, V20, P917, DOI 10.1109/42.952729; Gering DT, 1999, LECT NOTES COMPUT SC, V1679, P809; GOSS SA, 1978, J ACOUST SOC AM, V64, P423, DOI 10.1121/1.382016; Hill C.R., 2004, PHYS PRINCIPLES MED; HORN BKP, 1987, J OPT SOC AM A, V4, P629, DOI 10.1364/JOSAA.4.000629; HYNYNEN K, 1987, INT J HYPERTHER, V3, P21, DOI 10.3109/02656738709140370; Jensen V., 2006, METHOD ESTIMATING DY; Kitada T, 2008, HEPATOL RES, V38, P565, DOI 10.1111/j.1872-034X.2007.00308.x; Kong G, 2000, CANCER RES, V60, P4440; Kruse DE, 2010, IEEE T BIO-MED ENG, V57, P155, DOI 10.1109/TBME.2009.2029703; Lai CY, 2010, IEEE T ULTRASON FERR, V57, P2671, DOI 10.1109/TUFFC.2010.1741; LEFOR AT, 1985, J SURG ONCOL, V28, P297, DOI 10.1002/jso.2930280412; Mercier L, 2005, ULTRASOUND MED BIOL, V31, P449, DOI 10.1016/j.ultrasmedbio.2004.11.015; More, 1977, LEVENBERG MARQUARDT; Needham D, 2000, CANCER RES, V60, P1197; Nelsona TR, 2008, MED PHYS, V35, P1078, DOI 10.1118/1.2839439; Pace DF, 2009, MIDAS J; Pieper S, 2004, IEEE INT S BIOMED IM, V26, P632, DOI DOI 10.1109/ISBI.2004.1398617; Pieper S, 2006, I S BIOMED IMAGING, P698; Prager RW, 1998, ULTRASOUND MED BIOL, V24, P855, DOI 10.1016/S0301-5629(98)00044-1; Rieke V, 2008, J MAGN RESON IMAGING, V27, P376, DOI 10.1002/jmri.21265; Seip R, 1996, IEEE T ULTRASON FERR, V43, P1063, DOI 10.1109/58.542050; Simon C, 1998, IEEE T ULTRASON FERR, V45, P1088, DOI 10.1109/58.710592; SONG CW, 1984, CANCER RES, V44, P4721; Ukimura O, 2008, BJU INT, V101, P707, DOI 10.1111/j.1464-410X.2007.07324.x; unicap, UN API IM ACQ DEV; Wallace MJ, 2009, J VASC INTERV RADIOL, V20, pS523, DOI 10.1016/j.jvir.2009.04.059; Yang K, 2008, MED PHYS, V35, P5317, DOI 10.1118/1.3002411; Yoshizumi T, 1999, RADIOLOGY, V211, P283, DOI 10.1148/radiology.211.1.r99ap15283	40	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e27372	10.1371/journal.pone.0027372	http://dx.doi.org/10.1371/journal.pone.0027372			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132098	Green Published, gold, Green Submitted			2022-12-27	WOS:000298162000016
J	Gutierrez, H; Castillo, A; Monzon, J; Urrutia, AO				Gutierrez, Humberto; Castillo, Atahualpa; Monzon, Jimena; Urrutia, Araxi O.			Protein Amino Acid Composition: A Genomic Signature of Encephalization in Mammals	PLOS ONE			English	Article							BRAIN EVOLUTION; LIFE-HISTORY; GENES; HYPOTHESIS; METABOLISM; SELECTION; COSTS; SIZE	Large brains relative to body size represent an evolutionarily costly adaptation as they are metabolically expensive and demand substantial amounts of time to reach structural and functional maturity thereby exacerbating offspring mortality while delaying reproductive age. In spite of its cost and adaptive impact, no genomic features linked to brain evolution have been found. By conducting a genome-wide analysis in all 37 fully sequenced mammalian genomes, we show that encephalization is significantly correlated with overall protein amino acid composition. This correlation is not a by-product of changes in nucleotide content, lifespan, body size, absolute brain size or genome size; is independent of phylogenetic effects; and is not restricted to brain expressed genes. This is the first report of a relationship between this fundamental and complex trait and changes in protein AA usage, possibly reflecting the high selective demands imposed by the process of encephalization across mammalian lineages.	[Gutierrez, Humberto; Castillo, Atahualpa; Monzon, Jimena] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Mexico City 04510, DF, Mexico; [Urrutia, Araxi O.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England	Universidad Nacional Autonoma de Mexico; University of Bath	Gutierrez, H (corresponding author), Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Mexico City 04510, DF, Mexico.	hgutierrez@ifc.unam.mx		Monzon-Sandoval, Jimena/0000-0002-4190-2188; Gutierrez, Humberto/0000-0002-5021-8636; Urrutia, Araxi/0000-0001-9011-8675; Castillo Morales, Atahualpa/0000-0001-9733-6923	National University of Mexico	National University of Mexico	This work was carried out with institutional funding from the National University of Mexico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi H, 2002, P NATL ACAD SCI USA, V99, P3695, DOI 10.1073/pnas.062526999; Allen JS, 2005, AM J HUM BIOL, V17, P673, DOI 10.1002/ajhb.20439; Barrickman NL, 2008, J HUM EVOL, V54, P568, DOI 10.1016/j.jhevol.2007.08.012; Barton MD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011935; Deaner RO, 2000, BRAIN BEHAV EVOLUT, V55, P44, DOI 10.1159/000006641; Dorus S, 2004, CELL, V119, P1027, DOI 10.1016/j.cell.2004.11.040; Dunbar RIM, 2007, PHILOS T R SOC B, V362, P649, DOI 10.1098/rstb.2006.2001; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Garland T, 2005, J EXP BIOL, V208, P3015, DOI 10.1242/jeb.01745; Gonzalez-Lagos C, 2010, J EVOLUTION BIOL, V23, P1064, DOI 10.1111/j.1420-9101.2010.01976.x; Herculano-Houzel S, 2007, P NATL ACAD SCI USA, V104, P3562, DOI 10.1073/pnas.0611396104; Herculano-Houzel S, 2011, ANN NY ACAD SCI, V1225, P191, DOI 10.1111/j.1749-6632.2011.05976.x; Isler K, 2006, J HUM EVOL, V51, P228, DOI 10.1016/j.jhevol.2006.03.006; Leonard WR, 2007, ANNU REV NUTR, V27, P311, DOI 10.1146/annurev.nutr.27.061406.093659; Leonard WR, 2003, COMP BIOCHEM PHYS A, V136, P5, DOI 10.1016/S1095-6433(03)00132-6; Lynch M, 2003, SCIENCE, V302, P1401, DOI 10.1126/science.1089370; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Roth G, 2005, TRENDS COGN SCI, V9, P250, DOI 10.1016/j.tics.2005.03.005; Shi P, 2006, TRENDS GENET, V22, P608, DOI 10.1016/j.tig.2006.09.001; Shultz S, 2010, P NATL ACAD SCI USA, V107, P21582, DOI 10.1073/pnas.1005246107; Swire J, 2007, J MOL EVOL, V64, P558, DOI 10.1007/s00239-006-0206-8; Urrutia AO, 2003, GENOME RES, V13, P2260, DOI 10.1101/gr.641103; Wang GZ, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-263; Weisbecker V, 2010, P NATL ACAD SCI USA, V107, P16216, DOI 10.1073/pnas.0906486107	25	4	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e27261	10.1371/journal.pone.0027261	http://dx.doi.org/10.1371/journal.pone.0027261			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132093	Green Submitted, Green Published, gold			2022-12-27	WOS:000298162000014
J	Jung, JW; Park, SB; Lee, SJ; Seo, MS; Trosko, JE; Kang, KS				Jung, Ji-Won; Park, Sang-Bum; Lee, Soo-Jin; Seo, Min-Soo; Trosko, James E.; Kang, Kyung-Sun			Metformin Represses Self-Renewal of the Human Breast Carcinoma Stem Cells via Inhibition of Estrogen Receptor-Mediated OCT4 Expression	PLOS ONE			English	Article							JUNCTIONAL INTERCELLULAR COMMUNICATION; CANCER CELLS; DIABETIC-PATIENTS; TRANSCRIPTIONAL ACTIVITY; POU-DOMAIN; IN-VITRO; ER-ALPHA; RISK; CARCINOGENESIS; GROWTH	Metformin, a Type II diabetic treatment drug, which inhibits transcription of gluconeogenesis genes, has recently been shown to lower the risk of some diabetes-related tumors, including breast cancer. Recently, "cancer stem cells" have been demonstrated to sustain the growth of tumors and are resistant to therapy. To test the hypothesis that metformin might be reducing the risk to breast cancers, the human breast carcinoma cell line, MCF-7, grown in 3-dimensional mammospheres which represent human breast cancer stem cell population, were treated with various known and suspected breast cancer chemicals with and without non-cytotoxic concentrations of metformin. Using OCT4 expression as a marker for the cancer stem cells, the number and size were measured in these cells. Results demonstrated that TCDD (100 nM) and bisphenol A (10 mM) increased the number and size of the mammospheres, as did estrogen (10 nM E2). By monitoring a cancer stem cell marker, OCT4, the stimulation by these chemicals was correlated with the increased expression of OCT4. On the other hand, metformin at 1 and 10 mM concentration dramatically reduced the size and number of mammospheres. Results also demonstrated the metformin reduced the expression of OCT4 in E2 & TCDD mammospheres but not in the bisphenol A mammospheres, suggesting different mechanisms of action of the bisphenol A on human breast carcinoma cells. In addition, these results support the use of 3-dimensional human breast cancer stem cells as a means to screen for potential human breast tumor promoters and breast chemopreventive and chemotherapeutic agents.	[Jung, Ji-Won; Park, Sang-Bum; Lee, Soo-Jin; Seo, Min-Soo; Trosko, James E.; Kang, Kyung-Sun] Seoul Natl Univ, Coll Vet Med, Dept Vet Publ Hlth, Adult Stem Cell Res Ctr, Seoul, South Korea; [Trosko, James E.; Kang, Kyung-Sun] Michigan State Univ, Dept Pediat & Human Dev, Coll Human Med, Ctr Integrat Toxicol, E Lansing, MI 48824 USA	Seoul National University (SNU); Michigan State University; Michigan State University College of Human Medicine	Jung, JW (corresponding author), Korea Natl Inst Hlth, Ctr Biomed Sci, Div Intractable Dis, Chungbuk, South Korea.	kangpub@snu.ac.kr	Trosko, James/J-5954-2019; Kang, Kyung-Sun/G-6205-2013	Lee, Soojin/0000-0002-0383-5025	National Research Foundation [NRF-M1AXA002]; Ministry of Education, Science and Technology of Korea; Ministry of Education, Science and Technology; Korea Ministry of Science and Technology; Brain Korea 21 Program for Veterinary Science	National Research Foundation; Ministry of Education, Science and Technology of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korea Ministry of Science and Technology(Ministry of Science & Technology (MOST), Republic of Korea); Brain Korea 21 Program for Veterinary Science(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea)	This work was supported by the Global Frontier Project grant (NRF-M1AXA002) of the National Research Foundation funded by the Ministry of Education, Science and Technology of Korea, and the Ministry of Education, Science and Technology. Professor Trosko's contribution at Seoul National University was supported by the Korea Ministry of Science and Technology, "Brain Pool" award. This work was supported by Brain Korea 21 Program for Veterinary Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ailles LE, 2007, CURR OPIN BIOTECH, V18, P460, DOI 10.1016/j.copbio.2007.10.007; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Alimova IN, 2009, CELL CYCLE, V8, P909, DOI 10.4161/cc.8.6.7933; Azoulay L, 2011, CANCER EPIDEM BIOMAR, V20, P337, DOI 10.1158/1055-9965.EPI-10-0940; Balan G, 2001, J PHARM SCI, V90, P1176, DOI 10.1002/jps.1071; BERTHOIS Y, 1986, P NATL ACAD SCI USA, V83, P2496, DOI 10.1073/pnas.83.8.2496; Bhat HK, 2003, P NATL ACAD SCI USA, V100, P3913, DOI 10.1073/pnas.0437929100; Bosco JLF, 2011, CANCER EPIDEM BIOMAR, V20, P101, DOI 10.1158/1055-9965.EPI-10-0817; Cavalieri E, 2000, J Natl Cancer Inst Monogr, P75; Cavalieri EL, 1997, P NATL ACAD SCI USA, V94, P10937, DOI 10.1073/pnas.94.20.10937; Chang CC, 2001, RADIAT RES, V155, P201, DOI 10.1667/0033-7587(2001)155[0201:AHBECT]2.0.CO;2; Chong CR, 2009, ONCOLOGIST, V14, P1178, DOI 10.1634/theoncologist.2009-0286; Clarke RB, 2005, DEV BIOL, V277, P443, DOI 10.1016/j.ydbio.2004.07.044; DeCensi A, 2010, CANCER PREV RES, V3, P1451, DOI 10.1158/1940-6207.CAPR-10-0157; Evans JMM, 2005, BMJ-BRIT MED J, V330, P1304, DOI 10.1136/bmj.38415.708634.F7; Gonzalez-Angulo AM, 2010, CLIN CANCER RES, V16, P1695, DOI 10.1158/1078-0432.CCR-09-1805; Hansis C, 2001, MOL HUM REPROD, V7, P155, DOI 10.1093/molehr/7.2.155; Hirsch HA, 2009, CANCER RES, V69, P7507, DOI 10.1158/0008-5472.CAN-09-2994; Hosono K, 2010, CANCER PREV RES, V3, P1077, DOI 10.1158/1940-6207.CAPR-10-0186; Huang MZ, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-80; Iliopoulos D, 2011, CANCER RES, V71, P3196, DOI 10.1158/0008-5472.CAN-10-3471; Itoh Y, 2007, J IMMUNOL, V178, P3059, DOI 10.4049/jimmunol.178.5.3059; Jiralerspong S, 2009, J CLIN ONCOL, V27, P3297, DOI 10.1200/JCO.2009.19.6410; Kang KS, 2011, TOXICOL SCI, V120, pS269, DOI 10.1093/toxsci/kfq370; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Klinge CM, 2001, NUCLEIC ACIDS RES, V29, P2905, DOI 10.1093/nar/29.14.2905; Lee IK, 2007, ARCH PHARM RES, V30, P337, DOI 10.1007/BF02977615; Li DH, 2009, GASTROENTEROLOGY, V137, P482, DOI 10.1053/j.gastro.2009.04.013; Libby G, 2009, DIABETES CARE, V32, P1620, DOI 10.2337/dc08-2175; Liu BL, 2009, CELL CYCLE, V8, P2031, DOI 10.4161/cc.8.13.8814; Ogawa T, 2005, CANCER RES, V65, P9771, DOI 10.1158/0008-5472.CAN-05-0227; Ovitt CE, 1998, MOL HUM REPROD, V4, P1021, DOI 10.1093/molehr/4.11.1021; Pesce M, 2001, STEM CELLS, V19, P271, DOI 10.1634/stemcells.19-4-271; PITOT HC, 1980, CANCER RES, V40, P3616; Pollak M, 2010, CANCER PREV RES, V3, P1060, DOI 10.1158/1940-6207.CAPR-10-0175; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Rattan R, 2011, NEOPLASIA, V13, P483, DOI 10.1593/neo.11148; ROSNER MH, 1990, NATURE, V345, P686, DOI 10.1038/345686a0; Rozengurt E, 2010, CLIN CANCER RES, V16, P2505, DOI 10.1158/1078-0432.CCR-09-2229; SCHOLER HR, 1990, NATURE, V344, P435, DOI 10.1038/344435a0; Seifert A, 2009, INT J ONCOL, V35, P417, DOI 10.3892/ijo_00000354; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Tai MH, 2005, CARCINOGENESIS, V26, P495, DOI 10.1093/carcin/bgh321; Trosko JE, 2009, VET PATHOL, V46, P176, DOI 10.1354/vp.46-2-176; Wright JL, 2009, CANCER CAUSE CONTROL, V20, P1617, DOI 10.1007/s10552-009-9407-y; Yang HM, 2005, J CELL BIOCHEM, V96, P821, DOI 10.1002/jcb.20588; Zakikhani M, 2006, CANCER RES, V66, P10269, DOI 10.1158/0008-5472.CAN-06-1500	47	107	111	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e28068	10.1371/journal.pone.0028068	http://dx.doi.org/10.1371/journal.pone.0028068			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132214	gold, Green Published, Green Submitted			2022-12-27	WOS:000298162000068
J	Greatorex, JS; Digard, P; Curran, MD; Moynihan, R; Wensley, H; Wreghitt, T; Varsani, H; Garcia, F; Enstone, J; Nguyen-Van-Tam, JS				Greatorex, Jane S.; Digard, Paul; Curran, Martin D.; Moynihan, Robert; Wensley, Harrison; Wreghitt, Tim; Varsani, Harsha; Garcia, Fayna; Enstone, Joanne; Nguyen-Van-Tam, Jonathan S.			Survival of Influenza A(H1N1) on Materials Found in Households: Implications for Infection Control	PLOS ONE			English	Article							A VIRUS; TRANSMISSION PARAMETERS; SURFACES; COPPER; INACTIVATION; SPREAD; AGENTS; RNA	Background: The majority of influenza transmission occurs in homes, schools and workplaces, where many frequently touched communal items are situated. However the importance of transmission via fomites is unclear since few data exist on the survival of virus on commonly touched surfaces. We therefore measured the viability over time of two H1N1 influenza strains applied to a variety of materials commonly found in households and workplaces. Methodology and Principal Findings: Influenza A/PuertoRico/8/34 (PR8) or A/Cambridge/AHO4/2009 (pandemic H1N1) viruses were inoculated onto a wide range of surfaces used in home and work environments, then sampled at set times following incubation at stabilised temperature and humidity. Virus genome was measured by RT-PCR; plaque assay (for PR8) or fluorescent focus formation (for pandemic H1N1) was used to assess the survival of viable virus. Conclusions/Significance: The genome of either virus could be detected on most surfaces 24 h after application with relatively little drop in copy number, with the exception of unsealed wood surfaces. In contrast, virus viability dropped much more rapidly. Live virus was recovered from most surfaces tested four hours after application and from some nonporous materials after nine hours, but had fallen below the level of detection from all surfaces at 24 h. We conclude that influenza A transmission via fomites is possible but unlikely to occur for long periods after surface contamination (unless reinoculation occurs). In situations involving a high probability of influenza transmission, our data suggest a hierarchy of priorities for surface decontamination in the multi-surface environments of home and hospitals.	[Greatorex, Jane S.; Curran, Martin D.; Wreghitt, Tim; Varsani, Harsha; Garcia, Fayna] Addenbrookes Hosp, Hlth Protect Agcy, Cambridge, England; [Digard, Paul; Moynihan, Robert; Wensley, Harrison] Univ Cambridge, Dept Pathol, Div Virol, Cambridge CB2 1QP, England; [Enstone, Joanne; Nguyen-Van-Tam, Jonathan S.] Univ Nottingham, Div Epidemiol & Publ Hlth, Nottingham NG7 2RD, England; [Nguyen-Van-Tam, Jonathan S.] Hlth Protect Agcy, Nottingham, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; Health Protection Agency; University of Cambridge; University of Cambridge; University of Nottingham; Health Protection Agency	Greatorex, JS (corresponding author), Addenbrookes Hosp, Hlth Protect Agcy, Cambridge, England.	jvt@nottingham.ac.uk	Digard, Paul/B-7717-2008; Nguyen-Van-Tam, Jonathan/I-2162-2019	Digard, Paul/0000-0002-0872-9440; Nguyen-Van-Tam, Jonathan/0000-0003-2579-4655; Wensley, Harrison/0000-0002-9634-5462	UK Health Protection Agency	UK Health Protection Agency	This study was funded by the UK Health Protection Agency. The funder had no role in study design, data collection, analysis, decision to publish or preparation of the manuscript. Since several authors are employees of the funder, approval to submit for peer-review was obtained via the funder's Manuscript Approval Process.	BEAN B, 1982, J INFECT DIS, V146, P47, DOI 10.1093/infdis/146.1.47; Blachere FM, 2011, J VIROL METHODS, V176, P120, DOI 10.1016/j.jviromet.2011.05.030; Boone SA, 2005, J INFECTION, V51, P103, DOI 10.1016/j.jinf.2004.09.011; Borkow G, 2007, ANTIMICROB AGENTS CH, V51, P2605, DOI 10.1128/AAC.00125-07; Brankston G, 2007, LANCET INFECT DIS, V7, P257, DOI 10.1016/S1473-3099(07)70029-4; Bright KR, 2010, J SCH NURS, V26, P33, DOI 10.1177/1059840509354383; BUCKLAND FE, 1962, NATURE, V195, P1063, DOI 10.1038/1951063a0; Dellanno C, 2009, AM J INFECT CONTROL, V37, P649, DOI 10.1016/j.ajic.2009.03.012; Elton D, 2001, J VIROL, V75, P408, DOI 10.1128/JVI.75.1.408-419.2001; Enstone J., 2009, Introduction to pandemic influenza, P57, DOI 10.1079/9781845936259.0057; Greatorex JS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008987; Horie M, 2008, ARCH VIROL, V153, P1467, DOI 10.1007/s00705-008-0154-2; Hutchinson EC, 2010, J GEN VIROL, V91, P313, DOI 10.1099/vir.0.017608-0; Hutchinson EC, 2008, J VIROL, V82, P11869, DOI 10.1128/JVI.01634-08; Killingley B, 2010, HEALTH TECHNOL ASSES, V14, P237, DOI 10.3310/hta14460-04; LONGINI IM, 1982, AM J EPIDEMIOL, V115, P736, DOI 10.1093/oxfordjournals.aje.a113356; LONGINI IM, 1984, INT J EPIDEMIOL, V13, P496, DOI 10.1093/ije/13.4.496; LONGINI IM, 1984, INT J EPIDEMIOL, V13, P99, DOI 10.1093/ije/13.1.99; Noyce JO, 2007, APPL ENVIRON MICROB, V73, P2748, DOI 10.1128/AEM.01139-06; Pappas DE, 2010, PEDIATR INFECT DIS J, V29, P102, DOI 10.1097/INF.0b013e3181b6e482; Parker ER, 1944, J LAB CLIN MED, V29, P37; SILVA TY, 1992, PHARM CHEM J, V26, P613; Simmerman JM, 2010, CLIN INFECT DIS, V51, P1053, DOI 10.1086/656581; TAKIMOTO S, 1991, J CLIN MICROBIOL, V29, P470, DOI 10.1128/JCM.29.3.470-474.1991; Tellier R, 2006, EMERG INFECT DIS, V12, P1657, DOI 10.3201/eid1211.060426; Thomas Y, 2008, APPL ENVIRON MICROB, V74, P3002, DOI 10.1128/AEM.00076-08; Wallinga J, 2006, AM J EPIDEMIOL, V164, P936, DOI 10.1093/aje/kwj317; Wei Z, 2007, J VIROL METHODS, V144, P122, DOI 10.1016/j.jviromet.2007.04.008	28	59	60	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2011	6	11							e27932	10.1371/journal.pone.0027932	http://dx.doi.org/10.1371/journal.pone.0027932			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858JH	22132172	Green Published, gold, Green Submitted			2022-12-27	WOS:000297792400023
J	Hajduk, P; Sato, H; Puri, P; Murphy, P				Hajduk, Piotr; Sato, Hideaki; Puri, Prem; Murphy, Paula			Abnormal Notochord Branching Is Associated with Foregut Malformations in the Adriamycin Treated Mouse Model	PLOS ONE			English	Article							OPTICAL PROJECTION TOMOGRAPHY; ESOPHAGEAL ATRESIA; TRACHEOESOPHAGEAL FISTULA; LUNG MORPHOGENESIS; SONIC-HEDGEHOG; FLOOR PLATE; RAT MODEL; 3D REPRESENTATION; GENE-EXPRESSION; ENDODERM	Oesophageal atresia (OA) and tracheooesophageal fistula (TOF) are relatively common human congenital malformations of the foregut where the oesophagus does not connect with the stomach and there is an abnormal connection between the stomach and the respiratory tract. They require immediate corrective surgery and have an impact on the future health of the individual. These abnormalities are mimicked by exposure of rat and mouse embryos in utero to the drug adriamycin. The causes of OA/TOF during human development are not known, however a number of mouse mutants where different signalling pathways are directly affected, show similar abnormalities, implicating multiple and complex signalling mechanisms. The similarities in developmental outcome seen in human infants and in the adriamycin treated mouse model underline the potential of this model to unravel the early embryological events and further our understanding of the processes disturbed, leading to such abnormalities. Here we report a systematic study of the foregut and adjacent tissues in embryos treated with adriamycin at E7 and E8 and analysed between E9 and E12, comparing morphology in 3D in 149 specimens. We describe a spectrum of 8 defects, the most common of which is ventral displacement and branching of the notochord (in 94% of embryos at E10) and a close spatial correspondence between the site of notochord branching and defects of the foregut. In addition gene expression analysis shows altered dorso-ventral foregut patterning in the vicinity of notochord branches. This study shows a number of features of the adriamycin mouse model not previously reported, implicates the notochord as a primary site of disturbance in such abnormalities and underlines the importance of the model to further address the mechanistic basis of foregut congenital abnormalities.	[Hajduk, Piotr; Sato, Hideaki; Murphy, Paula] Univ Dublin, Dept Zool, Sch Nat Sci, Trinity Coll, Dublin, Ireland; [Hajduk, Piotr; Sato, Hideaki; Puri, Prem] Our Ladys Childrens Hosp, Natl Childrens Res Ctr, Dublin, Ireland	Trinity College Dublin; National Children's Research Centre (NCRC); Our Ladys Children Hospital Crumlin; Trinity College Dublin	Hajduk, P (corresponding author), Univ Dublin, Dept Zool, Sch Nat Sci, Trinity Coll, Dublin, Ireland.	paula.murphy@tcd.ie		Murphy, Paula/0000-0002-8048-6850	National Children's Research Centre, Dublin, Ireland [E/07/3]; Science Foundation Ireland [02/IN1/B267]; Edinburgh Mouse Atlas Project	National Children's Research Centre, Dublin, Ireland; Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Edinburgh Mouse Atlas Project	This work was funded by the National Children's Research Centre, Dublin, Ireland (grant number E/07/3) and Science Foundation Ireland (Programme Award 02/IN1/B267) to PM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Dr K. Roddy for technical advice, Dr Colby Tanner for guidance on statistical analysis and The Edinburgh Mouse Atlas Project for computational tools and support. Also Prof. L.Lundh for the plasmids carrying Shh and Foxf1 cDNA clones, Dr L.Magno for the plasmid carrying Nkx2.1 cDNA, and Prof. R. Lovell-Badge for the Sox2 conatining plasmid.	Alanentalo T, 2007, NAT METHODS, V4, P31, DOI 10.1038/NMETH985; Brunner HG, 2005, CURR OPIN GENET DEV, V15, P341, DOI 10.1016/j.gde.2005.04.010; Cardoso WV, 2006, DEVELOPMENT, V133, P1611, DOI 10.1242/dev.02310; CLARK D, 1999, AM FAM PHYSICIAN, V15, P919; Clark DC, 1999, AM FAM PHYSICIAN, V59, P910; Cleaver O, 2001, DEV BIOL, V234, P1, DOI 10.1006/dbio.2001.0214; Dawrant MJ, 2007, PEDIATR SURG INT, V23, P469, DOI 10.1007/s00383-006-1847-9; Dawrant MJ, 2007, J PEDIATR SURG, V42, P375, DOI 10.1016/j.jpedsurg.2006.10.011; Dawrant MJ, 2007, J PEDIATR SURG, V42, P1652, DOI 10.1016/j.jpedsurg.2007.05.018; DiezPardo JA, 1996, J PEDIATR SURG, V31, P498, DOI 10.1016/S0022-3468(96)90482-0; Dodd J, 1998, SCIENCE, V282, P1654, DOI 10.1126/science.282.5394.1654; Domyan ET, 2011, DEVELOPMENT, V138, P971, DOI 10.1242/dev.053694; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; Gillick J, 2008, PEDIATR SURG INT, V24, P113, DOI 10.1007/s00383-007-2035-2; Gross RE, 1953, SURG INFANCY CHILHOO; Hajduk P, 2010, PEDIATR SURG INT, V26, P23, DOI 10.1007/s00383-009-2519-3; HALPERN ME, 1993, CELL, V75, P99, DOI 10.1016/0092-8674(93)90682-G; Ioannides AS, 2010, DEV BIOL, V337, P351, DOI 10.1016/j.ydbio.2009.11.005; Ioannides AS, 2003, J PEDIATR SURG, V38, P29, DOI 10.1053/jpsu.2003.50005; Ioannides AS, 2002, J PEDIATR SURG, V37, P185, DOI 10.1053/jpsu.2002.30252; JURAND A, 1974, J EMBRYOL EXP MORPH, V32, P1; Kaufman M.H, 1999, ATLAS MOUSE DEV; Kim SK, 1997, DEVELOPMENT, V124, P4243; Kluth Dietrich, 2003, Semin Pediatr Surg, V12, P3, DOI 10.1016/S1055-8586(03)70002-X; LAWSON KA, 1986, DEV BIOL, V115, P325, DOI 10.1016/0012-1606(86)90253-8; Li CG, 2002, DEV BIOL, V248, P68, DOI 10.1006/dbio.2002.0729; Li Y, 2008, DEV BIOL, V322, P145, DOI 10.1016/j.ydbio.2008.07.021; Li Y, 2007, DEV DYNAM, V236, P746, DOI 10.1002/dvdy.21075; Litingtung Y, 1998, NAT GENET, V20, P58, DOI 10.1038/1717; Maeda Y, 2007, PHYSIOL REV, V87, P219, DOI 10.1152/physrev.00028.2006; Mahlapuu M, 1998, DEV BIOL, V202, P183, DOI 10.1006/dbio.1998.9010; Mahlapuu M, 2001, DEVELOPMENT, V128, P2397; Merei J, 1999, PEDIATR SURG INT, V15, P11, DOI 10.1007/s003830050501; Merei JM, 2002, PEDIATR SURG INT, V18, P319, DOI 10.1007/s00383-002-0751-1; Metzger RJ, 2008, NATURE, V453, P745, DOI 10.1038/nature07005; Minoo P, 1999, DEV BIOL, V209, P60, DOI 10.1006/dbio.1999.9234; Morrisey EE, 2010, DEV CELL, V18, P8, DOI 10.1016/j.devcel.2009.12.010; Mortell A, 2005, J PEDIATR SURG, V40, P403, DOI 10.1016/j.jpedsurg.2004.10.056; Oi BQ, 1999, J PEDIATR SURG, V34, P1593, DOI 10.1016/S0022-3468(99)90623-1; Orford J, 2001, J PEDIATR SURG, V36, P985, DOI 10.1053/jpsu.2001.24722; Peterson RS, 1997, CELL GROWTH DIFFER, V8, P69; PLACZEK M, 1995, CURR OPIN GENET DEV, V5, P499, DOI 10.1016/0959-437X(95)90055-L; Possoegel AK, 1999, PEDIATR SURG INT, V15, P201, DOI 10.1007/s003830050555; Qi BQ, 2000, DEV GROWTH DIFFER, V42, P145; Que J, 2007, DEVELOPMENT, V134, P2521, DOI 10.1242/dev.003855; Que JW, 2006, DIFFERENTIATION, V74, P422, DOI 10.1111/j.1432-0436.2006.00096.x; Roberts DJ, 1998, DEVELOPMENT, V125, P2791; Roddy KA, 2009, J ANAT, V214, P374, DOI 10.1111/j.1469-7580.2008.01040.x; Sasaki T, 2001, SURG TODAY, V31, P133, DOI 10.1007/s005950170197; Sharpe J, 2003, J ANAT, V202, P175, DOI 10.1046/j.1469-7580.2003.00155.x; Sharpe J, 2002, SCIENCE, V296, P541, DOI 10.1126/science.1068206; Spitz L, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-24; Stemple DL, 2005, DEVELOPMENT, V132, P2503, DOI 10.1242/dev.01812; Stottmann RW, 2001, DEV BIOL, V240, P457, DOI 10.1006/dbio.2001.0479; Summerhurst K, 2008, GENE EXPR PATTERNS, V8, P331, DOI 10.1016/j.gep.2008.01.007; Theiler K, 1989, HOUSE MOUSE ATLAS EM, DOI 10.1007/978-3-642-88418-4; THOMPSON DJ, 1978, TERATOLOGY, V17, P151, DOI 10.1002/tera.1420170207; Tomaselli V, 2003, PEDIATR SURG INT, V19, P40, DOI 10.1007/s00383-002-0887-z; Weaver M, 2000, DEVELOPMENT, V127, P2695; Wells JM, 1999, ANNU REV CELL DEV BI, V15, P393, DOI 10.1146/annurev.cellbio.15.1.393; Williams AK, 2003, J PEDIATR SURG, V38, P173, DOI 10.1053/jpsu.2003.50037; Williams AK, 2001, PEDIATR SURG INT, V17, P21, DOI 10.1007/s003830000440	62	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2011	6	11							e27635	10.1371/journal.pone.0027635	http://dx.doi.org/10.1371/journal.pone.0027635			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IO	22132119	Green Submitted, gold, Green Published			2022-12-27	WOS:000297789900014
J	Sternberg, L; Ellsworth, PFV				Sternberg, Leonel; Ellsworth, Patricia Fernandes Vendramini			Divergent Biochemical Fractionation, Not Convergent Temperature, Explains Cellulose Oxygen Isotope Enrichment across Latitudes	PLOS ONE			English	Article							TREE-RING CELLULOSE; WATER; RATIOS; HYDROGEN; CARBON; EXCHANGE; ALDOLASE	Recent findings based on the oxygen isotope ratios of tree trunk cellulose indicate that the temperature of biomass production in biomes ranging from boreal to subtropical forests converge to an average leaf temperature of 21.4 degrees C. The above conclusion has been drawn under the assumption that biochemically related isotopic fractionations during cellulose synthesis are not affected by temperature. Here we test the above assumption by heterotrophically generating cellulose at different temperatures and measuring the proportion of carbohydrate oxygen that exchange with water during cellulose synthesis and the average biochemical fractionation associated with this exchange. We observed no variation in the proportion of oxygen that exchange with different temperatures, which averaged 0.42 as it has been observed in other studies. On the other hand, the biochemical oxygen isotope fractionation during cellulose synthesis is affected by temperature and can be described by a 2(nd) order polynomial equation. The biochemical fractionation changes little between temperatures of 20 and 30 degrees C averaging 26 parts per thousand but increases at lower temperatures to values of 31 parts per thousand. This temperature sensitive biochemical fractionation explains the pattern of cellulose oxygen isotope ratios of aquatic plants encompassing several latitudes. The observed temperature sensitive biochemical fractionation also indicates that divergent biochemical fractionation and not convergent leaf temperature explains the increase in oxygen isotope enrichment of cellulose across several biomes.	[Sternberg, Leonel; Ellsworth, Patricia Fernandes Vendramini] Univ Miami, Dept Biol, Coral Gables, FL 33124 USA	University of Miami	Sternberg, L (corresponding author), Univ Miami, Dept Biol, Coral Gables, FL 33124 USA.	leo@bio.miami.edu			National Science Foundation [ARC-0803352]	National Science Foundation(National Science Foundation (NSF))	Research was partly funded by the National Science Foundation Grant # ARC-0803352. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Barbour MM, 2000, PLANT CELL ENVIRON, V23, P473, DOI 10.1046/j.1365-3040.2000.00575.x; Black CC, 1995, PHOTOSYNTH RES, V46, P169, DOI 10.1007/BF00020427; Cernusak LA, 2005, TREE PHYSIOL, V25, P129, DOI 10.1093/treephys/25.2.129; Cernusak LA, 2003, FUNCT PLANT BIOL, V30, P1059, DOI 10.1071/FP03137; Clark I., 1997, ENV ISOTOPES HYDROLO; Corbineau F, 2004, PHYSIOL PLANTARUM, V122, P28, DOI 10.1111/j.1399-3054.2004.00351.x; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P1885, DOI 10.1016/0016-7037(81)90018-1; Helliker BR, 2008, NATURE, V454, P511, DOI 10.1038/nature07031; HILL SA, 1995, PLANT CELL ENVIRON, V18, P931, DOI 10.1111/j.1365-3040.1995.tb00603.x; Hoefs J., 2004, STABLE ISOTOPE GEOCH, V5th; Lambers H., 2008, PLANT PHYSL ECOLOGY, DOI DOI 10.1007/978-0-387-78341-3_9; LEAVITT SW, 1993, ANAL CHEM, V65, P87, DOI 10.1021/ac00049a017; LUO YH, 1992, J EXP BOT, V43, P47, DOI 10.1093/jxb/43.1.47; MODEL P, 1968, BIOCHEMISTRY-US, V7, P1339, DOI 10.1021/bi00844a014; REYNOLDS SJ, 1971, BIOCHEM J, V122, P285, DOI 10.1042/bj1220285; Roden JS, 2000, GEOCHIM COSMOCHIM AC, V64, P21, DOI 10.1016/S0016-7037(99)00195-7; Sauer PE, 2001, J PALEOLIMNOL, V25, P43, DOI 10.1023/A:1008133523139; STERNBERG LDL, 1988, NATURE, V333, P59, DOI 10.1038/333059a0; STERNBERG LDL, 1986, PLANT PHYSIOL, V82, P423, DOI 10.1104/pp.82.2.423; STERNBERG LDLO, 1983, GEOCHIM COSMOCHIM AC, V47, P2271; Sternberg L, 2006, PLANT CELL ENVIRON, V29, P1881, DOI 10.1111/j.1365-3040.2006.01564.x; Sternberg LDLO, 2009, NEW PHYTOL, V181, P553, DOI 10.1111/j.1469-8137.2008.02661.x; Vendramini PF, 2007, RAPID COMMUN MASS SP, V21, P164, DOI 10.1002/rcm.2826; YAKIR D, 1990, PLANT PHYSIOL, V93, P325, DOI 10.1104/pp.93.1.325; ZHOU YP, 2005, CARBON OXYGEN HYDROG; MOISTURE ISOTOPES BI	26	81	81	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2011	6	11							e28040	10.1371/journal.pone.0028040	http://dx.doi.org/10.1371/journal.pone.0028040			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IO	22132203	Green Published, gold			2022-12-27	WOS:000297789900044
J	Liu, Z; Luo, WR; Zhou, Y; Zhen, Y; Yang, HL; Yu, XL; Ye, YF; Li, X; Wang, H; Jiang, QP; Zhang, YJ; Yao, KT; Fang, WY				Liu, Zhen; Luo, Weiren; Zhou, Ying; Zhen, Yan; Yang, Huiling; Yu, Xiaoli; Ye, Yanfen; Li, Xin; Wang, Hao; Jiang, Qinping; Zhang, Yajie; Yao, Kaitai; Fang, Weiyi			Potential Tumor Suppressor NESG1 as an Unfavorable Prognosis Factor in Nasopharyngeal Carcinoma (Publication with Expression of Concern. See vol. 15, 2020)	PLOS ONE			English	Article; Publication with Expression of Concern							EXPRESSION; GROWTH; PROLIFERATION; KINASE; ATF-2; CELLS; GENE	Background: Recently we identified nasopharyngeal epithelium specific protein 1 (NESG1) as a potential tumor suppressor in nasopharyngeal carcinoma (NPC). The purpose of this study is to investigate the involvement of NESG1 in tumor progression and prognosis of human NPC. Methodology/Principal Findings: NESG1 protein expression in NPC was examined. Survival analysis was performed using Kaplan-Meier method. The effect of NESG1 on cell proliferation, migration, and invasion were also investigated. Results: NESG1 expression was downregulated in atypical hyperplasia and NPC samples compared to normal and squamous nasopharynx tissues. Reduced protein expression was negatively associated with the status of NPC progression. Patients with lower NESG1 expression had a shorter overall survival and disease-free time than did patients with higher NESG1 expression. Multivariate analysis suggested NESG1 expression as an independent prognostic indicator for NPC patient survival. Proliferation, migration, and invasion ability were significantly increased in cell lines following lentiviral-mediated shRNA suppression of NESG1 expression. Microarray analysis indicated that NESG1 participated in multiple pathways, including MAPK signaling and cell cycle regulation. Finally, DNA methylation microarray examination revealed a lack of hypermethylation at the NESG1 promoter, suggesting other mechanisms are involved in suppressing NESG1 expression in NPC. Conclusion: Our studies are the first to demonstrate that decreased NESG1 expression is an unfavorable prognostic factor for NPC.	[Liu, Zhen; Zhang, Yajie] Guangzhou Med Univ, Dept Pathol, Basic Sch, Guangzhou, Guangdong, Peoples R China; [Liu, Zhen; Luo, Weiren; Zhou, Ying; Zhen, Yan; Yu, Xiaoli; Ye, Yanfen; Li, Xin; Wang, Hao; Yao, Kaitai; Fang, Weiyi] So Med Univ, Canc Res Inst, Guangzhou, Guangdong, Peoples R China; [Luo, Weiren] Guangdong Med Coll, Dept Pathol, Dongguan, Peoples R China; [Jiang, Qinping] Guangzhou Med Univ, Affiliated Hosp 3, Guangzhou, Guangdong, Peoples R China; [Yang, Huiling] Guangdong Med Coll, Sch Pharm, Dongguan, Peoples R China	Guangzhou Medical University; Southern Medical University - China; Guangdong Medical University; Guangzhou Medical University; Guangdong Medical University	Liu, Z (corresponding author), Guangzhou Med Univ, Dept Pathol, Basic Sch, Guangzhou, Guangdong, Peoples R China.	fangweiyi1975@yahoo.com.cn	Ren, Jian/D-3270-2011; Xue, Yu/G-5929-2011; Luo, Weiren/AAI-8364-2020; Liu, Zexian/D-1153-2011	Ren, Jian/0000-0002-4161-1292; Xue, Yu/0000-0002-9403-6869; Luo, Weiren/0000-0002-2762-6332; Liu, Zexian/0000-0001-9698-0610	National Nature Science Fund of China [81071632, 30870973]; Natural Science Fund of Guangdong Province [8451051501000314]	National Nature Science Fund of China(National Natural Science Foundation of China (NSFC)); Natural Science Fund of Guangdong Province(National Natural Science Foundation of Guangdong Province)	This study was supported by National Nature Science Fund of China (NO. 81071632 and NO. 30870973)(http://www.nsfc.gov.cn), Natural Science Fund of Guangdong Province (NO. 8451051501000314) (http://www.gdstc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhandari DR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010493; Cho WCS, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-1; Cui Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002990; Dong WJ, 2010, INT J CANCER, V127, P1526, DOI 10.1002/ijc.25161; Du ZM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019137; Fang WY, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-32; Haines E, 2009, MOL CELL BIOL, V29, P2505, DOI 10.1128/MCB.00034-09; Henkens R, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-147; Jadeski LC, 2003, INT J CANCER, V106, P496, DOI 10.1002/ijc.11268; Johansen C, 2009, CARCINOGENESIS, V30, P2100, DOI 10.1093/carcin/bgp238; Jonak C, 2011, J DERMATOL SCI, V61, P32, DOI 10.1016/j.jdermsci.2010.10.009; Knippen S, 2009, ANTICANCER RES, V29, P183; Koga Y, 2009, GENOME RES, V19, P1462, DOI 10.1101/gr.091447.109; Kumar B, 2010, CANCER RES, V70, P832, DOI 10.1158/0008-5472.CAN-09-2918; Langlois B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011584; Li ZK, 1999, GENE, V237, P235, DOI 10.1016/S0378-1119(99)00234-6; Liu Z, 2011, INT J CANCER, V128, P2562, DOI 10.1002/ijc.25595; Lung HL, 2010, INT J CANCER, V127, P304, DOI 10.1002/ijc.25047; Manke IA, 2005, MOL CELL, V17, P37, DOI 10.1016/j.molcel.2004.11.021; Modi H, 2011, LEUKEMIA, V25, P305, DOI 10.1038/leu.2010.257; Poage GM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009651; Rahmouni S, 2006, NAT CELL BIOL, V8, P524, DOI 10.1038/ncb1398; Rauhala HE, 2010, INT J CANCER, V127, P1363, DOI 10.1002/ijc.25162; Recio JA, 2002, ONCOGENE, V21, P1000, DOI 10.1038/sj.onc.1205150; Reinhardt HC, 2007, CANCER CELL, V11, P175, DOI 10.1016/j.ccr.2006.11.024; Song LB, 2009, J CLIN INVEST, V119, P3626, DOI 10.1172/JCI39374; Ungefroren H, 2007, INT J CANCER, V120, P1641, DOI 10.1002/ijc.22393; Wang SA, 2011, HISTOPATHOLOGY, V58, P217, DOI 10.1111/j.1365-2559.2010.03739.x; Wu AB, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-38; Zhou YH, 2008, INT J CANCER, V123, P2065, DOI 10.1002/ijc.23727; Zoumpourlis V, 2000, ONCOGENE, V19, P4011, DOI 10.1038/sj.onc.1203732	31	104	112	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2011	6	11							e27887	10.1371/journal.pone.0027887	http://dx.doi.org/10.1371/journal.pone.0027887			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KW	22140479	Green Published, Green Submitted, gold			2022-12-27	WOS:000298163400020
J	Liu, ZX; Cao, J; Gao, XJ; Ma, Q; Ren, J; Xue, Y				Liu, Zexian; Cao, Jun; Gao, Xinjiao; Ma, Qian; Ren, Jian; Xue, Yu			GPS-CCD: A Novel Computational Program for the Prediction of Calpain Cleavage Sites	PLOS ONE			English	Article							PHOSPHORYLATION SITES; MEDIATED CLEAVAGE; PEPTIDE LIBRARY; PROTEIN; DATABASE; IDENTIFICATION; APOPTOSIS; SUBSTRATE; AUTOPHAGY; PATHWAY	As one of the most essential post-translational modifications (PTMs) of proteins, proteolysis, especially calpain-mediated cleavage, plays an important role in many biological processes, including cell death/apoptosis, cytoskeletal remodeling, and the cell cycle. Experimental identification of calpain targets with bona fide cleavage sites is fundamental for dissecting the molecular mechanisms and biological roles of calpain cleavage. In contrast to time-consuming and labor-intensive experimental approaches, computational prediction of calpain cleavage sites might more cheaply and readily provide useful information for further experimental investigation. In this work, we constructed a novel software package of GPS-CCD (Calpain Cleavage Detector) for the prediction of calpain cleavage sites, with an accuracy of 89.98%, sensitivity of 60.87% and specificity of 90.07%. With this software, we annotated potential calpain cleavage sites for hundreds of calpain substrates, for which the exact cleavage sites had not been previously determined. In this regard, GPS-CCD 1.0 is considered to be a useful tool for experimentalists. The online service and local packages of GPS-CCD 1.0 were implemented in JAVA and are freely available at: http://ccd.biocuckoo.org/.	[Liu, Zexian; Cao, Jun; Gao, Xinjiao; Ma, Qian] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Peoples R China; [Liu, Zexian; Cao, Jun; Gao, Xinjiao; Ma, Qian] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Peoples R China; [Liu, Zexian; Xue, Yu] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Dept Syst Biol, Hubei Bioinformat & Mol Imaging Key Lab, Wuhan 430074, Hubei, Peoples R China; [Ren, Jian] Sun Yat Sen Univ, State Key Lab Biocontrol, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Huazhong University of Science & Technology; Sun Yat Sen University	Liu, ZX (corresponding author), Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Peoples R China.	renjian.sysu@gmail.com; xueyu@mail.hust.edu.cn	Ren, Jian/D-3270-2011; Xue, Yu/G-5929-2011; Luo, Weiren/AAI-8364-2020; Liu, Zexian/D-1153-2011	Ren, Jian/0000-0002-4161-1292; Xue, Yu/0000-0002-9403-6869; Luo, Weiren/0000-0002-2762-6332; Liu, Zexian/0000-0001-9698-0610	National Basic Research Program (973 project) [2010CB945400, 2011CB910400]; National Natural Science Foundation of China [90919001, 31071154, 30900835, 30830036, 91019020, 21075045]; Fundamental Research Funds for the Central Universities [HUST: 2010JC049, 2010ZD018, SYSU: 11lgzd11, 11lgjc09]	National Basic Research Program (973 project)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by grants from the National Basic Research Program (973 project) (2010CB945400, 2011CB910400), National Natural Science Foundation of China (90919001, 31071154, 30900835, 30830036, 91019020, 21075045), and Fundamental Research Funds for the Central Universities (HUST: 2010JC049, 2010ZD018; SYSU: 11lgzd11, 11lgjc09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arrington DD, 2006, AM J PHYSIOL-CELL PH, V291, pC1159, DOI 10.1152/ajpcell.00207.2006; Barrell D, 2009, NUCLEIC ACIDS RES, V37, pD396, DOI 10.1093/nar/gkn803; Boehmerle W, 2007, P NATL ACAD SCI USA, V104, P11103, DOI 10.1073/pnas.0701546104; Bougie JK, 2009, J NEUROCHEM, V109, P1129, DOI 10.1111/j.1471-4159.2009.06045.x; Boyd Sarah E., 2005, Journal of Bioinformatics and Computational Biology, V3, P551, DOI 10.1142/S021972000500117X; Boyd SE, 2004, 2004 IEEE COMPUTATIONAL SYSTEMS BIOINFORMATICS CONFERENCE, PROCEEDINGS, P372; Chen Q, 2006, J NEUROCHEM, V99, P1133, DOI 10.1111/j.1471-4159.2006.04160.x; Croall DE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-218; Cuerrier D, 2005, J BIOL CHEM, V280, P40632, DOI 10.1074/jbc.M506870200; duVerle David, 2010, V22, P202; Franco SJ, 2005, J CELL SCI, V118, P3829, DOI 10.1242/jcs.02562; Futai E, 1999, MOL GEN GENET, V260, P559, DOI 10.1007/s004380050929; Glading A, 2002, TRENDS CELL BIOL, V12, P46, DOI 10.1016/S0962-8924(01)02179-1; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Hayashi M, 2005, MOL CELL BIOL, V25, P9478, DOI 10.1128/MCB.25.21.9478-9490.2005; Huang YH, 2001, TRENDS MOL MED, V7, P355, DOI 10.1016/S1471-4914(01)02049-4; Igarashi Y, 2007, NUCLEIC ACIDS RES, V35, pD546, DOI 10.1093/nar/gkl813; Joy J, 2006, BIOL CHEM, V387, P329, DOI 10.1515/BC.2006.044; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liu J, 2008, SCI SIGNAL, V1, DOI [10.1126/stke.114re1, 10.1126/scisignal.123tr3]; Ottens AK, 2008, J NEUROCHEM, V104, P1404, DOI 10.1111/j.1471-4159.2007.05086.x; Rawlings ND, 2009, LARGE ACCURATE COLLE; Rawlings ND, 2008, NUCLEIC ACIDS RES, V36, pD320, DOI 10.1093/nar/gkm954; Ren J, 2009, CELL RES, V19, P271, DOI 10.1038/cr.2009.6; Squier MKT, 1999, J CELL PHYSIOL, V178, P311, DOI 10.1002/(SICI)1097-4652(199903)178:3<311::AID-JCP5>3.3.CO;2-K; Tan Y, 2006, J BIOL CHEM, V281, P17689, DOI 10.1074/jbc.M601978200; Thomas DA, 2006, PROTEOMICS, V6, P2112, DOI 10.1002/pmic.200500153; Tompa P, 2004, J BIOL CHEM, V279, P20775, DOI 10.1074/jbc.M313873200; Verspurten J, 2009, TRENDS BIOCHEM SCI, V34, P319, DOI 10.1016/j.tibs.2009.04.001; Williams A, 2008, NAT CHEM BIOL, V4, P295, DOI 10.1038/nchembio.79; Xu J, 2009, J NEUROSCI, V29, P9330, DOI 10.1523/JNEUROSCI.2212-09.2009; Xue Y, 2005, NUCLEIC ACIDS RES, V33, pW184, DOI 10.1093/nar/gki393; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; Yousefi S, 2006, NAT CELL BIOL, V8, P1124, DOI 10.1038/ncb1482; Zatz M, 2005, NEW ENGL J MED, V352, P2413, DOI 10.1056/NEJMra043361; Zhou FF, 2005, FEBS LETT, V579, P3369, DOI 10.1016/j.febslet.2005.04.076	37	104	112	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e19001	10.1371/journal.pone.0019001	http://dx.doi.org/10.1371/journal.pone.0019001			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752UE	22140479	Green Published, gold, Green Submitted			2022-12-27	WOS:000289719400047
J	Sun, YC; Yin, J; Cao, HF; Li, CY; Kang, L; Ge, F				Sun, Yucheng; Yin, Jin; Cao, Haifeng; Li, Chuanyou; Kang, Le; Ge, Feng			Elevated CO2 Influences Nematode-Induced Defense Responses of Tomato Genotypes Differing in the JA Pathway	PLOS ONE			English	Article							ATMOSPHERIC CO2; CARBON-DIOXIDE; SIGNALING PATHWAY; NATURAL ENEMIES; JASMONIC ACID; ROOT; RESISTANCE; HERBIVORY; COSTS; BIOSYNTHESIS	Rising atmospheric CO2 concentrations can affect the induced defense of plants against chewing herbivores but little is known about whether elevated CO2 can change the induced defense of plants against parasitic nematodes. This study examined the interactions between the root-knot nematode Meloidogyne incognita and three isogenic tomato (Lycopersicon esculentum) genotypes grown under ambient (390 ppm) and elevated (750 ppm) CO2 in growth chambers. In a previous study with open-top chambers in the field, we reported that elevated CO2 increased the number of nematode-induced root galls in a JA-defense-dominated genotype but not in a wild-type or JA-defense-recessive genotype. In the current study, we tested the hypothesis that elevated CO2 will favor the salicylic acid (SA)-pathway defense but repress the jasmonic acid (JA)-pathway defense of plants against plant-parasitic nematodes. Our data showed that elevated CO2 reduced the JA-pathway defense against M. incognita in the wild-type and in a genotype in which defense is dominated by the JA pathway (a JA-defense-dominated genotype) but up-regulated the SA-pathway defense in the wild type and in a JA-defense-recessive genotype (jasmonate-deficient mutant). Our results suggest that, in terms of defense genes, secondary metabolites, and volatile organic compounds, induced defense of nematode-infected plants could be affected by elevated CO2, and that CO2-induced changes of plant resistance may lead to genotype-specific responses of plants to nematodes under elevated CO2. The changes in resistance against nematodes, however, were small relative to those reported for chewing insects.	[Sun, Yucheng; Yin, Jin; Cao, Haifeng; Kang, Le; Ge, Feng] Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest & Rodent, Beijing, Peoples R China; [Li, Chuanyou] Chinese Acad Sci, Natl Ctr Plant Gene Res, Inst Genet & Dev Biol, State Key Lab Plant Genom, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Sun, YC (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest & Rodent, Beijing, Peoples R China.	gef@ioz.ac.cn	Kang, Le/ABD-1116-2022; Li, Chuanyou/ABF-4143-2020; Jiang, Xingyu/U-3976-2018	Kang, Le/0000-0003-4262-2329; Jiang, Xingyu/0000-0002-5008-4703; Sun, Yi/0000-0002-1746-0404; Sun, Yucheng/0000-0003-2353-0218	National Basic Research Program of China (973 Program) [2009CB119200]; National Nature Science Fund of China [30970510, 31000854, 30921063]; Chinese Academy of Science [KSCX3-YW-N-005, 2010-Biols-CAS-0102]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Nature Science Fund of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Science(Chinese Academy of Sciences)	This work was supported by National Basic Research Program of China (973 Program) (No. 2009CB119200), the National Nature Science Fund of China (No. 30970510, 31000854 and 30921063) and the Innovation Program of Chinese Academy of Science (KSCX3-YW-N-005, 2010-Biols-CAS-0102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad P, 2003, MOL PLANT PATHOL, V4, P217, DOI [10.1046/j.1364-3703.2003.00170.x, 10.1046/J.1364-3703.2003.00170.X]; Ayres E, 2008, SOIL BIOL BIOCHEM, V40, P978, DOI 10.1016/j.soilbio.2007.11.018; Barbehenn RV, 2004, GLOBAL CHANGE BIOL, V10, P1565, DOI 10.1111/j.1365-2486.2004.00833.x; Bhattarai KK, 2008, MOL PLANT MICROBE IN, V21, P1205, DOI 10.1094/MPMI-21-9-1205; Bidart-Bouzat MG, 2005, OECOLOGIA, V145, P415, DOI 10.1007/s00442-005-0158-5; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; [陈法军 Chen Fajun], 2004, [昆虫知识, Entomological  Knowledge], V41, P279; Cooper WR, 2005, J CHEM ECOL, V31, P1953, DOI 10.1007/s10886-005-6070-y; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Hamilton JG, 2001, ECOL LETT, V4, P86, DOI 10.1046/j.1461-0248.2001.00192.x; Hartley SE, 2000, GLOBAL CHANGE BIOL, V6, P497, DOI 10.1046/j.1365-2486.2000.00333.x; HOWE GA, 2007, ANNU REV PLANT BIOL, V17, P41; HUSSEY RS, 1973, PLANT DIS REP, V57, P1025; *INT PAN CLIM CHAN, 2007, CLIM CHANG 2007 PHYS; Jia Z, 1999, FOOD CHEM, V64, P555, DOI 10.1016/S0308-8146(98)00102-2; Koricheva J, 2002, ECOLOGY, V83, P176, DOI 10.2307/2680130; Kujala TS, 2000, J AGR FOOD CHEM, V48, P5338, DOI 10.1021/jf000523q; Lau JA, 2009, OECOLOGIA, V161, P401, DOI 10.1007/s00442-009-1384-z; Li CR, 2002, PLANT CELL ENVIRON, V25, P369, DOI 10.1046/j.0016-8025.2001.00818.x; Li CY, 2003, PLANT CELL, V15, P1646, DOI 10.1105/tpc.012237; Li CY, 2002, PLANT PHYSIOL, V130, P494, DOI 10.1104/pp.005314; Li PH, 2008, PLANT CELL ENVIRON, V31, P1673, DOI 10.1111/j.1365-3040.2008.01874.x; Loreto F, 2001, GLOBAL CHANGE BIOL, V7, P709, DOI 10.1046/j.1354-1013.2001.00442.x; Melillo MT, 2006, NEW PHYTOL, V170, P501, DOI 10.1111/j.1469-8137.2006.001724.x; Niklaus PA, 2003, GLOBAL CHANGE BIOL, V9, P585, DOI 10.1046/j.1365-2486.2003.00614.x; Soriano IR, 2004, J CHEM ECOL, V30, P1885, DOI 10.1023/B:JOEC.0000045584.56515.11; Stevens MT, 2007, EVOL ECOL, V21, P829, DOI 10.1007/s10682-006-9154-4; Stiling P, 2007, GLOBAL CHANGE BIOL, V13, P1823, DOI 10.1111/j.1365-2486.2007.01392.x; Strauss SY, 2002, TRENDS ECOL EVOL, V17, P278, DOI 10.1016/S0169-5347(02)02483-7; Sun YC, 2010, PLANT CELL ENVIRON, V33, P729, DOI 10.1111/j.1365-3040.2009.02098.x; Sun YC, 2010, AGR ECOSYST ENVIRON, V135, P140, DOI 10.1016/j.agee.2009.09.011; TERRILL TH, 1992, J SCI FOOD AGR, V58, P321, DOI 10.1002/jsfa.2740580306; TISSUE DT, 1995, FUNCT ECOL, V9, P518, DOI 10.2307/2390018; Turlings TCJ, 1998, BIOL CONTROL, V11, P122, DOI 10.1006/bcon.1997.0591; Vasyukova N. I., 2003, Doklady Akademii Nauk, V391, P419; Vuorinen T, 2004, PLANT PHYSIOL, V135, P1984, DOI 10.1104/pp.104.047084; Vuorinen T, 2004, ATMOS ENVIRON, V38, P675, DOI 10.1016/j.atmosenv.2003.10.029; Williamson VM, 1998, ANNU REV PHYTOPATHOL, V36, P277, DOI 10.1146/annurev.phyto.36.1.277; Yeates GW, 2003, BIOL FERT SOILS, V38, P319, DOI 10.1007/s00374-003-0659-5; Yin J, 2009, AGR ECOSYST ENVIRON, V132, P267, DOI 10.1016/j.agee.2009.04.010; Zavala JA, 2008, P NATL ACAD SCI USA, V105, P5129, DOI 10.1073/pnas.0800568105; Zavala JA, 2009, OECOLOGIA, V161, P35, DOI 10.1007/s00442-009-1360-7	42	61	63	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e19751	10.1371/journal.pone.0019751	http://dx.doi.org/10.1371/journal.pone.0019751			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IJ	21629688	Green Submitted, Green Published, gold			2022-12-27	WOS:000291005800007
J	He, S; Kato, K; Jiang, J; Wahl, DR; Mineishi, S; Fisher, EM; Murasko, DM; Glick, GD; Zhang, Y				He, Shan; Kato, Koji; Jiang, Jiu; Wahl, Daniel R.; Mineishi, Shin; Fisher, Erin M.; Murasko, Donna M.; Glick, Gary D.; Zhang, Yi			Characterization of the Metabolic Phenotype of Rapamycin-Treated CD8(+) T Cells with Augmented Ability to Generate Long-Lasting Memory Cells	PLOS ONE			English	Article							VERSUS-HOST-DISEASE; HUMAN CEREBRAL GLIOMA; DONOR TH2 CELLS; ENERGY-METABOLISM; MAMMALIAN TARGET; VIRAL-INFECTION; IN-VIVO; RESISTANT PROLIFERATION; PROTECTIVE IMMUNITY; DENDRITIC CELLS	Background: Cellular metabolism plays a critical role in regulating T cell responses and the development of memory T cells with long-term protections. However, the metabolic phenotype of antigen-activated T cells that are responsible for the generation of long-lived memory cells has not been characterized. Design and Methods: Using lymphocytic choriomeningitis virus (LCMV) peptide gp33-specific CD8(+) T cells derived from T cell receptor transgenic mice, we characterized the metabolic phenotype of proliferating T cells that were activated and expanded in vitro in the presence or absence of rapamycin, and determined the capability of these rapamycin-treated T cells to generate long-lived memory cells in vivo. Results: Antigen-activated CD8(+) T cells treated with rapamycin gave rise to 5-fold more long-lived memory T cells in vivo than untreated control T cells. In contrast to that control T cells only increased glycolysis, rapamycin-treated T cells upregulated both glycolysis and oxidative phosphorylation (OXPHOS). These rapamycin-treated T cells had greater ability than control T cells to survive withdrawal of either glucose or growth factors. Inhibition of OXPHOS by oligomycin significantly reduced the ability of rapamycin-treated T cells to survive growth factor withdrawal. This effect of OXPHOS inhibition was accompanied with mitochondrial hyperpolarization and elevation of reactive oxygen species that are known to be toxic to cells. Conclusions: Our findings indicate that these rapamycin-treated T cells may represent a unique cell model for identifying nutrients and signals critical to regulating metabolism in both effector and memory T cells, and for the development of new methods to improve the efficacy of adoptive T cell cancer therapy.	[He, Shan; Kato, Koji; Mineishi, Shin; Zhang, Yi] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Jiang, Jiu; Fisher, Erin M.; Murasko, Donna M.] Drexel Univ, Dept Biosci & Biotechnol, Philadelphia, PA 19104 USA; [Wahl, Daniel R.] Univ Michigan, Chem Biol Doctoral Program, Ann Arbor, MI 48109 USA; [Glick, Gary D.] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; Drexel University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	He, S (corresponding author), Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA.	yizha@med.umich.edu	He, Shan/C-4989-2015; Ma, Zhonghua/J-6972-2014	Yin, Yanni/0000-0002-0798-3420; Ma, Zhonghua/0000-0002-5426-0997	Damon Runyon-Rachleff Innovation Award; American Cancer Society; NIH [R01 CA102464, R01 AI47450]; National Institutes of Health through the University of Michigan [P30CA46592]; NATIONAL CANCER INSTITUTE [R01CA102464, P30CA046592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047450] Funding Source: NIH RePORTER	Damon Runyon-Rachleff Innovation Award; American Cancer Society(American Cancer Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health through the University of Michigan; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a Damon Runyon-Rachleff Innovation Award (YZ), American Cancer Society (YZ) and the NIH [R01 CA102464 (YZ) and R01 AI47450 (GDG)]. This research is supported in part by a grant from the National Institutes of Health through the University of Michigan's Cancer Center Support Grant (P30CA46592). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuto O, 2003, NAT REV IMMUNOL, V3, P939, DOI 10.1038/nri1248; Adams MM, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-19; Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Ahmed R, 2009, NAT REV IMMUNOL, V9, P662, DOI 10.1038/nri2619; Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Badovinac VP, 2006, IMMUNOL REV, V211, P67, DOI 10.1111/j.0105-2896.2006.00384.x; Bannard O, 2009, SCIENCE, V323, P505, DOI 10.1126/science.1166831; BENKE PJ, 1991, BIOCHEM MED METAB B, V45, P28, DOI 10.1016/0885-4505(91)90005-6; Bevan MJ, 2004, NAT REV IMMUNOL, V4, P595, DOI 10.1038/nri1413; Brown NF, 2007, METABOLISM, V56, P1500, DOI 10.1016/j.metabol.2007.06.016; Buzzai M, 2007, CANCER RES, V67, P6745, DOI 10.1158/0008-5472.CAN-06-4447; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Chen C, 2008, J EXP MED, V205, P2397, DOI 10.1084/jem.20081297; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; DWARAKANATH BS, 1991, INDIAN J BIOCHEM BIO, V28, P203; DWARKANATH BS, 1989, INT J RADIAT ONCOL, V17, P1033, DOI 10.1016/0360-3016(89)90152-1; Foley JE, 2005, J IMMUNOL, V175, P5732, DOI 10.4049/jimmunol.175.9.5732; Fox CJ, 2005, NAT REV IMMUNOL, V5, P844, DOI 10.1038/nri1710; Fox CJ, 2005, J EXP MED, V201, P259, DOI 10.1084/jem.20042020; Gattinoni L, 2005, J CLIN INVEST, V115, P1616, DOI 10.1172/JCI24480; Gattinoni L, 2006, NAT REV IMMUNOL, V6, P383, DOI 10.1038/nri1842; GUPPY M, 1993, EUR J BIOCHEM, V212, P95, DOI 10.1111/j.1432-1033.1993.tb17637.x; Hitchon CA, 2004, ARTHRITIS RES THER, V6, P265, DOI 10.1186/ar1447; Jameson SC, 2002, NAT REV IMMUNOL, V2, P547, DOI 10.1038/nri853; Jones RG, 2007, IMMUNITY, V27, P173, DOI 10.1016/j.immuni.2007.07.008; Joshi NS, 2008, J IMMUNOL, V180, P1309, DOI 10.4049/jimmunol.180.3.1309; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; June CH, 2007, J CLIN INVEST, V117, P1204, DOI 10.1172/JCI31446; Jung US, 2006, BIOL BLOOD MARROW TR, V12, P905, DOI 10.1016/j.bbmt.2006.05.014; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Kaech SM, 2007, IMMUNITY, V27, P393, DOI 10.1016/j.immuni.2007.08.007; Kallies A, 2008, IMMUNOL CELL BIOL, V86, P325, DOI 10.1038/icb.2008.16; Kuhnke A, 2003, ANN RHEUM DIS, V62, P133, DOI 10.1136/ard.62.2.133; Lefrancois L, 2006, NAT REV IMMUNOL, V6, P618, DOI 10.1038/nri1866; Liang YL, 2009, WORLD J SURG, V33, P661, DOI 10.1007/s00268-008-9840-1; Lombard DB, 2005, CELL, V120, P497, DOI 10.1016/j.cell.2005.01.028; Mariotti J, 2008, J IMMUNOL, V180, P89, DOI 10.4049/jimmunol.180.1.89; Masopust D, 2007, EUR J IMMUNOL, V37, pS103, DOI 10.1002/eji.200737584; Mehrotra S, 2009, ADV CANCER RES, V102, P197, DOI 10.1016/S0065-230X(09)02006-5; OROURKE AM, 1989, BIOCHIM BIOPHYS ACTA, V1010, P342, DOI 10.1016/0167-4889(89)90059-1; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Peng T, 2002, MOL CELL BIOL, V22, P5575, DOI 10.1128/MCB.22.15.5575-5584.2002; Perl A, 2004, TRENDS IMMUNOL, V25, P360, DOI 10.1016/j.it.2004.05.001; Plas DR, 2002, NAT IMMUNOL, V3, P515, DOI 10.1038/ni0602-515; Prlic M, 2008, P NATL ACAD SCI USA, V105, P16689, DOI 10.1073/pnas.0808997105; Rao RR, 2010, IMMUNITY, V32, P67, DOI 10.1016/j.immuni.2009.10.010; Rathmell JC, 2003, EUR J IMMUNOL, V33, P2223, DOI 10.1002/eji.200324048; ROOS D, 1973, EXP CELL RES, V77, P127, DOI 10.1016/0014-4827(73)90561-2; SARIBANSOHRABY S, 1983, CANCER RES, V43, P4662; Schieke SM, 2006, J BIOL CHEM, V281, P27643, DOI 10.1074/jbc.M603536200; Sipula IJ, 2006, METABOLISM, V55, P1637, DOI 10.1016/j.metabol.2006.08.002; Slavik JM, 2004, J BIOL CHEM, V279, P910, DOI 10.1074/jbc.M209733200; Slavik JM, 2001, J IMMUNOL, V166, P3201, DOI 10.4049/jimmunol.166.5.3201; Sprent J, 2003, MICROBES INFECT, V5, P227, DOI 10.1016/S1286-4579(03)00015-7; Tejero-Taldo MI, 1999, J MOL CELL CARDIOL, V31, P1863, DOI 10.1006/jmcc.1999.1020; Thoren FB, 2007, J IMMUNOL, V179, P21, DOI 10.4049/jimmunol.179.1.21; Thoren FB, 2006, J IMMUNOL, V176, P7301, DOI 10.4049/jimmunol.176.12.7301; WAHL DR, LUPUS; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Wherry EJ, 2004, J VIROL, V78, P5535, DOI 10.1128/JVI.78.11.5535-5545.2004; Williams MA, 2006, IMMUNOL REV, V211, P146, DOI 10.1111/j.0105-2896.2006.00389.x; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zhang Y, 2005, J IMMUNOL, V174, P3051, DOI 10.4049/jimmunol.174.5.3051; Zhang Y, 1998, BLOOD, V92, P118, DOI 10.1182/blood.V92.1.118.413a01_118_128; Zhang Y, 2004, BLOOD, V103, P3970, DOI 10.1182/blood-2003-09-3135; Zhang Y, 2002, J CLIN INVEST, V109, P1335, DOI 10.1172/JCI200214989; Zhao YX, 2008, METHOD ENZYMOL, V442, P439, DOI [10.1016/S0076-0879(08)01422-5, 10.1016/S0076-6879(08)01422-5]; Zhou Q, 2009, FREE RADICAL BIO MED, V47, P891, DOI 10.1016/j.freeradbiomed.2009.06.033	69	101	110	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2011	6	5							e20107	10.1371/journal.pone.0020107	http://dx.doi.org/10.1371/journal.pone.0020107			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TX	22140571	gold, Green Submitted, Green Published			2022-12-27	WOS:000290657500043
J	Yu, XY; Chen, HM; Liang, JL; Lin, QX; Tan, HH; Fu, YH; Liu, XY; Shan, ZX; Li, XH; Yang, HZ; Yang, M; Li, YX; Lin, SG				Yu, Xi-Yong; Chen, Hong-Mei; Liang, Jia-Liang; Lin, Qiu-Xiong; Tan, Hong-Hong; Fu, Yong-Heng; Liu, Xiao-Ying; Shan, Zhi-Xin; Li, Xiao-Hong; Yang, Hua-Zhang; Yang, Min; Li, Yangxin; Lin, Shu-Guang			Hyperglycemic Myocardial Damage Is Mediated by Proinflammatory Cytokine: Macrophage Migration Inhibitory Factor	PLOS ONE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; COUPLED RECEPTOR KINASES; DIABETIC CARDIOMYOPATHY; DIASTOLIC DYSFUNCTION; DEFICIENT MICE; ATHEROSCLEROSIS; MIF; INFLAMMATION; MECHANISMS; EXPRESSION	Background: Diabetes has been regarded as an inflammatory condition which is associated with left ventricular diastolic dysfunction (LVDD). The purpose of this study was to examine the expression levels of macrophage migration inhibitory factor (MIF) and G protein-coupled receptor kinase 2 (GRK2) in patients with early diabetic cardiomyopathy, and to investigate the mechanisms involved in MIF expression and GRK2 activation. Methods: 83 patients in the age range of 30-64 years with type 2 diabetes and 30 matched healthy men were recruited. Left ventricular diastolic function was evaluated by cardiac Doppler echocardiography. Plasma MIF levels were determined by ELISA. To confirm the clinical observation, we also studied MIF expression in prediabetic rats with impaired glucose tolerance (IGT) and relationship between MIF and GRK2 expression in H9C2 cardiomyoblasts exposed to high glucose. Results: Compared with healthy subjects, patients with diabetes have significantly increased levels of plasma MIF which was further increased in diabetic patients with Left ventricular diastolic dysfunction (LVDD). The increased plasma MIF levels in diabetic patients correlated with plasma glucose, glycosylated hemoglobin and urine albumin levels. We observed a significant number of TUNEL-positive cells in the myocardium of IGT-rats but not in the control rats. Moreover, we found higher MIF expression in the heart of IGT with cardiac dysfunction compared to that of the controls. In H9C2 cardiomyoblast cells, MIF and GRK2 expression was significantly increased in a glucose concentration-dependant manner. Furthermore, GRK2 expression was abolished by siRNA knockdown of MIF and by the inhibition of CXCR4 in H9C2 cells. Conclusions: Our findings indicate that hyperglycemia is a causal factor for increased levels of pro-inflammatory cytokine MIF which plays a role in the development of cardiomyopathy occurring in patients with type 2 diabetes. The elevated levels of MIF are associated with cardiac dysfunction in diabetic patients, and the MIF effects are mediated by GRK2.	[Yu, Xi-Yong; Chen, Hong-Mei; Liang, Jia-Liang; Lin, Qiu-Xiong; Tan, Hong-Hong; Fu, Yong-Heng; Liu, Xiao-Ying; Shan, Zhi-Xin; Li, Xiao-Hong; Yang, Min; Lin, Shu-Guang] Guangdong Acad Med Sci, Guangdong Gen Hosp, Guangdong Prov Cardiovasc Inst, Med Res Ctr, Guangzhou, Guangdong, Peoples R China; [Chen, Hong-Mei; Yang, Hua-Zhang] Guangdong Acad Med Sci, Guangdong Gen Hosp, Div Endocrinol, Guangzhou, Guangdong, Peoples R China; [Li, Yangxin] Texas Heart Inst, Houston, TX 77025 USA; [Li, Yangxin] Univ Texas Hlth Sci Ctr, Houston, TX USA	Guangdong Academy of Medical Sciences & Guangdong General Hospital; Guangdong Academy of Medical Sciences & Guangdong General Hospital; Texas Heart Institute; University of Texas System; University of Texas Health Science Center Houston	Yu, XY (corresponding author), Guangdong Acad Med Sci, Guangdong Gen Hosp, Guangdong Prov Cardiovasc Inst, Med Res Ctr, Guangzhou, Guangdong, Peoples R China.	yuxycn@hotmail.com; yangxin_li@yahoo.com; yuxycn@163.com	LIANG, JIALIANG/L-5865-2015	LIANG, JIALIANG/0000-0001-8033-741X; Liang, Jialiang/0000-0002-1556-7195	National Natural Science Foundation of China [30772142, 81070103, 81070102, 30900610]; National Key Basic Research Program (NKBRP) of China [2006CB503806]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program (NKBRP) of China(National Basic Research Program of China)	This work was supported by grants from the National Natural Science Foundation of China (Nos. 30772142, 81070103, 81070102, 30900610) and the National Key Basic Research Program (NKBRP) of China (No. 2006CB503806). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An D, 2006, AM J PHYSIOL-HEART C, V291, pH1489, DOI 10.1152/ajpheart.00278.2006; Bacha F, 2009, DIABETES CARE, V32, P100, DOI 10.2337/dc08-1030; Bartels ED, 2009, EUR J CLIN INVEST, V39, P190, DOI 10.1111/j.1365-2362.2009.02086.x; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; Boyer JK, 2004, AM J CARDIOL, V93, P870, DOI 10.1016/j.amjcard.2003.12.026; Burger-Kentischer A, 2002, CIRCULATION, V105, P1561, DOI 10.1161/01.CIR.0000012942.49244.82; Dandona P, 2004, J CLIN ENDOCR METAB, V89, P5043, DOI 10.1210/jc.2004-0436; Dhanantwari P, 2008, BIOCHEM BIOPH RES CO, V371, P298, DOI 10.1016/j.bbrc.2008.04.070; Garner LB, 2003, AM J PHYSIOL-HEART C, V285, pH2500, DOI 10.1152/ajpheart.00432.2003; Grandi AM, 2006, AM J CARDIOL, V97, P71, DOI 10.1016/j.amjcard.2005.07.110; Hansen JL, 2006, TRENDS CARDIOVAS MED, V16, P169, DOI 10.1016/j.tcm.2006.03.004; Herder C, 2006, DIABETES CARE, V29, P368, DOI 10.2337/diacare.29.02.06.dc05-1474; Liang JL, 2010, CLIN EXP PHARMACOL P, V37, P969, DOI 10.1111/j.1440-1681.2010.05420.x; Mandrup-Poulsen T, 2003, BIOCHEM PHARMACOL, V66, P1433, DOI 10.1016/S0006-2952(03)00494-5; Morand EF, 2006, NAT REV DRUG DISCOV, V5, P399, DOI 10.1038/nrd2029; Noels H, 2009, TRENDS CARDIOVAS MED, V19, P76, DOI 10.1016/j.tcm.2009.05.002; O'Keefe JH, 2007, AM J CARDIOL, V100, P899, DOI 10.1016/j.amjcard.2007.03.107; Pan JH, 2004, CIRCULATION, V109, P3149, DOI 10.1161/01.CIR.0000134704.84454.D2; Park TS, 2008, J LIPID RES, V49, P2101, DOI 10.1194/jlr.M800147-JLR200; Penela P, 2006, CARDIOVASC RES, V69, P46, DOI 10.1016/j.cardiores.2005.09.011; Penela P, 2003, CELL SIGNAL, V15, P973, DOI 10.1016/S0898-6568(03)00099-8; Poirier P, 2001, DIABETES CARE, V24, P5, DOI 10.2337/diacare.24.1.5; Schober A, 2004, CIRCULATION, V109, P380, DOI 10.1161/01.CIR.0000109201.72441.09; Suys BE, 2004, DIABETES CARE, V27, P1947, DOI 10.2337/diacare.27.8.1947; Takahashi M, 2001, CARDIOVASC RES, V52, P438, DOI 10.1016/S0008-6363(01)00408-4; Tevaearai HT, 2004, TRENDS CARDIOVAS MED, V14, P252, DOI 10.1016/j.tcm.2004.07.002; Tripathy D, 2003, DIABETES, V52, P2882, DOI 10.2337/diabetes.52.12.2882; Verschuren L, 2009, CIRC RES, V105, P99, DOI 10.1161/CIRCRESAHA.109.199166; Willis MS, 2005, AM J PHYSIOL-HEART C, V288, pH795, DOI 10.1152/ajpheart.00189.2004; Yabunaka N, 2000, DIABETES CARE, V23, P256, DOI 10.2337/diacare.23.2.256; Yu XY, 2008, BIOCHEM BIOPH RES CO, V376, P548, DOI 10.1016/j.bbrc.2008.09.025; Yu XY, 2007, J INTERF CYTOK RES, V27, P103, DOI 10.1089/jir.2006.0054	32	81	84	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e16239	10.1371/journal.pone.0016239	http://dx.doi.org/10.1371/journal.pone.0016239			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712IZ	22163012	Green Submitted, gold, Green Published			2022-12-27	WOS:000286661400038
J	Zhang, LJ; Xi, J; Xu, GQ; Shu, H; Wang, XY; Li, P				Zhang, Linjun; Xi, Jie; Xu, Guoqing; Shu, Hua; Wang, Xiaoyi; Li, Ping			Cortical Dynamics of Acoustic and Phonological Processing in Speech Perception	PLOS ONE			English	Article							HUMAN AUDITORY-CORTEX; TOP-DOWN INFLUENCES; HIERARCHICAL ORGANIZATION; INTELLIGIBLE SPEECH; MECHANISMS; PITCH; NEUROANATOMY; INFORMATION; MODULATION; NETWORKS	In speech perception, a functional hierarchy has been proposed by recent functional neuroimaging studies: Core auditory areas on the dorsal plane of superior temporal gyrus (STG) are sensitive to basic acoustic characteristics, whereas downstream regions, specifically the left superior temporal sulcus (STS) and middle temporal gyrus (MTG) ventral to Heschl's gyrus (HG) are responsive to abstract phonological features. What is unclear so far is the relationship between the dorsal and ventral processes, especially with regard to whether low-level acoustic processing is modulated by high-level phonological processing. To address the issue, we assessed sensitivity of core auditory and downstream regions to acoustic and phonological variations by using within-and across-category lexical tonal continua with equal physical intervals. We found that relative to within-category variation, across-category variation elicited stronger activation in the left middle MTG (mMTG), apparently reflecting the abstract phonological representations. At the same time, activation in the core auditory region decreased, resulting from the top-down influences of phonological processing. These results support a hierarchical organization of the ventral acoustic-phonological processing stream, which originates in the right HG/STG and projects to the left mMTG. Furthermore, our study provides direct evidence that low-level acoustic analysis is modulated by high-level phonological representations, revealing the cortical dynamics of acoustic and phonological processing in speech perception. Our findings confirm the existence of reciprocal progression projections in the auditory pathways and the roles of both feed-forward and feedback mechanisms in speech perception.	[Zhang, Linjun; Xi, Jie; Shu, Hua] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Zhang, Linjun] Beijing Language & Culture Univ, Coll Chinese Studies, Beijing, Peoples R China; [Xi, Jie] Chinese Acad Sci, Inst Psychol, Beijing 100101, Peoples R China; [Xu, Guoqing] Dalian Med Univ, Dept Psychol, Dalian, Peoples R China; [Wang, Xiaoyi] Capital Med Univ, Xuanwu Hosp, Dept Radiol, Beijing, Peoples R China; [Li, Ping] Penn State Univ, Dept Psychol, University Pk, PA 16802 USA; [Li, Ping] Penn State Univ, Ctr Language Sci, University Pk, PA 16802 USA	Beijing Normal University; Beijing Language & Culture University; Chinese Academy of Sciences; Institute of Psychology, CAS; Dalian Medical University; Capital Medical University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Zhang, LJ (corresponding author), Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China.	shuh@bnu.edu.cn; pul8@psu.edu	; Speicher, Andreas/B-3134-2014	Li, Ping/0000-0002-3314-943X; Speicher, Andreas/0000-0001-6608-3994; Lin, Jinxing/0000-0001-9338-1356	Program for Changjiang Scholars and Innovative Research Team in University [IRT0710]; Natural Science Foundation of China [30870758]; Natural Science Foundation of Beijing [7092051]; Fund for Foreign Scholars in University Research and Teaching Programs [B07008]	Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Beijing(Beijing Natural Science Foundation); Fund for Foreign Scholars in University Research and Teaching Programs	The research was supported by the Program for Changjiang Scholars and Innovative Research Team in University (IRT0710, http://www.cksp.edu.cn/index.php), by grants from the Natural Science Foundation of China (30870758, http://www.nsfc.gov.cn/Portal0/default124.htm), by grants from the Natural Science Foundation of Beijing (7092051, http://www.bjnsf.org/) to HS, and the Fund for Foreign Scholars in University Research and Teaching Programs (B07008, http://www.bjnsf.org/) to PL and HS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bendor D, 2006, CURR OPIN NEUROBIOL, V16, P391, DOI 10.1016/j.conb.2006.07.001; Binder J, 2000, BRAIN, V123, P2371, DOI 10.1093/brain/123.12.2371; Brechmann A, 2005, CEREB CORTEX, V15, P578, DOI 10.1093/cercor/bhh159; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Dehaene-Lambertz G, 2005, NEUROIMAGE, V24, P21, DOI 10.1016/j.neuroimage.2004.09.039; Gandour J, 2004, NEUROIMAGE, V23, P344, DOI 10.1016/j.neuroimage.2004.06.004; Gilbert CD, 2007, NEURON, V54, P677, DOI 10.1016/j.neuron.2007.05.019; Hesling I, 2005, NEUROIMAGE, V24, P937, DOI 10.1016/j.neuroimage.2004.11.003; Hickok G, 2004, COGNITION, V92, P67, DOI 10.1016/j.cognition.2003.10.011; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; Humphries C, 2005, HUM BRAIN MAPP, V26, P128, DOI 10.1002/hbm.20148; Joanisse MF, 2007, CEREB CORTEX, V17, P2084, DOI 10.1093/cercor/bhl124; Li W, 2004, NAT NEUROSCI, V7, P651, DOI 10.1038/nn1255; Liebenthal E, 2005, CEREB CORTEX, V15, P1621, DOI 10.1093/cercor/bhi040; Liebenthal E, 2010, CEREB CORTEX, V20, P2958, DOI 10.1093/cercor/bhq045; Meyer M, 2004, BRAIN LANG, V89, P277, DOI 10.1016/S0093-934X(03)00350-X; Naatanen R, 1997, NATURE, V385, P432, DOI 10.1038/385432a0; Narain C, 2003, CEREB CORTEX, V13, P1362, DOI 10.1093/cercor/bhg083; Obleser J, 2007, CEREB CORTEX, V17, P2251, DOI 10.1093/cercor/bhl133; Okada K, 2010, CEREB CORTEX, V20, P2486, DOI 10.1093/cercor/bhp318; Patterson RD, 2002, NEURON, V36, P767, DOI 10.1016/S0896-6273(02)01060-7; Rinne T, 2009, J NEUROSCI, V29, P13338, DOI 10.1523/JNEUROSCI.3012-09.2009; Rogalsky C, 2009, CEREB CORTEX, V19, P786, DOI 10.1093/cercor/bhn126; Schofield TM, 2009, P NATL ACAD SCI USA, V106, P11765, DOI 10.1073/pnas.0811402106; Scott SK, 2004, COGNITION, V92, P13, DOI 10.1016/j.cognition.2002.12.002; Scott SK, 2000, BRAIN, V123, P2400, DOI 10.1093/brain/123.12.2400; Scott SK, 2006, J ACOUST SOC AM, V120, P1075, DOI 10.1121/1.2216725; Shulman GL, 1997, CEREB CORTEX, V7, P193, DOI 10.1093/cercor/7.3.193; Sussman E, 2002, COGNITIVE BRAIN RES, V13, P393, DOI 10.1016/S0926-6410(01)00131-8; Talairach J., 1988, COPLANAR STEREOTAXIC; Tervaniemi M, 2000, HUM BRAIN MAPP, V10, P74, DOI 10.1002/(SICI)1097-0193(200006)10:2<74::AID-HBM30>3.0.CO;2-2; Tervaniemi M, 2006, J NEUROSCI, V26, P8647, DOI 10.1523/JNEUROSCI.0995-06.2006; Wessinger CM, 2001, J COGNITIVE NEUROSCI, V13, P1, DOI 10.1162/089892901564108; Xi J, 2010, NEUROSCIENCE, V170, P223, DOI 10.1016/j.neuroscience.2010.06.077; ZATORRE RJ, 1994, J NEUROSCI, V14, P1908, DOI 10.1523/jneurosci.14-04-01908.1994; Zhang LJ, 2010, HUM BRAIN MAPP, V31, P1106, DOI 10.1002/hbm.20922	36	344	349	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2011	6	6							e20963	10.1371/journal.pone.0020963	http://dx.doi.org/10.1371/journal.pone.0020963			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777ZG	22163016	Green Submitted, gold, Green Published			2022-12-27	WOS:000291663300033
